Phenotypic	O
analysis	O
demonstrates	O
that	O
trio	B
and	O
Abl	B
cooperate	O
in	O
regulating	O
axon	O
outgrowth	O
in	O
the	O
embryonic	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
.	O

We	O
measured	O
electromyograms	O
(	O
EMG	O
)	O
of	O
the	O
alae	O
nasi	O
to	O
determine	O
the	O
relationship	O
between	O
their	O
activity	O
and	O
timing	O
to	O
contraction	O
of	O
the	O
rib	O
cage	O
muscles	O
and	O
diaphragm	O
during	O
obstructive	O
apnea	O
in	O
nine	O
patients	O
.	O

However	O
the	O
precise	O
function	O
of	O
DNA	B
-	I
PK	I
in	O
DNA	O
double	O
-	O
strand	O
break	O
repair	O
is	O
not	O
known	O
.	O

The	O
COR	B
biosynthetic	O
gene	O
cluster	O
in	O
P.	O
syringae	O
pv	O
.	O

glycinea	O
PG4180	O
is	O
encoded	O
by	O
a	O
32-kb	O
region	O
which	O
contains	O
both	O
the	O
structural	O
and	O
regulatory	O
genes	O
needed	O
for	O
COR	B
synthesis	O
.	O

FEurea	O
was	O
also	O
measured	O
during	O
stable	O
graft	O
function	O
,	O
7	O
-	O
14	O
days	O
prior	O
to	O
allograft	O
dysfunction	O
.	O

On	O
the	O
other	O
hand	O
hypokalemia	O
,	O
induced	O
by	O
diuretics	O
,	O
may	O
also	O
be	O
accompanied	O
by	O
a	O
significant	O
depletion	O
of	O
total	O
body	O
K	O
,	O
bringing	O
about	O
more	O
general	O
consequences	O
.	O

We	O
present	O
here	O
the	O
complete	O
primary	O
structure	O
of	O
human	B
gp330	I
,	O
the	O
human	O
variant	O
of	O
the	O
principal	O
kidney	O
autoantigen	O
causing	O
Heymann	O
membranous	O
glomerulonephritis	O
in	O
rats	O
.	O

A	O
series	O
of	O
deletion	O
mutants	O
was	O
expressed	O
transiently	O
in	O
two	O
human	O
hepatocytes	O
,	O
HepG2	O
and	O
PLC	O
.	O

Biol	O
.	O

The	O
P	B
-	I
ITIM	I
-	I
compelled	I
multi	I
-	I
phosphoprotein	I
complex	I
binds	O
to	O
and	O
activates	O
SHP-2	B
,	O
which	O
in	O
turn	O
dephosphorylates	O
SHIP	B
and	O
Shc	B
and	O
probably	O
other	O
substrates	O
.	O

cDNA	O
cloning	O
and	O
transcriptional	O
properties	O
of	O
a	O
novel	O
GC	B
box	I
-	I
binding	I
protein	I
,	O
BTEB2	B
.	O

Of	O
81	O
girls	O
cured	O
from	O
the	O
bacteriuria	O
24	O
recurred	O
,	O
5	O
with	O
a	O
symptomatic	O
pyelonephritis	O
and	O
3	O
with	O
cystitis	O
.	O

Partial	O
hepatectomy	O
in	O
metastatic	O
Wilms	O
'	O
tumor	O
.	O

MRS	O
allowed	O
the	O
differentiation	O
of	O
the	O
following	O
metabolites	O
in	O
5	O
patients	O
:	O
N	O
-	O
acetyl	O
-	O
aspartate	O
(	O
NAA	O
)	O
,	O
creatine	O
and	O
phosphocreatine	O
,	O
phosphorylcholine	O
and	O
glycerophosphorylcholine	O
,	O
beta-	O
and	O
gamma	O
-	O
glutamate	O
(	O
GLU	O
)	O
.	O

Studies	O
of	O
fetal	O
maturity	O

A	O
comparison	O
of	O
the	O
rate	O
of	O
recovery	O
and	O
time	O
for	O
detection	O
of	O
mycobacteria	O
from	O
clinical	O
specimens	O
of	O
the	O
newly	O
developed	O
Mycobacteria	O
Growth	O
Indicator	O
Tube	O
(	O
MGIT	O
)	O
,	O
the	O
biphasic	O
Septi	O
-	O
Chek	O
,	O
and	O
the	O
egg	O
-	O
based	O
Ogawa	O
medium	O
was	O
made	O
.	O

A	O
clinical	O
study	O
.	O

Thirty	O
-	O
five	O
pts	O
were	O
transplanted	O
for	O
constitutional	O
disease	O
:	O
Fanconi	O
anemia	O
(	O
FA	O
)	O
(	O
26	O
pts	O
)	O
,	O
Dyskeratosis	O
congenita	O
(	O
2	O
pts	O
)	O
,	O
Blackfan	O
-	O
Diamond	O
erythroblastopenia	O
(	O
2	O
pts	O
)	O
,	O
Glanzmann	O
thrombasthenia	O
(	O
1	O
pt	O
)	O
,	O
osteopetrosis	O
(	O
1	O
pt	O
)	O
and	O
Gaucher	O
's	O
disease	O
(	O
1	O
pt	O
)	O
.	O

Using	O
the	O
same	O
approach	O
we	O
have	O
shown	O
that	O
hFIRE	B
binds	O
the	O
stimulatory	O
proteins	O
Sp1	B
and	O
Sp3	B
in	O
addition	O
to	O
CBF	B
.	O

Cellular	O
fractionation	O
and	O
Percoll	O
gradient	O
centrifugation	O
combined	O
with	O
immunoblotting	O
show	O
that	O
p67	B
cofractionates	O
with	O
nuclei	O
and	O
is	O
enriched	O
in	O
resistant	O
structure	O
that	O
is	O
insoluble	O
in	O
2	O
M	O
NaCl	O
,	O
25	O
mM	O
lithium	O
3,5'-diiodosalicylate	O
,	O
and	O
1	O
%	O
Triton	O
but	O
is	O
soluble	O
in	O
8	O
M	O
urea	O
.	O

Gene	O
expression	O
is	O
in	O
part	O
controlled	O
by	O
chromatin	O
remodeling	O
factors	O
and	O
the	O
acetylation	O
state	O
of	O
nucleosomal	B
histones	I
.	O

Corticosteroid	O
treatment	O
before	O
,	O
during	O
,	O
or	O
after	O
fludarabine	O
treatment	O
in	O
patients	O
with	O
alkylator	O
-	O
resistant	O
,	O
low	O
-	O
grade	O
lymphoid	O
malignancies	O
who	O
have	O
not	O
received	O
PCP	O
prophylaxis	O
is	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
opportunistic	O
pulmonary	O
infections	O
.	O

Here	O
we	O
demonstrate	O
that	O
several	O
genes	O
associated	O
with	O
NHEJ	O
perform	O
essential	O
functions	O
in	O
the	O
repair	O
of	O
endonuclease	O
-	O
induced	O
DSBs	O
in	O
vivo	O
.	O

The	O
primary	O
structure	O
of	O
cholesterol	B
esterase	I
displayed	O
no	O
significant	O
homology	O
with	O
other	O
lipases	B
,	O
although	O
the	O
putative	O
lipid	O
interfacial	O
recognition	O
site	O
of	O
G	O
-	O
X	O
-	O
S	O
-	O
X	O
-	O
G	O
is	O
present	O
in	O
the	O
cholesterol	B
esterase	I
sequence	I
.	O

Subtype-	O
and	O
response	O
element	O
-	O
dependent	O
differences	O
in	O
transactivation	O
by	O
peroxisome	B
proliferator	I
-	I
activated	I
receptors	I
alpha	I
and	I
gamma	I
.	O

Monoclonal	O
antibodies	O
to	O
the	O
hapten	O
phenyloxazolone	O
were	O
raised	O
7	O
days	O
after	O
immunization	O
in	O
mice	O
of	O
six	O
strains	O
(	O
BALB	O
/	O
c	O
,	O
C57BL	O
-	O
Igha	O
,	O
DBA2	O
,	O
RF	O
,	O
A	O
/	O
J	O
,	O
and	O
CE	O
)	O
.	O

Although	O
the	O
QT	O
duration	O
was	O
higher	O
(	O
p	O
=	O
0.0001	O
)	O
at	O
night	O
,	O
the	O
beat	O
-	O
to	O
-	O
beat	O
variability	O
of	O
this	O
interval	O
was	O
lower	O
:	O
in	O
the	O
time	O
domain	O
(	O
decreased	O
standard	O
deviation	O
,	O
p	O
=	O
0.0005	O
)	O
,	O
in	O
the	O
frequency	O
domain	O
(	O
decreased	O
low	O
-	O
frequency	O
power	O
of	O
the	O
spectra	O
,	O
p	O
=	O
0.004	O
)	O
,	O
and	O
the	O
chaotic	O
domain	O
(	O
tighter	O
clustering	O
of	O
the	O
points	O
in	O
the	O
Poincare	O
plots	O
)	O
.	O

J.	O

We	O
have	O
earlier	O
proposed	O
that	O
CG	O
rich	O
sequences	O
resembling	O
CpG	O
islands	O
,	O
which	O
are	O
associated	O
with	O
many	O
imprinted	O
genes	O
and	O
often	O
subject	O
to	O
parental	O
-	O
specific	O
methylation	O
,	O
could	O
act	O
as	O
a	O
common	O
imprinting	O
element	O
.	O

Electrophoretic	O
mobility	O
-	O
shift	O
assays	O
showed	O
a	O
rapid	O
induction	O
of	O
nuclear	O
proteins	O
that	O
bound	O
to	O
the	O
consensus	B
kappa	I
B	I
motif	I
.	O

The	O
thalamic	O
SD	O
was	O
regularly	O
triggered	O
by	O
short	O
(	O
0.02	O
-	O
0.05	O
s	O
)	O
high	O
-	O
frequency	O
(	O
200	O
-	O
500	O
Hz	O
)	O
ES	O
of	O
the	O
parietal	O
cortical	O
surface	O
.	O

Genetic	O
analysis	O
places	O
CWH43	B
upstream	O
of	O
the	O
BCK2	B
branch	O
of	O
the	O
PKC1	B
signalling	O
pathway	O
,	O
since	O
cwh43	B
mutations	O
were	O
synthetic	O
lethal	O
with	O
pkc1	B
deletion	O
,	O
whereas	O
the	O
cwh43	B
defects	O
could	O
be	O
rescued	O
by	O
overexpression	O
of	O
BCK2	B
and	O
not	O
by	O
high	O
-	O
copy	O
-	O
number	O
expression	O
of	O
genes	O
encoding	O
downstream	O
proteins	O
of	O
the	O
PKC1	B
pathway	O
However	O
,	O
unlike	O
BCK2	B
,	O
whose	O
disruption	O
in	O
a	O
cln3	B
mutant	I
resulted	O
in	O
growth	O
arrest	O
in	O
G	O
(	O
1	O
)	O
,	O
no	O
growth	O
defect	O
was	O
observed	O
in	O
a	O
double	O
cwh43	B
cln3	B
mutants	I
.	O

Expression	O
of	O
the	O
E2	B
protein	I
resulted	O
in	O
rapid	O
repression	O
of	O
HPV	B
E6	I
and	O
E7	B
expression	O
,	O
followed	O
approximately	O
12	O
h	O
later	O
by	O
profound	O
inhibition	O
of	O
cellular	O
DNA	O
synthesis	O
.	O

Peak	O
reactive	O
hyperemia	O
(	O
mL.min-1.100	O
mL-1	O
)	O
was	O
determined	O
in	O
the	O
calf	O
and	O
forearm	O
immediately	O
before	O
and	O
after	O
12	O
weeks	O
of	O
training	O
.	O

The	O
hematopoietic	O
form	O
of	O
PTPN6	B
transcript	I
is	O
initiated	O
at	O
a	O
downstream	O
promoter	O
separated	O
by	O
7	O
kb	O
from	O
the	O
first	O
.	O

Reversal	O
of	O
biliary	O
sphincter	O
spasm	O
with	O
low	O
dose	O
glucagon	B
during	O
operative	O
cholangiography	O
.	O

In	O
ten	O
other	O
endotoxin	O
-	O
albumin	B
-	O
treated	O
pigs	O
PGE1	O
infusion	O
(	O
0.25	O
micrograms	O
X	O
kg-1	O
X	O
min-1	O
)	O
was	O
begun	O
after	O
established	O
pulmonary	O
and	O
cardiovascular	O
dysfunction	O
,	O
for	O
closer	O
mimicking	O
of	O
clinical	O
use	O
.	O

In	O
particular	O
,	O
MF	O
males	O
receiving	O
either	O
a	O
5.0-mg	O
/	O
kg	O
CDP	O
dose	O
or	O
a	O
3.0-mg	O
/	O
kg	O
RO	O
dose	O
explored	O
the	O
object	O
more	O
often	O
than	O
MM	O
males.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

A	O
single	O
HD	O
session	O
using	O
cellulose	O
triacetate	O
or	O
polysulfone	O
membrane	O
significantly	O
increased	O
water	O
content	O
both	O
at	O
forearm	O
and	O
lower	O
leg	O
(	O
p<0.05	O
)	O
.	O

In	O
the	O
yeast	O
two	O
-	O
hybrid	O
assays	O
,	O
PNRC	B
interacted	O
with	O
the	O
orphan	O
receptors	O
SF1	B
and	O
ERRalpha1	B
in	O
a	O
ligand	O
-	O
independent	O
manner	O
.	O

Further	O
,	O
we	O
will	O
review	O
our	O
evaluation	O
of	O
the	O
survival	O
rate	O
and	O
prognostic	O
factors	O
for	O
9,262	O
patients	O
from	O
1981	O
to	O
1996	O
.	O

The	O
results	O
were	O
subjected	O
to	O
analysis	O
of	O
23	O
autopsies	O
carried	O
out	O
in	O
children	O
dying	O
of	O
intoxication	O
with	O
Amanita	O
phalloides	O
.	O

Microscopic	O
examination	O
of	O
these	O
colonies	O
showed	O
a	O
high	O
percentage	O
of	O
histiocytes	O
identical	O
to	O
those	O
seen	O
in	O
the	O
patient	O
's	O
bone	O
marrow	O
.	O

Additional	O
genetic	O
analyses	O
described	O
herein	O
suggest	O
that	O
Skb1	B
is	O
a	O
component	O
of	O
the	O
morphology	O
control	O
branch	O
of	O
the	O
Ras	B
signaling	O
cascade	O
in	O
S.	O
pombe	O
and	O
that	O
it	O
positively	O
modulates	O
Shk1	B
function	O
.	O

Transient	O
transfection	O
assays	O
indicated	O
that	O
the	O
(	O
-4551	O
)	O
UCP1-CAT	B
construct	O
,	O
containing	O
the	O
5'-regulatory	O
region	O
of	O
the	O
rat	B
ucp-1	I
gene	I
,	O
was	O
activated	O
by	O
PPARalpha	B
co	O
-	O
transfection	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
and	O
this	O
activation	O
was	O
potentiated	O
by	O
Wy	O
14,643	O
and	O
retinoid	B
X	I
receptor	I
alpha	I
.	O

Idealized	O
versus	O
realized	O
overall	O
treatment	O
times	O
.	O

Serum	B
C3	I
was	O
measured	O
in	O
1,282	O
school	O
children	O
with	O
abnormal	O
urinary	O
findings	O
between	O
1980	O
and	O
1997	O
.	O

Tc-99	O
m	O
HMPAO	O
brain	O
SPECT	O
compared	O
to	O
CT	O
and	O
EEG	O
after	O
seizures	O
in	O
childhood	O
.	O

The	O
adenovirus	B
E1B	I
19,000-molecular	I
-	I
weight	I
(	I
19	I
K	I
)	I
protein	I
is	O
a	O
potent	O
inhibitor	O
of	O
apoptosis	O
and	O
cooperates	O
with	O
E1A	B
to	O
transform	O
primary	O
rodent	O
cells	O
.	O

Subclones	O
of	O
R15	O
which	O
reverted	O
to	O
kappa	B
light	I
chain	I
production	O
contained	O
genomic	O
deletions	O
of	O
R15ns	O
and/or	O
the	O
surrounding	O
intron	O
.	O

Region	O
-	O
specific	O
enhancers	O
near	O
two	O
mammalian	B
homeo	I
box	I
genes	I
define	O
adjacent	O
rostrocaudal	O
domains	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Cells	O
were	O
cotransfected	O
with	O
this	O
plasmid	O
,	O
and	O
the	O
appropriate	O
responder	O
plasmids	O
and	O
clonies	O
were	O
selected	O
on	O
the	O
basis	O
of	O
their	O
resistance	O
to	O
Geneticin	O
(	O
via	O
the	O
neomycin	B
aminoglycoside	I
phosphotransferase	I
gene	I
)	O
.	O

To	O
clone	O
cDNAs	O
for	O
the	O
beta	O
subunit	O
of	O
rabbit	B
eIF-2B	I
,	O
amino	O
acid	O
sequence	O
data	O
was	O
first	O
obtained	O
and	O
used	O
to	O
design	O
redundant	O
oligonucleotide	O
primers	O
for	O
use	O
in	O
PCR	O
.	O

Deletion	O
analysis	O
of	O
the	O
3.5	O
kb	O
DNA	O
fragment	O
revealed	O
that	O
the	O
region	O
between	O
-125	O
to	O
+	O
1	O
,	O
containing	O
a	O
single	O
Sp1	B
binding	I
site	I
,	O
is	O
essential	O
for	O
transcription	O
of	O
the	O
embigin	B
gene	I
.	O

By	O
applying	O
a	O
sufficiently	O
strong	O
crusher	O
gradient	O
in	O
the	O
EPI	O
pulse	O
sequence	O
,	O
the	O
temporal	O
variation	O
induced	O
by	O
SSFP	O
disturbance	O
can	O
be	O
suppressed	O
due	O
to	O
diffusion	O
.	O

The	O
cdc42W97R	B
temperature	I
-	I
sensitive	I
allele	I
in	O
S.	O
cerevisiae	O
displayed	O
the	O
same	O
cell	O
-	O
division	O
-	O
cycle	O
arrest	O
phenotype	O
(	O
large	O
,	O
round	O
unbudded	O
cells	O
)	O
as	O
the	O
cdc42	B
-	I
1ts	I
mutant	I
.	O

Wolf	O
-	O
Hirschhorn	O
syndrome	O
(	O
WHS	O
)	O
is	O
a	O
malformation	O
syndrome	O
associated	O
with	O
a	O
hemizygous	O
deletion	O
of	O
the	O
distal	O
short	O
arm	O
of	O
chromosome	O
4	O
(	O
4p16.3	O
)	O
.	O

To	O
address	O
this	O
question	O
with	O
respect	O
to	O
skeletal	O
muscle	O
,	O
we	O
have	O
examined	O
the	O
effects	O
of	O
the	O
Providence	O
mutation	O
in	O
cultured	O
muscle	O
cells	O
,	O
after	O
adoptive	O
gene	O
transfer	O
to	O
adult	O
mice	O
,	O
and	O
in	O
two	O
infants	O
homozygous	O
for	O
spectrin	B
Providence	I
.	O

Adenovirus	O
-	O
mediated	O
gene	O
transfer	O
of	O
MMAC1	B
/	O
PTEN	B
to	O
glioblastoma	O
cells	O
inhibits	O
S	O
phase	O
entry	O
by	O
the	O
recruitment	O
of	O
p27Kip1	B
into	O
cyclin	B
E	I
/	O
CDK2	B
complexes	O
.	O

Increasing	O
insulin	B
sensitivity	O
in	O
type	O
I	O
diabetic	O
patients	O
should	O
alert	O
clinicians	O
to	O
the	O
possibility	O
of	O
glucocorticoid	O
deficiency	O
.	O

Experiment	O
B	O
:	O
Clinical	O
,	O
biochemical	O
,	O
and	O
histological	O
variables	O
were	O
measured	O
over	O
a	O
12-day	O
period	O
after	O
the	O
zymosan	O
had	O
been	O
given	O
.	O

Lesions	O
of	O
this	O
kind	O
resemble	O
those	O
in	O
vitamin	O
A	O
-	O
deficient	O
chickens	O
and	O
are	O
the	O
first	O
to	O
be	O
induced	O
by	O
excess	O
vitamin	O
E.	O

Spinophilin	B
,	O
a	O
novel	O
protein	B
phosphatase	I
1	I
binding	I
protein	I
localized	O
to	O
dendritic	O
spines	O
.	O

The	O
Htf9-a	B
gene	I
encodes	O
the	O
RanBP1	B
protein	I
,	O
a	O
major	O
partner	O
of	O
the	O
Ran	B
GTPase	I
.	O

Membrane	O
extraction	O
has	O
been	O
interfaced	O
with	O
gas	O
chromatography	O
and	O
mass	O
spectroscopy	O
for	O
the	O
analysis	O
of	O
volatile	O
organics	O
in	O
water	O
.	O

More	O
than	O
80	O
%	O
appropriate	O
lever	O
responding	O
was	O
established	O
after	O
27	O
,	O
38	O
and	O
44	O
daily	O
training	O
sessions	O
with	O
DN-2327	O
,	O
diazepam	O
and	O
PTZ	O
,	O
respectively	O
,	O
as	O
the	O
training	O
drug	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
investigated	O
the	O
effects	O
of	O
SDZ	O
ENA	O
713	O
on	O
spatial	O
learning	O
deficits	O
in	O
aged	O
rats	O
.	O

One	O
of	O
the	O
major	O
transcripts	O
encodes	O
MEQ	B
,	O
a	O
339-amino	O
-	O
acid	O
bZIP	B
protein	I
which	O
is	O
homologous	O
to	O
the	O
Jun	B
/	O
Fos	B
family	O
of	O
transcription	O
factors	O
.	O

An	O
identical	O
polypeptide	O
was	O
detected	O
by	O
Western	O
blot	O
analysis	O
of	O
K1F	O
virions	O
.	O

The	O
predictive	O
value	O
of	O
the	O
remotely	O
sensed	O
map	O
based	O
on	O
NDVI	O
data	O
appears	O
to	O
be	O
better	O
than	O
that	O
from	O
forecast	O
indices	O
based	O
only	O
on	O
climatic	O
data	O
.	O

The	O
concentration	O
of	O
vitamin	O
B1	O
,	O
B2	O
and	O
B6	O
are	O
found	O
to	O
be	O
9.96	O
,	O
9.92	O
and	O
3.01	O
mg	O
,	O
respectively	O
in	O
240	O
mg	O
of	O
capsule	O
powder	O
of	O
a	O
standard	O
company	O
(	O
name	O
has	O
not	O
been	O
disclosed	O
due	O
to	O
secrecy	O
purpose	O
)	O
.	O

We	O
have	O
shown	O
that	O
the	O
human	O
cell	O
MRC	O
closely	O
resembles	O
the	O
murine	O
cell	O
MRC	O
,	O
in	O
both	O
its	O
protein	O
composition	O
and	O
its	O
fractionation	O
and	O
chromatographic	O
profile	O
.	O

Red	O
blood	O
cell	O
binding	O
of	O
99mTc	O
-	O
EC	O
and	O
131I	O
-	O
OIH	O
was	O
6.1	O
%	O
and	O
20	O
%	O
,	O
respectively	O
.	O

To	O
identify	O
the	O
GRK6	B
homologue	I
on	O
chromsome	O
13	O
,	O
several	O
sets	O
of	O
closely	O
-	O
spaced	O
primers	O
were	O
designed	O
based	O
on	O
the	O
GRK6	B
cDNA	I
sequence	I
and	O
then	O
used	O
to	O
amplify	O
human	O
genomic	O
DNA	O
by	O
PCR	O
.	O

During	O
the	O
burst	O
period	O
(	O
approximately	O
5	O
-	O
10	O
min	O
)	O
,	O
local	O
blood	O
H2O2	O
concentrations	O
and	O
xanthine	B
oxidase	I
activities	O
were	O
highly	O
correlated	O
(	O
r	O
=	O
0.999	O
)	O
.	O

This	O
mutant	O
also	O
functions	O
in	O
vivo	O
as	O
a	O
trans	O
-	O
acting	O
dominant	O
negative	O
regulator	O
:	O
the	O
transcriptional	O
inducibility	O
of	O
the	O
HIV	B
long	I
terminal	I
repeat	I
(	O
which	O
contains	O
two	O
potential	O
NF	B
-	I
kappa	I
B	I
binding	I
sites	I
)	O
by	O
phorbol	O
ester	O
(	O
PMA	O
)	O
is	O
inhibited	O
when	O
it	O
is	O
co	O
-	O
transfected	O
into	O
CD4	B
+	I
T	O
cells	O
with	O
the	O
delta	O
SP	O
mutant	O
.	O

We	O
demonstrate	O
that	O
the	O
WRM-1	B
protein	I
binds	O
to	O
LIT-1	B
in	O
vivo	O
and	O
that	O
WRM-1	B
can	O
activate	O
the	O
LIT-1	B
protein	I
kinase	I
when	O
coexpressed	O
in	O
vertebrate	O
tissue	O
culture	O
cells	O
.	O

To	O
assess	O
the	O
safety	O
of	O
the	O
angiotensin	B
converting	I
enzyme	I
inhibitor	O
enalapril	O
a	O
multicenter	O
,	O
open	O
,	O
randomized	O
,	O
prazosin	O
-	O
controlled	O
trial	O
was	O
designed	O
comparing	O
the	O
incidence	O
and	O
severity	O
of	O
symptomatic	O
hypotension	O
on	O
the	O
first	O
day	O
of	O
treatment	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
cloning	O
and	O
sequencing	O
of	O
several	O
overlapping	O
cDNAs	O
encoding	O
approximately	O
4.1	O
kb	O
of	O
the	O
human	B
homologue	I
of	I
Wnt-5A	I
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
in	O
myeloid	O
and	O
B	O
cell	O
extracts	O
,	O
PU.1	B
forms	O
a	O
novel	O
,	O
specific	O
,	O
more	O
slowly	O
migrating	O
complex	O
(	O
PU	B
-	I
SF	I
)	O
when	O
binding	O
the	O
GM	B
-	I
CSF	I
receptor	I
alpha	I
promoter	O
PU.1	B
site	O
.	O

Cytokine	O
inducibility	O
of	O
VCAM1	B
in	O
endothelial	O
cells	O
utilizes	O
the	O
interaction	O
of	O
heterodimeric	O
p50	B
/	O
p65	B
proteins	O
with	O
IRF-1	B
.	O

The	O
cases	O
with	O
terminal	O
forces	O
of	O
left	O
ventricular	O
activation	O
in	O
the	O
same	O
direction	O
as	O
the	O
delta	O
wave	O
,	O
superiorly	O
and	O
to	O
the	O
left	O
at	O
-60	O
degrees	O
or	O
inferiorly	O
and	O
to	O
the	O
right	O
at	O
+	O
120	O
degrees	O
,	O
forming	O
a	O
single	O
deflection	O
of	O
over	O
0,12	O
seconds	O
'	O
duration	O
,	O
are	O
the	O
result	O
of	O
delayed	O
activation	O
of	O
the	O
anterior	O
or	O
posterior	O
fascicle	O
of	O
the	O
left	O
bundle	O
after	O
a	O
long	O
delay	O
.	O

Manifestation	O
of	O
superfluidity	O
in	O
an	O
evolving	O
bose	O
-	O
einstein	O
condensed	O
Gas	O
We	O
study	O
the	O
generation	O
of	O
excitations	O
due	O
to	O
an	O
""""	O
impurity	O
""""	O
(	O
static	O
perturbation	O
)	O
placed	O
into	O
an	O
oscillating	O
Bose	O
-	O
Einstein	O
condensed	O
gas	O
in	O
the	O
time	O
-	O
dependent	O
trapping	O
field	O
.	O

By	O
sequencing	O
of	O
exonuclease	B
III	I
deletion	O
clones	O
an	O
open	O
reading	O
frame	O
of	O
405	O
nucleotides	O
was	O
found	O
coding	O
for	O
a	O
protein	O
of	O
135	O
amino	O
acids	O
with	O
a	O
molecular	O
mass	O
of	O
15	O
kDa	O
.	O

The	O
c	B
-	I
raf-1	I
proto	I
-	I
oncogene	I
is	O
the	O
cellular	B
homologue	I
of	I
v	I
-	I
raf	I
,	O
the	O
oncogene	O
of	O
the	O
acutely	O
transforming	O
retrovirus	O
3611-MSV	O
.	O

Furthermore	O
,	O
we	O
detect	O
hCoch-5B2	B
on	O
three	O
overlapping	O
YACs	O
,	O
two	O
of	O
which	O
also	O
contain	O
one	O
of	O
the	O
markers	O
linked	O
to	O
DFNA9	B
.	O

mCoch-5B2	B
was	O
genetically	O
mapped	O
in	O
the	O
mouse	O
to	O
chromosome	O
12	O
,	O
in	O
a	O
region	O
of	O
homologous	O
synteny	O
with	O
human	O
14q11.2-q13	O
,	O
which	O
contains	O
the	O
asp1	B
(	O
audiogenic	B
seizure	I
prone	I
)	O
locus	O
in	O
the	O
mouse	O
.	O

Reasons	O
are	O
given	O
for	O
suggesting	O
that	O
tiapamil	O
warrants	O
further	O
clinical	O
evaluation	O
,	O
after	O
which	O
it	O
may	O
join	O
the	O
more	O
established	O
calcium	O
antagonists	O
as	O
a	O
valuable	O
therapeutic	O
agent	O
.	O

Histopathologic	O
studies	O
displaying	O
spongiform	O
changes	O
in	O
the	O
gray	O
matter	O
,	O
neuronal	O
loss	O
,	O
and	O
atrogliosis	O
confirmed	O
the	O
clinical	O
diagnosis	O
of	O
Creutzfeldt	O
-	O
Jakob	O
disease	O
.	O

Its	O
activity	O
was	O
twice	O
that	O
of	O
a	O
construct	O
where	O
the	O
CAT	B
gene	I
was	O
driven	O
by	O
the	O
H-2Kb	B
5	I
'	I
enhancer	I
region	I
(	O
H2TF1	B
/	O
KBF1	B
site	O
)	O
and	O
comparable	O
to	O
that	O
of	O
pRSVCAT	O
construct	B
carrying	I
the	I
strong	I
Rous	I
sarcoma	I
virus	I
LTR	I
enhancer	I
.	O

The	O
dipper	O
(	O
RONF	O
of	O
BP	O
(	O
or	O
HR	O
)	O
>	O
or	O
=	O
10	O
%	O
2	O
.	O

I.	O

Nonsuicidal	O
mortality	O
in	O
late	O
-	O
life	O
depression	O
.	O

However	O
,	O
both	O
peptides	O
1	O
-	O
49	O
and	O
63	O
-	O
87	O
bound	O
to	O
PDE	B
alpha	I
/	I
beta	I
in	O
a	O
solid	O
-	O
phase	O
binding	O
assay	O
.	O

SETTING	O
:	O
A	O
private	O
office	O
-	O
based	O
fertility	O
program	O
.	O

The	O
consensus	O
mammalian	O
ER	O
stress	O
response	O
element	O
(	O
ERSE	O
)	O
conserved	O
among	O
grp	B
promoters	I
consists	O
of	O
a	O
tripartite	O
structure	O
CCAAT	O
(	O
N9	O
)	O
CCACG	O
,	O
with	O
N	O
being	O
a	O
strikingly	O
GC	O
-	O
rich	O
region	O
of	O
9	O
bp	O
.	O

Further	O
,	O
we	O
find	O
that	O
the	O
BMI1	B
protein	I
can	O
also	O
interact	O
with	O
itself	O
.	O

These	O
data	O
suggest	O
that	O
certain	O
of	O
the	O
nuclear	O
protein	O
import	O
functions	O
of	O
NTF2	B
and	O
Ran	B
/	O
TC4	B
are	O
closely	O
linked	O
and	O
that	O
NTF2	B
may	O
serve	O
to	O
modulate	O
a	O
transport	O
step	O
involving	O
Ran	B
/	O
TC4	B
.	O

Because	O
controlled	O
-	O
release	O
niacin	O
seems	O
to	O
be	O
more	O
potent	O
than	O
crystalline	O
niacin	O
,	O
product	O
substitution	O
without	O
dose	O
adjustment	O
should	O
be	O
avoided	O
.	O

Expression	O
of	O
the	O
gene	O
encoding	O
transcription	B
factor	I
cyclic	I
adenosine	I
3',5'-monophosphate	I
(	I
cAMP	I
)	I
response	I
element	I
-	I
binding	I
protein	I
(	O
CREB	B
)	O
:	O
regulation	O
by	O
follicle	B
-	I
stimulating	I
hormone	I
-	O
induced	O
cAMP	O
signaling	O
in	O
primary	O
rat	O
Sertoli	O
cells	O
.	O

Comparison	O
of	O
the	O
therapeutic	O
effectiveness	O
of	O
membrane	O
and	O
centrifugation	O
plasmapheresis	O

To	O
investigate	O
the	O
effect	O
of	O
hyperthyroidism	O
on	O
the	O
pattern	O
and	O
time	O
course	O
of	O
O2	O
uptake	O
(	O
VO2	O
)	O
following	O
the	O
transition	O
from	O
rest	O
to	O
exercise	O
,	O
six	O
patients	O
and	O
six	O
healthy	O
subjects	O
performed	O
cycle	O
exercise	O
at	O
an	O
average	O
work	O
rate	O
(	O
WR	O
)	O
of	O
18	O
and	O
20	O
W	O
respectively	O
.	O

88	O
,	O
3739	O
-	O
3743	O
)	O
)	O
.	O

CHIEF	O
OUTCOME	O
MEASURES	O
:	O
Endoluminal	O
release	O
of	O
prostacyclin	O
(	O
6-Keto	O
-	O
PGF1	O
alpha	O
)	O
and	O
thromboxane	O
B2	O
(	O
TxB2	O
)	O
,	O
patency	O
,	O
EC	O
coverage	O
and	O
cell	O
identity	O
.	O

Seasonal	O
variation	O
of	O
the	O
cadmium	O
content	O
of	O
Murex	O
trunculus	O
in	O
a	O
non	O
-	O
cadmium	O
polluted	O
environment	O
.	O

However	O
,	O
electron	O
microscopy	O
revealed	O
that	O
while	O
sec4	B
mutant	I
cells	O
accumulate	O
secretory	O
vesicles	O
,	O
ypt31	B
/	I
32	I
mutant	I
cells	O
accumulate	O
aberrant	O
Golgi	O
structures	O
.	O

Furthermore	O
,	O
Grap	B
is	O
associated	O
with	O
a	O
Ras	B
guanine	I
nucleotide	I
exchange	I
factor	I
mSos1	B
,	O
primarily	O
through	O
its	O
N	B
-	I
terminal	I
SH3	I
domain	I
.	O

This	O
regimen	O
may	O
be	O
considered	O
front	O
-	O
line	O
therapy	O
when	O
autologous	O
stem	O
cell	O
transplantation	O
is	O
not	O
feasible	O
and	O
when	O
a	O
rapid	O
response	O
is	O
particularly	O
important	O
.	O

To	O
investigate	O
this	O
issue	O
,	O
we	O
used	O
a	O
recognition	O
task	O
in	O
which	O
two	O
strings	O
of	O
letters	O
are	O
presented	O
sequentially	O
.	O

Comparison	O
to	O
the	O
murine	O
homologues	O
of	O
these	O
molecules	O
reveals	O
a	O
high	O
degree	O
of	O
conservation	O
between	O
the	O
products	O
of	O
one	O
of	O
these	O
genes	O
,	O
Fc	B
gamma	I
RIIb	I
,	O
and	O
the	O
murine	B
beta	I
gene	I
in	O
primary	O
sequence	O
,	O
splicing	O
pattern	O
,	O
and	O
tissue	O
distribution	O
.	O

A	O
rabbit	O
antiserum	O
raised	O
against	O
a	O
unique	O
(	O
V3	O
domain	O
)	O
bacterially	O
expressed	O
PKC	B
theta	I
fragment	I
immunoprecipitated	O
specifically	O
an	O
82-kDa	O
protein	O
from	O
Jurkat	O
cell	O
lysates	O
.	O

Hematological	O
parameters	O
(	O
leukocyte	O
,	O
neutrophil	O
and	O
platelet	O
counts	O
)	O
and	O
liver	O
function	O
tests	O
were	O
determined	O
by	O
standard	O
procedures	O
.	O

(	O
1993	O
)	O
8	O
,	O
94	O
-	O
99	O
)	O
.	O

It	O
would	O
seem	O
that	O
caution	O
should	O
be	O
exercised	O
in	O
using	O
HPL	B
values	O
as	O
an	O
index	O
of	O
placental	O
function	O
in	O
anaemic	O
women	O
.	O

No	O
IORT	O
related	O
mortality	O
has	O
been	O
observed	O
.	O

Characterization	O
of	O
a	O
tonB	B
-	O
phoA	B
gene	O
fusion	O
suggests	O
that	O
the	O
amino	O
-	O
terminal	O
41	O
amino	O
acids	O
of	O
TonB	B
are	O
sufficient	O
to	O
promote	O
export	O
of	O
the	O
fusion	O
protein	O
and	O
presumably	O
TonB	B
as	O
well	O
.	O

Characterization	O
of	O
a	O
unique	O
protein	O
component	O
of	O
yeast	B
RNase	I
MRP	I
:	O
an	O
RNA	O
-	O
binding	O
protein	O
with	O
a	O
zinc	O
-	O
cluster	O
domain	O
.	O

This	O
raises	O
the	O
possibility	O
that	O
recombination	O
occurred	O
between	O
corresponding	O
LTR	O
and	O
vif	B
loci	I
of	O
the	O
quasi	O
-	O
species	O
present	O
in	O
the	O
isolates	O
described	O
here	O
.	O

2	O
.	O

The	O
antihypertensive	O
action	O
corresponds	O
to	O
those	O
of	O
established	O
diuretics	O
.	O

The	O
aromatic	B
hydrocarbon	I
receptor	I
(	O
AHR	B
)	O
is	O
a	O
ligand	O
-	O
activated	O
transcription	O
factor	O
that	O
regulates	O
the	O
expression	O
of	O
several	O
drug	O
-	O
metabolizing	O
enzymes	O
and	O
has	O
been	O
implicated	O
in	O
immunosuppression	O
,	O
teratogenesis	O
,	O
cell	O
-	O
specific	O
hyperplasia	O
,	O
and	O
certain	O
types	O
of	O
malignancies	O
and	O
toxicities	O
.	O

The	O
metalloproteinase	B
mediating	O
Met	B
cleavage	O
was	O
specifically	O
inhibited	O
by	O
the	O
tissue	B
inhibitor	I
of	I
metalloproteinases	I
(	I
TIMP	I
)	I
-3	I
,	O
but	O
not	O
by	O
TIMP-1	B
or	O
TIMP-2	B
.	O

METHODS	O
AND	O
RESULTS	O
:	O
The	O
effect	O
of	O
prolonged	O
nitrate	O
therapy	O
between	O
2	O
days	O
and	O
6	O
weeks	O
during	O
healing	O
after	O
infarction	O
on	O
serial	O
parameters	O
of	O
ventricular	O
remodeling	O
(	O
scar	O
expansion	O
,	O
scar	O
thinning	O
,	O
ventricular	O
dilation	O
,	O
and	O
hypertrophy	O
)	O
and	O
function	O
(	O
asynergy	O
or	O
akinesis	O
plus	O
dyskinesis	O
and	O
ejection	O
fraction	O
)	O
by	O
serial	O
two	O
-	O
dimensional	O
echocardiography	O
,	O
hemodynamics	O
,	O
postmortem	O
topography	O
(	O
computerized	O
planimetry	O
,	O
geometric	O
maps	O
,	O
and	O
radiographs	O
)	O
,	O
and	O
collagen	B
content	O
(	O
hydroxyproline	O
)	O
was	O
studied	O
in	O
64	O
instrumented	O
dogs	O
randomized	O
2	O
days	O
after	O
left	O
anterior	O
descending	O
coronary	O
artery	O
ligation	O
to	O
various	O
nitrate	O
regimens	O
(	O
n	O
=	O
32	O
)	O
over	O
the	O
first	O
2	O
weeks	O
(	O
subgroup	O
1	O
:	O
2	O
%	O
transdermal	O
nitroglycerin	O
at	O
8	O
AM	O
and	O
4	O
PM	O
,	O
n	O
=	O
6	O
;	O
subgroup	O
2	O
:	O
2	O
%	O
transdermal	O
nitroglycerin	O
plus	O
2.6	O
mg	O
of	O
sustained	O
-	O
release	O
oral	O
nitroglycerin	O
at	O
8	O
AM	O
,	O
3	O
PM	O
,	O
and	O
10	O
PM	O
,	O
n	O
=	O
5	O
;	O
subgroup	O
3	O
:	O
oral	O
isosorbide	O
dinitrate	O
,	O
30	O
mg	O
at	O
8	O
AM	O
and	O
4	O
PM	O
,	O
n	O
=	O
11	O
)	O
or	O
6	O
weeks	O
(	O
subgroup	O
4	O
:	O
isosorbide	O
dinitrate	O
,	O
n	O
=	O
10	O
)	O
and	O
in	O
matching	O
controls	O
(	O
n	O
=	O
32	O
)	O
.	O

We	O
have	O
found	O
that	O
pro	B
-	I
IGF-2	I
can	O
initially	O
form	O
two	O
disulfide	O
isomers	O
that	O
undergo	O
rearrangement	O
to	O
a	O
single	O
conformation	O
in	O
vivo	O
.	O

Thus	O
,	O
primate	O
vs.	O
rodent	O
promoter	O
selectivity	O
mediated	O
by	O
the	O
TBP	B
-	O
TAFI	B
complex	O
is	O
likely	O
to	O
be	O
the	O
result	O
of	O
cumulative	O
subtle	O
differences	O
between	O
individual	O
subunits	O
that	O
lead	O
to	O
species	O
-	O
specific	O
properties	O
of	O
RNA	B
polymerase	I
I	I
transcription	O
.	O

The	O
structure	O
and	O
expression	O
of	O
the	O
murine	B
gene	I
encoding	I
granulocyte	I
-	I
macrophage	I
colony	I
stimulating	I
factor	I
:	O
evidence	O
for	O
utilisation	O
of	O
alternative	O
promoters	O
.	O

Central	O
treatment	O
unit	O
saves	O
nurses	O
,	O
adds	O
income	O
,	O
improves	O
care	O
.	O

The	O
QCS	O
appears	O
comparable	O
with	O
the	O
MMSE	O
and	O
is	O
quicker	O
to	O
administer	O
.	O

A	O
positive	O
FTA	B
-	I
ABS-19S	I
-	O
IgM	B
test	O
indicates	O
the	O
necessity	O
of	O
treatment	O
.	O

Uterine	O
contractions	O
began	O
with	O
a	O
mean	O
latency	O
of	O
62	O
min	O
in	O
the	O
PGF2	O
alpha	O
infused	O
women	O
,	O
in	O
controls	O
uterine	O
activity	O
remained	O
unchanged	O
.	O

The	O
implication	O
of	O
Rac	B
and	O
Cdc42	B
was	O
analyzed	O
in	O
transient	O
transfection	O
experiments	O
using	O
either	O
constitutively	O
active	O
(	O
V12	O
)	O
or	O
dominant	O
-	O
interfering	O
(	O
N17	O
)	O
mutants	O
.	O

The	O
evolutionary	O
significance	O
of	O
the	O
similarities	O
of	O
intron	O
secondary	O
structures	O
and	O
open	O
reading	O
frames	O
of	O
the	O
ND3	B
,	I
4	I
and	I
ATPase	I
6	I
genes	I
is	O
discussed	O
,	O
including	O
the	O
possible	O
separate	O
evolution	O
of	O
structural	O
and	O
coding	O
sequences	O
.	O

Procedures	O
with	O
perfected	O
method	O

A	O
case	O
of	O
functioning	O
parathyroid	O
carcinoma	O
with	O
hypereninemic	O
hypertension	O
.	O

The	O
study	O
was	O
performed	O
in	O
a	O
class	O
100	O
laminar	O
flow	O
clean	O
bench	O
in	O
order	O
to	O
minimize	O
particulate	O
contamination	O
from	O
extraneous	O
sources	O
.	O

The	O
sequence	O
of	O
LZ321	B
matched	O
that	O
of	O
RREB1	B
,	O
a	O
transcription	O
factor	O
that	O
bound	O
to	O
a	O
Ras	B
responsive	I
element	I
(	O
RRE	B
)	O
very	O
different	O
from	O
the	O
sequence	O
with	O
which	O
we	O
isolated	O
LZ321	B
.	O

Phosphorylation	O
at	O
Ser	O
(	O
670	O
)	O
impairs	O
the	O
ability	O
of	O
GRK2	B
to	O
phosphorylate	O
both	O
soluble	O
and	O
membrane	O
-	O
incorporated	O
receptor	O
substrates	O
and	O
dramatically	O
attenuates	O
Gbetagamma	B
-	O
mediated	O
activation	O
of	O
this	O
enzyme	O
.	O

The	O
longest	O
S1-S2	O
interval	O
at	O
which	O
S2	O
failed	O
to	O
capture	O
(	O
effective	O
refractory	O
period	O
)	O
was	O
longer	O
by	O
5.5	O
+	O
/-	O

8.2	O
msec	O
at	O
twice	O
threshold	O
(	O
0.05	O
less	O
than	O
p	O
less	O
than	O
0.10	O
)	O
and	O
5.5	O
+	O
/-	O

3.5	O
msec	O
at	O
5	O
times	O
threshold	O
stimulation	O
(	O
p	O
less	O
than	O
0.01	O
)	O
when	O
the	O
basic	O
drive	O
and	O
extrastimuli	O
were	O
delivered	O
to	O
separate	O
sites	O
.	O

Using	O
lasers	O
,	O
PRK	O
involves	O
reshaping	O
the	O
cornea	O
so	O
that	O
its	O
refractive	O
power	O
is	O
increased	O
.	O

Inhibition	O
of	O
Raf-1	B
signaling	O
by	O
a	O
monoclonal	O
antibody	O
,	O
which	O
interferes	O
with	O
Raf-1	B
activation	O
and	O
with	O
Mek	B
substrate	O
binding	O
.	O

Laparoscopic	O
examination	O
1	O
year	O
after	O
surgery	O
revealed	O
an	O
enlarged	O
,	O
thin	O
-	O
walled	O
,	O
and	O
fluid	O
-	O
filled	O
uterine	O
segment	O
cranial	O
to	O
the	O
midcornus	O
occlusion	O
sites	O
in	O
all	O
animals	O
.	O

NBSII	O
is	O
essential	O
for	O
ribosome	O
-	O
stimulated	O
activity	O
.	O

Gel	O
shift	O
and	O
southwestern	O
experiments	O
revealed	O
nuclear	O
proteins	O
of	O
43	O
kDa	O
and	O
30	O
kDa	O
in	O
GC	O
and	O
fish	O
cells	O
,	O
respectively	O
,	O
that	O
bind	O
specifically	O
to	O
the	O
tGH	B
CRE	O
,	O
suggesting	O
the	O
involvement	O
of	O
CRE	B
-	I
binding	I
-	I
protein	I
/	O
activating	B
-	I
transcription	I
-	I
factor	I
-	I
l	I
-	O
related	O
peptides	O
in	O
cAMP	O
response	O
.	O

Moreover	O
,	O
such	O
mutations	O
lead	O
to	O
a	O
dramatic	O
transition	O
in	O
chromatin	O
structure	O
:	O
the	O
DNase	B
I	I
hypersensitive	I
region	I
is	O
replaced	O
by	O
two	O
stable	O
,	O
sequence	O
-	O
positioned	O
nucleosomes	O
.	O

Two	O
measures	O
of	O
sensory	O
inhibition	O
were	O
employed	O
,	O
S2	O
/	O
S1	O
x	O
100	O
amplitude	O
ratio	O
and	O
S1-S2	O
amplitude	O
difference	O
.	O

The	O
transcriptional	O
start	O
site	O
,	O
identified	O
by	O
primer	O
extension	O
and	O
S1	B
nuclease	I
assay	O
,	O
is	O
34	O
nt	O
upstream	O
of	O
the	O
translation	O
initiation	O
codon	O
.	O

The	O
clinical	O
effects	O
of	O
valproate	O
and	O
ethosuximide	O
can	O
be	O
related	O
to	O
this	O
differential	O
modulation	O
of	O
thalamocortical	O
excitability	O
.	O

Central	O
projections	O
of	O
gastric	O
afferent	O
vagal	O
inputs	O
.	O

Like	O
Mdm2	B
,	O
MdmX	B
is	O
able	O
to	O
bind	O
p53	B
and	O
inhibit	O
p53	B
transactivation	O
;	O
however	O
,	O
the	O
ability	O
of	O
MdmX	B
to	O
degrade	O
p53	B
has	O
yet	O
to	O
be	O
examined	O
.	O

The	O
structure	O
of	O
the	O
mAR	B
ORF	O
was	O
confirmed	O
by	O
sequence	O
analysis	O
of	O
mAR	B
cDNA	O
fragments	O
,	O
which	O
were	O
obtained	O
by	O
PCR	O
amplification	O
of	O
mouse	O
testis	O
cDNA	O
,	O
using	O
mAR	B
specific	O
primers	O
.	O

Transforming	B
growth	I
factor	I
-	I
beta	I
(	O
TGF	B
-	I
beta	I
)	O
inhibits	O
cell	O
cycle	O
progression	O
,	O
in	O
part	O
through	O
up	O
-	O
regulation	O
of	O
gene	O
expression	O
of	O
the	O
p21	B
(	O
WAF1	B
/	O
Cip1	B
)	O
(	O
p21	B
)	O
cell	O
cycle	O
inhibitor	O
.	O

Decreased	O
plasma	O
level	O
of	O
antithrombin	B
III	I
was	O
assumed	O
to	O
be	O
one	O
of	O
the	O
major	O
factors	O
underlying	O
hypercoagulable	O
state	O
in	O
nephrotic	O
syndrome	O
.	O

In	O
both	O
RAW	O
cells	O
and	O
the	O
microglia	O
cell	O
line	O
EOC20	O
,	O
two	O
IFN	B
-	I
gamma	I
-	O
activated	O
transcription	O
factors	O
,	O
STAT-1alpha	B
and	O
IRF-1	B
,	O
bind	O
the	O
GAS	B
and	O
IRF	B
elements	I
,	O
respectively	O
.	O

All	O
patients	O
received	O
marrow	O
from	O
HLA	B
-	O
identical	O
sibling	O
donors	O
,	O
underwent	O
similar	O
myeloablative	O
regimens	O
,	O
and	O
had	O
similar	O
pretreatment	O
characteristics	O
.	O

Immunoblot	O
analyses	O
revealed	O
that	O
the	O
loss	O
of	O
activator	O
function	O
coincides	O
with	O
selective	O
removal	O
of	O
the	O
C	B
-	I
terminal	I
domain	I
(	I
CTD	I
)	I
-hyperphosphorylated	I
RNAP	I
IIO	I
along	O
with	O
NC2	B
.	O

In	O
bell	O
pepper	O
,	O
a	O
gene	O
encoding	O
a	O
major	O
plastid	O
-	O
lipid	O
associated	O
protein	O
is	O
expressed	O
as	O
both	O
partially	O
and	O
totally	O
spliced	O
transcripts	O
(	O
respectively	O
PAP2	B
and	O
PAP1	B
)	O
.	O

Aggregation	O
in	O
washed	O
platelets	O
from	O
rats	O
with	O
diabetes	O
was	O
enhanced	O
.	O

The	O
authors	O
investigate	O
in	O
a	O
group	O
of	O
211	O
children	O
aged	O
2	O
-	O
6	O
years	O
,	O
incl	O
.	O

in	O
particular	O
a	O
group	O
of	O
33	O
2-year	O
-	O
old	O
ones	O
,	O
in	O
1990	O
and	O
checked	O
in	O
1991	O
at	O
two	O
sites	O
in	O
Bratislava	O
--	O
a	O
town	O
with	O
a	O
varying	O
concentration	O
of	O
NOX	O
,	O
SO2	O
,	O
dustiness	O
and	O
dust	O
fallout	O
--	O
their	O
influence	O
on	O
the	O
incidence	O
,	O
type	O
and	O
course	O
of	O
relapsing	O
respiratory	O
disease	O
.	O

CONCLUSION	O
:	O
DaunoXome	O
has	O
an	O
improved	O
pharmacokinetic	O
profile	O
compared	O
with	O
free	O
daunorubicin	O
,	O
and	O
is	O
well	O
tolerated	O
.	O

Furthermore	O
,	O
the	O
zincon	O
-	O
loaded	O
resin	O
was	O
applied	O
to	O
the	O
selective	O
concentration	O
of	O
trace	O
amounts	O
of	O
chalcophile	O
elements	O
in	O
natural	O
water	O
samples	O
prior	O
to	O
neutron	O
activation	O
analysis	O
.	O

The	O
NH	O
(	O
2	O
)	O
-terminus	O
of	O
all	O
three	O
proteins	O
contains	O
a	O
POZ	O
domain	O
,	O
a	O
conserved	O
120	O
amino	O
acid	O
motif	O
involved	O
in	O
transcriptional	O
repression	O
and	O
protein	O
dimerization	O
.	O

Recognition	O
of	O
DNA	O
by	O
single	O
-	O
chain	O
derivatives	O
of	O
the	O
phage	O
434	O
repressor	O
:	O
high	O
affinity	O
binding	O
depends	O
on	O
both	O
the	O
contacted	O
and	O
non	O
-	O
contacted	O
base	O
pairs	O
.	O

In	O
the	O
absence	O
of	O
Mg2	O
+	O
,	O
the	O
extent	O
of	O
destabilization	O
of	O
tRNAPhe	B
is	O
greater	O
but	O
appears	O
to	O
be	O
confined	O
to	O
internal	O
regions	O
of	O
the	O
acceptor	O
and	O
T	O
psi	O
C	O
helices	O
,	O
as	O
evidenced	O
by	O
the	O
selectively	O
enhanced	O
exchange	O
rates	O
for	O
imino	O
protons	O
associated	O
with	O
these	O
base	O
pairs	O
.	O

The	O
carboxyl	O
-	O
terminal	O
75	O
amino	O
acids	O
of	O
the	O
two	O
proteins	O
contain	O
the	O
bHLH	O
motif	O
and	O
differ	O
from	O
each	O
other	O
by	O
only	O
three	O
conservative	O
amino	O
acid	O
changes	O
,	O
while	O
the	O
amino	O
-	O
terminal	O
portions	O
are	O
markedly	O
divergent	O
from	O
each	O
other	O
.	O

A	O
Drosophila	O
subobscura	O
genomic	O
fragment	O
containing	O
all	O
the	O
exons	O
and	O
the	O
late	O
and	O
early	O
promotors	O
in	O
the	O
Sxl	B
gene	I
of	I
D.	I
melanogaster	I
was	O
isolated	O
.	O

The	O
results	O
of	O
the	O
transient	O
-	O
transfection	O
assay	O
showed	O
that	O
the	O
Sp1	B
binding	I
element	I
located	O
in	O
the	O
core	O
region	O
(	O
positions	O
--64	O
to	O
+	O
1	O
)	O
of	O
the	O
alpha2-integrin	B
promoter	I
plays	O
an	O
essential	O
role	O
in	O
the	O
alpha2-integrin	B
promoter	I
activity	O
and	O
its	O
downregulation	O
by	O
Erb	B
-	O
B2	B
.	O

These	O
observations	O
suggest	O
that	O
the	O
AF-1	O
region	O
of	O
PPARalpha	B
is	O
partially	O
silenced	O
by	O
corepressor	O
proteins	O
,	O
which	O
might	O
interact	O
in	O
a	O
phosphorylation	O
-	O
dependent	O
manner	O
.	O

Insertion	O
of	O
alternatively	O
spliced	O
exon	O
W	O
into	O
CREB	B
mRNA	I
during	O
spermatogenesis	O
results	O
in	O
a	O
polycistronic	O
RNA	O
that	O
encodes	O
two	O
novel	O
internally	O
translated	O
CREB	B
repressor	I
isoforms	I
called	O
I	B
-	I
CREBs	I
,	O
consisting	O
of	O
the	O
carboxy	O
-	O
terminal	O
DNA	O
-	O
binding	O
domain	O
devoid	O
of	O
the	O
transactivation	O
domains	O
.	O

The	O
human	B
BRCA1	I
promoter	I
also	O
contains	O
a	O
conserved	O
E2F	B
site	I
and	O
is	O
similarly	O
regulated	O
by	O
E2F1	B
and	O
Rb	B
.	O

In	O
the	O
studies	O
described	O
in	O
this	O
report	O
,	O
we	O
have	O
identified	O
two	O
potential	O
Ets	B
binding	O
sites	O
,	O
EBS1	B
and	O
EBS2	B
,	O
which	O
are	O
conserved	O
in	O
both	O
the	O
human	O
and	O
murine	O
interleukin-2	B
enhancers	O
.	O

An	O
enhancement	O
of	O
benign	O
liver	O
tumors	O
(	O
tumorigenic	O
effect	O
)	O
was	O
observed	O
only	O
in	O
CF1	O
male	O
mice	O
(	O
17	O
/	O
56	O
at	O
the	O
only	O
tested	O
dose	O
:	O
400	O
ppm	O
vs.	O

Stamps	O
in	O
cardiology	O
:	O
de	O
Musset	O
sign	O
.	O

268	O
,	O
6858	O
-	O
6861	O
)	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
transcriptional	O
activator	O
CREM	B
is	O
highly	O
expressed	O
in	O
postmeiotic	O
cells	O
.	O

For	O
more	O
detailed	O
mapping	O
,	O
we	O
constructed	O
mouse	O
A9	O
cells	O
containing	O
STFs	O
derived	O
from	O
human	O
chromosome	O
2	O
tagged	O
with	O
pSTneo	O
at	O
different	O
regions	O
in	O
2q31-qter	O
.	O

We	O
therefore	O
propose	O
that	O
PRR2	B
,	O
and	O
not	O
PVR	B
,	O
is	O
the	O
true	O
human	O
homolog	O
of	O
MPH	B
.	O

Cbl	B
is	O
a	O
signaling	O
molecule	O
with	O
multiple	O
functional	O
domains	O
:	O
an	O
SH2	B
domain	I
which	O
binds	O
phosphotyrosine	O
residues	O
,	O
a	O
RING	O
finger	O
domain	O
which	O
acts	O
as	O
a	O
ubiquitin	B
ligase	I
,	O
a	O
proline	O
-	O
rich	O
region	O
which	O
serves	O
as	O
a	O
docking	O
site	O
for	O
SH3-containing	B
proteins	I
,	O
phosphotyrosine	O
residues	O
which	O
serve	O
as	O
docking	O
sites	O
for	O
SH2-containing	B
proteins	I
such	O
a	O
CrkL	B
and	O
the	O
p85	B
subunit	I
of	O
PI	B
3-kinase	I
,	O
and	O
a	O
nuclear	O
localization	O
signal	O
.	O

No	O
interaction	O
with	O
epidural	O
anesthesia	O
was	O
observed	O
.	O

Region	O
I	O
includes	O
the	O
two	O
cysteine	O
-	O
cysteine	O
zinc	O
fingers	O
that	O
comprise	O
a	O
DNA	O
-	O
binding	O
domain	O
which	O
typifies	O
all	O
members	O
of	O
the	O
superfamily	O
.	O

In	O
contrast	O
to	O
Phase	O
III	O
,	O
which	O
has	O
a	O
single	O
study	O
design	O
--	O
the	O
controlled	O
,	O
randomized	O
,	O
double	O
-	O
blind	O
study	O
--	O
Phase	O
IV	O
requires	O
different	O
designs	O
for	O
each	O
of	O
the	O
many	O
different	O
questions	O
.	O

This	O
bound	O
[	O
3H	O
]	O
iloprost	O
with	O
high	O
affinity	O
and	O
stimulated	O
cAMP	O
production	O
when	O
exposed	O
to	O
agonist	O
.	O

Juvenile	O
idiopathic	O
inflammatory	O
myopathies	O
:	O
the	O
value	O
of	O
magnetic	O
resonance	O
imaging	O
in	O
the	O
detection	O
of	O
muscle	O
involvement	O
.	O

The	O
methods	O
used	O
were	O
the	O
AOAC	O
method	O
of	O
dilution	O
and	O
heating	O
;	O
the	O
addition	O
of	O
mercuric	O
chloride	O
,	O
charcoal	O
,	O
and	O
Carrez	O
reagents	O
at	O
2	O
different	O
pH	O
values	O
;	O
and	O
direct	O
analysis	O
of	O
sample	O
supernatants	O
with	O
no	O
treatment	O
(	O
control	O
)	O
.	O

A	O
review	O
of	O
156	O
patients	O
younger	O
than	O
40	O
treated	O
at	O
our	O
Department	O
between	O
1960	O
and	O
1991	O
with	O
transitional	O
cell	O
carcinoma	O
of	O
the	O
bladder	O
revealed	O
that	O
89.1	O
%	O
had	O
superficial	O
(	O
Ta	O
/	O
T1	O
)	O
disease	O
and	O
the	O
remaining	O
10.9	O
%	O
presented	O
with	O
invasive	O
disease	O
.	O

Expression	O
of	O
the	O
Asp	O
but	O
not	O
the	O
Ala	O
gB	B
mutation	O
resulted	O
in	O
an	O
increase	O
in	O
the	O
steady	O
-	O
state	O
expression	O
of	O
gB	B
at	O
the	O
plasma	O
membrane	O
(	O
PM	O
)	O
in	O
U373	O
cells	O
.	O

Large	O
volumes	O
of	O
bone	O
marrow	O
may	O
be	O
required	O
for	O
certain	O
types	O
of	O
autologous	O
bone	O
marrow	O
transplants	O
.	O

These	O
results	O
suggest	O
that	O
dauricine	O
and	O
verapamil	O
have	O
a	O
salutary	O
effect	O
in	O
extracorporeal	O
circulation	O
.	O

For	O
evaluation	O
of	O
the	O
model	O
,	O
simulations	O
of	O
physiological	O
excitation	O
and	O
of	O
pathologies	O
(	O
Wolff	O
-	O
Parkinson	O
-	O
White	O
syndrome	O
,	O
complete	O
AV	O
-	O
block	O
,	O
inferior	O
wall	O
ischaemia	O
)	O
were	O
examined	O
.	O

For	O
rotating	O
stimuli	O
presented	O
to	O
the	O
dominant	O
eye	O
,	O
this	O
class	O
of	O
neurons	O
responded	O
best	O
to	O
rotation	O
of	O
the	O
visual	O
world	O
about	O
an	O
axis	O
oriented	O
near	O
the	O
horizontal	O
plane	O
and	O
approximately	O
45	O
degrees	O
azimuth	O
.	O

The	O
incidence	O
of	O
the	O
variability	O
of	O
the	O
free	O
PSA	B
/	O
total	O
PSA	B
ratio	O
on	O
the	O
early	O
diagnosis	O
of	O
prostate	O
cancer	O

A	O
TAAATA	O
sequence	O
is	O
present	O
26	O
nt	O
upstream	O
from	O
the	O
major	O
CAP	O
site	O
,	O
and	O
within	O
the	O
5'-flanking	O
region	O
there	O
are	O
several	O
putative	O
transcription	O
factor	O
binding	O
sites	O
.	O

Iris	O
binding	O
and	O
bioavailability	O
.	O

The	O
dopamine	B
D1	I
dopamine	I
receptor	I
antagonist	O
SCH	O
23390	O
dose	O
dependently	O
(	O
7.5	O
-	O
30	O
micrograms	O
/	O
kg	O
s.c	O
.	O
)	O
antagonized	O
the	O
stimulant	O
locomotor	O
effect	O
on	O
both	O
drugs	O
but	O
did	O
not	O
prevent	O
their	O
antiimmobility	O
effect	O
on	O
the	O
behavioral	O
despair	O
test	O
.	O

Neither	O
symptoms	O
,	O
virions	O
,	O
nor	O
viral	O
RNA	O
was	O
detectable	O
in	O
plants	O
inoculated	O
with	O
this	O
mutant	O
or	O
a	O
mutant	O
with	O
a	O
frameshift	O
mutation	O
in	O
the	O
coat	B
gene	I
.	O

Chromaffin	O
cells	O
transfected	O
with	O
a	O
plasmid	O
with	O
the	O
entire	O
coding	O
sequence	O
of	O
c	B
-	I
Rabphilin3a	I
inserted	O
in	O
the	O
antisense	O
orientation	O
inhibited	O
secretion	O
of	O
co	O
-	O
expressed	O
GH	B
by	O
approximately	O
30	O
%	O
.	O

A	O
sequence	O
-	O
ready	O
3-Mb	O
PAC	O
contig	O
covering	O
16	O
breakpoints	O
of	O
the	O
Wilms	B
tumor	I
/	I
anirida	I
region	I
of	O
human	O
chromosome	O
11p13	O
.	O

Compression	O
of	O
pulmonary	O
artery	O
and	O
right	O
ventricular	O
outflow	O
tract	O
by	O
aneurysm	O
of	O
ascending	O
aorta	O
.	O

High	O
expression	O
of	O
p51A	B
(	O
TAp63gamma	B
)	O
in	O
the	O
skeletal	O
muscle	O
tissue	O
drove	O
us	O
to	O
investigate	O
a	O
differentiation	O
-	O
inducible	O
myoblastic	O
cell	O
line	O
which	O
showed	O
increased	O
p51A	B
expression	O
after	O
differentiation	O
induction	O
.	O

Nosographic	O
problems	O

Since	O
UmuD	B
protein	I
is	O
proteolytically	O
processed	O
to	O
an	O
active	O
form	O
(	O
UmuD	B
*	I
)	O
in	O
a	O
RecA*-dependent	B
fashion	O
,	O
and	O
MucA	B
shares	O
extensive	O
amino	O
acid	O
homology	O
with	O
UmuD	B
,	O
we	O
examined	O
whether	O
MucA	B
is	O
similarly	O
processed	O
in	O
the	O
cell	O
,	O
using	O
antiserum	O
against	O
a	O
LacZ'-'MucA	B
fusion	O
protein	O
.	O

Changes	O
in	O
BHR	O
were	O
found	O
to	O
correlate	O
significantly	O
with	O
changes	O
in	O
the	O
levels	O
of	O
24	O
h	O
mean	O
SO2	O
,	O
NO2	O
and	O
smoke	O
;	O
48	O
h	O
mean	O
NO2	O
and	O
smoke	O
;	O
24	O
h	O
lag	O
NO2	O
;	O
although	O
the	O
effect	O
was	O
only	O
small	O
,	O
accounting	O
for	O
approximately	O
10	O
%	O
of	O
the	O
variability	O
in	O
within	O
-	O
subject	O
BHR	O
between	O
visits	O
.	O

Identification	O
of	O
domains	O
mediating	O
transcription	O
activation	O
,	O
repression	O
,	O
and	O
inhibition	O
in	O
the	O
paired	B
-	I
related	I
homeobox	I
protein	I
,	O
Prx2	B
(	O
S8	B
)	O
.	O

Where	O
the	O
resonator	O
has	O
two	O
holes	O
,	O
these	O
terms	O
should	O
be	O
somewhat	O
modified	O
:	O
A	O
is	O
the	O
combined	O
area	O
of	O
the	O
two	O
holes	O
,	O
L	O
is	O
16	O
/	O
3pi	O
r	O
(	O
~1.7r	O
)	O
for	O
a	O
simple	O
hole	O
in	O
a	O
thin	O
-	O
walled	O
vessel	O
and	O
r	O
is	O
the	O
radius	O
of	O
one	O
hole	O
(	O
Seto	O
,	O
1971	O
)	O
.	O

The	O
most	O
distal	O
active	O
site	O
in	O
TIGA	B
is	O
created	O
by	O
excision	O
of	O
a	O
66-bp	O
intron	O
.	O

GeneCalling	O
analysis	O
was	O
successful	O
in	O
detecting	O
members	O
of	O
complex	O
metabolic	O
pathways	O
and	O
uncovering	O
novel	O
genes	O
that	O
were	O
either	O
coincidentally	O
regulated	O
or	O
directly	O
involved	O
in	O
such	O
pathways	O
.	O

Wingless	B
/	O
Wnt	B
signaling	O
directs	O
cell	O
-	O
fate	O
choices	O
during	O
embryonic	O
development	O
.	O

Patients	O
with	O
the	O
chronic	O
photosensitivity	O
dermatitis	O
with	O
actinic	O
reticuloid	O
syndrome	O
have	O
high	O
total	O
serum	O
IgE	B
concentrations	O
.	O

Furthermore	O
,	O
the	O
cognate	O
binding	O
protein	O
is	O
present	O
in	O
both	O
rat	O
and	O
human	O
(	O
HeLa	O
)	O
cell	O
nuclear	O
extracts	O
.	O

The	O
effect	O
of	O
stimulation	O
of	O
the	O
entopeduncular	O
nucleus	O
(	O
EP	O
)	O
on	O
the	O
jaw	O
-	O
opening	O
reflex	O
(	O
JOR	O
)	O
was	O
studied	O
in	O
the	O
cat	O
anesthetized	O
with	O
sodium	O
pentobarbital	O
.	O

We	O
cloned	O
the	O
BamHI	B
-	I
F	I
fragment	I
from	O
the	O
left	O
end	O
of	O
Ad4	O
in	O
pUC13	O
-	O
1	O
between	O
the	O
SalI	B
and	O
BamHI	B
sites	I
in	O
order	O
to	O
carry	O
out	O
the	O
structural	O
analysis	O
of	O
the	O
E1A	B
region	I
of	I
Ad4	I
.	O

The	O
objective	O
of	O
this	O
research	O
was	O
to	O
determine	O
if	O
ergotamine	O
,	O
an	O
ergopeptine	O
alkaloid	O
isolated	O
from	O
Neotyphodium	O
-	O
infected	O
grasses	O
and	O
associated	O
with	O
toxicoses	O
in	O
livestock	O
,	O
altered	O
plasma	O
concentrations	O
of	O
reproductive	O
hormones	O
in	O
follicular	O
phase	O
heifers	O
and	O
in	O
cows	O
given	O
a	O
progestin	O
implant	O
.	O

The	O
following	O
parameters	O
were	O
measured	O
:	O
onset	O
time	O
(	O
time	O
interval	O
from	O
injection	O
to	O
maximal	O
or	O
total	O
block	O
)	O
,	O
T125	O
/	O
75	O
(	O
time	O
for	O
T1	O
to	O
reach	O
25	O
%	O
or	O
75	O
%	O
of	O
control	O
)	O
,	O
TOF70	O
(	O
time	O
for	O
TOF	O
ratio	O
to	O
reach	O
70	O
%	O
of	O
control	O
)	O
,	O
heart	O
rate	O
and	O
blood	O
pressure	O
.	O

Ectopic	O
Xbra	B
can	O
induce	O
Xegr-1	B
transcription	O
by	O
an	O
indirect	O
mechanism	O
that	O
appears	O
to	O
operate	O
via	O
primary	O
activation	O
of	O
fibroblast	B
growth	I
factor	I
secretion	O
.	O

For	O
example	O
,	O
the	O
presence	O
of	O
two	O
related	O
genes	O
,	O
b	B
and	O
b	B
'	I
,	O
in	O
the	O
cyanobacterium	O
suggests	O
that	O
its	O
ATP	B
synthase	I
is	O
a	O
complex	O
of	O
nine	O
polypeptides	O
,	O
and	O
that	O
it	O
may	O
have	O
single	O
copies	O
of	O
related	O
b	B
and	O
b	B
'	I
proteins	I
rather	O
than	O
two	O
copies	O
of	O
identical	O
b	B
subunits	I
as	O
found	O
in	O
the	O
E.	O
coli	O
enzyme.4+off	O

DDD	O
(	O
R	O
)	O
pacing	O
with	O
automatic	O
mode	O
switch	O
in	O
patients	O
with	O
paroxysmal	O
atrial	O
fibrillation	O
following	O
AV	O
nodal	O
ablation	O
.	O

These	O
events	O
were	O
only	O
weakly	O
stimulated	O
by	O
the	O
activated	B
PDGF	I
alpha	I
-	I
receptor	I
.	O

These	O
results	O
establish	O
that	O
the	O
DNA	O
fragment	O
we	O
have	O
isolated	O
contains	O
the	O
human	B
gp130	I
promoter	I
and	O
that	O
interleukin-6	B
type	I
cytokines	I
may	O
influence	O
the	O
activity	O
of	O
this	O
promoter	O
via	O
activated	O
STATs	B
.	O

Only	O
53	O
%	O
of	O
all	O
injuries	O
and	O
12.5	O
%	O
of	O
serious	O
injuries	O
involved	O
children	O
,	O
and	O
in	O
contrast	O
to	O
the	O
1950s	O
and	O
early	O
1960s	O
,	O
young	O
adults	O
appear	O
at	O
greatest	O
risk	O
in	O
the	O
1980s	O
.	O

Three	O
simple	O
methods	O
of	O
detecting	O
malnutrition	O
on	O
medical	O
wards	O
.	O

We	O
also	O
show	O
that	O
an	O
internal	O
fragment	O
of	O
U24	B
methylation	I
guide	I
snoRNA	I
,	O
encompassing	O
the	O
upstream	O
antisense	O
element	O
and	O
the	O
D	O
'	O
and	O
C	O
'	O
box	O
motifs	O
,	O
can	O
support	O
the	O
site	O
-	O
specific	O
methylation	O
of	O
rRNA	O
.	O

The	O
gap	B
protein	O
knirps	B
mediates	O
both	O
quenching	O
and	O
direct	O
repression	O
in	O
the	O
Drosophila	O
embryo	O
.	O

An	O
infant	O
of	O
8	O
months	O
with	O
congenital	O
glaucoma	O
and	O
hemophilia	O
A	O
lost	O
one	O
eye	O
due	O
to	O
haemorrhages	O
after	O
trabeculotomy	O
in	O
an	O
eye	O
hospital	O
.	O

Encapsulation	O
of	O
sodium	O
fluorescein	O
for	O
dye	O
release	O
studies	O
.	O

Ethanol	O
preference	O
in	O
strains	O
of	O
rats	O
selectively	O
bred	O
for	O
behavioral	O
characteristics	O
.	O

Incubation	O
of	O
HeLa	O
cell	O
cytoplasmic	O
extracts	O
with	O
a	O
purified	O
recombinant	O
glutathione	B
S	I
-	I
transferase	I
-	O
raf	B
fusion	O
protein	O
in	O
the	O
presence	O
of	O
ATP	O
released	O
active	O
NF	B
-	I
kappa	I
B	I
that	O
could	O
be	O
detected	O
by	O
electrophoretic	O
gel	O
mobility	O
shift	O
assay	O
.	O

Both	O
the	O
p38	B
kinase	I
inhibitor	O
SB205380	O
(	O
SB	O
)	O
and	O
cotransfection	O
of	O
a	O
dominant	O
-	O
negative	O
mutant	O
of	O
p38	B
kinase	I
reduced	O
IL-1beta	B
stimulation	O
of	O
the	O
hBNP	B
promoter	I
.	O

Recent	O
geological	O
studies	O
focusing	O
on	O
the	O
Davie	O
Fracture	O
Zone	O
of	O
the	O
Mozambique	O
Channel	O
offer	O
a	O
resolution	O
to	O
this	O
situation	O
,	O
by	O
suggesting	O
the	O
presence	O
of	O
a	O
land	O
-	O
bridge	O
from	O
the	O
mid	O
-	O
Eocene	O
to	O
the	O
early	O
Miocene	O
,	O
an	O
interval	O
that	O
matches	O
the	O
ages	O
of	O
Madagascar	O
's	O
mammalian	O
groups	O
.	O

On	O
the	O
basis	O
of	O
8	O
cases	O
,	O
the	O
authors	O
report	O
different	O
clinical	O
pictures	O
all	O
caused	O
by	O
cardiac	O
toxicity	O
of	O
5FU	O
.	O

The	O
immunoprofile	O
of	O
60	O
adult	O
patients	O
of	O
pulmonary	O
tuberculosis	O
was	O
studied	O
and	O
compared	O
with	O
22	O
normal	O
controls	O
.	O

Effects	O
of	O
long	O
-	O
term	O
use	O
of	O
raloxifene	O
,	O
a	O
selective	O
estrogen	B
receptor	I
modulator	O
,	O
on	O
thyroid	O
function	O
test	O
profiles	O
.	O

Module	O
2	O
of	O
RifA	B
lacks	O
a	O
beta	B
-	I
ketoacyl	I
:	I
acyl	I
carrier	I
protein	I
reductase	I
(	O
KR	B
)	O
domain	O
and	O
the	O
one	O
in	O
module	O
3	O
has	O
an	O
apparently	O
inactive	O
NADPH	B
binding	I
motif	I
,	O
similar	O
to	O
one	O
found	O
in	O
the	O
Er	B
PKS	I
,	O
while	O
the	O
other	O
eight	O
KR	B
domains	I
of	O
the	O
Rf	B
PKS	I
should	O
be	O
functional	O
.	O

Synergy	O
between	O
interferon	B
-	I
gamma	I
and	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
in	O
transcriptional	O
activation	O
is	O
mediated	O
by	O
cooperation	O
between	O
signal	B
transducer	I
and	I
activator	I
of	I
transcription	I
1	I
and	O
nuclear	B
factor	I
kappaB.	I

CONCLUSIONS	O
:	O
In	O
the	O
results	O
of	O
this	O
study	O
,	O
SDB	O
,	O
even	O
snoring	O
,	O
was	O
independently	O
associated	O
with	O
hypertension	O
in	O
both	O
men	O
and	O
women	O
.	O

Transfection	O
of	O
both	O
Calu-6	O
and	O
JEG-3	O
cells	O
with	O
a	O
PKA	B
expression	O
vector	O
resulted	O
in	O
a	O
10-fold	O
induction	O
of	O
human	B
renin	I
transcriptional	O
activity	O
in	O
constructs	O
containing	O
the	O
native	O
or	O
consensus	O
CRE	O
and	O
5-fold	O
activation	O
in	O
a	O
construct	O
containing	O
a	O
nonfunctional	O
CRE	O
.	O

In	O
renal	O
vein	O
thrombosis	O
,	O
similar	O
pattern	O
to	O
acute	O
tubular	O
necrosis	O
was	O
found	O
but	O
RI	O
venography	O
was	O
helpful	O
.	O

Restricted	O
expression	O
of	O
a	O
novel	O
murine	B
atonal	I
-	I
related	I
bHLH	I
protein	I
in	O
undifferentiated	O
neural	O
precursors	O
.	O

Oligo-	O
[	O
alpha	O
]	O
-deoxynucleotides	O
can	O
be	O
derived	O
by	O
stabilizing	O
(	O
intercalating	O
)	O
agents	O
or	O
reactive	O
groups	O
(	O
cleaving	O
reagents	O
,	O
cross	O
-	O
linkers	O
...	O
)	O
.	O

In	O
addition	O
,	O
two	O
cis	O
-	O
acting	O
elements	O
direct	O
the	O
first	O
zygotic	O
expression	O
of	O
Kr	B
in	O
a	O
striped	O
subpattern	O
within	O
the	O
central	O
region	O
of	O
the	O
blastoderm	O
embryo	O
.	O

For	O
capsules	O
containing	O
only	O
the	O
drug	O
,	O
the	O
value	O
of	O
T50	O
increased	O
as	O
the	O
particle	O
size	O
of	O
the	O
drug	O
decreased	O
.	O

Its	O
prognostic	O
impact	O
is	O
superior	O
to	O
the	O
T1	O
/	O
2	O
one	O
(	O
RR	O
=	O
2.9	O
;	O
p	O
=	O
0.0010	O
)	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
the	O
21-	O
or	O
the	O
72-bp	O
repeat	O
transcriptional	O
control	O
elements	O
enhance	O
the	O
efficiency	O
of	O
SV40	O
DNA	O
replication	O
in	O
vivo	O
,	O
provided	O
either	O
of	O
these	O
repeats	O
is	O
located	O
near	O
the	O
end	O
of	O
the	O
core	O
replication	O
origin	O
containing	O
the	O
17-bp	O
A	O
+	O
T	O
-	O
containing	O
sequence	O
.	O

ER	O
and	O
DR	O
were	O
significantly	O
correlated	O
with	O
MIB-1	B
LI	O
(	O
P<0.01	O
and	O
P<0.05	O
,	O
respectively	O
)	O
,	O
but	O
RI	O
and	O
Td	O
/	O
Te	O
were	O
not	O
.	O

D.	O
,	O
and	O
Long	O
,	O
C.	O

A	O
lead	O
phthalocyanin	O
method	O
for	O
the	O
demonstration	O
of	O
acid	B
hydrolases	I
in	O
plant	O
and	O
animal	O
tissues	O
.	O

Here	O
,	O
we	O
describe	O
the	O
three	O
-	O
dimensional	O
structure	O
of	O
the	O
enzyme	O
from	O
Escherichia	O
colidetermined	O
and	O
refined	O
to	O
2.0	O
A	O
resolution	O
.	O

cDNA	O
cloning	O
,	O
sequencing	O
and	O
chromosome	O
mapping	O
of	O
a	O
non	B
-	I
erythroid	I
spectrin	I
,	O
human	B
alpha	I
-	I
fodrin	I
.	O

In	O
serial	O
recall	O
from	O
short	O
-	O
term	O
memory	O
,	O
repeated	O
items	O
are	O
recalled	O
well	O
when	O
close	O
together	O
(	O
repetition	O
facilitation	O
)	O
,	O
but	O
not	O
when	O
far	O
apart	O
(	O
repetition	O
inhibition	O
;	O
the	O
Ranschburg	O
effect	O
)	O
.	O

Posterior	O
osteophytes	O
around	O
the	O
posterior	O
edges	O
of	O
vertebral	O
body	O
resulted	O
in	O
intervertebral	O
insufficiency	O
,	O
and	O
corresponded	O
to	O
hypertrophic	O
spur	O
in	O
osteochondrosis	O
.	O

Biol	O
.	O

Nuclear	O
extracts	O
from	O
Sertoli	O
cells	O
were	O
found	O
to	O
cause	O
an	O
E	O
-	O
box	O
gel	O
shift	O
when	O
the	O
cells	O
were	O
stimulated	O
to	O
differentiate	O
in	O
culture	O
,	O
but	O
not	O
under	O
basal	O
conditions	O
.	O

The	O
combination	O
of	O
ICP47	B
and	O
US11	B
rendered	O
fibroblasts	O
negative	O
for	O
surface	B
class	I
I	I
MHC	I
and	O
allowed	O
a	O
class	B
I	I
MHC	I
-	O
low	O
population	O
of	O
T	O
cells	O
to	O
be	O
sorted	O
by	O
flow	O
cytometry	O
.	O

The	O
recovery	O
of	O
adults	O
schistosomes	O
by	O
extracorporeal	O
filtration	O
.	O

Biochemical	O
studies	O
and	O
studies	O
of	O
cells	O
expressing	O
mutant	O
IL-2	B
receptors	I
indicate	O
that	O
IL-2-induced	B
tyrosine	B
kinase	I
activation	O
initiates	O
a	O
complex	O
signaling	O
cascade	O
.	O

Serum	O
levels	O
of	O
angiotensin	B
converting	I
enzyme	I
were	O
well	O
maintained	O
.	O

We	O
tested	O
the	O
effects	O
of	O
antifungal	O
drugs	O
on	O
adherence	O
of	O
Candida	O
albicans	O
in	O
vitro	O
.	O

Portions	O
of	O
the	O
3'-coding	O
and	O
3'-untranslated	O
regions	O
were	O
found	O
to	O
be	O
missing	O
from	O
the	O
7.2-	B
and	I
4.8-kb	I
topo	I
II	I
alpha	I
mRNAs	I
by	O
Northern	O
blot	O
analysis	O
.	O

An	O
analogue	O
of	O
calcium	O
,	O
strontium	O
chloride	O
Sr	O
89	O
is	O
rapidly	O
cleared	O
from	O
the	O
blood	O
after	O
i.v	O
.	O

injection	O
.	O

These	O
mutants	O
,	O
assayed	O
by	O
injection	O
into	O
Xenopus	O
oocyte	O
nuclei	O
,	O
delimit	O
the	O
promoter	O
to	O
36	O
bp	O
of	O
DNA	O
upstream	O
of	O
the	O
cap	O
site	O
and	O
73	O
bp	O
of	O
the	O
untranslated	O
mRNA	O
leader	O
.	O

(	O
3	O
)	O
With	O
the	O
exception	O
of	O
the	O
anteroposterior	O
direction	O
of	O
layers	O
II	O
--	O
III	O
and	O
the	O
mediolateral	O
direction	O
of	O
layer	O
IV	O
,	O
the	O
vertical	O
conductivity	O
of	O
the	O
cortex	O
was	O
always	O
greater	O
than	O
either	O
of	O
the	O
horizontal	O
conductivities	O
.	O

Acad	O
.	O

To	O
obtain	O
information	O
on	O
the	O
functional	O
role	O
of	O
the	O
Rac1	B
/	O
p38	B
/	O
MAPKAPK-2	B
pathway	O
in	O
RA	O
signaling	O
,	O
the	O
effects	O
of	O
pharmacological	O
inhibition	O
of	O
p38	B
on	O
RA	O
-	O
induced	O
gene	O
transcription	O
and	O
cell	O
differentiation	O
were	O
determined	O
.	O

CONCLUSIONS	O
:	O
The	O
MC	O
/	O
UA	O
ratio	O
improves	O
the	O
sensitivity	O
for	O
the	O
prediction	O
of	O
poor	O
perinatal	O
outcome	O
when	O
it	O
is	O
combined	O
with	O
the	O
NST	O
.	O

Evolution	O
of	O
cytomegalovirus	O
antibodies	O
of	O
maternal	O
origin	O
and	O
acquired	O
,	O
throughout	O
the	O
first	O
year	O
of	O
life	O

The	O
sequence	O
contained	O
five	O
repeats	O
of	O
the	O
hypothetical	O
leucine	O
zipper	O
motif	O
:	O
one	O
is	O
in	O
the	O
N	O
-	O
terminal	O
globular	O
domain	O
,	O
and	O
four	O
are	O
in	O
the	O
central	O
alpha	O
-	O
helical	O
stalk	O
.	O

Zta	B
stimulated	O
the	O
HAT	B
activity	O
of	O
CBP	B
that	O
had	O
been	O
partially	O
purified	O
or	O
immunoprecipitated	O
from	O
mammalian	O
cells	O
as	O
well	O
as	O
from	O
affinity	O
-	O
purified	O
,	O
baculovirus	O
expressed	O
CBP	B
.	O

Previous	O
studies	O
using	O
partial	O
sequences	O
have	O
suggested	O
the	O
potential	O
of	O
26S	B
or	O
large	B
-	I
subunit	I
(	O
LSU	B
)	O
rDNA	O
for	O
phylogeny	O
retrieval	O
at	O
taxonomic	O
levels	O
comparable	O
to	O
those	O
investigated	O
with	O
18S	B
rDNA	I
.	O

P53	B
mutations	I
also	O
offer	O
new	O
approaches	O
to	O
the	O
study	O
of	O
the	O
origins	O
of	O
mutations	O
in	O
human	O
cancer	O
.	O

Due	O
to	O
significant	O
homology	O
to	O
the	O
C	O
-	O
terminus	O
of	O
the	O
Mutator	B
transposase	I
this	O
alternative	O
gene	O
product	O
was	O
named	O
Trap	B
(	O
transposon	B
-	I
associated	I
protein	I
)	O
.	O

A	O
novel	O
serine	B
kinase	I
activated	O
by	O
rac1	B
/	O
CDC42Hs	B
-	O
dependent	O
autophosphorylation	O
is	O
related	O
to	O
PAK65	B
and	O
STE20	B
.	O

CYP51P1	B
is	O
96.5	O
%	O
identical	O
to	O
the	O
human	B
CYP51	I
coding	O
sequence	O
and	O
is	O
not	O
interrupted	O
with	O
introns	O
but	O
has	O
six	O
in	O
-	O
frame	O
stop	O
codons	O
resulting	O
from	O
point	O
mutations	O
.	O

IgE	B
-	I
binding	I
proteins	I
of	O
Psocoptera	O
were	O
determined	O
by	O
immunoblotting	O
experiments	O
.	O

174	O
,	O
233	O
-	O
247	O
)	O
and	O
Serrate	O
(	O
Serrate1	O
and	O
2	O
;	O
Myat	O
,	O
A.	O
,	O
Henrique	O
,	O
D.	O
,	O
Ish	O
-	O
Horowicz	O
,	O
D.	O
and	O
Lewis	O
,	O
J.	O
,	O
1996	O
.	O

A	O
new	O
technique	O
for	O
the	O
identification	O
of	O
phases	O
contained	O
within	O
a	O
polymer	O
blend	O
is	O
described	O
in	O
this	O
paper	O
.	O

Our	O
studies	O
indicate	O
no	O
single	O
trans	O
-	O
acting	O
factor	O
is	O
absolutely	O
essential	O
for	O
enhancer	O
activity	O
,	O
and	O
that	O
the	O
enhancer	O
activity	O
of	O
MerI	B
is	O
mediated	O
via	O
a	O
combinatorial	O
and	O
additive	O
mechanism	O
.	O

We	O
recently	O
reported	O
the	O
cloning	O
and	O
sequencing	O
of	O
the	O
alpha	B
7	I
integrin	I
chain	I
and	O
its	O
regulated	O
expression	O
during	O
the	O
development	O
of	O
skeletal	O
muscle	O
(	O
Song	O
et	O
al.	O

A	O
structural	O
model	O
for	O
Vpu	B
is	O
proposed	O
in	O
which	O
the	O
membrane	O
anchor	O
precedes	O
a	O
region	O
comprising	O
two	O
amphipathic	O
alpha	O
-	O
helices	O
of	O
opposed	O
polarity	O
,	O
joined	O
by	O
a	O
strongly	O
acidic	O
turn	O
that	O
protrudes	O
into	O
the	O
cytoplasm	O
and	O
contains	O
the	O
CK-2	B
phosphorylation	I
sites	I
.	O

Primer	O
extension	O
analysis	O
and	O
subcloning	O
of	O
the	O
virJ	B
-	O
phoA	B
fusion	O
indicate	O
that	O
the	O
acetosyringone	O
-	O
inducible	O
promoter	O
lies	O
directly	O
upstream	O
of	O
the	O
virJ	B
structural	I
gene	I
.	O

METHODS	O
:	O
A	O
discriminant	O
function	O
predicting	O
surgery	O
outcome	O
(	O
seizure	O
-	O
free	O
vs.	O
non	O
-	O
seizure	O
-	O
free	O
)	O
was	O
computed	O
separately	O
for	O
samples	O
of	O
patients	O
with	O
left	O
(	O
n	O
=	O
79	O
)	O
and	O
right	O
(	O
n	O
=	O
62	O
)	O
temporal	O
lobectomy	O
(	O
LATL	O
,	O
RATL	O
)	O
.	O

A	O
porcine	O
model	O
of	O
diffuse	O
axonal	O
injury	O
,	O
developed	O
with	O
information	O
from	O
these	O
physical	O
models	O
and	O
earlier	O
in	O
vitro	O
tissue	O
modeling	O
studies	O
,	O
is	O
used	O
to	O
correlate	O
histologic	O
and	O
radiologic	O
evidence	O
of	O
axonal	O
injury	O
to	O
predicted	O
regions	O
of	O
injury	O
from	O
the	O
experimental	O
and	O
theoretical	O
analysis	O
.	O

Control	O
of	O
ovulation	O
in	O
mares	O
in	O
the	O
early	O
breeding	O
season	O
with	O
ovarian	O
steroids	O
and	O
prostaglandin	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
response	O
properties	O
of	O
the	O
human	O
visual	O
cortex	O
to	O
chromatic	O
stimuli	O
using	O
magnetoencephalography	O
(	O
MEG	O
)	O
.	O

3	O
.	O

The	O
root	O
-	O
mean	O
-	O
square	O
deviation	O
of	O
bond	O
lengths	O
from	O
the	O
ideal	O
values	O
is	O
0.02	O
A.	O

Sugar	O
analysis	O
was	O
performed	O
on	O
alpha	B
-	I
TM	I
to	O
investigate	O
a	O
possible	O
biosynthetic	O
mechanism	O
for	O
part	O
-	O
time	O
PGs	O
.	O

4	O
.	O

Prevalence	O
of	O
rheumatic	O
diseases	O
in	O
a	O
rural	O
population	O
in	O
western	O
India	O
:	O
a	O
WHO	O
-	O
ILAR	O
COPCORD	O
Study	O
.	O

We	O
conclude	O
that	O
clonidine	O
3	O
micrograms	O
/	O
kg	O
produces	O
sedation	O
comparable	O
to	O
diazepam	O
0.2	O
mg	O
/	O
kg	O
and	O
also	O
attenuates	O
the	O
intubation	O
response	O
without	O
increasing	O
the	O
incidence	O
of	O
complications	O
.	O

The	O
Saccharomyces	O
cerevisiae	O
targets	O
of	O
rapamycin	O
,	O
TOR1	B
and	O
TOR2	B
,	O
signal	O
activation	O
of	O
cell	O
growth	O
in	O
response	O
to	O
nutrient	O
availability	O
.	O

Gene	O
structure	O
and	O
precursor	O
processing	O
.	O

Blood	O
and	O
whole	O
-	O
brain	O
mercury	O
concentrations	O
were	O
determined	O
in	O
pups	O
on	O
PN	O
0	O
(	O
birth	O
)	O
and	O
PN	O
21	O
(	O
weaning	O
)	O
.	O

The	O
blood	O
pressures	O
in	O
43	O
subjects	O
were	O
compared	O
during	O
rapid	O
weight	O
loss	O
and	O
at	O
identical	O
weights	O
during	O
post	O
-	O
fast	O
weight	O
gain	O
(	O
Study	O
A	O
)	O
.	O

Mol	O
.	O

Arg-130	O
,	O
Gly-132	O
and	O
Lys-167	O
are	O
conserved	O
in	O
all	O
members	O
of	O
the	O
type	B
IB	I
topoisomerase	I
family	I
.	O

The	O
maximal	O
rise	O
in	O
plasma	O
adrenaline	O
was	O
of	O
similar	O
magnitude	O
in	O
all	O
three	O
groups	O
but	O
a	O
lower	O
plasma	O
glucose	O
was	O
required	O
to	O
stimulate	O
this	O
hormonal	O
response	O
in	O
the	O
'	O
unaware	O
'	O
patients	O
,	O
in	O
whom	O
the	O
plasma	O
adrenaline	O
concentration	O
was	O
lower	O
at	O
the	O
time	O
of	O
the	O
reaction	O
.	O

PATIENTS--125	O
women	O
consulting	O
the	O
general	O
practitioner	O
for	O
symptomatic	O
bacterial	O
vaginosis	O
.	O

Promoter	O
activity	O
of	O
the	O
proliferating	B
-	I
cell	I
nuclear	I
antigen	I
gene	I
is	O
associated	O
with	O
inducible	O
CRE	B
-	I
binding	I
proteins	I
in	O
interleukin	B
2-stimulated	I
T	O
lymphocytes	O
.	O

The	O
mutation	O
also	O
preferentially	O
limits	O
(	O
compared	O
with	O
total	O
protein	O
synthesis	O
)	O
translation	O
of	O
an	O
induced	O
gene	O
that	O
depends	O
on	O
five	O
AGA	O
codons	O
,	O
i.e.	O
,	O
the	O
lambda	B
cI	I
repressor	I
gene	I
.	O

In	O
contrast	O
,	O
inhibition	O
of	O
MAPK	B
activity	O
by	O
MAPK	B
kinase	I
inhibitor	O
(	O
PD	O
98059	O
)	O
or	O
by	O
overexpression	O
of	O
kinase	O
-	O
deficient	O
MAPKs	B
activated	O
basal	O
and	O
GnRH	B
-	I
A	I
-	O
stimulated	O
GnRHR	B
-	O
Luc	B
activity	O
.	O

For	O
the	O
first	O
,	O
short	O
-	O
term	O
(	O
concurrent	O
)	O
TAL	O
,	O
two	O
different	O
-	O
flavored	O
stimuli	O
were	O
presented	O
at	O
the	O
same	O
time	O
,	O
one	O
associated	O
with	O
simultaneous	O
intragastric	O
administration	O
of	O
an	O
aversive	O
product	O
,	O
hypertonic	O
NaCl	O
,	O
and	O
the	O
other	O
with	O
saline	O
.	O

Heterodimerization	B
mutant	I
RXR	I
failed	O
to	O
alter	O
GFP	B
-	O
VDR	B
and	O
nlsGFP	B
-	O
VDR	B
distribution	O
or	O
activity	O
.	O

Smectic	O
-	O
A	O
ordering	O
at	O
a	O
liquid	O
-	O
vapor	O
interface	O
.	O

These	O
results	O
demonstrate	O
that	O
the	O
entire	O
E3L	B
gene	I
is	O
required	O
for	O
pathogenesis	O
in	O
the	O
mouse	O
model	O
.	O

Parelaphostrongylus	O
odocoilei	O
is	O
redescribed	O
from	O
worms	O
collected	O
from	O
the	O
type	O
host	O
(	O
Odocoileus	O
hemionus	O
columbianus	O
)	O
in	O
California	O
,	O
as	O
well	O
as	O
material	O
from	O
experimentally	O
infected	O
mule	O
deer	O
(	O
O.	O
h.	O
heminus	O
)	O
in	O
Alberta	O
.	O

Particle	O
bombardment	O
of	O
barley	O
aleurone	O
with	O
a	O
B22EL8	B
promoter	I
-	O
GUS	B
(	O
beta	B
-	I
glucuronidase	I
)	O
construct	O
demonstrates	O
that	O
the	O
promoter	O
(	O
3	O
kb	O
)	O
is	O
active	O
in	O
developing	O
barley	O
grains	O
.	O

They	O
elicit	O
similar	O
regional	O
cerebral	O
blood	O
flow	O
(	O
rCBF	O
)	O
patterns	O
,	O
even	O
though	O
sign	O
language	O
is	O
dependent	O
on	O
spatial	O
information	O
.	O

First	O
,	O
a	O
GATA-1	B
motif	I
was	O
found	O
to	O
bind	O
nuclear	O
factor	O
(	O
s	O
)	O
,	O
presumably	O
the	O
GATA-1	B
factor	I
,	O
present	O
in	O
K-562	O
cell	O
extracts	O
and	O
in	O
living	O
K-562	O
cells	O
.	O

There	O
was	O
a	O
direct	O
proportional	O
relationship	O
between	O
the	O
spiral	O
artery	O
flow	O
and	O
the	O
pressure	O
difference	O
between	O
the	O
spiral	O
artery	O
and	O
the	O
amniotic	O
fluid	O
;	O
the	O
pressure	O
difference	O
per	O
flow	O
(	O
the	O
resistance	O
of	O
the	O
cotyledonary	O
unit	O
)	O
was	O
found	O
to	O
be	O
1	O
-	O
-3	O
mm	O
Hg	O
.	O

ml-1	O
.	O

min	O
(	O
8	O
-	O
-24kPa	O
.	O

ml-1	O
.	O

s	O
)	O
.	O

Truncations	O
from	O
Hip	B
's	O
N	O
terminus	O
resulted	O
in	O
an	O
apparent	O
loss	O
of	O
Hip	B
homo	O
-	O
oligomerization	O
,	O
but	O
these	O
mutants	O
retained	O
association	O
with	O
hsp70	B
and	O
were	O
recovered	O
in	O
receptor	O
complexes	O
.	O

3	O
.	O

The	O
rate	O
of	O
collagen	B
synthesis	O
in	O
normal	O
scar	O
was	O
approximately	O
constant	O
between	O
6	O
months	O
and	O
20	O
years	O
after	O
the	O
initial	O
wounding	O
,	O
but	O
in	O
both	O
hypertrophic	O
scar	O
and	O
keloid	O
the	O
rate	O
was	O
initially	O
approximately	O
twice	O
that	O
in	O
normal	O
scar	O
,	O
and	O
2	O
-	O
3	O
years	O
after	O
wounding	O
it	O
fell	O
to	O
approximately	O
the	O
same	O
level	O
as	O
in	O
normal	O
scar	O
.	O

W.	O
,	O
and	O
Touster	O
,	O
O.	O

There	O
was	O
a	O
57	O
%	O
reduction	O
in	O
IGF	B
IR	I
mRNA	I
levels	O
in	O
clone	O
CA9	O
after	O
confluence	O
compared	O
with	O
clone	O
ME10	O
.	O

Uncertainty	O
exists	O
about	O
the	O
function	O
of	O
these	O
potential	O
isoforms	O
of	O
the	O
Cbfa1	B
gene	I
.	O

The	O
RTI40	B
gene	I
spans	O
35	O
kilobase	O
pairs	O
;	O
it	O
contains	O
6	O
exons	O
and	O
at	O
least	O
6	O
rat	O
Identifier	O
repetitive	O
elements	O
.	O

The	O
characteristics	O
of	O
a	O
simple	O
apparatus	O
for	O
clinical	O
use	O
to	O
measure	O
DEOAEs	O
are	O
described	O
together	O
with	O
typical	O
examples	O
of	O
emissions	O
.	O

During	O
seed	O
maturation	O
,	O
the	O
transcriptional	O
activity	O
of	O
napin	B
genes	I
is	O
regulated	O
by	O
developmental	O
signals	O
involving	O
the	O
transcriptional	B
activator	I
ABI3	I
and	O
abscisic	O
acid	O
(	O
ABA	O
)	O
.	O

The	O
isomerization	O
of	O
the	O
pre	O
-	O
existing	O
closed	O
complex	O
to	O
an	O
open	O
promoter	O
form	O
,	O
as	O
judged	O
by	O
the	O
local	O
denaturation	O
of	O
promoter	O
DNA	O
which	O
rendered	O
sequences	O
from	O
+	O
5	O
to	O
-10	O
reactive	O
towards	O
KMnO4	O
,	O
was	O
shown	O
to	O
be	O
fully	O
dependent	O
on	O
NifA.	B

The	O
predicted	O
product	O
exhibits	O
91	O
%	O
amino	O
acid	O
identity	O
to	O
the	O
murine	B
voltage	I
-	I
gated	I
potassium	I
channel	I
protein	I
Kv1.7	I
(	O
Kcna7	B
)	O
,	O
which	O
plays	O
an	O
important	O
role	O
in	O
the	O
repolarization	O
of	O
cell	O
membranes	O
.	O

Elective	O
replacement	O
of	O
the	O
aortic	O
root	O
in	O
Marfan	O
's	O
syndrome	O
.	O

Their	O
main	O
representatives	O
are	O
the	O
American	O
diagnostic	O
and	O
statistical	O
manual	O
of	O
mental	O
disorders	O
,	O
DSM	O
-	O
III	O
,	O
its	O
revised	O
version	O
DSM	O
-	O
III	O
-	O
R	O
and	O
the	O
new	O
international	O
classification	O
of	O
mental	O
disorders	O
iCD-10	O
.	O

Time	O
for	O
action	O
on	O
hepatitis	O
B	O
immunisation	O
.	O

Kramer	O
Hamburg	O
1988	O
,	O
ISBN	O
:	O
3	O
926952	O
07	O
5	O
)	O
,	O
the	O
syndromatic	O
day	O
-	O
to	O
-	O
day	O
shifting	O
of	O
the	O
psychopathological	O
features	O
with	O
manic	O
,	O
depressive	O
and	O
several	O
mixed	O
states	O
has	O
a	O
well	O
-	O
defined	O
time	O
structure	O
,	O
as	O
in	O
25	O
patients	O
studied	O
and	O
reported	O
on	O
in	O
this	O
paper	O
.	O

Internal	O
controls	O
over	O
the	O
volume	O
of	O
milk	O
suckled	O
do	O
not	O
appear	O
until	O
infant	O
rats	O
are	O
about	O
2	O
weeks	O
of	O
age	O
at	O
which	O
time	O
gastric	O
distension	O
,	O
milk	O
,	O
systemic	O
dehydration	O
,	O
and	O
intestinal	B
hormone	I
cholecystokinin	I
suppress	O
milk	O
intake	O
derived	O
through	O
suckling	O
.	O

In	O
addition	O
,	O
WR-3689	O
,	O
WR-109342	O
,	O
and	O
WR-168643	O
were	O
used	O
with	O
per	O
os	O
administration	O
to	O
determine	O
hematopoietic	O
lethality	O
.	O

Isolation	O
and	O
characterization	O
of	O
human	O
orthologs	O
of	O
yeast	O
CCR4-NOT	B
complex	O
subunits	O
.	O

The	O
paper	O
calls	O
for	O
standardized	O
question	O
formats	O
and	O
a	O
centralized	O
body	O
to	O
monitor	O
changes	O
in	O
these	O
parameters	O
of	O
sexual	O
behaviour	O
.	O

A	O
long	O
-	O
term	O
follow	O
-	O
up	O
study	O
of	O
a	O
children	O
's	O
psychiatric	O
day	O
treatment	O
center	O
.	O

Risk	O
factors	O
for	O
atherosclerosis	O
related	O
to	O
nutrition	O
are	O
hypercholesterolemia	O
,	O
hyperglycemia	O
-	O
diabetes	O
,	O
and	O
for	O
hypertension	O
,	O
obesity	O
,	O
high	O
salt	O
intake	O
,	O
and	O
excessive	O
use	O
of	O
alcohol	O
.	O

We	O
demonstrate	O
that	O
the	O
recently	O
proposed	O
synthetic	O
imaging	O
technique	O
[	O
J.	O

We	O
compared	O
the	O
quantities	O
collected	O
with	O
both	O
pollen	O
traps	O
during	O
February	O
,	O
March	O
and	O
April	O
1988	O
and	O
1989	O
.	O

Of	O
the	O
CSF	O
tested	O
,	O
24	O
stimulated	O
oxygen	O
consumption	O
above	O
our	O
cut	O
off	O
,	O
and	O
8	O
did	O
not	O
(	O
0.84	O
+	O
/-	O

0.34	O
,	O
n	O
=	O
24	O
compared	O
with	O
the	O
rate	O
of	O
0.27	O
+	O
/-	O

0.1	O
mumol	O
/	O
min	O
/	O
g	O
dry	O
wt	O
,	O
respectively	O
;	O
SD	O
n	O
=	O
8)	O
at	O
180	O
minutes	O
.	O

We	O
report	O
here	O
on	O
an	O
eight	O
-	O
year	O
-	O
old	O
boy	O
who	O
first	O
developed	O
acute	O
intravascular	O
hemolysis	O
following	O
therapy	O
with	O
amphotericin	O
B	O
(	O
AmB	O
)	O
and	O
subsequently	O
a	O
delayed	O
hemolytic	O
transfusion	O
reaction	O
due	O
to	O
alloantibodies	O
.	O

However	O
,	O
no	O
significant	O
difference	O
in	O
either	O
the	O
Valsalva	O
ratio	O
or	O
delta	O
SBP	O
was	O
found	O
between	O
diabetic	O
patients	O
and	O
controls	O
.	O

The	O
PDSS	O
identified	O
17	O
(	O
94	O
%	O
)	O
of	O
the	O
women	O
diagnosed	O
with	O
major	O
postpartum	O
depression	O
,	O
the	O
EPDS	O
identified	O
14	O
of	O
these	O
women	O
(	O
78	O
%	O
)	O
,	O
and	O
the	O
BDI	O
-	O
II	O
identified	O
10	O
of	O
the	O
18	O
women	O
(	O
56	O
%	O
)	O
.	O

One	O
ORF	O
extends	O
from	O
nucleotides	O
415	O
to	O
1620	O
,	O
encodes	O
402	O
amino	O
acids	O
,	O
and	O
is	O
preceded	O
by	O
a	O
ribosome	O
-	O
binding	O
site	O
.	O

Blood	B
coagulation	I
Factor	I
X	I
and	O
its	O
activated	O
form	O
Factor	B
Xa	I
play	O
an	O
essential	O
role	O
in	O
the	O
midphase	O
of	O
the	O
clotting	O
cascade	O
.	O

On	O
a	O
national	O
level	O
,	O
undiscounted	O
costs	O
are	O
expected	O
to	O
increase	O
up	O
to	O
approximately	O
DF1	O
42	O
million	O
annually	O
during	O
the	O
first	O
40	O
years	O
after	O
introduction	O
of	O
the	O
preventative	O
strategy	O
.	O

Reduction	O
of	O
p53	B
protein	I
was	O
detected	O
after	O
1	O
day	O
of	O
OM	B
treatment	O
and	O
reached	O
maximal	O
suppression	O
of	O
10	O
-	O
20	O
%	O
of	O
control	O
after	O
3	O
days	O
in	O
H3922	O
and	O
40	O
%	O
of	O
control	O
after	O
4	O
days	O
in	O
MCF-7	O
cells	O
.	O

This	O
seems	O
to	O
take	O
place	O
in	O
the	O
same	O
nuclear	O
compartment	O
as	O
normal	O
cis	O
splicing	O
and	O
proceeds	O
through	O
Y	O
-	O
branched	O
intermediates	O
analogous	O
to	O
the	O
lariats	O
formed	O
in	O
cis	O
splicing	O
.	O

These	O
results	O
suggest	O
that	O
E6010	B
may	O
be	O
of	O
clinical	O
value	O
in	O
the	O
treatment	O
of	O
coronary	O
occlusion	O
.	O

We	O
determined	O
their	O
N	O
-	O
terminal	O
amino	O
acid	O
sequence	O
and	O
found	O
that	O
these	O
polypeptides	O
were	O
CotT	B
,	O
YeeK	B
,	O
YxeE	B
,	O
CotF	B
,	O
YrbA	B
(	O
31	O
and	O
45	O
kDa	O
)	O
,	O
and	O
SpoIVA	B
,	O
respectively	O
.	O

The	O
determination	O
of	O
diacetyl	O
,	O
2,3-pentanedione	O
and	O
acetoin	O
was	O
performed	O
in	O
two	O
steps	O
.	O

The	O
same	O
pattern	O
of	O
firing	O
was	O
seen	O
with	O
saccades	O
in	O
light	O
and	O
in	O
complete	O
darkness	O
.	O

The	O
critical	O
obstacle	O
in	O
modeling	O
psychiatric	O
disorders	O
has	O
been	O
limited	O
information	O
about	O
their	O
origin	O
and	O
underlying	O
neural	O
mechanisms	O
.	O

These	O
results	O
suggest	O
that	O
both	O
the	O
distinct	O
DNA	O
binding	O
properties	O
of	O
PMLRAR	B
homodimers	I
and	O
the	O
sequestration	O
of	O
RXR	B
by	O
PMLRARs	B
may	O
contribute	O
to	O
the	O
molecular	O
mechanisms	O
which	O
underlie	O
the	O
pathogenesis	O
of	O
APL	O
.	O

CONCLUSIONS	O
:	O
Patients	O
'	O
attainment	O
of	O
TGB	O
monotherapy	O
was	O
associated	O
with	O
their	O
achievement	O
of	O
positive	O
changes	O
of	O
varying	O
degree	O
on	O
psychological	O
tests	O
.	O

Sixtieth	O
anniversary	O
of	O
Angiotensin	B
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
the	O
transactivation	O
mediated	O
by	O
the	O
p68c	B
-	I
ets-1	I
pr	I
p55erg	B
through	O
the	O
Polyomavirus	B
enhancer	I
sequence	I
is	O
specifically	O
inhibited	O
by	O
the	O
p46kDaPax	B
-	I
QNR	I
in	O
transient	O
transfection	O
assay	O
.	O

SCAN	B
boxes	O
are	O
found	O
in	O
eight	O
other	O
genes	O
in	O
the	O
GenBank	O
database	O
,	O
five	O
of	O
which	O
are	O
also	O
in	O
the	O
Kruppel	B
family	I
of	O
zinc	B
finger	I
proteins	I
lacking	O
KRAB	B
A	I
and	I
B	I
domains	O
and	O
thereby	O
define	O
a	O
new	O
subclass	O
of	O
zinc	B
finger	I
proteins	I
.	O

Since	O
blood	O
serotonin	O
is	O
primarily	O
produced	O
peripherally	O
,	O
these	O
results	O
suggest	O
that	O
some	O
aspect	O
of	O
peripheral	O
serotonin	O
metabolism	O
is	O
abnormal	O
in	O
major	O
depression	O
.	O

Partial	O
albinism	O
and	O
immunodeficiency	O
:	O
ultrastructural	O
study	O
of	O
haemophagocytosis	O
and	O
bone	O
marrow	O
erythroblasts	O
in	O
one	O
case	O
.	O

RESULTS	O
:	O
Twenty	O
-	O
two	O
patients	O
(	O
30	O
%	O
)	O
showed	O
ST	O
-	O
segment	O
depression	O
during	O
AEM	O
and	O
34	O
(	O
49	O
%	O
)	O
on	O
ExT.	O

Enhanced	O
quantum	O
correlations	O
in	O
bound	O
higher	O
-	O
order	O
solitons	O
Quantum	O
effects	O
in	O
N	O
-	O
bound	O
solitons	O
can	O
be	O
drastically	O
enhanced	O
compared	O
to	O
the	O
fundamental	O
soliton	O
.	O

Acute	O
intoxication	O
with	O
cypermethrin	O
(	O
NRDC	O
149	O
)	O
.	O

Whereas	O
the	O
sequence	O
of	O
alpha	B
-	I
actinin	I
(	O
Noegel	O
,	O
A.	O
,	O
W.	O

Overall	O
,	O
it	O
appears	O
that	O
prenatal	O
exposure	O
to	O
androgen	O
-	O
based	O
synthetic	O
progestin	O
exerted	O
a	O
masculinizing	O
and/or	O
defeminizing	O
influence	O
on	O
human	O
behavioral	O
development	O
,	O
whereas	O
prenatal	O
exposure	O
to	O
natural	O
progesterone	O
and	O
progesterone	O
-	O
based	O
synthetic	O
progestin	O
had	O
a	O
feminizing	O
and/or	O
demasculinizing	O
influence	O
,	O
particularly	O
among	O
female	O
subjects	O
.	O

CONCLUSION	O
:	O
In	O
an	O
acute	O
canine	O
model	O
of	O
progressive	O
LCX	O
coronary	O
stenosis	O
,	O
CFR	O
was	O
impaired	O
in	O
both	O
ischemic	O
and	O
remote	O
nonischemic	O
regions	O
in	O
association	O
with	O
mild	O
to	O
moderate	O
ischemic	O
-	O
induced	O
regional	O
myocardial	O
dysfunction	O
.	O

Parathyroid	B
hormone	I
responses	O
of	O
cyclic	O
AMP-	O
,	O
serum-	O
and	O
phorbol	O
ester	O
-	O
responsive	O
reporter	O
genes	O
in	O
osteoblast	O
-	O
like	O
UMR-106	O
cells	O
.	O

Genome	O
timeline	O
.	O

The	O
""""	O
Ulm	O
Zucker	O
Uhr	O
System	O
""""	O
comprises	O
a	O
microdialysis	O
probe	O
,	O
a	O
biosensor	O
(	O
Glucosensor	O
Unitec	O
Ulm	O
s.c	O
.	O
)	O
,	O
a	O
sender	O
transferring	O
telemetrically	O
the	O
glucose	O
concentrations	O
,	O
and	O
a	O
receiving	O
indicator	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
glucose	O
repression	O
of	O
PRB1	B
transcription	O
is	O
not	O
mediated	O
by	O
HXK2	B
or	O
by	O
the	O
SNF1	B
,	O
SNF4	B
,	O
and	O
SNF6	B
genes	I
(	O
C.	O

Our	O
objective	O
was	O
to	O
find	O
possible	O
predictors	O
for	O
the	O
expression	O
and	O
progression	O
of	O
LJM	O
and	O
to	O
evaluate	O
the	O
relationship	O
between	O
LJM	O
and	O
other	O
long	O
-	O
term	O
complications	O
of	O
insulin	B
-	O
dependent	O
diabetes	O
mellitus	O
.	O

To	O
test	O
this	O
hypothesis	O
,	O
we	O
developed	O
a	O
system	O
of	O
transient	O
transfection	O
of	O
rat	O
adipocytes	O
with	O
constructs	O
containing	O
glyceraldehyde-3-phosphate	B
dehydrogenase	I
(	O
GAPDH	B
)	O
and	O
fatty	B
acid	I
synthetase	I
(	O
FAS	B
)	O
promoters	O
fused	O
to	O
gene	B
reporter	I
CAT	I
.	O

Comparison	O
of	O
this	O
gene	O
with	O
the	O
available	O
databases	O
reveals	O
very	O
significant	O
homology	O
to	O
the	O
ETS	B
factor	I
PE-1	B
and	O
probable	O
near	O
-	O
identity	O
with	O
the	O
recently	O
cloned	O
factor	O
ERF	B
.	O

Eight	O
of	O
these	O
suppressors	O
for	O
into	O
two	O
complementation	O
groups	O
,	O
designated	O
KCS1	B
and	O
KCS2	B
.	O

Also	O
,	O
the	O
absence	O
of	O
PdNi	O
between	O
the	O
segments	O
reduces	O
the	O
heat	O
production	O
of	O
the	O
seed	O
.	O

Further	O
analysis	O
of	O
the	O
CAP59	B
locus	I
of	I
Cryptococcus	I
neoformans	I
:	O
structure	O
defined	O
by	O
forced	O
expression	O
and	O
description	O
of	O
a	O
new	O
ribosomal	B
protein	I
-	I
encoding	I
gene	I
.	O

The	O
results	O
showed	O
a	O
significant	O
group	O
effect	O
only	O
on	O
the	O
active	O
task	O
.	O

Localization	O
of	O
the	O
porcine	O
enzyme	O
in	O
the	O
endoplasmic	O
reticulum	O
is	O
consistent	O
with	O
immuno	O
-	O
electron	O
-	O
microscopic	O
studies	O
using	O
pig	O
hepatocytes	O
.	O

International	O
efforts	O
are	O
now	O
being	O
made	O
to	O
standardize	O
haemolytic	O
test	O
conditions	O
and	O
the	O
present	O
study	O
is	O
meant	O
as	O
a	O
contribution	O
to	O
this	O
.	O

The	O
DFA	O
slide	O
prepared	O
from	O
the	O
ThinPrep	O
Test	O
and	O
the	O
conventional	O
DFA	O
sample	O
prepared	O
from	O
the	O
endocervical	O
swab	O
were	O
evaluated	O
independently	O
.	O

We	O
suggest	O
that	O
the	O
responses	O
to	O
types	B
I	I
and	I
II	I
collagen	I
were	O
caused	O
by	O
a	O
cross	O
-	O
reaction	O
with	O
type	B
III	I
collagen	I
peptides	O
.	O

The	O
ventricular	O
demand	O
pacemaker	O
(	O
VVI	O
)	O
was	O
implanted	O
three	O
years	O
ago	O
and	O
because	O
of	O
further	O
impairment	O
of	O
cardiac	O
performance	O
an	O
av	O
-	O
sequential	O
pacemaker	O
(	O
DDD	O
)	O
was	O
used	O
to	O
restore	O
atrio	O
-	O
ventricular	O
synchronisation	O
.	O

Individual	O
and	O
combined	O
effects	O
of	O
fumonisin	B
B1	I
present	O
in	O
Fusarium	O
moniliforme	O
culture	O
material	O
and	O
diacetoxyscirpenol	O
or	O
ochratoxin	O
A	O
in	O
turkey	O
poults	O
.	O

This	O
C	O
-	O
terminal	O
domain	O
contains	O
several	O
YxxI	O
/	O
L	O
motifs	O
reminiscent	O
of	O
LMP2A	B
and	O
a	O
putative	O
TRAF	B
binding	I
site	I
as	O
in	O
LMP1	B
.	O

Muscle	O
and	O
liver	O
biopsies	O
demonstrated	O
the	O
same	O
anomalies	O
,	O
again	O
without	O
branching	B
enzyme	I
deficiency	O
in	O
the	O
liver	O
.	O

The	O
1031-bp	B
wild	I
-	I
type	I
HIT1	I
DNA	I
which	O
contained	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
164	O
amino	O
acids	O
and	O
the	O
AGG	B
arginine	I
tRNA	I
gene	I
complemented	O
all	O
hit1	B
-	I
1	I
mutant	I
phenotypes	I
,	O
indicating	O
that	O
the	O
mutant	O
phenotypes	O
were	O
caused	O
by	O
the	O
deletion	O
of	O
these	O
genes	O
.	O

Heterotrimeric	O
guanine	B
nucleotide	I
-	I
binding	I
proteins	I
(	O
G	B
-	I
proteins	I
)	O
function	O
as	O
signal	O
transducers	O
for	O
a	O
variety	O
of	O
hormone	O
-	O
coupled	O
enzyme	O
and	O
ion	O
transport	O
systems	O
in	O
eukaryotic	O
cells	O
.	O

Mibefradil	O
(	O
Ro	O
40	O
-	O
5967	O
)	O
is	O
a	O
novel	O
nondihydropyridine	O
calcium	O
antagonist	O
.	O

The	O
recombinant	O
containing	O
the	O
full	O
-	O
length	O
polyhedrin	B
leader	O
sequence	O
gave	O
levels	O
of	O
N	B
mRNA	I
comparable	O
to	O
those	O
of	O
AcNPV	B
polyhedrin	I
mRNA	I
.	O

Four	O
of	O
12	O
patients	O
(	O
33	O
%	O
)	O
were	O
initially	O
diagnosed	O
as	O
having	O
a	O
benign	O
disease	O
(	O
false	O
-	O
negatives	O
)	O
.	O

Using	O
reporter	O
gene	O
constructs	O
driven	O
by	O
the	O
CD4	B
promoter	I
,	O
we	O
report	O
that	O
HHV-6	O
can	O
efficiently	O
transactivate	O
such	O
genetic	O
elements	O
.	O

Removal	O
of	O
ink4a	B
dramatically	O
reduces	O
the	O
lymphoid	O
and	O
neurological	O
defects	O
seen	O
in	O
bmi-1-deficient	B
mice	O
,	O
indicating	O
that	O
ink4a	B
is	O
a	O
critical	O
in	O
vivo	O
target	O
for	O
Bmi-1	B
.	O

In	O
fifty	O
non	O
selected	O
ductal	O
carcinomas	O
of	O
the	O
breast	O
we	O
found	O
that	O
a	O
marked	O
tumoral	O
inflammatory	O
infiltrate	O
(	O
P	O
less	O
than	O
0.025	O
)	O
,	O
perinodal	O
tumoral	O
infiltrate	O
(	O
P	O
less	O
than	O
0.01	O
)	O
,	O
sinus	O
catarrh	O
(	O
P	O
less	O
than	O
0.05	O
)	O
,	O
follicular	O
hyperplasia	O
(	O
P	O
less	O
than	O
0.025	O
)	O
,	O
mixed	O
pattern	O
in	O
lymph	O
nodes	O
(	O
P	O
less	O
than	O
0.01	O
)	O
and	O
with	O
54	O
years	O
of	O
age	O
or	O
younger	O
(	O
P	O
less	O
than	O
0.01	O
)	O
correlated	O
significantly	O
with	O
lymph	O
node	O
metastases	O
and/or	O
high	O
histologic	O
grade	O
.	O

The	O
herpesvirus	B
entry	I
mediator	I
C	I
(	O
HveC	B
)	O
,	O
previously	O
known	O
as	O
poliovirus	B
receptor	I
-	I
related	I
protein	I
1	I
(	O
PRR1	B
)	O
,	O
and	O
the	O
herpesvirus	B
Ig	I
-	I
like	I
receptor	I
(	O
HIgR	B
)	O
are	O
the	O
bona	O
fide	O
receptors	O
employed	O
by	O
herpes	O
simplex	O
virus-1	O
and	O
-2	O
(	O
HSV-1	O
and	O
-2	O
)	O
for	O
entry	O
into	O
the	O
human	O
cell	O
lines	O
most	O
frequently	O
used	O
in	O
HSV	O
studies	O
.	O

Spinal	O
injuries	O
in	O
a	O
multiple	O
trauma	O
patient	O
.	O

Creatinine	O
and	O
creatine	B
phosphokinase	I
(	O
CPK	B
)	O
.	O

The	O
glyoxysomal	O
and	O
plastid	O
molecular	O
chaperones	O
(	O
70-kDa	B
heat	I
shock	I
protein	I
)	O
of	O
watermelon	O
cotyledons	O
are	O
encoded	O
by	O
a	O
single	O
gene	O
.	O

Thus	O
,	O
cross	O
-	O
resistance	O
between	O
fluoroquinolones	O
was	O
shown	O
for	O
both	O
enterococci	O
and	O
MRSA	O
.	O

Furthermore	O
we	O
elucidate	O
the	O
subtle	O
highly	O
anisotropic	O
interchain	O
correlations	O
and	O
reveal	O
the	O
detailed	O
atomic	O
structure	O
of	O
the	O
low	O
-	O
temperature	O
(	O
8x2	O
)	O
phase	O
.	O

With	O
stimulation	O
beyond	O
the	O
theta	O
-	O
range	O
three	O
phenomena	O
occurred	O
:	O
shift	O
of	O
the	O
burst	O
frequencies	O
to	O
higher	O
or	O
lower	O
harmonics	O
of	O
stimulation	O
frequencies	O
;	O
complex	O
interactions	O
of	O
basic	O
background	O
frequency	O
with	O
rhythm	O
of	O
stimulation	O
(	O
""""	O
beating	O
""""	O
)	O
;	O
return	O
to	O
background	O
theta	O
-	O
burst	O
frequency	O
in	O
spite	O
of	O
continuing	O
stimulation	O
(	O
""""	O
escape	O
""""	O
)	O
.	O

Incorporation	O
of	O
this	O
information	O
in	O
the	O
data	O
brought	O
about	O
a	O
revised	O
five	O
-	O
year	O
survival	O
estimate	O
of	O
55	O
percent	O
.	O

Our	O
previous	O
studies	O
demonstrated	O
that	O
the	O
promyelocytic	O
leukemia	O
gene	O
,	O
PML	B
which	O
involved	O
in	O
the	O
15;17	O
translocation	O
in	O
acute	O
promyelocytic	O
leukemia	O
(	O
APL	O
)	O
is	O
a	O
growth	O
and	O
transformation	O
suppressor	O
.	O

These	O
characteristics	O
add	O
to	O
the	O
suitability	O
of	O
NM441	O
as	O
an	O
effective	O
prodrug	O
of	O
NM394	O
.	O

Sequence	O
analysis	O
of	O
cDNA	O
clones	O
encoding	O
human	O
gamma	O
revealed	O
an	O
open	O
reading	O
frame	O
predicting	O
a	O
protein	O
of	O
299	O
amino	O
acids	O
(	O
approximately	O
32	O
kDa	O
)	O
,	O
half	O
the	O
size	O
of	O
the	O
bovine	O
gamma	O
subunit	O
.	O

DISCUSSION	O
:	O
The	O
higher	O
absolute	O
knee	O
extension	O
strength	O
measures	O
of	O
leg	O
and	O
the	O
similar	O
extension	O
strength	O
of	O
the	O
trunk	O
in	O
the	O
obese	O
sample	O
compared	O
to	O
the	O
lean	O
might	O
be	O
explained	O
by	O
the	O
training	O
effect	O
of	O
weight	O
bearing	O
and	O
support	O
of	O
a	O
larger	O
body	O
mass	O
.	O

Measuring	O
the	O
dim	O
light	O
melatonin	O
onset	O
(	O
DLMO	O
)	O
is	O
a	O
useful	O
and	O
practical	O
way	O
to	O
assess	O
circadian	O
phase	O
position	O
in	O
humans	O
.	O

A	O
survey	O
of	O
children	O
with	O
HBsAg	B
markers	I
related	O
to	O
their	O
parents	O
HBV	O
markers	O
.	O

Rv	O
was	O
7.7	O
+	O
/-	O

1.4	O
mmHg.ml-1.min.100	O
g-1	O
and	O
Cv	O
was	O
0.59	O
+	O
/-	O

0.25	O
ml	O
/	O
mmHg	O
,	O
tau	O
v	O
calculated	O
from	O
the	O
product	O
of	O
Rv	O
and	O
Cv	O
was	O
4.20	O
+	O
/-	O

1.58	O
s	O
and	O
from	O
the	O
ratio	O
of	O
delta	O
V	O
to	O
delta	O
Q	O
was	O
4.95	O
+	O
/-	O

1.53	O
s	O
(	O
P	O
=	O
NS	O
)	O
at	O
a	O
mean	O
Pel	O
of	O
17.6	O
+	O
/-	O

3.7	O
mmHg	O
.	O

delta	O
V	O
was	O
also	O
produced	O
by	O
changing	O
Pv	O
;	O
the	O
average	O
tau	O
v	O
(	O
1.95	O
+	O
/-	O

0.37	O
s	O
)	O
,	O
was	O
shorter	O
than	O
that	O
with	O
changes	O
in	O
flow	O
.	O

Peripheral	O
neuropathy	O
in	O
the	O
cherry	O
-	O
red	O
spot	O
-	O
myoclonus	O
syndrome	O
(	O
sialidosis	O
type	O
I	O
)	O
.	O

For	O
O3	O
,	O
the	O
correlation	O
between	O
personal	O
exposures	O
and	O
ambient	O
levels	O
was	O
weakest	O
in	O
the	O
winter	O
for	O
residential	O
microenvironments	O
(	O
rs	O
=	O
0.05	O
,	O
p	O
>	O
0.05	O
)	O
,	O
and	O
was	O
strongest	O
in	O
the	O
summer	O
for	O
outdoor	O
near	O
-	O
roadway	O
microenvironments	O
(	O
rs	O
=	O
0.91	O
,	O
p	O
<	O
0.05	O
)	O
.	O

The	O
""""	O
Gregg	O
phenomenon	O
""""	O
implies	O
that	O
myocardial	O
function	O
and	O
oxygen	O
consumption	O
(	O
MVO2	O
)	O
increase	O
when	O
coronary	O
perfusion	O
is	O
enhanced	O
within	O
or	O
above	O
the	O
autoregulatory	O
range	O
.	O

Pollinosis	O
in	O
the	O
U.A.R.	O

We	O
found	O
that	O
the	O
PRP20	B
gene	I
is	O
identical	O
to	O
the	O
yeast	B
SRM1	I
gene	I
(	O
Clark	O
and	O
Sprague	O
1989	O
)	O
.	O

Transcriptional	O
activation	O
of	O
the	O
proopiomelanocortin	B
gene	I
by	O
cyclic	B
AMP	I
-	I
responsive	I
element	I
binding	I
protein	I
.	O

After	O
discharge	O
,	O
he	O
was	O
finally	O
given	O
a	O
diagnosis	O
of	O
PCH	O
because	O
a	O
Donath	O
-	O
Landsteiner	O
test	O
was	O
positive	O
.	O

Human	O
forearm	O
was	O
used	O
as	O
a	O
dummy	O
ear	O
and	O
the	O
electrode	O
HN-5	O
was	O
fixed	O
thereon	O
,	O
and	O
a	O
sound	O
stimulus	O
of	O
90dBnHL	O
was	O
delivered	O
by	O
the	O
earphone	O
(	O
NC-3	O
)	O
.	O

However	O
,	O
their	O
stability	O
was	O
low	O
as	O
already	O
reported	O
for	O
the	O
ARS	O
in	O
S.	O
occidentalis	O
.	O

When	O
gene	O
conversion	O
is	O
initiated	O
by	O
a	O
double	O
-	O
strand	O
break	O
(	O
DSB	O
)	O
,	O
any	O
nonhomologous	O
DNA	O
that	O
may	O
be	O
present	O
at	O
the	O
ends	O
must	O
be	O
removed	O
before	O
new	O
DNA	O
synthesis	O
can	O
be	O
initiated	O
.	O

MRI	O
visualization	O
of	O
proteoglycan	O
depletion	O
in	O
articular	O
cartilage	O
via	O
intravenous	O
administration	O
of	O
Gd	O
-	O
DTPA	O
.	O

Furthermore	O
,	O
the	O
GC	O
-	O
rich	O
sequences	O
could	O
confer	O
Sp1-dependent	B
transactivation	O
to	O
a	O
heterologous	O
prolactin	B
minimal	I
promoter	I
.	O

Neuronal	O
activity	O
of	O
58	O
dopaminergic	O
(	O
DA	O
)	O
and	O
200	O
non	O
-	O
dopaminergic	O
(	O
non	O
-	O
DA	O
)	O
neurons	O
in	O
the	O
ventral	O
tegmental	O
area	O
(	O
VTA	O
)	O
of	O
female	O
monkeys	O
was	O
recorded	O
,	O
and	O
correlation	O
to	O
bar	O
press	O
feeding	O
,	O
sensory	O
stimulation	O
and	O
change	O
in	O
motivation	O
was	O
investigated	O
.	O

It	O
is	O
required	O
for	O
correct	O
expression	O
of	O
both	O
genes	O
.	O

Cloning	O
the	O
cDNA	O
for	O
a	O
new	O
human	B
zinc	I
finger	I
protein	I
defines	O
a	O
group	O
of	O
closely	O
related	O
Kruppel	B
-	I
like	I
transcription	I
factors	I
.	O

Recently	O
,	O
we	O
and	O
other	O
laboratories	O
have	O
identified	O
a	O
family	O
of	O
caveolin	B
-	I
related	I
proteins	I
;	O
caveolin	B
has	O
been	O
re	O
-	O
termed	O
caveolin-1	B
.	O

Six	O
cDNAs	O
represent	O
human	O
homologs	O
of	O
genes	O
known	O
in	O
other	O
species	O
,	O
namely	O
,	O
mouse	B
HSPE71	I
,	O
Rat	B
RhoGAP	I
protein	I
,	O
S	B
cerevisiae	I
leucyl	I
tRNA	I
synthetase	I
and	O
S	B
cerevisiae	I
chromosome	I
II	I
ORF	I
YBLO44W	I
.	O

The	O
hepatic	O
isoform	O
of	O
6-phosphofructo-2-kinase	B
/	O
fructose-2,6-bisphosphatase	B
(	O
PF2K	B
/	O
Fru-2,6-BPase	B
)	O
is	O
transcriptionally	O
stimulated	O
by	O
glucocorticoids	O
,	O
whereas	O
insulin	B
blocks	O
this	O
stimulatory	O
effect	O
.	O

I.	O

Such	O
simple	O
injuries	O
may	O
however	O
be	O
accompanied	O
by	O
far	O
reaching	O
consequences	O
.	O

The	O
132-bp	B
PHO8p	I
fragment	I
,	O
connected	O
at	O
position	O
-281	O
of	O
the	O
5	O
'	O
upstream	O
region	O
of	O
a	O
HIS5'-'lacZ	B
fused	O
gene	O
,	O
could	O
sense	O
Pi	O
signals	O
in	O
vivo	O
,	O
but	O
a	O
20-bp	O
synthetic	O
oligonucleotide	O
having	O
the	O
same	O
sequence	O
from	O
-544	O
to	O
-525	O
of	O
the	O
PHO8p	B
DNA	I
could	O
not	O
.	O

In	O
resume	O
response	O
to	O
treatment	O
with	O
usual	O
regimens	O
,	O
doxycycline	O
plus	O
streptomycin	O
of	O
doxycycline	O
rifampicin	O
is	O
good	O
,	O
being	O
however	O
time	O
elapsed	O
until	O
pain	O
ceases	O
of	O
mean	O
length	O
in	O
hospital	O
stay	O
shorter	O
in	O
the	O
group	O
receiving	O
doxycycline	O
plus	O
streptomycin	O
.	O

Having	O
demonstrated	O
proper	O
localization	O
of	O
GFP	B
-	O
calmodulin	B
in	O
budding	O
yeast	O
,	O
we	O
examined	O
the	O
localization	O
of	O
a	O
fusion	O
between	O
GFP	B
and	O
calmodulin	B
(	O
GFP	B
-	I
Camlp	I
)	O
in	O
fission	O
yeast	O
,	O
where	O
calmodulin	B
had	O
not	O
been	O
localized	O
by	O
any	O
method	O
.	O

Fourteen	O
eyes	O
(	O
38.9	O
%	O
)	O
developed	O
DLK	O
after	O
an	O
epithelial	O
defect	O
,	O
representing	O
an	O
odds	O
ratio	O
of	O
13	O
times	O
.	O

Each	O
subject	O
was	O
injected	O
in	O
the	O
antecubital	O
vein	O
with	O
7	O
mg	O
/	O
kg	O
of	O
sodium	O
fluorescein	O
(	O
25	O
%	O
solution	O
)	O
and	O
measurements	O
were	O
taken	O
1	O
hr	O
postinjection	O
at	O
4.5	O
mm	O
and	O
7.5	O
mm	O
from	O
the	O
retina	O
.	O

Such	O
tetranucleotides	O
are	O
common	O
in	O
promoter	O
regions	O
,	O
particularly	O
in	O
activating	B
transcription	I
factor	I
/	O
cyclic	B
AMP	I
response	I
element	I
-	I
binding	I
protein	I
(	O
ATF	B
/	O
CREB	B
)	O
and	O
E	O
-	O
box	O
motifs	O
,	O
suggesting	O
that	O
PIF	B
may	O
modulate	O
the	O
transcription	O
of	O
many	O
genes	O
.	O

The	O
long	O
terminal	O
repeat	O
is	O
590	O
bp	O
in	O
length	O
,	O
with	O
the	O
U3	O
region	O
containing	O
consensus	O
sequences	O
likely	O
to	O
be	O
involved	O
in	O
viral	O
gene	O
expression	O
.	O

A	O
pathogenetic	O
relation	O
with	O
the	O
Eisenmenger	O
's	O
syndrome	O
is	O
discussed	O
.	O

The	O
PHO5	B
gene	I
is	O
activated	O
by	O
the	O
Pho4p	B
transcription	I
factor	I
,	O
which	O
itself	O
is	O
negatively	O
regulated	O
through	O
phosphorylation	O
by	O
the	O
products	O
of	O
PHO80	B
and	O
PHO85	B
.	O

This	O
deletion	O
disrupts	O
the	O
PU.1	B
Ets	B
domain	I
.	O

Basal	O
urinary	O
17-hydroxycorticoid	O
(	O
17-OHCS	O
)	O
values	O
were	O
elevated	O
in	O
9	O
/	O
12	O
patients	O
and	O
low	O
dose	O
dexamethasone	O
suppression	O
test	O
favoured	O
Cushing	O
's	O
syndrome	O
in	O
8	O
/	O
9	O
patients	O
.	O

In	O
this	O
cross	O
-	O
over	O
controlled	O
study	O
,	O
five	O
male	O
volunteers	O
donated	O
one	O
unit	O
of	O
red	O
cells	O
by	O
MCS	O
and	O
one	O
unit	O
of	O
whole	O
blood	O
by	O
the	O
conventional	O
manual	O
method	O
,	O
3	O
months	O
apart	O
.	O

D.	O

1	O
.	O

1995	O
.	O

Although	O
immunoglobulin	B
and	O
CRP	B
concentration	O
increased	O
,	O
anemia	O
obviously	O
improved	O
with	O
hemoglobin	B
levels	O
increasing	O
from	O
4.8	O
g	O
/	O
dl	O
to	O
8.5	O
g	O
/	O
dl	O
without	O
any	O
side	O
effects	O
.	O

These	O
data	O
also	O
demonstrate	O
that	O
insulin	B
and	O
TPA	O
activate	O
MBP	B
/	O
MAP2	B
kinase	O
activity	O
by	O
de	O
novo	O
phosphorylation	O
of	O
threonine	O
and	O
tyrosine	O
residues	O
via	O
a	O
very	O
similar	O
pathway	O
.	O

100	O
and	O
51	O

p.	O

The	O
results	O
obtained	O
with	O
[	B
F304	I
]	I
R2	I
indicate	O
that	O
structural	O
changes	O
in	O
E.	B
coli	I
R2	I
in	O
the	O
vicinity	O
of	O
this	O
helix	O
distortion	O
can	O
influence	O
the	O
catalytic	O
activity	O
of	O
the	O
holoenzyme	O
.	O

This	O
result	O
is	O
consistent	O
with	O
the	O
previous	O
observation	O
that	O
expression	O
of	O
the	O
hsp70	B
genes	I
in	I
T.	I
brucei	I
is	O
mainly	O
controlled	O
at	O
the	O
posttranscriptional	O
level	O
.	O

The	O
cloned	O
rRNA	O
operon	O
was	O
transcribed	O
in	O
vitro	O
by	O
using	O
purified	B
RNA	I
polymerase	I
of	I
Escherichia	I
coli	I
.	O

To	O
test	O
whether	O
Cd	O
exposure	O
would	O
increase	O
Ca	O
release	O
from	O
bone	O
during	O
pregnancy	O
and	O
lactation	O
in	O
relation	O
to	O
the	O
etiological	O
mechanism	O
of	O
Itai	O
-	O
Itai	O
disease	O
,	O
virgin	O
female	O
mice	O
with	O
45Ca	O
prelabeled	O
skeletons	O
(	O
15	O
microCi	O
/	O
mouse	O
)	O
were	O
subjected	O
to	O
one	O
round	O
of	O
pregnancy	O
/	O
lactation	O
and	O
were	O
exposed	O
to	O
a	O
Ca	O
-	O
deficient	O
diet	O
containing	O
0	O
,	O
5	O
,	O
or	O
25	O
ppm	O
Cd	O
or	O
25	O
ppm	O
Pb	O
for	O
32	O
days	O
,	O
from	O
conception	O
until	O
Lactation	O
Day	O
14	O
.	O

G	B
-	I
box	I
binding	I
factors	I
(	O
GBFs	B
)	O
constitute	O
a	O
family	O
of	O
plant	O
DNA	O
-	O
binding	O
proteins	O
that	O
bind	O
to	O
the	O
G	O
-	O
box	O
motif	O
,	O
a	O
regulatory	O
cis	O
element	O
present	O
in	O
many	O
plant	O
genes	O
with	O
a	O
palindromic	O
DNA	O
motif	O
of	O
CACGTG	O
.	O

Anovulatory	O
cycles	O
with	O
an	O
apparently	O
normal	O
level	O
of	O
blood	O
prolactin	B
.	O

Cardiovascular	O
drug	O
use	O
and	O
hospitalizations	O
attributable	O
to	O
type	O
2	O
diabetes	O
.	O

Renal	O
cell	O
carcinoma	O
induced	O
Coombs	O
negative	O
autoimmune	O
hemolytic	O
anemia	O
and	O
severe	O
thrombocytopenia	O
responsive	O
to	O
nephrectomy	O
.	O

The	O
c	B
-	I
Jun	I
delta	I
-	I
domain	I
inhibits	O
neuroendocrine	O
promoter	O
activity	O
in	O
a	O
DNA	O
sequence-	O
and	O
pituitary	O
-	O
specific	O
manner	O
.	O

Finally	O
,	O
antisense	O
mediated	O
reduction	O
of	O
Elk-1	B
in	O
GH4	O
cells	O
decreased	O
insulin	B
-	O
increased	O
prolactin	B
gene	I
expression	O
and	O
confirmed	O
the	O
requirement	O
for	O
Elk-1	B
for	O
insulin	B
-	O
increased	O
prolactin	B
gene	I
expression	O
.	O

Smooth	O
pursuit	O
gain	O
and	O
the	O
percentage	O
of	O
total	O
eye	O
movement	O
due	O
to	O
various	O
saccadic	O
subtypes	O
were	O
computed	O
using	O
infrared	O
oculography	O
and	O
computerized	O
pattern	O
recognition	O
software	O
.	O

Mitoxantrone	O
plus	O
ara	O
-	O
C	O
is	O
an	O
active	O
combination	O
with	O
great	O
promise	O
for	O
the	O
therapy	O
of	O
previously	O
untreated	O
patients	O
with	O
AML	O
.	O

During	O
an	O
observation	O
period	O
of	O
12	O
weeks	O
after	O
halving	O
atenolol	O
from	O
a	O
mean	O
dose	O
of	O
82	O
mg	O
to	O
41	O
mg	O
,	O
no	O
significant	O
changes	O
in	O
systolic	O
and	O
diastolic	O
blood	O
pressure	O
or	O
in	O
response	O
rate	O
(	O
defined	O
as	O
a	O
diastolic	O
blood	O
pressure	O
of	O
95	O
mm	O
Hg	O
or	O
less	O
)	O
were	O
observed	O
.	O

Diet	O
imbalances	O
and	O
aflatoxicosis	O

WBC	O
differential	O
(	O
SEG	O
,	O
BAND	O
,	O
LYMPH	O
,	O
MONO	O
,	O
EOSINO	O
,	O
BASO	O
)	O
usually	O
showed	O
log	O
-	O
normal	O
distribution	O
.	O

Recombinant	O
protein	O
encoded	O
by	O
ESX	B
(	O
for	O
epithelial	B
-	I
restricted	I
with	I
serine	I
box	I
)	O
exhibits	O
Ets	B
-	I
like	I
DNA	O
binding	O
specificity	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
,	O
in	O
transient	O
transfection	O
assays	O
,	O
transactivates	O
Ets	B
-	I
responsive	I
promoter	I
elements	I
including	O
that	O
found	O
in	O
the	O
HER2	B
/	O
neu	B
oncogene	O
.	O

Two	O
adjacent	O
,	O
highly	O
homologous	B
endoglucanase	I
genes	I
,	O
celD	B
and	O
celE	B
from	O
Fibrobacter	O
succinogenes	O
S85	O
,	O
which	O
were	O
separated	O
by	O
an	O
AT	O
-	O
rich	O
223-nucleotide	O
intergenic	O
region	O
were	O
characterized	O
.	O

Sequence	O
analysis	O
of	O
this	O
region	O
showed	O
it	O
contained	O
five	O
potential	O
copies	O
of	O
the	O
sterol	O
regulatory	O
element	O
(	O
SRE-1	O
)	O
(	O
Smith	O
,	O
J.R.	O
,	O
Osborne	O
,	O
T.F.	O
,	O
Brown	O
,	O
M.S.	O
,	O
Goldstein	O
,	O
J.L.	O
,	O
and	O
Gil	O
,	O
G.	O

Fetal	O
PaO2	O
fell	O
somewhat	O
during	O
the	O
recovery	O
stages	O
in	O
both	O
NIT	O
and	O
control	O
groups	O
.	O

It	O
also	O
showed	O
which	O
amino	O
acid	O
residues	O
would	O
contact	O
an	O
extended	O
TATA	O
box	O
with	O
a	O
B	B
recognition	I
element	I
,	O
and	O
evolutionary	O
conservation	O
of	O
the	O
TBP	B
-	O
TFB	B
-	O
DNA	O
complex	O
orientation	O
between	O
two	O
archaeal	O
organisms	O
with	O
widely	O
different	O
optimal	O
temperature	O
for	O
growth	O
(	O
37	O
and	O
100	O
degrees	O
C	O
)	O
.	O

The	O
average	O
progression	O
was	O
11.6	O
(	O
SD	O
9.0	O
)	O
.	O

Result	O
were	O
as	O
followed	O
:	O
1	O
)	O
Early	O
cancer	O
-	O
like	O
advanced	O
cancers	O
were	O
consisted	O
of	O
133	O
lesions	O
,	O
of	O
which	O
128	O
lesions	O
(	O
96.2	O
%	O
)	O
had	O
peptic	O
ulcer	O
in	O
cancerous	O
lesion	O
(	O
73	O
lesions	O
were	O
active	O
stage	O
and	O
55	O
lesions	O
were	O
scarring	O
stage	O
)	O
.	O

The	O
unexpected	O
prevalence	O
of	O
c	B
-	I
myc	I
and	O
alpha	B
-	I
tubulin	I
in	O
the	O
S	O
-	O
phase	O
library	O
is	O
supported	O
by	O
Northern	O
analysis	O
of	O
RNA	O
from	O
phase	O
-	O
synchronous	O
cells	O
.	O

A	O
spectrophotometric	O
method	O
for	O
the	O
microdetermination	O
of	O
periodate	O
.	O

Eleven	O
of	O
the	O
12	O
exons	O
have	O
complete	O
sequence	O
homology	O
with	O
the	O
RBM-1	B
sequence	I
.	O

Polyoma	O
virus	O
in	O
urine	O
during	O
pregnancy	O
.	O

Using	O
probes	O
from	O
these	O
regions	O
,	O
rearrangements	O
have	O
been	O
identified	O
in	O
each	O
of	O
nine	O
cases	O
of	O
t	O
(	O
8;21	O
)	O

AML	O
examined	O
.	O

The	O
delta	O
G	O
values	O
of	O
these	O
regions	O
were	O
higher	O
,	O
i.e.	O
potential	O
secondary	O
structural	O
elements	O
were	O
fewer	O
,	O
than	O
in	O
TIR	O
of	O
genes	O
from	O
E.	O
coli	O
.	O

In	O
each	O
patient	O
,	O
MBF	O
was	O
quantified	O
in	O
the	O
three	O
major	O
vascular	O
territories	O
:	O
the	O
left	O
anterior	O
descending	O
and	O
left	O
circumflex	O
coronary	O
artery	O
territories	O
and	O
the	O
right	O
coronary	O
artery	O
(	O
control	O
region	O
)	O
territory	O
.	O

We	O
conclude	O
that	O
99mTc	O
-	O
HL91	O
is	O
a	O
potent	O
marker	O
of	O
myocardial	O
viability	O
when	O
used	O
during	O
the	O
early	O
acute	O
phase	O
after	O
reperfusion	O
.	O

The	O
community	O
-	O
acquired	O
bacteremia	O
was	O
mainly	O
due	O
to	O
E.	O
coli	O
.	O

The	O
benzo	O
-	O
pyrone	O
drug	O
Venalot	O
had	O
a	O
considerable	O
effect	O
in	O
reducing	O
the	O
protein	O
concentration	O
in	O
the	O
air	O
spaces	O
and	O
the	O
interstitial	O
tissue	O
,	O
and	O
of	O
the	O
oedema	O
in	O
the	O
latter	O
.	O

The	O
brains	O
were	O
bisected	O
and	O
T1	O
and	O
T2	O
relaxation	O
times	O
were	O
determined	O
for	O
the	O
right	O
and	O
left	O
hemispheres	O
by	O
MR	O
spectroscopy	O
immediately	O
after	O
dissection	O
.	O

The	O
exact	O
function	O
of	O
IP-30	B
is	O
not	O
yet	O
known	O
,	O
but	O
it	O
may	O
play	O
a	O
role	O
in	O
gamma	B
-	I
interferon	I
mediated	O
immune	O
reactions	O
.	O

Finally	O
,	O
gel	O
shift	O
assays	O
showed	O
that	O
ORF2	O
was	O
able	O
to	O
bind	O
to	O
promoter	O
fragment	O
566	O
-	O
888	O
.	O

In	O
normal	O
B	O
cells	O
stimulated	O
by	O
LPS	O
or	O
IL-4	B
,	O
new	O
complexes	O
appear	O
that	O
bind	O
to	O
C	B
/	I
EBP	I
and	O
NF	B
-	I
IL-4	I
elements	I
,	O
respectively	O
,	O
located	O
within	O
the	O
-125	O
/	O
-101	O
region	O
.	O

Phylogenetic	O
analysis	O
using	O
a	O
neighbor	O
-	O
joining	O
algorithm	O
showed	O
closest	O
similarity	O
of	O
the	O
horse	B
mu	I
chain	I
-	I
encoding	I
constant	I
region	I
gene	I
to	O
human	O
and	O
dog	O
sequences	O
.	O

Progressive	O
immunodeficiency	O
in	O
a	O
patient	O
with	O
IgA	B
deficiency	O

Mouse	O
embryo	O
cells	O
(	O
C57BL	O
/	O
6	O
,	O
H-2b	O
)	O
transformed	O
by	O
the	O
E1A	B
and	O
E1B	B
genes	O
of	O
adenovirus	O
type	O
5	O
(	O
Ad5E1	O
MEC	O
)	O
are	O
highly	O
immunogenic	O
.	O

The	O
major	O
open	O
reading	O
frame	O
of	O
the	O
cDNA	O
predicts	O
a	O
protein	O
of	O
59	O
kD	O
,	O
with	O
a	O
leucine	O
zipper	O
situated	O
adjacent	O
to	O
an	O
myc	B
-	I
related	I
motif	I
that	O
has	O
been	O
proposed	O
to	O
assume	O
a	O
helix	O
-	O
loop	O
-	O
helix	O
structure	O
.	O

Evidence	O
from	O
four	O
areas	O
--	O
sensory	O
deprivation	O
,	O
enriched	O
environments	O
,	O
nervous	O
system	O
plasticity	O
,	O
and	O
sensitive	O
periods	O
of	O
neurodevelopment	O
--	O
suggests	O
that	O
sensory	O
stimulation	O
programs	O
are	O
potentially	O
beneficial	O
for	O
STR	O
patients	O
.	O

The	O
limb	O
defects	O
,	O
oligodactyly	O
and	O
syndactyly	O
,	O
have	O
been	O
traced	O
to	O
improper	O
differentiation	O
of	O
the	O
apical	O
ectodermal	O
ridge	O
(	O
AER	O
)	O
and	O
shortening	O
of	O
the	O
anteroposterior	O
limb	O
axis	O
.	O

Donehower	O
and	O
H.	O

Children	O
with	O
repeated	O
proteinuria	O
during	O
follow	O
-	O
up	O
tend	O
to	O
have	O
a	O
higher	O
incidence	O
of	O
pathologic	O
findings	O
on	O
the	O
i.v	O
.-	O
pyelogram	O
.	O

The	O
translated	O
sequence	O
of	O
the	O
FLI	B
LRR	I
associated	I
protein	I
(	O
FLAP	B
)	O
encodes	O
a	O
novel	O
protein	O
not	O
represented	O
in	O
the	O
data	O
base	O
.	O

In	O
two	O
separate	O
studies	O
,	O
specimens	O
of	O
saliva	O
from	O
57	O
individuals	O
over	O
the	O
age	O
of	O
65	O
years	O
(	O
mean	O
age	O
,	O
76.7	O
years	O
)	O
and	O
37	O
persons	O
under	O
the	O
age	O
of	O
40	O
years	O
(	O
mean	O
age	O
,	O
28.8	O
years	O
)	O
were	O
examined	O
for	O
concentrations	O
of	O
IgA	B
as	O
functions	O
of	O
volume	O
,	O
total	O
protein	O
,	O
and	O
electrolyte	O
conductivity	O
;	O
some	O
were	O
also	O
tested	O
for	O
IgG	B
and	O
IgM	B
content	O
.	O

In	O
the	O
plant	B
malate	I
synthases	I
,	O
the	O
extension	O
is	O
probably	O
involved	O
in	O
routing	O
to	O
the	O
microbodies	O
,	O
since	O
it	O
contains	O
the	O
potential	O
peroxisomal	O
targeting	O
signal	O
,	O
Ser	O
-	O
Arg	O
/	O
Lys	O
-	O
Leu	O
,	O
at	O
the	O
carboxy	O
terminus	O
.	O

In	O
agreement	O
with	O
this	O
model	O
,	O
elimination	O
of	O
the	O
ADAM13	B
cytoplasmic	I
domain	I
increased	O
developmental	O
alterations	O
attributable	O
to	O
ADAM13	B
proteolytic	O
activity	O
.	O

The	O
strangulated	O
intestinal	O
pathologies	O
of	O
horses	O
are	O
accompanied	O
by	O
a	O
local	O
activation	O
of	O
the	O
neutrophils	O
,	O
that	O
can	O
be	O
revealed	O
by	O
measuring	O
the	O
tissular	O
enzymatic	O
activity	O
of	O
the	O
granulocytic	O
enzyme	O
myeloperoxidase	B
(	O
MPO	B
)	O
.	O

The	O
two	O
redox	O
centers	O
in	O
the	O
protein	O
,	O
FAD	O
and	O
a	O
[	O
4Fe4S	O
]	O
+2,+1	O
cluster	O
,	O
are	O
present	O
in	O
a	O
64-kDa	O
monomer	O
.	O

Failure	O
to	O
demonstrate	O
a	O
major	O
anti	O
-	O
inflammatory	O
effect	O
with	O
alpha	O
tocopherol	O
supplementation	O
(	O
400	O
IU	O
/	O
day	O
)	O
in	O
normal	O
subjects	O
.	O

The	O
flanking	O
open	O
reading	O
frames	O
in	O
pARGC2	O
showed	O
no	O
homologies	O
to	O
arginine	O
biosynthetic	O
genes	O
.	O

The	O
interaction	O
of	O
different	O
protein	O
systems	O
with	O
microtubules	O
is	O
a	O
critical	O
step	O
in	O
the	O
cellular	O
function	O
of	O
these	O
organelles	O
.	O

SHBG	B
concentrations	O
in	O
women	O
were	O
also	O
significantly	O
higher	O
at	O
T-2	O
and	O
T-3	O
when	O
compared	O
to	O
T-1	O
values	O
.	O

Chromosome	O
-	O
specific	O
STSs	O
for	O
27	O
telomeres	O
were	O
identified	O
from	O
the	O
196	O
TYACs	O
.	O

The	O
two	O
yeast	B
pheromone	I
receptors	I
,	O
the	O
a	B
and	I
alpha	I
-	I
factor	I
receptors	I
,	O
share	O
many	O
functional	O
similarities	O
:	O
both	O
G	B
protein	I
-	I
coupled	I
receptors	I
couple	O
to	O
the	O
same	O
downstream	O
signal	O
transduction	O
pathway	O
,	O
and	O
both	O
receptors	O
undergo	O
feedback	O
regulation	O
involving	O
increased	O
phosphorylation	O
on	O
their	O
C	O
-	O
terminal	O
domains	O
in	O
response	O
to	O
ligand	O
challenge	O
.	O

Heart	O
rate	O
and	O
oxygen	O
consumption	O
increased	O
75+	O
/	O
-4	O
bpm	O
and	O
26.3+	O
/	O
-1.4	O
ml	O
O2	O
/	O
kg	O
x	O
min	O
(	O
-1	O
)	O
from	O
supine	O
resting	O
values	O
,	O
respectively	O
.	O

It	O
also	O
produces	O
an	O
NH2	O
terminus	O
that	O
corresponds	O
to	O
an	O
equivalent	O
NH2	O
terminus	O
on	O
the	O
processed	O
matrix	O
form	O
of	O
the	O
similar	O
alpha1	B
(	I
XI	I
)	I
chain	I
,	O
thus	O
suggesting	O
physiological	O
significance	O
.	O

To	O
determine	O
the	O
transactivation	O
potential	O
of	O
each	O
of	O
the	O
four	O
Ahr	B
Sp1	B
sites	I
,	O
we	O
fused	O
the	O
Ahr	B
promoter	I
to	O
a	O
luciferase	B
(	O
LUC	B
)	O
reporter	O
gene	O
and	O
transfected	O
the	O
construct	O
into	O
the	O
Drosophila	O
cell	O
line	O
Schneider-2	O
,	O
which	O
contains	O
no	O
Sp1	B
or	O
Sp1-like	B
factors	I
.	O

Based	O
on	O
the	O
results	O
of	O
this	O
analysis	O
,	O
we	O
also	O
predict	O
that	O
the	O
budding	B
yeast	I
arsenate	I
resistance	I
protein	I
Acr2	B
and	O
the	O
ORF	B
Ygr203w	I
encode	O
protein	O
phosphatases	O
with	O
catalytic	O
properties	O
similar	O
to	O
that	O
of	O
the	O
Cdc25	B
family	I
.	O

However	O
,	O
in	O
7	O
patients	O
with	O
normal	O
CT	O
results	O
the	O
latter	O
method	O
showed	O
areas	O
of	O
cerebral	O
activity	O
anatomically	O
correlated	O
with	O
neurological	O
signs	O
or	O
vascular	O
lesions	O
.	O

Signal	O
transduction	O
in	O
fibroblasts	O
stably	O
transformed	O
by	O
[	O
Val12	O
]	O
Ras	O
--	O
the	O
activities	O
of	O
extracellular	B
-	I
signal	I
-	I
regulated	I
kinase	I
and	O
Jun	B
N	I
-	I
terminal	I
kinase	I
are	O
only	O
moderately	O
increased	O
,	O
and	O
the	O
activity	O
of	O
the	O
delta	O
-	O
inhibitor	O
of	O
c	B
-	I
Jun	I
is	O
not	O
alleviated	O
.	O

Avian	B
EMILIN	I
was	O
extracted	O
from	O
19-day	O
-	O
old	O
embryonic	O
chick	O
aortas	O
and	O
associated	O
blood	O
vessels	O
and	O
purified	O
by	O
ion	O
-	O
exchange	O
chromatography	O
and	O
gel	O
filtration	O
.	O

Asymptomatic	O
ischaemia	O
during	O
daily	O
life	O
in	O
stable	O
coronary	O
artery	O
disease	O
:	O
relevant	O
or	O
redundant	O
?	O

Individual	O
intolerance	O
to	O
betaxolol	O
will	O
continue	O
to	O
occur	O
and	O
care	O
is	O
always	O
required	O
when	O
patients	O
with	O
cardiac	O
or	O
respiratory	O
dysfunction	O
are	O
exposed	O
to	O
any	O
beta	O
-	O
antagonist	O
.	O

DESIGN	O
:	O
Prospective	O
case	O
study	O
(	O
Canadian	O
Task	O
Force	O
classification	O
II-2	O
)	O
.	O

Peak	O
insulin	B
response	O
to	O
glucose	O
infusion	O
declined	O
from	O
Groups	O
1	O
to	O
3	O
(	O
51	O
+	O
/-	O

14	O
,	O
42.4	O
+	O
/-	O

31	O
,	O
20.4	O
+	O
/-	O

6.8	O
microU	O
/	O
ml	O
,	O
respectively	O
)	O
with	O
Group	O
3	O
exhibiting	O
a	O
significantly	O
decreased	O
mean	O
peak	O
level	O
compared	O
to	O
the	O
other	O
groups	O
.	O

Chemical	O
structure	O
of	O
antibiotic	O
SF-837	O
.	O

Reexamination	O
of	O
the	O
cdc4	B
-	I
1	I
mutant	I
revealed	O
that	O
,	O
in	O
addition	O
to	O
being	O
defective	O
in	O
the	O
onset	O
of	O
S	O
phase	O
,	O
it	O
is	O
also	O
defective	O
in	O
G	O
(	O
2	O
)	O
/	O
M	O
transition	O
when	O
released	O
from	O
hydroxyurea	O
-	O
induced	O
S	O
-	O
phase	O
arrest	O
.	O

Structure	O
and	O
regulation	O
of	O
the	O
luteinizing	B
hormone	I
receptor	I
gene	I
.	O

Unconventional	O
mRNA	O
processing	O
in	O
the	O
expression	O
of	O
two	O
calcineurin	B
B	I
isoforms	I
in	O
Dictyostelium	O
.	O

T1	O
and	O
T2	O
values	O
were	O
calculated	O
from	O
guinea	O
pig	O
brain	O
in	O
vivo	O
at	O
0.5	O
T.	O

A	O
chest	O
-	O
X	O
ray	O
film	O
showed	O
infiltrative	O
shadows	O
in	O
the	O
right	O
middle	O
and	O
lower	O
lung	O
fields	O
,	O
but	O
a	O
chest	O
CT	O
scan	O
showed	O
an	O
abnormal	O
lung	O
density	O
in	O
the	O
right	O
lower	O
lobe	O
.	O

Plasma	B
insulin	I
responses	O
to	O
glucose	O
in	O
femoral	O
,	O
hepatic	O
,	O
and	O
pancreatic	O
veins	O
in	O
dogs	O
.	O

The	O
reading	O
achievement	O
of	O
students	O
with	O
learning	O
disabilities	O
who	O
received	O
reading	O
instruction	O
through	O
the	O
DISTAR	O
program	O
was	O
compared	O
to	O
that	O
of	O
similar	O
students	O
using	O
basal	O
reader	O
materials	O
.	O

SM	B
binds	O
RNA	O
in	O
vitro	O
,	O
suggesting	O
that	O
sequence-	O
or	O
structure	O
-	O
specific	O
mRNA	O
interactions	O
might	O
mediate	O
SM	B
specificity	O
.	O

Stress	O
-	O
induced	O
suppression	O
of	O
the	O
prolactin	B
afternoon	O
surge	O
in	O
ovariectomized	O
,	O
estrogen	O
-	O
treated	O
rats	O
and	O
the	O
nocturnal	O
surge	O
in	O
pseudopregnant	O
rats	O
are	O
accompanied	O
by	O
an	O
increase	O
in	O
median	O
eminence	O
dihydroxyphenylacetic	O
acid	O
concentrations	O
.	O

In	O
vitro	O
kinase	O
assays	O
on	O
isolated	O
microvilli	O
and	O
microvillar	O
fractions	O
enriched	O
in	O
the	O
putative	O
signal	O
transduction	O
particle	O
showed	O
a	O
high	O
specific	O
activity	O
of	O
tyrosine	B
kinase	I
activity	O
compared	O
to	O
that	O
of	O
membranes	O
from	O
EGF	B
receptor	I
-	O
overexpressing	O
A431	O
cells	O
maximally	O
activated	O
by	O
EGF	B
.	O

Among	O
these	O
,	O
four	O
patients	O
had	O
the	O
AIDS	O
syndrome	O
,	O
while	O
42	O
individuals	O
were	O
HIV	O
carriers	O
.	O

Carcinogenic	O
action	O
of	O
groundnut	O
meal	O
containing	O
aflatoxin	O
in	O
rats	O
.	O

The	O
UASB	O
reactors	O
treated	O
a	O
VFA	O
mixture	O
(	O
with	O
an	O
acetate	O
:	O
propionate	O
:	O
butyrate	O
ratio	O
of	O
5:3:2	O
on	O
COD	O
basis	O
)	O
or	O
acetate	O
as	O
the	O
sole	O
substrate	O
at	O
different	O
COD	O
:	O
sulfate	O
ratios	O
.	O

The	O
initial	O
oral	O
administration	O
of	O
the	O
1	O
and	O
2	O
mg	O
/	O
kg	O
doses	O
of	O
enoximone	O
improved	O
central	O
hemodynamic	O
parameters	O
with	O
apparent	O
preferential	O
reduction	O
of	O
limb	O
vascular	O
resistance	O
and	O
augmentation	O
of	O
blood	O
flow	O
to	O
the	O
limb	O
region	O
(	O
peripheral	O
musculoskeletal	O
system	O
)	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

The	O
role	O
of	O
phosphorylation	O
on	O
receptor	O
desensitization	O
was	O
assessed	O
using	O
receptor	O
mutants	O
expressed	O
in	O
COS	O
cells	O
or	O
Chinese	O
hamster	O
lung	O
fibroblasts	O
.	O

For	O
il8ra	B
,	O
it	O
is	O
formed	O
from	O
two	O
exons	O
,	O
whereas	O
for	O
il8rb	B
,	O
seven	O
distinct	O
neutrophil	O
mRNAs	O
are	O
formed	O
by	O
alternative	O
splicing	O
of	O
11	O
exons	O
.	O

By	O
deletion	O
analysis	O
,	O
we	O
identified	O
the	O
regions	O
of	O
c	B
-	I
Jun	I
encoding	O
transformation	O
and	O
transactivation	O
functions	O
.	O

Several	O
waveforms	O
of	O
both	O
the	O
somatosensory	O
(	O
N20	O
,	O
P	O
/	O
N	O
30	O
,	O
and	O
P200	O
)	O
and	O
the	O
brainstem	O
auditory	O
-	O
evoked	O
response	O
(	O
I	O
,	O
III	O
,	O
IV	O
,	O
and	O
V	O
)	O
demonstrated	O
shorter	O
(	O
p	O
less	O
than	O
0.05	O
)	O
latencies	O
in	O
growth	O
-	O
retarded	O
fetuses	O
relative	O
to	O
normal	O
-	O
sized	O
fetuses	O
.	O

Interactions	O
were	O
also	O
detected	O
between	O
full	O
-	O
length	O
HSF1	B
and	O
the	O
small	O
subunit	O
(	O
gamma	O
)	O
of	O
TFIIA	B
.	O

Pyknotic	O
osteocytes	O
increased	O
at	O
12	O
h	O
(	O
p	O
less	O
than	O
0.01	O
)	O
and	O
2	O
days	O
(	O
p	O
less	O
than	O
0.001	O
)	O
of	O
ischemia	O
.	O

Northern	O
blot	O
analysis	O
indicated	O
that	O
both	O
human	O
and	O
murine	O
genes	O
encode	O
approximately	O
6-kb	O
transcripts	O
.	O

ALT	B
(	O
alanine	B
aminotransferase	I
)	O
and	O
Hb	B
(	O
hemoglobin	B
)	O
appeared	O
to	O
be	O
predictive	O
for	O
efficacy	O
.	O

Maternal	O
behavior	O
was	O
assessed	O
using	O
observational	O
techniques	O
.	O

Effects	O
of	O
timepidium	O
bromide	O
(	O
TB	O
;	O
anticholinergic	O
agent	O
)	O
,	O
acetylcholine	O
(	O
ACh	O
)	O
and	O
neostigmine	O
(	O
Neost	O
)	O
on	O
gastric	O
and	O
duodenal	O
blood	O
flow	O
distribution	O
were	O
studied	O
by	O
the	O
use	O
of	O
131I	O
-	O
labeled	O
macroaggregated	O
human	O
serum	O
albumin	O
(	O
MAA	B
)	O
in	O
rabbits	O
.	O

Nucleotide	O
sequence	O
of	O
the	O
gag	B
gene	I
and	O
gag	B
-	O
pol	B
junction	O
of	O
feline	O
leukemia	O
virus	O
.	O

In	O
addition	O
,	O
reduced	O
metabolism	O
to	O
cotinine	O
from	O
the	O
proliposomes	O
and	O
MP	O
was	O
apparently	O
responsible	O
for	O
the	O
sustained	O
plasma	O
nicotine	O
levels	O
.	O

D.	O

BCR	B
-	O
ABL	B
expression	O
confers	O
cross	O
-	O
resistance	O
to	O
multiple	O
genotoxic	O
anticancer	O
drugs	O
by	O
inhibition	O
of	O
the	O
apoptotic	O
response	O
to	O
DNA	O
damage	O
in	O
association	O
with	O
cell	O
cycle	O
arrest	O
at	O
the	O
G2-M	O
restriction	O
point	O
.	O

In	O
area	O
CA1	O
of	O
the	O
hippocampus	O
,	O
numbers	O
of	O
normal	O
neurons	O
were	O
increased	O
11-	O
to	O
14-fold	O
by	O
MK-801	O
treatment	O
(	O
p	O
<	O
0.01	O
)	O
.	O

Considering	O
these	O
two	O
facts	O
together	O
,	O
we	O
propose	O
that	O
vasectomy	O
may	O
lead	O
to	O
decrease	O
in	O
the	O
incidence	O
of	O
prostatic	O
tumors	O
-	O
a	O
disease	O
that	O
claims	O
nearly	O
22,000	O
lives	O
each	O
year	O
in	O
the	O
United	O
States	O
alone	O
.	O

At	O
least	O
one	O
such	O
complex	O
is	O
eliminated	O
by	O
preincubating	O
the	O
nuclear	O
extract	O
with	O
an	O
antibody	O
with	O
broad	O
cross	O
-	O
reactivity	O
with	O
Ets-1	B
and	O
Ets-2	B
proteins	I
,	O
thus	O
confirming	O
that	O
an	O
ETS	B
transcription	I
factor	I
(	I
s	I
)	I
recognizes	O
the	O
-12	O
motif	O
.	O

BACKGROUND	O
:	O
Peripheral	O
kappa	B
receptor	I
agonists	O
may	O
provide	O
a	O
new	O
therapeutic	O
approach	O
for	O
the	O
treatment	O
of	O
functional	O
dyspepsia	O
.	O

Checking	O
for	O
patient	O
compliance	O
,	O
samples	O
(	O
n	O
=	O
10	O
)	O
with	O
a	O
FK	O
I	O
concentration	O
of	O
0	O
ng	O
/	O
mL	O
were	O
re	O
-	O
analyzed	O
.	O

These	O
results	O
support	O
an	O
in	O
vivo	O
interaction	O
between	O
Nck	B
and	O
CKI	B
-	I
gamma2	I
and	O
suggest	O
that	O
CKI	B
-	I
gamma2	I
could	O
be	O
involved	O
in	O
signaling	O
pathways	O
downstream	O
of	O
RTKs	B
.	O

4-Hydroxyproline	O
assays	O
were	O
performed	O
to	O
determine	O
collagen	B
content	O
.	O

The	O
biological	O
basis	O
for	O
the	O
changes	O
in	O
CNAPs	O
produced	O
by	O
CS2	O
is	O
under	O
investigation	O
.	O

Non	O
-	O
suppressed	O
thyroidal	O
radioactive	O
iodine	O
uptake	O
(	O
RAIU	O
)	O
in	O
thyrotoxic	O
phase	O
in	O
a	O
case	O
of	O
subacute	O
thyroiditis	O
with	O
thyroid	O
-	O
stimulating	O
antibodies	O
(	O
TSAb	O
)	O
.	O

Blotting	O
analysis	O
of	O
intestinal	O
RNA	O
and	O
hybridization	O
of	O
the	O
blots	O
with	O
carboxy	O
apoB	B
cDNA	O
probes	O
produced	O
a	O
single	O
15-kb	O
hybridization	O
band	O
whereas	O
hybridization	O
with	O
amino	O
terminal	O
probes	O
produced	O
two	O
hybridization	O
bands	O
of	O
15	O
and	O
8	O
kb	O
.	O

The	O
temporal	O
expression	O
of	O
CRAlBP	B
is	O
similar	O
to	O
IRBP	B
while	O
bFGF	B
is	O
not	O
expressed	O
until	O
after	O
photoreceptor	O
differentiation	O
is	O
complete	O
.	O

Several	O
components	O
in	O
cytokine	O
signaling	O
remain	O
unidentified	O
.	O

Virgin	O
,	O
P.	O

Kudzu	O
extract	O
shows	O
potential	O
for	O
moderating	O
alcohol	O
abuse	O
.	O

Serum	O
IgG	B
and	O
IgA	B
level	O
were	O
decreased	O
.	O

A	O
novel	O
zinc	O
finger	O
-	O
containing	O
RNA	O
-	O
binding	O
protein	O
conserved	O
from	O
fruitflies	O
to	O
humans	O
.	O

High	O
-	O
affinity	O
binding	O
was	O
also	O
observed	O
with	O
recombinant	B
SH2	I
domains	I
from	O
v	B
-	I
src	I
and	O
v	B
-	I
fps	I
,	O
raising	O
the	O
possibility	O
of	O
protein	O
-	O
protein	O
interactions	O
between	O
various	O
members	O
of	O
the	O
cytoplasmic	B
PTK	I
family	I
.	O

Youssoufian	O
,	O
A.	O

Since	O
1988	O
Modulit	O
-	O
SZ-20	O
has	O
been	O
tested	O
for	O
localization	O
of	O
nephroliths	O
and	O
ureteroliths	O
.	O

Lactate	O
,	O
pyruvate	O
and	O
actual	O
pH	O
values	O
in	O
the	O
venous	O
blood	O
of	O
newborn	O
calves	O

The	O
dermatoglyphic	O
pattern	O
demostrates	O
a	O
distal	O
triradius	O
and	O
small	O
whorl	O
abnormalities	O
.	O

The	O
MI	O
site	O
is	O
predictive	O
of	O
hemodynamic	O
left	O
ventricular	O
dysfunction	O
both	O
at	O
rest	O
and	O
during	O
exercise	O
:	O
anterior	O
MIs	O
are	O
more	O
impaired	O
than	O
inferior	O
MIs	O
.	O

The	O
median	O
survival	O
time	O
was	O
18	O
months	O
.	O

Biology	O
of	O
Anopheles	O
quadrimaculatus	O
under	O
field	O
conditions	O
in	O
central	O
Florida	O
.	O

This	O
transformation	O
suppression	O
by	O
Rb	B
was	O
further	O
shown	O
to	O
be	O
due	O
to	O
transcriptional	O
repression	O
of	O
neu	B
using	O
Rb	B
expressing	O
effector	O
plasmid	O
and	O
neu	B
promoter	O
-	O
chloramphenicol	B
acetyltransferase	I
reporter	O
gene	O
.	O

Collectively	O
,	O
a	O
unique	O
mechanism	O
involving	O
NF	B
-	I
ATp	I
appears	O
to	O
regulate	O
the	O
cell	O
type	O
-	O
specific	O
and	O
activation	O
-	O
dependent	O
expression	O
of	O
the	O
SCM-1	B
genes	I
.	O

In	O
seven	O
patients	O
(	O
7.8	O
%	O
)	O
with	O
new	O
Q	O
-	O
waves	O
and	O
a	O
pathologic	O
CK	B
-	I
MB	I
profile	O
(	O
group	O
II	O
)	O
troponin	B
T	I
reached	O
median	O
levels	O
of	O
10.47	O
micrograms	O
/	O
l	O
(	O
quartile	O
6.34	O
-	O
12.50	O
micrograms	O
/	O
l	O
)	O
(	O
P	O
<	O
0.001	O
I	O
vs	O
II	O
)	O
.	O

EMG	O
-	O
based	O
measures	O
of	O
fatigue	O
during	O
a	O
repetitive	O
squat	O
exercise	O
.	O

Southern	O
blot	O
analysis	O
revealed	O
that	O
CCaMK	B
is	O
encoded	O
by	O
a	O
single	O
gene	O
.	O

A	O
fine	O
-	O
structure	O
radiation	O
hybrid	O
map	O
for	O
the	O
region	O
that	O
extends	O
from	O
D8S520	B
(	O
distal	O
)	O
to	O
D8S1759	B
(	O
proximal	O
)	O
was	O
prepared	O
,	O
followed	O
by	O
construction	O
of	O
a	O
single	O
,	O
integrated	O
YAC	O
/	O
BAC	O
contig	O
for	O
the	O
interval	O
.	O

Messenger	O
RNA	O
for	O
the	O
Ad2	B
DNA	I
binding	I
protein	I
:	O
DNA	O
sequences	O
encoding	O
the	O
first	O
leader	O
and	O
heterogenity	O
at	O
the	O
mRNA	O
5	O
'	O
end	O
.	O

All	O
rights	O
reserved	O
.	O

These	O
results	O
were	O
not	O
obtained	O
using	O
either	O
preimmune	O
sera	O
or	O
antiserum	O
specific	O
for	O
the	O
luminal	O
portion	O
of	O
the	O
glycoprotein	O
precursor	O
.	O

The	O
fz-1	B
and	O
fz-2	B
genes	I
are	O
widely	O
expressed	O
in	O
rat	O
tissues	O
with	O
the	O
highest	O
steady	O
-	O
state	O
levels	O
of	O
mRNA	O
in	O
kidney	O
,	O
liver	O
,	O
heart	O
,	O
uterus	O
,	O
and	O
ovary	O
.	O

fz-1	B
and	I
-2	I
mRNA	I
levels	O
were	O
greater	O
in	O
neonatal	O
than	O
in	O
corresponding	O
adult	O
tissues	O
.	O

Mean	O
concentration	O
of	O
insulin	B
in	O
maternal	O
plasma	O
across	O
all	O
sampling	O
times	O
was	O
higher	O
in	O
ethanol	O
treated	O
animals	O
.	O

Triaxiality	O
in	O
the	O
proton	O
-	O
neutron	O
interacting	O
boson	O
model	O
:	O
Perturbed	O
O	O
(	O
6	O
)	O
symmetry	O
with	O
application	O
to	O
the	O
mass	O
A	O

Role	O
of	O
distinct	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
pathways	O
and	O
cooperation	O
between	O
Ets-2	B
,	O
ATF-2	B
,	O
and	O
Jun	B
family	I
members	I
in	O
human	B
urokinase	I
-	I
type	I
plasminogen	I
activator	I
gene	I
induction	O
by	O
interleukin-1	B
and	O
tetradecanoyl	O
phorbol	O
acetate	O
.	O

Comparative	O
volumetric	O
analysis	O
is	O
defined	O
as	O
the	O
difference	O
between	O
mean	O
corpuscular	O
erythrocyte	O
volume	O
in	O
peripheral	O
blood	O
(	O
MCVB	O
)	O
diluted	O
in	O
urine	O
supernatant	O
after	O
centrifugation	O
and	O
mean	O
corpuscular	O
volume	O
of	O
urinary	O
erythrocytes	O
(	O
MCVU	O
)	O
.	O

To	O
assess	O
whether	O
thallium-201	O
thallous	O
chloride	O
(	O
Tl	O
)	O
can	O
detect	O
childhood	O
tumors	O
and	O
whether	O
diagnostic	O
effectiveness	O
improves	O
with	O
combined	O
blood	O
flow	O
imaging	O
,	O
28	O
children	O
(	O
1.0	O
-	O
18.6	O
years	O
)	O
were	O
studied	O
using	O
single	O
photon	O
emission	O
computed	O
tomography	O
(	O
SPECT	O
)	O
:	O
Tl	O
(	O
1.3	O
-	O
1.8	O
mCi	O
intravenously	O
)	O
,	O
followed	O
in	O
13	O
of	O
the	O
patients	O
by	O
technetium-99m	O
-	O
hexamethylpropyleneamine	O
oxime	O
(	O
99mTc	O
-	O
HMPAO	O
;	O
8	O
-	O
18	O
mCi	O
intravenously	O
)	O
.	O

Analysis	O
of	O
tobacco	O
mRNA	O
using	O
the	O
ACBF	B
cDNA	I
as	O
probe	O
showed	O
that	O
while	O
ACBF	B
mRNA	I
was	O
present	O
in	O
all	O
tissues	O
examined	O
,	O
the	O
highest	O
transcript	O
accumulation	O
occurred	O
in	O
stem	O
tissues	O
.	O

When	O
PCR	O
was	O
used	O
to	O
amplify	O
agar	O
cultures	O
which	O
do	O
not	O
express	O
the	O
fimbriae	O
,	O
the	O
switch	O
region	O
was	O
OFF	O
only	O
.	O

We	O
therefore	O
investigated	O
whether	O
the	O
promoter	O
activity	O
of	O
the	O
mouse	B
TRH	I
gene	I
is	O
directly	O
regulated	O
by	O
RA	O
using	O
a	O
transient	O
transfection	O
assay	O
into	O
CV-1	O
cells	O
.	O

Sin4	B
and	O
Srb10	B
,	O
components	O
of	O
specific	O
RNA	B
polymerase	I
II	I
sub	I
-	I
complexes	I
that	O
are	O
required	O
for	O
Ssn6-Tup1	B
repression	O
activity	O
,	O
are	O
found	O
to	O
be	O
required	O
for	O
Sfl1	B
repression	O
function	O
.	O

Functional	O
PET	O
scanning	O
in	O
the	O
preoperative	O
assessment	O
of	O
cerebral	O
arteriovenous	O
malformations	O
.	O

The	O
MEE	O
was	O
significantly	O
greater	O
than	O
the	O
BEE	O
and	O
significantly	O
less	O
than	O
the	O
calculated	O
energy	O
expenditure	O
.	O

Differences	O
were	O
not	O
found	O
in	O
colons	O
by	O
SEM	O
.	O

The	O
human	O
RIL	B
gene	I
:	O
mapping	O
to	O
human	O
chromosome	O
5q31.1	O
,	O
genomic	O
organization	O
and	O
alternative	O
transcripts	O
.	O

These	O
findings	O
indicated	O
that	O
p35	B
is	O
a	O
trans	O
-	O
dominant	O
factor	O
that	O
facilitates	O
AcMNPV	O
growth	O
in	O
a	O
cell	O
line	O
-	O
specific	O
manner	O
.	O

We	O
found	O
remarkable	O
differences	O
in	O
the	O
expression	O
patterns	O
of	O
MTB	B
-	I
Zf	I
mRNA	I
and	O
two	O
other	O
hybridizable	O
mRNAs	O
of	O
5	O
kb	O
and	O
8.5	O
kb	O
when	O
human	O
brain	O
and	O
primary	O
brain	O
tumors	O
were	O
compared	O
.	O

We	O
have	O
recently	O
shown	O
that	O
induced	O
expression	O
of	O
a	O
CDK	B
target	O
site	O
-	O
deficient	O
mutant	O
,	O
Op18-S25A	B
,	O
S38A	O
,	O
blocks	O
human	O
cell	O
lines	O
during	O
G2	O
/	O
M	O
transition	O
.	O

ATF6	B
,	O
a	O
basic	B
-	I
leucine	I
zipper	I
protein	I
,	O
was	O
isolated	O
by	O
binding	O
to	O
SRF	B
and	O
in	O
particular	O
to	O
its	O
transcriptional	O
activation	O
domain	O
.	O

These	O
results	O
provide	O
strong	O
evidence	O
that	O
conserved	O
interhelical	O
packing	O
interactions	O
in	O
the	O
gp41	B
core	I
are	O
important	O
determinants	O
of	O
HIV-1	O
entry	O
and	O
its	O
inhibition	O
.	O

Natl	O
.	O

In	O
contrast	O
,	O
NF	B
-	I
kappa	I
B	I
activation	O
was	O
observed	O
in	O
these	O
cells	O
after	O
PMA	O
stimulation	O
.	O

From	O
our	O
own	O
investigations	O
on	O
phantoms	O
,	O
the	O
smallest	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
(	O
delta	O
S	O
min	O
/	O
delta	O
R	O
)	O
was	O
obtained	O
which	O
determines	O
the	O
minimal	O
contrast	O
,	O
given	O
the	O
film	O
properties	O
(	O
film	O
response	O
S	O
,	O
film	O
gradient	O
gamma	O
)	O
and	O
the	O
amount	O
of	O
scatter	O
.	O

We	O
functionally	O
characterised	O
AtXPO1	B
by	O
its	O
interaction	O
with	O
NESs	O
of	O
animal	O
and	O
plant	O
proteins	O
,	O
which	O
is	O
inhibited	O
by	O
the	O
cytotoxin	O
leptomycin	O
B	O
(	O
LMB	O
)	O
,	O
and	O
also	O
by	O
its	O
interaction	O
with	O
the	O
small	B
GTPase	I
Ran1	B
in	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
.	O

The	O
use	O
of	O
self	O
-	O
measured	O
blood	O
pressure	O
determinations	O
in	O
assessing	O
dynamics	O
of	O
drug	O
compliance	O
in	O
a	O
study	O
with	O
amlodipine	O
once	O
a	O
day	O
,	O
morning	O
versus	O
evening	O
.	O

We	O
propose	O
that	O
unc-37	B
may	O
be	O
regulated	O
by	O
unc-4	B
.	O

The	O
gag	B
-	O
myc	B
proteins	O
encoded	O
by	O
these	O
variants	O
efficiently	O
localized	O
to	O
the	O
cell	O
nucleus	O
.	O

From	O
the	O
supposition	O
that	O
there	O
exists	O
a	O
possible	O
connection	O
between	O
certain	O
psychopathological	O
symptoms	O
,	O
and/or	O
syndromes	O
(	O
e.g.	O
,	O
hallucinations	O
)	O
and	O
regional	O
cerebral	O
dysfunction	O
,	O
patients	O
suffering	O
from	O
auditory	O
and	O
tactile	O
hallucinations	O
were	O
investigated	O
,	O
in	O
a	O
symptom	O
-	O
oriented	O
study	O
,	O
using	O
the	O
method	O
of	O
technetium-99m	O
-	O
Hexamethyl	O
-	O
propylenamine	O
Oxime	O
(	O
99m	O
-	O
Tc	O
-	O
HMPAO	O
)	O
-Single	O
Photon	O
Emission	O
Computed	O
Tomography	O
(	O
SPECT	O
)	O
and	O
compared	O
with	O
normal	O
controls	O
.	O

A	O
novel	O
alternative	O
spliced	O
variant	O
of	O
the	O
transcription	O
factor	O
AP2alpha	B
is	O
expressed	O
in	O
the	O
murine	O
ocular	O
lens	O
.	O

Thus	O
,	O
the	O
end	O
of	O
a	O
linearized	O
DNA	O
fragment	O
can	O
initiate	O
new	O
DNA	O
synthesis	O
by	O
BIR	O
in	O
which	O
the	O
newly	O
synthesized	O
DNA	O
is	O
displaced	O
and	O
subsequently	O
forms	O
circles	O
by	O
NHEJ	O
.	O

From	O
the	O
deduced	O
amino	O
acid	O
sequence	O
,	O
a	O
molecular	O
weight	O
of	O
38,549	O
was	O
calculated	O
for	O
the	O
ADH	B
subunit	I
.	O

Nine	O
months	O
after	O
the	O
end	O
of	O
the	O
vaccination	O
anti	B
-	I
HBsAg	I
levels	O
had	O
dropped	O
to	O
9	O
+	O
/-	O

4	O
IU	O
/	O
1	O
(	O
M	O
+	O
/-	O

SE	O
)	O
,	O
with	O
a	O
geometric	O
mean	O
of	O
5	O
IU	O
/	O
1	O
,	O
in	O
the	O
nine	O
remaining	O
evaluable	O
patients	O
.	O

The	O
point	O
mutation	O
Asp-316	O
-	O
->Asn	O
in	O
the	O
C	O
-	O
terminus	O
of	O
p38	B
,	O
analogous	O
to	O
the	O
ERK2	B
(	O
extracellular	B
-	I
signal	I
-	I
regulated	I
kinase	I
2	I
)	O
sevenmaker	B
mutation	O
,	O
dramatically	O
decreases	O
its	O
binding	O
to	O
MKP-1	B
and	O
substantially	O
compromises	O
its	O
stimulatory	O
effect	O
on	O
the	O
catalytic	O
activity	O
of	O
this	O
phosphatase	O
.	O

Cortical	O
somatosensory	O
evoked	O
potentials	O
to	O
median	O
nerve	O
stimulation	O
revealed	O
significantly	O
delayed	O
peak	O
latencies	O
of	O
N20	O
,	O
P20	O
,	O
P25	O
,	O
and	O
N26	O
,	O
although	O
N16	O
latency	O
was	O
normal	O
.	O

The	O
results	O
suggest	O
that	O
proenzyme	O
processing	O
is	O
not	O
essential	O
for	O
secretion	O
of	O
PC2	B
,	O
but	O
peptides	O
containing	O
mutations	O
that	O
affect	O
the	O
ability	O
of	O
the	O
propeptide	O
(	O
and	O
cleavage	O
sites	O
)	O
to	O
fold	O
within	O
the	O
catalytic	O
pocket	O
are	O
not	O
transferred	O
beyond	O
the	O
early	O
stages	O
of	O
the	O
secretory	O
pathway	O
.	O

Cloning	O
,	O
sequence	O
analysis	O
,	O
and	O
expression	O
of	O
the	O
gene	B
encoding	I
formaldehyde	I
dismutase	I
from	I
Pseudomonas	I
putida	I
F61	I
.	O

The	O
IGFBP-1	B
IRS	B
and	O
PEPCK	B
IRS	B
both	O
bind	O
the	O
alpha	O
and	O
beta	O
forms	O
of	O
hepatic	B
nuclear	I
factor	I
3	I
(	O
HNF-3	B
)	O
,	O
although	O
the	O
latter	O
does	O
so	O
with	O
a	O
sixfold	O
-	O
lower	O
relative	O
affinity	O
.	O

Free	O
protein	B
S	I
deficiency	O
in	O
acute	O
ischemic	O
stroke	O
.	O

This	O
domain	O
encompasses	O
the	O
region	O
of	O
ARP-1	B
/	O
COUP	B
-	I
TFII	I
corresponding	O
to	O
helices	O
3	O
to	O
12	O
in	O
the	O
recently	O
published	O
crystal	O
structure	O
of	O
other	O
members	O
of	O
the	O
nuclear	B
receptor	I
superfamily	I
.	O

When	O
medical	O
aid	O
was	O
sought	O
a	O
false	O
history	O
was	O
given	O
and	O
the	O
true	O
nature	O
of	O
the	O
child	O
's	O
illness	O
,	O
heat	O
stroke	O
,	O
was	O
not	O
determined	O
until	O
after	O
death	O
.	O

BACKGROUND	O
.	O

To	O
test	O
the	O
role	O
of	O
myb	B
family	I
members	I
in	O
progression	O
through	O
the	O
cell	O
cycle	O
,	O
we	O
comicroinjected	O
c	B
-	I
myc	I
and	O
myb	B
expression	O
vectors	O
into	O
serum	O
-	O
deprived	O
quiescent	O
SMCs	O
.	O

CONCLUSION	O
:	O
Ultrasound	O
biomicroscopy	O
is	O
a	O
useful	O
tool	O
for	O
the	O
evaluation	O
of	O
APVR	O
,	O
which	O
is	O
difficult	O
by	O
ordinary	O
methods	O
.	O

Like	O
the	O
human	O
gene	O
,	O
the	O
Drosophila	O
gene	O
encodes	O
at	O
least	O
three	O
isoforms	O
of	O
full	B
length	I
dystrophin	I
-	I
like	I
proteins	I
(	O
dmDLP1	B
,	O
dmDLP2	B
and	O
dmDLP3	B
,	O
)	O
,	O
regulated	O
by	O
different	O
promoters	O
located	O
at	O
the	O
5	O
'	O
end	O
of	O
the	O
gene	O
,	O
and	O
a	O
smaller	O
product	O
regulated	O
by	O
an	O
internal	O
promoter	O
(	O
dmDp186	B
)	O
.	O

In	O
this	O
study	O
,	O
the	O
case	O
of	O
a	O
patient	O
presenting	O
a	O
second	O
hepatocellular	O
carcinoma	O
13	O
years	O
after	O
resection	O
of	O
a	O
first	O
tumor	O
of	O
the	O
same	O
type	O
is	O
reported	O
.	O

The	O
equation	O
for	O
mean	O
trabecular	O
number	O
passed	O
the	O
test	O
,	O
whereas	O
the	O
validity	O
of	O
the	O
equations	O
for	O
mean	O
trabecular	O
separation	O
and	O
Tb	O
.	O

Wi	O
appeared	O
limited	O
.	O

The	O
performances	O
of	O
two	O
tests	O
,	O
the	O
ProstAsure	O
index	O
and	O
the	O
percent	O
free	O
PSA	B
test	O
,	O
were	O
evaluated	O
in	O
detecting	O
cancer	O
.	O

But	O
if	O
one	O
equalizes	O
the	O
upper	O
limits	O
of	O
normal	O
for	O
both	O
markers	O
to	O
a	O
common	O
95	O
%	O
specificity	O
,	O
the	O
tumour	O
-	O
indicating	O
sensitivity	O
of	O
CA	B
19	I
-	I
9	I
clearly	O
surpasses	O
that	O
of	O
CA	B
50	I
.	O

For	O
economical	O
reasons	O
,	O
we	O
could	O
not	O
send	O
a	O
questionnaire	O
to	O
all	O
the	O
35,779	O
individuals	O
,	O
but	O
based	O
the	O
investigation	O
on	O
a	O
SRS	O
of	O
4,000	O
men	O
,	O
post	O
-	O
stratified	O
in	O
a	O
high	O
-	O
risk	O
and	O
a	O
low	O
-	O
risk	O
group	O
.	O

Thus	O
,	O
over	O
a	O
wide	O
range	O
of	O
arterial	O
dimensions	O
,	O
results	O
obtained	O
with	O
caliper	O
estimates	O
of	O
luminal	O
area	O
and	O
diameter	O
are	O
comparable	O
to	O
those	O
obtained	O
with	O
videodensitometry	O
using	O
the	O
XR-70	O
system	O
.	O

Oncogenic	O
activation	O
of	O
RET	B
is	O
detected	O
in	O
human	O
papillary	O
thyroid	O
tumours	O
and	O
in	O
multiple	O
endocrine	O
neoplasia	O
type	O
2	O
syndromes	O
.	O

Evasion	O
of	O
host	O
immunity	O
by	O
Toxocara	O
canis	O
infective	O
larvae	O
is	O
mediated	O
by	O
the	O
nematode	O
surface	O
coat	O
,	O
which	O
is	O
shed	O
in	O
response	O
to	O
binding	O
by	O
host	O
antibody	O
molecules	O
or	O
effector	O
cells	O
.	O

The	O
predicted	O
proteins	O
show	O
strong	O
homology	O
to	O
an	O
ABA	B
-	I
inducible	I
glycine	I
-	I
rich	I
protein	I
from	O
maize	O
embryos	O
and	O
to	O
the	O
mammalian	B
RNA	I
-	I
binding	I
protein	I
A1	I
of	O
the	O
heterogeneous	O
nuclear	O
ribonucleoprotein	O
complex	O
involved	O
in	O
pre	O
-	O
mRNA	O
splicing	O
.	O

Reactive	O
mesothelial	O
cells	O
,	O
usually	O
seen	O
as	O
exfoliated	O
cells	O
,	O
were	O
consistently	O
strongly	O
positive	O
for	O
alpha	B
1-antichymotrypsin	I
and	O
more	O
variably	O
for	O
alpha	B
1-antitrypsin	I
and	O
lysozyme	B
.	O

However	O
,	O
all	O
pathophysiologic	O
assessments	O
reported	O
to	O
date	O
have	O
been	O
carried	O
out	O
during	O
or	O
immediately	O
after	O
IVOX	O
utilization	O
.	O

The	O
wet	O
and	O
dry	O
methods	O
of	O
the	O
HA	O
synthesis	O
are	O
considered	O
.	O

In	O
agreement	O
with	O
other	O
authors	O
,	O
we	O
recommend	O
the	O
procedure	O
as	O
a	O
safe	O
one	O
,	O
providing	O
satisfactory	O
results	O
.	O

In	O
several	O
steps	O
we	O
converted	O
the	O
retinoid	O
specific	O
response	O
element	O
of	O
the	O
human	B
retinoic	I
acid	I
receptor	I
beta	I
promoter	I
into	O
the	O
vitamin	O
D	O
/	O
retinoic	O
acid	O
response	O
element	O
of	O
the	O
human	B
osteocalcin	I
promoter	I
.	O

The	O
plasmid	O
was	O
found	O
to	O
confer	O
drug	O
resistance	O
specifically	O
to	O
LMB	O
.	O

Our	O
results	O
suggest	O
that	O
at	O
least	O
some	O
chloroplast	B
-	I
like	I
tRNA	I
genes	I
in	O
wheat	O
mtDNA	O
are	O
transcribed	O
,	O
with	O
transcripts	O
undergoing	O
processing	O
,	O
post	O
-	O
transcriptional	O
modification	O
and	O
3'-CCA	O
addition	O
,	O
to	O
produce	O
mature	O
tRNAs	O
that	O
may	O
participate	O
in	O
mitochondrial	O
protein	O
synthesis	O
.	O

Immunologic	O
tolerance	O
in	O
rats	O
during	O
13	O
weeks	O
of	O
inhalation	O
exposure	O
to	O
trimellitic	O
anhydride	O
.	O

Rat	B
cholesterol	I
side	I
-	I
chain	I
cleavage	I
cytochrome	I
P-450	I
(	O
P-450scc	B
)	O
gene	O
.	O

Almost	O
every	O
image	O
that	O
appears	O
during	O
a	O
therapy	O
session	O
reveals	O
a	O
symbolic	O
nature	O
,	O
but	O
the	O
very	O
concept	O
of	O
symbol	O
is	O
not	O
free	O
from	O
ambiguity	O
some	O
positions	O
originated	O
in	O
different	O
areas	O
of	O
investigation	O
are	O
mentioned	O
,	O
ending	O
with	O
a	O
description	O
of	O
the	O
traits	O
that	O
,	O
according	O
to	O
the	O
writer	O
,	O
bestow	O
a	O
symbolic	O
character	O
to	O
images	O
.	O

A	O
trend	O
was	O
observed	O
toward	O
increased	O
graft	O
half	O
-	O
life	O
in	O
era	O
2	O
(	O
p	O
=	O
NS	O
)	O
.	O

Human	B
CD38	I
,	O
a	O
leukocyte	O
receptor	O
and	O
ectoenzyme	O
,	O
is	O
a	O
member	O
of	O
a	O
novel	O
eukaryotic	O
gene	O
family	O
of	O
nicotinamide	B
adenine	I
dinucleotide+-converting	I
enzymes	I
:	O
extensive	O
structural	O
homology	O
with	O
the	O
genes	O
for	O
murine	B
bone	I
marrow	I
stromal	I
cell	I
antigen	I
1	I
and	O
aplysian	B
ADP	I
-	I
ribosyl	I
cyclase	I
.	O

Juvenile	O
angiofibromas	O
.	O

Mutation	O
of	O
the	O
HNF3	B
element	I
significantly	O
reduced	O
promoter	O
activity	O
in	O
HepG2	O
cells	O
,	O
whereas	O
this	O
element	O
in	O
isolation	O
conferred	O
HNF3beta	B
responsiveness	O
to	O
a	O
heterologous	O
promoter	O
.	O

Patients	O
adopt	O
new	O
sets	O
based	O
partly	O
on	O
the	O
original	O
topic	O
and	O
partly	O
on	O
their	O
own	O
personal	O
idiosyncratic	O
concerns	O
.	O

RESULTS	O
:	O
PET	O
revealed	O
wide	O
variations	O
in	O
CBF	O
between	O
regions	O
during	O
isoflurane	O
anaesthesia	O
,	O
particularly	O
in	O
comparison	O
with	O
propofol	O
anaesthesia	O
,	O
while	O
rCMRO2	O
decreased	O
globally	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
during	O
both	O
isoflurane	O
and	O
propofol	O
anaesthesia	O
.	O

Long	O
chain	O
acyl	O
-	O
CoA	O
esters	O
are	O
important	O
intermediates	O
in	O
degradation	O
and	O
synthesis	O
of	O
fatty	O
acids	O
,	O
as	O
well	O
as	O
having	O
important	O
functions	O
in	O
regulation	O
of	O
intermediary	O
metabolism	O
and	O
gene	O
expression	O
.	O

Buchstein	O
,	O
L	O
.-	O
L.	O

The	O
model	O
of	O
the	O
complex	O
provides	O
a	O
rationale	O
for	O
conserved	O
ITAM	B
residues	O
,	O
substrate	O
specificity	O
,	O
and	O
suggests	O
that	O
substrate	O
binds	O
only	O
the	O
active	O
conformation	O
of	O
the	O
Src	B
family	I
tyrosine	I
kinase	I
,	O
unlike	O
the	O
ATP	O
cofactor	O
,	O
which	O
can	O
bind	O
the	O
inactive	O
form	O
.	O

Sucrose	O
-	O
specific	O
signalling	O
represses	O
translation	O
of	O
the	O
Arabidopsis	B
ATB2	I
bZIP	I
transcription	I
factor	I
gene	I
.	O

This	O
is	O
probably	O
because	O
,	O
in	O
vivo	O
,	O
some	O
bacteria	O
(	O
perhaps	O
dormant	O
forms	O
)	O
are	O
not	O
entirely	O
dependent	O
upon	O
urease	B
for	O
survival	O
.	O

Our	O
aim	O
was	O
to	O
evaluate	O
this	O
technique	O
by	O
cross	O
-	O
calibrating	O
the	O
DXA	O
method	O
with	O
the	O
carcass	O
chemical	O
analysis	O
in	O
a	O
heterogeneous	O
population	O
of	O
nondiabetic	O
Wistar	O
and	O
diabetic	O
GK	O
rats	O
(	O
21	O
animals	O
were	O
used	O
for	O
precision	O
error	O
and	O
reproducibility	O
determinations	O
and	O
26	O
were	O
used	O
for	O
accuracy	O
studies	O
)	O
.	O

There	O
was	O
a	O
highly	O
significant	O
decrease	O
in	O
serum	B
eosinophil	I
cationic	I
protein	I
in	O
patients	O
with	O
elevated	O
AGA	B
.	O

The	O
prototype	O
now	O
structures	O
oncology	O
-	O
related	O
information	O
available	O
on	O
the	O
Internet	O
and	O
also	O
places	O
resources	O
maintained	O
locally	O
at	O
users	O
'	O
disposal	O
.	O

Ischaemia	O
and	O
reperfusion	O
injury	O
in	O
the	O
kidney	O
:	O
current	O
status	O
and	O
future	O
direction	O
.	O

As	O
to	O
the	O
side	O
effects	O
of	O
SISO	O
,	O
cylindruria	O
with	O
aggravation	O
of	O
microscopic	O
hematuria	O
and	O
elevations	O
of	O
GOT	B
,	O
GPT	B
and	O
A1-P	B
were	O
observed	O
each	O
one	O
of	O
them	O
,	O
respectively	O
.	O

From	O
1981	O
to	O
1989	O
,	O
a	O
total	O
of	O
26	O
women	O
with	O
locally	O
or	O
regionally	O
advanced	O
carcinoma	O
of	O
the	O
uterine	O
cervix	O
were	O
treated	O
with	O
radiotherapy	O
(	O
RT	O
)	O
and	O
pelvic	O
regional	O
hyperthermia	O
(	O
HT	O
)	O
,	O
in	O
the	O
Divisions	O
of	O
Radiation	O
Oncology	O
at	O
the	O
University	O
of	O
Utah	O
Medical	O
Center	O
(	O
UU	O
)	O
and	O
the	O
Kenneth	O
Norris	O
Jr	O
Cancer	O
Hospital	O
of	O
the	O
University	O
of	O
Southern	O
California	O
(	O
USC	O
)	O
.	O

These	O
proteins	O
were	O
detected	O
by	O
an	O
antibody	O
which	O
recognizes	O
the	O
N	O
-	O
terminus	O
of	O
SRK3	B
and	O
,	O
in	O
an	O
F2	O
progeny	O
segregating	O
for	O
the	O
S3	B
haplotype	I
,	O
were	O
only	O
expressed	O
in	O
plants	O
possessing	O
the	O
S3	B
haplotype	I
.	O

Like	O
other	O
IAPs	B
,	O
ch	B
-	I
IAP1	I
contains	O
the	O
N	B
-	I
terminal	I
baculovirus	I
IAP	I
repeats	I
and	O
C	O
-	O
terminal	O
RING	O
finger	O
motifs	O
.	O

Mutations	O
in	O
Saccharomyces	O
cerevisiae	O
that	O
block	O
meiotic	O
prophase	O
chromosome	O
metabolism	O
and	O
confer	O
cell	O
cycle	O
arrest	O
at	O
pachytene	O
identify	O
two	O
new	O
meiosis	B
-	I
specific	I
genes	I
SAE1	I
and	O
SAE3	B
.	O

Following	O
EGF	B
or	O
NGF	B
stimulation	O
of	O
the	O
v	O
-	O
CrkPC12	O
cells	O
,	O
the	O
v	B
-	I
Crk	I
protein	O
itself	O
became	O
tyrosine	O
phosphorylated	O
within	O
1	O
min	O
.	O

Enzymatic	O
and	O
chemical	O
structure	O
probing	O
revealed	O
mainly	O
the	O
conserved	O
terminal	O
part	O
(	O
termed	O
3'C	O
)	O
of	O
the	O
DI9c	O
3	O
'	O
UTR	O
containing	O
distinctive	O
RNA	O
motifs	O
,	O
i.e.	O
,	O
a	O
stable	O
stem	O
-	O
loop	O
,	O
SL	O
I	O
,	O
near	O
the	O
RNA	O
3	O
'	O
terminus	O
and	O
a	O
considerably	O
less	O
stable	O
stem	O
-	O
loop	O
,	O
SL	O
II	O
,	O
that	O
forms	O
the	O
5	O
'	O
portion	O
of	O
3'C.	O

Attention	O
is	O
devoted	O
in	O
particular	O
to	O
the	O
action	O
of	O
thermoregulating	O
nervous	O
and	O
hormonal	O
mechanisms	O
.	O

ES	O
cells	O
in	O
which	O
the	O
gene	O
for	O
the	O
erythroid	O
transcription	O
factor	O
GATA-1	B
has	O
been	O
disrupted	O
fail	O
to	O
produce	O
mature	O
erythroid	O
cells	O
either	O
in	O
vivo	O
or	O
in	O
vitro	O
.	O

Acidic	O
carboxyl	O
-	O
terminal	O
domain	O
of	O
gene	B
2.5	I
protein	I
of	I
bacteriophage	I
T7	I
is	O
essential	O
for	O
protein	O
-	O
protein	O
interactions	O
.	O

Three	O
of	O
these	O
positions	O
are	O
novel	O
in	O
that	O
they	O
had	O
not	O
been	O
identified	O
to	O
be	O
important	O
for	O
binding	O
PC	O
by	O
previous	O
crystallographic	O
analysis	O
.	O

Three	O
transcriptional	O
control	O
elements	O
within	O
300	O
base	O
pairs	O
of	O
the	O
5'-flanking	O
region	O
of	O
the	O
rat	B
glucagon	I
gene	I
interact	O
with	O
regulatory	O
cellular	O
proteins	O
and	O
direct	O
transcription	O
only	O
in	O
glucagon	B
-	O
producing	O
islet	O
cells	O
.	O

Fusion	O
proteins	O
were	O
isolated	O
by	O
affinity	O
chromatography	O
on	O
APTG	O
-	O
Sepharose	O
.	O

(	O
99m	O
)	O
Tc	O
Ethyl	O
Cysteinate	O
Dimer	O
stable	O
during	O
6h	O
has	O
contributed	O
to	O
develop	O
ictal	O
studies	O
to	O
evaluate	O
the	O
location	O
of	O
partial	O
seizure	O
.	O

A	O
less	O
common	O
and	O
much	O
more	O
perplexing	O
circumstance	O
occurs	O
when	O
evaluating	O
patients	O
with	O
sarcoidosis	O
established	O
for	O
several	O
years	O
present	O
with	O
evidence	O
of	O
progressive	O
or	O
chronic	O
pulmonary	O
involvement	O
and	O
dyspnea	O
.	O

The	O
training	O
programs	O
had	O
a	O
duration	O
of	O
30	O
days	O
,	O
5	O
days	O
/	O
week	O
,	O
and	O
was	O
performed	O
on	O
a	O
motor	O
-	O
driven	O
treadmill	O
.	O

The	O
avian	O
carcinoma	O
virus	O
MH2	O
contains	O
a	O
hybrid	O
gene	O
delta	B
gag	I
-	O
mht	B
with	O
a	O
contiguous	O
open	O
reading	O
frame	O
of	O
2682	O
base	O
pairs	O
as	O
well	O
as	O
v	B
-	I
myc	I
and	O
avian	O
helper	O
virus	O
-	O
related	O
sequences	O
.	O

delta	B
gag	I
is	O
a	O
partial	O
retroviral	B
core	I
protein	I
gene	I
while	O
v	B
-	I
mht	I
and	O
v	B
-	I
myc	I
are	O
cell	O
-	O
drived	O
sequences	O
.	O

The	O
recent	O
concept	O
of	O
a	O
bioartificial	O
organ	O
is	O
an	O
attempt	O
to	O
avoid	O
such	O
disadvantages	O
.	O

The	O
pressure	O
measurements	O
under	O
steady	O
flow	O
conditions	O
showed	O
that	O
the	O
hemodynamic	O
performance	O
(	O
including	O
pressure	O
gradient	O
and	O
effective	O
orifice	O
area	O
)	O
of	O
SPAB	O
is	O
superior	O
to	O
that	O
of	O
its	O
stented	O
counterpart	O
,	O
especially	O
in	O
the	O
smaller	O
sizes	O
.	O

Cerebral	O
blood	O
flow	O
was	O
measured	O
using	O
the	O
iv	O
method	O
of	O
133-Xe	O
CBF	O
determination	O
and	O
AVDO2	O
was	O
measured	O
using	O
systemic	O
arterial	O
-	O
jugular	O
venous	O
oxygen	O
content	O
differences	O
.	O

Possible	O
consequences	O
of	O
such	O
binder	O
distribution	O
through	O
powder	O
aggregates	O
are	O
discussed	O
.	O

Bile	O
salts	O
,	O
hormonal	O
control	O
,	O
and	O
the	O
male	O
disadvantage	O
.	O

The	O
fusion	O
gene	O
cassette	O
was	O
placed	O
under	O
the	O
control	O
of	O
a	O
vaccinia	B
virus	I
early	I
promoter	I
and	O
cloned	O
in	O
a	O
host	O
-	O
restricted	O
fowlpox	O
viral	O
vector	O
.	O

We	O
describe	O
a	O
novel	O
stat	B
-	I
related	I
factor	I
,	O
p93	B
,	O
that	O
is	O
found	O
in	O
EGF	B
-	O
treated	O
A431	O
cell	O
extracts	O
but	O
appears	O
to	O
be	O
absent	O
in	O
bovine	B
fibroblast	I
growth	I
factor	I
(	O
bFGF	B
)	O
,	O
IFN	B
-	I
gamma	I
,	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
,	O
and	O
untreated	O
cells	O
.	O

p93	B
appears	O
to	O
be	O
antigenically	O
related	O
to	O
stat91	B
.	O

p185c	B
-	O
neu+	B
,	O
EGFr+	B
(	O
M1	B
)	O
,	O
and	O
p185c	B
-	O
neu-	B
kinase	O
inactive	O
,	O
EGFr+	B
(	O
NEN757	B
)	O
expressing	O
cells	O
undergo	O
different	O
mitotic	O
responses	O
to	O
EGF	B
.	O

Phosphorylated	O
tyrosine	O
residues	O
were	O
subsequently	O
identified	O
by	O
sequencing	O
the	O
separated	O
phosphopeptides	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
ionization	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
MS	O
)	O
and	O
Edman	O
degradation	O
.	O

Superovulation	O
with	O
intrauterine	O
insemination	O
(	O
SO	O
-	O
IUI	O
)	O
has	O
been	O
suggested	O
as	O
an	O
alternative	O
to	O
gamete	O
intrafallopian	O
transfer	O
(	O
GIFT	O
)	O
,	O
despite	O
the	O
absence	O
of	O
controlled	O
or	O
comparative	O
trials	O
.	O

One	O
of	O
the	O
repeating	O
domains	O
(	O
Yheb1	B
)	O
,	O
consisting	O
of	O
67	O
amino	O
acids	O
,	O
was	O
cloned	O
from	O
the	O
E.	O
coli	O
chromosome	O
and	O
purified	O
by	O
metal	O
chelating	O
chromatography	O
.	O

Assessment	O
of	O
two	O
anion	O
-	O
exchange	O
resins	O
for	O
direct	O
use	O
in	O
the	O
screening	O
method	O
for	O
urinary	O
porphobilinogen	O
.	O

A	O
previously	O
developed	O
kinetic	O
model	O
was	O
used	O
to	O
identify	O
major	O
chemical	O
reaction	O
pathways	O
involving	O
PAH	O
in	O
the	O
afterburner	O
.	O

Regulation	O
of	O
the	O
p21-activated	B
kinase	I
(	O
PAK	B
)	O
by	O
a	O
human	B
Gbeta	I
-like	I
WD	O
-	O
repeat	O
protein	O
,	O
hPIP1	B
.	O

Activation	O
of	O
HIV-1	O
requires	O
the	O
binding	O
of	O
host	O
cell	O
transcription	O
factors	O
to	O
cis	O
elements	O
in	O
the	O
proviral	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
.	O

Based	O
on	O
the	O
ratios	O
of	O
the	O
areas	O
under	O
the	O
concentration	O
-	O
time	O
curves	O
in	O
CSF	O
and	O
serum	O
,	O
the	O
overall	O
penetration	O
of	O
rifampicin	O
into	O
CSF	O
was	O
0.13	O
-	O
0.42	O
(	O
median	O
=	O
0.22	O
)	O
.	O

Adaptability	O
of	O
Nippostrongylus	O
brasiliensis	O
(	O
Travassos	O
,	O
1914	O
)	O
to	O
lead	O
contamination	O

In	O
early	O
midgestation	O
embryos	O
it	O
is	O
expressed	O
in	O
telencephalic	O
,	O
diencephalic	O
and	O
mesencephalic	O
regions	O
but	O
from	O
day	O
11.75	O
of	O
gestation	O
its	O
expression	O
disappears	O
from	O
dorsal	O
telencephalon	O
and	O
is	O
confined	O
to	O
diencephalic	O
and	O
mesencephalic	O
regions	O
.	O

A	O
child	O
presumed	O
to	O
have	O
the	O
21-hydroxylase	B
deficiency	O
form	O
of	O
congenital	O
adrenal	O
hyperplasia	O
was	O
studied	O
extensively	O
as	O
an	O
infant	O
.	O

The	O
size	O
and	O
the	O
predicted	O
N	O
-	O
terminal	O
sequence	O
of	O
the	O
mouse	O
protein	O
were	O
confirmed	O
experimentally	O
.	O

It	O
was	O
found	O
that	O
Nopp140	B
binds	O
primarily	O
to	O
the	O
CK2	B
regulatory	I
subunit	I
,	I
beta	I
.	O

Further	O
,	O
more	O
recent	O
communications	O
suggest	O
that	O
liver	O
disease	O
led	O
to	O
a	O
differential	O
alteration	O
of	O
the	O
cytochrome	B
P-450s	I
with	O
regard	O
to	O
protein	O
content	O
and	O
activity	O
.	O

Alignment	O
of	O
the	O
rat	B
and	I
human	I
WIN	I
cDNAs	I
and	O
their	O
comparison	O
with	O
mouse	O
genomic	O
sequence	O
revealed	O
that	O
the	O
WIN	B
DNA	I
binding	I
domain	I
is	O
encoded	O
by	O
four	O
exons	O
,	O
two	O
of	O
which	O
(	O
exons	O
4	O
and	O
6	O
)	O
are	O
alternatively	O
spliced	O
to	O
generate	O
at	O
least	O
three	O
classes	O
of	O
mRNA	O
transcripts	O
.	O

25	O
patients	O
received	O
20	O
mgs	O
of	O
hyoscine	O
N	O
-	O
butyl	O
bromide	O
and	O
the	O
rest	O
5	O
mgs	O
propinoxate	O
,	O
i.v	O
.	O
plus	O
diazepam	O
.	O

The	O
activity	O
of	O
plasminogen	B
activator	I
has	O
been	O
measured	O
in	O
tissue	O
sections	O
with	O
the	O
aid	O
of	O
a	O
modified	O
Todd	O
technique	O
.	O

DESIGN	O
,	O
SETTING	O
AND	O
SUBJECTS	O
:	O
The	O
analysis	O
is	O
based	O
on	O
data	O
collected	O
in	O
the	O
first	O
two	O
rounds	O
of	O
the	O
nationally	O
representative	O
Ghana	O
Living	O
Standards	O
Survey	O
,	O
held	O
in	O
1987	O
/	O
88	O
(	O
GLSS	O
-	O
I	O
)	O
and	O
1988	O
/	O
89	O
(	O
GLSS	O
-	O
II	O
)	O
,	O
with	O
both	O
surveys	O
covering	O
approximately	O
3000	O
households	O
.	O

Moclobemide	O
is	O
a	O
well	O
-	O
tolerated	O
alternative	O
antidepressant	O
,	O
but	O
there	O
is	O
a	O
need	O
for	O
prospective	O
controlled	O
trials	O
to	O
evaluate	O
its	O
long	O
-	O
term	O
efficacy	O
.	O

Northern	O
blot	O
analyses	O
were	O
used	O
to	O
examine	O
the	O
regulated	O
expression	O
of	O
the	O
cys-14	B
+	I
gene	I
.	O

We	O
propose	O
that	O
,	O
while	O
Y.	O
lipolytica	O
CEN	O
DNA	O
is	O
essential	O
for	O
plasmid	O
maintenance	O
,	O
this	O
function	O
can	O
be	O
supplied	O
by	O
several	O
sub	O
-	O
fragments	O
which	O
,	O
together	O
,	O
form	O
the	O
active	O
chromosomal	O
centromere	O
.	O

These	O
three	O
groups	O
were	O
further	O
examined	O
with	O
regard	O
to	O
the	O
modulation	O
of	O
discharge	O
rate	O
i	O
)	O
during	O
motor	O
activity	O
in	O
W	O
,	O
ii	O
)	O
at	O
the	O
transitional	O
phase	O
from	O
SS	O
to	O
paradoxical	O
sleep	O
(	O
PS	O
)	O
,	O
iii	O
)	O
during	O
rapid	O
eye	O
movements	O
(	O
REMs	O
)	O
in	O
PS	O
,	O
and	O
iv	O
)	O
following	O
electrical	O
stimulation	O
of	O
the	O
midbrain	O
reticular	O
formation	O
(	O
MRF	O
)	O
.	O

Normal	O
dogs	O
were	O
exposed	O
to	O
either	O
10	O
,	O
15	O
,	O
or	O
30	O
Gy	O
of	O
X	O
rays	O
to	O
a	O
single	O
hemisphere	O
and	O
the	O
gross	O
and	O
histopathologic	O
changes	O
were	O
evaluated	O
qualitatively	O
.	O

The	O
characterization	O
of	O
fly	O
receptors	O
with	O
features	O
similar	O
to	O
mammalian	B
glycoprotein	I
hormone	I
receptors	I
allows	O
a	O
better	O
understanding	O
of	O
the	O
evolution	O
of	O
this	O
unique	O
group	O
of	O
GPCRs	B
and	O
future	O
elucidation	O
of	O
their	O
ligand	O
signaling	O
mechanisms	O
.	O

In	O
summary	O
,	O
the	O
only	O
treatment	O
-	O
related	O
effect	O
noted	O
in	O
this	O
study	O
was	O
hydrocarbon	O
nephropathy	O
in	O
male	O
rats	O
,	O
which	O
is	O
not	O
considered	O
relevant	O
for	O
human	O
health	O
.	O

Furthermore	O
,	O
deletion	O
of	O
two	O
potential	O
Ste11	B
recognition	I
sites	I
in	O
the	O
fus1	B
promoter	I
region	O
abolished	O
transcription	O
,	O
and	O
expression	O
could	O
be	O
restored	O
when	O
we	O
inserted	O
a	O
different	O
Ste11	B
site	I
from	O
the	O
mat1-P	B
promoter	I
.	O

PRIP	B
contains	O
two	O
LXXLL	O
signature	O
motifs	O
.	O

BPN	O
can	O
be	O
experimentally	O
produced	O
by	O
intratracheal	O
inoculation	O
of	O
microorganisms	O
in	O
high	O
concentrations	O
and	O
ventilator	O
-	O
associated	O
BPN	O
by	O
ventilating	O
baboons	O
with	O
oleic	O
-	O
acid	O
lung	O
injury	O
.	O

Coexpression	O
of	O
a	O
dominant	B
negative	I
c	I
-	I
jun	I
antagonized	O
the	O
ras	B
-	O
dependent	O
stimulation	O
of	O
the	O
92-kDa	B
gelatinase	I
B	I
promoter	O
-	O
driven	O
CAT	B
reporter	I
.	O

However	O
,	O
the	O
safety	O
of	O
design	O
4	O
was	O
assured	O
as	O
long	O
as	O
all	O
patients	O
received	O
three	O
courses	O
of	O
chemotherapy	O
,	O
which	O
is	O
unusual	O
in	O
phase	O
I	O
studies	O
in	O
Japan	O
.	O

The	O
plants	O
were	O
then	O
brought	O
to	O
our	O
Houston	O
laboratory	O
where	O
they	O
were	O
measured	O
and	O
analyzed	O
for	O
lignin	O
and	O
protein	O
content	O
and	O
for	O
phenylalanine	B
ammonia	I
-	I
lyase	I
(	O
PAL	B
)	O
and	O
peroxidase	B
activities	O
.	O

Activation	O
of	O
tyrosine	B
kinase	I
-	I
containing	I
receptors	I
,	O
heterotrimeric	B
G	I
proteins	I
,	O
and	O
protein	B
kinase	I
C	I
enhanced	O
the	O
activities	O
of	O
both	O
MEK	B
isoforms	I
in	O
293	O
and	O
PC12	O
cells	O
.	O

CONCLUSIONS	O
:	O
Transpulmonary	O
stable	O
air	O
microbubbles	O
bound	O
to	O
a	O
galactose	O
carrier	O
represent	O
a	O
useful	O
and	O
safe	O
contrast	O
agent	O
in	O
case	O
of	O
an	O
insufficient	O
native	O
signal	O
in	O
transcranial	O
Doppler	O
investigation	O
.	O

Specifically	O
,	O
we	O
engineered	O
two	O
chimeras	O
in	O
which	O
the	O
N	O
-	O
terminal	O
lobe	O
of	O
the	O
SH1	B
domain	I
of	O
c	B
-	I
Abl	I
was	O
swapped	O
with	O
that	O
of	O
v	B
-	I
Src	I
.	O

Although	O
IL-6	B
can	O
activate	O
ERK-1	B
in	O
HepG2	O
cells	O
,	O
STAT3	B
transactivation	O
and	O
Ser	O
(	O
727	O
)	O
phosphorylation	O
were	O
not	O
reduced	O
by	O
using	O
the	O
MAP	B
kinase	I
/	O
ERK	B
kinase	I
(	O
MEK	B
)	O
inhibitor	O
PD98059	O
or	O
by	O
overexpression	O
of	O
dominant	O
-	O
negative	O
Raf	B
.	O

Mean	O
disposition	O
constants	O
(	O
+	O
/-	O

SD	O
)	O
were	O
obtained	O
from	O
individualized	O
fits	O
(	O
V1	O
:	O
0.398	O
+	O
/-	O

0.336	O
LITER	O
/	O
KG	O
,	O
Vdarea	O
:	O
2.53	O
+	O
/-	O

0.72	O
liter	O
/	O
kg	O
,	O
alpha	O
:	O
0.316	O
+	O
/-	O

0.294	O
min	O
-1	O
,	O
beta	O
:	O
0.00204	O
+	O
/-	O

0.00262	O
min	O
-1	O
,	O
k2	O
:	O
0.0305	O
+	O
/-	O

0.0101	O
min	O
-1	O
)	O
.	O

Clinical	O
trials	O
bring	O
informations	O
for	O
pharmacology	O
and	O
epidemiology	O
.	O

The	O
peptides	O
are	O
generated	O
in	O
the	O
cytosol	O
,	O
then	O
translocated	O
across	O
the	O
membrane	O
of	O
the	O
endoplasmic	O
reticulum	O
by	O
the	O
transporter	B
associated	I
with	I
antigen	I
processing	I
(	O
TAP	B
)	O
.	O

An	O
in	O
vitro	O
'	O
glass	O
stomach	O
'	O
(	O
containing	O
various	O
volumes	O
of	O
hydrochloric	O
acid	O
[	O
HCl	O
]	O
and	O
ammonium	O
chloride	O
[	O
NH4Cl	O
]	O
)	O
was	O
used	O
to	O
evaluate	O
the	O
means	O
of	O
increasing	O
'	O
gastric	O
'	O
pH	O
to	O
that	O
of	O
the	O
NH4	O
+	O
-->NH3	O
transition	O
that	O
occurs	O
significantly	O
at	O
pH	O
9.24	O
.	O

Northern	O
analyses	O
further	O
confirm	O
that	O
the	O
expression	O
of	O
endogenous	O
alpha	B
-	I
ENaC	I
gene	I
in	O
salivary	O
Pa-4	O
cells	O
is	O
suppressed	O
by	O
an	O
ectopic	O
HMGI	B
-	I
C	I
overexpression	O
.	O

Finally	O
,	O
we	O
demonstrated	O
that	O
although	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
c	B
-	I
myb	I
is	O
required	O
for	O
both	O
the	O
differentiation	O
block	O
and	O
the	O
shift	O
in	O
cell	O
cycle	O
after	O
PMA	O
treatment	O
,	O
phosphorylation	O
by	O
casein	B
kinase	I
II	I
and	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
at	O
positions	O
11	O
and	O
12	O
or	O
532	O
of	O
c	B
-	I
myb	I
,	O
respectively	O
,	O
are	O
not	O
.	O

We	O
found	O
that	O
RXR	B
and	O
VDR	B
transactivated	O
selectively	O
from	O
VDRE	O
-	O
linked	O
templates	O
exclusively	O
as	O
a	O
heterodimeric	O
complex	O
,	O
since	O
neither	O
receptor	O
alone	O
enhanced	O
transcription	O
in	O
vitro	O
.	O

Assays	O
of	O
APRE	O
-	O
luciferase	B
reporter	O
plasmids	O
transfected	O
into	O
HepG2	O
cells	O
show	O
that	O
a	O
mutated	O
APRE	O
that	O
binds	O
only	O
BPi	B
functions	O
as	O
an	O
IL-1	B
alpha	I
inducible	O
enhancer	O
,	O
whereas	O
a	O
mutated	O
APRE	O
that	O
binds	O
only	O
BPc	B
does	O
not	O
.	O

Compared	O
with	O
controls	O
,	O
patients	O
in	O
the	O
unmedicated	O
state	O
had	O
low	O
smooth	O
pursuit	O
gain	O
,	O
had	O
a	O
higher	O
rate	O
of	O
corrective	O
catch	O
-	O
up	O
saccades	O
,	O
and	O
tended	O
to	O
spend	O
less	O
time	O
engaged	O
in	O
the	O
tracking	O
task	O
.	O

Epstein	B
-	I
Barr	I
virus	I
nuclear	I
antigen	I
2	I
exerts	O
its	O
transactivating	O
function	O
through	O
interaction	O
with	O
recombination	B
signal	I
binding	I
protein	I
RBP	I
-	I
J	I
kappa	I
,	O
the	O
homologue	O
of	O
Drosophila	B
Suppressor	I
of	I
Hairless	I
.	O

The	O
three	O
-	O
dimensional	O
structure	O
of	O
the	O
E.	O
coli	O
CR	O
domain	O
indicates	O
that	O
this	O
sequence	O
conservation	O
is	O
likely	O
to	O
result	O
in	O
a	O
conserved	O
structural	O
motif	O
.	O

Co	O
-	O
expression	O
of	O
PLD1	B
in	O
COS-7	O
cells	O
with	O
the	O
two	O
recombinant	B
CK2	I
subunits	I
,	O
alpha	O
or	O
beta	O
,	O
suggests	O
that	O
the	O
association	O
of	O
PLD1	B
with	O
the	O
kinase	O
is	O
through	O
the	O
beta	O
subunit	O
.	O

Despite	O
this	O
dependency	O
,	O
however	O
,	O
a	O
B.	B
japonicum	I
fixK	I
mutant	I
did	O
not	O
have	O
the	O
phenotypic	O
characteristics	O
of	O
B.	B
japonicum	I
fixL	I
and	O
fixJ	B
mutants	I
:	O
the	O
fixK	B
mutant	I
was	O
neither	O
Fix-	O
in	O
symbiosis	O
with	O
soybean	O
plants	O
nor	O
defective	O
in	O
anaerobic	O
respiration	O
with	O
nitrate	O
as	O
the	O
terminal	O
electron	O
acceptor	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
Pst1p	B
possessed	O
high	O
sequence	O
homology	O
with	O
the	O
Sin3	B
family	I
of	O
proteins	O
,	O
known	O
for	O
their	O
interaction	O
with	O
histone	B
deacetylases	I
.	O

This	O
selective	O
squelching	O
activity	O
suggests	O
that	O
GRIM	B
can	O
interact	O
with	O
an	O
essential	O
component	O
of	O
the	O
RNA	B
polymerase	I
II	I
transcription	O
machinery	O
.	O

The	O
S.	B
typhimurium	I
aspartyl	I
/	I
asparaginyl	I
beta	I
-	I
hydroxylase	I
homologue	I
(	O
designated	O
lpxO	B
)	O
was	O
cloned	O
into	O
pBluescriptSK	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
K-12	O
,	O
which	O
does	O
not	O
contain	O
lpxO.	B

Translation	O
of	O
mok	B
is	O
tightly	O
regulated	O
by	O
Sok	B
RNA	I
,	O
and	O
Sok	B
RNA	I
thus	O
regulates	O
hok	B
translation	O
indirectly	O
through	O
mok	B
.	O

In	O
this	O
work	O
,	O
we	O
determined	O
the	O
sequences	O
of	O
eight	O
VirF	B
-	I
binding	I
sites	I
from	O
four	O
different	O
genes	O
,	O
by	O
DNase	B
I	I
or	O
hydroxyl	O
radical	O
footprinting	O
.	O

Treatment	O
with	O
ACE	B
inhibitors	O
after	O
acute	O
myocardial	O
infarction	O

One	O
-	O
hour	O
O3	O
,	O
NO2	O
,	O
and	O
SO2	O
personal	O
exposures	O
were	O
measured	O
using	O
samplers	O
developed	O
in	O
our	O
laboratory	O
,	O
while	O
short	O
-	O
term	O
PM2.5	O
,	O
CO	O
,	O
and	O
VOCs	O
exposures	O
were	O
measured	O
using	O
currently	O
available	O
monitors	O
.	O

However	O
,	O
UV	O
resistance	O
is	O
only	O
minimally	O
restored	O
,	O
and	O
mutant	O
cells	O
remain	O
sensitive	O
to	O
gamma	O
radiation	O
.	O

Diagnostic	O
importance	O
of	O
determining	O
leucine	B
aminotransferase	I
activity	O
in	O
acute	O
pancreatitis	O

Synchronous	O
multicentric	O
giant	O
cell	O
tumour	O
:	O
a	O
case	O
report	O
with	O
review	O
of	O
literature	O
.	O

Lysates	O
of	O
COS	O
cells	O
transfected	O
with	O
modified	B
hGrzB	I
cDNA	I
were	O
able	O
to	O
hydrolyze	O
tert	O
-	O
butyloxycarbonyl	O
-	O
Ala	O
-	O
Ala	O
-	O
Asp	O
-	O
thiobenzyl	O
ester	O
(	O
Boc	O
-	O
Ala	O
-	O
Ala	O
-	O
Asp	O
-	O
SBzl	O
)	O
,	O
whereas	O
lysates	O
transfected	O
with	O
unmodified	B
hGrzB	I
cDNA	I
were	O
inactive	O
.	O

The	O
POU	B
-	O
specific	O
domain	O
of	O
Pit-1	B
is	O
essential	O
for	O
sequence	O
-	O
specific	O
,	O
high	O
affinity	O
DNA	O
binding	O
and	O
DNA	O
-	O
dependent	O
Pit-1-Pit-1	B
interactions	O
.	O

3	O
)	O
The	O
progress	O
of	O
fibrinolysis	O
was	O
observed	O
by	O
serial	O
collection	O
of	O
middle	O
ear	O
fluid	O
in	O
the	O
same	O
side	O
ear	O
of	O
5	O
cases	O
out	O
of	O
17	O
cases	O
having	O
much	O
activity	O
for	O
fibrin	B
degradation	O
,	O
and	O
lowering	O
of	O
fibrinolytic	O
activity	O
was	O
revealed	O
in	O
4	O
out	O
of	O
these	O
5	O
cases	O
as	O
the	O
result	O
.	O

In	O
lyzozyme	B
activity	O
there	O
was	O
periodicity	O
in	O
three	O
groups	O
but	O
not	O
in	O
the	O
youngest	O
foals	O
.	O

Alternative	O
roles	O
of	O
these	O
DNA	O
motifs	O
as	O
activators	O
of	O
early	O
mRNA	O
transcription	O
and	O
as	O
an	O
initiator	O
element	O
for	O
late	O
mRNA	O
transcription	O
help	O
explain	O
how	O
polyomavirus	O
gene	O
expression	O
is	O
regulated	O
during	O
lytic	O
growth	O
and	O
provides	O
a	O
model	O
for	O
cellular	O
transcription	O
during	O
development	O
.	O

The	O
Mer1	B
protein	I
contains	O
the	O
KH	O
motif	O
found	O
in	O
some	O
RNA	O
-	O
binding	O
proteins	O
,	O
and	O
RNA	O
gel	O
mobility	O
shift	O
assays	O
demonstrate	O
that	O
Mer1	B
binds	O
specifically	O
to	O
MER2	B
RNA	I
.	O

Collectively	O
,	O
these	O
studies	O
suggest	O
that	O
the	O
major	O
EGF	B
-	O
stimulated	O
mitotic	O
growth	O
pathways	O
may	O
not	O
be	O
absolutely	O
linked	O
to	O
the	O
stat91	B
signaling	O
pathways	O
and	O
that	O
such	O
transcription	O
complexes	O
are	O
more	O
complex	O
than	O
previously	O
reported	O
.	O

A	O
procaryotic	O
regulatory	O
factor	O
with	O
a	O
histone	B
H1-like	I
carboxy	I
-	I
terminal	I
domain	I
:	O
clonal	O
variation	O
of	O
repeats	O
within	O
algP	B
,	O
a	O
gene	O
involved	O
in	O
regulation	O
of	O
mucoidy	O
in	O
Pseudomonas	O
aeruginosa	O
.	O

Innervation	O
of	O
reticular	O
papillae	O
in	O
sheep	O
and	O
goats	O
.	O

The	O
monkeys	O
had	O
been	O
administered	O
a	O
common	O
lead	O
isotope	O
""""	O
mix	O
""""	O
at	O
the	O
rate	O
of	O
about	O
1300	O
micrograms	O
Pb	O
/	O
kg	O
body	O
wt	O
/	O
day	O
from	O
age	O
10	O
months	O
until	O
the	O
start	O
of	O
the	O
study	O
.	O

Previous	O
studies	O
showed	O
that	O
a	O
palindromic	O
sequence	O
located	O
at	O
-159	O
base	O
pairs	O
is	O
essential	O
for	O
induction	O
of	O
cutinase	B
gene	I
in	O
Fusarium	O
solani	O
f.	O
sp.	O
pisi	O
(	O
Nectria	O
haematococca	O
mating	O
type	O
VI	O
)	O
by	O
the	O
hydroxy	O
fatty	O
acids	O
from	O
plant	O
cutin	O
and	O
that	O
a	O
50-kDa	O
nuclear	O
protein	O
binds	O
to	O
a	O
promoter	O
that	O
contains	O
this	O
element	O
.	O

In	O
cells	O
co	O
-	O
expressing	O
high	O
levels	O
of	O
the	O
p38	B
(	O
MAPK	B
)	O
kinase	O
(	O
MKK3	B
)	O
together	O
with	O
the	O
p38	B
(	O
MAPK	B
)	O
,	O
a	O
significant	O
inhibition	O
of	O
mitogen	O
-	O
induced	O
cyclin	B
D1	I
expression	O
was	O
observed	O
.	O

ANL-7535	O
.	O

Restriction	O
analysis	O
of	O
the	O
isolated	O
genomic	O
clones	O
indicated	O
that	O
the	O
endogenous	O
sequences	O
abutting	O
the	O
3	O
'	O
ends	O
of	O
the	O
94-A	O
and	O
94-K	O
transgenes	O
are	O
separated	O
by	O
less	O
than	O
20	O
kb	O
,	O
providing	O
strong	O
support	O
for	O
the	O
single	O
integration	O
model	O
.	O

Phylogenetic	O
analysis	O
of	O
yeast	O
,	O
invertebrate	O
,	O
and	O
multiple	O
mammalian	O
isoforms	O
of	O
SNF4	B
shows	O
that	O
the	O
gene	O
duplication	O
likely	O
occurred	O
early	O
in	O
the	O
metazoan	O
lineage	O
,	O
as	O
the	O
protein	O
products	O
of	O
the	O
different	O
loci	O
are	O
relatively	O
divergent	O
.	O

The	O
delta	O
mean	O
VAF	O
and	O
delta	O
mean	O
SABP	O
indicated	O
varied	O
mean	O
values	O
of	O
VAF	O
and	O
SABP	O
,	O
respectively	O
.	O

Gel	O
mobility	O
shift	O
analyses	O
reveal	O
that	O
FRTL-5	O
thyroid	O
cell	O
nuclear	O
extracts	O
form	O
a	O
specific	O
protein	O
/	O
DNA	O
complex	O
with	O
this	O
region	O
,	O
which	O
is	O
prevented	O
by	O
the	O
TTF-1	B
binding	I
element	I
from	O
the	O
TG	B
promoter	I
;	O
FRT	O
and	O
BRL	O
cell	O
nuclear	O
extracts	O
do	O
not	O
have	O
TTF-1	B
and	O
do	O
not	O
form	O
this	O
complex	O
.	O

Thallium-201	O
scintigraphy	O
after	O
dipyridamole	O
infusion	O
with	O
low	O
level	O
exercise	O
.	O

Dominant	O
-	O
negative	O
upf1	B
mutations	O
were	O
isolated	O
following	O
in	O
vitro	O
mutagenesis	O
of	O
a	O
plasmid	O
containing	O
the	O
UPF1	B
gene	I
.	O

Such	O
saturation	O
often	O
occurs	O
for	O
several	O
recording	O
sweeps	O
after	O
large	O
amplitude	O
signals	O
such	O
as	O
eye	O
blinks	O
are	O
rejected	O
.	O

To	O
define	O
the	O
molecular	O
mechanism	O
regulating	O
FGFR-1	B
gene	I
expression	O
in	O
proliferating	O
myoblasts	O
and	O
post	O
-	O
mitotic	O
muscle	O
fibers	O
,	O
we	O
have	O
isolated	O
and	O
partially	O
characterized	O
the	O
avian	O
FGFR-1	B
gene	I
promoter	O
.	O

Men	O
and	O
women	O
entering	O
psychotherapy	O
more	O
often	O
had	O
negative	O
Wish	O
elements	O
than	O
others	O
.	O

Serum	B
prolactin	I
and	O
oestradiol	O
levels	O
at	O
different	O
stages	O
of	O
puberty	O
.	O

The	O
sequence	O
of	O
three	O
of	O
them	O
revealed	O
pure	O
CAG	O
stretches	O
.	O

PCC	O
6803	O
mutant	O
impaired	O
in	O
cytochrome	B
c	I
maturation	O
.	O

Seroconversion	O
after	O
hepatitis	O
B	O
vaccination	O
.	O

On	O
day	O
1	O
at	O
3500	O
m	O
,	O
RI	O
showed	O
a	O
significant	O
fall	O
in	O
body	O
weight	O
(	O
BW	O
)	O
with	O
respect	O
to	O
SL	O
but	O
AI	O
maintained	O
it	O
.	O

Expression	O
of	O
CBP	B
/	O
p300	B
potentiated	O
HS2-mediated	O
transactivation	O
.	O

Using	O
lasers	O
in	O
diabetic	O
wound	O
healing	O
.	O

Protein	O
metabolism	O
disorders	O
in	O
burns	O

RNA	O
unwinding	O
in	O
U4	B
/	O
U6	B
snRNPs	O
requires	O
ATP	O
hydrolysis	O
and	O
the	O
DEIH	O
-	O
box	O
splicing	O
factor	O
Brr2	B
.	O

Preface	O
and	O
acknowledgements	O
.	O

G	B
-	I
CSF	I
(	O
10	O
microg	O
/	O
kg	O
)	O
was	O
started	O
on	O
day	O
+	O
1	O
and	O
all	O
patients	O
engrafted	O
within	O
a	O
median	O
day	O
number	O
of	O
12	O
(	O
range	O
,	O
10	O
-	O
22	O
)	O
until	O
leukocytes	O
>	O
1.0	O
x	O
10	O
(	O
9	O
)	O
/	O
l	O
and	O
a	O
median	O
day	O
number	O
of	O
56	O
(	O
range	O
,	O
10	O
-	O
180	O
)	O
until	O
platelets	O
>	O
20.0	O
x	O
10	O
(	O
9	O
)	O
/	O
l	O
(	O
ie	O
platelet	O
transfusion	O
independence	O
)	O
.	O

The	O
present	O
study	O
indicates	O
that	O
the	O
high	O
-	O
dose	O
5-fluorouracil	O
regimen	O
shows	O
weak	O
activity	O
in	O
advanced	O
pancreatic	O
cancer	O
which	O
seems	O
comparable	O
to	O
gemcitabine	O
.	O

At	O
D28	O
,	O
149	O
of	O
386	O
patients	O
(	O
49	O
%	O
)	O
had	O
had	O
episodes	O
of	O
automatic	O
mode	O
switch	O
prompted	O
by	O
atrial	O
arrhythmias	O
.	O

Thus	O
,	O
the	O
rates	O
of	O
a	B
-	I
factor	I
receptor	I
endocytosis	O
and	O
consequent	O
vacuolar	O
turnover	O
depend	O
on	O
the	O
available	O
level	O
of	O
ubiquitin	B
in	O
the	O
cell	O
.	O

Early	O
diagnosis	O
and	O
early	O
surgical	O
division	O
of	O
the	O
biliary	O
tract	O
and	O
pancreatic	O
duct	O
is	O
recommended	O
for	O
children	O
with	O
AAPBD	O
.	O

This	O
approach	O
allowed	O
examination	O
of	O
baseline	O
factors	O
as	O
well	O
as	O
the	O
effect	O
of	O
change	O
in	O
mileage	O
,	O
the	O
occurrence	O
of	O
a	O
musculoskeletal	O
problem	O
,	O
or	O
the	O
occurrence	O
of	O
another	O
health	O
problem	O
on	O
the	O
rate	O
of	O
dropout	O
.	O

In	O
addition	O
,	O
the	O
results	O
suggest	O
that	O
N	O
region	O
diversity	O
at	O
V	B
(	O
D	B
)	O
J	B
junctions	O
within	O
rearranged	O
immunoglobulin	B
and	O
T	B
cell	I
receptor	I
gene	I
loci	I
can	O
only	O
be	O
introduced	O
after	O
the	O
generation	O
of	O
RAG	B
-	O
catalyzed	O
DNA	O
double	O
-	O
strand	O
breaks	O
,	O
i.e.	O
during	O
the	O
DNA	O
end	O
joining	O
phase	O
of	O
the	O
V	B
(	O
D	B
)	O
J	B
recombination	O
reaction	O
.	O

The	O
pra2	B
gene	I
encodes	O
a	O
pea	B
(	I
Pisum	I
sativum	I
)	I
small	I
GTPase	I
belonging	O
to	O
the	O
YPT	B
/	O
rab	B
family	O
,	O
and	O
its	O
expression	O
is	O
down	O
-	O
regulated	O
by	O
light	O
,	O
mediated	O
by	O
phytochrome	B
.	O

To	O
directly	O
address	O
this	O
issue	O
,	O
we	O
used	O
a	O
tetracycline	O
-	O
regulated	O
system	O
in	O
human	O
U2OS	O
osteosarcoma	O
cells	O
and	O
thus	O
found	O
that	O
BCL6	B
mediates	O
growth	O
suppression	O
associated	O
with	O
impaired	O
S	O
phase	O
progression	O
and	O
apoptosis	O
.	O

To	O
explore	O
the	O
effect	O
of	O
persistent	O
cardiomegaly	O
on	O
cardiovascular	O
function	O
,	O
groups	O
of	O
newborn	O
rats	O
inhaled	O
up	O
to	O
500	O
ppm	O
CO	O
for	O
33	O
days	O
,	O
after	O
which	O
development	O
continued	O
in	O
ambient	O
air	O
.	O

Cutaneous	O
melanoma	O
and	O
bilateral	O
retinoblastoma	O
.	O

This	O
complex	O
was	O
eliminated	O
by	O
mutation	O
of	O
either	O
half	O
-	O
site	O
,	O
and	O
it	O
was	O
supershifted	O
by	O
antibodies	O
against	O
chicken	B
ovalbumin	I
upstream	I
promoter	I
-	I
transcription	I
factor	I
(	O
COUP	B
-	I
TF	I
)	O
.	O

The	O
material	O
then	O
was	O
cut	O
with	O
a	O
diamond	O
saw	O
into	O
sheets	O
of	O
8	O
x	O
10	O
x	O
3	O
mm	O
,	O
and	O
the	O
upper	O
surface	O
was	O
polished	O
by	O
colloidal	O
SiO2	O
and/or	O
covered	O
with	O
a	O
carbon	O
-	O
titanium	O
(	O
C	O
:	O
Ti	O
)	O
layer	O
(	O
3.3	O
microm	O
)	O
using	O
the	O
plasma	O
-	O
enhanced	O
physical	O
vapor	O
deposition	O
method	O
.	O

We	O
present	O
here	O
a	O
statistical	O
technique	O
we	O
developed	O
to	O
identify	O
the	O
sequence	O
elements	O
that	O
may	O
be	O
responsible	O
for	O
this	O
cell	O
cycle	O
regulation	O
.	O

From	O
the	O
comparison	O
of	O
the	O
nod	B
box	I
sequences	I
of	O
(	O
brady	O
)	O
rhizobia	O
with	O
a	O
more	O
divergent	O
nod	B
box	I
from	O
Azorhizobium	O
caulinodans	O
,	O
we	O
now	O
propose	O
a	O
modular	O
build	O
-	O
up	O
of	O
the	O
nod	B
box	I
with	O
the	O
sequence	O
A	O
-	O
T	O
-	O
C	O
-	O
N9-G	O
-	O
A	O
-	O
T	O
as	O
the	O
binding	O
target	O
of	O
the	O
NodD	B
protein	I
(	O
the	O
NodD	B
box	I
)	O
.	O

This	O
dip	O
also	O
occurred	O
during	O
prednisone	O
and	O
vitamin	O
D	O
treatment	O
,	O
but	O
did	O
not	O
occur	O
when	O
calcium	O
was	O
added	O
to	O
prednisone	O
,	O
although	O
the	O
baseline	O
value	O
was	O
lower	O
at	O
the	O
start	O
of	O
combined	O
treatment	O
with	O
prednisone	O
and	O
calcium	O
.	O

Highly	O
conserved	O
regions	O
called	O
src	B
homology	I
2	I
and	O
3	O
(	O
SH2	B
and	O
SH3	B
)	O
,	O
comprising	O
amino	O
acid	O
residues	O
88	O
to	O
250	O
,	O
are	O
believed	O
to	O
modulate	O
the	O
protein	B
-	I
tyrosine	I
kinase	I
activity	O
present	O
in	O
the	O
carboxy	O
-	O
terminal	O
halves	O
of	O
the	O
src	B
proteins	I
.	O

Acanthamoeba	B
myosin	I
I	I
heavy	I
chain	I
kinase	I
(	O
MIHCK	B
)	O
phosphorylates	O
the	O
heavy	O
chains	O
of	O
amoeba	B
myosins	I
I	I
,	O
increasing	O
their	O
actin	B
-	O
activated	O
ATPase	B
activities	O
.	O

Two	O
different	O
genes	O
(	O
polA	B
and	O
polB	B
)	O
encoding	O
family	B
B	I
DNA	I
polymerases	I
were	O
cloned	O
from	O
the	O
organism	O
by	O
PCR	O
using	O
degenerated	O
primers	O
based	O
on	O
the	O
two	O
conserved	O
motifs	O
(	O
motif	O
A	O
and	O
B	O
)	O
.	O

The	O
polypeptide	O
encoded	O
by	O
the	O
cDNA	O
contained	O
450	O
amino	O
acids	O
with	O
a	O
calculated	O
M	O
(	O
r	O
)	O
of	O
52,057	O
,	O
and	O
showed	O
significant	O
homology	O
with	O
human	O
and	O
mouse	B
CAD	I
(	O
22	O
%	O
identity	O
)	O
.	O

Cytokine	O
-	O
mediated	O
I	B
kappa	I
B	I
alpha	I
reappearance	O
was	O
completely	O
blocked	O
by	O
the	O
protein	O
synthesis	O
inhibitor	O
cycloheximide	O
.	O

NGF	B
also	O
induced	O
a	O
synthetic	O
promoter	O
with	O
repeated	O
Sp1	B
sites	I
linked	O
to	O
a	O
core	O
promoter	O
,	O
and	O
a	O
plasmid	O
regulated	O
by	O
a	O
chimeric	O
transactivator	O
in	O
which	O
the	O
Gal4	B
DNA	I
binding	I
domain	I
is	O
fused	O
to	O
the	O
Sp1	B
transactivation	I
domain	I
,	O
indicating	O
that	O
this	O
transactivation	O
domain	O
is	O
regulated	O
by	O
NGF	B
.	O

These	O
results	O
suggest	O
that	O
UvrA	B
is	O
involved	O
in	O
triplet	O
repeat	O
instability	O
in	O
cells	O
.	O

We	O
conclude	O
,	O
therefore	O
,	O
that	O
in	O
the	O
absence	O
of	O
E1A	B
,	O
E4orf4	B
is	O
sufficient	O
by	O
itself	O
to	O
trigger	O
a	O
p53-independent	B
apoptosis	O
pathway	O
that	O
may	O
operate	O
independently	O
of	O
the	O
known	O
zVAD	O
-	O
inhibitable	O
caspases	B
,	O
and	O
that	O
may	O
involve	O
an	O
as	O
yet	O
uncharacterized	O
mechanism	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
gene	O
encoding	O
this	O
product	O
was	O
determined	O
and	O
the	O
amino	O
acid	O
sequence	O
deduced	O
.	O

Evidence	O
for	O
Gcr1p	B
/	O
Gcr2p	B
interaction	O
has	O
been	O
presented	O
earlier	O
and	O
is	O
now	O
supported	O
by	O
the	O
isolation	O
of	O
mutations	O
in	O
Gcr1p	B
suppressing	O
gcr2	B
,	O
as	O
assessed	O
by	O
growth	O
and	O
enzyme	O
assay	O
.	O

Mammalian	O
ribonucleotide	B
reductase	I
shows	O
S	O
-	O
phase	O
specific	O
expression	O
and	O
consists	O
of	O
two	O
non	O
-	O
identical	O
subunits	O
,	O
proteins	B
R1	I
(	O
large	O
subunit	O
)	O
and	O
R2	B
(	O
small	O
subunit	O
)	O
.	O

We	O
analyzed	O
the	O
effects	O
of	O
light	O
on	O
tubulin	B
mRNA	I
abundance	O
in	O
Arabidopsis	O
seedlings	O
using	O
RNA	O
gel	O
blot	O
hybridizations	O
and	O
gene	O
-	O
specific	O
probes	O
.	O

It	O
is	O
suggested	O
that	O
death	O
of	O
S.	O
mansoni	O
cercariae	O
during	O
penetration	O
of	O
mammalian	O
host	O
skin	O
is	O
probably	O
due	O
to	O
exhaustion	O
of	O
their	O
energy	O
reserves	O
.	O

Recent	O
research	O
on	O
lipolysis	O
.	O

Instead	O
,	O
HBx	B
is	O
shown	O
to	O
activate	O
the	O
cyclin	B
A	I
promoter	I
,	O
induce	O
cyclin	B
A	I
-	O
cyclin	B
-	I
dependent	I
kinase	I
2	I
complexes	O
,	O
and	O
promote	O
cycling	O
of	O
growth	O
-	O
arrested	O
cells	O
into	O
G1	O
through	O
a	O
pathway	O
involving	O
activation	O
of	O
Src	B
tyrosine	I
kinases	I
.	O

Fifty	O
-	O
seven	O
per	O
cent	O
of	O
the	O
primary	O
patients	O
reporting	O
mild	O
symptoms	O
had	O
abnormal	O
levels	O
of	O
leucocytes	O
in	O
their	O
CSF	O
.	O

The	O
PRP4	B
protein	I
of	I
Saccharomyces	I
cerevisiae	I
is	O
an	O
essential	O
part	O
of	O
the	O
U4	B
/	O
U6	B
snRNP	O
,	O
a	O
component	O
of	O
the	O
mRNA	O
splicing	O
apparatus	O
.	O

Binding	O
of	O
transformed	O
Ah	B
receptor	I
complex	I
to	O
a	O
dioxin	O
responsive	O
transcriptional	O
enhancer	O
:	O
evidence	O
for	O
two	O
distinct	O
heteromeric	O
DNA	O
-	O
binding	O
forms	O
.	O

Characterization	O
of	O
the	O
chromosome	O
19	O
breakpoint	O
region	O
revealed	O
that	O
the	O
transcription	B
factor	I
-	I
encoding	I
USF2	I
gene	I
is	O
affected	O
.	O

It	O
is	O
dangerous	O
to	O
label	O
such	O
conditions	O
as	O
'	O
inappropriate	O
'	O
secretion	O
of	O
ADH	B
since	O
the	O
maintenance	O
of	O
circulating	O
volume	O
is	O
at	O
least	O
as	O
important	O
a	O
physiological	O
requirement	O
as	O
the	O
defence	O
of	O
tonicity	O
.	O

Using	O
a	O
simulated	O
cough	O
machine	O
,	O
we	O
analyzed	O
the	O
effect	O
of	O
adding	O
tensio	O
-	O
active	O
liquids	O
as	O
sol	O
phase	O
simulant	O
on	O
the	O
clearance	O
of	O
gel	O
mucus	O
simulant	O
by	O
cough	O
.	O

The	O
effects	O
of	O
4	O
weeks	O
of	O
cyclosporin	O
A	O
(	O
7	O
mg	O
/	O
kg	O
per	O
day	O
)	O
(	O
CyA	O
)	O
on	O
the	O
survival	O
of	O
vascularized	O
osteochondral	O
grafts	O
between	O
rat	O
strains	O
[	O
DA	O
(	O
donor	O
)	O
and	O
Lewis	O
(	O
recipient	O
)	O
]	O
and	O
the	O
presence	O
and	O
significance	O
of	O
host	O
immune	O
tolerance	O
and	O
graft	O
antigen	O
modulation	O
after	O
cessation	O
of	O
immunosuppression	O
have	O
been	O
examined	O
.	O

Insulin	B
binding	O
to	O
the	O
alpha	O
-	O
subunit	O
of	O
its	O
receptor	O
stimulates	O
the	O
receptor	B
tyrosine	I
kinase	I
to	O
phosphorylate	O
the	O
beta	O
-	O
subunit	O
and	O
several	O
endogenous	O
protein	O
substrates	O
,	O
including	O
pp120	B
/	O
HA4	B
,	O
a	O
liver	O
-	O
specific	O
plasma	O
membrane	O
glycoprotein	O
of	O
M	O
(	O
r	O
)	O
20,000	O
.	O

The	O
second	O
intron	O
is	O
the	O
smallest	O
of	O
all	O
the	O
introns	O
(	O
116	O
bp	O
)	O
.	O

Moreover	O
,	O
our	O
recent	O
findings	O
on	O
the	O
Tc52	B
encoding	I
gene	I
underline	O
the	O
interest	O
of	O
genetic	O
manipulation	O
of	O
T.	O
cruzi	O
,	O
not	O
only	O
making	O
it	O
possible	O
to	O
use	O
more	O
closely	O
an	O
in	O
vitro	O
approach	O
to	O
find	O
out	O
how	O
genes	O
function	O
,	O
but	O
also	O
to	O
obtain	O
'	O
attenuated	O
'	O
strains	O
that	O
could	O
be	O
used	O
in	O
the	O
development	O
of	O
vaccinal	O
strategies	O
.	O

The	O
promoter	O
for	O
HMG	B
-	I
CoA	I
synthase	I
contains	O
two	O
binding	O
sites	O
for	O
the	O
sterol	B
regulatory	I
element	I
-	I
binding	I
proteins	I
(	O
SREBPs	B
)	O
.	O

Using	O
the	O
same	O
electrical	O
analog	O
,	O
we	O
present	O
an	O
analysis	O
that	O
allows	O
calculation	O
of	O
these	O
parameters	O
,	O
as	O
well	O
as	O
the	O
corner	O
frequency	O
of	O
the	O
network	O
(	O
f1	O
)	O
,	O
without	O
need	O
for	O
similar	O
assumptions	O
.	O

In	O
contrast	O
,	O
a	O
similar	O
fusion	O
protein	O
(	O
hGH	B
-	O
LDLR	B
-	O
DAF17	B
,	O
abbreviated	O
HLD	B
)	O
containing	O
a	O
fragment	O
of	O
the	O
serine	O
/	O
threonine	O
-	O
rich	O
domain	O
of	O
the	O
LDL	B
receptor	I
(	O
LDLR	B
)	O
in	O
place	O
of	O
the	O
DAF	B
-	I
derived	I
serine	I
/	I
threonine	I
-	I
rich	I
sequences	I
,	O
does	O
not	O
become	O
GPI	O
anchored	O
.	O

Of	O
concern	O
is	O
the	O
high	O
,	O
unexplained	O
prevalence	O
of	O
BV	O
among	O
African	O
-	O
American	O
women	O
,	O
who	O
are	O
also	O
at	O
extremely	O
high	O
risk	O
for	O
preterm	O
birth	O
.	O

The	O
RAG-2	B
gene	I
encodes	O
a	O
component	O
of	O
the	O
V	B
(	I
D	I
)	I
J	I
recombinase	I
which	O
is	O
essential	O
for	O
the	O
assembly	O
of	O
antigen	O
receptor	O
genes	O
in	O
B	O
and	O
T	O
lymphocytes	O
.	O

Cell	O
-	O
free	O
extracts	O
of	O
E.	O
coli	O
(	O
fpg	B
mutY	B
)	O
harboring	O
pYSB10	O
possess	O
an	O
enzymatic	O
activity	O
that	O
cleaves	O
a	O
34-mer	O
oligonucleotide	O
containing	O
a	O
single	O
8-oxoG	O
opposite	O
a	O
cytosine	O
(	O
8-OxoG	O
/	O
C	O
)	O
.	O

Magnification	O
-	O
corrected	O
planimetry	O
of	O
the	O
parapapillary	O
region	O
was	O
performed	O
according	O
to	O
Littmann	O
's	O
method	O
in	O
312	O
unselected	O
eyes	O
with	O
chronic	O
primary	O
open	O
-	O
angle	O
glaucoma	O
and	O
in	O
125	O
normal	O
eyes	O
of	O
an	O
age-	O
and	O
refraction	O
-	O
matched	O
control	O
group	O
using	O
optic	O
disk	O
photographs	O
.	O

Both	O
merR	B
genes	I
consist	O
of	O
a	O
408	O
bp	O
ORF	O
coding	O
for	O
135	O
amino	O
acids	O
.	O

The	O
1.3-kb	O
DNA	O
,	O
when	O
placed	O
upstream	O
of	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
,	O
was	O
shown	O
to	O
be	O
functionally	O
active	O
.	O

Polar	O
effects	O
of	O
transposon	O
insertions	O
demonstrated	O
that	O
all	O
of	O
these	O
mRNAs	O
arose	O
from	O
a	O
single	O
promoter	O
region	O
,	O
where	O
transcription	O
initiated	O
80	O
bp	O
5	O
'	O
to	O
nifH.	B

Here	O
,	O
we	O
identify	O
the	O
analytical	O
form	O
of	O
the	O
PDF	O
of	O
one	O
such	O
measure	O
,	O
the	O
order	O
parameter	O
in	O
the	O
low	O
temperature	O
phase	O
of	O
the	O
2D	O
XY	O
model	O
.	O

The	O
determination	O
of	O
antithrombin	B
III	I
(	O
AT	B
III	I
)	O
and	O
its	O
clinical	O
significance	O

With	O
this	O
study	O
,	O
a	O
total	O
of	O
13	O
operators	O
for	O
the	O
glp	B
regulon	I
have	O
been	O
characterized	O
.	O

Southern	O
zoo	O
blot	O
analysis	O
indicated	O
that	O
ZNF236	B
is	O
conserved	O
in	O
the	O
genomes	O
of	O
all	O
mammalian	O
species	O
tested	O
,	O
but	O
not	O
in	O
yeast	O
.	O

3	O
.	O

This	O
alternative	O
splice	O
acceptor	O
site	O
is	O
also	O
used	O
by	O
a	O
biologically	O
active	O
provirus	O
with	O
an	O
efficiency	O
of	O
approximately	O
5	O
%	O
compared	O
with	O
the	O
upstream	O
site	O
.	O

In	O
this	O
study	O
,	O
the	O
effect	O
of	O
the	O
antibiotic	O
lasalocid	O
on	O
the	O
rumen	O
anaerobic	O
fungus	O
Neocallimastix	O
frontalis	O
RK	O
21	O
was	O
examined	O
.	O

4	O
382	O
new	O
mothers	O
were	O
examined	O
retrospectively	O
with	O
the	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
for	O
IgG	B
activity	O
to	O
cytomegalovirus	O
(	O
CMV	O
)	O
during	O
pregnancy	O
.	O

Our	O
results	O
suggest	O
a	O
dose	O
-	O
dependent	O
activity	O
of	O
lysine	B
vasopressin	I
on	O
the	O
EEG	O
,	O
which	O
might	O
be	O
similar	O
to	O
that	O
observed	O
in	O
animal	O
and	O
man	O
after	O
administration	O
of	O
nicotine	O
.	O

However	O
,	O
elimination	O
of	O
the	O
kinase	O
activity	O
of	O
DCAMKL1	B
has	O
no	O
detectable	O
effect	O
on	O
its	O
microtubule	O
polymerization	O
activity	O
.	O

Sequencing	O
and	O
restriction	O
enzyme	O
analysis	O
demonstrated	O
that	O
this	O
single	O
-	O
copy	O
gene	O
contains	O
11	O
exons	O
and	O
spans	O
9596	O
base	O
pairs	O
.	O

The	O
anaesthetic	O
management	O
of	O
41	O
patients	O
who	O
underwent	O
cardiac	O
transplantation	O
during	O
a	O
40	O
month	O
period	O
at	O
Clinica	O
Puerta	O
de	O
Hierro	O
is	O
reviewed	O
.	O

In	O
uraemic	O
patients	O
,	O
similar	O
maximum	O
serum	O
concentrations	O
were	O
found	O
after	O
a	O
single	O
7.5	O
mg	O
/	O
kg	O
iv	O
dose	O
.	O

In	O
the	O
unit	O
housing	O
of	O
a	O
compact	O
cyclotron	O
and	O
positron	O
emission	O
CT	O
(	O
PET	O
)	O
,	O
positron	O
emitting	O
gas	O
such	O
as	O
15O	O
,	O
11C	O
,	O
C15O2	O
,	O
C15O	O
etc	O
.	O
is	O
supplied	O
from	O
a	O
cyclotron	O
to	O
a	O
PET	O
room	O
through	O
a	O
transportation	O
pipe	O
with	O
an	O
appropriate	O
shield	O
to	O
reduce	O
positron	O
annihilation	O
radiation	O
.	O

Here	O
we	O
describe	O
the	O
cloning	O
and	O
initial	O
characterization	O
of	O
IPP	B
,	O
a	O
novel	O
human	O
gene	O
that	O
predicts	O
a	O
kelch	B
family	I
protein	I
homologous	O
to	O
the	O
mouse	B
Ipp	I
gene	I
,	O
a	O
previously	O
described	O
kelch	B
family	I
member	I
.	O

Sequence	O
analysis	O
identifies	O
a	O
ras	B
-	I
associating	I
(	O
RA	B
)	O
-like	O
domain	O
in	O
the	O
N	O
-	O
termini	O
of	O
band	B
4.1	I
/	I
JEF	I
domains	I
and	O
in	O
the	O
Grb7	B
/	I
10	I
/	I
14	I
adapter	I
family	I
.	O

Sleeping	O
position	O
and	O
sudden	O
infant	O
death	O
syndrome	O
(	O
SIDS	O
)	O
:	O
effect	O
of	O
an	O
intervention	O
programme	O
to	O
avoid	O
prone	O
sleeping	O
.	O

Statistical	O
conservation	O
laws	O
in	O
turbulent	O
transport	O
.	O

Characterization	O
and	O
targeted	O
disruption	O
of	O
murine	B
Nup50	I
,	O
a	O
p27	B
(	O
Kip1	B
)	O
-interacting	O
component	O
of	O
the	O
nuclear	O
pore	O
complex	O
.	O

p27	B
(	O
Kip1	B
)	O
is	O
a	O
member	O
of	O
the	O
Cip	B
-	O
Kip	B
family	O
of	O
cyclin	B
-	I
dependent	I
kinase	I
(	O
Cdk	B
)	O
inhibitors	O
that	O
binds	O
to	O
cyclin	B
-	O
Cdk	B
complexes	O
and	O
inhibits	O
their	O
catalytic	O
activity	O
in	O
response	O
to	O
antiproliferative	O
stimuli	O
.	O

p27	B
(	O
Kip1	B
)	O
is	O
regulated	O
by	O
several	O
posttranscriptional	O
mechanisms	O
,	O
including	O
subcellular	O
localization	O
.	O

We	O
have	O
identified	O
the	O
gene	O
encoding	O
sigma	B
E	I
using	O
a	O
genetic	O
screen	O
designed	O
to	O
isolate	O
trans	O
-	O
acting	O
mutations	O
that	O
abolish	O
expression	O
from	O
either	O
htrA	B
or	O
rpoHP3	B
,	O
two	O
promoters	O
recognized	O
uniquely	O
by	O
sigma	B
E	I
-	O
containing	O
RNA	B
polymerase	I
.	O

Based	O
on	O
these	O
results	O
,	O
it	O
has	O
been	O
concluded	O
that	O
an	O
IPFSA	O
can	O
promote	O
the	O
healing	O
process	O
in	O
the	O
avascular	O
zone	O
of	O
a	O
torn	O
meniscus	O
in	O
rabbits	O
and	O
that	O
systemic	O
vascularity	O
to	O
the	O
synovium	O
or	O
the	O
meniscus	O
is	O
not	O
essential	O
for	O
healing	O
to	O
occur	O
.	O

Biomass	O
growth	O
monitoring	O
using	O
pressure	O
drop	O
in	O
a	O
cocurrent	O
biofilter	O

Inspection	O
of	O
X.	B
tropicalis	I
,	I
mouse	I
and	I
human	I
U6	I
DNA	I
upstream	I
sequences	I
revealed	O
the	O
presence	O
of	O
a	O
TATA	O
box	O
as	O
well	O
as	O
of	O
the	O
proximal	O
and	O
enhancer	O
(	O
octamer	O
motif	O
)	O
elements	O
contained	O
in	O
snRNA	O
genes	O
transcribed	O
by	O
RNA	B
polymerase	I
II	I
.	O

When	O
expressed	O
in	O
thymidine	B
kinase	I
-	O
deficient	O
L	O
cells	O
or	O
3T3	O
cells	O
,	O
C	B
/	I
EBPalpha	I
is	O
detected	O
in	O
a	O
protein	O
complex	O
which	O
binds	O
to	O
the	O
E2F	B
binding	I
sites	I
found	O
in	O
the	O
promoters	O
of	O
the	O
genes	O
for	O
E2F-1	B
and	O
dihydrofolate	B
reductase	I
(	O
DHFR	B
)	O
.	O

Phenylalanine	O
and	O
tyrosine	O
levels	O
were	O
higher	O
in	O
those	O
who	O
received	O
Vamin	O
9	O
glucose	O
but	O
55	O
%	O
of	O
infants	O
given	O
Vamin	O
Infant	O
had	O
tyrosine	O
levels	O
below	O
the	O
lower	O
limit	O
of	O
the	O
target	O
range	O
.	O

CONCLUSIONS	O
:	O
Neurodevelopmental	O
assessment	O
at	O
1	O
year	O
is	O
predictive	O
of	O
school	O
performance	O
and	O
outcome	O
in	O
the	O
adolescent	O
period	O
.	O

Phenotypic	O
responses	O
of	O
additional	O
mutants	O
,	O
including	O
exo1	B
,	O
srs2	B
,	O
rad5	B
,	O
and	O
rdh54	B
strains	O
,	O
suggest	O
roles	O
in	O
recombinational	O
repair	O
,	O
but	O
not	O
in	O
NHEJ	O
.	O

Although	O
hSSTR5	B
displays	O
approximately	O
75	O
%	O
sequence	O
identity	O
with	O
rat	B
SSTR5	I
,	O
the	O
two	O
receptors	O
display	O
significantly	O
different	O
pharmacological	O
profiles	O
,	O
especially	O
with	O
respect	O
to	O
their	O
binding	O
affinities	O
for	O
the	O
SST	B
analogue	O
SMS	O
201	O
-	O
995	O
.	O

These	O
findings	O
suggest	O
that	O
IL-1-stimulated	B
,	O
Rho	B
-	O
dependent	O
cytoskeletal	O
reorganization	O
may	O
cluster	O
signaling	O
molecules	O
in	O
specific	O
architectures	O
that	O
are	O
necessary	O
for	O
persistent	O
cell	O
activation	O
in	O
chronic	O
inflammatory	O
disease	O
.	O

Deletion	O
mutants	O
of	O
the	O
human	B
CHOP	I
promoter	I
identify	O
a	O
region	O
comprising	O
nucleotides	O
-75	O
to	O
-104	O
required	O
for	O
both	O
constitutive	O
and	O
ER	O
-	O
stress	O
-	O
inducible	O
expression	O
.	O

Anderson	O
Hospital	O
and	O
Tumor	O
Institute	O
at	O
Houston	O
during	O
a	O
30-year	O
interval	O
(	O
1944	O
to	O
1974	O
)	O
,	O
with	O
a	O
minimum	O
of	O
ten	O
years	O
of	O
follow	O
-	O
up	O
,	O
we	O
determined	O
that	O
the	O
major	O
prognostic	O
factor	O
of	O
survival	O
was	O
the	O
number	O
of	O
positive	O
nodes	O
.	O

It	O
is	O
concluded	O
that	O
the	O
atherogenic	O
process	O
includes	O
stimulation	O
of	O
collagen	B
and	O
elastin	B
synthesis	O
.	O

The	O
absolute	O
CD4	B
count	O
of	O
patients	O
with	O
de	O
novo	O
IBD	O
was	O
210	O
-	O
700	O
cells	O
/	O
ml	O
at	O
the	O
time	O
of	O
IBD	O
.	O

Four	O
of	O
these	O
fibroblast	O
clones	O
were	O
infected	O
with	O
a	O
retrovirus	O
containing	O
the	O
cDNA	B
encoding	I
myoD	I
and	O
a	O
puromycin	O
selection	O
marker	O
.	O

This	O
study	O
demonstrates	O
the	O
feasibility	O
and	O
potential	O
usefulness	O
of	O
syngeneic	O
BM	O
Txp	O
in	O
myeloma	O
.	O

Results	O
obtained	O
from	O
the	O
tritium	O
test	O
and	O
direct	O
chemical	O
analysis	O
were	O
compared	O
.	O

The	O
levels	O
of	O
soluble	O
L	B
-	I
selectin	I
and	O
ICAM-1	B
in	O
the	O
serum	O
were	O
determined	O
by	O
the	O
ELISA	O
method	O
.	O

Within	O
the	O
last	O
few	O
years	O
,	O
the	O
WWW	O
has	O
grown	O
enormously	O
.	O

Characterization	O
of	O
insertion	O
mutations	O
in	O
the	O
Saccharomyces	B
cerevisiae	I
MSH1	I
and	O
MSH2	B
genes	I
:	O
evidence	O
for	O
separate	O
mitochondrial	O
and	O
nuclear	O
functions	O
.	O

These	O
cells	O
also	O
showed	O
an	O
increase	O
in	O
cyclin	B
A	I
and	O
cyclin	B
A-	I
and	I
E	I
-	I
associated	I
kinase	I
activities	O
characteristic	O
of	O
S	O
phase	O
induction	O
.	O

Obtaining	O
kidney	O
cells	O
from	O
a	O
beagle	O
puppy	O
(	O
RPB-1	O
)	O
and	O
the	O
establishment	O
of	O
a	O
cryopreservation	O
bank	O

During	O
each	O
step	O
of	O
the	O
pulse	O
infusion	O
the	O
osteocalcin	B
responses	O
to	O
changes	O
in	O
CaI	O
in	O
general	O
were	O
parallel	O
to	O
the	O
changes	O
in	O
PTH	B
(	O
r	O
=	O
0.462	O
;	O
P	O
=	O
0.02	O
)	O
and	O
were	O
inversely	O
correlated	O
to	O
CaI	O
(	O
r	O
=	O
-0.562	O
;	O
P	O
=	O
0.003	O
)	O
.	O

These	O
data	O
suggest	O
that	O
overexpression	O
of	O
MT	B
potentiates	O
the	O
growth	O
of	O
MCF7	O
cells	O
,	O
whereas	O
downregulation	O
of	O
MT	B
elicits	O
antiproliferative	O
effects	O
.	O

The	O
induction	O
by	O
dexamethasone	O
of	O
rat	B
liver	I
CYP3A1	I
differs	O
from	O
classical	O
glucocorticoid	O
gene	O
regulation	O
in	O
part	O
because	O
both	O
glucocorticoids	O
and	O
antiglucocorticoids	O
such	O
as	O
pregnenolone	O
16	O
alpha	O
-	O
carbonitrile	O
(	O
PCN	O
)	O
induce	O
CYP3A1	B
through	O
transcriptional	O
gene	O
activation	O
.	O

A	O
pharmacokinetic	O
interaction	O
between	O
LY354740	O
and	O
diazepam	O
,	O
leading	O
to	O
the	O
lowering	O
of	O
the	O
plasma	O
level	O
of	O
free	O
diazepam	O
,	O
was	O
also	O
demonstrated	O
.	O

Also	O
,	O
in	O
patients	O
with	O
MYD	O
,	O
there	O
was	O
a	O
significant	O
decrease	O
in	O
arterial	O
PO2	O
from	O
the	O
seated	O
posture	O
to	O
the	O
supine	O
posture	O
,	O
without	O
a	O
significant	O
change	O
in	O
the	O
arterial	O
PCO2	O
.	O

The	O
animals	O
were	O
followed	O
over	O
a	O
1-	O
to	O
6-h	O
posttraumatic	O
course	O
,	O
and	O
processed	O
for	O
the	O
LM	O
and	O
TEM	O
visualization	O
of	O
HRP	B
.	O

Glucose	O
consumption	O
of	O
the	O
human	O
brain	O
under	O
the	O
influence	O
of	O
intravenous	O
infusions	O
of	O
glucose	O
,	O
glucagon	B
and	O
glucose	O
-	O
insulin	B

The	O
lowest	O
PaCO2	O
values	O
were	O
significantly	O
lower	O
in	O
MCE	O
than	O
in	O
the	O
F	O
,	O
W	O
,	O
and	O
D	O
(	O
F	O
+	O
W	O
+	O
D	O
)	O
group	O
or	O
controls	O
.	O

The	O
psychosomatic	O
approach	O
to	O
temporomandibular	O
arthrosis	O

Detection	O
of	O
sinusoidal	O
gratings	O
by	O
pattern	O
-	O
specific	O
detectors	O
:	O
further	O
evidence	O
for	O
the	O
correlation	O
principle	O
in	O
human	O
vision	O
.	O

Left	O
ventricle	O
to	O
coronary	O
sinus	O
fistula	O
.	O

No	O
other	O
transcripts	O
of	O
different	O
length	O
could	O
be	O
detected	O
after	O
prolonged	O
exposure	O
.	O

We	O
have	O
isolated	O
and	O
sequenced	O
cDNA	O
sequences	O
corresponding	O
to	O
two	O
novel	O
genes	O
that	O
map	O
to	O
Xq28	O
.	O

The	O
vaccinia	O
virus	O
D6R	B
open	O
reading	O
frame	O
encodes	O
the	O
small	O
subunit	O
of	O
the	O
heterodimeric	O
vaccinia	B
virus	I
early	I
transcription	I
factor	I
(	O
VETF	B
)	O
that	O
activates	O
transcription	O
of	O
early	B
genes	I
in	O
vitro	O
.	O

We	O
have	O
used	O
nuclear	O
magnetic	O
resonance	O
(	O
NMR	O
)	O
to	O
obtain	O
the	O
structure	O
of	O
an	O
RNA	O
""""	O
kissing	O
""""	O
hairpin	O
complex	O
formed	O
between	O
the	O
HIV-2	O
TAR	O
hairpin	O
loop	O
and	O
a	O
hairpin	O
with	O
a	O
complementary	O
loop	O
sequence	O
.	O

Xnr3	B
is	O
transcriptionally	O
activated	O
by	O
wnt	B
signaling	O
during	O
gastrulation	O
in	O
the	O
Xenopus	O
embryo	O
.	O

Renal	O
dysplasia	O
with	O
multisystem	O
malformation	O
--	O
a	O
study	O
of	O
9	O
cases	O
.	O

Brome	B
mosaic	I
virus	I
polymerase	I
-	O
like	O
protein	B
2a	I
is	O
directed	O
to	O
the	O
endoplasmic	O
reticulum	O
by	O
helicase	B
-	O
like	O
viral	B
protein	I
1a	I
.	O

Mutations	O
abolishing	O
MalK	B
function	O
not	O
only	O
result	O
in	O
inability	O
to	O
transport	O
maltose	O
but	O
also	O
cause	O
constitutive	O
expression	O
of	O
the	O
maltose	B
regulon	I
.	O

The	O
D.	O
discoideum	O
proteins	O
were	O
entirely	O
conserved	O
over	O
the	O
four	O
regions	O
known	O
to	O
be	O
important	O
for	O
GTP	O
binding	O
and	O
all	O
contained	O
the	O
C	O
-	O
terminal	O
CAAX	O
aa	O
motifs	O
shared	O
by	O
other	O
Rho	B
proteins	I
.	O

The	O
lack	O
of	O
chronically	O
depressed	O
LCBF	O
(	O
after	O
1	O
day	O
)	O
may	O
be	O
related	O
to	O
the	O
quick	O
structural	O
repair	O
of	O
endothelium	O
.	O

Functional	O
uncoupling	O
of	O
the	O
Janus	B
kinase	I
3-Stat5	I
pathway	O
in	O
malignant	O
growth	O
of	O
human	O
T	O
cell	O
leukemia	O
virus	O
type	O
1-transformed	O
human	O
T	O
cells	O
.	O

We	O
used	O
event	O
-	O
related	O
functional	O
magnetic	O
resonance	O
imaging	O
(	O
fMRI	O
)	O
during	O
a	O
cued	O
spatial	O
-	O
attention	O
task	O
to	O
dissociate	O
brain	O
activity	O
related	O
to	O
attentional	O
control	O
from	O
that	O
related	O
to	O
selective	O
processing	O
of	O
target	O
stimuli	O
.	O

A	O
V1	B
mutant	I
generated	O
in	O
vivo	O
with	O
11	O
of	O
the	O
14	O
N	O
-	O
terminal	O
amino	O
acids	O
altered	O
,	O
was	O
viable	O
and	O
produced	O
symptoms	O
typical	O
of	O
a	O
wild	O
-	O
type	O
infection	O
.	O

These	O
observations	O
suggest	O
that	O
clr4	B
+	I
and	O
rik1	B
+	I
must	O
play	O
a	O
role	O
in	O
the	O
assembly	O
of	O
Swi6p	B
into	O
a	O
transcriptionally	O
silent	O
,	O
inaccessible	O
chromatin	O
structure	O
at	O
fission	O
yeast	O
centromeres	O
which	O
is	O
required	O
to	O
facilitate	O
interactions	O
with	O
spindle	O
microtubules	O
and	O
to	O
ensure	O
normal	O
chromosome	O
segregation	O
.	O

The	O
gene	O
sequence	O
predicts	O
a	O
150,825	O
mol	O
wt	O
apoprotein	O
of	O
1363	O
amino	O
acids	O
having	O
an	O
N	O
-	O
terminal	O
hydrophobic	O
signal	O
sequence	O
of	O
17	O
amino	O
acids	O
,	O
19	O
potential	O
N	O
-	O
linked	O
glycosylation	O
sites	O
,	O
a	O
hydrophobic	O
anchor	O
sequence	O
of	O
approximately	O
17	O
amino	O
acids	O
near	O
the	O
C	O
terminus	O
,	O
and	O
a	O
hydrophilic	O
cysteine	O
-	O
rich	O
C	O
terminus	O
of	O
35	O
amino	O
acids	O
.	O

Likewise	O
,	O
epidural	O
morphine	O
does	O
not	O
modify	O
the	O
intraoperative	O
metabolic	O
and	O
hormonal	O
responses	O
.	O

Omitting	O
part	O
of	O
the	O
experimental	O
NOE	O
-	O
derived	O
distances	O
results	O
in	O
reduced	O
restraint	O
violations	O
and	O
lower	O
R	O
factors	O
but	O
impairs	O
structural	O
convergence	O
in	O
the	O
rMD	O
refinement	O
.	O

Cell	O
cycle	O
regulatory	O
components	O
have	O
been	O
largely	O
conserved	O
in	O
eukaryotes	O
;	O
however	O
,	O
orthologs	O
of	O
neither	O
CAK1	B
nor	O
csk1	B
have	O
been	O
identified	O
in	O
other	O
species	O
to	O
date	O
.	O

Within	O
any	O
cell	O
line	O
,	O
several	O
Tcfs	B
and	O
TLEs	B
are	O
co	O
-	O
expressed	O
.	O

In	O
marked	O
contrast	O
to	O
the	O
previously	O
published	O
human	B
CD6	I
sequence	I
,	O
the	O
mouse	O
sequence	O
predicts	O
a	O
long	O
cytoplasmic	O
tail	O
that	O
is	O
not	O
closely	O
related	O
to	O
other	O
proteins	O
and	O
possesses	O
two	O
proline	O
-	O
rich	O
motifs	O
containing	O
the	O
SH3-domain	B
binding	I
consensus	I
sequence	I
,	O
three	O
protein	B
kinase	I
C	I
phosphorylation	I
site	I
motifs	I
,	O
nine	O
casein	B
kinase-2	I
phosphorylation	I
site	I
motifs	I
,	O
and	O
a	O
serine	O
-	O
threonine	O
-	O
rich	O
motif	O
repeated	O
three	O
times	O
.	O

Divergent	O
regions	O
of	O
the	O
posterior	O
left	O
hemisphere	O
used	O
for	O
decoding	O
and	O
storage	O
of	O
information	O
emerged	O
in	O
each	O
working	O
memory	O
versus	O
control	O
task	O
comparison	O
.	O

Among	O
the	O
different	O
epithelial	O
cell	O
lines	O
tested	O
,	O
only	O
RTS3b	O
cells	O
allowed	O
an	O
expression	O
pattern	O
similar	O
to	O
that	O
observed	O
in	O
naturally	O
infected	O
benign	O
condylomas	O
.	O

Evidence	O
for	O
involvement	O
of	O
proteins	O
HU	B
and	O
RpoS	B
in	O
transcription	O
of	O
the	O
osmoresponsive	O
proU	B
operon	I
in	O
Escherichia	O
coli	O
.	O

Detonation	O
-	O
traumatic	O
load	O
during	O
military	O
service	O

Deletion	O
of	O
CDC5	B
was	O
lethal	O
and	O
resulted	O
in	O
a	O
dumbbell	O
-	O
shaped	O
terminal	O
morphology	O
,	O
with	O
the	O
nuclei	O
almost	O
divided	O
but	O
still	O
connected	O
.	O

Thus	O
,	O
the	O
pathway	O
to	O
Fc	B
epsilonRI	I
-	O
mediated	O
MEK	B
/	O
ERK	B
and	O
ERK	B
activation	O
can	O
apparently	O
bypass	O
Ras	B
and	O
Raf-1	B
.	O

The	O
starting	O
dose	O
was	O
8	O
mg	O
/	O
m2	O
administered	O
intravenously	O
(	O
IV	O
)	O
as	O
a	O
short	O
infusion	O
daily	O
for	O
5	O
days	O
,	O
repeated	O
every	O
3	O
weeks	O
with	O
dose	O
adjustments	O
depending	O
on	O
patient	O
tolerance	O
.	O

The	O
related	O
adhesion	B
focal	I
tyrosine	I
kinase	I
is	O
tyrosine	O
-	O
phosphorylated	O
after	O
beta1-integrin	B
stimulation	O
in	O
B	O
cells	O
and	O
binds	O
to	O
p130cas	B
.	O

The	O
cerebellar	O
cortical	O
vessels	O
:	O
they	O
are	O
compared	O
to	O
the	O
cerebral	O
vessels	O
.	O

We	O
present	O
the	O
case	O
of	O
a	O
patient	O
who	O
presented	O
an	O
unusually	O
large	O
mucoid	O
cyst	O
measuring	O
38	O
x	O
25	O
mm	O
in	O
an	O
uncommon	O
localization	O
,	O
the	O
right	O
maxillary	O
.	O

Twenty	O
male	O
volunteers	O
were	O
studied	O
during	O
almokalant	O
infusion	O
aiming	O
at	O
plasma	O
concentrations	O
(	O
Cpl	O
)	O
of	O
20	O
,	O
50	O
,	O
100	O
,	O
and	O
150	O
nmol	O
/	O
l	O
.	O

A	O
significant	O
difference	O
in	O
the	O
distribution	O
of	O
antibodies	O
to	O
thyroglobulin	B
and	O
thyroid	B
peroxidase	I
was	O
found	O
in	O
subgroup	O
2	O
.	O

Protein	B
kinase	I
C	I
(	O
PKC	B
)	O
activation	O
after	O
treatment	O
of	O
human	O
neuroblastoma	O
SK	O
-	O
N	O
-	O
BE	O
(	O
2	O
)	O
C	O
cells	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
was	O
found	O
to	O
enhance	O
transcription	O
of	O
the	O
human	O
dopamine	B
beta	I
-	I
hydroxylase	I
(	O
DBH	B
)	O
in	O
those	O
cells	O
.	O

The	O
originally	O
embryonic	B
gamma	I
-	I
globin	I
locus	I
duplicated	O
and	O
acquired	O
a	O
novel	O
(	O
fetal	O
)	O
pattern	O
of	O
expression	O
in	O
a	O
defined	O
time	O
period	O
(	O
55	O
-	O
40	O
million	O
years	O
ago	O
)	O
during	O
primate	O
phylogeny	O
.	O

Thus	O
,	O
the	O
i	B
-	I
leader	I
protein	I
is	O
a	O
viral	O
gene	O
product	O
of	O
unknown	O
function	O
and	O
high	O
stability	O
that	O
is	O
made	O
in	O
large	O
quantities	O
at	O
intermediate	O
times	O
of	O
productive	O
infection.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

The	O
Pi	O
signals	O
are	O
conveyed	O
to	O
PHO8	B
by	O
binding	O
of	O
PHO4	B
protein	I
,	O
a	O
positive	O
regulatory	O
factor	O
,	O
to	O
a	O
promoter	O
region	O
of	O
PHO8	B
(	O
PHO8p	B
)	O
under	O
the	O
influence	O
of	O
the	O
PHO	B
regulatory	O
circuit	O
.	O

Mutational	O
analysis	O
of	O
the	O
IME2	B
UAS	I
reveals	O
two	O
critical	O
sequence	O
elements	O
:	O
a	O
G+C	O
-	O
rich	O
sequence	O
(	O
called	O
URS1	O
)	O
,	O
previously	O
identified	O
at	O
many	O
meiotic	O
genes	O
,	O
and	O
a	O
newly	O
described	O
element	O
,	O
the	O
T4C	O
site	O
,	O
that	O
we	O
found	O
at	O
a	O
subset	O
of	O
meiotic	O
genes	O
.	O

The	O
authors	O
recommend	O
in	O
cases	O
with	O
an	O
elevated	O
transaminase	O
serum	O
activity	O
more	O
frequent	O
check	O
-	O
up	O
examinations	O
to	O
avoid	O
missing	O
of	O
a	O
relapse	O
,	O
and	O
to	O
examine	O
repeatedly	O
IgM	B
anti	B
-	I
HAV	I
as	O
in	O
protracted	O
forms	O
of	O
hepatitis	O
IgM	B
anti	B
-	I
HAV	I
may	O
persist	O
even	O
when	O
the	O
transaminase	O
activity	O
is	O
normal	O
.	O

Effects	O
were	O
studied	O
of	O
extremely	O
high	O
-	O
frequency	O
electromagnetic	O
radiation	O
(	O
EHF	O
EMR	O
)	O
on	O
indices	O
for	O
the	O
immune	O
and	O
endocrine	O
systems	O
in	O
a	O
series	O
of	O
48	O
patients	O
presenting	O
with	O
hyperplastic	O
processes	O
in	O
endometrium	O
.	O

Effect	O
of	O
hyperaemia	O
on	O
thallium-201	O
redistribution	O
in	O
normal	O
canine	O
myocardium	O
.	O

After	O
dialysis	O
online	O
,	O
lactate	O
was	O
converted	O
by	O
means	O
of	O
lactate	B
oxidase	I
immobilized	O
to	O
porous	O
glass	O
,	O
and	O
the	O
depletion	O
of	O
oxygen	O
was	O
registered	O
by	O
means	O
of	O
a	O
Clark	O
electrode	O
.	O

These	O
data	O
show	O
that	O
both	O
Sp1	B
and	O
Sp3	B
transcription	I
factors	I
upregulate	O
HGF	B
promoter	I
activity	O
by	O
binding	O
to	O
the	O
Sp1	B
binding	I
site	I
at	O
position	O
-318	O
to	O
-303	O
bp	O
in	O
the	O
HGF	B
gene	I
promoter	I
.	O

Hepatitis	O
B	O
markers	O
in	O
Lancashire	O
police	O
officers	O
.	O

Xa4	B
is	O
a	O
dominantly	O
inherited	O
rice	O
gene	O
that	O
confers	O
resistance	O
to	O
Philippine	O
race	O
1	O
of	O
the	O
bacterial	O
blight	O
pathogen	O
Xanthomonas	O
oryzae	O
pv	O
.	O

oryzae	O
in	O
rice	O
.	O

Screening	O
of	O
human	O
cDNA	O
libraries	O
has	O
identified	O
two	O
different	O
5'-termini	O
and	O
alternatively	O
spliced	O
forms	O
of	O
the	O
human	B
Fli-1	I
gene	I
(	O
Fli-1b	B
)	O
,	O
suggesting	O
the	O
possible	O
existence	O
of	O
two	O
independent	O
promoters	O
.	O

Consistent	O
with	O
an	O
effect	O
on	O
transcription	O
,	O
p21	B
was	O
localized	O
in	O
nuclei	O
of	O
transfected	O
cells	O
.	O

When	O
yeast	O
cells	O
reach	O
a	O
critical	O
size	O
in	O
late	O
G1	O
they	O
simultaneously	O
start	O
budding	O
,	O
initiate	O
DNA	O
synthesis	O
,	O
and	O
activate	O
transcription	O
of	O
a	O
set	O
of	O
genes	O
that	O
includes	O
G1	B
cyclins	I
CLN1	B
,	O
CLN2	B
,	O
and	O
many	O
DNA	O
synthesis	O
genes	O
.	O

After	O
a	O
1-h	O
rest	O
(	O
for	O
T2	O
return	O
to	O
baseline	O
)	O
,	O
subjects	O
repeated	O
the	O
5-min	O
protocol	O
,	O
followed	O
by	O
a	O
final	O
MRI	O
/	O
MRS	O
.	O

Use	O
of	O
ELISAs	O
for	O
the	O
diagnosis	O
of	O
canine	O
atopy	O
.	O

A	O
single	O
dose	O
of	O
Cef	O
was	O
administered	O
intravenously	O
to	O
11	O
patients	O
with	O
autoimmune	O
diseases	O
and	O
varying	O
degrees	O
of	O
renal	O
impairment	O
(	O
Group	O
I	O
CLCR	O
less	O
than	O
50	O
ml	O
/	O
min	O
,	O
Group	O
II	O
CLCR	O
greater	O
than	O
50	O
ml	O
/	O
min	O
)	O
.	O

Postheparin	O
lipoprotein	B
lipase	I
,	O
measured	O
using	O
fat	O
emulsion	O
as	O
substrate	O
,	O
also	O
was	O
significantly	O
greater	O
in	O
female	O
rats	O
compared	O
with	O
males	O
.	O

The	O
results	O
obtained	O
demonstrate	O
the	O
applicability	O
of	O
countercurrent	O
chromatography	O
to	O
the	O
determination	O
of	O
ultratrace	O
elements	O
.	O

Clinical	O
evidence	O
provides	O
tentative	O
suggestions	O
on	O
(	O
a	O
)	O
possible	O
additional	O
risk	O
of	O
cigarette	O
smoking	O
(	O
b	O
)	O
avoidance	O
of	O
venography	O
(	O
c	O
)	O
avoidance	O
of	O
varicose	O
vein	O
surgery	O
.	O

However	O
,	O
using	O
wet	O
weight	O
/	O
dry	O
weight	O
methodology	O
,	O
we	O
found	O
that	O
administration	O
of	O
U74006F	O
significantly	O
reduced	O
water	O
content	O
in	O
the	O
right	O
hippocampus	O
(	O
contralateral	O
to	O
the	O
site	O
of	O
injury	O
)	O
compared	O
to	O
saline	O
-	O
treated	O
animals	O
(	O
p	O
less	O
than	O
0.05	O
)	O
.	O

The	O
authors	O
suggest	O
that	O
alprazolam	O
may	O
have	O
enhanced	O
specificity	O
for	O
a	O
subpopulation	O
of	O
benzodiazepine	B
receptors	I
.	O

Transcription	O
start	O
sites	O
of	O
sal	B
and	O
salR	B
genes	I
were	O
determined	O
to	O
lie	O
30-	O
and	O
24-bp	O
upstream	O
of	O
the	O
respective	O
initiation	O
codons	O
and	O
separated	O
from	O
each	O
other	O
by	O
78	O
nucleotides	O
.	O

Henry	O
Quastler	O
brought	O
experience	O
from	O
an	O
actual	O
x	O
-	O
ray	O
treatment	O
,	O
and	O
Dr.	O

(	O
4	O
)	O
Expression	O
in	O
different	O
sites	O
in	O
the	O
central	O
nervous	O
system	O
is	O
driven	O
by	O
separable	O
elements	O
widely	O
dispersed	O
throughout	O
8	O
kb	O
3	O
'	O
of	O
the	O
gene	O
.	O

The	O
virus	O
must	O
progress	O
past	O
the	O
immediate	O
-	O
early	O
phase	O
and	O
express	O
an	O
early	B
gene	I
product	I
(	I
s	I
)	I
for	O
activation	O
of	O
cyclin	B
E	I
expression	O
.	O

The	O
software	O
is	O
in	O
BASIC	O
adapted	O
for	O
the	O
Hewlett	O
-	O
Packard	O
calculators	O
HP-9845B	O
and	O
HP-85A	O
.	O

Genealogical	O
analysis	O
suggested	O
mainly	O
a	O
mother	O
-	O
to	O
-	O
offspring	O
transmission	O
of	O
this	O
STLV-1	O
.	O

Patients	O
commonly	O
considered	O
the	O
external	O
frame	O
cumbersome	O
.	O

In	O
contrast	O
,	O
the	O
tail	O
deviated	O
ipsilaterally	O
in	O
cats	O
with	O
a	O
hemisection	O
,	O
and	O
the	O
tail	O
was	O
ventroflexed	O
in	O
cats	O
with	O
a	O
transection	O
.	O

Peak	O
plasma	O
ACTH	B
responses	O
were	O
not	O
significantly	O
different	O
between	O
control	O
and	O
patient	O
groups	O
.	O

We	O
demonstrate	O
inhibition	O
of	O
2-deoxyglucose	O
uptake	O
in	O
isolated	O
primary	O
rat	O
adipocytes	O
and	O
3T3-L1	O
adipocytes	O
pretreated	O
with	O
U73122	O
.	O

In	O
this	O
report	O
we	O
describe	O
the	O
structure	O
and	O
DNA	O
sequence	O
of	O
transcriptional	O
control	O
regions	O
from	O
both	O
human	B
and	I
Wistar	I
-	I
rat	I
single	I
copy	I
EGF	I
genes	I
and	O
their	O
functional	O
analysis	O
in	O
epithelial	O
cell	O
cultures	O
.	O

Along	O
with	O
these	O
species	O
,	O
F.	O
graminearum	O
group	O
2	O
(	O
ZON	O
,	O
DON	O
and/or	O
3AcDON	O
or	O
15AcDON	O
)	O
;	O
F.	O
chlamydosporum	O
;	O
F.	O
acuminatum	O
(	O
type	O
-	O
A	O
trichothecene	O
derivatives	O
)	O
;	O
and	O
F.	O
semitectum	O
were	O
often	O
found	O
to	O
be	O
associated	O
.	O

It	O
was	O
observed	O
that	O
muscle	O
infarction	O
in	O
the	O
IPC	O
(	O
24	O
+	O
/-	O

2	O
%	O
)	O
and	O
preischemic	O
LMK	O
(	O
21	O
+	O
/-	O

2	O
%	O
)	O
groups	O
were	O
smaller	O
(	O
P	O
<	O
0.05	O
)	O
than	O
that	O
in	O
the	O
control	O
(	O
42	O
+	O
/-	O

2	O
%	O
)	O
.	O

A	O
characteristic	O
feature	O
is	O
their	O
tendency	O
to	O
form	O
homo-	O
and/or	O
heterodimeric	O
complexes	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

Methodological	O
considerations	O
limiting	O
causal	O
assertions	O
permissible	O
with	O
nonexperimental	O
data	O
are	O
discussed	O
.	O

Skytthe	O
,	O
and	O
K.	O

S	O
-	O
phase	O
-	O
promoting	O
cyclin	B
-	I
dependent	I
kinases	I
(	O
Cdks	B
)	O
and	O
the	O
kinase	O
Dbf4-Cdc7	B
then	O
act	O
to	O
initiate	O
replication	O
.	O

The	O
cleft	O
walls	O
are	O
lined	O
with	O
highly	O
conserved	O
residues	O
and	O
NADP	O
is	O
bound	O
along	O
one	O
wall	O
.	O

Non	O
-	O
specific	O
immunological	O
abnormalities	O
were	O
detected	O
in	O
8	O
of	O
the	O
13	O
patients	O
in	O
whom	O
they	O
were	O
looked	O
for	O
.	O

OBJECTIVE	O
:	O
To	O
assess	O
laboratory	O
practice	O
in	O
the	O
examination	O
of	O
blood	O
films	O
for	O
malarial	O
parasites	O
.	O

We	O
conclude	O
that	O
GRF1	B
and	O
GRF2	B
can	O
form	O
homo-	O
and	O
hetero	O
-	O
oligomers	O
via	O
their	O
DH	B
domains	I
,	O
that	O
mutational	O
inactivation	O
of	O
oligomer	O
formation	O
by	O
GRF1	B
is	O
associated	O
with	O
impaired	O
biological	O
and	O
signaling	O
activities	O
,	O
and	O
that	O
in	O
293	O
T	O
cells	O
GRF1	B
mediates	O
at	O
least	O
two	O
pathways	O
for	O
Raf	B
activation	O
:	O
one	O
a	O
constitutive	O
signal	O
that	O
is	O
mainly	O
Ras	B
-	O
dependent	O
,	O
and	O
one	O
an	O
ionomycin	O
-	O
induced	O
signal	O
that	O
cooperates	O
with	O
the	O
constitutive	O
signal	O
without	O
further	O
augmenting	O
the	O
level	O
of	O
GTP	B
-	I
Ras	I
.	O

These	O
results	O
extend	O
our	O
knowledge	O
of	O
this	O
SNF2-like	B
family	I
member	I
and	O
suggest	O
a	O
role	O
for	O
PASG	B
in	O
leukemogenesis	O
.	O

In	O
the	O
absence	O
of	O
c	B
-	I
fos	I
gene	I
expression	O
,	O
c	B
-	I
Fos	I
protein	I
appears	O
to	O
be	O
replaced	O
by	O
proteins	O
of	O
Fos	B
family	I
(	O
Fra-1	B
)	O
and	O
ATF	B
family	I
(	O
ATF-2	B
and	O
ATFa	B
)	O
.	O

To	O
elucidate	O
the	O
molecular	O
mechanism	O
by	O
which	O
the	O
Ras	B
signaling	O
pathway	O
activates	O
a	O
cell	O
-	O
type	O
-	O
specific	O
gene	O
,	O
we	O
have	O
used	O
the	O
pituitary	B
-	I
specific	I
rat	I
prolactin	I
(	O
rPRL	B
)	O
promoter	O
as	O
a	O
target	O
of	O
oncogenic	B
Ras	I
and	O
Raf	B
in	O
GH4	O
rat	O
pituitary	O
cells	O
.	O

The	O
results	O
indicate	O
that	O
expression	O
of	O
proU	B
in	O
E.	O
coli	O
is	O
directed	O
from	O
two	O
promoters	O
,	O
one	O
(	O
P2	O
)	O
characterized	O
earlier	O
by	O
other	O
workers	O
with	O
the	O
start	O
site	O
of	O
transcription	O
60	O
nucleotides	O
upstream	O
of	O
the	O
initiation	O
codon	O
of	O
the	O
first	O
structural	O
gene	O
(	O
proV	B
)	O
,	O
and	O
the	O
other	O
(	O
P1	O
)	O
situated	O
250	O
nucleotides	O
upstream	O
of	O
proV.	B

Coexpression	O
of	O
CREB	B
-	I
binding	I
protein	I
(	O
CBP	B
)	O
/	O
p300	B
with	O
TReP-132	B
has	O
an	O
additive	O
effect	O
on	O
promoter	O
activity	O
,	O
and	O
the	O
proteins	O
were	O
demonstrated	O
to	O
interact	O
physically	O
.	O

Thirty	O
minutes	O
after	O
reperfusion	O
,	O
lung	O
lymph	O
flow	O
(	O
QL	O
)	O
increased	O
from	O
4.3	O
to	O
8.3	O
ml	O
/	O
30	O
minutes	O
(	O
p	O
less	O
than	O
0.05	O
)	O
,	O
lymph	O
/	O
plasma	O
protein	O
ratio	O
was	O
unchanged	O
from	O
0.6	O
,	O
and	O
the	O
lymph	O
protein	O
clearance	O
increased	O
from	O
2.6	O
to	O
4.6	O
ml	O
/	O
30	O
minutes	O
(	O
p	O
less	O
than	O
0.05	O
)	O
,	O
data	O
consistent	O
with	O
increased	O
microvascular	O
permeability	O
.	O

The	O
shift	O
from	O
complex	O
I	O
to	O
complex	O
II	O
seen	O
only	O
in	O
SCM-1-producer	B
T	O
cell	O
lines	O
upon	O
activation	O
was	O
completely	O
suppressed	O
by	O
cyclosporin	O
A.	O

Database	O
searches	O
revealed	O
a	O
50	O
-	O
63	O
%	O
similarity	O
and	O
34	O
-	O
42	O
%	O
identity	O
with	O
several	O
families	O
of	O
serine	B
proteases	I
,	O
in	O
particular	O
the	O
trypsin	B
-	I
like	I
proteases	I
,	O
members	O
of	O
the	O
glandular	B
kallikrein	I
family	I
(	O
including	O
prostate	B
-	I
specific	I
antigen	I
,	O
nerve	B
growth	I
factor	I
gamma	I
,	O
and	O
epidermal	B
growth	I
factor	I
-	I
binding	I
protein	I
)	O
and	O
the	O
activators	O
for	O
the	O
kringle	B
family	I
proteins	I
(	O
including	O
the	O
human	B
tissue	I
plasminogen	I
activator	I
and	O
human	B
hepatocyte	I
growth	I
factor	I
activator	I
)	O
.	O

No	O
bafilomycin	O
-	O
sensitive	O
ATPase	B
is	O
detected	O
in	O
a	O
vacuolar	O
fraction	O
.	O

The	O
kinase	O
domains	O
encoded	O
in	O
the	O
COOH	O
-	O
terminal	O
moiety	O
are	O
94	O
%	O
conserved	O
;	O
the	O
NH2-terminal	O
moieties	O
are	O
approximately	O
65	O
%	O
homologous	O
,	O
suggesting	O
this	O
region	O
may	O
encode	O
sequences	O
conferring	O
differential	O
regulation	O
of	O
the	O
two	O
kinases	O
.	O

From	O
this	O
asymmetry	O
,	O
we	O
suggested	O
previously	O
that	O
GCN4	B
interacts	O
with	O
nonequivalent	O
and	O
possibly	O
overlapping	O
half	O
-	O
sites	O
(	O
ATGAC	O
and	O
ATGAG	O
)	O
that	O
have	O
different	O
affinities	O
.	O

The	O
essential	O
questions	O
about	O
hepatitis	O
C	O

DRAP27	B
is	O
recognized	O
by	O
CD9	B
antibodies	I
.	O

YACs	O
selected	O
from	O
our	O
contig	O
will	O
be	O
the	O
starting	O
point	O
for	O
the	O
cloning	O
of	O
the	O
LGMD2B	B
gene	I
and	O
thereby	O
establish	O
the	O
biological	O
basis	O
for	O
this	O
form	O
of	O
muscular	O
dystrophy	O
and	O
its	O
relationship	O
with	O
the	O
other	O
limb	O
-	O
girdle	O
muscular	O
dystrophies	O
.	O

Starches	O
had	O
no	O
effect	O
.	O

The	O
tensile	O
strengths	O
of	O
an	O
adhesive	O
luting	O
resin	O
'	O
Panavia	O
EX	O
'	O
to	O
the	O
bovine	O
dentin	O
decreased	O
significantly	O
by	O
the	O
zinc	O
iontophoresis	O
.	O

In	O
addition	O
,	O
renal	O
sympathetic	O
activity	O
was	O
measured	O
in	O
a	O
separate	O
group	O
of	O
rats	O
.	O

In	O
humans	O
,	O
there	O
was	O
a	O
statistically	O
significant	O
decrease	O
of	O
TEWL	O
on	O
both	O
forearm	O
and	O
thigh	O
in	O
CS	O
-	O
treated	O
patients	O
compared	O
to	O
non	O
-	O
CS	O
-	O
treated	O
patients	O
and	O
controls	O
(	O
p	O
less	O
than	O
0.05	O
)	O
.	O

Southern	O
hybridization	O
of	O
genomic	O
DNA	O
from	O
WT	O
and	O
Lp	B
/	O
Lp	B
embryos	O
failed	O
to	O
identify	O
specific	O
rearrangements	O
at	O
or	O
near	O
the	O
Nhlh1	B
locus	I
,	O
and	O
Northern	O
RNA	O
blotting	O
and	O
RT	O
-	O
PCR	O
evaluation	O
of	O
Nhlh1	B
mRNA	I
expression	O
indicated	O
that	O
both	O
the	O
levels	O
and	O
types	O
of	O
Nhlh1	B
mRNAs	I
produced	O
in	O
WT	O
and	O
Lp	B
/	O
Lp	B
embryos	O
were	O
indistinguishable	O
.	O

Mutations	O
of	O
the	O
human	B
PTEN	I
gene	I
.	O

MGF	B
is	O
a	O
novel	O
member	O
of	O
the	O
cytokine	B
-	I
regulated	I
transcription	I
factor	I
gene	I
family	I
.	O

One	O
month	O
after	O
administration	O
of	O
131I	O
,	O
the	O
29	O
cats	O
evaluated	O
were	O
clinically	O
improved	O
,	O
and	O
24	O
(	O
83	O
%	O
)	O
of	O
the	O
29	O
cats	O
evaluated	O
had	O
normal	O
serum	O
T4	O
concentrations	O
,	O
3	O
cats	O
(	O
10	O
%	O
)	O
remained	O
hyperthyroxinemic	O
,	O
and	O
2	O
cats	O
(	O
7	O
%	O
)	O
were	O
hypothyroxinemic	O
.	O

Csk	B
(	O
C	B
-	I
terminal	I
Src	I
kinase	I
)	O
is	O
a	O
protein	B
tyrosine	I
kinase	I
that	O
phosphorylates	O
Src	B
family	I
member	I
C	I
-	I
terminal	I
tails	I
,	O
resulting	O
in	O
downregulation	O
of	O
Src	B
family	O
members	O
.	O

Northern	O
blot	O
analysis	O
of	O
enoyl	B
-	I
ACP	I
reductase	I
mRNA	I
steady	O
-	O
state	O
levels	O
during	O
seed	O
development	O
suggests	O
that	O
the	O
increase	O
in	O
enzyme	O
activity	O
during	O
the	O
phase	O
of	O
storage	O
lipid	O
accumulation	O
is	O
regulated	O
at	O
the	O
level	O
of	O
gene	O
expression	O
.	O

Lung	O
transplantation	O
is	O
warranted	O
for	O
stable	O
,	O
ventilator	O
-	O
dependent	O
recipients	O
.	O

A	O
new	O
myocyte	B
-	I
specific	I
enhancer	I
-	I
binding	I
factor	I
that	O
recognizes	O
a	O
conserved	O
element	O
associated	O
with	O
multiple	O
muscle	O
-	O
specific	O
genes	O
.	O

The	O
magnesium	O
content	O
in	O
leukocytes	O
could	O
not	O
be	O
estimated	O
because	O
of	O
interaction	O
between	O
the	O
ion	O
and	O
the	O
Percoll	O
(	O
R	O
)	O
media	O
.	O

The	O
need	O
for	O
such	O
guidelines	O
is	O
clear	O
on	O
both	O
clinical	O
and	O
scientific	O
grounds	O
.	O

This	O
activity	O
creates	O
a	O
4-bp	O
staggered	O
cut	O
with	O
3	O
'	O
OH	O
overhangs	O
within	O
a	O
specific	O
sequence	O
of	O
the	O
21S	B
rRNA	I
gene	I
of	O
omega-	O
strains	O
.	O

Herewith	O
C.	O
psittaci	O
could	O
be	O
diagnosed	O
in	O
all	O
positive	O
samples	O
.	O

Chem	O
.	O

Is	O
it	O
time	O
for	O
a	O
wine	O
trial	O
?	O

Three	O
patients	O
treated	O
with	O
amphotericin	O
B	O
,	O
single	O
course	O
as	O
well	O
as	O
multiple	O
courses	O
,	O
and	O
other	O
antifungal	O
agents	O
(	O
hydroxystilbamidine	O
and	O
miconazole	O
)	O
have	O
all	O
relapsed	O
.	O

In	O
contrast	O
to	O
Torpedo	O
,	O
where	O
only	O
a	O
single	O
transcript	O
is	O
seen	O
,	O
the	O
mouse	O
expresses	O
several	O
mRNAs	O
encoding	O
different	O
isoforms	O
.	O

Latex	O
products	O
(	O
gloves	O
,	O
balloons	O
,	O
and	O
condoms	O
)	O
directly	O
bound	O
IgE	B
from	O
all	O
four	O
patients	O
.	O

Effect	O
of	O
infantile	O
undernutrition	O
on	O
adult	O
sucrose	O
solution	O
consumption	O
in	O
the	O
rat	O
.	O

The	O
transcriptional	O
activity	O
of	O
P-450	B
(	I
11	I
beta	I
)	I
gene	I
was	O
studied	O
with	O
an	O
in	O
vitro	O
transcription	O
system	O
using	O
nuclear	O
extracts	O
prepared	O
from	O
bovine	O
adrenal	O
cortex	O
.	O

Appl	O
.	O

These	O
include	O
urinalysis	O
,	O
chest	O
X	O
-	O
P	O
,	O
ECG	O
,	O
hematological	O
examinations	O
(	O
RBC	O
,	O
WBC	O
,	O
Ht	O
,	O
Hb	B
,	O
PLT	O
and	O
ESR	O
)	O
and	O
biochemical	O
tests	O
(	O
AST	B
,	O
ALT	B
,	O
ALP	B
,	O
gamma	B
GTP	I
,	O
LDH	B
,	O
CPK	B
,	O
Chol	O
,	O
T	O
-	O
Bil	O
,	O
TP	O
,	O
Alb	B
,	O
TG	O
,	O
BUN	O
,	O
Cr	O
,	O
Glu	O
,	O
Na	O
,	O
K	O
,	O
Ca	O
,	O
P	O
and	O
CRP	B
)	O
.	O

We	O
challenge	O
each	O
of	O
55	O
consecutive	O
ragweed	O
(	O
RW	O
)	O
-allergic	O
patients	O
with	O
hay	O
fever	O
and	O
with	O
graded	O
increasing	O
doses	O
of	O
ragweed	O
extract	O
to	O
investigate	O
the	O
frequency	O
and	O
relationship	O
between	O
the	O
early	O
(	O
ER	O
)	O
,	O
late	O
(	O
LPR	O
)	O
,	O
and	O
rechallenge	O
reactions	O
(	O
RCRs	O
)	O
to	O
nasal	O
challenge	O
.	O

The	O
5	O
'	O
ends	O
of	O
the	O
P	B
and	O
O	B
gene	I
mRNAs	I
are	O
separated	O
by	O
109	O
nucleotide	O
pairs	O
in	O
the	O
DNA	O
template	O
.	O

We	O
have	O
thus	O
cloned	O
two	O
yeast	O
homologs	O
of	O
mammalian	B
p220	I
.	O

A	O
phase	O
II	O
clinical	O
trial	O
on	O
MDS	O
was	O
conducted	O
in	O
a	O
cooperative	O
study	O
with	O
orally	O
administrable	O
ara	O
-	O
C	O
analogue	O
,	O
PLAC	O
,	O
which	O
is	O
resistant	O
to	O
cytidine	B
deaminase	I
and	O
had	O
shown	O
an	O
anti	O
-	O
tumor	O
activity	O
on	O
various	O
experimental	O
tumors	O
by	O
oral	O
route	O
.	O

The	O
arrangement	O
of	O
amino	O
acids	O
in	O
the	O
helix	O
1	O
and	O
helix	O
2	O
regions	O
is	O
quite	O
similar	O
to	O
those	O
of	O
Mxi	B
and	O
Mad	B
,	O
but	O
different	O
from	O
those	O
of	O
E2F-1	B
and	O
DP-1	B
.	O

Thus	O
,	O
the	O
mutants	O
are	O
deficient	O
in	O
production	O
of	O
the	O
O	B
-	I
antigen	I
polymerase	I
and	O
were	O
termed	O
rfc	B
mutants	I
.	O

The	O
program	O
for	O
myogenic	O
differentiation	O
is	O
subject	O
to	O
negative	O
control	O
by	O
several	O
peptide	O
growth	O
factors	O
and	O
by	O
the	O
products	O
of	O
mutationally	O
activated	O
ras	B
oncogenes	I
,	O
which	O
persistently	O
activate	O
intracellular	O
cascades	O
normally	O
triggered	O
by	O
specific	O
growth	O
factors	O
.	O

The	O
p58	B
(	O
PITSLRE	B
beta	I
1	I
)	O
protein	O
kinase	O
(	O
PK	O
)	O
is	O
a	O
member	O
of	O
a	O
large	O
supergene	O
family	O
related	O
to	O
the	O
master	B
mitotic	I
protein	I
kinase	I
,	O
p34cdc2	B
.	O

By	O
a	O
combination	O
of	O
alternative	O
promoter	O
usage	O
and	O
exon	O
splicing	O
,	O
each	O
ROR	B
gene	I
generates	O
several	O
isoforms	O
that	O
differ	O
only	O
in	O
their	O
amino	O
terminus	O
.	O

Despite	O
this	O
loss	O
,	O
YEpFAS1	B
is	O
still	O
able	O
to	O
complement	O
a	O
fas1	B
mutation	O
at	O
the	O
enoyl	B
reductase	I
domain	O
.	O

In	O
this	O
study	O
,	O
a	O
site	O
of	O
PDGF	B
-	O
induced	O
tyrosine	O
phosphorylation	O
was	O
mapped	O
to	O
Tyr	O
138	O
in	O
the	O
SH3	B
domain	I
;	O
Tyr	O
138	O
is	O
exposed	O
on	O
the	O
SH3	B
peptide	I
binding	I
surface	I
.	O

Our	O
results	O
showed	O
that	O
the	O
5-hydroxytryptamine	O
(	O
5-HT	O
)	O
content	O
in	O
platelets	O
was	O
:	O
(	O
1	O
)	O
increased	O
in	O
the	O
subgroup	O
of	O
anti	O
-	O
social	O
alcoholics	O
;	O
(	O
2	O
)	O
transiently	O
and	O
differently	O
altered	O
in	O
alcoholics	O
compared	O
to	O
opiate	O
addicts	O
;	O
and	O
(	O
3	O
)	O
lowered	O
in	O
drinking	O
alcoholics	O
and	O
normal	O
in	O
alcoholics	O
who	O
were	O
drinking	O
as	O
well	O
as	O
smoking	O
(	O
that	O
may	O
occur	O
via	O
MAO	B
-	I
B	I
inhibition	O
by	O
smoke	O
)	O
.	O

Recently	O
,	O
we	O
reported	O
that	O
SMRT	B
also	O
directly	O
associates	O
with	O
LAZ3	B
(	O
BCL-6	B
)	O
,	O
a	O
POZ	O
/	O
Zn	O
finger	O
transcriptional	O
repressor	O
involvedin	O
the	O
pathogenesis	O
of	O
non	O
-	O
Hodgkin	O
lymphomas	O
.	O

Regulation	O
of	O
activating	B
transcription	I
factor-1	I
and	O
the	O
cAMP	B
response	I
element	I
-	I
binding	I
protein	I
by	O
Ca2+	B
/	I
calmodulin	I
-	I
dependent	I
protein	I
kinases	I
type	I
I	I
,	I
II	I
,	I
and	I
IV	I
.	O

Accordingly	O
,	O
constitutive	O
downregulation	O
of	O
expression	O
of	O
accessory	O
molecules	O
of	O
the	O
MHC	B
class	I
I	I
pathway	I
can	O
reveal	O
differences	O
between	O
H2	B
class	I
I	I
alleles	I
in	O
antigen	O
presentation	O
not	O
encountered	O
when	O
the	O
expression	O
levels	O
are	O
augmented	O
.	O

Cross	O
-	O
sectional	O
studies	O
continue	O
to	O
dominate	O
.	O

The	O
tau	O
v	O
at	O
rest	O
was	O
4.06	O
+	O
/-	O

2.16	O
s	O
and	O
decreased	O
to	O
2.44	O
+	O
/-	O

1.07	O
s	O
(	O
P	O
<	O
0.05	O
)	O
at	O
1	O
Hz	O
and	O
to	O
1.81	O
+	O
/-	O

0.4	O
s	O
at	O
5	O
Hz	O
.	O

The	O
cDNA	O
contains	O
a	O
reading	O
frame	O
for	O
a	O
145-amino	O
-	O
acid	O
protein	O
and	O
it	O
lacks	O
the	O
UGA	O
codons	O
,	O
which	O
have	O
been	O
found	O
in	O
the	O
reading	O
frame	O
of	O
the	O
mouse	B
MCS	I
cDNA	I
and	O
have	O
been	O
presumed	O
to	O
encode	O
the	O
selenocysteine	O
in	O
the	O
amino	O
terminal	O
of	O
the	O
deduced	O
mouse	O
amino	O
acid	O
sequence	O
.	O

It	O
differed	O
significantly	O
by	O
country	O
(	O
from	O
2.4	O
%	O
in	O
the	O
United	O
Kingdom	O
to	O
24.7	O
%	O
in	O
Portugal	O
)	O
and	O
by	O
transmission	O
category	O
(	O
2.7	O
%	O
among	O
homo	O
/	O
bisexuals	O
,	O
5.8	O
%	O
among	O
injecting	O
drug	O
users	O
,	O
13.6	O
%	O
among	O
heterosexual	O
subgroup	O
1	O
)	O
.	O

The	O
results	O
showed	O
differential	O
activation	O
of	O
each	O
parahippocampal	O
region	O
during	O
verbal	O
memory	O
tasks	O
in	O
which	O
the	O
side	O
activated	O
shifted	O
depending	O
on	O
the	O
nature	O
of	O
the	O
task	O
employed	O
;	O
an	O
increase	O
in	O
rCBF	O
in	O
the	O
left	O
parahippocampal	O
gyrus	O
was	O
associated	O
with	O
retrieval	O
strategy	O
of	O
non	O
-	O
matching	O
,	O
and	O
an	O
increase	O
in	O
rCBF	O
in	O
the	O
right	O
parahippocampal	O
gyrus	O
was	O
associated	O
with	O
retrieval	O
strategy	O
of	O
matching	O
.	O

Cells	O
were	O
co	O
-	O
infected	O
simultaneously	O
with	O
IBV	O
,	O
the	O
recombinant	O
FPV	O
(	O
rFPV	O
)	O
containing	O
the	O
D	O
-	O
RNA	O
sequence	O
and	O
a	O
second	O
rFPV	O
expressing	O
T7	B
RNA	I
polymerase	I
for	O
the	O
initial	O
expression	O
of	O
the	O
D	O
-	O
RNA	O
transcript	O
,	O
subsequently	O
rescued	O
by	O
helper	O
IBV	O
.	O

The	O
more	O
sustained	O
effect	O
of	O
cyclofenil	O
on	O
prolactin	B
secretion	O
with	O
a	O
reduced	O
frequency	O
of	O
relapse	O
,	O
and	O
the	O
lower	O
oestradiol	O
level	O
,	O
which	O
might	O
indicate	O
a	O
reduced	O
risk	O
of	O
thromboembolism	O
,	O
suggest	O
that	O
this	O
drug	O
has	O
some	O
advantage	O
over	O
bromocriptine	O
in	O
the	O
inhibition	O
of	O
postpartum	O
lactation	O
.	O

Epithelial	O
cell	O
-	O
specific	O
activation	O
is	O
achieved	O
by	O
the	O
cooperative	O
interaction	O
of	O
apparently	O
ubiquitous	O
transcriptional	O
factors	O
.	O

This	O
set	O
of	O
genetic	O
and	O
physical	O
interactions	O
suggests	O
a	O
role	O
for	O
yeast	O
RNA	O
-	O
binding	O
proteins	O
in	O
transcriptional	O
regulation	O
.	O

A	O
new	O
B	O
-	O
cell	O
-	O
specific	O
enhancer	O
element	O
has	O
been	O
identified	O
3	O
'	O
of	O
E4	B
and	O
the	O
octamerlike	O
motifs	O
in	O
the	O
human	B
immunoglobulin	I
heavy	I
-	I
chain	I
gene	I
enhancer	I
.	O

Electrically	O
induced	O
undulations	O
and	O
their	O
competition	O
with	O
electrically	O
induced	O
convection	O
in	O
cholesteric	O
liquid	O
crystals	O
.	O

A	O
visibly	O
distinct	O
muscular	O
hypertrophy	O
(	O
mh	O
)	O
,	O
commonly	O
known	O
as	O
double	O
muscling	O
,	O
occurs	O
with	O
high	O
frequency	O
in	O
the	O
Belgian	O
Blue	O
and	O
Piedmontese	O
cattle	O
breeds	O
.	O

The	O
LS	B
gene	I
promoter	I
sequence	I
has	O
homology	O
with	O
Escherichia	O
coli	O
promoter	O
sequences	O
;	O
its	O
terminator	O
sequence	O
is	O
capable	O
of	O
forming	O
a	O
stem	O
-	O
and	O
-	O
loop	O
structure	O
.	O

In	O
pituitary	O
GH3	O
cells	O
,	O
vitamin	O
D	O
increases	O
the	O
levels	O
of	O
PRL	B
transcripts	I
and	O
stimulates	O
the	O
PRL	B
promoter	I
.	O

Present	O
investigation	O
was	O
undertaken	O
to	O
elucidate	O
what	O
pharmacokinetic	O
parameters	O
in	O
animal	O
experiment	O
could	O
be	O
of	O
more	O
predictable	O
for	O
human	O
clinical	O
trial	O
of	O
beta	O
-	O
blocking	O
agents	O
.	O

Association	O
of	O
Smads	B
with	O
lymphoid	B
enhancer	I
binding	I
factor	I
1	I
/	O
T	B
cell	I
-	I
specific	I
factor	I
mediates	O
cooperative	O
signaling	O
by	O
the	O
transforming	B
growth	I
factor	I
-	I
beta	I
and	O
wnt	B
pathways	O
.	O

In	O
the	O
univariate	O
models	O
of	O
either	O
fixed	O
or	O
time	O
dependent	O
covariates	O
,	O
many	O
variables	O
were	O
significantly	O
associated	O
with	O
risk	O
of	O
progression	O
to	O
AIDS	O
(	O
T4	O
cell	O
count	O
,	O
T4	O
/	O
T8	O
ratio	O
,	O
blastogenic	O
responses	O
to	O
phytohemagglutinin	B
,	O
concanavalin	B
A	I
,	O
and	O
pokeweed	B
mitogen	I
,	O
serum	B
IgA	I
,	O
appearance	O
of	O
p24	B
antigen	I
,	O
and	O
the	O
development	O
of	O
oral	O
hairy	O
leukoplakia	O
,	O
thrush	O
,	O
or	O
herpes	O
zoster	O
)	O
.	O

But	O
,	O
when	O
mated	O
males	O
built	O
nests	O
in	O
the	O
absence	O
of	O
young	O
,	O
T	O
levels	O
were	O
higher	O
than	O
in	O
all	O
other	O
conditions	O
,	O
though	O
only	O
for	O
early	O
broods	O
.	O

RESULTS	O
:	O
At	O
short	O
dwell	O
times	O
,	O
uncorrected	O
(	O
whole	O
plasma	O
)	O
D	O
/	O
P	O
and	O
Cp	O
of	O
urea	O
values	O
were	O
higher	O
than	O
the	O
corrected	O
(	O
plasma	O
water	O
)	O
values	O
by	O
5.7%-5.9	O
%	O
.	O

The	O
AmyI	B
specific	O
3'-UTR	O
is	O
characterized	O
by	O
the	O
absence	O
of	O
IR	O
sequences	O
and	O
the	O
presence	O
of	O
a	O
putative	O
'	O
AATAAA	O
'	O
polyadenylation	O
signal	O
.	O

The	O
atf1	B
+	I
gene	I
of	I
Schizosaccharomyces	I
pombe	I
encodes	O
a	O
bZIP	B
transcription	I
factor	I
with	O
strong	O
homology	O
to	O
the	O
mammalian	B
factor	I
ATF-2	I
.	O

Cotransfection	O
experiments	O
revealed	O
that	O
both	O
hGATA-4	B
and	O
PMA	O
/	O
A23187	O
stimulation	O
are	O
necessary	O
for	O
the	O
IL-5	B
promoter	I
activation	O
.	O

(	O
5	O
)	O
.	O

1	O
.	O

Mortality	O
rates	O
were	O
not	O
different	O
(	O
chi2	O
:	O
0.0298	O
,	O
p	O
>	O
0.5	O
)	O
.	O

Cox	O
proportional	O
hazard	O
analysis	O
identified	O
dialysis	O
modality	O
and	O
pre	O
-	O
dialysis	O
UV	O
of	O
less	O
than	O
1,000	O
ml	O
/	O
m2	O
per	O
24	O
h	O
as	O
the	O
only	O
significant	O
risk	O
factors	O
for	O
UV	O
survival	O
.	O

The	O
sequence	O
of	O
the	O
25-kDa	O
chain	O
of	O
the	O
alpha	O
subunit	O
was	O
found	O
in	O
a	O
cDNA	O
clone	O
,	O
and	O
the	O
amino	O
acid	O
sequence	O
deduced	O
from	O
the	O
cDNA	O
establishes	O
the	O
complete	O
amino	O
acid	O
sequence	O
of	O
the	O
25-kDa	O
chain	O
.	O

The	O
Gastrointestinal	O
Tumor	O
Study	O
Group	O
(	O
GITSG	O
)	O
protocol	O
GI-7175	O
randomized	O
227	O
patients	O
between	O
1975	O
and	O
1980	O
following	O
complete	O
surgical	O
resection	O
of	O
stages	O
B2	O
and	O
C	O
rectal	O
adenocarcinoma	O
to	O
four	O
treatment	O
arms	O
:	O
(	O
1	O
)	O
no	O
adjuvant	O
therapy	O
,	O
(	O
2	O
)	O
chemotherapy	O
only	O
,	O
(	O
3	O
)	O
radiotherapy	O
only	O
,	O
and	O
(	O
4	O
)	O
radiotherapy	O
and	O
chemotherapy	O
(	O
combined	O
modality	O
)	O
.	O

Cell	O
lines	O
expressing	O
single	O
amino	O
acid	O
substitutions	O
of	O
the	O
carboxyl	O
-	O
terminal	O
asparagine	O
of	O
CD2	B
are	O
incapable	O
of	O
avidity	O
regulation	O
by	O
TCR	B
signaling	O
,	O
PMA	O
treatment	O
,	O
or	O
elevation	O
of	O
intracellular	O
cAMP	O
levels	O
,	O
demonstrating	O
that	O
each	O
of	O
these	O
stimuli	O
utilizes	O
a	O
common	O
structural	O
element	O
for	O
regulating	O
CD2	B
avidity	O
.	O

Iomazenil	O
-	O
SPECT	O
revealed	O
a	O
highly	O
significant	O
increase	O
in	O
the	O
benzodiazepine	B
receptor	I
uptake	O
in	O
all	O
studied	O
cortical	O
regions	O
except	O
temporal	O
cortices	O
.	O

The	O
WEB2	B
gene	I
encodes	O
a	O
1,522-amino	O
-	O
acid	O
protein	O
with	O
homology	O
to	O
nucleic	B
acid	I
-	I
dependent	I
ATPases	I
.	O

Increasing	O
the	O
height	O
of	O
the	O
agar	O
column	O
overlying	O
the	O
SN	O
fabric	O
diminished	O
the	O
inhibitory	O
effect	O
of	O
SN	O
on	O
microbial	O
growth	O
.	O

Biochem	O
.	O

When	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
SH	B
-	I
PTP2	I
displays	O
tyrosine	B
-	I
specific	I
phosphatase	I
activity	O
.	O

It	O
is	O
hypothesized	O
this	O
occurs	O
through	O
antagonism	O
of	O
PML	B
/	O
RAR	B
alpha	I
actions	O
in	O
these	O
leukemic	O
cells	O
.	O

Fli-1	B
is	O
a	O
proto	O
-	O
oncogene	O
which	O
is	O
rearranged	O
in	O
tumors	O
induced	O
by	O
three	O
different	O
retroviruses	O
,	O
Cas	O
-	O
Br	O
-	O
E	O
,	O
F	O
-	O
MuLV	O
,	O
and	O
10A1	O
.	O

Routine	O
imaging	O
modalities	O
revealed	O
a	O
total	O
of	O
79	O
metastases	O
.	O

Cervical	O
CT	O
revealed	O
an	O
irregular	O
low	O
density	O
at	O
the	O
periphery	O
of	O
the	O
cervical	O
vertebra	O
from	O
the	O
C2	O
to	O
C4	O
level	O
.	O

Human	B
myotonic	I
dystrophy	I
protein	I
kinase	I
(	O
DMPK	B
)	O
is	O
a	O
member	O
of	O
a	O
novel	O
class	O
of	O
multidomain	O
protein	O
kinases	O
that	O
regulate	O
cell	O
size	O
and	O
shape	O
in	O
a	O
variety	O
of	O
organisms	O
.	O

Sequential	O
immunoprecipitation	O
showed	O
all	O
detectable	O
p53	B
to	O
be	O
of	O
the	O
PAb246	B
+	I
class	O
in	O
each	O
LPV	O
-	O
transformed	O
cell	O
line	O
,	O
suggesting	O
that	O
the	O
stable	O
p53	B
was	O
indeed	O
wild	O
type	O
.	O

Increased	O
platelet	B
-	I
derived	I
growth	I
factor	I
production	O
and	O
intimal	O
thickening	O
during	O
healing	O
of	O
Dacron	O
grafts	O
in	O
a	O
canine	O
model	O
.	O

Interestingly	O
,	O
the	O
NES	B
mutant	I
proteins	I
appeared	O
to	O
have	O
altered	O
interactions	O
with	O
the	O
splicing	O
complex	O
,	O
binding	O
more	O
tightly	O
to	O
SC35	B
in	O
co	O
-	O
immunoprecipitation	O
assays	O
.	O

The	O
results	O
of	O
these	O
studies	O
indicate	O
that	O
EHV-1	B
gp13	I
is	O
the	O
structural	O
homolog	O
of	O
herpes	B
simplex	I
virus	I
glycoprotein	I
C	I
and	O
further	O
suggest	O
that	O
the	O
epitope	O
-	O
containing	O
N	O
-	O
terminal	O
amino	O
acid	O
sequences	O
of	O
the	O
herpesvirus	B
gC	I
-	I
like	I
glycoproteins	I
have	O
undergone	O
more	O
extensive	O
evolutionary	O
divergence	O
than	O
the	O
C	O
-	O
terminal	O
sequences	O
.	O

Previously	O
,	O
a	O
cDNA	O
(	O
GT2	B
)	O
encoding	O
this	O
protein	O
was	O
isolated	O
from	O
a	O
mouse	O
3T3-L1	O
adipocyte	O
library	O
and	O
was	O
sequenced	O
.	O

By	O
RT	O
-	O
PCR	O
,	O
different	O
levels	O
of	O
E75	B
expression	O
can	O
be	O
detected	O
in	O
the	O
epidermis	O
,	O
nerve	O
cord	O
and	O
the	O
eyestalk	O
of	O
early	O
pre	O
-	O
molt	O
shrimp	O
.	O

The	O
chromosomal	O
location	O
of	O
these	O
YACs	O
was	O
verified	O
using	O
FISH	O
,	O
which	O
also	O
demonstrated	O
their	O
nonchimeric	O
nature	O
.	O

There	O
is	O
no	O
indication	O
from	O
these	O
experiments	O
that	O
linker	B
histones	I
bind	O
fundamentally	O
differently	O
to	O
5	B
S	I
and	O
bulk	O
nucleosomes	O
.	O

Gas	O
chromatographic	O
analysis	O
of	O
headspace	O
samples	O
of	O
alkalinized	O
vaginal	O
discharges	O
indicated	O
the	O
presence	O
of	O
trimethylamine	O
in	O
all	O
11	O
samples	O
with	O
the	O
fishy	O
odor	O
but	O
not	O
in	O
the	O
other	O
samples	O
.	O

The	O
transcription	O
start	O
site	O
was	O
identified	O
by	O
primer	O
extension	O
analysis	O
and	O
over	O
800	O
bp	O
of	O
5	O
'	O
flanking	O
DNA	O
was	O
sequenced	O
.	O

PURPOSE	O
:	O
To	O
evaluate	O
the	O
effect	O
of	O
adding	O
a	O
pulsating	O
bristle	O
action	O
to	O
the	O
established	O
oscillating	O
/	O
rotating	O
action	O
of	O
the	O
Braun	O
Oral	O
-	O
B	O
Ultra	O
Plaque	O
Remover	O
(	O
D9	O
)	O
on	O
plaque	O
removal	O
.	O

The	O
high	O
degree	O
of	O
sequence	O
conservation	O
together	O
with	O
the	O
ability	O
to	O
direct	O
nucleolar	O
protein	O
transport	O
supports	O
the	O
hypothesis	O
that	O
MAK16	B
proteins	I
play	O
a	O
key	O
role	O
in	O
the	O
biogenesis	O
of	O
60S	B
subunits	I
.	O

NO2	O
pollution	O
on	O
major	O
trunk	O
roads	O
frequently	O
exceeded	O
British	O
and	O
European	O
Union	O
air	O
quality	O
standards	O
,	O
while	O
particle	O
pollution	O
was	O
lower	O
.	O

The	O
human	O
RFC-1	B
gene	I
differs	O
from	O
the	O
mouse	O
and	O
hamster	O
genes	O
both	O
in	O
terms	O
of	O
the	O
total	O
number	O
of	O
exons	O
and	O
in	O
regard	O
to	O
alternatives	O
of	O
exon	O
1	O
which	O
encode	O
5	O
'	O
end	O
heterogeneity	O
.	O

The	O
recombinant	B
L	I
/	I
F	I
-	I
transferase	I
is	O
as	O
active	O
as	O
the	O
previously	O
purified	O
wild	O
type	O
enzyme	O
and	O
contains	O
no	O
detectable	O
RNA	O
component	O
.	O

AST	B
activity	O
in	O
PMNs	O
was	O
significantly	O
low	O
,	O
approximately	O
2	O
%	O
of	O
that	O
observed	O
in	O
HPLFs	O
.	O

Intraspinal	O
and	O
mediastinal	O
foregut	O
cyst	O
compressing	O
the	O
spinal	O
cord	O
.	O

The	O
H5	B
mutants	I
were	O
:	O
DH5	B
(	O
all	O
amino	O
acids	O
in	O
D	O
configuration	O
)	O
and	O
H5F	B
(	O
where	O
all	O
His	O
are	O
replaced	O
by	O
Phe	O
at	O
positions	O
3	O
,	O
7	O
,	O
8	O
,	O
15	O
,	O
18	O
,	O
19	O
,	O
21	O
)	O
.	O

Accordingly	O
,	O
infection	O
of	O
IFN	B
-	O
pretreated	O
HeLa	O
S3	O
cells	O
with	O
an	O
E3L	O
-	O
deficient	O
VV	O
(	O
VVDeltaE3L	O
)	O
resulted	O
in	O
increased	O
phosphorylation	O
levels	O
of	O
both	O
PKR	B
and	O
eIF2alpha	B
.	O

The	O
human	O
sequence	O
contains	O
the	O
element	O
TGACTCT	O
that	O
also	O
is	O
found	O
in	O
a	O
murine	B
ras	I
-	I
responsive	I
enhancer	I
.	O

GAGA	B
factor	I
is	O
known	O
to	O
remodel	O
the	O
chromatin	O
structure	O
in	O
concert	O
with	O
nucleosome	B
-	I
remodeling	I
factor	I
NURF	B
in	O
a	O
Drosophila	O
embryonic	O
S150	O
extract	O
.	O

After	O
30	O
weeks	O
of	O
amifostine	O
therapy	O
,	O
the	O
morphology	O
of	O
the	O
MDS	O
switched	O
to	O
a	O
chronic	O
myelomonocytic	O
leukemia	O
(	O
CMML	O
)	O
-like	O
appearance	O
,	O
with	O
continuously	O
increasing	O
leukocytes	O
,	O
so	O
that	O
we	O
discontinued	O
amifostine	O
therapy	O
for	O
1	O
month	O
to	O
exclude	O
a	O
possible	O
side	O
effect	O
of	O
amifostine	O
.	O

A	O
gene	O
with	O
a	O
high	O
degree	O
of	O
sequence	O
identity	O
with	O
mammalian	B
ADP	I
-	I
ribosylation	I
factors	I
(	O
ARFs	B
)	O
,	O
believed	O
to	O
be	O
important	O
in	O
vesicular	O
transport	O
,	O
was	O
identified	O
.	O

Theophylline	O
QID	O
,	O
TID	O
,	O
BID	O
and	O
now	O
QD	O
?	O

A	O
report	O
on	O
24-hour	O
dosing	O
with	O
slow	O
-	O
release	O
theophylline	O
formulations	O
with	O
emphasis	O
on	O
analyses	O
of	O
data	O
used	O
to	O
obtain	O
Food	O
and	O
Drug	O
Administration	O
approval	O
for	O
Theo-24	O
.	O

We	O
anticipated	O
SNS	O
function	O
after	O
CVA	O
to	O
be	O
asymmetric	O
and	O
selected	O
null	O
hypotheses	O
of	O
bilaterally	O
symmetric	O
SSR	O
latencies	O
and	O
amplitudes	O
irrespective	O
of	O
side	O
of	O
stimulation	O
and/or	O
recording	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
the	O
BSMV	B
coat	I
protein	I
is	O
the	O
sole	O
translation	O
product	O
of	O
the	O
genomic	B
RNA	I
beta	I
,	O
whereas	O
sgRNA	B
beta	I
1	I
serves	O
as	O
a	O
messenger	O
for	O
translation	O
of	O
the	O
beta	B
b	I
protein	I
,	O
and	O
sgRNA	B
beta	I
2	I
functions	O
as	O
a	O
messenger	O
for	O
translation	O
of	O
beta	B
c	I
and	O
beta	B
d	I
and	O
the	O
newly	O
discovered	O
beta	B
d	I
'	I
protein	I
.	O

Without	O
a	O
team	O
,	O
there	O
is	O
little	O
hope	O
for	O
fetal	O
survival	O
;	O
mortality	O
will	O
be	O
80	O
-	O
100	O
%	O
.	O

The	O
RNA	O
,	O
whether	O
antisense	O
,	O
ribozyme	O
,	O
or	O
RNA	O
aptamer	O
,	O
must	O
be	O
efficiently	O
transcribed	O
,	O
stabilized	O
against	O
rapid	O
degradation	O
,	O
folded	O
correctly	O
,	O
and	O
directed	O
to	O
the	O
part	O
of	O
the	O
cell	O
where	O
it	O
can	O
be	O
most	O
effective	O
.	O

Recurrent	O
infections	O
,	O
episodic	O
lymphopenia	O
and	O
impaired	O
cellular	O
immunity	O
.	O

In	O
this	O
report	O
,	O
we	O
describe	O
a	O
patient	O
with	O
renal	O
cell	O
carcinoma	O
who	O
experienced	O
ventricular	O
tachycardia	O
while	O
undergoing	O
treatment	O
with	O
high	O
-	O
dose	O
bolus	O
IL-2	B
.	O

We	O
report	O
the	O
cloning	O
of	O
the	O
ade1	B
gene	I
on	O
a	O
4.4	B
kb	I
Sau3A	I
insert	I
in	O
the	O
yeast	O
shuttle	O
vector	O
pWH5	O
.	O

We	O
found	O
that	O
secretion	O
of	O
chitinolytic	O
enzymes	O
by	O
cultured	O
L.	O
major	O
parasites	O
is	O
inhibited	O
by	O
blood	O
or	O
hemoglobin	B
,	O
and	O
hence	O
these	O
enzymes	O
are	O
apparently	O
absent	O
from	O
the	O
blood	O
-	O
fed	O
infected	O
flies	O
,	O
where	O
the	O
cardiac	O
valve	O
appears	O
undamaged	O
.	O

Oral	O
hypoglycemic	O
agents	O

Identification	O
and	O
characterization	O
of	O
a	O
yeast	O
gene	O
encoding	O
the	O
U2	B
small	I
nuclear	I
ribonucleoprotein	I
particle	I
B	I
""""	I
protein	I
.	O

Nature	O
of	O
the	O
thermopower	O
in	O
bipolar	O
semiconductors	O
.	O

Overexpression	O
of	O
SNURF	B
in	O
cultured	O
mammalian	O
cells	O
enhanced	O
not	O
only	O
androgen	O
,	O
glucocorticoid	O
,	O
and	O
progesterone	B
receptor	I
-	O
dependent	O
transactivation	O
but	O
also	O
basal	O
transcription	O
from	O
steroid	O
-	O
regulated	O
promoters	O
.	O

Usher	O
syndrome	O
1C	O
(	O
USH1C	O
)	O
is	O
a	O
congenital	O
condition	O
manifesting	O
profound	O
hearing	O
loss	O
,	O
the	O
absence	O
of	O
vestibular	O
function	O
,	O
and	O
eventual	O
retinal	O
degeneration	O
.	O

On	O
the	O
basis	O
of	O
these	O
findings	O
we	O
suggest	O
that	O
the	O
acceptor	O
peptide	O
binds	O
the	O
transferase	O
in	O
a	O
beta	O
-	O
like	O
conformation	O
and	O
that	O
penultimate	O
residue	O
side	O
chain	O
steric	O
interactions	O
may	O
play	O
a	O
role	O
in	O
determining	O
extent	O
that	O
a	O
given	O
Ser	O
or	O
Thr	O
is	O
glycosylated	O
.	O

A	O
higher	O
median	O
proportion	O
of	O
spirochaetes	O
was	O
observed	O
in	O
sites	O
after	O
diagnosis	O
of	O
loss	O
of	O
attachment	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Although	O
cDNA	O
encoding	O
a	O
human	B
phagocyte	I
formyl	I
peptide	I
-	I
binding	I
protein	I
has	O
been	O
reported	O
recently	O
(	O
Boulay	O
,	O
F.	O
,	O
Tardif	O
,	O
M.	O
,	O
Brouchon	O
,	O
L.	O
,	O
and	O
Vignais	O
,	O
P.	O

These	O
results	O
suggest	O
that	O
the	O
PVB	O
therapy	O
is	O
not	O
sufficient	O
to	O
cure	O
the	O
cases	O
with	O
choriocarcinoma	O
element	O
or	O
bulky	O
metastasis	O
.	O

For	O
large	O
breasts	O
(	O
>	O
70	O
mm	O
)	O
the	O
use	O
of	O
X	O
-	O
ray	O
sets	O
such	O
as	O
the	O
IGE	O
DMR	O
,	O
which	O
automatically	O
select	O
the	O
beam	O
quality	O
for	O
each	O
breast	O
,	O
resulted	O
in	O
lower	O
doses	O
compared	O
with	O
sets	O
using	O
manual	O
tube	O
potential	O
selection	O
.	O

Deletion	O
mutagenesis	O
of	O
the	O
promoter	O
indicated	O
that	O
a	O
positive	O
regulatory	O
element	O
(	O
PRE	O
)	O
was	O
likely	O
to	O
exist	O
downstream	O
of	O
the	O
UL94	B
mRNA	I
start	I
site	I
,	O
while	O
a	O
negative	O
regulatory	O
element	O
(	O
NRE	O
)	O
was	O
present	O
upstream	O
of	O
the	O
TATA	O
box	O
.	O

An	O
ERp60-like	B
protein	I
from	O
the	O
filarial	O
parasite	O
Dirofilaria	O
immitis	O
has	O
both	O
transglutaminase	O
and	O
protein	O
disulfide	O
isomerase	O
activity	O
.	O

Fos	B
/	O
Jun	B
bound	O
to	O
an	O
unacetylated	O
nucleosome	O
with	O
only	O
a	O
4-	O
to	O
5-fold	O
reduction	O
in	O
DNA	O
binding	O
affinity	O
compared	O
with	O
naked	O
DNA	O
.	O

The	O
extent	O
of	O
myocardial	O
ischemia	O
in	O
the	O
coronary	O
sinus	O
study	O
was	O
significantly	O
correlated	O
to	O
the	O
coronary	O
diameters	O
of	O
the	O
proximal	O
and	O
middle	O
segments	O
of	O
the	O
Ramus	O
interventricularis	O
anterior	O
and	O
the	O
middle	O
segment	O
of	O
the	O
Ramus	O
circumflexus	O
(	O
r	O
=	O
0.87	O
,	O
p	O
<	O
0.02	O
)	O
.	O

S1	B
nuclease	I
analysis	O
of	O
the	O
RNA	O
from	O
a	O
number	O
of	O
QT6-LD	O
clones	O
gave	O
similar	O
results	O
,	O
indicating	O
that	O
the	O
LD	O
population	O
was	O
composed	O
of	O
viruses	O
with	O
similar	O
but	O
not	O
identical	O
deletion	O
endpoints	O
.	O

The	O
prevalence	O
of	O
ocular	O
/	O
adnexal	O
SCC	O
was	O
significantly	O
greater	O
for	O
all	O
hair	O
colors	O
when	O
compared	O
with	O
bay	O
,	O
brown	O
,	O
or	O
black	O
(	O
P	O
less	O
than	O
0.01	O
)	O
.	O

ZNS	O
,	O
in	O
the	O
mmolar	O
range	O
,	O
scavenged	O
hydroxyl	O
and	O
nitric	O
oxide	O
radicals	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

The	O
three	O
more	O
slower	O
migrating	O
Stat5B	B
bands	O
observed	O
in	O
response	O
to	O
GH	B
contain	O
phosphorylated	O
tyrosyl	O
residues	O
.	O

During	O
the	O
1st	O
week	O
of	O
treatment	O
all	O
subjects	O
received	O
either	O
mianserin	O
30	O
mg	O
or	O
clomipramine	O
75	O
mg	O
once	O
daily	O
.	O

EMBO	O
(	O
Eur	O
.	O

When	O
stratifying	O
FLM	O
values	O
<	O
34	O
and	O
>	O
34	O
wks	O
'	O
gestation	O
,	O
again	O
no	O
difference	O
was	O
found	O
in	O
mean	O
difference	O
of	O
L	O
/	O
S	O
and	O
LB	O
before	O
and	O
after	O
34	O
wks	O
.	O

Are	O
there	O
any	O
lessons	O
to	O
be	O
learnt	O
?	O

The	O
other	O
five	O
from	O
within	O
the	O
SRO	O
may	O
provide	O
an	O
entrance	O
point	O
for	O
the	O
cloning	O
of	O
candidate	O
genes	O
for	O
neuroblastoma	O
.	O

Three	O
distinct	O
human	B
HDACs	I
are	O
homologous	O
to	O
RPD3	B
,	O
a	O
yeast	O
transcriptional	O
regulator	O
.	O

The	O
vaccine	O
was	O
at	O
least	O
80	O
%	O
efficacious	O
against	O
Chlamydia	O
and	O
Campylobacter	O
spp	O
and	O
appeared	O
to	O
be	O
protective	O
.	O

The	O
RPC31	B
gene	I
encoding	O
the	O
C31	B
subunit	I
of	I
Saccharomyces	I
cerevisiae	I
RNA	I
polymerase	I
C	I
(	I
III	I
)	I
has	O
been	O
isolated	O
,	O
starting	O
from	O
a	O
C	O
-	O
terminal	O
fragment	O
cloned	O
on	O
a	O
lambda	O
gt11	O
library	O
.	O

Slowly	O
adapting	O
type	O
I	O
mechanoreceptor	O
discharge	O
as	O
a	O
function	O
of	O
dynamic	O
force	O
versus	O
dynamic	O
displacement	O
of	O
glabrous	O
skin	O
of	O
raccoon	O
and	O
squirrel	O
monkey	O
hand	O
.	O

The	O
goal	O
of	O
this	O
investigation	O
was	O
to	O
determine	O
whether	O
BMIPP	O
uptake	O
can	O
be	O
used	O
to	O
differentiate	O
viable	O
myocardium	O
from	O
scar	O
tissue	O
soon	O
after	O
coronary	O
thrombolysis	O
for	O
acute	O
myocardial	O
infarction	O
.	O

IRIS	B
/	O
GAS	B
DNA	O
also	O
formed	O
a	O
number	O
of	O
specific	O
complexes	O
with	O
constitutively	O
expressed	O
factors	O
,	O
none	O
of	O
which	O
were	O
affected	O
by	O
the	O
above	O
Abs	O
.	O

Recovery	O
rates	O
of	O
energy	O
level	O
and	O
intracellular	O
pH	O
during	O
stimulation	O
at	O
100Hz	O
were	O
greater	O
than	O
those	O
observed	O
during	O
stimulation	O
at	O
30Hz	O
.	O

The	O
data	O
obtained	O
included	O
1	O
)	O
the	O
mean	O
frequency	O
of	O
abnormal	O
teased	O
myelinated	O
fibers	O
and	O
its	O
upper	O
limit	O
value	O
of	O
95	O
%	O
confidence	O
interval	O
,	O
and	O
2	O
)	O
the	O
mean	O
densities	O
of	O
total	O
,	O
large	O
and	O
small	O
myelinated	O
fibers	O
and	O
of	O
unmyelinated	O
fibers	O
and	O
their	O
lower	O
limit	O
value	O
of	O
95	O
%	O
confidence	O
interval	O
for	O
each	O
decade	O
.	O

The	O
yield	O
of	O
endocervical	O
cells	O
and	O
the	O
incidence	O
of	O
dysplasia	O
was	O
determined	O
for	O
both	O
the	O
prenatal	O
and	O
the	O
postpartum	O
Pap	O
smears	O
performed	O
for	O
this	O
group	O
of	O
patients	O
.	O

Others	O
as	O
for	O
example	O
C-11	O
labeled	O
short	O
chain	O
fatty	O
acids	O
are	O
on	O
the	O
horizon	O
.	O

We	O
conclude	O
that	O
the	O
BR	B
-	I
C	I
early	I
gene	I
directly	O
activates	O
late	B
gene	I
transcription	O
by	O
interacting	O
with	O
late	B
gene	I
cis	O
-	O
acting	O
regulatory	O
elements	O
and	O
that	O
this	O
interaction	O
is	O
responsible	O
for	O
the	O
temporal	O
linkage	O
of	O
early	O
and	O
late	O
ecdysone	O
-	O
induced	O
gene	O
expression	O
.	O

We	O
tested	O
the	O
hypothesis	O
that	O
PEH	O
is	O
associated	O
with	O
reductions	O
in	O
TPR	O
and	O
sympathetic	O
nerve	O
activity	O
(	O
SNA	O
)	O
.	O

A	O
short	O
conserved	O
motif	O
is	O
required	O
for	O
repressor	O
domain	O
function	O
in	O
the	O
myeloid	O
-	O
specific	O
transcription	O
factor	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
epsilon	I
.	O

Purified	O
fER	B
exhibited	O
a	O
distribution	O
constant	O
(	O
KD	O
)	O
for	O
17	O
beta	O
-	O
estradiol	O
of	O
0.45	O
nM.	O

However	O
,	O
strains	O
in	O
which	O
both	O
of	O
the	O
two	O
most	O
highly	O
related	O
genes	O
,	O
DdPIK1	B
and	O
DdPIK2	B
,	O
were	O
disrupted	O
showed	O
both	O
growth	O
and	O
developmental	O
defects	O
,	O
while	O
double	O
knockouts	O
of	O
DdPIK1	B
and	O
DdPIK3	B
and	O
DdPIK2	B
and	O
DdPIK3	B
appear	O
to	O
be	O
lethal	O
.	O

The	O
exon	O
sequences	O
determined	O
from	O
genomic	O
DNA	O
sequencing	O
showed	O
some	O
differences	O
when	O
compared	O
to	O
the	O
published	O
rat	B
GLUT2	I
cDNA	I
.	O

This	O
integration	O
results	O
in	O
the	O
production	O
of	O
MMTV	B
/	I
mdr3	I
fusion	I
transcripts	I
that	O
originate	O
from	O
the	O
antisense	O
5'LTR	B
of	O
the	O
provirus	O
.	O

This	O
surface	O
in	O
specimens	O
from	O
unfertilized	O
eggs	O
is	O
almost	O
flat	O
.	O

These	O
results	O
are	O
discussed	O
in	O
the	O
context	O
of	O
a	O
model	O
of	O
the	O
myogenic	O
lineage	O
that	O
is	O
based	O
on	O
the	O
expression	O
of	O
desmin	B
.	O

Characterization	O
of	O
a	O
DEAD	B
box	I
ATPase	I
/	O
RNA	B
helicase	I
protein	O
of	O
Arabidopsis	O
thaliana	O
.	O

The	O
host	O
range	O
(	O
HR	O
)	O
of	O
poliovirus	O
is	O
thought	O
to	O
be	O
primarily	O
determined	O
by	O
a	O
cell	O
surface	O
molecule	O
that	O
functions	O
as	O
poliovirus	B
receptor	I
(	O
PVR	B
)	O
,	O
since	O
it	O
has	O
been	O
shown	O
that	O
transgenic	O
mice	O
are	O
made	O
poliovirus	O
sensitive	O
by	O
introducing	O
the	O
human	B
PVR	I
gene	I
into	O
the	O
genome	O
.	O

In	O
this	O
paper	O
,	O
the	O
authors	O
used	O
measured	O
weight	O
for	O
1,259	O
white	O
women	O
aged	O
65	O
-	O
74	O
years	O
from	O
the	O
Epidemiologic	O
Follow	O
-	O
up	O
Study	O
of	O
the	O
First	O
National	O
Health	O
and	O
Nutrition	O
Examination	O
Survey	O
to	O
examine	O
the	O
effect	O
of	O
overweight	O
on	O
coronary	O
heart	O
disease	O
incidence	O
(	O
mean	O
length	O
of	O
follow	O
-	O
up	O
,	O
14	O
years	O
)	O
.	O

In	O
contrast	O
to	O
the	O
reciprocal	O
effects	O
of	O
Gab1	B
and	O
Gab2	B
in	O
mediating	O
Elk-1	B
induction	O
,	O
these	O
two	O
molecules	O
have	O
a	O
similar	O
function	O
in	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
activation	O
induced	O
by	O
either	O
oncogenic	O
Ras	B
or	O
growth	O
factor	O
stimulation	O
.	O

We	O
were	O
able	O
to	O
demonstrate	O
a	O
significant	O
statistical	O
interaction	O
effect	O
between	O
gender	O
and	O
globulin	B
protein	I
concentration	O
on	O
Vu	O
(	O
p	O
=	O
0.022	O
)	O
.	O

The	O
NS-2	B
isoforms	I
were	O
resolved	O
at	O
a	O
pI	O
value	O
close	O
to	O
5.5	O
as	O
three	O
groups	O
of	O
unevenly	O
phosphorylated	O
polypeptides	O
,	O
each	O
composed	O
of	O
at	O
least	O
two	O
protein	O
species	O
.	O

Effect	O
of	O
isobarin	O
on	O
electrocardiographic	O
indices	O
in	O
hypertensive	O
disease	O

TAAG	O
sites	O
that	O
serve	O
as	O
functional	O
late	O
promoters	O
in	O
OpMNPV	O
were	O
found	O
to	O
mediate	O
transcription	O
initiation	O
at	O
only	O
basal	O
levels	O
in	O
the	O
context	O
of	O
the	O
AcMNPV	O
genome	O
,	O
suggesting	O
that	O
late	O
promoter	O
activation	O
may	O
be	O
virus	O
specific	O
within	O
the	O
family	O
Baculoviridae	O
.	O

The	O
carboxyl	O
globular	O
domain	O
was	O
found	O
to	O
be	O
encoded	O
by	O
six	O
exons	O
which	O
appear	O
to	O
delineate	O
its	O
structural	O
subdomains	O
.	O

Fus3p	B
and	O
Kss1p	B
together	O
increase	O
the	O
expression	O
of	O
CLN3	B
and	O
PCL2	B
genes	I
that	O
promote	O
budding	O
,	O
and	O
Kss1p	B
inhibits	O
the	O
MAP	B
kinase	I
cascade	O
.	O

Measurement	O
of	O
the	O
spectral	O
sensitivity	O
and	O
the	O
ERG	O
can	O
thus	O
help	O
in	O
the	O
diagnosis	O
of	O
these	O
three	O
hereditary	O
diseases	O
.	O

On	O
both	O
indocyanine	O
green	O
video	O
and	O
fluorescein	O
angiography	O
,	O
hypofluorescent	O
lesions	O
were	O
almost	O
the	O
same	O
size	O
as	O
the	O
light	O
yellow	O
area	O
and	O
the	O
dark	O
yellow	O
center	O
of	O
a	O
placoid	O
lesion	O
.	O

Possibility	O
of	O
using	O
gynecologic	O
nurses	O
in	O
the	O
independently	O
administered	O
health	O
centers	O

Platelet	O
count	O
and	O
plasma	O
volume	O
were	O
significantly	O
higher	O
in	O
group	O
A	O
than	O
in	O
group	O
B	O
throughout	O
pregnancy	O
.	O

The	O
complexity	O
of	O
some	O
of	O
the	O
reports	O
of	O
VACURG	O
studies	O
has	O
led	O
some	O
to	O
believe	O
that	O
this	O
group	O
was	O
opposed	O
to	O
estrogens	O
,	O
but	O
that	O
is	O
not	O
true	O
.	O

Mycobacterium	O
tuberculosis	O
inhibits	O
IFN	B
-	I
gamma	I
transcriptional	O
responses	O
without	O
inhibiting	O
activation	O
of	O
STAT1	B
.	O

Upstream	O
of	O
the	O
afa-3	B
gene	I
cluster	I
,	O
a	O
1.2-kb	O
region	O
was	O
found	O
to	O
be	O
96	O
%	O
identical	O
to	O
the	O
RepFIB	B
sequence	I
of	O
one	O
of	O
the	O
enterotoxigenic	O
E.	O
coli	O
plasmids	O
(	O
P307	O
)	O
,	O
suggesting	O
a	O
common	O
ancestor	O
plasmid	O
.	O

Maintenance	O
metabolizable	O
-	O
energy	O
(	O
ME	O
)	O
requirement	O
averaged	O
31.0	O
kcal	O
/	O
kg	O
body	O
wt	O
.	O

The	O
secondary	O
end	O
points	O
included	O
creatine	B
kinase	I
peak	O
,	O
ventricular	O
fibrillation	O
/	O
tachycardia	O
within	O
the	O
first	O
24	O
hours	O
,	O
death	O
and	O
congestive	O
heart	O
failure	O
within	O
the	O
30-day	O
follow	O
-	O
up	O
,	O
and	O
30-day	O
left	O
ventricular	O
ejection	O
fraction	O
.	O

The	O
contribution	O
of	O
reviewers	O
and	O
editors	O
to	O
the	O
scientific	O
work	O
of	O
the	O
authors	O

Comparisons	O
of	O
defective	O
HTLV	O
-	O
I	O
proviruses	O
predict	O
the	O
mode	O
of	O
origin	O
and	O
coding	O
potential	O
of	O
internally	O
deleted	O
genomes	O
.	O

When	O
proper	O
controls	O
were	O
used	O
,	O
the	O
psychophysical	O
data	O
and	O
computer	O
simulation	O
gave	O
remarkably	O
comparable	O
results	O
.	O

The	O
phosphoprotein	B
pUL69	I
of	O
human	O
cytomegalovirus	O
(	O
HCMV	O
)	O
,	O
which	O
is	O
a	O
herpesvirus	O
of	O
considerable	O
medical	O
importance	O
in	O
immunosuppressed	O
patients	O
and	O
newborns	O
,	O
has	O
previously	O
been	O
identified	O
as	O
an	O
early	B
-	I
late	I
viral	I
protein	I
that	O
can	O
stimulate	O
several	O
viral	O
and	O
cellular	O
promoters	O
and	O
thus	O
exerts	O
a	O
rather	O
broad	O
activation	O
pattern	O
.	O

Effects	O
of	O
acute	O
exposure	O
to	O
cold	O
on	O
pulmonary	O
arterial	O
blood	O
pressure	O
in	O
awake	O
rats	O
.	O

RNase	B
protection	O
analysis	O
reveals	O
a	O
10-fold	O
increase	O
in	O
the	O
expression	O
of	O
SCD2	B
mRNA	I
during	O
3T3-L1	O
preadipocyte	O
differentiation	O
.	O

The	O
response	O
sequences	O
were	O
localized	O
between	O
-67	O
and	O
+	O
30	O
in	O
the	O
simian	O
cytomegalovirus	O
IE94	B
promoter	I
and	O
upstream	O
of	O
position	O
+	O
9	O
in	O
the	O
HCMV	B
IE68	I
promoter	I
.	O

The	O
expression	O
of	O
Scmh1	B
and	O
rae28	B
/	O
mph1	B
is	O
well	O
correlated	O
in	O
most	O
tissues	O
of	O
embryos	O
.	O

Retinoic	O
acid	O
,	O
which	O
inhibits	O
the	O
progression	O
of	O
certain	O
cancers	O
,	O
repressed	O
v	B
-	I
src	I
-	O
induced	O
MMP-1	B
transcription	O
.	O

Untransformed	O
3T3	O
cells	O
carry	O
abundant	O
1.9	O
kb	O
Hox	B
1.3	I
RNA	O
,	O
whereas	O
the	O
methylcholanthrene	O
-	O
transformed	O
MB66	O
and	O
LTK-	O
cells	O
or	O
3T3	O
cells	O
transformed	O
by	O
the	O
oncogenes	O
src	B
,	O
fos	B
or	O
SV40	B
T	I
antigen	I
express	O
only	O
low	O
levels	O
.	O

Furthermore	O
,	O
it	O
is	O
also	O
established	O
that	O
serine	O
phosphorylation	O
of	O
STAT5a	B
transactivation	O
domain	O
,	O
via	O
the	O
MAPK	B
pathway	O
,	O
is	O
a	O
means	O
of	O
modifying	O
GH	B
-	O
induced	O
transcriptional	O
activation	O
.	O

Blood	O
pressure	O
was	O
controlled	O
long	O
term	O
(	O
with	O
/	O
without	O
diuretics	O
/	O
beta	B
-	I
adrenoreceptor	I
blocking	O
drugs	O
)	O
in	O
sixteen	O
out	O
of	O
nineteen	O
patients	O
with	O
mild	O
-	O
moderate	O
hypertension	O
.	O

This	O
may	O
be	O
another	O
example	O
of	O
the	O
principle	O
--	O
less	O
is	O
more	O
.	O

The	O
predicted	O
amino	O
-	O
acid	O
sequence	O
includes	O
an	O
N	O
-	O
terminal	O
signal	O
sequence	O
of	O
27	O
amino	O
acids	O
,	O
a	O
27	O
amino	O
-	O
acid	O
pro	O
-	O
region	O
,	O
a	O
251	O
amino	O
-	O
acid	O
catalytic	O
domain	O
typical	O
of	O
a	O
serine	B
protease	I
with	O
trypsin	B
-	O
like	O
specificity	O
,	O
and	O
a	O
C	O
-	O
terminal	O
hydrophobic	O
extension	O
which	O
is	O
predicted	O
to	O
function	O
as	O
a	O
membrane	O
anchor	O
.	O

Phenotypic	O
and	O
molecular	O
analyses	O
of	O
patients	O
with	O
partial	O
chromosome	O
21	O
monosomy	O
enabled	O
us	O
to	O
define	O
a	O
region	O
,	O
spanning	O
2.4	O
Mb	O
between	O
D21S190	B
and	O
D21S226	B
,	O
associated	O
with	O
arthrogryposis	O
,	O
mental	O
retardation	O
,	O
hypertonia	O
,	O
and	O
several	O
facial	O
anomalies	O
.	O

Relation	O
between	O
circulating	O
immune	O
complexes	O
and	O
serum	B
ferritin	I
in	O
hemosiderosis	O
of	O
different	O
etiologies	O

The	O
zinc	B
finger	I
protein	I
A20	I
is	O
a	O
tumor	B
necrosis	I
factor	I
(	O
TNF	B
)	O
-	O
and	O
interleukin	B
1	I
(	O
IL-1	B
)	O
-inducible	O
protein	O
that	O
negatively	O
regulates	O
nuclear	B
factor	I
-	I
kappa	I
B	I
(	O
NF	B
-	I
kappaB	I
)	O
-dependent	O
gene	O
expression	O
.	O

Treatments	O
were	O
two	O
adrenocorticotrophin	B
(	O
ACTH	B
)	O
preparations	O
given	O
intramuscularly	O
at	O
2.2	O
U	O
/	O
kg	O
,	O
one	O
of	O
the	O
ACTH	B
preparations	O
given	O
intramuscularly	O
at	O
1	O
U	O
/	O
kg	O
and	O
a	O
synthetic	O
polypeptide	O
with	O
ACTH	B
-	I
like	I
activity	O
(	O
tetracosactrin	O
,	O
cosyntropin	O
)	O
given	O
intravenously	O
at	O
5	O
micrograms	O
/	O
kg	O
.	O

The	O
deviation	O
site	O
is	O
equivalent	O
to	O
the	O
exon	O
1	O
/	O
exon	O
2	O
splice	O
site	O
of	O
the	O
mouse	O
C	O
-	O
subunit	O
.	O

The	O
liver	O
-	O
specific	O
sequence	O
contains	O
unique	O
consensus	O
sites	O
for	O
phosphorylation	O
by	O
cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinase	I
and	O
by	O
protein	B
kinase	I
C.	I

Seizure	O
recurrence	O
(	O
HR	O
1.30	O
;	O
95	O
%	O
CI	O
=	O
0.84	O
,	O
2.01	O
)	O
and	O
antiepileptic	O
drug	O
treatment	O
(	O
HR	O
0.97	O
;	O
95	O
%	O
CI	O
=	O
0.67	O
,	O
1.38	O
)	O
did	O
not	O
influence	O
mortality	O
rate	O
.	O

Fas	B
(	O
APO-1	B
/	O
CD95	B
)	O
,	O
which	O
is	O
a	O
member	O
of	O
the	O
tumor	B
necrosis	I
factor	I
receptor	I
superfamily	I
,	O
is	O
a	O
cell	O
surface	O
receptor	O
that	O
induces	O
apoptosis	O
.	O

Soft	O
independent	O
modelling	O
of	O
class	O
analogy	O
(	O
SIMCA	O
)	O
is	O
applied	O
to	O
identify	O
near	O
-	O
infrared	O
(	O
NIR	O
)	O
spectra	O
of	O
ten	O
excipients	O
used	O
in	O
the	O
pharmaceutical	O
industry	O
.	O

Implantation	O
is	O
contraindicated	O
for	O
severe	O
dysplasia	O
of	O
the	O
cochlea	O
and	O
for	O
the	O
recently	O
described	O
variety	O
of	O
x	O
-	O
linked	O
deafness	O
with	O
deficient	O
bone	O
at	O
the	O
fundus	O
of	O
the	O
internal	O
auditory	O
meatus	O
.	O

The	O
RsmA-	B
mutant	I
,	O
like	O
its	O
parent	O
,	O
produces	O
N-	O
(	O
3-oxohexanoyl	O
)	O
-L	O
-	O
homoserine	O
lactone	O
(	O
HSL	O
)	O
,	O
a	O
starvation	O
/	O
cell	O
density	O
-	O
sensing	O
signal	O
required	O
for	O
extracellular	O
enzyme	O
production	O
.	O

The	O
101st	O
annual	O
meeting	O
of	O
the	O
Japanese	O
Ophthalmological	O
Society	O
.	O

In	O
patients	O
in	O
which	O
these	O
criteria	O
were	O
not	O
met	O
only	O
the	O
reproducibility	O
of	O
the	O
VO2	O
obtained	O
in	O
both	O
the	O
P	O
-	O
MET	O
and	O
the	O
C	O
-	O
MET	O
indicated	O
that	O
the	O
maximal	O
VO2	O
for	O
these	O
4	O
patients	O
had	O
been	O
reached	O
.	O

In	O
conclusion	O
,	O
ORCA3	B
regulates	O
jasmonate	O
-	O
responsive	O
expression	O
of	O
the	O
Str	B
gene	I
via	O
direct	O
interaction	O
with	O
the	O
JERE	O
.	O

Pseudotumor	O
form	O
of	O
pulmonary	O
nocardia	O
infection	O
(	O
Nocardia	O
nova	O
)	O
in	O
a	O
renal	O
transplant	O
patient	O

Deoxyuridine	O
-	O
suppression	O
test	O
and	O
bone	O
marrow	O
culture	O
for	O
the	O
diagnosis	O
of	O
macrocytic	O
refractory	O
anaemias	O
.	O

A	O
computerized	O
database	O
of	O
veterans	O
discharged	O
from	O
the	O
military	O
after	O
1967	O
was	O
selected	O
as	O
the	O
source	O
because	O
it	O
contains	O
about	O
50	O
%	O
of	O
the	O
total	O
Vietnam	O
era	O
veteran	O
population	O
,	O
is	O
reasonably	O
unbiased	O
,	O
and	O
provides	O
a	O
feasible	O
method	O
for	O
identifying	O
twins	O
.	O

Keys	O
can	O
be	O
used	O
for	O
identifying	O
species	O
from	O
the	O
European	O
part	O
of	O
the	O
USSR	O
and	O
north	O
-	O
eastern	O
Kazakhstan	O
.	O

To	O
initiate	O
our	O
analysis	O
of	O
factors	O
required	O
for	O
eIF-2	B
alpha	I
expression	O
,	O
selected	O
a	O
CAP	O
-	O
proximal	O
element	O
shown	O
by	O
in	O
vivo	O
methylation	O
protection	O
analysis	O
to	O
bind	O
a	O
potential	O
regulatory	O
factor	O
.	O

The	O
effect	O
of	O
monaural	O
middle	O
ear	O
destruction	O
on	O
postnatal	O
development	O
of	O
mouse	O
inferior	O
colliculus	O
.	O

The	O
specificity	O
and	O
sensitivity	O
of	O
this	O
method	O
(	O
limit	O
of	O
detection	O
in	O
plasma	O
0.025	O
micrograms	O
/	O
mL	O
and	O
<	O
or	O
=	O
0.0125	O
micrograms	O
/	O
mL	O
for	O
febantel	O
and	O
its	O
metabolites	O
,	O
respectively	O
)	O
were	O
sufficiently	O
high	O
to	O
enable	O
us	O
to	O
characterize	O
the	O
time	O
course	O
of	O
the	O
drug	O
in	O
the	O
plasma	O
after	O
oral	O
administration	O
of	O
therapeutic	O
doses	O
to	O
sheep	O
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
A	O
seven	O
-	O
wavelength	O
frequency	O
-	O
domain	O
photon	O
migration	O
probe	O
was	O
used	O
to	O
perform	O
noninvasive	O
NIR	O
measurements	O
in	O
the	O
breasts	O
of	O
28	O
healthy	O
women	O
,	O
both	O
pre-	O
and	O
postmenopausal	O
,	O
aged	O
18	O
-	O
64	O
years	O
.	O

It	O
is	O
targeted	O
to	O
peroxisomes	O
when	O
expressed	O
in	O
mammalian	O
cells	O
and	O
yeast	O
.	O

All	O
except	O
the	O
last	O
two	O
interventions	O
are	O
physical	O
treatments	O
that	O
create	O
a	O
wound	O
-	O
tissue	O
environment	O
conducive	O
to	O
healing	O
.	O

Consistent	O
with	O
our	O
observation	O
that	O
AP-1	B
binding	O
does	O
not	O
contribute	O
to	O
c	B
-	I
Jun	I
coactivation	O
is	O
the	O
observation	O
that	O
the	O
activation	O
of	O
PU.1	B
by	O
c	B
-	I
Jun	I
is	O
blocked	O
by	O
overexpression	O
of	O
c	B
-	I
Fos	I
.	O

In	O
a	O
series	O
of	O
papers	O
,	O
the	O
staging	O
system	O
for	O
melanoma	O
was	O
critically	O
analyzed	O
,	O
and	O
many	O
shortcomings	O
were	O
identified	O
.	O

The	O
levels	O
of	O
products	O
expressed	O
from	O
these	O
chimeric	O
cDNAs	O
in	O
COS	O
cells	O
were	O
assessed	O
by	O
activity	O
assay	O
and	O
by	O
metabolic	O
labeling	O
of	O
the	O
proteins	O
followed	O
by	O
immunoprecipitation	O
and	O
SDS	O
-	O
PAGE	O
.	O

The	O
leucine	O
zipper	O
region	O
of	O
ATF	B
proteins	I
is	O
also	O
similar	O
to	O
that	O
of	O
the	O
AP-1	B
/	O
c	B
-	I
jun	I
family	O
of	O
transcription	O
factors	O
,	O
whose	O
DNA	O
-	O
binding	O
site	O
differs	O
from	O
the	O
ATF	B
-	O
binding	O
site	O
at	O
a	O
single	O
position	O
.	O

Immunoblotting	O
with	O
antiphosphotyrosine	O
antibody	O
showed	O
that	O
many	O
yeast	O
proteins	O
,	O
including	O
the	O
p34CDC28	B
kinase	I
,	O
became	O
phosphorylated	O
at	O
tyrosine	O
in	O
cells	O
expressing	O
v	B
-	I
src	I
.	O

AIMS	O
:	O
We	O
postulated	O
that	O
perhexiline	O
,	O
a	O
novel	O
anti	O
-	O
ischaemic	O
agent	O
with	O
an	O
oxygen	O
-	O
sparing	O
metabolic	O
effect	O
in	O
the	O
myocardium	O
(	O
via	O
inhibition	O
of	O
carnitine	B
palmitoyltransferase-1	I
)	O
and	O
no	O
adverse	O
haemodynamic	O
effects	O
,	O
may	O
improve	O
symptomatic	O
status	O
in	O
elderly	O
patients	O
with	O
severe	O
aortic	O
stenosis	O
.	O

Developmentally	O
-	O
regulated	O
interaction	O
of	O
a	O
transcription	O
factor	O
complex	O
containing	O
CDP	B
/	O
cut	B
with	O
the	O
early	B
histone	I
H3	I
gene	I
promoter	I
of	I
the	I
sea	I
urchin	I
Tetrapygus	I
niger	I
is	O
associated	O
with	O
changes	O
in	O
chromatin	O
structure	O
and	O
gene	O
expression	O
.	O

In	O
this	O
group	O
of	O
patients	O
,	O
the	O
mean	O
LH	B
(	O
9.3	O
+	O
/-	O

5.9	O
IU	O
/	O
l	O
)	O
and	O
sex	B
-	I
hormone	I
binding	I
globulin	I
(	O
SHBG	B
)	O
(	O
54.5	O
+	O
/-	O

22.9	O
nmol	O
/	O
l	O
)	O
concentrations	O
were	O
significantly	O
greater	O
than	O
those	O
of	O
five	O
normal	O
control	O
subjects	O
(	O
4.7	O
+	O
/-	O

1.11	O
IU	O
/	O
l	O
and	O
26.0	O
+	O
/-	O

7.0	O
nmol	O
/	O
l	O
respectively	O
)	O
.	O

Structural	O
organization	O
of	O
the	O
human	B
Elk1	I
gene	I
and	O
its	O
processed	O
pseudogene	B
Elk2	I
.	O

Prematurely	O
inactivating	O
p42	B
MAPK	I
in	O
egg	O
extracts	O
resulted	O
in	O
a	O
corresponding	O
hastening	O
of	O
the	O
first	O
mitosis	O
.	O

Anxiogenic	O
effects	O
of	O
pentagastrin	O
in	O
patients	O
with	O
social	O
phobia	O
and	O
healthy	O
controls	O
.	O

Identification	O
of	O
a	O
putative	O
chromosomal	O
replication	O
origin	O
from	O
Helicobacter	O
pylori	O
and	O
its	O
interaction	O
with	O
the	O
initiator	B
protein	I
DnaA.	I

Sub	O
-	O
inhibitory	O
and	O
post	O
-	O
antibiotic	O
effects	O
of	O
spiramycin	O
and	O
erythromycin	O
on	O
Staphylococcus	O
aureus	O
.	O

Because	O
the	O
variation	O
in	O
the	O
carbohydrate	O
content	O
of	O
human	O
milk	O
is	O
very	O
small	O
,	O
a	O
more	O
simple	O
alternative	O
approach	O
would	O
be	O
to	O
include	O
only	O
an	O
average	O
carbohydrate	O
value	O
for	O
an	O
estimate	O
of	O
energy	O
content	O
.	O

It	O
is	O
suggested	O
that	O
biliary	O
secretion	O
of	O
both	O
TBZ	O
and	O
FBZ	O
and	O
their	O
metabolites	O
may	O
contribute	O
to	O
this	O
recycling	O
.	O

Hyperlipemia	O
has	O
been	O
recently	O
described	O
in	O
children	O
with	O
migraine	O
,	O
being	O
suggested	O
that	O
this	O
alteration	O
is	O
in	O
the	O
base	O
of	O
the	O
disease	O
.	O

BACKGROUND	O
:	O
A	O
thorough	O
understanding	O
of	O
malignant	O
fibrous	O
histiocytoma	O
(	O
MFH	O
)	O
,	O
the	O
most	O
common	O
subtype	O
of	O
soft	O
tissue	O
sarcoma	O
,	O
will	O
lead	O
to	O
improved	O
histologic	O
-	O
specific	O
protocols	O
.	O

Using	O
yeast	O
two	O
-	O
hybrid	O
screening	O
,	O
we	O
isolated	O
histone	B
H3	I
as	O
an	O
interacting	O
factor	O
of	O
CIA	B
.	O

Elevated	O
total	O
serum	O
calcium	O
to	O
a	O
level	O
of	O
11.9	O
+	O
/-	O

0.2	O
mg	O
/	O
dl	O
(	O
p	O
less	O
than	O
0.001	O
compared	O
to	O
control	O
group	O
)	O
developed	O
in	O
the	O
gentamicin	O
/	O
1,25	O
(	O
OH	O
)	O
2	O
vitamin	O
D3	O
group	O
on	O
day	O
4	O
,	O
2	O
days	O
prior	O
to	O
pronounced	O
structural	O
damage	O
,	O
and	O
continued	O
to	O
be	O
elevated	O
through	O
day	O
7	O
.	O

Treatment	O
of	O
steroid	O
resistant	O
rejection	O
following	O
renal	O
transplantation	O
:	O
benefits	O
and	O
risks	O
of	O
OKT3	B
therapy	O
.	O

SETTING	O
:	O
University	O
research	O
laboratory	O
.	O

Binding	O
of	O
C	B
/	I
EBPs	I
to	O
all	O
three	O
spi	B
2.3	I
3	I
'	I
UTR	I
repressor	I
sites	I
,	O
although	O
rather	O
weak	O
,	O
was	O
confirmed	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
that	O
otherwise	O
failed	O
to	O
reveal	O
specific	O
interactions	O
with	O
other	O
liver	O
nuclear	O
proteins	O
in	O
vitro	O
.	O

Despite	O
the	O
fact	O
that	O
biochemical	O
estimates	O
of	O
bone	O
turnover	O
indicate	O
that	O
(	O
short	O
-	O
term	O
)	O
administration	O
of	O
rhGH	B
and	O
IGF	B
-	I
I	I
stimulates	O
bone	O
metabolism	O
in	O
non	O
-	O
osteoporotic	O
older	O
people	O
,	O
no	O
significant	O
changes	O
have	O
been	O
observed	O
in	O
bone	O
mineral	O
density	O
at	O
the	O
proximal	O
femur	O
.	O

Our	O
studies	O
suggest	O
that	O
the	O
helicase	B
assembly	O
protein	O
is	O
responsible	O
for	O
loading	O
T4	B
gene	I
41	I
helicase	I
specifically	O
at	O
replication	O
forks	O
,	O
and	O
that	O
its	O
binding	O
sites	O
for	O
each	O
arm	O
must	O
hold	O
more	O
than	O
six	O
,	O
but	O
not	O
more	O
than	O
12	O
nucleotides	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
HSV-1	O
infection	O
inhibits	O
host	O
cell	O
splicing	O
through	O
the	O
action	O
of	O
ICP27	B
.	O

Sci	O
.	O

In	O
our	O
initial	O
studies	O
,	O
we	O
treated	O
MCF-7	O
cells	O
with	O
paclitaxel	O
,	O
which	O
results	O
in	O
the	O
arrest	O
of	O
cells	O
in	O
G1	O
with	O
4n	O
DNA	O
content	O
(	O
pseudo	O
G1	O
)	O
.	O

A	O
GTP	O
/	O
GDP	O
exchange	O
assay	O
was	O
used	O
to	O
assess	O
the	O
potential	O
role	O
of	O
Ras	B
in	O
the	O
pathway	O
leading	O
to	O
ERK	B
phosphorylation	O
;	O
DADLE	O
failed	O
to	O
stimulate	O
GTP	O
/	O
GDP	O
exchange	O
in	O
comparison	O
to	O
PMA	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

The	O
remaining	O
77	O
nucleotides	O
at	O
the	O
3	O
'	O
end	O
of	O
domain	O
II	O
and	O
all	O
of	O
domains	O
III	O
(	O
655	O
nucleotides	O
)	O
and	O
IV	O
(	O
770	O
nucleotides	O
)	O
are	O
not	O
present	O
in	O
DIssE	B
RNA	I
.	O

Changes	O
in	O
tension	O
were	O
monitored	O
isometrically	O
on	O
spiral	O
strips	O
of	O
freshly	O
obtained	O
bovine	O
basilar	O
arteries	O
.	O

The	O
preparative	O
regimen	O
consisted	O
of	O
fractionated	O
total	O
body	O
irradiation	O
(	O
TBI	O
)	O
and	O
cyclophosphamide	O
(	O
CY	O
)	O
.	O

Consistent	O
with	O
the	O
large	O
pocket	O
of	O
Rb	B
binding	O
to	O
TAF	B
(	I
II	I
)	I
250	I
,	O
the	O
large	O
pocket	O
domains	O
of	O
both	O
p107	B
and	O
p130	B
are	O
able	O
to	O
bind	O
to	O
TAF	B
(	I
II	I
)	I
250	I
in	O
vivo	O
.	O

Comparison	O
of	O
the	O
derived	O
amino	O
acid	O
sequence	O
with	O
that	O
of	O
the	O
HCMV	B
UL99	I
gene	I
product	I
reveals	O
34.8	O
%	O
identity	O
in	O
an	O
overlap	O
of	O
66	O
amino	O
acids	O
.	O

Fentanyl	O
citrate	O
(	O
0.1	O
mL	O
)	O
and	O
2H5-fentanyl	O
(	O
internal	O
standard	O
,	O
0.05	O
mL	O
,	O
100	O
mg	O
/	O
L	O
)	O
were	O
extracted	O
with	O
Toxi	O
-	O
A	O
tubes	O
(	O
Toxi	O
-	O
Lab	O
,	O
Irvine	O
,	O
CA	O
)	O
and	O
analyzed	O
by	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
.	O

O5257	B
shows	O
homology	O
with	O
the	O
SAS2	B
protein	I
and	O
another	O
hypothetical	O
protein	O
from	O
yeast	O
.	O

Cotransfection	O
of	O
expression	O
plasmids	O
encoding	O
the	O
protein	B
kinase	I
A	I
inhibitor	O
,	O
or	O
an	O
inactive	O
protein	B
kinase	I
A	I
(	O
PKA	B
)	O
catalytic	O
beta	O
subunit	O
,	O
inhibited	O
both	O
forskolin	O
and	O
PACAP	B
activation	O
of	O
chromogranin	B
A	I
transcription	O
,	O
revealing	O
that	O
PACAP	B
-	O
induced	O
trans	O
-	O
activation	O
is	O
highly	O
dependent	O
on	O
PKA	B
.	O

The	O
uap100	B
cis	O
-	O
acting	O
,	O
up	O
-	O
promoter	O
,	O
constitutive	O
mutation	O
is	O
a	O
duplication	O
that	O
comprises	O
two	O
GATA	O
sites	O
and	O
suppresses	O
weakly	O
the	O
AREA	B
zinc	I
finger	I
mutation	I
but	O
does	O
not	O
alleviate	O
the	O
need	O
for	O
functional	O
UAY	B
and	O
AREA	B
proteins	I
.	O

With	O
BCPP	O
protocol	O
,	O
12	O
achieved	O
a	O
complete	O
response	O
,	O
11	O
evidenced	O
a	O
75	O
%	O
response	O
,	O
and	O
7	O
displayed	O
a	O
50	O
%	O
response	O
.	O

The	O
effects	O
of	O
tilmicosin	O
administration	O
in	O
the	O
feed	O
at	O
400	O
mg	O
/	O
kg	O
and	O
an	O
injection	O
therapy	O
of	O
clinically	O
diseased	O
pigs	O
with	O
long	O
-	O
acting	O
oxytetracycline	O
(	O
Terramycine	O
LA	O
)	O
at	O
20	O
mg	O
/	O
kg	O
bodyweight	O
were	O
compared	O
.	O

In	O
7	O
men	O
and	O
1	O
woman	O
who	O
died	O
suddenly	O
the	O
functionally	O
important	O
areas	O
of	O
myocardium	O
in	O
the	O
sino	O
-	O
auricular	O
area	O
and	O
the	O
subendocardial	O
layers	O
of	O
left	O
ventricle	O
were	O
obtained	O
by	O
necropsy	O
no	O
more	O
than	O
3	O
h	O
after	O
death	O
,	O
and	O
then	O
prepared	O
for	O
study	O
by	O
electron	O
microscopy	O
.	O

Pyridostigmine	O
pretreatment	O
was	O
supplemented	O
by	O
therapy	O
with	O
two	O
doses	O
of	O
an	O
antidotal	O
combination	O
(	O
A	O
,	O
TM	O
,	O
B	O
)	O
consisting	O
of	O
0.05	O
mg	O
/	O
kg	O
atropine	O
,	O
2.24	O
mg	O
/	O
kg	O
TMB-4	O
,	O
and	O
0.4	O
mg	O
/	O
kg	O
benactyzine	O
which	O
assured	O
survival	O
in	O
five	O
of	O
six	O
animals	O
following	O
three	O
separate	O
exposures	O
to	O
10	O
LD50	O
soman	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
and	O
DNase	B
I	I
protection	O
analyses	O
revealed	O
that	O
FP	B
I	I
was	O
bound	O
by	O
the	O
transcription	O
factor	O
PU.1	B
/	O
Spi-1	B
.	O

Motilin	B
serum	O
levels	O
were	O
measured	O
for	O
one	O
hour	O
.	O

Parameters	O
of	O
sperm	O
quality	O
were	O
evaluated	O
before	O
and	O
after	O
freezing	O
/	O
thawing	O
.	O

Comment	O
on	O
""""	O
Critical	O
behavior	O
of	O
a	O
binary	O
mixture	O
of	O
protein	O
and	O
salt	O
water	O
""""	O

Site	O
-	O
directed	O
mutagenesis	O
was	O
conducted	O
to	O
investigate	O
the	O
functional	O
significance	O
of	O
this	O
element	O
and	O
the	O
3	O
'	O
minus	O
-	O
strand	O
terminal	O
sequence	O
""""	O
3'-OH	O
-	O
CCCUAU	O
,	O
""""	O
which	O
contains	O
the	O
minus	O
-	O
strand	O
3'-end	O
sequence	O
""""	O
3'-OH	O
-	O
CC	O
(	O
1	O
-	O
2	O
)	O
(	O
A	O
/	O
U	O
)	O
(	O
A	O
/	O
U	O
)	O
(	O
A	O
/	O
U	O
)	O
""""	O
found	O
in	O
all	O
carmovirus	O
RNAs	O
.	O

Characterization	O
of	O
a	O
nuclear	B
deformed	I
epidermal	I
autoregulatory	I
factor-1	I
(	O
DEAF-1	B
)	O
-related	O
(	O
NUDR	B
)	O
transcriptional	O
regulator	O
protein	O
.	O

Effect	O
of	O
family	O
visits	O
on	O
the	O
blood	O
pressure	O
and	O
heart	O
rate	O
of	O
patients	O
in	O
the	O
coronary	O
-	O
care	O
unit	O
.	O

Prospects	O
of	O
chemosterilant	O
and	O
genetic	O
control	O
of	O
rodents	O
.	O

Neurological	O
toxicity	O
occurred	O
in	O
8	O
/	O
219	O
patients	O
treated	O
with	O
fludarabine	O
(	O
FAMP	O
)	O
,	O
30	O
mg	O
/	O
m2	O
per	O
day	O
and	O
cytosine	O
arabinoside	O
(	O
Ara	O
-	O
C	O
)	O
,	O
0.5	O
g	O
/	O
m2	O
per	O
hour	O
for	O
2	O
-	O
6	O
hours	O
for	O
5	O
days	O
,	O
for	O
new	O
or	O
relapsed	O
acute	O
leukemia	O
or	O
myelodysplasia	O
.	O

Paclitaxel	O
caused	O
a	O
rapid	O
and	O
transient	O
increase	O
in	O
c	B
-	I
Jun	I
NH2-terminal	I
kinase	I
(	O
JNK	B
)	O
activity	O
,	O
a	O
proposed	O
mediator	O
of	O
stress	O
activation	O
pathways	O
.	O

Expression	O
of	O
the	O
Hox	B
genes	I
egl-5	B
and	O
mab-5	B
is	O
reduced	O
in	O
lin-49	B
and	O
lin-59	B
mutants	I
,	O
suggesting	O
lin-49	B
and	O
lin-59	B
regulate	O
HOM	B
-	I
C	I
gene	I
expression	O
in	O
C.	O
elegans	O
as	O
the	O
trx	B
-	I
G	I
genes	I
do	O
in	O
Drosophila	O
.	O

lin-49	B
and	O
lin-59	B
transgenes	I
are	O
expressed	O
widely	O
throughout	O
C.	O
elegans	O
animals	O
.	O

In	O
cotransfection	O
assays	O
,	O
a	O
small	O
fragment	O
of	O
Sin	B
retaining	O
the	O
Src	B
-	O
SH3-binding	B
site	O
and	O
one	O
tyrosine	O
-	O
containing	O
motif	O
induced	O
c	B
-	I
Src	I
activation	O
as	O
measured	O
by	O
a	O
transcriptional	O
reporter	O
.	O

TFIIB	B
and	O
VDR	B
can	O
also	O
interact	O
directly	O
,	O
and	O
these	O
factors	O
synergize	O
to	O
mediate	O
transactivation	O
.	O

In	O
addition	O
,	O
269	O
mice	O
from	O
a	O
(	O
Mus	O
spretus	O
x	O
C57BL	O
/	O
6J	O
)	O
F1	O
x	O
C57BL	O
/	O
6J	O
interspecific	O
backcross	O
were	O
also	O
used	O
to	O
order	O
marker	O
loci	O
and	O
calculate	O
intergene	O
distances	O
for	O
this	O
region	O
.	O

Reduced	O
concentrations	O
of	O
antithrombin	B
III	I
,	O
plasminogen	B
,	O
(	O
free	O
)	O
protein	B
S	I
,	O
and	O
protein	B
C	I
were	O
found	O
in	O
some	O
patients	O
but	O
were	O
not	O
associated	O
with	O
either	O
thrombosis	O
or	O
lupus	O
anticoagulant	O
.	O

Three	O
RasV12	B
mutants	I
(	O
S35	B
,	O
G37	B
,	O
and	O
C40	B
)	O
which	O
differ	O
by	O
their	O
ability	O
to	O
bind	O
to	O
Ras	B
effectors	I
(	O
Raf	B
,	O
Ral	B
-	I
GEFs	I
,	O
and	O
the	O
p110	B
subunit	I
of	I
PI	I
3-kinase	I
,	O
respectively	O
)	O
were	O
able	O
to	O
induce	O
sustained	O
NR	O
cell	O
proliferation	O
,	O
although	O
none	O
of	O
these	O
mutants	O
was	O
reported	O
to	O
transform	O
NIH	O
3T3	O
cells	O
.	O

A	O
possible	O
correlation	O
between	O
mandibular	O
growth	O
retardation	O
and	O
palatal	O
clefting	O
is	O
discussed	O
.	O

Total	O
cross	O
sections	O
for	O
electron	O
scattering	O
by	O
CO2	O
molecules	O
in	O
the	O
energy	O
range	O
400	O
-	O
5000	O
eV.	O

However	O
,	O
depending	O
upon	O
the	O
promoter	O
context	O
,	O
we	O
observed	O
cooperative	O
interactions	O
between	O
the	O
two	O
domains	O
to	O
confer	O
high	O
DNA	O
-	O
binding	O
affinity	O
and	O
specificity	O
.	O

This	O
experience	O
would	O
recommend	O
consideration	O
of	O
home	O
nutritional	O
support	O
in	O
patients	O
with	O
systemic	O
scleroderma	O
when	O
the	O
disease	O
is	O
relatively	O
stable	O
and	O
no	O
major	O
organ	O
failure	O
is	O
present	O
.	O

Adult	O
-	O
onset	O
parkinsonism	O
has	O
appeared	O
in	O
several	O
previously	O
unaffected	O
members	O
in	O
families	O
with	O
DRD	O
suggesting	O
that	O
this	O
may	O
be	O
an	O
additional	O
phenotypical	O
expression	O
of	O
the	O
disease	O
.	O

Production	O
of	O
VT	O
was	O
also	O
examined	O
retrospectively	O
in	O
32	O
E.	O
coli	O
strains	O
of	O
serotype	O
O26	O
:	O
H11	O
isolated	O
from	O
children	O
with	O
diarrhoea	O
;	O
eight	O
(	O
25	O
%	O
)	O
of	O
them	O
produced	O
moderate	O
to	O
high	O
levels	O
of	O
verotoxin	B
1	I
despite	O
several	O
years	O
storage	O
in	O
vitro	O
.	O

The	O
5'-flanking	O
region	O
of	O
the	O
gene	O
,	O
approximately	O
1.1	O
kbp	O
long	O
,	O
had	O
no	O
known	O
regulatory	O
elements	O
for	O
transcription	O
such	O
as	O
TATA	O
,	O
GC	O
,	O
and	O
CCAAT	O
boxes	O
.	O

The	O
Molteno	O
implant	O
is	O
an	O
effective	O
procedure	O
in	O
the	O
treatment	O
of	O
complicated	O
and	O
refractory	O
cases	O
of	O
glaucoma	O
in	O
high	O
-	O
risk	O
eyes	O
.	O

Two	O
of	O
the	O
three	O
groups	O
were	O
submitted	O
to	O
two	O
different	O
levels	O
of	O
hypoxia	O
(	O
FiO2	O
=	O
0.05	O
,	O
group	O
F5	O
and	O
FiO2	O
=	O
0.1	O
,	O
group	O
F10	O
)	O
and	O
the	O
third	O
to	O
normoxia	O
(	O
FiO2	O
=	O
0.21	O
,	O
group	O
F21	O
)	O
in	O
a	O
thermoneutral	O
and	O
controlled	O
environment	O
.	O

Genotype	O
-	O
phenotype	O
correlations	O
in	O
male	O
patients	O
with	O
a	O
partial	O
nullisomy	O
of	O
the	O
X	O
chromosome	O
have	O
suggested	O
that	O
at	O
least	O
one	O
locus	O
involved	O
in	O
MRX	O
is	O
on	O
Xp22.3	O
.	O

We	O
have	O
now	O
completed	O
the	O
primary	O
structure	O
of	O
fibrillin	B
,	O
elucidated	O
the	O
exon	O
/	O
intron	O
organization	O
of	O
the	O
gene	O
and	O
derived	O
a	O
physical	O
map	O
of	O
the	O
genetic	O
locus	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
PutR	B
(	O
154	O
amino	O
acid	O
residues	O
)	O
showed	O
homology	O
to	O
the	O
small	O
regulatory	O
proteins	O
Lrp	B
,	O
BkdR	B
,	O
and	O
AsnC.	B

NF	B
-	I
kappaB	I
only	O
partially	O
mediates	O
Epstein	B
-	I
Barr	I
virus	I
latent	I
membrane	I
protein	I
1	I
activation	O
of	O
B	O
cells	O
.	O

The	O
mammalian	O
UPR	O
is	O
mediated	O
by	O
the	O
cis	O
-	O
acting	O
ER	O
stress	O
response	O
element	O
consisting	O
of	O
19	O
nt	O
(	O
CCAATN	O
(	O
9	O
)	O
CCACG	O
)	O
,	O
the	O
CCACG	O
part	O
of	O
which	O
is	O
considered	O
to	O
provide	O
specificity	O
.	O

Effects	O
of	O
dietary	O
lipids	O
on	O
whole	O
-	O
body	O
retention	O
and	O
organ	O
distribution	O
of	O
organic	O
and	O
inorganic	O
mercury	O
in	O
mice	O
.	O

This	O
region	O
shows	O
46	O
%	O
identity	O
with	O
the	O
calmodulin	B
-	I
binding	I
region	I
of	O
rat	B
brain	I
Ca2+	I
/	I
calmodulin	I
-	I
dependent	I
protein	I
kinase	I
II	I
and	O
32	O
%	O
identity	O
with	O
the	O
equivalent	O
region	O
of	O
chicken	B
smooth	I
muscle	I
myosin	I
light	I
chain	I
kinase	I
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

We	O
identified	O
clones	O
of	O
Chlamydomonas	O
genomic	O
DNA	O
that	O
rescued	O
the	O
Ca	O
(	O
2+	O
)	O
-dependent	O
axonemal	O
microtubule	O
severing	O
defect	O
of	O
fa1	B
mutants	I
.	O

STUDY	O
SELECTION	O
:	O
Not	O
applicable	O
.	O

Sequence	O
and	O
deletion	O
analysis	O
of	O
the	O
recombination	B
enhancement	I
gene	I
(	O
ref	B
)	O
of	O
bacteriophage	O
P1	O
:	O
evidence	O
for	O
promoter	O
-	O
operator	O
and	O
attenuator	O
-	O
antiterminator	O
control	O
.	O

Viral	B
protein	I
U	I
(	O
Vpu	B
)	O
is	O
a	O
protein	O
encoded	O
by	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
that	O
promotes	O
the	O
degradation	O
of	O
the	O
virus	O
receptor	O
,	O
CD4	B
,	O
and	O
enhances	O
the	O
release	O
of	O
virus	O
particles	O
from	O
cells	O
.	O

The	O
overall	O
objective	O
response	O
rate	O
(	O
RR	O
)	O
was	O
50	O
%	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
)	O
=	O
29	O
-	O
71	O
%	O
]	O
including	O
four	O
complete	O
responses	O
and	O
eight	O
partial	O
responses	O
.	O

SH3A	B
competes	O
with	O
the	O
SH3	B
domains	I
of	O
Grb2	B
in	O
binding	O
to	O
mSos1	B
,	O
and	O
the	O
intersectin	B
-	O
mSos1	B
complex	O
can	O
be	O
separated	O
from	O
Grb2	B
by	O
sucrose	O
gradient	O
centrifugation	O
.	O

Both	O
oligonucleotide	O
cross	O
-	O
competition	O
and	O
antibody	O
supershift	O
experiments	O
established	O
that	O
the	O
double	O
-	O
strand	O
binding	O
protein	O
is	O
equivalent	O
to	O
Sp1	B
.	O

Epithelial	O
cells	O
had	O
abnormal	O
and	O
accelerated	O
exfoliation	O
which	O
resulted	O
in	O
multifocal	O
epithelial	O
defects	O
.	O

Influenza	O
virus	O
-	O
induced	O
NF	B
-	I
kappaB	I
-	I
dependent	I
gene	I
expression	O
is	O
mediated	O
by	O
overexpression	O
of	O
viral	O
proteins	O
and	O
involves	O
oxidative	O
radicals	O
and	O
activation	O
of	O
IkappaB	B
kinase	I
.	O

This	O
demonstrates	O
a	O
relative	O
independence	O
of	O
the	O
given	O
synchronizer	O
of	O
rhythmicity	O
at	O
a	O
tissue	O
level	O
from	O
any	O
influence	O
of	O
the	O
higher	O
regulatory	O
center	O
.	O

Since	O
nearly	O
all	O
transformants	O
involving	O
homeologous	O
DNAs	O
carried	O
a	O
single	O
recombinant	O
plasmid	O
in	O
both	O
Pms+	B
and	O
Pms-	B
strains	O
,	O
stable	O
heteroduplex	O
DNA	O
appears	O
less	O
likely	O
than	O
for	O
homologous	O
DNAs	O
.	O

Western	O
and	O
immunocytochemical	O
analysis	O
implied	O
that	O
PREB	B
accumulates	O
specifically	O
in	O
GH3	O
cell	O
nuclei	O
.	O

Coronary	O
arteries	O
were	O
found	O
in	O
the	O
biopsy	O
tissue	O
of	O
30	O
(	O
76	O
%	O
)	O
of	O
the	O
39	O
patients	O
who	O
formed	O
the	O
study	O
group	O
.	O

Cotransfection	O
of	O
a	O
junB	B
stimulated	O
the	O
basal	O
activity	O
of	O
the	O
alpha	B
2	I
(	I
I	I
)	I
collagen	I
promoter	I
93-fold	O
,	O
respectively	O
.	O

Anesthesia	O
was	O
induced	O
by	O
droperidol	O
0.2	O
mg.kg-1	O
,	O
fentanyl	O
50	O
micrograms	O
,	O
thiamylal	O
150	O
-	O
250	O
mg	O
,	O
and	O
succinylcholine	O
1	O
mg.kg-1	O
,	O
and	O
maintained	O
with	O
nitrous	O
oxide	O
and	O
O2	O
(	O
67:33	O
)	O
supplemented	O
with	O
repeated	O
i.v	O
.	O

doses	O
of	O
fentanyl	O
(	O
within	O
15	O
micrograms.kg-1	O
)	O
.	O

In	O
this	O
system	O
,	O
enhancers	O
act	O
primarily	O
to	O
increase	O
the	O
probability	O
of	O
rapid	O
and	O
efficient	O
transcription	O
complex	O
formation	O
and	O
initiation	O
.	O

(	O
i	O
)	O
p60	B
bound	O
fast	O
-	O
migrating	O
,	O
underprocessed	O
wild	B
-	I
type	I
ICP22	I
and	O
ICP22	B
lacking	O
the	O
carboxyl	O
-	O
terminal	O
24	O
amino	O
acids	O
but	O
not	O
ICP22	B
lacking	O
the	O
carboxyl	O
-	O
terminal	O
40	O
amino	O
acids	O
,	O
whereas	O
the	O
previously	O
identified	O
cellular	B
protein	I
p78	I
(	O
R.	O

This	O
group	O
showed	O
the	O
presence	O
of	O
bacteria	O
infiltrated	O
at	O
the	O
dentinal	O
tubules	O
coronally	O
and	O
into	O
the	O
root	O
canals	O
.	O

Hydroxyl	O
radical	O
footprinting	O
of	O
DNA	O
complexes	O
of	O
the	O
ets	B
domain	I
of	O
PU.1	B
and	O
its	O
comparison	O
to	O
the	O
crystal	O
structure	O
.	O

The	O
generation	O
of	O
dorso	O
-	O
ventral	O
polarity	O
during	O
Drosophila	O
embryogenesis	O
is	O
regulated	O
by	O
the	O
action	O
of	O
12	O
maternally	O
expressed	O
gene	O
products	O
,	O
the	O
dorsal	B
group	I
.	O

Immunoblot	O
analysis	O
of	O
purified	O
and	O
protease	O
-	O
digested	O
intracellular	O
mature	O
virus	O
(	O
IMV	O
)	O
and	O
extracellular	O
enveloped	O
virus	O
(	O
EEV	O
)	O
showed	O
that	O
the	O
A36R	B
proteins	I
were	O
present	O
on	O
the	O
surface	O
of	O
EEV	O
with	O
type	O
II	O
membrane	O
topology	O
,	O
but	O
were	O
absent	O
from	O
IMV	O
.	O

To	O
prevent	O
section	O
wrinkles	O
usually	O
encountered	O
with	O
the	O
use	O
of	O
coated	O
single	O
-	O
hole	O
grids	O
,	O
a	O
simple	O
method	O
was	O
developed	O
.	O

Both	O
v	B
-	I
Myb	I
and	O
c	B
-	I
Myb	I
bind	O
specifically	O
to	O
delta	B
E3	I
.	O

After	O
at	O
least	O
one	O
year	O
follow	O
-	O
up	O
,	O
argon	O
laser	O
showed	O
a	O
statistically	O
significant	O
effect	O
(	O
p	O
less	O
of	O
0,01	O
;	O
Kolmogorow	O
-	O
Smirnov	O
test	O
)	O
on	O
the	O
stabilization	O
or	O
the	O
amelioration	O
of	O
visual	O
acuity	O
compared	O
with	O
the	O
non	O
treated	O
group	O
.	O

Relationship	O
between	O
age	O
-	O
associated	O
endocrine	O
deficiencies	O
and	O
muscle	O
function	O
in	O
elderly	O
women	O
:	O
a	O
cross	O
-	O
sectional	O
study	O
.	O

Intensity	O
variations	O
from	O
the	O
variable	O
TR	O
were	O
removed	O
,	O
and	O
the	O
data	O
were	O
evaluated	O
for	O
correlation	O
with	O
the	O
lateralized	O
stimulus	O
.	O

Improvement	O
of	O
some	O
pharmaceutical	O
properties	O
of	O
clofibrate	O
by	O
cyclodextrin	O
complexation	O
.	O

We	O
assessed	O
cardiovascular	O
variables	O
and	O
blood	O
O2	O
contents	O
in	O
order	O
to	O
characterize	O
O2	O
transport	O
in	O
ponies	O
during	O
treadmill	O
exercise	O
.	O

In	O
HepG2	O
cells	O
,	O
SREBP-1c	B
mRNA	I
and	O
precursor	O
protein	O
levels	O
were	O
induced	O
by	O
treatment	O
with	O
22	O
(	O
R	O
)	O
-hydroxycholesterol	O
and	O
9-cis	O
-	O
retinoic	O
acid	O
,	O
confirming	O
that	O
endogenous	O
LXR	B
-	O
RXR	B
activation	O
can	O
induce	O
endogenous	B
SREBP-1c	I
expression	O
.	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
determine	O
the	O
specific	O
effect	O
of	O
HIV	B
protease	I
inhibitors	O
on	O
patient	O
weight	O
.	O

E1	B
recognition	O
sequences	O
in	O
the	O
bovine	O
papillomavirus	O
type	O
1	O
origin	O
of	O
DNA	O
replication	O
:	O
interaction	O
between	O
half	O
sites	O
of	O
the	O
inverted	O
repeats	O
.	O

Phase	O
I	O
study	O
of	O
5-fluorouracil	O
and	O
leucovorin	O
by	O
a	O
14-day	O
circadian	O
infusion	O
in	O
metastatic	O
adenocarcinoma	O
patients	O
.	O

Although	O
polyubiquitin	B
chains	I
linked	O
through	O
Lys	O
(	O
29	O
)	O
of	O
ubiquitin	B
have	O
been	O
implicated	O
in	O
the	O
targeting	O
of	O
certain	O
substrates	O
to	O
proteasomes	O
,	O
the	O
signaling	O
properties	O
of	O
these	O
chains	O
are	O
poorly	O
understood	O
.	O

B	B
and	O
C1	B
fusions	I
with	O
yeast	B
GAL4	I
DNA	I
-	I
binding	I
and	I
transcriptional	I
activation	I
domains	I
were	O
also	O
found	O
to	O
interact	O
when	O
synthesized	O
and	O
assayed	O
in	O
yeast	O
.	O

Deletion	O
analysis	O
of	O
the	O
7.3-kb	B
GATA-2	I
promoter	I
region	I
revealed	O
that	O
a	O
1.1-kb	O
DNA	O
sequence	O
is	O
critical	O
for	O
expression	O
of	O
GATA-2	B
in	O
neurons	O
.	O

In	O
this	O
study	O
,	O
we	O
verified	O
that	O
PI	B
3-kinase	I
associates	O
with	O
the	O
CD4	B
:	O
p56lck	B
complex	I
as	O
judged	O
by	O
the	O
presence	O
of	O
PI	O
3-phosphate	O
generated	O
from	O
anti	B
-	I
CD4	I
immunoprecipitates	O
and	O
detected	O
by	O
high	O
-	O
pressure	O
liquid	O
chromatographic	O
analysis	O
.	O

We	O
have	O
previously	O
shown	O
that	O
UNC-4	B
expression	O
in	O
the	O
VA	O
motor	O
neurons	O
specifies	O
the	O
wild	O
-	O
type	O
pattern	O
of	O
presynaptic	O
input	O
.	O

Transesophageal	O
echocardiography	O
risk	O
factors	O
for	O
stroke	O
in	O
nonvalvular	O
atrial	O
fibrillation	O
.	O

Therefore	O
,	O
in	O
VDR	B
-	O
mediated	O
transcriptional	O
activation	O
,	O
1,25	O
(	O
OH	O
)	O
2D3	O
binding	O
to	O
VDR	B
alters	O
the	O
conformation	O
of	O
the	O
ligand	O
binding	O
domain	O
such	O
that	O
it	O
:	O
(	O
i	O
)	O
engages	O
in	O
strong	O
heterodimerization	O
with	O
RXR	B
to	O
facilitate	O
VDRE	O
binding	O
,	O
(	O
ii	O
)	O
influences	O
the	O
RXR	B
ligand	I
binding	I
domain	I
such	O
that	O
it	O
is	O
resistant	O
to	O
the	O
binding	O
of	O
9-cis	O
RA	O
but	O
active	O
in	O
recruiting	O
coactivator	O
to	O
its	O
AF-2	O
and	O
(	O
iii	O
)	O
presents	O
the	O
AF-2	O
region	O
in	O
VDR	B
for	O
coactivator	O
association	O
.	O

Second	O
,	O
overexpression	O
of	O
RIM11	B
can	O
suppress	O
an	O
ime1	B
missense	O
mutation	O
(	O
ime1-L321F	B
)	O
but	O
not	O
an	O
ime1	B
deletion	O
.	O

Nimodipine	O
(	O
5	O
micrograms	O
/	O
kg	O
)	O
followed	O
by	O
infusion	O
of	O
0.75	O
microgram	O
/	O
kg	O
/	O
min	O
lowered	O
the	O
blood	O
pressure	O
by	O
10	O
%	O
in	O
both	O
normotensive	O
and	O
hypertensive	O
rats	O
;	O
the	O
same	O
dose	O
schedule	O
of	O
nifedipine	O
did	O
not	O
lower	O
MAP	O
.	O

Using	O
unidirectional	O
PCR	O
we	O
isolated	O
a	O
361-bp	O
5	O
'	O
promoter	O
region	O
and	O
delineated	O
the	O
intronic	O
/	O
exonic	O
boundaries	O
which	O
include	O
a	O
non	O
-	O
coding	O
exon	O
1	O
,	O
a	O
single	O
intron	O
,	O
and	O
a	O
coding	O
exon	O
2	O
,	O
a	O
structure	O
that	O
is	O
typical	O
of	O
genes	O
of	O
the	O
RNase	B
A	I
superfamily	I
.	O

Results	O
of	O
these	O
studies	O
indicate	O
that	O
binding	O
of	O
biotin	O
to	O
the	O
protein	O
results	O
in	O
protection	O
of	O
regions	O
of	O
the	O
central	O
domain	O
in	O
the	O
vicinity	O
of	O
the	O
active	O
site	O
and	O
the	O
C	O
-	O
terminal	O
domain	O
from	O
chemical	O
cleavage	O
.	O

The	O
family	O
histories	O
were	O
obtained	O
from	O
the	O
parents	O
.	O

The	O
structure	O
of	O
the	O
murine	B
Dtk	I
gene	I
has	O
been	O
determined	O
.	O

These	O
data	O
demonstrate	O
that	O
oleosin	B
gene	I
transcription	O
is	O
regulated	O
in	O
a	O
tissue	O
-	O
specific	O
and	O
temporally	O
regulated	O
manner	O
and	O
clearly	O
indicate	O
that	O
oleosin	B
protein	I
expression	O
is	O
co	O
-	O
ordinated	O
primarily	O
at	O
the	O
transcriptional	O
level	O
.	O

Allergic	O
field	O
:	O
how	O
to	O
detect	O
it	O
?	O

The	O
actual	O
placement	O
of	O
the	O
lesions	O
was	O
determined	O
after	O
mapping	O
of	O
the	O
GPi	O
by	O
microrecording	O
,	O
using	O
stimulation	O
to	O
identify	O
the	O
sensorimotor	O
region	O
and	O
its	O
somatotopic	O
organization	O
.	O

The	O
0.018-inch	O
FloWire	O
provides	O
a	O
high	O
-	O
fidelity	O
continuous	O
Doppler	O
signal	O
.	O

Mutational	O
analysis	O
of	O
yeast	B
CEG1	I
demonstrated	O
that	O
four	O
of	O
the	O
five	O
conserved	O
motifs	O
are	O
essential	O
for	O
capping	B
enzyme	I
function	O
in	O
vivo	O
.	O

Purified	O
phosphorylated	O
PhoP	B
(	O
PhoPP	B
)	O
had	O
a	O
half	O
-	O
life	O
of	O
approximately	O
2.5	O
h	O
,	O
which	O
was	O
reduced	O
to	O
about	O
15	O
min	O
by	O
addition	O
of	O
the	O
same	O
molar	O
amount	O
of	O
*	B
PhoR	I
(	O
the	O
cytoplasmic	O
region	O
of	O
PhoR	B
)	O
.	O

It	O
spans	O
20	O
kilobases	O
,	O
consists	O
of	O
7	O
exons	O
and	O
6	O
introns	O
,	O
and	O
contains	O
a	O
TATA	O
motif	O
24	O
nucleotides	O
upstream	O
of	O
the	O
transcriptional	O
start	O
site	O
.	O

A	O
survey	O
of	O
274	O
late	O
detected	O
cases	O
of	O
CDH	O
born	O
in	O
the	O
years	O
1970	O
-	O
-74	O
is	O
presented	O
.	O

This	O
distinct	O
biochemical	O
difference	O
between	O
STAT5A	B
and	O
STAT5B	B
was	O
confirmed	O
with	O
purified	O
activated	O
STAT5	B
recombinant	I
proteins	I
.	O

Enoxacin	O
has	O
been	O
shown	O
to	O
be	O
an	O
effective	O
well	O
tolerated	O
and	O
convenient	O
treatment	O
for	O
gonorrhoea	O
.	O

Thus	O
,	O
Tax1	B
activates	O
CArG	O
-	O
mediated	O
transcription	O
without	O
mitogenic	O
signals	O
through	O
interaction	O
with	O
a	O
CArG	B
-	I
binding	I
factor	I
,	O
p67SRF	B
.	O

In	O
5	O
cases	O
,	O
combined	O
sensitization	O
to	O
mercury	O
and	O
other	O
metal	O
salts	O
,	O
particularly	O
gold	O
sodium	O
thiosulfate	O
(	O
GST	O
)	O
and	O
palladium	O
chloride	O
(	O
PDC	O
)	O
,	O
was	O
observed	O
.	O

Amongst	O
53	O
""""	O
inoperable	O
""""	O
(	O
T4	O
,	O
N0	O
,	O
N1	O
,	O
T.	O
,	O
N2	O
,	O
N3	O
)	O
cases	O
,	O
5	O
(	O
10	O
%	O
)	O
had	O
a	O
positive	O
scan	O
and	O
5	O
a	O
doubtful	O
scan	O
.	O

Acyclovir	O
(	O
3	O
%	O
ointment	O
)	O
used	O
topically	O
one	O
to	O
five	O
times	O
a	O
day	O
on	O
acute	O
ocular	O
HSV	O
infection	O
gave	O
beneficial	O
results	O
as	O
measured	O
by	O
a	O
reduction	O
in	O
corneal	O
involvement	O
,	O
conjunctivitis	O
,	O
iritis	O
,	O
and	O
corneal	O
clouding	O
.	O

The	O
efficiency	O
of	O
transfections	O
was	O
normalized	O
relative	O
to	O
the	O
net	O
amount	O
of	O
CAT	B
plasmid	O
actually	O
transfected	O
into	O
recipient	O
cells	O
,	O
determined	O
by	O
a	O
modified	O
Southern	O
hybridization	O
procedure	O
.	O

Initial	O
computer	O
based	O
similarity	O
searches	O
identified	O
human	B
retinoblastoma	I
binding	I
protein	I
1	I
(	O
RBP-1	B
)	O
,	O
Drosophila	B
melanogaster	I
male	I
specific	I
lethal-3	I
(	O
Msl-3	B
)	O
,	O
S.	B
pombe	I
altered	I
polarity-13	I
(	O
Alp13	B
)	O
and	O
S.	B
cerevisiae	I
Eaf3p	I
,	O
a	O
component	O
of	O
the	O
yeast	B
NuA4	I
HAT	B
complex	O
(	O
Galarneau	O
et	O
al.	O
,	O
2000	O
.	O

These	O
aa	O
residues	O
correspond	O
to	O
codons	O
59	O
and	O
108	O
in	O
the	O
P.	B
falciparum	I
DHFR	I
active	I
site	I
in	O
which	O
similar	O
aa	O
substitutions	O
(	O
Cys	O
Arg-59	O
and	O
Ser	O
Asn-108	O
)	O
are	O
associated	O
with	O
pyrimethamine	O
resistance	O
.	O

Short	O
-	O
term	O
growth	O
:	O
rhythms	O
,	O
chaos	O
,	O
or	O
noise	O
?	O

Sequences	O
homologous	O
to	O
the	O
consensus	O
TUF	B
-	I
binding	I
UAS	I
boxes	I
are	O
present	O
in	O
the	O
5	O
'	O
flanking	O
regions	O
of	O
both	O
genes	O
.	O

The	O
gene	B
atp6	I
,	O
encoding	O
subunit	O
6	O
of	O
the	O
mitochondrial	O
F0-ATPase	B
complex	O
,	O
has	O
been	O
characterized	O
from	O
both	O
the	O
normal	O
(	O
fertile	O
)	O
and	O
Ogura	O
(	O
male	O
-	O
sterile	O
)	O
radish	O
cytoplasms	O
in	O
order	O
to	O
determine	O
if	O
previously	O
identified	O
atp6	B
transcriptional	O
differences	O
could	O
play	O
a	O
role	O
in	O
cytoplasmic	O
male	O
sterility	O
.	O

The	O
expression	O
of	O
CAPL	B
,	O
a	O
second	O
protein	O
involved	O
in	O
calcium	O
metabolism	O
,	O
was	O
only	O
moderately	O
elevated	O
in	O
the	O
doxorubicin	O
-	O
resistant	O
cells	O
.	O

The	O
reconstituted	O
enzyme	O
binds	O
DNA	O
with	O
an	O
affinity	O
that	O
is	O
approximately	O
20-fold	O
lower	O
than	O
that	O
of	O
the	O
intact	O
topo70	B
.	O

In	O
late	O
October	O
,	O
1974	O
,	O
Staphylococcus	O
aureus	O
postoperative	O
wound	O
infection	O
was	O
recorded	O
in	O
a	O
nonhuman	O
primate	O
(	O
Macaca	O
mulatta	O
)	O
which	O
had	O
recently	O
undergone	O
surgical	O
operation	O
.	O

Thus	O
,	O
the	O
in	O
vivo	O
function	O
of	O
Gle2p	B
is	O
strictly	O
coupled	O
to	O
the	O
short	O
GLEBS	B
within	O
Nup116p	B
which	O
links	O
this	O
putative	O
mRNA	O
transport	O
factor	O
to	O
the	O
nuclear	O
pores	O
.	O

Seminal	O
prolactin	B
levels	O
were	O
significantly	O
elevated	O
in	O
all	O
infertile	O
males	O
.	O

The	O
recruitment	O
of	O
constitutively	O
phosphorylated	O
p185	B
(	O
neu	B
)	O
and	O
the	O
activated	O
mitogenic	O
pathway	O
proteins	O
to	O
this	O
membrane	O
-	O
microfilament	O
interaction	O
site	O
provides	O
a	O
physical	O
model	O
for	O
integrating	O
the	O
assembly	O
of	O
the	O
mitogenic	O
pathway	O
with	O
the	O
transmission	O
of	O
growth	O
factor	O
signal	O
to	O
the	O
cytoskeleton	O
.	O

The	O
pattern	O
of	O
net	B
RNA	I
expression	O
in	O
adult	O
mouse	O
tissues	O
is	O
different	O
.	O

Effect	O
of	O
capsaicin	O
on	O
hexobarbital	O
-	O
anesthetized	O
rats	O

A	O
physical	O
and	O
genetic	O
map	O
covering	O
the	O
entire	O
RP12	B
candidate	I
gene	I
region	I
was	O
constructed	O
.	O

In	O
both	O
immortalized	O
and	O
normal	O
diploid	O
human	O
cells	O
,	O
wt	O
AAV	O
targeted	O
integration	O
to	O
ch-19	O
.	O

It	O
was	O
found	O
that	O
both	O
versions	O
of	O
the	O
brief	O
SL­ASIA	O
had	O
similar	O
correlations	O
to	O
the	O
target	O
variables	O
as	O
the	O
full	O
scale	O
SL­ASIA	O
.	O

These	O
operons	O
encode	O
subunits	O
of	O
photosystems	B
I	I
(	O
psa	B
)	O
and	O
II	O
(	O
psb	B
)	O
,	O
the	O
cytochrome	B
bGf	I
complex	I
(	O
pet	B
)	O
,	O
the	O
plastid	O
NAD	B
(	I
P	I
)	I
H	I
dehydrogenase	I
(	O
ndh	B
)	O
,	O
and	O
the	O
unidentified	O
open	O
reading	O
frame	O
ycf9	B
.	O

In	O
contrast	O
,	O
dominant	B
negative	I
Rac	I
(	O
N17Rac1	B
)	O
inhibited	O
JNK	B
activation	O
by	O
Galpha12	B
in	O
HEK293	O
cells	O
as	O
well	O
as	O
three	O
other	O
cell	O
lines	O
.	O

A	O
major	O
feature	O
of	O
this	O
genomic	O
sequence	O
is	O
the	O
presence	O
of	O
a	O
first	O
intron	O
(	O
Il	O
)	O
,	O
215	O
bp	O
long	O
,	O
located	O
48	O
bp	O
downstream	O
of	O
the	O
translation	O
start	O
ATG	O
codon	O
.	O

We	O
reviewed	O
the	O
different	O
published	O
cases	O
of	O
acute	O
high	O
dose	O
methotrexate	O
neurotoxicity	O
and	O
the	O
different	O
underlying	O
mechanisms	O
.	O

The	O
expected	O
products	O
of	O
the	O
cloned	O
bph	B
genes	I
,	O
except	O
bphA3	B
,	O
were	O
observed	O
in	O
E.	O
coli	O
in	O
an	O
in	O
vitro	O
transcription	O
-	O
translation	O
system	O
.	O

The	O
immunoreactive	O
antithrombin	B
III	I
increased	O
significantly	O
while	O
the	O
increase	O
in	O
antithrombin	B
III	I
activity	O
was	O
insignificant	O
in	O
20	O
male	O
Caucasian	O
Danes	O
upon	O
3	O
weeks	O
supplementation	O
of	O
the	O
diet	O
with	O
10	O
ml	O
daily	O
of	O
a	O
cod	O
liver	O
oil	O
concentrate	O
.	O

Only	O
the	O
27-kDa	O
protein	O
was	O
detected	O
after	O
N	B
-	I
glycosidase	I
treatment	O
,	O
indicating	O
that	O
PLP	B
-	I
H	I
is	O
a	O
glycoprotein	O
.	O

These	O
observed	O
changes	O
were	O
not	O
found	O
when	O
assessing	O
NPY	B
level	O
in	O
plasma	O
fluid	O
.	O

In	O
three	O
other	O
patients	O
the	O
electrophysiologic	O
characteristics	O
of	O
atrioventricular	O
conduction	O
prevented	O
a	O
demonstration	O
of	O
these	O
differences	O
.	O

These	O
sequence	O
differences	O
are	O
reflected	O
in	O
differences	O
in	O
gene	O
expression	O
in	O
three	O
cell	O
lines	O
.	O

The	O
cumulative	O
dose	O
to	O
nursing	O
staff	O
for	O
the	O
week	O
after	O
treatment	O
was	O
dependent	O
on	O
patient	O
mobility	O
and	O
was	O
estimated	O
at	O
0.08	O
mSv	O
for	O
a	O
self	O
-	O
caring	O
patient	O
to	O
6.3	O
mSv	O
for	O
a	O
totally	O
helpless	O
patient	O
(	O
1840	O
MBq	O
/	O
group	O
A	O
)	O
.	O

The	O
analysis	O
consisted	O
of	O
1	O
)	O
fitting	O
first-	O
and	O
second	O
-	O
order	O
autoregressive	O
models	O
(	O
AR1	O
and	O
AR2	O
)	O
and	O
2	O
)	O
obtaining	O
the	O
power	O
spectra	O
of	O
the	O
data	O
by	O
fast	O
-	O
Fourier	O
transform	O
.	O

Of	O
921	O
specimens	O
,	O
95	O
yielded	O
non	O
-	O
albicans	O
species	O
,	O
mainly	O
from	O
patients	O
with	O
low	O
CD4	B
lymphocyte	O
counts	O
and	O
extensive	O
previous	O
azole	O
exposure	O
.	O

Sequence	O
analysis	O
and	O
electrophoretic	O
mobility	O
shift	O
experiments	O
suggest	O
that	O
GnSE	B
response	I
elements	I
interact	O
,	O
in	O
these	O
two	O
regions	O
,	O
with	O
GATA-	B
and	I
LIM	I
-	I
related	I
factors	I
,	O
respectively	O
.	O

Hamdija	O
Karamehmedovic	O
;	O
Ibn	O
al	O
-	O
Nefis	O
,	O
""""	O
Mudzez	O
al	O
-	O
Kanum	O
""""	O
,	O
Republicki	O
zavod	O
za	O
zdravstvenu	O
zastitu	O
Sarajevo	O
,	O
1961	O
,	O
1	O
-	O
219	O
;	O

Mr	O
ph	O
Samuel	O
Elazar	O
,	O
Ajnija	O
Omanic	O
:	O
""""	O
Bibliografija	O
medicinskih	O
djela	O
u	O
SR	O
BiH	O
do	O
1895	O
.	O
""""	O

Medicinska	O
knjiga	O
Beograd	O
-	O
Zagreb	O
1984	O
;	O
Besides	O
,	O
the	O
great	O
contribution	O
in	O
bibliography	O
was	O
given	O
by	O
dr	O
Lujo	O
Taler	O
,	O
prof	O
.	O

dr	O
.	O

Patients	O
randomized	O
into	O
the	O
active	O
treatment	O
groups	O
A30	O
(	O
n	O
=	O
49	O
)	O
and	O
A60	O
(	O
n	O
=	O
48	O
)	O
received	O
topical	O
treatment	O
with	O
3.0	O
%	O
diclofenac	O
in	O
2.5	O
%	O
hyaluronan	O
gel	O
0.5	O
g	O
twice	O
daily	O
for	O
30	O
or	O
60	O
days	O
,	O
respectively	O
.	O

Human	B
PDNP3	I
is	O
expressed	O
in	O
glioma	O
cells	O
,	O
prostate	O
,	O
and	O
uterus	O
,	O
but	O
not	O
in	O
the	O
alimentary	O
tract	O
.	O

13:961	O
-	O
969	O
,	O
1993	O
)	O
suggested	O
that	O
T	B
antigen	I
could	O
mediate	O
transcriptional	O
activation	O
through	O
interaction	O
with	O
the	O
TATA	B
-	I
binding	I
protein	I
,	O
as	O
well	O
as	O
upstream	O
bound	O
transcription	O
factors	O
.	O

Identification	O
of	O
a	O
putative	O
infC	B
-	O
rpmI	B
-	O
rplT	B
operon	O
flanked	O
by	O
long	O
inverted	O
repeats	O
in	O
Mycoplasma	O
fermentans	O
(	O
incognitus	O
strain	O
)	O
.	O

IgE	B
antibody	I
to	O
twelve	O
common	O
food	O
and	O
inhalant	O
allergens	O
was	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
in	O
the	O
sera	O
of	O
thirteen	O
atopic	O
patients	O
with	O
one	O
or	O
more	O
allergic	O
disorders	O
(	O
asthma	O
occurring	O
in	O
eleven	O
;	O
rhinitis	O
in	O
ten	O
;	O
eczema	O
in	O
six	O
;	O
urticaria	O
in	O
four	O
;	O
mouth	O
and	O
gastro	O
-	O
intestinal	O
symptoms	O
in	O
six	O
)	O
,	O
of	O
twelve	O
non	O
-	O
atopic	O
patients	O
with	O
various	O
clinical	O
symptoms	O
(	O
asthma	O
in	O
four	O
;	O
rhinitis	O
in	O
four	O
;	O
eczema	O
in	O
one	O
;	O
urticaria	O
in	O
two	O
;	O
mouth	O
and	O
gastro	O
-	O
intestinal	O
symptoms	O
in	O
four	O
)	O
and	O
sixteen	O
cord	O
blood	O
sera	O
.	O

Analysis	O
of	O
1	O
Mb	O
of	O
published	O
sequence	O
from	O
the	O
region	O
of	O
conserved	O
synteny	O
on	O
human	O
chromosome	O
5q31-q33	O
identified	O
45	O
gene	O
candidates	O
,	O
including	O
35	O
expressed	O
genes	O
in	O
the	O
human	B
IL-4	I
cytokine	I
gene	I
cluster	O
.	O

These	O
p21-E2F	B
complexes	O
,	O
while	O
present	O
in	O
young	O
G1	O
cells	O
at	O
very	O
low	O
levels	O
,	O
were	O
elevated	O
in	O
senescent	O
cells	O
.	O

The	O
delta	O
Mo	O
+	O
SV	O
tumor	O
DNAs	O
from	O
B	O
-	O
lineage	O
tumors	O
were	O
typically	O
rearranged	O
at	O
the	O
immunoglobulin	B
gene	I
loci	I
and	O
contained	O
germ	O
line	O
configurations	O
of	O
the	O
T	B
-	I
cell	I
receptor	I
beta	I
gene	I
.	O

Earlier	O
reports	O
have	O
localized	O
mutations	O
which	O
affect	O
the	O
processing	O
and	O
transport	O
of	O
herpes	O
simplex	O
virus	O
1	O
glycoproteins	O
to	O
a	O
region	O
located	O
between	O
the	O
genes	O
specifying	O
glycoprotein	B
B	I
and	O
the	O
major	O
viral	O
DNA	O
-	O
binding	O
protein	O
(	O
beta	B
8)	I
.	O

Magnetic	O
force	O
and	O
torque	O
at	O
1.5	O
T	O
did	O
not	O
dislodge	O
the	O
GF	O
or	O
result	O
in	O
perforation	O
of	O
canine	O
IVC	O
by	O
the	O
GF	O
.	O

The	O
rec8	B
(	I
+	I
)	I
,	O
rec10	B
(	I
+	I
)	I
,	O
and	O
rec11	B
(	I
+	I
)	I
genes	I
of	I
the	I
fission	I
yeast	I
Schizosaccharomyces	I
pombe	I
exhibit	O
similar	O
specificities	O
for	O
meiotic	O
recombination	O
and	O
rec8	B
(	I
+	I
)	I
is	O
required	O
for	O
sister	O
chromatid	O
cohesion	O
and	O
homolog	O
pairing	O
.	O

The	O
formation	O
of	O
a	O
D	O
-	O
loop	O
is	O
an	O
essential	O
step	O
in	O
DNA	O
double	O
-	O
strand	O
break	O
repair	O
through	O
recombination	O
.	O

Using	O
a	O
set	O
of	O
sera	O
for	O
which	O
full	O
chlamydial	O
micro	O
-	O
immunofluorescence	O
results	O
suggested	O
a	O
clear	O
diagnosis	O
,	O
we	O
have	O
evaluated	O
the	O
Chlamydia	O
Spot	O
-	O
IF	O
test	O
(	O
bioMerieux	O
)	O
,	O
which	O
allows	O
a	O
comparison	O
of	O
titres	O
to	O
Chlamydia	B
trachomatis	I
and	I
C.	I
psittaci	I
antigens	I
.	O

CONCLUSION	O
:	O
DMIPP	O
detects	O
regionally	O
hypoperfused	O
myocardium	O
,	O
in	O
which	O
agreement	O
between	O
MBF	O
and	O
fatty	O
acid	O
uptake	O
deteriorates	O
.	O

The	O
majority	O
of	O
putative	O
TSC2	B
mutations	I
were	O
found	O
in	O
sporadic	O
rather	O
than	O
TSC2-linked	B
families	O
.	O

None	O
of	O
the	O
10	O
sequences	O
has	O
hitherto	O
been	O
recognized	O
as	O
part	O
of	O
the	O
p53	B
signaling	O
pathway	O
.	O

Comparison	O
of	O
the	O
genes	O
coding	O
for	O
mouse	O
and	O
human	O
p36	B
(	O
annexin	B
II	I
)	O
and	O
mouse	O
,	O
rat	O
and	O
human	O
p35	B
(	O
annexin	B
I	I
)	O
and	O
pigeon	O
cp35	B
(	O
an	O
annexin	B
I	I
-	I
related	I
protein	I
)	O
shows	O
strong	O
genomic	O
structural	O
conservation	O
supporting	O
the	O
hypothesis	O
that	O
these	O
genes	O
had	O
a	O
common	O
ancestor	O
.	O

Now	O
:	O
pleasure	O
in	O
work	O

Mammalian	O
homologues	O
of	O
the	O
Polycomb	B
-	I
group	I
gene	I
Enhancer	B
of	I
zeste	I
mediate	O
gene	O
silencing	O
in	O
Drosophila	O
heterochromatin	O
and	O
at	O
S.	O
cerevisiae	O
telomeres	O
.	O

Xanthoepocin	O
,	O
a	O
new	O
antibiotic	O
from	O
Penicillium	O
simplicissimum	O
IFO5762	O
.	O

Additionally	O
,	O
VAHS	O
is	O
often	O
associated	O
with	O
fatal	O
infectious	O
mononucleosis	O
(	O
IM	O
)	O
.	O

273	O
,	O
27420	O
-	O
27429	O
)	O
a	O
putative	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
response	O
element	O
(	O
PPRE	O
)	O
is	O
present	O
from	O
-458	O
to	O
-474	O
.	O

In	O
T	O
cells	O
these	O
two	O
signal	O
pathways	O
are	O
critical	O
for	O
interleukin-2	B
production	O
.	O

A	O
plasma	O
cell	O
-	O
rich	O
infiltrate	O
was	O
present	O
in	O
the	O
connective	O
tissue	O
cores	O
of	O
the	O
papillae	O
.	O

Peptide	O
competition	O
studies	O
have	O
localized	O
a	O
cyclin	B
A	I
interaction	I
site	I
to	O
a	O
Lys381Lys382Leu383Met384Phe385	O
sequence	O
within	O
C	O
-	O
terminal	O
negative	O
regulatory	O
domain	O
of	O
human	B
p53	I
.	O

While	O
some	O
still	O
automatically	O
refuse	O
all	O
patients	O
with	O
positive	O
mediastinoscopy	O
,	O
most	O
authors	O
still	O
remain	O
very	O
interventionistic	O
for	O
N2	O
patients	O
selected	O
on	O
very	O
accurate	O
criteria	O
that	O
are	O
analyzed	O
above	O
.	O

A	O
yeast	O
mitochondrial	O
translation	O
initiation	O
codon	O
mutation	O
affecting	O
the	O
gene	O
for	O
cytochrome	B
oxidase	I
subunit	I
III	I
(	O
COX3	B
)	O
was	O
partially	O
suppressed	O
by	O
a	O
spontaneous	O
nuclear	O
mutation	O
.	O

Patients	O
with	O
endocarditis	O
or	O
vascular	O
infection	O
were	O
more	O
frequently	O
immunocompromised	O
and	O
older	O
than	O
those	O
with	O
acute	O
Q	O
fever	O
.	O

MEASURES	O
:	O
SF-36	O
questionnaires	O
were	O
completed	O
by	O
patients	O
at	O
both	O
initial	O
and	O
discharge	O
examinations	O
.	O

Hormonal	O
replacement	O
therapy	O
for	O
women	O
with	O
a	O
personal	O
history	O
of	O
breast	O
cancer	O
?	O

Mutant	O
beta2-adrenergic	B
receptors	I
with	O
a	O
Tyr	O
-	O
to	O
-	O
Phe	O
substitution	O
at	O
Tyr-350	O
do	O
not	O
display	O
agonist	O
-	O
induced	O
desensitization	O
,	O
Src	B
recruitment	O
,	O
or	O
Src	B
activation	O
.	O

Furthermore	O
,	O
disruption	O
of	O
pcr1	B
reduced	O
expression	O
of	O
fbp1	B
,	O
a	O
glucose	O
-	O
repressible	O
gene	O
negatively	O
regulated	O
by	O
PKA	B
.	O

This	O
B	O
-	O
box	O
is	O
not	O
present	O
in	O
ETS1	B
,	O
ETS2	B
,	O
PEA3	B
or	O
PU.1	B
and	O
these	O
proteins	O
were	O
unable	O
to	O
form	O
ternary	O
complexes	O
with	O
SRF	B
and	O
Egrl	B
-	O
SREs	O
or	O
c	B
-	I
fos	I
SRE	O
.	O

Excretion	O
of	O
radiopharmaceuticals	O
into	O
breast	O
milk	O
.	O

It	O
is	O
concluded	O
that	O
the	O
drinking	O
ampules	O
of	O
VP-16	O
-	O
213	O
can	O
be	O
replaced	O
with	O
the	O
new	O
oral	O
capsules	O
with	O
a	O
recommended	O
initial	O
dose	O
of	O
100	O
-	O
130	O
mg	O
/	O
m2	O
given	O
in	O
5-day	O
courses	O
every	O
21	O
-	O
28	O
days	O
.	O

Deletion	O
of	O
the	O
region	O
from	O
amino	O
acid	O
residues	O
2	O
-	O
67	O
in	O
E1A	B
,	O
which	O
has	O
been	O
postulated	O
to	O
interact	O
with	O
p300	B
/	O
CBP	B
,	O
also	O
abolished	O
the	O
inhibitory	O
effect	O
of	O
E1A	B
,	O
whereas	O
deletion	O
of	O
the	O
region	O
from	O
residues	O
120	O
to	O
140	O
had	O
no	O
effect	O
.	O

We	O
found	O
both	O
the	O
v	B
-	I
Ras-	I
and	O
PC	B
-	I
PLC	I
-	O
transformed	O
cells	O
to	O
be	O
insensitive	O
to	O
stimulation	O
with	O
platelet	B
-	I
derived	I
growth	I
factor	I
(	O
PDGF	B
)	O
.	O

Furthermore	O
,	O
it	O
was	O
found	O
that	O
the	O
Shb	B
-	O
overexpressing	O
cells	O
extended	O
neurites	O
in	O
response	O
to	O
epidermal	B
growth	I
factor	I
.	O

Tre	O
during	O
exercise	O
at	O
35	O
W	O
at	O
23	O
degrees	O
C	O
correlated	O
r	O
=	O
-70	O
with	O
Vo2max	O
and	O
r	O
=	O
0.80	O
with	O
Tre	O
during	O
exercise	O
in	O
heat	O
.	O

Should	O
we	O
use	O
thiazide	O
diuretics	O
in	O
hypertensive	O
patients	O
with	O
non	O
-	O
insulin	B
-	O
dependent	O
diabetes	O
mellitus	O
?	O

The	O
University	O
of	O
North	O
Carolina	O
caries	O
risk	O
assessment	O
was	O
conducted	O
between	O
1986	O
and	O
1989	O
with	O
5000	O
children	O
initially	O
in	O
grades	O
1	O
and	O
5	O
from	O
low	O
fluoride	O
sites	O
in	O
South	O
Carolina	O
and	O
Maine	O
.	O

Treatment	O
of	O
cells	O
for	O
10	O
min	O
with	O
TNF	B
-	I
alpha	I
resulted	O
in	O
activation	O
of	O
p44	B
/	I
42	I
MAPK	O
,	O
p38	B
,	O
and	O
JNK	B
.	O

In	O
phase	O
II	O
studies	O
,	O
MDL	O
72,974A	O
is	O
proving	O
to	O
be	O
a	O
useful	O
adjunct	O
to	O
conventional	O
therapy	O
.	O

A	O
derived	O
RA	O
-	O
resistant	O
line	O
,	O
NT2	O
/	O
D1-R1	O
,	O
is	O
deficient	O
in	O
this	O
activity	O
and	O
is	O
co	O
-	O
resistant	O
to	O
cisplatin	O
.	O

Phenacetin	O
nephritis	O

Both	O
claR	B
and	O
car	B
are	O
expressed	O
as	O
monocistronic	O
transcripts	O
;	O
the	O
level	O
of	O
transcript	O
declined	O
rapidly	O
after	O
48h	O
in	O
complex	O
media	O
,	O
but	O
low	O
sustained	O
levels	O
of	O
both	O
transcripts	O
were	O
observed	O
in	O
defined	O
GSPG	O
medium	O
until	O
96h	O
.	O

claR	B
and	O
car	B
were	O
not	O
significantly	O
expressed	O
in	O
mutants	O
disrupted	O
in	O
the	O
ccaR	B
gene	I
,	O
a	O
regulatory	O
gene	O
that	O
controls	O
positively	O
clavulanic	O
acid	O
and	O
cephamycin	O
biosynthesis	O
.	O

Experiments	O
were	O
performed	O
without	O
polarization	O
or	O
with	O
cathodic	O
and	O
anodic	O
polarization	O
of	O
the	O
adsorbent	O
.	O

Our	O
results	O
suggest	O
that	O
Sp1	B
binding	I
site	I
can	O
function	O
as	O
a	O
distinct	O
TGF	B
-	I
beta	I
responsive	I
element	I
for	O
TGF	B
-	I
beta	I
mediated	O
promoter	O
expression	O
and	O
Sp1	B
per	O
se	O
can	O
mediate	O
this	O
response	O
.	O

A	O
positive	O
correlation	O
was	O
also	O
established	O
between	O
the	O
level	O
of	O
FP9C	B
binding	O
and	O
the	O
degree	O
of	O
cell	O
differentiation	O
in	O
vitro	O
.	O

In	O
another	O
patient	O
,	O
IRPF	O
recurred	O
in	O
the	O
ureter	O
of	O
a	O
living	O
related	O
renal	O
graft	O
6	O
months	O
after	O
transplantation	O
.	O

Similar	O
to	O
the	O
D	B
,	O
B	B
/	O
B	B
'	I
and	O
E	B
proteins	I
,	O
the	O
F	B
and	O
G	B
proteins	I
do	O
not	O
possess	O
any	O
of	O
the	O
known	O
RNA	O
binding	O
motifs	O
,	O
suggesting	O
that	O
other	O
types	O
of	O
RNA	O
-	O
protein	O
interactions	O
occur	O
in	O
the	O
snRNP	O
core	O
.	O

Ultrasound	O
-	O
guided	O
fine	O
-	O
needle	O
aspiration	O
biopsy	O
(	O
US	O
-	O
FNAB	O
)	O
revealed	O
normal	O
-	O
looking	O
squamous	O
cells	O
.	O

In	O
EGF	B
receptor	I
-	O
mediated	O
signaling	O
,	O
the	O
protein	B
kinase	I
PKB	I
/	O
Akt	B
and	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
c	I
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
,	O
but	O
not	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
2	I
,	O
function	O
downstream	O
of	O
phosphatidylinositol	B
3-kinase	I
(	O
PI	B
3-kinase	I
)	O
.	O

Blockade	O
of	O
T	O
cell	O
activation	O
using	O
a	O
surface	O
-	O
linked	O
single	O
-	O
chain	O
antibody	O
to	O
CTLA-4	B
(	O
CD152	B
)	O
.	O

Complementary	O
DNA	O
libraries	O
from	O
liver	O
and	O
ovary	O
of	O
an	O
immature	O
female	O
channel	O
catfish	O
were	O
screened	O
with	O
a	O
homologous	B
ERalpha	I
cDNA	I
probe	O
.	O

Examination	O
of	O
the	O
Coomassie	O
-	O
stained	O
gels	O
revealed	O
that	O
the	O
capsid	O
-	O
like	O
particles	O
composed	O
of	O
the	O
N11-VP1	B
protein	O
did	O
not	O
contain	O
any	O
host	O
-	O
derived	O
histones	B
.	O

Here	O
we	O
show	O
that	O
one	O
nudF	B
suppressor	I
also	O
suppresses	O
hs-	O
mutations	O
in	O
nudA	B
,	O
nudC	B
,	O
and	O
nudG	B
and	O
deletions	O
in	O
nudA	B
and	O
nudF.	B

Thus	O
,	O
the	O
potential	O
induction	O
of	O
this	O
gene	O
rearrangement	O
by	O
E1A	B
gene	I
therapy	O
is	O
unlikely	O
to	O
be	O
clinically	O
significant	O
in	O
the	O
treatment	O
of	O
advanced	O
malignant	O
disease	O
.	O

Our	O
results	O
suggest	O
that	O
Bry1	B
/	O
Skn7	B
can	O
influence	O
the	O
expression	O
of	O
MCB-	O
and	O
SCB	O
-	O
driven	O
gene	O
expression	O
in	O
budding	O
yeast	O
,	O
perhaps	O
including	O
genes	O
involved	O
in	O
cell	O
wall	O
metabolism	O
,	O
via	O
a	O
two	O
-	O
component	O
signal	O
transduction	O
pathway	O
which	O
activates	O
Bry1	B
/	O
Skn7	B
in	O
response	O
to	O
an	O
unidentified	O
signal	O
.	O

Buspirone	O
therapy	O
for	O
Type	O
A	O
behavior	O
,	O
hostility	O
,	O
and	O
perceived	O
stress	O
in	O
cardiac	O
patients	O
.	O

When	O
furA	B
alone	O
was	O
introduced	O
into	O
the	O
Delta	O
(	O
furA	B
-	O
katG	B
)	O
mutant	O
,	O
survival	O
in	O
mouse	O
lungs	O
was	O
moderately	O
increased	O
,	O
suggesting	O
that	O
FurA	B
could	O
regulate	O
genes	O
,	O
other	O
than	O
katG	B
,	O
that	O
are	O
involved	O
in	O
pathogenesis	O
.	O

The	O
resulting	O
threshold	O
elevation	O
curves	O
fell	O
into	O
a	O
small	O
number	O
of	O
distinct	O
groups	O
,	O
suggesting	O
the	O
existence	O
of	O
discrete	O
spatial	O
frequency	O
mechanisms	O
in	O
human	O
central	O
vision	O
.	O

Through	O
interactions	O
with	O
the	O
pre	O
-	O
mRNA	O
and	O
the	O
CTD	O
domain	O
of	O
the	O
Polymerase	B
II	I
,	O
SR	B
proteins	I
have	O
been	O
shown	O
to	O
regulate	O
alternative	O
splicing	O
.	O

Electrophoretic	O
mobility	O
shift	O
analysis	O
of	O
protein	O
-	O
DNA	O
complexes	O
formed	O
with	O
nuclear	O
proteins	O
isolated	O
from	O
I3C	O
-	O
treated	O
and	O
-untreated	O
cells	O
,	O
in	O
combination	O
with	O
supershift	O
assays	O
using	O
Sp1	B
antibodies	I
,	O
demonstrated	O
that	O
the	O
Sp1-binding	B
site	I
in	O
the	O
CDK6	B
promoter	I
forms	O
a	O
specific	O
I3C	O
-	O
responsive	O
DNA	O
-	O
protein	O
complex	O
that	O
contains	O
the	O
Sp1	B
transcription	I
factor	I
.	O

However	O
,	O
C	B
/	I
EBP	I
beta	I
stimulated	O
transcription	O
primarily	O
through	O
the	O
cAMP	O
-	O
responsive	O
element	O
(	O
CRE	O
)	O
,	O
which	O
maps	O
between	O
positions	O
-77	O
to	O
-94	O
,	O
but	O
not	O
at	O
the	O
more	O
5'-binding	O
sites	O
.	O

The	O
observed	O
alterations	O
in	O
lung	O
functions	O
in	O
these	O
subjects	O
indicate	O
that	O
individuals	O
performing	O
heavy	O
continuous	O
exercise	O
are	O
more	O
likely	O
to	O
be	O
affected	O
by	O
lower	O
O3	O
levels	O
.	O

A	O
personal	O
view	O
of	O
future	O
trends	O
in	O
the	O
field	O
of	O
immunoassay	O
concludes	O
this	O
review	O
.	O

Our	O
results	O
admit	O
that	O
a	O
ribosome	O
scanning	O
mechanism	O
of	O
the	O
MP	B
gene	I
expression	O
from	O
I	O
(	O
2	O
)	O
sgRNA	O
operates	O
concurrently	O
.	O

22.6	O
%	O
of	O
patients	O
were	O
found	O
to	O
be	O
positive	O
at	O
histology	O
in	O
the	O
corpus	O
mucosa	O
;	O
all	O
but	O
one	O
of	O
these	O
patients	O
had	O
elevated	O
circulating	O
IgG	B
to	O
H.	O
pylori	O
(	O
Group	O
C	O
)	O
.	O

Concerning	O
the	O
practical	O
approach	O
in	O
a	O
clinical	O
setting	O
,	O
it	O
has	O
to	O
be	O
pointed	O
out	O
that	O
with	O
these	O
diseases	O
a	O
hepatitis	O
C	O
infection	O
has	O
to	O
be	O
considered	O
and	O
testing	O
for	O
hepatitis	B
C	I
antibodies	I
and	O
,	O
if	O
positive	O
,	O
hepatitis	B
C	I
-	I
RNA	I
is	O
indicated	O
.	O

In	O
order	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
local	O
direct	O
action	O
of	O
danazol	O
upon	O
endometriosis	O
,	O
intravaginal	O
and	O
intrauterine	O
application	O
were	O
tried	O
.	O

80	O
bp	O
)	O
surrounding	O
the	O
site	O
of	O
transcription	O
initiation	O
.	O

BCR	B
-	O
ABL	B
elicits	O
transformation	O
of	O
both	O
fibroblast	O
and	O
hematopoietic	O
cells	O
and	O
blocks	O
apoptosis	O
following	O
cytokine	O
deprivation	O
in	O
various	O
factor	O
-	O
dependent	O
cells	O
.	O

The	O
transcriptional	B
transactivator	I
(	O
Tas	B
)	O
of	O
simian	O
foamy	O
virus	O
type	O
1	O
strongly	O
augments	O
gene	O
expression	O
directed	O
by	O
both	O
the	O
promoter	O
in	O
the	O
viral	O
long	O
terminal	O
repeat	O
and	O
the	O
newly	O
discovered	O
internal	O
promoter	O
located	O
within	O
the	O
env	B
gene	I
.	O

Analysis	O
of	O
nt	O
sequence	O
was	O
carried	O
out	O
on	O
three	O
out	O
of	O
the	O
more	O
than	O
15	O
of	O
these	O
regions	O
present	O
in	O
the	O
mouse	O
genome	O
.	O

Moreover	O
,	O
site	O
-	O
specific	O
integration	O
of	O
the	O
ITR	O
-	O
flanked	O
DNA	O
was	O
also	O
detected	O
by	O
PCR	O
amplification	O
of	O
the	O
ITR	B
-	I
aavs1	I
junction	I
in	O
transduced	O
human	O
fibroblasts	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
animals	O
carrying	O
a	O
snf	B
mutation	O
that	O
converts	O
SNF	B
from	O
a	O
bifunctional	O
protein	O
to	O
a	O
U1	B
snRNP	I
-	I
specific	I
protein	I
are	O
viable	O
.	O

For	O
this	O
interaction	O
,	O
the	O
C	O
-	O
terminal	O
part	O
of	O
Sp1	B
and	O
the	O
N	O
terminus	O
of	O
E2F1	B
,	O
a	O
domain	O
also	O
present	O
in	O
E2F2	B
and	O
E2F3	B
but	O
absent	O
in	O
E2F4	B
and	O
E2F5	B
,	O
were	O
essential	O
.	O

To	O
gain	O
additional	O
insights	O
into	O
this	O
novel	O
apoptotic	O
checkpoint	O
,	O
we	O
have	O
now	O
characterized	O
the	O
mouse	B
survivin	I
locus	I
.	O

Since	O
RIP140	B
generally	O
down	O
-	O
regulates	O
receptor	O
activity	O
in	O
mammalian	O
cells	O
and	O
specifically	O
down	O
-	O
regulates	O
coactivation	O
mediated	O
by	O
SRC-1	B
,	O
we	O
propose	O
a	O
model	O
in	O
which	O
RIP140	B
indirectly	O
regulates	O
nuclear	B
receptor	I
AF-2	I
activity	O
by	O
competition	O
for	O
coactivators	O
such	O
as	O
SRC-1	B
.	O

We	O
constructed	O
a	O
stable	O
,	O
doubly	O
transfected	O
cell	O
line	O
(	O
TIS-10	O
)	O
carrying	O
a	O
chromosomally	O
integrated	O
ptetO7-CMV	B
-	I
L	I
reporter	O
construct	O
and	O
expressing	O
the	O
TetR	B
-	O
KRAB	B
protein	O
.	O

Value	O
of	O
bone	O
scintigraphy	O
with	O
Tc99MDP	O
in	O
the	O
early	O
diagnosis	O
of	O
mobilization	O
of	O
the	O
total	O
hip	O
prosthesis	O

The	O
isolation	O
of	O
crt5	B
-	I
262	I
,	O
an	O
additional	O
cdc	B
allele	I
of	O
POL1	B
/	O
CDC17	B
,	O
suggests	O
for	O
the	O
first	O
time	O
that	O
directly	O
blocking	O
DNA	O
replication	O
can	O
provide	O
a	O
signal	O
to	O
induce	O
the	O
DNA	O
damage	O
response	O
.	O

crt2	B
mutants	I
show	O
a	O
defect	O
in	O
basal	O
level	O
expression	O
of	O
RNR1-lacZ	B
reporter	O
constructs	O
.	O

Mouse	B
GRK6-C	I
displays	O
none	O
of	O
these	O
motifs	O
.	O

CTDK1	B
and	O
CTDK2	B
also	O
differ	O
in	O
their	O
protein	O
substrate	O
specificity	O
.	O

Protease	O
digestion	O
and	O
alkaline	O
extraction	O
of	O
microsomes	O
containing	O
labeled	O
mutant	O
proteins	O
further	O
showed	O
that	O
segment	O
3	O
was	O
sufficient	O
for	O
stable	O
membrane	O
anchoring	O
of	O
the	O
glycoproteins	O
,	O
indicating	O
that	O
this	O
segment	O
may	O
specify	O
the	O
transmembrane	O
domain	O
of	O
the	O
gB	B
glycoprotein	I
.	O

87	O
,	O
7270	O
-	O
7274	O
)	O
.	O

These	O
properties	O
prompted	O
us	O
to	O
investigate	O
Ets-1	B
expression	O
in	O
32	O
human	O
astroglial	O
tumors	O
of	O
WHO	O
grades	O
I	O
-	O
IV	O
and	O
to	O
correlate	O
the	O
data	O
with	O
the	O
expression	O
pattern	O
of	O
VEGF	B
,	O
Flt-1	B
,	O
and	O
KDR	B
.	O

The	O
CydDC	B
system	I
appears	O
to	O
be	O
the	O
first	O
prokaryotic	O
example	O
of	O
a	O
heterodimeric	B
ABC	I
transport	I
system	I
in	O
which	O
each	O
polypeptide	O
contains	O
both	O
hydrophobic	O
and	O
ATP	O
-	O
binding	O
domains	O
.	O

Older	O
females	O
had	O
lumbar	O
(	O
0.6	O
+	O
/-	O

1.3	O
)	O
and	O
TB	O
(	O
1.1	O
+	O
/-	O

1.1	O
)	O
BMD	O
Z	O
scores	O
greater	O
than	O
0	O
(	O
both	O
,	O
p	O
<	O
0.001	O
)	O
.	O

Mutation	O
of	O
the	O
distal	O
E2F	B
binding	I
site	I
in	O
the	O
cdc25A	B
promoter	I
abolished	O
E2-induced	B
repression	O
,	O
whereas	O
mutation	O
of	O
the	O
proximal	O
E2F	B
site	I
or	O
the	O
E2	B
site	I
had	O
no	O
effect	O
.	O

Psychopathological	O
,	O
vegetative	O
,	O
and	O
vital	O
parameters	O
were	O
assessed	O
every	O
hour	O
.	O

The	O
mitochondrial	B
tyrosyl	I
-	I
tRNA	I
synthetase	I
of	O
Podospora	O
anserina	O
is	O
a	O
bifunctional	O
enzyme	O
active	O
in	O
protein	O
synthesis	O
and	O
RNA	O
splicing	O
.	O

We	O
found	O
that	O
the	O
central	O
nonconserved	O
region	O
of	O
the	O
large	O
subunit	O
is	O
not	O
essential	O
for	O
function	O
and	O
likely	O
acts	O
as	O
a	O
spacer	O
between	O
the	O
conserved	O
N-	O
and	O
C	O
-	O
terminal	O
regions	O
.	O

Surprisingly	O
,	O
apo	B
-	I
iso-1-cytochrome	I
c	I
is	O
absent	O
in	O
cyc3-	B
strains	O
,	O
although	O
apo	B
-	I
iso-2-cytochrome	I
c	I
is	O
present	O
at	O
approximately	O
the	O
same	O
level	O
at	O
which	O
holo	B
-	I
iso-2-cytochrome	I
c	I
is	O
found	O
in	O
CYC3	B
+	I
strains	O
.	O

An	O
exception	O
is	O
the	O
Bcl-6	B
gene	I
,	O
encoding	O
a	O
transcription	O
factor	O
,	O
which	O
was	O
found	O
to	O
be	O
mutated	O
in	O
normal	O
human	O
memory	O
B	O
cells	O
.	O

Serum	O
PRL	B
concentrations	O
significantly	O
increased	O
after	O
MCP	O
administration	O
in	O
normal	O
women	O
,	O
hyperprolactinemic	O
patients	O
with	O
normal	O
sella	O
and	O
patients	O
with	O
microadenoma	O
,	O
but	O
not	O
in	O
macroadenoma	O
patients	O
with	O
and	O
without	O
suprasellar	O
expansion	O
(	O
SSE	O
)	O
.	O

These	O
include	O
not	O
only	O
antioxidants	O
,	O
N	B
-	I
methyl	I
-	I
D	I
-	I
aspartate	I
receptor	I
antagonists	O
,	O
inhibitors	O
of	O
glutamate	O
release	O
,	O
calcium	O
channel	O
blockers	O
,	O
polyamine	O
antagonists	O
,	O
and	O
nitric	B
oxide	I
synthase	I
inhibitors	O
,	O
but	O
cannabinoids	O
,	O
aspirin	O
,	O
melatonin	O
,	O
and	O
vitamin	O
B-12	O
.	O

In	O
conclusion	O
,	O
ANH	O
had	O
no	O
negative	O
effects	O
on	O
the	O
endocrine	O
stress	O
response	O
during	O
orthopedic	O
surgery	O
under	O
epidural	O
anesthesia	O
.	O

Calculation	O
of	O
energy	O
levels	O
,	O
E1	O
transition	O
amplitudes	O
,	O
and	O
parity	O
violation	O
in	O
francium	O
.	O

Northern	O
blot	O
analysis	O
confirmed	O
that	O
ADAMTS-1	B
was	O
up	O
-	O
regulated	O
in	O
both	O
metaphyseal	O
(	O
14-	O
to	O
35-fold	O
)	O
and	O
diaphyseal	O
(	O
4.2-fold	O
)	O
bone	O
1	O
h	O
after	O
PTH-	B
(	I
1	I
-	I
38	I
)	I
injection	O
and	O
returned	O
to	O
control	O
levels	O
by	O
24	O
h.	O

The	O
findings	O
in	O
the	O
human	O
multiple	O
myeloma	O
cell	O
lines	O
represent	O
the	O
first	O
examples	O
of	O
B	O
cells	O
with	O
downregulated	O
PU.1	B
expression	O
and	O
apparently	O
contradict	O
observations	O
in	O
the	O
murine	O
system	O
in	O
which	O
PU.1	B
is	O
expressed	O
and	O
active	O
in	O
plasmacytoma	O
cell	O
lines	O
.	O

The	O
STP1	B
locus	I
is	O
located	O
on	O
chromosome	O
IV	O
close	O
to	O
at	O
least	O
two	O
other	O
genes	O
involved	O
in	O
RNA	O
splicing	O
:	O
PRP3	B
and	O
SPP41	B
.	O

The	O
presence	O
of	O
highly	O
correlated	O
frequencies	O
provided	O
strong	O
evidence	O
of	O
a	O
medium	O
-	O
frequency	O
pattern	O
generator	O
which	O
may	O
remain	O
operative	O
beyond	O
the	O
neonatal	O
period	O
.	O

Pancreatic	O
expression	O
of	O
the	O
glucagon	B
gene	I
depends	O
on	O
multiple	O
transcription	O
factors	O
interacting	O
with	O
at	O
least	O
three	O
DNA	O
control	O
elements	O
:	O
G1	O
,	O
the	O
upstream	O
promoter	O
element	O
,	O
and	O
G2	O
and	O
G3	O
,	O
two	O
enhancer	O
-	O
like	O
sequences	O
.	O

Before	O
and	O
6	O
and	O
12	O
months	O
after	O
H.	O
pylori	O
eradication	O
the	O
patients	O
were	O
evaluated	O
for	O
fasting	O
gastrinemia	O
and	O
pepsinogen	B
I	I
,	O
basal	O
and	O
peak	O
acid	O
output	O
,	O
and	O
detailed	O
histological	O
assessment	O
including	O
the	O
ECL	O
cell	O
proliferative	O
patterns	O
.	O

Thus	O
,	O
CARP	B
is	O
a	O
YB-1	B
associated	I
factor	I
and	O
represents	O
the	O
first	O
identified	O
cardiac	O
-	O
restricted	O
downstream	O
regulatory	O
gene	O
in	O
the	O
homeobox	O
gene	O
Nkx2	B
-	I
5	I
pathway	O
and	O
may	O
serve	O
as	O
a	O
negative	O
regulator	O
of	O
HF-1-dependent	B
pathways	O
for	O
ventricular	O
muscle	O
gene	O
expression	O
.	O

Structure	O
and	O
chromosomal	O
localization	O
of	O
the	O
human	O
gene	O
of	O
the	O
phosphotyrosyl	B
phosphatase	I
activator	I
(	O
PTPA	B
)	O
of	O
protein	B
phosphatase	I
2A	I
.	O

This	O
article	O
expands	O
the	O
analysis	O
of	O
a	O
numeric	O
example	O
included	O
in	O
the	O
SAS	O
GLM	O
procedure	O
to	O
cover	O
several	O
crucial	O
statistical	O
aspects	O
relevant	O
to	O
ANCOVA	O
,	O
and	O
to	O
highlight	O
the	O
meaning	O
of	O
the	O
statistical	O
results	O
obtained	O
.	O

The	O
PEP4	B
gene	I
was	O
isolated	O
from	O
a	O
genomic	O
DNA	O
library	O
by	O
complementation	O
of	O
the	O
pep4	B
-	I
3	I
mutation	O
.	O

These	O
results	O
suggest	O
that	O
panretinal	O
photocoagulation	O
offers	O
a	O
highly	O
effective	O
means	O
of	O
dealing	O
with	O
early	O
and	O
moderately	O
advanced	O
cases	O
of	O
angle	O
neovascularization	O
.	O

Bilateral	O
renal	O
oncocytoma	O
in	O
a	O
Greyhound	O
dog	O
.	O

The	O
E.	O
multilocularis	O
/	O
Mongolian	O
gerbil	O
system	O
can	O
replace	O
the	O
natural	O
canid	O
hosts	O
as	O
a	O
new	O
way	O
to	O
obtain	O
infective	O
eggs	O
and	O
to	O
analyze	O
host	O
-	O
parasite	O
interactions	O
.	O

The	O
Fugu	O
rubripes	O
(	O
Fugu	O
)	O
gene	O
fragment	O
was	O
used	O
to	O
isolate	O
the	O
GH	B
gene	I
from	O
a	O
Fugu	O
genomic	O
library	O
.	O

For	O
the	O
first	O
time	O
also	O
a	O
genomic	O
sequence	O
for	O
a	O
red	B
algal	I
lhc	I
gene	I
is	O
presented	O
.	O

Comparison	O
with	O
the	O
data	O
of	O
clinical	O
development	O
and	O
hemodynamic	O
results	O

Despite	O
a	O
lowering	O
of	O
her	O
plasma	O
ACTH	B
concentration	O
during	O
therapy	O
with	O
valproic	O
acid	O
,	O
the	O
patient	O
's	O
tumour	O
showed	O
no	O
evidence	O
of	O
regression	O
while	O
she	O
was	O
taking	O
the	O
drug	O
.	O

2	O
.	O

The	O
D443N	B
substitution	I
is	O
an	O
activating	O
mutation	O
that	O
increases	O
the	O
activity	O
of	O
SCAP	B
and	O
renders	O
it	O
resistant	O
to	O
inhibition	O
by	O
25-hydroxycholesterol	O
.	O

Transcriptional	O
modulation	O
of	O
the	O
anti	B
-	I
apoptotic	I
protein	I
BCL	I
-	I
XL	I
by	O
the	O
paired	B
box	I
transcription	I
factors	I
PAX3	B
and	O
PAX3	B
/	O
FKHR	B
.	O

In	O
this	O
case	O
myogenic	O
factors	O
are	O
not	O
initially	O
expressed	O
and	O
these	O
migratory	O
cells	O
are	O
characterized	O
by	O
the	O
expression	O
of	O
the	O
paired	B
-	O
box	O
gene	O
Pax3	B
.	O

The	O
fecal	O
excretion	O
is	O
found	O
to	O
be	O
only	O
one	O
third	O
of	O
that	O
measured	O
in	O
urine	O
.	O

Forty	O
-	O
five	O
per	O
cent	O
of	O
the	O
dose	O
was	O
excreted	O
as	O
methyldopa	O
as	O
opposed	O
to	O
18	O
%	O
normally	O
seen	O
after	O
oral	O
methyldopa	O
dosages	O
.	O

Standing	O
values	O
:	O
placebo	O
114	O
/	O
79	O
;	O
BHT-933	O
92	O
/	O
67	O
.	O

In	O
cases	O
in	O
which	O
it	O
was	O
identified	O
,	O
insulitis	O
affected	O
23	O
%	O
of	O
islets	O
containing	O
insulin	B
,	O
but	O
affected	O
only	O
1	O
%	O
of	O
islets	O
which	O
were	O
insulin	B
deficient	O
,	O
thus	O
supporting	O
the	O
concept	O
that	O
insulitis	O
represents	O
an	O
immunologically	O
mediated	O
destruction	O
of	O
insulin	B
secreting	O
B	O
cells	O
.	O

Proteins	O
PBP-1	B
and	O
PBP-2	B
bind	O
to	O
two	O
of	O
the	O
three	O
promoter	O
elements	O
in	O
the	O
trypanosomatid	O
Leptomonas	O
seymouri	O
.	O

The	O
vicinity	O
of	O
large	O
industrial	O
emissions	O
of	O
lead	O
,	O
where	O
mean	O
Pb	O
-	O
B	O
concentrations	O
were	O
usually	O
twice	O
as	O
high	O
as	O
in	O
rural	O
areas	O
of	O
the	O
Katowice	O
voivodship	O
.	O

Thus	O
,	O
BCR	B
ligation	O
initiates	O
a	O
PI	B
3-kinase	I
/	O
Akt	B
/	O
GSK-3	B
signaling	O
pathway	O
.	O

Effect	O
of	O
a	O
new	O
positive	O
inotropic	O
agent	O
(	O
OPC-8212	O
)	O
on	O
intracellular	O
potential	O
of	O
isolated	O
canine	O
ventricular	O
papillary	O
muscle	O

At	O
the	O
same	O
acoustic	O
power	O
,	O
the	O
rate	O
of	O
chloride	O
formation	O
with	O
20	O
kHz	O
ultrasound	O
was	O
greater	O
when	O
a	O
probe	O
with	O
a	O
larger	O
tip	O
area	O
was	O
used	O
,	O
but	O
significantly	O
less	O
than	O
the	O
rate	O
with	O
900	O
kHz	O
.	O

This	O
is	O
the	O
first	O
report	O
demonstrating	O
specificity	O
at	O
the	O
level	O
of	O
the	O
energy	O
coupling	O
proteins	O
of	O
the	O
PTS	O
.	O

As	O
expected	O
,	O
the	O
QOLS	O
-	O
N	O
had	O
a	O
lower	O
correlation	O
with	O
physical	O
health	O
(	O
r	O
=	O
0.24	O
,	O
p	O
<	O
0.000	O
)	O
and	O
self	O
-	O
reported	O
symptoms	O
(	O
r	O
=	O
-0.20	O
,	O
p	O
<	O
0.001	O
)	O
,	O
and	O
a	O
higher	O
correlation	O
with	O
mental	O
health	O
(	O
r	O
=	O
0.52	O
,	O
p	O
<	O
0.000	O
)	O
.	O

Like	O
pimethixene	O
and	O
cyproheptadine	O
,	O
WA	O
335	O
has	O
no	O
distinct	O
antagonistic	O
qualities	O
against	O
bradykinin	B
.	O

Additional	O
simulations	O
account	O
for	O
interactions	O
of	O
spatial	O
frequency	O
with	O
stimulus	O
duration	O
,	O
effects	O
of	O
adaptation	O
,	O
and	O
properties	O
of	O
residual	O
traces	O
,	O
as	O
opposed	O
to	O
visual	O
persistence	O
.	O

A	O
DNA	O
fragment	O
that	O
complements	O
the	O
uvs-2	B
mutation	O
was	O
subcloned	O
by	O
monitoring	O
its	O
ability	O
to	O
transform	O
the	O
uvs-2	B
mutant	I
to	O
MMS	O
resistance	O
.	O

Back	O
-	O
ground	O
factors	O
which	O
affect	O
the	O
outcome	O
of	O
steroid	O
withdrawal	O
therapy	O
in	O
patients	O
with	O
chronic	O
type	O
B	O
hepatitis	O
--	O
statistical	O
evaluation	O
of	O
the	O
importance	O
of	O
the	O
mode	O
of	O
HBV	O
transmission	O

Effect	O
of	O
food	O
on	O
hemodynamics	O
.	O

PTP1-lacZ	B
studies	O
indicate	O
that	O
PTP1	B
is	O
spatially	O
localized	O
to	O
prestalk	O
and	O
anterior	O
-	O
like	O
cell	O
types	O
.	O

Morphologic	O
evidence	O
that	O
rhe	O
renal	O
calyx	O
and	O
pelvis	O
control	O
ureteric	O
activity	O
in	O
the	O
rabbit	O
.	O

Human	B
alcohol	I
dehydrogenase	I
(	O
ADH	B
)	O
exists	O
as	O
a	O
heterogeneous	O
group	O
of	O
isozymes	O
capable	O
of	O
oxidizing	O
a	O
wide	O
variety	O
of	O
aliphatic	O
and	O
aromatic	O
alcohols	O
.	O

We	O
reviewed	O
81	O
patients	O
with	O
dementia	O
and	O
autopsy	O
findings	O
of	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
to	O
identify	O
patients	O
with	O
seizures	O
or	O
myoclonus	O
after	O
onset	O
of	O
dementia	O
.	O

The	O
second	O
system	O
(	O
VacFix	O
)	O
uses	O
a	O
0.15	O
mm	O
thick	O
plastic	O
bag	O
loosely	O
filled	O
with	O
1	O
mm	O
polysterol	O
spheres	O
.	O

Expression	O
in	O
all	O
lines	O
was	O
decreased	O
by	O
the	O
inclusion	O
of	O
regions	O
further	O
upstream	O
,	O
and	O
extinguished	O
by	O
the	O
inclusion	O
of	O
the	O
first	O
intron	O
.	O

U.	O

A	O
Laboratory	O
Manual	O
,	O
2nd	O
ed	O
.	O

A	O
protein	O
which	O
promotes	O
DNA	O
strand	O
transfer	O
between	O
linear	O
double	O
-	O
stranded	O
M13mp19	O
DNA	O
and	O
single	O
-	O
stranded	O
viral	O
M13mp19	O
DNA	O
has	O
been	O
isolated	O
from	O
recA-	B
E.coli	O
.	O

We	O
speculate	O
that	O
the	O
enhancing	O
effect	O
of	O
glucose	O
and	O
galactose	O
on	O
fructose	O
absorption	O
may	O
be	O
due	O
to	O
activation	O
of	O
the	O
fructose	B
carrier	I
.	O

The	O
nutraceuticals	O
of	O
specific	O
vitamins	O
,	O
minerals	O
,	O
phytoestrogens	O
,	O
and	O
essential	O
fatty	O
acid	O
supplementations	O
are	O
a	O
vital	O
component	O
of	O
the	O
risk	O
reduction	O
health	O
program	O
.	O

An	O
scrR	B
promoter	I
fragment	I
,	O
which	O
dose	O
not	O
contain	O
a	O
sequence	O
resembling	O
OB	B
,	O
was	O
not	O
shifted	O
by	O
the	O
fusion	O
protein	O
.	O

We	O
screened	O
an	O
A.	O
thaliana	O
cDNA	O
library	O
,	O
whose	O
inserts	O
are	O
under	O
the	O
control	O
of	O
the	O
galactose	O
-	O
inducible	O
GAL10	B
promoter	I
,	O
for	O
cDNAs	O
which	O
enabled	O
YDH8	O
cells	O
to	O
grow	O
at	O
the	O
restrictive	O
temperature	O
.	O

Therefore	O
,	O
we	O
have	O
reevaluated	O
the	O
age	O
-	O
related	O
changes	O
in	O
serum	B
leptin	I
levels	O
and	O
their	O
relationship	O
with	O
adiposity	O
and	O
androgen	O
levels	O
in	O
a	O
large	O
group	O
of	O
community	O
dwelling	O
men	O
.	O

While	O
reviewing	O
gastric	O
specimens	O
from	O
215	O
baboons	O
,	O
we	O
found	O
diffuse	O
giant	O
mucosal	O
folds	O
in	O
2	O
specimens	O
and	O
multiple	O
giant	O
mucosal	O
nodules	O
in	O
another	O
3	O
.	O

Morphologically	O
,	O
corrugation	O
of	O
the	O
internal	O
elastic	O
lamina	O
of	O
vessels	O
was	O
often	O
observed	O
in	O
the	O
vehicle	O
-	O
treated	O
group	O
,	O
but	O
was	O
not	O
prominent	O
in	O
the	O
GLNVA	O
-	O
treated	O
groups	O
or	O
healthy	O
controls	O
.	O

Transcripts	O
initiating	O
at	O
the	O
CAGT	O
motif	O
(	O
proximal	O
transcripts	O
)	O
were	O
abolished	O
by	O
deletion	O
of	O
the	O
proximal	O
TATA	O
box	O
located	O
at	O
-29	O
relative	O
to	O
CAGT	O
.	O

We	O
conclude	O
that	O
the	O
MMF	O
lesion	O
is	O
secondary	O
to	O
intramuscular	O
injection	O
of	O
aluminium	O
hydroxide	O
-	O
containing	O
vaccines	O
,	O
shows	O
both	O
long	O
-	O
term	O
persistence	O
of	O
aluminium	O
hydroxide	O
and	O
an	O
ongoing	O
local	O
immune	O
reaction	O
,	O
and	O
is	O
detected	O
in	O
patients	O
with	O
systemic	O
symptoms	O
which	O
appeared	O
subsequently	O
to	O
vaccination	O
.	O

Advisory	O
Committee	O
report	O
recommends	O
that	O
US	O
make	O
amends	O
for	O
human	O
radiation	O
experiments	O
.	O

An	O
evaluation	O
of	O
a	O
positive	O
control	O
for	O
platelet	O
neutralization	O
procedure	O
testing	O
with	O
seven	O
commercial	O
activated	O
partial	O
thromboplastin	B
time	O
reagents	O
.	O

Transmission	O
of	O
mutans	O
streptococci	O
to	O
infants	O
following	O
short	O
term	O
application	O
of	O
an	O
iodine	O
-	O
NaF	O
solution	O
to	O
mothers	O
'	O
dentition	O
.	O

Glycoprotein	O
biosynthesis	O
in	O
Saccharomyces	O
cerevisiae	O
:	O
ngd29	B
,	O
an	O
N	O
-	O
glycosylation	O
mutant	O
allelic	O
to	O
och1	B
having	O
a	O
defect	O
in	O
the	O
initiation	O
of	O
outer	O
chain	O
formation	O
.	O

The	O
effects	O
of	O
erythrosine	O
(	O
Red	O
3	O
)	O
,	O
rose	O
bengal	O
B	O
(	O
Red	O
105	O
)	O
and	O
thyroidectomy	O
on	O
the	O
development	O
of	O
thyroid	O
tumor	O
were	O
examined	O
in	O
male	O
Wistar	O
rats	O
treated	O
with	O
N	O
-	O
bis	O
(	O
2-hydroxypropyl	O
)	O
nitrosamine	O
(	O
DHPN	O
)	O
.	O

The	O
region	O
surrounding	O
the	O
ZNF35	B
zinc	I
finger	I
protein	I
gene	I
on	O
3p21	O
is	O
of	O
particular	O
interest	O
,	O
as	O
this	O
region	O
of	O
chromosome	O
3	O
is	O
frequently	O
involved	O
in	O
rearrangements	O
and/or	O
deletions	O
associated	O
with	O
various	O
human	O
tumors	O
including	O
lung	O
and	O
renal	O
carcinoma	O
.	O

In	O
contrast	O
,	O
no	O
change	O
in	O
the	O
level	O
of	O
either	O
p53	B
or	O
activation	O
of	O
mdm2	B
protein	I
by	O
p53	B
was	O
observed	O
in	O
hamster	O
UV61	O
cells	O
after	O
UV	O
exposure	O
.	O

Complete	O
activation	O
of	O
signal	B
transducer	I
and	I
activator	I
of	I
transcription	I
1	I
(	O
STAT1	B
)	O
requires	O
phosphorylation	O
at	O
both	O
Y701	O
and	O
a	O
conserved	O
PMS	O
(	O
727	O
)	O
P	O
sequence	O
.	O

On	O
the	O
basis	O
of	O
experiments	O
with	O
mutant	O
virus	O
and	O
transfection	O
with	O
isolated	O
genes	O
,	O
the	O
herpes	B
simplex	I
virus	I
immediate	I
-	I
early	I
gene	I
product	O
ICP4	B
is	O
known	O
to	O
positively	O
regulate	O
the	O
transcription	O
of	O
viral	B
early	I
and	I
late	I
genes	I
and	O
negatively	O
regulate	O
expression	O
from	O
its	O
own	O
promoter	O
.	O

Alcohol	O
abuse	O
and	O
treatment	O
resistance	O
in	O
skin	O
disease	O
.	O

The	O
first	O
270	O
bp	O
of	O
the	O
promoter	O
region	O
were	O
sequenced	O
and	O
found	O
to	O
contain	O
a	O
CATAA	O
box	O
rather	O
than	O
a	O
TATAA	O
box	O
and	O
several	O
DNA	O
motifs	O
found	O
in	O
activation	O
genes	O
.	O

The	O
reduced	O
expression	O
caused	O
by	O
multimerization	O
of	O
UAS2	O
in	O
the	O
native	O
promoter	O
was	O
observed	O
only	O
in	O
the	O
presence	O
of	O
ADR1	B
.	O

One	O
child	O
,	O
recently	O
fed	O
,	O
vomited	O
a	O
small	O
amount	O
of	O
breast	O
milk	O
after	O
a	O
short	O
period	O
of	O
crying	O
and	O
apparently	O
had	O
a	O
laryngospasm	O
,	O
shown	O
by	O
a	O
sudden	O
drop	O
in	O
the	O
PtcO2	O
level	O
without	O
any	O
other	O
signs	O
of	O
discomfort	O
.	O

The	O
central	O
venous	O
O2	O
saturation	O
test	O
in	O
acute	O
pulmonary	O
fat	O
embolism	O
.	O

Sequence	O
comparisons	O
reveal	O
that	O
the	O
P.	B
woesei	I
GTP	I
-	I
binding	I
protein	I
is	O
strikingly	O
related	O
in	O
sequence	O
to	O
eubacterial	B
FtsZ	I
and	O
is	O
marginally	O
more	O
similar	O
to	O
eukaryotic	B
tubulins	I
than	O
are	O
bacterial	B
FtsZ	I
proteins	I
.	O

Cross	O
-	O
talk	O
between	O
transcription	O
factors	O
NF	B
-	I
kappa	I
B	I
and	O
C	B
/	I
EBP	I
in	O
the	O
transcriptional	O
regulation	O
of	O
genes	O
.	O

FDP-1	O
(	O
200	O
micrograms.kg-1	O
)	O
of	O
intracoronary	O
injection	O
increased	O
collateral	O
flow	O
,	O
reduced	O
systemic	O
artery	O
resistance	O
,	O
and	O
coronary	O
systolic	O
pressure	O
in	O
infarcted	O
region	O
and	O
the	O
area	O
of	O
infarction	O
decreased	O
from	O
28.9	O
+	O
/-	O

1.3	O
%	O
to	O
15.3	O
+	O
/-	O

1.2	O
%	O
(	O
P	O
<	O
0.01	O
,	O
n	O
=	O
6	O
)	O
.	O

Heterologous	O
hybridization	O
with	O
a	O
rps12	B
gene	I
specific	O
probe	O
from	O
Euglena	O
has	O
revealed	O
the	O
presence	O
of	O
rps12	B
homologous	I
sequences	I
within	O
the	O
inverted	O
repeat	O
of	O
Spirodela	O
chloroplast	O
DNA	O
on	O
the	O
fragment	B
BamHI	I
-	I
V.	I

In	O
6	O
patients	O
(	O
9	O
kidneys	O
)	O
irrigation	O
with	O
Solution	O
G	O
in	O
the	O
renal	O
pelvis	O
was	O
performed	O
for	O
the	O
dissolution	O
of	O
their	O
infectious	O
stones	O
.	O

Derepression	O
of	O
RAR	B
signaling	O
by	O
expressing	O
a	O
dominant	O
-	O
negative	O
corepressor	O
resulted	O
in	O
embryos	O
that	O
exhibited	O
phenotypes	O
similar	O
to	O
those	O
treated	O
by	O
RA	O
.	O

Within	O
the	O
final	O
11	O
amino	O
acids	O
there	O
are	O
5	O
aromatic	O
,	O
2	O
basic	O
,	O
and	O
no	O
acidic	O
residues	O
and	O
it	O
has	O
been	O
proposed	O
that	O
these	O
residues	O
stack	O
with	O
and	O
electrostatically	O
interact	O
with	O
the	O
kinked	O
DNA	O
at	O
the	O
site	O
of	O
a	O
pyrimidine	O
dimer	O
.	O

Molecular	O
cloning	O
of	O
cDNAs	O
encoding	O
alpha	O
-	O
subunits	O
of	O
guanine	B
nucleotide	I
-	I
binding	I
regulatory	I
proteins	I
(	O
G	B
-	I
proteins	I
)	O
has	O
revealed	O
the	O
existence	O
of	O
nine	O
species	O
of	O
alpha	O
-	O
subunits	O
.	O

In	O
all	O
cases	O
,	O
a	O
large	O
fraction	O
of	O
soluble	O
Al	O
became	O
insoluble	O
in	O
the	O
stomach	O
after	O
ingestion	O
.	O

The	O
prominent	O
fracture	O
of	O
women	O
older	O
than	O
75	O
years	O
is	O
the	O
hip	O
fracture	O
(	O
type	O
II	O
osteoporosis	O
)	O
.	O

Under	O
anaerobic	O
conditions	O
(	O
a	O
50-day	O
experiment	O
)	O
these	O
organisms	O
degraded	O
15	O
-	O
18	O
%	O
of	O
the	O
TEM	O
,	O
20	O
-	O
25	O
%	O
of	O
some	O
alkanes	O
,	O
and	O
15	O
-	O
18	O
%	O
of	O
selected	O
polycyclic	O
aromatic	O
hydrocarbons	O
.	O

They	O
cause	O
temporary	O
disability	O
,	O
invalidity	O
and	O
mortality	O
of	O
a	O
great	O
part	O
of	O
the	O
productive	O
population	O
,	O
significantly	O
damaging	O
the	O
economic	O
status	O
of	O
the	O
country	O
.	O

In	O
addition	O
,	O
wild	O
-	O
type	O
and	O
mutated	O
DNA	O
templates	O
were	O
used	O
as	O
probes	O
in	O
DNase	B
I	I
protection	O
experiments	O
to	O
determine	O
sites	O
of	O
protein	O
-	O
DNA	O
interaction	O
.	O

CONCLUSIONS	O
--	O
Postlumbar	O
puncture	O
headache	O
may	O
be	O
mediated	O
by	O
the	O
release	O
of	O
substance	B
P	I
triggered	O
by	O
lumbar	O
puncture	O
,	O
in	O
patients	O
predisposed	O
to	O
headache	O
by	O
a	O
hypersensitivity	O
to	O
substance	B
P.	I

They	O
are	O
found	O
to	O
have	O
several	O
advantages	O
over	O
the	O
conventional	O
indices	O
of	O
skewness	O
and	O
kurtosis	O
(	O
square	O
root	O
of	O
b1	O
and	O
b2	O
)	O
and	O
no	O
serious	O
drawbacks	O
.	O

Second	O
,	O
CGGA	O
-	O
containing	O
sequences	O
placed	O
at	O
-88	O
in	O
the	O
delta	B
MTV	I
-	I
CAT	I
reporter	I
plasmid	O
conferred	O
insulin	B
responsiveness	O
to	O
the	O
mammary	B
tumor	I
virus	I
promoter	I
.	O

Hemorrheological	O
evaluation	O
and	O
proposed	O
pharmacological	O
uses	O
.	O

Stimulation	O
of	O
the	O
endosteal	O
bone	O
formation	O
rate	O
was	O
mainly	O
impaired	O
in	O
D	O
-	O
depleted	O
rats	O
,	O
resulting	O
in	O
trabecular	O
bone	O
loss	O
,	O
which	O
,	O
in	O
-D	O
mother	O
rats	O
,	O
was	O
associated	O
with	O
decreased	O
bone	O
ash	O
and	O
total	O
bone	O
calcium	O
.	O

Biochemical	O
status	O
was	O
examined	O
using	O
erythrocyte	O
enzyme	O
function	O
and	O
blood	O
vitamin	O
levels	O
.	O

The	O
proliferative	O
potential	O
of	O
the	O
pilocytic	O
astrocytoma	O
:	O
the	O
relation	O
between	O
MIB-1	B
labeling	O
and	O
clinical	O
and	O
neuro	O
-	O
radiological	O
follow	O
-	O
up	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
determine	O
whether	O
exercise	O
training	O
can	O
augment	O
left	O
ventricular	O
diastolic	O
filling	O
at	O
rest	O
and	O
during	O
exercise	O
in	O
patients	O
with	O
ischemic	O
cardiomyopathy	O
and	O
whether	O
any	O
correlation	O
exists	O
between	O
changes	O
in	O
diastolic	O
filling	O
and	O
changes	O
in	O
exercise	O
tolerance	O
.	O

There	O
is	O
an	O
overall	O
functional	O
similarity	O
between	O
IL-6	B
and	O
c	B
-	I
fos	I
promoters	I
,	O
since	O
transfection	O
of	O
excess	O
amounts	O
of	O
either	O
promoter	O
DNA	O
into	O
intact	O
HeLa	O
cells	O
modulates	O
the	O
function	O
of	O
the	O
heterologous	O
promoter	O
construct	O
.	O

Detailed	O
comparison	O
of	O
the	O
sequences	O
of	O
cp35	B
and	O
human	B
calpactin	I
II	I
shows	O
that	O
the	O
only	O
substantial	O
sequence	O
dissimilarity	O
is	O
a	O
domain	O
encoding	O
amino	O
acids	O
between	O
residues	O
20	O
and	O
40	O
which	O
includes	O
a	O
tyrosine	O
phosphorylation	O
site	O
in	O
the	O
human	O
molecule	O
,	O
along	O
with	O
other	O
residues	O
of	O
possible	O
physiological	O
significance	O
.	O

Power	O
deposition	O
by	O
inverse	O
-	O
bremsstrahlung	O
is	O
modeled	O
with	O
a	O
scheme	O
based	O
on	O
Gaussian	O
quadrature	O
to	O
accommodate	O
a	O
deposition	O
rate	O
whose	O
spatial	O
variation	O
is	O
highly	O
nonuniform	O
.	O

However	O
,	O
the	O
malaria	O
vectors	O
Anopheles	O
funestus	O
and	O
An	O
.	O

gambiae	O
have	O
both	O
become	O
more	O
abundant	O
during	O
the	O
1970s	O
and	O
1980s	O
and	O
sporozoite	O
-	O
positive	O
specimens	O
of	O
both	O
have	O
been	O
found	O
.	O

Expression	O
of	O
Msx-1	B
and	O
Msx-2	B
has	O
been	O
studied	O
during	O
development	O
of	O
the	O
osteoblast	O
phenotype	O
,	O
but	O
the	O
role	O
of	O
Dlx	B
in	O
this	O
context	O
and	O
in	O
the	O
regulation	O
of	O
bone	O
-	O
expressed	O
genes	O
is	O
unknown	O
.	O

The	O
salt	O
sensitivity	O
of	O
the	O
interaction	O
indicated	O
that	O
two	O
ion	O
pairs	O
are	O
involved	O
in	O
the	O
association	O
of	O
Zn2	O
+	O
(	O
NC	O
-	O
F1	O
)	O
with	O
polynucleotide	O
,	O
whereas	O
one	O
ion	O
pair	O
is	O
found	O
in	O
the	O
metal	O
-	O
free	O
peptide	O
-	O
nucleic	O
acid	O
complex	O
.	O

The	O
overall	O
rate	O
of	O
biohydrogenation	O
of	O
C18:2	O
was	O
14.3%	O
/	O
h	O
,	O
but	O
declined	O
1.2%	O
/	O
h	O
for	O
each	O
percentage	O
unit	O
increase	O
in	O
C18:2	O
added	O
to	O
the	O
substrate	O
.	O

Transient	O
thyrotoxicosis	O
in	O
primary	O
anti	O
-	O
phospholipid	O
syndrome	O
.	O

The	O
highest	O
TTX	B
content	O
is	O
10.0	O
microg	O
/	O
g	O
in	O
N.	O
livescens	O
.	O

The	O
BUR	O
was	O
set	O
at	O
20	O
/	O
min	O
and	O
the	O
IT	O
at	O
.5	O
seconds	O
.	O

In	O
this	O
study	O
,	O
to	O
elucidate	O
the	O
possible	O
mechanism	O
of	O
action	O
of	O
EM	O
,	O
we	O
examined	O
the	O
effect	O
of	O
the	O
drug	O
on	O
the	O
expression	O
of	O
neutrophil	O
adhesion	O
molecules	O
such	O
as	O
L	B
-	I
selectin	I
and	O
Mac-1	B
.	O

It	O
contains	O
31	O
exons	O
and	O
a	O
high	O
proportion	O
of	O
class	O
0	O
introns	O
,	O
alternative	O
splicing	O
of	O
which	O
results	O
in	O
significant	O
levels	O
of	O
variant	O
transcripts	O
that	O
maintain	O
the	O
original	O
open	O
reading	O
frame	O
of	O
MRP	B
mRNA	I
.	O

This	O
nuclear	O
/	O
organellar	O
gene	O
transfer	O
event	O
is	O
strikingly	O
similar	O
to	O
the	O
experimentally	O
accessible	O
process	O
of	O
nuclear	O
integration	O
of	O
introduced	O
heterologous	O
DNA	O
.	O

Under	O
control	O
conditions	O
,	O
pretreatment	O
with	O
lithium	O
during	O
7	O
days	O
did	O
not	O
modify	O
the	O
hyperlocomotion	O
produced	O
by	O
d	O
-	O
amphetamine	O
.	O

This	O
article	O
describes	O
a	O
program	O
that	O
resulted	O
in	O
a	O
75-percent	O
reduction	O
of	O
inventory	O
over	O
a	O
five	O
-	O
year	O
interval	O
.	O

Risk	O
ratios	O
decreased	O
with	O
increasing	O
age	O
and	O
increased	O
with	O
number	O
of	O
breast	O
biopsies	O
,	O
family	O
history	O
of	O
breast	O
cancer	O
,	O
estrogen	O
use	O
,	O
time	O
between	O
screenings	O
,	O
no	O
comparison	O
with	O
previous	O
mammograms	O
,	O
and	O
the	O
radiologist	O
's	O
tendency	O
to	O
call	O
mammograms	O
abnormal	O
.	O

However	O
,	O
the	O
relative	O
substrate	O
specificity	O
of	O
RSK3	B
differed	O
from	O
that	O
reported	O
for	O
other	O
isoforms	O
.	O

Fosinopril	O
decreased	O
blood	O
pressure	O
from	O
174	O
/	O
101	O
mm	O
Hg	O
to	O
149	O
/	O
88	O
mm	O
Hg	O
in	O
patients	O
with	O
diastolic	O
hypertension	O
and	O
from	O
182	O
/	O
86	O
mm	O
Hg	O
to	O
151	O
/	O
80	O
mm	O
Hg	O
in	O
patients	O
with	O
ISH	O
.	O

Loss	O
of	O
pRb	B
or	O
p107	B
binding	O
results	O
in	O
the	O
loss	O
of	O
transforming	O
activity	O
.	O

Influence	O
of	O
huanglian	O
used	O
in	O
combination	O
with	O
huangqin	O
and	O
gancao	O
on	O
the	O
erythrocytic	O
osmotic	O
fragilitas	O
of	O
experimental	O
glucose-6-phosphate	B
dehydrogenase	I
deficiency	O
in	O
rats	O
]	O
OBJECTIVE	O
:	O
To	O
study	O
the	O
influence	O
of	O
common	O
combination	O
of	O
Huanglian	O
(	O
Coptis	O
chinensis	O
)	O
on	O
the	O
erythrocytic	O
osmotic	O
fragilitas	O
of	O
glucose-6-phosphate	B
dehydrogenase	I
(	O
G6PD	B
)	O
deficiency	O
in	O
rats	O
.	O

Comparison	O
of	O
Healon	O
and	O
Amvisc	O
.	O

2,4-	O
and	O
2,6-toluenediamine	O
in	O
hydrolysed	O
plasma	O
and	O
urine	O
after	O
test	O
-	O
chamber	O
exposure	O
of	O
humans	O
to	O
2,4-	O
and	O
2,6-toluene	O
diisocyanate	O
.	O

Interaction	O
between	O
the	O
tobacco	O
DNA	O
-	O
binding	O
activity	O
CBF	B
and	O
the	O
cyt-1	B
promoter	I
element	I
of	O
the	O
Agrobacterium	O
tumefaciens	O
T	O
-	O
DNA	O
gene	O
T	B
-	I
CYT	I
correlates	O
with	O
cyt-1	B
directed	O
gene	O
expression	O
in	O
multiple	O
tobacco	O
tissue	O
types	O
.	O

These	O
results	O
suggest	O
that	O
repetitive	O
GAA	O
sequences	O
enhance	O
splicing	O
by	O
binding	O
a	O
protein	O
complex	O
containing	O
a	O
sequence	O
-	O
specific	O
RNA	O
binding	O
protein	O
and	O
a	O
general	O
splicing	O
activator	O
that	O
,	O
in	O
turn	O
,	O
recruit	O
additional	O
SR	B
proteins	I
.	O

Organization	O
of	O
exons	O
suggests	O
that	O
,	O
similar	O
to	O
the	O
human	B
VEGF	I
gene	I
,	O
alternative	O
splicing	O
generates	O
the	O
120-	O
,	O
164-	O
,	O
and	O
188-amino	O
acid	O
isoforms	O
,	O
but	O
does	O
not	O
predict	O
a	O
fourth	O
VEGF	B
isoform	I
corresponding	O
to	O
human	B
VEGF206	I
.	O

The	O
papers	O
provide	O
a	O
broad	O
perspective	O
of	O
MPAs	O
and	O
include	O
social	O
,	O
economic	O
,	O
cultural	O
,	O
biological	O
and	O
statistical	O
components	O
.	O

The	O
great	O
cardiac	O
vein	O
flow	O
became	O
zero	O
due	O
to	O
the	O
cardiac	O
arrest	O
and	O
remained	O
at	O
zero	O
for	O
a	O
moment	O
(	O
dead	O
time	O
)	O
after	O
the	O
initiation	O
of	O
reperfusion	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
suggest	O
that	O
histamine-2	B
receptor	I
activation	O
mechanisms	O
may	O
not	O
be	O
involved	O
in	O
postoperative	O
IL-6	B
synthesis	O
.	O

LAC9	B
is	O
a	O
DNA	O
-	O
binding	O
protein	O
that	O
regulates	O
transcription	O
of	O
the	O
lactose	B
-	I
galactose	I
regulon	I
in	O
Kluyveromyces	O
lactis	O
.	O

Some	O
cells	O
were	O
excited	O
,	O
others	O
inhibited	O
by	O
,	O
and	O
only	O
some	O
were	O
directionally	O
sensitive	O
to	O
the	O
optomotor	O
stimulus	O
.	O

The	O
molecular	O
event	O
(	O
s	O
)	O
underlying	O
the	O
functional	O
specificities	O
of	O
these	O
receptors	O
(	O
in	O
regulating	O
the	O
expression	O
of	O
their	O
native	O
target	O
genes	O
)	O
is	O
a	O
very	O
important	O
issue	O
that	O
remains	O
poorly	O
understood	O
.	O

For	O
Thermus	O
strain	O
ZO5	B
dihydroorotase	I
(	O
DHOase	B
;	O
encoded	O
by	O
pyrC	B
)	O
,	O
the	O
highest	O
similarity	O
scores	O
(	O
about	O
40	O
%	O
identity	O
)	O
were	O
obtained	O
with	O
DHOases	B
from	O
B.	O
caldolyticus	O
and	O
Bacillus	O
subtilis	O
.	O

This	O
difference	O
between	O
SP-1	B
and	O
SP-2	B
peptides	I
was	O
not	O
due	O
to	O
their	O
differential	O
uptake	O
by	O
cell	O
,	O
since	O
approximately	O
100	O
times	O
more	O
SP-2	B
peptide	I
could	O
be	O
found	O
in	O
cytoplasmic	O
extracts	O
than	O
SP-1	B
peptide	I
in	O
experiments	O
using	O
radiolabeled	O
peptides	O
.	O

The	O
product	O
of	O
one	O
gene	O
,	O
Bv80	B
,	O
has	O
a	O
single	O
divergent	O
copy	O
of	O
a	O
sequence	O
of	O
149	O
amino	O
acids	O
(	O
approx	O
.	O

The	O
sequences	O
at	O
-10	O
and	O
-35	O
relative	O
to	O
the	O
transcriptional	O
starting	O
site	O
showed	O
55	O
%	O
homology	O
with	O
the	O
consensus	O
sequences	O
of	O
the	O
Escherichia	B
coli	I
sigma	I
70-type	I
promoter	I
.	O

The	O
two	O
ORFs	O
had	O
significant	O
similarity	O
with	O
the	O
putative	O
replication	O
protein	O
from	O
plasmid	O
pTiK12	O
of	O
Thiobacillus	O
intermedius	O
and	O
other	O
CoIE2-related	O
plasmids	O
.	O

A	O
clinical	O
double	O
-	O
blind	O
trial	O
of	O
topical	O
miconazole	O
and	O
clotrimazole	O
against	O
superficial	O
fungal	O
infections	O
and	O
erythrasma	O
.	O

CONCLUSIONS	O
:	O
Systemic	O
factors	O
that	O
increase	O
bone	O
mineral	O
density	O
appear	O
to	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
ossification	O
of	O
the	O
posterior	O
longitudinal	O
ligament	O
,	O
and	O
these	O
factors	O
may	O
be	O
activated	O
after	O
middle	O
age	O
.	O

FdsR	B
purified	O
to	O
homogeneity	O
after	O
overexpression	O
of	O
fdsR	B
in	O
E.	O
coli	O
is	O
a	O
130	O
kDa	O
homotetramer	O
binding	O
to	O
the	O
fds	B
control	O
region	O
located	O
between	O
the	O
fdsR	B
and	O
fdsG	B
genes	I
.	O

Surgical	O
methods	O
in	O
the	O
treatment	O
of	O
rhinophyma	O
.	O

The	O
adeno	O
-	O
associated	O
virus	O
type	O
2	O
(	O
AAV-2	O
)	O
Rep78	B
/	O
Rep68	B
regulatory	O
proteins	O
are	O
pleiotropic	O
effectors	O
of	O
viral	O
and	O
cellular	O
DNA	O
replication	O
,	O
of	O
cellular	O
transformation	O
by	O
viral	O
and	O
cellular	O
oncogenes	O
,	O
and	O
of	O
homologous	O
and	O
heterologous	O
gene	O
expression	O
.	O

We	O
show	O
here	O
that	O
Spb1p	B
is	O
able	O
to	O
bind	O
[	O
(	O
3	O
)	O
H	O
]	O
AdoMet	O
in	O
vitro	O
,	O
suggesting	O
that	O
it	O
is	O
a	O
novel	O
methylase	O
,	O
whose	O
possible	O
substrates	O
will	O
be	O
discussed	O
.	O

These	O
data	O
suggest	O
that	O
weight	O
gain	O
or	O
increased	O
caloric	O
intake	O
,	O
in	O
contrast	O
to	O
its	O
large	O
effect	O
on	O
peripheral	O
thyroid	O
function	O
,	O
has	O
relatively	O
little	O
effect	O
on	O
CNS	B
TRH	I
activity	O
.	O

Hematopoietic	B
progenitor	I
kinase	I
1	I
(	O
HPK1	B
)	O
is	O
a	O
member	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
kinase	I
kinase	I
kinase	I
(	O
MAP4	B
K	I
)	O
family	O
and	O
an	O
upstream	O
activator	O
of	O
the	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
)	O
signaling	O
cascade	O
.	O

We	O
conclude	O
that	O
the	O
outcome	O
of	O
patients	O
with	O
uterine	O
MMMT	O
is	O
mainly	O
influenced	O
by	O
the	O
initial	O
stage	O
and	O
the	O
type	O
of	O
epithelial	O
component	O
.	O

Increased	O
susceptibility	O
of	O
aphasics	O
to	O
a	O
distractor	O
task	O
in	O
the	O
recall	O
of	O
verbal	O
commands	O
.	O

We	O
hypothesized	O
that	O
conjugated	O
estrogens	O
,	O
which	O
contain	O
several	O
vasoactive	O
estrogenic	O
compounds	O
,	O
may	O
favorably	O
influence	O
the	O
vasomotor	O
response	O
to	O
acetylcholine	O
in	O
men	O
.	O

Calcium	O
bilirubinate	O
crystals	O
were	O
seen	O
in	O
gallbladder	O
bile	O
or	O
wall	O
scrapings	O
of	O
7	O
of	O
8	O
TPN	O
animals	O
but	O
in	O
none	O
of	O
the	O
controls	O
(	O
P	O
less	O
than	O
0.001	O
)	O
.	O

Alcohol	O
and	O
stomach	O
diseases	O

In	O
our	O
case	O
the	O
development	O
of	O
the	O
tumor	O
at	O
the	O
posterior	O
side	O
of	O
the	O
prostate	O
,	O
the	O
lack	O
of	O
PSA	B
immunoreactivity	O
and	O
the	O
presence	O
of	O
mucinous	O
glands	O
,	O
sometimes	O
""""	O
endocervical	O
-	O
like	O
""""	O
,	O
could	O
suggest	O
an	O
origin	O
from	O
embryonic	O
mullerian	O
remnants	O
in	O
the	O
prostatic	O
utricle	O
rather	O
than	O
urogenital	O
sinus	O
.	O

Analysis	O
of	O
the	O
DNA	O
-	O
binding	O
and	O
transcriptional	O
activation	O
functions	O
of	O
human	B
Fli-1	I
protein	I
.	O

The	O
second	O
patient	O
was	O
successfully	O
treated	O
with	O
intravenous	O
prostaglandin	O
F2	O
alpha	O
(	O
PGF2	O
alpha	O
)	O
.	O

Base	O
substitutions	O
within	O
this	O
NFIL-6	B
site	I
resulted	O
in	O
virtual	O
elimination	O
of	O
LPS	O
-	O
induced	O
IL-1	B
beta	I
gene	I
transcription	O
.	O

Different	O
clinical	O
variants	O
of	O
the	O
empty	O
sella	O
turcica	O
syndrome	O
are	O
demonstrated	O
,	O
including	O
variants	O
resultant	O
from	O
substitution	O
therapy	O
of	O
thyroid	O
hypofunction	O
,	O
from	O
dopamine	O
agonist	O
therapy	O
for	O
hyperprolactinemic	O
hypogonadism	O
,	O
from	O
radiotherapy	O
of	O
hypophyseal	O
adenoma	O
.	O

Our	O
data	O
suggest	O
that	O
association	O
of	O
TBP	B
with	O
the	O
TATA	O
box	O
may	O
be	O
regulated	O
,	O
directly	O
or	O
indirectly	O
,	O
by	O
a	O
substrate	O
of	O
Snf1	B
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
the	O
T4	B
endonuclease	I
V	I
gene	I
:	O
role	O
of	O
lysine-130	O
.	O

Simulations	O
of	O
velocities	O
,	O
vorticity	O
,	O
pressure	O
and	O
certain	O
stress	O
values	O
were	O
developed	O
by	O
a	O
computer	O
and	O
displayed	O
for	O
man	O
-	O
machine	O
interaction	O
.	O

Together	O
,	O
these	O
results	O
implicate	O
Fal1p	B
in	O
the	O
18S	B
rRNA	I
maturation	O
pathway	O
rather	O
than	O
in	O
translation	O
initiation	O
.	O

Heliox	O
improves	O
pulsus	O
paradoxus	O
and	O
peak	O
expiratory	O
flow	O
in	O
nonintubated	O
patients	O
with	O
severe	O
asthma	O
.	O

Both	O
DMP2	B
and	O
DMP3	B
are	O
closely	O
localized	O
on	O
mouse	O
chromosome	O
5q21	O
,	O
corresponding	O
to	O
human	O
chromosome	O
4q21	O
.	O

A	O
kinetic	O
model	O
for	O
99mTc	O
-	O
DMSA	O
in	O
the	O
rat	O
.	O

Together	O
with	O
the	O
up	O
-	O
regulation	O
of	O
the	O
cAMP	B
response	I
element	I
modulator	I
protein	I
(	O
CREM	B
)	O
mRNA	O
and	O
protein	O
levels	O
demonstrated	O
previously	O
in	O
CREB	B
mutant	I
mice	O
,	O
we	O
suggest	O
that	O
the	O
up	O
-	O
regulation	O
of	O
CREB	B
beta	I
may	O
also	O
contribute	O
to	O
compensation	O
within	O
the	O
CREB	B
/	O
ATF	B
family	O
of	O
transcription	O
factors	O
,	O
when	O
CREB	B
delta	I
and	O
CREB	B
alpha	I
are	O
absent	O
.	O

The	O
transition	O
from	O
expression	O
of	O
early	O
meiotic	O
genes	O
to	O
expression	O
of	O
middle	O
sporulation	O
-	O
specific	O
genes	O
occurs	O
at	O
about	O
the	O
time	O
that	O
cells	O
exit	O
from	O
pachytene	O
and	O
form	O
the	O
meiosis	O
I	O
spindle	O
.	O

Mutations	O
away	O
from	O
splice	O
site	O
recognition	O
sequences	O
might	O
cis	O
-	O
modulate	O
alternative	O
splicing	O
of	O
goat	O
alpha	B
s1-casein	I
transcripts	I
.	O

Fig1p	B
and	O
Fig2p	B
are	O
likely	O
to	O
act	O
at	O
the	O
cell	O
surface	O
as	O
Fig1	B
:	O
:	O
beta	B
-	I
gal	I
and	O
Fig2::beta	B
-	B
gal	I
fusion	I
proteins	I
localize	O
to	O
the	O
periphery	O
of	O
mating	O
cells	O
.	O

There	O
is	O
little	O
supportive	O
evidence	O
that	O
ACE	B
inhibitors	O
(	O
captopril	O
or	O
enalapril	O
)	O
are	O
teratogenic	O
.	O

These	O
results	O
suggest	O
that	O
the	O
PVB	O
therapy	O
is	O
not	O
sufficient	O
to	O
cure	O
the	O
cases	O
with	O
choriocarcinoma	O
element	O
or	O
bulky	O
metastasis	O
.	O

Evaluation	O
of	O
gamma	B
-	I
glutamyl	I
transpeptidase	I
in	O
myocardial	O
infarction	O
.	O

The	O
yjr041c	B
delta	I
haploid	O
cells	O
gave	O
rise	O
to	O
microcolonies	O
comprising	O
about	O
20	O
to	O
50	O
cells	O
.	O

Mean	O
latency	O
periods	O
were	O
29.6	O
among	O
insulators	O
,	O
35.4	O
among	O
dock	O
workers	O
,	O
43.7	O
in	O
a	O
heterogeneous	O
group	O
defined	O
as	O
various	O
,	O
46.4	O
in	O
non	O
-	O
shipbuilding	O
industry	O
workers	O
,	O
49.4	O
in	O
shipyard	O
workers	O
,	O
51.7	O
among	O
women	O
with	O
a	O
history	O
of	O
domestic	O
exposure	O
to	O
asbestos	O
,	O
and	O
56.2	O
in	O
people	O
employed	O
in	O
maritime	O
trades	O
.	O

7-Nitroindazole	O
(	O
7NI	O
)	O
,	O
a	O
relatively	O
selective	O
neuronal	O
nitric	B
oxide	I
synthase	I
(	O
nNOS	B
)	O
inhibitor	O
.	O
was	O
intraperitoneally	O
administered	O
to	O
the	O
guinea	O
pigs	O
30	O
minutes	O
before	O
the	O
onset	O
of	O
local	O
anoxia	O
.	O

New	O
protein	O
-	O
free	O
products	O
for	O
diet	O
therapy	O
in	O
chronic	O
renal	O
insufficiency	O

The	O
human	O
protein	O
binds	O
most	O
strongly	O
to	O
the	O
SH3	B
domain	I
from	O
the	O
abl	B
proto	I
-	I
oncogene	I
.	O

Like	O
troponin	B
Cs	I
and	O
calmodulins	B
,	O
PfCPK	B
also	O
contains	O
four	O
EF	O
hand	O
calcium	O
-	O
binding	O
motifs	O
.	O

Roller	O
pumps	O
,	O
coronary	O
suction	O
and	O
an	O
open	O
cardiotomy	O
reservoir	O
were	O
used	O
.	O

Our	O
data	O
indicate	O
that	O
the	O
various	O
subunits	O
of	O
the	O
human	O
P	B
-	I
TEFb	I
complex	O
may	O
play	O
distinct	O
roles	O
at	O
multiple	O
stages	O
to	O
mediate	O
Tat	B
activation	O
of	O
HIV-1	O
transcription	O
elongation	O
.	O

The	O
organelles	O
synthesize	O
their	O
own	O
set	O
of	O
Fe	B
/	I
S	I
proteins	I
,	O
and	O
they	O
initiate	O
the	O
generation	O
of	O
extramitochondrial	B
Fe	I
/	I
S	I
proteins	I
.	O

Orlistat	O
is	O
a	O
specific	O
lipase	B
inhibitor	O
that	O
impairs	O
fat	O
absorption	O
,	O
thereby	O
reducing	O
fat	O
uptake	O
.	O

ORF3	O
encodes	O
a	O
putative	O
periplasmic	B
c	I
-	I
type	I
cytochrome	I
with	O
a	O
molecular	O
mass	O
of	O
94	O
,	O
000	O
Da	O
and	O
contains	O
seven	O
c	O
-	O
heme	O
-	O
binding	O
motifs	O
but	O
shows	O
no	O
sequence	O
homology	O
to	O
occ	B
or	O
ORF1	O
.	O

The	O
rat	O
anococcygeus	O
muscle	O
was	O
used	O
in	O
postsynaptic	O
studies	O
.	O

These	O
results	O
suggest	O
that	O
camptothecin	O
resistance	O
in	O
CEM	O
/	O
DOX	O
cells	O
is	O
due	O
to	O
different	O
mechanism	O
(	O
s	O
)	O
than	O
topoisomerase-	B
or	O
P	B
-	I
glycoprotein	I
-	O
associated	O
multidrug	O
resistance	O
.	O

Because	O
of	O
gut	O
fermentation	O
,	O
a	O
substantial	O
portion	O
(	O
16	O
-	O
80	O
%	O
)	O
of	O
N	O
is	O
absorbed	O
as	O
ammonia	O
N	O
(	O
NH3N	O
)	O
.	O

Interestingly	O
,	O
PMA-	O
,	O
PDGF-	B
,	O
and	O
serum	O
-	O
induced	O
GHR	B
proteolysis	O
was	O
associated	O
with	O
substantial	O
decreases	O
in	O
GH	B
-	O
induced	O
activation	O
of	O
Janus	B
kinase-2	I
,	O
which	O
were	O
also	O
prevented	O
by	O
IC3	O
.	O

The	O
centromeric	O
dodeca	O
-	O
satellite	O
of	O
Drosophila	O
forms	O
altered	O
DNA	O
structures	O
in	O
vitro	O
in	O
which	O
its	O
purine	O
-	O
rich	O
strand	O
(	O
G	O
-	O
strand	O
)	O
forms	O
stable	O
fold	O
-	O
back	O
structures	O
,	O
while	O
the	O
complementary	O
C	O
-	O
strand	O
remains	O
unstructured	O
.	O

The	O
Aspergillus	B
uvsH	I
gene	I
encodes	O
a	O
product	O
homologous	O
to	O
yeast	B
RAD18	I
and	O
Neurospora	B
UVS-2	I
.	O

These	O
data	O
also	O
suggest	O
the	O
existence	O
of	O
a	O
mechanism	O
by	O
which	O
regulatory	O
subunits	O
modulate	O
the	O
PI	B
3-kinase	I
-	O
mediated	O
signals	O
,	O
independent	O
of	O
the	O
kinase	O
activity	O
,	O
possibly	O
through	O
subcellular	O
localization	O
of	O
the	O
catalytic	O
subunit	O
or	O
interaction	O
with	O
additional	O
signaling	O
molecules	O
.	O

A	O
continuous	O
-	O
flow	O
BIPAP	O
system	O
consists	O
of	O
a	O
high	O
-	O
flow	O
CPAP	O
system	O
,	O
a	O
reservoir	O
bag	O
,	O
and	O
a	O
pneumatically	O
controlled	O
membrane	O
valve	O
in	O
the	O
expiratory	O
limb	O
.	O

This	O
study	O
demonstrates	O
that	O
the	O
exposure	O
to	O
sulphur	O
mustard	O
results	O
in	O
very	O
low	O
androgen	O
levels	O
and	O
hypo	O
-	O
responsiveness	O
to	O
GnRH	B
in	O
the	O
first	O
five	O
weeks	O
and	O
normalization	O
by	O
the	O
twelfth	O
week	O
after	O
injury	O
.	O

In	O
the	O
present	O
study	O
we	O
prospectively	O
compared	O
side	O
effects	O
occurring	O
in	O
12	O
patients	O
after	O
the	O
first	O
administration	O
of	O
low	O
-	O
dose	O
OKT3	O
(	O
0.5	O
mg	O
twice	O
daily	O
)	O
induction	O
therapy	O
with	O
those	O
in	O
10	O
patients	O
who	O
were	O
treated	O
with	O
a	O
conventional	O
dose	O
of	O
OKT3	O
(	O
5	O
mg	O
daily	O
)	O
for	O
acute	O
rejection	O
.	O

Plasma	B
prolactin	I
concentrations	O
during	O
incubation	O
,	O
25.8	O
+	O
/-	O

2.3	O
ng	O
/	O
ml	O
,	O
decreased	O
to	O
baseline	O
levels	O
,	O
10.8	O
+	O
/-	O

1.9	O
ng	O
/	O
ml	O
,	O
within	O
24	O
hr	O
after	O
nestbox	O
removal	O
.	O

Our	O
findings	O
suggest	O
that	O
resting	O
Tl-201	O
scintigraphy	O
has	O
limited	O
value	O
in	O
the	O
detection	O
of	O
coronary	O
artery	O
disease	O
in	O
patients	O
with	O
Hurler	O
syndrome	O
.	O

Also	O
,	O
residues	O
273	O
to	O
287	O
,	O
which	O
are	O
identical	O
in	O
sequence	O
to	O
a	O
15-amino	O
-	O
acid	O
segment	O
near	O
the	O
carboxy	O
terminus	O
of	O
the	O
simian	B
foamy	I
virus	I
transcriptional	I
activator	I
Taf	I
,	O
can	O
independently	O
enhance	O
the	O
activity	O
of	O
the	O
minimal	O
activator	O
region	O
.	O

The	O
side	O
effect	O
of	O
pulmonary	O
fibrosis	O
occurs	O
in	O
20	O
to	O
30	O
percent	O
of	O
patients	O
receiving	O
this	O
drug	O
.	O

Of	O
the	O
47	O
women	O
with	O
AGCUS	O
,	O
16	O
had	O
intraepithelial	O
or	O
invasive	O
neoplasms	O
(	O
34	O
%	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
21	O
-	O
49	O
%	O
)	O
,	O
including	O
9	O
low	O
or	O
high	O
grade	O
squamous	O
intraepithelial	O
lesions	O
,	O
1	O
adenocarcinoma	O
in	O
situ	O
of	O
the	O
cervix	O
,	O
3	O
adenocarcinomas	O
of	O
the	O
cervix	O
,	O
2	O
adenocarcinomas	O
of	O
the	O
endometrium	O
and	O
1	O
adenoid	O
basal	O
cell	O
carcinoma	O
of	O
the	O
cervix	O
.	O

Thus	O
in	O
this	O
study	O
we	O
used	O
in	O
vitro	O
methods	O
to	O
directly	O
evaluate	O
whether	O
isolated	O
human	O
saphenous	O
vein	O
segments	O
respond	O
to	O
vasoconstrictor	O
agents	O
at	O
arterial	O
pressure	O
levels	O
.	O

Genomic	O
Southern	O
blot	O
analysis	O
suggests	O
that	O
the	O
human	O
haploid	O
genome	O
contains	O
a	O
single	O
Gs	B
alpha	I
gene	I
.	O

The	O
facilitation	O
started	O
preceding	O
the	O
onset	O
of	O
electromyographic	O
activity	O
of	O
the	O
masseter	O
muscle	O
.	O

Reactivation	O
of	O
hepatitis	O
B	O
virus	O
replication	O
is	O
a	O
rare	O
event	O
during	O
the	O
natural	O
history	O
of	O
chronic	O
hepatitis	O
B.	O

SETTING	O
--	O
Hospital	O
laboratories	O
in	O
the	O
United	O
States	O
submitting	O
pneumococcal	O
isolates	O
to	O
the	O
CDC	O
between	O
October	O
1	O
,	O
1991	O
,	O
and	O
September	O
30	O
,	O
1992	O
.	O

To	O
determine	O
whether	O
transcription	O
of	O
orfX	O
and	O
vfr	B
are	O
controlled	O
by	O
the	O
same	O
mechanisms	O
that	O
control	O
transcription	O
of	O
the	O
region	O
of	O
the	O
divergent	O
ORF	O
(	O
dorf	O
)	O
and	O
of	O
crp	B
,	O
we	O
compared	O
the	O
vfr	B
-	O
orfX	O
and	O
crp	B
-	O
dorf	O
intergenic	O
regions	O
.	O

Cotransfection	O
with	O
C	B
/	I
EBPbeta	I
and	O
GATA-1	B
expression	O
vectors	O
produced	O
a	O
5-fold	O
increase	O
compared	O
with	O
cotransfection	O
with	O
the	O
C	B
/	I
EBPbeta	I
or	O
GATA-1	B
expression	O
vectors	O
individually	O
.	O

Eighteen	O
patients	O
with	O
advanced	O
epidermoid	O
carcinoma	O
of	O
the	O
head	O
and	O
neck	O
were	O
entered	O
into	O
a	O
phase	O
II	O
trial	O
of	O
N	O
-	O
Methylformamide	O
(	O
NMF	O
)	O
,	O
800	O
mg	O
/	O
M2	O
IV	O
daily	O
for	O
5	O
days	O
every	O
4	O
weeks	O
.	O

Total	O
body	O
water	O
and	O
distribution	O
space	O
of	O
Na24	O
in	O
women	O
with	O
various	O
body	O
weight	O

Transient	O
cotransfection	O
analyses	O
indicate	O
that	O
the	O
cooperative	O
association	O
of	O
NF	B
-	I
IL-6	I
and	O
RelA	B
with	O
the	O
IL-8	B
promoter	I
results	O
in	O
synergistic	O
transcriptional	O
activation	O
.	O

Sera	O
from	O
33	O
newborn	O
infants	O
with	O
gestational	O
ages	O
ranging	O
from	O
27	O
to	O
41	O
weeks	O
were	O
tested	O
by	O
radioimmunoassay	O
for	O
IgG	B
antibodies	O
to	O
surface	O
antigens	O
of	O
group	O
B	O
streptococci	O
(	O
GBS	O
)	O
types	O
Ia	O
,	O
Ib	O
,	O
II	O
and	O
III	O
.	O

On	O
average	O
,	O
rCMRglc	O
values	O
were	O
23	O
%	O
below	O
control	O
values	O
for	O
all	O
regions	O
studied	O
,	O
with	O
the	O
greatest	O
differences	O
in	O
posterior	O
brain	O
regions	O
(	O
visual	O
association	O
cortex	O
,	O
primary	O
visual	O
cortex	O
,	O
and	O
parietal	O
cortex	O
)	O
and	O
thalamus	O
.	O

The	O
NF1	B
family	I
members	O
and	O
HNF4	B
interacted	O
with	O
overlapping	O
sequences	O
of	O
the	O
L	O
-	O
II	O
element	O
,	O
wherein	O
the	O
5	O
'	O
half	O
-	O
site	O
was	O
more	O
critical	O
for	O
NF1	B
binding	O
,	O
and	O
the	O
3	O
'	O
site	O
was	O
more	O
important	O
for	O
HNF4	B
binding	O
.	O

VP4	B
differentially	O
regulates	O
TRAF2	B
signaling	O
,	O
disengaging	O
JNK	B
activation	O
while	O
directing	O
NF	B
-	I
kappa	I
B	I
to	O
effect	O
rotavirus	O
-	O
specific	O
cellular	O
responses	O
.	O

From	O
the	O
autopsy	O
findings	O
,	O
in	O
5	O
out	O
of	O
the	O
remaining	O
23	O
expired	O
patients	O
,	O
Legionella	O
pneumonia	O
seemed	O
to	O
be	O
successfully	O
treated	O
,	O
but	O
other	O
disease	O
or	O
other	O
bacterial	O
pneumonia	O
put	O
an	O
end	O
to	O
the	O
patients	O
.	O

We	O
found	O
a	O
prevalence	O
of	O
eating	O
disorders	O
of	O
5.9	O
%	O
(	O
lifetime	O
prevalence	O
of	O
10	O
%	O
)	O
,	O
irrespective	O
of	O
gender	O
and	O
type	O
of	O
diabetes	O
;	O
4.1	O
%	O
of	O
the	O
whole	O
sample	O
reported	O
intentional	O
insulin	B
undertreatment	O
or	O
omission	O
.	O

NER	O
was	O
also	O
measured	O
by	O
a	O
plasmid	O
host	O
cell	O
re	O
-	O
activation	O
assay	O
using	O
a	O
vector	O
containing	O
a	O
luciferase	B
reporter	I
gene	I
.	O

Also	O
,	O
like	O
TUB	B
,	O
it	O
has	O
a	O
wider	O
pattern	O
of	O
tissue	O
expression	O
than	O
either	O
TULP1	B
or	O
TULP2	B
.	O

Moist	O
healing	O
versus	O
wet	O
-	O
to	O
-	O
dry	O
.	O

Despite	O
the	O
same	O
decreases	O
or	O
increases	O
in	O
MAP	O
,	O
RSNA	O
was	O
attenuated	O
after	O
15	O
and	O
30	O
min	O
of	O
propofol	O
infusion	O
in	O
both	O
groups	O
compared	O
with	O
control	O
(	O
P	O
<	O
0.05	O
)	O
.	O

Acute	O
morphine	O
treatment	O
did	O
not	O
increase	O
the	O
locomotor	O
activity	O
of	O
mice	O
withdrawn	O
for	O
1	O
day	O
,	O
after	O
withdrawal	O
for	O
3	O
days	O
the	O
increase	O
was	O
similar	O
to	O
that	O
in	O
controls	O
,	O
and	O
after	O
5	O
days	O
the	O
increase	O
was	O
clearly	O
larger	O
than	O
in	O
controls	O
.	O

A	O
significant	O
and	O
specific	O
reduction	O
in	O
binaural	O
peak	O
amplitude	O
and	O
area	O
of	O
the	O
echo	O
-	O
evoked	O
middle	O
-	O
latency	O
component	O
Pa	O
was	O
observed	O
.	O

Non	O
-	O
dialyzable	O
transfer	B
factor	I

Stress	O
thallium-201	O
myocardial	O
imaging	O
was	O
used	O
in	O
two	O
angina	O
-	O
free	O
patients	O
with	O
severe	O
congestive	O
heart	O
failure	O
to	O
identify	O
clinically	O
silent	O
areas	O
of	O
ischemic	O
myocardium	O
and	O
to	O
distinguish	O
between	O
scar	O
and	O
reversibly	O
ischemic	O
myocardium	O
as	O
a	O
cause	O
for	O
akinesia	O
of	O
left	O
ventricular	O
wall	O
segments	O
.	O

The	O
6.5-kb	O
genomic	O
fragment	O
contains	O
the	O
complete	O
coding	O
region	O
of	O
MyoD	B
,	O
distributed	O
over	O
three	O
exons	O
,	O
plus	O
2.3	O
kb	O
of	O
5'-noncoding	O
sequence	O
and	O
1.4	O
kb	O
of	O
3'-noncoding	O
sequence	O
.	O

These	O
observations	O
demonstrate	O
that	O
KSR	B
is	O
capable	O
of	O
uncoupling	O
the	O
MAP	B
kinase	I
activation	O
from	O
its	O
target	O
phosphorylation	O
,	O
and	O
thus	O
provide	O
a	O
novel	O
mechanism	O
for	O
modulating	O
the	O
Ras	B
-	O
MAP	B
kinase	I
signaling	O
pathway	O
.	O

Since	O
1985	O
the	O
combination	O
of	O
chlorambucil	O
(	O
10	O
mg	O
daily	O
,	O
initially	O
for	O
six	O
weeks	O
,	O
then	O
alternating	O
fortnights	O
for	O
12	O
weeks	O
)	O
and	O
interferon	B
-	I
alpha	I
2b	I
(	O
Schering	O
-	O
Plough	O
;	O
2	O
x	O
10	O
(	O
6	O
)	O
U	O
/	O
m2	O
three	O
times	O
weekly	O
by	O
subcutaneous	O
injection	O
for	O
18	O
weeks	O
)	O
has	O
been	O
compared	O
in	O
a	O
randomised	O
trial	O
with	O
chlorambucil	O
alone	O
in	O
previously	O
untreated	O
patients	O
with	O
stage	O
III	O
or	O
IV	O
follicular	O
lymphoma	O
.	O

Correlation	O
of	O
alpha	O
activity	O
between	O
the	O
frontal	O
and	O
occipital	O
cortex	O
.	O

Nonetheless	O
,	O
the	O
majority	O
were	O
located	O
within	O
three	O
short	O
sequences	O
at	O
the	O
N	O
terminus	O
,	O
middle	O
,	O
and	O
C	O
terminus	O
that	O
are	O
phylogenetically	O
conserved	O
among	O
all	O
known	O
eubacterial	O
and	O
chloroplast	O
versions	O
of	O
this	O
protein	O
.	O

All	O
other	O
cysts	O
showed	O
a	O
unilocular	O
,	O
purely	O
cystic	O
pattern	O
,	O
with	O
homogeneous	O
fluids	O
,	O
although	O
the	O
T2	O
relaxation	O
times	O
of	O
four	O
lesions	O
overlapped	O
those	O
of	O
odontogenic	O
keratocysts	O
.	O

Recombinant	B
caspases	I
are	O
typically	O
produced	O
in	O
Escherichia	O
coli	O
expression	O
systems	O
with	O
the	O
attendant	O
problems	O
of	O
solubilization	O
,	O
re	O
-	O
folding	O
and	O
activation	O
of	O
the	O
protease	O
.	O

Nuclear	O
runoff	O
assays	O
show	O
that	O
complementation	O
by	O
HPV16	B
E7	I
restores	O
the	O
ability	O
of	O
the	O
E1A	B
mutants	I
to	O
stimulate	O
early	B
gene	I
expression	O
at	O
the	O
level	O
of	O
transcription	O
.	O

The	O
effect	O
of	O
deferoxamine	O
B	O
on	O
the	O
blood	O
sugar	O
behavior	O
in	O
intravenous	O
glucose	O
loading	O
in	O
healthy	O
persons	O

Constructs	O
containing	O
fragments	O
of	O
the	O
upstream	O
region	O
of	O
the	O
cytotactin	B
gene	I
fused	O
to	O
a	O
promoterless	O
gene	O
for	O
chloramphenicol	B
acetyltransferase	I
were	O
transiently	O
transfected	O
into	O
chicken	O
embryo	O
fibroblasts	O
to	O
define	O
functional	O
promoter	O
sequences	O
.	O

Like	O
the	O
human	B
erythrocyte	I
P4.2	I
,	O
mouse	B
erythrocyte	I
P4.2	I
contains	O
regions	O
strikingly	O
homologous	O
with	O
the	O
transglutaminase	O
(	O
TGase	O
)	O
proteins	O
although	O
it	O
too	O
most	O
likely	O
lacks	O
TGase	O
crosslinking	O
activity	O
.	O

The	O
rate	O
for	O
Arm	O
III	O
(	O
CAF	O
therapy	O
)	O
was	O
61.5	O
%	O
(	O
32	O
/	O
52	O
)	O
,	O
a	O
little	O
higher	O
than	O
that	O
for	O
the	O
other	O
two	O
.	O

Mutating	O
this	O
sequence	O
eliminated	O
complex	O
formation	O
and	O
markedly	O
reduced	O
basal	O
and	O
cAMP	O
-	O
dependent	O
promoter	O
activity	O
of	O
transfected	O
reporter	O
genes	O
.	O

The	O
induction	O
of	O
the	O
composite	O
H	B
-	I
PK	I
/	O
Tag	B
and	O
SV	B
-	I
PK	I
/	O
Tag	B
transgenes	O
by	O
a	O
carbohydrate	O
-	O
rich	O
diet	O
in	O
the	O
liver	O
was	O
similar	O
to	O
that	O
of	O
the	O
endogenous	B
L	I
-	I
PK	I
gene	I
.	O

For	O
routine	O
medical	O
applications	O
,	O
no	O
sophisticated	O
adjustment	O
of	O
the	O
CHESS	O
pulse	O
is	O
needed	O
,	O
as	O
reported	O
in	O
previous	O
methods	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
of	O
the	O
hemF	B
gene	I
,	O
encoding	O
the	O
aerobic	O
coproporphyrinogen	B
III	I
oxidase	I
from	I
Escherichia	I
coli	I
,	O
by	O
functional	O
complementation	O
of	O
a	O
Saccharomyces	B
cerevisiae	I
HEM13	I
mutant	I
.	O

Efficacy	O
of	O
probiotic	O
feed	O
additives	O
:	O
guidelines	O
for	O
the	O
evaluation	O
of	O
the	O
efficiency	O
of	O
microorganisms	O
in	O
dogs	O
,	O
cats	O
,	O
and	O
horses	O
]	O

Probiotic	O
microorganisms	O
are	O
frequently	O
in	O
use	O
as	O
feed	O
additives	O
for	O
farm	O
and	O
pet	O
animals	O
.	O

We	O
analyzed	O
the	O
contribution	O
of	O
the	O
three	O
different	O
types	O
of	O
UV	O
-	O
inducible	O
mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinases	I
(	O
ERK	B
,	O
JNK	B
/	O
SAPK	B
,	O
and	O
p38	B
)	O
to	O
the	O
activation	O
of	O
the	O
murine	O
uPA	B
promoter	O
by	O
UV	O
.	O

Mean	O
total	O
homocysteine	O
(	O
tHcy	O
)	O
was	O
21.1	O
+	O
/-9.5	O
micromol	O
/	O
L	O
and	O
median	O
concentration	O
was	O
19	O
micromol	O
/	O
L.	O

To	O
facilitate	O
the	O
characterization	O
of	O
NF	B
-	I
E2	I
functions	O
in	O
human	O
cells	O
,	O
we	O
isolated	O
cDNAs	O
encoding	O
two	O
members	O
of	O
the	O
small	B
Maf	I
family	I
,	O
MafK	B
and	O
MafG.	B

In	O
this	O
first	O
-	O
person	O
account	O
,	O
the	O
author	O
chronicles	O
her	O
experience	O
of	O
being	O
mentally	O
ill	O
and	O
homeless	O
in	O
New	O
York	O
and	O
New	O
Jersey	O
in	O
the	O
early	O
1980s	O
.	O

Pharmacokinetics	O
of	O
skin	O
penetration	O
.	O

Dmyd	B
clone	O
encodes	O
a	O
polypeptide	O
of	O
332	O
amino	O
acids	O
with	O
82	O
%	O
identity	O
to	O
MyoD	B
in	O
the	O
41	O
amino	O
acids	O
of	O
the	O
putative	O
helix	O
-	O
loop	O
-	O
helix	O
region	O
and	O
100	O
%	O
identity	O
in	O
the	O
13	O
amino	O
acids	O
of	O
the	O
basic	O
domain	O
proposed	O
to	O
contain	O
the	O
essential	O
recognition	O
code	O
for	O
muscle	O
-	O
specific	O
gene	O
activation	O
.	O

Enterotoxin	O
production	O
by	O
staphylococci	O
isolated	O
from	O
foods	O
in	O
France	O
.	O

Binding	O
sites	O
were	O
mapped	O
for	O
each	O
factor	O
.	O

The	O
majority	O
of	O
these	O
cells	O
were	O
also	O
OKT4	B
positive	O
(	O
helper	O
/	O
inducer	O
T	O
lymphocytes	O
)	O
,	O
while	O
the	O
minority	O
were	O
OKT8	B
positive	O
(	O
suppressor	O
/	O
cytotoxic	O
T	O
lymphocytes	O
)	O
.	O

Toxicological	O
effects	O
of	O
dietary	O
Maillard	O
reaction	O
products	O
in	O
the	O
rat	O
.	O

All	O
relapses	O
occurred	O
within	O
the	O
first	O
year	O
and	O
were	O
confined	O
to	O
patients	O
with	O
PS	O
II	O
disease	O
and	O
four	O
or	O
more	O
sites	O
of	O
involvement	O
.	O

These	O
patients	O
developed	O
severe	O
diabetic	O
symptoms	O
including	O
glucose	O
intolerance	O
,	O
weight	O
loss	O
,	O
impaired	O
energy	O
utilization	O
,	O
and	O
nerve	O
and	O
brain	O
disorders	O
that	O
were	O
refractory	O
to	O
insulin	B
.	O

BCV	B
mRNAs	I
5	I
and	I
5	I
-	I
1	I
appear	O
to	O
be	O
used	O
for	O
the	O
synthesis	O
of	O
the	O
12.7-	O
and	O
9.5-kDa	O
proteins	O
,	O
respectively	O
,	O
which	O
demonstrates	O
a	O
pattern	O
of	O
expression	O
strikingly	O
different	O
from	O
that	O
utilized	O
by	O
MHV	O
.	O

Consistent	O
with	O
this	O
observation	O
,	O
introduction	O
of	O
Smad	B
sites	I
into	O
a	O
TGFbeta	B
-	O
insensitive	O
LEF1	B
/	O
TCF	B
target	O
gene	O
confers	O
cooperative	O
TGFbeta	B
and	O
Wnt	B
responsiveness	O
to	O
the	O
promoter	O
.	O

Recombinant	O
vaccinia	O
viruses	O
that	O
express	O
the	O
bacteriophage	B
T3	I
RNA	I
polymerase	I
(	O
VV	B
-	I
T3pol	I
)	O
or	O
the	O
Escherichia	B
coli	I
lac	I
repressor	I
(	O
VV	B
-	I
lacI	I
)	O
under	O
control	O
of	O
the	O
early	B
-	I
late	I
vaccinia	I
promoter	I
P7.5	I
were	O
constructed	O
.	O

Tritiated	O
1,24,25-trihydroxyvitamin	O
D3	O
was	O
synthesized	O
biologically	O
and	O
used	O
as	O
tracer	O
to	O
monitor	O
the	O
recovery	O
of	O
endogenous	O
metabolite	O
during	O
isolation	O
from	O
serum	O
.	O

This	O
study	O
examines	O
LEIBNIZ	O
'	O
idea	O
of	O
Veterinary	O
medicine	O
in	O
a	O
biographical	O
context	O
.	O

Using	O
the	O
conflict	O
drinking	O
test	O
as	O
a	O
model	O
,	O
we	O
studied	O
in	O
rats	O
the	O
effect	O
of	O
the	O
nonselective	O
beta	B
-	I
adrenoceptor	I
blockers	O
pindolol	O
and	O
cyanopindolol	O
which	O
bind	O
to	O
5-HT1A	B
and	I
5-HT1B	I
receptors	I
,	O
and	O
of	O
the	O
selective	O
beta	B
1-	I
and	I
beta	I
2-adrenoceptor	I
antagonists	O
betaxolol	O
and	O
ICI	O
118,551	O
,	O
respectively	O
,	O
which	O
have	O
a	O
negligible	O
affinity	O
for	O
5-HT	B
receptors	I
.	O

Rewarding	O
properties	O
of	O
methylphenidate	O
:	O
sensitization	O
by	O
prior	O
exposure	O
to	O
the	O
drug	O
and	O
effects	O
of	O
dopamine	B
D1-	I
and	I
D2-receptor	I
antagonists	O
.	O

METHODS	O
:	O
Children	O
with	O
attention	O
-	O
deficit	O
/	O
hyperactivity	O
disorder	O
(	O
ADHD	O
;	O
n	O
=	O
282	O
)	O
,	O
all	O
subtypes	O
,	O
ages	O
6	O
to	O
12	O
years	O
,	O
were	O
randomized	O
to	O
placebo	O
(	O
n	O
=	O
90	O
)	O
,	O
immediate	O
-	O
release	O
methylphenidate	O
(	O
IR	O
MPH	O
)	O
3	O
times	O
a	O
day	O
(	O
tid	O
;	O
dosed	O
every	O
4	O
hours	O
;	O
n	O
=	O
97	O
)	O
,	O
or	O
OROS	O
MPH	O
once	O
a	O
day	O
(	O
qd	O
;	O
n	O
=	O
95	O
)	O
in	O
a	O
double	O
-	O
blind	O
,	O
28-day	O
trial	O
.	O

The	O
possibility	O
to	O
use	O
this	O
method	O
for	O
common	O
diagnostic	O
problems	O
is	O
indicated	O
.	O

Female	O
Wistar	O
rats	O
receiving	O
alcohol	O
(	O
5	O
%	O
)	O
in	O
drinking	O
water	O
during	O
lactation	O
(	O
N	O
=	O
7	O
)	O
were	O
compared	O
to	O
normal	O
controls	O
fed	O
ad	O
libitum	O
(	O
N	O
=	O
6	O
)	O
.	O

Eph	B
receptors	I
and	O
their	O
membrane	O
-	O
associated	O
ephrin	B
ligands	I
regulate	O
cell	O
-	O
cell	O
interactions	O
during	O
development	O
.	O

Vk8	B
/	O
Jk2	B
and	O
Vk1	B
/	O
Jk5	B
rearrangements	O
encoded	O
the	O
respective	O
L	B
chain	I
V	I
-	I
regions	I
.	O

An	O
analysis	O
of	O
the	O
c	B
-	I
kit	I
5	I
'	I
flanking	I
region	I
using	O
the	O
bacterial	B
chloramphenicol	I
acetyltransferase	I
gene	I
(	O
CAT	B
assay	O
)	O
in	O
human	O
erythroleukemia	O
HEL	O
cells	O
,	O
which	O
express	O
the	O
endogenous	O
c	B
-	I
kit	I
mRNA	I
at	O
high	O
levels	O
,	O
showed	O
that	O
a	O
region	O
from	O
-180	O
to	O
-22	O
is	O
important	O
for	O
the	O
expression	O
of	O
the	O
c	B
-	I
kit	I
gene	I
.	O

Following	O
immunization	O
of	O
transgenic	O
mice	O
,	O
hybrid	O
molecules	O
were	O
isolated	O
from	O
B	O
cell	O
DNA	O
which	O
contained	O
the	O
transgene	O
recombined	O
with	O
the	O
endogenous	B
IgH	I
locus	I
.	O

(	O
LH	B
P	O
<	O
0.05	O
,	O
LH	B
/	O
FSH	B
P	O
<	O
0.01	O
)	O
.	O

None	O
of	O
the	O
19	O
women	O
with	O
probable	O
RA	O
and	O
100	O
of	O
the	O
116	O
women	O
with	O
definite	O
RA	O
met	O
the	O
1987	O
criteria	O
.	O

In	O
response	O
to	O
the	O
need	O
for	O
better	O
quantitative	O
estimates	O
of	O
the	O
regional	O
distribution	O
of	O
the	O
active	O
bone	O
marrow	O
organ	O
in	O
infants	O
and	O
children	O
,	O
a	O
method	O
using	O
various	O
anatomical	O
data	O
has	O
been	O
developed	O
.	O

Thus	O
the	O
Hi	O
-	O
RARE	O
represents	O
a	O
new	O
type	O
of	O
RA	O
response	O
element	O
with	O
a	O
role	O
in	O
the	O
modulation	O
of	O
the	O
expression	O
of	O
MHC	B
class	I
1	I
family	O
genes	O
.	O

Our	O
results	O
strongly	O
suggest	O
that	O
activation	O
of	O
the	O
beta	O
origin	O
by	O
a	O
distant	O
replication	O
enhancer	O
element	O
requires	O
a	O
small	O
target	O
sequence	O
essential	O
for	O
initiator	O
protein	O
-	O
mediated	O
DNA	O
looping	O
.	O

Three	O
experiments	O
using	O
20	O
microM	O
2-	O
(	O
hydroxyamino	O
)	O
-1-methyl-6-phenylimidazo	O
[	O
4,5-b	O
]	O
pyridine	O
(	O
N	O
-	O
OH	O
-	O
PhIP	O
)	O
were	O
performed	O
to	O
induce	O
mutations	O
in	O
the	O
dihydrofolate	B
reductase	I
(	O
DHFR	B
)	O
gene	O
of	O
a	O
hemizygous	O
Chinese	O
hamster	O
ovary	O
(	O
CHO	O
)	O
cell	O
line	O
(	O
UA21	O
)	O
.	O

The	O
UL3	B
ORF	I
of	O
204	O
amino	O
acids	O
shows	O
significant	O
homology	O
to	O
UL3	B
(	O
nuclear	O
phosphoprotein	O
)	O
of	O
HSV-1	O
(	O
62	O
%	O
)	O
and	O
PRV	O
(	O
53	O
%	O
)	O
.	O

Immunogenicity	O
tested	O
in	O
experiments	O
on	O
guinea	O
pigs	O
and	O
rabbits	O
was	O
not	O
reduced	O
and	O
corresponded	O
to	O
that	O
of	O
the	O
reference	O
STI-1	O
vaccine	O
.	O

Supportive	O
therapy	O
with	O
xenogenous	O
peptides	O
in	O
patients	O
with	O
metastatic	O
breast	O
cancer	O
undergoing	O
aggressive	O
chemotherapy	O
(	O
modified	O
AC	O
-	O
protocol	O
)	O
:	O
a	O
prospective	O
,	O
randomized	O
double	O
-	O
blind	O
study	O

The	O
inactive	O
X	O
allele	O
,	O
however	O
,	O
is	O
hypermethylated	O
in	O
leukocytes	O
,	O
presumably	O
reflecting	O
early	O
X	O
inactivation	O
events	O
that	O
become	O
important	O
for	O
gene	O
dosage	O
in	O
expressing	O
lineages	O
.	O

Development	O
of	O
neural	O
control	O
of	O
alimentary	O
motor	O
function	O
in	O
the	O
vertebrates	O
.	O

Cell	O
rounding	O
was	O
abrogated	O
by	O
expression	O
of	O
either	O
kinase	O
-	O
dead	O
forms	O
of	O
US3	B
PK	I
or	O
a	O
mutant	O
protein	O
lacking	O
the	O
acidic	O
cluster	O
in	O
the	O
kinase	O
regulatory	O
domain	O
.	O

The	O
genes	O
expressed	O
during	O
the	O
embryonic	O
(	O
zeta	B
)	O
or	O
fetal	O
and	O
adult	O
stage	O
(	O
alpha	B
2	I
and	O
alpha	B
1	I
)	O
can	O
be	O
modified	O
by	O
point	O
mutations	O
which	O
affect	O
either	O
the	O
processing	O
-	O
translation	O
of	O
mRNA	O
or	O
make	O
the	O
polypeptide	O
chains	O
extremely	O
unstable	O
.	O

Acoustic	O
-	O
property	O
measurements	O
of	O
the	O
oxide	O
superconductor	O
BaPb1-xBixO3	O
by	O
the	O
sphere	O
-	O
resonance	O
method	O
.	O

Rabbit	B
KCC1	I
(	O
rbKCC1	B
)	O
and	O
rat	B
KCC1	I
(	O
rtKCC1	B
)	O
were	O
cloned	O
by	O
screening	O
rabbit	O
kidney	O
and	O
rat	O
brain	O
cDNA	O
libraries	O
using	O
homologous	O
cDNA	O
probes	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
demonstrate	O
that	O
ZNF76	B
and	O
ZNF143	B
are	O
two	O
members	O
of	O
a	O
same	O
family	O
of	O
transactivator	O
proteins	O
.	O

This	O
model	O
system	O
exploits	O
the	O
polyomavirus	O
late	O
transcription	O
termination	O
and	O
polyadenylation	O
signals	O
,	O
which	O
are	O
sufficiently	O
weak	O
to	O
allow	O
the	O
production	O
of	O
many	O
multigenome	O
-	O
length	O
primary	O
transcripts	O
with	O
repeating	O
introns	O
,	O
exons	O
,	O
and	O
poly	O
(	O
A	O
)	O
sites	O
.	O

The	O
disorders	O
are	O
accompanied	O
by	O
consistent	O
,	O
but	O
similarly	O
reversible	O
,	O
electroencephalographic	O
changes	O
.	O

Electronic	O
structure	O
and	O
optical	O
properties	O
of	O
the	O
B12O2	O
crystal	O
.	O

Basic	B
helix	I
-	I
loop	I
-	I
helix	I
proteins	I
can	O
act	O
at	O
the	O
E	O
-	O
box	O
within	O
the	O
serum	O
response	O
element	O
of	O
the	O
c	B
-	I
fos	I
promoter	I
to	O
influence	O
hormone	O
-	O
induced	O
promoter	O
activation	O
in	O
Sertoli	O
cells	O
.	O

Recent	O
developments	O
in	O
the	O
study	O
of	O
growth	O
factors	O
:	O
GRF	B
and	O
somatomedins	B
.	O

Phenotypic	O
screening	O
of	O
mutations	O
in	O
Pmr1	B
,	O
the	O
yeast	B
secretory	I
pathway	I
Ca2+	I
/	I
Mn2	I
+	I
-ATPase	I
,	O
reveals	O
residues	O
critical	O
for	O
ion	O
selectivity	O
and	O
transport	O
.	O

IV	O
.	O

Routine	O
and	O
default	O
retrieval	O
home	O
visits	O
were	O
given	O
to	O
ensure	O
maximal	O
drug	O
compliance	O
.	O

Thus	O
,	O
an	O
unmodified	O
threonine	O
at	O
position	O
169	O
in	O
Cdc28	B
is	O
important	O
for	O
interaction	O
with	O
G1	B
cyclins	I
.	O

These	O
alterations	O
occurred	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
but	O
did	O
not	O
significantly	O
affect	O
the	O
subcellular	O
distribution	O
of	O
any	O
of	O
the	O
four	O
isoforms	O
.	O

Treatment	O
of	O
chronic	O
hepatitis	O
B	O
with	O
interferon	B
:	O
experience	O
in	O
western	O
countries	O
.	O

Phenazopyridine	O
-	O
induced	O
hemolytic	O
anemia	O
in	O
a	O
patient	O
with	O
G6PD	B
deficiency	O
.	O

The	O
novel	O
gene	O
spans	O
16.7	O
kb	O
of	O
genomic	O
sequence	O
and	O
it	O
is	O
formed	O
of	O
11	O
exons	O
and	O
10	O
intervening	O
introns	O
.	O

Overexpression	O
of	O
a	O
HIF-1alpha	B
construct	O
with	O
deletions	O
of	O
the	O
basic	O
domain	O
and	O
carboxy	O
terminus	O
blocked	O
reporter	O
gene	O
activation	O
by	O
endogenous	O
HIF-1	B
in	O
hypoxic	O
cells	O
.	O

With	O
rats	O
fed	O
on	O
the	O
Zn	O
-	O
sufficient	O
diet	O
,	O
NaFe3+EDTA	O
and	O
Na2EDTA	O
similarly	O
increased	O
the	O
absorption	O
,	O
urinary	O
excretion	O
and	O
retention	O
of	O
Zn	O
but	O
to	O
a	O
lesser	O
extent	O
.	O

The	O
requirement	O
for	O
an	O
essential	O
interaction	O
between	O
NPH	B
I	I
and	O
H4L	B
provides	O
an	O
explanation	O
for	O
the	O
observed	O
restriction	O
of	O
transcription	O
termination	O
to	O
early	O
viral	O
genes	O
.	O

Other	O
clinicopathological	O
features	O
have	O
no	O
definite	O
influence	O
in	O
survival	O
expectancy	O
.	O

One	O
day	O
postoperatively	O
,	O
the	O
mononuclear	O
leukocyte	O
beta	B
2-receptor	I
density	O
decreased	O
maximally	O
by	O
45	O
+	O
/-	O

11	O
%	O
in	O
the	O
enflurane	O
patients	O
,	O
and	O
by	O
53	O
+	O
/-	O

6	O
%	O
in	O
the	O
neurolept	O
patients	O
.	O

A	O
direct	O
statistically	O
reliable	O
correction	O
of	O
decrease	O
of	O
the	O
enzymes	O
with	O
the	O
initial	O
state	O
of	O
the	O
patients	O
has	O
been	O
established	O
in	O
an	O
analysis	O
of	O
25	O
patients	O
aged	O
from	O
18	O
to	O
60	O
years	O
in	O
prosthesis	O
of+	O
the	O
mitral	O
valve	O
(	O
n-9	O
)	O
and	O
closed	O
mitral	O
commissurotomy	O
(	O
n-16	O
)	O
.	O

However	O
,	O
it	O
was	O
observed	O
that	O
storage	O
time	O
affected	O
significantly	O
the	O
biochemical	O
changes	O
occurring	O
in	O
the	O
constituents	O
of	O
carrots	O
exposed	O
to	O
gamma	O
-	O
irradiation	O
.	O

Partial	O
proteolysis	O
of	O
cell	O
surface	O
-	O
iodinated	O
B	B
-	I
G	I
molecules	I
generates	O
extremely	O
similar	O
patterns	O
of	O
spots	O
,	O
both	O
within	O
and	O
between	O
haplotypes	O
.	O

Here	O
we	O
demonstrate	O
the	O
ability	O
of	O
oligonucleotides	O
containing	O
the	O
C4	O
T	O
sequence	O
to	O
confer	O
heat	O
shock	O
inducibility	O
on	O
the	O
reporter	O
gene	O
and	O
show	O
that	O
the	O
presence	O
of	O
two	O
such	O
elements	O
produces	O
more	O
than	O
additive	O
effects	O
on	O
induction	O
.	O

An	O
X	O
-	O
linked	O
zinc	B
finger	I
gene	I
mapping	O
to	O
Xq21.1-q21.3	O
closely	O
related	O
to	O
ZFX	B
and	O
ZFY	B
:	O
possible	O
origins	O
from	O
a	O
common	O
ancestral	O
gene	O
.	O

Promoter	O
activity	O
was	O
assayed	O
by	O
transient	O
transfection	O
of	O
luciferase	B
reporter	I
constructs	I
containing	O
nested	O
deletions	O
of	O
the	O
upstream	O
sequence	O
in	O
the	O
human	O
RPE	O
cell	O
lines	O
ARPE19	O
and	O
D407	O
,	O
as	O
well	O
as	O
in	O
the	O
SK	O
-	O
Mel-28	O
and	O
HeLa	O
cell	O
lines	O
.	O

These	O
results	O
suggest	O
an	O
essential	O
role	O
of	O
the	O
binding	O
of	O
HNF-4	B
and/or	O
HNF-4-related	B
nuclear	I
factors	I
to	O
the	O
6	O
beta	O
A	O
-	O
A	O
site	O
on	O
the	O
basal	O
transcriptional	O
activation	O
of	O
the	O
CYP3A2	B
gene	I
in	O
liver	O
cells	O
.	O

A	O
vascular	O
component	O
to	O
impotence	O
was	O
shown	O
to	O
be	O
common	O
in	O
those	O
with	O
neurological	O
impairment	O
,	O
and	O
may	O
alter	O
management	O
.	O

Bandwidth	O
of	O
auditory	O
units	O
in	O
the	O
chick	O
forebrain	O
(	O
field	O
L	O
/	O
Hv	O
complex	O
)	O
was	O
measured	O
with	O
isointensity	O
tone	O
stimuli	O
.	O

The	O
promoter	O
of	O
this	O
methyltransferase	O
gene	O
lacks	O
an	O
identifiable	O
TATA	O
box	O
but	O
is	O
characterized	O
by	O
a	O
CpG	O
island	O
which	O
begins	O
approximately	O
723	O
nucleotides	O
upstream	O
of	O
the	O
major	O
transcriptional	O
start	O
site	O
and	O
extends	O
through	O
exon	O
1	O
and	O
into	O
the	O
first	O
intron	O
.	O

Three	O
patients	O
with	O
Mirizzi	O
type	O
II	O
syndrome	O
and	O
two	O
patients	O
with	O
Mirizzi	O
type	O
I	O
syndrome	O
were	O
treated	O
laparoscopically	O
.	O

The	O
pregnancies	O
were	O
terminated	O
at	O
19	O
and	O
12	O
weeks	O
of	O
gestation	O
,	O
respectively	O
.	O

The	O
treatment	O
with	O
glucocorticoids	O
and	O
immunosuppressants	O
resulted	O
in	O
a	O
more	O
noticeable	O
decrease	O
in	O
the	O
levels	O
of	O
T3	O
and	O
E	B
-	I
RCF	I
.	O

Rapid	O
,	O
sensitive	O
gas	O
chromatographic	O
analysis	O
of	O
8-methoxypsoralen	O
in	O
human	O
plasma	O
.	O

RESULTS	O
:	O
Sixty	O
-	O
one	O
percent	O
of	O
the	O
patients	O
had	O
damage	O
within	O
7	O
years	O
of	O
onset	O
(	O
mean	O
3.8	O
yrs	O
)	O
.	O

We	O
concluded	O
that	O
HFV	O
can	O
achieve	O
values	O
of	O
CO2	O
elimination	O
close	O
to	O
the	O
estimated	O
metabolic	O
CO2	O
production	O
in	O
normal	O
unintubated	O
subjects	O
over	O
short	O
periods	O
of	O
time	O
.	O

We	O
have	O
characterized	O
21	O
mutations	O
in	O
the	O
type	B
VII	I
collagen	I
gene	I
(	O
COL7A1	B
)	O
encoding	O
the	O
anchoring	O
fibrils	O
,	O
18	O
of	O
which	O
were	O
not	O
previously	O
reported	O
,	O
in	O
patients	O
from	O
15	O
unrelated	O
families	O
with	O
recessive	O
dystrophic	O
epidermolysis	O
bullosa	O
(	O
RDEB	O
)	O
.	O

A	O
case	O
of	O
heterotopic	O
gastric	O
mucosa	O
(	O
pyloric	O
gland	O
)	O
in	O
the	O
wall	O
of	O
the	O
gallbladder	O
was	O
reported	O
.	O

Ribosome	O
association	O
of	O
GCN2	B
protein	I
kinase	I
,	O
a	O
translational	O
activator	O
of	O
the	O
GCN4	B
gene	I
of	O
Saccharomyces	O
cerevisiae	O
.	O

These	O
segments	O
may	O
represent	O
pseudogenes	O
.	O

Corresponding	O
oligonucleotides	O
were	O
used	O
to	O
screen	O
a	O
rat	O
liver	O
cDNA	O
library	O
constructed	O
in	O
the	O
plasmid	O
cloning	O
vector	O
,	O
pcDV	O
.	O

Extracellular	B
regulated	I
kinases	I
(	I
ERK	I
)	I
1	I
and	O
ERK2	B
are	O
authentic	O
substrates	O
for	O
the	O
dual	B
-	I
specificity	I
protein	I
-	I
tyrosine	I
phosphatase	I
VHR	I
.	O

The	O
model	O
therefore	O
predicts	O
that	O
1	O
)	O
on	O
-	O
line	O
calculation	O
of	O
airway	O
dead	O
space	O
and	O
end	O
-	O
expired	O
lung	O
volume	O
can	O
be	O
made	O
by	O
the	O
addition	O
of	O
an	O
oxygen	O
sine	O
-	O
wave	O
perturbation	O
component	O
to	O
the	O
mean	O
FIO2	O
;	O
and	O
(	O
2	O
)	O
QS	O
/	O
QT	O
can	O
be	O
measured	O
from	O
the	O
resultant	O
oxygen	O
perturbation	O
sine	O
-	O
wave	O
amplitudes	O
in	O
the	O
expired	O
gas	O
and	O
in	O
arterial	O
and	O
mixed	O
-	O
venous	O
blood	O
and	O
is	O
independent	O
of	O
the	O
mean	O
blood	O
oxygen	O
partial	O
pressure	O
and	O
oxyhemoglobin	B
saturation	O
values	O
.	O

An	O
anoerxiant	O
,	O
mazindol	O
suppresses	O
food	O
intake	O
by	O
1	O
)	O
stimulating	O
beta	B
-	I
adrenergic	I
receptors	I
,	O
2	O
)	O
inhibiting	O
the	O
feeding	O
center	O
and	O
,	O
3	O
)	O
stimulating	O
the	O
satiety	O
center	O
in	O
the	O
hypothalamus	O
.	O

When	O
patients	O
were	O
admitted	O
within	O
one	O
week	O
of	O
the	O
onset	O
of	O
dark	O
urine	O
,	O
45	O
%	O
were	O
found	O
to	O
be	O
shedding	O
HAV	O
,	O
whereas	O
only	O
11	O
%	O
of	O
specimens	O
obtained	O
from	O
patients	O
admitted	O
during	O
the	O
second	O
week	O
contained	O
virus	O
.	O

Positive	O
effects	O
of	O
radioactive	O
therapy	O
in	O
Guarapari	O

Nevertheless	O
,	O
lower	O
doses	O
which	O
alone	O
were	O
lacking	O
in	O
activity	O
(	O
100	O
-	O
250	O
mg	O
/	O
kg	O
B1	O
and	O
B6	O
,	O
1	O
-	O
2.5	O
mg	O
/	O
kg	O
B12	O
p.o	O
.	O
)	O

dose	O
-	O
dependently	O
potentiated	O
the	O
antinociceptive	O
of	O
diclofenac	O
.	O

Escherichia	O
coli	O
strains	O
carrying	O
recA730	B
(	O
or	O
other	O
recA	B
*	I
alleles	I
)	O
exhibit	O
dramatic	O
increases	O
in	O
SOS	O
-	O
dependent	O
spontaneous	O
mutator	O
activity	O
.	O

On	O
the	O
contrary	O
i.v	O
.	O

administration	O
of	O
calcitonin	B
increased	O
intrapyloric	O
pressure	O
via	O
vagal	O
nerves	O
in	O
atropinized	O
or	O
gallaminized	O
animals	O
.	O

Overall	O
,	O
free	O
-	O
chlorine	O
treatments	O
(	O
0.3	O
or	O
1.0	O
mg	O
/	O
L	O
)	O
showed	O
significantly	O
lower	O
heterotrophic	O
plate	O
numbers	O
than	O
those	O
without	O
free	O
chlorine	O
.	O

The	O
curse	O
of	O
the	O
Pharaohs	O
.	O

The	O
enigma	O
of	O
aging	O
bone	O
loss	O
.	O

In	O
both	O
cell	O
types	O
,	O
insulin	B
led	O
to	O
a	O
dose	O
-	O
dependent	O
increase	O
in	O
the	O
association	O
of	O
tyrosine	B
phosphorylated	I
IRS-1	I
with	O
the	O
SH2	B
domain	I
of	O
the	O
p85	B
regulatory	I
subunit	I
of	O
PI-3	B
kinase	I
,	O
and	O
also	O
increased	O
the	O
amount	O
of	O
PI	B
kinase	I
activity	O
detected	O
in	O
anti	B
-	I
IRS-1	I
immunoprecipitates	O
.	O

Twelve	O
(	O
92	O
%	O
)	O
showed	O
cognitive	O
dysfunction	O
including	O
impairments	O
in	O
memory	O
,	O
attention	O
,	O
and	O
affective	O
disturbances	O
(	O
anxiety	O
,	O
depression	O
,	O
irritability	O
,	O
and	O
poor	O
frustration	O
tolerance	O
)	O
.	O

These	O
effects	O
were	O
antagonized	O
by	O
prior	O
administration	O
of	O
1-	O
(	O
2-methoxyphenyl	O
)	O
-4-	O
[	O
-	O
(	O
2-phthalimido	O
)	O
butyl	O
]	O
piperazine	O
)	O
(	O
0.5	O
mg	O
/	O
kg	O
,	O
i.p	O
.	O
)	O
.	O

Transcription	O
initiation	O
from	O
this	O
region	O
was	O
also	O
detected	O
in	O
vivo	O
,	O
when	O
the	O
cloned	O
rRNA	O
gene	O
cluster	O
was	O
present	O
on	O
a	O
multi	O
-	O
copy	O
plasmid	O
.	O

The	O
effects	O
of	O
dopamine	O
and	O
of	O
dopamine	B
D2	I
receptor	I
blocker	O
haloperidol	O
on	O
the	O
activity	O
of	O
carotid	O
chemoreceptors	O
were	O
studied	O
in	O
24	O
anesthetized	O
,	O
paralyzed	O
and	O
artificially	O
ventilated	O
newborn	O
kittens	O
aged	O
0	O
-	O
17	O
days	O
.	O

DNMT2	B
binds	O
AdoHcy	O
in	O
the	O
same	O
conformation	O
as	O
confirmed	O
m	B
(	I
5	I
)	I
C	I
MTases	I
and	O
,	O
while	O
DNMT2	B
shares	O
all	O
sequence	O
and	O
structural	O
features	O
with	O
m	B
(	I
5	I
)	I
C	I
MTases	I
,	O
it	O
has	O
failed	O
to	O
demonstrate	O
detectable	O
transmethylase	O
activity	O
.	O

The	O
standardized	O
incidence	O
in	O
Europeans	O
has	O
risen	O
significantly	O
to	O
4.7	O
/	O
10	O
(	O
5	O
)	O
/	O
year	O
from	O
3.4	O
/	O
10	O
(	O
5	O
)	O
/	O
year	O
in	O
the	O
1970s	O
(	O
chi	O
2	O
=	O
8.1	O
,	O
p	O
less	O
than	O
0.005	O
)	O
.	O

Multiple	O
aortic	O
thrombi	O
associated	O
with	O
protein	B
C	I
and	O
S	B
deficiency	O
.	O

The	O
practice	O
of	O
measuring	O
of	O
AChE	B
levels	O
in	O
acute	O
poisoning	O
is	O
limited	O
.	O

M.	O
,	O
Adrich	O
,	O
Z.	O
,	O
Fournet	O
,	O
B.	O
,	O
Capon	O
,	O
C.	O
,	O
Bonicel	O
,	O
J.	O

Confocal	O
fluorescent	O
microscopy	O
analysis	O
demonstrated	O
that	O
WT	O
,	O
VaI	O
,	O
and	O
VaII	O
all	O
distribute	O
equally	O
to	O
the	O
cell	O
surface	O
while	O
,	O
as	O
expected	O
,	O
a	O
WT	O
mutant	O
lacking	O
the	O
two	O
C	O
-	O
terminal	O
valine	O
residues	O
does	O
not	O
.	O

The	O
amount	O
of	O
ERCC1	B
detectable	O
by	O
immunoblotting	O
is	O
reduced	O
in	O
group	O
1	O
,	O
group	O
4	O
and	O
XP	O
-	O
F	O
extracts	O
.	O

Letter	O
:	O
Ballistocardiography	O
.	O

Metabolic	O
studies	O
of	O
tetrabenazine	O
,	O
a	O
psychotropic	O
drug	O
in	O
animals	O
and	O
man	O
.	O

Gene	O
transcripts	O
are	O
detected	O
on	O
tissues	O
such	O
as	O
bovine	O
liver	O
,	O
kidney	O
,	O
lung	O
,	O
and	O
brain	O
.	O

Plasma	B
enteroglucagon	I
was	O
measured	O
before	O
and	O
during	O
three	O
hours	O
after	O
a	O
standard	O
meal	O
in	O
21	O
untreated	O
adult	O
patients	O
with	O
suspected	O
coeliac	O
disease	O
who	O
all	O
had	O
villous	O
atrophy	O
of	O
the	O
small	O
intestinal	O
mucosa	O
and	O
malabsorption	O
,	O
and	O
in	O
nine	O
control	O
subjects	O
.	O

In	O
this	O
report	O
,	O
we	O
establish	O
that	O
the	O
heteromeric	O
CCAAT	B
-	I
binding	I
factor	I
CBF	B
is	O
the	O
major	O
component	O
of	O
the	O
C1-binding	B
factor	I
(	O
C1F	B
)	O
in	O
human	O
cells	O
.	O

This	O
growth	O
-	O
inhibitory	O
effect	O
was	O
suppressed	O
by	O
the	O
mpk1	B
delta	I
mutation	O
,	O
suggesting	O
that	O
hyperactivation	O
of	O
the	O
Mpk1	B
pathway	O
is	O
toxic	O
to	O
cells	O
.	O

The	O
human	B
PAX8	I
gene	I
generates	O
at	O
least	O
five	O
different	O
alternatively	O
spliced	O
transcripts	O
encoding	O
different	O
PAX8	B
isoforms	I
.	O

The	O
use	O
of	O
specific	O
somatic	O
cell	O
hybrids	O
have	O
allowed	O
us	O
to	O
locate	O
the	O
YAC	O
contig	O
telomeric	O
to	O
the	O
D3F15S2	B
locus	I
,	O
in	O
a	O
region	O
which	O
is	O
frequently	O
deleted	O
in	O
lung	O
carcinomas	O
.	O

Characterization	O
of	O
Chlamydomonas	O
reinhardtii	O
zygote	O
-	O
specific	O
cDNAs	O
that	O
encode	O
novel	O
proteins	O
containing	O
ankyrin	B
repeats	O
and	O
WW	O
domains	O
.	O

Subsequent	O
analysis	O
revealed	O
that	O
MyD88	B
possesses	O
a	O
unique	O
modular	O
structure	O
,	O
which	O
consists	O
of	O
an	O
N	O
-	O
terminal	O
""""	O
death	O
domain	O
,	O
""""	O
similar	O
to	O
the	O
intracellular	O
segments	O
of	O
TNF	B
receptor	I
1	I
and	O
Fas	B
,	O
and	O
a	O
C	O
-	O
terminal	O
region	O
related	O
to	O
the	O
cytoplasmic	O
domains	O
of	O
the	O
Drosophila	B
morphogen	I
Toll	I
and	O
vertebrate	O
interleukin-1	B
receptors	I
.	O

Role	O
of	O
zinc	B
-	I
finger	I
proteins	I
Sp1	I
and	O
zif268	B
/	O
egr-1	B
in	O
transcriptional	O
regulation	O
of	O
the	O
human	B
synaptobrevin	I
II	I
gene	I
.	O

The	O
GvpE	B
protein	I
involved	O
in	O
the	O
regulation	O
of	O
gas	O
vesicles	O
synthesis	O
in	O
halophilic	O
archaea	O
has	O
been	O
identified	O
as	O
the	O
transcriptional	O
activator	O
for	O
the	O
promoter	O
located	O
upstream	O
of	O
the	O
gvpA	B
gene	I
encoding	O
the	O
major	O
gas	O
vesicle	O
structural	O
protein	O
GvpA.	B

Experience	O
in	O
using	O
the	O
Romashka-1	O
laser	O
surgical	O
unit	O
in	O
treating	O
suppurative	O
wounds	O

At	O
a	O
cutoff	O
point	O
for	O
KISA%	O
of	O
100	O
,	O
280	O
of	O
281	O
participants	O
(	O
99.6	O
%	O
)	O
were	O
correctly	O
classified	O
.	O

The	O
AP-1	B
recruited	O
by	O
ARF1.GTP	B
is	O
released	O
from	O
the	O
Golgi	O
membrane	O
by	O
treatment	O
with	O
1	O
M	O
Tris	O
-	O
HCl	O
(	O
pH	O
7	O
)	O
or	O
upon	O
reincubation	O
at	O
37	O
degreesC	O
,	O
whereas	O
AP-1	B
recruited	O
with	O
GTPgammaS	O
or	O
by	O
a	O
constitutively	O
active	O
point	O
mutant	O
,	O
ARF1	B
(	I
Q71L	I
)	I
,	O
remains	O
membrane	O
bound	O
after	O
either	O
treatment	O
.	O

In	O
K562	O
cells	O
,	O
using	O
the	O
bicistronic	O
vector	O
,	O
selection	O
with	O
colchicine	O
led	O
to	O
at	O
least	O
20-fold	O
higher	O
expression	O
of	O
the	O
MDR1	B
gene	I
product	I
than	O
did	O
selection	O
with	O
G418	O
,	O
suggesting	O
that	O
the	O
stringent	O
MDR1	B
selection	O
system	O
is	O
very	O
efficient	O
for	O
obtaining	O
overexpression	O
of	O
foreign	O
genes	O
.	O

A	O
surge	O
in	O
the	O
rate	O
of	O
ascorbyl	O
radical	O
production	O
,	O
directly	O
correlated	O
with	O
oxyradical	O
stress	O
and	O
an	O
abrupt	O
fall	O
in	O
superoxide	B
dismutase	I
activity	O
in	O
the	O
granuloma	O
,	O
indicates	O
'	O
switching	O
on	O
'	O
of	O
a	O
free	O
radical	O
-	O
dependent	O
machinery	O
for	O
the	O
formation	O
of	O
granuloma	O
after	O
vasectomy	O
.	O

The	O
vaccine	O
was	O
highly	O
immunogenic	O
,	O
since	O
111	O
of	O
113	O
patients	O
(	O
98	O
%	O
)	O
produced	O
anti	B
-	I
HBs	I
(	O
10	O
mIU	O
/	O
ml	O
or	O
more	O
)	O
.	O

Papillomavirus	O
type	O
16	O
oncogenes	O
downregulate	O
expression	O
of	O
interferon	B
-	O
responsive	O
genes	O
and	O
upregulate	O
proliferation	O
-	O
associated	O
and	O
NF	B
-	I
kappaB	I
-	O
responsive	O
genes	O
in	O
cervical	O
keratinocytes	O
.	O

Our	O
results	O
show	O
that	O
a	O
combination	O
of	O
Pfu	B
exo	I
(	I
-	I
)	I
at	O
the	O
primer	O
extension	O
step	O
and	O
Taq	B
at	O
the	O
PCR	O
amplification	O
step	O
is	O
ideal	O
for	O
in	O
vivo	O
DNA	O
analysis	O
and	O
DNA	O
damage	O
mapping	O
using	O
LMPCR	O
.	O

KU-1257	O
also	O
significantly	O
accelerated	O
the	O
healing	O
of	O
acetic	O
acid	O
-	O
induced	O
duodenal	O
ulcers	O
as	O
well	O
as	O
famotidine	O
and	O
roxatidine	O
acetate	O
.	O

Prolongation	O
of	O
prothrombin	B
time	O
was	O
not	O
due	O
to	O
depletion	O
of	O
vitamin	O
K	O
-	O
dependent	O
coagulation	O
factors	O
or	O
manifest	O
fibrinolysis	O
,	O
but	O
due	O
to	O
the	O
presence	O
of	O
circulating	O
fibrinogen	B
fibrinmonomer	I
-	O
FDP	O
complexes	O
.	O

Clostridium	O
botulinum	O
in	O
marine	O
sediment	O

Upstream	B
stimulatory	I
factor	I
USF	B
is	O
a	O
human	O
transcriptional	O
activation	O
factor	O
,	O
which	O
uses	O
a	O
basic	O
/	O
helix	O
-	O
loop	O
-	O
helix	O
/	O
leucin	O
zipper	O
(	O
b	O
/	O
HLH	O
/	O
Z	O
)	O
motif	O
to	O
homodimerize	O
and	O
recognize	O
specific	O
sequences	O
in	O
the	O
promoter	O
region	O
of	O
both	O
nuclear	O
and	O
viral	O
genes	O
transcribed	O
by	O
RNA	B
polymerase	I
II	I
.	O

Fusion	O
of	O
mouse	B
CD8	I
+	I
class	B
I	I
MHC	I
-	O
restricted	O
T	O
cells	O
with	O
the	O
BW5147	O
thymoma	O
invariably	O
yields	O
CD8-	B
hybridomas	O
in	O
which	O
RNA	O
transcribed	O
from	O
the	O
CD8	B
alpha	I
(	O
Lyt-2	B
)	O
gene	O
is	O
undetectable	O
.	O

Consistent	O
with	O
this	O
hypothesis	O
,	O
alpha1-PDX	B
prevents	O
cleavage	O
of	O
BMP-4	B
in	O
an	O
oocyte	O
translation	O
assay	O
.	O

In	O
this	O
study	O
we	O
cloned	O
the	O
cDNA	O
of	O
AD1	B
Ag	I
from	O
a	O
rat	O
basophilic	O
leukemia	O
2H3	O
cDNA	O
library	O
.	O

Several	O
sequences	O
resembling	O
binding	O
sites	O
for	O
liver-	O
and	O
fat	O
body	O
-	O
specific	O
transcription	O
factors	O
were	O
identified	O
within	O
1	O
kb	O
upstream	O
and	O
downstream	O
of	O
the	O
gene	O
.	O

Root	O
surface	O
caries	O
incidence	O
in	O
the	O
groups	O
inoculated	O
with	O
A.	O
viscosus	O
and	O
A.	O
viscosus	O
plus	O
S.	O
sobrinus	O
did	O
not	O
differ	O
.	O

The	O
prgX	B
gene	I
is	O
adjacent	O
to	O
prgQ	B
which	O
provides	O
the	O
promoter	O
for	O
prgB	B
expression	O
.	O

Frequency	O
of	O
recurrence	O
of	O
fibroids	O
after	O
myomectomy	O
has	O
been	O
evaluated	O
in	O
145	O
women	O
(	O
median	O
age	O
38	O
years	O
,	O
range	O
21	O
-	O
52	O
)	O
who	O
underwent	O
myomectomy	O
.	O

There	O
is	O
a	O
good	O
correlation	O
between	O
the	O
occurrence	O
in	O
any	O
particular	O
vascular	O
segment	O
of	O
the	O
transient	O
contractile	O
response	O
and	O
intrinsic	O
tone	O
as	O
assessed	O
by	O
relaxation	O
to	O
papaverine	O
(	O
10	O
(	O
-6	O
)	O
M	O
)	O
.	O

The	O
antimicrobial	O
of	O
choice	O
for	O
initial	O
prophylactic	O
therapy	O
among	O
asymptomatic	O
pregnant	O
women	O
exposed	O
to	O
Bacillus	O
anthracis	O
is	O
ciprofloxacin	O
,	O
500	O
mg	O
twice	O
a	O
day	O
for	O
60	O
days	O
.	O

Nickel	O
release	O
from	O
tools	O
on	O
the	O
Swedish	O
market	O
.	O

There	O
was	O
no	O
correlation	O
between	O
starting	O
platelet	O
-	O
associated	O
IgG	B
levels	O
or	O
changes	O
in	O
platelet	O
-	O
associated	O
IgG	B
levels	O
with	O
therapy	O
and	O
the	O
increment	O
in	O
the	O
patient	O
's	O
platelet	O
count	O
.	O

In	O
a	O
rat	O
model	O
of	O
SAH	O
,	O
we	O
assessed	O
BBB	O
changes	O
by	O
means	O
of	O
the	O
quantitative	O
[	O
14C	O
]	O
-alpha	O
-	O
aminoisobutyric	O
acid	O
technique	O
.	O

BAG-1	B
also	O
prevented	O
growth	O
arrest	O
following	O
UV	O
-	O
irradiation	O
-	O
induced	O
genotoxic	O
injury	O
without	O
interfering	O
with	O
accumulation	O
of	O
p53	B
protein	I
or	O
p21	B
(	O
waf-1	B
)	O
expression	O
.	O

During	O
the	O
last	O
three	O
days	O
of	O
the	O
study	O
,	O
mean	O
urine	O
osmolality	O
(	O
Uosm	O
)	O
and	O
free	O
water	O
reabsorption	O
(	O
TCH2O	O
)	O
increased	O
significantly	O
:	O
[	O
formula	O
:	O
see	O
text	O
]	O
.	O

[	O
(	O
OP	O
)	O
2Cu	O
]	O
+	O
also	O
detected	O
protections	O
in	O
the	O
C	O
alpha	O
-	O
helix	O
,	O
the	O
interdomain	O
hinge	O
,	O
and	O
beta	O
-	O
strands	O
2	O
-	O
7	O
.	O

The	O
gene	O
,	O
from	O
the	O
initiator	O
methionine	O
to	O
the	O
polyadenylation	O
site	O
,	O
is	O
contained	O
within	O
13	O
244	O
basepairs	O
and	O
contains	O
19	O
exons	O
.	O

To	O
study	O
structural	O
diversity	O
of	O
the	O
three	O
homologous	O
loci	O
encoding	O
a	O
KN1-like	B
homeobox	I
protein	I
in	O
the	O
hexaploid	O
wheat	O
genome	O
,	O
we	O
isolated	O
clones	O
from	O
a	O
cDNA	O
library	O
of	O
young	O
spikes	O
of	O
Japanese	O
common	O
wheat	O
cultivar	O
'	O
Norin	O
26	O
'	O
.	O

Controversy	O
exists	O
regarding	O
both	O
the	O
natural	O
life	O
cycle	O
for	O
this	O
parasite	O
as	O
well	O
as	O
the	O
species	O
identity	O
of	O
opossum	O
Sarcocystis	O
.	O

Here	O
we	O
report	O
that	O
components	O
of	O
the	O
Ras	B
/	O
Raf	B
/	O
MAPK	B
pathway	O
are	O
constitutively	O
activated	O
in	O
these	O
lck	B
-	O
transformed	O
immature	O
thymoblasts	O
.	O

p56	B
(	O
lck	B
)	O
utilizes	O
Shc	B
and	O
Grb2	B
adaptors	I
to	O
mediate	O
activation	O
of	O
p21	B
(	O
ras	B
)	O
in	O
the	O
thymoblast	O
lines	O
by	O
promoting	O
tyrosine	O
phosphorylation	O
of	O
the	O
Shc	B
protein	I
and	O
constitutive	O
interaction	O
between	O
Shc	B
and	O
Grb2	B
.	O

Unfractionated	O
heparin	O
(	O
UFH	O
)	O
given	O
at	O
a	O
dose	O
of	O
0.3	O
mg	O
x	O
kg-1	O
bolus	O
+	O
0.3	O
mg	O
x	O
kg-1	O
x	O
h-1	O
infusion	O
did	O
not	O
improve	O
the	O
incidence	O
of	O
reperfusion	O
or	O
lower	O
the	O
incidence	O
of	O
reocclusion	O
.	O

The	O
quantification	O
limit	O
was	O
50	O
ng	O
/	O
ml	O
for	O
each	O
of	O
PHT	O
,	O
m	O
-	O
HPPH	O
and	O
p	O
-	O
HPPH	O
.	O

Plasma	B
hemopexin	I
homeostasis	O
during	O
the	O
acute	O
phase	O
response	O
.	O

Our	O
aim	O
was	O
to	O
check	O
whether	O
,	O
during	O
PG	O
-	O
DS	O
administration	O
,	O
serum	O
lipase	B
activity	O
changes	O
simultaneously	O
with	O
serum	O
amylase	B
activity	O
,	O
and	O
,	O
if	O
so	O
,	O
what	O
the	O
reason	O
is	O
for	O
the	O
detected	O
change	O
.	O

Cytokines	O
and	O
steroid	O
hormones	O
use	O
different	O
sets	O
of	O
signal	O
transduction	O
pathways	O
,	O
which	O
seem	O
to	O
be	O
unrelated	O
.	O

This	O
is	O
the	O
most	O
northern	O
and	O
,	O
at	O
the	O
same	O
time	O
largest	O
,	O
Q	O
fever	O
epidemic	O
recorded	O
in	O
Germany	O
over	O
the	O
last	O
28	O
years	O
.	O

Genetic	O
analysis	O
of	O
the	O
role	O
of	O
herpes	B
simplex	I
virus	I
type	I
1	I
glycoprotein	I
K	I
in	O
infectious	O
virus	O
production	O
and	O
egress	O
.	O

The	O
5	O
'	O
half	O
of	O
the	O
EWS	B
gene	I
has	O
recently	O
been	O
described	O
to	O
be	O
fused	O
to	O
the	O
3	O
'	O
regions	O
of	O
genes	O
encoding	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
several	O
transcriptional	O
regulators	O
,	O
including	O
ATF1	B
,	O
FLI-1	B
,	O
and	O
ERG	B
,	O
in	O
several	O
human	O
tumors	O
.	O

We	O
used	O
high	O
-	O
resolution	O
ultrasound	O
to	O
characterize	O
postprandial	O
antral	O
excursion	O
characteristics	O
in	O
15	O
healthy	O
volunteers	O
.	O

Multivariable	O
logistic	O
regression	O
showed	O
that	O
mean	O
blood	O
glucose	O
level	O
for	O
the	O
first	O
2	O
days	O
(	O
p	O
=	O
0.002	O
)	O
,	O
obesity	O
(	O
p	O
<	O
0.002	O
)	O
,	O
and	O
use	O
of	O
the	O
internal	O
mammary	O
artery	O
(	O
p	O
<	O
0.02	O
)	O
were	O
all	O
independent	O
predictors	O
of	O
deep	O
wound	O
infection	O
.	O

Fine	O
tangled	O
pili	O
expressed	O
by	O
Haemophilus	O
ducreyi	O
are	O
a	O
novel	O
class	O
of	O
pili	O
.	O

CONCLUSIONS	O
:	O
The	O
RRM	O
is	O
one	O
of	O
the	O
most	O
common	O
and	O
best	O
characterized	O
RNA	O
-	O
binding	O
motifs	O
.	O

Serum	O
levels	O
of	O
total	O
and	O
specific	B
immunoglobulin	I
E	I
(	O
IgE	B
)	O
have	O
been	O
determined	O
by	O
radioimmunoassays	O
in	O
sixty	O
-	O
nine	O
allergic	O
subjects	O
.	O

The	O
largest	O
one	O
probably	O
corresponds	O
to	O
the	O
precursor	O
form	O
of	O
PS2	B
in	O
E.	O
coli	O
.	O

The	O
identification	O
of	O
SRP54sc	B
and	O
SRP54sp	B
provides	O
the	O
first	O
evidence	O
for	O
SRP	B
related	O
proteins	O
in	O
yeast	O
.	O

Urease	B
activity	O
,	O
judged	O
as	O
the	O
amount	O
of	O
ammonia	O
production	O
from	O
urea	O
,	O
could	O
be	O
measured	O
at	O
25	O
ng	O
per	O
tube	O
(	O
S	O
/	O
N	O
=	O
1.5	O
)	O
with	O
Jack	B
bean	I
meal	I
urease	I
.	O

In	O
a	O
previous	O
study	O
of	O
transforming	B
growth	I
factor	I
-	I
beta1-mediated	I
inhibition	O
of	O
the	O
cyclin	B
A	I
promoter	I
,	O
we	O
mapped	O
the	O
inhibitory	O
effect	O
to	O
the	O
ATF	B
site	I
;	O
in	O
the	O
present	O
study	O
of	O
IFN	B
-	I
gamma	I
treatment	O
,	O
functional	O
analysis	O
by	O
transient	O
transfection	O
showed	O
that	O
inhibition	O
of	O
the	O
cyclin	B
A	I
promoter	I
persisted	O
despite	O
mutation	O
of	O
the	O
ATF	B
,	O
NF	B
-	I
Y	I
,	O
or	O
CDE	O
elements	O
.	O

We	O
show	O
that	O
GCNF	B
binds	O
to	O
one	O
of	O
the	O
two	O
DRO	O
sequences	O
in	O
the	O
Prm1	B
promoter	I
,	O
and	O
to	O
the	O
DRO	O
sequence	O
in	O
the	O
Prm2	B
promoter	I
in	O
a	O
specific	O
manner	O
.	O

From	O
1977	O
to	O
1985	O
,	O
42	O
patients	O
with	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
anal	O
canal	O
were	O
treated	O
with	O
mitomycin	O
C	O
(	O
15	O
mg	O
/	O
m2	O
)	O
and	O
5-fluorouracil	O
(	O
750	O
mg	O
/	O
m2	O
)	O
on	O
day	O
1	O
,	O
5-FU	O
(	O
750	O
mg	O
/	O
m2	O
/	O
d	O
)	O
alone	O
on	O
days	O
2	O
to	O
5	O
,	O
and	O
radiation	O
therapy	O
(	O
3000	O
cGy	O
)	O
on	O
days	O
7	O
to	O
28	O
.	O

Effect	O
of	O
choline	O
magnesium	O
trisalicylate	O
on	O
prostacyclin	O
production	O
by	O
isolated	O
vascular	O
tissue	O
of	O
the	O
rat	O
.	O

The	O
magnitude	O
of	O
all	O
four	O
parameters	O
increased	O
in	O
an	O
exponential	O
fashion	O
with	O
increasing	O
sperm	O
number	O
up	O
to	O
400	O
x	O
10	O
(	O
6	O
)	O
per	O
ejaculate	O
.	O

In	O
HMEC	O
stably	O
transfected	O
with	O
an	O
ER	B
mutant	I
containing	O
a	O
deletion	O
in	O
the	O
second	O
zinc	O
finger	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
,	O
E	O
and	O
HT	O
had	O
different	O
effects	O
on	O
EBBP	B
gene	I
expression	O
;	O
EBBP	B
regulation	O
by	O
E	O
was	O
dramatically	O
reduced	O
while	O
the	O
effects	O
of	O
HT	O
were	O
augmented	O
.	O

6	O
h	O
after	O
ingestion	O
of	O
aspirin	O
on	O
day	O
1	O
to	O
day	O
14	O
,	O
both	O
TX	O
and	O
PGI2	O
levels	O
also	O
significantly	O
decreased	O
(	O
p	O
<	O
0.0001	O
)	O
.	O

NF	B
-	I
kappaB	I
DNA	O
-	O
protein	O
binding	O
and	O
ICAM-1	B
promoter	I
activity	O
were	O
enhanced	O
by	O
IL-1beta	B
and	O
these	O
effects	O
were	O
inhibited	O
by	O
tyrphostin	O
23	O
,	O
but	O
not	O
by	O
PD	O
98059	O
or	O
SB	O
203580	O
.	O

In	O
murine	O
cells	O
,	O
FPGS	B
expression	O
is	O
controlled	O
by	O
two	O
promoters	O
that	O
,	O
as	O
we	O
show	O
here	O
,	O
vary	O
substantially	O
in	O
their	O
efficiency	O
,	O
at	O
least	O
in	O
the	O
context	O
of	O
a	O
reporter	O
gene	O
assay	O
.	O

Quantitative	O
measurement	O
of	O
antigamma	B
globulin	I
factors	I
(	O
rheumatoid	B
factors	I
)	O
using	O
laser	O
-	O
nephelometry	O
in	O
comparison	O
with	O
the	O
latex	O
agglutination	O
test	O
and	O
the	O
Waaler	O
-	O
Rose	O
test	O

The	O
complete	O
nucleotide	O
sequence	O
of	O
odontoglossum	O
ringspot	O
virus	O
(	O
Cy-1	O
strain	O
)	O
genomic	O
RNA	O
.	O

The	O
B.	B
aphidicola	I
argS	I
-	I
rrn	I
DNA	I
fragments	I
from	O
endosymbionts	O
from	O
seven	O
species	O
of	O
aphids	O
had	O
promoter	O
activities	O
in	O
E.	O
coli	O
which	O
ranged	O
from	O
6	O
to	O
135	O
%	O
of	O
that	O
observed	O
with	O
a	O
comparable	O
DNA	O
fragment	O
of	O
E.	B
coli	I
rrnB.	I

CONCLUSIONS	O
:	O
These	O
principally	O
structural	O
studies	O
support	O
the	O
hypothesis	O
that	O
the	O
thrombus	O
is	O
a	O
self	O
-	O
sustaining	O
entity	O
that	O
may	O
have	O
significance	O
in	O
the	O
pathophysiologic	O
mechanism	O
of	O
abdominal	O
aortic	O
aneurysms	O
.	O

The	O
authors	O
report	O
about	O
the	O
exeresis	O
of	O
a	O
pyelonephrictic	O
left	O
small	O
kidney	O
with	O
laparoscopic	O
surgery	O
.	O

AMPK	B
is	O
a	O
heterotrimer	O
composed	O
of	O
a	O
catalytic	O
subunit	O
(	O
alpha	O
)	O
and	O
two	O
regulatory	O
subunits	O
(	O
beta	O
and	O
gamma	O
)	O
.	O

The	O
genes	O
encoding	O
these	O
carotenoids	O
in	O
E.	O
herbicola	O
Eho13	O
are	O
clustered	O
in	O
a	O
7	O
kb	O
DNA	O
fragment	O
.	O

Genetic	O
diagnosis	O
of	O
respiratory	O
diseases	O

Whereas	O
mutant	B
6C4	I
specified	O
a	O
wild	B
-	I
type	I
-	I
size	I
Pol	I
protein	I
,	O
we	O
detected	O
no	O
full	B
-	I
length	I
Pol	I
protein	I
in	O
7E4-infected	O
cell	O
extracts	O
.	O

Incidence	O
of	O
beta	O
-	O
thalassemia	O
carriers	O
and	O
those	O
deficient	O
in	O
erythrocyte	B
glucose-6-phosphate	I
dehydrogenase	I
in	O
the	O
greater	O
Buenos	O
Aires	O
area	O

These	O
transcripts	O
directed	O
the	O
synthesis	O
of	O
three	O
proteins	O
:	O
the	O
virus	B
trans	I
-	I
activator	I
protein	I
(	O
EIAV	B
Tat	I
)	O
encoded	O
by	O
ORF	O
S1	O
,	O
a	O
protein	O
of	O
unknown	O
function	O
encoded	O
by	O
ORF	O
S2	O
,	O
and	O
the	O
virus	O
envelope	B
glycoprotein	I
.	O

In	O
addition	O
,	O
because	O
SB203580	O
had	O
no	O
effect	O
of	O
TNF-	B
or	O
ceramide	O
-	O
induced	O
apoptosis	O
,	O
our	O
results	O
strongly	O
argue	O
against	O
a	O
role	O
for	O
p38	B
MAPK	I
in	O
the	O
induction	O
of	O
TNF--	B
or	O
ceramide	O
-	O
induced	O
apoptosis	O
.	O

YACs	O
,	O
BACs	O
,	O
cosmids	O
,	O
and	O
STSs	O
are	O
defined	O
to	O
aid	O
in	O
further	O
study	O
of	O
this	O
gene	O
.	O

This	O
chimera	O
transduced	O
IL-4-specific	B
signals	O
in	O
response	O
to	O
IL-2	B
binding	O
and	O
dramatically	O
enhanced	O
type	O
2	O
responses	O
(	O
IL-4	B
,	O
IL-5	B
,	O
and	O
immunoglobulin	B
E	I
production	O
)	O
upon	O
in	O
vitro	O
TCR	B
stimulation	O
or	O
in	O
vivo	O
antigen	O
challenge	O
.	O

We	O
previously	O
demonstrated	O
that	O
AKT2	B
,	O
a	O
member	O
of	O
protein	B
kinase	I
B	I
family	I
,	O
is	O
activated	O
by	O
a	O
number	O
of	O
growth	O
factors	O
via	O
Ras	B
and	O
PI	B
3-kinase	I
signaling	O
pathways	O
.	O

This	O
demonstrates	O
the	O
presence	O
of	O
a	O
PKC	B
-	O
dependent	O
pathway	O
which	O
functions	O
independently	O
from	O
Lck	B
in	O
MAP	B
kinase	I
activation	O
.	O

Finally	O
,	O
transfection	O
of	O
Grb10	B
genes	I
with	O
specific	O
mutations	O
in	O
their	O
SH2	B
domains	I
induces	O
apoptosis	O
in	O
HTC	O
-	O
IR	O
and	O
COS-7	O
cells	O
.	O

Physical	O
map	O
of	O
the	O
genome	O
of	O
sonchus	O
yellow	O
net	O
virus	O
,	O
a	O
plant	O
rhabdovirus	O
with	O
six	O
genes	O
and	O
conserved	O
gene	O
junction	O
sequences	O
.	O

It	O
is	O
an	O
untested	O
argument	O
that	O
conventional	O
beta	B
-	I
adrenoceptor	I
antagonists	O
possess	O
unwanted	O
metabolic	O
effects	O
that	O
may	O
counter	O
some	O
of	O
their	O
potential	O
cardiac	O
benefits	O
.	O

An	O
11.5-kb	O
intron	O
is	O
found	O
at	O
the	O
end	O
of	O
transmembrane	O
6	O
,	O
and	O
the	O
rest	O
of	O
the	O
ORF	O
is	O
in	O
exon	O
3	O
.	O

To	O
assay	O
for	O
sequences	O
that	O
could	O
potentially	O
regulate	O
Xenopus	B
proenkephalin	I
expression	O
,	O
we	O
transfected	O
constructs	O
that	O
contained	O
upstream	O
genomic	O
sequences	O
linked	O
to	O
the	O
CAT	B
reporter	I
gene	I
into	O
various	O
eukaryotic	O
cell	O
lines	O
.	O

It	O
is	O
also	O
conceivable	O
that	O
elevated	O
insulin	B
levels	O
may	O
cause	O
hypertriglyceridaemia	O
and	O
possibly	O
other	O
abnormalities	O
of	O
lipid	O
metabolism	O
.	O

To	O
quantify	O
the	O
normal	O
coupling	O
patterns	O
,	O
fresh	O
cadaveric	O
human	O
lumbar	O
spine	O
specimens	O
(	O
L1-S1	O
)	O
were	O
used	O
.	O

Deletion	O
mutations	O
were	O
constructed	O
,	O
removing	O
residues	O
2	O
-	O
30	O
,	O
31	O
-	O
60	O
,	O
61	O
-	O
90	O
,	O
and	O
49	O
-	O
78	O
of	O
the	O
N	O
-	O
terminal	O
cytoplasmic	O
domain	O
,	O
as	O
well	O
as	O
a	O
missense	O
mutation	O
of	O
a	O
dileucine	O
motif	O
.	O

Indigenous	O
microbial	O
flora	O
and	O
the	O
large	O
intestine	O
in	O
tadpoles	O
.	O

3	O
patients	O
with	O
acute	O
leukaemia	O
,	O
HLA	B
antibodies	O
and	O
thrombocytopenia	O
refractory	O
to	O
random	O
donor	O
platelet	O
transfusions	O
were	O
treated	O
with	O
high	O
-	O
dose	O
i.v	O
.	O

immunoglobulin	B
.	O

Plasma	B
renin	I
activity	O
in	O
end	O
-	O
stage	O
kidney	O
disease	O
.	O

Computer	O
system	O
trains	O
employees	O
to	O
meet	O
JCAHO	O
safety	O
ED	O
requirements	O
.	O

All	O
of	O
this	O
region	O
is	O
part	O
of	O
a	O
prominent	O
CpG	O
island	O
that	O
may	O
be	O
acting	O
as	O
an	O
extended	O
,	O
enhancer	O
-	O
independent	O
promoter	O
.	O

One	O
function	O
of	O
p53	B
is	O
in	O
regulating	O
cell	O
cycle	O
check	O
-	O
point	O
control	O
after	O
DNA	O
damage	O
.	O

100	O
.	O

In	O
patients	O
autografted	O
in	O
CR1	O
,	O
the	O
transplant	O
-	O
related	O
mortality	O
(	O
TRM	O
)	O
was	O
15	O
+	O
/-	O

4	O
%	O
,	O
the	O
relapse	O
incidence	O
(	O
RI	O
)	O
was	O
58	O
+	O
/-	O

5	O
%	O
,	O
the	O
leukaemia	O
-	O
free	O
survival	O
(	O
LFS	O
)	O
was	O
36	O
+	O
/-	O

5	O
%	O
and	O
the	O
overall	O
survival	O
was	O
47	O
+	O
/-	O

5	O
%	O
at	O
3	O
years	O
.	O

However	O
,	O
H19	B
and	O
IGF2	B
lie	O
within	O
a	O
larger	O
imprinted	O
domain	O
,	O
and	O
the	O
gene	O
specificity	O
of	O
H19	B
epimutation	O
has	O
been	O
a	O
persistent	O
question	O
.	O

Antibiotics	O
and	O
CDCA	O
-	O
mediation	O
are	O
essential	O
for	O
symptomatic	O
therapy	O
.	O

The	O
effectiveness	O
and	O
pathogenetic	O
expediency	O
of	O
correcting	O
disorders	O
of	O
lipid	O
metabolism	O
in	O
atherosclerosis	O
with	O
enterosorbents	O
is	O
substantiated	O
.	O

Adaptive	O
effects	O
of	O
repeated	O
immersion	O
exposure	O
on	O
the	O
human	O
body	O

The	O
human	O
cDNA	O
was	O
cloned	O
and	O
sequenced	O
;	O
it	O
was	O
shown	O
to	O
have	O
an	O
open	O
reading	O
frame	O
encoding	O
a	O
296-amino	O
-	O
acid	O
protein	O
in	O
which	O
could	O
be	O
identified	O
four	O
peptides	O
previously	O
identified	O
by	O
micro	O
-	O
sequencing	O
purified	O
protein	O
.	O

Dipetalonema	O
(	O
Acanthocheilonema	O
)	O
didelphis	O
sp.	O

n.	O

The	O
promyelocytic	B
leukemia	I
protein	I
interacts	O
with	O
Sp1	B
and	O
inhibits	O
its	O
transactivation	O
of	O
the	O
epidermal	B
growth	I
factor	I
receptor	I
promoter	O
.	O

Here	O
,	O
we	O
characterize	O
TCR	B
/	O
CD48	B
and	O
TCR	B
/	O
CD28	B
costimulation	O
in	O
T	O
cells	O
expressing	O
Lck	B
Src	B
homology	I
3	I
(	O
SH3	B
)	O
mutants	O
.	O

Thus	O
,	O
it	O
appears	O
that	O
moxalactam	O
is	O
a	O
reliable	O
and	O
useful	O
antibiotic	O
for	O
the	O
treatment	O
of	O
complicated	O
urinary	O
tract	O
infections	O
.	O

In	O
the	O
second	O
,	O
37	O
students	O
were	O
given	O
trimethoprim	O
/	O
sulphamethoxazole	O
(	O
160	O
mg	O
TMP	O
-	O
SMX	O
800	O
mg	O
)	O
,	O
38	O
TMP	O
(	O
200	O
mg	O
)	O
,	O
and	O
in	O
35	O
a	O
placebo	O
was	O
given	O
b.i.d	O
.	O

for	O
five	O
days	O
.	O

The	O
infection	O
of	O
cells	O
with	O
Moloney	O
murine	O
leukemia	O
virus	O
(	O
M	O
-	O
MuLV	O
)	O
causes	O
an	O
increase	O
in	O
specific	O
cellular	O
gene	O
products	O
,	O
including	O
the	O
major	B
histocompatibility	I
complex	I
(	I
MHC	I
)	I
class	I
I	I
antigens	I
.	O

Apparent	O
Buschke	O
-	O
Loewenstein	O
tumour	O
of	O
the	O
penis	O
.	O

The	O
orthologs	O
of	O
the	O
Y	B
(	I
1	I
)	I
and	O
Y	B
(	I
2	I
)	I
subtypes	I
display	O
high	O
amino	O
acid	O
sequence	O
identities	O
between	O
pig	O
,	O
human	O
,	O
and	O
mouse	O
(	O
92%-94	O
%	O
)	O
,	O
whereas	O
the	O
Y	B
(	I
4	I
)	I
,	O
Y	B
(	I
5	I
)	I
,	O
and	O
y	B
(	I
6	I
)	I
subtypes	I
display	O
lower	O
identities	O
(	O
76%-87	O
%	O
)	O
.	O

Enhanced	O
phospholipid	O
hydrolysis	O
with	O
free	O
fatty	O
acid	O
and	O
thromboxane	O
accumulation	O
,	O
increased	O
release	O
of	O
excitatory	O
amino	O
acids	O
,	O
and	O
decreased	O
tissue	O
magnesium	O
levels	O
may	O
each	O
serve	O
to	O
worsen	O
secondary	O
tissue	O
damage	O
and	O
diminish	O
neurologic	O
recovery	O
after	O
spinal	O
cord	O
injury	O
associated	O
with	O
acute	O
alcohol	O
intoxication	O
.	O

With	O
six	O
reports	O
in	O
the	O
literature	O
that	O
show	O
there	O
is	O
an	O
order	O
to	O
melanoma	O
nodal	O
metastases	O
and	O
that	O
the	O
SLN	O
histology	O
is	O
reflective	O
of	O
the	O
histology	O
of	O
the	O
remainder	O
of	O
the	O
nodal	O
basin	O
,	O
the	O
more	O
conservative	O
SLN	O
biopsy	O
can	O
be	O
performed	O
to	O
adequately	O
stage	O
nodally	O
the	O
patient	O
with	O
melanoma	O
.	O

In	O
addition	O
,	O
a	O
double	O
mutant	O
(	O
E482A	O
,	O
D489A	O
)	O
which	O
removed	O
negative	O
charges	O
along	O
one	O
side	O
of	O
the	O
helix	O
had	O
negligible	O
effects	O
on	O
fusion	O
activity	O
.	O

Escherichia	O
coli	O
cells	O
expressing	O
a	O
mutant	B
glyV	I
(	O
glycine	B
tRNA	I
)	O
gene	O
have	O
a	O
UVM	O
-	O
constitutive	O
phenotype	O
:	O
implications	O
for	O
mechanisms	O
underlying	O
the	O
mutA	B
or	O
mutC	B
mutator	I
effect	O
.	O

Synthetic	O
studies	O
on	O
furan	O
derivatives	O
by	O
the	O
wittig	O
reaction	O

Positive	O
linear	O
correlations	O
were	O
found	O
when	O
the	O
AUC	O
(	O
0	O
-	O
12	O
)	O
(	O
r	O
=	O
0.68	O
;	O
P	O
less	O
than	O
0.01	O
)	O
,	O
the	O
maximum	O
plasma	O
concentration	O
(	O
r	O
=	O
0.34	O
;	O
P	O
less	O
than	O
0.01	O
)	O
,	O
the	O
minimum	O
plasma	O
concentration	O
(	O
r	O
=	O
0.55	O
;	O
P	O
less	O
than	O
0.01	O
)	O
,	O
and	O
the	O
elimination	O
t1	O
/	O
2	O
(	O
r	O
=	O
0.46	O
;	O
P	O
less	O
than	O
0.01	O
)	O
were	O
regressed	O
with	O
age	O
.	O

Furthermore	O
,	O
the	O
social	O
learning	O
theory	O
of	O
depression	O
,	O
developed	O
by	O
Lewinsohn	O
,	O
is	O
described	O
.	O

Intramolecular	O
interaction	O
is	O
believed	O
to	O
result	O
in	O
the	O
formation	O
of	O
MxA	B
monomers	I
,	O
whereas	O
intermolecular	O
interaction	O
may	O
induce	O
the	O
formation	O
of	O
large	B
MxA	I
oligomers	I
.	O

Analysis	O
of	O
a	O
Het-	B
mutation	O
in	O
Anabaena	O
sp.	O
strain	O
PCC	O
7120	O
implicates	O
a	O
secondary	O
metabolite	O
in	O
the	O
regulation	O
of	O
heterocyst	O
spacing	O
.	O

He	O
presented	O
with	O
left	O
lower	O
abdominal	O
pain	O
and	O
hematoma	O
after	O
a	O
fall	O
.	O

To	O
this	O
end	O
we	O
generated	O
a	O
detailed	O
physical	O
map	O
of	O
the	O
genomic	O
region	O
spanning	O
between	O
sequence	O
-	O
tagged	O
site	O
markers	O
D16S518	B
and	O
D16S516	B
.	O

The	O
kinetics	O
of	O
erythromycin	O
(	O
E.	O
)	O
was	O
studied	O
in	O
16	O
patients	O
with	O
different	O
degrees	O
of	O
impairment	O
of	O
renal	O
function	O
after	O
a	O
single	O
intravenous	O
dose	O
.	O

Lasting	O
paraplegia	O
caused	O
by	O
loss	O
of	O
lumbar	O
spinal	O
cord	O
interneurons	O
in	O
rats	O
:	O
no	O
direct	O
correlation	O
with	O
motor	O
neuron	O
loss	O
.	O

Some	O
CHOP	B
-	O
C	B
/	I
EBP	I
heterodimers	O
apparently	O
bind	O
to	O
alternative	O
DNA	O
sequence	O
and	O
thereby	O
regulate	O
the	O
transcription	O
of	O
other	O
genes	O
.	O

Furthermore	O
,	O
addition	O
of	O
the	O
recombinant	B
NF	I
-	I
YA	I
subunit	I
restores	O
NF	B
-	I
Y	I
binding	O
.	O

The	O
specificity	O
of	O
the	O
transcriptional	O
activation	O
by	O
ISGF3	B
is	O
mediated	O
by	O
specific	O
elements	O
termed	O
IFN	B
-	I
stimulatory	I
response	I
element	I
(	O
ISRE	B
)	O
located	O
in	O
the	O
promoter	O
region	O
of	O
IFN	B
-	O
inducible	O
genes	O
.	O

Clinical	O
development	O
of	O
interleukin-10	B
.	O

The	O
system	O
consists	O
of	O
a	O
microcomputer	O
and	O
six	O
laboratory	O
analyzers	O
:	O
a	O
blood	O
gas	O
analyzer	O
,	O
a	O
flame	O
photometer	O
,	O
a	O
plasma	O
osmotic	O
pressure	O
meter	O
,	O
a	O
chloride	O
ion	O
titrator	O
,	O
a	O
blood	O
sugar	O
analyzer	O
,	O
and	O
a	O
hemoglobin	B
concentration	O
and	O
saturation	O
meter	O
.	O

Of	O
these	O
,	O
23	O
(	O
13.6	O
%	O
)	O
were	O
due	O
to	O
GIB	O
(	O
Upper	O
GIB	O
=	O
19	O
,	O
Lower	O
GIB	O
=	O
4	O
)	O
.	O

Saturated	O
fatty	O
acids	O
induce	O
a	O
1.6-fold	O
increase	O
in	O
transcription	O
activity	O
,	O
whereas	O
a	O
large	O
family	O
of	O
unsaturated	O
fatty	O
acids	O
repress	O
OLE1	B
transcription	O
as	O
much	O
as	O
60-fold	O
.	O

A	O
third	O
GEF	B
,	O
GRP3	B
(	O
KIAA0846	B
)	O
,	O
activated	O
both	O
Ras	B
and	O
Rap1	B
and	O
shared	O
significant	O
sequence	O
homology	O
with	O
the	O
calcium-	O
and	O
diacylglycerol	O
-	O
activated	O
GEFs	B
,	O
GRP1	B
and	O
GRP2	B
.	O

The	O
time	O
-	O
dependent	O
changes	O
in	O
measured	O
facility	O
of	O
outflow	O
or	O
""""	O
washout	O
phenomenon	O
""""	O
appeared	O
to	O
result	O
from	O
the	O
gradual	O
dissolution	O
of	O
the	O
hyaluronidase	B
-	O
sensitive	O
component	O
of	O
the	O
barriers	O
to	O
aqueous	O
outflow	O
in	O
the	O
canine	O
eye	O
.	O

Melioidosis	O
in	O
Sika	O
deer	O
(	O
Cervus	O
nippon	O
nippon	O
)	O
.	O

Many	O
human	O
malignant	O
cells	O
lack	O
methylthioadenosine	B
phosphorylase	I
(	O
MTAP	B
)	O
enzyme	O
activity	O
.	O

We	O
propose	O
2	O
separate	O
PAI-1	B
inductory	O
pathways	O
for	O
PMA	O
and	O
IL-1alpha	B
in	O
HepG2	O
,	O
both	O
involving	O
protein	B
tyrosine	I
kinase	I
activation	O
;	O
the	O
serum	O
-	O
induced	O
signaling	O
pathway	O
may	O
(	O
partially	O
)	O
overlap	O
with	O
the	O
PMA	O
-	O
activated	O
protein	B
kinase	I
C	I
/	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
kinase	I
pathway	O
,	O
leading	O
to	O
c	B
-	I
Jun	I
homodimer	I
binding	O
to	O
the	O
PAI-1	B
TRE	O
.	O

Crude	O
drugs	O
from	O
aquatic	O
plants	O
.	O

These	O
data	O
show	O
that	O
tyrosine	O
phosphorylation	O
by	O
FES	B
affects	O
the	O
interaction	O
of	O
BCR	B
with	O
multiple	O
signaling	O
partners	O
and	O
suggest	O
a	O
general	O
role	O
for	O
BCR	B
in	O
non	O
-	O
receptor	O
protein	B
-	I
tyrosine	I
kinase	I
regulation	O
and	O
signal	O
transduction	O
.	O

Replication	O
regions	O
from	O
plant	O
-	O
pathogenic	O
Pseudomonas	O
syringae	O
plasmids	O
are	O
similar	O
to	O
ColE2-related	O
replicons	O
.	O

Comparison	O
of	O
dose	O
volume	O
histograms	O
revealed	O
that	O
the	O
6-field	O
plan	O
spared	O
relatively	O
more	O
heart	O
whereas	O
the	O
8-field	O
plan	O
spared	O
relatively	O
more	O
lung	O
.	O

STUDY	O
OBJECTIVE	O
:	O
to	O
characterize	O
gas	O
exchange	O
and	O
cardiopulmonary	O
performance	O
during	O
maximal	O
progressive	O
arm	O
crank	O
exercise	O
.	O

The	O
most	O
frequent	O
abnormality	O
was	O
GH	B
deficiency	O
(	O
six	O
cases	O
)	O
,	O
followed	O
by	O
gonadotropin	B
(	O
four	O
cases	O
)	O
,	O
cortisol	O
(	O
four	O
cases	O
)	O
,	O
and	O
TSH	B
(	O
one	O
case	O
)	O
,	O
whereas	O
four	O
patients	O
showed	O
high	O
serum	B
PRL	I
values	O
.	O

The	O
nramp2	B
gene	I
is	O
comprised	O
of	O
17	O
exons	O
and	O
spans	O
more	O
than	O
36	O
kb	O
.	O

BACKGROUND	O
:	O
In	O
lung	O
protective	O
strategy	O
,	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
slightly	O
higher	O
than	O
the	O
Pflex	O
(	O
the	O
airway	O
pressure	O
corresponding	O
to	O
the	O
lower	O
inflection	O
point	O
(	O
LIP	O
)	O
on	O
the	O
inspiratory	O
pressure	O
-	O
volume	O
(	O
P	O
-	O
V	O
)	O
curve	O
measured	O
with	O
ZEEP	O
)	O
is	O
generally	O
recommended	O
.	O

Effect	O
of	O
a	O
constant	O
magnetic	O
field	O
on	O
different	O
models	O
of	O
carcinogenesis	O

Similarly	O
,	O
beta	B
adrenoceptors	I
blockade	O
has	O
been	O
shown	O
to	O
be	O
of	O
value	O
in	O
achieving	O
continence	O
in	O
a	O
small	O
group	O
of	O
patients	O
.	O

Effectively	O
,	O
the	O
upstream	O
,	O
housekeeping	O
-	O
type	O
promoter	O
responds	O
to	O
FIXK	B
and	O
positively	O
regulates	O
the	O
downstream	O
,	O
sigma	B
54-type	I
promoter	I
.	O

Km	O
values	O
of	O
the	O
uncoupled	O
enzymes	O
IIGlc	B
for	O
glucose	O
ranged	O
from	O
0.5	O
to	O
2.5	O
mM	O
,	O
2	O
orders	O
of	O
magnitude	O
higher	O
than	O
the	O
value	O
of	O
normal	O
IIGlc	B
.	O

Disruption	O
of	O
PML	B
subnuclear	I
domains	I
by	O
the	O
acidic	B
IE1	I
protein	I
of	O
human	O
cytomegalovirus	O
is	O
mediated	O
through	O
interaction	O
with	O
PML	B
and	O
may	O
modulate	O
a	O
RING	O
finger	O
-	O
dependent	O
cryptic	O
transactivator	O
function	O
of	O
PML	B
.	O

The	O
fate	O
of	O
ochratoxin	O
A	O
during	O
malting	O
and	O
brewing	O
.	O

To	O
further	O
investigate	O
the	O
role	O
of	O
PKR	B
in	O
transcriptional	O
signaling	O
,	O
we	O
expressed	O
the	O
wild	B
type	I
human	I
PKR	I
and	O
a	O
catalytically	O
inactive	O
dominant	O
negative	O
PKR	B
mutant	I
in	O
the	O
murine	O
pre	O
-	O
B	O
lymphoma	O
70Z	O
/	O
3	O
cells	O
.	O

Consistent	O
with	O
other	O
experiments	O
with	O
these	O
compounds	O
,	O
cocaine	O
was	O
the	O
most	O
potent	O
of	O
the	O
group	O
.	O

Atrial	O
dissociation	O
.	O

It	O
is	O
envisaged	O
that	O
the	O
WHOQOL	O
-	O
BREF	O
will	O
be	O
most	O
useful	O
in	O
studies	O
that	O
require	O
a	O
brief	O
assessment	O
of	O
quality	O
of	O
life	O
,	O
for	O
example	O
,	O
in	O
large	O
epidemiological	O
studies	O
and	O
clinical	O
trials	O
where	O
quality	O
of	O
life	O
is	O
of	O
interest	O
.	O

Hepatitis	B
B	I
immune	I
globulins	I
and	O
HIV	B
antibodies	I
.	O

In	O
the	O
spontaneous	O
abortion	O
group	O
,	O
the	O
levels	O
of	O
PAPP	B
-	I
A	I
were	O
significantly	O
lower	O
than	O
in	O
normal	O
pregnancy	O
but	O
higher	O
than	O
in	O
non	O
-	O
pregnant	O
controls	O
.	O

The	O
gene	O
encoding	O
rat	O
peptidylglycine	B
alpha	I
-	I
amidating	I
monooxygenase	I
(	O
PAM	B
)	O
contains	O
26	O
protein	O
-	O
coding	O
exons	O
.	O

Whether	O
this	O
lack	O
of	O
preferential	O
repair	O
has	O
to	O
be	O
explained	O
by	O
a	O
defect	O
in	O
repair	O
or	O
in	O
general	O
transcription	O
is	O
unclear	O
at	O
present	O
.	O

MUS81	B
encodes	O
a	O
novel	O
helix	B
-	I
hairpin	I
-	I
helix	I
protein	I
involved	O
in	O
the	O
response	O
to	O
UV-	O
and	O
methylation	O
-	O
induced	O
DNA	O
damage	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

All	O
possessed	O
cutaneous	O
receptive	O
fields	O
on	O
the	O
distal	O
segments	O
of	O
digits	O
2	O
,	O
3	O
,	O
or	O
4	O
.	O

A	O
GT	O
-	O
rich	O
sequence	O
binding	O
the	O
transcription	B
factor	I
Sp1	I
is	O
crucial	O
for	O
high	O
expression	O
of	O
the	O
human	B
type	I
VII	I
collagen	I
gene	I
(	O
COL7A1	B
)	O
in	O
fibroblasts	O
and	O
keratinocytes	O
.	O

Using	O
in	O
vivo	O
genomic	O
dimethyl	O
sulfate	O
and	O
KMnO4	O
footprinting	O
,	O
we	O
showed	O
that	O
the	O
promoter	O
region	O
is	O
differentially	O
protected	O
,	O
depending	O
upon	O
which	O
holoenzyme	O
is	O
bound	O
.	O

We	O
conclude	O
that	O
these	O
cDNAs	O
belong	O
to	O
a	O
novel	O
GST	B
class	O
hereby	O
designated	O
Kappa	O
,	O
with	O
the	O
rat	B
GST	I
subunit	I
13	I
gene	I
designated	O
rGSTK1	B
and	O
the	O
human	O
gene	O
being	O
called	O
hGSTK1	B
.	O

At	O
onset	O
of	O
first	O
post	O
-	O
weaning	O
estrus	O
,	O
sows	O
received	O
either	O
an	O
intravulval	O
injection	O
of	O
3.75	O
mg	O
of	O
prostaglandin	O
analogue	O
(	O
PGF	O
)	O
or	O
,	O
served	O
as	O
a	O
non	O
-	O
injected	O
control	O
(	O
CON	O
)	O
.	O

Tbx6	B
maps	O
to	O
chromosome	O
7	O
and	O
does	O
not	O
appear	O
to	O
be	O
linked	O
to	O
any	O
known	O
mutation	O
.	O

Before	O
therapy	O
was	O
started	O
,	O
trabecular	O
bone	O
alterations	O
could	O
be	O
observed	O
which	O
were	O
typical	O
for	O
Paget	O
's	O
disease	O
of	O
bone	O
as	O
there	O
were	O
bulky	O
trabeculare	O
,	O
increased	O
remodelling	O
surfaces	O
and	O
giant	O
osteoclasts	O
.	O

Contraindications	O
to	O
adenosine	O
and	O
drug	O
interactions	O
are	O
noted	O
in	O
this	O
article	O
.	O

The	O
extent	O
of	O
the	O
odontoblast	O
process	O
in	O
human	O
dentin	O
.	O

On	O
transfer	O
from	O
glucose	O
,	O
succinate	O
,	O
malate	O
,	O
or	O
glycerol	O
medium	O
to	O
citrate	O
medium	O
,	O
the	O
Cit+	O
Escherichia	O
coli	O
strains	O
showed	O
a	O
delay	O
of	O
36	O
to	O
48	O
h	O
before	O
growth	O
.	O

Additionally	O
,	O
the	O
members	O
of	O
this	O
family	O
display	O
strong	O
sequence	O
homologies	O
between	O
their	O
larger	O
C	O
-	O
terminal	O
effector	O
binding	O
/	O
oligomerization	O
domains	O
.	O

Long	O
-	O
term	O
ambulatory	O
measurement	O
of	O
transcutaneous	O
arterial	O
CO2	O
pressure	O
(	O
PCO2	O
)	O
offers	O
an	O
opportunity	O
to	O
test	O
directly	O
the	O
co	O
-	O
occurrence	O
of	O
panic	O
and	O
hyperventilation	O
under	O
natural	O
conditions	O
.	O

An	O
association	O
was	O
found	O
between	O
zafirlukast	O
plasma	O
concentrations	O
and	O
increases	O
in	O
PC8SRaw	O
10	O
h	O
after	O
treatment	O
(	O
p	O
=	O
0.001	O
)	O
.	O

Most	O
interestingly	O
,	O
although	O
the	O
effector	O
plasmid	O
containing	O
the	O
ICP27	B
gene	I
had	O
little	O
effect	O
on	O
its	O
own	O
,	O
two	O
different	O
and	O
marked	O
effects	O
depending	O
on	O
the	O
target	O
were	O
observed	O
when	O
ICP27	B
was	O
combined	O
with	O
ICP4	B
or	O
ICP0	B
or	O
both	O
.	O

Water	O
pair	O
and	O
three	O
-	O
body	O
potential	O
of	O
spectroscopic	O
quality	O
from	O
Ab	O
initio	O
calculations	O

Because	O
the	O
wa-2	B
mutation	I
was	O
mapped	O
previously	O
to	O
the	O
vicinity	O
of	O
the	O
EGF	B
/	I
TGF	I
-	I
alpha	I
receptor	I
(	O
EGFR	B
)	O
gene	O
on	O
mouse	O
chromosome	O
11	O
,	O
we	O
hypothesized	O
that	O
the	O
wa-2	B
phenotype	I
might	O
result	O
from	O
a	O
defect	O
in	O
either	O
the	O
expression	O
or	O
activity	O
of	O
EGFR	B
,	O
or	O
both	O
.	O

4	O
)	O
Mutation	O
of	O
the	O
three	O
extracellular	O
cysteine	O
residues	O
of	O
GFKAR	B
beta	I
indicated	O
that	O
the	O
two	O
conserved	O
cysteine	O
residues	O
(	O
C305	O
and	O
C385	O
)	O
,	O
located	O
between	O
two	O
transmembrane	O
segments	O
,	O
form	O
a	O
solvent	O
-	O
accessible	O
disulfide	O
bond	O
.	O

R	O
of	O
the	O
chest	O
wall	O
was	O
maximum	O
(	O
35.6	O
cmH2O.L-	O
1.sec-1	O
+	O
/-	O

2.2	O
SE	O
)	O
at	O
0.2	O
Hz-10	O
ml	O
and	O
decreased	O
with	O
increasing	O
f	O
and	O
VT	O
,	O
although	O
the	O
VT	O
effect	O
diminished	O
at	O
the	O
higher	O
f.	O

Comparison	O
of	O
the	O
predicted	O
amino	O
acid	O
sequence	O
with	O
that	O
of	O
the	O
Drosophila	B
virilis	I
gene	I
shows	O
that	O
several	O
blocks	O
of	O
amino	O
acid	O
sequence	O
have	O
been	O
very	O
highly	O
conserved	O
.	O

The	O
N	O
-	O
terminal	O
exon1	O
had	O
no	O
homology	O
at	O
the	O
amino	O
acid	O
level	O
with	O
NGFI	B
-	I
B	I
,	O
the	O
mammalian	O
homologue	O
.	O

Although	O
RAD17	B
,	O
RAD24	B
and	O
MEC3	B
are	O
not	O
required	O
for	O
cell	O
cycle	O
arrest	O
when	O
S	O
phase	O
is	O
inhibited	O
by	O
hydroxyurea	O
(	O
HU	O
)	O
,	O
they	O
do	O
contribute	O
to	O
the	O
viability	O
of	O
yeast	O
cells	O
grown	O
in	O
the	O
presence	O
of	O
HU	O
,	O
possibly	O
because	O
they	O
are	O
required	O
for	O
the	O
repair	O
of	O
HU	O
-	O
induced	O
DNA	O
damage	O
.	O

Single	O
oblique	O
-	O
view	O
mammography	O
for	O
periodic	O
screening	O
for	O
breast	O
cancer	O
in	O
women	O
.	O

Nicotinic	B
receptor	I
antagonists	O
mecamylamine	O
(	O
0.5	O
and	O
1	O
mg	O
/	O
kg	O
)	O
and	O
hexamethonium	O
(	O
5	O
and	O
10	O
mg	O
/	O
kg	O
)	O
reduced	O
the	O
response	O
induced	O
by	O
nicotine	O
(	O
0.25	O
mg	O
/	O
kg	O
)	O
.	O

The	O
matrix	O
of	O
the	O
CBs	O
contains	O
the	O
diagnostic	O
protein	O
p80-coilin	B
,	O
which	O
is	O
colocalized	O
with	O
the	O
U7	B
small	I
nuclear	I
ribonucleoprotein	I
(	O
snRNP	O
)	O
,	O
whereas	O
the	O
attached	O
and	O
embedded	O
B	O
-	O
snurposomes	O
contain	O
splicing	O
snRNPs	O
.	O

Tritium	O
concentrations	O
in	O
environmental	O
water	O
samples	O
were	O
found	O
to	O
be	O
determined	O
within	O
an	O
accuracy	O
of	O
10	O
%	O
by	O
this	O
method	O
when	O
Vi	O
/	O
Vf	O
was	O
14	O
-	O
25	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
in	O
patients	O
with	O
syndrome	O
X	O
,	O
myocardial	O
ischemia	O
frequently	O
develops	O
during	O
daily	O
life	O
;	O
silent	O
ischemia	O
is	O
an	O
important	O
component	O
of	O
this	O
syndrome	O
;	O
and	O
increased	O
oxygen	O
demand	O
in	O
the	O
presence	O
of	O
impaired	O
coronary	O
vasodilatory	O
capacity	O
is	O
not	O
the	O
only	O
cause	O
of	O
myocardial	O
ischemia	O
.	O

Two	O
patients	O
with	O
Ewing	O
's	O
sarcoma	O
relapsed	O
(	O
1	O
patient	O
with	O
both	O
local	O
and	O
distant	O
failure	O
)	O
at	O
26	O
and	O
58	O
months	O
and	O
were	O
again	O
rendered	O
disease	O
-	O
free	O
with	O
surgery	O
,	O
total	O
body	O
irradiation	O
and	O
further	O
chemotherapy	O
.	O

When	O
single	O
-	O
point	O
mutation	O
was	O
introduced	O
to	O
each	O
GC	O
box	O
,	O
EBS	B
,	O
and	O
GT	O
box	O
in	O
PFP9a20	B
,	O
at	O
least	O
3-fold	O
less	O
CAT	B
activity	O
was	O
observed	O
in	O
CTLL	O
-	O
R8	O
cells	O
.	O

Thirty	O
-	O
three	O
percent	O
had	O
elevated	O
titers	O
(	O
above	O
1:20	O
dilution	O
)	O
.	O

Both	O
the	O
inactive	O
domain	B
II	I
P68	I
mutant	I
and	O
the	O
deletion	O
mutant	O
lacking	O
aa	O
91	O
-	O
243	O
were	O
less	O
inhibitory	O
to	O
growth	O
in	O
yeast	O
due	O
to	O
the	O
reduced	O
ability	O
to	O
phosphorylate	O
initiation	B
factor	I
2	I
alpha	I
in	O
vivo	O
.	O

As	O
the	O
mechanism	O
of	O
the	O
intractability	O
,	O
cell	O
function	O
involved	O
in	O
the	O
defense	O
against	O
infection	O
was	O
evaluated	O
.	O

IV	O
.	O

After	O
5-h	O
thermal	O
induction	O
of	O
cells	O
carrying	O
the	O
runaway	O
recombinant	O
pBS1	O
,	O
protein	B
B2	I
constituted	O
40	O
%	O
of	O
the	O
soluble	O
protein	O
fraction	O
of	O
the	O
cells	O
.	O

The	O
highest	O
concentration	O
of	O
respirable	O
mineral	O
fibres	O
was	O
found	O
during	O
the	O
overhaul	O
of	O
a	O
truck	O
with	O
asbestos	O
insulation	O
;	O
respirable	O
fibre	O
concentration	O
reached	O
the	O
value	O
of	O
5	O
f	O
/	O
cm3	O
,	O
and	O
total	O
dust	O
concentration	O
-	O
the	O
value	O
of	O
about	O
80	O
mg	O
/	O
m3	O
.	O

By	O
contrast	O
,	O
footprint	O
II	O
at	O
position	O
-125	O
is	O
common	O
to	O
both	O
HeLa	O
and	O
GH3	O
cell	O
extracts	O
and	O
overlies	O
a	O
15-base	O
-	O
pair	O
sequence	O
found	O
in	O
all	O
members	O
of	O
the	O
growth	B
hormone	I
gene	I
family	I
.	O

Unlike	O
LANA1	B
,	O
LANA2	B
does	O
not	O
elicit	O
a	O
serologic	O
response	O
from	O
patients	O
with	O
KS	O
,	O
PEL	O
,	O
or	O
CD	O
as	O
measured	O
by	O
Western	O
blot	O
hybridization	O
.	O

CD4	B
degradation	O
mediated	O
by	O
Vpu	B
does	O
not	O
require	O
the	O
ER	O
chaperone	O
calnexin	B
and	O
is	O
dependent	O
on	O
an	O
intact	O
ubiquitin	B
-	O
conjugating	O
system	O
.	O

The	O
revaluation	O
at	O
the	O
end	O
of	O
the	O
study	O
showed	O
a	O
good	O
compliance	O
for	O
the	O
proposed	O
diet	O
scheme	O
by	O
children	O
,	O
but	O
a	O
poor	O
compliance	O
by	O
their	O
families	O
.	O

Cytostatic	O
activity	O
of	O
some	O
essential	O
oils	O
against	O
HEp-2	O
cells	O
.	O

Excess	O
recombinant	B
PTB	I
squelches	O
the	O
splicing	O
switch	O
and	O
reestablishes	O
exon	O
skipping	O
as	O
the	O
predominant	O
splicing	O
pathway	O
.	O

Among	O
women	O
,	O
plasma	B
factor	I
VII	I
:	O
Ag	O
was	O
inversely	O
associated	O
with	O
income	O
.	O

Recently	O
,	O
we	O
demonstrated	O
that	O
platelet	B
-	I
derived	I
growth	I
factor	I
(	I
PDGF	I
)	I
-beta	I
receptor	I
stimulation	O
,	O
but	O
not	O
various	O
other	O
growth	O
factors	O
,	O
inhibits	O
transcription	O
of	O
alpha1D-	B
,	O
but	O
not	O
alpha1A-	B
or	O
alpha1B	B
-	I
ARs	I
,	O
resulting	O
in	O
reduced	O
norepinephrine	O
-	O
mediated	O
SMC	O
growth	O
.	O

(	O
A	O
short	O
account	O
of	O
Karl	O
Touton	O
's	O
life	O
is	O
also	O
included	O
.	O
)	O

After	O
reviewing	O
the	O
historical	O
development	O
of	O
the	O
concept	O
of	O
giant	O
cells	O
and	O
current	O
interpretations	O
of	O
their	O
nature	O
,	O
the	O
unitarian	O
view	O
of	O
polykaryons	O
now	O
favored	O
by	O
workers	O
in	O
the	O
field	O
is	O
extended	O
to	O
include	O
also	O
the	O
""""	O
xanthelasmatic	O
giant	O
cell	O
""""	O
of	O
Touton	O
,	O
whose	O
characteristic	O
appearance	O
is	O
determined	O
merely	O
by	O
the	O
presence	O
of	O
demonstrable	O
lipid	O
in	O
the	O
cytoplasm	O
.	O

After	O
birth	O
,	O
there	O
was	O
a	O
significantly	O
higher	O
increase	O
of	O
IgA	B
and	O
IgM	B
anti	I
-	I
M.	I
leprae	I
antibody	I
activity	O
in	O
sera	O
taken	O
3	O
-	O
6	O
months	O
after	O
birth	O
from	O
babies	O
of	O
Group	O
1	O
compared	O
to	O
Group	O
2	O
,	O
but	O
the	O
IgA	B
and	O
IgM	B
activity	O
in	O
sera	O
taken	O
after	O
6	O
months	O
of	O
age	O
showed	O
the	O
same	O
increase	O
in	O
the	O
two	O
groups	O
.	O

Serum	O
estriol	O
levels	O
during	O
beta	B
-	I
receptor	I
agonist	O
infusion	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

These	O
tiny	O
premature	O
infants	O
also	O
received	O
PN	O
for	O
significantly	O
longer	O
periods	O
of	O
time	O
,	O
and	O
the	O
longer	O
the	O
infusions	O
were	O
administered	O
the	O
greater	O
was	O
the	O
risk	O
of	O
cholestasis	O
developing	O
.	O

We	O
show	O
that	O
sae1	B
-	I
1	I
and	O
sae3	B
-	I
1	I
mutations	I
each	O
confer	O
a	O
distinct	O
defect	O
in	O
meiotic	O
recombination	O
.	O

sae1	B
-	I
1	I
produces	O
recombinants	O
but	O
very	O
slowly	O
and	O
ultimately	O
to	O
less	O
than	O
half	O
the	O
wild	O
-	O
type	O
level	O
;	O
sae3	B
-	I
1	I
makes	O
persistent	O
hyper	O
-	O
resected	O
meiotic	O
double	O
-	O
strand	O
breaks	O
and	O
has	O
a	O
severe	O
defect	O
in	O
formation	O
of	O
recombinants	O
.	O

Patients	O
in	O
the	O
mucinous	O
cyst	O
group	O
had	O
significantly	O
lower	O
CA	B
125	I
cystic	O
fluid	O
levels	O
compared	O
with	O
women	O
with	O
endometriomas	O
and	O
dermoids	O
(	O
P<0.05	O
)	O
.	O

The	O
brains	O
were	O
processed	O
according	O
to	O
the	O
tetramethylbenzidine	O
(	O
TMB	O
)	O
protocol	O
of	O
Mesulam	O
(	O
'	O
78	O
)	O
and	O
studied	O
with	O
darkfield	O
microscopy	O
.	O

Analysis	O
of	O
WT1	B
target	I
gene	I
expression	O
in	O
stably	O
transfected	O
cell	O
lines	O
.	O

Amniotic	O
fluid	O
ionic	O
concentration	O
in	O
response	O
to	O
chronic	O
fetal	B
vasopressin	I
infusion	O
.	O

The	O
genomic	O
organization	O
in	O
this	O
region	O
is	O
similar	O
to	O
the	O
neural	O
-	O
restricted	O
family	O
members	O
,	O
Hel	B
-	I
N1	I
(	O
ELAVL2	B
)	O
and	O
mHuD	B
(	O
Elavl4	B
)	O
.	O

CONCLUSION	O
:	O
The	O
biodistribution	O
of	O
111In	O
IgG	B
is	O
similar	O
to	O
that	O
of	O
99mTc	O
-	O
HMPAO	O
-	O
labeled	O
leukocytes	O
.	O

Since	O
it	O
is	O
often	O
necessary	O
to	O
resort	O
to	O
thoracotomy	O
as	O
a	O
final	O
step	O
in	O
making	O
such	O
a	O
diagnosis	O
,	O
we	O
have	O
sought	O
a	O
procedure	O
that	O
is	O
simpler	O
while	O
capable	O
of	O
providing	O
the	O
same	O
information	O
.	O

On	O
the	O
optic	O
tentacle	O
-	O
gonadal	O
axis	O
in	O
the	O
control	O
of	O
the	O
male	O
-	O
phase	O
ovotestis	O
in	O
the	O
slug	O
(	O
Ariolimax	O
californicus	O
)	O
.	O

The	O
protein	B
kinase	I
C	I
inhibitor	O
GF-109203X	O
abolished	O
the	O
activation	O
by	O
phorbol	O
ester	O
and	O
inhibited	O
the	O
effect	O
of	O
CCK	B
by	O
78	O
%	O
but	O
had	O
no	O
effect	O
on	O
EGF	B
-	O
activated	O
MAPK	B
activity	O
.	O

These	O
morphological	O
changes	O
are	O
associated	O
with	O
a	O
marked	O
induction	O
of	O
P450arom	B
gene	I
expression	O
.	O

DNase	B
I	I
protection	O
analysis	O
as	O
well	O
as	O
oligonucleotide	O
competition	O
experiments	O
indicate	O
that	O
this	O
binding	O
is	O
sequence	O
specific	O
.	O

METHOD	O
:	O
After	O
eligibility	O
,	O
patients	O
were	O
randomly	O
allocated	O
in	O
one	O
of	O
the	O
following	O
groups	O
:	O
M	O
=	O
methylprednisolone	O
30	O
mg.kg-1	O
over	O
1	O
hour	O
,	O
followed	O
by	O
5.4	O
mg.kg-1.h-1	O
for	O
23	O
hours	O
,	O
N	O
=	O
nimodipine	O
0.015	O
mg.kg-1.h-1	O
over	O
2	O
hours	O
followed	O
by	O
0.03	O
mg.kg-1.h-1	O
for	O
7	O
days	O
,	O
MN	O
or	O
P.	O

We	O
have	O
shown	O
previously	O
that	O
EGF	B
receptor	I
activation	O
stimulates	O
gastrin	B
gene	O
expression	O
through	O
a	O
GC	O
-	O
rich	O
element	O
called	O
gERE	O
.	O

To	O
determine	O
cis	O
-	O
acting	O
elements	O
controlling	O
the	O
rat	O
B-50	B
/	O
GAP-43	B
gene	O
expression	O
,	O
the	O
genomic	O
DNA	O
encoding	O
exon	O
1	O
and	O
the	O
5	O
'	O
flanking	O
sequence	O
was	O
isolated	O
.	O

Any	O
opacity	O
on	O
a	O
chest	O
radiograph	O
has	O
a	O
wide	O
differential	O
diagnosis	O
.	O

Levels	O
of	O
p53	B
were	O
substantially	O
increased	O
by	O
E1A	B
expression	O
during	O
adenovirus	O
infection	O
.	O

This	O
pathway	O
has	O
been	O
reported	O
to	O
mediate	O
heterodimer	O
interactions	O
with	O
the	O
proapoptotic	O
regulator	O
,	O
Bad	B
.	O

We	O
sought	O
to	O
test	O
whether	O
a	O
prolonged	O
infusion	O
of	O
magnesium	O
sulfate	O
(	O
MgSO	O
(	O
4	O
)	O
;	O
40	O
mmol	O
/	O
24	O
hours	O
)	O
would	O
normalize	O
QT	O
interval	O
variability	O
in	O
patients	O
with	O
compensated	O
heart	O
failure	O
.	O

Long	O
-	O
term	O
follow	O
-	O
up	O
of	O
kidney	O
donors	O
:	O
a	O
longitudinal	O
study	O
.	O

Gore	O
&	O
Associates	O
,	O
Inc.	O
)	O
standard	O
wall	O
graft	O
segments	O
varying	O
in	O
length	O
from	O
4	O
to	O
12	O
cm	O
.	O

This	O
report	O
describes	O
the	O
isolation	O
and	O
recombinant	O
expression	O
of	O
a	O
cDNA	O
clone	O
encoding	O
HER4	B
,	O
the	O
fourth	O
member	O
of	O
the	O
human	B
epidermal	I
growth	I
factor	I
receptor	I
(	O
EGFR	B
)	O
family	O
.	O

Precision	O
of	O
data	O
from	O
models	O
of	O
sodium	O
kinetics	O
in	O
hemodialysis	O

Cytochrome	B
bd	I
biosynthesis	O
in	O
Escherichia	O
coli	O
:	O
the	O
sequences	O
of	O
the	O
cydC	B
and	O
cydD	B
genes	I
suggest	O
that	O
they	O
encode	O
the	O
components	O
of	O
an	O
ABC	B
membrane	I
transporter	I
.	O

We	O
exposed	O
Dorper	O
-	O
cross	O
ewes	O
at	O
approximately	O
120	O
-	O
135	O
days	O
of	O
gestation	O
to	O
a	O
hot	O
(	O
40	O
degrees	O
C	O
,	O
60	O
%	O
relative	O
humidity	O
)	O
and	O
a	O
cold	O
(	O
4	O
degrees	O
C	O
,	O
90	O
%	O
relative	O
humidity	O
)	O
environment	O
and	O
to	O
treadmill	O
exercise	O
(	O
2.1	O
km	O
/	O
h	O
,	O
5	O
degrees	O
gradient	O
)	O
and	O
measured	O
fetal	O
lamb	O
and	O
ewe	O
body	O
temperatures	O
using	O
previously	O
implanted	O
abdominal	O
radiotelemeters	O
.	O

Amino	O
-	O
terminal	O
polymorphisms	O
of	O
the	O
human	B
beta	I
2-adrenergic	I
receptor	I
impart	O
distinct	O
agonist	O
-	O
promoted	O
regulatory	O
properties	O
.	O

A	O
brief	O
discussion	O
for	O
the	O
relationship	O
among	O
these	O
formulas	O
is	O
given	O
.	O

The	O
embryology	O
of	O
the	O
vertebral	O
column	O
is	O
reviewed	O
briefly	O
,	O
and	O
the	O
origin	O
of	O
each	O
anomaly	O
of	O
the	O
C2	O
vertebra	O
is	O
traced	O
to	O
one	O
of	O
the	O
two	O
early	O
stages	O
in	O
development	O
as	O
follows	O
:	O
1	O
)	O
the	O
formation	O
of	O
the	O
mesenchymal	O
vertebra	O
or	O
2	O
)	O
its	O
induction	O
to	O
cartilage	O
.	O

Visualization	O
of	O
the	O
cells	O
by	O
phase	O
contrast	O
microscopy	O
indicated	O
that	O
murine	B
PKCepsilon	I
expression	O
in	O
the	O
presence	O
of	O
glycerol	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
the	O
number	O
of	O
yeast	O
cells	O
exhibiting	O
very	O
small	O
buds	O
.	O

12	O
per	O
cent	O
was	O
observed	O
with	O
the	O
use	O
of	O
tetracycline	O
and	O
4-epianhydrotetracycline	O
in	O
doses	O
of	O
1000	O
and	O
100gamma	O
per	O
embryo	O
respectively	O
.	O

Bodily	O
referents	O
and	O
the	O
experience	O
of	O
affect	O
.	O

We	O
studied	O
about	O
the	O
histological	O
findings	O
of	O
the	O
kidneys	O
including	O
of	O
the	O
infiltrated	O
macrophages	O
in	O
one	O
hour	O
post	O
-	O
transplantation	O
kidney	O
biopsies	O
(	O
one	O
hour	O
biopsies	O
)	O
and	O
re	O
-	O
biopsies	O
on	O
11	O
patients	O
.	O

The	O
human	B
lbc	I
oncogene	I
product	I
is	O
a	O
guanine	B
nucleotide	I
exchange	I
factor	I
that	O
specifically	O
activates	O
the	O
Rho	B
small	I
GTP	I
binding	I
protein	I
,	O
thus	O
resulting	O
in	O
biologically	O
active	O
,	O
GTP	O
-	O
bound	O
Rho	B
,	O
which	O
in	O
turn	O
mediates	O
actin	B
cytoskeletal	O
reorganization	O
,	O
gene	O
transcription	O
,	O
and	O
entry	O
into	O
the	O
mitotic	O
S	O
phase	O
.	O

RESULTS	O
:	O
There	O
were	O
no	O
significant	O
differences	O
in	O
the	O
mean	O
serum	O
vitamin	O
A	O
,	O
E	O
concentrations	O
and	O
vitamin	O
E	O
/	O
cholesterol	O
ratio	O
between	O
pregnant	O
women	O
with	O
normal	O
hemoglobin	B
and	O
hemoglobinopathies	O
,	O
while	O
confounding	O
variables	O
that	O
might	O
affect	O
serum	O
vitamin	O
levels	O
i.e.	O
maternal	O
age	O
,	O
gravida	O
,	O
BMI	O
,	O
gestational	O
age	O
,	O
hematocrit	O
,	O
hemoglobin	B
,	O
mean	O
corpuscular	O
hemoglobin	B
concentration	O
and	O
blood	O
group	O
were	O
not	O
different	O
.	O

These	O
data	O
indicate	O
that	O
SB	O
203580	O
sensitive	O
p38	B
MAP	I
kinases	I
are	O
not	O
involved	O
in	O
okadaic	O
acid	O
mediated	O
increases	O
in	O
TRE	O
DNA	O
binding	O
and	O
transactivation	O
.	O

Evidence	O
for	O
a	O
role	O
of	O
Smad6	B
in	O
chick	O
cardiac	O
development	O
.	O

The	O
overall	O
response	O
rate	O
including	O
CR	O
and	O
PR	O
was	O
23.5	O
%	O
(	O
4	O
/	O
17	O
)	O
.	O

After	O
5,850	O
C14	O
BP	O
,	O
the	O
decrease	O
in	O
Acer	O
stands	O
could	O
be	O
attributed	O
to	O
fire	O
as	O
suggested	O
by	O
the	O
strong	O
increase	O
in	O
Betula	O
and	O
by	O
the	O
delayed	O
expansion	O
of	O
Pinus	O
cembra	O
.	O

4.7	O
+	O
/-	O

0.6	O
micromol	O
.	O

kg-1	O
.	O

min-1	O
)	O
but	O
was	O
not	O
changed	O
by	O
training	O
.	O

RET	B
/	O
PTC	B
oncogenes	O
,	O
generated	O
by	O
chromosomal	O
rearrangements	O
in	O
papillary	O
thyroid	O
carcinomas	O
,	O
are	O
constitutively	O
activated	O
versions	O
of	O
proto	B
-	I
RET	I
,	O
a	O
gene	O
coding	O
for	O
a	O
receptor	B
-	I
type	I
tyrosine	I
kinase	I
(	O
TK	B
)	O
whose	O
ligand	O
is	O
still	O
unknown	O
.	O

Diclofenac	O
sodium	O
:	O
blood	O
concentration	O
of	O
the	O
slow	O
-	O
release	O
form	O
and	O
influence	O
on	O
the	O
metabolism	O
of	O
kallikrein	B
.	O

The	O
unc-101	B
,	O
sli-1	B
,	O
and	O
rok-1	B
genes	I
encode	O
a	O
distinct	O
set	O
of	O
negative	O
regulators	O
of	O
vulval	O
differentiation	O
.	O

Optimized	O
USF	B
and	O
MYC	B
DNA	O
-	O
binding	O
sites	O
,	O
which	O
differ	O
in	O
the	O
nucleotides	O
bordering	O
the	O
hexanucleotide	O
box	O
displace	O
the	O
E	B
-	I
C4	I
factor	I
in	O
competition	O
assays	O
but	O
with	O
lesser	O
efficiency	O
than	O
the	O
E	B
-	I
C4	I
site	I
itself	O
.	O

DESIGN	O
:	O
Intradermally	O
injected	O
human	O
squamous	O
cell	O
carcinoma	O
cells	O
were	O
grown	O
to	O
40	O
to	O
80	O
mm3	O
in	O
athymic	O
nude	O
mice	O
and	O
irradiated	O
with	O
675-nm	O
light	O
(	O
75	O
J	O
/	O
cm2	O
,	O
75	O
mW	O
/	O
cm2	O
)	O
24	O
hours	O
after	O
the	O
intraperitoneal	O
injection	O
of	O
SiPc	O
IV	O
(	O
1.0	O
mg	O
/	O
kg	O
)	O
.	O

There	O
are	O
two	O
regulatory	O
regions	O
between	O
the	O
US3	B
and	O
the	O
US6	B
transcription	I
units	I
.	O

Thus	O
,	O
the	O
predicted	O
M3	O
ORF	O
is	O
a	O
functional	O
gene	O
that	O
encodes	O
an	O
abundant	O
secreted	O
protein	O
which	O
is	O
a	O
candidate	O
for	O
interacting	O
with	O
host	O
cellular	O
receptors	O
or	O
cytokines	O
.	O

The	O
protein	O
encoded	O
by	O
the	O
NF2	B
gene	I
has	O
a	O
similarity	O
to	O
ezrin	B
,	O
radixin	B
and	O
moesin	B
(	O
ERM	B
)	O
proteins	O
that	O
link	O
membrane	O
proteins	O
to	O
the	O
cytoskeleton	O
.	O

80	O
v	B
-	I
ets	I
-	O
encoded	O
amino	O
-	O
acids	O
located	O
immediately	O
after	O
the	O
v	B
-	I
myb	I
/	O
v	B
-	I
ets	I
junction	O
are	O
not	O
found	O
in	O
P54	B
/	O
56c	B
-	I
ets	I
,	O
the	O
translation	O
product	O
of	O
the	O
c	B
-	I
ets	I
proto	I
-	I
oncogene	I
,	O
nor	O
in	O
a	O
set	O
of	O
cellular	O
proteins	O
of	O
64	O
,	O
62	O
,	O
and	O
60	O
kDa	O
related	O
to	O
but	O
distinct	O
from	O
P54	B
/	O
56c	B
-	I
ets	I
.	O

In	O
contrast	O
translocation	O
of	O
G1	B
to	O
the	O
Golgi	O
was	O
not	O
observed	O
when	O
G1	B
was	O
coexpressed	O
with	O
NSm	B
,	O
although	O
NSm	B
itself	O
was	O
still	O
detected	O
in	O
the	O
Golgi	O
.	O

In	O
this	O
technique	O
,	O
the	O
posterior	O
wall	O
of	O
the	O
neopharynx	O
consists	O
only	O
of	O
the	O
prevertebral	O
tissue	O
,	O
while	O
the	O
flap	O
forms	O
the	O
anterior	O
and	O
lateral	O
walls	O
.	O

These	O
data	O
may	O
indicate	O
redundancy	O
between	O
members	O
of	O
the	O
NGFI	B
-	I
B	I
/	O
Nurr1	B
/	O
Nor1	B
subfamily	O
and	O
could	O
explain	O
why	O
no	O
phenotypic	O
disturbances	O
have	O
yet	O
been	O
found	O
in	O
mice	O
in	O
which	O
the	O
NGFI	B
-	I
B	I
gene	I
has	O
been	O
inactivated	O
.	O

Activation	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
MAPK	B
)	O
pathway	O
enhances	O
long	O
-	O
range	O
transactivation	O
by	O
the	O
beta	B
-	I
globin	I
locus	I
control	I
region	I
(	O
LCR	O
)	O
(	O
W.	O

The	O
gp41	B
peptide	I
(	I
Glu	I
-	I
Leu	I
-	I
Asp	I
-	I
Lys	I
-	I
Trp	I
-	I
Ala	I
)	I
fused	O
to	O
the	O
C	O
-	O
terminus	O
of	O
Sj	B
GST	I
forms	O
a	O
loop	O
stabilized	O
by	O
symmetry	O
-	O
related	O
GSTs	B
.	O

The	O
testes	O
of	O
8	O
specimens	O
of	O
Triturus	O
marmoratus	O
were	O
collected	O
during	O
each	O
month	O
of	O
1987	O
and	O
processed	O
for	O
electron	O
microscopy	O
and	O
light	O
microscopy	O
demonstration	O
of	O
testosterone	O
(	O
T	O
)	O
following	O
the	O
ABC	B
(	O
avidin	B
-	I
biotin	I
peroxidase	I
complex	I
)	O
method	O
.	O

Thus	O
,	O
apoptosis	O
in	O
hematopoietic	O
cells	O
is	O
the	O
end	O
result	O
of	O
a	O
conflict	O
between	O
death	O
and	O
survival	O
signals	O
,	O
rather	O
than	O
a	O
simple	O
death	O
by	O
default	O
.	O

Changes	O
in	O
testicular	O
testosterone	O
and	O
acid	O
and	O
alkaline	B
phosphatase	I
activity	O
in	O
testis	O
and	O
accessory	O
sex	O
organs	O
after	O
induction	O
of	O
varicocele	O
in	O
Noble	O
rats	O
.	O

The	O
reconstituted	O
RNA	B
polymerases	I
containing	O
the	O
mutant	O
alpha	O
subunits	O
were	O
examined	O
for	O
their	O
response	O
to	O
transcription	O
activation	O
by	O
cAMP	B
-	I
CRP	I
and	O
the	O
rrnBP1	B
UP	I
element	I
.	O

Changes	O
in	O
the	O
greater	O
omentum	O
of	O
mice	O
of	O
different	O
strains	O
after	O
intraperitoneal	O
immunization	O
with	O
sheep	O
erythrocytes	O
.	O

In	O
patients	O
,	O
750	O
mL	O
of	O
saline	O
lowered	O
DL	O
(	O
CO	O
)	O
(	O
-8	O
%	O
,	O
P<0.01	O
versus	O
baseline	O
)	O
,	O
D	O
(	O
M	O
)	O
(	O
-10	O
%	O
,	O
P<0.01	O
versus	O
baseline	O
)	O
,	O
aldosterone	O
(	O
-29	O
%	O
,	O
P<0.01	O
versus	O
baseline	O
)	O
,	O
renin	B
(	O
-52	O
%	O
,	O
P<0.01	O
versus	O
baseline	O
)	O
,	O
and	O
hematocrit	O
(	O
-6	O
%	O
,	O
P<0.05	O
versus	O
baseline	O
)	O
and	O
increased	O
V	O
(	O
C	O
)	O
(	O
20	O
%	O
,	O
P<0.01	O
versus	O
baseline	O
)	O
,	O
without	O
changing	O
rap	O
and	O
wpp	O
.	O

Reversible	O
pressure	O
-	O
induced	O
amorphization	O
in	O
solid	O
C70	O
:	O
Raman	O
and	O
photoluminescence	O
study	O
.	O

Mean	O
CD4	B
percentages	O
were	O
lower	O
postpartum	O
(	O
21.9	O
+	O
/-	O

3.4	O
)	O
than	O
prepartum	O
(	O
45.1	O
+	O
/-	O

6.7	O
)	O
in	O
all	O
five	O
patients	O
studied	O
,	O
although	O
proliferative	O
responses	O
to	O
the	O
mitogens	B
phytohemagglutinin	I
and	I
pokeweed	I
were	O
unchanged	O
during	O
the	O
study	O
period	O
.	O

Significance	O
of	O
the	O
determination	O
of	O
vascular	O
tonus	O
in	O
the	O
differential	O
diagnosis	O
of	O
rheumatic	O
and	O
arteriosclerotic	O
lesions	O
of	O
the	O
heart	O
and	O
vessels	O
in	O
middle	O
-	O
aged	O
and	O
elderly	O
persons	O
with	O
fibrillation	O
arrhythmia	O

Under	O
control	O
conditions	O
and	O
in	O
the	O
presence	O
of	O
3	O
micromol	O
/	O
kg	O
MIB	O
and	O
VER	O
the	O
maximal	O
effect	O
of	O
noradrenaline	O
was	O
reached	O
at	O
0.1	O
micromol	O
/	O
kg	O
whereas	O
in	O
the	O
presence	O
of	O
10	O
micromol	O
/	O
kg	O
MIB	O
and	O
VER	O
it	O
was	O
reached	O
at	O
a	O
dose	O
of	O
1	O
micromol	O
/	O
kg	O
.	O

The	O
highly	O
conserved	O
region	O
of	O
U6	B
snRNA	I
has	O
a	O
structural	O
similarity	O
with	O
the	O
catalytic	O
domain	O
of	O
the	O
negative	O
strand	O
of	O
the	O
satellite	O
RNA	O
of	O
tobacco	O
ring	O
spot	O
virus	O
[	O
(	O
-	O
)	O
sTRSV	O
]	O
,	O
suggesting	O
that	O
the	O
highly	O
conserved	O
region	O
of	O
U6	B
snRNA	I
forms	O
the	O
catalytic	O
center	O
.	O

By	O
computed	O
homology	O
search	O
,	O
we	O
noticed	O
significant	O
similarities	O
between	O
US3	B
PK	I
and	O
p21-activated	B
kinase	I
(	O
PAK	B
)	O
,	O
which	O
is	O
activated	O
by	O
the	O
Cdc42	B
or	O
Rac	B
.	O

Drosophila	B
melanogaster	I
casein	I
kinase	I
II	I
(	O
DmCKII	B
)	O
is	O
composed	O
of	O
catalytic	O
(	O
alpha	O
)	O
and	O
regulatory	O
(	O
beta	O
)	O
subunits	O
associated	O
as	O
an	O
alpha2beta2	O
heterotetramer	O
.	O

Inhibition	O
of	O
DNA	B
topoisomerase	I
II	I
alpha	I
gene	I
expression	O
by	O
the	O
p53	B
tumor	I
suppressor	I
.	O

Vav	B
and	O
Dbl	B
are	O
members	O
of	O
a	O
novel	O
class	O
of	O
oncogene	O
proteins	O
that	O
share	O
significant	O
sequence	O
identity	O
in	O
a	O
approximately	O
250-amino	O
-	O
acid	O
domain	O
,	O
designated	O
the	O
Dbl	B
homology	I
domain	I
.	O

METHODS	O
:	O
Levels	O
of	O
sIL-2R	B
were	O
measured	O
simultaneously	O
in	O
plasma	O
and	O
pleural	O
fluid	O
in	O
111	O
patients	O
with	O
pleural	O
effusions	O
of	O
unknown	O
causes	O
.	O

The	O
LIF	B
appeared	O
to	O
be	O
released	O
by	O
the	O
patient	O
's	O
peripheral	O
blood	O
lymphocytes	O
when	O
cultured	O
with	O
optimal	O
doses	O
of	O
propranolol	O
.	O

This	O
regulation	O
is	O
mediated	O
by	O
several	O
kinases	O
that	O
phosphorylate	O
specific	O
residues	O
in	O
the	O
different	O
functional	O
domains	O
of	O
the	O
p53	B
molecule	I
.	O

In	O
group	O
I	O
during	O
the	O
pain	O
free	O
period	O
26	O
of	O
81	O
patients	O
had	O
positive	O
thallium-201	O
scans	O
,	O
whereas	O
20	O
patients	O
had	O
an	O
abnormal	O
ECG	O
at	O
that	O
time	O
;	O
during	O
angina	O
18	O
patients	O
had	O
transient	O
ECG	O
changes	O
.	O

We	O
examined	O
the	O
contribution	O
of	O
the	O
M	B
-	I
MuLV	I
enhancers	I
to	O
the	O
transcriptional	O
activity	O
and	O
pathogenesis	O
of	O
M	O
-	O
MuLV	O
by	O
constructing	O
LTRs	O
containing	O
heterologous	O
enhancer	O
elements	O
.	O

Acute	O
respiratory	O
distress	O
syndrome	O
.	O

Serum	O
creatinine	B
kinase	I
activity	O
was	O
7,800	O
-	O
17,500	O
U	O
/	O
l	O
,	O
making	O
acute	O
muscle	O
damage	O
likely	O
,	O
probably	O
rhabdomyolysis	O
.	O

Fetal	O
arterial	O
and	O
sagittal	O
sinus	O
pH	O
,	O
base	O
excess	O
,	O
po2	O
,	O
and	O
oxygen	O
saturation	O
decreased	O
,	O
and	O
hydrogen	O
ion	O
concentrations	O
and	O
pco2	O
increased	O
during	O
asphyxia	O
alone	O
and	O
asphyxia	O
plus	O
isoflurane	O
-	O
oxygen	O
.	O

For	O
the	O
most	O
part	O
,	O
only	O
aerobic	O
microbial	O
degradation	O
systems	O
have	O
been	O
reported	O
so	O
far	O
.	O

This	O
is	O
mediated	O
by	O
vascular	O
remodeling	O
,	O
an	O
active	O
process	O
that	O
results	O
in	O
a	O
change	O
in	O
the	O
geometry	O
of	O
the	O
blood	O
vessel	O
.	O

Although	O
cardiac	O
output	O
decreased	O
slightly	O
with	O
PCF	O
,	O
hemodynamic	O
changes	O
due	O
to	O
PCF	O
were	O
unlikely	O
to	O
account	O
for	O
the	O
observed	O
fall	O
in	O
PaO2	O
.	O

Swarming	O
of	O
Moraxella	O

Two	O
patient	O
groups	O
were	O
studied	O
:	O
Type	O
I	O
--	O
with	O
a	O
new	O
ePTFE	O
graft	O
;	O
and	O
Type	O
II	O
--	O
with	O
thrombectomy	O
and/or	O
revision	O
of	O
a	O
previously	O
placed	O
ePTFE	O
graft	O
.	O

As	O
a	O
quantitative	O
index	O
of	O
cochlear	O
function	O
,	O
2f1-f2	O
distortion	O
-	O
product	O
otoacoustic	O
emissions	O
(	O
DPOAEs	O
)	O
were	O
monitored	O
systematically	O
over	O
time	O
in	O
three	O
groups	O
of	O
rabbits	O
,	O
with	O
each	O
group	O
experiencing	O
a	O
unique	O
paradigm	O
that	O
incorporated	O
repeated	O
exposure	O
to	O
the	O
low	O
-	O
frequency	O
tone	O
.	O

Quasidiatomic	O
study	O
of	O
Ly-	O
alpha	O
-producing	O
H2	O
+	O
-Ne	O
collisions	O
at	O
keV	O
energies	O
.	O

Detailed	O
analysis	O
of	O
the	O
predicted	O
amino	O
acid	O
sequence	O
revealed	O
sequence	O
elements	O
which	O
are	O
conserved	O
in	O
many	O
DNA	B
and	I
RNA	I
polymerases	I
.	O

139La	O
NQR	O
relaxation	O
and	O
microSR	O
study	O
of	O
Zn	O
-	O
doping	O
effects	O
in	O
La2CuO4	O
.	O

Our	O
study	O
investigated	O
the	O
hypothesis	O
that	O
the	O
combination	O
of	O
a	O
high	O
NaCl	O
diet	O
and	O
social	O
isolation	O
stress	O
would	O
increase	O
systolic	O
blood	O
pressure	O
(	O
SBP	O
)	O
and	O
endogenous	O
sodium	O
pump	O
ligands	O
(	O
SPL	O
)	O
,	O
ouabainlike	O
compound	O
(	O
OLC	O
)	O
,	O
and	O
marinobufagenin	O
(	O
MBG	O
)	O
.	O

Percentage	O
incremental	O
18-OHB	O
responses	O
to	O
metoclopramide	O
were	O
greater	O
(	O
P	O
less	O
than	O
0.01	O
)	O
in	O
the	O
subjects	O
after	O
5	O
days	O
on	O
a	O
200-meq	O
sodium	O
intake	O
than	O
after	O
5	O
days	O
on	O
a	O
10-meq	O
sodium	O
intake	O
.	O

PURPOSE	O
:	O
Second	O
malignant	O
neoplasms	O
(	O
SMNs	O
)	O
are	O
a	O
rare	O
occurrence	O
after	O
the	O
successful	O
treatment	O
of	O
childhood	O
cancer	O
.	O

A	O
p53	B
cDNA	I
deletion	O
mutant	O
(	O
delta	O
pro	O
AE	O
)	O
,	O
which	O
lacks	O
this	O
entire	O
proline	O
-	O
rich	O
domain	O
(	O
deleted	O
for	O
amino	O
acids	O
62	O
-	O
91	O
)	O
,	O
was	O
created	O
and	O
characterized	O
for	O
a	O
variety	O
of	O
p53	B
functions	O
.	O

Candidate	O
factors	O
have	O
been	O
identified	O
by	O
the	O
observation	O
that	O
changes	O
in	O
glucocorticoid	O
induction	O
parameters	O
in	O
CV-1	O
cells	O
could	O
be	O
reproduced	O
by	O
varying	O
the	O
cellular	O
levels	O
of	O
coactivators	O
[	O
transcriptional	B
intermediary	I
factor	I
2	I
(	O
TIF2	B
)	O
,	O
steroid	B
receptor	I
coactivator	I
1	I
(	O
SRC-1	B
)	O
,	O
and	O
amplified	B
in	I
breast	I
cancer	I
1	I
(	O
AIB1	B
)	O
]	O
,	O
comodulator	O
[	O
CREB	B
-	I
binding	I
protein	I
(	O
CBP	B
)	O
]	O
,	O
or	O
corepressor	O
[	O
silencing	B
mediator	I
for	I
retinoid	I
and	I
thyroid	I
-	I
hormone	I
receptors	I
(	O
SMRT	B
)	O
]	O
without	O
concomitant	O
increases	O
in	O
GR	B
.	O

The	O
pyridostigmine	O
inhibited	O
AChE	B
recovered	O
only	O
in	O
the	O
100	O
mumol	O
kg-1	O
kg	O
oxime	O
groups	O
at	O
the	O
end	O
of	O
the	O
experiment	O
.	O

We	O
compared	O
retrospectively	O
the	O
efficacy	O
of	O
granulocyte	B
colony	I
stimulating	I
factor	I
(	O
G	B
-	I
CSF	I
)	O
alone	O
with	O
chemotherapy	O
plus	O
G	B
-	I
CSF	I
in	O
mobilizing	O
CD34-positive	B
cells	O
in	O
patients	O
with	O
malignant	O
lymphoma	O
.	O

Activation	O
of	O
the	O
receptor	O
induces	O
Ret	B
phosphorylation	O
that	O
leads	O
the	O
survival	O
-	O
promoting	O
effects	O
.	O

Adenovirus	O
infection	O
of	O
hepatoma	O
cells	O
inhibited	O
transcription	O
of	O
the	O
phosphoenolpyruvate	B
carboxykinase	I
(	O
GTP	O
)	O
(	O
EC	B
4.1.1.32	I
)	O
(	O
PEPCK	B
)	O
gene	O
and	O
virtually	O
eliminated	O
transcription	O
of	O
a	O
chimeric	O
gene	O
which	O
contained	O
the	O
PEPCK	B
promoter	I
linked	O
to	O
the	O
structural	O
gene	O
for	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
.	O

Circulating	O
immune	O
complexes	O
were	O
determined	O
by	O
the	O
method	O
of	O
phagocytosis	O
and	O
immunofluorescence	O
.	O

LCCH1	B
was	O
identical	O
to	O
the	O
Rdl	B
gene	I
,	O
a	O
known	O
GABA	B
receptor	I
subunit	I
gene	I
from	O
D.	O
melanogaster	O
,	O
whereas	O
LCCH2	B
and	O
LCCH3	B
were	O
novel	O
D.	O
melanogaster	O
sequences	O
that	O
exhibited	O
structural	O
similarity	O
to	O
other	O
members	O
of	O
the	O
ligand	B
-	I
gated	I
chloride	I
channel	I
gene	I
family	I
.	O

In	O
this	O
report	O
,	O
we	O
investigated	O
whether	O
the	O
cleavage	O
of	O
the	O
RRKR	O
motif	O
of	O
MT	B
-	I
MMP1	I
by	O
Golgi	B
-	I
associated	I
furin	I
is	O
analogous	O
to	O
a	O
similar	O
enzyme	O
activation	O
mechanism	O
observed	O
with	O
stromelysin-3	B
.	O

Lifestyle	O
characteristics	O
were	O
ascertained	O
by	O
a	O
self	O
-	O
administered	O
questionnaire	O
.	O

The	O
oxalate	B
oxidase	I
method	O
results	O
in	O
a	O
mean	O
and	O
reference	O
interval	O
for	O
oxalate	O
excretion	O
that	O
are	O
comparable	O
with	O
those	O
by	O
isotope	O
dilution	O
,	O
gas	O
-	O
chromatographic	O
,	O
colorimetric	O
,	O
and	O
other	O
enzymic	O
procedures	O
.	O

Normal	O
replication	O
of	O
DNA	B
A	I
still	O
carrying	O
the	O
AC3	B
ORF	I
mutation	O
was	O
found	O
in	O
extracts	O
from	O
these	O
plants	O
.	O

Kohtz	O
,	O
J.	O

These	O
data	O
are	O
discussed	O
in	O
the	O
context	O
of	O
the	O
pathogenesis	O
and	O
differential	O
diagnosis	O
of	O
EEC	O
.	O

These	O
data	O
suggest	O
that	O
the	O
fibrinogen	B
gamma	I
chain	I
region	I
Gly190-Val202	I
functions	O
as	O
a	O
minimal	O
recognition	O
sequence	O
for	O
the	O
leukocyte	O
integrin	O
CD11b	B
/	O
CD18	B
.	O

OBJECTIVE	O
:	O
The	O
audiologic	O
presentation	O
of	O
vestibular	O
schwannoma	O
(	O
VS	O
)	O
associated	O
with	O
neurofibromatosis	O
type	O
2	O
(	O
NF2	O
)	O
has	O
not	O
been	O
well	O
characterized	O
.	O

The	O
effect	O
of	O
the	O
NMDA	B
-	I
receptor	I
antagonist	O
(	O
+	O
/-	O
)	O
-CPP	O
on	O
the	O
conditioned	O
-	O
reflex	O
activation	O
of	O
an	O
operant	O
reaction	O
in	O
the	O
brain	O
electrical	O
self	O
-	O
stimulation	O
test	O
in	O
rats	O

Treatment	O
with	O
H7	O
did	O
not	O
affect	O
IL-4R	B
-	O
mediated	O
immediate	O
signaling	O
events	O
such	O
as	O
tyrosine	O
phosphorylation	O
of	O
Jak1	B
,	O
Jak3	B
,	O
insulin	B
receptor	I
substrate	I
(	I
IRS	I
)	I
-1	I
and	O
IRS-2	B
,	O
or	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
of	O
Stat6	B
.	O

(	O
1982	O
)	O
.	O

Vasodilation	O
in	O
congestive	O
heart	O
failure	O
is	O
an	O
established	O
therapeutic	O
principal	O
.	O

The	O
translational	O
product	O
of	O
UL26.5	B
is	O
infected	B
-	I
cell	I
protein	I
35c	I
,	I
d	I
(	O
ICP35c	B
,	I
d	I
)	O
(	O
F.	O

Minor	O
changes	O
within	O
the	O
transmembrane	O
domains	O
(	O
TMs	O
)	O
sometimes	O
produced	O
major	O
effects	O
and	O
more	O
drastic	O
changes	O
in	O
the	O
TMs	O
ablated	O
surface	O
expression	O
entirely	O
.	O

Mammalian	O
chromosome	O
ends	O
contain	O
long	O
arrays	O
of	O
TTAGGG	O
repeats	O
that	O
are	O
complexed	O
to	O
a	O
telomere	O
specific	O
protein	O
,	O
the	O
TTAGGG	B
repeat	I
binding	I
factor	I
,	O
TRF1	B
.	O

HPV-16	O
MARs	O
are	O
context	O
dependent	O
transcriptional	O
enhancers	O
,	O
and	O
activated	O
expression	O
of	O
HPV-16	O
oncogenes	O
dependent	O
on	O
chromosomal	O
integration	O
may	O
positively	O
select	O
tumorigenic	O
cells	O
during	O
the	O
multistep	O
etiology	O
of	O
cervical	O
cancer	O
.	O

Vancomycin	O
and	O
tetracycline	O
eliminated	O
toxin	O
in	O
stools	O
and	O
delayed	O
death	O
.	O

The	O
duration	O
of	O
naloxone	O
appears	O
to	O
be	O
dose	O
-	O
related	O
,	O
statistically	O
significant	O
up	O
to	O
approximately	O
1.5	O
hr	O
.	O

Reconstruction	O
time	O
for	O
a	O
64	O
x	O
64	O
matrix	O
is	O
approximately	O
45	O
s	O
/	O
transaxial	O
slice	O
.	O

The	O
immediate	O
and	O
remote	O
results	O
of	O
surgical	O
treatment	O
of	O
renal	O
adenocarcinomas	O
.	O

However	O
,	O
the	O
MCMI	O
-	O
III	O
group	O
profile	O
was	O
significantly	O
lower	O
in	O
magnitude	O
compared	O
with	O
the	O
MCMI	O
-	O
II	O
.	O

The	O
impairment	O
of	O
the	O
nocturnal	O
secretion	O
was	O
related	O
to	O
the	O
subjects	O
'	O
age	O
and	O
,	O
for	O
the	O
GH	B
secretory	O
pattern	O
only	O
,	O
also	O
to	O
the	O
MMSE	O
score	O
.	O

Earlier	O
nonoptical	O
methods	O
probably	O
did	O
not	O
include	O
the	O
portion	O
of	O
the	O
film	O
that	O
contained	O
mucus	O
.	O

Here	O
we	O
report	O
that	O
point	O
mutations	O
of	O
the	O
Abd	B
-	I
B	I
gene	I
in	O
trans	O
suppress	O
the	O
Fab-7	B
phenotype	I
in	O
a	O
pairing	O
-	O
dependent	O
manner	O
and	O
thus	O
represent	O
a	O
type	O
of	O
transvection	O
.	O

The	O
glucose	O
effect	O
on	O
the	O
pyruvate	B
kinase	I
gene	I
is	O
reversibly	O
antagonized	O
by	O
agents	O
increasing	O
intracellular	O
cAMP	O
.	O

Here	O
,	O
we	O
report	O
the	O
isolation	O
of	O
a	O
new	O
spindle	O
checkpoint	O
gene	O
,	O
mph1	B
(	O
Mps1p	B
-	I
like	I
pombe	I
homolog	I
)	O
,	O
in	O
the	O
fission	O
yeast	O
Schizosaccharomyces	O
pombe	O
,	O
that	O
is	O
required	O
for	O
checkpoint	O
activation	O
in	O
response	O
to	O
spindle	O
defects	O
.	O

mph1	B
functions	O
upstream	O
of	O
mad2	B
,	O
a	O
previously	O
characterized	O
component	O
of	O
the	O
spindle	O
checkpoint	O
.	O

In	O
addition	O
,	O
measurements	O
of	O
shielded	O
and	O
unshielded	O
syringes	O
containing	O
99mTc	O
-	O
labelled	O
radiopharmaceuticals	O
were	O
carried	O
out	O
.	O

The	O
well	O
-	O
trained	O
group	O
was	O
measured	O
once	O
in	O
the	O
respiration	O
chamber	O
for	O
36	O
h	O
according	O
to	O
the	O
same	O
protocol	O
.	O

PtdIns	B
(	I
4,5	I
)	I
P2	I
synthesis	O
,	O
on	O
the	O
other	O
hand	O
,	O
is	O
only	O
moderately	O
affected	O
even	O
in	O
fab1Delta	B
mutants	I
.	O

Protein	O
sequencing	O
,	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
and	O
immunoblot	O
analyses	O
identify	O
p54	B
and	O
p47	B
/	I
48	I
as	O
members	O
of	O
the	O
hepatocyte	B
nuclear	I
factor	I
3	I
(	O
HNF3	B
[	O
forkhead	B
]	O
)	O
family	O
of	O
transcription	O
factors	O
.	O

p54	B
belongs	O
to	O
the	O
subfamily	O
of	O
HNF3	B
beta	I
proteins	I
,	O
while	O
p47	B
/	I
48	I
binding	O
activity	O
includes	O
HNF3	B
gamma	I
.	O

The	O
TCR	B
beta	I
enhancer	I
was	O
active	O
on	O
both	O
the	O
minimal	B
simian	I
virus	I
40	I
promoter	I
and	O
a	O
TCR	B
beta	I
variable	I
gene	I
promoter	I
in	O
both	O
TCR	B
alpha	I
/	I
beta	I
+	O
and	O
TCR	B
gamma	I
/	I
delta	I
+	O
T	O
cells	O
.	O

Fibrosis	O
of	O
the	O
adjacent	O
myocardium	O
was	O
seen	O
in	O
five	O
cases	O
.	O

These	O
findings	O
suggest	O
that	O
T3R	B
can	O
repress	O
or	O
activate	O
transcription	O
while	O
tethered	O
to	O
the	O
LBD	O
of	O
GAL4-RXR	B
and	O
that	O
heterodimerization	O
can	O
occur	O
in	O
vivo	O
without	O
stabilization	O
by	O
hormone	O
response	O
elements	O
.	O

Surprisingly	O
,	O
in	O
adult	O
animals	O
,	O
the	O
suprabasal	O
expression	O
of	O
dnRXR	B
alpha	I
significantly	O
reduced	O
the	O
ability	O
of	O
topically	O
applied	O
tRA	O
to	O
stimulate	O
proliferation	O
of	O
undifferentiated	O
keratinocytes	O
in	O
the	O
basal	O
layer	O
of	O
epidermis	O
.	O

A	O
third	O
-	O
order	O
polynominal	O
fit	O
showed	O
a	O
good	O
correlation	O
for	O
the	O
parameter	O
Q	O
*	O
and	O
MTT	O
,	O
whereas	O
T	O
and	O
SImax	O
were	O
found	O
to	O
have	O
a	O
poor	O
correlation	O
.	O

These	O
results	O
demonstrate	O
the	O
extensive	O
homology	O
in	O
sequence	O
among	O
light	O
chains	O
of	O
IgM	B
kappa	I
autoantibodies	I
and	O
indicate	O
that	O
a	O
particular	O
V	B
kappa	I
germ	I
line	I
gene	I
,	O
kappa	B
IIIb	I
,	O
is	O
expressed	O
as	O
a	O
phylogenetic	O
response	O
to	O
certain	O
self	O
antigens	O
or	O
as	O
part	O
of	O
a	O
selection	O
process	O
by	O
which	O
these	O
autoimmune	O
responses	O
are	O
regulated	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
influence	O
of	O
long	O
term	O
intravenous	O
administration	O
of	O
naftidrofuryl	O
(	O
Dusodril	O
-	O
Lipha	O
Arzn	O
)	O
twice	O
daily	O
in	O
a	O
dose	O
of	O
200	O
mg	O
in	O
continuous	O
,	O
4-hour	O
infusion	O
in	O
500	O
ml	O
0.9	O
%	O
NaCl	O
to	O
the	O
patients	O
suffering	O
from	O
a	O
peripheral	O
arterial	O
occlusive	O
disease	O
(	O
PAOD	O
)	O
in	O
a	O
clinical	O
condition	O
with	O
special	O
attention	O
paid	O
to	O
transcutaneous	O
partial	O
oxygen	O
pressure	O
measurements	O
(	O
tcPO2	O
)	O
and	O
rheographic	O
parameters	O
.	O

We	O
concluded	O
that	O
RXR	B
-	I
gamma	I
induced	O
terminal	O
differentiation	O
in	O
SCC	O
lines	O
,	O
suggesting	O
a	O
potential	O
tumor	O
suppressor	O
function	O
for	O
this	O
transcription	O
factor	O
.	O

A	O
very	O
large	O
PC	O
LAN	O
as	O
the	O
basis	O
for	O
a	O
hospital	O
information	O
system	O
.	O

After	O
institution	O
of	O
insulin	B
treatment	O
,	O
diabetic	O
control	O
was	O
improved	O
as	O
demonstrated	O
by	O
decreasing	O
levels	O
of	O
HbA1	B
.	O

Both	O
parameters	O
were	O
determined	O
in	O
an	O
individual	O
eye	O
by	O
applying	O
the	O
dye	O
first	O
by	O
iontophoresis	O
and	O
then	O
by	O
intravitreal	O
injection	O
,	O
which	O
allows	O
the	O
influence	O
of	O
fluorescein	O
glucuronide	O
on	O
the	O
fluorophotometric	O
measurements	O
to	O
be	O
excluded	O
.	O

Phase	O
I	O
clinical	O
trial	O
with	O
a	O
combination	O
of	O
methotrexate	O
and	O
mitomycin	O
C.	O

A	O
total	O
of	O
114	O
animals	O
were	O
infected	O
by	O
E.	O
coli	O
O2	O
:	O
K1	O
:	O
H4	O
by	O
the	O
hematogenic	O
route	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
suggest	O
that	O
,	O
by	O
interacting	O
with	O
cellular	O
transcription	O
factors	O
and	O
cofactors	O
,	O
vIRF-2	B
may	O
modulate	O
the	O
expression	O
of	O
the	O
early	O
inflammatory	O
genes	O
and	O
potentially	O
deregulate	O
the	O
immune	O
system	O
.	O

AIMS	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
static	O
and	O
dynamic	O
bone	O
changes	O
in	O
patients	O
suffering	O
from	O
rickets	O
.	O

The	O
homeodomain	B
transcription	I
factor	I
CDP	B
/	O
cut	B
interacts	O
with	O
the	O
cell	O
cycle	O
regulatory	O
element	O
of	O
histone	B
H4	I
genes	I
packaged	O
into	O
nucleosomes	O
.	O

K.	O
,	O
Weiss	O
,	O
M.	O

Thus	O
,	O
IF	O
-	O
laser	O
therapy	O
has	O
a	O
certain	O
antioxidative	O
effect	O
by	O
increasing	O
SOD	B
activity	O
in	O
RA	O
patients	O
'	O
blood	O
cells	O
and	O
reducing	O
the	O
production	O
of	O
highly	O
reactive	O
oxygen	O
and	O
nitrogen	O
forms	O
.	O

During	O
hexamethylene	O
bisactamide	O
(	O
HMBA	O
)	O
-induced	O
differentiation	O
of	O
murine	O
erythroleukemia	O
(	O
MEL	O
)	O
cells	O
erythroid	O
genes	O
are	O
transcriptionally	O
activated	O
while	O
c	B
-	I
myb	I
and	O
several	O
other	O
nuclear	O
proto	O
-	O
oncogenes	O
are	O
down	O
-	O
regulated	O
.	O

We	O
now	O
report	O
identification	O
and	O
analysis	O
of	O
transcriptional	O
activities	O
mediated	O
by	O
three	O
cis	O
-	O
acting	O
sites	O
within	O
a	O
90-bp	O
portion	O
of	O
the	O
rDNA	O
enhancer	O
designated	O
the	O
modulator	O
region	O
.	O

In	O
human	O
WI38	O
cells	O
,	O
the	O
E1B	B
19	I
K	I
gene	I
mutant	I
viruses	O
had	O
a	O
substantial	O
growth	O
advantage	O
over	O
the	O
wild	O
-	O
type	O
virus	O
,	O
yielding	O
500-fold	O
-	O
higher	O
titers	O
.	O

The	O
N	O
-	O
terminal	O
sequence	O
of	O
the	O
extracellular	B
MEP20	I
,	O
TKVAS	B
,	O
was	O
found	O
at	O
aa	O
194	O
-	O
198	O
within	O
the	O
ORF	O
.	O

Furthermore	O
,	O
mutations	O
in	O
element	O
II	O
result	O
in	O
changes	O
in	O
the	O
RNA	O
structure	O
near	O
element	O
III	O
,	O
consistent	O
with	O
a	O
long	O
-	O
range	O
interaction	O
that	O
may	O
promote	O
translation	O
.	O

(	O
We	O
observed	O
a	O
ferritin	B
value	O
as	O
high	O
as	O
47	O
mg	O
/	O
L	O
in	O
one	O
patient	O
.	O
)	O

Results	O
with	O
all	O
these	O
kits	O
did	O
not	O
inter	O
-	O
compare	O
well	O
for	O
ferritin	B
concentrations	O
greater	O
than	O
300	O
micrograms	O
/	O
L	O
,	O
a	O
finding	O
that	O
casts	O
further	O
doubt	O
on	O
the	O
controversial	O
use	O
of	O
serum	B
ferritin	I
measurement	O
in	O
cases	O
of	O
iron	O
overload	O
.	O

A.	O

We	O
propose	O
that	O
U73	B
is	O
involved	O
in	O
methylation	O
of	O
the	O
G1739	O
residue	O
of	O
the	O
human	B
28S	I
rRNA	I
.	O

Animals	O
were	O
divided	O
into	O
six	O
equal	O
groups	O
as	O
follows	O
:	O
(	O
1	O
)	O
no	O
oral	O
drug	O
(	O
water	O
)	O
,	O
no	O
hemodilution	O
,	O
no	O
IV	O
drug	O
(	O
saline	O
)	O
;	O
(	O
2	O
)	O
oral	O
water	O
,	O
hemodilution	O
,	O
IV	O
saline	O
;	O
(	O
3	O
)	O
oral	O
water	O
,	O
no	O
hemodilution	O
,	O
IV	O
propranolol	O
;	O
(	O
4	O
)	O
oral	O
water	O
,	O
hemodilution	O
,	O
IV	O
propranolol	O
;	O
(	O
5	O
)	O
oral	O
propranolol	O
,	O
no	O
hemodilution	O
,	O
IV	O
saline	O
;	O
and	O
(	O
6	O
)	O
oral	O
propranolol	O
,	O
hemodilution	O
,	O
IV	O
saline	O
.	O

We	O
found	O
4	O
highly	O
conserved	O
regions	O
to	O
vertebrate	B
Hsp90	I
exclusively	O
and	O
27	O
amino	O
acids	O
conserved	O
among	O
but	O
differing	O
between	O
Hsp90	B
alpha	I
and	O
Hsp90	B
beta	I
sequences	I
.	O

Four	O
newborns	O
in	O
this	O
group	O
became	O
HBsAg	B
carriers	O
.	O

It	O
tends	O
to	O
be	O
higher	O
between	O
frazioni	O
of	O
the	O
same	O
community	O
than	O
between	O
communities	O
.	O

In	O
previous	O
studies	O
,	O
we	O
showed	O
that	O
the	O
nuclear	O
import	O
of	O
SREBP-2	B
occurs	O
via	O
the	O
direct	O
interaction	O
of	O
importin	B
beta	I
with	O
the	O
HLH	O
-	O
Zip	O
domain	O
.	O

Ftz	B
,	O
on	O
the	O
other	O
hand	O
,	O
influences	O
Ftz	B
-	O
F1	B
activity	O
by	O
interacting	O
with	O
its	O
AF-2	O
domain	O
in	O
a	O
manner	O
that	O
mimics	O
a	O
nuclear	O
receptor	O
coactivator	O
.	O

CONCLUSIONS	O
:	O
In	O
the	O
majority	O
of	O
patients	O
with	O
severe	O
ulcerative	O
colitis	O
,	O
circulating	O
concentrations	O
of	O
NOX	O
are	O
increased	O
at	O
presentation	O
and	O
fall	O
promptly	O
during	O
parenteral	O
steroid	O
therapy	O
,	O
irrespective	O
of	O
clinical	O
outcome	O
.	O

A	O
cDNA	O
for	O
human	B
microfibril	I
-	I
associated	I
glycoprotein-2	I
(	O
MAGP-2	B
)	O
was	O
used	O
to	O
screen	O
a	O
human	O
leukocyte	O
genomic	O
DNA	O
library	O
in	O
EMBL-3	O
vector	O
.	O

They	O
are	O
transduced	O
through	O
TM	O
to	O
the	O
cytoplasmic	O
portion	O
(	O
cytoloops	O
and	O
the	O
C	O
-	O
terminal	O
tail	O
)	O
of	O
the	O
receptor	O
and	O
then	O
,	O
transferred	O
to	O
cytoplasmic	O
signaling	O
molecules	O
,	O
such	O
as	O
G	B
protein	I
.	O

Primary	O
TJRs	O
were	O
clinically	O
evaluated	O
for	O
degree	O
of	O
osteoarthrosis	O
.	O

It	O
produced	O
extrapyramidal	O
disturbances	O
in	O
nearly	O
every	O
subject	O
,	O
the	O
most	O
common	O
being	O
akathisia	O
and	O
the	O
most	O
severe	O
,	O
in	O
the	O
case	O
of	O
one	O
individual	O
,	O
being	O
acute	O
dystonia	O
.	O

Electron	O
microscopy	O
of	O
pH	O
7.5-treated	O
TMV	O
particles	O
incubated	O
in	O
SPN	B
-	O
treated	O
wheatgerm	O
extract	O
or	O
rabbit	O
reticulocyte	O
lysate	O
,	O
showed	O
that	O
approximately	O
10	O
%	O
of	O
virions	O
complexed	O
with	O
one	O
ribosome	O
and	O
approximately	O
10	O
%	O
with	O
two	O
bound	O
ribosomes	O
,	O
confirming	O
that	O
omega	O
at	O
least	O
had	O
been	O
uncoated	O
.	O

The	O
absorbance	O
of	O
the	O
eluent	O
was	O
monitored	O
at	O
254	O
nm	O
.	O

All	O
patients	O
studied	O
were	O
pregnant	O
women	O
and	O
their	O
delivered	O
children	O
.	O

Using	O
this	O
oligonucleotide	O
as	O
a	O
probe	O
,	O
an	O
8-kilobase	O
HindIII	B
fragment	O
of	O
genomic	O
DNA	O
was	O
isolated	O
and	O
subjected	O
to	O
Sanger	O
dideoxy	O
DNA	O
sequencing	O
.	O

The	O
Rep	B
proteins	I
of	O
adeno	O
-	O
associated	O
virus	O
type	O
2	O
(	O
AAV	O
)	O
are	O
known	O
to	O
bind	O
to	O
Rep	B
recognition	I
sequences	I
(	O
RRSs	B
)	O
in	O
the	O
AAV	O
inverted	O
terminal	O
repeats	O
(	O
ITRs	O
)	O
,	O
the	O
AAV	B
p5	I
promoter	I
,	O
and	O
the	O
preferred	O
AAV	O
integration	O
site	O
in	O
human	O
chromosome	O
19	O
,	O
called	O
AAVS1	O
.	O

It	O
is	O
noteworthy	O
that	O
under	O
more	O
physiological	O
conditions	O
mimicking	O
the	O
cellular	O
GDP	O
/	O
GTP	O
ratio	O
,	O
Raf	B
enhances	O
the	O
GEF	B
-	O
stimulated	O
GDP	O
/	O
GTP	O
exchange	O
on	O
Ha	B
-	I
Ras	I
,	O
in	O
agreement	O
with	O
the	O
sequestration	O
of	O
Ras	B
.	I

GTP	B
by	O
Raf	B
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
HNF-4	B
,	O
a	O
member	O
of	O
the	O
steroid	B
hormone	I
receptor	I
superfamily	I
,	O
binds	O
the	O
AF-1	B
site	I
on	O
the	O
apoB	B
promoter	I
and	O
through	O
it	O
activates	O
transcription	O
in	O
transient	O
transfection	O
assays	O
in	O
both	O
liver	O
and	O
non	O
-	O
liver	O
cell	O
lines	O
,	O
HepG2	O
and	O
HeLa	O
,	O
respectively	O
.	O

In	O
Cos	O
7	O
cells	O
transfected	O
with	O
oCRF1var	B
,	O
cAMP	O
accumulation	O
was	O
only	O
observed	O
at	O
the	O
highest	O
concentration	O
of	O
oCRF	B
utilized	O
(	O
100	O
nM	O
)	O
.	O

Usefulness	O
of	O
glucocorticoids	O
in	O
the	O
treatment	O
of	O
congestive	O
heart	O
failure	O

Plasma	B
renin	I
activity	O
in	O
essential	O
arterial	O
hypertension	O
.	O

In	O
vitro	O
,	O
cytokine-	O
or	O
hypoxia	O
-	O
induced	O
up	O
-	O
regulation	O
of	O
Fas	B
expression	O
is	O
associated	O
with	O
RTC	O
apoptosis	O
.	O

These	O
results	O
suggest	O
that	O
the	O
Reg1-Glc7	B
phosphatase	O
is	O
a	O
cytoplasmic	O
component	O
of	O
the	O
machinery	O
responsible	O
for	O
returning	O
Snf1	B
kinase	I
activity	O
to	O
its	O
basal	O
level	O
and	O
reestablishing	O
glucose	O
repression	O
.	O

To	O
explore	O
further	O
the	O
role	O
of	O
the	O
carboxyl	O
-	O
terminal	O
domain	O
in	O
determining	O
the	O
cell	O
cycle	O
function	O
of	O
CDC34	B
,	O
we	O
constructed	O
and	O
characterized	O
genes	O
encoding	O
chimeric	B
E2s	I
incorporating	O
sequences	O
from	O
CDC34	B
and	O
the	O
related	O
but	O
functionally	O
distinct	O
E2	B
RAD6	B
(	O
UBC2	B
)	O
.	O

In	O
F9	O
,	O
which	O
is	O
a	O
prototype	O
of	O
embryonal	O
carcinoma	O
cells	O
expressing	O
hst	B
,	O
the	O
expression	O
of	O
hst	B
gene	I
is	O
positively	O
regulated	O
by	O
a	O
downstream	O
octamer	O
motif	O
that	O
functions	O
as	O
an	O
enhancer	O
.	O

Only	O
viable	O
bacteria	O
at	O
a	O
high	O
concentration	O
induced	O
purulent	O
otitis	O
media	O
,	O
which	O
was	O
culture	O
positive	O
in	O
58	O
%	O
of	O
the	O
cases	O
on	O
day	O
4	O
.	O

The	O
law	O
and	O
the	O
chiropractor	O
.	O

A	O
distinct	O
5'-sequence	O
in	O
clone	O
hMIWC2	O
suggested	O
an	O
alternative	O
upstream	O
transcription	O
initiation	O
site	O
.	O

98	O
,	O
93	O
-	O
98	O
)	O
.	O

However	O
,	O
the	O
pre3	B
-	I
2	I
mutation	I
strengthened	O
phenotypes	O
induced	O
by	O
other	O
20	B
S	I
proteasomal	I
mutations	I
,	O
indicating	O
that	O
the	O
peptidylglutamyl	O
peptide	O
-	O
hydrolyzing	O
activity	O
has	O
to	O
fulfill	O
some	O
rescue	O
functions	O
.	O

A	O
mammalian	O
protein	O
called	O
RFX	B
or	O
NF	B
-	I
X	I
binds	O
to	O
the	O
X	O
box	O
(	O
or	O
X1	O
box	O
)	O
in	O
the	O
promoters	O
of	O
a	O
number	O
of	O
major	B
histocompatibility	I
(	I
MHC	I
)	I
class	I
II	I
genes	I
.	O

This	O
result	O
suggests	O
that	O
the	O
target	O
protein	O
specificity	O
of	O
E2s	B
can	O
be	O
altered	O
by	O
the	O
addition	O
of	O
appropriate	O
C	O
-	O
terminal	O
extensions	O
,	O
thus	O
providing	O
a	O
way	O
to	O
modify	O
the	O
selectivity	O
of	O
the	O
ubiquitin	B
system	O
.	O

This	O
pattern	O
of	O
expression	O
and	O
differential	O
processing	O
suggests	O
a	O
role	O
for	O
inrpk1	B
in	O
some	O
aspect	O
of	O
SD	O
photoperiodic	O
-	O
induced	O
flowering	O
in	O
morning	O
glory	O
.	O

Co	O
-	O
expression	O
of	O
a	O
gag	B
-	O
TRalpha	B
fusion	O
protein	O
in	O
AEV	O
-	O
transformed	O
cells	O
and	O
addition	O
of	O
ligand	O
derepresses	O
CAII	B
transcription	O
.	O

A	O
400-bp	O
fragment	O
(	O
bp	O
-339	O
through	O
+	O
71	O
)	O
of	O
the	O
CD22	B
promoter	I
region	I
was	O
subcloned	O
into	O
a	O
pGEM	O
-	O
chloramphenicol	B
acetyltransferase	I
vector	O
and	O
after	O
transfection	O
into	O
B	O
and	O
T	O
cells	O
was	O
found	O
to	O
be	O
active	O
in	O
both	O
B	O
and	O
T	O
cells	O
.	O

Five	O
RNA	O
transcripts	O
of	O
about	O
1.2	O
to	O
1.7	O
kilobases	O
were	O
mapped	O
to	O
a	O
part	O
of	O
the	O
genome	O
of	O
insect	O
iridescent	O
virus	O
type	O
6	O
(	O
Chilo	O
iridescent	O
virus	O
;	O
CIV	O
)	O
between	O
genome	O
coordinates	O
0.832	O
and	O
0.856	O
within	O
the	O
EcoRI	B
DNA	I
fragment	I
F.	I

Cutting	O
the	O
intraorbital	O
nerves	O
produced	O
a	O
temporary	O
retrieval	O
impairment	O
that	O
was	O
indistinguishable	O
from	O
that	O
produced	O
by	O
intramystacial	O
lidocaine	O
injection	O
.	O

The	O
comparisons	O
of	O
swimming	O
performance	O
before	O
and	O
after	O
treatments	O
with	O
deltamethrin	O
have	O
shown	O
a	O
significant	O
effect	O
on	O
locomotory	O
ability	O
of	O
rainbow	O
trout	O
which	O
at	O
the	O
end	O
of	O
strong	O
exposure	O
(	O
e.g.	O

Increased	O
trabecular	O
spacing	O
,	O
such	O
as	O
it	O
occurs	O
in	O
osteoporosis	O
,	O
reduces	O
the	O
spatial	O
field	O
inhomogeneity	O
and	O
thus	O
prolongs	O
T2	O
*	O
,	O
which	O
has	O
been	O
shown	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Decidual	B
/	I
trophoblast	I
prolactin	I
-	I
related	I
protein	I
:	O
characterization	O
of	O
gene	O
structure	O
and	O
cell	O
-	O
specific	O
expression	O
.	O

RMR	O
was	O
positively	O
correlated	O
with	O
TEF	O
(	O
r	O
=	O
0.613	O
,	O
p	O
<	O
0.01	O
)	O
and	O
net	O
TEF	O
(	O
r	O
=	O
0.648	O
,	O
p	O
<	O
0.005	O
)	O
in	O
the	O
luteal	O
but	O
not	O
the	O
follicular	O
phase	O
.	O

Nine	O
individuals	O
who	O
were	O
stable	O
after	O
1	O
month	O
of	O
therapy	O
at	O
low	O
dosage	O
were	O
randomized	O
to	O
a	O
further	O
month	O
of	O
therapy	O
at	O
low	O
or	O
high	O
dosage	O
,	O
during	O
which	O
one	O
of	O
four	O
at	O
high	O
dosage	O
had	O
a	O
partial	O
response	O
,	O
and	O
none	O
of	O
five	O
at	O
low	O
dosage	O
manifested	O
response	O
.	O

Bile	O
reflux	O
demonstrated	O
by	O
99	O
m	O
Tc	O
disofenin	O
.	O

The	O
mode	O
of	O
action	O
is	O
often	O
suggested	O
as	O
an	O
explanation	O
for	O
the	O
different	O
slopes	O
of	O
concentration	O
-	O
effect	O
curves	O
.	O

Two	O
full	O
-	O
length	O
clones	O
(	O
pBCH1	O
and	O
pBCH2	O
)	O
were	O
isolated	O
.	O

In	O
dehydrated	O
animals	O
at	O
Ta	O
38	O
degrees	O
C	O
,	O
Tb	O
and	O
EWL	O
were	O
both	O
significantly	O
altered	O
(	O
P	O
less	O
than	O
0.001	O
)	O
from	O
the	O
normally	O
hydrated	O
state	O
and	O
were	O
measured	O
at	O
39.9	O
+	O
/-	O

0.2	O
degree	O
C	O
and	O
0.84	O
+	O
/-	O

0.09	O
W	O
.	O

kg-1	O
respectively	O
.	O

The	O
optimum	O
cooling	O
rate	O
from	O
RT	O
to	O
5	O
degrees	O
C	O
resulting	O
in	O
maximum	O
survival	O
of	O
human	O
spermatozoa	O
was	O
found	O
to	O
be	O
0.5	O
to	O
1	O
degree	O
per	O
minute	O
when	O
cooled	O
from	O
RT	O
to	O
5	O
degrees	O
C	O
and	O
subsequently	O
frozen	O
-	O
thawed	O
in	O
liquid	O
nitrogen	O
(	O
LN2	O
)	O
.	O

Methylprednisolone	O
and	O
U-74006F	O
were	O
equally	O
effective	O
at	O
preventing	O
neurological	O
dysfunction	O
compared	O
to	O
the	O
control	O
group	O
(	O
p	O
less	O
than	O
0.01	O
)	O
;	O
U-78517F	O
was	O
slightly	O
less	O
effective	O
than	O
U-74006F	O
and	O
methylprednisolone	O
but	O
was	O
significantly	O
better	O
than	O
vehicle	O
in	O
preventing	O
neurological	O
dysfunction	O
.	O

Comparison	O
between	O
the	O
Ricketts	O
and	O
Bimler	O
therapeutic	O
technics	O
in	O
the	O
treatment	O
of	O
cases	O
of	O
class	O
II	O
,	O
division	O
I	O
mmalocclusion	O

Transfection	O
assays	O
using	O
the	O
first	O
600	O
bp	O
of	O
the	O
upstream	O
nucleotide	O
sequences	O
indicated	O
that	O
a	O
region	O
from	O
-75	O
to	O
-120	O
was	O
necessary	O
for	O
the	O
ALDH2	B
gene	I
expression	O
,	O
and	O
especially	O
NF	B
-	I
Y	I
/	O
CP1	B
binding	O
site	O
from	O
-92	O
to	O
-96	O
(	O
CCAAT	O
box	O
)	O
is	O
important	O
in	O
the	O
expression	O
of	O
the	O
gene	O
.	O

We	O
report	O
five	O
of	O
13	O
evaluable	O
patients	O
undergoing	O
allogeneic	O
sibling	O
BM	O
or	O
PBSC	O
transplantation	O
for	O
MM	O
between	O
1990	O
and	O
1997	O
who	O
met	O
the	O
criteria	O
for	O
adjuvant	O
alpha	B
-	I
IFN	I
therapy	O
.	O

Hepatocyte	B
growth	I
factor	I
(	O
HGF	B
)	O
is	O
an	O
inducible	O
cytokine	O
that	O
is	O
essential	O
for	O
the	O
normal	O
growth	O
and	O
development	O
of	O
various	O
tissues	O
,	O
such	O
as	O
the	O
liver	O
.	O

OBJECTIVE	O
:	O
To	O
summarise	O
quantitatively	O
the	O
association	O
between	O
moderate	O
alcohol	O
intake	O
and	O
biological	O
markers	O
of	O
risk	O
of	O
coronary	O
heart	O
disease	O
and	O
to	O
predict	O
how	O
these	O
changes	O
would	O
lower	O
the	O
risk	O
.	O

(	O
1991	O
)	O
EMBO	O
J.	O

Teratospermia	O
is	O
therefore	O
an	O
important	O
factor	O
in	O
evaluating	O
fertilization	O
capacity	O
.	O

Genetic	O
polymorphisms	O
in	O
the	O
5'-flanking	O
region	O
change	O
transcriptional	O
regulation	O
of	O
the	O
human	B
cytochrome	I
P450IIE1	I
gene	I
.	O

Basal	O
JNK	B
MAPK	I
kinase	I
activity	O
was	O
also	O
specifically	O
induced	O
by	O
deltaEGFR	B
,	O
which	O
correlated	O
with	O
increased	O
phosphorylation	O
of	O
a	O
54-kDa	B
JNK2	I
protein	I
observed	O
in	O
deltaEGFR	B
-	O
containing	O
cells	O
.	O

Isolation	O
and	O
properties	O
of	O
Drosophila	B
melanogaster	I
ferritin	I
--	O
molecular	O
cloning	O
of	O
a	O
cDNA	O
that	O
encodes	O
one	O
subunit	O
,	O
and	O
localization	O
of	O
the	O
gene	O
on	O
the	O
third	O
chromosome	O
.	O

The	O
single	O
-	O
copy	O
U20	B
sequence	I
is	O
located	O
on	O
the	O
same	O
DNA	O
strand	O
as	O
the	O
nucleolin	B
mRNA	I
.	O

Maximum	O
baroreceptor	O
activity	O
measured	O
at	O
140	O
mm	O
Hg	O
and	O
the	O
slope	O
of	O
the	O
pressure	O
-	O
activity	O
curve	O
were	O
reduced	O
in	O
atherosclerotic	O
(	O
n	O
=	O
15	O
)	O
compared	O
with	O
normal	O
(	O
n	O
=	O
13	O
)	O
rabbits	O
(	O
425	O
+	O
/-	O

34	O
versus	O
721	O
+	O
/-	O

30	O
spikes	O
per	O
second	O
and	O
6.2	O
+	O
/-	O

0.6	O
versus	O
10.8	O
+	O
/-	O

0.8	O
spikes	O
per	O
second	O
per	O
mm	O
Hg	O
,	O
respectively	O
,	O
P	O
<	O
.05	O
)	O
.	O

The	O
effective	O
use	O
of	O
superoxide	B
dismutase	I
from	O
human	O
erythrocytes	O
in	O
the	O
late	O
stages	O
of	O
experimental	O
influenza	O
infection	O

EMT	B
was	O
localized	O
to	O
chromosome	O
5q31	O
-	O
32	O
,	O
a	O
region	O
that	O
contains	O
the	O
genes	O
for	O
several	O
growth	O
factors	O
and	O
receptors	O
as	O
well	O
as	O
early	O
activation	O
genes	O
,	O
particularly	O
those	O
involved	O
in	O
the	O
hematopoietic	O
system	O
.	O

Both	O
purH	B
and	O
purD	B
genes	I
constitute	O
a	O
single	O
operon	O
and	O
are	O
coregulated	O
in	O
expression	O
by	O
purines	O
as	O
other	O
purine	B
genes	I
are	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
was	O
used	O
to	O
investigate	O
the	O
physical	O
distribution	O
and	O
revealed	O
that	O
both	O
retrotransposon	O
families	O
are	O
present	O
on	O
all	O
sugar	O
beet	O
chromosomes	O
and	O
largely	O
excluded	O
from	O
chromosomal	O
regions	O
harbouring	O
the	O
18S-5.8S-25S	B
rRNA	O
genes	O
.	O

Application	O
of	O
the	O
method	O
using	O
an	O
11-year	O
microseismicity	O
record	O
revealed	O
systematic	O
spatial	O
and	O
temporal	O
changes	O
in	O
the	O
slip	O
rate	O
that	O
were	O
synchronous	O
with	O
earthquake	O
activity	O
and	O
other	O
independent	O
measures	O
of	O
fault	O
-	O
zone	O
slip	O
.	O

Furthermore	O
,	O
we	O
have	O
identified	O
the	O
major	O
open	O
reading	O
frame	O
(	O
RF4	O
;	O
2.3	O
kb	O
)	O
as	O
being	O
essential	O
for	O
activation	O
,	O
and	O
we	O
have	O
shown	O
that	O
the	O
NF	B
kappa	I
B	I
,	O
SP1	B
,	O
and	O
TATA	O
box	O
motifs	O
in	O
the	O
human	B
immunodeficiency	I
virus	I
LTR	I
are	O
all	O
required	O
for	O
full	O
induction	O
of	O
the	O
promoter	O
by	O
the	O
HHV-6-encoded	B
transactivator	I
.	O

Two	O
conserved	O
motifs	O
,	O
W89RKRRY94	O
and	O
P156KKIKP161	O
,	O
seemed	O
to	O
act	O
as	O
nuclear	O
addressing	O
signals	O
.	O

All	O
testosterone	O
treatments	O
raised	O
plasma	O
testosterone	O
concentrations	O
above	O
control	O
and	O
pretreatment	O
levels	O
(	O
testosterone	O
and	O
synovex	O
+	O
testosterone	O
>	O
synovex	O
>	O
control	O
;	O
all	O
P	O
<	O
0.05	O
)	O
.	O

The	O
educational	O
program	O
was	O
the	O
significant	O
factor	O
that	O
influenced	O
the	O
change	O
of	O
concern	O
trajectories	O
,	O
and	O
the	O
recurrent	O
/	O
non	O
-	O
recurrent	O
factor	O
influenced	O
the	O
change	O
of	O
concern	O
only	O
in	O
pamphlet	O
group	O
.	O

Biol	O
.	O

Evidence	O
that	O
the	O
AT1A	B
receptor	I
activates	O
transcription	B
factor	I
-	I
Stat91	I
and/or	O
a	O
related	O
protein	O
.	O

The	O
full	O
-	O
length	O
cDNA	O
was	O
cloned	O
and	O
sequenced	O
,	O
and	O
the	O
inferred	O
amino	O
acid	O
sequence	O
was	O
found	O
to	O
encode	O
a	O
novel	O
protein	O
,	O
which	O
we	O
named	O
cystatin	B
M	I
,	O
with	O
40	O
%	O
homology	O
to	O
human	B
family	I
2	I
cystatins	I
and	O
similar	O
overall	O
structure	O
.	O

Thus	O
,	O
oxyR	B
mutants	I
are	O
locked	O
on	O
for	O
Ag43	B
expression	O
,	O
whereas	O
dam	B
mutants	I
are	O
locked	O
off	O
for	O
Ag43	B
expression	O
.	O

GH	B
induced	O
rapid	O
tyrosine	O
phosphorylation	O
of	O
a	O
protein	O
at	O
approximately	O
93	O
kDa	O
in	O
normal	O
fibroblasts	O
,	O
and	O
Western	O
blotting	O
with	O
STAT	B
-	I
specific	I
antibodies	I
revealed	O
STAT5	B
activation	O
(	O
phosphorylation	O
)	O
by	O
GH	O
.	O

A	O
retrospective	O
study	O
of	O
clozapine	O
and	O
electroencephalographic	O
abnormalities	O
in	O
schizophrenic	O
patients	O
.	O

While	O
working	O
on	O
the	O
toxicity	O
of	O
war	O
gases	O
.	O

he	O
formulated	O
'	O
Haber	O
's	O
rule	O
'	O
,	O
also	O
known	O
as	O
C	O
x	O
T=	O
constant	O
in	O
order	O
to	O
characterize	O
the	O
toxicity	O
of	O
an	O
inhalant	O
.	O

Furthermore	O
,	O
the	O
regulation	O
conferred	O
on	O
a	O
reporter	O
gene	O
in	O
Drosophila	O
by	O
three	O
closely	O
related	O
sequences	O
demonstrates	O
that	O
even	O
subtle	O
sequence	O
changes	O
within	O
an	O
E	O
box	O
or	O
flanking	O
bases	O
have	O
dramatic	O
consequences	O
on	O
the	O
overall	O
repertoire	O
of	O
proteins	O
that	O
can	O
bind	O
in	O
vivo	O
.	O

Two	O
putative	O
ATP	O
-	O
binding	O
domains	O
were	O
identified	O
,	O
one	O
in	O
the	O
amino	O
-	O
terminal	O
half	O
of	O
the	O
argA	B
-	I
encoded	I
protein	I
and	O
the	O
other	O
in	O
the	O
carboxy	O
-	O
terminal	O
half	O
.	O

Previously	O
,	O
we	O
identified	O
two	O
human	B
SMC	I
family	I
proteins	I
,	O
hCAP	B
-	I
C	I
and	O
hCAP	B
-	I
E	I
,	O
which	O
form	O
a	O
heterodimeric	O
complex	O
(	O
hCAP	B
-	I
C	I
-	O
hCAP	B
-	I
E	I
)	O
in	O
the	O
cell	O
.	O

There	O
were	O
no	O
major	O
postoperative	O
complications	O
and	O
at	O
follow	O
-	O
up	O
of	O
the	O
13	O
patients	O
at	O
10	O
to	O
26	O
months	O
after	O
operation	O
the	O
results	O
were	O
satisfactory	O
.	O

The	O
interleukin-2	B
receptor	I
alpha	I
(	O
IL-2R	B
alpha	I
)	O
chain	O
gene	O
contains	O
a	O
sequence	O
similar	O
to	O
the	O
immunoglobulin	B
(	I
Ig	I
)	I
kappa	I
(	O
kappa	O
)	O
enhancer	O
NF	B
-	I
kappa	I
B	I
binding	I
site	I
.	O

The	O
presence	O
of	O
a	O
short	O
(	O
70	O
bp	O
)	O
intron	O
near	O
the	O
N	O
-	O
terminus	O
of	O
the	O
atX	B
gene	I
was	O
predicted	O
that	O
contains	O
the	O
canonical	O
GT	O
and	O
AG	O
dinucleotides	O
at	O
its	O
5'-	O
and	O
3'-splicing	O
junctions	O
.	O

In	O
accordance	O
with	O
Ann	O
Arbor	O
classification	O
,	O
we	O
observed	O
12	O
CS	O
IA	O
(	O
21.3	O
%	O
)	O
,	O
2	O
CS	O
IB	O
(	O
3.5	O
%	O
)	O
,	O
14	O
CS	O
IIA	O
(	O
25.4	O
%	O
)	O
and	O
27	O
CS	O
IIB	O
(	O
49.7	O
%	O
)	O
.	O

HL	B
is	O
hypothesized	O
to	O
directly	O
couple	O
HDL	B
lipid	O
metabolism	O
to	O
tissue	O
/	O
cellular	O
lipid	O
metabolism	O
.	O

The	O
analysis	O
of	O
the	O
organization	O
of	O
the	O
sequence	O
of	O
the	O
human	O
ABP	B
/	O
DAO	B
gene	O
reveals	O
that	O
the	O
2.4-kilobase	O
messenger	O
RNA	O
is	O
transcribed	O
from	O
two	O
close	O
origins	O
identifying	O
the	O
proximal	O
promoter	O
.	O

Several	O
DNA	O
clones	O
were	O
obtained	O
by	O
this	O
procedure	O
,	O
one	O
of	O
which	O
,	O
clone	O
18	O
,	O
is	O
reported	O
and	O
characterized	O
here	O
.	O

Immunoprecipitation	O
of	O
cell	O
lysates	O
with	O
anti	B
-	I
phosphotyrosine	I
and	O
immunoblotting	O
showed	O
phosphorylated	O
forms	O
of	O
the	O
mitogenic	O
pathway	O
proteins	O
Shc	B
and	O
MAPK	B
in	O
addition	O
to	O
p185	B
(	O
neu	B
)	O
,	O
suggesting	O
that	O
the	O
Ras	B
to	O
MAPK	B
mitogenic	O
pathway	O
is	O
activated	O
.	O

The	O
sequence	O
immediately	O
upstream	O
of	O
the	O
translation	O
start	O
site	O
was	O
G	O
+	O
C	O
rich	O
(	O
greater	O
than	O
75	O
%	O
)	O
and	O
contained	O
a	O
consensus	O
CCAAT	O
sequence	O
despite	O
the	O
absence	O
of	O
a	O
TATA	O
box	O
.	O

In	O
the	O
latter	O
,	O
the	O
cells	O
and	O
adjacent	O
matrix	O
had	O
several	O
characteristics	O
of	O
fibrocartilage	O
,	O
including	O
chondrocytes	O
.	O

Radiation	O
sensitivity	O
of	O
rats	O
irradiated	O
in	O
a	O
condition	O
of	O
hypoxia	O

When	O
the	O
opioid	O
antagonist	O
was	O
administered	O
to	O
animals	O
24	O
hr	O
after	O
termination	O
of	O
single	O
or	O
multiple	O
exposures	O
to	O
restraint	O
,	O
NALT	O
-	O
induced	O
increases	O
in	O
basal	O
plasma	B
LH	I
were	O
significantly	O
attenuated	O
in	O
the	O
chronically	O
stressed	O
rats	O
compared	O
to	O
animals	O
subjected	O
to	O
stress	O
only	O
once	O
or	O
not	O
at	O
all.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Analysis	O
of	O
exon	O
2	O
of	O
the	O
factor	B
IX	I
gene	I
revealed	O
a	O
C-->T	O
mutation	O
in	O
codon	O
10	O
of	O
the	O
propeptide	O
region	O
,	O
resulting	O
in	O
the	O
substitution	O
of	O
alanine	O
by	O
valine	O
.	O

In	O
contrast	O
to	O
the	O
restricted	O
tissue	O
expression	O
of	O
gonadotropin	B
and	O
TSH	B
receptors	I
in	O
gonads	O
and	O
thyroid	O
,	O
respectively	O
,	O
LGR4	B
is	O
expressed	O
in	O
diverse	O
tissues	O
including	O
ovary	O
,	O
testis	O
,	O
adrenal	O
,	O
placenta	O
,	O
thymus	O
,	O
spinal	O
cord	O
,	O
and	O
thyroid	O
,	O
whereas	O
LGR5	B
is	O
found	O
in	O
muscle	O
,	O
placenta	O
,	O
spinal	O
cord	O
,	O
and	O
brain	O
.	O

We	O
now	O
show	O
that	O
purified	O
recombinant	O
c	B
-	I
sis	I
/	O
PDGF	B
can	O
induce	O
this	O
binding	O
activity	O
which	O
we	O
have	O
termed	O
SIF	B
,	O
for	O
sis	B
-	I
inducible	I
factor	I
.	O

Antinuclear	O
antibodies	O
,	O
rheumatoid	B
factor	I
and	O
C	B
-	I
reactive	I
protein	I
in	O
serum	O
of	O
normal	O
women	O
using	O
oral	O
contraceptives	O
.	O

The	O
relationship	O
between	O
donor	O
status	O
for	O
antibody	O
to	O
hepatitis	B
B	I
core	I
antigen	I
and	O
the	O
occurrence	O
of	O
non	O
-	O
A	O
,	O
non	O
-	O
B	O
posttransfusion	O
hepatitis	O
in	O
the	O
recipient	O
was	O
prospectively	O
studied	O
in	O
112	O
patients	O
undergoing	O
open	O
-	O
heart	O
surgery	O
who	O
were	O
followed	O
for	O
6.5	O
months	O
after	O
surgery	O
.	O

Both	O
control	O
and	O
Mn	O
-	O
exposed	O
quail	O
accumulated	O
5	O
to	O
10	O
times	O
more	O
Mn	O
in	O
their	O
livers	O
than	O
similarly	O
treated	O
rodents	O
.	O

These	O
data	O
suggested	O
that	O
mutant	B
PS1	I
may	O
cause	O
disease	O
as	O
a	O
result	O
of	O
reduction	O
in	O
PS1	B
function	O
.	O

The	O
effects	O
of	O
pretreatment	O
with	O
the	O
non	O
-	O
competitive	O
NMDA	O
antagonist	O
(	O
+	O
)	O
MK-801	O
on	O
the	O
behavioral	O
alterations	O
induced	O
by	O
repeated	O
restraint	O
stress	O
were	O
investigated	O
.	O

MsEPV	O
genes	O
with	O
putative	O
functions	O
in	O
prevention	O
and	O
repair	O
of	O
DNA	O
damage	O
include	O
a	O
complete	O
base	O
excision	O
repair	O
pathway	O
(	O
uracil	B
DNA	I
glycosylase	I
,	O
AP	B
endonuclease	I
,	O
DNA	B
polymerase	I
beta	I
,	O
and	O
an	O
NAD+-dependent	B
DNA	I
ligase	I
)	O
,	O
a	O
photoreactivation	O
repair	O
pathway	O
(	O
cyclobutane	B
pyrimidine	I
dimer	I
photolyase	I
)	O
,	O
a	O
LINE	B
-	I
type	I
reverse	I
transcriptase	I
,	O
and	O
a	O
mutT	B
homologue	I
.	O

In	O
isolated	O
olfactory	O
cilia	O
certain	O
odorants	O
elicit	O
a	O
rapid	O
and	O
transient	O
cAMP	O
response	O
,	O
terminated	O
by	O
a	O
concerted	O
process	O
which	O
requires	O
the	O
action	O
of	O
two	O
protein	O
kinases	O
,	O
protein	B
kinase	I
A	I
(	O
PKA	B
)	O
and	O
a	O
receptor	B
-	I
specific	I
kinase	I
(	O
GRK3	B
)	O
(	O
Schleicher	O
,	O
S.	O
,	O
Boekhoff	O
,	O
I.	O

Two	O
hundred	O
and	O
eighty	O
-	O
three	O
patients	O
,	O
217	O
females	O
(	O
median	O
age	O
24	O
years	O
,	O
range	O
0.5	O
-	O
73	O
)	O
and	O
66	O
males	O
(	O
median	O
age	O
20	O
years	O
,	O
range	O
0.75	O
-	O
72	O
)	O
,	O
were	O
examined	O
.	O

Pneumatic	O
dilation	O
of	O
the	O
lower	O
esophageal	O
sphincter	O
was	O
accomplished	O
by	O
endoscopic	O
visualization	O
and	O
positioning	O
of	O
a	O
modified	O
polyurethane	O
dilator	O
(	O
90	O
F	O
diameter	O
)	O
without	O
fluoroscopy	O
in	O
17	O
consecutive	O
patients	O
with	O
advanced	O
symptomatic	O
achalasia	O
.	O

The	O
organotins	O
.	O

A	O
series	O
of	O
mutations	O
were	O
constructed	O
within	O
the	O
E2	B
open	O
reading	O
frame	O
which	O
delete	O
various	O
regions	O
of	O
the	O
conserved	O
DNA	O
binding	O
and	O
transactivation	O
domains	O
as	O
well	O
as	O
the	O
internal	O
hinge	O
region	O
.	O

These	O
data	O
indicate	O
that	O
chromatic	O
processing	O
in	O
areas	O
V1	O
and	O
V2	O
is	O
normal	O
after	O
V4	O
lesions	O
and	O
,	O
together	O
with	O
the	O
behavioural	O
evidence	O
,	O
that	O
these	O
areas	O
are	O
sufficient	O
for	O
some	O
basic	O
aspects	O
of	O
colour	O
perception	O
.	O

The	O
non	B
-	I
major	I
histocompatibility	I
complex	I
(	O
MHC	B
)	O
-encoded	O
CD1	B
family	I
has	O
recently	O
emerged	O
as	O
a	O
new	O
antigen	O
-	O
presenting	O
system	O
that	O
is	O
distinct	O
from	O
either	O
MHC	B
class	I
I	I
or	I
class	I
II	I
molecules	I
.	O

Doxazosin	O
produced	O
increases	O
in	O
both	O
mean	O
and	O
maximum	O
urinary	O
flow	O
rates	O
of	O
1.01	O
ml	O
/	O
s	O
and	O
3.2	O
ml	O
/	O
s	O
respectively	O
,	O
compared	O
with	O
0.21	O
ml	O
/	O
s	O
and	O
2.2	O
ml	O
/	O
s	O
on	O
placebo	O
.	O

We	O
determined	O
the	O
complete	O
nucleotide	O
sequence	O
of	O
the	O
gypsy	B
element	I
present	O
at	O
the	O
forked	B
locus	I
of	O
Drosophila	O
melanogaster	O
in	O
the	O
f1	O
allele	O
.	O

Cloning	O
and	O
nucleotide	O
sequence	O
analysis	O
reveals	O
that	O
BUR6	B
encodes	O
a	O
homolog	O
of	O
DRAP1	B
(	O
also	O
called	O
NC2alpha	B
)	O
,	O
a	O
mammalian	O
repressor	O
of	O
basal	O
transcription	O
.	O

The	O
ATF	B
/	O
CRE	O
site	O
is	O
also	O
essential	O
for	O
CD4	B
promoter	I
activation	O
by	O
forskolin	O
,	O
an	O
activator	O
of	O
adenylate	B
cyclase	I
.	O

They	O
are	O
growth	O
-	O
inhibited	O
by	O
TGF	B
-	I
beta1	I
.	O

Chronic	O
active	O
hepatitis	O
and	O
cirrhosis	O
of	O
the	O
liver	O
.	O

Colonization	O
increased	O
with	O
level	O
of	O
care	O
:	O
from	O
9	O
per	O
cent	O
in	O
independent	O
residents	O
of	O
apartments	O
to	O
60	O
per	O
cent	O
in	O
patients	O
on	O
an	O
acute	O
hospital	O
ward	O
(	O
P	O
less	O
than	O
0.0001	O
)	O
.	O

Interaction	O
of	O
the	O
v	B
-	I
rel	I
protein	I
with	O
an	O
NF	B
-	I
kappa	I
B	I
DNA	I
binding	I
site	I
.	O

CVO2	O
saturation	O
is	O
a	O
reliable	O
and	O
sensitive	O
method	O
for	O
detecting	O
blood	O
loss	O
.	O

In	O
the	O
Saccharomyces	B
cerevisiae	I
actin	I
intron	I
a	O
silent	O
branch	O
point	O
-	O
like	O
sequence	O
(	O
UACUAAG	O
)	O
is	O
located	O
7	O
nt	O
upstream	O
of	O
the	O
canonical	O
sequence	O
.	O

PrRP	B
rapidly	O
and	O
transiently	O
activated	O
extracellular	B
signal	I
-	I
regulated	I
protein	I
kinase	I
(	O
ERK	B
)	O
in	O
both	O
types	O
of	O
cells	O
.	O

Reversible	O
topology	O
of	O
a	O
bifunctional	O
transmembrane	O
protein	O
depends	O
upon	O
the	O
charge	O
balance	O
around	O
its	O
transmembrane	O
domain	O
.	O

We	O
have	O
documented	O
previously	O
that	O
glucocorticoid	O
hormones	O
modulate	O
the	O
posttranslational	O
localization	O
of	O
cell	O
surface	O
mouse	O
mammary	O
tumor	O
virus	O
(	O
MMTV	O
)	O
glycoproteins	O
in	O
the	O
viral	O
-	O
infected	O
M1.54	O
rat	O
HTC	O
hepatoma	O
cell	O
line	O
.	O

Spodoptera	O
frugiperda	O
(	O
Sf9	O
)	O
cells	O
have	O
proved	O
a	O
suitable	O
cell	O
system	O
in	O
which	O
to	O
study	O
this	O
association	O
and	O
to	O
produce	O
recombinant	B
CR3	I
,	O
and	O
we	O
show	O
here	O
that	O
another	O
lepidopteran	O
cell	O
line	O
,	O
Trichoplusia	O
niTN-5B1	O
-	O
4	O
(	O
High	O
-	O
Five	O
)	O
cells	O
,	O
allows	O
the	O
recovery	O
of	O
large	O
amounts	O
of	O
functional	B
recombinant	I
CR3	I
.	O

Using	O
the	O
standard	O
scoring	O
,	O
children	O
with	O
full	O
scale	O
IQ	O
<	O
or	O
=	O
84	O
on	O
the	O
Wechsler	O
Preschool	O
and	O
Primary	O
Scale	O
of	O
Intelligence	O
at	O
age	O
4	O
-	O
5	O
years	O
were	O
poorly	O
identified	O
(	O
sensitivity	O
54	O
%	O
)	O
from	O
the	O
composite	O
S	O
-	O
B	O
IV	O
score	O
at	O
age	O
3	O
.	O

To	O
clarify	O
the	O
mechanisms	O
that	O
regulate	O
transcription	O
of	O
the	O
GTP	B
cyclohydrolase	I
I	I
gene	I
and	O
to	O
generate	O
multiple	O
species	O
of	O
mRNA	O
,	O
we	O
isolated	O
genomic	O
DNA	O
clones	O
for	O
the	O
human	O
and	O
mouse	O
GTP	B
cyclohydrolase	I
I	I
genes	I
.	O

Perception	O
of	O
sweetness	O
can	O
not	O
be	O
used	O
to	O
accurately	O
meter	O
the	O
metabolizable	O
energy	O
or	O
nutritive	O
value	O
of	O
a	O
food	O
.	O

When	O
labeled	O
by	O
the	O
described	O
method	O
,	O
99mTc	O
on	O
DTPA	O
coupled	O
antibodies	O
shows	O
instability	O
in	O
serum	O
but	O
superior	O
stability	O
than	O
99mTc	O
on	O
antibodies	O
without	O
the	O
attached	O
DTPA	O
.	O

The	O
crystal	O
structure	O
of	O
the	O
yeast	O
Phe	B
-	I
tRNAPhe	I
ternary	I
complex	I
with	O
Thermus	O
aquaticus	O
EF	B
-	I
Tu	I
-	O
GDPNP	O
(	O
Phe	B
-	I
TC	I
)	O
has	O
previously	O
been	O
determined	O
as	O
one	O
representative	O
of	O
this	O
general	O
yet	O
highly	O
discriminating	O
complex	O
formation	O
.	O

U.S.A.	O

Human	B
plastin	I
genes	I
.	O

Role	O
of	O
the	O
CCAAT	B
/	I
enhancer	I
binding	I
protein	I
-	I
alpha	I
transcription	I
factor	I
in	O
the	O
glucocorticoid	O
stimulation	O
of	O
p21waf1	B
/	O
cip1	B
gene	O
promoter	O
activity	O
in	O
growth	O
-	O
arrested	O
rat	O
hepatoma	O
cells	O
.	O

We	O
also	O
demonstrate	O
that	O
a	O
p110RB1	B
mutant	I
,	O
which	O
is	O
refractory	O
to	O
cell	O
cycle	O
phosphorylation	O
but	O
intact	O
in	O
E1a	B
/	O
large	B
T	I
antigen	I
-	O
binding	O
properties	O
,	O
represses	O
EIIaE	B
with	O
50-	O
to	O
80-fold	O
greater	O
efficiency	O
than	O
wild	B
-	I
type	I
p110RB1	I
.	O

For	O
the	O
target	O
stimuli	O
,	O
P3	O
amplitude	O
and	O
latency	O
were	O
negatively	O
correlated	O
and	O
most	O
tightly	O
coupled	O
over	O
the	O
frontal	O
-	O
central	O
and	O
right	O
medial	O
/	O
lateral	O
recording	O
sites	O
.	O

We	O
have	O
characterized	O
a	O
new	O
cDNA	O
,	O
33k-6	O
,	O
potentially	O
encoding	O
a	O
tobacco	B
33	I
kDa	I
chloroplast	I
RNP	I
(	I
cp33	I
)	I
homologue	I
.	O

Though	O
it	O
has	O
been	O
established	O
that	O
skinfold	O
anthropometry	O
has	O
severe	O
limitations	O
as	O
a	O
method	O
of	O
deriving	O
total	O
body	O
fat	O
(	O
TBF	O
)	O
,	O
the	O
possibility	O
that	O
the	O
problem	O
might	O
be	O
related	O
more	O
to	O
the	O
assumptions	O
implicit	O
in	O
densitometry	O
has	O
to	O
be	O
addressed	O
.	O

Gene	B
GPR	I
51	I
was	O
localized	O
by	O
radiation	O
hybrid	O
mapping	O
to	O
chromosome	O
9	O
,	O
4.81	O
cR	O
from	O
the	O
WI-8684	O
marker	O
,	O
and	O
proximal	O
to	O
the	O
hereditary	B
sensory	I
neuropathy	I
type	I
1	I
locus	I
.	O

A	O
)	O
During	O
O2-ischemia	O
both	O
extracellular	O
[	O
K+	O
]	O
and	O
change	O
of	O
pH	O
in	O
the	O
subepicardium	O
are	O
significantly	O
less	O
than	O
in	O
the	O
midmyocardium	O
.	O

Some	O
of	O
these	O
physiological	O
responses	O
are	O
regulated	O
via	O
activation	O
of	O
transcription	O
factors	O
such	O
as	O
activator	B
protein	I
1	I
(	O
AP-1	B
)	O
.	O

The	O
1.6-kb	O
cDNA	O
(	O
CBF	B
-	I
A	I
)	O
encoding	O
285	O
amino	O
acids	O
(	O
aa	O
)	O
was	O
obtained	O
,	O
and	O
a	O
beta	B
-	I
galactosidase	I
fusion	I
protein	I
,	O
bacterially	O
produced	O
from	O
the	O
cDNA	O
,	O
bound	O
to	O
DNA	O
fragments	O
containing	O
several	O
CArG	O
boxes	O
.	O

Alveoli	O
-	O
capillary	O
diffusion	O
.	O

Interobserver	O
agreement	O
of	O
the	O
Nottingham	O
histologic	O
grading	O
scheme	O
for	O
infiltrating	O
duct	O
carcinoma	O
breast	O
.	O

To	O
determine	O
the	O
role	O
of	O
the	O
transmembrane	O
region	O
of	O
HN	B
on	O
fusion	O
-	O
promoting	O
activity	O
,	O
mutant	B
HN	I
proteins	I
were	O
expressed	O
and	O
their	O
biological	O
activities	O
examined	O
.	O

Thus	O
,	O
transgene	O
expression	O
directed	O
by	O
both	O
the	O
human	O
and	O
mouse	B
Rb	I
promoters	I
is	O
restricted	O
to	O
a	O
subset	O
of	O
tissues	O
in	O
which	O
Rb	B
is	O
normally	O
expressed	O
during	O
embryogenesis	O
.	O

The	O
cDNA	O
is	O
predicted	O
to	O
encode	O
a	O
polypeptide	O
of	O
298	O
amino	O
acids	O
that	O
is	O
homologous	O
to	O
the	O
Y	B
-	I
box	I
(	I
inverted	I
CCAAT	I
)	I
family	I
of	I
DNA	I
-	I
binding	I
transcription	I
factors	I
.	O

RAP	B
has	O
been	O
shown	O
to	O
be	O
a	O
useful	O
vaccine	O
target	O
site	O
,	O
and	O
RIP	B
and	O
inhibitory	O
AIPs	B
as	O
therapeutic	O
molecules	O
to	O
prevent	O
and	O
suppress	O
S.	O
aureus	O
infections	O
.	O

However	O
,	O
both	O
RAR-	B
and	O
RXR	B
-	O
specific	O
ligands	O
increase	O
CaSki	O
number	O
by	O
>	O
or	O
=	O
20	O
%	O
.	O

Tight	O
-	O
binding	O
band	O
structure	O
calculations	O
for	O
beta	O
-	O
MNX	O
(	O
M	O
=	O
Zr	O
,	O
X	O
=	O
Cl	O
,	O
Br	O
;	O
M	O
=	O
Hf	O
,	O
X	O
=	O
Cl	O
)	O
,	O
ZrCl	O
,	O
and	O
Y	O
(	O
2	O
)	O
C	O
(	O
2	O
)	O
Br	O
(	O
2	O
)	O
are	O
reported	O
.	O

On	O
the	O
basis	O
of	O
the	O
physical	O
interactions	O
between	O
Sxl	B
and	O
Snf	B
,	O
we	O
present	O
a	O
model	O
for	O
Sxl	B
splicing	O
regulation	O
.	O

It	O
thus	O
seems	O
likely	O
that	O
genistein	O
affects	O
a	O
common	O
pathway	O
downstream	O
of	O
these	O
signals	O
.	O

LiF	O
thermoluminescence	O
dosimeters	O
(	O
TLD	O
)	O
in	O
chip	O
form	O
were	O
placed	O
onto	O
1	O
eyelid	O
,	O
the	O
skin	O
over	O
the	O
thyroid	O
,	O
and	O
the	O
patient	O
's	O
clothes	O
covering	O
the	O
region	O
of	O
breasts	O
and	O
ovaries	O
of	O
female	O
patients	O
and	O
the	O
testicles	O
of	O
male	O
patients	O
.	O

We	O
conclude	O
from	O
these	O
observations	O
that	O
the	O
cTnC	B
3'Ile	I
element	I
is	O
a	O
composite	O
enhancer	O
that	O
functions	O
through	O
the	O
combined	O
interactions	O
of	O
at	O
least	O
five	O
regulatory	O
elements	O
and	O
their	O
cognate	O
binding	O
factors	O
:	O
three	O
or	O
four	O
E	O
-	O
boxes	O
,	O
a	O
MEF-2	B
site	I
,	O
and	O
a	O
MEF-3	B
site	I
.	O

These	O
data	O
suggest	O
that	O
the	O
secreted	O
,	O
truncated	O
receptor	O
encoded	O
by	O
the	O
2.6-kb	B
c	I
-	I
erbB	I
transcript	I
can	O
bind	O
to	O
TGF	B
alpha	I
and	O
may	O
play	O
an	O
important	O
growth	O
-	O
regulatory	O
function	O
in	O
vitro	O
.	O

In	O
this	O
paper	O
we	O
review	O
evidence	O
on	O
smoking	O
and	O
lung	O
cancer	O
among	O
Latinos	O
,	O
including	O
findings	O
from	O
several	O
unpublished	O
studies	O
and	O
technical	O
reports	O
.	O

Although	O
several	O
large	O
waterborne	O
outbreaks	O
occurred	O
during	O
the	O
past	O
decade	O
,	O
most	O
were	O
in	O
small	O
communities	O
.	O

Uptake	O
of	O
colicins	B
required	O
different	O
domains	O
in	O
TonB	B
,	O
for	O
colicin	B
B	I
and	I
M	I
around	O
residue	O
160	O
and	O
for	O
colicin	B
Ia	I
,	O
a	O
domain	O
closer	O
to	O
the	O
C	O
-	O
terminal	O
end	O
.	O

A	O
phase	O
II	O
study	O
of	O
interferon	B
-	I
alpha	I
,	O
interleukin-2	B
and	O
5-fluorouracil	O
in	O
advanced	O
renal	O
carcinoma	O
:	O
clinical	O
data	O
and	O
laboratory	O
evidence	O
of	O
protease	O
activation	O
.	O

Most	O
significantly	O
,	O
the	O
cyclin	B
E	I
-	O
Cdk2	B
complex	O
is	O
maximally	O
active	O
at	O
the	O
G1	O
/	O
S	O
transition	O
,	O
and	O
overexpression	O
of	O
cyclin	B
E	I
decreases	O
the	O
time	O
it	O
takes	O
the	O
cell	O
to	O
complete	O
G1	O
and	O
enter	O
S	O
phase	O
.	O

In	O
static	O
conditions	O
,	O
body	O
sway	O
was	O
assessed	O
using	O
a	O
conventional	O
force	O
platform	O
with	O
eyes	O
open	O
and	O
with	O
eyes	O
closed	O
.	O

Antiserum	O
raised	O
against	O
rat	B
liver	I
S6	I
kinase	I
specifically	O
immunoprecipitates	O
the	O
purified	O
32P	O
-	O
labeled	O
H4	O
hepatoma	O
insulin	O
-	O
stimulated	O
S6	B
kinase	I
.	O

In	O
vitro	O
,	O
SHIP	B
catalyzes	O
the	O
conversion	O
of	O
the	O
phosphoinositide	B
3-kinase	I
(	O
PI3	B
K	I
)	O
product	O
phosphatidylinositol	O
3,4	O
,	O
5-trisphosphate	O
(	O
PIP3	O
)	O
into	O
phosphatidylinositol	O
3,4-bisphosphate	O
.	O

Diabetic	O
osteopathy	O
.	O

These	O
data	O
,	O
taken	O
together	O
,	O
suggest	O
that	O
CRF	B
produces	O
its	O
behavioral	O
activating	O
and	O
anxiogenic	O
effects	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
increasing	O
the	O
activity	O
of	O
LC	O
noradrenergic	O
neurons	O
.	O

SN-38	O
rebound	O
concentrations	O
were	O
observed	O
in	O
many	O
courses	O
at	O
about	O
0.5	O
to	O
1	O
hour	O
following	O
the	O
end	O
of	O
the	O
i.v	O
.	O

infusion	O
,	O
which	O
is	O
suggestive	O
of	O
enterohepatic	O
recycling	O
.	O

The	O
S3	B
protein	I
also	O
contains	O
a	O
DNA	O
repair	O
activity	O
,	O
efficiently	O
processing	O
8-oxoguanine	O
residues	O
in	O
DNA	O
via	O
an	O
N	B
-	I
glycosylase	I
/	O
apurinic	B
-	I
apyrimidinic	I
(	I
AP	I
)	I
lyase	I
activity	O
.	O

The	O
orf2	O
gene	O
product	O
is	O
a	O
protein	O
of	O
79	O
amino	O
acids	O
with	O
characteristics	O
similar	O
to	O
those	O
of	O
the	O
Tat	B
(	O
transactivator	B
)	O
proteins	O
of	O
the	O
ungulate	O
lentiviruses	O
.	O

This	O
finding	O
is	O
of	O
importance	O
because	O
it	O
completes	O
an	O
explanation	O
for	O
central	O
near	O
-	O
location	O
errors	O
in	O
the	O
partial	O
-	O
report	O
bar	O
-	O
probe	O
task	O
.	O

Treatment	O
of	O
JEA2	O
cells	O
with	O
interleukin	B
(	I
IL	I
)	I
-7	I
induces	O
CBLB	B
phosphorylation	O
as	O
well	O
.	O

Plasmid	O
pNK21	O
,	O
in	O
which	O
2.05-kb	O
sequence	O
covering	O
the	O
region	O
encoding	O
the	O
nitrilase	B
was	O
was	O
placed	O
under	O
the	O
control	O
of	O
the	O
lac	B
promoter	I
,	O
directed	O
overproduction	O
of	O
enzymatically	B
active	I
nitrilase	I
in	O
response	O
to	O
addition	O
of	O
isopropyl	O
beta	O
-	O
D	O
-	O
thiogalactopyranoside	O
in	O
Escherichia	O
coli	O
.	O

CONCLUSIONS	O
:	O
Elevation	O
of	O
TBARS	O
and	O
decrease	O
of	O
GSH	O
show	O
the	O
presence	O
of	O
oxidative	O
stress	O
during	O
the	O
PFD	O
treatment	O
with	O
hemodiafilter	O
SG3	O
.	O

It	O
is	O
of	O
interest	O
that	O
,	O
aside	O
from	O
starvation	O
,	O
the	O
nutrition	O
catastrophes	O
of	O
the	O
past	O
,	O
including	O
scurvy	O
(	O
vitamin	O
C	O
deficiency	O
)	O
resulting	O
from	O
lack	O
of	O
fresh	O
vegetables	O
and	O
fruit	O
and	O
beriberi	O
(	O
vitamin	O
B1	O
deficiency	O
)	O
from	O
consumption	O
of	O
polished	O
rice	O
,	O
are	O
forgotten	O
and	O
only	O
of	O
interest	O
as	O
history	O
.	O

In	O
contrast	O
,	O
overexpression	O
of	O
the	O
DREB2A	B
cDNA	I
induced	O
weak	O
expression	O
of	O
the	O
target	O
genes	O
under	O
unstressed	O
conditions	O
and	O
caused	O
growth	O
retardation	O
of	O
the	O
transgenic	O
plants	O
.	O

In	O
vitro	O
,	O
c	B
-	I
Src	I
phosphorylated	O
FAK	B
Tyr-925	I
in	O
a	O
glutathione	B
S	I
-	I
transferase	I
-	O
FAK	B
C	O
-	O
terminal	O
domain	O
fusion	O
protein	O
,	O
whereas	O
FAK	O
did	O
not	O
.	O

The	O
aetiology	O
and	O
management	O
of	O
diabetic	O
impotence	O
is	O
well	O
-	O
documented	O
;	O
the	O
effects	O
of	O
diabetes	O
on	O
female	O
sexuality	O
are	O
not	O
so	O
clear	O
.	O

The	O
percentage	O
distribution	O
of	O
types	O
of	O
fixation	O
disparity	O
curves	O
was	O
found	O
to	O
be	O
similar	O
to	O
some	O
previous	O
studies	O
,	O
with	O
a	O
higher	O
prevalence	O
of	O
Type	O
I	O
curve	O
(	O
64.3	O
%	O
)	O
,	O
followed	O
by	O
Type	O
II	O
(	O
28.6	O
%	O
)	O
and	O
Type	O
III	O
(	O
7.1	O
%	O
)	O
curves	O
.	O

Reading	O
disability	O
in	O
twins	O
.	O

The	O
mean	O
amount	O
of	O
blood	O
loss	O
prior	O
to	O
time	O
of	O
injection	O
was	O
4.5	O
units	O
(	O
a	O
range	O
of	O
3	O
to	O
10	O
units	O
)	O
.	O

Several	O
of	O
the	O
drugs	O
used	O
in	O
the	O
management	O
of	O
MAC	O
have	O
been	O
associated	O
with	O
significant	O
drug	O
interactions	O
involving	O
the	O
cytochrome	B
P450	I
(	O
CYP	B
)	O
enzyme	O
system	O
.	O

Therapy	O
and	O
prevention	O
of	O
irreversible	O
shock	O
with	O
pharmacological	O
doses	O
of	O
some	O
corticosteroids	O

Suppression	O
of	O
the	O
cka1	B
delta	I
cka2	I
-	I
8	I
mutant	I
phenotype	O
occurs	O
by	O
interaction	O
of	O
CKB1	B
with	O
the	O
defective	O
,	O
cka2	B
-	I
8-encoded	I
,	O
catalytic	O
subunit	O
.	O

Reduced	O
glutathione	O
in	O
whole	O
blood	O
decreases	O
within	O
a	O
blood	O
Se	O
range	O
of	O
1.01	O
to	O
2.28	O
micrograms	O
in	O
the	O
high	O
Se	O
area	O
.	O

Promoter	O
elements	O
and	O
transcriptional	O
control	O
of	O
the	O
mouse	B
acetylcholinesterase	I
gene	I
.	O

The	O
authors	O
report	O
two	O
cases	O
of	O
orbital	O
cavernous	O
hemangioma	O
diagnosed	O
by	O
Tc-99	O
m	O
RBC	O
SPECT	O
.	O

250	O
,	O
302	O
-	O
311	O
]	O
.	O

Arterial	O
compliance	O
measurements	O
using	O
intraarterial	O
pulse	O
contour	O
analysis	O
and	O
a	O
modified	O
Windkessel	O
model	O
were	O
carried	O
out	O
in	O
19	O
patients	O
with	O
isolated	O
systolic	O
hypertension	O
(	O
>	O
or	O
=	O
160	O
/	O
<	O
or	O
=	O
90	O
mm	O
Hg	O
)	O
and	O
compared	O
to	O
measurements	O
in	O
29	O
patients	O
with	O
essential	O
hypertension	O
(	O
diastolic	O
blood	O
pressure	O
[	O
BP	O
]	O
>	O
or	O
=	O
95	O
mm	O
Hg	O
)	O
and	O
47	O
normotensive	O
control	O
subjects	O
.	O

The	O
relationship	O
between	O
CSF	B
somatostatin	I
and	O
peripheral	O
thyroid	O
hormones	O
was	O
assessed	O
in	O
11	O
affectively	O
ill	O
patients	O
before	O
and	O
during	O
carbamazepine	O
treatment	O
.	O

Based	O
on	O
the	O
requirement	O
for	O
CREM	B
/	O
ICER	B
and	O
Rad6B	B
proteins	I
in	O
spermatogenesis	O
,	O
we	O
determined	O
expression	O
of	O
Cdc34	B
,	O
Rad6B	B
,	O
CREM	B
/	O
ICER	B
isoforms	O
,	O
and	O
the	O
Skp1-Cullin	B
-	O
F	O
-	O
box	O
ubiquitin	B
protein	O
ligase	O
subunits	O
Cul-1	B
and	O
Cul-2	B
,	O
which	O
are	O
associated	O
with	O
Cdc34	B
activity	O
during	O
murine	O
testicular	O
development	O
.	O

Since	O
the	O
early	O
1900s	O
,	O
a	O
genetic	O
hypothesis	O
has	O
been	O
suggested	O
.	O

Kettin	B
is	O
a	O
large	O
modular	O
protein	O
associated	O
with	O
thin	O
filaments	O
in	O
the	O
Z	O
-	O
disc	O
region	O
of	O
insect	O
muscles	O
.	O

This	O
is	O
the	O
first	O
description	O
of	O
an	O
integron	O
located	O
on	O
a	O
composite	O
transposon	O
.	O

By	O
means	O
of	O
early	O
detection	O
and	O
correction	O
of	O
the	O
possible	O
causes	O
,	O
the	O
goal	O
of	O
increasing	O
therapeutic	O
efficacy	O
can	O
be	O
achieved	O
.	O

Mutations	O
in	O
the	O
beta	B
-	I
galactosidase	I
gene	I
result	O
in	O
the	O
lysosomal	O
storage	O
disorders	O
GM1-gangliosidosis	O
and	O
Morquio	O
B	O
syndrome	O
.	O

Angiographic	O
follow	O
-	O
up	O
was	O
obtained	O
in	O
92	O
%	O
of	O
patients	O
with	O
a	O
primary	O
success	O
of	O
angioplasty	O
.	O

Electron	O
microscopic	O
visualization	O
of	O
the	O
general	O
population	O
of	O
active	O
genes	O
in	O
flies	O
overexpressing	O
hnRNP	B
proteins	I
also	O
indicated	O
that	O
the	O
great	O
majority	O
of	O
genes	O
seemed	O
normal	O
in	O
terms	O
of	O
cotranscriptional	O
RNA	O
processing	O
events	O
,	O
although	O
there	O
were	O
a	O
few	O
abnormalities	O
consistent	O
with	O
rare	O
exon	O
-	O
skipping	O
events	O
.	O

ESR	O
spectra	O
of	O
Er3	O
+	O
in	O
SmB6	O
single	O
crystals	O
:	O
Dynamic	O
Jahn	O
-	O
Teller	O
effect	O
in	O
a	O
mixed	O
-	O
valence	O
compound	O
.	O

These	O
results	O
indicate	O
that	O
the	O
2127-bp	O
cDNA	O
encodes	O
a	O
functional	O
feline	O
L	B
/	I
B	I
/	I
K	I
-	I
type	I
ALP	I
expressed	O
on	O
cell	O
surfaces	O
via	O
phosphatidylinositol	O
-	O
glycan	O
linkage	O
.	O

Inhibition	O
of	O
endogenous	B
Cdk2	I
by	O
dominant	B
negative	I
Cdk2	I
attenuated	O
phosphorylation	O
of	O
Thr447	O
,	O
Thr490	O
and	O
Thr497	O
,	O
but	O
had	O
no	O
effect	O
upon	O
Ser581	O
modification	O
.	O

Treatment	O
of	O
excessive	O
bleeding	O
after	O
cardiopulmonary	O
bypass	O
was	O
based	O
on	O
an	O
algorithm	O
using	O
point	O
-	O
of	O
-	O
care	O
testing	O
with	O
whole	O
blood	B
prothrombin	I
time	O
,	O
activated	O
partial	O
thromboplastin	B
time	O
,	O
heparinase	B
activated	O
clotting	O
time	O
,	O
and	O
platelet	O
count	O
.	O

The	O
high	O
prevalence	O
of	O
atrial	O
septal	O
defect	O
in	O
tetralogy	O
of	O
Fallot	O
is	O
cited	O
as	O
a	O
possible	O
analogy	O
because	O
right	O
ventricular	O
pressure	O
is	O
high	O
and	O
right	O
ventricular	O
compliance	O
is	O
low	O
from	O
birth	O
.	O

Experience	O
in	O
a	O
Kenya	O
district	O
hospital	O

Moreover	O
,	O
we	O
studied	O
the	O
relationship	O
between	O
initial	O
percentage	O
of	O
bone	O
marrow	O
plasma	O
cells	O
and	O
prognosis	O
.	O

Analysis	O
of	O
larger	O
cDNA	O
clones	O
demonstrates	O
that	O
there	O
are	O
at	O
least	O
two	O
isoforms	O
of	O
RIP14	B
that	O
differ	O
in	O
the	O
N	O
-	O
terminal	O
(	O
A	O
and	O
B	O
)	O
and	O
hinge	O
(	O
D	O
)	O
domains	O
.	O

The	O
entire	O
coding	O
region	O
of	O
an	O
ovine	B
endometrial	I
oxytocin	I
receptor	I
(	O
OTR	B
)	O
cDNA	O
was	O
generated	O
by	O
PCR	O
,	O
subcloned	O
into	O
the	O
SV40	B
major	I
late	I
promoter	I
expression	O
vector	O
pSVLJ	O
and	O
transiently	O
expressed	O
in	O
Cos-7	O
cells	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

Critical	O
review	O
of	O
tests	O
for	O
the	O
HBs	B
antigen	I
in	O
the	O
detection	O
of	O
infectious	O
blood	O

Disease	O
-	O
free	O
interval	O
was	O
greater	O
in	O
node	O
-	O
negative	O
Lx	O
patients	O
for	O
both	O
T1	O
(	O
P	O
less	O
than	O
0.007	O
)	O
and	O
T2	O
(	O
P	O
less	O
than	O
0.05	O
)	O
presentations	O
.	O

Allergen	O
-	O
stimulated	O
levels	O
of	O
PGD2	O
were	O
1274	O
+	O
/-	O

565	O
versus	O
1468	O
+	O
/-	O

679	O
after	O
prednisone	O
;	O
likewise	O
,	O
allergen	O
-	O
stimulated	O
5-HETE	O
levels	O
were	O
95	O
+	O
/-	O

21	O
versus	O
82	O
+	O
/-	O

21	O
;	O
those	O
of	O
LTE4	O
were	O
54	O
+	O
/-	O

20	O
versus	O
91	O
+	O
/-	O

51	O
;	O
and	O
those	O
of	O
15-HETE	O
were	O
63	O
+	O
/-	O

19	O
versus	O
60	O
+	O
/-	O

25	O
.	O

To	O
confirm	O
the	O
data	O
obtained	O
using	O
the	O
HPLC	O
-	O
ESI	O
-	O
MS	O
procedure	O
,	O
fractions	O
of	O
the	O
glycosides	O
from	O
four	O
berries	O
were	O
separated	O
,	O
hydrolyzed	O
,	O
silylated	O
and	O
the	O
sugars	O
were	O
analyzed	O
using	O
gas	O
chromatography	O
-	O
mass	O
spectrometry	O
.	O

Usefulness	O
of	O
computerized	O
tomography	O
in	O
hemodialysis	O
patients	O
.	O

Prevalence	O
of	O
use	O
,	O
claims	O
volume	O
,	O
and	O
expenditures	O
were	O
compared	O
for	O
cisapride	O
,	O
proton	O
pump	O
inhibitors	O
,	O
histamine-2	B
receptor	I
antagonists	O
,	O
and	O
the	O
prokinetic	O
agent	O
metoclopramide	O
during	O
these	O
periods	O
.	O

However	O
,	O
the	O
quasiparticle	O
scattering	O
rate	O
tau	O
(	O
-1	O
)	O
is	O
such	O
that	O
Planck	O
's	O
over	O
2pi	O
/	O
tau	O
approximately	O
6	O
t	O
(	O
perpendicular	O
)	O
,	O
implying	O
that	O
kappa	O
-	O
(	O
BEDT	O
-	O
TTF	O
)	O
2Cu	O
(	O
NCS	O
)	O
(	O
2	O
)	O
meets	O
the	O
criterion	O
used	O
to	O
identify	O
interlayer	O
incoherence	O
.	O

The	O
deduced	O
gene	O
product	O
was	O
found	O
to	O
have	O
significant	O
sequence	O
similarity	O
to	O
the	O
yeast	B
and	I
prokaryotic	I
RNA	I
polymerase	I
subunits	I
involved	O
with	O
subunit	O
assembly	O
.	O

In	O
two	O
of	O
these	O
nine	O
patients	O
,	O
a	O
decrease	O
in	O
dyskinesia	O
score	O
was	O
observed	O
without	O
a	O
concomitant	O
worsening	O
of	O
parkinsonian	O
symptoms	O
,	O
whereas	O
in	O
the	O
remaining	O
seven	O
,	O
full	O
parkinsonian	O
akinesia	O
followed	O
THDL	O
administration	O
.	O

A	O
proposed	O
method	O
.	O

A	O
clinical	O
trial	O
of	O
a	O
new	O
mitomycin	O
C	O
derivative	O
,	O
KW-2083	O
(	O
7-N-	O
(	O
p	O
-	O
hydroxyphenyl	O
)	O
-mitomycin	O
C	O
)	O

Complexities	O
in	O
the	O
host	O
-	O
pathogen	O
interactions	O
during	O
actual	O
infection	O
with	O
Gram	O
-	O
negative	O
bacteria	O
may	O
account	O
for	O
the	O
difficulties	O
in	O
demonstrating	O
this	O
phenomena	O
in	O
vivo	O
.	O

6,320	O
cells	O
/	O
mm3	O
,	O
respectively	O
;	O
P	O
less	O
than	O
.005	O
)	O
;	O
twelve	O
(	O
86	O
%	O
)	O
of	O
the	O
14	O
inmates	O
who	O
developed	O
AIDS	O
had	O
counts	O
of	O
less	O
than	O
5,000	O
cells	O
/	O
mm3	O
,	O
compared	O
with	O
only	O
six	O
(	O
14	O
%	O
)	O
of	O
the	O
42	O
controls	O
(	O
P	O
less	O
than	O
.00001	O
)	O
.	O

A	O
new	O
model	O
for	O
objective	O
assessment	O
of	O
cervical	O
ripening	O
:	O
the	O
effect	O
of	O
prostaglandin	O
E2	O
and	O
prelabor	O
contractility	O
.	O

Insulin	B
-	O
secreting	O
islet	O
-	O
cell	O
tumours	O
of	O
the	O
pancreas	O
.	O

Suprapubic	O
and	O
intravesical	O
methods	O

The	O
use	O
of	O
ALAD	B
activity	O
and	O
EP	O
as	O
cumulative	O
lead	O
exposure	O
indicators	O
is	O
suggested	O
.	O

CONCLUSIONS	O
:	O
The	O
present	O
study	O
showed	O
it	O
is	O
possible	O
to	O
use	O
a	O
modified	O
Stroop	O
task	O
as	O
a	O
measure	O
of	O
implicit	O
processing	O
of	O
alcohol	O
stimuli	O
.	O

Furthermore	O
,	O
the	O
rapid	O
light	O
-	O
mediated	O
increase	O
of	O
CPRF	B
proteins	I
was	O
insensitive	O
to	O
transcriptional	O
inhibitors	O
,	O
suggesting	O
that	O
a	O
post	O
-	O
transcriptional	O
mechanism	O
controls	O
CPRF	B
accumulation	O
.	O

43	O
%	O
,	O
6	O
/	O
14	O
;	O
P	O
=	O
0.013	O
)	O
,	O
whereas	O
,	O
in	O
RCC	O
samples	O
with	O
VHL	B
methylation	O
or	O
mutation	O
,	O
the	O
frequency	O
of	O
3p14-p21	O
LOH	O
did	O
not	O
differ	O
from	O
that	O
of	O
sp25-p26	O
(	O
72	O
%	O
,	O
18	O
/	O
25	O
vs.	O

One	O
patient	O
had	O
chronic	O
dysphoria	O
and	O
one	O
encephalopatia	O
toxica	O
.	O

A	O
single	O
clone	O
,	O
which	O
was	O
conserved	O
and	O
had	O
near	O
-	O
perfect	O
homology	O
to	O
eight	O
human	O
/	O
rodent	O
expressed	O
sequence	O
tags	O
,	O
was	O
used	O
as	O
template	O
for	O
5	O
'	O
and	O
3	O
'	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
and	O
SPICE	O
(	O
system	O
for	O
polymerase	O
chain	O
reaction	O
amplification	O
of	O
cDNA	O
ends	O
)	O
reactions	O
to	O
obtain	O
the	O
3.6-kb	O
cDNA	O
,	O
LGL2	B
(	O
Genbank	B
,	I
AF	I
110195	I
)	O
encoding	O
a	O
deduced	O
polypeptide	O
(	O
lgl2	B
)	O
of	O
963	O
amino	O
acids	O
.	O

Effect	O
of	O
dimethyl	O
sulfoxide	O
on	O
cooling	O
rates	O
of	O
unrestrained	O
rats	O
.	O

The	O
GIS	O
software	O
program	O
,	O
ArcView	O
,	O
was	O
used	O
for	O
spatial	O
analysis	O
and	O
distance	O
calculations	O
.	O

chi2	O
Tests	O
were	O
used	O
to	O
compare	O
the	O
distribution	O
of	O
the	O
characteristics	O
between	O
intersection	O
and	O
midblock	O
collisions	O
.	O

We	O
have	O
analyzed	O
the	O
role	O
of	O
the	O
HU	B
protein	I
in	O
invertasome	O
assembly	O
when	O
the	O
enhancer	O
is	O
located	O
at	O
variable	O
positions	O
close	O
to	O
one	O
of	O
the	O
recombination	O
sites	O
.	O

The	O
likelihood	O
of	O
death	O
was	O
more	O
than	O
3	O
times	O
higher	O
among	O
patients	O
in	O
the	O
ERA	O
-	O
II	O
group	O
(	O
mortality	O
risk	O
ratio	O
3.82	O
[	O
95	O
%	O
CI	O
1.48	O
%	O
to	O
9.84	O
]	O
,	O
p	O
=	O
0.006	O
)	O
.	O

Here	O
we	O
show	O
that	O
the	O
nucleotide	O
in	O
the	O
middle	O
of	O
the	O
anticodon	O
(	O
i.e.	O
,	O
psi	O
35	O
)	O
also	O
contributes	O
to	O
the	O
suppressor	O
efficiency	O
displayed	O
by	O
cytoplasmic	B
tRNA	I
(	I
Tyr	I
)	I
.	O

Similarly	O
,	O
an	O
increase	O
in	O
CAT	B
expression	O
from	O
the	O
same	O
construct	O
(	O
pBLCAT	O
-	O
ENDOA	B
)	O
was	O
also	O
observed	O
in	O
7AQS2.1	O
cells	O
.	O

Although	O
the	O
occurrence	O
of	O
any	O
ventricular	O
ectopic	O
activity	O
,	O
as	O
detected	O
by	O
either	O
or	O
both	O
methods	O
,	O
was	O
common	O
,	O
the	O
incidence	O
was	O
significantly	O
higher	O
(	O
P	O
less	O
than	O
0.001	O
)	O
in	O
patients	O
with	O
coronary	O
heart	O
disease	O
(	O
86	O
percent	O
;	O
77	O
/	O
90	O
)	O
,	O
as	O
compared	O
to	O
that	O
in	O
normal	O
subjects	O
(	O
40	O
percent	O
;	O
12	O
/	O
30	O
)	O
.	O

These	O
8-oxoguanine	B
DNA	I
glycosylases	I
,	O
hOgg1	B
(	O
human	O
)	O
and	O
mOgg1	B
(	O
murine	O
)	O
,	O
are	O
homologous	O
to	O
each	O
other	O
and	O
to	O
yeast	B
Ogg1	I
.	O

Model	O
experiments	O
on	O
pheasants	O
using	O
single	O
doses	O
of	O
the	O
insecticide	O
(	O
Lindane	O
)	O
the	O
herbicide	O
(	O
Terbutryn	O
)	O
a	O
mineral	O
fertilizer	O
(	O
calcium	O
ammonium	O
nitrate	O
)	O
and	O
the	O
fungicide	O
(	O
HCB	O
)	O
.	O

The	O
main	O
side	O
-	O
effects	O
were	O
myelosuppression	O
,	O
mucositis	O
and	O
peripheral	O
neuropathy	O
,	O
which	O
were	O
all	O
common	O
and	O
often	O
severe	O
.	O

Repression	O
was	O
strictly	O
dependent	O
on	O
the	O
presence	O
of	O
upstream	O
Oshox1	B
binding	O
sites	O
in	O
the	O
reporter	O
gene	O
constructs	O
and	O
a	O
function	O
of	O
the	O
N	O
-	O
terminal	O
region	O
of	O
Oshox1	B
,	O
preceding	O
the	O
homeodomain	B
.	O

Experimental	O
studies	O
and	O
clinical	O
application	O
of	O
plasma	B
ACTH	I
radioimmunoassay	O
kit	O
without	O
extraction	O
process	O

Defects	O
in	O
RT6	B
expression	O
coincide	O
with	O
increased	O
susceptibility	O
in	O
animal	O
models	O
for	O
insulin	B
-	O
dependent	O
diabetes	O
mellitus	O
and	O
other	O
autoimmune	O
diseases	O
.	O

By	O
cloning	O
genes	O
encoding	O
benzene	O
-	O
degradative	O
enzymes	O
,	O
we	O
found	O
that	O
strain	O
JS150	O
also	O
carries	O
genes	O
for	O
a	O
toluene	B
/	I
benzene-2-monooxygenase	I
.	O

Thus	O
G17	B
targets	O
the	O
c	B
-	I
fos	I
promoter	I
CArG	I
sequence	I
via	O
Rho	B
A	I
-	O
dependent	O
pathways	O
,	O
and	O
Rho	B
A	I
appears	O
to	O
play	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
the	O
trophic	O
action	O
of	O
G17	B
.	O

By	O
contrast	O
with	O
ama-1	B
,	O
rpc-1	B
was	O
not	O
deleted	O
by	O
mDf4	O
or	O
larger	O
deficiencies	O
examined	O
,	O
indicating	O
that	O
these	O
genes	O
are	O
no	O
closer	O
than	O
150	O
kb	O
.	O

Dual	O
signal	O
peptides	O
mediate	O
the	O
signal	B
recognition	I
particle	I
/	O
Sec	B
-	O
independent	O
insertion	O
of	O
a	O
thylakoid	O
membrane	O
polyprotein	O
,	O
PsbY.	B

The	O
three	O
respective	O
time	O
control	O
groups	O
(	O
C5	O
,	O
C10	O
,	O
and	O
C15	O
)	O
were	O
injected	O
with	O
saline	O
solution	O
.	O

Next	O
,	O
to	O
examine	O
the	O
regulation	O
mechanism	O
of	O
CD44	B
/	O
ERM	B
interaction	O
in	O
vivo	O
,	O
we	O
reexamined	O
the	O
immunoprecipitated	O
CD44	B
/	O
ERM	B
complex	O
from	O
BHK	O
cells	O
and	O
found	O
that	O
it	O
contains	O
Rho	B
-	I
GDP	I
dissociation	I
inhibitor	I
(	O
GDI	B
)	O
,	O
a	O
regulator	O
of	O
Rho	B
GTPase	I
.	O

Ten	O
patients	O
(	O
aged	O
28	O
-	O
76	O
years	O
)	O
with	O
a	O
terminal	O
jejunostomy	O
located	O
within	O
the	O
first	O
meter	O
of	O
jejunum	O
were	O
treated	O
by	O
infusion	O
of	O
an	O
elemental	O
diet	O
into	O
the	O
distal	O
small	O
bowel	O
(	O
IEDDSB	O
)	O
.	O

The	O
goals	O
of	O
these	O
experiments	O
were	O
to	O
determine	O
whether	O
lactational	O
anestrus	O
would	O
be	O
prolonged	O
by	O
a	O
48-h	O
fast	O
at	O
days	O
13	O
and	O
14	O
postpartum	O
(	O
pp	O
)	O
and	O
,	O
if	O
so	O
,	O
to	O
determine	O
whether	O
this	O
effect	O
could	O
be	O
reversed	O
by	O
treatment	O
with	O
the	O
Ob	B
protein	I
leptin	B
.	O

RESULTS	O
:	O
In	O
patients	O
with	O
necrotising	O
fasciitis	O
the	O
arterial	O
PO2	O
rose	O
about	O
7-fold	O
whereas	O
the	O
arterial	O
PCO2	O
increased	O
only	O
slightly	O
during	O
exposure	O
to	O
2.5	O
absolute	O
atmospheres	O
(	O
ATA	O
)	O
of	O
oxygen	O
.	O

Being	O
implicated	O
in	O
insulin	B
and	O
GK	B
gene	I
regulations	O
as	O
a	O
common	O
transcription	O
factor	O
,	O
IPF1	B
/	O
STF-1	B
/	O
PDX-1	B
is	O
likely	O
to	O
play	O
an	O
essential	O
role	O
in	O
maintaining	O
normal	O
beta	O
-	O
cell	O
functions	O
.	O

MATERIAL	O
AND	O
METHODS	O
:	O

Finally	O
,	O
synthetic	O
peptides	O
corresponding	O
to	O
the	O
mutant	O
proteins	O
were	O
assessed	O
for	O
the	O
ability	O
to	O
act	O
as	O
substrates	O
for	O
PR	B
.	O

As	O
an	O
approach	O
to	O
the	O
determination	O
of	O
structure	O
-	O
function	O
relationships	O
in	O
the	O
PRP4	B
protein	I
,	O
we	O
have	O
isolated	O
more	O
than	O
fifty	O
new	O
alleles	O
of	O
the	O
PRP4	B
gene	I
through	O
random	O
and	O
site	O
-	O
directed	O
mutagenesis	O
,	O
and	O
have	O
analyzed	O
the	O
phenotypes	O
of	O
many	O
of	O
them	O
.	O

Brainstem	O
auditory	O
evoked	O
potential	O
responses	O
(	O
BAEPs	O
)	O
were	O
recorded	O
from	O
CZ	O
-	O
A1	O
and	O
CZ	O
-	O
A2	O
scalp	O
regions	O
in	O
23	O
hypertensive	O
and	O
14	O
normotensive	O
subjects	O
.	O

Although	O
the	O
Gly252Arg	O
substitution	O
observed	O
in	O
UM	O
:	O
JG5	O
is	O
non	O
-	O
conservative	O
,	O
it	O
was	O
not	O
possible	O
to	O
distinguish	O
whether	O
it	O
is	O
a	O
mutation	O
or	O
a	O
polymorphism	O
.	O

Phosphorylation	O
of	O
the	O
ras	B
GTPase	B
-	I
activating	I
protein	I
(	O
GAP	B
)	O
by	O
the	O
p93c	B
-	I
fes	I
protein	B
-	I
tyrosine	I
kinase	I
in	O
vitro	O
and	O
formation	O
of	O
GAP	B
-	O
fes	B
complexes	O
via	O
an	O
SH2	B
domain	O
-	O
dependent	O
mechanism	O
.	O

This	O
resulted	O
in	O
a	O
shift	O
of	O
C1	O
/	O
C2	O
,	O
so	O
that	O
the	O
effect	O
of	O
collagen	B
was	O
more	O
pronounced	O
(	O
maximal	O
increase	O
of	O
C1	O
/	O
C2	O
=	O
134	O
%	O
)	O
than	O
ADP	O
(	O
maximal	O
increase	O
of	O
C1	O
/	O
C2	O
=	O
79	O
%	O
)	O
.	O

ZF87	B
specifically	O
binds	O
the	O
ME1a1	O
element	O
with	O
higher	O
affinity	O
than	O
the	O
ME1a2	O
element	O
.	O

Structure	O
of	O
the	O
connective	O
stroma	O
of	O
the	O
epididymis	O
in	O
the	O
zebu	O

These	O
data	O
suggest	O
that	O
multiple	O
genetic	O
recombination	O
among	O
bacteriophages	O
with	O
different	O
immunities	O
took	O
place	O
to	O
generate	O
the	O
prophage	O
VT1-Sakai	O
.	O

Transient	O
-	O
expression	O
assay	O
analysis	O
of	O
subclones	O
of	O
pPstI	O
-	O
G	O
localized	O
the	O
trans	O
-	O
active	O
factor	O
to	O
a	O
3.0-kilobase	B
XbaI	I
fragment	I
.	O

Concentrations	O
of	O
platelet	O
nitrite	O
and	O
total	O
nitrate	O
/	O
nitrite	O
were	O
determined	O
using	O
simple	O
and	O
sensitive	O
nitrate	O
/	O
nitrite	O
fluorometric	O
assay	O
techniques	O
.	O

Using	O
a	O
GTP	O
-	O
dependent	O
,	O
brefeldin	O
A	O
-	O
sensitive	O
in	O
vitro	O
AP-1	B
binding	O
assay	O
,	O
we	O
have	O
determined	O
here	O
the	O
parameters	O
of	O
the	O
AP-1	B
binding	O
reaction	O
.	O

By	O
using	O
methanol-0.15	O
M	O
borate	O
buffer	O
of	O
pH	O
8.0	O
,	O
cate	B
-	I
chol	I
-	I
O	I
-	I
methyltransferase	I
activity	O
might	O
be	O
assayed	O
.	O

Replacement	O
of	O
Val20-Leu21	O
with	O
Ala	O
-	O
Ala	O
produced	O
a	O
dimeric	B
RII	I
beta	I
protein	I
that	O
binds	O
AKAP75	B
approximately	O
4	O
%	O
as	O
avidly	O
as	O
wild	B
-	I
type	I
RII	I
beta	I
.	O

Plasmodium	O
vivax	O
malaria	O
.	O

Postcontrast	O
images	O
were	O
also	O
acquired	O
in	O
the	O
sagittal	O
(	O
six	O
patients	O
)	O
and	O
coronal	O
(	O
three	O
patients	O
)	O
planes	O
.	O

In	O
vitro	O
death	O
assays	O
with	O
transient	O
overexpression	O
of	O
deletion	O
constructs	O
of	O
both	O
isoforms	O
using	O
beta	B
-	I
galactosidase	I
as	O
a	O
reporter	O
gene	O
in	O
MCF7	O
cells	O
suggest	O
the	O
following	O
:	O
1	O
)	O
the	O
nucleotide	O
binding	O
domain	O
may	O
act	O
as	O
a	O
negative	O
regulator	O
of	O
the	O
killing	O
activity	O
of	O
DEFCAP	B
;	O
2	O
)	O
the	O
LRR	B
/	O
CARD	B
represents	O
a	O
putative	O
constitutively	O
active	O
inducer	O
of	O
apoptosis	O
;	O
3	O
)	O
the	O
killing	O
activity	O
of	O
LRR	B
/	O
CARD	B
is	O
inhibitable	O
by	O
benzyloxycarbonyl	O
-	O
Val	O
-	O
Ala	O
-	O
Asp	O
(	O
OMe	O
)	O
-fluoromethyl	O
ketone	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
Asp	O
-	O
Glu	O
-	O
Val	O
-	O
Asp	O
(	O
OMe	O
)	O
-fluoromethyl	O
ketone	O
;	O
and	O
4	O
)	O
the	O
CARD	B
is	O
critical	O
for	O
killing	O
activity	O
of	O
DEFCAP	B
.	O

Here	O
,	O
we	O
provide	O
direct	O
evidence	O
that	O
the	O
meiotic	O
defect	O
caused	O
by	O
either	O
unregulated	O
cAPK	B
activity	O
or	O
unregulated	O
ran1	B
+	I
kinase	I
activity	O
is	O
due	O
to	O
inability	O
to	O
induce	O
transcription	O
of	O
the	O
mei2	B
+	I
gene	I
,	O
which	O
is	O
required	O
for	O
meiotic	O
initiation	O
.	O

Sailer	O
,	O
K.	O

As	O
tat	B
itself	O
dramatically	O
increases	O
HIV-1	O
gene	O
expression	O
,	O
it	O
too	O
is	O
presumably	O
regulated	O
in	O
the	O
latent	O
state	O
,	O
and	O
may	O
also	O
be	O
activated	O
by	O
mitogenic	O
stimulation	O
.	O

The	O
CBS-1	B
gene	I
was	O
mapped	O
to	O
human	O
chromosome	O
10p12	O
between	O
markers	O
WI-8535	B
and	O
WI-4724	B
,	O
and	O
is	O
tightly	O
linked	O
to	O
the	O
two	O
STRP	O
markers	O
of	O
D10S1789	B
and	O
D10S550	B
.	O

We	O
have	O
previously	O
described	O
the	O
partial	O
purification	O
of	O
Ap4A	B
hydrolase	I
from	O
S.	O
pombe	O
[	O
Robinson	O
,	O
de	O
la	O
Pena	O
and	O
Barnes	O
(	O
1993	O
)	O
Biochim	O
.	O

Together	O
,	O
these	O
results	O
indicate	O
that	O
YTS1	B
is	O
a	O
bifunctional	O
protein	O
active	O
in	O
both	O
splicing	O
and	O
protein	O
synthesis	O
.	O

The	O
first	O
operon	O
,	O
orf1-tolQRA	O
,	O
is	O
iron	O
regulated	O
throughout	O
growth	O
,	O
but	O
iron	O
-	O
regulated	O
expression	O
of	O
tolB	B
and	O
oprL	B
fusions	I
occurs	O
only	O
in	O
late	O
log	O
phase	O
.	O

The	O
human	B
IFI16	I
gene	I
is	O
a	O
member	O
of	O
an	O
interferon	B
-	O
inducible	O
family	O
of	O
mouse	O
and	O
human	O
genes	O
closely	O
linked	O
on	O
syntenic	O
regions	O
of	O
chromosome	O
1	O
.	O

Late	O
results	O
in	O
the	O
treatment	O
of	O
urotuberculosis	O

Methylation	O
interference	O
analysis	O
established	O
at	O
single	O
nucleotide	O
resolution	O
that	O
purified	O
recombinant	O
Fos	B
and	O
Jun	B
proteins	I
bind	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
to	O
the	O
AP-1	B
sites	I
within	O
the	O
VDRE	O
and	O
OC	B
box	I
.	O

The	O
human	B
p18	I
gene	I
spans	O
at	O
least	O
7.5	O
kb	O
and	O
is	O
composed	O
of	O
three	O
exons	O
,	O
two	O
of	O
which	O
encode	O
the	O
p18	B
protein	I
.	O

Partial	O
characterization	O
of	O
the	O
CCAAT	O
box	O
in	O
the	O
promoter	O
of	O
the	O
hLGFBP-1	B
gene	I
:	O
interaction	O
with	O
negatively	O
acting	O
transcription	O
factors	O
in	O
decidualized	O
human	O
endometrial	O
stromal	O
cells	O
.	O

These	O
cDNAs	O
were	O
found	O
to	O
be	O
derived	O
from	O
the	O
"3""-untranslated"	O
region	O
(	O
"3""-UTR"	O
)	O
of	O
the	O
methyl	B
-	I
CpG	I
-	I
binding	I
protein	I
2	I
gene	I
(	O
MeCP2	B
)	O
.	O

Carotid	O
body	O
chemoreceptor	O
activity	O
as	O
recorded	O
from	O
the	O
petrosal	O
ganglion	O
in	O
cats	O
.	O

The	O
NF	B
-	I
kappaB	I
/	O
Rel	B
transcription	O
factors	O
participate	O
in	O
the	O
activation	O
of	O
immune	O
system	O
regulatory	O
genes	O
and	O
viral	B
early	I
genes	I
including	O
the	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
long	I
terminal	I
repeat	I
.	O

BK	B
-	O
induced	O
translocation	O
and	O
overexpression	O
of	O
PKC	B
isoforms	I
as	O
well	O
as	O
coexpression	O
of	O
inactive	O
or	O
constitutively	O
active	O
mutants	O
of	O
different	O
PKC	B
isozymes	I
provided	O
evidence	O
for	O
a	O
role	O
of	O
the	O
diacylglycerol	O
-	O
sensitive	O
PKCs	B
alpha	I
and	I
epsilon	I
in	O
BK	B
signaling	O
toward	O
MAPK	B
.	O

Clinical	O
trial	O
endpoints	O
based	O
on	O
magnitude	O
of	O
reduction	O
in	O
HIV-1	O
RNA	O
levels	O
provide	O
an	O
important	O
complement	O
to	O
endpoints	O
based	O
on	O
percentage	O
of	O
patients	O
achieving	O
complete	O
virologic	O
suppression	O
.	O

The	O
expression	O
of	O
cor14b	B
was	O
strongly	O
impaired	O
in	O
the	O
barley	O
albino	O
mutant	O
an	O
,	O
suggesting	O
the	O
involvement	O
of	O
a	O
plastidial	O
factor	O
in	O
the	O
control	O
of	O
gene	O
expression	O
.	O

Pulse	O
monitors	O
in	O
outpatient	O
dental	O
anaesthesia	O
.	O

Synthesis	O
of	O
2-	O
(	O
2'-thiazolyl	O
)	O
alkanebenzimidazoles	O
--	O
potential	O
anthelmintics	O

Wild	O
type	O
MEKK1	B
enhances	O
promoter	O
activity	O
and	O
the	O
activity	O
can	O
be	O
inhibited	O
by	O
dominant	O
negative	O
MEKK1	B
,	O
MEK1	B
,	O
MEK7	B
,	O
MEK3	B
,	O
p38	B
/	O
RK	B
,	O
and	O
c	B
-	I
Jun	I
.	O

Our	O
current	O
study	O
aims	O
at	O
clarifying	O
the	O
role	O
of	O
myristoylation	O
in	O
caveolar	O
targeting	O
using	O
well	O
-	O
characterized	O
acylation	O
mutants	O
of	O
two	O
model	O
proteins	O
,	O
namely	O
Gi1	B
alpha	I
and	O
c	B
-	I
Src	I
.	O

Immunoprecipitation	O
of	O
spinophilin	B
or	O
neurabin	B
from	O
crude	O
brain	O
extracts	O
selectively	O
coprecipitated	O
PP1gamma	B
(	I
1	I
)	I
over	O
PP1beta	B
.	O

Most	O
important	O
,	O
after	O
all	O
,	O
is	O
not	O
the	O
ionization	O
technique	O
but	O
the	O
stage	O
with	O
a	O
47.1	O
%	O
five	O
-	O
year	O
survival	O
rate	O
in	O
T1N0	O
as	O
compared	O
to	O
T2N0	O
with	O
28.6	O
%	O
and	O
T1N1	O
with	O
19.4	O
%	O
.	O

The	O
encoded	O
Arabidopsis	B
U3	I
snRNAs	I
can	O
be	O
folded	O
into	O
a	O
secondary	O
structure	O
which	O
is	O
more	O
similar	O
to	O
that	O
of	O
U3	B
RNAs	I
from	O
lower	O
eukaryotes	O
rather	O
than	O
from	O
metazoa	O
.	O

Cytokinetics	O
of	O
the	O
Krebs	O
2	O
carcinoma	O
.	O

We	O
investigated	O
whether	O
two	O
WT1	B
splice	I
variants	I
lacking	O
or	O
including	O
a	O
three	O
-	O
amino	O
-	O
acid	O
(	O
KTS	O
)	O
insertion	O
between	O
the	O
third	O
and	O
fourth	O
zinc	O
finger	O
in	O
the	O
DNA	O
-	O
binding	O
domain	O
could	O
repress	O
the	O
IR	B
promoter	I
in	O
vitro	O
.	O

These	O
back	O
mutations	O
led	O
to	O
a	O
modest	O
decrease	O
in	O
kinase	O
activity	O
,	O
decreased	O
tumorigenic	O
potential	O
in	O
chickens	O
,	O
and	O
an	O
unexpected	O
increase	O
in	O
transforming	O
activity	O
in	O
rat	O
cells	O
.	O

Plasma	O
NE	O
and	O
E	O
increased	O
to	O
significantly	O
higher	O
values	O
after	O
15	O
min	O
in	O
the	O
young	O
subjects	O
:	O
1.68	O
+	O
/-	O

0.18	O
vs.	O

E.	O
granulosus	O
infection	O
has	O
been	O
confirmed	O
in	O
25	O
patients	O
(	O
20.6	O
%	O
)	O
,	O
in	O
16	O
cases	O
by	O
finding	O
parasite	O
protoscoleces	O
or	O
hooks	O
and	O
in	O
nine	O
cases	O
by	O
detection	O
of	O
an	O
antigen	O
specific	O
for	O
E.	B
granulosus	I
,	I
antigen	I
5	I
(	O
Ag5	B
)	O
.	O

Transcription	O
of	O
FN	B
promoter	I
-	O
chloramphenicol	B
acetyltransferase	I
fusion	O
genes	O
carrying	O
the	O
base	O
substitution	O
in	O
one	O
or	O
more	O
of	O
these	O
G	O
-	O
rich	O
sequences	O
both	O
in	O
vivo	O
and	O
in	O
vitro	O
revealed	O
that	O
the	O
base	O
substitution	O
in	O
any	O
G	O
-	O
rich	O
sequence	O
results	O
in	O
reduction	O
of	O
promoter	O
activity	O
,	O
although	O
the	O
downstream	O
GC	O
box	O
(	O
GCd	O
)	O
plays	O
a	O
primary	O
role	O
.	O

Teboroxime	O
is	O
a	O
new	O
boronic	O
acid	O
adduct	O
of	O
technetium	O
dioxime	O
(	O
BATO	O
)	O
compound	O
that	O
demonstrates	O
favorable	O
characteristics	O
in	O
preliminary	O
studies	O
.	O

It	O
is	O
our	O
conclusion	O
that	O
Sonoclot	O
coagulation	O
analysis	O
is	O
unlikely	O
to	O
identify	O
patients	O
with	O
prolonged	O
bleeding	O
time	O
in	O
whom	O
platelet	O
count	O
and	O
other	O
coagulation	O
factors	O
are	O
normal	O
.	O

The	O
single	O
copy	O
flotillin-1	B
gene	I
is	O
located	O
at	O
6p21.3	O
in	O
the	O
MHC	B
class	I
I	I
region	I
and	O
consists	O
of	O
13	O
exons	O
over	O
15	O
kb	O
.	O

Low	O
plasma	O
glucose	O
concentrations	O
that	O
may	O
or	O
may	O
not	O
be	O
sufficiently	O
low	O
to	O
result	O
in	O
symptoms	O
can	O
be	O
observed	O
as	O
a	O
concomitant	O
of	O
several	O
diverse	O
diseases	O
.	O

However	O
,	O
patients	O
with	O
DPX	O
should	O
be	O
observed	O
for	O
the	O
potential	O
occurrence	O
of	O
an	O
associated	O
condition	O
.	O

Effect	O
of	O
TNF	B
,	O
IL-1	B
,	O
and	O
IL-6	B
on	O
the	O
proliferation	O
of	O
human	O
Tenon	O
's	O
capsule	O
fibroblasts	O
in	O
tissue	O
culture	O
.	O

Previous	O
analysis	O
of	O
this	O
motif	O
in	O
the	O
lactose	B
permease	I
(	O
A.	O

Several	O
reports	O
assert	O
that	O
prolactin	B
affects	O
the	O
delta	O
5	O
and	O
delta	O
4	O
pathways	O
through	O
its	O
effect	O
on	O
the	O
activity	O
of	O
3beta	B
-	I
hydroxysteroid	I
dehydrogenase	I
(	O
3beta	B
-	I
OHSD	I
)	O
.	O

A	O
decrease	O
was	O
also	O
found	O
of	O
the	O
levels	O
of	O
total	O
cholesterol	O
and	O
LDL	B
-	I
cholesterol	I
.	O

Low	O
serum	B
C3	I
values	O
were	O
observed	O
in	O
all	O
11	O
children	O
at	O
some	O
stage	O
of	O
their	O
illness	O
.	O

In	O
spite	O
of	O
the	O
presence	O
of	O
a	O
physician	O
,	O
the	O
real	O
pathology	O
of	O
an	O
indian	O
population	O
of	O
Colombie	O
is	O
not	O
very	O
well	O
known	O
.	O

During	O
chordotonal	O
organ	O
development	O
,	O
the	O
3	O
'	O
enhancer	O
directs	O
expression	O
in	O
proneural	O
clusters	O
;	O
whereas	O
successive	O
modular	O
enhancers	O
located	O
in	O
the	O
5	O
'	O
region	O
drive	O
tissue	O
-	O
specific	O
expression	O
in	O
chordotonal	O
organ	O
precursors	O
in	O
the	O
embryo	O
and	O
larval	O
leg	O
,	O
wing	O
and	O
antennal	O
imaginal	O
discs	O
.	O

Is	O
conventional	O
sperm	O
analysis	O
of	O
any	O
use	O
?	O

The	O
computerised	O
records	O
of	O
867	O
couples	O
were	O
used	O
to	O
investigate	O
the	O
prognostic	O
significance	O
of	O
semen	O
volume	O
,	O
motility	O
,	O
density	O
and	O
morphology	O
.	O

Antisense	O
oligonucleotides	O
complementary	O
to	O
the	O
5	O
'	O
end	O
of	O
PKC	B
-	I
zeta	I
mRNA	I
sequences	I
significantly	O
reduced	O
the	O
collagen	B
lattice	O
-	O
stimulated	O
alpha2	O
and	O
MMP-1	B
mRNA	I
levels	O
.	O

The	O
most	O
valid	O
method	O
was	O
the	O
AXB	O
bearing	O
with	O
the	O
cephalometric	O
clinical	O
diagnosis	O
a	O
90.91	O
%	O
concordance	O
.	O

However	O
,	O
coligation	O
of	O
Fc	B
gamma	I
RIIB1	I
with	O
B	B
cell	I
Ag	I
receptors	I
(	O
BCR	B
)	O
inhibits	O
BCR	B
-	O
mediated	O
signaling	O
by	O
a	O
mechanism	O
that	O
may	O
involve	O
recruitment	O
of	O
phosphatases	B
SHP-1	I
,	O
SHP-2	B
,	O
and	O
the	O
SH2	B
containing	I
inositol	I
5'phosphatase	I
(	O
SHIP	B
)	O
to	O
the	O
phosphorylated	O
Fc	B
gamma	I
RIIB1	I
immunoreceptor	I
tyrosine	I
-	I
based	I
inhibitory	I
motif	I
.	O

The	O
slope	O
of	O
QD	O
versus	O
QEMF	O
for	O
the	O
four	O
tubes	O
was	O
near	O
unity	O
.	O

The	O
sequence	O
of	O
the	O
127	B
residue	I
NrfF	I
polypeptide	I
,	I
M	I
(	I
r	I
)	I
14,522	I
,	O
is	O
strikingly	O
similar	O
to	O
the	O
CcI2	B
protein	I
of	O
R.	O
capsulatus	O
,	O
especially	O
in	O
the	O
putative	O
haem	O
-	O
binding	O
motif	O
,	O
RCPQCQNQN.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

When	O
cotransfected	O
with	O
the	O
HIV	B
LTR	I
CAT	B
into	O
CV-1	O
cells	O
,	O
both	O
the	O
pCD41	B
and	O
pGD41	B
clones	O
trans	O
-	O
activated	O
the	O
HIV	B
LTR	I
.	O

From	O
this	O
comparison	O
of	O
aa	O
sequences	O
,	O
the	O
ATPK7	B
protein	I
is	O
considered	O
to	O
be	O
a	O
member	O
of	O
a	O
novel	O
subfamily	O
of	O
Ser	B
/	I
Thr	I
PKs	I
in	O
plants	O
.	O

It	O
is	O
very	O
probable	O
that	O
this	O
change	O
was	O
due	O
to	O
mechanical	O
effects	O
induced	O
by	O
injecting	O
a	O
hypertonic	O
solution	O
of	O
MT-141	O
at	O
a	O
rate	O
of	O
70	O
-	O
-130	O
ml	O
/	O
dog	O
.	O

Both	O
viruses	O
express	O
the	O
mil	B
/raf	O
oncogene	O
product	O
as	O
a	O
gag	B
-	I
fusion	I
polyprotein	O
,	O
while	O
the	O
myc	B
oncogene	O
of	O
MH2	O
is	O
expressed	O
via	O
a	O
subgenomic	O
mRNA	O
.	O

Transmural	O
metabolic	O
heterogeneity	O
at	O
high	O
cardiac	O
work	O
states	O
.	O

A	O
flow	O
probe	O
for	O
direct	O
measurement	O
of	O
blood	O
flow	O
of	O
the	O
mitral	O
valve	O
was	O
devised	O
.	O

Liver	O
disease	O
and	O
HCV	O
infection	O
after	O
transplantation	O
of	O
organs	O
from	O
hepatitis	B
C	I
antibody	I
positive	O
donors	O
.	O

To	O
investigate	O
whether	O
the	O
two	O
RPG	B
-	I
boxes	I
mediate	O
transcription	O
activation	O
of	O
both	O
the	O
L46	B
and	O
S24	B
gene	I
,	O
two	O
experimental	O
strategies	O
were	O
followed	O
:	O
cloning	O
of	O
the	O
respective	O
genes	O
on	O
multicopy	O
vectors	O
and	O
construction	O
of	O
fusion	O
genes	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
that	O
sequences	O
within	O
this	O
region	O
bind	O
members	O
of	O
the	O
Sp1	B
family	I
of	I
transcription	I
factors	I
.	O

To	O
date	O
,	O
6	O
mammalian	O
GRKs	B
have	O
been	O
identified	O
by	O
molecular	O
cloning	O
.	O

OBJECTIVE	O
:	O
To	O
report	O
a	O
case	O
of	O
fulminant	O
neuropathy	O
with	O
severe	O
quadriparesis	O
associated	O
with	O
vincristine	O
chemotherapy	O
.	O

The	O
1.5-Mb	O
region	O
was	O
covered	O
by	O
137	O
cosmids	O
with	O
a	O
minimum	O
overlap	O
set	O
of	O
52	O
cosmids	O
assigned	O
to	O
17	O
bins	O
and	O
9	O
contigs	O
.	O

Homodimers	O
of	O
RIP60	B
(	O
replication	B
initiation	I
-	I
region	I
protein	I
60	I
kDA	I
)	O
purified	O
from	O
nuclear	O
extract	O
bind	O
two	O
ATT	O
-	O
rich	O
sites	O
in	O
oribeta	O
and	O
foster	O
the	O
formation	O
of	O
a	O
twisted	O
720	O
bp	O
DNA	O
loop	O
in	O
vitro	O
.	O

Effect	O
of	O
age	O
on	O
glucose	O
,	O
reducing	O
sugars	O
and	O
plasma	B
insulin	I
in	O
blood	O
of	O
milk	O
-	O
fed	O
calves	O
.	O

Principal	O
component	O
analysis	O
using	O
psychosocial	O
factors	O
in	O
women	O
showed	O
two	O
psychosocial	O
structures	O
,	O
i.e.	O
the	O
second	O
principal	O
(	O
high	O
SOC	O
,	O
high	O
lifestyle	O
,	O
and	O
low	O
stress	O
)	O
and	O
the	O
4th	O
principal	O
components	O
(	O
high	O
supernatural	O
HLC	O
,	O
and	O
high	O
PHLC	O
)	O
.	O

Availability	O
of	O
a	O
less	O
palatable	O
diet	O
(	O
chow	O
)	O
following	O
presentation	O
of	O
palatable	O
diets	O
will	O
not	O
result	O
in	O
diminished	O
caloric	O
intake	O
,	O
body	O
weight	O
,	O
obesity	O
and	O
hyperinsulinemia	O
.	O

Type	O
II	O
neuroleptanalgesia	O
in	O
odonto	O
-	O
stomatology	O

In	O
addition	O
,	O
there	O
was	O
an	O
increase	O
in	O
the	O
amount	O
of	O
p120	B
Ras	I
-	O
specific	O
GTPase	B
-	I
activating	I
protein	I
(	O
GAP	B
)	O
and	O
GAP	B
-	O
associated	O
p190	O
.	O

Jornvall	O
,	O
B.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Three	O
modern	O
hematology	O
analyzers	O
(	O
Abbott	O
Cell	O
-	O
Dyn	O
3000	O
,	O
Coulter	O
STKS	O
,	O
and	O
Sysmex	O
NE-8000	O
)	O
with	O
high	O
throughput	O
and	O
5-part	O
differential	O
capability	O
were	O
evaluated	O
using	O
a	O
protocol	O
designed	O
by	O
a	O
quality	O
team	O
.	O

Effect	O
of	O
prostaglandin	O
E2	O
on	O
experimental	O
atherosclerosis	O
.	O

The	O
tro	B
operon	I
is	O
flanked	O
by	O
a	O
Holliday	B
structure	I
DNA	I
helicase	I
homolog	O
(	O
upstream	O
)	O
and	O
two	O
ORFs	O
representing	O
a	O
purine	B
nucleoside	I
phosphorylase	I
homolog	O
and	O
tpp15	B
,	O
a	O
previously	O
characterized	O
gene	O
encoding	O
a	O
membrane	O
lipoprotein	O
(	O
downstream	O
)	O
.	O

However	O
,	O
a	O
few	O
sites	O
in	O
the	O
genomes	O
of	O
EC	O
cells	O
permit	O
M	B
-	I
MuLVneo	I
delta	I
Enh	I
proviral	O
expression	O
.	O

We	O
have	O
been	O
developing	O
a	O
digital	O
fluoroscopic	O
imaging	O
system	O
to	O
replace	O
the	O
portal	O
films	O
that	O
are	O
currently	O
used	O
to	O
verify	O
patient	O
positioning	O
during	O
radiotherapy	O
treatments	O
.	O

Interestingly	O
,	O
unlike	O
PAK65	B
,	O
HPK1	B
does	O
not	O
contain	O
the	O
small	B
GTPase	I
Rac1	B
/	O
Cdc42-binding	B
domain	O
and	O
does	O
not	O
bind	O
to	O
either	O
Rac1	B
or	O
Cdc42	B
,	O
suggesting	O
that	O
HPK1	B
.	O

activation	O
is	O
Rac1	B
/	O
Cdc42-independent	B
.	O

Transformations	O
with	O
circular	O
plasmids	O
yielded	O
slowly	O
and	O
irregularly	O
growing	O
geneticin	O
-	O
resistant	O
mycelia	O
in	O
which	O
1	O
%	O
of	O
nuclei	O
contained	O
plasmid	O
sequences	O
.	O

Using	O
a	O
combined	O
pharmacokinetic	O
-	O
pharmacodynamic	O
model	O
,	O
the	O
impact	O
of	O
various	O
factors	O
on	O
the	O
effective	O
bioavailability	O
and	O
on	O
its	O
estimation	O
,	O
using	O
the	O
intravenous	O
-	O
to	O
-	O
oral	O
dose	O
ratio	O
required	O
to	O
produce	O
the	O
same	O
area	O
under	O
the	O
response	O
time	O
curve	O
after	O
acute	O
administration	O
,	O
are	O
explored	O
.	O

We	O
found	O
that	O
in	O
anesthetized	O
,	O
paralyzed	O
cats	O
,	O
the	O
visual	O
evoked	O
potential	O
(	O
VEP	O
)	O
was	O
dependent	O
only	O
on	O
magnitude	O
of	O
delta	O
C	O
at	O
each	O
pattern	O
transition	O
,	O
and	O
was	O
independent	O
of	O
the	O
starting	O
or	O
ending	O
contrast	O
level	O
.	O

Plasmid	O
pSP64E6E7	O
which	O
contains	O
the	O
reading	O
frames	O
of	O
both	O
E6	B
and	O
E7	B
was	O
constructed	O
in	O
order	O
to	O
study	O
the	O
expression	O
of	O
both	O
proteins	O
in	O
a	O
coupled	O
transcription	O
/	O
rabbit	O
reticulocyte	O
translation	O
system	O
.	O

In	O
addition	O
,	O
FOP	B
-	O
FGFR1-expressing	B
cells	O
show	O
constitutive	O
phosphorylation	O
of	O
the	O
positive	O
regulator	O
of	O
translation	O
p70S6	B
kinase	I
;	O
this	O
phosphorylation	O
is	O
inhibited	O
by	O
PI3-kinase	B
and	O
mTOR	B
(	O
mammalian	B
target	I
of	I
rapamycin	I
)	O
inhibitors	O
.	O

As	O
a	O
test	O
of	O
this	O
hypothesis	O
,	O
we	O
predicted	O
that	O
mice	O
which	O
have	O
altered	O
expression	O
of	O
class	O
I	O
gene	O
products	O
,	O
the	O
beta2-microglobulin	B
knockout	O
mice	O
,	O
[	B
beta2m	I
(	I
-	I
/	I
-	I
)	I
]	I
,	O
would	O
develop	O
Fe	O
overload	O
.	O

The	O
synthesis	O
of	O
endo	O
-	O
adduct	O
[	O
4aS,5S,8R,8aR	O
,	O
SS	O
]	O
-9d	O
resulting	O
from	O
cycloaddition	O
on	O
the	O
substituted	O
C	O
(	O
2	O
)	O
-C	O
(	O
3	O
)	O
double	O
bond	O
was	O
achieved	O
in	O
a	O
chemo-	O
and	O
diastereoselective	O
way	O
from	O
quinone	O
1d	O
in	O
the	O
presence	O
of	O
ZnBr	O
(	O
2	O
)	O
.	O

Mad3	B
and	O
Mad4	B
:	O
novel	O
Max	B
-	O
interacting	O
transcriptional	O
repressors	O
that	O
suppress	O
c	B
-	I
myc	I
dependent	O
transformation	O
and	O
are	O
expressed	O
during	O
neural	O
and	O
epidermal	O
differentiation	O
.	O

This	O
polypeptide	O
includes	O
the	O
first	O
three	O
zinc	O
fingers	O
of	O
the	O
TFIIIA	B
DNA	I
binding	I
domain	I
.	O

Transcription	O
of	O
eukaryotic	O
tRNA	O
genes	O
is	O
dependent	O
on	O
the	O
A-	O
and	O
B	O
-	O
Box	O
internal	O
control	O
regions	O
(	O
ICRs	O
)	O
and	O
the	O
upstream	O
transcription	O
modulatory	O
region	O
.	O

This	O
dose	O
of	O
Na3	O
citrate	O
produced	O
no	O
clinical	O
symptoms	O
suggestive	O
of	O
hypocalcaemia	O
in	O
these	O
subjects	O
,	O
even	O
though	O
the	O
use	O
of	O
acid	O
-	O
citrate	O
-	O
dextrose	O
,	O
NIH	O
formula	O
A	O
(	O
ACD	O
-	O
A	O
)	O
under	O
identical	O
conditions	O
has	O
been	O
reported	O
to	O
reduce	O
significantly	O
the	O
level	O
of	O
total	O
calcium	O
in	O
serum	O
,	O
and	O
concomitantly	O
increase	O
the	O
number	O
or	O
reactions	O
occurring	O
in	O
donors	O
.	O

A	O
multivariant	O
study	O
of	O
pituitary	O
adenoma	O
,	O
obtainment	O
of	O
two	O
logistic	O
regression	O
equations	O
as	O
an	O
auxiliary	O
support	O
in	O
the	O
diagnosis	O
of	O
these	O
tumors	O
.	O

APL	O
patients	O
showed	O
a	O
low	O
,	O
yet	O
variable	O
,	O
level	O
of	O
JEM-1	B
mRNA	I
in	O
bone	O
marrow	O
.	O

The	O
cDNA	O
clones	O
encode	O
a	O
polypeptide	O
of	O
657	O
amino	O
acids	O
with	O
a	O
bHLH	O
(	O
basic	O
-	O
helix	O
-	O
loop	O
-	O
helix	O
)	O
domain	O
,	O
characteristic	O
of	O
a	O
large	O
family	O
of	O
transcription	O
factors	O
,	O
and	O
a	O
PAS	B
(	O
Per	B
-	O
Arnt	B
-	O
Sim	B
)	O
domain	O
in	O
the	O
amino	O
-	O
terminal	O
half	O
region	O
.	O

Nedocromil	O
sodium	O
shifted	O
the	O
severity	O
of	O
the	O
early	O
allergic	O
reaction	O
(	O
EAR	O
)	O
from	O
mean	O
-34.8	O
%	O
to	O
-6.9	O
%	O
and	O
inhibited	O
the	O
later	O
allergic	O
reaction	O
(	O
LAR	O
)	O
from	O
-30.5	O
%	O
to	O
+	O
0.4	O
%	O
(	O
p	O
less	O
than	O
0.005	O
)	O
.	O

Values	O
of	O
K1	O
and	O
Vd	O
were	O
significantly	O
increased	O
in	O
the	O
tumour	O
tissue	O
.	O

The	O
binding	O
of	O
PTB	B
was	O
antagonistic	O
to	O
the	O
binding	O
of	O
U2AF	B
to	O
the	O
enhancer	O
-	O
located	O
pyrimidine	O
tract	O
.	O

Similar	O
tissue	O
-	O
specific	O
patterns	O
are	O
observed	O
with	O
a	O
fusion	O
between	O
the	O
caufliflower	B
mosaic	I
virus	I
35S	I
RNA	I
promotor	I
and	O
the	O
GUS	B
gene	I
.	O

The	O
results	O
obtained	O
show	O
that	O
expression	O
of	O
the	O
gene	O
is	O
low	O
at	O
23	O
degrees	O
C	O
and	O
is	O
induced	O
rapidly	O
at	O
37	O
degrees	O
C.	O

The	O
effects	O
on	O
survival	O
of	O
adjuvant	O
treatments	O
,	O
including	O
pre-	O
or	O
postoperative	O
systemic	O
or	O
postoperative	O
intra	O
-	O
arterial	O
chemotherapy	O
,	O
are	O
currently	O
under	O
evaluation	O
.	O

Malformations	O
of	O
the	O
regenerating	O
optic	O
tectum	O
of	O
larvae	O
of	O
the	O
Egyptian	O
toad	O
,	O
Bufo	O
regularis	O
Reuss	O
.	O

To	O
be	O
a	O
nurse	O
.	O

Chronic	O
granulocytic	O
leukemia	O
in	O
children	O
.	O

Charcot	O
joints	O
.	O

Recombinant	B
apoA	I
-	I
I	I
protein	I
recovered	O
from	O
the	O
soluble	O
fraction	O
of	O
the	O
bacterial	O
cell	O
pellet	O
was	O
purified	O
to	O
greater	O
than	O
95	O
%	O
homogeneity	O
by	O
reversed	O
-	O
phase	O
high	O
-	O
performance	O
liquid	O
chromatography	O
.	O

Kaposi	O
's	O
sarcoma	O
-	O
associated	O
herpesvirus	O
/	O
human	O
herpesvirus-8	O
ORF50	B
gene	O
product	O
contains	O
a	O
potent	O
C	O
-	O
terminal	O
activation	O
domain	O
which	O
activates	O
gene	O
expression	O
via	O
a	O
specific	O
target	O
sequence	O
.	O

Competition	O
and	O
methylation	O
interference	O
assays	O
showed	O
that	O
the	O
binding	O
site	O
for	O
the	O
novel	O
factor	O
was	O
limited	O
to	O
nucleotides	O
in	O
the	O
3	O
'	O
half	O
of	O
the	O
kappa	B
B	I
site	I
.	O

Both	O
proteins	O
share	O
sequence	O
similarity	O
with	O
the	O
myelin	B
-	I
associated	I
glycoprotein	I
,	O
an	O
adhesion	O
molecule	O
of	O
oligodendrocytes	O
and	O
Schwann	O
cells	O
that	O
has	O
been	O
implicated	O
in	O
the	O
process	O
of	O
myelination	O
,	O
raising	O
the	O
important	O
question	O
of	O
whether	O
myelin	B
-	I
associated	I
glycoprotein	I
is	O
also	O
a	O
sialic	B
acid	I
-	I
binding	I
protein	I
.	O

By	O
24	O
h	O
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
FFA	O
levels	O
from	O
shams	O
.	O

As	O
much	O
thrombin	B
was	O
formed	O
during	O
cardiopulmonary	O
bypass	O
(	O
measured	O
by	O
the	O
prothrombin	B
activation	I
fragment	I
F1	I
+	I
2	I
and	O
thrombin	B
-	O
antithrombin	B
complexes	O
)	O
as	O
in	O
normal	O
patients	O
,	O
showing	O
that	O
factor	B
XII	I
was	O
not	O
necessary	O
for	O
thrombin	B
generation	O
.	O

The	O
phosphatase	O
active	O
site	O
is	O
located	O
within	O
residues	O
367	O
-	O
374	O
.	O

Moreover	O
,	O
antibody	O
binding	O
to	O
the	O
same	O
two	O
determinants	O
was	O
also	O
inhibited	O
when	O
ZAP-70	B
or	O
the	O
SH2	B
domains	I
bound	O
to	O
the	O
zeta	O
chain	O
or	O
to	O
a	O
2pY	B
-	I
ITAM	I
.	O

These	O
extrachromosomal	O
copies	O
can	O
be	O
isolated	O
as	O
covalently	O
closed	O
molecules	O
with	O
lengths	O
around	O
3mu	O
.	O

After	O
multivariate	O
analysis	O
,	O
TWA	O
correlated	O
with	O
age	O
(	O
P	O
=	O
0.02	O
)	O
and	O
LV	O
function	O
(	O
P	O
=	O
0.002	O
)	O
and	O
occurred	O
more	O
often	O
in	O
patients	O
after	O
nonanterior	O
MI	O
(	O
P	O
=	O
0.03	O
)	O
.	O

This	O
cDNA	O
corresponded	O
to	O
FGF	B
-	I
binding	I
protein	I
(	O
FGF	B
-	I
BP	I
)	O
,	O
a	O
secreted	O
protein	O
previously	O
shown	O
to	O
bind	O
acidic	O
and	O
basic	B
FGF	I
and	O
to	O
modulate	O
their	O
activities	O
.	O

Electrophoretic	O
mobility	O
-	O
shift	O
assays	O
using	O
oligonucleotides	O
derived	O
from	O
these	O
sites	O
demonstrated	O
formation	O
of	O
specific	O
DNA	O
-	O
protein	O
complexes	O
.	O

For	O
the	O
P	B
transcript	I
from	O
phage	O
with	O
the	O
G	O
(	O
-	O
)	O
orientation	O
,	O
full	O
termination	O
activity	O
required	O
both	O
the	O
region	O
containing	O
the	O
stem	O
-	O
loop	O
structure	O
and	O
upstream	O
sequences	O
.	O

One	O
day	O
after	O
injection	O
48	O
%	O
of	O
the	O
injected	O
activity	O
was	O
in	O
the	O
skeleton	O
,	O
9.3	O
%	O
in	O
the	O
liver	O
,	O
3	O
%	O
in	O
the	O
kidneys	O
and	O
4.4	O
%	O
in	O
the	O
rest	O
of	O
the	O
organs	O
.	O

Of	O
these	O
four	O
PP2C	B
genes	I
,	O
the	O
expression	O
of	O
the	O
PP2Cbeta	B
gene	I
has	O
been	O
reported	O
to	O
be	O
tissue	O
-	O
specific	O
and	O
development	O
-	O
dependent	O
.	O

Combined	O
chemotherapy	O
with	O
VM	O
26	O
and	O
BCNU	O
for	O
recurrent	O
malignant	O
gliomas	O
after	O
operation	O
and	O
irradiation	O
.	O

Administration	O
of	O
FR	O
34235	O
reduced	O
aortic	O
blood	O
pressure	O
and	O
increased	O
cardiac	O
output	O
in	O
anesthetized	O
dogs	O
with	O
an	O
ameroid	O
-	O
induced	O
coronary	O
artery	O
occlusion	O
.	O

Alternative	O
immune	B
globulin	I
preparation	O
when	O
standard	O
immune	B
serum	I
globulin	I
is	O
not	O
available	O
.	O

Two	O
sibs	O
with	O
identical	O
features	O
of	O
short	O
-	O
limbed	O
dwarfism	O
,	O
a	O
normal	O
skull	O
and	O
face	O
and	O
normal	O
intelligence	O
are	O
described	O
.	O

Effect	O
of	O
a	O
high	O
sugar	O
intake	O
on	O
some	O
metabolic	O
and	O
regulatory	O
indicators	O
in	O
young	O
men	O
.	O

Expression	O
of	O
putative	O
constitutively	O
active	O
forms	O
of	O
DdMEK1	B
in	O
a	O
ddmek1	B
null	O
background	O
is	O
capable	O
,	O
at	O
least	O
partially	O
,	O
of	O
complementing	O
the	O
small	O
aggregate	O
size	O
defect	O
and	O
the	O
ability	O
to	O
activate	O
guanylyl	B
cyclase	I
.	O

Five	O
girls	O
with	O
Turner	O
's	O
syndrome	O
aged	O
12	O
to	O
17	O
years	O
showed	O
LH	B
values	O
(	O
5.0	O
-	O
14.5	O
IU	O
/	O
12	O
h	O
)	O
at	O
the	O
upper	O
end	O
of	O
or	O
slightly	O
above	O
the	O
normal	O
range	O
and	O
pathologically	O
high	O
values	O
(	O
22.2	O
-	O
43.5	O
IU	O
/	O
12	O
h	O
)	O
for	O
FSH	B
.	O

Thirty	O
-	O
seven	O
patients	O
with	O
severe	O
temporal	O
lobe	O
epilepsy	O
were	O
studied	O
interictally	O
with	O
[	O
18F	O
]	O
fluorodeoxyglucose	O
-	O
PET	O
in	O
each	O
of	O
three	O
conditions	O
:	O
resting	O
,	O
during	O
emotional	O
speech	O
,	O
and	O
while	O
performing	O
a	O
visual	O
recognition	O
task	O
.	O

The	O
sequence	O
of	O
Vac1p	B
contains	O
two	O
putative	O
zinc	O
-	O
binding	O
RING	O
motifs	O
,	O
a	O
zinc	O
finger	O
motif	O
,	O
and	O
a	O
coiled	O
-	O
coil	O
motif	O
.	O

The	O
immune	O
response	O
seems	O
to	O
be	O
partially	O
responsible	O
for	O
both	O
protection	O
and	O
the	O
destructive	O
consequences	O
of	O
chlamydial	O
infection	O
.	O

Activated	O
FGFR3	B
predominantly	O
interacts	O
with	O
GRB2.Sos	B
in	O
complex	O
with	O
a	O
previously	O
identified	O
90-kDa	O
protein	O
and	O
designated	O
protein	B
80K	I
-	I
H.	I

It	O
was	O
predicted	O
that	O
the	O
Stroop	O
task	O
would	O
trigger	O
greater	O
consumption	O
of	O
ice	O
cream	O
than	O
a	O
fearful	O
film	O
,	O
and	O
that	O
this	O
effect	O
would	O
be	O
more	O
pronounced	O
for	O
binge	O
-	O
eaters	O
than	O
non	O
-	O
binge	O
-	O
eaters	O
.	O

Plasma	B
colony	I
-	I
stimulating	I
factor	I
analysis	O
and	O
the	O
clinical	O
significance	O

We	O
identified	O
two	O
potential	O
phosphorylation	O
sites	O
at	O
serine49	O
and	O
serine133	O
,	O
both	O
of	O
which	O
seem	O
to	O
be	O
necessary	O
for	O
Myf-5	B
activity	O
.	O

Exposure	O
of	O
raft	O
cultures	O
to	O
activators	O
of	O
protein	B
kinase	I
C	I
,	O
such	O
as	O
phorbol	O
esters	O
,	O
results	O
in	O
the	O
further	O
induction	O
of	O
late	B
gene	I
expression	O
as	O
well	O
as	O
virion	O
assembly	O
.	O

Behavioral	O
effects	O
of	O
benzodiazepine	O
ligands	O
in	O
non	O
-	O
dependent	O
,	O
diazepam	O
-	O
dependent	O
and	O
diazepam	O
-	O
withdrawn	O
baboons	O
.	O

Gastrointestinal	O
accumulation	O
of	O
indium-111	O
labelled	O
granulocytes	O
in	O
reactive	O
arthritis	O
.	O

TNF	B
-	I
alpha	I
stimulated	O
these	O
changes	O
in	O
part	O
by	O
increasing	O
transcription	O
and	O
stabilization	O
of	O
RNA	O
for	O
amphiregulin	B
,	O
an	O
EGF	B
receptor	I
ligand	O
,	O
and	O
amphiregulin	B
directly	O
increased	O
HPV-16	O
E6	B
/	O
E7	B
and	O
cyclin	B
A	I
RNAs	I
.	O

Biochemical	O
analyses	O
revealed	O
that	O
the	O
concentration	O
of	O
norepinephrine	O
was	O
reduced	O
significantly	O
in	O
cortex	O
-	O
hippocampus	O
and	O
olfactory	O
bulb	O
but	O
not	O
in	O
other	O
regions	O
,	O
while	O
dopamine	O
and	O
serotonin	O
levels	O
were	O
not	O
altered	O
in	O
any	O
brain	O
region	O
examined	O
.	O

A	O
mouth	O
asymmetry	O
study	O
.	O

Transformation	O
of	O
chicken	O
embryo	O
fibroblasts	O
(	O
CEF	O
)	O
with	O
the	O
Gag	B
-	O
Crk	B
fusion	O
protein	O
results	O
in	O
the	O
elevation	O
of	O
tyrosine	O
phosphorylation	O
on	O
specific	O
cellular	O
proteins	O
with	O
molecular	O
weights	O
of	O
130,000	O
,	O
110,000	O
,	O
and	O
70,000	O
(	O
p130	B
,	O
p110	B
,	O
and	O
p70	B
,	O
respectively	O
)	O
,	O
an	O
event	O
which	O
has	O
been	O
correlated	O
with	O
cell	O
transformation	O
.	O

Tilisolol	O
and	O
carboxymethylcellulose	O
sodium	O
salt	O
(	O
CMC	O
)	O
were	O
used	O
as	O
the	O
model	O
ophthalmic	O
drug	O
and	O
viscous	O
polymer	O
,	O
respectively	O
.	O

Fetal	O
transplants	O
rescue	O
axial	O
muscle	O
representations	O
in	O
M1	O
cortex	O
of	O
neonatally	O
transected	O
rats	O
that	O
develop	O
weight	O
support	O
.	O

However	O
,	O
to	O
encourage	O
good	O
contact	O
between	O
the	O
farmers	O
and	O
the	O
inseminating	O
personnel	O
,	O
it	O
is	O
beneficial	O
that	O
herdsmen	O
are	O
present	O
when	O
cows	O
are	O
inseminated	O
.	O

It	O
is	O
recommended	O
that	O
area	O
correction	O
be	O
attempted	O
in	O
bioequivalence	O
studies	O
of	O
drugs	O
where	O
high	O
intrasubject	O
variability	O
in	O
clearance	O
is	O
known	O
or	O
suspected	O
.	O

A	O
method	O
for	O
determining	O
the	O
toxicity	O
of	O
neutralizers	O
for	O
antimicrobial	O
agents	O
to	O
A.	O
castellanii	O
was	O
also	O
evaluated	O
.	O

In	O
the	O
present	O
study	O
we	O
use	O
a	O
tnaC	B
-	O
UGA-'lacZ	O
construct	O
lacking	O
the	O
tnaC	B
-	O
tnaA	B
spacer	O
region	O
to	O
analyze	O
the	O
effect	O
of	O
TnaC	B
synthesis	O
on	O
the	O
behavior	O
of	O
the	O
ribosome	O
that	O
translates	O
tnaC.	B

Promoter	O
region	O
of	O
the	O
human	B
alpha	I
2A	I
adrenergic	I
receptor	I
gene	I
.	O

Schottky	O
-	O
barrier	O
heights	O
of	O
Ti	O
and	O
TiSi2	O
on	O
n	O
-	O
type	O
and	O
p	O
-	O
type	O
Si	O
(	O
100	O
)	O
.	O

The	O
majority	O
of	O
the	O
human	B
Ig	I
heavy	I
chain	I
(	I
IgH	I
)	I
constant	I
(	I
C	I
)	I
region	I
locus	I
has	O
been	O
cloned	O
and	O
mapped	O
.	O

On	O
guanidine	O
and	O
the	O
treatment	O
of	O
botulism	O
.	O

Most	O
of	O
these	O
elements	O
are	O
adjacent	O
to	O
type	O
X	O
telomeric	O
repeats	O
,	O
and	O
regions	O
flanking	O
four	O
of	O
five	O
characterized	O
S.	O
paradoxus	O
insertions	O
carry	O
autonomously	O
replicating	O
sequences	O
.	O

Mutational	O
analysis	O
of	O
the	O
putative	O
effector	O
domain	O
of	O
the	O
GTP	B
-	I
binding	I
Ypt1	I
protein	I
in	O
yeast	O
suggests	O
specific	O
regulation	O
by	O
a	O
novel	O
GAP	B
activity	O
.	O

From	O
the	O
present	O
results	O
a	O
concept	O
of	O
hormone	O
-	O
dependent	O
AR	B
activation	O
is	O
proposed	O
,	O
which	O
requires	O
a	O
functional	O
,	O
direct	O
or	O
indirect	O
intramolecular	O
interaction	O
between	O
the	O
TAD	O
and	O
the	O
LBD	O
.	O

All	O
patients	O
were	O
peritonitis	O
-	O
free	O
at	O
least	O
6	O
weeks	O
before	O
each	O
PET	O
.	O

After	O
control	O
for	O
body	O
mass	O
index	O
,	O
trait	O
anxiety	O
and	O
anger	O
-	O
in	O
remained	O
independent	O
predictors	O
of	O
diastolic	O
blood	O
pressure	O
among	O
the	O
women	O
.	O

The	O
predicted	O
vav	B
oncogene	I
protein	I
sequence	I
exhibits	O
several	O
motifs	O
reminiscent	O
of	O
transcriptional	O
factors	O
.	O

The	O
platelet	B
membrane	I
glycoprotein	I
IIb	I
/	I
IIIa	I
receptor	I
inhibitor	O
abciximab	O
is	O
used	O
for	O
the	O
treatment	O
of	O
patients	O
undergoing	O
high	O
-	O
risk	O
percutaneous	O
coronary	O
interventions	O
and	O
is	O
used	O
in	O
approximately	O
one	O
third	O
of	O
coronary	O
interventions	O
in	O
the	O
United	O
States	O
and	O
a	O
growing	O
number	O
of	O
procedures	O
in	O
Europe	O
.	O

The	O
mean	O
times	O
to	O
LNR	O
in	O
these	O
groups	O
were	O
42.0	O
months	O
(	O
range	O
,	O
3.0	O
-	O
194.5	O
months	O
)	O
and	O
49.0	O
months	O
(	O
range	O
,	O
3.6	O
-	O
209.0	O
months	O
)	O
respectively	O
.	O

The	O
cells	O
were	O
densely	O
ciliated	O
,	O
each	O
cilium	O
showing	O
a	O
typical	O
9	O
+	O
2	O
fibrilar	O
pattern	O
.	O

Searching	O
the	O
human	O
DNA	O
data	O
base	O
of	O
expressed	O
sequence	O
tags	O
(	O
EST	O
)	O
revealed	O
novel	O
partial	O
sequences	O
similar	O
to	O
,	O
but	O
distinct	O
from	O
,	O
the	O
sequences	O
of	O
the	O
previously	O
known	O
PEF	B
proteins	I
.	O

RXRalpha	B
/	O
RARalpha	B
heterodimers	O
and	O
HNF-4	B
homodimers	I
bind	O
to	O
DR-1	O
motifs	O
on	O
elements	O
B	O
and	O
I4	O
,	O
respectively	O
.	O

Adenomas	O
in	O
the	O
upper	O
gastrointestinal	O
tract	O
were	O
found	O
in	O
all	O
of	O
the	O
patients	O
:	O
Vater	O
's	O
papilla--12	O
,	O
duodenum	O
--	O
nine	O
,	O
and	O
gastric	O
antrum	O
--	O
seven	O
.	O

A	O
new	O
direct	O
hemagglutination	O
test	O
(	O
HI	O
-	O
GONAVIS	O
)	O
for	O
urinary	O
LH	B
was	O
compared	O
with	O
the	O
serum	O
radioimmuno	O
-	O
assay	O
of	O
LH	B
.	O

They	O
also	O
show	O
that	O
M.	O
malmoense	O
can	O
be	O
isolated	O
from	O
the	O
environment	O
which	O
may	O
be	O
the	O
source	O
of	O
the	O
infection	O
.	O

Binding	O
of	O
the	O
TorR	B
regulator	I
to	O
cis	O
-	O
acting	O
direct	O
repeats	O
activates	O
tor	B
operon	I
expression	O
.	O

Histological	O
and	O
immunophenotypic	O
studies	O
revealed	O
12	O
large	O
cell	O
lymphomas	O
(	O
11	O
B	O
cell	O
and	O
one	O
T	O
cell	O
)	O
,	O
two	O
small	O
noncleaved	O
cell	O
lymphomas	O
(	O
B	O
-	O
cell	O
phenotype	O
)	O
,	O
and	O
five	O
low	O
grade	O
B	O
-	O
cell	O
lymphomas	O
(	O
two	O
small	O
lymphocytic	O
and	O
three	O
follicular	O
mixed	O
lymphomas	O
)	O
.	O

An	O
emended	O
diagnosis	O
of	O
Tylocephalum	O
is	O
proposed	O
excluding	O
this	O
feature	O
,	O
along	O
with	O
distribution	O
of	O
the	O
testes	O
in	O
the	O
preovarian	O
field	O
and	O
circummedullary	O
distribution	O
of	O
vitelline	O
follicles	O
.	O

Role	O
of	O
double	B
-	I
stranded	I
RNA	I
-	I
dependent	I
protein	I
kinase	I
in	O
mediating	O
hypersensitivity	O
of	O
Fanconi	O
anemia	O
complementation	O
group	O
C	O
cells	O
to	O
interferon	B
gamma	I
,	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
,	O
and	O
double	O
-	O
stranded	O
RNA	O
.	O

Different	O
effects	O
of	O
reoxygenation	O
on	O
the	O
electrical	O
activity	O
of	O
ventricular	O
muscle	O
.	O

Similar	O
observations	O
were	O
obtained	O
when	O
these	O
mutated	O
versions	O
of	O
site	O
A	O
were	O
evaluated	O
by	O
transient	O
cotransfection	O
assays	O
in	O
CV1	O
cells	O
.	O

YLL031c	B
is	O
an	O
essential	O
gene	O
.	O

Further	O
,	O
cells	O
cotransfected	O
with	O
a	O
UF	B
promoter	I
-	O
luciferase	B
(	O
-1935UF	O
-	O
Luc	B
)	O
reporter	O
gene	O
and	O
the	O
BTEB	B
expression	O
vector	O
had	O
2-fold	O
higher	O
Luc	B
activity	O
than	O
those	O
cotransfected	O
with	O
reporter	O
gene	O
and	O
pcDNA-3	O
.	O

Although	O
IRS-1	B
,	I
-2	I
,	I
and	I
-4	I
are	O
similar	O
in	O
overall	O
structure	O
,	O
IRS-3	B
is	O
approximately	O
50	O
%	O
shorter	O
and	O
differs	O
with	O
respect	O
to	O
sites	O
of	O
tyrosine	O
phosphorylation	O
.	O

These	O
results	O
demonstrate	O
a	O
specific	O
association	O
of	O
SIV	O
and	O
HIV-2	B
nef	I
,	O
but	O
not	O
HIV-1	B
nef	I
,	O
with	O
TCRzeta	B
.	O

Rac2	B
,	O
a	O
member	O
of	O
the	O
Rho	B
family	I
of	O
GTPases	B
,	O
is	O
highly	O
expressed	O
in	O
myeloid	O
cells	O
and	O
is	O
a	O
regulator	O
of	O
the	O
NADPH	B
-	I
oxidase	I
complex	I
.	O

The	O
best	O
sequences	O
for	O
pelvic	O
study	O
are	O
,	O
in	O
our	O
experience	O
,	O
IR	O
or	O
short	O
TR	O
spin	O
-	O
echo	O
for	O
T1-weighted	O
images	O
,	O
and	O
spin	O
-	O
echo	O
with	O
1200	O
TR	O
for	O
T2	O
images	O
.	O

We	O
now	O
report	O
that	O
both	O
HSCR	B
mutations	O
impair	O
the	O
fixation	O
of	O
Shc	B
to	O
RET	B
and	O
consequently	O
prevent	O
its	O
phosphorylation	O
.	O

We	O
now	O
describe	O
a	O
HepG2	B
cell	I
casein	I
kinase	I
II	I
beta	I
subunit	I
cDNA	I
of	O
2.57	O
kb	O
containing	O
96	O
bases	O
of	O
5	O
'	O
untranslated	O
sequence	O
,	O
645	O
bases	O
of	O
open	O
reading	O
frame	O
,	O
and	O
1832	O
bases	O
of	O
3	O
'	O
untranslated	O
sequence	O
with	O
two	O
polyadenylation	O
consensus	O
signal	O
sequences	O
and	O
two	O
poly	O
(	O
A	O
)	O
stretches	O
.	O

Platelet	B
factor	I
4	I
levels	O
in	O
patients	O
with	O
coronary	O
artery	O
disease	O
.	O

Serum	O
pituitary	O
and	O
steroid	O
hormone	O
levels	O
in	O
the	O
adult	O
male	O
:	O
one	O
value	O
is	O
as	O
good	O
as	O
the	O
mean	O
of	O
three	O
.	O

However	O
,	O
a	O
lesser	O
extent	O
effect	O
was	O
noticed	O
in	O
nonpregnant	O
than	O
seen	O
in	O
pregnant	O
rats	O
.	O

Despite	O
their	O
high	O
degree	O
of	O
sequence	O
similarity	O
,	O
all	O
five	O
RFC	B
genes	I
are	O
essential	O
for	O
cell	O
proliferation	O
in	O
S.	O
cerevisiae	O
.	O

The	O
strongly	O
DNA	O
binding	O
p50	B
subunit	I
showed	O
only	O
very	O
weak	O
,	O
if	O
any	O
,	O
induction	O
of	O
gene	O
expression	O
.	O

Stability	O
of	O
125	O
I	O
-	O
labeled	O
insulin	B
used	O
in	O
radioimmunoassay	O
of	O
insulin	B
.	O

Influence	O
of	O
long	O
-	O
term	O
zimelidine	O
treatment	O
on	O
LSD	O
-	O
induced	O
behavioural	O
effects	O
.	O

Using	O
mammalian	O
expression	O
vectors	O
(	O
pRSV	O
-	O
neo	O
and	O
pSV2-neo	O
)	O
,	O
antisense	O
constructs	O
for	O
perforin	B
and	O
granzyme	B
B	I
were	O
independently	O
electroporated	O
into	O
YT	O
-	O
INDY	O
,	O
a	O
human	O
non	O
-	O
MHC	B
-	O
restricted	O
,	O
IL-2-independent	B
,	O
cytotoxic	O
lymphocyte	O
.	O

Like	O
Rev	B
-	O
Erb	B
,	O
BD73	B
binds	O
as	O
a	O
monomer	O
to	O
a	O
DNA	O
sequence	O
which	O
consists	O
of	O
a	O
specific	O
A	O
/	O
T	O
-	O
rich	O
sequence	O
upstream	O
of	O
the	O
consensus	O
hexameric	O
half	O
-	O
site	O
specified	O
by	O
the	O
P	O
box	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
.	O

BACKGROUND	O
:	O
Allergic	O
rhinoconjunctivitis	O
is	O
a	O
common	O
disorder	O
,	O
affecting	O
>	O
20	O
%	O
of	O
people	O
of	O
all	O
socioeconomic	O
strata	O
.	O

The	O
striking	O
similarity	O
in	O
preference	O
for	O
mismatched	O
and	O
weakly	O
paired	O
nucleotides	O
for	O
binding	O
and	O
for	O
excision	O
suggests	O
a	O
functional	O
relationship	O
between	O
binding	O
and	O
cleavage	O
reactions	O
.	O

New	O
results	O
of	O
importance	O
for	O
optimization	O
of	O
the	O
postoperative	O
course	O
]	O
Complications	O
after	O
major	O
surgery	O
may	O
be	O
related	O
to	O
factors	O
in	O
the	O
surgical	O
stress	O
response	O
with	O
endocrine	O
-	O
metabolic	O
and	O
inflammatory	O
changes	O
.	O

Immunoblotting	O
showed	O
that	O
both	O
the	O
(	O
1	O
-	O
404	O
)	O
-peptide	O
and	O
(	O
1	O
-	O
506	O
)	O
-peptide	O
are	O
recognized	O
by	O
95J10	B
,	O
a	O
monoclonal	O
antibody	O
that	O
was	O
previously	O
raised	O
against	O
perlecan-	B
(	I
24	I
-	I
404	I
)	I
-peptide	I
expressed	O
in	O
Escherichia	O
coli	O
.	O

Tumor	B
necrosis	I
factor	I
levels	O
were	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunoabsorbent	O
assay	O
in	O
plasma	O
samples	O
obtained	O
from	O
the	O
hyperthermic	O
isolated	O
limb	O
perfusion	O
circuit	O
and	O
systemic	O
circulation	O
.	O

The	O
activity	O
of	O
platelet	B
factor	I
4	I
in	O
plasma	O
of	O
healthy	O
and	O
high	O
risk	O
newborns	O
.	O

Studies	O
of	O
HS2-gamma	B
gene	I
reporter	I
constructs	I
carrying	O
CACCC	O
box	O
deletions	O
revealed	O
that	O
the	O
CACCC	O
box	O
sequence	O
of	O
the	O
gamma	O
gene	O
promoter	O
mediates	O
the	O
activation	O
of	O
the	O
gamma	O
gene	O
by	O
FKLF	B
.	O

In	O
addition	O
,	O
mrp17	B
-	I
1	I
,	O
in	O
combination	O
with	O
some	O
mutations	O
affecting	O
another	O
mitochondrial	O
ribosomal	O
protein	O
,	O
caused	O
a	O
synthetic	O
defective	O
phenotype	O
.	O

Characterization	O
of	O
human	B
activating	I
transcription	I
factor	I
4	I
,	O
a	O
transcriptional	O
activator	O
that	O
interacts	O
with	O
multiple	O
domains	O
of	O
cAMP	B
-	I
responsive	I
element	I
-	I
binding	I
protein	I
(	O
CREB	B
)	O
-binding	O
protein	O
.	O

The	O
Ixodes	O
fauna	O
in	O
the	O
Michourin	O
region	O
,	O
where	O
the	O
pastures	O
in	O
1971	O
were	O
grazed	O
only	O
by	O
sheep	O
,	O
shows	O
the	O
following	O
trends	O
:	O
H.	O
punctata	O
and	O
R.	O
turanicus	O
ticks	O
,	O
which	O
are	O
preferably	O
parasitising	O
in	O
sheep	O
,	O
increase	O
their	O
relative	O
share	O
.	O

The	O
contribution	O
of	O
residues	O
outside	O
the	O
Ras	B
binding	I
domain	I
of	O
Raf	B
(	O
RafRBD	B
)	O
to	O
Ras	B
-	O
Raf	B
interaction	O
and	O
Ras	B
-	O
dependent	O
Raf	B
activation	O
has	O
remained	O
unresolved	O
.	O

We	O
suggest	O
that	O
electrical	O
stimulation	O
of	O
the	O
NTS	O
in	O
rats	O
undergoing	O
such	O
surgical	O
preparation	O
to	O
observe	O
the	O
pressor	O
response	O
and/or	O
increase	O
in	O
pVP	O
,	O
represents	O
a	O
rapid	O
approach	O
for	O
screening	O
the	O
neurosecretory	O
function	O
of	O
the	O
central	O
neural	O
integration	O
to	O
release	O
vasopressin	B
.	O

CONCLUSION	O
/	O
INTERPRETATION	O
:	O
We	O
found	O
an	O
increased	O
risk	O
of	O
hip	O
fracture	O
in	O
women	O
younger	O
than	O
75	O
years	O
with	O
Type	O
I	O
diabetes	O
or	O
with	O
Type	O
II	O
diabetes	O
of	O
long	O
duration	O
.	O

They	O
represent	O
a	O
physiologically	O
more	O
meaningful	O
pattern	O
than	O
the	O
arithmetic	O
mean	O
with	O
standard	O
deviation	O
.	O

The	O
influence	O
of	O
gas	O
composition	O
in	O
the	O
air	O
cell	O
on	O
pipping	O
and	O
liver	O
metabolism	O
in	O
embryonic	O
chicks	O
.	O

In	O
conclusion	O
,	O
when	O
pulmonary	O
abnormalities	O
are	O
found	O
in	O
HTLV-1	O
carriers	O
,	O
we	O
should	O
be	O
careful	O
in	O
determining	O
whether	O
such	O
pulmonary	O
involvements	O
are	O
etiologically	O
related	O
to	O
HTLV-1	O
infection	O
.	O

Cross	O
-	O
species	O
characterization	O
of	O
the	O
promoter	B
region	I
of	I
the	I
cystic	I
fibrosis	I
transmembrane	I
conductance	I
regulator	I
gene	I
reveals	O
multiple	O
levels	O
of	O
regulation	O
.	O

We	O
have	O
isolated	O
a	O
unique	O
murine	B
FLT3	I
cDNA	I
that	O
codes	O
for	O
a	O
variant	O
isoform	O
of	O
FLT3	B
,	O
devoid	O
of	O
the	O
fifth	O
Ig	B
-	I
like	I
domain	I
,	O
by	O
comparison	O
with	O
the	O
prototypic	O
form	O
.	O

Thus	O
,	O
22	O
%	O
of	O
MDS	O
responded	O
to	O
oral	O
PLAC	O
.	O

The	O
Synechococcus	B
gene	I
rps1	I
encoding	O
S1	B
is	O
located	O
1.1	O
kb	O
downstream	O
from	O
psbB	B
,	O
which	O
encodes	O
the	O
photosystem	B
II	I
P680	I
chlorophyll	I
a	I
apoprotein	I
.	O

Additions	O
of	O
NH4	O
+	O
up	O
to	O
200	O
micrograms	O
1	O
(	O
-1	O
)	O
were	O
not	O
stimulatory	O
,	O
whereas	O
at	O
1.0	O
mg	O
1	O
(	O
-1	O
)	O
levels	O
,	O
Ke	O
was	O
50	O
%	O
greater	O
than	O
for	O
NO3-	O
enriched	O
medium	O
.	O

Pretreatment	O
with	O
lipid	O
X	O
was	O
not	O
necessary	O
to	O
improve	O
survival	O
:	O
16	O
of	O
17	O
(	O
94	O
%	O
)	O
infected	O
and	O
visibly	O
ill	O
animals	O
that	O
received	O
lipid	O
X	O
and	O
ticarcillin	O
6	O
h	O
after	O
thigh	O
inoculation	O
survived	O
versus	O
30	O
of	O
44	O
(	O
68	O
%	O
)	O
control	O
animals	O
treated	O
with	O
ticarcillin	O
alone	O
(	O
P	O
less	O
than	O
0.0001	O
)	O
.	O

Between	O
1988	O
and	O
1994	O
,	O
data	O
from	O
3	O
large	O
sites	O
revealed	O
a	O
3	O
-	O
5	O
fold	O
increase	O
in	O
the	O
prevalence	O
of	O
antidepressant	O
(	O
ATD	O
)	O
treatment	O
for	O
U.S.	O
youths	O
aged	O
2	O
-	O
19	O
years	O
.	O

4	O
.	O

RESULTS	O
:	O
Analysis	O
by	O
Pearson	O
's	O
correlation	O
showed	O
that	O
the	O
subjects	O
who	O
had	O
higher	O
scores	O
of	O
SSMS	O
during	O
the	O
drum	O
rotation	O
generated	O
the	O
following	O
:	O
a	O
)	O
a	O
higher	O
rating	O
of	O
over	O
-	O
all	O
sickness	O
(	O
r	O
=	O
0.76	O
)	O
;	O
b	O
)	O
a	O
higher	O
ratio	O
of	O
spectral	O
power	O
of	O
EGG	O
at	O
4	O
-	O
9	O
cycles	O
per	O
minute	O
(	O
cpm	O
)	O
between	O
drum	O
rotation	O
and	O
baseline	O
periods	O
(	O
r	O
=	O
0.63	O
)	O
;	O
c	O
)	O
a	O
higher	O
net	O
percent	O
increase	O
of	O
spectral	O
power	O
in	O
the	O
EEG	O
frequency	O
band	O
0.5	O
-	O
4	O
Hz	O
between	O
drum	O
rotation	O
and	O
baseline	O
periods	O
on	O
C3	O
(	O
r	O
=	O
0.29	O
)	O
and	O
C4	O
(	O
r	O
=	O
0.31	O
)	O
;	O
d	O
)	O
a	O
higher	O
ratio	O
of	O
spectral	O
power	O
of	O
EEG	O
frequency	O
band	O
0.5	O
-	O
4	O
Hz	O
between	O
drum	O
rotation	O
and	O
baseline	O
periods	O
on	O
C3	O
(	O
r	O
=	O
0.31	O
)	O
;	O
and	O
e	O
)	O
a	O
higher	O
level	O
of	O
net	O
increase	O
in	O
skin	O
conductance	O
from	O
baseline	O
to	O
drum	O
rotation	O
(	O
r	O
=	O
0.30	O
)	O
.	O

However	O
,	O
the	O
addition	O
of	O
intravenous	O
injection	O
of	O
FPFD	O
101	O
resulted	O
in	O
a	O
marked	O
improvement	O
in	O
their	O
symptoms	O
.	O

We	O
report	O
that	O
Gcn5	B
,	O
a	O
histone	B
H3	I
acetylase	I
,	O
plays	O
a	O
central	O
role	O
in	O
initiation	O
of	O
meiosis	O
via	O
effects	O
on	O
IME2	B
expression	O
.	O

The	O
amino	O
acid	O
residues	O
and	O
subdomains	O
important	O
for	O
DNA	O
binding	O
,	O
hormone	O
binding	O
,	O
dimerization	O
,	O
and	O
transactivation	O
are	O
mostly	O
conserved	O
among	O
all	O
VDR	B
species	O
.	O

Here	O
,	O
we	O
describe	O
the	O
nucleotide	O
(	O
nt	O
)	O
sequence	O
and	O
genomic	O
organization	O
of	O
ipiB	B
and	O
ipiO.	B

The	O
phosphatidylglycerol	B
/	I
phosphatidylinositol	I
transfer	I
protein	I
(	O
PG	B
/	I
PI	I
-	I
TP	I
)	O
is	O
a	O
new	O
and	O
original	O
phospholipid	B
transfer	I
protein	I
(	O
PLTP	B
)	O
isolated	O
from	O
the	O
Deuteromycete	O
,	O
Aspergillus	O
oryzae	O
.	O

Endotoxemia	O
and	O
bacteremia	O
in	O
patients	O
with	O
sepsis	O
syndrome	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

The	O
mRNA	O
for	O
this	O
protein	O
is	O
expressed	O
in	O
the	O
T	O
-	O
ALL	O
cell	O
line	O
Jurkat	O
and	O
has	O
been	O
designated	O
HUG1	B
,	O
for	O
HOX11	B
Upstream	I
Gene	I
.	O

The	O
MEF-2	B
proteins	I
are	O
a	O
family	O
of	O
transcriptional	O
activators	O
that	O
have	O
been	O
detected	O
in	O
a	O
wide	O
variety	O
of	O
cell	O
types	O
.	O

Treatment	O
of	O
diabetes	O
and	O
retinal	O
complications	O

In	O
contrast	O
,	O
an	O
N	B
-	I
terminal	I
RNAP	I
mutant	I
that	O
has	O
a	O
decreased	O
capacity	O
to	O
bind	O
single	O
-	O
stranded	O
RNA	O
forms	O
halted	O
complexes	O
with	O
much	O
lower	O
levels	O
of	O
stability	O
than	O
the	O
WT	O
enzyme	O
,	O
and	O
these	O
complexes	O
are	O
not	O
stabilized	O
by	O
the	O
presence	O
of	O
the	O
NT	O
strand	O
.	O

The	O
densities	O
ranged	O
between	O
2	O
and	O
3976	O
neurites	O
/	O
mm2	O
skin	O
surface	O
,	O
but	O
the	O
overlap	O
between	O
subjects	O
and	O
without	O
PHN	O
was	O
small	O
.	O

The	O
present	O
study	O
demonstrates	O
that	O
the	O
proto	B
-	I
oncogene	I
c	I
-	I
jun	I
represses	O
transcription	O
of	O
the	O
human	B
CG	I
alpha	I
and	O
CG	B
beta	I
promoters	I
.	O

c	B
-	I
Jun	I
repressed	O
the	O
CG	B
alpha	I
promoter	I
through	O
a	O
canonical	O
cAMP	O
response	O
element	O
(	O
CRE	O
)	O
that	O
is	O
known	O
to	O
bind	O
c	B
-	I
Jun	I
and	O
other	O
members	O
of	O
the	O
B	B
-	I
Zip	I
transcription	I
factor	I
family	I
.	O

This	O
is	O
the	O
first	O
report	O
that	O
the	O
PH	B
domain	I
of	O
an	O
IRS	B
protein	I
can	O
function	O
in	O
a	O
dominant	O
negative	O
manner	O
to	O
inhibit	O
insulin	B
signaling	O
.	O

Is	O
exposure	O
to	O
a	O
patient	O
with	O
Crohn	O
's	O
disease	O
an	O
environmental	O
factor	O
for	O
developing	O
the	O
disease	O
.	O

These	O
findings	O
suggest	O
that	O
low	O
-	O
power	O
laser	O
irradiation	O
can	O
be	O
used	O
for	O
promotion	O
of	O
vascularization	O
and	O
take	O
of	O
tissue	O
transplants	O
.	O

In	O
experiment	O
1	O
,	O
subjects	O
were	O
required	O
to	O
discriminate	O
male	O
from	O
female	O
faces	O
and	O
no	O
hemispheric	O
asymmetries	O
were	O
found	O
.	O

1	O
.	O

For	O
the	O
albino	O
,	O
both	O
the	O
ST1	O
and	O
ST2	O
spatial	O
responses	O
peak	O
at	O
around	O
0.3	O
cycles	O
deg-1	O
,	O
and	O
both	O
curves	O
are	O
displaced	O
considerably	O
to	O
the	O
low	O
spatial	O
frequency	O
side	O
of	O
the	O
normal	O
ST2	O
spatial	O
response	O
.	O

The	O
scores	O
for	O
these	O
three	O
factors	O
,	O
which	O
corresponded	O
to	O
recognizable	O
dimensions	O
of	O
depressive	O
illness	O
,	O
were	O
then	O
correlated	O
with	O
rCBF	O
.	O

The	O
etiology	O
was	O
established	O
in	O
73	O
(	O
76.8	O
%	O
)	O
out	O
of	O
95	O
cases	O
.	O

Depending	O
on	O
the	O
patient	O
's	O
body	O
position	O
telemetrically	O
measured	O
CSF	O
-	O
pressures	O
varied	O
between	O
-20	O
cmH2O	O
in	O
erect	O
and	O
15	O
cmH2O	O
in	O
supine	O
position	O
.	O

These	O
findings	O
suggest	O
that	O
NMDA	B
receptor	I
blockade	O
may	O
ameliorate	O
the	O
dyskinetic	O
complications	O
of	O
long	O
-	O
term	O
levodopa	O
therapy	O
,	O
without	O
diminishing	O
the	O
beneficial	O
effects	O
on	O
parkinsonian	O
signs	O
.	O

Before	O
flecainide	O
,	O
all	O
patients	O
had	O
easily	O
inducible	O
VT	O
that	O
was	O
morphologically	O
identical	O
to	O
their	O
spontaneously	O
occurring	O
arrhythmia	O
.	O

In	O
cells	O
infected	O
with	O
a	O
recombinant	O
vaccinia	O
virus	O
expressing	O
HCV	O
structural	O
proteins	O
(	O
core	B
,	O
E1	B
,	O
and	O
E2	B
)	O
,	O
DDX3	B
and	O
core	B
colocalized	O
in	O
distinct	O
spots	O
in	O
the	O
perinuclear	O
region	O
of	O
the	O
cytoplasm	O
.	O

However	O
,	O
PC12	O
cell	O
clones	O
which	O
expressed	O
p33rsu-1	B
at	O
an	O
increased	O
level	O
in	O
a	O
regulatable	O
fashion	O
in	O
response	O
to	O
dexamethasone	O
were	O
isolated	O
.	O

Differential	O
decay	O
of	O
a	O
polycistronic	O
Escherichia	O
coli	O
transcript	O
is	O
initiated	O
by	O
RNaseE	B
-	O
dependent	O
endonucleolytic	O
processing	O
.	O

Monosulfates	O
of	O
16-oxygenated	O
ketonic	O
C19	O
steroids	O
in	O
adult	O
human	O
urine	O
.	O

A	O
case	O
of	O
2	O
cancers	O
of	O
the	O
colon	O

However	O
,	O
mutations	O
of	O
the	O
C	O
-	O
rich	O
element	O
that	O
disrupted	O
a	O
GC	O
box	O
located	O
on	O
the	O
inverse	O
strand	O
eliminated	O
PMA	O
responsiveness	O
and	O
,	O
in	O
gel	O
mobility	O
shift	O
assays	O
,	O
eliminated	O
binding	O
of	O
Sp1	B
.	O

Down	O
-	O
regulation	O
of	O
Id1	B
mRNA	I
correlated	O
with	O
mitogenesis	O
and	O
occurred	O
when	O
quiescent	O
cells	O
were	O
treated	O
with	O
growth	O
factors	O
that	O
activate	O
G	B
protein	I
-	I
coupled	I
receptors	I
and	O
receptor	B
protein	I
tyrosine	I
kinases	I
but	O
not	O
with	O
a	O
non	O
-	O
mitogenic	O
cAMP	O
analog	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
5	O
'	O
flanking	O
region	O
of	O
human	B
ATP	I
-	I
citrate	I
lyase	I
gene	I
.	O

Defective	O
concanavalin	B
A	I
-	O
induced	O
suppression	O
in	O
bancroftian	O
filariasis	O
.	O

Demonstration	O
of	O
changes	O
in	O
fetal	O
liver	O
erythropoiesis	O
using	O
echo	O
-	O
planar	O
magnetic	O
resonance	O
imaging	O
.	O

Reaction	O
of	O
aromatic	O
/	O
heterocyclic	O
sulfonamides	O
possessing	O
free	O
amino	O
,	O
imino	O
or	O
hydrazino	O
moieties	O
with	O
7-chloro-4-chloromethylcoumarin	O
afforded	O
a	O
series	O
of	O
N-	O
[	O
(	O
7-chloro-4-coumarinyl	O
)	O
-methyl	O
]	O
-	O
derivatives	O
which	O
showed	O
effective	O
inhibition	O
of	O
three	O
carbonic	B
anhydrase	I
(	O
CA	B
)	O
isozymes	O
.	O

In	O
addition	O
,	O
these	O
results	O
suggest	O
that	O
the	O
interactions	O
,	O
and	O
consequently	O
the	O
mechanisms	O
,	O
governing	O
transcriptional	O
activation	O
by	O
CTF	B
are	O
distinct	O
from	O
those	O
mediating	O
DNA	O
replication	O
.	O

These	O
proteins	O
,	O
called	O
variant	B
surface	I
glycoproteins	I
(	O
VSGs	B
)	O
,	O
are	O
expressed	O
from	O
a	O
specific	O
locus	O
,	O
the	O
VSG	B
gene	I
expression	I
site	I
(	I
ES	I
)	I
.	O

In	O
situ	O
hybridization	O
of	O
whole	O
-	O
mount	O
mouse	O
embryos	O
with	O
Mex5	B
antisense	I
RNA	I
provide	O
no	O
evidence	O
for	O
the	O
exclusion	O
of	O
Mex5	B
during	O
embryonic	O
development	O
.	O

Karyo-	O
and	O
cytometric	O
investigations	O
of	O
cortical	O
layer	O
V	O
pyramidal	O
neurons	O
of	O
albino	O
rat	O
after	O
three	O
various	O
fixations	O

The	O
cloning	O
of	O
human	B
apo	I
B-100	I
has	O
provided	O
new	O
insights	O
into	O
the	O
structure	O
and	O
physicochemical	O
properties	O
of	O
apo	B
B-100	I
and	O
will	O
facilitate	O
studies	O
on	O
the	O
factors	O
modulating	O
apo	B
B-100	I
biosynthesis	O
and	O
the	O
expression	O
of	O
the	O
apo	B
B-100	I
gene	I
in	O
patients	O
with	O
dyslipoproteinemias	O
.	O

In	O
the	O
green	O
unicellular	O
alga	O
Chlamydomonas	O
eugametos	O
,	O
cellular	O
division	O
is	O
readily	O
synchronized	O
by	O
light	O
/	O
dark	O
cycles	O
.	O

Northern	O
blot	O
analysis	O
linked	O
Plk	B
expression	O
to	O
the	O
proliferative	O
activity	O
of	O
cells	O
and	O
tissues	O
.	O

A	O
1.5-month	O
-	O
old	O
boy	O
with	O
Sandifer	O
's	O
syndrome	O
is	O
described	O
.	O

A	O
40-fold	O
stimulation	O
of	O
chloramphenicol	B
acetyltransferase	I
activity	O
mediated	O
by	O
four	O
tandem	O
repeats	O
of	O
the	O
SNE	B
could	O
be	O
induced	O
within	O
2	O
h	O
(	O
and	O
up	O
to	O
250-fold	O
within	O
6	O
h	O
)	O
after	O
addition	O
of	O
TPA	O
in	O
DNA	O
-	O
transfected	O
U-937	O
cells	O
,	O
indicating	O
that	O
the	O
stimulation	O
appeared	O
likely	O
to	O
be	O
a	O
true	O
protein	B
kinase	I
C	I
-	O
mediated	O
signal	O
transduction	O
event	O
rather	O
than	O
a	O
differentiation	O
response	O
.	O

Between	O
1988	O
and	O
1995	O
,	O
341	O
children	O
with	O
acute	O
myeloid	O
leukaemia	O
(	O
AML	O
)	O
were	O
treated	O
on	O
the	O
Medical	O
Research	O
Council	O
Acute	O
Myeloid	O
Leukaemia	O
Trial	O
(	O
MRC	O
AML10	O
)	O
.	O

Using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
we	O
have	O
isolated	O
an	O
835	O
amino	O
acid	O
RING	O
finger	O
(	O
C3HC4	O
zinc	O
finger	O
)	O
protein	O
,	O
TIF1	B
beta	I
(	O
also	O
named	O
KAP-1	B
)	O
,	O
that	O
specifically	O
interacts	O
with	O
the	O
KRAB	B
domain	I
of	O
the	O
human	O
zinc	O
finger	O
factor	O
KOX1	B
/	O
ZNF10	B
.	O

Their	O
central	O
projections	O
were	O
indistinguishable	O
from	O
those	O
of	O
control	O
axons	O
in	O
all	O
four	O
trigeminal	O
subnuclei	O
.	O

Typicality	O
is	O
probably	O
a	O
better	O
representation	O
of	O
Alexander	O
,	O
Dunbar	O
and	O
others	O
'	O
conclusions	O
than	O
specificity	O
,	O
which	O
was	O
always	O
too	O
absolute	O
a	O
term	O
.	O

In	O
addition	O
to	O
TAK1	B
,	O
TGF	B
-	I
beta	I
also	O
stimulated	O
JNK	B
activity	O
.	O

The	O
study	O
was	O
carried	O
out	O
according	O
to	O
the	O
BSI	O
(	O
1980	O
)	O
recommendations	O
for	O
testing	O
restorative	O
materials	O
in	O
vivo	O
.	O

A	O
case	O
report	O
.	O

Oxalates	O
and	O
the	O
digestive	O
tract	O

Analysis	O
of	O
the	O
MCV-1	B
RPO1	I
revealed	O
high	O
amino	O
acid	O
homologies	O
to	O
the	O
corresponding	O
polypeptides	O
of	O
vaccinia	O
and	O
variola	O
virus	O
.	O

This	O
interaction	O
is	O
functional	O
as	O
it	O
leads	O
to	O
retargeting	O
of	O
NF	B
-	I
kappa	I
B	I
p50	B
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
.	O

Identification	O
of	O
masked	O
toxins	O
in	O
the	O
exotoxin	O
complex	O
of	O
Staphylococcus	O
pyogenes	O
und	O
Cl	O
.	O

perfringens	O
;	O
significance	O
of	O
their	O
existence	O
for	O
clarifying	O
of	O
the	O
masking	O
mechanism	O

Correlation	O
coefficients	O
between	O
SF	O
thickness	O
and	O
NIR	O
optical	O
density	O
readings	O
at	O
940	O
nm	O
(	O
OD1	O
)	O
and	O
950	O
nm	O
(	O
OD2	O
)	O
wavelengths	O
ranged	O
from	O
r	O
=	O
-0.30	O
(	O
subscapula	O
)	O
to	O
r	O
=	O
-0.67	O
(	O
biceps	O
)	O
for	O
OD1	O
and	O
r	O
=	O
-0.39	O
(	O
axilla	O
)	O
to	O
r	O
=	O
-0.68	O
(	O
biceps	O
)	O
for	O
OD2	O
.	O

The	O
clinical	O
picture	O
,	O
the	O
light	O
and	O
electron	O
microscopic	O
appearance	O
,	O
and	O
the	O
histochemical	O
findings	O
are	O
described	O
in	O
six	O
cases	O
of	O
fibroma	O
of	O
tendon	O
sheath	O
.	O

We	O
hypothesize	O
that	O
the	O
ability	O
of	O
these	O
acidic	O
activators	O
to	O
specifically	O
interact	O
with	O
multiple	O
components	O
of	O
the	O
transcription	O
initiation	O
complex	O
likely	O
underlies	O
the	O
dramatic	O
functional	O
synergy	O
exhibited	O
by	O
this	O
class	O
of	O
activation	O
domains	O
in	O
vivo	O
.	O

High	O
and	O
pathological	O
PAI-1	B
levels	O
before	O
and	O
after	O
the	O
VO	O
test	O
were	O
consistent	O
with	O
a	O
defective	O
fibrinolytic	O
potential	O
due	O
to	O
the	O
inhibitory	O
effect	O
of	O
PAI-1	B
on	O
plasminogen	B
activation	O
.	O

MAPKK	B
kinase	I
/	O
MEKK	B
phosphorylates	O
and	O
activates	O
its	O
downstream	O
protein	O
kinase	O
,	O
MAPK	B
kinase	I
/	O
MEK	B
,	O
which	O
in	O
turn	O
activates	O
MAPK	B
.	O

The	O
author	O
describes	O
the	O
technique	O
in	O
detail	O
and	O
presents	O
the	O
findings	O
for	O
25	O
patients	O
(	O
10	O
men	O
and	O
15	O
women	O
)	O
examined	O
for	O
suspected	O
ileostomy	O
dysfunction	O
,	O
recurrent	O
Crohn	O
's	O
disease	O
or	O
ileal	O
obstruction	O
remote	O
from	O
the	O
stoma	O
.	O

Biochemical	O
studies	O
have	O
identified	O
a	O
cellular	O
non	B
-	I
P	I
element	I
-	I
encoded	I
DNA	I
binding	I
protein	I
,	O
termed	O
the	O
inverted	B
repeat	I
binding	I
protein	I
(	O
IRBP	B
)	O
,	O
that	O
specifically	O
interacts	O
with	O
the	O
outer	O
half	O
of	O
the	O
31-bp	O
terminal	O
inverted	O
repeats	O
.	O

These	O
findings	O
suggest	O
that	O
eIF5-eIF2beta	B
interaction	O
plays	O
an	O
essential	O
role	O
in	O
eIF5	B
function	O
in	O
eukaryotic	O
cells	O
.	O

The	O
delayed	O
activation	O
of	O
the	O
prostaglandin	B
G	I
/	I
H	I
synthase-2	I
promoter	O
in	O
bovine	O
granulosa	O
cells	O
is	O
associated	O
with	O
down	O
-	O
regulation	O
of	O
truncated	O
upstream	B
stimulatory	I
factor-2	I
.	O

E1A	B
+	O
cHa	B
-	I
ras	I
transformed	O
rat	O
embryo	O
fibroblast	O
cells	O
are	O
characterized	O
by	O
high	O
and	O
constitutive	O
DNA	O
binding	O
activities	O
of	O
AP-1	B
dimers	I
with	O
significantly	O
altered	O
composition	O
.	O

In	O
the	O
present	O
study	O
we	O
have	O
used	O
Southern	O
blot	O
analysis	O
to	O
demonstrate	O
that	O
TSG6	B
is	O
a	O
single	O
-	O
copy	O
gene	O
in	O
the	O
human	O
and	O
murine	O
species	O
.	O

CONCLUSIONS	O
:	O
Latanoprost	O
administered	O
once	O
daily	O
was	O
significantly	O
more	O
effective	O
in	O
reducing	O
IOP	O
compared	O
with	O
unoprostone	O
administered	O
twice	O
daily	O
in	O
patients	O
with	O
POAG	O
and	O
OH	O
.	O

Activation	O
of	O
HIV	O
gene	O
expression	O
by	O
UV	O
must	O
therefore	O
involve	O
additional	O
cellular	O
processes	O
,	O
such	O
as	O
those	O
triggered	O
by	O
DNA	O
damage	O
,	O
for	O
generation	O
of	O
a	O
full	O
gene	O
expression	O
response	O
.	O

Radiological	O
imaging	O
such	O
as	O
UGI	O
series	O
and	O
CT	O
scan	O
was	O
useful	O
to	O
arrive	O
at	O
an	O
accurate	O
diagnosis	O
.	O

We	O
propose	O
that	O
optimal	O
transcription	O
of	O
the	O
gD	B
gene	I
depends	O
on	O
the	O
interaction	O
of	O
ICP4	B
with	O
multiple	O
binding	O
sites	O
across	O
the	O
gene	O
and	O
cellular	O
factors	O
that	O
recognize	O
specific	O
sequence	O
elements	O
in	O
the	O
promoter	O
.	O

Cetn1	B
possesses	O
the	O
sequence	O
features	O
of	O
an	O
expressed	O
retroposon	O
:	O
the	O
gene	O
lacks	O
introns	O
,	O
the	O
open	O
reading	O
frame	O
is	O
not	O
interrupted	O
by	O
stop	O
codons	O
,	O
and	O
the	O
coding	O
region	O
is	O
flanked	O
by	O
a	O
pair	O
of	O
direct	O
repeats	O
.	O

Substitutions	O
of	O
Asp11	O
led	O
to	O
dominant	O
lethality	O
.	O

We	O
prospectively	O
studied	O
serum	B
prolactin	I
(	O
PRL	B
)	O
elevation	O
after	O
different	O
types	O
of	O
documented	O
seizures	O
in	O
17	O
patients	O
.	O

To	O
further	O
identify	O
the	O
residues	O
responsible	O
for	O
the	O
activity	O
,	O
we	O
isolated	O
the	O
mutant	O
viruses	O
that	O
were	O
not	O
neutralized	O
with	O
the	O
soluble	O
form	O
of	O
MHV	B
receptor	I
proteins	I
,	O
since	O
such	O
mutants	O
were	O
expected	O
to	O
have	O
mutations	O
in	O
amino	O
acids	O
responsible	O
for	O
receptor	O
-	O
binding	O
activity	O
.	O

When	O
lipid	O
X	O
was	O
combined	O
with	O
ticarcillin	O
,	O
survival	O
differences	O
were	O
both	O
significant	O
and	O
prolonged	O
.	O

Furthermore	O
,	O
the	O
secondary	O
stress	O
responses	O
were	O
more	O
pronounced	O
and	O
the	O
ability	O
to	O
recover	O
from	O
them	O
seemed	O
to	O
be	O
impaired	O
in	O
exposed	O
fish	O
as	O
compared	O
to	O
unexposed	O
fish	O
.	O

Focal	O
glomerulosclerosis	O
-	O
like	O
disease	O
with	O
nephrotic	O
syndrome	O
in	O
a	O
horse	O
.	O

Treatment	O
with	O
polyinosinic	O
-	O
polycytidylic	O
acid	O
to	O
induce	O
expression	O
of	O
Cre	B
resulted	O
in	O
complete	O
disruption	O
of	O
the	O
Arnt	B
gene	I
and	O
loss	O
of	O
ARNT	B
messenger	I
RNA	I
(	O
mRNA	O
)	O
expression	O
in	O
liver	O
.	O

Twelve	O
patients	O
of	O
leprosy	O
with	O
arthritis	O
and	O
161	O
patients	O
without	O
arthritis	O
were	O
studied	O
for	O
immunological	O
parameters	O
like	O
immunoglobulins	B
(	O
IgG	B
,	O
IgM	B
,	O
IgA	B
)	O
,	O
C	B
-	I
reactive	I
proteins	I
and	O
rheumatoid	B
factor	I
.	O

All	O
depressive	O
groups	O
showed	O
improved	O
error	O
measures	O
post	O
-	O
treatment	O
.	O

Plasmid	O
subclones	O
of	O
the	O
hr1a	B
-	O
containing	O
AcMNPV	O
HindIII	B
-	O
N	O
fragment	O
were	O
examined	O
for	O
their	O
ability	O
to	O
replicate	O
in	O
virus	O
-	O
infected	O
(	O
Spodoptera	O
frugiperda	O
)	O
Sf9	O
cells	O
,	O
and	O
to	O
stimulate	O
transcription	O
when	O
linked	O
in	O
cis	O
with	O
a	O
39	B
K	I
gene	I
promoter	I
-	I
beta	I
-	I
glucuronidase	I
fusion	I
and	O
cotransfected	O
into	O
cells	O
along	O
with	O
a	O
plasmid	O
(	O
ple-1	O
)	O
containing	O
the	O
gene	O
encoding	O
the	O
trans	O
-	O
acting	O
factor	O
IE-1	B
.	O

This	O
new	O
receptor	O
,	O
TOR	B
(	O
thymus	B
orphan	I
receptor	I
)	O
,	O
is	O
most	O
closely	O
related	O
in	O
both	O
its	O
DNA	O
-	O
binding	O
domain	O
and	O
ligand	O
-	O
binding	O
domain	O
,	O
90	O
%	O
and	O
53	O
%	O
,	O
respectively	O
,	O
to	O
ROR	B
alpha	I
/	O
RZR	B
alpha	I
and	O
clusters	O
with	O
these	O
two	O
receptors	O
and	O
RZR	B
beta	I
in	O
a	O
phylogenetic	O
tree	O
,	O
when	O
both	O
the	O
DNA	O
-	O
binding	O
domain	O
and	O
the	O
ligand	O
-	O
binding	O
domain	O
sequences	O
of	O
nuclear	O
receptors	O
are	O
compared	O
.	O

Laser	O
soldering	O
with	O
exogenous	O
fibrinogen	B
is	O
feasible	O
without	O
topical	O
administration	O
of	O
additional	O
clotting	O
agents	O
,	O
significantly	O
improves	O
the	O
bursting	O
strength	O
of	O
primary	O
laser	O
welded	O
anastomoses	O
,	O
and	O
appears	O
to	O
result	O
from	O
urokinase	B
-	O
resistant	O
fibrinogen	B
cross	O
-	O
linking	O
.	O

Raman	O
scattering	O
from	O
VO2	O
single	O
crystals	O
:	O
A	O
study	O
of	O
the	O
effects	O
of	O
surface	O
oxidation	O
.	O

Left	O
ventricular	O
insufficiency	O
requires	O
two	O
SP	O
/	O
patient	O
,	O
with	O
good	O
results	O
in	O
approximately	O
81	O
p.	O
cent	O
.	O

50-fold	O
increase	O
in	O
foreign	O
protein	O
production	O
.	O

A	O
rare	O
tRNA	B
-	I
Arg	I
(	I
CCU	I
)	I
that	O
regulates	O
Ty1	B
element	I
ribosomal	O
frameshifting	O
is	O
essential	O
for	O
Ty1	B
retrotransposition	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

In	O
addition	O
,	O
putative	O
binding	O
sites	O
for	O
SH3	B
and	O
SH2	B
domains	I
are	O
present	O
in	O
the	O
amino	O
-	O
terminal	O
half	O
of	O
the	O
molecule	O
.	O

The	O
technique	O
used	O
by	O
this	O
system	O
involves	O
a	O
transient	O
,	O
externally	O
applied	O
increase	O
in	O
resistance	O
to	O
breathing	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

Vorozole	O
(	O
Rivizor	O
)	O
is	O
a	O
potent	O
and	O
stereospecific	O
inhibitor	O
of	O
aromatase	B
having	O
shown	O
promising	O
endocrine	O
effects	O
in	O
phase	O
I	O
studies	O
.	O

Mapping	O
the	O
5	O
'	O
and	O
3	O
'	O
termini	O
of	O
TED	B
RNAs	I
indicated	O
that	O
the	O
LTRs	O
have	O
a	O
retroviral	O
U3-R	O
-	O
U5	O
structural	O
organization	O
that	O
is	O
capable	O
of	O
directing	O
the	O
synthesis	O
of	O
transcripts	O
that	O
represent	O
potential	O
substrates	O
for	O
reverse	O
transcription	O
and	O
intermediates	O
in	O
transposition	O
.	O

However	O
,	O
sphincter	O
length	O
decreased	O
with	O
age	O
from	O
24.3	O
to	O
14.8	O
mm	O
.	O
,	O
maximal	O
urethral	O
pressure	O
from	O
88.7	O
to	O
55	O
cm	O
.	O

water	O
and	O
maximal	O
urethral	O
pressure	O
during	O
voluntary	O
contraction	O
from	O
221.4	O
to	O
166.3	O
cm	O
.	O

water	O
.	O

A	O
cephalothoracophagus	O
disymmetros	O
buffalo	O
calf	O
.	O

Electromobility	O
shift	O
analysis	O
using	O
oligonucleotides	O
encompassing	O
the	O
proximal	O
,	O
distal	O
,	O
and	O
BED	O
/	O
AP-1-binding	B
regions	O
failed	O
to	O
demonstrate	O
selective	O
transactivation	O
after	O
CD2	B
signaling	O
of	O
LPMC	O
.	O

Four	O
families	O
of	O
homing	B
endonucleases	I
have	O
been	O
identified	O
,	O
including	O
the	O
LAGLIDADG	B
,	O
the	O
His	B
-	I
Cys	I
box	I
,	O
the	O
GIY	B
-	I
YIG	I
and	O
the	O
H	B
-	I
N	I
-	I
H	I
endonucleases	I
.	O

Administration	O
of	O
SnCl2	O
and	O
ZnSO4	O
(	O
group	O
V	O
)	O
resulted	O
in	O
a	O
decrease	O
of	O
ALA	B
-	I
D	I
activity	O
and	O
in	O
an	O
increase	O
in	O
CP	O
-	O
U.	O

Coexistence	O
of	O
Turner	O
's	O
syndrome	O
and	O
schizophrenia	O

A	O
selectable	O
marker	O
for	O
transformation	O
was	O
constructed	O
by	O
transcriptional	O
fusion	O
of	O
a	O
Ustilago	B
maydis	I
heat	I
shock	I
gene	I
promoter	I
with	O
the	O
hygromycin	B
B	I
phosphotransferase	I
gene	I
of	I
Escherichia	I
coli	I
.	O

All	O
exon	O
/	O
intron	O
splice	O
junctions	O
follow	O
the	O
GT	O
/	O
AG	O
rule	O
.	O

These	O
studies	O
suggest	O
that	O
tandem	O
alpha	O
-	O
helices	O
located	O
near	O
the	O
C	O
-	O
terminus	O
of	O
PC	B
-	I
TP	I
facilitate	O
membrane	O
binding	O
and	O
extraction	O
of	O
phosphatidylcholines	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
mechanism	O
by	O
which	O
Tax	B
activates	O
gene	O
expression	O
in	O
conjunction	O
with	O
members	O
of	O
the	O
ATF	B
/	O
CREB	B
family	O
.	O

We	O
studied	O
18	O
dogs	O
,	O
anaesthetised	O
and	O
spontaneously	O
breathing	O
both	O
room	O
air	O
and	O
after	O
the	O
inhalation	O
of	O
a	O
gas	O
mixture	O
containing	O
10	O
%	O
CO2	O
,	O
20.9	O
%	O
O2	O
,	O
and	O
69.1	O
%	O
N2	O
,	O
to	O
determine	O
the	O
role	O
of	O
histamine	O
,	O
serotonin	O
,	O
and	O
acidaemia	O
in	O
pulmonary	O
hypertension	O
produced	O
by	O
hypercapnia	O
.	O

In	O
both	O
liver	O
and	O
pancreatic	O
islet	O
,	O
glucokinase	B
is	O
subject	O
to	O
inhibition	O
by	O
a	O
regulatory	O
protein	O
(	O
GCKR	B
)	O
.	O

In	O
this	O
second	O
clinical	O
paper	O
,	O
the	O
genetic	O
features	O
of	O
the	O
case	O
of	O
microphthalmia	O
in	O
sheep	O
reported	O
by	O
Wagenaar	O
is	O
discussed	O
in	O
greater	O
detail	O
.	O

Both	O
the	O
arterial	O
and	O
venous	O
thrombi	O
were	O
clearly	O
discernible	O
at	O
2	O
to	O
8	O
h	O
after	O
injection	O
of	O
99Tcm	O
-	O
SZ-51	O
.	O

However	O
,	O
the	O
blend	O
of	O
Metanil	O
yellow	O
and	O
Orange	O
II	O
(	O
1:1	O
)	O
resulted	O
in	O
the	O
D1	O
50.value	O
of	O
288	O
min	O
.	O

In	O
this	O
study	O
,	O
we	O
show	O
that	O
the	O
activating	O
effect	O
of	O
this	O
mutation	O
is	O
not	O
the	O
result	O
of	O
creating	O
an	O
exonic	O
splicing	O
enhancer	O
(	O
ESE	O
)	O
or	O
disrupting	O
a	O
putative	O
secondary	O
structure	O
.	O

The	O
architecture	O
of	O
the	O
hRap1	B
Myb	B
domain	I
is	O
very	O
close	O
to	O
that	O
of	O
each	O
of	O
the	O
Myb	B
domains	I
from	O
TRF1	B
,	O
scRap1p	B
and	O
c	B
-	I
Myb	I
.	O

However	O
,	O
this	O
posttranslational	O
modification	O
of	O
the	O
gar2	B
protein	I
does	O
not	O
appear	O
to	O
be	O
essential	O
for	O
normal	O
production	O
of	O
18S	B
rRNA	I
.	O

The	O
BRSV	B
L	I
gene	I
is	O
6573	O
nt	O
in	O
length	O
and	O
the	O
derived	O
polypeptide	O
has	O
2162	O
aa	O
.	O

BRAP2	B
also	O
shares	O
significant	O
homology	O
with	O
a	O
hypothetical	O
protein	O
from	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
especially	O
in	O
the	O
zinc	O
finger	O
region	O
.	O

We	O
identified	O
Tyr	O
(	O
112	O
)	O
and	O
Leu	O
(	O
175	O
)	O
within	O
the	O
RNA	O
-	O
binding	O
domain	O
of	O
the	O
U1	B
70	I
K	I
protein	I
to	O
be	O
cross	O
-	O
linked	O
to	O
G	O
(	O
28	O
)	O
and	O
U	O
(	O
30	O
)	O
in	O
stem	O
-	O
loop	O
I	O
,	O
respectively	O
.	O

In	O
general	O
,	O
the	O
scallop	O
extract	O
potentiated	O
phototactic	O
suppression	O
.	O

Only	O
Staphylococcus	O
xylosus	O
SX63	O
was	O
detected	O
as	O
a	O
strain	O
with	O
high	O
adherence	O
activity	O
.	O

METHODS	O
:	O
The	O
Die	O
Deutsche	O
Diabetes	O
Dialyse	O
Studie	O
is	O
a	O
prospective	O
randomized	O
placebo	O
-	O
controlled	O
trial	O
that	O
tests	O
the	O
hypothesis	O
that	O
atorvastatin	O
,	O
a	O
hydroxymethyl	B
-	I
glutaryl	I
coenzyme	I
A	I
reductase	I
inhibitor	O
,	O
decreases	O
the	O
rate	O
of	O
cardiovascular	O
mortality	O
and	O
of	O
nonfatal	O
myocardial	O
infarction	O
in	O
patients	O
with	O
type	O
2	O
diabetes	O
who	O
have	O
been	O
on	O
hemodialysis	O
treatment	O
for	O
no	O
more	O
than	O
two	O
years	O
.	O

This	O
high	O
dose	O
5-FU	O
+	O
Act	O
-	O
D	O
protocol	O
was	O
effective	O
for	O
drug	O
resistant	O
cases	O
with	O
MEA	O
protocol	O
.	O

Therefore	O
,	O
it	O
appears	O
that	O
GCN2	B
protein	I
kinase	I
function	O
is	O
stimulated	O
posttranslationally	O
in	O
amino	O
acid	O
-	O
starved	O
cells	O
.	O

HIV-2	O
in	O
Spain	O
.	O

Reversal	O
of	O
mefloquine	O
resistance	O
in	O
rodent	O
Plasmodium	O
.	O

Airborne	O
rabies	O
encephalitis	O
:	O
demonstration	O
of	O
rabies	O
virus	O
in	O
the	O
human	O
central	O
nervous	O
system	O
.	O

No	O
promoter	O
activity	O
could	O
be	O
detected	O
with	O
various	O
mouse	B
Fli-1	I
promoter	I
-	O
CAT	B
constructs	O
containing	O
600	O
bp	O
of	O
the	O
5	O
'	O
flanking	O
region	O
,	O
the	O
complete	O
exon	O
1	O
,	O
the	O
5	O
'	O
end	O
of	O
intron	O
1	O
and/or	O
retroviral	O
LTR	O
sequence	O
.	O

We	O
now	O
show	O
that	O
the	O
FRAP	B
Ser2035	O
-	O
->Ala	O
mutant	O
displays	O
similar	O
binding	O
affinity	O
when	O
compared	O
with	O
the	O
wild	O
-	O
type	O
protein	O
,	O
whereas	O
all	O
other	O
mutations	O
at	O
this	O
site	O
,	O
including	O
mimics	O
of	O
phosphoserine	O
,	O
abolish	O
binding	O
,	O
presumably	O
due	O
to	O
either	O
unfavorable	O
steric	O
interactions	O
or	O
induced	O
conformational	O
changes	O
.	O

This	O
sequence	O
can	O
interact	O
with	O
at	O
least	O
two	O
proteins	O
in	O
a	O
fibroblast	O
nuclear	O
extract	O
that	O
have	O
binding	O
characteristics	O
of	O
an	O
Ets	B
family	I
protein	I
and	O
a	O
serum	B
response	I
factor	I
-	I
like	I
protein	I
.	O

Response	O
properties	O
of	O
single	O
units	O
in	O
the	O
accessory	O
optic	O
system	O
of	O
the	O
dark	O
-	O
reared	O
cat	O
.	O

Effect	O
of	O
tetracycline	O
on	O
the	O
glycogen	O
-	O
producing	O
function	O
of	O
the	O
liver	O
and	O
intestinal	O
microflora	O
in	O
white	O
mice	O

However	O
,	O
only	O
plasma	B
fibrinogen	I
concentrations	O
showed	O
statistically	O
significant	O
positive	O
associations	O
with	O
IMT	O
in	O
both	O
groups	O
.	O

METHODS	O
.	O

Presently	O
,	O
we	O
made	O
chain	O
pair	O
switch	O
,	O
chimeric	O
,	O
and	O
site	O
mutant	B
gamma	I
delta	I
TCRs	I
and	O
transfected	O
them	O
into	O
TCR-	O
mutant	O
Jurkat	O
T	O
cells	O
to	O
examine	O
the	O
effects	O
of	O
changing	O
the	O
TCR	B
gamma	I
junctional	I
region	I
sequences	I
on	O
reactivity	O
to	O
prenyl	B
pyrophosphate	I
Ags	I
.	O

The	O
molecular	O
dynamics	O
simulations	O
provide	O
insight	O
into	O
the	O
conformational	O
flexibility	O
of	O
these	O
analogs	O
.	O

Modified	O
Grocott	O
's	O
methenamine	O
silver	O
nitrate	O
method	O
for	O
quick	O
staining	O
of	O
Pneumocystis	O
carinii	O
.	O

The	O
control	O
of	O
human	B
aromatase	I
expression	O
is	O
complex	O
in	O
that	O
several	O
promoters	O
drive	O
aromatase	B
expression	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
.	O

To	O
isolate	O
genes	O
that	O
contain	O
zinc	O
finger	O
motifs	O
,	O
a	O
human	O
brain	O
cDNA	O
library	O
was	O
screened	O
with	O
an	O
oligonucleotide	O
complementary	O
to	O
the	O
conserved	O
""""	O
linker	O
""""	O
sequence	O
between	O
adjacent	O
zinc	O
fingers	O
.	O

Transforming	B
growth	I
factor	I
beta	I
activates	O
the	O
promoter	O
of	O
cyclin	B
-	I
dependent	I
kinase	I
inhibitor	O
p15INK4B	B
through	O
an	O
Sp1	B
consensus	I
site	I
.	O

Sociological	O
analysis	O
of	O
the	O
family	O
.	O

Like	O
other	O
known	O
GCD	B
genes	I
,	O
GCD14	B
and	O
GCD15	B
are	O
therefore	O
probably	O
required	O
for	O
general	O
translation	O
initiation	O
in	O
addition	O
to	O
their	O
roles	O
in	O
GCN4-specific	B
translational	O
control	O
.	O

Sorting	O
information	O
to	O
the	O
chloroplastic	O
inner	O
envelope	O
is	O
contained	O
in	O
an	O
NH2-proximal	O
part	O
of	O
mature	B
IEP110	I
(	O
110N	B
)	O
.	O

Both	O
algorithms	O
have	O
been	O
implemented	O
and	O
applied	O
to	O
data	O
simulated	O
for	O
a	O
scanner	O
with	O
a	O
large	O
axial	O
aperture	O
(	O
30	O
degrees	O
)	O
,	O
and	O
also	O
to	O
data	O
acquired	O
with	O
the	O
ECAT	O
HR	O
and	O
the	O
ECAT	O
HR+	O
scanners	O
.	O

BACKGROUND	O
:	O
Murine	B
Nramp	I
is	O
a	O
candidate	O
for	O
the	O
macrophage	O
resistance	O
gene	O
Ity	B
/	O
Lsh	B
/	O
Bcg	B
.	O

Pregnancy	O
was	O
ensued	O
in	O
4	O
cases	O
in	O
group	O
I.	O

Western	O
immunoblot	O
analysis	O
detected	O
p55gag	B
and	O
its	O
cleavage	O
products	O
p39	B
and	O
p27	B
in	O
purified	O
particles	O
derived	O
by	O
expression	O
of	O
gag	B
and	O
gag	B
-	O
pol	B
,	O
respectively	O
.	O

These	O
three	O
phases	O
of	O
cyclin	B
E	I
association	O
with	O
chromatin	O
may	O
facilitate	O
the	O
diverse	O
activities	O
of	O
cyclin	B
E	I
--	O
Cdk2	B
in	O
initiating	O
replication	O
,	O
blocking	O
rereplication	O
,	O
and	O
allowing	O
resetting	O
of	O
origins	O
after	O
mitosis	O
.	O

It	O
has	O
been	O
shown	O
that	O
renin	B
secretion	O
is	O
stimulated	O
by	O
endothelin	B
,	O
a	O
recently	O
discovered	O
peptide	O
with	O
strong	O
vasoconstrictive	O
properties	O
and	O
stimulating	O
effects	O
on	O
renin	B
secretion	O
.	O

A	O
higher	O
percentage	O
of	O
children	O
with	O
cerebral	O
malaria	O
(	O
40	O
per	O
cent	O
)	O
than	O
with	O
non	O
-	O
cerebral	O
malaria	O
(	O
29	O
per	O
cent	O
)	O
or	O
controls	O
(	O
20	O
per	O
cent	O
)	O
also	O
had	O
either	O
serum	B
ferritin	I
<	O
100	O
micrograms	O
/	O
l	O
and	O
inflammation	O
or	O
sTfR	B
>	O
7.3	O
mg	O
/	O
l	O
or	O
both	O
.	O

Patients	O
received	O
BPB	O
using	O
bupivacaine	O
2	O
mg	O
kg-1	O
with	O
adrenaline	O
1	O
in	O
200,000	O
,	O
either	O
with	O
or	O
without	O
hyaluronidase	B
3000	O
iu	O
,	O
in	O
a	O
volume	O
of	O
0.5	O
ml	O
per	O
2.54	O
cm	O
of	O
the	O
patient	O
's	O
height	O
.	O

The	O
rifampicin	O
resistance	O
of	O
uvsW	B
-	O
repressed	O
replication	O
suggests	O
that	O
it	O
involves	O
either	O
tertiary	O
initiation	O
or	O
some	O
novel	O
mode	O
of	O
initiation	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
proteolipids	O
of	O
the	O
vacuolar	B
H+-ATPases	I
were	O
evolved	O
in	O
parallel	O
with	O
the	O
eubacterial	O
proteolipid	O
,	O
from	O
a	O
common	O
ancestral	O
gene	O
that	O
underwent	O
gene	O
duplication	O
.	O

Coexpression	O
of	O
c	B
-	I
Rel	I
in	O
combination	O
with	O
ATF-1	B
,	O
CREB2	B
,	O
or	O
ATF-1	B
/	O
CREB2	B
leads	O
to	O
synergistic	O
transactivation	O
of	O
a	O
CD28RE	B
-	I
TRE	I
reporter	I
plasmid	O
in	O
quiescent	O
Jurkat	O
T	O
-	O
cells	O
.	O

Characterization	O
of	O
a	O
cDNA	B
encoding	I
CNN	I
predicts	O
a	O
novel	O
structural	O
protein	O
with	O
three	O
leucine	O
zipper	O
motifs	O
and	O
several	O
coiled	O
-	O
coil	O
domains	O
exhibiting	O
limited	O
homology	O
to	O
the	O
rod	O
portion	O
of	O
myosin	B
.	O

It	O
is	O
suggested	O
that	O
the	O
loss	O
of	O
weight	O
,	O
the	O
decrease	O
in	O
food	O
intake	O
and	O
the	O
increase	O
in	O
brain	O
MOPEG	O
-	O
SO4	O
induced	O
by	O
cyanamide	O
reflect	O
possible	O
anorectic	O
properties	O
of	O
the	O
drug	O
.	O

The	O
differential	O
diagnosis	O
of	O
mineral	O
oil	O
lipidosis	O
in	O
lymph	O
nodes	O
with	O
reaction	O
to	O
radiopaque	O
oils	O
and	O
Whipple	O
's	O
disease	O
is	O
discussed	O
.	O

The	O
serum	O
levels	O
of	O
cortisol	O
and	O
prolactin	B
after	O
nasal	O
instillation	O
of	O
a	O
suspension	O
of	O
vaginal	O
exudate	O
showed	O
lower	O
values	O
than	O
in	O
control	O
conditions	O
(	O
nasal	O
instillation	O
of	O
saline	O
)	O
.	O

The	O
data	O
when	O
used	O
to	O
stimulate	O
the	O
collection	O
of	O
the	O
information	O
at	O
antenatal	O
or	O
postnatal	O
visits	O
,	O
nonetheless	O
provide	O
an	O
accurate	O
description	O
of	O
under-3	O
mortality	O
trends	O
and	O
differences	O
for	O
the	O
two	O
periods	O
examined	O
--	O
before	O
1984	O
and	O
before	O
1989	O
.	O

The	O
BHV-1	B
UL24	I
,	O
UL25	B
,	O
UL26	B
and	O
UL26.5	B
transcripts	I
all	O
terminated	O
at	O
a	O
common	O
3'-polyadenylation	O
site	O
and	O
varied	O
significantly	O
in	O
their	O
relative	O
abundance	O
.	O

A.	O

Ligand	O
binding	O
of	O
multi	O
-	O
chain	O
antigen	O
receptors	O
and	O
hematopoietin	B
/	O
cytokine	O
receptors	O
results	O
in	O
rapid	O
activation	O
of	O
protein	B
tyrosine	I
kinase	I
(	O
PTK	B
)	O
-dependent	O
signalling	O
molecules	O
such	O
as	O
phosphatidylinositol	B
3-kinase	I
(	O
PI	B
3-kinase	I
)	O
.	O

Post	O
-	O
CPB	O
cardiac	O
index	O
was	O
superior	O
in	O
group	O
B	O
(	O
3.9+	O
/	O
-0.3	O
vs.	O

The	O
regulatory	O
genes	O
cnrYXH	B
have	O
been	O
cloned	O
,	O
overexpressed	O
,	O
and	O
purified	O
in	O
Escherichia	O
coli	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
1	O
)	O
to	O
quantify	O
the	O
comparative	O
structural	O
static	O
and	O
fatigue	O
properties	O
of	O
the	O
pointe	O
shoe	O
toe	O
box	O
,	O
and	O
2	O
)	O
to	O
evaluate	O
the	O
preferred	O
shoe	O
characteristics	O
as	O
determined	O
by	O
a	O
survey	O
of	O
local	O
dancers	O
.	O

We	O
report	O
on	O
a	O
case	O
of	O
a	O
43-old	O
-	O
male	O
with	O
a	O
bronchogenic	O
cyst	O
in	O
the	O
distal	O
esophagus	O
,	O
which	O
was	O
misdiagnosed	O
as	O
a	O
malignant	O
esophageal	O
tumor	O
based	O
on	O
preoperative	O
imaging	O
and	O
high	O
levels	O
of	O
the	O
tumor	O
markers	O
CA	B
19	I
-	I
9	I
and	O
CA	B
125	I
.	O

Oscillatory	O
flow	O
is	O
reestablished	O
in	O
the	O
model	O
at	O
the	O
capillary	O
-	O
cerebrospinal	O
fluid	O
and	O
capillary	O
-	O
venous	O
interfaces	O
.	O

Human	B
and	I
murine	I
cytotoxic	I
T	I
lymphocyte	I
serine	I
proteases	I
:	O
subsite	O
mapping	O
with	O
peptide	O
thioester	O
substrates	O
and	O
inhibition	O
of	O
enzyme	O
activity	O
and	O
cytolysis	O
by	O
isocoumarins	O
.	O

Regulation	O
of	O
the	O
human	B
stress	I
response	I
gene	I
GADD153	I
expression	O
:	O
role	O
of	O
ETS1	B
and	O
FLI-1	B
gene	I
products	I
.	O

Each	O
receptor	O
must	O
therefore	O
engage	O
a	O
unique	O
subset	O
of	O
the	O
available	O
signaling	O
elements	O
--	O
at	O
least	O
partly	O
through	O
the	O
selection	O
of	O
proteins	O
with	O
src	B
-	I
homology	I
2	I
domains	I
(	O
SH2	B
proteins	I
)	O
.	O

NSAIDS	O
and	O
the	O
microcirculation	O
of	O
the	O
stomach	O
.	O

Highly	O
significant	O
similarities	O
were	O
detected	O
between	O
the	O
N	O
-	O
terminal	O
region	O
of	O
P30	B
and	O
those	O
of	O
GENA	B
[	O
the	O
product	O
of	O
another	O
unidentified	O
gene	O
(	O
geneA	B
)	O
located	O
upstream	O
of	O
the	O
aceEF	B
-	O
lpd	B
operon	O
]	O
,	O
and	O
GNTR	B
(	O
a	O
putative	O
transcriptional	O
repressor	O
of	O
the	O
gluconate	B
operon	I
of	O
Bacillus	O
subtilis	O
)	O
.	O

Promoting	O
fat	O
utilisation	O
by	O
reducing	O
the	O
carbohydrate	O
-	O
fat	O
ratio	O
of	O
the	O
TPN	O
reduces	O
free	O
radical	O
activity	O
to	O
a	O
similar	O
extent	O
as	O
fat	O
exclusion	O
.	O

It	O
is	O
postulated	O
that	O
the	O
synthesis	O
of	O
the	O
peptidoglycan	O
layer	O
was	O
affected	O
by	O
the	O
antimetabolites	O
since	O
the	O
morphological	O
effects	O
were	O
strikingly	O
similar	O
to	O
those	O
caused	O
by	O
treatment	O
of	O
E.	O
cloacae	O
with	O
disodium	O
edetate	O
plus	O
lysozyme	B
.	O

The	O
selective	O
5-HT2	B
receptor	I
blocker	O
ketanserin	O
was	O
found	O
to	O
reduce	O
maximal	O
urethral	O
pressures	O
in	O
healthy	O
females	O
by	O
about	O
40	O
%	O
without	O
reducing	O
blood	O
pressure	O
.	O

Finally	O
,	O
the	O
conservation	O
of	O
the	O
two	O
residues	O
most	O
sensitive	O
to	O
mutations	O
(	O
Y949	O
and	O
Y953	O
)	O
in	O
TM11	O
,	O
and	O
in	O
the	O
homologous	O
TM5	O
,	O
of	O
all	O
mammalian	B
P	I
-	I
gps	I
and	O
also	O
in	O
other	O
ABC	B
transporters	I
,	O
suggests	O
that	O
these	O
residues	O
and	O
domains	O
may	O
play	O
an	O
important	O
role	O
in	O
structural	O
as	O
well	O
as	O
mechanistic	O
aspects	O
common	O
to	O
this	O
family	O
of	O
proteins	O
.	O

SF1	B
/	O
mBBP	B
utilizes	O
a	O
""""	B
maxi	I
-	I
K	I
homology	I
""""	I
(	O
maxi	B
-	I
KH	I
)	O
domain	O
for	O
recognition	O
of	O
the	O
single	O
-	O
stranded	O
BPS	O
and	O
requires	O
a	O
cooperative	O
interaction	O
with	O
splicing	O
factor	O
U2AF65	B
bound	O
to	O
an	O
adjacent	O
polypyrimidine	O
tract	O
(	O
PPT	O
)	O
for	O
high	O
-	O
affinity	O
binding	O
.	O

The	O
in	O
vivo	O
response	O
of	O
the	O
PacC	B
-	I
like	I
decamers	I
to	O
external	O
pH	O
was	O
dependent	O
on	O
the	O
status	O
of	O
the	O
pH	O
-	O
regulated	O
activator	O
YlRim101p	B
,	O
which	O
is	O
homologous	O
to	O
the	O
A.	O
nidulans	O
PacC	B
regulator	O
.	O

Spongiosa	O
regeneration	O
in	O
the	O
millipore	O
chamber	O

MTX	O
therapy	O
decreased	O
Ga-67	O
uptake	O
in	O
liver	O
,	O
tumor	O
,	O
and	O
muscle	O
.	O

No	O
transactivation	O
of	O
the	O
ovalbumin	B
promoter	I
(	O
pLovTATA	B
)	O
template	O
control	O
was	O
observed	O
.	O

Removal	O
of	O
cyclin	B
-	I
dependant	I
kinases	I
(	O
cdks	B
)	O
or	O
cdk2	B
from	O
these	O
extracts	O
using	O
affinity	O
matrices	O
severely	O
inhibits	O
initiation	O
of	O
S	O
phase	O
.	O

Consistent	O
with	O
this	O
hypothesis	O
,	O
stimulation	O
of	O
A	B
(	I
2A	I
)	I
-R	I
or	O
PKA	B
enhanced	O
nuclear	B
aPKC	I
activity	O
.	O

JCAHO	O
to	O
use	O
ORYX	O
data	O
to	O
detect	O
sentinel	O
events	O
.	O

Comparisons	O
of	O
the	O
efficacy	O
of	O
benazepril	O
and	O
hydrochlorothiazide	O
alone	O
and	O
in	O
combination	O
have	O
shown	O
that	O
benazepril	O
20	O
mg	O
once	O
daily	O
is	O
as	O
effective	O
as	O
or	O
more	O
effective	O
in	O
lowering	O
diastolic	O
blood	O
pressure	O
than	O
hydrochlorothiazide	O
25	O
mg	O
once	O
daily	O
and	O
that	O
the	O
combination	O
of	O
benazepril	O
20	O
mg	O
and	O
hydrochlorothiazide	O
25	O
mg	O
has	O
a	O
possibly	O
synergistic	O
effect	O
on	O
diastolic	O
blood	O
pressure	O
.	O

Carcinoma	B
-	I
related	I
protein	I
production	O
may	O
have	O
played	O
a	O
role	O
in	O
the	O
development	O
of	O
the	O
observed	O
renal	O
lesions	O
.	O

Single	O
amino	O
acid	O
substitutions	O
were	O
shown	O
to	O
result	O
from	O
the	O
mutations	O
pdr1	B
-	I
2	I
(	O
M308I	O
)	O
,	O
pdr1	B
-	I
3	I
(	O
F815S	O
)	O
,	O
pdr1	B
-	I
6	I
(	O
K302Q	O
)	O
,	O
pdr1	B
-	I
7	I
(	O
P298A	O
)	O
and	O
pdr1	B
-	I
8	I
(	O
L1036	O
W	O
)	O
,	O
whereas	O
the	O
intragenic	O
suppressor	O
mutant	O
pdr1	B
-	I
100	I
is	O
deleted	O
for	O
the	O
two	O
amino	O
acids	O
L537	O
and	O
A538	O
.	O

However	O
,	O
no	O
statistical	O
difference	O
in	O
the	O
Ca	O
/	O
P	O
ratio	O
,	O
carbon	O
concentration	O
and	O
surface	O
energy	O
were	O
observed	O
with	O
different	O
heat	O
treatments	O
.	O

These	O
motions	O
were	O
found	O
in	O
the	O
N-	O
and	O
C-	O
terminal	O
tails	O
,	O
in	O
segment	O
33	O
-	O
35	O
which	O
forms	O
the	O
turn	O
between	O
beta	O
-	O
strands	O
S1	O
and	O
S2	O
,	O
and	O
residues	O
47	O
-	O
52	O
located	O
in	O
a	O
long	O
loop	O
preceding	O
strand	O
S3	O
.	O

Enterobius	O
vermicularis	O
eggs	O
were	O
demonstrated	O
during	O
microscopic	O
examination	O
of	O
a	O
smear	O
taken	O
from	O
the	O
posterior	O
fornix	O
of	O
the	O
vagina	O
.	O

Differentiation	O
of	O
porcine	O
mycoplasma	O
strains	O
by	O
means	O
of	O
a	O
simple	O
paper	O
chromatography	O
test	O
.	O

D.	O
,	O
Hughes	O
,	O
F.	O

Sequence	O
analysis	O
of	O
AEBP2	B
cDNA	I
revealed	O
that	O
it	O
encodes	O
a	O
protein	O
containing	O
three	O
Gli	B
-	O
Kruppel	B
(	O
Cys2-His2	O
)	O
-type	O
zinc	O
fingers	O
.	O

To	O
elucidate	O
the	O
mechanism	O
of	O
these	O
hormonal	O
effects	O
,	O
we	O
have	O
studied	O
the	O
regulatory	O
regions	O
of	O
the	O
PFK-2	B
gene	I
in	O
transfection	O
experiments	O
.	O

Tryptophan	O
induction	O
prevents	O
Rho	B
-	O
dependent	O
transcription	O
termination	O
in	O
the	O
leader	O
region	O
of	O
the	O
operon	O
.	O

An	O
in	O
vitro	O
Raf-1	B
kinase	I
assay	O
,	O
however	O
,	O
failed	O
to	O
detect	O
LPS	O
-	O
induced	O
Raf-1	B
kinase	I
activity	O
in	O
RAW	O
264.7	O
cells	O
,	O
suggesting	O
that	O
in	O
RAW	O
264.7	O
cells	O
,	O
Raf-1	B
kinase	I
is	O
not	O
an	O
activating	O
component	O
of	O
the	O
LPS	O
signaling	O
pathway	O
regulating	O
MAPK	B
activity	O
or	O
sIL-1Ra	B
promoter	I
activity	O
.	O

Our	O
Northern	O
and	O
Southern	O
blot	O
analyses	O
of	O
meningiomas	O
clearly	O
suggest	O
the	O
CLH-22	B
gene	I
may	O
be	O
involved	O
in	O
the	O
tumor	O
development	O
and	O
can	O
be	O
considered	O
as	O
a	O
candidate	O
for	O
a	O
tumor	O
suppressor	O
.	O

The	O
difference	O
between	O
the	O
results	O
in	O
the	O
high	O
dose	O
AHLG	B
and	O
in	O
the	O
control	O
group	O
was	O
significant	O
(	O
p	O
less	O
than	O
0.05	O
)	O
.	O

The	O
stress	O
/	O
BHV-1	O
model	O
resulted	O
in	O
a	O
mild	O
respiratory	O
infection	O
in	O
all	O
calves	O
with	O
no	O
difference	O
observed	O
between	O
treatment	O
groups	O
.	O

The	O
pepI	B
gene	I
was	O
overexpressed	O
in	O
Escherichia	O
coli	O
.	O

Deep	O
bite	O
CL	O
II	O
Div	O
.	O

Negative	O
modulation	O
of	O
alpha1	B
(	I
I	I
)	I
procollagen	I
gene	I
expression	O
in	O
human	O
skin	O
fibroblasts	O
:	O
transcriptional	O
inhibition	O
by	O
interferon	B
-	I
gamma	I
.	O

In	O
summary	O
,	O
FGFR3	B
signaling	O
pathway	O
utilizes	O
two	O
GRB2-containing	B
complexes	I
;	O
Shc	B
.	O

GRB2.Sos	B
and	O
80K	B
-	I
H.pp66.GRB2.Sos	I
;	O
these	O
two	O
complexes	O
may	O
alternatively	O
link	O
FGFG3	B
to	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
.	O

STUDY	O
DESIGN	O
:	O
Retrospective	O
review	O
.	O

One	O
had	O
a	O
48-hour	O
cycle	O
and	O
the	O
other	O
a	O
24-hour	O
cycle	O
.	O

1	O
The	O
effects	O
of	O
high	O
doses	O
of	O
piretanide	O
,	O
a	O
new	O
diuretic	O
agent	O
chemically	O
related	O
to	O
frusemide	O
and	O
bumetanide	O
were	O
evaluated	O
in	O
twelve	O
patients	O
with	O
severe	O
chronic	O
renal	O
insufficiency	O
(	O
creatinine	O
clearance	O
below	O
25	O
ml	O
/	O
min	O
)	O
.	O

S1	B
nuclease	I
protection	O
mapping	O
and	O
primer	O
extension	O
analysis	O
allowed	O
us	O
to	O
propose	O
that	O
the	O
A	O
residue	O
located	O
19	O
bp	O
upstream	O
from	O
the	O
translation	O
initiation	O
codon	O
is	O
the	O
site	O
of	O
transcription	O
initiation	O
.	O

Various	O
stimuli	O
inactivate	O
IkappaB	B
alpha	I
by	O
triggering	O
phosphorylation	O
of	O
the	O
N	O
-	O
terminal	O
residues	O
Ser32	O
and	O
Ser36	O
.	O

A	O
mouse	O
brain	O
cDNA	O
library	O
in	O
lambdagt11	O
was	O
screened	O
for	O
this	O
association	O
,	O
and	O
two	O
positive	O
clones	O
encoding	O
tyrosine	B
phosphatase	I
SH	B
-	I
PTP2	I
were	O
isolated	O
.	O

Intensive	O
therapy	O
of	O
viral	O
hepatitis	O

Adjusting	O
a	O
steady	O
-	O
state	O
warfarin	O
dose	O
depends	O
on	O
the	O
measured	O
INR	O
values	O
and	O
clinical	O
factors	O
:	O
the	O
dose	O
does	O
not	O
need	O
to	O
be	O
adjusted	O
for	O
a	O
single	O
INR	O
that	O
is	O
slightly	O
out	O
of	O
range	O
,	O
and	O
most	O
changes	O
should	O
alter	O
the	O
total	O
weekly	O
dose	O
by	O
5	O
%	O
to	O
20	O
%	O
.	O

Successful	O
resolution	O
of	O
progressive	O
multifocal	O
leukoencephalopathy	O
after	O
combination	O
therapy	O
with	O
cidofovir	O
and	O
cytosine	O
arabinoside	O
.	O

FTF	O
(	O
Joint	O
Council	O
of	O
Civil	O
Servants	O
and	O
Functionaries	O
)	O
:	O
clarification	O
about	O
membership	O
in	O
the	O
main	O
organizations	O

The	O
differences	O
in	O
binding	O
(	O
Kdapp	O
)	O
,	O
incorporation	O
,	O
and	O
extension	O
kinetics	O
of	O
8-oxo	O
-	O
dGTP	O
compared	O
to	O
normal	O
dNTP	O
incorporation	O
at	O
template	O
8-oxo	O
-	O
G	O
adducts	O
indicate	O
that	O
polymerase	O
fidelity	O
does	O
not	O
depend	O
solely	O
upon	O
the	O
overall	O
geometry	O
of	O
Watson	O
-	O
Crick	O
base	O
pairs	O
and	O
reflects	O
the	O
asymmetry	O
of	O
the	O
enzyme	O
active	O
site	O
.	O

Retroviral	O
vector	O
producer	O
cell	O
populations	O
and	O
cell	O
clones	O
were	O
established	O
for	O
each	O
chLTR	B
vector	O
,	O
and	O
all	O
were	O
capable	O
of	O
yielding	O
high	O
vector	O
titers	O
(	O
>	O
10	O
(	O
5	O
)	O
G418R	B
cfu	O
/	O
ml	O
on	O
NIH-3T3	O
)	O
.	O

None	O
of	O
these	O
patients	O
developed	O
clinical	O
events	O
before	O
disappearance	O
of	O
the	O
phospholipid	O
-	O
dependent	O
inhibitors	O
of	O
coagulation	O
.	O

It	O
is	O
not	O
well	O
known	O
that	O
giant	O
cell	O
arteritis	O
can	O
cause	O
fatal	O
complications	O
due	O
to	O
rupture	O
of	O
aortic	O
aneurysms	O
or	O
cerebral	O
and	O
myocardial	O
infarctions	O
.	O

Temporal	O
recruitment	O
of	O
the	O
mSin3A	B
-	O
histone	B
deacetylase	I
corepressor	O
complex	O
to	O
the	O
ETS	B
domain	I
transcription	I
factor	I
Elk-1	B
.	O

By	O
screening	O
a	O
human	O
testis	O
cDNA	O
library	O
with	O
a	O
probe	O
containing	O
the	O
mouse	B
PEA3	I
ETS	B
domain	O
,	O
we	O
isolated	O
a	O
2.2	O
kb	O
clone	O
containing	O
a	O
510	O
AA	O
open	O
reading	O
frame	O
.	O

It	O
is	O
also	O
affected	O
by	O
the	O
HAP2	B
/	I
3	I
/	I
4	I
transcription	I
factor	I
complex	I
and	O
by	O
SNF1	B
and	O
SSN6	B
.	O

These	O
results	O
indicate	O
that	O
H-2RIIBP	B
(	O
i	O
)	O
is	O
a	O
member	O
of	O
the	O
superfamily	O
of	O
nuclear	B
hormone	I
receptors	I
and	O
(	O
ii	O
)	O
may	O
regulate	O
not	O
only	O
MHC	B
class	I
I	I
genes	I
but	O
also	O
genes	O
containing	O
the	O
ERE	O
and	O
related	O
sequences	O
.	O

The	O
occurrence	O
of	O
the	O
different	O
types	O
of	O
TCRB	B
rearrangement	O
patterns	O
has	O
implications	O
for	O
PCR	O
-	O
based	O
clonality	O
assessment	O
and	O
for	O
PCR	O
-	O
based	O
detection	O
of	O
minimal	O
residual	O
disease	O
via	O
TCRB	B
gene	I
analysis	O
.	O

Directional	O
growth	O
of	O
a	O
smectic	O
-	O
A	O
-	O
smectic	O
-	O
B	O
interface	O
lying	O
along	O
a	O
forbidden	O
orientation	O
.	O

METHODS	O
:	O
We	O
performed	O
nasal	O
mupirocin	O
treatment	O
on	O
10	O
infants	O
who	O
were	O
MRSA	O
-	O
positive	O
either	O
in	O
the	O
nose	O
or	O
the	O
pharynx	O
and	O
evaluated	O
the	O
effect	O
of	O
mupirocin	O
on	O
the	O
eradication	O
of	O
MRSA	O
.	O

TOM1	B
encodes	O
a	O
member	O
of	O
the	O
hect	B
-	O
domain	O
-	O
containing	O
E3	B
ubiquitin	B
-	I
protein	I
ligase	I
family	O
that	O
is	O
required	O
for	O
growth	O
at	O
elevated	O
temperatures	O
.	O

These	O
results	O
demonstrate	O
that	O
m2	B
receptors	I
couple	O
to	O
both	O
G	B
alpha	I
i2	I
and	O
G	B
alpha	I
i3	I
in	O
vivo	O
and	O
that	O
this	O
interaction	O
is	O
integral	O
to	O
both	O
positive	O
and	O
negative	O
regulatory	O
pathways	O
leading	O
to	O
activation	O
of	O
PLC	B
and	O
desensitization	O
of	O
receptor	O
signaling	O
.	O

The	O
cholesterol	B
7alpha	I
-	I
hydroxylase	I
gene	I
(	O
CYP7A	B
)	O
is	O
transcriptionally	O
regulated	O
by	O
a	O
number	O
of	O
factors	O
,	O
including	O
hormones	O
,	O
bile	O
acids	O
,	O
and	O
diurnal	O
rhythm	O
.	O

Restriction	O
mapping	O
showed	O
that	O
the	O
two	O
recombinant	O
plasmids	O
shared	O
an	O
EcoRI	B
fragment	I
of	O
8.9	O
kb	O
.	O

Two	O
mutants	O
,	O
mapping	O
at	O
the	O
HindIII	B
site	I
(	O
between	O
the	O
consensus	O
sequences	O
)	O
of	O
the	O
pSC101	B
tetA	I
promoter	I
,	O
were	O
studied	O
:	O
MA2	O
corresponds	O
to	O
a	O
4	O
bp	O
deletion	O
between	O
positions	O
-12	O
and	O
-15	O
;	O
B30	O
bears	O
a	O
44	O
bp	O
insertion	O
C	O
(	O
TA	O
)	O
21	O
G	O
at	O
the	O
HindIII	B
site	I
.	O

Meq	B
/	O
c	B
-	I
Jun	I
heterodimers	O
bind	O
to	O
an	O
AP1-like	B
sequence	I
in	O
the	O
meq	B
promoter	I
region	I
with	O
an	O
affinity	O
much	O
greater	O
than	O
that	O
of	O
Meq	B
/	O
Meq	B
or	O
c	B
-	I
Jun	I
/	O
c	B
-	I
Jun	I
homodimers	O
.	O

Infra	O
-	O
red	O
spectroscopy	O
of	O
tissues	O
in	O
the	O
700	O
-	O
400	O
cm-1	O
region	O
.	O

Although	O
no	O
detectable	O
phenotypes	O
are	O
associated	O
with	O
a	O
disruption	O
allele	O
of	O
ABP1	B
,	O
mutations	O
that	O
create	O
a	O
requirement	O
for	O
this	O
protein	O
have	O
now	O
been	O
isolated	O
in	O
the	O
previously	O
identified	O
gene	B
SAC6	I
and	O
in	O
two	O
new	O
genes	O
,	O
SLA1	B
and	O
SLA2	B
.	O

The	O
claustrocortical	O
connection	O
was	O
investigated	O
in	O
13	O
cats	O
with	O
selective	O
injections	O
of	O
30	O
%	O
HRP	O
in	O
the	O
three	O
subdivisions	O
of	O
the	O
auditory	O
cortex.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

A	O
significant	O
reduction	O
in	O
total	O
cellular	O
p27	B
protein	I
levels	O
and	O
a	O
moderate	O
reduction	O
in	O
p27	B
mRNA	I
are	O
observed	O
,	O
but	O
no	O
changes	O
in	O
Cdk	B
regulatory	O
kinases	O
and	O
phosphatases	O
occur	O
.	O

This	O
result	O
,	O
together	O
with	O
the	O
fact	O
that	O
unrearranged	B
V	I
kappa	I
genes	I
are	O
transcriptionally	O
silent	O
,	O
suggests	O
that	O
structural	O
features	O
of	O
both	O
the	O
V	B
kappa	I
and	O
C	B
kappa	I
loci	I
contribute	O
to	O
the	O
overall	O
transcriptional	O
efficiency	O
of	O
a	O
rearranged	B
V	I
kappa	I
-	I
C	I
kappa	I
gene	I
.	O

Level	O
II	O
mosaicism	O
occurred	O
in	O
0.9	O
per	O
cent	O
of	O
CVS	O
mesenchyme	O
and	O
1.5	O
per	O
cent	O
of	O
amniotic	O
fluid	O
cultures	O
and	O
in	O
general	O
was	O
not	O
perceived	O
to	O
be	O
of	O
sufficient	O
concern	O
to	O
warrant	O
cytogenetic	O
follow	O
-	O
up	O
studies	O
.	O

There	O
are	O
three	O
types	O
of	O
problems	O
:	O
problems	O
arising	O
before	O
the	O
drug	O
enters	O
the	O
body	O
(	O
solubilization	O
,	O
stabilization	O
and	O
improved	O
acceptability	O
)	O
;	O
problems	O
associated	O
with	O
the	O
penetration	O
and	O
fate	O
of	O
the	O
drug	O
in	O
the	O
body	O
(	O
absorption	O
,	O
barrier	O
crossing	O
,	O
duration	O
of	O
action	O
)	O
;	O
problems	O
relating	O
to	O
the	O
therapeutic	O
target	O
(	O
selective	O
local	O
delivery	O
)	O
.	O

CONCLUSION	O
:	O
Urbanisation	O
is	O
associated	O
with	O
an	O
increase	O
in	O
the	O
prevalence	O
rates	O
of	O
some	O
risk	O
behaviours	O
.	O

The	O
authors	O
emphasize	O
absence	O
of	O
specific	O
signs	O
of	O
vagal	O
involvement	O
,	O
importance	O
for	O
diagnosis	O
of	O
surgical	O
extirpation	O
,	O
and	O
mildness	O
of	O
post	O
operative	O
course	O
.	O

Both	O
in	O
the	O
Federal	O
Republic	O
of	O
Germany	O
and	O
in	O
some	O
neighbouring	O
countries	O
the	O
epizootic	O
situation	O
of	O
Aujeszky	O
's	O
disease	O
has	O
been	O
unsatisfactory	O
for	O
a	O
long	O
time	O
,	O
especially	O
in	O
areas	O
with	O
a	O
high	O
pig	O
density	O
.	O

The	O
sensitivity	O
of	O
99mTc	O
-	O
IgG	B
scintigraphy	O
ranged	O
between	O
71	O
%	O
and	O
100	O
%	O
.	O

Acad	O
.	O

Aggravation	O
of	O
peripheral	O
-	O
blood	O
cytopenia	O
during	O
the	O
first	O
weeks	O
and	O
hypocellularity	O
of	O
bone	O
-	O
marrow	O
aspirates	O
at	O
the	O
end	O
of	O
therapy	O
suggest	O
that	O
low	O
-	O
dose	O
Ara	O
C	O
exerts	O
its	O
main	O
activity	O
by	O
suppression	O
of	O
leukaemic	O
growth	O
,	O
rather	O
than	O
by	O
induction	O
of	O
differentiation	O
in	O
malignant	O
cells	O
.	O

Those	O
participating	O
in	O
this	O
investigation	O
(	O
65	O
centers	O
=	O
79	O
%	O
)	O
received	O
a	O
series	O
of	O
computer	O
disks	O
containing	O
50	O
99mTc	O
-	O
DMSA	O
studies	O
.	O

Probiotics	O
,	O
prebiotics	O
,	O
vaccination	O
,	O
and	O
acidification	O
of	O
drinking	O
water	O
were	O
assessed	O
as	O
means	O
of	O
reducing	O
Salmonella	O
.	O

Mutation	O
of	O
this	O
threonine	O
to	O
isoleucine	O
had	O
no	O
observable	O
effect	O
on	O
either	O
nuclear	O
localization	O
of	O
E1	B
or	O
DNA	O
replication	O
of	O
the	O
intact	O
viral	O
genome	O
.	O

The	O
recovery	O
of	O
xanthomegnin	O
added	O
to	O
corn	O
samples	O
at	O
levels	O
of	O
0.75	O
-	O
-9.6	O
mg	O
/	O
kg	O
averaged	O
41	O
%	O
with	O
a	O
coefficient	O
of	O
variation	O
of	O
25	O
%	O
.	O

Because	O
of	O
the	O
data	O
,	O
we	O
suggest	O
that	O
LAC9	B
contacts	O
positions	O
6	O
,	O
7	O
,	O
and	O
8	O
,	O
both	O
plus	O
and	O
minus	O
,	O
of	O
the	O
UAS	O
,	O
which	O
are	O
separated	O
by	O
more	O
than	O
one	O
turn	O
of	O
the	O
DNA	O
helix	O
,	O
and	O
twists	O
part	O
way	O
around	O
the	O
DNA	O
,	O
thus	O
protecting	O
the	O
broad	O
region	O
of	O
the	O
minor	O
groove	O
between	O
the	O
major	O
-	O
groove	O
contacts	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
FlaB2	B
polypeptide	I
was	O
92	O
%	O
identical	O
to	O
that	O
of	O
T.	B
pallidum	I
FlaB2	I
,	O
with	O
a	O
76	O
%	O
identity	O
at	O
the	O
nucleotide	O
level	O
.	O

Ion	O
-	O
Bernstein	O
-	O
wave	O
heating	O
and	O
improved	O
confinement	O
in	O
the	O
Alcator	O
C	O
tokamak	O
.	O

The	O
subjects	O
were	O
started	O
on	O
indomethacin	O
25	O
mg	O
thrice	O
daily	O
.	O

Human	B
parvovirus	I
B19	I
gene	I
expression	O
from	O
the	O
viral	B
p6	I
promoter	I
(	O
B19p6	B
)	O
is	O
restricted	O
to	O
primary	O
human	O
hematopoietic	O
cells	O
undergoing	O
erythroid	O
differentiation	O
.	O

The	O
atopic	O
disposition	O
,	O
indicated	O
by	O
positive	O
skin	O
reactions	O
and	O
IgE	B
antibody	O
titers	O
etc	O
.	O
,	O
and	O
the	O
bronchial	O
reactivity	O
to	O
inhaled	O
acetylcholine	O
were	O
examined	O
on	O
the	O
following	O
three	O
groups	O
:	O
(	O
1	O
)	O
20	O
young	O
adults	O
with	O
a	O
history	O
of	O
childhood	O
asthma	O
who	O
have	O
been	O
symptom	O
-	O
free	O
for	O
more	O
than	O
4	O
yr	O
;	O
(	O
2	O
)	O
20	O
current	O
asthmatics	O
,	O
and	O
(	O
3	O
)	O
20	O
healthy	O
young	O
adults	O
.	O

Continuous	O
arterial	O
blood	O
sampling	O
method	O
based	O
on	O
the	O
microsphere	O
model	O
was	O
used	O
as	O
a	O
quantitative	O
rCBF	O
measurement	O
.	O

Members	O
of	O
the	O
steroid	B
/	I
hormone	I
nuclear	I
receptor	I
superfamily	I
regulate	O
target	O
gene	O
transcription	O
via	O
recognition	O
and	O
association	O
with	O
specific	O
cis	O
-	O
acting	O
sequences	O
of	O
DNA	O
,	O
called	O
hormone	O
response	O
elements	O
(	O
HREs	O
)	O
.	O

Thomas	O
,	O
S.S.	O

In	O
addition	O
to	O
these	O
cases	O
,	O
patients	O
w	O
with	O
high	O
Loa	O
microfilaremia	O
also	O
developed	O
milder	O
neurologic	O
manifestations	O
causing	O
functional	O
impairment	O
lasting	O
for	O
at	O
least	O
one	O
week	O
after	O
treatment	O
.	O

The	O
patient	O
demographics	O
(	O
means	O
+	O
/-	O

standard	O
deviations	O
)	O
were	O
as	O
follows	O
:	O
age	O
,	O
57	O
+	O
/-	O

12	O
years	O
;	O
sex	O
,	O
nine	O
males	O
and	O
three	O
females	O
;	O
APACHE	O
II	O
score	O
,	O
15	O
+	O
/-	O

3	O
;	O
diagnosis	O
,	O
9	O
of	O
12	O
patients	O
with	O
pneumonia	O
.	O

In	O
contrast	O
,	O
corticotropin	B
releasing	I
factor	I
(	O
CRF	B
)	O
,	O
injected	O
centrally	O
produces	O
a	O
suppression	O
of	O
punished	O
and	O
non	O
-	O
punished	O
responding	O
in	O
the	O
conflict	O
test	O
consistent	O
with	O
its	O
hypothesized	O
role	O
in	O
mediating	O
behavioral	O
responses	O
to	O
stress	O
.	O

Analysis	O
of	O
replicative	O
intermediates	O
shows	O
that	O
plasmid	O
YRp7	O
,	O
which	O
contains	O
the	O
chromosomal	O
replicator	O
ARS1	O
,	O
initiates	O
bidirectional	O
replication	O
in	O
a	O
100	O
bp	O
region	O
within	O
the	O
sequence	O
required	O
for	O
autonomous	O
replication	O
in	O
vivo	O
.	O

Concentrations	O
of	O
Co	O
,	O
Cu	O
,	O
Fe	O
,	O
Hg	O
,	O
Mn	O
,	O
Sb	O
,	O
Se	O
and	O
Zn	O
in	O
IAEA	O
milk	O
(	O
dry	O
)	O
standard	O
A-11	O
were	O
re	O
-	O
evaluated	O
with	O
the	O
help	O
of	O
instrumental	O
and	O
radiochemical	O
neutron	O
activation	O
analysis	O
(	O
NAA	O
)	O
.	O

Here	O
we	O
show	O
that	O
these	O
sequences	O
are	O
essential	O
for	O
processing	O
of	O
U18	B
and	O
snR38	B
snoRNAs	I
and	O
that	O
they	O
compensate	O
for	O
the	O
lack	O
of	O
a	O
canonical	O
terminal	O
stem	O
.	O

In	O
serum	O
-	O
starved	O
NIH	O
3T3	O
cells	O
,	O
v	B
-	I
raf	I
increased	O
mdr1	B
promoter	I
activity	O
approximately	O
10-fold	O
compared	O
to	O
a	O
v	B
-	I
raf	I
frame	O
-	O
shift	O
control	O
.	O

A	O
minimal	O
pheromone	O
induction	O
domain	O
,	O
delineated	O
as	O
residues	O
301	O
to	O
335	O
of	O
Ste12p	B
,	O
is	O
dependent	O
on	O
the	O
pheromone	O
mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinase	I
pathway	O
for	O
induction	O
activity	O
.	O

To	O
assess	O
the	O
effect	O
on	O
thrombus	O
growth	O
,	O
we	O
determined	O
the	O
accretion	O
of	O
125I	O
-	O
labeled	O
fibrinogen	B
onto	O
autologous	O
non	O
-	O
radioactive	O
thrombi	O
preformed	O
in	O
the	O
jugular	O
veins	O
of	O
rabbits	O
.	O

In	O
the	O
other	O
two	O
cases	O
,	O
fluoxetine	O
adjunct	O
produced	O
benefits	O
with	O
no	O
additional	O
side	O
effects	O
.	O

This	O
radiolabeled	O
,	O
900-bp	O
amplicon	O
was	O
used	O
as	O
a	O
hybridization	O
probe	O
to	O
screen	O
a	O
cDNA	O
library	O
constructed	O
from	O
poly	O
(	O
A	O
)	O
(	O
+	O
)	O
RNA	O
isolated	O
from	O
induced	O
Taxus	O
cells	O
,	O
from	O
which	O
a	O
full	O
-	O
length	O
transacetylase	O
sequence	O
was	O
obtained	O
.	O

For	O
the	O
second	O
phase	O
,	O
it	O
was	O
12.5	O
wk	O
for	O
RIR	O
and	O
10	O
for	O
WL	O
males	O
,	O
whereas	O
it	O
was	O
5	O
wk	O
for	O
RIR	O
and	O
6	O
for	O
WL	O
females	O
.	O

TFEC	B
RNA	I
is	O
found	O
in	O
many	O
tissues	O
of	O
adult	O
rats	O
,	O
but	O
the	O
relative	O
concentrations	O
of	O
TFEC	B
and	O
TFE3	B
RNAs	I
vary	O
considerably	O
in	O
these	O
different	O
tissues	O
.	O

VLA-4	B
integrin	I
cross	O
-	O
linking	O
on	O
human	O
monocytic	O
THP-1	O
cells	O
induces	O
tissue	O
factor	O
expression	O
by	O
a	O
mechanism	O
involving	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
.	O

Diethyldithiocarbamate	O
and	O
amphetamine	O
stereotype	O
behavior	O
.	O

Oct-1	B
is	O
a	O
ubiquitously	O
expressed	O
regulatory	O
gene	O
of	O
the	O
POU	B
domain	I
family	I
.	O

Both	O
RNA14	B
and	O
RNA15	B
wild	I
-	I
type	I
genes	I
,	O
when	O
cloned	O
on	O
a	O
multicopy	O
plasmid	O
,	O
are	O
able	O
to	O
suppress	O
the	O
temperature	O
-	O
sensitive	O
phenotype	O
of	O
strains	O
bearing	O
either	O
the	O
rna14	B
or	O
the	O
rna15	B
mutation	I
,	O
suggesting	O
that	O
the	O
encoded	O
proteins	O
could	O
interact	O
with	O
each	O
other	O
.	O

In	O
addition	O
,	O
while	O
GCN1	B
is	O
required	O
in	O
vivo	O
for	O
phosphorylation	O
of	O
eIF-2	B
alpha	I
by	O
GCN2	B
,	O
cell	O
extracts	O
from	O
gcn1	B
delta	I
strains	O
contained	O
wild	O
-	O
type	O
levels	O
of	O
GCN2	B
eIF-2	B
alpha	I
-	O
kinase	O
activity	O
.	O

The	O
phP1	B
mutation	O
was	O
induced	O
by	O
insertion	O
of	O
a	O
1.2-kb	O
P	B
element	I
into	O
the	O
5	O
'	O
transcribed	O
nontranslated	O
region	O
of	O
the	O
proximal	O
polyhomeotic	B
gene	I
.	O

By	O
contrast	O
,	O
clonidine	O
(	O
1	O
micrograms	O
/	O
kg	O
)	O
elicited	O
an	O
immediate	O
and	O
prolonged	O
fall	O
in	O
blood	O
pressure	O
and	O
heart	O
rate	O
when	O
given	O
into	O
the	O
vertebral	O
artery	O
,	O
but	O
not	O
intravenously	O
.	O

To	O
investigate	O
the	O
in	O
vivo	O
role	O
of	O
this	O
chimeric	B
bZIP	I
protein	I
in	O
oncogenic	O
transformation	O
,	O
its	O
expression	O
was	O
directed	O
to	O
the	O
lymphoid	O
compartments	O
of	O
transgenic	O
mice	O
.	O

The	O
MALDI	O
-	O
TOF	O
experiment	O
,	O
however	O
,	O
proved	O
to	O
be	O
superior	O
to	O
the	O
GC	O
experiment	O
,	O
particularly	O
with	O
regard	O
to	O
baseline	O
resolution	O
of	O
unsaturated	O
acids	O
.	O

The	O
mean	O
serum	O
CDT	O
increased	O
from	O
8.5	O
(	O
SD	O
2.2	O
)	O
U	O
/	O
l	O
to	O
16.6	O
(	O
SD	O
7.2	O
)	O
U	O
/	O
l	O
(	O
P	O
<	O
0.001	O
)	O
.	O

In	O
female	O
toads	O
,	O
Bufo	O
bufo	O
,	O
feeding	O
at	O
different	O
rates	O
,	O
the	O
uncorrected	O
value	O
of	O
n	O
was	O
0.44	O
,	O
when	O
metabolism	O
and	O
growth	O
were	O
expressed	O
as	O
kJ	O
kJ-1	O
.	O

In	O
contrast	O
,	O
vRel	B
lacks	O
a	O
strong	O
C	O
-	O
terminal	O
gene	O
activation	O
function	O
,	O
since	O
a	O
LexA	B
fusion	I
protein	I
containing	O
C	B
-	I
terminal	I
vRel	I
sequences	I
alone	O
only	O
weakly	O
activated	O
transcription	O
.	O

Our	O
study	O
reveals	O
a	O
consequence	O
of	O
adhesion	O
receptor	O
-	O
mediated	O
signaling	O
in	O
T	O
cells	O
,	O
which	O
is	O
potentially	O
important	O
in	O
the	O
regulation	O
of	O
T	O
cell	O
activation	O
,	O
including	O
production	O
of	O
cytokines	O
and	O
expression	O
of	O
proto	O
-	O
oncogenes	O
,	O
many	O
of	O
which	O
are	O
controlled	O
through	O
3	O
'	O
AU	O
-	O
rich	O
elements	O
.	O

So	O
it	O
is	O
sometimes	O
more	O
convenient	O
to	O
use	O
the	O
back	O
Radon	O
transform	O
R-1	O
and	O
then	O
to	O
correct	O
the	O
result	O
,	O
taking	O
into	O
account	O
attenuation	O
.	O

These	O
results	O
indicate	O
that	O
(	O
1	O
)	O
RXR	B
-	O
TR	B
heterodimers	O
play	O
a	O
role	O
in	O
basal	O
transactivation	O
and	O
T3	O
suppression	O
of	O
negatively	O
regulated	O
genes	O
,	O
and	O
(	O
2	O
)	O
RXRs	B
increase	O
the	O
dominant	O
negative	O
effect	O
of	O
some	O
mutant	O
TRs	B
on	O
specific	O
negative	O
TREs	O
.	O

Injections	O
of	O
PD	O
solutions	O
with	O
13.6	O
,	O
22.7	O
,	O
and	O
38.6	O
g	O
/	O
liter	O
of	O
glucose	O
reduced	O
the	O
ingestion	O
of	O
sucrose	O
by	O
12.4	O
%	O
,	O
23.6	O
%	O
and	O
36.1	O
%	O
,	O
respectively	O
,	O
but	O
did	O
not	O
affect	O
the	O
ingestion	O
of	O
protein	O
.	O

The	O
Seldinger	O
technique	O
for	O
difficult	O
transurethral	O
catheterization	O
:	O
a	O
gentle	O
alternative	O
to	O
suprapubic	O
puncture	O
(	O
Br	O
J	O
Surg	O
2000	O
;	O
87	O
:	O
1729	O
-	O
30	O
)	O
.	O

Gingival	O
retraction	O
for	O
class	O
V	O
restorations	O
.	O

In	O
contrast	O
to	O
p62	B
(	O
dok	B
)	O
,	O
DOKL	B
lacks	O
YxxP	O
motifs	O
in	O
the	O
C	O
terminus	O
and	O
does	O
not	O
bind	O
to	O
Ras	B
GTPase	I
-	I
activating	I
protein	I
(	O
RasGAP	B
)	O
upon	O
phosphorylation	O
.	O

The	O
presence	O
of	O
chloroquine	O
in	O
saliva	O
from	O
seven	O
healthy	O
volunteers	O
for	O
21	O
days	O
after	O
a	O
single	O
600	O
mg	O
oral	O
dose	O
of	O
the	O
drug	O
was	O
established	O
by	O
chromatographic	O
and	O
spectroscopic	O
methods	O
.	O

In	O
vitro	O
binding	O
studies	O
previously	O
showed	O
that	O
NF	B
-	I
kappa	I
B	I
p50	B
homodimer	O
binds	O
the	O
switch	B
nuclear	I
B	I
-	I
site	I
protein	I
(	O
SNIP	B
)	O
of	O
the	O
S	B
gamma	I
3	I
tandem	I
repeat	I
.	O

Estimating	O
the	O
health	O
care	O
costs	O
of	O
smokers	O
.	O

Although	O
paclitaxel	O
alone	O
failed	O
to	O
induce	O
p38	B
MAPK	O
activation	O
,	O
subsequent	O
(	O
but	O
not	O
prior	O
)	O
exposure	O
to	O
PD98059	O
induced	O
a	O
dramatic	O
increase	O
in	O
p38	B
MAPK	O
phosphorylation	O
.	O

Early	O
detection	O
and	O
signs	O
of	O
hepatoangiosarcoma	O
among	O
vinyl	O
chloride	O
workers	O
.	O

Many	O
retroviruses	O
,	O
including	O
the	O
human	O
and	O
simian	O
immunodeficiency	O
viruses	O
,	O
contain	O
a	O
leucine	O
zipper	O
-	O
like	O
repeat	O
in	O
a	O
highly	O
conserved	O
region	O
of	O
the	O
external	O
domain	O
of	O
the	O
transmembrane	O
(	O
TM	O
)	O
glycoprotein	O
.	O

Conversion	O
of	O
an	O
NF	B
-	I
kappaB	I
into	O
a	O
GABP	B
binding	O
site	O
is	O
likely	O
to	O
have	O
occurred	O
also	O
during	O
the	O
worldwide	O
spread	O
of	O
HIV-1	O
,	O
as	O
we	O
noticed	O
the	O
same	O
LTR	O
modification	O
in	O
subtype	O
E	O
isolates	O
from	O
Thailand	O
.	O

Ciprofloxacin	O
attained	O
a	O
peak	O
serum	O
concentration	O
of	O
1.2	O
mg	O
/	O
l	O
and	O
a	O
serum	O
half	O
-	O
life	O
of	O
34	O
min	O
.	O

As	O
usual	O
tests	O
,	O
such	O
as	O
""""	O
time	O
""""	O
of	O
cephalin	O
are	O
slightly	O
sensible	O
to	O
LMW	O
-	O
Hep	O
,	O
only	O
anti	O
-	O
Xa	O
activity	O
can	O
be	O
used	O
.	O

Choline	B
acetyltransferase	I
immunohistochemistry	O
combined	O
with	O
the	O
retrograde	O
transport	O
of	O
horseradish	B
peroxidase	I
showed	O
that	O
the	O
reticular	O
and	O
mediodorsal	O
thalamic	O
nuclei	O
of	O
the	O
cat	O
receive	O
an	O
important	O
input	O
from	O
cholinergic	O
and	O
non	O
-	O
cholinergic	O
neurons	O
of	O
substantia	O
innominata	O
and	O
adjacent	O
structures	O
in	O
the	O
basal	O
forebrain	O
.	O

The	O
purified	O
RAG1	B
protein	I
overexpressed	O
in	O
E.coli	O
exhibited	O
the	O
expected	O
cleavage	O
activity	O
when	O
combined	O
with	O
RAG2	B
purified	O
from	O
transfected	O
293	O
T	O
cells	O
.	O

These	O
mutant	B
rps7	I
leaders	O
were	O
ligated	O
into	O
an	O
aadA	O
expression	O
cassette	O
and	O
transformed	O
into	O
the	O
chloroplast	O
of	O
C.	O
reinhardtii	O
and	O
into	O
E.	O
coli	O
.	O

The	O
use	O
of	O
medication	O
is	O
of	O
minor	O
importance	O
in	O
the	O
treatment	O
of	O
flight	O
phobia	O
.	O

We	O
previously	O
described	O
the	O
upregulation	O
of	O
the	O
MT2	B
antigen	I
during	O
urodele	O
limb	O
regeneration	O
and	O
characterized	O
the	O
MT2	B
antigen	I
as	O
a	O
310-	O
to	O
325-kDa	O
chondroitin	O
-	O
sulfated	O
glycoprotein	O
with	O
a	O
core	O
protein	O
of	O
285	O
-	O
300	O
kDa	O
.	O

Southern	O
blot	O
analysis	O
following	O
reverse	O
transcription	O
and	O
PCR	O
showed	O
that	O
B2R	B
is	O
expressed	O
in	O
most	O
mouse	O
tissues	O
,	O
except	O
the	O
liver	O
and	O
spleen	O
,	O
which	O
is	O
consistent	O
with	O
the	O
wide	O
distribution	O
of	O
B2R	B
activity	O
as	O
deduced	O
from	O
pharmacological	O
studies	O
.	O

Using	O
the	O
interaction	O
-	O
trap	O
assay	O
to	O
identify	O
candidate	O
proteins	O
that	O
bind	O
the	O
cytoplasmic	O
region	O
of	O
the	O
LAR	B
transmembrane	I
protein	I
tyrosine	I
phosphatase	I
(	O
PT	B
-	I
Pase	I
)	O
,	O
we	O
isolated	O
a	O
cDNA	O
encoding	O
a	O
2861-amino	O
acid	O
protein	O
termed	O
Trio	B
that	O
contains	O
three	O
enzyme	O
domains	O
:	O
two	O
functional	O
GEF	B
domains	I
and	O
a	O
protein	B
serine	I
/	I
threonine	I
kinase	I
(	O
PSK	B
)	O
domain	O
.	O

The	O
role	O
of	O
the	O
putative	O
C2	B
domain	O
of	O
Nedd4	B
has	O
not	O
been	O
elucidated	O
.	O

Additionally	O
,	O
these	O
findings	O
have	O
important	O
implications	O
for	O
the	O
understanding	O
of	O
the	O
mechanisms	O
of	O
HIV-1	O
latency	O
and	O
reactivation	O
.	O

The	O
average	O
mean	O
difference	O
compared	O
with	O
the	O
low	O
and	O
the	O
intermediate	O
calcium	O
group	O
was	O
11	O
%	O
for	O
the	O
femoral	O
neck	O
,	O
8	O
-	O
11	O
%	O
for	O
the	O
lumbar	O
spine	O
and	O
5	O
-	O
6	O
%	O
for	O
total	O
body	O
BMDs	O
.	O

Although	O
the	O
number	O
of	O
kits	O
has	O
increased	O
,	O
the	O
precision	O
has	O
improved	O
,	O
showing	O
that	O
more	O
robust	O
methods	O
are	O
now	O
employed	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
contained	O
all	O
consensus	O
regions	O
for	O
S	B
-	I
adenosyl	I
methionine	I
methyltransferases	I
and	O
presented	O
26	O
%	O
identity	O
with	O
Saccharomyces	B
cerevisiae	I
DHHB	I
-	I
methyltransferase	I
and	O
38	O
%	O
identity	O
with	O
the	O
rat	O
protein	O
,	O
as	O
well	O
as	O
with	O
a	O
bacterial	O
(	O
Escherichia	O
coli	O
and	O
Salmonella	O
typhimurium	O
)	O
methyltransferase	B
encoded	O
by	O
the	O
UBIG	B
gene	I
.	O

To	O
investigate	O
its	O
transcription	O
,	O
1.1	O
kilobases	O
of	O
the	O
5'-flanking	O
sequence	O
were	O
fused	O
to	O
a	O
luciferase	B
reporter	I
gene	I
.	O

A	O
selective	O
transcriptional	O
induction	O
system	O
for	O
mammalian	O
cells	O
based	O
on	O
Gal4-estrogen	B
receptor	B
fusion	O
proteins	O
.	O

The	O
cyanobacterial	B
phycobilisome	I
is	O
a	O
large	O
protein	O
complex	O
located	O
on	O
the	O
photosynthetic	O
membrane	O
.	O

Lamivudine	O
therapy	O
for	O
acute	O
hepatitis	O
B	O
infection	O
following	O
peripheral	O
blood	O
stem	O
cell	O
transplantation	O
.	O

The	O
collicular	O
labels	O
found	O
after	O
injections	O
within	O
the	O
MST	O
area	O
exhibited	O
their	O
distribution	O
over	O
the	O
deep	O
SC	O
subdivision	O
,	O
whereas	O
they	O
spared	O
all	O
the	O
superficial	O
layers	O
but	O
the	O
deep	O
part	O
of	O
the	O
SO	O
.	O

Modern	O
aspects	O
of	O
shock	O
-	O
treatment	O
in	O
extensive	O
burns	O
(	O
author	O
's	O
transl	O
)	O

Mapping	O
of	O
the	O
region	O
in	O
KAP-1	B
required	O
for	O
HP1	B
interaction	O
showed	O
that	O
amino	O
acid	O
substitutions	O
which	O
abolish	O
HP1	B
binding	O
in	O
vitro	O
reduce	O
KAP-1	B
mediated	O
repression	O
in	O
vivo	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
the	O
Smad3	B
/	O
Smad4	B
complex	O
has	O
at	O
least	O
two	O
separable	O
nuclear	O
functions	O
:	O
it	O
forms	O
a	O
rapid	O
,	O
yet	O
transient	O
sequence	O
-	O
specific	O
DNA	O
binding	O
complex	O
,	O
and	O
it	O
potentiates	O
AP1-dependent	B
transcriptional	O
activation	O
.	O

The	O
donors	O
of	O
10	O
patients	O
were	O
ABO	O
-	O
incompatible	O
,	O
and	O
for	O
five	O
pairs	O
the	O
ABO	O
incompatibility	O
was	O
major	O
.	O

The	O
major	O
promoter	O
element	O
of	O
the	O
Xenopus	B
laevis	I
5S	I
RNA	I
gene	I
is	O
located	O
within	O
the	O
transcribed	O
region	O
of	O
the	O
gene	O
and	O
forms	O
the	O
binding	O
site	O
for	O
the	O
transcription	O
initiation	O
factor	O
TFIIIA	B
.	O

Small	O
cell	O
tumors	O
in	O
children	O
:	O
contribution	O
to	O
the	O
solution	O
of	O
the	O
problem	O
of	O
differential	O
diagnosis	O
with	O
immunohistochemistry	O
and	O
electron	O
microscopy	O

Four	O
experiments	O
examined	O
the	O
role	O
of	O
the	O
cholinergic	O
projections	O
from	O
the	O
septum	O
and	O
vertical	O
limb	O
nucleus	O
of	O
the	O
diagonal	O
band	O
of	O
Broca	O
(	O
VDB	O
)	O
in	O
acquisition	O
and	O
performance	O
of	O
a	O
conditional	O
visual	O
discrimination	O
.	O

Microsporum	O
persicolor	O
,	O
an	O
easily	O
misinterpreted	O
dermatophyt	O

When	O
they	O
were	O
exposed	O
to	O
intermittent	O
schedules	O
of	O
punishment	O
(	O
fixed	O
-	O
interval	O
[	O
FI	O
]	O
120	O
s	O
or	O
FI	O
300	O
s	O
)	O
,	O
SIB	O
for	O
all	O
but	O
1	O
of	O
the	O
participants	O
increased	O
to	O
levels	O
similar	O
to	O
those	O
observed	O
during	O
baseline	O
.	O

PKK	B
exists	O
in	O
three	O
discernible	O
forms	O
at	O
steady	O
state	O
:	O
an	O
underphosphorylated	O
form	O
of	O
100	O
kDa	O
;	O
a	O
soluble	O
,	O
cytosolic	O
,	O
phosphorylated	O
form	O
of	O
110	O
kDa	O
;	O
and	O
a	O
phosphorylated	O
,	O
detergent	O
-	O
insoluble	O
form	O
of	O
112	O
kDa	O
.	O

The	O
lamina	O
densa	O
was	O
always	O
interrupted	O
by	O
numerous	O
small	O
gaps	O
and	O
in	O
some	O
areas	O
the	O
basement	O
membrane	O
could	O
not	O
be	O
identified	O
over	O
a	O
long	O
distance	O
.	O

The	O
human	B
CA11	I
gene	I
appears	O
to	O
be	O
located	O
between	O
the	O
secretor	B
type	I
alpha	I
(	I
1,2	I
)	I
-fucosyltransferase	I
gene	I
cluster	I
(	O
FUT1-FUT2-FUT2P	B
)	O
and	O
the	O
D	B
-	I
site	I
binding	I
protein	I
gene	I
(	O
DBP	B
)	O
on	O
chromosome	O
19q13.3	O
.	O

To	O
determine	O
the	O
role	O
of	O
elevated	O
FAK	B
expression	O
in	O
facilitating	O
epidermal	B
growth	I
factor	I
(	O
EGF	B
)	O
-stimulated	O
human	O
adenocarcinoma	O
(	O
A549	O
)	O
cell	O
motility	O
,	O
antisense	O
oligonucleotides	O
were	O
used	O
to	O
reduce	O
FAK	B
protein	I
expression	O
>	O
75	O
%	O
.	O

Evaluation	O
of	O
materials	O
and	O
technics	O
in	O
vascular	O
surgery	O
using	O
111-Indium	O

In	O
the	O
postoperative	O
patient	O
with	O
tetralogy	O
of	O
Fallot	O
with	O
symptomatic	O
ventricular	O
arrhythmias	O
,	O
it	O
is	O
concluded	O
that	O
electrophysiologic	O
study	O
is	O
useful	O
in	O
reproducing	O
clinical	O
episodes	O
of	O
VT	O
and	O
in	O
selecting	O
effective	O
antiarrhythmic	O
medication	O
;	O
a	O
small	O
number	O
of	O
patients	O
with	O
ventricular	O
premature	O
complexes	O
alone	O
will	O
have	O
inducible	O
sustained	O
VT	O
during	O
electrophysiologic	O
study	O
;	O
prognosis	O
of	O
these	O
patients	O
may	O
be	O
improved	O
by	O
treatment	O
that	O
results	O
in	O
prevention	O
of	O
VT	O
induction	O
;	O
and	O
in	O
patients	O
with	O
right	O
ventricular	O
hypertension	O
,	O
VT	O
is	O
likely	O
to	O
be	O
refractory	O
to	O
drug	O
treatment	O
.	O

In	O
human	O
myxoid	O
liposarcoma	O
,	O
a	O
chromosomal	O
rearrangement	O
leads	O
to	O
fusion	O
of	O
the	O
growth	O
-	O
arresting	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
transcription	O
factor	O
CHOP	B
(	O
GADD153	B
)	O
to	O
a	O
peptide	O
fragment	O
encoded	O
by	O
the	O
TLS	B
gene	I
.	O

Categorisation	O
of	O
the	O
different	O
substructures	O
within	O
the	O
sections	O
allows	O
them	O
to	O
be	O
analysed	O
and	O
displayed	O
separately	O
.	O

The	O
only	O
quantities	O
which	O
were	O
significantly	O
different	O
between	O
appendicitis	O
and	O
a	O
normal	O
appendix	O
were	O
sex	O
,	O
duration	O
of	O
symptoms	O
,	O
anorexia	O
and	O
vomiting	O
.	O

Signaling	O
through	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
and	O
Rac	B
/	O
Rho	B
does	O
not	O
duplicate	O
the	O
effects	O
of	O
activated	O
Ras	B
on	O
skeletal	O
myogenesis	O
.	O

Unlike	O
these	O
contaminant	O
-	O
responsive	O
T	O
cells	O
,	O
those	O
that	O
are	O
truly	O
specific	O
for	O
natural	O
AChR	B
epitopes	I
appear	O
less	O
heterogeneous	O
and	O
therefore	O
more	O
suitable	O
targets	O
for	O
selective	O
immunotherapy	O
.	O

CONCLUSIONS	O
:	O
This	O
initial	O
experience	O
indicates	O
that	O
there	O
is	O
short-	O
to	O
middle	O
-	O
term	O
efficiency	O
and	O
safety	O
when	O
using	O
GKS	O
to	O
treat	O
MTLE	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
examine	O
whether	O
the	O
EORTC	O
(	O
European	O
Organisation	O
for	O
Research	O
and	O
Treatment	O
of	O
Cancer	O
)	O
QLQ	O
-	O
C30	O
core	O
questionnaire	O
alone	O
could	O
distinguish	O
between	O
two	O
clinically	O
different	O
groups	O
of	O
patients	O
and	O
to	O
design	O
a	O
module	O
,	O
which	O
included	O
relevant	O
patient	O
-	O
defined	O
gastric	O
cancer	O
-	O
specific	O
variables	O
.	O

Causal	O
modeling	O
combines	O
theory	O
and	O
research	O
,	O
and	O
because	O
the	O
interpretation	O
of	O
data	O
is	O
possible	O
only	O
within	O
the	O
context	O
of	O
the	O
proposed	O
theory	O
,	O
it	O
offers	O
an	O
important	O
method	O
for	O
advancing	O
the	O
science	O
while	O
maintaining	O
the	O
specificity	O
of	O
the	O
practice	O
.	O

Comparison	O
with	O
alkaline	B
phosphatases	I
and	O
5-nucleotidase	B

Beta	O
blocking	O
agents	O
.	O

When	O
extracorporeal	O
CO2	O
removal	O
approximated	O
CO2	O
production	O
(	O
VCO2	O
)	O
,	O
alveolar	O
ventilation	O
almost	O
ceased	O
.	O

Intravenous	O
administration	O
(	O
25	O
mg	O
/	O
kg	O
)	O
of	O
carbonic	B
anhydrase	I
inhibitors	O
(	O
acetazolamide	O
,	O
methazolamide	O
,	O
dichlorphenamide	O
,	O
sulthiame	O
)	O
induced	O
an	O
early	O
important	O
rise	O
of	O
cortical	O
p	O
O2	O
,	O
which	O
is	O
not	O
dependent	O
on	O
increase	O
of	O
p	O
O2	O
and	O
p	O
CO2	O
and	O
decrease	O
of	O
pH	O
in	O
arterial	O
blood	O
.	O

Teratological	O
study	O
of	O
etoperidone	O
in	O
the	O
rat	O
and	O
rabbit	O
.	O

Colorectal	O
polyps	O
should	O
be	O
removed	O
endoscopically	O
whenever	O
possible	O
.	O

When	O
the	O
CO2	O
content	O
reached	O
9	O
Vol%	O
the	O
animals	O
became	O
apathic	O
and	O
lost	O
body	O
weight	O
.	O

Serum	B
gamma	I
glutamyltransferase	I
in	O
the	O
diagnosis	O
of	O
liver	O
disease	O
in	O
cattle	O
.	O

By	O
contrast	O
,	O
secretory	B
HI	I
antibodies	I
were	O
not	O
demonstrated	O
at	O
the	O
onset	O
of	O
illness	O
in	O
any	O
of	O
the	O
patients	O
,	O
but	O
their	O
formation	O
started	O
early	O
and	O
the	O
antibodies	O
reached	O
maximal	O
levels	O
about	O
10	O
days	O
after	O
onset	O
of	O
illness	O
.	O

With	O
the	O
exception	O
of	O
virus	O
assay	O
and	O
quantitation	O
,	O
these	O
methods	O
are	O
simple	O
and	O
inexpensive	O
enough	O
to	O
be	O
done	O
in	O
typical	O
shellfish	O
microbiology	O
laboratories	O
.	O

Takayasu	O
's	O
disease	O
:	O
association	O
with	O
HLA	B
-	I
B5	I
.	O

Patients	O
with	O
Parkinson	O
's	O
disease	O
showed	O
a	O
relatively	O
high	O
incidence	O
to	O
psychoses	O
during	O
drug	O
treatment	O
(	O
51.47	O
%	O
)	O
.	O

Selective	O
stimulation	O
of	O
central	O
alpha	B
-	I
autoreceptors	I
following	O
treatment	O
with	O
alpha	O
-	O
methyldopa	O
and	O
FLA	O
136	O
.	O

Abstracts	O
.	O

Removal	O
of	O
thick	O
,	O
permanently	O
altered	O
mucoas	O
is	O
recommended	O
even	O
in	O
the	O
absence	O
of	O
squamous	O
epithelium	O
.	O

An	O
IgG	B
monoclonal	O
gammopathy	O
was	O
present	O
in	O
the	O
serum	O
of	O
4	O
patients	O
and	O
Bence	O
-	O
Joanes	O
proteinuria	O
was	O
found	O
in	O
1	O
patient	O
.	O

Studies	O
on	O
immunoglobulin	B
E	I
:	O
the	O
impact	O
of	O
a	O
sojourn	O
with	O
Professor	O
Dan	O
H.	O

Peroxydase	B
reaction	O
stains	O
were	O
negative	O
,	O
chloroacetate	B
esterase	I
were	O
strongly	O
positive	O
.	O

Of	O
600	O
mediastinoscopies	O
carried	O
out	O
from	O
1966	O
to	O
1973	O
,	O
479	O
were	O
performed	O
to	O
assess	O
the	O
operability	O
of	O
a	O
pulmonary	O
carcinoma	O
.	O

A	O
mixture	O
of	O
human	B
albumin	I
5	O
%	O
and	O
hydroxy	O
-	O
ethyl	O
-	O
starch	O
was	O
used	O
as	O
a	O
solution	O
for	O
dilution	O
.	O

Late	O
complications	O
of	O
catheterisation	O
for	O
intravenous	O
nutrition	O
.	O

Sings	O
which	O
are	O
indicative	O
of	O
metaplastic	O
erythropoiesis	O
are	O
absent	O
.	O

Serum	O
-	O
ferritin	B
in	O
diagnosis	O
of	O
haemochromatosis	O
.	O

Preface	O
.	O

Thirty	O
-	O
five	O
strains	O
of	O
Legionnaires	O
'	O
disease	O
bacteria	O
were	O
shown	O
to	O
belong	O
in	O
four	O
distinct	O
serologic	O
groups	O
on	O
the	O
basis	O
of	O
findings	O
obtained	O
with	O
direct	O
fluorescent	O
antibody	O
testing	O
.	O

On	O
the	O
other	O
hand	O
factor	B
IX	I
activity	O
is	O
decreased	O
in	O
coumarin	O
treatment	O
with	O
factor	B
IX	I
antigen	O
remaining	O
normal	O
.	O

The	O
concentration	O
of	O
alpha	B
2-macroglobulin	I
,	O
alpha	B
1-antitrypsin	I
,	O
plasminogen	B
,	O
C3-complement	B
,	O
fibrinogen	B
degradation	I
products	I
(	O
FDP	B
)	O
and	O
fibrinolytic	O
activity	O
,	O
were	O
studied	O
in	O
the	O
aqueous	O
humour	O
and	O
serum	O
from	O
nine	O
patients	O
with	O
Fuchs	O
'	O
endothelial	O
dystrophy	O
,	O
17	O
patients	O
with	O
uncomplicated	O
senile	O
cataract	O
and	O
in	O
the	O
secondary	O
aqueous	O
from	O
six	O
cataract	O
patients	O
.	O

Only	O
17	O
%	O
of	O
all	O
patients	O
admitted	O
it	O
at	O
all	O
times	O
.	O

Prazosin	O
alone	O
was	O
effective	O
in	O
volume	O
responsive	O
patients	O
at	O
a	O
dose	O
of	O
5	O
+	O
/-	O

1.0	O
mg	O
daily	O
.	O

T4	O
and	O
FT4I	O
followed	O
parallel	O
courses	O
in	O
both	O
groups	O
;	O
during	O
the	O
first	O
45	O
days	O
,	O
however	O
,	O
the	O
values	O
were	O
significantly	O
lower	O
in	O
premature	O
infants	O
under	O
34	O
weeks	O
'	O
EGA	O
than	O
in	O
term	O
infants	O
(	O
P	O
less	O
than	O
0.001	O
)	O
.	O

Aspirin	O
intolerance	O
:	O
unaltered	O
susceptibility	O
of	O
platelet	B
cyclo	I
-	I
oxygenase	I
to	O
inhibition	O
by	O
aspirin	O
in	O
vitro	O
.	O

59	O
cases	O
of	O
surgically	O
resectable	O
cancers	O
(	O
T1	O
,	O
T2	O
,	O
T3	O
,	O
N0	O
,	O
N1	O
)	O
had	O
a	O
minimum	O
followup	O
of	O
two	O
years	O
(	O
average	O
4	O
years	O
+	O
/-	O

3	O
months	O
)	O
.	O

The	O
effect	O
of	O
CBZ	O
and	O
DPH	O
can	O
be	O
explained	O
by	O
interference	O
with	O
thyroid	O
hormone	O
binding	O
to	O
TBG	B
combined	O
with	O
enzyme	O
-	O
induced	O
increased	O
metabolic	O
clearance	O
rate	O
of	O
thyroid	O
hormones	O
without	O
homeostatic	O
maintenance	O
of	O
premedication	O
levels	O
of	O
FT4	O
and	O
FT3	O
.	O

The	O
present	O
research	O
evaluated	O
the	O
possibility	O
that	O
polyethylene	O
glycol	O
400	O
(	O
PEG	O
400	O
)	O
might	O
be	O
efficacious	O
,	O
toxic	O
,	O
or	O
both	O
.	O

According	O
to	O
their	O
functional	O
properties	O
the	O
latter	O
neurons	O
were	O
subdivided	O
into	O
:	O
(	O
a	O
)	O
neurons	O
responding	O
to	O
stimuli	O
near	O
the	O
eyes	O
;	O
(	O
b	O
)	O
neurons	O
triggered	O
by	O
complex	O
visual	O
stimuli	O
;	O
(	O
c	O
)	O
neurons	O
inhibited	O
by	O
visual	O
stimuli	O
.	O

All	O
groups	O
were	O
tested	O
in	O
a	O
Hebb	O
-	O
Williams	O
maze	O
at	O
100	O
approximately	O
10	O
days	O
of	O
age	O
.	O

Erythromycin	O
and	O
clindamycin	O
resistance	O
in	O
Corynebacterium	O
diphtheriae	O
from	O
skin	O
lesions	O
.	O

Imposed	O
angular	O
displacements	O
of	O
monkey	O
's	O
wrist	O
produce	O
three	O
major	O
peaks	O
of	O
activity	O
(	O
terms	O
M1	O
,	O
M2	O
,	O
and	O
M3	O
peaks	O
)	O
in	O
the	O
averaged	O
gross	O
EMG	O
activity	O
ot	O
the	O
stretched	O
muscles	O
.	O

Hemolytic	O
disease	O
of	O
African	O
newborn	O
.	O

The	O
majority	O
of	O
MRF	O
units	O
were	O
behaviorally	O
incongruent	O
;	O
in	O
the	O
most	O
frequently	O
observed	O
case	O
,	O
their	O
activity	O
failed	O
to	O
change	O
reliably	O
when	O
behavior	O
habituated	O
.	O

Variability	O
within	O
Down	O
's	O
syndrome	O
(	O
trisomy-21	O
)	O
:	O
empirically	O
observed	O
sex	O
differences	O
in	O
IQs	O
.	O

Eight	O
hours	O
after	O
the	O
administration	O
of	O
colchicine	O
,	O
the	O
serum	B
ceruloplasmin	I
level	O
began	O
to	O
rise	O
again	O
in	O
female	O
rats	O
,	O
but	O
not	O
in	O
male	O
rats	O
.	O

Radioimmunoassays	O
of	O
pregnenolone	O
,	O
progesterone	O
,	O
dehydroepiandrosterone	O
(	O
DHA	O
)	O
16	O
alpha	O
-	O
hydroxy	O
-	O
DHA	O
,	O
estriol	O
,	O
and	O
cortisol	O
were	O
performed	O
on	O
a	O
total	O
of	O
0;1	O
ml	O
;	O
of	O
fetal	O
plasma	O
,	O
collected	O
during	O
the	O
course	O
of	O
normal	O
vaginal	O
delivery	O
.	O

In	O
only	O
two	O
patients	O
were	O
we	O
able	O
to	O
demonstrate	O
changes	O
suggestive	O
of	O
pulmonary	O
metastases	O
any	O
earlier	O
with	O
a	O
99mTc	O
-	O
EHDP	O
scan	O
than	O
with	O
chest	O
radiographs	O
and	O
one	O
of	O
these	O
resolved	O
spontaneously	O
.	O

The	O
majority	O
of	O
tumors	O
occurred	O
in	O
the	O
nasal	O
cavities	O
,	O
although	O
significant	O
incidences	O
were	O
also	O
found	O
in	O
the	O
larynx	O
,	O
trachea	O
and	O
stem	O
bronchi	O
.	O

Native	O
human	B
fibrinogen	I
was	O
brought	O
to	O
coagulation	O
by	O
adding	O
thrombin	B
.	O

The	O
Southern	O
technique	O
allowed	O
a	O
further	O
localization	O
of	O
the	O
region	O
of	O
most	O
extensive	O
transcription	O
to	O
a	O
1.8	O
kb	O
HindIII	B
-	O
EcoRI	B
fragment	O
.	O

SV	O
increased	O
less	O
in	O
SHR	O
,	O
mainly	O
reflecting	O
the	O
reduced	O
diastolic	O
compliance	O
of	O
the	O
hypertrophied	O
SHR	O
left	O
ventricle	O
and	O
the	O
consequent	O
rightward	O
shift	O
of	O
its	O
Frank	O
-	O
Starling	O
curve	O
.	O

The	O
carcass	O
of	O
a	O
great	O
horned	O
owl	O
(	O
Bubo	O
virginianus	O
)	O
,	O
which	O
had	O
been	O
found	O
moribund	O
in	O
southern	O
Ontario	O
,	O
was	O
presented	O
for	O
necropsy	O
.	O

Steroid	O
glucuronides	O
in	O
amniotic	O
fluid	O
at	O
term	O
.	O

Polyglactin	O
910	O
suture	O
absorption	O
and	O
the	O
role	O
of	O
cellular	O
enzymes	O
.	O

Studies	O
of	O
lipoproteins	O
should	O
,	O
however	O
,	O
be	O
made	O
in	O
children	O
from	O
families	O
known	O
to	O
have	O
FH	O
or	O
early	O
coronary	O
heart	O
disease	O
.	O

Sixteen	O
other	O
normal	O
subjects	O
with	O
2	O
g	O
of	O
Metyrapone	O
are	O
best	O
responses	O
.	O

EEG	O
theta	O
waves	O
and	O
psychological	O
phenomena	O
:	O
a	O
review	O
and	O
analysis	O
.	O

REM	O
dream	O
content	O
was	O
scored	O
for	O
categories	O
suggesting	O
the	O
predominant	O
influence	O
of	O
the	O
left	O
hemisphere	O
,	O
e.g.	O
,	O
good	O
ego	O
functioning	O
,	O
verbalization	O
,	O
or	O
the	O
right	O
hemisphere	O
,	O
e.g.	O
,	O
music	O
,	O
spatial	O
salience	O
,	O
bizarreness	O
.	O

Innervation	O
of	O
the	O
ventral	O
diaphragm	O
of	O
the	O
locust	O
(	O
Locusta	O
migratoria	O
)	O
.	O

Ectopic	O
ACTH	B
syndrome	O
and	O
medullary	O
thyroid	O
carcinoma	O
.	O

Chronic	O
hypophosphatemia	O
is	O
the	O
most	O
common	O
type	O
of	O
""""	O
resistant	O
""""	O
rickets	O
.	O

There	O
was	O
no	O
correlation	O
between	O
serum	B
LH	I
and	O
chronological	O
or	O
bone	O
age	O
in	O
this	O
age	O
group	O
,	O
which	O
suggests	O
that	O
the	O
correlation	O
found	O
is	O
not	O
due	O
to	O
age	O
-	O
related	O
parallel	O
phenomena	O
.	O

Molecular	O
neurochemistry	O
of	O
addictive	O
drugs	O
.	O

Efforts	O
were	O
made	O
to	O
determine	O
the	O
amount	O
of	O
time	O
required	O
for	O
kidney	O
lesions	O
to	O
develop	O
and	O
,	O
if	O
possible	O
,	O
to	O
delineate	O
the	O
potential	O
site	O
of	O
action	O
of	O
PBB	O
.	O

Effect	O
of	O
succimer	O
on	O
the	O
intensity	O
of	O
tricarboxylic	B
acid	I
dehydrogenase	I
reactions	O
in	O
the	O
brain	O
of	O
rats	O
poisoned	O
with	O
mercuric	O
chloride	O

Technetium-99	O
m	O
stannous	O
pyrophosphate	O
myocardial	O
scintigrams	O
were	O
obtained	O
in	O
138	O
clinically	O
stable	O
patients	O
32.7	O
+	O
/-	O

47.3	O
weeks	O
(	O
range	O
6	O
to	O
260	O
)	O
after	O
acute	O
myocardial	O
infarction	O
.	O

A	O
similar	O
phenomenon	O
has	O
been	O
reported	O
in	O
a	O
few	O
humans	O
.	O

The	O
decline	O
in	O
the	O
activity	O
of	O
cytochrome	B
oxidase	I
,	O
peroxidase	B
and	O
in	O
the	O
lipid	O
content	O
of	O
peripheral	O
neutrophils	O
was	O
followed	O
by	O
a	O
decrease	O
in	O
the	O
phagocytic	O
activity	O
.	O

Treatment	O
of	O
2	O
patients	O
with	O
pseudohypoparathyroidism	O
type	O
I	O
with	O
vitamin	O
-	O
D-3	O
and	O
1	O
alpha	O
-	O
Hydroxycholecalciferol	O
consecutively	O
resulted	O
in	O
a	O
nonuniform	O
response	O
with	O
regard	O
to	O
the	O
normalisation	O
of	O
serum	O
-	O
calcium	O
.	O

Total	O
VO2	O
was	O
decreased	O
in	O
both	O
groups	O
during	O
severe	O
hypoxia	O
but	O
limb	O
VO2	O
was	O
maintained	O
in	O
the	O
beta	O
-	O
block	O
group	O
.	O

beta	O
-	O
Block	O
prevented	O
the	O
fall	O
in	O
total	O
and	O
limb	O
peripheral	O
resistance	O
seen	O
in	O
severe	O
hypoxia	O
but	O
did	O
not	O
alter	O
the	O
consistently	O
more	O
efficient	O
utilization	O
of	O
total	O
O2	O
delivery	O
shown	O
by	O
the	O
limb	O
in	O
comparison	O
to	O
the	O
whole	O
body	O
by	O
higher	O
O2	O
extraction	O
ratios	O
and	O
lower	O
venous	O
O2	O
pressure	O
.	O

beta	B
-	I
Vasodilator	I
receptors	I
evidently	O
played	O
an	O
active	O
part	O
in	O
the	O
vasodilatation	O
seen	O
during	O
severe	O
hypoxia	O
.	O

Phenobarbital	O
-	O
induced	O
alterations	O
in	O
the	O
metabolism	O
of	O
[	O
3H	O
]	O
vitamin	O
D3	O
by	O
the	O
perfused	O
rachitic	O
rat	O
liver	O
in	O
vitro	O
.	O

Effect	O
of	O
corticosteroid	O
-	O
containing	O
antirheumatic	O
combination	O
drugs	O
on	O
endogenous	O
ACTH	B
and	O
cortisol	O
production	O
.	O

Anatomy	O
of	O
the	O
RNA	O
and	O
gene	O
products	O
of	O
MC29	O
and	O
MH2	O
,	O
two	O
defective	O
avian	O
tumor	O
viruses	O
causing	O
acute	O
leukemia	O
and	O
carcinoma	O
:	O
evidence	O
for	O
a	O
new	O
class	O
of	O
transforming	O
genes	O
.	O

Gamma	B
glutamyl	I
transpeptidase	I
activity	O
was	O
increased	O
up	O
to	O
15	O
times	O
above	O
the	O
upper	O
normal	O
limit	O
in	O
children	O
,	O
who	O
received	O
aminopyrine	O
for	O
two	O
weeks	O
or	O
longer	O
.	O

XXI	O
.	O

A	O
gas	O
-	O
liquid	O
chromatographic	O
method	O
for	O
the	O
determination	O
of	O
p	O
-	O
chlorophenoxyisobutyric	O
(	O
CPIB	O
)	O
acid	O
in	O
blood	O
plasma	O
is	O
described	O
.	O

Dopamine	B
receptor	I
blockade	O
and	O
the	O
neuroleptics	O
,	O
a	O
crystallographic	O
study	O
.	O

V.	O

How	O
do	O
graduates	O
of	O
different	O
types	O
of	O
programs	O
perform	O
on	O
state	O
boards	O
?	O

Because	O
of	O
serious	O
infections	O
(	O
fever	O
larger	O
than	O
or	O
equal	O
to	O
101	O
degrees	O
F.	O
granulocytes	O
less	O
than	O
1,000	O
/	O
mm	O
,	O
3	O
and	O
hospitalization	O
)	O
and	O
1	O
drug	O
death	O
in	O
the	O
first	O
4	O
patients	O
,	O
oral	O
calcium	O
leucovorin	O
,	O
20	O
to	O
30	O
mg	O
/	O
m2	O
orally	O
,	O
was	O
given	O
2	O
days	O
after	O
methotrexate	O
in	O
subsequent	O
treatment	O
cycles	O
.	O

Here	O
the	O
conventional	O
tests	O
clearly	O
pointed	O
to	O
the	O
presence	O
of	O
retrocochlear	O
disease	O
.	O

The	O
end	O
-	O
stage	O
or	O
involutional	O
phase	O
of	O
proliferative	O
diabetic	O
retinopathy	O
may	O
result	O
in	O
stabilization	O
of	O
vision	O
for	O
long	O
periods	O
of	O
time	O
.	O

In	O
patients	O
who	O
were	O
not	O
vented	O
,	O
there	O
was	O
overall	O
significant	O
depression	O
of	O
function	O
(	O
67	O
+	O
/-	O

5	O
%	O
of	O
control	O
;	O
range	O
,	O
91	O
-	O
-45	O
%	O
,	O
p	O
less	O
than	O
0.01	O
)	O
.	O

Changes	O
in	O
body	O
weight	O
and	O
agonistic	O
behavior	O
were	O
also	O
recorded	O
.	O

Use	O
of	O
radioactive	O
isotopes	O
in	O
the	O
chemistry	O
of	O
proteins	O

Antenatal	O
diagnosis	O
of	O
haematological	O
disorders--'1978	O
'	O
.	O

Gonadal	O
dysfunction	O
in	O
patients	O
with	O
ataxia	O
telangiectasia	O
.	O

Most	O
of	O
the	O
phenomena	O
of	O
azotaemic	O
osteodystrophy	O
are	O
encountered	O
in	O
simple	O
vitamin	O
D	O
deficiency	O
;	O
as	O
in	O
that	O
condition	O
,	O
deficiency	O
of	O
1,25-dihydroxycholecalciferol	O
may	O
be	O
of	O
primary	O
significance	O
in	O
causing	O
secondary	O
hyperparathyroidism	O
in	O
renal	O
failure	O
.	O

Basal	O
FSH	B
and	O
LH	B
levels	O
were	O
significantly	O
lower	O
in	O
addicts	O
;	O
after	O
GnRH	B
stimulation	O
the	O
addicts	O
'	O
FSH	B
and	O
LH	B
values	O
increased	O
but	O
not	O
significantly	O
compared	O
to	O
controls	O
.	O

Adriamycin	O
:	O
comparison	O
of	O
a	O
5-week	O
schedule	O
with	O
a	O
3-week	O
schedule	O
in	O
the	O
treatment	O
of	O
breast	O
cancer	O
.	O

Follow	O
-	O
up	O
controls	O
of	O
luteinizing	B
hormone	I
(	O
LH	B
)	O
,	O
follicle	B
stimulating	I
hormone	I
(	O
FSH	B
)	O
,	O
prolactin	B
(	O
HPRL	B
)	O
,	O
oestradiol	O
(	O
E2	O
)	O
,	O
progesterone	O
(	O
P	O
)	O
and	O
testosterone	O
(	O
T	O
)	O
in	O
the	O
catabolic	O
and	O
healing	O
phase	O
of	O
burn	O
disease	O
.	O

Renin	B
studies	O
performed	O
in	O
34	O
hypertensive	O
patients	O
and	O
in	O
a	O
control	O
group	O
of	O
11	O
recipients	O
showed	O
that	O
elevation	O
of	O
plasma	B
renin	I
activity	O
and	O
of	O
plasma	O
aldosterone	O
level	O
is	O
frequent	O
but	O
difficult	O
to	O
interpret	O
,	O
particularly	O
when	O
a	O
renal	O
artery	O
stenosis	O
is	O
observed	O
.	O

A	O
randomized	O
clinical	O
trial	O
in	O
sixty	O
-	O
two	O
adult	O
patients	O
suffering	O
from	O
typhoid	O
fever	O
,	O
proved	O
by	O
blood	O
and	O
marrow	O
culture	O
,	O
showed	O
that	O
amoxycillin	O
in	O
a	O
dosage	O
schedule	O
of	O
1	O
g	O
8-hourly	O
orally	O
for	O
fourteen	O
days	O
was	O
better	O
than	O
chloramphenicol	O
with	O
regard	O
to	O
clinical	O
and	O
temperature	O
response	O
and	O
in	O
respect	O
of	O
carriers	O
and	O
relapse	O
rates	O
.	O

Thus	O
,	O
the	O
inhibition	O
of	O
pepsin	B
in	O
human	O
gastric	O
juice	O
does	O
not	O
appear	O
to	O
have	O
a	O
major	O
influence	O
on	O
the	O
healing	O
of	O
duodenal	O
ulcer	O
.	O

The	O
IDF	O
standard	O
method	O
for	O
the	O
detection	O
of	O
penicillin	O
in	O
milk	O
is	O
not	O
suitable	O
for	O
the	O
detection	O
of	O
sulphonamide	O
residues	O
in	O
milk	O
.	O

Capsular	O
antigens	O
of	O
Staphylococcus	O
aureus	O

The	O
course	O
of	O
endotoxin	O
fever	O
remained	O
uninfluenced	O
by	O
ALS	O
.	O

2	O
new	O
Algerian	O
cases	O

Seventy	O
-	O
one	O
percent	O
of	O
patients	O
treated	O
with	O
ticarcillin	O
alone	O
responded	O
favorably	O
.	O

Accurate	O
pathologic	O
staging	O
identifies	O
patients	O
who	O
are	O
potentially	O
curable	O
with	O
radiotherapy	O
.	O

2	O
.	O

Changes	O
in	O
tissue	O
PCO2	O
were	O
less	O
dramatic	O
and	O
did	O
not	O
vary	O
significantly	O
from	O
those	O
recorded	O
in	O
venous	O
blood	O
.	O

Ultrasonic	O
evaluation	O
of	O
renal	O
calculi	O
.	O

Isolation	O
of	O
T.	O
gambiense	O
strains	O
in	O
Zaire	O
and	O
their	O
adaptation	O
to	O
laboratory	O
animals	O

Intestinal	O
adaptation	O
(	O
first	O
of	O
two	O
parts	O
)	O
.	O

These	O
techniques	O
have	O
been	O
used	O
by	O
many	O
people	O
for	O
many	O
years	O
and	O
no	O
claim	O
is	O
being	O
made	O
for	O
any	O
innovation	O
in	O
this	O
regard	O
.	O

A	O
total	O
of	O
57	O
patients	O
with	O
Hodgkin	O
's	O
disease	O
limited	O
to	O
above	O
the	O
diaphragm	O
(	O
Stages	O
I	O
and	O
II	O
,	O
A	O
and	O
B	O
)	O
were	O
treated	O
with	O
radiation	O
therapy	O
alone	O
at	O
the	O
University	O
of	O
Florida	O
between	O
1964	O
and	O
1974	O
.	O

Year	O
one	O
of	O
the	O
first	O
general	O
practitioner	O
medical	O
unit	O
in	O
the	O
greater	O
Glasgow	O
area	O
.	O

This	O
multiple	O
-	O
electrode	O
array	O
for	O
round	O
window	O
cochlear	O
implantation	O
is	O
a	O
robust	O
,	O
reliable	O
system	O
for	O
inserting	O
20	O
mm	O
along	O
the	O
scala	O
tympani	O
with	O
a	O
minimum	O
of	O
trauma	O
and	O
can	O
provide	O
for	O
bipolar	O
stimulation	O
.	O

As	O
authorized	O
by	O
the	O
World	O
Health	O
Organization	O
29th	O
Expert	O
Committee	O
on	O
Biological	O
Standardization	O
,	O
the	O
preparation	O
of	O
human	B
prolactin	I
in	O
ampoules	O
coded	O
75	O
/	O
504	O
has	O
been	O
established	O
as	O
the	O
International	O
Reference	O
Preparation	O
(	O
IRP	O
)	O
of	O
human	B
prolactin	I
for	O
immunoassay	O
.	O

i.	O

Biliary	O
-	O
enteric	O
fistulas	O

Such	O
marked	O
differences	O
are	O
found	O
occasionally	O
in	O
the	O
literature	O
:	O
heterophile	O
antibodies	O
against	O
bovine	B
gammaglobulin	I
are	O
regarded	O
as	O
responsible	O
for	O
the	O
interference	O
in	O
the	O
Sephadex	O
system	O
of	O
RIST	O
.	O

""""	O
Let	O
the	O
hundred	O
flowers	O
bloom	O
""""	O
.	O

Various	O
treatment	O
modalities	O
are	O
reviewed	O
in	O
the	O
context	O
of	O
the	O
psychology	O
as	O
well	O
as	O
the	O
physiology	O
of	O
severe	O
intractable	O
pain	O
.	O

Lethal	O
Tachmalcor	O
(	O
4-	O
(	O
3'-diethylamino-2'-hydroxypropyl	O
)	O
-ajmaline	O
)	O
poisoning	O
in	O
childhood	O

Serum	O
ferritin	B
concentration	O
and	O
bone	O
marrow	O
iron	O
stores	O
.	O

A	O
prospective	O
trail	O
comparing	O
hysterectomy	O
,	O
hysterectomy	O
plus	O
vaginal	O
radium	O
,	O
and	O
uterine	O
radium	O
plus	O
hysterectomy	O
in	O
stage	O
I	O
endometrial	O
carcinoma	O
.	O

On	O
the	O
basis	O
of	O
a	O
patient	O
's	O
report	O
of	O
one	O
inaccurate	O
Clinitemp	O
,	O
we	O
undertook	O
to	O
investigate	O
the	O
accuracy	O
of	O
this	O
thermometer	O
.	O

Cryoglobulinemia	O
in	O
Raynaud	O
's	O
syndrome	O

Data	O
were	O
processed	O
with	O
a	O
semi	O
-	O
automatic	O
computer	O
program	O
which	O
develops	O
an	O
averaged	O
-	O
volume	O
curve	O
from	O
an	O
assigned	O
LV	O
region	O
-	O
of	O
-	O
interest	O
.	O

The	O
preferential	O
serum	B
IgA	I
response	O
observed	O
in	O
the	O
patient	O
population	O
suggests	O
that	O
bronchial	O
associated	O
lymphoid	O
tissue	O
in	O
the	O
diseased	O
lung	O
is	O
an	O
important	O
source	O
of	O
circulating	O
IgA.	B

Ultimate	O
strengthes	O
seem	O
to	O
be	O
reached	O
for	O
cast	O
cobalt	O
alloys	O
,	O
whereas	O
titanium	O
alloys	O
,	O
such	O
as	O
Ta	O
6	O
V	O
,	O
present	O
very	O
high	O
fatigue	O
limit	O
under	O
corrosion	O
.	O

The	O
effects	O
of	O
intracisternal	O
injection	O
(	O
i.c.i	O
.	O
)	O
of	O
clonidine	O
(	O
1	O
microgram	O
kg-1	O
)	O
on	O
blood	O
pressure	O
and	O
heart	O
rate	O
were	O
studied	O
in	O
conscious	O
rabbits	O
with	O
an	O
implanted	O
catheter	O
in	O
the	O
cisterna	O
magna	O
.	O

In	O
the	O
8	O
patients	O
the	O
difference	O
betweent	O
he	O
mean	O
diastolic	O
values	O
of	O
delta	O
PU	O
and	O
delta	O
PM	O
was	O
-	O
0.54	O
+	O
/-	O

1.0	O
(	O
SD	O
)	O
mmHg	O
.	O

A	O
rise	O
of	O
hemoglobin	B
concentration	O
accompanied	O
by	O
an	O
increase	O
of	O
the	O
total	O
iron	O
in	O
the	O
blood	O
serum	O
of	O
white	O
mice	O
was	O
found	O
under	O
oxygen	O
pressure	O
of	O
4	O
atm	O
for	O
an	O
hour	O
(	O
preconvulsive	O
state	O
)	O
and	O
6	O
atm	O
(	O
convulsive	O
state	O
)	O
.	O

Effects	O
of	O
methylene	O
chloride	O
,	O
trichloroethane	O
,	O
trichloroethylene	O
,	O
tetrachloroethylene	O
and	O
toluene	O
on	O
the	O
development	O
of	O
chick	O
embryos	O
.	O

Effect	O
of	O
intraventricular	O
administration	O
of	O
streptolysin	B
O	I
on	O
the	O
electroencephalogram	O
of	O
rabbits	O
.	O

The	O
biochemistry	O
of	O
amniotic	O
fluid	O
with	O
poor	O
fetal	O
growth	O
.	O

Resistance	O
to	O
the	O
simulated	O
physiologic	O
environment	O
was	O
tested	O
by	O
measured	O
retention	O
of	O
mechanical	O
properties	O
after	O
immersion	O
times	O
in	O
pseudo	O
-	O
extracellular	O
fluid	O
(	O
PECF	O
)	O
at	O
37	O
degrees	O
C	O
for	O
as	O
long	O
as	O
three	O
years	O
.	O

Isolated	O
calcaneal	O
tuberculous	O
osteomyelitis	O
.	O

In	O
case	O
of	O
a	O
pathologically	O
convoluted	O
internal	O
carotid	O
the	O
common	O
carotid	O
artery	O
was	O
resected	O
with	O
an	O
end	O
-	O
to	O
-	O
end	O
anastomosis	O
.	O

These	O
data	O
confirm	O
the	O
existence	O
of	O
hyperlipemic	O
abdominal	O
crisis	O
as	O
a	O
distinct	O
entity	O
and	O
testify	O
to	O
the	O
importance	O
of	O
recognizing	O
this	O
syndrome	O
in	O
order	O
to	O
avoid	O
the	O
occurrence	O
of	O
acute	O
pancreatitis	O
and	O
the	O
performance	O
of	O
unnecessary	O
and	O
potentially	O
harmful	O
surgery	O
.	O

Their	O
conduction	O
velocity	O
ranged	O
from	O
0.23	O
to	O
0.98	O
m	O
/	O
sec	O
(	O
group	O
C	O
)	O
.	O

The	O
failures	O
frequently	O
were	O
related	O
to	O
patient	O
intolerance	O
or	O
poor	O
mechanical	O
fit	O
and	O
occurred	O
in	O
the	O
first	O
few	O
days	O
or	O
first	O
few	O
months	O
after	O
insertion	O
.	O

The	O
major	O
urinary	O
metabolites	O
were	O
3-	O
(	O
3-carboxyphenyl	O
)	O
-5-hydroxymethyl-2-oxazolidinone	O
and	O
a	O
glucuronide	O
of	O
toloxatone	O
.	O

Carbohydrate	O
metabolism	O
and	O
the	O
semen	O
profile	O
:	O
glucose	O
,	O
insulin	B
,	O
and	O
sperm	O
studies	O
.	O

The	O
sub	O
-	O
acute	O
inhalation	O
toxicity	O
of	O
furfural	O
was	O
studied	O
in	O
Syrian	O
golden	O
hamsters	O
.	O

Changes	O
of	O
thirtynine	O
serum	O
protein	O
components	O
following	O
surgical	O
stress	O
.	O

These	O
differences	O
are	O
smaller	O
than	O
those	O
described	O
in	O
standard	O
textbooks	O
.	O

An	O
intravenous	O
preparation	O
of	O
doxycycline	O
(	O
DOTC	O
,	O
Vibramycin	O
'	O
Pfizer	O
'	O
)	O
,	O
a	O
long	O
-	O
lasting	O
tetracycline	O
,	O
was	O
administered	O
mainly	O
by	O
drip	O
infusion	O
for	O
a	O
series	O
of	O
study	O
in	O
the	O
pediatrics	O
field	O
,	O
and	O
the	O
results	O
were	O
as	O
follows	O
:	O
1	O
)	O
DOTC	O
(	O
100	O
mg	O
)	O
was	O
dissolved	O
in	O
a	O
100	O
ml	O
of	O
glucose	O
solution	O
and	O
2	O
-	O
-3	O
mg	O
/	O
kg	O
was	O
administered	O
intravenously	O
.	O

5	O
)	O
Before	O
and	O
ten	O
days	O
after	O
DOTC	O
infusion	O
,	O
laboratory	O
tests	O
for	O
liver	O
and	O
renal	O
functions	O
and	O
blood	O
were	O
performed	O
.	O

The	O
enteric	O
route	O
is	O
the	O
principal	O
mode	O
of	O
transmission	O
for	O
hepatitis	O
A	O
,	O
but	O
maximal	O
levels	O
of	O
hepatitis	O
A	O
virus	O
excretion	O
occur	O
before	O
the	O
onset	O
of	O
jaundice	O
.	O

Irradiation	O
of	O
human	O
blood	O
platelets	O
with	O
UV	O
-	O
A	O
in	O
vitro	O
impairs	O
their	O
ability	O
to	O
aggregate	O
after	O
challenge	O
with	O
collagen	B
.	O

With	O
certain	O
exceptions	O
the	O
method	O
was	O
considered	O
suitable	O
in	O
the	O
routine	O
intravenous	O
cholangiography	O
.	O

The	O
six	O
commonest	O
causes	O
of	O
death	O
varied	O
in	O
the	O
three	O
ethnic	O
groups	O
.	O

Although	O
Grice	O
's	O
operation	O
has	O
been	O
used	O
all	O
over	O
the	O
world	O
,	O
no	O
systematic	O
account	O
of	O
it	O
has	O
been	O
found	O
in	O
the	O
literature	O
(	O
including	O
publications	O
dealing	O
with	O
technique	O
)	O
,	O
which	O
presents	O
it	O
in	O
terms	O
related	O
to	O
the	O
basic	O
""""	O
classical	O
""""	O
principles	O
on	O
which	O
the	O
operation	O
was	O
conceived	O
.	O

(	O
5	O
)	O
No	O
changes	O
were	O
observed	O
in	O
the	O
gastric	O
venous	O
blood	O
flow	O
by	O
continuous	O
intravenous	O
injection	O
of	O
cimetidine	O
,	O
but	O
by	O
rapid	O
injection	O
both	O
the	O
flow	O
was	O
augmented	O
and	O
the	O
systemic	O
blood	O
pressure	O
decreased	O
transiently	O
.	O

Study	O
on	O
re	O
-	O
establishment	O
of	O
ovulation	O
after	O
termination	O
of	O
sex	O
-	O
steroidal	O
treatment	O
--compared	O
with	O
re	O
-	O
appearance	O
of	O
ovulation	O
after	O
abortion	O
and	O
premature	O
delivery	O
.	O

Pharmacokinetics	O
of	O
Carbamazepine	O
in	O
man	O
:	O
a	O
review	O
.	O

Of	O
the	O
compounds	O
tested	O
,	O
alpha-	O
(	O
3-methyl-2-quinoxalinyl	O
)	O
-N	O
-	O
methylnitrone	O
1,4-dioxide	O
(	O
2	O
)	O
was	O
the	O
most	O
active	O
agent	O
in	O
vivo	O
against	O
the	O
gram	O
-	O
negative	O
and	O
the	O
gram	O
-	O
positive	O
organisms	O
.	O

Changes	O
in	O
ionic	O
content	O
of	O
the	O
mucous	O
suggest	O
that	O
cholinergic	O
mechanisms	O
affect	O
pressure	O
in	O
the	O
excretory	O
duct	O
of	O
the	O
gland	O
.	O

Delayed	O
mortality	O
of	O
mice	O
following	O
inhalation	O
of	O
acute	O
doses	O
of	O
CH2O	O
,	O
SO2Cl2	O
,	O
and	O
Br2	O
.	O

Under	O
halothane	O
anesthesia	O
,	O
the	O
flow	O
pneumocardiogram	O
(	O
PnCG	O
)	O
and	O
its	O
time	O
derivative	O
(	O
acceleration	O
pneumocardiogram	O
or	O
dPn	O
/	O
dt	O
)	O
were	O
transduced	O
during	O
apnea	O
by	O
a	O
small	O
high	O
-	O
gain	O
pneumotachograph	O
.	O

It	O
is	O
concluded	O
that	O
stereotypy	O
can	O
be	O
evoked	O
also	O
in	O
the	O
case	O
when	O
the	O
striatal	O
dopaminergic	O
tone	O
is	O
normal	O
or	O
even	O
below	O
normal	O
:	O
it	O
is	O
the	O
equilibrium	O
of	O
the	O
striatal	O
cholinergic	O
-	O
dopaminergic	O
systems	O
which	O
must	O
be	O
shifted	O
towards	O
dopamine	O
,	O
which	O
is	O
necessary	O
for	O
the	O
development	O
of	O
this	O
behavioral	O
manifestation	O
.	O

In	O
the	O
duodenum	O
a	O
small	O
part	O
of	O
the	O
administered	O
dose	O
was	O
transformed	O
to	O
3H	O
-	O
alpha	O
-	O
acetyldigoxin	O
.	O

Functional	O
effects	O
following	O
subacute	O
administration	O
.	O

Although	O
it	O
has	O
been	O
shown	O
that	O
it	O
is	O
possible	O
to	O
use	O
orally	O
administered	O
testosterone	O
to	O
maintain	O
se	O
-	O
T	O
levels	O
in	O
the	O
normal	O
male	O
range	O
,	O
the	O
convenience	O
to	O
the	O
patient	O
must	O
be	O
balanced	O
against	O
the	O
cost	O
and	O
possible	O
side	O
effects	O
of	O
the	O
large	O
doses	O
required	O
.	O

Nursing	O
of	O
patients	O
with	O
gynecological	O
diseases	O

Ovarian	O
allotransplantation	O
in	O
human	O
.	O

Allergic	O
reaction	O
to	O
Patent	O
Blue	O
Violet	O
during	O
lymphography	O
.	O

Screening	O
of	O
asthma	O
patients	O
by	O
determination	O
of	O
IgE	B
and	O
by	O
comprehension	O
of	O
spectrum	O
of	O
allergospecific	B
IgE	I
antibodies	I

One	O
-	O
third	O
of	O
the	O
men	O
with	O
azoospermia	O
and	O
with	O
sperm	O
density	O
of	O
less	O
than	O
10	O
million	O
had	O
marked	O
FSH	B
elevation	O
and	O
our	O
experience	O
confirms	O
the	O
work	O
of	O
others	O
that	O
this	O
indicates	O
a	O
poor	O
prognosis	O
.	O

In	O
girls	O
prolactin	B
levels	O
rise	O
at	O
stage	O
2	O
,	O
and	O
are	O
higher	O
after	O
menarche	O
;	O
in	O
boys	O
there	O
is	O
no	O
change	O
in	O
prolactin	B
levels	O
.	O

In	O
one	O
patient	O
with	O
severe	O
diarrhea	O
the	O
estriol	O
concentration	O
in	O
serum	O
was	O
low	O
until	O
the	O
intestinal	O
function	O
normalised	O
and	O
the	O
estriol	O
concentration	O
went	O
up	O
exactly	O
when	O
the	O
diarrhea	O
stopped	O
.	O

Serum	O
levels	O
of	O
IgG	B
and	O
IgM	B
were	O
also	O
raised	O
,	O
but	O
contrary	O
to	O
the	O
findings	O
of	O
other	O
observers	O
IgA	B
levels	O
were	O
normal	O
.	O

To	O
study	O
the	O
sensitivity	O
of	O
some	O
central	O
brain	O
structures	O
to	O
the	O
action	O
of	O
an	O
electromagnetic	O
field	O
of	O
decimeter	O
waves	O
(	O
EMF	O
of	O
DW	O
)	O
a	O
dynamic	O
investigation	O
of	O
single	O
unit	O
activity	O
was	O
undertaken	O
.	O

No	O
systematic	O
L	O
-	O
R	O
differences	O
were	O
observed	O
.	O

A	O
decrease	O
of	O
the	O
lysozyme	B
activity	O
coincided	O
with	O
the	O
clinical	O
improvement	O
of	O
the	O
bacterial	O
meningitis	O
.	O

This	O
implies	O
that	O
the	O
groups	O
do	O
not	O
just	O
differ	O
along	O
one	O
dimension	O
,	O
but	O
along	O
three	O
dimensions	O
.	O

Deep	O
tans	O
were	O
induced	O
over	O
the	O
backs	O
of	O
volunteers	O
with	O
repeated	O
exposure	O
to	O
longwave	O
ultraviolet	O
radiation	O
(	O
UV	O
-	O
A	O
)	O
.	O

1	O
The	O
effects	O
in	O
normal	O
subjects	O
of	O
a	O
single	O
oral	O
dose	O
of	O
Motival	O
(	O
one	O
tablet	O
,	O
containing	O
fluphenazine	O
0.5	O
mg	O
and	O
nortriptyline	O
10	O
mg	O
)	O
on	O
the	O
contingent	O
negative	O
variation	O
(	O
CNV	O
)	O
,	O
reaction	O
time	O
,	O
heart	O
rate	O
,	O
blood	O
pressure	O
and	O
self	O
-	O
rating	O
scales	O
for	O
alertness	O
,	O
anxiety	O
,	O
tension	O
,	O
detachment	O
and	O
depression	O
were	O
compared	O
with	O
those	O
of	O
diazepam	O
(	O
5	O
mg	O
and	O
7.5	O
mg	O
)	O
and	O
placebo	O
or	O
propranolol	O
(	O
60	O
mg	O
)	O
.	O

Smoking	O
was	O
regarded	O
as	O
the	O
major	O
contribution	O
to	O
pulmonary	O
dysfunction	O
.	O

The	O
malignity	O
of	O
nevoid	O
lentigo	O
.	O

Elimination	O
of	O
bagassosis	O
in	O
Louisiana	O
paper	O
manufacturing	O
plant	O
workers	O
.	O

Internally	O
oriented	O
patients	O
'	O
scores	O
on	O
Rotter	O
's	O
Internal	O
-	O
External	O
Locus	O
of	O
Control	O
Scale	O
remained	O
the	O
same	O
over	O
treatment	O
but	O
those	O
of	O
externally	O
oriented	O
patients	O
shifted	O
toward	O
greater	O
internal	O
control	O
.	O

2	O
)	O
The	O
time	O
-	O
sharing	O
principle	O
was	O
applied	O
to	O
gain	O
high	O
stability	O
.	O

When	O
blood	O
samples	O
of	O
patients	O
with	O
hyperbilirubinemia	O
were	O
analyzed	O
,	O
direct	O
measurement	O
of	O
ZPP	O
by	O
this	O
fluorimeter	O
yielded	O
significantly	O
higher	O
levels	O
than	O
did	O
an	O
alternate	O
extraction	O
method	O
.	O

Delayed	O
hypersensitivity	O
in	O
man	O
:	O
effects	O
of	O
systemic	O
anticoagulation	O
.	O

In	O
three	O
of	O
the	O
seven	O
,	O
inhalation	O
of	O
2	O
ml	O
normal	O
saline	O
produced	O
FEV1	O
falls	O
of	O
25	O
%	O
to	O
30	O
%	O
,	O
but	O
these	O
falls	O
were	O
not	O
as	O
great	O
as	O
each	O
subject	O
's	O
reactions	O
to	O
the	O
test	O
solutions	O
.	O

Experimental	O
studies	O
on	O
virus	O
excretion	O
and	O
non	O
-	O
arthropod	O
transmission	O
.	O

At	O
the	O
same	O
time	O
we	O
obtained	O
easily	O
understandable	O
EEG	O
-	O
information	O
which	O
has	O
never	O
previously	O
been	O
available	O
to	O
us	O
.	O

Female	O
mice	O
were	O
significantly	O
more	O
resistant	O
to	O
infection	O
than	O
males	O
.	O

Angiotensin	B
effect	O
in	O
the	O
human	O
kidney	O
.	O

Procion	O
yellow	O
dye	O
was	O
injected	O
intracellularly	O
into	O
large	O
auditory	O
fibers	O
of	O
goldfish	O
to	O
investigate	O
the	O
relationship	O
between	O
the	O
response	O
type	O
of	O
these	O
fibers	O
and	O
their	O
site	O
of	O
termination	O
in	O
the	O
saccular	O
macula	O
.	O

Silicosis	O
mortality	O

These	O
consisted	O
of	O
beading	O
and	O
strictures	O
mainly	O
of	O
the	O
intrahepatic	O
biliary	O
tree	O
(	O
IHB	O
)	O
.	O

Pentane	O
and	O
ethane	O
,	O
which	O
arise	O
during	O
lipid	O
peroxidation	O
in	O
vivo	O
,	O
were	O
measured	O
by	O
gas	O
chromatography	O
in	O
breath	O
samples	O
of	O
rats	O
fed	O
for	O
8	O
weeks	O
a	O
vitamin	O
E	O
-	O
deficient	O
diet	O
to	O
which	O
had	O
been	O
added	O
0	O
,	O
11	O
,	O
or	O
40	O
IU	O
vitamin	O
E	O
acetate	O
per	O
kg	O
.	O

The	O
authors	O
report	O
the	O
clinicopathologic	O
findings	O
in	O
four	O
cases	O
of	O
adult	O
women	O
with	O
rhabdomyosarcomas	O
that	O
originated	O
in	O
the	O
endometrium	O
or	O
cervix	O
,	O
or	O
both	O
.	O

The	O
effect	O
of	O
pure	O
natural	O
porcine	B
secretin	I
on	O
endocrine	O
and	O
exocrine	O
pancreatic	O
secretion	O
was	O
studied	O
in	O
the	O
totally	O
isolated	O
perfused	O
porcine	O
pancreas	O
.	O

Urine	O
antibodies	O
could	O
not	O
be	O
demonstrated	O
in	O
any	O
other	O
cases	O
.	O

99mTc	O
phytate	O
,	O
198Au	O
colloid	O
,	O
and	O
99mTc	O
antimony	O
sulfide	O
have	O
been	O
used	O
;	O
the	O
last	O
appears	O
to	O
have	O
been	O
the	O
most	O
satisfactory	O
.	O

Synovial	O
cysts	O
of	O
the	O
hip	O
joint	O

A	O
suspected	O
hypothalamic	O
dysfunction	O
and	O
a	O
slightly	O
impaired	O
pituitary	O
function	O
manifested	O
as	O
GH	B
deficiency	O
were	O
their	O
common	O
endocrinological	O
features	O
.	O

A	O
sharp	O
outbreak	O
of	O
influenza	O
A	O
occurred	O
on	O
the	O
base	O
during	O
February	O
that	O
was	O
due	O
to	O
an	O
A	O
/	O
Texas	O
/	O
1	O
/	O
77-like	O
virus	O
,	O
a	O
variant	O
of	O
the	O
A	O
/	O
Victoria	O
/	O
3	O
/	O
75	O
prototpye	O
.	O

Effect	O
of	O
time	O
and	O
dose	O
on	O
alterations	O
following	O
inhalation	O
of	O
plutonium-239	O
dioxide	O
aerosol	O
in	O
rat	O
.	O

Several	O
free	O
2nd	O
-	O
generation	O
schizonts	O
,	O
which	O
varied	O
in	O
diameter	O
from	O
11	O
to	O
21.6	O
micrometer	O
,	O
were	O
found	O
on	O
the	O
epithelial	O
surface	O
of	O
the	O
cecum	O
.	O

Newcastle	O
disease	O
virus	O
surveillance	O
in	O
Hong	O
Kong	O
on	O
local	O
and	O
imported	O
poultry	O
.	O

It	O
was	O
postulated	O
that	O
persistent	O
challenge	O
by	O
M.	O
leprae	O
or	O
its	O
antigens	O
to	O
the	O
IgA	B
immunocytes	O
of	O
the	O
intestinal	O
epithelium	O
might	O
have	O
induced	O
tolerance	O
leading	O
to	O
IgA	B
deficiency	O
and	O
subsequent	O
subtotal	O
atrophy	O
of	O
the	O
intestinal	O
villi	O
in	O
the	O
patients	O
with	O
lepromatous	O
leprosy	O
.	O

Thyroid	O
disease	O
and	O
pregnancy	O
.	O

Pathogens	O
(	O
Staphylococcus	O
aureus	O
or	O
Gram	O
-	O
negative	O
bacilli	O
)	O
were	O
isolated	O
from	O
only	O
one	O
member	O
of	O
staff	O
in	O
small	O
numbers	O
and	O
irregularly	O
and	O
rarely	O
in	O
large	O
numbers	O
from	O
patients	O
.	O

The	O
histochemistry	O
and	O
ultrastructure	O
of	O
calcified	O
cerebellar	O
deposits	O
described	O
by	O
Tonge	O
et	O
al.	O

Reaction	O
times	O
to	O
tachistoscopically	O
presented	O
stimuli	O
in	O
diabetics	O

The	O
data	O
indicate	O
a	O
three	O
-	O
phase	O
reaction	O
after	O
B1	O
injection	O
:	O
Phase	O
1	O
-	O
-shortly	O
after	O
injection	O
there	O
is	O
a	O
drop	O
of	O
all	O
parameters	O
lasting	O
for	O
30	O
sec.	O

A	O
--	O
A	O
natural	O
hydrostatic	O
phenomenon	O
,	O
at	O
the	O
level	O
of	O
the	O
ends	O
of	O
the	O
plantar	O
arcs	O
,	O
diffuses	O
body	O
weight	O
,	O
as	O
PAIN	O
plays	O
the	O
role	O
of	O
outsentry	O
(	O
fig.--1	O
)	O
(	O
5	O
)	O
;	O
B	O
--	O
Plantar	O
perforating	O
ulceration	O
(	O
PPU	O
)	O
is	O
caused	O
by	O
a	O
combination	O
of	O
INSENSITIVITY	O
and	O
TRAUMATIS	O
(	O
1	O
)	O
;	O
C	O
--	O
The	O
patient	O
reposing	O
,	O
as	O
body	O
weight	O
(	O
traumatism	O
)	O
effects	O
disappear	O
,	O
cicatrization	O
process	O
can	O
be	O
easily	O
observed	O
;	O
D	O
--	O
PNEUMATIC	O
INSOLE	O
,	O
being	O
elastic	O
,	O
diffuses	O
localized	O
compression	O
at	O
the	O
ends	O
of	O
the	O
plantar	O
arcs	O
,	O
reduces	O
attrition	O
,	O
makes	O
easier	O
blood	O
circulation	O
,	O
as	O
well	O
as	O
cure	O
and	O
prophylaxis	O
of	O
PPU	O
(	O
fig.--6	O
)	O
(	O
3	O
)	O
.	O

As	O
expected	O
,	O
the	O
heparin	O
did	O
produce	O
increased	O
recalcification	O
times	O
and	O
the	O
development	O
of	O
occasional	O
subcutaneous	O
hematomas	O
.	O

Contingency	O
contracting	O
between	O
clients	O
and	O
their	O
parents	O
/	O
caregivers	O
was	O
used	O
to	O
specify	O
consequences	O
for	O
daily	O
self	O
-	O
monitoring	O
,	O
reduced	O
caloric	O
intake	O
,	O
weight	O
loss	O
,	O
and	O
exercise	O
.	O

Dietetics	O
of	O
childhood-	O
and	O
juvenile	O
diabetes	O

The	O
micromethod	O
uses	O
microcuvettes	O
and	O
substitutes	O
ferrozine	O
for	O
the	O
bathophenanthroline	O
chromogen	O
of	O
the	O
ICSH	O
.	O

The	O
overall	O
incidence	O
of	O
SIDS	O
was	O
1.43	O
per	O
1,000	O
live	O
births	O
.	O

Significant	O
increases	O
in	O
mean	O
serum	O
E2	O
concentration	O
(	O
100	O
to	O
150	O
pg	O
/	O
ml	O
)	O
were	O
noted	O
at	O
6	O
and	O
8	O
hours	O
after	O
administration	O
on	O
day	O
1	O
and	O
at	O
8	O
hours	O
on	O
day	O
4	O
.	O

Avian	O
reproductive	O
system	O
:	O
daily	O
variations	O
in	O
responses	O
to	O
hormones	O
.	O

Biological	O
properties	O
of	O
sumithion	O
.	O

Serological	O
studies	O
of	O
antibodies	O
to	O
Epstein	O
-	O
Barr	O
virus	O
in	O
infectious	O
mononucleosis	O

Carcinoembryonic	B
antigen	I
(	O
CEA	B
)	O
procedures	O
and	O
clinical	O
evaluation	O
.	O

On	O
the	O
basis	O
of	O
a	O
global	O
assessment	O
patients	O
showed	O
a	O
highly	O
significant	O
preference	O
for	O
imipramine	O
compared	O
with	O
placebo	O
as	O
adjunctive	O
therapy	O
.	O

39	O
-	O
47	O
.	O

Patients	O
were	O
subclassified	O
into	O
age	O
-	O
matched	O
groups	O
of	O
primary	O
untreated	O
cancer	O
(	O
21	O
)	O
,	O
recurrent	O
cancer	O
(	O
18	O
)	O
,	O
and	O
""""	O
cured	O
""""	O
patients	O
who	O
had	O
been	O
free	O
of	O
disease	O
for	O
at	O
least	O
9	O
months	O
(	O
16	O
)	O
.	O

Advances	O
in	O
the	O
management	O
of	O
gynecologic	O
cancer	O
--	O
radiation	O
therapy	O
.	O

The	O
clinico	O
-	O
pathological	O
data	O
from	O
a	O
patient	O
with	O
irreversible	O
post	O
-	O
partum	O
renal	O
failure	O
(	O
IPRF	O
)	O
are	O
presented	O
.	O

Dialyzable	O
transfer	B
factor	I
.	O

19	O
-	O
32	O
.	O

Rheumatoid	B
factor	I
and	O
antinuclear	O
antibody	O
tests	O
were	O
frequently	O
positive	O
,	O
and	O
reactions	O
to	O
gold	O
therapy	O
were	O
more	O
frequent	O
than	O
in	O
other	O
rheumatoid	O
populations	O
.	O

The	O
effect	O
of	O
hydrostatic	O
pressure	O
on	O
the	O
swimming	O
activity	O
of	O
three	O
hyponeustonic	O
crustacea	O
,	O
Anomalocera	O
patersoni	O
,	O
Pontella	O
mediterranea	O
,	O
Labidocera	O
wollastoni	O

This	O
report	O
presents	O
an	O
analysis	O
of	O
the	O
vocal	O
repertoire	O
of	O
howler	O
monkeys	O
(	O
Alouatta	O
palliata	O
)	O
observed	O
during	O
a	O
field	O
study	O
in	O
southwestern	O
Panama	O
.	O

III	O
.	O

Pancreatic	O
and	O
biliary	O
secretion	O
and	O
gastric	O
emptying	O
rates	O
of	O
a	O
liquid	O
test	O
meal	O
(	O
LTM	O
)	O
were	O
determined	O
in	O
normal	O
persons	O
,	O
in	O
patients	O
with	O
subtotal	O
gastrectomy	O
with	O
gastroduodenostomy	O
(	O
STG	O
-	O
BI	O
)	O
or	O
with	O
gastrojejunostomy	O
(	O
STG	O
-	O
BII	O
)	O
,	O
and	O
in	O
patients	O
with	O
truncal	O
vagotomy	O
and	O
pyloroplasty	O
(	O
V&P	O
)	O
.	O

Abnormal	O
calcium	O
metabolism	O
in	O
normocalcaemic	O
sarcoidosis	O
.	O

Also	O
,	O
except	O
in	O
one	O
patient	O
who	O
developed	O
gallstones	O
following	O
institution	O
of	O
colestipol	O
,	O
saturation	O
of	O
gallbladder	O
bile	O
with	O
cholesterol	O
was	O
not	O
markedly	O
increased	O
by	O
this	O
drug	O
alone	O
.	O

The	O
responsiveness	O
of	O
visual	O
cortex	O
(	O
VC	O
)	O
and	O
superior	O
colliculus	O
(	O
SC	O
)	O
was	O
simultaneously	O
compared	O
following	O
conditioning	O
""""	O
ON	O
""""	O
or	O
""""	O
OFF	O
""""	O
stimulation	O
,	O
in	O
the	O
rabbit	O
.	O

If	O
,	O
however	O
,	O
the	O
mean	O
temperature	O
rise	O
was	O
higher	O
(	O
0.57	O
degrees	O
C	O
or	O
0.69	O
degrees	O
C	O
)	O
,	O
such	O
a	O
selection	O
practically	O
resulted	O
in	O
the	O
disappearance	O
of	O
'	O
passable	O
'	O
qualifications	O
in	O
the	O
triplet	O
groups	O
and	O
a	O
great	O
predominance	O
of	O
'	O
to	O
be	O
rejected	O
'	O
qualifications	O
in	O
the	O
large	O
groups	O
.	O

The	O
background	O
processes	O
depending	O
on	O
the	O
etiological	O
factor	O
and	O
the	O
character	O
of	O
lesion	O
of	O
the	O
epithelium	O
are	O
divided	O
into	O
dyshormonal	O
,	O
inflammatory	O
,	O
and	O
posttraumatic	O
.	O

The	O
sense	O
of	O
self	O
.	O

Current	O
diagnostic	O
uses	O
of	O
computerized	O
tomography	O
in	O
clinical	O
medicine	O
.	O

A	O
follow	O
-	O
up	O
study	O
of	O
22	O
patients	O
with	O
Ebstein	O
's	O
anomaly	O
has	O
been	O
performed	O
.	O

Recurrence	O
of	O
bladder	O
tumors	O
among	O
the	O
original	O
9	O
cases	O
has	O
occurred	O
only	O
among	O
the	O
5	O
whose	O
properdin	B
levels	O
remained	O
below	O
the	O
median	O
.	O

Treatment	O
with	O
heparin	O
,	O
plasminogen	B
activators	O
and	O
fibrinogenolytic	O
agents	O
was	O
disappointing	O
although	O
renal	O
function	O
has	O
stabilized	O
in	O
one	O
patient	O
on	O
long	O
term	O
oral	O
anticoagulant	O
therapy	O
.	O

The	O
data	O
normally	O
available	O
are	O
insufficient	O
and	O
take	O
no	O
account	O
of	O
the	O
direction	O
of	O
recirculation	O
,	O
which	O
may	O
be	O
a	O
determining	O
factor	O
.	O

Estimation	O
of	O
L	O
-	O
alanine	O
in	O
serum	O
or	O
plasma	O
using	O
the	O
LKB	O
reaction	O
rate	O
analyser	O
.	O

The	O
acids	O
were	O
obtained	O
by	O
hydrolysis	O
of	O
the	O
corresponding	O
esters	O
,	O
and	O
their	O
anti	O
-	O
inflammatory	O
activity	O
was	O
tested	O
.	O

Unrecognized	O
amnionitis	O
and	O
prematurity	O
:	O
a	O
preliminary	O
report	O
.	O

Serum	B
amylase	I
became	O
markedly	O
elevated	O
(	O
2,624	O
CU	O
/	O
100	O
ml	O
)	O
,	O
as	O
did	O
the	O
serum	O
FFA	O
(	O
29.19	O
mEq	O
/	O
liter	O
)	O
.	O

The	O
morphological	O
effects	O
of	O
two	O
snake	O
venoms	O
,	O
N.	O
naja	O
and	O
A.	O
piscivorus	O
,	O
and	O
of	O
the	O
Direct	B
Lytic	I
Factor	I
and	O
Phospholipase	B
-	I
A	I
,	O
compounds	O
purified	O
from	O
N.	O
naja	O
crude	O
venom	O
,	O
were	O
investigated	O
on	O
lung	O
and	O
cremaster	O
vessels	O
of	O
rats	O
.	O

The	O
length	O
scales	O
of	O
the	O
turbulence	O
were	O
also	O
estimated	O
:	O
at	O
a	O
Reynolds	O
number	O
near	O
4,000	O
the	O
macroscale	O
is	O
about	O
1.25	O
mm	O
,	O
the	O
Taylor	O
microscale	O
is	O
about	O
0.85	O
mm	O
,	O
and	O
the	O
Kolmogoroff	O
scale	O
is	O
near	O
0.075	O
mm	O
.	O

Diallylnitrosamine	O
(	O
DAN	O
)	O
,	O
one	O
of	O
the	O
few	O
nitrosamines	O
tested	O
thus	O
far	O
that	O
has	O
not	O
induced	O
neoplasms	O
in	O
rats	O
,	O
caused	O
a	O
high	O
incidence	O
of	O
respiratory	O
tract	O
tumors	O
in	O
Syrian	O
golden	O
hamsters	O
treated	O
sc	O
with	O
single	O
or	O
weekly	O
doses	O
of	O
the	O
compound	O
.	O

Near	O
term	O
,	O
under	O
experimental	O
conditions	O
,	O
maternal	O
and	O
fetal	O
blood	O
gases	O
,	O
pH	O
,	O
uterine	O
and	O
umbilical	O
blood	O
flows	O
were	O
measured	O
or	O
calculated	O
.	O

Self	O
-	O
emasculation	O
is	O
the	O
end	O
result	O
of	O
an	O
unusual	O
psychiatric	O
disorder	O
,	O
which	O
initially	O
requires	O
surgical	O
treatment	O
.	O

The	O
prevalence	O
of	O
hepatitis	B
B	I
surface	I
antigen	I
(	O
HBsAg	B
)	O
and	O
anti	B
-	I
HBs	I
was	O
determined	O
by	O
a	O
sensitive	O
double	O
-	O
antibody	O
radio	O
-	O
immunoassay	O
technique	O
in	O
a	O
series	O
of	O
patients	O
with	O
chronic	O
liver	O
diseases	O
.	O

It	O
was	O
concluded	O
that	O
patients	O
with	O
acute	O
respiratory	O
failure	O
requiring	O
artificial	O
ventilation	O
have	O
two	O
componenents	O
of	O
the	O
pulmonary	O
shunt	O
,	O
one	O
parallel	O
with	O
and	O
the	O
other	O
inversely	O
related	O
with	O
the	O
PAO2	O
.	O

Levels	O
of	O
both	O
PGF	O
and	O
PGFM	O
were	O
significantly	O
higher	O
during	O
early	O
spontaneous	O
labour	O
,	O
at	O
a	O
cervical	O
dilatation	O
of	O
less	O
than	O
4	O
cm	O
,	O
than	O
before	O
the	O
onset	O
of	O
labour	O
.	O

The	O
most	O
common	O
cause	O
of	O
renal	O
deterioration	O
in	O
the	O
spinal	O
cord	O
injured	O
patient	O
is	O
irreversible	O
vesicoureteral	O
reflux	O
.	O

Propranolol	O
(	O
Inderal	O
)	O
administered	O
in	O
a	O
dose	O
which	O
blocks	O
the	O
beta	O
-	O
adrenergic	O
apparatus	O
of	O
the	O
heart	O
prevents	O
the	O
development	O
of	O
the	O
positive	O
inotropic	O
effect	O
of	O
therapeutic	O
doses	O
of	O
strophanthin	O
K	O
on	O
a	O
hypodynamic	O
left	O
ventricular	O
myocardium	O
.	O

Recent	O
studies	O
have	O
shown	O
the	O
rat	O
larynx	O
to	O
be	O
an	O
important	O
organ	O
in	O
the	O
evaluation	O
of	O
irritancy	O
of	O
inhaled	O
materials	O
.	O

Feeding	O
behavior	O
,	O
circannual	O
body	O
weight	O
and	O
hibernation	O
rhythms	O
in	O
European	O
hamsters	O
lesioned	O
in	O
the	O
noradrenergic	O
ascending	O
bundles	O

At	O
a	O
systolic	O
blood	O
pressure	O
(	O
BP	O
)	O
of	O
60	O
mmHg	O
,	O
C02	O
responsiveness	O
was	O
abolished	O
,	O
but	O
was	O
maintained	O
at	O
higher	O
levels	O
of	O
BP	O
.	O

Iodine-123	O
was	O
satisfactorily	O
imaged	O
only	O
with	O
the	O
MEC	O
and	O
pinhole	O
collimators	O
,	O
which	O
in	O
turn	O
yielded	O
MTF	O
values	O
comparable	O
to	O
those	O
measured	O
for	O
99mTc	O
.	O

Petrous	O
meningioma	O
en	O
plaque	O
presenting	O
as	O
a	O
right	O
middle	O
ear	O
tumor	O
.	O

The	O
difficulties	O
to	O
analyse	O
prostaglandins	O
(	O
PG	O
)	O
by	O
gas	O
-	O
liquid	O
chromatography	O
are	O
mainly	O
due	O
to	O
the	O
lack	O
of	O
sensitivity	O
of	O
the	O
gas	O
-	O
chromatograph	O
itself	O
(	O
higher	O
than	O
200	O
ng	O
)	O
and	O
to	O
the	O
poor	O
resolution	O
of	O
the	O
packed	O
columns	O
.	O

On	O
cessation	O
of	O
steroid	O
therapy	O
the	O
patient	O
was	O
noted	O
to	O
have	O
radiologic	O
manifestations	O
of	O
hypertrophic	O
osteoarthropathy	O
(	O
HOA	O
)	O
as	O
well	O
as	O
clinical	O
and	O
laboratory	O
features	O
of	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
.	O

RESULTS	O
:	O
Total	O
IgE	B
levels	O
showed	O
a	O
tendency	O
to	O
diminish	O
.	O

Does	O
afferent	O
loop	O
syndrome	O
exist	O
?	O
]	O

It	O
is	O
the	O
author	O
's	O
opinion	O
that	O
diagnosis	O
of	O
the	O
""""	O
adducent	O
loop	O
syndrome	O
""""	O
is	O
unlikely	O
to	O
be	O
correct	O
in	O
patients	O
subjected	O
to	O
Billroth	O
-	O
II	O
gastrectomy	O
.	O

Letter	O
:	O
Is	O
actinic	O
(	O
solar	O
)	O
damage	O
the	O
provoking	O
cause	O
of	O
'	O
post	O
-	O
inflammatory	O
elastolysis	O
and	O
cutis	O
laxa	O
(	O
PECL	O
)	O
'	O
?	O

Also	O
,	O
samples	O
of	O
serum	O
were	O
absorbed	O
with	O
the	O
various	O
solid	O
-	O
phase	O
allergens	O
and	O
the	O
reactivity	O
of	O
the	O
remaining	O
IgE	B
antibodies	I
was	O
determined	O
.	O

Hematology	O
problem	O
of	O
the	O
month	O
:	O
band	O
or	O
seg	O
?	O

Haemodilution	O
in	O
cardiopulmonary	O
bypass	O
using	O
a	O
gelatine	O
derivative	O
for	O
priming	O
.	O

The	O
neuroleptic	O
-	O
induced	O
increase	O
in	O
central	O
DA	O
turnover	O
(	O
an	O
indicator	O
for	O
the	O
degree	O
of	O
DA	B
receptor	I
blocking	O
)	O
was	O
found	O
to	O
be	O
positively	O
correlated	O
with	O
the	O
therapeutic	O
effect	O
of	O
neuroleptics	O
and	O
the	O
development	O
of	O
hypokinetic	O
-	O
rigid	O
symptoms	O
.	O

Rainbow	O
trout	O
were	O
obtained	O
from	O
a	O
commercial	O
trout	O
farm	O
,	O
kept	O
in	O
running	O
water	O
and	O
feeding	O
in	O
experimental	O
pellets	O
for	O
4	O
to	O
8	O
weeks	O
.	O

Stimulation	O
of	O
macrophage	O
function	O
by	O
killed	O
Bordetella	O
pertussis	O
cells	O
did	O
not	O
show	O
any	O
beneficial	O
effect	O
as	O
an	O
increased	O
susceptibility	O
became	O
apparent	O
.	O

Primary	O
amenorrhoea	O
in	O
a	O
phenotypically	O
female	O
individual	O
with	O
a	O
karyotype	O
46	O
,	O
xy	O
and	O
bilateral	O
gonadoblastoma	O

Application	O
of	O
the	O
2-deoxy	O
-	O
D	O
-	O
glucose	O
method	O
to	O
the	O
coupling	O
of	O
cerebral	O
metabolism	O
and	O
blood	O
flow	O
.	O

Serum	O
gastrin	B
levels	O
did	O
not	O
change	O
in	O
either	O
group	O
;	O
however	O
,	O
background	O
serum	O
gastrin	B
concentrations	O
were	O
significantly	O
greater	O
for	O
V&P	O
patients	O
than	O
V&A	O
patients	O
throughout	O
the	O
study	O
.	O

Mean	O
corpuscular	B
hemoglobin	I
concentrations	O
remained	O
normal	O
for	O
48	O
h	O
and	O
then	O
decreased	O
in	O
both	O
groups	O
,	O
the	O
CO2	O
group	O
showing	O
the	O
larger	O
decrease	O
.	O

All	O
Cu	O
values	O
obtained	O
from	O
the	O
organs	O
investigated	O
had	O
reached	O
a	O
saturation	O
level	O
at	O
8	O
mug	O
Cu	O
/	O
g	O
diet	O
with	O
the	O
exception	O
of	O
the	O
values	O
for	O
body	O
Cu	O
found	O
in	O
the	O
dams	O
that	O
were	O
killed	O
on	O
the	O
day	O
of	O
delivery	O
.	O

The	O
effect	O
of	O
calcitonin	B
,	O
a	O
large	O
amount	O
of	O
calcium	O
given	O
orally	O
,	O
pentagastrin	O
and	O
glucagon	B
on	O
plasma	O
47Ca	O
radioactivity	O
curves	O
in	O
subjects	O
pretreated	O
with	O
47Ca	O
was	O
examined	O
.	O

State	O
of	O
the	O
body	O
in	O
disorders	O
of	O
diurnal	O
physiological	O
rhythms	O
and	O
long	O
-	O
term	O
hypokinesia	O

Oxygen	O
tension	O
of	O
the	O
small	O
lymph	O
vessels	O
(	O
PLO2	O
)	O
of	O
the	O
rabbit	O
hind	O
limb	O
was	O
measured	O
with	O
both	O
a	O
flow	O
-	O
through	O
micro	O
chamber	O
and	O
a	O
polarographic	O
catheter	O
-	O
tip	O
oxygen	O
electrode	O
to	O
obtain	O
experimental	O
data	O
on	O
the	O
source	O
of	O
oxygen	O
in	O
the	O
lymph	O
.	O

Since	O
myoglobin	B
is	O
co	O
-	O
extracted	O
with	O
the	O
hemoglobin	B
,	O
the	O
2	O
heme	O
pigments	O
are	O
separated	O
in	O
one	O
portion	O
of	O
the	O
extract	O
by	O
precipitating	O
the	O
hemoglobin	B
in	O
an	O
85	O
%	O
(	O
NH4	O
)	O
2SO4	O
solution	O
.	O

Considering	O
these	O
sources	O
of	O
error	O
some	O
of	O
the	O
variability	O
in	O
the	O
present	O
investigation	O
might	O
be	O
avoided	O
by	O
systematic	O
instructions	O
.	O

Six	O
patients	O
with	O
the	O
diagnosis	O
of	O
acute	O
mania	O
were	O
treated	O
with	O
high	O
doses	O
of	O
the	O
beta	O
-	O
adrenergic	O
blocking	O
agent	O
propranolol	O
.	O

Compared	O
to	O
controls	O
,	O
both	O
UB	O
and	O
OCS	O
rats	O
showed	O
a	O
small	O
but	O
significant	O
post	O
-	O
operative	O
reduction	O
in	O
the	O
nocturnality	O
of	O
drinking	O
.	O

Dual	O
innervation	O
of	O
fast	O
fibers	O
in	O
trunk	O
muscles	O
of	O
lamprey	O
larvae	O

The	O
feed	O
consumed	O
which	O
was	O
lowered	O
by	O
25	O
%	O
initially	O
,	O
did	O
not	O
alter	O
later	O
.	O

The	O
influence	O
of	O
adrenergic	O
nerves	O
of	O
the	O
response	O
of	O
blood	O
vessels	O
in	O
the	O
rabbit	O
ear	O
to	O
2	B
-	I
-phenylalanine-8-lysine	I
vasopressin	I
(	O
Octapressin	B
)	O
.	O

I.	O

When	O
a	O
tumour	O
is	O
present	O
nipple	O
discharge	O
is	O
of	O
little	O
importance	O
for	O
the	O
diagnosis	O
and	O
treatment	O
.	O

Who	O
says	O
'	O
National	O
Health	O
Dis	O
-	O
service	O
'	O
.	O

Improvement	O
of	O
nursing	O
instruction	O
to	O
be	O
given	O
at	O
the	O
time	O
of	O
discharge	O
from	O
the	O
ward	O
for	O
premature	O
infants	O

After	O
90	O
d	O
a	O
subsurface	O
,	O
radiolucent	O
caries	O
-	O
like	O
lesion	O
was	O
observed	O
in	O
two	O
specimens	O
only	O
.	O

The	O
contraceptive	O
pattern	O
of	O
157	O
women	O
was	O
analysed	O
and	O
13.8	O
percent	O
were	O
using	O
inefficient	O
methods	O
.	O

Plethysmographic	O
technique	O
and	O
indirect	O
blood	O
pressure	O
recordings	O
were	O
used	O
.	O

The	O
second	O
and	O
third	O
responded	O
similarly	O
to	O
either	O
a	O
combined	O
cyclophosphamide	O
+	O
antilymphocyte	B
globulin	I
(	O
ALG	B
)	O
treatment	O
or	O
to	O
ALG	B
administration	O
preceded	O
by	O
a	O
small	O
dosage	O
of	O
cyclophosphamide	O
,	O
which	O
had	O
proved	O
ineffective	O
when	O
administered	O
alone	O
.	O

Evidence	O
is	O
presented	O
that	O
Leber	O
's	O
military	O
aneurysm	O
retinitis	O
is	O
not	O
a	O
separate	O
entity	O
but	O
a	O
special	O
form	O
of	O
Coats	O
'	O
disease	O
.	O

Fibrin	B
cloaking	O
along	O
the	O
catheter	O
was	O
found	O
in	O
20	O
patients	O
studied	O
by	O
pull	O
-	O
out	O
arteriography	O
and	O
was	O
unassociated	O
with	O
clinical	O
symptoms	O
.	O

The	O
influence	O
of	O
a	O
mobile	O
pupil	O
on	O
the	O
response	O
in	O
the	O
DC	O
-	O
ERG	O
is	O
demonstrated	O
.	O

A	O
newly	O
synthesized	O
anti	O
-	O
inflammatory	O
agent	O
,	O
Y-8004	O
demonstrated	O
a	O
greater	O
inhibition	O
than	O
did	O
indomethacin	O
(	O
IM	O
)	O
.	O

on	O
inflammatory	O
response	O
such	O
as	O
ultraviolet	O
erythema	O
in	O
guinea	O
pigs	O
,	O
carrageenin	O
edema	O
,	O
evans	O
blue	O
and	O
carrageenin	O
-	O
induced	O
pleuritis	O
and	O
acetic	O
acid	O
-	O
induced	O
peritonitis	O
in	O
rats	O
.	O

Lymphocyte	O
subpopulations	O
,	O
serum	B
IgE	I
and	O
total	O
eosinophil	O
counts	O
in	O
patients	O
with	O
bronchial	O
asthma	O
.	O

A	O
comparison	O
of	O
physical	O
and	O
cytogenetic	O
estimates	O
of	O
radiation	O
dose	O
in	O
patients	O
treated	O
with	O
iodine-131	O
for	O
thyroid	O
carcinoma	O
.	O

Technique	O
for	O
obtaining	O
refined	O
ceramics	O
with	O
dense	O
mass	O

Mean	O
total	O
lung	O
capacity	O
,	O
functional	O
residual	O
capacity	O
,	O
and	O
residual	O
volume	O
increased	O
significantly	O
,	O
and	O
the	O
mean	O
closing	O
volume	O
,	O
the	O
lung	O
volume	O
above	O
residual	O
volume	O
at	O
which	O
phase	O
IV	O
begins	O
,	O
decreased	O
significantly	O
with	O
11	O
cm	O
H20	O
continuous	O
positive	O
airway	O
pressure	O
;	O
differences	O
at	O
5	O
cm	O
H20	O
were	O
not	O
significant	O
.	O

Current	O
status	O
of	O
zinc	O
deficiency	O
in	O
the	O
pathogenesis	O
of	O
neurological	O
,	O
dermatological	O
and	O
musculoskeletal	O
disorders	O
.	O

Calcium	O
and	O
phosphorus	O
metabolism	O
in	O
chronic	O
uremia	O
.	O

The	O
correcting	O
action	O
of	O
tropatepine	O
hydrochloride	O
upon	O
the	O
extrapyramidal	O
effects	O
induced	O
by	O
neuroleptics	O
has	O
been	O
studied	O
in	O
32	O
acute	O
psychotic	O
states	O
.	O

Epididymal	O
growth	O
was	O
retarded	O
in	O
animals	O
maintained	O
solely	O
on	O
chickpea	O
haulm	O
and	O
improved	O
with	O
supplementation	O
.	O

Residual	O
amphotericin	O
B	O
was	O
detected	O
in	O
the	O
feces	O
of	O
the	O
mice	O
only	O
while	O
they	O
were	O
receiving	O
the	O
0.3	O
mg	O
/	O
ml	O
dose	O
level	O
.	O

Following	O
intravenous	O
administration	O
,	O
the	O
myocardial	O
concentration	O
of	O
tracer	O
thallium-201	O
,	O
potassium-43	O
,	O
and	O
rubidium-81	O
were	O
determined	O
in	O
mice	O
;	O
thallium	O
was	O
present	O
in	O
the	O
greatest	O
concentration	O
in	O
the	O
myocardium	O
(	O
2.08	O
%	O
compared	O
1.25	O
%	O
for	O
potassium	O
and	O
1.15	O
%	O
for	O
rubidium	O
at	O
10	O
minutes	O
)	O
.	O

Thromboplastin	B
time	O
,	O
partial	O
thromboplastin	B
time	O
,	O
thrombin	B
time	O
,	O
heat	O
-	O
dependent	O
fibrin	B
,	O
clot	O
retraction	O
,	O
and	O
clotting	B
factors	I
II	I
,	I
V	I
,	I
VIII	I
,	I
IX	I
,	I
X	I
,	O
and	O
the	O
platelet	O
count	O
were	O
determined	O
.	O

The	O
data	O
support	O
the	O
notion	O
that	O
suppression	O
of	O
images	O
during	O
binocular	O
rivalry	O
is	O
independent	O
in	O
both	O
eyes	O
.	O

Glycogen	O
utilization	O
was	O
increased	O
,	O
but	O
tissue	O
levels	O
of	O
creatine	O
phosphate	O
,	O
ATP	O
,	O
and	O
lactate	O
were	O
similar	O
to	O
those	O
in	O
hearts	O
receiving	O
normal	O
flow	O
.	O

The	O
other	O
hypoglycaemic	O
patient	O
showed	O
an	O
exaggerated	O
insulin	B
release	O
in	O
response	O
to	O
tolbutamide	O
.	O

Risk	O
of	O
infection	O
in	O
the	O
treatment	O
of	O
fractures	O

Vitrectomy	O
with	O
an	O
alternative	O
instrument	O
system	O
.	O

The	O
metabolic	O
clearance	O
rate	O
of	O
progesterone	O
was	O
295	O
+	O
/-	O

49	O
(	O
S.E.	O
)	O
1	O
/	O
day	O
.	O

This	O
sequence	O
is	O
almost	O
identical	O
with	O
that	O
of	O
human	B
luteinizing	I
hormone	I
(	O
Sairam	O
,	O
M.	O

Editorial	O
:	O
Low	O
-	O
dose	O
heparin	O
and	O
the	O
prevention	O
of	O
venous	O
thromboembolic	O
disease	O
.	O

Effects	O
of	O
perceptual	O
salience	O
on	O
the	O
matrix	O
task	O
performance	O
of	O
four-	O
and	O
six	O
-	O
year	O
-	O
old	O
children	O
.	O

Glucose-6-phosphate	B
dehydrogenase	I
(	O
G-6-PD	B
)	O
deficiency	O
in	O
the	O
newborn	O
.	O

The	O
eluting	O
solvent	O
was	O
methanol	O
-	O
chloroform	O
(	O
10	O
+	O
90	O
)	O
at	O
a	O
flow	O
rate	O
of	O
2.0	O
ml	O
/	O
min	O
.	O

The	O
bronchial	O
epithelia	O
of	O
all	O
smoke	O
-	O
exposed	O
animals	O
were	O
hyperplastic	O
,	O
and	O
their	O
ultrastructure	O
showed	O
invaginations	O
,	O
tilt	O
of	O
nuclear	O
axes	O
,	O
an	O
increase	O
in	O
the	O
number	O
and	O
size	O
of	O
lysosomes	O
and	O
multivesiculated	O
bodies	O
,	O
and	O
increased	O
numbers	O
of	O
enlarged	O
intramitochondrial	O
granules	O
.	O

The	O
routine	O
administration	O
of	O
fat	O
-	O
soluble	O
vitamins	O
appears	O
unnecessary	O
but	O
it	O
is	O
prudent	O
to	O
measure	O
prothrombin	B
time	O
and	O
serum	O
vitamins	O
A	O
and	O
E	O
at	O
intervals	O
.	O

Prostaglandins	O
F	O
(	O
PGF	O
)	O
were	O
measured	O
in	O
uterine	O
vein	O
,	O
ovarian	O
artery	O
,	O
and	O
jugular	O
vein	O
plasma	O
and	O
in	O
the	O
endometrial	O
tissues	O
at	O
various	O
times	O
during	O
the	O
bovine	O
estrous	O
cycle	O
,	O
and	O
were	O
compared	O
to	O
peripheral	O
plasma	O
progesterone	O
levels	O
.	O

Groups	O
of	O
ten	O
dependent	O
and	O
ten	O
saline	O
mice	O
were	O
singly	O
tested	O
in	O
both	O
light	O
and	O
dark	O
conditions	O
in	O
each	O
of	O
five	O
covered	O
cylinders	O
(	O
2	O
-	O
23	O
in	O
high	O
)	O
.	O

The	O
effects	O
initiated	O
from	O
the	O
nucleus	O
accumbens	O
septi	O
were	O
most	O
marked	O
.	O

The	O
appearance	O
of	O
dyskinetic	O
movement	O
disorders	O
in	O
humans	O
following	O
the	O
chronic	O
use	O
of	O
levodopa	O
or	O
amphetamine	O
may	O
be	O
a	O
manifestation	O
of	O
similarly	O
increased	O
dopamine	B
receptor	I
site	I
sensitivity	O
within	O
the	O
striatum	O
.	O

Association	O
with	O
HL	B
-	I
A	I
W-27	I
.	O

Atherosclerosis	O

However	O
,	O
a	O
10	O
-	O
-15	O
%	O
lengthening	O
of	O
the	O
partial	O
thromboplastin	B
time	O
is	O
evident	O
after	O
24	O
hours	O
of	O
storage	O
.	O

This	O
reveals	O
a	O
new	O
test	O
for	O
short	O
saphenous	O
incompetence	O
and	O
shows	O
that	O
14	O
per	O
cent	O
of	O
varices	O
stem	O
from	O
a	O
saphenopopliteal	O
reflux	O
.	O

Air	O
ion	O
action	O
on	O
bacteria	O
.	O

No	O
evidence	O
of	O
either	O
positive	O
or	O
negative	O
chemography	O
was	O
found	O
.	O

Study	O
of	O
the	O
physico	O
-	O
chemical	O
state	O
of	O
plutonium-239	O
in	O
a	O
citrate	O
solution	O
-	O
blood	O
system	O

Tobramycin	O
60	O
mg	O
did	O
not	O
show	O
any	O
remarkable	O
effect	O
,	O
but	O
dibecacin	O
100	O
mg	O
produced	O
a	O
slight	O
potentiating	O
effect	O
on	O
the	O
action	O
of	O
d	O
-	O
tubocurarine	O
.	O

The	O
specific	O
electrical	O
resistance	O
of	O
the	O
cerebrospinal	O
fluid	O
was	O
measured	O
by	O
means	O
of	O
conductometry	O
in	O
14	O
cases	O
of	O
meningitis	O
purulenta	O
,	O
17	O
cases	O
of	O
meningitis	O
serosa	O
,	O
10	O
cases	O
of	O
encephalitis	O
and	O
in	O
32	O
control	O
subjects	O
.	O

2	O
-	O
Chemical	O
occlusion	O
of	O
vas	O
is	O
quite	O
effective	O
in	O
producing	O
a	O
block	O
in	O
the	O
vas	O
deferens	O
of	O
dogs	O
.	O

Besides	O
,	O
we	O
found	O
in	O
3	O
patients	O
increased	O
serum	B
immunoglobulins	I
,	O
chiefly	O
IgG	B
,	O
as	O
first	O
Russe	O
,	O
Busey	O
and	O
Barbeau	O
demonstrated	O
in	O
a	O
large	O
French	O
-	O
Canadian	O
family	O
.	O

Generally	O
,	O
a	O
correlation	O
was	O
observed	O
between	O
highest	O
concentrations	O
of	O
CSF	B
immunoglobulins	I
and	O
degree	O
of	O
meningeal	O
inflammatory	O
response	O
,	O
even	O
if	O
this	O
was	O
a	O
component	O
of	O
other	O
neurological	O
diseases	O
.	O

Maternal	O
lactation	O

Experimental	O
cardiotoxicity	O
of	O
adriamycin	O

Muscular	O
pathology	O

Demonstration	O
of	O
the	O
agent	O
was	O
performed	O
from	O
the	O
6th	O
to	O
the	O
11th	O
day	O
p.i	O
.	O

by	O
direct	O
microscopic	O
methods	O
(	O
Stamp	O
and	O
auramine	O
staining	O
,	O
fluorescent	O
antibody	O
technique	O
)	O
;	O
the	O
Coxiella	O
content	O
was	O
determined	O
by	O
titration	O
in	O
embryonated	O
hen	O
's	O
eggs	O
.	O

The	O
alterations	O
of	O
5-HT	O
and	O
5-HIAA	O
levels	O
in	O
several	O
regions	O
of	O
the	O
brain	O
under	O
the	O
conditions	O
examined	O
may	O
indicate	O
that	O
IDPN	O
's	O
neurotoxicity	O
primarily	O
affects	O
5-HT	O
-	O
containing	O
neurones	O
.	O

(	O
5	O
)	O
An	O
increase	O
in	O
leukocyte	O
-	O
counts	O
occurred	O
on	O
the	O
administration	O
of	O
serum	O
obtained	O
from	O
rabbit	O
during	O
phase-2	O
.	O

The	O
results	O
obtained	O
tend	O
to	O
prove	O
that	O
the	O
reticuloendothelial	O
system	O
mainly	O
participated	O
in	O
beryllium	O
retention	O
.	O

In	O
both	O
cases	O
,	O
at	O
the	O
end	O
of	O
exposure	O
the	O
same	O
level	O
of	O
blood	B
carboxyhemoglobin	I
(	O
COHb	B
)	O
(	O
about	O
50	O
%	O
)	O
was	O
reached	O
.	O

The	O
results	O
indicate	O
that	O
increased	O
pulmonary	O
blood	O
flow	O
and	O
decreased	O
pulmonary	O
vascular	O
resistance	O
with	O
advancing	O
gestation	O
are	O
due	O
to	O
an	O
increase	O
in	O
the	O
total	O
number	O
of	O
vessels	O
and	O
increased	O
vasomotor	O
reactivity	O
is	O
related	O
to	O
an	O
increase	O
in	O
the	O
total	O
amount	O
of	O
smooth	O
muscle	O
while	O
the	O
thickness	O
of	O
muscle	O
in	O
individual	O
vessels	O
remains	O
constant	O
.	O

Reduction	O
in	O
dosage	O
restored	O
normal	O
taste	O
sense	O
in	O
all	O
three	O
,	O
but	O
in	O
two	O
the	O
drug	O
had	O
to	O
be	O
discontinued	O
because	O
of	O
persisting	O
high	O
transaminase	O
levels	O
.	O

A	O
late	O
diagnosis	O
of	O
retinoblastoma	O
is	O
an	O
unquestionable	O
fact	O
that	O
allows	O
its	O
growth	O
and	O
leads	O
to	O
a	O
deterioration	O
in	O
the	O
outlook	O
.	O

A	O
note	O
on	O
the	O
phase	O
-	O
plane	O
technique	O
representation	O
of	O
cardiac	O
action	O
potentials	O
.	O

3	O
activities	O
of	O
the	O
factor	B
II	I
molecule	O
in	O
the	O
newborn	O
infant	O
at	O
term	O

The	O
concept	O
of	O
""""	O
structural	O
identifiability	O
""""	O
is	O
employed	O
in	O
this	O
analysis	O
to	O
determine	O
which	O
model	O
parameters	O
can	O
be	O
and	O
which	O
can	O
not	O
be	O
determined	O
""""	O
uniquely	O
""""	O
from	O
given	O
input	O
-	O
output	O
data	O
;	O
a	O
step	O
-	O
by	O
-	O
step	O
procedure	O
based	O
on	O
an	O
extension	O
of	O
this	O
concept	O
is	O
presented	O
for	O
adapting	O
the	O
overall	O
approach	O
to	O
the	O
experimental	O
design	O
problem	O
.	O

However	O
,	O
we	O
did	O
detect	O
lot	O
-	O
to	O
-	O
lot	O
variation	O
and	O
differences	O
in	O
performance	O
between	O
narrow	O
bandpass	O
and	O
wide	O
bandpass	O
spectrophotometers	O
.	O

The	O
cochlear	O
compromise	O
.	O

Biohydrogenation	O
of	O
linoleic	O
acid	O
into	O
octadecenoic	O
acid	O
was	O
observed	O
.	O

Chlamydial	O
agents	O
were	O
isolated	O
from	O
the	O
semen	O
near	O
the	O
end	O
of	O
the	O
chlamydemic	O
phase	O
.	O

Because	O
of	O
the	O
increased	O
CPK	B
activity	O
found	O
in	O
normal	O
newborns	O
,	O
screening	O
for	O
Duchenne	O
-	O
type	O
muscular	O
dystrophy	O
should	O
be	O
postponed	O
for	O
a	O
few	O
weeks	O
after	O
delivery	O
.	O

The	O
authors	O
report	O
the	O
results	O
of	O
a	O
series	O
of	O
toxicological	O
tests	O
conducted	O
on	O
plastic	O
materials	O
(	O
polyethylene	O
)	O
activated	O
with	O
tetraphenylbutadiene	O
(	O
TPB	O
)	O
an	O
additive	O
recently	O
proposed	O
as	O
a	O
sensitizer	O
capable	O
of	O
photodegrading	O
plastic	O
materials	O
.	O

One	O
site	O
,	O
PAL	B
,	O
occurs	O
within	O
the	O
10	O
bp	O
sequence	O
GGGGAGGAGG	O
.	O

Nuclear	O
extracts	O
prepared	O
from	O
both	O
neural	O
and	O
non	O
-	O
neural	O
cell	O
lines	O
,	O
mouse	O
brain	O
,	O
and	O
mouse	O
liver	O
contain	O
proteins	O
that	O
recognize	O
and	O
bind	O
to	O
the	O
PROX	O
and	O
PAL	O
sequences	O
indicating	O
that	O
proteins	O
which	O
bind	O
to	O
these	O
target	O
sequences	O
are	O
widespread	O
.	O

To	O
determine	O
if	O
the	O
NF	B
(	I
H	I
)	I
promoter	I
can	O
be	O
activated	O
in	O
a	O
tissue	O
specific	O
manner	O
during	O
development	O
transgenic	O
mice	O
containing	O
the	O
promoter	O
region	O
linked	O
to	O
a	O
beta	B
-	I
galactosidase	I
reporter	I
gene	I
were	O
generated	O
.	O

A	O
significant	O
direct	O
relationship	O
was	O
observed	O
between	O
the	O
percent	O
area	O
density	O
of	O
smooth	O
muscle	O
and	O
the	O
percent	O
change	O
in	O
peak	O
urinary	O
flow	O
rate	O
.	O

Rabbit	B
skeletal	I
muscle	I
glycogenin	I
.	O

Animals	O
that	O
received	O
DSP-4	O
were	O
significantly	O
retarded	O
in	O
motor	O
recovery	O
compared	O
with	O
the	O
saline	O
group	O
.	O

The	O
prophylactic	O
use	O
of	O
new	O
medication	O
for	O
patients	O
between	O
the	O
first	O
and	O
second	O
cycle	O
of	O
chemotherapy	O
,	O
in	O
agreement	O
with	O
the	O
estimates	O
calculated	O
,	O
does	O
not	O
save	O
health	O
care	O
costs	O
but	O
may	O
improve	O
the	O
quality	O
of	O
life	O
in	O
these	O
patients	O
and	O
permit	O
the	O
continuation	O
of	O
a	O
therapeutic	O
schedule	O
without	O
interruption	O
which	O
may	O
improve	O
the	O
life	O
expectancy	O
of	O
the	O
patient	O
.	O

The	O
isolation	O
of	O
this	O
gene	O
was	O
based	O
on	O
the	O
identification	O
of	O
the	O
Y-231	O
cosmid	O
that	O
contains	O
CpG	O
rich	O
sequences	O
(	O
HTF	O
islands	O
)	O
in	O
its	O
human	O
insert	O
.	O

Tissue	B
plasminogen	I
activator	I
,	O
its	O
inhibitor	O
and	O
other	O
parameters	O
of	O
fibrinolysis	O
in	O
blood	O
of	O
patients	O
operated	O
for	O
mild	O
hypertrophy	O
of	O
the	O
prostate	O

Gene	O
constructs	O
consisting	O
of	O
human	B
growth	I
hormone	I
(	O
hGH	B
)	O
gene	O
driven	O
by	O
promoter	O
/	O
regulatory	O
sequence	O
of	O
mouse	B
metallothionein	I
(	O
mMT	B
)	O
,	O
viral	B
thymidine	I
kinase	I
(	O
vTK	B
)	O
,	O
rat	B
cholecystokinin	I
(	O
rCCK	B
)	O
,	O
or	O
chicken	B
beta	I
-	I
actin	I
(	O
cBA	B
)	O
gene	O
were	O
injected	O
into	O
the	O
cytoplasm	O
of	O
fertilized	O
medaka	O
eggs	O
via	O
the	O
micropyle	O
.	O

Serum	O
gastrin	B
and	O
AFP	B
levels	O
had	O
the	O
same	O
evolution	O
and	O
appear	O
to	O
have	O
the	O
same	O
interest	O
to	O
follow	O
the	O
course	O
of	O
the	O
disease	O
.	O

Prospects	O
for	O
controlled	O
-	O
delivery	O
systems	O
.	O

Though	O
hepatomegaly	O
and	O
mild	O
elevation	O
of	O
enzymes	O
can	O
be	O
observed	O
in	O
a	O
significant	O
proportion	O
of	O
patients	O
,	O
involvement	O
of	O
liver	O
leading	O
to	O
acute	O
hepatitis	O
or	O
liver	O
cell	O
necrosis	O
is	O
a	O
relatively	O
uncommon	O
complication	O
in	O
P.	O
falciparum	O
malaria	O
.	O

A	O
statistically	O
significant	O
improvement	O
due	O
to	O
the	O
administration	O
of	O
Bromergon	O
was	O
observed	O
in	O
symptoms	O
associated	O
with	O
overreactiveness	O
to	O
normal	O
prolactin	B
levels	O
,	O
i.e.	O
abdominal	O
tension	O
,	O
edema	O
,	O
weight	O
gain	O
and	O
breast	O
tenderness	O
.	O

Most	O
of	O
the	O
patients	O
presented	O
with	O
Transient	O
Ischemic	O
Attacks	O
(	O
64	O
%	O
)	O
or	O
Reversible	O
Ischemic	O
Neurologic	O
Deficits	O
(	O
19	O
%	O
)	O
.	O

We	O
cloned	O
the	O
third	O
human	O
gene	O
for	O
the	O
LD78	B
,	O
termed	O
LD78	B
gamma	I
and	O
the	O
sequence	O
analysis	O
showed	O
that	O
it	O
is	O
a	O
5'-truncated	O
pseudogene	O
.	O

This	O
analysis	O
,	O
together	O
with	O
a	O
consideration	O
of	O
the	O
SCBs	O
found	O
upstream	O
of	O
known	O
SWI4,6-dependent	B
genes	O
,	O
leads	O
to	O
the	O
proposal	O
of	O
a	O
revised	O
consensus	O
sequence	O
for	O
this	O
important	O
regulatory	O
element	O
.	O

Mutational	O
analysis	O
of	O
a	O
DNA	O
sequence	O
involved	O
in	O
linking	O
gene	O
expression	O
to	O
the	O
cell	O
cycle	O
.	O

The	O
method	O
was	O
adapted	O
for	O
the	O
determination	O
of	O
nadolol	O
racemate	O
A	O
by	O
a	O
change	O
in	O
mobile	O
phase	O
composition	O
.	O

In	O
7	O
of	O
9	O
cases	O
,	O
the	O
enhancer	O
is	O
fused	O
to	O
the	O
c	B
-	I
myc	I
bearing	I
sequences	I
of	O
chromosome	O
8	O
.	O

These	O
components	O
both	O
had	O
a	O
median	O
R2	O
of	O
0.84	O
,	O
compared	O
to	O
median	O
R2s	O
ranging	O
from	O
0.37	O
to	O
0.83	O
for	O
five	O
commonly	O
used	O
ad	O
hoc	O
EEG	O
components	O
.	O

66:469	O
-	O
479	O
,	O
1992	O
)	O
.	O

Synergistic	O
transactivation	O
of	O
the	O
BMRF1	B
promoter	I
by	O
the	O
Z	B
/	O
c	B
-	I
myb	I
combination	O
appears	O
to	O
involve	O
direct	O
binding	O
by	O
the	O
Z	B
protein	I
but	O
not	O
the	O
c	B
-	I
myb	I
protein	I
.	O

The	O
cellular	O
sequences	O
5	O
'	O
to	O
the	O
viral	O
integration	O
site	O
exhibited	O
85	O
to	O
97	O
%	O
identity	O
to	O
several	O
sequences	O
belonging	O
to	O
the	O
mouse	B
L1	I
family	I
of	O
long	O
interspersed	O
repetitive	O
sequences	O
.	O

Both	O
Rep78	B
and	O
Rep68	B
cut	O
the	O
terminal	O
AAV	O
sequence	O
at	O
the	O
same	O
site	O
(	O
nucleotide	O
124	O
)	O
.	O

Nucleotide	O
sequence	O
analysis	O
revealed	O
that	O
TAR	B
-	I
binding	I
protein	I
is	O
very	O
similar	O
to	O
the	O
CREB2	B
protein	I
.	O

Drosophila	B
UbcD1	I
encodes	O
a	O
highly	O
conserved	O
ubiquitin	B
-	O
conjugating	O
enzyme	O
involved	O
in	O
selective	O
protein	O
degradation	O
.	O

The	O
goal	O
of	O
the	O
present	O
study	O
was	O
to	O
determine	O
the	O
feasibility	O
of	O
retrovirus	O
mediated	O
expression	O
of	O
rp47phox	B
in	O
the	O
HL60	O
and	O
U937	O
human	O
hematopoietic	O
cell	O
lines	O
,	O
and	O
in	O
an	O
Epstein	O
-	O
Barr	O
virus	O
transformed	O
B	O
-	O
lymphocyte	O
cell	O
line	O
(	O
EBV	O
-	O
BCL	O
)	O
derived	O
from	O
a	O
p47phox	B
-	O
deficient	O
CGD	O
patient	O
.	O

Comparison	O
with	O
the	O
sequence	O
databanks	O
show	O
that	O
Tactile	B
is	O
a	O
member	O
of	O
the	O
immunoglobulin	B
gene	I
superfamily	I
,	O
with	O
similarity	O
to	O
Drosophila	B
amalgam	I
,	O
the	O
melanoma	B
Ag	I
MUC-18	I
,	O
members	O
of	O
the	O
carcinoembryonic	B
Ag	I
family	I
,	O
the	O
poliovirus	B
receptor	I
,	O
and	O
the	O
neural	B
cell	I
adhesion	I
molecule	I
.	O

The	O
phenotypes	O
of	O
the	O
ICP0	B
nonsense	O
mutants	O
were	O
intermediate	O
between	O
those	O
of	O
the	O
wild	O
-	O
type	O
virus	O
and	O
7134	O
in	O
that	O
the	O
more	O
ICP0-coding	B
sequence	I
expressed	O
by	O
a	O
given	O
nonsense	O
mutant	O
,	O
the	O
more	O
wild	O
type	O
-	O
like	O
was	O
its	O
phenotype	O
.	O

Analysis	O
of	O
nucleotide	O
sequence	O
of	O
the	O
rightmost	O
43	O
kbp	O
of	O
herpesvirus	O
saimiri	O
(	O
HVS	O
)	O
L	O
-	O
DNA	O
:	O
general	O
conservation	O
of	O
genetic	O
organization	O
between	O
HVS	O
and	O
Epstein	O
-	O
Barr	O
virus	O
.	O

Treatment	O
with	O
MK-801	O
induced	O
a	O
burst	O
suppression	O
in	O
the	O
EEG	O
and	O
a	O
transient	O
drop	O
(	O
11.4	O
+	O
/-	O

6.5	O
mm	O
Hg	O
)	O
in	O
the	O
mean	O
arterial	O
pressure	O
.	O

Myogenic	O
differentiation	O
can	O
be	O
inhibited	O
by	O
the	O
adenovirus	O
E1a	B
protein	I
in	O
the	O
rat	O
L6	O
muscle	O
cell	O
line	O
.	O

The	O
experiment	O
results	O
showed	O
:	O
(	O
i	O
)	O
not	O
only	O
1O2	O
,	O
but	O
also	O
free	O
radicals	O
(	O
O2-	O
.	O

.OH	O
and	O
YHPD-	O
.	O
)	O
can	O
be	O
formed	O
by	O
the	O
aid	O
of	O
YHPD	O
;	O
and	O
(	O
ii	O
)	O
as	O
to	O
the	O
ability	O
of	O
producing	O
1O2	O
,	O
YHPD	O
less	O
than	O
BHPD	O
,	O
while	O
for	O
generating	O
O2-	O
.	O

and	O
.OH	O
,	O
YHPD	O
greater	O
than	O
BHPD	O
.	O

Acad	O
.	O

Both	O
in	O
vitro	O
-	O
synthesized	O
S2	B
protein	I
and	O
synthetic	O
peptides	O
corresponding	O
to	O
S2	B
are	O
shown	O
to	O
react	O
positively	O
with	O
sera	O
obtained	O
from	O
EIAV	O
-	O
infected	O
horses	O
,	O
providing	O
the	O
first	O
direct	O
evidence	O
of	O
expression	O
of	O
this	O
protein	O
in	O
infected	O
animals	O
.	O

Many	O
canonical	O
TATA	O
sequences	O
are	O
present	O
upstream	O
from	O
these	O
VZV	O
transcriptional	O
start	O
sites	O
but	O
,	O
apparently	O
,	O
are	O
not	O
used	O
.	O

The	O
ORF	O
4	O
gene	O
was	O
minimally	O
active	O
,	O
whereas	O
the	O
ORF	O
62	O
gene	O
gave	O
twofold	O
induction	O
;	O
both	O
genes	O
,	O
acting	O
together	O
,	O
gave	O
fivefold	O
induction	O
.	O

Interestingly	O
,	O
the	O
IR5	B
ORF	I
of	O
EHV-1	O
possesses	O
a	O
sequence	O
of	O
13	O
amino	O
acids	O
(	O
CAYWCCLGHAFAC	O
)	O
that	O
is	O
a	O
perfect	O
match	O
to	O
the	O
consensus	O
zinc	O
finger	O
motif	O
(	O
C	O
-	O
X2	O
-	O
4-C	O
-	O
X2	O
-	O
15-C	O
/	O
H	O
-	O
X2	O
-	O
4-C	O
/	O
H	O
)	O
.	O

The	O
DNA	O
sequence	O
of	O
the	O
sulfate	B
activation	I
locus	I
from	O
Escherichia	O
coli	O
K-12	O
has	O
been	O
determined	O
.	O

Plasma	O
membranes	O
of	O
cultured	O
cells	O
contain	O
high	O
affinity	O
receptors	O
for	O
high	B
density	I
lipoprotein	I
(	O
HDL	B
)	O
that	O
appear	O
to	O
mediate	O
removal	O
of	O
excess	O
intracellular	O
cholesterol	O
.	O

After	O
the	O
first	O
28	O
patients	O
vincristine	O
was	O
replaced	O
by	O
teniposide	O
(	O
VM-26	O
)	O
due	O
to	O
neurotoxicity	O
.	O

These	O
results	O
indicate	O
that	O
an	O
internal	O
short	O
element	O
located	O
at	O
the	O
very	O
5	O
'	O
terminal	O
of	O
L1	B
sequence	I
and	O
the	O
nuclear	O
factor	O
binding	O
to	O
the	O
element	O
play	O
a	O
crucial	O
role	O
in	O
the	O
transcription	O
of	O
human	B
L1	I
.	O

Tumor	O
cells	O
were	O
focally	O
immunoreactive	O
for	O
neuron	B
-	I
specific	I
enolase	I
,	O
insulin	B
,	O
glucagon	B
and	O
VIP	B
.	O

A	O
recombinant	O
with	O
a	O
5	O
'	O
end	O
from	O
src	B
and	O
a	O
3	O
'	O
end	O
from	O
ros	B
,	O
called	O
SRC	B
x	O
ROS	B
,	O
transformed	O
chicken	O
embryo	O
fibroblasts	O
(	O
CEF	O
)	O
to	O
a	O
spindle	O
shape	O
morphology	O
,	O
mimicking	O
that	O
of	O
UR2	B
.	O

Transient	O
transfection	O
assays	O
showed	O
that	O
site	O
A	O
is	O
necessary	O
and	O
sufficient	O
for	O
RXR	B
alpha	I
-	O
mediated	O
transactivation	O
of	O
the	O
apoAI	B
gene	I
basal	I
promoter	I
in	O
human	O
hepatoma	O
HepG2	O
cells	O
in	O
the	O
presence	O
of	O
RA	O
and	O
that	O
this	O
transactivation	O
is	O
abolished	O
by	O
increasing	O
amounts	O
of	O
cotransfected	O
ARP-1	B
.	O

The	O
enhancer	O
region	O
of	O
Akv	O
murine	O
leukemia	O
virus	O
contains	O
the	O
sequence	O
motif	O
ACAGATGG	O
.	O

A	O
third	O
prominent	O
component	O
of	O
apparent	O
molecular	O
mass	O
16	O
kDa	O
displayed	O
several	O
properties	O
,	O
including	O
ability	O
to	O
bind	O
45Ca2	O
+	O
,	O
that	O
are	O
characteristic	O
of	O
the	O
regulatory	O
(	O
B	O
)	O
subunit	O
of	O
mammalian	B
calcineurin	I
and	O
was	O
recognized	O
by	O
an	O
antiserum	O
raised	O
against	O
bovine	B
calcineurin	I
.	O

As	O
was	O
observed	O
previously	O
for	O
MATa	B
cna1	B
cna2	B
double	O
mutants	O
,	O
MATa	B
cnb1	B
mutants	I
were	O
defective	O
in	O
their	O
ability	O
to	O
recover	O
from	O
alpha	B
-	I
factor	I
-	O
induced	O
growth	O
arrest	O
.	O

Antibodies	O
against	O
this	O
purified	O
protein	O
localize	O
RIM1	B
to	O
mitochondria	O
.	O

HNF-3	B
beta	I
amino	I
-	I
terminal	I
sequences	I
defined	O
by	O
conserved	O
region	O
IV	O
also	O
contributed	O
to	O
transactivation	O
,	O
but	O
region	O
IV	O
activity	O
required	O
the	O
participation	O
of	O
the	O
region	O
II	O
-	O
III	O
domain	O
.	O

The	O
319	O
base	O
pair	O
region	O
immediately	O
upstream	O
of	O
the	O
CAP	O
site	O
is	O
characterized	O
by	O
the	O
lack	O
of	O
a	O
proximal	O
TATA	O
box	O
and	O
the	O
presence	O
of	O
sequences	O
similar	O
to	O
GC	O
boxes	O
,	O
CACCC	O
boxes	O
,	O
CCAAT	O
boxes	O
,	O
activator	B
protein	I
2	I
(	O
Ap-2	B
)	O
sites	O
,	O
partial	O
glucocorticoid	O
response	O
elements	O
(	O
GREs	O
)	O
,	O
and	O
partial	O
cyclic	O
AMP	O
response	O
elements	O
(	O
CREs	O
)	O
.	O

In	O
rats	O
anaesthetized	O
with	O
+	O
-chloralose	O
the	O
changes	O
in	O
extracellular	O
pH	O
and	O
K+	O
in	O
spinal	O
cord	O
dorsal	O
horn	O
were	O
studied	O
using	O
pH	O
and	O
K+	O
ion	O
-	O
selective	O
electrodes	O
.	O

NSCL-1	B
is	O
expressed	O
in	O
a	O
larger	O
number	O
of	O
these	O
cell	O
lines	O
.	O

Labile	O
LTR	B
-	I
binding	I
proteins	I
appear	O
to	O
be	O
essential	O
for	O
c	B
-	I
myc	I
hyperexpression	O
,	O
since	O
both	O
LTR	O
-	O
enhanced	O
transcription	O
and	O
the	O
activities	O
of	O
LTR	B
-	I
binding	I
proteins	I
are	O
specifically	O
decreased	O
after	O
inhibition	O
of	O
protein	O
synthesis	O
(	O
A.	O

Ruddell	O
,	O
M.	O

Intermediate	O
levels	O
of	O
gene	O
activity	O
were	O
observed	O
for	O
TnI	B
enhancers	I
containing	O
E	O
-	O
boxes	O
derived	O
from	O
the	O
MCK	B
left	I
E	I
-	I
box	I
site	I
or	O
from	O
the	O
Ig	B
kappa	I
E2	I
E	I
-	I
box	I
.	O

The	O
CANNTG	O
motifs	O
were	O
found	O
to	O
bind	O
MyoD	B
and	O
myogenin	B
fusion	I
proteins	I
and	O
to	O
interact	O
with	O
proteins	O
in	O
nuclear	O
extracts	O
from	O
cultured	O
myotubes	O
.	O

Peripheral	O
polyneuropathy	O
associated	O
with	O
multiple	O
myeloma	O
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
COX12	B
,	O
the	O
nuclear	O
gene	O
for	O
subunit	B
VIb	I
of	O
Saccharomyces	B
cerevisiae	I
cytochrome	I
c	I
oxidase	I
.	O

The	O
basal	O
promoter	O
elements	O
of	O
murine	B
cytochrome	I
c	I
oxidase	I
subunit	I
IV	I
gene	I
consist	O
of	O
tandemly	O
duplicated	O
ets	B
motifs	O
that	O
bind	O
to	O
GABP	B
-	I
related	I
transcription	I
factors	I
.	O

Here	O
we	O
show	O
that	O
short	O
synthetic	O
peptides	O
containing	O
the	O
pRB	B
-	I
binding	I
sequences	I
of	O
E1A	B
are	O
sufficient	O
for	O
interaction	O
with	O
p107	B
,	O
cyclin	B
A	I
,	O
and	O
p130	B
.	O

Mapping	O
the	O
cAMP	B
receptor	I
protein	I
contact	I
site	I
on	O
the	O
alpha	O
subunit	O
of	O
Escherichia	B
coli	I
RNA	I
polymerase	I
.	O

A	O
combination	O
of	O
comparative	O
sequence	O
analysis	O
and	O
thermodynamic	O
methods	O
reveals	O
the	O
conservation	O
of	O
tertiary	O
structure	O
elements	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
human	O
enteroviruses	O
and	O
rhinoviruses	O
.	O

This	O
soluble	O
form	O
of	O
the	O
HGFr	B
(	O
sHGFr	B
)	O
bound	O
HGF	B
with	O
an	O
affinity	O
similar	O
to	O
that	O
of	O
the	O
authentic	O
,	O
membrane	O
-	O
associated	O
receptor	O
.	O

Strategies	O
for	O
blood	O
screening	O
for	O
the	O
hepatitis	O
C	O
virus	O
and	O
for	O
the	O
human	O
immunodeficiency	O
virus	O
in	O
high	O
risk	O
groups	O
.	O

Comparison	O
of	O
data	O
obtained	O
with	O
the	O
results	O
of	O
chronic	O
treatment	O
with	O
the	O
opioid	O
antagonist	O
permits	O
to	O
conclude	O
that	O
the	O
chronic	O
blockade	O
increases	O
the	O
fatiguability	O
to	O
a	O
great	O
extent	O
than	O
chronic	O
activation	O
of	O
opioid	O
system	O
.	O

We	O
have	O
cloned	O
and	O
characterized	O
a	O
55-kb	O
region	O
of	O
DNA	O
surrounding	O
HRAS1	B
.	O

The	O
ORF1	O
protein	O
was	O
found	O
to	O
be	O
highly	O
homologous	O
to	O
the	O
putative	O
potexvirus	B
RNA	I
replicases	I
;	O
ORF2	O
,	O
-3	O
,	O
-5	O
and	O
-6	O
proteins	O
also	O
have	O
analogues	O
among	O
the	O
potex-	O
and/or	O
carlavirus	O
-	O
encoded	O
proteins	O
.	O

A	O
total	O
of	O
281	O
patients	O
were	O
divided	O
into	O
groups	O
according	O
to	O
their	O
clinical	O
diagnosis	O
and	O
were	O
examined	O
using	O
capnography	O
,	O
spirometry	O
and	O
blood	O
-	O
gas	O
analysis	O
.	O

No	O
significant	O
correlations	O
of	O
peak	O
VO2	O
were	O
observed	O
between	O
the	O
3	O
tests	O
.	O

An	O
RNA	B
-	I
binding	I
protein	I
gene	I
(	O
rbp1	B
)	O
from	O
Drosophila	O
melanogaster	O
,	O
encoding	O
an	O
RNA	O
recognition	O
motif	O
and	O
an	O
Arg	O
-	O
Ser	O
rich	O
(	O
RS	O
)	O
domain	O
,	O
has	O
been	O
characterized	O
.	O

Some	O
research	O
studies	O
have	O
related	O
this	O
kind	O
of	O
tumors	O
with	O
prolonged	O
ingestion	O
of	O
H2	O
inhibitors	O
and	O
others	O
antacid	O
.	O

A	O
comparative	O
study	O
of	O
the	O
total	O
protein	O
profiles	O
of	O
wild	O
-	O
type	O
S.	O
entomophila	O
UC9	O
and	O
mutant	O
UC21	O
revealed	O
that	O
the	O
mutant	O
lacked	O
an	O
approximately	O
44-kDa	O
protein	O
and	O
overexpressed	O
an	O
approximately	O
20-kDa	O
protein	O
.	O

Characterization	O
of	O
the	O
regulon	O
controlled	O
by	O
the	O
leucine	B
-	I
responsive	I
regulatory	I
protein	I
in	O
Escherichia	O
coli	O
.	O

Mapping	O
of	O
the	O
mouse	B
ornithine	I
decarboxylase	I
-	I
related	I
sequence	I
family	I
.	O

This	O
mutation	O
also	O
results	O
in	O
markedly	O
decreased	O
levels	O
of	O
CAD	B
mRNA	I
and	O
protein	O
in	O
the	O
mutant	O
.	O

The	O
rationale	O
for	O
continuous	O
dopaminergic	O
stimulation	O
in	O
patients	O
with	O
Parkinson	O
's	O
disease	O
.	O

Mutational	O
studies	O
revealed	O
that	O
it	O
was	O
the	O
homeodomain	B
binding	I
site	I
II	I
sequence	I
that	O
was	O
required	O
for	O
this	O
regulation	O
.	O

Interestingly	O
,	O
the	O
positions	O
of	O
these	O
introns	O
have	O
been	O
conserved	O
in	O
comparison	O
with	O
the	O
genes	O
of	O
two	O
other	O
transglutaminase	O
-	O
like	O
activities	O
described	O
in	O
the	O
literature	O
,	O
but	O
the	O
TGM1	B
gene	I
is	O
by	O
far	O
the	O
smallest	O
characterized	O
to	O
date	O
because	O
its	O
introns	O
are	O
relatively	O
smaller	O
.	O

In	O
a	O
retrospective	O
analysis	O
of	O
data	O
from	O
35	O
cases	O
with	O
malignant	O
lymphoma	O
from	O
a	O
cohort	O
of	O
2017	O
HIV	O
-	O
infected	O
patients	O
,	O
the	O
stage	O
of	O
HIV	O
-	O
disease	O
,	O
the	O
CD4	B
counts	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
and	O
the	O
use	O
of	O
antineoplastic	O
agents	O
or	O
radiotherapy	O
were	O
correlated	O
with	O
outcome	O
.	O

1	O
.	O

The	O
single	O
site	O
of	O
glycosylation	O
is	O
located	O
near	O
the	O
C	O
-	O
terminus	O
in	O
the	O
N	O
-	O
glycosylation	O
sequon	O
-Asn	O
-	O
Cys	O
-	O
Ser-	O
in	O
which	O
Cys	O
forms	O
part	O
of	O
a	O
disulphide	O
bridge	O
.	O

The	O
pulmonary	O
toxic	O
events	O
induced	O
by	O
acute	O
nitrogen	O
dioxide	O
(	O
NO	O
)	O
2	O
exposure	O
were	O
studied	O
in	O
the	O
rat	O
to	O
develop	O
an	O
inhalation	O
model	O
to	O
investigate	O
therapeutic	O
measures	O
.	O

Interaction	O
of	O
H-2Eb	B
with	O
an	O
IAP	B
retrotransposon	I
in	O
the	O
A20	O
/	O
2J	O
B	O
cell	O
lymphoma	O
.	O

The	O
subunit	O
protein	O
of	O
curli	B
was	O
highly	O
homologous	O
at	O
its	O
amino	O
terminus	O
to	O
SEF-17	B
,	O
the	O
subunit	O
protein	O
of	O
thin	O
,	O
aggregative	O
fimbriae	O
of	O
Salmonella	O
enteritidis	O
27655	O
strain	O
3b	O
,	O
suggesting	O
that	O
these	O
fibres	O
form	O
a	O
novel	O
class	O
of	O
surface	O
organelles	O
on	O
enterobacteria	O
.	O

Substitution	O
of	O
the	O
DR1	B
beta	I
chain	I
with	O
H-2E	B
beta	I
k	I
led	O
to	O
a	O
dramatic	O
loss	O
of	O
recognition	O
;	O
alpha	O
chain	O
substitution	O
had	O
a	O
less	O
marked	O
effect	O
.	O

The	O
distal	O
portion	O
of	O
the	O
rat	B
insulin	I
I	I
gene	I
5'-flanking	I
DNA	I
contains	O
two	O
sequence	O
elements	O
,	O
the	O
Far	O
and	O
FLAT	O
elements	O
,	O
that	O
can	O
function	O
in	O
combination	O
,	O
but	O
not	O
separately	O
,	O
as	O
a	O
beta	O
-	O
cell	O
-	O
specific	O
transcriptional	O
enhancer	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
exhibited	O
98	O
%	O
identity	O
to	O
the	O
human	O
cellular	O
transglutaminase	O
sequence	O
.	O

This	O
computation	O
is	O
performed	O
by	O
a	O
parallel	O
network	O
of	O
locally	O
connected	O
neuron	O
-	O
like	O
elements	O
.	O

Repeated	O
efforts	O
to	O
isolate	O
recombinant	O
baculoviruses	O
containing	O
a	O
wild	O
-	O
type	O
kinase	O
failed	O
,	O
whereas	O
recombinants	O
expressing	O
a	O
nonfunctional	O
kinase	O
with	O
a	O
catalytic	O
domain	O
II	O
mutation	O
were	O
readily	O
isolated	O
.	O

In	O
addition	O
,	O
a	O
21-mer	O
subrepeat	O
structure	O
is	O
also	O
present	O
in	O
each	O
unit	O
.	O

We	O
propose	O
that	O
plasmids	O
of	O
the	O
pLS1	O
family	O
(	O
pE194	O
,	O
pADB201	O
,	O
and	O
pLB4	O
)	O
share	O
functional	O
and	O
structural	O
characteristics	O
for	O
the	O
regulation	O
of	O
their	O
copy	O
numbers	O
.	O

Differential	O
expression	O
of	O
the	O
""""	O
B	O
""""	O
subunit	O
of	O
the	O
vacuolar	B
H	I
(	I
+	I
)	I
-ATPase	I
in	O
bovine	O
tissues	O
.	O

We	O
have	O
isolated	O
and	O
characterised	O
a	O
differentially	O
-	O
regulated	O
gene	O
family	O
in	O
the	O
protozoan	O
parasite	O
Leishmania	O
major	O
.	O

At	O
some	O
sites	O
,	O
%	O
T	O
is	O
greatly	O
increased	O
by	O
Cl-	O
concentrations	O
up	O
to	O
1	O
M	O
,	O
while	O
at	O
other	O
sites	O
%	O
T	O
is	O
reduced	O
or	O
unaffected	O
by	O
these	O
conditions	O
.	O

In	O
summary	O
,	O
the	O
segments	O
of	O
C3	B
represented	O
by	O
amino	O
acid	O
residues	O
1082	O
-	O
1118	O
,	O
1117	O
-	O
1155	O
,	O
1234	O
-	O
1294	O
and	O
1312	O
-	O
1404	O
accommodate	O
C3	B
(	I
D	I
)	I
epitopes	I
that	O
are	O
expressed	O
by	O
erythrocyte	O
-	O
bound	O
C3	B
fragments	I
,	O
but	O
not	O
by	O
the	O
corresponding	O
fluid	O
-	O
phase	O
fragment	O
,	O
whereas	O
the	O
segments	O
spanning	O
residues	O
973	O
-	O
1026	O
and	O
1477	O
-	O
1510	O
contain	O
C3	B
(	I
D	I
)	I
epitopes	I
that	O
are	O
exposed	O
exclusively	O
in	O
denatured	O
C3	B
and	O
therefore	O
hidden	O
in	O
physiological	O
fragments	O
of	O
the	O
protein	O
.	O

These	O
exons	O
,	O
further	O
identified	O
as	O
exons	O
9	O
,	O
10	O
,	O
and	O
11	O
,	O
together	O
encode	O
the	O
37	O
amino	O
acid	O
residues	O
present	O
in	O
alpha	B
s1-casein	I
variant	I
A	I
but	O
missing	O
in	O
variant	O
F.	O

We	O
also	O
report	O
here	O
the	O
complete	O
structural	O
organization	O
of	O
the	O
goat	B
alpha	I
s1-casein	I
transcription	I
unit	I
,	O
deduced	O
from	O
polymerase	O
chain	O
reaction	O
experiments	O
.	O

Neither	O
gene	O
possesses	O
a	O
distinct	O
transcriptional	O
start	O
site	O
as	O
shown	O
by	O
nuclease	B
S1	I
analysis	O
.	O

Each	O
group	O
received	O
15	O
ml	O
/	O
kg	O
of	O
either	O
6	O
%	O
pentafraction	O
,	O
6	O
%	O
pentastarch	O
,	O
or	O
plasma	O
followed	O
two	O
hours	O
later	O
by	O
1.5	O
micrograms	O
/	O
kg	O
/	O
0.5	O
hr	O
E.	O

Genetic	O
and	O
biochemical	O
evidence	O
suggests	O
that	O
v	B
-	I
Crk	I
can	O
induce	O
transformation	O
of	O
chicken	O
embryo	O
fibroblasts	O
by	O
influencing	O
the	O
activity	O
of	O
cellular	O
proteins	O
involved	O
in	O
growth	O
regulation	O
.	O

We	O
have	O
constructed	O
,	O
using	O
synthetic	O
DNA	O
oligonucleotides	O
,	O
a	O
U14	B
snRNA	I
gene	I
which	O
has	O
been	O
positioned	O
behind	O
a	O
T7	B
RNA	I
polymerase	I
promoter	I
site	I
and	O
then	O
inserted	O
into	O
a	O
plasmid	O
.	O

Gene	O
and	O
pseudogene	O
of	O
the	O
mouse	O
cation	O
-	O
dependent	O
mannose	B
6-phosphate	I
receptor	I
.	O

The	O
chick	O
axon	O
-	O
associated	O
surface	O
glycoprotein	O
neurofascin	B
is	O
implicated	O
in	O
axonal	O
growth	O
and	O
fasciculation	O
as	O
revealed	O
by	O
antibody	O
perturbation	O
experiments	O
.	O

The	O
carcinoma	O
was	O
restricted	O
within	O
the	O
epithelium	O
in	O
one	O
,	O
the	O
mucosal	O
layer	O
in	O
five	O
,	O
and	O
the	O
submucosal	O
layer	O
in	O
two	O
.	O

In	O
addition	O
,	O
C	B
/	I
EBP	I
beta	I
and	O
C	B
/	I
EBP	I
gamma	I
readily	O
heterodimerize	O
with	O
each	O
other	O
as	O
well	O
as	O
with	O
C	B
/	I
EBP	I
alpha	I
.	O

In	O
contrast	O
,	O
tobacco	B
GS-2	I
is	O
composed	O
of	O
subunits	O
of	O
identical	O
size	O
in	O
all	O
organs	O
examined	O
.	O

Between	O
acoR	B
and	O
acoXABC	B
,	O
two	O
different	O
types	O
of	O
sequences	O
with	O
dual	O
rotational	O
symmetry	O
[	O
CAC-	O
(	O
N11	O
to	O
N18	O
)	O
-GTG	O
and	O
TGT-	O
(	O
N10	O
to	O
N14	O
)	O
-ACA	O
]	O
were	O
found	O
;	O
these	O
sequences	O
are	O
similar	O
to	O
NtrC	B
and	O
NifA	B
upstream	I
activator	I
sequences	I
,	O
respectively	O
.	O

Although	O
the	O
effects	O
of	O
the	O
calcium	O
supplement	O
or	O
calcium	O
antagonist	O
alone	O
were	O
significant	O
,	O
such	O
hypotensive	O
responses	O
were	O
not	O
optimal	O
or	O
predictable	O
or	O
clearly	O
dose	O
-	O
dependent	O
.	O

Surprisingly	O
,	O
the	O
full	O
-	O
deletion	O
mutant	O
showed	O
a	O
strong	O
block	O
in	O
virus	O
release	O
,	O
suggesting	O
that	O
NC	B
is	O
involved	O
in	O
virus	O
assembly	O
.	O

The	O
method	O
requires	O
a	O
reversed	O
-	O
phase	O
column	O
and	O
a	O
paired	O
-	O
ion	O
technique	O
to	O
separate	O
docusate	O
sodium	O
from	O
other	O
components	O
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
protein	O
product	O
of	O
the	O
ref-1	B
gene	I
stimulates	O
the	O
DNA	O
binding	O
activity	O
of	O
Fos	B
-	O
Jun	B
heterodimers	O
,	O
Jun	B
-	O
Jun	B
homodimers	O
and	O
Hela	O
cell	O
AP-1	B
proteins	I
as	O
well	O
as	O
that	O
of	O
several	O
other	O
transcription	O
factors	O
including	O
NF	B
-	I
kappa	I
B	I
,	O
Myb	B
and	O
members	O
of	O
the	O
ATF	B
/	O
CREB	B
family	O
.	O

The	O
pulpal	O
tissues	O
of	O
the	O
permanent	O
mandibular	O
molars	O
were	O
amputated	O
and	O
then	O
dressed	O
with	O
calcium	O
hydrate	O
.	O

The	O
ARG	B
SH2	B
domain	I
exhibited	O
relatively	O
weak	O
affinity	O
for	O
BCR	B
and	O
was	O
determined	O
to	O
bind	O
about	O
10-fold	O
less	O
strongly	O
than	O
the	O
ABL	B
SH2	B
domain	I
.	O

Interestingly	O
,	O
this	O
activation	O
occurred	O
only	O
when	O
the	O
regions	O
were	O
cloned	O
in	O
the	O
same	O
relative	O
orientation	O
in	O
which	O
they	O
exist	O
on	O
wild	O
-	O
type	O
pCF10	O
.	O

In	O
rats	O
,	O
we	O
examined	O
the	O
effect	O
of	O
an	O
omentum	O
wrapping	O
on	O
the	O
vascularization	O
of	O
the	O
trachea	O
and	O
on	O
regeneration	O
of	O
the	O
mucosal	O
epithelium	O
in	O
the	O
very	O
early	O
stage	O
after	O
free	O
tracheal	O
grafting	O
.	O

To	O
study	O
a	O
possible	O
functional	O
role	O
of	O
this	O
putative	O
chicken	O
ICS	B
,	O
an	O
oligonucleotide	O
spanning	O
the	O
upstream	O
sequences	O
of	O
the	O
BF	B
-	I
IV	I
gene	I
(	O
-174	O
/	O
-194	O
)	O
was	O
cloned	O
singly	O
or	O
in	O
multiple	O
copies	O
before	O
the	O
herpes	O
TK	B
promoter	I
controlling	O
the	O
chloramphenicol	B
acetyl	I
transferase	I
(	O
CAT	B
)	O
gene	O
(	O
pBLCAT2	B
)	O
.	O

Through	O
Southern	O
blot	O
analyses	O
of	O
DNA	O
from	O
backcross	O
and	O
cogenic	O
mice	O
,	O
recombinant	O
inbred	O
strains	O
,	O
and	O
somatic	O
cell	O
hybrids	O
,	O
the	O
genetic	O
loci	O
that	O
produce	O
the	O
cyclin	B
B1-related	I
sequences	I
(	O
designated	O
loci	B
Cycb1-rs1	I
to	O
Cycb1-rs9	B
)	O
were	O
mapped	O
on	O
mouse	O
chromosomes	O
5	O
,	O
1	O
,	O
17	O
,	O
4	O
,	O
14	O
,	O
13	O
,	O
7	O
,	O
X	O
,	O
and	O
8	O
,	O
respectively	O
.	O

Porcelain	O
to	O
dentin	O
bond	O
strength	O
with	O
a	O
dentin	O
adhesive	O
.	O

It	O
was	O
concluded	O
that	O
Scotchbond	O
2	O
and	O
Prisma	O
Universal	O
Bond	O
2	O
are	O
effective	O
and	O
are	O
the	O
dentine	O
bonding	O
agents	O
of	O
choice	O
.	O

From	O
all	O
clinically	O
important	O
yeasts	O
species	O
,	O
a	O
total	O
of	O
96	O
%	O
were	O
identified	O
by	O
ATB	O
method	O
according	O
to	O
conventional	O
methods	O
.	O

Comments	O
are	O
given	O
on	O
the	O
present	O
status	O
of	O
regulations	O
concerning	O
water	O
in	O
swimming	O
pools	O
and	O
baths--1991	O
-	O
-	O
(	O
in	O
connection	O
with	O
the	O
KOK	O
regulations--1972	O
-	O
-and	O
the	O
Federal	O
German	O
standard	O
[	O
DIN	O
]	O

No.	O

If	O
no	O
reply	O
was	O
received	O
,	O
telephone	O
contact	O
or	O
home	O
visits	O
were	O
made	O
.	O

Urease	B
activity	O
,	O
judged	O
as	O
the	O
amount	O
of	O
ammonia	O
production	O
from	O
urea	O
,	O
could	O
be	O
measured	O
at	O
25	O
ng	O
per	O
tube	O
(	O
S	O
/	O
N	O
=	O
1.5	O
)	O
with	O
Jack	B
bean	I
meal	I
urease	I
.	O

Consequently	O
,	O
significant	O
differences	O
between	O
the	O
measured	O
and	O
calculated	O
methods	O
were	O
noted	O
in	O
oxygen	O
uptake	O
(	O
213	O
+	O
/-	O

41	O
ml	O
/	O
min	O
vs	O
193	O
+	O
/-	O

25	O
ml	O
/	O
min	O
,	O
p	O
<	O
0.001	O
)	O
,	O
oxygen	O
delivery	O
(	O
780	O
+	O
/-	O

297	O
ml	O
/	O
min	O
vs	O
716	O
+	O
/-	O

296	O
ml	O
/	O
min	O
,	O
p	O
<	O
0.001	O
)	O
,	O
and	O
cardiac	O
output	O
(	O
5.8	O
+	O
/-	O

2.2	O
L	O
/	O
min	O
vs	O
5.3	O
+	O
/-	O

1.8	O
L	O
/	O
min	O
,	O
p	O
<	O
0.001	O
)	O
.	O

Although	O
a	O
wide	O
range	O
of	O
cognitive	O
functions	O
had	O
been	O
tested	O
,	O
all	O
but	O
one	O
seizure	O
occurred	O
during	O
assessment	O
of	O
memory	O
performance	O
.	O

The	O
experiments	O
show	O
that	O
it	O
is	O
the	O
micromilieu	O
of	O
the	O
alveoli	O
and	O
the	O
condition	O
of	O
the	O
AM	O
(	O
certain	O
physiological	O
activation	O
states	O
,	O
such	O
as	O
phagocytic	O
activity	O
)	O
that	O
essentially	O
determine	O
the	O
degree	O
of	O
recovery	O
.	O

Negatively	O
supercoiled	O
plasmid	O
pUC19	O
did	O
not	O
compete	O
,	O
whereas	O
an	O
otherwise	O
identical	O
plasmid	O
pUC19	O
(	O
CG	O
)	O
,	O
which	O
contained	O
a	O
(	O
dG	O
-	O
dC	O
)	O
7	O
segment	O
in	O
the	O
Z	O
-	O
form	O
was	O
an	O
excellent	O
competitor	O
.	O

Our	O
experiments	O
suggest	O
that	O
the	O
SCL	B
gene	I
can	O
be	O
a	O
target	O
for	O
the	O
erythroid	B
transcription	I
factor	I
GATA-1	I
and	O
that	O
the	O
SCL	B
gene	I
product	I
serves	O
as	O
a	O
positive	O
regulator	O
of	O
erythroid	O
differentiation	O
.	O

The	O
gene	O
sequence	O
also	O
identified	O
a	O
340-nucleotide	O
RNA	O
in	O
total	O
yeast	O
RNA	O
and	O
in	O
purified	O
RNase	B
MRP	I
enzyme	I
preparations	O
.	O

The	O
RNase	B
MRP	I
RNA	I
gene	I
was	O
deleted	O
by	O
insertional	O
replacement	O
and	O
found	O
to	O
be	O
essential	O
for	O
cellular	O
viability	O
,	O
indicating	O
a	O
critical	O
nuclear	O
role	O
for	O
RNase	B
MRP	I
.	O

From	O
these	O
results	O
,	O
CBF	B
-	I
A	I
is	O
a	O
novel	O
CArG	O
box-	O
,	O
ssDNA-	B
and	I
RNA	I
-	I
binding	I
protein	I
,	O
as	O
well	O
as	O
a	O
repressive	O
transcriptional	O
factor	O
.	O

Cleavage	O
by	O
the	O
intron	O
-	O
encoded	O
enzyme	O
(	O
I	B
-	I
CreI	I
)	O
occurs	O
5	O
bp	O
and	O
1	O
bp	O
3	O
'	O
to	O
the	O
intron	O
insertion	O
site	O
(	O
in	O
the	O
3'-exon	O
)	O
in	O
the	O
top	O
(	O
/	O
)	O
and	O
bottom	O
(	O
,	O
)	O
strands	O
,	O
respectively	O
,	O
resulting	O
in	O
4-nt	O
single	O
-	O
stranded	O
overhangs	O
with	O
3'-OH	O
termini	O
.	O

Western	O
blot	O
analyses	O
detect	O
anti	B
-	I
E	I
-	O
specific	O
immunoreactivity	O
in	O
affinity	O
-	O
purified	O
extracts	O
derived	O
from	O
the	O
bacterial	O
expression	O
of	O
a	O
truncated	B
AMPD3	I
cDNA	I
.	O

These	O
results	O
demonstrate	O
that	O
endogenous	O
N	O
-	O
methylation	O
of	O
salsolinol	O
into	O
N	O
-	O
methylsalsolinol	O
occurs	O
in	O
the	O
brain	O
in	O
vivo	O
.	O

DR1	B
molecules	I
purified	O
from	O
human	O
lymphoblastoid	O
cell	O
lines	O
could	O
specifically	O
bind	O
to	O
these	O
peptide	O
sequences	O
expressed	O
on	O
the	O
phage	O
surface	O
.	O

Chronic	O
hepatitis	O
B	O
in	O
adopted	O
Romanian	O
children	O
.	O

Behind	O
the	O
ATPase	B
cluster	I
,	O
two	O
open	O
reading	O
frames	O
were	O
detected	O
that	O
are	O
not	O
homologous	O
to	O
any	O
known	O
chloroplast	O
gene	O
.	O

Therefore	O
,	O
recombinant	O
human	O
Ads	O
that	O
express	O
noninfectious	O
HIV	O
or	O
other	O
microbial	O
proteins	O
are	O
attractive	O
vaccine	O
candidates	O
.	O

Alignment	O
of	O
the	O
selected	O
sequences	O
allowed	O
us	O
to	O
predict	O
a	O
consensus	O
sequence	O
for	O
binding	O
of	O
the	O
individual	O
homodimeric	O
Rel	B
-	I
related	I
proteins	I
,	O
and	O
DNA	O
-	O
protein	O
binding	O
analysis	O
of	O
the	O
selected	O
DNA	O
sequences	O
revealed	O
sequence	O
specificity	O
of	O
the	O
proteins	O
.	O

Using	O
either	O
a	O
p50-	B
or	O
p65-selected	B
kappa	B
B	I
motif	I
,	O
which	O
displayed	O
differential	O
binding	O
with	O
respect	O
to	O
the	O
other	O
protein	O
,	O
little	O
to	O
no	O
binding	O
was	O
observed	O
with	O
the	O
heterodimeric	B
NF	I
-	I
kappa	I
B	I
complex	I
.	O

However	O
,	O
a	O
cosmid	O
clone	O
containing	O
the	O
entire	O
mouse	B
alpha	I
1	I
(	I
I	I
)	I
gene	I
,	O
including	O
3.7	O
kb	O
of	O
5'-	O
and	O
4	O
kb	O
of	O
3'-flanking	O
DNA	O
,	O
was	O
expressed	O
at	O
reduced	O
levels	O
in	O
fibroblasts	O
overexpressing	O
oncogenic	B
ras	I
.	O

Sequencing	O
analysis	O
has	O
shown	O
that	O
each	O
rap1	B
t	I
allele	I
contains	O
a	O
nonsense	O
mutation	O
within	O
a	O
discrete	O
region	O
between	O
amino	O
acids	O
663	O
and	O
684	O
.	O

Autopsy	O
demonstrated	O
good	O
survival	O
of	O
the	O
transplanted	O
cells	O
with	O
good	O
integration	O
with	O
the	O
brain	O
of	O
the	O
recipient	O
and	O
traces	O
of	O
positive	O
immunocytochemical	O
reaction	O
for	O
tyrosine	B
hydroxylase	I
.	O

In	O
the	O
eight	O
patients	O
with	O
persistent	O
generalized	O
lymph	O
-	O
adenopathy	O
(	O
PGL	O
)	O
and	O
nontender	O
,	O
nonenlarging	O
nodes	O
,	O
pathologic	O
analysis	O
revealed	O
lymphoid	O
hyperplasia	O
.	O

By	O
using	O
lambda	O
gt11	O
expression	O
cloning	O
with	O
oligonucleotides	O
corresponding	O
to	O
the	O
human	O
immunodeficiency	O
virus	O
1	O
TATA	O
element	O
,	O
we	O
report	O
the	O
identification	O
of	O
a	O
cellular	O
protein	O
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
123	O
kDa	O
that	O
we	O
designate	O
TATA	B
element	I
modulatory	I
factor	I
(	O
TMF	B
)	O
.	O

Blood	O
levels	O
of	O
melatonin	O
,	O
serotonin	O
,	O
cortisol	O
,	O
and	O
prolactin	B
in	O
relation	O
to	O
the	O
circadian	O
rhythm	O
of	O
platelet	O
serotonin	O
uptake	O
.	O

In	O
8	O
healthy	O
volunteers	O
there	O
were	O
no	O
significant	O
differences	O
in	O
AUC	O
,	O
peak	O
plasma	O
concentrations	O
or	O
time	O
to	O
peak	O
concentration	O
when	O
OXC	O
was	O
administered	O
either	O
with	O
or	O
without	O
ERY	O
.	O

Using	O
5	O
ng	O
/	O
mL	O
as	O
the	O
cutoff	O
,	O
the	O
sensitivity	O
of	O
CEA	B
was	O
68	O
%	O
.	O

Rolandic	O
spikes	O
and	O
cognitive	O
function	O
.	O

The	O
effect	O
of	O
sodium	O
18	O
beta	O
-	O
glycyrrhetate	O
(	O
SGA	O
)	O
on	O
experimental	O
arrhythmia	O
was	O
investigated	O
.	O

The	O
effects	O
of	O
diltiazem	O
were	O
stereoselective	O
,	O
thus	O
the	O
potentiation	O
induced	O
by	O
d	O
-	O
cis	O
diltiazem	O
was	O
significantly	O
greater	O
in	O
all	O
cases	O
than	O
that	O
induced	O
by	O
l	O
-	O
cis	O
diltiazem	O
,	O
which	O
suggests	O
that	O
calcium	O
channel	O
blockade	O
plays	O
a	O
role	O
in	O
these	O
interactions	O
.	O

Substitution	O
of	O
either	O
Val33	O
(	O
by	O
Gly	O
)	O
or	O
Gly28	O
(	O
by	O
Ser	O
)	O
,	O
two	O
of	O
the	O
most	O
conserved	O
residues	O
in	O
all	O
protein	O
kinases	O
,	O
resulted	O
in	O
enzyme	O
with	O
marginally	O
detectable	O
activity	O
.	O

The	O
TIMP	B
(	O
-59	O
/	O
-53	O
)	O
AP1	B
site	O
is	O
a	O
promiscuous	O
motif	O
that	O
binds	O
c	B
-	I
Fos	I
/	O
c	B
-	I
Jun	I
AP1	B
translated	O
in	O
vitro	O
and	O
is	O
an	O
effective	O
competitor	O
for	O
binding	O
of	O
nuclear	B
AP1	I
factors	I
to	O
the	O
consensus	O
TRE	O
,	O
but	O
in	O
addition	O
it	O
binds	O
factors	O
that	O
do	O
not	O
associate	O
with	O
the	O
consensus	O
TRE	O
.	O

Involvement	O
of	O
AP1	B
and	O
PEA3	B
binding	I
sites	I
in	O
the	O
regulation	O
of	O
murine	B
tissue	I
inhibitor	I
of	I
metalloproteinases-1	I
(	O
TIMP-1	B
)	O
transcription	O
.	O

A	O
controlled	O
trial	O
of	O
recombinant	B
human	I
granulocyte	I
-	I
macrophage	I
colony	I
-	I
stimulating	I
factor	I
after	O
total	O
body	O
irradiation	O
,	O
high	O
-	O
dose	O
chemotherapy	O
,	O
and	O
autologous	O
bone	O
marrow	O
transplantation	O
for	O
acute	O
lymphoblastic	O
leukemia	O
or	O
malignant	O
lymphoma	O
.	O

These	O
data	O
demonstrate	O
that	O
DMVA	O
does	O
not	O
cause	O
more	O
myocardial	O
trauma	O
than	O
CPB	O
when	O
used	O
to	O
provide	O
resuscitative	O
circulatory	O
support	O
.	O

Examination	O
of	O
ANCA	B
is	O
not	O
only	O
a	O
significant	O
contribution	O
towards	O
a	O
more	O
accurate	O
diagnosis	O
of	O
renal	O
vasculitis	O
,	O
but	O
also	O
an	O
indicator	O
of	O
the	O
activity	O
of	O
the	O
disease	O
and	O
thus	O
of	O
the	O
effectiveness	O
of	O
immunosuppressive	O
treatment	O
.	O

Cicatricial	O
pemphigoid	O
is	O
an	O
autoimmune	O
systemic	O
disease	O
characterized	O
by	O
chronic	O
conjunctival	O
cicatrization	O
.	O

4	O
.	O

The	O
in	O
vivo	O
profile	O
of	O
ZFH-2	B
in	O
the	O
larval	O
CNS	O
shows	O
intriguing	O
overlap	O
with	O
DDC	B
in	O
specific	O
serotonin	O
and	O
dopamine	O
neurons	O
.	O

Therefore	O
,	O
it	O
would	O
be	O
advantageous	O
to	O
identify	O
such	O
persons	O
and	O
treat	O
them	O
preferentially	O
.	O

On	O
the	O
basis	O
of	O
these	O
unique	O
properties	O
,	O
the	O
newly	O
characterized	O
hemagglutinin	B
has	O
been	O
termed	O
Limulus	B
18	I
K	I
agglutination	I
-	I
aggregation	I
factor	I
(	O
18K	B
-	I
LAF	I
)	O
.	O

It	O
corresponds	O
to	O
the	O
complete	O
mitochondrial	O
presequence	O
and	O
the	O
lipoyl	O
-	O
bearing	O
domain	O
that	O
are	O
encoded	O
by	O
exons	O
I	O
through	O
IV	O
of	O
the	O
functional	O
E2	B
gene	I
.	O

Human	O
neutrophil	O
response	O
to	O
short	O
-	O
term	O
exposure	O
to	O
F-75	O
cobalt	O
-	O
based	O
alloy	O
.	O

The	O
second	O
method	O
,	O
the	O
""""	O
macro	O
""""	O
assay	O
,	O
has	O
a	O
sensitivity	O
range	O
of	O
0.03	O
-	O
5.0	O
micrograms	O
phosphorus	O
with	O
100	O
-	O
500	O
microliters	O
HClO4	O
.	O

Nucleotide	O
sequence	O
and	O
transcriptional	O
analysis	O
of	O
the	O
polyhedrin	B
gene	I
of	O
Spodoptera	O
exigua	O
nuclear	O
polyhedrosis	O
virus	O
.	O

As	O
a	O
consequence	O
of	O
dark	O
rearing	O
,	O
the	O
numerical	O
density	O
of	O
cortical	O
neurons	O
in	O
area	O
17	O
amounted	O
to	O
about	O
double	O
of	O
the	O
value	O
observed	O
in	O
normally	O
reared	O
kittens	O
and	O
was	O
also	O
significantly	O
higher	O
in	O
area	O
18	O
.	O

These	O
results	O
suggest	O
that	O
decreased	O
class	O
I	O
enhancer	O
activity	O
in	O
Ad12-transformed	O
cells	O
may	O
,	O
at	O
least	O
in	O
part	O
,	O
be	O
due	O
to	O
the	O
higher	O
levels	O
of	O
an	O
enhancer	O
-	O
specific	O
factor	O
,	O
possibly	O
acting	O
as	O
a	O
repressor	O
.	O

A	O
second	O
domain	O
,	O
located	O
in	O
the	O
C	O
-	O
terminal	O
437	O
amino	O
acids	O
of	O
IE1	B
,	O
is	O
required	O
for	O
inhibitory	O
and	O
DNA	O
-	O
binding	O
activities	O
.	O

205	O
,	O
285	O
-	O
290	O
]	O
and	O
was	O
subsequently	O
cloned	O
and	O
sequenced	O

[	O
J.	O

Nonreplicating	O
vaccinia	O
vector	O
efficiently	O
expresses	O
recombinant	O
genes	O
.	O

No	O
other	O
changes	O
in	O
hematopoietic	O
differentiation	O
status	O
were	O
observed	O
in	O
association	O
with	O
Id	B
-	I
SCL	I
expression	O
.	O

Respiratory	O
interaction	O
after	O
spinal	O
anesthesia	O
and	O
sedation	O
with	O
midazolam	O
.	O

One	O
air	O
embolism	O
occurred	O
;	O
this	O
was	O
the	O
only	O
filter-	O
or	O
retrieval	O
-	O
related	O
complication	O
.	O

The	O
5	O
'	O
region	O
of	O
ADH5	B
contains	O
consensus	O
binding	O
sites	O
for	O
the	O
transcriptional	O
regulatory	O
proteins	O
,	O
Sp1	B
,	O
AP2	B
,	O
LF	B
-	I
A1	I
,	O
NF-1	B
,	O
NF	B
-	I
A2	I
,	O
and	O
NF	B
-	I
E1	I
.	O

Purification	O
and	O
cloning	O
of	O
a	O
novel	O
serine	B
protease	I
,	O
RNK	B
-	I
Met-1	I
,	O
from	O
the	O
granules	O
of	O
a	O
rat	O
natural	O
killer	O
cell	O
leukemia	O
.	O

Administration	O
of	O
growth	B
hormone	I
leads	O
to	O
faster	O
growth	O
,	O
but	O
also	O
faster	O
bone	O
maturation	O
.	O

Comparisons	O
with	O
the	O
available	O
amino	O
acid	O
residue	O
(	O
aa	O
)	O
sequence	O
information	O
from	O
the	O
complete	O
CPMV	B
RNA	I
1	I
sequence	I
and	O
the	O
partial	O
sequence	O
of	O
red	B
clover	I
mottle	I
virus	I
RNA	I
1	I
suggest	O
that	O
CPSMV	B
RNA	I
1	I
specifies	O
the	O
expected	O
set	O
of	O
five	O
mature	O
proteins	O
:	O
32	B
K	I
proteinase	I
cofactor	I
,	O
58	B
K	I
presumed	I
helicase	I
,	O
VPg	B
5'-linked	I
protein	I
of	O
the	O
genomic	O
RNAs	O
,	O
24	B
K	I
proteinase	I
,	O
and	O
87	B
K	I
presumed	I
polymerase	I
,	O
separated	O
by	O
four	O
cleavage	O
sites	O
.	O

In	O
addition	O
,	O
the	O
utility	O
of	O
beta	B
2	I
transferrin	I
assay	O
in	O
the	O
diagnosis	O
of	O
cerebrospinal	O
fluid	O
otorrhea	O
is	O
presented	O
.	O

The	O
addition	O
of	O
diatrizoate	O
to	O
the	O
IPRK	O
led	O
to	O
a	O
dose	O
-	O
dependent	O
biphasic	O
change	O
in	O
RPF	O
and	O
GFR	O
characterized	O
by	O
an	O
initial	O
transient	O
increase	O
followed	O
by	O
a	O
marked	O
and	O
sustained	O
decrease	O
.	O

The	O
structural	O
genes	O
encoding	O
glyceraldehyde-3-phosphate	B
dehydrogenase	I
(	O
GAPDH	B
)	O
,	O
3-phosphoglycerate	B
kinase	I
(	O
PGK	B
)	O
and	O
the	O
N	O
-	O
terminal	O
part	O
of	O
triosephosphate	B
isomerase	I
(	O
TIM	B
)	O
from	O
mesophilic	O
Bacillus	O
megaterium	O
DSM319	O
have	O
been	O
cloned	O
as	O
a	O
gene	O
cluster	O
(	O
gap	B
operon	I
)	O
by	O
complementation	O
of	O
an	O
Escherichia	O
coli	O
gap	B
amber	I
mutant	I
.	O

Laboratory	O
studies	O
showed	O
that	O
the	O
direct	O
fluorescent	O
-	O
antibody	O
kits	O
were	O
the	O
least	O
sensitive	O
in	O
this	O
case	O
and	O
did	O
not	O
detect	O
fewer	O
than	O
10	O
(	O
4	O
)	O
elementary	O
bodies	O
per	O
ml	O
,	O
while	O
most	O
ELISA	O
kits	O
detected	O
between	O
130	O
and	O
600	O
elementary	O
bodies	O
per	O
ml	O
.	O

For	O
this	O
reason	O
,	O
the	O
particle	O
forming	O
capacity	O
of	O
derivatives	O
of	O
the	O
HIV-1	B
group	I
specific	I
core	I
antigen	I
p55	I
gag	I
was	O
assayed	O
and	O
compared	O
dependent	O
on	O
various	O
expression	O
systems	O
:	O
recombinant	O
bacteria	O
,	O
vaccinia-	O
and	O
baculoviruses	O
were	O
established	O
encoding	O
the	O
entire	O
core	B
protein	I
p55	I
either	O
in	O
its	O
authentic	O
sequence	O
or	O
lacking	O
the	O
myristylation	O
consensus	O
signal	O
.	O

The	O
tramtrack	B
(	O
ttk	B
)	O
gene	O
of	O
Drosophila	O
encodes	O
69-kDa	O
and	O
88-kDa	O
proteins	O
through	O
alternative	O
splicing	O
of	O
the	O
primary	O
ttk	B
transcript	I
.	O

Removal	O
of	O
beta	B
2-microglobulin	I
by	O
hemodialysis	O
and	O
hemofiltration	O
:	O
a	O
four	O
year	O
follow	O
up	O
.	O

Removal	O
of	O
beta	B
2-microglobulin	I
by	O
hemodialysis	O
and	O
hemofiltration	O
:	O
a	O
four	O
year	O
follow	O
up	O
.	O

Adapromine	O
was	O
established	O
to	O
evoke	O
a	O
decrease	O
of	O
the	O
amplitude	O
of	O
the	O
dominant	O
peak	O
and	O
dominant	O
theta	O
-	O
activity	O
in	O
power	O
spectra	O
of	O
the	O
EEG	O
in	O
the	O
cortex	O
and	O
hippocamp	O
,	O
with	O
an	O
increase	O
of	O
rapid	O
wave	O
activity	O
in	O
the	O
beta	O
2	O
range	O
in	O
the	O
right	O
cortex	O
and	O
hippocamp	O
.	O

After	O
28	O
days	O
of	O
haloperidol	O
treatment	O
,	O
similar	O
changes	O
were	O
observed	O
for	O
delta	O
,	O
together	O
with	O
an	O
increase	O
of	O
alpha	O
1	O
,	O
and	O
a	O
decrease	O
of	O
fast	O
beta	O
.	O

Truncated	B
ICSBP	I
lacking	O
the	O
first	O
33	O
amino	O
-	O
terminal	O
amino	O
acids	O
fails	O
to	O
bind	O
to	O
the	O
ICS	B
,	O
indicating	O
that	O
at	O
least	O
part	O
of	O
the	O
DNA	O
binding	O
domain	O
is	O
located	O
within	O
the	O
well	O
conserved	O
amino	O
terminus	O
.	O

Therefore	O
,	O
ICSBP	B
may	O
be	O
involved	O
in	O
maintaining	O
submaximal	O
transcriptional	O
activity	O
of	O
IFN	B
-	O
inducible	O
genes	O
in	O
hematopoietic	O
cells	O
.	O

Comparable	O
amounts	O
of	O
alpha	B
5	I
beta	I
1	I
integrin	I
were	O
isolated	O
from	O
these	O
cells	O
by	O
chromatography	O
of	O
detergent	O
extracts	O
on	O
a	O
fibronectin	B
cell	O
-	O
binding	O
fragment	O
affinity	O
column	O
and	O
elution	O
with	O
EDTA	O
.	O

Abstracts	O
.	O

From	O
this	O
library	O
,	O
LEU2	B
and	O
HIS3	B
cDNAs	O
were	O
recovered	O
at	O
a	O
frequency	O
of	O
about	O
1	O
in	O
10	O
(	O
4	O
)	O
and	O
in	O
12	O
out	O
of	O
13	O
cases	O
these	O
were	O
expressed	O
in	O
a	O
galactose	O
-	O
dependent	O
manner	O
.	O

However	O
,	O
in	O
the	O
subgroup	O
with	O
normal	O
Ht	O
(	O
<	O
0.45	O
l	O
/	O
l	O
;	O
n	O
=	O
201	O
)	O
there	O
was	O
a	O
significant	O
reduction	O
(	O
p	O
<	O
0.05	O
)	O
of	O
the	O
mortality	O
after	O
3	O
months	O
(	O
27	O
%	O
and	O
16	O
%	O
,	O
respectively	O
)	O
and	O
an	O
increase	O
of	O
independence	O
at	O
home	O
(	O
35	O
%	O
and	O
48	O
%	O
,	O
respectively	O
)	O
due	O
to	O
a	O
reduction	O
of	O
the	O
viscosity	O
by	O
means	O
of	O
haemodilution	O
with	O
albumin	B
(	O
a	O
specific	O
viscosity	O
effect	O
in	O
the	O
normovolaemic	O
group	O
)	O
.	O

The	O
appropriate	O
use	O
and	O
benefits	O
of	O
bile	O
acid	O
sequestrants	O
,	O
nicotinic	O
acid	O
,	O
fibric	O
acids	O
,	O
3-hydroxy-3-methylglutaryl	B
coenzyme	I
A	I
(	I
HMG	I
-	I
CoA	I
)	I
reductase	I
inhibitors	O
,	O
and	O
probucol	O
are	O
individually	O
discussed	O
,	O
whereas	O
nonpharmacologic	O
approaches	O
used	O
in	O
conjunction	O
with	O
the	O
drugs	O
are	O
recommended	O
emphatically	O
.	O

The	O
major	O
pathological	O
findings	O
of	O
the	O
placenta	O
were	O
prematuration	O
and	O
hypoplasia	O
.	O

Brucellosis--1990	O

Assay	O
of	O
urea	O
by	O
immobilized	O
urease	B
coupled	O
to	O
a	O
differential	O
pH	O
-	O
meter	O
.	O

Therefore	O
,	O
the	O
molecular	O
mechanisms	O
of	O
the	O
estrogen	O
action	O
that	O
govern	O
the	O
lactoferrin	B
gene	I
expression	O
differ	O
between	O
mouse	O
and	O
human	O
.	O

BiP670	B
retains	O
basal	O
and	O
Ca2	O
+	O
ionophore	O
A23187-inducible	O
activities	O
.	O

Magnetic	O
resonance	O
spectroscopy	O
(	O
MRS	O
)	O
and	O
imaging	O
(	O
MRI	O
)	O
are	O
now	O
well	O
established	O
techniques	O
for	O
the	O
study	O
of	O
cellular	O
metabolism	O
and	O
gross	O
structure	O
of	O
muscle	O
.	O

Simultaneously	O
a	O
greater	O
NA	O
was	O
found	O
with	O
no	O
change	O
in	O
plasma	O
epinephrine	O
response	O
.	O

We	O
investigated	O
the	O
diagnostic	O
value	O
of	O
a	O
new	O
in	O
vitro	O
test	O
,	O
Pharmacia	O
CAP	O
System	O
(	O
Pharmacia	O
Diagnostics	O
AB	O
,	O
Uppsala	O
,	O
Sweden	O
)	O
,	O
for	O
the	O
quantitative	O
measurement	O
of	O
allergen	B
-	I
specific	I
IgE	I
antibodies	I
by	O
comparison	O
with	O
RAST	O
in	O
2	O
groups	O
of	O
patients	O
,	O
71	O
atopic	O
and	O
48	O
non	O
-	O
atopic	O
.	O

As	O
a	O
part	O
of	O
a	O
large	O
examination	O
,	O
total	O
and	O
free	O
serum	O
cholesterol	O
,	O
total	O
lipid	O
and	O
triglyceride	O
levels	O
were	O
determined	O
.	O

Caries	O
and	O
parodontitis	O
have	O
been	O
one	O
of	O
the	O
most	O
spread	O
diseases	O
of	O
mankind	O
.	O

A	O
second	O
large	O
group	O
of	O
disorders	O
in	O
pregnancy	O
is	O
caused	O
by	O
effects	O
of	O
infections	O
of	O
the	O
mother	O
without	O
pathogens	O
being	O
transmitted	O
to	O
the	O
embryo	O
or	O
the	O
placenta	O
.	O

The	O
case	O
described	O
is	O
that	O
of	O
a	O
72-year	O
-	O
old	O
man	O
with	O
ochronosis	O
who	O
suffered	O
a	O
hyperextension	O
injury	O
to	O
his	O
spine	O
in	O
a	O
fall	O
,	O
resulting	O
in	O
a	O
fracture	O
through	O
an	O
ankylosed	O
L2-L3	O
disk	O
space	O
.	O

ME1a1	B
,	O
a	O
16-base	O
-	O
pair	O
nuclear	O
factor	O
binding	O
site	O
residing	O
between	O
the	O
c	B
-	I
MYC	I
P1	I
and	I
P2	I
transcription	I
initiation	I
sites	I
,	O
is	O
required	O
for	O
P2	O
activity	O
.	O

Exogenous	O
LHRH	B
is	O
also	O
known	O
to	O
facilitate	O
mating	O
behavior	O
in	O
several	O
species	O
.	O

Replacing	O
the	O
aspartic	O
acid	O
with	O
a	O
lysine	O
but	O
not	O
with	O
an	O
alanine	O
or	O
valine	O
residue	O
allowed	O
formation	O
of	O
disulfide	O
-	O
linked	O
dimers	O
.	O

During	O
V	O
-	O
A	O
bypass	O
,	O
hemodynamics	O
were	O
stable	O
.	O

Greater	O
rupture	O
force	O
was	O
required	O
in	O
the	O
adult	O
pigs	O
than	O
in	O
the	O
young	O
pigs	O
.	O

Exposure	O
to	O
hepatitis	O
B	O
virus	O
in	O
the	O
general	O
population	O
of	O
Hisayama	O
,	O
Japan	O
:	O
significance	O
of	O
isolated	O
antibody	O
to	O
hepatitis	B
B	I
surface	I
antigen	I
in	O
general	O
population	O
.	O

High	O
-	O
resolution	O
computed	O
tomography	O
in	O
the	O
diagnosis	O
of	O
miliary	O
tuberculosis	O
.	O

Previously	O
,	O
we	O
showed	O
that	O
SNF2	B
,	O
SNF5	B
,	O
and	O
SNF6	B
function	O
interdependently	O
in	O
transcriptional	O
activation	O
,	O
possibly	O
forming	O
a	O
heteromeric	O
complex	O
.	O

We	O
show	O
that	O
LexA	B
-	O
GAL4	B
and	O
LexA	B
-	O
Bicoid	B
fusion	O
proteins	O
are	O
both	O
dependent	O
on	O
SNF2	B
,	O
SNF5	B
,	O
and	O
SNF6	B
for	O
activation	O
of	O
target	O
genes	O
containing	O
one	O
or	O
multiple	O
lexA	B
operators	I
.	O

George	O
T.	O

NE	B
and	O
PR3	B
assist	O
in	O
the	O
destruction	O
of	O
phagocytosed	O
microorganisms	O
,	O
cleave	O
the	O
important	O
connective	B
-	I
tissue	I
protein	I
elastin	I
,	O
and	O
generate	O
chemotactic	O
activities	O
by	O
forming	O
alpha	B
1-proteinase	I
inhibitor	I
complexes	I
and	O
elastin	B
peptides	I
.	O

Factors	O
associated	O
with	O
afterdrop	O
included	O
age	O
,	O
end	O
-	O
of	O
-	O
surgery	O
temperature	O
(	O
both	O
positively	O
)	O
and	O
body	O
mass	O
(	O
negatively	O
)	O
.	O

By	O
contrast	O
,	O
d	B
(	I
T2AG3	I
T	I
)	I
and	O
d	B
(	I
T2G4	I
T	I
)	I
form	O
only	O
the	O
G	O
-	O
quadruplex	O
monomer	O
structures	O
independent	O
of	O
K	O
cation	O
concentration	O
as	O
reported	O
previously	O
[	O
Sen	O
,	O
D.	O
,	O
&	O
Gilbert	O
,	O
W.	O

Differentiating	O
among	O
renal	O
stones	O
.	O

IFI	B
16	I
mRNA	I
was	O
found	O
to	O
be	O
constitutively	O
expressed	O
in	O
lymphoid	O
cells	O
and	O
in	O
cell	O
lines	O
of	O
both	O
the	O
T	O
and	O
B	O
lineages	O
.	O

Mitochondria	O
-	O
lytic	O
action	O
of	O
warfarin	O
in	O
lymphocytes	O
.	O

The	O
cDNA	O
has	O
an	O
open	O
reading	O
frame	O
of	O
900	O
amino	O
acids	O
capable	O
of	O
encoding	O
a	O
97-kDa	O
protein	O
.	O

Thus	O
,	O
this	O
study	O
provides	O
evidence	O
that	O
a	O
novel	O
,	O
ubiquitous	O
factor	O
(	O
HF-1a	B
)	O
and	O
a	O
muscle	O
factor	O
(	O
HF-1b	B
/	O
MEF-2	B
)	O
can	O
form	O
a	O
novel	O
,	O
E	O
-	O
box	O
-	O
independent	O
pathway	O
for	O
muscle	O
-	O
specific	O
expression	O
in	O
ventricular	O
cardiac	O
muscle	O
cells	O
.	O

Mutations	O
in	O
either	O
gene	O
block	O
some	O
crucial	O
late	O
step	O
in	O
assembly	O
of	O
F1	B
,	O
causing	O
the	O
alpha	O
and	O
beta	O
subunits	O
to	O
accumulate	O
in	O
mitochondria	O
as	O
inactive	O
aggregates	O
(	O
Ackerman	O
,	O
S.	O

Estrogen	O
replacement	O
therapy	O
and	O
risk	O
of	O
breast	O
cancer	O
:	O
results	O
of	O
two	O
meta	O
-	O
analyses	O
.	O

Switching	O
FDC	O
-	O
P1	O
/	O
MAC	O
cells	O
from	O
growth	O
in	O
M	B
-	I
CSF	I
to	O
GM	B
-	I
CSF	I
caused	O
the	O
selective	O
degradation	O
of	O
c	B
-	I
fms	I
mRNA	I
within	O
6	O
h	O
after	O
factor	O
switching	O
.	O

There	O
was	O
however	O
,	O
no	O
significant	O
difference	O
in	O
the	O
prevalence	O
of	O
chronic	O
respiratory	O
symptoms	O
between	O
animal	O
food	O
workers	O
with	O
positive	O
and	O
negative	O
skin	O
tests	O
to	O
house	O
dust	O
or	O
to	O
fish	O
flour	O
or	O
among	O
those	O
with	O
increased	O
or	O
normal	O
IgE	B
(	O
except	O
for	O
dyspnea	O
)	O
.	O

Using	O
bovine	B
and	I
murine	I
c	I
-	I
myb	I
clones	O
,	O
no	O
change	O
in	O
the	O
rate	O
of	O
c	B
-	I
myb	I
gene	I
transcription	O
or	O
mRNA	O
stability	O
was	O
detected	O
during	O
the	O
cell	O
cycle	O
.	O

A	O
13	O
base	O
-	O
pair	O
oligonucleotide	O
spanning	O
nucleotides	O
+	O
80	O
to	O
+	O
92	O
of	O
the	O
5	B
S	I
RNA	I
gene	I
retained	O
specific	O
and	O
high	O
-	O
affinity	O
binding	O
,	O
although	O
the	O
latter	O
was	O
reduced	O
sixfold	O
relative	O
to	O
longer	O
DNA	O
fragments	O
.	O

A	O
comparison	O
of	O
the	O
amino	O
acid	O
sequence	O
of	O
the	O
T.	O
thermophilus	O
enzyme	O
with	O
that	O
of	O
the	O
Escherichia	O
coli	O
enzyme	O
showed	O
(	O
i	O
)	O
a	O
37	O
%	O
overall	O
similarity	O
;	O
(	O
ii	O
)	O
the	O
conservation	O
of	O
the	O
Ser	O
residue	O
,	O
which	O
is	O
known	O
to	O
be	O
phosphorylated	O
in	O
the	O
E.	O
coli	O
enzyme	O
,	O
and	O
of	O
the	O
surrounding	O
sequence	O
;	O
and	O
(	O
iii	O
)	O
the	O
presence	O
of	O
141	O
extra	O
residues	O
at	O
the	O
C	O
terminus	O
of	O
the	O
T.	O
thermophilus	O
enzyme	O
.	O

Radiolabelled	O
palmitate	O
was	O
not	O
incorporated	O
into	O
the	O
mutated	O
protein	O
,	O
showing	O
that	O
lipid	O
modification	O
occurs	O
at	O
the	O
Cys-22	O
residue	O
.	O

17	O
volunteer	O
deaf	O
Ss	O
were	O
compared	O
with	O
18	O
volunteer	O
hearing	O
Ss	O
on	O
the	O
Stanford	O
Hypnotic	O
Clinical	O
Scale	O
(	O
SHCS	O
)	O
of	O
Morgan	O
and	O
J.	O

The	O
gene	O
encoding	O
IFN	B
-	I
gamma	I
was	O
previously	O
found	O
to	O
contain	O
an	O
intronic	O
enhancer	O
element	O
that	O
was	O
not	O
tissue	O
-	O
specific	O
in	O
its	O
activity	O
,	O
despite	O
the	O
restricted	O
expression	O
of	O
the	O
intact	O
IFN	B
-	I
gamma	I
-	I
encoding	I
gene	I
.	O

Molecular	O
cloning	O
of	O
the	O
polypeptide	O
component	O
of	O
the	O
Rel	B
-	I
related	I
human	I
p75	I
nucleoprotein	I
complex	I
has	O
revealed	O
its	O
identity	O
with	O
the	O
65-kDa	O
(	O
p65	B
)	O
subunit	O
of	O
NF	B
-	I
kappa	I
B.	I

When	O
transiently	O
transfected	O
into	O
K562	O
cells	O
,	O
this	O
Lg	B
genomic	O
clone	O
is	O
actively	O
transcribed	O
,	O
suggesting	O
that	O
,	O
although	O
it	O
possesses	O
the	O
characteristics	O
of	O
a	O
processed	O
pseudogene	O
,	O
it	O
is	O
likely	O
to	O
correspond	O
to	O
the	O
gene	O
encoding	O
this	O
new	O
ferritin	B
subunit	I
.	O

Of	O
the	O
drugs	O
orally	O
administered	O
,	O
WR-168643	O
was	O
the	O
best	O
protector	O
with	O
a	O
DMF	O
of	O
1.51	O
.	O

During	O
the	O
1980	O
's	O
,	O
quantifications	O
of	O
immunoserological	O
testings	O
,	O
especially	O
C	B
reactive	I
protein	I
,	O
rheumatoid	B
factor	I
and	O
antistreptolysin	B
O	I
,	O
progressed	O
rapidly	O
.	O

Within	O
the	O
human	O
enhancer	O
,	O
these	O
two	O
sites	O
are	O
located	O
within	O
the	O
previously	O
defined	O
DNase	B
I	I
footprints	I
,	O
NFAT-1	B
and	O
NFIL-2B	B
,	O
respectively	O
.	O

The	O
cardiac	B
myosin	I
light	I
chain-2	I
(	O
MLC-2	B
)	O
gene	O
promoter	O
contains	O
several	O
positive	O
and	O
negative	O
cis	O
-	O
acting	O
sequences	O
that	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
its	O
expression	O
.	O

Deletion	O
mutagenesis	O
demonstrated	O
that	O
these	O
two	O
elements	O
are	O
involved	O
in	O
the	O
positive	O
regulation	O
of	O
MLC-2	B
gene	I
transcription	O
.	O

Disruption	O
mutations	O
have	O
been	O
constructed	O
in	O
the	O
SLK1	B
gene	I
.	O

slk1	B
null	I
mutants	I
can	O
not	O
grow	O
at	O
37	O
degrees	O
C	O
,	O
but	O
many	O
cells	O
can	O
grow	O
at	O
30	O
,	O
24	O
,	O
and	O
17	O
degrees	O
C.	O

Molecular	O
and	O
genetic	O
analysis	O
of	O
the	O
yeast	B
early	I
meiotic	I
recombination	I
genes	I
REC102	I
and	O
REC107	B
/	O
MER2	B
.	O

These	O
data	O
support	O
a	O
possible	O
biological	O
significance	O
of	O
the	O
frameshift	O
to	O
occur	O
at	O
this	O
position	O
of	O
the	O
large	O
overlap	O
by	O
including	O
the	O
putative	O
RNA	O
template	O
-	O
binding	O
site	O
of	O
the	O
PLRV	B
replicase	I
in	O
the	O
ORF2a	B
/	I
ORF2b	I
transframe	I
protein	I
.	O

Proprotein	O
processing	O
occurs	O
intracellularly	O
.	O

A	O
32P	O
-	O
labeled	O
LAP	B
DNA	O
-	O
binding	O
and	O
dimerization	O
domain	O
""""	O
zipper	O
probe	O
""""	O
was	O
used	O
to	O
isolate	O
a	O
clone	O
that	O
encodes	O
a	O
new	O
C	B
/	I
EBP	I
-	I
homologous	I
protein	I
:	O
CHOP-10	B
.	O

The	O
level	O
of	O
carboxyl	B
-	I
terminal	I
parathyroid	I
hormone	I
in	O
the	O
patients	O
with	O
thyroid	O
carcinoma	O
was	O
higher	O
than	O
that	O
in	O
the	O
patients	O
without	O
thyroid	O
carcinoma	O
(	O
P	O
less	O
than	O
0.05	O
)	O
.	O

The	O
Caenorhabditis	B
elegans	I
vitellogenin	I
genes	I
are	O
subject	O
to	O
sex-	O
,	O
stage-	O
,	O
and	O
tissue	O
-	O
specific	O
regulation	O
:	O
they	O
are	O
expressed	O
solely	O
in	O
the	O
adult	O
hermaphrodite	O
intestine	O
.	O

The	O
MET4	B
gene	O
was	O
cloned	O
,	O
and	O
its	O
sequence	O
reveals	O
that	O
it	O
encodes	O
a	O
protein	O
related	O
to	O
the	O
family	O
of	O
the	O
bZIP	B
transcriptional	I
activators	I
.	O

The	O
functions	O
of	O
isolated	O
portions	O
of	O
the	O
insulin	B
,	O
IAPP	B
,	O
and	O
beta	B
GK	I
promoters	I
were	O
studied	O
by	O
using	O
transient	O
expression	O
and	O
DNA	O
binding	O
assays	O
.	O

The	O
c	B
-	I
Ets-1	I
oncoprotein	I
is	O
a	O
transcription	O
activator	O
that	O
specifically	O
binds	O
to	O
DNA	O
.	O

Previous	O
transactivation	O
experiments	O
indicated	O
that	O
three	O
amino	O
acids	O
residing	O
in	O
this	O
region	O
,	O
Gly	O
,	O
Ser	O
and	O
Val	O
,	O
appear	O
to	O
be	O
critical	O
for	O
target	O
-	O
site	O
discrimination	O
.	O

This	O
vector	O
transfected	O
into	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
directs	O
expression	O
of	O
a	O
secreted	O
mature	O
protein	O
at	O
levels	O
up	O
to	O
200	O
mg	O
of	O
LAPP	O
/	O
liter	O
of	O
culture	O
medium	O
.	O

This	O
DNA	O
motif	O
represents	O
a	O
novel	O
protein	O
-	O
binding	O
sequence	O
.	O

Intrapocket	O
chemotherapy	O
in	O
adult	O
periodontitis	O
using	O
a	O
new	O
controlled	O
-	O
release	O
insert	O
containing	O
ofloxacin	O
(	O
PT-01	O
)	O
.	O

Electromagnetic	O
blood	O
flow	O
(	O
BF	O
)	O
probe	O
was	O
applied	O
on	O
the	O
left	O
anterior	O
descending	O
artery	O
(	O
LAD	O
)	O
.	O

Hence	O
temperature	O
and	O
virF	B
are	O
both	O
required	O
for	O
the	O
induction	O
of	O
the	O
yop	B
regulon	I
.	O

Problems	O
remain	O
to	O
be	O
resolved	O
in	O
the	O
area	O
of	O
quantitative	O
risk	O
assessment	O
.	O

The	O
recently	O
developed	O
gamma	B
-	I
interferon	I
(	O
IFN	B
-	I
gamma	I
)	O
assay	O
system	O
for	O
the	O
diagnosis	O
of	O
bovine	O
tuberculosis	O
in	O
cattle	O
has	O
been	O
accredited	O
by	O
the	O
Standing	O
Committee	O
on	O
Agriculture	O
for	O
use	O
in	O
Australia	O
.	O

Control	O
Tmuscle	O
was	O
35.8	O
+	O
/-	O

0.7	O
degrees	O
C	O
,	O
with	O
control	O
Wi	O
,	O
max	O
being	O
51.6	O
(	O
SD	O
8.7	O
)	O
W.kg-1	O
.	O

The	O
Klebsiella	B
aerogenes	I
gene	I
maoA	I
,	O
which	O
is	O
involved	O
in	O
the	O
synthesis	O
of	O
monoamine	B
oxidase	I
,	O
was	O
induced	O
by	O
tyramine	O
and	O
the	O
related	O
compounds	O
,	O
subjected	O
to	O
catabolite	O
and	O
ammonium	O
ion	O
repression	O
,	O
and	O
cloned	O
.	O

However	O
,	O
other	O
regions	O
of	O
the	O
plasmid	O
are	O
also	O
efficiently	O
repaired	O
.	O

Thus	O
,	O
the	O
human	B
D1A	I
gene	I
belongs	O
to	O
the	O
category	O
of	O
tissue	O
-	O
specific	O
,	O
regulated	O
genes	O
that	O
have	O
housekeeping	O
-	O
type	O
promoters	O
.	O

Similar	O
observations	O
have	O
been	O
made	O
previously	O
for	O
other	O
genes	O
.	O

Preceptorship	O
of	O
CNS	O
students	O
:	O
an	O
exploratory	O
study	O
.	O

To	O
determine	O
the	O
genetic	O
basis	O
for	O
the	O
differences	O
between	O
the	O
cardiac	O
and	O
brain	B
AE3	I
variants	I
,	O
we	O
isolated	O
and	O
characterized	O
the	O
rat	O
gene	O
.	O

Institution	O
of	O
both	O
intravenous	O
and	O
intracisternal	O
administration	O
of	O
amphotericin	O
B	O
and	O
possibly	O
concomitant	O
intravenous	O
administration	O
of	O
dexamethasone	O
may	O
be	O
warranted	O
in	O
situations	O
in	O
which	O
the	O
association	O
of	O
C.	O
immitis	O
with	O
CNS	O
vasculitis	O
or	O
encephalitis	O
appears	O
likely	O
before	O
serologic	O
or	O
cultural	O
confirmation	O
of	O
C.	O
immitis	O
infection	O
involving	O
the	O
CNS	O
is	O
available	O
.	O

Lac	B
operators	O
were	O
introduced	O
into	O
several	O
positions	O
within	O
the	O
CAB	B
promoter	I
and	O
operator	O
-	O
free	O
plasmid	O
was	O
used	O
as	O
control	O
.	O

Overproduction	O
,	O
purification	O
and	O
characterization	O
of	O
M.HinfI	B
methyltransferase	I
and	O
its	O
deletion	O
mutant	O
.	O

Various	O
companies	O
produce	O
this	O
type	O
of	O
lens	O
.	O

From	O
March	O
5	O
through	O
October	O
26	O
,	O
1991	O
,	O
eight	O
persons	O
were	O
diagnosed	O
with	O
elevated	O
blood	O
lead	O
levels	O
(	O
BLLs	O
)	O
at	O
a	O
local	O
hospital	O
and	O
were	O
reported	O
to	O
the	O
notifiable	O
disease	O
surveillance	O
system	O
maintained	O
by	O
the	O
Alabama	O
Department	O
of	O
Public	O
Health	O
(	O
ADPH	O
)	O
.	O

A	O
possible	O
mechanism	O
is	O
that	O
elevated	O
alveolar	O
pressure	O
and	O
decreased	O
cardiac	O
output	O
eliminate	O
blood	O
flow	O
from	O
corner	O
vessels	O
in	O
nondependent	O
high	O
VA	O
/	O
Q	O
regions	O
.	O

Domain	O
II	O
is	O
highly	O
homologous	O
to	O
the	O
LDL	B
receptor	I
and	O
contains	O
four	O
repeats	O
with	O
perfect	O
conservation	O
of	O
all	O
6	O
consecutive	O
cysteines	O
.	O

Here	O
,	O
we	O
present	O
evidence	O
for	O
a	O
model	O
in	O
which	O
mRNA	O
sequences	O
up	O
to	O
around	O
100	O
nucleotides	O
downstream	O
from	O
the	O
start	O
codon	O
of	O
21	O
K	O
fold	O
back	O
and	O
base	O
-	O
pair	O
to	O
the	O
21	O
K	O
translation	O
initiation	O
region	O
,	O
thereby	O
decreasing	O
the	O
translation	O
initiation	O
frequency	O
.	O

Hybridization	O
data	O
indicate	O
that	O
6F6.2	B
corresponds	O
to	O
the	O
previously	O
characterized	O
m6F6	B
cDNA	I
clone	I
and	O
that	O
6F6.1	B
and	O
6F6.3	B
,	O
but	O
not	O
6F6.2	B
,	O
are	O
adjacent	O
to	O
alpha	B
-	I
type	I
genes	I
.	O

Protein	B
tyrosine	I
kinases	I
(	O
PTKs	B
)	O
are	O
implicated	O
in	O
the	O
control	O
of	O
cell	O
growth	O
by	O
virtue	O
of	O
their	O
frequent	O
appearance	O
as	O
products	O
of	O
retroviral	O
oncogenes	O
,	O
as	O
intracellular	O
signal	O
transducers	O
,	O
and	O
as	O
growth	B
factor	I
receptors	I
or	O
components	O
thereof	O
.	O

The	O
IA4	B
mAb	I
was	O
identified	O
among	O
a	O
series	O
of	O
antibodies	O
raised	O
in	O
BALB	O
/	O
c	O
mice	O
after	O
immunization	O
against	O
a	O
HLA	B
class	O
I	O
-	O
deficient	O
,	O
lymphokine	O
-	O
activated	O
killer	O
(	O
LAK	O
)	O
-susceptible	O
EBV	O
-	O
B	O
lymphocyte	O
line	O
.	O

In	O
a	O
randomized	O
double	O
-	O
blind	O
cross	O
-	O
over	O
study	O
,	O
the	O
subjects	O
received	O
theophylline	O
5	O
mg.kg-1	O
per	O
day	O
with	O
omeprazole	O
20	O
mg	O
per	O
day	O
or	O
identical	O
placebo	O
during	O
two	O
periods	O
,	O
each	O
of	O
7	O
days	O
,	O
separated	O
by	O
a	O
washout	O
period	O
of	O
7	O
days	O
.	O

Primer	O
extension	O
and	O
mung	B
bean	I
and	I
S1	I
nuclease	I
mapping	O
indicated	O
multiple	O
transcription	O
initiation	O
sites	O
and	O
were	O
consistent	O
with	O
Northern	O
analyses	O
.	O

Unlike	O
the	O
typical	O
enhancer	O
element	O
,	O
this	O
region	O
functions	O
in	O
an	O
orientation	O
-	O
dependent	O
manner	O
.	O

Allagille	O
's	O
syndrome	O
associated	O
with	O
antenatal	O
ascites	O

Sensitivity	O
and	O
specificity	O
was	O
established	O
for	O
the	O
Pharmacia	O
CAP	O
System	O
and	O
the	O
DPC	O
AlaSTAT	O
System	O
by	O
comparison	O
with	O
results	O
of	O
the	O
skin	O
prick	O
test	O
.	O

PSI	B
-	I
G	I
and	O
PSI	B
-	I
K	I
probably	O
have	O
evolved	O
from	O
a	O
gene	O
duplication	O
of	O
an	O
ancestral	O
gene	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
revealed	O
that	O
two	O
clusters	O
of	O
basic	O
amino	O
acids	O
within	O
a	O
conserved	O
basic	O
region	O
and	O
two	O
amphipathic	O
helices	O
within	O
the	O
adjacent	O
HLH	O
domain	O
are	O
essential	O
for	O
sequence	O
-	O
specific	O
DNA	O
binding	O
and	O
hetero	O
-	O
oligomerization	O
,	O
respectively	O
.	O

Dimerization	O
of	O
Myf-5	B
with	O
the	O
ubiquitously	O
expressed	O
bHLH	O
protein	O
E12	B
not	O
only	O
increases	O
the	O
affinity	O
for	O
DNA	O
but	O
also	O
stimulates	O
transactivation	O
independently	O
of	O
DNA	O
binding	O
.	O

The	O
circadian	O
rhythmicity	O
of	O
sleep	O
was	O
pronounced	O
.	O

SEA	O
was	O
recorded	O
with	O
bidirectional	O
filters	O
at	O
25	O
-	O
250	O
HZ	O
and	O
40	O
-	O
250	O
Hz	O
using	O
Simson	O
method	O
.	O

Drug	O
-	O
drug	O
interactions	O
are	O
most	O
likely	O
to	O
occur	O
in	O
patients	O
receiving	O
multiple	O
medications	O
and	O
with	O
drugs	O
that	O
have	O
a	O
narrow	O
therapeutic	O
window	O
.	O

Total	O
body	O
irradiation	O
was	O
delivered	O
according	O
to	O
a	O
hyperfractionated	O
scheme	O
of	O
12	O
fractions	O
given	O
three	O
per	O
day	O
5	O
hr	O
apart	O
for	O
4	O
days	O
.	O

A	O
reduction	O
in	O
blood	O
pressure	O
was	O
only	O
observed	O
at	O
the	O
end	O
of	O
the	O
study	O
,	O
from	O
142	O
+	O
/-	O

17	O
/	O
86.6	O
+	O
/-	O

9.1	O
to	O
139	O
+	O
/-	O

13	O
/	O
82.9	O
+	O
/-	O

8.9	O
mmHg	O
(	O
P	O
less	O
than	O
0.05	O
for	O
DBP	O
)	O
.	O

AgMNPV	O
and	O
Orgyia	O
pseudotsugata	O
MNPV	O
(	O
OpMNPV	O
)	O
are	O
similar	O
in	O
terms	O
of	O
promoter	O
structure	O
and	O
polyhedrin	B
primary	I
sequence	I
,	O
and	O
the	O
polyhedrin	B
gene	I
of	O
both	O
viruses	O
is	O
transcribed	O
in	O
the	O
anti	O
-	O
clockwise	O
direction	O
in	O
relation	O
to	O
their	O
physical	O
maps	O
.	O

A	O
gene	O
homologous	O
to	O
the	O
Escherichia	B
coli	I
dnaA	I
gene	I
was	O
isolated	O
from	O
Pseudomonas	O
putida	O
and	O
its	O
transcription	O
was	O
investigated	O
in	O
E.	O
coli	O
as	O
well	O
as	O
in	O
P.	O
putida	O
.	O

STP1	B
is	O
an	O
unessential	O
yeast	O
gene	O
involved	O
in	O
the	O
removal	O
of	O
intervening	O
sequences	O
from	O
some	O
,	O
but	O
not	O
all	O
,	O
families	O
of	O
intervening	O
sequence	O
-	O
containing	O
pre	O
-	O
tRNAs	O
.	O

GCR1	B
gene	I
function	O
is	O
required	O
for	O
high	O
-	O
level	O
glycolytic	O
gene	O
expression	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
decay	O
curves	O
of	O
chlorophyll	O
fluorescence	O
showed	O
a	O
superposition	O
of	O
three	O
exponentially	O
decaying	O
components	O
with	O
time	O
constants	O
of	O
T1	O
=	O
100	O
-	O
200	O
ps	O
,	O
T2	O
=	O
300	O
-	O
500	O
ps	O
and	O
T3	O
=	O
2.0	O
-	O
3.5	O
ns	O
.	O

After	O
tilting	O
,	O
systolic	O
blood	O
pressure	O
fell	O
an	O
average	O
of	O
17	O
%	O
in	O
patients	O
who	O
cramped	O
infrequently	O
(	O
p	O
=	O
0.0031	O
)	O
but	O
only	O
10	O
%	O
in	O
frequently	O
cramping	O
patients	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
roles	O
that	O
CCK	B
and	O
trypsin	B
inhibitors	O
are	O
believed	O
to	O
play	O
in	O
the	O
negative	O
feedback	O
control	O
of	O
pancreatic	O
exocrine	O
function	O
.	O

Eight	O
rabbits	O
were	O
exposed	O
to	O
0.7	O
+	O
/-	O

0.4	O
mg	O
/	O
m3	O
Co2	O
+	O
as	O
CoCl2	O
and	O
1.2	O
+	O
/-	O

0.7	O
mg	O
/	O
m3	O
Cr3	O
+	O
as	O
Cr	O
(	O
NO3	O
)	O
3	O
(	O
group	O
Co	O
+	O
Cr	O
)	O
,	O
eight	O
to	O
0.6	O
+	O
/-	O

0.5	O
mg	O
/	O
m3	O
Co2	O
+	O
(	O
group	O
Co	O
)	O
,	O
and	O
eight	O
to	O
filtered	O
air	O
(	O
control	O
group	O
)	O
,	O
for	O
4	O
months	O
,	O
5	O
days	O
/	O
week	O
,	O
and	O
6	O
hr	O
/	O
day	O
.	O

16	O
women	O
were	O
treated	O
with	O
methadone	O
to	O
prevent	O
withdrawal	O
symptoms	O
.	O

Disruption	O
demonstrates	O
that	O
CDC14	B
is	O
an	O
essential	O
gene	O
.	O

Coronary	O
flow	O
was	O
reduced	O
by	O
10	O
%	O
in	O
the	O
phosphocreatine	O
and	O
by	O
18	O
%	O
in	O
the	O
control	O
group	O
.	O

The	O
60A	B
transcripts	I
and	O
protein	O
are	O
first	O
detected	O
at	O
the	O
onset	O
of	O
gastrulation	O
,	O
primarily	O
in	O
the	O
mesoderm	O
of	O
the	O
extending	O
germ	O
band	O
.	O

A	O
724-bp	O
segment	O
of	O
the	O
5'-flanking	O
region	O
consisting	O
of	O
the	O
proximal	O
E	O
-	O
box	O
flanked	O
upstream	O
by	O
a	O
mammalian	O
-	O
specific	O
352-bp	O
region	O
was	O
sufficient	O
for	O
maximal	O
transcriptional	O
activation	O
in	O
postconfluent	O
BC3H1	O
myoblasts	O
.	O

These	O
results	O
indicate	O
that	O
baculovirus	O
-	O
expressed	O
TR	B
mediates	O
transcriptional	O
activation	O
and	O
repression	O
in	O
a	O
promoter	O
-	O
specific	O
manner	O
in	O
vitro	O
.	O

Influence	O
of	O
neural	O
regulation	O
on	O
anti	O
-	O
arrhythmic	O
effects	O
of	O
GABA	O
in	O
rats	O

Recent	O
investigations	O
have	O
detailed	O
a	O
selective	O
dye	O
release	O
technique	O
in	O
which	O
a	O
pulse	O
of	O
laser	O
light	O
induces	O
the	O
release	O
of	O
a	O
fluorescent	O
dye	O
from	O
temperature	O
-	O
sensitive	O
liposomes	O
circulating	O
in	O
the	O
retinal	O
vasculature	O
.	O

And	O
the	O
natural	O
barriers	O
?	O

Three	O
pyridoxine	O
derivatives	O
have	O
been	O
isolated	O
from	O
the	O
fresh	O
stem	O
bark	O
of	O
Albizzia	O
julibrissin	O
DURAZZ	O
..	O

The	O
serum	O
erythropoietin	B
(	O
EPO	B
)	O
concentrations	O
of	O
15	O
male	O
triathletes	O
(	O
26.3	O
U.ml-1	O
)	O
were	O
significantly	O
lower	O
than	O
those	O
of	O
45	O
male	O
distance	O
runners	O
(	O
31.6	O
U.ml-1	O
;	O
P	O
less	O
than	O
0.05	O
)	O
.	O

The	O
coating	O
materials	O
were	O
poloxamine	O
904	O
,	O
poloxamine	O
908	O
,	O
poloxamine	O
1508	O
,	O
poloxamer	O
338	O
,	O
and	O
Brij	O
35	O
.	O

The	O
eating	O
and	O
drinking	O
patterns	O
of	O
pygmy	O
goats	O
fed	O
ad	O
lib	O
and	O
kept	O
on	O
a	O
12	O
h	O
light	O
/	O
12	O
h	O
dark	O
cycle	O
were	O
recorded	O
and	O
analyzed	O
.	O

The	O
present	O
study	O
highlights	O
the	O
improvement	O
in	O
sputum	O
amoxycillin	O
(	O
amoxy	O
)	O
levels	O
when	O
a	O
combination	O
tablet	O
,	O
amoxy	O
500	O
mg	O
plus	O
bromhexeine	O
8	O
mg	O
,	O
is	O
administered	O
as	O
compared	O
to	O
plain	O
amoxy	O
500	O
mg	O
.	O

His	O
HC	B
II	I
activity	O
and	O
antigen	O
levels	O
were	O
49	O
%	O
and	O
50	O
%	O
,	O
respectively	O
,	O
and	O
his	O
daughter	O
also	O
showed	O
similar	O
low	O
levels	O
.	O

FDA	O
regulations	O
for	O
growth	O
factors	O
and	O
related	O
products	O
.	O

Because	O
the	O
adrenergic	O
nervous	O
system	O
influences	O
cardiac	O
arrhythmias	O
and	O
myocardial	O
infarction	O
can	O
directly	O
affect	O
sympathetic	O
innervation	O
in	O
the	O
heart	O
,	O
we	O
investigated	O
the	O
role	O
of	O
the	O
sympathetic	O
nervous	O
system	O
on	O
reentry	O
in	O
the	O
canine	O
heart	O
4	O
days	O
after	O
infarction	O
.	O

DESIGN	O
:	O
Serum	O
aldosterone	O
and	O
plasma	B
renin	I
activity	O
were	O
measured	O
supine	O
prior	O
to	O
and	O
60	O
,	O
90	O
,	O
120	O
minutes	O
after	O
oral	O
captopril	O
,	O
25	O
mg	O
.	O

The	O
mean	O
minimum	O
steady	O
-	O
state	O
concentration	O
after	O
the	O
oral	O
regimen	O
(	O
23	O
micrograms.l-1	O
)	O
was	O
78	O
%	O
of	O
that	O
after	O
the	O
intramuscular	O
regime	O
(	O
29	O
micrograms.l-1	O
)	O
.	O

These	O
mutant	O
proteins	O
retained	O
the	O
ability	O
to	O
competitively	O
inhibit	O
kappa	B
B	I
-	O
mediated	O
transcriptional	O
activation	O
of	O
the	O
human	B
immunodeficiency	I
virus	I
long	I
terminal	I
repeat	I
but	O
failed	O
to	O
efficiently	O
transform	O
chicken	O
lymphoid	O
cells	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

In	O
conclusion	O
,	O
to	O
study	O
and	O
overcome	O
TI	O
region	O
-	O
based	O
expression	O
problems	O
it	O
is	O
worthwhile	O
to	O
start	O
out	O
with	O
a	O
versatile	O
vector	O
containing	O
exhaustive	O
mutations	O
in	O
the	O
periShine	O
-	O
Dalgarno	O
sequences	O
;	O
as	O
a	O
rule	O
the	O
coding	O
MTI	O
subregion	O
can	O
be	O
kept	O
unchanged	O
.	O

Four	O
of	O
these	O
five	O
subjects	O
also	O
performed	O
mixed	O
sequences	O
under	O
conditional	O
control	O
of	O
the	O
words	O
(	O
e.g.	O
,	O
A1	O
-	O
---B2	O
-	O
---A3	O
-	O
---B4	O
-	O
---A5	O
and	O
its	O
reversal	O
)	O
,	O
verifying	O
that	O
the	O
stimuli	O
which	O
occupied	O
the	O
same	O
position	O
in	O
each	O
sequence	O
were	O
members	O
of	O
the	O
same	O
class	O
.	O

UF-021	O
ophthalmic	O
solution	O
(	O
0.03	O
to	O
0.24	O
%	O
)	O
,	O
when	O
topically	O
applied	O
to	O
the	O
eyes	O
of	O
rabbits	O
,	O
caused	O
dose	O
-	O
dependent	O
IOP	O
reduction	O
(	O
2.8	O
to	O
5.2	O
mmHg	O
)	O
,	O
without	O
transient	O
IOP	O
rise	O
.	O

Wild	O
-	O
type	O
protein	O
bound	O
azido	O
-	O
ATP	O
well	O
,	O
but	O
mutants	O
with	O
substitutions	O
in	O
the	O
consensus	O
amino	O
acids	O
were	O
unable	O
to	O
bind	O
azido	O
-	O
ATP	O
.	O

Therefore	O
,	O
with	O
a	O
biopsy	O
from	O
the	O
stoma	O
site	O
there	O
is	O
a	O
risk	O
of	O
missing	O
early	O
rejection	O
.	O

Tissues	O
and	O
exudates	O
contain	O
sufficient	O
thymidine	O
for	O
growth	O
of	O
anaerobic	O
bacteria	O
in	O
the	O
presence	O
of	O
inhibitory	O
levels	O
of	O
trimethoprim	O
-	O
sulfamethoxazole	O
.	O

In	O
a	O
similar	O
experiment	O
,	O
simultaneous	O
nitrofurazone	O
administration	O
and	O
S.	O
enteritidis	O
challenge	O
resulted	O
in	O
no	O
significant	O
differences	O
in	O
S.	O
enteritidis	O
isolation	O
frequency	O
.	O

Incidence	O
rate	O
ranging	O
between	O
122	O
/	O
100,000	O
/	O
year	O
and	O
190	O
/	O
100,000	O
/	O
year	O
were	O
found	O
(	O
minimum	O
,	O
estimated	O
and	O
raw	O
datasets	O
)	O
.	O

We	O
identified	O
a	O
protein	O
,	O
termed	O
NFIL-1	B
beta	I
A	I
(	O
NF	B
beta	I
A	I
)	O
,	O
that	O
binds	O
to	O
a	O
highly	O
conserved	O
12-bp	O
DNA	O
sequence	O
(	O
-49	O
to	O
-38	O
)	O
located	O
upstream	O
of	O
the	O
TATA	O
box	O
motif	O
in	O
both	O
the	O
human	B
and	I
murine	I
IL-1	I
beta	I
genes	I
.	O

We	O
tried	O
amphotericin	O
B	O
(	O
AmB	O
)	O
,	O
and	O
remission	O
of	O
the	O
tumor	O
was	O
obtained	O
.	O

Cutis	O
aplasia	O
.	O

The	O
DRF-2	B
nuclear	I
protein	I
has	O
characteristics	O
similar	O
to	O
those	O
of	O
the	O
muscle	O
-	O
specific	O
regulatory	O
factor	O
,	O
MEF-2	B
(	O
Buskin	O
and	O
Hauschka	O
1989	O
;	O
Gossett	O
et	O
al.	O
,	O
1989	O
)	O
.	O

From	O
the	O
15-kb	O
clone	O
a	O
4-kb	B
EcoRI	I
fragment	I
containing	O
the	O
first	O
two	O
exons	O
and	O
2.6	O
kb	O
of	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
opn	B
gene	I
was	O
sequenced	O
,	O
and	O
the	O
transcriptional	O
start	O
site	O
determined	O
by	O
primer	O
extension	O
analysis	O
and	O
S1	B
nuclease	I
mapping	O
.	O

Production	O
costs	O
included	O
feed	O
,	O
non	O
-	O
feed	O
operating	O
,	O
fixed	O
,	O
and	O
replacement	O
stock	O
costs	O
.	O

We	O
report	O
a	O
patient	O
developing	O
factor	B
VII	I
inhibitor	I
possibly	O
as	O
a	O
reaction	O
to	O
penicillin	O
administration	O
;	O
it	O
gave	O
rise	O
to	O
fatal	O
haemorrhage	O
.	O

This	O
is	O
in	O
contrast	O
with	O
the	O
classical	O
'	O
oxygen	O
debt	O
hypothesis	O
'	O
,	O
which	O
states	O
that	O
the	O
oxygen	O
debt	O
and	O
lactate	O
clearance	O
are	O
linked	O
.	O

The	O
clinical	O
application	O
of	O
the	O
antibody	O
-	O
targeted	O
Phthalocyanine	O
was	O
performed	O
in	O
3	O
patients	O
suffering	O
from	O
an	O
advanced	O
ovarian	O
carcinoma	O
(	O
FIGO	O
III	O
)	O
.	O

We	O
found	O
that	O
lung	O
cancer	O
tissues	O
of	O
positive	O
67Ga	O
scan	O
expressed	O
TFR	B
,	O
but	O
those	O
of	O
a	O
negative	O
scan	O
did	O
not	O
.	O

This	O
open	O
reading	O
frame	O
was	O
confirmed	O
the	O
correct	O
one	O
by	O
direct	O
amino	O
-	O
terminal	O
sequence	O
analysis	O
of	O
the	O
overproduced	O
msgB	B
gene	I
product	I
.	O

In	O
this	O
study	O
,	O
we	O
purified	O
and	O
characterized	O
the	O
recombinant	B
furin	I
from	O
the	O
conditioned	O
medium	O
of	O
these	O
cells	O
.	O

Altogether	O
these	O
results	O
indicate	O
that	O
the	O
Syn	B
5	I
locus	I
segregates	O
from	O
the	O
gene	O
specifying	O
gH	B
,	O
to	O
a	O
region	O
encompassing	O
portions	O
of	O
the	O
TK	B
and	O
UL	B
24	I
genes	I
,	O
and	O
that	O
the	O
syn	B
mutation	I
does	O
not	O
affect	O
the	O
expression	O
or	O
activity	O
of	O
TK	B
.	O

Nucleoprotein	O
(	O
N	O
)	O
expressed	O
by	O
both	O
recombinant	O
vaccinia	O
virus	O
and	O
TGEV	O
had	O
a	O
relative	O
molecular	O
mass	O
(	O
Mr	O
)	O
of	O
47,000	O
and	O
was	O
susceptible	O
to	O
degradation	O
at	O
the	O
C	O
-	O
terminus	O
yielding	O
discrete	O
breakdown	O
products	O
.	O

Recently	O
,	O
the	O
3.6-kb	B
full	I
-	I
length	I
alpha	I
-	I
GalNAc	I
cDNA	I
sequence	I
was	O
isolated	O
and	O
found	O
to	O
have	O
remarkable	O
nucleotide	O
and	O
predicted	O
amino	O
acid	O
homology	O
(	O
55.8	O
and	O
46.9	O
%	O
,	O
respectively	O
)	O
with	O
the	O
human	B
alpha	I
-	I
galactosidase	I
A	I
(	O
alpha	B
-	I
Gal	I
A	I
)	O
cDNA	O
.	O

Patients	O
with	O
an	O
enzymatic	O
activity	O
below	O
X--1	O
manifested	O
a	O
decrease	O
of	O
the	O
content	O
of	O
IgA	B
,	O
IgG	B
,	O
IgM	B
,	O
T	O
and	O
B	O
lymphocytes	O
,	O
and	O
of	O
phagocytic	O
activity	O
of	O
neutrophils	O
as	O
compared	O
to	O
patients	O
exhibiting	O
a	O
high	O
enzymatic	O
activity	O
.	O

The	O
reason	O
that	O
nitrous	O
oxide	O
does	O
not	O
produce	O
hydroxyl	O
radicals	O
readily	O
might	O
be	O
that	O
the	O
one	O
-	O
electron	O
reduction	O
proceeds	O
through	O
an	O
N2O-	O
intermediate	O
which	O
is	O
energetically	O
very	O
unfavourable	O
:	O
EO	O
(	O
N2O	O
/	O
N2O-	O
)	O
=	O
-1.1	O
V.	O

All	O
mutant	B
JCV	I
T	I
antigens	I
bound	O
to	O
JCV	O
and	O
SV40	O
origins	O
of	O
DNA	O
replication	O
.	O

The	O
relation	O
between	O
myocardial	B
beta	I
-	I
adrenergic	I
receptor	I
and	O
left	O
ventricular	O
(	O
LV	O
)	O
function	O
was	O
studied	O
in	O
10	O
patients	O
,	O
aged	O
41	O
to	O
61	O
years	O
(	O
average	O
51	O
)	O
,	O
with	O
LV	O
volume	O
overload	O
mainly	O
due	O
to	O
chronic	O
mitral	O
regurgitation	O
.	O

Since	O
each	O
transcript	O
appears	O
to	O
encode	O
the	O
same	O
protein	O
,	O
this	O
complexity	O
may	O
reflect	O
the	O
need	O
for	O
lineage	O
-	O
specific	O
or	O
differentiation	O
-	O
dependent	O
control	O
of	O
expression	O
.	O

In	O
patients	O
with	O
limited	O
disease	O
,	O
the	O
survival	O
in	O
the	O
alternating	O
arm	O
was	O
significantly	O
superior	O
to	O
the	O
survival	O
in	O
the	O
CAV	O
arm	O
(	O
P	O
=	O
.014	O
)	O
or	O
the	O
survival	O
in	O
the	O
PE	O
arm	O
(	O
P	O
=	O
.023	O
)	O
.	O

Transfecting	O
the	O
cloned	O
bovine	O
PBR	B
/	O
IBP	B
cDNA	O
into	O
COS-7	O
cells	O
resulted	O
in	O
an	O
11-fold	O
increase	O
in	O
the	O
density	O
of	O
high	O
affinity	O
[	O
3H	O
]	O
PK	O
11195	O
binding	O
sites	O
which	O
had	O
only	O
low	O
affinity	O
for	O
Ro5	O
-	O
4864	O
.	O

The	O
initial	O
phase	O
of	O
increased	O
vascular	O
permeability	O
in	O
the	O
peritoneal	O
cavity	O
and	O
LTB4	O
production	O
was	O
dose	O
dependently	O
inhibited	O
by	O
the	O
5-LO	O
inhibitors	O
phenidone	O
,	O
BW	O
A4C	O
,	O
A63162	O
,	O
and	O
ICI	O
207	O
968	O
but	O
not	O
by	O
dexamethasone	O
or	O
colchicine	O
.	O

Discrepant	O
results	O
with	O
a	O
latex	O
agglutination	O
test	O
in	O
the	O
assessment	O
of	O
cytomegalovirus	O
antibody	O
status	O
of	O
cardiac	O
transplant	O
donors	O
.	O

We	O
have	O
identified	O
SWI5	B
's	O
nuclear	O
localization	O
signal	O
(	O
NLS	O
)	O
and	O
show	O
that	O
it	O
can	O
confer	O
cell	O
cycle	O
-	O
dependent	O
nuclear	O
entry	O
to	O
a	O
heterologous	O
protein	O
.	O

We	O
did	O
not	O
detect	O
p50	B
in	O
association	O
with	O
native	B
glucocorticoid	I
receptor	I
in	O
L	O
cells	O
or	O
with	O
the	O
overexpressed	O
glucocorticoid	B
receptor	I
in	O
Chinese	O
hamster	O
ovary	O
cells	O
.	O

TPA	O
and	O
TGF	B
-	I
beta	I
1	I
did	O
not	O
markedly	O
affect	O
the	O
activities	O
of	O
the	O
72-kDa	O
enzyme	O
.	O

They	O
were	O
almost	O
regularly	O
excited	O
by	O
pressure	O
to	O
the	O
ipsilateral	O
cornea	O
or	O
to	O
both	O
corneas	O
at	O
a	O
strength	O
well	O
above	O
the	O
human	O
corneal	O
pain	O
threshold	O
.	O

Alignment	O
of	O
the	O
amino	O
acid	O
sequences	O
surrounding	O
Tyr-766	O
with	O
corresponding	O
regions	O
of	O
other	O
FGFRs	B
revealed	O
conserved	O
tyrosine	O
residues	O
in	O
all	O
known	O
members	O
of	O
the	O
FGFR	B
family	I
.	O

The	O
transcription	O
initiation	O
site	O
was	O
determined	O
to	O
occur	O
66	O
bp	O
upstream	O
of	O
the	O
initiating	O
Met	O
.	O

All	O
anti	B
-	I
I	I
and	O
anti	B
-	I
i	I
CA	I
were	O
shown	O
to	O
express	O
VH4	B
heavy	I
chains	I
,	O
and	O
14	O
of	O
17	O
CA	B
expressed	O
a	O
previously	O
described	O
VH4	B
second	O
hypervariable	O
region	O
determinant	O
,	O
termed	O
VH4-HV2a	B
.	O

Intron	O
K1	B
cox1.2	I
is	O
not	O
found	O
in	O
S.	O
cerevisiae	O
and	O
appears	O
at	O
an	O
unique	O
location	O
in	O
K.	O
lactis	O
.	O

However	O
,	O
alterations	O
in	O
electrostatic	O
and	O
hydrophobic	O
interactions	O
created	O
by	O
the	O
three	O
amino	O
acid	O
substitutions	O
prevent	O
the	O
conformational	O
change	O
in	O
the	O
enzyme	O
usually	O
produced	O
by	O
calmodulin	B
binding	O
.	O

The	O
nucleotide	O
sequences	O
at	O
the	O
5	O
'	O
and	O
3	O
'	O
ends	O
of	O
these	O
introns	O
are	O
characteristic	O
of	O
spliced	O
transcripts	O
from	O
eukaryotic	O
protein	O
-	O
encoding	O
genes	O
,	O
with	O
one	O
significant	O
difference	O
;	O
i.e.	O
,	O
the	O
5	O
'	O
end	O
of	O
the	O
LAT	B
intron	I
is	O
GC	O
instead	O
of	O
the	O
consensus	O
sequence	O
GT	O
.	O

Two	O
independent	O
promoters	O
as	O
well	O
as	O
5	O
'	O
untranslated	O
regions	O
regulate	O
Dd	B
ras	I
expression	O
in	O
Dictyostelium	O
.	O

The	O
results	O
suggested	O
that	O
,	O
depending	O
upon	O
the	O
cell	O
type	O
,	O
gene	O
cotransfer	O
using	O
aminoglycoside	O
resistance	O
as	O
a	O
selectable	O
marker	O
may	O
seriously	O
perturb	O
important	O
cellular	O
control	O
mechanisms	O
such	O
as	O
the	O
PKC	B
pathway	O
leading	O
to	O
activation	O
of	O
gene	O
expression	O
.	O

Transfer	O
RNA	O
genes	O
from	O
Dictyostelium	O
discoideum	O
are	O
frequently	O
associated	O
with	O
repetitive	O
elements	O
and	O
contain	O
consensus	O
boxes	O
in	O
their	O
5	O
'	O
and	O
3'-flanking	O
regions	O
.	O

The	O
factor	O
which	O
binds	O
to	O
the	O
TR	B
promoter	I
co	O
-	O
sedimented	O
with	O
SV40	O
chromosomes	O
extracted	O
late	O
in	O
infection	O
.	O

The	O
patient	O
with	O
a	O
prolonged	O
fever	O
caused	O
by	O
dissecting	O
aneurysm	O
of	O
the	O
aorta	O
in	O
whom	O
pleuropneumonia	O
masked	O
the	O
real	O
diseases	O
has	O
been	O
presented	O
.	O

The	O
resulting	O
clone	O
pKB11	B
,	O
which	O
has	O
a	O
1369-base	O
pair	O
(	O
bp	O
)	O
cDNA	O
insert	O
,	O
overlapping	O
pCAD142	B
by	O
781	O
bp	O
,	O
was	O
identified	O
by	O
hybridization	O
methods	O
and	O
sequence	O
analysis	O
and	O
found	O
to	O
contain	O
the	O
entire	O
cDNA	O
sequence	O
for	O
the	O
amino	O
end	O
of	O
the	O
CAD	B
polypeptide	I
.	O

This	O
conclusion	O
was	O
confirmed	O
by	O
Northern	O
blotting	O
analysis	O
of	O
the	O
5'-flanking	O
region	O
of	O
CAD	B
gene	I
.	O

We	O
report	O
the	O
isolation	O
of	O
genomic	O
and	O
cDNA	O
clones	O
of	O
the	O
light	O
-	O
independent	O
Sn	B
:	I
bol3	I
allele	I
.	O

Its	O
clearance	O
has	O
been	O
found	O
to	O
be	O
decreased	O
(	O
typically	O
by	O
around	O
25	O
%	O
,	O
but	O
often	O
by	O
far	O
more	O
)	O
by	O
erythromycin	O
,	O
troleandomycin	O
(	O
triacetyloleandomycin	O
)	O
,	O
roxithromycin	O
,	O
enoxacin	O
,	O
ciprofloxacin	O
,	O
pefloxacin	O
,	O
norfloxacin	O
,	O
ofloxacin	O
,	O
fluoroquinolone	O
T-3262	O
,	O
pipemidic	O
acid	O
,	O
cimetidine	O
,	O
etintidine	O
,	O
propranolol	O
,	O
verapamil	O
,	O
diltiazem	O
,	O
nifedipine	O
,	O
furosemide	O
(	O
frusemide	O
)	O
,	O
at	O
least	O
some	O
anovulent	O
agents	O
,	O
viloxazine	O
,	O
allopurinol	O
,	O
ticlopidine	O
,	O
idrocilamide	O
,	O
thiabendazole	O
,	O
disulfiram	O
,	O
influenza-	O
and	O
BCG	O
-	O
vaccination	O
,	O
interferon	B
,	O
and	O
caffeine	O
(	O
half	O
-	O
life	O
increase	O
)	O
.	O

A	O
third	O
is	O
a	O
partial	O
element	O
terminating	O
at	O
a	O
probable	O
internal	O
restriction	O
site	O
used	O
for	O
cloning	O
.	O

We	O
enrolled	O
253	O
HIV	B
-	I
antibody	I
positive	O
heroin	O
addicts	O
without	O
HIV	O
-	O
related	O
disease	O
(	O
n	O
=	O
81	O
)	O
or	O
with	O
persistent	O
generalized	O
lymphadenopathy	O
(	O
n	O
=	O
172	O
)	O
in	O
a	O
prospective	O
study	O
to	O
evaluate	O
clinical	O
progression	O
to	O
AIDS	O
related	O
complex	O
(	O
ARC	O
)	O
or	O
AIDS	O
and	O
to	O
identify	O
factors	O
of	O
possible	O
prognostic	O
relevance	O
.	O

No	O
homology	O
was	O
found	O
between	O
RNA14	B
and	O
RNA15	B
or	O
between	O
RNA14	B
and	O
other	O
proteins	O
contained	O
in	O
data	O
banks	O
.	O

Mutations	O
in	O
the	O
yeast	B
RNA14	I
and	O
RNA15	B
genes	I
result	O
in	O
an	O
abnormal	O
mRNA	O
decay	O
rate	O
;	O
sequence	O
analysis	O
reveals	O
an	O
RNA	O
-	O
binding	O
domain	O
in	O
the	O
RNA15	B
protein	I
.	O

The	O
most	O
striking	O
difference	O
in	O
the	O
birch	B
NAD	I
(	I
P	I
)	I
H	I
-	I
NR	I
sequence	I
in	O
comparison	O
to	O
NADH	B
-	I
NR	I
sequences	I
was	O
found	O
at	O
the	O
putative	O
pyridine	O
nucleotide	O
binding	O
site	O
.	O

A	O
single	O
amino	O
acid	O
difference	O
in	O
the	O
C	O
-	O
terminal	O
region	O
influences	O
dominant	O
negative	O
activity	O
and	O
receptor	O
dimer	O
formation	O
.	O

No	O
such	O
benefits	O
were	O
seen	O
for	O
children	O
with	O
CD4	B
+	I
counts	O
below	O
0.2	O
x	O
10	O
(	O
9	O
)	O
per	O
liter	O
at	O
entry	O
.	O

Because	O
the	O
human	B
Antp	I
TATAA	I
binding	I
protein	I
is	O
expressed	O
in	O
both	O
lymphoid	O
and	O
non	O
-	O
lymphoid	O
cells	O
,	O
we	O
suggest	O
that	O
this	O
homeobox	B
gene	I
has	O
evolved	O
a	O
more	O
general	O
transcriptional	O
regulatory	O
function	O
in	O
higher	O
eukaryotic	O
cells	O
.	O

Among	O
953	O
infants	O
in	O
22	O
neonatal	O
care	O
units	O
studied	O
,	O
23	O
%	O
(	O
median	O
value	O
,	O
range	O
0	O
-	O
78	O
)	O
were	O
found	O
to	O
be	O
faecally	O
colonized	O
with	O
one	O
of	O
21	O
distinct	O
nosocomial	O
strains	O
of	O
Escherichia	O
coli	O
,	O
Klebsiella	O
or	O
Enterobacter	O
spp	O
.	O

Biochemical	O
studies	O
revealed	O
the	O
expected	O
loss	O
of	O
ChAT	B
activity	O
in	O
the	O
dorsal	O
and	O
ventral	O
hippocampi	O
of	O
lesioned	O
animals	O
along	O
with	O
elevated	O
levels	O
of	O
norepinephrine	O
(	O
NE	O
)	O
in	O
the	O
dorsal	O
hippocampus	O
of	O
MS	O
/	O
HSI	O
animals.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
localization	O
of	O
this	O
proteoglycan	O
locus	O
in	O
the	O
human	O
genome	O
and	O
the	O
availability	O
of	O
new	O
RFLPs	O
provide	O
the	O
tools	O
for	O
future	O
studies	O
of	O
human	O
diseases	O
where	O
the	O
HSPG2	B
proteoglycan	I
gene	I
is	O
suspected	O
to	O
be	O
involved	O
.	O

After	O
2	O
min	O
of	O
dobutamine	O
injection	O
,	O
or	O
after	O
20	O
min	O
of	O
pimobendan	O
injection	O
,	O
the	O
myocardium	O
was	O
removed	O
,	O
and	O
used	O
for	O
determination	O
of	O
the	O
tissue	O
levels	O
of	O
metabolites	O
of	O
energy	O
and	O
carbohydrate	O
metabolism	O
.	O

In	O
a	O
country	O
where	O
general	O
HIV	O
prevalence	O
is	O
low	O
,	O
the	O
strategy	O
is	O
cost	O
-	O
effective	O
for	O
location	O
and	O
counselling	O
of	O
unknowingly	O
seropositive	O
individuals	O
.	O

The	O
cis	O
-	O
acting	O
element	O
mediating	O
glucocorticoid	O
inducibility	O
of	O
the	O
chicken	B
glutamine	I
synthetase	I
gene	I
has	O
been	O
identified	O
.	O

However	O
,	O
the	O
increase	O
in	O
biliary	O
excretion	O
did	O
not	O
compensate	O
for	O
the	O
reduced	O
elimination	O
of	O
bretylium	O
and	O
hexylsalicylic	O
acid	O
via	O
the	O
kidney	O
.	O

Diagnostic	O
value	O
of	O
cerebrospinal	B
fluid	I
immunoglobulin	I
G	I
(	O
IgG	B
)	O
in	O
pediatric	O
neurological	O
diseases	O
.	O

Venkatesan	O
,	O
and	O
D.	O

The	O
presence	O
of	O
the	O
corresponding	O
mature	O
mRNA	O
transcripts	O
(	O
3.2	O
-	O
3.5	O
kilobase	O
pairs	O
(	O
kb	O
]	O
in	O
human	O
fibroblasts	O
was	O
shown	O
by	O
Northern	O
blot	O
hybridization	O
,	O
S1	B
nuclease	I
protection	O
assay	O
,	O
and	O
the	O
polymerase	O
chain	O
reaction	O
.	O

Gap	B
b3	I
consists	O
of	O
two	O
polypeptide	O
chains	O
(	O
Mr	O
=	O
110,000	O
and	O
30,000	O
)	O
,	O
which	O
seem	O
to	O
be	O
proteolytic	O
cleavage	O
products	O
connected	O
by	O
disulfide	O
bonds	O
from	O
a	O
precursor	O
protein	O
.	O

However	O
,	O
the	O
rtFc	B
gamma	I
R	I
alpha	I
cDNA	I
clone	O
is	O
complementary	O
to	O
at	O
least	O
two	O
different	O
-	O
sized	O
mRNAs	O
expressed	O
by	O
CRNK-16	O
cells	O
,	O
contrasting	O
the	O
single	O
Fc	B
gamma	I
R	I
-	I
related	I
mRNA	I
species	O
expressed	O
by	O
human	O
and	O
mouse	O
natural	O
killer	O
cells	O
.	O

Treatment	O
of	O
human	O
myeloid	O
cell	O
lines	O
HL-60	O
and	O
U937	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
increased	O
within	O
2	O
h	O
cellular	O
levels	O
of	O
the	O
RNA	O
hybridizable	O
to	O
LD78	B
cDNA	I
.	O

Serum	O
IgG	B
was	O
initially	O
elevated	O
in	O
6	O
patients	O
.	O

The	O
patient	O
initially	O
attained	O
complete	O
remission	O
(	O
CR1	O
)	O
with	O
conventional	O
chemotherapy	O
and	O
then	O
relapsed	O
14	O
months	O
later	O
.	O

157	O
+	O
/-	O

16	O
mg	O
/	O
dl	O
;	O
NS	O
)	O
,	O
glucose	O
levels	O
,	O
and	O
basal	O
(	O
17	O
+	O
/-	O

4	O
vs.	O

Platelet	O
aggregation	O
and	O
metabolic	O
control	O
are	O
not	O
affected	O
by	O
calcium	O
antagonist	O
treatment	O
in	O
type	O
II	O
diabetes	O
mellitus	O
.	O

Induction	O
of	O
Jurkat	O
leukemic	O
T	O
cells	O
with	O
phorbol	O
12-myristate	O
13-acetate	O
and	O
ionomycin	O
did	O
not	O
affect	O
the	O
level	O
of	O
FKBP	B
mRNA	I
.	O

GLUT5	B
mRNA	I
is	O
expressed	O
at	O
highest	O
levels	O
in	O
small	O
intestine	O
and	O
at	O
much	O
lower	O
levels	O
in	O
kidney	O
,	O
skeletal	O
muscle	O
,	O
and	O
adipose	O
tissue	O
.	O

e.	O

Surprisingly	O
,	O
there	O
is	O
no	O
sequence	O
homology	O
between	O
this	O
region	O
of	O
Ly-6E	B
and	O
the	O
established	O
consensus	O
for	O
the	O
interferon	B
-	I
stimulated	I
response	I
element	I
,	O
which	O
has	O
been	O
shown	O
functionally	O
important	O
to	O
all	O
previously	O
characterized	O
alpha	B
/	I
beta	I
interferon	I
-	O
inducible	O
promoters	O
.	O

Relatively	O
large	O
DNA	O
rearrangements	O
spanning	O
the	O
region	O
with	O
tandem	O
direct	O
repeats	O
encoding	O
the	O
carboxy	O
-	O
terminal	O
histone	B
H1-like	I
structure	O
of	O
AlgP	B
were	O
detected	O
in	O
several	O
strains	O
upon	O
conversion	O
from	O
the	O
mucoid	O
to	O
the	O
nonmucoid	O
phenotype	O
.	O

(	O
1988	O
)	O
J.	O

These	O
results	O
strongly	O
suggested	O
that	O
similar	O
,	O
if	O
not	O
identical	O
,	O
the	O
CArG	B
box	I
binding	I
proteins	I
interact	O
with	O
the	O
functionally	O
different	O
promoter	O
element	O
in	O
the	O
VLC1	B
,	O
cardiac	B
alpha	I
-	I
actin	I
,	O
and	O
c	B
-	I
fos	I
genes	I
.	O

Co	O
-	O
existence	O
of	O
these	O
regulatory	O
elements	O
with	O
other	O
elements	O
,	O
such	O
as	O
the	O
AP-2	B
element	I
or	O
CCAAT	O
box	O
,	O
was	O
also	O
found	O
.	O

Recently	O
,	O
studies	O
of	O
agents	O
that	O
disrupt	O
collagen	B
synthesis	O
and	O
deposition	O
have	O
yielded	O
several	O
new	O
angiogenesis	O
inhibitors	O
.	O

Since	O
the	O
5'-flanking	O
region	O
of	O
this	O
gene	O
is	O
likely	O
involved	O
in	O
hormonal	O
regulation	O
of	O
its	O
expression	O
,	O
we	O
have	O
isolated	O
and	O
partially	O
characterized	O
an	O
avian	O
fatty	B
acid	I
synthase	I
gene	O
.	O

A	O
new	O
set	O
of	O
cDNA	O
clones	O
spanning	O
approximately	O
3.2	O
kb	O
was	O
isolated	O
from	O
a	O
lambda	O
-	O
ZAP	O
goose	O
liver	O
cDNA	O
library	O
using	O
the	O
5'-most	O
exon	O
-	O
containing	O
fragment	O
of	O
the	O
5'-most	O
genomic	O
DNA	O
clone	O
.	O

Northern	O
blotting	O
analysis	O
indicates	O
that	O
expression	O
of	O
the	O
genes	O
corresponding	O
to	O
these	O
clones	O
is	O
confined	O
to	O
pollen	O
tissue	O
.	O

Whereas	O
cDNA	O
hybridization	O
to	O
genomic	O
DNA	O
blots	O
indicated	O
a	O
small	O
subfamily	O
of	O
G0S19	B
genes	I
,	O
simple	O
patterns	O
of	O
bands	O
indicated	O
that	O
most	O
cDNAs	O
,	O
including	O
G0S30	B
cDNA	I
,	O
corresponded	O
to	O
single	O
-	O
copy	O
genes	O
.	O

Lymphoproliferative	O
disorders	O
arising	O
under	O
immunosuppression	O
with	O
FK	O
506	O
:	O
initial	O
observations	O
in	O
a	O
large	O
transplant	O
population	O
.	O

Sequence	O
determination	O
of	O
isolated	O
peptides	O
suggested	O
that	O
Asn120	O
is	O
glycosylated	O
,	O
Asn65	O
and	O
Asn109	O
glycosylated	O
in	O
some	O
molecules	O
but	O
not	O
in	O
others	O
,	O
and	O
Asn72	O
not	O
glycosylated	O
.	O

Isolation	O
and	O
characterization	O
of	O
the	O
rat	O
chromosomal	O
gene	O
for	O
a	O
polypeptide	O
(	O
pS1	B
)	O
antigenically	O
related	O
to	O
statin	B
.	O

The	O
proteins	O
differ	O
in	O
the	O
presence	O
or	O
absence	O
of	O
a	O
21-amino	O
-	O
acid	O
sequence	O
located	O
24	O
amino	O
acids	O
C	O
terminal	O
of	O
the	O
translational	O
initiation	O
codon	O
.	O

Our	O
results	O
also	O
indicate	O
the	O
existence	O
of	O
sequences	O
downstream	O
of	O
-0.11	O
kb	O
which	O
can	O
influence	O
the	O
pattern	O
of	O
tissue	O
-	O
specific	O
expression	O
of	O
the	O
HLA	B
-	I
B7	I
gene	I
and	O
the	O
ability	O
of	O
this	O
gene	O
to	O
respond	O
to	O
gamma	B
interferon	I
.	O

The	O
SH2	B
and	O
SH3	B
domains	I
of	O
pp60src	B
direct	O
stable	O
association	O
with	O
tyrosine	O
phosphorylated	O
proteins	O
p130	B
and	O
p110	B
.	O

Chem	O
.	O

These	O
clones	O
overlapped	O
and	O
contained	O
the	O
structural	O
gene	O
encoding	O
the	O
complete	O
C5	B
alpha	I
-	I
chain	I
and	O
90	O
%	O
of	O
the	O
beta	O
-	O
chain	O
.	O

Heterozygous	O
mutation	O
in	O
the	O
G+5	O
position	O
of	O
intron	O
33	O
of	O
the	O
pro	B
-	I
alpha	I
2	I
(	I
I	I
)	I
gene	I
(	O
COL1A2	B
)	O
that	O
causes	O
aberrant	O
RNA	O
splicing	O
and	O
lethal	O
osteogenesis	O
imperfecta	O
.	O

The	O
nucleotide	O
sequences	O
of	O
these	O
genes	O
differ	O
at	O
only	O
nine	O
positions	O
,	O
resulting	O
in	O
three	O
amino	O
acid	O
differences	O
.	O

The	O
protein	O
predicted	O
by	O
the	O
sequence	O
of	O
the	O
human	B
pim-1	I
proto	I
-	I
oncogene	I
shares	O
extensive	O
homology	O
with	O
known	O
serine	B
/	I
threonine	I
protein	I
kinases	I
,	O
and	O
yet	O
the	O
human	B
Pim-1	I
enzyme	I
has	O
previously	O
been	O
reported	O
to	O
exhibit	O
protein	B
tyrosine	I
kinase	I
activity	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

This	O
report	O
substantiates	O
that	O
at	O
least	O
two	O
of	O
the	O
18	O
kDa	O
hsps	B
in	O
maize	O
are	O
products	O
of	O
different	O
but	O
related	O
genes	O
.	O

The	O
10	O
kDa	O
polypeptide	O
was	O
phosphorylated	O
in	O
vitro	O
by	O
incubating	O
wheat	O
etioplast	O
membranes	O
with	O
[	O
gamma	O
32P	O
]	O
ATP	O
.	O

In	O
addition	O
to	O
targeting	O
partially	O
assembled	O
Ti	B
alpha	I
-	I
beta	I
CD3	B
gamma	I
delta	I
epsilon	I
TCR	B
complexes	I
to	O
the	O
cell	O
surface	O
,	O
CD3	B
zeta	I
appears	O
to	O
be	O
essential	O
for	O
interleukin-2	B
production	O
after	O
TCR	B
stimulation	O
with	O
antigen	B
/	I
major	I
histocompatibility	I
complex	I
.	O

When	O
desipramine	O
was	O
injected	O
16	O
hrs	O
after	O
fluoxetine	O
injection	O
,	O
brain	O
levels	O
of	O
desipramine	O
were	O
no	O
longer	O
elevated	O
.	O

Opposite	O
effects	O
of	O
CYP1	B
are	O
observed	O
in	O
aerobic	O
,	O
heme	O
-	O
sufficient	O
cells	O
.	O

A	O
segmental	O
analysis	O
of	O
the	O
key	O
regions	O
of	O
HLA	B
-	I
DR1	I
that	O
control	O
T	O
cell	O
allorecognition	O
was	O
performed	O
by	O
using	O
a	O
series	O
of	O
transfected	O
cell	O
lines	O
expressing	O
the	O
products	O
of	O
recombinant	O
DRB	B
/	O
H-2Eb	B
genes	O
,	O
paired	O
with	O
either	O
DR	B
alpha	I
or	O
H-2E	B
alpha	I
.	O

Finally	O
,	O
some	O
point	O
mutations	O
in	O
the	O
Gag	B
-	O
Pol	B
PR	O
domain	O
inhibited	O
activation	O
of	O
RT	B
in	O
trans	O
by	O
a	O
wild	O
-	O
type	O
PR	B
,	O
suggesting	O
that	O
the	O
correct	O
conformation	O
of	O
the	O
PR	B
domain	O
in	O
Gag	B
-	O
Pol	B
is	O
prerequisite	O
for	O
activation	O
of	O
RT	B
.	O

The	O
alpha	B
inhibin	I
promoter	I
containing	O
a	O
mutated	O
CRE	O
was	O
not	O
regulated	O
by	O
forskolin	O
in	O
granulosa	O
cells	O
and	O
did	O
not	O
bind	O
the	O
CREB	B
protein	I
.	O

Comparison	O
of	O
the	O
nucleotide	O
sequences	O
between	O
the	O
human	O
and	O
bovine	O
DNA	O
showed	O
that	O
the	O
sequence	O
similarity	O
extended	O
2400	O
bp	O
downstream	O
from	O
the	O
coding	O
region	O
.	O

Cloning	O
of	O
a	O
human	O
cDNA	O
encoding	O
a	O
CDC2-related	B
kinase	I
by	O
complementation	O
of	O
a	O
budding	B
yeast	I
cdc28	I
mutation	O
.	O

In	O
patients	O
with	O
osteomyelitis	O
and	O
joint	O
empyema	O
(	O
n	O
=	O
48	O
)	O
PMN	B
elastase	I
had	O
a	O
sensitivity	O
of	O
77	O
%	O
,	O
which	O
was	O
only	O
exceeded	O
by	O
that	O
of	O
the	O
unspecific	O
erythrocyte	O
sedimentation	O
rate	O
(	O
sensitivity	O
89	O
%	O
)	O
.	O

The	O
above	O
results	O
mean	O
that	O
the	O
increase	O
in	O
alpha	B
-	I
adrenergic	I
receptors	I
makes	O
the	O
prostate	O
,	O
which	O
has	O
been	O
already	O
hypertrophied	O
,	O
less	O
elastic	O
,	O
inhibiting	O
external	O
urinary	O
sphincter	O
function	O
.	O

Pharmacokinetics	O
of	O
FK	O
506	O
in	O
transplant	O
patients	O
.	O

Analysis	O
of	O
the	O
deduced	O
amino	O
acid	O
sequence	O
suggests	O
that	O
CHIP28	B
protein	I
contains	O
six	O
bilayer	O
-	O
spanning	O
domains	O
,	O
two	O
exofacial	O
potential	O
N	O
-	O
glycosylation	O
sites	O
,	O
and	O
intracellular	O
N	O
and	O
C	O
termini	O
.	O

The	O
qualitative	O
concentrations	O
of	O
HCG	B
had	O
a	O
sensitivity	O
of	O
37.5	O
%	O
and	O
a	O
specificity	O
of	O
100	O
%	O
.	O

The	O
reduced	O
rate	O
of	O
F	O
absorption	O
and	O
slower	O
rise	O
in	O
plasma	O
F	O
concentration	O
accompanying	O
delayed	O
gastric	O
emptying	O
indicate	O
that	O
passage	O
of	O
F	O
into	O
the	O
small	O
intestine	O
is	O
the	O
major	O
factor	O
in	O
rapid	O
F	O
absorption	O
.	O

Epidemiology	O
and	O
prevention	O
of	O
hospital	O
infections	O
in	O
the	O
Local	O
Health	O
Unit	O
of	O
Sassari	O
:	O
profile	O
of	O
bacterial	O
resistance	O
and	O
antimicrobial	O
agents	O
of	O
large	O
usage	O
.	O

Max	B
:	O
functional	O
domains	O
and	O
interaction	O
with	O
c	B
-	I
Myc	I
.	O

86	O
:	O
3199	O
-	O
3203	O
)	O
or	O
G1	O
to	O
S	O
phase	O
(	O
Reilly	O
,	O
C.	O

Substitutions	O
introduced	O
at	O
bases	O
surrounding	O
the	O
ICR2	B
motif	I
yielded	O
levels	O
of	O
pRNA	O
replication	O
that	O
differed	O
,	O
depending	O
on	O
the	O
maintenance	O
of	O
a	O
putative	O
5	O
'	O
stem	O
-	O
loop	O
structure	O
in	O
the	O
positive	O
strand	O
of	O
the	O
viral	O
genome	O
.	O

Zn	O
(	O
II	O
)	O
coordination	O
domain	O
mutants	O
of	O
T4	B
gene	I
32	I
protein	I
.	O

The	O
pathophysiology	O
and	O
clinical	O
management	O
of	O
acute	O
brain	O
injury	O
in	O
infancy	O
and	O
childhood	O
are	O
presented	O
using	O
acute	O
traumatic	O
brain	O
injury	O
as	O
a	O
model	O
.	O

Transcripts	O
from	O
a	O
second	O
POU	B
-	I
domain	I
gene	I
,	O
Oct-25	B
,	O
were	O
present	O
at	O
low	O
levels	O
in	O
oocytes	O
and	O
early	O
embryos	O
and	O
were	O
dramatically	O
upregulated	O
during	O
early	O
gastrulation	O
.	O

In	O
some	O
early	O
B	O
cells	O
and	O
Abelson	O
murine	O
leukemia	O
virus	O
-	O
transformed	O
pre	O
-	O
B	O
-	O
cell	O
lines	O
,	O
LT	B
mRNA	I
is	O
constitutively	O
expressed	O
.	O

The	O
genome	O
of	O
Thogoto	O
virus	O
comprises	O
six	O
segments	O
of	O
single	O
-	O
stranded	O
,	O
negative	O
sense	O
RNA	O
.	O

These	O
tumors	O
were	O
classified	O
into	O
three	O
broad	O
groups	O
:	O
I	O
,	O
cystadenoma	O
;	O
II	O
,	O
cystadenocarcinoma	O
;	O
and	O
III	O
,	O
adenocarcinoma	O
with	O
mucin	B
production	O
or	O
an	O
associated	O
cyst	O
.	O

Immunostaining	O
of	O
cells	O
transfected	O
with	O
these	O
constructs	O
revealed	O
that	O
both	O
the	O
myristoylated	O
and	O
nonmyristoylated	O
mutants	O
were	O
localized	O
in	O
nuclei	O
,	O
whereas	O
wild	B
-	I
type	I
PKC	I
alpha	I
was	O
primarily	O
cytoplasmic	O
and	O
perinuclear	O
.	O

We	O
have	O
partially	O
sequenced	O
the	O
RAP74	B
protein	I
from	O
purified	O
HeLa	O
cells	O
,	O
cloned	O
its	O
complementary	O
DNA	O
and	O
shown	O
that	O
its	O
translation	O
product	O
can	O
interact	O
with	O
RAP30	B
in	O
vitro	O
as	O
well	O
as	O
in	O
vivo	O
.	O

Effects	O
of	O
thromboxane	B
synthetase	I
inhibition	O
on	O
postburn	O
mesenteric	O
vascular	O
resistance	O
and	O
the	O
rate	O
of	O
bacterial	O
translocation	O
in	O
a	O
chronic	O
porcine	O
model	O
.	O

The	O
primary	O
pancreatic	O
insult	O
seemed	O
to	O
be	O
unaffected	O
by	O
the	O
treatment	O
,	O
because	O
neither	O
the	O
rise	O
in	O
plasma	B
lipase	I
nor	O
the	O
development	O
of	O
ascites	O
or	O
the	O
extension	O
of	O
the	O
pancreatic	O
necrosis	O
were	O
diminished	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
exhibited	O
70	O
%	O
identity	O
to	O
that	O
of	O
Bacillus	B
stearothermophilus	I
TyrTS	I
and	O
55	O
%	O
identity	O
to	O
that	O
of	O
E.	B
coli	I
TyrTS	I
,	O
while	O
identity	O
to	O
a	O
second	O
cryptic	O
B.	B
subtilis	I
TyrTS	I
gene	I
,	O
designated	O
tyrZ	B
,	O
was	O
only	O
27	O
%	O
.	O

Heat	O
-	O
inducible	O
CAT	B
activity	O
was	O
detectable	O
when	O
additional	O
sequences	O
from	O
the	O
native	O
promoter	O
containing	O
three	O
CCAAT	O
boxes	O
and	O
a	O
single	O
HSE	O
were	O
present	O
in	O
the	O
constructions	O
.	O

SETTING	O
--	O
Women	O
,	O
Infants	O
,	O
and	O
Children	O
clinics	O
in	O
Minneapolis	O
,	O
Minn.	O

Testosterone	O
,	O
free	O
testosterone	O
,	O
non	B
-	I
sex	I
hormone	I
-	I
binding	I
globulin	I
-	O
bound	O
testosterone	O
,	O
and	O
free	O
androgen	O
index	O
:	O
which	O
testosterone	O
measurement	O
is	O
most	O
relevant	O
to	O
reproductive	O
and	O
sexual	O
function	O
in	O
men	O
with	O
epilepsy	O
?	O

BACKGROUND	O
:	O
The	O
effectiveness	O
of	O
monoamine	B
oxidase	I
inhibitors	O
(	O
MAOIs	O
)	O
in	O
tricyclic	O
resistant	O
depression	O
has	O
received	O
surprisingly	O
little	O
systematic	O
study	O
.	O

The	O
upstream	O
delta	O
-	O
alpha	O
breakpoint	O
is	O
flanked	O
by	O
the	O
direct	O
repeats	O
of	O
the	O
acceptor	O
splice	O
site	O
,	O
whereas	O
the	O
down	O
-	O
stream	O
alpha	O
-	O
delta	O
breakpoint	O
is	O
located	O
in	O
the	O
adjacent	O
intron	O
.	O

Management	O
often	O
involves	O
beta-	O
and	O
calcium	O
channel	O
blocking	O
drugs	O
or	O
type	O
IC	O
antiarrhythmic	O
drugs	O
.	O

Toxicity	O
was	O
mild	O
,	O
mainly	O
consisting	O
of	O
emesis	O
(	O
81	O
%	O
of	O
the	O
patients	O
;	O
66	O
%	O
of	O
the	O
courses	O
)	O
,	O
leukopenia	O
of	O
World	O
Health	O
Organization	O
(	O
WHO	O
)	O
grade	O
1	O
to	O
2	O
(	O
47	O
%	O
of	O
the	O
patients	O
;	O
18	O
%	O
of	O
the	O
courses	O
)	O
,	O
and	O
thrombocytopenia	O
(	O
12	O
%	O
of	O
the	O
patients	O
;	O
3	O
%	O
of	O
the	O
courses	O
)	O
.	O

W.G.	O

This	O
study	O
confirms	O
,	O
although	O
individual	O
reaction	O
is	O
remarkably	O
different	O
,	O
transportation	O
as	O
a	O
potent	O
stressor	O
for	O
Beagle	O
dogs	O
.	O

RESULTS	O
:	O
Plasma	B
AVP	I
responses	O
to	O
osmotic	O
stimulation	O
,	O
and	O
non	O
-	O
osmotic	O
inhibition	O
by	O
drinking	O
,	O
were	O
normal	O
in	O
patients	O
with	O
compulsive	O
water	O
drinking	O
.	O

The	O
csbA	B
fusion	I
was	O
maximally	O
expressed	O
during	O
early	O
stationary	O
phase	O
in	O
cells	O
grown	O
in	O
Luria	O
broth	O
containing	O
5	O
%	O
glucose	O
and	O
0.2	O
%	O
glutamine	O
.	O

The	O
constraints	O
of	O
primase	B
recognition	I
sequences	I
,	O
nucleotide	O
substrate	O
requirements	O
,	O
and	O
the	O
effects	O
of	O
additional	O
proteins	O
on	O
oligoribonucleotide	O
synthesis	O
by	O
the	O
63-kDa	B
gene	I
4	I
protein	I
have	O
been	O
examined	O
using	O
templates	O
of	O
defined	O
sequence	O
.	O

When	O
both	O
lesions	O
were	O
complete	O
lateral	O
hemisections	O
in	O
weanling	O
operates	O
,	O
little	O
behavioral	O
recovery	O
was	O
observed	O
,	O
similar	O
to	O
complete	O
spinal	O
cord	O
transection	O
(	O
N	O
=	O
3	O
)	O
.	O

Human	O
SRF	B
-	I
related	I
proteins	I
:	O
DNA	O
-	O
binding	O
properties	O
and	O
potential	O
regulatory	O
targets	O
.	O

Growth	O
factor	O
stimulation	O
of	O
cells	O
causes	O
the	O
phosphorylation	O
of	O
the	O
c	B
-	I
Myc	I
transcriptional	I
activation	I
domain	I
at	O
Ser62	O
within	O
a	O
proline	O
-	O
rich	O
region	O
that	O
is	O
highly	O
conserved	O
among	O
members	O
of	O
the	O
Myc	B
family	I
(	O
Alvarez	O
,	O
E.	O
,	O
Northwood	O
,	O
I.C.	O
,	O
Gonzalez	O
,	O
F.	O

The	O
authors	O
evaluated	O
the	O
potential	O
for	O
thrombotic	O
complications	O
arising	O
from	O
implantation	O
of	O
a	O
ventricular	O
assist	O
device	O
(	O
Sarns	O
/	O
3M	O
-	O
VAD	O
)	O
in	O
four	O
calves	O
.	O

Cardiac	O
output	O
(	O
CO	O
)	O
was	O
significantly	O
higher	O
(	O
p	O
less	O
than	O
0.0005	O
)	O
in	O
the	O
MBBF	O
group	O
.	O

Amino	O
acid	O
residues	O
147	O
-	O
167	O
of	O
the	O
previously	O
reported	O
sequence	O
are	O
replaced	O
by	O
new	O
residues	O
147	O
to	O
150	O
.	O

These	O
results	O
strongly	O
suggest	O
that	O
locally	O
-	O
applied	O
TTC	O
in	O
combination	O
with	O
FDBA	O
enhances	O
new	O
bone	O
formation	O
in	O
experimental	O
alveolar	O
bone	O
defects	O
.	O

As	O
an	O
initial	O
step	O
towards	O
the	O
characterization	O
of	O
replicative	O
DNA	B
polymerases	I
of	I
trypanosomes	I
,	O
we	O
have	O
cloned	O
,	O
sequenced	O
and	O
examined	O
the	O
expression	O
of	O
the	O
Trypanosoma	O
(	O
Trypanozoon	O
)	O
brucei	O
brucei	O
gene	O
that	O
encodes	O
the	O
DNA	B
polymerase	I
alpha	I
catalytic	I
core	I
(	O
pol	B
alpha	I
)	O
.	O

In	O
addition	O
,	O
there	O
was	O
a	O
significant	O
increase	O
in	O
postdexamethasone	O
cortical	O
concentrations	O
with	O
age	O
(	O
p	O
less	O
than	O
0.01	O
;	O
r	O
=	O
0.31	O
)	O
.	O

Pulmonary	O
hypertension	O
,	O
with	O
or	O
without	O
coronary	O
arterial	O
narrowing	O
,	O
is	O
the	O
major	O
condition	O
leading	O
to	O
isolated	O
atrial	O
infarction	O
.	O

The	O
volume	O
fraction	O
(	O
Vv	O
)	O
and	O
number	O
/	O
mm2	O
(	O
Na	O
)	O
of	O
all	O
capillaries	O
(	O
perfused	O
and	O
nonperfused	O
)	O
in	O
a	O
given	O
area	O
of	O
brain	O
were	O
determined	O
after	O
staining	O
for	O
alkaline	B
phosphatase	I
.	O

Airway	O
pressure	O
and	O
air	O
flow	O
were	O
measured	O
at	O
the	O
endotracheal	O
tube	O
in	O
13	O
children	O
on	O
a	O
variety	O
of	O
ventilators	O
.	O

Appl	O
.	O

Issues	O
of	O
distribution	O
of	O
kinetic	O
energy	O
of	O
traumatizing	O
object	O
in	O
direct	O
contact	O
interaction	O
with	O
head	O
during	O
impact	O
are	O
discussed	O
from	O
position	O
of	O
biomechanics	O
.	O

CONCLUSION	O
:	O
Monitoring	O
SpO2	O
at	O
the	O
nasal	O
septum	O
site	O
is	O
more	O
reliable	O
than	O
monitoring	O
it	O
at	O
the	O
finger	O
site	O
in	O
hypothermic	O
patients	O
.	O

Diltiazem	O
decreased	O
the	O
total	O
body	O
clearance	O
from	O
34.0	O
+	O
/-	O

8.0	O
to	O
28.6	O
+	O
/-	O

6.1	O
mL	O
/	O
min	O
(	O
P	O
less	O
than	O
.01	O
)	O
,	O
and	O
prolonged	O
the	O
elimination	O
half	O
-	O
life	O
from	O
12.6	O
+	O
/-	O

3.0	O
to	O
14.3	O
+	O
/-	O

2.5	O
hours	O
(	O
P	O
less	O
than	O
.01	O
)	O
of	O
antipyrine	O
without	O
any	O
changes	O
in	O
volume	O
of	O
distribution	O
.	O

Hence	O
,	O
the	O
uPA	B
promoter	I
contains	O
multiple	O
weak	O
cis	O
-	O
acting	O
elements	O
distributed	O
over	O
7.0	O
kb	O
5	O
'	O
to	O
the	O
translation	O
start	O
site	O
.	O

P.	O

These	O
introns	O
belong	O
to	O
the	O
class	O
of	O
nuclear	O
pre	O
-	O
mRNA	O
introns	O
and	O
contain	O
typical	O
5'-	O
and	O
3'-consensus	O
sequences	O
,	O
as	O
well	O
as	O
unique	O
features	O
.	O

In	O
this	O
report	O
,	O
almost	O
6	O
kb	O
of	O
DNA	O
sequence	O
is	O
presented	O
,	O
including	O
1251	O
bp	O
5	O
'	O
to	O
the	O
gene	O
,	O
over	O
4	O
kb	O
of	O
exon	O
and	O
exon	O
-	O
intron	O
junctions	O
,	O
and	O
583	O
bp	O
3	O
'	O
to	O
the	O
gene	O
.	O

Antibodies	O
specific	O
to	O
rE12	B
and	O
rNFIL-6	B
disrupt	O
nucleoprotein	O
complexes	O
with	O
these	O
DNA	O
-	O
binding	O
sites	O
,	O
confirming	O
the	O
interaction	O
of	O
native	O
in	O
vivo	O
factors	O
.	O

A	O
method	O
is	O
described	O
for	O
detecting	O
targeted	O
events	O
at	O
the	O
mu	B
heavy	I
chain	I
gene	I
which	O
relies	O
on	O
co	O
-	O
conversion	O
(	O
or	O
co	O
-	O
exchange	O
)	O
of	O
a	O
point	O
mutation	O
with	O
a	O
selectable	O
marker	O
contained	O
on	O
a	O
replacement	O
vector	O
.	O

Allergenic	O
activity	O
of	O
allergen	O
extract	O
Ambrosia	O
elatior	O
(	O
AE	O
)	O
was	O
tested	O
in	O
fifteen	O
volunteers	O
extremely	O
sensitive	O
to	O
the	O
allergen	O
.	O

This	O
study	O
was	O
aimed	O
at	O
assessing	O
whether	O
c	O
-	O
DDP	O
administration	O
immediately	O
before	O
radiotherapy	O
could	O
increase	O
frequency	O
and	O
duration	O
of	O
objective	O
responses	O
,	O
as	O
well	O
as	O
survival	O
,	O
in	O
patients	O
affected	O
with	O
locally	O
advanced	O
stages	O
of	O
squamous	O
carcinomas	O
of	O
the	O
head	O
and	O
neck	O
.	O

Two	O
potential	O
regulatory	O
sequences	O
for	O
DNA	O
binding	O
proteins	O
were	O
found	O
in	O
the	O
non	O
-	O
coding	O
5	O
'	O
region	O
:	O
a	O
HAP2	B
/	O
HAP3	B
consensus	O
recognition	O
sequence	O
at	O
nucleotide-154	O
and	O
a	O
BAF1	B
consensus	I
recognition	I
sequence	I
at	O
nucleotide-136	O
.	O

Marked	O
thrombocytopenia	O
,	O
depletion	O
of	O
serum	B
fibrinogen	I
and	O
prolonged	O
prothrombin	B
and	O
activated	O
partial	O
thromboplastin	B
time	O
,	O
were	O
recorded	O
at	O
5	O
to	O
10	O
and	O
30	O
to	O
40	O
minutes	O
after	O
intravenous	O
envenomation	O
.	O

We	O
exploit	O
the	O
properties	O
of	O
LexA	B
fusion	I
proteins	I
to	O
study	O
the	O
dimerization	O
and	O
DNA	O
-	O
contacting	O
domains	O
of	O
cRel	B
.	O

The	O
alcoholic	O
patient	O
,	O
his	O
work	O
and	O
the	O
subjectivity	O
of	O
the	O
period	O

These	O
data	O
suggest	O
that	O
the	O
combined	O
treatment	O
with	O
a	O
thromboxane	B
synthetase	I
inhibitor	O
and	O
a	O
thromboxane	B
receptor	I
antagonist	O
provides	O
a	O
better	O
protection	O
against	O
digoxin	O
intoxication	O
than	O
with	O
either	O
agent	O
alone	O
.	O

Interspecific	O
backcross	O
analysis	O
using	O
progeny	O
derived	O
from	O
matings	O
of	O
(	O
C57BL	O
/	O
6J	O
x	O
Mus	O
spretus	O
)	O
F1	O
x	O
C57BL	O
/	O
6J	O
mice	O
indicates	O
that	O
the	O
thrombospondin	B
gene	I
is	O
tightly	O
linked	O
to	O
the	O
Fshb	B
,	O
Actcl	B
,	O
Ltk	B
,	O
and	O
B2	B
M	I
loci	I
on	O
murine	O
chromosome	O
2	O
.	O

Adverse	O
foetal	O
outcome	O
in	O
specific	O
IgM	B
positive	O
Chlamydia	O
trachomatis	O
infection	O
in	O
pregnancy	O
.	O

Using	O
an	O
image	O
-	O
processing	O
computer	O
,	O
regional	O
LV	O
time	O
-	O
density	O
curves	O
were	O
constructed	O
for	O
one	O
cardiac	O
cycle	O
.	O

In	O
a	O
second	O
patient	O
the	O
VT	O
became	O
nonsustained	O
.	O

The	O
possible	O
mechanisms	O
underlying	O
differences	O
in	O
post	O
-	O
tetanic	O
effects	O
from	O
muscle	O
and	O
cutaneous	O
afferents	O
in	O
adults	O
and	O
neonates	O
are	O
discussed	O
.	O

The	O
EPO	B
levels	O
were	O
distinctly	O
increased	O
before	O
transfusion	O
;	O
they	O
did	O
not	O
significantly	O
change	O
just	O
after	O
transfusion	O
,	O
but	O
subsequently	O
decreased	O
.	O

This	O
differential	O
sensitivity	O
to	O
DB	O
,	O
as	O
measured	O
by	O
a	O
lower	O
concentration	O
of	O
DB	O
which	O
caused	O
loss	O
of	O
righting	O
in	O
LS	O
,	O
was	O
accompanied	O
by	O
an	O
equal	O
rate	O
of	O
water	O
-	O
soluble	O
barbiturate	O
brain	O
distribution	O
and	O
elimination	O
in	O
the	O
two	O
lines	O
.	O

Ten	O
out	O
of	O
10	O
patients	O
with	O
progressive	O
disease	O
had	O
mast	O
cells	O
greater	O
than	O
or	O
equal	O
to	O
0.5	O
%	O
,	O
hyaluronan	O
greater	O
than	O
or	O
equal	O
to	O
50	O
micrograms.l-1	O
and	O
fibronectin	B
greater	O
than	O
or	O
equal	O
to	O
350	O
micrograms.l-1	O
compared	O
to	O
eight	O
out	O
of	O
41	O
patients	O
with	O
stable	O
or	O
regressive	O
disease.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Our	O
mapping	O
results	O
did	O
not	O
suggest	O
involvement	O
of	O
this	O
gene	O
in	O
previously	O
mapped	O
genetic	O
disorders	O
or	O
in	O
known	O
neoplasia	O
-	O
associated	O
translocation	O
breakpoints	O
.	O

Arsenic	O
contents	O
in	O
native	O
copper	O

In	O
ten	O
other	O
experiments	O
(	O
5	O
experimental	O
and	O
5	O
control	O
rats	O
)	O
99mTc	O
-	O
sulfur	O
colloid	O
was	O
injected	O
intravenously	O
.	O

Extramedullary	O
relapse	O
in	O
childhood	O
leukemia	O
.	O

Mycoplasma	O
pneumoniae	O
was	O
isolated	O
from	O
the	O
pleural	O
fluid	O
of	O
this	O
patient	O
.	O

RU486	O
and	O
ONO	O
802	O
in	O
combination	O
have	O
been	O
shown	O
to	O
be	O
effective	O
in	O
early	O
termination	O
of	O
pregnancy	O
.	O

In	O
line	O
with	O
the	O
small	O
values	O
for	O
QS	O
/	O
QC	O
,	O
our	O
results	O
further	O
indicate	O
that	O
even	O
large	O
,	O
well	O
-	O
perfused	O
,	O
occluded	O
air	O
spaces	O
in	O
the	O
lung	O
will	O
hardly	O
affect	O
the	O
recovered	O
ventilation	O
/	O
perfusion	O
distribution	O
obtained	O
from	O
inert	O
gas	O
data	O
when	O
CDCSF6	O
exceeds	O
0.1	O
ml.min-1.mmHg-1	O
.	O

Many	O
cells	O
were	O
negative	O
for	O
endothelial	O
-	O
cell	O
markers	O
,	O
and	O
they	O
reacted	O
with	O
a	O
monoclonal	O
antibody	O
against	O
muscle	O
actin	B
.	O

The	O
effects	O
of	O
contrast	O
media	O
on	O
coagulation	B
factor	I
XII	I
.	O

Pigs	O
were	O
switched	O
from	O
the	O
growing	O
to	O
the	O
finishing	O
diet	O
at	O
57	O
and	O
61	O
kg	O
in	O
Exp	O
.	O

In	O
sixteen	O
patients	O
with	O
moderate	O
essential	O
hypertension	O
the	O
effects	O
of	O
10-day	O
nifedipine	O
treatment	O
on	O
serum	O
uric	O
acid	O
and	O
renal	O
excretion	O
of	O
uric	O
acid	O
were	O
evaluated	O
.	O

Examples	O
are	O
using	O
more	O
subjects	O
or	O
an	O
improved	O
research	O
design	O
,	O
developing	O
consensus	O
statements	O
or	O
using	O
meta	O
-	O
analysis	O
.	O

A	O
two	O
phase	O
slug	O
flow	O
tubular	O
heat	O
exchanger	O
was	O
used	O
for	O
the	O
thermal	O
inactivation	O
of	O
Listeria	O
monocytogenes	O
in	O
natural	O
infected	O
milk	O
from	O
seven	O
cows	O
.	O

Regional	O
cerebral	O
blood	O
flow	O
(	O
rCBF	O
)	O
measurements	O
and	O
psychiatric	O
ratings	O
were	O
performed	O
on	O
seven	O
schizophrenic	O
patients	O
(	O
mean	O
age	O
=	O
41.4	O
years	O
)	O
who	O
had	O
been	O
examined	O
18	O
years	O
previously	O
in	O
a	O
study	O
that	O
used	O
similar	O
psychiatric	O
ratings	O
and	O
a	O
comparable	O
rCBF	O
technique	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
identified	O
a	O
strong	O
positive	O
cis	O
-	O
regulatory	O
element	O
at	O
-70	O
bp	O
to	O
-75	O
bp	O
in	O
the	O
LpS1	B
beta	I
promoter	I
with	O
the	O
sequence	O
(	O
G	O
)	O
6	O
and	O
a	O
similar	O
,	O
more	O
distal	O
cis	O
-	O
element	O
at	O
-721	O
bp	O
to	O
-726	O
bp	O
.	O

No	O
case	O
of	O
SMF	O
demonstrated	O
expansive	O
tumorous	O
growth	O
.	O

Review	O
of	O
the	O
literature	O
and	O
report	O
of	O
a	O
case	O
of	O
a	O
dermoid	O
cyst	O
.	O

In	O
all	O
instances	O
the	O
apparent	O
alcohol	O
responses	O
were	O
very	O
small	O
and	O
never	O
exceeded	O
a	O
reading	O
of	O
1	O
microgram	O
/	O
100ml	O
for	O
breath	O
samples	O
more	O
than	O
10min	O
post	O
-	O
exposure	O
.	O

Maize	B
rbcS	I
promoter	I
activity	O
depends	O
on	O
sequence	O
elements	O
not	O
found	O
in	O
dicot	B
rbcS	I
promoters	I
.	O

The	O
relatively	O
scanty	O
number	O
of	O
examples	O
,	O
which	O
could	O
be	O
justified	O
by	O
the	O
variety	O
and	O
complexity	O
of	O
combined	O
exposure	O
,	O
allows	O
to	O
conclude	O
that	O
life	O
-	O
style	O
factors	O
have	O
considerable	O
influence	O
on	O
interindividual	O
differences	O
in	O
susceptibility	O
to	O
xenobiotics	O
toxicity	O
.	O

After	O
treatment	O
with	O
tunicamycin	O
,	O
the	O
transfectants	O
secreted	O
unglycosylated	O
18-kDa	O
polypeptides	O
which	O
could	O
also	O
bind	O
IgE.	B

PAS1	B
,	O
a	O
yeast	O
gene	O
required	O
for	O
peroxisome	O
biogenesis	O
,	O
encodes	O
a	O
member	O
of	O
a	O
novel	O
family	O
of	O
putative	O
ATPases	B
.	O

The	O
gene	O
is	O
1,139	O
base	O
pairs	O
(	O
bp	O
)	O
long	O
,	O
and	O
,	O
like	O
other	O
members	O
of	O
the	O
SIG	B
family	I
,	O
the	O
beta	B
TG	I
gene	I
is	O
divided	O
into	O
3	O
exons	O
.	O

The	O
pp90rsk	B
-	I
protein	I
kinase	I
activity	O
(	O
referred	O
to	O
as	O
rsk	B
-	I
kinase	I
)	O
is	O
also	O
not	O
related	O
to	O
cofactor	O
-	O
dependent	O
signal	O
transducing	O
protein	O
kinases	O
such	O
as	O
the	O
cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinases	I
,	O
members	O
of	O
the	O
protein	B
kinase	I
C	I
family	I
,	O
or	O
other	O
Ca2	B
(	I
+	I
)	I
-dependent	I
protein	I
kinases	I
.	O

Human	B
GATA-3	I
:	O
a	O
lineage	O
-	O
restricted	O
transcription	O
factor	O
that	O
regulates	O
the	O
expression	O
of	O
the	O
T	B
cell	I
receptor	I
alpha	I
gene	I
.	O

Like	O
many	O
eukaryotic	O
transcription	O
factors	O
,	O
these	O
proteins	O
bind	O
to	O
DNA	O
as	O
dimers	O
.	O

Southwestern	O
blot	O
analysis	O
demonstrated	O
that	O
this	O
phosphoprotein	O
can	O
bind	O
the	O
kappa	B
B	I
element	I
directly	O
and	O
specifically	O
.	O

Thus	O
,	O
the	O
positive	O
effect	O
of	O
NS1	B
on	O
the	O
steady	O
-	O
state	O
levels	O
of	O
P4	B
transcripts	I
depends	O
on	O
the	O
amplification	O
of	O
gene	O
copy	O
number	O
and	O
the	O
integrity	O
of	O
the	O
terminal	O
repeats	O
.	O

The	O
minus	O
-	O
end	O
-	O
directed	O
microtubule	O
motors	O
,	O
the	O
dyneins	B
,	O
may	O
also	O
constitute	O
a	O
superfamily	O
of	O
force	O
-	O
generating	O
proteins	O
with	O
distinct	O
attachment	O
domains	O
.	O

It	O
is	O
transparent	O
,	O
cheap	O
to	O
be	O
made	O
,	O
and	O
easy	O
to	O
empty	O
and	O
was	O
tested	O
in	O
118	O
animals	O
for	O
two	O
and	O
four	O
weeks	O
.	O

The	O
incompatibility	O
group	O
W	O
plasmid	O
pSa	O
suppresses	O
Agrobacterium	O
tumefaciens	O
oncogenicity	O
(	O
J.	O

Potential	O
translational	O
start	O
signals	O
are	O
upstream	O
of	O
ORF1	O
and	O
ORF2	O
.	O

Imaging	O
of	O
D2	B
dopamine	I
receptor	I

The	O
Thr161Val	O
mutation	O
causes	O
a	O
lethal	O
phenotype	O
in	O
the	O
fission	O
yeast	O
Schizosaccharomyces	O
pombe	O
,	O
while	O
replacement	O
of	O
Thr161	O
with	O
glutamic	O
acid	O
,	O
potentially	O
mimicking	O
phosphorylation	O
,	O
causes	O
uncoordination	O
of	O
mitosis	O
and	O
multiple	O
cytokinesis	O
.	O

Deregulation	O
of	O
their	O
expression	O
may	O
contribute	O
to	O
malignant	O
transformation	O
associated	O
with	O
HTLV-1	O
infection	O
.	O

The	O
murine	B
Mov-34	I
gene	I
:	O
full	O
-	O
length	O
cDNA	O
and	O
genomic	O
organization	O
.	O

CREB	B
was	O
identified	O
as	O
one	O
of	O
the	O
protein	O
components	O
in	O
several	O
of	O
the	O
gel	O
shift	O
complexes	O
formed	O
with	O
the	O
variant	O
CRE	O
.	O

The	O
RNA	O
genome	O
of	O
rabbit	O
hemorrhagic	O
disease	O
virus	O
(	O
RHDV	O
)	O
was	O
molecularly	O
cloned	O
.	O

Therefore	O
,	O
we	O
have	O
developed	O
a	O
system	O
to	O
study	O
nuclear	O
targeting	O
in	O
plants	O
and	O
have	O
established	O
that	O
the	O
nuclear	O
transport	O
machinery	O
is	O
similar	O
in	O
monocots	O
and	O
dicots	O
.	O

A	O
vector	O
containing	O
a	O
transcriptionally	O
inactive	O
neomycin	B
phosphotransferase	I
II	I
gene	I
was	O
used	O
to	O
select	O
promoter	O
sequences	O
from	O
a	O
pool	O
of	O
random	O
genomic	O
DNA	O
fragments	O
.	O

Previous	O
analysis	O
of	O
the	O
98-bp	O
sequence	O
has	O
delineated	O
several	O
protein	O
-	O
binding	O
domains	O
that	O
are	O
recognized	O
by	O
nuclear	O
factors	O
present	O
in	O
human	O
brain	O
cells	O
.	O

The	O
second	O
transcriptional	O
unit	O
,	O
designated	O
UL26.5	B
,	O
predicted	O
to	O
specify	O
a	O
protein	O
of	O
329	O
amino	O
acids	O
,	O
encodes	O
the	O
family	B
35	I
proteins	I
;	O
it	O
is	O
transcribed	O
by	O
an	O
mRNA	O
which	O
initiates	O
at	O
approximately	O
nucleotide	O
+	O
1000	O
of	O
the	O
UL26	B
transcription	O
initiation	O
site	O
and	O
is	O
translated	O
from	O
the	O
methionine	O
initiation	O
codon	O
located	O
at	O
position	O
+	O
1099	O
of	O
the	O
UL26	B
transcriptional	I
unit	I
.	O

The	O
adeno	B
-	I
associated	I
virus	I
(	I
AAV	I
)	I
rep	I
gene	I
encodes	O
four	O
proteins	O
(	O
Rep78	B
,	O
Rep68	B
,	O
Rep52	B
,	O
and	O
Rep40	B
)	O
required	O
for	O
AAV	O
DNA	O
replication	O
and	O
AAV	O
gene	O
regulation	O
.	O

A	O
larger	O
region	O
upstream	O
of	O
human	B
CMV	I
dbp	I
also	O
mediated	O
replication	O
in	O
transient	O
assays	O
.	O

However	O
,	O
the	O
relative	O
positions	O
of	O
the	O
VV	O
genes	O
(	O
genus	O
Orthopoxvirus	O
)	O
are	O
different	O
than	O
those	O
of	O
the	O
corresponding	O
ORFs	O
in	O
SFV	O
(	O
genus	O
Leporipoxvirus	O
)	O
,	O
indicating	O
complex	O
rearrangements	O
of	O
DNA	O
in	O
the	O
genome	O
of	O
one	O
or	O
both	O
of	O
these	O
viruses	O
subsequent	O
to	O
their	O
divergence	O
from	O
a	O
common	O
ancestor	O
.	O

This	O
result	O
suggests	O
that	O
phosphorylation	O
of	O
Thr	O
14	O
and/or	O
Tyr	O
15	O
inhibits	O
p34cdc2	B
kinase	I
activity	O
,	O
in	O
line	O
with	O
the	O
location	O
of	O
these	O
residues	O
within	O
the	O
putative	O
ATP	O
binding	O
site	O
of	O
the	O
kinase	O
.	O

In	O
short	O
-	O
term	O
cotransfections	O
,	O
a	O
pFRTK	B
-	O
CAT	B
target	O
containing	O
EBNA-1-binding	B
sites	I
from	O
the	O
EBV	O
origin	O
of	O
plasmid	O
replication	O
,	O
ori	B
-	I
P	I
,	O
was	O
transactivated	O
by	O
a	O
carboxy	B
-	I
terminal	I
EBNA-1	I
construction	I
(	O
amino	O
acids	O
450	O
to	O
641	O
)	O
that	O
also	O
carried	O
a	O
c	B
-	I
myc	I
nuclear	I
localization	I
signal	I
.	O

The	O
findings	O
are	O
compatible	O
with	O
the	O
idea	O
that	O
the	O
genes	O
encoding	O
PDGF	B
receptors	I
in	O
glioma	O
cells	O
are	O
regulated	O
in	O
concert	O
with	O
other	O
genes	O
,	O
the	O
expression	O
of	O
which	O
may	O
reflect	O
the	O
developmental	O
program	O
of	O
normal	O
glia	O
cell	O
lineages	O
.	O

This	O
study	O
tested	O
the	O
hypothesis	O
that	O
sodium	O
channel	O
blocking	O
drugs	O
selectively	O
prolong	O
the	O
late	O
potential	O
,	O
or	O
terminal	O
low	O
amplitude	O
signal	O
,	O
portion	O
of	O
the	O
signal	O
-	O
averaged	O
QRS	O
complex	O
and	O
that	O
prolongation	O
of	O
the	O
late	O
potential	O
would	O
correlate	O
with	O
slowing	O
of	O
ventricular	O
tachycardia	O
.	O

Whereas	O
a	O
PR55	B
beta	I
transcript	I
of	O
about	O
2.3	O
kb	O
was	O
detected	O
at	O
high	O
levels	O
in	O
the	O
neuroblastoma	O
derived	O
cell	O
line	O
LA	O
-	O
N-1	O
,	O
the	O
level	O
of	O
the	O
mRNA	O
was	O
very	O
low	O
in	O
the	O
other	O
human	O
cell	O
lines	O
analyzed	O
.	O

The	O
effects	O
of	O
c	B
-	I
myc	I
were	O
further	O
dissected	O
by	O
showing	O
that	O
c	B
-	I
myc	I
can	O
inhibit	O
differentiation	O
independently	O
of	O
I	B
d	I
,	O
a	O
negative	O
regulator	O
of	O
muscle	O
differentiation	O
.	O

Stable	O
association	O
of	O
U2	B
snRNP	I
with	O
the	O
branchpoint	O
sequence	O
of	O
mammalian	O
pre	O
-	O
mRNAs	O
requires	O
binding	O
of	O
a	O
non	O
-	O
snRNP	O
protein	O
to	O
the	O
polypyrimidine	O
tract	O
.	O

Biol	O
.	O

Nucleotide	O
sequences	O
between	O
the	O
env	B
gene	I
and	O
the	O
LTR	B
of	I
SFV-1	I
were	O
determined	O
.	O

This	O
element	O
was	O
used	O
to	O
screen	O
an	O
EMBL3	O
mouse	O
genomic	O
library	O
.	O

The	O
rad9.192	B
DNA	I
repair	I
mutant	I
from	I
the	I
fission	I
yeast	I
,	I
Schizosaccharomyces	I
pombe	I
,	O
is	O
sensitive	O
to	O
both	O
UV	O
and	O
ionising	O
radiation	O
.	O

The	O
patient	O
was	O
a	O
78-year	O
-	O
old	O
male	O
in	O
whom	O
skin	O
lesions	O
preceded	O
the	O
diagnosis	O
of	O
myelofibrosis	O
.	O

After	O
resection	O
of	O
the	O
proximal	O
fragment	O
,	O
all	O
scaphoid	O
contact	O
area	O
and	O
pressure	O
was	O
born	O
by	O
the	O
distal	O
scaphoid	O
fragment	O
.	O

Plate	O
luting	O
,	O
a	O
technique	O
that	O
uses	O
polymethylmethacrylate	O
(	O
PMMA	O
)	O
interposed	O
between	O
the	O
plate	O
and	O
the	O
bone	O
,	O
as	O
well	O
as	O
between	O
the	O
screw	O
heads	O
and	O
the	O
plate	O
,	O
to	O
improve	O
the	O
stability	O
of	O
internal	O
fixation	O
was	O
tested	O
in	O
vitro	O
using	O
20	O
paired	O
equine	O
third	O
metacarpal	O
bones	O
with	O
mid	O
-	O
diaphyseal	O
osteotomies	O
plated	O
with	O
six	O
-	O
hole	O
broad	O
ASIF	O
compression	O
plates	O
.	O

Thyroid	O
lymphoma	O
and	O
its	O
management	O
.	O

The	O
protein	O
encoded	O
by	O
ORF113	B
contains	O
a	O
transmembrane	O
domain	O
.	O

Dd	B
PK1	I
RNA	I
decreases	O
after	O
6	O
h	O
of	O
starvation	O
to	O
re	O
-	O
accumulate	O
once	O
the	O
cells	O
have	O
aggregated	O
.	O

The	O
various	O
forms	O
of	O
sickle	O
cell	O
disease	O
share	O
the	O
common	O
feature	O
of	O
an	O
abnormal	O
globin	B
chain	I
that	O
,	O
under	O
certain	O
conditions	O
such	O
as	O
hypoxia	O
,	O
results	O
in	O
the	O
sickling	O
of	O
red	O
blood	O
cells	O
and	O
obstruction	O
of	O
blood	O
vessels	O
.	O

The	O
primary	O
structure	O
of	O
each	O
of	O
the	O
three	O
proteins	O
has	O
about	O
70	O
%	O
homology	O
with	O
that	O
of	O
mouse	B
contrapsin	I
,	O
in	O
contrast	O
to	O
43	O
-	O
46	O
%	O
homology	O
with	O
that	O
of	O
rat	B
alpha	I
1-protease	I
inhibitor	O
.	O

Linear	O
regression	O
analysis	O
was	O
performed	O
and	O
the	O
following	O
result	O
was	O
obtained	O
:	O
clearance	O
(	O
HMPAO	O
)	O
=	O
0.07	O
+	O
0.43	O
.	O

rCBF	O
with	O
a	O
high	O
significance	O
(	O
p	O
less	O
than	O
0.001	O
)	O
.	O

Human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV-1	I
)	I
IN	I
,	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
was	O
purified	O
to	O
near	O
homogeneity	O
.	O

Thigh	O
girth	O
correlated	O
positively	O
with	O
HDL	B
and	O
HDL2-C	B
and	O
mass	O
,	O
and	O
with	O
LDL	B
particle	O
size	O
among	O
women	O
.	O

Contributions	O
from	O
pairs	O
of	O
source	O
and	O
target	O
volume	O
elements	O
are	O
summed	O
for	O
the	O
S	O
values	O
between	O
the	O
tumor	O
and	O
itself	O
,	O
between	O
the	O
remaining	O
healthy	O
host	O
organ	O
and	O
itself	O
,	O
and	O
between	O
the	O
tumor	O
and	O
the	O
remaining	O
healthy	O
host	O
organ	O
,	O
with	O
the	O
reciprocity	O
theorem	O
assumed	O
for	O
the	O
last	O
.	O

Paradoxically	O
,	O
however	O
,	O
the	O
GH	B
receptor	I
cloned	O
from	O
liver	O
exhibits	O
no	O
sequence	O
similarity	O
to	O
receptors	O
with	O
known	O
signal	O
transduction	O
mechanisms	O
,	O
including	O
those	O
exhibiting	O
ligand	O
-	O
activated	O
tyrosine	B
kinase	I
activity	O
.	O

Identification	O
of	O
Ets-	B
and	O
notch	B
-	O
related	O
subunits	O
in	O
GA	B
binding	I
protein	I
.	O

In	O
the	O
ileum	O
,	O
enterotoxin	O
increased	O
the	O
luminal	O
disappearance	O
(	O
P	O
less	O
than	O
0.05	O
)	O
and	O
peripheral	O
blood	O
appearance	O
(	O
P	O
less	O
than	O
0.001	O
)	O
of	O
chloroquine	O
.	O

Formalin	O
activated	O
both	O
SNO	O
NS	O
and	O
NnS	O
neurones	O
,	O
but	O
,	O
when	O
they	O
responded	O
,	O
NS	O
neurones	O
(	O
n	O
=	O
5	O
)	O
showed	O
only	O
the	O
first	O
phase	O
of	O
activity	O
while	O
NnS	O
neurones	O
showed	O
either	O
one	O
(	O
n	O
=	O
13	O
)	O
or	O
two	O
phases	O
(	O
n	O
=	O
6	O
)	O
.	O

Uptake	O
of	O
ofloxacin	O
by	O
Escherichia	O
coli	O

The	O
effectiveness	O
of	O
alpha	O
-	O
mercapto	O
-	O
beta-	O
(	O
2-furyl	O
)	O
acrylic	O
acid	O
(	O
MFA	O
)	O
and	O
N	O
-	O
benzyl	O
-	O
N	O
-	O
dithiocarboxy	O
-	O
D	O
-	O
glucamine	O
(	O
NaB	O
)	O
,	O
used	O
in	O
combination	O
,	O
in	O
the	O
mobilization	O
and	O
excretion	O
of	O
lead	O
was	O
investigated	O
in	O
rats	O
.	O

These	O
results	O
suggest	O
that	O
beta-1	B
may	O
act	O
as	O
a	O
tissue	O
-	O
specific	O
,	O
trans	O
-	O
acting	O
regulator	O
of	O
the	O
expression	O
of	O
the	O
beta	B
-	I
zein	I
gene	I
in	O
developing	O
maize	O
endosperm	O
.	O

This	O
study	O
examines	O
the	O
effects	O
of	O
hypovolemia	O
on	O
the	O
extracellular	O
ptO2	O
and	O
ptH	O
distributions	O
at	O
multiple	O
tissue	O
sites	O
using	O
a	O
recently	O
developed	O
multipoint	O
microelectrode	O
,	O
that	O
provides	O
simultaneous	O
measurements	O
of	O
ptO2	O
and	O
ptH.	O

The	O
domains	O
involved	O
in	O
superactivation	O
appear	O
to	O
be	O
a	O
subset	O
of	O
those	O
necessary	O
to	O
achieve	O
synergistic	O
activation	O
.	O

Chlamydia	O
trachomatis	O
and	O
Chlamydia	O
psittaci	O
were	O
not	O
affected	O
by	O
methanol	O
fixation	O
.	O

Although	O
human	O
infections	O
with	O
bacteraemia	O
due	O
to	O
Pasteurella	O
multocida	O
are	O
not	O
uncommon	O
,	O
endocarditis	O
associated	O
with	O
P.	O
haemolytica	O
is	O
rare	O
.	O

For	O
SMX	O
at	O
pH	O
7.0	O
,	O
a	O
1:1	O
complex	O
is	O
formed	O
,	O
but	O
at	O
pH	O
7.5	O
HPCD	O
has	O
little	O
effect	O
on	O
the	O
solubility	O
of	O
the	O
highly	O
ionized	O
SMX	O
,	O
presumably	O
since	O
only	O
un	O
-	O
ionized	O
molecules	O
can	O
form	O
inclusion	O
complexes	O
with	O
the	O
HPCD	O
.	O

PO2	O
measurements	O
using	O
a	O
double	O
barrelled	O
recess	O
type	O
microelectrodes	O
were	O
measured	O
in	O
the	O
optic	O
nerve	O
head	O
of	O
miniature	O
pigs	O
in	O
normoxia	O
and	O
hyperoxia	O
.	O

POU	B
-	O
specific	O
and	O
POU	B
-	O
homeo	O
domains	O
of	O
Oct3	B
were	O
produced	O
in	O
Echerichia	O
coli	O
for	O
characterization	O
of	O
DNA	O
binding	O
to	O
the	O
octamer	O
sequence	O
.	O

A	O
deletion	O
series	O
of	O
the	O
5	O
'	O
flanking	O
region	O
was	O
created	O
from	O
position	O
-1329	O
to	O
-74	O
relative	O
to	O
the	O
transcriptional	O
initiation	O
site	O
and	O
similarly	O
examined	O
in	O
transgenic	O
tobacco	O
.	O

The	O
nucleotide	O
(	O
nt	O
)	O
sequences	O
of	O
the	O
exons	O
,	O
exon	O
/	O
intron	O
boundaries	O
and	O
5'-	O
and	O
3'-untranslated	O
regions	O
were	O
determined	O
.	O

Out	O
of	O
40	O
patients	O
,	O
who	O
initially	O
did	O
not	O
show	O
eye	O
complications	O
due	O
to	O
leprosy	O
,	O
37	O
patients	O
were	O
essentially	O
the	O
same	O
10	O
years	O
later	O
.	O

Toxicity	O
was	O
very	O
mild	O
with	O
both	O
regimens	O
,	O
although	O
sedation	O
was	O
significantly	O
higher	O
in	O
arm	O
B	O
(	O
p	O
less	O
than	O
0.001	O
)	O
.	O

Increasing	O
mean	O
arterial	O
pressure	O
by	O
phenylephrine	O
infusion	O
to	O
levels	O
much	O
greater	O
than	O
produced	O
by	O
NMA	O
and	O
NNA	O
caused	O
only	O
small	O
reductions	O
in	O
cardiac	O
output	O
.	O

J.	O

With	O
stepwise	O
reductions	O
in	O
flow	O
,	O
the	O
peak	O
(	O
S	O
)	O
and	O
trough	O
(	O
D	O
)	O
points	O
of	O
the	O
maximum	O
shifted	O
-	O
frequency	O
envelope	O
fell	O
in	O
parallel	O
in	O
a	O
linear	O
fashion	O
until	O
D	O
reached	O
zero	O
.	O

Moreover	O
,	O
promoters	O
containing	O
a	O
TATA	O
box	O
in	O
the	O
absence	O
of	O
Sp1	B
sites	I
or	O
Sp1	B
sites	I
in	O
the	O
absence	O
of	O
a	O
TATA	O
box	O
were	O
equally	O
inducible	O
in	O
vitro	O
,	O
as	O
was	O
an	O
RNA	B
polymerase	I
III	I
promoter	I
.	O

Evaluation	O
of	O
left	O
ventricular	O
function	O
using	O
gated	O
planar	O
myocardial	O
imaging	O
with	O
Tc-99m	O
-	O
MIBI	O

Ivermectin	O
uptake	O
and	O
distribution	O
in	O
the	O
plasma	O
and	O
tissue	O
of	O
Sudanese	O
and	O
Mexican	O
patients	O
infected	O
with	O
Onchocerca	O
volvulus	O
.	O

Bone	O
marrow	O
abnormalities	O
in	O
Hodgkin	O
's	O
disease	O
are	O
reviewed	O
and	O
the	O
current	O
understanding	O
of	O
the	O
pathological	O
mechanisms	O
leading	O
to	O
aplastic	O
anemia	O
is	O
discussed	O
.	O

DNA	O
hybridization	O
analysis	O
revealed	O
that	O
both	O
pigmented	O
and	O
nonpigmented	O
cells	O
of	O
Y.	O
pestis	O
possess	O
a	O
DNA	O
locus	O
homologous	O
to	O
the	O
Escherichia	B
coli	I
fur	I
gene	I
.	O

Expression	O
was	O
cell	O
cycle	O
controlled	O
,	O
with	O
steady	O
-	O
state	O
RNA	O
levels	O
significantly	O
higher	O
in	O
growth	O
-	O
arrested	O
than	O
in	O
growth	O
-	O
stimulated	O
cells	O
.	O

Relationship	O
between	O
mitochondrial	B
NADH	I
-	I
ubiquinone	I
reductase	I
and	O
a	O
bacterial	B
NAD	I
-	I
reducing	I
hydrogenase	I
.	O

Analysis	O
of	O
mRNA	O
expression	O
shows	O
that	O
AT	B
-	I
BP1	I
and	O
AT	B
-	I
BP2	I
are	O
expressed	O
in	O
all	O
the	O
tissues	O
examined	O
.	O

We	O
report	O
two	O
patients	O
receiving	O
maintenance	O
valproate	O
,	O
one	O
with	O
resolving	O
acute	O
hepatitis	O
C	O
and	O
the	O
other	O
with	O
chronic	O
persistent	O
hepatitis	O
C	O
,	O
with	O
incidental	O
microvesicular	O
steatosis	O
demonstrated	O
on	O
oil	O
-	O
red	O
O	O
stains	O
.	O

If	O
this	O
is	O
the	O
case	O
,	O
identification	O
and	O
characterization	O
of	O
transcripts	O
from	O
the	O
Ig	B
loci	I
should	O
permit	O
a	O
better	O
understanding	O
of	O
the	O
gene	O
rearrangement	O
process	O
.	O

Transcription	O
of	O
the	O
metH	B
gene	I
in	I
Salmonella	I
typhimurium	I
and	I
Escherichia	I
coli	I
is	O
positively	O
regulated	O
by	O
the	O
metR	B
gene	I
product	I
,	O
a	O
DNA	O
binding	O
protein	O
.	O

Disruption	O
of	O
the	O
chromosomal	B
AAR1	I
gene	I
in	O
alpha	O
and	O
a	O
/	O
alpha	O
cells	O
conferred	O
the	O
nonmating	O
phenotype	O
,	O
and	O
the	O
a	O
/	O
alpha	O
diploids	O
could	O
not	O
sporulate	O
.	O

The	O
ORF	O
was	O
analyzed	O
for	O
secondary	O
structural	O
features	O
,	O
and	O
the	O
sequence	O
data	O
bases	O
were	O
searched	O
for	O
homologies	O
.	O

Mitomycin	O
-	O
C	O
can	O
cause	O
severe	O
necrosis	O
and	O
ulceration	O
when	O
extravasated	O
inadvertently	O
into	O
skin	O
and	O
soft	O
tissues	O
following	O
IV	O
drug	O
administration	O
.	O

INTERVENTIONS	O
:	O
Patients	O
received	O
rt	B
-	I
PA	I
,	O
heparin	O
,	O
and	O
aspirin	O
.	O

Consistent	O
with	O
the	O
in	O
vivo	O
result	O
,	O
the	O
pseudorevertant	O
endonucleases	O
in	O
the	O
crude	O
cell	O
extract	O
display	O
site	O
-	O
specific	O
partial	O
DNA	O
cleavage	O
activity	O
.	O

Sequence	O
analysis	O
reveals	O
that	O
the	O
DNA	O
binding	O
domain	O
of	O
ILF	B
has	O
strong	O
homology	O
to	O
the	O
recently	O
described	O
fork	B
head	I
DNA	I
binding	I
domain	I
found	O
in	O
the	O
Drosophila	B
homeotic	I
protein	I
fork	I
head	I
and	O
a	O
family	O
of	O
hepatocyte	B
nuclear	I
factors	I
,	O
HNF-3	B
.	O

Lengthy	O
and	O
repeated	O
hemodialyses	O
were	O
required	O
to	O
lower	O
lithemia	O
to	O
nontoxic	O
ranges	O
.	O

A	O
single	O
i.p	O
.	O

injection	O
of	O
d	O
,	O
l	O
-	O
baclofen	O
10	O
mg	O
/	O
kg	O
both	O
reduced	O
noradrenaline	O
(	O
NA	O
)	O
biosynthesis	O
in	O
vivo	O
(	O
31	O
%	O
)	O
and	O
the	O
endogenous	O
concentration	O
of	O
normetanephrine	O
(	O
NMN	O
)	O
(	O
32	O
%	O
)	O
and	O
increased	O
NA	O
levels	O
(	O
28	O
%	O
)	O
.	O

Fufang	O
wuzi	O
yanzong	O
pills	O
have	O
strong	O
leukogenic	O
effect	O
on	O
cyclophosphamide	O
induced	O
leukopenia	O
in	O
mice	O
.	O

Mutations	O
in	O
the	O
small	O
subunit	O
of	O
ribulosebisphosphate	B
carboxylase	I
affect	O
subunit	O
binding	O
and	O
catalysis	O
.	O

These	O
results	O
suggest	O
that	O
NZ-107	O
may	O
be	O
a	O
useful	O
drug	O
for	O
the	O
treatment	O
of	O
bronchial	O
asthma	O
by	O
reducing	O
late	O
-	O
phase	O
airway	O
responses	O
and	O
airway	O
hyperreactivity	O
.	O

In	O
study	O
2	O
,	O
the	O
correlation	O
coefficients	O
between	O
the	O
ISO2	O
measurements	O
obtained	O
at	O
the	O
ulcer	O
margin	O
and	O
at	O
the	O
adjacent	O
normal	O
mucosa	O
,	O
and	O
delta	O
ISO2	O
obtained	O
by	O
the	O
experienced	O
observer	O
and	O
one	O
of	O
the	O
three	O
learners	O
were	O
0.94	O
,	O
0.97	O
,	O
and	O
0.94	O
,	O
respectively	O
.	O

Anti	B
-	I
HBc	I
production	O
of	O
PBMC	O
was	O
enhanced	O
remarkably	O
in	O
this	O
case	O
.	O

Sequence	O
analysis	O
of	O
the	O
sMtCK	B
genomic	I
upstream	I
sequences	I
reveals	O
a	O
typical	O
TATAA	O
box	O
within	O
the	O
80	O
base	O
pairs	O
(	O
bp	O
)	O
that	O
,	O
by	O
transfection	O
experiments	O
,	O
are	O
sufficient	O
to	O
promote	O
expression	O
of	O
chimeric	O
plasmids	O
with	O
the	O
chloramphenicol	B
acetyltransferase	I
reporter	I
.	O

The	O
cDNA	O
segment	O
is	O
flanked	O
by	O
the	O
immunoglobulin	B
gene	I
recombination	I
signal	I
sequences	I
so	O
that	O
the	O
cDNA	O
segment	O
can	O
invert	O
and	O
the	O
human	B
IL-2R	I
L	I
chain	I
is	O
subsequently	O
expressed	O
under	O
the	O
control	O
of	O
the	O
SV40	B
promoter	I
.	O

Deletion	O
of	O
the	O
proximal	O
octanucleotide	O
motif	O
from	O
the	O
plasmid	O
containing	O
the	O
-461	O
fragment	O
of	O
the	O
LPL	B
promoter	I
,	O
resulted	O
in	O
a	O
79	O
and	O
76	O
%	O
decrease	O
in	O
the	O
level	O
of	O
expression	O
in	O
transfected	O
3T3-L1	O
adipocytes	O
and	O
HepG2	O
hepatocytes	O
,	O
respectively	O
.	O

Ventilatory	O
management	O
casebook	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
in	O
addition	O
to	O
the	O
non	O
-	O
spliced	O
variant	O
,	O
multiple	O
mRNA	O
species	O
were	O
generated	O
by	O
alternative	O
splicing	O
resulting	O
in	O
the	O
exclusion	O
of	O
92	O
,	O
166	O
,	O
170	O
,	O
174	O
and	O
263	O
nucleotides	O
(	O
nt	O
)	O
,	O
respectively	O
,	O
from	O
exon	O
1	O
.	O

Position	O
22	O
is	O
an	O
isoleucine	O
in	O
the	O
complete	B
SsoL12	I
protein	I
sequence	I
,	O
coded	O
by	O
an	O
AUA	O
codon	O
.	O

In	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
,	O
copper	O
levels	O
exert	O
some	O
control	O
over	O
the	O
level	O
of	O
SOD1	B
expression	O
.	O

Of	O
these	O
179	O
samples	O
,	O
Mobiluncus	O
SP	O
was	O
observed	O
in	O
35	O
(	O
19.6	O
%	O
)	O
using	O
Gram	O
staining	O
and	O
in	O
18	O
(	O
10.1	O
%	O
)	O
this	O
microorganism	O
was	O
isolated	O
in	O
agar	O
RLK	O
and	O
anaerobic	O
atmosphere	O
.	O

Since	O
the	O
morphology	O
of	O
the	O
lesions	O
can	O
mimic	O
that	O
of	O
other	O
cutaneous	O
disorders	O
,	O
Bowen	O
's	O
disease	O
is	O
often	O
not	O
recognized	O
initially	O
.	O

To	O
lower	O
the	O
current	O
high	O
incidence	O
of	O
NANB	O
-	O
induced	O
PTH	O
,	O
in	O
1986	O
,	O
the	O
American	O
Association	O
of	O
Blood	O
Banks	O
(	O
AABB	O
)	O
recommended	O
testing	O
for	O
these	O
PTH	O
-	O
associated	O
""""	O
surrogate	O
""""	O
markers	O
on	O
all	O
donated	O
units	O
of	O
blood	O
.	O

Insulin	B
-	I
like	I
growth	I
factor	I
1	I
(	O
IGF-1	B
)	O
in	O
burn	O
patients	O
.	O

Fusion	O
of	O
ubiquitin	B
to	O
pADPRP	B
increased	O
the	O
yield	O
of	O
pADPRP	B
approximately	O
10-fold	O
compared	O
to	O
that	O
of	O
the	O
unfused	O
enzyme	O
.	O

In	O
group	O
III	O
,	O
patients	O
also	O
received	O
their	O
own	O
mediastinal	O
drainage	O
blood	O
,	O
shed	O
for	O
6	O
hours	O
after	O
operation	O
,	O
after	O
concentration	O
and	O
washing	O
in	O
a	O
MBRS	O
.	O

The	O
suppression	O
was	O
also	O
demonstrated	O
in	O
a	O
transient	O
expression	O
assay	O
in	O
vivo	O
using	O
isolated	O
barley	O
endosperms	O
.	O

The	O
examinations	O
were	O
performed	O
on	O
two	O
groups	O
of	O
20	O
(	O
using	O
AmF	O
/	O
SnF2	O
)	O
-	O
,	O
resp	O
.	O

RNA	O
gel	O
retardation	O
and	O
competition	O
analyses	O
indicate	O
that	O
TRP-185	B
binding	O
is	O
strongly	O
dependent	O
on	O
the	O
TAR	O
RNA	O
loop	O
sequences	O
.	O

The	O
vaccine	O
used	O
was	O
known	O
to	O
be	O
immunogenic	O
for	O
older	O
children	O
and	O
adults	O
.	O

Both	O
groups	O
then	O
underwent	O
hypnotic	O
induction	O
,	O
and	O
completed	O
the	O
test	O
again	O
(	O
R2	O
)	O
.	O

Applications	O
of	O
three	O
-	O
dimensional	O
analysis	O
to	O
the	O
auditory	O
P300	O
.	O

The	O
construct	O
was	O
introduced	O
into	O
BW2001	O
(	O
xth-11	O
,	O
nfo-2	O
)	O
strain	O
cells	O
of	O
Escherichia	O
coli	O
.	O

Recombinant	B
human	I
TFIID	I
supported	O
weak	O
basal	O
transcription	O
in	O
heat	O
-	O
treated	O
nuclear	O
extracts	O
whereas	O
a	O
partially	O
purified	O
TFIID	B
fraction	O
from	O
HeLa	O
cells	O
reconstituted	O
a	O
maximal	O
level	O
of	O
transcription	O
.	O

Only	O
after	O
a	O
pretreatment	O
aimed	O
at	O
increasing	O
its	O
oxide	O
surface	O
layer	O
was	O
titanium	O
powder	O
found	O
to	O
accelerate	O
the	O
precipitation	O
from	O
solutions	O
containing	O
2	O
mmol	O
/	O
L	O
CaCl2	O
,	O
2	O
mmol	O
/	O
L	O
KH2PO4	O
,	O
50	O
mmol	O
/	O
L	O
Hepes	O
,	O
pH	O
7.2	O
,	O
and	O
to	O
induce	O
precipitation	O
from	O
metastable	O
solutions	O
containing	O
1.2	O
mmol	O
/	O
L	O
CaCl2	O
,	O
1.2	O
mmol	O
/	O
L	O
KH2PO4	O
,	O
50	O
mmol	O
/	O
L	O
Hepes	O
,	O
pH	O
7.2	O
,	O
at	O
37	O
degrees	O
C.	O

Neither	O
model	O
,	O
as	O
applied	O
,	O
provided	O
a	O
satisfactory	O
account	O
of	O
the	O
effects	O
of	O
the	O
main	O
variables	O
of	O
number	O
of	O
tones	O
and	O
amount	O
of	O
perturbation.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

(	O
2	O
)	O
Diffusion	O
limitation	O
in	O
the	O
heterogeneous	O
model	O
sets	O
in	O
at	O
a	O
lower	O
O2	O
requirement	O
value	O
,	O
and	O
increases	O
more	O
gradually	O
with	O
increasing	O
O2	O
requirement	O
,	O
than	O
in	O
the	O
corresponding	O
homogeneous	O
models	O
with	O
the	O
same	O
average	O
cylinder	O
diameter	O
.	O

At	O
the	O
time	O
of	O
the	O
seizure	O
,	O
the	O
patient	O
was	O
asked	O
to	O
read	O
a	O
test	O
phrase	O
aloud	O
until	O
it	O
was	O
read	O
correctly	O
and	O
clearly	O
.	O

Echinococcus	O
granulosus	O
was	O
diagnosed	O
by	O
fine	O
-	O
needle	O
aspiration	O
cytology	O
of	O
a	O
lung	O
cyst	O
in	O
a	O
6-yr	O
-	O
old	O
white	O
female	O
in	O
central	O
Missouri	O
.	O

The	O
sequence	O
was	O
determined	O
of	O
6493	O
nucleotides	O
encompassing	O
the	O
bet	B
genes	I
of	I
Escherichia	I
coli	I
which	O
encode	O
the	O
osmoregulatory	O
choline	O
-	O
glycine	O
betaine	O
pathway	O
.	O

Confocal	O
fluorescence	O
microscopy	O
in	O
modern	O
cell	O
biology	O
.	O

Fortunately	O
DDT-	O
,	O
HCH-	O
and	O
HCB	O
-	O
levels	O
decreased	O
in	O
breast	O
milk	O
during	O
the	O
last	O
years	O
.	O

A	O
herpesvirus	O
proteinase	O
activity	O
has	O
been	O
identified	O
and	O
partially	O
characterized	O
by	O
using	O
the	O
cloned	O
enzyme	O
and	O
substrate	O
genes	O
in	O
transient	O
transfection	O
assays	O
.	O

Adult	O
H	O
,	O
but	O
not	O
R	O
,	O
manifested	O
the	O
burrowing	O
preference	O
whenever	O
offered	O
the	O
opportunity	O
.	O

The	O
rear	O
silver	O
liquid	O
chamber	O
was	O
threefold	O
thick	O
to	O
17	O
MeV	O
protons	O
in	O
water	O
and	O
it	O
efficiently	O
produced	O
either	O
13N	O
by	O
the	O
16O	O
(	O
p	O
,	O
alpha	O
)	O
13N	O
reaction	O
or	O
[	O
18F	O
]	O
fluoride	O
ion	O
by	O
the	O
18O	O
(	O
p	O
,	O
n	O
)	O
18F	O
reaction	O
.	O

Heterogeneous	O
electron	O
transfer	O
of	O
cytochrome	B
c	I
facilitated	O
by	O
polypyrrole	O
and	O
methylene	O
blue	O
polypyrrole	O
film	O
modified	O
electrodes	O
.	O

Selective	O
activation	O
of	O
adrenaline	O
secretion	O
by	O
the	O
rat	O
adrenal	O
in	O
neuroglycopenia	O
detected	O
via	O
microdialysis	O

Urine	O
specimens	O
containing	O
either	O
phencyclidine	O
(	O
PCP	O
)	O
or	O
11-nor	O
-	O
delta	O
9-tetrahydrocannabinol-9-carboxylic	O
acid	O
(	O
9-THC	O
-	O
COOH	O
)	O
were	O
adulterated	O
with	O
sodium	O
chloride	O
,	O
bleach	O
,	O
vinegar	O
,	O
potassium	O
hydroxide	O
,	O
liquid	O
soap	O
,	O
2-propanol	O
,	O
and	O
ammonia	O
.	O

Four	O
putative	O
positive	O
cDNA	O
clones	O
were	O
isolated	O
,	O
and	O
the	O
largest	O
insert	O
(	O
pASB-1	B
)	O
was	O
sequenced	O
in	O
both	O
orientations	O
.	O

Sci	O
.	O

Dose	O
standardisation	O
of	O
botulinum	B
toxin	I
.	O

We	O
conclude	O
that	O
the	O
beta	O
-	O
adrenergic	O
agonist	O
,	O
isoproterenol	O
,	O
has	O
little	O
influence	O
on	O
vascular	O
capacitance	O
or	O
liver	O
volume	O
of	O
dogs	O
,	O
unless	O
the	O
hepatic	O
outflow	O
resistance	O
is	O
elevated	O
by	O
agents	O
such	O
as	O
histamine	O
.	O

DNA	O
sequence	O
and	O
evolution	O
of	O
the	O
CPS	B
domain	I
of	O
the	O
Syrian	B
hamster	I
multifunctional	I
protein	I
CAD	I
.	O

A	O
high	O
-	O
frequency	O
restriction	O
fragment	O
length	O
polymorphism	O
was	O
evident	O
in	O
the	O
DNA	O
from	O
29	O
unrelated	O
individuals	O
using	O
the	O
enzyme	O
BglII	B
.	O

The	O
antilog	O
transformation	O
of	O
pH	O
did	O
not	O
improve	O
the	O
results	O
.	O

Telomeres	O
prevent	O
end	O
-	O
to	O
-	O
end	O
fusions	O
and	O
exonucleolytic	O
degradation	O
,	O
enable	O
the	O
end	O
of	O
the	O
linear	O
DNA	O
molecule	O
to	O
replicate	O
,	O
and	O
function	O
in	O
cell	O
division	O
.	O

One	O
of	O
these	O
is	O
located	O
in	O
the	O
5'-untranslated	O
region	O
,	O
and	O
may	O
encode	O
regulatory	O
sequences	O
.	O

The	O
native	O
enzyme	O
purified	O
from	O
protease	B
-	I
B	I
-	O
deficient	O
URA2-transformed	B
cells	O
,	O
was	O
phosphorylated	O
in	O
vitro	O
using	O
catalytic	O
subunits	O
of	O
pure	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
.	O

This	O
study	O
suggests	O
that	O
BSPMs	O
are	O
useful	O
in	O
the	O
assessment	O
of	O
AMI	O
in	O
terms	O
of	O
diagnosis	O
,	O
location	O
and	O
extent	O
of	O
myocardial	O
infarct	O
.	O

A	O
bovine	O
abomasum	O
lambda	O
gt11	O
cDNA	O
library	O
was	O
screened	O
with	O
a	O
monoclonal	O
antibody	O
raised	O
against	O
the	O
rabbit	B
H	I
,	I
K	I
-	I
ATPase	I
beta	I
subunit	I
.	O

Characterization	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
growth	O
-	O
regulated	O
Syrian	B
hamster	I
CAD	I
gene	I
.	O

Examination	O
of	O
immediate	B
-	I
early	I
transcription	I
factor	I
expression	O
during	O
the	O
MDI	O
regimen	O
revealed	O
that	O
RA	O
mediated	O
an	O
elevated	O
,	O
prolonged	O
expression	O
of	O
c	B
-	I
Jun	I
mRNA	I
accompanied	O
by	O
diminished	O
expression	O
of	O
c	B
-	I
Fos	I
and	O
Jun	B
-	I
B	I
mRNAs	I
.	O

Although	O
heart	O
rate	O
and	O
diastolic	O
pressure	O
rose	O
in	O
some	O
degree	O
1	O
min	O
after	O
intubation	O
,	O
free	O
and	O
total	O
CA	O
concentrations	O
did	O
not	O
increase	O
during	O
study	O
period	O
.	O

Processing	O
,	O
secretion	O
,	O
and	O
immunoreactivity	O
of	O
carboxy	B
terminally	I
truncated	I
dengue-2	I
virus	I
envelope	I
proteins	I
expressed	O
in	O
insect	O
cells	O
by	O
recombinant	O
baculoviruses	O
.	O

Combined	O
therapy	O
with	O
MK-801	O
and	O
nimodipine	O
for	O
protection	O
of	O
ischemic	O
brain	O
damage	O
.	O

Initial	O
screening	O
of	O
a	O
rat	O
liver	O
cDNA	O
library	O
with	O
an	O
oligonucleotide	O
probe	O
derived	O
from	O
the	O
rat	O
SCP2	B
protein	O
sequence	O
revealed	O
an	O
825-base	O
pair	O
cDNA	O
clone	O
coding	O
for	O
the	O
complete	O
SCP2	B
protein	O
sequence	O
.	O

The	O
addition	O
of	O
an	O
equimolar	O
complex	O
of	O
the	O
fourth	O
and	O
seventh	O
largest	O
subunits	O
,	O
purified	O
from	O
pol	B
II	I
holoenzyme	I
by	O
ion	O
-	O
exchange	O
chromatography	O
in	O
the	O
presence	O
of	O
urea	O
,	O
restored	O
promoter	O
-	O
directed	O
initiation	O
activity	O
to	O
pol	B
II	I
delta	I
4	I
/	I
7	I
.	O

We	O
report	O
here	O
the	O
identification	O
of	O
HSF	B
in	O
the	O
fission	O
yeast	O
Schizosaccharomyces	O
pombe	O
.	O

Induction	O
requires	O
the	O
ACE1	B
gene	I
product	I
,	O
which	O
binds	O
to	O
specific	O
sites	O
in	O
the	O
promoter	O
region	O
of	O
the	O
CUP1	B
gene	I
.	O

Gel	O
mobility	O
shift	O
assays	O
using	O
a	O
synthetic	O
E6	B
motif	I
detected	O
a	O
B	O
-	O
cell	O
-	O
specific	O
complex	O
in	O
addition	O
to	O
a	O
ubiquitous	O
band	O
found	O
also	O
in	O
T	O
cells	O
and	O
HeLa	O
cells	O
.	O

Seven	O
clones	O
encoding	O
interferon	B
response	I
element	I
binding	I
factors	I
have	O
been	O
isolated	O
from	O
a	O
mouse	O
fibroblast	O
lambda	O
gt11	O
cDNA	O
library	O
by	O
using	O
a	O
32P	O
end	O
-	O
labeled	O
tandem	O
trimer	O
of	O
the	O
mouse	B
(	I
2'-5'	I
)	I
oligoadenylate	I
synthetase	I
gene	I
interferon	O
response	O
element	O
as	O
a	O
probe	O
.	O

Adenylosuccinate	B
synthetase	I
(	O
IMP	O
:	O
L	B
-	I
aspartate	I
ligase	I
(	O
GDP	O
)	O
,	O
EC	B
6.3.4.4	I
)	O
plays	O
an	O
important	O
role	O
in	O
purine	O
biosynthesis	O
catalyzing	O
the	O
GTP	O
-	O
dependent	O
conversion	O
of	O
IMP	O
to	O
AMP	O
.	O

Immunophenotyping	O
in	O
four	O
cases	O
,	O
demonstrated	O
non	O
-	O
B	O
,	O
non	O
-	O
T	O
cell	O
origin	O
in	O
three	O
and	O
pre	O
-	O
B	O
cell	O
origin	O
in	O
one	O
.	O

DNA	O
-	O
protein	O
UV	O
cross	O
-	O
linking	O
studies	O
indicated	O
that	O
UHF-1	B
has	O
an	O
electrophoretic	O
mobility	O
on	O
sodium	O
dodecyl	O
sulfate	O
-	O
acrylamide	O
gels	O
of	O
approximately	O
85	O
kDa	O
and	O
suggested	O
that	O
additional	O
proteins	O
,	O
specific	O
to	O
each	O
promoter	O
,	O
bind	O
to	O
each	O
site	O
.	O

The	O
specific	O
interaction	O
between	O
a	O
defined	O
structural	O
element	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
mRNA	O
(	O
RRE	B
,	O
the	O
Rev	B
response	I
element	I
)	O
and	O
the	O
virus	B
-	I
encoded	I
protein	I
Rev	I
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
the	O
export	O
of	O
unspliced	O
or	O
singly	O
spliced	O
mRNA	O
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
.	O

Alanine	B
aminotransferase	I
in	O
clinical	O
practice	O
.	O

DNA	O
from	O
PCR	O
was	O
labeled	O
and	O
used	O
to	O
isolate	O
several	O
lambda	O
gt11	O
cDNA	O
clones	O
,	O
including	O
one	O
full	O
-	O
length	O
one	O
(	O
Dd	B
kinase-2	I
)	O
.	O

Radiation	O
-	O
induced	O
changes	O
in	O
the	O
area	O
of	O
alveoli	O
and	O
septa	O
as	O
well	O
as	O
collagen	B
content	O
were	O
seen	O
11	O
weeks	O
after	O
irradiation	O
.	O

The	O
first	O
follow	O
-	O
up	O
was	O
at	O
a	O
nearly	O
constant	O
interval	O
of	O
5.1	O
years	O
in	O
Caerphilly	O
and	O
3.2	O
years	O
in	O
Speedwell	O
;	O
251	O
major	O
IHD	O
events	O
had	O
occurred	O
.	O

Perilunar	O
luxation	O
--	O
an	O
unusual	O
injury	O
demanding	O
immediate	O
and	O
correct	O
treatment	O

Landsberg	O
(	O
La	O
-	O
O	O
)	O
and	O
cv	O
.	O

Isoform	B
C	I
beta	I
2	I
,	O
an	O
unusual	O
form	O
of	O
the	O
bovine	O
catalytic	O
subunit	O
of	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
.	O

Salient	O
applications	O
of	O
PB	O
-	O
PK	O
modeling	O
to	O
toxicological	O
problems	O
are	O
illustrated	O
with	O
examples	O
.	O

Occupational	O
asthma	O
and	O
rhinoconjunctivitis	O
from	O
inhalation	O
of	O
crystalline	O
bovine	B
serum	I
albumin	I
powder	O
.	O

A	O
further	O
subdivision	O
of	O
Category	O
pN1	O
into	O
pN1a	O
(	O
metastasis	O
in	O
single	O
node	O
)	O
and	O
pN1b	O
(	O
two	O
or	O
more	O
nodes	O
)	O
is	O
recommended	O
.	O

Amino	O
acid	O
sequence	O
comparisons	O
of	O
the	O
E74A	B
protein	I
reveal	O
a	O
highly	O
conserved	O
C	O
-	O
terminal	O
region	O
that	O
is	O
rich	O
in	O
basic	O
amino	O
acid	O
residues	O
and	O
which	O
has	O
been	O
proposed	O
to	O
possess	O
sequence	O
-	O
specific	O
DNA	O
binding	O
activity	O
.	O

Age	O
at	O
POI	O
and	O
asymptote	O
were	O
achieved	O
later	O
for	O
Line	O
RBC2	O
than	O
for	O
Line	O
F.	O

A	O
dose	O
of	O
3	O
and	O
6	O
micrograms	O
/	O
kg	O
/	O
day	O
GM	B
-	I
CSF	I
reduces	O
the	O
severity	O
of	O
neutropenia	O
and	O
thrombocytopenia	O
after	O
carboplatin	O
-	O
cyclophosphamide	O
chemotherapy	O
,	O
which	O
may	O
lead	O
to	O
more	O
effective	O
chemotherapy	O
for	O
ovarian	O
cancer	O
in	O
the	O
future	O
.	O

I	O
propose	O
that	O
their	O
gene	O
products	O
bind	O
to	O
the	O
chromatin	O
to	O
establish	O
or	O
maintain	O
a	O
proper	O
higher	O
order	O
structure	O
as	O
a	O
prerequisite	O
for	O
a	O
regulated	O
gene	O
expression	O
.	O

The	O
C4BP	B
alpha	I
gene	I
is	O
organized	O
as	O
follows	O
:	O
the	O
first	O
exon	O
codes	O
for	O
the	O
first	O
198	O
nucleotides	O
of	O
the	O
5	O
'	O
UTR	O
.	O

The	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV-1	I
)	I
Rev	I
protein	I
is	O
a	O
positive	O
posttranscriptional	O
regulator	O
of	O
viral	O
structural	O
gene	O
expression	O
and	O
essential	O
for	O
virus	O
replication	O
.	O

Once	O
the	O
proliferation	O
of	O
fibroblasts	O
and	O
collagen	B
synthesis	O
had	O
led	O
to	O
an	O
increase	O
of	O
mechanical	O
strength	O
,	O
no	O
negative	O
effect	O
on	O
wound	O
healing	O
could	O
be	O
detected	O
applying	O
the	O
same	O
chemotherapeutic	O
agents	O
.	O

The	O
CDC7	B
gene	I
has	O
two	O
in	O
-	O
frame	O
AUG	O
codons	O
as	O
possible	O
translation	O
start	O
sites	O
,	O
which	O
would	O
produce	O
58-	O
and	O
56-kDa	O
proteins	O
,	O
respectively	O
.	O

During	O
the	O
years	O
1980	O
-	O
87	O
a	O
total	O
of	O
287	O
persons	O
received	O
disability	O
pensions	O
in	O
the	O
municipality	O
of	O
Nordreisa	O
in	O
northern	O
Norway	O
.	O

HeLa	O
and	O
Jurkat	O
cell	O
lines	O
carrying	O
the	O
nef	B
gene	I
linked	O
to	O
the	O
CMV	O
promoter	O
or	O
the	O
HIV-1	B
LTR	I
were	O
isolated	O
by	O
coselection	O
for	O
neomycin	O
resistance	O
.	O

MEASUREMENTS	O
AND	O
MAIN	O
RESULTS	O
:	O
The	O
two	O
groups	O
were	O
similar	O
on	O
entry	O
into	O
the	O
study	O
,	O
including	O
mean	O
FEV1	O
measurements	O
(	O
0.70	O
L	O
atropine	O
/	O
0.60	O
L	O
metaproterenol	O
,	O
P	O
greater	O
than	O
.05	O
)	O
.	O

In	O
view	O
of	O
the	O
short	O
t1	O
/	O
2	O
,	O
we	O
used	O
three	O
doses	O
/	O
day	O
.	O

Temporal	O
control	O
of	O
GUS	B
expression	O
was	O
found	O
to	O
involve	O
two	O
negative	O
regulatory	O
sequences	O
,	O
NRS1	O
(	O
-391	O
to	O
-295	O
)	O
and	O
NRS2	O
(	O
-518	O
to	O
-418	O
)	O
,	O
as	O
well	O
as	O
the	O
positive	O
domain	O
UAS1	O
.	O

In	O
most	O
cases	O
,	O
DR4-homozygous	B
,	O
DRB1-heterozygous	B
individuals	O
could	O
be	O
genotyped	O
with	O
the	O
panel	O
of	O
probes	O
.	O

Two	O
patients	O
had	O
immediate	O
adverse	O
effects	O
from	O
NMF	O
;	O
one	O
had	O
a	O
grand	O
mal	O
seizure	O
and	O
the	O
other	O
developed	O
severe	O
abdominal	O
pain	O
.	O

The	O
muscles	O
from	O
the	O
ischemic	O
group	O
had	O
significantly	O
lower	O
(	O
P	O
less	O
than	O
.05	O
)	O
values	O
for	O
capillary	O
density	O
and	O
capillary	O
to	O
fiber	O
ratio	O
and	O
significantly	O
higher	O
intercapillary	O
distance	O
than	O
those	O
from	O
the	O
normal	O
group	O
.	O

Polymerase	O
chain	O
reaction	O
analysis	O
of	O
ETS1	B
cDNA	I
identified	O
several	O
amplified	O
products	O
,	O
indicating	O
alternative	O
splicing	O
.	O

Most	O
of	O
the	O
expressed	O
human	B
E3	I
polypeptides	I
(	O
five	O
bands	O
)	O
were	O
found	O
in	O
the	O
insoluble	O
pellet	O
while	O
primarily	O
full	B
-	I
length	I
mature	I
E3	I
was	O
found	O
in	O
the	O
soluble	O
fraction	O
.	O

Two	O
homologues	O
of	O
the	O
rhombotin	B
gene	I
have	O
now	O
been	O
isolated	O
.	O

Angina	O
haemorrhagica	O
bullosa	O
causing	O
respiratory	O
obstruction	O
postoperatively	O
.	O

Conclusion	O
:	O
inlet	O
type	O
VSD	O
and	O
perimembranous	O
type	O
TOF	O
have	O
anatomic	O
features	O
in	O
which	O
the	O
proximal	O
His	O
bundle	O
tends	O
to	O
be	O
jeopardized	O
by	O
suturing	O
for	O
VSD	O
closure	O
.	O

The	O
gcd2	B
-	I
503	I
mutation	O
also	O
results	O
in	O
polysome	O
runoff	O
,	O
accumulation	O
of	O
inactive	O
80S	B
ribosomal	I
couples	I
,	O
and	O
accumulation	O
of	O
at	O
least	O
one	O
of	O
the	O
subunits	O
of	O
the	O
general	B
translation	I
initiation	I
factor	I
2	I
(	O
eIF-2	B
alpha	I
)	O
in	O
43S-48S	B
particles	O
following	O
a	O
shift	O
to	O
the	O
restrictive	O
temperature	O
.	O

To	O
measure	O
the	O
enhancer	O
activity	O
of	O
DR60	B
,	O
a	O
reporter	O
plasmid	O
was	O
constructed	O
that	O
contained	O
DR60	B
cloned	O
upstream	O
of	O
the	O
reporter	O
chloramphenicol	B
acetyltransferase	I
gene	I
under	O
the	O
control	O
of	O
the	O
delayed	O
-	O
early	O
39	O
K	O
promoter	O
.	O

A	O
single	O
case	O
of	O
an	O
adenocarcinoma	O
,	O
arising	O
in	O
a	O
retroperitoneal	O
enterogenous	O
cyst	O
and	O
which	O
presented	O
as	O
a	O
left	O
renal	O
cyst	O
,	O
is	O
reported	O
.	O

Using	O
the	O
polymerase	O
chain	O
reaction	O
,	O
we	O
analyzed	O
the	O
U6	B
RNA	I
genes	I
of	O
52	O
organisms	O
.	O

Hydrophobicity	O
analysis	O
indicated	O
that	O
the	O
KlaA	B
and	O
KlaB	B
polypeptides	I
are	O
likely	O
to	O
be	O
soluble	O
,	O
whereas	O
the	O
KlaC	B
polypeptide	I
was	O
predicted	O
to	O
have	O
four	O
potential	O
membrane	O
-	O
spanning	O
domains	O
.	O

The	O
remainder	O
(	O
18.4	O
%	O
)	O
was	O
with	O
IgA	B
nephropathy	O
,	O
which	O
was	O
histologically	O
mild	O
.	O

3	O
.	O

To	O
determine	O
whether	O
mononuclear	O
cell	O
secretory	O
products	O
contribute	O
to	O
the	O
changes	O
in	O
bone	O
turnover	O
that	O
characterize	O
the	O
development	O
of	O
postmenopausal	O
osteoporosis	O
,	O
we	O
evaluated	O
the	O
effects	O
of	O
oophorectomy	O
and	O
subsequent	O
estrogen	O
replacement	O
on	O
the	O
spontaneous	O
secretion	O
of	O
interleukin	B
1	I
(	O
IL-1	B
)	O
and	O
tumor	B
necrosis	I
factor	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
and	O
on	O
the	O
phytohemagglutinin	B
A	I
-	O
induced	O
secretion	O
of	O
granulocyte	B
-	I
macrophage	I
colony	I
-	I
stimulating	I
factor	I
(	O
GM	B
-	I
CSF	I
)	O
from	O
peripheral	O
blood	O
mononuclear	O
cells	O
.	O

The	O
standard	O
principles	O
of	O
surgical	O
management	O
must	O
be	O
adhered	O
to	O
when	O
using	O
Sandostatin	O
to	O
treat	O
patients	O
with	O
these	O
disorders	O
.	O

The	O
sequence	O
of	O
the	O
pMxL1	O
plasmid	O
containing	O
the	O
invertible	O
region	O
contains	O
a	O
perfect	O
tandem	O
repeat	O
of	O
19	O
bp	O
in	O
the	O
orientation	O
1	O
nonexpressed	O
pilin	B
gene	I
at	O
the	O
middle	O
of	O
the	O
recombination	O
junction	O
site	O
.	O

No	O
evidence	O
for	O
the	O
presence	O
of	O
introns	O
within	O
the	O
acvA	B
gene	I
has	O
been	O
found	O
.	O

When	O
given	O
the	O
choice	O
between	O
an	O
estrous	O
female	O
and	O
a	O
sexually	O
active	O
male	O
in	O
the	O
AOF	O
,	O
flutamide	O
females	O
,	O
as	O
well	O
as	O
controls	O
,	O
preferred	O
the	O
male	O
partner	O
.	O

Hypoxic	O
ventilatory	O
responses	O
were	O
-1.99	O
+	O
/-	O

0.37	O
L	O
/	O
min	O
/	O
%	O
SaO2	O
in	O
the	O
relatives	O
and	O
-1.54	O
+	O
/-	O

0.25	O
L	O
/	O
min	O
/	O
%	O
SaO2	O
in	O
the	O
control	O
subjects.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

This	O
computerized	O
list	O
was	O
linked	O
to	O
the	O
central	O
files	O
of	O
the	O
Massachusetts	O
Cancer	O
Registry	O
and	O
cases	O
diagnosed	O
between	O
1982	O
and	O
1988	O
were	O
identified	O
.	O

We	O
also	O
present	O
evidence	O
for	O
a	O
negative	O
regulatory	O
element	O
in	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
Mlu	B
I	I
upstream	I
activation	I
sequence	I
.	O

A	O
method	O
for	O
establishing	O
stimulus	O
control	O
of	O
ethanol	O
responding	O
was	O
developed	O
.	O

Endothelial	O
cell	O
seeding	O
.	O

After	O
hemodynamic	O
stabilization	O
,	O
the	O
goal	O
of	O
therapy	O
is	O
to	O
diminish	O
the	O
chance	O
that	O
an	O
ulcer	O
will	O
continue	O
to	O
bleed	O
or	O
will	O
rebleed	O
.	O

The	O
stimulus	O
threshold	O
for	O
EER	O
showed	O
a	O
less	O
individual	O
variation	O
than	O
amplitude	O
.	O

Analysis	O
of	O
electrically	O
evoked	O
response	O
(	O
EER	O
)	O
in	O
relation	O
to	O
the	O
central	O
visual	O
pathway	O
of	O
the	O
cat	O
(	O
1	O
)	O
.	O

Furthermore	O
,	O
plasma	O
fibrinogen	B
levels	O
increased	O
by	O
a	O
mean	O
of	O
17.6	O
%	O
,	O
a	O
potentially	O
adverse	O
effect	O
of	O
gemfibrozil	O
that	O
has	O
not	O
been	O
previously	O
reported	O
.	O

Gemfibrozil	O
in	O
hyperlipidaemic	O
patients	O
with	O
peripheral	O
arterial	O
disease	O
:	O
some	O
undiscovered	O
actions	O
.	O

The	O
role	O
of	O
pharmacological	O
profiling	O
in	O
safety	O
assessment	O
.	O

In	O
all	O
cases	O
,	O
high	O
-	O
level	O
expression	O
of	O
the	O
truncated	B
avian	I
integrins	I
was	O
obtained	O
.	O

The	O
authors	O
evaluate	O
the	O
clinical	O
efficacy	O
of	O
EMB	O
AZS	O
in	O
recurrent	O
ulcer	O
after	O
operation	O
on	O
the	O
stomach	O
caused	O
by	O
a	O
high	O
level	O
of	O
acid	O
production	O
and	O
ulcerative	O
gastroduodenal	O
bleeding	O
.	O

In	O
adulthood	O
these	O
rats	O
were	O
hyperactive	O
and	O
learned	O
the	O
active	O
avoidance	O
response	O
later	O
than	O
the	O
controls	O
.	O

Phosphopeptide	O
mapping	O
revealed	O
the	O
same	O
autophosphorylation	O
sites	O
utilized	O
by	O
EGFR	B
-	I
IC	I
as	O
those	O
identified	O
in	O
wild	B
-	I
type	I
EGFR	I
.	O

The	O
TCF-1	B
alpha	I
binding	I
site	I
was	O
also	O
required	O
for	O
TCR	B
alpha	I
enhancer	I
activity	O
in	O
transcriptionally	O
active	O
extracts	O
from	O
Jurkat	O
but	O
not	O
HeLa	O
cells	O
,	O
confirming	O
that	O
TCF-1	B
alpha	I
is	O
a	O
T	B
-	I
cell	I
-	I
specific	I
transcription	I
factor	I
.	O

In	O
this	O
model	O
,	O
eltoprazine	O
has	O
a	O
very	O
specific	O
anti	O
-	O
aggressive	O
(	O
serenic	O
)	O
profile	O
,	O
inhibiting	O
aggression	O
while	O
social	O
interaction	O
and	O
exploration	O
are	O
not	O
decreased	O
but	O
even	O
enhanced	O
;	O
inactivity	O
,	O
a	O
measure	O
for	O
sedation	O
,	O
is	O
not	O
affected	O
.	O

Effect	O
of	O
separate	O
and	O
combined	O
effects	O
of	O
plutonium-239	O
,	O
hexachlorobutadiene	O
and	O
tributyl	O
phosphate	O
on	O
the	O
thymus	O
gland	O
of	O
rats	O

Data	O
collection	O
was	O
made	O
with	O
a	O
query	O
language	O
,	O
and	O
data	O
analysis	O
performed	O
with	O
an	O
interactive	O
knowledge	O
-	O
based	O
statistical	O
tool	O
,	O
MAXITAB	O
,	O
employing	O
a	O
multivariate	O
tabular	O
analysis	O
technique	O
.	O

Diuresis	O
was	O
induced	O
by	O
scheduled	O
drinking	O
of	O
tea	O
(	O
150	O
ml	O
/	O
h	O
)	O
.	O

Diagnostic	O
value	O
of	O
adenosine	B
deaminase	I
activity	O
in	O
tuberculous	O
effusions	O
.	O

Femoral	O
strain	O
adaptation	O
after	O
total	O
hip	O
replacement	O
:	O
a	O
comparison	O
of	O
cemented	O
and	O
porous	O
ingrowth	O
components	O
in	O
canines	O
.	O

Promoter	O
activities	O
were	O
estimated	O
using	O
beta	B
-	I
glucuronidase	I
and	O
neomycin	B
phosphotransferase	I
II	I
reporter	I
gene	I
systems	I
.	O

The	O
5	O
'	O
regions	O
of	O
these	O
two	O
soybean	B
actin	I
genes	I
contain	O
many	O
unusual	O
features	O
including	O
(	O
CT	O
)	O
repeats	O
and	O
long	O
stretches	O
of	O
pyrimidine	O
-	O
rich	O
DNA	O
.	O

No	O
patient	O
had	O
a	O
history	O
of	O
excess	O
alcohol	O
intake	O
,	O
or	O
prolonged	O
intake	O
of	O
hepatotoxic	O
drugs	O
and	O
steroids	O
,	O
and	O
were	O
not	O
obese	O
or	O
malnourished	O
.	O

An	O
evolutionary	O
comparison	O
of	O
amino	O
acid	O
sequences	O
of	O
34	O
HSP70	B
proteins	I
from	O
17	O
species	O
suggests	O
that	O
BiP	B
genes	I
share	O
a	O
common	O
ancestor	O
,	O
which	O
diverged	O
from	O
other	O
HSP70	B
genes	I
near	O
the	O
time	O
when	O
eukaryotes	O
first	O
appeared	O
.	O

Spore	O
inocula	O
(	O
approximately	O
10	O
(	O
6	O
)	O
/	O
coupon	O
)	O
were	O
dried	O
onto	O
0.5-in	O
.	O

Reverse	O
transcription	O
-	O
PCR	O
was	O
then	O
used	O
to	O
clone	O
from	O
human	O
poly	O
(	O
A	O
)	O
+	O
RNA	O
the	O
cDNA	O
corresponding	O
to	O
the	O
expressed	O
homolog	O
of	O
psi	B
ARF	I
4	I
,	O
referred	O
to	O
as	O
human	B
ARF	I
4	I
.	O

To	O
evaluate	O
the	O
cost	O
and	O
benefits	O
of	O
screening	O
tests	O
for	O
Chlamydia	O
trachomatis	O
in	O
adolescent	O
males	O
,	O
we	O
developed	O
a	O
decision	O
analysis	O
model	O
and	O
compared	O
the	O
leukocyte	B
esterase	I
urine	O
dipstick	O
test	O
with	O
culture	O
,	O
with	O
direct	O
-	O
smear	O
fluorescent	O
antibody	O
(	O
DFA	O
)	O
,	O
and	O
with	O
the	O
option	O
of	O
no	O
screening	O
(	O
no	O
treatment	O
)	O
.	O

The	O
N	O
-	O
terminal	O
115	O
amino	O
acids	O
correspond	O
to	O
a	O
putative	O
DNA	O
-	O
binding	O
domain	O
and	O
show	O
significant	O
sequence	O
similarity	O
with	O
other	O
cloned	O
IFN	B
response	I
factors	I
(	O
IRF-1	B
and	O
IRF-2	B
)	O
.	O

Maternal	O
seizures	O
had	O
occurred	O
during	O
pregnancy	O
in	O
52	O
per	O
cent	O
.	O

Krox-24	B
is	O
therefore	O
a	O
sequence	O
-	O
specific	O
transcriptional	O
activator	O
.	O

The	O
interindividual	O
variability	O
of	O
the	O
parameters	O
is	O
taken	O
into	O
consideration	O
by	O
interactively	O
determining	O
the	O
threshold	O
levels	O
.	O

Our	O
results	O
suggest	O
that	O
a	O
sequence	O
match	O
between	O
enhancers	O
and	O
certain	O
promoter	O
elements	O
is	O
critical	O
.	O

This	O
Mr	O
is	O
similar	O
to	O
those	O
of	O
the	O
purified	B
smg	I
p25A	I
GDI	I
estimated	O
by	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
sucrose	O
density	O
gradient	O
ultracentrifugation	O
,	O
which	O
are	O
about	O
54,000	O
and	O
65,000	O
,	O
respectively	O
.	O

Critical	O
residues	O
required	O
for	O
repression	O
are	O
located	O
within	O
the	O
C	O
-	O
terminal	O
27	O
amino	O
acids	O
of	O
c	B
-	I
Fos	I
,	O
since	O
v	B
-	I
Fos	I
and	O
C	O
-	O
terminal	O
truncations	O
of	O
c	B
-	I
Fos	I
did	O
not	O
down	O
regulate	O
.	O

In	O
this	O
paper	O
,	O
we	O
have	O
analyzed	O
the	O
structure	O
of	O
human	O
gene	O
for	O
Gx	B
alpha	I
,	O
which	O
spans	O
more	O
than	O
60	O
kilobases	O
.	O

Uses	O
of	O
orthoclone	O
OKT3	B
for	O
prophylaxis	O
of	O
rejection	O
and	O
induction	O
in	O
initial	O
nonfunction	O
in	O
kidney	O
transplantation	O
.	O

Uses	O
of	O
orthoclone	O
OKT3	O
for	O
prophylaxis	O
of	O
rejection	O
and	O
induction	O
in	O
initial	O
nonfunction	O
in	O
kidney	O
transplantation	O
.	O

Furthermore	O
,	O
we	O
notice	O
two	O
potential	O
consensus	O
motifs	O
which	O
are	O
also	O
found	O
in	O
corresponding	O
positions	O
in	O
the	O
genes	O
for	O
the	O
nerve	B
growth	I
factor	I
receptor	I
and	O
the	O
68-kDa	B
neurofilament	I
protein	I
.	O

In	O
addition	O
,	O
the	O
-119	O
to	O
-81	O
fragment	O
of	O
the	O
CCK	B
promoter	I
contains	O
a	O
transcriptional	O
enhancer	O
that	O
potentiates	O
the	O
transcription	O
from	O
the	O
herpes	O
simplex	O
virus	O
thymidine	B
kinase	I
promoter	I
in	O
a	O
position-	O
and	O
orientation	O
-	O
independent	O
manner	O
.	O

Five	O
of	O
10	O
scars	O
studied	O
decreased	O
at	O
least	O
50	O
%	O
in	O
linear	O
dimensions	O
.	O

Managing	O
dysphagia	O
in	O
a	O
chronic	O
care	O
setting	O
:	O
an	O
introduction	O
.	O

Gel	O
-	O
mobility	O
-	O
shift	O
assays	O
confirmed	O
that	O
the	O
Raji	O
nuclear	O
proteins	O
that	O
bound	O
to	O
W	O
and	O
V	O
elements	O
were	O
competed	O
with	O
by	O
an	O
HLA	B
-	I
DRA	I
X	I
-	I
box	I
oligonucleotide	I
.	O

The	O
NF1	B
locus	I
encodes	O
a	O
protein	O
functionally	O
related	O
to	O
mammalian	B
GAP	I
and	O
yeast	B
IRA	I
proteins	I
.	O

Hence	O
,	O
the	O
replacement	O
of	O
Phe-62	O
with	O
Ser	O
specifically	O
affects	O
a	O
determinant	O
on	O
the	O
lambda	B
I	I
light	I
chain	I
that	O
is	O
necessary	O
for	O
the	O
intracellular	O
transport	O
of	O
this	O
molecule	O
.	O

Disruption	O
of	O
ARF2	B
causes	O
no	O
detectable	O
phenotype	O
.	O

Human	O
recombinant	O
DNA	O
-	O
derived	O
antihemophilic	B
factor	I
(	O
factor	B
VIII	I
)	O
in	O
the	O
treatment	O
of	O
hemophilia	O
A.	O
recombinant	O
Factor	B
VIII	I
Study	O
Group	O
.	O

Furthermore	O
,	O
expression	O
of	O
the	O
promoter	O
in	O
embryonic	O
Drosophila	O
melanogaster	O
cells	O
that	O
lack	O
MyoD1	B
and	O
Sp1	B
is	O
strictly	O
dependent	O
on	O
all	O
three	O
sites	O
remaining	O
intact	O
and	O
on	O
the	O
presence	O
of	O
exogenously	O
supplied	O
Sp1	B
and	O
MyoD1	B
.	O

To	O
identify	O
structural	O
features	O
of	O
residues	O
flanking	O
the	O
c	O
-	O
region	O
that	O
influence	O
the	O
fidelity	O
and	O
efficiency	O
of	O
signal	O
peptidase	O
cleavage	O
as	O
well	O
as	O
co	O
-	O
translational	O
translocation	O
,	O
we	O
introduced	O
six	O
amino	O
acid	O
substitutions	O
into	O
the	O
COOH	O
terminus	O
of	O
the	O
hydrophobic	O
core	O
and	O
seven	O
substitutions	O
at	O
the	O
NH2	O
terminus	O
of	O
the	O
mature	O
region	O
(	O
the	O
+	O
1	O
position	O
)	O
of	O
a	O
model	O
eukaryotic	B
preprotein	I
-	I
human	I
pre	I
(	I
delta	I
pro	I
)	I
apoA	I
-	I
II	I
.	O

Of	O
848	O
patients	O
,	O
819	O
cases	O
with	O
complete	O
description	O
of	O
patient	O
's	O
background	O
were	O
evaluable	O
:	O
Group	O
A	O
(	O
surgery	O
+	O
MMC	O
+	O
5-FU	O
:	O
chemotherapy	O
)	O
253	O
cases	O
,	O
group	O
B	O
(	O
surgery	O
+	O
MMC	O
+	O
5-FU	O
+	O
OK-432	O
or	O
PSK	O
:	O
immunochemotherapy	O
)	O
282	O
and	O
group	O
C	O
(	O
surgery	O
alone	O
)	O
284	O
.	O

This	O
model	O
is	O
further	O
supported	O
by	O
binding	O
of	O
the	O
Fos	B
-	O
Jun	B
complex	O
at	O
an	O
AP-1	B
site	I
in	O
the	O
type	B
alpha	I
I	I
collagen	I
promoter	I
that	O
is	O
contiguous	O
with	O
,	O
but	O
not	O
overlapping	O
,	O
the	O
VDRE	O
.	O

In	O
the	O
controls	O
,	O
it	O
was	O
found	O
that	O
all	O
right	O
-	O
handed	O
and	O
10	O
out	O
of	O
14	O
left	O
-	O
handed	O
control	O
subjects	O
showed	O
a	O
right	O
VHF	O
(	O
i.e.	O
,	O
left	O
hemisphere	O
)	O
advantage	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
has	O
the	O
greatest	O
homology	O
(	O
61	O
%	O
)	O
to	O
the	O
green	B
alga	I
Scenedemus	I
obliquus	I
plastocyanin	I
.	O

Higher	O
fasting	O
serum	O
gastrin	B
concentration	O
(	O
102.0	O
+	O
/-	O

21.1	O
vs	O
63.3	O
+	O
/-	O

8.3	O
ng.l-1	O
)	O
,	O
and	O
greater	O
postprandial	O
gastrin	B
release	O
(	O
AUC0	O
-	O
120	O
:	O
16690	O
+	O
/-	O
2648	O
vs	O
10654	O
+	O
/-	O

1283	O
ng.l-1	O
min	O
)	O
were	O
observed	O
after	O
VTP	O
-	O
HM	O
than	O
after	O
VTP	O
-	O
Cas	O
.	O

The	O
experimental	O
group	O
consisted	O
of	O
61	O
examinees	O
class	O
II	O
/	O
2	O
orthodontic	O
anomalies	O
.	O

In	O
this	O
article	O
we	O
propose	O
to	O
find	O
out	O
the	O
percentage	O
of	O
normal	O
occlusion	O
and	O
the	O
distribution	O
of	O
maloclusions	O
,	O
according	O
to	O
the	O
anteroposterior	O
relationship	O
between	O
the	O
dental	O
archs	O
(	O
following	O
the	O
ANGLE3	O
classification	O
)	O
.	O

In	O
that	O
case	O
,	O
the	O
ratio	O
of	O
brush	O
abrasion	O
was	O
0.268	O
,	O
compressive	O
and	O
transverse	O
strength	O
,	O
124.3	O
and	O
86.3	O
MPa	O
respectively	O
,	O
hardness	O
,	O
43.2	O
Hk	O
,	O
water	O
absorption	O
14.2	O
micrograms	O
/	O
mm3	O
and	O
thermal	O
expansion	O
coefficient	O
,	O
47.4	O
x	O
10	O
(	O
-6	O
)	O
/	O
degrees	O
C.	O

9	O
,	O
1498	O
-	O
1506	O
)	O
.	O

We	O
have	O
previously	O
identified	O
,	O
by	O
screening	O
a	O
lambda	O
gt11	O
expression	O
library	O
,	O
murine	B
protein	I
mXBP	I
,	O
which	O
binds	O
to	O
a	O
sequence	O
which	O
overlaps	O
the	O
3	O
'	O
end	O
of	O
the	O
murine	B
class	I
II	I
major	I
histocompatibility	I
complex	I
A	I
alpha	I
gene	I
X	I
box	I
,	O
a	O
conserved	O
transcription	O
element	O
found	O
upstream	O
of	O
all	O
class	O
II	O
genes	O
.	O

The	O
p36	B
gene	I
is	O
at	O
least	O
22	O
kb	O
in	O
length	O
and	O
has	O
a	O
coding	O
sequence	O
of	O
approximately	O
1	O
kb	O
,	O
representing	O
only	O
4.5	O
%	O
of	O
the	O
gene.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

This	O
multimodality	O
treatment	O
for	O
locally	O
advanced	O
gynecologic	O
tumors	O
appears	O
feasible	O
with	O
modification	O
,	O
and	O
continued	O
work	O
exploring	O
this	O
approach	O
is	O
encouraged	O
.	O

With	O
the	O
modified	O
fingertip	O
-	O
to	O
-	O
floor	O
(	O
MFTF	O
)	O
method	O
,	O
patients	O
stand	O
on	O
a	O
stool	O
and	O
forward	O
bend	O
so	O
that	O
measurements	O
can	O
be	O
taken	O
on	O
patients	O
who	O
are	O
able	O
to	O
touch	O
the	O
floor	O
or	O
reach	O
beyond	O
the	O
level	O
of	O
the	O
floor	O
.	O

Luteinizing	B
hormone	I
-	I
releasing	I
hormone	I
analog	O
therapy	O
of	O
uterine	O
fibroid	O
:	O
analysis	O
of	O
results	O
obtained	O
with	O
buserelin	O
administered	O
intranasally	O
and	O
goserelin	O
administered	O
subcutaneously	O
as	O
a	O
monthly	O
depot	O
.	O

In	O
Experiments	O
1	O
and	O
2	O
,	O
infants	O
,	O
like	O
adults	O
,	O
initially	O
categorized	O
novel	O
objects	O
on	O
the	O
basis	O
of	O
physical	O
appearance	O
,	O
but	O
only	O
if	O
trained	O
with	O
multiple	O
exemplars	O
,	O
after	O
delays	O
of	O
1	O
and	O
7	O
days	O
.	O

The	O
clinical	O
picture	O
of	O
the	O
disease	O
was	O
significantly	O
different	O
from	O
anthropogenic	O
cutaneous	O
leishmaniasis	O
caused	O
by	O
L.	O
tropica	O
but	O
similar	O
to	O
cutaneous	O
patterns	O
caused	O
by	O
L.	O
infantum	O
which	O
was	O
a	O
prevalent	O
pattern	O
in	O
the	O
southern	O
France	O
.	O

Although	O
there	O
are	O
no	O
octamer	O
elements	O
in	O
the	O
adenovirus	O
genome	O
that	O
are	O
known	O
to	O
be	O
important	O
for	O
transcription	O
,	O
there	O
are	O
octamer	O
elements	O
in	O
the	O
viral	O
terminal	O
repeat	O
sequences	O
.	O

In	O
comparison	O
with	O
the	O
16	O
introns	O
reported	O
in	O
AHA3	B
,	O
AHA2	B
is	O
missing	O
one	O
intron	O
in	O
the	O
5'-untranslated	O
region	O
and	O
a	O
second	O
intron	O
in	O
the	O
C	O
-	O
terminal	O
coding	O
region	O
.	O

Impaction	O
of	O
gastrostomy	O
tube	O
in	O
the	O
abdominal	O
wall	O
.	O

Both	O
antidepressants	O
elevated	O
the	O
pain	O
threshold	O
acutely	O
,	O
while	O
pretreatment	O
with	O
pCPA	O
largely	O
blocked	O
the	O
analgesia	O
.	O

Sci	O
.	O

A	O
needs	O
assessment	O
of	O
these	O
families	O
was	O
also	O
done	O
.	O

TCR	B
alpha	I
and	I
beta	I
gene	I
expression	O
may	O
be	O
regulated	O
by	O
a	O
common	O
set	O
of	O
T	B
-	I
cell	I
nuclear	I
proteins	I
in	O
that	O
the	O
T	B
beta	I
2	I
element	I
binding	O
a	O
set	O
of	O
cyclic	B
AMP	I
response	I
element	I
-	I
binding	I
proteins	I
that	O
are	O
also	O
bound	O
by	O
the	O
T	B
alpha	I
1	I
element	I
of	O
the	O
human	O
TCR	B
alpha	I
enhancer	O
and	O
the	O
decamer	O
element	O
present	O
in	O
a	O
large	O
number	O
of	O
human	O
and	O
murine	O
TCR	B
beta	I
promoters	O
.	O

The	O
3	O
'	O
stem	O
-	O
loop	O
is	O
highly	O
divergent	O
in	O
structure	O
among	O
species	O
and	O
lies	O
immediately	O
upstream	O
of	O
the	O
binding	O
site	O
for	O
Sm	B
proteins	I
.	O

These	O
losses	O
account	O
for	O
the	O
resistance	O
of	O
EDS	O
-	O
IV	O
collagen	B
to	O
cyanogen	O
bromide	O
and	O
mammalian	B
collagenase	I
digestion	O
.	O

Two	O
other	O
peptides	O
,	O
either	O
partially	O
or	O
totally	O
lacking	O
the	O
basic	O
region	O
,	O
but	O
containing	O
the	O
intact	O
leucine	O
zipper	O
domain	O
,	O
readily	O
form	O
dimers	O
but	O
do	O
not	O
bind	O
to	O
the	O
CRE	O
.	O

In	O
contrast	O
,	O
the	O
CRE	O
of	O
the	O
human	B
c	I
-	I
fos	I
promoter	I
located	O
at	O
-60	O
was	O
weakly	O
induced	O
by	O
cAMP	O
and	O
E1a	B
in	O
both	O
HeLa	O
and	O
PC12	O
cells	O
.	O

Although	O
popular	O
this	O
hypothesis	O
is	O
far	O
from	O
explaining	O
all	O
the	O
clinical	O
facts	O
,	O
namely	O
that	O
rigidity	O
is	O
equal	O
in	O
extensor	O
and	O
flexor	O
,	O
proximal	O
and	O
distal	O
muscles	O
.	O

The	O
ratio	O
of	O
P-31	O
NMR	O
-	O
S	O
derived	O
inorganic	O
phosphates	O
[	O
Pi	O
]	O
to	O
phosphocreatine	O
[	O
PCr	O
]	O
was	O
significantly	O
greater	O
at	O
rest	O
in	O
LVH	O
baboons	O
[	O
0.53	O
+	O
/-	O

0.06	O
versus	O
controls	O
=	O
0.41	O
+	O
/-	O

0.17	O
;	O
P	O
less	O
than	O
0.05	O
]	O
.	O

Cutaneous	O
necrosis	O
associated	O
with	O
protein	B
S	I
deficiency	O
.	O

Critical	O
study	O

Regional	O
cerebral	O
blood	O
flow	O
was	O
measured	O
using	O
N	O
-	O
isopropyl-123I	O
-	O
iodoamphetamine	O
with	O
single	O
-	O
photon	O
emission	O
computed	O
tomography	O
(	O
CT	O
)	O
in	O
16	O
aged	O
patients	O
with	O
noninsulin	O
-	O
dependent	O
diabetes	O
mellitus	O
(	O
NIDDM	O
,	O
average	O
age	O
72.8	O
years	O
,	O
average	O
fasting	O
plasma	O
glucose	O
7.7	O
mmol	O
/	O
L	O
)	O
,	O
and	O
12	O
nondiabetic	O
subjects	O
(	O
71.6	O
years	O
,	O
5.3	O
mmol	O
/	O
L	O
)	O
.	O

Mean	O
ROI	O
-	O
A	O
/	O
B	O
ratio	O
was	O
49.6	O
+	O
/-	O

1.7	O
%	O
in	O
the	O
diabetic	O
group	O
,	O
significantly	O
lower	O
than	O
the	O
57.9	O
+	O
/-	O

1.6	O
%	O
at	O
the	O
nondiabetic	O
group	O
(	O
p	O
less	O
than	O
0.005	O
)	O
.	O

These	O
data	O
strongly	O
implicate	O
the	O
normal	O
product	O
of	O
the	O
int-2	B
gene	I
,	O
which	O
is	O
related	O
to	O
the	O
fibroblast	B
growth	I
factor	I
family	I
,	O
as	O
a	O
contributory	O
factor	O
in	O
virally	O
induced	O
mammary	O
tumors	O
.	O

The	O
PC2	B
protein	I
also	O
shows	O
great	O
similarity	O
to	O
the	O
incomplete	O
NH2-terminal	O
sequence	O
of	O
the	O
human	B
furin	I
gene	I
product	I
,	O
a	O
putative	O
membrane	O
-	O
inserted	O
receptor	O
-	O
like	O
molecule	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
footprinting	O
and	O
gel	O
mobility	O
retardation	O
assays	O
to	O
reveal	O
that	O
bacterially	O
synthesized	O
Zta	B
fusion	I
proteins	I
bound	O
directly	O
to	O
six	O
TGTGCAA	O
-	O
like	O
motifs	O
within	O
DSL	B
.	O

The	O
zta	B
transactivator	I
involved	O
in	O
induction	O
of	O
lytic	O
cycle	O
gene	O
expression	O
in	O
Epstein	O
-	O
Barr	O
virus	O
-	O
infected	O
lymphocytes	O
binds	O
to	O
both	O
AP-1	B
and	O
ZRE	B
sites	I
in	O
target	O
promoter	O
and	O
enhancer	O
regions	O
.	O

Fragments	O
containing	O
the	O
21-base	O
-	O
pair	O
repeat	O
region	O
,	O
the	O
enhancer	B
of	I
simian	I
virus	I
40	I
or	O
both	O
strongly	O
stimulated	O
beta	B
-	I
galactosidase	I
synthesis	O
,	O
and	O
three	O
fragments	O
from	O
the	O
polyomavirus	B
enhancer	I
region	I
stimulated	O
moderate	O
levels	O
.	O

The	O
sites	O
targeted	O
for	O
mutagenesis	O
,	O
residues	O
60	O
,	O
61	O
,	O
and	O
66	O
,	O
are	O
located	O
within	O
a	O
putative	O
helical	O
loop	O
structure	O
which	O
may	O
be	O
involved	O
in	O
substrate	O
recognition	O
by	O
the	O
enzyme	O
.	O

The	O
possible	O
benefits	O
of	O
LMW	O
heparin	O
(	O
reduced	O
frequency	O
of	O
bleeding	O
,	O
alleviation	O
of	O
hypertriglyceridemia	O
)	O
were	O
not	O
,	O
however	O
,	O
apparent	O
,	O
possibly	O
because	O
of	O
the	O
short	O
observation	O
period	O
and	O
the	O
low	O
incidence	O
of	O
hemorrhagic	O
complications	O
in	O
routine	O
dialyses	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
destrin	B
is	O
165	O
residues	O
long	O
and	O
is	O
very	O
similar	O
(	O
71	O
%	O
identical	O
)	O
to	O
that	O
of	O
cofilin	B
,	O
a	O
widely	O
distributed	O
,	O
pH	O
-	O
sensitive	O
actin	B
-	O
modulating	O
protein	O
.	O

With	O
only	O
purified	O
T	B
antigen	I
in	O
the	O
presence	O
of	O
topoisomerase	B
I	I
to	O
unwind	O
purified	O
DNA	O
,	O
ori	O
-	O
auxiliary	O
sequences	O
strongly	O
facilitated	O
T	B
-	I
antigen	I
-	O
dependent	O
DNA	O
conformational	O
changes	O
consistent	O
with	O
melting	O
the	O
first	O
50	O
base	O
pairs	O
.	O

Conservation	O
of	O
function	O
of	O
Drosophila	B
melanogaster	I
abl	I
and	O
murine	B
v	I
-	I
abl	I
proteins	I
in	O
transformation	O
of	O
mammalian	O
cells	O
.	O

In	O
transient	O
cotransfection	O
assays	O
using	O
Chang	O
liver	O
cells	O
(	O
CCL	O
13	O
)	O
,	O
pM1	O
DNA	O
exerts	O
a	O
6-	O
to	O
10-fold	O
trans	O
-	O
activating	O
effect	O
on	O
the	O
expression	O
of	O
the	O
pSV2CAT	O
reporter	O
plasmid	O
.	O

We	O
have	O
determined	O
the	O
nucleotide	O
(	O
nt	O
)	O
sequence	O
of	O
the	O
7.5-kb	B
COR	I
segment	I
that	O
encompasses	O
a	O
cluster	O
of	O
six	O
genes	O
(	O
CYC1	B
,	O
UTR1	B
,	O
UTR3	B
,	O
OSM1	B
,	O
tRNA	B
(	I
Gly	I
)	I
and	O
RAD7	B
)	O
located	O
on	O
chromosome	O
X	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

The	O
antinociceptive	O
properties	O
,	O
as	O
measured	O
by	O
the	O
tail	O
-	O
flick	O
and	O
hot	O
-	O
plate	O
tests	O
,	O
and	O
the	O
motor	O
effects	O
of	O
an	O
intrathecally	O
-	O
administered	O
benzodiazepine	O
agonist	O
midazolam	O
,	O
alone	O
,	O
and	O
in	O
combination	O
with	O
morphine	O
,	O
was	O
examined	O
in	O
rats	O
.	O

Constructs	O
were	O
made	O
in	O
which	O
an	O
AATAAA	O
and	O
the	O
GT	O
-	O
rich	O
region	O
were	O
separated	O
by	O
various	O
distances	O
ranging	O
from	O
7	O
to	O
43	O
bp	O
.	O

We	O
cloned	O
and	O
sequenced	O
the	O
cDNAs	O
against	O
genomic	O
RNA	O
and	O
mRNA	O
for	O
phosphoprotein	B
(	I
P	I
)	I
of	O
human	O
parainfluenza	O
type	O
2	O
virus	O
(	O
PIV-2	O
)	O
.	O

cDNA	O
clone	O
from	O
genomic	O
RNA	O
was	O
1439	O
nucleotides	O
in	O
length	O
excluding	O
poly	O
(	O
A	O
)	O
and	O
was	O
found	O
to	O
have	O
two	O
small	O
open	O
reading	O
frames	O
encoding	O
proteins	O
of	O
233	O
and	O
249	O
amino	O
acids	O
.	O

The	O
cDNA	O
sequence	O
has	O
an	O
813-bp	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
whose	O
predicted	O
amino	O
acid	O
sequence	O
is	O
97.6	O
%	O
identical	O
to	O
the	O
272	O
carboxy	O
-	O
terminal	O
amino	O
acids	O
of	O
the	O
human	B
ets-1	I
protein	I
.	O

The	O
sacT	B
gene	I
regulating	O
the	O
sacPA	B
operon	I
in	I
Bacillus	I
subtilis	I
shares	O
strong	O
homology	O
with	O
transcriptional	O
antiterminators	O
.	O

The	O
TraD	B
protein	I
(	I
83,899	I
Da	I
)	I
contains	O
three	O
hydrophobic	O
regions	O
,	O
of	O
which	O
two	O
are	O
located	O
near	O
the	O
amino	O
-	O
terminal	O
region	O
.	O

The	O
protein	O
product	O
of	O
orfD	B
,	O
which	O
is	O
probably	O
a	O
new	O
tra	B
gene	I
(	O
named	O
traX	B
)	O
,	O
contains	O
65	O
%	O
hydrophobic	O
amino	O
acids	O
,	O
especially	O
rich	O
in	O
alanine	O
and	O
leucine	O
.	O

Furthermore	O
,	O
analysis	O
of	O
the	O
E2	B
proteins	I
present	O
in	O
various	O
cell	O
lines	O
harboring	O
specific	O
BPV-1	O
mutants	O
,	O
including	O
the	O
2558	O
acceptor	O
mutant	O
,	O
proves	O
that	O
alternate	O
modes	O
of	O
E2	B
expression	O
exist	O
.	O

Disruption	O
of	O
the	O
IRA2	B
gene	I
resulted	O
in	O
(	O
i	O
)	O
increased	O
sensitivity	O
to	O
heat	O
shock	O
and	O
nitrogen	O
starvation	O
,	O
(	O
ii	O
)	O
sporulation	O
defects	O
,	O
and	O
(	O
iii	O
)	O
suppression	O
of	O
the	O
lethality	O
of	O
the	O
cdc25	B
mutant	I
.	O

A	O
gene	O
in	O
Drosophila	O
melanogaster	O
that	O
maps	O
cytologically	O
to	O
2C1	O
-	O
3	O
on	O
the	O
distal	O
portion	O
of	O
the	O
X	O
-	O
chromosome	O
encodes	O
a	O
member	O
of	O
the	O
steroid	B
/	I
thyroid	I
hormone	I
receptor	I
superfamily	I
.	O

A	O
portion	O
of	O
Region	O
II	O
also	O
resembles	O
part	O
of	O
the	O
human	O
c	B
-	I
jun	I
oncoprotein	O
's	O
leucine	O
zipper	O
,	O
which	O
in	O
turn	O
,	O
has	O
been	O
demonstrated	O
to	O
be	O
the	O
heterodimerization	O
site	O
between	O
the	O
jun	B
and	O
fos	B
oncoproteins	I
.	O

The	O
diagnosis	O
of	O
miliary	O
tuberculosis	O
should	O
be	O
systematically	O
considered	O
in	O
ARDS	O
of	O
unknown	O
origin	O
.	O

The	O
26S	B
rRNA	I
binding	I
ribosomal	I
protein	I
equivalent	O
to	O
bacterial	B
protein	I
L11	I
is	O
encoded	O
by	O
unspliced	O
duplicated	O
genes	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Five	O
healthy	O
male	O
subjects	O
inspired	O
air	O
for	O
20	O
min	O
and	O
then	O
5	O
%	O
CO2	O
/	O
95	O
%	O
O2	O
for	O
30	O
min	O
,	O
of	O
which	O
the	O
first	O
10	O
min	O
was	O
used	O
to	O
achieve	O
a	O
steady	O
-	O
state	O
end	O
-	O
tidal	O
CO2	O
measurement	O
.	O

Significant	O
correlations	O
were	O
obtained	O
between	O
changes	O
in	O
SSEP	O
in	O
response	O
to	O
AS	O
and	O
the	O
presence	O
of	O
not	O
deep	O
residual	O
-	O
organic	O
disturbances	O
,	O
so	O
-	O
called	O
""""	O
ground	O
""""	O
in	O
psychogenic	O
disorders	O
.	O

The	O
E6	B
/	O
E7	B
promoter	O
of	O
all	O
genital	O
human	O
papillomaviruses	O
is	O
responsible	O
for	O
expression	O
of	O
the	O
viral	O
transforming	O
genes	O
.	O

Immunohistochemical	O
analysis	O
of	O
several	O
rat	O
organs	O
also	O
showed	O
staining	O
in	O
epithelial	O
cells	O
.	O

Both	O
strains	O
grew	O
very	O
poorly	O
,	O
or	O
not	O
at	O
all	O
,	O
on	O
nonfermentable	O
carbon	O
sources	O
and	O
exhibited	O
,	O
at	O
most	O
,	O
only	O
5	O
%	O
of	O
wild	B
-	I
type	I
ubiquinol	I
-	I
cytochrome	I
c	I
oxidoreductase	I
activity	O
.	O

Transcription	O
of	O
the	O
first	O
operon	O
coding	O
for	O
m	O
-	O
xylene	O
-	O
degrading	O
enzymes	O
on	O
the	O
TOL	O
plasmid	O
of	O
Pseudomonas	O
putida	O
is	O
activated	O
by	O
the	O
xylR	B
gene	I
product	I
in	O
the	O
presence	O
of	O
m	O
-	O
xylene	O
.	O

We	O
show	O
also	O
that	O
RA	O
represses	O
the	O
transcriptional	O
activity	O
of	O
a	O
reporter	O
gene	O
containing	O
a	O
TPA	O
responding	O
AP1	B
binding	I
site	I
driving	O
the	O
HSV	B
tk	I
promoter	I
.	O

Risk	O
factors	O
influencing	O
lymph	O
nodes	O
metastasis	O
in	O
lung	O
cancer	O
with	O
stage	O
I	O
,	O
II	O
or	O
IIIA	O

Multifunctional	B
protein	I
kinase	I
(	O
MFPK	B
)	O
phosphorylates	O
ATP	B
-	I
citrate	I
lyase	I
on	O
peptide	B
B	I
on	O
two	O
sites	O
,	O
BT	O
and	O
BS	O
,	O
on	O
threonine	O
and	O
serine	O
,	O
respectively	O
,	O
inhibitor	B
2	I
on	O
a	O
threonyl	O
residue	O
,	O
and	O
glycogen	B
synthase	I
at	O
sites	O
2	O
and	O
3	O
.	O

The	O
characterized	O
Y	B
'	I
repeated	I
sequence	I
families	I
provide	O
an	O
experimental	O
system	O
in	O
which	O
repeated	O
sequence	O
interactions	O
and	O
subsequent	O
evolution	O
can	O
be	O
studied	O
.	O

Unlike	O
p59v	B
-	O
rel	B
,	O
which	O
is	O
a	O
nuclear	O
protein	O
in	O
CEF	O
,	O
indirect	O
immunofluorescence	O
showed	O
that	O
p68c	B
-	O
rel	B
in	O
JD214c	O
-	O
rel	O
infected	O
CEF	O
is	O
located	O
exclusively	O
in	O
the	O
cytoplasm	O
of	O
these	O
cells	O
,	O
even	O
though	O
the	O
sequence	O
of	O
p68c	B
-	O
rel	B
showed	O
that	O
it	O
contains	O
a	O
nuclear	O
localizing	O
sequence	O
identical	O
to	O
the	O
one	O
previously	O
identified	O
in	O
p59v	B
-	O
rel	B
.	O

However	O
,	O
primary	O
transcripts	O
of	O
a	O
variant	B
tRNA	I
(	I
Val	I
)	I
(	I
UAC	I
)	I
gene	I
are	O
processing	O
deficient	O
under	O
standard	O
growth	O
conditions	O
(	O
30	O
degrees	O
C	O
)	O
,	O
due	O
to	O
a	O
slightly	O
altered	O
5	O
'	O
flanking	O
region	O
.	O

Three	O
of	O
the	O
short	O
ORFs	O
in	O
the	O
central	O
region	O
of	O
BIV	O
have	O
been	O
identified	O
by	O
location	O
and	O
structural	O
similarity	O
to	O
the	O
nonstructural	O
/	O
regulatory	O
genes	O
(	O
vif	B
,	O
tat	B
,	O
and	O
rev	B
)	O
of	O
other	O
lentiviruses	O
;	O
we	O
also	O
discovered	O
two	O
unique	O
ORFs	O
,	O
termed	O
W	O
and	O
Y	O
,	O
which	O
may	O
serve	O
as	O
exons	O
for	O
novel	O
genes	O
.	O

Truncations	O
composed	O
of	O
78	O
and	O
64	O
amino	O
acids	O
were	O
translocated	O
across	O
the	O
endoplasmic	O
reticulum	O
membrane	O
,	O
and	O
translocation	O
was	O
found	O
to	O
be	O
strictly	O
co	O
-	O
translational	O
and	O
SRP	B
-	O
dependent	O
.	O

Pulmonary	O
vascular	O
resistance	O
was	O
not	O
altered	O
,	O
ejection	O
fraction	O
remained	O
unchanged	O
and	O
isovolumic	O
relaxation	O
period	O
was	O
lengthened	O
(	O
119	O
+	O
/-	O

20.1	O
to	O
147.39	O
+	O
/-	O

21.15	O
,	O
P	O
less	O
than	O
0.05	O
)	O
.	O

The	O
contribution	O
that	O
alternative	O
splicing	O
events	O
in	O
c	B
-	I
myb	I
expression	O
may	O
make	O
on	O
c	B
-	I
myb	I
function	O
remains	O
to	O
be	O
elucidated	O
.	O

R.	O

Specific	O
hyperimmune	B
globulins	I
to	O
pathogens	O
such	O
as	O
Haemophilus	O
influenzae	O
and	O
Streptococcus	O
pneumoniae	O
have	O
also	O
been	O
studied	O
.	O

Regulation	O
of	O
yeast	B
LEU2	I
.	O

Since	O
general	B
regulatory	I
factor	I
I	I
(	O
GRFI	B
)	O
/	O
repressor	B
/	I
activator	I
site	I
binding	I
protein	I
1	I
(	O
RAP1	B
)	O
/	O
translation	B
upstream	I
factor	I
(	O
TUF	B
)	O
is	O
believed	O
to	O
be	O
an	O
activator	O
of	O
MAT	B
alpha	I
expression	O
,	O
we	O
examined	O
whether	O
PYK1	B
,	O
which	O
is	O
known	O
to	O
be	O
regulated	O
by	O
GRFI	B
/	O
RAP1	B
/	O
TUF	B
,	O
is	O
also	O
affected	O
by	O
the	O
gal11	B
mutation	I
.	O

Deletion	O
from	O
either	O
the	O
N-	O
or	O
C	O
-	O
terminal	O
ends	O
of	O
repA	B
(	O
28	O
and	O
69	O
codons	O
,	O
respectively	O
,	O
out	O
of	O
the	O
286-codon	O
open	O
reading	O
frame	O
)	O
affected	O
the	O
initiator	O
but	O
not	O
the	O
inhibitory	O
activity	O
.	O

Guiding	O
patients	O
in	O
the	O
decision	O
should	O
involve	O
a	O
multidisciplinary	O
team	O
composed	O
of	O
a	O
surgical	O
oncologist	O
,	O
geneticist	O
,	O
pathologist	O
,	O
psychotherapist	O
and	O
plastic	O
surgeon	O
.	O

IgG	B
and	O
IgM	B
antibody	O
activity	O
was	O
determined	O
by	O
adding	O
a	O
1:100	O
dilution	O
of	O
serum	O
to	O
plates	O
coated	O
with	O
A60	B
antigen	I
.	O

These	O
factors	O
belong	O
to	O
a	O
set	O
of	O
genetically	O
distinct	O
molecules	O
,	O
including	O
AP-4	B
and	O
MLTF	B
,	O
that	O
bind	O
to	O
the	O
CACCTGTC	O
motif	O
or	O
related	O
sequences	O
.	O

Among	O
known	O
flea	O
larvae	O
,	O
the	O
genus	O
Anomiopsyllus	O
(	O
Anomiopsyllinae	O
,	O
Anomiopsyllini	O
)	O
is	O
as	O
distinctive	O
in	O
larval	O
form	O
as	O
are	O
the	O
adults	O
.	O

Here	O
,	O
we	O
have	O
used	O
specific	O
antibody	O
to	O
identify	O
and	O
characterize	O
the	O
SSN6	B
protein	I
.	O

Clinical	O
nutrition	O
of	O
adult	O
horses	O
.	O

The	O
computer	O
-	O
programmed	O
cytocentrifuge	O
is	O
currently	O
most	O
popular	O
.	O

RNase	B
protection	O
assays	O
reveal	O
that	O
this	O
gene	O
,	O
unr	B
,	O
is	O
transcribed	O
in	O
the	O
same	O
direction	O
as	O
N	B
-	I
ras	I
and	O
that	O
its	O
3	O
'	O
end	O
is	O
located	O
just	O
130	O
base	O
pairs	O
away	O
from	O
the	O
point	O
at	O
which	O
N	B
-	I
ras	I
transcription	O
begins	O
.	O

Isolation	O
of	O
a	O
temperature	O
-	O
sensitive	O
mutant	O
with	O
an	O
altered	O
tRNA	B
nucleotidyltransferase	I
and	O
cloning	O
of	O
the	O
gene	B
encoding	I
tRNA	I
nucleotidyltransferase	I
in	I
the	I
yeast	I
Saccharomyces	I
cerevisiae	I
.	O

The	O
juxtamembrane	O
region	O
of	O
the	O
insulin	B
receptor	I
(	I
IR	I
)	I
beta	I
-	I
subunit	I
contains	O
an	O
unphosphorylated	O
tyrosyl	O
residue	O
(	O
Tyr960	O
)	O
that	O
is	O
essential	O
for	O
insulin	B
-	O
stimulated	O
tyrosyl	O
phosphorylation	O
of	O
some	O
endogenous	O
substrates	O
and	O
certain	O
biological	O
responses	O
(	O
White	O
,	O
M.F.	O
,	O
Livingston	O
,	O
J.N.	O
,	O
Backer	O
,	O
J.M.	O
,	O
Lauris	O
,	O
V.	O
,	O
Dull	O
,	O
T.J.	O
,	O
Ullrich	O
,	O
A.	O
,	O
and	O
Kahn	O
,	O
C.R.	O

The	O
3	O
'	O
region	O
,	O
GA2	B
,	O
is	O
necessary	O
for	O
maximal	O
expression	O
.	O

Pups	O
placed	O
into	O
the	O
novel	O
environment	O
with	O
their	O
mothers	O
exhibited	O
an	O
intermediate	O
level	O
of	O
DA	O
turnover	O
.	O

The	O
grandfather	O
and	O
the	O
granddaughter	O
both	O
had	O
microtia	O
and	O
meatal	O
atresia	O
,	O
whereas	O
the	O
daughter	O
had	O
a	O
normal	O
outer	O
ear	O
except	O
for	O
a	O
narrow	O
meatus	O
and	O
auricular	O
appendages	O
.	O

The	O
urinary	O
protein	O
,	O
serum	O
albumin	B
,	O
BUN	O
and	O
SCr	O
all	O
had	O
very	O
significant	O
improvement	O
.	O

More	O
generally	O
,	O
Ets1	B
and	O
Ets2	B
could	O
regulate	O
transcription	O
of	O
cellular	O
genes	O
.	O

Within	O
this	O
sequence	O
the	O
MSAS	B
gene	I
was	O
identified	O
as	O
a	O
5322-bp	O
-	O
long	O
open	O
reading	O
frame	O
coding	O
for	O
a	O
protein	O
of	O
1774	O
amino	O
acids	O
and	O
190,731	O
Da	O
molecular	O
mass	O
.	O

Standardized	O
gastric	O
wall	O
specimens	O
from	O
the	O
area	O
of	O
grossly	O
healed	O
ulcers	O
were	O
obtained	O
,	O
processed	O
,	O
and	O
evaluated	O
by	O
light	O
microscopy	O
and	O
by	O
transmission	O
electron	O
microscopy	O
.	O

2	O
.	O

This	O
last	O
includes	O
tissue	O
O2	O
transfer	O
(	O
Ft	O
'	O
)	O
and	O
mitochondrial	O
O2	O
utilization	O
(	O
Fm	O
'	O
)	O
.	O

Foveating	O
saccades	O
,	O
therefore	O
,	O
can	O
be	O
distinguished	O
from	O
other	O
FEMs	O
on	O
the	O
basis	O
of	O
speed	O
.	O

Chick	B
brain	I
actin	I
depolymerizing	I
factor	I
(	O
ADF	B
)	O
is	O
a	O
19-kDa	O
protein	O
that	O
severs	O
actin	B
filaments	I
and	O
binds	O
actin	B
monomers	I
.	O

Initial	O
experience	O
with	O
a	O
serotonin	O
agonist	O
.	O

Primer	O
extension	O
analysis	O
and	O
RNA	O
sequencing	O
demonstrates	O
that	O
the	O
transcription	O
start	O
point	O
of	O
rat	B
ODC	I
mRNA	I
is	O
located	O
303	O
nt	O
upstream	O
from	O
the	O
A	O
residue	O
in	O
the	O
start	O
codon	O
.	O

For	O
85Sr	O
,	O
larger	O
-	O
than	O
-	O
expected	O
distribution	O
coefficients	O
were	O
obtained	O
in	O
the	O
desorption	O
experiments	O
,	O
an	O
indication	O
of	O
the	O
irreversible	O
formation	O
of	O
metal	O
-	O
oxyhydroxides	O
during	O
a	O
slow	O
reaction	O
.	O

This	O
growth	O
arrest	O
is	O
partly	O
suppressed	O
on	O
minimal	O
medium	O
or	O
under	O
conditions	O
in	O
which	O
the	O
cells	O
are	O
less	O
dependent	O
on	O
mitochondrial	O
metabolism	O
.	O

Giant	O
pilomatrix	O
carcinoma	O
:	O
report	O
and	O
review	O
of	O
the	O
literature	O
.	O

Further	O
studies	O
of	O
mandibular	O
movement	O
at	O
initial	O
tooth	O
contact	O
.	O

Each	O
parent	O
interacted	O
with	O
their	O
4-	O
or	O
5-year	O
-	O
old	O
son	O
or	O
daughter	O
in	O
each	O
of	O
two	O
conversations	O
--	O
unstructured	O
(	O
social	O
conversation	O
)	O
and	O
structured	O
(	O
task	O
activity	O
)	O
.	O

Droperidol	O
-	O
induced	O
extrapyramidal	O
symptoms	O
in	O
an	O
adolescent	O
following	O
strabismus	O
surgery	O
.	O

The	O
induction	O
by	O
pseudorabies	O
virus	O
of	O
an	O
IL-6	B
construct	I
containing	O
the	O
IL-6	B
TATA	I
box	I
and	O
the	O
RNA	O
start	O
site	O
(	O
""""	O
initiator	O
""""	O
or	O
Inr	O
element	O
)	O
but	O
not	O
the	O
MRE	O
region	O
was	O
also	O
repressed	O
by	O
Dex	O
in	O
the	O
presence	O
of	O
wild	B
-	I
type	I
GR	I
.	O

We	O
conclude	O
that	O
class	O
I	O
cytologic	O
smears	O
with	O
moderate	O
to	O
severe	O
inflammation	O
may	O
be	O
associated	O
with	O
findings	O
of	O
condylomata	O
and	O
cervical	O
dysplasia	O
.	O

As	O
in	O
mammals	O
,	O
considerable	O
nucleotide	O
diversity	O
was	O
observed	O
at	O
the	O
junctions	O
of	O
the	O
variable	O
,	O
diversity	O
,	O
and	O
joining	O
elements	O
in	O
chicken	B
TCR	I
beta	I
cDNAs	I
.	O

Rats	O
with	O
one	O
olfactory	O
bulb	O
removed	O
and	O
the	O
contralateral	O
naris	O
closed	O
can	O
detect	O
odors	O
.	O

The	O
Ets-1	B
binding	I
site	I
was	O
localized	O
to	O
a	O
17-base	O
pair	O
(	O
bp	O
)	O
region	O
from	O
the	O
3	O
'	O
end	O
of	O
T	B
alpha	I
2	I
.	O

We	O
have	O
now	O
identified	O
,	O
after	O
21	O
serial	O
undiluted	O
passages	O
of	O
MHV	O
,	O
a	O
small	B
DI	I
RNA	I
,	O
DIssF	B
,	O
which	O
is	O
efficiently	O
packaged	O
into	O
virions	O
.	O

The	O
Jenkins	O
Activity	O
Survey	O
and	O
the	O
CPI	O
-	O
revised	O
:	O
further	O
evidence	O
of	O
adaptive	O
and	O
maladaptive	O
type	O
A	O
traits	O
.	O

There	O
was	O
evidence	O
of	O
attenuated	O
regression	O
slopes	O
relating	O
recalled	O
to	O
observed	O
portion	O
sizes	O
for	O
4	O
of	O
the	O
10	O
food	O
groups	O
;	O
adjusted	O
r2	O
values	O
for	O
the	O
recalled	O
portion	O
sizes	O
ranged	O
from	O
0.02	O
to	O
0.94	O
.	O

The	O
SUP44	B
suppressor	I
mutation	I
occurs	O
near	O
a	O
region	O
of	O
the	O
protein	O
that	O
corresponds	O
to	O
the	O
known	O
positions	O
of	O
alterations	O
in	O
E.	B
coli	I
S5	I
ram	I
mutations	I
.	O

Interestingly	O
,	O
disruption	O
of	O
the	O
VPS34	B
locus	I
resulted	O
in	O
a	O
temperature	O
-	O
sensitive	O
growth	O
defect	O
,	O
indicating	O
that	O
the	O
VPS34	B
gene	I
is	O
essential	O
for	O
vegetative	O
growth	O
only	O
at	O
elevated	O
growth	O
temperatures	O
.	O

We	O
describe	O
a	O
case	O
of	O
a	O
perinephric	O
abscess	O
treated	O
with	O
amphotericin	O
B	O
and	O
nephrectomy	O
.	O

This	O
,	O
together	O
with	O
the	O
data	O
obtained	O
with	O
haloperidol	O
,	O
suggests	O
that	O
a	O
minimal	O
increase	O
in	O
the	O
firing	O
rate	O
of	O
LC	O
cells	O
(	O
+	O
140	O
%	O
)	O
is	O
required	O
before	O
it	O
could	O
influence	O
the	O
turnover	O
of	O
NA	O
,	O
as	O
measured	O
by	O
DOPAC	O
changes	O
.	O

Perceptions	O
of	O
illness	O
intrusiveness	O
were	O
significantly	O
higher	O
when	O
both	O
muscle	O
cramp	O
and	O
headache	O
symptoms	O
occurred	O
during	O
one	O
or	O
more	O
assessment	O
intervals	O
as	O
compared	O
to	O
when	O
muscle	O
cramps	O
or	O
headaches	O
,	O
only	O
,	O
occurred	O
.	O

Results	O
have	O
surprisingly	O
revealed	O
the	O
presence	O
of	O
three	O
U14	B
snRNA	I
-	I
homologous	I
regions	I
positioned	O
within	O
introns	O
5	O
,	O
6	O
,	O
and	O
8	O
of	O
the	O
mouse	O
cognate	O
hsc70	B
heat	O
shock	O
gene	O
.	O

The	O
highly	O
restrained	O
girls	O
had	O
a	O
significantly	O
higher	O
EAT	O
score	O
than	O
the	O
low	O
-	O
restrained	O
girls	O
,	O
and	O
shared	O
with	O
their	O
mothers	O
a	O
susceptibility	O
to	O
the	O
disinhibitory	O
effects	O
of	O
negative	O
mood	O
states	O
on	O
their	O
eating	O
behaviour	O
.	O

The	O
Mauriceville	O
and	O
Varkud	O
mitochondrial	O
plasmids	O
are	O
closely	O
related	O
,	O
closed	O
-	O
circular	O
DNAs	O
(	O
3.6	O
and	O
3.7	O
kb	O
,	O
respectively	O
)	O
that	O
have	O
characteristics	O
of	O
mtDNA	O
introns	O
and	O
retroid	O
elements	O
.	O

The	O
circadian	O
rhythm	O
,	O
however	O
,	O
was	O
not	O
affected	O
and	O
the	O
difference	O
between	O
minimum	O
(	O
12.00	O
h	O
)	O
and	O
maximum	O
(	O
18.50	O
h	O
)	O
serum	O
concentrations	O
was	O
31.3	O
%	O
.	O

Sequence	O
and	O
genetic	O
organization	O
of	O
a	O
Zymomonas	O
mobilis	O
gene	O
cluster	O
that	O
encodes	O
several	O
enzymes	O
of	O
glucose	O
metabolism	O
.	O

Most	O
strains	O
(	O
95	O
%	O
)	O
of	O
S.	O
lugdunensis	O
produced	O
a	O
delta	B
hemolysin	I
like	O
that	O
seen	O
with	O
nine	O
other	O
species	O
of	O
CNS	O
.	O

For	O
this	O
,	O
cDNAs	O
containing	O
the	O
60	O
K	O
,	O
87	O
K	O
,	O
110	O
K	O
and	O
170	O
K	O
protein	O
coding	O
sequences	O
were	O
each	O
provided	O
with	O
an	O
ATG	O
start	O
codon	O
and	O
the	O
cDNA	O
containing	O
the	O
60	O
K	O
coding	O
sequence	O
with	O
a	O
TAA	O
stop	O
codon	O
immediately	O
downstream	O
of	O
the	O
coding	O
sequence	O
.	O

Finally	O
,	O
a	O
complementary	O
footprinting	O
analysis	O
of	O
the	O
upstream	O
region	O
of	O
the	O
constitutively	O
expressed	O
HSC82	B
gene	I
reveals	O
the	O
presence	O
of	O
three	O
discrete	O
protein	O
complexes	O
.	O

Pathophysiology	O
of	O
bone	O
loss	O
in	O
castrated	O
animals	O
.	O

First	O
,	O
each	O
lung	O
was	O
cut	O
into	O
slices	O
,	O
from	O
which	O
primary	O
disectors	O
were	O
sampled	O
systematically	O
with	O
a	O
known	O
sampling	O
fraction	O
.	O

Assuming	O
O2	O
consumption	O
of	O
the	O
isolated	O
skin	O
to	O
be	O
same	O
as	O
in	O
situ	O
,	O
calculations	O
showed	O
that	O
when	O
water	O
PO2	O
was	O
high	O
(	O
150	O
mm	O
Hg	O
)	O
,	O
about	O
40	O
%	O
of	O
total	O
cutaneous	O
O2	O
uptake	O
was	O
consumed	O
by	O
the	O
skin	O
.	O

Experiments	O
showed	O
that	O
temporary	O
arrest	O
of	O
pulmonary	O
circulation	O
under	O
conditions	O
of	O
extracorporeal	O
circulation	O
is	O
attended	O
by	O
the	O
development	O
of	O
ischemia	O
of	O
the	O
respiratory	O
pulmonary	O
tissue	O
.	O

Plasma	O
Al	O
was	O
obtained	O
during	O
each	O
baseline	O
and	O
drug	O
course	O
.	O

The	O
survival	O
in	O
the	O
case	O
of	O
these	O
patients	O
was	O
studied	O
five	O
years	O
later	O
.	O

The	O
occurrence	O
,	O
maintenance	O
and	O
possible	O
involvement	O
of	O
these	O
repeated	O
sequences	O
,	O
capable	O
of	O
forming	O
stable	O
secondary	O
structures	O
,	O
are	O
discussed	O
in	O
relation	O
to	O
their	O
location	O
in	O
the	O
region	O
of	O
control	O
signals	O
.	O

The	O
endodontal	O
treatment	O
need	O
has	O
been	O
forming	O
a	O
clinical	O
order	O
of	O
magnitude	O
.	O

1	O
(	O
""""	O
long	O
method	O
""""	O
)	O
and	O
the	O
HML	O
method	O
.	O

These	O
results	O
may	O
suggest	O
involvement	O
of	O
peripheral	O
enkephalins	O
in	O
pain	O
modulation	O
in	O
patients	O
with	O
episodic	O
cluster	O
headache	O
.	O

Effects	O
of	O
cisapride	O
on	O
upper	O
-	O
gastrointestinal	O
motility	O
and	O
digestive	O
hormones	O

Common	O
foot	O
pathologies	O
are	O
heel	O
pain	O
,	O
metatarsalgia	O
,	O
hammertoes	O
and	O
clawtoes	O
,	O
bunions	O
,	O
hallux	O
rigidus	O
,	O
corns	O
and	O
calluses	O
,	O
nail	O
pathologies	O
,	O
arthritis	O
,	O
and	O
neuropathies	O
.	O

Liver	O
dysfunction	O
in	O
the	O
presence	O
of	O
different	O
adverse	O
reactions	O
presented	O
with	O
a	O
higher	O
activity	O
in	O
the	O
blood	O
serum	O
of	O
indicator	O
liver	O
enzymes	O
and	O
its	O
impaired	O
protein	O
-	O
forming	O
function	O
.	O

The	O
CT	O
characteristics	O
are	O
discussed	O
and	O
the	O
recent	O
literature	O
is	O
reviewed	O
.	O

Unfortunately	O
,	O
these	O
preservatives	O
may	O
also	O
interfere	O
with	O
microbiological	O
assays	O
used	O
to	O
determine	O
product	O
sterility	O
or	O
bioburden	O
levels	O
.	O

In	O
26	O
patients	O
with	O
angina	O
pectoris	O
,	O
the	O
changes	O
of	O
LVEF	O
,	O
LVESV	O
and	O
PSP	O
/	O
LVESV	O
were	O
more	O
sensitive	O
for	O
the	O
detection	O
of	O
exercise	O
-	O
induced	O
ischemia	O
than	O
the	O
appearance	O
of	O
chest	O
pain	O
and	O
the	O
changes	O
of	O
ECG	O
.	O

In	O
both	O
groups	O
there	O
were	O
5	O
management	O
failure	O
of	O
therapy	O
,	O
so	O
that	O
alternative	O
medication	O
or	O
a	O
cesarean	O
section	O
lead	O
to	O
delivery	O
.	O

The	O
uteroglobin	B
promoter	I
contains	O
a	O
noncanonical	O
estrogen	O
responsive	O
element	O
.	O

Significance	O
of	O
cytokine	O
production	O
and	O
adhesion	O
molecules	O
in	O
malarial	O
immunopathology	O
.	O

Further	O
research	O
is	O
recommended	O
to	O
identify	O
the	O
coping	O
styles	O
associated	O
with	O
the	O
high	O
EE	O
/	O
low	O
EE	O
research	O
classification	O
.	O

Ultrastructural	O
and	O
morphometric	O
study	O
of	O
the	O
myeloid	O
parenchyma	O
cells	O
of	O
mice	O
prior	O
and	O
after	O
X	O
-	O
ray	O
exposure	O

Using	O
an	O
audiotape	O
cassette	O
and	O
headphones	O
the	O
duration	O
of	O
the	O
hallucinations	O
decreased	O
significantly	O
.	O

Very	O
good	O
accuracy	O
(	O
r	O
greater	O
than	O
0.9	O
)	O
was	O
found	O
when	O
except	O
comparing	O
H*2	O
with	O
the	O
other	O
machine	O
and	O
the	O
reference	O
methods	O
,	O
except	O
for	O
MCHCH	O
and	O
basophil	O
count	O
.	O

Interlimb	O
coordination	O
during	O
fictive	O
locomotion	O
in	O
the	O
thalamic	O
cat	O
.	O

Antileukoproteinase	B
(	O
ALP	B
)	O
is	O
a	O
low	O
mol	O
wt	O
mucosal	O
secretory	O
protein	O
which	O
,	O
in	O
human	O
tissues	O
,	O
inhibits	O
the	O
activities	O
of	O
the	O
neutral	O
serine	B
lysosomal	I
proteinases	I
elastase	B
and	O
cathepsin	B
-	I
G.	I

In	O
particular	O
,	O
71	O
and	O
69	O
%	O
amino	O
acid	O
sequence	O
similarities	O
were	O
identified	O
with	O
hsp70	B
of	I
Escherichia	I
coli	I
and	I
Bacillus	I
megaterium	I
,	O
respectively	O
.	O

No	O
causal	O
relations	O
may	O
be	O
inferred	O
from	O
the	O
correlation	O
between	O
the	O
level	O
of	O
trapezius	O
activity	O
and	O
complaints	O
,	O
though	O
it	O
indicates	O
that	O
individual	O
,	O
inexpedient	O
muscle	O
activity	O
patterns	O
may	O
constitute	O
an	O
important	O
risk	O
factor	O
for	O
development	O
of	O
musculo	O
-	O
skeletal	O
complaints	O
.	O

All	O
89	O
participating	O
household	O
members	O
were	O
anti	B
-	I
HIV	I
seronegative	O
,	O
and	O
78	O
who	O
were	O
tested	O
were	O
serum	B
p24	I
antigen	I
negative	O
.	O

To	O
determine	O
the	O
effects	O
on	O
the	O
pulmonary	O
barrier	O
of	O
several	O
surface	O
active	O
agents	O
,	O
a	O
series	O
of	O
metered	O
dose	O
inhalers	O
(	O
MDIs	O
)	O
was	O
prepared	O
and	O
used	O
to	O
dose	O
aerosolized	O
surfactant	O
to	O
the	O
airways	O
of	O
isolated	O
perfused	O
rat	O
lungs	O
.	O

The	O
therapeutic	O
protocole	O
used	O
at	O
the	O
Gustave	O
Roussy	O
Institute	O
for	O
invasive	O
epithelioma	O
of	O
the	O
uterine	O
cervix	O
rests	O
,	O
for	O
limited	O
forms	O
(	O
T1B	O
-	O
T2	O
proximal	O
)	O
,	O
on	O
combined	O
radiology	O
and	O
surgery	O
.	O

The	O
introns	O
are	O
1.6	O
-	O
1.9	O
kbp	O
long	O
.	O

After	O
an	O
initial	O
titration	O
period	O
and	O
adjustment	O
of	O
the	O
therapeutic	O
dose	O
,	O
the	O
individual	O
doses	O
were	O
from	O
21	O
to	O
500	O
micrograms	O
/	O
24	O
hrs	O
(	O
mean	O
160	O
micrograms	O
/	O
24	O
hrs	O
)	O
.	O

Erythrocyte	O
protoporphyrin	O
concentration	O
increased	O
significantly	O
(	O
P	O
less	O
than	O
0.05	O
)	O
by	O
14	O
days	O
in	O
dogs	O
fed	O
the	O
basal	O
diet	O
,	O
and	O
remained	O
significantly	O
high	O
relative	O
to	O
that	O
in	O
dogs	O
of	O
the	O
other	O
dietary	O
groups	O
for	O
the	O
remainder	O
of	O
the	O
study	O
.	O

From	O
an	O
RNK-16	O
lambda	O
-	O
gt11	O
library	O
,	O
we	O
have	O
isolated	O
and	O
sequenced	O
a	O
novel	O
cDNA	O
rat	B
NK	I
cell	I
protease	I
1	I
(	O
RNKP-1	B
)	O
that	O
has	O
characteristics	O
unique	O
to	O
serine	B
proteases	I
.	O

The	O
induction	O
of	O
RNKP-1	B
expression	O
in	O
the	O
Con	B
A	I
-	O
cultured	O
spleen	O
cells	O
is	O
accompanied	O
by	O
increases	O
in	O
both	O
NK	O
and	O
lymphokine	O
-	O
activated	O
killer	O
lymphocyte	O
activities	O
.	O

The	O
abscess	O
was	O
debrided	O
and	O
the	O
septum	O
was	O
patched	O
with	O
a	O
single	O
layer	O
of	O
autologous	O
pericardium	O
.	O

In	O
18	O
%	O
lymphography	O
was	O
clearly	O
positive	O
and	O
CT	O
negative	O
.	O

The	O
present	O
study	O
examined	O
the	O
effect	O
of	O
intensity	O
,	O
rate	O
,	O
and	O
polarity	O
on	O
the	O
spectral	O
content	O
of	O
ABRs	O
of	O
15	O
normal	O
-	O
hearing	O
subjects	O
.	O

Similar	O
memory	O
impairments	O
found	O
in	O
medial	O
septal	O
-	O
vertical	O
diagonal	O
band	O
of	O
Broca	O
and	O
nucleus	O
basalis	O
lesioned	O
rats	O
:	O
are	O
memory	O
defects	O
induced	O
by	O
nucleus	O
basalis	O
lesions	O
related	O
to	O
the	O
degree	O
of	O
non	O
-	O
specific	O
subcortical	O
cell	O
loss	O
?	O

The	O
function	O
of	O
nucleus	O
basalis	O
(	O
NB	O
)	O
and	O
medial	O
septal	O
-	O
vertical	O
diagonal	O
band	O
of	O
Broca	O
(	O
MS	O
-	O
VDBB	O
)	O
in	O
a	O
place	O
navigation	O
task	O
requiring	O
reference	O
memory	O
was	O
investigated	O
.	O

The	O
kappa	O
coefficient	O
of	O
agreement	O
between	O
the	O
Patho	O
Dx	O
Kit	O
and	O
the	O
standard	O
method	O
was	O
0.958	O
.	O

Senior	O
systems--45	O
;	O
Mental	O
health	O
and	O
illness	O
in	O
old	O
age--3	O
.	O

Patients	O
with	O
acute	O
myocardial	O
infarction	O
had	O
higher	O
plasma	O
concentrations	O
of	O
neutrophil	B
elastase	I
and	O
the	O
non	O
-	O
peroxide	O
diene	O
conjugated	O
isomer	O
of	O
linoleic	O
acid	O
than	O
normal	O
volunteers	O
or	O
patients	O
with	O
stable	O
ischaemic	O
heart	O
disease	O
.	O

Determination	O
of	O
three	O
-	O
dimensional	O
imaging	O
properties	O
of	O
a	O
light	O
microscope	O
system	O
.	O

The	O
cis	O
-	O
acting	O
element	O
,	O
identified	O
as	O
CACGTGACCCG	O
,	O
is	O
located	O
34	O
bp	O
upstream	O
from	O
the	O
transcription	O
initiation	O
site	O
,	O
and	O
contains	O
the	O
core	O
sequence	O
of	O
the	O
upstream	O
promoter	O
sequence	O
of	O
Ad2MLP	B
.	O

The	O
clinical	O
relevance	O
of	O
these	O
findings	O
is	O
strengthened	O
by	O
the	O
observation	O
that	O
similar	O
results	O
were	O
obtained	O
when	O
P.HCl	O
was	O
given	O
by	O
the	O
intravenous	O
route	O
.	O

The	O
procedure	O
has	O
been	O
applied	O
to	O
three	O
materials	O
:	O
particle	O
board	O
with	O
carpet	O
;	O
gypsum	O
board	O
with	O
wallpaper	O
;	O
and	O
plywood	O
with	O
polyurethane	O
lacquer	O
,	O
for	O
which	O
the	O
steady	O
-	O
state	O
emission	O
factors	O
(	O
mg	O
m-2	O
h-1	O
)	O
of	O
several	O
compounds	O
are	O
given	O
.	O

Comparison	O
of	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
to	O
a	O
third	O
cell	O
-	O
surface	O
proteoglycan	O
,	O
48K5	B
from	O
human	O
lung	O
fibroblasts	O
(	O
Marynen	O
,	O
P.	O
,	O
Zhang	O
,	O
J.	O
,	O
Cassiman	O
,	O
J.	O
,	O
Vanden	O
Berghe	O
,	O
H.	O
,	O
and	O
David	O
,	O
C.	O

A	O
second	O
,	O
novel	O
C	O
subunit	O
(	O
CeCAT	B
alpha	I
'	I
,	O
374	O
residues	O
)	O
has	O
a	O
unique	O
56-residue	O
carboxyl	O
-	O
terminal	O
region	O
that	O
is	O
generated	O
by	O
the	O
alternative	O
splicing	O
of	O
the	O
C	B
pre	I
-	I
mRNA	I
.	O

The	O
alternative	O
exon	O
introduces	O
the	O
novel	O
carboxyl	O
terminus	O
and	O
a	O
new	O
translation	O
stop	O
signal	O
,	O
while	O
simultaneously	O
converting	O
the	O
coding	O
sequence	O
for	O
40	O
carboxyl	O
-	O
terminal	O
residues	O
in	O
CeCAT	B
alpha	I
into	O
3'-untranslated	O
nucleotides	O
.	O

Slowly	O
adapting	O
type	O
I	O
mechanoreceptor	O
discharge	O
as	O
a	O
function	O
of	O
dynamic	O
force	O
versus	O
dynamic	O
displacement	O
of	O
glabrous	O
skin	O
of	O
raccoon	O
and	O
squirrel	O
monkey	O
hand	O
.	O

Methods	O
used	O
include	O
Cobb	O
angle	O
and	O
a	O
segmental	O
evaluation	O
(	O
T7-T12	O
)	O
of	O
each	O
of	O
convex	O
and	O
concave	O
rib	O
-	O
vertebra	O
angles	O
(	O
RVAs	O
)	O
,	O
rib	O
-	O
vertebra	O
angle	O
differences	O
(	O
RVADs	O
)	O
,	O
vertebral	O
rotation	O
,	O
tilt	O
and	O
displacement	O
.	O

Lars	O
has	O
AIDS	O
--	O
a	O
more	O
dignified	O
life	O
with	O
care	O
at	O
home	O
.	O

The	O
application	O
of	O
these	O
microelectrodes	O
to	O
the	O
measurement	O
of	O
rapid	O
,	O
transient	O
changes	O
in	O
retinal	O
[	O
K+	O
]	O
o	O
is	O
presented	O
.	O

Combining	O
multiple	O
laboratory	O
studies	O
may	O
be	O
of	O
value	O
in	O
predetermining	O
the	O
eventual	O
outcome	O
in	O
near	O
-	O
drowning	O
.	O

Accumulations	O
of	O
Tl+1	O
(	O
202Tl	O
label	O
)	O
were	O
6	O
times	O
those	O
for	O
Ga	O
or	O
In	O
in	O
the	O
brain	O
and	O
muscles	O
,	O
and	O
.1	O
times	O
in	O
plasma	O
.	O

The	O
afferents	O
'	O
phase	O
of	O
response	O
was	O
unmodified	O
by	O
electrical	O
EVS	O
stimulation	O
.	O

Solving	O
an	O
age	O
old	O
problem	O
.	O

The	O
distribution	O
of	O
their	O
fibrinogen	B
levels	O
was	O
Gaussian	O
,	O
but	O
more	O
wide	O
-	O
based	O
than	O
the	O
distribution	O
of	O
our	O
normal	O
controls	O
.	O

The	O
examination	O
was	O
focused	O
on	O
assessment	O
of	O
different	O
types	O
of	O
drusen	O
,	O
on	O
evaluation	O
of	O
the	O
development	O
and	O
incidence	O
of	O
risk	O
factors	O
leading	O
to	O
complications	O
and	O
loss	O
of	O
central	O
vision	O
.	O

They	O
were	O
then	O
subjected	O
to	O
whole	O
-	O
body	O
heat	O
stress	O
(	O
water	O
-	O
perfused	O
suits	O
)	O
,	O
and	O
the	O
3	O
minutes	O
of	O
LBNP	O
was	O
repeated	O
.	O

An	O
NF1-related	B
vitellogenin	I
activator	I
element	I
mediates	O
transcription	O
from	O
the	O
estrogen	O
-	O
regulated	O
Xenopus	B
laevis	I
vitellogenin	I
promoter	I
.	O

At	O
the	O
carboxyl	O
terminus	O
,	O
deletion	O
as	O
far	O
as	O
residue	O
388	O
did	O
not	O
affect	O
in	O
vitro	O
TRF.C	B
assembly	O
,	O
although	O
trans	O
-	O
activating	O
activity	O
was	O
abolished	O
.	O

The	O
effects	O
of	O
mean	O
luminance	O
were	O
also	O
measured	O
and	O
a	O
general	O
expression	O
that	O
would	O
take	O
them	O
into	O
account	O
was	O
derived	O
.	O

Effect	O
of	O
hyperglycemia	O
on	O
pain	O
threshold	O
in	O
alloxan	O
-	O
diabetic	O
rats	O
.	O

We	O
have	O
synthesized	O
[	O
7,7	O
-	O
2H2	O
]	O
-19-OHA	O
with	O
high	O
deuterium	O
content	O
and	O
,	O
together	O
with	O
[	O
7,7	O
-	O
2H2	O
]	O
A	O
and	O
[	O
9,11	O
-	O
2H2	O
]	O
estrone	O
(	O
E1	O
)	O
,	O
have	O
developed	O
a	O
quantitative	O
assay	O
of	O
serum	O
level	O
19-OHA	O
,	O
A	O
,	O
and	O
E1	O
using	O
the	O
gas	O
chromatography	O
/	O
mass	O
spectrometry	O
-	O
mass	O
fragmentography	O
method	O
to	O
monitor	O
individual	O
subjects	O
throughout	O
pregnancy	O
.	O

Since	O
the	O
UfAP	B
and	O
UTMP	B
share	O
many	O
biosynthetic	O
and	O
structural	O
features	O
that	O
include	O
site	O
of	O
biosynthesis	O
in	O
the	O
endometrium	O
,	O
P4-responsiveness	O
,	O
the	O
presence	O
of	O
the	O
mannose	O
6-phosphate	O
lysosomal	O
recognition	O
marker	O
,	O
and	O
considerable	O
sequence	O
similarity	O
,	O
the	O
UfAP	B
and	O
the	O
UTMP	B
may	O
have	O
homologous	O
function	O
which	O
for	O
both	O
still	O
remains	O
obscure	O
.	O

Treating	O
renal	O
anaemia	O
with	O
recombinant	O
human	O
erythropoietin	B
.	O

The	O
pseudolymphoma	O
syndrome	O
is	O
a	O
reversible	O
reactive	O
condition	O
consisting	O
of	O
fever	O
,	O
lymphadenopathy	O
and	O
generalized	O
rash	O
.	O

In	O
the	O
local	O
geomagnetic	O
field	O
,	O
the	O
animals	O
preferred	O
the	O
SE	O
-	O
sector	O
.	O

In	O
the	O
artificial	O
lung	O
,	O
like	O
in	O
the	O
natural	O
lung	O
and	O
peripheral	O
tissues	O
,	O
gas	O
exchanges	O
depend	O
on	O
several	O
parameters	O
:	O
blood	O
inlet	O
conditions	O
,	O
blood	O
flow	O
rate	O
,	O
temperature	O
,	O
composition	O
of	O
the	O
gas	O
mixture	O
used	O
for	O
ventilation	O
,	O
blood	O
tissue	O
perfusion	O
,	O
O2	O
consumption	O
,	O
etc	O
.	O

We	O
conclude	O
that	O
DNA	O
ploidy	O
is	O
a	O
major	O
objective	O
prognostic	O
factor	O
and	O
therapeutic	O
determinant	O
for	O
endometrial	O
carcinoma	O
.	O

A	O
semiautomatic	O
digital	O
system	O
(	O
Videoplan	O
2	O
)	O
was	O
used	O
.	O

Environmental	O
factors	O
were	O
more	O
important	O
in	O
the	O
older	O
cohorts	O
(	O
perhaps	O
because	O
of	O
less	O
reliable	O
recall	O
)	O
.	O

The	O
order	O
of	O
the	O
helicase	B
motif	I
and	O
the	O
nsP3	B
homology	I
region	I
in	O
the	O
RUB	O
genome	O
is	O
reversed	O
with	O
respect	O
to	O
the	O
alphavirus	O
genome	O
indicating	O
that	O
a	O
genetic	O
rearrangement	O
has	O
occurred	O
during	O
the	O
evolution	O
of	O
these	O
viruses	O
.	O

The	O
results	O
suggest	O
followings--1	O
)	O
both	O
eosinophils	O
and	O
neutrophils	O
participate	O
in	O
hypersecretion	O
of	O
type	O
Ib	O
in	O
atopic	O
cases	O
,	O
and	O
only	O
eosinophils	O
in	O
non	O
-	O
atopic	O
cases	O
.	O

There	O
were	O
5	O
treatments	O
:	O
control	O
(	O
C	O
)	O
;	O
a	O
wooden	O
surround	O
in	O
one	O
rear	O
corner	O
of	O
the	O
cage	O
(	O
S	O
)	O
;	O
a	O
fiberglass	O
rollaway	O
hollow	O
in	O
one	O
rear	O
corner	O
of	O
the	O
cage	O
(	O
H	O
)	O
;	O
a	O
hollow	O
and	O
a	O
surround	O
(	O
H	O
/	O
S	O
)	O
;	O
a	O
nest	O
box	O
attached	O
to	O
the	O
back	O
of	O
the	O
cage	O
,	O
containing	O
a	O
hollow	O
(	O
N	O
)	O
.	O

While	O
no	O
significant	O
differences	O
in	O
the	O
tensile	O
responses	O
or	O
failure	O
characteristics	O
were	O
noted	O
for	O
irradiated	O
and	O
nonirradiated	O
grafts	O
in	O
the	O
drip	O
,	O
in	O
the	O
bath	O
environment	O
the	O
nonirradiated	O
tissues	O
had	O
greater	O
strength	O
and	O
modulus	O
.	O

The	O
patient	O
was	O
treated	O
with	O
benzathine	O
penicillin	O
,	O
2,400,000	O
U	O
weekly	O
for	O
three	O
weeks	O
.	O

A	O
consensus	O
binding	O
site	O
for	O
the	O
transcription	O
factor	O
SP1	B
was	O
identified	O
in	O
intron	O
As	O
downstream	O
of	O
the	O
proenkephalin	B
germ	I
cell	I
cap	I
site	I
region	I
.	O

This	O
proposed	O
method	O
is	O
similar	O
in	O
principle	O
to	O
the	O
sets	O
technique	O
but	O
is	O
shown	O
to	O
have	O
much	O
better	O
expected	O
time	O
to	O
alarm	O
properties	O
.	O

The	O
effects	O
on	O
reflex	O
latencies	O
but	O
not	O
on	O
paCO2	O
or	O
pHa	O
were	O
blocked	O
by	O
naloxone	O
(	O
2	O
mg	O
/	O
kg	O
)	O
,	O
and	O
were	O
not	O
present	O
in	O
morphine	O
-	O
tolerant	O
animals	O
.	O

Drug	O
and	O
personnel	O
costs	O
were	O
reduced	O
when	O
batch	O
manufacturing	O
with	O
40-mL	O
multidose	O
vials	O
was	O
compared	O
with	O
extemporaneous	O
compounding	O
with	O
unit	O
-	O
dose	O
vials	O
.	O

Dermal	O
toxicity	O
and	O
carcinogenicity	O
of	O
4-vinyl-1-cyclohexene	O
diepoxide	O
in	O
Fischer	O
rats	O
and	O
B6C3F1	O
mice	O
.	O

MK-927	O
:	O
a	O
topically	O
active	O
ocular	O
hypotensive	O
carbonic	B
anhydrase	I
inhibitor	O
.	O

PCR	O
-	O
derived	O
fragments	O
were	O
used	O
as	O
probes	O
for	O
the	O
isolation	O
of	O
the	O
U3	B
snRNA	I
genes	I
from	O
a	O
genomic	O
library	O
of	O
Arabidopsis	O
.	O

Co	O
-	O
administration	O
of	O
5FU	O
,	O
angiotensin	B
II	I
and	O
microspheres	O
via	O
the	O
hepatic	O
artery	O
may	O
reduce	O
drug	O
exposure	O
in	O
the	O
systemic	O
compartment	O
and	O
therefore	O
may	O
increase	O
the	O
therapeutic	O
ratio	O
of	O
5FU	O
administration	O
via	O
the	O
hepatic	O
artery	O
.	O

The	O
effects	O
of	O
tap	O
(	O
TW	O
)	O
or	O
carbonated	O
(	O
CW	O
)	O
water	O
on	O
arterial	O
pH	O
,	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
(	O
PCO2	O
)	O
and	O
plasma	O
lactate	O
were	O
determined	O
in	O
heat	O
-	O
stressed	O
broilers	O
.	O

Transient	O
expression	O
of	O
human	B
and	I
chicken	I
progesterone	I
receptors	I
does	O
not	O
support	O
alternative	O
translational	O
initiation	O
from	O
a	O
single	O
mRNA	O
as	O
the	O
mechanism	O
generating	O
two	O
receptor	O
isoforms	O
.	O

The	O
Community	O
Adjustment	O
Scale	O
provided	O
outcome	O
data	O
related	O
to	O
the	O
subjects	O
'	O
degree	O
of	O
productivity	O
,	O
ability	O
to	O
maintain	O
close	O
relationships	O
,	O
and	O
presence	O
/	O
absence	O
of	O
symptomatology	O
an	O
average	O
of	O
32	O
years	O
after	O
initial	O
admission	O
.	O

However	O
,	O
at	O
18	O
months	O
of	O
age	O
,	O
significantly	O
higher	O
levels	O
of	O
IgG1	B
(	O
P	O
less	O
than	O
0.05	O
)	O
and	O
of	O
IgG4	B
(	O
P	O
less	O
than	O
0.01	O
)	O
were	O
found	O
in	O
infants	O
with	O
an	O
elevated	O
IgE	B
(	O
greater	O
than	O
or	O
equal	O
to	O
8.0	O
kU	O
/	O
l	O
)	O
than	O
in	O
those	O
with	O
a	O
lower	O
level	O
.	O

The	O
protein	O
sequence	O
contains	O
seven	O
potential	O
N	O
-	O
linked	O
glycosylation	O
sites	O
and	O
a	O
threonine	O
/	O
serine	O
-	O
rich	O
region	O
which	O
is	O
a	O
potential	O
site	O
for	O
attachment	O
of	O
O	O
-	O
linked	O
carbohydrate	O
.	O

On	O
histologic	O
examination	O
the	O
cuboidal	O
epithelium	O
of	O
the	O
mucous	O
membrane	O
was	O
found	O
to	O
be	O
changed	O
into	O
columnar	O
epithelium	O
,	O
with	O
uneven	O
distribution	O
of	O
enlarged	O
nuclei	O
in	O
the	O
vacuolized	O
cytoplasm	O
.	O

The	O
same	O
trend	O
was	O
noted	O
between	O
YG	O
4.5	O
heifers	O
and	O
YG	O
5.5	O
steers	O
,	O
indicating	O
a	O
sex	O
-	O
related	O
deposition	O
of	O
seam	O
fat	O
in	O
fed	O
cattle	O
.	O

Toxicities	O
included	O
:	O
nausea	O
/	O
vomiting	O
(	O
69	O
%	O
)	O
,	O
headache	O
(	O
25	O
%	O
)	O
,	O
chills	O
(	O
69	O
%	O
)	O
,	O
pain	O
at	O
tumor	O
sites	O
(	O
63	O
%	O
)	O
,	O
hypotension	O
(	O
31	O
%	O
)	O
,	O
and	O
hypertension	O
(	O
38	O
%	O
)	O
.	O

Fatal	O
encephalitis	O
in	O
a	O
patient	O
with	O
chronic	O
graft	O
-	O
versus	O
-	O
host	O
disease	O
.	O

Compared	O
to	O
its	O
counterpart	O
in	O
the	O
GPB	B
gene	I
,	O
exon	O
3	O
of	O
the	O
GPE	B
gene	I
contains	O
several	O
point	O
mutations	O
,	O
an	O
insertion	O
of	O
24	O
bp	O
,	O
and	O
a	O
stop	O
codon	O
which	O
shortens	O
the	O
reading	O
frame	O
.	O

The	O
results	O
corroborate	O
the	O
idea	O
that	O
the	O
structure	O
of	O
relaxation	O
curves	O
contains	O
information	O
on	O
the	O
distance	O
scale	O
and	O
on	O
the	O
architecture	O
of	O
the	O
pore	O
space	O
,	O
even	O
if	O
it	O
is	O
difficult	O
to	O
extract	O
it	O
without	O
ambiguities	O
.	O

Serotonin	B
5-HT2	I
receptor	I
binding	O
on	O
blood	O
platelets	O
as	O
a	O
state	O
dependent	O
marker	O
in	O
major	O
affective	O
disorder	O
.	O

Although	O
%	O
BF	O
was	O
correlated	O
with	O
all	O
the	O
BMIs	O
(	O
r	O
=	O
0.60	O
-	O
0.82	O
)	O
,	O
applying	O
objective	O
definitions	O
of	O
obesity	O
based	O
on	O
BMIs	O
or	O
%	O
BF	O
by	O
densitometry	O
often	O
produced	O
conflicting	O
results	O
.	O

Promoter	O
elements	O
include	O
an	O
atypical	O
TATA	O
box	O
(	O
GTTA	O
)	O
,	O
one	O
CCAAT	O
box	O
much	O
further	O
from	O
the	O
initiation	O
site	O
,	O
three	O
reverse	O
compliments	O
of	O
CCAAT	O
(	O
ATTGG	O
)	O
,	O
and	O
two	O
pyrimidine	O
-	O
rich	O
nucleotide	O
stretches	O
.	O

The	O
cloned	O
genes	O
were	O
identified	O
in	O
genetic	O
libraries	O
by	O
hybridization	O
screening	O
using	O
four	O
deoxyoligonucleotide	O
probes	O
which	O
corresponded	O
to	O
the	O
partial	O
amino	O
acid	O
sequence	O
of	O
the	O
purified	O
enzyme	O
.	O

The	O
pattern	O
for	O
catalytic	O
zinc	O
sites	O
included	O
two	O
ligands	O
close	O
in	O
sequence	O
,	O
a	O
sequence	O
-	O
distant	O
ligand	O
,	O
and	O
a	O
main	O
-	O
chain	O
hydrogen	O
bond	O
joining	O
two	O
ligands	O
.	O

Results	O
of	O
the	O
long	O
-	O
term	O
observation	O
and	O
treatment	O
of	O
patients	O
with	O
arterial	O
hypertension	O

Comparison	O
of	O
propofol	O
and	O
thiopentone	O
as	O
anaesthetic	O
agents	O
for	O
electroconvulsive	O
therapy	O
.	O

In	O
Experiment	O
II	O
,	O
as	O
performing	O
moderate	O
supine	O
cycling	O
(	O
55	O
%	O
VO2	O
max	O
)	O
for	O
50	O
minutes	O
under	O
several	O
LBNP	O
conditions	O
in	O
5	O
sedentary	O
women	O
,	O
there	O
were	O
correspondingly	O
similar	O
changing	O
manners	O
of	O
the	O
cardiovascular	O
adjustments	O
to	O
each	O
of	O
the	O
phases	O
given	O
in	O
Experiment	O
I.	O

Commercially	O
available	O
formulations	O
of	O
2.5	O
%	O
and	O
5	O
%	O
lambdacyhalothrin	O
can	O
be	O
diluted	O
either	O
with	O
water	O
for	O
ULV	O
cold	O
aerosol	O
space	O
-	O
spraying	O
or	O
with	O
diesel	O
/	O
kerosene	O
for	O
thermal	O
fogging	O
at	O
recommended	O
application	O
rates	O
of	O
0.5	O
-	O
1	O
g	O
ai	O
/	O
ha	O
for	O
mosquito	O
control	O
and	O
2	O
g	O
ai	O
/	O
ha	O
for	O
housefly	O
control	O
.	O

The	O
trk-2h	B
oncogene	I
,	O
isolated	O
from	O
the	O
human	O
breast	O
carcinoma	O
cell	O
line	O
MDA	O
-	O
MB	O
231	O
by	O
genomic	O
DNA	O
-	O
transfection	O
into	O
NIH3T3	O
cells	O
,	O
consists	O
of	O
the	O
trk	B
proto	I
-	I
oncogene	I
receptor	I
kinase	I
domain	I
fused	O
to	O
a	O
N	O
-	O
terminal	O
41	O
amino	O
acid	O
activating	O
sequence	O
(	O
Kozma	O
,	O
S.C.	O
,	O
Redmond	O
,	O
S.M.S.	O
,	O
Xiao	O
-	O
Chang	O
,	O
F.	O
,	O
Saurer	O
,	O
S.M.	O
,	O
Groner	O
,	O
B.	O
and	O
Hynes	O
,	O
N.E.	O

Since	O
very	O
recent	O
scanning	O
-	O
deletion	O
analysis	O
indicates	O
that	O
there	O
is	O
a	O
critical	O
region	O
for	O
activity	O
near	O
Cys-118	O
and	O
that	O
Cys-118	O
is	O
necessary	O
for	O
maximal	O
activity	O
,	O
we	O
conclude	O
that	O
the	O
Cys-118	O
residue	O
is	O
necessary	O
for	O
proper	O
glycosylation	O
and	O
maximal	O
biologic	O
activity	O
of	O
GM	B
-	I
CSF	I
.	O

Molecular	O
and	O
functional	O
characterization	O
of	O
the	O
promoter	O
of	O
ETS2	B
,	O
the	O
human	O
c	B
-	I
ets-2	I
gene	O
.	O

Branch	O
occlusion	O
of	O
Heubner	O
's	O
artery	O
,	O
or	O
perforators	O
from	O
the	O
proximal	O
anterior	O
or	O
middle	O
cerebral	O
arteries	O
were	O
the	O
posited	O
mechanism	O
of	O
infarction	O
.	O

All	O
ABFI	B
-	I
binding	I
sites	I
,	O
regardless	O
of	O
origin	O
,	O
provided	O
weak	O
UAS	O
function	O
in	O
vivo	O
when	O
examined	O
in	O
test	O
plasmids	O
.	O

An	O
examination	O
of	O
the	O
properties	O
of	O
sequences	O
surrounding	O
ARS1	O
left	O
open	O
the	O
possibility	O
that	O
ABFI	B
enhances	O
the	O
initiation	O
of	O
DNA	O
replication	O
at	O
ARS1	O
by	O
transcriptional	O
activation	O
.	O

Nonvascular	O
ophthalmic	O
and	O
neurologic	O
disorders	O
that	O
can	O
be	O
confused	O
with	O
amaurosis	O
fugax	O
are	O
listed	O
,	O
and	O
an	O
algorithm	O
for	O
evaluation	O
(	O
which	O
includes	O
ophthalmic	O
examination	O
,	O
laboratory	O
studies	O
,	O
and	O
noninvasive	O
carotid	O
artery	O
studies	O
)	O
is	O
given	O
.	O

Likewise	O
,	O
whether	O
or	O
not	O
the	O
hypotensive	O
action	O
of	O
converting	O
enzyme	O
inhibitors	O
is	O
age	O
-	O
related	O
is	O
as	O
yet	O
unknown	O
.	O

Polyclonal	O
antiserum	O
generated	O
to	O
the	O
fusion	O
protein	O
was	O
capable	O
of	O
detecting	O
42-	O
and	O
46-kilodalton	O
polypeptides	O
from	O
virus	O
particles	O
;	O
both	O
polypeptides	O
were	O
also	O
shown	O
to	O
contain	O
HBsAg	B
determinants	I
.	O

At	O
maximum	O
photosensitivity	O
the	O
inhibitory	O
amino	O
acids	O
gamma	O
-	O
aminobutyric	O
acid	O
and	O
taurine	O
were	O
lower	O
,	O
and	O
those	O
of	O
asparagine	O
(	O
metabolite	O
of	O
the	O
excitatory	O
amino	O
acid	O
aspartate	O
)	O
were	O
higher	O
,	O
than	O
when	O
the	O
animals	O
were	O
not	O
photosensitive	O
.	O

We	O
evaluated	O
the	O
likelihood	O
of	O
tissues	O
to	O
be	O
positive	O
for	O
carcinoembryonic	B
antigen	I
and	O
the	O
intensity	O
of	O
carcinoembryonic	B
antigen	I
staining	O
in	O
specimens	O
of	O
villous	O
adenomas	O
,	O
mixed	O
polypoid	O
villous	O
adenomas	O
,	O
polypoid	O
adenomas	O
,	O
and	O
diverticulitis	O
using	O
the	O
peroxidase	B
-	O
antiperoxidase	B
technique	O
.	O

The	O
priming	O
activity	O
of	O
DNA	O
incised	O
by	O
either	O
of	O
the	O
Drosophila	O
enzymes	O
can	O
be	O
enhanced	O
,	O
however	O
,	O
by	O
an	O
additional	O
incubation	O
with	O
E.	B
coli	I
endonuclease	I
IV	I
,	O
which	O
is	O
known	O
to	O
cleave	O
depurinated	O
DNA	O
on	O
the	O
5'-side	O
of	O
an	O
apurinic	O
site	O
.	O

The	O
cDNAs	O
cross	O
-	O
hybridize	O
with	O
genomic	O
sequences	O
in	O
rat	O
,	O
human	O
,	O
and	O
chicken	O
DNA	O
,	O
but	O
not	O
with	O
DNA	O
from	O
frog	O
,	O
Drosophila	O
,	O
or	O
sea	O
urchin	O
.	O

Deletion	O
analysis	O
was	O
carried	O
out	O
within	O
a	O
part	O
of	O
the	O
5'-flanking	O
region	O
showing	O
homology	O
to	O
the	O
upstream	O
region	O
of	O
the	O
yeast	B
CYC1	I
gene	I
.	O

The	O
N1	O
and	O
P2	O
were	O
comparable	O
in	O
amplitude	O
and	O
both	O
had	O
prolonged	O
refractory	O
periods	O
.	O

Tolerance	O
to	O
fenfluramine	O
anorexia	O
:	O
fact	O
or	O
fiction	O
?	O

Recent	O
findings	O
in	O
this	O
laboratory	O
with	O
regard	O
to	O
tolerance	O
to	O
fenfluramine	O
anorexia	O
are	O
reviewed	O
with	O
respect	O
to	O
generality	O
of	O
the	O
behavioural	O
phenomenon	O
.	O

In	O
30	O
dogs	O
the	O
left	O
limb	O
(	O
tail	O
)	O
of	O
the	O
pancreas	O
was	O
removed	O
but	O
left	O
in	O
the	O
abdominal	O
cavity	O
after	O
cessation	O
of	O
blood	O
flow	O
to	O
produce	O
warm	O
ischemia	O
for	O
30	O
,	O
60	O
,	O
and	O
120	O
min	O
(	O
10	O
dogs	O
at	O
each	O
time	O
point	O
)	O
,	O
and	O
then	O
was	O
flushed	O
with	O
cold	O
Ringers	O
'	O
lactate	O
and	O
transplanted	O
to	O
the	O
iliac	O
vessels	O
.	O

Furthermore	O
,	O
beta	B
2-adrenoceptor	I
sensitivity	O
appears	O
to	O
be	O
unaltered	O
in	O
BHT	O
.	O

We	O
conclude	O
that	O
Hansel	O
's	O
stain	O
substantially	O
improves	O
the	O
recognition	O
of	O
eosinophiluria	O
as	O
compared	O
with	O
Wright	O
's	O
stain	O
.	O

These	O
results	O
suggest	O
that	O
the	O
negative	O
inotropic	O
action	O
of	O
nicorandil	O
is	O
caused	O
by	O
inhibition	O
of	O
Ca	O
influx	O
and	O
intracellular	O
mobilization	O
of	O
Ca	O
.	O

The	O
study	O
included	O
139	O
eyes	O
with	O
presumed	O
ocular	O
histoplasmosis	O
syndrome	O
(	O
POHS	O
)	O
and	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
AMD	O
)	O
.	O

Comparison	O
of	O
elastase-1	B
with	O
amylase	B
,	O
lipase	B
,	O
and	O
trypsin	B
-	O
like	O
immunoreactivity	O
in	O
the	O
diagnosis	O
of	O
acute	O
pancreatitis	O
.	O

Lysozyme	B
activity	O
was	O
evidently	O
increased	O
as	O
well	O
in	O
undiluted	O
as	O
in	O
diluted	O
sera	O
in	O
all	O
our	O
tested	O
patients	O
.	O

The	O
first	O
involved	O
measurements	O
of	O
the	O
steady	O
state	O
levels	O
of	O
mRNAs	O
for	O
subunit	O
5	O
of	O
cytochrome	B
oxidase	I
and	O
the	O
beta	O
subunit	O
of	O
F1	B
ATPase	I
in	O
wild	O
type	O
and	O
in	O
a	O
hem2	B
mutant	I
.	O

ATP	O
gamma	O
S	O
inhibition	O
can	O
be	O
overcome	O
by	O
high	O
concentrations	O
of	O
ATP	O
,	O
dATP	O
,	O
araATP	O
,	O
or	O
ddATP	O
.	O

ASL-8123	O
demonstrated	O
weak	O
competitive	O
beta	B
-	I
adrenoreceptor	I
blocking	O
activity	O
in	O
isolated	O
guinea	O
pig	O
right	O
atria	O
with	O
a	O
pA2	O
of	O
3.73	O
+	O
/-	O

0.07	O
;	O
no	O
agonist	O
-	O
like	O
activity	O
was	O
observed	O
in	O
this	O
tissue	O
at	O
concentrations	O
of	O
ASL-8123	O
from	O
3	O
X	O
10	O
(	O
-5	O
)	O
to	O
1	O
X	O
10	O
(	O
-2	O
)	O
M.	O

Enhancer	O
and	O
promoter	O
elements	O
directing	O
activation	O
and	O
glucocorticoid	O
repression	O
of	O
the	O
alpha	B
1-fetoprotein	I
gene	I
in	O
hepatocytes	O
.	O

Hybridization	O
of	O
a	O
probe	O
from	O
this	O
region	O
to	O
electrophoretic	O
blots	O
of	O
RNAs	O
from	O
different	O
human	O
tissues	O
showed	O
a	O
predominant	O
2.8-kilobase	O
(	O
kb	O
)	O
message	O
accompanied	O
by	O
weaker	O
bands	O
4.1	O
and	O
2.1	O
kb	O
in	O
size	O
.	O

Svensson	O
et	O
al.	O

In	O
this	O
report	O
we	O
describe	O
for	O
the	O
first	O
time	O
the	O
complete	O
primary	O
structure	O
of	O
type	B
X	I
collagen	I
,	O
based	O
on	O
cloning	O
and	O
sequencing	O
of	O
cDNA	O
and	O
genomic	O
DNA	O
.	O

Viable	O
flap	O
areas	O
were	O
established	O
following	O
vascular	O
pedicle	O
ligation	O
(	O
both	O
vessels	O
or	O
only	O
artery	O
or	O
vein	O
)	O
,	O
on	O
the	O
third	O
day	O
after	O
flap	O
replantation	O
in	O
both	O
island	O
and	O
free	O
flaps	O
.	O

A	O
9.5-kb	O
KpnI	B
-	O
SalI	B
fragment	O
,	O
where	O
all	O
the	O
DNA	O
changes	O
associated	O
with	O
su	B
(	I
Hw	I
)	I
mutations	I
were	O
mapped	O
,	O
was	O
able	O
to	O
rescue	O
the	O
su	B
(	I
Hw	I
)	I
mutant	I
phenotype	O
after	O
P	O
-	O
element	O
-	O
mediated	O
germ	O
-	O
line	O
transformation	O
.	O

The	O
corticosterone	O
synthesis	O
inhibitor	O
metyrapone	O
(	O
75	O
mg	O
/	O
kg	O
i.p	O
.	O
)	O
was	O
given	O
to	O
attenuate	O
the	O
rise	O
of	O
corticosterone	O
to	O
a	O
level	O
typical	O
of	O
stressed	O
males	O
.	O

The	O
effects	O
of	O
L655,240	O
,	O
a	O
selective	O
thromboxane	O
and	O
prostaglandin	O
endoperoxide	O
antagonist	O
,	O
on	O
ischemia-	O
and	O
reperfusion	O
-	O
induced	O
cardiac	O
arrhythmias	O
.	O

In	O
10	O
pentobarbitalized	O
dogs	O
,	O
plasma	O
viscosity	O
(	O
Ep	O
)	O
was	O
raised	O
fourfold	O
while	O
apparent	O
blood	O
viscosity	O
(	O
Ea	O
)	O
increased	O
about	O
twofold	O
by	O
two	O
steps	O
of	O
exchange	O
transfusion	O
of	O
200	O
ml	O
of	O
plasma	O
with	O
plasma	O
containing	O
high	O
molecular	O
weight	O
dextran	O
(	O
mol	O
wt	O
500,000	O
,	O
20	O
%	O
wt	O
/	O
vol	O
)	O
.	O

The	O
small	B
IGF	I
-	I
binding	I
protein	I
is	O
abundant	O
in	O
human	O
amniotic	O
fluid	O
.	O

The	O
investigation	O
was	O
thereafter	O
continued	O
in	O
an	O
open	O
fashion	O
by	O
administering	O
a	O
single	O
10	O
mg	O
dose	O
of	O
the	O
MAO	B
-	I
B	I
inhibitor	O
deprenyl	O
to	O
the	O
same	O
subjects	O
.	O

The	O
investigation	O
was	O
apt	O
at	O
studying	O
the	O
relationship	O
between	O
urinary	O
metabolites	O
of	O
serotonin	O
and	O
catecholamine	O
(	O
5-HIAA	O
and	O
VMA	O
)	O
,	O
T	O
-	O
cells	O
(	O
OKT3	B
+	I
)	O
,	O
T	O
-	O
helper	O
(	O
OKT4	B
+	I
)	O
,	O
T	O
-	O
suppressor	O
(	O
OKT8	B
+	I
)	O
and	O
B	O
-	O
cells	O
(	O
EAC	O
-	O
rosette	O
forming	O
cells	O
)	O
in	O
normal	O
(	O
10	O
subjects	O
,	O
1	O
female	O
,	O
9	O
male	O
,	O
age	O
21	O
+	O
/-	O

5	O
years	O
)	O
and	O
stress	O
administered	O
subjects	O
(	O
20	O
subjects	O
,	O
3	O
female	O
,	O
17	O
male	O
,	O
age	O
20	O
+	O
/-	O

4	O
years	O
)	O
.	O

Their	O
hydropathic	O
plots	O
are	O
very	O
similar	O
and	O
both	O
possess	O
three	O
hydrophobic	O
segments	O
that	O
are	O
likely	O
alpha	O
-	O
helical	O
transmembrane	O
segments	O
.	O

Angiotensin	B
converting	I
enzyme	I
inhibitors	O
enhance	O
the	O
antihypertensive	O
efficacy	O
of	O
diuretics	O
and	O
blunt	O
or	O
prevent	O
adverse	O
metabolic	O
effects	O
.	O

In	O
addition	O
to	O
the	O
significant	O
reduction	O
in	O
blood	O
pressure	O
,	O
the	O
angiotensin	B
converting	I
enzyme	I
(	O
ACE	B
)	O
inhibitor	O
ramipril	O
caused	O
a	O
significant	O
regression	O
of	O
pathologic	O
left	O
ventricular	O
hypertrophy	O
demonstrated	O
by	O
magnetic	O
resonance	O
imaging	O
and	O
echocardiography	O
.	O

Endocrine	O
cells	O
were	O
studied	O
by	O
means	O
of	O
Grimelius	O
'	O
silver	O
staining	O
and	O
immunostaining	O
for	O
chromogranin	B
,	O
a	O
general	O
marker	O
of	O
endocrine	O
cells	O
.	O

Tissue	O
necrosis	O
was	O
evaluated	O
using	O
triphenyltetrazolium	O
staining	O
and	O
was	O
related	O
to	O
two	O
major	O
baseline	O
predictors	O
of	O
infarct	O
size	O
:	O
anatomic	O
risk	O
zone	O
size	O
and	O
coronary	O
collateral	O
flow	O
.	O

To	O
study	O
the	O
retinal	O
surface	O
in	O
the	O
human	O
eye	O
in	O
normal	O
and	O
diseased	O
states	O
we	O
used	O
laser	O
scanning	O
tomography	O
.	O

Previously	O
,	O
we	O
reported	O
the	O
sequence	O
of	O
the	O
gene	B
encoding	I
human	I
K14	I
(	O
D.	O

Sequence	O
analysis	O
of	O
the	O
5	O
'	O
flanking	O
region	O
revealed	O
several	O
GC	O
boxes	O
but	O
no	O
identifiable	O
TATA	O
box	O
.	O

The	O
underlying	O
cirrhosis	O
was	O
alcoholic	O
in	O
11	O
(	O
53.3	O
%	O
)	O
,	O
cryptogenic	O
in	O
5	O
(	O
23.8	O
%	O
)	O
,	O
and	O
hepatitis	O
B	O
chronic	O
infection	O
related	O
in	O
5	O
(	O
23.8	O
%	O
)	O
.	O

Once	O
P-450scc	B
mRNA	I
is	O
induced	O
as	O
a	O
consequence	O
of	O
the	O
LH	B
/	O
hCG	B
surge	O
it	O
is	O
constitutively	O
maintained	O
by	O
luteinized	O
cells	O
in	O
vivo	O
(	O
0	O
-	O
4	O
days	O
)	O
and	O
in	O
vitro	O
(	O
0	O
-	O
9	O
days	O
)	O
in	O
the	O
absence	O
of	O
gonadotropins	B
,	O
is	O
susceptible	O
to	O
modulation	O
by	O
prolactin	B
and	O
is	O
no	O
longer	O
regulated	O
by	O
cAMP	O
.	O

NIK-244	O
suppressed	O
coronary	O
ligation-	O
and	O
digitalis	O
-	O
induced	O
arrhythmias	O
,	O
and	O
the	O
minimum	O
effective	O
plasma	O
concentrations	O
for	O
arrhythmias	O
induced	O
by	O
24-h	O
and	O
48-h	O
coronary	O
ligation	O
and	O
digitalis	O
were	O
0.41	O
+	O
/-	O

0.10	O
(	O
by	O
1	O
mg	O
/	O
kg	O
i.v	O
.	O
)	O
,	O
0.70	O
+	O
/-	O

0.13	O
(	O
by	O
1	O
mg	O
/	O
kg	O
i.v	O
.	O
)	O
,	O
and	O
0.21	O
+	O
/-	O

0.08	O
(	O
by	O
0.5	O
mg	O
/	O
kg	O
i.v	O
.	O
)	O
microgram	O
/	O
ml	O
,	O
respectively	O
(	O
mean	O
+	O
/-	O

SD	O
of	O
the	O
mean	O
,	O
n	O
=	O
6	O
)	O
.	O

Thus	O
,	O
phosphodiesterase	O
inhibitors	O
that	O
produce	O
an	O
opiate	O
quasi	O
-	O
withdrawal	O
syndrome	O
potentiate	O
interoceptive	O
stimuli	O
and	O
weight	O
loss	O
associated	O
with	O
the	O
withdrawal	O
syndrome	O
precipitated	O
by	O
naltrexone	O
in	O
morphine	O
-	O
dependent	O
rats	O
.	O

The	O
diagnostic	O
value	O
of	O
blood	O
serum	O
and	O
urinary	B
amylase	I
,	O
lipase	B
,	O
and	O
trypsin	B
in	O
exacerbations	O
of	O
chronic	O
relapsing	O
pancreatitis	O
is	O
discussed	O
.	O

Intravenous	O
gamma	B
globulins	I

Myocardial	O
perfusion	O
was	O
evaluated	O
using	O
the	O
enhanced	O
gray	O
level	O
after	O
contrast	O
injection	O
,	O
and	O
the	O
level	O
was	O
compared	O
with	O
the	O
morphology	O
and	O
degree	O
of	O
collateral	O
development	O
.	O

Once	O
NGF	B
administration	O
is	O
proven	O
effective	O
it	O
will	O
be	O
possible	O
to	O
develop	O
alternative	O
ways	O
of	O
NGF	B
administration	O
.	O

The	O
results	O
were	O
as	O
follows	O
:	O
1	O
)	O
Total	O
integrated	O
EMG	O
activity	O
of	O
FB	O
group	O
was	O
approximately	O
equal	O
in	O
any	O
occluded	O
position	O
,	O
whereas	O
that	O
of	O
CG	O
and	O
GF	O
group	O
varied	O
from	O
position	O
to	O
position	O
.	O

In	O
76	O
%	O
of	O
59	O
lead	O
-	O
toxic	O
children	O
,	O
bone	O
lead	O
values	O
measured	O
by	O
LXRF	O
were	O
equal	O
to	O
or	O
greater	O
than	O
those	O
measured	O
in	O
normal	O
and	O
industrially	O
exposed	O
adults	O
.	O

When	O
considered	O
with	O
the	O
known	O
neurotoxic	O
effects	O
on	O
children	O
of	O
""""	O
low	O
levels	O
""""	O
of	O
exposure	O
to	O
lead	O
,	O
these	O
results	O
also	O
suggest	O
that	O
either	O
an	O
excessively	O
narrow	O
margin	O
of	O
safety	O
or	O
insufficient	O
safety	O
is	O
provided	O
by	O
present	O
U.S.	O
guidelines	O
,	O
which	O
classify	O
an	O
elevated	O
blood	O
lead	O
concentration	O
as	O
25	O
micrograms	O
/	O
dl	O
or	O
greater	O
.	O

The	O
thrombolytic	O
effects	O
of	O
native	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
(	O
AK-124	B
)	O
on	O
experimental	O
canine	O
coronary	O
thrombosis	O
.	O

Enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
for	O
screening	O
aflatoxin	O
B1	O
in	O
cottonseed	O
products	O
and	O
mixed	O
feed	O
:	O
collaborative	O
study	O
.	O

However	O
,	O
experiments	O
with	O
S1	B
mapping	O
of	O
in	O
vivo	O
transcripts	O
,	O
gene	O
disruptions	O
in	O
the	O
alpha	O
region	O
,	O
and	O
a	O
single	O
-	O
copy	O
transcriptional	O
fusion	O
vector	O
all	O
suggested	O
that	O
these	O
possible	O
promoters	O
were	O
largely	O
inactive	O
during	O
logarithmic	O
growth	O
,	O
that	O
the	O
major	O
promoter	O
for	O
the	O
alpha	O
operon	O
lay	O
upstream	O
from	O
the	O
region	O
cloned	O
,	O
and	O
that	O
the	O
genes	O
in	O
the	O
IF1	B
to	O
L17	B
interval	O
were	O
cotranscribed	O
.	O

Functional	O
rearranged	O
antibody	O
genes	O
were	O
detected	O
with	O
JH	B
and	O
VH	B
heavy	I
chain	I
probes	O
and	O
with	O
Jk	B
and	O
Vk	B
light	I
chain	I
probes	O
.	O

Two	O
specific	O
DNA	O
-	O
protein	O
complexes	O
were	O
identified	O
in	O
gel	O
retardation	O
assays	O
using	O
HeLa	O
cell	O
nuclear	O
extracts	O
and	O
an	O
oligonucleotide	O
probe	O
spanning	O
the	O
footprinted	O
region	O
.	O

After	O
transfection	O
,	O
specific	O
TSH	B
beta	I
promoter	I
activity	O
was	O
evident	O
in	O
both	O
TRH	B
-	O
responsive	O
pituitary	O
-	O
derived	O
GH3	O
and	O
primary	O
pituitary	O
cell	O
cultures	O
.	O

In	O
transformed	O
E.	O
coli	O
,	O
constitutive	B
CAT	I
expression	O
is	O
maintained	O
when	O
as	O
little	O
as	O
0.3	O
kilobase	O
of	O
DNA	O
from	O
the	O
3	O
'	O
end	O
of	O
the	O
1.6-kilobase	O
segment	O
is	O
inserted	O
in	O
the	O
correct	O
orientation	O
in	O
front	O
of	O
the	O
CAT	B
gene	I
.	O

Lowering	O
of	O
the	O
renal	O
blood	O
flow	O
alters	O
the	O
glomerular	O
and	O
tubular	O
excretion	O
processes	O
.	O

Tonometry	O
of	O
blood	O
samples	O
from	O
patients	O
may	O
also	O
be	O
used	O
in	O
the	O
determination	O
of	O
acid	O
-	O
base	O
quantities	O
and	O
hemoglobin	B
-	O
oxygen	O
affinity	O
e.g.	O
p50	O
.	O

The	O
ORF1	O
product	O
was	O
required	O
for	O
competence	O
,	O
while	O
ORF2	O
,	O
which	O
was	O
cotranscribed	O
with	O
ORF1	O
and	O
encoded	O
a	O
predicted	O
protein	O
of	O
126	O
amino	O
acids	O
,	O
was	O
not	O
.	O

These	O
case	O
reports	O
provide	O
further	O
evidence	O
that	O
LiCO3	O
can	O
be	O
a	O
useful	O
medication	O
in	O
the	O
treatment	O
of	O
aggressive	O
behavior	O
and	O
affective	O
instability	O
after	O
brain	O
injury	O
,	O
but	O
that	O
it	O
has	O
significant	O
potential	O
for	O
neurotoxicity	O
in	O
this	O
population	O
,	O
particularly	O
when	O
used	O
in	O
conjunction	O
with	O
neuroleptic	O
agents	O
.	O

A	O
215-base	O
-	O
pair	O
(	O
bp	O
)	O
region	O
of	O
the	O
mouse	B
MOPC	I
41	I
kappa	I
light	I
-	I
chain	I
immunoglobulin	I
gene	I
enhancer	I
has	O
been	O
analyzed	O
for	O
specific	O
binding	O
of	O
lymphoid	O
and	O
nonlymphoid	O
nuclear	O
factors	O
.	O

This	O
paper	O
presents	O
the	O
reasons	O
why	O
countries	O
to	O
which	O
Chagas	O
disease	O
is	O
endemic	O
should	O
carry	O
out	O
the	O
relevant	O
research	O
themselves	O
.	O

Gastric	O
CO2	O
/	O
HCO3	O
was	O
determined	O
in	O
absence	O
of	O
simultaneous	O
inhibition	O
of	O
acid	O
secretion	O
by	O
intra-	O
and	O
extragastric	O
pCO2	O
/	O
pH	O
measurements	O
in	O
23	O
persons	O
and	O
calculated	O
using	O
the	O
equation	O
of	O
Henderson	O
-	O
Hasselbalch	O
.	O

pCO2	O
was	O
measured	O
with	O
use	O
of	O
a	O
new	O
electrode	O
.	O

Forty	O
patients	O
,	O
divided	O
according	O
to	O
their	O
initial	O
total	O
gastrointestinal	O
transit	O
times	O
and	O
presenting	O
symptoms	O
,	O
were	O
treated	O
with	O
cimetropium	O
bromide	O
50	O
mg	O
t.d.s	O
.	O

or	O
placebo	O
for	O
1	O
month	O
according	O
to	O
a	O
double	O
-	O
blind	O
,	O
parallel	O
group	O
design	O
.	O

An	O
immunologically	O
related	O
protein	O
was	O
detected	O
in	O
ribosome	O
and	O
membrane	O
fractions	O
of	O
mitochondria	O
from	O
Saccharomyces	O
cerevisiae	O
.	O

According	O
to	O
the	O
published	O
sequence	O
of	O
the	O
CHS1	B
gene	I
,	O
this	O
fragment	O
contains	O
four	O
repeats	O
of	O
a	O
TGAAACA	O
consensus	O
sequence	O
previously	O
identified	O
in	O
the	O
alpha	B
-	I
factor	I
-	O
inducible	O
BAR1	B
promoter	I
[	O
Kronstad	O
,	O
J.	O

Southern	O
blot	O
analyses	O
demonstrated	O
a	O
low	O
,	O
if	O
not	O
single	O
,	O
copy	O
number	O
for	O
this	O
gene	O
and	O
conservation	O
of	O
this	O
domain	O
in	O
other	O
vertebrates	O
.	O

Three	O
missense	O
mutants	O
in	O
subunit	O
a	O
of	O
the	O
Escherichia	B
coli	I
F1F0-ATPase	I
were	O
isolated	O
and	O
characterized	O
after	O
hydroxylamine	O
mutagenesis	O
of	O
a	O
plasmid	O
carrying	O
the	O
uncB	B
(	I
subunit	I
a	I
)	I
gene	I
.	O

In	O
supine	O
position	O
,	O
plasma	O
ANP	B
levels	O
ranged	O
from	O
12	O
pg	O
/	O
ml	O
to	O
51.5	O
pg	O
/	O
ml	O
,	O
with	O
an	O
average	O
level	O
of	O
35.3	O
+	O
/-	O

11.5	O
pg	O
/	O
ml	O
.	O

The	O
adenovirus	B
E1A	I
gene	I
encodes	O
a	O
protein	O
that	O
transcriptionally	O
activates	O
viral	B
early	I
genes	I
.	O

RNA	O
transcripts	O
that	O
hybridize	O
to	O
the	O
introduced	O
foreign	O
gene	O
have	O
been	O
identified	O
.	O

At	O
the	O
basal	O
unstimulated	O
condition	O
,	O
Ren1d	B
5	I
'	I
flanking	I
sequence	I
in	O
the	O
sense	O
orientation	O
inhibited	O
basal	O
CAT	B
expression	O
from	O
the	O
TK	B
promoter	I
of	O
pUTKAT1	O
,	O
whereas	O
the	O
same	O
sequence	O
in	O
the	O
antisense	O
orientation	O
did	O
not	O
.	O

None	O
were	O
restricted	O
from	O
clinical	O
duties	O
,	O
were	O
given	O
varicella	B
-	I
zoster	I
immune	I
globulin	I
,	O
or	O
developed	O
disease	O
.	O

In	O
the	O
formalin	O
test	O
,	O
however	O
,	O
naloxone	O
attenuated	O
morphine	O
analgesia	O
at	O
the	O
lower	O
doses	O
(	O
0.1	O
and	O
0.3	O
mg	O
/	O
kg	O
)	O
and	O
potentiated	O
morphine	O
analgesia	O
at	O
the	O
highest	O
dose	O
(	O
10	O
mg	O
/	O
kg	O
)	O
.	O

We	O
have	O
isolated	O
cDNA	O
clones	O
from	O
rat	O
brain	O
and	O
human	O
liver	O
encoding	O
a	O
putative	O
isoform	O
of	O
the	O
Na	B
,	I
K	I
-	I
ATPase	I
beta	I
subunit	I
.	O

We	O
have	O
determined	O
that	O
several	O
E1	B
mutants	I
mapping	O
in	O
both	O
the	O
M	O
and	O
R	O
regions	O
and	O
a	O
single	O
mutant	O
of	O
the	O
upstream	O
regulatory	O
region	O
have	O
a	O
higher	O
transforming	O
activity	O
on	O
mouse	O
C127	O
cells	O
than	O
the	O
wild	O
-	O
type	O
genome	O
does	O
.	O

UbiA	B
is	O
also	O
unique	O
among	O
known	O
polyubiquitin	B
genes	I
in	O
containing	O
four	O
cis	O
-	O
spliced	O
introns	O
within	O
its	O
coding	O
sequence	O
.	O

That	O
of	O
the	O
T2	B
gene	I
contains	O
numerous	O
potential	O
sites	O
for	O
binding	O
the	O
mammalian	B
transcription	I
factor	I
SP1	I
,	O
but	O
no	O
TATA	O
or	O
CCAAT	O
sequences	O
are	O
evident	O
near	O
to	O
its	O
5	O
'	O
end	O
,	O
although	O
these	O
latter	O
features	O
are	O
associated	O
with	O
the	O
human	B
T1	I
gene	I
.	O

Radiation	O
therapy	O
was	O
effective	O
in	O
controlling	O
symptomatic	O
metastasis	O
in	O
all	O
three	O
patients	O
.	O

The	O
methylation	O
of	O
nuclear	O
and	O
chloroplast	O
DNAs	O
has	O
been	O
examined	O
in	O
relation	O
to	O
the	O
known	O
differential	O
expression	O
of	O
C4	B
photosynthesis	I
genes	I
in	O
the	O
bundle	O
sheath	O
and	O
mesophyll	O
cells	O
of	O
etiolated	O
,	O
greening	O
,	O
and	O
fully	O
green	O
maize	O
leaves	O
.	O

We	O
conclude	O
that	O
(	O
a	O
)	O
the	O
likelihood	O
of	O
detecting	O
carcinoma	O
or	O
atypical	O
hyperplasia	O
exclusively	O
in	O
the	O
adipose	O
tissue	O
component	O
of	O
grossly	O
benign	O
breast	O
biopsies	O
is	O
extremely	O
low	O
,	O
and	O
(	O
b	O
)	O
a	O
possible	O
cost	O
-	O
effective	O
method	O
of	O
sampling	O
grossly	O
benign	O
breast	O
biopsies	O
consists	O
of	O
initially	O
submitting	O
a	O
maximum	O
of	O
10	O
blocks	O
of	O
fibrous	O
parenchyma	O
for	O
each	O
case	O
,	O
then	O
examining	O
the	O
remaining	O
tissue	O
histologically	O
only	O
if	O
carcinoma	O
or	O
atypical	O
hyperplasia	O
is	O
found	O
among	O
these	O
blocks	O
.	O

Analysis	O
of	O
the	O
DNA	O
from	O
15	O
cases	O
of	O
sporadic	O
and	O
familial	O
Wilms	O
'	O
tumor	O
did	O
not	O
reveal	O
any	O
changes	O
,	O
indicating	O
that	O
the	O
translocation	O
breakpoint	O
does	O
not	O
reside	O
in	O
this	O
gene	O
.	O

We	O
also	O
provide	O
evidence	O
that	O
neither	O
the	O
lambda	B
O	I
and	O
P	B
initiators	I
nor	O
the	O
E.	B
coli	I
DnaJ	I
and	O
DnaK	B
heat	O
shock	O
proteins	O
play	O
a	O
direct	O
role	O
in	O
the	O
propagation	O
of	O
lambda	O
replication	O
forks	O
in	O
vitro	O
.	O

Synthetic	O
oligonucleotides	O
representing	O
the	O
19	O
bp	O
repeat	O
unit	O
strongly	O
reduced	O
the	O
activity	O
of	O
the	O
IE1	B
/	I
2	I
enhancer	I
/	I
promoter	I
in	O
cotransfection	O
assays	O
after	O
transient	O
expression	O
.	O

Effects	O
of	O
nitrogen	O
(	O
PN2	O
:	O
5	O
and	O
14	O
MPa	O
)	O
and	O
helium	O
(	O
PHe	O
:	O
13	O
and	O
14	O
MPa	O
)	O
were	O
also	O
tested	O
.	O

Antibodies	O
raised	O
to	O
the	O
expressed	O
NS3	B
by	O
immunization	O
of	O
mice	O
detected	O
both	O
NS3	B
and	O
NS3A	B
in	O
BTV-10-infected	O
BHK	O
cells	O
but	O
not	O
in	O
purified	O
BTV-10	O
virus	O
particles	O
.	O

Similarly	O
,	O
supraventricular	O
tachycaydia	O
following	O
resuscitative	O
efforts	O
appeared	O
to	O
be	O
associated	O
with	O
a	O
negative	O
outcome	O
.	O

The	O
negative	O
calcium	O
balance	O
with	O
hyperparathyroidemia	O
occurred	O
after	O
continuous	O
oral	O
administration	O
of	O
Cd	O
and	O
developed	O
via	O
increased	O
urinary	O
excretion	O
of	O
calcium	O
.	O

Clone	O
4c	O
(	O
2681	O
bp	O
)	O
had	O
a	O
coding	O
region	O
identical	O
to	O
that	O
of	O
clone	O
22c	O
but	O
it	O
included	O
a	O
putative	O
intron	O
of	O
959	O
bp	O
.	O

The	O
application	O
of	O
ISH	O
and	O
IHC	O
did	O
not	O
change	O
significantly	O
the	O
routine	O
histologic	O
classification	O
of	O
pneumonias	O
into	O
CMV	O
-	O
IP	O
and	O
IIP	O
.	O

Validity	O
of	O
immunohistology	O
and	O
in	O
situ	O
hybridization	O
in	O
the	O
differential	O
diagnosis	O
of	O
cytomegalovirus	O
pneumonia	O
and	O
idiopathic	O
interstitial	O
pneumonia	O
after	O
allogenic	O
bone	O
marrow	O
transplantation	O

Erythrocytic	O
stages	O
of	O
mammalian	O
malarial	O
parasites	O
contain	O
acristate	O
mitochondria	O
whose	O
functions	O
are	O
not	O
well	O
understood	O
.	O

However	O
,	O
bilateral	O
diffuse	O
pulmonary	O
infiltrations	O
developed	O
21	O
days	O
later	O
.	O

VP5	B
,	O
which	O
encodes	O
the	O
major	B
capsid	I
protein	I
,	O
each	O
fused	O
to	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
.	O

Of	O
202	O
initially	O
seronegative	O
caretakers	O
(	O
observed	O
for	O
an	O
average	O
of	O
305	O
days	O
per	O
woman	O
)	O
,	O
19	O
seroconverted	O
,	O
for	O
an	O
annual	O
seroconversion	O
rate	O
of	O
11	O
percent	O
.	O

First	O
,	O
a	O
pet54::LEU2	B
cytoductant	O
bearing	O
the	O
'	O
short	O
'	O
mitochondrial	O
genome	O
that	O
lacks	O
both	O
COX1	B
introns	I
aI5	B
alpha	I
and	O
aI5	B
beta	I
is	O
defective	O
only	O
in	O
COX3	B
gene	I
expression	O
and	O
not	O
in	O
COX1	B
mRNA	I
splicing	O
or	O
mRNA	O
translation	O
.	O

Since	O
considerable	O
variations	O
in	O
length	O
and	O
primary	O
sequence	O
in	O
the	O
CDR3	B
(	O
complementarity	B
determining	I
region	I
)	O
peptides	O
of	O
all	O
the	O
H	B
-	I
chains	I
are	O
evident	O
,	O
conservation	O
of	O
the	O
D	B
-	I
region	I
structure	O
does	O
not	O
appear	O
to	O
be	O
necessary	O
for	O
effective	O
hapten	O
binding	O
.	O

Tyrosine	B
kinase	I
oncogenes	O
abrogate	O
interleukin-3	B
dependence	O
of	O
murine	O
myeloid	O
cells	O
through	O
signaling	O
pathways	O
involving	O
c	B
-	I
myc	I
:	O
conditional	O
regulation	O
of	O
c	B
-	I
myc	I
transcription	O
by	O
temperature	O
-	O
sensitive	O
v	B
-	I
abl	I
.	O

This	O
TC	B
-	I
II	I
enhanson	I
,	O
which	O
is	O
identical	O
to	O
the	O
kappa	B
B	I
motif	I
from	O
the	O
kappa	B
chain	I
enhancer	I
,	O
was	O
active	O
in	O
both	O
lymphoid	O
and	O
non	O
-	O
lymphoid	O
cells	O
,	O
which	O
contrasts	O
with	O
the	O
previously	O
reported	O
lymphoid	O
cell	O
specificity	O
of	O
the	O
kappa	B
B	I
motif	I
.	O

The	O
DNA	O
helix	O
at	O
the	O
tandemly	O
repeated	O
,	O
13mer	O
sequence	O
is	O
thermodynamically	O
unstable	O
,	O
as	O
evidenced	O
by	O
hypersensitivity	O
to	O
single	B
-	I
strand	I
-	I
specific	I
nuclease	I
in	O
a	O
negatively	O
supercoiled	O
plasmid	O
,	O
and	O
demonstrated	O
by	O
stable	O
DNA	O
unwinding	O
seen	O
after	O
two	O
-	O
dimensional	O
gel	O
electrophoresis	O
of	O
topoisomers	O
.	O

There	O
has	O
been	O
similar	O
improvement	O
in	O
treating	O
ampullary	O
and	O
periampullary	O
cancer	O
,	O
gallbladder	O
cancer	O
,	O
or	O
extrahepatic	O
bile	O
duct	O
cancer	O
.	O

Beta	B
-	I
endorphin	I
,	O
ACTH	B
and	O
cortisol	O
secretion	O
were	O
measured	O
in	O
twelve	O
healthy	O
adult	O
males	O
after	O
nasal	O
spray	O
administration	O
200	O
IU	O
salmon	B
calcitonin	I
.	O

The	O
data	O
indicate	O
that	O
calcitonin	B
induced	O
a	O
beta	B
-	I
endorphin	I
increase	O
independent	O
of	O
enhanced	O
corticotrophin	B
-	O
cortisol	O
release	O
.	O

Rare	O
neurogenic	O
tumor	O
with	O
metastasis	O
to	O
mouth	O
,	O
jaw	O
and	O
face	O
regions	O

We	O
have	O
designated	O
the	O
protein	O
""""	B
cellular	I
NBP	I
""""	I
(	O
CNBP	B
)	O
.	O

Responsiveness	O
to	O
beta-2	O
agonist	O
therapy	O
was	O
retained	O
with	O
both	O
agents	O
(	O
p	O
less	O
than	O
0.05	O
)	O
.	O

Drug	O
use	O
in	O
trauma	O
victims	O
.	O

A	O
critical	O
heart	O
rate	O
and/or	O
appropriate	O
sympathetic	O
state	O
was	O
found	O
to	O
provoke	O
all	O
instances	O
of	O
reentrant	O
or	O
automatic	O
atrial	O
tachycardia	O
and	O
atypical	O
junctional	O
tachycardia	O
.	O

In	O
contrast	O
,	O
the	O
neu	B
proto	I
-	I
oncogene	I
did	O
not	O
show	O
kinase	O
activity	O
or	O
transforming	O
properties	O
when	O
expressed	O
at	O
similar	O
levels	O
in	O
NIH	O
3T3	O
cells.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
65-bp	O
sequence	O
contains	O
the	O
octameric	O
cAMP	O
-	O
responsive	O
enhancer	O
(	O
CRE	O
)	O
TGACGTCA	O
(	O
nucleotides	O
-48	O
to	O
-41	O
)	O
.	O

In	O
contrast	O
,	O
the	O
full	O
mu	O
-	O
opioid	O
agonists	O
fentanyl	O
,	O
morphine	O
,	O
I	O
-	O
methadone	O
and	O
levorphanol	O
produced	O
50	O
%	O
fentanyl	O
-	O
appropriate	O
responding	O
at	O
doses	O
only	O
1.3	O
to	O
10.9	O
times	O
smaller	O
than	O
those	O
required	O
to	O
decrease	O
response	O
rates	O
by	O
50	O
%	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
putative	O
cytokine	O
which	O
is	O
induced	O
by	O
stimulation	O
via	O
the	O
CD2	B
structure	I
on	O
human	O
T	O
lymphocytes	O
.	O

After	O
termination	O
of	O
medication	O
the	O
animals	O
were	O
kindled	O
electrically	O
in	O
the	O
nucleus	O
amygdala	O
.	O

Tumour	B
necrosis	I
factor	I
and	O
adult	O
respiratory	O
distress	O
syndrome	O
.	O

Monitoring	O
of	O
rheumatoid	O
arthritis	O
.	O

The	O
decrease	O
in	O
left	O
ventricular	O
(	O
LV	O
)	O
stroke	O
volume	O
during	O
positive	O
end	O
-	O
expiratory	O
pressure	O
(	O
PEEP	O
)	O
has	O
been	O
attributed	O
to	O
reduced	O
LV	O
filling	O
and	O
a	O
decreased	O
contractile	O
state	O
.	O

An	O
experiment	O
on	O
the	O
return	O
-	O
of	O
-	O
fear	O
(	O
ROF	O
)	O
was	O
carried	O
out	O
on	O
40	O
snake-	O
or	O
spider	O
-	O
phobic	O
subjects	O
in	O
order	O
to	O
determine	O
whether	O
an	O
arousing	O
event	O
that	O
occurs	O
shortly	O
before	O
retest	O
influences	O
the	O
magnitude	O
of	O
the	O
ROF	O
.	O

Evolutionary	O
conservation	O
of	O
homeodomain	B
-	O
binding	O
sites	O
and	O
other	O
sequences	O
upstream	O
and	O
within	O
the	O
major	O
transcription	O
unit	O
of	O
the	O
Drosophila	B
segmentation	I
gene	I
engrailed	I
.	O

To	O
assess	O
the	O
functional	O
importance	O
of	O
these	O
NBS	O
in	O
the	O
overall	O
drug	O
resistance	O
phenotype	O
conferred	O
by	O
mdr1	B
,	O
we	O
introduced	O
amino	O
acid	O
substitutions	O
in	O
the	O
core	O
consensus	O
sequence	O
for	O
nucleotide	O
binding	O
,	O
GXGKST	O
.	O

When	O
the	O
first	O
twitch	O
of	O
TOF	O
spontaneously	O
recovered	O
to	O
10	O
%	O
of	O
control	O
value	O
,	O
neostigmine	O
was	O
injected	O
(	O
40	O
micrograms	O
/	O
kg	O
in	O
adults	O
,	O
30	O
micrograms	O
/	O
kg	O
in	O
infants	O
and	O
children	O
)	O
.	O

Selection	O
of	O
the	O
22	O
items	O
of	O
the	O
Clinical	O
Institute	O
Withdrawal	O
Assessment	O
-	O
Benzodiazepines	O
(	O
CIWA	O
-	O
B	O
)	O
was	O
based	O
on	O
statistically	O
significant	O
differences	O
between	O
baseline	O
and	O
critical	O
withdrawal	O
periods	O
in	O
high	O
-	O
dose	O
subjects	O
and	O
between	O
symptoms	O
associated	O
with	O
placebo	O
and	O
diazepam	O
in	O
low	O
-	O
dose	O
subjects	O
,	O
using	O
contingency	O
tables	O
and	O
logistic	O
regression	O
analysis	O
.	O

Antihistamines	O
in	O
asthma	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
multiple	O
oIGF	B
-	I
I	I
transcripts	I
in	O
a	O
broad	O
band	O
at	O
800	O
-	O
1,100	O
nucleotides	O
and	O
other	O
transcripts	O
of	O
higher	O
molecular	O
weight	O
in	O
liver	O
.	O

The	O
discussion	O
focuses	O
primarily	O
on	O
the	O
newer	O
drugs	O
like	O
angiotensin	B
converting	I
enzyme	I
inhibitors	O
,	O
alpha	B
-	I
adrenergic	I
receptor	I
blockers	O
,	O
and	O
calcium	O
antagonists	O
.	O

High	O
ATP	O
/	O
GTP	O
ratios	O
promoted	O
initiation	O
of	O
RNA	O
primer	O
synthesis	O
at	O
3'-dCTTT	O
sites	O
,	O
whereas	O
low	O
ATP	O
/	O
GTP	O
ratios	O
promoted	O
initiation	O
at	O
3'-dCCC	O
sites	O
.	O

After	O
hepatitis	O
B	O
vaccine	O
immunization	O
,	O
serum	O
antibody	O
response	O
was	O
of	O
primary	O
type	O
in	O
33	O
cases	O
with	O
anti	B
-	I
HBs	I
less	O
than	O
2.1	O
S	O
/	O
N	O
(	O
S	O
/	O
N	O
Ratio	O
Unit	O
)	O
at	O
T0	O
,	O
the	O
anti	B
-	I
HBs	I
positive	O
rate	O
was	O
39.4	O
%	O
,	O
84.8	O
%	O
,	O
96.7	O
%	O
and	O
96.7	O
%	O
in	O
T1	O
,	O
T2	O
,	O
T0	O
and	O
T12	O
respectively	O
.	O

The	O
experimental	O
design	O
incorporated	O
a	O
multiple	O
regression	O
model	O
,	O
sequential	O
treatments	O
and	O
a	O
proportional	O
end	O
point	O
(	O
95	O
%	O
)	O
for	O
protection	O
time	O
.	O

GN101	O
,	O
YC819	O
-	O
9	O
,	O
and	O
SB3	O
.	O

5	O
.	O

Of	O
165	O
women	O
with	O
non	O
-	O
malignant	O
diagnoses	O
26	O
(	O
16	O
%	O
)	O
had	O
CA	B
125	I
levels	O
in	O
excess	O
of	O
35	O
U	O
/	O
ml	O
and	O
8	O
(	O
5	O
%	O
)	O
greater	O
than	O
65	O
U	O
/	O
ml	O
.	O

We	O
conclude	O
that	O
at	O
steady	O
state	O
the	O
timing	O
of	O
a	O
light	O
meal	O
is	O
unlikely	O
to	O
alter	O
in	O
any	O
clinically	O
important	O
manner	O
the	O
pharmacokinetics	O
of	O
nifedipine	O
released	O
from	O
'	O
biphasic	O
'	O
tablets	O
.	O

Recent	O
investigations	O
have	O
shown	O
that	O
Grenz	O
rays	O
can	O
suppress	O
the	O
allergic	O
contact	O
dermatitis	O
reaction	O
completely	O
and	O
that	O
Langerhans	O
cells	O
,	O
identified	O
by	O
OKT6	B
antibodies	I
and	O
electron	O
microscopy	O
,	O
disappear	O
from	O
the	O
epidermis	O
at	O
the	O
same	O
time	O
.	O

The	O
elements	O
responsible	O
for	O
glucocorticoid	O
stimulation	O
of	O
ADH	B
gene	I
transcription	O
appear	O
to	O
reside	O
outside	O
of	O
this	O
region	O
.	O

1	O
.	O

With	O
respect	O
to	O
effective	O
diffusivity	O
of	O
platelets	O
(	O
De	O
)	O
and	O
the	O
surface	O
reactivity	O
constant	O
(	O
K	O
)	O
,	O
less	O
significant	O
differences	O
were	O
found	O
among	O
artificial	O
materials	O
.	O

Intracellular	O
activity	O
studies	O
indicated	O
that	O
,	O
at	O
ten	O
times	O
MBC	O
,	O
only	O
penicillin	O
had	O
any	O
significant	O
activity	O
against	O
intracellular	O
staphylococci	O
,	O
reducing	O
survival	O
by	O
28	O
%	O
.	O

Such	O
transgenic	O
plants	O
should	O
enable	O
not	O
only	O
the	O
mutational	O
analysis	O
of	O
sequence	O
elements	O
within	O
the	O
replication	O
origin	O
region	O
,	O
but	O
also	O
the	O
construction	O
of	O
a	O
new	O
generation	O
of	O
vectors	O
for	O
gene	O
amplification	O
in	O
plants	O
,	O
based	O
on	O
a	O
minimal	O
virus	O
replicon	O
.	O

Four	O
full	O
-	O
thickness	O
skin	O
incisions	O
were	O
made	O
in	O
the	O
back	O
of	O
10	O
female	O
pigs	O
that	O
treated	O
twice	O
a	O
day	O
for	O
14	O
days	O
with	O
2	O
ml	O
of	O
epidermal	B
growth	I
factor	I
(	O
300	O
ng	O
/	O
ml	O
)	O
or	O
2	O
ml	O
of	O
Ringer	O
's	O
lactate	O
solution	O
in	O
a	O
single	O
-	O
blind	O
,	O
randomized	O
fashion	O
.	O

During	O
challenge	O
,	O
rebiopsy	O
was	O
done	O
when	O
reticulin	B
antibodies	I
turned	O
positive	O
(	O
mean	O
0.6	O
years	O
,	O
range	O
0.2	O
-	O
2.0	O
)	O
or	O
at	O
the	O
end	O
of	O
the	O
two	O
year	O
study	O
.	O

The	O
effect	O
of	O
iron	O
intake	O
on	O
59Fe	O
absorption	O
throughout	O
pregnancy	O
,	O
and	O
on	O
maternal	O
and	O
fetal	O
Fe	O
status	O
towards	O
the	O
end	O
of	O
pregnancy	O
,	O
was	O
investigated	O
in	O
rats	O
.	O

The	O
deduced	O
protein	O
sequence	O
is	O
characterized	O
by	O
a	O
putative	O
16-residue	O
amino	O
-	O
terminal	O
signal	O
peptide	O
that	O
is	O
cleaved	O
,	O
resulting	O
in	O
a	O
239-residue	O
polypeptide	O
.	O

Reagent	O
strips	O
are	O
frequently	O
used	O
in	O
the	O
practice	O
of	O
laboratory	O
medicine	O
as	O
well	O
as	O
outside	O
the	O
professional	O
laboratories	O
.	O

The	O
lowest	O
detectable	O
concentration	O
was	O
1.0	O
ng	O
/	O
ml	O
in	O
the	O
serum	O
.	O

Precipitating	O
antibodies	O
for	O
Thermophilic	O
actinomycetes	O
and	O
M.f	O
.	O
were	O
negative	O
.	O

LON-72	O
(	O
34	O
isolates	O
)	O
,	O
LON-73	O
(	O
1	O
)	O
,	O
LON-71	O
(	O
2	O
)	O
and	O
LON-10	O
(	O
2	O
)	O
were	O
found	O
at	O
altitudes	O
around	O
2000	O
m	O
,	O
3	O
of	O
them	O
in	O
a	O
single	O
village	O
.	O

Significance	O
of	O
delta	O
-	O
aminolevulinic	O
acid	O
analysis	O
in	O
clinical	O
tests	O

Although	O
the	O
fertility	O
decline	O
in	O
the	O
black	O
population	O
in	O
the	O
Mississippi	O
Delta	O
between	O
the	O
late	O
1870	O
's	O
and	O
early	O
1930	O
's	O
closely	O
paralleled	O
that	O
of	O
the	O
national	O
black	O
population	O
,	O
it	O
rose	O
much	O
more	O
dramatically	O
in	O
the	O
1940	O
's	O
and	O
1950	O
's	O
to	O
almost	O
1880	O
levels	O
.	O

According	O
to	O
their	O
staining	O
affinity	O
for	O
anti	B
-	I
T	I
antibodies	I
,	O
the	O
glandular	O
tissue	O
cells	O
were	O
classified	O
as	O
T-	B
,	O
T+	B
,	O
T++	B
,	O
and	O
T	B
and	O
the	O
annual	O
changes	O
in	O
the	O
numbers	O
of	O
these	O
cell	O
populations	O
,	O
as	O
well	O
as	O
in	O
the	O
volume	O
occupied	O
by	O
the	O
glandular	O
tissue	O
,	O
were	O
calculated	O
.	O

Ampicillin	O
(	O
AMP	O
)	O
alone	O
or	O
with	O
an	O
aminoglycoside	O
(	O
AMI	O
)	O
was	O
the	O
treatment	O
in	O
9	O
and	O
16	O
cases	O
,	O
respectively	O
.	O

We	O
investigated	O
the	O
incidence	O
of	O
congenital	O
color	O
deficiency	O
among	O
Koreans	O
by	O
the	O
use	O
of	O
H	O
-	O
R	O
-	O
R	O
pseudoisochromatic	O
plates	O
.	O

The	O
differential	O
diagnosis	O
of	O
both	O
affections	O
is	O
based	O
on	O
the	O
clinical	O
course	O
,	O
sialography	O
and	O
CT	O
examination	O
which	O
along	O
with	O
modern	O
ATB	O
treatment	O
significantly	O
modify	O
hitherto	O
used	O
surgical	O
therapy	O
.	O

Retrograde	O
filling	O
consists	O
in	O
sealing	O
endodontics	O
system	O
directly	O
at	O
the	O
apical	O
zone	O
after	O
surgical	O
approach	O
.	O

The	O
maximum	O
stress	O
due	O
to	O
the	O
hygroscopic	O
examination	O
of	O
the	O
composite	O
was	O
0.74	O
kg	O
/	O
mm2	O
at	O
equilibrium	O
of	O
the	O
water	O
absorbed	O
of	O
the	O
composite	O
.	O

Ischemic	O
heart	O
disease	O
evaluated	O
by	O
exercise	O
stress	O
thallium-201	O
myocardial	O
scintigraphy	O
:	O
a	O
comparison	O
of	O
SPECT	O
and	O
bull	O
's	O
eye	O
display	O

Sequence	O
analysis	O
of	O
the	O
47-kilodalton	B
major	I
integral	I
membrane	I
immunogen	I
of	I
Treponema	I
pallidum	I
.	O

Potential	O
consensus	O
sequences	O
for	O
early	O
and	O
late	O
regulatory	O
elements	O
were	O
identified	O
.	O

An	O
FP	B
mutant	I
,	O
AcFP875	B
-	I
2	I
,	O
had	O
a	O
1.6-kbp	O
insertion	O
of	O
S.	O
frugiperda	O
DNA	O
near	O
the	O
5	O
'	O
end	O
of	O
these	O
transcripts	O
which	O
by	O
S1	B
analysis	O
were	O
shown	O
to	O
initiate	O
within	O
the	O
host	O
cell	O
sequence	O
.	O

Construction	O
of	O
a	O
RIP1	B
deletion	O
strain	O
and	O
isolation	O
of	O
temperature	O
-	O
sensitive	O
mutants	O
.	O

In	O
the	O
whole	O
group	O
,	O
basal	O
GH	B
and	O
somatomedin	B
-	I
C	I
levels	O
decreased	O
from	O
a	O
mean	O
(	O
+	O
/-	O

standard	O
error	O
of	O
the	O
mean	O
)	O
of	O
52.3	O
+	O
/-	O

12.7	O
to	O
11.1	O
+	O
/-	O

6.3	O
ng	O
/	O
ml	O
and	O
from	O
7.6	O
+	O
/-	O

0.7	O
to	O
2.5	O
+	O
/-	O

0.5	O
U	O
/	O
ml	O
,	O
respectively	O
.	O

Application	O
of	O
different	O
criteria	O
of	O
cure	O
revealed	O
that	O
19	O
patients	O
(	O
66	O
%	O
)	O
had	O
basal	O
GH	B
levels	O
below	O
5	O
ng	O
/	O
ml	O
,	O
17	O
patients	O
(	O
59	O
%	O
)	O
had	O
normal	O
somatomedin	B
-	I
C	I
values	O
,	O
16	O
patients	O
(	O
55	O
%	O
)	O
had	O
complete	O
GH	B
suppression	O
(	O
less	O
than	O
1	O
ng	O
/	O
ml	O
)	O
during	O
OGTT	O
,	O
and	O
13	O
patients	O
(	O
45	O
%	O
)	O
met	O
the	O
above	O
-	O
mentioned	O
criteria	O
with	O
disappearance	O
of	O
the	O
paradoxical	O
GH	B
response	O
to	O
TRH	B
/	O
GnRH	B
test	O
.	O

It	O
suggests	O
a	O
sequence	O
of	O
surgical	O
planning	O
that	O
can	O
prevent	O
them	O
and	O
also	O
offers	O
ways	O
of	O
dealing	O
with	O
the	O
problems	O
should	O
they	O
occur	O
.	O

Platelet	B
activating	I
factor	I
was	O
given	O
in	O
six	O
doses	O
at	O
15	O
minute	O
intervals	O
and	O
airway	O
response	O
measured	O
as	O
change	O
in	O
partial	O
expiratory	O
flow	O
at	O
30	O
%	O
of	O
vital	O
capacity	O
(	O
Vp30	O
)	O
.	O

There	O
was	O
no	O
significant	O
correlation	O
between	O
baseline	O
PC40	O
methacholine	O
and	O
the	O
maximal	O
fall	O
in	O
Vp30	O
after	O
either	O
the	O
first	O
(	O
12	O
micrograms	O
)	O
or	O
the	O
second	O
dose	O
(	O
24	O
micrograms	O
)	O
of	O
platelet	B
activating	I
factor	I
.	O

Both	O
BG	O
and	O
IRI	B
concentrations	O
during	O
the	O
OGTT	O
were	O
the	O
lowest	O
in	O
body	O
builders	O
,	O
medium	O
in	O
controls	O
,	O
and	O
the	O
highest	O
in	O
obese	O
men	O
.	O

Postcoital	O
contraception	O
:	O
a	O
family	O
planning	O
study	O
.	O

A	O
0.5	O
rating	O
was	O
intended	O
to	O
characterize	O
subjects	O
in	O
whom	O
mild	O
cognitive	O
impairment	O
due	O
to	O
senile	O
dementia	O
of	O
the	O
Alzheimer	O
type	O
was	O
suspected	O
but	O
was	O
insufficient	O
in	O
degree	O
to	O
warrant	O
a	O
diagnosis	O
of	O
definite	O
dementia	O
.	O

An	O
implant	O
may	O
release	O
a	O
drug	O
either	O
by	O
diffusion	O
concurrent	O
with	O
dissolution	O
of	O
the	O
polymeric	O
implant	O
material	O
without	O
depolymerization	O
(	O
Type	O
A	O
)	O
or	O
by	O
bioerosion	O
involving	O
depolymerization	O
(	O
Type	O
B	O
)	O
.	O

Although	O
it	O
is	O
well	O
known	O
that	O
calcium	O
channel	O
blockers	O
can	O
influence	O
contraction	O
of	O
vascular	O
smooth	O
muscle	O
,	O
there	O
is	O
less	O
knowledge	O
on	O
its	O
effect	O
on	O
excitation	O
contraction	O
coupling	O
in	O
the	O
endocrine	O
glands	O
and	O
more	O
specifically	O
on	O
insulin	B
and	O
glucagon	B
release	O
.	O

The	O
site	O
-	O
specific	O
DNA	O
inversion	O
system	O
Cin	B
encoded	O
by	O
the	O
bacteriophage	O
P1	O
consists	O
of	O
a	O
recombinase	B
,	O
two	O
inverted	O
crossing	O
-	O
over	O
sites	O
and	O
a	O
recombinational	O
enhancer	O
.	O

The	O
terminator	O
region	O
supported	O
termination	O
of	O
transcripts	O
initiated	O
by	O
RNA	B
polymerase	I
I	I
in	O
vivo	O
.	O

The	O
galactose	B
transporter	I
shows	O
both	O
sequence	O
and	O
structural	O
homology	O
with	O
a	O
superfamily	O
of	O
sugar	B
transporters	I
which	O
includes	O
the	O
human	B
HepG2-erythrocyte	I
and	I
fetal	I
muscle	I
glucose	I
transporters	I
,	O
the	O
rat	B
brain	I
and	I
liver	I
glucose	I
transporters	I
,	O
the	O
Escherichia	B
coli	I
xylose	I
and	I
arabinose	I
permeases	I
,	O
and	O
the	O
S.	B
cerevisiae	I
glucose	I
,	I
maltose	I
,	I
and	I
galactose	I
transporters	I
.	O

Of	O
110	O
previously	O
untreated	O
patients	O
who	O
had	O
entered	O
the	O
study	O
of	O
protocol	O
TCL821	O
,	O
96	O
were	O
evaluable	O
.	O

There	O
were	O
3	O
/	O
32	O
(	O
9.4	O
per	O
cent	O
)	O
adverse	O
reactions	O
(	O
ADRs	O
)	O
,	O
and	O
one	O
case	O
each	O
of	O
nausea	O
,	O
dizziness	O
and	O
increased	O
menstrual	O
flow	O
.	O

The	O
seventh	O
cysteine	O
residue	O
of	O
CTSE	B
is	O
located	O
within	O
the	O
activation	O
peptide	O
region	O
of	O
the	O
proenzyme	O
.	O

The	O
p34.8	B
gene	I
has	O
a	O
strong	O
codon	O
usage	O
bias	O
which	O
is	O
strikingly	O
different	O
from	O
that	O
of	O
the	O
polyhedrin	B
gene	I
.	O

Of	O
the	O
single	O
-	O
stranded	O
DNA	O
transformants	O
,	O
65	O
%	O
resulted	O
from	O
replacement	O
of	O
the	O
resident	O
met2	B
mutation	I
by	O
the	O
exogenous	O
wild	O
-	O
type	O
allele	O
.	O

The	O
results	O
strongly	O
support	O
the	O
notion	O
that	O
the	O
OBF1-binding	B
sites	I
and	O
the	O
OBF1	B
protein	I
are	O
important	O
for	O
normal	O
ARS	O
function	O
as	O
an	O
origin	O
of	O
replication	O
.	O

On	O
the	O
basis	O
of	O
S1	B
nuclease	I
protection	O
analysis	O
of	O
RNA	O
preparations	O
from	O
several	O
mouse	O
tissues	O
,	O
both	O
dhfr	B
and	O
divergent	O
genes	O
showed	O
similar	O
levels	O
of	O
expression	O
but	O
did	O
show	O
some	O
specificity	O
in	O
start	O
site	O
utilization	O
.	O

62:2491	O
-	O
2499	O
,	O
1987	O
)	O
.	O

With	O
both	O
wild	O
-	O
type	O
and	O
the	O
mutant	O
enzymes	O
,	O
ATP	O
activates	O
both	O
[	O
14C	O
]	O
Asp	O
in	O
equilibrium	O
N	O
-	O
carbamyl	O
-	O
L	O
-	O
aspartate	O
(	O
C	O
-	O
Asp	O
)	O
and	O
the	O
[	O
32P	O
]	O
carbamyl	O
phosphate	O
(	O
C	O
-	O
P	O
)	O
in	O
equilibrium	O
Pi	O
exchanges	O
.	O

Survival	O
rates	O
for	O
the	O
original	O
treatment	O
group	O
were	O
84.5	O
%	O
and	O
57.6	O
%	O
at	O
12	O
and	O
21	O
months	O
,	O
respectively	O
;	O
for	O
the	O
delayed	O
treatment	O
group	O
,	O
78.8	O
%	O
and	O
64.6	O
%	O
at	O
12	O
and	O
21	O
months	O
,	O
respectively	O
,	O
and	O
78.8	O
%	O
and	O
47.5	O
%	O
at	O
12	O
and	O
21	O
months	O
,	O
respectively	O
,	O
for	O
77	O
subjects	O
with	O
AIDS	O
and	O
93.0	O
%	O
and	O
71.8	O
%	O
,	O
respectively	O
,	O
for	O
50	O
subjects	O
with	O
AIDS	O
-	O
related	O
complex	O
in	O
the	O
original	O
treatment	O
group	O
.	O

Mapping	O
results	O
suggested	O
that	O
the	O
complementation	O
group	O
identified	O
by	O
these	O
mutants	O
is	O
allelic	O
to	O
the	O
ag	B
alpha	I
1	I
mutation	O
identified	O
previously	O
.	O

Agranulocytosis	O
treatment	O
with	O
rhGM	B
-	I
CSF	I

The	O
R.	B
meliloti	I
nifH	I
promoter	I
but	O
not	O
the	O
K.	B
pneumoniae	I
nifH	I
promoter	I
showed	O
sigma	B
54-dependent	I
methylation	O
protection	O
of	O
guanine	O
residues	O
at	O
-14	O
,	O
-25	O
and	O
-26	O
,	O
the	O
most	O
conserved	O
nucleotides	O
characteristic	O
of	O
sigma	B
54-dependent	I
promoters	I
.	O

Routine	O
clinical	O
analysis	O
revealed	O
lower	O
hematocrit	O
and	O
hemoglobin	B
,	O
and	O
elevated	O
BUN	O
and	O
alkaline	B
phosphatase	I
in	O
the	O
treated	O
group	O
.	O

To	O
assess	O
the	O
health	O
significance	O
of	O
the	O
early	O
renal	O
changes	O
after	O
chronic	O
exposure	O
to	O
cadmium	O
,	O
23	O
workers	O
removed	O
from	O
exposure	O
because	O
of	O
the	O
discovery	O
of	O
an	O
increased	O
urinary	O
excretion	O
of	O
beta	B
2-microglobulin	I
or	O
retinol	B
binding	I
protein	I
,	O
or	O
both	O
,	O
have	O
been	O
examined	O
once	O
a	O
year	O
for	O
five	O
years	O
.	O

A	O
transcription	O
factor	O
exclusion	O
assay	O
was	O
used	O
to	O
show	O
that	O
the	O
PCF1	B
mutation	I
affects	O
two	O
distinct	O
stages	O
in	O
transcription	O
:	O
one	O
prior	O
to	O
and	O
one	O
after	O
stable	O
complex	O
formation	O
;	O
and	O
that	O
these	O
effects	O
are	O
mediated	O
by	O
a	O
component	O
of	O
the	O
stable	O
complex	O
.	O

These	O
adverse	O
effects	O
usually	O
abate	O
with	O
time	O
.	O

Furthermore	O
,	O
the	O
3'-untranslated	O
regions	O
of	O
pmGT10	B
display	O
a	O
marked	O
degree	O
of	O
homology	O
to	O
the	O
3	O
'	O
region	O
of	O
the	O
rat	B
Yb1	I
gene	I
,	O
while	O
this	O
region	O
of	O
pmGT2	B
displays	O
marked	O
homology	O
to	O
the	O
corresponding	O
region	O
of	O
the	O
rat	B
Yb2	I
gene	I
.	O

Model	O
IV	O
:	O
primary	O
abutments	O
with	O
the	O
lateral	O
incisor	O
and	O
the	O
second	O
molar	O
as	O
secondary	O
abutments	O
.	O

The	O
incidence	O
of	O
fetal	O
breathing	O
movements	O
(	O
06.00	O
-	O
10.00	O
h	O
)	O
decreased	O
with	O
increasing	O
gestational	O
age	O
while	O
fetal	O
arterial	O
concentrations	O
of	O
plasma	O
PGE	O
increased	O
significantly	O
over	O
the	O
same	O
period	O
of	O
gestation	O
.	O

We	O
have	O
examined	O
the	O
role	O
of	O
two	O
recombination-	O
and	O
repair	O
-	O
defective	O
mutations	O
,	O
rad1	B
and	O
rad52	B
,	O
on	O
direct	O
repeat	O
recombination	O
in	O
transcriptionally	O
active	O
and	O
inactive	O
sequences	O
.	O

On	O
the	O
other	O
hand	O
,	O
knowledge	O
of	O
the	O
epidemiology	O
of	O
Parkinson	O
's	O
disease	O
is	O
necessary	O
in	O
creating	O
etiological	O
hypotheses	O
,	O
since	O
only	O
hypotheses	O
consistent	O
with	O
the	O
epidemiological	O
profile	O
deserve	O
careful	O
testing	O
.	O

The	O
stereoselectivity	O
of	O
drug	O
action	O
.	O

A	O
combination	O
of	O
cisplatin	O
and	O
5-fluorouracil	O
,	O
both	O
administered	O
4	O
days	O
continuously	O
as	O
infusion	O
,	O
was	O
assessed	O
in	O
advanced	O
head	O
and	O
neck	O
cancer	O
.	O

Diagnosis	O
of	O
primary	O
sclerosing	O
cholangitis	O
in	O
a	O
blood	O
donor	O
with	O
elevated	O
serum	B
alanine	I
aminotransferase	I
.	O

When	O
statistically	O
analyzed	O
in	O
various	O
subgroupings	O
,	O
the	O
obtained	O
average	O
sedimentation	O
coefficients	O
and	O
polydispersity	O
profiles	O
supported	O
the	O
following	O
conclusions	O
:	O
(	O
a	O
)	O
loss	O
of	O
proteoglycan	O
aggregation	O
and	O
sedimentability	O
is	O
confirmed	O
to	O
be	O
a	O
primary	O
sign	O
of	O
cartilage	O
matrix	O
degradation	O
;	O
(	O
b	O
)	O
higher	O
S	O
values	O
for	O
proteoglycans	O
of	O
the	O
high	O
weight	O
(	O
HW	O
)	O
-bearing	O
areas	O
and	O
lower	O
values	O
for	O
those	O
of	O
the	O
low	O
weight	O
(	O
LW	O
)	O
-bearing	O
areas	O
were	O
a	O
typical	O
finding	O
in	O
normal	O
cartilage	O
samples	O
;	O
(	O
c	O
)	O
inversion	O
of	O
this	O
pattern	O
was	O
indicative	O
of	O
matrix	O
degradation	O
,	O
suggesting	O
that	O
the	O
HW	O
regions	O
are	O
more	O
affected	O
than	O
the	O
LW	O
-	O
bearing	O
areas	O
;	O
(	O
d	O
)	O
the	O
average	O
S	O
value	O
distribution	O
across	O
cartilage	O
thickness	O
tended	O
to	O
resemble	O
the	O
corresponding	O
proteoglycan	O
content	O
versus	O
distance	O
from	O
articular	O
surface	O
;	O
and	O
(	O
e	O
)	O
the	O
deepest	O
cartilage	O
layer	O
had	O
,	O
in	O
most	O
cases	O
,	O
the	O
smallest	O
amount	O
of	O
aggregates	O
while	O
the	O
highest	O
average	O
sedimentability	O
was	O
observed	O
at	O
the	O
middle	O
zone	O
of	O
the	O
normal	O
samples	O
.	O

End	O
points	O
measured	O
were	O
perioperative	O
(	O
30-day	O
)	O
myocardial	O
infarction	O
(	O
MI	O
)	O
rate	O
and	O
death	O
.	O

Liquid	O
chromatography	O
with	O
amperometric	O
detection	O
(	O
LC	O
/	O
AD	O
)	O
is	O
used	O
to	O
determine	O
fluazifop	O
acid	O
produced	O
from	O
the	O
metabolism	O
or	O
base	O
hydrolysis	O
of	O
fluazifop	O
-	O
butyl	O
in	O
soybeans	O
and	O
soybean	O
oil	O
.	O

Validation	O
of	O
the	O
survey	O
of	O
work	O
styles	O
:	O
a	O
profile	O
measure	O
of	O
the	O
type	O
A	O
behaviour	O
pattern	O
.	O

Only	O
one	O
ADR	O
was	O
related	O
definitely	O
to	O
ciprofloxacin	O
therapy	O
.	O

HIV	O
infectiousness	O
and	O
the	O
AIDS	O
epidemic	O
.	O

From	O
day	O
30	O
after	O
turnout	O
,	O
the	O
PFB	O
-	O
group	O
had	O
significantly	O
lower	O
serum	B
pepsinogen	I
levels	O
,	O
which	O
reflects	O
the	O
low	O
degree	O
of	O
abomasal	O
damage	O
in	O
these	O
animals	O
.	O

The	O
corresponding	O
inhibition	O
of	O
acid	B
phosphatase	I
activity	O
in	O
control	O
male	O
and	O
female	O
guinea	O
pigs	O
was	O
15.91	O
%	O
and	O
20.33	O
%	O
respectively	O
.	O

Its	O
clinical	O
and	O
histopathologic	O
characteristics	O
.	O

Fundus	O
changes	O
in	O
(	O
type	O
II	O
)	O
mesangiocapillary	O
glomerulonephritis	O
simulating	O
drusen	O
:	O
a	O
histopathological	O
report	O
.	O

Chronic	O
dose	O
effects	O
of	O
methyl	O
parathion	O
on	O
nuthatches	O
:	O
cholinesterase	B
and	O
ptilochronology	O
.	O

A	O
method	O
for	O
determining	O
optimal	O
development	O
conditions	O
by	O
summary	O
oxygen	O
consumption	O

Men	O
were	O
more	O
positive	O
about	O
their	O
physical	O
fitness	O
than	O
women	O
.	O

Handgrip	O
dynamometry	O
was	O
also	O
carried	O
out	O
in	O
249	O
of	O
the	O
patients	O
.	O

In	O
cerebrospinal	O
fluid	O
,	O
an	O
ADA	B
catalytic	O
concentration	O
above	O
0.15	O
mu	O
kat	O
/	O
L	O
strongly	O
suggests	O
tuberculous	O
meningitis	O
in	O
patients	O
older	O
than	O
7	O
years	O
(	O
sensitivity	O
1.00	O
,	O
specificity	O
0.99	O
and	O
efficiency	O
0.99	O
)	O
.	O

NERVTRACK	O
contains	O
4000	O
anatomical	O
data	O
items	O
arranged	O
in	O
a	O
tree	O
-	O
like	O
manner	O
reflecting	O
structural	O
and	O
functional	O
relationships	O
.	O

Swim	O
-	O
over	O
:	O
an	O
alternative	O
method	O
for	O
harvesting	O
motile	O
spermatozoa	O
.	O

It	O
is	O
striking	O
that	O
the	O
active	O
CHO	O
spacer	O
promoter	O
violated	O
the	O
otherwise	O
universal	O
rule	O
that	O
metazoan	B
RNA	I
polymerase	I
I	I
promoters	I
all	O
have	O
a	O
G	O
residue	O
at	O
position	O
-16	O
.	O

The	O
author	O
provides	O
a	O
rationale	O
for	O
an	O
interactional	O
view	O
and	O
presents	O
a	O
case	O
in	O
which	O
post	O
-	O
surgical	O
hiccups	O
were	O
successfully	O
treated	O
,	O
using	O
principles	O
developed	O
by	O
the	O
Mental	O
Research	O
Institute	O
.	O

The	O
relative	O
toxicity	O
of	O
nickel	O
oxide	O
(	O
NiO	O
)	O
,	O
nickel	O
sulfate	O
hexahydrate	O
(	O
NiSO4.6H2O	O
)	O
,	O
and	O
nickel	O
subsulfide	O
(	O
Ni3S2	O
)	O
was	O
studied	O
in	O
F344	O
/	O
N	O
rats	O
and	O
B6C3F1	O
mice	O
after	O
inhalation	O
exposure	O
for	O
6	O
hr	O
/	O
day	O
,	O
5	O
days	O
/	O
week	O
,	O
for	O
13	O
weeks	O
.	O

From	O
the	O
National	O
Institutes	O
of	O
Health	O
.	O

In	O
the	O
final	O
model	O
,	O
grade	O
(	O
p	O
=	O
0.0002	O
)	O
,	O
peritoneal	O
cytologic	O
results	O
(	O
p	O
=	O
0.0002	O
)	O
,	O
progesterone	B
receptor	I
status	O
(	O
p	O
=	O
0.004	O
)	O
,	O
and	O
age	O
as	O
a	O
continuous	O
variable	O
(	O
p	O
=	O
0.008	O
)	O
were	O
most	O
closely	O
associated	O
with	O
disease	O
-	O
free	O
survival	O
.	O

In	O
Experiment	O
2	O
,	O
we	O
again	O
used	O
classification	O
,	O
but	O
the	O
fixed	O
standard	O
75	O
was	O
not	O
at	O
the	O
center	O
of	O
the	O
range	O
of	O
target	O
numbers	O
(	O
20	O
,	O
21	O
,	O
...	O

The	O
oxygen	O
uptake	O
(	O
VO2	O
)	O
,	O
carbon	O
dioxide	O
output	O
(	O
VCO2	O
)	O
,	O
respiratory	O
rate	O
(	O
fR	O
)	O
,	O
minute	O
ventilation	O
(	O
VE	O
)	O
,	O
alveolar	O
ventilation	O
(	O
VA	O
)	O
,	O
alveolar	O
oxygen	O
pressure	O
(	O
PAO2	O
)	O
,	O
and	O
VE	O
/	O
VO2	O
ratio	O
were	O
higher	O
in	O
the	O
cows	O
,	O
while	O
the	O
tidal	O
volume	O
(	O
VT	O
)	O
and	O
physiological	O
dead	O
space	O
(	O
VD	O
)	O
were	O
larger	O
in	O
the	O
horses	O
.	O

Epithelial	O
damage	O
was	O
not	O
observed	O
in	O
any	O
controls	O
but	O
was	O
in	O
all	O
tissues	O
exposed	O
to	O
SO2	O
.	O

Among	O
booked	O
patients	O
the	O
maternal	O
mortality	O
rate	O
was	O
0.32	O
and	O
among	O
unbooked	O
patients	O
11.13	O
per	O
1000	O
deliveries	O
.	O

The	O
present	O
study	O
investigates	O
whether	O
prostaglandins	O
""""	O
cytoprotect	O
""""	O
the	O
gastric	O
mucosa	O
against	O
hemorrhage	O
-	O
induced	O
stress	O
ulceration	O
by	O
assessing	O
the	O
influence	O
of	O
16,16-dimethyl	O
prostaglandin	O
E2	O
(	O
16,16-dm	O
PGE2	O
)	O
on	O
gross	O
and	O
microscopic	O
lesion	O
formation	O
,	O
intramucosal	O
tissue	O
pH	O
,	O
H+	O
back	O
-	O
diffusion	O
,	O
and	O
mucosal	O
blood	O
flow	O
in	O
rat	O
gastric	O
mucosa	O
exposed	O
to	O
luminal	O
acid	O
(	O
100	O
mM	O
HCl	O
)	O
during	O
hemorrhagic	O
shock	O
(	O
13	O
ml	O
/	O
kg	O
for	O
20	O
min	O
)	O
.	O

Transcripts	O
characterized	O
include	O
(	O
i	O
)	O
abundant	O
monocistronic	O
L11e	B
and	O
tricistronic	O
L1e	B
-	O
L10e	B
-	O
L12e	B
transcripts	O
;	O
(	O
ii	O
)	O
less	O
abundant	O
bicistronic	O
NAB	B
-	O
L11e	B
and	O
monocistronic	O
NAB	B
transcripts	I
and	O
(	O
iii	O
)	O
a	O
very	O
rare	O
ORF	O
monocistronic	O
transcript	O
.	O

At	O
each	O
level	O
of	O
PaO2	O
we	O
obtained	O
simultaneous	O
measures	O
of	O
arterial	O
and	O
venous	O
blood	O
gases	O
,	O
venous	O
lactate	O
concentration	O
,	O
and	O
changes	O
in	O
the	O
relative	O
concentrations	O
of	O
inorganic	O
phosphate	O
,	O
phosphocreatine	O
,	O
and	O
ATP	O
measured	O
with	O
31P	O
magnetic	O
resonance	O
spectroscopy	O
.	O

The	O
transcription	O
initiation	O
site	O
was	O
determined	O
by	O
S1	B
nuclease	I
mapping	O
.	O

The	O
mobility	O
of	O
the	O
upper	O
and	O
lower	O
premolars	O
under	O
load	O
was	O
investigated	O
in	O
relation	O
to	O
the	O
interproximal	O
contact	O
and	O
occlusal	O
facets	O
.	O

A	O
larval	B
albumin	I
-	I
like	I
protein	I
was	O
not	O
detectable	O
by	O
silver	O
staining	O
in	O
serum	O
of	O
tadpoles	O
before	O
the	O
beginning	O
of	O
metamorphosis	O
at	O
stage	O
48	O
.	O

Isolated	O
proteinuria	O
(	O
i.e.	O
without	O
hematuria	O
and/or	O
pyuria	O
)	O
is	O
a	O
frequent	O
finding	O
.	O

Dynamic	O
and	O
static	O
scintigrams	O
,	O
using	O
99mtechnetium	O
methylene	O
diphosphonate	O
,	O
were	O
obtained	O
at	O
zero	O
,	O
six	O
,	O
and	O
12	O
weeks	O
after	O
fracture	O
.	O

On	O
admission	O
to	O
our	O
department	O
in	O
September	O
,	O
1987	O
,	O
the	O
patient	O
was	O
alert	O
and	O
had	O
spastic	O
paraparesis	O
,	O
the	O
impairment	O
of	O
all	O
sensory	O
modalities	O
below	O
the	O
level	O
of	O
Th	O
10	O
and	O
urinary	O
disturbance	O
.	O

Prostaglandins	O
and	O
gallstones	O

The	O
nature	O
of	O
the	O
process	O
formed	O
by	O
the	O
successive	O
occurrences	O
of	O
this	O
arrhythmia	O
was	O
studied	O
in	O
8	O
patients	O
with	O
a	O
history	O
of	O
symptomatic	O
paroxysmal	O
AF	O
.	O

This	O
would	O
have	O
had	O
the	O
effect	O
of	O
positioning	O
the	O
genes	O
currently	O
on	O
the	O
long	O
arm	O
adjacent	O
to	O
the	O
centromeric	O
heterochromatin	O
,	O
perhaps	O
resulting	O
in	O
a	O
""""	O
position	O
effect	O
""""	O
on	O
transcription	O
of	O
these	O
genes	O
.	O

Obesity	O
was	O
strongly	O
associated	O
with	O
the	O
proportions	O
of	O
nonprotein	O
-	O
bound	O
and	O
albumin	B
-	O
bound	O
estradiol	O
,	O
and	O
inversely	O
associated	O
with	O
sex	B
hormone	I
binding	I
globulin	I
(	O
SHBG	B
)	O
levels	O
and	O
the	O
proportion	O
of	O
SHBG	B
-	O
bound	O
estradiol	O
.	O

The	O
effect	O
of	O
zinc	O
deficiency	O
on	O
trace	O
metals	O
in	O
the	O
liver	O
,	O
spleen	O
,	O
kidney	O
,	O
pancreas	O
and	O
duodenum	O
was	O
investigated	O
in	O
the	O
control	O
and	O
zinc	O
-	O
deficient	O
rats	O
at	O
17	O
days	O
and	O
20	O
days	O
of	O
pregnancy	O
.	O

Our	O
findings	O
support	O
the	O
view	O
of	O
a	O
multifactorial	O
genesis	O
of	O
the	O
cardiac	O
involvement	O
in	O
uremic	O
patients	O
.	O

Heating	O
cells	O
to	O
43	O
degrees	O
C	O
decreased	O
the	O
amount	O
of	O
newly	O
synthesized	O
rRNA	O
to	O
less	O
than	O
5	O
%	O
of	O
the	O
control	O
level	O
and	O
led	O
to	O
greater	O
than	O
95	O
%	O
inhibition	O
of	O
transcription	O
termination	O
at	O
a	O
region	O
355	O
to	O
362	O
nucleotides	O
downstream	O
of	O
the	O
3	O
'	O
end	O
of	O
28S	B
rRNA	I
,	O
with	O
readthrough	O
continuing	O
into	O
the	O
next	O
transcription	O
unit	O
.	O

Deletion	O
analysis	O
showed	O
that	O
the	O
NF-4FA	B
,	O
NF-4FB	B
,	O
and	O
AP-1	B
sequences	O
are	O
each	O
necessary	O
for	O
full	O
enhancer	O
activity	O
.	O

Reye	O
's	O
syndrome	O
:	O
reports	O
of	O
7	O
cases	O
in	O
the	O
period	O
1982	O
-	O
1987	O

When	O
two	O
-	O
dimensional	O
polyacrylamide	O
gel	O
electrophoretic	O
patterns	O
of	O
[	O
35S	O
]	O
methionine	O
-	O
labeled	O
proteins	O
secreted	O
from	O
cells	O
infected	O
with	O
parental	O
and	O
recombinant	O
viruses	O
were	O
compared	O
,	O
a	O
spot	O
missing	O
from	O
the	O
latter	O
corresponded	O
in	O
molecular	O
weigh	O
and	O
isoelectric	O
point	O
with	O
that	O
predicted	O
from	O
the	O
N1L	B
ORF	I
.	O

PULSE	O
is	O
used	O
to	O
set	O
such	O
NMR	O
spectroscopic	O
parameters	O
as	O
the	O
delay	O
and	O
duration	O
of	O
rf	O
transmit	O
and	O
receive	O
gates	O
,	O
rf	O
phase	O
,	O
sampling	O
times	O
,	O
and	O
such	O
imaging	O
parameters	O
as	O
rf	O
pulse	O
shape	O
and	O
gradient	O
waveforms	O
.	O

Definite	O
JPsA	O
(	O
24	O
patients	O
)	O
was	O
defined	O
as	O
arthritis	O
associated	O
,	O
but	O
not	O
necessarily	O
coincident	O
,	O
with	O
a	O
typical	O
psoriatic	O
rash	O
,	O
or	O
arthritis	O
plus	O
at	O
least	O
3	O
of	O
4	O
minor	O
criteria	O
:	O
dactylitis	O
,	O
nail	O
pitting	O
,	O
psoriasis	O
-	O
like	O
rash	O
,	O
or	O
family	O
history	O
of	O
psoriasis	O
.	O

Hence	O
follows	O
Kurti	O
's	O
demand	O
to	O
mete	O
out	O
appropriate	O
importance	O
to	O
the	O
arguments	O
.	O

The	O
author	O
gives	O
an	O
account	O
of	O
antipsychotic	O
,	O
analgetic	O
,	O
myorelaxing	O
and	O
vasodilatating	O
effects	O
of	O
some	O
calcium	O
antagonists	O
,	O
and	O
their	O
clinical	O
application	O
is	O
discussed	O
.	O

A	O
correlation	O
coefficient	O
was	O
used	O
for	O
assessing	O
the	O
similarity	O
of	O
each	O
map	O
pattern	O
with	O
the	O
normal	O
mean	O
IQRST	O
map	O
.	O

A	O
hospital	O
-	O
based	O
study	O
of	O
the	O
relationship	O
between	O
retained	O
placenta	O
and	O
mastitis	O
in	O
dairy	O
cows	O
.	O

Asthma	O
was	O
significantly	O
more	O
often	O
associated	O
with	O
ASA	O
group	O
(	O
91	O
%	O
)	O
vs	O
46	O
%	O
at	O
AT	O
and	O
in	O
only	O
16	O
%	O
at	O
INTR	O
group	O
.	O

A	O
value	O
of	O
1.1	O
l	O
/	O
kg	O
was	O
used	O
for	O
V	O
in	O
calculating	O
all	O
single	O
sample	O
estimates	O
of	O
clearance	O
(	O
CL	O
)	O
,	O
and	O
a	O
value	O
of	O
4.3	O
l	O
/	O
kg	O
was	O
used	O
to	O
calculate	O
single	O
sample	O
estimates	O
of	O
clearance	O
of	O
plasma	O
unbound	O
drug	O
(	O
CLunb	O
)	O
.	O

Halothane	O
is	O
metabolized	O
by	O
an	O
oxidative	O
pathway	O
to	O
stable	O
,	O
nonvolatile	O
end	O
products	O
,	O
trifluoroacetic	O
acid	O
(	O
TFAA	O
)	O
and	O
bromide	O
(	O
Br-	O
)	O
,	O
and	O
by	O
reductive	O
pathways	O
to	O
Br	O
-	O
and	O
inorganic	O
fluoride	O
(	O
F-	O
)	O
.	O

These	O
results	O
suggest	O
that	O
HAPE	O
-	O
S	O
-	O
S	O
are	O
prone	O
to	O
irregular	O
nocturnal	O
breathing	O
patterns	O
at	O
high	O
altitude	O
,	O
which	O
is	O
associated	O
with	O
the	O
development	O
of	O
AMS	O
,	O
but	O
it	O
was	O
not	O
possible	O
to	O
determine	O
whether	O
these	O
abnormal	O
breathing	O
patterns	O
are	O
a	O
cause	O
or	O
an	O
effect	O
of	O
AMS	O
.	O

Buflomedil	O
(	O
i.v	O
.	O
)	O
induced	O
a	O
dose	O
-	O
dependent	O
increase	O
of	O
cardiac	O
output	O
at	O
0.16	O
-	O
0.64	O
mg	O
/	O
kg	O
,	O
biphasic	O
changes	O
at	O
1.28	O
and	O
2.56	O
mg	O
/	O
kg	O
and	O
a	O
marked	O
decrease	O
and	O
subsequent	O
slight	O
increase	O
at	O
a	O
large	O
dose	O
of	O
5.12	O
mg	O
/	O
kg	O
.	O

It	O
was	O
possible	O
to	O
classify	O
the	O
animals	O
into	O
high	O
and	O
low	O
responders	O
according	O
to	O
the	O
pattern	O
of	O
humoral	O
immune	O
response	O
.	O

Heart	O
rate	O
(	O
HR	O
)	O
,	O
rectal	O
temperature	O
(	O
Tre	O
)	O
,	O
blood	O
pressure	O
,	O
temperature	O
and	O
relative	O
humidity	O
changes	O
inside	O
clothing	O
were	O
measured	O
on	O
18	O
professional	O
firemen	O
(	O
mean	O
age	O
29.4	O
+	O
/-	O

7.4	O
yr	O
,	O
VO2	O
max	O
41.4	O
+	O
8.8	O
ml	O
kg-1	O
min-1	O
)	O
wearing	O
fire	O
fighter	O
's	O
uniforms	O
(	O
SU	O
)	O
or	O
aluminized	O
,	O
fire	O
resistant	O
,	O
impermeable	O
clothing	O
with	O
self	O
contained	O
breathing	O
apparatus	O
(	O
FE	O
)	O
.	O

The	O
clinical	O
tolerance	O
and	O
pharmacokinetics	O
of	O
FCE	O
22101	O
(	O
sodium	O
(	O
5R	O
,	O
6S	O
)	O
-6-	O
[	O
(	O
1R	O
)	O
-hydroxyethyl	O
]	O
-2-carbamoyloxymethyl-2-penem-3-carboxylate	O
)	O
,	O
a	O
new	O
penem	O
antibiotic	O
,	O
have	O
been	O
studied	O
after	O
giving	O
a	O
single	O
i.v	O
.	O

dose	O
of	O
4	O
mg.kg-1	O
to	O
ten	O
healthy	O
male	O
volunteers	O
.	O

DNA	O
blot	O
hybridization	O
suggests	O
that	O
the	O
rat	O
genome	O
may	O
contain	O
more	O
than	O
one	O
gene	O
encoding	O
PtdIns	B
transfer	I
protein	I
.	O

Another	O
segment	O
of	O
CRL3	B
(	O
-296	O
to	O
-184	O
)	O
,	O
also	O
displaying	O
enhancer	O
function	O
,	O
contained	O
tandem	O
repeated	O
sequences	O
(	O
DR	O
-	O
A1	O
and	O
DR	O
-	O
A2	O
)	O
.	O

1-	O
(	O
1-Naphthyl	O
)	O
piperazine	O
(	O
1-NP	O
)	O
has	O
been	O
reported	O
to	O
have	O
serotonin	O
antagonist	O
properties	O
at	O
the	O
5-HT2	B
subtype	I
of	O
receptor	O
,	O
and	O
it	O
has	O
been	O
suggested	O
that	O
it	O
may	O
have	O
agonist	O
actions	O
at	O
the	O
5-HT1	B
site	I
.	O

The	O
characteristic	O
feature	O
of	O
liver	O
and	O
spleen	O
MP	O
function	O
in	O
patients	O
with	O
VHA	O
associated	O
with	O
HBsAg	B
carriership	O
consisted	O
in	O
the	O
lack	O
of	O
the	O
compensatory	O
reaction	O
on	O
the	O
part	O
of	O
spleen	O
MP	O
,	O
which	O
was	O
likely	O
to	O
be	O
connected	O
with	O
overstrain	O
of	O
long	O
standing	O
and	O
depletion	O
of	O
the	O
MP	O
system	O
due	O
to	O
permanent	O
antigenic	O
stimulation	O
of	O
HBsAg	B
.	O

A	O
soap	O
and	O
water	O
(	O
1:1	O
,	O
v	O
/	O
v	O
)	O
solution	O
effectively	O
decontaminated	O
powdered	O
stratum	O
corneum	O
.	O

Histiocytic	O
panniculitis	O
was	O
observed	O
in	O
biopsy	O
specimens	O
with	O
cytophagocytosis	O
.	O

Electrocardiographic	O
right	O
ventricular	O
hypertrophy	O
was	O
seen	O
in	O
4	O
,	O
and	O
biventricular	O
hypertrophy	O
in	O
5	O
patients	O
.	O

Sequencing	O
analysis	O
revealed	O
that	O
the	O
0.54-	O
and	O
0.4-kb	O
fragments	O
are	O
identical	O
except	O
for	O
150	O
nucleotides	O
missing	O
at	O
the	O
5	O
'	O
region	O
of	O
the	O
0.4-kb	O
fragment	O
.	O

The	O
mature	O
protein	O
also	O
contains	O
a	O
cysteine	O
-	O
rich	O
,	O
highly	O
hydrophilic	O
region	O
homologous	O
to	O
the	O
ovomucoid	B
serine	I
protease	I
inhibitors	I
(	O
residues	O
76	O
-	O
132	O
)	O
.	O

Within	O
each	O
lobe	O
,	O
the	O
PA	O
dispersion	O
was	O
up	O
to	O
10	O
cmH2O	O
at	O
CFV	O
of	O
90	O
l	O
/	O
min	O
;	O
when	O
flow	O
decreased	O
,	O
PA	O
at	O
all	O
sites	O
decreased	O
,	O
as	O
did	O
the	O
intralobar	O
dispersion	O
.	O

The	O
system	O
consisted	O
of	O
the	O
intact	O
canine	O
heart	O
connected	O
to	O
a	O
microcomputer	O
that	O
operated	O
as	O
the	O
modulated	O
parasystolic	O
pacemaker	O
.	O

In	O
order	O
to	O
identify	O
and	O
classify	O
the	O
basic	O
CT	O
appearances	O
of	O
interstitial	O
pneumonia	O
,	O
radiologic	O
-pathologic	O
correlative	O
study	O
was	O
performed	O
using	O
inflated	O
and	O
fixed	O
lungs	O
from	O
autopsy	O
and	O
surgery	O
.	O

The	O
disease	O
ran	O
an	O
atypical	O
course	O
;	O
with	O
early	O
jaundice	O
syndrome	O
,	O
severe	O
enterorrhagia	O
and	O
late	O
appearance	O
of	O
roseola	O
.	O

The	O
transcription	O
factor	O
Sp1	B
bound	O
to	O
eight	O
sites	O
,	O
as	O
demonstrated	O
by	O
footprinting	O
assays	O
and	O
gel	O
shift	O
analysis	O
with	O
purified	O
Sp1	B
.	O

The	O
combination	O
PIP	O
64	O
micrograms	O
-	O
PEF	O
4	O
micrograms	O
prevents	O
the	O
frequent	O
secondary	O
regrowth	O
seen	O
after	O
6	O
hours	O
with	O
the	O
antibiotics	O
used	O
alone	O
.	O

With	O
a	O
sample	O
of	O
mothers	O
of	O
healthy	O
infants	O
,	O
all	O
three	O
subscales	O
of	O
the	O
revised	O
instrument	O
,	O
WPL	O
-	O
R	O
,	O
had	O
acceptable	O
levels	O
of	O
internal	O
consistency	O
at	O
7	O
,	O
30	O
,	O
and	O
90	O
days	O
postpartum	O
,	O
and	O
stability	O
across	O
administrations	O
.	O

Acute	O
experiments	O
on	O
nembutal	O
-	O
anesthetized	O
cats	O
(	O
50	O
mg	O
/	O
kg	O
)	O
were	O
employed	O
to	O
investigate	O
the	O
effect	O
of	O
1	O
T	O
pulsating	O
magnetic	O
field	O
(	O
PMF	O
)	O
on	O
neuromuscular	O
system	O
of	O
the	O
leg	O
.	O

No	O
significant	O
differences	O
were	O
found	O
between	O
the	O
TS	O
and	O
the	O
PTS	O
.	O

A	O
genomic	O
DNA	O
clone	O
encoding	O
oryzacystatin	B
(	O
Oc	B
)	O
,	O
a	O
cysteine	B
proteinase	I
inhibitor	O
(	O
cystatin	B
)	O
of	O
rice	O
,	O
was	O
isolated	O
from	O
a	O
lambda	O
EMBL3	O
phage	O
library	O
constructed	O
with	O
Sau3AI	B
partial	O
digests	O
of	O
rice	O
chromosomal	O
DNA	O
,	O
by	O
screening	O
with	O
an	O
oc	B
cDNA	I
as	O
a	O
probe	O
.	O

The	O
use	O
of	O
an	O
appropriate	O
solution	O
of	O
methylene	O
blue	O
(	O
0.2	O
%	O
in	O
0.9	O
M	O
NaCl	O
for	O
15	O
min	O
)	O
permits	O
the	O
staining	O
of	O
premalignant	O
areas	O
and	O
CIS	O
,	O
and	O
their	O
early	O
diagnosis	O
.	O

Lower	O
limits	O
(	O
to	O
10	O
micrograms	O
/	O
kg	O
)	O
were	O
detectable	O
,	O
but	O
with	O
lower	O
reliability	O
(	O
60	O
%	O
)	O
.	O

Instead	O
,	O
some	O
small	O
negative	O
effects	O
are	O
observed	O
,	O
particularly	O
involving	O
effects	O
of	O
husbands	O
'	O
retirement	O
on	O
the	O
marital	O
satisfaction	O
of	O
employed	O
wives	O
.	O

In	O
one	O
acromegalic	O
patient	O
visual	O
improvement	O
was	O
obtained	O
while	O
the	O
abnormal	O
GH	B
secretion	O
remained	O
unaltered	O
.	O

In	O
contrast	O
,	O
the	O
PPSF	O
+	O
DBP	O
side	O
showed	O
large	O
amounts	O
of	O
bone	O
formation	O
,	O
and	O
bone	O
almost	O
covered	O
the	O
implant	O
.	O

Immunohistochemical	O
studies	O
revealed	O
positive	O
staining	O
for	O
S100	B
protein	I
in	O
all	O
the	O
granular	O
cell	O
tumors	O
of	O
the	O
adult	O
but	O
in	O
none	O
of	O
the	O
congenital	O
granular	O
cell	O
epulides	O
.	O

Pacing	O
the	O
Roux	O
limb	O
abolished	O
the	O
ectopic	O
pacemakers	O
,	O
restored	O
the	O
slow	O
emptying	O
of	O
liquids	O
to	O
the	O
more	O
rapid	O
rate	O
found	O
in	O
the	O
Billroth	O
dogs	O
(	O
t1	O
/	O
2	O
:	O
paced	O
Roux	O
,	O
72	O
+	O
/-	O

15	O
minutes	O
;	O
Billroth	O
,	O
43	O
+	O
/-	O

9	O
minutes	O
;	O
p	O
greater	O
than	O
0.05	O
)	O
and	O
did	O
not	O
change	O
emptying	O
of	O
solids	O
.	O

The	O
treatments	O
were	O
60	O
mg	O
t.i.d	O
.	O

and	O
120	O
mg	O
t.i.d	O
.	O

during	O
14	O
days	O
'	O
treatment	O
,	O
with	O
the	O
last	O
dose	O
pulsed	O
with	O
1.85	O
MBq	O
[	O
14C	O
]	O
diltiazem	O
.	O

A	O
great	O
deal	O
of	O
information	O
is	O
available	O
on	O
the	O
morphology	O
of	O
the	O
claustrum	O
in	O
various	O
animal	O
species	O
,	O
as	O
well	O
as	O
on	O
its	O
neuronal	O
distribution	O
and	O
relationships	O
with	O
the	O
cerebral	O
cortex	O
and	O
other	O
nuclei	O
.	O

Low	O
-	O
grade	O
glioma	O
.	O

In	O
terms	O
of	O
sequence	O
repetitions	O
,	O
seven	O
tandemly	O
repeated	O
copies	O
of	O
the	O
hexanucleotide	O
ATTGTT	O
and	O
three	O
flanking	O
regions	O
of	O
dyad	O
symmetry	O
were	O
detected	O
,	O
all	O
in	O
ORF	O
T3C	O
.	O

7	O
.	O

These	O
data	O
suggest	O
that	O
the	O
G	B
-	I
protein	I
gene	I
family	I
may	O
be	O
distributed	O
over	O
at	O
least	O
two	O
human	O
chromosomes	O
.	O

In	O
44	O
evaluable	O
patients	O
the	O
response	O
rate	O
was	O
50	O
%	O
,	O
with	O
one	O
complete	O
response	O
.	O

We	O
have	O
also	O
found	O
that	O
the	O
in	O
vitro	O
interaction	O
between	O
the	O
SV40	O
octamer	O
motif	O
and	O
the	O
lymphoid	B
cell	I
-	I
specific	I
protein	I
oct	I
-	I
B2	I
was	O
negatively	O
modulated	O
by	O
a	O
component	O
present	O
in	O
the	O
nuclear	O
extracts	O
from	O
several	O
lymphoid	O
cell	O
lines	O
.	O

Growth	O
,	O
4-PA	O
and	O
14C	O
turnover	O
data	O
indicated	O
that	O
WB	O
contributed	O
to	O
B-6	O
intake	O
of	O
these	O
rats	O
.	O

DNA	O
sequence	O
analysis	O
revealed	O
that	O
these	O
clones	O
encode	O
two	O
distinct	O
forms	O
of	O
translocase	B
.	O

The	O
effect	O
of	O
acetazolamide	O
(	O
ACZ	O
)	O
on	O
HCO3-	O
and	O
Cl-	O
activities	O
in	O
inner	O
ear	O
fluid	O
was	O
investigated	O
by	O
ion	O
-	O
selective	O
microelectrode	O
methods	O
.	O

These	O
offspring	O
of	O
the	O
alpha	B
-	I
MSH	I
treated	O
mothers	O
were	O
less	O
sensitive	O
to	O
pain	O
and	O
as	O
adults	O
showed	O
a	O
reduced	O
analgesic	O
response	O
to	O
morphine	O
.	O

Simian	O
immunodeficiency	O
virus	O
(	O
SIV	O
)	O
is	O
a	O
lentivirus	O
with	O
morphological	O
and	O
antigenic	O
similarities	O
to	O
human	O
immunodeficiency	O
virus	O
,	O
the	O
causative	O
agent	O
of	O
acquired	O
immunodeficiency	O
syndrome	O
(	O
AIDS	O
)	O
of	O
humans	O
.	O

The	O
lack	O
of	O
change	O
in	O
the	O
ratio	O
of	O
the	O
two	O
spliced	O
products	O
expressed	O
from	O
either	O
the	O
normal	O
or	O
the	O
5'-rearranged	B
myb	I
further	O
indicates	O
that	O
the	O
insertion	O
of	O
the	O
unique	O
121	O
amino	O
acids	O
in	O
the	O
larger	O
myb	B
transcripts	I
is	O
not	O
a	O
consequence	O
of	O
tumor	O
-	O
specific	O
activation	O
of	O
the	O
mouse	B
myb	I
oncogene	I
.	O

The	O
use	O
of	O
CRF-41	B
in	O
the	O
differential	O
diagnosis	O
of	O
Cushing	O
's	O
syndrome	O
and	O
obesity	O
.	O

The	O
predicted	O
L	B
mRNA	I
was	O
6398	O
nucleotides	O
long	O
and	O
contained	O
a	O
single	O
open	O
reading	O
frame	O
corresponding	O
to	O
an	O
L	B
protein	I
encompassing	I
2109	I
amino	I
acids	I
with	O
a	O
MW	O
of	O
241,546	O
.	O

The	O
results	O
suggest	O
that	O
the	O
organization	O
of	O
functional	O
units	O
of	O
the	O
72-bp	O
repeat	O
required	O
for	O
transcriptional	O
enhancement	O
of	O
the	O
early	O
promoter	O
is	O
different	O
from	O
that	O
required	O
for	O
late	O
promoter	O
function	O
.	O

Variations	O
in	O
the	O
5	O
'	O
half	O
of	O
U3	O
were	O
primarily	O
due	O
to	O
insertions	O
and	O
deletions	O
.	O

Either	O
two	O
or	O
more	O
different	O
sequences	O
can	O
promote	O
cleavage	O
,	O
or	O
a	O
single	O
element	O
exists	O
which	O
is	O
long	O
and	O
diffuse	O
.	O

The	O
bactericidal	O
activity	O
of	O
six	O
new	O
rifamycin	O
derivatives	O
--	O
rifabutin	O
(	O
RBU	O
)	O
,	O
FCE	O
22250	O
(	O
F22	O
)	O
,	O
rifapentine	O
(	O
RPE	O
)	O
,	O
CGP	O
29861	O
(	O
C29	O
)	O
,	O
CGP	O
7040	O
(	O
C70	O
)	O
and	O
CGP	O
27557	O
(	O
C27	O
)	O
and	O
rifampicin	O
(	O
RMP	O
)	O
--have	O
been	O
measured	O
against	O
log	O
phase	O
and	O
,	O
as	O
a	O
better	O
test	O
of	O
sterilising	O
activity	O
,	O
against	O
stationary	O
phase	O
cultures	O
of	O
Mycobacterium	O
tuberculosis	O
,	O
H37Rv	O
.	O

Mo	O
+	O
SV	O
M	O
-	O
MuLV	O
-	O
inoculated	O
animals	O
became	O
moribund	O
at	O
3	O
to	O
13	O
months	O
postinoculation	O
,	O
whereas	O
delta	O
Mo	O
+	O
SV	O
M	O
-	O
MuLV	O
-	O
inoculated	O
animals	O
became	O
moribund	O
at	O
6	O
to	O
24	O
months	O
postinoculation	O
.	O

Amino	O
acid	O
sequence	O
of	O
one	O
human	O
liver	O
clone	O
(	O
HL-14	O
)	O
was	O
identical	O
to	O
the	O
rabbit	B
skeletal	I
muscle	I
phosphatase	I
2A	I
cDNA	I
(	O
with	O
97	O
%	O
nucleotide	O
identity	O
)	O
.	O

Herpes	O
virus	O
infection	O
was	O
characterized	O
by	O
inversion	O
of	O
the	O
T4	O
/	O
T8	O
ratio	O
below	O
1.0	O
(	O
sensitivity	O
90	O
%	O
,	O
specificity	O
88	O
%	O
)	O
,	O
caused	O
by	O
proliferation	O
of	O
the	O
T8	O
subpopulation	O
,	O
which	O
--	O
compared	O
with	O
the	O
findings	O
in	O
patients	O
with	O
rejection	O
crises	O
--	O
was	O
significantly	O
raised	O
(	O
P	O
less	O
than	O
0.001	O
)	O
.	O

The	O
levels	O
of	O
NPY	B
-	O
ir	O
in	O
the	O
rat	O
vas	O
deferens	O
were	O
not	O
affected	O
by	O
either	O
surgical	O
or	O
pharmacological	O
treatment	O
.	O

The	O
mechanism	O
by	O
which	O
E2-C	B
represses	O
E2-dependent	B
enhancer	I
activity	O
most	O
likely	O
involves	O
competition	O
with	O
E2	B
for	O
binding	O
to	O
a	O
common	O
transcriptional	O
regulatory	O
site.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

Accurate	O
evaluation	O
of	O
the	O
treatment	O
results	O
in	O
unresectable	O
lung	O
cancer	O
patients	O
must	O
take	O
the	O
strong	O
prognostic	O
factors	O
into	O
account	O
.	O

(	O
anti	B
-	I
IIa	I
)	O
and	O
Holmer	O
et	O
al.	O

Introduction	O
of	O
v	B
-	I
fms	I
into	O
a	O
CSF-1	B
dependent	O
murine	O
macrophage	O
cell	O
line	O
induced	O
factor	O
independence	O
and	O
tumorigenicity	O
by	O
a	O
nonautocrine	O
mechanism	O
.	O

The	O
primary	O
structure	O
and	O
cotranscription	O
of	O
the	O
petCA	B
genes	I
encoding	O
the	O
Rieske	B
-	I
FeS	I
(	O
nuclear	B
encoded	I
in	I
plants	I
)	O
and	O
apocytochrome	B
f	I
proteins	I
has	O
been	O
described	O
previously	O
(	O
Kallas	O
,	O
T.	O
,	O
Spiller	O
,	O
S.	O
,	O
and	O
Malkin	O
,	O
R.	O

The	O
Nostoc	O
petBD	B
genes	I
are	O
not	O
closely	O
linked	O
to	O
the	O
psbB	B
gene	I
(	O
encoding	O
the	O
51-kDa	O
photosystem	B
II	I
polypeptide	I
)	O
and	O
do	O
not	O
contain	O
introns	O
as	O
do	O
the	O
closely	O
related	O
chloroplast	O
genes	O
.	O

Whereas	O
the	O
muscle	O
isoform	O
consists	O
of	O
997	O
amino	O
acids	O
and	O
terminates	O
with	O
the	O
sequence	O
Ala	O
-	O
Ile	O
-	O
Leu	O
-	O
Glu	O
,	O
the	O
second	O
isoform	O
is	O
1043	O
amino	O
acids	O
in	O
length	O
due	O
to	O
the	O
replacement	O
of	O
these	O
last	O
4	O
amino	O
acids	O
with	O
a	O
50-amino	O
acid	O
sequence	O
that	O
contains	O
a	O
potential	O
transmembrane	O
domain	O
followed	O
by	O
a	O
consensus	O
sequence	O
for	O
an	O
N	O
-	O
linked	O
glycosylation	O
site	O
.	O

Substitution	O
of	O
a	O
threonine	O
residue	O
by	O
an	O
alanine	O
residue	O
at	O
position	O
-2	O
(	O
P2	O
)	O
of	O
this	O
cleavage	O
site	O
abolished	O
cleavage	O
,	O
whereas	O
substitution	O
of	O
a	O
tyrosine	O
residue	O
by	O
a	O
phenylalanine	O
residue	O
at	O
amino	O
acid	O
position	O
-1	O
(	O
P1	O
)	O
of	O
the	O
cleavage	O
site	O
did	O
not	O
influence	O
processing	O
.	O

One	O
of	O
these	O
,	O
the	O
origin	O
core	O
,	O
is	O
required	O
only	O
for	O
DNA	O
replication	O
.	O

A	O
17-mer	O
oligodeoxynucleotide	O
,	O
corresponding	O
to	O
a	O
region	O
of	O
the	O
VtHb	B
amino	I
acid	I
sequence	I
was	O
used	O
as	O
a	O
hybridization	O
probe	O
to	O
screen	O
a	O
Vitreoscilla	O
genomic	O
library	O
constructed	O
in	O
broad	O
-	O
host	O
-	O
range	O
cosmid	O
vector	O
pVK102	O
.	O

(	O
total	O
soluble	O
solids	O
)	O
and	O
organoleptic	O
characteristics	O
under	O
the	O
influence	O
of	O
different	O
treatments	O
.	O

The	O
progression	O
of	O
non	O
-	O
A	O
,	O
non	O
-	O
B	O
hepatitis	O
to	O
chronic	O
diseases	O
,	O
and	O
the	O
transformation	O
to	O
hepatocellular	O
carcinoma	O

Elevated	O
IOP	O
developed	O
in	O
35	O
patients	O
(	O
44	O
eyes	O
)	O
during	O
the	O
study	O
.	O

Poor	O
response	O
when	O
laboratory	O
recommended	O
range	O
for	O
serum	O
lithium	O
is	O
changed	O
.	O

Further	O
analysis	O
of	O
this	O
DNA	O
fragment	O
showed	O
that	O
four	O
genes	O
are	O
present	O
encoding	O
proteins	O
of	O
16	O
,	O
18.5	O
,	O
21	O
and	O
89	O
kDal	O
.	O

Hantaan	O
virus	O
.	O

Replacement	B
variant	I
histone	I
genes	I
contain	O
intervening	O
sequences	O
.	O

Double	O
-	O
blind	O
randomised	O
trial	O
of	O
intravenous	O
tissue	B
-	I
type	I
plasminogen	I
activator	I
versus	O
placebo	O
in	O
acute	O
myocardial	O
infarction	O
.	O

Intravesical	O
chemotherapy	O
.	O

Bisoprolol	O
was	O
found	O
to	O
be	O
an	O
effective	O
beta	B
-	I
adrenoceptor	I
antagonist	O
,	O
the	O
pA2	O
values	O
determined	O
against	O
isoprenaline	O
in	O
guinea	O
pig	O
atria	O
and	O
tracheal	O
muscle	O
being	O
7.45	O
and	O
6.41	O
,	O
respectively	O
.	O

Output	O
of	O
99mTcO-4	O
by	O
the	O
parotid	O
gland	O
closely	O
mimicked	O
fluctuations	O
in	O
parotid	O
saliva	O
flow	O
rate	O
.	O

The	O
Hagen	O
-	O
Poiseuille	O
equation	O
is	O
used	O
to	O
assess	O
the	O
effects	O
of	O
attached	O
parasites	O
in	O
the	O
foregut	O
of	O
Leishmania	O
-	O
infected	O
sandflies	O
on	O
blood	O
flow	O
.	O

An	O
endometrial	O
luteal	O
phase	O
deficiency	O
was	O
detected	O
in	O
15	O
(	O
30	O
%	O
)	O
of	O
aborting	O
patients	O
.	O

Prenatal	O
exposure	O
to	O
the	O
fungicide	O
dinocap	O
causes	O
behavioral	O
torticollis	O
,	O
ballooning	O
and	O
cleft	O
palate	O
in	O
mice	O
,	O
but	O
not	O
rats	O
or	O
hamsters	O
.	O

The	O
sensitivity	O
of	O
the	O
vas	O
deferens	O
to	O
adrenaline	O
was	O
also	O
reduced	O
in	O
scorbutic	O
guinea	O
pigs	O
,	O
thus	O
decreasing	O
their	O
fertility	O
rate	O
.	O

In	O
metabolic	O
acidosis	O
there	O
was	O
a	O
marked	O
stimulation	O
when	O
clamped	O
at	O
-10	O
to	O
-100	O
mV.	O

Present	O
results	O
reveal	O
a	O
frequency	O
-	O
dependent	O
inhibition	O
of	O
ganglionic	O
transmission	O
by	O
diltiazem	O
,	O
and	O
suggest	O
that	O
diltiazem	O
may	O
depress	O
excessive	O
sympathetic	O
activity	O
without	O
affecting	O
normal	O
ganglionic	O
transmission	O
.	O

Body	O
temperature	O
and	O
overall	O
conductance	O
in	O
the	O
cold	O
appear	O
to	O
be	O
more	O
variable	O
in	O
P.	O
s.	O
campbelli	O
than	O
in	O
nominative	O
sp.	O

Two	O
polyadenylation	O
sites	O
were	O
used	O
,	O
one	O
at	O
the	O
end	O
of	O
the	O
early	B
(	I
E	I
)	I
region	I
of	O
the	O
viral	O
DNA	O
,	O
the	O
other	O
at	O
the	O
end	O
of	O
the	O
late	B
(	I
L	I
)	I
region	I
.	O

A	O
drug	O
with	O
ISA	O
""""	O
down	O
regulates	O
""""	O
beta	B
receptors	I
;	O
thus	O
,	O
when	O
the	O
drug	O
is	O
withdrawn	O
there	O
is	O
no	O
post	O
-	O
beta	O
-	O
blocking	O
drug	O
hypersensitivity	O
in	O
contrast	O
to	O
agents	O
without	O
ISA	O
.	O

Terazosin	O
,	O
a	O
structural	O
analog	O
of	O
prazosin	O
,	O
also	O
inhibits	O
alpha	B
1	I
adrenoceptors	I
and	O
is	O
recommended	O
as	O
once	O
or	O
twice	O
-	O
daily	O
therapy	O
.	O

Testing	O
blood	O
donors	O
for	O
non	O
-	O
A	O
,	O
non	O
-	O
B	O
hepatitis	O
:	O
irrational	O
,	O
perhaps	O
,	O
but	O
inescapable	O
.	O

In	O
a	O
randomised	O
double	O
-	O
blind	O
study	O
,	O
46	O
first	O
episode	O
schizophrenics	O
were	O
given	O
pimozide	O
or	O
flupenthixol	O
for	O
up	O
to	O
5	O
weeks	O
;	O
the	O
mean	O
daily	O
dose	O
at	O
the	O
end	O
was	O
18.8	O
mg	O
pimozide	O
and	O
20	O
mg	O
flupenthixol	O
.	O

We	O
have	O
been	O
able	O
to	O
map	O
specific	O
DNA	O
fragments	O
at	O
the	O
bases	O
of	O
chromatin	O
loops	O
with	O
the	O
help	O
of	O
a	O
novel	O
extraction	O
procedure	O
by	O
using	O
lithium-3',5'-diiodosalicylate	O
.	O

Finally	O
,	O
the	O
recovery	O
indexes	O
represented	O
by	O
the	O
times	O
required	O
for	O
T1	O
/	O
T0	O
and	O
T4	O
/	O
T1	O
to	O
rise	O
from	O
25	O
%	O
to	O
75	O
%	O
respectively	O
were	O
studied	O
.	O

DPA	O
attenuated	O
the	O
increase	O
of	O
the	O
intensity	O
of	O
the	O
ischemic	O
and	O
pressure	O
pain	O
components	O
with	O
increasing	O
ischemia	O
duration	O
,	O
but	O
only	O
the	O
effect	O
on	O
the	O
pressure	O
pain	O
component	O
was	O
significant	O
.	O

Topical	O
1	O
percent	O
isoproterenol	O
in	O
the	O
presence	O
of	O
the	O
phosphodiesterase	O
inhibitor	O
theophylline	O
was	O
tested	O
for	O
its	O
ability	O
to	O
stimulate	O
the	O
rate	O
of	O
aqueous	O
humor	O
flow	O
through	O
the	O
anterior	O
chamber	O
of	O
the	O
normal	O
and	O
the	O
partially	O
adrenergically	O
denervated	O
human	O
eye	O
(	O
Horner	O
's	O
syndrome	O
)	O
.	O

Hyperthyroidism	O
is	O
one	O
of	O
the	O
numerous	O
causes	O
of	O
infertility	O
and	O
recurrent	O
abortion	O
.	O

A	O
strong	O
correlation	O
exists	O
between	O
the	O
numbers	O
of	O
CFU	O
-	O
GM	O
transfused	O
and	O
the	O
rate	O
of	O
granulocytes	O
and	O
platelets	O
recovery	O
.	O

We	O
propose	O
that	O
the	O
technique	O
of	O
low	O
-	O
frequency	O
kindling	O
is	O
a	O
useful	O
experimental	O
model	O
in	O
assessing	O
the	O
effects	O
of	O
antipsychotic	O
or	O
antiepileptic	O
drugs	O
on	O
the	O
excitability	O
of	O
the	O
limbic	O
regions	O
.	O

Three	O
sequence	O
elements	O
are	O
shown	O
to	O
be	O
required	O
for	O
accurate	O
and	O
efficient	O
transcription	O
termination	O
by	O
RNA	B
polymerase	I
I	I
(	O
pol	B
I	I
)	O
assayed	O
both	O
in	O
a	O
cell	O
-	O
free	O
transcription	O
system	O
and	O
in	O
vivo	O
after	O
transfection	O
of	O
rDNA	O
minigene	O
constructs	O
into	O
3T6	O
cells	O
.	O

The	O
biosynthesis	O
and	O
stability	O
of	O
the	O
three	O
mutant	O
proteins	O
were	O
similar	O
to	O
those	O
of	O
the	O
wild	B
-	I
type	I
erbB	I
protein	I
,	O
and	O
all	O
three	O
retained	O
the	O
ability	O
to	O
transform	O
chicken	O
embryo	O
fibroblasts	O
.	O

A	O
new	O
physiopathological	O
treatment	O
of	O
HBV	O
-	O
related	O
polyarteritis	O
inspired	O
by	O
advances	O
in	O
the	O
treatment	O
of	O
chronic	O
active	O
hepatitis	O
B	O
was	O
tested	O
in	O
7	O
patients	O
.	O

Like	O
scrotal	O
testes	O
,	O
undescended	O
testes	O
were	O
hypointense	O
to	O
fat	O
on	O
sequences	O
with	O
a	O
short	O
repetition	O
time	O
(	O
TR	O
)	O
and	O
echo	O
time	O
(	O
TE	O
)	O
in	O
all	O
cases	O
,	O
and	O
hyperintense	O
or	O
isointense	O
to	O
fat	O
on	O
long	O
TR	O
/	O
TE	O
sequences	O
in	O
all	O
but	O
two	O
cases	O
.	O

Here	O
,	O
we	O
describe	O
the	O
isolation	O
of	O
bovine	B
and	I
rat	I
GHF-1	I
cDNA	I
clones	O
.	O

To	O
explore	O
the	O
functional	O
properties	O
of	O
the	O
protein	O
encoded	O
by	O
neu	B
,	O
we	O
created	O
a	O
fusion	O
gene	O
that	O
joins	O
the	O
cytoplasmic	O
domain	O
of	O
neu	B
to	O
the	O
extracellular	O
portion	O
of	O
an	O
immunoglobulin	B
heavy	I
chain	I
.	O

By	O
sequence	O
comparison	O
,	O
42	O
blocks	O
of	O
homology	O
are	O
defined	O
in	O
the	O
5'-terminal	O
region	O
,	O
of	O
which	O
36	O
appear	O
in	O
the	O
CpG	O
island	O
and	O
contain	O
numerous	O
conserved	O
CpG	O
dinucleotides	O
.	O

Efficacy	O
and	O
field	O
evaluation	O
of	O
Bacillus	O
thuringiensis	O
(	O
H-14	O
)	O
and	O
B.	O
sphaericus	O
against	O
floodwater	O
mosquitoes	O
in	O
California	O
.	O

This	O
loss	O
was	O
independent	O
of	O
drug	O
concentration	O
and	O
a	O
correction	O
factor	O
was	O
employed	O
to	O
calculate	O
the	O
true	O
free	O
diazepam	O
concentration	O
.	O

Effects	O
of	O
a	O
perfluorochemical	O
blood	O
substitute	O
on	O
diazepam	O
binding	O
by	O
human	B
albumin	I
.	O

A	O
second	O
promoter	O
activity	O
was	O
identified	O
in	O
the	O
region	O
between	O
the	O
two	O
major	O
transcriptional	O
start	O
sites	O
.	O

A	O
decamer	O
sequence	O
,	O
5'-CGA	O
-	O
CCCCUCC-3	O
'	O
,	O
complementary	O
to	O
a	O
conserved	O
sequence	O
adjacent	O
to	O
the	O
enzymatic	O
cleavage	O
site	O
on	O
the	O
mitochondrial	O
RNA	O
substrate	O
,	O
is	O
present	O
in	O
the	O
RNAase	B
MRP	I
RNA	I
.	O

Computer	O
analysis	O
included	O
digital	O
averaging	O
,	O
followed	O
by	O
digital	O
filtering	O
in	O
different	O
frequency	O
bands	O
in	O
order	O
to	O
determine	O
the	O
frequency	O
range	O
corresponding	O
to	O
notches	O
and	O
slurs	O
.	O

On	O
admission	O
to	O
the	O
ICU	O
,	O
117	O
patients	O
(	O
61	O
percent	O
)	O
had	O
hypomagnesemia	O
(	O
serum	O
Mg	O
less	O
than	O
1.5	O
mEq	O
/	O
dl	O
)	O
,	O
66	O
patients	O
(	O
34	O
percent	O
)	O
had	O
normomagnesemia	O
(	O
1.5	O
to	O
2.0	O
mEq	O
/	O
dl	O
)	O
,	O
and	O
ten	O
patients	O
(	O
5	O
percent	O
)	O
had	O
hypermagnesemia	O
(	O
greater	O
than	O
2.0	O
mEq	O
/	O
dl	O
)	O
.	O

Controlled	O
versus	O
uncontrolled	O
reperfusion	O
of	O
ischemic	O
myocardium	O
after	O
experimental	O
coronary	O
artery	O
occlusion	O
was	O
studied	O
to	O
determine	O
the	O
effect	O
on	O
regional	O
ventricular	O
wall	O
motion	O
and	O
associated	O
biochemical	O
alterations	O
.	O

We	O
also	O
examined	O
the	O
relationship	O
between	O
the	O
side	O
of	O
sinusitis	O
and	O
the	O
cleft	O
side	O
in	O
patients	O
with	O
unilateral	O
cleft	O
palate	O
.	O

We	O
conclude	O
that	O
at	O
these	O
low	O
levels	O
studied	O
,	O
aluminum	O
accumulates	O
in	O
intestinal	O
tissue	O
,	O
and	O
that	O
this	O
accumulation	O
is	O
enhanced	O
by	O
citrate	O
ligand	O
.	O

Recently	O
,	O
an	O
electrical	O
-	O
mechanical	O
analog	O
model	O
of	O
heat	O
flow	O
within	O
the	O
brain	O
has	O
been	O
developed	O
from	O
which	O
an	O
expression	O
for	O
CBF	O
has	O
been	O
derived	O
:	O
CBF	O
=	O
Cb	O
/	O
(	O
tau	O
rho	O
c	O
)	O
where	O
tau	O
is	O
the	O
thermal	O
decay	O
constant	O
,	O
rho	O
is	O
the	O
density	O
of	O
blood	O
,	O
and	O
c	O
is	O
its	O
specific	O
heat	O
.	O

All	O
of	O
the	O
newly	O
acquired	O
proviruses	O
identified	O
in	O
mosaic	O
founder	O
SWR	O
/	O
J	O
-	O
RF	O
/	O
J	O
mice	O
that	O
could	O
be	O
transmitted	O
through	O
the	O
germ	O
line	O
were	O
also	O
present	O
in	O
somatic	O
tissues	O
,	O
demonstrating	O
that	O
viral	O
integration	O
occurred	O
before	O
the	O
germ	O
line	O
was	O
set	O
aside	O
from	O
the	O
somatic	O
lineages	O
.	O

Molecular	O
cloning	O
of	O
the	O
cDNA	O
for	O
the	O
human	B
U2	I
snRNA	I
-	I
specific	I
A	I
'	I
protein	I
.	O

Successful	O
use	O
of	O
transureteroureterostomy	O
to	O
salvage	O
ureterosigmoidostomy	O
after	O
anastomotic	O
failure	O
.	O

Oxfendazole	O
,	O
which	O
was	O
active	O
for	O
the	O
shortest	O
time	O
(	O
about	O
65	O
days	O
)	O
from	O
the	O
start	O
of	O
grazing	O
(	O
May	O
1	O
)	O
,	O
produced	O
a	O
78.1	O
per	O
cent	O
reduction	O
in	O
Ostertagia	O
species	O
and	O
an	O
84.4	O
per	O
cent	O
reduction	O
in	O
D	O
viviparus	O
.	O

Platelet	O
function	O
and	O
platelet	O
-	O
polymorphonuclear	O
-	O
neutrophil	O
interaction	O
in	O
patients	O
with	O
deficient	O
platelet	B
lipoxygenase	I
activity	O
.	O

Spontaneous	O
degradation	O
of	O
atracurium	O
in	O
plasma	O
is	O
the	O
major	O
route	O
of	O
elimination	O
in	O
man	O
and	O
contributes	O
to	O
a	O
short	O
elimination	O
half	O
-	O
life	O
(	O
approximatively	O
20	O
min	O
)	O
.	O

Group	O
A	O
was	O
treated	O
with	O
three	O
or	O
four	O
doses	O
of	O
hepatitis	B
B	I
immune	I
globulin	I
(	O
HBIG	B
)	O
in	O
one	O
of	O
three	O
different	O
schedules	O
.	O

In	O
the	O
former	O
instance	O
,	O
in	O
addition	O
to	O
serum	O
calcium	O
and	O
phosphorous	O
ion	O
concentrations	O
,	O
tissue	O
pH	O
,	O
blood	O
supply	O
,	O
hormones	O
,	O
i.e.	O
,	O
vitamin	O
D	O
,	O
vitamin	O
A	O
,	O
and	O
various	O
enzymes	O
(	O
e.g.	O
,	O
alkaline	B
phosphatase	I
and	O
pyrophosphatase	B
)	O
may	O
all	O
play	O
significant	O
,	O
ancillary	O
,	O
time	O
-	O
dependent	O
,	O
but	O
as	O
yet	O
undetermined	O
roles	O
.	O

Penicillinase	B
production	O
in	O
Staphylococcus	O
aureus	O
strains	O
of	O
clinical	O
importance	O
.	O

Thus	O
,	O
quantitative	O
analysis	O
of	O
thallium-201	O
uptake	O
and	O
washout	O
provided	O
objective	O
evidence	O
for	O
improved	O
myocardial	O
perfusion	O
after	O
coronary	O
angioplasty	O
.	O

This	O
study	O
reports	O
the	O
effects	O
of	O
a	O
preparation	O
with	O
50	O
micrograms	O
ethinyl	O
estradiol	O
and	O
2	O
mg	O
cyproterone	O
acetate	O
on	O
gonadotropins	B
,	O
prolactin	B
,	O
testosterone	O
,	O
sex	B
hormone	I
binding	I
globulin	I
(	O
SHBG	B
)	O
,	O
androstenedione	O
,	O
and	O
calculated	O
free	O
testosterone	O
index	O
before	O
and	O
after	O
six	O
months	O
of	O
treatment	O
.	O

Preventive	O
effect	O
of	O
ONO-3708	O
on	O
thrombosis	O
and	O
vasospasms	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Monospecific	O
antibodies	O
,	O
eluted	O
from	O
the	O
beta	B
-	I
galactosidase	I
fusion	O
protein	O
of	O
either	O
clone	O
reacted	O
with	O
the	O
U1	B
snRNP	I
-	O
specific	O
A	B
antigen	I
.	O

Schedule	O
2	O
,	O
in	O
which	O
2.4	O
mg	O
/	O
kg	O
c	O
-	O
DDP	O
was	O
administered	O
immediately	O
before	O
X	O
-	O
ray	O
on	O
5	O
consecutive	O
days	O
produced	O
the	O
highest	O
degree	O
of	O
enhancement	O
of	O
radiation	O
effect	O
(	O
expressed	O
as	O
dose	O
-	O
effect	O
factor	O
)	O
;	O
and	O
the	O
next	O
greatest	O
enhancement	O
was	O
produced	O
by	O
12	O
mg	O
/	O
kg	O
c	O
-	O
DDP	O
administered	O
24	O
h	O
before	O
the	O
start	O
of	O
fractionated	O
daily	O
radiotherapy	O
.	O

The	O
cpc-1-encoded	B
transcript	I
contains	O
three	O
open	O
reading	O
frames	O
,	O
two	O
of	O
which	O
are	O
located	O
in	O
the	O
720-nucleotide	O
leader	O
segment	O
preceding	O
the	O
cpc-1	B
coding	I
region	I
.	O

Ig	B
D	I
-	O
JH	B
recombinations	O
may	O
precede	O
TcR	B
gene	I
recombination	O
in	O
these	O
early	O
T	O
cell	O
lines	O
,	O
and	O
some	O
but	O
not	O
all	O
express	O
sterile	O
Cmu	B
transcripts	I
.	O

The	O
RAD18	B
gene	I
open	I
reading	I
frame	I
encodes	O
a	O
protein	O
of	O
487	O
amino	O
acids	O
,	O
with	O
a	O
calculated	O
molecular	O
weight	O
of	O
55,512	O
.	O

The	O
absorbable	O
perisplenic	O
mesh	O
is	O
an	O
important	O
improvement	O
,	O
and	O
in	O
some	O
cases	O
it	O
may	O
replace	O
other	O
techniques	O
for	O
arresting	O
splenic	O
bleeding	O
.	O

A	O
rare	O
chronic	O
course	O
of	O
Budd	O
-	O
Chiari	O
syndrome	O
associated	O
with	O
thrombosis	O
of	O
the	O
portal	O
vein	O
was	O
observed	O
in	O
a	O
30-year	O
-	O
old	O
male	O
patient	O
suffering	O
from	O
postmyocarditic	O
cardiosclerosis	O
.	O

After	O
one	O
accommodation	O
night	O
,	O
sleep	O
EEG	O
recordings	O
were	O
performed	O
during	O
three	O
consecutive	O
nights	O
in	O
ten	O
drug	O
-	O
free	O
inpatients	O
presenting	O
generalized	O
anxiety	O
disorder	O
(	O
GAD	O
)	O
with	O
significant	O
depression	O
,	O
compared	O
with	O
a	O
age-	O
and	O
sex	O
-	O
matched	O
group	O
of	O
patients	O
with	O
GAD	O
and	O
a	O
group	O
of	O
primary	O
major	O
depressive	O
disorder	O
(	O
MDD	O
)	O
patients	O
.	O

Oligonucleotide	O
mutagenesis	O
of	O
these	O
binding	O
domains	O
indicated	O
their	O
importance	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
E3	B
promoter	I
in	O
yeast	O
cells	O
.	O

The	O
concentration	O
of	O
PGI2	O
on	O
the	O
newly	O
-	O
formed	O
luminal	O
surface	O
remained	O
low	O
.	O

Effects	O
of	O
single	O
and	O
combined	O
maltose	O
tetrapalmitate	O
immunotherapy	O
,	O
cyclophosphamide	O
chemotherapy	O
and	O
radiotherapy	O
on	O
ethyl	O
carbamate	O
accelerated	O
primary	O
lung	O
cancer	O
in	O
A	O
/	O
J	O
mice	O
.	O

A	O
114-base	O
pair	O
sequence	O
of	O
predominantly	O
repeating	O
purine	O
-	O
pyrimidine	O
nucleotides	O
separates	O
these	O
two	O
d	O
(	O
AC	O
)	O
repeats	O
.	O

When	O
the	O
coding	O
segments	O
,	O
including	O
both	O
framework	O
and	O
complementarity	O
-	O
determining	O
regions	O
,	O
of	O
these	O
genes	O
and	O
the	O
murine	O
probe	O
sequences	O
are	O
compared	O
by	O
metric	O
analysis	O
,	O
it	O
is	O
apparent	O
that	O
the	O
caiman	O
genes	O
are	O
only	O
slightly	O
more	O
related	O
to	O
each	O
other	O
than	O
to	O
the	O
mammalian	O
sequence	O
,	O
consistent	O
with	O
significant	O
preservation	O
of	O
nucleotide	O
sequence	O
over	O
an	O
extended	O
period	O
of	O
phylogenetic	O
time	O
.	O

Evidence	O
for	O
a	O
role	O
of	O
endogenous	B
corticotropin	I
-	I
releasing	I
factor	I
in	O
cold	O
,	O
ether	O
,	O
immobilization	O
,	O
and	O
traumatic	O
stress	O
.	O

81	O
milk	O
samples	O
collected	O
from	O
35	O
donors	O
3	O
days	O
to	O
7	O
months	O
after	O
delivery	O
were	O
examined	O
for	O
the	O
occurrence	O
of	O
cytomegalovirus	O
(	O
CMV	O
)	O
.	O

Three	O
cases	O
of	O
primary	O
signet	O
-	O
ring	O
cell	O
carcinoma	O
of	O
the	O
rectum	O
are	O
described	O
.	O

The	O
data	O
obtained	O
up	O
to	O
now	O
only	O
suggest	O
the	O
future	O
potentiality	O
of	O
Bestatin	O
treatment	O
for	O
these	O
types	O
of	O
malignancy	O
.	O

These	O
data	O
suggest	O
that	O
dopaminergic	O
regulation	O
of	O
adrenal	O
zona	O
glomerulosa	O
corticosteroid	O
and	O
renal	B
renin	I
secretion	O
is	O
absent	O
in	O
patients	O
with	O
high	O
spinal	O
cord	O
transections	O
,	O
suggesting	O
that	O
intact	O
neural	O
pathways	O
from	O
the	O
central	O
nervous	O
system	O
are	O
necessary	O
for	O
metoclopramide	O
stimulation	O
of	O
aldosterone	O
and	O
renin	B
secretion	O
in	O
men	O
.	O

In	O
the	O
absence	O
of	O
enhancer	O
sequences	O
,	O
the	O
adenovirus	B
E1A	I
gene	I
can	O
not	O
stimulate	O
CATase	B
synthesis	O
.	O

FK	O
33	O
-	O
824	O
,	O
a	O
methionine	O
-	O
enkephalin	B
analogue	O
,	O
suppressed	O
plasma	O
ACTH	B
to	O
85	O
%	O
of	O
basal	O
level	O
,	O
while	O
bromocriptine	O
(	O
CB-154	O
)	O
caused	O
no	O
significant	O
change	O
.	O

The	O
homology	O
to	O
v	B
-	I
mil	I
starts	O
within	O
the	O
coding	O
sequence	O
of	O
exon	O
1	O
and	O
ends	O
within	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
exon	O
11	O
,	O
12	O
nucleotides	O
downstream	O
from	O
the	O
nonsense	O
codon	O
terminating	O
the	O
large	O
open	O
reading	O
frame	O
shared	O
between	O
c	B
-	I
mil	I
and	O
v	B
-	I
mil	I
.	O

Six	O
(	O
four	O
FAP	O
;	O
two	O
primary	O
amyloidosis	O
)	O
also	O
had	O
diffusely	O
positive	O
myocardial	O
uptakes	O
,	O
but	O
the	O
intensity	O
was	O
less	O
than	O
that	O
of	O
the	O
sternum	O
.	O

The	O
intensity	O
of	O
myocardial	O
uptake	O
of	O
Tc-99m	O
-	O
PYP	O
in	O
patients	O
with	O
echocardiographic	O
left	O
ventricular	O
hypertrophy	O
and/or	O
highly	O
refractile	O
myocardial	O
echoes	O
,	O
so	O
-	O
called	O
granular	O
sparkling	O
appearance	O
(	O
GS	O
)	O
was	O
slightly	O
greater	O
than	O
that	O
in	O
patients	O
with	O
neither	O
myocardial	O
hypertrophy	O
nor	O
GS	O
.	O

The	O
210	O
kDa	O
precursor	O
is	O
converted	O
slowly	O
(	O
t	O
1	O
/	O
2	O
=	O
2	O
h	O
)	O
by	O
proteolytic	O
processing	O
into	O
a	O
125	O
kDa	O
(	O
alpha	O
'	O
)	O
and	O
83	O
kDa	O
(	O
beta	O
'	O
)	O
species	O
.	O

Alveolar	O
lymphocytes	O
were	O
surprisingly	O
increased	O
in	O
most	O
patients	O
with	O
AIDS	O
(	O
mean	O
26.1	O
+	O
/-	O

21.9	O
%	O
;	O
range	O
1	O
-	O
76	O
%	O
)	O
and	O
CGL	O
(	O
mean	O
26.6	O
+	O
/-	O

22.6	O
%	O
;	O
range	O
3	O
-	O
76	O
%	O
)	O
with	O
criteria	O
of	O
activation	O
contrasting	O
with	O
the	O
blood	O
lymphopenia	O
.	O

We	O
have	O
determined	O
that	O
these	O
nicks	O
occur	O
in	O
both	O
the	O
wild	O
-	O
type	O
and	O
the	O
mutant	O
sites	O
.	O

Its	O
predicted	O
amino	O
acid	O
sequence	O
shows	O
extensive	O
homology	O
to	O
those	O
of	O
Drosophila	B
hsp70	I
,	O
trout	B
hsp70	I
,	O
Xenopus	B
hsp70	I
,	O
yeast	B
hsp70	I
,	O
and	O
some	O
homology	O
to	O
the	O
heat	B
-	I
inducible	I
dnaK	I
gene	I
product	I
of	O
Escherichia	O
coli	O
.	O

When	O
phosphorylation	O
of	O
exogenous	O
peptide	O
substrates	O
was	O
measured	O
as	O
a	O
function	O
of	O
receptor	O
self	O
-	O
phosphorylation	O
,	O
tyrosine	B
kinase	I
activity	O
was	O
found	O
to	O
be	O
enhanced	O
two	O
to	O
threefold	O
at	O
1	O
-	O
2	O
mol	O
of	O
phosphate	O
per	O
mol	O
of	O
receptor	O
.	O

At	O
temperatures	O
permissive	O
for	O
transformation	O
,	O
6m2	O
cells	O
contain	O
P58gag	B
produced	O
from	O
the	O
4.0-kilobase	O
(	O
kb	O
)	O
viral	O
RNA	O
genome	O
and	O
P85gag	B
-	O
mos	B
translated	O
from	O
a	O
3.5-kb	O
spliced	O
mRNA	O
.	O

The	O
pet56	B
and	O
his3	B
genes	I
are	O
transcribed	O
divergently	O
from	O
initiation	O
sites	O
that	O
are	O
separated	O
by	O
only	O
192	O
bp	O
.	O

It	O
is	O
concluded	O
that	O
in	O
patients	O
with	O
first	O
-	O
attack	O
genital	O
herpes	O
,	O
the	O
type	O
of	O
HSV	O
is	O
the	O
most	O
important	O
determinant	O
of	O
subsequent	O
recurrences	O
and	O
that	O
intravenous	O
acyclovir	O
has	O
little	O
effect	O
on	O
subsequent	O
recurrences	O
.	O

One	O
group	O
(	O
n	O
=	O
9	O
)	O
was	O
premedicated	O
with	O
midazolam	O
,	O
0.1	O
mg	O
kg-1	O
,	O
and	O
atropine	O
0.2	O
-	O
0.4	O
mg	O
i.m	O
.	O

Comparison	O
with	O
a	O
recently	O
described	O
c	B
-	I
sis	I
cDNA	I
clone	I
(	O
Collins	O
et	O
al.	O
,	O
Nature	O
316	O
,	O
748	O
-	O
750	O
(	O
1985	O
)	O
)	O
revealed	O
that	O
the	O
1.9	O
kbp	O
DNA	O
region	O
contained	O
a	O
large	O
5	B
'	I
c	I
-	I
sis	I
exon	I
of	O
at	O
least	O
1050	O
bp	O
.	O

The	O
nucleotide	O
sequence	O
of	O
3874	O
bp	O
of	O
cloned	O
R.	O
sphaeroides	O
chromosomal	O
DNA	O
,	O
including	O
the	O
three	O
structural	O
genes	O
fbcF	B
,	O
fbcB	B
and	O
fbcC	B
has	O
been	O
determined	O
.	O

The	O
N	O
-	O
terminal	O
sequence	O
of	O
one	O
hydrophilic	O
peptide	O
of	O
the	O
FeS	B
protein	I
has	O
been	O
also	O
obtained	O
confirming	O
the	O
fbcF	B
reading	O
frame	O
.	O

The	O
5	O
'	O
and	O
3	O
'	O
untranslated	O
sequences	O
contain	O
characteristic	O
sequences	O
that	O
are	O
involved	O
in	O
the	O
initiation	O
and	O
termination	O
of	O
transcription	O
,	O
including	O
two	O
possible	O
promoters	O
,	O
one	O
of	O
which	O
may	O
contain	O
two	O
overlapping	O
-10	O
sequences	O
.	O

Unlike	O
P135gag	B
-	O
myb	B
-	O
ets	B
and	O
the	O
Mr	O
75,000	O
translation	O
product	O
of	O
c	B
-	I
myb	I
(	O
P75c	B
-	I
myb	I
)	O
,	O
which	O
are	O
nuclear	O
proteins	O
,	O
P54c	B
-	I
ets	I
was	O
found	O
to	O
be	O
predominantly	O
cytoplasmic	O
.	O

The	O
C	O
-	O
terminal	O
end	O
of	O
this	O
polypeptide	O
harbors	O
three	O
types	O
of	O
repeated	O
sequences	O
.	O

Further	O
outbreaks	O
of	O
ocular	O
disease	O
in	O
farmed	O
red	O
deer	O
calves	O
caused	O
by	O
HVC-1	O
were	O
investigated	O
.	O

From	O
our	O
ultrastructural	O
and	O
biochemical	O
studies	O
,	O
it	O
is	O
evident	O
that	O
Type	O
II	O
pneumocytes	O
are	O
an	O
early	O
target	O
of	O
radiation	O
and	O
the	O
release	O
of	O
surfactant	O
into	O
the	O
alveolus	O
shortly	O
after	O
exposure	O
persists	O
for	O
days	O
and	O
weeks	O
.	O

Two	O
copies	O
of	O
the	O
72-bp	O
repeat	O
provided	O
efficient	O
activation	O
of	O
gene	O
expression	O
.	O

The	O
open	O
reading	O
frames	O
of	O
rbsD	B
,	O
rbsA	B
,	O
and	O
rbsC	B
encode	O
proteins	O
of	O
139	O
,	O
501	O
,	O
and	O
321	O
amino	O
acid	O
residues	O
,	O
respectively	O
.	O

In	O
order	O
to	O
study	O
the	O
influence	O
of	O
iron	O
overload	O
on	O
the	O
polymorphonuclear	O
leucocyte	O
(	O
PMN	O
)	O
metabolism	O
of	O
patients	O
on	O
chronic	O
hemodialysis	O
,	O
generation	O
of	O
superoxide	O
anion	O
(	O
O2-	O
)	O
by	O
PMN	O
in	O
whole	O
blood	O
was	O
compared	O
in	O
two	O
groups	O
of	O
hemodialyzed	O
patients	O
:	O
group	O
A	O
consisted	O
of	O
twenty	O
-	O
one	O
individuals	O
with	O
serum	O
ferritin	B
levels	O
above	O
1000	O
ng	O
/	O
ml	O
and	O
group	O
B	O
of	O
nineteen	O
individuals	O
with	O
serum	O
ferritin	B
levels	O
below	O
1000	O
ng	O
/	O
ml	O
.	O

Osteocalcin	B
(	O
and	O
urinary	O
hydroxyproline	O
)	O
were	O
not	O
elevated	O
in	O
isolated	O
hyperphosphatasaemia	O
,	O
indicating	O
that	O
mechanisms	O
other	O
than	O
increased	O
bone	O
turnover	O
may	O
account	O
for	O
the	O
markedly	O
elevated	O
serum	B
alkaline	I
phosphatase	I
activity	O
in	O
these	O
subjects	O
.	O

Analysis	O
of	O
glucocorticoid	O
unresponsive	O
cell	O
variants	O
using	O
a	O
mouse	B
glucocorticoid	I
receptor	I
complementary	O
DNA	O
clone	O
.	O

Among	O
the	O
v	B
-	I
myc	I
codons	O
,	O
the	O
first	O
5	O
are	O
derived	O
from	O
the	O
noncoding	O
5	O
'	O
terminus	O
of	O
the	O
second	O
c	B
-	I
myc	I
exon	O
,	O
and	O
412	O
codons	O
correspond	O
to	O
the	O
c	B
-	I
myc	I
coding	O
region	O
.	O

A	O
recombinant	O
vector	O
,	O
p410	O
+	O
,	O
was	O
constructed	O
which	O
carried	O
the	O
BamHI	B
-	I
K	I
fragment	I
(	O
nucleotides	O
107565	O
to	O
112625	O
of	O
the	O
B95	O
-	O
8	O
strain	O
,	O
encoding	O
the	O
EBV	O
-	O
associated	O
nuclear	O
antigen	O
EBNA-1	B
)	O
,	O
the	O
cis	O
-	O
acting	O
sequence	O
from	O
the	O
BamHI	B
-	I
C	I
fragment	I
,	O
and	O
a	O
dominant	O
selectable	O
marker	O
gene	O
encoding	O
G-418	O
resistance	O
in	O
animal	O
cells	O
.	O

The	O
hexanucleotide	O
5'-TGTCCT-3	O
'	O
,	O
thought	O
to	O
be	O
important	O
for	O
GRE	O
activity	O
,	O
not	O
only	O
was	O
found	O
in	O
this	O
sequence	O
and	O
in	O
the	O
5'-flanking	O
region	O
,	O
but	O
also	O
was	O
present	O
twice	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
gene	O
that	O
did	O
not	O
show	O
specific	O
receptor	O
binding	O
.	O

Five	O
patients	O
developed	O
metastatic	O
spread	O
,	O
and	O
all	O
of	O
them	O
died	O
of	O
tumor	O
.	O

The	O
52-protein	O
subunit	O
of	O
T4	B
DNA	I
topoisomerase	I
is	O
homologous	O
to	O
the	O
gyrA	B
-	I
protein	I
of	O
gyrase	B
.	O

Translation	O
of	O
specific	O
cellular	O
genes	O
from	O
the	O
chimeric	O
viral	O
-	O
cellular	O
transcripts	O
seems	O
to	O
be	O
unlikely	O
.	O

The	O
molecular	O
weight	O
of	O
in	O
vivo	O
-	O
labeled	O
proteins	O
was	O
increased	O
relative	O
to	O
that	O
of	O
in	O
vitro	O
-	O
translated	O
proteins	O
,	O
indicating	O
that	O
a	O
posttranslational	O
modification	O
had	O
occurred	O
.	O

Insertion	O
of	O
4	O
bp	O
reduced	O
SV40	B
early	I
promoter	I
-	O
dependent	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
expression	O
by	O
six-	O
to	O
eightfold	O
.	O

Nuclease	O
footprinting	O
revealed	O
that	O
purified	O
glucocorticoid	B
receptor	I
bound	O
at	O
multiple	O
discrete	O
sites	O
within	O
and	O
at	O
the	O
borders	O
of	O
the	O
tandemly	O
repeated	O
sequence	O
motif	O
that	O
defines	O
Sa	B
.	O

The	O
coding	O
region	O
of	O
2385	O
nucleotides	O
corresponds	O
to	O
a	O
polypeptide	O
chain	O
of	O
795	O
amino	O
acids	O
,	O
giving	O
a	O
molecular	O
weight	O
of	O
91,555	O
for	O
the	O
hsp108	B
protein	I
.	O

Gluzman	O
,	O
EMBO	O
J.	O

A	O
single	O
exon	O
encodes	O
the	O
carboxyl	O
-	O
terminal	O
26	O
amino	O
acids	O
of	O
the	O
ssd	B
chain	I
and	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
its	O
mRNA	O
,	O
ending	O
with	O
a	O
poly	O
(	O
A	O
)	O
-addition	O
site	O
.	O

SPECT	O
examination	O
of	O
the	O
TMJ	O
using	O
99	O
m	O
Tc	O
-	O
MDP	O
was	O
performed	O
in	O
43	O
patients	O
with	O
arthrographically	O
proven	O
anterior	O
dislocation	O
of	O
the	O
disc	O
and	O
in	O
30	O
normals	O
.	O

Two	O
mutants	O
,	O
each	O
representative	O
of	O
a	O
separate	O
pet	B
complementation	O
group	O
,	O
have	O
been	O
analyzed	O
.	O

A	O
centromere	O
in	O
S.	O
cerevisiae	O
consists	O
of	O
a	O
region	O
of	O
DNA	O
,	O
approximately	O
150	O
bp	O
in	O
length	O
,	O
containing	O
three	O
important	O
sequence	O
elements	O
,	O
which	O
are	O
folded	O
with	O
proteins	O
into	O
a	O
specific	O
conformation	O
in	O
the	O
chromatin	O
(	O
the	O
yeast	O
kinetochore	O
)	O
.	O

Constitutive	O
function	O
of	O
a	O
positively	O
regulated	O
promoter	O
reveals	O
new	O
sequences	O
essential	O
for	O
activity	O
.	O

Two	O
separate	O
NF1-binding	B
loci	I
were	O
also	O
found	O
in	O
the	O
equivalent	O
IE68	B
gene	I
of	O
HCMV	O
(	O
Towne	O
)	O
DNA	O
,	O
but	O
in	O
this	O
case	O
the	O
DNA	O
sequence	O
and	O
competition	O
filter	O
binding	O
experiments	O
indicated	O
a	O
maximum	O
of	O
only	O
four	O
to	O
five	O
consensus	O
binding	O
sites	O
encompassing	O
the	O
promoter	O
-	O
enhancer	O
region	O
.	O

The	O
previously	O
described	O
four	O
sets	O
of	O
13-	O
to	O
18-base	O
-	O
pair	O
interspersed	O
repeat	O
elements	O
between	O
-55	O
and	O
-580	O
provide	O
most	O
of	O
the	O
high	O
basal	O
transcriptional	O
strength	O
,	O
whereas	O
the	O
arrangement	O
of	O
further	O
upstream	O
tandemly	O
repeated	O
NF1-binding	B
sites	I
may	O
contribute	O
significantly	O
to	O
the	O
expanded	O
biological	O
host	O
range	O
for	O
expression	O
of	O
SCMV	B
IE94	I
compared	O
with	O
HCMV	B
IE68	I
.	O

We	O
inserted	O
genes	O
or	O
gene	O
segments	O
,	O
that	O
code	O
for	O
the	O
bacterial	B
chloramphenicol	I
acetyltransferase	I
,	O
the	O
bacterial	O
gene	O
conferring	O
resistance	O
against	O
hygromycin	O
,	O
and	O
the	O
ORF	O
E7	B
of	O
the	O
human	O
papillomavirus	O
type	O
18	O
into	O
these	O
vectors	O
.	O

By	O
contrast	O
,	O
their	O
basal	O
adrenal	O
androgen	O
levels	O
were	O
significantly	O
decreased	O
compared	O
to	O
those	O
in	O
normal	O
subjects	O
on	O
both	O
the	O
day	O
on	O
and	O
the	O
day	O
off	O
prednisone	O
(	O
P	O
less	O
than	O
0.05	O
)	O
.	O

Active	O
lambda	B
and	I
kappa	I
antibody	I
gene	I
rearrangement	O
in	O
Abelson	O
murine	O
leukemia	O
virus	O
-	O
transformed	O
pre	O
-	O
B	O
cell	O
lines	O
.	O

During	O
pentobarbital	O
anesthesia	O
,	O
the	O
basal	O
VO2	O
was	O
5.26	O
ml	O
/	O
kg	O
/	O
min	O
and	O
was	O
increased	O
by	O
epinephrine	O
in	O
a	O
dose	O
dependent	O
manner	O
at	O
plasma	O
concentrations	O
between	O
3.9	O
ng	O
/	O
ml	O
(	O
VO2	O
=	O
5.68	O
ml	O
/	O
kg	O
/	O
min	O
)	O
and	O
36.5	O
ng	O
/	O
ml	O
(	O
VO2	O
=	O
6.47	O
ml	O
/	O
kg	O
/	O
min	O
)	O
.	O

Oligonucleotide	O
-	O
directed	O
mutagenesis	O
was	O
used	O
to	O
create	O
an	O
NdeI	B
restriction	I
site	I
at	O
the	O
natural	O
ATG	O
of	O
the	O
yeast	O
R.	O

One	O
group	O
of	O
six	O
cDNA	O
clones	O
was	O
derived	O
from	O
a	O
2.9-kilobase	O
early	O
transcript	O
encoded	O
by	O
the	O
IR2	O
repeat	O
element	O
and	O
showed	O
restriction	O
site	O
polymorphism	O
for	O
the	O
enzyme	B
SmaI.	I

Combined	O
immunochemotherapy	O
with	O
cyclophosphamide	O
plus	O
BCG	O
gave	O
a	O
better	O
enhancement	O
of	O
the	O
antitumor	O
effect	O
of	O
the	O
cytostatic	O
than	O
that	O
of	O
the	O
combination	O
of	O
methotrexate	O
plus	O
BCG	O
and	O
cyclophosphamide	O
plus	O
levamisole	O
.	O

The	O
presence	O
of	O
circulating	O
platelet	O
aggregates	O
and	O
elevated	O
levels	O
of	O
fibrinopeptide	B
A	I
(	O
a	O
cleavage	O
product	O
of	O
fibrin	B
)	O
suggests	O
that	O
platelet	O
activation	O
and	O
fibrin	B
deposition	O
may	O
play	O
a	O
role	O
in	O
the	O
pathogenesis	O
of	O
this	O
disorder	O
.	O

4	O
.	O

In	O
general	O
,	O
the	O
values	O
obtained	O
by	O
the	O
two	O
methods	O
were	O
in	O
agreement	O
for	O
each	O
species	O
of	O
epidermal	B
growth	I
factor	I
and	O
followed	O
the	O
order	O
:	O
wild	O
type	O
greater	O
than	O
Glu24	O
-	O
---Gly	O
greater	O
than	O
Asp27	O
-	O
---Gly	O
much	O
greater	O
than	O
Pro7	O
-	O
---Thr	O
greater	O
than	O
Tyr29	O
-	O
---Gly	O
greater	O
than	O
Leu47	O
-	O
---His	O
.	O

We	O
report	O
a	O
prevalence	O
study	O
of	O
the	O
best	O
visual	O
acuity	O
in	O
the	O
affected	O
eye	O
of	O
100	O
selected	O
patients	O
with	O
herpetic	O
keratitis	O
seen	O
during	O
a	O
two	O
-	O
year	O
period	O
.	O

Bacteriologic	O
culture	O
of	O
pancreatic	O
tissue	O
was	O
positive	O
in	O
6	O
/	O
8	O
IB	O
and	O
3	O
/	O
17	O
NIB	O
rats	O
(	O
p	O
less	O
than	O
0.01	O
)	O
.	O

After	O
infection	O
of	O
293	O
cells	O
(	O
which	O
provide	O
complementary	O
E1a	B
-	O
E1b	B
functions	O
)	O
,	O
both	O
viruses	O
directed	O
equal	O
amounts	O
of	O
P	B
/	I
C	I
-	I
specific	I
mRNA	I
transcription	O
.	O

This	O
makes	O
these	O
compounds	O
attractive	O
as	O
vehicles	O
for	O
these	O
and	O
other	O
gases	O
in	O
-	O
vivo	O
and	O
in	O
-	O
vitro	O
.	O

DNA	O
sequencing	O
of	O
the	O
DPM1	B
gene	I
revealed	O
an	O
open	O
reading	O
frame	O
of	O
801	O
bases	O
.	O

Administration	O
of	O
anticoagulants	O
,	O
i.e.	O
,	O
heparin	O
,	O
prostaglandin	O
E1	O
and	O
ticlopidine	O
seems	O
to	O
be	O
effective	O
in	O
alleviating	O
symptoms	O
and	O
might	O
prevent	O
further	O
deterioration	O
.	O

Mutational	O
analysis	O
of	O
the	O
L1	B
binding	I
site	I
of	O
23S	B
rRNA	I
in	I
Escherichia	I
coli	I
.	O

Prostacyclin	O
formation	O
,	O
reflected	O
by	O
the	O
excretion	O
rate	O
of	O
its	O
stable	O
metabolite	O
6-keto	O
-	O
prostaglandin	O
F1	O
alpha	O
,	O
was	O
measured	O
by	O
means	O
of	O
radioimmunoassay	O
in	O
4-hour	O
urine	O
specimens	O
obtained	O
during	O
a	O
smoking	O
-	O
free	O
period	O
and	O
after	O
participants	O
had	O
inhaled	O
smoke	O
from	O
four	O
high	O
-	O
nicotine	O
cigarettes	O
.	O

The	O
in	O
vitro	O
activity	O
of	O
mecillinam	O
and	O
amoxicillin	O
/	O
clavulanic	O
acid	O
against	O
Escherichia	O
coli	O
strains	O
producing	O
beta	B
-	I
lactamases	I
of	O
the	O
TEM-1	B
,	O
Oxa-1	B
and	O
chromosomal	O
type	O
were	O
studied	O
using	O
the	O
broth	O
and	O
agar	O
dilution	O
technique	O
.	O

These	O
results	O
imply	O
that	O
the	O
GCN3	B
product	I
can	O
promote	O
either	O
repression	O
or	O
activation	O
of	O
GCN4	B
expression	O
depending	O
on	O
amino	O
acid	O
availability	O
.	O

The	O
efficacy	O
of	O
these	O
immunosuppressive	O
drugs	O
is	O
clinical	O
proven	O
.	O

The	O
amino	O
acid	O
sequence	O
of	O
the	O
S.	O
aureus	O
peptide	O
carrying	O
the	O
phosphoryl	O
group	O
was	O
found	O
to	O
be	O
Gln	O
-	O
Val	O
-	O
Val	O
-	O
Ser	O
-	O
Thr	O
-	O
Phe	O
-	O
Met	O
-	O
Gly	O
-	O
Asn	O
-	O
Gly	O
-	O
Leu	O
-	O
Ala	O
-	O
Ile	O
-	O
Pro	O
-	O
His	O
-	O
Gly	O
-	O
Thr	O
-	O
Asp-	O
Asp	O
.	O

These	O
mutations	O
alter	O
two	O
regions	O
of	O
GAL4	B
protein	I
:	O
the	O
DNA	O
binding	O
domain	O
,	O
and	O
the	O
transcription	O
activation	O
domain	O
.	O

The	O
results	O
indicated	O
that	O
two	O
genes	O
(	O
citA	B
and	O
citB	B
)	O
have	O
separate	O
promoters	O
,	O
and	O
the	O
location	O
of	O
the	O
promoter	O
for	O
the	O
citB	B
gene	I
in	O
the	O
Tn3411	B
nucleotide	O
sequence	O
was	O
different	O
from	O
that	O
in	O
pMS185	O
.	O

The	O
rci	B
gene	I
was	O
fused	O
with	O
lacZ	B
and	O
its	O
gene	O
product	O
was	O
identified	O
by	O
Western	O
blot	O
analysis	O
.	O

Structure	O
and	O
regulation	O
of	O
a	O
nuclear	O
gene	O
in	O
Saccharomyces	O
cerevisiae	O
that	O
specifies	O
MRP13	B
,	O
a	O
protein	O
of	O
the	O
small	O
subunit	O
of	O
the	O
mitochondrial	O
ribosome	O
.	O

Although	O
large	O
epidemiologic	O
studies	O
are	O
best	O
able	O
to	O
identify	O
the	O
relative	O
contributions	O
of	O
specific	O
risk	O
factors	O
while	O
controlling	O
for	O
other	O
risk	O
factors	O
,	O
new	O
studies	O
need	O
to	O
focus	O
on	O
important	O
unresolved	O
questions	O
.	O

The	O
amino	O
acid	O
sequences	O
of	O
the	O
yeast	O
and	O
mammalian	O
mitochondrial	O
targeting	O
sequences	O
are	O
similar	O
but	O
less	O
related	O
than	O
the	O
mature	O
polypeptides	O
.	O

Van	O
der	O
Ende	O
,	O
R.	O

Amounts	O
of	O
glucose	O
infused	O
during	O
the	O
last	O
20	O
min	O
of	O
each	O
2	O
hour	O
insulin	B
infusion	O
were	O
(	O
at	O
1	O
and	O
10	O
m	O
/	O
kg	O
/	O
min	O
respectively	O
)	O
:	O
before	O
treatment	O
(	O
K+	O
=	O
2.7	O
mmol	O
/	O
l	O
)	O
:	O
2.4	O
and	O
8.4	O
mg	O
/	O
kg	O
/	O
min	O
;	O
after	O
spironolactone	O
(	O
K+	O
=	O
3.9	O
mmol	O
/	O
l	O
)	O
:	O
3.3	O
and	O
15.4	O
mg	O
/	O
kg	O
/	O
min	O
;	O
after	O
indomethacine	O
(	O
K+	O
=	O
3.7	O
mmol	O
/	O
l	O
)	O
:	O
5	O
and	O
19	O
mg	O
/	O
kg	O
/	O
min	O
after	O
stopping	O
drugs	O
(	O
K+	O
=	O
2.9	O
mmol	O
/	O
l	O
)	O
:	O
2.5	O
and	O
5.3	O
mg	O
/	O
kg	O
/	O
min	O
.	O

Mycobacterium	O
avium	O
-	O
intracellulare	O
complex	O
infections	O
in	O
the	O
acquired	O
immunodeficiency	O
syndrome	O
.	O

Recurrence	O
of	O
oxalate	O
deposition	O
in	O
a	O
renal	O
transplant	O
during	O
ciclosporin	O
A	O
therapy	O
.	O

The	O
bile	O
acid	O
sequestrants	O
(	O
cholestyramine	O
and	O
colestipol	O
)	O
,	O
nicotinic	O
acid	O
,	O
fenofibrate	O
and	O
inhibitors	O
of	O
hydroxymethylglutaryl	B
coenzyme	I
A	I
(	I
HMG	I
CoA	I
)	I
reductase	I
(	O
e.g.	O
lovastatin	O
or	O
simvastatin	O
)	O
are	O
the	O
most	O
effective	O
drugs	O
for	O
use	O
in	O
patients	O
with	O
primary	O
hypercholesterolaemia	O
;	O
these	O
agents	O
reduce	O
plasma	O
concentrations	O
of	O
total	O
and	O
LDL	B
-	I
cholesterol	I
by	O
15	O
to	O
45	O
%	O
.	O

Analysis	O
in	O
3	O
groups	O
of	O
patients	O
suffering	O
from	O
simple	O
acute	O
and	O
pernicious	O
malarial	O
flare	O
-	O
ups	O

Statement	O
on	O
the	O
development	O
of	O
guidelines	O
for	O
the	O
prevention	O
of	O
AIDS	O
transmission	O
in	O
the	O
workplace	O
.	O

Cocaine	O
-	O
treated	O
rats	O
acquired	O
a	O
preference	O
for	O
cocaine	O
-	O
associated	O
contextual	O
stimuli	O
(	O
CS	O
)	O
relative	O
to	O
saline	O
-	O
injected	O
control	O
rats	O
.	O

Intravenous	O
glucose	O
tolerance	O
tests	O
were	O
performed	O
before	O
operation	O
,	O
before	O
starting	O
CyA	O
and	O
after	O
3	O
weeks	O
.	O

The	O
effects	O
of	O
glutaraldehyde	O
on	O
dimensions	O
and	O
ultrastructure	O
of	O
microvascular	O
beds	O
in	O
rat	O
mesentery	O
were	O
studied	O
in	O
two	O
kinds	O
of	O
experiment	O
,	O
administering	O
the	O
fixative	O
by	O
intra	O
-	O
arterial	O
perfusion	O
at	O
a	O
pressure	O
of	O
80	O
mm	O
Hg	O
and	O
by	O
superfusion	O
of	O
the	O
exteriorized	O
mesenteric	O
membrane	O
.	O

This	O
gave	O
rise	O
to	O
RNA	O
molecules	O
with	O
3'-untranslated	O
regions	O
of	O
roughly	O
375	O
,	O
655	O
,	O
and	O
945	O
base	O
pairs	O
.	O

Clinical	O
findings	O
were	O
:	O
height	O
183	O
cm	O
,	O
weight	O
62	O
kg	O
,	O
increased	O
length	O
of	O
lower	O
limbs	O
,	O
P2-A2	O
pilosity	O
and	O
micropenis	O
.	O

Our	O
data	O
suggest	O
that	O
it	O
may	O
be	O
possible	O
to	O
individualize	O
hCG	B
administration	O
at	O
midcycle	O
by	O
determining	O
the	O
number	O
of	O
follicles	O
greater	O
than	O
1	O
cm	O
by	O
ultrasound	O
on	O
cycle	O
day	O
12	O
or	O
13	O
and	O
giving	O
hCG	B
when	O
serum	O
E2	O
levels	O
reach	O
1100	O
to	O
1200	O
pmol	O
/	O
l	O
per	O
follicle	O
.	O

The	O
8	O
patients	O
receiving	O
Ir192	O
implant	O
in	O
addition	O
to	O
external	O
radiation	O
showed	O
improved	O
(	O
p	O
=	O
0.06	O
)	O
survival	O
compared	O
to	O
the	O
9	O
receiving	O
external	O
only	O
:	O
median	O
15	O
months	O
(	O
range	O
1.5	O
-	O
34	O
+	O
months	O
)	O
versus	O
7	O
months	O
(	O
range	O
2.5	O
-	O
21	O
months	O
)	O
.	O

Within	O
Stage	O
IA	O
,	O
141	O
patients	O
had	O
well	O
differentiated	O
tumor	O
(	O
G1	O
)	O
,	O
20	O
had	O
moderately	O
well	O
differentiated	O
tumor	O
(	O
G2	O
)	O
,	O
and	O
12	O
patients	O
had	O
poorly	O
differentiated	O
(	O
G3	O
)	O
.	O

Mechanism	O
of	O
the	O
t	O
(	O
14;18	O
)	O
chromosomal	O
translocation	O
:	O
structural	O
analysis	O
of	O
both	O
derivative	O
14	O
and	O
18	O
reciprocal	O
partners	O
.	O

After	O
age	O
30	O
,	O
mean	O
hemoglobin	B
levels	O
for	O
men	O
gradually	O
declined	O
,	O
while	O
those	O
in	O
women	O
rose	O
,	O
so	O
that	O
the	O
sex	O
difference	O
diminished	O
after	O
60	O
years	O
of	O
age	O
.	O

Ritanserin	O
is	O
a	O
new	O
substance	O
with	O
highly	O
selective	O
blocking	O
activity	O
on	O
S2	B
receptors	I
for	O
5-HT	O
in	O
the	O
central	O
nervous	O
system	O
.	O

Ethylene	O
glycol	O
and	O
diethylene	O
glycol	O
were	O
each	O
administered	O
once	O
weekly	O
subcutaneously	O
to	O
groups	O
of	O
100	O
female	O
NMRI	O
mice	O
at	O
3	O
dosages	O
(	O
30	O
;	O
10	O
und	O
3	O
mg	O
single	O
dose	O
per	O
mouse	O
)	O
.	O

Comparison	O
of	O
beta	B
2-microglobulin	I
removal	O
using	O
the	O
same	O
polysulphone	O
membrane	O
for	O
haemodialysis	O
and	O
haemofiltration	O
shows	O
that	O
beta	B
2-microglobulin	I
is	O
more	O
effectively	O
removed	O
by	O
convection	O
than	O
by	O
diffusion	O
when	O
both	O
treatment	O
modes	O
are	O
matched	O
for	O
blood	O
flow	O
and	O
urea	O
clearance	O
.	O

40.3	O
+	O
/-	O

10.1	O
mg	O
/	O
l	O
(	O
SD	O
)	O
vs	O
31.2	O
+	O
/-	O

8.0	O
,	O
P	O
less	O
than	O
0.01	O
)	O
.	O

beta	B
2	I
m	I
was	O
not	O
significantly	O
higher	O
in	O
patients	O
with	O
bone	O
cysts	O
(	O
37.7	O
+	O
/-	O

11.4	O
mg	O
/	O
l	O
vs	O
37.0	O
+	O
/-	O

10.0	O
)	O
,	O
but	O
median	O
duration	O
of	O
dialysis	O
was	O
significantly	O
(	O
P	O
less	O
than	O
0.01	O
)	O
longer	O
in	O
patients	O
with	O
bone	O
cysts	O
(	O
90	O
vs	O
57	O
months	O
)	O
.	O

beta	B
2	I
m	I
was	O
lower	O
in	O
patients	O
maintained	O
on	O
dialysis	O
for	O
less	O
than	O
1	O
year	O
and	O
whose	O
residual	O
urine	O
volume	O
was	O
greater	O
than	O
0.1	O
litre	O
per	O
day	O
.	O

In	O
overdoses	O
up	O
to	O
2	O
g	O
fluvoxamine	O
no	O
lasting	O
toxic	O
effects	O
were	O
observed	O
.	O

It	O
is	O
concluded	O
that	O
the	O
plasma	B
prolactin	I
response	O
to	O
12.5	O
micrograms	O
i.v	O
.	O

No	O
effect	O
was	O
found	O
on	O
grooming	O
behavior	O
.	O

The	O
remaining	O
six	O
patients	O
had	O
slightly	O
decreased	O
(	O
n	O
=	O
3	O
)	O
or	O
normal	O
(	O
n	O
=	O
3	O
)	O
seminal	O
parameters	O
.	O

In	O
addition	O
,	O
a	O
wild	O
-	O
type	O
strain	O
containing	O
a	O
temperature	B
-	I
sensitive	I
threonyl	I
-	I
tRNA	I
synthetase	I
mutation	I
showed	O
increased	O
thr	B
operon	I
expression	O
at	O
the	O
non	O
-	O
permissive	O
temperature	O
,	O
whereas	O
none	O
of	O
the	O
mutants	O
showed	O
any	O
change	O
.	O

Significant	O
treatment	O
-	O
related	O
problems	O
appeared	O
during	O
the	O
second	O
decade	O
in	O
5	O
patients	O
,	O
including	O
one	O
chest	O
wall	O
sarcoma	O
;	O
all	O
of	O
these	O
patients	O
had	O
received	O
at	O
least	O
60	O
Gy	O
to	O
breast	O
and	O
regional	O
nodal	O
areas	O
.	O

Clinical	O
and	O
biological	O
correlates	O
of	O
panic	O
states	O
.	O

Effects	O
of	O
long	O
-	O
term	O
parenteral	O
nutrition	O
on	O
gastrin	B
release	O
in	O
dogs	O
.	O

Of	O
7	O
patients	O
treated	O
with	O
cyclophosphamide	O
,	O
hexamethylmelamine	O
,	O
adriamycin	O
and	O
cisplatin	O
(	O
CHAP-5	O
)	O
,	O
6	O
had	O
measurable	O
disease	O
,	O
of	O
whom	O
5	O
yielded	O
a	O
response	O
(	O
2	O
complete	O
responses	O
for	O
19	O
+	O
and	O
40	O
months	O
and	O
3	O
partial	O
responses	O
for	O
4	O
,	O
7	O
and	O
8	O
months	O
)	O
.	O

The	O
DNA	O
sequence	O
encodes	O
a	O
protein	O
of	O
1520	O
amino	O
acids	O
with	O
sequence	O
homology	O
to	O
the	O
human	B
c	I
-	I
abl	I
proto	I
-	I
oncogene	I
product	I
,	O
beginning	O
at	O
the	O
amino	O
terminus	O
and	O
extending	O
656	O
amino	O
acids	O
through	O
the	O
region	O
essential	O
for	O
tyrosine	B
kinase	I
activity	O
.	O

In	O
64	O
%	O
a	O
small	O
cardiac	O
vein	O
does	O
not	O
exist	O
,	O
but	O
its	O
origin	O
,	O
the	O
right	O
marginal	O
vein	O
,	O
joins	O
the	O
system	O
of	O
anterior	O
cardiac	O
veins	O
.	O

The	O
role	O
of	O
neuroplasticity	O
in	O
the	O
response	O
to	O
drugs	O
.	O

Biol	O
.	O

The	O
results	O
of	O
these	O
experiments	O
indicate	O
that	O
at	O
least	O
two	O
upstream	O
activator	O
sequences	O
(	O
UAS	O
)	O
mediate	O
maximum	O
induction	O
by	O
galactose	O
.	O

Reversal	O
of	O
the	O
increase	O
in	O
apomorphine	O
-	O
induced	O
stereotypy	O
and	O
aggression	O
in	O
REM	O
sleep	O
deprived	O
rats	O
by	O
dopamine	O
agonist	O
pretreatments	O
.	O

The	O
heart	O
rate	O
,	O
respiratory	O
rate	O
,	O
arterial	O
O2	O
and	O
systemic	O
vascular	O
resistance	O
were	O
not	O
significantly	O
altered	O
.	O

Human	B
rIL-3	I
expressed	O
in	O
COS7	O
cells	O
has	O
multipotential	O
CSF	B
activity	O
in	O
semisolid	O
cultures	O
of	O
bone	O
marrow	O
cells	O
,	O
and	O
selectively	O
induced	O
the	O
proliferation	O
of	O
My-10	O
+	O
marrow	O
or	O
cord	O
blood	O
cells	O
in	O
liquid	O
cultures	O
.	O

Our	O
findings	O
suggest	O
that	O
the	O
mtr	B
product	I
causes	O
both	O
transcription	O
attenuation	O
and	O
inhibition	O
of	O
translation	O
of	O
trpE	B
mRNA	I
.	O

Apropos	O
of	O
a	O
case	O

A	O
prostaglandin	O
analogue	O
given	O
in	O
early	O
pregnancy	O
and	O
human	B
chorionic	I
gonadotropin	I
given	O
near	O
the	O
end	O
of	O
the	O
ensuing	O
follicular	O
phase	O
were	O
used	O
for	O
controlling	O
the	O
reproductive	O
cycle	O
,	O
timing	O
oocyte	O
collection	O
,	O
and	O
synchronizing	O
the	O
cycles	O
of	O
oocyte	O
donors	O
and	O
embryo	O
recipients	O
.	O

The	O
nucleolin	B
gene	I
extends	O
over	O
9000	O
base	O
-	O
pairs	O
and	O
is	O
split	O
into	O
14	O
exons	O
that	O
encode	O
the	O
706	O
amino	O
acid	O
residues	O
of	O
the	O
protein	O
.	O

Although	O
L	O
-	O
threo	O
-	O
dihydroxyphenylserine	O
(	O
DOPS	O
)	O
,	O
an	O
artificial	O
norepinephrine	O
(	O
NE	O
)	O
precursor	O
,	O
did	O
not	O
change	O
immobility	O
in	O
intact	O
mice	O
,	O
DOPS	O
significantly	O
reduced	O
immobility	O
in	O
mice	O
pretreated	O
with	O
the	O
selective	O
NE	O
neurotoxin	O
DSP4	O
.	O

Here	O
we	O
report	O
the	O
complete	O
6-kilobase	O
cDNA	O
sequence	O
coding	O
for	O
a	O
chain	O
of	O
1775	O
amino	O
acids	O
,	O
as	O
well	O
as	O
the	O
genomic	O
structure	O
.	O

The	O
distribution	O
of	O
the	O
sites	O
of	O
recombinational	O
resolution	O
is	O
inversely	O
correlated	O
with	O
that	O
of	O
the	O
gradient	O
of	O
sequence	O
divergence	O
,	O
with	O
only	O
approximately	O
7	O
%	O
of	O
the	O
X	O
recombinants	O
resolved	O
within	O
the	O
3	O
'	O
third	O
of	O
the	O
X	O
blocks	O
where	O
two	O
diverged	O
Alu	B
family	O
repeats	O
reside	O
.	O

Potentiation	O
of	O
the	O
thrombolytic	O
efficacy	O
of	O
single	B
-	I
chain	I
urokinase	I
(	O
Pro	B
-	I
urokinase	I
)	O
by	O
heparin	O
.	O

Of	O
49	O
receptors	O
which	O
fired	O
in	O
phase	O
with	O
ventilation	O
,	O
13	O
behaved	O
like	O
mammalian	O
rapidly	O
adapting	O
pulmonary	O
stretch	O
receptors	O
,	O
19	O
like	O
mammalian	O
slowly	O
adapting	O
pulmonary	O
stretch	O
receptors	O
(	O
PSR	O
)	O
,	O
and	O
17	O
like	O
avian	O
intrapulmonary	O
CO2-sensitive	O
chemoreceptors	O
(	O
IPC	O
)	O
.	O

In	O
the	O
IA	O
task	O
,	O
post	O
-	O
training	O
intraperitoneal	O
injections	O
of	O
picrotoxin	O
and	O
bicuculline	O
induced	O
a	O
dose	O
-	O
dependent	O
enhancement	O
of	O
retention	O
measured	O
24	O
h	O
after	O
the	O
training	O
,	O
while	O
retention	O
was	O
not	O
affected	O
by	O
bicuculline	O
methiodide	O
(	O
a	O
GABA	B
receptor	I
antagonist	O
that	O
does	O
not	O
readily	O
cross	O
the	O
blood	O
-	O
brain	O
barrier	O
)	O
.	O

It	O
is	O
suggested	O
that	O
the	O
use	O
of	O
endogenous	O
creatinine	O
clearance	O
to	O
estimate	O
the	O
glomerular	O
filtration	O
rate	O
(	O
GFR	O
)	O
requires	O
caution	O
and	O
the	O
recognition	O
of	O
the	O
limitations	O
of	O
the	O
method	O
,	O
and	O
that	O
simpler	O
techniques	O
(	O
serum	O
creatinine	O
or	O
estimated	O
endogenous	O
creatinine	O
clearance	O
)	O
are	O
preferable	O
in	O
routine	O
practice	O
.	O

A	O
protein	O
footprint	O
also	O
was	O
identified	O
for	O
a	O
GC	O
box	O
element	O
at	O
nucleotides	O
-59	O
to	O
-45	O
.	O

The	O
central	O
visual	O
fields	O
of	O
2165	O
normal	O
and	O
106	O
glaucoma	O
eyes	O
were	O
measured	O
using	O
a	O
threshold	O
related	O
suprathreshold	O
strategy	O
.	O

The	O
variability	O
is	O
most	O
likely	O
a	O
result	O
of	O
alternative	O
splicing	O
of	O
exons	O
from	O
the	O
primary	O
elastin	B
transcripts	I
.	O

The	O
CHARGE	O
association	O
is	O
a	O
collection	O
of	O
multisystem	O
congenital	O
anomalies	O
including	O
choanal	O
atresia	O
.	O

Evaluation	O
of	O
human	O
and	O
bovine	O
modified	O
-	O
hemoglobin	B
solution	O
as	O
oxygen	O
-	O
carrying	O
fluid	O
for	O
blood	O
volume	O
replacement	O
.	O

26	O
micrograms	O
PAF	B
or	O
placebo	O
was	O
sprayed	O
into	O
each	O
nasal	O
cavity	O
8	O
h	O
and	O
1	O
h	O
before	O
a	O
nasal	O
allergen	O
challenge	O
.	O

Sci	O
.	O

Chem	O
.	O

Comparison	O
was	O
made	O
with	O
other	O
neuroradiological	O
imaging	O
modalities	O
including	O
CT	O
,	O
myelography	O
,	O
CT	O
ventriculography	O
,	O
and	O
CT	O
myelocisternography	O
.	O

The	O
test	O
for	O
alpha	B
-	I
naphthyl	I
esterase	I
and	O
quantitation	O
of	O
macrophages	O
(	O
absolute	O
number	O
)	O
per	O
infiltration	O
area	O
unit	O
adjacent	O
to	O
the	O
abscess	O
suggest	O
a	O
direct	O
correlation	O
between	O
the	O
absolute	O
number	O
of	O
macrophages	O
and	O
the	O
width	O
of	O
the	O
capsule	O
.	O

Determined	O
as	O
migration	O
differentials	O
,	O
chemotactic	O
and	O
chemokinetic	O
responsiveness	O
tended	O
to	O
be	O
higher	O
in	O
the	O
neutropenic	O
group	O
.	O

The	O
deduced	O
96-residue	O
amino	O
acid	O
coding	O
sequence	O
of	O
the	O
murine	O
HMG	B
-	I
I	I
(	I
Y	I
)	I
cDNA	O
is	O
very	O
similar	O
to	O
the	O
reported	O
amino	O
acid	O
sequence	O
of	O
human	O
HMG	B
-	I
I	I
,	O
except	O
that	O
it	O
lacks	O
11	O
internal	O
amino	O
acids	O
reported	O
in	O
the	O
human	O
protein	O
.	O

Interpersonal	O
style	O
differences	O
among	O
drug	O
abusers	O
were	O
explored	O
using	O
Ryan	O
's	O
(	O
1977	O
)	O
typological	O
system	O
of	O
FIRO	O
-	O
B	O
interpretation	O
.	O

Sera	O
from	O
euthyroid	O
post	O
-	O
menopausal	O
or	O
pregnant	O
women	O
yielded	O
TSH	B
levels	O
within	O
the	O
normal	O
range	O
.	O

No	O
UOxase	B
mRNA	I
was	O
detected	O
in	O
11	O
nonhepatic	O
tissues	O
of	O
rat	O
,	O
suggesting	O
tissue	O
specificity	O
of	O
expression	O
of	O
this	O
UOxase	B
gene	I
.	O

The	O
results	O
presented	O
suggest	O
that	O
TIQ	O
reduces	O
the	O
turnover	O
rate	O
of	O
the	O
nigrostriatal	O
dopamine	O
neurons	O
after	O
repeated	O
administration	O
for	O
a	O
long	O
period	O
in	O
mice	O
.	O

The	O
glomerular	O
filtration	O
rate	O
did	O
not	O
change	O
but	O
lithium	O
clearance	O
fell	O
by	O
30	O
%	O
.	O

The	O
pathogenesis	O
of	O
Dupuytren	O
's	O
contracture	O

An	O
ELISA	O
procedure	O
was	O
developed	O
for	O
monitoring	O
the	O
specific	O
IgE	B
response	O
in	O
dogs	O
to	O
Dirofilaria	O
immitis	O
infection	O
.	O

Fifty	O
min	O
after	O
release	O
from	O
stress	O
,	O
increases	O
in	O
plasma	O
corticosterone	O
levels	O
induced	O
by	O
stress	O
recovered	O
in	O
the	O
biting	O
group	O
but	O
remained	O
high	O
in	O
the	O
non	O
-	O
biting	O
group	O
.	O

The	O
only	O
isolate	O
of	O
Aeromonas	O
hydrophila	O
produced	O
cytotoxic	O
enterotoxin	O
and	O
was	O
invasive	O
.	O

Variety	O
of	O
cows	O
and	O
sires	O
according	O
to	O
types	O
of	O
dermatoglyphics	O
(	O
patterns	O
)	O
of	O
the	O
nose	O
-	O
labial	O
mirror	O
of	O
cattle	O

Although	O
not	O
consistently	O
identified	O
in	O
all	O
samples	O
,	O
secondary	O
Academic	O
,	O
Personal	O
Responsibility	O
,	O
and	O
Community	O
/	O
Vocational	O
dimensions	O
were	O
also	O
identified	O
.	O

Not	O
even	O
extensive	O
pancreatic	O
resection	O
could	O
prevent	O
pancreatic	O
remnant	O
infection	O
.	O

It	O
has	O
been	O
calculated	O
that	O
600,000	O
new	O
cases	O
of	O
lung	O
cancer	O
occur	O
worldwide	O
every	O
year	O
,	O
most	O
of	O
them	O
due	O
to	O
smoking	O
.	O

Effect	O
of	O
the	O
methods	O
of	O
cutaneous	O
administration	O
of	O
methyl	O
isobutyl	O
ketone	O
on	O
its	O
toxicity	O

Incorporation	O
of	O
0.1	O
or	O
0.2	O
M	O
sodium	O
dihydrogen	O
phosphate	O
in	O
the	O
sugar	O
solutions	O
resulted	O
in	O
a	O
decrease	O
in	O
the	O
shelf	O
-	O
life	O
of	O
diltiazem	O
.	O

Increasing	O
the	O
phosphorus	O
content	O
of	O
the	O
diet	O
improved	O
the	O
reabsorption	O
of	O
calcium	O
and	O
magnesium	O
.	O

The	O
increase	O
in	O
amplitudes	O
of	O
the	O
b	O
-	O
wave	O
during	O
the	O
adaptation	O
period	O
was	O
more	O
prominent	O
in	O
lead	O
-	O
exposed	O
subjects	O
than	O
in	O
controls	O
.	O

Possible	O
factors	O
for	O
the	O
development	O
of	O
psychotic	O
symptomatology	O
during	O
group	O
activities	O
and	O
the	O
role	O
of	O
group	O
dynamics	O
acting	O
as	O
stress	O
factors	O
precipitating	O
functional	O
psychoses	O
,	O
especially	O
bipolar	O
manifestations	O
,	O
are	O
discussed	O
.	O

Baseline	O
measurements	O
of	O
forced	O
expiratory	O
volume	O
in	O
1	O
s	O
(	O
FEV1	O
)	O
,	O
specific	O
airway	O
conductance	O
(	O
SGaw	O
)	O
and	O
the	O
provocative	O
dose	O
of	O
carbachol	O
causing	O
a	O
35	O
%	O
reduction	O
in	O
SGaw	O
(	O
PD35	O
)	O
,	O
and	O
a	O
20	O
%	O
reduction	O
in	O
FEV1	O
(	O
PD20	O
)	O
were	O
established	O
on	O
entry	O
while	O
each	O
subject	O
was	O
still	O
smoking	O
.	O

The	O
results	O
indicate	O
that	O
the	O
pooling	O
requirements	O
are	O
task	O
dependent	O
.	O

In	O
the	O
infected	O
neonates	O
serum	O
alpha	B
-	I
amylase	I
value	O
,	O
as	O
determined	O
by	O
the	O
blue	O
starch	O
method	O
,	O
was	O
only	O
40	O
%	O
that	O
of	O
healthy	O
controls	O
;	O
the	O
mean	O
value	O
of	O
175.1	O
+	O
/-	O

64.9	O
IU	O
/	O
l	O
for	O
healthy	O
neonates	O
was	O
significantly	O
higher	O
(	O
p	O
less	O
than	O
0.0010	O
)	O
than	O
the	O
value	O
of	O
82.8	O
+	O
/-	O

44.4	O
IU	O
/	O
l	O
for	O
the	O
infected	O
neonates	O
.	O

Records	O
of	O
31	O
children	O
with	O
AIDS	O
or	O
AIDS	O
-	O
related	O
complex	O
admitted	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
for	O
acute	O
respiratory	O
failure	O
throughout	O
a	O
46-month	O
period	O
were	O
reviewed	O
.	O

Fourteen	O
patients	O
were	O
in	O
the	O
multifocal	O
disease	O
group	O
;	O
13	O
were	O
detected	O
by	O
SPECT	O
and	O
10	O
by	O
TCT	O
.	O

SPECT	O
is	O
an	O
important	O
aid	O
in	O
the	O
diagnosis	O
of	O
AIDS	O
dementia	O
complex	O
and	O
contributes	O
to	O
the	O
understanding	O
of	O
the	O
pathophysiological	O
mechanisms	O
of	O
this	O
disorder	O
.	O

We	O
were	O
interested	O
in	O
studying	O
the	O
relationship	O
between	O
the	O
circadian	O
rhythm	O
in	O
body	O
temperature	O
and	O
24-h	O
variations	O
in	O
plasma	O
concentrations	O
of	O
iron	O
,	O
zinc	O
,	O
circulating	O
leukocyte	O
counts	O
,	O
and	O
plasma	O
interleukin	B
1	I
(	O
IL-1	B
)	O
activity	O
.	O

The	O
murine	B
MHC	I
class	I
I	I
genes	I
,	O
H-2Dq	B
and	O
H-2Lq	B
,	O
are	O
strikingly	O
homologous	O
to	O
each	O
other	O
,	O
H-2Ld	B
,	O
and	O
two	O
genes	O
reported	O
to	O
encode	O
tumor	O
-	O
specific	O
antigens	O
.	O

The	O
active	O
derivatives	O
of	O
the	O
present	O
series	O
were	O
also	O
tested	O
for	O
their	O
analgesic	O
activity	O
against	O
aconitine	O
-	O
induced	O
writhing	O
in	O
albino	O
mice	O
and	O
ulcerogenic	O
activity	O
in	O
albino	O
rats	O
.	O

In	O
untreated	O
mice	O
,	O
bactericidal	O
activity	O
of	O
peritoneal	O
macrophages	O
decreased	O
from	O
one	O
day	O
to	O
3	O
days	O
after	O
ip	O
injection	O
of	O
killed	O
L.	O
monocytogenes	O
.	O

Among	O
a	O
population	O
of	O
18,175	O
children	O
below	O
7	O
years	O
of	O
age	O
in	O
medium	O
sized	O
towns	O
and	O
rural	O
areas	O
in	O
south	O
-	O
western	O
Germany	O
552	O
(	O
3.03	O
%	O
)	O
cases	O
of	O
croup	O
were	O
registered	O
during	O
a	O
12	O
months	O
period	O
in	O
1984	O
-	O
85	O
by	O
their	O
physicians	O
.	O

We	O
concluded	O
that	O
Ga	O
-	O
fbg	O
scintigraphy	O
is	O
a	O
very	O
simple	O
method	O
and	O
sufficiently	O
useful	O
for	O
detecting	O
active	O
left	O
ventricular	O
thrombi	O
and	O
for	O
monitoring	O
the	O
effect	O
of	O
anticoagulant	O
therapy	O
.	O

In	O
vitro	O
assessment	O
of	O
the	O
biocompatibility	O
of	O
dental	O
materials	O
--	O
the	O
millipore	O
filter	O
method	O
.	O

Hypomagnesemia	O
was	O
due	O
to	O
magnesium	O
wasting	O
by	O
the	O
kidney	O
.	O

Dentalplaque	O
was	O
controlled	O
by	O
the	O
oral	O
higienic	O
index	O
of	O
the	O
whole	O
dentition	O
daily	O
,	O
after	O
staining	O
with	O
1	O
per	O
cent	O
alkaline	O
fuxin	O
.	O

GRFI	B
bound	O
to	O
sequences	O
at	O
the	O
negative	O
regulatory	O
elements	O
(	O
silencers	O
)	O
of	O
the	O
silent	B
mating	I
type	I
loci	I
HML	B
E	I
and	O
HMR	B
E	I
and	O
to	O
the	O
upstream	O
activating	O
sequence	O
(	O
UAS	O
)	O
required	O
for	O
transcription	O
of	O
the	O
MAT	B
alpha	I
genes	I
.	O

The	O
effects	O
of	O
these	O
mutations	O
on	O
RNA	B
polymerase	I
II	I
activity	O
were	O
assayed	O
by	O
measuring	O
the	O
ability	O
of	O
mutant	O
genes	O
to	O
confer	O
alpha	B
-	I
amanitin	I
resistance	O
after	O
transfection	O
of	O
susceptible	O
rodent	O
cells	O
.	O

We	O
report	O
the	O
use	O
of	O
a	O
new	O
technetium-99m	O
-	O
albumin	B
colloid	O
white	O
blood	O
cell	O
(	O
TAC	O
-	O
WBC	O
)	O
scan	O
in	O
the	O
evaluation	O
of	O
appendicitis	O
.	O

The	O
SSB	B
-	O
poly	O
(	O
dT	O
)	O
affinity	O
is	O
too	O
high	O
to	O
measure	O
in	O
buffers	O
containing	O
even	O
5	O
M	O
NaCl	O
;	O
however	O
,	O
in	O
1.8	O
-	O
2.5	O
M	O
NaBr	O
,	O
we	O
measure	O
alpha	O
log	O
Kobsd	O
/	O
alpha	O
log	O
[	O
NaBr	O
]	O
=	O
-5.7	O
+	O
/-	O

0.7	O
,	O
with	O
a	O
lower	O
value	O
of	O
omega	O
T	O
/	O
O	O
=	O
130	O
+	O
/-	O

70	O
.	O

The	O
behavior	O
of	O
suf12-null	B
/	I
SUF12	I
+	I
heterozygotes	I
indicates	O
that	O
suf12	B
is	O
co	O
-	O
dominantly	O
expressed	O
and	O
suggests	O
that	O
suf12	B
allele	O
-	O
specific	O
suppression	O
may	O
result	O
from	O
functionally	O
distinct	O
mutant	O
proteins	O
rather	O
than	O
variation	O
in	O
residual	O
wild	B
-	I
type	I
SUF12	I
+	I
activity	O
.	O

Antituberculosis	O
agents	O
.	O

The	O
putative	O
immunity	O
protein	O
was	O
detected	O
among	O
the	O
[	O
35S	O
]	O
methionine	O
-	O
labelled	O
proteins	O
produced	O
by	O
minicells	O
carrying	O
cni	B
cloned	O
under	O
lac	B
promoter	I
control	O
,	O
and	O
when	O
the	O
gene	O
was	O
subcloned	O
into	O
expression	O
vectors	O
under	O
the	O
control	O
of	O
a	O
bacteriophage	O
T7	O
promoter	O
.	O

Antibodies	O
made	O
against	O
fusion	O
protein	O
produced	O
by	O
the	O
DP1A	B
clone	O
reacted	O
specifically	O
with	O
DP	B
-	I
I	I
and	I
-II	I
on	O
immunoblots	O
.	O

Stable	O
patients	O
have	O
mucous	O
hypersecretion	O
and	O
little	O
evidence	O
of	O
acute	O
inflammation	O
.	O

Hyperprolactinaemia	O
,	O
moderate	O
hypogonadism	O
,	O
infraclinical	O
neuropathies	O
,	O
arterial	O
stenoses	O
and	O
moderate	O
venous	O
leakages	O
seem	O
to	O
play	O
a	O
partial	O
role	O
of	O
organic	O
starter	O
or	O
cofactor	O
,	O
the	O
sexual	O
consequences	O
of	O
which	O
are	O
amplified	O
by	O
psychological	O
factors	O
,	O
partly	O
secondary	O
to	O
the	O
initial	O
sexual	O
failures	O
.	O

Yang	O
and	O
H.	O

Six	O
healthy	O
male	O
subjects	O
received	O
single	O
oral	O
doses	O
of	O
regular	O
release	O
(	O
RR	O
)	O
quinidine	O
sulfate	O
,	O
sustained	O
release	O
(	O
SR	O
)	O
quinidine	O
bisulfate	O
and	O
the	O
same	O
dose	O
of	O
the	O
SR	O
product	O
with	O
food	O
(	O
SR	O
-	O
F	O
)	O
.	O

This	O
report	O
expands	O
on	O
previous	O
work	O
with	O
interferon	B
alfa-2b	I
(	I
Intron	I
A	I
;	I
Schering	I
-	I
Plough	I
)	I
in	O
the	O
treatment	O
of	O
hairy	O
cell	O
leukemia	O
(	O
HCL	O
)	O
.	O

Clinical	O
chemistry	O
.	O

Revascularization	O
after	O
anterior	O
maxillary	O
and	O
mandibular	O
osteotomy	O

Static	O
orthoses	O
for	O
the	O
management	O
of	O
microstomia	O
.	O

The	O
intrapancreatic	O
spread	O
of	O
the	O
carcinoma	O
correlated	O
with	O
portal	O
invasion	O
of	O
carcinoma	O
,	O
hardness	O
of	O
the	O
body	O
and	O
tail	O
,	O
obstruction	O
of	O
main	O
pancreatic	O
duct	O
and	O
irregular	O
pancreaticogram	O
.	O

Lysosomal	O
enzymes	O
that	O
degrade	O
cartilage	O
are	O
released	O
.	O

Contrary	O
to	O
the	O
observation	O
made	O
with	O
other	O
S.	O
pombe	O
genes	O
transcribed	O
in	O
the	O
budding	O
yeast	O
,	O
the	O
heterologous	O
actin	B
gene	I
transcript	I
is	O
initiated	O
39	O
nucleotides	O
upstream	O
of	O
the	O
initiation	O
start	O
site	O
used	O
in	O
the	O
homologous	O
yeast	O
.	O

A	O
multicentre	O
study	O
involving	O
9	O
Italian	O
institutions	O
was	O
carried	O
out	O
to	O
compare	O
the	O
efficacy	O
and	O
safety	O
of	O
ranitidine	O
150	O
mg	O
b.i.d	O
.	O
and	O
ranitidine	O
300	O
mg	O
nocte	O
in	O
the	O
treatment	O
of	O
reflux	O
oesophagitis	O
.	O

Proctoscopy	O
and	O
roentgenographic	O
studies	O
may	O
be	O
an	O
important	O
part	O
of	O
evaluation	O
,	O
especially	O
in	O
patients	O
who	O
present	O
with	O
perianal	O
suppuration	O
,	O
masses	O
,	O
or	O
anal	O
fissures	O
.	O

In	O
contrast	O
to	O
this	O
mRNA	O
,	O
90	O
%	O
of	O
alpha	B
and	I
beta	I
actin	I
mRNAs	I
were	O
translated	O
in	O
both	O
myoblasts	O
and	O
myotubes	O
.	O

Plasma	B
renin	I
activity	O
does	O
not	O
predict	O
the	O
antihypertensive	O
efficacy	O
of	O
chlorthalidone	O
.	O

Cephradine	O
250	O
mg	O
at	O
night	O
for	O
12	O
months	O
was	O
given	O
as	O
a	O
prophylactic	O
measure	O
to	O
33	O
female	O
patients	O
of	O
mean	O
age	O
41.6	O
years	O
,	O
who	O
had	O
a	O
history	O
in	O
the	O
preceding	O
12	O
months	O
of	O
between	O
three	O
and	O
24	O
(	O
median	O
=	O
7	O
)	O
episodes	O
of	O
frequency	O
and/or	O
dysuria	O
.	O

If	O
this	O
is	O
unavailable	O
,	O
then	O
Supramid	O
has	O
a	O
proven	O
record	O
for	O
good	O
tissue	O
compatibility	O
and	O
resistance	O
to	O
infection	O
.	O

The	O
activity	O
of	O
the	O
EGF	B
receptor	I
promoter	I
can	O
be	O
modulated	O
by	O
E1A	B
protein	I
and	O
receptor	O
RNA	O
levels	O
increased	O
by	O
stimulation	O
with	O
phorbol	O
ester	O
or	O
fetal	O
calf	O
serum	O
.	O

In	O
vitro	O
antimalarial	O
activity	O
of	O
neem	O
(	O
Azadirachta	O
indica	O
A.	O

""""	O
In	O
vitro	O
""""	O
study	O
of	O
dentin	O
adhesion	O
to	O
adhesives	O
made	O
from	O
urethane	O
molecules	O
with	O
free	O
groups	O
of	O
isocyanate	O

Hand	O
-	O
held	O
,	O
continuous	O
-	O
wave	O
Doppler	O
probes	O
,	O
coupled	O
with	O
sound	O
spectral	O
analysis	O
,	O
can	O
successfully	O
predict	O
carotid	O
artery	O
stenosis	O
.	O

The	O
program	O
has	O
been	O
written	O
in	O
a	O
generic	O
BASIC	O
in	O
order	O
to	O
make	O
the	O
procedure	O
user	O
-	O
friendly	O
.	O

Fifty	O
-	O
four	O
patients	O
were	O
divided	O
into	O
groups	O
according	O
to	O
their	O
clinical	O
presentation	O
;	O
seven	O
asymptomatic	O
volunteers	O
,	O
20	O
patients	O
with	O
duodenal	O
-	O
gastric	O
reflux	O
gastropathy	O
(	O
DRG	O
)	O
,	O
16	O
patients	O
with	O
recurrent	O
ulcers	O
of	O
the	O
duodenal	O
bulb	O
(	O
RUD	O
)	O
,	O
and	O
11	O
patients	O
with	O
Moynihan	O
's	O
disease	O
.	O

High	O
concentrations	O
of	O
tumor	O
-	O
associated	O
trypsin	B
inhibitor	O
in	O
hemodialyzed	O
patients	O
.	O

In	O
the	O
chicken	O
liver	O
,	O
levels	O
of	O
chicken	B
MT	I
mRNA	I
were	O
rapidly	O
induced	O
by	O
metals	O
(	O
Cd2	O
+	O
,	O
Zn2	O
+	O
,	O
Cu2	O
+	O
)	O
,	O
glucocorticoids	O
and	O
lipopolysaccharide	O
.	O

With	O
histology	O
and	O
Evans	O
blue	O
injections	O
,	O
blood	O
-	O
brain	O
barrier	O
alterations	O
were	O
seen	O
as	O
early	O
as	O
4	O
days	O
after	O
a	O
dose	O
of	O
50	O
Gy	O
.	O

Dosimetric	O
estimates	O
for	O
these	O
organs	O
were	O
2.3	O
+	O
/-	O

1.1	O
and	O
2.3	O
+	O
/-	O

1.4	O
rad	O
(	O
.02	O
+	O
/-	O

.01	O

Gy	O
)	O
,	O
respectively	O
,	O
with	O
a	O
whole	O
-	O
body	O
estimate	O
of	O
0.28	O
rad	O
(	O
.003	O
Gy	O
)	O
.	O

A	O
significant	O
association	O
between	O
a	O
family	O
history	O
and	O
a	O
higher	O
urinary	O
pH	O
was	O
observed	O
among	O
the	O
female	O
calcium	O
stone	O
patients	O
.	O

New	O
technologies	O
in	O
diagnosis	O
and	O
classification	O
of	O
malignancy	O
.	O

Thus	O
the	O
present	O
data	O
also	O
suggest	O
that	O
BP	O
and	O
HR	O
measurements	O
are	O
influenced	O
not	O
only	O
by	O
state	O
-	O
dependent	O
factors	O
but	O
also	O
by	O
at	O
least	O
three	O
different	O
factors	O
that	O
are	O
each	O
independent	O
of	O
the	O
state	O
:	O
one	O
leads	O
to	O
BP	O
and	O
HR	O
values	O
that	O
are	O
influenced	O
by	O
the	O
cycle	O
the	O
animal	O
is	O
in	O
and	O
the	O
other	O
two	O
influence	O
,	O
respectively	O
,	O
the	O
ranking	O
of	O
the	O
individual	O
's	O
BP	O
and	O
HR	O
levels	O
within	O
the	O
population	O
.	O

The	O
correlation	O
between	O
PaCO2	O
and	O
PtcO2	O
in	O
RDS	O
was	O
insufficient	O
to	O
make	O
clinical	O
judgement	O
.	O

One	O
millimolar	O
ouabain	O
completely	O
inhibited	O
net	O
HCO3-	O
secretion	O
.	O

The	O
same	O
rhythmic	O
structure	O
enables	O
a	O
prediction	O
to	O
be	O
made	O
concerning	O
when	O
vowels	O
of	O
stressed	O
syllables	O
will	O
be	O
auditorily	O
perceived	O
.	O

Vocal	O
cord	O
abduction	O
rehabilitation	O
by	O
nervous	O
selective	O
anastomosis	O
.	O

UK	O
's	O
biotechnology	O
lacking	O
specialists	O
.	O

A	O
case	O
of	O
AIDS	O
-	O
related	O
complex	O
(	O
ARC	O
/	O
LAS	O
)	O
in	O
a	O
health	O
worker	O

Distant	O
spread	O
was	O
found	O
in	O
46	O
patients	O
(	O
34	O
%	O
)	O
,	O
42	O
of	O
whom	O
had	O
serum	O
Tg	B
greater	O
than	O
10	O
micrograms	O
/	O
l	O
.	O

After	O
the	O
meal	O
containing	O
potato	O
,	O
plasma	O
glucose	O
levels	O
rose	O
sharply	O
,	O
peaked	O
at	O
30	O
-	O
45	O
min	O
and	O
fell	O
below	O
initial	O
levels	O
2	O
to	O
3	O
h	O
later	O
.	O

The	O
relations	O
among	O
various	O
negative	O
emotional	O
and	O
behavioral	O
characteristics	O
(	O
e.g.	O
,	O
aggression	O
,	O
anxiety	O
,	O
undercompliance	O
,	O
depressive	O
mood	O
)	O
and	O
adjustment	O
were	O
examined	O
through	O
use	O
of	O
data	O
from	O
the	O
31-year	O
-	O
old	O
New	O
York	O
Longitudinal	O
Study	O
.	O

We	O
have	O
improved	O
our	O
system	O
for	O
nuclear	O
contour	O
digitization	O
and	O
determined	O
its	O
theoretical	O
limitations	O
by	O
digitizing	O
standardized	O
objects	O
.	O

The	O
skin	O
site	O
,	O
6-cm	O
-	O
distal	O
and	O
-proximal	O
subcutaneous	O
segments	O
of	O
the	O
catheter	O
,	O
exudates	O
,	O
and	O
blood	O
were	O
cultured	O
.	O

Because	O
of	O
its	O
great	O
reliability	O
,	O
conventional	O
arteriography	O
occupies	O
a	O
place	O
of	O
choice	O
among	O
the	O
medical	O
imaging	O
techniques	O
.	O

Rapid	O
detection	O
of	O
radioisotopically	O
contaminated	O
test	O
serum	O
before	O
radioassay	O
of	O
vitamin	O
B12	O
.	O

The	O
former	O
group	O
did	O
excrete	O
less	O
dry	O
fecal	O
material	O
compared	O
to	O
both	O
other	O
groups	O
.	O

The	O
maximum	O
deflections	O
of	O
phase	O
IV	O
for	O
Ar	O
and	O
N2	O
from	O
extrapolated	O
phase	O
III	O
slopes	O
were	O
smaller	O
in	O
the	O
prone	O
position	O
,	O
suggesting	O
more	O
uniform	O
tracer	O
gas	O
concentrations	O
across	O
the	O
lungs	O
.	O

Recent	O
developments	O
in	O
drugs	O
antagonistic	O
to	O
factors	O
causing	O
peptic	O
ulcer	O
--	O
clinical	O
efficacy	O
and	O
problems	O
;	O
gastrin	B
receptor	I
blockaders	O

Static	O
magnetic	O
fields	O
affect	O
the	O
diffusion	O
of	O
biological	O
particles	O
in	O
solutions	O
through	O
the	O
Lorentz	O
force	O
and	O
Maxwell	O
stress	O
.	O

SPA	O
from	O
PAG	O
sites	O
was	O
associated	O
with	O
aversion	O
.	O

The	O
artery	O
cuff	O
was	O
slightly	O
superior	O
to	O
the	O
fat	O
wrap	O
,	O
particularly	O
in	O
having	O
fewer	O
adhesions	O
and	O
a	O
better	O
histological	O
picture	O
.	O

The	O
development	O
and	O
distribution	O
of	O
Trypanosoma	O
congolense	O
,	O
T	O
vivax	O
and	O
T	O
brucei	O
in	O
the	O
skin	O
of	O
goats	O
was	O
examined	O
after	O
the	O
animals	O
were	O
bitten	O
by	O
infected	O
Glossina	O
morsitans	O
centralis	O
.	O

Electroglottography	O
is	O
a	O
useful	O
,	O
non	O
-	O
invasive	O
technique	O
that	O
can	O
assist	O
in	O
the	O
assessment	O
of	O
vocal	O
fold	O
dysfunction	O
.	O

The	O
pharmacological	O
effects	O
of	O
the	O
novel	O
compound	O
WEB	O
1881	O
FU	O
(	O
4-amino	O
-	O
methyl-1-benzyl	O
-	O
pyrrolidine-2-one	O
-	O
fumarate	O
)	O
were	O
investigated	O
.	O

Histopathological	O
examination	O
revealed	O
dose	O
-	O
related	O
proliferation	O
of	O
type	O
II	O
pneumocytes	O
in	O
dams	O
and	O
proliferation	O
of	O
interstitial	O
cells	O
and	O
delayed	O
septal	O
/	O
capillary	O
development	O
in	O
neonates.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

So	O
far	O
no	O
problems	O
with	O
multiply	O
resistant	O
strains	O
have	O
developed	O
.	O

During	O
the	O
observation	O
period	O
of	O
0.4	O
-	O
30	O
weeks	O
,	O
cardiac	O
white	O
spots	O
on	O
the	O
right	O
ventricle	O
of	O
BALB	O
/	O
c	O
mice	O
were	O
first	O
detected	O
at	O
three	O
weeks	O
(	O
6	O
of	O
20	O
mice	O
;	O
30	O
%	O
)	O
,	O
and	O
the	O
maximal	O
incidence	O
of	O
cardiac	O
white	O
spots	O
was	O
obtained	O
at	O
nine	O
weeks	O
(	O
39	O
of	O
44	O
mice	O
;	O
88	O
%	O
)	O
.	O

Increasing	O
the	O
RH	O
beyond	O
32	O
%	O
resulted	O
in	O
solvation	O
of	O
the	O
peroxy	O
radical	O
,	O
sterically	O
hindering	O
the	O
radical	O
from	O
entering	O
the	O
propagation	O
transition	O
state	O
.	O

The	O
effects	O
produced	O
by	O
oral	O
administration	O
of	O
500	O
mg	O
/	O
kg	O
p	O
-	O
xylene	O
or	O
toluene	O
lasted	O
at	O
least	O
8	O
hr	O
,	O
while	O
the	O
effect	O
of	O
inhaled	O
p	O
-	O
xylene	O
dissipated	O
within	O
75	O
min	O
of	O
removal	O
from	O
the	O
exposure	O
.	O

PATIENTS	O
and	O
METHODS	O
:	O
Thallium-201	O
myocardial	O
scintigraphy	O
was	O
performed	O
at	O
rest	O
and	O
after	O
0.56	O
mg	O
/	O
kg	O
intravenous	O
dipyridamole	O
during	O
four	O
minutes	O
in	O
16	O
patients	O
with	O
sarcoidosis	O
.	O

The	O
TA	O
muscle	O
was	O
fatigued	O
by	O
four	O
forms	O
of	O
repeated	O
isometric	O
contractions	O
:	O
(	O
1	O
)	O
maximal	O
voluntary	O
contractions	O
(	O
MVC	O
)	O
,	O
(	O
2	O
)	O
MVC	O
with	O
circulation	O
occluded	O
,	O
(	O
3	O
)	O
electrically	O
evoked	O
contractions	O
with	O
20	O
Hz	O
supramaximal	O
voltage	O
stimulation	O
and	O
(	O
4	O
)	O
electrically	O
evoked	O
contractions	O
with	O
circulation	O
occluded	O
.	O

Which	O
cineangiographically	O
assessed	O
anatomic	O
variable	O
correlates	O
best	O
with	O
functional	O
measurements	O
of	O
stenosis	O
severity	O
?	O

A	O
comparison	O
of	O
quantitative	O
analysis	O
of	O
the	O
coronary	O
cineangiogram	O
with	O
measured	O
coronary	O
flow	O
reserve	O
and	O
exercise	O
/	O
redistribution	O
thallium-201	O
scintigraphy	O
.	O

Water	O
content	O
and	O
equilibrium	O
water	O
partition	O
in	O
immature	O
cartilage	O
.	O

Thyroid	O
function	O
tests	O
were	O
performed	O
on	O
300	O
admissions	O
,	O
leaving	O
707	O
untested	O
.	O

Data	O
on	O
the	O
line	O
spread	O
function	O
(	O
LSF	O
)	O
were	O
obtained	O
from	O
the	O
image	O
of	O
a	O
0.2	O
mm	O
wide	O
slit	O
between	O
tungsten	O
blocks	O
that	O
were	O
positioned	O
at	O
the	O
isocentre	O
in	O
front	O
of	O
a	O
polystyrene	O
phantom	O
.	O

Papers	O
of	O
the	O
Society	O
for	O
Clinical	O
Vascular	O
Surgery	O
.	O

Liquid	O
chromatographic	O
method	O
for	O
determination	O
of	O
citreoviridin	O
in	O
corn	O
and	O
rice	O
.	O

Pregnant	O
rats	O
were	O
exposed	O
to	O
one	O
of	O
the	O
following	O
:	O
(	O
1	O
)	O
10	O
%	O
O2	O
in	O
N2	O
or	O
100	O
%	O
O2	O
for	O
2	O
days	O
beginning	O
at	O
day	O
7	O
,	O
11	O
,	O
14	O
,	O
or	O
18	O
of	O
pregnancy	O
;	O
(	O
2	O
)	O
10	O
%	O
O2	O
in	O
N2	O
or	O
100	O
%	O
O2	O
for	O
10	O
h	O
/	O
day	O
beginning	O
at	O
day	O
7	O
;	O
or	O
(	O
3	O
)	O
14	O
-	O
11	O
%	O
O2	O
in	O
N2	O
continuously	O
beginning	O
at	O
day	O
14	O
till	O
day	O
21	O
when	O
they	O
were	O
sacrificed	O
.	O

Addition	O
of	O
sucralfate	O
or	O
De	O
-	O
Nol	O
resulted	O
in	O
increments	O
of	O
gastric	O
HCO3	O
secretion	O
,	O
reaching	O
about	O
45	O
%	O
and	O
59	O
%	O
,	O
respectively	O
,	O
of	O
the	O
maximal	O
HCO3	O
response	O
to	O
16,16-dimethyl	O
PGE2	O
(	O
dmPGE2	O
)	O
.	O

In	O
Salmo	O
gairdneri	O
,	O
no	O
specialized	O
system	O
of	O
portal	O
vessels	O
appears	O
to	O
exist	O
between	O
the	O
pineal	O
organ	O
and	O
other	O
portions	O
of	O
the	O
brain	O
.	O

The	O
4	O
degrees	O
stimuli	O
were	O
found	O
to	O
elicit	O
scalp	O
distributions	O
for	O
the	O
pattern	O
reversal	O
P100	O
and	O
the	O
pattern	O
onset	O
C1	O
consistent	O
with	O
striate	O
and	O
extrastriate	O
visual	O
cortical	O
origins	O
respectively	O
.	O

Nuclear	B
factor	I
III	I
(	O
NFIII	B
)	O
is	O
a	O
protein	O
from	O
HeLa	O
cells	O
that	O
stimulates	O
the	O
initiation	O
of	O
adenovirus	O
type	O
2	O
(	O
Ad2	O
)	O
DNA	O
replication	O
by	O
binding	O
to	O
a	O
specific	O
nucleotide	O
sequence	O
in	O
the	O
origin	O
,	O
adjacent	O
to	O
the	O
nuclear	B
factor	I
I	I
recognition	I
site	I
.	O

A	O
Golgi	O
study	O
of	O
the	O
sixth	O
layer	O
of	O
the	O
cerebral	O
cortex	O
.	O

We	O
conclude	O
that	O
cephalothin	O
clearance	O
of	O
S.	O
aureus	O
from	O
a	O
site	O
accessible	O
to	O
phagocytes	O
was	O
delayed	O
when	O
compared	O
to	O
a	O
phagocyte	O
-	O
inaccessible	O
site	O
.	O

The	O
findings	O
are	O
discussed	O
in	O
the	O
context	O
of	O
known	O
properties	O
of	O
cortical	O
-	O
bar	O
detectors	O
.	O

Mean	O
rCBF	O
increased	O
in	O
some	O
patients	O
4	O
-	O
8	O
weeks	O
after	O
surgery	O
on	O
the	O
ipsilateral	O
side	O
.	O

Quantitative	O
computed	O
tomography	O
for	O
measuring	O
vertebral	O
bone	O
mineral	O
content	O
offers	O
high	O
sensitivity	O
and	O
reproducibility	O
.	O

Kf	O
,	O
c	O
and	O
CT	O
(	O
referenced	O
to	O
the	O
initial	O
lung	O
mass	O
)	O
decreased	O
linearly	O
with	O
reductions	O
in	O
lung	O
mass	O
%	O
delta	O
Kf	O
,	O
c	O
=	O
1.26	O
-	O
0.98	O
%	O
mass	O
removed	O
(	O
r	O
=	O
0.90	O
,	O
P	O
less	O
than	O
0.01	O
)	O
and	O
%	O
delta	O
CT	O
=	O
-3.99	O
-	O
0.98	O
%	O
mass	O
removed	O
(	O
r	O
=	O
0.82	O
,	O
P	O
less	O
than	O
0.01	O
)	O
relationships	O
that	O
were	O
not	O
altered	O
by	O
blocker	O
pretreatment.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Research	O
was	O
carried	O
out	O
on	O
the	O
rheumatoid	B
factors	I
in	O
the	O
serum	O
of	O
917	O
patients	O
by	O
means	O
of	O
two	O
tests	O
(	O
one	O
using	O
polystyrene	O
and	O
one	O
with	O
erythrocytes	O
)	O
and	O
the	O
results	O
obtained	O
were	O
compared	O
using	O
a	O
method	O
of	O
reference	O
.	O

The	O
role	O
of	O
supercritical	O
fluid	O
chromatography	O
(	O
SFC	O
)	O
as	O
a	O
viable	O
technique	O
for	O
analyzing	O
agricultural	O
products	O
has	O
been	O
investigated	O
using	O
packed	O
and	O
capillary	O
column	O
methodology	O
.	O

Nitrofurazone	O
significantly	O
reduced	O
the	O
rise	O
in	O
LH	B
induced	O
by	O
LHRH	B
.	O

After	O
a	O
baseline	O
study	O
,	O
WPW	O
syndrome	O
was	O
simulated	O
by	O
stimulation	O
at	O
seven	O
different	O
sites	O
around	O
the	O
base	O
of	O
the	O
ventricles	O
,	O
and	O
RNV	O
's	O
were	O
obtained	O
.	O

Man	O
and	O
insect	O
,	O
past	O
,	O
present	O
,	O
future	O

The	O
criterion	O
was	O
reached	O
after	O
two	O
sessions	O
and	O
generalization	O
to	O
a	O
variety	O
of	O
pills	O
and	O
capsules	O
occurred	O
.	O

Enoxacin	O
appears	O
to	O
be	O
well	O
suited	O
for	O
the	O
treatment	O
of	O
complicated	O
UTI	O
.	O

In	O
14	O
cases	O
,	O
isolates	O
were	O
biotyped	O
yielding	O
eight	O
with	O
biotype	O
II	O
,	O
four	O
with	O
biotype	O
III	O
,	O
and	O
one	O
each	O
with	O
biotypes	O
IV	O
and	O
V.	O

In	O
a	O
previous	O
interim	O
report	O
we	O
noted	O
more	O
prompt	O
resolution	O
of	O
dermatomal	O
signs	O
and	O
symptoms	O
with	O
acyclovir	O
treatment	O
.	O

The	O
detectability	O
of	O
the	O
defects	O
in	O
RCA	O
or	O
LAD	O
region	O
was	O
80	O
%	O
in	O
single	O
-	O
position	O
scans	O
in	O
stress	O
studies	O
.	O

These	O
data	O
should	O
be	O
useful	O
in	O
developing	O
reagents	O
for	O
heterozygote	O
detection	O
and	O
prenatal	O
diagnosis	O
of	O
11	B
beta	I
-	I
hydroxylase	I
deficiency	O
,	O
the	O
second	O
most	O
frequent	O
cause	O
of	O
congenital	O
adrenal	O
hyperplasia	O
.	O

Osteocalcin	B
(	O
serum	B
bone	I
-	I
Gla	I
protein	I
,	O
sBGP	B
)	O
,	O
serum	B
alkaline	I
phosphatase	I
(	O
sAP	B
)	O
and	O
urinary	O
hydroxyproline	O
/	O
creatinine	O
ratio	O
(	O
uOH	O
-	O
Prol	O
/	O
creatinine	O
)	O
have	O
been	O
measured	O
in	O
21	O
patients	O
with	O
primary	O
hyperparathyroidism	O
(	O
PHPT	O
)	O
and	O
in	O
nine	O
patients	O
with	O
hypercalcaemia	O
of	O
malignancy	O
(	O
HM	O
)	O
.	O

Multivariate	O
logistic	O
regression	O
analysis	O
indicated	O
that	O
seropositivity	O
was	O
strongly	O
associated	O
with	O
the	O
prevalence	O
of	O
hepatitis	O
B	O
in	O
an	O
employee	O
's	O
country	O
of	O
birth	O
and	O
with	O
age	O
.	O

Natl	O
.	O

Neither	O
ethanol	O
nor	O
estrogen	O
has	O
been	O
shown	O
to	O
cause	O
UROD	B
-	O
deficiency	O
in	O
animals	O
.	O

Although	O
not	O
common	O
,	O
the	O
disorder	O
is	O
the	O
most	O
frequently	O
diagnosed	O
disturbance	O
of	O
porphyrin	O
metabolism	O
in	O
many	O
countries	O
,	O
and	O
further	O
insight	O
into	O
its	O
unusual	O
pathogenesis	O
may	O
clarify	O
the	O
hepatotoxic	O
effects	O
of	O
the	O
4	O
etiologic	O
agents	O
.	O

Five	O
out	O
of	O
eight	O
consecutive	O
cases	O
with	O
initial	O
symptoms	O
of	O
a	O
'	O
midline	O
granuloma	O
'	O
were	O
identified	O
as	O
malignant	O
histiocytosis	O
(	O
histiocytic	O
sarcoma	O
)	O
which	O
within	O
5	O
months	O
to	O
4	O
years	O
led	O
to	O
generalization	O
and	O
death	O
.	O

The	O
highest	O
postoperative	O
CK	B
-	I
MB	I
level	O
was	O
less	O
after	O
BC	O
(	O
BC	O
,	O
31	O
+	O
/-	O

17	O
U	O
/	O
L	O
;	O
CC	O
,	O
56	O
+	O
/-	O

13	O
U	O
/	O
L	O
;	O
p	O
less	O
than	O
0.05	O
)	O
.	O

No	O
relevant	O
changes	O
in	O
heart	O
rate	O
,	O
body	O
weight	O
,	O
and	O
plasma	O
levels	O
of	O
renin	B
activity	O
and	O
aldosterone	O
concentration	O
were	O
observed	O
.	O

State	O
-	O
approved	O
schools	O
of	O
nursing	O
R.N.	O

In	O
a	O
maxicell	O
system	O
a	O
protein	O
with	O
an	O
approximate	O
molecular	O
weight	O
of	O
36,000	O
was	O
synthesized	O
.	O

This	O
means	O
that	O
the	O
loss	O
of	O
recessives	O
must	O
be	O
calculated	O
by	O
using	O
a	O
hypergeometric	O
and	O
not	O
a	O
binomial	O
model	O
as	O
Fisher	O
did	O
.	O

The	O
small	O
size	O
and	O
placement	O
of	O
the	O
mutagenesis	O
marker	O
(	O
the	O
supF	B
suppressor	I
tRNA	I
gene	I
from	I
Escherichia	I
coli	I
)	O
within	O
the	O
vector	O
substantially	O
reduced	O
the	O
frequency	O
of	O
spontaneous	O
mutations	O
normally	O
observed	O
after	O
transfection	O
of	O
mammalian	O
cells	O
with	O
plasmid	O
DNA	O
;	O
hence	O
,	O
UV	O
-	O
induced	O
mutations	O
were	O
easily	O
identified	O
above	O
the	O
spontaneous	O
background	O
.	O

Tetrad	O
analysis	O
and	O
mitotic	O
recombination	O
experiments	O
localized	O
the	O
PEP4	B
gene	I
proximal	O
to	O
GAL4	B
on	O
chromosome	O
XVI	O
.	O

The	O
poly	O
(	O
A	O
)	O
segment	O
of	O
the	O
RNA	O
was	O
selectively	O
cross	O
-	O
linked	O
to	O
the	O
72,000-molecular	O
-	O
weight	O
protein	O
(	O
72	O
K	O
protein	O
)	O
.	O

Ciprofloxacin	O
:	O
an	O
overview	O
of	O
adverse	O
experiences	O
.	O

The	O
rho	B
genes	I
comprise	O
an	O
evolutionarily	O
conserved	O
family	O
with	O
significant	O
homology	O
to	O
the	O
ras	B
oncogene	I
family	I
.	O

Also	O
,	O
component	O
I	O
significantly	O
correlated	O
with	O
fasting	O
insulin	B
and	O
VO2	O
max	O
for	O
both	O
sexes	O
and	O
with	O
basal	O
metabolism	O
and	O
HDL	B
-	I
cholesterol	I
for	O
females	O
and	O
males	O
,	O
respectively	O
.	O

The	O
serum	B
insulin	I
response	O
can	O
not	O
.	O

SCL	O
prolonged	O
promptly	O
after	O
verapamil	O
,	O
and	O
sinus	O
arrest	O
developed	O
in	O
two	O
of	O
10	O
group	O
2	O
and	O
two	O
of	O
five	O
group	O
3	O
animals	O
.	O

Development	O
of	O
a	O
yeast	O
system	O
to	O
assay	O
mutational	O
specificity	O
.	O

The	O
present	O
investigation	O
sought	O
to	O
identify	O
the	O
principal	O
dimensions	O
of	O
the	O
Framingham	O
Type	O
A	O
scale	O
(	O
FTAS	O
)	O
and	O
then	O
to	O
examine	O
their	O
physiological	O
and	O
psychological	O
correlates	O
.	O

Legionella	O
,	O
microbial	O
ecology	O
,	O
and	O
inconspicuous	O
consumption	O
.	O

Lymphatics	O
in	O
the	O
aorta	O
of	O
rats	O
treated	O
with	O
a	O
soy	O
-	O
bean	O
oil	O
extract	O
(	O
lipofundin	O
)	O
.	O

As	O
a	O
last	O
resort	O
,	O
it	O
may	O
be	O
possible	O
to	O
maintain	O
a	O
patient	O
on	O
dialysis	O
in	O
reasonable	O
health	O
with	O
a	O
DiaTAP	O
button	O
graft	O
complex	O
infected	O
with	O
Staphylococcus	O
epidermidis	O
and	O
intermittent	O
positive	O
blood	O
cultures	O
using	O
long	O
term	O
vancomycin	O
therapy	O
.	O

For	O
signal	O
durations	O
less	O
than	O
10	O
ms	O
,	O
however	O
,	O
the	O
SoNo	O
and	O
S	O
pi	O
No	O
threshold	O
functions	O
converged	O
and	O
the	O
masking	O
-	O
level	O
difference	O
decreased	O
.	O

The	O
spleen	O
rate	O
of	O
about	O
600	O
villagers	O
of	O
RK	O
I	O
examined	O
was	O
54.3	O
%	O
and	O
the	O
parasite	O
rate	O
13.2	O
%	O
before	O
the	O
drug	O
intervention	O
.	O

Multiple	O
dosing	O
four	O
times	O
daily	O
for	O
7	O
days	O
of	O
indoprofen	O
200	O
mg	O
,	O
a	O
non	O
-	O
steroidal	O
anti	O
-	O
inflammatory	O
drug	O
with	O
a	O
short	O
half	O
-	O
life	O
(	O
t1	O
/	O
2	O
)	O
,	O
revealed	O
drug	O
accumulation	O
in	O
eight	O
elderly	O
subjects	O
.	O

In	O
10	O
patients	O
with	O
subacute	O
cardiac	O
tamponade	O
,	O
pulmonary	O
wedge	O
pressure	O
(	O
PWP	O
)	O
,	O
RAP	O
,	O
and	O
IPP	O
were	O
measured	O
along	O
with	O
indexes	O
of	O
systolic	O
function	O
.	O

Encompassing	O
tamponade	O
and	O
pericardiocentesis	O
data	O
,	O
left	O
ventricular	O
stroke	O
work	O
index	O
showed	O
positive	O
correlation	O
with	O
TMFP1	O
(	O
r	O
=	O
.59	O
)	O
and	O
TMFP2	O
(	O
r	O
=	O
.52	O
)	O
but	O
not	O
with	O
TMFP3	O
.	O

Similarly	O
,	O
actuarial	O
interpretations	O
for	O
the	O
second	O
protocols	O
were	O
not	O
more	O
frequently	O
selected	O
by	O
therapists	O
as	O
more	O
valid	O
,	O
regardless	O
of	O
treatment	O
condition	O
and	O
elevation	O
of	O
the	O
F	O
and	O
F	O
-	O
K	O
indices	O
on	O
the	O
first	O
MMPI	O
profile	O
.	O

The	O
study	O
disclosed	O
generalized	O
atrophy	O
and	O
diffuse	O
symmetric	O
white	O
matter	O
hypodensities	O
.	O

The	O
diagnosis	O
of	O
metachromatic	O
leukodystrophy	O
(	O
MLD	O
)	O
was	O
confirmed	O
by	O
the	O
finding	O
of	O
low	O
arylsulfatase	B
A	I
(	O
ASA	B
)	O
levels	O
in	O
cultured	O
fibroblasts	O
in	O
both	O
sisters	O
.	O

Significantly	O
lower	O
heart	O
rate	O
reactivity	O
and	O
significantly	O
less	O
pronounced	O
left	O
temporal	O
artery	O
pulse	O
amplitude	O
responses	O
were	O
found	O
in	O
non	O
-	O
medicated	O
TH	O
subjects	O
than	O
in	O
controls	O
.	O

Drugs	O
that	O
are	O
transformed	O
via	O
phase	O
II	O
reactions	O
usually	O
do	O
not	O
require	O
dosage	O
adjustment	O
.	O

Using	O
the	O
balloon	O
-	O
gas	O
procedure	O
with	O
a	O
single	O
gas	O
injection	O
,	O
a	O
bubble	O
was	O
obtained	O
that	O
was	O
large	O
enough	O
to	O
tamponade	O
a	O
giant	O
tear	O
without	O
prior	O
drainage	O
of	O
subretinal	O
fluid	O
or	O
vitrectomy	O
.	O

Heat	O
-	O
labile	O
-	O
like	O
enterotoxin	O
(	O
LT	B
)	O
was	O
produced	O
by	O
26	O
of	O
42	O
stool	O
isolates	O
(	O
62	O
%	O
)	O
,	O
while	O
only	O
1	O
of	O
the	O
42	O
isolates	O
(	O
2	O
%	O
)	O
produced	O
enterotoxinlike	O
activity	O
in	O
suckling	O
mice	O
;	O
65	O
%	O
of	O
the	O
cytotoxin	O
-	O
producing	O
strains	O
also	O
produced	O
an	O
LT	B
-	I
like	I
material	O
.	O

Persistent	O
acantholytic	O
dermatosis	O
with	O
increased	O
light	O
sensitivity	O

Thus	O
,	O
a	O
negative	O
test	O
is	O
compatible	O
with	O
low	O
disease	O
activity	O
and/or	O
efficacy	O
of	O
calcium	O
antagonist	O
treatment	O
.	O

Thus	O
,	O
a	O
negative	O
test	O
is	O
compatible	O
with	O
low	O
disease	O
activity	O
and/or	O
efficacy	O
of	O
calcium	O
antagonist	O
treatment	O
.	O

In	O
subjects	O
(	O
n	O
=	O
5	O
)	O
with	O
quadriplegia	O
and	O
reduced	O
sympathetic	O
tone	O
secondary	O
to	O
cervical	O
cord	O
trauma	O
,	O
TcpO2	O
at	O
42	O
degrees	O
C	O
and	O
vasodilation	O
index	O
were	O
increased	O
(	O
45.0	O
mmHg	O
and	O
0.61	O
)	O
;	O
TcpO2	O
at	O
45	O
degrees	O
C	O
did	O
not	O
change	O
.	O

The	O
other	O
model	O
was	O
a	O
continuous	O
exponential	O
plus	O
constant	O
of	O
the	O
form	O
La-	O
=	O
a	O
+	O
b	O
[	O
exp	O
(	O
cVO2	O
)	O
]	O
.	O

Cell	O
.	O

Timing	O
of	O
symptoms	O
and	O
oocyst	O
excretion	O
in	O
human	O
cryptosporidiosis	O
.	O

After	O
dopamine	O
infusion	O
in	O
women	O
with	O
polycystic	O
ovary	O
syndrome	O
and	O
in	O
matched	O
controls	O
,	O
steady	O
state	O
levels	O
of	O
plasma	O
dopamine	O
,	O
norepinephrine	O
,	O
and	O
the	O
ratio	O
of	O
dopamine	O
/	O
norepinephrine	O
were	O
similar	O
in	O
the	O
two	O
groups	O
.	O

In	O
the	O
normal	O
,	O
basal	O
(	O
unstimulated	O
)	O
condition	O
there	O
were	O
no	O
significant	O
correlations	O
(	O
p	O
greater	O
than	O
0.05	O
)	O
between	O
the	O
systolic	O
blood	O
pressure	O
and	O
dopamine	O
(	O
r	O
=	O
0.09	O
)	O
,	O
norepinephrine	O
(	O
r	O
=	O
0.26	O
)	O
,	O
or	O
epinephrine	O
(	O
r	O
=	O
0.27	O
)	O
,	O
nor	O
were	O
there	O
significant	O
correlations	O
between	O
melatonin	O
and	O
dopamine	O
(	O
r	O
=	O
-0.01	O
)	O
,	O
norepinephrine	O
(	O
r	O
=	O
-0.26	O
)	O
,	O
or	O
growth	B
hormone	I
(	O
r	O
=	O
0.17	O
)	O
.	O

The	O
4	O
patients	O
with	O
carboxyhemoglobin	B
levels	O
in	O
excess	O
of	O
10	O
%	O
may	O
represent	O
occult	O
carbon	O
monoxide	O
poisoning	O
in	O
this	O
population	O
.	O

Hypoglycemic	O
action	O
of	O
""""	O
he	O
xiang	O
zhuang	O
qi	O
gong	O
""""	O
and	O
its	O
mechanism	O
on	O
diabetes	O
mellitus	O

This	O
region	O
of	O
60	O
amino	O
acids	O
may	O
be	O
involved	O
in	O
coiled	O
-	O
coil	O
interactions	O
similar	O
to	O
those	O
that	O
facilitate	O
the	O
filament	O
formation	O
in	O
the	O
rod	O
region	O
.	O

It	O
is	O
largely	O
predicted	O
by	O
lupus	O
anticoagulant	O
(	O
estimated	O
by	O
activated	O
partial	O
thromboplastin	B
time	O
)	O
and/or	O
antibody	O
to	O
cardiolipin	O
.	O

The	O
effects	O
of	O
several	O
opioid	O
agonists	O
and	O
the	O
opioid	O
antagonist	O
naloxone	O
were	O
examined	O
in	O
rats	O
responding	O
under	O
a	O
fixed	O
-	O
consecutive	O
-	O
number	O
(	O
FCN	O
)	O
schedule	O
.	O

The	O
rate	O
-	O
decreasing	O
effects	O
of	O
morphine	O
and	O
U50488	O
were	O
reversed	O
completely	O
by	O
a	O
0.01	O
and	O
1.0	O
mg	O
/	O
kg	O
dose	O
of	O
naloxone	O
,	O
respectively	O
.	O

Convulsive	O
status	O
epilepticus	O
after	O
infusion	O
of	O
cisplatin	O

The	O
following	O
markers	O
were	O
looked	O
for	O
in	O
the	O
serum	O
,	O
skin	O
and	O
liver	O
of	O
all	O
patients	O
with	O
chronic	O
hepatitis	O
:	O
HBV	O
(	O
HBs	B
Ag	I
and	O
HBe	B
Ag	I
,	O
anti	B
-	I
HBs	I
,	O
anti	B
-	I
HBe	I
and	O
anti	B
-	I
HBc	I
in	O
the	O
serum	O
,	O
HBs	B
and	I
HBc	I
Ag	I
in	O
the	O
liver	O
)	O
;	O
non	B
-	I
A	I
non	I
-	I
B	I
(	O
non	B
-	I
A	I
,	I
non	I
-	I
B	I
Ag	I
and	I
antibody	I
,	O
anti	B
non	I
-	I
A	I
non	I
-	I
Bc	I
in	O
the	O
serum	O
,	O
non	B
-	I
A	I
,	I
non	I
-	I
Bc	I
Ag	I
in	O
the	O
liver	O
)	O
.	O

Groups	O
of	O
male	O
and	O
female	O
Fischer	O
344	O
rats	O
,	O
B6C3F1	O
mice	O
,	O
and	O
Hartley	O
guinea	O
pigs	O
were	O
exposed	O
once	O
for	O
6	O
hr	O
to	O
mean	O
concentrations	O
of	O
10.5	O
,	O
5.4	O
,	O
2.4	O
,	O
1.0	O
,	O
or	O
0	O
(	O
control	O
)	O
ppm	O
of	O
methyl	O
isocyanate	O
(	O
MIC	O
)	O
vapor	O
.	O

Radionuclide	O
study	O
and	O
endomyocardial	O
biopsy	O
revealed	O
remarkable	O
degeneration	O
of	O
myocardium	O
.	O

Typical	O
and	O
atypical	O
clinical	O
features	O
of	O
this	O
lacrimal	O
sac	O
cyst	O
are	O
emphasized	O
.	O

Samples	O
from	O
1415	O
neurological	O
patients	O
were	O
used	O
to	O
study	O
the	O
diagnostic	O
value	O
of	O
acid	B
alpha	I
1-glycoprotein	I
in	O
the	O
lumbar	O
cerebrospinal	O
fluid	O
.	O

For	O
patients	O
with	O
recurrent	O
or	O
metastatic	O
disease	O
,	O
the	O
data	O
suggest	O
that	O
I-131	O
MIBG	O
scintigraphy	O
is	O
the	O
examination	O
of	O
choice	O
.	O

In	O
addition	O
,	O
on	O
the	O
Cohler	O
's	O
maternal	O
scale	O
,	O
Korean	O
mothers	O
were	O
found	O
to	O
view	O
their	O
infants	O
as	O
more	O
passive	O
and	O
dependent	O
than	O
American	O
mothers	O
did	O
(	O
P	O
less	O
than	O
0.00	O
)	O
.	O

A	O
preoperative	O
teaching	O
booklet	O
for	O
pediatric	O
patients	O
.	O

We	O
conclude	O
that	O
for	O
mono	O
-	O
intronic	O
precursors	O
in	O
which	O
there	O
is	O
only	O
one	O
choice	O
of	O
splice	O
sites	O
,	O
most	O
of	O
the	O
exon	O
sequences	O
are	O
not	O
mechanistically	O
involved	O
in	O
the	O
splicing	O
process	O
.	O

A	O
careful	O
,	O
radiolabelled	O
tissue	O
-	O
distribution	O
study	O
is	O
warranted	O
to	O
elucidate	O
the	O
complicated	O
metabolic	O
fate	O
of	O
perhexiline	O
.	O

Systemic	O
lupus	O
erythematosus	O
was	O
diagnosed	O
.	O

In	O
the	O
evening	O
,	O
the	O
amplitude	O
of	O
the	O
responses	O
to	O
both	O
O2	O
and	O
CO2	O
increased	O
but	O
the	O
increase	O
in	O
CO2	O
sensitivity	O
was	O
proportionally	O
more	O
important	O
.	O

The	O
statistical	O
significance	O
of	O
the	O
prognosis	O
factors	O
was	O
studied	O
by	O
uni-	O
and	O
multivariative	O
methods	O
,	O
according	O
to	O
the	O
model	O
of	O
Cox	O
,	O
with	O
the	O
help	O
of	O
an	O
IMB	O
computer	O
.	O

These	O
results	O
suggest	O
that	O
less	O
antidopaminergic	O
activity	O
of	O
RHAL	O
in	O
this	O
neuroleptic	O
test	O
might	O
be	O
explained	O
by	O
the	O
lesser	O
conversion	O
of	O
RHAL	O
to	O
HAL	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
twofold	O
:	O
(	O
1	O
)	O
to	O
present	O
a	O
parallel	O
form	O
of	O
the	O
Gudjonsson	O
Suggestibility	O
Scale	O
(	O
GSS	O
,	O
Form	O
1	O
)	O
;	O
(	O
2	O
)	O
to	O
study	O
test	O
-	O
retest	O
reliabilities	O
of	O
interrogative	O
suggestibility	O
.	O

In	O
vivo	O
epiluminescence	O
microscopy	O
of	O
pigmented	O
skin	O
lesions	O
.	O

Statistically	O
significant	O
effects	O
were	O
noted	O
at	O
doses	O
which	O
did	O
not	O
appear	O
to	O
be	O
maternally	O
toxic	O
.	O

Low	O
MAO	B
subjects	O
showed	O
a	O
pattern	O
of	O
higher	O
scores	O
in	O
KSP	O
Impulsiveness	O
,	O
EPQ	O
Neuroticism	O
,	O
and	O
KSP	O
Somatic	O
Anxiety	O
and	O
Irritability	O
and	O
lower	O
scores	O
in	O
KSP	O
Socialization	O
,	O
in	O
line	O
with	O
personality	O
profiles	O
found	O
in	O
alcoholics	O
,	O
psychopaths	O
,	O
and	O
suicide	O
attempters	O
who	O
also	O
tend	O
to	O
have	O
low	O
platelet	O
MAO	B
activity	O
.	O

In	O
group	O
I	O
,	O
Paw	O
,	O
delta	O
V	O
,	O
PaO2	O
,	O
Vinj	O
and	O
VT	O
significantly	O
decreased	O
whereas	O
operating	O
pressure	O
and	O
E	O
significantly	O
increased	O
when	O
the	O
internal	O
diameter	O
of	O
the	O
injector	O
cannula	O
was	O
reduced	O
.	O

The	O
number	O
of	O
fecal	O
pellets	O
ingested	O
peaked	O
at	O
5	O
to	O
6	O
weeks	O
old	O
(	O
13	O
pellets	O
/	O
day	O
)	O
and	O
gradually	O
decreased	O
,	O
thereafter	O
(	O
2.1	O
pellets	O
at	O
78	O
weeks	O
old	O
,	O
1.5	O
pellets	O
at	O
104	O
weeks	O
old	O
)	O
.	O

For	O
colostral	O
milk	O
there	O
was	O
a	O
significant	O
correlation	O
of	O
vitamin	O
K1	O
to	O
cholesterol	O
(	O
r	O
=	O
0.62	O
)	O
but	O
not	O
to	O
total	O
lipid	O
or	O
phospholipid	O
suggesting	O
a	O
role	O
for	O
cholesterol	O
in	O
the	O
secretion	O
of	O
vitamin	O
K1	O
into	O
colostral	O
milk	O
.	O

A	O
rate	O
-	O
decreasing	O
dose	O
of	O
physostigmine	O
,	O
an	O
acetylcholinesterase	B
inhibitor	O
,	O
was	O
studied	O
in	O
combination	O
with	O
the	O
range	O
of	O
atropine	O
doses	O
.	O

Two	O
new	O
glucosidase	B
inhibitors	O
(	O
BAY	O
m	O
1099	O
and	O
BAY	O
o	O
1248	O
)	O
were	O
studied	O
in	O
volunteers	O
and	O
type	O
II	O
diabetics	O
under	O
various	O
conditions	O
.	O

The	O
models	O
accurately	O
localized	O
the	O
common	O
boundaries	O
between	O
the	O
PBB	O
and	O
CN	O
.	O

However	O
,	O
conversions	O
of	O
12	O
mm	O
or	O
more	O
from	O
a	O
documented	O
negative	O
result	O
indicated	O
spread	O
of	O
infection	O
.	O

The	O
maximum	O
amplitude	O
of	O
evoked	O
responses	O
in	O
the	O
cervical	O
sympathetic	O
trunk	O
was	O
obtained	O
when	O
the	O
T2	O
white	O
ramus	O
was	O
stimulated	O
and	O
decreased	O
gradually	O
when	O
followed	O
by	O
the	O
stimulation	O
of	O
T1	O
,	O
T3	O
,	O
T4	O
and	O
T5	O
white	O
rami	O
.	O

It	O
is	O
concluded	O
that	O
contact	O
allergy	O
to	O
K	O
-	O
CG	O
is	O
common	O
.	O

The	O
less	O
-	O
polar	O
mycolic	O
acid	O
-	O
containing	O
Rhodococcus	O
species	O
showed	O
chromatographic	O
patterns	O
that	O
partially	O
overlapped	O
(	O
in	O
elution	O
times	O
)	O
the	O
patterns	O
of	O
Nocardia	O
asteroides	O
,	O
N.	O
otitidiscaviarum	O
,	O
and	O
N.	O
brasiliensis	O
,	O
but	O
the	O
larger	O
number	O
of	O
peaks	O
in	O
the	O
last	O
species	O
made	O
separation	O
between	O
the	O
genera	O
possible	O
.	O

The	O
development	O
of	O
a	O
data	O
base	O
is	O
described	O
which	O
can	O
be	O
used	O
as	O
common	O
reference	O
for	O
ECG	O
computer	O
programs	O
analyzing	O
12	O
or	O
15	O
simultaneously	O
recorded	O
leads	O
.	O

Blood	B
serum	I
erythropoietin	I
level	O
and	O
basic	O
hematological	O
indices	O
during	O
the	O
adaptation	O
of	O
healthy	O
newborn	O
infants	O

49	O
,	O
XXXXY	O
chromosome	O
anomaly	O
:	O
an	O
unusual	O
variant	O
of	O
Klinefelter	O
's	O
syndrome	O
.	O

Contraction	O
of	O
the	O
tracheal	O
muscle	O
and	O
the	O
activity	O
of	O
stretch	O
receptors	O
in	O
the	O
trachea	O

Infants	O
of	O
this	O
sample	O
had	O
monocular	O
PL	O
visual	O
acuities	O
similar	O
to	O
those	O
established	O
by	O
McDonald	O
et	O
al.	O
in	O
a	O
laboratory	O
setting	O
.	O

The	O
number	O
of	O
crystalline	O
deposits	O
is	O
less	O
in	O
the	O
advanced	O
atrophic	O
areas	O
of	O
the	O
RPE	O
-	O
choriocapillaris	O
complex	O
.	O

The	O
subjects	O
received	O
a	O
single	O
500	O
mg	O
dose	O
of	O
acetaminophen	O
i.v	O
.	O
and	O
concentrations	O
in	O
plasma	O
were	O
measured	O
for	O
360	O
minutes	O
and	O
in	O
urine	O
for	O
24	O
h	O
in	O
order	O
to	O
estimate	O
the	O
production	O
of	O
metabolites	O
.	O

Mean	O
weighted	O
skin	O
temperature	O
(	O
Tsk	O
)	O
was	O
lower	O
(	O
P	O
less	O
than	O
0.01	O
)	O
following	O
acclimation	O
than	O
before	O
,	O
and	O
acclimation	O
resulted	O
in	O
a	O
larger	O
(	O
P	O
less	O
than	O
0.02	O
)	O
Tre	O
-	O
to	O
-	O
Tsk	O
gradient	O
.	O

The	O
effect	O
of	O
L	O
-	O
methionine	O
supplementation	O
on	O
the	O
utilization	O
of	O
a	O
soy	O
protein	O
isolate	O
(	O
SPI	O
)	O
was	O
evaluated	O
by	O
short	O
-	O
term	O
nitrogen	O
balance	O
studies	O
in	O
young	O
women	O
.	O

Primary	O
invasive	O
Haemophilus	O
influenzae	O
type	O
b	O
disease	O
:	O
a	O
population	O
-	O
based	O
assessment	O
of	O
risk	O
factors	O
.	O

Factors	O
that	O
showed	O
significant	O
correlation	O
to	O
elevated	O
CIC	O
's	O
in	O
the	O
highly	O
elevated	O
portion	O
of	O
our	O
CIC	O
population	O
were	O
poor	O
NIH	O
score	O
,	O
increased	O
patient	O
age	O
,	O
low	O
peak	O
expiratory	O
flow	O
rate	O
,	O
and	O
elevated	O
total	O
serum	B
IgG.	I

New	O
and	O
successful	O
steps	O
have	O
been	O
made	O
in	O
immunodiagnostics	O
,	O
immunotherapy	O
,	O
and	O
immunoprophylaxis	O
of	O
immunologically	O
conditioned	O
infertility	O
.	O

Amikacin	O
was	O
the	O
most	O
stable	O
and	O
tobramycin	O
was	O
the	O
least	O
stable	O
aminoglycoside	O
under	O
the	O
conditions	O
tested	O
.	O

This	O
may	O
explain	O
in	O
part	O
a	O
secular	O
trend	O
towards	O
reduced	O
birthweight	O
for	O
gestation	O
in	O
preterm	O
infants	O
.	O

Adhesion	O
,	O
phagocytosis	O
,	O
chemotactic	O
and	O
random	O
migration	O
,	O
nitroblue	O
tetrazolium	O
dye	O
reduction	O
of	O
peritoneal	O
exudate	O
neutrophils	O
and	O
macrophages	O
,	O
fibrinogen	B
level	O
,	O
gelation	O
of	O
soluble	O
fibrin	B
and	O
serial	O
dilution	O
protamine	O
sulfate	O
test	O
were	O
investigated	O
in	O
115	O
New	O
Zealand	O
white	O
rabbits	O
with	O
experimentally	O
induced	O
Shwartzman	O
phenomenon	O
in	O
the	O
colon	O
,	O
and	O
in	O
control	O
animals	O
.	O

He	O
visited	O
our	O
hospital	O
and	O
left	O
solitary	O
renal	O
cyst	O
was	O
suspected	O
.	O

A	O
significant	O
herd	O
X	O
period	O
interaction	O
existed	O
for	O
liver	O
TG	O
and	O
serum	O
dextran	O
precipitable	O
cholesterol	O
concentrations	O
.	O

The	O
results	O
show	O
that	O
nerve	O
and	O
roots	O
differ	O
considerably	O
both	O
in	O
the	O
force	O
they	O
sustain	O
before	O
failure	O
and	O
in	O
the	O
other	O
biomechanics	O
they	O
exhibit	O
.	O

When	O
the	O
coronary	O
sinus	O
pressure	O
reached	O
15	O
torr	O
,	O
there	O
was	O
a	O
significant	O
decrease	O
in	O
cardiac	O
index	O
(	O
3.60	O
+	O
/-	O

0.5	O
to	O
2.70	O
+	O
/-	O

0.6	O
L	O
/	O
min	O
/	O
m2	O
,	O
p	O
less	O
than	O
0.001	O
)	O
,	O
coronary	O
blood	O
flow	O
(	O
13.7	O
+	O
/-	O

3.1	O
to	O
7.0	O
+	O
/-	O

2.1	O
ml	O
/	O
min	O
,	O
p	O
less	O
than	O
0.001	O
)	O
,	O
rate	O
of	O
rise	O
of	O
left	O
ventricular	O
pressure	O
(	O
1,567	O
+	O
/-	O

275	O
to	O
1,331	O
+	O
/-	O

314	O
,	O
p	O
less	O
than	O
0.05	O
)	O
,	O
and	O
an	O
increase	O
in	O
coronary	O
arteriovenous	O
difference	O
(	O
62.8	O
%	O
+	O
/-	O

9.3	O
%	O
to	O
70.5	O
%	O
+	O
/-	O

5.4	O
%	O
saturation	O
,	O
p	O
less	O
than	O
0.03	O
)	O
.	O

In	O
a	O
series	O
of	O
402	O
consecutive	O
autopsies	O
,	O
parietal	O
pleural	O
plaques	O
(	O
PP	O
)	O
were	O
found	O
in	O
68	O
individuals	O
above	O
40	O
years	O
of	O
age	O
.	O

On	O
transition	O
from	O
high	O
to	O
low	O
voltage	O
there	O
was	O
a	O
significant	O
fall	O
in	O
arterial	O
pressure	O
(	O
7	O
%	O
)	O
and	O
an	O
increase	O
in	O
flow	O
(	O
19	O
-	O
38	O
%	O
)	O
to	O
areas	O
of	O
the	O
brain	O
corresponding	O
to	O
the	O
arborization	O
of	O
the	O
reticular	O
formation	O
,	O
i.e.	O
excluding	O
the	O
cerebrum	O
and	O
cerebellum	O
.	O

Findings	O
of	O
positive	O
potentials	O
showed	O
that	O
N1	O
originated	O
in	O
the	O
area	O
of	O
ventral	O
gray	O
matter	O
through	O
the	O
ventro	O
-	O
lateral	O
column	O
and	O
N2	O
through	O
the	O
dorsal	O
column	O
.	O

There	O
have	O
been	O
five	O
problems	O
(	O
extravasation	O
2	O
,	O
suspected	O
sepsis	O
1	O
,	O
and	O
hematoma	O
2	O
)	O
during	O
a	O
total	O
of	O
2,927	O
days	O
of	O
exposure	O
.	O

Two	O
studies	O
assessed	O
two	O
types	O
of	O
reliability	O
of	O
the	O
student	O
Jenkins	O
Activity	O
Survey	O
(	O
JAS	O
;	O
a	O
questionnaire	O
measure	O
of	O
Type	O
A	O
behavior	O
)	O
.	O

Splenectomized	O
patients	O
are	O
predisposed	O
toward	O
developing	O
overwhelming	O
bacterial	O
infections	O
.	O

Possibilities	O
and	O
outlook	O
for	O
wrist	O
joint	O
endoprosthesis	O

Study	O
of	O
the	O
energy	O
metabolism	O
of	O
the	O
sensomotor	O
cortex	O
and	O
hippocampus	O
by	O
the	O
(	O
14C	O
)	O
2-deoxyglucose	O
method	O
during	O
the	O
development	O
of	O
dissociated	O
states	O

Among	O
them	O
,	O
26	O
cases	O
were	O
benign	O
and	O
34	O
malignant	O
.	O

Fast	O
goal	O
-	O
directed	O
voluntary	O
movements	O
of	O
the	O
human	O
upper	O
extremity	O
are	O
known	O
to	O
be	O
associated	O
with	O
three	O
distinct	O
bursts	O
of	O
EMG	O
activity	O
in	O
antagonistic	O
muscles	O
.	O

The	O
combination	O
of	O
F1	O
and	O
F2	O
which	O
was	O
the	O
best	O
predictor	O
of	O
CHD	O
in	O
this	O
population	O
(	O
G1	O
)	O
might	O
be	O
interpreted	O
as	O
reflecting	O
trunk	O
adiposity	O
mainly	O
abdominal	O
.	O

The	O
relations	O
between	O
type	O
A	O
behavior	O
,	O
clinically	O
relevant	O
behavior	O
,	O
academic	O
achievement	O
,	O
and	O
IQ	O
in	O
children	O
.	O

The	O
rats	O
were	O
used	O
for	O
the	O
study	O
of	O
the	O
effects	O
of	O
sepsis	O
on	O
the	O
utilization	O
of	O
exogenous	O
fat	O
emulsion	O
.	O

Results	O
of	O
electron	O
therapy	O
of	O
tumors	O
in	O
different	O
sites	O

Incidences	O
of	O
nonfatal	O
stroke	O
,	O
myocardial	O
infarction	O
,	O
angina	O
pectoris	O
und	O
left	O
ventricular	O
hypertrophy	O
could	O
also	O
be	O
lowered	O
.	O

High	O
radial	O
r	O
values	O
with	O
small	O
standard	O
deviations	O
were	O
observed	O
in	O
normal	O
LV	O
(	O
0.972	O
+	O
/-	O

0.016	O
)	O
and	O
in	O
non	O
-	O
MI	O
regions	O
(	O
0.964	O
+	O
/-	O
0.018	O
)	O
,	O
indicating	O
temporally	O
homogeneous	O
radial	O
shortening	O
.	O

These	O
results	O
indicate	O
that	O
during	O
pregnancy	O
there	O
are	O
increases	O
in	O
bone	O
formation	O
rates	O
contributing	O
to	O
the	O
increases	O
in	O
skeletal	O
mass	O
.	O

Prevention	O
by	O
a	O
heparin	O
-	O
antithrombin	B
III	I
combination	O

N	O
-	O
Substituted	O
trimethylsilylcarbamates	O
were	O
tested	O
as	O
derivatizing	O
reagents	O
for	O
gas	O
chromatographic	O
analysis	O
.	O

MICs	O
of	O
four	O
antifungal	O
agents	O
(	O
5-fluorocytosine	O
,	O
miconazole	O
,	O
ketoconazole	O
,	O
and	O
amphotericin	O
B	O
)	O
for	O
84	O
clinical	O
isolates	O
of	O
various	O
Candida	O
species	O
were	O
then	O
determined	O
with	O
both	O
media	O
in	O
agar	O
dilution	O
and	O
microtiter	O
broth	O
dilution	O
systems	O
.	O

Evidence	O
that	O
opiate	O
addiction	O
is	O
in	O
part	O
an	O
immune	O
response	O
.	O

Parasitological	O
post	O
-	O
mortem	O
examination	O
of	O
all	O
seropositive	O
animals	O
showed	O
five	O
and	O
seven	O
false	O
-	O
positive	O
animals	O
when	O
E	B
/	I
S	I
and	I
CWE	I
antigens	I
were	O
used	O
,	O
respectively	O
.	O

Examples	O
of	O
its	O
use	O
in	O
the	O
intensive	O
therapy	O
unit	O
are	O
described	O
.	O

The	O
growing	O
drug	O
problem	O
is	O
also	O
reflected	O
in	O
the	O
increasing	O
number	O
of	O
cases	O
of	O
hepatitis	O
B	O
and	O
of	O
drug	O
-	O
related	O
deaths	O
.	O

A	O
large	O
increase	O
of	O
serum	O
ketones	O
occurred	O
under	O
all	O
conditions	O
,	O
and	O
the	O
exercise	O
respiratory	O
quotient	O
suggested	O
some	O
increase	O
of	O
fat	O
utilization	O
,	O
WW	O
(	O
0.85	O
)	O
through	O
CW	O
(	O
0.84	O
)	O
to	O
CC	O
(	O
0.83	O
)	O
.	O

Respiratory	O
adaptation	O
to	O
chronic	O
hypoxia	O
in	O
newborn	O
rats	O
.	O

RPS14	B
introns	O
3	O
and	O
4	O
both	O
contain	O
Alu	B
sequences	O
.	O

These	O
findings	O
suggest	O
that	O
there	O
may	O
be	O
a	O
relationship	O
between	O
the	O
pathogenesis	O
of	O
MAL	O
,	O
narcolepsy	O
,	O
and	O
OSA	O
.	O

While	O
the	O
examiner	O
observed	O
the	O
interior	O
of	O
the	O
eye	O
with	O
indirect	O
ophthalmoscopy	O
,	O
the	O
point	O
source	O
of	O
light	O
from	O
the	O
fiberoptic	O
light	O
pipe	O
was	O
moved	O
along	O
the	O
margins	O
of	O
the	O
episcleral	O
plaque	O
.	O

From	O
life	O
-	O
table	O
analyses	O
of	O
these	O
patients	O
,	O
we	O
estimated	O
that	O
the	O
incidence	O
of	O
secondary	O
chondrosarcoma	O
in	O
patients	O
who	O
have	O
Ollier	O
disease	O
is	O
about	O
25	O
per	O
cent	O
at	O
the	O
age	O
of	O
forty	O
years	O
,	O
and	O
that	O
malignant	O
degeneration	O
is	O
almost	O
a	O
certainty	O
in	O
patients	O
who	O
have	O
Maffucci	O
syndrome	O
.	O

The	O
lethal	O
toxicity	O
of	O
inorganic	O
(	O
HgCl2	O
)	O
and	O
organic	O
(	O
CH3HgCl	O
)	O
mercury	O
chloride	O
was	O
compared	O
for	O
Coturnix	O
(	O
Japanese	O
quail	O
,	O
Coturnix	O
japonica	O
)	O
of	O
different	O
ages	O
from	O
hatch	O
through	O
adulthood	O
by	O
single	O
-	O
dose	O
acute	O
oral	O
and	O
intramuscular	O
injections	O
and	O
by	O
a	O
5-d	O
dietary	O
trial	O
.	O

Since	O
the	O
integrated	O
13h00	O
-	O
16h00	O
plasma	O
cortisol	O
estimation	O
is	O
cheaper	O
and	O
simpler	O
than	O
the	O
mean	O
13h00	O
-	O
16h00	O
plasma	O
cortisol	O
estimation	O
,	O
we	O
recommend	O
it	O
as	O
an	O
adjunct	O
in	O
the	O
diagnosis	O
of	O
Cushing	O
's	O
syndrome	O
.	O

Most	O
of	O
the	O
patients	O
had	O
locally	O
advanced	O
lesions	O
(	O
63	O
T3	O
-	O
4	O
:	O
91.5	O
%	O
)	O
according	O
to	O
the	O
adopted	O
TNM	O
system	O
(	O
Lederman	O
-	O
Gadeberg	O
,	O
Sisson	O
-	O
Jesse	O
)	O
.	O

Selenium	O
(	O
.1	O
ppm	O
)	O
and	O
E	O
(	O
50	O
IU	O
/	O
kg	O
)	O
supplementation	O
of	O
the	O
diet	O
of	O
the	O
sow	O
increased	O
plasma	O
tocopherol	O
and	O
Se	O
concentrations	O
,	O
but	O
did	O
not	O
increase	O
plasma	B
glutathione	I
peroxidase	I
(	O
GSH	B
-	I
Px	I
)	O
activity	O
.	O

The	O
in	O
vitro	O
antibacterial	O
potency	O
is	O
greatest	O
when	O
the	O
1-substituent	O
is	O
2,4-difluorophenyl	O
and	O
the	O
7-substituent	O
is	O
a	O
3-amino-1-pyrrolidinyl	O
group	O
.	O

The	O
M	B
reading	I
frame	I
differed	O
from	O
the	O
reported	O
sequence	O
by	O
a	O
single	O
nucleotide	O
corresponding	O
to	O
a	O
conservative	O
lysine	O
to	O
arginine	O
amino	O
acid	O
substitution	O
near	O
the	O
carboxy	O
-	O
terminus	O
conserved	O
among	O
the	O
M	B
proteins	I
of	O
paramyxoviruses	O
.	O

Laryngographic	O
changes	O
following	O
endotracheal	O
intubation	O
in	O
adults	O
.	O

Intensification	O
of	O
human	O
myocardial	O
contractile	O
activity	O
as	O
affected	O
by	O
blood	O
serum	O

Autotransplantation	O
of	O
a	O
vein	O
segment	O
with	O
valve	O
in	O
the	O
treatment	O
of	O
deep	O
vein	O
valvular	O
insufficiency	O
of	O
the	O
lower	O
extremity	O

The	O
observation	O
of	O
late	O
effects	O
after	O
irradiations	O
or	O
after	O
space	O
flights	O
show	O
the	O
difficulties	O
encountered	O
in	O
assessing	O
radiative	O
risks	O
during	O
long	O
duration	O
space	O
flights	O
.	O

Practical	O
use	O
and	O
interpretation	O
of	O
viral	O
hepatitis	O
B	O
markers	O
and	O
hepatic	O
biopsy	O
in	O
HBs	B
Ag	I
carriers	O
and	O
at	O
the	O
chronic	O
hepatitis	O
stage	O

The	O
1	O
,	O
2	O
,	O
3	O
and	O
4	O
year	O
survival	O
rates	O
were	O
94	O
%	O
,	O
84	O
%	O
,	O
76	O
%	O
and	O
63	O
%	O
,	O
respectively	O
.	O

Inhibition	O
of	O
histalog	O
-	O
stimulated	O
gastric	O
secretion	O
by	O
40	O
749	O
RP	O
,	O
a	O
new	O
long	O
-	O
acting	O
gastric	O
antisecretory	O
agent	O
.	O

Five	O
-	O
year	O
prospective	O
study	O
of	O
peripheral	O
white	O
blood	O
cells	O
in	O
infectious	O
mononucleosis	O
.	O

Northern	O
blotting	O
with	O
a	O
unique	O
17-mer	O
oligonucleotide	O
demonstrated	O
the	O
absence	O
of	O
the	O
mutant	O
sequence	O
in	O
the	O
mRNA	O
from	O
which	O
the	O
cDNA	O
library	O
giving	O
rise	O
to	O
the	O
mutant	O
cDNA	O
was	O
constructed	O
.	O

Chemotherapy	O
of	O
metastasizing	O
breast	O
cancer	O

In	O
recent	O
years	O
,	O
successful	O
physiological	O
models	O
have	O
been	O
developed	O
for	O
a	O
variety	O
of	O
volatile	O
and	O
nonvolatile	O
chemicals	O
,	O
and	O
their	O
ability	O
to	O
perform	O
the	O
extrapolations	O
needed	O
in	O
risk	O
assessment	O
has	O
been	O
demonstrated	O
.	O

Linear	O
extrapolation	O
is	O
used	O
below	O
the	O
experimental	O
data	O
range	O
to	O
establish	O
an	O
upper	O
bound	O
on	O
carcinogenic	O
risk	O
at	O
low	O
doses	O
.	O

Hisako	O
Minowa	O
who	O
has	O
worked	O
as	O
a	O
psychiatric	O
counsellor	O
in	O
industry	O
for	O
the	O
past	O
20	O
years	O

Deletion	O
mapping	O
studies	O
revealed	O
that	O
the	O
upstream	O
DNA	O
sequences	O
up	O
to	O
-86	O
were	O
sufficient	O
for	O
the	O
optimal	O
basal	O
level	O
transcription	O
in	O
HeLa	O
cells	O
and	O
also	O
for	O
the	O
EIA	B
-	O
induced	O
transcription	O
.	O

Incorporation	O
of	O
the	O
polyene	O
antibiotic	O
amphotericin	O
B	O
(	O
AMB	O
)	O
in	O
liposomes	O
results	O
in	O
a	O
marked	O
reduction	O
in	O
drug	O
toxicity	O
with	O
no	O
loss	O
of	O
antifungal	O
potency	O
.	O

Serum	B
IgM	I
and	O
IgE	B
concentrations	O
,	O
allergen	B
-	I
specific	I
IgE	I
scores	O
,	O
and	O
the	O
tumor	O
E2R	B
status	O
were	O
combined	O
to	O
construct	O
a	O
three	O
-	O
level	O
risk	O
classification	O
that	O
was	O
more	O
prognostic	O
than	O
any	O
of	O
the	O
individual	O
components	O
.	O

These	O
results	O
indicate	O
that	O
T.C.	O
,	O
LDL	B
-	I
C.	I
,	O
HDL	B
-	I
C.	I
,	O
HDL2-C.	B
,	O
apo	B
B	I
,	O
apo	B
A	I
-	I
I	I
/	I
B	I
ratio	O
and	O
apo	B
A	I
-	I
II	I
/	I
B	I
ratio	O
are	O
predictive	O
risk	O
factors	O
of	O
the	O
coronary	O
heart	O
disease	O
.	O

It	O
is	O
concluded	O
that	O
the	O
unique	O
suppository	O
formulation	O
of	O
CZX	O
-	O
S	O
is	O
useful	O
in	O
the	O
treatment	O
of	O
infections	O
in	O
children	O
with	O
heavy	O
psychophysiologic	O
disorders	O
and	O
in	O
children	O
who	O
can	O
not	O
take	O
oral	O
drugs	O
because	O
of	O
severe	O
vomiting	O
.	O

In	O
addition	O
,	O
marked	O
hypertension	O
accompanied	O
this	O
disorder	O
and	O
all	O
abnormalities	O
,	O
including	O
the	O
hypertension	O
,	O
responded	O
to	O
1-desamino-8-D	B
-	I
arginine	I
vasopressin	I
therapy	O
.	O

Single	O
photon	O
emission	O
computerized	O
tomography	O
(	O
SPECT	O
)	O
,	O
by	O
providing	O
three	O
-	O
dimensional	O
representation	O
of	O
myocardial	O
Tl-201	O
,	O
offers	O
promise	O
for	O
improved	O
localization	O
of	O
CAD	O
.	O

The	O
results	O
obtained	O
are	O
similar	O
to	O
those	O
described	O
with	O
the	O
previous	O
Cremophor	O
formulation	O
although	O
greater	O
variability	O
in	O
induction	O
and	O
recovery	O
times	O
was	O
noted	O
with	O
the	O
emulsion	O
formulation	O
.	O

Diagnosis	O
of	O
unilateral	O
renal	O
artery	O
lesions	O
after	O
captopril	O
administration	O
.	O

A	O
yeast	O
DNA	O
fragment	O
carrying	O
the	O
gene	B
CP	I
A1	I
encoding	O
the	O
small	O
subunit	O
of	O
the	O
arginine	O
pathway	O
carbamoyl	B
-	I
phosphate	I
synthetase	I
has	O
been	O
sequenced	O
.	O

The	O
H2	B
receptor	I
antagonists	O
and	O
sucralfate	O
cost	O
about	O
the	O
same	O
and	O
have	O
few	O
side	O
effects	O
.	O

These	O
results	O
suggest	O
that	O
indoramin	O
may	O
have	O
Class	O
III	O
antiarrhythmic	O
activity	O
.	O

A	O
high	O
efficacy	O
of	O
the	O
combined	O
use	O
of	O
nontoxic	O
doses	O
of	O
two	O
pharmaceuticals	O
:	O
cystamine	O
(	O
50	O
mg	O
/	O
kg	O
)	O
and	O
mexamine	O
(	O
25	O
mg	O
/	O
kg	O
)	O
under	O
the	O
conditions	O
of	O
short	O
-	O
term	O
exogenous	O
hypoxia	O
(	O
7.5	O
%	O
O2	O
)	O
was	O
found	O
in	O
(	O
CBA	O
X	O
C57Bl	O
)	O
F1	O
mice	O
.	O

The	O
Mean	O
was	O
74,3	O
+	O
/-	O

53,6	O
micrograms	O
J	O
/	O
g	O
Cr	O
,	O
the	O
Median	O
61	O
micrograms	O
J	O
/	O
g	O
Cr	O
.	O

In	O
the	O
region	O
Walgau	O
with	O
mixed	O
industrial	O
-	O
rural	O
population	O
an	O
iodine	O
deficiency	O
I	O
was	O
found	O
in	O
81	O
%	O
and	O
an	O
iodine	O
deficiency	O
II	O
in	O
45	O
%	O
.	O

The	O
structural	O
gene	O
for	O
hydrogenase	B
encodes	O
a	O
protein	O
product	O
of	O
molecular	O
mass	O
45820	O
Da	O
.	O

Pancreaticoduodenal	O
lymph	O
node	O
enlargement	O
,	O
regardless	O
of	O
cause	O
,	O
has	O
been	O
a	O
source	O
of	O
imaging	O
confusion	O
because	O
of	O
its	O
propensity	O
to	O
mimic	O
pancreatic	O
malignancy	O
yet	O
not	O
cause	O
biliary	O
obstruction	O
.	O

Interference	O
with	O
rheumatoid	B
factor	I
was	O
only	O
observed	O
in	O
the	O
ELISA	O
enzygnost	O
if	O
sera	O
were	O
not	O
pretreated	O
with	O
latex	O
adsorbents	O
.	O

Such	O
studied	O
acquired	O
with	O
low	O
energy	O
or	O
medium	O
energy	O
collimation	O
and	O
a	O
window	O
centered	O
on	O
the	O
159	O
keV	O
123I	O
photopeak	O
contain	O
appreciable	O
septal	O
breakthrough	O
signals	O
originating	O
from	O
Compton	O
scatter	O
of	O
high	O
energy	O
photons	O
primarily	O
from	O
124I	O
.	O

Nursing	O
education	O
--	O
the	O
computer	O
obligation	O
.	O

Shear	O
bond	O
strength	O
of	O
a	O
composite	O
resin	O
to	O
an	O
etched	O
glass	O
ionomer	O
.	O

An	O
additional	O
advantage	O
is	O
that	O
the	O
resin	O
can	O
be	O
removed	O
and	O
the	O
immunoperoxidase	B
technique	O
carried	O
out	O
on	O
thin	O
sections	O
.	O

Such	O
a	O
concept	O
is	O
crucial	O
to	O
our	O
understanding	O
of	O
the	O
pathology	O
of	O
ageing	O
in	O
general	O
.	O

We	O
consider	O
that	O
DIL	O
-	O
CP	O
is	O
a	O
safe	O
and	O
excellent	O
CP	O
in	O
CABG	O
surgery	O
and	O
we	O
are	O
now	O
utilizing	O
this	O
CP	O
in	O
all	O
patients	O
requiring	O
CABG	O
surgery	O
.	O

Oral	O
candidiasis	O

In	O
addition	O
,	O
the	O
gcd1	B
-	I
101	I
mutation	I
suppressed	O
the	O
low	O
translational	O
efficiency	O
of	O
GCN4-lacZ	B
mRNA	O
observed	O
in	O
gcn2-	B
and	O
gcn3-	B
cells	O
.	O

This	O
suggests	O
that	O
alaproclate	O
acutely	O
increases	O
the	O
responsiveness	O
of	O
postsynaptic	O
muscarinic	B
and	I
alpha	I
1	I
adrenoceptors	I
.	O

The	O
concentrations	O
of	O
apo	B
A	I
-	I
I	I
and	O
apo	B
A	I
-	I
II	I
of	O
abstainers	O
decreased	O
significantly	O
compared	O
with	O
the	O
corresponding	O
changes	O
in	O
controls	O
.	O

The	O
distribution	O
of	O
patients	O
was	O
as	O
follows	O
:	O
group	O
1	O
-	O
-complex	O
gamma	O
-	O
therapy	O
(	O
55	O
cases	O
)	O
,	O
group	O
2	O
-	O
-complex	O
gamma	O
-	O
therapy	O
plus	O
iliac	O
lymphadenectomy	O
(	O
50	O
cases	O
)	O
and	O
group	O
3	O
-	O
-complex	O
radiation	O
treatment	O
with	O
megavolt	O
bremsstrahlung	O
beam	O
from	O
the	O
luc	O
type	O
installation	O
and	O
iliac	O
lymphadenectomy	O
(	O
50	O
cases	O
)	O
.	O

The	O
availability	O
of	O
cryoprecipitate	O
and	O
DDAVP	O
offers	O
an	O
alternative	O
and	O
effective	O
treatment	O
for	O
the	O
temporary	O
reversal	O
of	O
uremic	O
bleeding	O
in	O
patients	O
who	O
require	O
urgent	O
invasive	O
procedures	O
.	O

Biopsies	O
of	O
the	O
jejunal	O
mucosa	O
have	O
shown	O
abnormal	O
enzyme	O
activity	O
or	O
deficiencies	O
in	O
transport	O
mechanisms	O
.	O

A	O
significant	O
degree	O
of	O
homology	O
was	O
also	O
found	O
among	O
these	O
genes	O
and	O
the	O
Mtase	B
gene	I
of	O
related	O
phage	O
SPR	O
,	O
which	O
codes	O
for	O
an	O
enzyme	O
with	O
different	O
modification	O
specificity	O
.	O

Thyrotropin	B
-	I
releasing	I
hormone	I
-	O
induced	O
contraction	O
of	O
urethral	O
and	O
vaginal	O
muscle	O
.	O

In	O
a	O
blind	O
controlled	O
trial	O
,	O
15	O
patients	O
with	O
COCM	O
(	O
NYHA	O
II	O
-	O
III	O
)	O
with	O
sinus	O
rhythm	O
and	O
a	O
left	O
ventricular	O
ejection	O
fraction	O
(	O
LV	O
-	O
EF	O
)	O
of	O
34.5	O
+	O
/-	O

2.6	O
%	O
received	O
consecutively	O
D	O
(	O
0.25	O
-	O
0.5	O
mg	O
/	O
d	O
)	O
,	O
placebo	O
(	O
PLAC	O
)	O
,	O
P	O
(	O
slow	O
releases	O
=	O
SR	O
)	O
(	O
80	O
mg	O
/	O
d	O
SR	O
)	O
and	O
both	O
drugs	O
combined	O
in	O
respective	O
doses	O
.	O

The	O
sample	O
is	O
deproteinized	O
and	O
after	O
centrifugation	O
valproic	O
acid	O
in	O
the	O
supernatant	O
is	O
measured	O
in	O
the	O
free	O
form	O
by	O
direct	O
injection	O
into	O
the	O
gas	O
chromatograph	O
.	O

Changes	O
in	O
muscarinic	B
acetylcholine	I
receptors	I
in	O
guinea	O
-	O
pig	O
lung	O
:	O
effects	O
of	O
aging	O
,	O
inhalation	O
of	O
an	O
allergen	O
,	O
administration	O
of	O
drugs	O
,	O
and	O
vagotomy	O
.	O

Greek	O
classicism	O
in	O
living	O
structure	O
?	O

Some	O
deductive	O
pathways	O
in	O
animal	O
morphology	O
.	O

Three	O
chromosomal	B
crsA	I
mutations	I
,	O
crsA1	B
,	O
crsA4	B
,	O
and	O
crsA47	B
,	O
were	O
transferred	O
by	O
the	O
""""	O
gene	O
conversion	O
""""	O
process	O
to	O
B.	O
subtilis	O
plasmid	O
pRPD11	O
,	O
which	O
consists	O
of	O
the	O
entire	O
wild	B
-	I
type	I
rpoD	I
coding	I
sequence	I
,	O
encoding	O
the	O
major	B
sigma	I
43	I
factor	I
of	I
B.	I
subtilis	I
RNA	I
polymerase	I
,	O
and	O
pUB110	O
.	O

The	O
data	O
indicate	O
that	O
the	O
five	O
different	O
(	O
and	O
partially	O
overlapping	O
)	O
sry	B
messenger	I
RNAs	I
detectable	O
in	O
early	O
embryos	O
are	O
initiated	O
at	O
three	O
separate	O
sites	O
,	O
each	O
directly	O
upstream	O
from	O
one	O
of	O
the	O
three	O
protein	O
-	O
coding	O
regions	O
,	O
designated	O
(	O
in	O
5	O
'	O
to	O
3	O
'	O
order	O
)	O
beta	O
,	O
alpha	O
and	O
delta	O
.	O

Chronic	O
thyroiditis	O
as	O
a	O
risk	O
factor	O
of	O
B	O
-	O
cell	O
lymphoma	O
in	O
the	O
thyroid	O
gland	O
.	O

Plasma	B
secretin	I
levels	O
also	O
augmented	O
after	O
the	O
administration	O
of	O
ethanol	O
solutions	O
,	O
with	O
a	O
delay	O
of	O
about	O
one	O
hour	O
after	O
the	O
onset	O
of	O
acid	O
secretion	O
.	O

Spectrophotometric	O
microanalysis	O
of	O
ethylenediaminotetracetic	O
acid	O
in	O
pharmaceutical	O
preparations	O

A	O
comparison	O
among	O
the	O
5	O
'	O
flanking	O
regions	O
encompassing	O
the	O
presumptive	O
HS	B
promoter	I
of	O
the	O
soybean	B
HS	I
-	I
protein	I
genes	I
demonstrated	O
this	O
region	O
to	O
be	O
extremely	O
homologous	O
.	O

Results	O
of	O
this	O
study	O
indicate	O
that	O
GLC	O
of	O
short	O
chain	O
fatty	O
acids	O
produced	O
on	O
agar	O
medium	O
by	O
anaerobes	O
,	O
combined	O
with	O
simple	O
tests	O
such	O
as	O
Gram	O
's	O
stain	O
and	O
colonial	O
morphology	O
,	O
may	O
allow	O
fir	O
direct	O
presumptive	O
genus	O
identification	O
from	O
an	O
initial	O
pure	O
agar	O
culture	O
.	O

Using	O
this	O
method	O
,	O
we	O
measured	O
absorption	O
of	O
low	O
doses	O
of	O
vitamin	O
A	O
,	O
which	O
may	O
provide	O
a	O
more	O
physiological	O
approach	O
to	O
assessment	O
of	O
fat	O
malabsorption	O
.	O

Tissue	O
pressure	O
,	O
rCBF	O
,	O
and	O
water	O
content	O
were	O
measured	O
from	O
gray	O
matter	O
in	O
the	O
central	O
core	O
and	O
the	O
peripheral	O
margin	O
of	O
the	O
MCA	O
territory	O
over	O
6	O
h	O
after	O
MCAO	O
.	O

During	O
this	O
time	O
,	O
the	O
patients	O
all	O
had	O
the	O
characteristic	O
plasma	O
thyroid	O
hormone	O
changes	O
associated	O
with	O
amiodarone	O
therapy	O
,	O
i.e.	O
increased	O
T4	O
,	O
free	O
T4	O
,	O
and	O
rT3	O
and	O
decreased	O
T3	O
,	O
while	O
remaining	O
clinically	O
euthyroid	O
.	O

Drug	O
and	O
nutrient	O
interactions	O
.	O

In	O
each	O
compartment	O
O2	O
is	O
removed	O
by	O
the	O
tissues	O
as	O
a	O
chemical	O
reaction	O
takes	O
place	O
between	O
O2	O
and	O
oxyhemoglobin	B
(	O
HbO2	B
)	O
.	O

Cortisol	O
excretion	O
,	O
appeared	O
to	O
be	O
markedly	O
affected	O
by	O
the	O
season	O
although	O
other	O
factors	O
such	O
as	O
social	O
and	O
environmental	O
stress	O
can	O
not	O
be	O
discounted	O
.	O

Two	O
studies	O
on	O
the	O
relationship	O
between	O
taking	O
a	O
commercial	O
coaching	O
course	O
and	O
performance	O
on	O
the	O
Medical	O
College	O
Admission	O
Test	O
(	O
MCAT	O
)	O
are	O
reported	O
.	O

The	O
financial	O
impact	O
of	O
childhood	O
asthma	O
has	O
not	O
been	O
assessed	O
since	O
Vance	O
and	O
Taylor	O
reported	O
their	O
data	O
in	O
Annals	O
of	O
Allergy	O
13	O
years	O
ago	O
.	O

Hypersplenism	O

The	O
topography	O
and	O
trajectories	O
of	O
the	O
commissural	O
fibers	O
of	O
the	O
superior	O
temporal	O
region	O
(	O
STR	O
)	O
are	O
studied	O
using	O
the	O
autoradiographic	O
technique	O
.	O

The	O
primary	O
CT	O
findings	O
were	O
misinterpreted	O
as	O
a	O
brain	O
infarct	O
or	O
possibly	O
a	O
tumour	O
.	O

Shoulder	O
forearm	O
support	O
for	O
the	O
subluxed	O
shoulder	O
.	O

These	O
findings	O
suggest	O
that	O
both	O
in	O
the	O
early	O
stages	O
(	O
0	O
T	O
,	O
0N	O
)	O
and	O
in	O
more	O
severe	O
stages	O
of	O
VWF	O
(	O
stages	O
1	O
-	O
2	O
)	O
cold	O
induced	O
hyperreactivity	O
in	O
the	O
digital	O
vessels	O
and	O
Raynaud	O
's	O
syndrome	O
are	O
vascular	O
disorders	O
of	O
functional	O
origin	O
occurring	O
without	O
any	O
prethrombotic	O
alterations	O
.	O

In	O
MCCP	O
functions	O
of	O
the	O
source	O
emission	O
,	O
surface	O
reflection	O
,	O
photoacceptor	O
sensitivity	O
are	O
approximated	O
by	O
the	O
normal	O
distribution	O
curves	O
.	O

However	O
,	O
kidneys	O
perfused	O
for	O
72	O
hr	O
demonstrated	O
more	O
similar	O
renal	O
functions	O
when	O
tested	O
by	O
either	O
IMPK	O
or	O
IBPK	O
.	O

To	O
assess	O
the	O
effects	O
of	O
alveolar	O
hypoxia	O
and	O
angiotensin	B
II	I
infusion	O
on	O
distribution	O
of	O
blood	O
flow	O
to	O
the	O
lung	O
we	O
performed	O
perfusion	O
lung	O
scans	O
on	O
anesthetized	O
mechanically	O
ventilated	O
lambs	O
.	O

A	O
flow	O
rate	O
of	O
at	O
least	O
5	O
mL	O
/	O
h	O
is	O
required	O
through	O
the	O
receptor	O
(	O
volume	O
,	O
0.4	O
mL	O
)	O
for	O
accurate	O
results	O
.	O

We	O
have	O
now	O
located	O
the	O
5	O
'	O
ends	O
of	O
the	O
two	O
remaining	O
late	O
mRNAs	O
.	O

Recurrent	O
acute	O
rhinosinusitis	O
was	O
common	O
in	O
both	O
groups	O
of	O
patients	O
,	O
but	O
the	O
development	O
of	O
chronic	O
rhinosinusitis	O
was	O
only	O
found	O
in	O
patients	O
with	O
CVID	O
,	O
indicating	O
the	O
more	O
severe	O
nature	O
of	O
this	O
condition	O
compared	O
with	O
selective	O
IgA	B
deficiency	O
.	O

The	O
various	O
muscles	O
of	O
the	O
pelvic	O
floor	O
region	O
could	O
be	O
reflexly	O
activated	O
either	O
individually	O
or	O
as	O
a	O
mass	O
unit	O
depending	O
on	O
the	O
intensity	O
of	O
stimulation	O
.	O

It	O
has	O
been	O
reported	O
that	O
rat	O
blood	O
chloroform	O
levels	O
were	O
significantly	O
decreased	O
after	O
treatment	O
with	O
ClO2	O
.	O

The	O
frequency	O
of	O
lactase	B
phenotypes	I
in	O
Aymara	O
children	O
.	O

Activities	O
of	O
hepatic	O
cytochrome	B
P-450-dependent	I
metabolizing	O
enzymes	O
such	O
as	O
aminopyrine-	B
and	I
TMO	I
N	I
-	I
demethylase	I
and	O
aniline	B
hydroxylase	I
activity	O
were	O
decreased	O
by	O
pretreatment	O
of	O
rats	O
with	O
cimetidine	O
,	O
whereas	O
in	O
the	O
rats	O
pretreated	O
with	O
ranitidine	O
,	O
these	O
enzyme	O
activities	O
were	O
not	O
changed	O
.	O

Doxorubicin	O
,	O
dacarbazine	O
,	O
vincristine	O
,	O
and	O
cyclophosphamide	O
in	O
the	O
treatment	O
of	O
advanced	O
gastrointestinal	O
leiomyosarcoma	O
.	O

Electrochemical	O
detection	O
of	O
depressed	O
circulating	O
levels	O
of	O
vitamin	O
K1	O
in	O
osteoporosis	O
.	O

In	O
the	O
present	O
experiments	O
,	O
we	O
investigate	O
the	O
role	O
played	O
by	O
the	O
temporal	O
pattern	O
of	O
neural	O
activity	O
during	O
the	O
ontogeny	O
of	O
frequency	O
tuning	O
in	O
the	O
mouse	O
central	O
auditory	O
system	O
.	O

Ultrastructure	O
of	O
the	O
tumor	O
in	O
1	O
patient	O
in	O
whom	O
transurethral	O
resection	O
was	O
performed	O
2	O
weeks	O
after	O
alum	O
irrigation	O
revealed	O
well	O
preserved	O
nuclear	O
chromatin	O
,	O
thus	O
,	O
suggesting	O
that	O
whatever	O
changes	O
occur	O
after	O
alum	O
irrigation	O
are	O
short	O
-	O
lived	O
.	O

The	O
generally	O
adopted	O
criteria	O
enabling	O
to	O
classify	O
the	O
examined	O
persons	O
into	O
the	O
following	O
3	O
groups	O
have	O
been	O
used	O
:	O
(	O
a	O
)	O
diseased	O
of	O
BEN	O
;	O
(	O
b	O
)	O
suspect	O
to	O
be	O
diseased	O
of	O
BEN	O
,	O
and	O
(	O
c	O
)	O
individuals	O
without	O
signs	O
of	O
a	O
renal	O
disease	O
.	O

The	O
POEMS	O
syndrome	O
(	O
Polyneuropathy	O
,	O
Organomegaly	O
,	O
Endocrinopathy	O
,	O
Monoclonal	O
component	O
,	O
Skin	O
)	O
.	O

In	O
metastasis	O
-	O
free	O
patients	O
,	O
the	O
best	O
results	O
were	O
obtained	O
with	O
tumor	O
diameters	O
under	O
2	O
cm	O
regardless	O
of	O
their	O
localization	O
in	O
lung	O
tissue	O
and	O
with	O
2	O
-	O
-4.9	O
cm	O
tumors	O
embedded	O
in	O
lung	O
parenchyma	O
.	O

Two	O
siblings	O
with	O
hemolytic	O
anemia	O
caused	O
by	O
triosephosphate	B
isomerase	I
deficiency	O
developed	O
a	O
progressive	O
neurological	O
syndrome	O
featuring	O
dystonic	O
movements	O
,	O
tremor	O
,	O
pyramidal	O
tract	O
signs	O
,	O
and	O
evidence	O
of	O
spinal	O
motor	O
neuron	O
involvement	O
.	O

One	O
extract	O
with	O
the	O
lowest	O
PCA	O
content	O
was	O
non	O
-	O
carcinogenic	O
.	O

In	O
the	O
10	O
patients	O
with	O
a	O
more	O
severe	O
degree	O
of	O
steatorrhea	O
the	O
decrease	O
in	O
fat	O
loss	O
approached	O
20	O
%	O
and	O
a	O
close	O
relationship	O
was	O
found	O
(	O
r	O
=	O
0.84	O
,	O
p	O
less	O
than	O
0.01	O
)	O
between	O
the	O
extent	O
of	O
the	O
fatty	O
acid	O
loss	O
on	O
placebo	O
and	O
the	O
decrease	O
of	O
this	O
loss	O
on	O
taurine	O
.	O

Aortic	O
diameters	O
in	O
infants	O
and	O
young	O
children	O
:	O
normative	O
angiographic	O
data	O
.	O

Hydrocortisone	O
caused	O
lymphopenia	O
and	O
inhibited	O
the	O
blastogenic	O
response	O
of	O
peripheral	O
blood	O
lymphocytes	O
to	O
phytohemagglutinin	B
and	O
concanavalin	B
A	I
mitogens	O
.	O

Chenodeoxycholic	O
acid	O
(	O
cheno	O
)	O
and	O
ursodeoxycholic	O
acid	O
(	O
urso	O
)	O
dissolve	O
cholesterol	O
gallstones	O
in	O
man	O
.	O

Sensory	O
evoked	O
field	O
potentials	O
were	O
recorded	O
from	O
the	O
mesencephalic	O
reticular	O
formation	O
(	O
MRF	O
)	O
,	O
central	O
gray	O
(	O
CG	O
)	O
and	O
somatosensory	O
cortex	O
(	O
SCX	O
)	O
,	O
following	O
incremental	O
doses	O
of	O
halothane	O
in	O
freely	O
-	O
moving	O
rats	O
.	O

OODG	O
is	O
a	O
diagnostic	O
method	O
permitting	O
assessment	O
of	O
ocular	O
pulse	O
curves	O
and	O
objective	O
determination	O
of	O
blood	O
pressures	O
in	O
the	O
ophthalmic	O
circulatory	O
system	O
(	O
retinal	O
and	O
ciliary	O
arterial	O
blood	O
pressures	O
)	O
simultaneously	O
for	O
both	O
eyes	O
,	O
without	O
dilatation	O
of	O
the	O
pupils	O
.	O

Viral	O
infections	O
have	O
long	O
been	O
suspected	O
to	O
be	O
causative	O
agents	O
in	O
a	O
number	O
of	O
inner	O
ear	O
dysfunctions	O
.	O

Retrospective	O
analyses	O
of	O
this	O
death	O
revealed	O
a	O
significant	O
decrease	O
of	O
the	O
left	O
ventricular	O
(	O
LV	O
)	O
end	O
-	O
diastolic	O
volume	O
index	O
(	O
EDVI	O
)	O
of	O
21	O
ml	O
/	O
m2	O
(	O
36	O
%	O
of	O
normal	O
)	O
.	O

Polysorbate	O
80	O
did	O
not	O
have	O
a	O
direct	O
stimulant	O
or	O
relaxant	O
effect	O
on	O
either	O
guinea	O
pig	O
ileum	O
or	O
rat	O
uterus	O
,	O
however	O
,	O
it	O
antagonised	O
the	O
contractions	O
induced	O
by	O
acetylcholine	O
,	O
histamine	O
,	O
barium	O
,	O
5-hydroxytryptamine	O
and	O
carbachol	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Individual	O
alcohol	O
reaction	O
profiles	O
.	O

35	O
patients	O
with	O
acute	O
arterial	O
occlusions	O
[	O
27	O
]	O
and	O
graft	O
thromboses	O
[	O
8	O
]	O
,	O
responsible	O
for	O
severe	O
and	O
recent	O
ischemia	O
,	O
were	O
treated	O
by	O
fibrinolytic	O
therapy	O
(	O
Urokinase	B
:	O
1	O
000	O
units	O
/	O
kg	O
/	O
hour	O
,	O
and	O
Lys	O
Plasminogen	B
)	O
.	O

We	O
conclude	O
that	O
androgenic	O
hormones	O
reduce	O
HDL	B
-	I
cholesterol	I
concentrations	O
and	O
the	O
HDL2-cholesterol	B
subfraction	O
,	O
possibly	O
by	O
enhancing	O
hepatic	B
triglyceride	I
lipase	I
activity	O
.	O

Shape	O
factor	O
correlated	O
well	O
with	O
hemodynamic	O
data	O
for	O
RV	O
/	O
LV	O
systolic	O
pressure	O
ratios	O
(	O
r	O
=	O
0.93	O
,	O
p	O
less	O
than	O
0.001	O
)	O
for	O
normalized	O
interventricular	O
pressure	O
differences	O
(	O
r	O
=	O
-0.95	O
,	O
p	O
less	O
than	O
0.001	O
)	O
.	O

Furthermore	O
,	O
the	O
initial	O
plasma	O
retinol	O
level	O
in	O
conjunction	O
with	O
RBP	B
was	O
found	O
to	O
be	O
even	O
lower	O
in	O
12	O
patients	O
(	O
35.1	O
micrograms	O
dl-1	O
,	O
3.7	O
mg	O
dl-1	O
)	O
who	O
subsequently	O
had	O
cancer	O
recurrence	O
than	O
in	O
those	O
who	O
remained	O
free	O
of	O
apparent	O
cancer	O
(	O
44.5	O
micrograms	O
dl-1	O
,	O
4.6	O
mg	O
dl-1	O
)	O
.	O

The	O
results	O
indicate	O
that	O
:	O
1	O
)	O
the	O
initial	O
response	O
to	O
tethering	O
varies	O
according	O
to	O
previous	O
penning	O
and	O
handling	O
experience	O
,	O
2	O
)	O
although	O
the	O
circadian	O
rhythm	O
of	O
cortisol	O
was	O
either	O
altered	O
or	O
disrupted	O
during	O
estrus	O
,	O
such	O
disruptions	O
were	O
not	O
influenced	O
by	O
type	O
of	O
penning	O
and	O
3	O
)	O
tether	O
stalls	O
may	O
chronically	O
increase	O
cortisol	O
concentrations	O
in	O
gilts	O
.	O

Male	O
Japanese	O
quail	O
were	O
chronically	O
exposed	O
to	O
5000	O
ppm	O
manganese	O
(	O
Mn	O
)	O
as	O
particulate	O
manganese	O
oxide	O
(	O
Mn3O4	O
)	O
in	O
their	O
diet	O
from	O
hatching	O
to	O
75	O
days	O
of	O
age	O
.	O

This	O
study	O
indicated	O
that	O
the	O
Japanese	O
quail	O
was	O
less	O
sensitive	O
to	O
particulate	O
Mn3O4	O
exposure	O
than	O
rodents	O
treated	O
comparably	O
.	O

Scintigraphic	O
visualisation	O
of	O
Walker	O
carcinoma-256	O
in	O
Sprague	O
-	O
Dawley	O
rats	O
by	O
means	O
of	O
99mTc	O
-	O
labelled	O
monocytes	O
.	O

These	O
results	O
were	O
compared	O
with	O
those	O
obtained	O
in	O
-D	O
mothers	O
and	O
pups	O
,	O
after	O
giving	O
the	O
mothers	O
an	O
oral	O
supplement	O
(	O
10	O
i.u	O
.	O

vitamin	O
D3	O
/	O
day	O
)	O
during	O
the	O
period	O
of	O
lactation	O
(	O
20	O
days	O
)	O
.	O

Before	O
birth	O
,	O
there	O
were	O
a	O
few	O
perivascular	O
adrenergic	O
nerves	O
and	O
correspondingly	O
low	O
ovarian	O
NE	O
levels	O
.	O

Monitoring	O
changes	O
in	O
the	O
heart	O
rate	O
of	O
the	O
premature	O
fetus	O
during	O
tocolysis	O
with	O
the	O
beta	O
-	O
adrenomimetics	O
partusisten	O
and	O
Pre	O
-	O
par	O

Treatment	O
with	O
oxyphenylbutazone	O
and	O
hydrocortisone	O
failed	O
to	O
inhibit	O
the	O
raised	O
serum	B
CPN	I
levels	O
.	O

40,000	O
)	O
.	O

The	O
Cox	O
proportional	O
hazards	O
model	O
was	O
applied	O
to	O
the	O
data	O
in	O
order	O
to	O
determine	O
the	O
prognostic	O
factors	O
for	O
long	O
-	O
term	O
survival	O
.	O

These	O
data	O
showed	O
:	O
that	O
progesterone	O
secretion	O
is	O
pulsatile	O
throughout	O
the	O
human	O
luteal	O
phase	O
,	O
with	O
maximum	O
frequency	O
in	O
the	O
mid	O
-	O
luteal	O
phase	O
;	O
that	O
during	O
the	O
mid	O
-	O
luteal	O
phase	O
most	O
subjects	O
had	O
progesterone	O
levels	O
both	O
above	O
and	O
below	O
currently	O
accepted	O
ovulatory	O
thresholds	O
;	O
the	O
use	O
of	O
a	O
single	O
measurement	O
of	O
progesterone	O
in	O
the	O
mid	O
-	O
luteal	O
phase	O
is	O
not	O
always	O
a	O
reliable	O
indicator	O
of	O
ovulation	O
;	O
a	O
threshold	O
greater	O
than	O
20	O
nmol	O
/	O
l	O
may	O
yield	O
an	O
unacceptable	O
number	O
of	O
false	O
negative	O
results	O
.	O

The	O
fast	O
real	O
-	O
time	O
digital	O
processing	O
of	O
the	O
N2	O
and	O
flow	O
signals	O
incorporated	O
filtering	O
,	O
delay	O
compensation	O
,	O
and	O
corrections	O
for	O
the	O
effects	O
of	O
changes	O
in	O
gas	O
composition	O
and	O
temperature	O
.	O

Histamine	O
reactivity	O
was	O
significantly	O
reduced	O
after	O
the	O
nifedipine	O
aerosol	O
,	O
the	O
geometric	O
mean	O
provocative	O
concentration	O
causing	O
a	O
35	O
%	O
fall	O
in	O
specific	O
airway	O
conductance	O
,	O
rising	O
from	O
5.0	O
to	O
10.9	O
mg	O
/	O
ml	O
of	O
histamine	O
(	O
p	O
less	O
than	O
0.05	O
)	O
.	O

Pharmacologic	O
doses	O
of	O
vitamin	O
B6	O
administered	O
to	O
lactating	O
women	O
have	O
been	O
reported	O
to	O
suppress	O
plasma	B
prolactin	I
.	O

There	O
was	O
a	O
significant	O
but	O
similar	O
elevation	O
of	O
mean	O
O2	O
uptake	O
during	O
40	O
min	O
postexercise	O
by	O
13.6	O
%	O
in	O
both	O
the	O
fasted	O
(	O
p	O
less	O
than	O
0.001	O
)	O
and	O
fed	O
state	O
(	O
p	O
less	O
than	O
0.001	O
)	O
.	O

National	O
Institutes	O
of	O
Health	O
Consensus	O
Development	O
Conference	O
Statement	O
.	O

Greater	O
attenuation	O
of	O
the	O
N1-P2	O
and	O
baseline	O
-	O
P2	O
amplitude	O
of	O
the	O
probe	O
EPs	O
was	O
observed	O
when	O
the	O
probe	O
stimulus	O
was	O
presented	O
to	O
the	O
right	O
ear	O
and	O
the	O
verbal	O
material	O
presented	O
to	O
the	O
left	O
ear	O
than	O
when	O
the	O
opposite	O
stimulation	O
arrangement	O
was	O
used	O
.	O

Germ	O
-	O
free	O
rabbits	O
given	O
mouse	O
CRF	O
-	O
flora	O
showed	O
values	O
quite	O
different	O
from	O
control	O
animals	O
for	O
most	O
parameters	O
,	O
indicating	O
unsuitability	O
of	O
mouse	O
CRF	O
flora	O
to	O
'	O
normalize	O
'	O
rabbits	O
.	O

The	O
weak	O
relationships	O
between	O
F	O
and	O
Zn	O
to	O
Mg	O
clearly	O
have	O
no	O
significant	O
effect	O
on	O
the	O
contents	O
of	O
these	O
elements	O
in	O
bone	O
.	O

L3-L4	O
compressive	O
load	O
was	O
calculated	O
using	O
a	O
model	O
of	O
the	O
anatomy	O
of	O
the	O
trunk	O
musculoskeletal	O
system	O
.	O

Diagnosis	O
:	O
progressive	O
multifocal	O
leukoencephalopathy	O
.	O

Component	O
P100	O
was	O
associated	O
with	O
a	O
frontal	O
negativity	O
of	O
similar	O
latency	O
favoring	O
the	O
hypothesis	O
of	O
a	O
dipolar	O
occipital	O
generator	O
.	O

Although	O
no	O
differences	O
were	O
noted	O
in	O
the	O
decrease	O
in	O
platelet	O
counts	O
between	O
the	O
two	O
groups	O
,	O
fibrinogen	B
levels	O
and	O
alpha	B
2-antiplasmin	I
levels	O
declined	O
less	O
drastically	O
in	O
the	O
antithrombin	B
-	O
treated	O
group	O
.	O

Failure	O
of	O
stapedius	O
reflexometry	O
in	O
the	O
diagnosis	O
of	O
myasthenia	O
gravis	O
.	O

Factors	O
influencing	O
semen	O
characteristics	O
in	O
young	O
boars	O
reared	O
in	O
a	O
subtropical	O
environment	O
were	O
studied	O
.	O

[	O
14C	O
]	O
-beta	O
-	O
phenethylamine	O
,	O
its	O
distribution	O
after	O
administration	O
by	O
various	O
routes	O
to	O
cats	O
,	O
and	O
the	O
effects	O
of	O
monoamine	B
oxidase	I
inhibitors	O
.	O

All	O
runners	O
drank	O
a	O
total	O
of	O
1.4	O
L	O
of	O
water	O
during	O
the	O
race	O
.	O

The	O
rates	O
of	O
total	O
energy	O
use	O
(	O
mean	O
+	O
/-	O

SD	O
=	O
39.3	O
+	O
/-	O

1.2	O
vs	O
35.7	O
+	O
/-	O

1.3	O
kJ	O
X	O
min-1	O
;	O
P	O
less	O
than	O
0.05	O
)	O
were	O
significantly	O
higher	O
at	O
-10	O
degrees	O
C	O
than	O
at	O
22	O
degrees	O
C.	O

The	O
recommendation	O
is	O
made	O
that	O
specific	O
sub	O
-	O
groups	O
of	O
attempters	O
need	O
to	O
be	O
identified	O
and	O
may	O
warrant	O
specialized	O
intervention	O
strategies	O
.	O

Gains	O
increased	O
3.5	O
%	O
(	O
P	O
less	O
than	O
.10	O
)	O
and	O
feed	O
conversion	O
improved	O
5.9	O
%	O
(	O
P	O
less	O
than	O
.07	O
)	O
in	O
steers	O
fed	O
.28	O
%	O
AS	O
-	O
VFA	O
compared	O
with	O
gain	O
and	O
feed	O
conversion	O
of	O
the	O
control	O
steers	O
.	O

Postnatal	O
volumetric	O
development	O
of	O
the	O
prefrontal	O
cortex	O
in	O
the	O
rat	O
.	O

Daily	O
and	O
seasonal	O
rhythmicity	O
in	O
the	O
methylation	O
of	O
pineal	O
indolic	O
compounds	O
in	O
adult	O
male	O
golden	O
hamsters	O
,	O
kept	O
under	O
natural	O
conditions	O
.	O

Among	O
the	O
patients	O
grades	O
1	O
-	O
2	O
-	O
3	O
,	O
81	O
%	O
had	O
a	O
good	O
out	O
come	O
without	O
any	O
neurological	O
abnormality	O
,	O
among	O
the	O
patients	O
graded	O
4	O
-	O
5	O
,	O
only	O
27	O
%	O
had	O
a	O
fair	O
out	O
come	O
.	O

Treatment	O
of	O
Paget	O
's	O
disease	O
.	O

Improvement	O
of	O
the	O
CRT	O
display	O
of	O
an	O
averager	O
.	O

Is	O
desensitization	O
'	O
for	O
ragweed	O
hay	O
fever	O
immunologically	O
specific	O
?	O

Evaluation	O
of	O
thyroid	O
function	O
.	O

HL	B
-	I
A	I
antibodies	I
in	O
polytransfused	O
patients	O

Demonstration	O
of	O
fine	O
structure	O
of	O
the	O
guinea	O
pig	O
organ	O
of	O
Corti	O
after	O
electron	O
microscopic	O
silver	O
staining	O

Histamine	O
metabolism	O
in	O
hemorrhagic	O
-	O
hypotensive	O
shock	O

They	O
also	O
discuss	O
the	O
existing	O
nomenclature	O
.	O

Studies	O
on	O
alcoholic	O
liver	O
injury	O
.	O

Hypothalamic	O
control	O
of	O
coronary	O
circulation	O
in	O
the	O
dog	O
.	O

Poliomyelitis	O
from	O
a	O
vaccine	O
.	O

To	O
the	O
problem	O
of	O
the	O
stimulation	O
of	O
the	O
growth	O
of	O
transplantable	O
tumors	O
of	O
animals	O
previously	O
treated	O
with	O
antineoplastic	O
antibiotics	O

Assessment	O
of	O
nutrient	O
media	O
in	O
the	O
diagnosis	O
of	O
diptheria	O

Aluminium	O
resin	O
for	O
the	O
treatment	O
of	O
the	O
hyperkalamia	O
of	O
renal	O
failure	O
.	O

Serotonin	O
levels	O
in	O
infant	O
hypothyroidism	O
.	O

Cerebrospinal	O
fluid	O
transferrin	B
II	I
studies	O
in	O
ischemic	O
disorders	O
of	O
the	O
central	O
nervous	O
system	O
.	O

High	O
dosages	O
of	O
D	O
-	O
penicillamine	O
in	O
pulmonary	O
fibroses	O

Effect	O
of	O
immune	O
lymphocytes	O
and	O
of	O
rabbit	B
-	I
anti	I
-	I
lymphocyte	I
globulin	I
(	O
RAMLG	B
)	O
on	O
infected	O
macrophages	O
exposed	O
to	O
increased	O
incubation	O
temperature	O
in	O
vitro	O
.	O

Estral	O
cycle	O
in	O
white	O
rats	O
in	O
the	O
low	O
and	O
high	O
mountains	O
of	O
Kirghizia	O

Lactation	O
of	O
baboons	O
fed	O
a	O
low	O
protein	O
maintenance	O
diet	O
.	O

Studies	O
on	O
the	O
organic	O
matrix	O
of	O
human	O
ear	O
ossicles	O

A	O
medical	O
-	O
geographical	O
review	O

Sensitization	O
to	O
hyperlactatemia	O
induced	O
by	O
phenformin	O
after	O
subtotal	O
ablation	O
of	O
the	O
pancreas	O
.	O

Vitamin	O
D3	O
and	O
calcium	O
absorption	O
in	O
the	O
chick	O
.	O

The	O
incidence	O
of	O
tumours	O
in	O
young	O
chickens	O
.	O

Their	O
effect	O
on	O
the	O
guinea	O
pig	O
vas	O
deferens	O
.	O

Androgens	O
and	O
growth	O
.	O

Studies	O
on	O
swine	O
enteroviruses	O
.	O

Ultrasound	O
effect	O
on	O
the	O
cytochrome	B
oxidase	I
activity	O

Metastasis	O
of	O
colon	O
carcinoma	O
to	O
the	O
lip	O
.	O

Conditions	O
influencing	O
inhibitors	O
of	O
the	O
colony	B
-	I
stimulating	I
factor	I
(	O
CSF	B
)	O
.	O

An	O
automated	O
method	O
for	O
the	O
quantitative	O
analysis	O
of	O
the	O
polyamines	O
putrescine	O
,	O
spermidine	O
and	O
spermine	O
in	O
cerebrospinal	O
fluid	O
(	O
CSF	O
)	O
was	O
used	O
to	O
analyze	O
CSF	O
samples	O
from	O
37	O
patients	O
with	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
tumors	O
and	O
from	O
13	O
patients	O
without	O
tumors	O
.	O

Natural	O
and	O
induced	O
malarias	O
in	O
western	O
hemisphere	O
monkeys	O
.	O

Copper	O
and	O
ceruloplasmin	B
content	O
in	O
pregnant	O
women	O
and	O
in	O
women	O
with	O
certain	O
gynecological	O
diseases	O

Effect	O
of	O
noise	O
on	O
CO	O
-	O
induced	O
increases	O
of	O
LAP	B
and	O
GPT	B
activity	O
in	O
the	O
plasma	O
of	O
rats	O

Kinetics	O
of	O
calcium	O
metabolism	O
.	O

Pathology	O
of	O
neuritis	O
caudae	O
equinae	O
in	O
the	O
horse	O

Abnormal	O
characteristics	O
and	O
verticillation	O
in	O
Platynothrus	O
peltifer	O

Selected	O
topics	O
in	O
laboratory	O
animal	O
medicine	O
.	O

Clinical	O
course	O
and	O
nursing	O
care	O
of	O
patients	O
with	O
decubitus	O
ulcer	O
--	O
use	O
of	O
pillows	O
stuffed	O
with	O
buckwheat	O
chaff	O

From	O
the	O
Icelandic	O
Red	O
Cross	O
activities	O

Electrocardiograms	O
of	O
the	O
month	O
.	O

Composites	O
as	O
restoration	O
materials	O

Hodgkin	O
's	O
disease	O
.	O

Value	O
of	O
Normotest	O
and	O
antithrombin	B
3	I
in	O
the	O
assessment	O
of	O
liver	O
function	O
.	O

Glutathione	B
peroxidase	I
in	O
human	O
red	O
cells	O
in	O
health	O
and	O
disease	O
.	O

Histopathologic	O
response	O
of	O
gingival	O
tissues	O
to	O
hemodent	O
and	O
aluminum	O
chloride	O
solutions	O
as	O
tissue	O
displacement	O
materials	O
.	O

Intracellular	O
pH	O
,	O
H	O
ion	O
flux	O
and	O
H	O
ion	O
permeability	O
coefficient	O
in	O
bullfrog	O
toe	O
muscle	O
.	O

Proceedings	O
:	O

Reversible	O
complete	O
heart	O
block	O
following	O
surgery	O
of	O
congenital	O
heart	O
defects	O

Extracellular	O
fibril	O
formation	O
by	O
neuroglial	O
cells	O
at	O
the	O
vitreoretinal	O
junction	O
of	O
the	O
human	O
eye	O
.	O

Blood	O
platelets	O
,	O
coagulation	O
factors	O
and	O
morphologic	O
organ	O
changes	O
following	O
scalding	O
shock	O
in	O
rhesus	O
monkeys	O

Cell	O
viability	O
and	O
lysosomal	B
enzymes	I

Further	O
investigation	O
on	O
the	O
chemotactic	O
influence	O
of	O
thymic	B
hormone	I
on	O
lymphocytes	O

1,3-bis	O
(	O
2-chloroethyl	O
)	O
-1-nitrosourea	O
(	O
bcnu	O
)	O
and	O
other	O
nitrosoureas	O
in	O
cancer	O
treatment	O
:	O
a	O
review	O
.	O

Pneumothorax	O
following	O
lung	O
abscess	O
in	O
the	O
renal	O
transplant	O
patient	O
.	O

Temporal	O
relationships	O
and	O
the	O
development	O
phase	O
affected	O
.	O

Letter	O
:	O

Salmonella	O
detection	O

The	O
effect	O
of	O
antilymphocyte	O
sera	O
on	O
formation	O
of	O
transplantation	O
and	O
anti	O
-	O
infection	O
immunity	O
in	O
mice	O

60th	O
birthday	O
of	O
colonel	O
prof	O
.	O

e.cerny	O
m.d	O
.	O

Cortical	O
afferents	O
to	O
the	O
entorhinal	O
cortex	O
of	O
the	O
Rhesus	O
monkey	O
.	O

Mechanism	O
of	O
immunogenesis	O
in	O
vaccination	O
with	O
streptomycin	O
-	O
dependent	O
mutants	O
of	O
salmonellae	O
and	O
shigellae	O
.	O

Resistance	O
pattern	O
of	O
Mycobacterium	O
tuberculosis	O
(	O
H	O
37	O
Rv	O
)	O
to	O
a	O
new	O
antibiotic	O
,	O
lividomycin	O

Pulmonary	O
arterial	O
pressure	O
and	O
structure	O
in	O
the	O
patas	O
monkey	O
after	O
prolonged	O
administration	O
of	O
aminorex	O
fumarate	O
.	O

Effect	O
of	O
triftazin	O
and	O
aminazin	O
on	O
hippocampal	O
bioelectric	O
activity	O

Pathological	O
processes	O
in	O
the	O
cervix	O
uteri	O

Benign	O
intramural	O
tumors	O
of	O
the	O
esophagus	O

General	O
formulae	O
for	O
estimating	O
heritability	O
in	O
a	O
population	O
with	O
related	O
parents	O
.	O

Antibiotic	O
effect	O
of	O
the	O
mud	O
from	O
heviz	O

Role	O
of	O
histoclinical	O
studies	O
in	O
the	O
prophylaxis	O
of	O
spontaneous	O
abortions	O

Range	O
behavior	O
of	O
Hereford	O
,	O
Hereford	O
x	O
Holstein	O
and	O
Holstein	O
non	O
-	O
lactating	O
heifers	O
.	O

Chemical	O
constituents	O
of	O
the	O
gentianaceae	O
V	O
:	O
tetraoxygenated	O
xanthones	O
of	O
Swertia	O
chirata	O
Buch	O
.-	O
Ham	O
.	O

Compensative	O
justice	O
and	O
moral	O
investment	O
among	O
Japanese	O
,	O
Chinese	O
,	O
and	O
Koreans	O
.	O

Effects	O
of	O
cortisone	O
,	O
starvation	O
,	O
and	O
rickets	O
on	O
oxidative	O
enzyme	O
activities	O
of	O
epiphyseal	O
cartilage	O
from	O
rats	O
.	O

Estimation	O
of	O
renin	B
secretion	O
rate	O
and	O
renal	O
plasma	O
flow	O
from	O
peripheral	O
and	O
renal	B
vein	I
renin	I
levels	O
.	O

Choice	O
of	O
vessel	O
.	O

Pneumothorax	O
complicated	O
by	O
chronic	O
steroid	O
treatment	O
.	O

Polycythemia-1973	O
.	O

Familial	O
juvenile	O
nephronophthisis	O

Early	O
heparin	O
therapy	O
in	O
60	O
children	O
with	O
acute	O
meningococcemia	O
.	O

9,11-Seco	O
steroids	O
derived	O
from	O
estradiol	O
3-methyl	O
ether	O
.	O

Psychological	O
examinations	O
in	O
patients	O
with	O
chronic	O
kidney	O
insufficiency	O

Possibilities	O
of	O
needleless	O
administration	O
of	O
various	O
substances	O
to	O
animals	O

Observations	O
on	O
the	O
flight	O
activities	O
of	O
Chrysops	O
caecutiens	O
L.	O

Combination	O
of	O
3	O
multiple	O
primary	O
malignant	O
and	O
benign	O
tumors	O
of	O
the	O
breasts	O
and	O
uterus	O

Analysis	O
of	O
clearance	O
curve	O
of	O
rose	O
bengal	O
-	O
I-131	O

Proceedings	O
:	O
Barrels	O
and	O
somatotopy	O
in	O
S	O
I	O
neocortex	O
of	O
the	O
brush	O
-	O
tailed	O
possum	O
.	O

Canine	O
reproduction	O
:	O
effects	O
of	O
a	O
single	O
injection	O
of	O
medroxyprogesterone	O
acetate	O
on	O
the	O
reproductive	O
organs	O
of	O
the	O
bitch	O
.	O

3	O
.	O

Letter	O
:	O

Aryl	B
hydrocarbon	I
hydroxylase	I
and	O
smoking	O
.	O

Evaluation	O
of	O
1,10-phenanthroline	O
as	O
a	O
reagent	O
for	O
sialic	O
acid	O
determinations	O
.	O

Nonteratogenicity	O
in	O
rats	O
of	O
blighted	O
potatoes	O
and	O
compounds	O
contained	O
in	O
them	O
.	O

Effect	O
of	O
a	O
high	O
-	O
intensity	O
SHF	O
field	O
on	O
the	O
blood	O
coagulation	O
system	O

Relationship	O
between	O
gross	O
lesions	O
and	O
Escherichia	O
coli	O
serotypes	O
in	O
chronic	O
respiratory	O
disease	O
(	O
CRD	O
)	O
of	O
poultry	O
.	O

Plastic	O
solution	O
of	O
elbow	O
joint	O
ankylosis	O
with	O
a	O
decorticated	O
cylindrical	O
flap	O

The	O
Twentieth	O
Anniversary	O
of	O
the	O
Pomeranian	O
Medical	O
Academy	O
.	O

Immunelectrophoretic	O
pattern	O
of	O
Wassermann	O
reagin	O
and	O
comparison	O
of	O
the	O
appearance	O
time	O
between	O
RPCF	B
and	O
FTA	B
antibodies	I

Electrocardiographic	O
QRS	O
complexes	O
and	O
vectorcardiographic	O
QRS	O
loop	O

Study	O
of	O
antinuclear	O
autoantibodies	O
by	O
immunofluorescence	O
technic	O
in	O
collagen	B
diseases	O

Cardiac	O
preservation	O
.	O

Dr.	O

The	O
metabolism	O
and	O
pharmacology	O
of	O
5-fluorouracil	O
.	O

Human	O
synovial	O
fluid	O
:	O
detection	O
of	O
a	O
new	O
component	O
.	O

Effects	O
of	O
temperature	O
and	O
moulting	O
cycle	O
on	O
melanin	O
synthesis	O
in	O
the	O
newt	O
,	O
Triturus	O
cristatus	O
.	O

Morphological	O
and	O
functional	O
alterations	O
noted	O
after	O
baboon	O
renal	O
allotransplantation	O
.	O

Analysis	O
of	O
corticosteroids	O
.	O

Immunogenicity	O
of	O
various	O
mycobacteria	O
and	O
the	O
corresponding	O
levels	O
of	O
cross	O
-	O
protection	O
developed	O
between	O
species	O
.	O

Ten	O
-	O
year	O
experience	O
with	O
one	O
-	O
stage	O
proctocolectomy	O
and	O
anal	O
ileostomy	O
.	O

Nitrogen	O
-	O
hydrogen	O
tautomerism	O
in	O
porphyrins	O
and	O
chlorins	O
.	O

Photopic	O
spectral	O
sensitivity	O
determined	O
electroretinographically	O
for	O
the	O
pigeon	O
eye	O
.	O

Cholinesterase	B

Sodium	O
restriction	O
in	O
cardiac	O
failure	O
.	O

Clinical	O
and	O
angiographic	O
examinations	O
in	O
occlusion	O
disease	O
of	O
the	O
great	O
intestinal	O
arteries	O

Serum	O
lipid	O
changes	O
during	O
pregnancy	O
due	O
to	O
oral	O
calcium	O
administration	O

Successful	O
treatment	O
of	O
candidiasis	O
with	O
transfer	B
factor	I
.	O

A	O
possible	O
role	O
for	O
the	O
mixed	O
function	O
oxidase	B
enzyme	O
system	O
in	O
the	O
requirement	O
for	O
selenium	O
in	O
the	O
rat	O
.	O

On	O
the	O
constituents	O
of	O
Dryopteris	O
polylepis	O

Oscilloscope	O
triggering	O
circuit	O
for	O
recording	O
long	O
transients	O
at	O
fast	O
sweep	O
speeds	O
.	O

Derivatives	O
of	O
boswellic	O
acids	O
.	O

Coronary	O
arteries	O
--	O
old	O
and	O
new	O
.	O

Antiviral	O
agents	O
.	O

Separation	O
of	O
ninhydrin	O
-	O
positive	O
compounds	O
in	O
urine	O
by	O
the	O
combined	O
methods	O
of	O
medium	O
-	O
tension	O
intophoresis	O
and	O
partition	O
chromatography	O

Conservative	O
treatment	O
of	O
central	O
nervous	O
system	O
injuries	O

Spasmus	O
nutans	O
:	O
a	O
syndrome	O
of	O
auto	O
-	O
arousal	O
.	O

6	O
.	O

Slowed	O
lysosomal	B
enzyme	I
release	O
and	O
its	O
normalization	O
by	O
drugs	O
in	O
adjuvant	O
-	O
induced	O
polyarthritis	O
.	O

Treatment	O
of	O
ovarian	O
neoplasms	O

Bacterial	O
metabolism	O
of	O
4-chlorophenoxyacetate	O
.	O

I.	O

Surgical	O
treatment	O
of	O
pathologic	O
scars	O
of	O
myocardial	O
infarct	O

The	O
interaction	O
of	O
caffeine	O
,	O
theophylline	O
and	O
theobromine	O
with	O
monoamine	B
oxidase	I
inhibitors	O
.	O

A	O
case	O
of	O
M	O
hemoglobinosis	O

Radiosensitive	O
nature	O
of	O
paravascular	O
infiltrate	O
-	O
producing	O
potential	O
of	O
parental	O
spleen	O
cells	O
.	O

1	O
.	O

Results	O
of	O
the	O
official	O
inspection	O
of	O
the	O
commercial	O
anti	O
-	O
inflammatory	O
enzyme	O
preparations	O
containing	O
chymotrypsin	B
and	O
trypsin	B
by	O
means	O
of	O
modified	O
NF	O
13	O
methods	O

Second	O
report	O
of	O
the	O
Norwegian	O
Cancer	O
Society	O
.	O

Modification	O
of	O
the	O
growth	O
of	O
Tetrahymena	O
by	O
compounds	O
which	O
affect	O
the	O
adrenergic	O
mechanism	O
.	O

A	O
brief	O
discussion	O
of	O
color	O
deficiencies	O
.	O

BIM	O
130	O
.	O

Problems	O
in	O
the	O
determination	O
of	O
the	O
antigenic	O
content	O
of	O
influenza	O
vaccines	O
.	O

Aedes	O
aegypti	O
(	O
L.	O
)	O
and	O
Aedes	O
albopictus	O
(	O
Skuse	O
)	O
in	O
Singapore	O
City	O
.	O

Homograft	O
response	O
and	O
hemagglutinin	B
production	O
by	O
sensitized	O
thymectomized	O
irradiated	O
adult	O
mice	O
.	O

Comparative	O
study	O
on	O
acute	O
oral	O
overload	O
using	O
tolbutamide	O
and	O
tolazamide	O
in	O
normal	O
and	O
diabetic	O
subjects	O
.	O

Mycotoxins	O
in	O
feeds	O
and	O
foods	O
.	O

Factors	O
influencing	O
in	O
vitro	O
skin	B
permeability	I
factor	I
production	O
by	O
Vibrio	O
cholerae	O
.	O

Biological	O
action	O
and	O
kinetics	O
of	O
the	O
elimination	O
of	O
tritium	O
oxide	O
in	O
dogs	O

Renin	B
secretion	O
in	O
essential	O
and	O
accelerated	O
hypertension	O
.	O

The	O
need	O
for	O
including	O
forensic	O
medical	O
expertise	O
in	O
the	O
list	O
of	O
urgent	O
criminal	O
investigative	O
actions	O

Tolerance	O
test	O
of	O
HB	O
419	O
in	O
animal	O
experiments	O

The	O
""""	O
28	O
percent	O
""""	O
Venturi	O
mask	O
in	O
obstructive	O
airway	O
disease	O
.	O

3'-Methyl	O
,	O
8-methyl	O
,	O
and	O
8-phenyl	O
derivatives	O
of	O
5,9-dimethyl-6,7-benzomorphans	O
.	O

Antidromic	O
invasion	O
of	O
impulses	O
and	O
recurrent	O
collateral	O
inhibition	O
in	O
pyramidal	O
tract	O
neurones	O
.	O

The	O
distribution	O
of	O
body	O
fluids	O
following	O
hemorrhage	O
and	O
resuscitation	O
in	O
combat	O
casualties	O
.	O

Once	O
more	O
Hong	O
Kong	O
influenza	O
in	O
the	O
Netherlands	O

Difficulties	O
bound	O
to	O
measuring	O
of	O
sputum	O
viscosity	O

Lipid	O
concentration	O
and	O
lipase	B
activity	O
in	O
the	O
epiphysis	O
of	O
adrenalectomized	O
rats	O
consuming	O
food	O
with	O
different	O
sodium	O
content	O

Behavior	O
of	O
aspartate	B
aminotransferase	I
(	O
EC	B
2.6.1.1	I
)	O
and	O
alanine	B
aminotransferase	I
(	O
EC	B
2.6.1.2	I
)	O
in	O
rat	O
serum	O
during	O
the	O
course	O
of	O
acute	O
radiation	O
syndrome	O
following	O
whole	O
body	O
X	O
-	O
irradiation	O

Diminished	O
forearm	O
arteriolar	O
dilator	O
capacity	O
produced	O
by	O
mineralocorticoid	O
-	O
induced	O
salt	O
retention	O
in	O
man	O
.	O

Studies	O
on	O
the	O
pathogenicity	O
of	O
ECHO	O
9	O
(	O
HILL	O
)	O
virus	O
and	O
its	O
mutants	O
for	O
suckling	O
mice	O

Counter	O
-	O
current	O
heat	O
exchange	O
in	O
the	O
respiratory	O
passages	O
:	O
effect	O
on	O
water	O
and	O
heat	O
balance	O
.	O

Calibration	O
and	O
a	O
correction	O
of	O
blood	O
O2	O
content	O
measured	O
by	O
Po2	O
and	O
CO	O
saturation	O
.	O

Mae	O
West	O
and	O
the	O
doctor	O
shortage	O
.	O

Elimination	O
of	O
gamma	O
-	O
irradiation	O
induced	O
oxidation	O
in	O
aqueous	O
drug	O
preparations	O

Bimodal	O
cochlear	O
response	O
curves	O
in	O
rodents	O
.	O

A	O
new	O
hemagglutination	O
test	O
for	O
the	O
on	O
-	O
slide	O
assay	O
of	O
rheumatoid	B
factor	I

CO2	O
assimilation	O
by	O
chloroplasts	O
illuminated	O
on	O
filter	O
paper	O
.	O

The	O
biology	O
of	O
Hyostrongylus	O
ruidus	O
.	O

The	O
association	O
of	O
clopamide	O
and	O
hydergine	O
(	O
Brinedine	O
)	O
in	O
the	O
treatment	O
of	O
the	O
vasculo	O
-	O
renal	O
syndromes	O
of	O
pregnancy	O

Leukemia	O
in	O
twins	O
:	O
world	O
-	O
wide	O
review	O
of	O
clinical	O
cases	O
.	O

Quantitation	O
of	O
exocrine	B
IgA	I
in	O
human	O
serum	O
in	O
health	O
and	O
disease	O
.	O

Gastrointestinal	O
manifestations	O
of	O
systemic	O
sclerosis	O

Iodine	O
metabolism	O
in	O
chronic	O
thyroiditis	O
.	O

V.	O

Propagation	O
and	O
hormone	O
production	O
by	O
human	O
normal	O
and	O
malignant	O
trophoblast	O
in	O
rats	O
.	O

Sensitive	O
fluorometric	O
method	O
of	O
determining	O
SH-	O
and	O
S	O
-	O
S	O
-	O
groups	O
when	O
jointly	O
present	O

Morphogenesis	O
of	O
the	O
trochanter	O
produced	O
by	O
femoral	O
regeneration	O
in	O
the	O
phasmid	O
Carausius	O
morosus	O
Br	O

Behavioral	O
and	O
electrographic	O
expression	O
of	O
natural	O
sleep	O
and	O
wakefulness	O
in	O
reptiles	O

Sensitivities	O
of	O
thromboplastins	B
to	O
factor	B
VII	I
deficiency	O
.	O

3	O
.	O

Central	O
venous	O
catheter	O
used	O
for	O
recording	O
intracardiac	O
electrocardiogram	O
.	O

Two	O
Lab	O
8	O
computer	O
programmes	O
for	O
use	O
in	O
the	O
study	O
of	O
the	O
isometric	O
and	O
isotonic	O
contractile	O
characteristics	O
of	O
skeletal	O
muscle	O
.	O

Open	O
head	O
-	O
brain	O
injuries	O

The	O
modification	O
of	O
P32	O
uptake	O
into	O
the	O
Jensen	O
sarcoma	O
in	O
vitro	O
by	O
adding	O
of	O
peroxide	O
to	O
the	O
nutritive	O
medium	O

5-	O
(	O
Dimethylaminopropyl	O
)	O
-19,11-dihydro-5H	O
-	O
benzo	O
[	O
2,3	O
]	O
pyrido	O
[	O
6,7-b	O
]	O
azepine	O
.	O

Osteogenesis	O
imperfecta	O

Investigation	O
on	O
the	O
exchange	O
of	O
Ca45	O
in	O
intact	O
and	O
burned	O
rats	O
by	O
the	O
kinetic	O
analysis	O
method	O

Effect	O
of	O
thrombotic	O
and	O
antithrombotic	O
drugs	O
on	O
the	O
surface	O
charge	O
characteristics	O
of	O
canine	O
blood	O
vessels	O
:	O
in	O
vivo	O
and	O
in	O
vitro	O
studies	O
.	O

Measurements	O
of	O
activity	O
with	O
the	O
radioprotective	O
chamber	O
VA	O
-	O
K-254	O
of	O
the	O
osimeter	O
VA	O
-	O
J18	O

3-	O
(	O
N	O
-	O
Alkyl	O
-	O
N-2-chloroethylaminomethyl	O
)	O
-5-	O
or	O
7-halogenobenzo	O
[	O
b	O
]	O
thiophen	O
hydrochlorides	O
.	O

Nephrectomy	O
applied	O
to	O
cattle	O

Evaluation	O
of	O
automatic	O
blood	O
cell	O
counters	O
.	O

Determination	O
of	O
transaminases	O
with	O
an	O
autoanalyzer	O

Sterols	O
in	O
pollen	O
.	O

Histological	O
observations	O
on	O
the	O
decidua	O
in	O
the	O
second	O
half	O
of	O
pregnancy	O

Studies	O
on	O
the	O
method	O
of	O
size	O
reduction	O
of	O
medicinal	O
compounds	O
.	O

Identification	O
and	O
estimation	O
of	O
monosaccharides	O
and	O
disaccharides	O
in	O
urine	O
by	O
gas	O
-	O
liquid	O
chromatography	O
.	O

Steroids	O
in	O
germfree	O
and	O
conventional	O
rats	O
.	O

The	O
effects	O
of	O
loading	O
the	O
respiratory	O
pumps	O
on	O
the	O
oxygen	O
consumption	O
of	O
Callionymus	O
lyra	O
.	O

The	O
effect	O
of	O
a	O
constant	O
magnetic	O
field	O
on	O
the	O
phagocytic	O
activity	O
of	O
Paramecia	O

Studies	O
carried	O
out	O
with	O
the	O
Glossina	O
morsitans	O
colony	O
of	O
Lisbon	O
.	O

Relations	O
between	O
adrenergic	O
mechanisms	O
and	O
analgesic	O
effects	O

The	O
bearing	O
of	O
season	O
and	O
sequence	O
of	O
calving	O
on	O
frequency	O
of	O
male	O
,	O
female	O
and	O
total	O
calvings	O
in	O
Hariana	O
cows	O
.	O

Caries	O
prevention	O
in	O
the	O
dental	O
office	O
.	O

Clinical	O
applications	O
of	O
inhibition	O
of	O
beta	B
-	I
adrenergic	I
receptors	I
with	O
propranolol	O
.	O

Effect	O
of	O
castration	O
on	O
pituitary	B
and	I
serum	I
LH	I
and	O
FSH	B
in	O
testosterone	O
-	O
sterilized	O
rats	O
.	O

Evidence	O
forthe	O
electroosmosis	O
theory	O
of	O
transport	O
in	O
the	O
phloem	O
.	O

Effect	O
of	O
heparin	O
on	O
the	O
inactivation	O
of	O
serum	B
lipoprotein	I
lipase	I
by	O
the	O
liver	O
in	O
unanesthetized	O
dogs	O
.	O

Specialist	O
in	O
family	O
practice	O
--	O
prototype	O
of	O
a	O
doctor	O
.	O

The	O
possibility	O
of	O
selective	O
chemotherapy	O
of	O
progressive	O
recurring	O
ovarian	O
carcinoma	O
with	O
the	O
aid	O
of	O
cytodiagnosis	O
and	O
incorporation	O
of	O
tagged	O
idoxuridine	O

Variation	O
in	O
the	O
temporal	O
-	O
spatial	O
distribution	O
of	O
228Ra	O
and	O
224Ra	O
in	O
the	O
RES	O
and	O
marrow	O
-	O
free	O
skeleton	O
after	O
incorporation	O
of	O
colloidal	O
ThO2	O

Absorption	O
of	O
electrolytes	O
from	O
the	O
colon	O
in	O
cases	O
of	O
ulcerative	O
colitis	O
and	O
in	O
control	O
subjects	O
.	O

Ion	O
injection	O
.	O

Polyvinyl	O
alcohol	O
as	O
a	O
solution	O
mediator	O

Mining	O
the	O
diagnostic	O
iron	O
ore	O
.	O

The	O
need	O
in	O
the	O
small	O
hospital	O
.	O

On	O
the	O
character	O
of	O
changes	O
in	O
the	O
enzyme	O
activity	O
in	O
the	O
brain	O
tissue	O
during	O
reflex	O
epilepsy	O

A	O
malignant	O
true	O
teratoma	O
of	O
liver	O
in	O
childhood	O
.	O

Functional	O
disorders	O
of	O
the	O
ureter	O
following	O
gynecologic	O
surgery	O

Study	O
of	O
the	O
alterations	O
of	O
intestinal	O
absorption	O
,	O
by	O
means	O
of	O
I-131-triolein	O
,	O
in	O
the	O
whole	O
body	O
irradiated	O
rat	O

Chemical	O
histologic	O
and	O
immunologic	O
responses	O
in	O
rats	O
to	O
CC1	O
-	O
4	O
by	O
different	O
routes	O
of	O
administration	O
.	O

Statistics	O
of	O
the	O
past	O
5	O
years	O

On	O
the	O
diagnosis	O
of	O
bovine	O
leucosis	O
and	O
its	O
control	O
in	O
southern	O
Lower	O
Saxony	O

Studies	O
on	O
the	O
intracutaneous	O
infection	O
of	O
rabbits	O
by	O
Staphylococcus	O
aureus	O
.	O

On	O
catabolism	O
of	O
aminoketones	O
in	O
climacteric	O
age	O

Naphthalene	O
and	O
paradichlorobenzene	O
in	O
clinical	O
toxicology	O

IV	O
.	O

Studies	O
on	O
powdered	O
preparations	O
.	O

A	O
case	O
report	O
with	O
angiographic	O
follow	O
-	O
up	O
study	O
.	O

Further	O
studies	O
on	O
a	O
""""	O
new	O
""""	O
human	O
isoprecipitin	B
system	O
(	O
Australia	O
antigen	O
)	O
.	O

When	O
the	O
cervical	O
Pap	O
smear	O
is	O
positive	O
.	O

Persistence	O
of	O
toxaphene	O
in	O
treated	O
lakes	O
.	O

Studies	O
on	O
Coxsackie	O
B	O
Type	O
5	O
virus	O
infections	O
.	O

Value	O
of	O
the	O
method	O
of	O
passive	O
hemagglutination	O
with	O
polysaccharide	O
C	O
in	O
detecting	O
C	B
-	I
reactive	I
protein	I
as	O
compared	O
to	O
precipitation	O
in	O
capillaries	O
and	O
slide	O
latex	O
test	O
with	O
anti	B
-	I
CRP	I
serum	O

Concussion	O
of	O
the	O
spinal	O
cord	O

Antimicrobial	O
substance	O
isolated	O
from	O
an	O
acorn	O
extract	O
.	O

The	O
pathogenicity	O
of	O
Achromobacter	O
puntatum	O
for	O
cold	O
blooded	O
and	O
warm	O
blooded	O
animals	O

Consanguinity	O
and	O
migration	O
in	O
the	O
marriages	O
of	O
the	O
region	O
of	O
Nunoa	O
,	O
Santiago	O
,	O
1850	O
-	O
1960	O

On	O
the	O
amount	O
and	O
significance	O
of	O
the	O
effective	O
glucose	O
level	O
in	O
tumors	O
.	O

Studies	O
of	O
lipogenesis	O
by	O
labelled	O
precursors	O
in	O
the	O
pregnant	O
rat	O
.	O

Pharmacodynamic	O
studies	O
on	O
the	O
cardiovascular	O
system	O
of	O
spontaneously	O
hypertensive	O
rats	O
.	O

Nuclear	O
spin	O
of	O
249Bk	O
from	O
the	O
hyperfine	O
structure	O
in	O
its	O
emission	O
spectrum	O
.	O

Further	O
observations	O
on	O
resorption	O
in	O
guinea	O
pigs	O
following	O
injections	O
of	O
trypan	O
blue	O
.	O

Derivatives	O
of	O
fluorene	O
.	O

Retention	O
behavior	O
of	O
steroids	O
in	O
gas	O
chromatography	O
with	O
a	O
series	O
of	O
combination	O
columns	O
.	O

XXI	O
.	O

Electrophoretic	O
characteriaztion	O
of	O
virus	O
-	O
induced	O
interferon	B
of	O
the	O
blood	O
and	O
urine	O
in	O
rabbits	O

Iron	O
and	O
folate	O
deficiency	O
in	O
pregnancy	O

Symposium	O
on	O
presenile	O
spongy	O
encephalopathies	O
.	O

The	O
immuno	O
-	O
purified	O
mRNA	O
in	O
the	O
polysome	O
complex	O
was	O
used	O
to	O
prepare	O
cDNA	O
with	O
which	O
to	O
probe	O
a	O
D.	O
melanogaster	O
genomic	O
library	O
.	O

Elevated	O
maternal	B
alpha	I
fetoproteins	I
and	O
oligoamnios	O
:	O
fetal	O
prognosis	O

Also	O
discussed	O
is	O
the	O
possibility	O
of	O
a	O
combined	O
genetic	O
and	O
environmental	O
etiology	O
.	O

Courses	O
were	O
repeated	O
monthly	O
upon	O
recovery	O
of	O
myelosuppression	O
.	O

The	O
PEPCK	B
promoter	O
fragment	O
was	O
introduced	O
either	O
in	O
the	O
proper	O
orientation	O
for	O
transcription	O
of	O
the	O
TK	B
gene	I
or	O
in	O
the	O
opposite	O
orientation	O
.	O

Many	O
mammary	O
tumors	O
induced	O
by	O
mouse	O
mammary	O
tumor	O
virus	O
(	O
MMTV	O
)	O
contain	O
a	O
provirus	O
in	O
the	O
same	O
region	O
of	O
the	O
host	O
-	O
cell	O
genome	O
,	O
leading	O
to	O
expression	O
of	O
a	O
putative	O
cellular	O
oncogene	O
called	O
int-1	B
.	O

Hepatitis	O
B	O
virus	O
and	O
hepatoma	O
.	O

USA	O
80	O
,	O
3618	O
-	O
3622	O
)	O

The	O
two	O
proteins	O
show	O
36	O
%	O
identities	O
in	O
their	O
amino	O
acid	O
sequence	O
,	O
in	O
an	O
alignment	O
requiring	O
six	O
gaps	O
.	O

The	O
envelope	B
glycoproteins	I
of	I
Rous	I
sarcoma	I
virus	I
(	I
RSV	I
)	I
,	O
gp85	B
and	O
gp37	B
,	O
are	O
anchored	O
in	O
the	O
membrane	O
by	O
a	O
27-amino	O
acid	O
,	O
hydrophobic	O
domain	O
that	O
lies	O
adjacent	O
to	O
a	O
22-amino	O
acid	O
,	O
cytoplasmic	O
domain	O
at	O
the	O
carboxy	O
terminus	O
of	O
gp37	B
.	O

Effect	O
of	O
acute	O
and	O
chronic	O
psychogenic	O
stress	O
on	O
corticoadrenal	O
and	O
pituitary	B
-	I
thyroid	I
hormones	I
in	O
male	O
rats	O
.	O

It	O
is	O
concluded	O
that	O
haloperidol	O
selectively	O
reduced	O
the	O
animal	O
's	O
capacity	O
to	O
'	O
programme	O
non	O
-	O
stimulus	O
directed	O
motor	O
behaviour	O
'	O
.	O

The	O
results	O
presented	O
in	O
this	O
report	O
suggest	O
that	O
the	O
SV40	O
G	O
-	O
C	O
-	O
rich	O
sequences	O
can	O
function	O
as	O
independent	O
RNA	B
polymerase	I
II	I
transcriptional	O
-	O
control	O
elements	O
.	O

Theories	O
proffered	O
to	O
account	O
for	O
the	O
modality	O
shift	O
effect	O
are	O
critically	O
evaluated	O
.	O

The	O
effects	O
of	O
cardioselective	O
beta-1	O
adrenergic	O
agonist	O
,	O
1-	O
(	O
4-hydroxyphenoxy	O
)	O
-isopropylamino-2-propanol	O
)	O
,	O
i.e.	O
,	O
prenalterol	O
,	O
were	O
examined	O
on	O
direct	O
and	O
continuous	O
measurements	O
of	O
left	O
ventricular	O
(	O
LV	O
)	O
pressure	O
,	O
diameter	O
,	O
dP	O
/	O
dt	O
,	O
velocity	O
of	O
shortening	O
,	O
arterial	O
pressure	O
,	O
iliac	O
blood	O
flow	O
and	O
heart	O
rate	O
in	O
10	O
conscious	O
dogs	O
.	O

Endorphins	B
at	O
the	O
approach	O
of	O
death	O
.	O

The	O
roll	O
-	O
over	O
test	O
to	O
predict	O
toxemia	O
in	O
pregnancy	O
.	O

Can	O
thyroglobulin	B
assay	O
really	O
supplant	O
radioiodine	O
scans	O
in	O
patients	O
with	O
differentiated	O
thyroid	O
cancer	O
?	O

3	O
Significant	O
reductions	O
in	O
lying	O
mean	O
arterial	O
blood	O
pressure	O
were	O
observed	O
with	O
daily	O
doses	O
of	O
200	O
mg	O
(	O
-	O
9	O
%	O
)	O
,	O
400	O
mg	O
(	O
-	O
10	O
%	O
)	O
and	O
800	O
mg	O
(	O
-	O
14	O
%	O
)	O
,	O
and	O
were	O
associated	O
with	O
significant	O
decreases	O
in	O
heart	O
rate	O
and	O
plasma	B
renin	I
activity	O
.	O

Isolation	O
of	O
Aeromonas	O
from	O
faeces	O
.	O

Plasma	O
and	O
erthrocyte	O
lipid	O
profile	O
and	O
lipoprotein	B
lipase	I
activity	O
in	O
postheparin	O
plasma	O
on	O
vasectomized	O
rabbits	O
were	O
studied	O
and	O
also	O
the	O
incidence	O
of	O
atherosclerosis	O
in	O
different	O
arterial	O
beds	O
.	O

(	O
iii	O
)	O

The	O
mRNA	O
is	O
not	O
efficiently	O
polyadenylated	O
at	O
sequences	O
in	O
the	O
3	O
'	O
end	O
of	O
the	O
DHFR	B
cDNA	I
but	O
rather	O
uses	O
polyadenylation	O
signals	O
downstream	O
from	O
the	O
DHFR	B
cDNA	I
.	O

Propranolol	O
also	O
effectively	O
controlled	O
her	O
familial	O
tremor	O
.	O

The	O
distribution	O
phase	O
is	O
followed	O
by	O
an	O
elimination	O
phase	O
with	O
a	O
much	O
longer	O
half	O
-	O
life	O
(	O
mean	O
value	O
375	O
min	O
)	O
and	O
a	O
volume	O
of	O
distribution	O
of	O
approximately	O
200	O
-	O
400	O
l.	O

Risk	O
of	O
HTLV	O
infection	O
in	O
patients	O
on	O
haemodialysis	O
.	O

In	O
vitro	O
metabolism	O
of	O
progesterone	O
by	O
the	O
human	O
undescended	O
testis	O
.	O

Two	O
patients	O
withdrew	O
from	O
therapy	O
,	O
one	O
for	O
personal	O
reasons	O
and	O
one	O
because	O
a	O
paraspinal	O
mass	O
developed	O
.	O

All	O
patients	O
received	O
VCR	O
1.0	O
mg	O
/	O
m2	O
weekly	O
for	O
6	O
weeks	O
with	O
dose	O
modification	O
for	O
neurotoxicity	O
.	O

Glutamic	O
acid	O
in	O
a	O
dose	O
of	O
1	O
/	O
100	O
of	O
the	O
LD50	O
was	O
injected	O
in	O
the	O
form	O
of	O
sodium	O
salt	O
into	O
male	O
and	O
female	O
Wistar	O
rats	O
for	O
7	O
days	O
after	O
8-	O
and	O
12-day	O
injections	O
of	O
dexazone	O
.	O

Serum	O
ascorbic	O
acid	O
had	O
an	O
inverse	O
and	O
the	O
strongest	O
association	O
with	O
systolic	O
blood	O
pressure	O
among	O
the	O
risk	O
factors	O
including	O
blood	O
pressure	O
,	O
total	O
cholesterol	O
,	O
triglyceride	O
,	O
gamma	B
-	I
GTP	I
and	O
obesity	O
.	O

Plasma	B
secretin	I
,	O
pancreozymin	B
,	O
and	O
somatostatin	B
-	I
like	I
hormone	I
in	O
chronic	O
renal	O
failure	O
patients	O
.	O

Thalamotomy	O
aiming	O
at	O
the	O
CM	O
-	O
Pf	O
complex	O
and	O
using	O
stereotactic	O
gamma	O
irradiation	O
has	O
been	O
performed	O
in	O
a	O
series	O
of	O
52	O
patients	O
with	O
severe	O
pain	O
due	O
to	O
malignancy	O
.	O

2	O
Silastic	O
capsules	O
,	O
each	O
containing	O
22	O
-	O
23	O
mg	O
of	O
ethinyl	O
estradiol	O
,	O
were	O
inserted	O
subcutaneously	O
in	O
5	O
men	O
with	O
benign	O
prostatic	O
hypertrophy	O
.	O

When	O
used	O
subcutaneously	O
or	O
intravenously	O
in	O
maximum	O
tolerated	O
doses	O
the	O
antibiotic	O
inhibited	O
the	O
development	O
of	O
lymphadenosis	O
NK	O
/	O
Li	O
by	O
90	O
and	O
70	O
per	O
cent	O
respectively	O
.	O

Effect	O
of	O
2-	O
(	O
p	O
-	O
chlorophenyl	O
)	O
cyclopropylamine	O
on	O
5-hydroxyindole	O
concentration	O
and	O
monoamine	B
oxidase	I
activity	O
in	O
rat	O
brain	O
.	O

Then	O
,	O
pure	O
pancreatic	O
juice	O
was	O
infused	O
into	O
the	O
duodenum	O
.	O

An	O
experiment	O
was	O
carried	O
on	O
133	O
grown	O
up	O
fowls	O
and	O
broilers	O
from	O
4	O
industrial	O
farms	O
,	O
vaccinated	O
with	O
spray	O
lento	O
and	O
mesogenic	O
vaccines	O
for	O
straining	O
the	O
immunity	O
against	O
pseodopest	O
through	O
RIHA	O
and	O
provoking	O
pseudoplague	O
with	O
a	O
pathogenic	O
virus	O
.	O

(	O
2	O
)	O
The	O
inappropriateness	O
of	O
adaptive	O
segmentation	O
for	O
the	O
isolation	O
of	O
spikes	O
and	O
sharp	O
waves	O
,	O
which	O
had	O
been	O
anticipated	O
in	O
view	O
of	O
the	O
short	O
duration	O
of	O
such	O
transients	O
in	O
relation	O
to	O
the	O
length	O
of	O
the	O
window	O
(	O
1.2	O
sec	O
)	O
used	O
for	O
the	O
autocorrelation	O
functions	O
employed	O
in	O
the	O
segmentation	O
algorithm	O
,	O
was	O
confirmed	O
.	O

The	O
ability	O
of	O
chronic	O
UM-272	O
(	O
dimethylpropranolol	O
)	O
treatment	O
to	O
prevent	O
the	O
induction	O
of	O
reentrant	O
ventricular	O
tachyarrhythmias	O
was	O
assessed	O
in	O
the	O
conscious	O
dog	O
subjected	O
to	O
serial	O
programmed	O
electrical	O
stimulation	O
on	O
days	O
3	O
-	O
-5	O
after	O
myocardial	O
infarction	O
.	O

In	O
the	O
latter	O
category	O
particular	O
emphasis	O
is	O
being	O
placed	O
on	O
new	O
anthracycline	O
analogues	O
of	O
doxorubicin	O
and	O
analogues	O
of	O
cisplatinum	O
diammine	O
dichloride	O
.	O

Unusual	O
course	O
of	O
plasmocytosis	O
.	O

Late	O
mRNA	O
selected	O
by	O
a	O
cDNA	O
homologous	O
to	O
the	O
HindIII	B
-	I
P	I
/	O
EcoRI	B
-	I
B	I
region	O
of	O
the	O
AcNPV	O
map	O
directed	O
the	O
synthesis	O
of	O
31	O
K	O
and	O
30	O
K	O
proteins	O
which	O
comigrated	O
with	O
the	O
31	O
K	O
and	O
30	O
K	O
proteins	O
translated	O
from	O
RNA	O
selected	O
by	O
the	O
HindIII	B
-	I
A	I
/	O
EcoRI	B
-	I
C	I
/	O
SstI	B
-	I
G	I
cDNA	O
.	O

A	O
polypeptide	O
chain	O
of	O
34	O
residues	O
of	O
the	O
deduced	O
yeast	O
amino	O
acid	O
sequence	O
closely	O
resembles	O
a	O
peptide	O
sequence	O
at	O
the	O
ADP	O
binding	O
site	O
of	O
bovine	B
muscle	I
pyruvate	I
kinase	I
.	O

The	O
P165	O
component	O
,	O
however	O
,	O
could	O
be	O
differentiated	O
from	O
the	O
two	O
later	O
components	O
since	O
it	O
increased	O
in	O
amplitude	O
with	O
increased	O
task	O
demands	O
while	O
the	O
N2	O
and	O
P3	O
amplitudes	O
remained	O
constant	O
.	O

Differential	O
drawing	O
size	O
associated	O
with	O
unilateral	O
brain	O
damage	O
.	O

Toxicity	O
was	O
significant	O
in	O
selected	O
cases	O
;	O
three	O
patients	O
developed	O
WBC	O
counts	O
less	O
than	O
1,000	O
/	O
mm3	O
and	O
one	O
of	O
these	O
patients	O
died	O
with	O
sepsis	O
.	O

Subdural	O
electrodes	O
may	O
yield	O
larger	O
VEP	O
amplitudes	O
than	O
skull	O
or	O
scalp	O
electrodes	O
.	O

Use	O
of	O
the	O
immunofluorescence	O
method	O
for	O
identification	O
of	O
enteroviruses	O
in	O
cell	O
cultures	O

This	O
fraction	O
is	O
resistant	O
to	O
digestions	O
by	O
DNase	B
I	I
and	O
RNase	B
T1	I
and	O
disappears	O
completely	O
upon	O
alkali	O
hydrolysis	O
.	O

The	O
direct	O
effects	O
of	O
transmitter	O
release	O
were	O
(	O
a	O
)	O
an	O
early	O
fall	O
in	O
MAP	O
followed	O
by	O
a	O
late	O
pressor	O
effect	O
;	O
and	O
(	O
b	O
)	O
an	O
early	O
bradycardia	O
followed	O
by	O
a	O
late	O
tachycardia	O
.	O

The	O
number	O
of	O
elements	O
and	O
their	O
sizes	O
relative	O
to	O
the	O
configuration	O
were	O
varied	O
in	O
a	O
series	O
of	O
five	O
experiments	O
.	O

Immunochemotherapy	O
with	O
schizophyllan	O
(	O
SPG	O
)	O
combined	O
with	O
chemotherapeutic	O
agents	O
was	O
evaluated	O
in	O
two	O
syngeneic	O
tumor	O
-	O
C3H	O
/	O
He	O
mouse	O
systems	O
.	O

However	O
,	O
when	O
combined	O
with	O
mitomycin	O
C	O
given	O
with	O
1	O
to	O
5-days	O
interval	O
,	O
the	O
concurrent	O
administration	O
of	O
SPG	O
prolonged	O
significantly	O
the	O
life	O
-	O
span	O
of	O
the	O
tumor	O
-	O
bearing	O
mice	O
.	O

Data	O
are	O
presented	O
hinting	O
that	O
the	O
15	O
beta	O
-	O
hydroxy-	O
,	O
metabolite	O
of	O
CPA	O
may	O
actually	O
be	O
the	O
biologically	O
active	O
agent	O
.	O

The	O
abluminal	O
surface	O
is	O
often	O
almost	O
entirely	O
encircled	O
by	O
a	O
thick	O
layer	O
of	O
fibrillary	O
connective	O
tissue	O
.	O

In	O
contrast	O
,	O
in	O
LL	O
patients	O
during	O
ENL	O
the	O
ConA	B
-	O
induced	O
suppressor	O
response	O
was	O
markedly	O
reduced	O
.	O

Functional	O
characterization	O
of	O
a	O
fraction	O
identified	O
by	O
its	O
activity	O
in	O
a	O
second	O
template	O
rescue	O
assay	O
.	O

Fibrin	B
gels	O
and	O
their	O
possible	O
implication	O
for	O
surface	O
hemorheology	O
in	O
health	O
and	O
disease	O
.	O

Radiogallium	O
imaging	O
is	O
thus	O
of	O
limited	O
use	O
in	O
evaluation	O
of	O
suspected	O
giant	O
cell	O
tumors	O
of	O
bone	O
.	O

Ventricular	O
volume	O
stiffness	O
vs.	O
the	O
mean	O
wall	O
stress	O
relationship	O
of	O
LVH	O
shifted	O
upward	O
,	O
whereas	O
the	O
normalized	O
wall	O
muscle	O
stiffness	O
vs.	O
the	O
mean	O
wall	O
stress	O
relationship	O
of	O
LVH	O
showed	O
a	O
smaller	O
slope	O
.	O

Synthesis	O
of	O
(	O
+	O
)	O
-lysergic	O
acid	O
diethylamide	O
tartrate	O

Weight	O
loss	O
reduces	O
arterial	O
pressure	O
by	O
a	O
decrease	O
in	O
intravascular	O
volume	O
and	O
cardiac	O
output	O
associated	O
with	O
a	O
fall	O
in	O
sympathetic	O
activity	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
assess	O
the	O
effects	O
of	O
hypothermia	O
and	O
chemical	O
cardioplegia	O
on	O
the	O
functional	O
recovery	O
of	O
hypertrophied	O
non	O
-	O
failing	O
rat	O
hearts	O
subjected	O
to	O
an	O
extended	O
period	O
of	O
global	O
ischaemia	O
.	O

Among	O
six	O
different	O
library	O
isolates	O
containing	O
6.5-	B
to	I
7-kb	I
IAP	I
units	I
,	O
some	O
restriction	O
sites	O
were	O
highly	O
conserved	O
whereas	O
others	O
varied	O
in	O
both	O
occurrence	O
and	O
position	O
.	O

Catecholamines	O
and	O
aversive	O
learning	O
:	O
a	O
review	O
.	O

The	O
antibody	O
titer	O
of	O
202	O
chickens	O
to	O
SA-11	O
rotavirus	O
was	O
determined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
blocking	O
assay	O
.	O

Thus	O
it	O
appears	O
that	O
insertion	O
of	O
a	O
transposable	O
element	O
near	O
the	O
5	O
'	O
terminus	O
of	O
the	O
structural	O
gene	O
can	O
produce	O
constitutive	O
expression	O
of	O
a	O
normally	O
glucose	O
-	O
repressed	O
enzyme	O
.	O

Five	O
experiments	O
examined	O
the	O
influence	O
of	O
opiate	O
antagonists	O
on	O
both	O
the	O
short	O
-	O
term	O
analgesic	O
reaction	O
resulting	O
30	O
min	O
after	O
exposure	O
to	O
inescapable	O
shock	O
and	O
the	O
long	O
-	O
term	O
analgesic	O
reaction	O
resulting	O
after	O
reexposure	O
to	O
shock	O
24	O
hr	O
after	O
inescapable	O
shock	O
exposure	O
.	O

During	O
the	O
period	O
from	O
May	O
to	O
August	O
,	O
1978	O
,	O
an	O
epidemic	O
of	O
hand	O
,	O
foot	O
and	O
mouth	O
disease	O
(	O
HFMD	O
)	O
occurred	O
in	O
Gifu	O
prefecture	O
.	O

A	O
22	O
K	O
polypeptide	O
was	O
detected	O
as	O
a	O
translation	O
product	O
of	O
late	O
RNA	O
that	O
hybridized	O
to	O
this	O
DNA	O
fragment	O
.	O

The	O
genome	O
of	O
avian	O
erythroblastosis	O
virus	O
contains	O
two	O
independently	O
expressed	O
genetic	O
loci	O
(	O
v	B
-	I
erbA	I
and	O
v	B
-	I
erbB	I
)	O
whose	O
activities	O
are	O
probably	O
responsible	O
for	O
oncogenesis	O
by	O
the	O
virus	O
.	O

Both	O
neural	O
and	O
hormonal	O
pathways	O
and	O
both	O
opiate	O
and	O
nonopiate	O
substances	O
play	O
roles	O
in	O
the	O
complex	O
modulation	O
of	O
pain	O
transmission	O
.	O

WR-2721	O
(	O
S-2-	O
(	O
3	O
aminopropylamino	O
)	O
ethylphosphorothioic	O
acid	O
)	O
has	O
been	O
investigated	O
for	O
its	O
ability	O
to	O
protect	O
gut	O
,	O
lung	O
,	O
and	O
testis	O
,	O
as	O
well	O
as	O
fibrosarcoma	O
(	O
FSa	O
)	O
tumor	O
nodules	O
,	O
in	O
the	O
lungs	O
of	O
mice	O
from	O
gamma	O
-	O
radiation	O
injury	O
.	O

In	O
fact	O
,	O
families	O
of	O
polypeptides	O
were	O
produced	O
by	O
initiation	O
of	O
translation	O
at	O
AUG	O
codons	O
within	O
sequences	O
coding	O
for	O
VP1	B
and	O
T	B
,	O
presumably	O
as	O
a	O
result	O
of	O
transcription	O
initiation	O
events	O
that	O
generated	O
5	O
'	O
ends	O
immediately	O
upstream	O
from	O
these	O
AUGs	O
.	O

In	O
addition	O
,	O
TRP1	B
RI	O
Circle	O
DNA	O
is	O
organized	O
into	O
nucleosomes	O
whose	O
size	O
and	O
spacing	O
are	O
indistinguishable	O
from	O
that	O
of	O
bulk	O
yeast	O
chromatin	O
.	O

In	O
49	O
patients	O
in	O
whom	O
gated	O
equilibrium	O
ventriculography	O
and	O
cardiac	O
catheterization	O
were	O
performed	O
within	O
a	O
6	O
day	O
interval	O
,	O
total	O
and	O
fractional	O
portions	O
of	O
global	O
and	O
regional	O
right	O
ventricular	O
ejection	O
fraction	O
(	O
RVEF	O
)	O
were	O
correlated	O
with	O
pulmonary	O
arterial	O
systolic	O
pressure	O
.	O

74	O
,	O
193	O
-	O
197	O
)	O
.	O

Two	O
mutations	O
that	O
affect	O
larval	B
cuticle	I
protein	I
gene	I
expression	O
in	O
the	O
2	O
/	O
3	O
variant	O
Drosophila	O
melanogaster	O
strain	O
were	O
investigated	O
.	O

The	O
strong	O
conservation	O
of	O
the	O
inverted	O
terminal	O
repeat	O
sequence	O
may	O
reflect	O
a	O
common	O
integration	O
mechanism	O
for	O
VL30	B
elements	I
and	O
MuLV	O
proviruses	O
.	O

A	O
cDNA	O
cloning	O
vector	O
that	O
permits	O
expression	O
of	O
cDNA	O
inserts	O
in	O
mammalian	O
cells	O
.	O

Hybridization	O
of	O
plasmid	O
-	O
transformed	O
Escherichia	O
coli	O
RR1	O
colonies	O
with	O
32P	O
-	O
labeled	O
viral	O
genome	O
RNAs	O
demonstrated	O
the	O
presence	O
of	O
DNA	O
clones	O
representative	O
of	O
each	O
of	O
the	O
10	O
reovirus	O
RNAs	O
and	O
10	O
of	O
the	O
11	O
constituent	O
segments	O
of	O
the	O
rotavirus	O
genome	O
.	O

In	O
conclusion	O
,	O
these	O
studies	O
indicate	O
that	O
LiCl	O
(	O
1	O
)	O
decreases	O
histamine	O
-	O
stimulated	O
gastric	O
acid	O
secretion	O
,	O
and	O
(	O
2	O
)	O
diminishes	O
bile	O
-	O
induced	O
disruption	O
of	O
the	O
gastric	O
mucosal	O
barrier	O
in	O
the	O
canine	O
Heidenhain	O
pouch	O
.	O

The	O
junctions	O
between	O
viral	O
and	O
cellular	O
sequences	O
were	O
determined	O
by	O
DNA	O
sequence	O
analysis	O
to	O
be	O
517	O
nucleotides	O
into	O
the	O
p30	B
sequence	I
and	O
1,920	O
nucleotides	O
into	O
the	O
polymerase	O
sequence	O
.	O

Gel	O
route	O
preparation	O
of	O
low	O
fusing	O
dental	O
porcelain	O
frit	O
.	O

Viral	O
RNA	O
,	O
molecularly	O
cloned	O
proviral	O
DNA	O
,	O
and	O
virus	O
-	O
specific	O
protein	O
of	O
avian	O
retrovirus	O
MH2	O
were	O
analyzed	O
.	O

Intracellular	O
recordings	O
were	O
performed	O
on	O
the	O
optic	O
tectum	O
of	O
the	O
carp	O
in	O
vitro	O
.	O

Plasmids	O
for	O
the	O
cloning	O
and	O
expression	O
of	O
full	O
-	O
length	O
double	O
-	O
stranded	O
cDNAs	O
under	O
control	O
of	O
the	O
SV40	B
early	I
or	O
late	B
gene	I
promoter	O
.	O

Supplementing	O
a	O
soybean	O
protein	O
and	O
sucrose	O
-	O
based	O
diet	O
with	O
levels	O
of	O
2.2	O
,	O
11	O
,	O
and	O
55	O
ppm	O
of	O
the	O
antibiotic	O
,	O
from	O
the	O
two	O
sources	O
each	O
with	O
two	O
different	O
purities	O
,	O
improved	O
weight	O
gain	O
of	O
chicks	O
an	O
average	O
of	O
23	O
%	O
and	O
improved	O
feed	O
efficiency	O
an	O
average	O
of	O
13	O
%	O
at	O
the	O
higher	O
levels	O
(	O
all	O
P	O
less	O
than	O
.01	O
)	O
.	O

The	O
splice	O
acceptor	O
site	O
is	O
ca	O
.	O

This	O
is	O
consistent	O
with	O
a	O
model	O
proposing	O
that	O
SSV	O
was	O
generated	O
by	O
recombination	O
between	O
proviral	O
DNA	O
of	O
a	O
simian	O
sarcoma	O
associated	O
virus	O
and	O
proto	B
-	I
sis	I
and	O
that	O
introns	O
were	O
spliced	O
out	O
subsequently	O
from	O
a	O
fused	O
viral	B
-	I
sis	I
messenger	I
RNA	I
.	O

We	O
conclude	O
that	O
,	O
with	O
autonomic	O
nervous	O
system	O
activity	O
intact	O
,	O
carotid	O
chemoreceptor	O
reflex	O
activation	O
can	O
elicit	O
an	O
absolute	O
reflexly	O
mediated	O
reduction	O
in	O
coronary	O
blood	O
flow	O
in	O
the	O
normal	O
,	O
conscious	O
dog	O
,	O
despite	O
an	O
increase	O
in	O
arterial	O
pressure	O
.	O

Female	O
subjects	O
,	O
including	O
both	O
normal	O
subjects	O
and	O
idiopathic	O
calcium	O
stone	O
-	O
formers	O
,	O
have	O
higher	O
urinary	O
cyclic	O
AMP	O
levels	O
than	O
their	O
male	O
counterparts	O
,	O
and	O
this	O
difference	O
is	O
significant	O
when	O
urinary	O
cyclic	O
AMP	O
is	O
expressed	O
in	O
the	O
units	O
mumol	O
/	O
g	O
of	O
creatinine	O
.	O

The	O
effect	O
of	O
desipramine	O
probably	O
represents	O
inhibition	O
of	O
neuronal	O
uptake	O
and	O
that	O
of	O
amitriptyline	O
and	O
mianserin	O
blockade	O
of	O
neuronal	O
uptake	O
and	O
prejunctional	O
alpha	B
2-adrenoreceptors	I
.	O

We	O
conclude	O
that	O
the	O
gp54	B
structural	I
gene	I
is	O
required	O
for	O
initiation	O
or	O
amplification	O
of	O
the	O
splenic	O
erythroblast	O
hyperplasia	O
which	O
characterizes	O
the	O
preleukemic	O
phase	O
of	O
Rauscher	O
disease	O
.	O

Surgical	O
treatment	O
of	O
pulmonary	O
metastases	O
.	O

Each	O
of	O
these	O
spliced	O
mRNAs	O
has	O
an	O
untranslated	O
leader	O
sequence	O
of	O
249	O
bases	O
and	O
a	O
single	O
intron	O
of	O
approximately	O
540	O
bases	O
which	O
are	O
contained	O
entirely	O
within	O
TRs	O
/	O
IRs	O
sequences	O
.	O

The	O
expression	O
of	O
chloramphenicol	B
acetyltransferase	I
was	O
detected	O
within	O
1	O
h	O
after	O
infection	O
of	O
cells	O
with	O
recombinant	O
virus	O
,	O
reflecting	O
the	O
early	O
nature	O
of	O
the	O
promoters	O
used	O
.	O

NPT	B
II	I
synthesis	O
,	O
measured	O
by	O
agar	O
plate	O
assays	O
of	O
kanamycin	O
resistance	O
and	O
by	O
immunoprecipitation	O
of	O
the	O
NPT	B
II	I
protein	I
,	O
was	O
repressed	O
in	O
the	O
presence	O
of	O
cysteine	O
and	O
derepressed	O
in	O
its	O
absence	O
.	O

A	O
computed	O
tomographic	O
scan	O
obtained	O
after	O
EOE-13	O
infusion	O
accurately	O
showed	O
the	O
perfusion	O
pattern	O
of	O
the	O
implanted	O
catheter	O
.	O

No	O
significant	O
correlation	O
was	O
found	O
between	O
LVM	O
or	O
wall	O
thickness	O
and	O
body	O
surface	O
area	O
,	O
age	O
,	O
blood	O
pressure	O
,	O
heart	O
rate	O
,	O
cardiac	O
output	O
,	O
total	O
peripheral	O
resistance	O
and	O
left	O
ventricular	O
systolic	O
wall	O
stress	O
,	O
whereas	O
CD25	O
was	O
correlated	O
with	O
urinary	O
catecholamines	O
only	O
in	O
hypertensive	O
patients	O
(	O
r	O
=	O
0.606	O
,	O
p	O
less	O
than	O
0.001	O
)	O
.	O

The	O
gene	B
cat-86	I
,	O
specifying	O
chloramphenicol	B
-	I
inducible	I
chloramphenicol	I
acetyltransferase	I
,	O
is	O
located	O
on	O
the	O
1.1-kilobase	O
cloned	O
DNA	O
.	O

The	O
myeloproliferative	O
sarcoma	O
virus	O
(	O
MPSV	O
)	O
was	O
derived	O
by	O
passage	O
of	O
Moloney	O
sarcoma	O
virus	O
(	O
Mo	O
-	O
MuSV	O
)	O
in	O
adult	O
mice	O
.	O

The	O
same	O
-	O
sized	O
EBNA	B
protein	I
(	I
approximately	I
78,000	I
)	I
was	O
made	O
after	O
transfection	O
with	O
BamHI	B
-	I
K	I
(	I
5.2	I
kilobase	I
pairs	I
[	I
kbp	I
]	I
)	I
or	O
the	O
I1f	O
subfragment	O
(	O
2.9	O
kbp	O
)	O
.	O

They	O
generated	O
ca	O
.	O

An	O
immunologic	O
test	O
using	O
stomach	O
and	O
tumor	O
antigens	O
for	O
screening	O
of	O
those	O
at	O
high	O
risk	O
for	O
stomach	O
cancer	O
is	O
suggested	O
.	O

Thirty	O
isolates	O
of	O
Haemophilus	O
influenzae	O
type	O
b	O
were	O
obtained	O
during	O
an	O
outbreak	O
of	O
invasive	O
H.	O
influenzae	O
type	O
b	O
disease	O
and	O
were	O
classified	O
by	O
the	O
electrophoretic	O
profile	O
of	O
their	O
lipopolysaccharide	O
(	O
LPS	O
)	O
.	O

Tiaprofenic	O
acid	O
overdose	O
.	O

Frog	O
type	O
I	O
(	O
Ft	O
I	O
)	O
and	O
frog	O
type	O
II	O
(	O
Ft	O
II	O
)	O
slowly	O
adapting	O
(	O
SA	O
)	O
units	O
produced	O
spikes	O
only	O
at	O
the	O
indentation	O
phase	O
,	O
and	O
the	O
threshold	O
response	O
phase	O
(	O
TRP	O
)	O
,	O
i.e	O
..	O
the	O
phase	O
of	O
the	O
first	O
spike	O
was	O
for	O
ca	O
.	O

DMCM	O
also	O
permits	O
extension	O
of	O
the	O
possibilities	O
of	O
obtaining	O
and	O
transplanting	O
donor	O
organs	O
.	O

In	O
patients	O
in	O
group	O
A	O
(	O
""""	O
normal	O
""""	O
CI	O
)	O
,	O
the	O
CI	O
,	O
heart	O
rate	O
and	O
the	O
mean	O
circumferential	O
fiber	O
shortening	O
velocity	O
(	O
mVCF	O
)	O
were	O
normal	O
,	O
but	O
the	O
TPR	O
was	O
increased	O
significantly	O
.	O

Immunologically	O
reactive	O
insulin	B
levels	O
were	O
determined	O
in	O
freely	O
-	O
moving	O
normal	O
rats	O
offered	O
three	O
different	O
test	O
-	O
meals	O
.	O

The	O
genes	O
at	O
each	O
locus	O
are	O
divergently	O
transcribed	O
and	O
the	O
coding	O
sequences	O
are	O
separated	O
by	O
646	O
base	O
-	O
pairs	O
at	O
one	O
locus	O
and	O
676	O
base	O
-	O
pairs	O
at	O
the	O
other	O
.	O

The	O
enzymic	O
hydrolysis	O
of	O
urea	O
produces	O
ammonia	O
which	O
causes	O
a	O
vivid	O
yellow	O
to	O
purple	O
colour	O
change	O
in	O
the	O
pH	O
indicator	O
.	O

Plasma	O
renin	B
activity	O
did	O
not	O
change	O
in	O
response	O
to	O
head	O
-	O
up	O
tilt	O
or	O
isoprenaline	O
infusion	O
in	O
the	O
patients	O
.	O

Induced	O
gamma	O
-	O
ray	O
spectroscopy	O

Bepridil	O
,	O
a	O
calcium	O
antagonist	O
with	O
a	O
half	O
-	O
life	O
of	O
approximately	O
42	O
hours	O
,	O
was	O
compared	O
with	O
placebo	O
in	O
a	O
double	O
-	O
blind	O
,	O
randomized	O
,	O
crossover	O
trial	O
.	O

Effects	O
of	O
negative	O
pleural	O
pressure	O
on	O
left	O
ventricular	O
hemodynamics	O
.	O

Lauciello	O
describes	O
a	O
technique	O
for	O
the	O
placement	O
of	O
functionally	O
generated	O
amalgam	O
stops	O
as	O
restorations	O
within	O
mandibular	O
acrylic	O
teeth	O
.	O

These	O
data	O
suggest	O
that	O
a	O
major	O
part	O
of	O
the	O
reduction	O
in	O
food	O
intake	O
in	O
hyperphagic	O
rats	O
eating	O
a	O
quinine	O
-	O
adulterated	O
diet	O
is	O
due	O
to	O
postingestional	O
events	O
.	O

The	O
aspirate	O
from	O
a	O
parathyroid	O
cyst	O
was	O
watery	O
clear	O
and	O
contained	O
high	O
amount	O
of	O
parathyroid	B
hormone	I
.	O

The	O
numerous	O
tests	O
demonstrate	O
that	O
the	O
HDL-2	O
M	O
can	O
be	O
extensively	O
and	O
successfully	O
used	O
for	O
therapy	O
of	O
insulin	B
-	O
dependent	O
diabetes	O
mellitus	O
in	O
clinical	O
practice	O
.	O

Transplantation	O
of	O
kidneys	O
of	O
juvenile	O
donors	O
in	O
adult	O
recipients	O
.	O

Results	O
of	O
a	O
controlled	O
study	O

Hydrallazine	O
also	O
caused	O
a	O
slight	O
increase	O
in	O
plasma	B
renin	I
activity	O
and	O
urinary	O
excretion	O
of	O
noradrenaline	O
.	O

After	O
description	O
of	O
his	O
short	O
life	O
and	O
an	O
explanation	O
of	O
the	O
light	O
conductor	O
Bozzini	O
's	O
merit	O
is	O
emphasized	O
,	O
by	O
his	O
invention	O
as	O
first	O
physician	O
to	O
have	O
made	O
accessible	O
to	O
medicine	O
endoscopic	O
diagnostic	O
possibilities	O
.	O

The	O
susceptibility	O
of	O
the	O
PPNG	O
strains	O
to	O
clinically	O
relevant	O
antibiotics	O
varied	O
with	O
the	O
plasmid	O
pattern	O
;	O
this	O
stresses	O
the	O
necessity	O
of	O
permanent	O
surveillance	O
of	O
gonococcal	O
infections	O
and	O
of	O
regular	O
evaluation	O
of	O
the	O
recommendations	O
for	O
antimicrobial	O
treatment	O
.	O

195mPt	O
-	O
labeled	O
cisplatin	O
was	O
administered	O
iv	O
and	O
ip	O
to	O
control	O
mice	O
and	O
to	O
mice	O
bearing	O
Sarcoma	O
180	O
.	O

New	O
beta	O
-	O
blocking	O
drugs	O
have	O
been	O
introduced	O
which	O
may	O
prove	O
beneficial	O
in	O
certain	O
clinical	O
situations	O
since	O
they	O
exert	O
more	O
selective	O
blockade	O
of	O
the	O
cardiac	B
receptors	I
(	O
beta1	B
)	O
as	O
opposed	O
to	O
smooth	B
muscle	I
receptors	I
(	O
beta2	B
)	O
.	O

If	O
facilities	O
for	O
measurements	O
of	O
O2	O
consumption	O
and	O
hence	O
metabolic	O
rate	O
are	O
available	O
,	O
these	O
should	O
be	O
utilized	O
.	O

This	O
generally	O
means	O
an	O
energy	O
intake	O
of	O
1.4	O
to	O
1.6	O
times	O
the	O
energy	O
expenditure	O
,	O
with	O
a	O
N	O
intake	O
of	O
250	O
to	O
400	O
mg	O
/	O
kg	O
/	O
day	O
.	O

In	O
the	O
37	O
patients	O
without	O
lung	O
disease	O
respiratory	O
muscle	O
weakness	O
was	O
accompanied	O
by	O
significant	O
decreases	O
in	O
vital	O
capacity	O
,	O
total	O
lung	O
capacity	O
,	O
and	O
maximum	O
voluntary	O
ventilation	O
;	O
by	O
significant	O
increases	O
in	O
residual	O
volume	O
and	O
arterial	O
carbon	O
dioxide	O
tension	O
(	O
PaCO2	O
)	O
;	O
and	O
greater	O
likelihood	O
of	O
dependence	O
on	O
ventilators	O
,	O
atelectasis	O
,	O
and	O
pneumonia	O
.	O

Commun	O
.	O

The	O
statistical	O
analysis	O
of	O
data	O
of	O
TRH	B
test	O
on	O
a	O
sample	O
of	O
57	O
healthy	O
volunteers	O
has	O
permitted	O
an	O
evaluation	O
of	O
the	O
upper	O
limits	O
of	O
the	O
normal	O
thyrotropin	B
response	O
;	O
the	O
secretory	O
area	O
(	O
As	O
)	O
was	O
shown	O
to	O
be	O
more	O
discriminating	O
.	O

Total	O
cumulative	O
doses	O
of	O
doxorubicin	O
ranged	O
from	O
145	O
to	O
625	O
mg.	O
/	O
m.2	O
.	O

Movement	O
programming	O
depends	O
on	O
understanding	O
of	O
behavioral	O
requirements	O
.	O

Transitory	O
subclinical	O
and	O
permanent	O
hypothyroidism	O
in	O
the	O
course	O
of	O
subacute	O
thyroiditis	O
(	O
de	O
Quervain	O
)	O
.	O

Gonadotropin	B
levels	O
in	O
mothers	O
who	O
have	O
had	O
two	O
sets	O
of	O
DZ	O
twins	O
.	O

Freezing	O
of	O
plasma	O
to	O
obtain	O
better	O
yield	O
of	O
factor	B
VIII	I
:	O
C.	O

These	O
children	O
were	O
grouped	O
into	O
four	O
diagnostic	O
categories	O
:	O
1	O
)	O
idiopathic	O
GH	B
deficiency	O
(	O
n	O
=	O
10	O
)	O
;	O
2	O
)	O
organic	O
hypopituitarism	O
(	O
n	O
=	O
7	O
)	O
;	O
3	O
)	O
intrauterine	O
growth	O
retardation	O
(	O
n	O
=	O
5	O
)	O
;	O
and	O
4	O
)	O
constitutional	O
delay	O
of	O
growth	O
and/or	O
familial	O
short	O
stature	O
(	O
n	O
=	O
18	O
)	O
,	O
by	O
standard	O
clinical	O
criteria	O
and	O
physiological	O
and	O
pharmacological	O
tests	O
of	O
GH	B
reserve	O
.	O

Each	O
patient	O
had	O
measurable	O
LH	B
and	O
FSH	B
levels	O
,	O
with	O
pulsed	O
nocturnal	O
secretion	O
,	O
and	O
pubertal	O
LH	B
and	O
FSH	B
responses	O
to	O
LRH	B
.	O

Cimetidine	O
800	O
mg	O
given	O
at	O
night	O
is	O
as	O
effective	O
as	O
400	O
mg	O
twice	O
daily	O
;	O
the	O
single	O
dose	O
regimen	O
may	O
improve	O
patient	O
compliance	O
,	O
thus	O
facilitating	O
treatment	O
.	O

Ceftazidime	O
shows	O
promise	O
as	O
single	O
-	O
agent	O
therapy	O
for	O
serious	O
gram	O
-	O
negative	O
bacillary	O
infections	O
.	O

The	O
management	O
of	O
the	O
""""	O
chronic	O
""""	O
patient	O
.	O

Study	O
of	O
bacterial	O
motility	O
and	O
rate	O
of	O
movement	O
using	O
a	O
closed	O
circuit	O
television	O

Each	O
causative	O
organism	O
has	O
a	O
species	O
-	O
specific	O
preference	O
and	O
requirement	O
for	O
temperature	O
,	O
salinity	O
,	O
pH	O
,	O
the	O
basic	O
nutrients	O
,	O
and	O
growth	O
factors	O
,	O
and	O
the	O
toxin	O
formation	O
is	O
affected	O
by	O
these	O
environmental	O
factors	O
.	O

It	O
is	O
concluded	O
that	O
axillo	O
-	O
axillary	O
by	O
-	O
pass	O
is	O
a	O
simple	O
solution	O
for	O
a	O
complex	O
haemodynamic	O
,	O
clinical	O
and	O
therapeutic	O
problem	O
.	O

Deformities	O
of	O
the	O
tip	O
of	O
the	O
olecranon	O
and	O
of	O
the	O
coronoid	O
process	O
are	O
also	O
described	O
(	O
De	O
Palma	O
1956	O
,	O
Jordan	O
1958	O
,	O
Ahlberg	O
1965	O
,	O
Weseloh	O
1973	O
)	O
.	O

Statokinesimetric	O
recording	O
in	O
Huntington	O
choreas	O

In	O
doses	O
of	O
0.03	O
-	O
0.3	O
mg	O
/	O
kg	O
i.v	O
.	O
,	O
SG-75	O
did	O
not	O
significantly	O
affect	O
pulse	O
pressure	O
,	O
heart	O
rate	O
,	O
aortic	O
blood	O
flow	O
,	O
left	O
ventricular	O
pressure	O
(	O
LVP	O
)	O
and	O
LVdP	O
/	O
dt	O
max	O
.	O

Resting	O
VE	O
in	O
the	O
luteal	O
phase	O
was	O
7.8	O
%	O
greater	O
than	O
that	O
in	O
the	O
follicular	O
phase	O
.	O

Endothelium	O
of	O
the	O
central	O
ear	O
artery	O
of	O
an	O
anesthetized	O
rabbit	O
is	O
damaged	O
by	O
placing	O
artery	O
forceps	O
on	O
the	O
ear	O
directly	O
over	O
the	O
vessel	O
.	O

Despite	O
supraphysiologic	O
E2	O
concentrations	O
,	O
however	O
,	O
cervical	O
mucus	O
scores	O
were	O
significantly	O
reduced	O
in	O
the	O
CC	O
-	O
treated	O
group	O
(	O
P	O
less	O
than	O
0.01	O
)	O
.	O

Significant	O
clinical	O
differences	O
between	O
the	O
patients	O
treated	O
with	O
and	O
without	O
AMB	O
were	O
longer	O
survival	O
time	O
following	O
diagnosis	O
of	O
illness	O
(	O
P	O
less	O
than	O
0.05	O
)	O
and	O
more	O
frequent	O
cranial	O
nerve	O
signs	O
in	O
the	O
treated	O
patients	O
(	O
P	O
=	O
0.089	O
)	O
.	O

A	O
pharmacokinetic	O
study	O
of	O
apalcillin	O
was	O
performed	O
in	O
12	O
patients	O
in	O
an	O
intensive	O
-	O
care	O
unit	O
.	O

Catch	O
-	O
up	O
growth	O
was	O
observed	O
only	O
for	O
a	O
12-month	O
period	O
in	O
4	O
children	O
with	O
a	O
bone	O
age	O
of	O
7	O
to	O
8	O
years	O
.	O

Thrombocyte	O
function	O
was	O
impaired	O
in	O
all	O
patients	O
,	O
characterized	O
by	O
a	O
diminished	O
platelet	O
shape	O
change	O
.	O

The	O
findings	O
demonstrate	O
that	O
AMPH	O
administration	O
induces	O
a	O
significant	O
increase	O
in	O
the	O
height	O
of	O
a	O
major	O
electroactive	O
peak	O
in	O
the	O
caudate	O
nucleus	O
of	O
pigtail	O
monkeys	O
,	O
and	O
further	O
that	O
such	O
amphetamine	O
-	O
induced	O
increases	O
can	O
be	O
manipulated	O
by	O
altering	O
the	O
affective	O
and/or	O
emotional	O
state	O
of	O
the	O
animal	O
.	O

In	O
two	O
experiments	O
,	O
neonatal	O
female	O
BALB	O
/	O
cCrgl	O
or	O
BALB	O
/	O
cfC3HCrgl	O
mice	O
were	O
given	O
subcutaneous	O
injections	O
of	O
5	O
micrograms	O
17	O
beta	O
-	O
estradiol	O
or	O
sesame	O
oil	O
for	O
the	O
first	O
3	O
days	O
of	O
life	O
and	O
were	O
ovariectomized	O
at	O
60	O
days	O
of	O
age	O
,	O
at	O
which	O
time	O
vaginal	O
concretions	O
(	O
Experiments	O
I	O
and	O
II	O
)	O
or	O
silica	O
(	O
Experiment	O
II	O
)	O
were	O
implanted	O
intravaginally	O
.	O

For	O
228	O
of	O
425	O
deaths	O
(	O
54	O
%	O
)	O
occurring	O
among	O
26	O
100	O
people	O
of	O
known	O
age	O
in	O
the	O
Malumfashi	O
area	O
of	O
northern	O
Nigeria	O
,	O
data	O
were	O
collected	O
on	O
symptoms	O
present	O
prior	O
to	O
death	O
.	O

Other	O
than	O
d	O
7	O
,	O
there	O
was	O
no	O
significant	O
effect	O
on	O
the	O
number	O
of	O
implants	O
.	O

The	O
results	O
imply	O
that	O
kindling	O
does	O
not	O
produce	O
its	O
facilitating	O
effect	O
on	O
acquisition	O
of	O
HPC	O
SS	O
by	O
removing	O
a	O
disruptive	O
effect	O
of	O
the	O
stimulation	O
.	O

The	O
persistent	O
fetal	O
dispersion	O
of	O
nodal	O
and	O
Hiss	O
bundle	O
fragments	O
within	O
the	O
ventricular	O
septum	O
is	O
proposed	O
as	O
a	O
possible	O
explanation	O
.	O

SFP	O
was	O
significantly	O
elevated	O
in	O
Hn	O
(	O
s	O
)	O
.	O

The	O
average	O
birth	O
mass	O
of	O
these	O
newborns	O
was	O
3491.9	O
+	O
/-	O

2	O
SD	O
780.5	O
g	O
and	O
that	O
in	O
the	O
control	O
group	O
3,767.5	O
+	O
/-	O

2	O
SD	O
824.2	O
g	O
(	O
P	O
less	O
than	O
0.05	O
)	O
.	O

By	O
contrast	O
,	O
kidneys	O
from	O
rats	O
with	O
chronic	O
metabolic	O
acidosis	O
produced	O
significantly	O
more	O
NH3	O
than	O
both	O
these	O
groups	O
(	O
2.73	O
+	O
/-	O

0.29	O
mumol	O
X	O
min-1	O
X	O
g-1	O
)	O
.	O

Serodiagnosis	O
of	O
trypanosomiasis	O
in	O
dromedary	O
camels	O
using	O
a	O
card	O
agglutination	O
test	O
set	O
(	O
Testryp	O
CATT	O
)	O
.	O

Proteinuria	O
--	O
selected	O
physiopathological	O
and	O
clinical	O
problems	O

However	O
,	O
subcutaneously	O
administered	O
pneumococci	O
gave	O
a	O
lower	O
mortality	O
than	O
pneumococci	O
given	O
intravenously	O
or	O
intraperitoneally	O
.	O

Scientific	O
cooperation	O
of	O
CMEA	O
member	O
countries	O
has	O
been	O
carried	O
out	O
since	O
1974	O
under	O
the	O
sponsorship	O
of	O
the	O
Cancer	O
Research	O
Institute	O
,	O
Slovak	O
Academy	O
of	O
Sciences	O
(	O
Czechoslovakia	O
)	O
within	O
the	O
framework	O
of	O
CMEA	O
.	O

A	O
new	O
variant	O
of	O
the	O
EMG	O
-	O
BFB	O
method	O
(	O
multichannel	O
)	O
is	O
offered	O
which	O
has	O
made	O
it	O
possible	O
to	O
use	O
the	O
method	O
not	O
only	O
for	O
training	O
weakened	O
muscles	O
and	O
reducing	O
spasticity	O
in	O
their	O
antagonists	O
but	O
also	O
for	O
improving	O
motor	O
coordination	O
.	O

Lymphocytes	O
from	O
all	O
3	O
species	O
yielded	O
maximum	O
responses	O
with	O
a	O
48-hour	O
prelabel	O
and	O
12-	O
to-	O
16	O
hour	O
postlabel	O
incubation	O
period	O
at	O
41	O
C	O
and	O
1:20	O
blood	O
dilution	O
.	O

Removal	O
of	O
lipid	O
fractions	O
of	O
plant	O
extractions	O
with	O
hexane	O
is	O
recommended	O
to	O
avoid	O
damage	O
to	O
the	O
HPLC	O
column	O
.	O

In	O
the	O
Arithmetic	O
subtest	O
one	O
of	O
the	O
items	O
would	O
not	O
meet	O
the	O
difficulty	O
grading	O
shown	O
while	O
the	O
last	O
two	O
items	O
offer	O
very	O
little	O
possibility	O
of	O
success	O
for	O
all	O
subjects.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
toxicological	O
evaluation	O
of	O
chlorofluorocarbon	O
22	O
(	O
CFC	O
22	O
)	O
.	O

All	O
patients	O
were	O
evaluable	O
for	O
toxicity	O
and	O
9	O
for	O
response	O
.	O

Methods	O
of	O
clinical	O
and	O
experimental	O
algesimetry	O
are	O
described	O
that	O
have	O
been	O
used	O
to	O
evaluate	O
effects	O
of	O
peripherally	O
and	O
centrally	O
acting	O
analgesics	O
.	O

The	O
present	O
paper	O
elucidates	O
the	O
existing	O
discrepancies	O
,	O
and	O
offers	O
a	O
consistent	O
terminology	O
incorporating	O
also	O
such	O
terms	O
as	O
""""	O
additivity	O
""""	O
,	O
""""	O
potentiation	O
""""	O
,	O
and	O
""""	O
simple	O
similarity	O
""""	O
.	O

We	O
propose	O
that	O
the	O
ambiguous	O
discrimination	O
required	O
a	O
greater	O
time	O
for	O
simulus	O
evaluation	O
and	O
that	O
this	O
was	O
reflected	O
in	O
the	O
delayed	O
P3	O
latencies	O
.	O

In	O
this	O
respect	O
C	B
reactive	I
protein	I
concentrations	O
are	O
superior	O
to	O
white	O
cell	O
count	O
,	O
erythrocyte	O
sedimentation	O
rate	O
,	O
and	O
temperature	O
and	O
the	O
concentrations	O
of	O
antiproteases	O
.	O

Human	B
thyroid	I
stimulator	I
(	O
HTS	B
)	O
in	O
thyroid	O
diseases	O

Brainstem	O
auditory	O
evoked	O
responses	O
(	O
BAERs	O
)	O
and	O
quantitative	O
saccadic	O
eye	O
movement	O
studies	O
provide	O
information	O
on	O
the	O
integrity	O
of	O
pathways	O
traversing	O
the	O
brainstem	O
.	O

Effects	O
of	O
ketamine	O
on	O
the	O
circulatory	O
functions	O
and	O
body	O
tissue	O
oxygenation	O
in	O
dogs	O
under	O
normal	O
and	O
hypovolemic	O
conditions	O
.	O

The	O
salient	O
clinical	O
features	O
,	O
the	O
problems	O
of	O
management	O
and	O
the	O
modern	O
approaches	O
to	O
the	O
reconstruction	O
of	O
facial	O
deformities	O
seen	O
in	O
this	O
disease	O
are	O
described	O
.	O

Besides	O
,	O
it	O
was	O
considered	O
that	O
the	O
NPF	O
was	O
a	O
useful	O
tool	O
for	O
activation	O
of	O
velopharyngeal	O
activity	O
by	O
way	O
of	O
visual	O
feed	O
-	O
back	O
control	O
.	O

In	O
a	O
man	O
with	O
myelomonocytic	O
leukemia	O
,	O
the	O
association	O
of	O
increased	O
prostatic	B
acid	I
phosphatase	I
activity	O
in	O
serum	O
and	O
the	O
presence	O
of	O
typical	O
bone	O
lesions	O
on	O
roentgenography	O
suggested	O
the	O
existence	O
of	O
disseminated	O
prostatic	O
carcinoma	O
.	O

No	O
anisotropism	O
was	O
recorded	O
in	O
a	O
tetrahydrofuran	O
solution	O
.	O

As	O
pleural	O
thickening	O
is	O
seen	O
commonly	O
in	O
asbestosis	O
and	O
may	O
influence	O
lung	O
volumes	O
and	O
the	O
ratio	O
of	O
transfer	B
factor	I
to	O
effective	O
alveolar	O
volume	O
,	O
the	O
results	O
of	O
these	O
measurements	O
were	O
compared	O
only	O
in	O
the	O
cases	O
showing	O
absent	O
or	O
minimal	O
pleural	O
thickening	O
.	O

The	O
invasive	O
pattern	O
of	O
squamous	O
cell	O
carcinoma	O
in	O
the	O
mandibular	O
gingiva	O

Azygos	O
vein	O
abutting	O
the	O
posterior	O
wall	O
of	O
the	O
right	O
main	O
and	O
upper	O
lobe	O
bronchi	O
:	O
a	O
normal	O
CT	O
variant	O
.	O

However	O
,	O
the	O
history	O
of	O
acute	O
severe	O
complications	O
from	O
otitis	O
media	O
revealed	O
a	O
higher	O
frequency	O
in	O
those	O
individuals	O
with	O
alpha	B
1-antitrypsin	I
deficiency	O
as	O
compared	O
to	O
normals	O
.	O

The	O
Sarns	O
51F	O
cavoatrial	O
cannula	O
decompressed	O
the	O
venous	O
system	O
as	O
efficiently	O
as	O
the	O
double	O
caval	O
cannulas	O
.	O

All	O
other	O
changes	O
at	O
the	O
3-	O
,	O
5-	O
,	O
and	O
6-positions	O
,	O
as	O
well	O
as	O
the	O
replacement	O
of	O
the	O
phenyl	O
group	O
at	O
position	O
2	O
,	O
caused	O
a	O
marked	O
decrease	O
of	O
activity	O
.	O

Three	O
experiments	O
contrasted	O
the	O
effects	O
of	O
6-hydroxydopamine	O
-	O
induced	O
lesions	O
of	O
the	O
ventral	O
noradrenergic	O
and	O
dorsal	O
noradrenergic	O
projections	O
,	O
predominantly	O
to	O
hypothalamus	O
and	O
cortex	O
,	O
respectively	O
,	O
upon	O
body	O
weight	O
changes	O
and	O
food	O
-	O
related	O
behaviour	O
in	O
the	O
rat	O
.	O

Limb	O
allografts	O
in	O
rats	O
immunosuppressed	O
with	O
cyclosporin	O
A.	O

The	O
method	O
involved	O
deproteinizing	O
samples	O
with	O
two	O
volumes	O
of	O
acetonitrile	O
followed	O
by	O
injection	O
of	O
5	O
microliters	O
of	O
deproteinized	O
supernatant	O
onto	O
a	O
C18	O
reversed	O
-	O
phase	O
column	O
.	O

This	O
paper	O
brings	O
together	O
data	O
,	O
obtained	O
from	O
a	O
variety	O
of	O
sources	O
,	O
on	O
the	O
extent	O
of	O
prescription	O
and	O
use	O
of	O
psychotropic	O
drugs	O
in	O
the	O
late	O
1960s	O
and	O
early	O
1970s	O
.	O

Female	O
Wistar	O
rats	O
were	O
fed	O
a	O
liquid	O
diet	O
,	O
Sustacal	O
,	O
which	O
contained	O
ethanol	O
(	O
40	O
%	O
of	O
calories	O
)	O
or	O
isocaloric	O
sucrose	O
.	O

Four	O
patients	O
(	O
group	O
1	O
)	O
had	O
type	O
I	O
basement	O
membrane	O
nephropathy	O
,	O
characterized	O
by	O
marked	O
thickening	O
and	O
lamellation	O
of	O
the	O
basement	O
membrane	O
in	O
a	O
pattern	O
resembling	O
that	O
of	O
Alport	O
's	O
syndrome	O
.	O

Thin	O
-	O
layer	O
chromatographic	O
methods	O
were	O
up	O
-	O
dated	O
for	O
pharmacokinetic	O
studies	O
of	O
imipramine	O
in	O
plasma	O
and	O
urine	O
.	O

Increasing	O
the	O
cut	O
-	O
off	O
point	O
to	O
3	O
positive	O
responses	O
decreased	O
the	O
sensitivity	O
to	O
81	O
%	O
and	O
increased	O
the	O
specificity	O
to	O
94	O
%	O
.	O

This	O
phenomenon	O
may	O
be	O
regarded	O
as	O
a	O
variant	O
of	O
selective	O
individual	O
cell	O
death	O
,	O
currently	O
referred	O
to	O
as	O
apoptosis	O
,	O
which	O
has	O
not	O
been	O
previously	O
reported	O
in	O
a	O
case	O
of	O
embryonal	O
rhabdomyosarcoma	O
.	O

Combination	O
of	O
a	O
Shwachman	O
syndrome	O
and	O
a	O
complex	O
granulocyte	O
function	O
disorder	O
in	O
a	O
girl	O

A	O
combined	O
series	O
of	O
patients	O
experienced	O
a	O
TOL	O
after	O
two	O
or	O
more	O
previous	O
cesarean	O
deliveries	O
;	O
the	O
rate	O
of	O
vaginal	O
delivery	O
was	O
66	O
%	O
,	O
and	O
there	O
was	O
virtually	O
no	O
morbidity	O
.	O

Trial	O
3	O
broiler	O
chickens	O
were	O
maintained	O
on	O
control	O
feed	O
until	O
they	O
reached	O
3	O
weeks	O
of	O
age	O
at	O
which	O
time	O
they	O
were	O
taken	O
off	O
of	O
feed	O
for	O
2.5	O
hr	O
and	O
then	O
placed	O
on	O
either	O
control	O
feed	O
or	O
feed	O
containing	O
4.0	O
ppm	O
ochratoxin	O
A	O
,	O
and	O
heart	O
rate	O
and	O
blood	O
pressure	O
were	O
measured	O
every	O
half	O
hour	O
through	O
7	O
hr	O
.	O

The	O
carcinogen	O
bioassay	O
therefore	O
is	O
a	O
very	O
important	O
component	O
of	O
the	O
battery	O
of	O
toxicological	O
tests	O
used	O
in	O
hazard	O
evaluation	O
.	O

Harmful	O
effects	O
in	O
animals	O
and	O
man	O
may	O
result	O
from	O
both	O
deficient	O
or	O
excessive	O
amounts	O
of	O
intake	O
.	O

The	O
analysis	O
of	O
the	O
structure	O
of	O
the	O
sleep	O
period	O
as	O
a	O
whole	O
reveals	O
that	O
with	O
increasing	O
of	O
the	O
age	O
the	O
delta	O
-	O
wave	O
stage	O
(	O
DS	O
)	O
of	O
the	O
QS	O
(	O
determined	O
by	O
defined	O
polygraphic	O
parameters	O
)	O
increases	O
,	O
while	O
the	O
paradoxical	O
phase	O
of	O
sleep	O
(	O
PS	O
)	O
decreases	O
,	O
this	O
change	O
being	O
more	O
pronounced	O
during	O
the	O
first	O
six	O
months	O
than	O
during	O
the	O
second	O
ones	O
of	O
the	O
first	O
year	O
of	O
the	O
life	O
.	O

While	O
these	O
findings	O
may	O
reflect	O
the	O
sensitivity	O
of	O
a	O
thick	O
myocardial	O
wall	O
to	O
ischaemia	O
during	O
surgery	O
,	O
the	O
postoperative	O
recovery	O
was	O
not	O
related	O
to	O
the	O
serum	B
CK	I
-	I
MB	I
level	O
.	O

Morphofunctional	O
status	O
of	O
the	O
formed	O
elements	O
of	O
the	O
blood	O
in	O
rats	O
subjected	O
to	O
different	O
variants	O
of	O
combined	O
and	O
isolated	O
exposure	O
to	O
BR-1	O
benzene	O

Using	O
a	O
MOS	O
-	O
Hypersil	O
reversed	O
-	O
phase	O
column	O
with	O
a	O
phosphate	O
buffer	O
--	O
acetonitrile	O
mobile	O
phase	O
,	O
baseline	O
separation	O
of	O
antipyrine	O
,	O
its	O
metabolites	O
3-hydroxymethylantipyrine	O
,	O
norantipyrine	O
and	O
4-hydroxyantipyrine	O
,	O
and	O
the	O
internal	O
standard	O
,	O
phenacetin	O
,	O
was	O
achieved	O
within	O
6	O
min	O
.	O

The	O
liver	O
in	O
the	O
severely	O
ill	O

In	O
a	O
randomized	O
study	O
on	O
150	O
patients	O
(	O
ASA	O
1	O
)	O
undergoing	O
induction	O
of	O
anaesthesia	O
,	O
the	O
effects	O
of	O
Fentanyl	O
(	O
0.1	O
mg	O
)	O
,	O
the	O
combination	O
of	O
Fentanyl	O
(	O
0.1	O
mg	O
)	O
and	O
Droperidol	O
(	O
5	O
mg	O
)	O
(	O
Innovar	O
,	O
Thalamonal	O
)	O
and	O
Atropine	O
(	O
0.01	O
mg	O
/	O
kg	O
b.w	O
.	O
)	O
alone	O
on	O
cardiocirculatory	O
parameters	O
were	O
studied	O
.	O

These	O
results	O
confirming	O
the	O
high	O
validity	O
of	O
NOM	O
inhibiting	O
test	O
in	O
the	O
diagnosis	O
of	O
tumoural	O
hyperprolactinemic	O
states	O
,	O
reveal	O
contradictory	O
responses	O
to	O
CD	O
/	O
LD	O
,	O
LD	O
and	O
DOM	O
,	O
with	O
sustain	O
the	O
existence	O
of	O
2	O
sub	O
-	O
group	O
of	O
Prolactinomas	O
:	O
with	O
or	O
without	O
a	O
maintained	O
DA	O
central	O
tonus	O
supporting	O
the	O
possibility	O
of	O
different	O
etiopathogenetical	O
factors	O
in	O
inducing	O
a	O
tumoural	O
hyperprolactinemic	O
states	O
.	O

Amikacin	O
concentrations	O
in	O
serum	O
and	O
blister	O
fluid	O
in	O
healthy	O
volunteers	O
and	O
in	O
patients	O
with	O
renal	O
impairment	O
.	O

The	O
subgroup	O
innervating	O
the	O
medial	O
rectus	O
lies	O
exclusively	O
along	O
the	O
medial	O
face	O
of	O
the	O
oculomotor	O
nucleus	O
,	O
with	O
no	O
aberrant	O
neurons	O
in	O
the	O
medial	O
longitudinal	O
fasciculus	O
,	O
as	O
have	O
been	O
found	O
in	O
other	O
mammals	O
.	O

Hepatitis	O
B	O
vaccination	O
strategy	O
for	O
health	O
-	O
care	O
workers	O
in	O
a	O
country	O
of	O
intermediate	O
hepatitis	O
B	O
endemicity	O
.	O

An	O
intravenous	O
drip	O
infusion	O
of	O
AMK	O
in	O
adequate	O
dosage	O
would	O
be	O
beneficial	O
to	O
use	O
against	O
some	O
infectious	O
diseases	O
of	O
otorhinolaryngologic	O
field	O
.	O

The	O
authors	O
have	O
tested	O
the	O
interference	O
of	O
the	O
hemoglobin	B
by	O
two	O
routine	O
methods	O
(	O
Berthelot	O
classic	O
and	O
Berthelot	O
modified	O
)	O
for	O
the	O
determination	O
of	O
plasmatic	O
urea	O
.	O

Parkinsonian	O
patients	O
had	O
a	O
significantly	O
lower	O
prevalence	O
of	O
alcohol	O
use	O
.	O

These	O
cells	O
averaged	O
17	O
microns	O
in	O
diameter	O
and	O
reproduced	O
by	O
fission	O
,	O
forming	O
clusters	O
of	O
two	O
or	O
four	O
daughter	O
cells	O
.	O

Female	O
but	O
not	O
male	O
mortalities	O
were	O
significantly	O
higher	O
for	O
cake	O
-	O
fed	O
rats	O
than	O
for	O
those	O
fed	O
diet	O
41B	O
.	O

The	O
associations	O
between	O
sex	B
-	I
hormone	I
-	I
binding	I
globulin	I
capacity	O
(	O
SHBG	B
)	O
,	O
age	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
,	O
and	O
physical	O
fitness	O
have	O
been	O
studied	O
in	O
34	O
men	O
and	O
36	O
women	O
.	O

After	O
1.5	O
years	O
of	O
such	O
photoperiodic	O
control	O
,	O
all	O
ewes	O
were	O
blinded	O
by	O
bilateral	O
orbital	O
enucleation	O
.	O

The	O
concentrations	O
of	O
C4	B
and	O
C1-INH	B
increased	O
with	O
advancing	O
stage	O
of	O
disease	O
and	O
were	O
above	O
normal	O
mean	O
values	O
in	O
all	O
stages	O
.	O

Less	O
antibacterial	O
activity	O
was	O
shown	O
toward	O
the	O
Gram	O
-	O
negative	O
bacilli	O
,	O
i.e.	O
,	O
Pseudomonas	O
,	O
Klebsiella	O
-	O
Enterobacter	O
,	O
Shigella	O
,	O
Escherichia	O
coli	O
,	O
Serratia	O
marcescens	O
and	O
Proteus	O
.	O

The	O
mucosal	O
defence	O
capacity	O
against	O
proteolytic	O
leukocyte	O
enzymes	O
.	O

The	O
apparatus	O
consists	O
of	O
an	O
Am-241	O
exciting	O
source	O
(	O
300	O
mCi	O
)	O
and	O
pure	O
Ge	O
detector	O
(	O
50	O
mm2	O
X	O
5	O
mm	O
)	O
for	O
measuring	O
K	O
alpha	O
fluorescent	O
x	O
-	O
rays	O
(	O
28.3	O
and	O
28.6	O
KeV	O
)	O
emitted	O
from	O
exited	O
iodine	O
.	O

Ultrastructural	O
studies	O
of	O
retinopathy	O
of	O
premature	O
infants	O

The	O
effects	O
of	O
antithrombotic	O
drugs	O
in	O
patients	O
with	O
left	O
ventricular	O
thrombi	O
:	O
assessment	O
with	O
indium-111	O
platelet	O
imaging	O
and	O
two	O
-	O
dimensional	O
echocardiography	O
.	O

The	O
Prolactin	B
levels	O
were	O
within	O
the	O
physiological	O
norms	O
;	O
the	O
responses	O
to	O
TRH	B
were	O
normal	O
,	O
and	O
elevated	O
only	O
in	O
a	O
few	O
cases	O
.	O

Private	O
hospital	O
accreditation	O
.	O

Antithrombin	B
III	I
in	O
hip	O
surgery	O

In	O
14	O
of	O
21	O
infant	O
hearts	O
(	O
66	O
%	O
)	O
with	O
aortic	O
arch	O
interruption	O
between	O
the	O
left	O
common	O
carotid	O
and	O
left	O
subclavian	O
arteries	O
(	O
type	O
B	O
of	O
Celoria	O
and	O
Patton	O
)	O
,	O
the	O
right	O
subclavian	O
artery	O
(	O
SA	O
)	O
arose	O
anomalously	O
.	O

Absorption	O
was	O
rapid	O
,	O
with	O
a	O
mean	O
time	O
to	O
peak	O
of	O
39	O
min	O
.	O

Within	O
the	O
compartment	O
or	O
dimension	O
of	O
severity	O
of	O
depression	O
a	O
subscale	O
of	O
the	O
Hamilton	O
Depression	O
Scale	O
(	O
or	O
the	O
Melancholia	O
Scale	O
)	O
was	O
shown	O
to	O
have	O
reached	O
an	O
instrumental	O
perfection	O
,	O
e.g.	O
as	O
an	O
outcome	O
measure	O
of	O
antidepressant	O
treatment	O
.	O

Significant	O
immunoglobulinuria	O
developed	O
prior	O
to	O
the	O
development	O
of	O
azotemia	O
,	O
significantly	O
decreased	O
creatinine	O
clearance	O
,	O
significant	O
proteinuria	O
(	O
greater	O
than	O
or	O
equal	O
to	O
3	O
+	O
dipstick	O
or	O
greater	O
than	O
or	O
equal	O
to	O
5	O
gm	O
per	O
24-hour	O
urine	O
collection	O
)	O
,	O
or	O
oliguria	O
.	O

A	O
total	O
number	O
of	O
1628	O
cases	O
were	O
collected	O
from	O
135	O
medical	O
institutions	O
.	O

The	O
AD	O
components	O
were	O
markedly	O
more	O
dependent	O
on	O
the	O
affective	O
state	O
of	O
the	O
rat	O
then	O
was	O
the	O
V1	O
component	O
.	O

Monkeys	O
were	O
evaluated	O
before	O
and	O
after	O
unilateral	O
and	O
serial	O
bilateral	O
removal	O
of	O
superior	O
temporal	O
cortex	O
.	O

All	O
samples	O
exhibited	O
a	O
decline	O
in	O
ethanol	O
concentration	O
,	O
with	O
most	O
losses	O
falling	O
within	O
the	O
expected	O
20	O
to	O
40	O
mg%	O
range	O
.	O

Plasma	B
lactoferrin	I
and	O
the	O
blood	O
count	O
of	O
polynuclear	O
neutrophils	O

Pilot	O
study	O
of	O
blood	O
coagulation	O
in	O
gout	O
patients	O
.	O

The	O
statistical	O
analysis	O
consist	O
of	O
the	O
F	O
test	O
followed	O
by	O
Snedecor	O
's	O
contrast	O
test	O
.	O

In	O
a	O
recent	O
measles	O
epidemic	O
in	O
El	O
Paso	O
,	O
TX	O
,	O
120,000	O
records	O
were	O
screened	O
using	O
these	O
criteria	O
,	O
and	O
as	O
a	O
result	O
13,000	O
students	O
were	O
vaccinated	O
.	O

No	O
patient	O
with	O
bradyarrhythmia	O
-related	O
SCD	O
had	O
manifest	O
atrioventricular	O
block	O
or	O
bundle	O
branch	O
block	O
.	O

The	O
measurement	O
of	O
the	O
areas	O
of	O
fibrin	B
,	O
of	O
tissue	O
and	O
fibrinolysis	O
,	O
at	O
the	O
above	O
mentioned	O
times	O
,	O
has	O
been	O
effected	O
at	O
standard	O
magnification	O
(	O
15	O
X	O
)	O
by	O
an	O
image	O
analyser	O
(	O
Videoplan	O
)	O
scale	O
1:8	O
.	O

Diclofenac	O
sodium	O
-	O
chlormezanone	O
poisoning	O
.	O

Postprandial	O
plasma	B
enteroglucagon	I
concentration	O
after	O
90	O
minutes	O
in	O
untreated	O
patients	O
correlated	O
positively	O
to	O
the	O
faecal	O
fat	O
excretion	O
(	O
r	O
=	O
0.58	O
,	O
p	O
less	O
than	O
0.02	O
)	O
.	O

Blood	O
pressure	O
in	O
children	O
.	O

The	O
results	O
showed	O
that	O
the	O
sensitivity	O
of	O
the	O
3	O
given	O
guinea	O
pig	O
strains	O
was	O
comparable	O
.	O

Twenty	O
-	O
one	O
percent	O
of	O
these	O
patients	O
had	O
neurologic	O
disease	O
that	O
appeared	O
to	O
be	O
responsible	O
for	O
the	O
tinnitus	O
.	O

The	O
maps	O
of	O
Case	O
2	O
showed	O
that	O
a	O
maximum	O
first	O
appeared	O
on	O
the	O
upper	O
right	O
back	O
and	O
then	O
moved	O
down	O
the	O
right	O
side	O
of	O
the	O
posterior	O
thorax	O
.	O

Twenty	O
-	O
eight	O
were	O
excluded	O
as	O
gallstones	O
were	O
not	O
proved	O
:	O
of	O
the	O
remainder	O
,	O
21	O
patients	O
received	O
glucagon	B
and	O
22	O
placebo	O
.	O

Regions	O
of	O
the	O
translated	O
open	O
reading	O
frames	O
of	O
cobA	B
and	O
the	O
third	O
intron	O
of	O
the	O
cob	B
gene	I
in	I
yeast	I
show	O
high	O
amino	O
acid	O
homology	O
.	O

The	O
13,14-dihydro-15-keto	O
-	O
metabolites	O
of	O
PGE2	O
and	O
PGF2	O
alpha	O
had	O
no	O
statistically	O
significant	O
antiarrhythmic	O
effect	O
.	O

Nucleotide	O
sequence	O
of	O
DNA	O
controlling	O
expression	O
of	O
genes	O
for	O
maltosaccharide	O
utilization	O
in	O
Streptococcus	O
pneumoniae	O
.	O

The	O
hypertension	O
with	O
elevated	O
PRA	O
,	O
however	O
,	O
was	O
resistant	O
to	O
the	O
angiotensin	B
II	I
(	O
AII	B
)	O
analog	O
[	O
Sar1	O
,	O
Ile8	O
]	O
ALL	O
.	O

Effects	O
of	O
dopamine	O
and	O
of	O
a	O
dopaminergic	O
blocker	O
,	O
haloperidol	O
,	O
on	O
the	O
responses	O
of	O
carotid	O
body	O
chemoreceptors	O
to	O
hypoxia	O
and	O
hypercapnia	O
were	O
investigated	O
in	O
16	O
anesthetized	O
cats	O
.	O

HLA	B
-	I
A	I
and	I
B	I
phenotypes	O
of	O
105	O
patients	O
suffering	O
from	O
malignant	O
melanomas	O
were	O
determined	O
,	O
with	O
special	O
regard	O
for	O
metastatic	O
form	O
or	O
relapse	O
.	O

Trypanosoma	O
cruzi	O
.	O

The	O
subjects	O
of	O
the	O
study	O
were	O
10	O
normal	O
subjects	O
and	O
64	O
patients	O
with	O
gastroduodenal	O
disease	O
.	O

1	O
.	O

A	O
convenient	O
measure	O
of	O
this	O
impairment	O
may	O
be	O
obtained	O
using	O
the	O
ratio	O
of	O
urine	O
volume	O
(	O
V	O
)	O
divided	O
by	O
lithium	O
clearance	O
(	O
CLi	O
)	O
.	O

Nitrogen	O
balance	O
was	O
compared	O
,	O
and	O
metabolic	O
complications	O
were	O
monitored	O
by	O
evaluating	O
BUN	O
,	O
serum	O
creatinine	O
,	O
creatinine	O
clearance	O
,	O
serum	O
CO2	O
,	O
SGOT	B
,	O
SGPT	B
,	O
serum	B
LDH	I
,	O
and	O
serum	B
alkaline	I
phosphatase	I
.	O

Production	O
of	O
C	B
mu	I
RNAs	I
,	O
unlike	O
mu	B
mRNAs	I
,	O
does	O
not	O
require	O
recombination	O
with	O
the	O
joining	B
region	I
(	O
JH	B
)	O
locus	O
.	O

The	O
1.9-kb	O
C	B
mu	I
RNA	O
contains	O
the	O
3	O
'	O
sequence	O
characteristic	O
of	O
secreted	O
mu	B
chain	I
,	O
whereas	O
the	O
longer	O
species	O
bear	O
that	O
of	O
membrane	O
-	O
bound	O
mu	B
chin	O
.	O

Transcripts	O
of	O
the	O
immunoglobulin	B
C	I
mu	I
gene	I
vary	O
in	O
structure	O
and	O
splicing	O
during	O
lymphoid	O
development	O
.	O

The	O
role	O
of	O
DNA	O
rearrangement	O
and	O
alternative	O
RNA	O
processing	O
in	O
the	O
expression	O
of	O
immunoglobulin	B
delta	I
genes	I
.	O

Although	O
the	O
mechanism	O
of	O
action	O
of	O
ICRF-159	O
and	O
187	O
has	O
not	O
been	O
clearly	O
defined	O
,	O
it	O
is	O
evident	O
from	O
both	O
preclinical	O
and	O
early	O
clinical	O
studies	O
that	O
these	O
compounds	O
are	O
of	O
interest	O
.	O

All	O
62	O
isolates	O
were	O
resistant	O
to	O
lincomycin	O
,	O
colistin	O
,	O
nystatin	O
,	O
amphotericin	O
B	O
,	O
trimethoprim	O
lactate	O
,	O
polymyxin	O
B	O
,	O
and	O
anisomycin	O
.	O

The	O
evaluation	O
of	O
amniotic	O
fluid	O
delta	O
OD450	O
is	O
considered	O
to	O
be	O
the	O
cornerstone	O
of	O
clinical	O
management	O
.	O

Host	O
lipids	O
in	O
tuberculous	O
infection	O
.	O

Fenfluramine	O
(	O
in	O
doses	O
ranging	O
from	O
0.0625	O
-	O
4.0	O
mg	O
/	O
kg	O
/	O
infusion	O
)	O
did	O
not	O
maintain	O
self	O
-	O
administration	O
behavior	O
at	O
or	O
above	O
the	O
minimum	O
requirement	O
(	O
FR	O
30	O
)	O
.	O

The	O
effect	O
of	O
the	O
fatty	B
acid	I
cyclo	I
-	I
oxygenase	I
inhibitor	O
indomethacin	O
on	O
cerebral	O
blood	O
flow	O
(	O
CBF	O
)	O
and	O
the	O
metabolic	O
rate	O
for	O
oxygen	O
(	O
CMRO2	O
)	O
was	O
studied	O
in	O
paralyzed	O
and	O
artificially	O
ventilated	O
rats	O
.	O

The	O
rat	O
incisor	O
is	O
an	O
excellent	O
model	O
system	O
in	O
which	O
to	O
study	O
amelgenesis	O
.	O

The	O
already	O
elevated	O
prolactin	B
levels	O
in	O
nursing	O
women	O
were	O
not	O
influenced	O
by	O
chronic	O
oestradiol	O
administration	O
.	O

Factor	B
VIII	I
procoagulant	O
activity	O
,	O
antigen	O
concentration	O
and	O
von	B
Willebrand	I
activity	O
as	O
ristocetin	B
cofactor	I
were	O
determined	O
several	O
times	O
in	O
10	O
patients	O
with	O
DIC	O
.	O

Morphine	O
-	O
dependent	O
and	O
control	O
rats	O
in	O
an	O
oral	O
free	O
-	O
choice	O
protocol	O
were	O
treated	O
with	O
gamma	O
-	O
vinyl	O
GABA	O
(	O
GVG	O
)	O
,	O
60	O
,	O
120	O
and	O
240	O
mg	O
/	O
kg	O
IP	O
,	O
for	O
3	O
days	O
over	O
three	O
successive	O
periods	O
.	O

Significance	O
of	O
the	O
pulmonary	O
gas	O
exchange	O
reaction	O
to	O
physical	O
loading	O
in	O
evaluating	O
the	O
effectiveness	O
of	O
mitral	O
commissurotomy	O

Thyreoliberin	B
VUFB	O
in	O
thyroid	O
gammagraphy	O

For	O
steers	O
the	O
urinary	O
N	O
values	O
were	O
403	O
and	O
295	O
mg	O
/	O
kg	O
W0.75	O
at	O
200	O
and	O
350	O
kg	O
live	O
weight	O
respectively	O
and	O
total	O
N	O
excretion	O
including	O
faecal	O
N	O
was	O
408	O
and	O
320	O
mg	O
/	O
kg	O
W0.75	O
.	O

Advances	O
in	O
hemophilia	O
treatment	O
:	O
a	O
hepatitis	O
-	O
safe	O
factor	B
VIII	I
concentrate	O

Comparison	O
of	O
three	O
different	O
preparations	O
of	O
disodium	O
cromoglycate	O
in	O
the	O
prevention	O
of	O
exercise	O
-	O
induced	O
bronchospasm	O
:	O
a	O
double	O
-	O
blind	O
study	O
.	O

LCBF	O
in	O
normal	O
and	O
hypoxic	O
puppies	O
was	O
correlated	O
with	O
local	O
cerebral	O
glucose	O
utilization	O
(	O
LCGU	O
)	O
obtained	O
under	O
the	O
same	O
experimental	O
conditions	O
(	O
Duffy	O
et	O
al	O
,	O
1982	O
)	O
.	O

Detection	O
of	O
hemophilia	O
A	O
carriers	O
.	O

Bile	O
bilirubin	O
did	O
not	O
rise	O
within	O
12	O
h	O
after	O
haem	O
infusion	O
a	O
finding	O
which	O
warrants	O
further	O
investigation	O
.	O

Autoimmune	O
manipulation	O
aids	O
juvenile	O
diabetes	O
management	O
.	O

The	O
decrease	O
in	O
HDL	B
-	I
cholesterol	I
with	O
increasing	O
VLDL	B
-	I
triglycerides	I
was	O
relatively	O
much	O
larger	O
than	O
the	O
concomitant	O
decrease	O
in	O
apo	B
A	I
-	I
I.	I

Apo	B
A	I
-	I
I	I
level	O
was	O
unrelated	O
to	O
age	O
,	O
but	O
increased	O
with	O
ethanol	O
consumption	O
and	O
decreased	O
with	O
adiposity	O
.	O

TEMTU	O
and	O
DPTU	O
were	O
the	O
most	O
potent	O
teratogens	O
.	O

Selenium	O
,	O
as	O
a	O
constituent	O
of	O
glutathione	B
peroxidase	I
,	O
plays	O
a	O
role	O
in	O
the	O
antioxidant	O
defense	O
systems	O
of	O
the	O
body	O
,	O
but	O
other	O
metabolic	O
roles	O
for	O
selenium	O
may	O
yet	O
be	O
discovered	O
.	O

Diagnostic	O
value	O
of	O
serum	B
myoglobin	I
in	O
cases	O
of	O
neuromuscular	O
disease	O

During	O
the	O
last	O
6	O
months	O
of	O
the	O
study	O
a	O
striking	O
change	O
in	O
epidemiology	O
concerning	O
hepatitis	O
A	O
was	O
seen	O
,	O
apparently	O
caused	O
by	O
a	O
steep	O
increase	O
in	O
the	O
incidence	O
of	O
this	O
type	O
of	O
hepatitis	O
among	O
drug	O
addicts	O
.	O

Asthmatic	O
patients	O
showed	O
greater	O
responses	O
of	O
both	O
parameters	O
to	O
adrenaline	O
than	O
controls	O
indicating	O
that	O
long	O
-	O
term	O
corticosteroid	O
treatment	O
enhances	O
the	O
acute	O
responses	O
of	O
plasminogen	B
activator	I
and	O
clotting	B
factor	I
VIII	I
to	O
adrenaline	O
infusion	O
.	O

Sulphur	O
amino	O
acids	O
(	O
g	O
/	O
16	O
g	O
N	O
)	O
were	O
higher	O
in	O
the	O
isolates	O
than	O
in	O
the	O
flours	O
.	O

Time	O
shifts	O
increase	O
growth	B
hormone	I
release	O
.	O

Vesicles	O
could	O
be	O
induced	O
only	O
with	O
multiple	O
exposures	O
to	O
UVA	O
.	O

Self	O
-	O
heating	O
after	O
deep	O
hypothermia	O
(	O
20	O
degrees	O
C	O
)	O
causes	O
a	O
considerable	O
increase	O
in	O
the	O
brain	O
tissues	O
glutaminase	B
activity	O
at	O
all	O
studied	O
incubation	O
temperatures	O
(	O
37	O
,	O
30	O
,	O
20	O
and	O
10	O
degrees	O
C	O
)	O
as	O
compared	O
to	O
control	O
rats	O
and	O
rats	O
under	O
hypothermia	O
.	O

According	O
to	O
Sugiura	O
's	O
classification	O
,	O
they	O
consisted	O
of	O
Type	O
Ia	O
in	O
63	O
%	O
,	O
Type	O
Ib	O
in	O
11	O
%	O
,	O
Type	O
II	O
in	O
11	O
%	O
,	O
and	O
Type	O
III	O
in	O
16	O
%	O
.	O

This	O
study	O
was	O
undertaken	O
to	O
define	O
the	O
mechanism	O
for	O
the	O
respiratory	O
inhibition	O
observed	O
during	O
high	O
-	O
frequency	O
oscillatory	O
ventilation	O
(	O
HFOV	O
)	O
.	O

Determination	O
of	O
20	O
alpha	O
-	O
hydroxy-9	O
beta,10	O
alpha	O
-	O
pregna-4,6-dien-3-one	O
in	O
plasma	O
by	O
selected	O
ion	O
monitoring	O
.	O

Because	O
of	O
a	O
rapid	O
development	O
of	O
the	O
connective	O
tissue	O
scars	O
,	O
however	O
,	O
at	O
the	O
place	O
of	O
the	O
destroyed	O
glandular	O
parenchyma	O
areas	O
,	O
there	O
is	O
no	O
normalization	O
of	O
the	O
organ	O
's	O
structure	O
and	O
function	O
by	O
the	O
42d	O
day	O
.	O

Histological	O
signs	O
of	O
the	O
flare	O
-	O
up	O
reaction	O
were	O
already	O
present	O
at	O
6	O
hr	O
after	O
i.v	O
.	O

challenge	O
and	O
lasted	O
for	O
at	O
least	O
4	O
days	O
.	O

Plasma	O
fibrinogen	B
was	O
measured	O
by	O
the	O
turbidimetric	O
method	O
in	O
timol	O
turbidimetric	O
units	O
.	O

Five	O
patients	O
with	O
type	O
III	O
musculoskeletal	O
infection	O
from	O
nongonococcal	O
Neisseria	O
species	O
were	O
examined	O
during	O
a	O
13-month	O
period	O
.	O

Distal	O
tubular	O
acidification	O
and	O
the	O
threshold	O
for	O
proximal	O
tubular	O
bicarbonate	O
reabsorption	O
were	O
normal	O
,	O
as	O
was	O
urine	O
concentrating	O
capacity	O
.	O

Detection	O
of	O
exercise	O
-	O
induced	O
asynergy	O
by	O
M	O
-	O
mode	O
echocardiography	O
.	O

The	O
Tullio	O
phenomenon	O
,	O
fistula	O
test	O
,	O
and	O
Hennebert	O
's	O
sign	O
:	O
clinical	O
significance	O
.	O

Both	O
groups	O
were	O
subjected	O
to	O
tests	O
of	O
delayed	O
hypersensitivity	O
with	O
Candidin	B
,	O
Trycophytin	B
and	O
Tuberculin	B
.	O

Serum	O
lactate	B
dehydrogenase	I
and	O
haptoglobin	B
levels	O
were	O
normal	O
,	O
and	O
total	O
bilirubin	O
was	O
only	O
slightly	O
elevated	O
.	O

Low	O
-	O
dose	O
D	O
(	O
0.4	O
-	O
0.8	O
mg	O
)	O
and	O
DB	O
(	O
1.0	O
-	O
5.0	O
mg	O
)	O
did	O
not	O
significantly	O
alter	O
any	O
parameter	O
from	O
control	O
.	O

Leads	O
from	O
the	O
MMWR	O
.	O

The	O
presence	O
of	O
visna	O
-	O
maedi	O
in	O
Italy	O
is	O
reported	O
for	O
the	O
first	O
time	O
.	O

High	O
levels	O
of	O
IC	O
coincided	O
with	O
relative	O
hypocomplementemia	O
.	O

Circulating	O
platelets	O
may	O
be	O
activated	O
by	O
exposed	O
triple	O
-	O
helical	O
collagen	B
in	O
atherosclerotic	O
lesions	O
in	O
Mg	O
-	O
deficient	O
ruminants	O
.	O

Pathogenetic	O
relationships	O
between	O
renal	O
tubular	O
acidosis	O
and	O
sodium	O
metabolism	O
alterations	O
in	O
liver	O
cirrhosis	O
.	O

5	O
microU	O
/	O
l	O
thyrotropin	B
:	O
75	O
%	O
(	O
1974	O
)	O
,	O
45	O
%	O
(	O
1977	O
)	O
and	O
20	O
%	O
(	O
1980	O
)	O
.	O

The	O
prevalence	O
of	O
CPAF	O
was	O
similar	O
in	O
type	O
1	O
and	O
type	O
2	O
diabetes	O
,	O
was	O
greater	O
in	O
women	O
than	O
in	O
men	O
,	O
and	O
was	O
significantly	O
greater	O
after	O
repeated	O
administrations	O
than	O
after	O
one	O
single	O
administration	O
of	O
chlorpropamide	O
.	O

The	O
results	O
confirm	O
and	O
extend	O
previous	O
work	O
by	O
other	O
researchers	O
.	O

In	O
patients	O
with	O
complete	O
or	O
partial	O
remission	O
of	O
the	O
tumor	O
,	O
the	O
neopterine	O
excretion	O
dropped	O
to	O
normal	O
values	O
.	O

Total	O
PGE	O
levels	O
in	O
synovial	O
fluid	O
remained	O
significantly	O
depressed	O
in	O
the	O
patient	O
group	O
for	O
24	O
hours	O
after	O
the	O
400-mg	O
test	O
dose	O
of	O
tolmetin	O
on	O
day	O
8	O
.	O

Normal	O
rates	O
of	O
weight	O
gain	O
were	O
seen	O
once	O
absorbed	O
energy	O
intakes	O
reached	O
100	O
-	O
110	O
%	O
of	O
requirements	O
.	O

Its	O
vasodilatory	O
,	O
anti	O
-	O
vasopressor	O
,	O
and	O
platelet	O
stabilizing	O
effects	O
could	O
be	O
expected	O
to	O
counteract	O
the	O
placental	O
ischemia	O
,	O
hypertension	O
and	O
excessive	O
coagulation	O
that	O
are	O
seen	O
in	O
pre	O
-	O
eclampsia	O
.	O

Behcet	O
's	O
syndrome	O

The	O
effect	O
of	O
emotional	O
-	O
painful	O
stress	O
(	O
EPS	O
)	O
on	O
myocardial	O
extensibility	O
and	O
contractility	O
was	O
studied	O
on	O
an	O
isolated	O
rat	O
atrium	O
.	O

The	O
hyperacute	O
phase	O
of	O
posterolateral	O
myocardial	O
infarction	O
.	O

Statistics	O
for	O
nurse	O
managers--3	O
.	O

The	O
infection	O
rate	O
was	O
five	O
times	O
greater	O
in	O
patients	O
with	O
Hickman	O
catheters	O
than	O
in	O
those	O
with	O
Broviac	O
catheters	O
(	O
p	O
=	O
0.01	O
)	O
.	O

After	O
a	O
year	O
of	O
planning	O
in	O
the	O
Laboratory	O
Assistants	O
'	O
School	O
in	O
Stockholm	O
:	O
new	O
education	O
for	O
laboratory	O
assistants	O
is	O
now	O
arranged	O

The	O
electrocardiogram	O
.	O

Use	O
of	O
prostaglandin	O
F2	O
alpha	O
(	O
PGF2	O
alpha	O
)	O
in	O
cattle	O
breeding	O
.	O

Thus	O
it	O
appears	O
that	O
the	O
management	O
of	O
blood	O
,	O
including	O
washing	O
is	O
of	O
great	O
importance	O
.	O

Range	O
,	O
variations	O
and	O
neoplastic	O
potential	O
.	O

The	O
scores	O
are	O
dependent	O
in	O
part	O
on	O
the	O
reliability	O
of	O
faculty	O
evaluations	O
.	O

Utero	O
-	O
placental	O
blood	O
flow	O
and	O
the	O
effect	O
of	O
beta	B
2-adrenoceptor	I
stimulating	O
drugs	O
.	O

The	O
arginyl	O
peptide	O
bonds	O
that	O
are	O
cleaved	O
in	O
the	O
conversion	O
of	O
human	B
factor	I
IX	I
to	O
factor	B
IXa	I
by	O
factor	B
XIa	I
were	O
identified	O
as	O
Arg145-Ala146	O
and	O
Arg180-Val181	O
.	O

Fluorometric	O
methods	O
can	O
also	O
provide	O
information	O
about	O
porphyrin	O
binding	O
sites	O
that	O
is	O
useful	O
in	O
understanding	O
porphyrin	O
transport	O
and	O
clearance	O
.	O

Renal	O
and	O
extrarenal	O
arterial	O
fibromuscular	O
hyperplasia	O
with	O
hypertension	O
.	O

The	O
monoexponential	O
rate	O
of	O
clearance	O
of	O
tracer	O
--	O
obtained	O
from	O
the	O
portion	O
of	O
the	O
residue	O
-	O
detection	O
curve	O
reflecting	O
metabolism	O
of	O
fatty	O
acid	O
incorporated	O
into	O
neutral	O
lipids	O
--	O
correlated	O
directly	O
with	O
induced	O
changes	O
in	O
tension	O
-	O
time	O
index	O
after	O
injections	O
into	O
the	O
left	O
atrium	O
(	O
r	O
=	O
0.96	O
,	O
n	O
=	O
12	O
)	O
,	O
right	O
atrium	O
(	O
r	O
=	O
0.86	O
,	O
n	O
=	O
14	O
)	O
,	O
and	O
ear	O
vein	O
(	O
r	O
=	O
0.93	O
,	O
n	O
=	O
14	O
)	O
.	O

A	O
case	O
of	O
anterior	O
cleavage	O
syndrome	O
in	O
a	O
27-year	O
-	O
old	O
female	O
patient	O
is	O
described	O
.	O

The	O
daily	O
administration	O
of	O
betamethasone	O
for	O
three	O
weeks	O
markedly	O
reduced	O
the	O
absorption	O
of	O
calcium	O
and	O
phosphate	O
as	O
well	O
as	O
the	O
growth	O
rate	O
.	O

REV	O
I	O
:	O
All	O
vessels	O
up	O
to	O
50	O
%	O
stenosed	O
have	O
a	O
patent	O
graft	O
.	O

The	O
extraction	O
measurements	O
were	O
used	O
to	O
test	O
for	O
extracerebral	O
contamination	O
of	O
venous	O
outflow	O
.	O

On	O
line	O
calculation	O
of	O
steroid	O
concentrations	O
by	O
radioimmunoassay	O

Detection	O
of	O
congenital	O
hypothyroidism	O
in	O
26,282	O
newborn	O
infants	O

The	O
results	O
indicate	O
that	O
folate	O
compounds	O
decrease	O
formate	O
accumulation	O
after	O
methanol	O
by	O
stimulating	O
formate	O
oxidation	O
or	O
utilization	O
and	O
suggest	O
a	O
possible	O
use	O
for	O
folates	O
in	O
the	O
treatment	O
of	O
certain	O
cases	O
of	O
human	O
methanol	O
poisoning	O
.	O

The	O
effect	O
of	O
sodium	O
saccharin	O
in	O
the	O
diet	O
on	O
caecal	O
microflora	O
.	O

The	O
residue	O
functions	O
,	O
R	O
(	O
t	O
)	O
,	O
for	O
C-11	O
CPZ	O
and	O
In-113	O
m	O
transferrin	B
were	O
plotted	O
against	O
time	O
for	O
selected	O
areas	O
of	O
interest	O
,	O
and	O
the	O
CPZ	O
area	O
-	O
weighted	O
extraction	O
,	O
E	O
(	O
t	O
)	O
,	O
was	O
computed	O
for	O
the	O
same	O
areas	O
every	O
250	O
msec	O
using	O
the	O
formula	O
:	O
E	O
(	O
t	O
)	O
=	O
[	O
RT	O
(	O
t	O
)	O
-	O
RR	O
(	O
t	O
)	O
]	O
/	O
[	O
1	O
-	O
RR	O
(	O
t	O
)	O
]	O
,	O
where	O
RT	O
and	O
RR	O
are	O
the	O
normalized	O
residue	O
functions	O
for	O
CPZ	O
and	O
transferrin	B
,	O
respectively	O
.	O

Synchronous	O
extracts	O
showed	O
no	O
significant	O
migration	O
inhibition	O
in	O
allogeneic	O
assays	O
.	O

Ten	O
days	O
of	O
cefadroxil	O
therapy	O
was	O
used	O
to	O
treat	O
44	O
children	O
with	O
urinary	O
tract	O
infection	O
and	O
CRP	B
values	O
greater	O
than	O
or	O
equal	O
to	O
28	O
microgram	O
/	O
ml	O
(	O
CRP	B
-	O
positive	O
group	O
)	O
.	O

After	O
acclimation	O
,	O
resting	O
supine	O
and	O
sitting	O
DPB	O
decreased	O
(	O
P	O
less	O
than	O
0.05	O
)	O
by	O
6	O
and	O
9	O
mmHg	O
,	O
respectively	O
.	O

Based	O
on	O
peptide	O
map	O
similarities	O
,	O
partial	O
amino	O
-	O
terminal	O
sequence	O
data	O
,	O
and	O
common	O
genetic	O
origin	O
,	O
it	O
is	O
suggested	O
that	O
p60	B
and	O
p62	B
have	O
identical	O
amino	O
acid	O
sequences	O
carboxy	O
-	O
terminal	O
to	O
the	O
p60	B
initiator	O
methionine	O
(	O
residue	O
21	O
of	O
p62	B
)	O
.	O

All	O
patients	O
in	O
the	O
control	O
group	O
showed	O
a	O
significant	O
improvement	O
in	O
their	O
PEFR	O
while	O
only	O
3	O
patients	O
in	O
the	O
treated	O
group	O
showed	O
an	O
improvement	O
.	O

Facts	O
on	O
the	O
Economic	O
Recovery	O
Tax	O
Act	O
of	O
1981	O
for	O
speech	O
-	O
language	O
pathologists	O
and	O
audiologists	O
.	O

From	O
Pap	O
to	O
ApUp	O
.	O

The	O
relationship	O
between	O
the	O
rare	O
complications	O
mentioned	O
above	O
and	O
the	O
pathophysiology	O
of	O
Bartter	O
's	O
syndrome	O
is	O
still	O
obscure	O
.	O

Using	O
an	O
opsonophagocytic	O
bacterial	O
assay	O
and	O
a	O
suckling	O
rat	O
model	O
of	O
GBS	O
sepsis	O
,	O
we	O
analyzed	O
a	O
modified	O
human	B
immunoglobulin	I
for	O
opsonic	O
and	O
protective	O
antibody	O
.	O

Glomerular	O
lesions	O
in	O
renal	O
allografts	O
.	O

Commonly	O
observed	O
systemic	O
toxic	O
effects	O
(	O
bone	O
marrow	O
,	O
gastrointestinal	O
tract	O
,	O
and	O
heart	O
)	O
were	O
not	O
seen	O
in	O
this	O
study	O
.	O

2	O
.	O

When	O
vascular	O
pressure	O
(	O
Pvas	O
)	O
was	O
raised	O
abruptly	O
from	O
-5	O
to	O
+	O
25	O
cmH2O	O
by	O
air	O
inflation	O
for	O
60	O
min	O
,	O
Px	O
(	O
f	O
)	O
became	O
abruptly	O
less	O
negative	O
,	O
then	O
remained	O
stable	O
.	O

(	O
1980	O
)	O
:	O

Science	O
210	O
,	O
77	O
-	O
72	O
)	O
that	O
stimulating	O
the	O
crossed	O
olivocochlear	O
bundle	O
(	O
COCB	O
)	O
can	O
change	O
the	O
magnitude	O
of	O
the	O
distortion	O
product	O
(	O
f2-f1	O
)	O
in	O
the	O
ear	O
-	O
canal	O
sound	O
pressure	O
.	O

When	O
the	O
l	O
-	O
methadone	O
-	O
sensitive	O
,	O
opioid	B
receptor	I
is	O
blocked	O
by	O
naloxone	O
or	O
tolerance	O
has	O
developed	O
,	O
than	O
l	O
-	O
methadone	O
can	O
produce	O
behavioral	O
effects	O
by	O
a	O
nonopioid	O
mechanism	O
.	O

Microwave	O
hyperthermia	O
-	O
induced	O
blood	O
-	O
brain	O
barrier	O
alterations	O
.	O

Diagnosis	O
of	O
phenylalanine	B
hydroxylase	I
deficiency	O
(	O
phenylketonuria	O
)	O
.	O

In	O
10	O
control	O
sheep	O
mean	O
plasma	O
TXB2	O
concentration	O
increased	O
from	O
0.39	O
ng	O
/	O
ml	O
prebypass	O
to	O
about	O
1.1	O
ng	O
/	O
ml	O
at	O
8	O
and	O
16	O
min	O
of	O
bypass	O
.	O

The	O
respiratory	O
rate	O
was	O
13	O
+	O
/-	O

1	O
breaths	O
/	O
min	O
with	O
52	O
+	O
/-	O

4	O
%	O
of	O
the	O
respiratory	O
cycle	O
spent	O
in	O
inspiration	O
;	O
end	O
-	O
tidal	O
CO2	O
pressure	O
increased	O
by	O
3.3	O
+	O
/-	O

1.0	O
Torr	O
during	O
runs	O
at	O
SIP	O
.	O

There	O
was	O
no	O
further	O
increase	O
in	O
oxygen	O
consumption	O
when	O
these	O
subjects	O
breathed	O
with	O
inspiratory	O
pressures	O
above	O
SIP	O
.	O

We	O
compared	O
the	O
volume	O
of	O
the	O
pulmonary	O
extravascular	O
,	O
extracellular	O
water	O
space	O
using	O
sodium	O
and	O
sucrose	O
indicators	O
in	O
8	O
normal	O
and	O
11	O
edematous	O
rabbit	O
lungs	O
by	O
steady	O
-	O
state	O
techniques	O
.	O

Investigated	O
the	O
reliability	O
,	O
validity	O
and	O
dimensionality	O
of	O
scores	O
obtained	O
by	O
acute	O
psychiatric	O
inpatients	O
(	O
N	O
=	O
120	O
)	O
on	O
the	O
Michigan	O
Alcoholism	O
Screening	O
Test	O
adapted	O
to	O
assess	O
lifetime	O
and	O
current	O
symptomatology	O
.	O

A	O
simple	O
method	O
for	O
measuring	O
urinary	O
iron	O
following	O
the	O
administration	O
of	O
desferrioxamine	O
(	O
DF	O
)	O
is	O
described	O
.	O

Recommendations	O
to	O
deal	O
with	O
these	O
and	O
related	O
issues	O
are	O
presented	O
.	O

Use	O
of	O
subcutaneous	O
deferoxamine	O
in	O
a	O
child	O
with	O
hemochromatosis	O
associated	O
with	O
congenital	O
dyserythropoietic	O
anemia	O
,	O
type	O
I.	O

The	O
differential	O
investigation	O
of	O
lipoproteins	O
,	O
however	O
,	O
showed	O
that	O
the	O
high	B
-	I
density	I
lipoprotein	I
(	O
HDL	B
)	O
fractions	O
are	O
absolutely	O
or	O
relatively	O
decreased	O
with	O
respect	O
to	O
low	B
-	I
density	I
lipoproteins	I
(	O
LDL	B
)	O
in	O
cerebral	O
infarcts	O
and	O
in	O
transient	O
ischaemic	O
attacks	O
.	O

Preparation	O
of	O
a	O
stable	O
phospholipid	O
reagent	O
for	O
coagulation	O
assays	O
.	O

A	O
note	O
on	O
some	O
consequences	O
of	O
UV	O
vision	O
in	O
birds	O
.	O

Before	O
turnout	O
,	O
a	O
morantel	O
sustained	O
release	O
bolus	O
(	O
MSRB	O
)	O
was	O
administered	O
to	O
each	O
animal	O
in	O
the	O
""""	O
treated	O
""""	O
category	O
.	O

In	O
a	O
longitudinal	O
study	O
,	O
14	O
low	O
-	O
risk	O
fetuses	O
were	O
studied	O
at	O
2-week	O
intervals	O
from	O
32	O
weeks	O
of	O
gestation	O
onward	O
.	O

Further	O
,	O
intracerebroventricular	O
injections	O
of	O
KA	O
resulted	O
in	O
the	O
substantial	O
loss	O
of	O
pyramidal	O
cells	O
in	O
the	O
whole	O
CA3	O
field	O
of	O
the	O
hippocampus	O
.	O

Seventeen	O
of	O
the	O
35	O
patients	O
were	O
randomly	O
chosen	O
to	O
receive	O
a	O
training	O
program	O
(	O
lasting	O
approximately	O
1	O
month	O
)	O
designed	O
to	O
establish	O
a	O
systematic	O
strategy	O
of	O
organizing	O
complex	O
visual	O
material	O
.	O

The	O
duration	O
and	O
the	O
amplitude	O
of	O
the	O
negative	O
potential	O
were	O
greatest	O
for	O
completely	O
regenerating	O
ears	O
with	O
overgrowth	O
,	O
smaller	O
for	O
partially	O
regenerating	O
ears	O
,	O
and	O
smallest	O
for	O
the	O
nonregenerating	O
ears	O
.	O

The	O
steepness	O
of	O
the	O
standard	O
O2	O
dissociation	O
curve	O
becomes	O
greater	O
during	O
the	O
training	O
period	O
(	O
increase	O
in	O
Hill	O
's	O
n	O
from	O
2.68	O
+	O
/-	O

0.10	O
to	O
2.96	O
+	O
/-	O

0.15	O
)	O
.	O

Conjugated	O
and	O
unconjugated	O
phenylacetic	O
acid	O
and	O
m-	O
and	O
p	O
-	O
hydroxyphenylacetic	O
acid	O
have	O
been	O
determined	O
in	O
the	O
plasma	O
of	O
normal	O
,	O
healthy	O
subjects	O
after	O
fasting	O
,	O
consumption	O
of	O
a	O
meal	O
and	O
ingestion	O
of	O
deuterium	O
labelled	O
amine	O
precursors	O
,	O
by	O
high	O
-	O
resolution	O
gas	O
chromatography	O
--	O
high	O
resolution	O
mass	O
spectrometry	O
with	O
selected	O
ion	O
monitoring	O
of	O
their	O
trifluoroethyl	O
-	O
pentafluoropropionyl	O
derivatives	O
.	O

They	O
consisted	O
of	O
behavioural	O
disorders	O
,	O
tetraparesis	O
,	O
incontinence	O
and	O
oculomotor	O
paralysis	O
.	O

CSF	O
adenosine	B
deaminase	I
activity	O
(	O
ADA	O
)	O
was	O
measured	O
at	O
the	O
same	O
time	O
.	O

Histamine	O
reactivity	O
had	O
returned	O
to	O
normal	O
in	O
half	O
the	O
workers	O
who	O
had	O
left	O
their	O
original	O
factories	O
,	O
but	O
in	O
only	O
one	O
worker	O
who	O
had	O
moved	O
within	O
her	O
original	O
factory	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
EF	O
between	O
the	O
two	O
studies	O
,	O
both	O
at	O
rest	O
(	O
56.0	O
+	O
/-	O

13.8	O
%	O
vs	O
58.2	O
+	O
/-	O

11.7	O
%	O
,	O
p	O
=	O
NS	O
)	O
and	O
with	O
exercise	O
(	O
51.1	O
+	O
/-	O

17.6	O
%	O
vs	O
54.3	O
+	O
/-	O

17.6	O
%	O
,	O
p	O
=	O
NS	O
)	O
and	O
a	O
highly	O
significant	O
correlation	O
was	O
shown	O
between	O
the	O
two	O
groups	O
of	O
values	O
(	O
rest	O
r	O
=	O
0.90	O
,	O
exercise	O
r	O
=	O
0.93	O
,	O
p	O
less	O
than	O
0.001	O
)	O
.	O

Re	O
:	O
A	O
modified	O
method	O
for	O
the	O
in	O
vivo	O
labeling	O
of	O
red	O
blood	O
cells	O
with	O
Tc-99	O
m	O
.	O

Parasitological	O
and	O
pathological	O
findings	O
in	O
capuchin	O
monkeys	O
infected	O
with	O
Schistosoma	O
japonicum	O
or	O
Schistosoma	O
mansoni	O
.	O

The	O
pia	O
mater	O
at	O
the	O
site	O
of	O
the	O
entry	O
of	O
blood	O
vessels	O
into	O
the	O
central	O
nervous	O
system	O
.	O

Experimental	O
reproduction	O
of	O
malignant	O
catarrhal	O
fever	O
in	O
Bali	O
cattle	O

1	O
A	O
colonic	O
delivery	O
system	O
is	O
described	O
to	O
deliver	O
orally	O
ingested	O
drugs	O
to	O
the	O
colon	O
and	O
release	O
them	O
at	O
that	O
site	O
by	O
coating	O
with	O
an	O
acrylic	O
based	O
resin	O
(	O
Eudragit	O
S	O
)	O
.	O

Administration	O
of	O
the	O
dopamine	O
agonist	O
bromocriptine	O
(	O
2.5	O
mg	O
three	O
times	O
a	O
day	O
for	O
4	O
days	O
)	O
suppressed	O
(	O
P	O
less	O
than	O
0.01	O
)	O
mean	O
24-h	O
plasma	O
18-OHB	O
levels	O
from	O
21.9	O
+	O
/-	O

2.0	O
to	O
14.8	O
+	O
/-	O

1.4	O
ng	O
/	O
dl	O
.	O

Restarting	O
time	O
was	O
not	O
affected	O
by	O
magnesium	O
cardioplegia	O
.	O

The	O
most	O
common	O
types	O
of	O
malformations	O
were	O
eye	O
defects	O
and	O
open	O
coeloms	O
.	O

Repair	O
of	O
a	O
cosmetic	O
defect	O
of	O
the	O
lower	O
leg	O
with	O
a	O
myocutaneous	O
free	O
flap	O
.	O

In	O
Malmo	O
,	O
Sweden	O
,	O
17,181	O
school	O
children	O
born	O
in	O
the	O
years	O
1961	O
-	O
1965	O
were	O
screened	O
for	O
scoliosis	O
once	O
a	O
year	O
between	O
the	O
ages	O
of	O
7	O
and	O
16	O
years	O
,	O
during	O
1971	O
-	O
1980	O
.	O

In	O
the	O
past	O
,	O
immunology	O
in	O
Singapore	O
was	O
mainly	O
confined	O
to	O
serology	O
for	O
the	O
diagnosis	O
of	O
certain	O
infectious	O
diseases	O
.	O

Intra	O
-	O
articular	O
dislocation	O
of	O
the	O
patella	O
.	O

Histological	O
evaluation	O
revealed	O
a	O
more	O
than	O
twofold	O
increase	O
in	O
the	O
number	O
of	O
interepithelial	O
mononuclear	O
cells	O
(	O
p	O
less	O
than	O
0.005	O
)	O
,	O
while	O
the	O
number	O
of	O
epithelial	O
cells	O
/	O
100	O
microns	O
of	O
villous	O
mucosa	O
and	O
the	O
mean	O
height	O
of	O
the	O
epithelial	O
cells	O
were	O
comparable	O
in	O
both	O
groups	O
.	O

A	O
suspected	O
new	O
storage	O
disease	O
in	O
cattle	O
.	O

For	O
various	O
dog	O
vessels	O
in	O
vivo	O
,	O
Q	O
/	O
Dk	O
ranged	O
from	O
0.15	O
to	O
47	O
X	O
10	O
(	O
5	O
)	O
Torr	O
/	O
cm2	O
.	O

Modification	O
of	O
enteral	O
resorption	O
by	O
cytostatic	O
therapy	O

Asymptomatic	O
bacteriospermia	O
and	O
fertility	O

Triumph	O
of	O
Leninist	O
national	O
policy	O

The	O
application	O
of	O
ultrafiltration	O
to	O
sample	O
preparation	O
in	O
the	O
detection	O
and	O
quantification	O
of	O
ethylene	O
glycol	O
in	O
plasma	O
by	O
gas	O
chromatography	O
is	O
described	O
.	O

A	O
new	O
Onchocerca	O
species	O
,	O
a	O
parasite	O
of	O
domestic	O
cattle	O
,	O
in	O
Senegal	O

It	O
was	O
suggested	O
that	O
the	O
absence	O
of	O
pronounced	O
differences	O
between	O
conditions	O
may	O
have	O
been	O
due	O
to	O
the	O
complexity	O
of	O
the	O
task	O
or	O
the	O
type	O
of	O
prompts	O
employed	O
.	O

In	O
vitro	O
penetration	O
tests	O
of	O
human	O
sperm	O
into	O
cervical	O
mucus	O
were	O
introduced	O
in	O
order	O
to	O
study	O
the	O
interaction	O
between	O
sperm	O
and	O
cervical	O
mucus	O
.	O

Vibrio	O
fluvialis	O
(	O
group	O
F	O
vibrio	O
)	O
in	O
Maharashtra	O
.	O

Serum	B
creatine	I
kinase	I
(	O
SCK	B
)	O
was	O
measured	O
in	O
ten	O
subjects	O
in	O
the	O
laboratory	O
before	O
and	O
after	O
the	O
performance	O
of	O
bicycle	O
ergometry	O
and	O
a	O
lifting	O
task	O
.	O

Organisms	O
were	O
not	O
observed	O
in	O
the	O
5	O
bobcats	O
trapped	O
in	O
2	O
other	O
counties	O
.	O

The	O
cause	O
of	O
death	O
is	O
often	O
quite	O
apparent	O
from	O
the	O
pathological	O
and	O
toxicological	O
findings	O
;	O
however	O
,	O
the	O
manner	O
of	O
death	O
often	O
gives	O
the	O
examining	O
official	O
some	O
difficulty	O
.	O

The	O
average	O
annual	O
cost	O
per	O
head	O
of	O
population	O
was	O
US+0	O
X	O
46	O
.	O

Both	O
groups	O
rejected	O
pops	O
with	O
added	O
SOA	O
,	O
decreasing	O
mouthing	O
times	O
as	O
SOA	O
concentration	O
increased	O
.	O

The	O
mean	O
extracted	O
concentration	O
of	O
flucloxacillin	O
obtained	O
at	O
operation	O
was	O
12.9	O
micrograms	O
/	O
ml	O
(	O
SD	O
5.25	O
)	O
in	O
synovial	O
fluid	O
;	O
2.9	O
micrograms	O
/	O
g	O
(	O
SD	O
3.59	O
)	O
in	O
synovium	O
;	O
2.0	O
micrograms	O
/	O
g	O
(	O
SD	O
1.48	O
)	O
in	O
cancellous	O
bone	O
and	O
1.3	O
micrograms	O
/	O
g	O
(	O
SD	O
1.25	O
)	O
in	O
cortical	O
bone	O
.	O

A	O
preliminary	O
study	O
of	O
vincristine	O
,	O
methotrexate	O
,	O
and	O
prednisolone	O
(	O
VM*P	O
)	O
combination	O
chemotherapy	O
for	O
advanced	O
adult	O
non	O
-	O
Hodgkin	O
's	O
lymphoma	O

Lacrimal	O
secretion	O
in	O
hyperthyroidism	O

A	O
further	O
study	O
on	O
plasminogen	B
activator	I
release	O
by	O
vasoactive	O
agents	O
in	O
the	O
isolated	O
perfused	O
dog	O
leg	O
.	O

Treatment	O
of	O
meat	O
muscle	O
800	O
V	O
for	O
45	O
s	O
reduced	O
weeping	O
but	O
increased	O
slightly	O
the	O
rate	O
of	O
autoxidation	O
of	O
lipids	O
.	O

A	O
method	O
for	O
determining	O
cumulative	O
behavioral	O
toxicity	O
after	O
chronic	O
oral	O
administration	O
of	O
l	O
-	O
alpha	O
-	O
acetylmethadol	O
to	O
female	O
rats	O
.	O

The	O
number	O
of	O
muricidal	O
rats	O
increased	O
with	O
increase	O
in	O
the	O
duration	O
of	O
Cd	O
administration	O
in	O
association	O
with	O
greater	O
accumulation	O
of	O
Cd	O
in	O
the	O
olfactory	O
bulb	O
than	O
in	O
any	O
other	O
region	O
of	O
the	O
brain	O
.	O

This	O
test	O
should	O
provide	O
another	O
practical	O
means	O
to	O
study	O
leprosy	O
.	O

The	O
preferences	O
were	O
for	O
intact	O
vis	O
-	O
a	O
-	O
vis	O
castrated	O
males	O
,	O
though	O
injections	O
of	O
TP	O
restored	O
the	O
castrates	O
'	O
attractiveness	O
to	O
the	O
females	O
.	O

Inhibition	O
of	O
Fusarium	O
moniliforme	O
var	O
.	O

subglutinans	O
,	O
the	O
causal	O
agent	O
of	O
pine	O
pitch	O
canker	O
,	O
by	O
the	O
soil	O
bacterium	O
Arthrobacter	O
sp.	O

The	O
five	O
-	O
drug	O
combination	O
of	O
fluorouracil	O
imidazole	O
carboxamide	O
dimethyl	O
triazeno	O
,	O
vincristine	O
,	O
bis	O
-	O
chloroethyl	O
nitrosourea	O
,	O
and	O
prednisone	O
(	O
FIVB	O
+	O
P	O
)	O
was	O
given	O
to	O
120	O
women	O
with	O
metastatic	O
breast	O
cancer	O
.	O

Visual	O
response	O
properties	O
of	O
neurons	O
in	O
four	O
extrastriate	O
visual	O
areas	O
of	O
the	O
owl	O
monkey	O
(	O
Aotus	O
trivirgatus	O
)	O
:	O
a	O
quantitative	O
comparison	O
of	O
medial	O
,	O
dorsomedial	O
,	O
dorsolateral	O
,	O
and	O
middle	O
temporal	O
areas	O
.	O

A	O
unified	O
approach	O
to	O
the	O
standardization	O
of	O
allergens	O
.	O

Clinical	O
and	O
anatomical	O
considerations	O

Several	O
authors	O
have	O
recently	O
reported	O
interference	O
in	O
theophylline	O
analysis	O
by	O
paraxanthine	O
(	O
1,7-dimethylxanthine	O
)	O
,	O
an	O
important	O
metabolite	O
of	O
caffeine	O
.	O

Multi	O
drug	O
regimens	O
like	O
C	O
-	O
MOPP	O
,	O
CHOP	O
and	O
BACOP	O
led	O
to	O
high	O
remission	O
rates	O
and	O
in	O
some	O
cases	O
probably	O
also	O
to	O
a	O
cure	O
of	O
the	O
disease	O
.	O

For	O
monocytes	O
,	O
as	O
measured	O
on	O
the	O
Hematrak	O
,	O
it	O
was	O
13.4	O
%	O
.	O

Morphological	O
features	O
of	O
Jat	O
dentition	O
.	O

Clinical	O
accuracy	O
of	O
updated	O
version	O
of	O
the	O
Phadebas	O
RAST	O
test	O
.	O

Cross	O
reactivity	O
in	O
theophylline	O
RIA	O
kit	O
decreased	O
.	O

Strontium-90	O
was	O
inject	O
i.v	O
.	O

into	O
pregnant	O
rats	O
on	O
day	O
18	O
post	O
conception	O
(	O
p.c	O
.	O
)	O
.	O

Recording	O
of	O
the	O
digital	O
sphygmic	O
activity	O
in	O
the	O
lower	O
extremities	O
with	O
the	O
photoplethysmographic	O
and	O
strain	O
-	O
gauge	O
methods	O
.	O

Eight	O
hr	O
of	O
acidosis	O
caused	O
a	O
significant	O
(	O
P	O
less	O
than	O
0.01	O
)	O
decrease	O
in	O
P50	O
in	O
vitro	O
which	O
fell	O
from	O
29.0	O
to	O
24.4	O
torr	O
.	O

Catheter	O
transit	O
slows	O
the	O
response	O
to	O
a	O
step	O
increase	O
in	O
concentration	O
by	O
about	O
0.13	O
s	O
(	O
from	O
10	O
per	O
cent-90	O
per	O
cent	O
)	O
and	O
prolongs	O
the	O
transit	O
time	O
through	O
the	O
catheter	O
for	O
a	O
volatile	O
anesthetic	O
by	O
about	O
0.04	O
s	O
more	O
than	O
N2	O
.	O

These	O
women	O
should	O
not	O
be	O
given	O
the	O
current	O
estrogen	O
PPI	O
,	O
which	O
was	O
designed	O
to	O
warn	O
women	O
of	O
the	O
risks	O
of	O
long	O
-	O
term	O
estrogen	O
use	O
;	O
a	O
PPI	O
should	O
be	O
written	O
specifically	O
for	O
patients	O
receiving	O
short	O
courses	O
.	O

The	O
oral	O
temperature	O
rose	O
and	O
the	O
serum	B
creatine	I
kinase	I
levels	O
fell	O
only	O
in	O
those	O
patients	O
who	O
were	O
actively	O
warmed	O
.	O

Determination	O
of	O
aortic	O
distensibility	O
and	O
its	O
variations	O
in	O
arterial	O
hypertension	O
.	O

Effects	O
of	O
prostaglandin	O
inhibitors	O
on	O
the	O
onset	O
of	O
proteinuria	O
and	O
stroke	O
in	O
stroke	O
-	O
prone	O
spontaneously	O
hypertensive	O
rats	O
.	O

In	O
this	O
study	O
,	O
the	O
general	O
clinical	O
criteria	O
for	O
inhalation	O
injury	O
--	O
presence	O
of	O
facial	O
or	O
oropharyngeal	O
burns	O
,	O
carboxyhemoglobin	B
levels	O
,	O
carbonaceous	O
sputum	O
,	O
or	O
closed	O
space	O
injury	O
--	O
did	O
not	O
differentiate	O
patients	O
with	O
airway	O
injury	O
only	O
from	O
those	O
with	O
parenchymal	O
injury	O
.	O

Survival	O
was	O
calculated	O
both	O
from	O
the	O
date	O
of	O
onset	O
and	O
from	O
the	O
date	O
of	O
diagnosis	O
.	O

Methisergide	O
(	O
0.5	O
mg	O
/	O
kg	O
,	O
i.p	O
.	O
)	O
,	O
a	O
blocker	O
of	O
serotonin	B
receptors	I
,	O
prevented	O
the	O
development	O
of	O
the	O
antinociceptive	O
effect	O
of	O
serotonin	O
.	O

The	O
plasma	O
half	O
-	O
life	O
of	O
slow	O
disposition	O
phase	O
t1	O
/	O
2	O
beta	O
,	O
increases	O
from	O
0.26	O
hour	O
in	O
rabbits	O
with	O
normal	O
renal	O
function	O
to	O
5.41	O
hours	O
in	O
rabbits	O
with	O
severe	O
renal	O
impairment	O
.	O

Corticosteroid	O
therapy	O
is	O
known	O
to	O
be	O
hazardous	O
in	O
patients	O
with	O
occult	O
infection	O
but	O
the	O
mechanism	O
by	O
which	O
the	O
host	O
parasite	O
relationship	O
is	O
altered	O
by	O
steroids	O
is	O
not	O
known	O
.	O

We	O
have	O
used	O
an	O
intestinal	O
protozoal	O
parasite	O
,	O
Giardia	O
muris	O
,	O
to	O
examine	O
the	O
effects	O
of	O
corticosteroids	O
on	O
the	O
number	O
of	O
parasites	O
in	O
the	O
intestine	O
in	O
the	O
course	O
of	O
a	O
primary	O
infection	O
.	O

With	O
Sair	O
and	O
So2	O
,	O
mean	O
vital	O
capacity	O
was	O
reduced	O
by	O
44	O
%	O
from	O
control	O
.	O

The	O
relationship	O
between	O
estrogenic	O
properties	O
of	O
Tamoxifen	O
and	O
breast	O
cancer	O
management	O
is	O
discussed	O
.	O

The	O
new	O
semi	O
-	O
synthetic	O
oral	O
cephalosporin	O
,	O
CGP	O
9,000	O
,	O
has	O
been	O
evaluated	O
in	O
a	O
large	O
number	O
of	O
hospitalized	O
patients	O
with	O
urinary	O
infections	O
.	O

A	O
fluoroimmunoassay	O
for	O
the	O
determination	O
of	O
serum	O
of	O
plasma	O
levels	O
of	O
propranolol	O
was	O
developed	O
using	O
antibodies	O
to	O
propranolol	O
coupled	O
to	O
magnetizable	O
solid	O
-	O
phase	O
particles	O
and	O
fluorescein	O
-	O
labeled	O
propranolol	O
as	O
tracer	O
.	O

The	O
syncytial	O
microvillous	O
projections	O
seemed	O
to	O
be	O
more	O
numerous	O
and	O
longer	O
in	O
CNF	O
,	O
otherwise	O
the	O
structure	O
of	O
the	O
trophoblastic	O
layer	O
of	O
the	O
villi	O
and	O
the	O
lining	O
of	O
the	O
subtrophoblastic	O
vessels	O
were	O
identical	O
in	O
CNF	O
and	O
controls	O
.	O

It	O
has	O
been	O
shown	O
in	O
experiments	O
in	O
vitro	O
that	O
the	O
hepatotrophic	O
organic	O
anions	O
,	O
the	O
radiographic	O
contrast	O
agent	O
(	O
RCA	O
)	O
bilignost	O
used	O
in	O
cholecystography	O
and	O
Bengal	O
pink	O
,	O
have	O
an	O
affinity	O
,	O
unlike	O
the	O
urographic	O
RCA	O
triombrin	O
and	O
renotrophic	O
dye	O
indigo	O
-	O
carmine	O
,	O
for	O
the	O
plasmatic	O
membranes	O
(	O
PM	O
)	O
of	O
liver	O
cells	O
.	O

33	O
out	O
of	O
90	O
neurons	O
of	O
the	O
cat	O
medial	O
geniculate	O
body	O
revealed	O
the	O
selectivity	O
of	O
their	O
afterdischarges	O
to	O
movement	O
of	O
sound	O
when	O
velocity	O
of	O
the	O
movement	O
changed	O
from	O
30	O
to	O
180	O
deg	O
/	O
s	O
.	O

In	O
controls	O
,	O
only	O
modest	O
differences	O
were	O
observed	O
.	O

Assay	O
of	O
serum	B
immunoreactive	I
trypsin	I
in	O
dried	O
blood	O
spots	O
and	O
the	O
early	O
detection	O
of	O
cystic	O
fibrosis	O
.	O

Leukocyte	O
enzyme	O
activity	O
and	O
blood	O
lymphocyte	O
blast	O
transformation	O
in	O
chronic	O
bronchitis	O

Based	O
on	O
AUC	O
infinity	O
analyses	O
,	O
the	O
pharmacokinetics	O
of	O
buflomedil	O
were	O
found	O
to	O
be	O
linear	O
within	O
the	O
dose	O
ranges	O
studied	O
(	O
50	O
to	O
200	O
mg	O
for	O
i.	O
v.	O
injection	O
and	O
150	O
to	O
450	O
mg	O
for	O
oral	O
administration	O
)	O
.	O

Gastrin	B
secretion	O
during	O
food	O
stimulation	O
in	O
digestive	O
system	O
diseases	O

Delayed	O
or	O
paradoxically	O
emptying	O
regions	O
of	O
the	O
left	O
ventricle	O
were	O
detected	O
by	O
a	O
relatively	O
new	O
nuclear	O
technique	O
--	O
phase	O
imaging	O
.	O

Nineteen	O
patients	O
with	O
non	O
-	O
visualized	O
gallbladder	O
with	O
OCG	O
subsequently	O
had	O
Tc-99m	O
-	O
PyG	O
cholescintigraphy	O
performed	O
.	O

Anamnestic	O
data	O
were	O
obtained	O
from	O
case	O
history	O
,	O
smoking	O
habits	O
were	O
not	O
known	O
in	O
collective	O
A	O
and	O
C.	O

The	O
determination	O
of	O
physical	O
performance	O
capacity	O
was	O
based	O
on	O
W170	O
,	O
W85	O
%	O
and	O
on	O
predicted	O
VO2	O
max	O
measured	O
with	O
continuously	O
increasing	O
work	O
load	O
on	O
a	O
bicycle	O
ergometer	O
.	O

LD50	O
values	O
of	O
terms	O
of	O
KP	O
were	O
84	O
mg	O
/	O
kg	O
in	O
male	O
rats	O
and	O
122	O
mg	O
/	O
kg	O
in	O
female	O
rats	O
when	O
KP	O
-	O
CMC	O
was	O
administered	O
intrarectally	O
,	O
and	O
117	O
mg	O
/	O
kg	O
in	O
male	O
and	O
92	O
mg	O
/	O
kg	O
in	O
female	O
when	O
KP	O
-	O
T10	O
was	O
administered	O
intrarectally	O
.	O
,	O
while	O
peroral	O
administration	O
of	O
KP	O
-	O
CMC	O
showed	O
LD50	O
values	O
of	O
68	O
mg	O
/	O
kg	O
in	O
males	O
and	O
78	O
mg	O
/	O
kg	O
in	O
females	O
in	O
terms	O
of	O
KP	O
.	O

Autotransfusion	O
was	O
performed	O
as	O
follows	O
:	O
Heparin	O
-	O
ACD	O
-	O
B-	O
Heparin	O
-	O
DPD-	O
Heparin	O
-	O
ACD	O
-	O
B	O
etc	O
.	O

Generally	O
the	O
differences	O
between	O
short	O
gut	O
and	O
sham	O
operation	O
animals	O
disappeared	O
when	O
the	O
data	O
were	O
normalised	O
for	O
mucosal	O
weight	O
.	O

The	O
architecture	O
of	O
microvasculature	O
in	O
these	O
two	O
regions	O
was	O
also	O
examined	O
by	O
scanning	O
electron	O
microscopy	O
,	O
using	O
the	O
resin	O
casting	O
method	O
.	O

Chordoma	O
of	O
the	O
spinal	O
cord	O
in	O
a	O
F344	O
rat	O
.	O

Micro	O
high	O
-	O
performance	O
liquid	O
chromatographic	O
system	O
with	O
micro	O
precolumn	O
and	O
dual	O
electrochemical	O
detector	O
for	O
direct	O
injection	O
analysis	O
of	O
catecholamines	O
in	O
body	O
fluids	O
.	O

A	O
narrow	O
zone	O
of	O
myelin	O
-	O
axonal	O
dissociation	O
was	O
also	O
observed	O
.	O

The	O
IgA	B
deficiency	O
is	O
combined	O
with	O
the	O
IgE	B
one	O
.	O

Prevention	O
of	O
transfusion	O
reactions	O
by	O
the	O
use	O
of	O
saline	O
washed	O
red	O
blood	O
cells	O
.	O

The	O
geometric	O
mean	O
hemagglutination	O
-	O
inhibition	O
antibody	O
titers	O
(	O
GMT	O
)	O
of	O
non	O
-	O
immunized	O
,	O
once	O
-	O
immunized	O
,	O
and	O
twice	O
-	O
immunized	O
chickens	O
were	O
compared	O
at	O
2-week	O
intervals	O
following	O
primary	O
immunization	O
,	O
secondary	O
immunization	O
,	O
and	O
challenge	O
.	O

The	O
quantitative	O
determination	O
of	O
HBSAG	B
--	O
a	O
valuable	O
aid	O
in	O
evaluating	O
the	O
infectiousness	O
of	O
hepatitis	O
B	O
virus	O
carriers	O

2	O
.	O
numerous	O
narrow	O
shunt	O
vessels	O
departing	O
continuously	O
from	O
the	O
primary	O
arteries	O
to	O
feed	O
a	O
secondary	O
arterial	O
system	O
which	O
parallels	O
the	O
primary	O
one	O
.	O

Urological	O
complications	O
are	O
frequent	O
during	O
and	O
after	O
the	O
treatment	O
of	O
gynecological	O
malignancy	O
.	O

Arachnoid	O
cyst	O
.	O

100	O
more	O
than	O
in	O
the	O
summer	O
coat	O
)	O
.	O

Hypotension	O
was	O
produced	O
by	O
head	O
up	O
tilt	O
.	O

Therefore	O
the	O
procedure	O
of	O
Lich	O
-	O
Gregoir	O
is	O
not	O
to	O
be	O
recommended	O
in	O
adults	O
.	O

Mucoepidermoid	O
and	O
acinous	O
cell	O
carcinomas	O
of	O
salivary	O
tissues	O
.	O

Two	O
new	O
artifacts	O
in	O
automated	O
coagulation	O
testing	O
.	O

Longitudinal	O
force	O
-	O
length	O
relationships	O
of	O
guinea	O
pig	O
ureter	O
were	O
studied	O
in	O
vitro	O
in	O
animals	O
3	O
weeks	O
,	O
3	O
months	O
,	O
and	O
3	O
years	O
of	O
age	O
.	O

Angiographic	O
work	O
-	O
up	O
in	O
a	O
patient	O
with	O
late	O
vaginal	O
metastasis	O
from	O
a	O
renal	O
carcinoma	O
.	O

The	O
following	O
aspects	O
were	O
assessed	O
:	O
(	O
1	O
)	O
The	O
effect	O
on	O
the	O
cardiovascular	O
system	O
in	O
terms	O
of	O
brachial	O
arterial	O
pressure	O
,	O
pulse	O
rate	O
,	O
and	O
oxygen	O
consumption	O
(	O
VO2	O
)	O
during	O
exercise	O
in	O
5	O
health	O
volunteers	O
;	O
(	O
2	O
)	O
emg	O
activity	O
of	O
the	O
tibialis	O
anterior	O
and	O
gastrocnemius	O
muscles	O
during	O
exercise	O
in	O
the	O
same	O
5	O
volunteers	O
;	O
and	O
(	O
3	O
)	O
postexercise	O
ankle	O
pressure	O
changes	O
in	O
10	O
subjects	O
with	O
angiographically	O
proven	O
occlusive	O
arterial	O
diseases	O
of	O
the	O
lower	O
extremities	O
.	O

Changes	O
in	O
immunologic	O
reactivity	O
in	O
subjects	O
receiving	O
transfer	B
factor	I
could	O
not	O
be	O
distinguished	O
from	O
those	O
in	O
subjects	O
receiving	O
placebo	O
.	O

It	O
was	O
argued	O
that	O
this	O
arose	O
from	O
the	O
possibility	O
that	O
the	O
nature	O
of	O
blue	O
collar	O
jobs	O
was	O
physical	O
,	O
and	O
that	O
loss	O
of	O
myocardial	O
tissue	O
might	O
be	O
expected	O
to	O
more	O
markedly	O
interfere	O
with	O
their	O
work	O
efficiency	O
(	O
on	O
returning	O
to	O
work	O
)	O
than	O
it	O
would	O
the	O
efficiency	O
of	O
the	O
more	O
sedentary	O
jobs	O
of	O
white	O
collar	O
workers	O
.	O

Specific	O
clotting	O
factor	O
assays	O
showed	O
an	O
isolated	O
deficiency	O
of	O
factor	B
X	I
ranging	O
from	O
7	O
to	O
12	O
per	O
cent	O
on	O
three	O
determinations	O
.	O

Charcoal	O
-	O
facilitated	O
dialysis	O
.	O

Blood	O
variables	O
measured	O
at	O
eight	O
intervals	O
before	O
,	O
during	O
,	O
and	O
after	O
operation	O
were	O
as	O
follows	O
:	O
seven	O
plasma	O
proteins	O
,	O
free	O
hemoglobin	B
,	O
formed	O
elements	O
,	O
and	O
clotting	O
functions	O
.	O

Retinal	O
changes	O
in	O
pigmentary	O
retinopathy	O
in	O
children	O

As	O
a	O
result	O
,	O
beta	O
-	O
apo-8'-carotenoic	O
acid	O
ethyl	O
ester	O
(	O
apo	O
-	O
EE	O
)	O
was	O
used	O
as	O
a	O
reference	O
standard	O
in	O
Experiments	O
4	O
to	O
6	O
.	O

It	O
appears	O
that	O
the	O
pulmonary	O
gas	O
exchange	O
parenchyma	O
of	O
these	O
smallest	O
mammals	O
is	O
well	O
suited	O
to	O
supply	O
the	O
organism	O
with	O
the	O
comparatively	O
high	O
levels	O
of	O
O2	O
required	O
by	O
the	O
high	O
metabolic	O
rates	O
,	O
exhibiting	O
a	O
structural	O
adaptation	O
of	O
the	O
lung	O
to	O
higher	O
VO2	O
.	O

However	O
,	O
at	O
lower	O
temperature	O
the	O
positive	O
staircase	O
was	O
not	O
clear	O
and	O
rather	O
negative	O
staircase	O
appeared	O
(	O
1	O
-	O
-3	O
Hz	O
)	O
.	O

Visual	O
averaged	O
evoked	O
responses	O
and	O
platelet	B
monoamine	I
oxidase	I
in	O
patients	O
suffering	O
from	O
alcoholism	O
.	O

Six	O
hours	O
after	O
the	O
last	O
administration	O
,	O
uterus	O
of	O
Gf	O
and	O
Cv	O
mice	O
were	O
weight	O
337.6	O
mg%	O
and	O
423.5	O
mg%	O
respectively	O
,	O
the	O
difference	O
was	O
statistically	O
significant	O
(	O
p	O
less	O
than	O
0.01	O
)	O
.	O

Autoradiographic	O
localisation	O
of	O
its	O
cellular	O
distribution	O
in	O
the	O
kidney	O
.	O

Hippocampal	O
stimulation	O
overlapping	O
conditioned	O
stimulus	O
preexposure	O
produced	O
attenuation	O
of	O
latent	O
inhibition	O
,	O
as	O
did	O
stimulation	O
presented	O
during	O
conditioning	O
after	O
preexposure	O
.	O

Cataract	O
extraction	O
in	O
primary	O
glaucoma	O

In	O
the	O
intact	O
animal	O
,	O
postextrasystolic	O
potentiation	O
depended	O
on	O
the	O
basic	O
pacing	O
interval	O
,	O
t0	O
,	O
and	O
the	O
timing	O
of	O
the	O
extrasystole	O
,	O
t1	O
:	O
when	O
t0	O
was	O
held	O
constant	O
and	O
t1	O
was	O
increased	O
,	O
potentiation	O
decreased	O
;	O
when	O
t1	O
was	O
held	O
constant	O
and	O
t0	O
was	O
increased	O
,	O
potentiation	O
increased	O
.	O

Implications	O
of	O
this	O
observation	O
for	O
pediatrics	O
are	O
discussed	O
.	O

Treatment	O
of	O
suppurative	O
peritonitis	O

We	O
report	O
a	O
case	O
of	O
pheochromocytoma	O
manifesting	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Fasting	O
plasma	O
and	O
lipoprotein	O
lipid	O
concentrations	O
,	O
adipose	B
tissue	I
lipoprotein	I
lipase	I
activity	O
,	O
anthropometric	O
data	O
,	O
alcohol	O
consumption	O
,	O
smoking	O
habits	O
,	O
weekly	O
mileage	O
run	O
and	O
performance	O
on	O
a	O
bicycle	O
ergometer	O
were	O
recorded	O
before	O
and	O
after	O
the	O
training	O
period	O
.	O

The	O
C18:1	O
:	O
C10	O
value	O
is	O
a	O
convenient	O
measure	O
of	O
these	O
changes	O
and	O
can	O
be	O
determined	O
more	O
rapidly	O
than	O
determining	O
all	O
the	O
lower	O
fatty	O
acids	O
.	O

A	O
progressive	O
growth	O
of	O
blood	O
erythrocyte	O
membrane	O
injury	O
has	O
been	O
demonstrated	O
after	O
rats	O
were	O
exposed	O
to	O
gamma	O
-	O
irradiaton	O
at	O
a	O
dose	O
of	O
100	O
to	O
500	O
Gy	O
.	O

One	O
hundred	O
twenty	O
units	O
of	O
deglycerolized	O
red	O
blood	O
cells	O
,	O
some	O
with	O
glycerol	O
added	O
so	O
as	O
to	O
exceed	O
an	O
acceptable	O
1	O
%	O
glycerol	O
content	O
,	O
had	O
measurements	O
made	O
of	O
the	O
post	O
-	O
wash	O
supernatant	O
fluid	O
by	O
refractive	O
index	O
and	O
osmometry	O
.	O

The	O
symptoms	O
and	O
objective	O
findings	O
were	O
caused	O
by	O
a	O
malignant	O
lymphoma	O
,	O
and	O
the	O
diagnosis	O
was	O
established	O
from	O
a	O
drill	O
biopsy	O
.	O

Our	O
study	O
differs	O
from	O
previous	O
studies	O
in	O
that	O
it	O
is	O
limited	O
to	O
one	O
diagnostic	O
entity	O
,	O
yet	O
at	O
the	O
same	O
time	O
evaluates	O
a	O
broad	O
range	O
of	O
social	O
and	O
work	O
-	O
related	O
factors	O
in	O
disability	O
.	O

All	O
control	O
persons	O
had	O
a	O
normal	O
reaction	O
to	O
DNFB	O
.	O

In	O
a	O
control	O
group	O
both	O
common	O
carotid	O
arteries	O
(	O
CCA	O
)	O
were	O
ligated	O
.	O

At	O
pH	O
6.9	O
,	O
the	O
same	O
lidocaine	O
concentrations	O
significantly	O
reduced	O
resting	O
potential	O
(	O
3	O
-	O
10	O
%	O
)	O
,	O
action	O
potential	O
amplitude	O
(	O
3	O
-	O
8	O
%	O
)	O
and	O
Vmax	O
(	O
14	O
-	O
22	O
%	O
)	O
.	O

Simultaneous	O
right	O
and	O
left	O
adrenal	O
and	O
peripheral	O
blood	O
samples	O
were	O
collected	O
for	O
determination	O
of	O
oestrone	O
(	O
E1	O
)	O
and	O
oestradiol	O
(	O
E2	O
)	O
.	O

All	O
lambs	O
with	O
B	O
breeding	O
had	O
significantly	O
higher	O
Hb	B
levels	O
at	O
the	O
end	O
of	O
the	O
experiment	O
than	O
did	O
NB	O
lambs	O
.	O

b	O
and	O
S	O
x	O
B	O
lambs	O
had	O
higher	O
(	O
P	O
<	O
.05	O
)	O

Hb	B
levels	O
than	O
the	O
D	O
x	O
B	O
lambs	O
,	O
and	O
B	O
lambs	O
had	O
the	O
highest	O
(	O
P	O
<	O
.05	O
)	O
mean	O
corpuscular	O
hemoglobin	B
concentrations	O
.	O

The	O
same	O
response	O
occurs	O
whether	O
acrylamide	O
is	O
given	O
immediately	O
after	O
nerve	O
ligation	O
or	O
1	O
week	O
later	O
.	O

The	O
operation	O
recommended	O
is	O
excision	O
of	O
3	O
mm	O
of	O
central	O
slip	O
followed	O
by	O
end	O
-	O
to	O
-	O
end	O
repair	O
of	O
the	O
tendon	O
.	O

In	O
the	O
unclipped	O
group	O
arterial	O
pressure	O
decreased	O
50	O
mmHg	O
to	O
normal	O
by	O
24	O
h	O
and	O
was	O
associated	O
with	O
increased	O
diuresis	O
and	O
a	O
small	O
decrease	O
in	O
blood	O
volume	O
(	O
9.8	O
%	O
)	O
.	O

The	O
ESEG	O
's	O
are	O
a	O
direct	O
result	O
of	O
the	O
NEXT	O
study	O
.	O

A	O
third	O
series	O
of	O
mice	O
were	O
given	O
a	O
single	O
injection	O
of	O
5-OH	O
-	O
DA	O
,	O
sacrificed	O
,	O
and	O
prepared	O
for	O
ultrastructural	O
study	O
.	O

Fourteen	O
different	O
species	O
(	O
eight	O
Platyhelmintha	O
,	O
one	O
Nematoda	O
and	O
five	O
Crustacea	O
)	O
have	O
been	O
inventorized	O
.	O

No	O
symptoms	O
other	O
than	O
hot	O
flush	O
showed	O
such	O
significant	O
correlation	O
with	O
plasma	O
epinephrine	O
or	O
norepinephrine	O
levels	O
.	O

The	O
mean	O
values	O
of	O
the	O
concentrations	O
of	O
the	O
components	O
due	O
to	O
tobacco	O
smoke	O
are	O
:	O
CO	O
=	O
1.1	O
ppm	O
,	O
NO	O
=	O
32	O
ppb	O
,	O
NO2	O
=	O
24	O
ppb	O
,	O
nicotine	O
=	O
0.9	O
micrograms	O
/	O
m3	O
,	O
particulate	O
matter	O
=	O
133	O
micrograms	O
/	O
m3	O
.	O

The	O
average	O
backscatter	O
coefficient	O
was	O
six	O
time	O
larger	O
in	O
regions	O
of	O
infarct	O
studied	O
8	O
-	O
-10	O
weeks	O
after	O
occlusion	O
than	O
that	O
in	O
regions	O
of	O
infarct	O
studied	O
5	O
-	O
-6	O
weeks	O
after	O
occlusion	O
.	O

Early	O
infection	O
was	O
detected	O
in	O
one	O
of	O
50	O
control	O
women	O
who	O
gave	O
birth	O
to	O
a	O
healthy	O
infant	O
.	O

Family	O
planning	O
continues	O
to	O
play	O
a	O
minor	O
role	O
,	O
and	O
only	O
25.3	O
per	O
cent	O
of	O
all	O
patients	O
reviewed	O
took	O
to	O
oral	O
contraceptives	O
for	O
shorter	O
or	O
longer	O
periods	O
of	O
time	O
.	O

-	O
The	O
percentages	O
of	O
primiparae	O
and	O
secundiparae	O
in	O
all	O
births	O
as	O
well	O
as	O
the	O
high	O
percentage	O
of	O
multigravidity	O
are	O
parameters	O
by	O
which	O
the	O
approach	O
to	O
reproduction	O
differs	O
substantively	O
from	O
behaviour	O
patterns	O
in	O
Europe	O
.	O

The	O
identification	O
of	O
viable	O
myocardium	O
with	O
both	O
99mTc	O
-	O
tetrofosmin	O
and	O
201Tl	O
can	O
be	O
greatly	O
enhanced	O
to	O
a	O
similar	O
degree	O
if	O
the	O
severity	O
of	O
reduction	O
in	O
activity	O
within	O
nonreversible	O
defects	O
is	O
considered	O
.	O

The	O
temporal	O
component	O
lacked	O
a	O
mandibular	O
fossa	O
as	O
well	O
as	O
articular	O
eminence	O
.	O

The	O
protein	B
ELT-1	I
,	O
encoded	O
by	O
a	O
single	O
-	O
copy	O
gene	O
homologous	O
to	O
the	O
GATA	B
family	I
of	I
vertebrate	I
transcription	I
factors	I
,	O
is	O
potentially	O
capable	O
of	O
interacting	O
with	O
this	O
element	O
.	O

However	O
,	O
in	O
contrast	O
with	O
previous	O
in	O
vitro	O
cell	O
-	O
free	O
integration	O
studies	O
,	O
alteration	O
of	O
the	O
highly	O
conserved	O
CA	O
dinucleotide	O
resulted	O
in	O
a	O
mutant	O
which	O
still	O
retained	O
40	O
%	O
of	O
wild	O
-	O
type	O
integration	O
activity	O
.	O

The	O
resulting	O
R	B
protein	I
terminates	O
five	O
codons	O
downstream	O
of	O
the	O
frameshift	O
site	O
at	O
the	O
V	B
protein	I
stop	O
codon	O
.	O

By	O
site	O
-	O
specific	O
mutagenesis	O
,	O
we	O
also	O
show	O
that	O
individual	O
ICP27	B
C	I
-	I
terminal	I
amino	I
acid	I
residues	I
that	O
are	O
positionally	O
conserved	O
in	O
ICP27	B
homologs	I
in	O
other	O
herpesviruses	O
(	O
D-357	O
,	O
E-358	O
,	O
H-479	O
,	O
C-400	O
,	O
C-483	O
,	O
and	O
C-488	O
)	O
are	O
critical	O
for	O
trans	O
-	O
regulatory	O
activity	O
.	O

Magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
has	O
enabled	O
us	O
to	O
see	O
the	O
spinal	O
intramedullary	O
pathology	O
as	O
differences	O
in	O
signal	O
intensity	O
.	O

Malaria	O
,	O
anaemia	O
,	O
and	O
HIV-1	O
transmission	O
in	O
central	O
Africa	O
.	O

Peroxisome	B
proliferator	I
-	I
activated	I
receptors	I
(	O
PPARs	B
)	O
and	O
retinoid	B
X	I
receptors	I
(	O
RXRs	B
)	O
are	O
nuclear	B
hormone	I
receptors	I
that	O
are	O
activated	O
by	O
fatty	O
acids	O
and	O
9-cis	O
-	O
retinoic	O
acid	O
,	O
respectively	O
.	O

Some	O
strains	O
of	O
A.	O
parasiticus	O
produced	O
all	O
four	O
aflatoxins	O
B1	O
B2	O
G1	O
G2	O
,	O
while	O
the	O
other	O
ones	O
produced	O
AF	O
B1	O
+	O
G1	O
only	O
,	O
with	O
concentrations	O
of	O
aflatoxins	O
from	O
0.1	O
to	O
450	O
mg	O
/	O
kg	O
.	O

We	O
have	O
isolated	O
a	O
new	O
,	O
larger	O
rat	B
B	I
-	I
myc	I
genomic	I
clone	I
.	O

Both	O
classes	O
of	O
MHBst	B
proteins	I
were	O
found	O
to	O
form	O
dimers	O
;	O
an	O
which	O
is	O
involved	O
in	O
mediating	O
the	O
dimerization	O
.	O

Analysis	O
of	O
the	O
sequence	O
identified	O
four	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
which	O
are	O
designated	O
UL1	B
,	O
UL2	B
,	O
UL3	B
,	O
and	O
UL3.5	B
based	O
on	O
their	O
homology	O
with	O
proteins	O
of	O
herpes	O
simplex	O
virus-1	O
(	O
HSV-1	O
)	O
,	O
pseudorabies	O
virus	O
(	O
PRV	O
)	O
,	O
equine	O
herpesvirus-1	O
,	O
and	O
varicella	O
-	O
zoster	O
virus	O
.	O

The	O
serum	O
levels	O
of	O
IgE	B
,	O
and	O
asIgE	B
and	O
IgG-4	B
against	O
14	O
common	O
food	O
allergens	O
were	O
determined	O
.	O

Two	O
experiments	O
investigating	O
the	O
effects	O
of	O
short	O
-	O
term	O
spaceflight	O
on	O
cancellous	O
bone	O
turnover	O
were	O
carried	O
out	O
:	O
Physiological	O
Systems	O
Experiment-1	O
(	O
PSE-1	O
)	O
(	O
a	O
4-d	O
orbital	O
spaceflight	O
)	O
and	O
PSE-2	O
(	O
a	O
10-d	O
flight	O
)	O
.	O

That	O
sequence	O
strongly	O
promoted	O
the	O
transcription	O
of	O
the	O
promotorless	O
chloramphenicol	B
acetyltranferase	I
(	O
CAT	B
)	O
gene	O
in	O
cells	O
of	O
pancreatic	O
origin	O
(	O
AR-42J	O
)	O
but	O
not	O
in	O
cells	O
of	O
non	O
-	O
pancreatic	O
origin	O
(	O
Rat	O
2	O
and	O
IEC	O
6	O
)	O
.	O

An	O
approach	O
to	O
a	O
biomathematical	O
model	O
of	O
lymphocytopoiesis	O
.	O

These	O
are	O
two	O
regions	O
of	O
known	O
conserved	O
synteny	O
,	O
providing	O
further	O
evidence	O
that	O
the	O
human	B
STEP	I
is	O
a	O
true	O
homolog	O
of	O
the	O
murine	B
STEP	I
gene	I
.	O

Carbonic	B
anhydrase	I
V	I
(	O
CA	B
V	I
)	O
is	O
expressed	O
in	O
mitochondrial	O
matrix	O
in	O
liver	O
and	O
several	O
other	O
tissues	O
.	O

Vitamin	O
D3	O
plus	O
nicotine	O
treatment	O
produced	O
parallel	O
increases	O
in	O
cardiac	O
mass	O
and	O
elastic	O
modulus	O
,	O
with	O
a	O
significant	O
correlation	O
between	O
the	O
two	O
.	O

This	O
finding	O
is	O
consistent	O
with	O
the	O
notion	O
that	O
the	O
dsRNA	O
binding	O
domains	O
may	O
be	O
composed	O
of	O
two	O
separate	O
functional	O
subdomains	O
.	O

We	O
studied	O
the	O
GR	B
in	O
DMS-79	O
cells	O
derived	O
from	O
a	O
human	O
ACTH	B
-	O
secreting	O
small	O
cell	O
lung	O
cancer	O
.	O

Thus	O
,	O
as	O
expected	O
,	O
trans	O
-	O
splicing	O
depends	O
on	O
the	O
integrity	O
of	O
U2	B
,	O
U4	B
,	O
and	O
U6	B
snRNAs	I
.	O

Treatment	O
of	O
PCC4.aza1R	O
cells	O
with	O
an	O
RAR	B
-	O
selective	O
agonist	O
also	O
repressed	O
the	O
expression	O
of	O
EC-1	B
mRNA	I
while	O
treatment	O
with	O
an	O
RXR	B
-	O
selective	O
agonist	O
reduced	O
EC-1	B
expression	O
slightly	O
.	O

In	O
the	O
absence	O
of	O
E1A243	B
,	O
YY1	B
represses	O
CRE	O
-	O
dependent	O
transcription	O
of	O
c	B
-	I
fos	I
by	O
physically	O
interacting	O
with	O
ATF	B
/	O
CREB	B
proteins	O
bound	O
to	O
the	O
-67	O
CRE	O
.	O

Shift	O
-	O
down	O
experiments	O
indicated	O
that	O
the	O
10	O
(	O
4	O
)	O
-	O
to	O
10	O
(	O
5	O
)	O
-fold	O
reduction	O
in	O
virus	O
yield	O
at	O
the	O
nonpermissive	O
temperature	O
was	O
due	O
to	O
the	O
disfunction	O
of	O
alpha	B
TIF	I
late	O
in	O
infection	O
,	O
presumably	O
in	O
virion	O
maturation	O
.	O

Human	B
immunodeficiency	I
virus	I
type	I
1	I
Vpr	I
is	O
a	O
virion	O
-	O
associated	O
,	O
regulatory	O
protein	O
that	O
is	O
required	O
for	O
efficient	O
viral	O
replication	O
in	O
monocytes	O
/	O
macrophages	O
.	O

Thus	O
,	O
transcriptional	O
regulation	O
,	O
splicing	O
,	O
kinase	O
interaction	O
sites	O
,	O
and	O
tyrosine	O
phosphorylation	O
of	O
the	O
LMP2A	B
homologs	I
have	O
been	O
conserved	O
despite	O
significant	O
sequences	O
heterogeneity	O
in	O
the	O
preterminal	O
repeat	O
regions	O
of	O
these	O
human	O
and	O
nonhuman	O
primate	O
EBVs	O
.	O

Results	O
of	O
the	O
ECAT	O
Angina	O
Pectoris	O
Study	O
Group	O
.	O

These	O
motifs	O
include	O
a	O
Chi	O
motif	O
and	O
a	O
Chi	O
-	O
like	O
element	O
previously	O
found	O
in	O
the	O
recombination	O
hotspot	O
region	O
of	O
the	O
Bcl-2	B
proto	I
-	I
oncogene	I
and	O
close	O
to	O
chromosomal	O
breakpoints	O
in	O
T	O
-	O
ALL	O
lines	O
.	O

Common	O
history	O
and	O
prospects	O
in	O
surgical	O
gynecology	O
of	O
the	O
Charite	O
and	O
the	O
Vienna	O
University	O
Clinic	O

In	O
contrast	O
with	O
the	O
previously	O
reported	O
HMGR1	B
mRNA	I
(	O
HMGR1S	B
mRNA	I
)	O
,	O
which	O
is	O
detected	O
at	O
high	O
levels	O
in	O
all	O
tissues	O
of	O
the	O
plant	O
,	O
HMGR1L	B
mRNA	I
is	O
present	O
at	O
relatively	O
low	O
levels	O
and	O
its	O
expression	O
is	O
restricted	O
mostly	O
to	O
seedlings	O
,	O
roots	O
and	O
inflorescences	O
.	O

In	O
adult	O
tissues	O
,	O
it	O
was	O
less	O
restricted	O
,	O
indicating	O
that	O
RAFTK	B
expression	O
is	O
developmentally	O
up	O
-	O
regulated	O
.	O

J.	O

TPBF	B
has	O
two	O
potential	O
coiled	O
-	O
coil	O
regions	O
,	O
a	O
basic	O
region	O
,	O
a	O
proline	O
-	O
rich	O
region	O
,	O
a	O
histidine	O
-	O
rich	O
N	O
terminus	O
,	O
and	O
a	O
nuclear	O
targeting	O
sequence	O
.	O

A	O
tobacco	O
homologue	O
(	O
trolC	B
)	O
of	O
the	O
rolC	B
gene	I
of	I
the	I
Agrobacterium	I
rhizogenes	I
Ri	I
-	I
plasmid	I
was	O
cloned	O
and	O
sequenced	O
from	O
Nicotiana	O
tabacum	O
L.	O
cv	O
.	O

The	O
effects	O
of	O
a	O
1-	O
or	O
24-hour	O
pretreatment	O
regimen	O
with	O
monophosphoryl	O
lipid	O
A	O
(	O
MLA	O
,	O
35	O
micrograms	O
/	O
kg	O
i.v	O
.	O
)	O
on	O
myocardial	O
stunning	O
produced	O
by	O
repetitive	O
coronary	O
occlusions	O
were	O
studied	O
in	O
barbital	O
-	O
anesthetized	O
dogs	O
.	O

These	O
incisors	O
were	O
studied	O
by	O
scanning	O
electron	O
microscopy	O
-	O
energy	O
dispersive	O
spectroscopy	O
analysis	O
(	O
SEM	O
-	O
EDS	O
)	O
and	O
light	O
microscopy	O
to	O
examine	O
the	O
calciotraumatic	O
lines	O
of	O
strontium	O
in	O
the	O
rat	O
incisor	O
labial	O
dentin	O
.	O

A	O
platelet	B
-	I
derived	I
growth	I
factor	I
receptor	I
(	O
PDGF	B
-	I
R	I
)	O
phosphopeptide	O
containing	O
Tyr-857	O
does	O
not	O
bind	O
appreciably	O
to	O
the	O
Src	B
SH2	I
domain	I
,	O
suggesting	O
it	O
is	O
not	O
the	O
PDGF	B
-	I
R	I
binding	O
site	O
for	O
Src	B
as	O
previously	O
reported	O
.	O

We	O
have	O
also	O
tested	O
Src	B
SH2	B
mutants	O
for	O
their	O
binding	O
properties	O
and	O
have	O
interpreted	O
our	O
results	O
in	O
light	O
of	O
the	O
recent	O
crystal	O
structure	O
solution	O
for	O
the	O
Src	B
SH2	B
domain	O
.	O

These	O
observations	O
link	O
actin	B
plaque	O
assembly	O
to	O
increased	O
cell	O
substrate	O
adhesion	O
.	O

There	O
are	O
two	O
immunogenic	O
sites	O
on	O
the	O
type	O
A	O
influenza	O
A	O
/	O
Japan	O
/	O
57	O
(	O
H2N2	O
)	O
hemagglutinin	B
(	O
HA	B
)	O
that	O
can	O
be	O
recognized	O
by	O
class	B
I	I
major	I
histocompatibility	I
complex	I
(	O
MHC	B
)	O
,	O
H-2Kd	B
-	O
restricted	O
cytolytic	O
T	O
lymphocytes	O
(	O
CTLs	O
)	O
.	O

This	O
enhancer	O
activates	O
both	O
the	O
K19	B
and	O
TK	B
basal	I
promoters	I
in	O
HeLa	O
cells	O
.	O

Mechanism	O
of	O
enhancement	O
of	O
DNA	O
expression	O
consequent	O
to	O
cointernalization	O
of	O
a	O
replication	O
-	O
deficient	O
adenovirus	O
and	O
unmodified	O
plasmid	O
DNA	O
.	O

Interestingly	O
,	O
one	O
IRF	B
binding	I
site	I
was	O
found	O
within	O
the	O
IRF-2	B
promoter	I
,	O
and	O
expression	O
of	O
the	O
IRF-2	B
gene	I
was	O
affected	O
by	O
both	O
transient	O
and	O
stable	O
IRF-1	B
expression	O
.	O

The	O
highest	O
decrease	O
in	O
mutagenic	O
activity	O
was	O
observed	O
when	O
enzymatic	O
bleaching	O
was	O
used	O
together	O
with	O
chlorine	O
.	O

There	O
was	O
also	O
a	O
highly	O
significant	O
correlation	O
between	O
total	O
selenium	O
intake	O
and	O
liver	O
selenium	O
concentration	O
(	O
r	O
=	O
0.99	O
,	O
p	O
<	O
0.01	O
)	O
after	O
1	O
mo	O
of	O
treatment	O
,	O
but	O
this	O
time	O
liver	O
selenium	O
did	O
not	O
change	O
with	O
time	O
,	O
and	O
the	O
correlation	O
remained	O
highly	O
significant	O
throughout	O
the	O
investigation	O
.	O

Antibodies	O
affinity	O
-	O
purified	O
using	O
the	O
bacterially	O
expressed	O
recombinant	O
protein	O
recognized	O
the	O
56	B
K	I
autoantigen	I
in	O
a	O
HeLa	O
cell	O
extract	O
.	O

cDNA	O
sequencing	O
revealed	O
that	O
the	O
56	B
K	I
cDNA	I
shares	O
a	O
high	O
degree	O
of	O
homology	O
in	O
both	O
nucleotide	O
(	O
87	O
%	O
)	O
and	O
amino	O
acid	O
sequence	O
(	O
92.5	O
%	O
)	O
with	O
bovine	B
annexin	I
XI	I
,	O
indicating	O
that	O
the	O
56	B
K	I
cDNA	I
encodes	O
the	O
human	B
homologue	I
of	I
annexin	I
XI	I
,	O
a	O
member	O
of	O
the	O
Ca	B
(	I
2+	I
)	I
-dependent	I
phospholipid	I
binding	I
protein	I
family	I
.	O

The	O
avidin	B
-	I
biotin	I
complex	I
peroxidase	I
(	O
ABC	B
-	I
P	I
)	O
method	O
was	O
used	O
to	O
detect	O
Mycobacterium	O
bovis	O
,	O
and	O
the	O
results	O
were	O
compared	O
with	O
those	O
obtained	O
by	O
the	O
Ziehl	O
-	O
Neelsen	O
(	O
ZN	O
)	O
technique	O
.	O

Its	O
role	O
in	O
these	O
processes	O
suggests	O
that	O
the	O
function	O
of	O
c	B
-	I
Myb	I
may	O
be	O
important	O
early	O
in	O
the	O
establishment	O
of	O
the	O
hematopoietic	O
lineage	O
.	O

The	O
transforming	O
gene	O
of	O
the	O
avian	B
sarcoma	I
virus	I
CT10	I
encodes	O
a	O
fusion	O
protein	O
(	O
p47gag	B
-	O
crk	B
or	O
v	B
-	I
Crk	I
)	O
containing	O
viral	B
Gag	I
sequences	I
fused	O
to	O
cellular	O
sequences	O
consisting	O
primarily	O
of	O
Src	B
homology	I
regions	I
2	I
and	I
3	I
(	O
SH2	B
and	O
SH3	B
sequences	I
)	O
.	O

This	O
specific	O
methylation	O
pattern	O
caused	O
inactivation	O
of	O
the	O
HSV	B
tk	I
gene	I
,	O
while	O
methylation	O
of	O
the	O
cytosine	O
residues	O
within	O
the	O
nucleotide	O
sequence	O
from	O
+	O
811	O
to	O
+	O
1309	O
had	O
no	O
effect	O
on	O
HSV	B
tk	I
gene	I
activity	O
.	O

GTRE	O
,	O
TRE	O
,	O
and	O
CRE	O
oligonucleotides	O
all	O
compete	O
more	O
efficiently	O
for	O
protein	O
binding	O
to	O
their	O
labeled	O
congeners	O
than	O
for	O
protein	O
binding	O
to	O
either	O
of	O
the	O
other	O
labeled	O
oligonucleotides	O
,	O
suggesting	O
that	O
the	O
GTRE	O
,	O
TRE	O
,	O
and	O
CRE	O
oligonucleotides	O
,	O
suggesting	O
that	O
the	O
GTRE	O
,	O
TRE	O
,	O
and	O
CRE	O
oligonucleotides	O
each	O
bind	O
unique	O
as	O
well	O
as	O
common	O
proteins	O
,	O
likely	O
to	O
be	O
members	O
of	O
the	O
Jun	B
/	O
Fos	B
and	O
cAMP	B
-	I
responsive	I
element	I
-	I
binding	I
protein	I
/	O
activating	B
transcription	I
factors	I
(	O
CREB	B
/	O
ATF	B
)	O
families	O
of	O
transcription	O
factors	O
,	O
in	O
chromaffin	O
cells	O
.	O

One	O
patient	O
only	O
had	O
any	O
test	O
abnormalities	O
.	O

One	O
antibody	O
,	O
mAb1C2	B
,	O
and	O
a	O
synthetic	O
peptide	O
comprising	O
its	O
epitope	O
selectively	O
inhibited	O
in	O
vitro	O
transcription	O
from	O
TATA	O
-	O
containing	O
,	O
but	O
not	O
from	O
TATA	O
-	O
less	O
promoters	O
,	O
irrespective	O
of	O
whether	O
they	O
were	O
transcribed	O
by	O
Pol	B
II	I
or	O
Pol	B
III	I
.	O

The	O
lymph	O
nodes	O
from	O
two	O
of	O
the	O
patients	O
with	O
rheumatoid	O
arthritis	O
contained	O
numerous	O
sarcoid	O
like	O
granulomata	O
,	O
further	O
indicating	O
a	O
possible	O
association	O
between	O
sarcoidosis	O
and	O
rheumatoid	O
arthritis	O
.	O

HCV	O
infection	O
acquired	O
during	O
or	O
after	O
BMT	O
caused	O
only	O
mild	O
acute	O
hepatitis	O
C	O
,	O
which	O
progressed	O
to	O
chronic	O
hepatitis	O
C	O
in	O
one	O
patient	O
surviving	O
10	O
years	O
after	O
BMT	O
.	O

Hepatitis	O
C	O
virus	O
infection	O
is	O
a	O
risk	O
factor	O
for	O
liver	O
failure	O
from	O
veno	O
-	O
occlusive	O
disease	O
after	O
bone	O
marrow	O
transplantation	O
.	O

These	O
human	O
IFN	B
-	I
beta	I
-	O
transformed	O
cell	O
populations	O
have	O
acquired	O
a	O
low	O
,	O
constitutive	O
production	O
of	O
human	B
IFN	I
,	O
while	O
replicating	O
at	O
a	O
rate	O
similar	O
to	O
that	O
of	O
untransformed	O
cells	O
and	O
of	O
cells	O
transformed	O
with	O
the	O
control	O
vector	O
carrying	O
a	O
human	B
IFN	I
-	I
beta	I
sequence	I
encoding	O
an	O
inactive	O
,	O
mutated	O
protein	O
.	O

Improvement	O
of	O
the	O
polypyrimidine	O
tract	O
also	O
increased	O
the	O
splicing	O
efficiency	O
,	O
but	O
to	O
a	O
degree	O
slightly	O
less	O
than	O
that	O
obtained	O
with	O
the	O
branchpoint	O
mutation	O
.	O

Joys	O
and	O
F.	O

A	O
full	B
-	I
length	I
PRL	I
receptor	I
(	O
PRLR	B
)	O
complementary	O
DNA	O
from	O
pigeons	O
was	O
obtained	O
by	O
screening	O
pigeon	O
crop	O
sac	O
libraries	O
and	O
by	O
reverse	O
transcription	O
coupled	O
with	O
polymerase	O
chain	O
reaction	O
.	O

After	O
7	O
days	O
,	O
a	O
spontaneous	O
regression	O
of	O
the	O
morphologic	O
alterations	O
caused	O
by	O
caerulein	O
-	O
induced	O
acute	O
pancreatitis	O
occurs	O
;	O
however	O
,	O
recovery	O
of	O
the	O
secretory	O
function	O
of	O
the	O
pancreas	O
was	O
only	O
reached	O
after	O
this	O
period	O
of	O
time	O
when	O
L-364,718	O
was	O
administered	O
therapeutically	O
(	O
0.1	O
mg	O
/	O
kg	O
/	O
day	O
)	O
.	O

We	O
observed	O
that	O
dephosphorylation	O
severely	O
inhibits	O
the	O
DNA	O
-	O
binding	O
ability	O
of	O
C	B
/	I
EBP	I
-	I
delta	I
and	O
its	O
transactivating	O
potential	O
increases	O
in	O
the	O
presence	O
of	O
cellular	O
phosphatase	O
inhibitors	O
,	O
such	O
as	O
okadaic	O
acid	O
and	O
sodium	O
orthovanadate	O
.	O

Two	O
promoters	O
were	O
identified	O
by	O
S1	B
nuclease	I
mapping	O
:	O
P1	O
,	O
which	O
lies	O
about	O
72	O
bp	O
upstream	O
from	O
the	O
structural	O
gene	O
;	O
and	O
P2	O
,	O
which	O
lies	O
about	O
35	O
bp	O
upstream	O
.	O

Interleukin-8	B
(	O
IL-8	B
)	O
is	O
a	O
potent	O
inflammatory	O
mediator	O
that	O
belongs	O
to	O
the	O
family	O
of	O
C	B
-	I
X	I
-	I
C	I
chemokines	I
.	O

On	O
the	O
other	O
hand	O
,	O
cells	O
containing	O
a	O
PTP1C	B
in	O
which	O
the	O
catalytic	O
site	O
had	O
been	O
inactivated	O
through	O
mutagenesis	O
,	O
stably	O
phosphorylated	O
the	O
phosphatase	O
.	O

We	O
recently	O
found	O
that	O
the	O
p72syk	B
protein	I
tyrosine	I
kinase	I
is	O
physically	O
associated	O
with	O
the	O
TCR	B
/	O
CD3	B
complex	O
and	O
is	O
rapidly	O
tyrosine	O
phosphorylated	O
and	O
activated	O
by	O
receptor	O
triggering	O
also	O
in	O
T	O
cells	O
lacking	O
p56lck	B
.	O

The	O
transforming	O
protein	O
of	O
Rous	O
sarcoma	O
virus	O
,	O
pp60v	B
-	I
src	I
,	O
and	O
its	O
normal	O
cellular	O
homolog	O
,	O
pp60c	B
-	I
src	I
,	O
differ	O
not	O
only	O
in	O
oncogenic	O
potential	O
but	O
also	O
in	O
their	O
subcellular	O
localization	O
and	O
cytoskeletal	O
binding	O
ability	O
.	O

pp60v	B
-	I
src	I
has	O
been	O
shown	O
to	O
stably	O
associate	O
with	O
a	O
detergent	O
-	O
insoluble	O
cytoskeletal	O
matrix	O
,	O
whereas	O
pp60c	B
-	I
src	I
does	O
not	O
.	O

We	O
determined	O
whether	O
regional	O
myocardial	O
work	O
efficiency	O
(	O
segment	O
work	O
/	O
regional	O
O2	O
consumption	O
)	O
would	O
be	O
elevated	O
by	O
surgically	O
-	O
augmented	O
inflow	O
.	O

Anti	B
-	I
NPROSP	I
-	I
C	I
also	O
exclusively	O
detected	O
time	O
-	O
dependent	O
appearances	O
of	O
5	B
-	I
10-kDa	I
proSP	I
-	I
C	I
forms	O
in	O
lamellar	O
bodies	O
and	O
homogenates	O
.	O

In	O
the	O
B6-derived	O
Db	B
mutant	I
B6.CH-2bm13	I
(	I
bm13	I
)	I
strain	O
,	O
part	O
of	O
the	O
class	B
I	I
Db	I
antigen	I
-	I
presenting	I
groove	I
is	O
shaped	O
by	O
a	O
class	B
I	I
Kb	I
-	I
encoded	I
sequence	I
.	O

Our	O
findings	O
confirm	O
the	O
high	O
frequency	O
of	O
proximal	O
nerve	O
lesions	O
in	O
early	O
GBS	O
and	O
CIDP	O
,	O
not	O
all	O
of	O
which	O
are	O
associated	O
with	O
distal	O
motor	O
conduction	O
abnormalities	O
,	O
and	O
suggest	O
that	O
assessment	O
of	O
multiple	O
F	O
wave	O
parameters	O
,	O
in	O
particular	O
chronodispersion	O
,	O
mean	O
latency	O
and	O
mean	O
amplitude	O
(	O
in	O
addition	O
to	O
absence	O
and	O
minimum	O
latency	O
)	O
,	O
increases	O
the	O
yield	O
of	O
F	O
wave	O
studies	O
.	O

Effects	O
of	O
alterations	O
of	O
primer	O
-	O
binding	O
site	O
sequences	O
on	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
replication	O
.	O

Presentation	O
of	O
a	O
horse	B
cytochrome	I
c	I
peptide	I
by	O
multiple	O
H-2b	B
class	I
I	I
major	I
histocompatibility	I
complex	I
(	O
MHC	B
)	O
molecules	O
to	O
C57BL	O
/	O
6-	O
and	O
bm1-derived	O
cytotoxic	O
T	O
lymphocytes	O
:	O
presence	O
of	O
a	O
single	O
MHC	B
anchor	I
residue	I
may	O
confer	O
efficient	O
peptide	O
-	O
specific	O
CTL	O
recognition	O
.	O

A	O
particularly	O
striking	O
HpaII	B
tiny	O
fragment	O
island	O
,	O
extending	O
over	O
nearly	O
2,000	O
base	O
pairs	O
,	O
surrounds	O
the	O
USF2	B
translation	I
initiation	I
site	I
.	O

Diagnosis	O
of	O
prostatic	O
carcinoma	O
:	O
the	O
yield	O
of	O
serum	B
prostate	I
specific	I
antigen	I
,	O
digital	O
rectal	O
examination	O
and	O
transrectal	O
ultrasonography	O
.	O

The	O
results	O
revealed	O
a	O
hierarchy	O
of	O
ligand	O
affinities	O
that	O
mirrored	O
their	O
adhesive	O
activity	O
(	O
rsVCAM-1	B
>	O
fibronectin	B
variants	I
containing	O
CS1	B
>	O
>	O
other	O
fibronectin	B
variants	I
)	O
.	O

When	O
expressed	O
in	O
and	O
purified	O
from	O
Escherichia	O
coli	O
,	O
both	O
full	B
-	I
length	I
Fpr3	I
and	O
its	O
isolated	O
COOH	O
-	O
terminal	O
domain	O
exhibit	O
readily	O
detectable	O
PPIase	B
activity	O
.	O

Recent	O
studies	O
have	O
demonstrated	O
that	O
the	O
activated	O
GH	B
receptor	I
can	O
stimulate	O
Stat1	B
,	O
a	O
cytoplasmic	O
transcription	O
factor	O
that	O
becomes	O
tyrosine	O
phosphorylated	O
and	O
translocates	O
to	O
the	O
nucleus	O
,	O
where	O
it	O
can	O
interact	O
with	O
specific	O
DNA	O
sequences	O
to	O
modulate	O
gene	O
expression	O
.	O

In	O
viral	O
infections	O
,	O
G	B
-	I
CSF	I
was	O
correlated	O
with	O
mononuclear	O
cells	O
(	O
rs	O
=	O
0.41	O
,	O
P	O
<	O
0.05	O
)	O
,	O
white	O
blood	O
cell	O
counts	O
(	O
rs	O
=	O
0.56	O
,	O
P	O
<	O
0.01	O
)	O
,	O
neutrophils	O
(	O
rs	O
=	O
0.41	O
,	O
P	O
<	O
0.05	O
)	O
and	O
CRP	B
(	O
rs	O
=	O
0.47	O
,	O
P	O
<	O
0.05	O
)	O
.	O

Phosphoamino	O
acid	O
analysis	O
of	O
radiolabeled	O
ASGPR	B
subunits	I
identified	O
Ser	O
(	O
P	O
)	O
as	O
the	O
predominant	O
(	O
approximately	O
95	O
%	O
)	O
and	O
Thr	O
(	O
P	O
)	O
as	O
a	O
minor	O
(	O
approximately	O
5	O
%	O
)	O
phosphoamino	O
acid	O
in	O
each	O
polypeptide	O
and	O
confirmed	O
the	O
presence	O
of	O
Tyr	O
(	O
P	O
)	O
(	O
approximately	O
1	O
%	O
)	O
in	O
RHL1	B
.	O

To	O
further	O
define	O
the	O
structural	O
requirements	O
for	O
ZAP-70	B
interaction	O
with	O
the	O
TCR	B
,	O
we	O
developed	O
a	O
binding	O
assay	O
using	O
immobilized	O
glutathione	B
S	I
-	I
transferase	I
fusion	I
proteins	I
containing	O
the	O
NH2-	O
and/or	O
COOH	B
-	I
terminal	I
SH2	I
domains	I
of	O
ZAP-70	B
,	O
and	O
soluble	O
synthetic	O
peptides	O
with	O
the	O
sequence	O
of	O
the	O
cytoplasmic	O
region	O
of	O
the	O
TCR	B
zeta	I
chain	I
(	O
TCR	B
zeta	I
cyt	I
)	O
or	O
individual	O
TCR	B
zeta	I
and	O
CD3	B
epsilon	I
TAM	I
motifs	I
.	O

The	O
three	O
-	O
dimensional	O
structure	O
of	O
RT	B
shows	O
that	O
it	O
is	O
a	O
strikingly	O
asymmetric	O
heterodimer	O
consisting	O
of	O
two	O
differently	O
folded	O
subunits	O
(	O
molecular	O
weights	O
66	O
kDa	O
and	O
51	O
kDa	O
)	O
with	O
identical	O
amino	O
-	O
terminal	O
amino	O
acid	O
sequences	O
(	O
residues	O
1	O
-	O
428	O
)	O
.	O

All	O
subsequent	O
patients	O
were	O
treated	O
at	O
the	O
maximal	O
tolerated	O
dose	O
of	O
EDXR	O
(	O
35	O
mg	O
/	O
m2	O
/	O
day	O
)	O
.	O

The	O
median	O
post	O
-	O
treatment	O
,	O
pre	O
-	O
operative	O
serum	B
PSA	I
was	O
0.4	O
ng	O
/	O
ml	O
.	O

Membrane	O
-	O
bound	O
Steel	B
factor	I
induces	O
more	O
persistent	O
tyrosine	B
kinase	I
activation	O
and	O
longer	O
life	O
span	O
of	O
c	B
-	I
kit	I
gene	O
-	O
encoded	O
protein	O
than	O
its	O
soluble	O
form	O
.	O

Patients	O
with	O
more	O
than	O
250	O
PVC	O
/	O
24	O
hours	O
were	O
selected	O
for	O
distribution	O
of	O
PVC	O
and	O
CI	O
evaluation	O
.	O

Horvath	O
,	O
I.	O

Cell	O
lines	O
derived	O
from	O
the	O
tumors	O
were	O
examined	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
for	O
the	O
status	O
of	O
the	O
transferred	O
human	O
chromosome	O
and	O
by	O
PCR	O
for	O
marker	O
loss	O
.	O

The	O
amino	O
acid	O
sequences	O
of	O
the	O
predicted	O
RfbA	B
and	O
RfbB	B
homologs	I
showed	O
identities	O
of	O
75.7	O
%	O
(	O
87.9	O
%	O
total	O
similarity	O
)	O
and	O
78.0	O
%	O
(	O
86.5	O
%	O
total	O
similarity	O
)	O
,	O
respectively	O
.	O

However	O
,	O
multiple	O
alanine	O
substitutions	O
or	O
proline	O
(	O
helix	O
-	O
destabilizing	O
)	O
substitutions	O
disrupted	O
both	O
oligomerization	O
and	O
transport	O
of	O
GP64	B
EFP	I
.	O

The	O
FinO	B
protein	I
of	O
IncF	O
plasmids	O
binds	O
FinP	B
antisense	I
RNA	I
and	O
its	O
target	O
,	O
traJ	B
mRNA	I
,	O
and	O
promotes	O
duplex	O
formation	O
.	O

A	O
chicken	B
paxillin	I
cDNA	I
was	O
also	O
cloned	O
and	O
is	O
predicted	O
to	O
encode	O
a	O
protein	O
approximately	O
90	O
%	O
identical	O
to	O
human	B
paxil	I
-	I
lin	I
.	O

We	O
linked	O
a	O
4.1-kilobase	O
pair	O
HindIII	B
DNA	I
fragment	I
from	O
the	O
region	O
upstream	O
of	O
the	O
human	B
AP	I
endonuclease	I
gene	I
(	O
APE	B
)	O
to	O
the	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
gene	O
.	O

CD7+	B
/	O
CD3-	B
T	O
-	O
cell	O
precursors	O
exhibit	O
V	B
delta	I
2D	I
delta	I
3	I
rearrangements	I
.	O

Transcription	O
of	O
the	O
vascular	B
cell	I
adhesion	I
molecule	I
1	I
(	O
VCAM-1	B
)	O
gene	O
in	O
endothelial	O
cells	O
is	O
induced	O
by	O
lipopolysaccharide	O
and	O
the	O
inflammatory	O
cytokines	B
interleukin-1	I
beta	I
and	O
tumor	B
necrosis	I
factor	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
.	O

Experiments	O
with	O
recombinant	O
proteins	O
showed	O
that	O
p50	B
/	O
p65	B
and	O
high	B
-	I
mobility	I
-	I
group	I
I	I
(	I
Y	I
)	I
protein	I
cooperatively	O
facilitated	O
the	O
binding	O
of	O
IRF-1	B
to	O
the	O
VCAM1	B
IRF	B
binding	I
site	I
and	O
that	O
IRF-1	B
physically	O
interacted	O
with	O
p50	B
and	O
with	O
high	B
-	I
mobility	I
-	I
group	I
I	I
(	I
Y	I
)	I
protein	I
.	O

Based	O
on	O
these	O
results	O
the	O
minimal	O
control	O
element	O
(	O
AX	O
470	O
)	O
specifying	O
the	O
anterior	O
boundary	O
of	O
Hox	B
expression	O
was	O
designated	O
as	O
Hoxa-7	B
enhancer	I
.	O

In	O
this	O
report	O
we	O
describe	O
the	O
isolation	O
of	O
a	O
Fab	B
fragment	I
(	O
Fab	B
A8	I
)	O
showing	O
a	O
high	O
relative	O
affinity	O
for	O
the	O
receptor	O
(	O
0.5	O
nM	O
)	O
.	O

When	O
combined	O
with	O
independent	O
activating	O
mutations	O
in	O
the	O
c	B
-	I
abl	I
kinase	I
domain	I
or	O
NH2-terminus	O
,	O
the	O
G128R	B
mutation	O
blocked	O
transformation	O
by	O
the	O
double	O
mutant	O
,	O
suggesting	O
that	O
the	O
G128R	B
mutant	I
was	O
unable	O
to	O
transform	O
cells	O
for	O
trivial	O
reasons	O
.	O

Changes	O
induced	O
in	O
the	O
gills	O
of	O
milkfish	O
(	O
Chanos	O
chanos	O
Forsskal	O
)	O
fingerlings	O
after	O
acute	O
exposure	O
to	O
nifurpirinol	O
(	O
Furanace	O
;	O
P-7138	O
)	O
.	O

As	O
expected	O
,	O
the	O
insulin	B
effect	O
to	O
increase	O
ras	B
GTP	I
formation	O
and	O
MAP	B
kinase	I
activity	O
was	O
negligible	O
in	O
A	O
/	O
K1018	O
cells	O
but	O
normal	O
,	O
or	O
supernormal	O
,	O
in	O
Y	O
/	O
F2	O
cells	O
.	O

Sequence	O
analysis	O
of	O
these	O
regions	O
showed	O
a	O
CAAT	O
box	O
upstream	O
of	O
exon	O
1a	O
and	O
high	O
G	O
-	O
C	O
content	O
regions	O
within	O
both	O
P1	O
and	O
P2	O
.	O

GCD10	B
was	O
first	O
identified	O
genetically	O
as	O
a	O
translational	O
repressor	O
of	O
GCN4	B
.	O

GCD10	B
binds	O
RNA	O
in	O
vitro	O
and	O
we	O
present	O
strong	O
biochemical	O
evidence	O
that	O
it	O
is	O
identical	O
to	O
the	O
RNA	O
-	O
binding	O
subunit	O
of	O
yeast	B
initiation	I
factor-3	I
(	O
eIF-3	B
)	O
.	O

eIF-3	B
is	O
a	O
multisubunit	O
complex	O
that	O
stimulates	O
translation	O
initiation	O
in	O
vitro	O
at	O
several	O
different	O
steps	O
.	O

A	O
transformation	O
-	O
competent	O
mutant	O
,	O
like	O
the	O
wild	B
-	I
type	I
E5	I
protein	I
,	O
bound	O
the	O
receptor	O
and	O
induced	O
receptor	O
tyrosine	O
phosphorylation	O
and	O
down	O
-	O
regulation	O
.	O

Appropriate	O
restriction	O
sites	O
allow	O
one	O
to	O
insert	O
virtually	O
any	O
desired	O
cDNA	O
fragment	O
directly	O
behind	O
the	O
epitope	O
-	O
specific	O
sequence	O
and	O
before	O
a	O
long	O
poly	O
(	O
A	O
)	O
tail	O
.	O

Both	O
PPC-1	O
and	O
ALVA-31	O
cells	O
display	O
tumorigenesis	O
and	O
invasiveness	O
in	O
nude	O
mice	O
,	O
whereas	O
LNCap	O
cells	O
exhibit	O
a	O
less	O
malignant	O
phenotype	O
,	O
suggesting	O
a	O
correlation	O
between	O
CD44	B
variant	I
(	O
CD44v	B
)	O
expression	O
and	O
aggressive	O
prostate	O
tumor	O
behavior	O
.	O

Two	O
such	O
genes	O
,	O
designated	O
hsiggll150	B
and	O
hsiggll295	B
,	O
were	O
cloned	O
and	O
sequenced	O
from	O
genomic	O
DNA	O
.	O

A	O
retrospective	O
epidemiological	O
study	O
is	O
reported	O
concerning	O
burn	O
injuries	O
in	O
775	O
children	O
hospitalized	O
at	O
the	O
unit	O
of	O
burn	O
care	O
of	O
Casablanca	O
between	O
1985	O
and	O
1993	O
.	O

The	O
RAD6	B
/	O
UBC2	B
gene	O
from	O
Saccharomyces	O
cerevisiae	O
encodes	O
a	O
ubiquitin	B
-	I
conjugating	I
enzyme	I
involved	O
in	O
DNA	O
repair	O
,	O
induced	O
mutagenesis	O
,	O
and	O
sporulation	O
.	O

Echocardiography	O
revealed	O
right	O
ventricular	O
diastolic	O
collapse	O
(	O
RVDC	O
)	O
without	O
physical	O
signs	O
of	O
cardiac	O
tamponade	O
.	O

In	O
on	O
-	O
going	O
screening	O
programmes	O
,	O
the	O
Haemoccult	O
test	O
consists	O
of	O
six	O
slides	O
and	O
a	O
test	O
is	O
considered	O
positive	O
if	O
at	O
least	O
one	O
slide	O
is	O
coloured	O
.	O

We	O
showed	O
previously	O
that	O
a	O
fusion	O
protein	O
(	O
GAL4-p40	B
)	O
containing	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
GAL4	B
and	O
sequences	O
of	O
chicken	B
l	I
kappa	I
B	I
-	I
alpha	I
(	O
p40	B
)	O
inhibits	O
growth	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

We	O
have	O
demonstrated	O
previously	O
that	O
two	O
binding	O
sites	O
in	O
the	O
-184	B
HNF-3	I
beta	I
promoter	I
are	O
recognized	O
by	O
widely	O
distributed	O
factors	O
and	O
that	O
there	O
is	O
also	O
a	O
critical	O
autoregulatory	O
site	O
,	O
we	O
identified	O
a	O
binding	O
site	O
for	O
a	O
cell	O
-	O
specific	O
factor	O
,	O
LF	B
-	I
H3	I
beta	I
,	O
that	O
may	O
function	O
in	O
restricting	O
HNF-3	B
beta	I
gene	I
expression	O
to	O
hepatocytes	O
.	O

The	O
flow	O
rate	O
of	O
phosphate	O
buffered	O
saline	O
through	O
dermis	O
was	O
measured	O
as	O
a	O
function	O
of	O
applied	O
pressure	O
.	O

However	O
,	O
parallax	O
measurements	O
showed	O
that	O
at	O
150	O
K	O
,	O
collapse	O
of	O
Epon	O
sections	O
does	O
not	O
take	O
place	O
.	O

Although	O
within	O
normal	O
limits	O
,	O
latency	O
was	O
high	O
.	O

The	O
outcome	O
of	O
the	O
optimization	O
of	O
the	O
seven	O
-	O
field	O
plan	O
prompted	O
an	O
investigation	O
into	O
the	O
best	O
results	O
that	O
could	O
be	O
achieved	O
by	O
an	O
""""	O
ideal	O
""""	O
conformal	O
radiotherapy	O
technique	O
.	O

The	O
pea	B
rps10	I
intron	I
is	O
homologous	O
to	O
introns	O
in	O
rrn26	B
and	O
cox3	B
in	O
the	O
Marchantia	O
mitochondrial	O
genome	O
,	O
while	O
the	O
Marchantia	B
rps10	I
gene	I
lacks	O
an	O
intron	O
.	O

Serum	O
magnesium	O
in	O
79	O
patients	O
of	O
gynecologic	O
neoplasms	O
treated	O
with	O
cisplatin	O
and	O
their	O
controls	O
was	O
measured	O
.	O

Alanine	B
aminotransferase	I
(	O
ALT	B
)	O
levels	O
had	O
been	O
elevated	O
for	O
six	O
months	O
in	O
all	O
patients	O
and	O
hepatitis	O
B	O
viral	O
infection	O
was	O
replicative	O
.	O

In	O
this	O
study	O
we	O
have	O
investigated	O
the	O
role	O
of	O
C	B
/	I
EBP	I
beta	I
in	O
initiating	O
the	O
adipogenic	O
program	O
by	O
overexpressing	O
C	B
/	I
EBP	I
beta	I
in	O
multipotential	O
NIH-3T3	O
fibroblasts	O
.	O

XYL1	B
was	O
isolated	O
as	O
a	O
highly	O
expressed	O
fusion	O
clone	O
from	O
a	O
'	B
lacZ	I
translational	O
fusion	O
library	O
.	O

However	O
,	O
division	O
of	O
the	O
chest	O
wall	O
muscles	O
,	O
usually	O
with	O
diathermy	O
,	O
contributes	O
to	O
prolonged	O
pain	O
and	O
morbidity	O
.	O

Closure	O
of	O
an	O
open	O
high	O
below	O
-	O
knee	O
guillotine	O
amputation	O
wound	O
using	O
a	O
skin	O
-	O
stretching	O
device	O
.	O

Our	O
study	O
was	O
addressed	O
to	O
the	O
synthesis	O
of	O
some	O
derivatives	O
of	O
this	O
sequence	O
in	O
order	O
to	O
obtain	O
both	O
peptide	O
substrates	O
suitable	O
for	O
the	O
detection	O
of	O
the	O
Src	B
-	O
like	O
tyrosine	B
kinase	I
activity	O
and	O
active	O
site	O
-	O
directed	O
inhibitors	O
specific	O
for	O
this	O
class	O
of	O
enzymes	O
.	O

Citrate	B
synthase	I
activity	O
was	O
increased	O
in	O
the	O
medial	O
head	O
(	O
81	O
%	O
,	O
P	O
<	O
0.001	O
)	O
and	O
the	O
red	O
long	O
head	O
(	O
88	O
%	O
,	O
P	O
<	O
0.001	O
)	O
of	O
the	O
triceps	O
brachii	O
muscle	O
in	O
R	O
rats	O
but	O
not	O
in	O
the	O
white	O
long	O
head	O
(	O
25	O
%	O
,	O
P	O
=	O
0.06	O
)	O
.	O

The	O
expression	O
of	O
the	O
putative	O
operon	O
bglPH	B
of	O
Bacillus	O
subtilis	O
was	O
studied	O
by	O
using	O
bglP'-lacZ	B
transcriptional	O
fusions	O
.	O

Although	O
eight	O
contiguous	O
genes	O
necessary	O
for	O
urease	B
activity	O
have	O
been	O
cloned	O
and	O
sequenced	O
,	O
the	O
transcriptional	O
organization	O
and	O
regulation	O
of	O
specific	O
genes	O
within	O
the	O
Proteus	B
gene	I
cluster	I
has	O
not	O
been	O
investigated	O
in	O
detail	O
.	O

The	O
hypBFCDE	B
operon	I
from	O
Rhizobium	O
leguminosarum	O
biovar	O
viciae	O
is	O
expressed	O
from	O
an	O
Fnr	B
-	I
type	I
promoter	I
that	O
escapes	O
mutagenesis	O
of	O
the	O
fnrN	B
gene	I
.	O

We	O
demonstrate	O
that	O
a	O
VT+	O
peptide	O
was	O
specifically	O
phosphorylated	O
by	O
protein	B
kinase	I
C	I
(	O
PKC	B
)	O
in	O
vitro	O
,	O
but	O
not	O
by	O
protein	B
kinase	I
A	I
(	O
PKA	B
)	O
.	O

Indeed	O
,	O
ERM	B
and	O
c	B
-	I
Jun	I
synergistically	O
activated	O
the	O
EBS	O
-	O
CRE	O
without	O
making	O
an	O
apparent	O
ternary	O
complex	O
.	O

A	O
mutant	O
(	O
residues	O
1	O
-	O
332	O
)	O
showed	O
complete	O
Ca2+	O
/	O
CaM	B
-	O
dependent	O
activity	O
.	O

In	O
addition	O
,	O
the	O
R206S	B
HSF	I
substitution	O
exhibits	O
constitutive	O
transcriptional	O
activation	O
from	O
a	O
consensus	O
HSE	O
(	O
HSE2	O
)	O
.	O

The	O
two	O
bases	O
immediately	O
flanking	O
the	O
5	O
'	O
end	O
of	O
the	O
element	O
proved	O
to	O
be	O
very	O
important	O
to	O
its	O
function	O
as	O
a	O
UAS	O
element	O
as	O
did	O
the	O
two	O
bases	O
immediately	O
3	O
'	O
of	O
the	O
bHLH	O
core	O
motif	O
.	O

These	O
intron	O
chimeras	O
show	O
that	O
peripheral	O
sequences	O
and	O
the	O
elements	O
that	O
define	O
the	O
splice	O
sites	O
are	O
adequate	O
for	O
self	O
-	O
splicing	O
activity	O
but	O
that	O
the	O
central	O
portions	O
containing	O
the	O
catalytic	O
cores	O
of	O
ai4	B
and	O
bi4	B
are	O
deficient	O
;	O
these	O
cores	O
are	O
the	O
likely	O
targets	O
of	O
the	O
splicing	O
proteins	O
.	O

Twenty	O
food	O
products	O
were	O
contaminated	O
with	O
V.	O
cholerae	O
O1	O
,	O
Ogawa	O
,	O
toxigenic	O
and	O
not	O
toxigenic	O
strains	O
:	O
yoghurt	O
,	O
cream	O
cheese	O
,	O
apricot	O
marmelade	O
,	O
hip	O
rose	O
marmelade	O
,	O
mayonnaise	O
,	O
italian	O
pasta	O
for	O
""""	O
empanadas	O
""""	O
,	O
""""	O
dulce	O
de	O
leche	O
""""	O
,	O
meat	O
sausage	O
,	O
meat	O
and	O
spinach	O
ravioli	O
,	O
margarine	O
,	O
milk	O
dessert	O
(	O
made	O
with	O
cocoa	O
,	O
milk	O
confiture	O
,	O
starch	O
and	O
additives	O
)	O
,	O
lettuce	O
,	O
tuna	O
fish	O
,	O
ricotta	O
and	O
sterilized	O
milk	O
.	O

The	O
expression	O
of	O
the	O
pilin	B
gene	I
,	O
tcpA	B
,	O
is	O
dependent	O
upon	O
ToxR	B
and	O
upon	O
ToxT.	B

Ras	B
p21Val	I
inhibits	O
myogenesis	O
without	O
altering	O
the	O
DNA	O
binding	O
or	O
transcriptional	O
activities	O
of	O
the	O
myogenic	B
basic	I
helix	I
-	I
loop	I
-	I
helix	I
factors	I
.	O

In	O
cells	O
limited	O
for	O
His	O
,	O
increased	O
expression	O
of	O
arg-2	B
and	O
cpc-1	B
,	O
and	O
decreased	O
expression	O
of	O
cox-5	B
,	O
also	O
had	O
translational	O
and	O
transcriptional	O
components	O
.	O

The	O
peptide	O
sequences	O
reveal	O
that	O
the	O
factor	O
consists	O
of	O
GABP	B
alpha	I
and	O
GABP	B
beta	I
1	I
with	O
Ets	B
and	O
Notch	B
motifs	I
,	O
respectively	O
.	O

Immunofluorescence	O
microscopy	O
and	O
cell	O
fractionation	O
analyses	O
showed	O
that	O
the	O
110-kDa	O
protein	O
was	O
exclusively	O
nuclear	O
,	O
whereas	O
the	O
150-kDa	O
protein	O
was	O
present	O
in	O
both	O
the	O
cytoplasm	O
and	O
nucleus	O
of	O
human	O
cells	O
.	O

T	O
-	O
cell	O
hybridomas	O
,	O
thymocytes	O
,	O
and	O
T	O
cells	O
can	O
be	O
induced	O
to	O
undergo	O
apoptotic	O
cell	O
death	O
by	O
activation	O
through	O
the	O
T	B
-	I
cell	I
receptor	I
.	O

The	O
kinase	O
is	O
essential	O
in	O
vivo	O
for	O
normal	O
phosphorylation	O
of	O
the	O
CTD	O
and	O
for	O
normal	O
growth	O
and	O
differentiation	O
.	O

A	O
general	O
model	O
for	O
ARE	O
-	O
mediated	O
mRNA	O
degradation	O
involving	O
a	O
potential	O
role	O
for	O
certain	O
heterogeneous	O
nuclear	O
ribonucleoproteins	O
and	O
ARE	B
-	I
binding	I
proteins	I
is	O
proposed	O
.	O

Finally	O
,	O
we	O
demonstrate	O
that	O
C	B
/	I
EBP	I
alpha	I
can	O
also	O
active	O
the	O
GM	B
-	I
CSF	I
receptor	I
alpha	I
promoter	O
in	O
nonmyeloid	O
cells	O
.	O

Endocytosis	O
and	O
vacuolar	O
degradation	O
of	O
the	O
plasma	O
membrane	O
-	O
localized	O
Pdr5	B
ATP	I
-	I
binding	I
cassette	I
multidrug	I
transporter	I
in	O
Saccharomyces	O
cerevisiae	O
.	O

Mutational	O
analysis	O
of	O
mRNA	B
capping	I
enzyme	I
identifies	O
amino	O
acids	O
involved	O
in	O
GTP	O
binding	O
,	O
enzyme	O
-	O
guanylate	O
formation	O
,	O
and	O
GMP	O
transfer	O
to	O
RNA	O
.	O

Disruption	O
of	O
the	O
HOG1	B
and	O
PBS2	B
genes	I
leads	O
to	O
a	O
dramatic	O
decrease	O
of	O
the	O
HSP12	B
inducibility	O
in	O
osmostressed	O
cells	O
,	O
whereas	O
overproduction	O
of	O
Hog1	B
produces	O
a	O
fivefold	O
increase	O
in	O
wild	O
-	O
type	O
induced	O
levels	O
upon	O
a	O
shift	O
to	O
a	O
high	O
salt	O
concentration	O
.	O

(	O
1986	O
)	O
method	O
of	O
separation	O
of	O
Cryptosporidium	O
spp	O
.	O

oocysts	O
from	O
feces	O
by	O
using	O
a	O
percoll	O
discontinuous	O
density	O
gradient	O
appeared	O
a	O
method	O
of	O
choice	O
for	O
obtaining	O
large	O
numbers	O
of	O
oocysts	O
of	O
C.	O
parvum	O
free	O
of	O
fecal	O
contamination	O
.	O

Staphylococcal	B
enterotoxin	I
A	I
involvement	O
in	O
the	O
illness	O
of	O
a	O
20-month	O
-	O
old	O
burn	O
patient	O
.	O

Four	O
p53	B
DNA	I
-	I
binding	I
domain	I
peptides	I
bind	O
natural	O
p53-response	B
elements	I
and	O
bend	O
the	O
DNA	O
.	O

These	O
results	O
suggest	O
that	O
G	B
beta	I
gamma	I
-	O
stimulated	O
Shc	B
phosphorylation	O
represents	O
an	O
early	O
step	O
in	O
the	O
pathway	O
leading	O
to	O
p21ras	B
activation	O
,	O
similar	O
to	O
the	O
mechanism	O
utilized	O
by	O
growth	B
factor	I
tyrosine	I
kinase	I
receptors	I
.	O

This	O
report	O
focused	O
on	O
the	O
relationship	O
between	O
Type	O
A	O
behavior	O
and	O
eight	O
basic	O
emotion	O
dimensions	O
.	O

As	O
for	O
31	O
stage	O
I	O
-	O
II	O
lung	O
cancer	O
patients	O
,	O
CR	O
has	O
been	O
observed	O
in	O
82.8	O
%	O
of	O
them	O
and	O
PR	O
in	O
13.8	O
%	O
;	O
the	O
response	O
was	O
always	O
assessed	O
with	O
chest	O
radiography	O
,	O
CT	O
,	O
FBS	O
,	O
cytology	O
and/or	O
histology	O
.	O

Pediatric	O
medical	O
emergencies	O
in	O
a	O
regional	O
hospital	O
:	O
appropriate	O
locale	O
?	O

METHODS	O
:	O
All	O
these	O
30	O
non	O
-	O
responders	O
received	O
an	O
extra	O
dose	O
of	O
the	O
same	O
vaccine	O
2	O
months	O
after	O
primary	O
immunization	O
and	O
a	O
booster	O
dose	O
with	O
a	O
yeast	O
-	O
derived	O
vaccine	O
6	O
years	O
later	O
.	O

An	O
abnormally	O
high	O
percentage	O
of	O
hypertensive	O
patients	O
(	O
approximately	O
30	O
%	O
)	O
undergoing	O
cardiac	O
catheterization	O
because	O
of	O
anginal	O
pain	O
and/or	O
exercise	O
-	O
induced	O
ST	O
-	O
segment	O
depressions	O
has	O
angiographically	O
normal	O
coronary	O
arteries	O
.	O

Mibefradil	O
(	O
Ro	O
40	O
-	O
5967	O
)	O
is	O
a	O
novel	O
calcium	O
antagonist	O
from	O
a	O
new	O
chemical	O
class	O
and	O
is	O
the	O
first	O
that	O
selectively	O
blocks	O
the	O
T	O
-	O
type	O
calcium	O
channel	O
.	O

However	O
,	O
2	O
minimum	O
alveolar	O
concentration	O
anesthesia	O
did	O
significantly	O
decrease	O
the	O
calculated	O
VE	O
at	O
a	O
PCO2	O
of	O
60	O
mmHg	O
(	O
from	O
7.4	O
+	O
/-	O

1.2	O
to	O
4.0	O
+	O
/-	O

0.6	O
l.min-1	O
)	O
,	O
indicating	O
a	O
rightward	O
shift	O
in	O
the	O
response	O
relationship	O
.	O

cDNA	O
encoding	O
a	O
functional	O
feline	B
liver	I
/	I
bone	I
/	I
kidney	I
-	I
type	I
alkaline	I
phosphatase	I
.	O

Protein	B
kinase	I
C	I
(	O
PKC	B
)	O
,	O
a	O
widely	O
-	O
distributed	O
enzyme	O
implicated	O
in	O
the	O
regulation	O
of	O
many	O
physiological	O
processes	O
,	O
consists	O
of	O
a	O
family	O
of	O
at	O
least	O
twelve	O
isoenzymes	O
which	O
differ	O
in	O
tissue	O
distribution	O
,	O
subcellular	O
localization	O
,	O
regulatory	O
properties	O
,	O
etc	O
.	O

This	O
work	O
,	O
therefore	O
,	O
also	O
emphasizes	O
the	O
importance	O
of	O
careful	O
choice	O
of	O
oligonucleotide	O
and	O
cDNA	O
probes	O
to	O
study	O
PKC	B
zeta	I
mRNA	I
.	O

However	O
,	O
a	O
strongly	O
increased	O
frequency	O
of	O
CpG	O
dinucleotides	O
was	O
found	O
.	O

Here	O
we	O
focused	O
on	O
the	O
role	O
of	O
the	O
5	O
'	O
proximal	O
regulatory	O
cassette	O
(	O
-190	O
;	O
+	O
53	O
bp	O
)	O
of	O
the	O
rat	B
enkephalin	I
(	O
rENK	B
)	O
gene	O
in	O
the	O
developmental	O
regulation	O
of	O
the	O
enkephalin	B
phenotype	O
.	O

Unexpectedly	O
,	O
all	O
ENK	B
-	I
specific	I
motifs	I
formed	O
specific	O
and	O
highly	O
abundant	O
protein	O
-	O
DNA	O
complexes	O
when	O
nuclear	O
extracts	O
from	O
the	O
human	O
tumor	O
cell	O
line	O
(	O
HeLa	O
)	O
,	O
which	O
does	O
not	O
express	O
ENK	B
,	O
were	O
used	O
.	O

Infant	O
aged	O
3.5	O
years	O
presents	O
persistence	O
of	O
primordial	O
vitreous	O
body	O
with	O
crystalline	O
dislocation	O
in	O
the	O
camera	O
aquosa	O
and	O
secondary	O
buphthalmos	O
of	O
the	O
left	O
eye	O
and	O
microphthalmos	O
with	O
dislocation	O
of	O
the	O
crystalline	O
in	O
the	O
vitreous	O
body	O
of	O
the	O
right	O
eye	O
.	O

MZF-1	B
represses	O
CAT	B
reporter	I
gene	I
expression	O
via	O
GAL4	B
binding	I
sites	I
in	O
the	O
nonhematopoietic	O
cell	O
lines	O
NIH	O
3T3	O
and	O
293	O
.	O

As	O
with	O
the	O
heterologous	O
DNA	O
binding	O
domain	O
,	O
MZF-1	B
represses	O
reporter	O
gene	O
expression	O
in	O
nonhematopoietic	O
cell	O
lines	O
and	O
activates	O
expression	O
in	O
hematopoietic	O
cell	O
lines	O
.	O

Analyses	O
of	O
hGMR	B
beta	I
subunit	I
mutants	I
revealed	O
two	O
cytoplasmic	O
regions	O
involved	O
in	O
activation	O
of	O
the	O
c	B
-	I
myc	I
promoter	I
,	O
one	O
is	O
essential	O
and	O
the	O
other	O
is	O
dispensable	O
but	O
enhances	O
the	O
activity	O
.	O

Similarly	O
,	O
we	O
observed	O
synthetic	O
phenotypes	O
between	O
mutations	O
in	O
MIF2	B
and	O
trans	O
-	O
acting	O
mutations	O
in	O
three	O
known	O
yeast	O
centromere	O
protein	O
genes	O
-	O
CEP1	B
/	O
CBF1	B
/	O
CPF1	B
,	O
NDC10	B
/	O
CBF2	B
,	O
and	O
CEP3	B
/	O
CBF3B	B
.	O

Estimated	O
daily	O
intakes	O
(	O
EDIs	O
)	O
per	O
person	O
were	O
0.56	O
microgram	O
for	O
total	O
HCH	O
,	O
0.20	O
microgram	O
for	O
gamma	O
-	O
HCH	O
,	O
0.09	O
microgram	O
for	O
dieldrin	O
,	O
1.42	O
micrograms	O
for	O
total	O
DDT	O
,	O
and	O
0.15	O
microgram	O
for	O
HCB	O
.	O

In	O
two	O
further	O
cases	O
(	O
one	O
type	O
I	O
and	O
one	O
type	O
III	O
SMA	O
)	O
,	O
de	O
novo	O
deletions	O
of	O
only	O
one	O
copy	O
of	O
Ag1-CA	B
and	O
C212	B
were	O
found	O
.	O

With	O
each	O
of	O
the	O
three	O
pairs	O
of	O
isolates	O
(	O
case	O
and	O
suspicious	O
case	O
)	O
,	O
identical	O
IS6110	O
banding	O
patterns	O
were	O
found	O
suggesting	O
identical	O
MTB	O
strains	O
.	O

These	O
early	O
structural	O
processes	O
are	O
assumed	O
to	O
be	O
subserved	O
by	O
the	O
anterior	O
parts	O
of	O
the	O
left	O
hemisphere	O
,	O
as	O
event	O
-	O
related	O
brain	O
potentials	O
show	O
this	O
area	O
to	O
be	O
maximally	O
activated	O
when	O
phrase	O
structure	O
violations	O
are	O
processed	O
and	O
as	O
circumscribed	O
lesions	O
in	O
this	O
area	O
lead	O
to	O
an	O
impairment	O
of	O
the	O
on	O
-	O
line	O
structural	O
assignment	O
.	O

In	O
men	O
with	O
BMI	O
<	O
30	O
,	O
the	O
OR	O
was	O
1.83	O
for	O
postprandial	O
TG	O
(	O
P	O
=	O
.041	O
)	O
and	O
2.77	O
for	O
postprandial	O
RP	O
(	O
P	O
=	O
.032	O
)	O
in	O
models	O
that	O
included	O
fasting	O
TG	O
,	O
LDL	B
-	I
C	I
,	O
and	O
hypertension	O
.	O

SL1	B
trans	O
-	O
splicing	O
specified	O
by	O
AU	O
-	O
rich	O
synthetic	O
RNA	O
inserted	O
at	O
the	O
5	O
'	O
end	O
of	O
Caenorhabditis	O
elegans	O
pre	O
-	O
mRNA	O
.	O

A	O
pyrazolo	O
-	O
quinoline	O
compound	O
,	O
6-methoxy-4-	O
[	O
2-	O
[	O
(	O
2-hydroxyethoxyl	O
)	O
-ethyl	O
]	O
amino	O
]	O
-3-methyl-1M	O
-	O
pyrazo	O
lo	O
[	O
3,4-b	O
]	O
quinoline	O
(	O
SCH	O
51344	O
)	O
,	O
was	O
identified	O
based	O
on	O
its	O
ability	O
to	O
derepress	O
human	O
smooth	O
muscle	O
alpha	B
-	I
actin	I
promoter	I
activity	O
in	O
ras	B
-	O
transformed	O
cells	O
.	O

On	O
the	O
basis	O
of	O
these	O
relations	O
,	O
a	O
risk	O
factor	O
-	O
selection	O
scale	O
(	O
RFSS	O
)	O
(	O
range	O
,	O
0	O
to	O
10	O
)	O
was	O
developed	O
by	O
computing	O
appropriate	O
weights	O
for	O
each	O
risk	O
factor	O
.	O

Repression	O
of	O
glucocorticoid	B
receptor	I
-	O
mediated	O
transcriptional	O
activation	O
by	O
unliganded	O
thyroid	B
hormone	I
receptor	I
(	O
TR	B
)	O
is	O
TR	B
isoform	O
-	O
specific	O
.	O

Overexpression	O
of	O
wild	B
-	I
type	I
p53	I
also	O
induces	O
apoptosis	O
in	O
an	O
LCL	O
.	O

Cloning	O
,	O
sequencing	O
and	O
expression	O
of	O
the	O
3-phosphoglycerate	B
kinase	I
gene	I
of	O
Pyrococcus	O
woesei	O
in	O
Escherichia	O
coli	O
and	O
characterization	O
of	O
the	O
protein	O
.	O

We	O
sought	O
to	O
determine	O
whether	O
such	O
differences	O
in	O
polyadenylation	O
affect	O
the	O
steady	O
-	O
state	O
levels	O
of	O
DHFR	B
and	O
mRNAs	O
expressed	O
from	O
either	O
allele	O
and	O
,	O
in	O
a	O
more	O
general	O
sense	O
,	O
to	O
ask	O
whether	O
differences	O
in	O
3	O
'	O
end	O
RNA	O
processing	O
in	O
a	O
gene	O
containing	O
multiple	O
poly	O
(	O
A	O
)	O
sites	O
affects	O
the	O
final	O
level	O
of	O
gene	O
expression	O
.	O

We	O
have	O
isolated	O
a	O
Drosophila	O
melanogaster	O
(	O
Dm	O
)	O
cDNA	O
encoding	O
a	O
polypeptide	O
that	O
has	O
extensive	O
sequence	O
similarity	O
to	O
the	O
mammalian	B
MAPKAPK-2	I
.	O

The	O
finding	O
that	O
the	O
chimeric	B
TdT::Pol	I
beta	B
protein	I
possessed	O
significant	O
template	O
-	O
dependent	O
polymerase	O
activity	O
suggests	O
that	O
aa	O
1	O
-	O
60	O
of	O
Pol	B
beta	I
are	O
involved	O
in	O
template	O
utilization	O
during	O
the	O
polymerization	O
reaction	O
,	O
as	O
suggested	O
by	O
the	O
previous	O
finding	O
that	O
the	O
8-kDa	O
N	O
-	O
terminal	O
domain	O
of	O
Pol	B
beta	I
possesses	O
ssDNA	O
-	O
binding	O
activity	O
[	O
Kumar	O
et	O
al.	O
,	O
J.	O

The	O
integrity	O
of	O
the	O
cDNA	O
sequence	O
was	O
confirmed	O
by	O
analysis	O
of	O
several	O
overlapping	O
genomic	O
clones	O
that	O
span	O
the	O
GAR1	B
gene	I
.	O

In	O
Trial	O
1	O
,	O
eight	O
sows	O
were	O
allowed	O
to	O
farrow	O
naturally	O
(	O
d	O
114	O
,	O
NF	O
sows	O
)	O
and	O
eight	O
sows	O
were	O
induced	O
to	O
farrow	O
(	O
IF	O
sows	O
)	O
prematurely	O
by	O
injection	O
of	O
prostaglandin	O
F2	O
alpha	O
on	O
d	O
112	O
of	O
gestation	O
.	O

End	O
-	O
tidal	O
PO2	O
and	O
the	O
ratio	O
of	O
minute	O
ventilation	O
to	O
oxygen	O
consumption	O
(	O
VE	O
/	O
VO2	O
)	O
were	O
lower	O
while	O
PETCO2	O
was	O
higher	O
for	O
Hyp	O
(	O
P	O
<	O
or	O
=	O
0.01	O
)	O
.	O

These	O
results	O
suggested	O
that	O
NfxB	B
negatively	O
autoregulates	O
the	O
expression	O
of	O
nfxB	B
itself	O
.	O

If	O
NCR	O
-	O
sensitive	O
gene	O
expression	O
occurs	O
exclusively	O
by	O
this	O
pathway	O
,	O
as	O
has	O
been	O
thought	O
to	O
be	O
the	O
case	O
,	O
then	O
the	O
NCR	O
sensitivity	O
of	O
a	O
gene	O
's	O
expression	O
should	O
be	O
abolished	O
by	O
a	O
ure2	B
delta	I
mutation	I
.	O

The	O
single	O
-	O
stranded	O
DNA	O
Pur	B
alpha	I
recognition	I
element	I
disrupts	O
these	O
complexes	O
.	O

Association	O
of	O
human	B
Pur	I
alpha	I
with	O
the	O
retinoblastoma	B
protein	I
,	O
Rb	B
,	O
regulates	O
binding	O
to	O
the	O
single	O
-	O
stranded	O
DNA	O
Pur	B
alpha	I
recognition	I
element	I
.	O

The	O
insulin	B
-	O
induced	O
DNA	O
-	O
binding	O
complex	O
was	O
identified	O
as	O
the	O
p50	B
/	O
p65	B
heterodimer	O
.	O

Using	O
varying	O
conditions	O
,	O
three	O
distinct	O
complexes	O
were	O
shown	O
to	O
interact	O
specifically	O
with	O
the	O
NIP	B
region	I
,	O
although	O
only	O
one	O
correlates	O
with	O
repressor	O
activity	O
.	O

Exchange	O
of	O
the	O
LPL	B
and	O
HL	B
lids	O
resulted	O
in	O
a	O
reversal	O
of	O
the	O
phospholipase	B
/	O
neutral	O
lipase	B
ratio	O
,	O
establishing	O
the	O
important	O
role	O
of	O
this	O
region	O
in	O
mediating	O
substrate	O
specificity	O
.	O

The	O
interferon	B
-	O
inducible	O
protein	B
kinase	I
PKR	I
modulates	O
the	O
transcriptional	O
activation	O
of	O
immunoglobulin	B
kappa	I
gene	I
.	O

Truncated	O
forms	O
of	O
a	O
novel	O
yeast	O
protein	O
suppress	O
the	O
lethality	O
of	O
a	O
G	B
protein	I
alpha	I
subunit	I
deficiency	O
by	O
interacting	O
with	O
the	O
beta	O
subunit	O
.	O

Levels	O
of	O
TSG-14	B
protein	I
(	O
also	O
termed	O
PTX-3	B
)	O
become	O
elevated	O
in	O
the	O
serum	O
of	O
mice	O
and	O
humans	O
after	O
injection	O
with	O
bacterial	O
lipopolysaccharide	O
,	O
but	O
in	O
contrast	O
to	O
conventional	O
acute	O
phase	O
proteins	O
,	O
the	O
bulk	O
of	O
TSG-14	B
synthesis	O
in	O
the	O
intact	O
organism	O
occurs	O
outside	O
the	O
liver	O
.	O

The	O
mouse	B
beta	I
2-syntrophin	I
gene	I
(	O
>	O
33	O
kilobases	O
)	O
contains	O
seven	O
exons	O
,	O
all	O
of	O
which	O
have	O
homologues	O
at	O
the	O
corresponding	O
position	O
in	O
the	O
alpha	B
1-syntrophin	I
gene	I
.	O

We	O
report	O
here	O
the	O
cloning	O
of	O
the	O
murine	O
p44	B
MAP	B
kinase	I
(	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
1	I
)	O
gene	O
,	O
the	O
determination	O
of	O
its	O
intron	O
/	O
exon	O
boundaries	O
,	O
and	O
the	O
characterization	O
of	O
its	O
promoter	O
.	O

One	O
of	O
these	O
is	O
surrounded	O
by	O
an	O
adenine	O
-	O
uridine	O
rich	O
region	O
that	O
can	O
form	O
an	O
11-base	O
pair	O
stem	O
structure	O
.	O

Effects	O
of	O
verapamil	O
and	O
propranolol	O
on	O
early	O
afterdepolarizations	O
and	O
ventricular	O
arrhythmias	O
induced	O
by	O
epinephrine	O
in	O
congenital	O
long	O
QT	O
syndrome	O
.	O

Deletion	O
of	O
the	O
NF	B
-	I
IL6	I
beta	I
leucine	I
zipper	I
domain	I
also	O
greatly	O
diminished	O
the	O
interaction	O
between	O
these	O
two	O
proteins	O
.	O

Two	O
domains	O
of	O
EBNA2	B
defined	O
by	O
deletion	O
of	O
amino	O
acids	O
247	O
-	O
337	O
and	O
437	O
-	O
476	O
were	O
found	O
to	O
be	O
important	O
for	O
the	O
activation	O
of	O
both	O
promoters	O
,	O
while	O
two	O
different	O
domains	O
corresponding	O
to	O
residues	O
4	O
-	O
18	O
and	O
118	O
-	O
198	O
were	O
required	O
solely	O
for	O
the	O
LMP1	B
promoter	I
.	O

Additionally	O
,	O
the	O
enzyme	O
shows	O
activity	O
towards	O
triglycerides	O
such	O
as	O
olive	O
oil	O
and	O
tributyrin	O
and	O
towards	O
egg	O
-	O
yolk	O
emulsions	O
.	O

These	O
results	O
suggest	O
that	O
low	O
concentrations	O
of	O
IL-1	B
beta	I
may	O
be	O
useful	O
for	O
nonsurgical	O
treatment	O
of	O
human	O
vitreous	O
hemorrhage	O
.	O

Two	O
transcripts	O
of	O
1.6	O
kb	O
and	O
5.8	O
kb	O
are	O
5	O
'	O
coterminal	O
and	O
may	O
both	O
encode	O
the	O
novel	O
glycoprotein	B
gene	I
EUS4	I
.	O

However	O
,	O
the	O
few	O
studies	O
that	O
address	O
antimicrobial	O
prophylaxis	O
in	O
bone	O
marrow	O
transplantation	O
have	O
not	O
always	O
shown	O
a	O
survival	O
benefit	O
.	O

The	O
fracture	O
groups	O
were	O
significantly	O
older	O
and	O
had	O
more	O
years	O
since	O
menopause	O
than	O
the	O
control	O
groups	O
.	O

In	O
addition	O
,	O
we	O
found	O
differences	O
in	O
the	O
binding	O
of	O
nuclear	O
factors	O
from	O
shoots	O
versus	O
from	O
roots	O
,	O
in	O
agreement	O
with	O
the	O
different	O
activities	O
of	O
the	O
promoter	O
in	O
these	O
two	O
organs	O
.	O

The	O
prevalence	O
and	O
incidence	O
of	O
human	O
immunodeficiency	O
virus	O
types	O
1	O
and	O
2	O
(	O
HIV-1	O
,	O
HIV-2	O
)	O
,	O
human	O
T	O
-	O
lymphotropic	O
virus	O
types	O
I	O
and	O
II	O
(	O
HTLV	O
-	O
I	O
/	O
II	O
)	O
,	O
and	O
syphilitic	O
infections	O
and	O
the	O
association	O
between	O
these	O
infections	O
were	O
determined	O
in	O
a	O
cohort	O
of	O
police	O
officers	O
in	O
Guinea	O
-	O
Bissau	O
.	O

By	O
in	O
vitro	O
immunoprecipitations	O
and	O
gel	O
shift	O
assays	O
,	O
we	O
identified	O
two	O
classes	O
of	O
high	O
affinity	O
Engrailed	B
-	I
binding	I
sites	I
upstream	O
of	O
each	O
of	O
the	O
two	O
polyhomeotic	O
transcription	O
units	O
.	O

Analysis	O
of	O
this	O
sequence	O
combined	O
with	O
that	O
previously	O
reported	O
for	O
the	O
5'-flanking	O
region	O
directly	O
proximal	O
to	O
the	O
start	O
of	O
transcription	O
revealed	O
several	O
putative	O
regulatory	O
sequences	O
.	O

By	O
using	O
lacZ	B
fusions	I
,	O
it	O
was	O
possible	O
to	O
localize	O
the	O
DNA	O
sequences	O
required	O
to	O
mediate	O
nitrate	O
repression	O
to	O
the	O
pfl	B
promoter	I
-	I
regulatory	I
region	I
.	O

Vestibular	O
adaptation	O
exercises	O
and	O
recovery	O
:	O
acute	O
stage	O
after	O
acoustic	O
neuroma	O
resection	O
.	O

The	O
experimental	O
design	O
represents	O
a	O
2	O
x	O
3	O
factorial	O
arrangement	O
of	O
treatments	O
with	O
three	O
dietary	O
levels	O
of	O
incorporation	O
of	O
RSB	O
(	O
0	O
,	O
50	O
,	O
and	O
100	O
%	O
)	O
,	O
and	O
chickens	O
either	O
infected	O
or	O
uninfected	O
.	O

There	O
were	O
no	O
significant	O
changes	O
in	O
either	O
the	O
fatty	O
acid	O
composition	O
of	O
biliary	O
lecithin	O
or	O
in	O
the	O
bile	O
acid	O
composition	O
of	O
bile	O
.	O

Total	O
cholesterol	O
was	O
also	O
reduced	O
at	O
week	O
12	O
by	O
17.0	O
%	O
(	O
20	O
mg	O
/	O
day	O
)	O
and	O
15.7	O
%	O
(	O
20	O
-	O
30	O
mg	O
/	O
day	O
)	O
,	O
and	O
at	O
week	O
52	O
by	O
20.4	O
%	O
(	O
<	O
or	O
=	O
20	O
mg	O
/	O
day	O
)	O
and	O
19.2	O
%	O
(	O
>	O
or	O
=	O
30	O
mg	O
/	O
day	O
)	O
.	O

Although	O
further	O
studies	O
are	O
required	O
to	O
determine	O
the	O
precise	O
role	O
of	O
PEBP2	B
in	O
the	O
GM	B
-	I
CSF	I
promoter	I
activity	O
,	O
the	O
present	O
findings	O
suggested	O
the	O
importance	O
of	O
the	O
relative	O
ratio	O
of	O
different	O
PEBP2	B
isoforms	I
in	O
regulating	O
the	O
levels	O
of	O
the	O
promoter	O
activity	O
.	O

Piperacillin	O
-	O
tazobactam	O
can	O
be	O
used	O
for	O
the	O
treatment	O
of	O
infections	O
caused	O
by	O
gram	O
-	O
negative	O
,	O
gram	O
-	O
positive	O
,	O
aerobic	O
,	O
and	O
anaerobic	O
bacteria	O
.	O

The	O
spectrum	O
of	O
phenotypes	O
caused	O
by	O
these	O
mutations	O
was	O
strikingly	O
different	O
than	O
mutations	O
in	O
the	O
adaptor	O
for	O
the	O
VP16	B
activation	I
domain	I
.	O

Increase	O
in	O
urinary	O
calcium	O
and	O
oxalate	O
after	O
fructose	O
infusion	O
.	O

The	O
5'flanking	O
region	O
is	O
highly	O
GC	O
rich	O
,	O
with	O
multiple	O
CpG	O
doublets	O
,	O
and	O
contains	O
multiple	O
binding	O
sites	O
for	O
Sp1	B
.	O

Increased	O
blood	O
pressure	O
during	O
CyA	O
treatment	O
was	O
independent	O
of	O
circulating	O
ET-1	B
levels	O
.	O

Analysis	O
of	O
several	O
Tat	B
mutants	I
indicated	O
that	O
both	O
the	O
cysteine	O
-	O
rich	O
and	O
the	O
core	O
domains	O
of	O
this	O
transactivator	O
are	O
necessary	O
and	O
sufficient	O
to	O
activate	O
transcription	O
when	O
TBP	B
is	O
overexpressed	O
.	O

In	O
addition	O
,	O
depletion	O
of	O
Oct-1	B
from	O
the	O
nuclear	O
extract	O
by	O
using	O
Oct-1-specific	B
antiserum	O
or	O
a	O
sequence	O
-	O
specific	O
DNA	O
affinity	O
resin	O
decreased	O
in	O
vitro	O
transcription	O
from	O
the	O
wild	O
-	O
type	O
MMTV	O
promoter	O
to	O
a	O
level	O
identical	O
to	O
that	O
obtained	O
from	O
a	O
promoter	O
in	O
which	O
all	O
three	O
octamer	O
-	O
related	O
sequences	O
were	O
mutated	O
.	O

Transactivation	O
of	O
the	O
HIV-1	B
LTR	I
by	O
T3R	B
alpha	I
and	O
several	O
receptor	O
mutants	O
revealed	O
that	O
the	O
50-amino	O
-	O
acid	O
N	O
-	O
terminal	O
A	O
/	O
B	O
region	O
of	O
T3R	B
alpha	I
,	O
known	O
to	O
interact	O
with	O
the	O
basal	B
transcription	I
factor	I
TFIIB	I
,	O
is	O
critical	O
for	O
activation	O
of	O
both	O
Tat	B
-	O
dependent	O
and	O
Tat	B
-	O
independent	O
responsive	O
sequences	O
of	O
the	O
LTR	O
.	O

Finally	O
,	O
we	O
show	O
that	O
complexes	O
similar	O
to	O
the	O
C25	B
,	O
C30	B
and	O
C35	B
complexes	I
are	O
formed	O
by	O
rat	O
cortex	O
nuclear	O
extracts	O
and	O
the	O
SAA	O
element	O
in	O
EMSA	O
experiments	O
,	O
suggesting	O
the	O
relevance	O
of	O
our	O
in	O
vitro	O
observations	O
to	O
the	O
in	O
vivo	O
functioning	O
of	O
the	O
rat	B
APP	I
promoter	I
.	O

The	O
analysis	O
of	O
the	O
prevalence	O
values	O
shows	O
clearly	O
that	O
the	O
global	O
MS	O
-	O
frequency	O
is	O
closer	O
related	O
to	O
the	O
geomagnetic	O
than	O
to	O
the	O
geographic	O
latitude	O
.	O

Subhuman	O
primates	O
appear	O
to	O
be	O
more	O
sensitive	O
to	O
reproductive	O
and	O
other	O
adverse	O
effects	O
of	O
PCBs	O
than	O
humans	O
.	O

The	O
cryptococcal	B
antigen	I
test	O
was	O
positive	O
at	O
1:125	O
by	O
latex	O
agglutination	O
.	O

Both	O
mu	B
and	I
gamma	I
2b	I
heavy	I
chain	I
genes	I
cause	O
this	O
feedback	O
inhibition	O
of	O
heavy	O
chain	O
gene	O
rearrangement	O
.	O

Purified	O
CarP	B
binds	O
in	O
vitro	O
to	O
the	O
carAB	B
control	I
region	I
and	O
protects	O
against	O
DNase	B
I	I
two	O
approximately	O
25	O
bp	O
long	O
stretches	O
,	O
one	O
of	O
which	O
is	O
located	O
just	O
downstream	O
of	O
the	O
GATC	O
sequence	O
.	O

They	O
include	O
genes	O
encoding	O
three	O
subunits	O
of	O
the	O
cytochrome	B
oxidase	I
(	O
cox1	B
to	I
3	I
)	O
,	O
apocytochrome	B
b	I
(	O
cob	B
)	O
,	O
seven	O
subunits	O
of	O
the	O
NADH	B
dehydrogenase	I
complex	I
(	O
nad1	B
to	I
6	I
,	O
nad4L	B
)	O
,	O
two	O
ATPase	B
subunits	O
(	O
atp6	B
and	O
atp9	B
)	O
,	O
three	O
ribosomal	O
RNAs	O
(	O
rrn5	B
,	O
srn	B
and	O
lrn	B
)	O
,	O
23	O
tRNAs	O
and	O
four	O
ribosomal	O
proteins	O
(	O
rps3	B
,	O
rps11	B
,	O
rps12	B
and	O
rpl16	B
)	O
.	O

From	O
day	O
10	O
,	O
a	O
significant	O
increase	O
in	O
platelet	O
count	O
was	O
observed	O
in	O
eight	O
of	O
the	O
ten	O
patients	O
treated	O
with	O
heparin	O
(	O
p	O
<	O
0.05	O
)	O
,	O
with	O
return	O
to	O
the	O
initial	O
value	O
after	O
heparin	O
cessation	O
in	O
six	O
of	O
the	O
responders	O
.	O

The	O
Babcock	O
Surgical	O
Clinic	O
.	O

Resources	O
for	O
helping	O
patients	O
to	O
quit	O
smoking	O
.	O

The	O
PEBP2	B
alpha	I
proteins	I
contain	O
a	O
128-amino	O
-	O
acid	O
(	O
aa	O
)	O
region	O
highly	O
homologous	O
to	O
the	O
Drosophila	B
melanogaster	I
segmentation	I
gene	I
runt	I
.	O

Histopathological	O
features	O
of	O
relapsed	O
leprosy	O
.	O

One	O
of	O
these	O
factors	O
,	O
HRF-1	B
,	O
recognizes	O
a	O
cis	O
element	O
consisting	O
of	O
an	O
inverted	O
palindromic	O
motif	O
.	O

D.	O

It	O
was	O
proposed	O
that	O
the	O
synthetase	O
-	O
related	O
sequences	O
of	O
GCN2	B
stimulate	O
the	O
activity	O
of	O
the	O
kinase	O
by	O
interacting	O
directly	O
with	O
uncharged	O
tRNA	O
that	O
accumulates	O
during	O
amino	O
acid	O
limitation	O
.	O

To	O
compare	O
the	O
PAX3	B
and	O
putative	O
PAX3-FKHR	B
transactivation	O
domains	O
,	O
we	O
fused	O
C	O
-	O
terminal	O
test	O
fragments	O
to	O
the	O
heterologous	O
GAL4	B
DNA	I
-	I
binding	I
domain	I
and	O
tested	O
activation	O
of	O
a	O
reporter	O
gene	O
co	O
-	O
transfected	O
into	O
four	O
cell	O
types	O
.	O

All	O
subjects	O
were	O
submitted	O
to	O
ECG	O
and	O
arterial	O
blood	O
pressure	O
determination	O
and	O
were	O
assayed	O
for	O
TSH	B
,	O
thyroid	O
hormone	O
,	O
PRL	B
,	O
glucose	O
,	O
creatinine	O
,	O
nitrogen	O
,	O
glutamine	B
transaminase	I
,	O
cholesterol	O
and	O
triglycerides	O
plasma	O
levels	O
before	O
therapy	O
(	O
T0	O
)	O
,	O
after	O
30	O
treatment	O
days	O
(	O
T30	O
)	O
and	O
after	O
a	O
15	O
days	O
washout	O
(	O
T45	O
)	O
.	O

Acute	O
decrease	O
in	O
body	O
temperature	O
(	O
TB	O
)	O
lowered	O
PaCO2	O
(	O
32.5	O
to	O
14.5	O
mmHg	O
)	O
and	O
[	O
HCO3-	O
]	O
a	O
(	O
24.20	O
mEq	O
/	O
L	O
to	O
17.56	O
mEq	O
/	O
L	O
)	O
,	O
increased	O
pHa	O
(	O
7.481	O
to	O
7.608	O
)	O
and	O
diminished	O
the	O
[	O
OH-	O
]	O
/	O
[	O
H+	O
]	O
ratio	O
,	O
but	O
had	O
no	O
significant	O
effect	O
on	O
[	O
SID	O
]	O
or	O
[	O
Atot	O
]	O
,	O
although	O
both	O
total	O
phosphorus	O
[	O
PT	O
]	O
and	O
inorganic	O
phosphate	O
[	O
Pi	O
]	O
increased	O
.	O

Hepatitis	O
B	O
vaccine	O
:	O
still	O
has	O
its	O
problems	O
.	O

The	O
RAT3	B
gene	I
encodes	O
an	O
1157-amino	O
acid	O
protein	O
without	O
similarity	O
to	O
other	O
known	O
proteins	O
.	O

Tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
alpha	I
)	O
,	O
a	O
proinflammatory	O
cytokine	O
,	O
inhibits	O
cAMP	O
-	O
stimulated	O
testosterone	O
production	O
in	O
mouse	O
Leydig	O
cells	O
.	O

The	O
Drosophila	B
insulin	I
receptor	I
homolog	I
:	O
a	O
gene	O
essential	O
for	O
embryonic	O
development	O
encodes	O
two	O
receptor	O
isoforms	O
with	O
different	O
signaling	O
potential	O
.	O

We	O
show	O
here	O
that	O
RA	O
and	O
E1A	B
induce	O
phosphorylation	O
of	O
the	O
E1A	B
-	I
associated	I
300	I
kDa	I
protein	I
(	O
p300	B
)	O
during	O
the	O
differentiation	O
of	O
F9	O
cells	O
.	O

The	O
double	O
-	O
stranded	O
RNA	O
binding	O
domain	O
(	O
dsRBD	O
)	O
is	O
an	O
approximately	O
65	O
amino	O
acid	O
motif	O
that	O
is	O
found	O
in	O
a	O
variety	O
of	O
proteins	O
that	O
interact	O
with	O
double	O
-	O
stranded	O
(	O
ds	O
)	O
RNA	O
,	O
such	O
as	O
Escherichia	O
coli	O
RNase	B
III	I
and	O
the	O
dsRNA	B
-	I
dependent	I
kinase	I
,	O
PKR	B
.	O

SCA	B
was	O
resistant	O
to	O
inhibitors	O
of	O
serine	O
,	O
aspartyl	O
,	O
and	O
metalloproteases	B
,	O
but	O
it	O
was	O
sensitive	O
to	O
N	O
-	O
ethylmaleimide	O
.	O

Mutational	O
analysis	O
of	O
potential	O
activating	O
phosphorylation	O
sites	O
found	O
in	O
NIMA	B
,	O
NIM-1	B
,	O
and	O
related	O
protein	O
kinases	O
was	O
performed	O
on	O
NIMA	B
.	O

NH2-	O
and	O
COOH	O
-	O
terminal	O
deletion	O
analysis	O
revealed	O
that	O
both	O
the	O
PH	B
and	O
putative	O
guanine	B
nucleotide	I
exchange	I
factor	I
domains	I
are	O
required	O
,	O
but	O
the	O
zinc	O
butterfly	O
is	O
dispensable	O
,	O
for	O
transformation	O
.	O

The	O
objective	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
the	O
age	O
,	O
sex	O
,	O
clinical	O
conditions	O
,	O
family	O
history	O
,	O
site	O
,	O
catheter	O
association	O
,	O
means	O
of	O
radiologic	O
evaluation	O
,	O
development	O
of	O
pulmonary	O
involvement	O
,	O
prevalence	O
of	O
antithrombin	B
III	I
,	O
protein	B
C	I
and	O
protein	B
S	I
deficiencies	O
,	O
and	O
lupus	O
anticoagulants	O
in	O
children	O
who	O
suffered	O
a	O
thrombotic	O
event	O
.	O

Radiotherapy	O
and	O
early	O
orchiectomy	O
in	O
stage	O
D1	O
prostatic	O
carcinoma	O

The	O
ARX2	O
procedure	O
models	O
the	O
recorded	O
signal	O
as	O
the	O
sum	O
of	O
three	O
signals	O
:	O
(	O
a	O
)	O
the	O
background	O
EEG	O
activity	O
,	O
modelled	O
as	O
an	O
autoregressive	O
process	O
driven	O
by	O
a	O
white	O
noise	O
;	O
(	O
b	O
)	O
a	O
filtered	O
version	O
of	O
a	O
reference	O
signal	O
carrying	O
the	O
average	O
information	O
contained	O
in	O
each	O
sweep	O
;	O
(	O
c	O
)	O
a	O
signal	O
due	O
to	O
the	O
ocular	O
artefact	O
propagation	O
.	O

The	O
expression	O
of	O
the	O
gene	O
encoding	O
the	O
enzyme	O
(	O
CYP19	B
)	O
is	O
regulated	O
,	O
in	O
part	O
,	O
by	O
tissue	O
-	O
specific	O
promoters	O
through	O
the	O
use	O
of	O
alternative	O
-	O
splicing	O
mechanisms	O
.	O

Using	O
mutagenesis	O
,	O
we	O
have	O
identified	O
two	O
mutations	O
of	O
the	O
second	O
actin	B
-	I
binding	I
domain	I
that	O
can	O
also	O
suppress	O
the	O
act1	B
mutations	O
of	O
interest	O
.	O

CIITA	B
mRNA	I
is	O
normally	O
inducible	O
by	O
IFN	B
-	I
gamma	I
in	O
class	O
II	O
non	O
-	O
inducible	O
,	O
RB	O
-	O
defective	O
lines	O
,	O
and	O
in	O
one	O
line	O
,	O
re	O
-	O
expression	O
of	O
RB	B
has	O
no	O
effect	O
on	O
CIITA	B
mRNA	I
induction	O
levels	O
.	O

The	O
normal	O
cell	O
cycle	O
is	O
regulated	O
by	O
several	O
molecules	O
,	O
such	O
as	O
the	O
tumor	B
-	I
suppressor	I
protein	I
pRb	I
,	O
the	O
G1	B
cyclins	I
,	O
the	O
cyclin	B
-	I
dependent	I
kinases	I
,	O
and	O
their	O
inhibitors	O
.	O

These	O
results	O
are	O
very	O
useful	O
for	O
deciding	O
on	O
the	O
doses	O
of	O
hormones	O
and	O
the	O
expected	O
serum	O
estradiol	O
level	O
in	O
HRT	O
for	O
Japanese	O
women	O
.	O

One	O
month	O
after	O
the	O
DTaP	O
booster	O
vaccination	O
,	O
both	O
groups	O
had	O
6-	O
to	O
40-fold	O
increases	O
in	O
serum	O
antibody	O
concentrations	O
to	O
all	O
antigens	O
tested	O
;	O
the	O
concentrations	O
against	O
the	O
three	O
pertussis	B
antigens	I
were	O
higher	O
in	O
the	O
DTaP	O
-	O
primed	O
children	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Interestingly	O
,	O
this	O
amino	O
-	O
terminal	O
determinant	O
appears	O
not	O
to	O
reside	O
in	O
the	O
HSV	O
-	O
alpha	B
TIF	I
,	O
which	O
displays	O
no	O
independent	O
amino	O
-	O
terminal	O
activity	O
.	O

We	O
also	O
show	O
that	O
in	O
fusions	O
with	O
the	O
DNA	O
binding	O
domain	O
of	O
GAL4	B
,	O
full	O
activity	O
requires	O
the	O
entire	O
BHV	B
-	I
alpha	I
TIF	I
,	O
although	O
both	O
amino	O
and	O
carboxyl	O
termini	O
display	O
some	O
activity	O
on	O
their	O
own	O
.	O

Here	O
we	O
show	O
that	O
messenger	O
RNAs	O
encoding	O
trans	O
-	O
sialidases	O
containing	O
the	O
repeats	O
are	O
not	O
present	O
in	O
epimastigotes	O
but	O
are	O
abundant	O
in	O
trypomastigotes	O
.	O

From	O
May	O
1985	O
to	O
May	O
1989	O
,	O
126	O
necropsies	O
were	O
performed	O
at	O
the	O
Sao	O
Paulo	O
City	O
Morgue	O
on	O
cadavers	O
of	O
individuals	O
AIDS	O
victims	O
whose	O
unnatural	O
deaths	O
had	O
prompted	O
police	O
investigations	O
.	O

A	O
model	O
with	O
age	O
and	O
weight	O
described	O
the	O
best	O
fit	O
for	O
TBBMD	O
,	O
whereas	O
age	O
,	O
weight	O
,	O
and	O
height	O
described	O
the	O
best	O
fit	O
for	O
total	O
body	O
TBBMC	O
.	O

The	O
C	O
-	O
terminal	O
peptide	O
sequences	O
of	O
the	O
human	B
lymphocyte	I
-	I
specific	I
high	I
mobility	I
group	I
(	I
HMG	I
)	I
-box	I
transcription	I
factor	I
TCF-1	I
are	O
determined	O
by	O
alternative	O
splice	O
mechanisms	O
affecting	O
the	O
exons	O
VIII	O
to	O
X.	O

A	O
new	O
vector	O
,	O
pHBK280	O
,	O
was	O
designed	O
to	O
facilitate	O
this	O
analysis	O
.	O

A	O
TATA	O
-	O
less	O
promoter	O
containing	O
binding	O
sites	O
for	O
ubiquitous	O
transcription	O
factors	O
mediates	O
cell	O
type	O
-	O
specific	O
regulation	O
of	O
the	O
gene	O
for	O
transcription	B
enhancer	I
factor-1	I
(	O
TEF-1	B
)	O
.	O

Here	O
we	O
describe	O
an	O
in	O
vitro	O
assay	O
where	O
the	O
NS3	B
-	I
4A	I
polyprotein	I
,	O
NS3	B
,	O
the	O
serine	B
proteinase	I
domain	I
(	I
the	I
N	I
-	I
terminal	I
181	I
residues	I
of	I
NS3	I
)	I
,	O
and	O
the	O
NS4A	B
cofactor	I
were	O
produced	O
by	O
cell	O
-	O
free	O
translation	O
and	O
tested	O
for	O
trans	O
-	O
processing	O
of	O
radiolabeled	O
substrates	O
.	O

We	O
purified	O
both	O
proteins	O
from	O
human	O
platelet	O
membranes	O
using	O
DEAE	O
-	O
Sepharose	O
chromatography	O
followed	O
by	O
mAb	B
F11	I
affinity	O
chromatography	O
.	O

Our	O
evidence	O
derives	O
from	O
three	O
principal	O
observations	O
:	O
1	O
)	O
a	O
transfection	O
construct	O
containing	O
only	O
122	O
nucleotides	O
(	O
nt	O
)	O
of	O
promoter	O
1	O
and	O
328	O
nt	O
of	O
the	O
5'-UTR	O
retained	O
full	O
PGE2-stimulated	O
reporter	O
expression	O
;	O
2	O
)	O
maximal	O
PGE2-driven	O
reporter	O
expression	O
required	O
the	O
presence	O
of	O
nt	O
196	O
to	O
328	O
of	O
exon	O
1	O
when	O
tested	O
within	O
the	O
context	O
of	O
IGF	B
-	I
I	I
promoter	I
1	I
;	O
3	O
)	O
cotransfection	O
of	O
IGF	B
-	I
I	I
promoter	I
-	O
luciferase	B
-	O
reporter	O
constructs	O
with	O
a	O
plasmid	O
encoding	O
the	O
alpha	O
-	O
isoform	O
of	O
the	O
catalytic	O
subunit	O
of	O
murine	B
cAMP	I
-	I
dependent	I
protein	I
kinase	I
(	O
PKA	B
)	O
produced	O
results	O
comparable	O
to	O
those	O
seen	O
with	O
PGE2	O
treatment	O
,	O
whereas	O
cotransfection	O
with	O
a	O
plasmid	O
encoding	O
a	O
mutant	O
regulatory	O
subunit	O
of	O
PKA	B
that	O
can	O
not	O
bind	O
cAMP	O
blocked	O
PGE2-induced	O
reporter	O
expression	O
.	O

Retransformation	O
of	O
uvsH77	B
mutants	I
with	O
the	O
rescued	O
cosmids	O
from	O
the	O
MMS	O
-	O
resistant	O
transformants	O
resulted	O
in	O
restoration	O
of	O
both	O
UV	O
and	O
MMS	O
resistance	O
to	O
wild	O
-	O
type	O
levels	O
.	O

Furthermore	O
,	O
this	O
element	O
confers	O
p53	B
induction	O
to	O
the	O
otherwise	O
nonresponsive	O
adenovirus	O
major	O
late	O
promoter	O
.	O

In	O
flies	O
,	O
the	O
dShc	B
protein	I
physically	O
associates	O
with	O
the	O
activated	O
Drosophila	B
epidermal	I
growth	I
factor	I
receptor	I
homolog	I
(	O
DER	B
)	O
and	O
is	O
inducibly	O
phosphorylated	O
on	O
tyrosine	O
by	O
DER	B
.	O

A	O
Drosophila	B
shc	I
gene	I
product	I
is	O
implicated	O
in	O
signaling	O
by	O
the	O
DER	B
receptor	I
tyrosine	I
kinase	I
.	O

This	O
inhibition	O
can	O
be	O
overcome	O
by	O
mutating	O
either	O
the	O
exon	O
's	O
5	O
'	O
or	O
3	O
'	O
splice	O
site	O
to	O
make	O
it	O
correspond	O
more	O
closely	O
to	O
the	O
relevant	O
consensus	O
sequence	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
the	O
expression	O
of	O
LIMK-1	B
mRNA	I
predominantly	O
in	O
the	O
brain	O
and	O
the	O
expression	O
of	O
LIMK-2	B
mRNA	I
in	O
various	O
tissues	O
in	O
the	O
rat	O
.	O

However	O
,	O
the	O
relative	O
binding	O
affinity	O
for	O
the	O
motifs	O
is	O
different	O
.	O

On	O
the	O
basis	O
of	O
this	O
anatomic	O
concept	O
,	O
the	O
brachioplasty	O
procedure	O
was	O
modified	O
to	O
provide	O
secure	O
anchoring	O
of	O
the	O
arm	O
flap	O
to	O
the	O
axillary	O
fascia	O
along	O
with	O
strong	O
superficial	O
fascial	O
system	O
repair	O
of	O
incisions	O
,	O
reducing	O
the	O
risk	O
of	O
widening	O
or	O
migration	O
of	O
scars	O
and	O
unnatural	O
contours	O
.	O

INF	B
-	I
alpha	I
therapy	O
has	O
been	O
a	O
major	O
development	O
in	O
the	O
treatment	O
of	O
CML	O
.	O

Max	B
was	O
constantly	O
transcribed	O
at	O
a	O
relatively	O
low	O
level	O
during	O
cell	O
cycle	O
progression	O
.	O

Key	O
areas	O
of	O
the	O
selection	O
process	O
including	O
medical	O
and	O
surgical	O
alternatives	O
to	O
transplantation	O
,	O
the	O
composition	O
of	O
the	O
transplant	O
work	O
-	O
up	O
,	O
specific	O
inclusion	O
criteria	O
as	O
well	O
as	O
specific	O
psychosocial	O
factors	O
and	O
specific	O
disease	O
etiologies	O
and	O
co	O
-	O
morbidities	O
that	O
might	O
represent	O
contraindications	O
were	O
extensively	O
reviewed	O
.	O

The	O
transport	O
of	O
a	O
genetically	O
engineered	O
chimeric	O
transmembrane	O
protein	O
connected	O
to	O
this	O
ER	O
leader	O
sequence	O
was	O
as	O
efficient	O
as	O
that	O
of	O
the	O
original	O
protein	O
from	O
which	O
the	O
ER	O
sequence	O
has	O
been	O
derived	O
.	O

A	O
polymorphic	O
bipartite	O
motif	O
signals	O
nuclear	O
targeting	O
of	O
early	O
auxin	O
-	O
inducible	O
proteins	O
related	O
to	O
PS	B
-	I
IAA4	I
from	I
pea	I
(	I
Pisum	I
sativum	I
)	I
.	O

Comparative	O
DNA	O
sequence	O
analysis	O
showed	O
the	O
Genethon	O
microsatellite	B
D19S596	I
lies	O
2.2	O
kb	O
downstream	O
of	O
the	O
coding	O
region	O
of	O
FUT1	B
,	O
indicating	O
that	O
the	O
cluster	O
comprising	O
the	O
closely	O
linked	O
FUT1	B
and	O
FUT2	B
genes	I
is	O
located	O
4	O
cM	O
distal	O
to	O
D19S412	B
(	O
lod	O
score	O
13.7	O
)	O
and	O
9	O
cM	O
proximal	O
to	O
D19S571	B
(	O
lod	O
score	O
11.7	O
)	O
.	O

We	O
conclude	O
that	O
transcription	O
activation	O
by	O
LEF-1	B
in	O
vitro	O
is	O
a	O
chromatin	O
-	O
dependent	O
process	O
that	O
requires	O
a	O
functional	O
trans	O
-	O
activation	O
domain	O
in	O
addition	O
to	O
the	O
HMG	B
domain	I
.	O

TH	B
-	O
SH3	B
binding	O
in	O
vitro	O
is	O
abolished	O
by	O
specific	O
,	O
single	O
amino	O
acid	O
substitutions	O
within	O
the	O
Btk	B
TH	B
domain	I
or	O
the	O
Fyn	B
SH3	B
domain	I
.	O

These	O
results	O
indicate	O
that	O
K	B
-	I
glypican	I
is	O
a	O
novel	O
GPI	B
-	I
anchored	I
HSPG	I
involved	O
in	O
embryonic	O
development	O
.	O

The	O
plant	O
hormone	O
auxin	O
transcriptionally	O
activates	O
early	B
genes	I
.	O

The	O
ubiquitous	O
transcription	O
factor	O
Oct-1	B
forms	O
complexes	O
with	O
an	O
octamer	O
motif	O
present	O
within	O
FPIV	O
by	O
gel	O
shift	O
analysis	O
with	O
liver	O
and	O
kidney	O
extracts	O
,	O
making	O
Oct-1	B
an	O
intriguing	O
candidate	O
for	O
partnership	O
in	O
androgen	O
regulation	O
.	O

We	O
used	O
deletion	O
analysis	O
and	O
transfection	O
assays	O
with	O
reporter	O
gene	O
constructs	O
to	O
examine	O
the	O
transcription	O
control	O
elements	O
in	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
human	B
EpoR	I
gene	I
.	O

Adrenergic	O
system	O
activation	O
,	O
indicated	O
by	O
metanephrine	O
/	O
epinephrine	O
ratio	O
,	O
increased	O
with	O
time	O
in	O
losing	O
males	O
,	O
except	O
that	O
after	O
one	O
month	O
of	O
cohabitation	O
,	O
turnover	O
returned	O
to	O
levels	O
that	O
equaled	O
those	O
of	O
control	O
animals	O
.	O

A.	O

Transcription	O
factors	O
containing	O
a	O
basic	O
helix	O
-	O
loop	O
-	O
helix	O
(	O
bHLH	O
)	O
motif	O
regulate	O
the	O
expression	O
of	O
tissue	O
-	O
specific	O
genes	O
in	O
a	O
number	O
of	O
mammalian	O
and	O
insect	O
systems	O
.	O

Primer	O
extension	O
and	O
S1	B
nuclease	I
mapping	O
experiments	O
were	O
used	O
to	O
locate	O
the	O
transcription	O
initiation	O
site	O
of	O
Nramp1	B
and	O
revealed	O
the	O
presence	O
of	O
one	O
major	O
and	O
several	O
minor	O
initiation	O
sites	O
.	O

EsaR	B
can	O
repress	O
its	O
own	O
expression	O
but	O
seems	O
not	O
to	O
regulate	O
the	O
expression	O
of	O
esaI.	B

Sequence	O
analysis	O
of	O
the	O
5'-flanking	O
region	O
of	O
the	O
CD69	B
gene	I
revealed	O
the	O
presence	O
of	O
a	O
potential	O
TATA	O
element	O
30	O
base	O
pairs	O
upstream	O
of	O
the	O
major	O
transcription	O
initiation	O
site	O
and	O
several	O
putative	O
binding	O
sequences	O
for	O
inducible	O
transcription	O
factors	O
(	O
NF	B
-	I
kappa	I
B	I
,	O
Egr-1	B
,	O
AP-1	B
)	O
,	O
which	O
might	O
mediate	O
the	O
inducible	O
expression	O
of	O
this	O
gene	O
.	O

The	O
plasmin	B
-	I
derived	I
D	I
(	I
approximately	I
105-kDa	I
)	I
product	I
,	O
however	O
,	O
could	O
be	O
cross	O
-	O
linked	O
into	O
DD	O
dimers	O
.	O

All	O
clinical	O
isolates	O
were	O
concomitantly	O
tested	O
by	O
disk	O
diffusion	O
and	O
agar	O
dilution	O
procedures	O
as	O
outlined	O
by	O
the	O
National	O
Committee	O
for	O
Clinical	O
Laboratory	O
Standards	O
.	O

The	O
nucleotide	O
sequence	O
of	O
the	O
chloroplast	O
(	O
cp	O
)	O
DNA	O
from	O
maize	O
(	O
Zea	O
mays	O
)	O
has	O
been	O
completed	O
.	O

Investigation	O
of	O
the	O
control	O
of	O
coronavirus	O
subgenomic	O
mRNA	O
transcription	O
by	O
using	O
T7-generated	O
negative	O
-	O
sense	O
RNA	O
transcripts	O
.	O

Mean	O
longitudinal	O
extension	O
of	O
the	O
epidural	O
lesion	O
was	O
2.6	O
vertebral	O
segments	O
.	O

The	O
association	O
of	O
p255	B
with	O
splicing	O
complexes	O
is	O
suggested	O
by	O
the	O
finding	O
that	O
mAb	B
CC3	I
can	O
inhibit	O
in	O
vitro	O
splicing	O
and	O
immunoprecipitate	O
pre	O
-	O
messenger	O
RNA	O
and	O
splicing	O
products	O
.	O

L-735,524	O
free	O
base	O
or	O
sulfate	O
salt	O
was	O
administered	O
orally	O
as	O
suspension	O
,	O
solution	O
or	O
in	O
solid	O
dosage	O
forms	O
to	O
fasted	O
or	O
fed	O
Beagle	O
dogs	O
.	O

Doppler	O
ultrasound	O
studies	O
of	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
children	O
with	O
hemolytic	O
-	O
uremic	O
syndrome	O

Thus	O
,	O
endemic	O
cumlations	O
of	O
hepatitis	O
A	O
diseases	O
are	O
possible	O
.	O

The	O
properties	O
of	O
the	O
phi	O
29	O
SSB	B
-	I
ssDNA	I
complex	O
are	O
described	O
.	O

This	O
shows	O
that	O
the	O
characteristically	O
diffuse	O
banding	O
pattern	O
of	O
plant	O
nuclear	O
proteins	O
interacting	O
with	O
the	O
G	O
-	O
box	O
is	O
also	O
observed	O
in	O
a	O
binding	O
assay	O
using	O
only	O
one	O
recombinant	B
GBF	I
.	O

The	O
physical	O
linkage	O
of	O
the	O
FHR2	B
and	O
the	O
factor	B
H	I
genes	I
provides	O
additional	O
evidence	O
for	O
a	O
close	O
relatedness	O
of	O
complement	B
factor	I
H	I
and	O
the	O
factor	B
H	I
-	I
related	I
proteins	I
.	O

The	O
third	O
domain	O
had	O
the	O
motif	O
of	O
a	O
cAMP	O
response	O
element	O
(	O
CRE	O
)	O
.	O

The	O
tyrosine	O
-	O
phosphorylated	O
state	O
of	O
CAK	B
beta	I
was	O
not	O
reduced	O
on	O
trypsinization	O
,	O
nor	O
enhanced	O
in	O
response	O
to	O
plating	O
3Y1	O
cells	O
onto	O
fibronectin	B
.	O

Our	O
results	O
suggest	O
that	O
while	O
many	O
muscle	O
gene	O
E	O
-	O
boxes	O
are	O
capable	O
of	O
binding	O
the	O
previously	O
characterized	O
spectrum	O
of	O
MDF	B
/	I
bH	I
-	I
L	I
-	I
H	I
heterodimers	I
in	O
vitro	O
,	O
MCK	B
-	I
L	I
type	O
E	O
-	O
boxes	O
probably	O
bind	O
qualitatively	O
different	O
factors	O
in	O
vivo	O
.	O

We	O
conclude	O
that	O
,	O
in	O
comparison	O
to	O
reports	O
from	O
other	O
regions	O
,	O
Scandinavian	O
renal	O
transplant	O
recipients	O
are	O
at	O
high	O
risk	O
of	O
dying	O
of	O
IHD	O
.	O

The	O
serum	O
concentration	O
of	O
iP	O
before	O
dialysis	O
(	O
HD	O
)	O
was	O
on	O
average	O
3.06	O
(	O
+	O
/-	O
0.81	O
)	O
mmol	O
/	O
l	O
and	O
D	O
was	O
on	O
average	O
55.6	O
(	O
+	O
/-	O

10.0	O
)	O
mmol	O
.	O

A	O
significant	O
correlation	O
between	O
a	O
number	O
of	O
functional	O
parameters	O
of	O
gastric	O
secretion	O
,	O
incretion	O
and	O
histological	O
changes	O
of	O
gastric	O
mucosa	O
was	O
found	O
in	O
patients	O
with	O
chronic	O
gastritis	O
.	O

Little	O
or	O
no	O
protection	O
was	O
detected	O
using	O
adrenal	O
cortex	O
,	O
adrenal	O
medulla	O
,	O
liver	O
,	O
kidney	O
cortex	O
,	O
spleen	O
,	O
or	O
T	O
-	O
lymphocyte	O
total	O
RNA	O
.	O

We	O
found	O
a	O
direct	O
correlation	O
between	O
the	O
levels	O
of	O
transcription	O
of	O
the	O
acc	B
genes	I
and	O
the	O
rate	O
of	O
cellular	O
growth	O
.	O

The	O
hybridizing	O
clone	O
of	O
V.	O
vulnificus	O
chromosomal	O
DNA	O
complemented	O
a	O
V.	B
cholerae	I
fur	I
mutant	I
.	O

We	O
generated	O
transformed	O
B	O
lymphoblast	O
cell	O
lines	O
from	O
controls	O
,	O
from	O
four	O
patients	O
with	O
p47-phox	B
-	O
deficient	O
chronic	O
granulomatous	O
disease	O
,	O
and	O
from	O
three	O
parents	O
.	O

RNase	B
protection	O
and	O
primer	O
extension	O
assays	O
confirmed	O
that	O
the	O
5	O
'	O
non	O
-	O
coding	O
exon	O
is	O
included	O
in	O
the	O
DDT1	O
aFGF	B
mRNA	I
and	O
that	O
a	O
major	O
transcription	O
start	O
site	O
is	O
approximately	O
136	O
bp	O
upstream	O
of	O
the	O
5	O
'	O
non	O
-	O
coding	O
splice	O
junction	O
of	O
this	O
exon	O
.	O

The	O
roles	O
of	O
phorbol	O
esters	O
and	O
cyclic	O
AMP	O
in	O
mediating	O
the	O
GnRH	B
response	O
were	O
also	O
investigated	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
two	O
genes	B
encoding	I
gp138	I
,	O
a	O
cell	O
surface	O
glycoprotein	O
involved	O
in	O
the	O
sexual	O
cell	O
fusion	O
of	O
Dictyostelium	O
discoideum	O
.	O

Piroximone	O
is	O
a	O
new	O
phosphodiesterase	B
III	I
inhibitor	O
that	O
combines	O
inotropic	O
and	O
vasodilator	O
properties	O
.	O

Since	O
we	O
have	O
observed	O
effects	O
of	O
growth	O
factors	O
and	O
cAMP	O
as	O
well	O
as	O
estradiol	O
(	O
E2	O
)	O
on	O
regulation	O
of	O
expression	O
of	O
some	O
genes	O
stimulated	O
by	O
the	O
estrogen	B
receptor	I
(	O
ER	B
)	O
,	O
we	O
have	O
undertaken	O
studies	O
to	O
examine	O
directly	O
whether	O
activators	O
of	O
protein	O
kinases	O
can	O
modulate	O
transcriptional	O
activity	O
of	O
the	O
ER	B
.	O

RNA	B
polymerase	I
bound	O
to	O
the	O
+	O
10A	O
promoter	O
partially	O
protects	O
a	O
20	O
base	O
-	O
pair	O
sequence	O
from	O
DNase	B
I	I
digestion	O
upstream	O
of	O
the	O
start	O
site	O
.	O

Salivary	O
sodium	O
,	O
calcium	O
,	O
and	O
magnesium	O
concentrations	O
were	O
significantly	O
higher	O
in	O
the	O
SLE	O
patients	O
with	O
systemic	O
lupus	O
erythematosus	O
,	O
whereas	O
potassium	O
and	O
total	O
protein	O
concentrations	O
and	O
amylase	B
activity	O
did	O
not	O
differ	O
significantly	O
from	O
the	O
controls	O
.	O

Chem	O
.	O

Recombinant	O
plasmid	O
pFV100	O
was	O
subsequently	O
isolated	O
by	O
its	O
ability	O
to	O
complement	O
B	O
-	O
band	O
expression	O
in	O
ge6	B
.	O

We	O
here	O
demonstrate	O
that	O
a	O
temperature	O
-	O
sensitive	O
fission	O
yeast	O
mutant	O
which	O
has	O
a	O
mutation	O
in	O
a	O
homologous	O
gene	O
,	O
and	O
two	O
of	O
three	O
additional	O
(	O
mtr1	B
/	O
prp20	B
/	O
srm1	B
)	O
mutants	O
accumulate	O
nuclear	O
poly	O
(	O
A	O
)	O
+	O
RNA	O
at	O
37	O
degrees	O
C.	O

Since	O
RCC1p	B
acts	O
as	O
GNRP	B
for	O
Ran	B
,	O
a	O
small	B
nuclear	I
GTPase	I
of	O
the	O
ras	B
superfamily	I
,	O
we	O
have	O
identified	O
two	O
homologs	O
of	O
Ran	B
in	O
S.cerevisiae	O
(	O
CNR1	B
and	O
CNR2	B
)	O
.	O

Prostate	B
specific	I
antigen	I
shows	O
the	O
metastatic	O
cases	O
better	O
[	O
correction	O
of	O
worse	O
]	O
than	O
prostatic	B
acid	I
phosphatase	I
.	O

Protein	O
phosphorylation	O
appears	O
to	O
play	O
a	O
critical	O
role	O
in	O
uPA	B
gene	I
expression	O
in	O
these	O
cells	O
;	O
protein	B
kinase	I
C	I
-	O
activating	O
phorbol	O
esters	O
cooperate	O
with	O
pp60v	B
-	I
src	I
to	O
synergistically	O
increase	O
uPA	B
mRNA	I
,	O
whereas	O
cyclic	B
AMP	I
(	I
cAMP	I
)	I
-dependent	I
protein	I
kinase	I
-	O
activating	O
agents	O
(	O
e.g.	O
,	O
8-bromo	O
cAMP	O
)	O
repress	O
uPA	B
mRNA	I
levels	O
.	O

Of	O
these	O
carriers	O
149	O
were	O
diagnosed	O
to	O
be	O
asymptomatic	O
clinically	O
,	O
biochemically	O
and	O
echographically	O
.	O

Identification	O
of	O
mutations	O
in	O
the	O
coding	O
sequence	O
of	O
the	O
proto	B
-	I
oncogene	I
c	I
-	I
kit	I
in	O
a	O
human	O
mast	O
cell	O
leukemia	O
cell	O
line	O
causing	O
ligand	O
-	O
independent	O
activation	O
of	O
c	B
-	I
kit	I
product	I
.	O

BACKGROUND	O
:	O
Delineation	O
of	O
the	O
morphologic	O
aspects	O
of	O
age	O
-	O
related	O
macular	O
degeneration	O
(	O
ARMD	O
)	O
is	O
helpful	O
in	O
correlation	O
with	O
the	O
clinical	O
features	O
and	O
may	O
contribute	O
to	O
understanding	O
the	O
pathogenesis	O
.	O

Risk	O
factors	O
associated	O
with	O
a	O
high	O
seroprevalence	O
of	O
hepatitis	O
C	O
virus	O
infection	O
in	O
Egyptian	O
blood	O
donors	O
.	O

This	O
agent	O
,	O
isolated	O
from	O
the	O
fungus	O
Streptomyces	O
tsukubaensis	O
,	O
has	O
a	O
mechanism	O
of	O
action	O
similar	O
to	O
that	O
of	O
cyclosporine	O
.	O

Finally	O
,	O
the	O
stability	O
of	O
the	O
nucleotide	O
binding	O
function	O
of	O
the	O
two	O
proteins	O
is	O
similar	O
as	O
assessed	O
by	O
sensitivity	O
to	O
urea	O
.	O

By	O
contrast	O
,	O
all	O
proteins	O
initiated	O
with	O
a	O
methionine	O
placed	O
one	O
residue	O
upstream	O
of	O
the	O
natural	O
N	O
terminus	O
of	O
PR	B
failed	O
to	O
show	O
specific	O
proteolysis	O
.	O

However	O
,	O
there	O
were	O
some	O
properties	O
of	O
Rak	B
that	O
are	O
distinct	O
from	O
Src	B
-	I
like	I
kinases	I
:	O
(	O
a	O
)	O
expression	O
of	O
Rak	B
was	O
predominantly	O
in	O
epithelial	O
-	O
derived	O
cell	O
lines	O
and	O
tissues	O
,	O
especially	O
normal	O
liver	O
and	O
kidney	O
,	O
and	O
cell	O
lines	O
of	O
breast	O
and	O
colon	O
origin	O
;	O
(	O
b	O
)	O
Rak	B
does	O
not	O
harbor	O
the	O
NH2-terminal	O
glycine	O
essential	O
for	O
myristylation	O
and	O
membrane	O
localization	O
;	O
and	O
(	O
c	O
)	O
Rak	B
possesses	O
a	O
putative	O
bipartite	O
nuclear	O
localization	O
signal	O
in	O
the	O
SH2	B
domain	I
,	O
and	O
subcellular	O
fractionation	O
studies	O
revealed	O
that	O
p54rak	B
resides	O
predominantly	O
in	O
the	O
nucleus	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
We	O
report	O
our	O
experience	O
with	O
seven	O
children	O
with	O
active	O
small	O
bowel	O
Crohn	O
's	O
disease	O
given	O
a	O
casein	B
-	O
based	O
,	O
polymeric	O
feed	O
rich	O
in	O
TGF	B
-	I
beta	I
2	I
(	O
Specific	O
Polymeric	O
Diet	O
;	O
Nestle	O
-	O
Clintec	O
;	O
Vevey	O
,	O
Switzerland	O
)	O
as	O
complete	O
nutrition	O
for	O
8	O
weeks	O
.	O

The	O
leader	O
sequence	O
of	O
the	O
isolated	O
cDNA	O
clone	O
contains	O
several	O
small	O
open	O
reading	O
frames	O
upstream	O
of	O
the	O
initiation	O
codon	O
of	O
the	O
largest	O
open	O
reading	O
frame	O
coding	O
for	O
the	O
homeodomain	B
protein	I
.	O

A	O
small	O
amount	O
of	O
HSP81	B
-	I
1	I
mRNA	I
was	O
detected	O
only	O
in	O
roots	O
.	O

Cell	O
adhesion	O
and	O
migration	O
assays	O
demonstrate	O
that	O
alpha	B
6	I
beta	I
1	I
is	O
the	O
major	O
laminin	B
receptor	I
in	O
undifferentiated	O
F9	O
cells	O
as	O
well	O
as	O
F9-derived	O
PE	O
cells	O
.	O

Among	O
the	O
mixed	O
race	O
persons	O
one	O
Chukcha	O
-	O
Eskimo	O
had	O
AS	O
,	O
one	O
Eskimo	O
-	O
Russian	O
had	O
psoriatic	O
arthritis	O
(	O
PsA	O
)	O
.	O

Although	O
most	O
SH2-pTyr	B
interactions	O
occur	O
between	O
two	O
different	O
types	O
of	O
molecules	O
,	O
some	O
appear	O
to	O
involve	O
only	O
a	O
single	O
molecular	O
type	O
.	O

RESULTS	O
:	O
Closure	O
time	O
of	O
fistulas	O
in	O
patients	O
receiving	O
TPN	O
+	O
somatostatin	B
was	O
significantly	O
shorter	O
(	O
13.86	O
+	O
/-	O

1.84	O
versus	O
20.4	O
+	O
/-	O

2.89	O
days	O
)	O
than	O
in	O
those	O
receiving	O
TPN	O
alone	O
.	O

Experimental	O
adhesion	O
prophylaxis	O
with	O
recombinant	B
tissue	I
plasminogen	I
activator	I
.	O

To	O
determine	O
which	O
sequences	O
in	O
the	O
rat	B
P450c17	I
promoter	I
may	O
be	O
responsible	O
for	O
basal	O
and	O
cAMP	O
-	O
stimulated	O
gene	O
transcription	O
,	O
deletion	O
constructs	O
containing	O
between	O
-1,560	O
and	O
-53	O
base	O
pairs	O
of	O
5'-flanking	O
DNA	O
from	O
the	O
rat	B
P450c17	I
gene	I
were	O
ligated	O
to	O
plasmids	O
expressing	O
the	O
reporter	O
gene	O
luciferase	B
and	O
transfected	O
into	O
two	O
mouse	O
cell	O
lines	O
,	O
adrenal	O
Y-1	O
cells	O
,	O
and	O
testicular	O
Leydig	O
MA-10	O
cells	O
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
the	O
mouse	B
NMO1	I
cDNA	I
,	O
which	O
encodes	O
the	O
NAD	B
(	I
P	I
)	I
H	I
:	I
menadione	I
oxidoreductase	I
[	O
also	O
called	O
NAD	B
(	I
P	I
)	I
H:	I
(	I
quinone	I
acceptor	I
)	I
oxidoreductase	I
;	O
quinone	B
reductase	I
;	O
azo	B
dye	I
reductase	I
;	O
DT	B
diaphorase	I
;	O
EC	B
1.6.99.2	I
]	O
.	O

Escherichia	O
coli	O
JRG582	O
is	O
an	O
ampD	B
ampE	B
deletion	O
derivative	O
of	O
strain	O
HfrH	O
and	O
accordingly	O
it	O
is	O
derepressed	O
for	O
expression	O
of	O
the	O
cloned	O
inducible	O
beta	B
-	I
lactamase	I
gene	I
of	O
Citrobacter	O
freundii	O
,	O
carried	O
on	O
plasmid	O
pNU305	O
.	O

Male	O
contraception	O
:	O
ideas	O
for	O
the	O
future	O
.	O

While	O
daily	O
food	O
intake	O
was	O
almost	O
constant	O
regardless	O
of	O
the	O
dietary	O
protein	O
level	O
,	O
water	O
intake	O
and	O
urine	O
volume	O
increased	O
with	O
increasing	O
the	O
dietary	O
protein	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
vacuolar	B
H	I
(	I
+	I
)	I
-ATPase	I
B2	I
subunit	I
gene	I
in	O
differentiating	O
THP-1	O
cells	O
.	O

An	O
E	O
box	O
element	O
is	O
required	O
for	O
the	O
expression	O
of	O
the	O
ad4bp	B
gene	I
,	O
a	O
mammalian	B
homologue	I
of	I
ftz	I
-	I
f1	I
gene	I
,	O
which	O
is	O
essential	O
for	O
adrenal	O
and	O
gonadal	O
development	O
.	O

Mutations	O
in	O
the	O
VPS45	B
gene	I
,	O
a	O
SEC1	B
homologue	O
,	O
result	O
in	O
vacuolar	O
protein	O
sorting	O
defects	O
and	O
accumulation	O
of	O
membrane	O
vesicles	O
.	O

In	O
293	O
cells	O
,	O
expression	O
of	O
the	O
NF	B
-	I
kappa	I
B	I
inhibitor	O
,	O
I	B
kappa	I
B	I
-	I
alpha	I
,	O
reduced	O
the	O
stimulatory	O
activity	O
of	O
LMP	B
.	O

This	O
experimental	O
design	O
was	O
used	O
to	O
determine	O
the	O
effect	O
of	O
displacement	O
of	O
the	O
alpha	B
4	I
-	I
2	I
binding	I
site	I
on	O
the	O
repression	O
of	O
alpha	B
4	I
gene	I
transcription	O
by	O
ICP4	B
.	O

The	O
GRE	O
at	O
nucleotide	O
7640	O
is	O
a	O
composite	O
GRE	O
(	O
cGRE	O
)	O
containing	O
an	O
overlapping	O
activator	B
protein-1	I
(	O
AP-1	B
)	O
motif	O
for	O
the	O
c	B
-	I
jun	I
homodimer	I
and	O
c	B
-	I
jun	I
/	O
c	B
-	I
fos	I
heterodimer	O
.	O

Transcriptional	O
activation	O
by	O
thyroid	O
hormone	O
(	O
T3	O
)	O
requires	O
interactions	O
between	O
the	O
T3	B
receptor	I
(	O
TR	B
)	O
and	O
T3	O
response	O
elements	O
(	O
TREs	O
)	O
composed	O
of	O
two	O
copies	O
of	O
sequences	O
related	O
to	O
AGGTCA	O
.	O

A	O
multivariate	O
analysis	O
of	O
risk	O
factors	O
for	O
relapse	O
examined	O
age	O
,	O
WBC	O
at	O
diagnosis	O
,	O
blast	O
count	O
at	O
diagnosis	O
,	O
percentage	O
of	O
marrow	O
blasts	O
,	O
FAB	B
subtype	O
,	O
the	O
number	O
of	O
remission	O
induction	O
courses	O
to	O
achieve	O
a	O
remission	O
,	O
maintenance	O
therapy	O
,	O
consolidation	O
therapy	O
,	O
marrow	O
cell	O
dose	O
,	O
donor	O
-	O
recipient	O
sex	O
,	O
GVHD	O
prophylaxis	O
regimen	O
and	O
isolation	O
and	O
decontamination	O
in	O
laminar	O
airflow	O
rooms	O
.	O

We	O
show	O
that	O
these	O
three	O
gain	O
-	O
of	O
-	O
function	O
mutants	O
differ	O
considerably	O
in	O
their	O
ability	O
to	O
bypass	O
the	O
sex	O
determination	O
signal	O
,	O
with	O
SxlM4	B
being	O
the	O
strongest	O
and	O
SxlM1	B
the	O
weakest	O
.	O

We	O
show	O
that	O
these	O
three	O
gain	O
-	O
of	O
-	O
function	O
mutants	O
differ	O
considerably	O
in	O
their	O
ability	O
to	O
bypass	O
the	O
sex	O
determination	O
signal	O
,	O
with	O
SxlM4	B
being	O
the	O
strongest	O
and	O
SxlM1	B
the	O
weakest	O
.	O

No	O
significant	O
differences	O
were	O
identified	O
between	O
groups	O
for	O
pH	O
,	O
PaCO2	O
,	O
intracranial	O
pressure	O
,	O
heart	O
rate	O
,	O
brain	O
temperature	O
,	O
or	O
glucose	O
levels	O
.	O

Anesthesiologists	O
often	O
use	O
more	O
than	O
one	O
drug	O
in	O
a	O
patient	O
to	O
achieve	O
a	O
target	O
response	O
,	O
such	O
as	O
a	O
desired	O
blood	O
pressure	O
.	O

We	O
suggest	O
that	O
this	O
gene	O
cluster	O
codes	O
for	O
(	O
parts	O
of	O
)	O
a	O
multisubunit	B
cytochrome	I
c	I
haem	I
lyase	I
.	O

Standard	O
reference	O
sources	O
indicate	O
that	O
an	O
able	O
-	O
bodied	O
11-year	O
-	O
old	O
child	O
of	O
comparable	O
height	O
requires	O
1,493	O
kcal	O
/	O
d	O
for	O
support	O
of	O
basal	O
metabolic	O
functions	O
.	O

Weak	O
allergenicity	O
of	O
recombinant	B
hirudin	I
CGP	I
39393	I
(	O
REVASC	O
)	O
in	O
immunocompetent	O
volunteers	O
.	O

However	O
,	O
a	O
clear	O
difference	O
exists	O
between	O
myoblasts	O
and	O
10T1	O
/	O
2	O
cells	O
(	O
and	O
other	O
non	O
-	O
muscle	O
cell	O
types	O
)	O
in	O
the	O
chromatin	O
structure	O
of	O
the	O
chromosomal	O
myoD	B
core	I
enhancer	I
,	O
suggesting	O
that	O
the	O
myoD	B
enhancer	I
is	O
repressed	O
by	O
epigenetic	O
mechanisms	O
in	O
10T1	O
/	O
2	O
cells	O
.	O

Using	O
Ki	B
-	I
ras	I
-	O
transformed	O
3T3	O
cells	O
as	O
a	O
model	O
system	O
,	O
we	O
show	O
that	O
both	O
RA	O
and	O
the	O
'	O
dissociating	O
'	O
retinoids	O
inhibit	O
anchorage	O
-	O
independent	O
cell	O
proliferation	O
,	O
suggesting	O
that	O
retinoid	O
-	O
induced	O
growth	O
inhibition	O
may	O
be	O
related	O
to	O
AP1	B
transrepression	O
.	O

The	O
Oct	B
and	O
HMG2	B
proteins	I
also	O
interact	O
in	O
vivo	O
.	O

Atopic	O
dermatitis	O
is	O
an	O
""""	O
itch	O
which	O
rashes	O
and	O
not	O
a	O
rash	O
which	O
itches	O
""""	O
and	O
therefore	O
,	O
any	O
patient	O
treatment	O
program	O
should	O
address	O
the	O
multiplicity	O
of	O
potential	O
trigger	O
factors	O
that	O
provoke	O
this	O
itching	O
.	O

The	O
beta	O
subunit	O
of	O
the	O
Fc	B
epsilon	I
R1	I
is	O
a	O
33-kDa	O
tyrosine	O
phosphoprotein	O
,	O
but	O
the	O
p33	B
Grb2-binding	B
protein	I
described	O
in	O
the	O
present	O
report	O
is	O
not	O
the	O
Fc	B
epsilon	I
R1	I
beta	I
chain	I
and	O
its	O
identity	O
is	O
unknown	O
.	O

To	O
study	O
the	O
mechanisms	O
as	O
well	O
as	O
magnitude	O
of	O
the	O
transmembrane	O
transfer	O
of	O
bacterial	O
products	O
from	O
the	O
dialysate	O
,	O
we	O
developed	O
a	O
computerized	O
in	O
vitro	O
dialysis	O
model	O
which	O
provides	O
continuous	O
pressure	O
recording	O
from	O
the	O
arterial	O
,	O
venous	O
,	O
dialysate	O
inflow	O
and	O
outflow	O
ports	O
.	O

After	O
24	O
hour	O
incubation	O
,	O
total	O
cell	O
-	O
associated	O
IL-1Ra	B
and	O
IL-1	B
beta	I
were	O
measured	O
by	O
specific	O
radioimmunoassay	O
.	O

Each	O
dietary	O
treatment	O
was	O
fed	O
to	O
six	O
pen	O
replicates	O
of	O
five	O
chicks	O
per	O
pen	O
for	O
21	O
d.	O

In	O
contrast	O
,	O
recent	O
evidence	O
suggests	O
that	O
children	O
with	O
sickle	B
-	I
hemoglobin	I
C	I
disease	O
do	O
not	O
develop	O
functional	O
asplenia	O
before	O
3	O
to	O
4	O
years	O
of	O
age	O
and	O
thus	O
may	O
not	O
benefit	O
from	O
penicillin	O
prophylaxis	O
.	O

Deletion	O
analysis	O
indicates	O
that	O
TBP	B
and	O
hTAFII18	B
bind	O
to	O
distinct	O
domains	O
of	O
hTAFII28	B
.	O

hTAFII18	B
also	O
interacts	O
with	O
TBP	B
,	O
but	O
it	O
interacts	O
more	O
strongly	O
with	O
hTAFII28	B
and	O
hTAFII30	B
.	O

The	O
NarX	B
and	O
NarQ	B
proteins	I
with	O
amino	O
acid	O
substitutions	O
at	O
the	O
first	O
conserved	O
histidine	O
position	O
were	O
also	O
unable	O
to	O
dephosphorylate	O
NarL	B
-	O
phosphate	O
in	O
vitro	O
.	O

Because	O
ATF-1	B
and	O
CREM	B
are	O
known	O
to	O
bind	O
to	O
cAMP	O
response	O
elements	O
(	O
CRE	O
)	O
,	O
this	O
functional	O
sequence	O
was	O
named	O
the	O
kappa	B
E3'-CRE	I
.	O

The	O
TTG-2	B
gene	I
has	O
been	O
identified	O
at	O
the	O
site	O
of	O
chromosomal	O
translocations	O
in	O
acute	O
T	O
-	O
cell	O
leukemia	O
's	O
(	O
T	O
-	O
ALL	O
)	O
.	O

In	O
vitro	O
studies	O
with	O
blood	O
cells	O
incubated	O
with	O
acetate	O
or	O
bicarbonate	O
ions	O
in	O
concentrations	O
,	O
which	O
are	O
observed	O
in	O
vivo	O
during	O
hemodialysis	O
,	O
suggest	O
that	O
probably	O
these	O
ions	O
do	O
not	O
directly	O
affect	O
superoxide	O
anions	O
generation	O
,	O
erythrocyte	O
SOD-1	B
and	O
catalase	B
activities	O
and	O
erythrocyte	O
membrane	O
lipid	O
peroxidation	O
.	O

Short	O
therapy	O
with	O
omeprazole	O
20	O
mg	O
/	O
b.i.d	O
.	O
,	O
clarithromycin	O
500	O
mg	O
/	O
b.i.d	O
.	O
,	O
and	O
CBS	O
120	O
mg	O
/	O
q.i.d	O
.	O

is	O
a	O
safe	O
,	O
well	O
tolerated	O
combination	O
that	O
achieves	O
a	O
80.6	O
%	O
eradication	O
rate	O
of	O
H.	O
pylori	O
and	O
duodenal	O
ulcer	O
healing	O
rates	O
as	O
good	O
as	O
those	O
achieved	O
by	O
omeprazole	O
20	O
mg	O
/	O
d	O
when	O
given	O
for	O
4	O
wk	O
.	O

CONCLUSIONS	O
:	O
A	O
comparison	O
of	O
the	O
LysU	B
crystal	O
structure	O
with	O
the	O
structures	O
of	O
seryl-	B
and	I
aspartyl	I
-	I
tRNA	I
synthetases	I
enables	O
a	O
conserved	O
core	O
to	O
be	O
identified	O
.	O

Whole	O
bowel	O
irrigation	O
is	O
a	O
recently	O
described	O
technique	O
to	O
enhance	O
the	O
passage	O
of	O
drugs	O
already	O
beyond	O
the	O
pylorus	O
.	O

As	O
in	O
Tb	O
,	O
U6	B
is	O
a	O
single	O
-	O
copy	O
gene	O
and	O
two	O
tRNA	O
genes	O
,	O
tRNAGln	B
and	O
tRNAIle	B
,	O
are	O
found	O
upstream	O
to	O
the	O
gene	O
.	O

Hematopoietic	B
growth	I
factors	I
have	O
already	O
had	O
an	O
enormous	O
impact	O
on	O
transfusion	O
practice	O
by	O
eliminating	O
or	O
reducing	O
the	O
need	O
for	O
red	O
blood	O
cell	O
transfusions	O
in	O
a	O
variety	O
of	O
anemic	O
states	O
characterized	O
by	O
an	O
absolute	O
or	O
relative	O
decrease	O
in	O
erythropoietin	B
.	O

During	O
IC	O
breaths	O
and	O
following	O
EC	O
and	O
VC	O
breaths	O
at	O
rest	O
,	O
end	O
-	O
tidal	O
CO2	O
pressure	O
(	O
PET	O
,	O
CO2	O
)	O
fell	O
by	O
7.5	O
,	O
8.5	O
and	O
9.5	O
mmHg	O
,	O
respectively	O
.	O

2	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
the	O
SGC1	B
gene	I
product	I
includes	O
a	O
region	O
with	O
substantial	O
similarity	O
to	O
the	O
basic	O
-	O
helix	O
-	O
loop	O
-	O
helix	O
domain	O
of	O
the	O
Myc	B
family	I
of	O
DNA	O
-	O
binding	O
proteins	O
.	O

By	O
creating	O
Pax-6-BSAP	B
fusion	O
proteins	O
,	O
we	O
were	O
able	O
to	O
identify	O
a	O
short	O
amino	O
acid	O
stretch	O
in	O
the	O
N	O
-	O
terminal	O
part	O
of	O
the	O
paired	B
domain	O
which	O
is	O
responsible	O
for	O
these	O
differences	O
in	O
DNA	O
-	O
binding	O
specificity	O
.	O

To	O
establish	O
a	O
possible	O
association	O
between	O
familial	O
dysfibrinogenemia	O
and	O
thrombophilia	O
,	O
data	O
on	O
cases	O
with	O
both	O
affections	O
were	O
collected	O
in	O
a	O
study	O
within	O
the	O
framework	O
of	O
the	O
SSC	O
Subcommittee	O
on	O
Fibrinogen	B
of	O
the	O
International	O
Society	O
on	O
Thrombosis	O
and	O
Haemostasis	O
.	O

Conjugated	O
estrogens	O
shorten	O
bleeding	O
time	O
in	O
uraemia	O
:	O
a	O
possible	O
role	O
of	O
serotonin	O
?	O

Two	O
mammalian	O
enzymes	O
,	O
the	O
haem	B
-	I
controlled	I
repressor	I
(	O
HCR	B
)	O
and	O
the	O
double	B
-	I
stranded	I
RNA	I
-	I
activated	I
inhibitor	I
(	O
dsI	B
)	O
,	O
phosphorylate	O
Ser-51	O
of	O
the	O
alpha	O
subunit	O
,	O
thereby	O
inhibiting	O
the	O
exchange	O
of	O
bound	O
nucleotides	O
on	O
,	O
and	O
thus	O
the	O
recycling	O
of	O
,	O
eIF-2	B
.	O

A	O
triple	O
Ser-->Ala	O
mutant	O
form	O
of	O
yeast	O
eIF-2	B
alpha	I
was	O
found	O
to	O
be	O
no	O
longer	O
phosphorylated	O
by	O
either	O
of	O
the	O
yeast	O
(	O
or	O
mammalian	O
)	O
casein	B
kinase	I
activities	O
in	O
vitro	O
.	O

The	O
cases	O
included	O
35	O
de	O
novo	O
diffuse	O
aggressive	O
lymphomas	O
(	O
DAL	O
;	O
19	O
large	O
-	O
cell	O
,	O
4	O
mixed	O
-	O
cell	O
,	O
and	O
12	O
large	O
-	O
cell	O
immunoblastic	O
)	O
,	O
52	O
transformed	O
aggressive	O
lymphomas	O
derived	O
from	O
follicular	O
lymphomas	O
(	O
TFL	O
)	O
,	O
42	O
indolent	O
follicular	O
lymphomas	O
(	O
FL	O
)	O
,	O
14	O
mantle	O
cell	O
lymphomas	O
(	O
MCL	O
)	O
,	O
and	O
27	O
small	O
noncleaved	O
cell	O
lymphomas	O
(	O
SNCL	O
)	O
.	O

Female	O
patients	O
with	O
breast	O
cancer	O
diagnosed	O
between	O
1982	O
and	O
1991	O
at	O
Roswell	O
Park	O
Cancer	O
Institute	O
(	O
RPCI	O
)	O
in	O
Buffalo	O
,	O
New	O
York	O
,	O
who	O
provided	O
information	O
on	O
their	O
cigarette	O
smoking	O
history	O
at	O
the	O
time	O
of	O
their	O
diagnosis	O
were	O
included	O
.	O

Data	O
from	O
the	O
V	O
-	O
HeFT	O
II	O
show	O
that	O
at	O
2-year	O
follow	O
-	O
up	O
,	O
a	O
progressive	O
rise	O
of	O
plasma	O
norepinephrine	O
was	O
observed	O
in	O
both	O
treatment	O
arms	O
,	O
suggesting	O
that	O
disease	O
progresses	O
despite	O
treatment	O
with	O
either	O
an	O
angiotensin	B
-	I
converting	I
enzyme	I
inhibitor	O
,	O
enalapril	O
,	O
or	O
vasodilator	O
therapy	O
with	O
hydralazine	O
/	O
isosorbide	O
dinitrate	O
.	O

Transcript	O
analysis	O
reveals	O
that	O
lethal	O
B	B
block	I
substitutions	O
reduce	O
U6	B
RNA	I
synthesis	O
at	O
least	O
10-fold	O
in	O
vivo	O
and	O
20-fold	O
in	O
vitro	O
.	O

Analysis	O
of	O
Bcl-2	B
/	O
Bcl-2	B
homodimerization	O
using	O
both	O
in	O
vitro	O
binding	O
assays	O
as	O
well	O
as	O
a	O
yeast	O
two	O
-	O
hybrid	O
method	O
provided	O
evidence	O
in	O
support	O
of	O
a	O
head	O
-	O
to	O
-	O
tail	O
model	O
for	O
Bcl-2	B
/	O
Bcl-2	B
homodimerization	O
and	O
revealed	O
that	O
sequences	O
within	O
the	O
NH2-terminal	O
A	O
domain	O
interact	O
with	O
a	O
structure	O
that	O
requires	O
the	O
presence	O
of	O
both	O
the	O
carboxyl	O
B	O
and	O
C	O
domains	O
in	O
combination	O
.	O

The	O
protein	O
is	O
composed	O
of	O
a	O
central	O
alpha	O
-	O
helical	O
portion	O
with	O
globular	O
domains	O
at	O
both	O
NH2	O
and	O
COOH	O
termini	O
,	O
and	O
the	O
epitope	O
to	O
the	O
monoclonal	O
antibody	O
resides	O
in	O
the	O
central	O
alpha	O
-	O
helical	O
stalk	O
.	O

Radioligand	O
binding	O
was	O
indistinguishable	O
for	O
both	O
transiently	O
expressed	O
constructs	O
.	O

Diagnosis	O
of	O
FHCS	O
has	O
been	O
weighed	O
upon	O
laparoscopic	O
findings	O
.	O

Human	B
papillomavirus	I
type	I
31b	I
late	I
gene	I
expression	O
is	O
regulated	O
through	O
protein	B
kinase	I
C	I
-	O
mediated	O
changes	O
in	O
RNA	O
processing	O
.	O

Studies	O
using	O
an	O
inhibitor	O
or	O
a	O
mutant	B
Lb	I
proteinase	I
indicated	O
that	O
stimulation	O
of	O
IRES	O
-	O
driven	O
translation	O
is	O
mediated	O
via	O
proteolysis	O
of	O
some	O
cellular	O
component	O
(	O
s	O
)	O
.	O

As	O
it	O
had	O
been	O
previously	O
reported	O
that	O
the	O
18-bp	O
palindrome	O
contains	O
sufficient	O
nucleotide	O
sequence	O
information	O
for	O
E1	B
binding	O
,	O
we	O
speculate	O
that	O
a	O
minimal	O
E1	B
recognition	O
motif	O
is	O
presented	O
in	O
each	O
half	O
site	O
.	O

In	O
the	O
commercially	O
available	O
intravenous	O
formulation	O
of	O
Cyclosporin	O
A	O
(	O
Sandimmun	O
)	O
,	O
polyoxyethylated	O
castor	O
oil	O
(	O
Cremophor	O
EL	O
)	O
is	O
used	O
as	O
a	O
solubilizing	O
agent	O
.	O

Lung	O
function	O
tests	O
(	O
EFR	O
)	O
were	O
performed	O
on	O
these	O
patients	O
for	O
a	O
period	O
of	O
19.2	O
+	O
/-	O

3.4	O
months	O
.	O

The	O
mean	O
marginal	O
discrepancy	O
of	O
provisional	O
restorations	O
was	O
compared	O
for	O
restorations	O
fabricated	O
from	O
stone	O
,	O
low	O
-	O
viscosity	O
poly	O
(	O
vinyl	O
siloxane	O
)	O
,	O
and	O
medium	O
-	O
viscosity	O
poly	O
(	O
vinyl	O
siloxane	O
)	O
.	O

In	O
addition	O
,	O
two	O
internal	O
promoters	O
,	O
PmiaA	B
and	O
P1hfq	B
were	O
identified	O
and	O
mapped	O
to	O
201	O
and	O
837	O
nucleotides	O
upstream	O
from	O
the	O
respective	O
translation	O
start	O
sites	O
.	O

These	O
results	O
indicate	O
that	O
mutL	B
,	O
miaA	B
,	O
and	O
hfq	B
expression	O
could	O
be	O
regulated	O
by	O
multiple	O
mechanisms	O
,	O
including	O
degree	O
of	O
cotranscription	O
from	O
upstream	O
genes	O
,	O
modulation	O
of	O
internal	O
promoter	O
strength	O
,	O
and	O
by	O
RNase	B
E	I
activity	O
.	O

Coronary	O
T1	O
and	O
T2	O
weighted	O
images	O
were	O
obtained	O
.	O

Functional	O
analysis	O
of	O
the	O
sGTH	B
alpha	I
subunit	I
promoter	I
by	O
the	O
transient	O
transfection	O
of	O
several	O
sGTH	B
alpha	I
/	O
CAT	B
chimeric	O
plasmids	O
into	O
rainbow	O
trout	O
pituitary	O
cells	O
suggests	O
that	O
its	O
pituitary	O
-	O
specific	O
expression	O
is	O
GSE	B
-	O
dependent	O
.	O

Indium-111	O
OncoScint	O
CR	O
/	O
OV	O
and	O
F-18	O
FDG	O
in	O
colorectal	O
and	O
ovarian	O
carcinoma	O
recurrences	O
.	O

The	O
Myc	B
LZ	I
was	O
found	O
to	O
prevent	O
homodimeric	O
interactions	O
,	O
thus	O
explaining	O
Myc	B
inability	O
to	O
homodimerize	O
efficiently	O
.	O

Staphylococcus	O
aureus	O
and	O
CNS	O
showed	O
high	O
or	O
moderate	O
resistance	O
rates	O
to	O
methicillin	O
(	O
DMPPC	O
)	O
.	O

The	O
gene	O
pairs	O
psbB	B
-	O
psbT	B
and	O
psbH	B
-	O
psbN	B
are	O
cotranscribed	O
from	O
opposite	O
strands	O
.	O

Hybridization	O
signals	O
were	O
also	O
detected	O
with	O
total	O
DNAs	O
of	O
Rhizobium	O
leguminosarum	O
bv	O
.	O

phaseoli	O
,	O
Rhodobacter	O
capsulatus	O
and	O
Escherichia	O
coli	O
,	O
but	O
not	O
those	O
of	O
Xanthomonas	O
campestris	O
pv	O
.	O

campestris	O
and	O
Pseudomonas	O
putida	O
.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
contains	O
regions	O
identical	O
to	O
the	O
sequences	O
of	O
peptides	O
derived	O
from	O
bovine	B
liver	I
eIF-2B	I
alpha	I
subunit	I
.	O

When	O
RNA	O
encoding	O
the	O
tail	O
domain	O
of	O
desmoglein	B
was	O
coinjected	O
with	O
plakoglobin	B
RNA	I
,	O
both	O
the	O
dorsalizing	O
effect	O
and	O
nuclear	O
accumulation	O
of	O
plakoglobin	B
were	O
suppressed	O
.	O

Six	O
of	O
them	O
,	O
NUC1	B
,	O
PRP21	B
(	O
also	O
called	O
SPP91	B
)	O
,	O
CDC6	B
,	O
CRY2	B
,	O
the	O
gene	O
encoding	O
the	O
ribosomal	B
protein	I
S24	I
and	O
the	O
gene	O
coding	O
for	O
a	O
hypothetical	O
protein	O
of	O
599	O
amino	O
acids	O
,	O
have	O
been	O
sequenced	O
previously	O
.	O

Intrastriatal	O
grafts	O
of	O
nigral	O
and	O
adrenal	O
tissues	O
have	O
been	O
found	O
to	O
be	O
effective	O
in	O
alleviating	O
many	O
of	O
the	O
simple	O
motor	O
and	O
sensorimotor	O
deficits	O
associated	O
with	O
lesions	O
of	O
the	O
nigrostriatal	O
dopamine	O
system	O
.	O

Thereafter	O
,	O
the	O
aggregation	O
rose	O
to	O
the	O
initial	O
100	O
%	O
value	O
4	O
h	O
after	O
drug	O
application	O
and	O
remained	O
at	O
this	O
level	O
during	O
the	O
observation	O
period.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

The	O
emerging	O
complexity	O
of	O
the	O
5	O
'	O
regulatory	O
region	O
of	O
the	O
GH	B
receptor	I
gene	I
was	O
emphasised	O
by	O
the	O
observation	O
that	O
probes	O
derived	O
from	O
exon	O
1B	O
and	O
the	O
distal	O
3	O
'	O
intron	O
boundary	O
do	O
not	O
hybridise	O
with	O
previously	O
cloned	O
genomic	O
sequences	O
that	O
span	O
the	O
liver	O
-	O
specific	O
P1	O
promoter	O
and	O
exon	O
2	O
.	O

A	O
polymorphic	O
dinucleotide	O
(	O
GT	O
/	O
CA	O
)	O
n	O
repeat	O
contained	O
in	O
the	O
NHE5	O
cosmid	O
was	O
identified	O
and	O
developed	O
into	O
a	O
microsatellite	O
PCR	O
marker	O
.	O

The	O
proteins	O
are	O
more	O
than	O
90	O
%	O
identical	O
to	O
each	O
other	O
within	O
the	O
protein	O
kinase	O
domain	O
but	O
only	O
51	O
-	O
59	O
%	O
identical	O
to	O
other	O
casein	B
kinase	I
I	I
isoforms	I
within	O
this	O
region	O
.	O

UAS1	O
is	O
the	O
binding	O
site	O
for	O
the	O
transcriptional	O
regulator	O
Adr1p	B
.	O

In	O
the	O
context	O
of	O
the	O
ADH2	B
upstream	I
regulatory	I
region	I
,	O
including	O
UAS1	O
,	O
working	O
in	O
concert	O
with	O
the	O
ADH2	B
basal	I
promoter	I
elements	I
,	O
UAS2-dependent	O
gene	O
activation	O
was	O
dependent	O
on	O
orientation	O
,	O
copy	O
number	O
,	O
and	O
helix	O
phase	O
.	O

Induction	O
in	O
AP-1	B
DNA	O
binding	O
correlates	O
with	O
a	O
concomitant	O
GH	B
trans	O
-	O
activation	O
of	O
c	B
-	I
jun	I
and	O
c	B
-	I
fos	I
genes	I
described	O
previously	O
.	O

Short	O
-	O
course	O
amphotericin	O
B	O
therapy	O
for	O
candidemia	O
in	O
pediatric	O
patients	O
.	O

Since	O
AP-1	B
is	O
an	O
important	O
mediator	O
of	O
tumor	O
promoter	O
action	O
,	O
these	O
findings	O
may	O
explain	O
the	O
anti	O
-	O
tumor	O
-	O
promoting	O
activity	O
of	O
phenolic	O
antioxidants	O
.	O

The	O
second	O
complex	O
,	O
when	O
purified	O
,	O
contained	O
four	O
protein	O
components	O
including	O
the	O
36-kDa	O
protein	O
.	O

The	O
protein	O
expressed	O
from	O
the	O
cloned	O
cDNA	O
is	O
secreted	O
into	O
the	O
culture	O
medium	O
and	O
yields	O
of	O
up	O
to	O
40	O
mg	O
per	O
litre	O
have	O
been	O
obtained	O
.	O

The	O
study	O
was	O
repeated	O
after	O
administration	O
of	O
oral	O
amiodarone	O
,	O
50	O
mg	O
/	O
kg	O
/	O
day	O
for	O
2	O
days	O
in	O
8	O
divided	O
doses	O
(	O
mean	O
dose	O
6.9	O
+	O
/-	O

0.4	O
g	O
)	O
.	O

Plasmids	O
pAMS12	O
,	O
pAMS13	O
and	O
pAMS14	O
were	O
transformed	O
into	O
a	O
laboratory	O
strain	O
of	O
Saccharomyces	O
cerevisiae	O
,	O
whereas	O
pAMS15	O
was	O
stably	O
introduced	O
into	O
two	O
commercial	O
wine	O
yeast	O
strains	O
.	O

Repair	O
of	O
this	O
insertion	O
by	O
homologous	O
recombination	O
restores	O
the	O
activity	O
of	O
the	O
hprt	B
locus	I
,	O
thus	O
confirming	O
the	O
site	O
of	O
mutation	O
.	O

The	O
timing	O
of	O
fla	B
gene	I
expression	O
in	O
the	O
cell	O
cycle	O
is	O
determined	O
by	O
specialized	O
forms	O
of	O
RNA	B
polymerase	I
and	O
the	O
appearance	O
and/or	O
activation	O
of	O
regulatory	O
proteins	O
.	O

Polypeptides	O
of	O
the	O
same	O
apparent	O
sizes	O
are	O
detected	O
in	O
spores	O
of	O
a	O
cotE	B
null	O
mutant	O
,	O
on	O
which	O
basis	O
we	O
infer	O
that	O
the	O
products	O
of	O
the	O
cotJ	B
operon	I
are	O
required	O
for	O
the	O
normal	O
formation	O
of	O
the	O
inner	O
layers	O
of	O
the	O
coat	O
or	O
are	O
themselves	O
structural	O
components	O
of	O
the	O
coat	O
.	O

EEA1	B
is	O
a	O
conserved	O
alpha	O
-	O
helical	O
peripheral	O
membrane	O
protein	O
flanked	O
by	O
cysteine	O
""""	O
fingers	O
""""	O
and	O
contains	O
a	O
calmodulin	B
-	I
binding	I
IQ	I
motif	I
.	O

Sensing	O
with	O
chemically	O
and	O
biologically	O
modified	O
carbon	O
electrodes	O
.	O

Elevation	O
of	O
the	O
tissues	O
of	O
the	O
face	O
is	O
essentially	O
vertical	O
and	O
acts	O
on	O
the	O
forehead	O
,	O
temporal	O
region	O
,	O
gaze	O
and	O
cheekbones	O
.	O

This	O
region	O
binds	O
two	O
ubiquitous	O
nuclear	O
factors	O
,	O
USF	B
/	O
MLTF	B
and	O
the	O
CAAT	B
-	I
binding	I
transcription	I
factor	I
/	O
nuclear	B
factor	I
1	I
(	O
CTF	B
/	O
NF1	B
)	O
.	O

The	O
potential	O
impact	O
of	O
using	O
a	O
rapid	O
diagnostic	O
test	O
(	O
Strep	O
A	O
OIA	O
)	O
on	O
detection	O
and	O
treatment	O
of	O
group	O
A	O
beta	O
-	O
hemolytic	O
streptococcal	O
(	O
GABHS	O
)	O
pharyngitis	O
in	O
a	O
large	O
-	O
volume	O
pediatric	O
and	O
adolescent	O
clinic	O
was	O
examined	O
.	O

YAC	O
and	O
cosmid	O
contigs	O
spanning	O
the	O
BRCA1	B
region	I
were	O
used	O
to	O
select	O
cDNA	O
clones	O
from	O
pools	O
of	O
cDNAs	O
derived	O
from	O
human	O
placenta	O
,	O
HeLa	O
cells	O
,	O
activated	O
T	O
cells	O
,	O
and	O
fetal	O
head	O
.	O

This	O
study	O
assesses	O
the	O
feasibility	O
and	O
toxicity	O
of	O
adoptive	O
immunotherapy	O
with	O
tumor	O
infiltrating	O
lymphocytes	O
and	O
recombinant	B
interleukin-2	I
in	O
29	O
patients	O
who	O
underwent	O
resection	O
for	O
stage	O
III	O
non	O
-	O
small	O
-	O
cell	O
lung	O
cancer	O
.	O

MATERIAL	O
AND	O
METHODS	O
:	O
Of	O
the	O
17	O
men	O
and	O
17	O
women	O
,	O
who	O
were	O
21	O
to	O
80	O
years	O
of	O
age	O
,	O
27	O
had	O
hereditary	O
motor	O
and	O
sensory	O
neuropathy	O
type	O
I	O
and	O
7	O
had	O
acquired	O
demyelinating	O
polyneuropathy	O
.	O

DNA	O
sequencing	O
and	O
Southern	O
blot	O
analyses	O
established	O
that	O
the	O
cDNA	O
clones	O
are	O
derived	O
from	O
two	O
different	O
genes	O
.	O

Muscle	B
GSH	I
-	I
Px	I
activity	O
after	O
prolonged	O
exercise	O
,	O
training	O
,	O
and	O
selenium	O
supplementation	O
.	O

Mutation	O
of	O
the	O
Sp1	B
element	I
,	O
which	O
abolishes	O
Sp1	B
binding	O
,	O
results	O
in	O
a	O
6	O
-	O
10-fold	O
reduction	O
in	O
reporter	O
activity	O
.	O

Schooling	O
is	O
found	O
to	O
be	O
related	O
to	O
good	O
health	O
even	O
after	O
controlling	O
for	O
differences	O
in	O
observable	O
health	O
inputs	O
.	O

With	O
this	O
bisected	O
diastolic	O
driving	O
,	O
the	O
abnormal	O
echo	O
disappeared	O
completely	O
.	O

It	O
acts	O
on	O
Cdks	B
in	O
the	O
G1	O
and	O
S	O
phases	O
of	O
the	O
cell	O
cycle	O
,	O
and	O
also	O
binds	O
to	O
proliferating	B
cell	I
nuclear	I
antigen	I
(	O
PCNA	B
)	O
,	O
blocking	O
DNA	O
replication	O
in	O
vitro	O
.	O

Two	O
major	O
and	O
one	O
minor	O
transcription	O
initiation	O
sites	O
were	O
assigned	O
to	O
positions	O
+	O
1	O
and	O
+	O
24	O
and	O
position	O
+	O
14	O
,	O
respectively	O
,	O
by	O
a	O
combination	O
of	O
ribonuclease	O
protection	O
,	O
primer	O
extension	O
,	O
and	O
5	O
'	O
RACE	O
analyses	O
.	O

The	O
roxithromycin	O
doses	O
that	O
were	O
chosen	O
for	O
these	O
studies	O
were	O
less	O
than	O
achievable	O
blood	O
levels	O
.	O

Further	O
,	O
the	O
ORFs	O
of	O
components	O
3	O
and	O
5	O
potentially	O
encoded	O
proteins	O
of	O
about	O
20	O
kDa	O
,	O
the	O
size	O
of	O
the	O
BBTV	B
coat	I
protein	I
.	O

Serial	O
followup	O
strength	O
data	O
for	O
2	O
patients	O
were	O
compared	O
to	O
change	O
in	O
creatinine	B
kinase	I
(	O
CK	B
)	O
levels	O
.	O

An	O
explanation	O
explored	O
for	O
this	O
lack	O
of	O
gene	O
expression	O
was	O
that	O
increased	O
levels	O
of	O
RAR	B
alpha	I
or	O
PML	B
might	O
suppress	O
APL	O
cell	O
growth	O
.	O

Transfection	O
of	O
non	O
-	O
deleted	O
expression	O
vector	O
into	O
NIH3T3	O
cells	O
results	O
in	O
acquisition	O
of	O
focus	O
-	O
forming	O
activity	O
while	O
a	O
deleted	O
form	O
of	O
expression	O
vector	O
fails	O
to	O
show	O
this	O
activity	O
even	O
in	O
the	O
presence	O
of	O
basic	B
FGF	I
.	O

Cytosolic	O
extracts	O
from	O
a	O
variety	O
of	O
mammalian	O
cell	O
lines	O
(	O
monkey	O
Cos7	O
,	O
several	O
mouse	O
fibrosarcomas	O
and	O
human	O
HeLa	O
S3	O
)	O
demonstrated	O
similar	O
TGF	B
-	I
beta	I
1	I
dependent	O
RNA	O
-	O
protein	O
band	O
shifts	O
as	O
cell	O
extract	O
from	O
BALB	O
/	O
c	O
3T3	O
mouse	O
fibroblasts	O
.	O

CONCLUSION	O
:	O
The	O
MTD	O
for	O
CPT-11	O
administered	O
in	O
a	O
3	O
consecutive	O
-	O
days	O
-	O
every-3	O
weeks	O
schedule	O
in	O
this	O
patient	O
population	O
is	O
115	O
mg	O
/	O
m2	O
/	O
day	O
.	O

A	O
73	O
bp	O
fragment	O
(	O
X1	O
region	O
)	O
of	O
the	O
PRB-1b	B
promoter	I
,	O
located	O
between	O
positions	O
-213	O
and	O
-141	O
,	O
was	O
sufficient	O
to	O
confer	O
ethylene	O
responsiveness	O
to	O
the	O
reporter	O
gene	O
.	O

Although	O
the	O
extracellular	O
domain	O
of	O
the	O
TSH	B
-	I
R	I
is	O
sufficient	O
for	O
high	O
affinity	O
binding	O
of	O
TSH	B
,	O
we	O
conclude	O
that	O
the	O
hyt	O
mutation	O
in	O
the	O
fourth	O
transmembrane	O
domain	O
eliminates	O
TSH	B
binding	O
.	O

The	O
absence	O
of	O
other	O
regions	O
of	O
hybridization	O
suggests	O
that	O
there	O
are	O
no	O
closely	O
related	O
sequences	O
(	O
e.g.	O
,	O
reverse	O
transcribed	O
pseudogenes	O
)	O
scattered	O
throughout	O
the	O
genome	O
and	O
that	O
if	O
there	O
are	O
closely	O
related	O
genes	O
,	O
they	O
must	O
be	O
clustered	O
near	O
GSTT2	B
.	O

However	O
,	O
the	O
lens	O
dose	O
(	O
3.6	O
Gy	O
/	O
25	O
fractions	O
)	O
was	O
higher	O
compared	O
to	O
the	O
other	O
techniques	O
.	O

Antibodies	O
to	O
the	O
human	B
PTS1R	I
recognize	O
this	O
protein	O
in	O
human	O
,	O
monkey	O
,	O
rat	O
,	O
and	O
hamster	O
cells	O
.	O

We	O
report	O
here	O
that	O
in	O
cultured	O
Jurkat	O
T	O
cells	O
,	O
Cbl	B
is	O
coprecipitated	O
with	O
antibody	O
against	O
the	O
adapter	B
protein	I
Grb2	I
.	O

Otte	O
,	O
Mol	O
.	O

Scalp	O
flaps	O
can	O
be	O
expanded	O
just	O
to	O
the	O
point	O
of	O
becoming	O
noticeable	O
over	O
4	O
to	O
6	O
weeks	O
followed	O
by	O
scalp	O
flap	O
transposition	O
and	O
easy	O
closure	O
of	O
the	O
donor	O
site	O
.	O

In	O
the	O
Center	O
for	O
Human	O
Genetics	O
in	O
Leuven	O
,	O
predictive	O
DNA	O
-	O
testing	O
for	O
Huntington	O
's	O
disease	O
is	O
available	O
as	O
a	O
clinical	O
service	O
since	O
November	O
1987	O
,	O
initially	O
by	O
DNA	O
-	O
linkage	O
and	O
since	O
mid	O
1993	O
by	O
direct	O
mutation	O
analysis	O
.	O

Risks	O
of	O
chronicity	O
following	O
acute	O
hepatitis	O
B	O
virus	O
infection	O
:	O
a	O
review	O
.	O

Examination	O
of	O
neurohumoral	O
factors	O
revealed	O
a	O
hyperactive	O
sympathetic	O
nervous	O
system	O
and	O
an	O
increase	O
in	O
plasma	O
renin	B
activity	O
.	O

The	O
amino	O
-	O
terminal	O
DNA	O
-	O
binding	O
domain	O
of	O
Pip	B
exhibits	O
a	O
high	O
degree	O
of	O
homology	O
to	O
the	O
DNA	O
-	O
binding	O
domains	O
of	O
members	O
of	O
the	O
interferon	B
regulatory	I
factor	I
(	O
IRF	B
)	O
family	O
,	O
which	O
includes	O
IRF-1	B
,	O
IRF-2	B
,	O
ICSBP	B
,	O
and	O
ISGF3	B
gamma	I
.	O

The	O
RAP74	B
subunit	I
of	O
TFIIF	B
alone	O
contained	O
the	O
stimulatory	O
activity	O
and	O
the	O
minimal	O
region	O
sufficient	O
for	O
stimulation	O
corresponds	O
to	O
COOH	O
-	O
terminal	O
residues	O
358	O
-	O
517	O
.	O

The	O
hsp70	B
gene	I
family	I
of	O
Neurospora	O
crassa	O
:	O
cloning	O
,	O
sequence	O
analysis	O
,	O
expression	O
,	O
and	O
genetic	O
mapping	O
of	O
the	O
major	O
stress	O
-	O
inducible	O
member	O
.	O

The	O
deduced	O
amino	O
acid	O
sequences	O
of	O
each	O
of	O
the	O
W3A1	B
ETF	I
subunits	I
exhibit	O
only	O
approximately	O
30	O
%	O
identity	O
with	O
the	O
corresponding	O
subunits	O
of	O
the	O
ETF	B
from	O
human	O
,	O
rat	O
,	O
and	O
Paracoccus	O
denitrificans	O
,	O
which	O
as	O
a	O
group	O
are	O
greater	O
than	O
50	O
%	O
identical	O
.	O

Other	O
assays	O
also	O
distinguished	O
the	O
processive	O
replication	O
of	O
pNeo	O
.	O

Myc-2.4	O
from	O
the	O
dispersive	O
labeling	O
of	O
control	O
plasmids	O
.	O

Reconstitution	O
of	O
complexes	O
containing	O
p62	B
and	O
the	O
src	B
family	I
kinase	I
p59fyn	B
in	O
HeLa	O
cells	O
demonstrated	O
that	O
complex	O
formation	O
resulted	O
in	O
tyrosine	O
phosphorylation	O
of	O
p62	B
and	O
was	O
mediated	O
by	O
both	O
the	O
SH3	B
and	O
SH2	B
domains	I
of	O
p59fyn	B
.	O

Therefore	O
,	O
it	O
is	O
hoped	O
that	O
by	O
defining	O
the	O
transcriptional	O
control	O
of	O
the	O
L7	B
gene	I
insights	O
into	O
the	O
mechanisms	O
that	O
control	O
functional	O
fate	O
and	O
organization	O
in	O
the	O
nervous	O
system	O
can	O
be	O
gained	O
.	O

In	O
contrast	O
,	O
a	O
Maf	B
-	I
related	I
protein	I
,	O
Nrl	B
,	O
completely	O
mimicked	O
c	B
-	I
Maf	I
actions	O
.	O

In	O
studies	O
of	O
many	O
different	O
phenotypically	O
distinct	O
cells	O
,	O
the	O
CRE	O
of	O
the	O
somatostatin	B
gene	I
promoter	I
is	O
a	O
prototype	O
of	O
a	O
highly	O
cAMP	O
-	O
responsive	O
element	O
regulated	O
by	O
CREB	B
.	O

The	O
first	O
gene	O
,	O
NSR1	B
,	O
a	O
previously	O
identified	O
gene	O
,	O
encodes	O
a	O
protein	O
involved	O
in	O
ribosomal	O
RNA	O
maturation	O
and	O
possibly	O
in	O
transport	O
of	O
proteins	O
into	O
the	O
nucleus	O
.	O

Comparative	O
study	O
of	O
the	O
differential	O
white	O
blood	O
cell	O
count	O
using	O
three	O
automated	O
analyzers	O
:	O
Coulter	O
STKS	O
,	O
Sysmex	O
NE	O
8000	O
and	O
Technicon	O
H-1	O
.	O

Further	O
studies	O
established	O
that	O
the	O
Ep	B
-	O
induced	O
increase	O
in	O
beta	B
-	I
globin	I
mRNA	I
could	O
be	O
inhibited	O
by	O
the	O
tyrosine	B
kinase	I
inhibitor	O
genistein	O
and	O
the	O
protein	B
kinase	I
C	I
inhibitor	O
Compound	O
3.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

This	O
study	O
investigated	O
the	O
degree	O
to	O
which	O
racial	O
identity	O
influences	O
Mexican	O
-	O
Americans	O
'	O
performance	O
on	O
the	O
L	O
,	O
K	O
,	O
and	O
MF	O
scales	O
of	O
the	O
MMPI-2	O
.	O

To	O
do	O
this	O
,	O
segments	O
of	O
DNA	O
from	O
the	O
5	O
'	O
flank	O
of	O
the	O
initiation	O
sites	O
for	O
germline	O
epsilon	O
RNA	O
were	O
ligated	O
to	O
a	O
luciferase	B
reporter	I
gene	I
and	O
transfected	O
into	O
two	O
mouse	O
B	O
cell	O
lines	O
,	O
one	O
of	O
which	O
can	O
be	O
induced	O
to	O
switch	O
to	O
IgE.	B

Oncogenic	O
capacity	O
of	O
the	O
E2F1	B
gene	I
.	O

In	O
some	O
of	O
the	O
cases	O
of	O
solitary	O
lesion	O
,	O
serum	B
TSH	I
levels	O
,	O
serum	B
thyroglobulin	I
values	O
,	O
and	O
131I	O
protein	O
bounded	O
iodine	O
(	O
131I	O
-	O
PBI	O
)	O
were	O
measured	O
,	O
but	O
there	O
were	O
no	O
significant	O
differences	O
between	O
successful	O
and	O
unsuccessful	O
therapy	O
.	O

Endo16	B
transcripts	I
are	O
confined	O
to	O
the	O
definitive	O
vegetal	O
plate	O
in	O
blastula	O
stage	O
embryos	O
;	O
at	O
gastrula	O
stage	O
this	O
gene	O
is	O
expressed	O
throughout	O
the	O
archenteron	O
,	O
but	O
later	O
only	O
in	O
the	O
midgut	O
.	O

Another	O
full	O
ORF	O
was	O
found	O
on	O
the	O
opposite	O
strand	O
downstream	O
from	O
the	O
nspC	B
gene	I
.	O

The	O
U14	B
genes	I
of	O
mouse	O
as	O
well	O
as	O
rat	O
,	O
hamster	O
,	O
human	O
,	O
Xenopus	O
and	O
trout	O
are	O
encoded	O
within	O
introns	O
of	O
the	O
constitutively	O
expressed	O
70-kDa	B
-	I
cognate	I
-	I
heat	I
-	I
shock	I
protein	I
gene	I
(	O
hsc70	B
)	O
.	O

Inclusion	O
in	O
this	O
family	O
of	O
proteins	O
suggests	O
that	O
FliQ	B
and	O
FliR	B
may	O
participate	O
in	O
an	O
export	O
pathway	O
required	O
for	O
flagellum	O
assembly	O
.	O

Chem	O
.	O

Increase	O
in	O
blood	O
NEFA	O
was	O
further	O
augmented	O
by	O
fat	O
plus	O
AA	O
supplementation	O
,	O
but	O
no	O
changes	O
in	O
concentrations	O
of	O
Lys	O
or	O
Met	O
in	O
blood	O
were	O
found	O
.	O

Virol	O
.	O

Comparison	O
of	O
the	O
deduced	O
amino	B
acid	I
sequence	I
of	I
gamma	I
-	I
kafirin	I
with	O
the	O
published	O
sequences	B
of	I
gamma	I
-	I
prolamins	I
of	I
maize	I
,	I
and	I
Coix	I
revealed	O
highly	O
conserved	O
domains	O
.	O

Atcys1	B
,	O
Athyp1	B
,	O
AKin10	B
and	O
the	O
ORF	O
are	O
very	O
close	O
to	O
each	O
other	O
and	O
organized	O
in	O
the	O
same	O
polarity	O
;	O
hence	O
,	O
the	O
intergenic	O
regions	O
probably	O
contain	O
,	O
within	O
less	O
than	O
0.5	O
kb	O
,	O
all	O
the	O
regulatory	O
elements	O
necessary	O
to	O
govern	O
initiation	O
and	O
termination	O
of	O
transcription	O
.	O

Southern	O
blot	O
hybridization	O
experiments	O
suggest	O
the	O
presence	O
of	O
one	O
copy	O
of	O
Atcys1	B
,	O
Athyp1	B
and	O
AKin10	B
per	O
haploid	O
genome	O
,	O
and	O
Northern	O
blot	O
analysis	O
demonstrates	O
that	O
the	O
three	O
genes	O
are	O
differentially	O
expressed	O
in	O
roots	O
,	O
shoots	O
and	O
leaves	O
.	O

These	O
results	O
suggest	O
that	O
HAC1	B
may	O
also	O
be	O
one	O
of	O
the	O
meiotic	O
genes	O
.	O

Furthermore	O
,	O
the	O
identification	O
of	O
a	O
Dr1-like	B
protein	I
in	O
A.thaliana	O
strongly	O
argues	O
for	O
the	O
ubiquity	O
of	O
this	O
protein	O
among	O
eukaryotic	O
genera	O
and	O
for	O
a	O
conserved	O
mechanism	O
to	O
regulate	O
transcription	O
initiation	O
that	O
involves	O
Dr1	B
.	O

The	O
pre-	O
and	O
postoperative	O
haemoglobin	B
concentrations	O
in	O
the	O
autologous	O
group	O
were	O
lower	O
by	O
15	O
and	O
10	O
g	O
/	O
L	O
,	O
respectively	O
,	O
after	O
primary	O
THR	O
and	O
by	O
10	O
g	O
/	O
L	O
in	O
both	O
instances	O
after	O
revision	O
THR	O
.	O

(	O
iv	O
)	O
Although	O
UCRBP	B
has	O
been	O
previously	O
shown	O
to	O
act	O
as	O
a	O
transcriptional	O
repressor	O
,	O
we	O
show	O
here	O
that	O
UCRBP	B
can	O
also	O
act	O
as	O
a	O
positive	O
transactivator	O
of	O
a	O
reporter	O
driven	O
by	O
UCR	O
elements	O
when	O
used	O
in	O
co	O
-	O
transfection	O
assays	O
.	O

Chem	O
.	O

These	O
results	O
demonstrate	O
that	O
EKLF	B
provides	O
a	O
crucial	O
transactivation	O
function	O
for	O
globin	B
expression	O
and	O
further	O
reinforce	O
the	O
idea	O
that	O
EKLF	B
is	O
an	O
important	O
regulator	O
of	O
CACCC	O
element	O
-	O
directed	O
transcription	O
in	O
erythroid	O
cells	O
.	O

Using	O
a	O
battery	O
of	O
I	B
kappa	I
B	I
alpha	I
mutants	I
,	O
we	O
show	O
that	O
(	O
i	O
)	O
a	O
dimer	O
binds	O
a	O
single	O
I	B
kappa	I
B	I
alpha	I
molecule	I
,	O
(	O
ii	O
)	O
the	O
acidic	O
C	O
-	O
terminal	O
region	O
of	O
I	B
kappa	I
B	I
alpha	I
is	O
not	O
required	O
for	O
protein	O
-	O
protein	O
binding	O
and	O
does	O
not	O
mask	O
the	O
nuclear	O
localization	O
signal	O
of	O
the	O
dimer	O
,	O
(	O
iii	O
)	O
the	O
same	O
C	O
-	O
terminal	O
region	O
is	O
required	O
for	O
inhibition	O
of	O
DNA	O
binding	O
,	O
and	O
(	O
iv	O
)	O
this	O
inhibition	O
may	O
be	O
accomplished	O
by	O
direct	O
interaction	O
between	O
the	O
PEST	O
-	O
like	O
region	O
and	O
the	O
DNA	O
-	O
binding	O
region	O
of	O
one	O
of	O
the	O
subunits	O
of	O
the	O
dimer	O
.	O

The	O
negative	O
regulatory	O
activity	O
of	O
the	O
N	O
-	O
terminal	O
domain	O
was	O
antagonized	O
by	O
a	O
C	O
-	O
terminal	O
segment	O
of	O
Pho81p	B
supplied	O
in	O
trans	O
.	O

At	O
different	O
times	O
of	O
the	O
surgical	O
procedures	O
(	O
thorax	O
opening	O
and	O
closure	O
,	O
period	O
of	O
cardiopulmonary	O
bypass	O
)	O
67	O
to	O
100	O
%	O
of	O
the	O
patients	O
in	O
group	O
1	O
had	O
vancomycin	O
concentrations	O
in	O
the	O
studied	O
tissues	O
above	O
the	O
MIC	O
90	O
for	O
Staphylococcus	O
aureus	O
(	O
1	O
microgram	O
/	O
g	O
)	O
and	O
Staphylococcus	O
epidermidis	O
(	O
2	O
micrograms	O
/	O
g	O
)	O
.	O

On	O
-	O
line	O
angioscopic	O
images	O
of	O
tissue	O
flaps	O
floating	O
in	O
the	O
lumen	O
,	O
recent	O
or	O
structured	O
thrombi	O
,	O
artery	O
wall	O
dissections	O
,	O
plaque	O
ruptures	O
,	O
deep	O
fissurations	O
and	O
sub	O
-	O
intimal	O
haemorrhages	O
demonstrate	O
,	O
in	O
live	O
colour	O
,	O
the	O
pathophysiological	O
mechanisms	O
of	O
coronary	O
artery	O
stenosis	O
.	O

Basal	O
components	O
of	O
the	O
transcription	O
apparatus	O
(	O
RNA	B
polymerase	I
II	I
,	O
TATA	B
-	I
binding	I
protein	I
)	O
contain	O
activation	O
domains	O
:	O
is	O
the	O
repetitive	O
C	O
-	O
terminal	O
domain	O
(	O
CTD	O
)	O
of	O
RNA	B
polymerase	I
II	I
a	O
""""	O
portable	O
enhancer	O
domain	O
""""	O
?	O

Regions	O
rich	O
in	O
serine	O
,	O
threonine	O
,	O
and	O
proline	O
residues	O
can	O
be	O
found	O
in	O
transcriptional	O
activation	O
domains	O
,	O
as	O
well	O
as	O
in	O
the	O
N	O
-	O
terminal	O
parts	O
of	O
mammalian	B
TATA	I
-	I
binding	I
proteins	I
,	O
where	O
they	O
are	O
interrupted	O
by	O
polyglutamine	O
stretches	O
.	O

Mutagenesis	O
of	O
IM1	B
enhances	O
the	O
ability	O
of	O
c	B
-	I
Fos	I
to	O
activate	O
an	O
AP1	B
bearing	I
promoter	I
.	O

This	O
failure	O
to	O
execute	O
regulated	O
G1	O
/	O
S	O
arrest	O
is	O
correlated	O
with	O
enhanced	O
thermosensitivity	O
of	O
colony	O
-	O
forming	O
ability	O
.	O

The	O
marker	O
orders	O
from	O
the	O
genetic	O
and	O
RH	O
maps	O
were	O
consistent	O
.	O

Haplotype	O
mapping	O
and	O
sequence	O
analysis	O
of	O
the	O
mouse	O
Nramp	B
gene	I
predict	O
susceptibility	O
to	O
infection	O
with	O
intracellular	O
parasites	O
.	O

In	O
contrast	O
,	O
peak	O
filling	O
rate	O
(	O
PFR	O
)	O
,	O
normalized	O
to	O
end	O
diastolic	O
volume	O
(	O
EDV	O
)	O
,	O
or	O
stroke	O
volume	O
(	O
SV	O
)	O
,	O
or	O
expressed	O
as	O
the	O
ratio	O
of	O
PFR	O
-	O
to	O
-	O
PER	O
was	O
reduced	O
(	O
p	O
<	O
0.01	O
)	O
,	O
time	O
to	O
PFR	O
(	O
TPFR	O
)	O
was	O
prolonged	O
(	O
p	O
<	O
0.01	O
)	O
,	O
and	O
echocardiographic	O
left	O
ventricular	O
mass	O
index	O
was	O
higher	O
(	O
p	O
<	O
0.001	O
)	O
in	O
patients	O
with	O
acromegaly	O
compared	O
to	O
normals	O
.	O

A	O
genetic	O
complementation	O
system	O
was	O
developed	O
in	O
which	O
tobacco	B
etch	I
virus	I
(	I
TEV	I
)	I
polymerase	I
(	O
NIb	B
)	O
-expressing	O
transgenic	O
plants	O
or	O
protoplasts	O
were	O
inoculated	O
with	O
NIb	B
-	O
defective	O
TEV	B
mutants	I
.	O

Comparison	O
of	O
the	O
genomes	O
of	O
PMTV	O
,	O
BNYVV	O
,	O
and	O
SBWMV	O
shows	O
that	O
furoviruses	O
exhibit	O
considerable	O
heterogeneity	O
in	O
genome	O
organization	O
.	O

The	O
drug	O
sensitivity	O
was	O
100	O
%	O
for	O
vancomycin	O
(	O
VCM	O
)	O
,	O
30	O
%	O
for	O
imipenam	O
(	O
IMP	O
)	O
,	O
31	O
%	O
for	O
minomycin	O
(	O
MINO	O
)	O
,	O
31	O
%	O
for	O
amikacin	O
(	O
AMK	O
)	O
,	O
and	O
7	O
%	O
for	O
fosfomycin	O
(	O
FOM	O
)	O
.	O

Deglycosylation	O
with	O
endoglycosidase	B
H	I
showed	O
that	O
the	O
mutant	O
receptors	O
had	O
mainly	O
high	O
-	O
mannose	O
oligosaccharide	O
chains	O
.	O

Dietary	O
supplement	O
with	O
fish	O
oil	O
and	O
related	O
n-3	O
EFAs	O
has	O
been	O
used	O
to	O
study	O
their	O
antihypertensive	O
property	O
in	O
animals	O
and	O
humans	O
with	O
borderline	O
and	O
essential	O
hypertension	O
.	O

The	O
HSD3B1	B
and	O
HSD3B2	B
genes	I
encoding	O
the	O
types	B
I	I
and	I
II	I
3	I
beta	I
-	I
HSD	I
isoenzymes	I
,	O
respectively	O
,	O
have	O
been	O
previously	O
assigned	O
by	O
in	O
situ	O
hybridization	O
to	O
the	O
chromosome	O
1p13.1	O
region	O
.	O

Insulin	B
-	O
stimulated	O
glucose	O
transport	O
in	O
adipocytes	O
is	O
mediated	O
by	O
the	O
insulin	B
receptor	I
.	O

Intron	O
-	O
exon	O
structure	O
of	O
the	O
porcine	B
I	I
kappa	I
B	I
alpha	I
-	I
encoding	I
gene	I
.	O

The	O
kallistatin	B
gene	I
was	O
localized	O
by	O
in	O
situ	O
hybridization	O
to	O
human	O
chromosome	O
14q31-q32.1	O
,	O
close	O
to	O
the	O
serpin	B
genes	I
encoding	O
alpha	B
1-antichymotrypsin	I
,	O
protein	B
C	I
inhibitor	I
,	O
alpha	B
1-antitrypsin	I
,	O
and	O
corticosteroid	B
-	I
binding	I
globulin	I
.	O

The	O
locus	O
encoding	O
the	O
XD	B
gene	I
(	O
designated	O
Xd	B
)	O
was	O
mapped	O
to	O
the	O
distal	O
part	O
of	O
mouse	O
chromosome	O
17	O
by	O
haplotype	O
analysis	O
of	O
114	O
interspecific	O
backcross	O
mice	O
.	O

An	O
interatrial	O
communication	O
mitigates	O
the	O
impairment	O
of	O
LV	O
function	O
after	O
an	O
acute	O
and	O
sustained	O
drop	O
of	O
intrathoracic	O
pressure	O
.	O

Self	O
or	O
foreign	O
cellular	O
proteins	O
provide	O
peptides	O
for	O
presentation	O
by	O
major	B
histocompatibility	I
complex	I
(	I
MHC	I
)	I
class	I
I	I
molecules	I
on	O
the	O
surface	O
of	O
antigen	O
presenting	O
cells	O
(	O
APC	O
)	O
.	O

The	O
characteristics	O
of	O
the	O
VirD1	B
/	O
VirD2-mediated	B
cleavage	O
reaction	O
strongly	O
resemble	O
those	O
observed	O
with	O
relaxosomes	O
of	O
IncP	O
plasmids	O
involved	O
in	O
initiation	O
of	O
transfer	O
DNA	O
replication	O
during	O
bacterial	O
conjugation	O
.	O

Isoelectric	O
focusing	O
of	O
tryptic	O
peptides	O
generated	O
from	O
MHC	B
-	I
B	I
phosphorylated	O
with	O
cdc2	B
kinase	I
revealed	O
one	O
major	O
phosphopeptide	O
that	O
was	O
purified	O
by	O
reverse	O
-	O
phase	O
high	O
performance	O
liquid	O
chromatography	O
and	O
sequenced	O
.	O

The	O
deduced	O
protein	O
sequence	O
was	O
88	O
%	O
homologous	O
to	O
that	O
of	O
hNUC	B
I	I
,	O
isolated	O
from	O
human	O
osteosarcoma	O
cells	O
.	O

However	O
,	O
cotransfection	O
studies	O
indicate	O
that	O
RVR	B
does	O
not	O
activate	O
transcription	O
when	O
this	O
hormone	O
response	O
element	O
is	O
linked	O
to	O
a	O
reporter	O
gene	O
but	O
rather	O
acts	O
as	O
a	O
potent	O
competitive	O
repressor	O
of	O
ROR	B
alpha	I
function	O
.	O

These	O
studies	O
indicate	O
that	O
in	O
vitro	O
and	O
in	O
vivo	O
electrical	O
stimulation	O
generate	O
reactive	O
oxygen	O
species	O
and	O
affect	O
SOD	B
activity	O
,	O
which	O
in	O
part	O
are	O
responsible	O
for	O
decreased	O
sperm	O
motion	O
and	O
viability	O
.	O

Comparison	O
of	O
human	B
and	I
murine	I
blk	I
sequences	I
indicated	O
that	O
they	O
share	O
86	O
%	O
amino	O
acid	O
identity	O
,	O
the	O
most	O
conserved	O
region	O
being	O
the	O
catalytic	O
domain	O
(	O
93	O
%	O
identity	O
)	O
.	O

The	O
mRNAs	O
of	O
the	O
GRF	B
genes	I
are	O
encoded	O
by	O
six	O
exons	O
interrupted	O
by	O
five	O
introns	O
.	O

The	O
effect	O
of	O
ethanol	O
on	O
human	O
sensorimotor	O
reactivity	O
was	O
assessed	O
by	O
examining	O
the	O
acoustic	O
startle	O
response	O
.	O

Digitalis	O
glycosides	O
or	O
beta	B
-	I
receptor	I
antagonists	O
are	O
not	O
helpful	O
in	O
the	O
therapy	O
of	O
this	O
form	O
of	O
atrial	O
fibrillation	O
whereas	O
class	O
I	O
antiarrhythmic	O
drugs	O
have	O
been	O
shown	O
to	O
be	O
more	O
effective	O
.	O

Atrial	O
fibrillation	O
and	O
the	O
autonomic	O
nervous	O
system	O

VIII	O
in	O
doses	O
2	O
-	O
3	O
times	O
higher	O
than	O
usually	O
used	O
in	O
haemophiliacs	O
without	O
inhibitor	O
were	O
successful	O
.	O

Removal	O
of	O
PDMP	O
from	O
the	O
cell	O
medium	O
resulted	O
in	O
reversal	O
of	O
the	O
cell	O
cycle	O
changes	O
,	O
with	O
cells	O
re	O
-	O
entering	O
the	O
S	O
phase	O
.	O

A	O
major	O
task	O
for	O
sports	O
scientists	O
may	O
be	O
to	O
verify	O
empirically	O
the	O
nature	O
of	O
an	O
integrated	O
model	O
of	O
the	O
sport	O
performer	O
.	O

The	O
requirement	O
of	O
PilE	B
in	O
pilus	O
biogenesis	O
was	O
confirmed	O
by	O
demonstrating	O
that	O
chromosomal	B
pilE	I
insertion	I
mutants	I
were	O
pilus-	O
and	O
twitching	O
-	O
motility	O
deficient	O
.	O

The	O
pilE	B
gene	I
product	I
of	I
Pseudomonas	I
aeruginosa	I
,	O
required	O
for	O
pilus	O
biogenesis	O
,	O
shares	O
amino	O
acid	O
sequence	O
identity	O
with	O
the	O
N	O
-	O
termini	O
of	O
type	B
4	I
prepilin	I
proteins	I
.	O

Because	O
of	O
the	O
functional	O
conservation	O
of	O
cell	O
cycle	O
control	O
elements	O
,	O
the	O
expression	O
of	O
a	O
vertebrate	B
wee1	I
or	O
mik1	B
homolog	I
would	O
be	O
expected	O
to	O
rescue	O
such	O
lethal	O
mutations	O
in	O
yeast	O
.	O

Near	O
a	O
third	O
(	O
31.6	O
%	O
)	O
of	O
Insulin	B
Dependent	O
and	O
a	O
third	O
(	O
33.41	O
%	O
)	O
for	O
Non	O
Insulin	B
Dependent	O
were	O
of	O
D	O
,	O
F	O
,	O
H	O
White	O
's	O
Class	O
.	O

As	O
the	O
half	O
-	O
life	O
of	O
the	O
compound	O
did	O
never	O
exceed	O
8	O
-	O
9	O
h	O
,	O
the	O
data	O
do	O
not	O
support	O
any	O
change	O
of	O
pidotimod	O
administration	O
schedule	O
(	O
every	O
24	O
-	O
12	O
h	O
)	O
.	O

A	O
comparative	O
study	O
by	O
holographic	O
interferometry	O
of	O
ten	O
porcine	O
bioprosthetic	O
valves	O
(	O
seven	O
Carpentier	O
-	O
Edwards	O
SAV	O
,	O
two	O
BioImplant	O
and	O
one	O
Valcor	O
)	O
with	O
five	O
human	O
aortic	O
valves	O
before	O
and	O
after	O
glutaraldehyde	O
treatment	O
is	O
presented	O
.	O

No	O
serious	O
side	O
effects	O
were	O
observed	O
.	O

Specific	O
binding	O
was	O
not	O
observed	O
with	O
either	O
the	O
orthologous	O
rat	O
or	O
mouse	O
fragments	O
using	O
human	O
or	O
rodent	O
extracts	O
.	O

Lack	O
of	O
cyclin	B
D	I
-	O
Cdk	B
complexes	O
in	O
Rb	B
-	O
negative	O
cells	O
correlates	O
with	O
high	O
levels	O
of	O
p16INK4	B
/	O
MTS1	B
tumour	O
suppressor	O
gene	O
product	O
.	O

Recombinant	B
human	I
serum	I
albumin	I
(	O
rHSA	B
)	O
produced	O
by	O
cultured	O
fermentation	O
has	O
been	O
prepared	O
in	O
the	O
form	O
of	O
microcapsules	O
nominally	O
3	O
-	O
5	O
microns	O
in	O
diameter	O
and	O
radiolabelled	O
with	O
technetium-99	O
m	O
following	O
reduction	O
with	O
stannous	O
chloride	O
.	O

Such	O
an	O
intervention	O
may	O
be	O
of	O
considerable	O
use	O
for	O
the	O
treatment	O
of	O
angiogenesis	O
-	O
dependent	O
diseases	O
involving	O
FGF-2	B
.	O

We	O
have	O
attempted	O
to	O
clone	O
two	O
recessive	O
extragenic	O
suppressors	O
of	O
such	O
ts	O
mutants	O
(	O
sdp1	B
for	O
mutation	B
pol3	I
-	I
14	I
and	O
sdp5	B
-	I
1	I
for	O
mutation	B
pol3	I
-	I
11	I
)	O
by	O
transforming	O
thermoresistant	O
haploid	O
strains	O
pol3	B
-	I
14	I
sdp1	I
and	O
pol3	B
-	I
11	I
sdp5	I
-	I
1	I
with	O
wild	O
-	O
type	O
genomic	O
libraries	O
in	O
singlecopy	O
or	O
multicopy	O
vectors	O
.	O

UV	O
cross	O
-	O
linking	O
experiments	O
show	O
that	O
TEP	B
has	O
an	O
apparent	O
molecular	O
mass	O
of	O
approximately	O
65	O
kDa	O
.	O

In	O
acute	O
-	O
phase	O
livers	O
,	O
we	O
observed	O
a	O
dramatic	O
reduction	O
in	O
HNF-3	B
alpha	I
expression	O
which	O
correlates	O
with	O
a	O
decrease	O
in	O
the	O
expression	O
of	O
its	O
target	O
gene	O
,	O
the	O
TTR	B
gene	I
.	O

This	O
mutant	O
was	O
identified	O
by	O
screening	O
with	O
a	O
TGF	B
-	I
beta	I
-	O
inducible	O
vector	O
a	O
series	O
of	O
mink	O
lung	O
epithelial	O
cell	O
clones	O
that	O
have	O
normal	O
TGF	B
-	I
beta	I
binding	O
activity	O
but	O
have	O
lost	O
antiproliferative	O
and	O
transcriptional	O
responses	O
to	O
TGF	B
-	I
beta	I
.	O

By	O
treating	O
monkey	O
COS	O
cells	O
with	O
oligonucleotides	O
linked	O
to	O
psoralen	O
,	O
we	O
have	O
generated	O
targeted	O
mutations	O
in	O
a	O
simian	O
virus	O
40	O
(	O
SV40	O
)	O
vector	O
contained	O
within	O
the	O
cells	O
via	O
intracellular	O
triple	O
helix	O
formation	O
.	O

The	O
interleukin	B
2	I
receptor	I
alpha	I
-	I
chain	I
(	O
IL-2R	B
alpha	I
)	O
gene	O
is	O
rapidly	O
and	O
potently	O
induced	O
in	O
T	O
cells	O
in	O
response	O
to	O
mitogenic	O
stimuli	O
.	O

OBJECTIVES	O
:	O
1	O
)	O
to	O
determine	O
serum	B
ACE	I
activity	O
in	O
patients	O
with	O
COPD	O
treated	O
with	O
and	O
without	O
continuous	O
ambulatory	O
oxygen	O
therapy	O
(	O
CAOT	O
)	O
;	O
2	O
)	O
to	O
verify	O
whether	O
there	O
is	O
a	O
correlation	O
between	O
ACE	B
and	O
any	O
hematological	O
,	O
spirometric	O
or	O
gasometric	O
parameter	O
.	O

In	O
order	O
to	O
infer	O
shape	O
from	O
contour	O
,	O
the	O
human	O
visual	O
system	O
must	O
selectively	O
integrate	O
fragments	O
projecting	O
from	O
a	O
common	O
object	O
while	O
keeping	O
fragments	O
from	O
different	O
objects	O
separate	O
.	O

Constructs	O
designed	O
and	O
expressed	O
were	O
E2L1	B
(	I
1	I
-	I
98	I
)	I
,	O
E2L1.H1	B
(	I
1	I
-	I
128	I
)	I
,	O
E2L2	B
(	I
120	I
-	I
233	I
)	I
,	O
E2H1.L2	B
(	I
98	I
-	I
233	I
)	I
,	O
and	O
E2L1.H1.L2	B
(	I
1	I
-	I
233	I
)	I
,	O
where	O
numbers	O
in	O
parentheses	O
give	O
the	O
amino	O
acid	O
sequence	O
for	O
the	O
portions	O
of	O
the	O
E2	B
component	O
incorporated	O
into	O
a	O
construct	O
.	O

Thus	O
,	O
we	O
have	O
produced	O
lipoyl	O
domain	O
constructs	O
that	O
can	O
be	O
employed	O
in	O
sorting	O
the	O
specific	O
roles	O
of	O
E2L1	B
and	O
E2L2	B
in	O
facilitating	O
catalytic	O
and	O
regulatory	O
processes	O
.	O

METHODS	O
:	O
Ten	O
influenza	O
A	O
(	O
H3N2	O
)	O
viruses	O
isolated	O
during	O
the	O
outbreaks	O
were	O
examined	O
for	O
resistance	O
to	O
amantadine	O
and	O
rimantadine	O
by	O
means	O
of	O
an	O
enzyme	O
immunoassay	O
and	O
by	O
sequencing	O
of	O
the	O
viral	O
nucleic	O
acid	O
that	O
encodes	O
the	O
transmembrane	O
domain	O
of	O
the	O
M2	B
protein	I
.	O

The	O
first	O
contains	O
ATF	B
/	O
CRE	O
and	O
TBP	B
/	O
TATA	O
sequence	O
motifs	O
within	O
an	O
87-bp	O
region	O
.	O

Gene	O
expression	O
occurs	O
in	O
a	O
circadian	O
rhythm	O
and	O
induced	O
by	O
light	O
in	O
leaves	O
of	O
dark	O
-	O
adapted	O
plants	O
.	O

The	O
tissue	O
-	O
specific	O
expression	O
of	O
DP	B
family	I
members	I
suggests	O
that	O
the	O
combination	O
of	O
DP	B
/	O
E2F	B
heterodimers	O
that	O
constitute	O
DRTF1	B
/	O
E2F	B
is	O
influenced	O
by	O
the	O
phenotype	O
of	O
the	O
cell	O
.	O

Treatment	O
of	O
recurrent	O
FSGS	O
has	O
included	O
high	O
-	O
dose	O
steroids	O
,	O
high	O
-	O
dose	O
cyclosporine	O
(	O
CSA	O
)	O
,	O
plasmapheresis	O
,	O
and	O
ACE	B
inhibitors	O
with	O
mixed	O
results	O
.	O

Promoter	O
region	O
of	O
the	O
transcriptional	O
unit	O
for	O
human	B
alpha	I
1-chimaerin	I
,	O
a	O
neuron	B
-	I
specific	I
GTPase	I
-	I
activating	I
protein	I
for	O
p21rac	B
.	O

alpha	B
1-chimaerin	I
is	O
a	O
neuron	B
-	I
specific	I
GTPase	I
-	I
activating	I
protein	I
for	O
p21rac	B
,	O
a	O
protein	O
involved	O
in	O
morphological	O
events	O
.	O

Upstream	O
from	O
the	O
transcription	O
start	O
point	O
(	O
tsp	O
)	O
,	O
a	O
nucleotide	O
sequence	O
highly	O
homologous	O
to	O
the	O
consensus	B
sequence	I
motif	I
for	I
the	I
sigma	I
35-recognized	I
promoters	I
was	O
found	O
.	O

In	O
this	O
paper	O
,	O
an	O
analysis	O
of	O
the	O
dynamics	O
in	O
the	O
closing	O
phase	O
of	O
the	O
occluder	O
of	O
a	O
mechanical	O
monoleaflet	O
heart	O
valve	O
prosthesis	O
is	O
presented	O
.	O

When	O
expressed	O
per	O
kilogram	O
body	O
weight	O
,	O
mean	O
GIT	O
increased	O
in	O
the	O
dF	O
group	O
from	O
0.14	O
%	O
to	O
0.16	O
%	O
above	O
RMR	O
,	O
with	O
a	O
significant	O
decrease	O
from	O
0.15	O
%	O
to	O
0.13	O
%	O
in	O
the	O
P	O
group	O
.	O

However	O
,	O
inclusion	O
of	O
the	O
neighboring	O
CGGAAR	O
motifs	O
from	O
the	O
ICP4	B
promoter	I
,	O
which	O
bind	O
factors	O
GABP	B
alpha	I
and	I
beta	I
,	O
results	O
in	O
a	O
strong	O
synergistic	O
activation	O
.	O

This	O
finding	O
represents	O
both	O
a	O
potentially	O
important	O
mechanism	O
by	O
which	O
HPV	O
gene	O
expression	O
can	O
be	O
regulated	O
and	O
an	O
interesting	O
model	O
for	O
the	O
study	O
of	O
transcriptional	O
cooperativity	O
.	O

Analysis	O
of	O
the	O
sequence	O
upstream	O
of	O
this	O
initiation	O
codon	O
reveals	O
the	O
presence	O
of	O
a	O
promotor	O
sequence	O
.	O

SUP46	B
is	O
implicated	O
in	O
translation	O
fidelity	O
and	O
encodes	O
the	O
ribosomal	B
protein	I
S13	I
.	O

To	O
explore	O
the	O
functional	O
relationship	O
between	O
c	B
-	I
fos	I
and	O
Rb	B
,	O
a	O
eukaryotic	O
expression	O
plasmid	O
was	O
constructed	O
containing	O
the	O
c	B
-	I
fos	I
gene	I
under	O
control	O
of	O
the	O
SV40	B
promoter	I
complex	O
.	O

The	O
high	O
degree	O
of	O
sequence	O
identity	O
(	O
96	O
%	O
)	O
between	O
hydrolase	B
B	I
and	I
C	I
,	O
particularly	O
in	O
the	O
3	O
'	O
untranslated	O
region	O
,	O
suggests	O
that	O
the	O
genes	O
encoding	O
these	O
two	O
carboxylesterases	B
evolved	O
by	O
duplication	O
and	O
divergence	O
of	O
a	O
common	O
ancestral	O
gene	O
.	O

Secondary	O
pancreatic	O
involvement	O
of	O
mycosis	O
fungoides	O
detected	O
by	O
a	O
clinically	O
palpable	O
mass	O
.	O

The	O
NR2	O
hybrid	O
is	O
a	O
powerful	O
tool	O
for	O
the	O
mapping	O
of	O
new	O
probes	O
of	O
this	O
region	O
,	O
as	O
well	O
as	O
for	O
obtaining	O
new	O
informative	O
probes	O
specific	O
for	O
the	O
deletion	O
by	O
subtractive	O
cloning	O
of	O
the	O
region	O
.	O

Here	O
,	O
we	O
report	O
the	O
characterization	O
of	O
an	O
alternatively	O
processed	O
form	O
of	O
AFAP-110	B
that	O
encodes	O
an	O
additional	O
258	O
base	O
pair	O
(	O
bp	O
)	O
of	O
open	O
reading	O
frame	O
.	O

In	O
ICE	B
gamma	I
,	O
most	O
of	O
the	O
propeptide	O
(	O
amino	O
acids	O
20	O
-	O
112	O
)	O
is	O
deleted	O
,	O
which	O
suggests	O
that	O
it	O
may	O
function	O
as	O
a	O
catalyst	O
for	O
ICE	B
autoprocessing	O
in	O
vivo	O
.	O

The	O
p97-depleted	B
nuclei	O
remained	O
largely	O
competent	O
for	O
nuclear	O
protein	O
import	O
.	O

A	O
potential	O
outcome	O
of	O
these	O
biochemical	O
effects	O
may	O
include	O
the	O
limited	O
responsiveness	O
of	O
infected	O
T	O
cells	O
to	O
antigenic	O
stimulation	O
observed	O
during	O
HIV-1	O
infection	O
.	O

The	O
full	O
protocol	O
was	O
completed	O
by	O
33	O
patients	O
(	O
45	O
%	O
of	O
original	O
cohort	O
)	O
.	O

In	O
addition	O
,	O
we	O
found	O
that	O
cell	O
-	O
specific	O
suppression	O
of	O
RA	O
-	O
stimulated	O
zif268	B
gene	I
expression	O
can	O
be	O
attributed	O
to	O
a	O
29	O
base	O
pair	O
nucleotide	O
sequence	O
,	O
located	O
downstream	O
of	O
the	O
RA	O
-	O
responsive	O
region	O
in	O
the	O
zif268	B
gene	I
.	O

The	O
major	O
PKC	B
beta	I
transcription	O
initiation	O
site	O
was	O
identified	O
by	O
primer	O
extension	O
and	O
S1	B
nuclease	I
protection	O
.	O

Supplementary	O
Phase	O
Contraste	O
RSE	O
(	O
""""	O
Rapid	O
Sequential	O
Excitation	O
""""	O
)	O
sequences	O
were	O
carried	O
out	O
in	O
29	O
patients	O
.	O

In	O
yeast	O
,	O
the	O
products	O
of	O
the	O
UPF1	B
and	O
UPF3	B
genes	I
are	O
required	O
for	O
this	O
decay	O
pathway	O
,	O
and	O
in	O
this	O
report	O
we	O
focus	O
on	O
the	O
identification	O
and	O
characterization	O
of	O
additional	O
factors	O
required	O
for	O
rapid	O
decay	O
of	O
nonsense	O
-	O
containing	O
mRNAs	O
.	O

Mutations	O
in	O
UPF1	B
lead	O
to	O
the	O
selective	O
stabilization	O
of	O
mRNAs	O
containing	O
early	O
nonsense	O
mutations	O
without	O
affecting	O
the	O
decay	O
rates	O
of	O
most	O
other	O
mRNAs	O
.	O

A	O
DNA	O
fragment	O
encoding	O
the	O
DNA	O
-	O
binding	O
domain	O
(	O
amino	O
acids	O
1	O
-	O
60	O
)	O
of	O
the	O
Escherichia	B
coli	I
fru	I
transcriptional	I
regulator	I
was	O
cloned	O
into	O
the	O
pGEX	O
-	O
KT	O
vector	O
and	O
expressed	O
in	O
frame	O
with	O
the	O
fused	O
gene	O
encoding	O
glutathione	B
S	I
-	I
transferase	I
.	O

Using	O
gel	O
retardation	O
assays	O
with	O
HepG2	O
nuclear	O
extract	O
,	O
we	O
demonstrated	O
the	O
presence	O
of	O
a	O
specific	O
protein	O
which	O
bound	O
to	O
the	O
NRE	O
fragment	O
.	O

0.61	O
+	O
/-	O

0.04	O
)	O
.	O

Several	O
nuclear	O
factors	O
that	O
interact	O
with	O
sequences	O
in	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
mouse	B
tyrosinase	I
gene	I
were	O
identified	O
using	O
band	O
shift	O
and	O
methylation	O
interference	O
assays	O
.	O

Twenty	O
-	O
two	O
consecutive	O
patients	O
with	O
ischaemic	O
ulcers	O
had	O
tcPO2	O
measured	O
and	O
the	O
ankle	O
/	O
brachial	O
(	O
ABI	O
)	O
and	O
toe	O
/	O
brachial	O
(	O
TBI	O
)	O
indices	O
calculated	O
.	O

Current	O
status	O
of	O
telepathology	O
.	O

PMEK1	B
displays	O
96	O
and	O
80	O
%	O
identity	O
respectively	O
with	O
the	O
tobacco	B
NTF3	I
and	O
Arabidopsis	B
ATMPK1	I
kinases	I
,	O
and	O
only	O
50	O
%	O
to	O
the	O
more	O
distantly	O
related	O
plant	O
MAP	O
kinase	O
MsERK1	B
from	O
alfalfa	O
.	O

Translation	O
of	O
the	O
coding	O
segment	O
,	O
which	O
was	O
designated	O
MsPRP2	B
,	O
suggested	O
it	O
encodes	O
a	O
chimeric	O
40,569	O
Da	O
cell	O
wall	O
protein	O
with	O
an	O
amino	O
-	O
terminal	O
signal	O
sequence	O
,	O
a	O
repetitive	O
proline	O
-	O
rich	O
sequence	O
,	O
and	O
a	O
cysteine	O
-	O
rich	O
carboxyl	O
-	O
terminal	O
sequence	O
homologous	O
to	O
nonspecific	O
lipid	O
transfer	O
proteins	O
.	O

This	O
concept	O
is	O
supported	O
by	O
the	O
identification	O
of	O
RH	B
-	I
like	I
genes	I
in	O
non	O
human	O
primates	O
.	O

With	O
steady	O
illumination	O
,	O
outer	O
retinal	O
(	O
photoreceptor	O
)	O
QO2	O
decreased	O
to	O
1.4	O
+	O
/-	O

0.9	O
ml	O
O2	O
/	O
(	O
100	O
g.min	O
)	O
,	O
but	O
inner	O
retinal	O
QO2	O
remained	O
unchanged	O
at	O
3.7	O
+	O
/-	O

1.5	O
ml	O
O2	O
/	O
(	O
100	O
g.min	O
)	O
(	O
5	O
cats	O
)	O
.	O

The	O
catenins	B
bind	O
to	O
APC	B
and	O
E	B
-	I
cadherin	I
in	O
a	O
similar	O
fashion	O
,	O
but	O
APC	B
and	O
E	B
-	I
cadherin	I
do	O
not	O
associate	O
with	O
each	O
other	O
either	O
in	O
the	O
presence	O
or	O
absence	O
of	O
catenins	B
.	O

However	O
,	O
addition	O
of	O
core	B
DNA	I
polymerase	I
III	I
to	O
preinitiation	O
complex	O
,	O
fully	O
reconstituting	O
holoenzyme	O
resulted	O
in	O
replacement	O
of	O
gamma	O
by	O
alpha	O
at	O
the	O
primer	O
terminus	O
.	O

The	O
PSD2	B
gene	I
was	O
heterologously	O
expressed	O
by	O
infection	O
of	O
Sf-9	O
insect	O
cells	O
with	O
recombinant	O
baculovirus	O
,	O
resulting	O
in	O
a	O
10-fold	O
increase	O
in	O
PSD	B
activity	O
.	O

Computerized	O
detection	O
of	O
abnormal	O
asymmetry	O
in	O
digital	O
chest	O
radiographs	O
.	O

Like	O
Epo	B
,	O
HNF-4	B
is	O
expressed	O
in	O
kidney	O
,	O
liver	O
,	O
and	O
Hep3B	O
cells	O
but	O
not	O
in	O
HeLa	O
cells	O
.	O

These	O
observations	O
indicate	O
that	O
there	O
are	O
multiple	O
mechanisms	O
by	O
which	O
an	O
individual	O
transcript	O
can	O
be	O
degraded	O
following	O
deadenylation	O
.	O

We	O
show	O
here	O
that	O
the	O
binding	O
of	O
C1F	B
in	O
vitro	O
is	O
sensitive	O
to	O
the	O
concentration	O
of	O
calcium	O
ions	O
.	O

Survival	O
after	O
development	O
of	O
symptomatic	O
infection	O
(	O
P-2	O
)	O
did	O
not	O
differ	O
by	O
transmission	O
mode	O
.	O

The	O
aim	O
of	O
this	O
retrospective	O
study	O
was	O
to	O
demonstrate	O
that	O
in	O
certain	O
cases	O
of	O
expulsive	O
choroidal	O
hemorrhage	O
(	O
ECH	O
)	O
anatomical	O
success	O
and	O
useful	O
vision	O
can	O
be	O
obtained	O
with	O
repeated	O
vitreoretinal	O
surgery	O
.	O

The	O
function	O
of	O
the	O
C	O
-	O
terminal	O
tail	O
in	O
telomere	O
maintenance	O
is	O
not	O
mediated	O
through	O
the	O
RAP1	B
interacting	I
factor	I
RIF1	B
:	O
rap1	B
alleles	I
defective	O
in	O
both	O
the	O
C	O
-	O
terminal	O
tail	O
and	O
RIF1	B
interaction	I
domains	I
have	O
additive	O
effects	O
on	O
telomere	O
length	O
.	O

The	O
resulting	O
integrated	O
physical	O
,	O
genetic	O
,	O
and	O
cytogenetic	O
map	O
constitutes	O
a	O
resource	O
for	O
the	O
characterization	O
of	O
genes	O
that	O
may	O
be	O
involved	O
in	O
the	O
WAGR	O
syndrome	O
.	O

The	O
contribution	O
of	O
skin	O
flow	O
to	O
the	O
changes	O
in	O
760	O
-	O
800	O
nm	O
absorption	O
was	O
investigated	O
by	O
simultaneous	O
measurement	O
of	O
skin	O
flow	O
by	O
laser	O
flow	O
Doppler	O
and	O
NIR	O
recordings	O
during	O
hot	O
water	O
immersion	O
.	O

Proteins	O
immunoprecipitated	O
from	O
lysates	O
of	O
control-	O
and	O
VEGF	B
-	O
stimulated	O
BAEC	O
with	O
antisera	O
to	O
phospholipase	B
C	I
-	I
gamma	I
(	O
PLC	B
-	I
gamma	I
)	O
were	O
fractionated	O
by	O
SDS	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
transferred	O
to	O
Immobilon	O
-	O
P.	O

Involvement	O
of	O
early	B
growth	I
response	I
factor	I
Egr-1	I
in	O
apolipoprotein	B
AI	I
gene	I
transcription	O
.	O

Three	O
classes	O
of	O
test	O
objects	O
were	O
considered	O
:	O
(	O
1	O
)	O
a	O
multicompartment	O
test	O
object	O
for	O
31P	O
MRS	O
measurements	O
performed	O
with	O
slice	O
-	O
selective	O
sequences	O
;	O
(	O
2	O
)	O
a	O
two	O
-	O
compartment	O
test	O
object	O
for	O
volume	O
-	O
selection	O
1H	O
MRS	O
;	O
and	O
(	O
3	O
)	O
two	O
-	O
compartment	O
test	O
objects	O
for	O
assessing	O
the	O
performance	O
of	O
experimental	O
systems	O
using	O
ISIS	O
as	O
volume	O
localization	O
sequence	O
in	O
31P	O
MRS	O
.	O

Pregnancy	O
screening	O
by	O
uterine	O
artery	O
Doppler	O
velocimetry	O
--	O
which	O
criterion	O
performs	O
best	O
?	O

OBJECTIVE	O
:	O
To	O
test	O
whether	O
repeating	O
Doppler	O
studies	O
of	O
the	O
uteroplacental	O
circulation	O
late	O
in	O
gestation	O
will	O
improve	O
the	O
test	O
's	O
power	O
for	O
predicting	O
pregnancy	O
-	O
induced	O
hypertension	O
and	O
fetal	O
growth	O
restriction	O
(	O
FGR	O
)	O
,	O
and	O
whether	O
analysis	O
based	O
on	O
a	O
combination	O
of	O
quantitative	O
and	O
qualitative	O
assessments	O
of	O
the	O
uterine	O
arterial	O
waveforms	O
will	O
yield	O
better	O
results	O
than	O
analysis	O
based	O
on	O
either	O
alone	O
.	O

The	O
effect	O
of	O
the	O
Ca	O
entry	O
blocker	O
nitrendipine	O
,	O
the	O
antioxidant	O
superoxide	B
dismutase	I
(	O
SOD	B
)	O
,	O
and	O
a	O
combination	O
of	O
nitrendipine	O
and	O
superoxide	B
dismutase	I
on	O
postischemic	O
renal	O
function	O
was	O
studied	O
in	O
four	O
groups	O
(	O
n	O
=	O
24	O
)	O
of	O
rats	O
.	O

PURPOSE	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
bony	O
anchorage	O
of	O
a	O
new	O
implant	O
(	O
orderly	O
wired	O
surface	O
effect	O
with	O
alloy	O
Ti	O
Al	O
Va	O
and	O
ordered	O
pores	O
of	O
488	O
mu	O
)	O
.	O

To	O
determine	O
whether	O
food	O
and/or	O
water	O
in	O
the	O
gastrointestinal	O
tract	O
affects	O
restitution	O
of	O
blood	O
volume	O
and	O
plasma	O
protein	O
after	O
hemorrhage	O
,	O
fed	O
and	O
24-h	O
-	O
fasted	O
awake	O
rats	O
received	O
a	O
20	O
ml.kg-1	O
x	O
3	O
min-1	O
hemorrhage	O
,	O
and	O
restitution	O
of	O
blood	O
volume	O
was	O
measured	O
by	O
Evans	O
blue	O
dye	O
and	O
dilution	O
of	O
hematocrit	O
.	O

We	O
took	O
advantage	O
of	O
the	O
high	O
degree	O
of	O
aa	O
sequence	O
homology	O
between	O
DAHPSs	B
from	O
several	O
species	O
to	O
isolate	O
ARO3	B
homologues	I
from	O
the	O
pathogenic	O
yeast	O
Candida	O
albicans	O
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
BOX	O
DNA	O
enhances	O
transcription	O
from	O
the	O
thymidine	B
kinase	I
(	O
TK	B
)	O
promoter	O
in	O
various	O
EC	O
cells	O
.	O

Deletion	O
analyses	O
of	O
the	O
construct	O
revealed	O
that	O
the	O
transcription	O
of	O
BOXF1	B
gene	I
is	O
regulated	O
by	O
BOX	O
DNA	O
,	O
preferentially	O
in	O
undifferentiated	O
EC	O
cells	O
versus	O
differentiated	O
cells	O
.	O

The	O
presence	O
of	O
an	O
unusual	O
transcript	O
possessing	O
IVS2C	B
beta	I
1	I
at	O
the	O
5	O
'	O
terminus	O
suggests	O
that	O
cleavage	O
of	O
its	O
splice	O
acceptor	O
is	O
inefficient	O
or	O
negatively	O
regulated	O
.	O

During	O
chronic	O
treatment	O
,	O
when	O
plasma	O
concentrations	O
fluctuated	O
between	O
23.5	O
ng.ml-1	O
at	O
8	O
h	O
and	O
14	O
ng.ml-1	O
at	O
24	O
h	O
post	O
-	O
dosing	O
,	O
ST	O
segment	O
depression	O
at	O
an	O
individually	O
comparable	O
workload	O
was	O
significantly	O
decreased	O
by	O
28	O
%	O
compared	O
with	O
placebo	O
(	O
P	O
<	O
0.005	O
)	O
at	O
both	O
points	O
in	O
time	O
.	O

Evoked	O
electromyographic	O
response	O
to	O
indirect	O
supramaximal	O
stimulation	O
at	O
1	O
Hz	O
was	O
monitored	O
in	O
ten	O
adult	O
goats	O
under	O
thiopentone	O
-	O
halothane	O
anaesthesia	O
.	O

313	O
,	O
98	O
-	O
102	O
)	O
.	O

Group	O
6	O
was	O
given	O
physostigmine	O
,	O
0.1	O
mg	O
/	O
kg	O
i.v	O
.	O
,	O
known	O
to	O
inhibit	O
cholinesterase	B
degradation	O
,	O
5	O
min	O
before	O
bupivacaine	O
administration	O
,	O
and	O
Group	O
7	O
received	O
a	O
combination	O
of	O
physostigmine	O
pretreatment	O
and	O
electrical	O
vagal	O
stimulation	O
.	O

To	O
examine	O
the	O
possibility	O
that	O
LNNB	O
performance	O
of	O
the	O
schizophrenic	O
groups	O
may	O
have	O
been	O
related	O
to	O
neuroleptic	O
medication	O
,	O
analyses	O
were	O
completed	O
on	O
the	O
relationship	O
between	O
medication	O
levels	O
and	O
LNNB	O
scores	O
.	O

ISIS	O
5	O
possibilities	O
.	O

At	O
the	O
MTD	O
(	O
8	O
mg	O
/	O
m2	O
/	O
day	O
)	O
,	O
the	O
dose	O
-	O
limiting	O
toxicity	O
of	O
this	O
agent	O
is	O
myelosuppression	O
.	O

Mitogen	O
-	O
induced	O
lymphocyte	O
proliferation	O
was	O
diminished	O
.	O

Some	O
of	O
these	O
targets	O
were	O
reported	O
to	O
code	O
for	O
molecules	O
involved	O
in	O
cell	O
-	O
cell	O
interactions	O
,	O
whereas	O
no	O
relationship	O
has	O
yet	O
been	O
demonstrated	O
between	O
Hox	B
genes	I
and	O
other	O
transcription	O
factors	O
involved	O
in	O
determining	O
and/or	O
maintaining	O
tissue	O
specificity	O
.	O

HER2	B
overexpressing	O
cells	O
showed	O
a	O
single	O
prominent	O
DNase	B
I	I
hypersensitive	O
site	O
near	O
a	O
conserved	O
and	O
hitherto	O
unrecognized	O
ets	B
response	O
element	O
(	O
GAGGAA	O
)	O
,	O
located	O
38	O
bases	O
down	O
-	O
stream	O
from	O
the	O
CAAT	O
box	O
and	O
directly	O
5	O
'	O
of	O
the	O
TATA	O
box	O
in	O
the	O
human	B
HER2	I
promoter	I
.	O

Gel	O
-	O
shift	O
assays	O
with	O
nuclear	O
extracts	O
and	O
oligonucleotide	O
sequences	O
spanning	O
the	O
0.125-kb	O
promoter	O
region	O
detected	O
an	O
ETS	B
-	O
immunoreactive	O
complex	O
,	O
present	O
most	O
abundantly	O
in	O
cells	O
overexpressing	O
HER2	B
,	O
whose	O
high	O
-	O
affinity	O
binding	O
depended	O
on	O
the	O
GAGGAA	O
response	O
element	O
.	O

The	O
gene	O
for	O
the	O
RNA	B
-	I
dependent	I
eIF-2	I
alpha	I
protein	I
kinase	I
(	O
PKR	B
)	O
was	O
isolated	O
from	O
mouse	O
genomic	O
DNA	O
and	O
characterized	O
.	O

Similar	O
to	O
the	O
mouse	O
gene	O
,	O
the	O
5	O
'	O
flanking	O
region	O
of	O
human	B
CD79	I
alpha	I
lacks	O
a	O
TATA	O
box	O
;	O
however	O
,	O
unlike	O
mouse	B
CD79	I
alpha	I
,	O
a	O
classical	O
octamer	O
motif	O
could	O
not	O
be	O
identified	O
in	O
the	O
human	O
gene	O
.	O

Detailed	O
molecular	O
organization	O
of	O
the	O
coding	O
and	O
upstream	O
regulatory	O
regions	O
of	O
the	O
murine	O
homeodomain	B
-	I
containing	I
gene	I
,	O
Msx-1	B
,	O
is	O
reported	O
.	O

In	O
order	O
to	O
define	O
potential	O
candidate	O
genes	O
for	O
inherited	O
disorders	O
characterized	O
by	O
aberrant	O
gene	O
expression	O
,	O
we	O
utilized	O
Kruppel	B
-	I
related	I
sequences	I
to	O
isolate	O
zinc	O
finger	O
-	O
containing	O
cDNAs	O
.	O

The	O
ratio	O
of	O
the	O
activity	O
of	O
arogenate	B
dehydrogenase	I
to	O
that	O
of	O
prephenate	B
dehydrogenase	I
(	O
approximately	O
3:1	O
)	O
remained	O
constant	O
throughout	O
purification	O
,	O
and	O
the	O
two	O
activities	O
were	O
therefore	O
inseparable	O
.	O

The	O
Y.	O
lipolytica	O
genomic	O
POT1	B
gene	O
was	O
disrupted	O
by	O
replacing	O
120	O
bp	O
of	O
its	O
coding	O
sequence	O
with	O
2.7	O
kbp	O
of	O
DNA	O
including	O
the	O
Y.	O
lipolytica	O
LEU2	B
gene	I
.	O

It	O
is	O
concluded	O
that	O
CT	O
should	O
be	O
routinely	O
employed	O
in	O
patients	O
with	O
N1-N3	O
neck	O
disease	O
to	O
determine	O
the	O
proper	O
electron	O
-	O
energy	O
prescription	O
.	O

The	O
novel	O
Notch	B
homologue	I
mouse	B
Notch	I
3	I
lacks	O
specific	O
epidermal	B
growth	I
factor	I
-	I
repeats	I
and	O
is	O
expressed	O
in	O
proliferating	O
neuroepithelium	O
.	O

In	O
the	O
presence	O
of	O
the	O
in	O
vivo	O
reducing	O
system	O
(	O
thioredoxin	B
,	O
thioredoxin	B
reductase	I
,	O
and	O
NADPH	O
)	O
,	O
however	O
,	O
each	O
of	O
these	O
mutants	O
catalyzed	O
the	O
formation	O
of	O
only	O
0.6	O
-	O
0.8	O
dCTPs	O
per	O
mole	O
of	O
enzyme	O
.	O

In	O
addition	O
,	O
both	O
the	O
exon	O
1-	O
and	O
exon	O
2-initiated	O
forms	O
of	O
the	O
c	B
-	I
Myc	I
protein	I
stimulated	O
transcription	O
of	O
a	O
Myc	B
/	O
Max	B
-	O
responsive	O
reporter	O
construct	O
to	O
a	O
similar	O
level	O
.	O

Expression	O
is	O
exclusively	O
limited	O
to	O
the	O
CNS	O
at	O
this	O
and	O
later	O
stages	O
.	O

Disruption	O
of	O
any	O
one	O
of	O
the	O
four	O
genes	O
encoding	O
the	O
newly	O
identified	O
SRP	B
proteins	I
results	O
in	O
slow	O
cell	O
growth	O
and	O
inefficient	O
protein	O
translocation	O
across	O
the	O
ER	O
membrane	O
.	O

Genetic	O
alterations	O
in	O
elements	O
of	O
normal	O
signal	O
transduction	O
mechanisms	O
are	O
known	O
to	O
be	O
oncogenic	O
events	O
often	O
resulting	O
in	O
aberrant	O
activation	O
of	O
programs	O
of	O
gene	O
transcription	O
.	O

The	O
expression	O
pattern	O
of	O
GL2	B
,	O
as	O
demonstrated	O
by	O
in	O
situ	O
hybridization	O
,	O
indicated	O
that	O
the	O
gene	O
is	O
expressed	O
in	O
trichome	O
progenitor	O
cells	O
and	O
at	O
stages	O
associated	O
with	O
trichome	O
development	O
.	O

Binding	O
site	O
selection	O
using	O
in	O
vitro	O
-	O
synthesized	O
proteins	O
reveals	O
that	O
the	O
ROR	B
alpha	I
1	I
and	O
ROR	B
alpha	I
2	I
isoforms	I
bind	O
DNA	O
as	O
monomers	O
to	O
hormone	O
response	O
elements	O
composed	O
of	O
a	O
6-bp	O
AT	O
-	O
rich	O
sequence	O
preceding	O
a	O
half	O
-	O
site	O
core	O
motif	O
PuGGTCA	O
(	O
RORE	B
)	O
.	O

The	O
p73pct1	B
/	O
p85cdc10	B
complex	O
binds	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
to	O
MCB	B
but	O
not	O
SCB	B
or	O
E2F	B
sites	I
.	O

We	O
show	O
that	O
the	O
en	B
stripes	O
expand	O
anteriorly	O
in	O
slp	B
mutant	O
embryos	O
and	O
that	O
slp	B
activity	O
is	O
an	O
absolute	O
requirement	O
for	O
maintenance	O
of	O
wg	B
expression	O
at	O
the	O
same	O
time	O
that	O
wg	B
transcription	O
is	O
dependent	O
on	O
hh	B
.	O

CMV	O
hyperimmunoglobulin	B
treatment	O
(	O
Cytotect	O
,	O
Biotest	O
)	O
was	O
started	O
(	O
2	O
ml	O
/	O
kg	O
bw	O
on	O
day	O
1	O
and	O
3	O
,	O
and	O
1	O
ml	O
/	O
kg	O
on	O
days	O
5	O
,	O
7	O
and	O
9	O
)	O
,	O
which	O
led	O
to	O
the	O
eradication	O
of	O
the	O
residual	O
infiltrate	O
and	O
CMV	O
-	O
DNA	O
in	O
the	O
myocardium	O
.	O

ORF	O
2	O
potentially	O
encoded	O
a	O
hydrophobic	O
protein	O
of	O
29,705	O
Da	O
with	O
six	O
potential	O
membrane	O
-	O
spanning	O
regions	O
.	O

DNA	O
sequence	O
analysis	O
showed	O
that	O
the	O
gene	O
was	O
525	O
bp	O
long	O
and	O
encoded	O
a	O
175-amino	O
-	O
acid	O
protein	O
with	O
a	O
molecular	O
weight	O
of	O
19,094	O
containing	O
a	O
21-residue	O
typical	O
lipoprotein	O
signal	O
peptide	O
and	O
consensus	O
prolipoprotein	O
processing	O
site	O
.	O

DNA	O
sequence	O
and	O
functions	O
of	O
the	O
actVI	B
region	I
of	O
the	O
actinorhodin	B
biosynthetic	I
gene	I
cluster	I
of	I
Streptomyces	I
coelicolor	I
A3	I
(	I
2	I
)	I
.	O

(	O
1992	O
)	O
Genomics	O
12	O
,	O
58	O
-	O
62	O
)	O
.	O

A	O
comparison	O
of	O
the	O
predicted	O
polypeptide	O
sequence	O
of	O
the	O
Drosophila	O
protein	O
with	O
the	O
equivalent	O
subunits	O
from	O
mouse	O
and	O
yeast	O
suggests	O
that	O
they	O
are	O
closely	O
related	O
and	O
defines	O
three	O
conserved	O
regions	O
which	O
are	O
likely	O
to	O
be	O
important	O
for	O
enzyme	O
activity	O
.	O

Plasmids	O
were	O
constructed	O
with	O
the	O
mouse	O
promoter	O
region	O
linked	O
to	O
the	O
reporter	B
gene	I
chloramphenicol	I
acetyltransferase	I
(	O
CAT	B
)	O
,	O
and	O
transiently	O
and	O
stably	O
transfected	O
in	O
the	O
INS-1	O
cells	O
.	O

Cytoplasmic	B
dynein	I
is	O
a	O
multisubunit	O
,	O
microtubule	O
-	O
dependent	O
mechanochemical	O
enzyme	O
that	O
has	O
been	O
proposed	O
to	O
function	O
in	O
a	O
variety	O
of	O
intracellular	O
movements	O
,	O
including	O
minus	O
-	O
end	O
-	O
directed	O
transport	O
of	O
organelles	O
.	O

Identification	O
of	O
the	O
plakoglobin	B
-	O
binding	O
domain	O
in	O
desmoglein	B
and	O
its	O
role	O
in	O
plaque	O
assembly	O
and	O
intermediate	O
filament	O
anchorage	O
.	O

Specifically	O
,	O
this	O
study	O
determined	O
the	O
influence	O
of	O
:	O
(	O
1	O
)	O
an	O
awareness	O
strategy	O
,	O
(	O
2	O
)	O
a	O
non	O
-	O
awareness	O
strategy	O
,	O
(	O
3	O
)	O
a	O
Five	O
-	O
Step	O
Approach	O
strategy	O
and	O
(	O
4	O
)	O
a	O
control	O
condition	O
.	O

As	O
shown	O
previously	O
,	O
EBNA2	B
transactivates	O
the	O
promoters	O
of	O
the	O
viral	B
latent	I
membrane	I
proteins	I
.	O

A	O
simple	O
registration	O
as	O
an	O
incentive	O
for	O
improvement	O

The	O
transverse	O
magnetization	O
decays	O
mentioned	O
above	O
exhibited	O
two	O
components	O
,	O
a	O
T2	O
fast	O
(	O
T2f	O
)	O
and	O
a	O
T2	O
slow	O
(	O
T2s	O
)	O
component	O
.	O

RESULTS	O
:	O
The	O
diagnostic	O
quality	O
of	O
FDG	O
images	O
was	O
at	O
least	O
as	O
good	O
as	O
that	O
of	O
their	O
Tl-201	O
counterparts	O
,	O
with	O
less	O
liver	O
background	O
in	O
all	O
but	O
one	O
FDG	O
study	O
.	O

The	O
coordinated	O
expression	O
of	O
CD4	B
and	O
CD8	B
during	O
T	O
-	O
cell	O
development	O
is	O
tightly	O
coupled	O
with	O
the	O
maturation	O
state	O
of	O
the	O
T	O
cell	O
.	O

The	O
dying	O
tTG	B
-	O
transfected	O
cells	O
exhibit	O
both	O
cytoplasmic	O
and	O
nuclear	O
changes	O
characteristic	O
of	O
cells	O
undergoing	O
apoptosis	O
.	O

The	O
protein	O
encoded	O
is	O
114	O
kDa	O
and	O
contains	O
eight	O
zinc	O
finger	O
motifs	O
,	O
seven	O
of	O
which	O
are	O
present	O
in	O
two	O
clusters	O
at	O
opposite	O
ends	O
of	O
the	O
molecule	O
.	O

Tissue	O
-	O
specific	O
expression	O
of	O
the	O
diazepam	B
-	I
binding	I
inhibitor	I
in	O
Drosophila	O
melanogaster	O
:	O
cloning	O
,	O
structure	O
,	O
and	O
localization	O
of	O
the	O
gene	O
.	O

Using	O
a	O
v	B
-	I
erbA	I
probe	O
,	O
we	O
obtained	O
a	O
cDNA	O
which	O
encodes	O
a	O
novel	O
445-amino	O
-	O
acid	O
protein	O
,	O
RLD-1	B
,	O
that	O
contains	O
the	O
characteristic	O
domains	O
of	O
nuclear	O
receptors	O
.	O

Only	O
two	O
of	O
the	O
isoforms	O
possess	O
the	O
N	O
-	O
terminal	O
zinc	O
finger	O
domain	O
that	O
is	O
necessary	O
and	O
sufficient	O
for	O
TdT	B
promoter	I
binding	O
.	O

This	O
study	O
provides	O
direct	O
evidence	O
that	O
USF	B
,	O
a	O
member	O
of	O
the	O
basic	B
helix	I
-	I
loop	I
-	I
helix	I
leucine	I
zipper	I
family	I
,	O
binds	O
to	O
MLE1	B
,	O
HF-1a	B
,	O
and	O
PRE	B
B	I
sites	I
and	O
suggests	O
that	O
it	O
is	O
a	O
component	O
of	O
protein	O
complexes	O
that	O
may	O
coordinately	O
control	O
the	O
expression	O
of	O
MLC-2v	B
and	O
alpha	B
-	I
myosin	I
heavy	I
-	I
chain	I
genes	I
.	O

Human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
Tax	B
activation	O
of	O
NF	B
-	I
kappa	I
B	I
/	O
Rel	B
involves	O
phosphorylation	O
and	O
degradation	O
of	O
I	B
kappa	I
B	I
alpha	I
and	O
RelA	B
(	I
p65	I
)	I
-mediated	O
induction	O
of	O
the	O
c	B
-	I
rel	I
gene	I
.	O

Because	O
endogenous	O
HSF	B
DNA	O
-	O
binding	O
activity	O
is	O
low	O
and	O
anti	B
-	I
hHSF1	I
antibody	I
does	O
not	O
recognize	O
Xenopus	B
HSF	I
,	O
we	O
employed	O
this	O
system	O
for	O
mapping	O
regions	O
in	O
hHSF1	B
that	O
are	O
required	O
for	O
the	O
maintenance	O
of	O
the	O
monomeric	O
state	O
.	O

Enhancers	O
containing	O
disrupted	O
Ets-1	B
binding	I
sites	I
were	O
tested	O
in	O
transient	O
expression	O
assays	O
in	O
the	O
murine	O
T	O
-	O
cell	O
line	O
EL4.E1	O
;	O
alterations	O
in	O
the	O
LVb	O
element	O
affected	O
constitutive	O
enhancer	O
activity	O
,	O
while	O
mutation	O
of	O
either	O
the	O
LVb	O
or	O
LVc	O
element	O
disrupted	O
phorbol	O
ester	O
-	O
induced	O
enhancer	O
activity	O
.	O

These	O
RZR	B
subtypes	O
represent	O
members	O
of	O
a	O
new	O
family	O
of	O
orphan	B
nuclear	I
receptors	I
that	O
most	O
likely	O
regulate	O
specific	O
gene	O
expression	O
.	O

Interestingly	O
,	O
these	O
response	O
elements	O
display	O
dramatically	O
reduced	O
affinity	O
for	O
retinoic	B
acid	I
receptor	I
-	O
retinoid	B
-	I
X	I
receptor	I
heterodimers	O
.	O

The	O
unexpected	O
presence	O
of	O
the	O
tRNA	B
(	I
trp	I
)	I
(	I
CCA	I
)	I
-gene	I
transcript	I
in	I
mitochondria	I
is	O
also	O
reported	O
.	O

The	O
parameters	O
of	O
nonspecific	O
humoral	O
immunity	O
--	O
serum	B
immunoglobulins	I
and	O
immune	O
complexes	O
--	O
were	O
evaluated	O
in	O
irradiated	O
group	O
of	O
patients	O
with	O
uterine	O
cervix	O
carcinoma	O
(	O
Stages	O
IIB	O
and	O
IIIB	O
)	O
,	O
during	O
one	O
year	O
follow	O
up	O
.	O

Mutation	O
of	O
KRKR	O
to	O
NGER	O
retains	O
MO15	B
in	O
the	O
cytoplasmic	O
compartment	O
,	O
whilst	O
the	O
wild	O
-	O
type	O
protein	O
is	O
detected	O
exclusively	O
in	O
the	O
nucleus	O
.	O

Strikingly	O
,	O
this	O
subdomain	O
is	O
also	O
present	O
in	O
the	O
otherwise	O
unrelated	O
N	O
-	O
terminal	O
activating	O
region	O
of	O
p58c	B
-	I
ets-2	I
and	O
was	O
thus	O
named	O
BEC	B
for	O
Ets-1-beta	B
/	O
Ets-2-Conserved	B
sequence	I
.	O

This	O
work	O
unravels	O
a	O
new	O
model	O
for	O
the	O
ets-1	B
/	O
ets-2	B
gene	I
's	O
evolution	O
,	O
based	O
for	O
the	O
first	O
time	O
on	O
both	O
structural	O
and	O
functional	O
evidences	O
.	O

The	O
v	B
-	I
ets	I
oncogene	I
of	O
the	O
avian	O
retrovirus	O
E26	O
differs	O
from	O
its	O
cellular	O
progenitor	O
p68c	B
-	I
ets-1	I
by	O
two	O
amino	O
acid	O
substitutions	O
(	O
alanine	O
285	O
and	O
isoleucine	O
445	O
in	O
c	B
-	I
ets-1	I
both	O
substituted	O
by	O
valine	O
in	O
v	B
-	I
ets	I
,	O
mutations	O
A	O
and	O
B	O
respectively	O
)	O
and	O
its	O
carboxy	O
-	O
terminal	O
end	O
(	O
mutation	O
C	O
)	O
.	O

A	O
genetic	O
system	O
was	O
devised	O
to	O
select	O
for	O
pi	B
protein	I
mutants	I
which	O
discriminate	O
between	O
IR	O
and	O
DR	O
(	O
York	O
et	O
al.	O
,	O
Gene	O
(	O
Amst	O
.	O
)	O
116	O
,	O
7	O
-	O
12	O
,	O
1992	O
;	O
York	O
and	O
Filutowicz	O
,	O
J.	O

These	O
results	O
provide	O
evidence	O
of	O
a	O
bypass	O
of	O
p53-induced	B
Waf1	B
/	O
Cip1-mediated	B
cell	O
cycle	O
regulatory	O
pathways	O
by	O
a	O
member	O
of	O
the	O
myb	B
oncogene	I
family	I
.	O

HBx	B
strongly	O
elevates	O
levels	O
of	O
GTP	O
-	O
bound	O
Ras	B
,	O
activated	O
and	O
phosphorylated	O
Raf	B
,	O
and	O
tyrosine	O
-	O
phosphorylated	O
and	O
activated	O
MAP	B
kinase	I
.	O

Role	O
of	O
c	B
-	I
myc	I
in	O
simian	B
virus	I
40	I
large	I
tumor	I
antigen	I
-	O
induced	O
DNA	O
synthesis	O
in	O
quiescent	O
3T3-L1	O
mouse	O
fibroblasts	O
.	O

All	O
groups	O
were	O
challenged	O
subsequently	O
with	O
naloxone	O
(	O
0.4	O
mg	O
/	O
kg	O
)	O
in	O
the	O
distinctive	O
environment	O
and	O
then	O
observed	O
for	O
signs	O
of	O
opiate	O
withdrawal	O
.	O

Laser	O
therapy	O
of	O
penile	O
carcinoma	O

It	O
was	O
shown	O
that	O
estradiol	O
concentrations	O
obtained	O
after	O
estradiol	O
valerate	O
and	O
micronized	O
estradiol	O
ingestion	O
were	O
dependent	O
on	O
the	O
patient	O
's	O
age	O
as	O
well	O
as	O
on	O
the	O
constitutional	O
type	O
.	O

There	O
were	O
9	O
patients	O
in	O
NYHA	O
class	O
III	O
and	O
8	O
in	O
class	O
IV.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Constipation	O
is	O
not	O
a	O
risk	O
factor	O
for	O
hemorrhoids	O
:	O
a	O
case	O
-	O
control	O
study	O
of	O
potential	O
etiological	O
agents	O
.	O

TG	O
-	O
day	O
and	O
TG	O
-	O
night	O
were	O
19.4	O
+	O
/-	O

6.1	O
%	O
,	O
26.6	O
+	O
/-	O

5.3	O
%	O
,	O
(	O
750	O
mm3	O
<	O
T.	O

The	O
fibrinogen	B
,	O
serum	O
proteins	O
,	O
sodium	O
heparin	O
and	O
membrane	O
contributed	O
to	O
Cm	O
by	O
20	O
%	O
,	O
14	O
%	O
,	O
2	O
%	O
and	O
64	O
%	O
,	O
respectively	O
.	O

Optima	O
)	O
genomic	O
library	O
by	O
hybridizing	O
with	O
elicitor	O
-	O
induced	O
stilbene	B
synthase	I
cDNA	I
as	O
a	O
probe	O
.	O

The	O
site	O
-	O
directed	O
mutation	O
of	O
the	O
kappa	B
B	I
motif	I
in	O
IL-6	B
/	O
CAT	B
plasmid	O
resulted	O
in	O
the	O
complete	O
abrogation	O
of	O
IL-6	B
promoter	I
activity	O
in	O
these	O
cells	O
.	O

Use	O
of	O
the	O
vena	O
cava	O
to	O
extend	O
the	O
right	O
renal	O
vein	O
for	O
cadaver	O
transplantation	O
is	O
controversial	O
.	O

Enhanced	O
hepatic	O
portal	O
blood	O
flow	O
induced	O
by	O
prostaglandin	O
E1	O
following	O
liver	O
transplantation	O
in	O
pigs	O
.	O

One	O
gene	O
appears	O
ubiquitously	O
expressed	O
while	O
the	O
other	O
is	O
prominently	O
expressed	O
in	O
muscle	O
.	O

For	O
HeLa	O
,	O
293	O
,	O
U937	O
,	O
and	O
A549	O
cells	O
,	O
participation	O
of	O
E2F-1	B
,	O
DP-1	B
,	O
cyclin	B
A	I
,	O
and	O
RB	B
was	O
involved	O
in	O
formation	O
of	O
some	O
complexes	O
only	O
,	O
assuming	O
participation	O
of	O
factors	O
different	O
from	O
E2F-1	B
or	O
DP-1	B
in	O
others	O
.	O

E1A	B
autoactivation	O
mediated	O
by	O
these	O
sites	O
was	O
about	O
twofold	O
compared	O
with	O
a	O
ninefold	O
activation	O
described	O
for	O
the	O
complete	O
E1A	B
promoter	I
.	O

During	O
heat	O
exposure	O
,	O
chicks	O
that	O
had	O
been	O
subjected	O
to	O
early	O
60	O
%	O
restriction	O
with	O
non	O
-	O
metyrapone	O
-	O
treated	O
food	O
had	O
lower	O
H	O
/	O
L	O
ratios	O
and	O
improved	O
resistance	O
to	O
marble	O
spleen	O
disease	O
infection	O
.	O

Analyses	O
of	O
additional	O
tumors	O
induced	O
in	O
mice	O
from	O
two	O
reciprocal	O
crosses	O
,	O
A	O
/	O
J	O
x	O
C3H	O
/	O
HeJ	O
F1	O
(	O
hereafter	O
called	O
AC3F1	O
)	O
and	O
C3H	O
/	O
HeJ	O
x	O
A	O
/	O
J	O
F1	O
(	O
hereafter	O
called	O
C3AF1	O
)	O
,	O
provided	O
evidence	O
for	O
the	O
inactivation	O
of	O
one	O
allele	O
of	O
the	O
putative	O
chromosome	O
4	O
tumor	O
suppressor	O
gene	O
by	O
parental	O
imprinting	O
.	O

Lesion	O
diameters	O
of	O
greater	O
than	O
20	O
mm	O
and	O
the	O
large	O
sessile	O
-	O
type	O
configurations	O
were	O
factors	O
that	O
were	O
associated	O
with	O
incomplete	O
removal	O
.	O

Routinely	O
collected	O
,	O
processed	O
and	O
stored	O
breast	O
cancer	O
tissue	O
blocks	O
recovered	O
from	O
the	O
archives	O
of	O
the	O
Pathology	O
laboratory	O
in	O
Dar	O
es	O
Salaam	O
after	O
storage	O
of	O
up	O
to	O
3	O
years	O
were	O
analysed	O
by	O
a	O
flow	O
cytometry	O
for	O
DNA	O
ploidy	O
and	O
S	O
-	O
phase	O
fraction	O
.	O

Cbf3	B
contains	O
three	O
proteins	O
,	O
Cbf3a	B
,	O
Cbf3b	B
and	O
Cbf3c	B
.	O

Such	O
an	O
interaction	O
could	O
be	O
detected	O
using	O
a	O
GST	B
-	O
POU	B
fusion	O
protein	O
bound	O
to	O
glutathione	O
-	O
agarose	O
beads	O
.	O

These	O
mutations	O
are	O
localized	O
in	O
the	O
same	O
region	O
where	O
the	O
HSV	B
transactivator	I
VP16	I
binds	O
,	O
but	O
did	O
not	O
coincide	O
with	O
the	O
VP16	B
contacts	O
.	O

In	O
general	O
,	O
the	O
filtration	O
rate	O
in	O
relevant	O
areas	O
appears	O
to	O
be	O
an	O
integrative	O
and	O
easily	O
determined	O
parameter	O
,	O
reflecting	O
hormonal	O
and	O
neurogenic	O
vascular	O
as	O
well	O
as	O
local	O
interstitial	O
control	O
of	O
the	O
Starling	O
forces	O
.	O

Notably	O
,	O
these	O
residues	O
are	O
located	O
in	O
different	O
domains	O
.	O

However	O
,	O
rapamycin	O
inhibited	O
proliferation	O
of	O
Ba	O
/	O
F3-EpoRgp55	O
but	O
not	O
of	O
MEL	O
cells	O
despite	O
inhibition	O
of	O
p70	B
S6	I
kinase	I
activity	O
in	O
both	O
cells	O
.	O

Intraventricular	O
injection	O
of	O
(	O
2S,1'R,2'R,3'R	O
)	O
-2-	O
(	O
2,3-dicarboxycyclopropyl	O
)	O
glycine	O
(	O
DCG	O
-	O
IV	O
)	O
,	O
a	O
potent	O
agonist	O
for	O
metabotropic	O
glutamate	B
receptors	I
,	O
to	O
rats	O
retarded	O
dose	O
-	O
dependently	O
the	O
recovery	O
from	O
halothane	O
anesthesia	O
at	O
a	O
dose	O
range	O
from	O
30	O
to	O
300	O
pmol	O
/	O
rat	O
.	O

The	O
hepatocyte	B
nuclear	I
factor-3	I
(	O
HNF-3	B
)	O
/	O
forkhead	B
(	O
fkh	B
)	O
proteins	O
consist	O
of	O
an	O
extensive	O
family	O
of	O
tissue	O
-	O
specific	O
and	O
developmental	O
gene	O
regulators	O
which	O
share	O
homology	O
within	O
the	O
winged	O
helix	O
DNA	O
binding	O
motif	O
.	O

Homozygous	O
null	O
embryos	O
also	O
displayed	O
abnormalities	O
in	O
heart	O
development	O
,	O
consistent	O
with	O
the	O
conclusion	O
that	O
Tek	B
is	O
necessary	O
for	O
endocardial	O
/	O
myocardial	O
interactions	O
during	O
development	O
.	O

A	O
strong	O
trithorax	B
binding	I
site	I
was	O
found	O
at	O
the	O
cytological	O
location	O
of	O
the	O
fork	B
head	I
gene	I
,	O
a	O
region	O
-	O
specific	O
homeotic	B
gene	I
not	O
located	O
within	O
a	O
homeotic	B
complex	I
.	O

In	O
particular	O
,	O
changes	O
in	O
intracellular	O
Ca2	O
+	O
have	O
the	O
potential	O
to	O
either	O
inhibit	O
or	O
augment	O
the	O
ability	O
of	O
cAMP	O
to	O
stimulate	O
transcription	O
,	O
depending	O
on	O
the	O
presence	O
of	O
specific	O
forms	O
of	O
Ca2+	B
/	I
calmodulin	I
-	I
dependent	I
protein	I
kinases	I
.	O

Antibodies	O
directed	O
against	O
the	O
SNM1	B
protein	I
immunoprecipitated	O
RNase	B
MRP	I
RNA	I
from	O
whole	O
-	O
cell	O
extracts	O
without	O
precipitating	O
the	O
structurally	O
and	O
functionally	O
related	O
RNase	B
P	I
RNA	I
.	O

C	B
/	I
EBP	I
alpha	I
also	O
activates	O
the	O
promoter	O
of	O
the	O
rat	B
class	I
-	I
I	I
ADH	I
gene	I
in	O
a	O
sequence	O
-	O
specific	O
manner	O
[	O
Potter	O
et	O
al.	O
,	O
Arch	O
.	O

C	B
/	I
EBP	I
alpha	I
also	O
activates	O
the	O
promoter	O
of	O
the	O
rat	B
class	I
-	I
I	I
ADH	I
gene	I
in	O
a	O
sequence	O
-	O
specific	O
manner	O
[	O
Potter	O
et	O
al.	O
,	O
Arch	O
.	O

In	O
human	O
brain	O
,	O
contactin	B
was	O
first	O
identified	O
by	O
amino	O
terminal	O
and	O
peptide	O
sequencing	O
of	O
the	O
lentil	B
-	I
lectin	I
-	I
binding	I
glycoprotein	I
Gp135	I
.	O

A	O
cDNA	O
for	O
a	O
newly	O
discovered	O
pseudogene	O
,	O
closely	O
related	O
to	O
the	O
mouse	B
mast	I
cell	I
chymases	I
was	O
isolated	O
by	O
polymerase	O
chain	O
reaction	O
amplification	O
from	O
a	O
mouse	O
connective	O
tissue	O
-	O
like	O
mast	O
cell	O
line	O
.	O

Other	O
adverse	O
events	O
with	O
incidences	O
significantly	O
higher	O
than	O
with	O
placebo	O
were	O
dizziness	O
,	O
constipation	O
,	O
sweating	O
,	O
nervousness	O
,	O
and	O
abnormal	O
ejaculation	O
.	O

Homology	O
was	O
also	O
detected	O
between	O
the	O
putative	O
transit	O
peptide	O
sequence	O
of	O
cysteine	B
synthase	I
C	I
and	O
other	O
mitochondrion	O
-	O
targeting	O
leader	O
sequences	O
.	O

Furthermore	O
,	O
our	O
data	O
also	O
show	O
that	O
,	O
in	O
addition	O
to	O
TEF-1	B
,	O
another	O
HF-1a	B
-	I
related	I
factor	I
may	O
be	O
recognized	O
by	O
the	O
alpha	B
-	I
MHC	I
gene	I
EM	O
element	O
.	O

Therefore	O
,	O
mechanisms	O
that	O
control	O
activation	O
of	O
the	O
MAP	B
kinase	I
cascade	O
temporally	O
and	O
spatially	O
may	O
be	O
important	O
for	O
specification	O
of	O
cellular	O
responses	O
.	O

This	O
motif	O
is	O
similar	O
to	O
but	O
distinct	O
from	O
the	O
LIM	B
domain	I
and	O
the	O
RING	B
finger	I
family	I
,	O
and	O
is	O
reminiscent	O
of	O
known	O
metal	O
-	O
binding	O
regions	O
.	O

The	O
P131	O
ORF	O
is	O
followed	O
in	O
-	O
frame	O
by	O
a	O
second	O
ORF	O
which	O
is	O
probably	O
expressed	O
by	O
partial	O
readthrough	O
of	O
the	O
UGA	O
termination	O
codon	O
of	O
the	O
P131	O
ORF	O
to	O
produce	O
a	O
polypeptide	O
of	O
M	O
(	O
r	O
)	O
191044	O
(	O
P191	O
)	O
.	O

One	O
hundred	O
fifty	O
patients	O
were	O
reviewed	O
at	O
1	O
year	O
after	O
arthroplasty	O
.	O

Segments	O
with	O
more	O
reduced	O
BMIPP	O
uptake	O
than	O
MIBI	O
uptake	O
(	O
mismatching	O
)	O
showed	O
either	O
normal	O
wall	O
motion	O
or	O
demonstrated	O
inotropic	O
reserve	O
during	O
dobutamine	O
stimulation	O
.	O

The	O
defined	O
length	O
of	O
the	O
mRNA	O
,	O
1,838	O
nucleotides	O
,	O
was	O
in	O
agreement	O
with	O
that	O
of	O
a	O
1.9-kb	O
RNA	O
expressed	O
throughout	O
the	O
replication	O
cycle	O
,	O
starting	O
at	O
the	O
early	O
stages	O
of	O
infection	O
.	O

Transient	O
transfections	O
of	O
a	O
construct	O
expressing	O
the	O
RNA	O
transcript	O
defined	O
by	O
clone	O
B1.1	O
into	O
D17	O
cells	O
led	O
to	O
the	O
expression	O
of	O
an	O
Env	B
/	O
Mlvi-4	B
fusion	O
protein	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
33	O
kDa	O
.	O

Articles	O
addressing	O
valvular	O
heart	O
disease	O
or	O
heart	O
failure	O
secondary	O
to	O
acute	O
myocardial	O
infarction	O
or	O
Chagas	O
'	O
disease	O
were	O
excluded	O
.	O

All	O
nuclear	O
receptors	O
have	O
several	O
well	O
-	O
characterized	O
structural	O
domains	O
,	O
including	O
a	O
conserved	O
DNA	O
-	O
binding	O
domain	O
,	O
and	O
a	O
ligand	O
binding	O
domain	O
at	O
the	O
carboxyl	O
terminus	O
of	O
the	O
receptor	O
.	O

The	O
sample	O
includes	O
all	O
the	O
HIV	O
-	O
infected	O
-	O
patients	O
continuously	O
referred	O
to	O
the	O
Outpatient	O
Service	O
of	O
the	O
Infectious	O
Diseases	O
dept	O
.	O

of	O
Bologna	O
's	O
""""	O
Ospedale	O
Maggiore	O
""""	O
General	O
Hospital	O
during	O
some	O
five	O
days	O
(	O
19	O
-	O
23rd	O
,	O
July	O
1993	O
)	O
.	O

Thus	O
,	O
the	O
presence	O
of	O
the	O
Cln2	B
PEST	I
domain	I
was	O
sufficient	O
to	O
destabilize	O
a	O
heterologous	O
protein	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
with	O
each	O
of	O
these	O
sequences	O
demonstrated	O
complexes	O
with	O
mobilities	O
identical	O
to	O
those	O
of	O
the	O
NF	B
-	I
kappa	I
B	I
site	I
from	O
the	O
kappa	B
light	I
-	I
chain	I
gene	I
.	O

Although	O
a	O
carboxyl	O
-	O
terminal	O
HSF	B
transcriptional	O
activation	O
domain	O
is	O
critical	O
for	O
the	O
activation	O
of	O
CUP1	B
transcription	O
in	O
response	O
to	O
both	O
heat	O
shock	O
stress	O
and	O
glucose	O
starvation	O
,	O
this	O
region	O
is	O
dispensable	O
for	O
transient	O
heat	O
shock	O
activation	O
of	O
at	O
least	O
two	O
genes	O
encoding	O
members	O
of	O
the	O
S.	O
cerevisiae	O
hsp70	B
family	I
.	O

We	O
have	O
recently	O
detected	O
high	O
levels	O
of	O
CKB	B
mRNA	I
in	O
HeLa	O
cells	O
and	O
,	O
in	O
this	O
study	O
,	O
have	O
tested	O
whether	O
this	O
may	O
be	O
due	O
to	O
the	O
extremely	O
low	O
amounts	O
of	O
p53	B
protein	I
present	O
in	O
HeLa	O
cells	O
.	O

A	O
normal	O
systemic	O
response	O
was	O
obtained	O
after	O
IF	O
,	O
indicating	O
that	O
rhG	B
-	I
CSF	I
retains	O
activity	O
in	O
the	O
solid	O
state	O
.	O

PAI-1	B
levels	O
increased	O
significantly	O
in	O
patients	O
who	O
received	O
iohexol	O
but	O
not	O
in	O
those	O
who	O
received	O
ioxaglate	O
.	O

The	O
recovery	O
value	O
of	O
systolic	O
pressure	O
was	O
higher	O
than	O
diastolic	O
pressure	O
and	O
pulse	O
pressure	O
increased	O
.	O

The	O
importance	O
of	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
infection	O
as	O
a	O
cause	O
of	O
chronic	O
liver	O
disease	O
has	O
become	O
clear	O
with	O
the	O
introduction	O
of	O
serologic	O
detection	O
methods	O
.	O

Human	O
adenovirus	O
type	O
41	O
contains	O
two	O
fibers	O
.	O

Outflow	O
obstruction	O
of	O
pancreatic	O
juice	O
,	O
i.e.	O
,	O
""""	O
relative	O
stenosis	O
of	O
the	O
minor	O
papilla	O
,	O
""""	O
was	O
considered	O
to	O
be	O
present	O
in	O
the	O
patients	O
with	O
type	O
II	O
papilla	O
,	O
and	O
,	O
therefore	O
,	O
the	O
patients	O
with	O
type	O
II	O
papilla	O
might	O
suffer	O
from	O
acute	O
pancreatitis	O
resulting	O
from	O
poor	O
drainage	O
of	O
pancreatic	O
juice	O
and	O
excessive	O
pressure	O
in	O
the	O
dorsal	O
duct	O
.	O

In	O
the	O
ISO	O
group	O
,	O
at	O
pre	O
-	O
DEX	O
,	O
CBF	O
increased	O
from	O
86	O
+	O
/-	O

8	O
to	O
166	O
+	O
/-	O

19	O
mL.min-1.100	O
g-1	O
in	O
response	O
to	O
hypercapnia	O
(	O
PCO2	O
approximately	O
90	O
mmHg	O
)	O
.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

In	O
H4IIE	O
rat	O
hepatoma	O
cells	O
,	O
glucocorticoids	O
,	O
retinoic	O
acid	O
and	O
cyclic	O
AMP	O
(	O
cAMP	O
)	O
increase	O
PEPCK	B
gene	I
transcription	O
whereas	O
insulin	B
and	O
phorbol	O
esters	O
have	O
the	O
opposite	O
effect	O
.	O

Acta	O
572	O
,	O
113	O
-	O
120	O
]	O
.	O

A	O
stretch	O
of	O
16	O
nucleotides	O
just	O
upstream	O
of	O
the	O
IL-4RE	B
contributed	O
to	O
IL-4	B
inducibility	O
and	O
formed	O
nucleoprotein	O
complexes	O
with	O
constitutive	O
factors	O
.	O

Our	O
previous	O
study	O
suggested	O
that	O
pertussis	B
toxin	I
(	O
IAP	B
)	O
-sensitive	O
GTP	B
-	I
binding	I
protein	I
(	I
s	I
)	I
(	O
G	B
-	I
protein	I
)	O
is	O
involved	O
in	O
the	O
process	O
of	O
differentiation	O
by	O
hormones	O
/	O
IBMX	O
,	O
accompanied	O
by	O
c	B
-	I
fos	I
induction	O
.	O

ATX	B
,	O
like	O
PC-1	B
,	O
was	O
found	O
to	O
hydrolyze	O
the	O
type	B
I	I
phosphodiesterase	I
substrate	O
p	O
-	O
nitrophenyl	O
thymidine-5'-monophosphate	O
.	O

The	O
effect	O
of	O
site	O
-	O
specific	O
mutations	O
in	O
the	O
mouse	B
platelet	I
-	I
derived	I
growth	I
factor	I
(	I
PDGF	I
)	I
beta	I
-	I
receptor	I
on	O
activation	O
of	O
the	O
Na+	B
/	I
H+	I
exchanger	I
was	O
examined	O
in	O
normal	O
murine	O
mammary	O
gland	O
epithelial	O
(	O
NMuMG	O
)	O
and	O
Chinese	O
hamster	O
ovary	O
(	O
CHO	O
)	O
cells	O
.	O

Sequence	O
analysis	O
revealed	O
:	O
1	O
)	O
a	O
kinase	O
catalytic	O
domain	O
most	O
characteristic	O
of	O
serine	B
/	I
threonine	I
kinases	I
but	O
hybrid	O
between	O
members	O
of	O
the	O
family	O
of	O
microtubule	B
-	I
associated	I
protein	I
kinase	I
kinase	I
kinases	I
and	O
the	O
fibroblast	B
growth	I
factor	I
receptor	I
family	I
;	O
2	O
)	O
two	O
putative	O
alpha	O
-	O
helical	O
leucine	O
zipper	O
motifs	O
separated	O
by	O
a	O
25-amino	O
acid	O
charged	O
intermediate	O
segment	O
but	O
lacking	O
an	O
NH2-terminal	O
basic	O
domain	O
;	O
and	O
3	O
)	O
COOH	O
-	O
terminal	O
and	O
NH2-terminal	O
proline	O
-	O
rich	O
domains	O
suggestive	O
of	O
src	B
homology	I
3	I
(	O
SH3	B
)	O
domain	O
binding	O
regions	O
.	O

Type	O
2	O
genomes	O
containing	O
this	O
sequence	O
presumably	O
more	O
closely	O
reflect	O
the	O
structure	O
of	O
the	O
infectious	O
,	O
replication	O
-	O
competent	O
retrovirus	O
ancestors	O
of	O
the	O
HERV	O
-	O
K	O
family	O
than	O
do	O
type	O
1	O
genomes	O
that	O
lack	O
the	O
sequence	O
.	O

However	O
,	O
when	O
domain	O
I	O
and	O
domain	O
II	O
were	O
linked	O
on	O
the	O
same	O
plasmid	O
,	O
high	O
levels	O
of	O
replication	O
were	O
observed	O
.	O

Point	O
mutations	O
that	O
suppressed	O
the	O
in	O
vitro	O
binding	O
of	O
NF	B
-	I
Y	I
to	O
the	O
internal	O
palindromic	O
arm	O
reduced	O
the	O
activity	O
of	O
the	O
resident	O
P4	O
promoter	O
,	O
while	O
those	O
preventing	O
complex	O
formation	O
with	O
USF	B
did	O
not	O
,	O
as	O
determined	O
by	O
transient	O
expression	O
assays	O
using	O
the	O
luciferase	B
reporter	O
gene	O
.	O

Surprisingly	O
,	O
Northern	O
(	O
RNA	O
)	O
blot	O
analysis	O
and	O
reverse	B
transcriptase	I
-	O
PCRs	O
performed	O
after	O
transfection	O
of	O
COS-7	O
or	O
HeLa	O
cells	O
with	O
these	O
viral	O
RNAs	O
revealed	O
that	O
Y88S	B
and	O
Y88L	B
RNAs	I
replicated	O
at	O
only	O
very	O
low	O
levels	O
.	O

Moreover	O
,	O
by	O
complementation	O
of	O
the	O
WA	B
fyuA	I
mutant	I
by	O
the	O
cloned	O
fyuA	B
gene	I
,	O
yersiniabactin	O
uptake	O
and	O
mouse	O
virulence	O
were	O
restored	O
.	O

The	O
other	O
element	O
bound	O
RBP	B
-	I
J	I
kappa	I
with	O
low	O
affinity	O
.	O

The	O
basal	O
promoter	O
strength	O
of	O
constructs	O
that	O
contained	O
deletions	O
in	O
the	O
U5	B
region	I
of	O
the	O
LTR	O
was	O
analyzed	O
by	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
assays	O
following	O
transfection	O
of	O
HeLa	O
cells	O
or	O
Jurkat	O
T	O
-	O
cells	O
in	O
the	O
presence	O
or	O
absence	O
of	O
viral	O
transactivator	O
tax	B
protein	O
.	O

Recently	O
,	O
a	O
protein	O
designated	O
GF14	B
has	O
been	O
isolated	O
that	O
is	O
associated	O
with	O
the	O
GBF	B
protein	I
complex	I
.	O

Propafenone	O
is	O
well	O
tolerated	O
in	O
the	O
majority	O
of	O
young	O
patients	O
.	O

2	O
patients	O
(	O
11	O
%	O
)	O
had	O
significant	O
morbidity	O
502	O
and	O
529	O
days	O
respectively	O
after	O
transplantation	O
.	O

A	O
recent	O
index	O
(	O
Fluorosis	O
Risk	O
Index	O
)	O
developed	O
by	O
Pendrys	O
(	O
1990	O
)	O
is	O
also	O
included	O
in	O
this	O
review	O
.	O

Alternative	O
splicing	O
of	O
the	O
cytoplasmic	O
tail	O
appears	O
to	O
generate	O
multiple	O
PECAM-1	B
isoforms	I
that	O
may	O
regulate	O
phosphorylation	O
,	O
cytoskeletal	O
association	O
,	O
and	O
affinity	O
modulation	O
of	O
the	O
mature	O
protein	O
.	O

Transfer	O
also	O
correlated	O
inversely	O
with	O
gastric	O
juice	O
pH	O
(	O
r	O
=	O
-0.619	O
,	O
P	O
<	O
0.02	O
)	O
.	O

If	O
this	O
is	O
present	O
,	O
such	O
patients	O
should	O
be	O
closely	O
monitored	O
,	O
and	O
any	O
atypical	O
lesions	O
biopsied	O
.	O

Cumulated	O
maximum	O
lod	O
scores	O
between	O
FRDA	B
and	O
D9S5	B
and	O
between	O
FRDA	B
and	O
D9S15	B
are	O
above	O
36	O
and	O
61	O
,	O
respectively	O
,	O
at	O
a	O
recombination	O
fraction	O
of	O
0	O
,	O
indicating	O
that	O
recombination	O
events	O
needed	O
to	O
orient	O
the	O
search	O
of	O
the	O
gene	O
are	O
very	O
difficult	O
to	O
identify	O
and	O
ascertain	O
.	O

A	O
receptor	B
-	I
like	I
protein	I
kinase	I
,	O
OsPK10	B
,	O
has	O
been	O
cloned	O
from	O
rice	O
(	O
Oryza	O
sativa	O
)	O
.	O

Goodpasture's	O
-	O
like	O
syndrome	O
and	O
effect	O
of	O
extracorporeal	O
membrane	O
oxygenator	O
support	O
.	O

A	O
cDNA	O
clone	O
pCZ1	O
,	O
with	O
a	O
1.1	O
kb	O
insert	O
,	O
was	O
isolated	O
from	O
a	O
NaCl	O
-	O
adapted	O
tobacco	O
cell	O
cDNA	O
library	O
that	O
encodes	O
an	O
apparently	O
full	O
-	O
length	O
29	O
kDa	O
protein	O
(	O
251	O
amino	O
acids	O
)	O
with	O
a	O
calculated	O
pI	O
of	O
5.7	O
.	O

The	O
git1	B
,	O
git3	B
,	O
git5	B
,	O
git7	B
,	O
git8	B
and	O
git10	B
genes	I
act	O
upstream	O
of	O
adenylate	B
cyclase	I
,	O
presumably	O
encoding	O
an	O
adenylate	B
cyclase	I
activation	O
pathway	O
.	O

These	O
same	O
regions	O
showed	O
remarkable	O
homology	O
to	O
two	O
invertebrate	O
proteins	O
,	O
CNC	B
and	O
skin-1	B
,	O
postulated	O
to	O
regulate	O
embryonic	O
development	O
in	O
Drosophila	O
melanogaster	O
and	O
Caenorhabditis	O
elegans	O
,	O
respectively	O
.	O

DNA	O
sequence	O
analysis	O
has	O
confirmed	O
that	O
this	O
mutation	O
affects	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
alpha	O
subunit	O
,	O
changing	O
a	O
leucine	O
residue	O
at	O
position	O
290	O
to	O
a	O
histidine	O
(	O
rpoAL290H	B
)	O
.	O

CONCLUSIONS	O
:	O
These	O
findings	O
indicate	O
a	O
physical	O
barrier	O
of	O
oesophageal	O
surfactant	O
which	O
could	O
offer	O
some	O
degree	O
of	O
protection	O
against	O
gastro	O
-	O
oesophageal	O
reflux	O
but	O
one	O
which	O
is	O
particularly	O
prone	O
to	O
attack	O
by	O
bile	O
.	O

Differential	O
screening	O
of	O
mitochondrial	O
cDNA	O
libraries	O
from	O
male	O
-	O
fertile	O
and	O
cytoplasmic	O
male	O
-	O
sterile	O
sugar	O
-	O
beet	O
reveals	O
genome	O
rearrangements	O
at	O
atp6	B
and	O
atpA	B
loci	I
.	O

I	O
hypothesize	O
that	O
white	B
gene	I
expression	O
from	O
P	B
[	I
en	I
]	I
is	O
repressed	O
by	O
the	O
formation	O
of	O
a	O
protein	O
complex	O
which	O
is	O
initiated	O
at	O
the	O
engrailed	B
PS	I
sites	I
and	O
also	O
requires	O
interactions	O
with	O
flanking	O
genomic	O
DNA	O
.	O

SPP41	B
was	O
cloned	O
and	O
sequenced	O
and	O
found	O
to	O
be	O
essential	O
.	O

spp43	B
is	O
allelic	O
to	O
the	O
previously	O
identified	O
suppressor	B
srn1	I
,	O
which	O
encodes	O
a	O
negative	O
regulator	O
of	O
gene	O
expression	O
.	O

To	O
see	O
if	O
a	O
pulse	O
oximeter	O
can	O
monitor	O
the	O
fetus	O
during	O
labour	O
we	O
recruited	O
100	O
Caucasian	O
women	O
in	O
normal	O
uncomplicated	O
labour	O
.	O

A	O
causal	O
analysis	O
of	O
secondary	O
variables	O
showed	O
that	O
the	O
formation	O
of	O
FB	O
memories	O
was	O
primarily	O
associated	O
with	O
the	O
level	O
of	O
importance	O
attached	O
to	O
the	O
event	O
and	O
level	O
of	O
affective	O
response	O
to	O
the	O
news	O
.	O

The	O
IPL1	B
gene	I
is	O
required	O
for	O
high	O
-	O
fidelity	O
chromosome	O
segregation	O
in	O
the	O
budding	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

2	O
.	O

No	O
drop	O
in	O
oxygen	O
saturation	O
(	O
SaO2	O
)	O
or	O
visual	O
evidence	O
of	O
transient	O
electroencephalographic	O
(	O
EEG	O
)	O
arousals	O
can	O
be	O
found	O
at	O
repeat	O
polysomnography	O
.	O

The	O
complete	O
gene	O
organization	O
was	O
obtained	O
by	O
combining	O
the	O
results	O
of	O
the	O
sequence	O
of	O
these	O
clones	O
and	O
those	O
of	O
the	O
characterization	O
of	O
polymerase	O
chain	O
reaction	O
-	O
amplified	O
genomic	O
segments	O
.	O

Mammalian	B
ABPs	I
and	O
SHBGs	B
bind	O
sex	O
steroids	O
with	O
high	O
affinity	O
,	O
but	O
some	O
binding	O
properties	O
differ	O
among	O
species	O
.	O

Sample	O
treatment	O
was	O
optimized	O
in	O
order	O
to	O
achieve	O
a	O
complete	O
extraction	O
of	O
labetalol	O
diastereoisomers	O
and	O
to	O
avoid	O
racemization	O
during	O
extraction	O
.	O

A	O
more	O
complete	O
analysis	O
of	O
dose	O
response	O
,	O
time	O
and	O
mode	O
of	O
Ga	O
administration	O
(	O
preinjury	O
or	O
postinjury	O
)	O
,	O
and	O
availability	O
of	O
Ga	O
across	O
the	O
blood	O
-	O
brain	O
barrier	O
is	O
needed	O
to	O
further	O
evaluate	O
the	O
efficacy	O
of	O
this	O
compound	O
.	O

The	O
presence	O
of	O
regulatory	O
sequences	O
for	O
the	O
binding	O
of	O
transcription	O
factors	O
such	O
as	O
NF	B
-	I
kappa	I
B	I
and	O
AP-2	B
,	O
whose	O
activation	O
is	O
associated	O
with	O
the	O
immediate	O
response	O
of	O
the	O
cell	O
to	O
an	O
injury	O
,	O
may	O
be	O
an	O
indication	O
of	O
the	O
important	O
role	O
which	O
HO-1	B
may	O
play	O
in	O
defense	O
mechanisms	O
against	O
tissue	O
injury	O
.	O

The	O
femoroarterial	O
coronary	O
sinus	O
difference	O
in	O
lactate	O
turned	O
negative	O
,	O
and	O
pH	O
,	O
PCO2	O
and	O
potassium	O
differences	O
increased	O
in	O
group	O
2	O
during	O
pacing	O
.	O

A	O
randomised	O
,	O
controlled	O
trial	O
was	O
undertaken	O
in	O
40	O
patients	O
with	O
active	O
Crohn	O
's	O
disease	O
to	O
evaluate	O
clinical	O
and	O
nutritional	O
outcomes	O
after	O
an	O
amino	O
acid	O
based	O
diet	O
containing	O
3	O
%	O
fat	O
was	O
given	O
by	O
a	O
feeding	O
tube	O
compared	O
with	O
a	O
peptide	O
based	O
diet	O
containing	O
33	O
%	O
fat	O
.	O

The	O
fepA	B
-	O
entD	B
and	O
fes	B
-	O
entF	B
operons	O
in	O
the	O
enterobactin	O
synthesis	O
and	O
transport	O
system	O
are	O
divergently	O
transcribed	O
from	O
overlapping	O
promoters	O
,	O
and	O
both	O
are	O
inhibited	O
by	O
the	O
Fur	B
repressor	I
protein	I
under	O
iron	O
-	O
replete	O
conditions	O
.	O

Sequence	O
analysis	O
of	O
a	O
6.3-kbp	O
genomic	O
EcoRI	B
-	O
fragment	O
of	O
Alcaligenes	O
eutrophus	O
,	O
which	O
was	O
recently	O
identified	O
by	O
using	O
a	O
dihydrolipoamide	B
dehydrogenase	I
-	O
specific	O
DNA	O
probe	O
(	O
A.	O

In	O
addition	O
,	O
we	O
sought	O
to	O
test	O
the	O
hypothesis	O
that	O
,	O
when	O
equal	O
volumes	O
are	O
administered	O
intrathecally	O
,	O
significant	O
differences	O
exist	O
in	O
the	O
potential	O
to	O
three	O
commonly	O
used	O
anesthetic	O
solutions	O
to	O
induce	O
sensory	O
impairment	O
.	O

The	O
proteins	O
encoded	O
downstream	O
of	O
rpoN	B
are	O
known	O
to	O
negatively	O
regulate	O
sigma	B
54	I
activity	O
.	O

These	O
results	O
demonstrate	O
that	O
a	O
class	O
of	O
proline	O
-	O
rich	O
activator	O
proteins	O
and	O
RNA	B
polymerase	I
II	I
possess	O
a	O
common	O
structural	O
and	O
functional	O
component	O
which	O
can	O
interact	O
with	O
the	O
same	O
target	O
in	O
the	O
general	O
transcription	O
machinery	O
.	O

Cloning	O
of	O
higher	B
plant	I
omega-3	I
fatty	I
acid	I
desaturases	I
.	O

65	O
,	O
3829	O
-	O
3838	O
,	O
1991	O
)	O
,	O
a	O
truncated	O
form	O
of	O
the	O
IE	B
polypeptide	I
lacking	O
IE	B
amino	I
acid	I
residues	I
1	I
-	I
322	I
(	O
and	O
,	O
therefore	O
lacks	O
the	O
deduced	O
transcriptional	O
activation	O
domain	O
)	O
,	O
fails	O
to	O
transactivate	O
the	O
EHV-1	B
tk	I
promoter	I
,	O
but	O
retains	O
the	O
ability	O
to	O
down	O
-	O
regulate	O
the	O
EHV-1	B
IE	I
promoter	I
.	O

CONCLUSION	O
:	O
Human	O
preterm	O
birth	O
is	O
associated	O
with	O
significantly	O
lower	O
progesterone	O
/	O
17	O
beta	O
-	O
estradiol	O
ratios	O
than	O
those	O
of	O
women	O
with	O
preterm	O
labor	O
delivered	O
at	O
term	O
.	O

The	O
availability	O
of	O
sequence	O
from	O
multiple	O
species	O
has	O
permitted	O
us	O
to	O
determine	O
that	O
the	O
UBE	O
site	O
has	O
close	O
similarity	O
to	O
motifs	O
that	O
bind	O
members	O
of	O
the	O
NF-1	B
family	I
of	I
transcription	I
factors	I
.	O

The	O
mechanism	O
whereby	O
zeta	B
PKC	I
regulates	O
NF	B
-	I
kappa	I
B	I
most	O
probably	O
involves	O
the	O
activation	O
of	O
a	O
putative	O
I	B
kappa	I
B	I
kinase	I
of	O
molecular	O
mass	O
approximately	O
50	O
kDa	O
,	O
which	O
phosphorylates	O
and	O
inactivates	O
I	B
kappa	I
B.	I

Stable	O
expression	O
of	O
truncated	B
inositol	I
1,4,5-trisphosphate	I
receptor	I
subunits	I
in	O
3T3	O
fibroblasts	O
.	O

We	O
report	O
the	O
identification	O
and	O
characterization	O
of	O
myr	B
4	I
(	O
myosin	B
from	I
rat	I
)	O
,	O
the	O
first	O
mammalian	B
myosin	I
I	I
that	O
is	O
not	O
closely	O
related	O
to	O
brush	O
border	O
myosin	B
I.	I

In	O
addition	O
,	O
computer	O
analysis	O
suggests	O
that	O
sequences	O
similar	O
to	O
the	O
A	O
stem	O
element	O
are	O
present	O
within	O
the	O
three	O
AAV	B
promoter	I
regions	O
.	O

32Pi	O
labeling	O
or	O
isoelectric	O
focusing	O
analysis	O
of	O
eIF-2	B
alpha	I
from	O
conditional	O
casein	B
kinase	I
II	I
mutants	I
indicated	O
that	O
phosphorylation	O
of	O
eIF-2	B
alpha	I
is	O
abolished	O
or	O
dephosphorylated	O
forms	O
of	O
eIF-2	B
alpha	I
are	O
detected	O
when	O
these	O
strains	O
are	O
grown	O
at	O
the	O
restrictive	O
growth	O
conditions	O
.	O

The	O
R2	O
region	O
within	O
the	O
class	O
I	O
enhancer	O
acts	O
as	O
a	O
negative	O
element	O
in	O
Ad12-transformed	O
cells	O
and	O
exhibits	O
a	O
stronger	O
binding	O
activity	O
than	O
is	O
observed	O
in	O
nontumorigenic	O
Ad5-transformed	O
cells	O
,	O
which	O
are	O
not	O
reduced	O
in	O
class	O
I	O
expression	O
.	O

PURPOSE	O
:	O
To	O
evaluate	O
the	O
kinetics	O
of	O
erythropoietin	B
(	O
EPO	B
)	O
production	O
and	O
address	O
the	O
pathogenesis	O
of	O
anemia	O
of	O
prematurity	O
,	O
we	O
measured	O
EPO	B
levels	O
in	O
infants	O
during	O
the	O
first	O
year	O
of	O
life	O
.	O

We	O
speculate	O
that	O
mast	O
cell	O
degranulation	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
necrobiosis	O
by	O
altering	O
fibroblast	O
enzyme	O
activity	O
and/or	O
producing	O
prolonged	O
inflammatory	O
reactions	O
.	O

Molecular	O
cloning	O
of	O
a	O
cysteine	B
synthase	I
cDNA	I
from	O
Citrullus	O
vulgaris	O
(	O
watermelon	O
)	O
by	O
genetic	O
complementation	O
in	O
an	O
Escherichia	O
coli	O
Cys-	O
auxotroph	O
.	O

In	O
earlier	O
studies	O
we	O
identified	O
several	O
regulatory	O
elements	O
that	O
control	O
transcriptional	O
activation	O
and	O
aerobic	O
repression	O
of	O
one	O
of	O
these	O
genes	O
,	O
COX5b	B
.	O

However	O
,	O
Southern	O
blot	O
and	O
karyotype	O
analyses	O
did	O
not	O
reveal	O
any	O
significant	O
changes	O
in	O
copy	O
number	O
or	O
gross	O
rearrangements	O
of	O
the	O
p53	B
gene	I
in	O
any	O
of	O
the	O
p53-	B
cell	O
lines	O
.	O

HupI	B
showed	O
strong	O
identity	O
to	O
rubredoxin	B
and	O
rubredoxin	B
-	I
like	I
proteins	I
from	O
many	O
other	O
bacteria	O
.	O

An	O
examination	O
was	O
performed	O
in	O
15	O
patients	O
who	O
had	O
developed	O
pronounced	O
osteomalacia	O
following	O
gastric	O
resection	O
.	O

However	O
,	O
regional	O
MVO2	O
increased	O
to	O
about	O
the	O
same	O
extent	O
in	O
the	O
CFX	O
(	O
from	O
6.0	O
+	O
/-	O

0.7	O
to	O
12.4	O
+	O
/-	O

0.9	O
ml	O
O2.min-1	O
times	O
100	O
g-1	O
)	O
and	O
the	O
LAD	O
region	O
(	O
from	O
7.0	O
+	O
/-	O

0.6	O
to	O
14.5	O
+	O
/-	O

1.3	O
ml	O
O2.min-1	O
times	O
100	O
g-1	O
)	O
.	O

IGF	B
I	I
and	O
insulin	B
receptors	I
are	O
homologous	O
proteins	O
that	O
function	O
in	O
distinct	O
physiological	O
pathways	O
.	O

Tryptic	O
cleavage	O
and	O
peptide	O
sequence	O
analysis	O
demonstrated	O
that	O
the	O
98-kD	O
protein	O
is	O
identical	O
to	O
a	O
recently	O
cloned	O
protein	O
,	O
special	B
A	I
-	I
T	I
-	I
rich	I
binding	I
protein	I
1	I
(	O
SATB1	B
)	O
,	O
that	O
binds	O
selectively	O
to	O
nuclear	O
matrix	O
/	O
scaffold	O
-	O
associated	O
regions	O
of	O
DNA	O
(	O
MARs	O
/	O
SARs	O
)	O
.	O

Acute	O
pancreatitis	O
:	O
a	O
multisystem	O
disease	O
.	O

Alginate	O
biosynthesis	O
is	O
controlled	O
by	O
a	O
complex	O
regulatory	O
mechanism	O
.	O

The	O
sequence	O
upstream	O
of	O
the	O
rhlA	B
promoter	I
contains	O
two	O
inverted	O
repeats	O
which	O
define	O
putative	O
binding	O
sites	O
for	O
the	O
RhlR	B
regulator	I
.	O

Heparin	O
had	O
no	O
effect	O
on	O
rAC	B
-	I
st	I
myosin	I
light	I
chain	I
phosphatase	I
activity	O
,	O
while	O
the	O
B	O
subunit	O
-	O
containing	O
forms	O
were	O
stimulated	O
2	O
-	O
3-fold	O
.	O

BACKGROUND	O
AND	O
DESIGN	O
:	O
Fifty	O
-	O
nine	O
melanocytic	O
nevi	O
with	O
eccentric	O
foci	O
of	O
hyperpigmentation	O
(	O
""""	O
small	O
dark	O
dots	O
""""	O
)	O
that	O
measured	O
primarily	O
1	O
to	O
2	O
mm	O
in	O
diameter	O
were	O
prospectively	O
examined	O
to	O
determine	O
the	O
histologic	O
correlates	O
of	O
the	O
dark	O
dots	O
.	O

The	O
central	O
globular	O
domain	O
is	O
highly	O
similar	O
to	O
those	O
regions	O
from	O
other	O
H1	B
molecules	I
,	O
and	O
the	O
carboxyl	O
-	O
terminal	O
domain	O
contains	O
a	O
repeating	O
hexapeptide	O
motif	O
,	O
variants	O
of	O
which	O
are	O
conserved	O
among	O
H1	B
molecules	I
.	O

A	O
single	O
NMSC	O
was	O
present	O
in	O
69.4	O
%	O
,	O
two	O
in	O
16	O
%	O
,	O
three	O
in	O
6.4	O
%	O
,	O
four	O
in	O
3.5	O
%	O
,	O
five	O
to	O
nine	O
in	O
4.2	O
%	O
,	O
and	O
0.5	O
%	O
had	O
ten	O
or	O
more	O
.	O

A	O
constitutive	O
mutant	O
form	O
with	O
a	O
single	O
substitution	O
(	O
V88A	O
)	O
in	O
the	O
amino	O
-	O
terminal	O
(	O
response	O
regulator	O
)	O
region	O
was	O
used	O
.	O

CONCLUSION	O
:	O
Sonographic	O
angiography	O
has	O
a	O
possible	O
role	O
in	O
the	O
detection	O
of	O
small	O
nodules	O
in	O
patients	O
with	O
CRF	O
.	O

The	O
first	O
85	O
nt	O
upstream	O
of	O
the	O
transcription	O
initiation	O
site	O
of	O
the	O
mouse	B
desmin	I
gene	I
,	O
which	O
contain	O
an	O
E	O
box	O
(	O
E1	O
)	O
,	O
the	O
binding	O
site	O
of	O
the	O
helix	B
-	I
loop	I
-	I
helix	I
myogenic	I
regulators	I
,	O
are	O
sufficient	O
to	O
confer	O
low	O
level	O
muscle	O
-	O
specific	O
expression	O
.	O

We	O
find	O
that	O
beta	B
II	I
PKC	I
phosphorylates	O
nuclear	B
envelope	I
lamin	I
B	I
at	O
10	O
-	O
20	O
times	O
the	O
rate	O
of	O
alpha	B
PKC	I
,	O
whereas	O
both	O
kinases	O
phosphorylate	O
soluble	B
lamin	I
B	I
at	O
similar	O
rates	O
.	O

Regulation	O
of	O
parathyroid	B
hormone	I
-	I
related	I
protein	I
(	O
PTHrP	B
)	O
gene	O
expression	O
.	O

These	O
results	O
demonstrate	O
that	O
a	O
diverse	O
set	O
of	O
carboxyl	O
-	O
terminal	O
sequence	O
motifs	O
and	O
posttranslational	O
modifications	O
lead	O
to	O
functional	O
Ras	B
proteins	I
in	O
yeast	O
.	O

We	O
conclude	O
that	O
c	B
-	I
Abl	I
activates	O
c	B
-	I
myc	I
transcription	O
indirectly	O
with	O
no	O
requirement	O
for	O
DNA	O
binding	O
by	O
c	B
-	I
Abl	I
.	O

Extensive	O
DNA	O
rearrangement	O
occurs	O
during	O
the	O
development	O
of	O
the	O
somatic	O
macronucleus	O
from	O
the	O
germ	O
line	O
micronucleus	O
in	O
ciliated	O
protozoans	O
.	O

An	O
in	O
vitro	O
binding	O
site	O
selection	O
procedure	O
was	O
used	O
to	O
determine	O
DNA	O
sequences	O
preferentially	O
bound	O
by	O
wild	B
-	I
type	I
HLF	I
and	O
chimeric	O
E2A	B
-	O
HLF	B
proteins	O
isolated	O
from	O
various	O
t	O
(	O
17;19	O
)	O
-bearing	O
leukemias	O
.	O

The	O
Oct-2	B
glutamine	O
-	O
rich	O
and	O
proline	O
-	O
rich	O
activation	O
domains	O
can	O
synergize	O
with	O
each	O
other	O
or	O
duplicates	O
of	O
themselves	O
to	O
activate	O
transcription	O
.	O

Binding	O
of	O
U2	B
small	I
nuclear	I
ribonucleoprotein	I
(	O
snRNP	O
)	O
to	O
the	O
pre	O
-	O
mRNA	O
is	O
an	O
early	O
and	O
important	O
step	O
in	O
spliceosome	O
assembly	O
.	O

Marine	O
oils	O
and	O
cardiovascular	O
reactivity	O
.	O

The	O
diagnostic	O
significance	O
of	O
creatine	B
phosphokinase	I
antibodies	O
in	O
the	O
cardiac	O
muscle	O
in	O
non	O
-	O
coronarogenic	O
myocardial	O
diseases	O

According	O
to	O
the	O
results	O
of	O
assays	O
obtained	O
with	O
the	O
use	O
of	O
assay	O
systems	O
ORTHO	O
ELISA	O
and	O
ABBOTT	O
HCV	O
EIA	O
(	O
USA	O
)	O
,	O
the	O
detection	O
rate	O
of	O
anti	B
-	I
HCV	I
-	I
C100	I
-	I
3	I
among	O
primary	O
blood	O
donors	O
in	O
Moscow	O
was	O
1.37	O
%	O
and	O
was	O
not	O
different	O
from	O
that	O
among	O
HBsAg	B
carriers	O
(	O
1.8	O
%	O
)	O
and	O
among	O
donors	O
with	O
anti	B
-	I
HCV	I
-	I
C100	I
-	I
3	I
in	O
the	O
blood	O
(	O
1.6	O
%	O
)	O
(	O
p	O
<	O
0.01	O
)	O
.	O

We	O
examined	O
the	O
hypothesis	O
that	O
the	O
coronary	O
vasomotor	O
responses	O
to	O
etomidate	O
(	O
ETO	O
)	O
,	O
propofol	O
(	O
PRO	O
)	O
,	O
and	O
sodium	O
thiopental	O
(	O
STP	O
)	O
are	O
mediated	O
through	O
contrasting	O
effects	O
on	O
the	O
resting	O
nitric	O
oxide	O
(	O
NO	O
)	O
-dependent	O
vasodilator	O
tone	O
that	O
opposes	O
adrenergic	O
vasoconstrictor	O
activity	O
in	O
the	O
intact	O
dog	O
.	O

Significant	O
alterations	O
in	O
CBC	O
results	O
and	O
serum	B
CRP	I
concentration	O
,	O
compared	O
with	O
baseline	O
values	O
,	O
were	O
lacking	O
in	O
dogs	O
of	O
the	O
control	O
group	O
.	O

These	O
alternative	O
splice	O
variants	O
were	O
detected	O
in	O
RNA	O
isolated	O
from	O
several	O
sources	O
,	O
including	O
primary	O
leptomeningeal	O
tissue	O
and	O
an	O
established	O
line	O
of	O
leptomeningeal	O
cells	O
(	O
LMC	O
)	O
.	O

Surface	O
-	O
coil	O
experiments	O
on	O
phantoms	O
and	O
on	O
human	O
calf	O
muscles	O
in	O
vivo	O
are	O
presented	O
.	O

Large	O
interpatient	O
variation	O
in	O
peak	O
PCZ	O
plasma	O
levels	O
(	O
91	O
-	O
3215	O
ng	O
/	O
ml	O
)	O
was	O
seen	O
,	O
with	O
the	O
plasma	O
half	O
-	O
life	O
(	O
t1	O
/	O
2	O
alpha	O
)	O
being	O
approximately	O
57	O
min	O
in	O
patients	O
given	O
135	O
-	O
180	O
mg	O
/	O
m2	O
PCZ	O
.	O

The	O
maximal	O
effect	O
was	O
seen	O
at	O
100	O
ng	O
/	O
ml	O
EGF	B
,	O
with	O
a	O
time	O
lag	O
of	O
about	O
5	O
h.	O

KAR1	B
encodes	O
an	O
essential	O
component	O
of	O
the	O
yeast	O
spindle	O
pole	O
body	O
(	O
SPB	O
)	O
that	O
is	O
required	O
for	O
karyogamy	O
and	O
SPB	O
duplication	O
.	O

During	O
transcript	O
elongation	O
,	O
the	O
sizes	O
of	O
the	O
DNA	O
footprint	O
and	O
the	O
single	O
-	O
stranded	O
transcription	O
bubble	O
vary	O
markedly	O
among	O
transcription	O
complexes	O
halted	O
at	O
different	O
template	O
positions	O
.	O

All	O
our	O
patients	O
had	O
polyps	O
,	O
23	O
(	O
54	O
%	O
)	O
had	O
asthma	O
,	O
12	O
(	O
27	O
%	O
)	O
had	O
aspirin	O
sensitivity	O
,	O
20	O
(	O
65	O
%	O
)	O
had	O
eosinophilia	O
,	O
and	O
9	O
(	O
69	O
%	O
)	O
had	O
increased	O
total	O
IgE	B
levels	O
.	O

A	O
short	O
sequence	O
surrounding	O
the	O
major	O
JNK	B
phosphorylation	O
site	O
of	O
c	B
-	I
Jun	I
is	O
conserved	O
in	O
c	B
-	I
Fos	I
and	O
is	O
part	O
of	O
its	O
activation	O
domain	O
,	O
suggesting	O
that	O
c	B
-	I
Fos	I
may	O
be	O
similarly	O
regulated	O
.	O

c	B
-	I
Fos	I
transcriptional	O
activity	O
stimulated	O
by	O
H	B
-	I
Ras	I
-	I
activated	I
protein	I
kinase	I
distinct	O
from	O
JNK	B
and	O
ERK	B
.	O

A	O
new	O
generation	O
of	O
information	O
retrieval	O
tools	O
for	O
biologists	O
:	O
the	O
example	O
of	O
the	O
ExPASy	O
WWW	O
server	O
.	O

The	O
partial	O
ORF	O
was	O
found	O
to	O
be	O
identical	O
to	O
the	O
C	O
terminus	O
of	O
HrpJ2	B
.	O

The	O
binding	O
of	O
transcription	O
factor	O
AP-1	B
and	O
vitamin	B
D	I
receptor	I
(	O
VDR	B
)	O
to	O
the	O
composite	O
AP-1	B
plus	I
vitamin	I
-	I
D	I
-	I
responsive	I
promoter	I
region	O
(	O
AP-1	B
+	I
VDRE	I
)	O
of	O
the	O
human	B
osteocalcin	I
gene	I
was	O
characterized	O
in	O
osteocalcin	B
-	O
producing	O
(	O
MG-63	O
)	O
and	O
non	O
-	O
producing	O
(	O
U2-Os	O
,	O
SaOs-2	O
)	O
human	O
osteosarcoma	O
cell	O
lines	O
.	O

Rapid	O
detection	O
of	O
this	O
mutation	O
is	O
achieved	O
by	O
restriction	O
digestion	O
of	O
PCR	O
-	O
amplified	O
genomic	O
DNA	O
;	O
a	O
mismatch	O
primer	O
combined	O
with	O
the	O
point	O
mutation	O
creates	O
a	O
Tru9I	B
restriction	I
site	I
.	O

Wild	B
type	I
and	I
mutant	I
Epo	I
cDNAs	I
were	O
transiently	O
expressed	O
at	O
high	O
levels	O
in	O
COS1	O
and	O
COS7	O
cells	O
.	O

OBJECTIVE	O
--	O
To	O
assess	O
the	O
risk	O
of	O
hepatitis	O
A	O
in	O
international	O
travelers	O
and	O
to	O
recommend	O
preventive	O
measures	O
.	O

2	O
.	O

Acupuncture	O
effect	O
on	O
deep	O
receptors	O
was	O
not	O
limited	O
to	O
one	O
point	O
but	O
within	O
a	O
certain	O
area	O
,	O
namely	O
distant	O
effect	O
existed	O
.	O

Smoking	O
history	O
and	O
awake	O
oxygen	O
saturation	O
(	O
SaO2	O
)	O
was	O
recorded	O
in	O
all	O
of	O
them	O
.	O

This	O
mode	O
of	O
ternary	O
complex	O
formation	O
is	O
in	O
contrast	O
to	O
the	O
one	O
seen	O
in	O
the	O
promoter	O
of	O
the	O
c	B
-	I
fos	I
protooncogene	I
,	O
where	O
formation	O
of	O
the	O
ternary	O
complex	O
is	O
dependent	O
on	O
the	O
prior	O
assembly	O
of	O
the	O
serum	B
response	I
factor	I
-	I
DNA	I
binary	I
complex	I
.	O

These	O
results	O
suggest	O
that	O
leader	O
-	O
mRNA	O
fusion	O
in	O
coronavirus	O
transcription	O
does	O
not	O
require	O
direct	O
RNA	O
-	O
RNA	O
interaction	O
between	O
complementary	O
sequences	O
.	O

Vaccinia	O
virus	O
-	O
expressed	O
,	O
purified	O
full	B
-	I
length	I
HPV-16	I
and	I
BPV-1	I
E2	I
proteins	I
bound	O
a	O
consensus	O
E2	B
site	I
with	O
high	O
specific	O
affinities	O
(	O
Kd	O
=	O
approximately	O
10	O
(	O
-9	O
)	O
M	O
)	O
and	O
stimulated	O
in	O
vitro	O
transcription	O
up	O
to	O
six-	O
to	O
eightfold	O
.	O

This	O
alternatively	O
spliced	O
transcript	O
contained	O
an	O
open	O
reading	O
frame	O
extending	O
from	O
the	O
upstream	O
J	O
alpha	O
11	O
-	O
2	O
region	O
to	O
82	O
nucleotides	O
downstream	O
of	O
the	O
beginning	O
of	O
the	O
TCR	B
C	I
alpha	I
region	I
,	O
and	O
potentially	O
encoded	O
a	O
36	O
amino	O
acid	O
polypeptide	O
.	O

Demographic	O
characteristics	O
and	O
risk	O
factor	O
data	O
for	O
76,672	O
clients	O
were	O
studied	O
to	O
characterize	O
the	O
distribution	O
of	O
infection	O
with	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
and	O
the	O
use	O
of	O
counseling	O
and	O
testing	O
facilities	O
in	O
Houston	O
,	O
Tex	O
.	O

Results	O
indicate	O
that	O
KNM	O
-	O
LU	O
335	O
differs	O
from	O
both	O
human	O
and	O
chimpanzee	O
M1s	O
in	O
relative	O
distances	O
(	O
measured	O
in	O
three	O
dimensions	O
)	O
between	O
crown	O
fissure	O
termini	O
.	O

We	O
describe	O
49	O
cases	O
with	O
papillary	O
tumor	O
<	O
1	O
cm	O
.	O

Structure	O
,	O
promoter	O
analysis	O
and	O
chromosomal	O
assignment	O
of	O
the	O
human	B
APEX	I
gene	I
.	O

The	O
polyubiquitin	B
gene	I
was	O
transcribed	O
throughout	O
the	O
Volvox	O
life	O
cycle	O
with	O
peaks	O
in	O
the	O
1.6-kb	O
mRNA	O
levels	O
during	O
pre	O
-	O
cleavage	O
,	O
cleavage	O
,	O
and	O
post	O
-	O
inversion	O
.	O

Thus	O
,	O
in	O
stress	O
-	O
induced	O
arrhythmic	O
disease	O
as	O
well	O
as	O
in	O
ischemic	O
heart	O
disease	O
,	O
the	O
main	O
pathogenetic	O
links	O
are	O
outside	O
the	O
heart	O
,	O
but	O
they	O
differ	O
from	O
those	O
observed	O
in	O
ischemia	O
.	O

The	O
consensus	O
gene	O
order	O
deduced	O
by	O
combining	O
data	O
from	O
both	O
crosses	O
is	O
D2Mit1-	B
(	O
Dbh	B
,	O
Notch1	B
)	O
-	O
(	O
Col5a1,Rxra	B
)	O
-Spna2-Ab	O
l-	B
(	O
Ak1,Fpgs	B
)	O
-	O
(	O
Grp78,Pbx3	B
)	O
-	O
(	O
Epb7.2,Hc	B
,	I
Gsn	I
)	O
-Acra	O
.	O

In	O
addition	O
,	O
the	O
megabase	O
region	O
surrounding	O
the	O
dagA	B
locus	I
was	O
mapped	O
.	O

SECONDARY	O
OUTCOME	O
MEASURE	O
--	O
Double	O
-	O
blind	O
caffeine	O
-	O
withdrawal	O
evaluation	O
.	O

Elimination	O
of	O
natural	O
antibodies	O
in	O
discordant	O
xenografts	O

An	O
8-bp	O
sequence	O
(	O
ATTTCAAA	O
)	O
within	O
the	O
protected	O
region	O
shares	O
significant	O
homology	O
with	O
promoter	O
sequences	O
required	O
for	O
ethylene	O
responsiveness	O
from	O
the	O
tomato	O
fruit	O
-	O
ripening	O
E4	B
gene	I
.	O

Cowpox	O
virus	O
contains	O
two	O
copies	O
of	O
an	O
early	B
gene	I
encoding	O
a	O
soluble	O
secreted	O
form	O
of	O
the	O
type	B
II	I
TNF	I
receptor	I
.	O

DNase	B
I	I
footprinting	O
analysis	O
indicated	O
that	O
DREF	B
binds	O
to	O
the	O
24-bp	O
DRE	O
region	O
of	O
the	O
DNA	B
polymerase	I
alpha	I
gene	I
in	O
which	O
8-bp	O
palindromic	O
sequences	O
are	O
centered	O
.	O

However	O
,	O
tyrA	B
can	O
be	O
expressed	O
efficiently	O
from	O
an	O
internal	O
promoter	O
which	O
appears	O
to	O
lie	O
within	O
the	O
3	O
'	O
portion	O
of	O
aroF.	B

Within	O
the	O
span	O
of	O
attenuator	O
region	O
encoding	O
the	O
three	O
stem	O
-	O
loop	O
structures	O
of	O
mRNA	O
secondary	O
configuration	O
,	O
hot	O
spots	O
of	O
base	O
-	O
residue	O
divergence	O
were	O
localized	O
to	O
looped	O
-	O
out	O
regions	O
.	O

Most	O
,	O
however	O
,	O
would	O
tell	O
the	O
spouse	O
the	O
full	O
truth	O
about	O
both	O
diagnosis	O
and	O
prognosis	O
.	O

Previous	O
studies	O
showed	O
that	O
mutations	O
in	O
the	O
6	O
K	O
protein	O
led	O
to	O
the	O
slow	O
release	O
of	O
aberrant	O
,	O
multi	O
-	O
cored	O
infectious	O
virions	O
.	O

Metabolism	O
of	O
calcium	O
and	O
vitamin	O
D3	O
in	O
patients	O
with	O
acute	O
tubulointerstitial	O
nephritis	O
:	O
a	O
study	O
of	O
41	O
patients	O
with	O
nephropathia	O
epidemica	O
.	O

Furthermore	O
,	O
this	O
study	O
demonstrates	O
that	O
reduced	O
inotropy	O
with	O
timolol	O
helped	O
uniform	O
local	O
contraction	O
as	O
estimated	O
by	O
the	O
increased	O
LONG	O
/	O
CIRC	O
ratio	O
,	O
a	O
transition	O
that	O
could	O
improve	O
contraction	O
efficacy	O
.	O

Effects	O
of	O
moderate	O
hypercapnia	O
on	O
hypothermia	O
induced	O
by	O
cold	O
He	O
-	O
O2	O
in	O
rats	O
.	O

The	O
RFLP	O
patterns	O
of	O
the	O
isolates	O
from	O
six	O
of	O
these	O
patients	O
remained	O
essentially	O
unchanged	O
(	O
two	O
strains	O
showed	O
one	O
additional	O
band	O
)	O
despite	O
the	O
development	O
of	O
drug	O
resistance	O
.	O

We	O
recommend	O
that	O
ovarian	O
stimulation	O
is	O
done	O
only	O
if	O
there	O
is	O
a	O
valid	O
indication	O
after	O
proper	O
assessment	O
of	O
the	O
ovaries	O
,	O
and	O
that	O
women	O
who	O
have	O
had	O
ovarian	O
stimulation	O
are	O
followed	O
for	O
longer	O
than	O
at	O
present	O
.	O

Activation	O
of	O
the	O
aboral	O
ectoderm	B
-	I
specific	I
Spec2a	I
gene	I
in	O
blastula	O
-	O
stage	O
sea	O
urchin	O
embryos	O
requires	O
an	O
upstream	O
regulatory	O
region	O
that	O
is	O
part	O
of	O
a	O
repetitive	O
sequence	O
element	O
(	O
RSR	O
)	O
associated	O
with	O
all	O
Spec1	B
/	O
Spec2	B
genes	O
.	O

A	O
transcript	O
of	O
about	O
2	O
kb	O
is	O
expected	O
for	O
each	O
PPO	B
.	O

Mutations	O
in	O
a	O
region	O
located	O
15	O
to	O
30	O
bp	O
downstream	O
from	O
the	O
major	O
transcription	O
start	O
site	O
that	O
shows	O
good	O
homology	O
to	O
a	O
sequence	O
in	O
the	O
first	O
exon	O
of	O
c	B
-	I
fos	I
implicated	O
as	O
a	O
negative	O
regulatory	O
element	O
resulted	O
in	O
a	O
significant	O
increase	O
in	O
basal	O
gene	O
expression	O
but	O
did	O
not	O
affect	O
regulation	O
.	O

Salazopyrine	O
desensitization	O

During	O
exercise	O
,	O
the	O
Pes	O
-	O
Ves	O
relation	O
was	O
shifted	O
toward	O
the	O
left	O
and	O
the	O
slope	O
[	O
end	O
-	O
systolic	O
elastance	O
(	O
Ees	O
)	O
]	O
increased	O
from	O
7.7	O
+	O
/-	O

2.8	O
to	O
12.7	O
+	O
/-	O

4.2	O
(	O
SD	O
)	O
mmHg	O
/	O
ml	O
(	O
P	O
<	O
0.05	O
)	O
.	O

We	O
show	O
that	O
HRI	B
and	O
dsRNA	B
-	I
PK	I
phosphorylate	O
yeast	B
eIF-2	I
alpha	I
in	O
vitro	O
and	O
in	O
vivo	O
and	O
functionally	O
substitute	O
for	O
GCN2	B
protein	I
to	O
stimulate	O
GCN4	B
translation	O
in	O
yeast	O
.	O

Double	O
-	O
staining	O
confirmed	O
that	O
there	O
were	O
separate	O
populations	O
of	O
CD68-positive	B
macrophages	O
and	O
XIIIa	B
-	O
positive	O
dendrocytes	O
.	O

Southern	O
analysis	O
on	O
genomic	O
DNA	O
isolated	O
from	O
tissues	O
and	O
cell	O
lines	O
from	O
several	O
mouse	O
strains	O
using	O
mCD22	B
cDNA	I
demonstrated	O
that	O
the	O
Cd22	B
locus	I
encoding	O
mCD22	B
is	O
a	O
single	O
copy	O
gene	O
of	O
<	O
or	O
=	O
30	O
kb	O
.	O

The	O
concentrations	O
of	O
plasma	O
ACTH	B
and	O
cortisol	O
increased	O
by	O
40	O
%	O
and	O
60	O
%	O
after	O
MPTP	O
treatment	O
,	O
respectively	O
.	O

Instead	O
,	O
the	O
results	O
support	O
the	O
idea	O
that	O
Pc	B
group	I
products	I
provide	O
stable	O
memory	O
or	O
imprinting	O
of	O
boundaries	O
which	O
are	O
initially	O
specified	O
by	O
gap	O
and	O
pair	O
-	O
rule	O
regulators	O
.	O

To	O
investigate	O
the	O
regulation	O
of	O
expression	O
of	O
the	O
human	B
mdr1	I
gene	I
,	O
the	O
response	O
of	O
the	O
mdr1	B
promoter	I
to	O
signals	O
involved	O
in	O
cell	O
proliferation	O
was	O
examined	O
.	O

Fenoldopam	O
,	O
a	O
dopamine	B
receptor	I
agonist	O
,	O
has	O
been	O
shown	O
,	O
in	O
animal	O
experiments	O
,	O
to	O
improve	O
renal	O
perfusion	O
.	O

In	O
the	O
3	O
'	O
flanking	O
region	O
of	O
the	O
27	B
kDa	I
zein	I
gene	I
,	O
several	O
AATAAA	O
-	O
like	O
sequences	O
and	O
a	O
sequence	O
resembling	O
the	O
mammalian	O
GT	O
-	O
rich	O
sequence	O
are	O
present	O
around	O
the	O
polyadenylation	O
sites	O
.	O

When	O
the	O
promoter	O
region	O
was	O
linked	O
with	O
a	O
heterologous	O
reporter	O
gene	O
,	O
we	O
found	O
that	O
the	O
promoter	O
region	O
is	O
inducible	O
by	O
both	O
interferons	B
(	O
interferon	B
-	I
alpha	I
and	I
-gamma	I
)	O
and	O
interferon	B
regulatory	I
factor	I
1	I
.	O

The	O
approach	O
derives	O
from	O
a	O
recently	O
described	O
strategy	O
for	O
making	O
recombinants	O
from	O
five	O
overlapping	O
EBV	O
cosmid	O
-	O
cloned	O
DNAs	O
(	O
B.	O

Comparative	O
analysis	O
with	O
an	O
antiandrogen	O
niftolid	O
and	O
synthetic	B
GnRH	I
was	O
carried	O
out	O
in	O
22	O
normal	O
subjects	O
,	O
14	O
patients	O
with	O
primary	O
and	O
20	O
ones	O
with	O
secondary	O
hypogonadism	O
,	O
and	O
in	O
5	O
patients	O
with	O
clinical	O
signs	O
of	O
gonadal	O
insufficiency	O
and	O
obscure	O
diagnosis	O
in	O
order	O
to	O
elucidate	O
the	O
pituitary	B
gonadotropin	I
reserves	O
.	O

All	O
other	O
normal	O
and	O
transformed	O
lymphoid	O
and	O
nonlymphoid	O
cell	O
lines	O
and	O
normal	O
tissues	O
were	O
negative	O
for	O
PANG	B
expression	O
except	O
for	O
the	O
brain	O
,	O
wherein	O
unique	O
4.0-	O
and	O
6.1-kb	O
transcripts	O
were	O
detected	O
.	O

The	O
cis	O
-	O
acting	O
regulatory	O
properties	O
of	O
an	O
872	O
bp	O
promoter	O
fragment	O
of	O
a	O
B.	O
napus	O
oleosin	B
gene	I
were	O
examined	O
by	O
analysis	O
of	O
beta	B
-	I
glucuronidase	I
(	O
GUS	B
)	O
expression	O
in	O
transgenic	O
tobacco	O
plants	O
containing	O
an	O
oleosin	B
promoter	I
-	O
GUS	B
transcriptional	O
fusion	O
.	O

This	O
indicates	O
that	O
the	O
mechanism	O
by	O
which	O
CX	O
blocks	O
rapid	O
degradation	O
of	O
tubulin	B
mRNA	I
in	O
vivo	O
is	O
not	O
simply	O
by	O
preventing	O
its	O
translation	O
and	O
suggests	O
the	O
involvement	O
of	O
an	O
altered	O
trans	O
-	O
factor	O
.	O

L.	O
,	O
Greer	O
,	O
J.	O
&	O
Carter	O
,	O
G.	O

Increasing	O
the	O
extracellular	O
calcium	O
concentration	O
enhanced	O
detrusor	O
contractility	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
in	O
both	O
control	O
and	O
obstructed	O
bladders	O
.	O

Structural	O
organization	O
of	O
the	O
gene	O
encoding	O
the	O
human	B
lipocalin	I
tear	I
prealbumin	I
and	O
synthesis	O
of	O
the	O
recombinant	O
protein	O
in	O
Escherichia	O
coli	O
.	O

The	O
sequence	O
has	O
a	O
1092-bp	O
open	O
reading	O
frame	O
encoding	O
a	O
protein	O
of	O
364	O
amino	O
acids	O
.	O

The	O
gene	O
organization	O
of	O
CRSV	B
RNA-1	I
is	O
similar	O
to	O
those	O
of	O
red	O
clover	O
necrotic	O
mosaic	O
(	O
RCNMV	O
)	O
and	O
sweet	O
clover	O
necrotic	O
mosaic	O
(	O
SCNMV	O
)	O
dianthoviruses	O
with	O
the	O
exception	O
that	O
CRSV	B
RNA-1	I
contains	O
the	O
additional	O
3'-terminal	O
ORF	O
.	O

Members	O
of	O
the	O
myocyte	B
-	I
specific	I
enhancer	I
-	I
binding	I
factor	I
2	I
(	O
MEF2	B
)	O
family	O
of	O
transcription	O
factors	O
bind	O
a	O
conserved	O
A	O
/	O
T	O
-	O
rich	O
sequence	O
in	O
the	O
control	O
regions	O
of	O
numerous	O
muscle	O
-	O
specific	O
genes	O
.	O

The	O
films	O
were	O
analyzed	O
using	O
a	O
scanning	O
helium	O
-	O
neon	O
laser	O
densitometer	O
with	O
a	O
small	O
aperture	O
of	O
5	O
-	O
10	O
microns	O
.	O

Viral	O
genomic	O
RNA	O
for	O
these	O
reactions	O
was	O
obtained	O
directly	O
from	O
fecal	O
specimens	O
of	O
infected	O
infant	O
rats	O
.	O

GATA-1	B
mRNA	I
was	O
present	O
in	O
equivalent	O
levels	O
in	O
both	O
erythroid	O
cell	O
lines	O
,	O
but	O
at	O
a	O
low	O
level	O
in	O
FDC	O
-	O
P1	O
cells	O
.	O

We	O
have	O
investigated	O
the	O
role	O
of	O
cellular	B
p21ras	I
protein	I
in	O
insulin	B
and	O
insulin	B
-	I
like	I
growth	I
factor	I
-	I
I	I
(	O
IGF	B
-	I
I	I
)	O
signaling	O
pathways	O
.	O

The	O
lack	O
of	O
the	O
C2	B
domain	O
of	O
the	O
Ca	B
(	I
2+	I
)	I
-dependent	I
PKCs	I
and	O
the	O
presence	O
of	O
a	O
unique	O
NH2-terminal	O
sequence	O
with	O
a	O
potential	O
signal	O
peptide	O
and	O
a	O
transmembrane	O
domain	O
suggest	O
that	O
PKC	B
mu	I
is	O
a	O
novel	O
member	O
of	O
the	O
subgroup	O
of	O
atypical	O
PKCs	B
.	O

However	O
,	O
three	O
Hm1	B
mutants	I
that	O
were	O
moderately	O
deficient	O
in	O
stimulating	O
PI	O
turnover	O
displayed	O
normal	O
sequestration	O
,	O
suggesting	O
distinct	O
mechanisms	O
.	O

Furthermore	O
,	O
in	O
vitro	O
decay	O
reaction	O
mixtures	O
supplemented	O
with	O
the	O
20-nt	O
sense	O
RNA	O
transcript	O
resulted	O
in	O
stabilization	O
of	O
R2	B
message	I
.	O

Deletion	O
analyses	O
of	O
the	O
pCD41	B
ORF	I
-	I
A	I
and	O
the	O
use	O
of	O
promoter	O
constructs	O
further	O
mapped	O
an	O
internal	O
functional	O
promoter	O
within	O
the	O
pCD41	B
sequence	I
that	O
can	O
direct	O
the	O
synthesis	O
of	O
the	O
trans	O
-	O
activating	O
protein	O
.	O

Seven	O
of	O
these	O
had	O
counterparts	O
in	O
the	O
US	O
of	O
herpes	O
simplex	O
type	O
1	O
(	O
HSV-1	O
)	O
,	O
pseudorabies	O
virus	O
(	O
PRV	O
)	O
,	O
and	O
equine	O
herpesvirus	O
type	O
1	O
(	O
EHV-1	O
)	O
.	O

The	O
inferred	O
amino	O
acid	O
sequence	O
of	O
the	O
cyanobacterial	B
HemB	I
protein	I
indicates	O
a	O
significant	O
difference	O
in	O
the	O
metal	O
cofactor	O
requirement	O
from	O
the	O
higher	O
-	O
plant	O
enzymes	O
,	O
which	O
was	O
confirmed	O
by	O
overexpression	O
and	O
biochemical	O
analysis	O
.	O

METHODS	O
AND	O
RESULTS	O
:	O
In	O
25	O
open	O
-	O
chest	O
,	O
anesthetized	O
dogs	O
,	O
progressive	O
circumflex	O
artery	O
stenosis	O
led	O
to	O
a	O
concordant	O
decrease	O
of	O
circumflex	O
artery	O
resting	O
and	O
hyperemic	O
flow	O
,	O
coronary	O
flow	O
reserve	O
,	O
and	O
inverse	O
angiographic	O
mean	O
transit	O
time	O
Tmicro-1	O
(	O
P	O
<	O
.01	O
)	O
.	O

However	O
,	O
a	O
correlation	O
was	O
observed	O
between	O
SF	O
levels	O
of	O
IL-8	B
with	O
those	O
of	O
lactate	O
,	O
LDH	B
,	O
beta	B
2-microglobulin	I
and	O
glucose	O
.	O

Although	O
inactive	O
in	O
cells	O
under	O
normal	O
conditions	O
,	O
the	O
CHOP	B
gene	I
is	O
markedly	O
induced	O
by	O
a	O
variety	O
of	O
cellular	O
stresses	O
,	O
including	O
nutrient	O
deprivation	O
and	O
metabolic	O
perturbations	O
.	O

The	O
previously	O
described	O
enhanced	O
translation	O
of	O
spinach	O
L12	B
mRNA	I
from	O
its	O
two	O
tandem	O
AUG	O
codons	O
and	O
the	O
two	O
functional	O
rpl12	B
genes	I
in	O
Arabidopsis	O
probably	O
provide	O
two	O
mechanisms	O
for	O
generating	O
the	O
four	O
copies	O
of	O
L12	B
/	I
chloroplast	I
ribosome	I
,	O
qualitatively	O
different	O
from	O
those	O
attempted	O
in	O
eubacteria	O
.	O

The	O
alpha	O
7A	O
form	O
RNA	O
contains	O
an	O
additional	O
113	O
nucleotides	O
compared	O
to	O
the	O
B	O
form	O
,	O
and	O
a	O
common	O
coding	O
region	O
in	O
the	O
A	O
and	O
B	O
form	O
RNAs	O
is	O
used	O
in	O
alternate	O
reading	O
frames	O
.	O

CRS	B
function	O
in	O
a	O
5	O
'	O
LTR	O
-	O
linked	O
gene	O
expression	O
assay	O
correlates	O
with	O
the	O
ability	O
of	O
both	O
p60CRS	B
and	O
p40CRS	B
to	O
interact	O
with	O
5	O
'	O
LTR	O
RNA	O
in	O
vitro	O
.	O

Regionalization	O
of	O
drug	O
delivery	O
is	O
a	O
potential	O
method	O
to	O
avoid	O
this	O
problem	O
.	O

MEK	B
itself	O
is	O
activated	O
via	O
serine	O
phosphorylation	O
by	O
upstream	B
activator	I
kinases	I
,	O
including	O
c	B
-	I
raf	I
,	O
mos	B
and	O
MEK	B
kinase	I
.	O

The	O
c	B
-	I
myc	I
and	O
skeletal	B
alpha	I
-	I
actin	I
gene	I
promoters	I
contain	O
YY1	B
binding	I
sites	I
thought	O
to	O
act	O
either	O
as	O
positive	O
or	O
negative	O
cis	O
-	O
acting	O
elements	O
.	O

MSSP-1	B
produced	O
in	O
E.	O
coli	O
as	O
a	O
fusion	O
protein	O
with	O
GST	B
specifically	O
interacted	O
with	O
single	O
-	O
stranded	O
TCTTAT	O
(	O
plus	O
myc	B
(	O
H	O
-	O
P	O
)	O
21	O
)	O
and	O
ACT	O
-	O
ATT	O
(	O
in	O
minus	O
myc	B
(	O
H	O
-	O
P	O
)	O
21	O
)	O
,	O
the	O
consensus	O
of	O
which	O
can	O
be	O
referred	O
to	O
as	O
A	O
/	O
TCTA	O
/	O
TA	O
/	O
TT	O
.	O

Within	O
12	O
hours	O
after	O
MR	O
tomography	O
the	O
patients	O
were	O
surgically	O
explored	O
,	O
biopsied	O
and	O
if	O
necessary	O
orchiectomised	O
.	O

The	O
results	O
show	O
that	O
both	O
the	O
amino	O
and	O
carboxy	O
termini	O
of	O
the	O
NS1	B
protein	I
molecule	I
and	O
the	O
cysteines	O
at	O
residues	O
337	O
and	O
340	O
are	O
essential	O
for	O
tubule	O
formation	O
.	O

The	O
3	O
'	O
UTR	O
has	O
several	O
stable	O
hairpins	O
that	O
are	O
flanked	O
by	O
single	O
-	O
stranded	O
(	O
A	O
/	O
U	O
)	O
UGC	O
sequences	O
.	O

Moreover	O
,	O
the	O
major	O
site	O
of	O
transcriptional	O
initiation	O
,	O
which	O
was	O
localized	O
by	O
primer	O
extension	O
250	O
bp	O
upstream	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
Ets-1	B
cDNA	I
clone	I
,	O
was	O
shown	O
to	O
be	O
identical	O
in	O
normal	O
cells	O
and	O
tumors	O
carrying	O
a	O
provirus	O
in	O
the	O
Tpl-1	B
locus	I
.	O

In	O
this	O
report	O
,	O
we	O
present	O
two	O
lines	O
of	O
evidence	O
that	O
all	O
ribosomes	O
which	O
synthesize	O
GCN4	B
have	O
previously	O
translated	O
uORF1	O
,	O
resumed	O
scanning	O
,	O
and	O
reinitiated	O
at	O
the	O
GCN4	B
start	O
site	O
.	O

Concordantly	O
,	O
it	O
was	O
shown	O
that	O
the	O
dnHLH	B
protein	I
Id1	B
inhibits	O
differentiation	O
of	O
muscle	O
and	O
myeloid	O
cells	O
in	O
vitro	O
.	O

RNP1	B
,	O
a	O
new	O
ribonucleoprotein	O
gene	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

To	O
achieve	O
complete	O
dissection	O
of	O
the	O
anterior	O
vitreous	O
,	O
we	O
remove	O
even	O
a	O
clear	O
lens	O
during	O
the	O
first	O
surgical	O
intervention	O
in	O
selected	O
cases	O
.	O

Restoration	O
of	O
opponens	O
function	O
with	O
transplantation	O
of	O
free	O
composites	O
dorsal	O
pedal	O
skin	O
flap	O
containing	O
m.	O
extensor	O
hallucis	O
brevis	O

Neither	O
ethanol	O
regimen	O
impaired	O
spontaneous	O
alternation	O
,	O
but	O
the	O
4	O
g	O
ethanol.kg-1	O
x	O
day-1	O
regimen	O
increased	O
the	O
percent	O
completed	O
trials	O
.	O

The	O
mean	O
(	O
+	O
/-	O

sd	O
)	O
intra	O
-	O
vesicular	O
pressure	O
(	O
IVP	O
)	O
and	O
maximal	O
urethral	O
closure	O
pressures	O
(	O
MUCP	O
)	O
were	O
10.3	O
(	O
+	O
/-	O

1.7	O
)	O
and	O
129.8	O
(	O
+	O
/-	O

19.6	O
)	O
cmH2O	O
,	O
respectively	O
,	O
and	O
the	O
ratio	O
between	O
MUCP	O
and	O
IVP	O
was	O
13.2	O
(	O
+	O
/-	O

2.5	O
)	O
.	O

Several	O
highly	O
conserved	O
regions	O
were	O
identified	O
at	O
the	O
near	O
N	O
terminus	O
,	O
middle	O
and	O
C	O
terminus	O
.	O

Thioredoxin	B
(	O
TR	B
)	O
is	O
a	O
small	O
ubiquitous	O
dithiol	B
-	I
reductase	I
enzyme	I
first	O
identified	O
in	O
bacteria	O
and	O
plants	O
.	O

The	O
cysteine	O
-	O
rich	O
region	O
of	O
raf-1	B
kinase	I
contains	O
zinc	O
,	O
translocates	O
to	O
liposomes	O
,	O
and	O
is	O
adjacent	O
to	O
a	O
segment	O
that	O
binds	O
GTP	B
-	I
ras	I
.	O

Kinetic	O
coupling	O
and	O
requirement	O
for	O
ATP	O
hydrolysis	O
.	O

ATP	O
by	O
itself	O
also	O
reduced	O
polypeptide	O
binding	O
to	O
Ssb1	B
/	I
2p	I
to	O
a	O
level	O
that	O
was	O
intermediate	O
between	O
that	O
observed	O
for	O
the	O
Ssa	B
Hsp70	B
proteins	I
tested	O
and	O
BiP	B
and	O
DnaK.	B

Digestion	O
of	O
NF	B
-	I
IL6	I
with	O
endoprotease	B
Asp	I
-	I
N	I
produced	O
a	O
domain	O
smaller	O
than	O
the	O
TCD	B
(	O
NF	B
-	I
IL6	I
bZIP	I
domains	I
(	O
NFBD	B
)	O
(	O
272	O
-	O
345	O
)	O
)	O
,	O
a	O
domain	O
identified	O
either	O
in	O
the	O
absence	O
or	O
the	O
presence	O
of	O
DNA	O
.	O

Signaling	O
by	O
tyrosine	B
kinases	I
involves	O
direct	O
associations	O
between	O
proteins	O
with	O
Src	B
homology	I
2	I
(	O
SH2	B
)	O
domains	O
and	O
sites	O
of	O
tyrosine	O
phosphorylation	O
.	O

Structure	O
and	O
expression	O
of	O
the	O
alternative	O
sigma	B
factor	I
,	O
RpoN	B
,	O
in	O
Rhodobacter	O
capsulatus	O
;	O
physiological	O
relevance	O
of	O
an	O
autoactivated	O
nifU2-rpoN	B
superoperon	O
.	O

Thus	O
our	O
observations	O
establish	O
a	O
functional	O
link	O
between	O
the	O
PKC	B
and	O
retinoid	O
pathways	O
,	O
which	O
are	O
generally	O
considered	O
to	O
have	O
antagonistic	O
activities	O
on	O
differentiation	O
processes	O
.	O

Expression	O
plasmids	O
harboring	O
full	O
-	O
length	O
or	O
kinase	O
domain	O
of	O
PKC	B
alpha	I
and	O
PKC	B
delta	I
(	O
PKC	B
alpha	I
K	I
and	O
PKC	B
delta	I
K	I
)	O
were	O
constructed	O
.	O

These	O
results	O
indicate	O
that	O
both	O
PKC	B
alpha	I
(	O
calcium	O
dependent	O
)	O
and	O
PKC	B
delta	I
(	O
calcium	O
independent	O
)	O
may	O
mediate	O
the	O
transcription	O
of	O
TPA	O
-	O
inducible	O
genes	O
through	O
both	O
AP-1	B
and	O
non	O
-	O
AP-1	B
sequences	O
.	O

With	O
a	O
cutoff	O
level	O
for	O
TSST-1	B
of	O
less	O
than	O
100	O
pg	O
/	O
ml	O
,	O
28	O
samples	O
obtained	O
from	O
12	O
patients	O
were	O
positive	O
for	O
TSST-1	B
.	O

Mapping	O
of	O
intracellular	O
localization	O
domains	O
and	O
evidence	O
for	O
colocalization	O
interactions	O
between	O
the	O
IE110	B
and	O
IE175	B
nuclear	O
transactivator	O
proteins	O
of	O
herpes	O
simplex	O
virus	O
.	O

The	O
revertant	O
TATA	O
boxes	O
accelerated	O
the	O
kinetics	O
of	O
HIV	O
replication	O
when	O
present	O
in	O
the	O
context	O
of	O
an	O
LTR	O
containing	O
a	O
Sp1	B
mutation	O
(	O
deletion	O
or	O
site	O
specific	O
)	O
;	O
no	O
effect	O
was	O
observed	O
on	O
the	O
infectivity	O
of	O
wild	O
-	O
type	O
HIV	O
.	O

Panlobular	O
emphysema	O

Since	O
the	O
ETS	B
domain	I
,	O
which	O
is	O
localized	O
in	O
the	O
carboxy	O
terminal	O
region	O
of	O
the	O
encoded	O
protein	O
,	O
is	O
95	O
%	O
and	O
96	O
%	O
identical	O
to	O
that	O
of	O
PEA3	B
and	O
ER81	B
,	O
respectively	O
,	O
we	O
named	O
this	O
new	O
member	O
'	B
Ets	I
Related	I
Molecule	I
PEA3-like	I
'	I
(	O
ERM	B
)	O
.	O

Gel	O
shift	O
analysis	O
indicates	O
that	O
the	O
full	B
-	I
length	I
ERM	I
protein	I
is	O
able	O
to	O
bind	O
specifically	O
to	O
an	O
oligonucleotide	O
containing	O
the	O
consensus	O
nucleotide	O
core	O
sequence	O
GGAA	O
recognized	O
by	O
the	O
Ets	B
proteins	O
.	O

Effects	O
of	O
estradiol	O
on	O
worm	O
burden	O
and	O
peripheral	O
leukocytes	O
in	O
Parastrongylus	O
malaysiensis	O
-	O
infected	O
rats	O
.	O

Sequence	O
comparisons	O
have	O
shown	O
that	O
Aps1p	B
is	O
more	O
similar	O
to	O
the	O
sigma	O
subunit	O
of	O
the	O
Golgi	O
-	O
localized	O
mammalian	O
AP-1	B
complex	I
than	O
Aps2p	B
,	O
which	O
is	O
more	O
related	O
to	O
the	O
plasma	O
membrane	O
AP-2	B
sigma	I
subunit	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
APS1	I
gene	I
encodes	O
a	O
homolog	O
of	O
the	O
small	O
subunit	O
of	O
the	O
mammalian	B
clathrin	I
AP-1	B
complex	I
:	O
evidence	O
for	O
functional	O
interaction	O
with	O
clathrin	B
at	O
the	O
Golgi	O
complex	O
.	O

These	O
results	O
are	O
the	O
first	O
to	O
demonstrate	O
the	O
structural	O
organization	O
of	O
a	O
vertebrate	O
gene	O
encoding	O
an	O
integral	O
membrane	O
protein	O
of	O
the	O
nuclear	O
envelope	O
that	O
may	O
be	O
a	O
member	O
of	O
a	O
family	O
of	O
polypeptides	O
conserved	O
in	O
evolution	O
.	O

Biochemical	O
characterization	O
of	O
valosin	B
-	I
containing	I
protein	I
,	O
a	O
protein	B
tyrosine	I
kinase	I
substrate	O
in	O
hematopoietic	O
cells	O
.	O

All	O
patients	O
with	O
deterioriation	O
in	O
mental	O
status	O
showed	O
a	O
marked	O
increase	O
in	O
liver	O
enzymes	O
(	O
aspartate	B
and	I
alanine	I
aminotransaminases	I
)	O
and	O
severe	O
coagulopathy	O
.	O

Eleven	O
patients	O
tested	O
positive	O
for	O
the	O
hepatitis	B
B	I
surface	I
antigen	I
(	O
HBsAg	B
)	O
.	O

The	O
xylose	B
isomerase	I
-	I
encoding	I
gene	I
(	O
xylA	B
)	O
of	O
Clostridium	O
thermosaccharolyticum	O
:	O
cloning	O
,	O
sequencing	O
and	O
phylogeny	O
of	O
XylA	B
enzymes	I
.	O

Surprisingly	O
,	O
TFIIIC	B
alpha	I
has	O
no	O
homology	O
to	O
any	O
of	O
the	O
yeast	B
TFIIIC	I
subunits	I
already	O
cloned	O
,	O
suggesting	O
a	O
significant	O
degree	O
of	O
evolutionary	O
divergence	O
for	O
RNA	B
polymerase	I
III	I
factors	I
.	O

Transactivation	O
domain	O
is	O
located	O
downstream	O
of	O
the	O
128-amino	B
-	I
acid	I
runt	I
homology	I
region	I
,	O
referred	O
to	O
as	O
the	O
Runt	B
domain	I
.	O

We	O
estimate	O
that	O
the	O
protease	O
activity	O
is	O
at	O
least	O
35-fold	O
greater	O
in	O
mature	O
B	O
cells	O
than	O
in	O
pre	O
-	O
B	O
cells	O
.	O

The	O
ligand	O
for	O
RXR	B
,	O
9-cis	O
retinoic	O
acid	O
,	O
has	O
the	O
opposite	O
effect	O
of	O
destabilizing	O
the	O
heterodimeric	O
-	O
DNA	O
complex	O
.	O

Therefore	O
,	O
the	O
amino	O
-	O
terminal	O
sequence	O
of	O
the	O
purified	O
carA	B
product	I
is	O
identical	O
to	O
that	O
derived	O
from	O
the	O
nucleotide	O
sequence	O
in	O
both	O
organisms	O
,	O
P.	O
stutzeri	O
having	O
four	O
additional	O
amino	O
acids	O
.	O

Aneurysmal	O
bone	O
cyst	O
of	O
the	O
jaws	O
:	O
analysis	O
of	O
11	O
cases	O
.	O

Location	O
and	O
orientation	O
of	O
an	O
activating	O
region	O
in	O
the	O
Escherichia	O
coli	O
transcription	O
factor	O
,	O
FNR	B
.	O

Moxidectin	O
(	O
at	O
3	O
times	O
the	O
therapeutic	O
dose	O
)	O
did	O
not	O
have	O
deleterious	O
effects	O
on	O
cow	O
reproductive	O
performance	O
as	O
examined	O
(	O
eg	O
,	O
at	O
folliculogenesis	O
,	O
ovulation	O
,	O
and	O
the	O
early	O
embryonic	O
phase	O
of	O
development	O
)	O
.	O

Northern	O
-	O
blot	O
analysis	O
of	O
mRNA	O
from	O
Avicel	O
-	O
grown	O
N.	O
patriciarum	O
showed	O
that	O
xynB	B
hybridized	O
to	O
a	O
3.4	O
kb	O
mRNA	O
species	O
.	O

The	O
class	B
II	I
Escherichia	I
coli	I
alanine	I
tRNA	I
synthetase	I
aminoacylates	I
RNA	I
miniduplexes	I
,	O
which	O
reconstruct	O
the	O
acceptor	O
end	O
of	O
alanine	B
tRNA	I
with	O
the	O
critical	O
G3	O
:	O
U70	O
base	O
pair	O
.	O

Simple	O
reaction	O
time	O
(	O
RT	O
)	O
to	O
a	O
peripheral	O
visual	O
target	O
(	O
S2	O
)	O
is	O
shortened	O
when	O
a	O
non	O
-	O
informative	O
cue	O
(	O
S1	O
)	O
is	O
flashed	O
at	O
the	O
S2	O
location	O
100	O
-	O
150	O
ms	O
before	O
target	O
onset	O
(	O
early	O
facilitation	O
)	O
.	O

A	O
second	O
study	O
group	O
,	O
with	O
intact	O
cardiac	O
innervation	O
,	O
consisted	O
of	O
19	O
patients	O
with	O
stable	O
angina	O
pectoris	O
class	O
I	O
to	O
III	O
.	O

Treatment	O
was	O
well	O
-	O
tolerated	O
.	O

A	O
concentration	O
of	O
12.5	O
ppm	O
SO2	O
induced	O
a	O
decrease	O
from	O
baseline	O
values	O
of	O
approximately	O
80	O
%	O
in	O
mean	O
MCA	O
and	O
of	O
roughly	O
70	O
%	O
in	O
mean	O
CBF	O
.	O

We	O
have	O
used	O
these	O
modified	O
assay	O
conditions	O
to	O
extend	O
studies	O
on	O
the	O
transposition	O
pathway	O
.	O

Renal	O
cell	O
carcinoma	O
in	O
children	O
:	O
a	O
single	O
institution	O
's	O
experience	O
.	O

Factors	O
associated	O
with	O
intrafamilial	O
transmission	O
of	O
hepatitis	O
B	O
virus	O
infection	O
in	O
Korea	O
.	O

Northern	O
analysis	O
,	O
to	O
search	O
for	O
a	O
pcbAB	B
transcript	I
,	O
showed	O
no	O
distinct	O
transcript	O
and	O
indicated	O
severely	O
degraded	O
mRNA	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
minimal	O
requirements	O
for	O
induction	O
of	O
PEPCK	B
by	O
PKA	B
and	O
inhibition	O
by	O
insulin	B
include	O
:	O
1	O
)	O
the	O
CREB	B
activation	I
domain	I
,	O
2	O
)	O
the	O
PEPCK	B
TATA	I
sequence	I
,	O
and	O
3	O
)	O
insulin	B
-	O
responsive	O
hepatoma	O
cells	O
.	O

The	O
high	O
degree	O
of	O
conservation	O
between	O
NQO2	B
and	O
NQO1	B
gene	I
organization	O
and	O
sequence	O
confirmed	O
that	O
NQO2	B
gene	I
encodes	O
for	O
a	O
second	O
member	O
of	O
the	O
NQO	B
gene	I
family	I
in	O
human	O
.	O

The	O
efficacy	O
of	O
a	O
Propionibacterium	O
acnes	O
product	O
for	O
treatment	O
of	O
coliform	O
mastitis	O
was	O
evaluated	O
following	O
intramammary	O
infusion	O
of	O
Escherichia	O
coli	O
.	O

The	O
human	B
eps15	I
gene	I
,	O
encoding	O
a	O
tyrosine	B
kinase	I
substrate	O
,	O
is	O
conserved	O
in	O
evolution	O
and	O
maps	O
to	O
1p31-p32	O
.	O

The	O
gene	O
encoding	O
the	O
105-kDa	B
protein	I
(	I
p105	I
)	I
precursor	I
of	O
the	O
p50	B
subunit	I
of	O
transcription	O
factor	O
NF	B
-	I
kappa	I
B	I
also	O
encodes	O
a	O
p70	B
I	I
kappa	I
B	I
protein	I
,	O
I	B
kappa	I
B	I
gamma	I
,	O
which	O
is	O
identical	O
to	O
the	O
C	O
-	O
terminal	O
607	O
amino	O
acids	O
of	O
p105	B
.	O

Alternative	O
splicing	O
of	O
RNA	O
transcripts	O
encoded	O
by	O
the	O
murine	O
p105	B
NF	B
-	I
kappa	I
B	I
gene	O
generates	O
I	B
kappa	I
B	I
gamma	I
isoforms	I
with	O
different	O
inhibitory	O
activities	O
.	O

Topical	O
L	O
-	O
NNA	O
attenuated	O
the	O
hypercapnic	O
increase	O
of	O
CoBF	O
by	O
52	O
+	O
/-	O

6	O
%	O
and	O
CeBF	O
by	O
29	O
+	O
/-	O

5	O
%	O
after	O
45-min	O
exposure	O
.	O

Glutamyl	B
-	I
tRNA	I
synthetase	I
and	O
prolyl	B
-	I
tRNA	I
synthetase	I
belong	O
to	O
different	O
classes	O
of	O
aminoacyl	B
-	I
tRNA	I
synthetases	I
that	O
are	O
thought	O
to	O
have	O
evolved	O
along	O
independent	O
evolutionary	O
pathways	O
.	O

DESIGN	O
--	O
A	O
randomised	O
study	O
was	O
conducted	O
in	O
all	O
women	O
aged	O
50	O
-	O
70	O
years	O
who	O
were	O
eligible	O
for	O
breast	O
cancer	O
screening	O
and	O
living	O
in	O
the	O
city	O
of	O
Utrecht	O
.	O

Identification	O
of	O
an	O
immediate	B
-	I
early	I
gene	I
in	O
the	O
Marek	O
's	O
disease	O
virus	O
long	O
internal	O
repeat	O
region	O
which	O
encodes	O
a	O
unique	O
14-kilodalton	O
polypeptide	O
.	O

We	O
have	O
used	O
a	O
full	O
-	O
length	O
cDNA	O
clone	O
of	O
a	O
mouse	O
hepatitis	O
virus	O
strain	O
A59	O
defective	O
interfering	O
(	O
DI	O
)	O
RNA	O
,	O
pMIDI	B
-	I
C	I
,	O
and	O
cassette	O
mutagenesis	O
to	O
study	O
the	O
mechanism	O
of	O
coronavirus	O
subgenomic	O
mRNA	O
synthesis	O
.	O

To	O
study	O
the	O
structure	O
-	O
function	O
of	O
the	O
gene	B
5	I
product	I
,	O
wild	O
-	O
type	O
and	O
mutant	O
forms	O
of	O
NS53	B
were	O
produced	O
by	O
using	O
a	O
recombinant	O
baculovirus	O
expression	O
system	O
and	O
a	O
recombinant	O
vaccinia	O
virus	O
/	O
T7	O
(	O
vTF7	O
-	O
3	O
)	O
expression	O
system	O
.	O

Gel	O
electrophoresis	O
and	O
Western	O
immunoblot	O
analyses	O
of	O
intracellular	O
fractions	O
derived	O
from	O
infected	O
cells	O
revealed	O
that	O
large	O
amounts	O
of	O
NS53	B
were	O
present	O
in	O
the	O
cytosol	O
and	O
in	O
association	O
with	O
the	O
cytoskeletal	O
matrix	O
.	O

The	O
transcription	B
factor	I
AP-2	I
is	O
encoded	O
by	O
a	O
gene	O
located	O
on	O
chromosome	O
6	O
near	O
the	O
HLA	B
locus	I
.	O

San	O
Martin	O
's	O
psychological	O
traits	O
coupled	O
to	O
his	O
work	O
with	O
masonic	O
lodges	O
that	O
allowed	O
him	O
to	O
display	O
his	O
abilities	O
as	O
strategist	O
and	O
political	O
ruler	O
.	O

The	O
participants	O
were	O
homosexual	O
men	O
in	O
hepatitis	O
B	O
vaccine	O
trials	O
in	O
Amsterdam	O
(	O
n	O
=	O
74	O
)	O
,	O
New	O
York	O
City	O
(	O
n	O
=	O
120	O
)	O
,	O
and	O
San	O
Francisco	O
(	O
n	O
=	O
168	O
)	O
.	O

Thrombotic	O
thrombocytopenic	O
purpura	O
in	O
systemic	O
lupus	O
erythematosus	O
.	O

Comparison	O
with	O
the	O
crystal	O
structure	O
of	O
Desulfovibrio	O
gigas	O
,	O
Dg	O
,	O
Fd	B
(	O
Kissinger	O
et	O
al.	O
,	O
1991	O
)	O
reveals	O
a	O
very	O
similar	O
folding	O
topology	O
,	O
although	O
several	O
secondary	O
structural	O
elements	O
are	O
extended	O
in	O
Pf	O
relative	O
to	O
Dg	O
Fd	B
.	O

Eight	O
highly	O
trained	O
male	O
kayakers	O
were	O
studied	O
to	O
determine	O
the	O
relationship	O
between	O
critical	O
power	O
(	O
CP	O
)	O
and	O
the	O
onset	O
of	O
blood	O
lactate	O
accumulation	O
(	O
OBLA	O
)	O
.	O

Women	O
's	O
opportunities	O
for	O
paid	O
work	O
outside	O
the	O
home	O
are	O
constrained	O
by	O
their	O
role	O
as	O
primary	O
carer	O
within	O
the	O
family	O
,	O
writes	O
Trudy	O
Wynne	O
.	O

Bacterially	O
expressed	O
protein	O
,	O
as	O
well	O
as	O
the	O
in	O
vitro	O
reticulocyte	O
lysate	O
translation	O
product	O
,	O
comigrated	O
with	O
the	O
purified	O
37-kDa	O
protein	O
on	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gels	O
.	O

In	O
addition	O
,	O
this	O
kinase	O
is	O
well	O
conserved	O
evolutionarily	O
,	O
ubiquitously	O
expressed	O
,	O
and	O
its	O
genes	O
map	O
to	O
a	O
position	O
on	O
human	O
chromosome	O
1	O
frequently	O
deleted	O
in	O
the	O
late	O
stages	O
of	O
tumorigenesis	O
.	O

Deletion	O
analysis	O
of	O
the	O
ICL1	B
promoter	I
led	O
to	O
the	O
identification	O
of	O
an	O
upstream	O
activating	O
sequence	O
element	O
,	O
UASICL1	O
(	O
5	O
'	O
CATTCATCCG	O
3	O
'	O
)	O
,	O
necessary	O
and	O
sufficient	O
for	O
conferring	O
carbon	O
source	O
-	O
dependent	O
regulation	O
on	O
a	O
heterologous	O
reporter	O
gene	O
.	O

Interestingly	O
,	O
the	O
interaction	O
of	O
ZAP-70	B
with	O
the	O
motif	O
was	O
dependent	O
on	O
the	O
presence	O
of	O
both	O
ZAP-70	B
SH2	B
domains	I
and	O
both	O
of	O
the	O
tyrosine	O
residues	O
in	O
the	O
motif	O
,	O
suggesting	O
that	O
ZAP-70	B
interacts	O
with	O
two	O
phosphotyrosine	O
residues	O
and	O
that	O
the	O
binding	O
of	O
the	O
two	O
SH2	B
domains	I
is	O
cooperative	O
.	O

In	O
Mv1Lu	O
lung	O
epithelial	O
cells	O
,	O
ActR	B
-	I
IB	I
and	O
T	B
beta	I
R	I
-	I
I	I
signal	O
a	O
common	O
set	O
of	O
growth	O
-	O
inhibitory	O
and	O
transcriptional	O
responses	O
in	O
association	O
with	O
their	O
corresponding	O
ligands	O
and	O
type	B
II	I
receptors	I
.	O

50	O
kDa	O
and	O
130	O
-	O
170	O
kDa	O
were	O
detected	O
.	O

The	O
effects	O
of	O
systemic	O
glucose	O
concentration	O
on	O
brain	O
metabolism	O
following	O
repeated	O
brain	O
ischemia	O
.	O

On	O
physical	O
examination	O
a	O
mild	O
symmetrical	O
polyarthritis	O
of	O
small	O
and	O
large	O
joints	O
was	O
seen	O
.	O

In	O
addition	O
,	O
we	O
observe	O
that	O
the	O
hUBF	B
-	I
promoter	I
interaction	O
is	O
highly	O
sensitive	O
to	O
the	O
antagonistic	O
effects	O
of	O
cisplatin	O
-	O
DNA	O
adducts	O
.	O

A	O
total	O
of	O
7	O
(	O
4	O
males	O
and	O
3	O
females	O
)	O
patients	O
were	O
included	O
in	O
this	O
retrospective	O
study	O
to	O
determine	O
the	O
sensitivity	O
of	O
radioimmunoscintigraphy	O
with	O
I-131	O
labeled	O
anti	B
CEA	I
/	O
CA	B
19	I
-	I
9	I
monoclonal	O
antibodies	O
.	O

A	O
genomic	O
clone	O
for	O
the	O
cyc07	B
gene	I
,	O
which	O
is	O
expressed	O
specifically	O
at	O
the	O
S	O
phase	O
during	O
the	O
cell	O
cycle	O
in	O
synchronous	O
cultures	O
of	O
periwinkle	O
(	O
Catharanthus	O
roseus	O
)	O
cells	O
,	O
was	O
isolated	O
.	O

CONCLUSIONS	O
:	O
Translocation	O
of	O
bacteria	O
or	O
endotoxin	O
from	O
the	O
gastrointestinal	O
tract	O
into	O
the	O
bloodstream	O
has	O
been	O
noted	O
in	O
animal	O
experiments	O
;	O
however	O
,	O
translocation	O
was	O
not	O
detected	O
in	O
our	O
patients	O
with	O
hemorrhagic	O
shock	O
.	O

Southern	O
blotting	O
analysis	O
implied	O
the	O
occurrence	O
of	O
multiple	O
COXVb	B
genes	I
in	O
the	O
rat	O
genome	O
.	O

Subunit	O
composition	O
and	O
domain	O
structure	O
of	O
the	O
Spo0A	B
sporulation	I
transcription	I
factor	I
of	I
Bacillus	I
subtilis	I
.	O

Electrophoretic	O
mobility	O
shift	O
analysis	O
indicates	O
that	O
NF	B
-	I
IL-6	I
,	O
as	O
well	O
as	O
other	O
related	O
members	O
of	O
this	O
family	O
,	O
bind	O
specifically	O
to	O
the	O
NF	B
-	I
IL-6	I
site	O
in	O
the	O
IL-8	B
promoter	I
.	O

BYV	O
,	O
citrus	O
tristeza	O
virus	O
(	O
CTV	O
)	O
,	O
beet	O
yellow	O
stunt	O
virus	O
(	O
BYSV	O
)	O
and	O
carnation	O
necrotic	O
fleck	O
virus	O
templates	O
produced	O
1	O
kb	O
amplification	O
products	O
,	O
which	O
were	O
shown	O
by	O
sequencing	O
to	O
represent	O
fragments	O
of	O
the	O
respective	O
HSP70	B
genes	I
.	O

The	O
p53	B
tumor	I
suppressor	I
gene	I
product	I
,	O
a	O
sequence	O
-	O
specific	O
DNA	O
-	O
binding	O
protein	O
,	O
has	O
been	O
shown	O
to	O
act	O
as	O
a	O
transcriptional	O
activator	O
and	O
repressor	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

Mutational	O
analysis	O
of	O
chromosomal	O
segment	O
64AB	O
,	O
a	O
region	O
containing	O
the	O
glutamic	B
acid	I
decarboxylase	I
gene	I
.	O

Cloning	O
and	O
sequencing	O
of	O
the	O
corresponding	O
cDNAs	O
indicates	O
that	O
,	O
via	O
alternative	O
splicing	O
,	O
the	O
rearranged	O
gene	O
codes	O
for	O
two	O
proteins	O
of	O
84	O
and	O
85	O
kD	O
(	O
p84	B
/	I
85	I
)	O
which	O
retain	O
the	O
DNA	O
-	O
binding	O
rel	B
domain	I
and	O
the	O
first	O
five	O
ankyrin	B
repeats	O
,	O
but	O
have	O
lost	O
their	O
carboxy	O
-	O
terminus	O
including	O
the	O
seventh	O
ankyrin	B
repeat	O
.	O

Transient	O
co	O
-	O
transfection	O
assays	O
involving	O
NFKB2	B
expression	O
vectors	O
and	O
kappa	B
B	I
-	O
driven	O
reporter	O
plasmids	O
indicate	O
that	O
NFKB2	B
p85	B
has	O
lost	O
the	O
transcriptional	O
repressor	O
functions	O
typical	O
of	O
normal	O
NFKB2	B
p52	B
.	O

Also	O
,	O
HR21ap	B
as	O
well	O
as	O
HR21Xap	B
are	O
specific	O
in	O
their	O
inhibition	O
of	O
Sp1	B
binding	O
.	O

Intravenous	O
antibiotic	O
therapy	O
in	O
cystic	O
fibrosis	O
:	O
in	O
hospital	O
or	O
at	O
home	O
?	O

The	O
ns2	B
gene	I
comprises	O
an	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
encoding	O
a	O
putative	O
nonstructural	O
(	O
ns	O
)	O
protein	O
of	O
279	O
amino	O
acids	O
with	O
a	O
predicted	O
molecular	O
mass	O
of	O
32-kDa	O
.	O

Co	O
-	O
transfection	O
of	O
a	O
tat	B
expressing	O
plasmid	O
with	O
these	O
viruses	O
containing	O
the	O
tat	B
ORF	I
mutations	O
resulted	O
in	O
higher	O
levels	O
of	O
virus	O
production	O
demonstrating	O
that	O
the	O
effects	O
of	O
both	O
mutants	O
are	O
tat	B
specific	O
.	O

Analysis	O
of	O
the	O
gag	B
and	O
rev	B
proteins	I
in	O
the	O
transfected	O
cells	O
demonstrated	O
that	O
these	O
proteins	O
were	O
not	O
detectable	O
in	O
cells	O
transfected	O
with	O
the	O
tat	B
mutants	I
but	O
could	O
be	O
readily	O
detected	O
when	O
the	O
mutations	O
were	O
complemented	O
in	O
trans	O
with	O
a	O
tat	B
expression	O
vector	O
.	O

The	O
hydrophobicity	O
profile	O
of	O
the	O
methyltransferase	O
reveals	O
the	O
presence	O
of	O
at	O
least	O
five	O
potential	O
transmembrane	O
domains	O
.	O

The	O
patients	O
in	O
one	O
group	O
had	O
intrauterine	O
catheters	O
inserted	O
and	O
oxytocin	B
was	O
titrated	O
to	O
achieve	O
the	O
75th	O
percentile	O
of	O
uterine	O
activity	O
observed	O
in	O
spontaneous	O
normal	O
labour	O
according	O
to	O
parity	O
.	O

The	O
ultrastructure	O
of	O
retinal	O
vessels	O
was	O
examined	O
in	O
three	O
eyes	O
from	O
diabetic	O
patients	O
and	O
two	O
eyes	O
from	O
control	O
subjects	O
.	O

The	O
regulatory	O
region	O
also	O
has	O
a	O
sequence	O
similar	O
to	O
the	O
binding	O
site	O
for	O
a	O
liver	O
-	O
specific	O
transcription	O
factor	O
,	O
hepatocyte	B
nuclear	I
factor	I
1	I
(	O
HNF-1	B
)	O
,	O
at	O
positions	O
-120	O
to	O
-132	O
.	O

Thus	O
,	O
we	O
have	O
identified	O
a	O
GRE	O
sufficient	O
to	O
account	O
for	O
full	O
glucocorticoid	O
inducibility	O
and	O
an	O
HNF-1	B
site	I
close	O
to	O
the	O
promoter	O
that	O
are	O
major	O
determinants	O
of	O
transcriptional	O
control	O
of	O
the	O
Xenopus	B
fibrinogen	I
B	I
beta	I
subunit	I
gene	I
in	O
cells	O
from	O
normal	O
liver	O
tissue	O
.	O

Acad	O
.	O

The	O
PRB-1b	B
gene	I
encodes	O
for	O
a	O
basic	O
-	O
type	O
component	O
of	O
the	O
pathogenesis	O
-	O
related	O
PR-1	B
protein	I
family	I
.	O

Reviewing	O
manuscripts	O
:	O
developing	O
an	O
efficient	O
system	O
.	O

We	O
suggest	O
that	O
CT	O
scan	O
be	O
preferable	O
in	O
diagnosis	O
of	O
tumors	O
in	O
that	O
area	O
.	O

Effect	O
of	O
aging	O
on	O
respiratory	O
skeletal	O
muscles	O
.	O

The	O
lengths	O
of	O
the	O
complete	O
polypeptide	O
chain	O
of	O
the	O
recombinant	O
enzyme	O
and	O
its	O
transit	O
peptide	O
are	O
388	O
and	O
53	O
residues	O
,	O
respectively	O
.	O

We	O
also	O
compared	O
the	O
sequence	O
with	O
the	O
partly	O
homologous	O
products	O
of	O
the	O
S.	O
cerevisiae	O
genes	O
TPS2	B
and	O
TSL1	B
which	O
code	O
for	O
the	O
larger	O
subunits	O
of	O
the	O
trehalose	B
synthase	I
complex	I
and	O
with	O
a	O
TSL1	B
homologue	I
,	O
TPS3	B
,	O
of	O
unknown	O
function	O
.	O

The	O
nit-3	B
gene	I
of	I
the	I
filamentous	I
fungus	I
Neurospora	I
crassa	I
encodes	O
nitrate	B
reductase	I
,	O
the	O
enzyme	O
which	O
catalyzes	O
the	O
first	O
step	O
in	O
nitrate	O
assimilation	O
.	O

A	O
Dictyostelium	O
transformant	O
overexpressing	O
DdPTPa	B
does	O
not	O
develop	O
normally	O
.	O

This	O
motif	O
has	O
been	O
shown	O
to	O
mediate	O
protein	O
interactions	O
in	O
the	O
case	O
of	O
ankyrin	B
as	O
well	O
as	O
several	O
other	O
repeat	O
-	O
bearing	O
proteins	O
.	O

[	B
Ala85	I
]	I
Dk	I
(	I
69	I
-	I
85	I
)	I
retains	O
full	O
biological	O
activity	O
.	O

We	O
postulate	O
that	O
CaM	B
binding	O
by	O
HIV	B
envelope	I
proteins	I
is	O
likely	O
to	O
exert	O
diverse	O
modulatory	O
effects	O
,	O
and	O
the	O
mechanism	O
for	O
HIV	O
-	O
induced	O
cytotoxicity	O
may	O
involve	O
,	O
in	O
part	O
,	O
inhibition	O
of	O
CaM	B
-	O
regulated	O
cellular	O
functions	O
.	O

The	O
major	O
myosin	B
-	I
binding	I
domain	I
of	O
skeletal	B
muscle	I
MyBP	I
-	I
C	I
(	O
C	B
protein	I
)	O
resides	O
in	O
the	O
COOH	O
-	O
terminal	O
,	O
immunoglobulin	B
C2	B
motif	I
.	O

Our	O
results	O
indicate	O
that	O
periseizure	O
lipid	O
accumulation	O
is	O
related	O
to	O
cortical	O
oxygenation	O
.	O

Most	O
smokers	O
would	O
prefer	O
to	O
quit	O
smoking	O
on	O
their	O
own	O
.	O

The	O
inhibitory	O
response	O
to	O
taps	O
is	O
essentially	O
a	O
protective	O
reflex	O
which	O
probably	O
serves	O
to	O
reduce	O
the	O
activity	O
of	O
the	O
jaw	O
-	O
closing	O
muscles	O
when	O
one	O
bites	O
unexpectedly	O
on	O
hard	O
objects	O
.	O

The	O
product	O
of	O
the	O
vpr	B
open	I
reading	I
frame	I
of	I
human	I
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV-1	I
)	I
is	O
a	O
15-kDa	O
,	O
arginine	O
-	O
rich	O
protein	O
that	O
is	O
present	O
in	O
virions	O
in	O
molar	O
quantities	O
equivalent	O
to	O
that	O
of	O
Gag	B
.	O

In	O
contrast	O
,	O
capsid	B
proteins	I
derived	O
from	O
the	O
P1	B
precursor	I
with	O
a	O
valine	O
substitution	O
at	O
the	O
amino	O
terminus	O
of	O
VP1	B
(	O
VP1-G001V	B
)	O
assembled	O
empty	O
capsid	O
particles	O
but	O
were	O
deficient	O
in	O
assembling	O
RNA	O
-	O
containing	O
virions	O
.	O

RESULTS	O
:	O
In	O
an	O
18	O
moth	O
period	O
and	O
out	O
of	O
a	O
total	O
of	O
284	O
positive	O
blood	O
cultures	O
(	O
154	O
significant	O
isolations	O
)	O
14	O
episodes	O
of	O
bacteremia	O
by	O
M.	O
tuberculosis	O
were	O
studied	O
in	O
12	O
prison	O
patients	O
coinfected	O
by	O
the	O
human	O
immunodeficiency	O
virus	O
with	O
associated	O
severe	O
immunosuppression	O
(	O
mean	O
of	O
CD4	B
=	O
0.068	O
x	O
10	O
(	O
9	O
)	O
/	O
l	O
)	O
.	O

Acid	O
instilled	O
on	O
the	O
larynx	O
of	O
maturing	O
rabbits	O
resulted	O
in	O
significant	O
obstructive	O
,	O
central	O
,	O
and	O
mixed	O
apnea	O
.	O

By	O
using	O
total	O
-	O
protein	O
extracts	O
from	O
mycelia	O
grown	O
under	O
penicillin	O
producing	O
conditions	O
we	O
have	O
detected	O
a	O
DNA	O
-	O
binding	O
activity	O
that	O
specifically	O
shifts	O
a	O
promoter	O
fragment	O
located	O
between	O
-654	O
and	O
-455	O
(	O
relative	O
to	O
IPNS	B
tsp	I
)	O
.	O

Similar	O
synergistic	O
activation	O
was	O
observed	O
in	O
the	O
IL-8	B
promoter	I
,	O
which	O
also	O
contains	O
both	O
NF	B
-	I
IL6	I
and	O
NF	B
-	I
kappa	I
B	I
binding	I
sites	I
.	O

Notice	O
of	O
retraction	O
.	O

As	O
regards	O
lipid	O
metabolism	O
,	O
the	O
mean	O
values	O
for	O
total	O
triglycerides	O
,	O
cholesterol	O
,	O
LDL	B
-	I
cholesterol	I
and	O
HDL	B
-	I
cholesterol	I
seen	O
at	O
the	O
end	O
of	O
five	O
years	O
of	O
Norplant-2	O
rod	O
use	O
and	O
six	O
months	O
postremoval	O
were	O
similar	O
to	O
the	O
preinsertion	O
mean	O
.	O

At	O
a	O
PaCO2	O
of	O
40	O
mmHg	O
,	O
baseline	O
brain	O
pHi	O
measured	O
7.03	O
+	O
/-	O

0.04	O
,	O
while	O
regional	O
cortical	O
blood	O
flow	O
was	O
47.0	O
+	O
/-	O

4.3	O
ml.100	O
g-1.min-1	O
.	O

Effects	O
of	O
diltiazem	O
on	O
netilmicin	O
-	O
induced	O
nephrotoxicity	O
in	O
rabbits	O
.	O

About	O
20	O
%	O
of	O
single	O
-	O
stranded	O
DNA	O
binding	O
was	O
observed	O
in	O
the	O
presence	O
of	O
MgdTDP	O
,	O
but	O
none	O
was	O
detectable	O
in	O
the	O
absence	O
of	O
nucleotides	O
.	O

To	O
our	O
knowledge	O
this	O
is	O
the	O
first	O
case	O
in	O
which	O
a	O
probable	O
association	O
between	O
cholelithiasis	O
and	O
Wildervanck	O
's	O
syndrome	O
has	O
been	O
recorded	O
.	O

Both	O
4,8-DiMeIQx	O
and	O
A	O
alpha	O
C	O
were	O
found	O
at	O
<	O
1	O
p.p.b	O
.	O

Three	O
cysteine	O
and	O
four	O
tryptophan	O
residues	O
,	O
previously	O
identified	O
as	O
conserved	O
amongst	O
nitrous	B
-	I
oxide	I
reductases	I
,	O
are	O
found	O
in	O
the	O
Paracoccus	O
enzyme	O
.	O

Delineating	O
the	O
molecular	O
basis	O
for	O
agonist	O
-	O
induced	O
destabilization	O
of	O
mRNA	O
of	O
G	B
-	I
protein	I
-	I
linked	I
receptors	I
that	O
contributes	O
to	O
receptor	O
down	O
-	O
regulation	O
is	O
fundamental	O
to	O
our	O
understanding	O
of	O
long	O
-	O
term	O
regulation	O
of	O
receptors	O
by	O
agonist	O
.	O

Addition	O
of	O
phalloidin	O
-	O
stabilized	O
F	B
-	I
actin	I
nuclei	O
and	O
phalloidin	O
restored	O
L266D	O
actin	B
's	O
ability	O
to	O
polymerize	O
at	O
4	O
degrees	O
C.	O

These	O
cells	O
produce	O
a	O
low	O
level	O
of	O
IL-5	B
when	O
stimulated	O
with	O
PMA	O
alone	O
;	O
however	O
,	O
N6	O
,	O
O2-dibutyryl	O
cAMP	O
(	O
Bt2cAMP	O
)	O
,	O
in	O
combination	O
with	O
PMA	O
,	O
augmented	O
by	O
more	O
than	O
tenfold	O
the	O
IL-5	B
production	O
at	O
the	O
mRNA	O
and	O
the	O
protein	O
levels	O
.	O

Hu	B
-	I
Met-1	I
mRNA	I
expression	O
in	O
a	O
small	O
number	O
of	O
human	O
T	O
cell	O
tumor	O
lines	O
did	O
not	O
correlate	O
with	O
any	O
particular	O
phenotype	O
or	O
stage	O
of	O
development	O
.	O

Partial	O
engorgement	O
was	O
higher	O
in	O
the	O
treatments	O
.	O

Strains	O
bearing	O
the	O
drs2	B
mutation	I
process	O
the	O
20S	B
precursor	I
of	O
the	O
mature	B
18S	I
rRNA	I
slowly	O
and	O
are	O
deficient	O
in	O
40S	B
ribosomal	I
subunits	I
.	O

Hepatitis	O
B	O
and	O
liver	O
transplantation	O
.	O

One	O
complex	O
most	O
likely	O
contained	O
Sp1	B
,	O
and	O
another	O
complex	O
showed	O
S	O
-	O
phase	O
-	O
specific	O
binding	O
,	O
suggesting	O
a	O
direct	O
role	O
in	O
the	O
cell	O
-	O
cycle	O
-	O
dependent	O
R1	B
gene	I
expression	O
.	O

These	O
combined	O
observations	O
define	O
a	O
promoter	O
and	O
an	O
enhancer	O
for	O
the	O
chicken	B
L	I
-	I
CAM	I
gene	I
.	O

The	O
rate	O
of	O
enzymic	O
stimulation	O
induced	O
by	O
a	O
given	O
nitrate	O
correlates	O
closely	O
with	O
the	O
rate	O
of	O
measured	O
NO	O
production	O
from	O
the	O
nitrate	O
molecule	O
.	O

Clipping	O
resulted	O
in	O
a	O
serious	O
mislocalization	O
of	O
the	O
position	O
of	O
the	O
peak	O
of	O
the	O
epicortical	O
potential	O
field	O
.	O

The	O
247-kDa	O
complex	O
appears	O
to	O
contain	O
two	O
distinct	O
protein	O
-	O
DNA	O
complexes	O
of	O
approximately	O
232	O
and	O
256	O
kDa	O
and	O
represents	O
two	O
proteins	O
covalently	O
cross	O
-	O
linked	O
to	O
a	O
single	O
DRE	O
oligonucleotide	O
,	O
while	O
the	O
97	O
,	O
105	O
,	O
and	O
115-kDa	O
complexes	O
represent	O
single	O
protein	O
-	O
DRE	O
cross	O
-	O
links	O
.	O

The	O
promoter	O
and	O
upstream	O
region	O
of	O
the	O
Brassica	B
napus	I
2S	I
storage	I
protein	I
napA	I
gene	I
were	O
studied	O
to	O
identify	O
cis	O
-	O
acting	O
sequences	O
involved	O
in	O
developmental	O
seed	O
-	O
specific	O
expression	O
.	O

We	O
conclude	O
that	O
sequences	O
outside	O
of	O
the	O
hLEF	B
HMG	I
box	I
mediate	O
cell-	O
and	O
context	O
-	O
specific	O
activation	O
of	O
the	O
TCR	B
alpha	I
enhancer	I
and	O
may	O
facilitate	O
interactions	O
between	O
hLEF	B
and	O
other	O
T	O
-	O
cell	O
-	O
specific	O
factors	O
recruited	O
to	O
the	O
enhancer	O
.	O

A	O
cAMP	O
response	O
element	O
(	O
CRE	O
)	O
consensus	O
signal	O
was	O
identified	O
in	O
the	O
5'-noncoding	O
region	O
.	O

cAMP	O
regulates	O
the	O
expression	O
of	O
Kv1.5	B
gene	I
in	O
a	O
cell	O
-	O
specific	O
manner	O
.	O

A	O
number	O
of	O
serological	O
tests	O
measuring	O
the	O
presence	O
of	O
Helicobacter	O
pylori	O
-	O
specific	O
serum	O
immunoglobulin	B
G	I
(	O
IgG	B
)	O
are	O
now	O
commercially	O
available	O
.	O

The	O
degree	O
of	O
hypoperfusion	O
was	O
slightly	O
related	O
to	O
decrease	O
in	O
FEV1.0	O
%	O
,	O
V25	O
and	O
PaO2	O
and	O
increase	O
in	O
circulating	O
blood	O
volume	O
and	O
peripheral	O
red	O
blood	O
cell	O
counts	O
.	O

Two	O
patients	O
were	O
treated	O
successfully	O
with	O
a	O
combination	O
of	O
metronidazole	O
(	O
a	O
tissue	O
amoebicide	O
)	O
and	O
diloxanide	O
(	O
a	O
lumenal	O
amoebicide	O
)	O
.	O

We	O
have	O
identified	O
in	O
the	O
5	O
'	O
untranslated	O
region	O
of	O
the	O
Drosophila	B
copia	I
retrotransposon	I
,	O
3	O
'	O
to	O
the	O
left	O
LTR	O
,	O
a	O
sequence	O
for	O
transcriptional	O
regulation	O
by	O
homeoproteins	O
.	O

In	O
the	O
present	O
study	O
,	O
lesions	O
of	O
the	O
OPT	O
complex	O
(	O
the	O
thalamic	O
source	O
of	O
afferents	O
to	O
IHA	O
and	O
HD	O
)	O
were	O
found	O
to	O
have	O
no	O
effect	O
on	O
color	O
-	O
reversal	O
learning	O
performance	O
.	O

CONCLUSIONS	O
:	O
In	O
our	O
patients	O
and	O
within	O
the	O
range	O
of	O
treatment	O
variables	O
studied	O
,	O
age	O
,	O
Karnofsky	O
index	O
,	O
and	O
graft	O
-	O
versus	O
-	O
host	O
disease	O
are	O
the	O
most	O
important	O
factors	O
related	O
with	O
early	O
mortality	O
.	O

Nucleotide	O
sequence	O
analysis	O
of	O
the	O
HA	B
gene	I
in	O
these	O
two	O
mutants	O
confirmed	O
the	O
HA-	B
phenotype	O
.	O

The	O
drug	O
-	O
resistant	O
cell	O
lines	O
P388	O
/	O
ADR	O
/	O
3	O
and	O
P388	O
/	O
ADR	O
/	O
7	O
express	O
a	O
shortened	O
topo	B
II	I
alpha	I
mRNA	I
transcript	I
in	O
addition	O
to	O
the	O
native	O
transcript	O
present	O
in	O
the	O
drug	O
-	O
sensitive	O
P388	O
/	O
4	O
cell	O
line	O
.	O

The	O
phi	B
AP3	I
factor	I
is	O
a	O
nuclear	O
phosphoprotein	O
;	O
the	O
extent	O
of	O
its	O
phosphorylation	O
is	O
regulated	O
during	O
the	O
cell	O
cycle	O
.	O

The	O
functional	O
homology	O
of	O
Cwg2	B
with	O
Cdc43	B
,	O
which	O
has	O
been	O
implicated	O
in	O
the	O
control	O
of	O
cell	O
polarity	O
,	O
suggests	O
a	O
link	O
between	O
two	O
morphogenetic	O
events	O
such	O
as	O
establishment	O
of	O
cell	O
polarity	O
and	O
cell	O
wall	O
biosynthesis	O
.	O

By	O
using	O
the	O
full	O
-	O
length	O
cytoplasmic	O
domain	O
and	O
mutants	O
with	O
progressive	O
carboxy	O
-	O
terminal	O
deletions	O
,	O
internal	O
deletions	O
,	O
or	O
point	O
mutations	O
,	O
we	O
identified	O
the	O
first	O
150	O
amino	O
acid	O
residues	O
of	O
LIFR	B
as	O
the	O
minimal	O
region	O
necessary	O
for	O
signaling	O
.	O

To	O
examine	O
the	O
biochemical	O
basis	O
of	O
the	O
end	O
joining	O
,	O
nuclear	O
extracts	O
were	O
prepared	O
from	O
a	O
wide	O
variety	O
of	O
mammalian	O
cell	O
lines	O
and	O
tested	O
for	O
their	O
ability	O
to	O
join	O
test	O
plasmid	O
substrates	O
.	O

Recombinant	O
expression	O
of	O
a	O
chimeric	O
EGFR	B
/	O
ErbB-3	B
receptor	I
in	O
NIH	O
3T3	O
fibroblasts	O
allowed	O
us	O
to	O
investigate	O
cytoplasmic	O
events	O
associated	O
with	O
ErbB-3	B
signal	O
transduction	O
upon	O
ligand	O
activation	O
.	O

Oligonucleotide	O
competitors	O
were	O
used	O
to	O
evaluate	O
the	O
accessibility	O
of	O
the	O
TATA	O
-	O
binding	O
site	O
in	O
TIF	B
-	I
IB	I
,	O
TFIID	B
,	O
and	O
TFIIIB	B
.	O

The	O
227-to-239	O
region	O
blocked	O
ADR1	B
activity	O
independently	O
of	O
the	O
TAD	B
present	O
on	O
ADR1	B
,	O
ADR1	B
DNA	O
binding	O
,	O
and	O
specific	O
ADH2	B
promoter	I
sequences	I
.	O

Repeated	O
administration	O
of	O
GRg2	O
20	O
mg	O
/	O
kg	O
i.p	O
.	O

significantly	O
improved	O
the	O
CYP	O
-	O
induced	O
recognitional	O
deficits	O
by	O
increasing	O
the	O
CYP	O
-	O
decreased	O
rate	O
from	O
55.8	O
+	O
/-	O

9.6	O
to	O
80.8	O
+	O
/-	O

4.2	O
in	O
d	O
3	O
learning	O
acquisition	O
(	O
F	O
(	O
1,14	O
)	O
=	O
5.6	O
,	O
p	O
<	O
0.05	O
)	O
,	O
from	O
53.4	O
+	O
/-	O

8.4	O
to	O
60.0	O
+	O
/-	O

8.2	O
in	O
48	O
h	O
memory	O
acquisition	O
(	O
F	O
(	O
1,14	O
)	O
=	O
7.5	O
,	O
p	O
<	O
0.05	O
)	O
and	O
from	O
55.0	O
+	O
/-	O

5.5	O
to	O
88.3	O
+	O
/-	O

2.5	O
in	O
24	O
h	O
memory	O
retention	O
(	O
F	O
(	O
1,12	O
)	O
27.5	O
,	O
p	O
<	O
0.01	O
)	O
as	O
well	O
as	O
from	O
60.0	O
+	O
/-	O

6.8	O
to	O
85.6	O
+	O
/-	O

6.9	O
in	O
48	O
h	O
memory	O
retrieval	O
(	O
F	O
(	O
1,12	O
)	O
=	O
5.2	O
,	O
p	O
<	O
0.05	O
)	O
,	O
respectively	O
.	O

Human	B
bcl3	I
protein	I
specifically	O
displaces	O
(	B
p50	I
)	I
2-DNA	I
complexes	I
.	O

The	O
therapeutic	O
action	O
of	O
cyclosporin	O
A	O
(	O
Sandimmun	O
)	O
:	O
its	O
application	O
in	O
rheumatoid	O
arthritis	O
.	O

In	O
vitro	O
translation	O
experiments	O
show	O
that	O
human	O
cDNA	O
derived	O
RNA	O
translates	O
into	O
a	O
protein	O
with	O
a	O
mobility	O
of	O
44	O
-	O
46	O
kD	O
on	O
SDS	O
polyacrylamide	O
gels	O
.	O

Pentazocine	O
analgesia	O
:	O
is	O
there	O
a	O
niche	O
for	O
Talwin	O
Nx	O
?	O

Pentazocine	O
can	O
be	O
a	O
useful	O
analgesic	O
agent	O
for	O
the	O
management	O
of	O
acute	O
dental	O
pain	O
.	O

A	O
sequence	O
homology	O
analysis	O
between	O
human	B
nm23-H1	I
and	O
the	O
homolog	O
gene	O
of	O
the	O
rat	O
(	O
NDP	B
-	I
K	I
beta	I
)	O
shows	O
that	O
exon	O
-	O
intron	O
boundaries	O
are	O
well	O
conserved	O
between	O
these	O
two	O
species	O
.	O

Response	O
durations	O
were	O
short	O
.	O

In	O
addition	O
,	O
REP21	O
plants	O
were	O
resistant	O
to	O
an	O
unusually	O
broad	O
range	O
of	O
tobamoviruses	O
including	O
tomato	O
mosaic	O
virus	O
,	O
tobacco	O
mild	O
green	O
mosaic	O
virus	O
,	O
TMV	O
-	O
U5	O
,	O
green	O
tomato	O
atypical	O
mosaic	O
virus	O
,	O
and	O
ribgrass	O
mosaic	O
virus	O
.	O

Drug	O
effect	O
,	O
measured	O
as	O
postural	O
sway	O
,	O
was	O
also	O
similar	O
in	O
the	O
patients	O
with	O
cirrhosis	O
and	O
control	O
subjects	O
;	O
therefore	O
the	O
ratio	O
of	O
effect	O
area	O
under	O
the	O
curve	O
to	O
concentration	O
area	O
under	O
the	O
curve	O
,	O
a	O
measure	O
of	O
sensitivity	O
,	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
patients	O
with	O
cirrhosis	O
and	O
the	O
control	O
subjects	O
.	O

We	O
present	O
evidence	O
that	O
YY1	B
,	O
a	O
ubiquitously	O
expressed	O
DNA	O
-	O
binding	O
protein	O
,	O
regulates	O
the	O
activity	O
of	O
the	O
c	B
-	I
fos	I
promoter	I
primarily	O
through	O
an	O
effect	O
on	O
DNA	O
structure	O
.	O

In	O
a	O
retrospective	O
analysis	O
of	O
first	O
-	O
time	O
total	O
colonoscopies	O
in	O
685	O
patients	O
,	O
we	O
investigated	O
the	O
relationship	O
between	O
hyperplastic	O
and	O
adenomatous	O
polyps	O
.	O

The	O
rate	O
of	O
decrement	O
in	O
DPOAE	O
amplitude	O
over	O
a	O
prescribed	O
time	O
period	O
was	O
utilized	O
as	O
a	O
measure	O
of	O
susceptibility	O
to	O
the	O
acoustic	O
trauma	O
.	O

Effect	O
of	O
single	O
base	O
substitutions	O
at	O
glycine-870	O
codon	O
of	O
gramicidin	B
S	I
synthetase	I
2	I
gene	I
on	O
proline	O
activation	O
.	O

The	O
results	O
show	O
that	O
the	O
structure	O
of	O
the	O
decorin	B
gene	I
promoter	I
is	O
different	O
from	O
that	O
of	O
any	O
other	O
proteoglycan	O
promoter	O
characterized	O
so	O
far	O
and	O
indicate	O
that	O
the	O
pur	O
/	O
pyr	O
segment	O
plays	O
a	O
role	O
in	O
the	O
regulation	O
of	O
gene	O
transcription	O
.	O

267	O
,	O
4870	O
-	O
4877	O
)	O
)	O
indicates	O
an	O
overall	O
identity	O
of	O
58	O
and	O
56	O
%	O
,	O
respectively	O
,	O
with	O
a	O
91	O
and	O
92	O
%	O
identity	O
in	O
the	O
highly	O
conserved	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
.	O

S.	O
,	O
K.	O

The	O
survival	O
rate	O
at	O
forty	O
months	O
in	O
15	O
patients	O
with	O
N2	O
disease	O
who	O
underwent	O
R2b	O
operation	O
was	O
51	O
%	O
.	O

Mothers	O
with	O
severe	O
anatomical	O
abnormalities	O
,	O
who	O
are	O
HIV	O
positive	O
,	O
have	O
active	O
TB	O
or	O
whose	O
children	O
have	O
inherited	O
mono-	O
or	O
disaccharide	O
intolerances	O
should	O
not	O
breastfeed	O
.	O

G.	O

The	O
psaD	B
,	O
psaF	B
,	O
psaH	B
,	O
and	O
psaL	B
products	I
have	O
two	O
isoforms	O
each	O
that	O
are	O
distinguished	O
by	O
different	O
mobilities	O
in	O
polyacrylamide	O
gel	O
electrophoresis	O
,	O
and	O
the	O
psaE	B
product	I
has	O
four	O
isoforms	O
.	O

When	O
Hy	O
-	O
Vac	O
SPF	O
type	O
V	O
embryos	O
were	O
exposed	O
to	O
either	O
0.20	O
ml	O
50	O
%	O
ethanol	O
in	O
CRS	O
or	O
to	O
0.20	O
ml	O
CRS	O
(	O
controls	O
)	O
,	O
ethanol	O
-	O
treated	O
embryos	O
showed	O
a	O
VSD	O
incidence	O
of	O
34.1	O
%	O
compared	O
with	O
a	O
3.6	O
%	O
incidence	O
in	O
the	O
controls	O
(	O
P	O
=	O
0.0017	O
)	O
.	O

In	O
our	O
studies	O
,	O
we	O
utilized	O
HIV-1	O
HXB2	B
and	O
HIV-1	O
Z2Z6	B
core	I
enhancers	I
because	O
the	O
Z2Z6	B
strain	O
has	O
a	O
single	O
point	O
mutation	O
flanking	O
the	O
right	O
ETS	B
-	I
binding	I
site	I
.	O

The	O
secondary	O
,	O
but	O
not	O
the	O
primary	O
,	O
antibody	O
responses	O
of	O
male	O
C57Bl	O
/	O
6	O
mice	O
were	O
higher	O
among	O
mice	O
housed	O
alone	O
compared	O
to	O
mice	O
housed	O
in	O
groups	O
;	O
differences	O
were	O
observed	O
for	O
both	O
IgM	B
and	O
IgG	B
anti	I
-	I
KLH	I
antibodies	I
.	O

Interleukin-6	B
may	O
possibly	O
potentiate	O
metastasis	O
of	O
cardiac	O
myxoma	O
.	O

Responses	O
to	O
the	O
Plowright	O
Rinderpest	O
vaccine	O
by	O
43	O
calves	O
and	O
70	O
adult	O
cattle	O
in	O
Uganda	O
in	O
1990	O
,	O
through	O
the	O
production	O
of	O
IgG	B
antibodies	I
,	O
were	O
monitored	O
for	O
4	O
weeks	O
using	O
the	O
ELISA	O
assay	O
.	O

Because	O
of	O
the	O
small	O
number	O
of	O
visceral	O
angiography	O
procedures	O
performed	O
(	O
38	O
)	O
,	O
no	O
definitive	O
conclusions	O
could	O
be	O
drawn	O
as	O
to	O
the	O
differences	O
between	O
ionic	O
and	O
nonionic	O
agents	O
regarding	O
grade-2	O
and	O
grade-3	O
adverse	O
events	O
.	O

Tumours	O
of	O
the	O
cavum	O
oris	O
and	O
oropharynx	O
of	O
T1-stage	O
are	O
possible	O
only	O
in	O
1	O
of	O
3	O
cases	O
.	O

Plasma	O
,	O
LDL	B
and	O
liver	O
cholesterol	O
concentrations	O
were	O
higher	O
in	O
the	O
hyperlipidemic	O
control	O
than	O
the	O
nonhyperlipidemic	O
control	O
and	O
lower	O
in	O
the	O
groups	O
fed	O
diets	O
containing	O
pectin	B
or	O
prune	O
fiber	O
than	O
in	O
the	O
hyperlipidemic	O
control	O
group	O
.	O

Glomerular	O
mesangial	O
cells	O
expressed	O
an	O
abundant	O
1.1	O
kb	O
mRNA	O
transcript	O
for	O
Id1	B
,	O
but	O
in	O
contrast	O
to	O
other	O
cell	O
types	O
Id1	B
mRNA	I
was	O
expressed	O
in	O
both	O
randomly	O
cycling	O
cells	O
and	O
in	O
serum	O
-	O
deprived	O
,	O
quiescent	O
cultures	O
.	O

Routine	O
psychometric	O
screening	O
of	O
IHD	O
patients	O
may	O
provide	O
a	O
cost	O
-	O
effective	O
means	O
of	O
alerting	O
cardiologists	O
and	O
internists	O
to	O
the	O
relatively	O
high	O
levels	O
of	O
distress	O
among	O
their	O
patients	O
.	O

The	O
sequence	O
similarity	O
has	O
suggested	O
that	O
SCG10	B
and	O
stathmin	B
have	O
been	O
derived	O
from	O
structurally	O
and	O
evolutionarily	O
related	O
genes	O
.	O

These	O
data	O
are	O
consistent	O
with	O
the	O
idea	O
that	O
the	O
neuron	B
-	I
specific	I
SCG10	I
gene	I
evolved	O
by	O
duplication	O
and	O
modification	O
of	O
the	O
more	O
broadly	O
expressed	O
stathmin	B
/	O
Lap18	B
gene	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
the	O
mouse	B
HO-1	I
gene	I
is	O
identical	O
to	O
that	O
of	O
p32	B
,	O
initially	O
identified	O
as	O
a	O
stress	O
-	O
induced	O
protein	O
in	O
mouse	O
BALBc	O
/	O
3T3	O
cells	O
.	O

We	O
found	O
that	O
T3	O
(	O
10	O
(	O
-8	O
)	O
M	O
)	O
selectively	O
stimulates	O
transcription	O
from	O
rGH	B
-	O
TRE-	O
and	O
TREpal-	O
,	O
but	O
not	O
ME	O
-	O
TRE-	O
and	O
F2-TRE-	O
,	O
containing	O
templates	O
in	O
which	O
these	O
TREs	O
are	O
linked	O
in	O
front	O
of	O
the	O
rGH	B
minimal	I
promoter	I
containing	O
only	O
the	O
TATA	B
box	I
binding	I
protein	I
,	O
but	O
not	O
any	O
other	O
proximal	O
binding	O
protein	O
,	O
sequence	O
.	O

The	O
structural	O
analysis	O
also	O
demonstrated	O
that	O
the	O
heterogeneity	O
of	O
the	O
HDC	B
mRNA	I
is	O
caused	O
by	O
an	O
insertion	O
of	O
the	O
seventh	O
intron	O
sequence	O
and	O
alternative	O
use	O
of	O
the	O
splicing	O
acceptor	O
site	O
at	O
the	O
12th	O
exon	O
.	O

A	O
complementary	O
DNA	O
was	O
isolated	O
from	O
Caenorhabditis	O
elegans	O
that	O
encoded	O
a	O
polypeptide	O
of	O
1438	O
amino	O
acid	O
residues	O
,	O
CeGAP	B
,	O
which	O
contains	O
a	O
domain	O
with	O
sequence	O
similarity	O
to	O
the	O
COOH	B
-	I
terminal	I
segment	I
(	I
GTPase	I
-	I
activating	I
protein	I
region	I
)	I
of	O
Bcr	B
and	O
other	O
known	O
GTPase	B
-	I
activating	I
proteins	I
of	O
the	O
Rho	B
subfamily	I
.	O

Repression	O
is	O
alleviated	O
when	O
the	O
two	O
(	O
for	O
E2	B
)	O
or	O
three	O
(	O
for	O
E2-C	B
)	O
promoter	O
-	O
proximal	O
copies	O
of	O
E2-RS	B
are	O
mutated	O
.	O

A	O
mutant	O
in	O
the	O
AAV	O
terminal	O
resolution	O
site	O
(	O
trs	O
)	O
was	O
defective	O
for	O
DNA	O
replication	O
in	O
the	O
in	O
vitro	O
assay	O
.	O

The	O
results	O
indicate	O
that	O
rep	B
strongly	O
enhances	O
the	O
function	O
of	O
negative	O
regulatory	O
elements	O
of	O
the	O
LTR	O
.	O

However	O
,	O
artificially	O
ventilated	O
rats	O
,	O
pretreated	O
with	O
MK-801	O
,	O
were	O
more	O
sensitive	O
(	O
lethal	O
cocaine	O
dose	O
,	O
76.6	O
+	O
/-	O

8.0	O
mg	O
/	O
kg	O
,	O
n	O
=	O
5	O
)	O
than	O
vehicle	O
pretreated	O
rats	O
(	O
129.4	O
+	O
/-	O

15.8	O
mg	O
/	O
kg	O
,	O
n	O
=	O
6	O
)	O
,	O
indicating	O
that	O
MK-801	O
may	O
increase	O
both	O
the	O
respiratory	O
and	O
the	O
cardiac	O
toxicity	O
of	O
cocaine	O
in	O
urethane	O
anesthetized	O
rats	O
.	O

The	O
Oct-3	B
/	I
4	I
gene	I
product	I
,	O
which	O
belongs	O
to	O
the	O
POU	B
family	I
of	I
transcription	I
factors	I
,	O
is	O
a	O
good	O
candidate	O
for	O
regulating	O
initial	O
differentiation	O
decisions	O
.	O

Using	O
site	O
-	O
directed	O
mutagenesis	O
,	O
we	O
show	O
that	O
the	O
RAREoct	B
contributes	O
to	O
the	O
transcriptional	O
activation	O
of	O
Oct-3	B
/	I
4	I
promoter	I
in	O
P19	O
cells	O
and	O
,	O
most	O
interestingly	O
,	O
mediates	O
the	O
RA	O
-	O
induced	O
repression	O
in	O
RA	O
-	O
differentiated	O
EC	O
cells	O
.	O

176:787	O
-	O
792	O
,	O
1992	O
;	O
M.	O

When	O
expressed	O
alone	O
in	O
test	O
cells	O
,	O
Atr	B
-	I
I	I
is	O
unable	O
to	O
bind	O
TGF	B
-	I
beta	I
,	O
activin	B
,	O
or	O
bone	B
morphogenetic	I
protein	I
2	I
.	O

Therefore	O
,	O
Mxi1	B
and	O
Mad	B
might	O
antagonize	O
Myc	B
function	O
and	O
are	O
candidate	O
tumor	O
suppressor	O
genes	O
.	O

To	O
our	O
knowledge	O
,	O
type	O
IV	O
renal	O
tubular	O
acidosis	O
has	O
not	O
been	O
reported	O
previously	O
in	O
association	O
with	O
Alport	O
's	O
syndrome	O
in	O
an	O
adult	O
patient	O
.	O

Fast	O
continuous	O
expansion	O
.	O

Each	O
repeat	O
consists	O
of	O
12	O
nt	O
,	O
coding	O
for	O
the	O
reiterated	O
sequence	O
,	O
K	O
/	O
NPAG	O
.	O

ENV	B
also	O
was	O
secreted	O
from	O
P.	O
pastoris	O
using	O
the	O
S.	B
cerevisiae	I
alpha	I
-	I
factor	I
prepro	I
secretion	I
leader	I
and	O
the	O
S.	B
cerevisiae	I
invertase	I
signal	I
sequence	I
.	O

BACKGROUND	O
:	O
To	O
determine	O
the	O
predictors	O
of	O
desipramine	O
-	O
refractory	O
depression	O
,	O
the	O
authors	O
examined	O
the	O
outcome	O
in	O
patients	O
with	O
major	O
depression	O
who	O
were	O
admitted	O
to	O
a	O
general	O
hospital	O
and	O
treated	O
with	O
desipramine	O
adjusted	O
to	O
an	O
adequate	O
blood	O
level	O
.	O

Analysis	O
of	O
the	O
intact	O
hGH	B
gene	I
or	O
hGH	B
5'-flanking	I
DNA	I
(	I
5'-FR	I
)	I
coupled	O
to	O
the	O
hGh	B
cDNA	I
or	O
chloramphenicol	B
acetyltransferase	I
or	O
luciferase	B
genes	I
,	O
indicated	O
that	O
cAMP	O
primarily	O
stimulated	O
hGH	B
promoter	I
activity	O
.	O

The	O
Harleco	O
apparatus	O
is	O
a	O
simple	O
,	O
useful	O
,	O
cost	O
-	O
effective	O
adjunct	O
to	O
the	O
diagnosis	O
and	O
treatment	O
of	O
this	O
life	O
-	O
threatening	O
condition	O
.	O

Co	O
-	O
transfection	O
of	O
expression	O
vectors	O
for	O
CCAAT	B
/	I
enhancer	I
binding	I
protein	I
(	I
C	I
/	I
EBP	I
)	I
alpha	I
and	O
C	B
/	I
EBP	I
beta	I
trans	O
-	O
activated	O
the	O
rat	B
uncoupling	I
protein	I
gene	I
promoter	I
due	O
to	O
sequences	O
in	O
the	O
5	O
'	O
proximal	O
region	O
.	O

It	O
was	O
not	O
possible	O
to	O
study	O
the	O
basis	O
for	O
tissue	O
-	O
specific	O
expression	O
of	O
this	O
gene	O
,	O
because	O
the	O
beta	B
3	I
gene	I
promoter	I
had	O
not	O
been	O
isolated	O
previously	O
.	O

Isolation	O
and	O
characterization	O
of	O
a	O
TATA	O
-	O
less	O
promoter	O
for	O
the	O
human	B
beta	I
3	I
integrin	I
gene	I
.	O

Subretinal	O
fluid	O
was	O
punctured	O
on	O
the	O
poorer	O
eye	O
in	O
19	O
eyes	O
(	O
52.7	O
%	O
)	O
and	O
on	O
the	O
better	O
eye	O
in	O
7	O
eyes	O
(	O
19.4	O
%	O
)	O
.	O

These	O
data	O
indicate	O
that	O
activation	O
of	O
these	O
enzymes	O
is	O
not	O
sufficient	O
for	O
the	O
acute	O
stimulation	O
of	O
glucose	O
transport	O
.	O

Transcriptional	O
analysis	O
of	O
a	O
series	O
of	O
deletion	O
mutants	O
of	O
the	O
gene	O
in	O
the	O
nuclear	O
extracts	O
prepared	O
from	O
the	O
middle	O
silk	O
gland	O
of	O
2-day	O
-	O
old	O
fifth	O
instar	O
larvae	O
revealed	O
the	O
presence	O
of	O
multiple	O
cis	O
-	O
regulatory	O
elements	O
located	O
both	O
upstream	O
and	O
downstream	O
of	O
the	O
initiation	O
site	O
.	O

Concerted	O
action	O
of	O
three	O
distinct	O
domains	O
in	O
the	O
DNA	O
cleaving	O
-	O
joining	O
reaction	O
catalyzed	O
by	O
relaxase	B
(	O
TraI	B
)	O
of	O
conjugative	O
plasmid	O
RP4	O
.	O

The	O
HGF	B
-	O
induced	O
cell	O
motility	O
was	O
mimicked	O
by	O
12	O
-	O
0-tetradecanoyl	O
-	O
phorbol-13-acetate	O
,	O
a	O
protein	B
kinase	I
C	I
-	O
activating	O
phorbol	O
ester	O
,	O
but	O
not	O
by	O
Ca2	O
+	O
ionophore	O
.	O

In	O
the	O
present	O
report	O
,	O
66	O
hemochromatosis	O
families	O
yielding	O
151	O
hemochromatosis	O
chromosomes	O
and	O
182	O
normal	O
chromosomes	O
were	O
RFLP	O
-	O
typed	O
with	O
a	O
battery	O
of	O
probes	O
,	O
including	O
two	O
newly	O
derived	O
polymorphic	O
markers	O
from	O
the	O
6.7	O
and	O
HLA	B
-	I
F	I
loci	I
located	O
150	O
and	O
250	O
kb	O
telomeric	O
to	O
HLA	B
-	I
A	I
,	O
respectively	O
.	O

Pneumothorax	O
during	O
laparoscopic	O
dissection	O
of	O
the	O
diaphragmatic	O
hiatus	O
.	O

Mutations	O
in	O
the	O
nuclear	B
gene	I
CBP1	I
of	I
Saccharomyces	I
cerevisiae	I
result	O
in	O
degradation	O
of	O
mitochondrially	B
encoded	I
cytochrome	I
b	I
(	O
cob	B
)	O
RNA	O
;	O
thus	O
,	O
the	O
cells	O
are	O
unable	O
to	O
respire	O
.	O

To	O
gain	O
further	O
insight	O
into	O
the	O
pathogenesis	O
of	O
the	O
adult	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
,	O
the	O
authors	O
studied	O
possible	O
relationships	O
among	O
the	O
activation	O
status	O
of	O
circulating	O
polymorphonuclear	O
neutrophils	O
(	O
PMN	O
)	O
,	O
cytokine	O
levels	O
,	O
and	O
the	O
severity	O
of	O
lung	O
injury	O
in	O
31	O
patients	O
:	O
15	O
with	O
ARDS	O
,	O
9	O
with	O
severe	O
pneumonia	O
uncomplicated	O
by	O
ARDS	O
,	O
and	O
7	O
mechanically	O
ventilated	O
patients	O
with	O
neither	O
ARDS	O
nor	O
pneumonia	O
.	O

Amiodarone	O
,	O
seldom	O
used	O
as	O
first	O
-	O
line	O
treatment	O
,	O
appears	O
to	O
be	O
the	O
most	O
effective	O
drug	O
.	O

Two	O
experiments	O
were	O
conducted	O
to	O
study	O
the	O
vacuous	O
jaw	O
movements	O
induced	O
in	O
rats	O
by	O
acute	O
administration	O
of	O
the	O
monoamine	O
-	O
depleting	O
agent	O
reserpine	O
.	O

Depletion	O
of	O
dopamine	O
in	O
the	O
nucleus	O
accumbens	O
led	O
to	O
a	O
dramatic	O
shift	O
in	O
behavior	O
in	O
which	O
there	O
was	O
a	O
significant	O
decrease	O
in	O
lever	O
pressing	O
but	O
a	O
significant	O
increase	O
in	O
consumption	O
of	O
lab	O
chow	O
.	O

Recovery	O
of	O
carbimazole	O
-	O
induced	O
agranulocytosis	O
following	O
recombinant	B
granulocyte	I
-	I
macrophage	I
colony	I
stimulating	I
factor	I
(	O
rhGM	B
-	I
CSF	I
)	O
administration	O
.	O

Thus	O
,	O
the	O
system	O
can	O
be	O
used	O
to	O
detect	O
and	O
study	O
dynamic	O
perfusion	O
changes	O
from	O
the	O
brain	O
surface	O
with	O
minimal	O
tissue	O
damage	O
.	O

The	O
neglect	O
of	O
Richards	O
's	O
theory	O
demonstrates	O
the	O
range	O
of	O
factors	O
,	O
other	O
than	O
the	O
strictly	O
scientific	O
,	O
which	O
can	O
be	O
important	O
in	O
determining	O
the	O
influence	O
or	O
otherwise	O
of	O
a	O
psychological	O
theory	O
.	O

The	O
positive	O
-	O
acting	O
global	O
sulfur	O
regulatory	O
protein	O
,	O
CYS3	B
,	O
of	O
Neurospora	O
crassa	O
turns	O
on	O
the	O
expression	O
of	O
a	O
family	O
of	O
unlinked	O
structural	O
genes	O
that	O
encode	O
enzymes	O
of	O
sulfur	O
catabolism	O
.	O

Analysis	O
of	O
the	O
upstream	O
untranslated	O
region	O
of	O
CHL15	B
revealed	O
the	O
presence	O
of	O
the	O
hexamer	O
element	O
,	O
ACGCGT	O
(	O
an	O
MluI	B
restriction	I
site	I
)	O
controlling	O
both	O
the	O
periodic	O
expression	O
and	O
coordinate	O
regulation	O
of	O
the	O
DNA	O
synthesis	O
genes	O
in	O
budding	O
yeast	O
.	O

The	O
C	O
-	O
terminal	O
region	O
of	O
the	O
150-kDa	O
protein	O
contains	O
an	O
NTP	O
-	O
binding	O
helicase	B
motif	I
and	O
the	O
readthrough	O
region	O
,	O
an	O
RNA	B
polymerase	I
motif	I
,	O
indicating	O
that	O
these	O
two	O
overlapping	O
proteins	O
may	O
form	O
an	O
RNA	O
replication	O
complex	O
similar	O
to	O
those	O
of	O
tobamo-	O
and	O
tobraviruses	O
.	O

The	O
5	O
'	O
ends	O
of	O
F3R	B
late	O
transcripts	O
were	O
located	O
to	O
an	O
A	O
within	O
the	O
sequence	O
5'-TAAAG	O
,	O
41	O
nt	O
downstream	O
from	O
the	O
early	O
promoter	O
and	O
17	O
nt	O
upstream	O
from	O
the	O
initiation	O
codon	O
.	O

On	O
T2	O
weighted	O
images	O
,	O
low	O
intensity	O
areas	O
in	O
the	O
thalamus	O
,	O
the	O
striatum	O
,	O
the	O
anterior	O
limb	O
of	O
the	O
internal	O
capsule	O
,	O
the	O
tegmentum	O
of	O
midbrain	O
,	O
high	O
intensity	O
areas	O
in	O
middle	O
cerebellar	O
peduncle	O
,	O
the	O
posterior	O
limb	O
of	O
the	O
internal	O
capsule	O
,	O
the	O
lateral	O
part	O
of	O
the	O
cerebral	O
peduncle	O
,	O
and	O
the	O
cerebral	O
white	O
matter	O
were	O
noted	O
.	O

Using	O
the	O
rap1	B
t	I
alleles	I
to	O
generate	O
wild	O
-	O
type	O
cells	O
differing	O
only	O
in	O
telomere	O
tract	O
lengths	O
,	O
we	O
also	O
show	O
that	O
telomere	O
position	O
effects	O
are	O
highly	O
sensitive	O
to	O
changes	O
in	O
the	O
size	O
(	O
or	O
structure	O
)	O
of	O
the	O
telomeric	O
tract	O
.	O

Pronounced	O
microangiopathy	O
characterized	O
by	O
avascular	O
fields	O
,	O
enlarged	O
and	O
tortuous	O
capillaries	O
and	O
increased	O
transcapillary	O
diffusion	O
of	O
sodium	O
fluorescein	O
,	O
was	O
clearly	O
demonstrable	O
in	O
the	O
area	O
of	O
the	O
nodules	O
.	O

Epigenetic	O
switching	O
of	O
transcriptional	O
states	O
:	O
cis-	O
and	O
trans	O
-	O
acting	O
factors	O
affecting	O
establishment	O
of	O
silencing	O
at	O
the	O
HMR	B
locus	I
in	O
Saccharomyces	O
cerevisiae	O
.	O

NF	B
-	I
kappa	I
B	I
p65	B
,	O
p50	B
,	O
and	O
Rel	B
functionally	O
synergize	O
with	O
C	B
/	I
EBP	I
alpha	I
,	O
C	B
/	I
EBP	I
beta	I
,	O
and	O
C	B
/	I
EBP	I
delta	I
.	O

There	O
was	O
no	O
clear	O
correlation	O
between	O
the	O
MFA	O
and	O
the	O
severity	O
of	O
the	O
UTS	O
phenotype	O
.	O

The	O
plasmatic	B
albumin	I
concentration	O
(	O
3.5	O
-	O
4.5	O
g	O
/	O
dl	O
)	O
represents	O
about	O
60	O
%	O
of	O
the	O
total	O
plasma	O
protein	O
.	O

These	O
lesions	O
were	O
asymptomatic	O
,	O
but	O
both	O
were	O
characterized	O
clinically	O
by	O
central	O
ulceration	O
.	O

Neither	O
RD19	B
nor	O
RD21	B
mRNA	I
synthesis	O
was	O
responsive	O
to	O
cold	O
or	O
to	O
heat	O
stress	O
.	O

One	O
defective	O
RNA	O
with	O
a	O
large	O
deletion	O
in	O
the	O
p70	B
coding	I
region	I
was	O
able	O
to	O
replicate	O
efficiently	O
,	O
both	O
when	O
inoculated	O
with	O
the	O
helper	O
genome	O
and	O
when	O
inoculated	O
with	O
a	O
second	O
complementing	O
defective	O
RNA	O
that	O
supplied	O
a	O
wild	B
-	I
type	I
p70	I
.	O

Morphometrical	O
quantification	O
of	O
brain	O
edema	O
related	O
to	O
experimental	O
multiple	O
micro	O
-	O
infarcts	O
in	O
mice	O
:	O
assessment	O
of	O
neurotropin	B
effect	O
.	O

One	O
member	O
of	O
this	O
multigene	O
family	O
,	O
GATA-3	B
,	O
is	O
most	O
abundantly	O
expressed	O
in	O
T	O
lymphocytes	O
,	O
a	O
cellular	O
target	O
for	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
infection	O
and	O
replication	O
.	O

Pneumoscrotum	O
is	O
a	O
rare	O
condition	O
that	O
receives	O
little	O
discussion	O
in	O
standard	O
texts	O
of	O
urology	O
.	O

The	O
first	O
gene	O
codes	O
for	O
a	O
protein	O
containing	O
11	O
cystein	O
residues	O
in	O
an	O
arrangement	O
typical	O
for	O
Fe	B
/	I
S	I
proteins	I
.	O

Triton	O
-	O
disrupted	O
cells	O
retained	O
capacity	O
for	O
activation	O
of	O
the	O
pathway	O
by	O
both	O
peptide	O
growth	O
factors	O
and	O
by	O
addition	O
of	O
GTP	O
-	O
loaded	O
p21	B
rasVal12	B
.	O

To	O
begin	O
to	O
examine	O
the	O
mechanism	O
controlling	O
expression	O
of	O
this	O
gene	O
during	O
the	O
cell	O
-	O
cycle	O
,	O
a	O
mouse	B
B	I
-	I
myb	I
5	I
'	I
flanking	I
sequence	I
was	O
isolated	O
from	O
a	O
cosmid	O
library	O
and	O
shown	O
to	O
promote	O
efficiently	O
the	O
transcription	O
of	O
a	O
luciferase	B
reporter	I
gene	I
when	O
transfected	O
into	O
NIH3T3	O
fibroblasts	O
.	O

The	O
influence	O
of	O
a	O
high	O
ionic	O
strength	O
on	O
the	O
resolution	O
was	O
clearly	O
shown	O
.	O

The	O
number	O
of	O
bacteria	O
in	O
the	O
lung	O
,	O
peripheral	O
white	O
blood	O
cell	O
and	O
BAL	O
fluid	O
cell	O
also	O
decreased	O
by	O
the	O
administration	O
of	O
FN	B
.	O

In	O
mice	O
,	O
three	O
major	O
families	O
of	O
L1	O
elements	O
,	O
termed	O
""""	O
A	O
,	O
""""	O
""""	O
F	O
,	O
""""	O
and	O
""""	O
V	O
,	O
""""	O
have	O
been	O
defined	O
on	O
the	O
basis	O
of	O
the	O
sequence	O
found	O
at	O
the	O
5	O
'	O
terminus	O
.	O

TFEC	B
,	O
a	O
basic	B
helix	I
-	I
loop	I
-	I
helix	I
protein	I
,	O
forms	O
heterodimers	O
with	O
TFE3	B
and	O
inhibits	O
TFE3-dependent	B
transcription	O
activation	O
.	O

The	O
equivalent	O
of	O
the	O
third	O
ligand	O
,	O
H-87	O
,	O
is	O
T-47	O
in	O
the	O
PSTAIRE	O
sequence	O
motif	O
.	O

Similar	O
results	O
were	O
seen	O
on	O
Western	O
blots	O
of	O
Autographa	O
californica	O
MNPV	O
(	O
AcMNPV	O
)	O
-infected	O
Spodoptera	O
frugiperda	O
cells	O
.	O

In	O
infected	O
mammalian	O
cells	O
,	O
the	O
ARV	B
G	I
and	O
GNS	B
genes	I
are	O
transcribed	O
primarily	O
as	O
a	O
polycistronic	O
mRNA	O
which	O
appears	O
to	O
extend	O
from	O
the	O
consensus	O
sequence	O
(	O
AACAG	O
)	O
at	O
the	O
start	O
of	O
the	O
G	B
gene	I
to	O
the	O
next	O
recognized	O
polyadenylation	O
signal	O
(	O
CATG	O
[	O
A	O
]	O
7	O
)	O
located	O
697	O
nucleotides	O
downstream	O
of	O
the	O
GNS	B
protein	I
termination	O
codon	O
.	O

Molecular	O
cloning	O
and	O
expression	O
of	O
RPE65	B
,	O
a	O
novel	O
retinal	O
pigment	O
epithelium	O
-	O
specific	O
microsomal	O
protein	O
that	O
is	O
post	O
-	O
transcriptionally	O
regulated	O
in	O
vitro	O
.	O

The	O
mean	O
power	O
(	O
in	O
mu	O
W	O
)	O
required	O
to	O
produce	O
the	O
observed	O
flow	O
rate	O
was	O
estimated	O
at	O
each	O
outflow	O
pressure	O
as	O
the	O
product	O
of	O
the	O
flow	O
rate	O
and	O
the	O
pressure	O
across	O
the	O
lymphatic	O
vessel	O
.	O

Although	O
antisperm	O
antibodies	O
are	O
associated	O
with	O
infertility	O
,	O
many	O
hospital	O
laboratories	O
do	O
not	O
test	O
for	O
these	O
antibodies	O
.	O

PPD	B
-	O
specific	O
IgG	B
subclass	O
responses	O
were	O
evident	O
to	O
all	O
four	O
IgG	B
subclasses	O
.	O

Anterior	O
body	O
pattern	O
in	O
Drosophila	O
is	O
specified	O
by	O
the	O
graded	O
distribution	O
of	O
the	O
bicoid	B
protein	I
(	O
bcd	B
)	O
,	O
which	O
activates	O
subordinate	O
genes	O
in	O
distinct	O
anterior	O
domains	O
.	O

GAP	B
-	I
N	I
bound	O
constitutively	O
to	O
p190	B
in	O
both	O
serum	O
-	O
deprived	O
and	O
growth	O
factor	O
-	O
stimulated	O
cells	O
.	O

The	O
peptide	O
sequence	O
contains	O
a	O
region	O
of	O
80	O
amino	O
acids	O
that	O
shows	O
similarity	O
to	O
bcl-2	B
and	O
to	O
the	O
recently	O
described	O
bcl-2-related	B
gene	I
,	O
MCL1	B
.	O

Botulinum	B
toxin	I
:	O
preferred	O
treatment	O
for	O
hemifacial	O
spasm	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
GAL1	I
and	O
GAL10	B
genes	I
are	O
controlled	O
in	O
response	O
to	O
the	O
availability	O
of	O
galactose	O
and	O
glucose	O
by	O
multiple	O
activating	O
and	O
repressing	O
proteins	O
bound	O
at	O
adjacent	O
or	O
overlapping	O
sites	O
in	O
UASG	O
.	O

Surprisingly	O
,	O
the	O
results	O
of	O
several	O
experiments	O
suggest	O
that	O
the	O
TSF	B
genes	I
encode	O
global	O
regulatory	O
factors	O
.	O

tsf1	B
to	O
tsf6	B
mutations	O
derepressed	O
expression	O
from	O
yeast	O
CYC	B
-	O
GAL	B
hybrid	O
promoters	O
(	O
fused	O
to	O
lacZ	B
)	O
that	O
harbor	O
a	O
variety	O
of	O
operator	O
sequences	O
,	O
and	O
caused	O
pleiotropic	O
defects	O
in	O
cell	O
growth	O
,	O
mating	O
,	O
and	O
sporulation	O
.	O

Sex	O
of	O
calf	O
(	O
variate	O
2	O
)	O
was	O
associated	O
most	O
closely	O
with	O
width	O
of	O
muzzle	O
and	O
head	O
.	O

Sequence	O
comparison	O
indicates	O
that	O
exons	O
5'	O
/	O
L	O
and	O
L	O
/	O
N	O
in	O
PSG12	B
and	O
PSG12	B
psi	I
are	O
99	O
%	O
identical	O
,	O
except	O
that	O
the	O
L	O
/	O
N	O
exon	O
in	O
the	O
PSG12	B
psi	I
gene	I
contains	O
a	O
stop	O
codon	O
.	O

We	O
suggest	O
that	O
the	O
ER	O
lumenal	O
variable	O
domain	O
of	O
gp19	B
K	I
has	O
a	O
specific	O
tertiary	O
structure	O
that	O
is	O
important	O
for	O
binding	O
to	O
the	O
polymorphic	O
alpha	O
1	O
and	O
alpha	O
2	O
domains	O
of	O
class	B
I	I
heavy	I
(	I
alpha	I
)	I
chains	I
.	O

We	O
recently	O
found	O
that	O
17	O
beta	O
-	O
estradiol	O
(	O
E2	O
)	O
not	O
only	O
suppresses	O
bone	O
resorption	O
but	O
also	O
stimulates	O
bone	O
formation	O
in	O
the	O
cancellous	O
bone	O
of	O
female	O
rats	O
.	O

Single	O
-	O
photon	O
emission	O
computed	O
tomography	O
(	O
SPECT	O
)	O
with	O
99mTc	O
-	O
hexamethylpropyleneamine	O
oxime	O
(	O
HMPAO	O
)	O
was	O
used	O
to	O
investigate	O
changes	O
in	O
cerebral	O
blood	O
flow	O
in	O
seven	O
patients	O
with	O
cortical	O
visual	O
impairment	O
.	O

METHODS	O
:	O
Twenty	O
-	O
two	O
patients	O
were	O
grouped	O
according	O
to	O
their	O
etiology	O
based	O
on	O
the	O
study	O
of	O
antiadrenal	O
antibodies	O
at	O
diagnosis	O
of	O
the	O
disease	O
:	O
7	O
were	O
positive	O
(	O
autoimmune	O
etiology	O
or	O
EAA	O
)	O
,	O
11	O
were	O
negative	O
(	O
tuberculous	O
etiology	O
or	O
EAT	O
)	O
and	O
in	O
four	O
serologic	O
study	O
was	O
not	O
available	O
(	O
undetermined	O
etiology	O
or	O
EAI	O
)	O
.	O

2-AP	O
induced	O
marked	O
,	O
steady	O
rises	O
in	O
mRNA	O
accumulation	O
from	O
both	O
transfected	O
and	O
chromosomally	O
integrated	O
HIV-1	O
constructs	O
but	O
no	O
increases	O
from	O
an	O
endogenous	O
gene	O
encoding	O
gamma	B
-	I
actin	I
or	O
glucose	B
6-phosphate	I
dehydrogenase	I
.	O

Protein	B
tyrosine	I
phosphatases	I
(	O
PTPs	B
)	O
,	O
together	O
with	O
protein	B
tyrosine	I
kinases	I
(	O
PTKs	B
)	O
,	O
are	O
involved	O
in	O
the	O
regulation	O
of	O
cell	O
activation	O
,	O
growth	O
,	O
and	O
differentiation	O
.	O

Furthermore	O
,	O
a	O
p21X	B
protein	I
lacking	O
the	O
N	O
-	O
terminus	O
of	O
Rex1	B
was	O
expressed	O
at	O
high	O
levels	O
;	O
our	O
data	O
indicate	O
that	O
p21X	B
is	O
translated	O
from	O
the	O
1.6-kb	O
mRNA	O
which	O
is	O
derived	O
primarily	O
from	O
deleted	O
proviruses	O
.	O

Thus	O
,	O
it	O
was	O
confirmed	O
that	O
the	O
sodium	O
lauryl	O
sulfate	O
method	O
of	O
estimating	O
hemoglobin	B
concentration	O
is	O
an	O
appropriate	O
alternative	O
to	O
the	O
cyanmethemoglobin	B
method	O
and	O
avoids	O
the	O
generation	O
of	O
toxic	O
wastes	O
.	O

XII	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
structures	O
of	O
the	O
b	O
-	O
Zip	O
domain	O
are	O
well	O
conserved	O
among	O
these	O
Maf	B
-	I
related	I
proteins	I
.	O

Under	O
these	O
conditions	O
,	O
transfections	O
with	O
cDNAs	O
of	O
the	O
NF	B
-	I
kappa	I
B	I
p50	B
and	O
serum	B
response	I
factor	I
(	O
SRF	B
)	O
produced	O
a	O
factor	O
(	O
s	O
)	O
that	O
mediated	O
Tax	B
binding	O
to	O
the	O
NF	B
-	I
kappa	I
B	I
site	I
and	O
the	O
CArG	O
box	O
respectively	O
.	O

We	O
show	O
here	O
that	O
v	B
-	I
Rel	I
specifically	O
increased	O
expression	O
from	O
a	O
reporter	O
plasmid	O
containing	O
multiple	O
Sp1	B
binding	I
sites	I
approximately	O
sixfold	O
in	O
chicken	O
embryo	O
fibroblasts	O
(	O
CEFs	O
)	O
,	O
even	O
though	O
v	B
-	I
Rel	I
did	O
not	O
bind	O
directly	O
to	O
these	O
sites	O
.	O

v	B
-	I
Rel	I
also	O
increased	O
expression	O
from	O
a	O
reporter	O
plasmid	O
containing	O
a	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV-1	I
)	I
long	I
terminal	I
repeat	I
(	O
LTR	O
)	O
in	O
which	O
the	O
kappa	B
B	I
binding	I
sites	I
were	O
mutated	O
but	O
which	O
still	O
contained	O
intact	O
Sp1	B
binding	I
sites	I
.	O

CONCLUSION	O
:	O
This	O
retrospective	O
analysis	O
does	O
not	O
confirm	O
the	O
efficacy	O
of	O
one	O
course	O
of	O
simultaneous	O
Mitomycin	O
-	O
C	O
and	O
5-fluorouracil	O
,	O
at	O
least	O
in	O
association	O
with	O
full	O
-	O
dose	O
radiotherapy	O
incorporating	O
Iridium-192	O
boost	O
.	O

Despite	O
the	O
existence	O
of	O
30	O
cysteine	O
residues	O
,	O
carboxymethylation	O
prevented	O
the	O
formation	O
of	O
most	O
if	O
not	O
all	O
disulfide	O
bonds	O
that	O
otherwise	O
occurred	O
when	O
the	O
cells	O
were	O
sonicated	O
.	O

Cerebro	O
-	O
oculo	O
-	O
facioskeletal	O
syndrome	O
(	O
Pena	O
-	O
Shokeir	O
syndrome	O
II	O
)	O

Deletion	O
of	O
a	O
53-bp	O
early	O
promoter	O
region	O
containing	O
the	O
transcription	O
start	O
site	O
and	O
a	O
putative	O
TATA	O
box	O
completely	O
abolishes	O
the	O
ability	O
of	O
upstream	O
elements	O
to	O
drive	O
transcription	O
of	O
the	O
luciferase	B
cDNA	I
.	O

Dissipation	O
of	O
claudication	O
pain	O
after	O
walking	O
:	O
implications	O
for	O
endurance	O
training	O
.	O

Alternative	O
transcript	O
of	O
the	O
nonselective	O
-	O
type	O
endothelin	B
receptor	I
from	O
rat	O
brain	O
.	O

The	O
Functional	O
Independence	O
Measure	O
:	O
a	O
comparative	O
study	O
of	O
clinician	O
and	O
self	O
ratings	O
.	O

Polymyxin	O
B	O
was	O
given	O
intravenously	O
for	O
1	O
week	O
postburn	O
in	O
doses	O
designed	O
to	O
neutralize	O
circulating	O
endotoxemia	O
.	O

SvO2	O
can	O
be	O
determined	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
transverse	O
relaxation	O
time	O
(	O
T2	O
)	O
and	O
apparent	O
diffusion	O
coefficient	O
of	O
water	O
were	O
determined	O
.	O

The	O
Drosophila	O
clathrin	B
heavy	I
chain	I
gene	O
:	O
clathrin	B
function	O
is	O
essential	O
in	O
a	O
multicellular	O
organism	O
.	O

The	O
binding	O
specificity	O
of	O
this	O
protein	O
was	O
compared	O
to	O
that	O
of	O
human	B
E2F	I
using	O
a	O
number	O
of	O
mutant	B
E2F	I
sites	I
as	O
competitors	O
.	O

To	O
analyze	O
the	O
VH	O
regions	O
of	O
polyreactive	O
antibodies	O
,	O
with	O
particular	O
attention	O
at	O
their	O
somatically	O
mutated	O
status	O
,	O
we	O
generated	O
five	O
IgG	B
(	O
three	O
IgG1	B
and	O
two	O
IgG3	B
)	O
mAb	O
(	O
using	O
B	O
cells	O
from	O
a	O
healthy	O
subject	O
,	O
a	O
patient	O
with	O
insulin	B
-	O
dependent	O
diabetes	O
mellitus	O
and	O
a	O
patient	O
with	O
SLE	O
)	O
,	O
which	O
bound	O
with	O
various	O
efficiencies	O
a	O
number	O
of	O
different	O
self	O
and	O
foreign	O
Ag	O
.	O

These	O
findings	O
suggest	O
a	O
functional	O
cross	O
-	O
talk	O
between	O
RB	B
protein	I
and	O
p21ras	B
,	O
which	O
balances	O
the	O
cell	O
phenotype	O
between	O
normal	O
and	O
transformed	O
states	O
.	O

Kinetics	O
of	O
the	O
inhibition	O
indicated	O
that	O
this	O
polymerase	O
domain	O
can	O
inhibit	O
viral	O
replication	O
only	O
during	O
the	O
preinitiation	O
stage	O
.	O

3	O
.	O

McCann	O
III	O
,	O
F.	O

These	O
cell	O
lines	O
,	O
selected	O
for	O
the	O
ability	O
to	O
support	O
the	O
replication	O
of	O
a	O
temperature	O
-	O
sensitive	O
VP5	B
mutant	I
,	O
were	O
used	O
to	O
isolate	O
VP5	B
and	O
VP23	B
null	O
mutants	O
.	O

The	O
E1	B
nuclear	I
transport	I
motif	I
is	O
highly	O
conserved	O
in	O
the	O
animal	O
and	O
human	O
papillomaviruses	O
and	O
is	O
encoded	O
in	O
a	O
similar	O
region	O
in	O
the	O
related	O
E1	B
genes	I
.	O

The	O
E1	B
replication	I
protein	I
of	O
bovine	O
papillomavirus	O
type	O
1	O
contains	O
an	O
extended	O
nuclear	O
localization	O
signal	O
that	O
includes	O
a	O
p34cdc2	B
phosphorylation	O
site	O
.	O

In	O
order	O
to	O
investigate	O
to	O
what	O
extent	O
this	O
interaction	O
might	O
contribute	O
to	O
tumor	O
induction	O
by	O
the	O
virus	O
,	O
we	O
have	O
introduced	O
two	O
different	O
point	O
mutations	O
within	O
the	O
putative	O
pRb	B
-	I
binding	I
sequence	I
of	O
large	B
T	I
antigen	I
,	O
and	O
as	O
a	O
preliminary	O
to	O
in	O
vivo	O
experiments	O
we	O
have	O
studied	O
their	O
effects	O
in	O
vitro	O
on	O
some	O
biological	O
activities	O
relevant	O
to	O
tumor	O
induction	O
.	O

We	O
conclude	O
that	O
the	O
conservation	O
of	O
nucleotides	O
154	O
to	O
156	O
is	O
likely	O
to	O
be	O
a	O
consequence	O
of	O
their	O
role	O
as	O
a	O
sequence	O
-	O
specific	O
recognition	O
element	O
for	O
the	O
SRP54	B
protein	I
.	O

A	O
region	O
of	O
the	O
deduced	O
protein	O
shares	O
extensive	O
homology	O
with	O
a	O
catalytic	O
region	O
of	O
Raf	B
kinases	I
,	O
a	O
feature	O
shared	O
only	O
with	O
TFIIE	B
among	O
transcription	O
factors	O
.	O

The	O
low	O
molecular	O
mass	O
polypeptide	O
complex	O
is	O
assumed	O
to	O
be	O
involved	O
in	O
antigen	O
presentation	O
,	O
generating	O
peptides	O
from	O
cytosolic	O
protein	O
antigens	O
,	O
which	O
are	O
subsequently	O
presented	O
to	O
cytotoxic	O
T	O
-	O
lymphocytes	O
on	O
the	O
cell	O
surface	O
.	O

The	O
C	O
-	O
terminal	O
approximately	O
50	O
amino	O
acids	O
of	O
Bel-1	B
are	O
shown	O
to	O
be	O
essential	O
for	O
Bel-1	B
activity	O
but	O
can	O
be	O
effectively	O
substituted	O
by	O
the	O
C	O
-	O
terminal	O
activation	O
domain	O
of	O
VP16	B
.	O

Optimal	O
activation	O
of	O
T	O
cells	O
requires	O
at	O
least	O
two	O
signals	O
.	O

All	O
four	O
of	O
the	O
genes	O
have	O
a	O
similar	O
structure	O
,	O
with	O
the	O
receptor	O
protein	O
encoded	O
in	O
a	O
single	O
exon	O
.	O

Identity	O
of	O
GABP	B
with	O
NRF-2	B
,	O
a	O
multisubunit	O
activator	O
of	O
cytochrome	B
oxidase	I
expression	O
,	O
reveals	O
a	O
cellular	O
role	O
for	O
an	O
ETS	B
domain	I
activator	O
of	O
viral	O
promoters	O
.	O

The	O
intracellular	O
basic	B
region	I
/	I
helix	I
-	I
loop	I
-	I
helix	I
(	I
bHLH	I
)	I
dioxin	I
receptor	I
mediates	O
signal	O
transduction	O
by	O
dioxin	O
(	O
2,3,7,8-tetrachlorodibenzo	O
-	O
p	O
-	O
dioxin	O
)	O
and	O
functions	O
as	O
a	O
ligand	O
-	O
activated	O
DNA	O
binding	O
protein	O
directly	O
interacting	O
with	O
target	O
genes	O
by	O
binding	O
to	O
dioxin	O
response	O
elements	O
.	O

The	O
alpha	B
2A	I
-	I
adrenergic	I
receptor	I
(	O
alpha	B
2AAR	I
)	O
is	O
coupled	O
to	O
a	O
variety	O
of	O
effectors	O
via	O
pertussis	B
toxin	I
-	O
sensitive	O
GTP	B
-	I
binding	I
proteins	I
.	O

A	O
sequence	O
comparison	O
reveals	O
two	O
CCAAT	B
/	I
enhancer	I
binding	I
protein	I
(	O
C	B
/	I
EBP	I
)	O
consensus	O
sequences	O
,	O
basic	O
DNA	O
binding	O
region	O
and	O
leucine	O
zippers	O
1	O
and	O
2	O
(	O
bZIP1	O
and	O
bZIP2	O
)	O
,	O
within	O
this	O
region	O
.	O

One	O
of	O
these	O
genes	O
,	O
REC114	B
,	O
is	O
described	O
here	O
,	O
and	O
the	O
data	O
confirm	O
that	O
REC114	B
is	O
a	O
meiosis	O
-	O
specific	O
recombination	O
gene	O
with	O
no	O
detectable	O
function	O
in	O
mitosis	O
.	O

The	O
transactivation	O
function	O
of	O
EBNA2	B
was	O
also	O
observed	O
in	O
the	O
HeLa	O
epithelial	O
cell	O
line	O
,	O
which	O
suggests	O
that	O
EBV	O
and	O
HIV-1	O
infection	O
of	O
non	O
-	O
B	O
cells	O
may	O
result	O
in	O
HIV-1	B
promoter	I
activation	O
.	O

Nuclear	B
protein	I
phosphatase	I
2A	I
dephosphorylates	O
protein	B
kinase	I
A	I
-	O
phosphorylated	O
CREB	B
and	O
regulates	O
CREB	B
transcriptional	O
stimulation	O
.	O

We	O
show	O
that	O
IL-6	B
activates	O
JRE	B
-	I
IL6	I
through	O
an	O
H7-sensitive	O
pathway	O
that	O
does	O
not	O
involve	O
protein	B
kinase	I
C	I
,	O
cyclic	B
AMP	I
-	I
dependent	I
kinase	I
,	O
Ca	B
(	I
2+	I
)	I
-	I
or	I
calmodulin	I
-	I
dependent	I
kinases	I
,	O
Ras	B
,	O
Raf-1	B
,	O
or	O
NF	B
-	I
IL6	I
(	O
C	B
/	I
EBP	I
beta	I
)	O
.	O

Growth	O
factor	O
stimulation	O
rapidly	O
induces	O
a	O
reversible	O
change	O
in	O
the	O
electrophoretic	O
mobility	O
of	O
the	O
ternary	O
complex	O
,	O
accompanied	O
by	O
increased	O
phosphorylation	O
of	O
the	O
Elk-1	B
C	I
-	I
terminal	I
region	I
and	O
by	O
the	O
activation	O
of	O
a	O
42	B
kd	I
cellular	I
Elk-1	I
kinase	I
.	O

This	O
stimulatory	O
effect	O
could	O
also	O
be	O
elicited	O
by	O
c	B
-	I
Jun	I
,	O
which	O
interacts	O
with	O
topo	B
II	I
,	O
but	O
not	O
by	O
c	B
-	I
Fos	I
,	O
which	O
does	O
not	O
bind	O
topo	B
II	I
in	O
our	O
in	O
vitro	O
assay	O
.	O

After	O
surgery	O
,	O
patients	O
self	O
administered	O
one	O
of	O
three	O
possible	O
postsurgical	O
medications	O
,	O
which	O
included	O
placebo	O
,	O
codeine	O
60	O
mg	O
,	O
and	O
ibuprofen	O
400	O
mg	O
,	O
when	O
their	O
pain	O
reached	O
a	O
moderate	O
or	O
severe	O
intensity	O
.	O

Replacement	O
of	O
the	O
wild	O
-	O
type	O
5'-regulatory	O
region	O
with	O
either	O
of	O
the	O
mutants	O
'	O
cis	O
-	O
acting	O
regulatory	O
element	O
resulted	O
in	O
the	O
anaerobic	O
expression	O
of	O
active	B
Mn	I
-	I
superoxide	I
dismutase	I
.	O

The	O
orf61	B
gene	I
product	I
,	O
when	O
expressed	O
from	O
an	O
exogenous	O
promoter	O
,	O
inhibited	O
int	B
-	O
mediated	O
integration	O
at	O
the	O
chromosomal	B
attB	I
site	I
.	O

Analysis	O
by	O
cell	O
surface	O
immunofluorescence	O
showed	O
that	O
the	O
UL28	B
gene	I
is	O
not	O
required	O
for	O
expression	O
of	O
viral	O
glycoproteins	O
on	O
the	O
surface	O
of	O
infected	O
cells	O
.	O

Estrogen	O
treatment	O
in	O
high	O
doses	O
is	O
effective	O
in	O
reducing	O
adult	O
stature	O
in	O
constitutionally	O
tall	O
girls	O
.	O

Mutations	O
at	O
the	O
extreme	O
C	O
-	O
terminus	O
of	O
EIAV	B
Tat	I
impaired	O
both	O
RNA	O
binding	O
and	O
activation	O
domain	O
functions	O
,	O
suggesting	O
effects	O
on	O
secondary	O
or	O
tertiary	O
structure	O
.	O

This	O
observation	O
suggests	O
that	O
the	O
methyl	O
-	O
directed	O
repair	O
system	O
utilizes	O
the	O
proximal	O
d	O
(	O
GATC	O
)	O
sequence	O
to	O
direct	O
correction	O
.	O

Uracil	B
DNA	I
glycosylase	I
catalyzes	O
the	O
initial	O
step	O
in	O
the	O
repair	O
pathway	O
that	O
removes	O
potentially	O
mutagenic	O
uracil	O
from	O
duplex	O
DNA	O
.	O

Current	O
clinical	O
trials	O
should	O
answer	O
the	O
question	O
of	O
which	O
of	O
the	O
therapeutic	O
options	O
impairs	O
quality	O
of	O
life	O
less	O
.	O

Lithium	O
phthalocyanine	O
(	O
LiPc	O
)	O
is	O
a	O
prototype	O
of	O
another	O
generation	O
of	O
synthetic	O
,	O
metallic	O
-	O
organic	O
,	O
paramagnetic	O
crystallites	O
that	O
appear	O
very	O
useful	O
for	O
in	O
vitro	O
and	O
in	O
vivo	O
electron	O
paramagnetic	O
resonance	O
oximetry	O
.	O

Recipients	O
with	O
acute	O
leukaemia	O
in	O
first	O
remission	O
or	O
chronic	O
myeloid	O
leukaemia	O
in	O
first	O
chronic	O
phase	O
were	O
analysed	O
as	O
good	O
risk	O
,	O
and	O
those	O
beyond	O
these	O
stages	O
,	O
as	O
poor	O
risk	O
patients	O
.	O

Losses	O
during	O
the	O
complete	O
procedure	O
are	O
corrected	O
for	O
using	O
radioactive	O
estrogen	O
conjugates	O
during	O
the	O
first	O
steps	O
and	O
later	O
by	O
adding	O
deuterated	O
internal	O
standards	O
of	O
all	O
compounds	O
measured	O
(	O
matairesinol	O
,	O
enterodiol	O
,	O
enterolactone	O
,	O
daidzein	O
,	O
O	O
-	O
desmethylangolensin	O
,	O
equol	O
,	O
and	O
genistein	O
)	O
.	O

IE2-IE2	B
interactions	O
were	O
mapped	O
to	O
a	O
domain	O
containing	O
a	O
putative	O
helix	O
-	O
turn	O
-	O
helix	O
motif	O
located	O
near	O
the	O
C	O
terminus	O
of	O
IE2	B
,	O
between	O
amino	O
acids	O
456	O
and	O
539	O
.	O

A	O
sheep	O
testicular	O
cDNA	O
library	O
constructed	O
in	O
pcDNA1	O
vector	O
was	O
screened	O
with	O
a	O
probe	O
generated	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
and	O
corresponding	O
to	O
a	O
1.6	O
kb	O
fragment	O
of	O
the	O
rat	B
luteinizing	I
hormone	I
receptor	I
cDNA	I
.	O

The	O
ability	O
of	O
spt2	B
mutations	I
to	O
suppress	O
the	O
transcriptional	O
interference	O
caused	O
by	O
the	O
delta	B
promoter	I
insertion	I
his-4	I
-	I
912	I
delta	I
correlates	O
with	O
an	O
increase	O
in	O
wild	B
-	I
type	I
HIS4	I
mRNA	I
levels	O
.	O

The	O
conserved	O
ninth	O
C	O
-	O
terminal	O
heptad	O
in	O
thyroid	O
hormone	O
and	O
retinoic	B
acid	I
receptors	I
mediates	O
diverse	O
responses	O
by	O
affecting	O
heterodimer	O
but	O
not	O
homodimer	O
formation	O
.	O

Steroidogenic	B
factor	I
1	I
,	O
an	O
orphan	B
nuclear	I
receptor	I
,	O
regulates	O
the	O
expression	O
of	O
the	O
rat	B
aromatase	I
gene	I
in	O
gonadal	O
tissues	O
.	O

To	O
study	O
the	O
functional	O
differences	O
between	O
cutaneous	O
HPV5	O
and	O
HPV8	O
E7s	B
and	O
genital	B
HPV16	I
E7	I
,	O
we	O
cloned	O
each	O
of	O
the	O
E7	B
open	O
reading	O
frames	O
and	O
tested	O
their	O
immortalizing	O
and	O
transforming	O
activities	O
,	O
the	O
binding	O
ability	O
of	O
their	O
products	O
with	O
retinoblastoma	B
protein	I
(	O
RB	B
)	O
and	O
their	O
complementation	O
activity	O
of	O
a	O
RB	B
-	I
nonbinding	I
adenovirus	I
E1A	I
mutant	I
.	O

The	O
rhaB	B
transcription	I
start	I
site	I
was	O
mapped	O
to	O
-24	O
relative	O
to	O
the	O
start	O
of	O
translation	O
.	O

Several	O
lines	O
of	O
evidence	O
demonstrate	O
that	O
this	O
growth	O
inhibition	O
requires	O
active	O
PKA	B
subunits	I
and	O
cAMP	O
:	O
(	O
i	O
)	O
this	O
phenotype	O
is	O
dependent	O
on	O
cAMP	O
since	O
it	O
is	O
not	O
seen	O
in	O
a	O
strain	O
lacking	O
adenylyl	B
cyclase	I
activity	O
,	O
but	O
the	O
growth	O
rate	O
of	O
these	O
transformants	O
is	O
slower	O
when	O
exogenous	O
cAMP	O
is	O
added	O
;	O
(	O
ii	O
)	O
normal	O
growth	O
occurs	O
when	O
wild	O
-	O
type	O
RI	B
cDNA	O
is	O
replaced	O
by	O
a	O
mutant	B
RI	I
cDNA	I
encoding	O
a	O
RI	B
protein	I
with	O
reduced	O
cAMP	O
binding	O
;	O
and	O
(	O
iii	O
)	O
the	O
growth	O
-	O
inhibited	O
phenotype	O
of	O
the	O
transformed	O
BL21	O
(	O
DE3	O
)	O
cells	O
requires	O
soluble	O
,	O
active	O
C	B
alpha	I
protein	I
.	O

BCR	B
-	O
ABL	B
and	O
v	B
-	I
abl	I
oncogenes	I
induce	O
distinct	O
patterns	O
of	O
thymic	O
lymphoma	O
involving	O
different	O
lymphocyte	O
subsets	O
.	O

LDL	B
cholesterol	I
decreased	O
from	O
4.74	O
+	O
/-	O

0.87	O
to	O
3.78	O
+	O
/-	O

0.78	O
mmol	O
/	O
l	O
after	O
8	O
weeks	O
on	O
simvastatin	O
(	O
P	O
<	O
0.001	O
)	O
,	O
and	O
apo	B
B	I
fell	O
from	O
142	O
+	O
/-	O

31	O
to	O
112	O
+	O
/-	O

22	O
mg	O
/	O
dl	O
(	O
P	O
<	O
0.001	O
)	O
.	O

This	O
negative	O
element	O
may	O
,	O
at	O
least	O
in	O
part	O
,	O
be	O
responsible	O
for	O
the	O
cell	O
type	O
-	O
specific	O
expression	O
of	O
the	O
DGK	B
gene	I
.	O

A	O
new	O
bioencapsulation	O
technology	O
for	O
microbial	O
inoculants	O
.	O

It	O
contains	O
three	O
putative	O
binding	O
sites	O
for	O
transcription	B
factor	I
Sp1	I
as	O
well	O
as	O
several	O
short	O
sequences	O
that	O
are	O
similar	O
to	O
known	O
cis	O
-	O
acting	O
enhancers	O
or	O
binding	O
sites	O
for	O
transcription	O
factors	O
.	O

French	O
bean	O
contains	O
a	O
small	O
family	O
of	O
genes	B
encoding	I
PAL	I
and	O
two	O
of	O
these	O
genes	O
,	O
PAL2	B
and	O
PAL3	B
,	O
have	O
been	O
shown	O
to	O
be	O
differentially	O
expressed	O
at	O
the	O
mRNA	O
level	O
in	O
bean	O
tissues	O
.	O

By	O
stepwise	O
linear	O
multiple	O
regression	O
analysis	O
,	O
ionized	O
magnesium	O
was	O
significantly	O
related	O
to	O
cyclosporin	O
trough	O
level	O
and	O
total	O
cholesterol	O
but	O
not	O
to	O
serum	O
creatinine	O
,	O
time	O
after	O
transplant	O
or	O
the	O
dose	O
of	O
cyclosporin	O
.	O

The	O
human	B
insulin	I
-	I
like	I
growth	I
factor	I
II	I
(	O
IGF	B
-	I
II	I
)	O
gene	O
contains	O
four	O
promoters	O
(	O
P1	O
,	O
P2	O
,	O
P3	O
and	O
P4	O
)	O
.	O

Moreover	O
,	O
in	O
transient	O
transfection	O
assays	O
,	O
PU.1	B
alone	O
activated	O
reporter	O
constructs	O
containing	O
the	O
JB	O
cis	O
-	O
element	O
,	O
and	O
the	O
activation	O
was	O
shown	O
to	O
be	O
dependent	O
on	O
a	O
glutamine	O
-	O
rich	O
sequence	O
in	O
the	O
amino	O
-	O
terminal	O
portion	O
of	O
PU.1	B
.	O

Army	O
veterans	O
given	O
yellow	O
fever	O
vaccine	O
contaminated	O
with	O
hepatitis	O
B	O
virus	O
in	O
1942	O
and	O
controls	O
and	O
(	O
b	O
)	O
a	O
case	O
-	O
control	O
study	O
comparing	O
veterans	O
with	O
hepatocellular	O
carcinoma	O
in	O
Veterans	O
Affairs	O
hospitals	O
with	O
matched	O
controls	O
with	O
respect	O
to	O
receipt	O
of	O
contaminated	O
vaccine	O
in	O
1942	O
.	O

Defects	O
of	O
fibrillin	B
(	O
FBN1	B
)	O
,	O
a	O
glycoprotein	O
component	O
of	O
the	O
extracellular	O
microfibril	O
,	O
cause	O
Marfan	O
syndrome	O
.	O

Distinguishing	O
roles	O
of	O
the	O
membrane	O
-	O
cytoskeleton	O
and	O
cadherin	B
mediated	O
cell	O
-	O
cell	O
adhesion	O
in	O
generating	O
different	O
Na+,K	B
(	I
+	I
)	I
-ATPase	I
distributions	O
in	O
polarized	O
epithelia	O
.	O

Neonatal	O
lupus	O
erythematosus	O
is	O
most	O
often	O
associated	O
with	O
autoantibodies	O
against	O
Ro	B
and	O
La	B
antigens	O
.	O

Genetic	O
abnormalities	O
that	O
could	O
lead	O
to	O
mutagenesis	O
include	O
chromosomal	O
abnormalities	O
and	O
single	O
-	O
gene	O
mutations	O
.	O

Hops	O
,	O
and	O
L.	O

Continued	O
absorption	O
of	O
amino	O
acids	O
by	O
the	O
NBB	O
carrier	O
(	O
for	O
neutral	O
amino	O
acids	O
)	O
,	O
the	O
Y+	O
system	O
(	O
for	O
dibasic	O
amino	O
acids	O
)	O
,	O
and	O
the	O
PHE	O
carrier	O
were	O
operative	O
even	O
during	O
the	O
actively	O
purging	O
stage	O
of	O
watery	O
diarrhoea	O
due	O
to	O
cholera	O
.	O

1	O
)	O
CFDN	O
,	O
AMPC	O
and	O
MNZ	O
showed	O
a	O
potent	O
antimicrobial	O
activity	O
against	O
H.	O
pylori	O
,	O
and	O
especially	O
,	O
AMPC	O
showed	O
a	O
marked	O
bactericidal	O
activity	O
in	O
a	O
short	O
time	O
.	O

A	O
high	O
mean	O
intensity	O
of	O
CLTPA	O
(	O
standardized	O
multivariate	O
regression	O
coefficient	O
beta	O
-0.059	O
,	O
p	O
=	O
0.020	O
)	O
and	O
a	O
high	O
maximal	O
oxygen	O
uptake	O
(	O
beta	O
-0.163	O
,	O
p	O
<	O
0.001	O
)	O
were	O
associated	O
with	O
reduced	O
plasma	B
fibrinogen	I
when	O
adjusting	O
for	O
the	O
strongest	O
covariates	O
.	O

What	O
young	O
people	O
think	O
and	O
do	O
when	O
the	O
option	O
for	O
cystic	O
fibrosis	O
carrier	O
testing	O
is	O
available	O
.	O

A	O
patient	O
matches	O
a	O
PIC	O
patient	O
if	O
both	O
have	O
the	O
same	O
mechanism	O
of	O
injury	O
,	O
the	O
same	O
coding	O
of	O
Revised	O
Trauma	O
Score	O
variables	O
(	O
Glascow	O
Coma	O
Scale	O
score	O
,	O
systolic	O
blood	O
pressure	O
,	O
respiratory	O
rate	O
)	O
,	O
the	O
same	O
coded	O
age	O
per	O
A	O
Severity	O
Characterization	O
of	O
Trauma	O
)	O
(	O
ASCOT	O
)	O
,	O
and	O
if	O
they	O
differ	O
by	O
no	O
more	O
than	O
0.5	O
for	O
A	O
,	O
B	O
,	O
and	O
C	O
(	O
the	O
ASCOT	O
components	O
for	O
serious	O
injuries	O
)	O
.	O

We	O
have	O
isolated	O
a	O
cosmid	O
containing	O
DNA	O
that	O
corresponds	O
to	O
the	O
site	O
of	O
transposon	O
insertion	O
in	O
257DH4	O
and	O
have	O
localized	O
Tn5	B
on	O
an	O
8.0	B
kb	I
EcoRI	I
fragment	I
.	O

Transient	O
transfection	O
experiments	O
revealed	O
that	O
Pax-8	B
isoforms	I
a	I
and	I
b	I
,	O
but	O
not	O
c	O
and	O
d	O
,	O
strongly	O
stimulate	O
transcription	O
from	O
a	O
promoter	O
containing	O
six	O
copies	O
of	O
a	O
paired	B
-	I
domain	I
recognition	I
sequence	I
.	O

The	O
amino	O
-	O
terminal	O
third	O
of	O
the	O
protein	O
contains	O
a	O
high	B
-	I
mobility	I
-	I
group	I
motif	I
characteristic	O
of	O
DNA	O
-	O
binding	O
proteins	O
.	O

We	O
found	O
that	O
the	O
3'-end	O
-	O
adjacent	O
sequence	O
CA	O
(	O
N	O
)	O
3	O
-	O
10AGTNNAA	O
,	O
conserved	O
in	O
plant	O
Pol	B
II	I
-	O
specific	O
U	B
snRNA	I
genes	I
,	O
is	O
essential	O
for	O
the	O
3'-end	O
formation	O
of	O
U2	B
transcripts	I
and	O
,	O
similar	O
to	O
the	O
vertebrate	O
3	O
'	O
box	O
,	O
is	O
highly	O
tolerant	O
to	O
mutation	O
.	O

These	O
results	O
indicate	O
that	O
Rb	B
protein	I
is	O
interacting	O
with	O
some	O
component	O
(	O
s	O
)	O
of	O
the	O
cell	O
cycle	O
-	O
regulatory	O
machinery	O
during	O
G2	O
phase	O
.	O

MDBP	B
from	O
HeLa	O
and	O
Raji	O
cells	O
formed	O
DNA	O
-	O
protein	O
complexes	O
with	O
X	O
-	O
box	O
oligonucleotides	O
that	O
coelectrophoresed	O
with	O
those	O
containing	O
standard	O
MDBP	B
sites	I
.	O

Consistent	O
with	O
the	O
hypothesis	O
that	O
it	O
acts	O
as	O
transcriptional	O
regulator	O
,	O
wild	B
-	I
type	I
p53	I
protein	I
binds	O
DNA	O
and	O
activates	O
transcription	O
of	O
several	O
promoters	O
.	O

The	O
E1	B
gene	I
is	O
located	O
within	O
the	O
first	O
intron	O
of	O
the	O
gene	O
for	O
RCC1	B
,	O
a	O
protein	O
that	O
regulates	O
onset	O
of	O
mitosis	O
.	O

Genomic	O
Southern	O
blot	O
analysis	O
and	O
chromosome	O
mapping	O
showed	O
that	O
GPRK6	B
hybridizes	O
to	O
two	O
closely	O
related	O
genes	O
located	O
on	O
chromosomes	O
5	O
and	O
13	O
and	O
are	O
,	O
therefore	O
,	O
distinct	O
from	O
the	O
GPRK	B
located	O
near	O
the	O
Huntington	B
disease	I
locus	I
on	O
chromosome	O
4	O
.	O

These	O
CTD	B
kinases	I
,	O
designated	O
CTDK1	B
and	O
CTDK2	B
,	O
are	O
fractionated	O
by	O
chromatography	O
on	O
Mono	O
Q.	O

The	O
sequence	O
of	O
the	O
HIR1	B
gene	I
predicts	O
an	O
88-kDa	O
protein	O
with	O
three	O
repeats	O
of	O
a	O
motif	O
found	O
in	O
the	O
G	B
beta	I
subunit	I
of	O
retinal	B
transducin	I
and	O
in	O
a	O
yeast	O
transcriptional	O
repressor	O
,	O
Tup1	B
.	O

Biol	O
.	O

L.	O
,	O
Stange	O
,	O
G.	O
,	O
Markovich	O
,	O
D.	O
,	O
Biber	O
,	O
J.	O
,	O
Testar	O
,	O
X.	O
,	O
Zorzano	O
,	O
A.	O
,	O
Palacin	O
,	O
M.	O
,	O
and	O
Murer	O
,	O
H.	O

They	O
were	O
called	O
PACE4	B
and	O
PC4	B
.	O

265	O
,	O
1102	O
-	O
1110	O
)	O
.	O

Both	O
fusion	O
proteins	O
form	O
stable	O
specific	O
complexes	O
with	O
a	O
short	O
DNA	O
duplex	O
harboring	O
the	O
CTGT	O
(	O
at	O
)	O
4ACAG	O
consensus	O
sequence	O
of	O
the	O
LexA	B
repressor	I
.	O

As	O
the	O
components	O
of	O
these	O
complexes	O
,	O
at	O
least	O
five	O
TRBPs	B
(	O
p30	B
,	O
p37	B
,	O
p46	B
,	O
p50	B
,	O
and	O
p56	B
)	O
showing	O
specific	O
binding	O
to	O
the	O
TAR	O
RNA	O
were	O
detected	O
in	O
the	O
uv	O
cross	O
-	O
linking	O
assay	O
.	O

The	O
use	O
of	O
this	O
model	O
for	O
investigating	O
pathophysiologically	O
significant	O
issues	O
in	O
denervating	O
diseases	O
is	O
illustrated	O
with	O
five	O
different	O
sets	O
of	O
parameters	O
.	O

We	O
describe	O
a	O
novel	O
cytoplasmic	B
tyrosine	I
kinase	I
,	O
termed	O
BPK	B
(	O
B	B
cell	I
progenitor	I
kinase	I
)	O
,	O
which	O
is	O
expressed	O
in	O
all	O
stages	O
of	O
the	O
B	O
lineage	O
and	O
in	O
myeloid	O
cells	O
.	O

Large	O
differences	O
between	O
the	O
groups	O
were	O
not	O
observed	O
in	O
HA	B
-	I
synthesizing	I
enzyme	I
activity	O
,	O
but	O
degradative	O
enzyme	O
activity	O
was	O
much	O
higher	O
in	O
aspirin	O
-	O
induced	O
asthma	O
-	O
related	O
polyps	O
than	O
in	O
other	O
types	O
of	O
nasal	O
polyps	O
tested	O
.	O

In	O
the	O
multivariate	O
analysis	O
,	O
six	O
variables	O
were	O
independently	O
correlated	O
with	O
survival	O
:	O
blood	O
urea	O
nitrogen	O
level	O
,	O
serum	B
aspartate	I
aminotransferase	I
level	O
,	O
community	O
-	O
acquired	O
vs.	O
hospital	O
-	O
acquired	O
peritonitis	O
,	O
age	O
,	O
Child	O
-	O
Pugh	O
score	O
and	O
ileus	O
.	O

One	O
such	O
mutant	O
also	O
affects	O
the	O
overlapping	O
-10	O
hexamer	O
of	O
PR	O
and	O
results	O
in	O
reduced	O
occupancy	O
by	O
both	O
MerR	B
and	O
RNA	B
polymerase	I
,	O
likely	O
as	O
a	O
result	O
of	O
inefficient	O
transcriptional	O
initiation	O
of	O
merR	B
mRNA	I
.	O

Finally	O
,	O
we	O
present	O
evidence	O
that	O
fimbrin	B
is	O
a	O
third	O
distinct	O
plastin	B
isoform	I
which	O
is	O
specifically	O
expressed	O
at	O
high	O
levels	O
in	O
the	O
small	O
intestine	O
.	O

This	O
promoter	O
could	O
direct	O
the	O
constitutive	O
expression	O
of	O
the	O
reporter	O
beta	B
-	I
galactosidase	I
at	O
high	O
frequency	O
in	O
transfected	O
colonies	O
of	O
transformed	O
cells	O
that	O
express	O
L	B
-	I
plastin	I
constitutively	O
;	O
by	O
contrast	O
,	O
this	O
promoter	O
was	O
virtually	O
inactive	O
in	O
transfected	O
colonies	O
of	O
normal	O
fibroblasts	O
and	O
it	O
exhibited	O
a	O
low	O
frequency	O
of	O
constitutive	O
activation	O
in	O
transfected	O
colonies	O
of	O
in	O
vitro	O
SV40-transformed	O
fibroblasts	O
which	O
did	O
not	O
exhibit	O
L	B
-	I
plastin	I
expression	O
.	O

The	O
half	O
-	O
life	O
of	O
the	O
serum	O
-	O
induced	O
CBP	B
/	O
tk	B
binding	O
activity	O
was	O
estimated	O
to	O
be	O
less	O
than	O
1	O
h.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
400	O
WORDS	O
)	O

The	O
gene	O
includes	O
three	O
exons	O
and	O
two	O
introns	O
within	O
1.6	O
kilobases	O
of	O
DNA	O
,	O
and	O
the	O
entire	O
open	O
reading	O
frame	O
for	O
glycoprotein	B
IX	I
is	O
included	O
within	O
the	O
third	O
exon	O
.	O

Rhizobium	O
meliloti	O
large	O
plasmid	O
pRmeGR4b	O
carries	O
the	O
nodulation	O
competitiveness	O
locus	O
nfe	B
responsible	O
for	O
the	O
nodulation	O
efficiency	O
and	O
competitive	O
ability	O
of	O
strain	O
GR4	O
on	O
alfalfa	O
roots	O
.	O

Further	O
,	O
the	O
ability	O
of	O
recombinant	O
beta	O
and/or	O
gamma	O
chains	O
to	O
function	O
in	O
defined	O
biochemical	O
assays	O
of	O
beta	O
gamma	O
activity	O
was	O
assessed	O
for	O
membrane	O
extracts	O
and	O
supernatant	O
fractions	O
from	O
infected	O
Sf9	O
cells	O
.	O

These	O
data	O
establish	O
Smd1p	B
as	O
a	O
required	O
component	O
of	O
the	O
cellular	O
splicing	O
apparatus	O
and	O
a	O
factor	O
in	O
snRNA	O
maturation	O
and	O
stability	O
.	O

This	O
study	O
compared	O
the	O
gross	O
and	O
fine	O
motor	O
performance	O
of	O
14	O
traumatically	O
brain	O
-	O
injured	O
children	O
(	O
five	O
to	O
15	O
years	O
old	O
,	O
with	O
loss	O
of	O
consciousness	O
for	O
at	O
least	O
24	O
hours	O
)	O
to	O
14	O
normal	O
children	O
group	O
matched	O
for	O
age	O
and	O
sex	O
.	O

These	O
exons	O
were	O
identified	O
by	O
cloning	O
and	O
sequencing	O
cDNAs	O
obtained	O
by	O
polymerase	O
chain	O
reaction	O
amplification	O
of	O
a	O
fibroblast	O
cDNA	O
library	O
.	O

Deletion	O
of	O
the	O
apeA	B
gene	I
,	O
either	O
with	O
or	O
without	O
deletion	O
of	O
other	O
proteinases	O
(	O
protease	B
IV	I
and	O
aminopeptidase	B
N	I
)	O
,	O
did	O
not	O
have	O
any	O
effect	O
on	O
cell	O
growth	O
in	O
the	O
various	O
media	O
tested	O
.	O

In	O
Experiment	O
2	O
scopolamine	O
hydrobromide	O
,	O
0.5	O
and	O
1.0	O
mg	O
/	O
kg	O
i.p	O
.	O
,	O
was	O
administered	O
1	O
h	O
before	O
each	O
electrical	O
stimulation	O
until	O
each	O
rat	O
showed	O
the	O
stage-3	O
seizure	O
.	O

PNT	O
,	O
ADD	O
and	O
BSS	O
in	O
the	O
initial	O
stage	O
of	O
kindling	O
,	O
kindling	O
rate	O
for	O
the	O
stage-3	O
and	O
-5	O
seizures	O
,	O
seizure	O
parameters	O
at	O
the	O
first	O
stage-3	O
and	O
-5	O
were	O
recorded	O
and	O
compared	O
to	O
the	O
values	O
of	O
saline	O
-	O
treated	O
,	O
control	O
group	O
.	O

CONCLUSIONS	O
.	O

Naval	O
personnel	O
who	O
exceed	O
standards	O
for	O
%	O
BF	O
can	O
be	O
separated	O
from	O
active	O
duty	O
.	O

Weak	O
promoter	O
activity	O
was	O
observed	O
for	O
the	O
promoter	O
of	O
the	O
C1	B
and	O
C2	B
ORFs	O
(	O
C1-C2	B
gene	O
)	O
and	O
for	O
the	O
promoter	O
of	O
the	O
V1	B
ORF	I
.	O

The	O
amino	O
acid	O
sequence	O
alignment	O
of	O
TC	B
II	I
with	O
that	O
of	O
other	O
Cbl	B
binding	I
proteins	I
(	O
rat	B
intrinsic	I
factor	I
,	O
human	B
transcobalamin	I
I	I
and	O
porcine	B
haptocorrin	I
)	O
revealed	O
only	O
33	O
%	O
overall	O
homology	O
.	O

The	O
evaluation	O
was	O
performed	O
using	O
a	O
retrospective	O
study	O
design	O
with	O
newborn	O
blood	O
samples	O
from	O
three	O
screening	O
centres	O
.	O

A	O
region	O
in	O
the	O
C	O
-	O
terminus	O
of	O
adenovirus	B
2	I
/	I
5	I
E1a	I
protein	I
is	O
required	O
for	O
association	O
with	O
a	O
cellular	O
phosphoprotein	O
and	O
important	O
for	O
the	O
negative	O
modulation	O
of	O
T24-ras	O
mediated	O
transformation	O
,	O
tumorigenesis	O
and	O
metastasis	O
.	O

These	O
studies	O
demonstrate	O
that	O
both	O
G	B
alpha	I
i	I
genes	I
are	O
dynamically	O
regulated	O
in	O
LLC	O
-	O
PK1	O
cells	O
by	O
both	O
growth	O
,	O
differentiation	O
,	O
and	O
hormone	O
signals	O
.	O

When	O
ligated	O
to	O
the	O
proIL-1	B
beta	I
cap	I
site	I
-	I
proximal	I
region	I
(	O
located	O
between	O
-131	O
to	O
+	O
12	O
)	O
,	O
both	O
the	O
proIL-1	B
beta	I
and	O
the	O
simian	B
virus	I
40	I
enhancer	I
elements	I
functioned	O
more	O
efficiently	O
in	O
monocytes	O
than	O
in	O
HeLa	O
cells	O
,	O
which	O
are	O
not	O
normally	O
competent	O
for	O
IL-1	B
beta	I
expression	O
.	O

We	O
have	O
isolated	O
and	O
characterized	O
the	O
GCD6	B
and	O
GCD7	B
genes	I
and	O
shown	O
that	O
their	O
products	O
are	O
required	O
to	O
repress	O
GCN4	B
translation	O
under	O
nonstarvation	O
conditions	O
.	O

While	O
the	O
latter	O
corresponded	O
to	O
a	O
protein	O
of	O
824	O
amino	O
acids	O
,	O
an	O
upstream	O
open	O
reading	O
frame	O
(	O
uORF	O
)	O
within	O
the	O
5	O
'	O
leader	O
could	O
potentially	O
encode	O
a	O
54	O
amino	O
acid	O
peptide	O
.	O

The	O
SCH9	B
protein	I
kinase	I
mRNA	I
contains	O
a	O
long	O
5	O
'	O
leader	O
with	O
a	O
small	O
open	O
reading	O
frame	O
.	O

In	O
contrast	O
to	O
T	O
cells	O
,	O
in	O
fibroblasts	O
PILOT	B
gene	I
expression	O
requires	O
only	O
one	O
signal	O
(	O
PMA	O
)	O
and	O
is	O
not	O
affected	O
by	O
CyA.	O

In	O
order	O
to	O
investigate	O
how	O
these	O
expression	O
patterns	O
are	O
established	O
,	O
we	O
fused	O
promoter	O
regions	O
of	O
an	O
acidic	O
and	O
a	O
basic	O
glucanase	B
gene	I
to	O
the	O
beta	B
-	I
glucuronidase	I
(	O
GUS	B
)	O
reporter	O
gene	O
and	O
examined	O
expression	O
of	O
these	O
constructs	O
in	O
transgenic	O
tobacco	O
plants	O
.	O

Southern	O
blot	O
analysis	O
using	O
probes	O
from	O
the	O
3	O
'	O
portions	O
of	O
the	O
genomic	O
and	O
B.	B
napus	I
MA	I
and	O
MB	B
cDNA	I
clones	O
showed	O
that	O
MA	B
type	I
myrosinases	B
are	O
encoded	O
by	O
approximately	O
4	O
genes	O
,	O
while	O
MB	B
type	I
myrosinases	B
are	O
encoded	O
by	O
more	O
than	O
10	O
genes	O
in	O
B.	O
napus	O
.	O

Sudomoina	O
,	O
A.	O

Zinc	O
fingers	O
(	O
Zf	O
)	O
are	O
a	O
common	O
structural	O
motif	O
found	O
in	O
many	O
nucleic	O
acid	O
-	O
binding	O
proteins	O
.	O

The	O
deduced	O
bovine	O
EFIA#1	B
amino	O
acid	O
(	O
aa	O
)	O
sequence	O
is	O
98	O
%	O
identical	O
to	O
rat	O
EFIA	B
and	O
100	O
%	O
identical	O
to	O
human	O
EFIA	B
/	O
DbpB	B
/	O
YB-1	B
family	O
member	O
DNA	B
-	I
binding	I
protein	I
B	I
(	O
DbpB	B
)	O
.	O

Effect	O
of	O
tracheal	O
insufflation	O
of	O
deferoxamine	O
on	O
acute	O
ozone	O
toxicity	O
in	O
rats	O
.	O

Localization	O
of	O
the	O
insertion	O
locus	O
in	O
the	O
yeast	O
genome	O
and	O
complementation	O
studies	O
with	O
the	O
temperature	O
-	O
sensitive	O
mutant	O
indicate	O
that	O
the	O
two	O
mutations	O
are	O
allelic	O
.	O

Replacement	O
of	O
the	O
spacer	O
sequence	O
between	O
the	O
two	O
ARMs	O
with	O
a	O
shorter	O
stretch	O
of	O
sequence	O
also	O
reduced	O
RNA	O
binding	O
in	O
vitro	O
.	O

Second	O
,	O
the	O
transcription	B
factor	I
Gal	I
-	I
ER	I
was	O
rendered	O
more	O
potent	O
and	O
less	O
susceptible	O
to	O
cell	O
type	O
-	O
specific	O
variation	O
by	O
fusing	O
the	O
strong	O
activating	O
domain	O
of	O
the	O
herpesvirus	B
protein	I
VP16	I
onto	O
its	O
C	O
terminus	O
.	O

The	O
exogenous	O
fos	B
gene	I
was	O
rapidly	O
induced	O
to	O
maximal	O
levels	O
within	O
1	O
-	O
2	O
hr	O
of	O
estrogen	O
addition	O
.	O

Elimination	O
of	O
Haemophilus	O
influenzae	O
type	O
b	O
meningitis	O
after	O
introduction	O
of	O
vaccination	O

In	O
the	O
present	O
study	O
we	O
demonstrated	O
a	O
unique	O
mechanism	O
of	O
action	O
of	O
8-Cl	O
-	O
cAMP	O
in	O
the	O
regulation	O
of	O
these	O
kinase	O
isozymes	O
in	O
HL-60	O
human	O
promyelocytic	O
leukemia	O
cells	O
.	O

Overlapping	O
clones	O
representing	O
full	O
-	O
length	O
cDNAs	O
for	O
MMI	B
alpha	I
were	O
obtained	O
from	O
mouse	O
brain	O
.	O

Pathways	O
linking	O
the	O
olfactory	O
bulbs	O
with	O
the	O
medial	O
preoptic	O
anterior	O
hypothalamus	O
are	O
important	O
for	O
intermale	O
aggression	O
in	O
mice	O
.	O

Pokeweed	B
mitogen	I
(	O
PWM	B
)	O
or	O
anti	B
-	I
CD3	I
significantly	O
increases	O
c	B
-	I
jun	I
messenger	I
RNA	I
(	I
mRNA	I
)	I
levels	O
in	O
T	O
cells	O
.	O

Following	O
seizure	O
induction	O
,	O
MABP	O
increased	O
to	O
105	O
mm	O
Hg	O
and	O
brain	O
pHi	O
fell	O
to	O
6.79	O
+	O
/-	O

0.03	O
within	O
15	O
min	O
and	O
remained	O
at	O
this	O
level	O
for	O
1	O
h	O
(	O
P	O
<	O
0.001	O
)	O
.	O

In	O
contrast	O
,	O
rats	O
receiving	O
U74500A	O
(	O
2	O
mg	O
/	O
kg	O
i.v	O
.	O

infusion	O
commencing	O
30	O
min	O
prior	O
to	O
revascularisation	O
)	O
exhibited	O
enhanced	O
GMBF	O
throughout	O
reperfusion	O
[	O
PI	O
10	O
min	O
:	O
3.26	O
(	O
2.56	O
-	O
3.63	O
)	O
;	O
120	O
min	O
:	O
2.03	O
(	O
1.73	O
-	O
2.25	O
)	O
;	O
240	O
min	O
:	O
2.13	O
(	O
1.75	O
-	O
2.44	O
)	O
,	O
p	O
<	O
0.01	O
vs.	O
controls	O
and	O
normals	O
]	O
with	O
complete	O
muscle	O
salvage	O
[	O
GMV	O
100	O
%	O
in	O
all	O
reperfused	O
muscles	O
,	O
p	O
<	O
0.01	O
vs.	O
controls	O
,	O
not	O
significant	O
(	O
NS	O
)	O
vs.	O
normals	O
and	O
6	O
h	O
ischaemia	O
]	O
.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

Sterile	O
mutants	O
of	O
Saccharomyces	O
cerevisiae	O
were	O
isolated	O
from	O
alpha	O
*	O
cells	O
having	O
the	O
a	B
/	I
alpha	I
aar1	I
-	I
6	I
genotype	O
(	O
exhibiting	O
alpha	O
mating	O
ability	O
and	O
weak	O
a	O
mating	O
ability	O
as	O
a	O
result	O
of	O
a	O
defect	O
in	O
a1-alpha	B
2	I
repression	O
)	O
.	O

We	O
studied	O
the	O
functional	O
interaction	O
between	O
human	O
embryonic	O
zeta	B
2	I
globin	I
promoter	O
and	O
the	O
alpha	B
globin	I
regulatory	I
element	I
(	O
HS-40	B
)	O
located	O
40	O
kb	O
upstream	O
of	O
the	O
zeta	B
2	I
globin	I
gene	I
.	O

It	O
was	O
shown	O
by	O
transient	O
expression	O
assay	O
that	O
HS-40	B
behaved	O
as	O
an	O
authentic	O
enhancer	O
for	O
high	O
-	O
level	O
zeta	B
2	I
globin	I
promoter	I
activity	O
in	O
K562	O
cells	O
,	O
an	O
erythroid	O
cell	O
line	O
of	O
embryonic	O
and/or	O
fetal	O
origin	O
.	O

Breitbart	O
,	O
L.	O

This	O
study	O
evaluates	O
the	O
feasibility	O
of	O
indirect	O
mesenteric	O
lymphangiography	O
as	O
a	O
colonoscopic	O
technique	O
in	O
a	O
canine	O
model	O
.	O

5	O
micrograms	O
/	O
l	O
was	O
detected	O
in	O
urine	O
from	O
some	O
non	O
-	O
occupationally	O
exposed	O
persons	O
.	O

This	O
prospective	O
study	O
compared	O
the	O
measured	O
energy	O
expenditures	O
of	O
30	O
patients	O
using	O
indirect	O
calorimetry	O
with	O
their	O
predicted	O
basal	O
energy	O
expenditure	O
according	O
to	O
the	O
Harris	O
-	O
Benedict	O
equation	O
,	O
or	O
their	O
calculated	O
energy	O
expenditure	O
derived	O
from	O
basal	O
energy	O
expenditure	O
times	O
,	O
an	O
activity	O
factor	O
,	O
and	O
a	O
stress	O
factor	O
.	O

However	O
,	O
after	O
repeated	O
infections	O
,	O
hypobiotic	O
larvae	O
were	O
numerous	O
.	O

This	O
was	O
performed	O
in	O
a	O
double	O
blinded	O
,	O
randomized	O
,	O
placebo	O
-	O
controlled	O
study	O
.	O

There	O
was	O
either	O
no	O
change	O
or	O
an	O
improvement	O
in	O
renographic	O
findings	O
(	O
t1	O
/	O
2	O
time	O
and/or	O
split	O
function	O
)	O
in	O
40	O
patients	O
(	O
93	O
%	O
)	O
.	O

We	O
discuss	O
the	O
need	O
to	O
use	O
animals	O
older	O
than	O
3	O
months	O
for	O
the	O
study	O
of	O
'	O
adult	O
'	O
regeneration	O
phenomena	O
since	O
3-month	O
-	O
old	O
rats	O
may	O
be	O
somewhat	O
immature	O
.	O

Nuclear	B
beta	I
II	I
PKC	I
,	O
like	O
p34cdc2	B
kinase	I
,	O
may	O
function	O
to	O
regulate	O
nuclear	O
lamina	O
structural	O
stability	O
during	O
cell	O
cycle	O
.	O

In	O
situ	O
copper	O
-	O
phenanthroline	O
footprinting	O
of	O
individual	O
gel	O
shift	O
assembly	O
intermediates	O
shows	O
that	O
on	O
the	O
302-nucleotide	O
G4oric	O
,	O
the	O
first	O
two	O
SSB	B
tetramers	I
assemble	O
at	O
random	O
,	O
but	O
the	O
addition	O
of	O
more	O
SSB	B
tetramers	I
results	O
in	O
formation	O
of	O
a	O
unique	O
structure	O
.	O

Finger	B
associated	I
box	I
-	I
zinc	I
finger	I
proteins	I
(	O
FAX	B
-	I
ZFPs	I
)	O
constitute	O
a	O
subfamily	O
of	O
the	O
many	O
C2H2	B
type	I
ZFPs	I
in	O
Xenopus	O
laevis	O
.	O

Further	O
evidence	O
for	O
a	O
clustered	O
organization	O
of	O
FAX	B
-	O
ZFP	B
transcription	O
units	O
is	O
provided	O
by	O
Southern	O
blot	O
analysis	O
of	O
large	O
genomic	O
restriction	O
fragments	O
separated	O
by	O
transverse	O
field	O
gel	O
electrophoresis	O
,	O
and	O
by	O
in	O
situ	O
hybridization	O
on	O
intact	O
chromosomes	O
.	O

A	O
rat	O
cDNA	O
that	O
encodes	O
eIF-5	B
has	O
been	O
isolated	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
to	O
yield	O
a	O
catalytically	O
active	O
eIF-5	B
protein	I
.	O

In	O
F42A	O
-	O
stimulated	O
internalization	O
assays	O
on	O
forskolin	O
-	O
induced	O
YT-1	O
cells	O
,	O
the	O
IL-2R	B
alpha	I
chain	I
is	O
consistently	O
endocytosed	O
together	O
with	O
the	O
IL-2R	B
beta	I
subunit	I
indicating	O
that	O
IL-2R	B
alpha	I
is	O
stably	O
associated	O
with	O
the	O
F42A	B
-	I
IL-2R	I
beta	I
complex	I
even	O
though	O
the	O
alpha	O
-	O
subunit	O
contributes	O
little	O
if	O
any	O
affinity	O
to	O
the	O
F42A	O
binding	O
reaction	O
.	O

We	O
obtained	O
the	O
prevalence	O
of	O
IgG	B
antibodies	I
against	O
Trypanosoma	O
cruzi	O
among	O
1076	O
blood	O
donors	O
at	O
the	O
Instituto	O
Nacional	O
de	O
Cardiologia	O
""""	O
Ignacio	O
Chavez	O
""""	O
in	O
Mexico	O
City	O
.	O

Examination	O
of	O
the	O
immediate	O
sequence	O
5	O
'	O
to	O
the	O
mRNA	O
start	O
site	O
reveals	O
no	O
TATA	O
box	O
and	O
multiple	O
known	O
enhancer	O
sequences	O
.	O

The	O
short	O
-	O
term	O
synthesis	O
and	O
infant	O
-	O
regulated	O
removal	O
of	O
milk	O
in	O
lactating	O
women	O
.	O

Pseudosubstrate	O
(	O
19	O
-	O
36	O
)	O
,	O
derived	O
from	O
the	O
C	O
-	O
terminus	O
of	O
Ca	B
-	I
dependent	I
PKC	I
isotypes	I
,	O
inhibited	O
beta	B
-	I
PKC	I
but	O
not	O
nPKC	B
activity	O
using	O
either	O
Histone	B
IIIS	I
or	O
peptide	O
(	O
19	O
-	O
31	O
)	O
as	O
substrate	O
.	O

B	O
cell	O
-	O
specific	O
mb-1	B
and	O
B29	B
genes	I
encode	O
the	O
alpha	O
/	O
beta	O
components	O
of	O
the	O
BCR	B
-	I
associated	I
complex	I
in	O
mature	O
sIgM+	B
B	O
cells	O
.	O

Mutations	O
at	O
three	O
sites	O
have	O
larger	O
effects	O
in	O
muscle	O
than	O
nonmuscle	O
cells	O
;	O
an	O
A	O
/	O
T	O
-	O
rich	O
site	O
mutation	O
has	O
a	O
pronounced	O
effect	O
in	O
both	O
striated	O
muscle	O
types	O
,	O
mutations	O
at	O
the	O
MEF1	B
(	I
Right	I
E	I
-	I
box	I
)	I
site	I
are	O
relatively	O
specific	O
to	O
expression	O
in	O
skeletal	O
muscle	O
,	O
and	O
mutations	O
at	O
the	O
CArG	O
site	O
are	O
relatively	O
specific	O
to	O
expression	O
in	O
cardiac	O
muscle	O
.	O

Transient	O
transfection	O
analysis	O
with	O
these	O
mutations	O
revealed	O
that	O
only	O
a	O
10-bp	O
region	O
,	O
containing	O
precisely	O
the	O
Ets	B
and	O
proximal	O
LyF-1	B
binding	I
sites	I
,	O
was	O
needed	O
for	O
D	O
'	O
activity	O
.	O

We	O
report	O
here	O
that	O
a	O
25-bp	O
promoter	O
element	O
previously	O
shown	O
to	O
be	O
important	O
for	O
the	O
G1-S	O
activation	O
of	O
the	O
human	B
thymidine	I
kinase	I
(	O
htk	B
)	O
promoter	O
in	O
growth	O
-	O
stimulated	O
cells	O
is	O
a	O
cellular	O
target	O
of	O
cyclin	B
A	I
and	O
the	O
p33cdk2	B
complexes	I
.	O

These	O
protective	O
influences	O
were	O
observed	O
throughout	O
the	O
range	O
of	O
filling	O
pressures	O
measured	O
,	O
from	O
0	O
to	O
30	O
mmHg	O
.	O

DNase	B
I	I
footprinting	O
with	O
rat	O
liver	O
nuclear	O
extracts	O
identified	O
7	O
major	O
protein	O
-	O
binding	O
domains	O
termed	O
P1	O
through	O
P7	O
in	O
a	O
796	O
base	O
pair	O
DNA	O
fragment	O
(	O
base	O
pairs	O
-763	O
to	O
+	O
33	O
)	O
.	O

This	O
may	O
account	O
,	O
at	O
least	O
in	O
part	O
,	O
for	O
the	O
ability	O
of	O
excess	O
wt	B
p53	I
to	O
inhibit	O
cell	O
proliferation	O
and	O
to	O
interfere	O
with	O
neoplastic	O
processes	O
.	O

Northern	O
blot	O
analysis	O
of	O
total	O
cellular	O
RNA	O
indicated	O
that	O
xylP	B
encodes	O
a	O
1.3-kb	O
transcript	O
which	O
is	O
induced	O
by	O
xylan	O
.	O

The	O
nifJ	B
and	O
nifH	B
promoters	I
of	I
Klebsiella	I
pneumoniae	I
are	O
divergently	O
transcribed	O
sigma	B
54-dependent	I
promoters	I
that	O
are	O
positively	O
activated	O
by	O
the	O
NifA	B
protein	I
.	O

These	O
data	O
show	O
that	O
PTH	B
and	O
cAMP	O
can	O
repress	O
collagen	B
promoter	I
activity	O
in	O
calvariae	O
from	O
transgenic	O
mice	O
,	O
suggesting	O
that	O
the	O
alpha	B
1	I
(	I
I	I
)	I
collagen	I
promoter	I
may	O
contain	O
cis	O
elements	O
down	O
-	O
stream	O
of	O
-2.3	O
kilobases	O
that	O
mediate	O
PTH	B
and	O
cAMP	O
repression	O
of	O
collagen	B
gene	I
expression	O
in	O
bone	O
.	O

Both	O
inhaled	O
and	O
superfused	O
isoflurane	O
dilated	O
the	O
baseline	O
vein	O
diameter	O
before	O
stimulation	O
.	O

Prevalence	O
of	O
rheumatoid	O
arthritis	O
and	O
rheumatoid	B
factor	I
in	O
women	O
:	O
evidence	O
for	O
a	O
secular	O
decline	O
.	O

Sequence	O
comparison	O
between	O
the	O
translated	O
ORF	O
and	O
a	O
protein	O
database	O
reveal	O
between	O
26.5	O
and	O
23.4	O
%	O
aa	O
sequence	O
homology	O
to	O
bacterial	B
transmembrane	I
(	I
TM	I
)	I
proteins	I
including	O
those	O
mediating	O
chloramphenicol	O
(	O
Cm	O
)	O
and	O
tetracycline	O
(	O
Tc	O
)	O
resistance	O
and	O
an	O
arabinose	O
-	O
proton	O
symport	O
protein	O
.	O

The	O
yeast	O
gene	O
that	O
encodes	O
eIF-5	B
,	O
designated	O
TIF5	B
,	O
has	O
been	O
isolated	O
and	O
expressed	O
in	O
Escherichia	O
coli	O
to	O
yield	O
a	O
catalytically	O
active	O
eIF-5	B
protein	I
.	O

Xylose-	O
and	O
arabinose	O
-	O
containing	O
polymers	O
were	O
better	O
digested	O
than	O
was	O
cellulose	O
for	O
both	O
breads	O
.	O

The	O
technical	O
construction	O
of	O
the	O
mouth	O
protectors	O
is	O
illustrated	O
,	O
as	O
is	O
the	O
need	O
for	O
instrumentation	O
and	O
its	O
costs	O
and	O
the	O
materials	O
required	O
to	O
manufacture	O
these	O
mouth	O
protectors	O
.	O

The	O
alpha	O
-	O
subunit	O
by	O
itself	O
binds	O
to	O
telomeric	O
DNA	O
.	O

We	O
conclude	O
that	O
the	O
alpha	O
-	O
subunit	O
of	O
the	O
telomere	B
-	I
binding	I
protein	I
,	O
like	O
many	O
transcription	O
factors	O
,	O
has	O
separable	O
DNA	O
-	O
binding	O
and	O
protein	O
-	O
protein	O
interaction	O
domains	O
.	O

Three	O
patients	O
had	O
well-	O
,	O
6	O
patients	O
had	O
moderately-	O
,	O
and	O
5	O
patients	O
had	O
poorly	O
-	O
differentiated	O
adenocarcinoma	O
of	O
the	O
prostate	O
.	O

Spontaneous	O
burst	O
firing	O
in	O
cat	O
primary	O
auditory	O
cortex	O
:	O
age	O
and	O
depth	O
dependence	O
and	O
its	O
effect	O
on	O
neural	O
interaction	O
measures	O
.	O

By	O
applying	O
the	O
potentiometric	O
method	O
,	O
in	O
aqueous	O
medium	O
of	O
ionic	O
strength	O
mu	O
=	O
0.2	O
,	O
the	O
stability	O
constants	O
,	O
log	O
beta	O
1	O
=	O
4.42	O
and	O
log	O
beta	O
2	O
=	O
8.57	O
were	O
obtained	O
.	O

The	O
bcl-2	B
gene	I
can	O
potentially	O
encode	O
26-	O
and	O
22-kDa	O
proteins	O
that	O
differ	O
only	O
in	O
their	O
carboxyl	O
tails	O
because	O
of	O
an	O
alternative	O
splicing	O
mechanism	O
.	O

The	O
active	O
open	O
reading	O
frame	O
in	O
the	O
clone	O
maps	O
at	O
27	O
min	O
on	O
the	O
E.	O
coli	O
chromosome	O
and	O
is	O
identical	O
in	O
sequence	O
to	O
a	O
wild	O
type	O
counterpart	O
.	O

As	O
a	O
result	O
of	O
alternative	O
splicing	O
,	O
the	O
BGP	B
gene	I
is	O
transcribed	O
into	O
at	O
least	O
seven	O
distinct	O
mRNA	O
species	O
.	O

A	O
comparison	O
of	O
the	O
promoters	O
for	O
muMIP-1	B
beta	I
and	O
muMIP-1	B
alpha	I
reveals	O
a	O
conserved	O
CK-1	O
element	O
,	O
but	O
transient	O
expression	O
studies	O
in	O
RAW	O
264.7	O
macrophages	O
with	O
proximal	O
fragments	O
of	O
either	O
the	O
muMIP-1	B
beta	I
or	O
the	O
muMIP-1	B
alpha	I
5	I
'	I
promoter	I
fused	O
to	O
a	O
human	B
growth	I
hormone	I
reporter	I
gene	I
link	O
LPS	O
-	O
inducibility	O
in	O
both	O
to	O
promoter	O
segments	O
near	O
to	O
,	O
but	O
not	O
identical	O
with	O
,	O
the	O
consensus	O
CK-1	O
sequence	O
.	O

Sequence	O
analysis	O
and	O
identification	O
of	O
two	O
hyp	B
regulatory	I
mutants	I
.	O

The	O
level	O
of	O
the	O
SUP4A53T61	B
transcript	I
was	O
threefold	O
higher	O
in	O
the	O
tap1	B
-	I
1	I
mutant	I
than	O
in	O
the	O
wild	O
type	O
.	O

NF	B
-	I
HB	I
(	O
BSAP	B
)	O
is	O
a	O
repressor	O
of	O
the	O
murine	B
immunoglobulin	I
heavy	I
-	I
chain	I
3	I
'	I
alpha	I
enhancer	I
at	O
early	O
stages	O
of	O
B	O
-	O
cell	O
differentiation	O
.	O

Since	O
the	O
regulation	O
of	O
SWI4	B
is	O
required	O
for	O
normal	O
cell	O
cycle	O
progression	O
,	O
we	O
have	O
characterized	O
cis-	O
and	O
trans	O
-	O
acting	O
regulators	O
of	O
SWI4	B
transcription	O
.	O

In	O
17	O
patients	O
with	O
deletions	O
,	O
the	O
parental	O
origin	O
of	O
deletion	O
was	O
determined	O
.	O

We	O
conclude	O
that	O
grade	O
III	O
BGCT	O
can	O
be	O
treated	O
by	O
modified	O
intralesional	O
excision	O
provided	O
the	O
articular	O
surfaces	O
and	O
part	O
of	O
the	O
metaphysis	O
are	O
intact	O
.	O

Second	O
,	O
nitrate	O
induction	O
of	O
aeg-46.5	B
operon	I
expression	O
is	O
substantially	O
enhanced	O
in	O
narL	B
null	O
strains	O
(	O
M.H.	O

This	O
new	O
knowledge	O
has	O
contributed	O
to	O
the	O
development	O
of	O
a	O
successful	O
immunoprophylactic	O
strategy	O
for	O
eliminating	O
Hib	O
disease	O
.	O

The	O
HMG	B
CoA	I
reductase	I
inhibitors	O
are	O
the	O
most	O
effective	O
cholesterol	O
-	O
lowering	O
agents	O
currently	O
available	O
.	O

The	O
etiology	O
,	O
pathology	O
,	O
brain	O
CT	O
scan	O
features	O
,	O
clinical	O
manifestations	O
and	O
treatment	O
of	O
these	O
accidents	O
were	O
discussed	O
.	O

One	O
enigmatic	O
aspect	O
of	O
GATA	B
factor	I
expression	O
is	O
that	O
several	O
GATA	B
proteins	I
,	O
which	O
ostensibly	O
share	O
the	O
same	O
DNA	O
-	O
binding	O
site	O
specificity	O
,	O
are	O
coexpressed	O
in	O
erythroid	O
cells	O
.	O

Pit-1	B
is	O
a	O
tissue	O
-	O
specific	O
POU	B
domain	I
factor	I
obligatory	O
for	O
the	O
appearance	O
of	O
three	O
cell	O
phenotypes	O
in	O
the	O
anterior	O
pituitary	O
gland	O
.	O

Biol	O
.	O

Characterization	O
and	O
hormonal	O
regulation	O
of	O
the	O
promoter	O
of	O
the	O
rat	B
prostaglandin	I
endoperoxide	I
synthase	I
2	I
gene	I
in	O
granulosa	O
cells	O
.	O

In	O
mammalian	O
cells	O
,	O
phosphorylation	O
of	O
eIF-2	B
alpha	I
inhibits	O
the	O
activity	O
of	O
eIF-2B	B
,	O
the	O
GDP	B
-	I
GTP	I
exchange	I
factor	I
for	O
eIF-2	B
.	O

In	O
conclusion	O
,	O
these	O
observations	O
demonstrated	O
that	O
stratification	O
of	O
acute	O
MI	O
patients	O
by	O
plasma	O
ANF	B
level	O
is	O
a	O
useful	O
non	O
-	O
invasive	O
method	O
for	O
predicting	O
prognosis	O
and	O
for	O
identifying	O
individuals	O
at	O
high	O
risk	O
of	O
cardiac	O
death	O
.	O

Seven	O
out	O
of	O
34	O
patients	O
died	O
,	O
giving	O
a	O
mortality	O
rate	O
of	O
21	O
%	O
.	O

SSG1	B
,	O
a	O
gene	O
encoding	O
a	O
sporulation	B
-	I
specific	I
1,3-beta	I
-	I
glucanase	I
in	O
Saccharomyces	O
cerevisiae	O
.	O

Expression	O
of	O
this	O
protein	O
in	O
E.	O
coli	O
demonstrated	O
that	O
tyrosine	O
was	O
incorporated	O
during	O
suppression	O
and	O
that	O
yeast	B
cytoplasmic	I
TyrRS	I
activity	O
was	O
produced	O
.	O

It	O
is	O
reported	O
that	O
,	O
at	O
present	O
,	O
most	O
of	O
the	O
MRSAs	O
spreading	O
in	O
Japan	O
are	O
acceleratedly	O
acquiring	O
resistance	O
to	O
many	O
drugs	O
,	O
and	O
especially	O
,	O
they	O
are	O
developing	O
high	O
resistance	O
against	O
beta	O
-	O
lactams	O
.	O

Beg2	B
and	O
Beg1	B
are	O
regulated	O
differently	O
which	O
may	O
indicate	O
variation	O
in	O
storage	O
or	O
utilization	O
properties	O
among	O
the	O
barley	B
globulins	I
.	O

RESULTS	O
:	O
Statistically	O
significant	O
differences	O
were	O
obtained	O
between	O
group	O
I	O
and	O
II	O
concerning	O
the	O
number	O
of	O
patients	O
in	O
whom	O
induced	O
atrial	O
fibrillation	O
with	O
conduction	O
by	O
the	O
accessory	O
pathway	O
and	O
RR	O
<	O
or	O
=	O
250	O
msec	O
was	O
found	O
(	O
0	O
vs	O
6	O
,	O
p	O
=	O
0.0045	O
)	O
.	O

Both	O
immunophilins	B
may	O
have	O
important	O
roles	O
in	O
receptor	O
assembly	O
and	O
may	O
represent	O
a	O
new	O
category	O
of	O
ligand-	O
and	O
calcium	O
-	O
dependent	O
modulators	O
of	O
protein	O
function	O
.	O

The	O
GTPase	B
activity	O
of	O
CDC42Ce	B
is	O
moderately	O
stimulated	O
by	O
human	B
n	I
-	I
chimaerin	I
,	O
a	O
GTPase	B
-	I
activating	I
protein	I
for	O
the	O
related	O
p21	B
rac1	B
.	O

Tl-201	O
uptake	O
ratio	O
of	O
the	O
right	O
ventricle	O
,	O
which	O
represents	O
the	O
ratio	O
of	O
total	O
counts	O
of	O
the	O
right	O
ventricle	O
to	O
counts	O
of	O
the	O
administered	O
dose	O
of	O
Tl-201	O
,	O
was	O
higher	O
in	O
COPD	O
,	O
especially	O
in	O
pulmonary	O
emphysema	O
and	O
B	O
type	O
COPD	O
by	O
Burrows	O
classification	O
than	O
in	O
controls	O
.	O

A	O
second	O
hydrophobic	O
domain	O
,	O
bordered	O
by	O
two	O
hydrophilic	O
regions	O
strongly	O
suggests	O
a	O
transmembrane	O
region	O
.	O

This	O
gene	O
spans	O
23	O
kb	O
and	O
is	O
composed	O
of	O
five	O
exons	O
and	O
four	O
introns	O
.	O

These	O
findings	O
suggest	O
that	O
a	O
range	O
of	O
microenvironmental	O
conditions	O
exist	O
within	O
purified	O
water	O
systems	O
,	O
leading	O
to	O
variable	O
populations	O
of	O
bacteria	O
.	O

This	O
conclusion	O
is	O
based	O
on	O
the	O
observations	O
of	O
the	O
immunologic	O
changes	O
that	O
characterize	O
the	O
acute	O
stages	O
of	O
illness	O
as	O
well	O
as	O
on	O
the	O
demonstrated	O
association	O
with	O
toxin	O
-	O
producing	O
bacteria	O
in	O
the	O
pharynx	O
and	O
gastrointestinal	O
tract	O
.	O

These	O
cell	O
lines	O
displayed	O
methylation	O
of	O
the	O
CpG	O
island	O
surrounding	O
the	O
first	O
exon	O
of	O
p16INK4A	B
and	O
expressed	O
abundant	O
levels	O
of	O
a	O
nontranslated	O
mRNA	O
containing	O
an	O
alternative	O
first	O
exon	O
(	O
E1	O
beta	O
)	O
,	O
as	O
did	O
all	O
other	O
cell	O
lines	O
in	O
which	O
the	O
p16INK4A	B
locus	I
was	O
not	O
deleted	O
.	O

Umweltchem	O
.	O

Egd1p	B
is	O
homologous	O
to	O
human	B
BTF3b	I
,	O
recently	O
identified	O
as	O
the	O
beta	O
subunit	O
of	O
the	O
heterodimeric	B
nascent	I
-	I
polypeptide	I
-	I
associated	I
complex	I
(	O
NAC	B
)	O
involved	O
in	O
ensuring	O
signal	O
-	O
sequence	O
-	O
specific	O
protein	O
sorting	O
and	O
translocation	O
[	O
Wiedmann	O
et	O
al.	O
,	O
Nature	O
370	O
(	O
1994	O
)	O
434	O
-	O
440	O
]	O
.	O

The	O
5	O
'	O
flanking	O
regions	O
of	O
both	O
pelA	B
and	O
pelB	B
were	O
translationally	O
fused	O
to	O
the	O
beta	B
-	I
glucuronidase	I
gene	I
and	O
introduced	O
into	O
F.	O
solani	O
f.	O
sp.	O
pisi	O
,	O
and	O
beta	B
-	I
glucuronidase	I
activities	O
of	O
the	O
transformants	O
were	O
measured	O
.	O

We	O
failed	O
to	O
find	O
these	O
data	O
to	O
be	O
useful	O
in	O
predicting	O
the	O
time	O
of	O
onset	O
of	O
initial	O
seizures	O
after	O
acute	O
ischemic	O
stroke	O
and	O
recurrence	O
.	O

The	O
human	B
papillomavirus	I
type	I
16	I
E7	I
protein	I
complements	O
adenovirus	B
type	I
5	I
E1A	I
amino	O
-	O
terminus	O
-	O
dependent	O
transactivation	O
of	O
adenovirus	B
type	I
5	I
early	I
genes	I
and	O
increases	O
ATF	B
and	O
Oct-1	B
DNA	O
binding	O
activity	O
.	O

A	O
chaotropic	O
detergent	O
,	O
0.1	O
%	O
Nonidet	O
P-40	O
,	O
also	O
abolished	O
the	O
interaction	O
,	O
further	O
supporting	O
the	O
hydrophobic	O
nature	O
of	O
the	O
interaction	O
.	O

Degradation	O
of	O
the	O
soybean	B
ribulose-1,5-bisphosphate	I
carboxylase	I
small	I
-	I
subunit	I
mRNA	I
,	O
SRS4	B
,	O
initiates	O
with	O
endonucleolytic	O
cleavage	O
.	O

Cloning	O
and	O
sequencing	O
revealed	O
that	O
dMax	B
contains	O
a	O
deletion	O
spanning	O
the	O
basic	O
region	O
and	O
helix	O
1	O
and	O
the	O
loop	O
of	O
the	O
helix	O
-	O
loop	O
-	O
helix	O
region	O
,	O
presumably	O
as	O
a	O
result	O
of	O
alternative	O
splicing	O
of	O
max	B
RNA	I
.	O

The	O
domain	O
structure	O
of	O
bovine	B
LTBP-2	I
is	O
very	O
similar	O
to	O
that	O
of	O
the	O
human	B
LTBP-2	I
,	O
containing	O
20	O
examples	O
of	O
6-cysteine	O
epidermal	B
growth	I
factor	I
-	I
like	I
repeats	I
,	O
16	O
of	O
which	O
have	O
the	O
consensus	O
sequence	O
for	O
calcium	O
binding	O
,	O
together	O
with	O
4	O
examples	O
of	O
8-cysteine	O
motifs	O
characteristic	O
of	O
fibrillins	B
and	O
LTBP-1	B
.	O

We	O
now	O
report	O
the	O
isolation	O
and	O
expression	O
of	O
cDNAs	O
encoding	O
PTF	B
gamma	I
and	O
PTF	B
delta	I
,	O
as	O
well	O
as	O
functional	O
studies	O
with	O
cognate	O
antibodies	O
that	O
recognize	O
the	O
native	O
PTF	B
complex	I
in	O
HeLa	O
extracts	O
.	O

The	O
TEA1	B
(	O
Ty	B
enhancer	I
activator	I
)	O
gene	O
sequence	O
predicts	O
a	O
protein	O
of	O
86.9	O
kDa	O
whose	O
N	O
terminus	O
contains	O
a	O
zinc	O
cluster	O
and	O
dimerization	O
motif	O
typical	O
of	O
the	O
Gal4-type	B
family	I
of	O
DNA	O
-	O
binding	O
proteins	O
.	O

This	O
study	O
underlines	O
the	O
importance	O
of	O
terminal	O
SC5b-9	B
complement	I
complex	I
as	O
a	O
suitable	O
marker	O
in	O
the	O
evaluation	O
of	O
complement	O
activation	O
during	O
cardiopulmonary	O
bypass	O
.	O

Striking	O
sequence	O
similarities	O
(	O
57	O
and	O
53	O
%	O
)	O
were	O
observed	O
with	O
yeast	O
mitochondrial	O
proteins	O
,	O
SMF1	B
and	O
SMF2	B
,	O
especially	O
within	O
putative	O
functional	O
domains	O
:	O
exon	O
6	O
encoding	O
the	O
second	O
transmembrane	O
spanning	O
domain	O
,	O
site	O
of	O
the	O
murine	B
susceptibility	I
mutation	O
;	O
and	O
exon	O
11	O
encoding	O
a	O
conserved	O
transport	O
motif	O
.	O

Stems	O
contain	O
distinctly	O
less	O
P	B
protein	I
mRNA	I
and	O
the	O
relative	O
level	O
in	O
roots	O
is	O
very	O
low	O
but	O
still	O
clearly	O
detectable	O
.	O

The	O
B.	B
germanica	I
cyclophilin	I
amino	I
acid	I
sequence	I
shares	O
83	O
%	O
identity	O
with	O
the	O
cytosolic	B
cyclophilin	I
isoform	I
from	I
Drosophila	I
melanogaster	I
(	O
Cyp-1	B
)	O
.	O

Furthermore	O
,	O
we	O
have	O
identified	O
a	O
soluble	O
form	O
of	O
ERp57	B
/	O
GRP58	B
by	O
Western	O
blotting	O
and	O
biosynthetic	O
labeling	O
.	O

Comparison	O
of	O
promoters	O
repressed	O
by	O
c	B
-	I
myc	I
reveals	O
a	O
weak	O
consensus	O
sequence	O
of	O
the	O
initiator	O
(	O
Inr	O
)	O
element	O
:	O
TCA	O
(	O
+1	O
)	O
YYYNY	O
.	O

Transfection	O
analyses	O
indicate	O
that	O
mutation	O
of	O
any	O
one	O
of	O
these	O
TGACCT	O
motifs	O
or	O
truncation	O
of	O
the	O
entire	O
HD	B
PPRE	O
into	O
a	O
separate	O
DR1	O
and	O
DR2	O
element	O
significantly	O
reduced	O
the	O
transcriptional	O
response	O
of	O
HD	B
PPRE	O
to	O
peroxisome	O
proliferators	O
.	O

The	O
site	O
of	O
autophosphorylation	O
is	O
Tyr397	O
which	O
corresponds	O
to	O
the	O
consensus	O
autophosphorylation	O
site	O
of	O
other	O
Src	B
family	I
tyrosine	B
kinases	I
.	O

This	O
protein	O
-	O
protein	O
interaction	O
does	O
not	O
require	O
the	O
simultaneous	O
binding	O
of	O
Oct	B
proteins	I
to	O
DNA	O
,	O
and	O
high	O
resolution	O
footprinting	O
of	O
the	O
Oct	B
-	I
DNA	I
interaction	O
reveals	O
that	O
binding	O
of	O
BOB.1	B
/	O
OBF.1	B
to	O
Oct1	B
or	O
Oct2	B
does	O
not	O
alter	O
the	O
interaction	O
with	O
DNA	O
.	O

Unlike	O
ARF	B
,	O
the	O
ARP	B
immunoreactivity	O
was	O
detected	O
in	O
plasma	O
membranes	O
but	O
not	O
in	O
cytosol	O
of	O
fractionated	O
3T3-L1	O
cells	O
.	O

It	O
is	O
considered	O
that	O
the	O
recurrent	O
annular	O
erythema	O
is	O
a	O
specific	O
skin	O
manifestation	O
of	O
SjS	O
with	O
anti	B
SS	I
-	I
A	I
/	O
SS	B
-	I
B	I
antibodies	I
.	O

Competition	O
needs	O
to	O
be	O
better	O
studied	O
,	O
since	O
in	O
Central	O
America	O
and	O
Caribean	O
islands	O
this	O
kind	O
of	O
study	O
has	O
favored	O
the	O
biological	O
control	O
of	O
planorbid	O
species	O
.	O

In	O
this	O
paper	O
we	O
describe	O
properties	O
of	O
the	O
cdc10-C4	B
mutant	O
of	O
the	O
fission	O
yeast	O
Schizosaccharomyces	O
pombe	O
.	O

TIEG	B
expression	O
in	O
hFOB	O
cells	O
was	O
highly	O
induced	O
by	O
TGF	B
-	I
beta	I
and	O
bone	B
morphogenetic	I
protein-2	I
(	O
BMP-2	B
)	O
,	O
with	O
a	O
moderate	O
induction	O
by	O
epidermal	B
growth	I
factor	I
(	O
EGF	B
)	O
,	O
but	O
no	O
induction	O
by	O
other	O
growth	O
factors	O
/	O
cytokines	O
was	O
observed	O
.	O

An	O
infectious	O
origin	O
should	O
always	O
be	O
excluded	O
since	O
specific	O
etiologic	O
therapy	O
may	O
be	O
implemented	O
.	O

In	O
particular	O
,	O
the	O
highly	O
expressed	O
ADH1	B
gene	I
is	O
represented	O
in	O
this	O
database	O
by	O
no	O
less	O
than	O
20	O
EST	O
sequences	O
.	O

Five	O
families	O
of	O
Ashkenazi	O
Jewish	O
descent	O
carried	O
the	O
185delAG	O
mutation	O
and	O
shared	O
the	O
same	O
haplotype	O
at	O
eight	O
polymorphic	O
markers	O
spanning	O
approximately	O
850	O
kb	O
at	O
BRCA1	B
.	O

The	O
subjects	O
from	O
the	O
two	O
regions	O
with	O
a	O
higher	O
pollution	O
level	O
had	O
lower	O
FVC	O
and	O
FEV1	O
values	O
than	O
those	O
from	O
the	O
Viskovo	O
region	O
.	O

PTP	B
-	I
S3	I
differs	O
from	O
PTP	B
-	I
S4	I
in	O
having	O
a	O
deletion	O
of	O
19	O
amino	O
acids	O
corresponding	O
to	O
exon	O
E1	O
.	O

All	O
three	O
NR	B
isoforms	I
are	O
expressed	O
in	O
cv	O
.	O

The	O
Arabidopsis	B
FAD7	I
gene	I
encodes	O
a	O
chloroplast	B
omega-3	I
fatty	I
acid	I
desaturase	I
that	O
catalyzes	O
the	O
desaturation	O
of	O
lipid	O
-	O
linked	O
dienoic	O
fatty	O
acids	O
(	O
18:2	O
and	O
16:2	O
)	O
.	O

Protein	O
kinases	O
play	O
pivotal	O
roles	O
in	O
the	O
control	O
of	O
many	O
cellular	O
processes	O
.	O

Interestingly	O
,	O
internal	O
and	O
5	O
'	O
deletions	O
revealed	O
tha	O
the	O
distal	O
promoter	O
was	O
not	O
required	O
for	O
full	O
transcriptional	O
activity	O
and	O
that	O
the	O
first	O
631	O
base	O
pairs	O
of	O
WNT-5A	B
harbored	O
the	O
strongest	O
promoter	O
activity	O
.	O

The	O
protein	O
kinase	O
domains	O
of	O
LIMK1	B
and	O
LIMK2	B
are	O
unique	O
in	O
that	O
they	O
contain	O
an	O
unusual	O
sequence	O
motif	O
Asp	O
-	O
Leu	O
-	O
Asn	O
-	O
Ser	O
-	O
His	O
-	O
Asn	O
in	O
subdomain	O
VIB	O
and	O
a	O
highly	O
basic	O
insert	O
between	O
subdomains	O
VII	O
and	O
VIII	O
.	O

A	O
human	O
recombinant	O
cDNA	O
clone	O
that	O
encoded	O
253	O
amino	O
acids	O
residues	O
of	O
a	O
zinc	B
-	I
finger	I
protein	I
(	O
THZif-1	B
)	O
was	O
cloned	O
by	O
screening	O
a	O
cDNA	O
library	O
prepared	O
from	O
human	O
promyelocytic	O
leukemia	O
HL60	O
cells	O
with	O
synthetic	O
oligodeoxynucleotide	O
probes	O
that	O
corresponded	O
to	O
the	O
amino	O
acid	O
sequences	O
of	O
tryptic	O
peptides	O
derived	O
from	O
the	O
DNA	O
-	O
binding	O
protein	O
specific	O
for	O
the	O
nuclease	B
-	I
hypersensitive	I
element	I
(	O
NHE	B
)	O
of	O
the	O
human	B
c	I
-	I
myc	I
gene	I
.	O

Taking	O
into	O
consideration	O
weight	O
and	O
seasonal	O
changes	O
in	O
bone	O
mass	O
,	O
total	O
(	O
TBBMC	O
)	O
and	O
regional	O
body	O
bone	O
mineral	O
content	O
were	O
measured	O
in	O
38	O
women	O
treated	O
with	O
GnRH	B
agonists	O
for	O
6	O
months	O
for	O
endometriosis	O
or	O
leiomyomata	O
.	O

The	O
encoded	O
polypeptide	O
is	O
similar	O
in	O
sequence	O
to	O
the	O
ABA-1	B
allergen	I
of	I
Ascaris	I
,	O
the	O
gp15	B
/	I
400	I
'	I
ladder	I
'	I
protein	I
of	I
Brugia	I
malayi	I
,	I
Brugia	I
pahangi	I
and	I
Wuchereria	I
bancrofti	I
,	O
and	O
a	O
15-kDa	B
antigen	I
of	I
Dirofilaria	I
immitis	I
.	O

Certain	O
transcript	O
patterns	O
in	O
Epifagus	O
plastids	O
are	O
highly	O
complex	O
and	O
similar	O
to	O
those	O
of	O
tobacco	O
operons	O
.	O

Spontaneous	O
recovery	O
occurs	O
within	O
30	O
min	O
to	O
2	O
hrs	O
.	O

Diabetes	O
care	O
:	O
a	O
guideline	O
to	O
the	O
facilities	O
needed	O
to	O
support	O
internationally	O
endorsed	O
standards	O
.	O

To	O
identify	O
some	O
of	O
the	O
genes	O
expressed	O
in	O
LPS	O
-	O
activated	O
coelomocytes	O
,	O
we	O
sequenced	O
randomly	O
chosen	O
clones	O
from	O
a	O
directionally	O
constructed	O
cDNA	O
library	O
to	O
produce	O
a	O
set	O
of	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
.	O

Characterization	O
of	O
an	O
EcR	B
/	O
USP	B
heterodimer	O
target	O
site	O
that	O
mediates	O
ecdysone	O
responsiveness	O
of	O
the	O
Drosophila	B
Lsp-2	I
gene	I
.	O

In	O
vivo	O
,	O
selective	O
activation	O
of	O
SAPKs	B
stimulates	O
formation	O
of	O
the	O
ternary	O
complex	O
containing	O
Elk-1	B
,	O
serum	B
response	I
factor	I
and	O
the	O
serum	O
response	O
element	O
,	O
and	O
enhances	O
Elk-1-dependent	B
transcription	O
.	O

An	O
epidemic	O
of	O
hepatitis	O
B	O
virus	O
infection	O
among	O
intravenous	O
drug	O
users	O
in	O
Iceland	O
.	O

The	O
transposon	O
-	O
inactivated	O
gene	O
,	O
designated	O
pilP	B
,	O
is	O
525	O
bp	O
long	O
,	O
potentially	O
encoding	O
a	O
19.1-kDa	O
protein	O
precursor	O
that	O
contains	O
a	O
typical	O
membrane	O
lipoprotein	O
leader	O
sequence	O
.	O

Upstream	O
of	O
the	O
dra	B
gene	I
an	O
open	O
reading	O
frame	O
of	O
313	O
amino	O
acids	O
was	O
identified	O
.	O

Sucrose	O
-	O
specific	O
regulation	O
of	O
scrB	B
was	O
also	O
lost	O
upon	O
deletion	O
of	O
4	O
bp	O
of	O
a	O
palindromic	O
sequence	O
(	O
OB	O
)	O
covering	O
positions	O
+	O
6	O
to	O
+	O
21	O
downstream	O
of	O
the	O
scrB	B
transcriptional	O
start	O
site	O
.	O

CXC	O
chemokines	O
bind	O
to	O
unique	O
sets	O
of	O
selectivity	O
determinants	O
that	O
can	O
function	O
independently	O
and	O
are	O
broadly	O
distributed	O
on	O
multiple	O
domains	O
of	O
human	O
interleukin-8	B
receptor	I
B.	I

Oligodeoxynucleotides	O
antisense	O
to	O
the	O
predicted	O
translation	O
initiation	O
regions	O
of	O
ICP4	B
and	O
pp38	B
mRNAs	I
inhibited	O
proliferation	O
of	O
MSB1	O
cells	O
but	O
not	O
MDCC	O
-	O
CU91	O
(	O
CU91	O
)	O
reticuloendotheliosis	O
virus	O
-	O
transformed	O
cells	O
.	O

In	O
this	O
case	O
the	O
degree	O
of	O
promoter	O
methylation	O
,	O
which	O
could	O
extend	O
beyond	O
the	O
T	O
-	O
DNA	O
borders	O
,	O
was	O
not	O
correlated	O
with	O
the	O
reduction	O
in	O
steady	O
-	O
state	O
poly	O
(	O
A	O
)	O
+	O
mRNA	O
levels	O
,	O
the	O
silenced	O
state	O
was	O
transmitted	O
through	O
meiosis	O
and	O
reactivation	O
lasted	O
several	O
generations	O
.	O

Thus	O
,	O
the	O
consensus	O
sequences	O
for	O
phosphatase	O
regulation	O
are	O
5'-GCACGTGGG-3	O
'	O
and	O
5'-GCACGTTTT-3	O
'	O
which	O
differ	O
from	O
the	O
binding	O
sequences	O
for	O
the	O
Cpflp	B
protein	O
required	O
for	O
transcription	O
of	O
the	O
genes	O
in	O
methionine	O
biosynthesis	O
and	O
for	O
centromere	O
function	O
.	O

Here	O
we	O
report	O
that	O
the	O
proline	O
-	O
rich	O
region	O
of	O
CAP	B
is	O
recognized	O
by	O
the	O
SH3	B
domains	I
of	O
several	O
proteins	O
,	O
including	O
the	O
yeast	B
actin	I
-	I
associated	I
protein	I
Abp1p	I
.	O

We	O
have	O
identified	O
and	O
characterized	O
a	O
vitamin	O
D	O
response	O
element	O
(	O
VDRE	O
)	O
in	O
the	O
promoter	O
of	O
c	B
-	I
fos	I
.	O

In	O
addition	O
to	O
protein	O
binding	O
at	O
sequences	O
known	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
transcription	O
,	O
genomic	O
footprinting	O
of	O
the	O
entire	O
promoter	O
region	O
also	O
showed	O
that	O
a	O
protein	O
factor	O
is	O
constitutively	O
bound	O
to	O
the	O
first	O
intron	O
of	O
the	O
rep3	B
gene	I
.	O

Differentiation	O
was	O
not	O
observed	O
after	O
cellular	O
expression	O
of	O
GTPase	B
-	O
deficient	O
forms	O
of	O
alpha	B
i2	I
or	O
alpha	B
0	I
,	O
indicating	O
selectivity	O
for	O
the	O
Gq	B
family	I
of	O
G	B
proteins	I
.	O

Paf1p	B
may	O
therefore	O
be	O
required	O
for	O
both	O
positive	O
and	O
negative	O
regulation	O
of	O
subsets	O
of	O
yeast	O
genes	O
.	O

Molecular	O
characterization	O
of	O
malignant	O
melanoma	O
of	O
soft	O
parts	O
or	O
soft	O
tissue	O
clear	O
cell	O
sarcoma	O
which	O
shares	O
t	O
(	O
12;22	O
)	O
chromosome	O
translocation	O
revealed	O
fusion	O
of	O
EWS	B
with	O
a	O
transcriptional	O
factor	O
gene	B
ATF-1	I
.	O

A	O
short	O
open	O
reading	O
frame	O
(	O
ORF2	O
)	O
,	O
of	O
unknown	O
function	O
,	O
is	O
present	O
in	O
all	O
FIV	O
isolates	O
.	O

The	O
patient	O
was	O
homozygous	O
for	O
the	O
underlying	O
mutation	O
,	O
which	O
was	O
found	O
to	O
be	O
a	O
G-->T	O
transversion	O
within	O
the	O
acceptor	O
splice	O
site	O
between	O
intron	O
e	O
and	O
exon	O
6	O
,	O
abolishing	O
normal	O
RNA	O
splicing	O
.	O

These	O
regions	O
overlap	O
with	O
the	O
HIT	B
protein	I
similarity	I
regions	I
.	O

We	O
tested	O
10	O
rats	O
with	O
electrophysiologically	O
guided	O
,	O
ibotenic	O
acid	O
lesions	O
of	O
the	O
PBN	O
(	O
PBNx	O
)	O
to	O
determine	O
whether	O
they	O
could	O
acquire	O
a	O
LiCl	O
-	O
induced	O
CTA	O
to	O
l	O
-	O
alanine	O
(	O
0.3	O
M	O
)	O
or	O
demonstrate	O
a	O
sodium	O
appetite	O
following	O
furosemide	O
treatment	O
and	O
overnight	O
access	O
to	O
sodium	O
deficient	O
chow	O
.	O

Liposomal	O
Amphotericin	O
-	O
B	O
failed	O
in	O
6	O
/	O
7	O
patients	O
with	O
culture	O
-	O
proven	O
mycosis	O
who	O
died	O
from	O
infection	O
with	O
Aspergillus	O
(	O
n	O
=	O
2	O
)	O
and	O
Candida	O
(	O
n	O
=	O
4	O
)	O
,	O
respectively	O
.	O

Mg2	O
+	O
and	O
Mn2	O
+	O
compete	O
for	O
binding	O
sites	O
,	O
with	O
the	O
former	O
having	O
lower	O
affinity	O
.	O

Magnetic	O
storm	O
indicators	O
could	O
be	O
used	O
in	O
medicine	O
,	O
in	O
geophysics	O
and	O
for	O
special	O
purposes	O
.	O

Transgenic	O
tobacco	O
plants	O
(	O
ppa-1	B
)	O
constitutively	O
expressing	O
Escherichia	B
coli	I
pyrophosphatase	I
behind	O
the	O
35S	B
CaMV	I
promoter	I
accumulate	O
high	O
levels	O
of	O
soluble	O
sugars	O
in	O
their	O
leaves	O
[	O
27	O
]	O
.	O

Human	B
LAF-4	I
readily	O
hybridized	O
with	O
genes	O
in	O
mouse	O
and	O
chicken	O
,	O
thus	O
showing	O
that	O
this	O
gene	O
family	O
has	O
been	O
highly	O
conserved	O
during	O
vertebrate	O
evolution	O
.	O

CBT	O
is	O
discussed	O
in	O
comparison	O
with	O
the	O
Wisconsin	O
Card	O
Sorting	O
Test	O
as	O
a	O
potential	O
cognitive	O
activation	O
task	O
for	O
functional	O
neuroimaging	O
of	O
the	O
frontal	O
lobes	O
.	O

These	O
data	O
indicate	O
that	O
although	O
218leu	O
retains	O
normal	O
transactivation	O
activity	O
on	O
a	O
p53	B
promoter	I
in	O
yeast	O
at	O
physiological	O
temperatures	O
,	O
it	O
is	O
not	O
capable	O
of	O
normal	O
p53	B
function	O
in	O
the	O
presence	O
of	O
a	O
248trp	B
allele	I
in	O
SNU	O
-	O
C5	O
cells	O
.	O

Cycles	O
were	O
repeated	O
every	O
3	O
weeks	O
.	O

Neither	O
class	O
II	O
nor	O
IV	O
infections	O
precluded	O
transplantation	O
.	O

Although	O
a	O
great	O
deal	O
is	O
understood	O
about	O
how	O
bHLH	B
factors	I
activate	O
gene	O
transcription	O
via	O
E	O
-	O
box	O
DNA	O
consensus	O
sequences	O
,	O
studies	O
of	O
bHLH	B
factor	I
function	O
in	O
higher	O
eukaryotes	O
often	O
have	O
been	O
hindered	O
by	O
the	O
presence	O
of	O
multiple	O
family	O
members	O
.	O

Mobility	O
and	O
supershift	O
assays	O
demonstrated	O
that	O
upstream	B
stimulatory	I
factor	I
(	O
USF	B
)	O
and	O
Sp1	B
bind	O
to	O
the	O
former	O
elements	O
and	O
competition	O
experiments	O
confirmed	O
that	O
CREB	B
/	O
ATF	B
and	O
AP-1	B
bind	O
to	O
the	O
CRE	O
/	O
TRE	O
element	O
.	O

Upstream	O
of	O
-37	O
,	O
the	O
5	O
'	O
untranslated	O
sequences	O
of	O
the	O
isolates	O
differ	O
in	O
both	O
length	O
and	O
sequence	O
.	O

In	O
these	O
cases	O
,	O
greatly	O
increased	O
human	B
chorionic	I
gonadotropin	I
(	O
hCG	B
)	O
levels	O
and	O
suppressed	O
TSH	B
levels	O
suggest	O
that	O
hCG	B
has	O
thyrotropic	O
activity	O
.	O

High	O
fibrinogen	B
levels	O
could	O
thus	O
be	O
a	O
risk	O
for	O
perioperative	O
thrombosis	O
.	O

Strontium	O
chloride	O
Sr	O
89	O
is	O
costly	O
,	O
but	O
preliminary	O
analysis	O
indicates	O
that	O
it	O
may	O
reduce	O
management	O
expenditures	O
overall.	O
(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

This	O
study	O
determined	O
the	O
arthritogenic	O
potential	O
of	O
silicone	O
gel	O
by	O
either	O
mixing	O
it	O
with	O
bovine	B
collagen	I
II	I
(	O
BII	B
)	O
or	O
by	O
injecting	O
silicone	O
gel	O
alone	O
in	O
DA	O
rats	O
.	O

However	O
,	O
it	O
remains	O
an	O
open	O
question	O
whether	O
vertebrate	B
Hox	I
genes	I
expressed	O
under	O
the	O
control	O
of	O
Drosophila	O
regulatory	O
sequences	O
can	O
substitute	O
the	O
function	O
of	O
Drosophila	B
Hox	I
genes	I
.	O

We	O
propose	O
that	O
CTS1	B
and	I
CTS2	I
of	I
Ci	I
are	O
members	O
of	O
two	O
distinct	O
classes	O
of	O
fungal	B
chitinases	I
,	O
an	O
observation	O
not	O
previously	O
reported	O
for	O
a	O
single	O
fungus	O
.	O

Although	O
the	O
consumption	O
of	O
myoglobin	B
-	O
bound	O
O2	O
(	O
MbO2	O
)	O
stores	O
in	O
seal	O
muscles	O
has	O
been	O
demonstrated	O
in	O
seal	O
muscles	O
during	O
laboratory	O
simulations	O
of	O
diving	O
,	O
this	O
may	O
not	O
be	O
a	O
feature	O
of	O
normal	O
field	O
diving	O
in	O
which	O
measurements	O
of	O
heart	O
rate	O
and	O
lactate	O
production	O
show	O
marked	O
differences	O
from	O
the	O
profound	O
diving	O
response	O
induced	O
by	O
forced	O
immersion	O
.	O

The	O
human	B
purH	I
cDNA	I
is	O
1776	O
base	O
pairs	O
in	O
length	O
encoding	O
for	O
a	O
591-amino	O
acid	O
polypeptic	O
(	O
Mr	O
=	O
64,425	O
)	O
.	O

In	O
our	O
opinion	O
,	O
the	O
SM	O
-	O
CMA	O
system	O
is	O
,	O
despite	O
some	O
shortcomings	O
in	O
its	O
user	O
-	O
interface	O
,	O
a	O
useful	O
and	O
versatile	O
instrument	O
for	O
examination	O
of	O
human	O
semen	O
samples	O
,	O
with	O
desirable	O
features	O
.	O

The	O
purpose	O
of	O
the	O
study	O
reported	O
here	O
was	O
to	O
investigate	O
whether	O
differences	O
in	O
T1	O
and	O
T2	O
between	O
tumors	O
are	O
mainly	O
a	O
consequence	O
of	O
differences	O
in	O
the	O
fractional	O
volume	O
of	O
the	O
extracellular	O
compartment	O
.	O

Oligonucleotides	O
,	O
designed	O
on	O
the	O
basis	O
of	O
conserved	O
flanking	O
amino	O
acid	O
sequence	O
segments	O
within	O
the	O
catalytic	O
domain	O
of	O
eukaryotic	B
protein	I
kinase	I
C	I
(	O
PKC	B
)	O
proteins	O
,	O
were	O
used	O
as	O
primers	O
for	O
polymerase	O
chain	O
reactions	O
to	O
amplify	O
a	O
427-bp	O
chromosomal	O
DNA	O
fragment	O
from	O
the	O
filamentous	O
fungus	O
Trichoderma	O
reesei	O
.	O

This	O
region	O
contains	O
a	O
motif	O
with	O
partial	O
identity	O
with	O
the	O
binding	O
site	O
for	O
the	O
ubiquitous	O
transcription	O
factor	O
upstream	B
stimulatory	I
factor	I
(	O
USF	B
)	O
,	O
which	O
binds	O
to	O
the	O
human	B
insulin	I
promoter	I
.	O

The	O
method	O
has	O
been	O
satisfactorily	O
applied	O
to	O
the	O
determination	O
of	O
paracetamol	O
in	O
pharmaceutical	O
formulations	O
and	O
biological	O
fluids	O
.	O

The	O
Clb5	B
kinase	I
,	O
which	O
promotes	O
S	O
phase	O
,	O
remains	O
active	O
during	O
the	O
G2-phase	O
arrest	O
of	O
cells	O
of	O
the	O
parental	O
strain	O
,	O
but	O
its	O
activity	O
declines	O
rapidly	O
in	O
sim	B
mutants	I
.	O

Rad6	B
mutants	I
display	O
a	O
remarkably	O
pleiotropic	O
phenotype	O
,	O
implicating	O
the	O
protein	O
in	O
DNA	O
damage	O
-	O
induced	O
mutagenesis	O
,	O
postreplication	O
repair	O
,	O
repression	O
of	O
retrotransposition	O
,	O
and	O
sporulation	O
.	O

We	O
report	O
the	O
molecular	O
cloning	O
and	O
functional	O
characterization	O
of	O
USF2	B
isoforms	I
,	O
corresponding	O
to	O
a	O
44-kDa	O
subunit	O
,	O
USF2a	B
,	O
and	O
a	O
new	O
38-kDa	O
subunit	O
,	O
USF2b	B
,	O
generated	O
by	O
differential	O
splicing	O
.	O

The	O
preferential	O
heterodimerization	O
of	O
USF	B
subunits	I
was	O
reproduced	O
ex	O
vivo	O
,	O
while	O
the	O
in	O
vitro	O
association	O
of	O
cotranslated	O
subunits	O
,	O
or	O
recombinant	B
USF	I
proteins	I
,	O
appeared	O
to	O
be	O
random	O
.	O

GRP78	B
,	O
a	O
molecular	O
chaperone	O
expressed	O
in	O
the	O
endoplasmic	O
reticulum	O
,	O
is	O
a	O
""""	O
glucose	O
-	O
regulated	O
protein	O
""""	O
induced	O
by	O
stress	O
responses	O
that	O
deplete	O
glucose	O
or	O
intracisternal	O
calcium	O
or	O
otherwise	O
disrupt	O
glycoprotein	O
trafficking	O
.	O

To	O
elucidate	O
the	O
functional	O
significance	O
of	O
Fyn	B
in	O
the	O
expression	O
of	O
viral	O
promoters	O
,	O
we	O
transfected	O
a	O
Fyn	B
-	O
expression	O
vector	O
together	O
with	O
a	O
reporter	O
plasmid	O
containing	O
the	O
chloramphenicol	B
acetyltransferase	I
gene	I
driven	O
by	O
HIV	B
LTR	I
into	O
a	O
human	O
T	O
cell	O
line	O
,	O
Jurkat	O
.	O

We	O
conducted	O
a	O
prospective	O
,	O
randomized	O
controlled	O
trial	O
of	O
metoprolol	O
,	O
a	O
selective	O
beta	O
-	O
blocker	O
for	O
prevention	O
of	O
gastrointestinal	O
bleeding	O
from	O
portal	O
hypertension	O
in	O
29	O
non	O
-	O
selected	O
patients	O
with	O
liver	O
disease	O
and	O
previous	O
gastrointestinal	O
bleeding	O
.	O

A	O
genetic	O
and	O
molecular	O
analysis	O
of	O
non	O
-	O
inducible	O
qutA	B
mutants	I
showed	O
that	O
all	O
23	O
mutations	O
analysed	O
map	O
within	O
the	O
N	O
-	O
terminal	O
half	O
of	O
the	O
encoded	O
QUTA	B
protein	I
.	O

These	O
studies	O
indicate	O
that	O
the	O
acidimetric	O
test	O
was	O
less	O
sensitive	O
than	O
the	O
chromogenic	O
cephalosporin	O
substrates	O
and	O
that	O
nitrocefin	O
and	O
S1	O
could	O
be	O
used	O
to	O
screen	O
for	O
beta	B
-	I
lactamase	I
production	O
in	O
these	O
tested	O
species	O
.	O

Suppressors	O
of	O
defective	O
silencing	O
in	O
yeast	O
:	O
effects	O
on	O
transcriptional	O
repression	O
at	O
the	O
HMR	B
locus	I
,	O
cell	O
growth	O
and	O
telomere	O
structure	O
.	O

Although	O
ANP	B
induced	O
systemic	O
capillary	O
filtration	O
,	O
in	O
the	O
calf	O
,	O
filtration	O
was	O
reduced	O
with	O
ANP	B
.	O

With	O
current	O
methodology	O
beta-2	B
transferrin	I
does	O
not	O
appear	O
to	O
be	O
a	O
reliable	O
clinical	O
marker	O
for	O
perilymph	O
in	O
the	O
operative	O
setting	O
.	O

The	O
hIGF	B
-	I
I	I
gene	I
has	O
two	O
promoters	O
,	O
P1	O
and	O
P2	O
.	O

Gel	O
mobility	O
shift	O
assays	O
indicated	O
that	O
at	O
least	O
four	O
nuclear	O
proteins	O
with	O
distinct	O
biochemical	O
and	O
binding	O
properties	O
possess	O
the	O
ability	O
to	O
bind	O
the	O
3	O
beta	O
I	O
-	O
A	O
element	O
to	O
produce	O
four	O
DNA	O
-	O
protein	O
complexes	O
(	O
R1	O
to	O
R4	O
)	O
.	O

Sixty	O
-	O
five	O
patients	O
(	O
aged	O
between	O
3	O
years	O
5	O
months	O
and	O
60	O
years	O
)	O
suffering	O
from	O
medically	O
resistant	O
temporal	O
lobe	O
epilepsy	O
(	O
TLE	O
)	O
were	O
operated	O
on	O
over	O
a	O
period	O
of	O
33	O
months	O
in	O
Bethel	O
Epilepsy	O
Center	O
.	O

Significant	O
correlations	O
existed	O
between	O
FEV1	O
and	O
the	O
corresponding	O
values	O
of	O
Raw	O
,	O
MEF50	O
and	O
MEF25	O
,	O
although	O
there	O
were	O
considerable	O
individual	O
differences	O
between	O
test	O
results	O
.	O

This	O
region	O
also	O
contains	O
a	O
gene	O
specifying	O
a	O
Leu	B
-	I
tRNA	I
precursor	I
and	O
a	O
remnant	O
of	O
a	O
tau	O
element	O
.	O

Occupational	O
exposure	O
to	O
hepatitis	O
B	O
virus	O
and	O
human	O
immunodeficiency	O
virus	O
:	O
a	O
comparative	O
risk	O
analysis	O
.	O

Hybrid	O
female	O
mice	O
(	O
C57BL	O
x	O
CBA	O
)	O
were	O
paired	O
with	O
breeder	O
males	O
(	O
CD-1	O
)	O
and	O
LNG	O
pellets	O
were	O
implanted	O
on	O
day	O
0	O
,	O
the	O
day	O
on	O
which	O
copulation	O
plugs	O
were	O
found	O
,	O
or	O
on	O
day	O
2	O
or	O
day	O
3	O
in	O
the	O
postcoital	O
period	O
.	O

Studies	O
on	O
the	O
life	O
cycle	O
of	O
Haplorchis	O
pumilio	O
(	O
Looss	O
,	O
1896	O
)	O

Looss	O
,	O
1899	O
with	O
morphological	O
redescription	O
of	O
larval	O
and	O
adult	O
stages	O
.	O

Regressing	O
microaneurysms	O
in	O
5	O
cases	O
of	O
hepatitis	O
B	O
virus	O
related	O
polyarteritis	O
nodosa	O
.	O

A	O
3-week	O
regimen	O
of	O
erythropoietin	B
may	O
help	O
prevent	O
the	O
donor	O
's	O
need	O
to	O
receive	O
allogeneic	O
blood	O
transfusion	O
,	O
when	O
the	O
initial	O
Hb	B
levels	O
were	O
below	O
130	O
milligrams	O
.	O

Its	O
organization	O
and	O
regulation	O
indicate	O
that	O
the	O
S.	B
pombe	I
URA1	I
gene	I
product	I
appears	O
very	O
similar	O
to	O
the	O
S.	B
cerevisiae	I
URA2	I
gene	I
product	I
.	O

These	O
findings	O
demonstrate	O
that	O
haemodialysis	O
patients	O
with	O
chronic	O
hepatitis	O
C	O
respond	O
well	O
to	O
interferon	B
treatment	O
and	O
that	O
a	O
long	O
-	O
term	O
response	O
is	O
achieved	O
in	O
a	O
high	O
proportion	O
of	O
patients	O
.	O

Synthetic	O
enantiomers	O
of	O
drugs	O

Polysome	O
analysis	O
further	O
indicated	O
that	O
these	O
germ	B
cell	I
-	I
specific	I
Sp1	I
mRNAs	I
are	O
translated	O
,	O
albeit	O
with	O
a	O
lower	O
efficiency	O
than	O
the	O
somatic	O
transcript	O
.	O

This	O
study	O
proposes	O
an	O
estimator	O
for	O
such	O
global	O
synchronizing	O
effects	O
upon	O
unit	O
-	O
pair	O
correlations	O
based	O
on	O
local	O
field	O
potentials	O
(	O
LFPs	O
)	O
.	O

The	O
DNA	O
sequences	O
upstream	O
of	O
these	O
termini	O
exhibit	O
homology	O
to	O
plant	O
mitochondrial	O
-	O
processing	O
sites	O
,	O
therefore	O
the	O
proximal	O
5	O
'	O
ends	O
are	O
most	O
probably	O
generated	O
by	O
RNA	O
processing	O
.	O

Curing	O
shrinkage	O
and	O
volumetric	O
changes	O
of	O
resin	O
-	O
modified	O
glass	O
ionomer	O
restorative	O
materials	O
.	O

Effects	O
of	O
repeated	O
exposures	O
of	O
hydrogen	O
sulphide	O
on	O
rat	O
hippocampal	O
EEG	O
.	O

The	O
gene	O
encodes	O
an	O
ATP	B
-	I
binding	I
cassette	I
,	O
ABC	B
transporter	I
.	O

The	O
T	O
-	O
box	O
motif	O
is	O
present	O
in	O
a	O
family	O
of	O
genes	O
whose	O
structural	O
features	O
and	O
expression	O
patterns	O
support	O
their	O
involvement	O
in	O
developmental	O
gene	O
regulation	O
.	O

Do	O
overall	O
treatment	O
time	O
,	O
field	O
size	O
,	O
and	O
treatment	O
energy	O
influence	O
local	O
control	O
of	O
T1-T2	O
squamous	O
cell	O
carcinomas	O
of	O
the	O
glottic	O
larynx	O
?	O

PURPOSE	O
:	O
To	O
evaluate	O
treatment	O
and	O
patient	O
related	O
prognostic	O
factors	O
that	O
may	O
influence	O
local	O
control	O
in	O
the	O
treatment	O
of	O
T1-T2	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
glottic	O
larynx	O
.	O

Mutations	O
in	O
the	O
alpha	B
-	I
amanitin	I
conserved	O
domain	O
of	O
the	O
largest	O
subunit	O
of	O
yeast	B
RNA	I
polymerase	I
III	I
affect	O
pausing	O
,	O
RNA	O
cleavage	O
and	O
transcriptional	O
transitions	O
.	O

The	O
evidence	O
presented	O
here	O
suggests	O
that	O
the	O
p40	B
complex	I
is	O
a	O
ribonucleoprotein	O
complex	O
containing	O
L1Hs	B
RNA	I
(	I
s	I
)	I
and	O
that	O
protein	O
-	O
protein	O
interactions	O
in	O
which	O
alpha	O
-	O
helix	O
structures	O
participate	O
,	O
for	O
example	O
coiled	O
-	O
coils	O
,	O
may	O
occur	O
in	O
the	O
complex	O
.	O

The	O
5	O
'	O
external	O
transcribed	O
spacer	O
(	O
ETS	O
)	O
region	O
of	O
the	O
pre	O
-	O
rRNA	O
in	O
Saccharomyces	O
cerevisiae	O
contains	O
a	O
sequence	O
with	O
10	O
bp	O
of	O
perfect	O
complementarity	O
to	O
the	O
U3	B
snoRNA	I
.	O

These	O
animals	O
were	O
viable	O
and	O
fertile	O
.	O

This	O
spindle	O
defect	O
of	O
pds1	B
mutants	I
results	O
from	O
a	O
temperature	O
-	O
sensitive	O
step	O
that	O
occurs	O
around	O
the	O
G1	O
/	O
S	O
boundary	O
about	O
the	O
time	O
of	O
spindle	O
assembly	O
.	O

However	O
,	O
for	O
the	O
evaluable	O
cases	O
,	O
the	O
performances	O
of	O
the	O
CD3500	O
and	O
the	O
STKS	O
were	O
broadly	O
similar	O
and	O
generally	O
correlated	O
well	O
with	O
the	O
manual	O
reference	O
procedure	O
.	O

Both	O
EWS	B
-	O
FLI-1	B
and	O
FLI-1	B
proteins	I
function	O
as	O
transcription	O
factors	O
that	O
bind	O
specifically	O
to	O
ets	B
sequences	O
(	O
the	O
ets	B
boxes	O
)	O
present	O
in	O
promoter	O
elements	O
.	O

Additional	O
studies	O
with	O
new	O
and	O
reprocessed	O
regenerated	O
cellulose	O
dialyzers	O
comparing	O
450	O
and	O
220	O
mL	O
/	O
min	O
blood	O
flow	O
rates	O
at	O
10	O
minutes	O
showed	O
no	O
change	O
in	O
BTG	O
.	O

DNA	O
methylation	O
,	O
especially	O
of	O
either	O
one	O
or	O
both	O
of	O
the	O
deoxyadenosines	O
at	O
the	O
two	O
GATC	O
motifs	O
(	O
one	O
in	O
the	O
first	O
exon	O
and	O
the	O
other	O
in	O
the	O
first	O
intron	O
of	O
the	O
rice	O
CatA	B
gene	I
)	O
,	O
appeared	O
to	O
be	O
responsible	O
for	O
the	O
CatA	B
promoter	I
activity	O
identified	O
in	O
the	O
transient	O
assay	O
.	O

Overlapping	O
cDNA	O
clones	O
were	O
isolated	O
and	O
sequenced	O
.	O

Epitope	O
mapping	O
revealed	O
that	O
these	O
three	O
clones	O
appear	O
to	O
recognize	O
an	O
identical	O
epitope	O
domain	O
present	O
on	O
the	O
C	O
-	O
terminal	O
RNP	O
motif	O
of	O
the	O
U1A	B
protein	I
.	O

Variables	O
evaluated	O
were	O
number	O
of	O
weekly	O
anginal	O
events	O
,	O
data	O
from	O
ergometric	O
exercise	O
testing	O
with	O
simultaneous	O
electrocardiographic	O
registration	O
,	O
semiquantitative	O
evaluation	O
of	O
Tc-99	O
m	O
2-methoxy	O
isobutyl	O
isonitrile	O
(	O
MIBI	O
)	O
scans	O
and	O
rheologic	O
variables	O
.	O

As	O
the	O
length	O
of	O
the	O
fatty	O
acid	O
decreased	O
,	O
the	O
binding	O
affinity	O
was	O
reduced	O
;	O
myristic	O
acid	O
(	O
14:0	O
)	O
bound	O
with	O
a	O
K	O
(	O
d	O
)	O
of	O
1409	O
+	O
/-	O

423	O
nM	O
,	O
but	O
medium	O
-	O
chain	O
(	O
decanoic	O
acid	O
,	O
10:0	O
)	O
and	O
short	O
-	O
chain	O
(	O
octanoic	O
acid	O
,	O
8:0	O
)	O
lipids	O
were	O
not	O
bound	O
at	O
all	O
.	O

The	O
membrane	O
-	O
distal	O
cytoplasmic	O
region	O
of	O
human	B
granulocyte	I
colony	I
-	I
stimulating	I
factor	I
receptor	I
is	O
required	O
for	O
STAT3	B
but	O
not	O
STAT1	B
homodimer	I
formation	O
.	O

Although	O
some	O
residues	O
are	O
found	O
reactive	O
toward	O
dimethylsulphate	O
and	O
kethoxal	O
in	O
regions	O
predicted	O
to	O
be	O
unpaired	O
by	O
the	O
phylogenetic	O
secondary	O
structure	O
model	O
of	O
4.5S	B
RNA	I
,	O
generally	O
the	O
reactivity	O
is	O
low	O
,	O
and	O
some	O
residues	O
in	O
internal	O
loops	O
are	O
not	O
reactive	O
at	O
all	O
.	O

The	O
alpha	O
T3	O
-	O
1	O
cell	O
line	O
,	O
a	O
GnRH	B
-	O
responsive	O
gonadotroph	O
cell	O
line	O
developed	O
by	O
targeted	O
oncogenesis	O
in	O
transgenic	O
mice	O
,	O
was	O
used	O
to	O
study	O
regulation	O
of	O
the	O
glycoprotein	B
hormone	I
alpha	I
-	I
subunit	I
by	O
activin	B
.	O

Effects	O
of	O
posteroventral	O
pallidotomy	O
on	O
Parkinson	O
's	O
disease	O
.	O

However	O
,	O
only	O
complete	B
DnaJ	I
can	O
cooperate	O
with	O
DnaK	B
and	O
a	O
third	O
protein	O
,	O
GrpE	B
,	O
in	O
refolding	O
denatured	B
firefly	I
luciferase	I
.	O

TNF	B
Treatment	O
of	O
cell	O
activated	O
the	O
p38	B
MAP	I
kinase	I
pathway	O
,	O
as	O
revealed	O
by	O
increased	O
phosphorylation	O
of	O
p38	B
MAP	I
kinase	I
itself	O
,	O
activation	O
of	O
the	O
substrate	O
protein	O
MAPKAP	B
kinase-2	I
,	O
and	O
culminating	O
in	O
the	O
phosphorylation	O
of	O
the	O
heat	B
shock	I
protein	I
27	I
(	O
hsp27	B
)	O
.	O

We	O
have	O
isolated	O
a	O
novel	O
protein	O
from	O
Drosophila	O
nuclear	O
extracts	O
which	O
binds	O
specifically	O
to	O
a	O
site	O
in	O
this	O
second	O
region	O
.	O

DNase	B
I	I
footprinting	O
and	O
electrophoretic	O
mobility	O
shift	O
assays	O
indicate	O
that	O
PBP	B
binds	O
to	O
the	O
half	O
-	O
site	O
of	O
each	O
palindrome	O
with	O
the	O
core	O
recognition	O
sequence	O
TGGGAG	O
.	O

These	O
results	O
demonstrate	O
that	O
sequences	O
in	O
the	O
SH2	B
/	O
SH3	B
/	O
SH2	B
region	O
of	O
p120	B
GAP	B
are	O
required	O
for	O
full	O
catalytic	O
activity	O
toward	O
Ras	B
.	O

The	O
novel	O
hematopoietic	B
growth	I
factor	I
FLT3	I
ligand	I
(	O
FL	B
)	O
is	O
the	O
cognate	O
ligand	O
for	O
the	O
FLT3	B
,	O
tyrosine	B
kinase	I
receptor	I
(	O
R	B
)	O
,	O
also	O
referred	O
to	O
as	O
FLK-2	B
and	O
STK-1	B
.	O

In	O
contrast	O
to	O
the	O
selective	O
expression	O
of	O
the	O
receptor	O
,	O
FL	B
expression	O
was	O
detected	O
in	O
90	O
-	O
100	O
%	O
of	O
the	O
various	O
cell	O
types	O
of	O
leukemia	O
cell	O
lines	O
from	O
all	O
hematopoietic	O
cell	O
lineages	O
.	O

Further	O
analysis	O
of	O
this	O
domain	O
by	O
in	O
vitro	O
mutagenesis	O
pointed	O
to	O
a	O
core	O
of	O
hydrophobic	O
and	O
acidic	O
residues	O
as	O
critical	O
for	O
the	O
activity	O
.	O

The	O
neural	O
mechanism	O
of	O
parkinsonian	O
motor	O
symptoms	O
,	O
i.e.	O
,	O
rigidity	O
,	O
tremor	O
and	O
akinesia	O
,	O
which	O
are	O
the	O
result	O
of	O
nigrostriatal	O
dopamine	O
deficiency	O
,	O
is	O
interpreted	O
from	O
long	O
-	O
term	O
observations	O
on	O
the	O
effect	O
of	O
surgical	O
and	O
pharmacological	O
treatment	O
of	O
the	O
disease	O
in	O
relation	O
to	O
the	O
neuropathological	O
findings	O
within	O
the	O
substantia	O
nigra	O
zona	O
compacta	O
(	O
SNc	O
)	O
.	O

Protein	O
splicing	O
:	O
evidence	O
for	O
an	O
N	O
-	O
O	O
acyl	O
rearrangement	O
as	O
the	O
initial	O
step	O
in	O
the	O
splicing	O
process	O
.	O

LY290181	O
appears	O
to	O
inhibit	O
uPA	B
promoter	I
activation	O
by	O
blocking	O
phorbol	O
ester	O
-	O
stimulated	O
binding	O
of	O
nuclear	O
proteins	O
to	O
the	O
uPA	B
PEA3	B
/	O
12	O
-	O
0-tetradecanoylphorbol	O
13-acetate	O
responsive	O
element	O
(	O
TRE	O
)	O
.	O

Treatment	O
of	O
keratinocytes	O
expressing	O
a	O
normal	O
epidermal	B
growth	I
factor	I
receptor	I
(	O
EGFR	B
)	O
with	O
TGFalpha	B
or	O
epidermal	B
growth	I
factor	I
for	O
5	O
min	O
induced	O
PKCdelta	B
tyrosine	O
phosphorylation	O
.	O

Biol	O
.	O

Thus	O
,	O
hGRbeta	B
potentially	O
functions	O
as	O
a	O
dominant	O
negative	O
inhibitor	O
of	O
hGRalpha	B
activity	O
.	O

Gas6	B
contains	O
an	O
NH2-terminal	O
Gla	O
domain	O
followed	O
by	O
four	O
epidermal	B
growth	I
factor	I
-	I
like	I
repeats	I
and	O
tandem	O
globular	O
(	O
G	O
)	O
domains	O
.	O

Both	O
P5CDh	B
cDNA	I
clones	O
detect	O
a	O
single	O
3.2-kb	O
transcript	O
on	O
Northern	O
blots	O
of	O
multiple	O
human	O
tissues	O
,	O
indicating	O
the	O
long	O
cDNA	O
containing	O
the	O
3'-untranslated	O
intron	O
represents	O
the	O
predominant	O
transcript	O
.	O

Polymerization	O
of	O
neurofilament	B
L	I
protein	I
in	O
vitro	O
was	O
inhibited	O
by	O
phosphorylation	O
of	O
neurofilament	B
L	I
protein	I
by	O
PKN	B
.	O

The	O
protein	O
folds	O
correctly	O
with	O
two	O
disulfide	O
bonds	O
and	O
a	O
free	O
thiol	O
group	O
at	O
Cys25	O
.	O

We	O
and	O
others	O
have	O
demonstrated	O
that	O
the	O
c	B
-	I
cbl	I
proto	I
-	I
oncogene	I
product	I
is	O
one	O
of	O
the	O
earliest	O
targets	O
of	O
tyrosine	O
phosphorylation	O
upon	O
T	B
cell	I
receptor	I
stimulation	O
.	O

A	O
substantial	O
fraction	O
of	O
Cbl	B
was	O
constitutively	O
associated	O
with	O
Grb2	B
and	O
this	O
interaction	O
was	O
mediated	O
by	O
Grb2	B
SH3	B
domains	O
.	O

An	O
AP-1	B
binding	I
sequence	I
is	O
essential	O
for	O
regulation	O
of	O
the	O
human	B
alpha2	I
(	I
I	I
)	I
collagen	I
(	O
COL1A2	B
)	O
promoter	O
activity	O
by	O
transforming	B
growth	I
factor	I
-	I
beta	I
.	O

The	O
men	O
self	O
-	O
selected	O
a	O
prescribed	O
diet	O
at	O
home	O
emphasizing	O
saturated	O
fat	O
as	O
the	O
visible	O
fat	O
for	O
1	O
week	O
.	O

Conversely	O
,	O
when	O
VDR	B
is	O
overexpressed	O
,	O
vitamin	O
D3	O
attenuates	O
9-cis	O
RA	O
induction	O
from	O
an	O
RXR	B
-	O
responsive	O
element	O
.	O

These	O
results	O
illuminate	O
a	O
hitherto	O
unanticipated	O
function	O
of	O
U6	B
RNA	I
:	O
the	O
modulation	O
of	O
a	O
phosphorylation	O
-	O
dephosphorylation	O
cycle	O
of	O
C1	B
hnRNP	I
protein	I
that	O
influences	O
the	O
binding	O
affinity	O
of	O
this	O
protein	O
for	O
pre	O
-	O
mRNA	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
(	O
EMSAs	O
)	O
using	O
purified	O
glucocorticoid	B
receptor	I
DNA	I
binding	I
domain	I
(	O
DBD	O
)	O
demonstrated	O
that	O
both	O
GRE-2	B
and	I
-3	I
motifs	I
interact	O
with	O
DBD	O
and	O
oligonucleotide	O
competition	O
experiments	O
established	O
that	O
these	O
have	O
different	O
affinities	O
for	O
DBD	O
.	O

The	O
large	O
subfamily	O
of	O
receptor	B
tyrosine	I
kinases	I
(	O
RTKs	B
)	O
for	O
which	O
EPH	B
is	O
the	O
prototype	O
have	O
likely	O
roles	O
in	O
intercellular	O
communication	O
during	O
normal	O
mammalian	O
development	O
,	O
but	O
the	O
biochemical	O
signalling	O
pathways	O
utilised	O
by	O
this	O
family	O
are	O
poorly	O
characterised	O
.	O

The	O
17-kDa	O
protein	O
is	O
required	O
for	O
the	O
systemic	O
infection	O
of	O
plants	O
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
a	O
3574-bp	O
Bacillus	O
subtilis	O
(	O
Bs	O
)	O
DNA	O
fragment	O
located	O
between	O
the	O
nrdA	B
and	O
citB	B
genes	I
at	O
about	O
169	O
degrees	O
on	O
the	O
chromosome	O
.	O

Expression	O
of	O
Msp	B
was	O
toxic	O
to	O
E.	O
coli	O
when	O
the	O
entire	O
msp	B
gene	I
was	O
present	O
.	O

Lyn	B
kinase	I
immunoprecipitated	O
from	O
lysates	O
of	O
irradiated	O
BCP	O
as	O
well	O
as	O
a	O
full	O
-	O
length	O
glutathione	B
S	I
-	I
transferase	I
(	O
GST	B
)	O
-Lyn	O
fusion	O
protein	O
-	O
phosphorylated	O
recombinant	B
human	I
p34cdc2	I
on	O
tyrosine	O
15	O
.	O

Mutations	O
within	O
conserved	O
region	O
2	O
(	O
CR2	O
)	O
of	O
E1A	B
that	O
inhibit	O
the	O
binding	O
of	O
E1A	B
to	O
the	O
retinoblastoma	B
gene	I
product	I
(	O
pRb	B
)	O
further	O
enhanced	O
the	O
stimulation	O
of	O
transcription	O
from	O
the	O
PEPCK	B
promoter	I
by	O
2	O
3-fold	O
compared	O
with	O
wild	B
type	I
E1A	I
.	O

Using	O
autoantibodies	O
from	O
a	O
Sjogren	O
's	O
syndrome	O
patient	O
,	O
we	O
have	O
previously	O
identified	O
a	O
230-kDa	O
peripheral	O
membrane	O
protein	O
associated	O
with	O
the	O
cytosolic	O
face	O
of	O
the	O
trans	O
-	O
Golgi	O
(	O
Kooy	O
,	O
J.	O
,	O
Toh	O
,	O
B.	O

Apart	O
from	O
two	O
proline	O
-	O
rich	O
regions	O
(	O
amino	O
acids	O
1	O
-	O
117	O
and	O
239	O
-	O
270	O
)	O
,	O
p230	B
contains	O
a	O
very	O
high	O
frequency	O
of	O
heptad	O
repeats	O
,	O
characteristic	O
of	O
alpha	O
-	O
helices	O
that	O
form	O
dimeric	O
coiled	O
-	O
coil	O
structures	O
.	O

p230	B
also	O
includes	O
the	O
sequence	O
ESLALEELEL	O
(	O
amino	O
acids	O
538	O
-	O
546	O
)	O
,	O
a	O
motif	O
found	O
in	O
the	O
granin	B
family	I
of	O
acidic	O
proteins	O
present	O
in	O
secretory	O
granules	O
of	O
neuroendocrine	O
cells	O
.	O

Binding	O
specificity	O
and	O
modulation	O
of	O
the	O
ApoA	B
-	I
I	I
promoter	I
activity	O
by	O
homo-	O
and	O
heterodimers	O
of	O
nuclear	O
receptors	O
.	O

They	O
were	O
found	O
to	O
stimulate	O
at	O
nanomolar	O
concentrations	O
the	O
turnover	O
of	O
biosynthetically	O
labeled	O
ceramide	O
,	O
glucosylceramide	O
,	O
and	O
lactosylceramide	O
.	O

There	O
is	O
growing	O
evidence	O
that	O
mammalian	B
AMP	I
-	I
activated	I
protein	I
kinase	I
(	O
AMPK	B
)	O
plays	O
a	O
role	O
in	O
protecting	O
cells	O
from	O
stresses	O
that	O
cause	O
ATP	O
depletion	O
by	O
switching	O
off	O
ATP	O
-	O
consuming	O
biosynthetic	O
pathways	O
.	O

Sterol	O
-	O
mediated	O
suppression	O
of	O
cleavage	O
of	O
SREBP-1	B
was	O
found	O
to	O
be	O
dependent	O
on	O
the	O
extreme	O
COOH	O
-	O
terminal	O
region	O
(	O
residue	O
1034	O
to	O
the	O
COOH	O
terminus	O
)	O
,	O
which	O
exists	O
in	O
two	O
forms	O
as	O
a	O
result	O
of	O
alternative	O
splicing	O
.	O

Am	O
.	O

However	O
,	O
a	O
>	O
10-fold	O
increase	O
in	O
ERK3	B
activity	O
in	O
each	O
PKC	B
beta	I
transfectant	O
was	O
shown	O
by	O
immunoprecipitation	O
with	O
anti	B
-	I
ERK3	I
monoclonal	I
antibody	I
followed	O
by	O
either	O
immune	O
complex	O
kinase	O
assay	O
or	O
by	O
in	O
gel	O
kinase	O
assay	O
.	O

Sequence	O
analysis	O
of	O
this	O
100-bp	O
Col2a1	B
enhancer	I
revealed	O
several	O
sequence	O
motifs	O
similar	O
to	O
motifs	O
present	O
within	O
the	O
regulatory	O
region	O
of	O
the	O
link	B
protein	I
gene	I
,	O
another	O
cartilage	O
gene	O
.	O

Significantly	O
,	O
pPKR	B
is	O
capable	O
of	O
specifically	O
phosphorylating	O
Ser51	O
in	O
a	O
synthetic	B
eIF-2alpha	I
peptide	I
,	O
a	O
key	O
characteristic	O
of	O
the	O
eIF-2alpha	B
kinase	I
family	I
.	O

Vertebrate	B
synapsins	I
constitute	O
a	O
family	O
of	O
synaptic	O
proteins	O
that	O
participate	O
in	O
the	O
regulation	O
of	O
neurotransmitter	O
release	O
.	O

ZEBRA	B
and	O
cellular	O
AP-1	B
bZip	I
activators	I
,	O
such	O
as	O
c	B
-	I
Fos	I
,	O
have	O
homologous	O
DNA	O
-	O
binding	O
domains	O
,	O
and	O
their	O
DNA	O
-	O
binding	O
specificities	O
overlap	O
.	O

This	O
result	O
suggested	O
that	O
mutant	O
I299	O
has	O
diminished	O
cap	O
-	O
binding	O
activity	O
.	O

UV	O
cross	O
-	O
linking	O
experiments	O
demonstrated	O
that	O
HSV	O
infection	O
caused	O
enhanced	O
binding	O
of	O
protein	O
factors	O
,	O
including	O
the	O
64-kDa	B
component	I
of	I
cleavage	I
stimulation	I
factor	I
(	O
CstF	B
)	O
,	O
to	O
poly	O
(	O
A	O
)	O
site	O
RNAs	O
from	O
virus	O
genes	O
of	O
all	O
temporal	O
classes	O
and	O
that	O
this	O
enhanced	O
binding	O
required	O
expression	O
of	O
IE63	B
.	O

We	O
show	O
here	O
that	O
these	O
Jun	B
/	O
eb1	B
chimeras	O
are	O
potent	O
transactivators	O
of	O
AP1	B
sites	I
and	O
that	O
they	O
can	O
cooperate	O
with	O
c	B
-	I
Ha	I
-	I
Ras	I
to	O
induce	O
foci	O
.	O

In	O
synchronized	O
HeLa	O
cells	O
,	O
expression	O
of	O
luciferase	B
activity	O
was	O
induced	O
at	O
the	O
beginning	O
of	O
DNA	O
synthesis	O
and	O
was	O
dependent	O
on	O
the	O
presence	O
of	O
an	O
E2F	B
-	I
binding	I
site	I
in	O
the	O
H2A.1	B
promoter	I
.	O

We	O
constructed	O
a	O
yeast	O
reporter	O
strain	O
containing	O
the	O
lacZ	B
gene	I
under	O
the	O
control	O
of	O
the	O
CYC1	B
promoter	I
associated	O
with	O
three	O
copies	O
of	O
TRE-1	B
.	O

If	O
hnRNP	B
K	I
is	O
a	O
transcription	O
factor	O
,	O
then	O
interactions	O
with	O
the	O
RNA	B
polymerase	I
II	I
transcription	O
apparatus	O
are	O
predicted	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
increase	O
in	O
V	O
O2	O
may	O
have	O
been	O
a	O
consequence	O
of	O
the	O
increase	O
in	O
Q	O
O2	O
rather	O
than	O
a	O
response	O
to	O
the	O
procedure	O
itself	O
.	O

Several	O
cytokines	O
exhibit	O
a	O
high	O
degree	O
of	O
temporal	O
regulation	O
as	O
well	O
as	O
somnogenic	O
potency	O
(	O
e.g.	O
,	O
interleukin-1	B
[	O
IL-1	B
]	O
,	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
[	O
TNF	B
-	I
alpha	I
]	O
)	O
.	O

No	O
difference	O
in	O
elastin	B
peptide	I
concentration	O
was	O
observed	O
between	O
emphysematous	O
patients	O
and	O
control	O
subjects	O
(	O
mean	O
+	O
/-	O

SD	O
=	O
2.39	O
+	O
/-	O

1.18	O
micrograms	O
/	O
ml	O
in	O
patients	O
versus	O
2.55	O
+	O
/-	O

1.34	O
micrograms	O
/	O
ml	O
in	O
policemen	O
and	O
2.59	O
+	O
/-	O

1.20	O
micrograms	O
/	O
ml	O
in	O
coal	O
miners	O
)	O
.	O

Identification	O
of	O
this	O
region	O
as	O
the	O
E.	B
coli	I
tmk	I
gene	I
was	O
confirmed	O
by	O
functional	O
complementation	O
of	O
a	O
yeast	B
dTMP	I
kinase	I
temperature	O
-	O
sensitive	O
mutant	O
and	O
by	O
in	O
vitro	O
enzyme	O
assay	O
of	O
the	O
thymidylate	B
kinase	I
activity	O
in	O
cell	O
extracts	O
of	O
E.	O
coli	O
by	O
use	O
of	O
tmk	B
-	O
overproducing	O
plasmids	O
.	O

Consistent	O
with	O
ErbB-2	B
being	O
a	O
shared	O
receptor	O
subunit	O
,	O
its	O
tyrosine	O
phosphorylation	O
was	O
increased	O
by	O
both	O
heterologous	O
ligands	O
and	O
it	O
mediated	O
a	O
trans	O
-	O
inhibitory	O
effect	O
of	O
NDF	B
on	O
EGF	B
binding	O
.	O

The	O
cDNA	O
corresponding	O
to	O
the	O
FPS1	B
gene	I
was	O
isolated	O
by	O
functional	O
complementation	O
of	O
a	O
mutant	O
yeast	O
strain	O
defective	O
in	O
FPS	B
activity	O
(	O
Delourme	O
,	O
D.	O
,	O
Lacroute	O
,	O
F.	O
,	O
and	O
Karst	O
,	O
F.	O

The	O
isolated	O
plasmin	B
fragments	O
of	O
VEGF	B
were	O
compared	O
with	O
respect	O
to	O
heparin	O
binding	O
,	O
interaction	O
with	O
soluble	O
VEGF	B
receptors	I
,	O
and	O
ability	O
to	O
promote	O
endothelial	O
cell	O
mitogenesis	O
.	O

VDR	B
/	O
RXR	B
bound	O
well	O
to	O
the	O
VDREs	O
and	O
to	O
DR4	O
and	O
DR5	O
using	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

In	O
contrast	O
,	O
when	O
the	O
isoform	O
containing	O
the	O
C	O
epsilon4	O
domain	O
joined	O
directly	O
to	O
the	O
M2	O
exon	O
(	O
IgE	B
grande	I
)	O
is	O
expressed	O
in	O
the	O
J558L	O
cell	O
line	O
,	O
it	O
is	O
degraded	O
intracellularly	O
,	O
suggesting	O
a	O
cell	O
line	O
-	O
dependent	O
regulation	O
of	O
secretion	O
.	O

Human	B
cytomegalovirus	I
immediate	I
-	I
early	I
protein	I
IE2	I
tethers	O
a	O
transcriptional	O
repression	O
domain	O
to	O
p53	B
.	O

The	O
antibodies	O
inhibited	O
specifically	O
the	O
transcription	O
of	O
DNA	B
polymerase	I
alpha	I
promoter	O
in	O
vitro	O
.	O

Immunocytochemical	O
analysis	O
demonstrated	O
the	O
presence	O
of	O
DREF	B
polypeptide	I
in	O
nuclei	O
after	O
the	O
eighth	O
nuclear	O
division	O
cycle	O
,	O
suggesting	O
that	O
nuclear	O
accumulation	O
of	O
DREF	B
is	O
important	O
for	O
the	O
coordinate	O
zygotic	O
expression	O
of	O
DNA	O
replication	O
-	O
related	O
genes	O
carrying	O
DRE	O
sequences	O
.	O

A	O
DNA	O
fragment	O
carrying	O
1,100	O
nucleotides	O
derived	O
from	O
the	O
5'-flanking	O
region	O
of	O
the	O
UGT1A1	B
gene	I
was	O
enough	O
for	O
MC	O
induction	O
.	O

This	O
result	O
supports	O
the	O
argument	O
that	O
the	O
beta	O
'	O
subunit	O
plays	O
an	O
essential	O
role	O
in	O
determining	O
the	O
progress	O
of	O
transcription	O
elongation	O
.	O

The	O
extraction	O
recovery	O
of	O
Amphotericin	O
B	O
from	O
the	O
cerebrospinal	O
fluid	O
is	O
higher	O
than	O
90	O
%	O
over	O
the	O
entire	O
linear	O
range	O
.	O

HuEpo	B
-	I
R	I
Ab	I
inhibited	O
Epo	B
-	O
induced	O
parental	O
UT-7	O
cell	O
growth	O
,	O
but	O
not	O
that	O
of	O
cells	O
of	O
clone	O
12	O
,	O
suggesting	O
that	O
the	O
muEpo	B
-	I
R	I
is	O
able	O
to	O
induce	O
human	O
UT-7	O
cell	O
proliferation	O
.	O

The	O
sequence	O
and	O
isolated	O
cDNAs	O
will	O
provide	O
useful	O
reagents	O
for	O
studying	O
the	O
expression	O
of	O
Brca1	B
in	O
the	O
mouse	O
,	O
and	O
for	O
testing	O
the	O
importance	O
of	O
the	O
evolutionarily	O
conserved	O
domains	O
.	O

A	O
study	O
was	O
performed	O
to	O
compare	O
the	O
ONLINE	O
and	O
EMIT	O
II	O
immunoassays	O
with	O
gas	O
chromatographic	O
/	O
mass	O
spectrometric	O
(	O
GC	O
/	O
MS	O
)	O
analysis	O
of	O
methaqualone	O
metabolites	O
on	O
urine	O
using	O
samples	O
obtained	O
from	O
a	O
clinical	O
study	O
.	O

This	O
protein	O
encoded	O
by	O
this	O
cDNA	O
,	O
which	O
we	O
have	O
termed	O
p150TSP	B
(	O
for	O
TPR	O
-	O
containing	O
,	O
SH2-binding	B
phosphoprotein	I
)	O
,	O
is	O
located	O
predominantly	O
in	O
the	O
nucleus	O
and	O
is	O
highly	O
conserved	O
in	O
evolution	O
.	O

Both	O
mutant	O
receptors	O
were	O
expressed	O
on	O
the	O
cell	O
surface	O
and	O
bound	O
insulin	B
normally	O
,	O
but	O
showed	O
markedly	O
impaired	O
autophosphorylation	O
in	O
response	O
to	O
insulin	B
.	O

Transcription	O
from	O
adenovirus	B
E2-early	I
promoter	I
is	O
controlled	O
by	O
a	O
unique	O
array	O
of	O
four	O
cis	O
-	O
acting	O
elements	O
which	O
include	O
an	O
atypical	O
TBP	B
site	I
,	O
two	O
E2F	B
sites	I
present	O
in	O
an	O
inverted	O
orientation	O
relative	O
to	O
each	O
other	O
,	O
and	O
an	O
ATF	B
site	I
.	O

Furthermore	O
,	O
we	O
showed	O
that	O
the	O
IL-6	B
/	O
interferon	B
gamma	I
(	O
IFN	B
gamma	I
)	O
response	O
element	O
in	O
the	O
IRF-1	B
promoter	I
(	O
IR	B
/	O
IRF-1	B
)	O
,	O
which	O
contains	O
a	O
Stat	B
-	I
binding	I
site	I
and	O
an	O
adjacent	O
CRE	O
-	O
like	O
site	O
,	O
also	O
makes	O
IL-6-induced	B
binding	O
complexes	O
similar	O
to	O
JRE	O
-	O
IL6-BCs	B
.	O

A	O
second	O
peptide	O
(	O
amino	O
acids	O
58	O
-	O
77	O
)	O
also	O
antagonized	O
p21-activity	B
,	O
but	O
this	O
peptide	O
did	O
not	O
affect	O
the	O
ability	O
of	O
p21	B
to	O
interact	O
with	O
cyclin	B
E	I
/	O
Cdk2	B
.	O

A	O
p21	B
peptide	I
spanning	O
amino	O
acids	O
139	O
-	O
164	O
was	O
found	O
to	O
bind	O
PCNA	B
in	O
a	O
filter	O
binding	O
assay	O
and	O
this	O
peptide	O
suppressed	O
recombinant	O
p21-PCNA	B
interaction	O
.	O

OND	O
8	O
mg	O
tid	O
days	O
2	O
-	O
3	O
,	O
and	O
8	O
mg	O
tid	O
prn	O
days	O
4	O
-	O
5	O
and	O
prednisolone	O
75	O
-	O
100	O
mg	O
qds	O
days	O
2	O
-	O
5	O
and	O
2	O
)	O
MCP	O
30	O
mg	O
/	O
metylprednisolone	O
80	O
mg	O
i.v	O
.	O

before	O
CT	O
and	O
MCP	O
20	O
mg	O
p.r	O
.	O

after	O
4	O
and	O
8	O
h	O
respectively	O
.	O

The	O
dynamic	O
properties	O
of	O
this	O
protein	O
fragment	O
were	O
measured	O
and	O
analyzed	O
using	O
both	O
isotropic	O
and	O
anisotropic	O
models	O
of	O
molecular	O
motion	O
.	O

Isolation	O
by	O
PCR	O
of	O
a	O
cDNA	O
clone	O
from	O
pea	O
petals	O
with	O
similarity	O
to	O
petunia	O
and	O
wheat	B
zinc	I
finger	I
proteins	I
.	O

This	O
fragment	O
can	O
bind	O
several	O
trans	O
-	O
acting	O
factors	O
in	O
vitro	O
,	O
including	O
GATA-1	B
and	O
members	O
of	O
the	O
Ets	B
family	I
.	O

Exposure	O
of	O
peripheral	O
blood	O
T	O
cells	O
from	O
young	O
subjects	O
to	O
PHA	B
or	O
cross	O
-	O
linked	O
anti	B
-	I
CD3	I
monoclonal	I
antibodies	I
stimulated	O
rapid	O
increases	O
in	O
MAPK	B
and	O
MEK	B
enzymatic	O
activity	O
.	O

These	O
different	O
observations	O
exclude	O
a	O
heterozygosity	O
of	O
the	O
A	O
--	O
>	O
G	O
mutation	O
at	O
codon	O
beta	O
77	O
,	O
as	O
well	O
as	O
a	O
deletion	O
comparable	O
to	O
that	O
of	O
Hbs	B
Lepore	I
or	I
Kenya	I
,	O
or	O
a	O
beta	B
-	I
globin	I
gene	I
duplication	O
,	O
and	O
point	O
to	O
a	O
nontraditional	O
inheritance	O
of	O
Hb	B
Costa	I
Rica	I
.	O

This	O
is	O
the	O
first	O
description	O
,	O
to	O
our	O
knowledge	O
,	O
of	O
regulatory	O
elements	O
that	O
control	O
expression	O
of	O
a	O
gene	O
encoding	O
a	O
B7	B
costimulatory	I
molecule	I
.	O

T	O
cell	O
leukemia	O
-	O
associated	O
human	O
Notch	B
/	O
translocation	O
-	O
associated	O
Notch	B
homologue	O
has	O
I	B
kappa	I
B	I
-	O
like	O
activity	O
and	O
physically	O
interacts	O
with	O
nuclear	B
factor	I
-	I
kappa	I
B	I
proteins	O
in	O
T	O
cells	O
.	O

Polyprotein	O
processing	O
in	O
Southampton	O
virus	O
:	O
identification	O
of	O
3C	B
-	I
like	I
protease	I
cleavage	O
sites	O
by	O
in	O
vitro	O
mutagenesis	O
.	O

The	O
humanized	B
LL2	I
(	O
hLL2	B
)	O
,	O
lacking	O
light	B
chain	I
variable	I
region	I
glycosylation	O
,	O
exhibited	O
immunoreactivities	O
that	O
were	O
comparable	O
to	O
that	O
of	O
chimeric	B
LL2	I
(	O
cLL2	B
)	O
,	O
which	O
was	O
shown	O
previously	O
to	O
have	O
antigen	O
-	O
binding	O
properties	O
similar	O
to	O
its	O
murine	O
counterpart	O
,	O
suggesting	O
that	O
the	O
VK	O
-	O
appended	O
oligosaccharides	O
found	O
in	O
mLL2	B
are	O
not	O
necessary	O
for	O
antigen	O
binding	O
.	O

An	O
apparent	O
N	O
-	O
terminal	O
transit	O
peptide	O
in	O
the	O
coding	O
region	O
and	O
a	O
3	O
'	O
poly	O
(	O
A	O
)	O
tail	O
exist	O
in	O
the	O
cDNA	O
clone	O
indicated	O
that	O
this	O
chloroplast	O
protein	O
as	O
nuclear	O
encoded	O
.	O

Deletion	O
analysis	O
of	O
rOC	B
promoter	I
-	O
chloramphenicol	B
acetyltransferase	I
constructs	O
demonstrates	O
that	O
an	O
AML-1-binding	B
sequence	I
within	O
the	O
proximal	O
promoter	O
(	O
-138	O
to	O
-130	O
nt	O
)	O
contributes	O
to	O
75	O
%	O
of	O
the	O
level	O
of	O
osteocalcin	B
gene	I
expression	O
.	O

Thus	O
,	O
a	O
critical	O
question	O
is	O
how	O
HOX	B
proteins	I
select	O
the	O
correct	O
sets	O
of	O
target	O
genes	O
in	O
vivo	O
.	O

Moreover	O
,	O
the	O
Rho	B
family	I
protein	I
Cdc42	B
,	O
a	O
conserved	O
morphogenetic	B
G	I
protein	I
,	O
is	O
also	O
a	O
potent	O
regulator	O
of	O
filamentous	O
growth	O
and	O
FG	B
(	O
TyA	B
)	O
::lacZ	O
expression	O
in	O
S.	O
cerevisiae	O
.	O

This	O
region	O
includes	O
verA	B
,	O
a	O
structural	O
gene	O
previously	O
shown	O
to	O
be	O
required	O
for	O
ST	O
biosynthesis	O
,	O
and	O
24	O
additional	O
closely	O
spaced	O
transcripts	O
ranging	O
in	O
size	O
from	O
0.6	O
to	O
7.2	O
kb	O
that	O
are	O
coordinately	O
induced	O
only	O
under	O
ST	O
-	O
producing	O
conditions	O
.	O

Subcellular	O
localizations	O
of	O
the	O
wild	B
-	I
type	I
CBFbeta	I
and	O
the	O
CBFbeta	B
-	O
SMMHC	B
fusion	O
protein	O
were	O
determined	O
by	O
immunofluorescence	O
of	O
NIH	O
3T3	O
cells	O
that	O
overexpress	O
wild	O
-	O
type	O
or	O
fusion	O
protein	O
.	O

We	O
report	O
the	O
isolation	O
of	O
human	O
cDNAs	O
homologous	O
to	O
the	O
Drosophila	B
dishevelled	I
(	O
dsh	B
)	O
segment	O
-	O
polarity	O
gene	O
.	O

Escherichia	O
coli	O
BL21	O
(	O
DE3	O
)	O
plysS	O
,	O
harbouring	O
a	O
recombinant	O
plasmid	O
containing	O
the	O
catalase	B
-	O
peroxidase	B
gene	O
,	O
produced	O
a	O
large	O
amount	O
of	O
proteins	O
that	O
co	O
-	O
migrated	O
on	O
SDS	O
/	O
PAGE	O
with	O
the	O
native	O
enzyme	O
.	O

Cdk2	B
formed	O
a	O
complex	O
with	O
cyclin	B
D1	I
in	O
this	O
system	O
.	O

Large	B
T	I
antigen	I
was	O
coimmunoprecipitated	O
by	O
antibodies	O
to	O
epitope	O
-	O
tagged	O
TBP	B
,	O
endogenous	O
TBP	B
,	O
hTAF	B
(	I
II	I
)	I
100	I
,	O
hTAF	B
(	I
II	I
)	I
130	I
,	O
and	O
hTAF	B
(	I
II	I
)	I
250	I
,	O
under	O
conditions	O
where	O
holo	B
-	I
TFIID	I
would	O
be	O
precipitated	O
.	O

A	O
human	O
cytoplasmic	O
signaling	O
protein	O
has	O
been	O
cloned	O
that	O
possesses	O
the	O
same	O
structural	O
arrangement	O
of	O
SH3-SH2-SH3	B
domains	O
as	O
Grb2	B
.	O

E3	B
/	I
19	I
K	I
resides	O
in	O
the	O
endoplasmic	O
reticulum	O
where	O
it	O
binds	O
to	O
MHC	B
class	I
I	I
molecules	I
,	O
thereby	O
preventing	O
their	O
transport	O
to	O
the	O
cell	O
surface	O
.	O

Cloning	O
of	O
individual	O
ZI	O
domains	O
upstream	O
of	O
a	O
minimal	O
promoter	O
demonstrated	O
that	O
the	O
ZIA	O
,	O
ZIC	O
,	O
and	O
ZID	O
domains	O
,	O
but	O
not	O
the	O
ZIB	O
domain	O
,	O
are	O
TPA	O
responsive	O
.	O

Clb2	B
/	O
Cdc28	B
kinase	O
is	O
not	O
required	O
for	O
the	O
repression	O
of	O
MCB	B
-	I
binding	I
factor	I
transcriptional	O
activity	O
in	O
G2	O
and	O
M	O
phase	O
.	O

The	O
carboxy	O
terminus	O
of	O
Mbp1	B
is	O
sufficient	O
for	O
interaction	O
with	O
Swi6	B
,	O
and	O
the	O
carboxy	O
terminus	O
of	O
Swi6	B
is	O
required	O
for	O
interaction	O
with	O
Mbp1	B
.	O

A	O
new	O
UASH	O
consensus	O
sequence	O
derived	O
from	O
this	O
mutational	O
analysis	O
closely	O
matches	O
a	O
consensus	O
Abf1	B
binding	I
site	I
.	O

We	O
have	O
isolated	O
and	O
analyzed	O
human	B
CTCF	I
cDNA	I
clones	O
and	O
show	O
here	O
that	O
the	O
ubiquitously	O
expressed	O
11-zinc	B
-	I
finger	I
factor	I
CTCF	I
is	O
an	O
exceptionally	O
highly	O
conserved	O
protein	O
displaying	O
93	O
%	O
identity	O
between	O
avian	O
and	O
human	O
amino	O
acid	O
sequences	O
.	O

Mutational	O
analysis	O
of	O
the	O
P2-proximal	B
CTCF	I
binding	I
site	I
and	O
transient	O
-	O
cotransfection	O
experiments	O
demonstrate	O
that	O
CTCF	B
is	O
a	O
transcriptional	O
repressor	O
of	O
the	O
human	B
c	I
-	I
myc	I
gene	I
.	O

A	O
chromosome	B
transmission	I
fidelity	I
(	O
ctf	B
)	O
mutant	O
,	O
s138	O
,	O
of	O
Saccharomyces	O
cerevisiae	O
was	O
identified	O
by	O
its	O
centromere	O
(	O
CEN	O
)	O
transcriptional	O
readthrough	O
phenotype	O
,	O
suggesting	O
perturbed	O
kinetochore	O
integrity	O
in	O
vivo	O
.	O

The	O
growth	O
defect	O
of	O
a	O
reg1	B
reg2	B
double	I
mutant	I
is	O
alleviated	O
by	O
a	O
loss	O
-	O
of	O
-	O
function	O
mutation	O
in	O
the	O
SNF1-encoded	B
protein	I
kinase	I
.	O

Sp1	B
binds	O
two	O
sites	O
in	O
the	O
CD11c	B
promoter	I
in	O
vivo	O
specifically	O
in	O
myeloid	O
cells	O
and	O
cooperates	O
with	O
AP1	B
to	O
activate	O
transcription	O
.	O

Expression	O
of	O
the	O
phenylalanine	B
hydroxylase	I
gene	I
in	O
livers	O
and	O
kidneys	O
of	O
rodents	O
is	O
activated	O
at	O
birth	O
and	O
is	O
induced	O
by	O
glucocorticoids	O
and	O
cyclic	O
AMP	O
in	O
the	O
liver	O
.	O

We	O
report	O
here	O
the	O
identification	O
of	O
a	O
cDNA	O
that	O
encodes	O
a	O
new	O
member	O
of	O
the	O
GTPase	B
-	I
activating	I
protein	I
(	O
GAP	B
)	O
family	O
of	O
GTPase	B
regulators	O
.	O

In	O
this	O
study	O
,	O
we	O
further	O
investigated	O
the	O
regulation	O
of	O
the	O
synthesis	O
of	O
the	O
c	B
-	I
mos	I
oncogene	I
product	I
,	O
which	O
is	O
necessary	O
for	O
the	O
activation	O
of	O
Cdc2	B
.	O

The	O
heterogeneity	O
of	O
bovine	B
IgG2	I
-	I
-VIII	I
.	O

Positioning	O
this	O
uORF	O
,	O
together	O
with	O
its	O
accompanying	O
Kozak	O
sequences	O
,	O
between	O
a	O
heterologous	O
promoter	O
from	O
SV40	O
and	O
a	O
CAT	B
reporter	I
gene	I
resulted	O
in	O
marked	O
inhibition	O
of	O
CAT	B
protein	I
production	O
without	O
a	O
decrease	O
in	O
CAT	B
mRNA	I
.	O

Mesial	O
temporal	O
sclerosis	O
was	O
characterized	O
by	O
severe	O
neuronal	O
loss	O
accompanied	O
by	O
gliosis	O
occurring	O
in	O
the	O
CA1	O
/	O
prosubiculum	O
(	O
27	O
patients	O
,	O
100	O
%	O
)	O
,	O
focally	O
in	O
the	O
dentate	O
gyrus	O
(	O
12	O
patients	O
,	O
44	O
%	O
)	O
,	O
and	O
in	O
the	O
CA4	O
region	O
(	O
11	O
patients	O
,	O
41	O
%	O
)	O
.	O

Mesial	O
temporal	O
sclerosis	O
.	O

More	O
specific	O
adverse	O
events	O
,	O
also	O
frequently	O
considered	O
as	O
dose	O
-	O
limiting	O
toxicities	O
,	O
include	O
hypotension	O
with	O
IL-1	B
,	O
severe	O
headache	O
or	O
skin	O
rash	O
with	O
IL-3	B
,	O
and	O
nasal	O
congestion	O
and	O
gastroduodenal	O
lesions	O
with	O
IL-4	B
.	O

Therefore	O
,	O
magnetic	O
resonance	O
imaging	O
was	O
used	O
to	O
determine	O
liver	O
volume	O
in	O
pediatric	O
and	O
adolescent	O
patients	O
,	O
in	O
whom	O
systemic	O
clearance	O
of	O
three	O
model	O
substrates	O
[	O
lorazepam	O
(	O
0.03	O
mg	O
/	O
kg	O
)	O
,	O
antipyrine	O
(	O
10	O
mg	O
/	O
kg	O
)	O
,	O
and	O
indocyanine	O
green	O
(	O
ICG	O
;	O
0.5	O
mg	O
/	O
kg	O
)	O
]	O
was	O
also	O
determined	O
.	O

A	O
mutational	O
analysis	O
has	O
resolved	O
a	O
region	O
of	O
seven	O
amino	O
acids	O
(	O
amino	O
acids	O
26	O
-	O
32	O
)	O
in	O
the	O
N	O
-	O
terminus	O
of	O
Bob1	B
that	O
are	O
important	O
for	O
contacting	O
the	O
DNA	B
binding	I
POU	I
domain	I
of	O
Oct-1	B
or	O
Oct-2	B
.	O

Heme	B
oxygenase	I
1	I
is	O
an	O
essential	O
enzyme	O
in	O
heme	O
catabolism	O
that	O
cleaves	O
heme	O
to	O
form	O
biliverdin	O
,	O
iron	O
,	O
and	O
carbon	O
monoxide	O
.	O

155	O
aa	O
,	O
shares	O
78	O
%	O
identity	O
with	O
the	O
analogous	O
region	O
of	O
Xenopus	O
laevis	O
FGF3	B
and	O
72	O
%	O
identity	O
with	O
the	O
product	O
of	O
the	O
more	O
distantly	O
related	O
human	O
gene	O
.	O

Defects	O
in	O
the	O
Schizosaccharomyces	O
pombe	O
(	O
Sp	O
)	O
cell	O
cycle	O
-	O
controlling	O
genes	O
prevent	O
the	O
cell	O
cycle	O
progression	O
.	O

The	O
DNA	O
sequence	O
immediately	O
upstream	O
from	O
the	O
-	O
10	O
hexamer	O
contained	O
the	O
TGn	O
motif	O
described	O
as	O
an	O
extended	O
-10	O
region	O
in	O
prokaryotic	O
promoters	O
.	O

We	O
conclude	O
from	O
these	O
studies	O
that	O
CKII	B
may	O
act	O
as	O
a	O
positive	O
regulator	O
of	O
myogenesis	O
by	O
preventing	O
E	B
protein	I
homodimers	I
from	O
binding	O
to	O
muscle	O
gene	O
regulatory	O
elements	O
.	O

The	O
role	O
of	O
negative	O
regulators	O
such	O
as	O
NCE3	B
,	O
as	O
well	O
as	O
the	O
previously	O
described	O
SIN5	B
gene	I
,	O
in	O
determining	O
the	O
promoter	O
specificity	O
of	O
homologous	O
activators	O
is	O
discussed	O
.	O

We	O
found	O
strand	O
selective	O
repair	O
in	O
DNA	O
fragments	O
within	O
two	O
active	O
genes	O
,	O
DHFR	B
and	O
an	O
unknown	O
gene	O
adjacent	O
to	O
DHFR	B
.	O

MATERIALS	O
AND	O
METHODS	O
:	O
Coronal	O
3D	O
GRE	O
imaging	O
was	O
used	O
to	O
study	O
the	O
volar	O
,	O
middle	O
,	O
and	O
dorsal	O
portions	O
of	O
the	O
SLL	O
in	O
14	O
patients	O
with	O
an	O
arthroscopically	O
normal	O
SLL	O
and	O
in	O
five	O
cadaveric	O
wrists	O
that	O
had	O
a	O
normal	O
SLL	O
proved	O
with	O
dissection	O
.	O

In	O
an	O
effort	O
to	O
contribute	O
to	O
the	O
transcript	O
map	O
of	O
human	O
chromosome	O
21	O
and	O
the	O
understanding	O
of	O
the	O
pathophysiology	O
of	O
trisomy	O
21	O
,	O
we	O
have	O
used	O
exon	O
trapping	O
to	O
identify	O
fragments	O
of	O
chromosome	O
21	O
genes	O
.	O

The	O
model	O
captures	O
the	O
essence	O
of	O
predator	O
-	O
prey	O
dynamics	O
to	O
provide	O
reasonable	O
predictions	O
of	O
population	O
patterns	O
.	O

The	O
exon	O
-	O
intron	O
distribution	O
of	O
Cdebp	B
appears	O
strikingly	O
similar	O
to	O
that	O
of	O
the	O
App	B
gene	I
in	O
the	O
regions	O
encoding	O
the	O
conserved	O
domains	O
,	O
with	O
a	O
divergent	O
structure	O
in	O
the	O
other	O
parts	O
.	O

DNA	O
sequence	O
analysis	O
reveals	O
that	O
the	O
gene	O
encodes	O
a	O
protein	O
highly	O
homologous	O
to	O
rat	B
CRP1	I
.	O

Both	O
of	O
these	O
domains	O
have	O
striking	O
sequence	O
homology	O
with	O
human	O
SIM	B
and	O
Drosophila	O
SIM	B
proteins	O
.	O

Promoter	O
activity	O
was	O
high	O
in	O
cell	O
lines	O
that	O
expressed	O
high	O
levels	O
of	O
endogenous	O
D3	B
mRNA	I
,	O
as	O
indicated	O
by	O
Northern	O
blot	O
analyses	O
,	O
and	O
was	O
significantly	O
reduced	O
when	O
the	O
promoter	O
was	O
truncated	O
to	O
-122	O
bp	O
.	O

Some	O
users	O
will	O
willingly	O
comply	O
with	O
management	O
measures	O
,	O
other	O
users	O
will	O
comply	O
in	O
response	O
to	O
education	O
,	O
but	O
there	O
will	O
be	O
another	O
group	O
who	O
will	O
only	O
respond	O
to	O
enforcement	O
activities	O
.	O

Collectively	O
,	O
these	O
data	O
indicate	O
that	O
HIP	B
is	O
a	O
membrane	O
-	O
associated	O
HP	B
-	I
binding	I
protein	I
expressed	O
on	O
the	O
surface	O
of	O
normal	O
human	O
uterine	O
epithelia	O
and	O
uterine	O
epithelial	O
cell	O
lines	O
.	O

The	O
corresponding	O
gene	O
was	O
identified	O
in	O
the	O
GenBankTM	O
data	O
base	O
by	O
sequence	O
alignment	O
and	O
termed	O
RPS30A	B
.	O

The	O
location	O
of	O
multiple	O
GRK2	B
and	O
GRK5	B
phosphoacceptor	I
sites	I
at	O
the	O
extreme	O
carboxyl	O
terminus	O
of	O
the	O
beta2AR	B
is	O
highly	O
reminiscent	O
of	O
GRK1-mediated	B
phosphorylation	O
of	O
rhodopsin	B
.	O

This	O
regulation	O
could	O
not	O
be	O
appreciably	O
modified	O
by	O
enhanced	O
expression	O
of	O
STAT	B
proteins	I
.	O

Receptors	O
for	O
interleukin	B
(	I
IL	I
)	I
-10	I
and	O
IL-6-type	B
cytokines	I
use	O
similar	O
signaling	O
mechanisms	O
for	O
inducing	O
transcription	O
through	O
IL-6	B
response	O
elements	O
.	O

This	O
phenomenon	O
did	O
not	O
require	O
DNA	O
binding	O
by	O
the	O
""""	O
interfering	O
""""	O
receptor	O
but	O
required	O
it	O
to	O
be	O
hormone	O
-	O
bound	O
,	O
indicating	O
that	O
a	O
transcriptionally	O
active	O
form	O
of	O
the	O
interfering	O
receptor	O
is	O
essential	O
for	O
the	O
interfering	O
effect	O
.	O

The	O
receptor	B
for	I
hyaluronan	I
mediated	I
motility	I
(	B
RHAMM	I
)	I
gene	I
expression	O
is	O
markedly	O
elevated	O
in	O
fibrosarcomas	O
exposed	O
to	O
transforming	B
growth	I
factor	I
-	I
beta1	I
(	O
TGF	B
-	I
beta1	I
)	O
.	O

The	O
promoter	O
of	O
the	O
rat	B
PGS-2	I
gene	I
contains	O
a	O
CAAT	B
enhancer	I
-	I
binding	I
protein	I
consensus	I
site	I
(	I
CAAT	I
box	I
)	I
which	O
can	O
confer	O
hormone	O
inducibility	O
to	O
a	O
PGS-2.CAT	B
reporter	O
gene	O
,	O
as	O
well	O
as	O
a	O
putative	O
E	O
-	O
box	O
region	O
.	O

Notably	O
,	O
SRF	B
has	O
been	O
found	O
to	O
be	O
a	O
key	O
regulator	O
of	O
members	O
of	O
a	O
class	O
of	O
cellular	O
response	O
genes	O
termed	O
immediate	B
-	I
early	I
genes	I
(	O
IEGs	B
)	O
,	O
many	O
of	O
which	O
are	O
believed	O
to	O
be	O
involved	O
in	O
regulating	O
cell	O
growth	O
and	O
differentiation	O
.	O

Clinical	O
evaluation	O
of	O
the	O
Allergan	O
Humphrey	O
500	O
autorefractor	O
and	O
the	O
Nidek	O
AR-1000	O
autorefractor	O
.	O

None	O
of	O
the	O
five	O
proprotein	O
processing	O
proteases	O
tested	O
were	O
capable	O
of	O
cleaving	O
human	B
pro	I
-	I
LPH	I
,	O
strongly	O
suggesting	O
that	O
they	O
are	O
not	O
involved	O
in	O
the	O
maturation	O
of	O
this	O
enzyme	O
.	O

Selective	O
translation	O
initiation	O
by	O
ribosome	O
jumping	O
in	O
adenovirus	O
-	O
infected	O
and	O
heat	O
-	O
shocked	O
cells	O
.	O

These	O
findings	O
suggest	O
that	O
direct	O
cDNA	O
mapping	O
using	O
fluorescence	O
in	O
situ	O
hybridization	O
provides	O
an	O
accurate	O
and	O
rapid	O
approach	O
to	O
the	O
definition	O
of	O
a	O
transcribed	O
map	O
of	O
the	O
human	O
genome	O
.	O

YAC	O
and	O
cosmid	O
contigs	O
spanning	O
the	O
Batten	B
disease	I
(	O
CLN3	B
)	O
region	O
at	O
16p12.1-p11.2	O
.	O

Isolation	O
of	O
a	O
near	O
full	O
-	O
length	O
cDNA	O
from	O
a	O
human	O
fetal	O
brain	O
cDNA	O
library	O
revealed	O
a	O
protein	B
serine	I
-	I
threonine	I
phosphatase	I
with	O
a	O
tetratricopeptide	O
motif	O
,	O
almost	O
identical	O
to	O
human	B
PPP5C	I
(	O
PP5	B
)	O
and	O
highly	O
homologous	O
to	O
rat	B
PPT	I
.	O

Ly-49	B
is	O
a	O
family	B
type	I
II	I
transmembrane	I
proteins	I
encoded	O
by	O
a	O
gene	O
cluster	O
on	O
murine	O
chromosome	O
6	O
.	O

The	O
Dox	B
-	I
A2	I
ORF	I
driven	O
by	O
the	O
TDH3	B
promoter	I
complemented	O
the	O
phenotype	O
of	O
a	O
strain	O
deleted	O
for	O
sun2	B
.	O

The	O
introduction	O
of	O
hARF4	B
to	O
the	O
cells	O
maintained	O
the	O
balance	O
between	O
cytosolic	O
and	O
membrane	O
-	O
associated	O
Sec7p	B
pools	O
.	O

Our	O
data	O
demonstrate	O
directly	O
that	O
Rpm1r	B
is	O
transcribed	O
with	O
its	O
substrates	O
,	O
tRNA	B
met	I
f	I
and	O
tRNAPro	B
,	O
from	O
a	O
promoter	O
located	O
upstream	O
of	O
the	O
tRNA	B
met	I
f	I
gene	I
and	O
suggest	O
that	O
a	O
portion	O
also	O
originates	O
from	O
a	O
second	O
promoter	O
,	O
located	O
between	O
the	O
tRNA	B
met	I
f	I
gene	I
and	O
RPM1	B
.	O

Furthermore	O
,	O
strains	O
with	O
mutant	B
RPM1	I
genes	I
also	O
accumulate	O
precursor	B
Rpm1r	I
,	O
suggesting	O
that	O
mutations	O
in	O
either	O
gene	O
can	O
lead	O
to	O
similar	O
biogenesis	O
defects	O
.	O

FTF	B
is	O
also	O
abundantly	O
expressed	O
in	O
the	O
pancreas	O
and	O
may	O
exert	O
differentiation	O
functions	O
in	O
endodermal	O
sublineages	O
,	O
similar	O
to	O
SF-1	B
in	O
steroidogenic	O
tissues	O
.	O

Stylohyoid	O
chain	O
ossification	O
:	O
choice	O
of	O
the	O
surgical	O
approach	O
.	O

Cluster	O
formation	O
of	O
E	B
-	I
cadherin	I
on	O
the	O
cell	O
surface	O
is	O
believed	O
to	O
be	O
of	O
major	O
importance	O
for	O
cell	O
-	O
cell	O
adhesion	O
.	O

DNA	B
polymerase	I
E	I
,	O
DNA	B
ligase	I
III	I
and	O
a	O
DNA	O
structure	O
-	O
specific	O
endonuclease	O
co	O
-	O
purify	O
with	O
the	O
five	O
polypeptide	O
complex	O
.	O

Interestingly	O
,	O
however	O
,	O
it	O
is	O
homologous	O
to	O
several	O
expressed	O
sequence	O
tags	O
(	O
EST	O
)	O
of	O
unknown	O
function	O
from	O
Caenorhabditis	O
elegans	O
,	O
Oryza	O
sativa	O
and	O
Homo	O
sapiens	O
.	O

Mean	O
increase	O
of	O
milk	O
protein	O
yield	O
was	O
46	O
g	O
/	O
d	O
with	O
Met	O
plus	O
Lys	O
,	O
and	O
mean	O
increase	O
of	O
true	O
protein	O
content	O
was	O
1.1	O
g	O
/	O
kg	O
of	O
milk	O
.	O

Each	O
half	O
molecule	O
contains	O
four	O
disulfide	O
linkages	O
and	O
four	O
cis	O
peptides	O
.	O

Only	O
fully	O
processed	O
Pra	B
(	O
N0	O
and	O
Nb	O
)	O
and	O
ICP35	B
(	O
ICP35	B
e	I
,	I
f	I
)	O
are	O
present	O
in	O
B	O
capsids	O
,	O
which	O
are	O
believed	O
to	O
be	O
precursors	O
of	O
mature	O
virions	O
.	O

A	O
chimeric	O
VP16-Tat	B
construct	O
containing	O
the	O
leucine	O
mutations	O
showed	O
no	O
increased	O
AP-1	B
responsiveness	O
in	O
comparison	O
with	O
that	O
of	O
the	O
VP16	B
activation	I
domain	I
alone	O
.	O

Here	O
,	O
the	O
cloning	O
and	O
characterization	O
of	O
S	B
-	I
RNase	I
genes	I
from	O
two	O
species	O
of	O
Rosaceae	O
,	O
apple	O
(	O
Malus	O
x	O
domestica	O
)	O
and	O
Japanese	O
pear	O
(	O
Pyrus	O
serotina	O
)	O
is	O
described	O
and	O
these	O
sequences	O
are	O
compared	O
with	O
those	O
of	O
other	O
T2-type	B
RNases	I
.	O

A	O
phylogenetic	O
tree	O
of	O
members	O
of	O
the	O
T2	B
/	I
S	I
-	I
RNase	I
superfamily	I
in	O
plants	O
was	O
obtained	O
.	O

In	O
a	O
Hoosier	O
Oncology	O
Group	O
randomized	O
study	O
involving	O
extensive	O
-	O
disease	O
SCLC	O
patients	O
,	O
VIP	O
was	O
superior	O
to	O
etoposide	O
/	O
cisplatin	O
with	O
regard	O
to	O
median	O
time	O
to	O
progression	O
(	O
6.6	O
v	O
5.8	O
months	O
)	O
,	O
median	O
survival	O
times	O
(	O
9.1	O
v	O
7.3	O
months	O
)	O
,	O
and	O
2-	O
and	O
3-year	O
survival	O
rates	O
(	O
13	O
%	O
v	O
5	O
%	O
and	O
5	O
%	O
v	O
0	O
%	O
,	O
respectively	O
)	O
.	O

It	O
was	O
shown	O
that	O
administration	O
of	O
immunomodulator	O
neurotropin	B
(	O
NSP	B
)	O
results	O
in	O
more	O
steady	O
consolidation	O
and	O
retention	O
of	O
feeding	O
and	O
avoidance	O
behavior	O
,	O
and	O
some	O
neurophysiological	O
mechanisms	O
of	O
that	O
phenomena	O
were	O
revealed	O
.	O

Atopic	O
allergy	O
and	O
other	O
hypersensitivities	O
.	O

Despite	O
significant	O
lethality	O
and	O
cardiovascular	O
dysfunction	O
,	O
in	O
the	O
septic	O
group	O
on	O
Days	O
1	O
and	O
2	O
,	O
septic	O
versus	O
control	O
animals	O
had	O
no	O
significant	O
differences	O
in	O
mean	O
metabolic	O
cart	O
measured	O
(	O
Vo2DIR	O
,	O
ml	O
/	O
kg	O
/	O
min	O
;	O
Day	O
1	O
:	O
11.9	O
versus	O
12.4	O
,	O
p	O
=	O
0.81	O
;	O
Day	O
2	O
:	O
14.2	O
versus	O
13.5	O
,	O
p	O
=	O
0.72	O
,	O
respectively	O
)	O
and	O
intravascular	O
catheter	O
calculated	O
(	O
Vo2INDIR	O
,	O
ml	O
/	O
kg	O
/	O
min	O
;	O
Day	O
1	O
:	O
11.2	O
versus	O
11.2	O
,	O
p	O
=	O
0.99	O
;	O
Day	O
2	O
:	O
12.8	O
versus	O
15.4	O
,	O
p	O
=	O
0.49	O
,	O
respectively	O
)	O
.	O

After	O
6	O
h	O
of	O
reperfusion	O
,	O
PO2	O
/	O
FlO2	O
ratio	O
was	O
significantly	O
better	O
after	O
Combined	O
Therapy	O
(	O
372	O
+	O
/-	O

52	O
mm	O
Hg	O
)	O

than	O
in	O
the	O
Recipient	O
Instilled	O
(	O
117	O
+	O
/-	O

47	O
mm	O
Hg	O
)	O
and	O
Control	O
groups	O
(	O
87	O
+	O
/-	O

26	O
mm	O
Hg	O
)	O
,	O
with	O
intermediate	O
values	O
in	O
Donor	O
Aerosol	O
dogs	O
(	O
232	O
+	O
/-	O

64	O
mm	O
Hg	O
)	O
.	O

The	O
euglobulin	B
clot	O
lysis	O
time	O
was	O
slightly	O
longer	O
in	O
the	O
smokers	O
than	O
in	O
the	O
non	O
-	O
smokers	O
in	O
all	O
three	O
experimental	O
situations	O
,	O
but	O
the	O
differences	O
were	O
not	O
significant	O
.	O

Although	O
the	O
DSK2	B
-	I
1	I
mutation	I
alters	O
a	O
conserved	O
residue	O
in	O
the	O
Dsk2p	B
ubiquitin	B
-	I
like	I
domain	I
,	O
we	O
detect	O
no	O
differences	O
in	O
Dsk2p	B
or	O
Cdc31p	B
stability	O
.	O

Although	O
IL-2	B
and	O
IFN	B
-	I
alpha	I
activated	O
STAT1	B
alpha	I
and	O
STAT5	B
,	O
IL-2	B
predominantly	O
activated	O
STAT5	B
,	O
while	O
IFN	B
-	I
alpha	I
predominantly	O
activated	O
STAT1	B
alpha	I
.	O

Consistent	O
with	O
this	O
interpretation	O
,	O
recombinant	B
CREB	I
and	O
activating	B
transcription	I
factor	I
proteins	I
bound	O
the	O
junB	B
CRE	O
-	O
like	O
site	O
,	O
but	O
did	O
not	O
interact	O
with	O
a	O
mutant	O
CRE	O
-	O
like	O
site	O
.	O

One	O
complex	O
containing	O
a	O
70	O
D	O
protein	O
was	O
found	O
to	O
be	O
associated	O
specifically	O
with	O
transcriptionally	O
active	O
leukemia	O
cells	O
.	O

Our	O
results	O
confirm	O
the	O
participation	O
of	O
intron	O
1	O
in	O
transcriptional	O
regulation	O
of	O
the	O
c	B
-	I
myb	I
gene	I
(	O
in	O
mouse	O
and	O
human	O
)	O
and	O
implicate	O
multiple	O
and	O
complex	O
regulatory	O
mechanisms	O
of	O
activation	O
during	O
myelomonocytic	O
differentiation	O
and	O
leukemic	O
cell	O
growth	O
control	O
.	O

OBJECTIVE	O
:	O
To	O
compare	O
pregnancy	O
complications	O
in	O
women	O
having	O
genetic	O
amniocentesis	O
at	O
11	O
-	O
14	O
weeks	O
versus	O
those	O
undergoing	O
amniocentesis	O
at	O
16	O
-	O
19	O
weeks	O
'	O
gestation	O
.	O

Two	O
new	O
flavone	O
glucosides	O
,	O
nevadensin	O
5-O	O
-	O
beta	O
-	O
D	O
-	O
glucoside	O
and	O
nevadensin	O
5-O	O
-	O
beta	O
-	O
D	O
-	O
glucosyl	O
(	O
1	O
-	O
->6	O
)	O
beta	O
-	O
D	O
-	O
glucoside	O
,	O
have	O
been	O
isolated	O
from	O
the	O
aerial	O
parts	O
of	O
Lysionotus	O
pauciflorus	O
.	O

Reproductive	O
period	O
affects	O
water	O
intake	O
in	O
heat	O
-	O
stressed	O
dehydrated	O
goats	O
.	O

METHODS	O
:	O
Rats	O
received	O
continuous	O
intragastric	O
infusion	O
of	O
elemental	O
diet	O
or	O
with	O
supplementation	O
of	O
oatbase	O
,	O
Lactobacillus	O
reuteri	O
R2LC	O
,	O
and	O
Lactobacillus	O
plantarum	O
DSM	O
9843	O
,	O
with	O
and	O
without	O
fermentation	O
,	O
from	O
the	O
beginning	O
of	O
the	O
study	O
.	O

By	O
using	O
a	O
DNA	O
sequence	O
selected	O
for	O
its	O
ability	O
to	O
bind	O
recombinant	B
BCL-6	I
in	O
vitro	O
,	O
we	O
show	O
here	O
that	O
BCL-6	B
is	O
present	O
in	O
DNA	O
-	O
binding	O
complexes	O
in	O
nuclear	O
extracts	O
from	O
various	O
B	O
-	O
cell	O
lines	O
.	O

The	O
predictive	O
value	O
of	O
a	O
positive	O
flag	O
was	O
77.7	O
%	O
.	O

CONCLUSIONS	O
:	O
Our	O
findings	O
suggest	O
that	O
pre	O
-	O
treatment	O
with	O
coenzyme	O
Q10	O
may	O
play	O
a	O
protective	O
role	O
during	O
routine	O
vascular	O
procedures	O
requiring	O
abdominal	O
aortic	O
cross	O
clamping	O
by	O
attenuating	O
the	O
degree	O
of	O
peroxidative	O
damage	O
.	O

Gap1	B
(	I
IP4BP	I
)	I
,	O
one	O
of	O
a	O
member	O
of	O
Ras	B
GTPase	I
-	I
activating	I
proteins	I
,	O
has	O
been	O
identified	O
as	O
a	O
specific	O
inositol	B
1,3,4,5-tetrakisphosphate	I
(	I
IP4	I
)	I
-binding	I
protein	I
(	O
Cullen	O
,	O
P.	O

We	O
previously	O
described	O
the	O
purification	O
of	O
an	O
83-kDa	B
phosphatidic	I
acid	I
phosphatase	I
(	O
PAP	B
)	O
from	O
the	O
porcine	O
thymus	O
membranes	O
(	O
Kanoh	O
,	O
H.	O
,	O
Imai	O
,	O
S	O
.-	O
i	O
.	O
,	O
Yamada	O
,	O
K.	O
and	O
Sakane	O
,	O
F.	O
(	O
1992	O
)	O
J.	O

The	O
mechanism	O
involves	O
Gbetagamma	B
subunit	O
-	O
mediated	O
increases	O
in	O
tyrosine	O
phosphorylation	O
of	O
the	O
Shc	B
adapter	I
protein	I
,	O
Shc*Grb2	B
complex	O
formation	O
,	O
and	O
recruitment	O
of	O
Ras	B
guanine	I
nucleotide	I
exchange	I
factor	I
activity	O
.	O

Next	O
,	O
we	O
stably	O
overexpressed	O
wild	B
-	I
type	I
Shc	I
or	O
Y317F	B
mutant	I
Shc	I
into	O
HIRc	O
cells	O
.	O

The	O
small	B
GTPase	I
Rho	B
is	O
implicated	O
in	O
physiological	O
functions	O
associated	O
with	O
actin	B
-	O
myosin	B
filaments	O
such	O
as	O
cytokinesis	O
,	O
cell	O
motility	O
,	O
and	O
smooth	O
muscle	O
contraction	O
.	O

Conversely	O
,	O
activation	O
of	O
this	O
signaling	O
pathway	O
by	O
expression	O
of	O
a	O
constitutively	O
active	O
MKK1	B
mutant	I
dramatically	O
increased	O
cyclin	B
D1	I
promoter	O
activity	O
and	O
cyclin	B
D1	I
protein	I
expression	O
,	O
in	O
a	O
growth	O
factor	O
-	O
independent	O
manner	O
.	O

Furthermore	O
,	O
upstream	O
insertion	O
of	O
the	O
GSTP1	B
silencer	I
element	I
failed	O
to	O
inhibit	O
activity	O
of	O
a	O
heterologous	O
promoter	O
in	O
MCF7	O
cells	O
.	O

An	O
expression	O
library	O
was	O
constructed	O
by	O
inserting	O
5	O
'	O
portion	O
-	O
enriched	O
cDNAs	O
from	O
phytohemagglutinin	B
-	O
stimulated	O
peripheral	O
blood	O
mononuclear	O
cells	O
into	O
upstream	O
of	O
signal	B
sequence	I
-	I
deleted	I
CD4	I
cDNA	I
in	O
an	O
Epstein	O
-	O
Barr	O
virus	O
shuttle	O
vector	O
.	O

The	O
cis	O
-	O
acting	O
elements	O
that	O
control	O
promoter	O
activity	O
include	O
binding	O
sites	O
for	O
transcription	O
factors	O
Sp1	B
and	O
alphaCbf	B
,	O
a	O
60-kDa	B
CCAAT	I
box	I
-	I
binding	I
protein	I
.	O

Collectively	O
,	O
our	O
findings	O
demonstrate	O
that	O
SF-1	B
plays	O
a	O
key	O
role	O
in	O
controlling	O
the	O
basal	O
and	O
cAMP	O
-	O
stimulated	O
expression	O
of	O
the	O
StAR	B
gene	I
.	O

Using	O
one	O
of	O
the	O
six	O
fragments	O
(	O
CPK3	B
-	I
8	I
)	O
,	O
we	O
isolated	O
a	O
2022	B
bp	I
cDNA	I
(	I
VrCDPK-1	I
)	I
from	O
a	O
Vigna	O
radiata	O
lambda	O
gt11	O
library	O
.	O

Workplace	O
violence	O
--	O
nurses	O
at	O
risk	O
.	O

RESULTS	O
:	O
The	O
LV	O
maximum	O
brightness	O
and	O
area	O
under	O
the	O
curve	O
showed	O
significant	O
negative	O
correlations	O
(	O
p	O
=	O
<	O
0.004	O
)	O
with	O
the	O
FIO2	O
,	O
while	O
the	O
minimum	O
brightness	O
showed	O
a	O
significant	O
positive	O
correlation	O
(	O
p	O
=	O
<	O
0.002	O
)	O
.	O

The	O
results	O
also	O
imply	O
that	O
the	O
absence	O
of	O
perforin	B
expression	O
in	O
non	O
-	O
cytotoxic	O
cells	O
may	O
be	O
due	O
to	O
the	O
suppression	O
of	O
the	O
induction	O
of	O
the	O
killer	O
-	O
cell	O
-	O
specific	O
trans	O
-	O
acting	O
factor	O
NF	B
-	I
P2	I
.	O

We	O
identify	O
considerable	O
spatio	O
-	O
temporal	O
similarities	O
between	O
reported	O
expression	O
patterns	O
of	O
Ypr10	B
genes	I
and	O
ribonuclease	O
genes	O
,	O
which	O
,	O
together	O
with	O
the	O
significant	O
sequence	O
similarity	O
to	O
the	O
ginseng	B
ribonuclease	I
,	O
support	O
the	O
hypothesis	O
of	O
a	O
ribonuclease	O
function	O
for	O
PR-10	B
proteins	I
and	O
allow	O
the	O
prediction	O
of	O
possible	O
biological	O
roles	O
.	O

The	O
expression	O
of	O
ERV3	B
env	I
mRNA	I
was	O
found	O
to	O
be	O
differentiation	O
-	O
associated	O
,	O
with	O
high	O
expression	O
detected	O
in	O
the	O
late	O
stages	O
of	O
monocytic	O
development	O
.	O

It	O
is	O
exclusively	O
observed	O
in	O
smooth	O
muscle	O
cells	O
by	O
Northern	O
blotting	O
and	O
immunohistochemical	O
analysis	O
and	O
therefore	O
designated	O
""""	B
smoothelin	I
.	I
""""	I

A	O
human	O
smooth	O
muscle	O
cDNA	O
library	O
was	O
screened	O
with	O
the	O
monoclonal	B
antibody	I
R4A	I
,	O
and	O
a	O
full	O
-	O
size	O
cDNA	O
of	O
the	O
protein	O
was	O
selected	O
.	O

Using	O
immunogold	O
electron	O
microscopy	O
,	O
we	O
found	O
that	O
p58	B
/	O
p45	B
and	O
p54	B
are	O
localized	O
on	O
both	O
sides	O
of	O
the	O
nuclear	O
pore	O
complex	O
,	O
like	O
p62	B
.	O

Transcription	O
initiation	O
sites	O
of	O
the	O
rat	O
II	B
beta-	I
,	I
III	I
beta	I
,	I
and	I
O	I
beta	I
-	I
globin	I
genes	O
were	O
determined	O
to	O
be	O
52	O
base	O
pairs	O
(	O
bp	O
)	O
5'-upstream	O
of	O
the	O
translation	O
initiation	O
codon	O
(	O
ATG	O
)	O
,	O
in	O
each	O
gene	O
by	O
primer	O
extension	O
analysis	O
.	O

Aggravating	O
process	O
induced	O
by	O
indomethacin	O
on	O
chronic	O
gastric	O
lesion	O
in	O
rat	O
.	O

Epstein	B
-	I
Barr	I
virus	I
nuclear	I
protein	I
2	I
(	O
EBNA2	B
)	O
binds	O
to	O
a	O
component	O
of	O
the	O
human	O
SNF	B
-	O
SWI	B
complex	O
,	O
hSNF5	B
/	O
Ini1	B
.	O

Our	O
studies	O
also	O
excluded	O
the	O
possibility	O
that	O
the	O
phosphorylation	O
of	O
Ser-2	O
,	O
Ser-123	O
,	O
or	O
Ser-210	O
,	O
had	O
roles	O
in	O
the	O
trans	O
-	O
suppression	O
activity	O
of	O
the	O
large	B
HDAg	I
,	O
in	O
the	O
assembly	O
of	O
empty	O
virus	B
-	I
like	I
HDAg	I
particle	I
,	O
and	O
in	O
the	O
nuclear	O
transport	O
of	O
HDAgs	B
.	O

Homologous	O
recombination	O
between	O
the	O
Autographa	O
californica	O
nuclear	O
polyhedrosis	O
virus	O
(	O
AcNPV	O
)	O
genome	O
and	O
a	O
0.6-kbp	O
-	O
long	O
DNA	O
fragment	O
derived	O
from	O
the	O
putative	O
DNA	B
helicase	I
gene	I
of	I
Bombyx	I
mori	I
nuclear	I
polyhedrosis	I
virus	I
generates	O
eh2-AcNPV	O
,	O
an	O
expanded	O
-	O
host	O
-	O
range	O
AcNPV	O
mutant	O
(	O
S.	O

The	O
data	O
further	O
indicate	O
that	O
the	O
IL-7R	B
alpha	I
chains	I
are	O
directly	O
involved	O
in	O
the	O
activation	O
of	O
JAKs	B
and	O
STATs	B
and	O
have	O
a	O
major	O
role	O
in	O
proliferative	O
signaling	O
in	O
precursor	O
B	O
cells	O
.	O

5	O
)	O
We	O
've	O
noticed	O
that	O
the	O
mean	O
value	O
of	O
the	O
cost	O
for	O
episode	O
of	O
pnx	O
s.	O
in	O
class	O
A	O
was	O
more	O
than	O
15	O
%	O
compared	O
to	O
class	O
B	O
and	O
the	O
cost	O
for	O
patient	O
in	O
class	O
A	O
was	O
nearly	O
double	O
than	O
in	O
class	O
B.	O

We	O
have	O
been	O
studying	O
the	O
interaction	O
of	O
the	O
oncogenic	O
human	O
polyomavirus	O
BK	O
(	O
BKV	O
)	O
with	O
the	O
tumor	B
-	I
suppressor	I
protein	I
p53	I
to	O
understand	O
the	O
biology	O
of	O
this	O
virus	O
as	O
well	O
as	O
to	O
understand	O
the	O
basic	O
mechanisms	O
of	O
p53	B
transactivation	O
.	O

Site	O
S	O
-	O
II	O
also	O
spans	O
a	O
23	O
bp	O
sequence	O
containing	O
two	O
tandem	O
consensus	O
binding	O
sites	O
with	O
three	O
base	O
pair	O
mismatches	O
in	O
each	O
and	O
a	O
one	O
base	O
pair	O
deletion	O
.	O

Treatment	O
is	O
instituted	O
with	O
prednisone	O
and	O
cyclophosphamide	O
.	O

Microcomputer	O
management	O
of	O
chronic	O
hepatitis	O
B	O
virus	O
asymptomatic	O
patients	O

The	O
standard	O
dosage	O
of	O
anti	B
-	I
D	I
currently	O
given	O
at	O
all	O
gestational	O
ages	O
is	O
1	O
ampoule	O
containing	O
125	O
micrograms	O
of	O
anti	B
-	I
D.	I

We	O
report	O
here	O
the	O
molecular	O
cloning	O
of	O
a	O
putative	O
adhesive	O
molecule	O
from	O
P.	O
falciparum	O
that	O
shares	O
both	O
sequence	O
and	O
structural	O
similarities	O
with	O
a	O
sporozoite	O
surface	O
molecule	O
from	O
Plasmodium	O
termed	O
the	O
thrombospondin	B
-	I
related	I
anonymous	I
protein	I
(	O
TRAP	B
)	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
with	O
the	O
circumsporozoite	B
(	I
CS	I
)	I
protein	I
.	O

There	O
are	O
no	O
introns	O
within	O
the	O
gene	O
,	O
which	O
contains	O
a	O
9360-bp	O
open	O
reading	O
frame	O
and	O
encodes	O
a	O
377-kDa	O
protein	O
.	O

CONCLUSION	O
:	O
The	O
results	O
demonstrate	O
that	O
at	O
the	O
site	O
of	O
lumbar	O
disc	O
herniation	O
,	O
inflammatory	O
cytokines	O
such	O
as	O
interleukin-1	B
alpha	I
are	O
produced	O
,	O
which	O
increases	O
prostaglandin	O
E2	O
production	O
.	O

Our	O
results	O
demonstrate	O
that	O
distinct	O
cytoplasmic	O
domains	O
of	O
these	O
cytokine	O
receptors	O
elicit	O
convergent	O
signaling	O
pathways	O
and	O
provide	O
evidence	O
that	O
beta	B
c	I
and	O
IL-2R	B
beta	I
function	O
as	O
a	O
complete	O
signal	O
transducer	O
.	O

U24	B
has	O
two	O
separate	O
12	O
nt	O
long	O
complementarities	O
to	O
a	O
highly	O
conserved	O
tract	O
of	O
28S	B
rRNA	I
.	O

Possible	O
relationship	O
between	O
hyperinsulinemia	O
and	O
glomerular	O
hypertrophy	O
in	O
nephrosclerosis	O
.	O

Blood	O
GSH	B
-	I
Px	I
activity	O
was	O
measured	O
with	O
a	O
spectrophotometer	O
,	O
using	O
a	O
modification	O
of	O
a	O
previously	O
described	O
assay	O
.	O

The	O
concentrations	O
of	O
vitamin	O
A	O
precursors	O
and	O
vitamin	O
E	O
in	O
the	O
hay	O
were	O
below	O
currently	O
recommended	O
dietary	O
levels	O
for	O
llamas	O
,	O
and	O
alfalfa	O
hay	O
appears	O
to	O
provide	O
an	O
unreliable	O
source	O
of	O
vitamins	O
A	O
and	O
E	O
in	O
this	O
species	O
.	O

Eight	O
cats	O
infected	O
with	O
H.	O
pylori	O
were	O
used	O
in	O
the	O
study	O
.	O

However	O
,	O
as	O
determined	O
by	O
PCR	O
with	O
primers	O
specific	O
for	O
the	O
26-kDa	O
product	O
,	O
the	O
majority	O
of	O
cats	O
at	O
2	O
and	O
4	O
weeks	O
p.t	O
.	O
had	O
gastric	O
fluid	O
samples	O
which	O
were	O
positive	O
for	O
H.	O
pylori	O
and	O
three	O
of	O
three	O
cats	O
at	O
2	O
weeks	O
p.t	O
.	O
had	O
dental	O
plaque	O
which	O
was	O
positive	O
for	O
H.	O
pylori	O
.	O

STUDY	O
DESIGN	O
.	O

Differential	O
activation	O
of	O
the	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
,	O
Jun	B
kinase	I
and	O
Janus	B
kinase	I
-	O
Stat	B
pathways	O
by	O
oncostatin	B
M	I
and	O
basic	B
fibroblast	I
growth	I
factor	I
in	O
AIDS	O
-	O
derived	O
Kaposi	O
's	O
sarcoma	O
cells	O
.	O

Ten	O
weeks	O
after	O
reconstruction	O
,	O
the	O
regenerating	O
nerves	O
already	O
resembled	O
normal	O
nerves	O
.	O

The	O
distribution	O
and	O
organization	O
of	O
projections	O
from	O
the	O
spinal	O
cervical	O
enlargement	O
to	O
subnucleus	O
reticularis	O
dorsalis	O
(	O
SRD	O
)	O
and	O
the	O
neighbouring	O
Cuneate	O
nucleus	O
(	O
Cu	O
)	O
area	O
was	O
studied	O
in	O
the	O
rat	O
by	O
using	O
microinjections	O
of	O
Phaseolus	B
vulgaris	I
leucoagglutinin	I
(	O
PHA	B
-	I
L	I
)	O
into	O
different	O
laminae	O
around	O
the	O
C7	O
level	O
.	O

The	O
levels	O
of	O
fibrinogen	B
as	O
well	O
as	O
antithrombin	B
III	I
(	O
ATIII	B
)	O
and	O
heparin	B
cofactor	I
II	I
(	O
HCII	B
)	O
activities	O
were	O
steadily	O
increased	O
in	O
loop	O
-	O
bearing	O
animals	O
.	O

Facioscapulohumeral	O
muscular	O
dystrophy	O
(	O
FSHD	O
)	O
is	O
an	O
autosomal	O
dominant	O
,	O
neuromuscular	O
disorder	O
characterized	O
by	O
progressive	O
weakness	O
of	O
muscles	O
in	O
the	O
face	O
,	O
shoulder	O
and	O
upper	O
arm	O
.	O

Patients	O
who	O
have	O
undergone	O
thyroidectomy	O
for	O
thyroid	O
carcinoma	O
are	O
frequently	O
subjected	O
to	O
periods	O
of	O
induced	O
severe	O
hypothyroidism	O
in	O
preparation	O
for	O
131I	O
whole	O
body	O
scanning	O
and	O
measurement	O
of	O
serum	O
TG	B
.	O

Full	O
thyroid	O
function	O
testing	O
was	O
performed	O
on	O
600	O
randomly	O
selected	O
samples	O
with	O
normal	O
TSH	B
values	O
and	O
also	O
on	O
subjects	O
with	O
abnormal	O
TSH	B
levels	O
.	O

In	O
a	O
third	O
experiment	O
,	O
crossover	O
AM	O
between	O
dissimilar	O
textures	O
was	O
investigated	O
,	O
and	O
it	O
was	O
found	O
that	O
the	O
more	O
salient	O
textures	O
carried	O
the	O
AM	O
.	O

Catha	O
edulis	O
,	O
a	O
plant	O
that	O
has	O
amphetamine	O
effects	O
.	O

The	O
predicted	O
protein	O
,	O
Seb1p	B
,	O
consists	O
of	O
82	O
amino	O
acids	O
and	O
contains	O
one	O
potential	O
membrane	O
-	O
spanning	O
region	O
at	O
the	O
C	O
-	O
terminus	O
but	O
no	O
N	O
-	O
terminal	O
signal	O
sequence	O
.	O

Nonetheless	O
,	O
that	O
ventricular	O
afferents	O
,	O
in	O
certain	O
special	O
settings	O
,	O
are	O
able	O
to	O
induce	O
e.g.	O
generalised	O
vasodilation	O
and	O
hypotension	O
can	O
not	O
be	O
excluded	O
.	O

Fragments	O
and	O
analogs	O
of	O
the	O
hormone	O
ACTH	B
were	O
previously	O
shown	O
to	O
have	O
beneficial	O
effect	O
on	O
the	O
outcome	O
of	O
head	O
injury	O
,	O
while	O
elevated	O
levels	O
of	O
corticosterone	O
(	O
CS	O
)	O
exacerbate	O
it	O
.	O

Study	O
groups	O
were	O
control	O
,	O
and	O
those	O
treated	O
with	O
the	O
alpha1-adrenoceptor	B
-	I
subtype	I
blockers	O
WB4101	O
(	O
0.5	O
mg	O
/	O
kg	O
i.v	O
.	O
)	O
or	O
chloroethylclonidine	O
(	O
1.9	O
mg	O
/	O
kg	O
i.v	O
.	O
)	O
.	O

The	O
occurrence	O
of	O
multiple	O
malignancy	O
was	O
studied	O
in	O
674	O
patients	O
with	O
hematologic	O
malignancies	O
who	O
were	O
admitted	O
to	O
this	O
department	O
during	O
the	O
past	O
10	O
years	O
.	O

Transcriptional	O
control	O
of	O
a	O
nuclear	O
gene	O
encoding	O
a	O
mitochondrial	O
fatty	O
acid	O
oxidation	O
enzyme	O
in	O
transgenic	O
mice	O
:	O
role	O
for	O
nuclear	O
receptors	O
in	O
cardiac	O
and	O
brown	O
adipose	O
expression	O
.	O

Hoeben	O
,	O
F.J.	O

Twelve	O
genomic	O
fragments	O
containing	O
novel	O
response	O
elements	O
are	O
described	O
,	O
and	O
the	O
transcription	O
unit	O
associated	O
with	O
one	O
of	O
them	O
,	O
NN-84AG	B
,	O
was	O
characterized	O
in	O
detail	O
.	O

Biol	O
.	O

Alterations	O
of	O
the	O
5q23-q31	O
interval	O
are	O
frequently	O
observed	O
in	O
myelodysplasia	O
and	O
myeloid	O
leukemia	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
the	O
616	O
amino	O
acid	O
,	O
70-kDa	B
subunit	I
of	I
RPA	I
(	O
RPA	B
70	I
)	O
is	O
composed	O
of	O
multiple	O
structural	O
/	O
functional	O
domains	O
.	O

Neurons	O
were	O
held	O
at	O
-67	O
mV	O
to	O
equate	O
voltage	O
-	O
dependent	O
effects	O
.	O

This	O
site	O
acts	O
as	O
a	O
negative	O
element	O
when	O
transferred	O
to	O
the	O
thymidine	B
kinase	I
promoter	I
,	O
but	O
does	O
not	O
confer	O
inducibility	O
.	O

Our	O
results	O
support	O
a	O
model	O
where	O
both	O
E2F-	B
and	O
CDE	O
-	O
mediated	O
repression	O
,	O
acting	O
at	O
different	O
stages	O
in	O
the	O
cell	O
cycle	O
,	O
are	O
dependent	O
on	O
promoter	O
-	O
specific	O
CHR	O
elements	O
.	O

Comparison	O
of	O
the	O
deduced	O
amino	O
acid	O
sequences	O
with	O
protein	O
sequences	O
of	O
T.	O
pyriformis	O
H2As	B
showed	O
only	O
two	O
and	O
three	O
differences	O
respectively	O
,	O
in	O
a	O
total	O
of	O
137	O
amino	O
acids	O
for	O
H2A1	B
,	O
and	O
132	O
amino	O
acids	O
for	O
H2A2	B
,	O
indicating	O
the	O
two	O
genes	O
arose	O
before	O
the	O
divergence	O
of	O
these	O
two	O
species	O
.	O

Cognitive	O
visual	O
dysfunction	O
in	O
a	O
child	O
with	O
cerebral	O
damage	O
.	O

Interaction	O
was	O
apparently	O
determined	O
by	O
the	O
N	O
-	O
terminal	O
splice	O
region	O
of	O
RPDE-6	B
,	O
as	O
the	O
PDE4A	B
splice	O
variant	O
RPDE-39	B
,	O
which	O
differs	O
from	O
RPDE-6	B
at	O
the	O
extreme	O
N	O
-	O
terminus	O
,	O
failed	O
to	O
associate	O
with	O
v	B
-	I
Src	I
-	O
SH3	B
;	O
met26RD1	B
(	O
where	O
RD1	B
is	O
rat	B
'	I
dunc	I
-	I
like	I
'	I
PDE	I
)	O
,	O
which	O
has	O
the	O
N	O
-	O
terminal	O
splice	O
region	O
deleted	O
,	O
failed	O
to	O
associate	O
with	O
v	B
-	I
Src	I
-	O
SH3	B
,	O
and	O
the	O
association	O
of	O
RPDE-6	B
and	O
v	B
-	I
Src	I
-	O
SH3	B
was	O
blocked	O
by	O
a	O
fusion	O
protein	O
formed	O
from	O
the	O
N	O
-	O
terminal	O
splice	O
region	O
.	O

Large	O
strain	O
differences	O
were	O
found	O
for	O
all	O
variables	O
recorded	O
,	O
i.e.	O
,	O
the	O
proportion	O
of	O
attacking	O
males	O
,	O
the	O
time	O
spent	O
in	O
the	O
brightly	O
lit	O
box	O
,	O
and	O
the	O
number	O
of	O
transitions	O
between	O
the	O
lit	O
and	O
the	O
dark	O
boxes	O
.	O

It	O
is	O
the	O
oxidation	O
peak	O
of	O
this	O
product	O
,	O
arising	O
in	O
acidic	O
media	O
at	O
0.42	O
V	O
,	O
which	O
was	O
analysed	O
using	O
DPV	O
,	O
again	O
following	O
the	O
accumulation	O
of	O
clenbuterol	O
at	O
the	O
Nafion	O
-	O
modified	O
CPE	O
.	O

Phenylephrine	O
is	O
a	O
pure	O
alpha-1	B
adrenoreceptor	I
agonist	O
known	O
to	O
produce	O
marked	O
systemic	O
vasoconstriction	O
and	O
associated	O
hypertension	O
with	O
occasional	O
profound	O
reflex	O
bradycardia	O
.	O

The	O
expression	O
of	O
the	O
first	O
two	O
genes	O
located	O
in	O
this	O
unit	O
(	O
c	B
-	I
gvpD	I
and	O
c	B
-	I
gvpE	I
)	O
was	O
also	O
monitored	O
by	O
Western	O
blot	O
(	O
immunoblot	O
)	O
analyses	O
using	O
antisera	O
raised	O
against	O
these	O
proteins	O
synthesized	O
in	O
Escherichia	O
coli	O
.	O

CASE	O
REPORT	O
:	O
Referred	O
because	O
of	O
a	O
right	O
corneal	O
perforation	O
with	O
cellular	O
reaction	O
in	O
anterior	O
chamber	O
,	O
a	O
patient	O
was	O
sutured	O
and	O
treated	O
with	O
a	O
single	O
intravitreal	O
injection	O
of	O
0.2	O
ml	O
(	O
1	O
mg	O
)	O
Amikacin	O
and	O
0.2	O
ml	O
(	O
1	O
mg	O
)	O
Vancomycin	O
.	O

The	O
P	B
-	I
wr	I
and	O
P	B
-	I
rr	I
cDNA	I
sequences	I
are	O
very	O
similar	O
in	O
their	O
5	O
'	O
regions	O
.	O

The	O
structure	O
of	O
these	O
genes	O
suggests	O
a	O
common	O
ancestor	O
for	O
all	O
viperid	B
PLA2	I
genes	I
.	O

Increased	O
PTHRP	B
production	O
by	O
a	O
tyrosine	B
kinase	I
oncogene	I
,	O
Tpr	B
-	I
Met	I
:	O
role	O
of	O
the	O
Ras	B
signaling	O
pathway	O
.	O

All	O
patients	O
had	O
abnormal	O
von	B
Willebrand	I
factor	I
(	O
vWF	B
)	O
fragmentation	O
as	O
reflected	O
by	O
decreased	O
high	O
molecular	O
weight	O
and	O
increased	O
low	O
molecular	O
weight	O
vWF	B
multimers	I
in	O
the	O
circulation	O
.	O

In	O
an	O
attempt	O
to	O
investigate	O
whether	O
the	O
intergenic	O
region	O
between	O
the	O
oleosin	B
and	O
a	O
second	O
open	O
reading	O
frame	O
(	O
ORFII	O
)	O
in	O
Brassica	O
napus	O
(	O
L.	O
)	O
is	O
a	O
divergent	O
promoter	O
,	O
and	O
also	O
to	O
characterize	O
the	O
ORFII	B
,	O
cDNA	B
clones	I
homologous	I
to	I
ORFII	I
were	O
isolated	O
from	O
a	O
leaf	O
cDNA	O
library	O
.	O

The	O
ORFII	B
gene	I
product	I
is	O
targeted	O
to	O
the	O
chloroplast	O
,	O
which	O
is	O
consistent	O
with	O
previous	O
data	O
indicating	O
the	O
presence	O
of	O
PMSR	B
activity	O
in	O
the	O
chloroplast	O
.	O

The	O
patients	O
are	O
two	O
healthy	O
adult	O
males	O
.	O

Indoor	O
concentrations	O
were	O
only	O
weakly	O
correlated	O
with	O
outdoor	O
concentrations	O
,	O
however	O
,	O
and	O
personal	O
exposures	O
were	O
even	O
more	O
poorly	O
correlated	O
with	O
outdoor	O
concentrations	O
.	O

The	O
5	O
'	O
flanking	O
region	O
of	O
the	O
mouse	B
Met	I
-	I
ase-1	I
gene	I
also	O
shares	O
considerable	O
regions	O
of	O
identity	O
with	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
rat	B
Met	I
-	I
ase-1	I
gene	I
.	O

The	O
[	O
18F	O
]	O
FMISO	O
TMRR	O
is	O
a	O
simple	O
and	O
clinically	O
useful	O
index	O
for	O
detecting	O
tumour	O
hypoxia	O
in	O
NPC	O
.	O

Improved	O
methods	O
have	O
been	O
developed	O
for	O
maintaining	O
and	O
breeding	O
the	O
neotropical	O
short	O
-	O
tailed	O
fruit	O
bat	O
,	O
Carollia	O
perspicillata	O
,	O
in	O
an	O
easily	O
-	O
reproduced	O
,	O
laboratory	O
setting	O
.	O

In	O
addition	O
,	O
the	O
time	O
to	O
engraftment	O
was	O
significantly	O
shorter	O
in	O
the	O
amifostine	O
arm	O
in	O
both	O
cohorts	O
.	O

Also	O
like	O
the	O
thrombin	B
receptor	I
,	O
PAR2	B
can	O
be	O
activated	O
by	O
the	O
hexapeptide	O
corresponding	O
to	O
its	O
tethered	O
ligand	O
sequence	O
independent	O
of	O
receptor	O
cleavage	O
.	O

Using	O
fluorescence	O
in	O
situ	O
hybridization	O
,	O
we	O
mapped	O
the	O
chromosome-17	O
breakpoint	O
in	O
a	O
patient	O
with	O
acampomelic	O
CMPD	O
and	O
sex	O
reversal	O
,	O
who	O
carries	O
a	O
de	O
novo	O
constitutional	O
t	O
(	O
12;17	O
)	O
translocation	O
,	O
between	O
two	O
known	O
cosmid	O
markers	O
in	O
the	O
17q24-q25	O
region	O
.	O

This	O
is	O
concluded	O
from	O
the	O
isolation	O
of	O
cDNAs	O
from	O
spinach	O
(	O
Spinacia	O
oleracea	O
)	O
and	O
barley	O
(	O
Hordeum	O
vulgare	O
cv	O
.	O

The	O
data	O
presented	O
in	O
this	O
work	O
indicate	O
that	O
thi1	B
may	O
also	O
be	O
involved	O
in	O
DNA	O
damage	O
tolerance	O
in	O
plant	O
cells	O
.	O

DESIGN	O
:	O
A	O
cross	O
-	O
sectional	O
study	O
.	O

In	O
the	O
SPK	O
and	O
PTA	O
category	O
,	O
anti	O
-	O
T	O
-	O
cell	O
therapy	O
significantly	O
lowered	O
the	O
risk	O
of	O
graft	O
loss	O
.	O

A	O
transgenic	O
complementation	O
assay	O
was	O
used	O
to	O
test	O
whether	O
NIa	B
supplied	O
in	O
trans	O
could	O
rescue	O
amplification	O
-	O
defective	O
viral	O
genomes	O
encoding	O
altered	O
NIa	B
proteins	I
.	O

The	O
rCBF	O
and	O
vasomotion	O
were	O
recorded	O
by	O
laser	O
-	O
doppler	O
fluxmetry	O
.	O

The	O
triple	O
combination	O
of	O
nizatidine	O
,	O
clarithromycin	O
,	O
and	O
bismuth	O
subcitrate	O
resulted	O
in	O
an	O
ulcer	O
healing	O
rate	O
of	O
98	O
%	O
and	O
an	O
H.	O
pylori	O
eradication	O
rate	O
of	O
90	O
%	O
.	O

Serine	O
528	O
is	O
phosphorylated	O
in	O
vivo	O
in	O
several	O
cell	O
lines	O
,	O
and	O
substitution	O
of	O
serine	O
528	O
to	O
alanine	O
(	O
S528A	O
)	O
resulted	O
in	O
an	O
increased	O
ability	O
of	O
Myb	B
to	O
transactivate	O
a	O
synthetic	O
promoter	O
containing	O
five	O
copies	O
of	O
the	O
mim-1A	B
Myb	B
-	O
responsive	O
element	O
and	O
a	O
minimal	O
herpes	B
tk	I
promoter	I
.	O

The	O
DNA	O
binding	O
and	O
multimerization	O
activities	O
of	O
c	B
-	I
Myb	I
appear	O
to	O
be	O
unaffected	O
by	O
the	O
S528A	O
substitution	O
,	O
suggesting	O
that	O
phosphorylation	O
of	O
serine	O
528	O
may	O
mediate	O
its	O
effect	O
on	O
the	O
transcription	O
transactivating	O
activity	O
of	O
c	B
-	I
Myb	I
by	O
regulating	O
interactions	O
with	O
other	O
proteins	O
.	O

The	O
amount	O
of	O
these	O
factors	O
was	O
reduced	O
in	O
GEO	O
cells	O
in	O
which	O
the	O
u	B
-	I
PAR	I
gene	I
is	O
only	O
weakly	O
transcriptionally	O
activated	O
.	O

Biol	O
.	O

Cys-757	O
within	O
the	O
(	O
Fe4S4	O
)	O
-siroheme	O
-	O
binding	O
domain	O
was	O
essential	O
for	O
native	O
enzyme	O
activity	O
.	O

Altogether	O
,	O
our	O
results	O
indicate	O
that	O
the	O
transcriptional	O
activity	O
of	O
Cut	B
proteins	I
is	O
modulated	O
by	O
PKC	B
.	O

Furthermore	O
,	O
freezing	O
in	O
the	O
presence	O
of	O
bovine	B
lactalbumin	I
resulted	O
in	O
a	O
good	O
maintenance	O
of	O
the	O
cellular	O
viability	O
and	O
of	O
the	O
CCCD	O
heterogeneity	O
in	O
respect	O
to	O
fresh	O
cells	O
.	O

Five	O
-	O
year	O
survivals	O
amounted	O
to	O
100	O
%	O
,	O
86.2	O
%	O
,	O
59.4	O
%	O
,	O
29.8	O
%	O
,	O
and	O
20	O
%	O
for	O
stages	O
I	O
,	O
II	O
,	O
III	O
,	O
IVA	O
and	O
IVB	O
respectively	O
.	O

Targeted	O
disruption	O
of	O
the	O
OGG1	B
gene	I
in	O
yeast	O
revealed	O
a	O
second	O
OG	B
glycosylase	I
/	I
lyase	I
protein	I
,	O
tentatively	O
named	O
Ogg2	B
,	O
which	O
differs	O
from	O
Ogg1	B
in	O
that	O
it	O
preferentially	O
acts	O
on	O
OG	O
:	O
G.	O

Sequence	O
analysis	O
of	O
the	O
isolated	O
genomic	O
clone	O
revealed	O
that	O
the	O
DNA	O
binding	O
domain	O
of	O
this	O
orphan	O
receptor	O
is	O
most	O
homologous	O
to	O
the	O
human	B
TR2	I
receptor	I
.	O

Genomic	O
DNA	O
hybridization	O
suggests	O
that	O
SpSHR2	B
is	O
a	O
single	O
-	O
copy	O
gene	O
in	O
the	O
S.	O
purpuratus	O
genome	O
.	O

A	O
3-yr	O
retrospective	O
review	O
is	O
effective	O
and	O
detects	O
94	O
%	O
of	O
the	O
undercalls	O
.	O

Isolation	O
and	O
identification	O
of	O
genes	O
activating	O
UAS2-dependent	B
ADH2	I
expression	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

Patients	O
with	O
low	O
probability	O
of	O
having	O
aluminum	O
overload	O
(	O
serum	O
iron	O
levels	O
<	O
40	O
micrograms	O
/	O
L	O
and	O
DAI	O
<	O
150	O
micrograms	O
/	O
L	O
)	O
had	O
significantly	O
higher	O
values	O
of	O
serum	O
iron	O
,	O
iron	O
transferrin	B
saturation	O
,	O
and	O
serum	B
ferritin	I
levels	O
compared	O
with	O
those	O
patients	O
with	O
a	O
high	O
probability	O
of	O
having	O
aluminum	O
overload	O
(	O
serum	O
aluminum	O
levels	O
>	O
40	O
micrograms	O
/	O
L	O
and	O
DAI	O
>	O
150	O
micrograms	O
/	O
L	O
)	O
.	O

Ha	B
-	I
RasV12	I
and	O
activated	O
proteins	O
in	O
both	O
the	O
extra	B
-	I
cellular	I
regulated	I
kinase	I
(	O
ERK	B
)	O
and	O
the	O
stress	B
-	I
activated	I
protein	I
kinase	I
(	O
SAPK	B
)	O
or	O
Jun	B
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
)	O
cascades	O
independently	O
stimulated	O
PEA3-mediated	B
gene	O
expression	O
.	O

Sequence	O
analysis	O
of	O
reverse	O
transcribed	O
,	O
amplified	O
cDNA	O
generated	O
from	O
total	O
RNA	O
isolated	O
from	O
transfected	O
cells	O
demonstrated	O
the	O
presence	O
of	O
abnormally	O
spliced	O
products	O
containing	O
13	O
and	O
78	O
additional	O
bases	O
as	O
well	O
as	O
the	O
accumulation	O
of	O
unspliced	O
mRNA	O
.	O

A	O
1.5-kb	O
HindIII	B
genomic	O
fragment	O
carrying	O
the	O
vspA	B
gene	O
from	O
M.	O
bovis	O
PG45	O
was	O
cloned	O
and	O
sequenced	O
.	O

A	O
subsequent	O
screen	O
for	O
the	O
loss	O
of	O
the	O
positively	O
selectable	O
target	O
locus	O
marker	O
detects	O
the	O
desired	O
replacement	O
at	O
modest	O
frequency	O
(	O
>	O
2	O
%	O
)	O
.	O

The	O
effects	O
of	O
procedural	O
variations	O
on	O
lateralized	O
Stroop	O
effects	O
.	O

In	O
a	O
third	O
experiment	O
,	O
a	O
Chessmaster	O
gradually	O
increases	O
the	O
number	O
of	O
boards	O
he	O
can	O
reproduce	O
with	O
higher	O
than	O
70	O
%	O
average	O
accuracy	O
to	O
nine	O
,	O
replacing	O
as	O
many	O
as	O
160	O
pieces	O
correctly	O
.	O

PCNA	B
mRNA	I
has	O
a	O
3'UTR	O
antisense	O
to	O
yellow	O
crescent	O
RNA	O
and	O
is	O
localized	O
in	O
ascidian	O
eggs	O
and	O
embryos	O
.	O

A	O
1.8-kb	O
cDNA	O
clone	O
(	O
designed	O
hKID	B
,	O
gene	B
symbol	I
AQP2L	I
)	O
with	O
homology	O
to	O
the	O
aquaporins	B
was	O
isolated	O
from	O
a	O
human	O
kidney	O
cDNA	O
library	O
.	O

PCR	O
/	O
Southern	O
blot	O
analysis	O
of	O
human	O
kidney	O
cDNA	O
using	O
primers	O
flanking	O
the	O
hKID	B
coding	I
sequence	I
revealed	O
expression	O
of	O
a	O
full	O
-	O
length	O
mRNA	O
and	O
short	O
transcripts	O
with	O
partial	O
exon	O
1	O
and	O
partial	O
exon	O
4	O
deletions	O
.	O

The	O
high	O
sequence	O
homology	O
,	O
similar	O
genomic	O
structure	O
,	O
and	O
identical	O
chromosomal	O
loci	O
of	O
hKID	B
,	O
MIP	B
,	O
and	O
AQP-2	B
suggest	O
a	O
MIP	B
family	I
gene	I
cluster	I
at	O
chromosome	O
locus	O
12q13	O
.	O

The	O
importance	O
of	O
temporal	O
factors	O
on	O
the	O
presence	O
and	O
severity	O
of	O
ethanol	O
withdrawal	O
signs	O
in	O
the	O
rat	O
was	O
quantified	O
using	O
rating	O
scale	O
,	O
tremor	O
,	O
and	O
acoustic	O
startle	O
paradigms	O
.	O

Thus	O
,	O
the	O
multidomained	O
ROK	B
alpha	I
appears	O
to	O
be	O
involved	O
in	O
reorganization	O
of	O
the	O
cytoskeleton	O
,	O
with	O
the	O
N	O
and	O
C	O
termini	O
acting	O
as	O
positive	O
and	O
negative	O
regulators	O
,	O
respectively	O
,	O
of	O
the	O
kinase	O
domain	O
whose	O
activity	O
is	O
crucial	O
for	O
formation	O
of	O
stress	O
fibers	O
and	O
focal	O
adhesion	O
complexes	O
.	O

These	O
findings	O
and	O
the	O
differential	O
tissue	O
distribution	O
of	O
p54	B
suggest	O
that	O
this	O
novel	O
SR	B
protein	I
may	O
participate	O
in	O
regulation	O
of	O
alternative	O
splicing	O
in	O
a	O
tissue-	O
and	O
substrate	O
-	O
dependent	O
manner	O
.	O

An	O
interaction	O
screen	O
with	O
the	O
repression	O
domain	O
of	O
the	O
orphan	B
receptor	I
RevErb	I
identified	O
N	B
-	I
CoR	I
,	O
the	O
corepressor	O
for	O
thyroid	B
hormone	I
receptor	I
(	O
TR	B
)	O
and	O
retinoic	B
acid	I
receptor	I
(	O
RAR	B
)	O
.	O

Our	O
analysis	O
suggests	O
that	O
Upf1p	B
is	O
a	O
multifunctional	O
protein	O
with	O
separable	O
activities	O
that	O
can	O
affect	O
mRNA	O
turnover	O
and	O
nonsense	O
suppression	O
.	O

Identification	O
of	O
Ste4	B
as	O
a	O
potential	O
regulator	O
of	O
Byr2	B
in	O
the	O
sexual	O
response	O
pathway	O
of	O
Schizosaccharomyces	O
pombe	O
.	O

Platelet	B
-	I
derived	I
growth	I
factor	I
-	O
dependent	O
activation	O
of	O
phosphatidylinositol	B
3-kinase	I
is	O
regulated	O
by	O
receptor	O
binding	O
of	O
SH2-domain	B
-	I
containing	I
proteins	I
which	O
influence	O
Ras	B
activity	O
.	O

In	O
transient	O
cotransfections	O
E1A	B
could	O
induce	O
the	O
activity	O
of	O
the	O
p53	B
promoter	I
to	O
a	O
high	O
level	O
;	O
12S	B
E1A	I
was	O
threefold	O
as	O
efficient	O
as	O
13S	B
E1A	I
in	O
this	O
activity	O
,	O
and	O
YY1	B
bound	O
to	O
the	O
composite	O
element	O
was	O
shown	O
to	O
mediate	O
55	O
%	O
of	O
this	O
induction	O
.	O

DNA	B
-	I
dependent	I
protein	I
kinase	I
(	O
DNA	B
-	I
PK	I
)	O
consists	O
of	O
a	O
heterodimeric	O
protein	O
(	O
Ku	B
)	O
and	O
a	O
large	O
catalytic	O
subunit	O
(	O
DNA	B
-	I
PKcs	I
)	O
.	O

However	O
,	O
in	O
a	O
multivariate	O
analysis	O
considering	O
age	O
,	O
gender	O
,	O
and	O
a	O
previous	O
history	O
of	O
cardiovascular	O
diseases	O
,	O
female	O
gender	O
was	O
not	O
independently	O
associated	O
with	O
death	O
.	O

Despite	O
the	O
presence	O
of	O
one	O
additional	O
ribonucleotide	B
reductase	I
,	O
the	O
nrdAB	B
-	I
encoded	I
enzyme	I
is	O
essential	O
to	O
the	O
aerobic	O
growth	O
of	O
the	O
cell	O
because	O
nrdAB	B
-	I
defective	I
mutants	I
of	O
both	O
species	O
are	O
not	O
viable	O
in	O
the	O
presence	O
of	O
oxygen	O
.	O

Motivational	O
factors	O
focusing	O
on	O
attitudes	O
,	O
perceived	O
susceptibility	O
to	O
pregnancy	O
,	O
and	O
normative	O
factors	O
were	O
also	O
relevant	O
.	O

High	O
-	O
resolution	O
structure	O
of	O
the	O
diphtheria	B
toxin	I
repressor	I
complexed	O
with	O
cobalt	O
and	O
manganese	O
reveals	O
an	O
SH3-like	B
third	O
domain	O
and	O
suggests	O
a	O
possible	O
role	O
of	O
phosphate	O
as	O
co	O
-	O
corepressor	O
.	O

FEV1	O
did	O
not	O
fall	O
significantly	O
in	O
patients	O
without	O
acute	O
or	O
chronic	O
GVHD	O
and	O
recovered	O
earlier	O
than	O
in	O
patients	O
without	O
posttransplant	O
pulmonary	O
infection	O
.	O

Therapy	O
with	O
dietary	O
modification	O
and	O
triglyceride	O
lowering	O
drugs	O
resulted	O
in	O
resolution	O
of	O
symptoms	O
and	O
parotid	O
swelling	O
in	O
one	O
patient	O
.	O

We	O
have	O
cloned	O
a	O
novel	O
protein	O
kinase	O
,	O
termed	O
hematopoietic	B
progenitor	I
kinase	I
1	I
(	O
HPK1	B
)	O
,	O
that	O
is	O
expressed	O
predominantly	O
in	O
hematopoietic	O
cells	O
,	O
including	O
early	O
progenitor	O
cells	O
.	O

The	O
fragments	O
are	O
separated	O
and	O
directly	O
sized	O
by	O
agarose	O
gel	O
electrophoresis	O
.	O

Linkage	O
studies	O
have	O
shown	O
locus	O
heterogeneity	O
with	O
one	O
TSC	B
gene	I
mapped	O
to	O
chromosome	O
9q34	O
and	O
a	O
second	O
to	O
16p13.3	O
.	O

The	O
cytogenetic	O
expression	O
of	O
the	O
folate	O
sensitive	O
fragile	O
site	O
,	O
FRAXE	B
,	O
is	O
due	O
to	O
the	O
expansion	O
of	O
a	O
GCC	O
repeat	O
in	O
proximal	O
Xq28	O
of	O
the	O
human	O
X	O
chromosome	O
and	O
is	O
associated	O
with	O
a	O
mild	O
form	O
of	O
mental	O
handicap	O
.	O

DNA	O
sequence	O
analysis	O
of	O
a	O
3213	O
bp	O
BamHI	B
-	O
ClaI	B
fragment	O
revealed	O
that	O
three	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
were	O
encoded	O
in	O
the	O
same	O
orientation	O
.	O

The	O
initial	O
inpatient	O
experience	O
for	O
individuals	O
with	O
HIV	O
-	O
related	O
TB	O
may	O
be	O
pivotal	O
to	O
the	O
acceptance	O
of	O
and	O
participation	O
in	O
ongoing	O
TB	O
care	O
.	O

Tristetraprolin	B
(	O
TTP	B
)	O
is	O
the	O
prototype	O
of	O
a	O
group	O
of	O
potential	O
transcription	O
factors	O
that	O
contain	O
two	O
or	O
more	O
unusual	O
CCCH	O
zinc	O
fingers	O
.	O

This	O
element	O
,	O
termed	O
CREsp	O
-	O
a	O
(	O
TGACCTCA	O
)	O
,	O
differs	O
by	O
one	O
nucleotide	O
from	O
a	O
palindromic	O
CRE	O
(	O
CREpal	O
,	O
TGACGTCA	O
)	O
,	O
which	O
is	O
known	O
to	O
bind	O
CREB	B
as	O
a	O
homodimer	O
.	O

An	O
inverted	O
Alu	B
repeat	O
element	O
,	O
flanked	O
by	O
nonamer	O
direct	O
repeats	O
,	O
was	O
identified	O
within	O
the	O
region	O
-913	O
/	O
-620	O
,	O
relative	O
to	O
the	O
cap	O
site	O
.	O

The	O
ewes	O
were	O
returned	O
to	O
normoxia	O
,	O
and	O
monitoring	O
was	O
continued	O
for	O
1	O
h.	O

Comparison	O
of	O
the	O
amino	O
acid	O
sequences	O
of	O
the	O
RPO1	B
polypeptides	I
of	I
IIV6	I
,	I
LCDV	I
,	I
and	I
MCV-1	I
with	O
the	O
corresponding	O
prokaryotic	O
,	O
eukaryotic	O
,	O
and	O
viral	O
proteins	O
revealed	O
differences	O
in	O
amino	O
acid	O
similarity	O
and	O
phylogenetic	O
relationships	O
.	O

The	O
use	O
of	O
primary	O
GE	O
cells	O
thus	O
provides	O
a	O
convenient	O
in	O
vitro	O
system	O
for	O
further	O
study	O
of	O
the	O
endocrine	O
,	O
paracrine	O
,	O
and	O
autocrine	O
factors	O
regulating	O
endometrial	O
gene	O
expression	O
during	O
pregnancy	O
.	O

We	O
performed	O
dipole	O
estimation	O
of	O
spikes	O
and	O
SEP	O
components	O
in	O
identical	O
patients	O
.	O

Proximal	O
CBD	O
was	O
inversely	O
correlated	O
with	O
bone	B
alkaline	I
phosphatase	I
(	O
r	O
=	O
-0.71	O
,	O
p	O
<	O
0.01	O
)	O
and	O
intact	O
PTH	B
(	O
r	O
=	O
-0.59	O
,	O
p	O
<	O
0.05	O
)	O
.	O

In	O
addition	O
,	O
a	O
comparison	O
of	O
the	O
hCHLR	B
gene	I
sequences	I
with	O
available	O
databases	O
indicates	O
that	O
a	O
large	O
portion	O
of	O
these	O
genes	O
,	O
including	O
exons	O
encoding	O
two	O
functional	O
domains	O
of	O
the	O
carboxyl	O
-	O
terminal	O
region	O
of	O
these	O
proteins	O
,	O
has	O
been	O
duplicated	O
as	O
part	O
of	O
a	O
larger	O
human	O
telomeric	O
repeat	O
sequence	O
found	O
on	O
many	O
human	O
chromosomes	O
.	O

We	O
show	O
here	O
that	O
the	O
LIM	B
domain	I
homeobox	B
protein	I
isl-1	B
activates	O
the	O
rat	B
amylin	I
promoter	I
in	O
both	O
fibroblast	O
and	O
islet	O
cell	O
lines	O
.	O

It	O
is	O
likely	O
that	O
other	O
pathways	O
involve	O
alternate	O
signal	O
transduction	O
events	O
(	O
e.g.	O
,	O
calcium	O
mobilization	O
)	O
and	O
promoter	O
response	O
elements	O
(	O
e.g.	O
,	O
SRE	O
)	O
.	O

The	O
CD4	B
count	O
at	O
which	O
remission	O
occurs	O
may	O
reflect	O
severe	O
immunodeficiency	O
such	O
that	O
risk	O
for	O
AIDS	O
-	O
related	O
infection	O
is	O
high	O
.	O

Although	O
diagnostic	O
laparoscopy	O
is	O
still	O
considered	O
the	O
standard	O
reference	O
in	O
the	O
diagnosis	O
of	O
ectopic	O
pregnancy	O
(	O
EP	O
)	O
,	O
use	O
of	O
high	O
-	O
resolution	O
endovaginal	O
sonography	O
,	O
in	O
conjunction	O
with	O
qualitative	O
serum	O
assays	O
of	O
the	O
beta	O
subunit	O
of	O
human	B
chorionic	I
gonadotropin	I
(	O
beta	B
-	I
hCG	I
)	O
,	O
allows	O
detection	O
of	O
earlier	O
and	O
smaller	O
EPs	O
.	O

Bifunctionality	O
of	O
the	O
AcMNPV	B
homologous	I
region	I
sequence	I
(	O
hr1	B
)	O
:	O
enhancer	O
and	O
ori	O
functions	O
have	O
different	O
sequence	O
requirements	O
.	O

RVR	B
'	O
loss	O
of	O
function	O
'	O
studies	O
by	O
constitutive	O
over	O
-	O
expression	O
of	O
a	O
dominant	O
negative	O
RVR	B
delta	I
E	I
resulted	O
in	O
increased	O
levels	O
of	O
p21Cip1	B
/	O
Waf1	B
and	O
myogenin	B
mRNAs	I
after	O
serum	O
withdrawal	O
.	O

These	O
two	O
repeat	O
motifs	O
are	O
organized	O
in	O
an	O
extremely	O
well	O
-	O
ordered	O
pattern	O
in	O
each	O
domain	O
,	O
which	O
suggests	O
that	O
SbHRGP3	B
belongs	O
to	O
a	O
new	O
group	O
of	O
proteins	O
having	O
the	O
repeat	O
motifs	O
of	O
two	O
distinct	O
groups	O
of	O
dicot	B
extensins	I
.	O

Their	O
use	O
established	O
that	O
the	O
BrAAP	O
activity	O
catalyzed	O
both	O
a	O
postproline	O
and	O
a	O
postglutamate	O
cleavage	O
and	O
therefore	O
has	O
a	O
broader	O
specificity	O
than	O
previously	O
recognized	O
.	O

A	O
stable	O
heterologous	O
cell	O
line	O
containing	O
the	O
mouse	B
TRH	I
receptor	I
was	O
constructed	O
by	O
transfection	O
of	O
nonexcitable	O
293	O
cells	O
,	O
which	O
lack	O
L	O
channel	O
activity	O
.	O

To	O
understand	O
further	O
the	O
expression	O
and	O
regulation	O
of	O
the	O
V1aR	B
,	O
we	O
now	O
describe	O
the	O
genomic	O
characteristics	O
,	O
tissue	O
expression	O
,	O
chromosomal	O
localization	O
,	O
and	O
regional	O
mapping	O
of	O
the	O
human	B
V1aR	I
gene	I
,	O
AVPR1A	B
.	O

The	O
final	O
predicted	O
structure	O
has	O
an	O
overall	O
backbone	O
deviation	O
of	O
0.7	O
A	O
from	O
that	O
of	O
ras	B
-	O
p21	B
.	O

Genomic	O
organization	O
of	O
the	O
human	B
beta	I
-	I
catenin	I
gene	I
(	O
CTNNB1	B
)	O
.	O

Furthermore	O
,	O
although	O
the	O
regional	O
distribution	O
of	O
lean	O
tissue	O
mass	O
in	O
the	O
trunk	O
and	O
legs	O
remained	O
fairly	O
constant	O
at	O
different	O
pubertal	O
stages	O
,	O
the	O
regional	O
distribution	O
of	O
fat	O
was	O
altered	O
significantly	O
,	O
becoming	O
more	O
central	O
and	O
less	O
peripheral	O
.	O

17.5	O
%	O
of	O
cycles	O
)	O
.	O

We	O
report	O
here	O
the	O
discovery	O
of	O
a	O
new	O
actin	B
-	I
related	I
gene	I
in	O
this	O
organism	O
,	O
which	O
we	O
have	O
named	O
ACT4	B
.	O

Two	O
of	O
the	O
ORFs	O
are	O
completely	O
internal	O
to	O
longer	O
ones	O
and	O
a	O
third	O
is	O
partially	O
embedded	O
in	O
G2850	B
.	O

MVR	O
typing	O
of	O
rare	O
-	O
length	O
alleles	O
indicates	O
that	O
they	O
are	O
comprised	O
of	O
disorganized	O
sequences	O
,	O
although	O
they	O
usually	O
bear	O
a	O
resemblance	O
to	O
one	O
of	O
the	O
common	O
alleles	O
at	O
the	O
5'-most	O
end	O
.	O

Two	O
classes	O
of	O
inactive	O
receptors	O
were	O
identified	O
:	O
one	O
in	O
which	O
both	O
transcriptional	O
activation	O
and	O
dimerization	O
were	O
compromised	O
and	O
a	O
second	O
in	O
which	O
only	O
transcriptional	O
activation	O
was	O
abolished	O
.	O

Here	O
we	O
localize	O
a	O
transferable	O
40-amino	O
acid	O
region	O
within	O
the	O
LBDs	B
of	O
RXR	B
,	O
RAR	B
,	O
TR	B
,	O
and	O
chicken	B
ovalbumin	I
upstream	I
promoter	I
transcription	I
factor	I
that	O
is	O
critical	O
for	O
determining	O
identity	O
in	O
the	O
heterodimeric	O
interaction	O
and	O
for	O
high	O
-	O
affinity	O
DNA	O
binding	O
.	O

Restriction	O
enzyme	O
mapping	O
and	O
Southern	O
analysis	O
indicated	O
further	O
that	O
the	O
human	B
MZF-1	I
gene	I
is	O
a	O
single	O
-	O
copy	O
gene	O
.	O

The	O
detection	O
ratio	O
peaked	O
at	O
ages	O
30	O
to	O
34	O
and	O
decreased	O
heavily	O
during	O
the	O
next	O
15	O
years	O
of	O
age	O
.	O

The	O
nonconsensus	O
TATA	O
box	O
in	O
promoter	O
B	O
plays	O
a	O
more	O
important	O
role	O
in	O
promoter	O
activity	O
than	O
the	O
TATA	O
box	O
in	O
promoter	O
A.	O

Demispan	O
is	O
a	O
reliable	O
and	O
reproducible	O
measure	O
of	O
stature	O
in	O
the	O
elderly	O
.	O

We	O
have	O
performed	O
toeprinting	O
analyses	O
on	O
repA	B
mRNA	I
of	O
plasmid	O
R1	O
,	O
both	O
free	O
and	O
in	O
duplex	O
with	O
the	O
antisense	O
RNA	O
,	O
CopA.	B

Previous	O
work	O
showed	O
that	O
repA	B
(	O
initiator	O
protein	O
)	O
expression	O
requires	O
tap	B
(	O
leader	O
peptide	O
)	O
translation	O
.	O

Tonsillectomy	O
is	O
an	O
effective	O
means	O
of	O
prophylaxis	O
for	O
upper	O
respiratory	O
infection	O
in	O
habitual	O
angina	O
patients	O
.	O

Pharmacokinetic	O
parameters	O
were	O
similar	O
to	O
values	O
given	O
in	O
the	O
literature	O
for	O
intravenous	O
(	O
IV	O
)	O
or	O
intraarterial	O
(	O
IA	O
)	O
bolus	O
MMC	O
injections	O
(	O
Tmax	O
=	O
7.0	O
min	O
following	O
the	O
beginning	O
of	O
MMC	O
infusion	O
,	O
Vss	O
=	O
0.57	O
1	O
/	O
kg	O
,	O
C1	O
=	O
8.9	O
ml	O
/	O
min.kg	O
,	O
T1	O
/	O
2	O
alpha	O
=	O
8.3	O
min	O
,	O
T1	O
/	O
2	O
beta	O
=	O
58.6	O
min	O
)	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
four	O
distinct	O
E2F	B
complexes	I
present	O
in	O
aged	O
and	O
senescent	O
normal	O
,	O
human	O
diploid	O
fibroblasts	O
.	O

If	O
we	O
apply	O
the	O
finding	O
of	O
non	O
-	O
visualization	O
of	O
the	O
GB	O
at	O
4	O
h	O
post	O
injection	O
as	O
the	O
criterion	O
for	O
the	O
diagnosis	O
of	O
AC	O
,	O
the	O
diagnostic	O
accuracy	O
was	O
only	O
40.7	O
%	O
(	O
11	O
/	O
27	O
)	O
.	O

Evidence	O
for	O
the	O
promoting	O
role	O
of	O
the	O
intra	B
-	I
uterine	I
kinin	I
release	O
in	O
the	O
development	O
of	O
late	O
hypertonic	O
saline	O
-	O
induced	O
abortion	O
.	O

This	O
GAP	B
activity	O
was	O
observed	O
in	O
3T3-L1	O
adipocyte	O
lysates	O
,	O
and	O
was	O
able	O
to	O
accelerate	O
the	O
hydrolysis	O
of	O
the	O
[	O
alpha-32P	O
]	O
GTP	O
bound	O
to	O
GST	B
-	O
Rab4	B
into	O
[	O
alpha-32P	O
]	O
GDP	O
.	O

CONCLUSION	O
:	O
During	O
chronic	O
treatment	O
,	O
the	O
haemodynamic	O
response	O
to	O
oral	O
cilazapril	O
was	O
attenuated	O
,	O
indicating	O
that	O
continued	O
clinical	O
improvement	O
in	O
patients	O
with	O
CHF	O
on	O
CLZ	O
is	O
independent	O
of	O
to	O
its	O
acute	O
haemodynamic	O
effects	O
.	O

We	O
conclude	O
that	O
,	O
in	O
AIDS	O
patients	O
with	O
cryptococcosis	O
,	O
tolerance	O
to	O
ILd	O
-	O
AmB	O
was	O
acceptable	O
when	O
the	O
daily	O
dosage	O
did	O
not	O
exceed	O
1	O
mg	O
/	O
kg	O
,	O
but	O
the	O
higher	O
1.5	O
mg	O
/	O
kg	O
daily	O
dosage	O
was	O
associated	O
with	O
an	O
unacceptable	O
rate	O
of	O
nephrotoxicity	O
.	O

Moreover	O
,	O
the	O
second	O
RCC1-like	B
motif	I
located	O
at	O
the	O
amino	O
-	O
terminus	O
of	O
p619	B
stimulates	O
guanine	O
nucleotide	O
exchange	O
on	O
ARF1	B
and	O
on	O
members	O
of	O
the	O
related	O
Rab	B
proteins	I
,	O
but	O
not	O
on	O
other	O
small	B
GTP	I
binding	I
proteins	I
such	O
as	O
Ran	B
or	O
R	B
-	I
Ras2	I
/	O
TC21	B
.	O

The	O
reconstituted	O
RNA	B
polymerases	I
containing	O
the	O
mutant	O
alpha	O
subunits	O
were	O
examined	O
for	O
their	O
response	O
to	O
transcription	O
activation	O
by	O
cAMP	B
-	I
CRP	I
and	O
the	O
rrnBP1	B
UP	I
element	I
.	O

A	O
decrease	O
of	O
erythrocyte	O
Mn	O
with	O
age	O
,	O
expressed	O
in	O
nmol	O
/	O
L	O
,	O
was	O
noted	O
(	O
p	O
<	O
0.02	O
)	O
.	O

Expression	O
of	O
thymidine	B
kinase	I
gene	I
in	O
normal	O
human	O
diploid	O
cells	O
is	O
both	O
cell	O
cycle-	O
and	O
age	O
-	O
dependent	O
and	O
appears	O
to	O
be	O
transcriptionally	O
regulated	O
.	O

These	O
bacteria	O
produce	O
and	O
export	O
proteins	O
capable	O
of	O
specific	O
interactions	O
with	O
key	O
mammalian	O
cell	O
regulatory	O
molecules	O
in	O
order	O
to	O
derail	O
the	O
normal	O
functions	O
of	O
the	O
cells	O
.	O

The	O
elevations	O
achieved	O
by	O
LDEE	O
given	O
s.c	O
.	O
were	O
higher	O
than	O
those	O
achieved	O
after	O
i.p	O
.	O

administration	O
and	O
lasted	O
for	O
longer	O
periods	O
.	O

Thus	O
,	O
although	O
p28	B
may	O
play	O
only	O
a	O
limited	O
role	O
during	O
the	O
early	O
embryonic	O
cleavages	O
,	O
it	O
may	O
function	O
later	O
in	O
development	O
to	O
establish	O
a	O
somatic	O
type	O
of	O
cell	O
cycle	O
.	O

It	O
is	O
suggested	O
that	O
the	O
observed	O
clinical	O
phenomena	O
in	O
response	O
to	O
morphine	O
can	O
be	O
explained	O
by	O
differences	O
in	O
expression	O
and	O
sensitivity	O
of	O
some	O
opioid	B
receptor	I
subtypes	O
in	O
migraine	O
.	O

Previous	O
studies	O
demonstrated	O
that	O
the	O
flavin	B
-	I
containing	I
monooxygenases	I
(	O
FMO	B
)	O
are	O
expressed	O
in	O
a	O
tissue	O
-	O
specific	O
manner	O
.	O

Taken	O
together	O
,	O
these	O
observations	O
indicate	O
that	O
the	O
C	O
-	O
terminal	O
24	O
amino	O
acids	O
are	O
sufficient	O
for	O
NodO	B
secretion	O
although	O
the	O
region	O
adjacent	O
to	O
this	O
domain	O
appears	O
to	O
affect	O
secretion	O
efficiency	O
.	O

Thus	O
,	O
despite	O
the	O
potential	O
for	O
common	O
regulatory	O
mechanisms	O
,	O
the	O
available	O
evidence	O
indicates	O
that	O
the	O
Mtx	B
minimal	I
promoter	I
does	O
not	O
significantly	O
affect	O
Thbs3	B
gene	I
expression	O
.	O

MSSP	B
proteins	I
have	O
been	O
identified	O
by	O
their	O
binding	O
to	O
an	O
upstream	O
element	O
of	O
c	B
-	I
myc	I
.	O

Gene	B
1	I
has	O
been	O
completely	O
sequenced	O
.	O

Both	O
alleles	O
are	O
functionally	O
expressed	O
and	O
are	O
distributed	O
within	O
CD4+	B
/	O
CD8	B
+	O
T	O
cell	O
subsets	O
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
of	O
LvUSF2	B
is	O
nearly	O
identical	O
to	O
LvUSF1	B
except	O
at	O
the	O
amino	O
end	O
,	O
where	O
they	O
are	O
sharply	O
divergent	O
.	O

ECM	O
disruption	O
in	O
Lytechinus	O
embryos	O
caused	O
a	O
relative	O
drop	O
in	O
USF	B
RNA	I
accumulation	O
levels	O
to	O
approximately	O
60	O
%	O
of	O
control	O
embryos	O
,	O
while	O
LpS1	B
RNA	I
accumulation	O
levels	O
dropped	O
to	O
less	O
than	O
5	O
%	O
.	O

Sixty	O
days	O
after	O
the	O
intervention	O
,	O
twitch	O
and	O
tetanic	O
tensions	O
remained	O
dependent	O
upon	O
the	O
extracellular	O
Ca2	O
+	O
concentration	O
(	O
[	O
Ca	O
]	O
o	O
)	O
both	O
in	O
groups	O
A	O
and	O
B.	O

Discrimination	O
between	O
HIV-1	O
and	O
HIV-2	O
showed	O
evidence	O
for	O
the	O
presence	O
of	O
HIV-1	O
only	O
.	O

The	O
HiNF	B
-	I
D	I
(	O
CDP	B
/	O
cut	B
)	O
complex	O
with	O
the	O
H4	B
promoter	I
is	O
immunoreactive	O
with	O
antibodies	O
against	O
CDP	B
/	O
cut	B
and	O
pRB	B
but	O
not	O
p107	B
,	O
whereas	O
the	O
CDP	B
/	O
cut	B
complex	O
with	O
a	O
nonhistone	O
promoter	O
(	O
gp91-phox	B
)	O
reacts	O
only	O
with	O
CDP	B
and	O
p107	B
antibodies	O
.	O

The	O
amplification	O
was	O
achieved	O
using	O
two	O
primers	O
which	O
correspond	O
to	O
TRH	B
progenitor	I
sequence	I
(	O
Lys	O
/	O
Arg	O
-	O
Arg	O
-	O
Gln	O
-	O
His	O
-	O
Pro	O
-	O
Gly	O
-	O
Lys	O
/	O
Arg	O
-	O
Arg	O
)	O
.	O

The	O
intranodal	O
mesothelial	O
cells	O
occupied	O
the	O
sinusoids	O
of	O
the	O
lymph	O
nodes	O
and	O
were	O
initially	O
suspected	O
of	O
being	O
metastatic	O
from	O
the	O
ovarian	O
tumor	O
in	O
each	O
case	O
.	O

Administration	O
of	O
RIFA	O
at	O
200	O
mg	O
/	O
kg	O
/	O
day	O
in	O
combination	O
with	O
ATO	O
at	O
100	O
mg	O
/	O
kg	O
/	O
day	O
resulted	O
in	O
a	O
marked	O
prolongation	O
of	O
survival	O
compared	O
with	O
that	O
for	O
mice	O
that	O
received	O
ATO	O
or	O
RIFA	O
alone	O
.	O

Eight	O
-	O
four	O
ACOAs	O
were	O
tested	O
in	O
order	O
to	O
examine	O
the	O
fit	O
of	O
the	O
model	O
to	O
the	O
data	O
by	O
path	O
analysis	O
with	O
LISREL	O
VII	O
.	O

Two	O
of	O
seven	O
initiation	O
sites	O
were	O
flanked	O
by	O
a	O
sequence	O
homologous	O
to	O
the	O
consensus	O
promoter	O
motif	O
that	O
includes	O
the	O
CRTA	O
motif	O
(	O
where	O
R	O
is	O
A	O
or	O
G	O
)	O
of	O
the	O
rice	O
mitochondrion	O
.	O

Selection	O
using	O
SC	O
EPD	O
was	O
more	O
effective	O
than	O
phenotypic	O
selection	O
in	O
reducing	O
age	O
at	O
puberty	O
in	O
daughters	O
.	O

The	O
mammalian	B
homeodomain	I
proteins	I
encoded	O
by	O
Hox	B
genes	I
play	O
an	O
important	O
role	O
in	O
embryonic	O
development	O
by	O
providing	O
positional	O
queues	O
which	O
define	O
developmental	O
identities	O
along	O
the	O
anteroposterior	O
axis	O
of	O
developing	O
organisms	O
.	O

Interferon	B
stimulated	I
gene	I
factor	I
3	I
(	O
ISGF3	B
)	O
is	O
a	O
trimeric	O
transcription	O
factor	O
activated	O
on	O
treatment	O
of	O
cells	O
with	O
interferon	B
-	I
alpha	I
and	I
beta	I
(	O
type	B
I	I
IFNs	I
)	O
.	O

The	O
TYAC	O
/	O
P1	O
resource	O
,	O
derivative	O
STSs	O
,	O
and	O
polymorphisms	O
constitute	O
an	O
enabling	O
resource	O
to	O
further	O
studies	O
of	O
telomere	O
structure	O
and	O
function	O
and	O
a	O
means	O
for	O
physical	O
and	O
genetic	O
map	O
integration	O
and	O
closure	O
.	O

Three	O
mutants	O
were	O
isolated	O
from	O
the	O
widely	O
used	O
strain	O
,	O
PAO1	O
.	O

We	O
conclude	O
that	O
common	O
upstream	O
signals	O
cause	O
activation	O
of	O
Ras	B
and	O
TC21	B
,	O
but	O
activated	O
TC21	B
controls	O
cell	O
growth	O
via	O
distinct	O
Raf	B
-	O
independent	O
downstream	O
signaling	O
pathways	O
.	O

Fission	B
yeast	I
mal2	I
+	I
is	O
required	O
for	O
chromosome	O
segregation	O
.	O

The	O
requirement	O
of	O
Tyr-19	O
dephosphorylation	O
for	O
spindle	O
assembly	O
is	O
also	O
observed	O
under	O
conditions	O
in	O
which	O
spindle	O
formation	O
is	O
independent	O
of	O
mitosis	O
,	O
suggesting	O
that	O
the	O
involvement	O
of	O
Cdc28	B
/	O
Clb	B
kinase	O
in	O
SPB	O
separation	O
is	O
direct	O
.	O

A	O
subset	O
of	O
these	O
DMP1	B
recognition	I
sequences	I
containing	O
a	O
GGA	O
trinucleotide	O
core	O
can	O
also	O
function	O
as	O
Ets	B
-	I
responsive	I
elements	I
.	O

This	O
technique	O
was	O
employed	O
in	O
12	O
patients	O
with	O
a	O
unicameral	O
bone	O
cyst	O
.	O

Enterococcus	O
faecium	O
strains	O
with	O
vanA	O
-	O
mediated	O
glycopeptide	O
resistance	O
were	O
isolated	O
by	O
enrichment	O
culture	O
from	O
the	O
intestines	O
and	O
feces	O
of	O
several	O
animal	O
species	O
,	O
mainly	O
horses	O
and	O
dogs	O
(	O
8	O
%	O
positive	O
)	O
,	O
chickens	O
(	O
7	O
%	O
positive	O
)	O
,	O
and	O
pigs	O
(	O
6	O
%	O
positive	O
)	O
.	O

The	O
amino	O
-	O
terminal	O
region	O
of	O
E1A	B
binds	O
several	O
high	O
molecular	O
weight	O
proteins	O
and	O
inhibits	O
the	O
transcriptional	O
coactivator	O
function	O
of	O
p300	B
and	O
the	O
homologous	O
cAMP	B
response	I
element	I
(	I
CRE	I
)	I
-binding	I
protein	I
.	O

Transient	O
transfection	O
assays	O
using	O
reporter	O
gene	O
constructs	O
containing	O
various	O
lengths	O
of	O
the	O
5	B
'	I
mdr1b	I
sequences	I
revealed	O
that	O
the	O
sequence	O
located	O
between-247	O
to	O
-126	O
bp	O
was	O
important	O
for	O
the	O
expression	O
of	O
the	O
reporter	O
gene	O
in	O
many	O
different	O
cell	O
lines	O
.	O

We	O
show	O
that	O
the	O
5'UTR	O
characteristic	O
of	O
testis	B
-	I
specific	I
c	I
-	I
mos	I
mRNA	I
strongly	O
represses	O
translation	O
relative	O
to	O
the	O
translation	O
of	O
transcripts	O
that	O
contain	O
a	O
5'UTR	O
derived	O
from	O
beta	B
-	I
globin	I
mRNA	I
,	O
and	O
this	O
is	O
mainly	O
due	O
to	O
the	O
four	O
uORFs	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
F	O
-	O
wave	O
may	O
be	O
elicited	O
in	O
motoneuron	O
of	O
different	O
depolarization	O
threshold	O
but	O
primarily	O
in	O
larger	O
and	O
faster	O
nerve	O
fibers	O
,	O
with	O
a	O
lower	O
threshold	O
of	O
depolarization	O
.	O

Northern	O
analysis	O
of	O
the	O
3.1-kb	B
PWP2H	I
cDNA	I
revealed	O
that	O
a	O
3.3-kb	O
major	O
transcript	O
is	O
ubiquitously	O
expressed	O
in	O
human	O
adult	O
tissues	O
.	O

Forty	O
-	O
eight	O
10	O
-	O
12-week	O
-	O
old	O
male	O
Sprague	O
-	O
Dawley	O
rats	O
were	O
randomized	O
to	O
receive	O
,	O
daily	O
for	O
28	O
days	O
:	O
(	O
1	O
)	O
CsA	O
vehicle	O
p.o	O
.	O
plus	O
FB	O
vehicle	O
sc	O
;	O
(	O
2	O
)	O
CsA	O
(	O
15	O
mg	O
/	O
kg	O
)	O
p.o	O
.	O
plus	O
FB	O
vehicle	O
sc	O
,	O
(	O
3	O
)	O
CsA	O
vehicle	O
p.o	O
.	O

plus	O
FB	O
(	O
1.5	O
mg	O
/	O
kg	O
)	O
sc	O
;	O
and	O
(	O
4	O
)	O
CsA	O
(	O
15	O
mg	O
/	O
kg	O
)	O
p.o	O
.	O
plus	O
FB	O
(	O
1.5	O
mg	O
/	O
kg	O
)	O
sc	O
.	O

Oncogenic	O
activation	O
of	O
the	O
tyrosine	B
kinase	I
domain	I
of	O
the	O
human	B
trk	I
proto	I
-	I
oncogene	I
by	O
fusion	O
to	O
a	O
cell	O
adhesion	O
molecule	O
.	O

Physiol	O
.	O

The	O
nucleotide	O
sequence	O
of	O
22,846	O
bp	O
of	O
the	O
left	O
arm	O
of	O
chromosome	O
IV	O
is	O
described	O
.	O

Natural	O
FL	B
protein	I
has	O
been	O
purified	O
from	O
a	O
stromal	O
cell	O
line	O
and	O
shown	O
to	O
be	O
a	O
65	O
kD	O
nondisulfide	O
-	O
linked	O
homodimeric	O
glycoprotein	O
comprised	O
of	O
30	O
kD	O
subunits	O
,	O
each	O
containing	O
12	O
kD	O
of	O
N-	O
and	O
O	O
-	O
linked	O
sugars	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
influence	O
of	O
HHCA	O
and	O
other	O
serological	O
factors	O
upon	O
the	O
development	O
of	O
VGS	O
.	O

Spliced	O
exons	O
of	O
adenovirus	O
late	O
RNAs	O
colocalize	O
with	O
snRNP	O
in	O
a	O
specific	O
nuclear	O
domain	O
.	O

Using	O
Spurr	O
's	O
resin	O
as	O
a	O
mounting	O
medium	O
,	O
we	O
could	O
observe	O
thick	O
specimens	O
with	O
oil	O
immersion	O
objective	O
lens	O
without	O
the	O
use	O
of	O
coverslips	O
,	O
then	O
avoid	O
air	O
bubbles	O
near	O
the	O
specimen	O
.	O

Beyond	O
the	O
Tower	O
of	O
Babel	O
:	O
a	O
nomenclature	O
for	O
suicidology	O
.	O

Infection	O
with	O
Neisseria	O
meningitidis	O
group	O
B	O
has	O
been	O
difficult	O
to	O
detect	O
,	O
partly	O
because	O
this	O
bacterial	O
group	O
's	O
polysaccharide	O
is	O
a	O
weak	O
immunogen	O
.	O

RNase	B
protection	O
analysis	O
of	O
two	O
rRNA	O
fragments	O
whose	O
genes	O
are	O
adjacent	O
provided	O
evidence	O
for	O
a	O
polycistronic	O
transcript	O
containing	O
sequences	O
from	O
both	O
,	O
as	O
well	O
as	O
separate	O
small	O
RNAs	O
.	O

The	O
PAI-2	B
gene	I
is	O
one	O
of	O
the	O
most	O
TNF	B
-	I
responsive	I
genes	I
known	O
and	O
is	O
also	O
highly	O
induced	O
by	O
the	O
phorbol	O
ester	O
phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
and	O
the	O
phosphatase	O
inhibitor	O
,	O
okadaic	O
acid	O
,	O
in	O
both	O
HT-1080	O
fibrosarcoma	O
and	O
U-937	O
histiocytic	O
cells	O
.	O

220	O
,	O
263	O
-	O
273	O
)	O
.	O

These	O
two	O
contigs	O
contain	O
a	O
total	O
of	O
163	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
in	O
26	O
-	O
29	O
putative	O
operons	O
;	O
56	O
ORFs	O
could	O
be	O
identified	O
with	O
reasonable	O
certainty	O
.	O

Growth	O
factors	O
induce	O
the	O
expression	O
of	O
the	O
immediate	B
early	I
gene	I
products	I
MAP	B
kinase	I
phosphatase-1	I
(	O
MKP-1	B
)	O
,	O
c	B
-	I
Fos	I
and	O
c	B
-	I
Jun	I
.	O

Vascular	O
responses	O
to	O
reactive	O
hyperemia	O
(	O
with	O
flow	O
increase	O
leading	O
to	O
endothelium	O
-	O
dependent	O
dilation	O
)	O
and	O
to	O
sublingual	O
glyceryl	O
trinitrate	O
(	O
GTN	O
;	O
endothelium	O
-	O
independent	O
dilation	O
)	O
were	O
recorded	O
.	O

During	O
this	O
period	O
,	O
administration	O
of	O
additional	O
exogenous	B
PRL	I
did	O
not	O
stimulate	O
further	O
activation	O
(	O
binding	O
)	O
of	O
the	O
Stat	B
factors	I
.	O

Intraperitoneal	O
administration	O
of	O
L-5-hydroxytryptophan	O
(	O
L-5-HTP	O
)	O
at	O
doses	O
of	O
25	O
to	O
100	O
mg	O
/	O
kg	O
dramatically	O
increase	O
defecation	O
in	O
mice	O
.	O

In	O
the	O
VA	O
-	O
SMV	O
mode	O
,	O
the	O
connection	O
was	O
made	O
with	O
valved	O
conduits	O
from	O
the	O
LV	O
apex	O
(	O
inflow	O
)	O
to	O
the	O
ascending	O
aorta	O
(	O
outflow	O
)	O
(	O
n	O
=	O
11	O
)	O
or	O
to	O
the	O
DAo	O
(	O
n	O
=	O
12	O
)	O
.	O

The	O
evidence	O
in	O
support	O
of	O
this	O
was	O
derived	O
from	O
the	O
fact	O
that	O
the	O
affinity	O
or	O
interaction	O
between	O
the	O
two	O
subunits	O
was	O
impaired	O
as	O
indicated	O
by	O
the	O
first	O
order	O
rate	O
constant	O
of	O
hCG	B
alpha	I
1	I
beta	I
(	O
km	O
=	O
4.1	O
x	O
10	O
(	O
-2	O
)	O
min-1	O
)	O
at	O
pH	O
3.0	O
at	O
23	O
degrees	O
C	O
which	O
is	O
one	O
order	O
of	O
magnitude	O
greater	O
relative	O
to	O
rehCG	B
(	O
kw	O
=	O
4.6	O
x	O
10	O
(	O
-3	O
)	O
min-1	O
)	O
.	O

The	O
majority	O
of	O
the	O
cases	O
with	O
0-I	O
or	O
0-III	O
components	O
were	O
sm	O
.	O

cancer	O
.	O

These	O
patients	O
appear	O
to	O
have	O
slightly	O
better	O
pulmonary	O
function	O
and	O
nutritional	O
status	O
;	O
yet	O
,	O
they	O
seem	O
to	O
have	O
a	O
higher	O
degree	O
of	O
health	O
care	O
utilization	O
.	O

We	O
have	O
found	O
that	O
PEA2	B
is	O
also	O
required	O
for	O
the	O
bipolar	O
budding	O
pattern	O
and	O
that	O
it	O
encodes	O
a	O
novel	O
protein	O
with	O
a	O
predicted	O
coiled	O
-	O
coil	O
domain	O
.	O

Signaling	O
from	O
the	O
small	B
GTP	I
-	I
binding	I
proteins	I
Rac1	I
and	O
Cdc42	B
to	O
the	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
/	O
stress	B
-	I
activated	I
protein	I
kinase	I
pathway	O
.	O

Correlating	O
with	O
the	O
previous	O
observation	O
that	O
CBF	B
binding	O
to	O
the	O
78C1	O
site	O
is	O
enhanced	O
by	O
EGTA	O
and	O
EDTA	O
,	O
these	O
divalent	O
cation	O
chelators	O
specifically	O
stimulate	O
78C1-directed	O
transcription	O
.	O

The	O
human	O
gene	O
fragment	O
ligated	O
to	O
the	O
minimal	O
rat	O
liver	O
glucokinase	B
promoter	O
was	O
shown	O
to	O
work	O
as	O
an	O
enhancer	O
in	O
the	O
hepatocyte	O
transfection	O
system	O
.	O

However	O
,	O
the	O
truncated	O
deer	B
receptor	I
lacks	O
the	O
most	O
C	O
-	O
terminal	O
tyrosine	O
residue	O
in	O
the	O
intracellular	O
domain	O
which	O
is	O
believed	O
to	O
be	O
essential	O
for	O
activation	O
of	O
the	O
beta	B
-	I
casein	I
promoter	I
.	O

This	O
report	O
provides	O
further	O
evidence	O
for	O
the	O
riMLF	O
in	O
the	O
control	O
of	O
downgaze	O
,	O
and	O
a	O
synkinesis	O
is	O
postulated	O
for	O
the	O
development	O
of	O
the	O
convergence	O
retraction	O
nystagmus	O
.	O

Rifabutin	O
has	O
substantial	O
efficacy	O
when	O
combined	O
with	O
other	O
agents	O
.	O

The	O
STE20	B
gene	I
,	O
encoding	O
a	O
protein	O
kinase	O
required	O
for	O
pheromone	O
signal	O
transduction	O
,	O
has	O
recently	O
been	O
identified	O
in	O
a	O
genetic	O
screen	O
for	O
high	O
-	O
gene	O
-	O
dosage	O
suppressors	O
of	O
a	O
partly	O
defective	O
G	B
beta	I
mutation	O
.	O

This	O
enzyme	O
is	O
designated	O
(	B
1	I
-	I
->4	I
)	I
-beta	I
-	I
xylan	I
endohydrolase	I
isoenzyme	I
X	I
-	I
I.	I

Magnetic	O
resonance	O
imaging	O
in	O
coccidioidal	O
arthritis	O
.	O

REM	O
sleep	O
deprivation	O
was	O
performed	O
using	O
the	O
platform	O
technique	O
.	O

The	O
same	O
ligands	O
also	O
exhibit	O
a	O
similar	O
inhibitory	O
effect	O
on	O
PDGF	B
-	I
BB	I
-	O
dependent	O
[	O
3H	O
]	O
thymidine	O
incorporation	O
in	O
PAE	O
cells	O
expressing	O
the	O
PDGF	B
beta	I
-	I
receptors	I
.	O

We	O
analyzed	O
serial	O
biopsy	O
specimens	O
from	O
eight	O
patients	O
with	O
FL	O
for	O
secondary	O
alterations	O
of	O
the	O
rearranged	B
bcl-2	I
gene	I
in	O
the	O
breakpoint	O
and	O
open	O
reading	O
frame	O
(	O
ORF	O
)	O
regions	O
.	O

In	O
all	O
eight	O
cases	O
,	O
neither	O
FL	O
nor	O
DLL	O
cells	O
showed	O
alterations	O
of	O
bcl-2	B
gene	I
sequences	I
in	O
the	O
breakpoint	O
region	O
,	O
suggesting	O
high	O
conservation	O
of	O
the	O
bcl-2	B
gene	I
during	O
both	O
t	O
(	O
14	O
;	O
18	O
)	O
translocation	O
and	O
morphologic	O
transformation	O
of	O
the	O
FL	O
cells	O
.	O

The	O
optimal	O
sequence	O
for	O
interaction	O
with	O
mu	B
2	I
and	O
with	O
AP-2	B
has	O
tyrosine	O
as	O
an	O
anchor	O
and	O
prefers	O
arginine	O
at	O
position	O
Y	O
+	O
2	O
and	O
leucine	O
at	O
position	O
Y	O
+	O
3	O
.	O

STK	B
/	O
RON	B
-	O
expressing	O
Ba	O
/	O
F3	O
pro	O
-	O
B	O
cells	O
(	O
BaF	O
/	O
STK	B
)	O
exhibited	O
MSP	B
-	O
dependent	O
growth	O
,	O
whereas	O
STK	B
/	O
RON	B
-	O
expressing	O
mouse	O
erythroleukaemia	O
cells	O
(	O
MEL	O
/	O
STK	B
)	O
displayed	O
MSP	B
-	O
induced	O
apoptosis	O
.	O

Kss1	B
binds	O
specifically	O
to	O
a	O
GST	B
-	O
Dig1	B
fusion	O
in	O
the	O
absence	O
of	O
any	O
other	O
yeast	O
protein	O
.	O

In	O
contrast	O
,	O
dig1	B
dig2	B
cells	O
constitutively	O
invade	O
agar	O
medium	O
,	O
whereas	O
a	O
dig1	B
dig2	B
ste12	B
triple	O
mutant	O
does	O
not	O
,	O
indicating	O
that	O
Dig1	B
and	O
Dig2	B
share	O
a	O
role	O
in	O
negatively	O
regulating	O
the	O
invasive	O
growth	O
pathway	O
.	O

Transient	O
expression	O
of	O
VSF-1	B
in	O
protoplasts	O
stimulated	O
vs-1	B
dependent	O
activation	O
of	O
the	O
-76	B
/	I
grp1.8	I
minimal	I
promoter	I
.	O

Keeping	O
in	O
mind	O
the	O
limited	O
range	O
of	O
age	O
and	O
dosages	O
,	O
advantages	O
and	O
disadvantages	O
of	O
the	O
drug	O
are	O
discussed	O
,	O
comparing	O
the	O
experimental	O
results	O
with	O
those	O
derived	O
from	O
the	O
literature	O
.	O

Blood	O
sampling	O
procedures	O
were	O
videotaped	O
.	O

The	O
current	O
study	O
defines	O
the	O
vinculin-	B
and	O
FAK	B
-	I
interaction	I
domains	I
on	O
paxillin	B
and	O
identifies	O
the	O
principal	O
paxillin	B
focal	O
adhesion	O
targeting	O
motif	O
.	O

These	O
data	O
demonstrate	O
the	O
presence	O
of	O
a	O
single	O
binding	O
site	O
for	O
vinculin	B
,	O
and	O
at	O
least	O
two	O
binding	O
sites	O
for	O
FAK	B
that	O
are	O
separated	O
by	O
an	O
intervening	O
stretch	O
of	O
100	O
amino	O
acids	O
.	O

These	O
data	O
demonstrate	O
that	O
paxillin	B
localizes	O
to	O
focal	O
adhesions	O
independent	O
of	O
interactions	O
with	O
vinculin	B
and/or	O
FAK	B
,	O
and	O
represents	O
the	O
first	O
definitive	O
demonstration	O
of	O
LIM	B
domains	I
functioning	O
as	O
a	O
primary	O
determinant	O
of	O
protein	O
subcellular	O
localization	O
to	O
focal	O
adhesions	O
.	O

Several	O
agents	O
have	O
been	O
tried	O
for	O
treatment	O
,	O
often	O
limited	O
by	O
toxic	O
side	O
effects	O
.	O

These	O
results	O
are	O
consistent	O
with	O
the	O
well	O
established	O
polarity	O
of	O
RXR	B
heterodimer	O
binding	O
to	O
bipartite	O
hormone	O
response	O
elements	O
,	O
with	O
the	O
VDR	B
recognizing	O
the	O
3'-half	O
-	O
element	O
.	O

PPAR	B
gamma	I
mRNA	I
levels	O
were	O
reduced	O
by	O
95	O
%	O
with	O
3	O
nM	O
TNF	B
alpha	I
treatment	O
for	O
24	O
h.	O

Exons	O
III	O
to	O
VIII	O
,	O
which	O
cover	O
the	O
coding	O
region	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
,	O
are	O
almost	O
identical	O
in	O
all	O
types	O
of	O
PST	B
or	O
AST	B
cDNAs	I
.	O

Growth	O
factor	O
allows	O
effective	O
dose	O
-	O
intensive	O
regimen	O
in	O
advanced	O
breast	O
cancer	O
patients	O
.	O

Recombinant	B
erythropoietin	I
(	O
r	B
-	I
HuEPO	I
)	O
in	O
the	O
treatment	O
of	O
anemia	O
in	O
multiple	O
myeloma	O

Ki	B
-	I
ras	I
and	O
p53	B
mutations	I
in	O
pancreatic	O
ductal	O
adenocarcinoma	O
.	O

Epidemiological	O
data	O
are	O
quite	O
controversial	O
but	O
sudden	O
death	O
occurring	O
during	O
sporting	O
activity	O
is	O
probably	O
not	O
a	O
rare	O
occurrence	O
.	O

However	O
,	O
the	O
ratio	O
M	O
/	O
Pc	O
provides	O
a	O
useful	O
index	O
that	O
seems	O
to	O
be	O
independent	O
of	O
the	O
metabolic	O
demand	O
.	O

The	O
mobility	O
shift	O
assay	O
of	O
the	O
65	O
bp	O
(	O
-318	O
/	O
-254	O
)	O
fragment	O
with	O
nuclear	O
extract	O
from	O
the	O
dark	O
-	O
adapted	O
sample	O
showed	O
an	O
additional	O
band	O
,	O
not	O
seen	O
with	O
the	O
light	O
-	O
grown	O
sample	O
.	O

When	O
the	O
E1A	B
N	I
-	I
terminus	I
is	O
used	O
as	O
a	O
competitor	O
in	O
squelshing	O
experiments	O
it	O
abolishes	O
CBP	B
-	O
induced	O
activation	O
of	O
E2F1	B
/	O
DP1	B
,	O
whereas	O
an	O
E1A	B
mutant	I
lacking	O
CBP	B
binding	O
ability	O
fails	O
to	O
do	O
so	O
.	O

On	O
the	O
third	O
occasion	O
water	O
(	O
W	O
)	O
was	O
ingested	O
throughout	O
the	O
run	O
.	O

The	O
nm23-H1	B
/	O
nm23-H2	B
gene	O
transcriptional	O
activity	O
ratio	O
varied	O
depending	O
on	O
the	O
cell	O
line	O
.	O

Discordance	O
on	O
the	O
cost	O
dimension	O
correlated	O
negatively	O
with	O
G	B
Hb	I
,	O
suggesting	O
better	O
glycemic	O
control	O
with	O
greater	O
disagreement	O
.	O

DATA	O
SOURCES	O
:	O
Epidemiologic	O
studies	O
,	O
research	O
studies	O
,	O
review	O
articles	O
,	O
and	O
government	O
reports	O
pertaining	O
to	O
epidemiology	O
of	O
lung	O
cancer	O
.	O

RESULTS	O
:	O
The	O
age	O
distribution	O
was	O
28	O
to	O
83	O
years	O
old	O
(	O
mean	O
was	O
54.1	O
years	O
)	O
.	O

Histological	O
changes	O
,	O
including	O
cortical	O
cell	O
involution	O
and	O
hemorrhage	O
occurring	O
during	O
the	O
neonatal	O
period	O
,	O
would	O
seem	O
to	O
have	O
crucial	O
relevance	O
to	O
the	O
remodeling	O
of	O
the	O
adrenal	O
vasculature	O
.	O

Furthermore	O
,	O
co	O
-	O
expression	O
of	O
both	O
p46	B
and	O
p54	B
subunits	I
markedly	O
altered	O
the	O
subcellular	O
distribution	O
of	O
p46	B
;	O
co	O
-	O
expressed	O
p46	B
was	O
transported	O
into	O
the	O
nucleus	O
as	O
efficiently	O
as	O
p54	B
.	O

The	O
results	O
suggest	O
that	O
,	O
although	O
both	O
the	O
N-	O
and	O
C	O
-	O
terminal	O
regions	O
of	O
talin	B
bind	O
actin	B
,	O
the	O
properties	O
of	O
these	O
two	O
regions	O
of	O
the	O
protein	O
are	O
distinct	O
.	O

Merr	O
.	O
)	O

embryo	O
library	O
.	O

In	O
3Y1	O
and	O
3Y1	O
v	B
-	I
crk	I
-	O
transformed	O
fibroblasts	O
,	O
almost	O
all	O
of	O
the	O
total	O
PTP1B	B
and	O
about	O
40	O
%	O
of	O
total	O
p130	B
(	O
Cas	B
)	O
co	O
-	O
sediment	O
with	O
membranes	O
composed	O
primarily	O
of	O
endoplasmic	O
reticulum	O
.	O

Replacing	O
residues	O
405	O
-	O
419	O
on	O
delta419	O
with	O
the	O
conserved	O
AF-2	O
domain	O
from	O
the	O
vitamin	B
D3	I
receptor	I
or	O
the	O
estrogen	B
receptor	I
results	O
in	O
a	O
receptor	O
with	O
wild	O
-	O
type	O
or	O
low	O
transcriptional	O
activity	O
,	O
respectively	O
.	O

Administration	O
of	O
a	O
second	O
dose	O
of	O
vaccine	O
during	O
the	O
outbreak	O
was	O
not	O
protective	O
.	O

But	O
,	O
as	O
Theriault	O
explains	O
,	O
improvements	O
in	O
assessing	O
exposure	O
have	O
not	O
yet	O
translated	O
into	O
clear	O
and	O
consistent	O
findings	O
.	O

Biol	O
.	O

Evolutive	O
morphology	O
of	O
the	O
olfactory	O
bulb	O
in	O
man	O
and	O
certain	O
non	O
-	O
human	O
mammals	O

From	O
these	O
results	O
,	O
we	O
concluded	O
that	O
this	O
ORF	O
is	O
the	O
FRDS	B
gene	I
.	O

These	O
results	O
suggest	O
that	O
Rho1p	B
regulates	O
cytoskeletal	O
reorganization	O
at	O
least	O
through	O
Bni1p	B
and	O
Pkc1p	B
.	O

The	O
ERH	B
expression	O
profile	O
is	O
similar	O
,	O
to	O
that	O
of	O
An3	B
,	O
which	O
localizes	O
to	O
the	O
animal	O
hemisphere	O
of	O
oocytes	O
and	O
is	O
abundantly	O
expressed	O
in	O
the	O
embryo	O
.	O

Waves	O
N1	O
,	O
P3	O
and	O
CNV	O
were	O
recorded	O
during	O
a	O
CNV	O
paradigm	O
in	O
a	O
simple	O
reaction	O
time	O
task	O
with	O
a	O
constant	O
interstimulus	O
interval	O
(	O
ISI	O
)	O
of	O
1	O
sec.	O

Therefore	O
,	O
both	O
the	O
Chilean	O
and	O
the	O
Japanese	O
samples	O
collected	O
in	O
high	O
-	O
risk	O
areas	O
showed	O
higher	O
mutagenic	O
rates	O
than	O
the	O
Japanese	O
ones	O
in	O
a	O
low	O
-	O
risk	O
area	O
,	O
with	O
a	O
statistical	O
significance	O
(	O
p	O
<	O
0.001	O
)	O
,	O
chi	O
-	O
square	O
test	O
)	O
.	O

Regulation	O
of	O
ASN1	B
and	O
ASN2	B
expression	O
was	O
studied	O
using	O
lacZ	B
fusions	I
and	O
both	O
genes	O
were	O
found	O
to	O
be	O
several	O
times	O
less	O
expressed	O
in	O
the	O
absence	O
of	O
the	O
transcription	O
activator	O
Gcn4p	B
.	O

Several	O
particular	O
features	O
of	O
this	O
polypeptide	O
fragment	O
from	O
the	O
hamster	B
lysyl	I
-	I
tRNA	I
synthetase	I
suggest	O
that	O
it	O
is	O
implicated	O
in	O
the	O
assembly	O
of	O
that	O
enzyme	O
within	O
the	O
multisynthetase	O
complex	O
.	O

The	O
effects	O
of	O
oral	O
vanadyl	O
sulfate	O
(	O
VOSO4	O
)	O
(	O
0.5	O
mg	O
/	O
kg	O
/	O
day	O
)	O
on	O
anthropometry	O
,	O
body	O
composition	O
,	O
and	O
performance	O
were	O
investigated	O
in	O
a	O
12-week	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
involving	O
weight	O
-	O
training	O
volunteers	O
.	O

Later	O
in	O
development	O
,	O
Tbx6	B
expression	O
is	O
restricted	O
to	O
presomitic	O
,	O
paraxial	O
mesoderm	O
and	O
to	O
the	O
tail	O
bud	O
,	O
which	O
replaces	O
the	O
streak	O
as	O
the	O
source	O
of	O
mesoderm	O
.	O

Disruption	O
of	O
re	O
-	O
replication	O
control	O
by	O
overexpression	O
of	O
human	B
ORC1	I
in	O
fission	O
yeast	O
.	O

Human	B
acid	I
ceramidase	I
(	O
(	B
AC	I
)	I
N	I
-	I
acylsphingosine	I
amidohydrolase	I
,	O
EC	B
3.5	I
.	O

The	O
0.22-kb	O
NheI	B
/	O
BglII	B
promoter	O
exhibited	O
PMA	O
inducibility	O
in	O
myeloid	O
cells	O
and	O
contained	O
a	O
PMA	O
-	O
responsive	O
element	O
recognized	O
by	O
Sp1	B
and	O
EGR-1	B
transcription	I
factors	I
.	O

When	O
the	O
degree	O
of	O
exercise	O
was	O
maximal	O
,	O
mPAP	O
was	O
maintained	O
,	O
SVI	O
decreased	O
,	O
HR	O
was	O
unchanged	O
,	O
and	O
CO	O
and	O
VO2	O
decreased	O
.	O

To	O
elucidate	O
whether	O
potential	O
endocrine	O
changes	O
resulted	O
from	O
acute	O
hypoxaemia	O
alone	O
,	O
the	O
underlying	O
disease	O
,	O
or	O
unspecific	O
influences	O
connected	O
with	O
the	O
ICU	O
setting	O
,	O
all	O
measurements	O
were	O
compared	O
to	O
those	O
of	O
a	O
completely	O
healthy	O
reference	O
group	O
(	O
REF	O
)	O
with	O
comparable	O
acute	O
experimental	O
hypoxaemia	O
.	O

There	O
were	O
no	O
significant	O
differences	O
in	O
graft	O
survival	O
between	O
groups	O
with	O
early	O
graft	O
function	O
(	O
EGF	O
)	O
and	O
DGF	O
,	O
either	O
in	O
first	O
transplantations	O
or	O
retransplantations	O
.	O

Thrombosis	O
of	O
the	O
renal	O
vein	O
may	O
be	O
dramatic	O
and	O
include	O
renal	O
failure	O
.	O

327	O
and	O
736	O
protocols	O
of	O
postmortem	O
examinations	O
from	O
Moscow	O
hospitals	O
N	O
31	O
and	O
57	O
,	O
respectively	O
,	O
were	O
evaluated	O
statistically	O
.	O

The	O
sequencing	O
of	O
the	O
conditional	O
lethal	O
mutation	O
ts	O
-	O
A13	O
,	O
localized	O
in	O
the	O
nrdE	B
cistron	I
,	O
and	O
the	O
lethality	O
of	O
insertional	O
mutations	O
targeted	O
in	O
the	O
internal	O
region	O
of	O
nrdE	B
and	O
nrdF	B
,	O
demonstrated	O
the	O
essential	O
role	O
of	O
this	O
locus	O
.	O

The	O
microdensitometric	O
scores	O
and	O
their	O
side	O
-	O
to	O
-	O
side	O
differences	O
in	O
patients	O
correlated	O
negatively	O
with	O
the	O
serum	O
25-OHD	O
concentration	O
and	O
positively	O
with	O
the	O
degree	O
of	O
paralysis	O
.	O

This	O
correlated	O
with	O
reduced	O
levels	O
of	O
secreted	O
hepatitis	B
B	I
e	I
antigen	I
and	O
increased	O
intracellular	O
levels	O
of	O
core	B
and	O
Pol	B
proteins	I
and	O
replicative	O
HBV	O
DNA	O
intermediates	O
.	O

The	O
SCMV	B
SNE	I
sites	I
contain	O
potential	O
overlapping	O
core	O
recognition	O
binding	O
motifs	O
for	O
SRF	B
,	O
Rel	B
/	O
NFkappaB	B
,	O
ETS	B
,	O
and	O
YY1	B
class	I
transcription	I
factors	I
but	O
fail	O
to	O
respond	O
to	O
either	O
serum	O
or	O
tumor	B
necrosis	I
factor	I
alpha	I
.	O

Upon	O
serum	O
withdrawal	O
at	O
the	O
permissive	O
temperature	O
,	O
p53-mediated	B
apoptosis	O
was	O
induced	O
in	O
50	O
to	O
60	O
%	O
of	O
the	O
cells	O
.	O

To	O
circumvent	O
this	O
problem	O
,	O
a	O
simple	O
two	O
-	O
step	O
strategy	O
was	O
devised	O
by	O
which	O
essential	O
cis	O
-	O
acting	O
sites	O
like	O
the	O
a	O
sequence	O
can	O
be	O
readily	O
deleted	O
from	O
their	O
natural	O
loci	O
in	O
large	O
viral	O
DNA	O
genomes	O
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
hGCN5	B
is	O
also	O
an	O
HAT	B
and	O
has	O
the	O
same	O
substrate	O
specificity	O
as	O
yGCN5	B
.	O

The	O
effect	O
of	O
six	O
arginine	O
mutations	O
of	O
oxidative	O
phosphorylation	O
and	O
AAC	B
expression	O
.	O

The	O
implications	O
for	O
estimates	O
of	O
cortical	O
magnification	O
and	O
possible	O
differences	O
in	O
the	O
specializations	O
of	O
foveal	O
and	O
peripheral	O
vision	O
are	O
discussed	O
.	O

G	B
-	I
CSF	I
activates	O
multiple	O
signaling	O
molecules	O
,	O
including	O
the	O
JAK1	B
and	O
JAK2	B
kinases	I
and	O
the	O
STAT	B
transcription	O
factors	O
.	O

The	O
RI	B
alpha	I
gene	I
is	O
composed	O
of	O
nine	O
coding	O
exons	O
of	O
varying	O
lengths	O
,	O
separated	O
by	O
introns	O
,	O
giving	O
the	O
gene	O
a	O
total	O
length	O
of	O
at	O
least	O
21	O
kb	O
.	O

our	O
recent	O
cloning	O
of	O
a	O
processed	O
RI	B
alpha	I
pseudogene	I
with	O
a	O
5'-noncoding	O
region	O
different	O
from	O
the	O
previously	O
reported	O
RI	B
alpha	I
complementary	I
RNA	I
indicated	O
that	O
the	O
RI	B
alpha	I
gene	I
may	O
have	O
multiple	O
leader	O
exons	O
giving	O
rise	O
to	O
alternately	O
spliced	O
messenger	O
RNAs	O
(	O
mRNAs	O
)	O
.	O

In	O
addition	O
,	O
double	O
mutants	O
with	O
either	O
dim1-delta	B
or	O
dim2	B
-	I
1	I
and	O
the	O
endocytosis	O
mutants	B
end4	I
-	I
1	I
or	O
act1	B
-	I
1	I
displayed	O
synthetic	O
growth	O
defects	O
,	O
indicating	O
that	O
the	O
DIM	B
gene	I
products	I
function	O
in	O
a	O
common	O
or	O
parallel	O
endocytic	O
pathway	O
.	O

Stable	O
transfection	O
of	O
the	O
BL	O
cell	O
line	O
Raji	O
with	O
constructs	O
containing	O
core	O
promoter	O
mutations	O
confirmed	O
that	O
the	O
proximal	O
Sp1	B
site	I
and	O
the	O
TATA	O
box	O
are	O
essential	O
for	O
the	O
activation	O
of	O
promoter	O
P1	O
by	O
the	O
Ig	B
kappa	I
enhancers	I
.	O

Finally	O
,	O
the	O
C	O
-	O
terminal	O
region	O
of	O
ENBP1	B
shows	O
strong	O
homology	O
to	O
a	O
protein	O
from	O
rat	O
that	O
is	O
specifically	O
expressed	O
in	O
testis	O
tissue	O
.	O

The	O
conservation	O
of	O
both	O
the	O
G	O
-	O
box	O
and	O
H	O
-	O
box	O
in	O
different	O
CHS	B
promoters	I
emphasizes	O
their	O
importance	O
as	O
regulatory	O
motifs	O
.	O

Mortality	O
on	O
the	O
last	O
ranch	O
was	O
particularly	O
severe	O
among	O
certain	O
segregated	O
groups	O
of	O
turkeys	O
that	O
included	O
toms	O
,	O
heavier	O
birds	O
,	O
and	O
birds	O
undergoing	O
a	O
stressful	O
event	O
such	O
as	O
artificial	O
insemination	O
.	O

Further	O
,	O
the	O
PIP2	O
content	O
of	O
the	O
85	O
-	O
90	O
kDa	O
protein	O
appeared	O
to	O
decrease	O
with	O
CSF-1	B
treatment	O
.	O

Further	O
,	O
the	O
PIP2	O
content	O
of	O
the	O
85	O
-	O
90	O
kDa	O
protein	O
appeared	O
to	O
decrease	O
with	O
CSF-1	B
treatment	O
.	O

Just	O
before	O
inserting	O
on	O
the	O
anterior	O
margin	O
and	O
apex	O
of	O
the	O
iliac	O
crest	O
it	O
widens	O
,	O
assuming	O
the	O
aspect	O
of	O
a	O
small	O
cone	O
.	O

The	O
first	O
identification	O
of	O
the	O
active	O
37LRP	B
/	O
p40	B
gene	O
presented	O
in	O
this	O
study	O
is	O
a	O
critical	O
step	O
toward	O
the	O
isolation	O
of	O
the	O
corresponding	O
human	O
gene	O
and	O
the	O
understanding	O
of	O
the	O
molecular	O
mechanisms	O
involved	O
in	O
the	O
up	O
-	O
regulation	O
of	O
its	O
expression	O
during	O
tumor	O
invasion	O
and	O
metastasis	O
.	O

The	O
STAT-1	B
signaling	O
pathway	O
provides	O
at	O
least	O
one	O
mechanism	O
for	O
activation	O
of	O
the	O
CAEV	B
LTR	I
by	O
IFN	B
-	I
gamma	I
in	O
monocytes	O
.	O

Reperfusion	O
caused	O
a	O
transient	O
reduction	O
in	O
lactate	O
production	O
and	O
a	O
significant	O
increase	O
in	O
LDH	B
release	O
.	O

INTERVENTION	O
(	O
S	O
)	O
:	O
Twenty	O
-	O
six	O
hemostasis	O
parameters	O
evaluated	O
repeatedly	O
in	O
patients	O
undergoing	O
IVF	O
-	O
ET	O
.	O

Unlike	O
wild	B
-	I
type	I
p53	I
,	O
the	O
delta	B
proAE	I
mutant	I
cDNA	I
can	O
be	O
stably	O
expressed	O
in	O
tumor	O
derived	O
cell	O
lines	O
with	O
few	O
immediate	O
detrimental	O
effects	O
.	O

The	O
patient	O
's	O
role	O
,	O
organized	O
by	O
the	O
prerequisites	O
of	O
expressive	O
freedom	O
,	O
is	O
counter	O
posed	O
with	O
the	O
psychoanalyst	O
's	O
,	O
which	O
is	O
structured	O
to	O
empower	O
listening	O
and	O
understanding	O
.	O

The	O
most	O
common	O
risk	O
factor	O
reported	O
for	O
both	O
recent	O
and	O
all	O
other	O
hepatitis	O
C	O
cases	O
was	O
a	O
history	O
of	O
injecting	O
drug	O
use	O
,	O
although	O
the	O
proportion	O
of	O
cases	O
with	O
that	O
history	O
was	O
different	O
in	O
NT	O
from	O
ACT	O
and	O
Queensland	O
.	O

Silencing	O
can	O
be	O
restored	O
by	O
creation	O
of	O
a	O
telomere	O
at	O
13	O
kb	O
from	O
the	O
reporter	O
construct	O
,	O
or	O
by	O
insertion	O
of	O
340	O
bp	O
of	O
yeast	O
telomeric	O
repeat	O
sequence	O
at	O
this	O
site	O
without	O
chromosomal	O
truncation	O
.	O

In	O
contrast	O
with	O
previous	O
two	O
-	O
pool	O
models	O
,	O
provisions	O
were	O
made	O
for	O
folate	O
turnover	O
by	O
urinary	O
folate	O
excretion	O
(	O
as	O
measured	O
here	O
)	O
and	O
by	O
fecal	O
excretion	O
and	O
catabolic	O
processes	O
.	O

Several	O
artifacts	O
occurred	O
that	O
interfered	O
with	O
visualization	O
of	O
the	O
diaphragm	O
.	O

The	O
syndrome	O
of	O
resistance	O
to	O
thyroid	O
hormone	O
is	O
characterized	O
by	O
elevated	O
serum	O
free	O
thyroid	O
hormones	O
,	O
failure	O
to	O
suppress	O
pituitary	B
thyrotropin	I
secretion	O
,	O
and	O
variable	O
peripheral	O
refractoriness	O
to	O
hormone	O
action	O
.	O

Finally	O
,	O
nonphotosynthetic	O
mutants	O
,	O
including	O
the	O
tscA	B
-	I
lacking	I
photosystem	I
I	I
mutant	I
,	O
H13	O
,	O
did	O
not	O
show	O
evidence	O
of	O
light	O
-	O
stimulated	O
RNA	O
processing	O
.	O

The	O
progression	O
of	O
acute	O
bronchitis	O
is	O
associated	O
with	O
elevated	O
blood	O
concentrations	O
of	O
acute	O
-	O
phase	O
proteins	O
,	O
KKS	B
activation	O
in	O
the	O
blood	O
and	O
high	O
serotonin	O
and	O
lactic	O
acid	O
content	O
in	O
the	O
humor	O
condensated	O
from	O
the	O
exhaled	O
air	O
.	O

During	O
skeletal	O
muscle	O
development	O
,	O
different	O
types	O
of	O
muscle	O
fibers	O
are	O
generated	O
,	O
which	O
express	O
different	O
combinations	O
of	O
muscle	O
-	O
specific	O
gene	O
products	O
.	O

We	O
discuss	O
these	O
results	O
with	O
respect	O
to	O
the	O
transcriptional	O
induction	O
of	O
the	O
HNF-3	B
alpha	I
gene	I
in	O
respiratory	O
epithelium	O
during	O
embryogenesis	O
.	O

BACKGROUND	O
:	O
Mitosis	O
is	O
regulated	O
by	O
MPF	B
(	O
maturation	B
promoting	I
factor	I
)	O
,	O
the	O
active	O
form	O
of	O
Cdc2	B
/	I
28-cyclin	I
B	B
complexes	O
.	O

Ectopic	O
expression	O
of	O
Apo-3	B
in	O
HEK293	O
or	O
HeLa	O
cells	O
induced	O
marked	O
apoptosis	O
.	O

An	O
N	O
-	O
terminal	O
arm	O
from	O
each	O
subunit	O
wraps	O
around	O
the	O
dinucleotide	O
-	O
binding	O
domain	O
of	O
an	O
adjacent	O
subunit	O
,	O
covering	O
the	O
adenine	O
ring	O
of	O
NADP	O
.	O

Similarity	O
is	O
most	O
striking	O
in	O
the	O
zinc	O
knuckle	O
region	O
,	O
a	O
region	O
characteristic	O
of	O
gag	B
genes	I
of	O
most	O
replication	O
-	O
competent	O
retroelements	O
.	O

D.	O
melanogaster	O
HeT	B
-	I
A	I
coding	O
sequences	O
have	O
a	O
polymorphic	O
region	O
with	O
insertions	O
/	O
deletions	O
of	O
1	O
-	O
31	O
codons	O
and	O
many	O
nucleotide	O
changes	O
.	O

Eukaryotic	B
initiation	I
factor	I
3	I
(	O
eIF3	B
)	O
is	O
a	O
large	O
multisubunit	O
complex	O
that	O
stabilizes	O
the	O
ternary	O
complex	O
,	O
eIF2	B
x	O
GTP	O
x	O
tRNA	B
(	I
Met	I
)	I
i	I
and	O
promotes	O
mRNA	O
binding	O
to	O
the	O
40	B
S	I
ribosomal	I
subunit	I
.	O

eIF3	B
also	O
functions	O
as	O
a	O
ribosome	O
subunit	O
anti	O
-	O
association	O
factor	O
.	O

Our	O
data	O
,	O
combined	O
with	O
those	O
of	O
Hershey	O
and	O
co	O
-	O
workers	O
,	O
suggest	O
that	O
mammalian	B
eIF3	I
is	O
composed	O
of	O
at	O
least	O
10	O
subunits	O
:	O
p170	B
,	O
p116	B
(	O
hPrt1	B
)	O
,	O
p110	B
,	O
p66	B
,	O
p48	B
,	O
p47	B
,	O
p44	B
,	O
p40	B
,	O
p36	B
,	O
and	O
p35	B
.	O

Identification	O
of	O
a	O
cis	O
-	O
acting	O
element	O
in	O
the	O
class	B
I	I
major	I
histocompatibility	I
complex	I
gene	I
promoter	I
responsive	O
to	O
activation	O
by	O
retroviral	O
sequences	O
.	O

Lack	O
of	O
sufficient	O
data	O
on	O
vibration	O
measurements	O
and	O
employment	O
durations	O
add	O
to	O
the	O
uncertainty	O
,	O
as	O
do	O
variations	O
in	O
tool	O
conditions	O
(	O
grinder	O
wheels	O
,	O
etc	O
)	O
and	O
inherent	O
difficulties	O
in	O
measurement	O
.	O

C	B
/	I
EBP	I
beta	I
V	I
>	O
A	O
selectively	O
binds	O
only	O
the	O
subset	O
of	O
C	B
/	I
EBP	I
sites	I
that	O
are	O
also	O
DBP	B
sites	I
,	O
both	O
as	O
oligonucleotides	O
and	O
within	O
the	O
natural	O
contexts	O
of	O
the	O
albumin	B
and	O
cholesterol	B
hydroxylase	I
promoters	I
.	O

Specific	O
IgG	B
,	O
specific	O
IgE	B
and	O
total	O
IgE	B
immunoglobulins	I
against	O
Toxocara	B
canis	I
excretory	I
/	I
secretory	I
antigens	I
(	O
TES	B
)	O
were	O
detected	O
by	O
using	O
ELISA	O
technique	O
.	O

Mutating	O
the	O
E	O
-	O
box	O
in	O
the	O
context	O
of	O
the	O
3'-flanking	O
region	O
confirmed	O
that	O
it	O
contributes	O
to	O
the	O
enhancement	O
of	O
transcriptional	O
activity	O
of	O
the	O
alpha1	B
(	I
I	I
)	I
collagen	I
gene	I
promoter	I
.	O

Expression	O
of	O
neuronal	O
traits	O
in	O
pancreatic	O
beta	O
cells	O
.	O

We	O
propose	O
that	O
Mnt	B
:	O
Max	B
:	O
Sin3	B
complexes	O
normally	O
function	O
to	O
restrict	O
Myc	B
:	O
Max	B
activities	O
associated	O
with	O
cell	O
proliferation	O
.	O

Phenotypic	O
changes	O
induced	O
by	O
wild	B
type	I
and	I
variant	I
c	I
-	I
src	I
genes	I
carrying	O
C	O
-	O
terminal	O
sequence	O
alterations	O
.	O

The	O
resurgence	O
of	O
drug	O
-	O
resistant	O
malaria	O
makes	O
urgent	O
the	O
evaluation	O
of	O
new	O
antimalarial	O
agents	O
.	O

In	O
the	O
p51	B
subunit	I
,	O
the	O
Cys181	O
side	O
-	O
chain	O
is	O
oriented	O
in	O
a	O
similar	O
direction	O
to	O
the	O
Tyr181	O
side	O
-	O
chain	O
in	O
the	O
wild	O
-	O
type	O
complex	O
.	O

The	O
relatively	O
high	O
level	O
transcription	O
from	O
this	O
gene	O
shows	O
that	O
the	O
polymorphic	O
chromosome	O
ends	O
of	O
P.	O
falciparum	O
,	O
which	O
have	O
been	O
proposed	O
to	O
be	O
transcriptionally	O
silent	O
,	O
can	O
be	O
active	O
expression	O
sites	O
for	O
var	B
genes	I
.	O

NUP145	B
was	O
previously	O
identified	O
by	O
using	O
a	O
genetic	O
synthetic	O
lethal	O
screen	O
(	O
E.	O

Prevalence	O
of	O
sleep	O
-	O
disordered	O
breathing	O
(	O
SDB	O
)	O
is	O
reported	O
to	O
increase	O
in	O
menopausal	O
women	O
.	O

A	O
total	O
of	O
1459	O
men	O
aged	O
48	O
to	O
84	O
years	O
,	O
who	O
were	O
diagnosed	O
for	O
the	O
first	O
time	O
by	O
physicians	O
as	O
having	O
BPH	O
in	O
1994	O
and	O
who	O
had	O
not	O
received	O
treatment	O
,	O
participated	O
in	O
the	O
study	O
.	O

In	O
vitro	O
translation	O
of	O
the	O
mTRF1	B
cDNA	I
resulted	O
in	O
a	O
56	O
kDa	O
protein	O
that	O
binds	O
to	O
TTAGGG	O
repeat	O
arrays	O
.	O

mTRF1	B
displayed	O
the	O
same	O
sequence	O
specificity	O
as	O
hTRF1	B
,	O
preferring	O
arrays	O
of	O
TTAGGG	O
repeats	O
as	O
a	O
binding	O
substrate	O
over	O
TTAGGC	O
and	O
TTGGGG	O
repeats	O
.	O

The	O
ubiquitously	O
expressed	O
E12	B
bHLH	I
protein	I
dimerizes	O
with	O
numerous	O
cell	O
-	O
specific	O
bHLH	B
factors	I
.	O

The	O
E	O
-	O
box	O
sequence	O
in	O
the	O
SE2	B
fragment	I
of	O
the	O
transferrin	B
promoter	I
was	O
CATCTG	O
and	O
was	O
similar	O
in	O
gel	O
shifts	O
to	O
the	O
consensus	O
E	O
-	O
box	O
elements	O
(	O
CANNTG	O
)	O
previously	O
characterized	O
.	O

A	O
5.3-kb	O
DNA	O
fragment	O
,	O
which	O
included	O
the	O
entire	O
structural	O
porin	B
gene	I
(	O
named	O
porCa	B
)	O
and	O
its	O
flanking	O
regions	O
,	O
was	O
identified	O
.	O

Full	B
-	I
length	I
AT	I
-	I
PHH1	I
,	O
and	O
both	O
AT	B
-	I
PHH1	I
and	O
AT	B
-	I
PHH1	I
delta	I
C-513	I
(	O
truncated	O
to	O
be	O
approximately	O
the	O
size	O
of	O
microbial	B
photolyase	I
genes	I
)	O
cDNAs	O
,	O
were	O
overexpressed	O
,	O
respectively	O
,	O
in	O
yeast	O
and	O
Escherichia	O
coli	O
mutants	O
hypersensitive	O
to	O
ultraviolet	O
light	O
.	O

This	O
report	O
presents	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
5'-flanking	O
region	O
(	O
1.2	O
kb	O
)	O
and	O
exon	O
1	O
of	O
the	O
human	B
RII	I
alpha	I
gene	I
.	O

A	O
cohort	O
of	O
Swedish	O
children	O
was	O
monitored	O
from	O
6	O
months	O
to	O
11	O
years	O
of	O
age	O
.	O

The	O
primary	O
structure	O
of	O
a	O
2671	O
bp	O
DNA	O
fragment	O
between	O
the	O
pla	B
gene	I
(	O
encoding	O
plasminogen	B
activator	I
)	O
and	O
the	O
origin	O
of	O
replication	O
of	O
the	O
wild	O
-	O
type	O
Yersinia	O
pestis	O
plasmid	O
pYP358	O
was	O
determined	O
.	O

MAIN	O
OUTCOME	O
MEASURES	O
:	O
Associations	O
of	O
factor	O
analysis	O
-	O
derived	O
syndromes	O
with	O
risk	O
factors	O
for	O
chemical	O
interactions	O
that	O
inhibit	O
butyrylcholinesterase	B
and	O
neuropathy	O
target	O
esterase	B
.	O

Control	O
examination	O
was	O
performed	O
at	O
the	O
end	O
of	O
each	O
period	O
.	O

The	O
GHR	B
mRNA	I
:	O
GHBP	B
mRNA	I
ratio	O
was	O
1.1	O
+	O
/-	O

0.12	O
and	O
remained	O
unchanged	O
during	O
differentiation	O
.	O

The	O
results	O
demonstrate	O
(	O
i	O
)	O
that	O
the	O
selenocysteine	O
-	O
specific	O
UGA	O
codon	O
is	O
readily	O
suppressed	O
under	O
conditions	O
where	O
the	O
homologous	B
SelB	I
protein	I
is	O
absent	O
and	O
(	O
ii	O
)	O
that	O
apart	O
from	O
the	O
specificity	O
of	O
the	O
SelB	B
-	I
mRNA	I
interaction	O
,	O
a	O
structural	O
compatibility	O
of	O
the	O
quaternary	O
complex	O
with	O
the	O
ribosome	O
is	O
required	O
.	O

One	O
linker	O
-	O
peptide	O
insertion	O
in	O
the	O
RsaA	B
C	I
terminus	I
(	I
amino	I
acid	I
784	I
)	I
had	O
no	O
effect	O
on	O
S	O
-	O
layer	O
biogenesis	O
,	O
while	O
another	O
(	O
amino	O
acid	O
907	O
)	O
disrupted	O
secretion	O
of	O
the	O
protein	O
,	O
suggesting	O
that	O
RsaA	B
possesses	O
a	O
secretion	O
signal	O
lying	O
C	O
terminal	O
to	O
amino	O
acid	O
784	O
,	O
near	O
or	O
including	O
amino	O
acid	O
907	O
.	O

To	O
characterize	O
the	O
gene	O
products	O
,	O
the	O
cvaA	B
gene	I
was	O
subcloned	O
and	O
expressed	O
under	O
the	O
control	O
of	O
T7	B
RNA	I
polymerase	I
promoter	I
.	O

PrpB	B
showed	O
homology	O
to	O
carboxyphosphonoenolpyruvate	B
phosphonomutase	I
of	I
Streptomyces	I
hygroscopicus	I
and	O
to	O
its	O
homolog	O
in	O
the	O
carnation	O
Dianthus	O
caryophyllus	O
;	O
PrpC	B
was	O
homologous	O
to	O
both	O
archaeal	B
and	I
bacterial	I
citrate	I
synthases	I
;	O
PrpD	B
showed	O
homology	O
to	O
yeast	O
and	O
Bacillus	O
subtilis	O
proteins	O
of	O
unknown	O
function	O
;	O
PrpE	B
showed	O
homology	O
to	O
acetyl	B
coenzyme	I
A	I
synthetases	I
.	O

JNK	B
and	O
p38	B
are	O
constitutively	O
present	O
in	O
the	O
nucleus	O
,	O
and	O
DNA	O
-	O
bound	O
c	B
-	I
JUN	I
and	O
ATF-2	B
are	O
stably	O
contacted	O
by	O
JNK	B
and	O
p38	B
,	O
respectively	O
.	O

The	O
effects	O
of	O
dominant	O
interfering	O
forms	O
of	O
the	O
JNK	B
/	O
p38	B
signaling	O
pathway	O
demonstrate	O
that	O
activation	O
of	O
these	O
kinases	O
is	O
critical	O
for	O
cytokine	O
-	O
induced	O
E	B
-	I
selectin	I
gene	I
expression	O
.	O

Sp1	B
binds	O
the	O
CTC	O
repeat	O
with	O
an	O
affinity	O
,	O
KD	O
=	O
0.37	O
nM	O
,	O
at	O
least	O
as	O
high	O
as	O
the	O
consensus	O
GC	O
box	O
.	O

Mutant	O
enzyme	O
forms	O
were	O
prepared	O
to	O
eliminate	O
the	O
initial	O
autoprocessing	O
site	O
and	O
thus	O
form	O
an	O
active	O
single	O
-	O
chain	O
protein	O
for	O
structure	O
-	O
function	O
studies	O
.	O

The	O
primer	O
is	O
generated	O
by	O
a	O
cleavage	O
that	O
occurs	O
between	O
bases	O
11	O
and	O
12	O
of	O
the	O
Tf1	B
mRNA	I
.	O

Similarly	O
,	O
we	O
examined	O
whether	O
the	O
ELK1	B
,	O
SAP1a	B
,	O
FLI1	B
,	O
EWS	B
-	O
FLI1	B
,	O
ETS1	B
,	O
ETS2	B
,	O
PEA3	B
and	O
PU.1	B
proteins	I
can	O
form	O
ternary	O
complexes	O
with	O
SRF	B
on	O
the	O
Egr1	B
SREI	B
and	I
II	I
.	O

This	O
R	O
-	O
domain	O
may	O
modulate	O
the	O
interaction	O
with	O
SRF	B
,	O
providing	O
a	O
mechanism	O
that	O
would	O
be	O
unique	O
to	O
FLI1	B
and	O
EWS	B
-	O
FLI1	B
,	O
thus	O
implicating	O
a	O
novel	O
function	O
for	O
these	O
ETS	B
transcription	I
factors	I
in	O
the	O
regulation	O
of	O
the	O
Egr1	B
gene	I
.	O

The	O
total	O
number	O
of	O
specimens	O
was	O
131	O
with	O
78	O
nonsmokers	O
and	O
53	O
smokers	O
.	O

CDNA	O
cloning	O
of	O
chick	B
brain	I
alpha	I
-	I
amino-3-hydroxy-5-methyl-4-isoxazolepropionic	I
acid	I
receptors	I
reveals	O
conservation	O
of	O
structure	O
,	O
function	O
and	O
post	O
-	O
transcriptional	O
processes	O
with	O
mammalian	O
receptors	O
.	O

Remarkably	O
,	O
both	O
TTD	O
-	O
A	O
and	O
XP	O
-	O
D	O
defects	O
are	O
associated	O
with	O
subunits	O
of	O
TFIIH	B
,	O
a	O
basal	O
transcription	O
factor	O
with	O
a	O
second	O
function	O
in	O
DNA	O
repair	O
.	O

In	O
Experiment	O
1	O
,	O
pups	O
that	O
had	O
received	O
an	O
injection	O
of	O
the	O
noncompetitive	O
N	B
-	I
methyl	I
-	I
D	I
-	I
aspartate	I
receptor	I
antagonist	O
MK-801	O
(	O
0.1	O
mg	O
/	O
kg	O
,	O
i.p	O
.	O
)	O
either	O
30	O
min	O
before	O
or	O
immediately	O
after	O
conditioning	O
spent	O
less	O
time	O
over	O
the	O
conditioned	O
odor	O
than	O
saline	O
-	O
treated	O
controls	O
.	O

Cholesterol	B
side	I
-	I
chain	I
cleavage	I
cytochrome	I
P450	I
(	O
CYP11A	B
;	O
P450scc	B
)	O
gene	O
expression	O
is	O
regulated	O
by	O
gonadotropins	B
via	O
cAMP	O
in	O
the	O
ovary	O
and	O
by	O
ACTH	B
via	O
cAMP	O
in	O
adrenal	O
cortical	O
cells	O
.	O

One	O
possible	O
solution	O
is	O
a	O
thin	O
radial	O
forearm	O
free	O
flap	O
.	O

Phylogenetic	O
analysis	O
gave	O
evidence	O
for	O
a	O
close	O
evolutionary	O
relationship	O
between	O
PhHV-1	O
and	O
members	O
of	O
the	O
Varicellovirus	O
genus	O
of	O
the	O
alpha	O
-	O
Herpesvirinae	O
and	O
canid	O
herpesvirus	O
in	O
particular	O
.	O

In	O
this	O
method	O
,	O
PLP	O
in	O
plasma	O
can	O
be	O
determined	O
with	O
high	O
sensitivity	O
using	O
derivatization	O
with	O
sodium	O
bisulfite	O
in	O
the	O
mobile	O
phase	O
.	O

Moreover	O
,	O
the	O
effect	O
exerted	O
by	O
TIS1	B
appeared	O
to	O
be	O
selective	O
for	O
the	O
MCK	B
promoter	I
.	O

Experimental	O
data	O
showed	O
that	O
these	O
abnormal	O
proteins	O
are	O
constitutively	O
localized	O
in	O
the	O
nucleus	O
,	O
have	O
lost	O
the	O
transcriptional	O
repressor	O
functions	O
typical	O
of	O
normal	O
NF	B
-	I
kappa	I
B2p52	I
and	O
may	O
be	O
capable	O
of	O
transactivation	O
activity	O
.	O

Because	O
L	B
-	I
plastin	I
expression	O
in	O
tissue	O
-	O
specifically	O
regulated	O
in	O
both	O
humans	O
and	O
rodents	O
,	O
it	O
is	O
likely	O
that	O
similar	O
mechanisms	O
regulate	O
L	B
-	I
plastin	I
gene	I
expression	O
in	O
human	O
and	O
rodent	O
cells	O
and	O
that	O
they	O
could	O
be	O
identified	O
by	O
comparing	O
the	O
function	O
and	O
nucleotide	O
sequences	O
of	O
the	O
human	O
and	O
murine	O
L	B
-	I
plastin	I
gene	O
promoters	O
.	O

What	O
's	O
new	O
in	O
gynecologic	O
and	O
obstetrical	O
surgery	O
.	O

Moreover	O
,	O
expression	O
of	O
CBF1	B
in	O
yeast	O
was	O
found	O
to	O
activate	O
transcription	O
of	O
reporter	O
genes	O
containing	O
the	O
C	O
-	O
repeat	O
/	O
DRE	O
as	O
an	O
upstream	O
activator	O
sequence	O
but	O
not	O
mutant	O
versions	O
of	O
the	O
DNA	O
element	O
.	O

Forty	O
-	O
one	O
ASA	O
physical	O
status	O
I	O
or	O
II	O
adult	O
patients	O
undergoing	O
a	O
variety	O
of	O
1	O
-	O
1.5	O
h	O
surgical	O
procedures	O
were	O
randomly	O
allocated	O
to	O
receive	O
CCA	O
with	O
desflurane	O
or	O
isoflurane	O
with	O
ventilation	O
being	O
either	O
spontaneous	O
or	O
controlled	O
.	O

OBJECTIVE	O
:	O
Our	O
goal	O
was	O
to	O
determine	O
whether	O
chlamydia	O
-	O
infected	O
women	O
have	O
a	O
higher	O
rate	O
of	O
febrile	O
complications	O
after	O
postpartum	O
tubal	O
ligation	O
.	O

In	O
the	O
electrophoresis	O
mobility	O
shift	O
assay	O
using	O
nuclear	O
extracts	O
of	O
the	O
myogenic	O
cells	O
,	O
MyoD	B
and	O
myogenin	B
bound	O
to	O
the	O
right	O
E	O
-	O
box	O
in	O
the	O
enhancer	O
region	O
of	O
the	O
MCK	B
gene	I
even	O
in	O
the	O
presence	O
of	O
BMP-2	B
.	O

Finally	O
,	O
antibody	O
binding	O
to	O
site	O
IIIa	O
on	O
the	O
hCG	B
-	I
ectodomain	I
complex	I
was	O
also	O
hindered	O
by	O
an	O
anti	O
-	O
peptide	O
mAb	O
directed	O
against	O
a	O
peptide	O
encoded	O
by	O
the	O
eighth	O
exon	O
(	O
pE	O
x	O
8)	O
of	O
the	O
LHR	B
.	O

cDNA	O
cloning	O
,	O
expression	O
analysis	O
,	O
and	O
chromosomal	O
localization	O
of	O
a	O
gene	O
with	O
high	O
homology	O
to	O
wheat	B
eIF-	I
(	I
iso	I
)	I
4F	I
and	O
mammalian	B
eIF-4	I
G	I
.	O

Human	B
granulocyte	I
-	I
macrophage	I
colony	I
-	I
stimulating	I
factor	I
(	O
hGM	B
-	I
CSF	I
)	O
activates	O
a	O
set	O
of	O
genes	O
such	O
as	O
c	B
-	I
fos	I
,	O
jun	B
,	O
myc	B
,	O
and	O
early	B
growth	I
response	I
gene	I
1	I
(	O
egr-1	B
)	O
.	O

When	O
expressed	O
in	O
COS-7	O
cells	O
,	O
MKP-4	B
blocks	O
activation	O
of	O
MAP	B
kinases	I
with	O
the	O
selectivity	O
ERK	B
>	O
p38	B
=	O
JNK	B
/	O
SAPK	B
.	O

Most	O
kinases	O
are	O
not	O
significantly	O
inhibited	O
by	O
roscovitine	O
.	O

cdc2	B
/	O
cyclin	B
B	I
,	O
cdk2	B
/	O
cyclin	B
A	I
,	O
cdk2	B
/	O
cyclin	B
E	I
and	O
cdk5	B
/	O
p35	B
only	O
are	O
substantially	O
inhibited	O
(	O
IC50	O
values	O
of	O
0.65	O
,	O
0.7	O
,	O
0.7	O
and	O
0.2	O
microM	O
,	O
respectively	O
)	O
.	O

cdk4	B
/	O
cyclin	B
D1	I
and	O
cdk6	B
/	O
cyclin	B
D2	I
are	O
very	O
poorly	O
inhibited	O
by	O
roscovitine	O
(	O
IC50	O
>	O
100	O
microM	O
)	O
.	O

Although	O
Pho85	B
is	O
not	O
essential	O
for	O
viability	O
,	O
Pcl1,2-Pho85	B
kinase	O
complexes	O
become	O
essential	O
for	O
Start	O
in	O
the	O
absence	O
of	O
Cln1,2-Cdc28	B
kinases	O
.	O

Using	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
to	O
screen	O
for	O
proteins	O
which	O
interact	O
with	O
Tax1	B
,	O
we	O
isolated	O
the	O
B	O
subunit	O
of	O
the	O
CCAAT	O
binding	O
protein	O
NF	B
-	I
Y	I
from	O
a	O
HeLa	O
cDNA	O
library	O
.	O

Enhancer	O
activity	O
requires	O
both	O
the	O
AP-1	B
site	I
and	O
these	O
adjacent	O
sequences	O
.	O

Constitutive	O
activation	O
of	O
Rac1	B
and	O
RhoA	B
causes	O
tumorigenic	O
transformation	O
of	O
NIH	O
3T3	O
cells	O
,	O
and	O
their	O
functions	O
may	O
be	O
required	O
for	O
full	O
Ras	B
transformation	O
.	O

DNA	O
sequencing	O
of	O
a	O
17-kb	O
segment	O
encompassing	O
a	O
gammaherpesvirus	O
divergent	O
locus	O
(	O
DL	O
-	O
B	O
)	O
between	O
ORF11	O
and	O
ORF17	O
revealed	O
the	O
presence	O
of	O
nine	O
viral	O
ORFs	O
with	O
predicted	O
gene	O
products	O
related	O
to	O
cellular	O
proteins	O
.	O

Studies	O
in	O
mammalian	O
cells	O
have	O
correlated	O
induction	O
of	O
inhibitory	O
tyrosine	O
15	O
(	O
Y15	O
)	O
phosphorylation	O
on	O
p34cdc2	B
with	O
the	O
response	O
to	O
DNA	O
damage	O
.	O

We	O
report	O
herein	O
the	O
case	O
of	O
a	O
30-year	O
-	O
old	O
man	O
in	O
whom	O
ectopic	O
mediastinal	O
parathyroid	O
adenoma	O
was	O
detected	O
by	O
99mTc	O
-	O
methoxyisobutylisonitrile	O
scintigraphy	O
(	O
99mTc	O
-	O
MIBI	O
)	O
.	O

Cardiac	B
endothelin	I
release	O
and	O
infarct	O
size	O
,	O
myocardial	O
blood	O
flow	O
,	O
and	O
ventricular	O
function	O
in	O
canine	O
infarction	O
and	O
reperfusion	O
.	O

Recent	O
application	O
of	O
recombinant	O
canarypox	O
ALVAC	O
/	O
HIV-1	O
vectors	O
as	O
vaccine	O
immunogens	O
in	O
HIV-1,-noninfected	O
volunteers	O
has	O
produced	O
CTL	O
responses	O
in	O
a	O
significant	O
number	O
of	O
vaccinees	O
.	O

The	O
relevance	O
of	O
these	O
elements	O
in	O
conferring	O
anaerobic	O
induction	O
of	O
gpc4	B
gene	I
expression	O
is	O
discussed	O
.	O

These	O
data	O
support	O
the	O
idea	O
that	O
the	O
repression	O
activity	O
of	O
NRSF	B
/	O
REST	B
depends	O
upon	O
the	O
species	O
of	O
promoter	O
to	O
which	O
it	O
is	O
linked	O
and	O
upon	O
the	O
proteins	O
that	O
bind	O
to	O
those	O
promoters	O
.	O

In	O
summary	O
,	O
p56	B
(	O
lck	B
)	O
activity	O
stimulates	O
G1	O
/	O
S	O
transition	O
in	O
immature	O
thymoblasts	O
and	O
maintains	O
cell	O
viability	O
via	O
transduction	O
of	O
constitutive	O
activation	O
signals	O
downstream	O
to	O
components	O
of	O
the	O
Ras	B
/	O
Raf	B
/	O
MAPK	B
pathway	O
.	O

The	O
FBF	O
questionnaire	O
did	O
not	O
highlight	O
a	O
characteristic	O
basic	O
symptoms	O
profile	O
of	O
schizoaffective	O
disorder	O
,	O
when	O
compared	O
with	O
bipolar	O
affective	O
disorder	O
and	O
schizophrenia	O
.	O

Cognate	O
promoter	O
elements	O
implicated	O
in	O
glucocorticoid-	O
and	O
cAMP	O
-	O
mediated	O
regulation	O
as	O
well	O
as	O
in	O
liver-	O
,	O
myeloid-	O
,	O
and	O
lymphocyte	O
-	O
specific	O
expression	O
are	O
located	O
within	O
the	O
5	O
'	O
flanking	O
sequence	O
.	O

We	O
have	O
studied	O
the	O
biokinetics	O
of	O
BLM	O
labeled	O
with	O
indium-111	O
(	O
In-111	O
)	O
.	O

Acetoin	O
-	O
dependent	O
expression	O
of	O
the	O
acoABCD	B
operon	I
could	O
be	O
restored	O
in	O
the	O
E.	B
coli	I
acoK	I
mutants	I
by	O
supplying	O
a	O
plasmid	O
carrying	O
an	O
intact	O
acoK	B
,	O
suggesting	O
a	O
transactivating	O
function	O
of	O
the	O
gene	O
product	O
.	O

Mutations	O
in	O
the	O
alpha	B
and	I
sigma-70	I
subunits	I
of	I
RNA	I
polymerase	I
affect	O
expression	O
of	O
the	O
mer	B
operon	I
.	O

Taken	O
together	O
,	O
we	O
provide	O
evidence	O
for	O
the	O
existence	O
of	O
an	O
activator	O
,	O
NFE	B
,	O
which	O
in	O
combination	O
with	O
the	O
p50	B
and	O
c	B
-	I
Rel	I
proteins	I
,	O
are	O
part	O
of	O
the	O
transcription	O
factor	O
machinery	O
that	O
regulates	O
3	O
'	O
enhancer	O
activity	O
,	O
and	O
thus	O
the	O
control	O
of	O
the	O
IgH	B
locus	I
in	O
late	O
B	O
lymphocyte	O
development	O
.	O

The	O
genes	O
encoding	O
the	O
transcription	B
factor	I
yTAFII60	I
,	O
the	O
G4p1	B
protein	I
and	O
a	O
putative	O
glucose	O
transporter	O
are	O
contained	O
in	O
a	O
12.3	O
kb	O
DNA	O
fragment	O
on	O
the	O
left	O
arm	O
of	O
Saccharomyces	O
cerevisiae	O
chromosome	O
VII	O
.	O

The	O
protector	O
doubled	O
the	O
estimated	O
fall	O
distance	O
for	O
fracture	O
of	O
the	O
trochanter	O
.	O

Marinol	O
/	O
marijuana	O
usage	O
was	O
associated	O
with	O
depressed	O
CD4	B
+	I
counts	O
and	O
elevated	O
amylase	B
levels	O
within	O
the	O
DDI	O
subgroup	O
.	O

METHODS	O
:	O
Fifty	O
-	O
eight	O
patients	O
who	O
underwent	O
a	O
curative	O
hepatic	O
resection	O
for	O
HCC	O
and	O
whose	O
preoperative	O
AFP	B
levels	O
were	O
>	O
100	O
ng	O
/	O
ml	O
,	O
were	O
selected	O
for	O
this	O
study	O
.	O

Calmodulin	B
-	I
binding	I
peptide	I
(	O
CBP	B
)	O
,	O
a	O
peptide	O
of	O
26	O
amino	O
acids	O
derived	O
from	O
muscle	B
myosin	I
light	I
chain	I
kinase	I
(	O
MLCK	B
)	O
,	O
binds	O
to	O
calmodulin	B
with	O
nanomolar	O
affinity	O
.	O

Here	O
we	O
show	O
that	O
the	O
type	O
of	O
tyrosine	B
kinase	I
receptor	I
stimulated	O
also	O
participates	O
in	O
the	O
nature	O
of	O
the	O
cAMP	O
effect	O
.	O

Northern	O
blot	O
analysis	O
of	O
LeMT	B
(	I
A	I
)	I
and	O
LeMT	B
(	I
B	I
)	I
showed	O
that	O
transcripts	O
of	O
both	O
MT	B
-	I
like	I
genes	I
were	O
more	O
abundant	O
in	O
leaves	O
than	O
roots	O
in	O
tomato	O
plants	O
grown	O
without	O
addition	O
of	O
extra	O
metal	O
ions	O
,	O
a	O
characteristic	O
of	O
type	B
II	I
MTs	I
.	O

In	O
some	O
instances	O
,	O
this	O
is	O
partly	O
mediated	O
by	O
the	O
expression	O
of	O
virally	O
encoded	O
proteases	O
which	O
lead	O
to	O
the	O
cleavage	O
of	O
initiation	B
factor	I
eIF4	I
G	I
.	O

Unlike	O
class	O
II-	O
and	O
III	O
-	O
specific	O
TBP	B
-	O
TAF	B
complexes	O
,	O
the	O
corresponding	O
murine	O
and	O
human	O
class	O
I	O
-	O
specific	O
transcription	O
initiation	O
factor	O
TIF	B
-	I
IB	I
/	O
SL1	B
exhibits	O
a	O
pronounced	O
selectivity	O
for	O
its	O
homologous	O
promoter	O
.	O

We	O
now	O
describe	O
the	O
identification	O
of	O
DEK	B
as	O
this	O
43-kDa	B
pets	I
factor	I
.	O

These	O
elements	O
comprise	O
a	O
binding	O
site	O
for	O
Krox	B
proteins	I
,	O
one	O
for	O
nuclear	B
factor	I
1	I
,	O
an	O
octamer	O
motif	O
that	O
binds	O
POU	B
-	I
homeodomain	I
proteins	I
,	O
and	O
a	O
novel	O
TN	B
control	I
element	I
.	O

Therefore	O
,	O
the	O
impaired	O
floor	O
plate	O
development	O
in	O
oep	B
mutants	I
is	O
not	O
caused	O
by	O
the	O
absence	O
of	O
the	O
floor	B
plate	I
inducer	I
shh	I
.	O

RESULTS	O
:	O
The	O
medians	O
of	O
average	O
daily	O
CD34	B
+	I
cell	O
yields	O
for	O
patients	O
who	O
received	O
paclitaxel	O
plus	O
CY	O
,	O
CE	O
,	O
and	O
CEP	O
with	O
G	B
-	I
CSF	I
were	O
12.9	O
,	O
11.03	O
,	O
and	O
5.37	O
x	O
10	O
(	O
6	O
)	O
/	O
kg	O
,	O
respectively	O
,	O
compared	O
with	O
2.02	O
x	O
10	O
(	O
6	O
)	O
/	O
kg	O
in	O
the	O
reference	O
group	O
that	O
received	O
CY	O
with	O
G	B
-	I
CSF	I
(	O
P	O
=	O
<	O
.0001	O
,	O
.002	O
,	O
and	O
.09	O
,	O
respectively	O
)	O
.	O

Increased	O
p53	B
activity	O
induced	O
by	O
OP	O
is	O
not	O
due	O
to	O
elevated	O
p53	B
mRNA	I
nor	O
to	O
protein	O
levels	O
.	O

CONCLUSION	O
:	O
Chronic	O
administration	O
of	O
misoprostol	O
may	O
have	O
caused	O
a	O
negative	O
natriuretic	O
effect	O
in	O
cirrhotic	O
patients	O
with	O
ascites	O
.	O

The	O
region	O
of	O
plasmid	O
pCM2	O
encoding	O
the	O
pathogenicity	B
locus	I
pat-1	I
was	O
mapped	O
by	O
deletion	O
analysis	O
and	O
complementation	O
studies	O
to	O
a	O
1.5-kb	O
Bg	B
/	I
II	I
/	O
SmaI	B
DNA	O
fragment	O
.	O

Transient	O
cotransfection	O
of	O
tat	B
cDNA	I
in	O
sense	O
orientation	O
(	O
tat	B
/	I
S	I
)	O
,	O
together	O
with	O
a	O
plasmid	O
containing	O
the	O
c	B
-	I
fos	I
promoter	I
(	O
FC3	B
,	O
from	O
-711	O
to	O
+	O
42	O
)	O
in	O
front	O
of	O
the	O
bacterial	B
chloramphenicol	I
acetyltransferase	I
(	O
CAT	B
)	O
gene	O
significantly	O
enhanced	O
CAT	B
activity	O
in	O
Jurkat	O
cells	O
activated	O
by	O
the	O
addition	O
of	O
15	O
%	O
fetal	O
calf	O
serum	O
(	O
FCS	O
)	O
or	O
5	O
micrograms	O
/	O
mL	O
phytohemagglutinin	B
plus	O
10	O
(	O
-7	O
)	O
mol	O
/	O
L	O
phorbol	O
myristate	O
acetate	O
(	O
PMA	O
)	O
and	O
U937	O
cells	O
activated	O
by	O
15	O
%	O
FCS	O
or	O
10	O
(	O
-7	O
)	O
mol	O
/	O
L	O
PMA	O
.	O

Snail	O
mortality	O
did	O
not	O
differ	O
among	O
the	O
various	O
treatment	O
conditions	O
.	O

Derepression	O
of	O
gene	O
expression	O
mediated	O
by	O
the	O
5	O
'	O
upstream	O
region	O
of	O
the	O
isocitrate	B
lyase	I
gene	I
of	I
Candida	I
tropicalis	I
is	O
controlled	O
by	O
two	O
distinct	O
regulatory	O
pathways	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

To	O
avoid	O
complications	O
,	O
accurate	O
quantitative	O
analysis	O
of	O
NO	O
and	O
NO2	O
is	O
necessary	O
during	O
this	O
therapy	O
.	O

Our	O
results	O
demonstrate	O
that	O
cis	O
elements	O
positioned	O
between	O
the	O
alpha	B
3	I
and	O
beta	B
4	I
coding	O
regions	O
are	O
important	O
for	O
establishing	O
part	O
of	O
the	O
restricted	O
CNS	O
patterns	O
of	O
beta	B
4	I
,	O
alpha	B
3	I
,	O
and	O
alpha	B
5	I
gene	I
transcription	O
.	O

RNase	B
protection	O
experiments	O
confirmed	O
the	O
presence	O
of	O
the	O
GHR1	B
-	I
279	I
variant	I
in	O
IM-9	O
cells	O
and	O
human	O
liver	O
.	O

Functional	O
tests	O
using	O
a	O
reporter	O
gene	O
,	O
containing	O
Stat5-binding	B
elements	I
,	O
confirmed	O
that	O
while	O
the	O
variant	O
form	O
was	O
inactive	O
by	O
itself	O
,	O
it	O
could	O
inhibit	O
the	O
function	O
of	O
the	O
full	O
-	O
length	O
receptor	O
.	O

Conversely	O
,	O
activated	O
glucocorticoid	B
receptors	I
suppressed	O
the	O
transactivation	O
function	O
of	O
p53	B
,	O
while	O
transrepression	O
by	O
p53	B
was	O
largely	O
unaffected	O
.	O

This	O
brief	O
review	O
analyses	O
these	O
interactions	O
and	O
defines	O
clinical	O
settings	O
where	O
antibiotic	O
-	O
induced	O
endotoxin	O
release	O
may	O
prove	O
to	O
be	O
clinically	O
relevant	O
.	O

This	O
promoter	O
segment	O
could	O
drive	O
expression	O
of	O
a	O
luciferase	B
reporter	I
gene	I
,	O
could	O
confer	O
correct	O
transcriptional	O
initiation	O
to	O
the	O
reporter	O
and	O
could	O
confer	O
the	O
EGF	B
-	O
responsiveness	O
previously	O
observed	O
in	O
the	O
native	O
gene	O
.	O

This	O
is	O
the	O
first	O
report	O
that	O
an	O
in	O
vitro	O
-	O
synthesized	O
alphavirus	O
RNA	O
lacking	O
a	O
poly	O
(	O
A	O
)	O
tail	O
can	O
initiate	O
infection	O
and	O
produce	O
3	O
'	O
polyadenylated	O
viral	O
genome	O
in	O
vivo	O
.	O

The	O
human	O
coreceptor	O
was	O
as	O
active	O
as	O
the	O
simian	O
for	O
SIV	O
entry	O
.	O

These	O
changes	O
in	O
virus	O
entry	O
features	O
may	O
result	O
in	O
coronaviruses	O
with	O
novel	O
pathogenic	O
properties	O
.	O

RESULTS	O
:	O
Among	O
women	O
,	O
the	O
age	O
-	O
related	O
decline	O
in	O
BMD	O
at	O
all	O
non	O
-	O
spine	O
skeletal	O
sites	O
was	O
significantly	O
different	O
from	O
zero	O
,	O
with	O
the	O
largest	O
decline	O
seen	O
at	O
the	O
femoral	O
neck	O
(	O
-.0038	O
g	O
/	O
cm2	O
/	O
y	O
,	O
p	O
<	O
.001	O
)	O
and	O
the	O
smallest	O
at	O
the	O
trochanter	O
of	O
the	O
hip	O
(	O
-.0023	O
g	O
/	O
cm2	O
/	O
y	O
,	O
p	O
=	O
.03	O
)	O
.	O

Sixty	O
-	O
nine	O
(	O
44	O
%	O
)	O
patients	O
were	O
administered	O
250	O
MBq	O
(	O
7	O
mCi	O
)	O
99Tcm	O
-	O
tetrofosmin	O
at	O
rest	O
followed	O
4	O
h	O
later	O
by	O
750	O
MBq	O
(	O
21	O
mCi	O
)	O
during	O
stress	O
(	O
the	O
1	O
day	O
protocol	O
)	O
,	O
whereas	O
88	O
(	O
56	O
%	O
)	O
patients	O
had	O
rest	O
and	O
stress	O
imaging	O
studies	O
on	O
two	O
separate	O
days	O
,	O
receiving	O
a	O
500	O
MBq	O
(	O
14	O
mCi	O
)	O
dose	O
of	O
99Tcm	O
-	O
tetrofosmin	O
on	O
each	O
occasion	O
(	O
the	O
2	O
day	O
protocol	O
)	O
.	O

We	O
have	O
thus	O
identified	O
the	O
first	O
mammalian	B
homolog	I
of	I
yeast	I
UPF1	I
,	O
a	O
protein	O
that	O
regulates	O
levels	O
of	O
nonsense	O
mRNA	O
,	O
and	O
we	O
tentatively	O
name	O
this	O
protein	O
human	B
HUPF1	I
(	O
for	O
human	B
homolog	I
of	I
UPF1	I
)	O
.	O

In	O
cell	O
lines	O
transformed	O
by	O
BCR	B
/	O
ABL	B
,	O
CRKL	B
was	O
tyrosine	O
phosphorylated	O
,	O
while	O
CRK	B
was	O
not	O
.	O

In	O
untransformed	O
cells	O
,	O
three	O
major	O
proteins	O
coprecipitated	O
with	O
CRKL	B
,	O
identified	O
as	O
C3	B
G	I
,	O
SOS	B
and	O
c	B
-	I
ABL	I
.	O

Circulating	O
oxytocin	B
in	O
male	O
guinea	O
pigs	O
affected	O
by	O
the	O
female	O
cohabitation	O
and	O
reproductive	O
condition	O
.	O

In	O
cellular	O
supernatant	O
fraction	O
,	O
SHRSP	O
showed	O
a	O
decrease	O
of	O
magnesium	O
in	O
many	O
tissues	O
and	O
an	O
elevation	O
of	O
the	O
calcium	O
to	O
magnesium	O
ratio	O
when	O
compared	O
to	O
age	O
-	O
matched	O
WKY	O
and	O
SHRSR	O
.	O

Antisense	O
transcription	O
of	O
a	O
murine	B
FGFR-3	I
psuedogene	I
during	O
fetal	O
developement	O
.	O

GH	B
deficiency	O
may	O
be	O
absolute	O
,	O
but	O
often	O
is	O
not	O
and	O
the	O
diagnosis	O
may	O
be	O
complicated	O
by	O
a	O
constellation	O
of	O
physical	O
and	O
hormonal	O
findings	O
that	O
are	O
along	O
a	O
spectrum	O
from	O
low	O
normal	O
GH	B
sufficiency	O
to	O
absent	O
GH	B
secretion	O
.	O

Positive	O
CRP	B
test	O
were	O
seen	O
.	O

During	O
the	O
febrile	O
period	O
,	O
pleocytosis	O
was	O
associated	O
with	O
high	O
levels	O
of	O
IgG	B
,	O
IL-6	B
,	O
TNF	B
-	I
alpha	I
,	O
and	O
PGE2	O
in	O
the	O
cerebrospinal	O
fluid	O
.	O

Recognition	O
mechanisms	O
of	O
the	O
minus	O
-	O
strand	O
origin	O
of	O
phage	O
f1	O
by	O
Escherichia	B
coli	I
RNA	I
polymerase	I
.	O

The	O
minimum	O
and	O
essential	O
subunits	O
for	O
RNA	O
synthesis	O
have	O
not	O
yet	O
been	O
identified	O
.	O

Syndecan-4	B
is	O
a	O
focal	O
adhesion	O
component	O
,	O
and	O
this	O
interaction	O
may	O
both	O
localize	O
PKC	B
and	O
amplify	O
its	O
activity	O
at	O
sites	O
of	O
forming	O
adhesions	O
.	O

Members	O
of	O
the	O
MAPK	B
family	I
include	O
the	O
extracellular	B
response	I
kinases	I
(	O
ERKs	B
or	O
p42	B
/	I
44	I
(	O
MAPK	B
)	O
)	O
,	O
the	O
c	B
-	I
Jun	I
amino	I
-	I
terminal	I
kinases	I
(	O
JNKs	B
)	O
,	O
and	O
the	O
p38	B
/	O
Hog	B
1	I
protein	O
kinases	O
.	O

MOP5	B
contained	O
the	O
characteristic	O
PAS	B
domain	O
and	O
a	O
variable	O
C	O
terminus	O
;	O
it	O
is	O
possible	O
that	O
the	O
cDNA	O
contains	O
a	O
bHLH	O
domain	O
,	O
but	O
the	O
entire	O
open	O
reading	O
frame	O
has	O
yet	O
to	O
be	O
completed	O
.	O

Some	O
8.8	O
kb	O
of	O
the	O
Lactobacillus	O
sake	O
plasmid	O
pCIM1	O
was	O
sequenced	O
,	O
revealing	O
eight	O
tightly	O
clustered	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
downstream	O
from	O
lasA	B
,	O
which	O
encodes	O
pre	B
-	I
lactocin	I
S.	I

Purified	B
Pra	I
was	O
also	O
shown	O
to	O
physically	O
interact	O
with	O
pyruvate	B
kinase	I
(	O
Pk	B
)	O
;	O
Pk	B
and	O
Pra	B
can	O
form	O
a	O
complex	O
,	O
but	O
when	O
the	O
12-kDa	B
Ndk	I
,	O
Pk	B
,	O
and	O
Pra	B
are	O
all	O
present	O
,	O
Pk	B
has	O
a	O
higher	O
affinity	O
than	O
Pra	B
for	O
forming	O
a	O
complex	O
with	O
the	O
12-kDa	B
Ndk	I
.	O

Apart	O
from	O
iron	O
regulation	O
,	O
sodA	B
expression	O
was	O
affected	O
by	O
changes	O
in	O
DNA	O
topology	O
induced	O
by	O
coumermycin	O
A	O
but	O
not	O
by	O
the	O
global	O
virulence	O
regulatory	O
Bvg	B
system	I
.	O

M.	B
leprae	I
OxyR	I
was	O
overproduced	O
and	O
purified	O
,	O
and	O
its	O
binding	O
to	O
the	O
oxyR	B
-	O
ahpC	B
intergenic	O
region	O
of	O
M.	O
leprae	O
was	O
demonstrated	O
.	O

The	O
binding	O
site	O
for	O
OxyR	B
overlapped	O
P1oxyR	B
,	O
reminiscent	O
of	O
the	O
autoregulatory	O
loops	O
controlling	O
expression	O
of	O
oxyR	B
in	O
enteric	O
bacteria	O
and	O
characteristic	O
of	O
the	O
LysR	B
superfamily	I
in	O
general	O
.	O

Thirty	O
-	O
five	O
patients	O
were	O
included	O
.	O

Therefore	O
more	O
active	O
and	O
tolerable	O
salvage	O
regimens	O
are	O
needed	O
.	O

While	O
TGF	B
-	I
beta1	I
does	O
not	O
alter	O
the	O
mitogen	O
-	O
induced	O
expression	O
and	O
abundance	O
of	O
G1	O
phase	O
cyclin	B
D1	I
and	O
cdks	B
4	I
and	I
2	I
in	O
MCs	O
,	O
it	O
inhibits	O
cyclin	B
E	I
-	O
cdk	B
2	I
activity	O
,	O
thus	O
preventing	O
mitogen	O
-	O
elicited	O
phosphorylation	O
and	O
inactivation	O
of	O
pRb	B
in	O
G1	O
phase	O
and	O
transition	O
to	O
S	O
phase	O
.	O

However	O
,	O
the	O
range	O
of	O
values	O
observed	O
is	O
suggestive	O
of	O
the	O
need	O
to	O
investigate	O
districts	O
with	O
contrasting	O
values	O
of	O
SYPLR	O
with	O
respect	O
to	O
the	O
inter	O
-	O
relationships	O
between	O
sociodemographic	O
characteristics	O
,	O
duration	O
of	O
symptoms	O
,	O
clinical	O
presentation	O
and	O
treatment	O
efficacy	O
.	O

The	O
prominent	O
lesions	O
were	O
confined	O
to	O
the	O
cerebral	O
surface	O
layer	O
and	O
leptomeningeal	O
tissue	O
including	O
the	O
arachnoid	O
vessels	O
,	O
which	O
were	O
all	O
bathed	O
in	O
the	O
cerebrospinal	O
fluid	O
,	O
suggesting	O
that	O
some	O
necrotizing	O
toxins	O
had	O
been	O
secreted	O
into	O
the	O
fluid	O
by	O
the	O
B.	O
cereus	O
.	O

Movement	O
time	O
and	O
kinematic	O
characteristics	O
were	O
analyzed	O
together	O
with	O
the	O
magnitude	O
of	O
cerebral	O
blood	O
flow	O
to	O
identify	O
areas	O
of	O
brain	O
activity	O
proportionate	O
to	O
task	O
and	O
movement	O
variables	O
.	O

Areas	O
with	O
significantly	O
greater	O
rCBF	O
for	O
targeting	O
were	O
the	O
left	O
motor	O
cortex	O
,	O
left	O
intraparietal	O
sulcus	O
,	O
and	O
left	O
caudate	O
.	O

Thus	O
,	O
the	O
tri	O
-	O
snRNP	O
-	O
specific	O
27	O
K	O
protein	O
could	O
potentially	O
be	O
involved	O
in	O
SR	B
protein	O
-	O
mediated	O
protein	O
/	O
protein	O
interactions	O
and	O
,	O
additionally	O
,	O
its	O
phosphorylation	O
state	O
could	O
modulate	O
pre	O
-	O
mRNA	O
splicing	O
.	O

Purified	B
P7	I
could	O
be	O
assembled	O
onto	O
particles	O
lacking	O
P7	B
and	O
particles	O
lacking	O
both	O
P2	B
(	O
RNA	B
polymerase	I
)	O
and	O
P7	B
.	O

However	O
,	O
the	O
same	O
U1A	B
peptide	I
,	O
when	O
conjugated	O
to	O
BSA	B
,	O
inhibits	O
vertebrate	B
PAP	I
.	O

Plasma	O
levels	O
of	O
protein	B
C	I
,	O
protein	B
S	I
,	O
and	O
antithrombin	B
III	I
in	O
patients	O
with	O
subarachnoid	O
haemorrhage	O
.	O

Recombinant	O
plasmids	O
containing	O
the	O
entire	O
322	O
nt	O
5	O
'	O
UTR	O
of	O
exon	O
1	O
and	O
a	O
1630	O
nt	O
segment	O
of	O
5	O
'	O
flanking	O
sequence	O
stimulated	O
luciferase	B
activity	O
nearly	O
70	O
times	O
higher	O
than	O
a	O
promoterless	O
control	O
plasmid	O
.	O

Analysis	O
for	O
DNA	O
-	O
protein	O
interactions	O
by	O
in	O
vitro	O
DNase	B
-	I
I	I
footprinting	O
identified	O
a	O
broad	O
region	O
of	O
protection	O
extending	O
from	O
nt	O
-12	O
to	O
+	O
38	O
.	O

It	O
is	O
also	O
homologous	O
to	O
other	O
sugar	O
carriers	O
from	O
human	O
,	O
mouse	O
and	O
Escherichia	O
coli	O
.	O

Although	O
methods	O
to	O
align	O
the	O
control	O
and	O
activation	O
fMR	O
images	O
may	O
correct	O
for	O
some	O
of	O
this	O
motional	O
error	O
,	O
they	O
will	O
be	O
incomplete	O
in	O
correcting	O
for	O
those	O
that	O
depend	O
on	O
spatial	O
orientation	O
.	O

Three	O
women	O
have	O
had	O
abnormal	O
endocervical	O
follow	O
up	O
cytology	O
suggestive	O
of	O
residual	O
disease	O
.	O

Analysis	O
of	O
homologous	O
DNA	O
sequences	O
within	O
the	O
first	O
intron	O
of	O
the	O
mouse	B
and	I
human	I
mts1	I
genes	I
:	O
kB	B
-	I
like	I
site	I
and	O
microsatellite	O
DNA	O

The	O
integration	O
at	O
the	O
VIP	B
CyRE	B
of	O
the	O
Jak	B
-	O
Stat	B
and	O
AP-1	B
signaling	O
pathways	O
with	O
other	O
pre	O
-	O
existing	O
proteins	O
provides	O
a	O
cellular	O
mechanism	O
for	O
cell-	O
and	O
cytokine	O
-	O
specific	O
signaling	O
.	O

Our	O
results	O
show	O
that	O
the	O
temperature	B
-	I
sensitive	I
rad54	I
-	I
3	I
allele	I
blocks	O
mitotic	O
recombination	O
between	O
tandemly	O
repeated	O
DYZ3	B
satellite	I
sequences	I
and	O
significantly	O
stabilizes	O
a	O
human	B
DYZ5	I
satellite	O
-	O
containing	O
YAC	O
clone	O
.	O

Circularized	O
Ac	B
/	O
Ds	B
transposons	O
:	O
formation	O
,	O
structure	O
and	O
fate	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
examined	O
the	O
regulation	O
of	O
B	B
-	I
Myb	I
activity	O
by	O
cyclin	B
-	O
Cdks	B
.	O

This	O
locus	O
maps	O
approximately	O
160	O
kbp	O
from	O
the	O
genes	O
encoding	O
cytadherence	O
-	O
associated	O
proteins	O
HMW1	B
and	O
HMW3	B
,	O
and	O
yet	O
insertions	O
therein	O
result	O
in	O
loss	O
of	O
these	O
proteins	O
and	O
a	O
hemadsorption	O
-	O
negative	O
(	O
HA-	O
)	O
phenotype	O
,	O
prompting	O
the	O
designation	O
cytadherence	B
-	I
regulatory	I
locus	I
(	O
crl	B
)	O
.	O

Coliphage	B
186	I
B	I
is	O
a	O
72-amino	O
acid	O
protein	O
belonging	O
to	O
the	O
Ogr	B
family	O
of	O
analogous	O
transcription	O
factors	O
present	O
in	O
P2-like	O
phage	O
,	O
which	O
contain	O
a	O
Cys	O
-	O
X2-Cys	O
-	O
X22-Cys	O
-	O
X4-Cys	O
presumptive	O
zinc	O
-	O
finger	O
motif	O
.	O

Diacylglycerol	B
kinase	I
(	O
DGK	B
)	O
attenuates	O
levels	O
of	O
second	O
messenger	O
diacylglycerol	O
in	O
cells	O
and	O
produces	O
another	O
(	O
putative	O
)	O
messenger	O
,	O
phosphatidic	O
acid	O
.	O

Active	O
complexes	O
eluted	O
at	O
a	O
higher	O
molecular	O
weight	O
than	O
inactive	O
complexes	O
,	O
were	O
relatively	O
deficient	O
in	O
both	O
p21	B
and	O
p27	B
,	O
and	O
contained	O
Cdk2	B
with	O
increased	O
threonine	O
160	O
phosphorylation	O
,	O
consistent	O
with	O
a	O
mechanism	O
of	O
activation	O
of	O
cyclin	B
E	I
-	O
Cdk2	B
involving	O
both	O
reduced	O
CDK	B
inhibitor	O
association	O
and	O
CDK	B
-	I
activating	I
kinase	I
-	O
mediated	O
phosphorylation	O
of	O
Cdk2	B
.	O

The	O
derivatives	O
of	O
the	O
latter	O
two	O
cell	O
lines	O
showed	O
increased	O
expression	O
of	O
the	O
p27Kip1	B
protein	I
and	O
inhibition	O
of	O
cell	O
growth	O
.	O

Chronic	O
renal	O
failure	O
patients	O
essentially	O
die	O
from	O
cardiovascular	O
causes	O
,	O
and	O
the	O
frequency	O
of	O
malignant	O
disease	O
responsible	O
for	O
death	O
is	O
estimated	O
to	O
be	O
10	O
%	O
.	O

The	O
new	O
FIGO	O
definition	O
of	O
cervical	O
cancer	O
stage	O
IA	O
:	O
a	O
critique	O
.	O

The	O
effect	O
of	O
Vpu	B
on	O
class	O
I	O
biogenesis	O
was	O
analyzed	O
in	O
more	O
detail	O
using	O
a	O
Vpu	B
-	O
expressing	O
recombinant	O
vaccinia	O
virus	O
(	O
VV	O
)	O
.	O

This	O
study	O
indicates	O
that	O
the	O
phenotype	O
of	O
myofibrillar	O
disarray	O
seen	O
in	O
HCM	O
patients	O
which	O
harbor	O
either	O
of	O
these	O
two	O
mutations	O
may	O
not	O
be	O
directly	O
due	O
to	O
the	O
failure	O
of	O
the	O
mutant	B
myosin	I
heavy	I
chain	I
protein	I
to	O
assemble	O
and	O
form	O
normal	O
sarcomeres	O
,	O
but	O
may	O
rather	O
be	O
a	O
secondary	O
effect	O
possibly	O
resulting	O
from	O
the	O
chronic	O
stress	O
of	O
decreased	O
beta	B
MHC	I
function	O
.	O

Inductively	O
coupled	O
plasma	O
atomic	O
emission	O
spectroscopy	O
was	O
employed	O
to	O
obtain	O
the	O
tissue	O
silicon	O
measurements	O
.	O

A	O
method	O
for	O
the	O
simultaneous	O
determination	O
of	O
de	O
(	O
N	O
-	O
methyl	O
)	O
-N	O
-	O
ethyl-8,9	O
-anhydroerythromycin	O
A	O
6,9-hemiacetal	O
(	O
EM523	O
,	O
I	O
)	O
and	O
its	O
three	O
metabolites	O
in	O
human	O
plasma	O
and	O
urine	O
has	O
been	O
developed	O
using	O
high	O
-	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
with	O
chemiluminescence	O
(	O
CL	O
)	O
detection	O
.	O

Similarly	O
,	O
the	O
DNA	O
-	O
binding	O
activity	O
of	O
activator	B
protein	I
1	I
(	O
AP-1	B
)	O
is	O
modified	O
by	O
a	O
DNA	B
repair	I
enzyme	I
,	O
redox	B
factor	I
1	I
(	O
Ref-1	B
)	O
,	O
which	O
is	O
identical	O
to	O
a	O
DNA	B
repair	I
enzyme	I
,	O
AP	B
endonuclease	I
.	O

Results	O
from	O
our	O
and	O
other	O
laboratories	O
have	O
suggested	O
that	O
UCN-01	O
induces	O
preferential	O
G1-phase	O
accumulation	O
in	O
several	O
human	O
tumor	O
cell	O
lines	O
tested	O
.	O

Northern	O
and	O
RT	O
-	O
PCR	O
analysis	O
of	O
Ube3a	B
expression	O
in	O
mouse	O
tissues	O
from	O
animals	O
with	O
segmental	O
,	O
paternal	O
uniparental	O
disomy	O
failed	O
to	O
detect	O
substantially	O
reduced	O
or	O
absent	O
expression	O
compared	O
to	O
control	O
animals	O
,	O
failing	O
to	O
provide	O
any	O
evidence	O
for	O
maternal	O
-	O
specific	O
expression	O
from	O
this	O
locus	O
.	O

A	O
novel	O
,	O
testis	B
-	I
specific	I
mRNA	I
transcript	I
encoding	O
an	O
NH2-terminal	B
truncated	I
nitric	I
-	I
oxide	I
synthase	I
.	O

mRNA	O
diversity	O
represents	O
a	O
major	O
theme	O
of	O
neuronal	B
nitric	I
-	I
oxide	I
synthase	I
(	O
nNOS	B
)	O
gene	O
expression	O
in	O
somatic	O
cells	O
/	O
tissues	O
.	O

Unlike	O
the	O
MAR	O
-	O
binding	O
domain	O
,	O
the	O
homeodomain	B
when	O
isolated	O
binds	O
poorly	O
and	O
with	O
low	O
specificity	O
to	O
DNA	O
.	O

Cyclin	B
D1	I
could	O
not	O
be	O
displaced	O
from	O
cdk4	B
in	O
the	O
resistant	O
184A1L5R	O
cell	O
lysates	O
.	O

The	O
importance	O
of	O
posttranslational	O
regulation	O
of	O
p15INK4B	B
by	O
TGF	B
-	I
beta	I
is	O
underlined	O
by	O
the	O
observation	O
that	O
in	O
TGF	B
-	I
beta	I
-	O
resistant	O
184A1L5R	O
,	O
although	O
the	O
p15	B
transcript	I
increased	O
,	O
p15INK4B	B
protein	I
was	O
not	O
stabilized	O
and	O
did	O
not	O
accumulate	O
,	O
and	O
cyclin	B
D1-cdk	I
association	O
and	O
kinase	O
activation	O
were	O
not	O
inhibited	O
.	O

The	O
Rlm1	B
protein	I
,	O
a	O
member	O
of	O
the	O
MADS	B
box	I
family	I
of	O
transcription	O
factors	O
,	O
functions	O
downstream	O
of	O
Mpk1	B
in	O
the	O
pathway	O
.	O

DNA	O
-	O
binding	O
activity	O
was	O
not	O
increased	O
by	O
the	O
addition	O
of	O
forskolin	O
to	O
thecal	O
or	O
luteal	O
cells	O
.	O

Upon	O
induction	O
of	O
SOS	O
,	O
viability	O
increased	O
2	O
-	O
6-fold	O
.	O

In	O
particular	O
,	O
Western	O
,	O
supershift	O
,	O
and	O
promoter	O
deletion	O
analyses	O
suggested	O
a	O
role	O
for	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
-	I
beta	I
(	O
C	B
/	I
EBP	I
-	I
beta	I
)	O
binding	O
site	O
between	O
-2010	O
and	O
-1954	O
in	O
regulating	O
transcription	O
of	O
collagenase-1	B
in	O
monocytic	O
cells	O
.	O

Cdc2	B
co	O
-	O
precipitates	O
with	O
Pch1	B
in	O
S.	O
pombe	O
cell	O
lysates	O
,	O
although	O
Cdc2	B
may	O
not	O
be	O
the	O
major	O
catalytic	O
partner	O
of	O
a	O
Pch1	B
kinase	I
in	O
vivo	O
.	O

Little	O
is	O
known	O
about	O
the	O
mechanism	O
,	O
but	O
the	O
availability	O
of	O
rapid	O
facile	O
assays	O
for	O
monitoring	O
immunoglobulin	B
hypermutation	O
would	O
greatly	O
aid	O
the	O
development	O
of	O
culture	O
systems	O
for	O
hypermutating	O
B	O
cells	O
as	O
well	O
as	O
the	O
screening	O
for	O
individuals	O
deficient	O
in	O
the	O
process	O
.	O

Expression	O
of	O
the	O
human	B
heat	I
shock	I
protein	I
70	I
gene	I
(	O
hsp70	B
)	O
is	O
induced	O
by	O
various	O
kinds	O
of	O
stress	O
and	O
by	O
oncogenes	O
.	O

Of	O
these	O
proteins	O
,	O
five	O
have	O
previously	O
been	O
shown	O
to	O
be	O
phosphorylated	O
during	O
mitosis	O
(	O
epithelial	B
-	I
microtubule	I
associated	I
protein-115	I
,	O
Oct91	B
,	O
Elongation	B
factor	I
1gamma	I
,	O
BRG1	B
and	O
Ribosomal	B
protein	I
L18A	I
)	O
,	O
five	O
are	O
related	O
to	O
proteins	O
postulated	O
to	O
have	O
roles	O
in	O
mitosis	O
(	O
epithelial	B
-	I
microtubule	I
associated	I
protein-115	I
,	O
Schizosaccharomyces	B
pombe	I
Cdc5	I
,	O
innercentrosome	B
protein	I
,	O
BRG1	B
and	O
the	O
RNA	B
helicase	I
WM6	I
)	O
,	O
and	O
nine	O
are	O
related	O
to	O
transcription	O
factors	O
(	O
BRG1	B
,	O
negative	B
co	I
-	I
factor	I
2alpha	I
,	O
Oct91	B
,	O
S.	O
pombe	O
Cdc5	B
,	O
HoxD1	B
,	O
Sox3	B
,	O
Vent2	B
,	O
and	O
two	O
isoforms	O
of	O
Xbr1b	B
)	O
.	O

Thus	O
,	O
depending	O
on	O
their	O
location	O
,	O
psoralen	O
cross	O
-	O
links	O
affected	O
different	O
steps	O
in	O
the	O
initiation	O
process	O
.	O

L	O
-	O
canavanine	O
,	O
a	O
selective	O
inhibitor	O
of	O
the	O
inducible	O
nitric	B
oxide	I
synthase	I
,	O
increases	O
the	O
mean	O
systemic	O
filling	O
pressure	O
,	O
thereby	O
improving	O
venous	O
return	O
,	O
under	O
these	O
conditions	O
.	O

The	O
different	O
holoenzyme	B
RNA	I
polymerases	I
generated	O
upon	O
reconstituting	O
these	O
mutants	O
independently	O
with	O
core	B
RNA	I
polymerase	I
(	O
alpha2beta	B
beta	I
'	I
)	O
have	O
shown	O
reduced	O
transcriptional	O
activity	O
in	O
comparison	O
to	O
the	O
enzyme	O
containing	O
wild	B
-	I
type	I
sigma	I
factor	I
.	O

These	O
data	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
GATA-5	B
performs	O
a	O
unique	O
temporally	O
and	O
spatially	O
restricted	O
function	O
in	O
the	O
embryonic	O
heart	O
and	O
lung	O
.	O

The	O
exonic	O
sequence	O
encodes	O
a	O
protein	O
of	O
495	O
amino	O
acids	O
that	O
is	O
nearly	O
identical	O
to	O
the	O
previously	O
reported	O
protein	O
sequence	O
of	O
human	B
GPT-1	I
.	O

Here	O
we	O
characterize	O
an	O
S.	B
cerevisiae	I
Swi3	I
homolog	I
(	O
Swh3	B
)	O
and	O
present	O
evidence	O
that	O
it	O
associates	O
in	O
a	O
complex	O
with	O
a	O
Snf2	B
homolog	I
,	O
Sthl	B
.	O

Shc	B
stimulates	O
Ras	B
/	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
MAPK	B
)	O
through	O
forming	O
a	O
complex	O
with	O
Grb2	B
at	O
the	O
phosphorylated	O
tyrosine	O
(	O
Y	O
)	O
residue	O
317	O
.	O

In	O
contrast	O
,	O
Y239	B
/	I
240F	I
Shc	I
,	O
but	O
not	O
Y317F	B
Shc	I
,	O
reduced	O
the	O
EGF	B
-	O
induced	O
c	B
-	I
myc	I
message	O
.	O

The	O
Ras	B
guanine	I
nucleotide	I
-	I
binding	I
protein	I
functions	O
as	O
a	O
molecular	O
switch	O
in	O
signalling	O
downstream	O
of	O
protein	B
-	I
tyrosine	I
kinases	I
.	O

We	O
show	O
that	O
Rlm1	B
and	O
Smp1	B
have	O
MEF2-related	B
DNA	O
-	O
binding	O
specificities	O
:	O
Rlm1	B
binds	O
with	O
the	O
same	O
specificity	O
as	O
MEF2	B
,	O
CTA	B
(	I
T	I
/	I
A	I
)	I
4TAG	I
,	O
while	O
SMP1	B
binds	O
a	O
more	O
extended	O
consensus	O
sequence	O
,	O
ACTACTA	O
(	O
T	O
/	O
A	O
)	O
4TAG	O
.	O

Domains	O
I	O
and	O
II	O
of	O
B	B
""""	I
are	O
buried	O
upon	O
assembly	O
of	O
the	O
TFIIIB	B
-	I
DNA	I
complex	I
,	O
as	O
determined	O
by	O
protein	O
footprinting	O
.	O

Domain	O
switch	O
experiments	O
reveal	O
that	O
C	B
/	I
EBP	I
beta	I
proteins	I
containing	O
either	O
the	O
leucine	O
zipper	O
or	O
the	O
activation	O
domain	O
of	O
C	B
/	I
EBP	I
alpha	I
are	O
unable	O
to	O
stimulate	O
the	O
2D5	B
promoter	I
yet	O
are	O
fully	O
capable	O
of	O
transactivating	O
an	O
artificial	O
promoter	O
bearing	O
a	O
high	O
-	O
affinity	O
C	B
/	I
EBP	I
site	I
.	O

The	O
similar	O
phenotypes	O
of	O
bur6	B
and	O
bur3	B
(	O
mot1	B
)	O
mutations	O
suggest	O
that	O
Bur6p	B
and	O
Mot1p	B
have	O
related	O
,	O
but	O
not	O
identical	O
,	O
functions	O
in	O
modulating	O
the	O
activity	O
of	O
the	O
general	O
transcription	O
machinery	O
in	O
vivo	O
.	O

Time	O
-	O
activity	O
curves	O
from	O
the	O
gastric	O
region	O
of	O
interest	O
were	O
used	O
,	O
after	O
subjection	O
to	O
appropriate	O
corrective	O
procedures	O
,	O
to	O
calculate	O
the	O
mean	O
gastric	O
transit	O
time	O
(	O
MTT	O
90	O
)	O
and	O
the	O
fraction	O
of	O
the	O
test	O
meal	O
retained	O
in	O
the	O
stomach	O
after	O
90	O
min	O
(	O
F90	O
)	O
.	O

This	O
study	O
provides	O
a	O
direct	O
demonstration	O
of	O
a	O
role	O
for	O
G	B
betagamma	I
in	O
mediating	O
the	O
agonist	O
-	O
stimulated	O
translocation	O
of	O
GRK2	B
and	O
GRK3	B
in	O
an	O
intact	O
cellular	O
system	O
and	O
demonstrates	O
isoform	O
specificity	O
in	O
the	O
interaction	O
of	O
these	O
components	O
.	O

Our	O
results	O
indicate	O
that	O
RA	O
-	O
mediated	O
repression	O
of	O
the	O
hMGP	B
gene	I
is	O
due	O
to	O
binding	O
of	O
liganded	O
RAR	B
/	O
RXR	B
to	O
a	O
novel	O
negative	O
RA	O
response	O
element	O
.	O

Point	O
mutations	O
of	O
the	O
five	O
tyrosine	O
residues	O
in	O
the	O
cytoplasmic	O
domain	O
of	O
the	O
receptor	O
were	O
subsequently	O
used	O
to	O
confirm	O
our	O
conclusions	O
.	O

We	O
describe	O
a	O
novel	O
method	O
using	O
Saccharomyces	O
cerevisiae	O
for	O
detecting	O
protein	O
-	O
truncating	O
mutations	O
in	O
any	O
gene	O
of	O
interest	O
.	O

The	O
electromyographically	O
recorded	O
responses	O
consisted	O
of	O
an	O
early	O
R1	O
response	O
in	O
the	O
orbicularis	O
oculi	O
muscle	O
ipsilateral	O
to	O
the	O
side	O
of	O
stimulation	O
,	O
a	O
bilateral	O
late	O
response	O
(	O
ipsilateral	O
R2	O
and	O
contralateral	O
Rc	O
)	O
and	O
a	O
third	O
,	O
R3	O
response	O
,	O
in	O
the	O
ipsilateral	O
orbicularis	O
oculi	O
muscle	O
.	O

The	O
prognosis	O
of	O
seven	O
patients	O
who	O
received	O
ABSCT	O
was	O
significantly	O
better	O
than	O
that	O
of	O
13	O
patients	O
who	O
received	O
conventional	O
therapy	O
alone	O
.	O

The	O
Jem	B
peptide	O
sequence	O
shows	O
a	O
'	O
leucine	O
-	O
zipper	O
'	O
dimerisation	O
motif	O
with	O
limited	O
homology	O
to	O
Fos	B
/	O
Jun	B
and	O
ATF	B
/	O
CREB	B
proteins	O
and	O
several	O
putative	O
phosphorylation	O
sites	O
.	O

A	O
genetic	O
screen	O
applied	O
to	O
mutants	O
in	O
the	O
branch	O
site	O
region	O
shows	O
that	O
all	O
positions	O
in	O
the	O
conserved	O
TACTAAC	O
sequence	O
are	O
important	O
for	O
intron	O
recognition	O
.	O

Comparison	O
of	O
the	O
p50	B
sequence	I
to	O
other	O
cloned	O
proteins	O
revealed	O
89	O
%	O
homology	O
with	O
a	O
glycosaminoglycan	O
-	O
binding	O
protein	O
and	O
54	O
%	O
homology	O
with	O
Drosophila	B
cell	I
cycle	I
control	I
protein	I
(	I
cdc	I
)	I
37	O
.	O

The	O
atp	B
1	I
and	O
atp	B
2	I
types	O
of	O
cDNA	O
sequences	O
were	O
the	O
most	O
redundant	O
among	O
the	O
28	O
different	O
isoperoxidases	B
identified	O
among	O
about	O
200	O
peroxidase	B
encoding	I
ESTs	I
.	O

Additional	O
information	O
including	O
echocardiographic	O
sequences	O
,	O
perioperative	O
video	O
sequences	O
,	O
x	O
-	O
ray	O
analysis	O
,	O
angiograms	O
,	O
etc	O
.	O
is	O
represented	O
in	O
the	O
program	O
.	O

In	O
Schizosaccharomyces	O
pombe	O
,	O
the	O
activity	O
of	O
the	O
M	O
-	O
phase	O
-	O
inducing	O
Cdc2	B
/	O
Cdc13	B
cyclin	O
-	O
dependent	O
kinase	O
is	O
inhibited	O
by	O
Wee1	B
and	O
Mik1	B
tyrosine	B
kinases	I
,	O
and	O
activated	O
by	O
Cdc25	B
and	O
Pyp3	B
tyrosine	B
phosphatases	I
.	O

4.26	O
+	O
/-	O

1.54	O
mmol	O
/	O
l	O
,	O
P	O
<	O
0.01	O
)	O
,	O
and	O
systolic	O
BP	O
responses	O
to	O
intravenous	O
norepinephrine	O
and	O
angiotensin	B
II	I
were	O
significantly	O
higher	O
on	O
glibenclamide	O
than	O
on	O
metformin	O
(	O
P	O
<	O
0.02	O
and	O
P	O
<	O
0.05	O
,	O
respectively	O
)	O
.	O

The	O
sequencing	O
of	O
Stellate	B
copies	O
located	O
along	O
the	O
discontinuous	O
cluster	O
revealed	O
a	O
complex	O
pattern	O
of	O
diversification	O
.	O

The	O
results	O
indicate	O
that	O
DNA	O
methylation	O
,	O
chromatin	O
structure	O
,	O
and	O
transactivation	O
at	O
an	O
Sp1	B
site	I
contribute	O
to	O
the	O
highly	O
restricted	O
expression	O
of	O
this	O
myelomonocytic	O
lineage	O
specific	O
gene	O
.	O

Finally	O
,	O
we	O
show	O
that	O
PhLP	B
complexes	O
,	O
at	O
least	O
partially	O
,	O
with	O
Gbetagamma	B
in	O
vivo	O
.	O

CTF1alpha	B
,	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
showed	O
specific	O
binding	O
to	O
the	O
palindrome	O
2	O
DNA	O
fragment	O
but	O
not	O
to	O
palindrome	O
1	O
or	O
mutant	O
palindrome	O
2	O
DNA	O
fragments	O
,	O
suggesting	O
specific	O
binding	O
of	O
CTF1alpha	B
to	O
palindrome	O
2	O
.	O

Cyclin	B
G2	I
is	O
highly	O
expressed	O
in	O
the	O
immune	O
system	O
where	O
immunologic	O
tolerance	O
subjects	O
self	O
-	O
reactive	O
lymphocytes	O
to	O
negative	O
selection	O
and	O
clonal	O
deletion	O
via	O
apoptosis	O
.	O

A	O
sterol	O
-	O
regulated	O
protease	O
initiates	O
release	O
of	O
the	O
NH2-terminal	O
segments	O
of	O
sterol	B
regulatory	I
element	I
-	I
binding	I
proteins	I
(	O
SREBPs	B
)	O
from	O
cell	O
membranes	O
,	O
thereby	O
allowing	O
them	O
to	O
enter	O
the	O
nucleus	O
and	O
to	O
stimulate	O
transcription	O
of	O
genes	O
involved	O
in	O
the	O
uptake	O
and	O
synthesis	O
of	O
cholesterol	O
and	O
fatty	O
acids	O
.	O

Thus	O
,	O
the	O
P.	O
aeruginosa	O
orfX	O
and	O
vfr	B
promoters	I
are	O
arranged	O
in	O
a	O
back	O
-	O
to	O
-	O
back	O
orientation	O
rather	O
than	O
the	O
face	O
-	O
to	O
-	O
face	O
orientation	O
of	O
the	O
dorf	O
and	O
crp	B
promoters	I
.	O

Sequence	O
analysis	O
of	O
cloned	O
PCR	O
products	O
confirmed	O
the	O
presence	O
of	O
two	O
different	O
nifV	B
-	I
like	I
DNA	I
fragments	I
,	O
which	O
were	O
subsequently	O
used	O
as	O
nifV-	B
and	O
leuA	B
-	I
specific	I
probes	I
,	O
respectively	O
,	O
to	O
clone	O
XbaI	B
fragments	I
of	O
2.1	O
kbp	O
(	O
pOST4	O
)	O
and	O
2.6	O
kbp	O
(	O
pOST2	O
)	O
.	O

(	O
3	O
)	O
This	O
effect	O
occurs	O
without	O
removing	O
TRs	B
from	O
the	O
TRE	O
.	O

In	O
a	O
model	O
of	O
the	O
ternary	O
complex	O
,	O
the	O
segment	O
of	O
NFAT	B
nearest	O
AP-1	B
is	O
the	O
Rel	B
insert	O
region	O
(	O
RIR	O
)	O
,	O
a	O
feature	O
that	O
is	O
notable	O
for	O
its	O
hypervariability	O
in	O
size	O
and	O
in	O
sequence	O
amongst	O
members	O
of	O
the	O
Rel	B
transcription	I
factor	I
family	I
.	O

This	O
protein	O
can	O
bind	O
to	O
a	O
region	O
of	O
the	O
promoter	O
of	O
an	O
Arabidopsis	B
light	I
-	I
harvesting	I
chlorophyll	I
a	I
/	I
b	I
protein	I
gene	I
,	O
Lhcb1	B
*	I
3	I
,	O
which	O
is	O
necessary	O
for	O
its	O
regulation	O
by	O
phytochrome	B
.	O

It	O
has	O
repeatedly	O
been	O
shown	O
that	O
HCMV	O
IE1	B
/	O
IE2	B
can	O
independently	O
transactivate	O
HIV-1	B
LTR	I
.	O

Respiratory	O
chain	O
enzyme	O
activity	O
was	O
normal	O
.	O

Children	O
's	O
temperament	O
and	O
maternal	O
socialization	O
at	O
Time	O
1	O
(	O
n	O
=	O
103	O
,	O
aged	O
2	O
-	O
3	O
years	O
)	O
were	O
considered	O
predictors	O
of	O
future	O
conscience	O
,	O
assessed	O
using	O
new	O
observational	O
and	O
narrative	O
measures	O
.	O

FN	B
-	O
stimulated	O
c	B
-	I
Src	I
PTK	B
activity	O
was	O
enhanced	O
by	O
wild	O
type	O
FAK	B
expression	O
,	O
whereas	O
FN	B
-	O
stimulated	O
activation	O
of	O
ERK2	B
was	O
blocked	O
by	O
expression	O
of	O
the	O
c	B
-	I
Src	I
binding	I
site	I
Phe-397	I
mutant	I
of	O
FAK	B
.	O

Each	O
sample	O
was	O
analysed	O
as	O
soon	O
as	O
possible	O
,	O
and	O
repeated	O
15	O
,	O
30	O
,	O
60	O
and	O
120	O
min	O
after	O
sampling	O
.	O

Anesthesia	O
was	O
maintained	O
with	O
isoflurane	O
(	O
ISO	O
)	O
/	O
N2O	O
/	O
O2	O
inhalation	O
.	O

The	O
altered	O
amino	O
acid	O
residues	O
of	O
the	O
seven	O
mutant	B
9ORF1	I
polypeptides	I
clustered	O
within	O
three	O
separate	O
regions	O
referred	O
to	O
as	O
region	O
I	O
(	O
residues	O
34	O
to	O
41	O
)	O
,	O
region	O
II	O
(	O
residues	O
89	O
to	O
91	O
)	O
,	O
and	O
C	O
-	O
terminal	O
region	O
III	O
(	O
residues	O
122	O
to	O
125	O
)	O
.	O

The	O
C	O
-	O
LIP	O
also	O
was	O
compared	O
with	O
transcather	O
arterial	O
embolization	O
(	O
TAE	O
;	O
C	O
-	O
LIP	O
followed	O
by	O
gelatin	O
sponge	O
)	O
and	O
percutaneous	O
ethanol	O
injection	O
therapy	O
(	O
PEIT	O
)	O
.	O

We	O
also	O
demonstrate	O
that	O
preformed	O
triplexes	O
are	O
quite	O
stable	O
when	O
precipitated	O
with	O
ethanol	O
and	O
resuspended	O
in	O
water	O
.	O

Transfection	O
experiments	O
using	O
preformed	O
triplexes	O
with	O
a	O
reporter	O
plasmid	O
containing	O
the	O
collagen	B
promoter	I
sequence	I
showed	O
significant	O
inhibition	O
of	O
transcription	O
when	O
compared	O
with	O
a	O
control	O
phosphorothioate	O
ODN	O
.	O

In	O
several	O
studies	O
the	O
RDFS	O
has	O
shown	O
evidence	O
of	O
reliability	O
and	O
validity	O
.	O

Latanoprost	O
produces	O
an	O
additional	O
reduction	O
of	O
intraocular	O
pressure	O
(	O
IOP	O
)	O
when	O
used	O
in	O
combination	O
with	O
timolol	O
,	O
pilocarpine	O
,	O
acetazolamide	O
and	O
dipivefrin	O
.	O

These	O
results	O
suggest	O
that	O
dietary	O
safflower	O
phospholipids	O
may	O
be	O
a	O
valuable	O
ingredient	O
to	O
layers	O
for	O
reducing	O
liver	O
triglycerides	O
and	O
serum	O
cholesterol	O
without	O
any	O
adverse	O
effects	O
.	O

Transient	O
overexpression	O
of	O
c	B
-	I
Jun	I
induced	O
tenascin	B
-	I
C	I
expression	O
in	O
primary	O
REF	O
and	O
in	O
FR3T3	O
,	O
an	O
established	O
fibroblast	O
cell	O
line	O
.	O

Inhibition	O
of	O
the	O
Raf-1	B
kinase	I
by	O
cyclic	O
AMP	O
agonists	O
causes	O
apoptosis	O
of	O
v	B
-	I
abl	I
-	O
transformed	O
cells	O
.	O

Selected	O
parameters	O
:	O
heart	O
rate	O
(	O
HR	O
)	O
,	O
arterial	O
blood	O
pressure	O
(	O
ABP	O
)	O
and	O
arterial	O
O2	O
saturation	O
(	O
SaO2	O
)	O
monitored	O
by	O
pulsoximetry	O
were	O
measured	O
during	O
the	O
procedure	O
.	O

Both	O
quantitative	O
and	O
qualitative	O
analysis	O
of	O
individual	O
cytoarchitectonic	O
peculiarities	O
of	O
Meynart	O
's	O
nucleus	O
as	O
well	O
as	O
of	O
external	O
part	O
of	O
dorsomedial	O
nucleus	O
of	O
thalamus	O
was	O
performed	O
in	O
mentally	O
normal	O
individuals	O
.	O

Positional	O
cloning	O
has	O
already	O
produced	O
the	O
sequences	O
of	O
more	O
than	O
70	O
human	O
genes	O
associated	O
with	O
specific	O
diseases	O
.	O

Genes	O
for	O
ocs	B
element	I
binding	I
factors	I
(	O
OBFs	B
)	O
,	O
belonging	O
to	O
a	O
specific	O
class	O
of	O
basic	B
-	I
region	I
leucine	I
zipper	I
(	I
bZIP	I
)	I
transcription	I
factors	I
,	O
have	O
been	O
isolated	O
in	O
a	O
number	O
of	O
plants	O
.	O

The	O
30-day	O
mortality	O
in	O
the	O
CPB	O
group	O
and	O
the	O
non	O
-	O
CPB	O
group	O
were	O
20	O
%	O
and	O
4.6	O
%	O
,	O
respectively	O
which	O
was	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0.06	O
)	O
.	O

This	O
association	O
appears	O
to	O
be	O
mediated	O
by	O
Src	B
-	O
SH2	B
domain	O
,	O
because	O
PECAM-1	B
can	O
be	O
precipitated	O
by	O
a	O
GST	B
-	O
Src	B
-	O
SH2	B
affinity	O
matrix	O
.	O

An	O
alternatively	O
spliced	O
MAdCAM-1	B
variant	O
was	O
identified	O
that	O
lacks	O
exon	O
4	O
encoding	O
the	O
mucin	B
domain	O
,	O
and	O
may	O
mediate	O
leukocyte	O
adhesion	O
to	O
LPAM-1	B
without	O
adhesion	O
to	O
the	O
alternate	O
receptor	O
,	O
L	B
-	I
selectin	I
.	O

In	O
summary	O
,	O
the	O
data	O
establish	O
that	O
the	O
previously	O
reported	O
human	B
MAdCAM-1	I
cDNA	I
does	O
indeed	O
encode	O
the	O
human	O
homologue	O
of	O
mouse	B
MAdCAM-1	I
,	O
despite	O
gross	O
dissimilarities	O
in	O
the	O
MAdCAM-1	B
C	O
-	O
terminal	O
structures	O
.	O

MATERIAL	O
AND	O
METHODS	O
:	O
The	O
authors	O
analyzed	O
41	O
persons	O
formerly	O
submitted	O
to	O
surgery	O
(	O
after	O
8	O
years	O
and	O
4	O
months	O
,	O
as	O
a	O
mean	O
)	O
,	O
31	O
to	O
highly	O
selective	O
vagotomy	O
,	O
and	O
10	O
to	O
truncal	O
or	O
selective	O
vagotomy	O
plus	O
gastroduodenal	O
drainage	O
.	O

The	O
monkey	B
LHR	I
cDNA	I
displayed	O
83	O
-	O
94	O
%	O
overall	O
sequence	O
homology	O
with	O
the	O
other	O
mammalian	B
LHR	I
cDNAs	I
.	O

In	O
unc-4	B
mutants	I
,	O
VA	O
motor	O
neurons	O
assume	O
the	O
pattern	O
of	O
synaptic	O
input	O
normally	O
reserved	O
for	O
their	O
lineal	O
sister	O
cells	O
,	O
the	O
VB	O
motor	O
neurons	O
;	O
the	O
loss	O
of	O
normal	O
input	O
to	O
the	O
VAs	O
produces	O
a	O
distinctive	O
backward	O
movement	O
defect	O
.	O

No	O
patient	O
in	O
group	O
2	O
developed	O
HAT	O
(	O
P	O
=	O
0.006	O
versus	O
group	O
1	O
)	O
.	O

Sequence	O
comparison	O
of	O
the	O
0.38	O
kb	O
promoter	O
sequence	O
with	O
the	O
promoters	O
of	O
the	O
Sm	B
-	I
E	I
gene	O
and	O
U1	B
snRNA	I
genes	I
revealed	O
several	O
homologous	O
motifs	O
,	O
suggesting	O
that	O
genes	O
encoding	O
the	O
snRNP	O
components	O
may	O
be	O
coordinately	O
regulated	O
.	O

A	O
xylE	B
transcriptional	I
fusion	I
to	O
the	O
putative	O
mxbD	B
promoter	I
showed	O
low	O
-	O
level	O
expression	O
in	O
wild	O
-	O
type	O
cells	O
grown	O
on	O
one	O
-	O
carbon	O
(	O
C1	O
)	O
compounds	O
and	O
no	O
detectable	O
expression	O
in	O
cells	O
grown	O
on	O
succinate	O
.	O

In	O
the	O
studies	O
reported	O
here	O
,	O
the	O
5'-flanking	O
region	O
of	O
the	O
human	B
gp130	I
gene	I
was	O
isolated	O
and	O
the	O
transcription	O
initiation	O
sites	O
were	O
mapped	O
.	O

Insulin	B
regulation	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
kinase	I
(	O
MEK	B
)	O
,	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
and	O
casein	B
kinase	I
in	O
the	O
cell	O
nucleus	O
:	O
a	O
possible	O
role	O
in	O
the	O
regulation	O
of	O
gene	O
expression	O
.	O

Sequencing	O
of	O
the	O
three	O
pag-3	B
alleles	I
showed	O
that	O
two	O
apparent	O
null	O
alleles	O
encode	O
a	O
nonsense	O
mutation	O
before	O
the	O
zinc	O
fingers	O
and	O
a	O
missense	O
mutation	O
in	O
the	O
fourth	O
zinc	O
finger	O
that	O
changes	O
a	O
coordinating	O
histidine	O
to	O
a	O
tyrosine	O
.	O

Pax-3	B
is	O
a	O
paired	B
-	I
type	I
homeobox	I
gene	I
that	O
is	O
specifically	O
expressed	O
in	O
the	O
dorsal	O
and	O
posterior	O
neural	O
tube	O
.	O

Instead	O
,	O
they	O
contained	O
dendritic	O
cells	O
that	O
express	O
melanogenic	O
marker	O
proteins	O
such	O
as	O
tyrosinase	B
and	O
tyrosinase	B
-	I
related	I
protein	I
1	I
.	O

Cloning	O
and	O
characterization	O
of	O
a	O
cDNA	O
encoding	O
a	O
bacteriophage	B
-	I
type	I
RNA	I
polymerase	I
from	O
the	O
higher	O
plant	O
Chenopodium	O
album	O
.	O

These	O
six	O
amino	O
acids	O
are	O
part	O
of	O
an	O
amphipathic	O
helix	O
that	O
is	O
highly	O
conserved	O
among	O
nuclear	B
hormone	I
receptors	I
and	O
contains	O
the	O
core	O
domain	O
of	O
the	O
ligand	O
-	O
dependent	O
transactivation	O
function	O
,	O
AF-2	O
.	O

Surprisingly	O
,	O
the	O
RXR	B
-	O
specific	O
ligand	O
9-cis	O
-	O
retinoic	O
acid	O
induced	O
binding	O
of	O
SRC-1	B
to	O
the	O
RXR	B
component	I
of	O
the	O
TRE	O
-	O
bound	O
heterodimer	O
.	O

Diver	O
respiratory	O
responses	O
to	O
a	O
tunable	O
closed	O
-	O
circuit	O
breathing	O
apparatus	O
.	O

Measurement	O
of	O
the	O
time	O
constant	O
of	O
VO2	O
and	O
oxygen	O
pulse	O
during	O
constant	O
work	O
rate	O
exercise	O
are	O
useful	O
for	O
the	O
objective	O
evaluation	O
of	O
the	O
training	O
effect	O
of	O
patients	O
with	O
COPD	O
.	O

Characterization	O
of	O
CR1	B
repeat	O
random	O
PCR	O
markers	O
for	O
mapping	O
the	O
chicken	O
genome	O
.	O

A	O
reversed	O
-	O
phase	O
high	O
-	O
performance	O
liquid	O
chromatographic	O
(	O
HPLC	O
)	O
method	O
for	O
the	O
determination	O
of	O
cocaine	O
metabolites	O
produced	O
in	O
vitro	O
by	O
serum	B
and	I
liver	I
esterases	I
is	O
described	O
.	O

Mutational	O
studies	O
provide	O
evidence	O
to	O
this	O
end	O
and	O
indicate	O
that	O
the	O
side	O
chains	O
of	O
subdomain	O
4.2	O
make	O
specific	O
contacts	O
with	O
the	O
nucleotides	O
at	O
-35	O
.	O

Concomitantly	O
,	O
p34CDC2	B
histone	B
H1	I
kinase	O
activity	O
increases	O
in	O
the	O
former	O
,	O
but	O
not	O
in	O
the	O
latter	O
cell	O
lines	O
,	O
hence	O
suggesting	O
a	O
role	O
for	O
this	O
protein	O
in	O
radiation	O
-	O
induced	O
cell	O
death	O
.	O

Using	O
PRL	B
-	I
R	I
tagged	O
both	O
in	O
the	O
N	O
-	O
terminal	O
or	O
C	O
-	O
terminal	O
regions	O
of	O
the	O
mature	O
receptor	O
excludes	O
the	O
possibility	O
of	O
a	O
cleaved	O
fragment	O
which	O
could	O
have	O
been	O
subsequently	O
imported	O
into	O
the	O
nucleus	O
.	O

A	O
similar	O
chimera	O
was	O
assembled	O
from	O
the	O
two	O
halves	O
of	O
the	O
molecule	O
expressed	O
separately	O
in	O
different	O
bacteria	O
and	O
refolded	O
together	O
.	O

All	O
six	O
genes	O
were	O
cloned	O
and	O
characterised	O
.	O

We	O
analysed	O
two	O
regions	O
involved	O
in	O
preS2	B
/	O
S	B
gene	I
transcription	O
of	O
the	O
HBV	O
adw	O
subtype	O
:	O
the	O
diverged	O
TATA	O
box	O
and	O
a	O
putative	O
initiator	O
element	O
.	O

Indeed	O
the	O
predicted	O
folding	O
of	O
the	O
5	O
'	O
and	O
3'-untranslated	O
regions	O
revealed	O
patterns	O
of	O
stem	O
and	O
loop	O
structures	O
conserved	O
for	O
all	O
tick	O
-	O
borne	O
flaviviruses	O
suggesting	O
a	O
purifying	O
selection	O
for	O
preservation	O
of	O
essential	O
RNA	O
secondary	O
structures	O
which	O
could	O
be	O
involved	O
in	O
translational	O
control	O
and	O
replication	O
.	O

Recently	O
we	O
have	O
performed	O
a	O
detailed	O
analysis	O
of	O
specific	O
neuronal	O
populations	O
affected	O
by	O
the	O
mutation	O
which	O
shed	O
new	O
light	O
on	O
the	O
role	O
of	O
Krox-20	B
in	O
the	O
segmentation	O
and	O
on	O
the	O
physiological	O
consequences	O
of	O
its	O
inactivation	O
.	O

The	O
most	O
important	O
one	O
among	O
them	O
is	O
Cyclosporin	O
A	O
,	O
which	O
is	O
a	O
selective	O
immunosuppressive	O
drug	O
.	O

Consistent	O
with	O
its	O
role	O
in	O
p53	B
ubiquitination	O
,	O
mE6-AP	B
was	O
found	O
both	O
in	O
the	O
nucleus	O
and	O
cytosol	O
,	O
while	O
Nedd-4	B
was	O
found	O
only	O
in	O
the	O
cytosol	O
.	O

SPP	B
also	O
induced	O
transient	O
tyrosine	O
phosphorylation	O
of	O
focal	B
adhesion	I
kinase	I
(	O
p125	B
(	O
FAK	B
)	O
)	O
,	O
a	O
cytosolic	B
tyrosine	I
kinase	I
that	O
localizes	O
in	O
focal	O
adhesions	O
,	O
and	O
of	O
the	O
cytoskeleton	B
-	I
associated	I
protein	I
paxillin	I
.	O

Using	O
a	O
conditional	O
-	O
lethal	O
mutant	O
allele	O
of	O
SUP45	B
(	O
sup45	B
-	I
2	I
)	O
and	O
a	O
combination	O
of	O
in	O
vivo	O
and	O
in	O
vitro	O
approaches	O
,	O
we	O
demonstrate	O
that	O
the	O
product	O
of	O
the	O
SUP45	B
gene	I
(	O
Sup45p	B
or	O
eRF1	B
)	O
is	O
a	O
factor	O
required	O
for	O
translation	O
termination	O
in	O
yeast	O
.	O

A	O
neonatal	O
alloimmune	O
thrombocytopenia	O
with	O
an	O
HPA-3a	B
(	O
Baka	O
)	O
incompatibility	O
was	O
confirmed	O
.	O

Most	O
eukaryotic	O
mRNAs	O
are	O
translated	O
by	O
a	O
""""	O
scanning	O
ribosome	O
""""	O
mechanism	O
.	O

Comparison	O
of	O
Tc-99	O
m	O
sestamibi	O
perfusion	O
imaging	O
and	O
echocardiography	O
using	O
an	O
arbutamine	O
infusion	O
for	O
the	O
detection	O
of	O
coronary	O
artery	O
disease	O
.	O

Also	O
,	O
transient	O
overexpression	O
of	O
this	O
protein	O
in	O
C2C12	O
cells	O
reduced	O
the	O
transcription	O
of	O
a	O
CAT	B
-	O
reporter	O
regulated	O
by	O
an	O
E12	B
/	O
MyoD	B
driven	O
enhancer	O
.	O

Five	O
of	O
these	O
have	O
ocular	O
or	O
oculocutaneous	O
albinism	O
.	O

Comprising	O
a	O
126-nucleotide	O
5	O
'	O
untranscribed	O
genomic	O
sequence	O
and	O
a	O
466-nucleotide	O
5	O
'	O
noncoding	O
cDNA	O
sequence	O
,	O
the	O
592-nucleotide	O
5	O
'	O
CpG	O
island	O
lacked	O
TATA	O
and	O
CAAT	O
boxes	O
but	O
displayed	O
a	O
high	O
G+C	O
content	O
,	O
was	O
enriched	O
for	O
CpG	O
dinucleotides	O
,	O
and	O
contained	O
a	O
potential	O
Sp1-binding	B
site	I
,	O
i.e.	O
,	O
features	O
compatible	O
with	O
a	O
housekeeping	O
gene	O
.	O

SSeCKS	B
(	O
pronounced	O
essex	O
)	O
encodes	O
a	O
major	O
protein	B
kinase	I
C	I
substrate	O
,	O
the	O
expression	O
of	O
which	O
is	O
down	O
-	O
regulated	O
in	O
src-	B
and	O
ras	B
-	O
transformed	O
rodent	O
fibroblasts	O
but	O
not	O
in	O
raf	O
-	O
transformed	O
rodent	O
fibroblasts	O
(	O
X.	O

Type	O
I	O
position	O
-	O
vestibular	O
-	O
pause	O
(	O
PVP	O
I	O
)	O
and	O
vestibular	O
-	O
only	O
(	O
V	O
I	O
)	O
neurons	O
,	O
as	O
well	O
as	O
a	O
smaller	O
number	O
of	O
other	O
type	O
I	O
and	O
type	O
II	O
eye	O
-	O
plus	O
-	O
vestibular	O
neurons	O
were	O
studied	O
.	O

Taurine	O
deficiency	O
significantly	O
depressed	O
the	O
amplitude	O
of	O
OP1	O
and	O
OP4	O
.	O

Alternative	O
splicing	O
of	O
CDC25B	B
may	O
therefore	O
contribute	O
to	O
the	O
control	O
of	O
cell	O
proliferation	O
.	O

The	O
findings	O
suggest	O
that	O
ERP	O
effects	O
of	O
distinct	O
memory	O
processes	O
are	O
differentially	O
influenced	O
by	O
the	O
encoding	O
instructions	O
.	O

The	O
second	O
primary	O
mutant	O
contained	O
a	O
proline	O
-	O
to	O
-	O
leucine	O
change	O
at	O
position	O
243	O
(	O
P243L	O
)	O
.	O

Induction	O
of	O
correctly	O
spliced	O
germline	O
transcripts	O
is	O
necessary	O
to	O
target	O
a	O
switch	O
region	O
for	O
recombination	O
and	O
switching	O
.	O

Thus	O
,	O
the	O
PCE	B
binds	O
a	O
Pbx	B
dimer	I
partner	I
that	O
behaves	O
unlike	O
Class	B
I	I
Hox	I
proteins	I
.	O

Furthermore	O
,	O
the	O
NH2-terminal	O
portion	O
of	O
the	O
homologue	O
was	O
not	O
translocated	O
into	O
the	O
outer	O
membrane	O
without	O
its	O
COOH	O
-	O
terminal	O
part	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
a	O
cDNA	O
,	O
CHEMR1	B
,	O
encoding	O
a	O
chemokine	O
receptor	O
with	O
a	O
homology	O
to	O
the	O
human	B
C	I
-	I
C	I
chemokine	I
receptor	I
,	O
CCR-4	B
.	O

Organization	O
of	O
the	O
human	B
LU	I
gene	I
and	O
molecular	O
basis	O
of	O
the	O
Lu	B
(	I
a	I
)	I
/	O
Lu	B
(	I
b	I
)	I
blood	O
group	O
polymorphism	O
.	O

The	O
active	O
state	O
is	O
terminated	O
by	O
hydrolysis	O
of	O
bound	O
GTP	O
,	O
producing	O
inactive	O
ARF	B
-	I
GDP	I
.	O

We	O
suggest	O
that	O
apart	O
from	O
the	O
World	O
Summit	O
for	O
Children	O
's	O
under	O
-	O
five	O
mortality	O
target	O
for	O
the	O
year	O
2000	O
,	O
intraregional	O
targets	O
to	O
reduce	O
geographical	O
inequalities	O
in	O
under	O
-	O
five	O
mortality	O
should	O
be	O
specified	O
.	O

The	O
immunophilin	B
,	O
which	O
can	O
be	O
of	O
the	O
FK506-	O
or	O
cyclosporin	O
A	O
-	O
binding	O
class	O
,	O
binds	O
to	O
hsp90	B
via	O
its	O
tetratricopeptide	O
repeat	O
(	O
TPR	O
)	O
domain	O
,	O
and	O
different	O
receptor	O
heterocomplexes	O
exist	O
depending	O
upon	O
which	O
immunophilin	B
occupies	O
the	O
TPR	O
-	O
binding	O
region	O
of	O
hsp90	B
.	O

Secretion	O
in	O
milk	O
and	O
transplacental	O
transfer	O
of	O
two	O
iodized	O
oils	O
,	O
Lipiodol	O
UF	O
and	O
Oriodol	O
,	O
in	O
rabbits	O
.	O

Sequencing	O
of	O
the	O
facB	B
gene	I
revealed	O
that	O
it	O
encodes	O
a	O
protein	O
that	O
contains	O
an	O
N	O
-	O
terminal	O
GAL4-like	B
Zn	O
(	O
II	O
)	O
2Cys6	O
(	O
or	O
C6	O
zinc	O
)	O
binuclear	O
cluster	O
for	O
DNA	O
binding	O
,	O
leucine	O
zipper	O
-	O
like	O
heptad	O
repeat	O
motifs	O
and	O
central	O
and	O
C	O
-	O
terminal	O
acidic	O
alpha	O
-	O
helical	O
regions	O
,	O
consistent	O
with	O
a	O
function	O
as	O
a	O
DNA	O
-	O
binding	O
transcriptional	O
activator	O
.	O

Overexpression	O
of	O
Sed5p	B
allowed	O
growth	O
in	O
the	O
absence	O
of	O
Vti1p	B
.	O

Furthermore	O
,	O
p150	B
suppresses	O
actin	B
gelation	O
,	O
which	O
is	O
induced	O
by	O
smooth	B
muscle	I
alpha	I
-	I
actinin	I
.	O

Denaturation	O
of	O
the	O
simian	O
virus	O
40	O
origin	O
of	O
replication	O
mediated	O
by	O
human	B
replication	I
protein	I
A.	I

This	O
effect	O
was	O
abolished	O
once	O
the	O
EM	O
motif	O
in	O
the	O
promoter	O
-	O
reporter	O
construct	O
was	O
mutated	O
,	O
thus	O
suggesting	O
that	O
the	O
synergistic	O
transactivation	O
function	O
of	O
the	O
TEF-1-Max	B
heterotypic	O
complex	O
is	O
mediated	O
through	O
binding	O
of	O
the	O
complex	O
to	O
the	O
EM	O
motif	O
.	O

Interdigitated	O
residues	O
within	O
a	O
small	O
region	O
of	O
VP16	B
interact	O
with	O
Oct-1	B
,	O
HCF	B
,	O
and	O
DNA	O
.	O

With	O
a	O
view	O
to	O
identifying	O
other	O
important	O
U14	B
interactions	O
,	O
a	O
stem	O
-	O
loop	O
domain	O
required	O
for	O
activity	O
of	O
Saccharomyces	B
cerevisiae	I
U14	I
RNAs	I
(	O
the	O
Y	O
domain	O
)	O
was	O
first	O
subjected	O
to	O
detailed	O
mutational	O
analysis	O
.	O

Based	O
on	O
these	O
results	O
and	O
because	O
Cdc68	B
has	O
been	O
implicated	O
as	O
a	O
regulator	O
of	O
chromatin	O
structure	O
,	O
we	O
postulate	O
that	O
polymerase	B
alpha	I
may	O
interact	O
with	O
these	O
proteins	O
to	O
gain	O
access	O
to	O
its	O
template	O
or	O
to	O
origins	O
of	O
replication	O
in	O
vivo	O
.	O

In	O
12	O
cases	O
(	O
3.1	O
%	O
)	O
,	O
a	O
change	O
in	O
stage	O
resulted	O
.	O

Promoter	O
recognition	O
algorithms	O
identified	O
divergent	O
promoter	O
elements	O
within	O
the	O
CpG	O
island	O
,	O
which	O
lies	O
between	O
the	O
ATM	B
and	O
E14	B
/	O
NPAT	B
genes	O
,	O
and	O
provide	O
evidence	O
for	O
a	O
putative	O
second	O
ATM	B
promoter	I
located	O
within	O
intron	O
3	O
,	O
immediately	O
upstream	O
of	O
the	O
first	O
coding	O
exon	O
.	O

Recombinant	B
soluble	I
pMCP	I
that	O
lacked	O
transmembrane	O
and	O
cytoplasmic	O
domains	O
had	O
factor	B
I	I
cofactor	I
activity	O
in	O
C3b	B
cleavage	O
,	O
indicating	O
that	O
it	O
is	O
functionally	O
,	O
as	O
well	O
as	O
structurally	O
homologous	O
to	O
MCP	B
.	O

Liquid	O
chromatographic	O
separation	O
was	O
achieved	O
on	O
a	O
Zorbax	O
RX	O
C8	O
analytical	O
column	O
using	O
gradient	O
elution	O
.	O

The	O
linear	O
plasmid	O
pDHL1	O
from	O
Debaryomyces	O
hansenii	O
encodes	O
a	O
protein	O
highly	O
homologous	O
to	O
the	O
pGKL1-plasmid	B
DNA	I
polymerase	I
.	O

The	O
RNA	O
-	O
binding	O
and	O
RNA	B
-	I
DNA	I
helicase	I
activities	O
of	O
the	O
Escherichia	B
coli	I
transcription	I
termination	I
factor	I
rho	I
have	O
been	O
investigated	O
using	O
natural	O
RNA	O
molecules	O
that	O
are	O
255	O
and	O
391	O
nucleotide	O
residues	O
in	O
length	O
and	O
that	O
contain	O
the	O
trp	B
t	I
'	I
rho	I
-	I
dependent	I
termination	I
sequence	I
of	O
E.	O
coli	O
.	O

The	O
p20-CGGBP	B
gene	I
is	O
conserved	O
among	O
mammals	O
but	O
shows	O
no	O
homology	O
to	O
non	O
-	O
vertebrate	O
species	O
.	O

The	O
pWP-19	B
also	O
encodes	O
the	O
AAV	O
inverted	O
terminal	O
repeats	O
for	O
integration	O
and	O
replication	O
and	O
the	O
herpes	O
virus	O
thymidine	B
kinase	I
promoter	O
-	O
driven	O
gene	O
for	O
neomycin	O
resistance	O
(	O
neoR	B
)	O
.	O

We	O
have	O
developed	O
a	O
rAAV	O
-	O
mediated	O
gene	O
transfer	O
system	O
for	O
the	O
rat	B
preproinsulin	I
II	I
gene	I
.	O

The	O
serum	O
levels	O
of	O
beta	B
-	I
human	I
chorionic	I
gonadotropin	I
(	O
HCG	B
)	O
and	O
placental	B
alkaline	I
phosphatase	I
(	O
PLAP	B
)	O
were	O
not	O
elevated	O
.	O

This	O
indicates	O
that	O
recruitment	O
of	O
large	B
T	I
antigen	I
to	O
the	O
rRNA	O
promoter	O
by	O
SL1	B
constitutes	O
a	O
crucial	O
step	O
in	O
the	O
activation	O
process	O
.	O

In	O
1990	O
,	O
an	O
International	O
Commission	O
for	O
the	O
Certification	O
of	O
Eradication	O
of	O
Poliomyelitis	O
Eradication	O
(	O
ICCPE	O
)	O
was	O
established	O
by	O
the	O
Pan	O
American	O
Health	O
Organization	O
to	O
eventually	O
determine	O
if	O
transmission	O
was	O
interrupted	O
.	O

Functional	O
and	O
regulatory	O
analysis	O
of	O
the	O
two	O
copies	O
of	O
the	O
fixNOQP	B
operon	I
of	O
Rhizobium	O
leguminosarum	O
strain	O
VF39	O
.	O

Thus	O
E14.1TG3B1	O
is	O
a	O
useful	O
ES	O
cell	O
line	O
for	O
modifying	O
the	O
mouse	O
genome	O
using	O
the	O
HPRT	B
gene	I
as	O
a	O
selection	O
marker	O
and	O
for	O
transmission	O
at	O
a	O
high	O
frequency	O
into	O
the	O
mouse	O
germ	O
line	O
.	O

Lung	O
and	O
multi	O
-	O
system	O
damage	O
were	O
early	O
indicators	O
of	O
poor	O
outcome	O
in	O
severe	O
non	O
-	O
fatal	O
disease	O
.	O

The	O
results	O
suggest	O
that	O
the	O
bulbospinal	O
micturition	O
reflex	O
evoked	O
by	O
bladder	O
filling	O
and	O
L	O
-	O
dopa	O
involves	O
a	O
descending	O
pathway	O
where	O
transmission	O
is	O
partly	O
mediated	O
by	O
spinal	B
alpha	I
1-adrenoceptors	I
.	O

OBJECTIVE	O
:	O
This	O
study	O
was	O
designed	O
to	O
analyze	O
the	O
common	O
cause	O
of	O
asthenopia	O
,	O
mixed	O
astigmatism	O
.	O

Disturbance	O
of	O
regeneration	O
in	O
the	O
above	O
pathological	O
condition	O
results	O
from	O
the	O
damage	O
to	O
tunica	O
propria	O
and	O
loss	O
of	O
its	O
function	O
for	O
the	O
support	O
of	O
structural	O
homeostasis	O
.	O

The	O
C	O
-	O
terminal	O
mature	O
region	O
is	O
highly	O
conserved	O
in	O
other	O
serine	B
carboxypeptidases	I
.	O

Here	O
we	O
demonstrate	O
that	O
AML1a	B
,	O
which	O
solely	O
has	O
no	O
effects	O
as	O
a	O
transcriptional	O
regulator	O
,	O
dominantly	O
suppresses	O
transcriptional	O
activation	O
by	O
AML1b	B
,	O
and	O
that	O
AML1a	B
exhibits	O
the	O
higher	O
affinity	O
for	O
DNA	O
-	O
binding	O
than	O
AML1b	B
.	O

However	O
,	O
using	O
ATL-16	O
T	O
nuclear	O
extract	O
,	O
we	O
demonstrated	O
that	O
GATA-4	B
is	O
the	O
only	O
GATA	B
-	I
binding	I
protein	I
that	O
forms	O
specific	O
DNA	O
-	O
protein	O
complex	O
with	O
the	O
-70	O
GATA	O
site	O
.	O

The	O
impact	O
of	O
social	O
support	O
on	O
the	O
relationships	O
of	O
gay	O
male	O
couples	O
is	O
examined	O
.	O

The	O
ubiquitously	O
expressed	O
hypoxia	B
-	I
inducible	I
factor-1	I
(	O
HIF-1	B
)	O
is	O
involved	O
in	O
expression	O
of	O
a	O
large	O
number	O
of	O
oxygen	O
-	O
regulated	O
genes	O
.	O

Stromelysin-1	B
,	O
matrix	B
metalloproteinase-3	I
(	O
MMP-3	B
)	O
,	O
is	O
an	O
important	O
endopeptidase	O
selectively	O
expressed	O
by	O
somatic	O
cells	O
in	O
organ	O
tissues	O
.	O

Tendon	O
also	O
shows	O
a	O
degree	O
of	O
extensibility	O
.	O

Surveillance	O
for	O
preeclampsia	O
was	O
conducted	O
by	O
personnel	O
unaware	O
of	O
treatment	O
-	O
group	O
assignments	O
,	O
using	O
standardized	O
measurements	O
of	O
blood	O
pressure	O
and	O
urinary	O
protein	O
excretion	O
at	O
uniformly	O
scheduled	O
prenatal	O
visits	O
,	O
protocols	O
for	O
monitoring	O
these	O
measurements	O
during	O
the	O
hospitalization	O
for	O
delivery	O
,	O
and	O
reviews	O
of	O
medical	O
records	O
of	O
unscheduled	O
outpatient	O
visits	O
and	O
all	O
hospitalizations	O
.	O

We	O
also	O
provide	O
evidence	O
that	O
gar2	B
is	O
phosphorylated	O
in	O
vitro	O
by	O
a	O
p13	B
(	O
suc1	B
)	O
-Sepharose	O
-	O
bound	O
kinase	O
from	O
Schizosaccharomyces	O
pombe	O
extracts	O
that	O
displays	O
cell	O
cycle	O
-	O
regulated	O
activity	O
similar	O
to	O
that	O
of	O
the	O
p34	B
(	O
cdc2	B
(	O
kinase	O
.	O

However	O
,	O
by	O
immobilized	O
metal	O
affinity	O
chromatography	O
assay	O
,	O
self	O
-	O
association	O
of	O
PR	B
-	I
A	I
was	O
3.5-fold	O
more	O
efficient	O
than	O
that	O
of	O
either	O
the	O
DhLBD	O
or	O
hLBD	O
constructs	O
.	O

The	O
overall	O
results	O
of	O
this	O
paper	O
are	O
consistent	O
with	O
the	O
conclusion	O
that	O
the	O
carboxyl	O
-	O
terminal	O
LBD	O
is	O
not	O
sufficient	O
for	O
mediating	O
PR	B
dimerization	O
and	O
that	O
multiple	O
regions	O
,	O
including	O
the	O
hinge	O
and	O
amino	O
-	O
terminal	O
sequences	O
,	O
contribute	O
either	O
directly	O
or	O
indirectly	O
to	O
homodimerization	O
of	O
PR	B
.	O

Here	O
,	O
we	O
correlate	O
Dox	O
effects	O
on	O
cell	O
cycle	O
with	O
changes	O
of	O
E2F	B
/	O
DP	B
complexes	O
and	O
activity	O
in	O
differentiating	O
C2C12	O
myocytes	O
.	O

Vitrectomy	O
was	O
still	O
a	O
significant	O
risk	O
factor	O
when	O
macular	O
holes	O
were	O
excluded	O
.	O

Invited	O
editorial	O
on	O
""""	O
Acute	O
and	O
chronic	O
effects	O
of	O
exercise	O
on	O
leptin	B
levels	O
in	O
humans	O
""""	O
.	O

Both	O
promoters	O
lack	O
a	O
TATA	O
box	O
,	O
and	O
Pint	B
belongs	O
to	O
the	O
MED-1	B
class	O
of	O
promoters	O
,	O
which	O
initiate	O
transcription	O
at	O
multiple	O
sites	O
.	O

We	O
have	O
initiated	O
studies	O
to	O
identify	O
candidate	O
signal	O
transducers	O
that	O
associate	O
with	O
the	O
cytosolic	O
domain	O
(	O
cd	O
)	O
of	O
the	O
IL-1R	B
.	O

In	O
this	O
study	O
,	O
we	O
sought	O
to	O
identify	O
mechanisms	O
that	O
could	O
account	O
for	O
the	O
antimitogenic	O
effects	O
of	O
IL-4	B
.	O

A	O
soluble	O
62-kDa	O
protein	O
was	O
produced	O
without	O
the	O
proteolytic	O
processing	O
by	O
inserting	O
the	O
coding	O
sequence	O
of	O
amino	O
acids	O
112	O
to	O
660	O
of	O
ORF-2	O
in	O
a	O
baculovirus	O
expression	O
vector	O
and	O
using	O
the	O
corresponding	O
virus	O
to	O
infect	O
Sf9	O
cells	O
.	O

The	O
CPK	B
-	I
MB	I
isoenzyme	O
showed	O
no	O
percentage	O
increase	O
of	O
total	O
CPK	B
higher	O
than	O
5	O
%	O
,	O
measured	O
at	O
6	O
,	O
12	O
,	O
and	O
24	O
h	O
after	O
the	O
shock	O
,	O
independent	O
of	O
the	O
number	O
of	O
attempts	O
of	O
cardioversion	O
.	O

Results	O
support	O
the	O
hypothesis	O
that	O
endogenous	B
corticotropin	I
-	I
releasing	I
factor	I
,	O
perhaps	O
acting	O
at	O
a	O
peripheral	O
binding	O
site	O
,	O
suppresses	O
the	O
active	O
behavioral	O
response	O
characteristic	O
of	O
pups	O
during	O
the	O
early	O
phase	O
of	O
isolation	O
in	O
novel	O
surroundings	O
.	O

The	O
gray	O
matter	O
NAA	O
/	O
mI	O
ratio	O
clearly	O
separated	O
the	O
two	O
groups	O
.	O

As	O
with	O
the	O
murine	B
and	I
human	I
mb-1	I
genes	I
,	O
the	O
5	O
'	O
region	O
of	O
the	O
bovine	B
mb-1	I
gene	I
lacked	O
a	O
TATA	O
box	O
.	O

Chloramphenicol	B
acetyltransferase	I
assays	O
examining	O
the	O
ability	O
of	O
IE86	B
to	O
repress	O
activity	O
from	O
the	O
HCMV	O
major	O
IE	B
promoter	I
or	O
activate	O
the	O
HCMV	B
early	I
promoter	I
for	O
the	O
2.2-kb	O
class	O
of	O
RNAs	O
demonstrated	O
the	O
functional	O
integrity	O
of	O
the	O
IE86	B
protein	I
.	O

Transcription	O
factor	O
binding	O
sites	O
downstream	O
of	O
the	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
transcription	O
start	O
site	O
are	O
important	O
for	O
virus	O
infectivity	O
.	O

Crystal	O
structure	O
of	O
an	O
oligomer	O
of	O
proteolytic	O
zymogens	O
:	O
detailed	O
conformational	O
analysis	O
of	O
the	O
bovine	O
ternary	O
complex	O
and	O
implications	O
for	O
their	O
activation	O
.	O

We	O
suppose	O
that	O
this	O
injection	O
speed	O
(	O
0.1	O
-	O
0.2	O
ml.s-1	O
)	O
is	O
suitable	O
for	O
spinal	O
anesthesia	O
.	O

Alternative	O
splicing	O
of	O
ClC-6	B
(	O
a	O
member	O
of	O
the	O
CIC	B
chloride	I
-	I
channel	I
family	I
)	O
transcripts	O
generates	O
three	O
truncated	O
isoforms	O
one	O
of	O
which	O
,	O
ClC-6c	B
,	O
is	O
kidney	O
-	O
specific	O
.	O

The	O
behavior	O
of	O
different	O
types	O
of	O
polytetrafluoroethylene	O
(	O
PTFE	O
)	O
prostheses	O
in	O
the	O
reparative	O
scarring	O
process	O
of	O
abdominal	O
wall	O
defects	O
.	O

The	O
control	O
group	O
revealed	O
significantly	O
higher	O
levels	O
of	O
coagulation	B
factors	I
II	I
,	I
V	I
and	I
VIII	I
,	O
compared	O
to	O
the	O
index	O
group	O
.	O

The	O
frequency	O
of	O
positive	O
anti	B
-	I
GM1	I
antibody	I
titers	O
in	O
the	O
Guillain	O
-	O
Barre	O
syndrome	O
patients	O
with	O
PEN	O
19	O
isolates	O
was	O
higher	O
than	O
that	O
in	O
the	O
Guillain	O
-	O
Barre	O
syndrome	O
and	O
Fisher	O
's	O
syndrome	O
patients	O
without	O
PEN	O
19	O
isolates	O
.	O

NF	B
-	I
kappa	I
B	I
/	O
Rel	B
transcription	O
factors	O
participate	O
in	O
the	O
activation	O
of	O
numerous	O
genes	O
involved	O
in	O
immune	O
regulation	O
/	O
inflammation	O
including	O
cytokines	O
,	O
cell	O
surface	O
receptors	O
,	O
adhesion	O
molecules	O
,	O
and	O
acute	O
phase	O
proteins	O
.	O

We	O
have	O
separated	O
a	O
dermatan	O
sulfate	O
proteoglycan	O
,	O
epiphycan	O
,	O
from	O
decorin	B
and	O
biglycan	O
by	O
using	O
dissociative	O
extraction	O
of	O
bovine	O
fetal	O
epiphyseal	O
cartilage	O
,	O
followed	O
by	O
sequential	O
ion	O
-	O
exchange	O
,	O
gel	O
permeation	O
,	O
hydrophobic	O
,	O
and	O
Zn2	O
+	O
chelate	O
chromatographic	O
steps	O
.	O

These	O
analyses	O
demonstrate	O
that	O
the	O
dUTPase	B
isoforms	O
are	O
encoded	O
by	O
the	O
same	O
gene	O
with	O
isoform	O
-	O
specific	O
transcripts	O
arising	O
through	O
the	O
use	O
of	O
alternative	O
5	O
'	O
exons	O
.	O

3600-fold	O
to	O
apparent	O
homogeneity	O
with	O
a	O
41	O
%	O
yield	O
by	O
affinity	O
chromatography	O
utilizing	O
DNA	O
-	O
cellulose	O
;	O
the	O
purity	O
of	O
the	O
final	O
preparation	O
was	O
assessed	O
by	O
SDS	O
/	O
PAGE	O
,	O
lack	O
of	O
contamination	O
by	O
other	O
nucleases	O
and	O
production	O
of	O
a	O
monospecific	O
antibody	O
against	O
the	O
enzyme	O
.	O

We	O
further	O
found	O
that	O
KmMig1p	B
is	O
fully	O
functional	O
when	O
expressed	O
in	O
S.	O
cerevisiae	O
.	O

A	O
pre	O
-	O
boutonniere	O
deformity	O
was	O
simulated	O
by	O
dividing	O
the	O
central	O
slip	O
.	O

Future	O
analysis	O
of	O
long	O
-	O
term	O
outcome	O
measures	O
of	O
performance	O
with	O
the	O
implant	O
will	O
confirm	O
or	O
dispute	O
the	O
benefit	O
of	O
ear	O
selection	O
using	O
the	O
Prom	O
-	O
EABR	O
.	O

This	O
protein	O
,	O
designated	O
p532	B
based	O
on	O
its	O
predicted	O
molecular	O
weight	O
(	O
EMBO	O
J	O
15	O
:	O
5738	O
,	O
1996	O
)	O
,	O
contains	O
multiple	O
structural	O
domains	O
including	O
two	O
regions	O
of	O
seven	O
internal	O
repeats	O
highly	O
related	O
to	O
the	O
cell	O
cycle	O
regulator	O
RCC1	B
,	O
a	O
guanine	B
nucleotide	I
exchange	I
factor	I
for	O
the	O
small	B
GTP	I
-	I
binding	I
protein	I
Ran	B
,	O
seven	O
beta	O
-	O
repeat	O
domains	O
characteristic	O
of	O
the	O
beta	O
subunit	O
of	O
heterotrimeric	B
G	I
proteins	I
,	O
three	O
putative	O
SH3	B
binding	I
sites	I
,	O
a	O
putative	O
leucine	O
-	O
zipper	O
and	O
a	O
carboxy	B
-	I
terminal	I
HECT	I
domain	I
characteristic	O
of	O
E3	B
ubiquitin	I
-	I
protein	I
ligases	I
.	O

Thus	O
,	O
the	O
L45	O
sequence	O
between	O
kinase	O
subdomains	O
IV	O
and	O
V	O
specifies	O
TGF	B
-	I
beta	I
responsiveness	O
of	O
the	O
type	B
I	I
receptor	I
.	O

The	O
two	O
mouse	O
lines	O
carrying	O
the	O
unfragmented	O
Hnf3g	B
-	O
lacZ	B
YAC	O
showed	O
tissue	O
-	O
specific	O
,	O
copy	O
number	O
-	O
dependent	O
and	O
position	O
-	O
independent	O
expression	O
,	O
proving	O
that	O
170	O
kb	O
of	O
the	O
Hnf3	B
g	I
locus	O
contain	O
all	O
elements	O
important	O
in	O
the	O
regulation	O
of	O
Hnf3	B
g	I
.	O

Upstream	O
activating	O
sequences	O
(	O
UASs	O
)	O
derived	O
from	O
known	O
Ste12p	B
-	O
dependent	O
genes	O
have	O
previously	O
been	O
characterized	O
to	O
require	O
either	O
multiple	O
PREs	O
or	O
a	O
single	O
PRE	O
coupled	O
to	O
a	O
binding	O
site	O
for	O
a	O
second	O
protein	O
.	O

Prominent	O
protein	O
kinase	O
cascades	O
are	O
those	O
that	O
activate	O
mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinases	I
.	O

JNK	B
is	O
additionally	O
regulated	O
by	O
the	O
Ras	B
-	O
related	O
G	B
proteins	I
Rac	B
and	O
Cdc42	B
.	O

While	O
important	O
for	O
ligand	O
-	O
dependent	O
transactivation	O
,	O
this	O
interaction	O
surface	O
is	O
not	O
directly	O
involved	O
in	O
transrepression	O
of	O
AP-1	B
activity	O
.	O

Gal4-Eed	B
fusion	O
protein	O
represses	O
transcription	O
of	O
a	O
reporter	O
gene	O
driven	O
by	O
a	O
promoter	O
that	O
contains	O
Gal4-binding	B
DNA	I
elements	I
.	O

In	O
situ	O
hybridization	O
analysis	O
in	O
adult	O
rat	O
tissue	O
reveals	O
good	O
correlation	O
with	O
this	O
pattern	O
and	O
indicates	O
that	O
drm	B
mRNA	I
is	O
most	O
highly	O
expressed	O
in	O
nondividing	O
and	O
terminally	O
differentiated	O
cells	O
,	O
such	O
as	O
neurons	O
,	O
type	O
1	O
lung	O
cells	O
,	O
and	O
goblet	O
cells	O
.	O

Neither	O
of	O
these	O
proteins	O
,	O
individually	O
or	O
as	O
a	O
pair	O
,	O
can	O
bind	O
the	O
alpha	B
-	I
globin	I
3'UTR	I
unless	O
they	O
are	O
complexed	O
with	O
the	O
remaining	O
non	O
-	O
poly	O
(	O
C	O
)	O
binding	O
proteins	O
of	O
the	O
alpha	B
-	I
complex	I
.	O

A	O
2	O
years	O
and	O
9	O
months	O
old	O
female	O
patient	O
,	O
with	O
the	O
diagnosis	O
of	O
Weaver	O
syndrome	O
is	O
reported	O
.	O

Confirming	O
measures	O
made	O
by	O
nurses	O
and	O
additionally	O
,	O
ABPM	O
for	O
women	O
,	O
seem	O
to	O
lessen	O
this	O
effect	O
.	O

(	O
1996a	O
)	O
Biochemistry	O
35	O
,	O
1589	O
-	O
1598	O
]	O
.	O

Our	O
results	O
suggest	O
that	O
Lrp	B
binds	O
a	O
central	O
palindromic	O
site	O
,	O
interacting	O
predominantly	O
with	O
the	O
major	O
groove	O
of	O
its	O
DNA	O
target	O
,	O
and	O
that	O
additional	O
dimers	O
bind	O
to	O
flanking	O
sites	O
to	O
form	O
a	O
nucleoprotein	O
activation	O
complex	O
.	O

Sustained	O
activation	O
of	O
p21	B
expression	O
is	O
proposed	O
to	O
be	O
a	O
distinguishing	O
feature	O
of	O
the	O
activity	O
of	O
NGF	B
that	O
contributes	O
to	O
PC12	O
growth	O
arrest	O
during	O
differentiation	O

The	O
remaining	O
80	O
patients	O
underwent	O
recordings	O
of	O
ECG	O
,	O
beat	O
-	O
to	O
-	O
beat	O
arterial	O
oxygen	O
saturation	O
(	O
SaO2	O
)	O
,	O
and	O
respiration	O
during	O
both	O
spontaneous	O
and	O
controlled	O
breathing	O
.	O

The	O
mean	O
total	O
white	O
cell	O
count	O
increased	O
from	O
a	O
baseline	O
of	O
11.3	O
x	O
10	O
(	O
9	O
)	O
/	O
L	O
(	O
SD	O
2.3	O
)	O
to	O
16.2	O
x	O
10	O
(	O
9	O
)	O
/	O
L	O
(	O
SD	O
4.6	O
)	O
on	O
day	O
1	O
,	O
normalising	O
thereafter	O
.	O

These	O
lesions	O
may	O
be	O
treated	O
by	O
propranolol	O
or	O
phentolamine	O
.	O

Both	O
of	O
these	O
dogs	O
had	O
low	O
serum	O
IgG	B
(	O
3.5	O
to	O
7.2	O
mg	O
/	O
ml	O
)	O
and	O
the	O
second	O
littermate	O
also	O
had	O
reduced	O
serum	O
IgA	B
(	O
<	O
0.1	O
to	O
0.15	O
mg	O
/	O
ml	O
)	O
.	O

CONCLUSIONS	O
:	O
Valproate	O
appears	O
to	O
inhibit	O
the	O
glucuronidation	O
of	O
carbamazepine-10,11-trans	O
-	O
diol	O
,	O
and	O
probably	O
also	O
inhibits	O
the	O
conversion	O
of	O
carbamazepine-10,11-epoxide	O
to	O
this	O
trans	O
-	O
diol	O
derivative	O
,	O
rather	O
than	O
simply	O
inhibiting	O
the	O
latter	O
reaction	O
only	O
.	O

The	O
Ogg1	B
protein	I
efficiently	O
cleaves	O
a	O
DNA	O
duplex	O
where	O
a	O
preformed	O
AP	B
site	I
is	O
placed	O
opposite	O
a	O
cytosine	O
(	O
AP	O
/	O
C	O
)	O
.	O

A	O
consensus	O
sequence	O
indicates	O
a	O
highly	O
conserved	O
lysine	O
residue	O
,	O
K120	O
of	O
endonuclease	B
III	I
or	O
K241	O
of	O
Ogg1	B
,	O
respectively	O
.	O

Overall	O
,	O
these	O
findings	O
demonstrate	O
that	O
mutations	O
E768D	O
and	O
V804L	O
are	O
gain	O
-	O
of	O
-	O
function	O
mutations	O
that	O
confer	O
to	O
the	O
long	B
RET	I
isoform	I
the	O
capacity	O
to	O
exert	O
a	O
biological	O
effect	O
,	O
although	O
these	O
mutations	O
are	O
more	O
weakly	O
activating	O
than	O
the	O
MEN2A	B
and	O
MEN2B	B
mutations	O
.	O

E2F	B
is	O
a	O
heterodimeric	O
complex	O
consisting	O
of	O
E2F	B
family	I
members	I
(	I
1	I
-	I
5	I
)	I
and	O
DP	B
proteins	I
(	I
1	I
-	I
3	I
)	I
.	O

EBER1	B
mRNA	I
,	O
a	O
consistent	O
marker	O
of	O
viral	O
latency	O
,	O
was	O
positive	O
in	O
all	O
PEL	O
cases	O
,	O
although	O
at	O
lower	O
levels	O
than	O
in	O
the	O
non	O
-	O
PEL	O
controls	O
due	O
to	O
EBER1	B
expression	O
by	O
only	O
a	O
variable	O
subset	O
of	O
lymphoma	O
cells	O
.	O

METHODS	O
:	O
Four	O
hundred	O
fifty	O
patients	O
with	O
the	O
diagnosis	O
of	O
squamous	O
cell	O
carcinoma	O
of	O
the	O
oral	O
cavity	O
received	O
their	O
primary	O
treatment	O
at	O
Roswell	O
Park	O
Cancer	O
Center	O
(	O
RPCI	O
)	O
from	O
1971	O
to	O
1991	O
.	O

Therefore	O
,	O
use	O
of	O
presaturation	O
is	O
recommended	O
for	O
myocardial	O
motion	O
studies	O
using	O
cine	O
PC	O
velocity	O
data	O
.	O

PURPOSE	O
/	O
OBJECTIVES	O
:	O
To	O
examine	O
the	O
question	O
of	O
whether	O
an	O
early	O
first	O
full	O
-	O
term	O
pregnancy	O
(	O
FFTP	O
)	O
protects	O
against	O
breast	O
cancer	O
and	O
whether	O
interruption	O
of	O
the	O
pregnancy	O
with	O
an	O
induced	O
abortion	O
increases	O
breast	O
cancer	O
risk	O
.	O

Two	O
related	O
studies	O
conducted	O
over	O
a	O
five	O
week	O
period	O
measured	O
and	O
typed	O
HLA	B
-	I
DQA1	I
from	O
accumulated	O
DNA	O
on	O
autopsy	O
room	O
and	O
Forensic	O
DNA	O
Laboratory	O
structures	O
.	O

BRCA1	B
,	O
a	O
familial	O
breast	O
and	O
ovarian	O
cancer	O
susceptibility	O
gene	O
encodes	O
nuclear	O
phosphoproteins	O
that	O
function	O
as	O
tumor	O
suppressors	O
in	O
human	O
breast	O
cancer	O
cells	O
.	O

The	O
alternative	O
splice	O
sites	O
for	O
the	O
smallest	O
adducin	B
isoform	O
,	O
beta-3	B
,	O
are	O
alternative	O
donor	O
and	O
acceptor	O
sites	O
within	O
exons	O
7	O
and	O
12	O
.	O

Neural	O
blockade	O
in	O
chronic	O
and	O
cancer	O
pain	O
.	O

Two	O
new	O
temperature	O
-	O
sensitive	O
alleles	O
of	O
SEC3	B
,	O
1	O
of	O
10	O
late	O
-	O
acting	O
SEC	B
genes	I
required	O
for	O
targeting	O
or	O
fusion	O
of	O
post	O
-	O
Golgi	O
secretory	O
vesicles	O
to	O
the	O
plasma	O
membrane	O
in	O
Saccharomyces	O
cerevisiae	O
,	O
were	O
isolated	O
in	O
a	O
screen	O
for	O
temperature	O
-	O
sensitive	O
secretory	O
mutants	O
that	O
are	O
synthetically	O
lethal	O
with	O
sec4	B
-	I
8	I
.	O

Five	O
cell	O
strains	O
of	O
human	O
dermal	O
fibroblasts	O
were	O
each	O
treated	O
with	O
three	O
samples	O
of	O
burn	O
blister	O
fluid	O
and	O
the	O
effect	O
compared	O
with	O
the	O
rate	O
of	O
contraction	O
of	O
free	O
floating	O
fibroblast	O
populated	O
collagen	B
lattices	O
(	O
FPCL	O
)	O
.	O

Cell	O
49	O
,	O
753	O
-	O
761	O
]	O
.	O

Twenty	O
-	O
one	O
ELISA	O
-	O
positive	O
sera	O
were	O
tested	O
and	O
confirmed	O
positive	O
by	O
plaque	O
reduction	O
neutralization	O
testing	O
.	O

Tyrosine	O
1356	O
forms	O
a	O
multisubstrate	O
binding	O
site	O
for	O
the	O
Grb2	B
and	O
Shc	B
adaptor	I
proteins	I
,	O
the	O
p85	B
subunit	I
of	O
phosphatidylinositol	B
3'-kinase	I
,	O
phospholipase	B
Cgamma	I
,	O
and	O
a	O
phosphatase	O
,	O
SHP2	B
.	O

Gtx	B
mRNA	I
accumulates	O
in	O
parallel	O
with	O
the	O
RNAs	O
encoding	O
the	O
major	O
structural	O
proteins	O
of	O
myelin	O
,	O
myelin	B
basic	I
protein	I
(	O
MBP	B
)	O
,	O
and	O
proteolipid	B
protein	I
(	O
PLP	B
)	O
during	O
postnatal	O
brain	O
development	O
;	O
Gtx	B
mRNA	I
decreases	O
in	O
parallel	O
with	O
MBP	B
and	O
PLP	B
mRNAs	I
in	O
the	O
brains	O
of	O
myelin	O
-	O
deficient	O
rats	O
,	O
which	O
have	O
a	O
point	O
mutation	O
in	O
the	O
PLP	B
gene	I
.	O

Contacts	O
between	O
Bacillus	O
subtilis	O
catabolite	O
regulatory	O
protein	O
CcpA	B
and	O
amyO	B
target	O
site	O
.	O

They	O
also	O
interact	O
with	O
GTPase	B
activating	I
proteins	I
encoded	O
by	O
IRA1	B
and	O
IRA2	B
.	O

For	O
E2	O
,	O
each	O
cat	O
was	O
given	O
either	O
5	O
(	O
group	O
[	O
G	O
]	O
1	O
)	O
or	O
10	O
(	O
G2	O
)	O
mg	O
of	O
itraconazole	O
/	O
kg	O
(	O
capsules	O
)	O
twice	O
daily	O
for	O
6	O
weeks	O
.	O

RESULTS	O
:	O
For	O
E1	O
,	O
itraconazole	O
plasma	O
drug	O
concentration	O
extrapolated	O
to	O
time	O
zero	O
(	O
IV	O
dose	O
)	O
was	O
5.2	O
+	O
/-	O

1.4	O
micrograms	O
/	O
ml	O
,	O
and	O
mean	O
residence	O
time	O
(	O
MRT	O
)	O
was	O
37	O
+	O
/-	O

16	O
hours	O
.	O

G	B
-	I
CSF	I
was	O
started	O
on	O
day	O
3	O
of	O
each	O
cycle	O
(	O
5	O
microg	O
/	O
kg	O
/	O
day	O
)	O
and	O
was	O
stopped	O
the	O
day	O
before	O
the	O
last	O
apheresis	O
or	O
when	O
absolute	O
neutrophil	O
count	O
was	O
above	O
0.5	O
x	O
10	O
(	O
9	O
)	O
/	O
l	O
.	O

Crosstalk	O
among	O
the	O
pathways	O
may	O
explain	O
how	O
some	O
forms	O
of	O
stress	O
can	O
contribute	O
to	O
the	O
development	O
of	O
a	O
malignancy	O
.	O

The	O
majority	O
of	O
PI	B
kinase	I
activity	O
appeared	O
to	O
be	O
cbl	B
-	O
associated	O
after	O
PRL	B
stimulation	O
.	O

Mutation	O
of	O
Enh4	B
,	O
an	O
essential	O
GT	B
-	I
IIC	I
-	I
like	I
enhanson	I
in	O
the	O
context	O
of	O
the	O
intact	O
enhancer	O
,	O
abolishes	O
silencer	O
activity	O
,	O
and	O
multimerized	O
GT	B
-	I
IIC	I
enhansons	I
mimic	O
the	O
intact	O
CSEn	B
enhancer	I
/	I
silencer	I
activities	O
in	O
BeWo	O
and	O
GC	O
cells	O
,	O
respectively	O
.	O

Using	O
lectin	B
-	O
affinity	O
chromatography	O
,	O
discordance	O
between	O
the	O
pattern	O
of	O
O	O
-	O
glycosylation	O
of	O
SSBP	B
and	O
DSBP	B
was	O
demonstrated	O
.	O

Deletion	O
mapping	O
experiments	O
determined	O
that	O
the	O
sequences	O
required	O
for	O
full	O
activity	O
in	O
MSC-1	O
cells	O
were	O
included	O
within	O
619	O
bp	O
of	O
the	O
start	O
site	O
and	O
identified	O
several	O
regions	O
that	O
demonstrated	O
increased	O
luciferase	B
activity	O
:	O
the	O
-583	O
bp	O
to	O
-564	O
bp	O
,	O
-503	O
bp	O
to	O
-484	O
bp	O
,	O
and	O
-114	O
bp	O
to	O
-65	O
regions	O
.	O

Furthermore	O
,	O
the	O
PH	B
and	O
PTB	O
domains	O
are	O
highly	O
homologous	O
(	O
at	O
least	O
40	O
%	O
identical	O
)	O
to	O
those	O
found	O
in	O
insulin	B
receptor	I
substrates	I
1	I
,	I
2	I
,	I
and	I
3	I
(	O
IRS-1	B
,	O
IRS-2	B
,	O
and	O
IRS-3	B
)	O
.	O

As	O
demonstrated	O
by	O
gel	O
mobility	O
shift	O
analysis	O
and	O
supershift	O
experiments	O
,	O
FIRE1	B
,	O
located	O
between	O
-516	O
and	O
-498	O
,	O
is	O
responsible	O
for	O
binding	O
NF	B
-	I
Y.	I

MR	O
imaging	O
of	O
traumatic	O
head	O
injuries	O
using	O
FLAIR	O
technique	O

Gag	B
protein	O
sequence	O
motifs	O
of	O
the	O
NC	B
domain	I
of	O
primate	O
foamy	O
viruses	O
assumed	O
to	O
be	O
involved	O
in	O
genome	O
encapsidation	O
are	O
not	O
conserved	O
in	O
FeFV	O
.	O

MEASUREMENTS	O
AND	O
MAIN	O
RESULTS	O
:	O
Lung	O
elastance	O
(	O
EL	O
)	O
and	O
resistance	O
(	O
RL	O
)	O
were	O
calculated	O
from	O
measurements	O
of	O
airway	O
pressure	O
,	O
esophageal	O
pressure	O
,	O
and	O
airway	O
flow	O
in	O
five	O
anesthetized	O
,	O
paralyzed	O
dogs	O
during	O
sinusoidal	O
forcing	O
at	O
a	O
constant	O
mean	O
airway	O
pressure	O
of	O
10	O
cmH2O	O
in	O
a	O
wide	O
range	O
of	O
breathing	O
frequencies	O
(	O
0.2	O
to	O
1.0	O
Hz	O
in	O
intervals	O
of	O
0.2	O
)	O
and	O
tidal	O
volumes	O
(	O
50	O
,	O
100	O
,	O
200	O
,	O
and	O
to	O
300	O
mL	O
)	O
.	O

The	O
Cut9	B
subunit	I
is	O
likely	O
to	O
be	O
a	O
target	O
for	O
regulating	O
APC	B
/	I
cyclosome	I
function	O
through	O
protein	O
-	O
protein	O
interactions	O
and	O
phosphorylation	O
.	O

The	O
dose	O
was	O
50	O
Gy	O
/	O
20	O
fractions	O
/	O
5	O
weeks	O
.	O

All	O
the	O
women	O
received	O
13.5	O
mg	O
plain	O
bupivacaine	O
via	O
subarachnoid	O
injection	O
at	O
the	O
L2	O
-	O
3	O
interspace	O
.	O

Naltrexone	O
has	O
been	O
recently	O
approved	O
by	O
the	O
Food	O
and	O
Drug	O
Administration	O
for	O
the	O
treatment	O
of	O
alcohol	O
dependence	O
.	O

Ent	B
-	I
kaurene	I
synthase	I
from	I
the	I
fungus	I
Phaeosphaeria	I
sp.	O

We	O
describe	O
a	O
novel	O
zinc	B
finger	I
protein	I
,	O
dsRBP	B
-	I
ZFa	I
,	O
isolated	O
by	O
screening	O
an	O
expression	O
library	O
with	O
dsRNA	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
retroplasmid	O
reverse	B
transcriptase	I
is	O
uniquely	O
adapted	O
to	O
initiate	O
cDNA	O
synthesis	O
by	O
recognizing	O
a	O
3	O
'	O
CCA	O
sequence	O
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
EGF	B
/	O
Ras	B
/	O
Raf	B
induces	O
transcription	O
via	O
combined	O
activation	O
of	O
ATF3	B
/	O
c	B
-	I
Jun	I
and	O
a	O
52-kDa	O
nuclear	O
factor	O
,	O
whereas	O
JunD	B
acts	O
as	O
a	O
repressor	O
of	O
this	O
response	O
.	O

Together	O
,	O
these	O
data	O
support	O
a	O
model	O
in	O
which	O
Tax	B
anchors	O
CBP	B
to	O
the	O
HTLV-1	B
promoter	I
,	O
with	O
strong	O
transcriptional	O
activation	O
resulting	O
from	O
the	O
CBP	B
-	O
associated	O
activities	O
of	O
nucleosome	O
remodeling	O
and	O
recruitment	O
of	O
the	O
general	O
transcription	O
machinery	O
.	O

Consistent	O
with	O
this	O
model	O
,	O
a	O
synthetic	O
construct	O
containing	O
three	O
tandem	O
copies	O
of	O
the	O
native	O
LDL	B
receptor	I
SREBP	B
site	O
linked	O
to	O
a	O
single	O
Sp1	B
site	I
was	O
also	O
significantly	O
activated	O
in	O
a	O
buttonhead	B
-	O
independent	O
fashion	O
.	O

Various	O
assays	O
demonstrate	O
promoter	O
activity	O
in	O
this	O
sequence	O
that	O
reproduces	O
the	O
normal	O
control	O
of	O
E2F2	B
expression	O
during	O
a	O
growth	O
stimulation	O
.	O

In	O
the	O
adult	O
mouse	O
,	O
ERR	B
alpha	I
is	O
most	O
highly	O
expressed	O
in	O
kidney	O
,	O
heart	O
,	O
and	O
brown	O
adipocytes	O
,	O
tissues	O
which	O
preferentially	O
metabolize	O
fatty	O
acids	O
.	O

Analysis	O
of	O
the	O
5	O
'	O
flanking	O
region	O
of	O
the	O
gene	O
also	O
revealed	O
the	O
presence	O
of	O
multiple	O
TATA	O
and	O
CAAT	O
sequences	O
.	O

The	O
complete	O
response	O
(	O
CR	O
)	O
rate	O
was	O
34	O
%	O
in	O
the	O
CODE	O
with	O
rhG	B
-	I
CSF	I
group	O
and	O
23	O
%	O
in	O
the	O
CODE	O
alone	O
group	O
;	O
the	O
median	O
survival	O
was	O
59	O
and	O
32	O
weeks	O
,	O
respectively	O
,	O
in	O
these	O
groups	O
(	O
P	O
=	O
0.004	O
)	O
.	O

Heterogeneous	B
nuclear	I
ribonucleoprotein	I
A1	I
binds	O
to	O
the	O
transcription	O
-	O
regulatory	O
region	O
of	O
mouse	O
hepatitis	O
virus	O
RNA	O
.	O

In	O
the	O
first	O
part	O
of	O
our	O
study	O
,	O
the	O
highest	O
mutagenicity	O
was	O
revealed	O
by	O
TA98	O
strain	O
without	O
enzymatic	O
activation	O
,	O
suggesting	O
a	O
direct	O
-	O
acting	O
mutagenicity	O
prevalence	O
in	O
diesel	O
particulate	O
.	O

The	O
addition	O
of	O
culture	O
to	O
the	O
CC	O
and	O
CC	O
:	O
SW	O
by	O
-	O
products	O
resulted	O
in	O
pH	O
values	O
lower	O
(	O
P	O
<	O
0.05	O
)	O
than	O
those	O
without	O
culture	O
on	O
Day	O
21	O
,	O
and	O
the	O
15	O
%	O
carbohydrate	O
treatment	O
significantly	O
reduced	O
pH	O
beyond	O
the	O
5	O
%	O
carbohydrate	O
.	O

Myocardial	O
interstitial	O
edema	O
is	O
more	O
likely	O
a	O
potential	O
mechanism	O
of	O
diastolic	O
dysfunction	O
after	O
DC	O
shocks	O
.	O

Two	O
experiments	O
(	O
N	O
=	O
20	O
each	O
)	O
were	O
carried	O
out	O
to	O
explore	O
the	O
nature	O
of	O
ERP	O
negativities	O
in	O
a	O
visuospatial	O
memory	O
task	O
and	O
in	O
an	O
auditory	O
spatial	O
memory	O
task	O
,	O
respectively	O
.	O

Biol	O
.	O

The	O
pattern	O
and	O
timing	O
of	O
CARP	B
mRNA	I
expression	O
,	O
including	O
transient	O
expression	O
in	O
the	O
tongue	O
at	O
14.5	O
days	O
p.c	O
.	O
,	O
coincides	O
with	O
that	O
of	O
Nkx2.5	B
/	O
Csx	B
(	O
a	O
putative	O
homolog	O
of	O
tinman	B
,	O
the	O
Drosophila	O
melanogaster	O
gene	O
responsible	O
for	O
cardiac	O
development	O
)	O
.	O

Overexpression	O
of	O
CARP	B
in	O
cardiomyocytes	O
suppresses	O
cardiac	B
troponin	I
C	I
and	O
atrial	B
natriuretic	I
factor	I
transcription	O
.	O

Hence	O
,	O
scs32	B
only	O
partially	O
suppressed	O
the	O
ts	O
phenotype	O
and	O
was	O
unable	O
to	O
suppress	O
the	O
Ino	O
-	O
phenotype	O
of	O
rpo26	B
-	I
31	I
.	O

CONCLUSION	O
:	O
Patients	O
wit	O
clinically	O
palpable	O
neck	O
disease	O
(	O
N1	O
-	O
3	O
)	O
,	O
histological	O
evidence	O
of	O
metastatic	O
nodal	O
disease	O
,	O
extracapsular	O
spread	O
,	O
and	O
three	O
or	O
more	O
positive	O
lymph	O
nodes	O
are	O
at	O
greater	O
risk	O
of	O
developing	O
failure	O
at	O
distant	O
sites	O
.	O

We	O
have	O
subcloned	O
into	O
pBR322	O
deoxyribonucleic	O
acid	O
(	O
DNA	O
)	O
sequences	O
mapping	O
either	O
in	O
the	O
coding	O
region	O
,	O
the	O
5	O
'	O
spacer	O
,	O
or	O
the	O
3	O
'	O
spacer	O
of	O
the	O
H2B	B
histone	I
gene	I
.	O

4	O
.	O

The	O
combination	O
of	O
hydralazine	O
hydrochloride	O
and	O
isosorbide	O
dinitrate	O
also	O
improves	O
survival	O
,	O
but	O
direct	O
comparison	O
of	O
both	O
regimens	O
provided	O
evidence	O
for	O
a	O
less	O
favourable	O
effect	O
than	O
that	O
of	O
the	O
ACE	B
inhibitors	O
.	O

To	O
address	O
mechanisms	O
that	O
define	O
interactions	O
of	O
Site	B
II	I
regulatory	I
factors	I
with	O
this	O
cell	O
cycle	O
control	O
element	O
,	O
we	O
have	O
investigated	O
these	O
determinants	O
of	O
transcriptional	O
regulation	O
at	O
the	O
G1	O
/	O
S	O
phase	O
transition	O
in	O
FDC	O
-	O
P1	O
hematopoietic	O
progenitor	O
cells	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
identify	O
neuronal	O
cell	O
cultures	O
that	O
express	O
RC3	B
/	O
neurogranin	B
,	O
to	O
check	O
whether	O
they	O
are	O
sensitive	O
to	O
T3	O
,	O
and	O
to	O
examine	O
the	O
mechanism	O
of	O
regulation	O
.	O

Their	O
circadian	O
responses	O
to	O
both	O
photic	O
and	O
non	O
-	O
photic	O
cues	O
were	O
then	O
tested	O
.	O

Although	O
previous	O
data	O
have	O
suggested	O
that	O
Rev	B
uses	O
the	O
same	O
export	O
pathway	O
as	O
uracil	O
-	O
rich	O
small	O
nuclear	O
RNAs	O
and	O
5S	B
ribosomal	I
RNA	I
,	O
the	O
CTE	O
seems	O
to	O
interact	O
with	O
evolutionarily	O
conserved	O
factors	O
that	O
are	O
essential	O
for	O
cellular	O
mRNA	O
export	O
.	O

ArgR	B
was	O
shown	O
to	O
be	O
a	O
dimer	O
of	O
two	O
equal	O
subunits	O
,	O
each	O
with	O
a	O
molecular	O
mass	O
of	O
37,000	O
Da	O
.	O

Plasma	B
leptin	I
concentrations	O
were	O
higher	O
in	O
women	O
than	O
men	O
,	O
even	O
after	O
the	O
adjustment	O
for	O
differences	O
in	O
fat	O
mass	O
(	O
28	O
+	O
/-	O

3	O
ng	O
/	O
ml	O
for	O
women	O
vs.	O

This	O
interaction	O
involved	O
the	O
SH3	B
region	I
of	O
p50	B
(	O
csk	B
)	O
and	O
a	O
proline	O
-	O
rich	O
region	O
(	O
PPPLPERTPESFVLADM	O
)	O
outside	O
the	O
catalytic	O
region	O
of	O
PTP	B
-	O
PEST	O
.	O

Following	O
2.5	O
Gy	O
,	O
HbO2	B
changes	O
were	O
minimal	O
.	O

Polarised	O
expression	O
of	O
human	O
intestinal	O
N	B
-	I
benzoyl	I
-	I
L	I
-	I
tyrosyl	I
-	I
p	I
-	I
aminobenzoic	I
acid	I
hydrolase	I
(	O
human	B
meprin	I
)	O
alpha	O
and	O
beta	O
subunits	O
in	O
Madin	O
-	O
Darby	O
canine	O
kidney	O
cells	O
.	O

The	O
cycle	O
length	O
of	O
induced	O
VT	O
(	O
n	O
=	O
10	O
VTs	O
)	O
was	O
380	O
+	O
/-	O

41	O
msec	O
.	O

Transient	O
hyperammonaemia	O
in	O
an	O
adult	O
German	O
shepherd	O
dog	O
.	O

We	O
established	O
that	O
the	O
2.6	O
kb	O
mRNA	O
V-1	O
and	O
the	O
2.3	O
kb	O
GGT	B
mRNA	O
V-2	O
derive	O
,	O
by	O
alternate	O
splicing	O
,	O
from	O
a	O
primary	O
transcript	O
initiated	O
on	O
a	O
distal	O
promoter	O
on	O
the	O
rat	B
GGT	I
gene	I
.	O

These	O
repressor	O
sites	O
are	O
pyrimidine	O
rich	O
and	O
bind	O
avidly	O
to	O
the	O
polypyrimidine	B
tract	I
binding	I
protein	I
(	O
PTB	B
)	O
in	O
HeLa	O
nuclear	O
extracts	O
as	O
determined	O
by	O
UV	O
crosslinking	O
/	O
competition	O
assays	O
.	O

For	O
higher	O
expression	O
of	O
lipA	B
in	O
S.	O
lividans	O
,	O
the	O
gene	O
was	O
cloned	O
next	O
to	O
the	O
strong	O
aphII	B
promoter	I
.	O

In	O
contrast	O
to	O
the	O
wild	O
-	O
type	O
protein	O
,	O
expression	O
of	O
p45	B
NF	B
-	I
E2	I
lacking	O
this	O
activation	O
domain	O
in	O
an	O
NF	B
-	I
E2	I
null	O
cell	O
line	O
fails	O
to	O
support	O
enhancer	O
-	O
dependent	O
transcription	O
in	O
transient	O
assays	O
.	O

These	O
findings	O
suggest	O
one	O
potential	O
mechanism	O
for	O
direct	O
recruitment	O
of	O
distal	O
regulatory	O
regions	O
of	O
the	O
globin	B
loci	I
to	O
the	O
individual	O
promoters	O
.	O

The	O
promoter	O
region	O
showed	O
no	O
consensus	O
TATA	O
box	O
but	O
it	O
contains	O
CCAAT	O
and	O
CreA	B
boxes	O
known	O
to	O
be	O
involved	O
in	O
both	O
stress	O
and	O
carbon	O
-	O
catabolite	O
regulation	O
of	O
fungal	O
promoters	O
.	O

The	O
ORF3	O
mutant	O
produced	O
reduced	O
levels	O
of	O
tabtoxin	B
,	O
indicating	O
that	O
ORF3	O
may	O
have	O
a	O
role	O
in	O
T	B
beta	I
L	I
biosynthesis	O
.	O

These	O
transcripts	O
contain	O
the	O
5	O
'	O
ends	O
of	O
mature	O
UbCRBP	B
mRNAs	I
;	O
extend	O
through	O
UbCRBP	B
,	O
across	O
the	O
intergenic	O
region	O
,	O
and	O
a	O
significant	O
distance	O
3	O
'	O
into	O
the	O
enolase	B
gene	I
.	O

As	O
a	O
result	O
,	O
the	O
subendocardial	O
/	O
subepicardial	O
blood	O
flow	O
ratio	O
(	O
ENDO	O
/	O
EPI	O
)	O
increased	O
from	O
0.44	O
+	O
/-	O

0.09	O
during	O
control	O
stenosis	O
to	O
0.85	O
+	O
/-	O

0.13	O
after	O
ITF	O
1129	O
(	O
10	O
micrograms	O
/	O
kg	O
/	O
min	O
i.v	O
.	O
)	O
and	O
to	O
0.81	O
+	O
/-	O

0.12	O
after	O
NTG	O
.	O

In	O
support	O
of	O
this	O
interpretation	O
we	O
demonstrate	O
that	O
MQ9b	B
binds	O
strongly	O
5	O
of	O
17	O
motif	O
-	O
positive	O
,	O
pathogen	O
-	O
derived	O
synthetic	O
peptides	O
.	O

However	O
,	O
although	O
deletion	O
of	O
Fp1	B
in	O
the	O
hCRBP1	B
gene	I
yielded	O
increased	O
CAT	B
activity	O
,	O
pointing	O
toward	O
a	O
negative	O
regulatory	O
function	O
exerted	O
by	O
this	O
element	O
,	O
its	O
insertion	O
upstream	O
of	O
the	O
p12	B
basal	I
promoter	I
results	O
in	O
an	O
impressive	O
positive	O
stimulation	O
of	O
CAT	B
gene	I
expression	O
.	O

Gaucher	O
's	O
disease	O
is	O
a	O
rare	O
metabolic	O
disorder	O
characterized	O
by	O
the	O
lack	O
of	O
beta	B
-	I
glucocerebrosidase	I
enzyme	I
.	O

Overexpression	O
of	O
BAG-1	B
also	O
protected	O
certain	O
cell	O
lines	O
from	O
heat	O
shock	O
-	O
induced	O
cell	O
death	O
.	O

The	O
5	O
'	O
flanking	O
region	O
contains	O
potential	O
binding	O
sites	O
for	O
TATA	B
-	I
binding	I
protein	I
,	O
Sp1	B
,	O
nuclear	B
factor	I
1	I
(	O
NF1	B
)	O
,	O
CAAT	B
-	I
box	I
binding	I
protein	I
(	O
C	B
/	I
EBP	I
)	O
,	O
hepatocyte	B
nuclear	I
factors	I
1	I
and	I
5	I
(	O
HNF1	B
,	O
HNF5	B
)	O
and	O
activator	B
proteins	I
1	I
and	I
2	I
(	O
AP1	B
,	O
AP2	B
)	O
.	O

The	O
recognition	O
specificity	O
of	O
the	O
p55	B
PDZ	B
domain	I
appears	O
to	O
be	O
unique	O
,	O
since	O
the	O
three	O
PDZ	B
domains	I
of	O
hDlg	B
(	O
human	O
lymphocyte	O
homologue	O
of	O
the	O
Drosophila	B
discs	I
large	I
tumor	I
suppressor	I
)	O
do	O
not	O
bind	O
the	O
cytoplasmic	O
domain	O
of	O
glycophorin	B
C.	I

By	O
analyzing	O
the	O
RanGAP	B
activity	O
of	O
a	O
series	O
of	O
recombinantly	O
expressed	O
rna1p	B
mutant	I
derivatives	O
,	O
we	O
show	O
that	O
the	O
highly	O
acidic	O
sequence	O
in	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
both	O
yeast	O
proteins	O
is	O
indispensable	O
for	O
activating	O
Ran	B
-	O
mediated	O
GTP	O
hydrolysis	O
.	O

In	O
the	O
absence	O
of	O
MHC	B
class	I
II	I
,	O
purified	B
soluble	I
D10	I
TCR	I
bound	O
to	O
Staphylococcus	B
aureus	I
enterotoxin	I
C2	I
with	O
an	O
association	O
rate	O
of	O
1.69+	O
/	O
-0.12	O
x	O
10	O
(	O
4	O
)	O
M	O
(	O
-1	O
)	O
sec	O
(	O
-1	O
)	O
and	O
a	O
dissociation	O
rate	O
of	O
1.9+	O
/	O
-0.47	O
x	O
10	O
(	O
-2	O
)	O
sec	O
(	O
-1	O
)	O
,	O
giving	O
a	O
dissociation	O
constant	O
of	O
1.1	O
microM.	O

Evidence	O
for	O
such	O
peak	O
shifts	O
has	O
been	O
found	O
in	O
the	O
responses	O
of	O
auditory	O
nerve	O
fibers	O
,	O
cochlear	O
microphonics	O
,	O
and	O
the	O
responses	O
of	O
outer	O
hair	O
cells	O
and	O
supporting	O
cells	O
in	O
the	O
cochlea	O
,	O
as	O
well	O
as	O
in	O
basilar	O
membrane	O
vibration	O
measurements	O
,	O
and	O
indirectly	O
,	O
in	O
psychophysical	O
data	O
.	O

Mnt	B
:	O
Max	B
complexes	O
also	O
efficiently	O
suppress	O
Myc	B
-	O
dependent	O
activation	O
from	O
the	O
same	O
promoter	O
.	O

In	O
the	O
United	O
States	O
high	O
-	O
MW	O
HES	O
480	O
which	O
is	O
difficult	O
to	O
degrade	O
is	O
most	O
frequently	O
used	O
and	O
results	O
in	O
a	O
larger	O
in	O
vivo	O
MW	O
and	O
subsequent	O
decrease	O
in	O
factor	B
VIII	I
/	O
von	B
Willebrand	I
factor	I
levels	O
.	O

Assays	O
of	O
total	O
cholesterol	O
as	O
well	O
as	O
the	O
HDL	B
,	O
HDL2	B
,	O
LDL	B
,	O
triglycerides	O
,	O
endothelin-1	B
,	O
lipoprotein	B
(	I
a	I
)	I
,	O
estradiol	O
and	O
FSH	B
were	O
also	O
obtained	O
at	O
baseline	O
before	O
receiving	O
ERT	O
and	O
after	O
3	O
months	O
of	O
ERT	O
.	O

The	O
distributed	O
current	O
density	O
J	O
is	O
calculated	O
within	O
the	O
volume	O
defined	O
by	O
the	O
motor	O
unit	O
.	O

The	O
cleavage	O
dipeptides	O
of	O
C1YVV	B
NIa	I
protease	I
are	O
Q	O
(	O
E	O
)	O
/	O
S	O
(	O
A	O
,	O
G	O
)	O
.	O

However	O
,	O
we	O
were	O
unable	O
to	O
identify	O
a	O
p4	B
molecule	O
.	O

(	O
iv	O
)	O
The	O
accumulation	O
of	O
cyclin	B
D3	I
protein	I
in	O
Vero	O
cells	O
infected	O
with	O
an	O
alpha0	B
deletion	I
mutant	I
was	O
reduced	O
relative	O
to	O
that	O
of	O
cells	O
infected	O
with	O
wild	O
-	O
type	O
virus	O
or	O
a	O
recombinant	O
virus	O
in	O
which	O
the	O
deleted	O
alpha0	B
sequences	I
were	O
restored	O
.	O

These	O
effects	O
were	O
abrogated	O
by	O
co	O
-	O
expression	O
of	O
kinase	B
-	I
deficient	I
PKC	I
zeta	I
and	O
inhibition	O
of	O
phosphatidylinositol	B
3-kinase	I
p85alpha	B
-	O
p110	B
by	O
wortmannin	O
,	O
LY294002	O
and	O
a	O
dominant	O
-	O
negative	O
mutant	O
of	O
p85alpha	B
.	O

Protein	B
phosphatase	I
2A	I
is	O
a	O
critical	O
regulator	O
of	O
protein	B
kinase	I
C	I
zeta	I
signaling	O
targeted	O
by	O
SV40	B
small	I
t	I
to	O
promote	O
cell	O
growth	O
and	O
NF	B
-	I
kappaB	I
activation	O
.	O

Underlying	O
the	O
clustering	O
of	O
these	O
risk	O
variables	O
were	O
three	O
factors	O
.	O

Supplementation	O
was	O
stopped	O
when	O
pl	B
-	I
ALB	I
reached	O
2.0	O
g	O
/	O
dL.	O

Detection	O
of	O
airborne	O
Mycobacterium	O
tuberculosis	O
by	O
air	O
filtration	O
and	O
polymerase	O
chain	O
reaction	O
.	O

These	O
findings	O
show	O
that	O
EBP50	B
is	O
a	O
physiologically	O
relevant	O
ezrin	B
binding	I
protein	I
.	O

Deletion	O
of	O
the	O
POR2	B
gene	I
alone	O
had	O
no	O
detectable	O
phenotype	O
,	O
while	O
yeasts	O
with	O
deletions	O
of	O
both	O
the	O
POR1	B
and	O
POR2	B
genes	I
were	O
viable	O
and	O
able	O
to	O
grow	O
on	O
glycerol	O
at	O
30	O
degrees	O
C	O
,	O
albeit	O
more	O
slowly	O
than	O
delta	B
por1	I
single	I
mutants	I
.	O

Furthermore	O
,	O
our	O
novel	O
observation	O
that	O
expression	O
of	O
a	O
highly	O
activated	O
FGFR3	B
kinase	I
domain	I
is	O
able	O
to	O
morphologically	O
transform	O
fibroblasts	O
suggests	O
that	O
dysregulation	O
of	O
FGFR3	B
has	O
the	O
potential	O
to	O
play	O
a	O
role	O
in	O
human	O
neoplasia	O
.	O

However	O
,	O
Cbf5p	B
was	O
found	O
to	O
be	O
nucleolar	O
and	O
is	O
highly	O
homologous	O
to	O
the	O
rat	B
nucleolar	I
protein	I
NAP57	I
,	O
which	O
coimmunoprecipitates	O
with	O
Nopp140	B
and	O
which	O
is	O
postulated	O
to	O
be	O
involved	O
in	O
nucleolar	O
-	O
cytoplasmic	O
shuttling	O
(	O
U.	O

Ig	B
heavy	I
chain	I
class	O
switching	O
is	O
directed	O
by	O
cytokines	O
inducing	O
transcription	O
from	O
unrearranged	O
CH	B
genes	I
.	O

The	O
available	O
data	O
suggest	O
that	O
the	O
NF	B
kappa	I
B2	I
nucleoprotein	I
complex	I
may	O
cooperate	O
with	O
DNA	O
-	O
bound	O
STAT6	B
to	O
achieve	O
IL-4-dependent	B
activation	O
of	O
the	O
human	B
IgE	I
germline	I
gene	I
.	O

EXERCISE	O
IN	O
THE	O
TERRESTRIAL	O
CHRISTMAS	O
ISLAND	O
RED	O
CRAB	O
GECARCOIDEA	O
NATALIS	O
-	O
ENERGETICS	O
OF	O
LOCOMOTION	O

THE	O
SCALING	O
OF	O
SONG	O
FREQUENCY	O
IN	O
CICADAS	O

In	O
this	O
study	O
we	O
have	O
introduced	O
mutations	O
into	O
the	O
corresponding	O
elements	O
of	O
two	O
cox3	B
promoters	I
and	O
show	O
that	O
while	O
the	O
core	O
element	O
is	O
essential	O
for	O
cox3	B
promoter	I
activity	O
,	O
upstream	O
element	O
mutations	O
have	O
little	O
or	O
no	O
effect	O
.	O

The	O
histidine	O
-	O
tagged	O
gene	O
,	O
rpoCHIS	B
,	O
was	O
used	O
to	O
replace	O
the	O
wild	O
-	O
type	O
allele	O
in	O
the	O
chromosome	O
of	O
S.	O
coelicolor	O
and	O
S.	O
lividans	O
.	O

The	O
malate	B
synthase	I
gene	I
,	O
MLS1	B
,	O
of	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
is	O
transcriptionally	O
regulated	O
by	O
the	O
carbon	O
source	O
in	O
the	O
growth	O
medium	O
.	O

Lack	O
of	O
controlled	O
prospective	O
studies	O
of	O
sleep	O
electroencephalograms	O
(	O
EEG	O
)	O
,	O
and	O
the	O
use	O
of	O
medication	O
,	O
in	O
children	O
with	O
developmental	O
dysphasia	O
,	O
may	O
deny	O
appropriate	O
treatment	O
strategies	O
to	O
children	O
with	O
severe	O
developmental	O
speech	O
and	O
language	O
disorders	O
.	O

Prior	O
to	O
meals	O
2	O
to	O
3	O
times	O
daily	O
,	O
1	O
-	O
2	O
tablespoons	O
of	O
Alzoon	O
are	O
recommended	O
.	O

Widening	O
of	O
the	O
abdominal	O
aortic	O
wall	O
on	O
an	O
ultrasound	O
examination	O
was	O
the	O
key	O
to	O
the	O
incidental	O
diagnosis	O
of	O
a	O
clinically	O
unsuspected	O
type	O
B	O
dissection	O
.	O

Ovaries	O
of	O
10	O
animals	O
per	O
group	O
from	O
16	O
studies	O
in	O
CD-1	O
mice	O
and	O
1	O
study	O
each	O
in	O
C3H	O
and	O
C57BL	O
/	O
6	O
mice	O
were	O
sectioned	O
serially	O
at	O
6	O
microm	O
.	O

The	O
sequenced	O
cDNA	O
predicts	O
a	O
704-amino	O
acid	O
protein	O
80	O
%	O
identical	O
to	O
human	B
progelatinase	I
B.	I

The	O
inhibition	O
by	O
cytosolic	O
Ca2	O
+	O
was	O
caused	O
by	O
a	O
decrease	O
in	O
cooperativity	O
and	O
by	O
a	O
shift	O
in	O
EC50	O
toward	O
higher	O
InsP3	O
concentrations	O
.	O

RESULTS	O
:	O
The	O
standardised	O
mortality	O
ratio	O
(	O
SMR	O
)	O
for	O
all	O
malignant	O
neoplasms	O
was	O
94	O
(	O
95	O
%	O
CI	O
74	O
to	O
118	O
)	O
.	O

Sequence	O
analysis	O
of	O
this	O
region	O
revealed	O
three	O
eight	O
-	O
bp	O
repetitive	O
elements	O
,	O
the	O
deletion	O
of	O
which	O
restored	O
wild	O
-	O
type	O
levels	O
of	O
luciferase	B
activity	O
to	O
the	O
-916-bp	O
reporter	O
plasmid	O
.	O

Using	O
5'RACE	O
and	O
reverse	O
transcription	O
-	O
PCR	O
(	O
RT	O
-	O
PCR	O
)	O
methodologies	O
,	O
we	O
cloned	O
these	O
sequences	O
from	O
brain	O
and	O
placenta	O
and	O
found	O
this	O
material	O
to	O
be	O
composed	O
of	O
alternatively	O
spliced	O
exons	O
using	O
a	O
previously	O
reported	O
noncoding	O
exon	O
(	O
1A	O
)	O
and	O
a	O
novel	O
97-bp	O
noncoding	O
exon	O
(	O
1B	O
)	O
.	O

This	O
is	O
the	O
first	O
study	O
in	O
which	O
mutation	O
screening	O
has	O
been	O
performed	O
for	O
both	O
the	O
EXT1	B
and	O
EXT2	B
genes	I
prior	O
to	O
any	O
linkage	O
analysis	O
.	O

The	O
regurgitation	O
of	O
large	O
vitreous	O
injections	O
.	O

Positron	O
emission	O
tomography	O
radioligands	O
for	O
dopamine	B
transporters	I
and	O
studies	O
in	O
human	O
and	O
nonhuman	O
primates	O
.	O

Attenuation	O
from	O
the	O
vit	B
A2	I
consensus	O
ERE	O
is	O
not	O
necessarily	O
dependent	O
on	O
DNA	O
binding	O
as	O
the	O
TR	B
alpha	I
DNA	O
binding	O
mutant	O
was	O
still	O
able	O
to	O
inhibit	O
E	O
-	O
dependent	O
transactivation	O
.	O

Expression	O
from	O
this	O
element	O
is	O
regulated	O
by	O
a	O
heteromeric	O
protein	O
complex	O
containing	O
ubiquitous	O
(	O
i.e.	O
the	O
E2A-	B
and	O
HEB	B
-	I
encoded	I
proteins	I
)	O
and	O
islet	O
-	O
enriched	O
members	O
of	O
the	O
bHLH	B
family	I
.	O

The	O
most	O
common	O
grade	O
3	O
toxicity	O
was	O
neutropenia	O
,	O
thrombocytopenia	O
,	O
and	O
parasthesias	O
(	O
observed	O
in	O
<	O
10	O
%	O
of	O
cycles	O
)	O
.	O

Serum	O
concentrations	O
of	O
E2	O
and	O
TBOH	O
were	O
measured	O
on	O
d	O
0	O
,	O
1	O
,	O
3	O
,	O
5	O
,	O
7	O
,	O
13	O
,	O
21	O
,	O
28	O
,	O
42	O
,	O
56	O
,	O
84	O
,	O
112	O
,	O
and	O
140	O
in	O
finishing	O
heifers	O
administered	O
the	O
following	O
treatments	O
:	O
1	O
)	O
control	O
;	O
2	O
)	O
MGA	O
,	O
.5	O
mg	O
per	O
heifer	O
daily	O
;	O
3	O
)	O
Revalor	O
-	O
H	O
(	O
140	O
mg	O
TBA	O
+	O
14	O
mg	O
E2	O
)	O
;	O
4	O
)	O
Revalor	O
-	O
H	O
+	O
MGA	O
;	O
5	O
)	O
Finaplix	O
-	O
H	O
(	O
200	O
mg	O
TBA	O
)	O
;	O
and	O
6	O
)	O
Finaplix	O
-	O
H	O
+	O
MGA	O
.	O

Serum	O
E2	O
concentrations	O
increased	O
numerically	O
two-	O
to	O
threefold	O
from	O
d	O
56	O
to	O
140	O
in	O
controls	O
fed	O
MGA	O
,	O
compared	O
with	O
controls	O
not	O
fed	O
MGA	O
.	O

Interferon	B
Regulatory	I
Factor	I
(	I
IRF	I
)	I
-1	I
has	O
been	O
characterized	O
as	O
an	O
important	O
growth	O
regulatory	O
and	O
immunomodulatory	O
transcription	O
factor	O
.	O

The	O
genomic	O
structure	O
of	O
brk	B
consists	O
of	O
8	O
exons	O
,	O
whose	O
boundaries	O
are	O
distinct	O
from	O
other	O
non	O
-	O
receptor	O
PTK	B
family	I
members	O
,	O
again	O
indicating	O
a	O
structural	O
and	O
functional	O
divergence	O
.	O

We	O
have	O
previously	O
reported	O
that	O
expression	O
of	O
a	O
tumour	O
derived	O
brk	B
cDNA	I
in	O
mouse	O
embryonic	O
fibroblasts	O
and	O
human	O
mammary	O
epithelial	O
cells	O
supports	O
anchorage	O
independent	O
growth	O
,	O
and	O
in	O
the	O
latter	O
potentiates	O
the	O
mitogenic	O
response	O
to	O
epidermal	B
growth	I
factor	I
.	O

Anti	B
-	I
hepatitis	I
A	I
virus	O
(	O
HAV	O
)	O
titer	O
after	O
vaccination	O
was	O
measured	O
in	O
83	O
HIV	O
-	O
positive	O
and	O
39	O
HIV	O
-	O
negative	O
men	O
.	O

One	O
skull	O
does	O
not	O
a	O
species	O
make	O
.	O

Surprisingly	O
,	O
calf	B
thymus	I
CstF	I
contained	O
an	O
additional	O
,	O
novel	O
form	O
of	O
the	O
64-kDa	O
subunit	O
with	O
a	O
molecular	O
mass	O
of	O
70	O
kDa	O
.	O

Null	O
mutations	O
in	O
daf-3	B
suppress	O
mutations	O
in	O
genes	O
encoding	O
this	O
TGF	B
-	I
beta	I
signal	O
,	O
its	O
receptors	O
,	O
and	O
associated	O
Smad	B
signal	I
transduction	I
proteins	I
.	O

daf-3	B
encodes	O
a	O
Smad	B
protein	I
that	O
is	O
most	O
closely	O
related	O
to	O
mammalian	B
DPC4	I
,	O
and	O
is	O
expressed	O
throughout	O
development	O
in	O
many	O
of	O
the	O
tissues	O
that	O
are	O
remodeled	O
during	O
dauer	O
development	O
.	O

Our	O
results	O
favor	O
the	O
possibility	O
that	O
the	O
Drosophila	B
EGF	I
receptor	I
DER	B
/	O
Egfr	B
expressed	O
by	O
the	O
EMA	O
cells	O
functions	O
as	O
a	O
receptor	O
for	O
Vein	B
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
In	O
807	O
consecutive	O
patients	O
from	O
the	O
Chilean	O
National	O
Registry	O
of	O
Acute	O
Myocardial	O
Infarction	O
we	O
analyzed	O
the	O
resolution	O
of	O
chest	O
pain	O
and	O
ST	O
segment	O
elevation	O
over	O
50	O
%	O
within	O
the	O
first	O
90	O
min	O
,	O
abrupt	O
CK	B
rise	O
within	O
8	O
h	O
and	O
T	O
wave	O
inversion	O
in	O
infarct	O
related	O
EKG	O
leads	O
within	O
the	O
first	O
24	O
h	O
after	O
thrombolysis	O
.	O

Because	O
of	O
the	O
operon	O
structure	O
of	O
this	O
organism	O
,	O
traditional	O
methods	O
such	O
as	O
insertional	O
mutagenesis	O
run	O
the	O
risk	O
of	O
introducing	O
polar	O
effects	O
on	O
downstream	O
genes	O
or	O
creating	O
secondary	O
mutations	O
elsewhere	O
in	O
the	O
genome	O
.	O

Nucleotide	O
sequence	O
analysis	O
of	O
R	O
has	O
revealed	O
similarities	O
to	O
the	O
R1	O
plasmid	O
found	O
in	O
some	O
South	O
American	O
maize	O
races	O
with	O
RU	O
cytoplasm	O
,	O
to	O
the	O
M1	O
plasmid	O
found	O
in	O
one	O
source	O
of	O
Zea	O
luxurians	O
teosinte	O
,	O
to	O
the	O
atp9	B
mitochondrial	I
gene	I
and	O
its	O
3	O
'	O
flanking	O
sequence	O
,	O
and	O
also	O
to	O
a	O
region	O
3	O
'	O
to	O
the	O
orf221	B
gene	I
.	O

Cloning	O
of	O
a	O
human	B
phosphoinositide	I
3-kinase	I
with	O
a	O
C2	B
domain	O
that	O
displays	O
reduced	O
sensitivity	O
to	O
the	O
inhibitor	O
wortmannin	O
.	O

Functional	O
analysis	O
of	O
promoter	O
activity	O
of	O
the	O
5'-flanking	O
region	O
of	O
cyclin	B
D2	I
suggested	O
that	O
the	O
region	O
-	O
1,100	O
to	O
-	O
805	O
including	O
C	B
/	I
EBP	I
,	O
PEA3	B
,	O
AP2	B
,	O
NF	B
-	I
Y	I
,	O
c	B
-	I
Myc	I
,	O
and	O
Sp1	B
may	O
have	O
a	O
major	O
positive	O
regulatory	O
activity	O
for	O
expression	O
of	O
cyclin	B
D2	I
.	O

Effect	O
of	O
alcohol	O
on	O
minimal	O
effective	O
nCPAP	O
pressure	O

In	O
contrast	O
,	O
resensitization	O
of	O
a	O
sequestration	O
-	O
impaired	O
beta2AR	B
mutant	O
(	O
Y326A	O
)	O
was	O
reestablished	O
following	O
the	O
overexpression	O
of	O
either	O
GRK2	B
or	O
beta	B
-	I
arrestin	I
1	I
.	O

We	O
have	O
overexpressed	O
,	O
purified	O
,	O
characterized	O
,	O
and	O
crystallized	O
the	O
BTB	B
/	O
POZ	O
domain	O
from	O
PLZF	B
(	O
PLZF	B
-	O
BTB	B
/	O
POZ	O
)	O
.	O

We	O
also	O
identified	O
Sp1	B
,	O
Sp3	B
,	O
and	O
NGFI	B
-	I
A	I
/	O
Egr-1	B
as	O
the	O
primary	O
nuclear	O
transcription	O
factors	O
binding	O
to	O
TRE1	B
which	O
mediate	O
Tax	B
responsiveness	O
.	O

Interestingly	O
,	O
segment	O
nesting	O
differentially	O
increases	O
the	O
copy	O
number	O
of	O
genes	O
encoded	O
by	O
segment	O
W	O
,	O
suggesting	O
that	O
the	O
unusual	O
genomic	O
organization	O
of	O
PDVs	O
may	O
be	O
directly	O
linked	O
to	O
the	O
unique	O
functions	O
of	O
this	O
virus	O
in	O
its	O
obligate	O
mutualistic	O
association	O
with	O
parasitic	O
wasps	O
.	O

Furthermore	O
,	O
deletion	O
and	O
mutation	O
analyses	O
of	O
the	O
VCAM-1	B
promoter	I
performed	O
with	O
chloramphenicol	B
acetyltransferase	I
constructs	I
revealed	O
that	O
Tax	B
was	O
trans	O
activating	O
the	O
VCAM-1	B
promoter	I
via	O
two	O
NF	B
-	I
kappaB	I
sites	I
present	O
at	O
bp	O
-72	O
and	O
-57	O
in	O
the	O
VCAM-1	B
gene	I
promoter	I
,	O
with	O
both	O
of	O
them	O
being	O
required	O
for	O
the	O
Tax	B
-	O
induced	O
expression	O
of	O
this	O
adhesion	O
molecule	O
.	O

Processivity	O
of	O
DNA	O
synthesis	O
by	O
the	O
mutant	O
holoenzyme	O
containing	O
pcna-79	B
was	O
unaffected	O
on	O
poly	O
(	O
dA	O
)	O
x	O
oligo	O
(	O
dT	O
)	O
but	O
was	O
dramatically	O
reduced	O
on	O
a	O
natural	O
template	O
with	O
secondary	O
structure	O
.	O

The	O
Scm	B
and	O
ph	B
proteins	O
share	O
a	O
homology	O
domain	O
with	O
38	O
%	O
identity	O
over	O
a	O
length	O
of	O
65	O
amino	O
acids	O
,	O
termed	O
the	O
SPM	O
domain	O
,	O
that	O
is	O
located	O
at	O
their	O
respective	O
C	O
termini	O
.	O

It	O
has	O
been	O
previously	O
shown	O
that	O
genes	O
transcribed	O
by	O
RNA	B
polymerase	I
II	I
(	O
RNAP	B
II	I
)	O
are	O
subject	O
to	O
position	O
effect	O
variegation	O
when	O
located	O
near	O
yeast	O
telomeres	O
.	O

In	O
the	O
predicted	O
transmembrane	O
domain	O
,	O
Casr	B
-	I
rs2	I
and	O
Casr	B
-	I
rs3	I
are	O
95	O
%	O
identical	O
to	O
Casr	B
-	I
rs1	I
.	O

Recently	O
,	O
roles	O
also	O
have	O
been	O
suggested	O
for	O
the	O
nuclear	O
trans	O
-	O
factor	O
GATA-1	B
in	O
regulating	O
progenitor	O
cell	O
proliferation	O
.	O

PET	O
activation	O
studies	O
are	O
performed	O
widely	O
to	O
study	O
human	O
brain	O
function	O
.	O

F	B
-	I
box	I
proteins	I
are	O
receptors	O
that	O
recruit	O
phosphorylated	O
substrates	O
to	O
the	O
SCF	B
ubiquitin	B
-	O
ligase	B
complex	O
.	O

In	O
the	O
context	O
of	O
liver	O
allograft	O
shortage	O
,	O
our	O
results	O
suggest	O
that	O
an	O
ELT	O
should	O
not	O
be	O
performed	O
in	O
patients	O
with	O
cardiac	O
failure	O
,	O
more	O
than	O
two	O
OSF	O
,	O
or	O
an	O
APACHE	O
II	O
score	O
higher	O
than	O
30	O
.	O

The	O
SH3	B
domains	I
of	O
Grb2	B
bound	O
in	O
vitro	O
to	O
specific	O
proline	O
-	O
rich	O
motifs	O
in	O
the	O
HPK1	B
tail	O
and	O
functioned	O
synergistically	O
to	O
direct	O
the	O
stable	O
binding	O
of	O
Grb2	B
to	O
HPK1	B
in	O
transfected	O
Cos1	O
cells	O
.	O

By	O
far	O
-	O
Western	O
analysis	O
and	O
coimmunoprecipitation	O
studies	O
,	O
we	O
demonstrate	O
that	O
ZNF74	B
interacts	O
,	O
via	O
its	O
zinc	O
finger	O
domain	O
,	O
with	O
the	O
hyperphosphorylated	O
largest	O
subunit	O
of	O
RNA	B
polymerase	I
II	I
(	O
pol	B
IIo	I
)	O
but	O
not	O
with	O
the	O
hypophosphorylated	O
form	O
.	O

The	O
cellular	O
rate	O
of	O
anticoagulant	B
heparan	I
sulfate	I
proteoglycan	I
(	O
HSPGact	B
)	O
generation	O
is	O
determined	O
by	O
the	O
level	O
of	O
a	O
kinetically	O
limiting	O
microsomal	O
activity	O
,	O
HSact	O
conversion	O
activity	O
,	O
which	O
is	O
predominantly	O
composed	O
of	O
the	O
long	O
sought	O
heparan	B
sulfate	I
D	I
-	I
glucosaminyl	I
3-O	I
-	I
sulfotransferase	I
(	O
3-OST	B
)	O
(	O
Shworak	O
,	O
N.	O

An	O
end	O
to	O
the	O
lottery	O
.	O

We	O
previously	O
showed	O
that	O
the	O
N	O
-	O
terminal	O
portion	O
common	O
to	O
various	O
chimeric	B
MLL	I
products	I
,	O
as	O
well	O
as	O
to	O
MLL	B
-	I
LTG9	I
and	O
MLL	B
-	I
LTG19	I
,	O
localizes	O
in	O
the	O
nuclei	O
,	O
and	O
therefore	O
suggested	O
that	O
it	O
might	O
play	O
an	O
important	O
role	O
in	O
leukemogenesis	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
pattern	O
of	O
blood	O
supply	O
is	O
relevant	O
to	O
the	O
structural	O
organisation	O
of	O
mature	O
lamellar	O
bone	O
around	O
the	O
implant	O
.	O

Induction	O
of	O
AtP5CS1	B
mRNA	I
accumulation	O
in	O
salt	O
-	O
treated	O
seedlings	O
involves	O
an	O
immediate	O
early	O
transcriptional	O
response	O
regulated	O
by	O
ABA	O
signalling	O
that	O
is	O
not	O
inhibited	O
by	O
cycloheximide	O
,	O
but	O
abolished	O
by	O
the	O
deficiency	O
of	O
ABA	O
biosynthesis	O
in	O
the	O
aba1	B
Arabidopsis	I
mutant	I
.	O

(	O
ii	O
)	O
An	O
AF	O
G	B
-	I
CSF	I
level	O
>	O
2000	O
pg	O
/	O
ml	O
is	O
a	O
strong	O
positive	O
predictor	O
of	O
CAM	O
.	O

A	O
positive	O
correlation	O
between	O
serum	B
myoglobin	I
and	O
CA	B
III	I
concentrations	O
(	O
rs	O
=	O
0.933	O
,	O
P	O
<	O
0.001	O
)	O
was	O
observed	O
in	O
hemodialyzed	O
patients	O
with	O
chronic	O
renal	O
failure	O
.	O

Furthermore	O
,	O
the	O
over	O
-	O
replication	O
phenotype	O
produced	O
by	O
this	O
mutant	B
p65cdc18	I
is	O
resistant	O
to	O
increased	O
mitotic	O
cyclin	B
/	O
CDK	B
activity	O
,	O
a	O
known	O
inhibitor	O
of	O
over	O
-	O
replication	O
.	O

Rip1p	B
is	O
inessential	O
,	O
associated	O
with	O
nuclear	O
pore	O
complexes	O
,	O
and	O
structurally	O
related	O
to	O
the	O
FG	B
-	I
nucleoporin	I
family	I
of	O
pore	O
proteins	O
.	O

The	O
CNXA	O
domain	O
is	O
similar	O
at	O
the	O
amino	O
acid	O
level	O
to	O
the	O
Escherichia	B
coli	I
moaA	I
gene	I
product	I
,	O
while	O
CNXC	O
is	O
similar	O
to	O
the	O
E.	B
coli	I
moaC	I
product	I
,	O
with	O
both	O
E.	O
coli	O
products	O
encoded	O
by	O
different	O
cistrons	O
.	O

Deletions	O
in	O
each	O
of	O
these	O
regions	O
abolish	O
membrane	O
localization	O
of	O
Tiam1	B
and	O
membrane	O
ruffling	O
,	O
suggesting	O
that	O
they	O
function	O
cooperatively	O
.	O

Histological	O
slides	O
of	O
one	O
biopsy	O
of	O
each	O
patient	O
(	O
formalin	O
-	O
fixed	O
and	O
paraffin	O
-	O
embedded	O
)	O
were	O
stained	O
with	O
a	O
Modified	O
Giemsa	O
(	O
MG	O
)	O
,	O
the	O
Warthin	O
-	O
Starry	O
(	O
WS	O
)	O
,	O
and	O
an	O
immunohistochemical	O
method	O
(	O
IMM	O
)	O
using	O
purified	O
polyclonal	O
H.	O
pylori	O
antiserum	O
(	O
DAKO	O
B471	O
)	O
.	O

These	O
findings	O
indicate	O
that	O
the	O
t	O
(	O
4	O
;	O
14	O
)	O
(	O
p16.3	O
;	O
q32	O
)	O
represents	O
a	O
novel	O
,	O
recurrent	O
chromosomal	O
translocation	O
in	O
MM	O
,	O
and	O
suggest	O
that	O
the	O
FGFR3	B
gene	I
may	O
be	O
the	O
target	O
of	O
this	O
abnormality	O
and	O
thus	O
contribute	O
to	O
tumorigenesis	O
in	O
MM	O
.	O

The	O
full	O
length	O
cDNA	O
sequence	O
of	O
a	O
Type	B
I	I
transforming	I
growth	I
factor	I
-	I
beta	I
(	I
TGF	I
-	I
beta	I
)	I
receptor	I
has	O
been	O
isolated	O
from	O
the	O
filarial	O
parasitic	O
nematode	O
Brugia	O
pahangi	O
.	O

This	O
sequence	O
possessed	O
homology	O
with	O
a	O
methylation	O
-	O
sensitive	O
promoter	O
element	O
,	O
Enh2	O
,	O
present	O
in	O
the	O
LTR	O
of	O
mouse	O
intractisternal	O
A	O
-	O
particles	O
.	O

Codon	O
optimization	O
for	O
high	O
-	O
level	O
expression	O
of	O
human	B
erythropoietin	I
(	O
EPO	B
)	O
in	O
mammalian	O
cells	O
.	O

Parodoxical	O
rise	O
in	O
urinary	B
albumin	I
levels	O
after	O
treatment	O
of	O
essential	O
hypertension	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
Rat7p	B
/	O
Nup159p	B
is	O
anchored	O
within	O
the	O
NPC	O
through	O
its	O
coiled	O
-	O
coil	O
region	O
and	O
adjacent	O
sequences	O
.	O

In	O
a	O
group	O
of	O
13	O
patients	O
with	O
obliterative	O
arteriopathies	O
of	O
the	O
lower	O
limbs	O
the	O
plasma	O
levels	O
of	O
thrombomodulin	B
(	O
TM	B
)	O
,	O
betathromboglobulin	B
(	O
beta	B
-	I
TG	I
)	O
,	O
D	O
-	O
dimer	O
(	O
DD	O
)	O
and	O
plasminogen	B
activator	I
-	I
inhibitor	I
(	O
pAI-1	B
)	O
were	O
measured	O
,	O
and	O
compared	O
to	O
the	O
values	O
obtained	O
from	O
10	O
healthy	O
volunteers	O
.	O

We	O
have	O
now	O
shown	O
that	O
in	O
vivo	O
phosphorylation	O
of	O
14	B
-	I
3	I
-	I
3	I
zeta	I
at	O
the	O
CKIalpha	B
site	I
(	I
Thr-233	I
)	I
negatively	O
regulates	O
its	O
binding	O
to	O
c	B
-	I
Raf	I
,	O
and	O
may	O
be	O
important	O
in	O
Raf	B
-	O
mediated	O
signal	O
transduction	O
.	O

Mouse	B
mast	I
cell	I
protease	I
9	I
,	O
a	O
novel	O
member	O
of	O
the	O
chromosome	O
14	O
family	O
of	O
serine	B
proteases	I
that	O
is	O
selectively	O
expressed	O
in	O
uterine	O
mast	O
cells	O
.	O

A	O
DNase	B
I	I
-	I
hypersensitive	I
site	I
has	O
also	O
been	O
mapped	O
in	O
the	O
258-base	O
pair	O
enhancer	O
region	O
.	O

[	O
Pulmonary	O
vascular	O
resistance	O
(	O
PVR	O
)	O
during	O
10	O
%	O
O2-PVR	O
during	O
21	O
%	O
O2	O
/	O
PVR	O
during	O
21	O
%	O
O2	O
]	O
x	O
100	O
was	O
termed	O
as	O
hypoxic	O
pulmonary	O
vasoconstriction	O
(	O
HPV	O
)	O
.	O

Protein	O
phosphatases	O
play	O
a	O
critical	O
role	O
in	O
the	O
regulation	O
of	O
the	O
eukaryotic	O
cell	O
cycle	O
and	O
signal	O
transduction	O
.	O

The	O
cell	O
cycle	O
-	O
regulated	O
transcription	O
factor	O
E2F	B
is	O
also	O
known	O
to	O
bend	O
DNA	O
upon	O
binding	O
.	O

Transcriptional	O
regulation	O
of	O
SUP35	B
and	O
SUP45	B
in	I
Saccharomyces	I
cerevisiae	I
.	O

Xenopus	B
Ran	I
-	I
binding	I
protein	I
1	I
:	O
molecular	O
interactions	O
and	O
effects	O
on	O
nuclear	O
assembly	O
in	O
Xenopus	O
egg	O
extracts	O
.	O

METHODS	O
:	O
Total	O
muscle	O
paralysis	O
was	O
induced	O
under	O
general	O
anesthesia	O
in	O
a	O
group	O
of	O
obese	O
persons	O
(	O
n	O
=	O
9	O
;	O
body	O
mass	O
index	O
,	O
32	O
+	O
/-	O

3	O
kg	O
[	O
-2	O
]	O
)	O
and	O
in	O
a	O
group	O
of	O
nonobese	O
persons	O
(	O
n	O
=	O
9	O
;	O
body	O
mas	O
index	O
,	O
21	O
+	O
/-	O

2	O
kg	O
[	O
-2	O
]	O
)	O
.	O

Our	O
findings	O
provide	O
the	O
first	O
evidence	O
that	O
the	O
function	O
of	O
WT1	B
can	O
be	O
modulated	O
by	O
its	O
phosphorylation	O
in	O
vivo	O
.	O

The	O
presence	O
of	O
an	O
additional	O
sequence	O
of	O
nucleotides	O
145	O
-	O
165	O
from	O
the	O
3	O
'	O
end	O
of	O
RNA3	B
enhanced	O
template	O
recognition	O
by	O
RdRp	B
in	O
vitro	O
and	O
accumulation	O
of	O
RNA3	B
in	O
vivo	O
to	O
wild	O
-	O
type	O
levels	O
.	O

Restriction	O
enzyme	O
mapping	O
,	O
subcloning	O
,	O
and	O
DNA	O
sequencing	O
analysis	O
of	O
recombinant	O
phage	O
lambda	O
and	O
P1	O
clones	O
revealed	O
that	O
exons	O
encoding	O
the	O
1.9-kb	O
mouse	B
TS	I
mRNA	I
are	O
dispersed	O
over	O
>	O
150	O
kb	O
genomic	O
DNA	O
.	O

Transfection	O
analyses	O
indicated	O
that	O
the	O
expression	O
of	O
Tbxas1	B
is	O
controlled	O
by	O
a	O
short	O
(	O
70-bp	O
)	O
positive	O
regulatory	O
sequence	O
and	O
several	O
upstream	O
repressive	O
elements	O
.	O

The	O
results	O
of	O
this	O
study	O
suggest	O
that	O
NF	B
-	I
kappaB	I
activity	O
may	O
be	O
regulated	O
by	O
its	O
interaction	O
with	O
the	O
cell	O
cycle	O
regulatory	O
protein	O
,	O
E2F-1	B
.	O

However	O
,	O
one	O
CAK	B
-	O
phosphorylated	O
phosphopeptide	O
comigrates	O
with	O
a	O
Cdc2-phosphorylated	B
phosphopeptide	O
previously	O
shown	O
to	O
be	O
mitosis	O
-	O
specific	O
,	O
suggesting	O
that	O
,	O
in	O
vitro	O
,	O
CAK	B
is	O
able	O
to	O
phosphorylate	O
at	O
least	O
one	O
site	O
that	O
is	O
also	O
phosphorylated	O
in	O
vivo	O
.	O

The	O
mHIF-1	B
alpha	I
structural	I
gene	I
is	O
composed	O
of	O
15	O
exons	O
.	O

However	O
,	O
when	O
a	O
second	O
,	O
upstream	B
IRE	I
-	I
like	I
sequence	I
was	O
evaluated	O
by	O
EMSA	O
,	O
a	O
DNA	O
binding	O
pattern	O
distinct	O
from	O
that	O
seen	O
following	O
exposure	O
to	O
IFN	B
-	I
gamma	I
alone	O
was	O
observed	O
after	O
prolonged	O
stimulation	O
with	O
both	O
IFN	B
-	I
alpha	I
and	O
IFN	B
-	I
gamma	I
.	O

In	O
Arabidopsis	O
,	O
the	O
induction	O
of	O
a	O
dehydration	O
-	O
responsive	O
gene	O
,	O
rd22	B
,	O
is	O
mediated	O
by	O
abscisic	O
acid	O
(	O
ABA	O
)	O
and	O
requires	O
protein	O
biosynthesis	O
for	O
ABA	O
-	O
dependent	O
gene	O
expression	O
.	O

A	O
cDNA	O
encoding	O
a	O
MYC	B
-	I
related	I
DNA	I
binding	I
protein	I
was	O
isolated	O
by	O
DNA	O
-	O
ligand	O
binding	O
screening	O
,	O
using	O
the	O
67-bp	O
region	O
as	O
a	O
probe	O
,	O
and	O
designated	O
rd22BP1	B
.	O

Human	B
PDK1	I
is	O
homologous	O
to	O
the	O
Drosophila	B
protein	I
kinase	I
DSTPK61	I
,	O
which	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
sex	O
differentiation	O
,	O
oogenesis	O
and	O
spermatogenesis	O
.	O

Thus	O
,	O
the	O
synergistic	O
effects	O
of	O
HNF-1beta	B
and	O
the	O
GR	B
on	O
dexamethasone	O
-	O
stimulated	O
promoter	O
activity	O
require	O
that	O
they	O
are	O
bound	O
to	O
the	O
HNF-1	B
site	I
and	O
the	O
GRE	O
,	O
respectively	O
,	O
and	O
may	O
involve	O
protein	O
-	O
protein	O
interactions	O
between	O
the	O
transcription	O
factors	O
,	O
or	O
between	O
them	O
and	O
the	O
basal	O
transcription	O
machinery	O
or	O
a	O
steroid	B
receptor	I
coactivator	I
.	O

An	O
open	O
reading	O
frame	O
of	O
2862	O
bp	O
encoding	O
a	O
954	O
amino	O
acid	O
protein	O
was	O
identified	O
.	O

One	O
of	O
these	O
,	O
an	O
AACA	O
motif	O
,	O
has	O
been	O
shown	O
to	O
be	O
a	O
negative	O
regulator	O
in	O
non	O
-	O
seed	O
tissues	O
and	O
has	O
a	O
similarity	O
to	O
the	O
barley	O
gibberellin	O
responsive	O
element	O
recognized	O
by	O
MYB	B
-	I
like	I
DNA	I
binding	I
proteins	I
.	O

Strain	O
CFN037	O
is	O
an	O
R.	O
etli	O
mutant	O
induced	O
by	O
a	O
single	O
Tn5mob	B
insertion	O
in	O
the	O
promoter	O
region	O
of	O
the	O
thiCOGE	B
gene	I
cluster	I
.	O

We	O
have	O
cloned	O
and	O
sequenced	O
a	O
region	O
encoding	O
a	O
lipase	B
operon	I
and	O
a	O
putative	O
,	O
previously	O
uncharacterized	O
metalloprotease	B
of	I
Vibrio	I
cholerae	I
O1	I
.	O

Furthermore	O
,	O
the	O
amount	O
of	O
tRNA	B
(	I
3Lys	I
)	I
that	O
was	O
placed	O
onto	O
viral	O
RNA	O
in	O
mutated	O
viruses	O
was	O
significantly	O
less	O
than	O
that	O
placed	O
in	O
the	O
wild	O
-	O
type	O
virus	O
.	O

This	O
protein	O
is	O
present	O
in	O
both	O
HeLa	O
nuclear	O
extracts	O
and	O
S100	B
extracts	O
but	O
absent	O
from	O
SR	B
protein	I
preparations	O
,	O
suggesting	O
that	O
it	O
is	O
not	O
a	O
classical	O
SR	B
protein	I
.	O

Differential	O
regulation	O
of	O
the	O
pre	B
-	I
C	I
and	O
pregenomic	O
promoters	O
of	O
human	O
hepatitis	O
B	O
virus	O
by	O
members	O
of	O
the	O
nuclear	B
receptor	I
superfamily	I
.	O

Acad	O
.	O

We	O
previously	O
described	O
two	O
alanine	O
cluster	O
mutations	O
,	O
R77	O
to	O
A	O
(	O
R77A	O
)	O
-K79A	O
and	O
E192A	O
-	O
E194A	O
,	O
which	O
selectively	O
inactivated	O
the	O
triphosphatase	O
component	O
.	O

Both	O
inserts	O
are	O
larger	O
than	O
their	O
homologues	O
in	O
eIF-2alpha	B
kinases	I
.	O

Three	O
monopolar	O
electrodes	O
were	O
inserted	O
into	O
the	O
left	O
and	O
right	O
lateral	O
vestibulospinal	O
tract	O
(	O
LVST	O
)	O
and	O
medial	O
vestibulospinal	O
tract	O
(	O
MVST	O
)	O
of	O
the	O
C1	O
segment	O
,	O
to	O
determine	O
the	O
pathway	O
of	O
axons	O
.	O

Polyhomeotic	B
and	I
Posterior	I
Sex	I
Combs	I
may	O
participate	O
in	O
a	O
more	O
general	O
transcriptional	O
mechanism	O
that	O
causes	O
modulated	O
gene	O
repression	O
,	O
whereas	O
the	O
inclusion	O
of	O
Polycomb	B
protein	I
in	O
the	O
complex	O
at	O
PREs	B
leads	O
to	O
stable	O
silencing	O
.	O

The	O
yeast	O
silent	B
information	I
regulator	I
Sir4p	I
anchors	O
and	O
partitions	O
plasmids	O
.	O

Polysome	O
analyses	O
in	O
a	O
temperature	O
-	O
sensitive	O
fal1	B
-	I
1	I
mutant	I
and	O
a	O
Fal1p	B
-	O
depleted	O
strain	O
reveal	O
a	O
decrease	O
in	O
the	O
number	O
of	O
40S	B
ribosomal	I
subunits	I
.	O

Sequence	O
analysis	O
identified	O
some	O
of	O
these	O
cDNA	O
clones	O
as	O
Dlc-1	B
,	O
a	O
sequence	O
encoding	O
a	O
small	O
,	O
9-kDa	B
human	I
homolog	I
of	I
the	I
outer	I
-	I
arm	I
dynein	I
light	I
-	I
chain	I
protein	O
.	O

Importantly	O
,	O
in	O
HeLa	O
and	O
293	O
cells	O
,	O
endogenous	O
and	O
transfected	O
I	B
kappaB	I
alpha	I
coimmunoprecipitated	O
with	O
Myc	B
-	O
tagged	O
or	O
endogenous	O
Dlc-1	B
.	O

Identification	O
of	O
dynein	B
heavy	I
chain	I
genes	I
expressed	O
in	O
human	O
and	O
mouse	O
testis	O
:	O
chromosomal	O
localization	O
of	O
an	O
axonemal	B
dynein	I
gene	I
.	O

The	O
proposed	O
mechanism	O
of	O
effect	O
states	O
that	O
mono	O
(	O
2-ethylhexyl	O
)	O
phthalate	O
(	O
MEHP	O
)	O
,	O
the	O
primary	O
hydrolysis	O
product	O
of	O
DEHP	O
,	O
mimics	O
the	O
inducing	O
prostaglandins	O
(	O
PG	O
)	O
PGD	O
(	O
2	O
)	O
,	O
9alpha,11betaPGF2	O
,	O
and	O
PGF2alpha	O
,	O
and	O
thromboxanes	O
in	O
the	O
lungs	O
,	O
thereby	O
increasing	O
the	O
risk	O
of	O
inducing	O
inflammation	O
in	O
the	O
airways	O
,	O
which	O
is	O
a	O
characteristic	O
of	O
asthma	O
.	O

We	O
found	O
14	O
protein	O
binding	O
sites	O
that	O
were	O
occupied	O
in	O
vivo	O
.	O

Constitutive	O
protection	O
of	O
E2F	B
recognition	I
sequences	I
in	O
the	O
human	B
thymidine	I
kinase	I
promoter	I
during	O
cell	O
cycle	O
progression	O
.	O

Comparison	O
of	O
genomic	O
sequence	O
shows	O
that	O
the	O
ph	B
locus	I
has	O
been	O
duplicated	O
,	O
and	O
that	O
it	O
contains	O
proximal	O
and	O
distal	O
transcription	O
units	O
.	O

We	O
have	O
reviewed	O
the	O
experience	O
of	O
a	O
major	O
MMT	O
general	O
practice	O
with	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
infection	O
from	O
1991	O
to	O
1995	O
.	O

The	O
author	O
analyzes	O
extensive	O
own	O
data	O
based	O
on	O
study	O
into	O
particular	O
features	O
of	O
cardiovascular	O
disorders	O
in	O
chronic	O
renal	O
impairement	O
with	O
making	O
use	O
of	O
modern	O
diagnostic	O
tools	O
.	O

The	O
ZnF20	B
cDNA	I
hybridized	O
to	O
multiple	O
transcripts	O
in	O
a	O
thyroid	O
cancer	O
cell	O
line	O
(	O
8.0	O
,	O
4.5	O
and	O
2	O
kb	O
)	O
that	O
increased	O
after	O
cycloheximide	O
treatment	O
and	O
decayed	O
<	O
2	O
h	O
after	O
addition	O
of	O
actinomycin	O
D.	O

Glutathione	B
S	I
-	I
transferase	I
(	O
GST	B
)	O
-E2F	O
and	O
GST	B
-	O
DP	B
fusion	O
proteins	O
were	O
found	O
to	O
cooperate	O
in	O
binding	O
to	O
the	O
three	O
E2F	B
sites	I
in	O
the	O
DNA	B
polymerase	I
alpha	I
gene	I
promoter	I
in	O
vitro	O
.	O

Two	O
sterol	O
regulatory	O
element	O
-	O
like	O
sequences	O
mediate	O
up	O
-	O
regulation	O
of	O
caveolin	B
gene	I
transcription	O
in	O
response	O
to	O
low	B
density	I
lipoprotein	I
free	O
cholesterol	O
.	O

CONCLUSIONS	O
:	O
We	O
obtained	O
normal	O
EPO	B
levels	O
for	O
mothers	O
and	O
newborns	O
for	O
our	O
area	O
,	O
similarly	O
to	O
the	O
previously	O
described	O
ones	O
.	O

Ischaemia	O
was	O
induced	O
by	O
a	O
low	O
flow	O
rate	O
of	O
0.8	O
mL	O
min-1	O
for	O
30	O
min	O
,	O
and	O
was	O
followed	O
by	O
a	O
40-minute	O
reperfusion	O
.	O

First	O
,	O
two	O
MCTs	O
using	O
a	O
long	O
electrode	O
,	O
3	O
cm	O
in	O
size	O
,	O
were	O
performed	O
in	O
the	O
central	O
area	O
of	O
the	O
tumor	O
,	O
and	O
eight	O
MCTs	O
by	O
a	O
short	O
electrode	O
,	O
2	O
cm	O
in	O
size	O
,	O
were	O
done	O
in	O
the	O
peripheral	O
and	O
surrounding	O
area	O
of	O
the	O
tumor	O
.	O

BACKGROUND	O
:	O
Checkpoint	O
pathways	O
prevent	O
cell	O
-	O
cycle	O
progression	O
in	O
the	O
event	O
of	O
DNA	O
lesions	O
.	O

Direct	O
proof	O
that	O
the	O
heightened	O
renal	O
cellular	O
apoptosis	O
in	O
PKD	O
is	O
not	O
occurring	O
through	O
p53	B
was	O
obtained	O
by	O
successive	O
matings	O
between	O
SBM	O
and	O
p53	B
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Accumulated	O
evidence	O
indicates	O
that	O
,	O
upon	O
stimulation	O
with	O
interferon	B
-	I
gamma	I
(	O
IFN	B
-	I
gamma	I
)	O
,	O
three	O
beta	O
-	O
type	O
subunits	O
,	O
designated	O
LMP2	B
,	O
LMP7	B
,	O
and	O
PSMB10	B
,	O
are	O
incorporated	O
into	O
the	O
20S	B
proteasome	I
by	O
displacing	O
the	O
housekeeping	O
beta	O
-	O
type	O
subunits	O
designated	O
PSMB6	B
,	O
PSMB5	B
,	O
and	O
PSMB7	B
,	O
respectively	O
.	O

This	O
difference	O
may	O
result	O
from	O
the	O
lower	O
match	O
to	O
the	O
ARG	O
box	O
consensus	O
of	O
the	O
O	B
(	I
rocD	I
)	I
site	I
.	O

Ask	O
AONE	O
's	O
experts	O
...	O
about	O
productivity	O
indicators	O
.	O

The	O
progress	O
of	O
morphological	O
research	O
on	O
the	O
parabrachial	O
nucleus	O

In	O
an	O
effort	O
to	O
separate	O
domains	O
of	O
FadR	B
required	O
for	O
DNA	O
binding	O
,	O
dimerization	O
,	O
and	O
ligand	O
binding	O
,	O
chimeric	O
protein	O
fusions	O
between	O
the	O
DNA	O
binding	O
domain	O
of	O
LexA	B
and	O
different	O
regions	O
of	O
FadR	B
were	O
constructed	O
.	O

Inhibition	O
appears	O
to	O
result	O
from	O
titration	O
of	O
general	O
transcription	O
factors	O
because	O
MDM2	B
overexpression	O
inhibits	O
c	B
-	I
fos	I
as	O
well	O
as	O
other	O
promoters	O
in	O
vivo	O
and	O
basal	O
transcription	O
in	O
vitro	O
.	O

We	O
also	O
show	O
by	O
immunogold	O
electron	O
microscopy	O
immunocytochemistry	O
that	O
amphiphysin	B
I	I
is	O
localized	O
in	O
the	O
nerve	O
terminal	O
cytomatrix	O
and	O
is	O
partially	O
associated	O
with	O
endocytic	O
intermediates	O
.	O

During	O
the	O
aftermath	O
of	O
excitation	O
of	O
the	O
skin	O
sympathetic	O
nerve	O
by	O
mental	O
arithmetics	O
,	O
3	O
/	O
12	O
A	O
delta	O
units	O
were	O
turned	O
to	O
the	O
active	O
state	O
with	O
decreased	O
mechanical	O
threshold	O
.	O

Thus	O
,	O
Hex	B
expression	O
marks	O
the	O
earliest	O
unequivocal	O
molecular	O
anteroposterior	O
asymmetry	O
in	O
the	O
mouse	O
embryo	O
and	O
indicates	O
that	O
the	O
anteroposterior	O
axis	O
of	O
the	O
embryo	O
develops	O
from	O
conversion	O
of	O
a	O
proximodistal	O
asymmetry	O
established	O
in	O
the	O
primitive	O
endoderm	O
lineage	O
.	O

CONCLUSIONS	O
:	O
While	O
INR	O
correction	O
may	O
be	O
achieved	O
by	O
all	O
the	O
above	O
methods	O
,	O
that	O
relating	O
log	O
reference	O
INR	O
to	O
log	O
local	O
prothrombin	B
time	O
by	O
linear	O
regression	O
analysis	O
is	O
the	O
simplest	O
to	O
perform	O
.	O

Western	O
blot	O
analysis	O
of	O
various	O
bovine	O
tissues	O
with	O
human	O
NMT	B
peptide	I
antibody	I
indicated	O
a	O
common	O
prominent	O
immunoreactive	O
band	O
with	O
an	O
apparent	O
molecular	O
mass	O
of	O
48.5	O
-	O
50	O
kDa	O
in	O
all	O
tissues	O
.	O

Transcription	O
start	O
sites	O
of	O
the	O
plastid	O
ACCase	B
genes	I
were	O
estimated	O
from	O
the	O
longest	O
cDNA	O
clones	O
obtained	O
by	O
5'-RACE	O
(	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
)	O
.	O

AIDS	O
-	O
related	O
disseminated	O
histoplasmosis	O
in	O
San	O
Francisco	O
,	O
California	O
.	O

Thus	O
,	O
Fis	B
acts	O
as	O
an	O
accessory	O
transcriptional	O
activator	O
at	O
the	O
mar	B
promoter	I
.	O

TNF	B
-	I
alpha	I
exposure	O
markedly	O
increased	O
activity	O
of	O
several	O
RNA	O
-	O
binding	O
proteins	O
,	O
especially	O
a	O
novel	O
Mr	O
50,000	O
-	O
55,000	O
RNA	O
-	O
binding	O
protein	O
.	O

Southern	O
blot	O
analysis	O
of	O
endonuclease	O
-	O
digested	O
genomic	O
DNA	O
from	O
primary	O
chick	O
embryo	O
fibroblasts	O
(	O
CEF	O
)	O
suggested	O
that	O
MEK2	B
is	O
a	O
single	O
-	O
copy	O
gene	O
in	O
this	O
vertebrate	O
species	O
.	O

SCID	O
V	B
(	O
D	B
)	O
J	B
recombination	O
can	O
be	O
partly	O
rescued	O
in	O
T	O
-	O
lymphocytes	O
by	O
either	O
DNA	O
-	O
damaging	O
agents	O
(	O
gamma	O
-	O
irradiation	O
and	O
bieomycin	O
)	O
or	O
a	O
null	O
mutation	O
of	O
the	O
p53	B
gene	I
,	O
possibly	O
because	O
of	O
transiently	O
elevated	O
DNA	O
repair	O
activity	O
in	O
response	O
to	O
DNA	O
damage	O
or	O
to	O
delayed	O
apoptosis	O
in	O
the	O
absence	O
of	O
p53	B
.	O

Coexpression	O
of	O
mouse	O
PKR	B
(	I
1	I
-	I
515	I
)	I
WT	I
as	O
a	O
Gal4	B
DNA	O
-	O
binding	O
domain	O
fusion	O
with	O
either	O
the	O
catalytic	O
-	O
deficient	O
human	O
PKR	B
(	I
1	I
-	I
551	I
)	I
K296R	O
mutant	O
,	O
the	O
RNA	O
-	O
binding	O
-	O
deficient	O
human	O
PKR	B
(	I
1	I
-	I
551	I
)	I
K64E	I
/	I
K296R	I
double	O
mutant	O
,	O
or	O
wild	O
-	O
type	O
mouse	O
PKR	B
(	I
1	I
-	I
515	I
)	I
WT	I
as	O
full	O
-	O
length	O
PKR	B
-	O
Gal4	B
activation	O
domain	O
fusions	O
resulted	O
in	O
activation	O
of	O
the	O
HIS3	B
and	O
lacZ	B
reporters	O
.	O

An	O
even	O
greater	O
inflammatory	O
response	O
was	O
observed	O
after	O
intratracheal	O
instillation	O
of	O
ufCB	O
,	O
but	O
not	O
after	O
CB	O
instillation	O
.	O

These	O
defects	O
no	O
doubt	O
impair	O
the	O
folding	O
and	O
configuration	O
necessary	O
for	O
normal	O
processing	O
of	O
the	O
AVP	B
gene	I
precursor	I
.	O

Similarities	O
between	O
the	O
hIGFBP-1	B
and	O
phosphoenolpyruvate	B
kinase	I
(	O
PEPCK	B
)	O
promoters	O
,	O
including	O
regions	O
conferring	O
insulin	B
,	O
glucocorticoid	O
,	O
and	O
cyclic	O
adenosine	O
-	O
monophosphate	O
responses	O
,	O
are	O
consistent	O
with	O
our	O
previous	O
hypothesis	O
that	O
IGFBP-1	B
is	O
involved	O
in	O
regulation	O
of	O
glucose	O
metabolism	O
.	O

This	O
binary	O
repeat	O
contains	O
repetitive	O
DNA	O
elements	O
that	O
include	O
LINES	O
,	O
SINES	O
,	O
medium	O
reiteration	O
frequency	O
repeats	O
,	O
and	O
a	O
transposon	O
-	O
like	O
element	O
.	O

At	O
60	O
days	O
the	O
amount	O
of	O
gangliosides	O
was	O
on	O
average	O
lower	O
in	O
females	O
than	O
in	O
males	O
,	O
even	O
if	O
with	O
some	O
exception	O
.	O

The	O
existence	O
of	O
these	O
two	O
categories	O
of	O
strains	O
offers	O
a	O
new	O
genetic	O
system	O
in	O
which	O
the	O
properties	O
of	O
a	O
potential	O
invertebrate	O
retrovirus	O
can	O
be	O
tested	O
.	O

As	O
a	O
sequence	O
-	O
specific	O
DNA	O
binding	O
transcription	O
factor	O
,	O
p53	B
specifically	O
binds	O
to	O
a	O
20-bp	O
consensus	O
motif	O
5'-PuPuPuC	O
(	O
A	O
/	O
T	O
)	O
(	O
T	O
/	O
A	O
)	O
GPyPyPyPuPuPuC	O
(	O
A	O
/	O
T	O
)	O
(	O
T	O
/	O
A	O
)	O
GPyPyPy-3	O
'	O
.	O

TSA	O
treatment	O
,	O
however	O
,	O
did	O
not	O
detectably	O
alter	O
enhancer	O
factor	O
binding	O
or	O
the	O
positioning	O
of	O
nuc-1	B
on	O
the	O
majority	O
of	O
the	O
chromatin	O
templates	O
indicating	O
that	O
protein	O
acetylation	O
and	O
chromatin	O
remodeling	O
may	O
be	O
limiting	O
steps	O
that	O
occur	O
only	O
on	O
transcriptionally	O
competent	O
templates	O
,	O
or	O
that	O
remodeling	O
of	O
nuc-1	B
requires	O
additional	O
factors	O
.	O

Moreover	O
,	O
moderate	O
overexpression	O
of	O
Chk1	B
suppresses	O
the	O
phenotypes	O
of	O
cut5	B
and	O
crb2	B
mutants	I
.	O

Tcn1p	B
/	O
Crz1p	B
,	O
a	O
calcineurin	O
-	O
dependent	O
transcription	O
factor	O
that	O
differentially	O
regulates	O
gene	O
expression	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

We	O
introduced	O
the	O
gel	O
technique	O
as	O
a	O
routine	O
assay	O
for	O
antibody	O
detection	O
and	O
identification	O
in	O
1993	O
.	O

Stability	O
of	O
pyrimethamine	O
in	O
a	O
liquid	O
dosage	O
formulation	O
stored	O
for	O
three	O
months	O
.	O

Bilateral	O
basal	O
arteries	O
were	O
measured	O
by	O
the	O
transtemporal	O
approach	O
with	O
a	O
2	O
MHz	O
pulsed	O
Doppler	O
instrument	O
(	O
TC-2	O
64B	O
EME	O
)	O
.	O

The	O
Saccharomyces	B
cerevisiae	I
RAD30	I
gene	I
,	O
a	O
homologue	B
of	I
Escherichia	I
coli	I
dinB	I
and	O
umuC	B
,	O
is	O
DNA	O
damage	O
inducible	O
and	O
functions	O
in	O
a	O
novel	O
error	O
-	O
free	O
postreplication	O
repair	O
mechanism	O
.	O

However	O
,	O
in	O
a	O
new	O
experiment	O
in	O
which	O
the	O
deletion	O
task	O
was	O
presented	O
as	O
a	O
puppet	O
game	O
,	O
and	O
with	O
pretraining	O
and	O
selection	O
on	O
vowel	O
deletion	O
,	O
a	O
significantly	O
higher	O
level	O
of	O
success	O
was	O
achieved	O
by	O
the	O
children	O
working	O
with	O
the	O
CVCC	O
material	O
.	O

Gel	O
-	O
shift	O
assays	O
identified	O
two	O
Sp1	B
binding	I
sites	I
within	O
this	O
element	O
.	O

These	O
results	O
suggest	O
that	O
,	O
in	O
this	O
experimental	O
model	O
,	O
ACE	B
inhibitors	O
limit	O
the	O
arrhythmias	O
following	O
ischemia	O
-	O
reperfusion	O
and	O
free	O
radical	O
scavenging	O
action	O
of	O
these	O
drugs	O
does	O
not	O
have	O
a	O
major	O
contributory	O
role	O
in	O
their	O
protective	O
effect	O
.	O

The	O
mean	O
values	O
of	O
the	O
first	O
three	O
components	O
were	O
not	O
significantly	O
different	O
in	O
ARVD	O
patients	O
and	O
control	O
subjects	O
.	O

Two	O
disulphide	O
bridges	O
,	O
which	O
are	O
conserved	O
in	O
all	O
spermadhesin	O
molecules	O
and	O
many	O
CUB	O
domains	O
,	O
crosslink	O
loop	O
LA	O
and	O
strand	O
beta	O
4	O
and	O
loops	O
LE	O
and	O
LG	O
,	O
respectively	O
,	O
at	O
opposite	O
edges	O
of	O
the	O
same	O
face	O
of	O
the	O
domain	O
.	O

Mg	B
-	I
chelatase	I
of	O
tobacco	O
:	O
identification	O
of	O
a	O
Chl	B
D	I
cDNA	I
sequence	I
encoding	O
a	O
third	O
subunit	O
,	O
analysis	O
of	O
the	O
interaction	O
of	O
the	O
three	O
subunits	O
with	O
the	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
and	O
reconstitution	O
of	O
the	O
enzyme	O
activity	O
by	O
co	O
-	O
expression	O
of	O
recombinant	B
CHL	I
D	I
,	O
CHL	B
H	I
and	O
CHL	B
I.	I

One	O
R	O
-	O
EST	O
and	O
one	O
Pto	B
-	I
like	I
sequence	I
each	O
mapped	O
to	O
two	O
locations	O
.	O

These	O
results	O
indicate	O
that	O
in	O
addition	O
to	O
Grb2-mediated	B
activation	O
of	O
Ras	B
,	O
PLC	B
-	I
gamma1-mediated	I
DAG	O
production	O
is	O
required	O
for	O
EGF-	B
and	O
PDGF	B
-	O
induced	O
S	O
-	O
phase	O
entry	O
and	O
gene	O
expression	O
,	O
possibly	O
through	O
activation	O
of	O
PKC	B
.	O

In	O
serum	O
-	O
stimulated	O
cells	O
,	O
the	O
binding	O
of	O
NF	B
-	I
Y	I
/	O
CBF	B
to	O
TKC1	B
increased	O
gradually	O
,	O
reaching	O
a	O
plateau	O
at	O
the	O
S	O
phase	O
.	O

CONCLUSION	O
:	O
In	O
our	O
animal	O
model	O
,	O
blood	O
-	O
brain	O
barrier	O
disruption	O
was	O
a	O
reproducible	O
,	O
integral	O
finding	O
of	O
single	O
-	O
fraction	O
,	O
high	O
-	O
dose	O
irradiation	O
injury	O
.	O

Cell	O
factor	O
-	O
mediated	O
regulatory	O
interactions	O
are	O
involved	O
in	O
regulating	O
the	O
restricted	O
expression	O
of	O
the	O
HCMV	B
major	I
immediate	I
-	I
early	I
(	O
IE	B
)	O
gene	O
(	O
J.	O

C.	O

The	O
5	O
'	O
end	O
of	O
the	O
genomic	O
RNA	O
of	O
rubella	O
virus	O
(	O
RUB	O
)	O
contains	O
a	O
14-nucleotide	O
(	O
nt	O
)	O
single	O
-	O
stranded	O
leader	O
(	O
ss	O
-	O
leader	O
)	O
followed	O
by	O
a	O
stem	O
-	O
and	O
-	O
loop	O
structure	O
[	O
5'	O
(	O
+	O
)	O
SL	O
]	O
(	O
nt	O
15	O
to	O
65	O
)	O
,	O
the	O
complement	O
of	O
which	O
at	O
the	O
3	O
'	O
end	O
of	O
the	O
minus	O
-	O
strand	O
RNA	O
[	O
3'	O
(	O
-	O
)	O
SL	O
]	O
has	O
been	O
proposed	O
to	O
function	O
as	O
a	O
promoter	O
for	O
synthesis	O
of	O
genomic	O
plus	O
strands	O
.	O

To	O
investigate	O
the	O
requirements	O
for	O
CBF2	B
binding	O
,	O
we	O
synthesized	O
a	O
series	O
of	O
oligonucleotides	O
carrying	O
double	O
transversion	O
mutations	O
spanning	O
both	O
the	O
conserved	O
core	O
sequence	O
and	O
outside	O
flanking	O
sequences	O
.	O

To	O
investigate	O
the	O
activity	O
of	O
TCF11	B
through	O
this	O
selected	O
site	O
,	O
both	O
alone	O
and	O
in	O
the	O
presence	O
of	O
MafG	B
,	O
we	O
have	O
used	O
a	O
transient	O
transfection	O
assay	O
.	O

Ca2+	B
/	I
calmodulin	I
-	I
dependent	I
protein	I
kinase	I
II	I
(	O
CaMK	B
II	I
)	O
is	O
a	O
multifunctional	O
serine	B
/	I
threonine	I
protein	I
kinase	I
that	O
regulates	O
ion	O
channels	O
,	O
metabolic	O
enzymes	O
,	O
cytoskeletal	O
proteins	O
,	O
and	O
possibly	O
transcription	O
factors	O
.	O

In	O
addition	O
,	O
a	O
catalytically	O
inactive	O
version	O
of	O
the	O
Src	B
family	I
member	O
,	O
Lck	B
(	O
lymphoid	B
cell	I
kinase	I
)	O
,	O
was	O
expressed	O
,	O
purified	O
,	O
and	O
evaluated	O
as	O
a	O
Csk	B
substrate	O
.	O

A.	O
,	O
Swift	O
,	O
A.	O

Neuronal	O
mechanisms	O
underlying	O
stimulus	O
-	O
response	O
(	O
S	O
-	O
R	O
)	O
associations	O
in	O
S	O
-	O
R	O
compatibility	O
tasks	O
were	O
identified	O
in	O
2	O
experiments	O
with	O
monkeys	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
the	O
antagonistic	O
effects	O
of	O
CRP	B
and	O
KdgR	B
on	O
the	O
expression	O
of	O
the	O
pectinolysis	B
genes	I
occur	O
by	O
different	O
mechanisms	O
,	O
including	O
direct	O
competition	O
between	O
the	O
two	O
regulators	O
or	O
between	O
the	O
repressor	O
and	O
RNA	B
polymerase	I
for	O
the	O
occupation	O
of	O
a	O
common	O
DNA	O
region	O
on	O
the	O
target	O
genes	O
.	O

The	O
well	O
-	O
known	O
Rel	B
/	O
NF	B
-	I
kappaB	I
family	O
of	O
vertebrate	O
transcription	O
factors	O
comprises	O
a	O
number	O
of	O
structurally	O
related	O
,	O
interacting	O
proteins	O
that	O
bind	O
DNA	O
as	O
dimers	O
and	O
whose	O
activity	O
is	O
regulated	O
by	O
subcellular	O
location	O
.	O

Lysine	B
-	I
ketoglutarate	I
reductase	I
and	O
saccharopine	B
dehydrogenase	I
from	O
Arabidopsis	O
thaliana	O
:	O
nucleotide	O
sequence	O
and	O
characterization	O
.	O

The	O
purpose	O
of	O
this	O
investigation	O
was	O
to	O
describe	O
a	O
new	O
formulation	O
of	O
silver	O
sulfadiazine	O
in	O
a	O
water	O
soluble	O
gel	O
,	O
poloxamer	O
188	O
.	O

The	O
study	O
goals	O
were	O
to	O
isolate	O
a	O
full	O
-	O
length	O
clone	O
encoding	O
CO	B
-	I
Ag	I
from	O
a	O
bovine	O
corneal	O
cDNA	O
library	O
and	O
to	O
express	O
this	O
clone	O
in	O
Escherichia	O
coli	O
(	O
E.	O
coli	O
)	O
.	O

The	O
gene	O
contains	O
six	O
exons	O
separated	O
by	O
1.1	O
-	O
5.8	O
kb	O
introns	O
and	O
has	O
been	O
localized	O
to	O
the	O
murine	O
chromosome	O
2	O
by	O
linkage	O
analysis	O
.	O

A	O
cytosolic	O
variant	O
of	O
the	O
protein	O
underwent	O
efficient	O
transphosphorylation	O
,	O
yet	O
failed	O
to	O
activate	O
appreciably	O
either	O
p70	B
(	O
S6k	B
)	O
or	O
MAP	B
kinase	I
following	O
treatment	O
with	O
FK1012	O
.	O

Conversely	O
,	O
the	O
inactive	O
dAK	B
subunit	I
is	O
progressively	O
activated	O
by	O
1	O
)	O
association	O
with	O
a	O
dGK	B
or	O
dCK	B
subunit	I
and	O
2	O
)	O
the	O
conformationally	O
driven	O
heterotropic	O
affect	O
of	O
dGuo	B
or	O
dCyd	B
bound	O
to	O
the	O
opposing	O
subunit	O
.	O

CONCLUSIONS	O
:	O
A	O
50-mg	O
daily	O
dose	O
of	O
bicalutamide	O
is	O
sufficient	O
when	O
given	O
in	O
combination	O
with	O
an	O
agent	O
,	O
such	O
as	O
a	O
LHRH	B
-	O
A	O
,	O
that	O
lowers	O
serum	O
testosterone	O
,	O
but	O
higher	O
doses	O
of	O
bicalutamide	O
may	O
be	O
needed	O
when	O
the	O
drug	O
is	O
given	O
as	O
monotherapy	O
.	O

Although	O
the	O
gene	O
is	O
substantially	O
smaller	O
than	O
the	O
human	O
genes	O
for	O
other	O
mitochondrial	O
enzymes	O
,	O
its	O
intron	O
/	O
exon	O
organization	O
is	O
very	O
similar	O
,	O
especially	O
to	O
that	O
of	O
P450scc	B
.	O

RESULTS	O
:	O
Looking	O
at	O
the	O
question	O
of	O
its	O
benefits	O
,	O
we	O
were	O
unable	O
to	O
find	O
any	O
methodologically	O
sound	O
studies	O
that	O
have	O
shown	O
efficacy	O
for	O
EMDR	O
in	O
eating	O
disorders	O
,	O
or	O
,	O
indeed	O
,	O
any	O
psychiatric	O
disorder	O
.	O

Transient	O
overexpression	O
of	O
mutant	B
EphB1	I
receptors	I
(	O
Y594F	O
)	O
blocked	O
Nck	B
recruitment	O
to	O
EphB1	B
,	O
attenuated	O
downstream	O
JNK	B
activation	O
,	O
and	O
blocked	O
cell	O
attachment	O
responses	O
.	O

S.	O
,	O
and	O
Walter	O
,	O
P.	O

Here	O
we	O
demonstrate	O
that	O
Hh	B
and	O
Patched	B
(	O
Ptc	B
)	O
act	O
through	O
those	O
Ci	B
binding	O
sites	O
to	O
modulate	O
the	O
level	O
of	O
Ci	B
-	O
dependent	O
transcriptional	O
activation	O
in	O
S2	O
cells	O
.	O

Furthermore	O
the	O
median	O
increase	O
in	O
cyclosporine	O
DR	O
/	O
C	O
(	O
SS	O
trough	O
)	O
was	O
18	O
l	O
h-1	O
(	O
-3.1	O
to	O
42.1	O
l	O
h-1	O
,	O
interquartile	O
range	O
)	O
.	O

Patients	O
and	O
their	O
relatives	O
must	O
be	O
informed	O
about	O
the	O
available	O
effective	O
treatment	O
possibilities	O
and	O
about	O
the	O
right	O
moment	O
for	O
their	O
application	O
in	O
an	O
individual	O
patient	O
.	O

Several	O
PTPases	B
were	O
expressed	O
abundantly	O
in	O
the	O
5-FU	O
-	O
treated	O
bone	O
marrow	O
stem	O
cells	O
.	O

Expression	O
of	O
PTPRO	B
was	O
also	O
observed	O
in	O
human	B
CD34	I
+	I
bone	O
marrow	O
cells	O
and	O
5-FU	O
-	O
treated	O
murine	O
primitive	O
stem	O
cells	O
.	O

The	O
organization	O
of	O
SPP1	B
genes	I
involved	O
in	O
the	O
replication	O
,	O
DNA	O
packaging	O
and	O
phage	O
assembly	O
proteins	O
resembles	O
the	O
organization	O
of	O
genes	O
of	O
equivalent	O
regions	O
of	O
different	O
E.	O
coli	O
double	O
-	O
stranded	O
DNA	O
phages	O
.	O

Our	O
results	O
showed	O
that	O
compared	O
to	O
the	O
primary	O
photon	O
fluence	O
,	O
the	O
extra	O
-	O
focal	O
photon	O
fluence	O
from	O
the	O
primary	O
collimator	O
and	O
the	O
flattening	O
filter	O
was	O
11%-16	O
%	O
at	O
the	O
isocenter	O
,	O
among	O
which	O
70	O
%	O
was	O
contributed	O
by	O
the	O
flattening	O
filter	O
.	O

The	O
functional	O
mature	O
domain	O
of	O
pediocin	B
AcH	I
(	I
Lys+1	I
to	I
Cys+44	I
)	I
is	O
targeted	O
into	O
the	O
E.	O
coli	O
sec	O
machinery	O
and	O
secreted	O
to	O
the	O
periplasm	O
in	O
active	O
form	O
when	O
fused	O
in	O
frame	O
to	O
the	O
COOH	O
terminus	O
of	O
the	O
secretory	B
protein	I
maltose	I
-	I
binding	I
protein	I
(	O
MBP	B
)	O
.	O

Isomers	O
were	O
differentiated	O
based	O
on	O
the	O
MS	O
-	O
MS	O
data	O
of	O
the	O
trofluoroacetyl	O
-	O
biphenylol	O
derivatives	O
.	O

Although	O
RAD17	B
,	O
RAD24	B
and	O
MEC3	B
are	O
not	O
required	O
for	O
cell	O
cycle	O
arrest	O
when	O
S	O
phase	O
is	O
inhibited	O
by	O
hydroxyurea	O
(	O
HU	O
)	O
,	O
they	O
do	O
contribute	O
to	O
the	O
viability	O
of	O
yeast	O
cells	O
grown	O
in	O
the	O
presence	O
of	O
HU	O
,	O
possibly	O
because	O
they	O
are	O
required	O
for	O
the	O
repair	O
of	O
HU	O
-	O
induced	O
DNA	O
damage	O
.	O

Clinical	O
value	O
of	O
the	O
estimation	O
of	O
growth	O
kinetics	O
of	O
primary	O
ovarian	O
cancer	O
recurrences	O
by	O
CA125	B
doubling	O
time	O

The	O
patient	O
underwent	O
two	O
intracytoplasmic	O
sperm	O
injection	O
cycles	O
with	O
thawed	O
epididymal	O
spermatozoa	O
,	O
in	O
which	O
,	O
due	O
to	O
a	O
pharmacist	O
's	O
mistake	O
,	O
ovarian	O
stimulation	O
was	O
carried	O
out	O
by	O
a	O
combination	O
of	O
long	O
-	O
acting	O
gonadotrophin	B
-	I
releasing	I
hormone	I
agonist	O
(	O
leuprolide	O
depot	O
)	O
and	O
gonadotrophins	B
.	O

Protein	B
C	I
deficiency	O
or	O
protein	B
S	I
deficiency	O
was	O
the	O
only	O
identified	O
risk	O
factor	O
for	O
5.4	O
%	O
(	O
2	O
patients	O
)	O
and	O
13.5	O
%	O
(	O
5	O
patients	O
)	O
,	O
respectively	O
,	O
of	O
these	O
37	O
children	O
.	O

Perhaps	O
in	O
addition	O
to	O
,	O
or	O
as	O
part	O
of	O
,	O
its	O
essential	O
function	O
in	O
late	O
mitosis	O
,	O
MOB1	B
is	O
required	O
for	O
a	O
cell	O
cycle	O
reset	O
function	O
necessary	O
for	O
the	O
initiation	O
of	O
the	O
spindle	O
pole	O
body	O
duplication	O
.	O

In	O
contrast	O
,	O
overproduction	O
of	O
Der3p	B
is	O
lethal	O
in	O
a	O
sec61	B
-	I
2	I
strain	O
at	O
the	O
permissive	O
temperature	O
of	O
25	O
degrees	O
C.	O

Normal	O
baseline	O
(	O
day-8	O
)	O
PC	O
levels	O
(	O
86	O
and	O
89	O
%	O
)	O
were	O
markedly	O
reduced	O
in	O
both	O
patients	O
at	O
the	O
time	O
of	O
VOD	O
manifestation	O
on	O
day	O
20	O
and	O
40	O
,	O
respectively	O
(	O
26	O
and	O
31	O
%	O
)	O
.	O

To	O
examine	O
the	O
role	O
of	O
this	O
CE2	O
element	O
in	O
regulating	O
Hoxa1	B
expression	O
in	O
vivo	O
,	O
transgenic	O
mice	O
were	O
generated	O
which	O
express	O
a	O
Hoxa1	B
beta	B
-	I
galactosidase	I
reporter	O
gene	O
that	O
contains	O
a	O
mutation	O
in	O
the	O
CE2	O
element	O
.	O

An	O
evolutionary	O
conserved	O
element	O
is	O
essential	O
for	O
somite	O
and	O
adjacent	O
mesenchymal	O
expression	O
of	O
the	O
Hoxa1	B
gene	I
.	O

Altogether	O
46	O
phase	O
III	O
activities	O
were	O
recorded	O
.	O

We	O
have	O
previously	O
identified	O
a	O
liver	O
-	O
enriched	O
transcription	O
factor	O
,	O
HNF-6	B
,	O
which	O
is	O
required	O
for	O
HNF-3	B
beta	I
promoter	I
activity	O
and	O
also	O
recognizes	O
the	O
regulatory	O
region	O
of	O
numerous	O
hepatocyte	O
-	O
specific	O
genes	O
.	O

A	O
cDNA	O
clone	O
was	O
identified	O
encoding	O
a	O
second	O
GHS	B
-	I
R	I
-	I
related	I
gene	I
(	O
GPR39	B
)	O
.	O

(	O
1997	O
)	O
Science	O
275	O
,	O
1927	O
-	O
1930	O
)	O
.	O

A	O
hybridoma	O
clone	O
(	O
7H1	O
)	O
resulting	O
from	O
the	O
fusion	O
between	O
CEMLAI	O
/	O
NP	O
and	O
human	O
embryonic	O
fibroblasts	O
MRC5	O
cells	O
produced	O
very	O
large	O
amounts	O
of	O
P47	B
that	O
was	O
purified	O
using	O
Jacalin	B
lectin	I
(	O
specific	O
for	O
O	O
-	O
glycans	O
)	O
and	O
microsequenced	O
.	O

In	O
vitro	O
DNase	B
I	I
footprinting	O
of	O
the	O
200-bp	O
proximal	O
region	O
of	O
the	O
promoter	O
with	O
a	O
murine	O
Hepa	O
1	O
-	O
6	O
cell	O
nuclear	O
extract	O
revealed	O
a	O
clear	O
footprint	O
of	O
a	O
region	O
corresponding	O
to	O
-80	O
to	O
-28	O
bp	O
of	O
the	O
murine	B
fVII	I
gene	I
,	O
suggesting	O
that	O
liver	O
factors	O
interact	O
with	O
this	O
region	O
of	O
the	O
DNA	O
.	O

A	O
comparative	O
study	O
was	O
undertaken	O
between	O
an	O
enzymatic	O
immunohistochemical	O
technique	O
(	O
EIT	O
)	O
developed	O
for	O
the	O
diagnosis	O
of	O
human	O
trichinellosis	O
and	O
the	O
indirect	O
immunofluorescence	O
test	O
(	O
IIF	O
)	O
,	O
analysing	O
sera	O
from	O
outbreaks	O
of	O
human	O
trichinellosis	O
in	O
Argentina	O
.	O

Our	O
results	O
establish	O
GKLF	B
as	O
a	O
sequence	O
-	O
specific	O
transcription	O
factor	O
likely	O
involved	O
in	O
regulation	O
of	O
expression	O
of	O
endogenous	O
genes	O
.	O

CES4	B
on	O
a	O
multicopy	O
plasmid	O
was	O
unable	O
to	O
suppress	O
tif1-A79V	B
.	O

We	O
have	O
used	O
mutation	O
-	O
directed	O
chemical	O
cross	O
-	O
linking	O
with	O
bis	O
(	O
sulfosuccinimidyl	O
)	O
suberate	O
(	O
BS3	O
)	O
to	O
investigate	O
the	O
architecture	O
of	O
the	O
gp41	B
oligomer	I
.	O

In	O
an	O
effort	O
to	O
identify	O
the	O
USH1C	B
disease	I
gene	I
we	O
have	O
isolated	O
the	O
region	O
between	O
these	O
markers	O
in	O
yeast	O
artificial	O
chromosomes	O
(	O
YACs	O
)	O
using	O
a	O
combination	O
of	O
STS	O
content	O
mapping	O
and	O
Alu	B
-	O
PCR	O
hybridization	O
.	O

PowerBLAST	O
analysis	O
identified	O
six	O
clusters	O
of	O
expressed	O
sequence	O
tags	O
(	O
ESTs	O
)	O
,	O
two	O
known	O
genes	O
(	O
BIR	B
,	O
SUR1	B
)	O
mapped	O
previously	O
to	O
this	O
region	O
,	O
and	O
a	O
previously	O
characterized	O
but	O
unmapped	O
gene	B
NEFA	I
(	O
DNA	B
binding	I
/	I
EF	I
hand	I
/	I
acidic	I
amino	I
-	I
acid	I
-	I
rich	I
)	O
.	O

In	O
addition	O
,	O
negatively	O
regulatory	O
region	O
may	O
exist	O
from	O
-1782	O
to	O
-1295	O
bp	O
.	O

We	O
have	O
cloned	O
a	O
kinase	O
,	O
Nlk	B
,	O
that	O
is	O
a	O
murine	B
homolog	I
of	I
the	I
Drosophila	I
nemo	I
(	O
nmo	B
)	O
gene	O
.	O

Genetic	O
analysis	O
has	O
subsequently	O
identified	O
subpathways	O
of	O
the	O
DNA	O
structure	O
checkpoints	O
,	O
including	O
the	O
reversible	O
arrest	O
of	O
DNA	O
synthesis	O
.	O

Thus	O
,	O
Esigma54	B
promoters	I
are	O
responsive	O
to	O
CRP	B
,	O
a	O
protein	O
unrelated	O
to	O
sigma54	B
activators	I
,	O
and	O
the	O
repression	O
exerted	O
is	O
the	O
direct	O
result	O
of	O
an	O
interaction	O
between	O
Esigma54	B
and	O
the	O
CRP	B
-	I
cAMP	I
complex	I
.	O

GlcNAc-	O
and	O
GlcNAc2-PP	O
-	O
Dolichol	O
biosynthesis	O
could	O
be	O
shown	O
with	O
isolated	O
S.cerevisiae	O
membranes	O
from	O
cells	O
harboring	O
the	O
recombinant	O
plasmid	O
and	O
grown	O
on	O
glucose	O
thus	O
suppressing	O
transcription	O
of	O
the	O
endogenous	O
gene	O
.	O

Demonstration	O
of	O
tissue	O
lesions	O
after	O
intramuscular	O
injection	O
by	O
determination	O
of	O
creatine	B
kinase	I
in	O
blood	O

Antibodies	O
raised	O
against	O
GST	B
mSH2-B	I
identified	O
a	O
cellular	O
protein	O
of	O
92	O
kDa	O
that	O
was	O
not	O
found	O
to	O
be	O
phosphorylated	O
on	O
Tyr	O
.	O

Interleukin-6	B
(	O
IL-6	B
)	O
is	O
a	O
pleiotropic	O
cytokine	O
,	O
which	O
is	O
involved	O
in	O
inflammatory	O
and	O
immune	O
responses	O
,	O
acute	O
phase	O
reactions	O
,	O
and	O
hematopoiesis	O
.	O

Levels	O
of	O
the	O
MEK	B
inhibitor	O
PD98059	O
that	O
block	O
EGF	B
-	O
induced	O
mitogenesis	O
and	O
MAP	B
kinase	I
phosphorylation	O
also	O
abrogate	O
EGF	B
-	O
induced	O
focal	O
adhesion	O
disassembly	O
and	O
cell	O
motility	O
.	O

51.9	O
%	O
(	O
P=0.0006	O
)	O
in	O
the	O
MMF	O
versus	O
the	O
AZA	O
groups	O
,	O
respectively	O
.	O

Pao2	O
increased	O
from	O
15.5	O
+	O
/-	O

5.6	O
kPa	O
(	O
116	O
+	O
/-	O

42	O
mm	O
Hg	O
)	O
to	O
17.3	O
+	O
/-	O

6.3	O
kPa	O
(	O
130	O
+	O
/-	O

47	O
mm	O
Hg	O
)	O
(	O
P	O
<	O
0.05	O
)	O
.	O

Nine	O
cats	O
received	O
PMEA	O
at	O
a	O
dosage	O
of	O
10	O
mg	O
/	O
kg	O
body	O
weight	O
,	O
nine	O
cats	O
received	O
FPMPA	O
at	O
a	O
dosage	O
of	O
25	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

We	O
present	O
the	O
preliminary	O
results	O
obtained	O
on	O
36	O
patients	O
which	O
were	O
followed	O
for	O
a	O
mean	O
period	O
of	O
12	O
months	O
.	O

PATIENTS	O
AND	O
METHOD	O
:	O
Since	O
1986	O
,	O
62	O
patients	O
were	O
irradiated	O
stereotactically	O
.	O

Training	O
for	O
audit	O
.	O

A	O
putative	O
inhibitor	O
(	O
s	O
)	O
appears	O
to	O
co	O
-	O
elute	O
in	O
the	O
inactive	O
fraction	O
that	O
blocked	O
the	O
L	B
(	I
alpha	I
)	I
activity	O
.	O

Using	O
himA	B
mutants	I
,	O
we	O
confirmed	O
that	O
IHF	B
plays	O
a	O
role	O
in	O
the	O
molybdate	O
-	O
dependent	O
regulation	O
of	O
dmsA	B
-	O
lacZ	B
expression	O
in	O
vivo	O
.	O

Cross	O
-	O
talking	O
among	O
Drosophila	O
nuclear	O
receptors	O
at	O
the	O
promiscuous	O
response	O
element	O
of	O
the	O
ng-1	B
and	O
ng-2	B
intermolt	I
genes	I
.	O

The	O
ipsilateral	O
breast	O
tumor	O
relapse	O
rate	O
was	O
similar	O
between	O
the	O
PALP	O
and	O
MGDET	O
groups	O
.	O

The	O
CAPLC1	B
protein	I
also	O
exhibited	O
several	O
unique	O
features	O
,	O
including	O
a	O
novel	O
stretch	O
of	O
18	O
-	O
19	O
amino	O
acid	O
residues	O
within	O
the	O
X	O
domain	O
and	O
an	O
unusually	O
long	O
N	O
-	O
terminus	O
which	O
did	O
not	O
contain	O
a	O
recognizable	O
EF	O
-	O
hand	O
Ca	O
(	O
2+	O
)	O
-binding	O
domain	O
.	O

This	O
hypothesis	O
is	O
consistent	O
with	O
the	O
occurrence	O
of	O
PEA3	B
binding	I
sites	I
in	O
the	O
PEA3	B
promoter	I
and	O
with	O
the	O
ability	O
of	O
PEA3	B
to	O
transactivate	O
this	O
promoter	O
.	O

Pet-1	B
can	O
bind	O
specifically	O
to	O
a	O
PEA3	B
ETS	B
DNA	O
-	O
binding	O
motif	O
and	O
can	O
modulate	O
transcription	O
of	O
synthetic	O
promoter	O
constructs	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
.	O

The	O
protein	O
expressed	O
by	O
F2771	B
cDNA	I
in	O
transfected	O
COS	O
cells	O
is	O
localized	O
in	O
the	O
cytoplasm	O
.	O

Northern	O
analysis	O
indicated	O
differential	O
expression	O
by	O
tissue	O
with	O
highest	O
expression	O
in	O
the	O
heart	O
.	O

The	O
mRNAs	O
of	O
these	O
genes	O
contain	O
respectively	O
one	O
(	O
YAP1	B
uORF	I
)	O
and	O
two	O
(	O
YAP2	B
uORF1	I
and	O
uORF2	O
)	O
upstream	O
open	O
reading	O
frames	O
.	O

uORF	O
-	O
mediated	O
modulation	O
of	O
post	O
-	O
termination	O
events	O
on	O
the	O
5'-untranslated	O
region	O
(	O
5'-UTR	O
)	O
directs	O
differential	O
control	O
not	O
only	O
of	O
translation	O
but	O
also	O
of	O
mRNA	O
decay	O
.	O

In	O
the	O
tissues	O
tested	O
,	O
except	O
brain	O
,	O
the	O
message	O
for	O
CLIP-170	B
was	O
more	O
abundant	O
than	O
that	O
for	O
Restin	B
.	O

BACKGROUND	O
:	O
Chemicals	O
vary	O
considerably	O
in	O
their	O
intrinsic	O
ability	O
to	O
cause	O
allergic	O
contact	O
dermatitis	O
.	O

Cytoskeletal	O
polarization	O
of	O
T	O
cells	O
is	O
regulated	O
by	O
an	O
immunoreceptor	O
tyrosine	O
-	O
based	O
activation	O
motif	O
-	O
dependent	O
mechanism	O
.	O

Also	O
,	O
the	O
deduced	O
amino	O
acids	O
of	O
the	O
antigenic	B
regions	I
A	I
,	I
B	I
and	I
C	I
of	I
VP7	I
were	O
nearly	O
conserved	O
within	O
the	O
phylogenetic	O
lineages	O
.	O

The	O
cloned	O
alcR	B
gene	I
provided	O
in	O
trans	O
restored	O
these	O
siderophore	O
system	O
activities	O
to	O
the	O
mutants	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

It	O
may	O
also	O
be	O
suggested	O
that	O
particular	O
care	O
should	O
be	O
taken	O
when	O
such	O
a	O
trans	O
-	O
dominant	O
Rev	B
mutant	I
is	O
considered	O
to	O
be	O
used	O
as	O
a	O
genetic	O
therapy	O
against	O
HIV	O
-	O
I	O
infection	O
,	O
in	O
individuals	O
infected	O
with	O
both	O
HIV	O
-	O
I	O
and	O
HTLV-1	O
.	O

We	O
analyzed	O
the	O
P	O
-	O
SAECG	O
in	O
the	O
time	O
and	O
frequency	O
domain	O
in	O
23	O
patients	O
with	O
Paf	O
and	O
19	O
controls	O
.	O

Competitive	O
reverse	O
transcription	O
-	O
polymerase	O
chain	O
reaction	O
and	O
HPLC	O
analysis	O
showed	O
that	O
RUSH-1alpha	B
is	O
the	O
progesterone	O
-	O
dependent	O
splice	O
variant	O
.	O

Transcervical	O
amnioinfusion	O
.	O

SETTING	O
:	O
A	O
division	O
of	O
a	O
large	O
tea	O
plantation	O
in	O
Kandy	O
.	O

In	O
order	O
to	O
decipher	O
the	O
pathway	O
that	O
leads	O
to	O
Hox	B
gene	I
induction	O
,	O
we	O
have	O
investigated	O
whether	O
a	O
Hox	B
gene	I
regulator	O
,	O
the	O
leucine	O
zipper	O
transcription	O
factor	O
MafB	B
/	O
Kr	B
,	O
is	O
itself	O
transcriptionally	O
regulated	O
by	O
the	O
environmental	O
signals	O
.	O

Reporter	O
constructs	O
function	O
in	O
a	O
parallel	O
manner	O
,	O
demonstrating	O
the	O
key	O
role	O
of	O
the	O
AhR	B
in	O
constitutive	O
as	O
well	O
as	O
TCDD	O
-	O
induced	O
expression	O
of	O
Cyp1B1	B
in	O
mouse	O
embryo	O
fibroblasts	O
.	O

Transfection	O
studies	O
also	O
showed	O
that	O
3'-deletion	O
of	O
sequences	O
downstream	O
of	O
the	O
transcriptional	O
start	O
site	O
(	O
+	O
1	O
/	O
+47	O
)	O
markedly	O
reduced	O
OSM	B
-fold	O
induction	O
.	O

The	O
COOH	O
-	O
terminal	O
region	O
of	O
the	O
transcripts	O
contained	O
fifteen	O
triplet	O
repeats	O
(	O
GCT	O
;	O
alanine	O
)	O
at	O
nucleotide	O
465	O
to	O
509	O
,	O
which	O
is	O
significantly	O
expanded	O
compared	O
to	O
the	O
rat	B
RL14	I
.	O

Control	O
of	O
fatty	O
liver	O
syndrome	O
in	O
a	O
Jersey	O
herd	O
by	O
a	O
change	O
of	O
diet	O
and	O
the	O
use	O
of	O
recombinant	O
bovine	O
somatotrophin	B
.	O

C.D2-Chr	O
4	O
congenic	O
strains	O
harboring	O
DBA	O
/	O
2	O
alleles	O
associated	O
with	O
the	O
Pctr1	B
locus	I
contained	O
DBA	O
/	O
2	O
""""	O
resistant	O
""""	O
alleles	O
of	O
the	O
CDK4	B
/	O
CDK6	B
inhibitors	O
p16	B
and	O
p15	B
.	O

Alison	O
Bell	O
Memorial	O
Award	O
.	O

METHODS	O
:	O
A	O
population	O
survey	O
was	O
undertaken	O
in	O
10,148	O
individuals	O
to	O
measure	O
the	O
prevalence	O
and	O
identify	O
the	O
causes	O
of	O
blindness	O
in	O
Lebanon	O
.	O

During	O
organogenesis	O
,	O
HFH-8	B
expression	O
is	O
found	O
in	O
the	O
splanchnic	O
mesoderm	O
in	O
close	O
apposition	O
of	O
the	O
gut	O
endoderm	O
,	O
suggesting	O
a	O
role	O
in	O
mesenchymal	O
-	O
epithelial	O
induction	O
of	O
lung	O
and	O
gut	O
morphogenesis	O
.	O

The	O
mean	O
duration	O
of	O
pain	O
relief	O
was	O
4	O
-	O
6	O
weeks	O
.	O

The	O
ESEM	O
differs	O
from	O
conventional	O
SEM	O
in	O
that	O
no	O
sample	O
preparation	O
is	O
needed	O
,	O
eliminating	O
artifactual	O
changes	O
.	O

Sp1	B
can	O
activate	O
transcription	O
through	O
immunoglobulin	B
kappa	I
-	I
chain	I
enhancer	I
or	O
P	B
-	I
selectin	I
promoter	I
NF	B
-	I
kappaB	I
sites	I
.	O

p50	B
homodimers	I
replace	O
Sp1	B
from	O
the	O
P	B
-	I
selectin	I
promoter	I
by	O
binding	O
site	O
competition	O
and	O
thereby	O
either	O
inhibit	O
basal	O
Sp1-driven	B
expression	O
or	O
,	O
in	O
concert	O
with	O
Bcl-3	B
,	O
stimulate	O
expression	O
.	O

The	O
TATA	B
box	I
-	I
binding	I
protein	I
(	O
TBP	B
)	O
plays	O
an	O
essential	O
role	O
in	O
transcription	O
by	O
all	O
three	O
eukaryotic	O
nuclear	B
RNA	I
polymerases	I
,	O
polymerases	B
(	I
Pol	I
)	I
I	I
,	I
II	I
,	I
and	I
III	I
.	O

A	O
triple	B
-	I
mutant	I
TBP	I
(	O
R231E	O
+	O
R235E	O
+	O
R239S	O
)	O
had	O
greatly	O
reduced	O
activity	O
for	O
yeast	B
U6	I
snRNA	I
gene	I
transcription	O
while	O
remaining	O
active	O
for	O
Pol	B
II	I
basal	O
transcription	O
.	O

To	O
determine	O
the	O
true	O
molecular	O
identity	O
of	O
SFD	B
,	O
both	O
the	O
50-	O
and	O
57-kDa	O
polypeptides	O
were	O
directly	O
sequenced	O
.	O

This	O
structure	O
interconnects	O
specific	O
triplets	O
of	O
the	O
basal	O
bodies	O
with	O
the	O
microtubular	O
bundles	O
that	O
emerge	O
from	O
the	O
basal	O
apparatus	O
.	O

To	O
understand	O
the	O
regulatory	O
mechanism	O
controlling	O
its	O
expression	O
at	O
low	O
temperature	O
,	O
the	O
promoter	O
region	O
has	O
been	O
characterized	O
.	O

For	O
the	O
5HT5A	B
receptor	I
the	O
addition	O
of	O
yohimbine	O
resulted	O
in	O
a	O
similar	O
but	O
smaller	O
effect	O
.	O

We	O
have	O
examined	O
reporter	O
gene	O
(	O
beta	B
-	I
gal	I
)	O
expression	O
directed	O
by	O
human	B
heat	I
shock	I
transcription	I
factors	I
1	I
and	I
2	I
(	O
HSF1	B
and	O
HSF2	B
)	O
in	O
HeLa	O
cells	O
and	O
in	O
yeast	O
(	O
Saccharomyces	O
cerevisiae	O
)	O
.	O

Its	O
expression	O
pattern	O
is	O
representative	O
of	O
many	O
B	O
cell	O
-	O
specific	O
proteins	O
,	O
which	O
are	O
essential	O
for	O
B	O
cell	O
development	O
and	O
activation	O
but	O
are	O
down	O
-	O
regulated	O
after	O
B	O
cells	O
become	O
terminally	O
differentiated	O
plasma	O
cells	O
.	O

Infectious	O
mutant	O
virus	O
progeny	O
was	O
obtained	O
only	O
on	O
complementing	O
gK	B
-	O
expressing	O
cells	O
,	O
suggesting	O
that	O
gK	B
has	O
an	O
important	O
function	O
in	O
the	O
replication	O
cycle	O
.	O

Cleavage	O
and	O
DNA	O
joining	O
reactions	O
,	O
carried	O
out	O
by	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
(	I
HIV-1	I
)	I
integrase	I
,	O
are	O
necessary	O
to	O
effect	O
the	O
covalent	O
insertion	O
of	O
HIV-1	O
DNA	O
into	O
the	O
host	O
genome	O
.	O

Activation	O
of	O
the	O
mitogen	B
activated	I
protein	I
(	I
MAP	I
)	I
kinase	I
is	O
a	O
primary	O
consequence	O
of	O
Ras	B
activation	O
and	O
plays	O
a	O
key	O
role	O
in	O
mediating	O
Ras	B
signal	O
transduction	O
.	O

Histone	B
acetylation	O
levels	O
in	O
cells	O
result	O
from	O
a	O
dynamic	O
equilibrium	O
between	O
competing	O
histone	B
acetylases	I
and	I
deacetylases	I
.	O

CONCLUSIONS	O
:	O
XCoe2	B
may	O
play	O
a	O
pivotal	O
role	O
in	O
the	O
transcriptional	O
cascade	O
that	O
specifies	O
primary	O
neurons	O
in	O
Xenopus	O
embryos	O
:	O
by	O
maintaining	O
Delta	B
-	O
Notch	B
signalling	O
,	O
XCoe2	B
stabilises	O
the	O
higher	O
neural	O
potential	O
of	O
selected	O
progenitor	O
cells	O
that	O
express	O
X	B
-	I
ngnr-1	I
,	O
ensuring	O
the	O
transition	O
between	O
neural	O
competence	O
and	O
irreversible	O
commitment	O
to	O
a	O
neural	O
fate	O
;	O
and	O
it	O
promotes	O
neuronal	O
differentiation	O
by	O
activating	O
XNeuroD	B
expression	O
,	O
directly	O
or	O
indirectly	O
.	O

RESULTS	O
:	O
Patients	O
in	O
Group	O
A	O
had	O
a	O
higher	O
incidence	O
of	O
posterolateral	O
wall	O
motion	O
abnormalities	O
(	O
p	O
<	O
0.001	O
)	O
on	O
radionuclide	O
ventriculography	O
,	O
a	O
larger	O
infarct	O
area	O
(	O
as	O
evidenced	O
by	O
higher	O
peak	O
creatine	B
kinase	I
levels	O
)	O
(	O
p	O
<	O
0.02	O
)	O
and	O
a	O
lower	O
left	O
ventricular	O
ejection	O
fraction	O
(	O
LVEF	O
)	O
at	O
hospital	O
discharge	O
(	O
p	O
<	O
0.008	O
)	O
than	O
those	O
in	O
Group	O
B.	O

CyIIa	B
transcription	O
follows	O
,	O
and	O
is	O
therefore	O
downstream	O
of	O
,	O
the	O
initial	O
specification	O
of	O
these	O
embryonic	O
domains	O
.	O

We	O
also	O
present	O
evidence	O
that	O
human	B
HYAL1	I
is	O
identical	O
to	O
an	O
uncharacterized	O
gene	O
positionally	O
cloned	O
by	O
others	O
from	O
chromosome	O
3p21.3	O
that	O
is	O
homozygously	O
deleted	O
in	O
several	O
small	O
-	O
cell	O
lung	O
carcinoma	O
cell	O
lines	O
.	O

In	O
patients	O
with	O
myalgia	O
,	O
Raynaud	O
's	O
syndrome	O
,	O
skin	O
vasculitis	O
and	O
vascular	O
diseases	O
WFAg	B
concentrations	O
were	O
higher	O
than	O
in	O
patients	O
without	O
them	O
.	O

Analysis	O
of	O
intragenic	O
revertants	O
shows	O
that	O
this	O
function	O
depends	O
on	O
the	O
amino	O
acid	O
preceding	O
the	O
first	O
cysteine	O
residue	O
of	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
Hap1p	B
.	O

A	O
review	O
of	O
studies	O
published	O
between	O
1983	O
and	O
1995	O
shows	O
that	O
there	O
are	O
some	O
common	O
factors	O
as	O
regards	O
the	O
psychological	O
distress	O
and	O
social	O
and	O
functional	O
limitations	O
this	O
group	O
of	O
patients	O
has	O
to	O
deal	O
with	O
.	O

We	O
further	O
show	O
that	O
proteolytic	O
targeting	O
by	O
calpain	B
II	I
and	O
the	O
proteasome	O
involves	O
different	O
structural	O
elements	O
of	O
YY1	B
.	O

Primers	O
for	O
subsequent	O
rounds	O
of	O
RACE	O
were	O
designed	O
from	O
the	O
5'-ends	O
of	O
amplified	O
RACE	O
products	O
.	O

Surprisingly	O
,	O
the	O
CSF1R	B
/	O
IRDelta960	B
was	O
as	O
effective	O
as	O
the	O
CSF1R	B
/	O
IR	B
in	O
mediating	O
CSF-1	B
protection	O
of	O
cells	O
from	O
staurosporine	O
-	O
induced	O
apoptosis	O
.	O

CONCLUSIONS	O
:	O
The	O
special	O
clinical	O
presentation	O
of	O
our	O
case	O
of	O
possible	O
Gardner	O
's	O
syndrome	O
is	O
discussed	O
.	O

These	O
results	O
would	O
suggest	O
that	O
a	O
high	O
UV	O
sensitivity	O
is	O
associated	O
with	O
high	O
phaeomelanin	O
and	O
low	O
eumelanin	O
levels	O
,	O
and	O
point	O
to	O
the	O
eumelanin	O
/	O
phaeomelanin	O
ratio	O
as	O
a	O
novel	O
chemical	O
parameter	O
that	O
could	O
be	O
used	O
for	O
predicting	O
individuals	O
at	O
high	O
risk	O
for	O
skin	O
cancer	O
and	O
melanoma	O
.	O

The	O
cAMP	O
-	O
dependent	O
mitogenic	O
pathway	O
is	O
unique	O
as	O
it	O
is	O
independent	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
activation	O
and	O
differs	O
from	O
growth	O
factor	O
-	O
dependent	O
pathways	O
at	O
the	O
level	O
of	O
the	O
expression	O
of	O
several	O
protooncogenes	O
/	O
transcription	O
factors	O
.	O

CONCLUSIONS	O
:	O
Use	O
of	O
the	O
first	O
method	O
was	O
associated	O
with	O
a	O
reduction	O
in	O
the	O
time	O
patients	O
remained	O
in	O
the	O
ICU	O
before	O
transfer	O
to	O
another	O
unit	O
and	O
savings	O
in	O
nursing	O
time	O
,	O
but	O
the	O
two	O
methods	O
did	O
not	O
differ	O
according	O
to	O
clinical	O
outcomes	O
.	O

We	O
have	O
elucidated	O
the	O
exon	O
-	O
intron	O
organization	O
of	O
the	O
entire	O
human	O
CD58	B
gene	I
,	O
including	O
approximately	O
2.5	O
kilobases	O
(	O
kb	O
)	O
of	O
5'-flanking	O
DNA	O
.	O

Two	O
hundred	O
sixty	O
-	O
four	O
patients	O
scheduled	O
for	O
DCBM	O
were	O
randomized	O
to	O
receive	O
intravenously	O
geG	O
0.25	O
mg	O
(	O
geG-25	O
)	O
,	O
or	O
geG	O
0.5	O
mg	O
(	O
geG-50	O
)	O
,	O
or	O
HBB	O
20	O
mg	O
as	O
hypotonic	O
agent	O
.	O

If	O
the	O
haemoglobin	B
concentration	O
(	O
Hb	B
)	O
was	O
less	O
than	O
12	O
g	O
dL-1	O
they	O
were	O
given	O
a	O
four	O
week	O
course	O
of	O
ferrous	O
sulphate	O
.	O

In	O
all	O
cells	O
,	O
the	O
accumulation	O
of	O
high	O
Dsg	B
protein	I
levels	O
required	O
calcium	O
and	O
was	O
not	O
observed	O
in	O
low	O
calcium	O
(	O
0.05	O
-	O
0.07	O
mM	O
)	O
media	O
.	O

Based	O
on	O
restriction	O
enzyme	O
analysis	O
,	O
Southern	O
blots	O
,	O
polymerase	O
chain	O
reaction	O
analysis	O
and	O
DNA	O
sequencing	O
,	O
it	O
was	O
confirmed	O
that	O
the	O
three	O
overlapping	O
clones	O
isolated	O
cover	O
the	O
entire	O
cHO-1	B
gene	I
,	O
as	O
well	O
as	O
approximately	O
10	O
kb	O
of	O
the	O
flanking	O
regions	O
on	O
both	O
ends	O
.	O

E1A	B
represses	O
apolipoprotein	B
AI	I
enhancer	I
activity	O
in	O
liver	O
cells	O
through	O
a	O
pRb-	B
and	O
CBP	B
-	O
independent	O
pathway	O
.	O

Position	O
-	O
independent	O
expression	O
of	O
a	O
human	O
nerve	B
growth	I
factor	I
-	O
luciferase	B
reporter	O
gene	O
cloned	O
on	O
a	O
yeast	O
artificial	O
chromosome	O
vector	O
.	O

Calcitriol	O
therapy	O
was	O
associated	O
with	O
a	O
decrease	O
in	O
serum	O
iPTH	B
levels	O
(	O
701	O
+	O
/-	O

103.9	O
vs.	O

Alterations	O
in	O
DNase	B
I	I
reactivity	O
of	O
the	O
GC	O
-	O
response	O
element	O
region	O
suggest	O
that	O
GC	B
receptor	I
-	I
GC	I
complexes	I
may	O
associate	O
,	O
in	O
a	O
transient	O
manner	O
,	O
with	O
the	O
promoter	O
in	O
the	O
actively	O
transcribing	O
control	O
state	O
.	O

Most	O
pituitary	O
hormone	O
-	O
coding	O
gene	O
promoters	O
are	O
activated	O
by	O
Ptx1	B
.	O

One	O
of	O
these	O
small	B
inteins	I
might	O
be	O
inactive	O
or	O
a	O
""""	B
pseudo	I
intein	I
.	I
""""	I

The	O
results	O
suggest	O
a	O
modular	O
architecture	O
for	O
inteins	B
,	O
clarify	O
their	O
origin	O
and	O
relationship	O
to	O
other	O
protein	O
families	O
,	O
and	O
extend	O
recent	O
experimental	O
findings	O
on	O
the	O
functional	O
roles	O
of	O
intein	B
N	I
,	I
C	I
,	I
and	I
EN	I
motifs	I
.	O

These	O
results	O
indicate	O
that	O
TGF	B
-	I
betaf	I
potentiates	O
the	O
c	B
-	I
fos	I
SRE	O
activated	O
by	O
PKC	B
through	O
the	O
SRF	B
binding	I
site	I
.	O

RT	O
-	O
PCR	O
indicated	O
that	O
p21	B
mRNA	I
was	O
induced	O
1.4-	O
,	O
2.0-	O
,	O
and	O
3.1-fold	O
in	O
the	O
2-day	O
neonatal	O
,	O
7-day	O
neonatal	O
,	O
and	O
adult	O
stages	O
,	O
respectively	O
,	O
compared	O
to	O
the	O
17-day	O
fetal	O
stage	O
.	O

Ganciclovir	O
and	O
foscarnet	O
efficacy	O
in	O
AIDS	O
-	O
related	O
CMV	O
polyradiculopathy	O
.	O

We	O
have	O
identified	O
two	O
functional	O
elements	O
,	O
both	O
located	O
downstream	O
from	O
the	O
TATA	O
motif	O
,	O
that	O
control	O
Id4	B
promoter	I
activity	O
.	O

BACKGROUND	O
AND	O
OBJECTIVES	O
:	O
The	O
sexually	O
transmitted	O
diseases	O
(	O
STD	O
)	O
control	O
program	O
for	O
female	O
sex	O
workers	O
(	O
FSW	O
)	O
in	O
Lima	O
,	O
Peru	O
,	O
provided	O
periodic	O
serological	O
tests	O
for	O
syphilis	O
and	O
cervical	O
smears	O
for	O
gonococci	O
,	O
but	O
not	O
medication	O
for	O
STD	O
or	O
condoms	O
.	O

Two	O
rare	O
novel	O
mutations	O
,	O
D811N	O
in	O
exon	O
20	O
and	O
R835C	O
in	O
exon	O
21	O
,	O
were	O
identified	O
in	O
the	O
first	O
nucleotide	O
-	O
binding	O
fold	O
(	O
NBF	O
)	O
,	O
a	O
functionally	O
important	O
region	O
of	O
SUR1	B
,	O
in	O
one	O
patient	O
each	O
,	O
both	O
heterozygotes	O
.	O

Chimaeric	O
VP16-E2	B
molecules	O
suggest	O
that	O
the	O
epithelial	O
specific	O
transcriptional	O
activation	O
of	O
the	O
BPV-4	B
LCR	I
promoter	I
is	O
mediated	O
by	O
the	O
E2	B
transactivation	I
domain	I
.	O

These	O
changes	O
correlate	O
directly	O
with	O
an	O
increase	O
in	O
the	O
acetylation	O
levels	O
of	O
all	O
four	O
core	B
histones	I
in	O
vivo	O
.	O

Drosophila	B
orthodenticle	I
(	O
otd	B
)	O
and	O
murine	B
Otx	I
genes	I
exemplify	O
this	O
,	O
both	O
in	O
terms	O
of	O
expression	O
patterns	O
and	O
mutant	O
phenotypes	O
.	O

APETALA3	B
transcripts	I
are	O
first	O
detected	O
in	O
a	O
meristematic	O
region	O
that	O
will	O
give	O
rise	O
to	O
the	O
petal	O
and	O
stamen	O
primordia	O
,	O
and	O
expression	O
is	O
maintained	O
in	O
this	O
region	O
during	O
subsequent	O
development	O
of	O
these	O
organs	O
.	O

We	O
also	O
recovered	O
mutations	O
in	O
the	O
60A	B
gene	I
which	O
encodes	O
another	O
TGF	B
-	I
beta	I
-	I
related	I
factor	I
in	O
Drosophila	O
.	O

Cell	O
lines	O
are	O
checked	O
to	O
find	O
out	O
whether	O
they	O
develop	O
tumors	O
in	O
nude	O
mice	O
followed	O
by	O
an	O
analysis	O
of	O
the	O
karyotype	O
.	O

In	O
addition	O
,	O
IgM	B
can	O
be	O
absent	O
in	O
children	O
with	O
congenital	O
toxoplasmosis	O
or	O
subjects	O
with	O
secondary	O
reactivation	O
.	O

Both	O
variants	O
display	O
the	O
seven	O
-	O
transmembrane	O
topology	O
that	O
is	O
typical	O
for	O
G	B
protein	I
-	I
coupled	I
receptors	I
.	O

A	O
constitutive	O
allele	O
of	O
GPA2	B
could	O
stimulate	O
growth	O
of	O
a	O
strain	O
lacking	O
both	O
RAS	B
genes	I
.	O

The	O
COOH	O
-	O
terminus	O
of	O
this	O
new	O
isoform	O
,	O
which	O
we	O
designate	O
beta	B
4	I
,	O
lacks	O
a	O
22	O
amino	O
acid	O
lysine	O
-	O
rich	O
sequence	O
common	O
to	O
both	O
the	O
human	B
red	I
cell	I
alpha-	I
and	I
beta	I
-	I
adducin	I
subunits	I
and	O
homologous	O
to	O
a	O
highly	O
conserved	O
region	O
in	O
MARCKS	B
,	O
a	O
filamentous	O
actin	B
-	O
cross	O
linking	O
protein	O
regulated	O
by	O
protein	B
kinase	I
C	I
and	O
calcium	O
/	O
calmodulin	B
.	O

beta	B
4-adducin	I
preserves	O
a	O
previously	O
identified	O
calmodulin	B
binding	I
domain	I
.	O

The	O
plant	O
protein	O
maintains	O
all	O
the	O
functional	O
domains	O
found	O
in	O
the	O
other	O
proteins	O
,	O
including	O
nuclear	O
localization	O
signal	O
,	O
DNA	O
-	O
binding	O
domain	O
and	O
helicase	B
motifs	I
,	O
suggesting	O
that	O
it	O
might	O
also	O
act	O
as	O
part	O
of	O
the	O
RNA	O
transcription	O
apparatus	O
,	O
as	O
well	O
as	O
nucleotide	O
excision	O
repair	O
in	O
plant	O
cells	O
.	O

This	O
paper	O
describes	O
the	O
genomic	O
organization	O
of	O
mouse	O
gC1qBP	B
and	O
the	O
characterization	O
of	O
its	O
5	O
'	O
flanking	O
region	O
.	O

LysR	B
proteins	I
have	O
been	O
shown	O
to	O
regulate	O
urease	B
in	I
Klebsiella	I
aerogenes	I
(	O
NAC	B
)	O
,	O
and	O
catalase	B
in	I
Escherichia	I
coli	I
(	O
OxyR	B
)	O
,	O
which	O
offers	O
the	O
intracellular	O
bacterium	O
protection	O
from	O
phagolysosome	O
damage	O
.	O

Full	B
-	I
length	I
FLAP	I
clones	O
were	O
isolated	O
from	O
a	O
mouse	O
skeletal	O
muscle	O
cDNA	O
library	O
.	O

Members	O
of	O
the	O
meis1	B
and	O
pbx	B
homeodomain	I
protein	I
families	I
cooperatively	O
bind	O
a	O
cAMP	O
-	O
responsive	O
sequence	O
(	O
CRS1	O
)	O
from	O
bovine	B
CYP17	I
.	O

We	O
have	O
visualized	O
DNA	O
-	O
protein	O
complexes	O
by	O
electron	O
microscopy	O
and	O
a	O
high	O
-	O
affinity	O
binding	O
site	O
of	O
WDV	B
Rep	I
protein	I
within	O
the	O
core	O
element	O
has	O
been	O
mapped	O
to	O
approximately	O
144	O
+	O
/-	O

18	O
bp	O
upstream	O
from	O
the	O
initiation	O
site	O
,	O
between	O
the	O
start	O
site	O
for	O
complementary	O
-	O
sense	O
transcription	O
and	O
the	O
TATA	O
box	O
.	O

Alternative	O
splicing	O
of	O
fibroblast	B
growth	I
factor	I
receptor	I
2	I
(	O
FGF	B
-	I
R2	I
)	O
is	O
an	O
example	O
of	O
highly	O
regulated	O
alternative	O
splicing	O
in	O
which	O
exons	O
IIIb	O
and	O
IIIc	O
are	O
utilized	O
in	O
a	O
mutually	O
exclusive	O
manner	O
in	O
different	O
cell	O
types	O
.	O

The	O
genomic	O
fragments	O
were	O
fused	O
upstream	O
of	O
the	O
luciferase	B
reporter	I
gene	I
.	O

Deletion	O
of	O
the	O
last	O
two	O
Ser	O
residues	O
,	O
including	O
one	O
PKC	B
consensus	O
site	O
in	O
the	O
receptor	O
tail	O
,	O
prevented	O
only	O
phorbol	O
12-myristate	O
13-acetate	O
-	O
induced	O
desensitization	O
by	O
30	O
%	O
.	O

Despite	O
its	O
requirement	O
for	O
enhancer	O
-	O
dependent	O
splicing	O
activity	O
in	O
vitro	O
,	O
the	O
dU2AF38	B
RS	I
domain	I
was	O
also	O
inessential	O
in	O
vivo	O
.	O

The	O
addition	O
of	O
a	O
Paf	B
-	O
containing	O
extract	O
does	O
not	O
lead	O
to	O
significant	O
protein	O
binding	O
to	O
these	O
two	O
hly	B
target	I
sequences	I
in	O
the	O
absence	O
of	O
PrfA	B
but	O
converts	O
the	O
complex	O
(	O
CIII	O
)	O
consisting	O
of	O
PrfA	B
and	O
the	O
109	B
bp	I
hly	I
DNA	I
fragment	I
to	O
a	O
slower	O
migrating	O
PrfA	B
-	O
Paf	B
-	O
DNA	O
complex	O
(	O
CI	O
)	O
.	O

Moreover	O
,	O
it	O
is	O
the	O
assumptions	O
behind	O
steady	O
-	O
state	O
O2	O
uptake	O
that	O
do	O
not	O
permit	O
proper	O
interpretation	O
of	O
energy	O
expenditure	O
during	O
EPOC	O
;	O
1	O
l	O
O2	O
not	O
=	O
20.9	O
kJ.	O

The	O
predicted	O
amino	O
acid	O
sequence	O
of	O
m	B
-	I
Staf	I
is	O
highly	O
homologous	O
to	O
that	O
of	O
Staf	B
,	O
another	O
selenocysteine	B
tRNA	I
gene	I
transcription	I
activating	I
factor	I
of	O
Xenopus	O
laevis	O
.	O

Among	O
three	O
isoforms	O
,	O
the	O
beta	O
isoform	O
has	O
the	O
greatest	O
Vmax	O
value	O
for	O
the	O
PtdIns	B
(	I
4	I
)	I
P	I
kinase	I
activity	O
and	O
the	O
gamma	O
isoform	O
is	O
most	O
markedly	O
stimulated	O
by	O
phosphatidic	O
acid	O
.	O

Two	O
differentially	O
expressed	O
LNX	B
messages	I
encode	O
overlapping	O
proteins	O
with	O
predicted	O
molecular	O
masses	O
of	O
80	B
kDa	I
(	I
LNX	I
)	I
and	O
70	B
kDa	I
(	I
LNX	I
-	I
b	I
)	I
.	O

In	O
contrast	O
,	O
the	O
contractile	O
action	O
of	O
arachidonic	O
acid	O
,	O
via	O
a	O
presumed	O
cyclooxygenase	B
product	O
that	O
mediated	O
the	O
contractions	O
caused	O
by	O
both	O
TF	B
and	O
EGF	B
,	O
was	O
not	O
blocked	O
by	O
any	O
of	O
the	O
signal	O
pathway	O
probe	O
inhibitors	O
.	O

Recent	O
studies	O
have	O
revealed	O
unconventional	O
myosin	B
V	I
to	O
be	O
an	O
important	O
actin	B
-	O
based	O
molecular	O
motor	O
involved	O
in	O
vesicular	O
movement	O
.	O

Furthermore	O
,	O
a	O
minor	O
start	O
site	O
was	O
localized	O
179	O
bp	O
upstream	O
of	O
the	O
major	O
site	O
using	O
reverse	B
transcriptase	I
-	O
polymerase	O
chain	O
reaction	O
with	O
various	O
P1	O
primers	O
(	O
primer	O
walking	O
)	O
,	O
primer	O
extension	O
,	O
and	O
cDNA	O
cloning	O
.	O

The	O
iron	O
dependence	O
of	O
transcription	O
and	O
expression	O
of	O
cvaA	B
,	O
which	O
encodes	O
a	O
transporter	O
accessory	O
protein	O
,	O
and	O
cvi	B
,	O
encoding	O
the	O
colicin	B
V	I
immunity	I
protein	I
,	O
was	O
assessed	O
under	O
conditions	O
of	O
iron	O
excess	O
or	O
depletion	O
.	O

In	O
a	O
gntR	B
deletion	I
mutant	I
,	O
the	O
expression	O
of	O
a	O
chromosomal	O
gntT::lacZ	B
fusion	O
is	O
both	O
high	O
and	O
constitutive	O
,	O
confirming	O
that	O
GntR	B
is	O
the	O
negative	O
regulator	O
of	O
gntT.	B

Furthermore	O
,	O
the	O
deletion	O
of	O
bcp	B
from	O
the	O
chromosome	O
had	O
no	O
effect	O
on	O
gcv	B
-	O
lacZ	B
expression	O
.	O

The	O
mitochondrial	B
regulatory	I
region	I
(	O
mrr	B
)	O
located	O
between	O
the	O
tRNAPhe	B
and	O
tRNAPro	B
genes	I
of	O
mitochondrial	O
DNA	O
(	O
mtDNA	O
)	O
is	O
essential	O
for	O
regulation	O
of	O
replication	O
and	O
transcription	O
of	O
the	O
mitochondrial	O
genome	O
.	O

In	O
this	O
report	O
,	O
we	O
investigate	O
the	O
mechanism	O
underlying	O
Ras	B
activation	O
upon	O
stimulation	O
of	O
these	O
two	O
types	O
of	O
receptors	O
in	O
hematopoietic	O
cells	O
.	O

Therefore	O
,	O
we	O
conclude	O
that	O
DnaA	B
may	O
contact	O
the	O
beta	O
subunit	O
of	O
RNA	B
polymerase	I
during	O
activation	O
of	O
the	O
pR	B
promoter	I
.	O

Expression	O
of	O
Bcl	B
-	I
XL	I
inhibited	O
the	O
association	O
of	O
Apaf-1	B
with	O
caspase-9	B
in	O
mammalian	O
cells	O
.	O

Whole	O
-	O
mount	O
in	O
situ	O
hybridization	O
to	O
early	O
mouse	O
embryos	O
of	O
9.5	O
-	O
10.5	O
days	O
indicated	O
a	O
complex	O
pattern	O
of	O
Arp1	B
expression	O
spatially	O
overlapping	O
with	O
the	O
expression	O
of	O
All1	B
.	O

These	O
mutants	O
were	O
tested	O
for	O
ability	O
to	O
bind	O
each	O
of	O
the	O
Site	B
II	I
cognate	I
proteins	I
,	O
and	O
subsequently	O
evaluated	O
for	O
ability	O
to	O
confer	O
H4	B
transcriptional	O
activity	O
using	O
chimeric	O
H4	B
promoter	O
/	O
CAT	B
fusion	O
constructs	O
in	O
different	O
cell	O
types	O
.	O

Increased	O
plasma	O
IgE	B
was	O
also	O
confirmed	O
in	O
the	O
NC	O
mice	O
,	O
and	O
treatment	O
with	O
FK506	O
ointment	O
reduced	O
the	O
plasma	O
IgE	B
level	O
.	O

Furthermore	O
,	O
in	O
the	O
ischemia	O
/	O
angiotension	B
II	I
-	O
induced	O
AHF	O
model	O
,	O
NIC	O
decreased	O
left	O
ventricular	O
end	O
-	O
diastolic	O
pressure	O
(	O
LVEDP	O
)	O
.	O

Group	O
A	O
(	O
68.7+	O
/	O
-2.7	O
years	O
)	O
consisted	O
of	O
patients	O
with	O
0	O
or	O
1	O
risk	O
factors	O
;	O
B	O
(	O
68.3+	O
/	O
-4.2	O
years	O
)	O
those	O
with	O
2	O
risk	O
factors	O
;	O
and	O
C	O
(	O
69.2+	O
/	O
-3.6	O
years	O
)	O
those	O
with	O
3	O
or	O
more	O
risk	O
factors	O
.	O

We	O
further	O
demonstrate	O
that	O
RU486-PR	O
-	B
B	I
interacts	O
physically	O
with	O
NCoR	B
in	O
vitro	O
.	O

PRL	B
receptor	I
also	O
activates	O
SHP-2	B
,	O
a	O
cytosolic	B
tyrosine	I
phosphatase	I
.	O

CONCLUSIONS	O
:	O
These	O
routinely	O
collected	O
data	O
provided	O
quantitative	O
estimates	O
of	O
changes	O
in	O
CBZ	O
Cl	O
/	O
F	O
due	O
to	O
comedication	O
and	O
an	O
age	O
-	O
related	O
decrease	O
in	O
Cl	O
/	O
F	O
The	O
derived	O
regression	O
equations	O
reasonably	O
predicted	O
concentrations	O
in	O
a	O
separate	O
validation	O
set	O
.	O

ATP	O
-	O
dependent	O
assembly	O
of	O
a	O
ternary	O
complex	O
consisting	O
of	O
a	O
DNA	O
mismatch	O
and	O
the	O
yeast	O
MSH2-MSH6	B
and	O
MLH1-PMS1	B
protein	O
complexes	O
.	O

Instead	O
,	O
it	O
contained	O
two	O
tandem	O
kappaB	B
elements	I
and	O
a	O
variant	O
activating	B
transcription	I
factor	I
/	I
cAMP	I
response	I
element	I
site	O
,	O
which	O
closely	O
resembled	O
sites	O
in	O
the	O
E	B
-	I
selectin	I
gene	I
that	O
are	O
required	O
for	O
TNF	B
-	I
alpha-	I
or	O
LPS	O
-	O
inducible	O
expression	O
.	O

We	O
recently	O
characterized	O
a	O
single	O
yeast	B
hnRNP	I
methyltransferase	I
(	O
HMT1	B
)	O
.	O

Identification	O
and	O
characterization	O
of	O
two	O
putative	O
human	B
arginine	I
methyltransferases	I
(	O
HRMT1L1	B
and	O
HRMT1L2	B
)	O
.	O

Interestingly	O
,	O
the	O
activated	O
PDGF	B
beta	I
-	I
receptor	I
was	O
found	O
not	O
to	O
bind	O
Crk	B
proteins	I
.	O

In	O
addition	O
to	O
a	O
previously	O
characterized	O
promoter	O
(	O
P1	O
)	O
,	O
we	O
now	O
show	O
the	O
existence	O
of	O
a	O
second	O
promoter	O
for	O
the	O
human	B
IL-5Ralpha	I
gene	I
.	O

Overall	O
agreement	O
between	O
rest	O
/	O
postnitroglycerin	O
technetium-99	O
m	O
tetrofosmin	O
SPET	O
studies	O
and	O
rest	O
/	O
redistribution	O
or	O
rest	O
/	O
reinjection	O
thallium-201	O
SPET	O
studies	O
,	O
regarding	O
the	O
presence	O
of	O
myocardial	O
viability	O
,	O
was	O
87	O
%	O
and	O
90	O
%	O
,	O
respectively	O
.	O

Their	O
use	O
resulted	O
in	O
a	O
sensitivity	O
of	O
73	O
%	O
and	O
a	O
specificity	O
of	O
74	O
%	O
with	O
regard	O
to	O
predictability	O
of	O
ALT	B
levels	O
increasing	O
during	O
the	O
trial	O
.	O

One	O
hundred	O
replicate	O
data	O
sets	O
of	O
100	O
subjects	O
each	O
were	O
simulated	O
for	O
each	O
missing	O
data	O
scenario	O
.	O

Spatial	O
accuracy	O
of	O
primary	O
and	O
secondary	O
memory	O
-	O
guided	O
saccades	O
in	O
schizophrenic	O
patients	O
.	O

Successful	O
treatment	O
with	O
nasal	O
continuous	O
positive	O
airway	O
pressure	O
(	O
8.3	O
+	O
/-	O

1.5	O
cmH2O	O
)	O
for	O
3	O
days	O
caused	O
a	O
significant	O
decrease	O
in	O
mean	O
blood	O
pressure	O
in	O
OSAS	O
.	O

When	O
data	O
were	O
expressed	O
in	O
a	O
cumulative	O
manner	O
,	O
the	O
response	O
to	O
intravenous	O
adenosine	O
3	O
mg	O
,	O
6	O
mg	O
,	O
9	O
mg	O
and	O
12	O
mg	O
in	O
the	O
24	O
episodes	O
of	O
PSVT	O
were	O
5	O
episodes	O
(	O
21	O
%	O
)	O
,	O
16	O
episodes	O
(	O
67	O
%	O
)	O
,	O
20	O
episodes	O
(	O
83	O
%	O
)	O
and	O
20	O
episodes	O
(	O
83	O
%	O
)	O
respectively	O
.	O

To	O
study	O
retinoid	O
signalling	O
in	O
zebrafish	O
embryos	O
,	O
we	O
developed	O
a	O
novel	O
method	O
to	O
detect	O
endogenous	O
retinoids	O
in	O
situ	O
in	O
embryos	O
,	O
using	O
a	O
fusion	O
protein	O
of	O
the	O
ligand	O
inducible	O
transactivation	O
domain	O
of	O
a	O
retinoic	B
acid	I
receptor	I
and	O
a	O
heterologous	O
DNA	O
binding	O
domain	O
.	O

Fluorescence	O
in	O
situ	O
hybridization	O
of	O
metaphase	O
spreads	O
of	O
chromosome	O
8	O
,	O
containing	O
hybrid	O
cell	O
line	O
706-B6	O
clone	O
17	O
(	O
CL-17	O
)	O
with	O
cosmid	O
c101F1	O
,	O
placed	O
the	O
9804	B
gene	I
close	O
to	O
the	O
telomere	O
at	O
8q24.3	O
.	O

The	O
interaction	O
between	O
piroxicam	O
and	O
poloxamer	O
was	O
studied	O
by	O
x	O
-	O
ray	O
diffractometry	O
(	O
XRD	O
)	O
,	O
infrared	O
(	O
IR	O
)	O
spectroscopy	O
and	O
differential	O
thermal	O
analysis	O
(	O
DTA	O
)	O
with	O
a	O
solid	O
dispersion	O
,	O
coprecipitate	O
,	O
or	O
physical	O
mixture	O
.	O

The	O
N	O
-	O
syndecan	O
-	O
dependent	O
neurite	O
outgrowth	O
is	O
inhibited	O
by	O
the	O
tyrosine	B
kinase	I
inhibitors	O
herbimycin	O
A	O
and	O
PP1	B
.	O

An	O
in	O
vivo	O
ZAP-70	B
substrate	O
,	O
SLP-76	B
,	O
implicated	O
in	O
Erk	B
activation	O
,	O
also	O
became	O
rapidly	O
tyrosine	O
-	O
phosphorylated	O
in	O
Jurkat	O
cells	O
,	O
but	O
not	O
in	O
P116	O
cells	O
,	O
upon	O
treatment	O
with	O
H2O2	O
.	O

The	O
results	O
confirm	O
that	O
a	O
single	O
base	O
change	O
in	O
the	O
branchpoint	O
consensus	O
sequence	O
of	O
an	O
intron	O
can	O
cause	O
human	O
disease	O
although	O
this	O
sequence	O
is	O
poorly	O
conserved	O
in	O
mammals	O
.	O

Conversely	O
,	O
the	O
central	O
regions	O
are	O
highly	O
variable	O
.	O

Among	O
the	O
H	B
/	I
ACA	I
snoRNAs	I
associated	O
with	O
Gar1p	B
,	O
one	O
can	O
distinguish	O
a	O
large	O
group	O
of	O
snoRNAs	O
that	O
are	O
not	O
essential	O
in	O
yeast	O
and	O
serve	O
as	O
guides	O
for	O
pseudouridine	O
synthesis	O
onto	O
the	O
pre	O
-	O
rRNA	O
molecule	O
.	O

It	O
bound	O
to	O
vitamin	B
D	I
receptor	I
(	O
VDR	B
)	O
but	O
not	O
retinoic	B
acid	I
Xalpha	I
receptor	I
(	O
RXRalpha	B
)	O
in	O
the	O
human	O
T	O
cell	O
line	O
MT2	O
cells	O
.	O

We	O
previously	O
demonstrated	O
that	O
acute	O
expression	O
of	O
the	O
bovine	O
papillomavirus	O
type	O
1	O
(	O
BPV1	O
)	O
E2	B
protein	I
in	O
HeLa	O
and	O
HT-3	O
cervical	O
carcinoma	O
cell	O
lines	O
greatly	O
reduced	O
cellular	O
proliferation	O
by	O
imposing	O
a	O
specific	O
G1	O
/	O
S	O
phase	O
growth	O
arrest	O
.	O

Specialized	O
actin	B
tails	O
that	O
propel	O
IEV	O
particles	O
to	O
the	O
periphery	O
and	O
virus	O
-	O
tipped	O
microvilli	O
(	O
both	O
common	O
in	O
wild	O
-	O
type	O
-	O
infected	O
cells	O
)	O
were	O
absent	O
in	O
cells	O
infected	O
with	O
vA33delta	O
.	O

Their	O
mean	O
IOP	O
was	O
15.3	O
(	O
SD	O
3.7	O
)	O
mmHg	O
prior	O
to	O
induction	O
of	O
anesthesia	O
,	O
13.5	O
(	O
SD	O
3.5	O
)	O
mmHg	O
after	O
loss	O
of	O
eyelash	O
reflex	O
following	O
injection	O
of	O
methohexitone	O
,	O
16.1	O
(	O
SD	O
2.4	O
)	O
mmHg	O
after	O
cessation	O
of	O
muscle	O
fasciculations	O
induced	O
by	O
suxamethonium	O
,	O
19.2	O
(	O
SD	O
5.6	O
)	O
mmHg	O
after	O
cessation	O
of	O
convulsion	O
and	O
15.5	O
(	O
SD	O
4.4	O
)	O
mmHg	O
following	O
resumption	O
of	O
regular	O
spontaneous	O
respiration	O
.	O

Post	O
-	O
translational	O
modifications	O
such	O
as	O
glycosylation	O
and	O
phosphorylation	O
could	O
be	O
excluded	O
as	O
potential	O
explanations	O
for	O
the	O
protein	O
heterogeneity	O
.	O

Rhesus	O
macaques	O
and	O
BALB	O
/	O
c	O
mice	O
inoculated	O
with	O
the	O
Mengo	O
virus	O
SIV	O
recombinants	O
failed	O
to	O
develop	O
CTL	O
responses	O
against	O
the	O
SIV	O
gene	O
products	O
,	O
while	O
one	O
of	O
the	O
HIV	B
-	I
Nef	I
recombinants	I
induced	O
a	O
weak	O
CTL	O
response	O
in	O
mice	O
directed	O
to	O
an	O
HIV1	B
Nef	I
peptide	I
spanning	O
positions	O
182	O
-	O
198	O
.	O

Trichloroethylene	O
,	O
in	O
turn	O
,	O
increased	O
the	O
AUC	O
5.0	O
(	O
1.9	O
-	O
13.4	O
)	O
,	O
25.8	O
(	O
8.2	O
-	O
80.8	O
)	O
and	O
2.9	O
(	O
1.6	O
-	O
5.4	O
)	O
,	O
respectively	O
,	O
whereas	O
the	O
corresponding	O
values	O
for	O
n	O
-	O
hexane	O
were	O
1.9	O
(	O
0.7	O
-	O
5.1	O
)	O
,	O
1.5	O
(	O
0.5	O
-	O
4.6	O
)	O
,	O
and	O
3.2	O
(	O
1.8	O
-	O
5.9	O
)	O
.	O

Solution	O
structure	O
of	O
the	O
IRF-2	B
DNA	I
-	I
binding	I
domain	I
:	O
a	O
novel	O
subgroup	O
of	O
the	O
winged	B
helix	I
-	I
turn	I
-	I
helix	I
family	I
.	O

In	O
contrast	O
,	O
receptor	B
/	I
G	I
protein	I
coupling	O
appeared	O
unaffected	O
by	O
expression	O
of	O
loop	O
3i	O
domains	O
derived	O
from	O
two	O
receptors	O
coupled	O
to	O
G	B
(	I
i	I
/	I
o	I
)	I
proteins	I
(	O
M2Ach	B
-	I
muscarinic	I
and	I
alpha2A	I
-	I
adrenergic	I
receptors	I
)	O
.	O

A	O
catalytic	O
domain	O
of	O
eukaryotic	B
DNA	I
topoisomerase	I
I.	I

Another	O
stem	O
-	O
loop	O
called	O
structure	O
III	O
near	O
the	O
3'-end	O
of	O
repY	B
sequesters	O
both	O
the	O
5'-rCGCC-3	O
'	O
sequence	O
and	O
the	O
repZ	B
ribosome	I
-	I
binding	I
site	I
.	O

All	O
three	O
genes	O
have	O
been	O
mapped	O
precisely	O
to	O
a	O
small	O
region	O
on	O
human	O
chromosome	O
16p12.1-p11.2	O
(	O
homologous	O
to	O
mouse	O
chromosome	O
7	O
)	O
,	O
using	O
somatic	O
cell	O
hybrids	O
and	O
cosmid	O
clones	O
.	O

In	O
fus3	B
mutants	I
,	O
the	O
levels	O
of	O
Ty1	B
RNA	I
,	O
protein	O
synthesis	O
,	O
and	O
proteolytic	O
processing	O
were	O
not	O
altered	O
relative	O
to	O
those	O
in	O
FUS3	B
strains	O
but	O
steady	O
-	O
state	O
levels	O
of	O
TyA	B
,	O
integrase	B
,	O
and	O
reverse	B
transcriptase	I
proteins	O
and	O
Ty1	B
cDNA	I
were	O
all	O
increased	O
.	O

Posttranslational	O
regulation	O
of	O
Ty1	B
retrotransposition	O
by	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
Fus3	I
.	O

The	O
general	O
transcription	B
factor	I
IIA	I
(	O
TFIIA	B
)	O
interacts	O
with	O
the	O
TATA	B
binding	I
protein	I
(	O
TBP	B
)	O
and	O
promoter	O
DNA	O
to	O
mediate	O
transcription	O
activation	O
in	O
vitro	O
.	O

Their	O
function	O
is	O
not	O
only	O
to	O
recruit	O
Pho2	B
to	O
the	O
promoter	O
but	O
to	O
allow	O
cooperative	O
binding	O
of	O
Pho4	B
together	O
with	O
Pho2	B
.	O

Substitution	O
of	O
the	O
Ser	O
-	O
Thr	O
sites	O
with	O
the	O
phosphomimetic	O
Asp	O
generated	O
a	O
constitutively	O
active	O
form	O
of	O
IRF-3	B
that	O
functioned	O
as	O
a	O
very	O
strong	O
activator	O
of	O
promoters	O
containing	O
PRDI	B
-	O
PRDIII	B
or	O
ISRE	B
regulatory	I
elements	I
.	O

In	O
addition	O
to	O
DNA	O
-	O
protein	O
interactions	O
,	O
protein	O
-	O
protein	O
interactions	O
with	O
partner	O
proteins	O
often	O
play	O
major	O
roles	O
in	O
targeting	O
ETS	B
-	I
domain	I
proteins	I
to	O
specific	O
promoters	O
.	O

Localization	O
of	O
67	O
exons	O
on	O
a	O
YAC	O
contig	O
spanning	O
1.5	O
Mb	O
around	O
the	O
multidrug	B
resistance	I
gene	I
region	I
of	O
human	O
chromosome	O
7q21.1	O
.	O

The	O
complete	O
exon	O
-	O
intron	O
organization	O
of	O
the	O
murine	O
gene	O
encoding	O
M	B
-	I
protein	I
,	O
a	O
structural	O
protein	O
of	O
sarcomeric	O
myofibrils	O
,	O
was	O
determined	O
.	O

Mean+	O
/	O
-SD	O
serum	B
VEGF	I
concentrations	O
were	O
significantly	O
higher	O
(	O
P	O
<	O
0.001	O
)	O
in	O
women	O
with	O
PCO	O
and	O
PCOS	O
(	O
3.4+	O
/	O
-0.7	O
and	O
3.2+	O
/	O
-0.66	O
ng	O
/	O
ml	O
respectively	O
)	O
compared	O
with	O
women	O
with	O
normal	O
ovaries	O
(	O
2.3+	O
/	O
-0.5	O
ng	O
/	O
ml	O
)	O
.	O

Strikingly	O
,	O
these	O
cells	O
contain	O
a	O
missense	O
mutation	O
of	O
the	O
p53	B
gene	I
at	O
codon	O
242	O
(	O
p53	B
(	O
242	O
)	O
)	O
,	O
which	O
substitutes	O
alanine	O
for	O
glycine	O
.	O

The	O
new	O
algorithm	O
,	O
called	O
RBI	O
-	O
MAP	O
,	O
is	O
based	O
on	O
the	O
rescaled	O
block	O
iterative	O
EM	O
(	O
RBI	O
-	O
EM	O
)	O
algorithm	O
.	O

A	O
third	O
ORF	O
,	O
ORF5	O
,	O
shows	O
homology	O
with	O
gene	B
agrB	I
from	O
Staphylococcus	O
aureus	O
,	O
which	O
is	O
involved	O
in	O
the	O
mechanism	O
of	O
regulation	O
of	O
the	O
virulence	O
phenotype	O
in	O
this	O
species	O
.	O

An	O
association	O
between	O
hSIE	B
and	O
Stat-3	B
after	O
MHC	B
-	I
I	I
ligation	O
was	O
directly	O
demonstrated	O
by	O
precipitating	O
Stat-3	B
from	O
nuclear	O
extracts	O
with	O
biotinylated	O
hSIE	B
probe	O
and	O
avidin	B
-	O
coupled	O
agarose	O
.	O

The	O
localization	O
of	O
ZAP-70	B
to	O
the	O
cell	O
cortex	O
is	O
,	O
therefore	O
,	O
regulated	O
by	O
the	O
activity	O
of	O
SRC	B
-	I
family	I
kinases	I
,	O
independently	O
of	O
their	O
ability	O
to	O
phosphorylate	O
immunoreceptor	O
tyrosine	O
-	O
based	O
activation	O
motifs	O
of	O
the	O
TCR	B
.	O

A	O
site	O
-	O
directed	O
R618	O
K	O
mutation	O
in	O
the	O
Stat5	B
SH2	B
domain	I
abolished	O
the	O
phosphorylation	O
by	O
Jak2	B
,	O
while	O
deletion	O
of	O
the	O
C	O
terminus	O
led	O
to	O
Stat5	B
hyperphosphorylation	O
.	O

The	O
effect	O
of	O
nitric	B
oxide	I
synthase	I
inhibitor	O
on	O
reperfusion	O
injury	O
of	O
the	O
brain	O
under	O
hypothermic	O
circulatory	O
arrest	O
.	O

We	O
studied	O
the	O
human	O
vestibulo	O
-	O
ocular	O
reflex	O
(	O
VOR	O
)	O
in	O
response	O
to	O
head	O
'	O
impulses	O
'	O
:	O
brief	O
,	O
unpredictable	O
,	O
passive	O
,	O
high	O
-	O
acceleration	O
(	O
up	O
to	O
4000	O
degrees	O
/	O
s2	O
)	O
,	O
low	O
-	O
amplitude	O
(	O
20	O
-	O
30	O
degrees	O
)	O
head	O
rotations	O
.	O

These	O
patients	O
failed	O
to	O
respond	O
to	O
intravenous	O
cyclophosphamide	O
and	O
steroids	O
and	O
were	O
then	O
changed	O
to	O
receive	O
oral	O
cyclosporine	O
A	O
,	O
at	O
a	O
dose	O
of	O
5	O
mg	O
/	O
kg	O
/	O
day	O
.	O

The	O
DNA	O
binding	O
activities	O
of	O
the	O
three	O
repressor	O
preparations	O
were	O
studied	O
using	O
fragments	O
containing	O
CIRs	O
(	O
CIR3-CIR6	O
)	O
from	O
the	O
essential	O
early	O
region	O
as	O
templates	O
for	O
DNase	B
I	I
footprinting	O
.	O

Molecular	O
modelling	O
suggested	O
that	O
the	O
tetramerization	O
domain	O
was	O
a	O
four	O
-	O
helix	O
bundle	O
,	O
stabilized	O
by	O
interactions	O
of	O
seven	O
conserved	O
aromatic	O
amino	O
acids	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
silymarin	O
may	O
exert	O
a	O
strong	O
anticarcinogenic	O
effect	O
against	O
PCA	O
and	O
that	O
this	O
effect	O
is	O
likely	O
to	O
involve	O
impairment	O
of	O
erbB1-SHC	B
-	O
mediated	O
signaling	O
pathway	O
,	O
induction	O
of	O
CDKIs	B
,	O
and	O
a	O
resultant	O
G1	O
arrest	O
.	O

Indeed	O
,	O
it	O
is	O
shown	O
that	O
it	O
mediates	O
the	O
formation	O
of	O
disulfide	O
-	O
linked	O
homodimers	O
and	O
that	O
the	O
formation	O
of	O
homo-	O
and	O
heterodimers	O
are	O
mutually	O
excluded	O
.	O

N.	O
,	O
and	O
Fanning	O
,	O
E.	O

We	O
have	O
shown	O
previously	O
that	O
GH3	O
cells	O
transfected	O
with	O
the	O
rat	B
GnRH	I
receptor	I
cDNA	I
(	O
GGH3	O
-	O
1	O
'	O
cells	O
)	O
support	O
the	O
expression	O
of	O
a	O
cotransfected	O
fusion	O
gene	O
composed	O
of	O
797	O
base	O
pairs	O
of	O
rat	B
LHbeta	I
gene	I
5'-flanking	I
sequence	I
and	O
the	O
first	O
5	O
base	O
pairs	O
of	O
the	O
5'-untranslated	O
region	O
fused	O
to	O
a	O
luciferase	B
reporter	I
(	I
-797	I
/	I
+5LHbetaLUC	I
)	I
and	O
respond	O
to	O
a	O
GnRH	B
agonist	O
with	O
a	O
10-fold	O
stimulation	O
of	O
activity	O
.	O

In	O
patients	O
with	O
type	O
IA	O
maple	O
syrup	O
urine	O
disease	O
,	O
the	O
E1alpha	B
subunit	I
is	O
affected	O
,	O
resulting	O
in	O
the	O
loss	O
of	O
E1	B
and	O
branched	B
-	I
chain	I
ketoacid	I
dehydrogenase	I
catalytic	O
activities	O
.	O

OBJECTIVES	O
:	O
To	O
measure	O
coagulation	B
factor	I
VIII	I
:	I
coagulant	I
(	O
F.VIII	B
:	I
C	I
)	O
and	O
C1-esterase	B
inhibitor	I
(	O
C1-INH	B
)	O
,	O
hemostasis	O
-	O
associated	O
acute	O
-	O
phase	O
reactant	O
proteins	O
and	O
coagulation	B
factors	I
VII	I
(	O
F.VII	B
)	O
,	O
IX	O
(	O
F.IX	B
)	O
,	O
and	O
X	O
(	O
F.X	B
)	O
,	O
hemostasis	O
proteins	O
not	O
associated	O
with	O
an	O
acute	O
-	O
phase	O
response	O
,	O
in	O
a	O
select	O
population	O
of	O
horses	O
with	O
colic	O
and	O
hemostasis	O
abnormalities	O
,	O
and	O
presumed	O
to	O
have	O
acute	O
-	O
phase	O
changes	O
.	O

The	O
data	O
suggest	O
that	O
plasminogen	B
,	O
alpha	B
2AP	I
,	O
and	O
C1-INH	B
,	O
should	O
be	O
considered	O
equine	O
acute	O
-	O
phase	O
proteins	O
.	O

None	O
of	O
the	O
patients	O
was	O
obese	O
.	O

RACK1	B
,	O
a	O
receptor	O
for	O
activated	B
C	I
kinase	I
and	O
a	O
homolog	O
of	O
the	O
beta	O
subunit	O
of	O
G	B
proteins	I
,	O
inhibits	O
activity	O
of	O
src	B
tyrosine	I
kinases	I
and	O
growth	O
of	O
NIH	O
3T3	O
cells	O
.	O

Peptide	O
sequences	O
of	O
the	O
zinc	B
finger	I
protein	I
Ttk	I
and	O
the	O
transcription	B
factor	I
Adf-1	I
were	O
obtained	O
.	O

HEF1	B
,	O
p130	B
(	O
Cas	B
)	O
,	O
and	O
Efs	B
/	O
Sin	B
constitute	O
a	O
family	O
of	O
multidomain	O
docking	O
proteins	O
that	O
have	O
been	O
implicated	O
in	O
coordinating	O
the	O
regulation	O
of	O
cell	O
adhesion	O
.	O

In	O
support	O
of	O
a	O
role	O
at	O
the	O
spindle	O
,	O
two	O
-	O
hybrid	O
library	O
screening	O
with	O
HEF1	B
identifies	O
the	O
human	O
homolog	O
of	O
the	O
G2	B
/	I
M	I
spindle	I
-	I
regulatory	I
protein	I
Dim1p	I
as	O
a	O
specific	O
interactor	O
with	O
a	O
region	O
of	O
HEF1	B
encompassed	O
in	O
p55	B
(	O
HEF1	B
)	O
.	O

However	O
,	O
a	O
zinc	O
-	O
depleted	O
enzyme	O
was	O
obtained	O
after	O
prolonged	O
dialysis	O
against	O
the	O
specific	O
chelating	O
agent	O
1,10-phenanthroline	O
.	O

All	O
patients	O
diagnosed	O
of	O
H.	O
influenza	O
type	O
b	O
meningitis	O
were	O
less	O
than	O
3	O
years	O
old	O
.	O

The	O
lines	O
also	O
differed	O
in	O
postsynaptic	O
,	O
but	O
not	O
presynaptic	O
,	O
5-HT1A	B
receptors	I
.	O

The	O
bZP2	B
cDNA	I
(	I
115	I
-	I
1914	I
nt	I
,	I
1.8	I
kb	I
)	I
,	O
excluding	O
sequences	O
coding	O
for	O
N	O
-	O
terminal	O
signal	O
sequence	O
and	O
C	O
-	O
terminal	O
transmembranelike	O
domain	O
,	O
was	O
PCR	O
amplified	O
and	O
Sac1-Sal1	B
restricted	O
fragment	O
cloned	O
in	O
frame	O
downstream	O
of	O
the	O
T5	O
promoter	O
under	O
the	O
lac	B
operator	I
control	O
in	O
a	O
pQE-30	O
vector	O
.	O

Control	O
subjects	O
'	O
evoked	O
potentials	O
(	O
EPs	O
)	O
were	O
characterized	O
by	O
an	O
initial	O
positivity	O
in	O
the	O
90	O
-	O
140	O
ms	O
range	O
(	O
P1	O
)	O
at	O
the	O
temporo	O
-	O
occipital	O
site	O
.	O

Class	B
I	I
alpha1,2-mannosidases	I
play	O
an	O
essential	O
role	O
in	O
the	O
elaboration	O
of	O
complex	O
and	O
hybrid	O
N	O
-glycans	O
in	O
mammalian	O
cells	O
.	O

Structural	O
features	O
of	O
the	O
minimal	O
DNA	O
binding	O
domain	O
(	O
M98-F219	O
)	O
of	O
human	B
nucleotide	I
excision	I
repair	I
protein	I
XPA	I
.	O

Amongst	O
other	O
qualities	O
,	O
the	O
book	O
's	O
importance	O
lies	O
in	O
the	O
fact	O
that	O
it	O
associates	O
an	O
elaborate	O
theoretical	O
construction	O
with	O
the	O
empirical	O
data	O
,	O
working	O
within	O
the	O
possibilities	O
provided	O
by	O
late	O
19th	O
-	O
century	O
moral	O
statistics	O
.	O

Recently	O
,	O
extremely	O
high	O
levels	O
of	O
endothelin-1	B
(	O
ET-1	B
)	O
were	O
detected	O
in	O
the	O
pericardial	O
fluid	O
of	O
patients	O
undergoing	O
cardiac	O
surgery	O
.	O

We	O
show	O
that	O
the	O
surfaces	O
of	O
tracheal	O
cartilage	O
matrix	O
are	O
collagen	B
-	O
rich	O
and	O
surround	O
a	O
proteoglycan	O
-	O
rich	O
core	O
.	O

Roles	O
of	O
the	O
Candida	B
albicans	I
mitogen	I
-	I
activated	I
protein	I
kinase	I
homolog	I
,	O
Cek1p	B
,	O
in	O
hyphal	O
development	O
and	O
systemic	O
candidiasis	O
.	O

Neither	O
the	O
reaction	O
of	O
monosaccharides	O
nor	O
the	O
disaccharides	O
with	O
beta	O
-	O
alanine	O
resulted	O
in	O
the	O
formation	O
of	O
maltol	O
.	O

Analysis	O
of	O
a	O
Mac1p	B
mutant	I
,	O
refractile	O
for	O
copper	O
-	O
dependent	O
repression	O
of	O
the	O
Cu	B
(	I
I	I
)	I
transport	I
genes	I
,	O
showed	O
an	O
aberrant	O
pattern	O
of	O
CUP1	B
expression	O
and	O
copper	O
sensitivity	O
.	O

The	O
clinical	O
and	O
laboratory	O
features	O
of	O
72	O
children	O
with	O
Henoch	O
-	O
Schonlein	O
purpura	O
(	O
HSP	O
)	O
were	O
examined	O
to	O
determine	O
if	O
there	O
were	O
associations	O
between	O
the	O
laboratory	O
indices	O
--	O
including	O
white	O
blood	O
cell	O
(	O
WBC	O
)	O
counts	O
,	O
serum	B
C	I
-	I
reactive	I
protein	I
(	O
CRP	B
)	O
levels	O
,	O
platelet	O
(	O
PLT	O
)	O
counts	O
--	O
and	O
the	O
clinical	O
manifestations	O
of	O
acute	O
HSP	O
.	O

In	O
contrast	O
to	O
other	O
known	O
retroviruses	O
,	O
the	O
FV	B
pol	I
genes	I
are	O
expressed	O
via	O
spliced	O
transcripts	O
.	O

The	O
5	O
'	O
flanking	O
region	O
of	O
the	O
CD1	B
gene	I
contained	O
the	O
binding	O
motifs	O
for	O
two	O
cytokine	O
-	O
inducible	O
transcription	O
factors	O
,	O
NF	B
-	I
IL2-A	I
and	O
NF	B
-	I
IL6	I
.	O

Fregnac	O
,	O
M.	O

GLRaV-2	O
is	O
the	O
only	O
closterovirus	O
,	O
so	O
far	O
,	O
that	O
matches	O
the	O
genome	O
organization	O
of	O
the	O
type	O
member	O
of	O
the	O
group	O
,	O
BYV	O
,	O
and	O
thus	O
can	O
be	O
unambiguously	O
classified	O
as	O
a	O
definitive	O
member	O
of	O
the	O
genus	O
Closterovirus	O
.	O

Demographic	O
and	O
clinical	O
data	O
were	O
compared	O
with	O
a	O
control	O
group	O
of	O
339	O
healthy	O
age	O
-	O
matched	O
women	O
and	O
with	O
a	O
sample	O
of	O
224	O
women	O
with	O
wrist	O
fracture	O
.	O

Identical	O
results	O
were	O
obtained	O
when	O
transfections	O
and	O
mobility	O
shift	O
assays	O
were	O
performed	O
in	O
primary	O
rat	O
hepatocytes	O
in	O
which	O
the	O
endogenous	O
ALS	B
gene	I
is	O
expressed	O
.	O

This	O
E	O
box	O
sequence	O
(	O
CACGTG	O
)	O
is	O
identical	O
to	O
the	O
binding	O
element	O
for	O
USF	B
(	O
upstream	B
stimulatory	I
factor	I
)	O
,	O
a	O
member	O
of	O
the	O
helix	B
-	I
loop	I
-	I
helix	I
family	I
of	I
transcription	I
factors	I
.	O

Interferon	B
beta	I
therapy	O
was	O
discontinued	O
for	O
4	O
weeks	O
.	O

Examination	O
of	O
the	O
mitochondrial	B
bc1	I
complex	I
crystal	I
structure	I
[	O
Zhang	O
,	O
Z.	O
,	O
Huang	O
,	O
L.	O
,	O
Shulmeister	O
,	O
V.	O

Two	O
protease	O
-	O
resistant	O
fragments	O
spanning	O
the	O
N-	O
and	O
C	O
-	O
terminal	O
halves	O
of	O
the	O
nuclease	O
were	O
identified	O
using	O
different	O
proteases	O
which	O
cleave	O
the	O
protein	O
in	O
the	O
same	O
region	O
.	O

The	O
side	O
-	O
to	O
-	O
side	O
difference	O
was	O
statistically	O
significant	O
at	O
EXT	O
30	O
degrees	O
/	O
s	O
and	O
60	O
degrees	O
/	O
s	O
(	O
p	O
<	O
0.05	O
)	O
.	O

The	O
ability	O
to	O
maintain	O
expression	O
of	O
FAS1	B
in	O
nmt1	B
-	O
451Dino2	B
Delta	O
cells	O
suggests	O
the	O
existence	O
of	O
another	O
transcription	O
factor	O
,	O
or	O
factors	O
,	O
whose	O
expression	O
/	O
activity	O
is	O
inversely	O
related	O
to	O
overall	O
levels	O
of	O
cellular	O
protein	O
N	O
-	O
myristoy	O
-	O
lation	O
.	O

Rev	B
-	O
erbAalpha	B
/	I
beta	I
)	O
,	O
Mxi-1	B
and	O
Mad	B
bHLH	O
-	O
zip	O
proteins	O
and	O
the	O
oncoproteins	O
PLZF	B
and	O
LAZ3	B
/	O
BCL6	B
is	O
mediated	O
by	O
the	O
corepressors	O
N	B
-	I
CoR	I
and	O
SMRT	B
.	O

There	O
was	O
no	O
evidence	O
of	O
any	O
persistent	O
oscillation	O
within	O
the	O
ULF	O
band	O
.	O

The	O
purified	O
recombinant	O
protein	O
was	O
assayed	O
for	O
its	O
enzyme	O
activity	O
by	O
monitoring	O
transfer	O
of	O
[	O
3H	O
]	O
methyl	O
groups	O
from	O
the	O
substrate	O
DNA	O
to	O
the	O
MGMT	B
protein	I
;	O
the	O
activity	O
was	O
found	O
to	O
be	O
stable	O
at	O
90	O
degrees	O
C	O
for	O
at	O
least	O
30	O
min	O
.	O

Elimination	O
of	O
the	O
inducible	O
response	O
requires	O
simultaneous	O
mutation	O
of	O
both	O
sequences	O
,	O
however	O
,	O
in	O
the	O
presence	O
of	O
an	O
intact	O
EpRE	O
the	O
upstream	O
AP-1	B
site	I
is	O
irrelevant	O
to	O
induction	O
.	O

Three	O
high	B
mobility	I
group	I
-	I
like	I
sequences	I
within	O
a	O
48-base	O
pair	O
enhancer	O
of	O
the	O
Col2a1	B
gene	I
are	O
required	O
for	O
cartilage	O
-	O
specific	O
expression	O
in	O
vivo	O
.	O

The	O
sequence	O
contains	O
an	O
open	O
reading	O
frame	O
of	O
1744	O
nt	O
in	O
the	O
virus	O
-	O
sense	O
strand	O
,	O
a	O
3	O
'	O
untranslated	O
region	O
of	O
1360	O
nt	O
and	O
a	O
3	O
'	O
poly	O
(	O
A	O
)	O
tail	O
.	O

A	O
phylogenetic	O
analysis	O
of	O
the	O
reverse	B
transcriptase	I
domain	I
confirms	O
our	O
differential	O
genetic	O
assessment	O
that	O
Cyclops	B
from	O
pea	O
is	O
a	O
novel	O
element	O
with	O
no	O
specific	O
relationship	O
to	O
the	O
previously	O
described	O
Gypsy	B
-	I
like	I
elements	I
from	O
plants	O
.	O

At	O
physiological	O
doses	O
,	O
either	O
insulin	B
-	I
like	I
growth	I
factor	I
I	I
(	O
IGF	B
-	I
I	I
)	O
or	O
insulin	B
turned	O
out	O
to	O
be	O
as	O
potent	O
as	O
dibutyryl	O
cAMP	O
(	O
dbcAMP	O
)	O
in	O
increasing	O
UCP1	B
gene	I
transcription	O
rate	O
(	O
1	O
h	O
)	O
and	O
also	O
UCP1	B
mRNA	I
accumulation	O
(	O
3	O
h	O
)	O
,	O
their	O
maximal	O
effect	O
(	O
15-fold	O
increase	O
)	O
reached	O
upon	O
treatment	O
for	O
24	O
h.	O

In	O
addition	O
,	O
insulin	B
induced	O
AP-1	B
DNA	O
binding	O
activity	O
,	O
this	O
effect	O
being	O
totally	O
prevented	O
in	O
the	O
presence	O
of	O
MEK-1	B
inhibitor	O
.	O

Regulation	O
of	O
the	O
human	O
p21	B
/	O
WAF1	B
/	O
Cip1	B
promoter	O
in	O
hepatic	O
cells	O
by	O
functional	O
interactions	O
between	O
Sp1	B
and	O
Smad	B
family	I
members	I
.	O

RESULTS	O
:	O
We	O
isolated	O
a	O
C.	O
elegans	O
cDNA	O
that	O
encoded	O
a	O
protein	O
which	O
was	O
similar	O
to	O
,	O
but	O
not	O
exactly	O
homologous	O
with	O
mammalian	O
p120	B
Ras	B
-	O
GAP	B
.	O

The	O
weak	O
base	O
ketoconazole	O
showed	O
complete	O
dissolution	O
from	O
a	O
tablet	O
formulation	O
in	O
Simulated	O
Gastric	O
Fluid	O
without	O
pepsin	B
(	O
SGFsp	O
)	O
within	O
30	O
minutes	O
,	O
70	O
%	O
dissolution	O
in	O
2	O
hours	O
under	O
fed	O
state	O
simulated	O
upper	O
jejunal	O
conditions	O
but	O
only	O
6	O
%	O
dissolution	O
in	O
2	O
hours	O
under	O
fasted	O
state	O
conditions	O
.	O

In	O
mammals	O
,	O
the	O
Rb	B
protein	I
interacts	O
specifically	O
with	O
D	B
-	I
type	I
cyclins	I
and	O
regulates	O
cell	O
proliferation	O
by	O
binding	O
and	O
inhibiting	O
E2F	B
transcription	I
factors	I
.	O

In	O
addition	O
to	O
the	O
signals	O
obtained	O
by	O
ligation	O
of	O
the	O
TCR	B
,	O
T	O
cells	O
need	O
additional	O
,	O
co	O
-	O
stimulatory	O
signals	O
to	O
be	O
activated	O
.	O

We	O
characterized	O
the	O
structure	O
of	O
this	O
leader	O
mRNA	O
by	O
using	O
the	O
program	O
Mfold	O
and	O
a	O
combination	O
of	O
nested	O
and	O
internal	O
deletions	O
transcriptionally	O
fused	O
to	O
a	O
promoterless	O
lac	B
operon	I
.	O

The	O
importance	O
of	O
these	O
sites	O
for	O
transcriptional	O
activation	O
was	O
studied	O
by	O
site	O
-	O
directed	O
mutagenesis	O
followed	O
by	O
promoter	O
function	O
analysis	O
of	O
the	O
mutants	O
with	O
a	O
chloramphenicol	B
acetyltransferase	I
reporter	I
system	O
.	O

Routine	O
blood	O
examination	O
showed	O
leukocytosis	O
,	O
thrombocytopenia	O
,	O
positive	O
CRP	B
,	O
and	O
elevated	O
myocardial	O
enzymes	O
.	O

Previous	O
studies	O
have	O
suggested	O
that	O
moderate	O
cooling	O
increases	O
the	O
responsiveness	O
of	O
vascular	B
alpha2-adrenoceptors	I
.	O

The	O
use	O
of	O
antibodies	O
to	O
the	O
polypyrimidine	B
tract	I
binding	I
protein	I
(	O
PTB	B
)	O
to	O
analyze	O
the	O
protein	O
components	O
that	O
assemble	O
on	O
alternatively	O
spliced	O
pre	O
-	O
mRNAs	O
that	O
use	O
distant	O
branch	O
points	O
.	O

We	O
have	O
applied	O
the	O
mRNA	O
differential	O
display	O
method	O
to	O
compare	O
and	O
analyze	O
mRNAs	O
prepared	O
from	O
five	O
normal	O
nasopharyngeal	O
epithelial	O
cell	O
cultures	O
and	O
five	O
nasopharyngeal	O
carcinoma	O
cell	O
lines	O
.	O

SETTING	O
:	O
University	O
hospital	O
-	O
based	O
,	O
tertiary	O
care	O
infertility	O
center	O
.	O

RESULT	O
(	O
S	O
)	O
:	O
In	O
patients	O
with	O
elevated	O
FSH	B
levels	O
on	O
cycle	O
day	O
3	O
,	O
a	O
low	O
oocyte	O
yield	O
was	O
achieved	O
(	O
7	O
versus	O
11	O
)	O
and	O
a	O
high	O
number	O
of	O
ampules	O
of	O
hMG	B
was	O
necessary	O
(	O
56	O
versus	O
33	O
)	O
.	O

RESULTS	O
:	O
Of	O
the	O
patients	O
with	O
IS	O
,	O
67	O
%	O
had	O
significantly	O
greater	O
values	O
of	O
directional	O
preponderance	O
on	O
the	O
OVAR	O
test	O
(	O
a	O
measure	O
of	O
otolith	O
system	O
imbalance	O
)	O
compared	O
with	O
control	O
subjects	O
.	O

As	O
predicted	O
by	O
the	O
Wing	O
and	O
Kristofferson	O
model	O
,	O
the	O
durations	O
of	O
successive	O
ISIs	O
tended	O
to	O
be	O
negatively	O
correlated	O
.	O

Thus	O
,	O
included	O
in	O
the	O
KG1a	O
EST	O
dataset	O
are	O
candidates	O
for	O
new	O
human	O
genes	O
that	O
may	O
play	O
roles	O
in	O
hematopoietic	O
differentiative	O
progression	O
and	O
lineage	O
commitment	O
.	O

We	O
found	O
the	O
following	O
:	O
Specific	O
mutations	O
affected	O
the	O
precise	O
carbohydrate	O
structure	O
and	O
folding	O
of	O
the	O
HA	B
trimer	I
.	O

The	O
results	O
show	O
that	O
ROS	O
production	O
by	O
viable	O
spermatozoa	O
is	O
highly	O
correlated	O
with	O
the	O
concentration	O
of	O
PMN	B
elastase	I
and	O
the	O
number	O
of	O
both	O
peroxidase	B
-	O
positive	O
and	O
round	O
cells	O
.	O

Yeast	B
U1	I
snRNP	I
is	O
considerably	O
more	O
complex	O
than	O
its	O
metazoan	O
counterpart	O
,	O
which	O
suggests	O
possible	O
differences	O
between	O
yeast	O
and	O
metazoa	O
in	O
early	O
splicing	O
events	O
.	O

The	O
opioid	O
antagonist	O
naltrexone	O
(	O
0.01	O
-	O
1.0	O
mg	O
/	O
kg	O
)	O
antagonized	O
the	O
discriminative	O
stimulus	O
effects	O
of	O
heroin	O
,	O
but	O
naltrexone	O
at	O
doses	O
up	O
to	O
10	O
mg	O
/	O
kg	O
had	O
no	O
effect	O
on	O
the	O
discriminative	O
stimulus	O
effects	O
of	O
cocaine	O
.	O

In	O
this	O
study	O
we	O
examined	O
hepatic	O
stellate	O
cell	O
regulation	O
of	O
M6P	B
/	O
IGFIIR	B
expression	O
and	O
found	O
that	O
M6P	B
/	O
IGFIIR	B
mRNA	O
transcript	O
levels	O
increased	O
in	O
stellate	O
cells	O
from	O
rats	O
exposed	O
to	O
carbon	O
tetrachloride	O
(	O
CCl4	O
)	O
,	O
a	O
potent	O
fibrogenic	O
stimulant	O
.	O

One	O
cDNA	O
clone	O
designated	O
NCoA-62	O
,	O
encoded	O
a	O
62	O
,	O
000-Da	O
protein	O
that	O
is	O
highly	O
related	O
to	O
BX42	B
,	O
a	O
Drosophila	O
melanogaster	O
nuclear	O
protein	O
involved	O
in	O
ecdysone	O
-	O
stimulated	O
gene	O
expression	O
.	O

These	O
widely	O
expressed	O
proteins	O
share	O
a	O
C	O
-	O
terminal	O
region	O
that	O
bears	O
significant	O
sequence	O
homology	O
to	O
a	O
group	O
of	O
GDP	B
/	I
GTP	I
exchange	I
proteins	I
for	O
the	O
Rab3	B
family	I
of	O
small	B
GTP	I
binding	I
proteins	I
.	O

Whereas	O
p82	B
expression	O
had	O
no	O
effect	O
on	O
ERK2	B
activation	O
by	O
p126	B
,	O
p70	B
completely	O
abrogated	O
this	O
activity	O
.	O

The	O
brackets	O
were	O
bonded	O
to	O
100	O
freshly	O
extracted	O
bovine	O
incisors	O
,	O
and	O
,	O
after	O
storage	O
in	O
tap	O
water	O
at	O
room	O
temperature	O
for	O
24	O
hours	O
,	O
they	O
were	O
subsequently	O
tested	O
in	O
a	O
shear	O
mode	O
using	O
a	O
universal	O
testing	O
machine	O
.	O

The	O
growth	O
of	O
Aer	O
.	O

hydrophila	O
in	O
filter	O
-	O
sterilized	O
lettuce	O
extract	O
was	O
completely	O
inhibited	O
by	O
0.1	O
%	O
(	O
v	O
/	O
v	O
)	O
BMC	O
whereas	O
that	O
of	O
Ps	O
.	O

fluorescens	O
was	O
not	O
significantly	O
affected	O
by	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
BMC	O
.	O

Despite	O
continuous	O
compliance	O
,	O
unexplained	O
resurgence	O
of	O
serum	O
ferritin	B
levels	O
occurred	O
in	O
4	O
/	O
7	O
patients	O
of	O
the	O
'	O
veteran	O
'	O
group	O
after	O
4	O
-	O
5	O
years	O
on	O
L1	O
.	O

Hematocrit	O
and	O
PaO2	O
did	O
not	O
change	O
.	O

Commutative	O
saccadic	O
generator	O
is	O
sufficient	O
to	O
control	O
a	O
3-D	O
ocular	O
plant	O
with	O
pulleys	O
.	O

The	O
virus	O
-	O
associated	O
VAI	B
RNA	O
of	O
adenovirus	O
is	O
a	O
small	O
highly	O
structured	O
RNA	O
that	O
is	O
required	O
for	O
the	O
efficient	O
translation	O
of	O
cellular	O
and	O
viral	O
mRNAs	O
at	O
late	O
times	O
after	O
infection	O
.	O

Structure	O
of	O
the	O
gene	O
encoding	O
the	O
human	O
cyclin	B
-	I
dependent	I
kinase	I
inhibitor	O
p18	B
and	O
mutational	O
analysis	O
in	O
breast	O
cancer	O
.	O

The	O
YccA	B
protein	I
was	O
found	O
to	O
be	O
degraded	O
in	O
an	O
FtsH	B
-	O
dependent	O
manner	O
in	O
vivo	O
and	O
in	O
vitro	O
,	O
whereas	O
the	O
YccA11	B
mutant	I
protein	I
,	O
lacking	O
eight	O
amino	O
acid	O
residues	O
within	O
the	O
amino	O
-	O
terminal	O
cytoplasmic	O
domain	O
,	O
was	O
refractory	O
to	O
the	O
degradation	O
.	O

The	O
major	O
type	O
involves	O
activator	O
proteins	O
that	O
bind	O
to	O
DNA	O
adjacent	O
to	O
where	O
the	O
RNA	B
polymerase	I
(	O
RNAP	B
)	O
holoenzyme	O
binds	O
,	O
usually	O
assisting	O
in	O
recruitment	O
of	O
the	O
RNAP	B
to	O
the	O
promoter	O
.	O

It	O
contains	O
a	O
5'-noncoding	O
region	O
(	O
NCR	O
)	O
of	O
73	O
nucleotides	O
,	O
five	O
open	O
reading	O
frames	O
(	O
ORFs	O
1	O
to	O
5	O
)	O
which	O
encode	O
proteins	O
with	O
M	O
(	O
r	O
)	O
160	B
kDa	I
RNA	I
-	I
dependent	I
RNA	I
polymerase	I
(	I
ORF1	I
)	I
,	O
26	B
kDa	I
movement	I
protein	I
1	I
(	I
ORF2	I
)	I
,	O
13	B
kDa	I
movement	I
protein	I
2	I
(	I
ORF3	I
)	I
,	O
10	B
kDa	I
movement	I
protein	I
3	I
(	I
ORF4	I
)	I
,	O
24	B
kDa	I
coat	I
protein	I
(	I
OFR5	I
)	I
,	O
and	O
a	O
3	O
'	O
NCR	O
of	O
76	O
nucleotides	O
.	O

After	O
profound	O
normovolemic	O
hemodilution	O
(	O
Hct	O
9	O
%	O
)	O
superiority	O
of	O
LV	O
MC	O
and	O
LV	O
diastolic	O
properties	O
was	O
found	O
,	O
when	O
myocardial	O
oxygenation	O
was	O
supported	O
by	O
i.v	O
.	O

perflubron	O
emulsion	O
,	O
a	O
temporary	O
O2	O
carrier	O
.	O

Sp1	B
and	O
two	O
Sp3	B
isoforms	I
were	O
detected	O
as	O
the	O
primary	O
cellular	O
constituents	O
of	O
DNA	O
-	O
protein	O
complexes	O
formed	O
with	O
the	O
NF	B
-	I
kappaB	I
-	I
proximal	I
site	I
.	O

These	O
genes	O
may	O
represent	O
interesting	O
targets	O
for	O
new	O
therapeutic	O
strategies	O
.	O

It	O
could	O
also	O
inhibit	O
C1q	B
-	O
dependent	O
haemolysis	O
of	O
both	O
IgG-	B
and	O
IgM	B
-	O
sensitized	O
erythrocytes	O
.	O

3	O
)	O
and	O
one	O
distal	O
(	O
-11.8	O
/	O
-10.9	O
)	O
,	O
presented	O
an	O
enhancer	O
activity	O
in	O
pituitary	O
cells	O
when	O
placed	O
upstream	O
of	O
the	O
SV40	B
promoter	I
.	O

3	O
-	O
-It	O
is	O
necessary	O
to	O
think	O
about	O
cosmetic	O
consequences	O
of	O
the	O
chinese	O
flap	O
and	O
consider	O
other	O
possibilities	O
of	O
the	O
flap	O
choice	O
.	O

However	O
,	O
it	O
is	O
only	O
one	O
-	O
half	O
and	O
one	O
-	O
third	O
the	O
size	O
of	O
the	O
proteolipids	O
from	O
M.	O
thermoautotrophicum	O
and	O
M.	O
jannaschii	O
,	O
respectively	O
.	O

ahaK	B
is	O
expressed	O
in	O
Escherichia	O
coli	O
,	O
and	O
it	O
is	O
incorporated	O
into	O
the	O
cytoplasmic	O
membrane	O
despite	O
the	O
different	O
chemical	O
natures	O
of	O
lipids	O
from	O
archaea	O
and	O
bacteria	O
.	O

The	O
cleavage	O
of	O
Fak	B
by	O
caspases	B
may	O
thus	O
play	O
an	O
important	O
role	O
in	O
the	O
execution	O
of	O
the	O
suicide	O
program	O
by	O
disabling	O
the	O
anti	O
-	O
apoptotic	O
function	O
of	O
Fak	B
.	O

Transcription	O
initiation	O
occurred	O
predominantly	O
at	O
the	O
putative	O
sigmaA	B
-	I
dependent	I
promoter	I
in	O
exponentially	O
growing	O
cells	O
and	O
was	O
induced	O
under	O
stress	O
conditions	O
.	O

The	O
genes	O
encoding	O
(	B
2Fe-2S	I
)	I
plant	I
-	I
like	I
ferredoxins	I
were	O
studied	O
in	O
the	O
widely	O
used	O
cyanobacterium	O
Synechocystis	O
PCC6803	O
.	O

A	O
major	O
pool	O
of	O
Dsg	B
-	O
plakoglobin	B
complexes	O
sedimented	O
at	O
8S	O
and	O
exhibited	O
a	O
1:1	O
stoichiometry	O
.	O

In	O
macrophages	O
,	O
LPS	O
-	O
inducible	O
HIV-1	O
gene	O
expression	O
is	O
mediated	O
in	O
part	O
by	O
binding	O
of	O
NF	B
-	I
kappa	I
B	I
to	O
identical	O
tandem	O
binding	O
sites	O
located	O
within	O
the	O
long	O
terminal	O
repeat	O
(	O
LTR	O
)	O
.	O

It	O
can	O
also	O
be	O
used	O
to	O
examine	O
various	O
laryngeal	O
parameters	O
obtained	O
from	O
videotaped	O
endoscopic	O
and	O
stroboscopic	O
examinations	O
.	O

CONCLUSIONS	O
:	O
Two	O
consecutive	O
sets	O
of	O
transrectal	O
ultrasound	O
guided	O
sextant	O
biopsies	O
of	O
the	O
prostate	O
performed	O
in	O
a	O
single	O
office	O
visit	O
represent	O
a	O
cost	O
-	O
effective	O
biopsy	O
strategy	O
for	O
men	O
presenting	O
with	O
an	O
abnormal	O
digital	O
rectal	O
examination	O
and/or	O
elevated	O
serum	B
PSA	I
.	O

Examination	O
of	O
nuclear	O
magnetic	O
resonance	O
(	O
NMR	O
)	O
spectra	O
of	O
a	O
series	O
of	O
N	B
-	I
terminally	I
truncated	I
MIP-1	I
beta	I
variants	I
reveals	O
that	O
these	O
proteins	O
possess	O
a	O
range	O
of	O
ability	O
to	O
dimerize	O
.	O

Interestingly	O
,	O
PKA	B
activity	O
is	O
dispensable	O
in	O
a	O
strain	O
lacking	O
Msn2p	B
and	O
Msn4p	B
activity	O
.	O

They	O
also	O
indicate	O
that	O
direct	O
interactions	O
between	O
C	B
/	I
EBPs	I
and	O
specific	O
Ets	B
family	O
members	O
,	O
together	O
with	O
GATA-1	B
,	O
are	O
important	O
for	O
eosinophil	O
lineage	O
determination	O
.	O

Recently	O
,	O
a	O
human	B
transcription	I
elongation	I
factor	I
P	I
-	I
TEFb	I
,	O
consisting	O
of	O
CDK9	B
kinase	I
,	O
cyclin	B
T	I
and	O
other	O
associated	O
factors	O
,	O
has	O
been	O
shown	O
to	O
interact	O
with	O
Tat	B
to	O
restore	O
Tat	B
activation	O
in	O
HeLa	O
nuclear	O
extract	O
depleted	O
of	O
P	B
-	I
TEFb	I
.	O

The	O
general	O
recombination	O
at	O
a	O
polarizing	O
voltage	O
of	O
300	O
V	O
is	O
less	O
than	O
2	O
%	O
for	O
dose	O
-	O
rates	O
up	O
to	O
about	O
100	O
mGy	O
min-1	O
.	O

The	O
low	O
number	O
of	O
false	O
positives	O
indicates	O
that	O
our	O
scheme	O
would	O
not	O
confuse	O
the	O
radiologist	O
by	O
suggesting	O
normal	O
regions	O
as	O
suspicious	O
.	O

Taken	O
together	O
,	O
these	O
data	O
indicate	O
that	O
the	O
VirD2	B
omega	I
domain	I
is	O
important	O
for	O
efficient	O
T	O
-	O
DNA	O
integration	O
.	O

The	O
DHEAS	O
levels	O
in	O
all	O
stages	O
of	O
decreased	O
BMD	O
were	O
significantly	O
lower	O
than	O
those	O
in	O
the	O
group	O
with	O
normal	O
BMD	O
.	O

Orientation	O
of	O
the	O
nuclear	O
spin	O
system	O
by	O
optical	O
pumping	O
causes	O
an	O
Overhauser	O
shift	O
of	O
the	O
excitonic	O
energy	O
levels	O
proportional	O
to	O
the	O
degree	O
of	O
nuclear	O
orientation	O
.	O

GTPase	B
activating	O
specificity	O
of	O
RGS12	B
and	O
binding	O
specificity	O
of	O
an	O
alternatively	O
spliced	O
PDZ	B
(	O
PSD-95	B
/	O
Dlg	B
/	O
ZO-1	B
)	O
domain	O
.	O

However	O
,	O
mutations	O
in	O
the	O
HNF-4	B
binding	I
site	I
on	O
element	B
CIIB	I
and	O
inhibition	O
of	O
HNF-4	B
synthesis	O
in	O
HepG2	O
cells	O
by	O
antisense	O
HNF-4	B
constructs	I
decreased	O
the	O
apoCII	B
promoter	I
activity	O
to	O
25	O
-	O
40	O
%	O
of	O
the	O
control	O
,	O
indicating	O
that	O
HNF-4	B
is	O
a	O
positive	O
regulator	O
of	O
the	O
apoCII	B
gene	I
.	O

In	O
addition	O
,	O
we	O
find	O
that	O
E2F-1	B
can	O
cause	O
apoptosis	O
in	O
p53-	B
/	I
-	I
tumour	O
cells	O
and	O
further	O
p300	B
,	O
which	O
also	O
functions	O
as	O
a	O
co	O
-	O
activator	O
for	O
the	O
E2F	B
/	O
DP	B
heterodimer	O
,	O
enhances	O
the	O
apoptotic	O
activity	O
of	O
E2F-1	B
.	O

Blocked	O
shift	O
/	O
supershift	O
analysis	O
indicates	O
that	O
Fos	B
family	I
member	O
proteins	O
especially	O
Fra-1	B
and	O
Fra-2	B
are	O
related	O
to	O
progression	O
and	O
no	O
changes	O
found	O
in	O
the	O
Jun	B
family	I
member	O
proteins	O
although	O
they	O
are	O
present	O
in	O
the	O
AP-1	B
/	I
DNA	I
binding	I
complex	I
.	O

Comparison	O
of	O
cDNA	O
and	O
genomic	O
sequences	O
shows	O
that	O
the	O
ZNF189	B
gene	I
spans	O
approximately	O
11	O
kb	O
and	O
is	O
organized	O
into	O
at	O
least	O
four	O
exons	O
,	O
the	O
large	O
3'-end	O
exon	O
coding	O
for	O
the	O
complete	O
zinc	O
finger	O
domain	O
and	O
the	O
3	O
'	O
untranslated	O
region	O
.	O

Five	O
additional	O
copies	O
of	O
Lian	B
elements	I
were	O
isolated	O
,	O
mapped	O
by	O
restriction	O
digestion	O
,	O
and	O
partially	O
sequenced	O
.	O

Role	O
of	O
the	O
transcription	O
start	O
site	O
core	O
region	O
and	O
transcription	B
factor	I
YY1	I
in	O
Rous	B
sarcoma	I
virus	I
long	I
terminal	I
repeat	I
promoter	I
activity	O
.	O

Fowlpox	O
virus	O
encodes	O
nonessential	O
homologs	O
of	O
cellular	B
alpha	I
-	I
SNAP	I
,	O
PC-1	B
,	O
and	O
an	O
orphan	O
human	O
homolog	O
of	O
a	O
secreted	O
nematode	O
protein	O
.	O

Addition	O
of	O
Rap	O
or	O
KN62	O
after	O
exposure	O
of	O
cells	O
to	O
progesterone	O
agonist	O
Org	O
2058	O
had	O
no	O
effect	O
on	O
induction	O
of	O
CAT	B
activity	O
.	O

The	O
Dax-1	B
gene	I
encodes	O
a	O
protein	O
that	O
is	O
structurally	O
related	O
to	O
members	O
of	O
the	O
orphan	B
nuclear	I
receptor	I
superfamily	I
.	O

Further	O
,	O
Ser	O
/	O
Thr	O
phosphorylation	O
of	O
downstream	O
molecules	O
Akt	B
and	O
p70	B
S6	I
kinase	I
was	O
inhibited	O
.	O

Quantitative	O
evaluation	O
of	O
the	O
steady	O
state	O
kinetics	O
of	O
MEK	B
inhibition	O
by	O
these	O
compounds	O
reveals	O
that	O
U0126	O
has	O
approximately	O
100-fold	O
higher	O
affinity	O
for	O
deltaN3-S218E	B
/	I
S222D	I
MEK	I
than	O
does	O
PD098059	O
.	O

Regulation	O
at	O
37	O
degrees	O
C	O
,	O
therefore	O
,	O
involves	O
the	O
action	O
of	O
three	O
protein	O
kinase	O
cascades	O
that	O
repress	O
HSF1	B
through	O
phosphorylation	O
of	O
serine	O
residues	O
303	O
,	O
307	O
,	O
and	O
363	O
and	O
may	O
promote	O
growth	O
by	O
suppressing	O
the	O
heat	O
shock	O
response	O
.	O

Clinical	O
implication	O
of	O
protein	O
levels	O
of	O
IL-5	B
in	O
induced	O
sputum	O
in	O
asthmatic	O
patients	O
.	O

In	O
these	O
cells	O
,	O
ras	B
-	O
induced	O
transition	O
is	O
accompanied	O
by	O
a	O
strong	O
induction	O
of	O
AP-1-binding	B
activity	O
along	O
with	O
increased	O
expression	O
of	O
CD44	B
mRNA	I
and	O
protein	O
.	O

However	O
,	O
little	O
is	O
known	O
regarding	O
the	O
genomic	O
organization	O
and	O
developmental	O
expression	O
of	O
the	O
caveolin	B
gene	I
family	I
.	O

Suppressive	O
therapy	O
for	O
thyroid	O
nodules	O
.	O

Structural	O
analysis	O
of	O
the	O
5'-regulatory	O
region	O
reveals	O
that	O
the	O
c	B
-	I
met	I
promoter	I
lacks	O
TATA	O
or	O
CAAT	O
elements	O
but	O
has	O
an	O
extremely	O
high	O
G	O
-	O
C	O
content	O
and	O
multiple	O
Sp1	B
binding	I
sites	I
.	O

Each	O
binding	O
site	O
,	O
however	O
,	O
was	O
different	O
in	O
its	O
preference	O
for	O
binding	O
partners	O
.	O

We	O
isolated	O
the	O
human	B
FGF	I
-	I
BP	I
promoter	I
and	O
determined	O
by	O
deletion	O
analysis	O
that	O
TPA	O
regulatory	O
elements	O
were	O
all	O
contained	O
in	O
the	O
first	O
118	O
base	O
pairs	O
upstream	O
of	O
the	O
transcription	O
start	O
site	O
.	O

Manipulation	O
of	O
the	O
checkpoint	O
regulators	O
involved	O
in	O
cell	O
cycle	O
arrest	O
and	O
apoptosis	O
may	O
thus	O
provide	O
a	O
novel	O
strategy	O
to	O
cancer	O
therapy	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
demonstrated	O
specific	O
nuclear	O
protein	O
binding	O
to	O
-85	O
/	O
-64	O
,	O
and	O
single	O
point	O
mutations	O
suggested	O
important	O
binding	O
nucleotides	O
between	O
-79	O
/	O
-68	O
with	O
five	O
critical	O
bases	O
between	O
-74	O
/	O
-70	O
(	O
5'-CTCCT-3	O
'	O
)	O
.	O

The	O
diagnostic	O
accuracy	O
of	O
serum	O
PE-1	B
was	O
0.80	O
,	O
and	O
that	O
of	O
amylase	B
0.97	O
.	O

We	O
demonstrate	O
that	O
Ddc1p	B
interacts	O
physically	O
in	O
vivo	O
with	O
Mec3p	B
,	O
and	O
this	O
interaction	O
requires	O
Rad17p	B
.	O

""""	O
Complex	O
partial	O
""""	O
seizures	O
.	O

B	B
cell	I
antigen	I
receptor	I
(	O
BCR	B
)	O
-mediated	O
formation	O
of	O
a	O
SHP-2-pp120	B
complex	O
and	O
its	O
inhibition	O
by	O
Fc	B
gamma	I
RIIB1-BCR	I
coligation	O
.	O

Deleting	O
SNF1	B
repressed	O
meiosis	O
at	O
the	O
same	O
three	O
steps	O
that	O
were	O
inhibited	O
by	O
glucose	O
,	O
suggesting	O
that	O
glucose	O
blocks	O
meiosis	O
by	O
inhibiting	O
Snf1	B
.	O

Here	O
we	O
investigate	O
the	O
role	O
of	O
c	B
-	I
Cbl	I
in	O
development	O
and	O
homeostasis	O
in	O
mice	O
by	O
targeted	O
disruption	O
of	O
the	O
c	B
-	I
Cbl	I
locus	I
.	O

c	B
-	I
Cbl	I
-	O
deficient	O
mice	O
were	O
viable	O
,	O
fertile	O
,	O
and	O
outwardly	O
normal	O
in	O
appearance	O
.	O

One	O
is	O
to	O
act	O
within	O
the	O
visceral	O
endoderm	O
to	O
promote	O
proper	O
streak	O
morphogenesis	O
.	O

We	O
propose	O
that	O
noi	B
/	O
pax2.1	B
participates	O
in	O
sequential	O
signaling	O
processes	O
as	O
a	O
key	O
integrator	O
of	O
midbrain	O
-	O
hindbrain	O
boundary	O
development	O
.	O

Ligand	O
-	O
independent	O
activation	O
of	O
platelet	B
-	I
derived	I
growth	I
factor	I
receptor	I
is	O
a	O
necessary	O
intermediate	O
in	O
lysophosphatidic	O
,	O
acid	O
-	O
stimulated	O
mitogenic	O
activity	O
in	O
L	O
cells	O
.	O

In	O
canrenoate	O
-	O
treated	O
rats	O
,	O
ANP	B
infusion	O
caused	O
greater	O
increases	O
in	O
sodium	O
excretion	O
(	O
FENA	O
from	O
3.05	O
+	O
/-	O

0.71	O
to	O
7.21	O
+	O
/-	O

0.45	O
%	O
;	O
P	O
<	O
0.05	O
;	O
n	O
=	O
8)	O
than	O
saline	O
infusion	O
(	O
FENA	O
from	O
4.16	O
+	O
/-	O

1.11	O
to	O
5.47	O
+	O
/-	O

0.66	O
%	O
;	O
n	O
=	O
6	O
)	O
,	O
despite	O
the	O
hypocapnia	O
.	O

Removal	O
of	O
the	O
carboxyl	O
region	O
severely	O
reduced	O
transcriptional	O
activation	O
.	O

A	O
""""	O
Level	O
A	O
""""	O
in	O
vitro	O
/	O
in	O
vivo	O
correlation	O
was	O
established	O
for	O
a	O
sustained	O
release	O
theophylline	O
(	O
CAS	O
58	O
-	O
55	O
-	O
9	O
)	O
preparation	O
(	O
Bronchoretard	O
)	O
under	O
investigation	O
.	O

METHOD	O
:	O
50	O
consecutive	O
children	O
aged	O
from	O
6	O
months	O
to	O
17	O
years	O
were	O
included	O
into	O
the	O
study	O
which	O
comprised	O
questionnaires	O
of	O
patient	O
and	O
family	O
histories	O
,	O
serological	O
screening	O
tests	O
for	O
common	O
inhalational	O
allergens	O
(	O
CAP	O
SX1	O
)	O
,	O
and	O
determination	O
of	O
total	O
serum	B
immunoglobulin	I
E	I
(	O
IgE	B
)	O
and	O
of	O
latex	O
-	O
specific	O
serum	B
IgE	I
by	O
solid	O
-	O
phase	O
immunoassays	O
.	O

The	O
PDE4A	B
-	I
subfamily	I
-	I
specific	I
linker	I
region	I
LR1	O
,	O
which	O
joins	O
UCR1	O
and	O
UCR2	O
,	O
is	O
encoded	O
by	O
two	O
exons	O
,	O
whereas	O
LR2	O
,	O
which	O
joins	O
UCR2	O
to	O
the	O
catalytic	O
unit	O
,	O
is	O
encoded	O
by	O
a	O
single	O
exon	O
.	O

Pol32Delta	B
strains	O
are	O
weak	O
antimutators	O
and	O
are	O
defective	O
for	O
damage	O
-	O
induced	O
mutagenesis	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
results	O
indicate	O
that	O
p53	B
plays	O
a	O
defensive	O
role	O
against	O
HBV	O
by	O
transcriptionally	O
repressing	O
the	O
HBV	B
core	I
promoter	I
through	O
liver	B
-	I
specific	I
enhancer	I
II	I
and	O
HBx	B
is	O
required	O
to	O
counteract	O
this	O
inhibitory	O
function	O
of	O
p53	B
.	O

To	O
gain	O
insight	O
into	O
the	O
expression	O
of	O
the	O
AtCP1	B
gene	I
,	O
northern	O
blot	O
analysis	O
was	O
carried	O
out	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
correlate	O
the	O
responsiveness	O
to	O
bronchoprovocation	O
with	O
methacholine	O
in	O
subjects	O
a	O
with	O
allergic	O
rhinitis	O
during	O
and	O
out	O
of	O
the	O
pollen	O
season	O
with	O
total	O
serum	O
IgE	B
and	O
blood	O
eosinophils	O
.	O

These	O
results	O
provide	O
the	O
first	O
demonstration	O
that	O
an	O
SR	B
protein	I
can	O
influence	O
splicing	O
of	O
specific	O
pre	O
-	O
mRNAs	O
in	O
vivo	O
.	O

In	O
particular	O
,	O
the	O
potential	O
for	O
prostate	O
cancer	O
chemoprevention	O
using	O
nonsteroidal	O
anti	O
-	O
inflammatory	O
drugs	O
(	O
cyclo	B
-	I
oxygenase	I
inhibitors	O
;	O
NSAIDs	O
)	O
has	O
received	O
little	O
attention	O
.	O

The	O
role	O
of	O
calcitonin	B
,	O
and	O
other	O
agonists	O
which	O
activate	O
the	O
cAMP	O
pathway	O
,	O
in	O
regulating	O
transcription	O
of	O
the	O
human	B
parathyroid	I
hormone	I
-	I
related	I
protein	I
(	O
PTHrP	B
)	O
gene	O
was	O
investigated	O
in	O
a	O
human	O
lung	O
cancer	O
cell	O
line	O
(	O
BEN	O
)	O
.	O

To	O
further	O
understand	O
the	O
role	O
of	O
cis	O
-	O
acting	O
elements	O
in	O
these	O
regulatory	O
mechanisms	O
,	O
we	O
have	O
characterized	O
a	O
transcriptional	O
promoter	O
that	O
drives	O
germline	O
expression	O
of	O
TCR	B
beta	I
gene	I
segments	I
in	O
vivo	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
crucial	O
role	O
of	O
the	O
mutations	O
activating	O
v	B
-	I
erbA	I
as	O
an	O
oncogene	O
is	O
to	O
'	O
freeze	O
'	O
c	B
-	I
ErbA	I
/	O
TRalpha	B
in	O
its	O
non	O
-	O
liganded	O
,	O
repressive	O
conformation	O
and	O
to	O
facilitate	O
its	O
overexpression	O
.	O

In	O
this	O
study	O
,	O
we	O
describe	O
a	O
mammalian	O
cell	O
-	O
free	O
transcription	O
system	O
reconstituted	O
with	O
only	O
recombinant	O
proteins	O
and	O
epitope	O
-	O
tagged	O
multiprotein	O
complexes	O
.	O

This	O
repressor	O
is	O
however	O
unlikely	O
to	O
mediate	O
spi	B
2.3	I
3	I
'	I
UTR	I
silencer	I
action	O
since	O
it	O
was	O
not	O
detected	O
in	O
rat	O
hepatocytes	O
.	O

A	O
prerequisite	O
for	O
the	O
synthesis	O
of	O
sialylated	O
glycoconjugates	O
is	O
the	O
activated	O
sugar	O
-	O
nucleotide	O
cytidine	O
5'-monophosphate	O
N	O
-	O
acetylneuraminic	O
acid	O
(	O
CMP	O
-	O
Neu5Ac	O
)	O
,	O
which	O
provides	O
a	O
substrate	O
for	O
Golgi	B
sialyltransferases	I
.	O

We	O
propose	O
a	O
model	O
in	O
which	O
Sro7	B
function	O
is	O
involved	O
in	O
the	O
targeting	O
of	O
the	O
myosin	B
proteins	I
to	O
their	O
intrinsic	O
pathways	O
.	O

We	O
found	O
sequences	O
related	O
to	O
this	O
insertion	O
in	O
wild	O
-	O
type	O
strains	O
of	O
N.	O
crassa	O
and	O
other	O
Neurospora	O
species	O
.	O

Human	B
ULK1	I
,	O
a	O
novel	O
serine	B
/	I
threonine	I
kinase	I
related	O
to	O
UNC-51	B
kinase	I
of	O
Caenorhabditis	O
elegans	O
:	O
cDNA	O
cloning	O
,	O
expression	O
,	O
and	O
chromosomal	O
assignment	O
.	O

Cochlear	O
microphonic	O
potentials	O
in	O
patients	O
with	O
vestibular	O
schwannomas	O
.	O

CONCLUSIONS	O
:	O
Significant	O
elevations	O
of	O
IL-1alpha	B
and	O
IL-1beta	B
occur	O
in	O
patients	O
with	O
bacterial	O
cystitis	O
and	O
microscopic	O
hematuria	O
.	O

Band	O
-	O
shift	O
assays	O
were	O
performed	O
using	O
the	O
LPS	B
-	I
and	I
IL-1-responsive	I
element	I
(	O
LILRE	B
)	O
oligonucleotide	O
,	O
a	O
gamma	B
interferon	I
activation	I
site	I
-	I
like	I
site	I
that	O
is	O
present	O
in	O
the	O
human	B
IL-1beta	I
promoter	I
.	O

The	O
C	O
-	O
terminal	O
region	O
contains	O
the	O
PTP	B
-	I
like	I
domain	I
,	O
whereas	O
the	O
N	O
-	O
terminal	O
region	O
shows	O
no	O
homology	O
to	O
any	O
known	O
mammalian	O
protein	O
.	O

A	O
safe	O
and	O
simple	O
system	O
for	O
the	O
detection	O
of	O
sudden	O
infant	O
death	O
syndrome	O
(	O
SIDS	O
)	O
is	O
proposed	O
.	O

The	O
mutant	O
protein	O
is	O
present	O
at	O
levels	O
slightly	O
greater	O
than	O
wild	O
-	O
type	O
,	O
but	O
exhibits	O
the	O
same	O
tissue	O
distribution	O
as	O
wild	O
-	O
type	O
protein	O
,	O
and	O
has	O
approximately	O
normal	O
affinity	O
for	O
known	O
target	O
sequences	O
(	O
though	O
no	O
DNA	O
targets	O
identified	O
to	O
date	O
require	O
the	O
first	O
cut	O
repeat	O
for	O
binding	O
)	O
.	O

METHODS	O
:	O
We	O
retrospectively	O
reviewed	O
242	O
adult	O
cadaveric	O
renal	O
transplant	O
recipients	O
treated	O
between	O
11	O
/	O
91	O
and	O
5	O
/	O
97	O
.	O

The	O
spectrum	O
of	O
age	O
-	O
associated	O
brain	O
abnormalities	O
:	O
their	O
measurement	O
and	O
histopathological	O
correlates	O
.	O

Our	O
laboratory	O
has	O
recently	O
identified	O
two	O
phosducin	B
-	I
like	I
orphan	I
proteins	I
(	O
PhLOP1	B
and	O
PhLOP2	B
)	O
that	O
lack	O
the	O
ability	O
to	O
interact	O
with	O
Gbetagamma	B
.	O

Reverse	B
transcriptase	I
-	O
polymerase	O
chain	O
reaction	O
(	O
RT	B
-	O
PCR	O
)	O
was	O
performed	O
using	O
eyestalk	O
complementary	O
DNA	O
of	O
the	O
sand	O
shrimp	O
Metapenaeus	O
ensis	O
.	O

In	O
contrast	O
,	O
transcription	O
initiating	O
from	O
opuE	B
P-1	I
(	O
sigma	B
A	I
)	O
rose	O
in	O
proportion	O
to	O
the	O
external	O
osmolarity	O
and	O
was	O
maintained	O
at	O
high	O
levels	O
.	O

In	O
insects	O
,	O
arylalkylamine	B
N	I
-	I
acetyltransferases	I
(	O
AANATs	B
)	O
have	O
been	O
implicated	O
in	O
several	O
physiological	O
processes	O
,	O
including	O
sclerotization	O
,	O
inactivation	O
of	O
certain	O
neurotransmitters	O
,	O
and	O
,	O
similar	O
to	O
the	O
function	O
in	O
vertebrates	O
,	O
catalysis	O
of	O
the	O
rate	O
-	O
limiting	O
step	O
in	O
melatonin	O
biosynthesis	O
.	O

These	O
results	O
establish	O
that	O
hydroquinones	O
lead	O
to	O
mutagenicity	O
and	O
carcinogenicity	O
.	O

IA	O
-	O
CT	O
with	O
cisplatin	O
50	O
mg	O
and	O
doxorubicin	O
30	O
mg	O
was	O
administered	O
by	O
one	O
shot	O
method	O
in	O
bilateral	O
internal	O
iliac	O
arteries	O
.	O

The	O
genomic	O
structure	O
and	O
chromosomal	O
location	O
of	O
the	O
human	B
TR2	I
orphan	I
receptor	I
,	O
a	O
member	O
of	O
the	O
steroid	B
receptor	I
superfamily	I
.	O

The	O
IE13.1	O
cell	O
line	O
was	O
able	O
to	O
complement	O
a	O
recombinant	O
virus	O
in	O
which	O
both	O
copies	O
of	O
the	O
IE	B
gene	I
were	O
replaced	O
by	O
insertion	O
of	O
the	O
Escherichia	B
coli	I
lacZ	I
gene	I
.	O

DNase	B
I	I
footprinting	O
and	O
electrophoretic	O
mobility	O
shift	O
analyses	O
revealed	O
two	O
hepatocyte	B
nuclear	I
factor-1	I
(	O
HNF1	B
)	O
,	O
three	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
(	O
C	B
/	I
EBP	I
)	O
,	O
and	O
one	O
consensus	O
palindromic	O
thyroid	O
hormone	O
response	O
elements	O
within	O
the	O
first	O
215	O
base	O
pairs	O
(	O
bp	O
)	O
of	O
the	O
promoter	O
sequence	O
of	O
rat	B
Std	I
.	O

Thus	O
,	O
these	O
studies	O
on	O
rat	B
Std	I
promoter	I
function	O
indicate	O
that	O
(	O
i	O
)	O
HNF1	B
and	O
C	B
/	I
EBP	I
are	O
responsible	O
for	O
liver	O
specificity	O
of	O
the	O
rat	B
Std	I
gene	I
;	O
(	O
ii	O
)	O
androgenic	O
repression	O
of	O
the	O
gene	O
requires	O
the	O
presence	O
of	O
all	O
of	O
the	O
OCT-1	B
and	O
C	B
/	I
EBP	I
elements	I
between	O
positions	O
-231	O
and	O
-292	O
;	O
and	O
(	O
iii	O
)	O
AR	B
may	O
exert	O
its	O
negative	O
regulatory	O
effect	O
indirectly	O
through	O
transcriptional	O
interference	O
of	O
OCT-1	B
and	O
C	B
/	I
EBP	I
rather	O
than	O
through	O
a	O
direct	O
DNA	B
-	I
AR	I
interaction	O
.	O

The	O
yeast	B
MMS2	I
gene	I
was	O
cloned	O
by	O
its	O
ability	O
to	O
complement	O
the	O
methyl	O
methanesulfonate	O
sensitivity	O
of	O
the	O
mms2	B
-	I
1	I
mutant	I
and	O
was	O
later	O
shown	O
to	O
be	O
involved	O
in	O
DNA	O
post	O
-	O
replication	O
repair	O
.	O

Expression	O
of	O
the	O
human	B
papillomavirus	I
type	I
11	I
E5A	I
protein	I
from	O
the	O
E1E4,E5	B
transcript	I
.	O

Toxicity	O
during	O
the	O
therapeutic	O
period	O
was	O
not	O
significant	O
in	O
the	O
study	O
group	O
compared	O
with	O
the	O
historical	O
control	O
,	O
treated	O
with	O
the	O
same	O
regimen	O
without	O
G	B
-	I
CSF	I
.	O

The	O
purpose	O
of	O
this	O
article	O
is	O
to	O
discuss	O
the	O
factors	O
involved	O
in	O
the	O
selection	O
of	O
antibodies	O
,	O
radionuclides	O
and	O
labeling	O
methods	O
in	O
the	O
development	O
of	O
radioimmunotherapy	O
(	O
RIT	O
)	O
for	O
non	O
-	O
Hodgkin	O
's	O
lymphoma	O
(	O
NHL	O
)	O
from	O
a	O
single	O
clinical	O
study	O
site	O
through	O
multicenter	O
trials	O
and	O
commercialization	O
.	O

The	O
effect	O
of	O
Rho	B
on	O
AP-1	B
is	O
independent	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
pathway	O
,	O
as	O
a	O
dominant	B
-	I
negative	I
MEK	I
and	O
a	O
MEK	B
inhibitor	O
(	O
PD98059	O
)	O
did	O
not	O
affect	O
Rho	B
-	O
induced	O
AP-1	B
activity	O
.	O

Mutations	O
within	O
the	O
C	O
terminus	O
of	O
c	B
-	I
fos	I
at	O
serine	O
residues	O
that	O
are	O
phosphorylation	O
targets	O
for	O
growth	O
factors	O
and	O
MAP	B
kinase	I
completely	O
abrogate	O
transactivation	O
and	O
block	O
potentiation	O
by	O
MAP	B
kinase	I
.	O

In	O
the	O
former	O
cells	O
,	O
ets-2	B
was	O
a	O
CSF-1	B
immediate	O
-	O
early	O
response	O
gene	O
,	O
and	O
phosphorylated	O
ets-2	B
was	O
detected	O
after	O
2	O
to	O
4	O
h	O
,	O
coincident	O
with	O
expression	O
of	O
ets-2	B
protein	I
.	O

Persistent	O
activation	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinases	I
p42	I
and	O
p44	B
and	O
ets-2	B
phosphorylation	O
in	O
response	O
to	O
colony	B
-	I
stimulating	I
factor	I
1	I
/	O
c	B
-	I
fms	I
signaling	O
.	O

Identification	O
of	O
a	O
proline	O
-	O
rich	O
sequence	O
in	O
the	O
CD2	B
cytoplasmic	I
domain	I
critical	O
for	O
regulation	O
of	O
integrin	B
-	O
mediated	O
adhesion	O
and	O
activation	O
of	O
phosphoinositide	B
3-kinase	I
.	O

Vam7p	B
,	O
a	O
SNAP-25-like	B
molecule	I
,	O
and	O
Vam3p	B
,	O
a	O
syntaxin	B
homolog	I
,	O
function	O
together	O
in	O
yeast	O
vacuolar	O
protein	O
trafficking	O
.	O

We	O
have	O
tested	O
this	O
possibility	O
by	O
constructing	O
a	O
consecutive	O
series	O
of	O
cysteine	O
substitutions	O
in	O
the	O
Neu	B
juxtamembrane	I
domain	I
in	O
order	O
to	O
force	O
dimerization	O
along	O
a	O
series	O
of	O
interreceptor	O
faces	O
.	O

It	O
has	O
been	O
demonstrated	O
previously	O
that	O
Pax-6	B
,	O
a	O
paired	B
domain	I
(	O
PD	B
)	O
/	O
homeodomain	B
(	O
HD	B
)	O
transcription	O
factor	O
critical	O
for	O
eye	O
development	O
,	O
contributes	O
to	O
the	O
activation	O
of	O
the	O
alphaB-	B
,	I
alphaA-	I
,	I
delta1-	I
,	I
and	I
zeta	I
-	I
crystallin	I
genes	O
in	O
the	O
lens	O
.	O

Tctex-1	B
binding	O
required	O
the	O
first	O
19	O
amino	O
acids	O
of	O
Fyn	B
and	O
integrity	O
of	O
two	O
lysine	O
residues	O
within	O
this	O
sequence	O
that	O
were	O
previously	O
shown	O
to	O
be	O
important	O
for	O
Fyn	B
interactions	O
with	O
the	O
immunoreceptor	O
tyrosine	O
-	O
based	O
activation	O
motifs	O
(	O
ITAMs	O
)	O
of	O
lymphocyte	B
Ag	I
receptors	I
.	O

The	O
prothrombin	B
gene	I
G20210A	I
mutation	I
is	O
not	O
found	O
among	O
Japanese	O
patients	O
with	O
deep	O
vein	O
thrombosis	O
and	O
healthy	O
individuals	O
.	O

Thus	O
,	O
TRAF2	B
initiates	O
SAPK	B
and	O
p38	B
activation	O
by	O
binding	O
two	O
proximal	O
protein	O
kinases	O
:	O
GCK	B
and	O
RIP	B
.	O

The	O
activity	O
of	O
the	O
minimal	O
promoter	O
was	O
found	O
to	O
be	O
controlled	O
by	O
a	O
combination	O
of	O
the	O
activities	O
of	O
the	O
transcription	O
factors	O
Sp1	B
,	O
Sp3	B
,	O
and	O
NF	B
-	I
Y.	I

In	O
the	O
studies	O
described	O
in	O
this	O
report	O
,	O
we	O
have	O
investigated	O
the	O
signaling	O
pathway	O
(	O
s	O
)	O
that	O
are	O
responsible	O
for	O
CREB	B
activation	O
in	O
normal	O
T	O
cells	O
.	O

Isolation	O
of	O
a	O
novel	O
TP53	B
target	I
gene	I
from	O
a	O
colon	O
cancer	O
cell	O
line	O
carrying	O
a	O
highly	O
regulated	O
wild	B
-	I
type	I
TP53	I
expression	O
system	O
.	O

Overexpression	O
of	O
MDR1	B
has	O
been	O
demonstrated	O
in	O
many	O
cancers	O
,	O
both	O
in	O
patient	O
tumors	O
and	O
in	O
cell	O
lines	O
selected	O
with	O
a	O
variety	O
of	O
chemotherapeutic	O
agents	O
.	O

Cytogenetic	O
and	O
molecular	O
characterization	O
of	O
random	O
chromosomal	O
rearrangements	O
activating	O
the	O
drug	O
resistance	O
gene	O
,	O
MDR1	B
/	O
P	B
-	I
glycoprotein	I
,	O
in	O
drug	O
-	O
selected	O
cell	O
lines	O
and	O
patients	O
with	O
drug	O
refractory	O
ALL	O
.	O

When	O
the	O
blood	O
pressure	O
increase	O
in	O
response	O
to	O
smoking	O
was	O
blunted	O
by	O
nitroprusside	O
infusion	O
,	O
there	O
was	O
a	O
striking	O
increase	O
in	O
muscle	O
SNA	O
.	O

After	O
that	O
report	O
,	O
carboxypeptidase	B
D	I
(	O
CPD	B
)	O
was	O
subsequently	O
purified	O
from	O
bovine	O
pituitary	O
and	O
characterized	O
as	O
a	O
novel	O
carboxypeptidase	B
E	I
(	O
CPE	B
)	O
-like	O
enzyme	O
,	O
with	O
many	O
characteristics	O
in	O
common	O
with	O
duck	O
gp180	B
(	O
Song	O
,	O
L.	O
,	O
Fricker	O
,	O
L.D.	O
,	O
1995	O
.	O

RA	O
-	O
treatment	O
of	O
these	O
transfectants	O
induced	O
morphologic	O
and	O
immunophenotypic	O
maturation	O
,	O
changes	O
in	O
RA	O
-	O
regulated	O
genes	O
,	O
and	O
a	O
G1	O
cell	O
cycle	O
arrest	O
in	O
a	O
manner	O
similar	O
to	O
parental	O
NT2	O
/	O
D1	O
cells	O
.	O

The	O
histopathology	O
and	O
neovascularization	O
did	O
not	O
appreciably	O
differ	O
between	O
xenograft	O
tumors	O
derived	O
from	O
FGF4	B
over	O
-	O
expressing	O
versus	O
control	O
transfectants	O
.	O

RXR	B
-	I
gamma	I
expression	O
produced	O
significant	O
reduction	O
in	O
levels	O
of	O
RA	O
-	O
responsive	O
genes	O
including	O
the	O
cyclin	B
-	I
dependent	I
kinase	I
inhibitors	O
p21Cip1	B
/	O
WAF1	B
and	O
p27Kip1	B
,	O
resulting	O
in	O
increased	O
cdc2	B
and	O
cdk2	B
kinase	I
activity	O
and	O
RB	B
phosphorylation	O
.	O

During	O
the	O
CR	O
/	O
PP	O
diet	O
only	O
the	O
HS	O
subjects	O
did	O
not	O
show	O
the	O
stress	O
-	O
induced	O
rise	O
in	O
depression	O
,	O
decline	O
in	O
vigour	O
and	O
cortisol	O
elevation	O
that	O
they	O
showed	O
after	O
the	O
PR	O
/	O
CP	O
diet	O
.	O

Generally	O
ILC	O
and	O
ILVF	O
values	O
decreased	O
with	O
increasing	O
exposure	O
time	O
with	O
rate	O
constants	O
ranging	O
from	O
0.03	O
to	O
0.33	O
day-1	O
(	O
wet	O
and	O
lipid	O
weight	O
)	O
for	O
ILC	O
and	O
0.03	O
to	O
0.31	O
day-1	O
for	O
ILVF	O
.	O

The	O
present	O
study	O
sought	O
to	O
develop	O
an	O
equation	O
to	O
estimate	O
VO2peak	O
in	O
peripheral	O
arterial	O
occlusive	O
disease	O
(	O
PAOD	O
)	O
patients	O
with	O
intermittent	O
claudication	O
and	O
to	O
determine	O
independent	O
predictors	O
of	O
VO2peak	O
in	O
this	O
population	O
.	O

Evidence	O
for	O
a	O
novel	O
MAPKKK	B
-	O
independent	O
pathway	O
controlling	O
the	O
stress	O
activated	O
Sty1	B
/	O
Spc1	B
MAP	O
kinase	O
in	O
fission	O
yeast	O
.	O

The	O
Abbreviated	O
Injury	O
Scale	O
(	O
AIS	O
)	O
,	O
Injury	O
Severity	O
Scale	O
and	O
TRISS	O
methodology	O
comprise	O
a	O
mathematically	O
sound	O
system	O
for	O
the	O
analysis	O
of	O
injuries	O
and	O
injured	O
patients	O
.	O

This	O
hypothesis	O
was	O
tested	O
by	O
introducing	O
mutations	O
at	O
each	O
of	O
the	O
three	O
histidine	O
pairs	O
,	O
the	O
H382-X2-H385	O
pair	O
,	O
the	O
H411-X2-H414	O
pair	O
and	O
the	O
H430-X5-H436	O
pair	O
,	O
which	O
constitute	O
the	O
histidine	O
-	O
rich	O
region	O
near	O
the	O
C	O
terminus	O
of	O
gp17	B
.	O

Using	O
backcross	O
analysis	O
,	O
both	O
exons	O
1	O
and	O
4	O
mapped	O
to	O
a	O
proximal	O
region	O
of	O
murine	O
Chromosome	O
4	O
indistinguishable	O
from	O
the	O
vacillans	B
gene	I
.	O

Seventy	O
-	O
five	O
percent	O
of	O
children	O
who	O
received	O
a	O
second	O
transplant	O
for	O
HCV	O
hepatitis	O
had	O
early	O
histologic	O
recurrence	O
that	O
led	O
to	O
liver	O
failure	O
and	O
death	O
.	O

Regulation	O
of	O
embryonic	O
growth	O
and	O
lysosomal	O
targeting	O
by	O
the	O
imprinted	O
Igf2	B
/	O
Mpr	B
gene	O
.	O

Furthermore	O
,	O
we	O
demonstrated	O
that	O
Galpha11	B
Q209L	I
stimulated	O
Src	B
family	I
kinase	O
activity	O
and	O
induced	O
tyrosine	O
phosphorylation	O
of	O
several	O
proteins	O
in	O
HEK-293	O
cells	O
.	O

The	O
micturition	O
pressure	O
was	O
significantly	O
decreased	O
only	O
after	O
injection	O
with	O
BUP-4	O
in	O
both	O
normal	O
and	O
obstructed	O
rats	O
.	O

Thus	O
,	O
in	O
the	O
presence	O
of	O
active	B
S	I
-	I
CDKs	I
and	O
Dbf4	B
/	O
Cdc7	B
,	O
Mcms	B
may	O
open	O
origins	O
and	O
thereby	O
facilitate	O
the	O
loading	O
of	O
RPA	B
.	O

Tyrosine	O
phosphorylated	O
STATs	B
dimerize	O
and	O
translocate	O
into	O
the	O
nucleus	O
to	O
activate	O
specific	O
genes	O
.	O

Nonsynonymous	O
substitution	O
in	O
abalone	O
sperm	O
fertilization	O
genes	O
exceeds	O
substitution	O
in	O
introns	O
and	O
mitochondrial	O
DNA	O
.	O

Gel	O
retardation	O
assays	O
detected	O
ZiaR	B
-	O
dependent	O
complexes	O
forming	O
with	O
the	O
zia	B
operator	I
-	I
promoter	I
and	O
ZiaR	B
-	O
DNA	O
binding	O
was	O
enhanced	O
by	O
treatment	O
with	O
a	O
metal	O
-	O
chelator	O
in	O
vitro	O
.	O

Alternatively	O
,	O
the	O
similarity	O
in	O
apparent	O
regulatory	O
action	O
of	O
the	O
genes	O
may	O
indicate	O
allelic	O
differences	O
wherein	O
the	O
IS1112C	B
Rf3	B
allele	I
may	O
differ	O
from	O
alleles	O
of	O
maintainer	O
lines	O
by	O
the	O
capability	O
to	O
regulate	O
both	O
orf107	B
and	O
urf209	B
processing	O
activities	O
.	O

Molecular	O
cloning	O
and	O
functional	O
characterization	O
of	O
murine	B
sphingosine	I
kinase	I
.	O

A	O
human	O
SPT3-TAFII31-GCN5-L	B
acetylase	B
complex	O
distinct	O
from	O
transcription	B
factor	I
IID	I
.	O

Mapping	O
of	O
the	O
DNA	O
binding	O
domain	O
of	O
the	O
copper	O
-	O
responsive	O
transcription	O
factor	O
Mac1	B
from	I
Saccharomyces	I
cerevisiae	I
.	O

A	O
further	O
mechanism	O
increasing	O
specific	O
activation	O
was	O
cooperation	O
of	O
receptors	O
at	O
multiple	O
and	O
weak	O
HREs	O
,	O
which	O
was	O
accentuated	O
in	O
the	O
presence	O
of	O
both	O
the	O
AR	B
N	O
terminus	O
and	O
ligand	O
binding	O
domain	O
.	O

The	O
CBF1	B
site	I
within	O
HS2	O
resides	O
near	O
sites	O
for	O
hematopoietic	O
regulators	O
such	O
as	O
GATA-1	B
,	O
NF	B
-	I
E2	I
,	O
and	O
TAL1	B
.	O

The	O
rat	B
branched	I
-	I
chain-2-oxo	I
-	I
acid	I
dehydrogenase	I
(	I
BCOD	I
)	I
kinase	I
mRNA	I
is	O
transcribed	O
from	O
a	O
TATA	O
-	O
less	O
promoter	O
that	O
has	O
GC	O
-	O
rich	O
sequences	O
and	O
two	O
putative	O
Sp1	B
binding	I
sites	I
near	O
the	O
transcription	O
start	O
site	O
.	O

Until	O
such	O
investigations	O
are	O
performed	O
,	O
we	O
conclude	O
that	O
the	O
role	O
for	O
adjuvant	O
treatment	O
is	O
questionable	O
and	O
that	O
TME	O
surgery	O
is	O
preferred	O
as	O
the	O
treatment	O
option	O
for	O
Stage	O
T1-T3	O
rectal	O
cancers	O
.	O

Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
the	O
cooperation	O
of	O
transcription	B
factors	I
NF	I
-	I
kappaB	I
and	O
AP-1	B
is	O
essential	O
for	O
transactivation	O
of	O
IL-8	B
gene	I
by	O
HTLV	B
-	I
I	I
Tax	I
.	O

This	O
study	O
examines	O
the	O
cooperative	O
effects	O
of	O
a	O
human	O
estrogen	B
receptor	I
-	I
alpha	I
(	O
ERalpha	B
)	O
isoform	O
on	O
estrogen	O
(	O
E2	O
)	O
-mediated	O
gene	O
activation	O
in	O
U2-OS	O
osteosarcoma	O
cells	O
.	O

Transfection	O
of	O
increasing	O
amounts	O
of	O
delta5ERalpha	B
expression	O
vector	O
into	O
[	O
ERalpha+	B
]	O
OS	O
cells	O
resulted	O
in	O
potentiation	O
of	O
E2-stimulated	O
ERELuc	B
activity	O
in	O
a	O
synergistic	O
,	O
dose	O
-	O
dependent	O
manner	O
.	O

This	O
sequence	O
,	O
Thr	O
-	O
Gly	O
-	O
X	O
-	O
X	O
-	O
Gly	O
-	O
Asp	O
-	O
Gly	O
-	O
Lys	O
-	O
Ile	O
-	O
Phe	O
,	O
forms	O
part	O
of	O
the	O
B	O
-	O
loop	O
and	O
is	O
conserved	O
in	O
a	O
wide	O
variety	O
of	O
organisms	O
that	O
include	O
bacteria	O
,	O
algae	O
and	O
archeabacteria	O
.	O

We	O
did	O
not	O
observe	O
any	O
changes	O
in	O
Bcl-2	B
or	O
Bcl-2-related	B
proteins	I
(	O
Bcl	B
-	I
x	I
,	O
Bax	B
,	O
and	O
Bad	B
)	O
in	O
control	O
or	O
KCREB	B
-	O
transfected	O
cells	O
before	O
or	O
after	O
treatment	O
with	O
Tg	O
.	O

The	O
only	O
abundant	O
viral	O
transcript	O
expressed	O
during	O
latency	O
is	O
the	O
latency	B
-	I
related	I
(	O
LR	B
)	O
RNA	O
.	O

To	O
improve	O
test	O
efficiency	O
,	O
we	O
modified	O
our	O
previously	O
introduced	O
contrast	O
/	O
color	O
card	O
test	O
by	O
including	O
a	O
patterned	O
test	O
stimulus	O
and	O
reducing	O
the	O
number	O
of	O
stimuli	O
in	O
both	O
experimental	O
phases	O
.	O

Second	O
,	O
the	O
wild	B
-	I
type	I
m8	I
3	I
'	I
UTR	I
strongly	O
reduces	O
accumulation	O
of	O
heterologous	O
transcripts	O
in	O
vivo	O
,	O
an	O
activity	O
that	O
requires	O
its	O
K	O
box	O
sequences	O
.	O

In	O
particular	O
,	O
unc-86	B
encodes	O
a	O
POU	B
-	I
type	I
homeodomain	I
protein	I
needed	O
for	O
the	O
production	O
of	O
the	O
touch	O
cells	O
,	O
while	O
mec-3	B
encodes	O
a	O
LIM	B
-	I
type	I
homeodomain	I
protein	I
needed	O
for	O
the	O
differentiation	O
of	O
the	O
touch	O
cells	O
.	O

During	O
the	O
2h	O
resuscitation	O
period	O
,	O
extracellular	O
aspartate	O
and	O
glutamate	O
concentrations	O
in	O
the	O
cerebral	O
striatum	O
were	O
higher	O
during	O
hypoxaemic	O
resuscitation	O
(	O
p	O
=	O
0.044	O
and	O
p	O
=	O
0.055	O
,	O
respectively	O
)	O
than	O
during	O
resuscitation	O
with	O
21	O
%	O
O2	O
or	O
100	O
%	O
O2	O
,	O
suggesting	O
an	O
unfavourable	O
accumulation	O
of	O
potent	O
excitotoxins	O
during	O
hypoxaemic	O
resuscitation	O
.	O

Expression	O
of	O
constitutively	O
active	O
MEK1	B
,	O
the	O
kinase	O
that	O
activates	O
ERKs	B
,	O
or	O
overexpression	O
of	O
ERK2	B
,	O
but	O
not	O
JNK1	B
,	O
inhibited	O
Stat3	B
activation	O
.	O

MEKs	B
and	O
ERKs	B
inhibited	O
IL-6	B
activation	O
of	O
Stat3	B
harboring	O
a	O
mutation	O
at	O
serine-727	O
,	O
the	O
major	O
site	O
for	O
serine	O
phosphorylation	O
,	O
similar	O
to	O
inhibition	O
of	O
wild	B
-	I
type	I
Stat3	I
,	O
and	O
inhibited	O
Janus	B
kinases	I
Jak1	B
and	O
Jak2	B
upstream	O
of	O
Stat3	B
in	O
the	O
Jak	B
-	O
STAT	B
-	O
signaling	O
pathway	O
.	O

Transfection	O
and	O
in	O
vitro	O
binding	O
studies	O
identified	O
within	O
HEFT1	B
a	I
promoter	I
whose	O
basal	O
activity	O
required	O
a	O
GC	O
box	O
activated	O
by	O
Sp1	B
or	O
Sp3	B
.	O

The	O
FAS	B
promoter	I
was	O
up	O
-	O
regulated	O
by	O
insulin	B
through	O
the	O
proximal	O
insulin	B
response	I
sequence	I
containing	O
an	O
E	O
-	O
box	O
motif	O
at	O
the	O
-65-base	O
pair	O
position	O
.	O

Effects	O
of	O
rhG	B
-	I
CSF	I
on	O
neutrophil	O
functions	O
and	O
survival	O
in	O
sepsis	O
induced	O
diabetic	O
rats	O
.	O

Anastrozole	O
is	O
the	O
first	O
aromatase	B
inhibitor	O
to	O
show	O
a	O
significant	O
survival	O
advantage	O
over	O
megestrol	O
acetate	O
in	O
post	O
-	O
menopausal	O
women	O
with	O
advanced	O
breast	O
cancer	O
.	O

W.	O

Moritta	O
)	O
and	O
contains	O
Bis	O
-	O
GMA	O
.	O

ANIMALS	O
:	O
Fifty	O
dogs	O
with	O
naturally	O
developing	O
DM	O
.	O

This	O
suggests	O
that	O
while	O
underpredictions	O
of	O
pain	O
do	O
not	O
hurt	O
more	O
,	O
disruption	O
on	O
primary	O
tasks	O
and	O
physiological	O
impact	O
are	O
higher	O
.	O

Laser	O
ablation	O
has	O
been	O
employed	O
as	O
a	O
therapeutic	O
measure	O
for	O
chronic	O
pulmonary	O
emphysema	O
.	O

The	O
SH2-containing	O
adapter	O
protein	O
GRB10	B
interacts	O
with	O
BCR	B
-	O
ABL	B
.	O

Saccharomyces	O
cerevisiae	O
contains	O
four	O
known	O
acyl	B
-	I
CoA	I
synthetases	I
(	O
fatty	B
acid	I
activation	I
proteins	I
,	O
Faaps	B
)	O
.	O

We	O
recently	O
reported	O
a	O
placenta	O
-	O
specific	O
enhancer	O
in	O
the	O
human	B
leukemia	I
inhibitory	I
factor	I
receptor	I
(	O
LIFR	B
)	O
gene	O
and	O
now	O
show	O
detailed	O
characterization	O
of	O
the	O
226-base	O
pair	O
enhancer	O
(	O
-4625	O
/	O
-4400	O
nucleotides	O
)	O
.	O

Copyright	O
1998	O
Elsevier	O
Science	O
B.V.	O

It	O
may	O
be	O
time	O
to	O
reevaluate	O
the	O
dichotomy	O
between	O
AD	O
and	O
VaD.	O

The	O
effects	O
of	O
high	O
intensity	O
light	O
emissions	O
,	O
produced	O
by	O
a	O
novel	O
pulsed	O
power	O
energization	O
technique	O
(	O
PPET	O
)	O
,	O
on	O
the	O
survival	O
of	O
bacterial	O
populations	O
of	O
verocytotoxigenic	O
Escherichia	O
coli	O
(	O
serotype	O
0157	O
:	O
H7	O
)	O
and	O
Listeria	O
monocytogenes	O
(	O
serotype	O
4b	O
)	O
were	O
investigated	O
.	O

POU	B
-	I
domain	I
proteins	I
,	O
such	O
as	O
the	O
pituitary	B
-	I
specific	I
factor	I
Pit-1	I
,	O
are	O
members	O
of	O
the	O
homeodomain	B
family	I
of	O
proteins	O
which	O
are	O
important	O
in	O
development	O
and	O
homeostasis	O
,	O
acting	O
constitutively	O
or	O
in	O
response	O
to	O
signal	O
-	O
transduction	O
pathways	O
to	O
either	O
repress	O
or	O
activate	O
the	O
expression	O
of	O
specific	O
genes	O
.	O

This	O
and	O
previous	O
results	O
suggest	O
that	O
the	O
CRE	O
and	O
Sp1	B
site	I
may	O
synergistically	O
activate	O
TH	B
transcription	O
in	O
a	O
promoter	O
context	O
-	O
dependent	O
manner	O
.	O

T7	O
transcription	O
could	O
be	O
manipulated	O
to	O
achieve	O
different	O
levels	O
of	O
constitutive	O
expression	O
,	O
through	O
the	O
use	O
of	O
promoter	O
mutations	O
.	O

Plants	O
transformed	O
with	O
the	O
35S-1-sst	B
construct	O
accumulated	O
the	O
oligofructans	O
1-kestose	O
(	O
GF2	O
)	O
,	O
1,1-nystose	O
(	O
GF3	O
)	O
and	O
1,1,1-fructosylnystose	O
(	O
GF4	O
)	O
.	O

Based	O
on	O
the	O
comparison	O
of	O
the	O
predicted	O
amino	O
acid	O
sequences	O
of	O
1-sst	B
and	O
1-fft	B
with	O
those	O
of	O
other	O
plant	O
fructosyl	B
transferase	I
genes	I
,	O
we	O
postulate	O
that	O
both	O
plant	O
fructan	B
genes	I
have	O
evolved	O
from	O
plant	O
invertase	B
genes	O
.	O

A	O
5.0-kb	O
transcript	O
detected	O
by	O
the	O
differential	O
display	O
amplicon	O
3G1	O
was	O
found	O
to	O
correlate	O
strongly	O
with	O
RAG1	B
mRNA	I
expression	O
in	O
various	O
human	O
cell	O
lines	O
.	O

Here	O
,	O
we	O
report	O
that	O
swa5	B
-	I
1	I
is	O
a	O
new	O
temperature	O
-	O
sensitive	O
allele	O
of	O
the	O
clathrin	B
heavy	I
chain	I
gene	I
(	O
chc1	B
-	I
5	I
)	O
,	O
which	O
carries	O
a	O
frameshift	O
mutation	O
near	O
the	O
3	O
'	O
end	O
of	O
the	O
CHC1	B
open	O
reading	O
frame	O
.	O

We	O
have	O
determined	O
the	O
molecular	O
lesions	O
of	O
nine	O
Scm	B
mutant	I
alleles	I
,	O
which	O
identify	O
functional	O
requirements	O
for	O
specific	O
domains	O
.	O

Northern	O
analysis	O
revealed	O
no	O
detectable	O
expression	O
of	O
the	O
transcript	O
in	O
diapause-	O
or	O
nondiapause	O
-	O
programmed	O
wandering	O
larvae	O
,	O
and	O
only	O
trace	O
expression	O
in	O
nondiapausing	O
pupae	O
.	O

Besides	O
the	O
characterization	O
and	O
discussion	O
of	O
the	O
experimental	O
setup	O
used	O
,	O
the	O
rate	O
constants	O
obtained	O
are	O
discussed	O
and	O
compared	O
with	O
estimated	O
values	O
.	O

Genomic	O
locus	O
of	O
chCTCF	B
contains	O
a	O
GC	O
-	O
rich	O
untranslated	O
exon	O
separated	O
from	O
seven	O
coding	O
exons	O
by	O
a	O
long	O
intron	O
.	O

The	O
presence	O
of	O
PDZ	B
and	O
SAM	O
domains	O
in	O
the	O
KS5	B
protein	I
suggests	O
that	O
it	O
may	O
act	O
as	O
a	O
molecular	O
adaptor	O
,	O
promoting	O
and	O
relaying	O
information	O
in	O
a	O
signal	O
transduction	O
pathway	O
.	O

BACKGROUND	O
:	O
Fluoroquinolones	O
(	O
FQ	O
)	O
are	O
contraindicated	O
in	O
children	O
because	O
of	O
the	O
risk	O
of	O
cartilage	O
damage	O
.	O

In	O
analyses	O
with	O
control	O
for	O
multiple	O
variables	O
,	O
relative	O
risk	O
for	O
microalbuminuria	O
(	O
urinary	O
albumin	B
excretion	O
,	O
20	O
-	O
199	O
microg	O
/	O
min	O
)	O
in	O
men	O
and	O
women	O
was	O
2.51	O
and	O
1.62	O
,	O
respectively	O
,	O
with	O
18	O
mm	O
Hg	O
higher	O
(	O
1	O
SD	O
)	O
systolic	O
blood	O
pressure	O
;	O
2.25	O
and	O
2.10	O
,	O
respectively	O
,	O
with	O
1.0-mmol	O
/	O
L	O
(	O
40	O
mg	O
/	O
dL	O
)	O
higher	O
plasma	O
cholesterol	O
level	O
;	O
1.99	O
and	O
1.91	O
,	O
respectively	O
,	O
for	O
smokers	O
vs	O
nonsmokers	O
;	O
and	O
1.83	O
and	O
1.33	O
,	O
respectively	O
,	O
with	O
4	O
kg	O
/	O
m2	O
higher	O
body	O
mass	O
index	O
.	O

However	O
,	O
while	O
IL-1beta	B
and	O
TNF	B
-	I
alpha	I
both	O
induced	O
nuclear	O
binding	O
of	O
the	O
Rel	B
proteins	I
p50	B
and	O
p65	B
to	O
an	O
NF	B
-	I
kappaB	I
consensus	I
oligonucleotide	I
in	O
gel	O
shift	O
assays	O
and	O
caused	O
transient	O
degradation	O
of	O
inhibitor	B
of	I
NF	I
-	I
kappaB	I
-	I
alpha	I
(	O
IkappaB	B
-	I
alpha	I
)	O
in	O
the	O
cytoplasm	O
of	O
myofibroblasts	O
,	O
only	O
IL-1beta	B
upregulated	O
PDGF	B
-	I
Ralpha	I
.	O

Phosphocreatine	O
hydrolysis	O
during	O
submaximal	O
exercise	O
:	O
the	O
effect	O
of	O
FIO2	O
.	O

GETS-1	B
is	O
expressed	O
in	O
many	O
tissues	O
,	O
but	O
is	O
enriched	O
in	O
retina	O
and	O
brain	O
.	O

The	O
interaction	O
of	O
U1	B
-	I
70	I
K	I
with	O
the	O
SRZ	B
proteins	I
is	O
confirmed	O
further	O
in	O
vitro	O
using	O
a	O
blot	O
overlay	O
assay	O
.	O

The	O
major	O
phenotypes	O
resulting	O
from	O
Fab1p	B
kinase	I
inactivation	O
include	O
temperature	O
-	O
sensitive	O
growth	O
,	O
vacuolar	O
acidification	O
defects	O
,	O
and	O
dramatic	O
increases	O
in	O
vacuolar	O
size	O
.	O

The	O
GEF	B
and	O
GAP	B
activities	O
for	O
Ypt1p	B
localize	O
to	O
particulate	O
cellular	O
fractions	O
.	O

Interestingly	O
,	O
an	O
antibody	O
against	O
N	B
-	I
SMase	I
can	O
abrogate	O
Ox	B
-	I
LDL-	I
and	O
TNF	B
-	I
alpha	I
-	O
induced	O
apoptosis	O
and	O
therefore	O
may	O
be	O
useful	O
for	O
in	O
vivo	O
studies	O
of	O
apoptosis	O
in	O
experimental	O
animals	O
.	O

We	O
found	O
that	O
virulent	O
Ngo	O
strains	O
induce	O
phosphorylation	O
and	O
activation	O
of	O
JNK	B
but	O
not	O
of	O
p38	B
kinase	O
.	O

Focused	O
beams	O
of	O
classical	O
light	O
ablate	O
elements	O
of	O
the	O
cell	O
division	O
machinery	O
and	O
switch	O
the	O
beating	O
of	O
hearts	O
on	O
a	O
cellular	O
basis	O
.	O

This	O
sequence	O
is	O
very	O
similar	O
to	O
the	O
insulin	B
response	I
sequence	I
found	O
in	O
the	O
regulatory	O
region	O
of	O
other	O
genes	O
negatively	O
regulated	O
by	O
insulin	B
such	O
as	O
those	O
encoding	O
phosphoenolpyruvate	B
carboxykinase	I
,	O
tyrosine	B
aminotransferase	I
,	O
and	O
insulin	B
-	I
like	I
growth	I
factor	I
-	I
binding	I
protein	I
1	I
.	O

The	O
levels	O
of	O
transactivation	O
are	O
correlated	O
with	O
the	O
respective	O
binding	O
affinities	O
of	O
the	O
response	O
elements	O
(	O
IRper-1	O
>	O
DR-4	O
>	O
IRhsp-1	O
)	O
.	O

The	O
high	O
density	O
of	O
tegumental	O
spines	O
on	O
posterior	O
half	O
of	O
the	O
body	O
and	O
the	O
distribution	O
of	O
type	O
II	O
papillae	O
on	O
dorsal	O
surface	O
are	O
considered	O
to	O
be	O
characteristic	O
of	O
C.	O
armatus	O
.	O

Inactivation	O
of	O
p53	B
but	O
not	O
p73	B
by	O
adenovirus	B
type	I
5	I
E1B	I
55-kilodalton	I
and	I
E4	I
34-kilodalton	I
oncoproteins	I
.	O

The	O
Epstein	B
-	I
Barr	I
virus	I
transactivator	I
Zta	I
triggers	O
lytic	O
gene	O
expression	O
and	O
is	O
essential	O
for	O
replication	O
of	O
the	O
lytic	O
origin	O
,	O
oriLyt	O
.	O

There	O
was	O
a	O
trend	O
in	O
all	O
studies	O
favouring	O
PVI	O
.	O

A	O
single	O
rectal	O
dose	O
of	O
25	O
mg	O
/	O
kg	O
will	O
obtain	O
this	O
lower	O
concentration	O
within	O
1	O
h	O
of	O
administration	O
and	O
maintain	O
it	O
for	O
up	O
to	O
6	O
h.	O

This	O
domain	O
,	O
although	O
adjacent	O
to	O
the	O
5	O
'	O
edge	O
of	O
the	O
SD	O
sequence	O
,	O
does	O
not	O
inhibit	O
ribosome	O
binding	O
as	O
long	O
as	O
the	O
single	O
-	O
stranded	O
region	O
of	O
domain	O
3	O
is	O
present	O
.	O

Previous	O
genetic	O
studies	O
led	O
to	O
the	O
conclusion	O
that	O
nitrate	O
and	O
nitrite	O
induction	O
of	O
nasF	B
operon	I
expression	O
is	O
determined	O
by	O
a	O
transcriptional	O
antitermination	O
mechanism	O
.	O

The	O
activation	O
and	O
injury	O
of	O
endothelial	O
cells	O
induced	O
by	O
TNF	B
and	O
other	O
proinflammatory	O
cytokines	O
may	O
underlie	O
the	O
local	O
effects	O
of	O
these	O
mediators	O
in	O
vivo	O
.	O

Here	O
we	O
demonstrate	O
that	O
THOV	B
NP	I
contains	O
a	O
motif	O
(	O
KRxxxxxxxxxKTKK	O
)	O
at	O
amino	O
acid	O
positions	O
179	O
-	O
193	O
that	O
represents	O
a	O
classical	O
bipartite	O
nuclear	O
localization	O
signal	O
(	O
NLS	O
)	O
.	O

As	O
PP2A	B
exerts	O
a	O
range	O
of	O
cellular	O
functions	O
including	O
cell	O
cycle	O
regulation	O
and	O
cell	O
fate	O
determination	O
,	O
we	O
were	O
surprised	O
to	O
find	O
that	O
these	O
embryos	O
develop	O
normally	O
until	O
postimplantation	O
,	O
around	O
embryonic	O
day	O
5.5	O
/	O
6.0	O
.	O

Furthermore	O
,	O
LB1	B
gene	I
mapped	O
to	O
chromosome	O
13q14	O
,	O
a	O
region	O
that	O
has	O
been	O
involved	O
as	O
a	O
chromosomal	O
breakpoint	O
in	O
DLBL	O
.	O

16	O
subjects	O
were	O
repatch	O
tested	O
to	O
ethylmercury	O
chloride	O
(	O
EtHgCl	O
)	O
and	O
to	O
solutions	O
containing	O
EtHgCl	O
mixed	O
with	O
L	O
-	O
cysteine	O
and	O
glutathione	O
,	O
respectively	O
.	O

Wild	B
-	I
type	I
AT1A	I
receptors	I
,	O
expressed	O
in	O
Chinese	O
hamster	O
ovary	O
cells	O
,	O
rapidly	O
internalized	O
after	O
Ang	B
II	I
stimulation	O
[	O
t1	O
/	O
2	O
2.3	O
min	O
;	O
maximal	O
level	O
of	O
internalization	O
(	O
Ymax	O
)	O
78.2	O
%	O
]	O
,	O
as	O
did	O
mutant	O
receptors	O
carrying	O
single	O
acidic	O
substitutions	O
(	O
T332E	O
,	O
t1	O
/	O
2	O
2.7	O
min	O
,	O
Ymax	O
76.3	O
%	O
;	O
S335D	O
,	O
t1	O
/	O
2	O
2.4	O
min	O
,	O
Ymax	O
76.7	O
%	O
;	O
T336E	O
,	O
t1	O
/	O
2	O
2.5	O
min	O
,	O
Ymax	O
78.2	O
%	O
;	O
S338D	O
,	O
t1	O
/	O
2	O
2.6	O
min	O
,	O
Ymax	O
78.4	O
%	O
)	O
.	O

Forskolin	O
significantly	O
enhanced	O
heregulin	B
-	O
stimulated	O
expression	O
of	O
cyclin	B
D	I
and	O
phosphorylation	O
of	O
the	O
retinoblastoma	B
gene	I
product	I
.	O

The	O
ARF	B
promoter	I
was	O
also	O
found	O
to	O
be	O
highly	O
responsive	O
to	O
E2F1	B
expression	O
,	O
in	O
keeping	O
with	O
previous	O
results	O
at	O
the	O
RNA	O
level	O
.	O

CM	O
reduced	O
the	O
nuclear	O
binding	O
activity	O
of	O
transcription	B
factor	I
AP-1	I
.	O

Observers	O
with	O
brain	O
injury	O
and	O
control	O
participants	O
performed	O
a	O
vigilance	O
task	O
during	O
which	O
they	O
received	O
periodic	O
whiffs	O
of	O
unscented	O
air	O
or	O
air	O
scented	O
with	O
peppermint	O
.	O

RESULTS	O
:	O
The	O
cardiac	O
index	O
significantly	O
changed	O
with	O
varying	O
PaCO2	O
levels	O
(	O
hypocapnia	O
,	O
-	O
9	O
%	O
;	O
hypercapnia	O
,	O
13	O
%	O
)	O
.	O

After	O
measuring	O
baseline	O
Vmca	O
at	O
a	O
partial	O
pressure	O
of	O
carbon	O
dioxide	O
in	O
arterial	O
blood	O
(	O
PaCO2	O
)	O
of	O
37.7	O
+	O
/-	O

4.5	O
mmHg	O
(	O
mean	O
+	O
/-	O

SD	O
)	O
,	O
measurements	O
were	O
repeated	O
at	O
a	O
PaCO	O
of	O
44.2	O
+	O
/-	O

3.8	O
mmHg	O
,	O
and	O
the	O
carbon	O
dioxide	O
reactivity	O
(	O
absolute	O
value	O
:	O
cm	O
x	O
s	O
(	O
-1	O
)	O
x	O
mmHg	O
(	O
-1	O
)	O
;	O
relative	O
value	O
:	O
percentage	O
of	O
baseline	O
Vmca	O
/	O
mmHg	O
)	O
was	O
calculated	O
.	O

Multivariate	O
Cox	O
survival	O
analysis	O
identified	O
baseline	O
EF	O
<	O
or	O
=	O
30	O
%	O
,	O
presence	O
of	O
significant	O
mitral	O
regurgitation	O
(	O
>	O
2	O
+	O
)	O
before	O
ablation	O
,	O
and	O
failure	O
to	O
exhibit	O
improved	O
cardiac	O
performance	O
by	O
1	O
month	O
after	O
ablation	O
as	O
the	O
only	O
independent	O
predictors	O
of	O
death	O
.	O

We	O
have	O
developed	O
a	O
new	O
method	O
for	O
estimation	O
of	O
regional	O
CBF	O
(	O
rCBF	O
)	O
and	O
cerebrovascular	O
reserve	O
capacity	O
on	O
a	O
pixel	O
-	O
by	O
-	O
pixel	O
basis	O
by	O
means	O
of	O
dynamic	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
.	O

Cost	O
-	O
effectiveness	O
analysis	O
provides	O
a	O
rational	O
means	O
of	O
allocating	O
limited	O
health	O
care	O
resources	O
by	O
allowing	O
the	O
comparison	O
of	O
the	O
costs	O
of	O
lipid	O
-	O
lowering	O
therapy	O
,	O
in	O
particular	O
,	O
therapy	O
with	O
beta	B
-	I
hydroxy	I
-	I
beta	I
-	I
methylglutaryl	I
-	I
CoA	I
(	I
coenzyme	I
A	I
)	I
reductase	I
inhibitors	O
(	O
statins	O
)	O
,	O
with	O
the	O
costs	O
of	O
atherosclerosis	O
that	O
could	O
be	O
prevented	O
by	O
lowering	O
cholesterol	O
.	O

Sequencing	O
of	O
a	O
40-kb	O
DNA	O
segment	O
of	O
the	O
FK506	O
gene	O
cluster	O
from	O
Streptomyces	O
sp.	O

The	O
predicted	O
domain	O
structures	O
of	O
FkbB	B
and	O
FkbC	B
are	O
analogous	O
to	O
that	O
of	O
FkbA	B
and	O
comprise	O
30	O
fatty	B
-	I
acid	I
-	I
synthase	I
(	O
FAS	B
)	O
-like	O
domains	O
arranged	O
in	O
6	O
modules	O
.	O

1	O
in	O
Ho	O
Chi	O
Minh	O
City	O
was	O
studied	O
by	O
culture	O
and	O
latex	O
agglutination	O
of	O
blood	O
,	O
cerebrospinal	O
fluid	O
,	O
urine	O
and	O
pleural	O
fluid	O
.	O

Glycogen	O
synthesis	O
and	O
catabolism	O
,	O
gluconeogenesis	O
,	O
glycolysis	O
,	O
motility	O
,	O
cell	O
surface	O
properties	O
and	O
adherence	O
are	O
modulated	O
by	O
csrA	B
in	I
Escherichia	I
coli	I
,	O
while	O
the	O
production	O
of	O
several	O
secreted	O
virulence	O
factors	O
,	O
the	O
plant	O
hypersensitive	O
response	O
elicitor	O
HrpN	B
(	O
Ecc	B
)	O
and	O
,	O
potentially	O
,	O
other	O
secondary	O
metabolites	O
are	O
regulated	O
by	O
rsmA	B
in	I
Erwinia	I
carotovora	I
.	O

Deletion	O
analysis	O
revealed	O
that	O
the	O
essential	O
domain	O
of	O
this	O
promoter	O
,	O
termed	O
the	O
ORF5	B
/	I
deltaX	I
transcript	I
promoter	I
,	O
mapped	O
to	O
nucleotides	O
1525	O
-	O
1625	O
.	O

Handling	O
on	O
PND	O
9	O
did	O
not	O
result	O
in	O
elevated	O
CORT	O
levels	O
in	O
any	O
of	O
the	O
groups	O
.	O

633+	O
/	O
-258	O
aggregates	O
/	O
ml	O
at	O
0	O
rpm	O
;	O
P	O
<	O
0.001	O
)	O
.	O

Thus	O
,	O
IRF-7	B
exhibits	O
functional	O
similarity	O
to	O
IRF-3	B
;	O
however	O
,	O
the	O
preferential	O
expression	O
of	O
IRF-7	B
in	O
lymphoid	O
cells	O
(	O
the	O
cell	O
type	O
that	O
expresses	O
IFNA	B
)	O
suggests	O
that	O
IRF-7	B
may	O
play	O
a	O
critical	O
role	O
in	O
regulating	O
the	O
IFNA	B
gene	I
expression	O
.	O

PURPOSE	O
:	O
The	O
role	O
interleukin-6	B
(	O
IL-6	B
)	O
in	O
the	O
treatment	O
of	O
congenital	O
thrombocytopenias	O
is	O
unknown	O
.	O

Additionally	O
in	O
seven	O
subjects	O
adrenaline	O
(	O
A	O
)	O
and	O
noradrenaline	O
(	O
NA	O
)	O
concentrations	O
were	O
determined	O
.	O

Northern	O
blot	O
analyses	O
show	O
that	O
the	O
hBub1	B
mRNA	I
level	O
is	O
abundantly	O
expressed	O
in	O
tissues	O
or	O
cells	O
with	O
a	O
high	O
mitotic	O
index	O
.	O

We	O
mapped	O
two	O
overlapping	O
expressed	O
sequence	O
tag	O
clones	O
within	O
a	O
genomic	O
contig	O
on	O
human	O
chromosome	O
5	O
,	O
band	O
q31	O
.	O

We	O
also	O
raised	O
a	O
polyclonal	O
antibody	O
against	O
the	O
glutathione	B
S	I
-	I
transferase	I
fusion	I
protein	I
containing	O
the	O
NH2-terminal	O
86	O
amino	O
acids	O
of	O
human	B
NRAMP2	I
.	O

Inhibition	O
of	O
the	O
apolipoprotein	B
B	I
mRNA	I
editing	O
enzyme	O
-	O
complex	O
by	O
hnRNP	B
C1	I
protein	I
and	O
40S	B
hnRNP	I
complexes	I
.	O

SRC-1	B
can	O
relieve	O
the	O
NF	B
-	I
kappaB	I
-	O
mediated	O
repression	O
of	O
GR	B
activity	O
.	O

However	O
the	O
sequence	O
surrounding	O
the	O
transcription	O
start	O
site	O
CTCA	O
(	O
+1	O
)	O
TTCC	O
was	O
similar	O
to	O
the	O
consensus	O
CTCA	O
(	O
+1	O
)	O
NTCT	O
(	O
N	O
is	O
any	O
nucleoside	O
)	O
for	O
an	O
initiator	O
element	O
found	O
in	O
terminal	B
deoxynucleotidyltransferase	I
and	O
a	O
number	O
of	O
other	O
highly	O
regulated	O
genes	O
.	O

These	O
results	O
indicate	O
that	O
the	O
total	O
number	O
of	O
subunit	O
c	O
in	O
F0	B
should	O
be	O
a	O
multiple	O
of	O
2	O
and	O
3	O
.	O

Expression	O
of	O
a	O
dominant	O
-	O
negative	O
mutant	O
of	O
JNK1	B
also	O
suppressed	O
glucose	O
deprivation	O
-	O
induced	O
JNK1	B
activation	O
as	O
well	O
as	O
HSP70	B
gene	I
expression	O
.	O

The	O
interaction	O
of	O
AF-1	O
with	O
proteins	O
that	O
regulate	O
distinct	O
steps	O
of	O
transcription	O
may	O
provide	O
a	O
mechanism	O
for	O
synergistic	O
activation	O
of	O
gene	O
expression	O
by	O
AF-1	O
.	O

The	O
role	O
of	O
protein	B
kinase	I
C	I
signaling	O
in	O
activated	O
DRA	B
transcription	O
.	O

Interestingly	O
,	O
an	O
increase	O
of	O
distance	O
per	O
se	O
did	O
not	O
have	O
a	O
deleterious	O
effect	O
on	O
translation	O
efficiency	O
.	O

We	O
also	O
mapped	O
a	O
3'-polyadenylation	O
site	O
504bp	O
downstream	O
of	O
the	O
TGA	O
stop	O
codon	O
,	O
consistent	O
with	O
the	O
2.5	O
kb	O
transcript	O
size	O
.	O

RBP56	B
protein	I
turned	O
out	O
to	O
be	O
hTAFII68	B
which	O
was	O
isolated	O
as	O
a	O
TATA	B
-	I
binding	I
protein	I
associated	I
factor	I
(	O
TAF	B
)	O
from	O
a	O
sub	O
-	O
population	O
of	O
TFIID	B
complexes	I
(	O
Bertolotti	O
A.	O
,	O
Lutz	O
,	O
Y.	O
,	O
Heard	O
,	O
D.J.	O
,	O
Chambon	O
,	O
P.	O
,	O
Tora	O
,	O
L.	O
,	O
1996	O
.	O
hTAFII68	B
,	O
a	O
novel	O
RNA	O
/	O
ssDNA	O
-	O
binding	O
protein	O
with	O
homology	O
to	O
the	O
proto	O
-	O
oncoproteins	O
TLS	B
/	O
FUS	B
and	O
EWS	B
is	O
associated	O
with	O
both	O
TFIID	B
and	O
RNA	B
polymerase	I
II	I
.	O

AMY-1	B
was	O
localized	O
in	O
the	O
cytoplasm	O
in	O
cells	O
expressing	O
c	B
-	I
myc	I
at	O
low	O
levels	O
,	O
but	O
in	O
the	O
nucleus	O
in	O
the	O
cells	O
of	O
a	O
high	O
c	B
-	I
myc	I
expression	O
in	O
transiently	O
transfected	O
cells	O
.	O

Antidepressant	O
-	O
like	O
properties	O
of	O
some	O
serotonin	B
receptor	I
ligands	O
and	O
calcium	O
channel	O
antagonists	O
measured	O
with	O
the	O
forced	O
swimming	O
test	O
in	O
mice	O
.	O

These	O
characteristic	O
structural	O
features	O
were	O
used	O
to	O
create	O
the	O
abbreviation	O
AZF1	B
(	O
Asparagine	B
-	I
rich	I
Zinc	I
Finger	I
protein	I
)	O
.	O

We	O
have	O
generated	O
a	O
computer	O
model	O
of	O
the	O
C	O
-	O
terminal	O
domain	O
of	O
the	O
434	O
repressor	O
based	O
on	O
the	O
crystal	O
structure	O
of	O
the	O
homologous	B
UmuD	I
'	I
protein	I
.	O

Large	O
-	O
scale	O
sequencing	O
of	O
two	O
regions	O
in	O
human	O
chromosome	O
7q22	O
:	O
analysis	O
of	O
650	O
kb	O
of	O
genomic	O
sequence	O
around	O
the	O
EPO	B
and	O
CUTL1	B
loci	I
reveals	O
17	O
genes	O
.	O

Because	O
Trp53	B
(	O
the	O
mouse	B
homolog	I
of	I
human	I
TP53	I
)	O
is	O
located	O
with	O
Tk1	B
on	O
chromosome	O
11	O
and	O
is	O
critical	O
in	O
regulating	O
cellular	O
responses	O
following	O
exposure	O
to	O
DNA	O
damaging	O
agents	O
,	O
we	O
wanted	O
to	O
determine	O
if	O
these	O
mouse	O
lymphoma	O
cells	O
harbor	O
mutations	O
in	O
Trp53	B
.	O

The	O
full	O
-	O
length	O
N	B
gene	I
,	O
encoded	O
by	O
open	O
reading	O
frame	O
7	O
,	O
was	O
cloned	O
from	O
the	O
Canadian	O
PRRS	O
virus	O
,	O
PA-8	O
.	O

We	O
have	O
previously	O
shown	O
that	O
ARNO	B
localizes	O
to	O
the	O
plasma	O
membrane	O
in	O
vivo	O
and	O
efficiently	O
catalyzes	O
ARF6	B
nucleotide	O
exchange	O
in	O
vitro	O
.	O

Renal	O
pathology	O
and	O
long	O
-	O
term	O
outcome	O
in	O
childhood	O
SLE	O
.	O

We	O
propose	O
that	O
two	O
pathways	O
regulate	O
Stat5	B
serine	O
phosphorylation	O
,	O
one	O
that	O
is	O
prolactin	B
-	O
activated	O
and	O
PD98059-resistant	O
and	O
one	O
that	O
is	O
constitutively	O
active	O
and	O
PD98059-sensitive	O
and	O
preferentially	O
targets	O
Stat5a	B
.	O

An	O
approximately	O
37-kDa	O
cytoplasmic	O
protein	O
is	O
rapidly	O
tyrosine	O
-	O
phosphorylated	O
in	O
the	O
response	O
of	O
mouse	O
BAC1.2F5	O
macrophages	O
to	O
colony	B
stimulating	I
factor-1	I
(	O
CSF-1	B
)	O
.	O

pp37	B
was	O
purified	O
from	O
the	O
cytosolic	O
fraction	O
by	O
anti	B
-	I
Tyr	I
(	I
P	I
)	I
affinity	O
chromatography	O
,	O
size	O
exclusion	O
chromatography	O
,	O
and	O
C4	O
reverse	O
phase	O
high	O
pressure	O
liquid	O
chromatography	O
.	O

Dose	O
of	O
20	O
ig	O
were	O
administered	O
within	O
a	O
scheme	O
from	O
0.1	O
to	O
6	O
months	O
in	O
order	O
to	O
study	O
its	O
immunogenicity	O
,	O
which	O
was	O
evaluated	O
at	O
2	O
,	O
7	O
,	O
and	O
12	O
months	O
after	O
the	O
first	O
dose	O
.	O

The	O
various	O
available	O
data	O
strongly	O
suggesting	O
an	O
environmental	O
toxic	O
origin	O
for	O
the	O
""""	O
sperm	O
fall	O
""""	O
will	O
be	O
presented	O
as	O
well	O
as	O
the	O
most	O
frequently	O
suspected	O
class	O
of	O
substances	O
,	O
the	O
xenoestrogens	O
.	O

This	O
association	O
was	O
independently	O
significant	O
for	O
patients	O
treated	O
primarily	O
(	O
not	O
for	O
recurrence	O
)	O
.	O

CONCLUSION	O
:	O
Local	O
control	O
was	O
highest	O
with	O
Preop	O
in	O
patients	O
presenting	O
primarily	O
with	O
gross	O
disease	O
,	O
and	O
with	O
Postop	O
in	O
patients	O
presenting	O
primarily	O
following	O
gross	O
total	O
excision	O
.	O

We	O
have	O
previously	O
mapped	O
the	O
defect	O
in	O
RIIIS	O
/	O
J	O
to	O
distal	O
mouse	O
Chr	O
11	O
,	O
distinct	O
from	O
the	O
Vwf	B
locus	I
on	O
Chr	O
6	O
.	O

These	O
data	O
may	O
also	O
aid	O
in	O
the	O
localization	O
of	O
other	O
disease	O
loci	O
mapped	O
to	O
this	O
region	O
,	O
including	O
the	O
gene	O
for	O
tricho	O
-	O
dento	O
-	O
osseous	O
syndrome	O
and	O
a	O
murine	O
locus	O
for	O
susceptibility	O
to	O
ozone	O
-	O
induced	O
acute	O
lung	O
injury	O
.	O

Copyright	O
1998	O
Academic	O
Press	O
.	O

Rather	O
,	O
usp	B
is	O
required	O
in	O
late	O
third	O
instar	O
larvae	O
for	O
appropriate	O
developmental	O
and	O
transcriptional	O
responses	O
to	O
the	O
ecdysone	O
pulse	O
that	O
triggers	O
puparium	O
formation	O
.	O

An	O
intact	O
neurovascular	O
supply	O
is	O
essential	O
for	O
the	O
viability	O
of	O
a	O
muscle	O
flap	O
.	O

RESULTS	O
:	O
An	O
herpetic	O
seroconversion	O
is	O
observed	O
with	O
presence	O
of	O
type	O
I	O
herpes	O
simplex	O
virus	O
(	O
HSV	O
I	O
)	O
nucleic	O
acids	O
in	O
the	O
recipient	O
's	O
aqueous	O
humor	O
.	O

These	O
results	O
indicate	O
that	O
HIV-1	O
Gag	B
sequences	I
can	O
influence	O
the	O
viral	B
PR	I
-	O
mediated	O
processing	O
of	O
the	O
MuLV	O
TM	B
Env	I
protein	I
p15	B
(	I
E	I
)	I
.	O

Mechanism	O
of	O
interferon	B
action	O
:	O
identification	O
of	O
essential	O
positions	O
within	O
the	O
novel	O
15-base	B
-	I
pair	I
KCS	I
element	I
required	O
for	O
transcriptional	O
activation	O
of	O
the	O
RNA	B
-	I
dependent	I
protein	I
kinase	I
pkr	I
gene	I
.	O

Expression	O
of	O
a	O
novel	O
murine	B
phospholipase	I
D	I
homolog	I
coincides	O
with	O
late	O
neuronal	O
development	O
in	O
the	O
forebrain	O
.	O

The	O
effect	O
of	O
low	O
-	O
profile	O
serine	O
substitutions	O
in	O
the	O
V3	B
loop	O
of	O
HIV-1	O
gp120	B
IIIB	I
/	O
LAI	B
on	O
the	O
immunogenicity	O
of	O
the	O
envelope	B
protein	O
.	O

The	O
human	B
2	I
'	I
,	I
5'-oligoadenylate	I
(	I
2	I
-	I
5A	I
)	I
synthetases	I
are	O
members	O
of	O
a	O
family	O
interferon	B
(	O
IFN	B
)	O
-inducible	O
anti	B
-	I
viral	I
proteins	I
.	O

Low	O
PbrO2	O
readings	O
,	O
however	O
,	O
could	O
be	O
caused	O
by	O
local	O
microhemorrhages	O
,	O
undetectable	O
on	O
CT	O
or	O
MRI	O
.	O

The	O
consequences	O
of	O
intensive	O
swine	O
production	O
on	O
the	O
environment	O
and	O
possible	O
solutions	O
by	O
means	O
of	O
nutrition	O
are	O
outlined	O
.	O

This	O
study	O
demonstrates	O
that	O
alteration	O
of	O
CDKN2	B
is	O
one	O
of	O
the	O
most	O
frequent	O
genetic	O
abnormalities	O
in	O
prostate	O
cancer	O
and	O
may	O
contribute	O
to	O
prostate	O
carcinogenesis	O
.	O

PURPOSE	O
:	O
To	O
determine	O
the	O
effects	O
of	O
hypercholesterolemia	O
and	O
atherosclerosis	O
-	O
induced	O
chronic	O
cavernosal	O
arterial	O
insufficiency	O
on	O
cavernosal	O
smooth	O
muscle	O
tone	O
,	O
nitric	B
oxide	I
synthase	I
(	O
NOS	B
)	O
activity	O
and	O
cavernosal	O
tissue	O
synthesis	O
of	O
constrictor	O
eicosanoids	O
.	O

(	O
1992	O
)	O
Biochemistry	O
31	O
,	O
3351	O
-	O
3358	O
]	O
.	O

Levels	O
of	O
serum	O
IgE	B
were	O
measured	O
monthly	O
,	O
and	O
nasal	O
IgE	B
was	O
measured	O
at	O
the	O
height	O
and	O
end	O
of	O
the	O
season	O
.	O

By	O
directly	O
interacting	O
with	O
both	O
Arfs	B
and	O
tyrosine	B
kinases	I
involved	O
in	O
regulating	O
cell	O
growth	O
and	O
cytoskeletal	O
organization	O
,	O
ASAP1	B
could	O
coordinate	O
membrane	O
remodeling	O
events	O
with	O
these	O
processes	O
.	O

By	O
DNase	B
I	I
footprint	O
analysis	O
of	O
the	O
PNR	O
element	O
,	O
a	O
palindrome	O
of	O
two	O
high	O
-	O
affinity	O
Ets	B
-	I
binding	I
sites	I
(	O
CTTCCCTGGAAG	O
)	O
was	O
identified	O
.	O

These	O
sorting	B
nexins	I
also	O
associated	O
with	O
the	O
long	O
isoform	O
of	O
the	O
leptin	B
receptor	I
but	O
not	O
with	O
the	O
short	O
and	O
medium	O
isoforms	O
.	O

In	O
vitro	O
protein	O
retention	O
experiments	O
in	O
which	O
Hsp90	B
heterocomplexes	I
were	O
precipitated	O
resulted	O
in	O
coprecipitation	O
of	O
Cns1	B
.	O

To	O
modulate	O
transcription	O
,	O
regulatory	O
factors	O
communicate	O
with	O
basal	O
transcription	O
factors	O
and/or	O
RNA	B
polymerases	I
in	O
a	O
variety	O
of	O
ways	O
.	O

The	O
mapping	O
was	O
completed	O
with	O
Southern	O
blotting	O
and	O
restriction	O
analysis	O
.	O

The	O
zona	O
pellucida	O
(	O
ZP	O
)	O
,	O
the	O
extracellular	O
glycocalyx	O
that	O
surrounds	O
the	O
oocyte	O
,	O
is	O
well	O
known	O
to	O
mediate	O
homologous	O
gamete	O
interaction	O
.	O

Although	O
pathological	O
thyroid	O
function	O
is	O
related	O
to	O
changes	O
in	O
energy	O
expenditure	O
and	O
body	O
composition	O
,	O
its	O
possible	O
influence	O
on	O
leptin	B
levels	O
remains	O
to	O
be	O
determined	O
.	O

These	O
cognitive	O
deficits	O
were	O
prevented	O
in	O
animals	O
treated	O
with	O
MK-801	O
during	O
SE	O
.	O

Thus	O
,	O
hypoxia	O
-	O
inducible	O
nuclear	O
import	O
and	O
transactivation	O
by	O
recruitment	O
of	O
CBP	B
can	O
be	O
functionally	O
separated	O
from	O
one	O
another	O
and	O
play	O
critical	O
roles	O
in	O
signal	O
transduction	O
by	O
HIF-1alpha	B
.	O

The	O
rat	B
aldolase	I
C	I
gene	I
encodes	O
a	O
glycolytic	O
enzyme	O
strongly	O
expressed	O
in	O
adult	O
brain	O
.	O

A	O
synergistic	O
effect	O
on	O
HCK	B
promoter	I
activity	O
was	O
observed	O
at	O
high	O
concentrations	O
of	O
Sp1	B
.	O

Western	O
analyses	O
with	O
antisera	O
raised	O
against	O
Lu	B
-	I
ECAM-1	I
peptides	I
show	O
that	O
the	O
N	O
-	O
terminal	O
region	O
of	O
the	O
predicted	O
open	O
reading	O
frame	O
is	O
present	O
only	O
in	O
the	O
larger	O
size	O
proteins	O
(	O
i.e.	O

Mammalian	O
sperm	O
motility	O
is	O
regulated	O
by	O
a	O
cascade	O
of	O
cAMP	O
-	O
dependent	O
protein	O
phosphorylation	O
events	O
mediated	O
by	O
protein	B
kinase	I
A.	I

In	O
this	O
paper	O
,	O
we	O
show	O
that	O
,	O
like	O
BAP2	B
,	O
the	O
expression	O
of	O
the	O
BAP3	B
gene	I
in	O
S.	O
cerevisiae	O
is	O
induced	O
by	O
the	O
addition	O
of	O
branched	O
-	O
chain	O
amino	O
acids	O
to	O
the	O
medium	O
.	O

Effect	O
of	O
enteral	O
nutritional	O
products	O
differing	O
in	O
carbohydrate	O
and	O
fat	O
on	O
indices	O
of	O
carbohydrate	O
and	O
lipid	O
metabolism	O
in	O
patients	O
with	O
NIDDM	O
.	O

These	O
studies	O
support	O
the	O
view	O
that	O
HMG	B
I	I
(	I
Y	I
)	I
is	O
an	O
important	O
cofactor	O
for	O
HLA	B
-	I
DRA	I
gene	I
activation	O
by	O
Oct-2A	B
and	O
provide	O
insights	O
into	O
its	O
mechanism	O
of	O
action	O
.	O

In	O
contrast	O
to	O
hemodynamic	O
and	O
histopathological	O
predictors	O
of	O
survival	O
,	O
vWF	B
:	O
Ag	O
does	O
not	O
require	O
invasive	O
techniques	O
to	O
be	O
determined	O
.	O

We	O
find	O
that	O
BCL-6	B
POZ	O
domain	O
mutations	O
that	O
disrupt	O
the	O
interaction	O
with	O
N	B
-	I
CoR	I
and	O
SMRT	B
no	O
longer	O
repress	O
transcription	O
.	O

Partial	O
characterization	O
of	O
the	O
active	O
site	O
human	B
platelet	I
cAMP	I
phosphodiesterase	I
,	O
PDE3A	B
,	O
by	O
site	O
-	O
directed	O
mutagenesis	O
.	O

This	O
core	O
sequence	O
,	O
along	O
with	O
additional	O
nonspecific	O
downstream	O
nucleotides	O
,	O
is	O
sufficient	O
for	O
partial	O
suppression	O
of	O
spliceosome	O
assembly	O
and	O
splicing	O
of	O
BPV-1	O
pre	O
-	O
mRNAs	O
.	O

Over	O
-	O
expression	O
of	O
the	O
cofactor	O
p300	B
,	O
which	O
functions	O
as	O
a	O
coactivator	O
of	O
myoD	B
-	O
mediated	O
transcription	O
,	O
alleviated	O
repression	O
by	O
COUP	B
-	I
TF	I
II	I
.	O

Familial	O
autoimmune	O
hepatitis	O
and	O
C4	B
deficiency	O

The	O
Schizosaccharomyces	B
pombe	I
rad1	I
+	I
cell	I
cycle	I
checkpoint	I
control	I
gene	I
is	O
required	O
for	O
S	O
-	O
phase	O
and	O
G2	O
/	O
M	O
arrest	O
in	O
response	O
to	O
both	O
DNA	O
damage	O
and	O
incomplete	O
DNA	O
replication	O
.	O

Positive	O
genetic	O
selections	O
for	O
inhibition	O
of	O
cyclin	B
/	O
CDK	B
function	O
were	O
characterized	O
using	O
the	O
E.	B
coli	I
neo	I
and	O
yeast	B
LEU2	I
genes	I
.	O

All	O
injections	O
of	O
CSF	B
were	O
given	O
after	O
the	O
initiation	O
of	O
neutropenia	O
and	O
continued	O
until	O
the	O
occurrence	O
of	O
an	O
absolute	O
neutrophil	O
recovery	O
.	O

rHu	B
GM	I
-	I
CSF	I
and	O
rHu	B
G	I
-	I
CSF	I
,	O
administered	O
once	O
daily	O
at	O
the	O
250	O
microg	O
m	O
(	O
-2	O
)	O
day	O
(	O
-1	O
)	O
and	O
5	O
microg	O
kg	O
(	O
-1	O
)	O
day	O
(	O
-1	O
)	O
level	O
,	O
were	O
effective	O
in	O
increasing	O
the	O
absolute	O
neutrophil	O
count	O
and	O
neutrophil	O
function	O
,	O
as	O
measured	O
by	O
an	O
automated	O
chemiluminescence	O
system	O
.	O

We	O
evaluated	O
regional	O
right	O
ventricular	O
wall	O
motion	O
during	O
systole	O
in	O
patients	O
with	O
surgically	O
repaired	O
tetralogy	O
of	O
Fallot	O
(	O
TOF	O
)	O
using	O
color	O
kinesis	O
imaging	O
.	O

RT	O
-	O
PCR	O
analysis	O
showed	O
that	O
PLP	B
-	I
H	I
as	O
well	O
as	O
PLP	B
-	I
C	I
and	O
PLP	B
-	I
D	I
are	O
expressed	O
in	O
all	O
rat	O
strains	O
examined	O
,	O
confirming	O
that	O
PLP	B
diversity	O
is	O
not	O
due	O
to	O
strain	O
differences	O
.	O

Interestingly	O
,	O
we	O
find	O
that	O
the	O
interaction	O
between	O
Tat	B
and	O
hCycT1	B
requires	O
zinc	O
as	O
well	O
as	O
essential	O
cysteine	O
residues	O
in	O
both	O
proteins	O
.	O

During	O
early	O
neurogenesis	O
,	O
Vnd	B
protein	I
is	O
restricted	O
to	O
ventral	O
column	O
neuroectoderm	O
and	O
neuroblasts	O
;	O
later	O
it	O
is	O
detected	O
in	O
a	O
complex	O
pattern	O
of	O
neurons	O
.	O

The	O
exodomain	O
alone	O
has	O
the	O
high	O
affinity	O
hormone	O
binding	O
site	O
but	O
is	O
not	O
capable	O
of	O
generating	O
hormonal	O
signal	O
.	O

Pyrrolidine	O
dithiocarbamate	O
,	O
a	O
potent	O
transcriptional	O
inhibitor	O
of	O
the	O
viral	B
LTR	I
,	O
abrogated	O
the	O
cytokine	O
responses	O
in	O
both	O
U1	O
and	O
ACH-2	O
cells	O
,	O
suggesting	O
a	O
common	O
TNF	B
-	I
alpha	I
-	O
mediated	O
transcriptional	O
mechanism	O
in	O
these	O
cell	O
types	O
despite	O
their	O
different	O
modes	O
of	O
provirus	O
latency	O
.	O

Furthermore	O
,	O
synergistic	O
activation	O
of	O
ERK2	B
occurred	O
in	O
the	O
absence	O
of	O
changes	O
in	O
intracellular	O
Ca2	O
+	O
,	O
and	O
was	O
not	O
blocked	O
by	O
inhibition	O
of	O
protein	B
kinase	I
C	I
activity	O
and	O
represents	O
a	O
separate	O
pathway	O
by	O
which	O
CD19	B
regulates	O
B	O
cell	O
function	O
.	O

Biochemical	O
analysis	O
reveals	O
that	O
KS1	B
is	O
a	O
nuclear	O
protein	O
containing	O
two	O
transcriptional	O
repressor	O
domains	O
,	O
R1	O
and	O
R2	O
.	O

However	O
,	O
the	O
BCH	O
group	O
showed	O
inferior	O
gross	O
motor	O
performance	O
on	O
the	O
Bruininks	O
-	O
Oseretsky	O
Test	O
of	O
Motor	O
Proficiency	O
(	O
Bruininks	O
1978	O
)	O
.	O

The	O
results	O
raise	O
the	O
possibility	O
that	O
pH	O
induced	O
post	O
-	O
translational	O
modifications	O
of	O
DdRPA	B
are	O
involved	O
in	O
events	O
that	O
halt	O
cell	O
proliferation	O
and	O
induce	O
differentiation	O
in	O
Dictyostelium	O
.	O

We	O
report	O
here	O
that	O
,	O
for	O
a	O
constant	O
amount	O
of	O
transfected	O
DNA	O
,	O
the	O
level	O
of	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
mRNA	O
is	O
increased	O
in	O
Vpr	B
-	O
expressing	O
cells	O
using	O
either	O
HIV-1	O
or	O
a	O
murine	O
leukemia	B
virus	I
(	I
MLV	I
)	I
SL3	I
-	I
3	I
LTR	I
-	O
CAT	B
reporter	O
construct	O
.	O

We	O
identified	O
telSMN	B
mutations	O
in	O
11	O
of	O
these	O
unrelated	O
SMA	O
-	O
like	O
individuals	O
who	O
carry	O
a	O
single	O
copy	O
of	O
telSMN	B
:	O
these	O
include	O
two	O
frameshift	O
mutations	O
(	O
800ins11	O
and	O
542delGT	O
)	O
and	O
three	O
missense	O
mutations	O
(	O
A2	O
G	O
,	O
S262I	O
,	O
and	O
T274I	O
)	O
.	O

The	O
decrease	O
of	O
TNF	B
receptors	I
by	O
IL-4	B
was	O
accompanied	O
by	O
down	O
-	O
regulation	O
of	O
TNF	B
-	O
induced	O
activities	O
,	O
including	O
cytotoxicity	O
,	O
caspase-3	B
activation	O
,	O
NF	B
-	I
kappaB	I
and	O
AP-1	B
activation	O
,	O
and	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
induction	O
.	O

We	O
have	O
identified	O
two	O
overlapping	O
expressed	O
sequence	O
tag	O
clones	O
,	O
which	O
contain	O
the	O
missing	O
4.4-kb	O
3'-UTR	O
of	O
the	O
human	B
D2	I
(	O
hD2	B
)	O
cDNA	O
.	O

Biol	O
.	O

Here	O
we	O
have	O
investigated	O
the	O
structural	O
requirements	O
and	O
consequences	O
of	O
regulatory	O
phosphorylation	O
for	O
the	O
interaction	O
between	O
c	B
-	I
Jun	I
and	O
JNK	B
in	O
vivo	O
.	O

P	B
-	I
CIP1	I
,	O
a	O
novel	O
protein	O
that	O
interacts	O
with	O
the	O
cytosolic	O
domain	O
of	O
peptidylglycine	B
alpha	I
-	I
amidating	I
monooxygenase	I
,	O
is	O
associated	O
with	O
endosomes	O
.	O

Immunolocalization	O
of	O
Sop1p	B
revealed	O
a	O
cytoplasmic	O
distribution	O
and	O
cell	O
fractionation	O
studies	O
showed	O
that	O
a	O
significant	O
fraction	O
of	O
Sop1p	B
was	O
recovered	O
in	O
a	O
sedimentable	O
fraction	O
of	O
the	O
cytosolic	O
material	O
.	O

Resultant	O
activation	O
of	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
/	O
stress	B
-	I
activated	I
protein	I
kinase	I
(	O
JNK	B
/	O
SAPK	B
)	O
.	O

Consistent	O
with	O
this	O
,	O
purified	O
Dlk	B
phosphorylated	O
core	O
histones	B
H3	I
,	O
H2A	B
and	O
H4	B
as	O
exogenous	O
substrates	O
and	O
endogenous	O
histone	B
H3	I
in	O
kinase	O
assays	O
with	O
nuclear	O
extracts	O
.	O

In	O
this	O
study	O
we	O
provide	O
evidence	O
that	O
B	B
-	I
Myb	I
is	O
a	O
direct	O
physiological	O
target	O
for	O
cyclin	B
A	I
/	O
Cdk2	B
.	O

We	O
have	O
isolated	O
a	O
novel	O
human	B
cyclin	I
,	O
cyclin	B
E2	I
,	O
that	O
contains	O
significant	O
homology	O
to	O
cyclin	B
E.	I

Initial	O
experience	O
with	O
the	O
new	O
technology	O
indicates	O
that	O
SieScape	O
is	O
an	O
alternative	O
to	O
other	O
methods	O
such	O
as	O
CT	O
and	O
MRI	O
.	O

The	O
dopamine	B
D4	I
receptor	I
as	O
well	O
as	O
many	O
other	O
catecholaminergic	B
receptors	I
contain	O
several	O
putative	O
SH3	B
binding	I
domains	I
.	O

The	O
highly	O
amyloidogenic	O
42-residue	O
form	O
of	O
Abeta	B
(	O
Abeta42	B
)	O
is	O
the	O
first	O
species	O
to	O
be	O
deposited	O
in	O
both	O
sporadic	O
and	O
familial	O
AD	O
.	O

A	O
-	O
tracts	O
functioned	O
best	O
when	O
positioned	O
close	O
to	O
the	O
-35	O
hexamer	O
rather	O
than	O
one	O
helical	O
turn	O
farther	O
upstream	O
,	O
similar	O
to	O
the	O
positioning	O
optimal	O
for	O
UP	O
element	O
function	O
.	O

Raf	B
is	O
a	O
key	O
serine	B
-	I
threonine	I
protein	I
kinase	I
which	O
participates	O
in	O
the	O
transmission	O
of	O
growth	O
,	O
anti	O
-	O
apoptotic	O
and	O
differentiation	O
messages	O
.	O

Collagen	B
was	O
extracted	O
from	O
the	O
skin	O
,	O
and	O
the	O
lack	O
of	O
type	B
III	I
collagen	I
was	O
determined	O
by	O
means	O
of	O
sodium	O
dodecyl	O
sulfate	O
-	O
polyacrylamide	O
gel	O
electrophoresis	O
(	O
SDS	O
-	O
PAGE	O
)	O
.	O

RESULTS	O
:	O
During	O
the	O
7-year	O
period	O
,	O
10,331	O
symptomatic	O
duodenal	O
ulcer	O
diseases	O
were	O
diagnosed	O
.	O

In	O
turn	O
,	O
assembly	O
of	O
this	O
complex	O
mediates	O
the	O
enzymatic	O
activation	O
of	O
the	O
p21-activated	B
protein	I
kinase	I
1	I
and	O
facilitates	O
actin	B
polymerization	O
.	O

The	O
tip	O
of	O
the	O
button	O
caused	O
a	O
perforation	O
of	O
the	O
posterior	O
stomach	O
wall	O
,	O
leading	O
to	O
death	O
.	O

Jembrana	O
disease	O
virus	O
(	O
JDV	O
)	O
is	O
a	O
newly	O
identified	O
bovine	O
lentivirus	O
that	O
is	O
closely	O
related	O
to	O
the	O
bovine	O
immunodeficiency	O
virus	O
(	O
BIV	O
)	O
.	O

Approximately	O
50	O
%	O
of	O
the	O
residues	O
are	O
conserved	O
among	O
all	O
three	O
sequences	O
,	O
yet	O
all	O
three	O
viruses	O
have	O
retained	O
response	O
elements	O
for	O
glucocorticoids	O
,	O
two	O
positionally	O
conserved	O
CCAAT	O
boxes	O
,	O
and	O
positionally	O
conserved	O
TATA	O
boxes	O
.	O

Nhp2p	B
is	O
a	O
highly	O
basic	O
protein	O
that	O
belongs	O
to	O
a	O
family	O
of	O
putative	O
RNA	O
-	O
binding	O
proteins	O
.	O

This	O
study	O
utilizes	O
the	O
mammalian	O
two	O
-	O
hybrid	O
system	O
to	O
examine	O
the	O
role	O
of	O
ligand	O
in	O
the	O
dimerization	O
of	O
human	B
progesterone	I
receptor	I
(	O
hPR	B
)	O
.	O

One	O
of	O
its	O
unique	O
features	O
appears	O
to	O
be	O
the	O
unusually	O
short	O
5'-untranslated	O
regions	O
(	O
UTR	O
)	O
(	O
1	O
-	O
6	O
nucleotides	O
(	O
nts	O
)	O
)	O
and	O
the	O
apparent	O
absence	O
of	O
5'-cap	O
structures	O
from	O
its	O
mRNAs	O
.	O

The	O
gene	B
encoding	I
human	I
tissue	I
-	I
type	I
plasminogen	I
activator	I
(	O
t	B
-	I
PA	I
)	O
is	O
regulated	O
in	O
a	O
cell	O
-	O
type	O
-	O
specific	O
manner	O
.	O

Both	O
the	O
presence	O
of	O
arginine	O
and	O
anaerobiosis	O
are	O
needed	O
to	O
trigger	O
induction	O
of	O
the	O
pathway	O
.	O

The	O
human	B
SHBG	I
proximal	I
promoter	I
was	O
analyzed	O
by	O
DNase	B
I	I
footprinting	O
,	O
and	O
the	O
functional	O
significance	O
of	O
6	O
footprinted	O
regions	O
(	O
FP1-FP6	O
)	O
within	O
the	O
proximal	O
promoter	O
was	O
studied	O
in	O
human	O
HepG2	O
hepatoblastoma	O
cells	O
.	O

In	O
vitro	O
translation	O
and	O
in	O
vivo	O
polysome	O
profile	O
analysis	O
indicated	O
that	O
transcripts	B
C	I
and	I
E	I
were	O
translated	O
with	O
similar	O
translational	O
efficiencies	O
that	O
are	O
substantially	O
greater	O
than	O
that	O
of	O
transcript	B
D	I
,	O
suggesting	O
that	O
5'-untranslated	O
regions	O
play	O
a	O
role	O
in	O
translational	O
control	O
.	O

We	O
have	O
introduced	O
a	O
mutation	O
(	O
Ser36	O
--	O
>	O
Asn	O
)	O
into	O
this	O
domain	O
of	O
p190	B
that	O
decreased	O
its	O
ability	O
to	O
bind	O
guanine	O
nucleotide	O
when	O
expressed	O
as	O
a	O
hemagglutinin	B
(	O
HA	B
)	O
-tagged	O
protein	O
in	O
COS	O
cells	O
.	O

Wild	O
type	O
HA	B
-	O
p190	B
induced	O
a	O
phenotype	O
of	O
rounded	O
cells	O
with	O
long	O
,	O
beaded	O
extensions	O
similar	O
to	O
that	O
seen	O
when	O
Rho	B
function	O
is	O
disrupted	O
by	O
ADP	O
-	O
ribosylation	O
.	O

We	O
emphasize	O
that	O
ANCA	B
-	O
associated	O
vasculitis	O
is	O
another	O
important	O
complication	O
of	O
RA	O
.	O

The	O
downstream	O
,	O
TATA	O
-	O
less	O
promoter	O
has	O
high	O
G+C	O
content	O
,	O
and	O
exon	O
1b	O
predominates	O
among	O
abundantly	O
expressed	O
mRNA	O
species	O
.	O

Although	O
we	O
predicted	O
that	O
overexpression	O
of	O
the	O
COOH	O
-	O
terminal	O
domains	O
,	O
which	O
were	O
thought	O
to	O
be	O
involved	O
in	O
the	O
regulation	O
of	O
SREBP	B
processing	O
,	O
would	O
result	O
in	O
disruption	O
of	O
the	O
SREBP	B
-	O
dependent	O
transcriptional	O
regulation	O
of	O
several	O
genes	O
,	O
the	O
mRNA	O
levels	O
for	O
3-hydroxy-3-methylglutaryl	B
coenzyme	I
A	I
(	I
HMG	I
CoA	I
)	I
synthase	I
in	O
these	O
two	O
cell	O
lines	O
were	O
regulated	O
in	O
a	O
sterol	O
-	O
dependent	O
manner	O
.	O

Dry	O
matter	O
intake	O
,	O
apparent	O
nutrient	O
digestibilities	O
,	O
serum	O
chemistry	O
profiles	O
,	O
sphingolipid	O
concentrations	O
,	O
and	O
persistency	O
of	O
FB1	O
in	O
tissues	O
were	O
evaluated	O
.	O

However	O
,	O
no	O
studies	O
have	O
been	O
conducted	O
to	O
further	O
investigate	O
this	O
potentially	O
hazardous	O
effect	O
of	O
lidocaine	O
.	O

E.	O
,	O
Scott	O
,	O
J.	O

Yap1p	B
is	O
constitutively	O
nuclear	O
in	O
a	O
crm1	B
mutant	I
,	O
and	O
Crm1p	B
binds	O
to	O
a	O
nuclear	O
export	O
sequence	O
(	O
NES	O
)	O
-like	O
sequence	O
in	O
Yap1p	B
in	O
the	O
presence	O
of	O
RanGTP	B
.	O

Also	O
,	O
the	O
amplitude	O
of	O
the	O
oscillatory	O
potentials	O
(	O
O1+O2+O3+O4	O
)	O
was	O
significantly	O
reduced	O
in	O
the	O
early	O
postoperative	O
period	O
.	O

Furthermore	O
,	O
RING1	B
overexpression	O
results	O
in	O
enhanced	O
expression	O
of	O
the	O
proto	O
-	O
oncogenes	O
c	B
-	I
jun	I
and	O
c	B
-	I
fos	I
.	O

The	O
yeast	O
retrotransposon	B
Ty5	I
preferentially	O
integrates	O
into	O
regions	O
of	O
silent	O
chromatin	O
.	O

The	O
loss	O
of	O
SKO1	B
completely	O
restored	O
ENA1	B
expression	O
in	O
a	O
hog1	B
mutant	I
and	O
partially	O
suppressed	O
the	O
osmotic	O
stress	O
sensitivity	O
,	O
qualifying	O
Sko1p	B
as	O
a	O
downstream	O
effector	O
of	O
the	O
HOG	B
pathway	O
.	O

Elevated	O
expression	O
of	O
a	O
previously	O
uncharacterized	O
gene	O
,	O
SPP381	B
,	O
efficiently	O
suppresses	O
the	O
growth	O
and	O
splicing	O
defects	O
of	O
a	O
temperature	O
-	O
sensitive	O
(	O
Ts	O
)	O
mutant	B
prp38	I
-	I
1	I
.	O

The	O
slower	O
-	O
electrophoretic	O
-	O
mobility	O
form	O
of	O
p68	B
was	O
absent	O
in	O
human	O
cells	O
in	O
G1	O
/	O
S	O
and	O
appeared	O
as	O
the	O
cells	O
entered	O
G2	O
/	O
M.	O

We	O
have	O
identified	O
amino	O
acid	O
sequences	O
in	O
mammalian	O
and	O
Xenopus	O
NeuroD1	B
/	O
BETA2	B
that	O
are	O
necessary	O
for	O
insulin	B
gene	I
expression	O
and	O
ectopic	O
neurogenesis	O
.	O

Recent	O
studies	O
have	O
suggested	O
that	O
Y319	O
also	O
positively	O
regulate	O
ZAP-70	B
function	O
.	O

Genetic	O
and	O
molecular	O
data	O
indicate	O
that	O
wild	B
-	I
type	I
Pan	I
and	O
CiD	B
compete	O
for	O
binding	O
to	O
Arm	B
,	O
leading	O
to	O
a	O
compromised	O
transduction	O
of	O
the	O
Wg	B
signal	O
in	O
heterozygous	O
ciD	B
/	I
+	I
animals	O
and	O
to	O
a	O
dramatic	O
enhancement	O
of	O
the	O
gain	O
-	O
of	O
-	O
function	O
activity	O
of	O
CiD	B
in	O
homozygous	O
mutants	O
.	O

The	O
location	O
of	O
the	O
IBS	O
within	O
the	O
catB	B
structural	I
gene	I
,	O
the	O
cooperativity	O
observed	O
in	O
footprinting	O
studies	O
and	O
phasing	O
studies	O
suggest	O
that	O
the	O
IBS	O
participates	O
in	O
the	O
interaction	O
of	O
CatR	B
with	O
the	O
upstream	O
binding	O
sites	O
by	O
looping	O
out	O
the	O
intervening	O
DNA	O
.	O

In	O
vitro	O
transcription	O
assays	O
demonstrate	O
that	O
the	O
TCA	O
-	O
cycle	O
intermediate	O
,	O
fumarate	O
,	O
directly	O
and	O
specifically	O
inhibits	O
the	O
formation	O
of	O
the	O
clcA	B
transcript	I
.	O

Expression	O
of	O
p130	B
(	O
Cas	B
)	O
(	O
Cas	B
)	O
,	O
a	O
major	O
binding	O
protein	O
for	O
the	O
Crk	B
SH2-domain	B
,	O
also	O
induced	O
JNK	B
activation	O
,	O
which	O
was	O
blocked	O
by	O
the	O
SH2-mutant	B
of	O
Crk	B
.	O

The	O
Og4C3	B
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
to	O
detect	O
circulating	O
Wuchereria	B
bancrofti	I
antigen	I
uses	O
50	O
microL	O
of	O
serum	O
.	O

We	O
now	O
show	O
that	O
gp200-MR6	B
ligation	O
can	O
also	O
mimic	O
IL-4	B
and	O
have	O
an	O
anti	O
-	O
proliferative	O
pro	O
-	O
maturational	O
influence	O
within	O
the	O
immune	O
system	O
,	O
causing	O
up	O
-	O
regulation	O
of	O
co	O
-	O
stimulatory	O
molecules	O
on	O
B	O
lymphocytes	O
.	O

Ethylene	O
is	O
involved	O
in	O
endosperm	O
rupture	O
and	O
high	O
-	O
level	O
betaGLU	B
I	I
expression	O
;	O
but	O
,	O
it	O
does	O
not	O
affect	O
the	O
spatial	O
and	O
temporal	O
pattern	O
of	O
betaGLU	B
I	I
expression	O
.	O

The	O
divergence	O
in	O
primary	O
structure	O
between	O
the	O
sheep	O
CRF1	B
and	O
the	O
other	O
mammalian	B
CRF1s	I
is	O
primarily	O
localized	O
to	O
the	O
extracellular	O
amino	O
terminal	O
domain	O
of	O
the	O
receptor	O
(	O
18	O
of	O
22	O
divergent	O
residues	O
,	O
ovine	O
vs	O
human	B
CRF1	I
)	O
.	O

Recurrent	O
arterial	O
thrombotic	O
disease	O
on	O
young	O
onset	O
and	O
protein	B
S	I
deficiency	O
.	O

We	O
showed	O
that	O
Stat3	B
and	O
Stat3beta	B
were	O
affinity	O
purified	O
using	O
phosphopeptides	O
containing	O
Y704	O
and	O
Y744	O
but	O
not	O
by	O
nonphosphorylated	O
peptide	O
analogues	O
or	O
by	O
phosphopeptides	O
containing	O
Y729	O
and	O
Y764	O
.	O

This	O
c	B
-	I
Jun	I
activity	O
is	O
inhibited	O
by	O
c	B
-	I
Fos	I
,	O
another	O
protooncoprotein	O
that	O
can	O
dimerize	O
with	O
c	B
-	I
Jun	I
to	O
form	O
the	O
transcription	O
factor	O
AP-1	B
.	O

Dorsal	O
root	O
ganglia	O
neuron	O
-	O
specific	O
promoter	O
activity	O
of	O
the	O
rabbit	B
beta	I
-	I
galactoside	I
alpha1,2-fucosyltransferase	I
gene	I
.	O

This	O
suggests	O
roles	O
for	O
both	O
the	O
CE1	O
and	O
CE2	O
elements	O
in	O
regulating	O
Hoxb1	B
gene	I
expression	O
during	O
development	O
.	O

CAL	O
gain	O
amounted	O
to	O
4.2+	O
/	O
-1.3	O
mm	O
,	O
60	O
%	O
of	O
the	O
defects	O
showing	O
CAL	O
gain	O
>	O
or	O
=	O
4	O
mm	O
.	O

However	O
,	O
there	O
has	O
not	O
been	O
any	O
evidence	O
of	O
A.	O
salmonicida	O
infections	O
,	O
specifically	O
furunculosis	O
,	O
associated	O
with	O
the	O
fish	O
in	O
this	O
loch	O
.	O

Further	O
,	O
we	O
show	O
that	O
this	O
EIA	B
-	O
inducible	O
CBF	O
/	O
cdc2	B
is	O
related	O
to	O
the	O
CBF	B
which	O
was	O
shown	O
to	O
activate	O
the	O
heat	B
shock	I
protein	I
70	I
promoter	I
.	O

The	O
BAL	O
concentrations	O
of	O
the	O
nine	O
cytokines	O
evaluated	O
for	O
the	O
more	O
and	O
less	O
affected	O
lungs	O
were	O
compared	O
:	O
interleukin-6	B
(	O
IL-6	B
)	O
,	O
IL-8	B
,	O
IL-12	B
,	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
,	O
and	O
interferon	B
gamma	I
(	O
IFN	B
-	I
gamma	I
)	O
showed	O
significant	O
differences	O
(	O
p	O
ranged	O
between	O
0	O
.	O

Phosphorylation	O
analyses	O
indicated	O
that	O
inhibition	O
of	O
ERK-1	B
/	I
2	I
decreased	O
okadaic	O
acid	O
-	O
elevated	O
phosphorylation	O
of	O
JunD	B
and	O
FosB.	B

The	O
human	O
pathogenic	O
bacterium	O
group	O
A	O
Streptococcus	O
produces	O
an	O
extracellular	O
cysteine	B
protease	I
[	O
streptococcal	B
pyrogenic	I
exotoxin	I
B	I
(	O
SpeB	B
)	O
]	O
that	O
is	O
a	O
critical	O
virulence	O
factor	O
for	O
invasive	O
disease	O
episodes	O
.	O

Consistent	O
with	O
these	O
findings	O
,	O
relatively	O
weak	O
transcriptional	O
silencing	O
by	O
the	O
native	O
VDR	B
was	O
observed	O
using	O
the	O
osteopontin	B
VDRE	O
.	O

In	O
PAV-3	O
,	O
the	O
E1A	B
region	I
is	O
located	O
between	O
1.5	O
and	O
3.8	O
map	O
units	O
.	O

Six	O
putative	O
MDV	O
genome	O
products	O
,	O
including	O
one	O
Rep	B
and	O
five	O
non	O
-	O
Rep	B
proteins	O
,	O
show	O
high	O
(	O
70.4	O
-	O
90.9	O
%	O
)	O
amino	O
acid	O
identity	O
to	O
the	O
corresponding	O
six	O
FBNYV	B
proteins	I
,	O
whereas	O
two	O
other	O
Rep	B
proteins	I
encoded	O
by	O
MDV	B
-	I
C2	I
and	O
C3	B
are	O
82.3	O
%	O
and	O
73.0	O
%	O
identical	O
to	O
those	O
encoded	O
by	O
SCSV	B
-	I
C2	I
and	O
C6	B
,	O
respectively	O
.	O

MPO	B
was	O
labeled	O
with	O
1	O
mCi	O
125I	O
by	O
a	O
technique	O
of	O
self	O
-	O
labeling	O
in	O
the	O
presence	O
of	O
10	O
(	O
-4	O
)	O
M	O
hydrogen	O
peroxide	O
.	O

The	O
data	O
indicate	O
that	O
Bmp2	B
is	O
directly	O
regulated	O
by	O
retinoic	O
acid	O
-	O
bound	O
receptors	O
and	O
Sp1	B
.	O

Both	O
proteins	O
were	O
shown	O
to	O
be	O
constitutively	O
associated	O
with	O
tubulin	B
.	O

HEED	B
was	O
found	O
to	O
bind	O
to	O
MA	B
protein	I
in	O
vitro	O
,	O
as	O
efficiently	O
as	O
in	O
vivo	O
in	O
yeast	O
cells	O
.	O

Fas	B
-	O
resistant	O
DT-40	O
lymphoma	O
B	O
-	O
cells	O
rendered	O
BTK	B
-	O
deficient	O
through	O
targeted	O
disruption	O
of	O
the	O
btk	B
gene	I
by	O
homologous	O
recombination	O
knockout	O
underwent	O
apoptosis	O
after	O
Fas	B
ligation	O
,	O
but	O
wild	O
-	O
type	O
DT-40	O
cells	O
or	O
BTK	B
-	O
deficient	O
DT-40	O
cells	O
reconstituted	O
with	O
wild	B
-	I
type	I
human	I
btk	I
gene	I
did	O
not	O
.	O

Therefore	O
,	O
in	O
order	O
to	O
search	O
for	O
the	O
latent	O
genes	O
,	O
we	O
used	O
allotype	O
-	O
specific	O
oligonucleotides	O
for	O
b5	O
,	O
b6	O
and	O
b9	O
to	O
probe	O
DNAs	O
from	O
both	O
normal	O
and	O
T.	O
brucei	O
-	O
infected	O
rabbits	O
by	O
Southern	O
blotting	O
.	O

TRAF2	B
is	O
known	O
to	O
associate	O
with	O
TRADD	B
,	O
and	O
expression	O
of	O
a	O
dominant	O
-	O
negative	O
N	O
-	O
terminal	O
deletion	O
TRAF2	B
mutant	I
was	O
found	O
to	O
partially	O
inhibit	O
LMP1-induced	B
JNK	B
activation	O
in	O
293	O
cells	O
.	O

In	O
contrast	O
,	O
transiently	O
transfected	O
cells	O
expressing	O
EBNA-3	B
revealed	O
a	O
sixfold	O
increase	O
in	O
EBNA-3	B
protein	I
expression	O
from	O
the	O
genomic	O
EBNA-3	B
gene	I
compared	O
to	O
EBNA-3	B
cDNA	I
.	O

However	O
,	O
serial	O
passages	O
of	O
fetal	O
lamb	O
kidney	O
(	O
FLK	O
)	O
cells	O
,	O
which	O
are	O
sensitive	O
to	O
infection	O
with	O
BLV	O
,	O
after	O
transient	O
transfection	O
revealed	O
that	O
mutation	O
of	O
a	O
second	O
tyrosine	O
residue	O
in	O
the	O
N	O
-	O
terminal	O
motif	O
completely	O
prevented	O
the	O
propagation	O
of	O
the	O
virus	O
.	O

Varicella	B
-	I
zoster	I
virus	I
(	I
VZV	I
)	I
glycoprotein	I
gI	I
is	O
a	O
type	B
1	I
transmembrane	I
glycoprotein	I
which	O
is	O
one	O
component	O
of	O
the	O
heterodimeric	O
gE	B
:	O
gI	B
Fc	I
receptor	I
complex	O
.	O

These	O
genes	O
were	O
expressed	O
in	O
a	O
Saccharomyces	O
cerevisiae	O
mutant	O
in	O
which	O
the	O
endogenous	B
ferrochelatase	I
gene	I
(	O
HEM15	B
)	O
had	O
been	O
deleted	O
,	O
and	O
the	O
phenotypes	O
of	O
the	O
transformants	O
were	O
characterized	O
.	O

In	O
the	O
second	O
experiment	O
,	O
a	O
stable	O
nickel	O
isotope	O
,	O
61Ni	O
,	O
was	O
given	O
in	O
drinking	O
water	O
to	O
20	O
nickel	O
-	O
sensitized	O
women	O
and	O
20	O
age	O
-	O
matched	O
controls	O
,	O
both	O
groups	O
having	O
vesicular	O
hand	O
eczema	O
of	O
the	O
pompholyx	O
type	O
.	O

Folded	O
tissue	O
and	O
crimped	O
collagen	B
fibers	O
in	O
the	O
tunica	O
albuginea	O
permit	O
its	O
expansion	O
during	O
erection	O
.	O

Comparison	O
of	O
the	O
sequences	O
of	O
attP	B
,	O
attB	B
and	O
bacteria	O
-	O
prophage	O
junctions	O
attL	B
and	O
attR	B
showed	O
a	O
26	O
bp	O
common	O
core	O
sequence	O
,	O
where	O
recombination	O
takes	O
place	O
,	O
near	O
the	O
5	O
'	O
end	O
of	O
the	O
integrase	B
gene	I
.	O

Immunological	O
testing	O
was	O
performed	O
on	O
all	O
brewery	O
workers	O
and	O
some	O
control	O
volunteers	O
using	O
skin	O
prick	O
testing	O
with	O
hops	O
,	O
barley	O
,	O
and	O
yeast	O
antigens	O
as	O
well	O
as	O
other	O
nonoccupational	O
allergens	O
,	O
and	O
by	O
determining	O
total	O
serum	B
IgE	I
levels	O
.	O

OBJECTIVE	O
:	O
To	O
evaluate	O
the	O
accuracy	O
of	O
working	O
casts	O
for	O
crown	O
and	O
bridge	O
restorations	O
made	O
from	O
twin	O
mix	O
putty	O
/	O
wash	O
silicone	O
elastomeric	O
impression	O
materials	O
using	O
different	O
types	O
of	O
stock	O
tray	O
.	O

OBJECTIVES	O
:	O
To	O
assess	O
the	O
ability	O
of	O
pretreatment	O
and	O
post	O
-	O
treatment	O
prostate	B
-	I
specific	I
antigen	I
(	O
PSA	B
)	O
measurements	O
,	O
clinical	O
tumor	O
stage	O
,	O
tumor	O
grade	O
,	O
Gleason	O
sum	O
,	O
race	O
,	O
age	O
,	O
and	O
radiation	O
dose	O
to	O
predict	O
the	O
recurrence	O
of	O
prostate	O
cancer	O
following	O
external	O
beam	O
radiation	O
therapy	O
(	O
XRT	O
)	O
since	O
the	O
introduction	O
of	O
PSA	B
as	O
a	O
tumor	O
marker	O
at	O
one	O
tertiary	O
care	O
center	O
.	O

To	O
evaluate	O
whether	O
the	O
human	O
gene	O
is	O
also	O
a	O
target	O
of	O
thyroid	O
hormone	O
we	O
have	O
searched	O
for	O
T3-responsive	O
elements	O
in	O
NRGN	B
cloned	O
genomic	O
fragments	O
spanning	O
the	O
whole	O
gene	O
.	O

BACKGROUND	O
:	O
Diazepam	O
,	O
one	O
of	O
the	O
benzodiazepine	O
group	O
of	O
tranquilizers	O
,	O
is	O
used	O
as	O
an	O
adjunctive	O
drug	O
for	O
sedation	O
and	O
for	O
relief	O
of	O
anxiety	O
in	O
the	O
treatment	O
of	O
epilepsy	O
.	O

Bioplastique	O
granuloma	O
presents	O
with	O
irregularly	O
shaped	O
cystic	O
spaces	O
of	O
varying	O
size	O
containing	O
jagged	O
,	O
translucent	O
,	O
nonbirefringent	O
foreign	O
bodies	O
whereas	O
Artecoll	O
granuloma	O
shows	O
numerous	O
round	O
vacuoles	O
nearly	O
identical	O
in	O
size	O
and	O
shape	O
enclosing	O
round	O
and	O
sharply	O
circumscribed	O
,	O
translucent	O
,	O
nonbirefringent	O
foreign	O
bodies	O
.	O

This	O
Tbx6-subfamily	B
gene	I
is	O
likely	O
to	O
participate	O
in	O
paraxial	O
mesoderm	O
formation	O
and	O
somitogenesis	O
in	O
human	O
embryo	O
.	O

Structure	O
-	O
function	O
analysis	O
of	O
the	O
Z	O
-	O
DNA	O
-	O
binding	O
domain	O
Zalpha	O
of	O
dsRNA	B
adenosine	I
deaminase	I
type	I
I	I
reveals	O
similarity	O
to	O
the	O
(	B
alpha	I
+	I
beta	I
)	I
family	I
of	O
helix	B
-	I
turn	I
-	I
helix	I
proteins	I
.	O

Carbohydrates	O
and	O
glycoconjugates	O
biophysical	O
methods	O
.	O

Molecular	O
cloning	O
of	O
mouse	B
glycolate	I
oxidase	I
.	O

In	O
such	O
a	O
manner	O
,	O
activated	O
PKR	B
inhibits	O
cell	O
growth	O
and	O
induces	O
apoptosis	O
,	O
whereas	O
disruption	O
of	O
normal	O
PKR	B
signaling	O
results	O
in	O
unregulated	O
cell	O
growth	O
.	O

We	O
isolated	O
a	O
ribosomal	B
protein	I
L18	I
by	O
interaction	O
with	O
PKR	B
.	O

Furthermore	O
,	O
rhoA	B
-	O
mediated	O
SRE	O
activation	O
was	O
blocked	O
by	O
dominant	O
negative	O
mutants	O
of	O
PKC	B
-	I
alpha	I
or	O
PKC	B
-	I
epsilon	I
.	O

Overexpression	O
of	O
PTTG	B
in	O
transfected	O
NIH	O
3T3	O
cells	O
also	O
stimulated	O
expression	O
and	O
secretion	O
of	O
basic	B
fibroblast	I
growth	I
factor	I
,	O
a	O
human	B
pituitary	I
tumor	I
growth	I
-	I
regulating	I
factor	I
.	O

Northern	O
blot	O
analysis	O
demonstrated	O
the	O
ubiquitous	O
expression	O
of	O
2.9	O
kb	O
and	O
3	O
.	O

Induction	O
of	O
anaesthesia	O
was	O
standardised	O
:	O
fentanyl	O
(	O
3	O
micrograms	O
/	O
kg	O
)	O
,	O
thiopentone	O
(	O
5	O
mg	O
/	O
kg	O
)	O
,	O
atracurium	O
(	O
0.4	O
mg	O
/	O
kg	O
)	O
.	O

A	O
comparison	O
of	O
the	O
clinical	O
profile	O
of	O
cavernous	O
malformations	O
with	O
and	O
without	O
associated	O
venous	O
malformations	O
.	O

Magnetically	O
induced	O
optical	O
self	O
-	O
pulsing	O
in	O
a	O
nonlinear	O
resonator	O
.	O

Wave	O
cybernetics	O
:	O
A	O
simple	O
model	O
of	O
wave	O
-	O
controlled	O
nonlinear	O
and	O
nonlocal	O
cooperative	O
phenomena	O
.	O

Autoionization	O
rates	O
and	O
energy	O
levels	O
of	O
triplet	O
nf	O
,	O
v=1	O
Rydberg	O
states	O
of	O
H2	O
.	O

Next	O
,	O
to	O
identify	O
regions	O
of	O
the	O
promoter	O
involved	O
,	O
we	O
examined	O
a	O
series	O
of	O
tenascin	B
-	I
C	I
promoter	I
constructs	I
with	O
5	O
'	O
deletions	O
and	O
showed	O
that	O
denatured	O
collagen	B
-	I
dependent	I
promoter	I
activity	O
was	O
retained	O
by	O
a	O
122-base	O
pair	O
element	O
,	O
located	O
-43	O
to	O
-165	O
bp	O
upstream	O
of	O
the	O
RNA	O
start	O
site	O
.	O

Nuclear	B
factor	I
kappa	I
B	I
(	O
NF	B
-	I
kappaB	I
)	O
is	O
an	O
important	O
transcription	O
factor	O
for	O
the	O
genes	O
of	O
many	O
pro	O
-	O
inflammatory	O
proteins	O
and	O
is	O
strongly	O
activated	O
by	O
the	O
cytokines	O
interleukin-1	B
and	O
tumor	B
necrosis	I
factor	I
(	I
TNF	I
)	I
alpha	I
under	O
various	O
pathological	O
conditions	O
.	O

Moreover	O
,	O
this	O
enhancement	O
of	O
transcriptional	O
activation	O
by	O
COUP	B
-	I
TFI	I
requires	O
specifically	O
the	O
AF-1	O
transactivation	O
function	O
of	O
ER	B
and	O
can	O
be	O
observed	O
in	O
the	O
presence	O
of	O
E2	O
or	O
4-hydroxytamoxifen	O
but	O
not	O
ICI	O
164384	O
.	O

Recombinant	B
Ffh	I
has	O
a	O
melting	O
point	O
of	O
tm	O
=	O
89	O
degreesC.	O

Unilateral	O
naris	O
occlusion	O
and	O
the	O
rat	O
accessory	O
olfactory	O
bulb	O
.	O

This	O
region	O
of	O
hsp90	B
mediates	O
ATP	O
-	O
independent	O
chaperone	O
activity	O
,	O
overlaps	O
the	O
hsp90	B
dimerization	I
domain	I
,	O
and	O
includes	O
structural	O
elements	O
important	O
for	O
steroid	B
receptor	I
interaction	O
.	O

The	O
promoter	O
of	O
the	O
rat	O
pgp2	B
/	O
mdr1b	B
gene	O
has	O
a	O
GC	O
-	O
rich	O
region	O
(	O
pgp2GC	B
)	O
that	O
is	O
highly	O
conserved	O
in	O
mdr	B
genes	I
and	O
contains	O
an	O
consensus	O
Sp1	B
site	I
.	O

Sp1	B
's	O
role	O
in	O
transactivation	O
of	O
the	O
pgp2	B
/	O
mdr1b	B
promoter	O
was	O
tested	O
in	O
Drosophila	O
Schneider	O
cells	O
.	O

Measurements	O
included	O
bone	O
mineral	O
density	O
of	O
the	O
lumbar	O
spine	O
and	O
proximal	O
femur	O
(	O
by	O
dual	O
-	O
energy	O
X	O
-	O
ray	O
absorptiometry	O
)	O
and	O
biochemical	O
markers	O
of	O
bone	O
remodeling	O
(	O
serum	O
bone	O
-	O
specific	O
alkaline	B
phosphatase	I
by	O
immunoassay	O
and	O
urine	O
deoxypyridinoline	O
by	O
high	O
-	O
pressure	O
liquid	O
chromatography	O
)	O
.	O

Human	B
MGP	I
is	O
a	O
10-kD	B
skeletal	I
extracellular	I
matrix	I
(	I
ECM	I
)	I
protein	I
that	O
consists	O
of	O
an	O
84-aa	O
mature	O
protein	O
and	O
a	O
19-aa	O
transmembrane	O
signal	O
peptide	O
.	O

Dual	O
roles	O
of	O
p82	B
,	O
the	O
clam	O
CPEB	B
homolog	I
,	O
in	O
cytoplasmic	O
polyadenylation	O
and	O
translational	O
masking	O
.	O

The	O
RNA	B
polymerase	I
III	I
-	I
recruiting	I
factor	I
TFIIIB	I
induces	O
a	O
DNA	O
bend	O
between	O
the	O
TATA	O
box	O
and	O
the	O
transcriptional	O
start	O
site	O
.	O

The	O
pattern	O
of	O
RNase	B
E	I
digestion	O
of	O
finP305	B
RNA	I
differed	O
from	O
FinP	B
,	O
and	O
GST	B
-	O
FinO	B
did	O
not	O
protect	O
finP305	B
RNA	I
from	O
cleavage	O
in	O
vitro	O
.	O

Analysis	O
of	O
hematopoietic	B
growth	I
factor	I
prescriptions	O
in	O
19	O
french	O
cancer	O
centers	O

In	O
the	O
second	O
case	O
,	O
an	O
epidermal	O
cyst	O
was	O
diagnosed	O
.	O

MotA	B
also	O
binds	O
a	O
DNA	O
sequence	O
(	O
a	O
MotA	B
box	I
)	O
,	O
centered	O
at	O
position	O
-30	O
.	O

The	O
S229A	O
variant	O
can	O
better	O
flip	O
modified	O
bases	O
but	O
does	O
not	O
tightly	O
lock	O
the	O
flipped	O
base	O
into	O
the	O
adenine	O
-	O
binding	O
pocket	O
,	O
suggesting	O
that	O
Ser229	O
could	O
form	O
a	O
contact	O
to	O
the	O
flipped	O
adenine	O
.	O

The	O
high	O
conservation	O
of	O
the	O
3	O
'	O
terminus	O
suggests	O
that	O
this	O
region	O
directs	O
the	O
assembly	O
of	O
proteins	O
required	O
for	O
the	O
initiation	O
of	O
RNA	O
replication	O
.	O

All	O
stimulations	O
were	O
down	O
-	O
regulated	O
with	O
GnRH	B
-	I
a	I
commenced	O
on	O
day	O
21	O
in	O
a	O
long	O
protocol	O
before	O
gonadotropin	B
stimulation	O
.	O

Chem	O
.	O

No	O
significant	O
differences	O
between	O
the	O
substituted	O
and	O
wild	O
type	O
peptides	O
were	O
observed	O
,	O
suggesting	O
that	O
this	O
substitution	O
in	O
the	O
intact	O
protein	O
may	O
cause	O
disruption	O
of	O
global	O
rather	O
than	O
local	O
structures	O
.	O

However	O
,	O
C3	B
toxin	I
alone	O
or	O
in	O
combination	O
with	O
growth	O
factors	O
did	O
not	O
stimulate	O
AP-1	B
:	O
Luc	B
activity	O
and	O
actually	O
antagonized	O
the	O
synergistic	O
activation	O
of	O
AP-1	B
:	O
Luc	B
observed	O
in	O
response	O
to	O
co	O
-	O
stimulation	O
with	O
growth	O
factors	O
and	O
Ro-31	O
-	O
8220	O
.	O

The	O
role	O
of	O
intraoperative	O
echocardiography	O
in	O
surgery	O
of	O
the	O
heart	O
and	O
large	O
vessels	O

Taken	O
together	O
,	O
our	O
results	O
demonstrate	O
that	O
CAP1	B
is	O
involved	O
in	O
multidrug	O
resistance	O
and	O
oxidative	O
stress	O
response	O
in	O
C.	O
albicans	O
.	O

The	O
RMRI	O
was	O
tested	O
for	O
interrater	O
reliability	O
using	O
three	O
simulated	O
and	O
10	O
actual	O
patients	O
.	O

Pokeweed	B
antiviral	I
protein	I
(	O
PAP	B
)	O
from	O
Phytolacca	O
americana	O
is	O
a	O
highly	O
specific	O
N	B
-	I
glycosidase	I
removing	O
adenine	O
residues	O
(	O
A4324	O
in	O
28S	B
rRNA	I
and	O
A2660	O
in	O
23S	B
rRNA	I
)	O
from	O
intact	O
ribosomes	O
of	O
both	O
eukaryotes	O
and	O
prokaryotes	O
.	O

OBJECTIVE	O
:	O
This	O
meta	O
-	O
analysis	O
of	O
67	O
controlled	O
trials	O
was	O
performed	O
to	O
quantify	O
the	O
cholesterol	O
-	O
lowering	O
effect	O
of	O
major	O
dietary	O
fibers	O
.	O

The	O
3.3-fold	O
higher	O
expression	O
in	O
the	O
fetal	O
heart	O
than	O
in	O
the	O
adult	O
heart	O
suggests	O
that	O
HFHZ	B
mRNA	I
is	O
downregulated	O
in	O
the	O
process	O
of	O
development	O
.	O

When	O
the	O
high	O
affinity	O
hnRNP	B
A1	I
binding	I
site	I
was	O
inserted	O
into	O
the	O
beta	B
-	I
globin	I
reporter	I
,	O
Rev	B
was	O
able	O
to	O
increase	O
the	O
cytoplasmic	O
levels	O
of	O
unspliced	O
mRNAs	O
to	O
14	O
%	O
.	O

To	O
date	O
,	O
two	O
such	O
proteins	O
,	O
PLZF	B
and	O
LAZ-3	B
/	O
BCL-6	B
,	O
have	O
been	O
implicated	O
in	O
oncogenesis	O
.	O

Overexpression	O
of	O
POG1	B
inhibits	O
alpha	B
-	I
factor	I
-	O
induced	O
G1	O
arrest	O
and	O
transcriptional	O
repression	O
of	O
the	O
CLN1	B
and	O
CLN2	B
genes	I
.	O

We	O
now	O
show	O
that	O
RNU2	B
fragility	O
can	O
be	O
induced	O
by	O
transfection	O
with	O
an	O
expression	O
vector	O
encoding	O
Ad12	B
E1B	I
55	O
kDa	O
alone	O
but	O
not	O
by	O
an	O
E1	B
vector	O
encoding	O
all	O
E1	B
products	I
(	O
3	O
E1A	B
proteins	I
,	O
as	O
well	O
as	O
the	O
E1B	B
19	O
kDa	O
and	O
55	O
kDa	O
proteins	O
)	O
.	O

Competitionsupershift	O
EMSA	O
assays	O
revealed	O
that	O
multiple	O
proteins	O
were	O
involved	O
in	O
bandshift	O
complex	O
formation	O
with	O
KCS	B
,	O
one	O
of	O
which	O
was	O
identified	O
as	O
factor	O
Sp1	O
.	O

Experiments	O
on	O
narcotized	O
cats	O
demonstrated	O
that	O
the	O
derivatives	O
of	O
2-mercaptobenzimidazole	O
possessing	O
the	O
properties	O
of	O
specific	O
bradycardic	O
agents	O
and	O
coded	O
as	O
CM-251	O
,	O
CM-266	O
,	O
and	O
CM-345	O
,	O
reduce	O
the	O
mean	O
rise	O
of	O
segment	O
ST	O
on	O
numerous	O
leads	O
of	O
the	O
epicardial	O
electrogram	O
during	O
5-min	O
occlusion	O
of	O
the	O
anterior	O
descending	O
branch	O
of	O
the	O
left	O
coronary	O
artery	O
.	O

Neither	O
the	O
p42	B
/	I
44	I
nor	O
the	O
JNK	B
pathway	O
was	O
involved	O
in	O
the	O
action	O
of	O
IL-1beta	B
.	O

In	O
protocol	O
2	O
,	O
eight	O
different	O
subjects	O
performed	O
Con	O
and	O
Ecc	O
arm	O
curls	O
to	O
fatigue	O
,	O
followed	O
by	O
postexercise	O
muscle	O
ischemia	O
,	O
by	O
using	O
the	O
same	O
resistance	O
as	O
in	O
protocol	O
1	O
.	O

Airflow	O
was	O
measured	O
with	O
a	O
custom	O
-	O
designed	O
turbine	O
and	O
a	O
45-ft	O
.-	O
long	O
cable	O
to	O
reach	O
the	O
volume	O
-	O
measuring	O
module	O
.	O

Both	O
mutations	O
confer	O
amino	O
acid	O
substitutions	O
in	O
the	O
viral	B
coat	I
protein	I
but	O
differ	O
in	O
their	O
relative	O
abilities	O
to	O
utilize	O
the	O
foreign	O
scaffolding	B
protein	I
.	O

Although	O
both	O
transcripts	O
share	O
the	O
first	O
nine	O
exons	O
,	O
exon	O
10	O
of	O
ZIS-2	B
is	O
lacking	O
in	O
ZIS-1	B
,	O
and	O
instead	O
,	O
exon	O
11	O
(	O
10th	O
exon	O
)	O
of	O
ZIS-1	B
is	O
larger	O
in	O
size	O
,	O
leading	O
to	O
the	O
longer	O
3'-UTR	O
.	O

Expression	O
of	O
the	O
second	O
gene	O
(	O
XT3	B
)	O
was	O
found	O
to	O
be	O
conserved	O
in	O
human	O
kidney	O
,	O
and	O
partial	O
sequence	O
was	O
obtained	O
from	O
a	O
human	O
cDNA	O
library	O
.	O

IFN	B
-	I
gamma	I
was	O
elevated	O
during	O
active	O
TB	O
when	O
compared	O
with	O
healthy	O
controls	O
,	O
declining	O
during	O
and	O
after	O
treatment	O
.	O

The	O
missing	O
5	O
'	O
sequences	O
were	O
obtained	O
by	O
5'-rapid	O
amplification	O
of	O
cDNA	O
ends	O
and	O
by	O
analysis	O
of	O
an	O
NHE5	B
genomic	I
clone	I
,	O
and	O
the	O
missing	O
3	O
'	O
sequences	O
were	O
obtained	O
by	O
3'-rapid	O
amplification	O
of	O
cDNA	O
ends	O
.	O

This	O
dependence	O
,	O
however	O
,	O
can	O
be	O
overcome	O
to	O
a	O
large	O
extent	O
by	O
dividing	O
min	O
LVdP	O
/	O
dt	O
by	O
mean	O
aortic	O
pressure	O
.	O

Genoa	O
,	O
Italy	O
,	O
24	O
-	O
28	O
August	O
1997	O
.	O

Electronic	O
structure	O
of	O
delta	O
-plutonium	O
and	O
of	O
single	O
Al	O
,	O
Ga	O
,	O
and	O
Sc	O
impurities	O
in	O
delta	O
-plutonium	O
.	O

Bound	O
-	O
exciton	O
transfer	O
and	O
photoluminescence	O
undulation	O
spectra	O
for	O
acceptors	O
in	O
ZnTe	O
.	O

Internal	O
modes	O
of	O
a	O
soliton	O
.	O

(	O
2	O
)	O
Erythroid	O
32D	O
Epo1	B
cells	O
showed	O
a	O
lower	O
level	O
of	O
bulk	O
PKC	B
catalytic	O
activity	O
,	O
lacked	O
the	O
expression	O
of	O
epsilon	B
and	I
eta	I
PKC	I
isoforms	I
,	O
and	O
showed	O
a	O
weak	O
or	O
absent	O
upregulation	O
of	O
the	O
remaining	O
isoforms	O
,	O
except	O
betaI	B
,	O
upon	O
readdition	O
of	O
Epo	B
to	O
growth	O
factor	O
-	O
starved	O
cells	O
.	O

We	O
used	O
expression	O
cloning	O
to	O
identify	O
interleukin-6	B
(	O
IL-6	B
)	O
as	O
one	O
factor	O
that	O
suppressed	O
growth	O
of	O
a	O
pre	O
-	O
B	O
-	O
cell	O
variant	O
line	O
,	O
1A9-M.	O

Airflow	O
through	O
the	O
dust	O
trap	O
was	O
controlled	O
with	O
a	O
vacuum	O
pump	O
.	O

Thus	O
,	O
in	O
normal	O
intestinal	O
epithelial	O
goblet	O
cells	O
,	O
TbetaRI	B
and	O
TbetaRII	B
can	O
respond	O
to	O
autocrine	O
but	O
not	O
exogenous	O
TGF	B
-	I
beta	I
without	O
the	O
participation	O
of	O
TbetaRIII	B
.	O

The	O
odds	O
ratio	O
for	O
CHD	O
was	O
1.21	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
0.84	O
-	O
1.75	O
)	O
given	O
a	O
positive	O
serostatus	O
of	O
specific	O
IgG	B
antibodies	O
after	O
adjustment	O
for	O
covariates	O
.	O

Another	O
group	O
of	O
HIPP-	O
and	O
HCX	O
-	O
lesioned	O
animals	O
trained	O
on	O
the	O
tasks	O
after	O
the	O
lesion	O
showed	O
reduced	O
impairments	O
of	O
the	O
type	O
described	O
above	O
,	O
suggesting	O
that	O
extrahippocampal	O
structures	O
trained	O
after	O
the	O
lesion	O
can	O
assume	O
the	O
role	O
of	O
the	O
hippocampus	O
to	O
some	O
degree	O
.	O

The	O
case	O
for	O
neutrinos	O
from	O
SN	O
1987A	O
.	O

Scaling	O
of	O
fluctuations	O
in	O
one	O
-	O
dimensional	O
interface	O
and	O
hopping	O
models	O
.	O

Mutations	O
affecting	O
only	O
CD4	B
regulation	O
mapped	O
to	O
residues	O
previously	O
shown	O
to	O
mediate	O
the	O
binding	O
of	O
Nef	B
to	O
this	O
receptor	O
,	O
such	O
as	O
W57	O
and	O
L58	O
,	O
as	O
well	O
as	O
to	O
an	O
AP	B
-	I
recruiting	I
dileucine	I
motif	I
and	O
to	O
an	O
acidic	O
dipeptide	O
in	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
protein	O
.	O

Several	O
mutations	O
disrupted	O
the	O
endonuclease	O
and	O
helicase	B
activities	O
;	O
however	O
,	O
only	O
one	O
amino	B
-	I
terminal	I
-	I
charge	I
cluster	I
mutant	I
protein	I
(	O
D40A	O
-	O
D42A	O
-	O
D44A	O
)	O
completely	O
lost	O
AAV	O
hairpin	O
DNA	O
binding	O
activity	O
.	O

We	O
conclude	O
that	O
(	O
i	O
)	O
we	O
have	O
identified	O
several	O
candidate	O
latency	O
genes	O
of	O
murine	O
gammaHV68	O
,	O
(	O
ii	O
)	O
expression	O
of	O
genes	O
during	O
latency	O
may	O
be	O
different	O
in	O
different	O
organs	O
,	O
consistent	O
with	O
multiple	O
latency	O
programs	O
and/or	O
multiple	O
cellular	O
sites	O
of	O
latency	O
,	O
and	O
(	O
iii	O
)	O
regions	O
of	O
the	O
viral	O
genome	O
(	O
v	B
-	I
bcl-2	I
gene	I
,	O
v	B
-	I
GCR	I
gene	I
,	O
and	O
gene	B
73	I
)	O
are	O
transcribed	O
during	O
latency	O
with	O
both	O
gammaHV68	O
and	O
primate	O
gammaherpesviruses	O
.	O

These	O
data	O
indicate	O
a	O
functional	O
role	O
for	O
U1	B
in	O
NRS	B
-	O
mediated	O
splicing	O
inhibition	O
.	O

This	O
suggests	O
that	O
the	O
DcuS	B
-	O
DcuR	B
system	O
responds	O
to	O
external	O
substrates	O
.	O

Crossover	O
in	O
the	O
specific	O
heat	O
of	O
dilute	O
magnets	O
induced	O
by	O
critical	O
spin	O
-	O
wave	O
dynamics	O
.	O

Interplane	O
coupling	O
in	O
the	O
superconductor	O
Y2Ba4Cu7O15	O
as	O
revealed	O
by	O
NQR	O
spin	O
-	O
echo	O
double	O
resonance	O
.	O

Electronic	O
structure	O
of	O
a	O
buried	O
NiSi2	O
or	O
CoSi2	O
layer	O
in	O
bulk	O
Si	O
.	O

Raman	O
investigation	O
of	O
YBa2-xLaxCu3O7	O
ceramics	O
.	O

Effects	O
of	O
point	O
defects	O
on	O
lattice	O
parameters	O
of	O
semiconductors	O
.	O

The	O
Scales	O
of	O
Cognitive	O
Impairment	O
Rated	O
From	O
Institutional	O
Records	O
(	O
SCIRFIR	O
)	O
,	O
a	O
battery	O
based	O
on	O
commonly	O
used	O
dementia	O
rating	O
instruments	O
,	O
was	O
tested	O
on	O
the	O
records	O
of	O
26	O
chronically	O
institutionalized	O
,	O
elderly	O
schizophrenia	O
patients	O
,	O
for	O
the	O
purpose	O
of	O
retrospectively	O
evaluating	O
the	O
long	O
-	O
term	O
course	O
of	O
cognitive	O
change	O
in	O
schizophrenia	O
and	O
relating	O
it	O
to	O
available	O
autopsy	O
materials	O
.	O

Most	O
recently	O
,	O
the	O
use	O
of	O
the	O
product	O
of	O
brain	O
weight	O
and	O
clearance	O
has	O
been	O
proposed	O
.	O

Recombination	O
and	O
transcription	O
of	O
the	O
endogenous	B
Ig	I
heavy	I
chain	I
locus	I
is	O
effected	O
by	O
the	O
Ig	B
heavy	I
chain	I
intronic	I
enhancer	I
core	I
region	I
in	O
the	O
absence	O
of	O
the	O
matrix	O
attachment	O
regions	O
.	O

Two	O
of	O
these	O
motifs	O
are	O
part	O
of	O
a	O
highly	O
conserved	O
and	O
inducible	O
dyad	O
symmetry	O
element	O
shown	O
previously	O
to	O
control	O
a	O
remote	O
IL-2	B
enhancer	I
and	O
the	O
CD18	B
promoter	I
.	O

In	O
concert	O
with	O
the	O
coactivator	O
CREB	B
binding	I
protein	I
/	O
p300	B
,	O
which	O
interacts	O
with	O
GABPalpha	B
,	O
the	O
binding	O
of	O
GABPalpha	B
and	I
-beta	I
to	O
the	O
dyad	O
symmetry	O
element	O
controls	O
the	O
induction	O
of	O
IL-16	B
promoter	I
in	O
T	O
cells	O
.	O

TPO	B
by	O
itself	O
did	O
not	O
activate	O
ERK1	B
,	O
ERK2	B
and	O
protein	B
kinase	I
C	I
(	O
PKC	B
)	O
,	O
whereas	O
TPO	B
directly	O
enhanced	O
the	O
PKC	B
-	O
dependent	O
activation	O
of	O
ERKs	B
induced	O
by	O
other	O
agonists	O
including	O
thrombin	B
and	O
phorbol	O
esters	O
,	O
without	O
affecting	O
the	O
PKC	B
activation	O
by	O
those	O
agonists	O
.	O

CONCLUSIONS	O
:	O
Fission	B
yeast	I
SCF	I
is	O
composed	O
of	O
Pop1	B
and	O
Pop2	B
,	O
two	O
structurally	O
related	O
but	O
functionally	O
independent	O
F	B
-	I
box	I
/	I
WD	I
-	I
repeat	I
proteins	I
.	O

19F	O
NMR	O
studies	O
in	O
ABF4-type	O
layered	O
antiferromagnets	O
.	O

Chirality	O
-	O
glass	O
and	O
spin	O
-	O
glass	O
correlations	O
in	O
the	O
two	O
-	O
dimensional	O
random	O
-	O
bond	O
XY	O
model	O
.	O

Echo	O
modulation	O
in	O
Pr3+:YAlO3	O
.	O

Surface	O
spin	O
waves	O
in	O
a	O
Heisenberg	O
ferrimagnet	O
with	O
a	O
single	O
-	O
ion	O
anisotropy	O
(	O
uniaxial	O
and	O
nonuniaxial	O
)	O
.	O

Optically	O
detected	O
librons	O
and	O
phonons	O
in	O
crystalline	O
C60	O
.	O

Multilayer	O
-	O
relaxation	O
geometry	O
and	O
electronic	O
structure	O
of	O
a	O
W	O
(	O
111	O
)	O
surface	O
.	O

GW	O
Gamma	O
approximation	O
for	O
electron	O
self	O
-	O
energies	O
in	O
semiconductors	O
and	O
insulators	O
.	O

Precision	O
measurement	O
of	O
the	O
pion	O
mass	O
difference	O
m	O
pi	O
--m	O
pi	O
0	O
.	O

Testing	O
gravity	O
to	O
second	O
post	O
-	O
Newtonian	O
order	O
:	O
A	O
field	O
-	O
theory	O
approach	O
.	O

Genetic	O
experiments	O
using	O
mutants	O
defective	O
in	O
apontic	B
and	O
bruno	B
reveal	O
a	O
functional	O
interaction	O
between	O
these	O
genes	O
.	O

In	O
the	O
current	O
model	O
,	O
Wingless	B
/	O
Wnt	B
signal	O
stabilizes	O
Armadillo	B
/	O
beta	B
-	I
catenin	I
,	O
which	O
then	O
accumulates	O
in	O
nuclei	O
and	O
binds	O
TCF	B
/	O
LEF	B
family	O
proteins	O
,	O
forming	O
bipartite	O
transcription	O
factors	O
which	O
activate	O
transcription	O
of	O
Wingless	B
/	O
Wnt	B
responsive	O
genes	O
.	O

In	O
support	O
of	O
clinical	O
antianginal	O
studies	O
,	O
the	O
vasodilator	O
nicorandil	O
(	O
NIC	O
)	O
was	O
combined	O
with	O
the	O
beta	B
-	I
adrenergic	I
receptor	I
antagonists	O
propranolol	O
(	O
PRO	O
)	O
and	O
atenolol	O
(	O
ATN	O
)	O
and	O
with	O
the	O
calcium	O
channel	O
blocker	O
diltiazem	O
(	O
DTZ	O
)	O
to	O
determine	O
their	O
cardiovascular	O
and	O
pharmacokinetic	O
interactions	O
.	O

Factors	O
influencing	O
direct	O
-	O
immersion	O
(	O
DI	O
)	O
-SPME	O
process	O
were	O
also	O
checked	O
and	O
chosen	O
experimentally	O
.	O

In	O
contrast	O
,	O
an	O
amino	O
-	O
terminal	O
fragment	O
containing	O
the	O
C	O
/	O
H1	O
domain	O
was	O
sufficient	O
for	O
coactivation	O
of	O
Zta	B
transcription	O
and	O
viral	O
reactivation	O
function	O
.	O

In	O
addition	O
,	O
a	O
potent	O
splicing	O
enhancer	O
sequence	O
isolated	O
in	O
the	O
selection	O
specifically	O
binds	O
a	O
20-kDa	B
SR	I
protein	I
.	O

Elimination	O
of	O
ETH1	B
in	O
apn1	B
strains	O
also	O
increased	O
spontaneous	O
mutation	O
rates	O
9-	O
or	O
31-fold	O
compared	O
to	O
the	O
wild	O
type	O
as	O
determined	O
by	O
reversion	O
to	O
adenine	O
or	O
lysine	O
prototrophy	O
,	O
respectively	O
.	O

Elimination	O
of	O
ETH1	B
in	O
apn1	B
strains	O
also	O
increased	O
spontaneous	O
mutation	O
rates	O
9-	O
or	O
31-fold	O
compared	O
to	O
the	O
wild	O
type	O
as	O
determined	O
by	O
reversion	O
to	O
adenine	O
or	O
lysine	O
prototrophy	O
,	O
respectively	O
.	O

These	O
data	O
suggest	O
that	O
other	O
Ras	B
effectors	I
can	O
collaborate	O
with	O
PI	B
3-kinase	I
and	O
with	O
each	O
other	O
to	O
activate	O
Pak	B
.	O

Mammalian	O
Ras	B
GTPase	B
-	I
activating	I
protein	I
(	O
GAP	B
)	O
,	O
p120	B
Ras	B
-	O
GAP	B
,	O
has	O
been	O
implicated	O
as	O
both	O
a	O
downregulator	O
and	O
effector	O
of	O
Ras	B
proteins	I
,	O
but	O
its	O
precise	O
role	O
in	O
Ras	B
-	O
mediated	O
signal	O
transduction	O
pathways	O
is	O
unclear	O
.	O

Three	O
mog-1	B
alleles	I
possess	O
premature	O
stop	O
codons	O
and	O
are	O
likely	O
to	O
be	O
null	O
alleles	O
,	O
and	O
one	O
is	O
a	O
missense	O
mutation	O
and	O
is	O
likely	O
to	O
retain	O
residual	O
activity	O
.	O

mog-1	B
mRNA	I
is	O
expressed	O
in	O
both	O
germ	O
line	O
and	O
somatic	O
tissues	O
and	O
appears	O
to	O
be	O
ubiquitous	O
.	O

However	O
,	O
unlike	O
the	O
SIN3	B
gene	I
of	O
Saccharomyces	O
cerevisiae	O
,	O
pst1	B
(	I
+	I
)	I
is	O
essential	O
for	O
cell	O
viability	O
.	O

The	O
Nmd3	B
protein	I
sequence	I
does	O
not	O
contain	O
readily	O
recognizable	O
motifs	O
of	O
known	O
function	O
.	O

The	O
distribution	O
of	O
the	O
various	O
repeats	O
suggests	O
its	O
organization	O
is	O
similar	O
to	O
the	O
beta	O
-	O
heterochromatic	O
regions	O
near	O
the	O
base	O
of	O
the	O
major	O
chromosome	O
arms	O
.	O

Calcitonin	B
simultaneously	O
regulates	O
both	O
periosteal	O
hyperostosis	O
and	O
trabecular	O
osteopenia	O
in	O
the	O
spinal	O
hyperostotic	O
mouse	O
(	O
twy	B
/	O
twy	B
)	O
in	O
vivo	O
.	O

Electrophoretic	O
mobility	O
-	O
shift	O
assays	O
performed	O
with	O
the	O
HNF-3	B
X	O
and	O
Y	O
sites	O
demonstrated	O
that	O
both	O
sites	O
are	O
capable	O
of	O
binding	O
HNF-3alpha	B
and	O
HNF-3beta	B
.	O

In	O
addition	O
,	O
we	O
also	O
show	O
that	O
cdk7	B
may	O
phosphorylate	O
the	O
carboxy	O
-	O
terminal	O
domain	O
(	O
CTD	O
)	O
of	O
RNA	B
pol	I
II	I
in	O
the	O
absence	O
of	O
promoter	O
opening	O
.	O

The	O
therapy	O
with	O
a	O
H2-receptor	B
antagonist	O
is	O
less	O
effective	O
than	O
the	O
triple	O
therapies	O
with	O
omeprazole	O
or	O
lansoprazole	O
.	O

In	O
humans	O
,	O
three	O
tissue	B
-	I
specific	I
plastin	I
isoforms	I
have	O
been	O
identified	O
.	O

No	O
TATA	O
or	O
Inr	O
sequence	O
was	O
found	O
.	O

The	O
inhibition	O
by	O
the	O
RIalpha	B
subunit	I
is	O
reversed	O
by	O
addition	O
of	O
nanomolar	O
concentrations	O
of	O
cAMP	O
(	O
Ka	O
=	O
40	O
nM	O
)	O
,	O
thus	O
demonstrating	O
that	O
PrKX	B
is	O
a	O
novel	O
,	O
type	B
I	I
cAMP	I
-	I
dependent	I
protein	I
kinase	I
that	O
is	O
activated	O
at	O
lower	O
cAMP	O
concentrations	O
than	O
the	O
holoenzyme	O
with	O
the	O
Calpha	B
subunit	I
of	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
.	O

Proteins	O
known	O
to	O
bind	O
the	O
PEPCK	B
CRE	O
include	O
the	O
CRE	B
-	I
binding	I
protein	I
(	O
CREB	B
)	O
and	O
members	O
of	O
the	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
(	O
C	B
/	I
EBP	I
)	O
family	O
.	O

This	O
construct	O
,	O
termed	O
pDeltaCREC	B
/	O
EBP	B
,	O
binds	O
C	B
/	I
EBPalpha	I
and	I
beta	I
but	O
not	O
CREB	B
,	O
yet	O
it	O
confers	O
a	O
nearly	O
complete	O
glucocorticoid	O
response	O
when	O
transiently	O
transfected	O
into	O
H4IIE	O
rat	O
hepatoma	O
cells	O
.	O

In	O
addition	O
,	O
in	O
vitro	O
mutagenesis	O
of	O
both	O
Engrailed	B
and	O
Pbx1	B
sites	I
indicated	O
that	O
other	O
unidentified	O
sites	O
are	O
responsible	O
for	O
the	O
transcriptional	O
enhancement	O
observed	O
with	O
the	O
intronic	O
fragment	O
.	O

Several	O
secondary	O
structure	O
elements	O
were	O
identified	O
.	O

Here	O
,	O
we	O
evidence	O
that	O
the	O
developmental	O
functions	O
of	O
the	O
family	O
of	O
transcription	O
factors	O
characterized	O
by	O
the	O
POU	B
DNA	I
binding	I
motif	I
exerts	O
roles	O
in	O
mammalian	O
development	O
.	O

High	O
-	O
affinity	O
site	O
-	O
specific	O
DNA	O
binding	O
by	O
POU	B
domain	I
transcription	I
factors	I
requires	O
both	O
the	O
POU	B
-	I
specific	I
and	O
the	O
POU	B
-	I
homeodomain	I
.	O

In	O
the	O
Oct-1	B
crystal	O
,	O
the	O
POU	B
-	I
specific	I
domain	I
recognizes	O
a	O
GCAT	O
half	O
-	O
site	O
,	O
while	O
the	O
corresponding	O
sequence	O
recognized	O
by	O
the	O
Pit-1	B
POU	B
-	O
specific	O
domain	O
,	O
GTAT	O
,	O
is	O
on	O
the	O
opposing	O
strand	O
.	O

Systematic	O
functional	O
analysis	O
of	O
V1a	B
/	I
V2	I
hybrid	I
receptors	I
showed	O
that	O
the	O
second	O
intracellular	O
loop	O
of	O
the	O
V1a	B
receptor	I
is	O
required	O
and	O
sufficient	O
for	O
efficient	O
coupling	O
to	O
Gq	B
/	I
11	I
,	O
whereas	O
the	O
third	O
intracellular	O
loop	O
of	O
the	O
V2	B
receptor	I
is	O
required	O
and	O
sufficient	O
for	O
coupling	O
to	O
Gs	B
.	O

Most	O
other	O
end	O
points	O
were	O
highly	O
significant	O
,	O
and	O
death	O
,	O
which	O
was	O
monitored	O
across	O
the	O
U.S.	O
program	O
,	O
was	O
different	O
with	O
p	O
<	O
0.0001	O
.	O

The	O
other	O
is	O
located	O
at	O
-1335	O
,	O
outside	O
this	O
highly	O
conserved	O
region	O
.	O

The	O
fatigue	O
exercise	O
showed	O
relatively	O
high	O
blood	O
lactate	O
concentration	O
[	O
12.5	O
(	O
SD	O
2.6	O
)	O
mmol	O
x	O
l	O
(	O
-1	O
)	O
]	O
and	O
an	O
increase	O
of	O
serum	B
creatine	I
kinase	I
(	O
CK	B
)	O
activity	O
delayed	O
by	O
2	O
days	O
[	O
540	O
(	O
SD	O
407	O
)	O
U	O
x	O
l	O
(	O
-1	O
)	O
]	O
.	O

Those	O
radiological	O
aspects	O
were	O
distributed	O
in	O
two	O
categories	O
:	O
1	O
)	O
type	O
I	O
-	O
presenting	O
variable	O
sinusoidal	O
filling	O
.	O

Results	O
demonstrated	O
that	O
the	O
presence	O
of	O
myofibroblasts	O
varied	O
considerably	O
from	O
case	O
to	O
case	O
and	O
was	O
always	O
related	O
to	O
smooth	O
muscle	O
cell	O
dispersion	O
,	O
which	O
occurred	O
around	O
medium	O
-	O
sized	O
damaged	O
portal	O
vein	O
branches	O
.	O

Radiative	O
corrections	O
to	O
beta	O
decay	O
and	O
the	O
possibility	O
of	O
a	O
fourth	O
generation	O
.	O

Magnetic	O
trapping	O
of	O
spin	O
-	O
polarized	O
atomic	O
hydrogen	O
.	O

Northern	O
blot	O
and	O
in	O
situ	O
hybridization	O
analyses	O
revealed	O
GPR34	B
mRNA	I
transcripts	I
in	O
several	O
human	O
and	O
rat	O
brain	O
regions	O
.	O

The	O
microphthalmia	B
-	I
TFE	I
(	O
MiT	B
)	O
subfamily	O
of	O
basic	B
helix	I
-	I
loop	I
-	I
helix	I
leucine	I
zipper	I
(	I
bHLH	I
-	I
ZIP	I
)	I
transcription	I
factors	I
,	O
including	O
TFE3	B
,	O
TFEB	B
,	O
TFEC	B
,	O
and	O
Mitf	B
,	O
has	O
been	O
implicated	O
in	O
the	O
regulation	O
of	O
tissue	O
-	O
specific	O
gene	O
expression	O
in	O
several	O
cell	O
lineages	O
.	O

Fifty	O
-	O
seven	O
patients	O
aged	O
<	O
55	O
years	O
with	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
in	O
second	O
or	O
third	O
bone	O
marrow	O
(	O
BM	O
)	O
relapse	O
or	O
refractory	O
to	O
first	O
-	O
line	O
therapy	O
were	O
enrolled	O
in	O
an	O
Italian	O
cooperative	O
study	O
.	O

The	O
dorsal	O
nerves	O
of	O
the	O
penis	O
were	O
anesthetized	O
bilaterally	O
with	O
lidocaine	O
.	O

In	O
the	O
brain	O
,	O
muscarinic	B
receptors	I
mediate	O
motor	O
and	O
memory	O
function	O
by	O
interaction	O
with	O
their	O
ligand	O
acetylcholine	O
.	O

Early	O
-	O
onset	O
scleral	O
necrosis	O
after	O
iodine	O
I	O
125	O
plaque	O
radiotherapy	O
for	O
ciliochoroidal	O
melanoma	O
.	O

Successful	O
interaction	O
of	O
ARF	B
and	O
PKC	B
-	I
alpha	I
with	O
PLD1	B
was	O
not	O
achieved	O
,	O
but	O
a	O
C	O
-	O
terminal	O
fragment	O
of	O
human	B
PLD1	I
(	O
denoted	O
""""	O
D4	O
""""	O
)	O
interacted	O
with	O
the	O
active	O
mutant	O
of	O
RhoA	B
,	O
RhoAVal-14	B
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
signal	O
transduction	O
pathways	O
that	O
are	O
involved	O
in	O
OM	B
-	O
induced	O
LDLR	B
transcription	O
.	O

High	O
-	O
pressure	O
effects	O
on	O
ultrafast	O
-	O
relaxation	O
kinetics	O
of	O
excitons	O
in	O
polydiacetylene	O
4BCMU	O
.	O

Drag	O
reduction	O
in	O
turbulent	O
flows	O
by	O
polymers	O
.	O

Current	O
world	O
literature	O
.	O

These	O
results	O
show	O
that	O
Ski	B
is	O
a	O
component	O
of	O
the	O
HDAC	B
complex	I
and	O
that	O
Ski	B
is	O
required	O
for	O
the	O
transcriptional	O
repression	O
mediated	O
by	O
this	O
complex	O
.	O

Recombinant	O
unr	B
acts	O
synergistically	O
with	O
recombinant	O
PTB	B
to	O
stimulate	O
translation	O
dependent	O
on	O
the	O
rhinovirus	O
IRES	O
.	O

Analysis	O
of	O
the	O
consensus	O
binding	O
sequence	O
and	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
ZF5	B
.	O

Mapping	O
of	O
the	O
human	B
Voltage	I
-	I
Dependent	I
Anion	I
Channel	I
isoforms	I
1	I
and	I
2	I
reconsidered	O
.	O

Identification	O
of	O
RNase	B
T	I
as	O
a	O
high	O
-	O
copy	O
suppressor	O
of	O
the	O
UV	O
sensitivity	O
associated	O
with	O
single	B
-	I
strand	I
DNA	I
exonuclease	I
deficiency	O
in	O
Escherichia	O
coli	O
.	O

Inhibition	O
of	O
phosphatidylinositol-3	B
kinase	I
did	O
not	O
have	O
a	O
significant	O
effect	O
on	O
p53	B
conformation	O
but	O
did	O
have	O
a	O
weak	O
but	O
significant	O
effect	O
on	O
Tpo	B
-	O
enhanced	O
viability	O
.	O

No	O
difference	O
in	O
percentage	O
of	O
males	O
in	O
semen	O
production	O
was	O
noted	O
between	O
strains	O
,	O
CP	O
levels	O
,	O
or	O
feeding	O
regimens	O
.	O

The	O
Lp	B
mouse	I
mutant	I
provides	O
a	O
model	O
for	O
the	O
severe	O
human	O
neural	O
tube	O
defect	O
(	O
NTD	O
)	O
,	O
cranio	O
-	O
rachischisis	O
.	O

Further	O
analysis	O
of	O
AP-1	B
DNA	O
binding	O
activities	O
in	O
7-	O
to	O
14-day	O
culture	O
activated	O
HSCs	O
led	O
to	O
the	O
discovery	O
of	O
high	B
mobility	I
AP-1	I
complexes	I
(	O
HMAP-1	B
)	O
.	O

Mutations	O
of	O
the	O
AP-1	B
site	I
of	O
the	O
TIMP-1	B
promoter	I
that	O
prevented	O
formation	O
of	O
HMAP-1	B
caused	O
a	O
70	O
%	O
loss	O
of	O
activity	O
in	O
transfected	O
activated	O
HSCs	O
.	O

Therefore	O
,	O
high	O
set	O
-	O
up	O
accuracy	O
and	O
reproducibility	O
are	O
mandatory	O
.	O

Role	O
of	O
g2	O
in	O
relating	O
the	O
Schwinger	O
and	O
Gerasimov	O
-	O
Drell	O
-	O
Hearn	O
sum	O
rules	O
.	O

Acoustic	O
transmission	O
spectra	O
in	O
the	O
Penrose	O
lattice	O
.	O

Two	O
-	O
Channel	O
Kondo	O
Lattice	O
:	O

An	O
Incoherent	O
Metal	O
.	O

Basal	O
midexpiratory	O
lower	O
esophageal	O
sphincter	O
pressure	O
was	O
similar	O
in	O
the	O
study	O
group	O
(	O
mean	O
[	O
SD	O
]	O
20.1	O
[	O
9.1	O
]	O
mmHg	O
)	O
and	O
controls	O
(	O
17.6	O
[	O
6.0	O
]	O
mmHg	O
)	O
;	O
the	O
pressure	O
did	O
not	O
change	O
following	O
EVS	O
or	O
EVL	O
.	O

CPDs	O
at	O
these	O
three	O
sites	O
may	O
partially	O
displace	O
TFIIIA	B
,	O
thereby	O
enabling	O
rapid	O
repair	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
hormone	O
receptor	O
status	O
between	O
the	O
cases	O
without	O
lymph	O
node	O
metastases	O
and	O
with	O
lymph	O
node	O
metastases	O
,	O
'	O
clandestine	O
'	O
or	O
macrometastases	O
.	O

On	O
the	O
other	O
hand	O
,	O
subjects	O
with	O
air	O
trapping	O
(	O
residual	O
volume	O
(	O
RV	O
)	O
/	O
total	O
lung	O
capacity	O
(	O
TLC	O
)	O
>	O
37	O
%	O
)	O
disclosed	O
not	O
only	O
a	O
higher	O
n	O
(	O
mit	O
)	O
(	O
0.63+	O
/	O
-0.17	O
versus	O
0.43+	O
/	O
-0.07	O
mt	O
x	O
microm	O
(	O
-2	O
)	O
,	O
p<0.05	O
)	O
but	O
shorter	O
sarcomeres	O
(	O
L	O
(	O
sar	O
)	O
)	O
than	O
subjects	O
without	O
this	O
functional	O
abnormality	O
(	O
2.08+	O
/	O
-0.16	O
to	O
2.27+	O
/	O
-0.15	O
microm	O
,	O
p<0.05	O
)	O
.	O

Gel	O
filtration	O
,	O
sedimentation	O
velocity	O
,	O
and	O
immunoprecipitation	O
experiments	O
revealed	O
that	O
beta4	O
is	O
a	O
component	O
of	O
a	O
multisubunit	O
complex	O
(	O
AP-4	B
)	O
that	O
also	O
contains	O
the	O
sigma4	O
polypeptide	O
and	O
two	O
additional	O
adaptor	O
subunit	O
homologs	O
named	O
mu4	O
(	O
mu	O
-	O
ARP2	O
)	O
and	O
epsilon	O
.	O

Cyclin	B
D1-associated	I
kinase	I
activity	O
and	O
protein	O
levels	O
were	O
increased	O
in	O
mammary	O
tumors	O
from	O
murine	O
mammary	O
tumor	O
virus	O
-	O
pp60	B
(	O
c	B
-	I
src527F	I
)	O
transgenic	O
mice	O
.	O

The	O
SH2	B
domain	I
-	I
containing	I
inositol	I
5'-phosphatase	I
(	O
SHIP	B
)	O
recruits	O
the	O
p85	B
subunit	I
of	O
phosphoinositide	B
3-kinase	I
during	O
FcgammaRIIb1-mediated	B
inhibition	O
of	O
B	B
cell	I
receptor	I
signaling	O
.	O

We	O
show	O
that	O
the	O
mouse	O
genome	O
contains	O
four	O
copies	O
of	O
the	O
ubc-9	B
gene	I
.	O

An	O
increase	O
in	O
bone	O
mineral	O
density	O
at	O
the	O
spine	O
,	O
total	O
hip	O
,	O
and	O
total	O
body	O
has	O
been	O
reported	O
with	O
raloxifene	O
but	O
seems	O
to	O
be	O
less	O
than	O
that	O
seen	O
with	O
estrogen	O
or	O
alendronate	O
therapy	O
.	O

However	O
,	O
in	O
those	O
studies	O
due	O
to	O
the	O
presence	O
of	O
thiol	O
agents	O
in	O
the	O
PKC	B
preparations	O
,	O
the	O
sensitive	O
reaction	O
of	O
BPO	O
with	O
redox	O
-	O
active	O
cysteine	O
residues	O
in	O
PKC	B
was	O
not	O
observed	O
.	O

Interestingly	O
,	O
Csx	B
/	O
Nkx2	B
.	O

We	O
also	O
identified	O
an	O
alternative	O
spliced	O
form	O
of	O
Lyp	B
RNA	I
,	O
Lyp2	B
.	O

The	O
costs	O
were	O
DM	O
11,562	O
for	O
a	O
PE	O
,	O
DM	O
12,477	O
for	O
a	O
VR	O
and	O
DM	O
7,532	O
for	O
a	O
MR	O
.	O

We	O
now	O
provide	O
evidence	O
for	O
physical	O
and	O
functional	O
interaction	O
between	O
Doa4	B
and	O
the	O
proteasome	O
.	O

Independent	O
splicing	O
events	O
involve	O
three	O
previously	O
described	O
cassette	O
exons	O
,	O
which	O
are	O
predicted	O
to	O
encode	O
most	O
of	O
the	O
second	O
transmembrane	O
domain	O
.	O

Each	O
of	O
these	O
genes	O
contains	O
a	O
putative	O
upstream	O
ORF	O
,	O
while	O
STA2	B
has	O
two	O
additional	O
in	O
-	O
frame	O
AUG	O
codons	O
5	O
'	O
to	O
the	O
major	O
cistron	O
.	O

In	O
addition	O
,	O
mapping	O
of	O
the	O
promoter	O
region	O
and	O
the	O
identification	O
of	O
putative	O
promoter	O
regulatory	O
sequences	O
should	O
give	O
insight	O
into	O
the	O
transcriptional	O
regulation	O
of	O
UCP2	B
expression	O
--	O
in	O
particular	O
by	O
anyone	O
of	O
the	O
above	O
mentioned	O
factors	O
--	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
rate	O
of	O
resectability	O
is	O
low	O
and	O
5-year	O
survival	O
is	O
very	O
poor	O
.	O

In	O
order	O
to	O
better	O
characterize	O
the	O
distribution	O
of	O
ML	O
and	O
MAP	O
estimates	O
under	O
these	O
conditions	O
,	O
we	O
derive	O
a	O
point	O
approximation	O
to	O
density	O
values	O
of	O
the	O
conditional	O
distribution	O
of	O
such	O
estimates	O
.	O

RT	O
-	O
PCR	O
was	O
performed	O
using	O
previously	O
reported	O
degenerate	O
oligonucleotide	O
primers	O
to	O
the	O
ligand	O
binding	O
domain	O
(	O
LBD	O
)	O
of	O
known	O
beta	B
integrin	I
subunits	I
and	O
Bge	B
cDNA	I
.	O

The	O
lowest	O
culture	O
failure	O
rate	O
of	O
0.2	O
per	O
cent	O
was	O
found	O
after	O
EAF	O
compared	O
with	O
0.9	O
per	O
cent	O
among	O
CVS	O
.	O

Ectopic	O
expression	O
of	O
d	B
-	I
axin	I
inhibited	O
Wingless	B
signaling	O
.	O

The	O
corresponding	O
differences	O
in	O
FVIIa	B
and	O
PAI-1	B
were	O
not	O
statistically	O
significant	O
.	O

Primary	O
and	O
secondary	O
structural	O
elements	O
required	O
for	O
synthesis	O
of	O
barley	O
yellow	O
dwarf	O
virus	O
subgenomic	O
RNA1	O
.	O

On	O
the	O
other	O
side	O
,	O
when	O
the	O
aortic	O
ring	O
was	O
perfused	O
with	O
L	O
-	O
NNA	O
(	O
NO	O
-	O
synthesis	O
inhibitor	O
)	O
or	O
methylene	O
blue	O
(	O
soluble	O
cGMPase	B
inhibitor	O
)	O
,	O
the	O
changes	O
could	O
be	O
attenuated	O
.	O

Nevertheless	O
,	O
inactivation	O
of	O
the	O
cyclin	B
E	I
-	O
Cdk2	B
complex	O
in	O
response	O
to	O
mitogen	O
starvation	O
occurs	O
normally	O
in	O
MEFs	O
that	O
have	O
a	O
homozygous	O
deletion	O
of	O
the	O
p27	B
gene	I
.	O

Identification	O
and	O
characterization	O
of	O
IS2404	B
and	O
IS2606	B
:	O
two	O
distinct	O
repeated	O
sequences	O
for	O
detection	O
of	O
Mycobacterium	O
ulcerans	O
by	O
PCR	O
.	O

Taken	O
together	O
,	O
these	O
results	O
are	O
consistent	O
with	O
the	O
possibility	O
that	O
p202	B
protein	I
contributes	O
to	O
the	O
cell	O
growth	O
retardation	O
activity	O
of	O
the	O
IFNs	B
,	O
at	O
least	O
in	O
part	O
,	O
by	O
modulating	O
p21	B
protein	I
levels	O
.	O

Similar	O
results	O
were	O
also	O
obtained	O
with	O
a	O
HepG2	O
hepatoblastoma	O
cell	O
line	O
carrying	O
wt	B
p53	I
.	O

Partial	O
sequencing	O
of	O
the	O
region	O
downstream	O
of	O
ORF	B
-	I
Pto	I
revealed	O
homology	O
to	O
the	O
ru	B
/	I
AB	I
genes	I
,	O
involved	O
in	O
UV	O
resistance	O
,	O
from	O
plasmid	O
pPSR1	O
.	O

The	O
MSY2	B
associated	O
kinase	O
is	O
not	O
casein	B
kinase	I
2	I
,	O
the	O
kinase	O
believed	O
to	O
phosphorylate	O
mRNP3	B
+	I
4	I
in	O
oocytes	O
,	O
but	O
a	O
yet	O
unidentified	O
kinase	O
.	O

This	O
suggests	O
that	O
helicase	B
-	I
like	I
genes	I
may	O
be	O
involved	O
in	O
the	O
biosynthesis	O
of	O
nucleic	O
acids	O
and	O
proteins	O
,	O
and	O
that	O
the	O
genes	O
can	O
be	O
transcriptionally	O
activated	O
by	O
heat	O
shock	O
to	O
compensate	O
for	O
the	O
repressed	O
synthesis	O
of	O
mRNA	O
and	O
protein	O
.	O

These	O
data	O
provide	O
the	O
molecular	O
tools	O
for	O
the	O
final	O
identification	O
of	O
the	O
MKS	B
and	O
the	O
MUL	B
genes	I
.	O

The	O
H	O
-	O
reflex	O
recovery	O
curve	O
was	O
obtained	O
after	O
stimulation	O
of	O
the	O
median	O
nerve	O
at	O
the	O
elbow	O
and	O
recording	O
from	O
the	O
flexor	O
carpi	O
radialis	O
.	O

The	O
origins	O
of	O
reflected	O
light	O
changes	O
associated	O
with	O
neuronal	O
activity	O
(	O
optical	O
signals	O
)	O
were	O
investigated	O
in	O
rat	O
somatosensory	O
cortex	O
with	O
optical	O
imaging	O
,	O
microspectrophotometry	O
,	O
and	O
laser	O
-	O
Doppler	O
flowmetry	O
,	O
and	O
dynamic	O
changes	O
in	O
local	O
hemoglobin	B
concentration	O
and	O
oxygenation	O
were	O
focused	O
on	O
.	O

Human	B
neuronal	I
Elav	I
-	I
like	I
proteins	I
contain	O
three	O
RNP	O
-	O
type	O
RNA	O
recognition	O
motifs	O
(	O
RRMs	O
)	O
.	O

Comparison	O
of	O
frequencies	O
of	O
atrial	O
fibrillation	O
after	O
coronary	O
artery	O
bypass	O
grafting	O
with	O
and	O
without	O
the	O
use	O
of	O
cardiopulmonary	O
bypass	O
.	O

The	O
results	O
of	O
supershift	O
analysis	O
using	O
specific	O
antibodies	O
against	O
transcription	O
factors	O
suggested	O
that	O
both	O
binding	O
complexes	O
contained	O
the	O
NF	B
-	I
kappaB	I
components	O
p50	B
and	O
p65	B
,	O
and	O
did	O
not	O
contain	O
other	O
NF	B
-	I
kappaB	I
proteins	I
(	O
p52	B
,	O
c	B
-	I
Rel	I
,	O
Rel	B
B	I
)	O
,	O
AP-1	B
proteins	I
(	O
c	B
-	I
Fos	I
,	O
C	B
-	I
Jun	I
)	O
,	O
CREB	B
or	O
C	B
/	I
EBPbeta	I
(	O
NF	B
-	I
IL6	I
)	O
.	O

A	O
set	O
of	O
peptides	O
corresponding	O
to	O
the	O
individual	O
elements	O
of	O
secondary	O
structure	O
derived	O
from	O
the	O
N	O
-	O
terminal	O
domain	O
of	O
the	O
ribosomal	B
protein	I
L9	I
have	O
been	O
synthesized	O
.	O

The	O
results	O
showed	O
that	O
IFN	B
-	I
gamma	I
stimulated	O
the	O
rapid	O
accumulation	O
of	O
interferon	B
regulated	I
factor	I
(	I
IRF	I
)	I
-1	I
mRNA	I
,	O
followed	O
by	O
a	O
delayed	O
and	O
dose	O
-	O
dependent	O
inhibition	O
of	O
alpha1	B
(	I
I	I
)	I
procollagen	I
mRNA	I
expression	O
in	O
skin	O
fibroblasts	O
from	O
several	O
different	O
donors	O
.	O

Functional	O
domains	O
of	O
c	B
-	I
myc	I
promoter	I
binding	I
protein	I
1	I
involved	O
in	O
transcriptional	O
repression	O
and	O
cell	O
growth	O
regulation	O
.	O

Therefore	O
,	O
we	O
have	O
named	O
this	O
gene	O
UBP43	B
.	O

These	O
results	O
continue	O
to	O
support	O
the	O
hypothesis	O
that	O
HS2	O
,	O
HS3	O
,	O
and	O
HS4	O
act	O
as	O
a	O
single	O
,	O
integral	O
unit	O
to	O
regulate	O
human	B
globin	I
gene	I
transcription	O
as	O
a	O
holocomplex	O
,	O
but	O
they	O
can	O
also	O
be	O
interpreted	O
to	O
say	O
that	O
formation	O
of	O
a	O
DNase	B
I	I
hypersensitive	O
holocomplex	O
alone	O
is	O
not	O
sufficient	O
for	O
mediating	O
high	O
-	O
level	O
globin	B
gene	I
transcription	O
.	O

To	O
identify	O
additional	O
non	O
-	O
Sir	B
factors	I
that	O
affect	O
rDNA	O
silencing	O
,	O
we	O
performed	O
a	O
genetic	O
screen	O
designed	O
to	O
isolate	O
mutations	O
which	O
alter	O
the	O
expression	O
of	O
reporter	O
genes	O
integrated	O
within	O
the	O
rDNA	O
.	O

Because	O
there	O
is	O
great	O
need	O
for	O
iron	O
in	O
the	O
EPO	B
-	O
stimulated	O
erythroid	O
progenitors	O
,	O
it	O
is	O
essential	O
that	O
serum	B
ferritin	I
and	O
transferrin	B
saturation	O
levels	O
should	O
be	O
maintained	O
over	O
300	O
microg	O
/	O
liter	O
and	O
30	O
%	O
,	O
respectively	O
.	O

These	O
results	O
indicate	O
that	O
the	O
p33	B
subunit	I
of	O
eIF3	B
plays	O
an	O
important	O
role	O
in	O
the	O
initiation	O
phase	O
of	O
protein	O
synthesis	O
and	O
that	O
its	O
RNA	O
-	O
binding	O
domain	O
is	O
required	O
for	O
optimal	O
activity	O
.	O

In	O
this	O
study	O
,	O
we	O
elucidate	O
signaling	O
pathways	O
induced	O
by	O
photodynamic	O
therapy	O
(	O
PDT	O
)	O
with	O
hypericin	O
.	O

These	O
results	O
indicate	O
that	O
ATF-2	B
plays	O
a	O
central	O
role	O
in	O
TGF	B
-	I
beta	I
signaling	O
by	O
acting	O
as	O
a	O
common	O
nuclear	O
target	O
of	O
both	O
Smad	B
and	O
TAK1	B
pathways	O
.	O

The	O
systolic	O
peak	O
of	O
pulmonary	O
vein	O
was	O
higher	O
than	O
the	O
diastolic	O
peak	O
in	O
45	O
out	O
of	O
56	O
cases	O
.	O

Specimens	O
were	O
assayed	O
for	O
alpha	B
-	I
fetoprotein	I
,	O
unconjugated	O
estriol	O
,	O
free	O
alpha	B
hCG	I
,	O
and	O
total	O
hCG	B
.	O

The	O
following	O
data	O
were	O
recorded	O
at	O
arrival	O
in	O
the	O
intensive	O
care	O
unit	O
6	O
,	O
12	O
,	O
24	O
,	O
and	O
48	O
hours	O
after	O
termination	O
of	O
CPB	O
:	O
heart	O
rate	O
,	O
blood	O
pressure	O
,	O
left	O
atrial	O
pressure	O
,	O
central	O
-	O
peripheral	O
temperature	O
difference	O
,	O
arterial	O
-	O
central	O
venous	O
oxygen	O
saturation	O
difference	O
,	O
urine	O
output	O
,	O
serum	O
creatinine	O
,	O
lactate	O
and	O
neutrophil	B
elastase	I
levels	O
,	O
the	O
Doppler	O
echocardiographic	O
factors	O
shortening	O
fraction	O
and	O
preejection	O
period	O
/	O
left	O
-	O
ventricular	O
ejection	O
time	O
,	O
and	O
cumulative	O
doses	O
of	O
catecholamines	O
(	O
epinephrine	O
)	O
,	O
enoximone	O
,	O
and	O
furosemide	O
.	O

MDS1	B
/	O
EVI1	B
,	O
located	O
on	O
chromosome	O
3	O
band	O
q26	O
,	O
encodes	O
a	O
zinc	B
-	I
finger	I
DNA	I
-	I
binding	I
transcription	I
activator	I
not	O
detected	O
in	O
normal	O
hematopoietic	O
cells	O
but	O
expressed	O
in	O
several	O
normal	O
tissues	O
.	O

Analysis	O
of	O
the	O
protein	O
sequences	O
of	O
these	O
two	O
replicases	B
,	O
together	O
with	O
previously	O
characterized	O
H.	B
pylori	I
plasmid	I
replication	I
proteins	I
,	O
supports	O
the	O
formation	O
of	O
a	O
distinct	O
class	O
of	O
H.	B
pylori	I
plasmid	I
proteins	I
.	O

The	O
JTc	O
delta	O
among	O
the	O
three	O
groups	O
did	O
not	O
differ	O
as	O
well	O
:	O
JTc	O
delta	O
of	O
the	O
VT	O
group	O
was	O
70	O
ms	O
+	O
/-	O

30	O
ms	O
,	O
the	O
JTc	O
delta	O
of	O
the	O
PVC	O
group	O
was	O
60	O
msec	O
+	O
/-	O

25	O
msec	O
,	O
and	O
the	O
JTc	O
delta	O
of	O
the	O
control	O
group	O
was	O
70	O
ms	O
+	O
/-	O

30	O
ms	O
.	O

In	O
contrast	O
,	O
deletion	O
of	O
the	O
upstream	O
portion	O
of	O
the	O
delta	O
promoter	O
led	O
to	O
a	O
10	O
fold	O
decrease	O
in	O
expression	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
binding	O
sites	O
for	O
the	O
repressor	B
proteins	I
BP1	I
and	O
BP2	B
in	O
the	O
upstream	O
portion	O
of	O
the	O
beta	B
globin	I
gene	I
flanking	I
region	I
led	O
to	O
a	O
4	O
-	O
6	O
fold	O
increase	O
in	O
promoter	O
activity	O
.	O

However	O
,	O
with	O
the	O
alpha1	O
antagonist	O
prazosin	O
(	O
5	O
x	O
10	O
(	O
-8	O
)	O
-5	O
x	O
10	O
(	O
-7	O
)	O
M	O
)	O
,	O
no	O
relaxation	O
occurred	O
.	O

Differential	O
expression	O
of	O
AP-2alpha	B
and	O
AP-2beta	B
in	O
the	O
developing	O
chick	O
retina	O
:	O
repression	O
of	O
R	B
-	I
FABP	I
promoter	I
activity	O
by	O
AP-2	B
.	O

The	O
algorithm	O
also	O
limited	O
TG	O
to	O
20	O
and	O
64	O
%	O
,	O
apoB	B
to	O
6	O
and	O
20	O
%	O
,	O
and	O
Lp	B
(	I
a	I
)	I
to	O
15	O
and	O
56	O
%	O
,	O
of	O
low-	O
and	O
high	O
-	O
risk	O
groups	O
,	O
respectively	O
.	O

The	O
mean	O
value	O
of	O
the	O
CD79b	B
to	O
the	O
CD79b	B
internally	O
deleted	O
ratio	O
was	O
0.64	O
+	O
/-	O

0.20	O
SD	O
in	O
normal	O
donors	O
and	O
0.44	O
+	O
/-	O

0.27	O
SD	O
in	O
B	O
-	O
CLL	O
(	O
P	O
=	O
.01	O
)	O
.	O

As	O
normal	O
B	O
cells	O
also	O
present	O
this	O
variant	O
,	O
the	O
mechanism	O
of	O
CD79b	B
posttranscriptional	O
regulation	O
might	O
reflect	O
the	O
activation	O
stage	O
of	O
the	O
normal	O
B	O
cell	O
from	O
which	O
B	O
-	O
CLL	O
derives	O
.	O

Conformational	O
studies	O
combining	O
secondary	O
structure	O
predictions	O
,	O
CD	O
and	O
NMR	O
spectroscopy	O
together	O
with	O
ELISA	O
assays	O
,	O
showed	O
that	O
the	O
greater	O
is	O
the	O
propensity	O
of	O
the	O
epitope	O
for	O
helix	O
formation	O
the	O
higher	O
is	O
the	O
recognition	O
by	O
anti	B
-	I
K159	I
.	O

Schwab	O
and	O
England	O
ADL	O
scores	O
in	O
the	O
""""	O
off	O
""""	O
state	O
were	O
improved	O
by	O
18	O
%	O
and	O
in	O
the	O
""""	O
on	O
""""	O
state	O
the	O
scores	O
declined	O
by	O
2	O
%	O
.	O

High	O
-	O
level	O
gains	O
(	O
HLGs	O
)	O
indicative	O
of	O
gene	O
amplifications	O
were	O
identified	O
at	O
11q13	O
in	O
two	O
cases	O
,	O
and	O
in	O
one	O
case	O
each	O
at	O
2q33	O
-	O
34	O
,	O
3q25	O
-	O
29	O
,	O
5p15.1	O
-	O
15.2	O
,	O
7q21	O
-	O
22	O
,	O
11p11.2	O
,	O
12p11.2	O
-	O
12	O
,	O
and	O
13q34	O
.	O

With	O
respect	O
to	O
the	O
distribution	O
of	O
active	O
MREs	O
over	O
the	O
promoter	O
region	O
,	O
the	O
hMT	B
-	I
IIA	I
gene	I
is	O
largely	O
different	O
from	O
the	O
mouse	O
metallothionein	B
-	I
I	I
gene	I
,	O
suggesting	O
that	O
MRE	O
arrangement	O
is	O
not	O
an	O
important	O
factor	O
for	O
metal	O
regulation	O
.	O

The	O
cDNA	O
was	O
expressed	O
in	O
Saccharomyces	O
cerevisiae	O
under	O
the	O
control	O
of	O
the	O
yeast	B
triose	I
phosphate	I
isomerase	I
promoter	I
.	O

Interestingly	O
,	O
the	O
RNA	O
sequences	O
selected	O
by	O
the	O
mutated	O
zinc	B
knuckle	I
9G8	I
variant	I
are	O
efficiently	O
recognized	O
by	O
SRp20	B
,	O
in	O
agreement	O
with	O
the	O
fact	O
that	O
the	O
RBD	O
of	O
9G8	B
and	O
SRp20	B
are	O
similar	O
.	O

Topoisomerase	B
II	I
is	O
a	O
major	O
target	O
of	O
the	O
protein	B
kinase	I
casein	I
kinase	I
2	I
(	O
PK	B
CK2	I
)	O
in	O
vivo	O
.	O

Recent	O
work	O
in	O
this	O
laboratory	O
has	O
shown	O
that	O
the	O
gene	O
coding	O
for	O
acetate	B
kinase	I
(	O
ackA	B
)	O
in	O
Sinorhizobium	O
meliloti	O
is	O
up	O
-	O
regulated	O
in	O
response	O
to	O
phosphate	O
limitation	O
.	O

All	O
numbers	O
refer	O
to	O
nucleotide	O
positions	O
on	O
the	O
wild	O
-	O
type	O
HIV-1	O
transcript	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
the	O
MEMA	B
protein	I
is	O
identical	O
with	O
a	O
160	B
kDa	I
nuclear	I
'	I
domain	I
rich	I
in	I
serines	I
'	I
(	I
DRS	I
)	I
protein	I
occurring	O
free	O
in	O
the	O
nucleoplasm	O
and	O
in	O
U2-ribonucleoprotein	B
structures	I
.	O

Here	O
,	O
we	O
report	O
the	O
complete	O
structure	O
of	O
the	O
human	B
topoisomerase	I
IIalpha	I
gene	I
,	O
which	O
consists	O
of	O
35	O
exons	O
spanning	O
27.5	O
kb	O
.	O

Dopaminergic	O
modulation	O
of	O
transcallosal	O
activity	O
of	O
cat	O
motor	O
cortical	O
neurons	O
.	O

Previous	O
studies	O
characterized	O
a	O
cytokine	O
-	O
inducible	O
,	O
functional	O
nuclear	B
factor	I
(	I
NF	I
)	I
-kappaB	I
consensus	I
element	I
in	O
the	O
immediate	O
5	O
'	O
regulatory	O
region	O
of	O
the	O
MGSA	B
/	O
GRO	B
-	I
alpha	I
gene	O
at	O
-78	O
bp	O
.	O

An	O
exon	O
that	O
prevents	O
transport	O
of	O
a	O
mature	O
mRNA	O
.	O

Four	O
CsA	O
-	O
treated	O
patients	O
developed	O
persistently	O
elevated	O
UAER	O
>	O
30	O
mg	O
/	O
24	O
h	O
(	O
n	O
=	O
3	O
with	O
microalbuminuria	O
)	O
,	O
whereas	O
all	O
the	O
17	O
placebo	O
-	O
treated	O
patients	O
had	O
normal	O
UAER	O
(	O
<	O
30	O
mg	O
/	O
24	O
h	O
)	O
after	O
7	O
years	O
of	O
follow	O
-	O
up	O
.	O

Mutational	O
analysis	O
of	O
the	O
-84	O
/	O
-55	O
DNA	O
showed	O
that	O
JEG-3	O
nuclear	O
proteins	O
bound	O
to	O
a	O
site	O
containing	O
,	O
but	O
not	O
identical	O
to	O
,	O
the	O
SF-1	B
sequence	I
.	O

In	O
contrast	O
,	O
no	O
change	O
was	O
detected	O
in	O
the	O
phenotype	O
of	O
'	O
unstressed	O
'	O
clones	O
,	O
with	O
respect	O
to	O
any	O
of	O
the	O
following	O
parameters	O
:	O
proliferation	O
rate	O
in	O
monolayer	O
,	O
serum	O
-	O
dependence	O
for	O
proliferation	O
or	O
survival	O
,	O
tumorigenicity	O
,	O
cellular	O
morphology	O
,	O
or	O
tissue	O
-	O
specific	O
differentiation	O
markers	O
.	O

A	O
high	O
reactor	O
pH	O
(	O
+	O
/-8	O
)	O
,	O
a	O
short	O
solid	O
retention	O
time	O
(	O
<	O
150	O
days	O
)	O
,	O
and	O
the	O
presence	O
of	O
a	O
substantial	O
SRB	O
population	O
in	O
the	O
inoculum	O
may	O
considerably	O
reduce	O
the	O
time	O
required	O
for	O
acetate	O
-	O
utilising	O
SRB	O
to	O
outcompete	O
MB	O
.	O

In	O
throttling	O
valves	O
,	O
the	O
aim	O
is	O
to	O
correlate	O
the	O
effect	O
of	O
shear	O
to	O
a	O
parameter	O
related	O
to	O
the	O
inner	O
geometry	O
of	O
the	O
valve	O
and	O
to	O
operating	O
conditions	O
.	O

The	O
induced	O
respiratory	O
burst	O
was	O
investigated	O
by	O
the	O
intracellular	O
oxidative	O
transformation	O
of	O
dihydrorhodamine	O
123	O
to	O
the	O
fluorescent	O
dye	O
rhodamine	O
123	O
via	O
flow	O
cytometry	O
.	O

A	O
mutation	O
linked	O
to	O
the	O
SOC1	B
gene	I
,	O
previously	O
defined	O
by	O
recessive	O
mutations	O
that	O
suppress	O
cbp1	B
ts	I
alleles	I
and	O
stabilize	O
many	O
mitochondrial	O
mRNAs	O
,	O
was	O
also	O
isolated	O
.	O

A	O
deletion	O
mutation	O
analysis	O
of	O
the	O
recombinant	O
protein	O
has	O
shown	O
that	O
the	O
N	O
-	O
terminal	O
region	O
and	O
the	O
two	O
leucine	O
zippers	O
are	O
necessary	O
for	O
the	O
binding	O
.	O

A	O
database	O
search	O
has	O
revealed	O
as	O
the	O
most	O
significative	O
homology	O
a	O
match	O
with	O
the	O
human	B
mitochondrial	I
transcription	I
termination	I
factor	I
(	O
mTERF	B
)	O
,	O
a	O
protein	O
that	O
also	O
binds	O
DNA	O
as	O
a	O
monomer	O
and	O
contains	O
three	O
leucine	O
zippers	O
forming	O
intramolecular	O
interactions	O
.	O

In	O
all	O
trials	O
,	O
antigen	O
challenge	O
followed	O
1	O
h	O
after	O
the	O
last	O
treatment	O
.	O

We	O
found	O
that	O
total	O
PSA	B
can	O
be	O
detected	O
in	O
all	O
cyst	O
fluids	O
and	O
in	O
about	O
75	O
%	O
of	O
female	O
sera	O
.	O

Type	O
I	O
cysts	O
(	O
with	O
a	O
high	O
K+	O
/	O
Na+	O
ratio	O
)	O
tend	O
to	O
have	O
higher	O
total	O
PSA	B
than	O
Type	O
II	O
cysts	O
.	O

Despite	O
this	O
DNA	O
binding	O
activity	O
,	O
AP-1	B
reporter	I
activity	O
was	O
suppressed	O
in	O
these	O
cells	O
.	O

A	O
single	O
N	O
-	O
glycosylation	O
site	O
present	O
in	O
chicken	B
gp42	I
is	O
conserved	O
among	O
all	O
five	O
of	O
these	O
proteins	O
:	O
carbohydrate	O
analysis	O
of	O
gp42	B
revealed	O
the	O
presence	O
of	O
a	O
complex	O
type	O
glycan	O
chain	O
at	O
this	O
site	O
.	O

Here	O
we	O
describe	O
the	O
optimization	O
and	O
characterization	O
of	O
a	O
140-residue	O
fragment	O
,	O
containing	O
the	O
Runt	B
domain	I
of	O
AML1	B
,	O
which	O
is	O
suitable	O
for	O
structural	O
studies	O
.	O

Groups	O
dicker	O
for	O
price	O
breaks	O
as	O
anesthetic	O
gas	O
goes	O
multi	O
-	O
source	O
.	O

Ultrasonography	O
provides	O
excellent	O
intraoperative	O
evaluation	O
of	O
spinal	O
cord	O
injury	O
.	O

UPMC	O
is	O
not	O
the	O
only	O
organization	O
pursuing	O
controlled	O
NHBC	O
organ	O
procurement	O
,	O
however	O
.	O

Because	O
of	O
concerns	O
regarding	O
blood	O
transfusion	O
-	O
related	O
communicable	O
disease	O
(	O
eg	O
,	O
acquired	O
immune	O
deficiency	O
syndrome	O
and	O
non	O
-	O
A	O
,	O
non	O
-	O
B	O
hepatitis	O
)	O
,	O
there	O
has	O
been	O
increasing	O
research	O
effort	O
into	O
postoperative	O
hemorrhage	O
related	O
to	O
cardiopulmonary	O
bypass	O
with	O
extracorporeal	O
circulation	O
.	O

They	O
contrast	O
trends	O
in	O
fertility	O
,	O
life	O
expectancy	O
ratios	O
,	O
and	O
gender	O
differences	O
in	O
these	O
countries	O
with	O
the	O
Hispanic	O
population	O
of	O
the	O
United	O
States	O
.	O

Hospital	O
hit	O
for	O
hiring	O
AHERF	O
physicians	O
.	O

Overexpression	O
of	O
either	O
DAP-1	B
or	O
sentrin	B
causes	O
apoptosis	O
of	O
TNF	B
-	O
sensitive	O
L929	O
fibroblast	O
cell	O
line	O
,	O
as	O
well	O
as	O
TNF	B
-	O
resistant	O
osteosarcoma	O
cell	O
line	O
,	O
U2OS	O
.	O

This	O
is	O
in	O
contrast	O
to	O
PPARgamma2	B
,	O
which	O
was	O
previously	O
shown	O
to	O
be	O
phosphorylated	O
at	O
a	O
single	O
site	O
in	O
a	O
motif	O
that	O
is	O
not	O
homologous	O
to	O
the	O
sites	O
now	O
described	O
in	O
PPARalpha	B
.	O

These	O
results	O
suggest	O
KCC3	B
is	O
a	O
new	O
member	O
of	O
the	O
KCC	B
family	I
that	O
is	O
under	O
distinct	O
regulation	O
from	O
KCC1	B
.	O

We	O
have	O
screened	O
the	O
elastin	B
gene	I
for	O
mutations	O
responsible	O
for	O
supravalvular	O
aortic	O
stenosis	O
(	O
SVAS	O
)	O
in	O
two	O
large	O
,	O
independently	O
collected	O
families	O
with	O
isolated	O
(	O
nonsyndromic	O
)	O
SVAS	O
.	O

Spatiotemporal	O
expression	O
of	O
the	O
PAX3	B
gene	I
is	O
tightly	O
regulated	O
during	O
development	O
.	O

25-OH	O
-	O
D3	O
did	O
not	O
adversely	O
affect	O
animal	O
health	O
at	O
the	O
proposed	O
use	O
level	O
of	O
99	O
micrograms	O
/	O
kg	O
feed	O
when	O
replacing	O
vitamin	O
D3	O
in	O
turkey	O
rations	O
.	O

A	O
list	O
of	O
12	O
names	O
for	O
the	O
disease	O
and	O
37	O
diagnostic	O
criteria	O
were	O
proposed	O
to	O
a	O
Consensus	O
Panel	O
of	O
12	O
Italian	O
experts	O
who	O
ranked	O
them	O
in	O
order	O
so	O
as	O
to	O
identify	O
a	O
core	O
set	O
of	O
criteria	O
.	O

Methanesulfonyl	O
fluoride	O
(	O
MSF	O
)	O
:	O
a	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
study	O
of	O
safety	O
and	O
efficacy	O
in	O
the	O
treatment	O
of	O
senile	O
dementia	O
of	O
the	O
Alzheimer	O
type	O
.	O

Voluntary	O
wheel	O
running	O
did	O
not	O
significantly	O
increase	O
estimated	O
alanine	O
or	O
pyruvate	O
Gneo	O
or	O
absolute	O
glycerol	O
Ra	O
.	O

Immediately	O
after	O
surgery	O
,	O
dialysate	O
PGE2	O
and	O
adenosine	O
concentrations	O
were	O
3.7	O
+	O
/-	O

0.7	O
and	O
296	O
+	O
/-	O

127	O
nM	O
,	O
respectively	O
.	O

Because	O
of	O
the	O
probable	O
causal	O
relationship	O
between	O
constitutive	O
p210	B
(	O
bcr	B
/	O
abl	B
)	O
protein	B
tyrosine	I
kinase	I
activity	O
and	O
manifestations	O
of	O
chronic	O
-	O
phase	O
chronic	O
myelogenous	O
leukemia	O
(	O
CML	O
;	O
myeloid	O
expansion	O
)	O
,	O
a	O
key	O
goal	O
is	O
to	O
identify	O
relevant	O
p210	B
substrates	O
in	O
primary	O
chronic	O
-	O
phase	O
CML	O
hematopoietic	O
progenitor	O
cells	O
.	O

In	O
vitro	O
precipitation	O
with	O
a	O
glutathione	B
-	I
S	I
-	I
transferase	I
-	I
fusion	I
protein	I
containing	O
the	O
C	O
-	O
terminal	O
transactivation	O
domain	O
of	O
STAT5a	B
showed	O
GH	B
-	O
regulated	O
association	O
of	O
ERK1	B
/	I
2	I
with	O
the	O
fusion	O
protein	O
,	O
while	O
this	O
was	O
not	O
seen	O
when	O
serine	O
780	O
in	O
STAT5a	B
was	O
changed	O
to	O
alanine	O
.	O

One	O
such	O
element	O
,	O
1P	O
,	O
was	O
employed	O
to	O
clone	O
from	O
a	O
rat	O
pituitary	O
cDNA	O
expression	O
library	O
a	O
novel	O
417-amino	B
acid	I
WD	I
protein	I
,	O
designated	O
PREB	B
(	I
PRL	I
regulatory	I
element	I
binding	I
)	I
protein	I
.	O

Characterization	O
of	O
the	O
transcription	B
factor	I
MTF-1	I
from	O
the	O
Japanese	O
pufferfish	O
(	O
Fugu	O
rubripes	O
)	O
reveals	O
evolutionary	O
conservation	O
of	O
heavy	O
metal	O
stress	O
response	O
.	O

The	O
peroxisome	B
proliferator	I
-	I
activated	I
receptors	I
(	O
PPARs	B
)	O
are	O
members	O
of	O
the	O
nuclear	B
hormone	I
receptor	I
superfamily	I
.	O

However	O
,	O
F	B
-	I
SRC-1	I
mutant	I
lacking	O
CBP	B
-	I
interacting	I
domain	I
still	O
preserved	O
enhancing	O
activity	O
.	O

The	O
catalytic	O
site	O
has	O
an	O
S1	O
pocket	O
lined	O
with	O
conserved	O
hydrophobic	O
residues	O
to	O
accommodate	O
the	O
pyroglutamyl	O
residue	O
.	O

The	O
complete	O
circular	O
TTV	O
genome	O
contained	O
a	O
novel	O
sequence	O
of	O
113	O
nt	O
(	O
nt	O
3740	O
to	O
3852	O
[	O
=	O
0	O
]	O
)	O
in	O
between	O
the	O
known	O
3'-	O
and	O
5'-end	O
arms	O
,	O
forming	O
a	O
117-nt	O
GC	O
-	O
rich	O
stretch	O
(	O
GC	O
content	O
,	O
90.6	O
%	O
at	O
nt	O
3736	O
to	O
3852	O
)	O
.	O

The	O
Asian	O
mouse	O
Mus	O
castaneus	O
is	O
resistant	O
to	O
infection	O
by	O
the	O
polytropic	O
mink	O
cell	O
focus	O
-	O
inducing	O
(	O
MCF	O
)	O
subgroup	O
of	O
murine	O
leukemia	O
viruses	O
(	O
MuLVs	O
)	O
.	O

To	O
determine	O
the	O
function	O
of	O
VZV	B
gK	I
in	O
virus	O
growth	O
,	O
a	O
series	O
of	O
gK	B
deletion	I
mutants	I
were	O
constructed	O
with	O
VZV	O
cosmid	O
DNA	O
derived	O
from	O
the	O
Oka	O
strain	O
.	O

CCAAT	B
displacement	I
protein	I
binds	O
to	O
and	O
negatively	O
regulates	O
human	O
papillomavirus	O
type	O
6	O
E6	B
,	O
E7	B
,	O
and	O
E1	B
promoters	O
.	O

As	O
such	O
the	O
findings	O
support	O
existing	O
studies	O
that	O
have	O
identified	O
given	O
social	O
characteristics	O
of	O
drink	O
drivers	O
.	O

Three	O
different	O
site	O
-	O
directed	O
mutations	O
of	O
the	O
cyclic	O
AMP	O
response	O
element	O
each	O
reduced	O
the	O
nerve	B
growth	I
factor	I
effect	O
by	O
>	O
90	O
%	O
.	O

Using	O
an	O
RNase	B
H	I
protection	O
assay	O
and	O
specific	O
blocking	O
oligonucleotides	O
,	O
we	O
find	O
that	O
recognition	O
of	O
the	O
5	O
'	O
splice	O
-	O
site	O
(	O
5'ss	O
)	O
and	O
branchpoint	O
sequence	O
(	O
BPS	O
)	O
elements	O
by	O
U11	B
and	O
U12	B
snRNPs	I
,	O
respectively	O
,	O
displays	O
strong	O
cooperativity	O
,	O
requiring	O
both	O
sites	O
in	O
the	O
pre	O
-	O
mRNA	O
substrate	O
for	O
efficient	O
complex	O
formation	O
.	O

Analysis	O
of	O
lacZ	B
transcriptional	I
fusions	I
shows	O
that	O
the	O
KdgR	B
-	I
binding	I
sites	I
negatively	O
affect	O
the	O
expression	O
of	O
rsmB.	B

Many	O
eukaryotic	O
cell	O
surface	O
proteins	O
are	O
anchored	O
in	O
the	O
lipid	O
bilayer	O
through	O
glycosylphosphatidylinositol	O
(	O
GPI	O
)	O
.	O

In	O
the	O
cell	O
-	O
free	O
import	O
assay	O
,	O
beta	B
-	I
catenin	I
rapidly	O
migrates	O
into	O
the	O
nucleus	O
without	O
the	O
exogenous	O
addition	O
of	O
cytosol	O
,	O
Ran	B
,	O
or	O
ATP	O
/	O
GTP	O
.	O

In	O
ischemic	O
and	O
hypoxic	O
hypoxia	O
,	O
a	O
strong	O
correlation	O
was	O
found	O
between	O
cyt	O
a	O
,	O
a3	O
oxidation	O
level	O
and	O
VO2	O
in	O
both	O
ischemic	O
and	O
hypoxic	O
hypoxia	O
(	O
r2	O
=	O
.90	O
and	O
.87	O
,	O
respectively	O
)	O
.	O

An	O
endogenous	O
mammalian	O
regulator	O
of	O
this	O
process	O
,	O
named	O
Usurpin	B
,	O
has	O
been	O
identified	O
(	O
aliases	O
for	O
Usurpin	B
include	O
CASH	B
,	O
Casper	B
,	O
CLARP	B
,	O
FLAME-1	B
,	O
FLIP	B
,	O
I	B
-	I
FLICE	I
and	O
MRIT	B
)	O
.	O

Plasma	O
glucose	O
,	O
immunoreactive	B
insulin	I
(	O
IRI	B
)	O
,	O
C	B
-	I
peptide	I
,	O
glucagon	B
,	O
and	O
GLP-1	B
levels	O
at	O
each	O
time	O
point	O
during	O
OGTT	O
were	O
measured	O
.	O

Each	O
recombinant	O
product	O
was	O
a	O
fusion	O
protein	O
with	O
a	O
B	O
domain	O
of	O
Staphylococcal	B
protein	I
A	I
(	O
SPA	B
)	O
.	O

Polypyrimidine	O
and	O
ssDNA	O
binding	O
by	O
the	O
isolated	O
VH	B
domain	I
of	O
immunization	O
-	O
induced	O
anti	O
-	O
Z	O
-	O
DNA	O
Ab	O
resembles	O
the	O
activity	O
of	O
natural	O
autoantibodies	O
and	O
suggests	O
that	O
VH	B
-	O
dependent	O
binding	O
to	O
a	O
ligand	O
mimicked	O
by	O
polypyrimidines	O
may	O
play	O
a	O
role	O
in	O
B	O
cell	O
selection	O
before	O
immunization	O
with	O
Z	O
-	O
DNA	O
.	O

Technetium-99	O
m	O
methylene	O
diphosphonate	O
scintimammography	O
for	O
evaluation	O
of	O
palpable	O
breast	O
masses	O
.	O

Nuclear	O
receptors	O
(	O
NRs	O
)	O
can	O
function	O
as	O
ligandinducible	O
transregulators	O
in	O
both	O
mammalian	O
and	O
yeast	O
cells	O
,	O
indicating	O
that	O
important	O
features	O
of	O
transcriptional	O
control	O
have	O
been	O
conserved	O
throughout	O
evolution	O
.	O

When	O
tethered	O
to	O
a	O
heterologous	O
DNA	O
-	O
binding	O
domain	O
,	O
PSU1	B
can	O
activate	O
transcription	O
on	O
its	O
own	O
.	O

OBJECTIVE	O
:	O
To	O
follow	O
-	O
up	O
prospectively	O
patients	O
with	O
arthritis	O
after	O
infection	O
with	O
beta	O
-	O
haemolytic	O
streptococci	O
of	O
Lancefield	O
group	O
A	O
(	O
beta	O
HSA	O
)	O
,	O
with	O
emphasis	O
on	O
clinical	O
characteristics	O
and	O
serological	O
features	O
.	O

Bacteria	O
can	O
also	O
cause	O
a	O
labyrinthitis	O
acting	O
directly	O
on	O
the	O
inner	O
ear	O
:	O
among	O
these	O
,	O
Treponemas	O
Pallidum	O
,	O
a	O
spirochaete	O
which	O
causes	O
syphilis	O
and	O
Borrelia	O
Burgdorferi	O
,	O
a	O
spirochaete	O
that	O
causes	O
Lyme	O
Disease	O
,	O
must	O
be	O
mentioned	O
.	O

We	O
found	O
that	O
the	O
expression	O
of	O
the	O
protein	O
was	O
maximum	O
in	O
mitosis	O
and	O
minimum	O
in	O
G1	O
,	O
which	O
correlated	O
with	O
the	O
expression	O
of	O
its	O
messenger	O
RNA	O
.	O

These	O
findings	O
demonstrate	O
that	O
signature	O
-	O
tagged	O
mutagenesis	O
is	O
a	O
viable	O
approach	O
to	O
identify	O
bacterial	O
genes	O
associated	O
with	O
the	O
ability	O
to	O
infect	O
the	O
urinary	O
tract	O
.	O

Pathol	O
.	O

The	O
eukaryotic	O
cell	O
cycle	O
is	O
governed	O
in	O
part	O
by	O
the	O
periodic	O
transcription	O
of	O
cyclin	B
genes	I
,	O
whose	O
protein	O
products	O
associate	O
with	O
and	O
positively	O
regulate	O
the	O
cyclin	B
-	I
dependent	I
kinases	I
.	O

The	O
GAC1	B
gene	I
encodes	O
the	O
regulatory	O
subunit	O
for	O
a	O
type	B
1	I
serine	I
/	I
threonine	I
phosphoprotein	I
phosphatase	I
,	O
Glc7	B
.	O

The	O
results	O
demonstrate	O
that	O
the	O
Glc7	B
phosphatase	I
and	O
its	O
Gac1	B
regulatory	O
subunit	O
play	O
positive	O
roles	O
in	O
HSF	B
activation	O
of	O
CUP1	B
transcription	O
.	O

MEF	B
and	O
AML1B	B
synergistically	O
transactivated	O
an	O
interleukin	B
3	I
promoter	I
reporter	I
gene	I
construct	I
,	O
yet	O
the	O
activating	O
activity	O
of	O
MEF	B
was	O
abolished	O
when	O
MEF	B
was	O
coexpressed	O
with	O
AML1	B
/	O
ETO	B
.	O

Mechanistically	O
,	O
the	O
presence	O
of	O
the	O
GRR	O
appears	O
to	O
stop	O
further	O
degradation	O
of	O
p50	B
and	O
to	O
stabilize	O
the	O
molecule	O
.	O

This	O
phosphorylation	O
can	O
be	O
catalyzed	O
by	O
a	O
break	O
-	O
ended	O
double	O
-	O
stranded	O
DNA	O
-	O
activated	O
protein	O
kinase	O
activity	O
from	O
the	O
sea	O
urchin	O
nucleus	O
in	O
vitro	O
.	O

Concomitantly	O
,	O
the	O
total	O
cellular	O
level	O
of	O
p21	B
increased	O
severalfold	O
via	O
a	O
posttranscriptional	O
mechanism	O
.	O

Overall	O
,	O
our	O
results	O
suggest	O
that	O
resistant	O
genotypes	O
exist	O
among	O
the	O
WAD	O
goat	O
population	O
.	O

The	O
molecular	O
mechanism	O
by	O
which	O
Gle2p	B
and	O
the	O
Gle2p	B
-	O
Nup116p	B
interaction	O
function	O
in	O
mRNA	O
export	O
is	O
unknown	O
.	O

The	O
Fyn	B
NH2	I
terminus	I
was	O
necessary	O
but	O
not	O
sufficient	O
for	O
interaction	O
with	O
zeta	O
and	O
both	O
Fyn	B
kinase	I
and	O
SH2	B
domains	I
were	O
required	O
,	O
directing	O
phosphorylation	O
of	O
zeta	B
ITAM	I
tyrosines	O
and	O
binding	O
to	O
zeta	B
ITAM	I
phosphotyrosines	O
.	O

In	O
budding	O
yeast	O
,	O
the	O
protein	O
Skp1p	B
,	O
the	O
cullin	B
-	I
family	I
member	I
Cdc53p	B
,	O
and	O
the	O
F	O
-	O
box	O
/	O
WD	O
-	O
repeat	O
protein	O
Cdc4p	B
form	O
the	O
SCFCdc4p	B
ubiquitin	B
ligase	I
complex	O
,	O
which	O
targets	O
the	O
cyclin	B
-	I
dependent	I
kinase	I
(	O
Cdk	B
)	O
inhibitor	O
Sic1p	B
for	O
proteolysis	O
[	O
3	O
]	O
[	O
4	O
]	O
[	O
5	O
]	O
[	O
6	O
]	O
[	O
7	O
]	O
[	O
8	O
]	O
.	O

We	O
show	O
here	O
that	O
,	O
despite	O
their	O
structural	O
and	O
functional	O
similarities	O
,	O
the	O
pop1	B
and	O
pop2	B
genes	I
fail	O
to	O
complement	O
each	O
other	O
's	O
deletion	O
phenotypes	O
,	O
indicating	O
that	O
they	O
perform	O
non	O
-	O
redundant	O
,	O
but	O
potentially	O
interdependent	O
,	O
functions	O
in	O
proteolysis	O
.	O

Antithrombin	B
III	I
prevents	O
60	O
min	O
warm	O
intestinal	O
ischemia	O
reperfusion	O
injury	O
in	O
rats	O
.	O

In	O
retrospect	O
,	O
the	O
diagnoses	O
were	O
reconsidered	O
applying	O
strict	O
criteria	O
.	O

Acute	O
pancreatitis	O
as	O
a	O
complication	O
of	O
polyarteritis	O
nodosa	O
.	O

Significantly	O
greater	O
improvement	O
(	O
p	O
<	O
0.05	O
)	O
in	O
the	O
sertraline	O
group	O
first	O
became	O
apparent	O
by	O
the	O
end	O
of	O
week	O
3	O
on	O
the	O
Y	O
-	O
BOCS	O
and	O
the	O
CGI	O
Improvement	O
scale	O
,	O
and	O
by	O
the	O
end	O
of	O
weeks	O
6	O
and	O
8	O
,	O
respectively	O
,	O
on	O
the	O
NIMH	O
and	O
CGI	O
Severity	O
scale	O
.	O

Stress	B
-	I
inducible	I
protein	I
kinases	I
capable	O
of	O
activating	O
c	B
-	I
jun	I
expression	O
include	O
stress	B
-	I
activated	I
protein	I
kinase	I
/	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
protein	I
kinase	I
(	O
SAPK	B
/	O
JNK	B
)	O
and	O
p38	B
members	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
MAPK	B
)	O
superfamily	O
of	O
signaling	O
molecules	O
.	O

Transforming	B
growth	I
factor	I
(	I
TGF	I
)	I
-beta1	I
induces	O
extracellular	O
matrix	O
deposition	O
and	O
proliferation	O
of	O
mesenchymal	O
cells	O
.	O

Chronotherapeutics	O
in	O
cardiovascular	O
disease	O
.	O

Group	O
psychometric	O
functions	O
for	O
listeners	O
with	O
hearing	O
loss	O
do	O
not	O
show	O
a	O
decrease	O
in	O
performance	O
at	O
the	O
largest	O
values	O
of	O
delta	O
f	O
included	O
in	O
this	O
study	O
.	O

Uroflowmetry	O
can	O
detect	O
dysuria	O
,	O
which	O
may	O
be	O
poorly	O
perceived	O
or	O
even	O
unknown	O
to	O
the	O
subjects	O
themselves	O
.	O

Marked	O
racial	O
variation	O
in	O
birthweight	O
percentiles	O
by	O
gestational	O
age	O
was	O
evident	O
.	O

Significant	O
correlations	O
between	O
mental	O
status	O
as	O
measured	O
by	O
the	O
Mini	O
-	O
Mental	O
State	O
Examination	O
and	O
NA	O
/	O
mI	O
,	O
mI	O
/	O
Cr	O
and	O
NA	O
were	O
found	O
.	O

Glucagon	B
also	O
induced	O
LUC	B
activity	O
very	O
strongly	O
when	O
the	O
CRE1	O
and	O
CRE2	O
sites	O
were	O
combined	O
;	O
induction	O
of	O
the	O
(	O
CRE1	O
)	O
3	O
(	O
CRE2	O
)	O
2SV40-LUC	O
constructs	O
was	O
positively	O
modulated	O
by	O
the	O
pO2	O
.	O

In	O
this	O
study	O
,	O
we	O
report	O
the	O
isolation	O
and	O
characterization	O
of	O
the	O
entire	O
rat	B
GSTA3	I
(	O
rGST	B
Yc1	I
)	O
subunit	O
gene	O
.	O

Initial	O
control	O
of	O
bleeding	O
is	O
similar	O
,	O
but	O
eradication	O
is	O
achieved	O
in	O
fewer	O
sessions	O
with	O
EVL	O
.	O

Finally	O
,	O
we	O
determined	O
the	O
genomic	O
organization	O
of	O
the	O
human	B
TrxR2	I
gene	I
,	O
which	O
consists	O
of	O
18	O
exons	O
spanning	O
about	O
67	O
kb	O
,	O
and	O
its	O
chromosomal	O
localization	O
at	O
position	O
22q11.2	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
determine	O
and	O
rank	O
the	O
frequency	O
of	O
self	O
reported	O
visual	O
disability	O
in	O
daily	O
tasks	O
performed	O
by	O
glaucoma	O
patients	O
;	O
to	O
examine	O
the	O
interrelation	O
between	O
disabilities	O
using	O
factor	O
analysis	O
;	O
to	O
study	O
the	O
relation	O
between	O
perceived	O
visual	O
difficulty	O
and	O
a	O
measure	O
of	O
the	O
severity	O
of	O
visual	O
field	O
loss	O
;	O
to	O
develop	O
a	O
glaucoma	O
specific	O
subgroup	O
of	O
questions	O
;	O
and	O
examine	O
the	O
validity	O
and	O
reliability	O
of	O
this	O
subgroup	O
of	O
questions	O
.	O

Furthermore	O
,	O
the	O
validity	O
of	O
this	O
new	O
subset	O
of	O
questions	O
was	O
shown	O
to	O
be	O
significant	O
(	O
r=0.037	O
,	O
p<0.05	O
)	O
for	O
the	O
correlation	O
between	O
a	O
measure	O
of	O
the	O
severity	O
of	O
binocular	O
visual	O
field	O
loss	O
and	O
the	O
mean	O
score	O
of	O
the	O
variables	O
used	O
in	O
the	O
glaucoma	O
specific	O
subgroup	O
of	O
questions	O
.	O

Sequence	O
comparison	O
of	O
cytochromes	B
bd	I
and	O
their	O
homologs	O
from	O
various	O
organisms	O
demonstrates	O
that	O
the	O
proteins	O
can	O
be	O
classified	O
into	O
two	O
subfamilies	O
,	O
a	O
proteobacterial	O
type	O
including	O
E.	B
coli	I
bd	I
and	O
a	O
more	O
widely	O
distributed	O
type	O
including	O
the	O
B.	O
stearothermophilus	O
enzyme	O
,	O
suggesting	O
that	O
the	O
latter	O
type	O
is	O
evolutionarily	O
older	O
.	O

Canalith	O
repositioning	O
is	O
the	O
mainstay	O
of	O
treatment	O
.	O

Solution	O
structure	O
and	O
mechanism	O
of	O
the	O
MutT	B
pyrophosphohydrolase	I
.	O

In	O
11	O
eyes	O
that	O
had	O
been	O
selected	O
at	O
random	O
10	O
micrograms	O
of	O
recombinant	B
tissue	I
plasminogen	I
activator	I
were	O
injected	O
midvitreally	O
24	O
hrs	O
later	O
.	O

Accordingly	O
,	O
we	O
designated	O
this	O
gene	B
CTL1	I
(	O
capping	B
enzyme	I
RNAtriphosphatase	I
-	I
like	I
1	I
)	O
.	O

The	O
binding	O
of	O
PH	B
domains	I
to	O
Gbetagamma	B
was	O
inhibited	O
by	O
preincubation	O
of	O
Gbetagamma	B
with	O
the	O
GDP	O
-	O
bound	O
but	O
not	O
the	O
GTP	O
-	O
bound	O
form	O
of	O
Gialpha	B
.	O

Their	O
afterglows	O
are	O
brighter	O
than	O
supernovae	O
and	O
therefore	O
are	O
called	O
hypernovae	O
.	O

Constrictive	O
pericarditis	O
and	O
pleuropulmonary	O
disease	O
linked	O
to	O
ergot	O
dopamine	O
agonist	O
therapy	O
(	O
cabergoline	O
)	O
for	O
Parkinson	O
's	O
disease	O
.	O

An	O
undilated	O
type	O
of	O
APBD	O
is	O
frequently	O
associated	O
with	O
AMT	O
and	O
we	O
believe	O
,	O
therefore	O
,	O
that	O
clinicians	O
should	O
be	O
aware	O
of	O
a	O
possible	O
coexistence	O
of	O
APBD	O
and	O
AMT	O
.	O

In	O
addition	O
,	O
we	O
also	O
constructed	O
and	O
expressed	O
chimeric	O
fusion	O
protein	O
that	O
contains	O
HIV-2	B
gag	I
with	O
V3	B
domains	O
of	O
HIV-1IIIB	O
,	O
HIV-1MN	O
,	O
HIV-1SF2	O
and	O
HIV-1RF	O
.	O

Our	O
results	O
indicate	O
that	O
V3	B
peptides	O
from	O
all	O
major	O
clades	O
of	O
HIV-1	O
carried	O
by	O
HIV-2	B
gag	I
can	O
be	O
used	O
as	O
a	O
potential	O
HIV	O
/	O
AIDS	O
vaccine	O
.	O

Efficacy	O
was	O
determined	O
by	O
responses	O
to	O
question	O
3	O
(	O
ability	O
to	O
achieve	O
an	O
erection	O
)	O
and	O
question	O
4	O
(	O
ability	O
to	O
maintain	O
an	O
erection	O
)	O
of	O
the	O
15-item	O
International	O
Index	O
of	O
Erectile	O
Function	O
(	O
IIEF	O
)	O
.	O

Evidence	O
for	O
the	O
involvement	O
of	O
the	O
Glc7-Reg1	B
phosphatase	O
and	O
the	O
Snf1-Snf4	B
kinase	O
in	O
the	O
regulation	O
of	O
INO1	B
transcription	O
in	O
Saccharomyces	O
cerevisiae	O
.	O

In	O
XO	O
males	O
,	O
two	O
her-1	B
mRNAs	I
,	O
her-1a	B
and	O
her-1b	B
,	O
are	O
transcribed	O
from	O
two	O
separate	O
promoters	O
:	O
P1	O
,	O
located	O
in	O
the	O
5'-flanking	O
region	O
,	O
and	O
P2	O
,	O
located	O
in	O
the	O
large	O
second	O
intron	O
.	O

Induction	O
of	O
Fas	B
ligand	I
expression	O
by	O
HIV	O
involves	O
the	O
interaction	O
of	O
Nef	B
with	O
the	O
T	B
cell	I
receptor	I
zeta	I
chain	I
.	O

Receptor	B
protein	I
tyrosine	I
phosphatases	I
(	O
RPTPs	B
)	O
comprise	O
a	O
family	O
of	O
proteins	O
that	O
feature	O
intracellular	O
phosphatase	O
domains	O
and	O
an	O
ectodomain	O
with	O
putative	O
ligand	O
-	O
binding	O
motifs	O
.	O

These	O
well	O
-	O
characterized	O
brain	O
regions	O
may	O
provide	O
a	O
basis	O
for	O
future	O
studies	O
of	O
RPTP	B
-	I
kappa	I
function	O
.	O

Commonly	O
used	O
stressors	O
are	O
mental	O
arithmetics	O
,	O
speech	O
tasks	O
,	O
the	O
Stroop	O
test	O
,	O
videogame	O
playing	O
,	O
films	O
or	O
videotapes	O
and	O
interviews	O
.	O

The	O
control	O
group	O
included	O
8	O
afterbirth	O
samples	O
from	O
physiological	O
full	O
-	O
term	O
pregnancies	O
.	O

However	O
,	O
we	O
identified	O
a	O
gene	O
between	O
the	O
MDV2	B
UL54	I
and	O
UL55	B
genes	I
with	O
homology	O
to	O
the	O
first	B
ORF	I
(	I
ORF-1	I
)	I
of	I
equine	I
herpesvirus	I
type	I
1	I
and	O
corresponding	O
gene	O
identified	O
in	O
pseudorabies	O
virus	O
.	O

In	O
contrast	O
,	O
the	O
loss	O
of	O
MAD2	B
staining	O
in	O
meiosis	O
was	O
not	O
correlated	O
with	O
initial	O
microtubule	O
attachment	O
but	O
was	O
correlated	O
with	O
a	O
measure	O
of	O
tension	O
:	O
the	O
distance	O
between	O
homologous	O
or	O
sister	O
kinetochores	O
(	O
in	O
meiosis	O
I	O
and	O
II	O
,	O
respectively	O
)	O
.	O

In	O
epithelial	O
cells	O
,	O
the	O
PH	B
domain	I
of	O
Akt	B
/	O
PKB	B
localised	O
to	O
sites	O
of	O
cell	O
-	O
cell	O
and	O
cell	O
-	O
matrix	O
contact	O
,	O
distinct	O
from	O
focal	O
contacts	O
,	O
even	O
in	O
the	O
absence	O
of	O
serum	O
.	O

The	O
5	O
'	O
untranslated	O
and	O
coding	O
regions	O
are	O
contained	O
within	O
12	O
exons	O
,	O
with	O
the	O
translation	O
start	O
site	O
located	O
within	O
the	O
first	O
exon	O
.	O

The	O
motility	O
of	O
sperm	O
,	O
except	O
for	O
those	O
adjacent	O
to	O
both	O
electrodes	O
,	O
did	O
not	O
change	O
after	O
stimulation	O
for	O
60s	O
,	O
despite	O
a	O
high	O
electrical	O
energy	O
.	O

Induction	O
of	O
the	O
CINC	B
promoter	I
by	O
IL-17	B
in	O
IEC-6	O
cells	O
was	O
TNF	B
receptor	I
-	I
associated	I
factor-6	I
(	O
TRAF6	B
)	O
,	O
but	O
not	O
TRAF2	B
,	O
dependent	O
.	O

SCFFWD1	B
may	O
be	O
critical	O
for	O
tumor	O
development	O
and	O
suppression	O
through	O
regulation	O
of	O
beta	B
-	I
catenin	I
protein	I
stability	O
.	O

A	O
Bub2p	B
-	O
dependent	O
spindle	O
checkpoint	O
pathway	O
regulates	O
the	O
Dbf2p	B
kinase	I
in	I
budding	I
yeast	I
.	O

We	O
analyzed	O
the	O
modular	O
organization	O
of	O
DNA	B
polymerase	I
beta	I
and	O
found	O
that	O
residues	O
making	O
contact	O
with	O
DNA	O
phosphates	O
were	O
localized	O
to	O
five	O
modules	O
.	O

Two	O
-	O
dimensional	O
gel	O
electrophoresis	O
of	O
anti	B
-	I
p59fyn	I
immunoprecipitates	O
obtained	O
from	O
non	O
-	O
transformed	O
resting	O
human	O
T	O
lymphocytes	O
resulted	O
in	O
the	O
identification	O
of	O
an	O
oligomeric	O
protein	O
complex	O
which	O
is	O
constitutively	O
formed	O
between	O
Fyn	B
and	O
several	O
additional	O
phosphoproteins	O
(	O
pp43	B
,	O
pp72	B
,	O
pp85	B
,	O
the	O
protein	B
tyrosine	I
kinase	I
Pyk2	B
,	O
as	O
well	O
as	O
the	O
two	O
recently	O
cloned	O
adaptor	O
proteins	O
,	O
SKAP55	B
and	O
SLAP-130	B
)	O
.	O

We	O
show	O
that	O
other	O
cdc33	B
mutants	I
also	O
arrest	O
in	O
G1	O
.	O

A	O
cdc33	B
-	I
1	I
strain	O
expressing	O
either	O
stable	O
Cln3p	B
(	O
Cln3	B
-	I
1p	I
)	O
or	O
a	O
hybrid	O
UBI4	B
5'-CLN3	I
mRNA	O
,	O
whose	O
translation	O
displays	O
decreased	O
dependence	O
on	O
eIF4E	B
,	O
arrested	O
randomly	O
in	O
the	O
cell	O
cycle	O
.	O

Regulatory	O
motifs	O
for	O
gene	O
expression	O
such	O
as	O
nuclear	B
-	I
factor	I
-	I
kappaB	I
-	I
binding	I
-	I
site	I
-	I
like	I
sequence	I
(	O
kappaB	B
site	I
)	O
and	O
nuclear	B
-	I
factor	I
-	I
interleukin-6-binding	I
-	I
site	I
-	I
like	I
sequence	I
(	O
NF	B
-	I
IL-6	I
site	I
)	O
were	O
found	O
in	O
the	O
5'-upstream	O
regulatory	O
region	O
.	O

The	O
gene	O
structure	O
of	O
Elk1	B
spans	O
15.2	O
kb	O
and	O
consists	O
of	O
seven	O
exons	O
and	O
six	O
introns	O
.	O

Total	O
serum	O
calcium	O
was	O
7.8	O
+	O
/-	O

0.8	O
mg	O
/	O
dl	O
,	O
whereas	O
ionized	O
calcium	O
was	O
5.7	O
+	O
/-	O

0.7	O
mg	O
/	O
dl	O
,	O
phosphorus	O
3.2	O
+	O
/-	O

1.2	O
mg	O
/	O
dl	O
,	O
and	O
alkaline	B
phosphatase	I
149	O
+	O
/-	O

48.6	O
U	O
/	O
liter	O
.	O

Sequence	O
analysis	O
suggests	O
that	O
TtrA	B
contains	O
a	O
molybdopterin	O
guanine	O
dinucleotide	O
cofactor	O
and	O
a	O
[	O
4Fe-4S	O
]	O
cluster	O
,	O
that	O
TtrB	B
binds	O
four	O
[	O
4Fe-4S	O
]	O
clusters	O
,	O
and	O
that	O
TtrC	B
is	O
an	O
integral	O
membrane	O
protein	O
containing	O
a	O
quinol	O
oxidation	O
site	O
.	O

Cranio	O
-	O
caudal	O
differences	O
in	O
granulation	O
tissue	O
formation	O
:	O
an	O
experimental	O
study	O
in	O
the	O
rat	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
showed	O
that	O
two	O
adjacent	O
SP1	B
sites	I
proximal	O
to	O
exon	O
1	O
were	O
equally	O
important	O
in	O
sustaining	O
basal	O
promoter	O
activity	O
.	O

Breast	O
-	O
fed	O
newborn	O
infants	O
synthesize	O
n-6	O
long	O
-	O
chain	O
polyunsaturated	O
fatty	O
acids	O
already	O
during	O
the	O
first	O
week	O
of	O
life	O
,	O
but	O
the	O
contribution	O
of	O
endogenous	O
synthesis	O
to	O
the	O
total	O
plasma	O
long	O
-	O
chain	O
polyunsaturated	O
pool	O
is	O
small	O
.	O

Ischemia	O
and	O
reperfusion	O
markedly	O
increased	O
the	O
release	O
of	O
6-keto	O
-	O
PGF1	O
alpha	O
and	O
TXB2	O
.	O

Prostate	B
-	I
specific	I
antigen	I
(	O
PSA	B
)	O
promoter	O
-	O
driven	O
androgen	O
-	O
inducible	O
expression	O
of	O
sodium	B
iodide	I
symporter	I
in	O
prostate	O
cancer	O
cell	O
lines	O
.	O

It	O
is	O
clear	O
that	O
subclinical	O
and	O
silent	O
CD	O
exist	O
in	O
a	O
large	O
subgroup	O
of	O
the	O
celiac	O
population	O
.	O

Ras2p	B
activates	O
invasive	O
growth	O
using	O
either	O
of	O
two	O
downstream	O
signaling	O
pathways	O
,	O
the	O
filamentation	O
MAPK	B
(	O
Cdc42p	B
/	O
Ste20p	B
/	O
MAPK	B
)	O
cascade	O
or	O
the	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
(	O
Cyr1p	B
/	O
cAMP	O
/	O
PKA	B
)	O
pathway	O
.	O

Consistent	O
with	O
this	O
prediction	O
,	O
transfections	O
into	O
the	O
hematopoietic	O
cell	O
line	O
Jurkat	O
showed	O
a	O
9.0-	O
and	O
2.5-fold	O
activation	O
of	O
the	O
mim-1	B
promoter	I
by	O
the	O
p32	B
and	O
p30	B
isoforms	I
,	O
respectively	O
.	O

Previous	O
work	O
has	O
shown	O
that	O
spleen	B
necrosis	I
virus	I
(	I
SNV	I
)	I
long	I
terminal	I
repeats	I
(	O
LTRs	O
)	O
are	O
associated	O
with	O
Rex	B
/	O
Rex	B
-	O
responsive	O
element	O
-	O
independent	O
expression	O
of	O
bovine	O
leukemia	O
virus	O
RNA	O
and	O
supports	O
the	O
hypothesis	O
that	O
SNV	O
RNA	O
contains	O
a	O
cis	O
-	O
acting	O
element	O
that	O
interacts	O
with	O
cellular	B
Rex	I
-	I
like	I
proteins	I
.	O

Despite	O
the	O
reported	O
detrimental	O
effects	O
on	O
CNS	O
development	O
,	O
a	O
number	O
of	O
animal	O
studies	O
have	O
shown	O
that	O
pretreatment	O
with	O
corticosteroids	O
nevertheless	O
protect	O
the	O
brain	O
from	O
hypoxia	O
-	O
ischemic	O
injury	O
;	O
however	O
,	O
clinically	O
such	O
treatment	O
is	O
no	O
longer	O
favored	O
.	O

In	O
one	O
mechanism	O
,	O
a	O
specialized	O
ubiquitin	B
-	O
dependent	O
proteolytic	O
system	O
(	O
called	O
the	O
APC	O
-	O
dependent	O
proteolysis	O
machinery	O
)	O
degrades	O
the	O
mitotic	O
(	O
Clb	B
)	O
cyclin	B
subunit	I
.	O

Predictors	O
of	O
success	O
in	O
pharmacy	O
school	O
:	O
PCAT	O
vs.	O
other	O
admission	O
criteria	O
.	O

Canadian	O
survey	O
reveals	O
widespread	O
dissatisfaction	O
among	O
physicians	O
.	O

In	O
a	O
series	O
of	O
16	O
full	O
-	O
scale	O
fire	O
tests	O
,	O
investigators	O
at	O
the	O
IIT	O
Research	O
Institute	O
have	O
concluded	O
that	O
automatic	O
door	O
control	O
in	O
the	O
room	O
of	O
fire	O
origin	O
can	O
significantly	O
reduce	O
the	O
spread	O
of	O
toxic	O
smoke	O
and	O
gases	O
.	O

Online	O
LATCH	O
demonstrates	O
a	O
shift	O
in	O
identification	O
of	O
the	O
library	O
as	O
an	O
isolated	O
unit	O
to	O
an	O
interactive	O
resource	O
center	O
.	O

Reporting	O
of	O
adverse	O
events	O
occurring	O
during	O
clinical	O
trials	O
of	O
investigational	O
drugs	O
is	O
a	O
complex	O
and	O
controversial	O
issue	O
.	O

In	O
this	O
paper	O
,	O
the	O
current	O
status	O
of	O
the	O
understanding	O
of	O
the	O
interaction	O
mechanisms	O
of	O
ultrasound	O
with	O
biological	O
media	O
and	O
the	O
factors	O
that	O
govern	O
different	O
biological	O
effects	O
are	O
surveyed	O
.	O

Members	O
of	O
the	O
mitogen	B
activated	I
protein	I
(	I
MAP	I
)	I
kinase	I
family	I
,	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
,	O
stress	B
-	I
activated	I
protein	I
kinase-1	I
/	O
c	B
-	I
Jun	I
NH2-terminal	I
kinase	I
,	O
and	O
p38	B
,	O
are	O
central	O
elements	O
that	O
transduce	O
the	O
signal	O
generated	O
by	O
growth	O
factors	O
,	O
cytokines	O
,	O
and	O
stressing	O
agents	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
investigated	O
the	O
functional	O
role	O
of	O
the	O
other	O
MAP	B
kinases	I
in	O
PDGF	B
-	O
mediated	O
cellular	O
responses	O
.	O

Analyses	O
of	O
tyrosine	O
residue	O
-	O
mutated	O
PDGF	B
receptors	I
show	O
that	O
Src	B
homology	I
2	I
domain	I
-	I
containing	I
proteins	I
including	O
Src	B
family	I
kinases	I
,	O
phosphatidylinositol	B
3-kinase	I
,	O
the	O
GTPase	B
-	I
activating	I
protein	I
of	O
Ras	B
,	O
the	O
Src	B
homology	I
2	I
domain	I
-	I
containing	I
phosphatase	I
SHP-2	B
,	O
phospholipase	B
C	I
-	I
gamma	I
,	O
and	O
Crk	B
do	O
not	O
play	O
a	O
major	O
role	O
in	O
mediating	O
the	O
PDGF	B
-	O
induced	O
activation	O
of	O
p38	B
.	O

Here	O
we	O
show	O
that	O
calpeptin	B
inhibits	O
tyrosine	B
phosphatases	I
,	O
enhancing	O
tyrosine	O
phosphorylation	O
particularly	O
of	O
paxillin	B
.	O

Three	O
-	O
dimensional	O
structural	O
studies	O
using	O
electron	O
cryomicroscopy	O
showed	O
that	O
the	O
binding	O
of	O
one	O
Fab	B
(	O
8H2	O
/	O
G5	O
)	O
does	O
not	O
affect	O
the	O
conformation	O
of	O
the	O
capsid	O
,	O
and	O
the	O
efficiency	O
of	O
mRNA	O
production	O
is	O
similar	O
to	O
that	O
of	O
the	O
native	O
subviral	O
particle	O
.	O

Further	O
,	O
mutational	O
analysis	O
of	O
NS5A	B
assigned	O
the	O
SH3-binding	B
region	I
to	O
a	O
proline	O
-	O
rich	O
motif	O
that	O
is	O
highly	O
conserved	O
among	O
HCV	O
genotypes	O
.	O

Taken	O
together	O
,	O
these	O
findings	O
show	O
that	O
16	B
K	I
hPRL	I
inhibits	O
the	O
VEGF	B
-	O
induced	O
Ras	B
activation	O
;	O
this	O
antagonism	O
represents	O
a	O
novel	O
and	O
potentially	O
important	O
mechanism	O
for	O
the	O
control	O
of	O
angiogenesis	O
.	O

Analysis	O
of	O
SRE	O
oligonucleotide	O
gel	O
mobility	O
shift	O
assays	O
with	O
nuclear	O
extracts	O
from	O
Sertoli	O
cells	O
demonstrated	O
the	O
presence	O
of	O
both	O
the	O
SRF	B
and	O
the	O
ubiquitously	O
expressed	O
bHLH	O
protein	O
E12	B
/	O
E47	B
.	O

We	O
calculated	O
differences	O
in	O
late	O
occlusion	O
rates	O
by	O
the	O
chi2	O
(	O
chi	O
-	O
square	O
)	O
test	O
,	O
and	O
found	O
these	O
differences	O
were	O
significant	O
(	O
P=.04	O
)	O
.	O

Baseline	O
electrocorticography	O
over	O
the	O
surface	O
of	O
the	O
temporal	O
lobe	O
and	O
depth	O
electrode	O
recordings	O
in	O
the	O
amygdala	O
and	O
hippocampus	O
were	O
obtained	O
,	O
followed	O
by	O
10	O
min	O
of	O
recording	O
before	O
and	O
after	O
the	O
i.v	O
.	O

administration	O
of	O
both	O
alfentanil	O
50	O
microg	O
/	O
kg	O
and	O
fentanyl	O
10	O
microg	O
/	O
kg	O
.	O

We	O
describe	O
a	O
genetic	O
system	O
for	O
further	O
characterizing	O
the	O
role	O
of	O
the	O
extreme	O
C	O
-	O
terminus	O
of	O
the	O
beta	O
subunit	O
of	O
E.	B
coli	I
RNA	I
polymerase	I
.	O

We	O
suggest	O
that	O
FlgN	B
and	O
FliT	B
are	O
substrate	O
-	O
specific	O
flagellar	O
chaperones	O
that	O
prevent	O
oligomerization	O
of	O
the	O
HAPs	B
by	O
binding	O
to	O
their	O
helical	O
domains	O
before	O
export	O
.	O

Post	O
and	O
core	O
fabrication	O
for	O
divergent	O
canals	O
with	O
a	O
cast	O
post	O
and	O
core	O
and	O
a	O
prefabricated	O
dowel	O
.	O

Rep63A	B
(	I
513	I
amino	I
acids	I
[	I
aa	I
]	I
)	I
,	O
encoded	O
by	O
the	O
largest	O
ORF	O
,	O
displayed	O
strong	O
similarity	O
(	O
40	O
%	O
identity	O
)	O
to	O
the	O
replication	O
proteins	O
from	O
plasmids	O
pAMbeta1	O
,	O
pIP501	O
,	O
and	O
pSM19035	O
,	O
indicating	O
that	O
the	O
pAW63	O
replicon	O
belongs	O
to	O
the	O
pAMbeta1	O
family	O
of	O
gram	O
-	O
positive	O
theta	O
-	O
replicating	O
plasmids	O
.	O

Here	O
we	O
report	O
the	O
cloning	O
and	O
characterization	O
of	O
Xenopus	B
Pax-5	I
and	O
Pax-8	B
,	O
two	O
orthologues	O
of	O
the	O
Pax-2	B
/	I
5	I
/	I
8	I
gene	I
family	I
.	O

Km	O
values	O
for	O
ammonium	O
,	O
2-oxoglutarate	O
,	O
NADH	O
,	O
glutamate	O
and	O
NAD+	O
were	O
6.5	O
,	O
3.5	O
,	O
0.06	O
,	O
37.1	O
and	O
0.046	O
mM	O
,	O
respectively	O
.	O

Interferon	B
-	I
alpha	I
may	O
exacerbate	O
cryoblobulinemia	O
-	O
related	O
ischemic	O
manifestations	O
:	O
an	O
adverse	O
effect	O
potentially	O
related	O
to	O
its	O
anti	O
-	O
angiogenic	O
activity	O
.	O

Interferon	B
-	I
alpha	I
may	O
exacerbate	O
cryoblobulinemia	O
-	O
related	O
ischemic	O
manifestations	O
:	O
an	O
adverse	O
effect	O
potentially	O
related	O
to	O
its	O
anti	O
-	O
angiogenic	O
activity	O
.	O

In	O
addition	O
,	O
we	O
demonstrate	O
that	O
the	O
production	O
of	O
active	B
recombinant	I
telomerase	I
requires	O
a	O
factor	O
in	O
rabbit	O
reticulocyte	O
lysate	O
that	O
promotes	O
ribonucleoprotein	O
assembly	O
.	O

The	O
enhanced	O
binding	O
of	O
c	B
-	I
Abl	I
to	O
DNA	O
containing	O
5-methylcytosine	O
residues	O
may	O
result	O
from	O
an	O
increased	O
propensity	O
of	O
the	O
double	O
helix	O
to	O
denature	O
locally	O
coupled	O
with	O
a	O
protein	O
-	O
induced	O
reduction	O
in	O
the	O
base	O
stacking	O
interaction	O
.	O

Homozygous	O
mutation	O
in	O
two	O
children	O
led	O
to	O
amputation	O
of	O
legs	O
due	O
to	O
purpura	O
fulminans	O
.	O

According	O
to	O
pilot	O
experiments	O
which	O
considered	O
various	O
durations	O
of	O
global	O
no	O
-	O
flow	O
ischemia	O
ranging	O
from	O
10	O
to	O
20	O
minutes	O
,	O
two	O
durations	O
were	O
chosen	O
for	O
the	O
present	O
study	O
:	O
20	O
minutes	O
(	O
group	O
20	O
)	O
in	O
which	O
ventricular	O
fibrillation	O
(	O
VF	O
)	O
was	O
the	O
predominant	O
form	O
of	O
arrhythmias	O
,	O
and	O
18	O
minutes	O
(	O
group	O
18	O
)	O
in	O
which	O
the	O
prevalence	O
of	O
VF	O
was	O
markedly	O
lower	O
despite	O
the	O
small	O
difference	O
in	O
the	O
duration	O
of	O
ischemia	O
.	O

An	O
end	O
-	O
to	O
-	O
end	O
pancreaticojejunostomy	O
using	O
a	O
mechanical	O
purse	O
-	O
string	O
device	O
.	O

We	O
further	O
demonstrate	O
that	O
the	O
Stress	B
-	I
Activated	I
-	I
Protein	I
-	I
Kinase	I
(	O
SAPK	B
)	O
target	O
sites	O
of	O
ATF2	B
,	O
Thr69	O
and	O
Thr71	O
are	O
not	O
required	O
for	O
the	O
formation	O
of	O
the	O
p300	B
/	O
CBP	B
-	O
ATF2	B
multiprotein	O
complex	O
.	O

Blood	O
samples	O
were	O
obtained	O
daily	O
during	O
this	O
supplementation	O
period	O
and	O
5	O
d	O
thereafter	O
(	O
d	O
11	O
to	O
15	O
)	O
.	O

These	O
results	O
suggest	O
that	O
mitochondrial	O
presequences	O
interact	O
with	O
the	O
mt	B
-	I
hsp70	I
during	O
or	O
after	O
mitochondrial	O
protein	O
import	O
.	O

The	O
3	O
'	O
terminus	O
of	O
the	O
genome	O
can	O
be	O
folded	O
into	O
a	O
tRNA	O
-	O
like	O
secondary	O
structure	O
that	O
has	O
a	O
valine	O
anticodon	O
;	O
the	O
tRNA	O
-	O
like	O
structure	O
lacks	O
a	O
pseudoknot	O
in	O
the	O
aminoacyl	O
stem	O
,	O
a	O
feature	O
common	O
to	O
both	O
genera	O
of	O
tetraviruses	O
.	O

O.	B
novo	I
-	I
ulmi	I
RNA-7	I
,	O
previously	O
believed	O
to	O
be	O
a	O
satellite	O
-	O
like	O
RNA	O
,	O
is	O
shown	O
to	O
be	O
a	O
defective	O
RNA	O
,	O
derived	O
from	O
OnuMV4-Ld	B
RNA	I
by	O
multiple	O
internal	O
deletions	O
.	O

Only	O
one	O
gene	O
,	O
fibronectin	B
(	O
FN	B
)	O
,	O
was	O
highly	O
overexpressed	O
(	O
>	O
60-fold	O
)	O
in	O
LNCaP	O
-	O
r	O
cells	O
,	O
consistent	O
with	O
previously	O
reported	O
overexpression	O
of	O
FN	B
in	O
prostate	O
cancer	O
.	O

We	O
also	O
observed	O
that	O
cell	O
surface	O
CD4	B
(	O
-	O
)	O
CD8	B
(	O
-	O
)	O
CD3	B
(	O
-	O
)	O
cells	O
with	O
rearranged	B
TCR	I
genes	I
developed	O
from	O
Id3-transduced	B
but	O
not	O
from	O
control	O
-	O
transduced	O
pre	O
-	O
T	O
cells	O
in	O
an	O
FTOC	O
.	O

As	O
determined	O
in	O
a	O
modified	O
yeast	O
two	O
-	O
hybrid	O
system	O
,	O
mIRS3	B
bound	O
strongly	O
to	O
the	O
p85	B
subunit	I
of	O
phosphatidylinositol	B
3-kinase	I
.	O

Insulin	B
stimulation	O
promoted	O
the	O
association	O
of	O
mIRS3	B
with	O
p85	B
,	O
SHP2	B
,	O
Nck	B
,	O
and	O
Shc	B
.	O

The	O
mRNA	O
expression	O
of	O
RFX1	B
,	O
RFX2	B
,	O
and	O
RFX3	B
was	O
detected	O
ubiquitously	O
,	O
but	O
in	O
transient	O
-	O
transfection	O
assays	O
,	O
multimerized	B
RFX	I
binding	I
sites	I
in	O
front	O
of	O
a	O
basal	O
promoter	O
efficiently	O
functioned	O
in	O
a	O
tissue-	O
and	O
lineage	O
-	O
specific	O
manner	O
.	O

In	O
the	O
case	O
of	O
the	O
unspliceable	O
intron	O
,	O
repression	O
of	O
luciferase	B
expression	O
likely	O
involved	O
two	O
AUF1-binding	B
sequences	I
,	O
since	O
luciferase	B
expression	O
was	O
increased	O
by	O
deletion	O
of	O
these	O
sites	O
.	O

Thus	O
,	O
VDR	B
acts	O
selectively	O
on	O
the	O
two	O
components	O
required	O
for	O
activation	O
of	O
this	O
promoter	O
/	O
enhancer	O
:	O
it	O
competes	O
with	O
NFAT1	B
for	O
binding	O
to	O
the	O
composite	O
site	O
,	O
positioning	O
itself	O
adjacent	O
to	O
Jun	B
-	O
Fos	B
on	O
the	O
DNA	O
.	O

Two	O
evolutionarily	O
conserved	O
kinases	O
,	O
the	O
cyclin	B
B	I
(	O
Clb	B
)	O
/	O
cyclin	B
-	I
dependent	I
kinase	I
(	O
Cdk	B
/	O
Cdc28p	B
)	O
and	O
Cdc7p	B
along	O
with	O
its	O
interacting	O
factor	O
Dbf4p	B
,	O
are	O
required	O
late	O
in	O
G1	O
to	O
initiate	O
DNA	O
replication	O
.	O

The	O
RanQ69L	B
preincubation	O
leads	O
to	O
accumulation	O
of	O
CRM1	B
at	O
the	O
cytoplasmic	O
periphery	O
of	O
the	O
nuclear	O
pore	O
complex	O
(	O
NPC	O
)	O
in	O
association	O
with	O
the	O
p62	B
complex	I
and	O
Can	B
/	O
Nup214	B
.	O

All	O
of	O
the	O
elements	O
exhibited	O
a	O
uniform	O
structure	O
.	O

In	O
contrast	O
,	O
the	O
deduced	O
amino	O
acid	O
sequence	O
of	O
a	O
second	O
family	O
(	O
ART5	B
)	O
of	O
transferases	O
,	O
cloned	O
from	O
murine	O
lymphoma	O
cells	O
and	O
expressed	O
in	O
high	O
abundance	O
in	O
testis	O
,	O
displays	O
a	O
hydrophobic	O
amino	O
terminus	O
,	O
consistent	O
with	O
a	O
signal	O
sequence	O
,	O
but	O
lacks	O
a	O
hydrophobic	O
signal	O
sequence	O
at	O
its	O
carboxyl	O
terminus	O
,	O
suggesting	O
that	O
the	O
protein	O
is	O
destined	O
for	O
export	O
.	O

RESULTS	O
:	O
Each	O
year	O
,	O
on	O
average	O
39	O
%	O
of	O
cases	O
seen	O
in	O
Sardinia	O
are	O
notified	O
;	O
646	O
(	O
40	O
%	O
)	O
of	O
the	O
1591	O
patients	O
notified	O
during	O
the	O
study	O
period	O
were	O
never	O
seen	O
by	O
regional	O
medical	O
centres	O
.	O

This	O
dimer	O
interface	O
is	O
likely	O
important	O
for	O
increasing	O
the	O
DNA	O
-	O
binding	O
specificity	O
and	O
affinity	O
of	O
the	O
trimeric	O
form	O
of	O
HSF	B
,	O
as	O
well	O
as	O
for	O
increasing	O
cooperativity	O
between	O
adjacent	O
trimers	O
.	O

The	O
paramyxovirus	B
fusion	I
(	I
F	I
)	I
protein	I
mediates	O
membrane	O
fusion	O
.	O

Additionally	O
,	O
deletion	O
analysis	O
of	O
the	O
UCP2	B
promoter	O
-	O
PLAP	B
constructs	O
indicated	O
that	O
the	O
minimal	O
region	O
exhibiting	O
the	O
promoter	O
activity	O
was	O
located	O
between	O
nt	O
-33	O
and	O
+	O
100	O
,	O
and	O
that	O
a	O
strong	O
enhancer	O
was	O
present	O
within	O
601	O
bp	O
of	O
the	O
5'-promoter	O
region	O
.	O

The	O
hTERT	B
gene	I
encompasses	O
more	O
than	O
37	O
kb	O
and	O
consists	O
of	O
16	O
exons	O
.	O

Both	O
betaAPP	B
mRNA	I
and	O
Abeta	B
levels	O
are	O
increased	O
in	O
trisomy	O
21	O
.	O

In	O
reperfusion	O
B	O
,	O
only	O
the	O
diabetic	O
group	O
demonstrated	O
a	O
significant	O
increase	O
in	O
IL-8	B
concentrations	O
at	O
1	O
and	O
15	O
min	O
compared	O
to	O
nondiabetics	O
.	O

This	O
repression	O
was	O
reversed	O
agonists	O
of	O
either	O
receptor	O
demonstrating	O
a	O
functional	O
interaction	O
between	O
NCoR	B
and	O
PPARalpha	B
.	O

RXRalpha	B
heterodimeric	O
complexes	O
in	O
mammalian	O
cells	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
show	O
that	O
SRm160	B
/	I
300	I
is	O
required	O
for	O
a	O
purine	O
-	O
rich	O
ESE	B
to	O
promote	O
the	O
splicing	O
of	O
a	O
pre	O
-	O
mRNA	O
derived	O
from	O
the	O
Drosophila	B
doublesex	I
gene	I
.	O

Spc42p	B
also	O
was	O
identified	O
as	O
a	O
component	O
of	O
a	O
cytoplasmic	O
SPB	O
subcomplex	O
containing	O
Spc94p	B
/	O
Nud1p	B
,	O
Cnm67p	B
,	O
and	O
Spc42p	B
.	O

The	O
average	O
coefficients	O
of	O
correlation	O
were	O
0.9998	O
and	O
0.9993	O
for	O
the	O
QMF	O
and	O
the	O
QIT	O
system	O
,	O
respectively	O
.	O

The	O
5-year	O
OS	O
for	O
stage	O
IIIB	O
was	O
30.9	O
%	O
,	O
compared	O
to	O
7.8	O
%	O
for	O
stage	O
IV	O
.	O

Furthermore	O
,	O
heparin	B
lyase	I
treatment	O
of	O
extracts	O
of	O
cells	O
expressing	O
recombinant	B
YD	I
-	I
repeat	I
protein	I
releases	O
this	O
protein	O
from	O
high	O
molecular	O
mass	O
aggregates	O
.	O

The	O
coefficient	O
of	O
determination	O
,	O
r2	O
,	O
of	O
the	O
other	O
scores	O
ranged	O
from	O
0.56	O
to	O
0.61	O
.	O

While	O
determination	O
of	O
the	O
protein	O
content	O
of	O
the	O
formulae	O
gave	O
no	O
valid	O
information	O
,	O
RAST	O
/	O
EAST	O
inhibition	O
was	O
highest	O
for	O
cow	O
's	O
milk	O
,	O
followed	O
by	O
the	O
partially	O
hydrolysed	O
whey	O
formula	O
,	O
partially	O
hydrolysed	O
whey	O
/	O
casein	B
formula	O
,	O
soy	B
/	I
pork	I
collagen	I
formula	O
,	O
and	O
the	O
amino	O
acid	O
formula	O
.	O

In	O
light	O
of	O
the	O
importance	O
of	O
GnRHR	B
,	O
the	O
molecular	O
mechanisms	O
underlying	O
the	O
transcriptional	O
regulation	O
of	O
the	O
human	B
GnRHR	I
(	O
hGnRHR	B
)	O
gene	O
become	O
a	O
key	O
issue	O
in	O
understanding	O
human	O
reproduction	O
.	O

Competitive	O
mobility	O
shift	O
assays	O
using	O
either	O
alphaT3	O
-	O
1	O
nuclear	O
extract	O
or	O
recombinant	B
SF-1	I
protein	I
clearly	O
indicated	O
that	O
SF-1	B
is	O
able	O
to	O
interact	O
specifically	O
with	O
this	O
GSE	B
element	I
positioned	O
at	O
-134	O
.	O

Grade	O
3	O
mucositis	O
was	O
reported	O
in	O
1	O
patient	O
.	O

CDK4	B
kinase	I
activities	O
were	O
unaffected	O
,	O
as	O
were	O
the	O
levels	O
of	O
the	O
CDK	B
inhibitor	O
p21Cip1	B
present	O
in	O
cyclin	B
E	I
immunocomplexes	I
.	O

The	O
recombinant	O
purified	O
protein	O
expressed	O
in	O
the	O
baculovirus	O
system	O
had	O
an	O
approximate	O
molecular	O
size	O
20	O
kDa	O
with	O
amino	O
-	O
terminal	O
sequence	O
of	O
AVQGP	O
.	O

Induction	O
of	O
the	O
urokinase	B
promoter	I
by	O
HGF	B
/	O
SF	B
via	O
the	O
Met	B
receptor	I
was	O
blocked	O
by	O
co	O
-	O
expression	O
of	O
a	O
dominant	O
-	O
negative	O
Grb2	B
and	O
Sos1	B
expression	O
construct	O
.	O

Serine	O
phosphorylation	O
of	O
STAT3	B
was	O
only	O
apparent	O
after	O
somatostatin	B
treatment	O
and	O
was	O
abolished	O
by	O
pertussis	B
toxin	I
or	O
PD	O
98059	O
,	O
together	O
with	O
the	O
associated	O
increases	O
in	O
proliferation	O
.	O

Nevertheless	O
,	O
we	O
demonstrate	O
that	O
the	O
entire	O
three	O
-	O
component	O
yeast	O
capping	O
apparatus	O
,	O
consisting	O
of	O
RNA	B
5'-triphosphatase	I
(	O
Cet1p	B
)	O
,	O
RNA	B
guanylyltransferase	I
(	O
Ceg1p	B
)	O
,	O
and	O
Abd1p	B
could	O
be	O
replaced	O
in	O
vivo	O
by	O
the	O
two	O
-	O
component	O
mammalian	O
apparatus	O
consisting	O
of	O
a	O
bifunctional	O
triphosphatase	B
-	I
guanylyltransferase	I
Mce1p	I
and	O
the	O
methyltransferase	B
Hcm1	I
(	I
121	I
-	I
476	I
)	I
p	I
.	O

The	O
IC50	O
values	O
for	O
rat	O
and	O
dog	O
urinary	O
bladder	O
were	O
3.9	O
x	O
10	O
(	O
-6	O
)	O
M	O
and	O
3.8	O
x	O
10	O
(	O
-6	O
)	O
M	O
,	O
respectively	O
.	O

Although	O
it	O
has	O
two	O
potential	O
binding	O
sites	O
,	O
the	O
purified	O
MerR	B
homodimer	I
binds	O
only	O
one	O
Hg	O
(	O
II	O
)	O
ion	O
,	O
employing	O
Cys82	O
from	O
one	O
monomer	O
and	O
Cys117	O
and	O
Cys126	O
from	O
the	O
other	O
.	O

The	O
results	O
of	O
the	O
lab	O
and	O
field	O
tests	O
yielded	O
high	O
levels	O
of	O
infestation	O
in	O
larvae	O
with	O
values	O
ranging	O
from	O
90	O
to	O
100	O
%	O
and	O
from	O
85	O
to	O
95	O
%	O
,	O
respectively	O
.	O

Amisulpride	O
400	O
mg	O
had	O
several	O
adverse	O
effects	O
on	O
psychomotor	O
and	O
,	O
although	O
less	O
severe	O
,	O
on	O
cognitive	O
performance	O
on	O
the	O
fifth	O
day	O
only	O
.	O

MutY	B
is	O
an	O
adenine	B
-	I
DNA	I
glycosylase	I
with	O
specificity	O
for	O
mismatches	O
involving	O
8-oxoguanine	O
(	O
oG.A	O
)	O
or	O
guanine	O
(	O
G.A	O
)	O
.	O

The	O
kinetics	O
of	O
kinase	O
activity	O
within	O
these	O
complexes	O
compared	O
to	O
CheA	B
alone	O
indicate	O
approximately	O
a	O
50	O
%	O
decrease	O
in	O
the	O
KM	O
for	O
ATP	O
and	O
a	O
100-fold	O
increase	O
in	O
the	O
Vmax	O
.	O

Latexin	B
,	O
a	O
carboxypeptidase	B
A	I
inhibitor	O
,	O
is	O
expressed	O
in	O
a	O
cell	O
type	O
-	O
specific	O
manner	O
in	O
both	O
central	O
and	O
peripheral	O
nervous	O
systems	O
in	O
the	O
rat	O
.	O

Regression	O
analyses	O
identified	O
7	O
risk	O
and	O
7	O
protective	O
factors	O
with	O
minimal	O
overlap	O
.	O

During	O
1985	O
,	O
1990	O
,	O
and	O
1995	O
,	O
respectively	O
,	O
11.7	O
,	O
11.3	O
,	O
and	O
11.4	O
infants	O
per	O
100,000	O
live	O
births	O
had	O
a	O
diagnosis	O
of	O
HSV	O
(	O
P=.98	O
)	O
.	O

Subsets	O
of	O
patients	O
were	O
performed	O
according	O
to	O
the	O
severity	O
of	O
trauma	O
(	O
ISS	O
<	O
9	O
;	O
9	O
-	O
17	O
;	O
18	O
-	O
31	O
;	O
>	O
32	O
)	O
,	O
based	O
on	O
the	O
different	O
injury	O
pattern	O
,	O
and	O
survivors	O
versus	O
nonsurvivors	O
as	O
well	O
.	O

The	O
median	O
age	O
was	O
33	O
years	O
(	O
range	O
17	O
-	O
56	O
years	O
)	O
.	O

Developmental	O
follow	O
-	O
up	O
at	O
age	O
2	O
years	O
was	O
performed	O
.	O

In	O
the	O
whole	O
group	O
of	O
infected	O
children	O
,	O
an	O
age	O
-	O
specific	O
z	O
score	O
<	O
-2	O
for	O
weight	O
and	O
for	O
FFM	O
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
death	O
[	O
relative	O
risk	O
(	O
95	O
%	O
CI	O
)	O
=	O
11.4	O
(	O
3.1	O
,	O
41.0	O
)	O
and	O
5.1	O
(	O
1.5	O
,	O
18.2	O
)	O
,	O
respectively	O
]	O
;	O
when	O
only	O
children	O
with	O
more	O
severe	O
disease	O
were	O
considered	O
,	O
only	O
z	O
score	O
for	O
weight	O
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
[	O
4.6	O
(	O
1.4	O
,	O
14.9	O
)	O
]	O
.	O

In	O
addition	O
,	O
these	O
cells	O
contained	O
one	O
,	O
two	O
,	O
or	O
multiple	O
nuclei	O
indicative	O
of	O
a	O
G2	O
/	O
M	O
delay	O
in	O
nuclear	O
division	O
and	O
also	O
a	O
defect	O
in	O
cytokinesis	O
and/or	O
cell	O
separation	O
.	O

DAF16	B
is	O
known	O
to	O
be	O
a	O
component	O
of	O
a	O
signaling	O
pathway	O
that	O
has	O
been	O
partially	O
dissected	O
genetically	O
and	O
includes	O
homologues	O
of	O
the	O
insulin	B
/	O
IGF-1	B
receptor	I
,	O
PtdIns	B
3-kinase	I
and	O
PKB	B
.	O

However	O
,	O
neu	B
differentiation	O
factor	O
-	O
induced	O
heterodimers	O
of	O
ErbB2	B
and	O
ErbB4	B
activated	O
Stat5	B
.	O

Although	O
linker	O
regions	O
in	O
transcription	O
factors	O
are	O
known	O
to	O
modulate	O
DNA	O
binding	O
specificity	O
,	O
our	O
studies	O
suggest	O
that	O
the	O
human	B
HSF1	I
linker	O
plays	O
no	O
role	O
in	O
determining	O
HSF1	B
binding	O
preferences	O
in	O
vivo	O
but	O
is	O
a	O
critical	O
determinant	O
in	O
regulating	O
the	O
HSF1	B
monomer	I
-	I
trimer	I
equilibrium	O
.	O

Modulation	O
of	O
human	B
heat	I
shock	I
factor	I
trimerization	O
by	O
the	O
linker	O
domain	O
.	O

Both	O
functional	O
analyses	O
in	O
undifferentiated	O
and	O
differentiated	O
F9	O
cells	O
and	O
characterization	O
of	O
DNA	O
-	O
protein	O
complexes	O
in	O
vitro	O
have	O
identified	O
the	O
sequence	O
motifs	O
GTGACT	O
(	O
C	O
)	O
,	O
ATTGT	O
,	O
and	O
GATA	O
as	O
the	O
key	O
transcription	O
factor	O
binding	O
sites	O
.	O

These	O
results	O
suggest	O
that	O
the	O
phenotype	O
of	O
XLP	O
may	O
result	O
from	O
perturbed	O
signaling	O
not	O
only	O
through	O
SLAM	B
,	O
but	O
also	O
other	O
cell	O
surface	O
molecules	O
that	O
utilize	O
SAP	B
as	O
a	O
signaling	O
adaptor	O
protein	O
.	O

We	O
also	O
localized	O
the	O
Fra-2	B
phosphorylation	I
sites	I
by	O
MAPK	B
to	O
three	O
threonine	O
and	O
three	O
serine	O
residues	O
in	O
the	O
COOH	O
-	O
terminal	O
region	O
by	O
means	O
of	O
site	O
-	O
directed	O
mutagenesis	O
and	O
showed	O
that	O
the	O
threonine	O
residues	O
were	O
more	O
susceptible	O
to	O
MAPK	B
.	O

Nevertheless	O
,	O
they	O
are	O
functionally	O
distinct	O
in	O
that	O
FcalphaRI	B
binds	O
human	B
IgA	I
(	O
hIgA	B
)	O
but	O
not	O
bovine	B
IgG2	I
(	O
bIgG2	B
)	O
,	O
whereas	O
bFcgamma2R	B
binds	O
bIgG2	B
but	O
not	O
hIgA.	B

Vac1p	B
was	O
found	O
to	O
bind	O
the	O
Sec1p	B
homologue	I
Vps45p	B
.	O

In	O
a	O
heterologous	O
transcriptional	O
system	O
in	O
which	O
the	O
upstream	O
regions	O
of	O
oIFNtau	B
were	O
inserted	O
in	O
front	O
of	O
simian	B
virus	I
40	I
(	I
SV40	I
)	I
promoter	I
,	O
the	O
regions	O
between	O
bases	O
-654	O
and	O
-555	O
were	O
determined	O
as	O
being	O
the	O
enhancer	O
region	O
required	O
for	O
oIFNtau	B
-	O
SV40-CAT	O
transactivation	O
.	O

In	O
co	O
-	O
transfection	O
studies	O
,	O
the	O
expression	O
of	O
c	B
-	I
Jun	I
plus	O
c	B
-	I
Fos	I
enhanced	O
the	O
transactivation	O
of	O
oIFNtau	B
-	O
CAT	B
but	O
the	O
expression	O
of	O
GATA-1	B
,	O
GATA-2	B
or	O
GATA-3	B
did	O
not	O
.	O

To	O
identify	O
these	O
sites	O
,	O
Cdk2-phosphorylated	B
MARCKS	B
was	O
digested	O
with	O
lysyl	B
endoprotease	I
and	O
analysed	O
by	O
electrospray	O
MS	O
.	O

The	O
yeast	B
LPD1	I
gene	I
encoding	O
lipoamide	B
dehydrogenase	I
is	O
subject	O
to	O
the	O
general	O
control	O
of	O
amino	O
acid	O
biosynthesis	O
mediated	O
by	O
the	O
GCN4	B
transcription	I
factor	I
.	O

The	O
relatively	O
mild	O
defects	O
observed	O
in	O
Rpd3	B
mutants	I
suggest	O
that	O
the	O
recently	O
identified	O
Groucho	B
and	O
dCtBP	B
corepressor	I
proteins	I
do	O
not	O
function	O
solely	O
through	O
the	O
recruitment	O
of	O
histone	B
deacetylases	I
.	O

However	O
,	O
the	O
serum	B
TNF	I
-	I
a	I
concentration	O
decreased	O
significantly	O
in	O
patients	O
receiving	O
pentoxifylline	O
(	O
basal	O
623+	O
/	O
-366	O
pg	O
/	O
ml	O
;	O
6th	O
month	O
562+	O
/	O
-358	O
pg	O
/	O
ml	O
,	O
p	O
<	O
0.01	O
)	O
,	O
but	O
not	O
in	O
the	O
control	O
group	O
.	O

In	O
addition	O
,	O
we	O
show	O
that	O
the	O
expression	O
of	O
individual	O
members	O
of	O
one	O
subfamily	O
of	O
KRAB	B
zinc	I
finger	I
genes	I
is	O
restricted	O
to	O
specific	O
hematopoietic	O
cell	O
lineages	O
.	O

Employing	O
fluorescence	O
spectroscopy	O
and	O
circular	O
dichroism	O
,	O
we	O
showed	O
that	O
the	O
binding	O
of	O
Ca2	O
+	O
to	O
ALG-2	B
induced	O
significant	O
conformational	O
changes	O
in	O
both	O
the	O
N	O
-	O
terminal	O
and	O
C	O
-	O
terminal	O
domains	O
of	O
the	O
protein	O
.	O

They	O
also	O
occur	O
in	O
similar	O
locations	O
in	O
the	O
promoters	O
of	O
several	O
other	O
ribosomal	B
protein	I
genes	I
.	O

Both	O
carbachol	O
(	O
100	O
microM	O
)	O
and	O
EGF	B
(	O
10	O
nM	O
)	O
induced	O
Ras	B
activation	O
.	O

Dominant	O
negative	O
Sos	B
did	O
not	O
affect	O
carbachol	O
stimulation	O
of	O
HA	B
-	O
ERK2	B
but	O
inhibited	O
the	O
stimulatory	O
effect	O
of	O
EGF	B
by	O
60	O
%	O
.	O

RESULTS	O
:	O
Transpulmonary	O
passage	O
of	O
contrast	O
occurred	O
in	O
sufficient	O
amounts	O
to	O
enhance	O
the	O
intensity	O
of	O
the	O
Doppler	O
signal	O
significantly	O
,	O
but	O
the	O
duration	O
of	O
this	O
effect	O
was	O
short	O
.	O

In	O
this	O
paper	O
,	O
such	O
lesions	O
in	O
two	O
cases	O
were	O
evaluated	O
by	O
ultrasonography	O
.	O

These	O
regions	O
contain	O
inverted	O
E	O
-	O
box	O
palindromic	O
or	O
direct	O
repeat	O
motifs	O
and	O
bind	O
SREBP-1	B
with	O
different	O
affinities	O
.	O

To	O
address	O
these	O
questions	O
,	O
a	O
recombinant	O
FRAP	B
/	O
mTOR	B
protein	O
and	O
a	O
FRAP	B
/	O
mTOR	B
immunoprecipitate	O
were	O
utilized	O
in	O
in	O
vitro	O
kinase	O
assays	O
to	O
phosphorylate	O
4E	B
-	I
BP1	I
.	O

Hrs	B
has	O
a	O
FYVE	O
double	O
zinc	O
finger	O
domain	O
,	O
which	O
specifically	O
binds	O
phosphatidylinositol	O
(	O
3	O
)	O
-phosphate	O
and	O
is	O
conserved	O
in	O
several	O
proteins	O
involved	O
in	O
vesicular	O
traffic	O
.	O

The	O
coexpression	O
of	O
full	O
-	O
length	O
expression	O
constructs	O
for	O
both	O
DBP	B
and	O
hepatic	B
leukemia	I
factor	I
resulted	O
in	O
a	O
dramatic	O
increase	O
in	O
activation	O
mediated	O
by	O
the	O
GAL4-DBP	B
fusion	O
proteins	O
,	O
suggesting	O
the	O
involvement	O
of	O
a	O
regulated	O
coactivator	O
in	O
this	O
process	O
.	O

Three	O
subgenomes	O
also	O
comprised	O
15	O
to	O
75	O
nucleotides	O
derived	O
from	O
the	O
5	O
'	O
part	O
of	O
the	O
NS2	B
gene	I
.	O

Cp	B
is	O
normally	O
the	O
main	O
promoter	O
for	O
EBNA	B
mRNA	I
initiation	O
,	O
so	O
it	O
appears	O
that	O
EBNA3C	B
contributes	O
to	O
a	O
negative	O
autoregulatory	O
control	O
loop	O
.	O

These	O
indications	O
of	O
deregulated	O
signalling	O
in	O
the	O
absence	O
of	O
tyrosine	O
118	O
were	O
substantiated	O
by	O
sustained	O
activation	O
of	O
STAT3	B
.	O

With	O
exon	O
trapping	O
,	O
we	O
could	O
isolate	O
five	O
potential	O
exons	O
from	O
the	O
YAC	O
946E12	O
that	O
spans	O
the	O
region	O
,	O
four	O
of	O
which	O
could	O
be	O
placed	O
in	O
the	O
contig	O
in	O
the	O
vicinity	O
of	O
the	O
breakpoints	O
.	O

Campomelic	O
dysplasia	O
translocation	O
breakpoints	O
are	O
scattered	O
over	O
1	O
Mb	O
proximal	O
to	O
SOX9	B
:	O
evidence	O
for	O
an	O
extended	O
control	O
region	O
.	O

The	O
most	O
common	O
characteristics	O
of	O
VRE	O
patients	O
were	O
recent	O
prior	O
vancomycin	O
use	O
,	O
recent	O
prior	O
susceptible	O
enterococcal	O
infection	O
,	O
coinfection	O
with	O
other	O
microbial	O
pathogens	O
,	O
and	O
concurrent	O
fungal	O
infection	O
.	O

A	O
coiled	O
-	O
coil	O
domain	O
,	O
conserved	O
within	O
each	O
encoded	O
protein	O
,	O
serves	O
as	O
a	O
potential	O
interaction	O
motif	O
for	O
FLI	B
LRR	I
.	O

Binding	O
affinities	O
of	O
these	O
recombinant	O
phages	O
as	O
determined	O
by	O
the	O
retention	O
of	O
these	O
phages	O
by	O
a	O
His	O
-	O
tag	O
immobilized	O
gp17	B
column	O
,	O
and	O
by	O
co	O
-	O
immunoprecipitation	O
with	O
purified	O
terminase	B
supported	O
the	O
specific	O
nature	O
of	O
the	O
portal	B
protein	I
and	O
terminase	B
interaction	I
sites	I
.	O

Although	O
the	O
terminase	B
apparently	O
interacts	O
with	O
this	O
gp20	B
portal	I
peptide	I
,	O
polyclonal	O
antibody	O
against	O
the	O
portal	O
peptide	O
appears	O
unable	O
to	O
access	O
it	O
in	O
the	O
native	O
structure	O
,	O
suggesting	O
intimate	O
association	O
of	O
gp20	B
and	O
gp17	B
possibly	O
internalizes	O
terminase	B
regions	I
within	O
the	O
portal	O
in	O
the	O
packasome	O
complex	O
.	O

The	O
hybrid	O
viruses	O
were	O
found	O
to	O
accumulate	O
to	O
high	O
levels	O
in	O
infected	O
plants	O
,	O
to	O
form	O
stable	O
virions	O
,	O
and	O
to	O
be	O
mechanically	O
transmissible	O
.	O

cDNA	O
and	O
structural	O
organization	O
of	O
the	O
gene	B
Pole1	I
for	O
the	O
mouse	B
DNA	I
polymerase	I
epsilon	I
catalytic	I
subunit	I
.	O

Nevertheless	O
cryopreservation	O
of	O
spermatozoa	O
in	O
a	O
medium	O
containing	O
neither	O
SP	O
nor	O
biological	O
substances	O
could	O
offer	O
an	O
acceptable	O
cryoprotection	O
of	O
spermatozoa	O
to	O
be	O
used	O
in	O
assisted	O
fertilization	O
procedures	O
,	O
especially	O
for	O
intracytoplasmic	O
sperm	O
injection	O
.	O

A	O
liquid	O
chromatographic	O
method	O
is	O
described	O
for	O
analysis	O
of	O
beta	O
-	O
carotene	O
in	O
medical	O
food	O
.	O

The	O
FCMS	O
conditions	O
were	O
as	O
follows	O
:	O
2	O
kW	O
maximum	O
electrical	O
power	O
consumption	O
,	O
800	O
V	O
maximum	O
capacitor	O
voltage	O
,	O
720	O
microseconds	O
pulsewidth	O
(	O
180	O
microseconds	O
rise	O
time	O
)	O
,	O
and	O
5	O
-	O
30	O
Hz	O
frequency	O
.	O

Severe	O
hemolysis	O
resulted	O
in	O
statistically	O
significant	O
changes	O
in	O
the	O
mean	O
values	O
of	O
the	O
above	O
analytes	O
in	O
addition	O
to	O
the	O
following	O
increases	O
:	O
alanine	B
aminotransferase	I
,	O
calcium	O
,	O
and	O
serum	B
globulins	I
(	O
P	O
<	O
0.001	O
)	O
and	O
albumin	B
and	O
total	O
protein	O
(	O
P	O
<	O
0.01	O
)	O
.	O

EMSA	O
with	O
crude	O
nuclear	O
extracts	O
demonstrated	O
that	O
stimulation	O
with	O
CD40L	B
results	O
in	O
the	O
induction	O
of	O
NF	B
-	I
kappaB	I
complexes	I
that	O
bind	O
to	O
each	O
of	O
the	O
three	O
NF	B
-	I
kappaB	I
sites	I
and	O
are	O
composed	O
mainly	O
of	O
p50	B
and	O
RelB	B
,	O
but	O
also	O
include	O
c	B
-	I
Rel	I
and	O
p65	B
.	O

Optimal	O
monitoring	O
of	O
ODA	O
remains	O
undefined	O
.	O

The	O
major	O
transcription	O
factors	O
controlling	O
arginine	O
metabolism	O
in	O
Escherichia	O
coli	O
and	O
Bacillus	O
subtilis	O
,	O
ArgR	B
and	O
AhrC	B
,	O
respectively	O
,	O
are	O
homologous	O
multimeric	O
proteins	O
that	O
form	O
l	O
-arginine	O
-	O
dependent	O
DNA	O
-	O
binding	O
complexes	O
capable	O
of	O
repressing	O
transcription	O
of	O
the	O
biosynthetic	O
genes	O
(	O
both	O
)	O
,	O
activating	O
transcription	O
of	O
catabolic	O
genes	O
(	O
AhrC	B
only	O
)	O
or	O
facilitating	O
plasmid	O
dimer	O
resolution	O
(	O
both	O
)	O
.	O

The	O
studied	O
protein	O
fragments	O
consist	O
of	O
residues	O
Arg183-His267	O
of	O
the	O
human	B
ER	I
and	O
residues	O
Lys438-Gln520	O
of	O
the	O
rat	O
GR	B
.	O

The	O
exon	O
:	O
intron	O
structure	O
of	O
chicken	B
IL8	I
corresponds	O
almost	O
exactly	O
to	O
that	O
of	O
human	B
IL8	I
and	O
differs	O
from	O
those	O
of	O
other	O
known	O
mammalian	B
CXC	I
chemokine	I
genes	I
.	O

The	O
Aa	B
-	I
Pri2	I
gene	I
,	O
specifically	O
expressed	O
during	O
basidiocarp	O
differentiation	O
of	O
the	O
mushroom	O
Agrocybe	O
aegerita	O
,	O
was	O
cloned	O
.	O

The	O
main	O
causes	O
of	O
liver	O
disease	O
in	O
the	O
patients	O
with	O
HCC	O
were	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
(	O
77	O
%	O
)	O
,	O
alcohol	O
abuse	O
(	O
73	O
%	O
)	O
,	O
and	O
the	O
combination	O
of	O
HCV	O
and	O
alcohol	O
abuse	O
(	O
50	O
%	O
)	O
.	O

Three	O
new	O
aromatase	B
inhibitors	O
have	O
recently	O
completed	O
phase	O
III	O
evaluation	O
as	O
treatment	O
of	O
metastatic	O
breast	O
cancer	O
in	O
post	O
-	O
menopausal	O
women	O
whose	O
disease	O
has	O
progressed	O
despite	O
tamoxifen	O
therapy	O
:	O
anastrozole	O
(	O
ARIMIDEX	O
,	O
Zeneca	O
)	O
,	O
letrozole	O
(	O
FEMARA	O
,	O
Novartis	O
)	O
and	O
vorozole	O
(	O
RIVIZOR	O
,	O
Janssen	O
)	O
.	O

Of	O
those	O
injuries	O
,	O
143	O
cases	O
were	O
snowboard	O
related	O
and	O
158	O
cases	O
were	O
ski	O
related	O
.	O

The	O
femoral	O
artery	O
/	O
vein	O
and	O
the	O
soleus	O
and	O
gastrocnemius	O
muscles	O
were	O
examined	O
in	O
healthy	O
human	O
male	O
volunteers	O
.	O

SRFDelta5	B
acts	O
as	O
a	O
naturally	O
occurring	O
dominant	O
negative	O
regulatory	O
mutant	O
that	O
blocks	O
SRF	B
-	O
dependent	O
skeletal	B
alpha	I
-	I
actin	I
,	O
cardiac	B
alpha	I
-	I
actin	I
,	O
smooth	B
alpha	I
-	I
actin	I
,	O
SM22alpha	B
,	O
and	O
SRF	B
promoter	O
-	O
luciferase	B
reporter	O
activities	O
.	O

In	O
serum	O
-	O
free	O
media	O
,	O
p50E4F	B
accelerated	O
E1A	B
-	O
induced	O
apoptosis	O
.	O

The	O
potency	O
of	O
the	O
effect	O
of	O
Nim	O
(	O
0.5	O
mg.kg-1	O
i.p	O
.	O
)	O
was	O
similar	O
to	O
that	O
of	O
NBP	O
(	O
10	O
mg.kg-1	O
i.p	O
.	O
)	O
.	O

CONCLUSION	O
:	O
NBP	O
pre	O
-	O
treatment	O
or	O
post	O
-	O
treatment	O
markedly	O
enhanced	O
the	O
rCBF	O
to	O
striatum	O
in	O
RMCAO	O
rats	O
.	O

Progression	O
after	O
first	O
-	O
line	O
chemotherapy	O
was	O
associated	O
with	O
significantly	O
worse	O
survival	O
for	O
patients	O
with	O
metastasis	O
.	O

Mutations	O
within	O
human	O
UTR1	O
modulate	O
NRF-1	B
expression	O
by	O
interfering	O
with	O
mRNA	O
translational	O
efficiency	O
in	O
transfected	O
cells	O
and	O
in	O
an	O
in	O
vitro	O
translation	O
system	O
.	O

As	O
is	O
deduced	O
from	O
the	O
nucleotide	O
sequence	O
of	O
the	O
cDNA	O
,	O
CBS-1	B
contains	O
an	O
open	O
reading	O
frame	O
consisting	O
of	O
182	O
amino	O
acids	O
,	O
with	O
a	O
molecular	O
weight	O
of	O
19.5kDa	O
.	O

Corticostriatal	O
and	O
corticosubthalamic	O
input	O
zones	O
from	O
the	O
presupplementary	O
motor	O
area	O
in	O
the	O
macaque	O
monkey	O
:	O
comparison	O
with	O
the	O
input	O
zones	O
from	O
the	O
supplementary	O
motor	O
area	O
.	O

Basic	B
fibroblast	I
growth	I
factor	I
(	O
bFGF	B
)	O
has	O
been	O
shown	O
to	O
induce	O
angiogenesis	O
in	O
various	O
animal	O
models	O
,	O
but	O
the	O
methods	O
of	O
administration	O
used	O
experimentally	O
are	O
not	O
clinically	O
feasible	O
.	O

Both	O
filters	O
equally	O
contributed	O
to	O
elevation	O
of	O
iliac	O
venous	O
pressure	O
(	O
median	O
,	O
9.3	O
and	O
7.2	O
mm	O
Hg	O
[	O
n	O
=	O
9	O
]	O
with	O
the	O
spring	O
filter	O
and	O
RF02	O
filter	O
,	O
respectively	O
)	O
.	O

12	O
healthy	O
women	O
(	O
age	O
18	O
-	O
38	O
years	O
)	O
were	O
examined	O
using	O
the	O
2-hour	O
's	O
method	O
of	O
passive	O
leg	O
rising	O
(	O
PLR	O
)	O
in	O
follicular	O
(	O
FP	O
)	O
and	O
luteal	O
(	O
LP	O
)	O
phases	O
of	O
normal	O
ovulatory	O
cycle	O
.	O

Thus	O
,	O
sgRNA2	B
has	O
the	O
3'TE	O
in	O
its	O
5	O
'	O
UTR	O
.	O

These	O
single	O
mutational	O
defects	O
in	O
the	O
eRF1-eRF3	B
interaction	O
became	O
evident	O
when	O
either	O
truncated	O
protein	O
eRF3C	B
or	O
C	O
-	O
terminally	O
altered	O
eRF1	B
proteins	O
were	O
used	O
for	O
the	O
authentic	O
protein	O
,	O
providing	O
further	O
support	O
for	O
the	O
presence	O
of	O
a	O
C	O
-	O
terminal	O
interaction	O
.	O

Removal	O
of	O
each	O
of	O
three	O
contiguous	O
segments	O
from	O
the	O
N	O
-	O
terminal	O
half	O
specifically	O
inhibits	O
the	O
formation	O
of	O
5.8Ss	B
rRNA	I
,	O
whereas	O
deleting	O
part	O
of	O
the	O
C	O
-	O
terminal	O
region	O
of	O
the	O
protein	O
only	O
blocks	O
the	O
production	O
of	O
18S	B
rRNA	I
.	O

Ras	B
is	O
not	O
associated	O
with	O
the	O
tegument	O
.	O

Green	O
fluorescent	O
protein	O
-	O
tagged	O
UNC-49B	B
and	O
UNC-49C	B
subunits	I
are	O
coexpressed	O
in	O
muscle	O
cells	O
and	O
are	O
colocalized	O
to	O
synaptic	O
regions	O
.	O

We	O
show	O
that	O
a	O
protein	O
,	O
UBC9	B
,	O
interacts	O
specifically	O
with	O
TEL	B
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
spontaneous	O
reports	O
of	O
suspected	O
adverse	O
drug	O
reactions	O
,	O
observed	O
in	O
elderly	O
patients	O
(	O
over	O
65	O
years	O
of	O
age	O
)	O
in	O
Sicily	O
(	O
Italy	O
)	O
during	O
the	O
period	O
from	O
1	O
January	O
1995	O
to	O
31	O
December	O
1997	O
.	O

Molecules	O
of	O
NH3	O
are	O
capable	O
of	O
emitting	O
stimulated	O
radiation	O
(	O
MASER	O
)	O
.	O

The	O
major	O
findings	O
of	O
our	O
studies	O
are	O
as	O
follows	O
:	O
1	O
)	O
There	O
are	O
no	O
detectable	O
signals	O
around	O
GDF-9-deficient	B
follicles	O
for	O
several	O
theca	O
cell	O
layer	O
markers	O
[	O
i.e.	O

Interestingly	O
,	O
highly	O
charged	O
residues	O
were	O
abundantly	O
possessed	O
in	O
the	O
carboxy	O
-	O
terminal	O
part	O
of	O
the	O
MDV2	B
UL10	I
protein	I
.	O

Identification	O
and	O
structure	O
of	O
the	O
Marek	B
's	I
disease	I
virus	I
serotype	I
2	I
glycoprotein	I
M	I
gene	I
:	O
comparison	O
with	O
glycoprotein	B
M	I
genes	I
of	O
Herpesviridae	O
family	O
.	O

OBJECTIVE	O
:	O
To	O
perform	O
a	O
cost	O
-	O
effectiveness	O
analysis	O
(	O
CEA	O
)	O
between	O
a	O
standard	O
antiemetic	O
regimen	O
-	O
chlorpromazine	O
+	O
dexamethasone	O
(	O
CPM	O
-	O
DEX	O
)	O
-	O
and	O
a	O
5-HT3	B
receptor	I
antagonist	O
-	O
tropisetron	O
(	O
TROP	O
)	O
--in	O
the	O
control	O
of	O
acute	O
emesis	O
induced	O
by	O
highly	O
emetogenic	O
chemotherapy	O
in	O
children	O
,	O
considering	O
two	O
analytic	O
perspectives	O
:	O
hospital	O
and	O
patients	O
.	O

Baseline	O
data	O
were	O
obtained	O
from	O
10	O
adults	O
.	O

A	O
comparison	O
of	O
the	O
nucleotide	O
and	O
deduced	O
amino	O
acid	O
sequences	O
of	O
the	O
core	O
regions	O
of	O
the	O
RNA	B
-	I
dependent	I
RNA	I
polymerase	I
domains	I
found	O
in	O
these	O
three	O
dsRNAs	O
suggested	O
that	O
these	O
dsRNAs	O
probably	O
evolved	O
independently	O
within	O
each	O
host	O
plant	O
from	O
a	O
common	O
ancestor	O
.	O

Consistent	O
with	O
this	O
possibility	O
,	O
a	O
non	O
-	O
MBD	B
region	O
of	O
Bin1	B
was	O
sufficient	O
to	O
recruit	O
a	O
repression	O
function	O
to	O
DNA	O
that	O
was	O
unrelated	O
to	O
histone	B
deacetylase	I
.	O

Forty	O
-	O
eight	O
sequences	O
,	O
30	O
not	O
previously	O
identified	O
as	O
IR	O
-	O
responsive	O
,	O
were	O
significantly	O
regulated	O
by	O
IR	O
.	O

A	O
recently	O
described	O
protein	O
,	O
metaxin	B
1	I
,	O
serves	O
as	O
a	O
component	O
of	O
a	O
preprotein	O
import	O
complex	O
in	O
the	O
outer	O
membrane	O
of	O
the	O
mammalian	O
mitochondrion	O
.	O

Molecular	O
cloning	O
of	O
rat	B
SH2-containing	I
inositol	I
phosphatase	I
2	I
(	O
SHIP2	B
)	O
and	O
its	O
role	O
in	O
the	O
regulation	O
of	O
insulin	B
signaling	O
.	O

Slp1	B
represses	O
transcription	O
via	O
this	O
binding	O
site	O
in	O
yeast	O
cells	O
,	O
consistent	O
with	O
its	O
role	O
as	O
a	O
direct	O
repressor	O
of	O
ftz	B
stripes	O
in	O
interstripe	O
regions	O
during	O
late	O
stages	O
of	O
embryogenesis	O
.	O

The	O
results	O
of	O
these	O
studies	O
support	O
a	O
model	O
in	O
which	O
VirB4	B
dimers	I
or	O
homomultimers	O
contribute	O
structural	O
information	O
for	O
the	O
assembly	O
of	O
a	O
transenvelope	O
channel	O
competent	O
for	O
bidirectional	O
DNA	O
transfer	O
,	O
whereas	O
an	O
ATP	O
-	O
dependent	O
activity	O
is	O
required	O
for	O
configuring	O
this	O
channel	O
as	O
a	O
dedicated	O
export	O
machine	O
.	O

The	O
penicillin	B
binding	I
proteins	I
(	O
PBPs	B
)	O
synthesize	O
and	O
remodel	O
peptidoglycan	O
,	O
the	O
structural	O
component	O
of	O
the	O
bacterial	O
cell	O
wall	O
.	O

TCR	B
alpha	I
(	O
TCRA	B
)	O
expression	O
was	O
examined	O
in	O
RNA	O
samples	O
from	O
PBMC	O
and	O
isolated	O
populations	O
of	O
CD4	B
+	I
,	O
CD8	B
+	I
,	O
and	O
DN	O
T	O
cells	O
from	O
15	O
healthy	O
individuals	O
.	O

Similar	O
results	O
were	O
obtained	O
with	O
xylitol	O
,	O
an	O
activator	O
of	O
the	O
pentose	O
phosphate	O
pathway	O
.	O

The	O
high	B
density	I
lipoprotein	I
(	I
HDL	I
)	I
receptor	I
mediates	O
the	O
uptake	O
of	O
cholesterol	O
and	O
cholesteryl	O
esters	O
,	O
substrates	O
for	O
steroidogenesis	O
,	O
from	O
an	O
HDL	B
particle	O
in	O
the	O
adrenal	O
gland	O
and	O
gonads	O
.	O

D3S1261	B
is	O
physically	O
located	O
at	O
or	O
near	O
the	O
MITF	B
locus	I
,	O
while	O
D3S2465	B
and	O
D3S1766	B
are	O
flanking	O
the	O
locus	O
at	O
about	O
17.5	O
cM	O
genetic	O
distance	O
each	O
side	O
.	O

The	O
percentages	O
of	O
recovery	O
decreased	O
with	O
storage	O
time	O
,	O
although	O
the	O
addition	O
of	O
dispersant	O
(	O
Tris	O
-	O
Tween	O
80	O
)	O
before	O
storage	O
appeared	O
to	O
partially	O
prevent	O
adhesion	O
.	O

Point	O
mutations	O
of	O
the	O
site	O
that	O
suppressed	O
Pit-1	B
binding	O
in	O
vitro	O
restored	O
full	O
tiGH	B
promoter	I
activity	O
.	O

A	O
human	B
Raf	I
-	I
responsive	I
zinc	I
-	I
finger	I
protein	I
that	O
binds	O
to	O
divergent	O
sequences	O
.	O

We	O
are	O
reporting	O
an	O
autopsy	O
case	O
of	O
so	O
-	O
called	O
""""	O
acute	O
multiple	O
sclerosis	O
""""	O
that	O
was	O
difficult	O
to	O
differentiate	O
from	O
a	O
brain	O
tumor	O
on	O
MRI	O
findings	O
.	O

Furthermore	O
,	O
MOM-4	B
and	O
TAK1	B
bind	O
related	O
proteins	O
that	O
promote	O
their	O
kinase	O
activities	O
.	O

Gab2	B
,	O
a	O
new	O
pleckstrin	B
homology	O
domain	O
-	O
containing	O
adapter	O
protein	O
,	O
acts	O
to	O
uncouple	O
signaling	O
from	O
ERK	B
kinase	I
to	O
Elk-1	B
.	O

The	O
presence	O
of	O
cutaneous	O
xanthomas	O
with	O
normal	O
serum	O
lipid	O
levels	O
is	O
due	O
to	O
the	O
antibetalipoproteic	O
activity	O
of	O
the	O
monoclonal	B
immunoglobulin	I
.	O

In	O
an	O
attempt	O
to	O
reduce	O
the	O
incidence	O
of	O
NSAID	O
-	O
induced	O
gastrointestinal	O
lesions	O
,	O
the	O
following	O
approaches	O
have	O
been	O
proposed	O
:	O
(	O
i	O
)	O
use	O
of	O
the	O
prostaglandin	O
analogue	O
misoprostol	O
,	O
which	O
is	O
an	O
antiulcer	O
drug	O
which	O
has	O
been	O
proven	O
to	O
be	O
as	O
effective	O
in	O
the	O
prevention	O
of	O
NSAID	O
-	O
induced	O
gastric	O
and	O
duodenal	O
ulcers	O
as	O
in	O
the	O
reduction	O
of	O
serious	O
upper	O
gastrointestinal	O
complications	O
;	O
(	O
ii	O
)	O
histamine	B
H2	I
receptor	I
antagonists	O
(	O
H2	O
antagonists	O
)	O
,	O
e.g.	O
ranitidine	O
,	O
cimetidine	O
and	O
famotidine	O
,	O
which	O
are	O
useful	O
in	O
the	O
prevention	O
of	O
NSAID	O
-	O
induced	O
duodenal	O
ulcers	O
during	O
long	O
term	O
treatment	O
,	O
but	O
not	O
in	O
the	O
prevention	O
of	O
NSAID	O
-	O
induced	O
gastric	O
ulcers	O
;	O
(	O
iii	O
)	O
proton	O
pump	O
inhibitors	O
,	O
e.g	O
omeprazole	O
,	O
and	O
pantoprazole	O
,	O
whose	O
efficacy	O
in	O
preventing	O
NSAID	O
-	O
associated	O
ulcers	O
has	O
been	O
recently	O
demonstrated	O
;	O
and	O
(	O
iv	O
)	O
barrier	O
agents	O
,	O
e.g.	O
sucralfate	O
,	O
which	O
can	O
not	O
be	O
recommended	O
as	O
prophylactic	O
agents	O
to	O
prevent	O
NSAID	O
-	O
induced	O
gastropathy	O
.	O

Lung	O
mesenchyme	O
serves	O
as	O
a	O
'	O
compleat	O
'	O
inducer	O
of	O
lung	O
morphogenesis	O
by	O
secreting	O
soluble	O
peptide	O
growth	O
factors	O
.	O

The	O
activation	O
of	O
the	O
HIV	O
promoter	O
required	O
the	O
nuclear	O
localization	O
of	O
c	B
-	I
Abl	I
and	O
could	O
be	O
correlated	O
with	O
increased	O
tyrosine	O
phosphorylation	O
of	O
RNA	B
polymerase	I
II	I
.	O

The	O
bovine	B
papillomavirus	I
E2	I
protein	I
can	O
inhibit	O
the	O
proliferation	O
of	O
HT-3	O
cells	O
,	O
a	O
p53-negative	B
cervical	O
carcinoma	O
cell	O
line	O
containing	O
integrated	O
human	O
papillomavirus	O
type	O
30	O
DNA	O
.	O

E2	B
point	O
mutants	O
unable	O
to	O
inhibit	O
cell	O
growth	O
did	O
not	O
repress	O
cdc25A	B
and	O
cdc25B	B
expression	O
,	O
nor	O
did	O
the	O
cell	O
cycle	O
inhibitors	O
hydroxyurea	O
and	O
mimosine	O
.	O

Neurospora	O
crassa	O
CYT-18	B
,	O
can	O
rescue	O
the	O
exonic	O
trap	O
and	O
intron	O
mutants	O
which	O
cause	O
a	O
structural	O
defect	O
.	O

DDP1	B
also	O
localizes	O
to	O
heterochromatin	O
in	O
interphase	O
nuclei	O
of	O
larval	O
neuroblasts	O
.	O

In	O
a	O
reconstituted	O
human	O
DNA	O
repair	O
system	O
containing	O
DNA	B
polymerase	I
beta	I
and	O
DNA	B
ligase	I
III	I
-	O
XRCC1	B
,	O
accurate	O
rejoining	O
of	O
a	O
3	O
'	O
mismatched	O
base	O
residue	O
at	O
a	O
single	O
-	O
strand	O
break	O
is	O
dependent	O
on	O
addition	O
of	O
the	O
exonuclease	O
.	O

The	O
PAC	O
clone	O
with	O
an	O
insert	O
size	O
of	O
120	O
kb	O
was	O
isolated	O
and	O
mapped	O
by	O
restriction	O
analysis	O
.	O

Sequence	O
of	O
10q24	B
locus	I
surrounding	O
the	O
HOX11	B
oncogene	I
reveals	O
a	O
new	O
gene	O
HUG1	B
expressed	O
in	O
a	O
T	O
-	O
ALL	O
cell	O
line	O
.	O

About	O
20	O
kb	O
upstream	O
of	O
LAMB2	B
we	O
found	O
a	O
gene	O
encoding	O
a	O
transcribed	O
,	O
non	O
-	O
processed	O
LAMB2-like	B
pseudogene	I
(	O
LAMB2L	B
)	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
the	O
R2	B
protein	I
was	O
used	O
to	O
provide	O
evidence	O
that	O
this	O
motif	O
is	O
also	O
part	O
of	O
the	O
active	O
site	O
of	O
the	O
endonuclease	O
encoded	O
by	O
this	O
element	O
.	O

The	O
infected	B
cell	I
protein	I
no.	I
0	I
(	O
ICP0	B
)	O
of	O
herpes	O
simplex	O
virus	O
1	O
is	O
a	O
promiscuous	O
transactivator	O
shown	O
to	O
enhance	O
the	O
expression	O
of	O
genes	O
introducted	O
into	O
cells	O
by	O
infection	O
or	O
transfection	O
.	O

Wrist	O
measurement	O
of	O
blood	O
pressure	O
:	O
some	O
critical	O
remarks	O
to	O
oscillometry	O
.	O

G	O
-	O
box	O
-	O
directed	O
expression	O
in	O
leaves	O
required	O
the	O
presence	O
of	O
an	O
enhancer	O
region	O
from	O
the	O
cauliflower	O
mosaic	O
virus	O
(	O
CaMV	O
)	O
35S	B
promoter	I
.	O

Another	O
element	O
necessary	O
for	O
augmenting	O
the	O
amplitude	O
of	O
the	O
oscillation	O
lies	O
between	O
-178	O
and	O
-264	O
.	O

There	O
was	O
no	O
competition	O
between	O
activin	B
A	I
and	O
OP-1	B
for	O
availability	O
of	O
Smad4	B
,	O
indicating	O
that	O
the	O
concentration	O
of	O
this	O
common	O
signal	O
transducer	O
is	O
not	O
limiting	O
for	O
generating	O
the	O
observed	O
biological	O
responses	O
.	O

Our	O
data	O
therefore	O
indicate	O
that	O
it	O
is	O
possible	O
to	O
engineer	O
the	O
HA	B
envelope	I
glycoprotein	I
by	O
fusing	O
ligands	O
to	O
its	O
amino	O
-	O
terminal	O
end	O
without	O
affecting	O
its	O
fusion	O
activity	O
.	O

However	O
,	O
the	O
favored	O
,	O
parallel	O
beta	O
helix	O
model	O
is	O
a	O
compact	O
coil	O
of	O
ten	O
helically	O
arranged	O
beta	O
strands	O
forming	O
two	O
parallel	O
beta	O
sheet	O
faces	O
.	O

This	O
is	O
predicted	O
to	O
encode	O
a	O
315-residue	O
protein	O
containing	O
seven	O
hydrophobic	O
helical	O
regions	O
and	O
a	O
17	O
amino	O
acid	O
motif	O
characteristic	O
of	O
the	O
R7	B
G	I
family	I
of	O
G	B
-	I
protein	I
coupled	I
membrane	I
-	I
bound	I
receptors	I
.	O

These	O
results	O
suggest	O
that	O
members	O
of	O
the	O
ATF	B
family	I
are	O
involved	O
in	O
mediating	O
the	O
transcriptional	O
regulation	O
of	O
the	O
KGF	B
gene	I
in	O
response	O
to	O
extracellular	O
stimuli	O
via	O
a	O
novel	O
CRE	O
regulatory	O
element	O
.	O

Moreover	O
,	O
a	O
high	O
proportion	O
of	O
blood	O
samples	O
from	O
a	O
random	O
sample	O
of	O
the	O
rest	O
of	O
the	O
suspects	O
tested	O
positive	O
for	O
trypanosome	O
-	O
specific	O
DNA	O
by	O
PCR	O
(	O
79.9	O
%	O
for	O
T.	O
b.	O
gambiense	O
and	O
13.9	O
%	O
for	O
T.	O
b.	O
rhodesiense	O
)	O
.	O

A	O
multi	O
-	O
centre	O
evaluation	O
of	O
the	O
card	O
indirect	O
agglutination	O
test	O
for	O
trypanosomiasis	O
(	O
TrypTect	O
CIATT	O
)	O
.	O

Results	O
for	O
men	O
who	O
drank	O
up	O
to	O
two	O
drinks	O
per	O
day	O
suggest	O
that	O
if	O
the	O
dependence	O
criteria	O
were	O
invalid	O
,	O
reductions	O
in	O
the	O
prevalence	O
of	O
specific	O
indicators	O
of	O
alcohol	O
dependence	O
would	O
range	O
from	O
0.3	O
%	O
to	O
5.2	O
%	O
.	O

Mutagenesis	O
of	O
the	O
CDE	O
/	O
CHR	O
elements	O
and	O
Sp1	B
sites	I
in	O
this	O
region	O
,	O
alone	O
or	O
in	O
combination	O
,	O
reduced	O
transcriptional	O
activity	O
by	O
40	O
-	O
60	O
%	O
in	O
asynchronously	O
growing	O
cells	O
and	O
abolished	O
cell	O
cycle	O
periodicity	O
in	O
G2-M	O
-	O
synchronized	O
cells	O
.	O

Using	O
Scheffe	O
's	O
procedure	O
as	O
an	O
illustration	O
,	O
comparisons	O
are	O
made	O
to	O
usual	O
sample	O
size	O
methods	O
that	O
incorrectly	O
ignore	O
the	O
stochastic	O
nature	O
of	O
S2p	O
.	O

The	O
crystal	O
structure	O
of	O
the	O
VP16	B
core	I
has	O
been	O
determined	O
at	O
2.1	O
A	O
resolution	O
.	O

Ozagrel	O
,	O
ifenprodil	O
,	O
cinnarizine	O
and	O
dilazep	O
were	O
more	O
effective	O
than	O
pentoxifylline	O
in	O
increasing	O
rCBF	O
at	O
the	O
HPC	O
.	O

The	O
latter	O
method	O
adds	O
clamping	O
of	O
the	O
inferior	O
vena	O
cava	O
,	O
which	O
results	O
in	O
hypotension	O
,	O
requiring	O
invasive	O
anesthetic	O
management	O
.	O

By	O
contrast	O
,	O
PvirE	B
or	O
Plac	B
promoter	I
constructs	I
yielded	O
functional	O
VirE2	B
only	O
if	O
virE1	B
was	O
coexpressed	O
with	O
virE2	B
.	O

Simian	O
parainfluenza	O
virus	O
5	O
(	O
SV5	O
)	O
is	O
a	O
prototype	O
of	O
the	O
Paramyxoviridae	O
family	O
of	O
nonsegmented	O
negative	O
-	O
sense	O
RNA	O
viruses	O
.	O

To	O
investigate	O
the	O
functions	O
of	O
GE	O
,	O
IG	O
,	O
and	O
GS	O
sequences	O
in	O
transcription	O
,	O
we	O
constructed	O
plasmids	O
containing	O
cDNAs	O
of	O
the	O
full	O
-	O
length	O
SV5	O
genome	O
in	O
which	O
the	O
gene	O
junction	O
sequences	O
(	O
GE	O
,	O
IG	O
,	O
and	O
GS	O
sequences	O
)	O
located	O
between	O
the	O
hemagglutinin	B
-	I
neuraminidase	I
(	O
HN	B
)	O
and	O
the	O
polymerase	B
(	I
L	I
)	I
genes	I
were	O
replaced	O
with	O
the	O
counterpart	O
sequences	O
from	O
other	O
gene	O
junctions	O
.	O

CXCR4	B
is	O
a	O
chemokine	O
receptor	O
and	O
a	O
coreceptor	O
for	O
T	O
-	O
cell	O
-	O
line	O
-	O
tropic	O
(	O
X4	O
)	O
and	O
dual	O
-	O
tropic	O
(	O
R5X4	O
)	O
human	O
immunodeficiency	O
virus	O
type	O
1	O
(	O
HIV-1	O
)	O
isolates	O
.	O

These	O
data	O
will	O
help	O
us	O
to	O
better	O
detail	O
the	O
CXCR4	B
structural	O
requirements	O
exhibited	O
by	O
different	O
HIV-1	O
strains	O
and	O
will	O
direct	O
further	O
mutagenesis	O
efforts	O
aimed	O
at	O
better	O
defining	O
the	O
domains	O
in	O
CXCR4	B
involved	O
in	O
the	O
HIV-1	O
Env	B
-	O
mediated	O
fusion	O
process	O
.	O

The	O
results	O
of	O
these	O
analyses	O
indicate	O
that	O
the	O
proteinase	O
cleaves	O
at	O
amino	O
acid	O
residues	O
E960-A961	O
,	O
E1071-S1072	O
,	O
E1345-T1346	O
,	O
and	O
E1419-G1420	O
;	O
however	O
,	O
the	O
cleavage	O
efficiency	O
is	O
varied	O
.	O

y.	O

SM	B
is	O
also	O
shown	O
to	O
be	O
associated	O
in	O
vivo	O
with	O
other	O
components	O
of	O
the	O
CRM	B
1	I
export	O
pathway	O
,	O
including	O
the	O
small	B
GTPase	I
Ran	I
and	O
the	O
nucleoporin	O
CAN	B
/	O
Nup214	B
.	O

Identification	O
of	O
a	O
spliced	O
gene	O
from	O
Kaposi	O
's	O
sarcoma	O
-	O
associated	O
herpesvirus	O
encoding	O
a	O
protein	O
with	O
similarities	O
to	O
latent	B
membrane	I
proteins	I
1	I
and	I
2A	I
of	I
Epstein	I
-	I
Barr	I
virus	I
.	O

Auditory	O
clicks	O
were	O
given	O
at	O
a	O
rate	O
of	O
20	O
s	O
(	O
-1	O
)	O
.	O

The	O
inhibition	O
of	O
StAR	B
gene	I
transcription	O
by	O
DAX-1	B
was	O
dose	O
-	O
dependent	O
reducing	O
transcription	O
to	O
6	O
%	O
of	O
control	O
levels	O
.	O

In	O
a	O
prospective	O
randomized	O
study	O
,	O
287	O
patients	O
with	O
advanced	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
(	O
NSCLC	O
)	O
stage	O
IIIb	O
or	O
IV	O
with	O
ECOG	O
performance	O
status	O
(	O
PS	O
)	O
0	O
-	O
1	O
or	O
2	O
were	O
randomly	O
assigned	O
to	O
receive	O
either	O
best	O
supportive	O
care	O
(	O
BSC	O
)	O
or	O
supportive	O
care	O
plus	O
combination	O
chemotherapy	O
(	O
IEP	O
regimen	O
:	O
ifosfamide	O
3	O
gm	O
/	O
m2	O
IV	O
with	O
mesna	O
uroprotection	O
,	O
epirubicin	O
60	O
mg	O
/	O
m2	O
IV	O
on	O
day	O
1	O
and	O
cisplatin	O
60	O
mg	O
/	O
m2	O
IV	O
on	O
day	O
2	O
;	O
or	O
MVP	O
regimen	O
:	O
mitomycin	O
-	O
C	O
8	O
mg	O
/	O
m2	O
,	O
cisplatin	O
100	O
mg	O
/	O
m2	O
IV	O
on	O
day	O
1	O
,	O
vinblastine	O
4	O
mg	O
/	O
m2	O
IV	O
on	O
days	O
1	O
and	O
15	O
)	O
.	O

Using	O
sequence	O
information	O
from	O
human	B
BMAL1	I
(	O
hBMAL1	B
)	O
cDNAs	O
previously	O
reported	O
by	O
our	O
laboratory	O
,	O
we	O
have	O
isolated	O
and	O
characterized	O
cDNAs	O
encoding	O
three	O
splice	O
variants	O
of	O
the	O
mouse	B
BMAL1	I
(	O
mBMAL1	B
)	O
gene	O
.	O

Comparison	O
with	O
the	O
bHLH	B
/	O
PAS	B
family	O
genes	O
revealed	O
that	O
the	O
intron	O
/	O
exon	O
splice	O
pattern	O
of	O
mBMAL1	B
most	O
closely	O
matches	O
that	O
of	O
the	O
mAhr	B
,	O
which	O
suggests	O
that	O
BMAL1	B
and	O
Ahr	B
belong	O
to	O
the	O
same	O
subclass	O
and	O
may	O
be	O
derived	O
from	O
a	O
common	O
primordial	O
gene	O
.	O

The	O
transcriptional	O
activities	O
of	O
the	O
full	O
-	O
length	O
promoter	O
(	O
-295	O
to	O
+	O
85	O
)	O
and	O
of	O
three	O
deletion	O
constructs	O
(	O
-197	O
,	O
-154	O
and	O
-74	O
to	O
+	O
85	O
)	O
were	O
significantly	O
down	O
-	O
regulated	O
in	O
resistant	O
cells	O
.	O

We	O
were	O
able	O
to	O
detect	O
significant	O
differences	O
in	O
functional	O
residual	O
capacity	O
adjusted	O
for	O
weight	O
or	O
height	O
,	O
and	O
compliance	O
of	O
the	O
respiratory	O
system	O
adjusted	O
for	O
weight	O
or	O
lung	O
volume	O
in	O
the	O
ILD	O
infants	O
compared	O
to	O
the	O
healthy	O
controls	O
or	O
infants	O
who	O
had	O
PPHN	O
,	O
indicating	O
that	O
these	O
PFTs	O
were	O
sensitive	O
enough	O
to	O
determine	O
abnormal	O
lung	O
function	O
in	O
this	O
age	O
group	O
.	O

A	O
13-bp	O
cis	O
-	O
regulatory	O
element	O
in	O
the	O
LTR	O
promoter	O
of	O
the	O
tobacco	B
retrotransposon	I
Tto1	I
is	O
involved	O
in	O
responsiveness	O
to	O
tissue	O
culture	O
,	O
wounding	O
,	O
methyl	O
jasmonate	O
and	O
fungal	O
elicitors	O
.	O

In	O
this	O
study	O
we	O
describe	O
that	O
platelet	B
-	I
derived	I
growth	I
factor	I
(	O
PDGF	B
)	O
,	O
12-O	O
-	O
tetradecanoyl	O
-	O
phorbol	O
-	O
acetate	O
(	O
TPA	O
)	O
,	O
and	O
forskolin	O
induced	O
CREB	B
(	O
cAMP	B
-	I
responsive	I
element	I
-	I
binding	I
protein	I
)	O
Ser-133	O
phosphorylation	O
with	O
comparable	O
magnitude	O
and	O
kinetics	O
in	O
NIH	O
3T3	O
cells	O
.	O

This	O
constitutes	O
evidence	O
for	O
an	O
in	O
vivo	O
role	O
of	O
SRC-1	B
in	O
dimerization	O
-	O
induced	O
activation	O
by	O
OR1	B
/	O
RXRalpha	B
.	O

By	O
contrast	O
,	O
mTRAP100	B
coprecipitates	O
in	O
vivo	O
with	O
another	O
component	O
of	O
the	O
TRAP	B
complex	I
(	O
TRAP220	B
)	O
,	O
which	O
directly	O
contacts	O
TR	B
and	O
the	O
vitamin	B
D	I
receptor	I
in	O
a	O
ligand	O
-	O
dependent	O
manner	O
.	O

This	O
sequence	O
also	O
confers	O
VDR	B
and	O
vitamin	O
D	O
responsiveness	O
to	O
a	O
heterologous	O
promoter	O
.	O

Classical	O
ligand	O
-	O
activated	O
nuclear	O
receptors	O
(	O
e.g.	O
thyroid	B
hormone	I
receptor	I
,	O
retinoic	B
acid	I
receptor	I
)	O
,	O
orphan	B
nuclear	I
receptors	I
(	O
e.g.	O

Expression	O
of	O
GlcNAc	B
-	I
TI	I
mRNA	I
in	O
tobacco	O
leaves	O
was	O
detected	O
using	O
RT	O
-	O
PCR	O
.	O

Chemical	O
stability	O
tests	O
and	O
site	O
-	O
specific	O
mutagenesis	O
identified	O
amino	O
acids	O
H219	O
and	O
D63	O
of	O
RegS	B
and	O
RegR	B
,	O
respectively	O
,	O
as	O
the	O
phosphorylated	O
residues	O
.	O

An	O
overexpression	O
of	O
the	O
betaAPP	B
gene	I
in	O
certain	O
areas	O
of	O
the	O
AD	O
brain	O
has	O
been	O
suggested	O
to	O
be	O
an	O
important	O
factor	O
in	O
the	O
neuropathology	O
of	O
AD	O
.	O

For	O
functional	O
studies	O
,	O
two	O
promoter	O
regions	O
were	O
cloned	O
upstream	O
of	O
the	O
reporter	O
gene	O
,	O
chloramphenicol	B
acetyl	I
transferase	I
(	O
CAT	B
)	O
:	O
(	O
i	O
)	O
phbetaE	O
-	O
B	O
-	O
the	O
plasmid	O
that	O
contains	O
the	O
human	O
(	O
h	O
)	O
promoter	O
region	O
(	O
-2832	O
to	O
+	O
101	O
)	O
including	O
URE	O
,	O
and	O
(	O
ii	O
)	O
prhbetaE	O
-	O
B	O
-	O
the	O
plasmid	O
that	O
contains	O
the	O
rhesus	O
(	O
rh	O
)	O
promoter	O
region	O
excluding	O
URE	O
as	O
it	O
lacks	O
a	O
270	O
bp	O
region	O
of	O
the	O
hbetaAPP	B
promoter	I
(	O
-2435	O
to	O
-2165	O
)	O
.	O

67	O
393	O
bp	O
of	O
contiguous	O
DNA	O
located	O
between	O
markers	O
cdc18	B
and	O
cdc14	B
on	O
the	O
right	O
arm	O
of	O
fission	O
yeast	O
chromosome	O
II	O
has	O
been	O
sequenced	O
as	O
part	O
of	O
the	O
European	O
Union	O
Schizosaccharomyces	O
pombe	O
genome	O
sequencing	O
project	O
.	O

67	O
393	O
bp	O
of	O
contiguous	O
DNA	O
located	O
between	O
markers	O
cdc18	B
and	O
cdc14	B
on	O
the	O
right	O
arm	O
of	O
fission	O
yeast	O
chromosome	O
II	O
has	O
been	O
sequenced	O
as	O
part	O
of	O
the	O
European	O
Union	O
Schizosaccharomyces	O
pombe	O
genome	O
sequencing	O
project	O
.	O

G	B
-	I
CSF	I
(	O
480	O
micrograms	O
subcutaneously	O
(	O
s.c	O
.	O
)	O
)	O
were	O
used	O
in	O
55	O
and	O
GM	B
-	I
CSF	I
(	O
400	O
micrograms	O
s.c	O
.	O
)	O
in	O
28	O
chemotherapeutic	O
cycles	O
.	O

Overexpression	O
of	O
H411	B
cDNA	I
in	O
the	O
RAW	O
264.7	O
macrophage	O
cell	O
line	O
promoted	O
an	O
increased	O
growth	O
rate	O
,	O
suggesting	O
that	O
expression	O
of	O
H411	B
is	O
part	O
of	O
the	O
proliferative	O
cell	O
response	O
to	O
LPS	O
.	O

Human	O
expressed	O
sequence	O
tag	O
clones	O
were	O
identified	O
by	O
sequence	O
similarity	O
to	O
mammalian	B
and	I
yeast	I
oligosaccharide	I
-	I
processing	I
mannosidases	I
,	O
and	O
the	O
full	O
-	O
length	O
coding	O
region	O
of	O
the	O
putative	O
mannosidase	B
homolog	I
was	O
isolated	O
by	O
a	O
combination	O
of	O
5'-rapid	O
amplification	O
of	O
cDNA	O
ends	O
and	O
direct	O
polymerase	O
chain	O
reaction	O
from	O
human	O
placental	O
cDNA	O
.	O

Activation	O
of	O
ERK1	B
/	I
2	I
is	O
correlated	O
with	O
induction	O
of	O
the	O
immediate	B
-	I
early	I
response	I
genes	I
.	O

The	O
transcription	O
of	O
most	O
RP	B
genes	I
is	O
activated	O
by	O
two	O
Rap1p	B
binding	I
sites	I
,	O
250	O
to	O
400	O
bp	O
upstream	O
from	O
the	O
initiation	O
of	O
transcription	O
.	O

We	O
have	O
isolated	O
three	O
mutant	O
alleles	O
of	O
CDC4	B
(	O
cdc4	B
-	I
10	I
,	O
cdc4	B
-	I
11	I
,	O
and	O
cdc4	B
-	I
16	I
)	O
which	O
suppress	O
the	O
nuclear	O
division	O
defect	O
of	O
cdc20	B
-	I
1	I
cells	O
.	O

Role	O
of	O
secondary	O
structure	O
in	O
discrimination	O
between	O
constitutive	O
and	O
inducible	O
activators	O
.	O

In	O
summary	O
,	O
Ca	O
(	O
2+	O
)	O
-dependent	O
activation	O
of	O
NO	O
production	O
mediates	O
apoptosis	O
after	O
TG	B
exposure	O
in	O
JT	O
/	O
Neo	O
cells	O
.	O

Accumulation	O
of	O
the	O
U4	B
/	O
U6	B
duplex	O
was	O
relieved	O
by	O
overexpression	O
of	O
wild	B
-	I
type	I
Prp44p	I
.	O

Our	O
results	O
,	O
when	O
combined	O
with	O
previously	O
published	O
in	O
vitro	O
results	O
,	O
support	O
a	O
direct	O
role	O
for	O
Prp44p	B
in	O
unwinding	O
of	O
the	O
U4	B
/	O
U6	B
helix	O
.	O

This	O
approximately	O
125-nt	O
RNA	O
proved	O
to	O
arise	O
via	O
RNase	B
E	I
cleavage	O
from	O
the	O
3'-terminal	O
region	O
of	O
the	O
mRNAs	O
bearing	O
the	O
terminator	O
.	O

The	O
mysteries	O
of	O
geographic	O
variability	O
in	O
nonmelanoma	O
skin	O
cancer	O
incidence	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
the	O
cAMP	B
-	I
dependent	I
kinases	I
(	O
PKAs	B
)	O
promote	O
cytoplasmic	O
growth	O
and	O
modulate	O
the	O
growth	O
-	O
regulated	O
mechanism	O
triggering	O
the	O
begin	O
of	O
DNA	O
synthesis	O
.	O

We	O
have	O
shown	O
previously	O
that	O
in	O
contrast	O
to	O
other	O
extracellular	O
matrix	O
molecules	O
pepsin	B
-	O
solubilized	O
collagen	B
VI	I
(	O
CVI	B
)	O
can	O
stimulate	O
DNA	O
synthesis	O
of	O
various	O
mesenchymal	O
cell	O
types	O
,	O
apparently	O
independent	O
of	O
integrin	B
-	O
mediated	O
signal	O
transduction	O
.	O

A	O
recombinant	O
derivative	O
harboring	O
the	O
pMJ101	O
replication	O
region	O
proved	O
to	O
be	O
compatible	O
with	O
pJM1	O
,	O
a	O
plasmid	O
containing	O
the	O
iron	O
acquisition	O
system	O
required	O
for	O
the	O
virulence	O
of	O
V.	O
anguillarum	O
775	O
,	O
another	O
important	O
pathogen	O
that	O
causes	O
vibriosis	O
.	O

FAK	B
localizes	O
to	O
sites	O
of	O
transmembrane	B
integrin	I
receptor	I
clustering	O
and	O
facilitates	O
intracellular	O
signaling	O
events	O
.	O

Expression	O
of	O
various	O
FAK	B
mutants	I
in	O
the	O
FAK-	B
cells	O
showed	O
that	O
FAK	B
kinase	I
activity	O
,	O
the	O
Tyr-397	B
/	I
SH2	I
domain	I
binding	I
site	I
,	O
and	O
the	O
first	O
proline	O
-	O
rich	O
SH3	B
binding	I
region	I
in	O
the	O
FAK	B
C	I
-	I
terminal	I
domain	I
were	O
individually	O
needed	O
to	O
promote	O
full	O
FAK	B
-	O
mediated	O
FAK-	B
cell	O
migration	O
to	O
FN	B
whereas	O
direct	O
paxillin	B
binding	O
to	O
FAK	B
was	O
not	O
required	O
.	O

This	O
dominant	O
-	O
negative	O
effect	O
of	O
FRNK	B
was	O
reversed	O
by	O
a	O
point	O
mutation	O
(	O
Leu-1034	O
to	O
Ser	O
)	O
which	O
prevented	O
FRNK	B
localization	O
to	O
focal	O
contact	O
sites	O
.	O

Fifty	O
six	O
young	O
patients	O
(	O
age	O
<	O
45	O
yr	O
)	O
with	O
doppler	O
-	O
proven	O
DVT	O
were	O
investigated	O
for	O
the	O
presence	O
of	O
resistance	O
to	O
activated	B
protein	I
C	I
(	O
APC	B
-	I
R	I
)	O
,	O
lupus	O
anticoagulant	O
(	O
LA	O
)	O
,	O
anticardiolipin	B
antibodies	I
and	O
deficiencies	O
of	O
protein	B
C	I
,	O
protein	B
S	I
,	O
ATIII	B
activities	O
.	O

DESIGN	O
:	O
Comparison	O
of	O
number	O
of	O
women	O
with	O
PKU	O
aged	O
15	O
-	O
44	O
years	O
on	O
the	O
NSW	O
PKU	O
database	O
(	O
observed	O
number	O
)	O
with	O
expected	O
number	O
derived	O
from	O
population	O
data	O
.	O

PURPOSE	O
:	O
The	O
purposes	O
of	O
the	O
present	O
study	O
were	O
to	O
assess	O
the	O
effects	O
of	O
a	O
12-wk	O
laboratory	O
based	O
aerobic	O
exercise	O
program	O
on	O
cardiopulmonary	O
function	O
,	O
CD4	B
cell	O
count	O
,	O
and	O
physician	O
-	O
assessed	O
health	O
status	O
among	O
symptomatic	O
pre	O
-	O
AIDS	O
HIV	O
-	O
infected	O
individuals	O
(	O
N	O
=	O
28	O
)	O
and	O
to	O
assess	O
the	O
degree	O
to	O
which	O
ill	O
health	O
was	O
associated	O
with	O
exercise	O
relapse	O
.	O

The	O
enzyme	O
displays	O
optimal	O
activity	O
at	O
about	O
0.5	O
mM	O
pantoate	O
(	O
k	O
(	O
cat	O
)	O
0.63	O
s	O
(	O
-1	O
)	O
)	O
and	O
at	O
pH	O
7.8	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
the	O
RP	B
,	O
like	O
the	O
20S	B
proteasome	I
,	O
is	O
functionally	O
and	O
structurally	O
conserved	O
among	O
eukaryotes	O
and	O
indicate	O
that	O
the	O
plant	B
RPT	I
subunits	I
,	O
like	O
their	O
yeast	O
counterparts	O
,	O
have	O
non	O
-	O
redundant	O
functions	O
.	O

Epidemiologic	O
evidence	O
indicates	O
that	O
estrogen	O
replacement	O
therapy	O
after	O
menopause	O
increases	O
breast	O
cancer	O
risk	O
.	O

In	O
addition	O
to	O
its	O
elongation	O
activity	O
,	O
ELL	B
contains	O
a	O
novel	O
type	O
of	O
RNA	B
polymerase	I
II	I
interaction	I
domain	I
that	O
is	O
capable	O
of	O
repressing	O
polymerase	O
activity	O
in	O
promoter	O
-	O
specific	O
transcription	O
.	O

A	O
diagnosis	O
of	O
IgA	B
lambda	I
multiple	O
myeloma	O
with	O
peritoneal	O
involvement	O
was	O
made	O
.	O

The	O
radiation	O
burden	O
associated	O
with	O
the	O
majority	O
of	O
examinations	O
in	O
nuclear	O
medicine	O
expressed	O
as	O
the	O
effective	O
dose	O
is	O
comparable	O
with	O
the	O
radiation	O
burden	O
of	O
radiodiagnostic	O
examinations	O
,	O
only	O
after	O
administration	O
of	O
preparations	O
with	O
131I	O
,	O
201Tl	O
,	O
67Ga	O
and	O
111In	O
it	O
is	O
markedly	O
higher	O
.	O

Although	O
the	O
risk	O
of	O
malformation	O
in	O
children	O
born	O
after	O
ICSI	O
is	O
not	O
increased	O
there	O
is	O
an	O
increased	O
risk	O
to	O
transmit	O
genetic	O
abnormalities	O
in	O
case	O
of	O
NOA	O
(	O
such	O
as	O
the	O
rate	O
of	O
sex	O
chromosome	O
,	O
or	O
microdeletions	O
of	O
the	O
Y	O
chromosome	O
)	O
and	O
in	O
case	O
of	O
congenital	O
OA	O
(	O
mutations	O
of	O
the	O
cystic	B
fibrosis	I
gene	I
)	O
.	O

TaV	O
particles	O
have	O
a	O
buoyant	O
density	O
of	O
1.296	O
g	O
/	O
cm3	O
in	O
CsCl	O
and	O
consist	O
of	O
two	O
capsid	B
proteins	I
of	O
56	O
and	O
6	O
kDa	O
.	O

In	O
about	O
770	O
bp	O
upstream	O
region	O
of	O
Spam1	B
that	O
has	O
been	O
cloned	O
and	O
sequenced	O
,	O
multiple	O
transcription	O
factor	O
binding	O
sites	O
including	O
a	O
CRE	O
(	O
cAMP	O
-	O
responsive	O
element	O
)	O
were	O
found	O
.	O

The	O
in	O
vitro	O
relaxivity	O
of	O
the	O
complex	O
is	O
16.24	O
s	O
(	O
-1	O
)	O
mM	O
(	O
-1	O
)	O
.	O

Structure	O
and	O
expression	O
of	O
the	O
mouse	B
growth	I
hormone	I
receptor	I
/	O
growth	B
hormone	I
binding	I
protein	I
gene	I
.	O

Bacterial	O
recovery	O
of	O
SA	O
from	O
the	O
liver	O
/	O
spleen	O
and	O
the	O
cecal	O
tonsil	O
in	O
contact	O
poults	O
and	O
SG	O
from	O
contact	O
chicks	O
treated	O
with	O
ILK	B
was	O
dramatically	O
reduced	O
when	O
compared	O
to	O
non	O
-	O
treated	O
contact	O
poults	O
and	O
chicks	O
.	O

The	O
results	O
of	O
the	O
ISIS-2	O
trial	O
and	O
the	O
data	O
from	O
the	O
Antiplatelet	O
Trialists	O
'	O
Collaboration	O
indicated	O
that	O
aspirin	O
is	O
mandatory	O
in	O
patients	O
with	O
acute	O
myocardial	O
infarction	O
and	O
for	O
secondary	O
prevention	O
.	O

This	O
study	O
was	O
performed	O
to	O
assess	O
the	O
role	O
of	O
additional	O
diagnostic	O
laparoscopy	O
in	O
the	O
preoperative	O
staging	O
of	O
patients	O
with	O
adenocarcinoma	O
of	O
the	O
esophagus	O
,	O
gastric	O
cancer	O
and	O
pancreatic	O
cancer	O
prior	O
to	O
intended	O
curative	O
surgery	O
.	O

This	O
report	O
presents	O
state	O
-	O
specific	O
MMRs	O
for	O
1987	O
-	O
1996	O
,	O
focusing	O
on	O
persistent	O
disparities	O
in	O
maternal	O
mortality	O
between	O
black	O
and	O
white	O
women	O
.	O

Preheparin	O
LPL	B
mass	O
level	O
did	O
not	O
significantly	O
differ	O
in	O
individuals	O
from	O
19	O
to	O
70	O
years	O
old	O
,	O
for	O
both	O
men	O
and	O
women	O
.	O

A	O
decrease	O
in	O
insulin	B
-	O
induced	O
receptor	O
kinase	O
activity	O
was	O
observed	O
for	O
solubilized	O
chimeric	O
receptors	O
.	O

Cat-1	B
is	O
identical	O
to	O
the	O
recently	O
identified	O
binding	O
partner	O
for	O
the	O
beta	B
-	I
adrenergic	I
receptor	I
kinase	I
(	O
betaARK	B
or	O
GRK-2	B
)	O
,	O
which	O
was	O
shown	O
to	O
have	O
Arf	B
-	O
GAP	B
activity	O
.	O

Cat	B
proteins	I
are	O
tyrosine	O
-	O
phosphorylated	O
when	O
co	O
-	O
expressed	O
in	O
cells	O
with	O
the	O
focal	B
adhesion	I
kinase	I
Fak	B
and	O
Src	B
.	O

Immunoprecipitation	O
experiments	O
using	O
DokR	B
-	I
specific	I
antibodies	I
revealed	O
an	O
interaction	O
between	O
endogenous	B
DokR	I
and	O
a	O
150-kDa	O
protein	O
that	O
is	O
tyrosine	O
-	O
phosphorylated	O
in	O
EGF	B
-	O
stimulated	O
BaF	O
/	O
3	O
cells	O
.	O

Expansins	B
are	O
a	O
family	O
of	O
proteins	O
that	O
catalyse	O
long	O
-	O
term	O
extension	O
of	O
isolated	O
plant	O
cell	O
walls	O
due	O
to	O
an	O
as	O
yet	O
unknown	O
biochemical	O
mechanism	O
.	O

This	O
review	O
summarizes	O
the	O
clinical	O
evidence	O
to	O
support	O
current	O
therapies	O
in	O
irritable	O
bowel	O
syndrome	O
(	O
IBS	O
)	O
.	O

Furthermore	O
,	O
addition	O
of	O
B	B
-	I
Myb	I
-	O
glutathionine	B
S	I
-	I
transferase	I
fusion	O
protein	O
inhibited	O
complex	O
formation	O
.	O

APOE	B
-	O
epsilon4	O
count	O
predicts	O
age	O
when	O
prevalence	O
of	O
AD	O
increases	O
,	O
then	O
declines	O
:	O
the	O
Cache	O
County	O
Study	O
.	O

Repair	O
of	O
double	O
-	O
strand	O
breaks	O
(	O
DSBs	O
)	O
in	O
chromosomal	O
DNA	O
by	O
nonhomologous	O
end	O
-	O
joining	O
(	O
NHEJ	O
)	O
is	O
not	O
well	O
characterized	O
in	O
the	O
yeast	O
Saccharomyces	O
cerevisiae	O
.	O

A	O
new	O
DNA	B
repair	I
gene	I
from	O
Schizosaccharomyces	O
pombe	O
with	O
homology	O
to	O
RecA	B
was	O
identified	O
and	O
characterized	O
.	O

Among	O
mucus	O
-	O
secreting	O
cells	O
,	O
the	O
gastric	O
gland	O
mucous	O
cells	O
,	O
Brunner	O
's	O
glands	O
,	O
accessory	O
glands	O
of	O
pancreaticobiliary	O
tract	O
,	O
and	O
pancreatic	O
ducts	O
exhibiting	O
gastric	O
metaplasia	O
are	O
unique	O
in	O
that	O
they	O
express	O
class	B
III	I
mucin	I
identified	O
by	O
paradoxical	O
Con	B
A	I
staining	O
composed	O
of	O
periodate	O
oxidation	O
,	O
sodium	O
borohydride	O
reduction	O
,	O
Con	B
A	I
,	O
and	O
horseradish	B
peroxidase	I
reaction	O
.	O

The	O
C	O
-	O
terminal	O
mutants	O
were	O
strongly	O
dominant	O
over	O
TraR	B
,	O
suggesting	O
that	O
they	O
can	O
form	O
heteromultimers	O
with	O
the	O
wild	O
-	O
type	O
activator	O
.	O

Thus	O
,	O
elongin	B
C	I
is	O
found	O
to	O
oligomerize	O
in	O
solution	O
and	O
to	O
undergo	O
significant	O
structural	O
rearrangements	O
upon	O
binding	O
of	O
two	O
different	O
partner	O
proteins	O
.	O

The	O
data	O
imply	O
that	O
JAK	B
/	O
STAT	B
signaling	O
has	O
a	O
role	O
in	O
EBV	O
-	O
associated	O
malignancies	O
.	O

There	O
were	O
27	O
men	O
and	O
156	O
women	O
.	O

A.	O
,	O
Bowers	O
,	O
K.E	O
,	O
and	O
Matthews	O
,	O
C.	O

Spfkh1	B
is	O
transcribed	O
in	O
one	O
open	O
reading	O
frame	O
that	O
contains	O
the	O
DNA	O
binding	O
domain	O
,	O
nuclear	O
localization	O
signal	O
and	O
transactivation	O
domain	O
.	O

The	O
molecular	O
mechanism	O
of	O
Tax	B
-	O
mediated	O
trans	O
-	O
activation	O
has	O
been	O
well	O
investigated	O
.	O

Gel	O
filtration	O
and	O
co	O
-	O
immunoprecipitation	O
analyses	O
reveal	O
that	O
Mad2p	B
tightly	O
associates	O
with	O
another	O
spindle	O
checkpoint	O
component	O
,	O
Mad1p	B
.	O

METHODS	O
:	O
109	O
suspected	O
cases	O
with	O
SS	O
underwent	O
the	O
biopsies	O
.	O

We	O
also	O
identify	O
several	O
regulatory	O
domain	O
mutants	O
in	O
which	O
Cd	O
(	O
2	O
+	O
)	O
tolerance	O
of	O
the	O
mutant	O
strain	O
and	O
transport	O
activity	O
of	O
the	O
protein	O
are	O
dissociated	O
.	O

The	O
human	B
immunodeficiency	I
virus	I
type-1	I
(	I
HIV-1	I
)	I
Tat	I
protein	I
regulates	O
transcription	O
by	O
stimulating	O
RNA	B
polymerase	I
processivity	O
.	O

One	O
of	O
these	O
SEBPs	B
,	O
SEBP2	B
,	O
was	O
shown	O
to	O
be	O
the	O
product	O
of	O
the	O
homeotic	B
gene	I
fork	B
head	I
.	O

Identity	O
elements	O
in	O
tRNA	O
for	O
mono-	O
and	O
dimethylation	O
reactions	O
by	O
the	O
recombinant	B
pfTrm1p	I
were	O
identified	O
using	O
in	O
vitro	O
T7	O
transcripts	O
of	O
33	O
variants	O
of	O
tRNA	B
(	I
Asp	I
)	I
and	O
tRNA	B
(	I
Phe	I
)	I
from	O
yeast	O
.	O

In	O
insulin	B
-	O
responsive	O
cells	O
,	O
Akt	B
phosphorylates	O
and	O
inactivates	O
the	O
serine	B
/	I
threonine	I
kinase	I
glycogen	B
synthase	I
kinase-3	I
(	O
GSK-3	B
)	O
.	O

The	O
B	B
cell	I
antigen	I
receptor	I
activates	O
the	O
Akt	B
(	O
protein	B
kinase	I
B	I
)	O
/	O
glycogen	B
synthase	I
kinase-3	I
signaling	O
pathway	O
via	O
phosphatidylinositol	B
3-kinase	I
.	O

Fewer	O
recombination	O
events	O
are	O
detected	O
in	O
four	O
different	O
B	O
and	O
T	O
cell	O
lines	O
that	O
do	O
not	O
undergo	O
switch	O
recombination	O
of	O
their	O
endogenous	O
genes	O
.	O

IL-1	B
and	O
TNF	B
increase	O
AND-34	B
transcript	I
levels	O
in	O
thymic	O
cortical	O
reticular	O
,	O
thymic	O
nurse	O
,	O
and	O
fibroblast	O
cell	O
lines	O
.	O

To	O
determine	O
what	O
role	O
eIF4E	B
might	O
play	O
in	O
c	B
-	I
myc	I
expression	O
,	O
the	O
c	B
-	I
myc	I
5	I
'	I
untranslated	I
region	I
(	I
UTR	I
)	I
was	O
fused	O
in	O
-	O
frame	O
to	O
CAT	B
reporters	I
,	O
and	O
several	O
more	O
derivative	O
constructs	O
were	O
made	O
.	O

Analysis	O
of	O
cell	O
cycle	O
proteins	O
showed	O
that	O
24	O
h	O
of	O
lovastatin	O
treatment	O
in	O
the	O
control	O
cells	O
caused	O
an	O
elevation	O
in	O
the	O
levels	O
of	O
the	O
cyclin	B
-	I
dependent	I
kinase	I
inhibitor	O
p27	B
(	O
kip1	B
)	O
,	O
inhibition	O
of	O
both	O
cyclin	B
E-	I
and	I
cyclin	I
A	I
-	I
dependent	I
kinase	I
activity	O
,	O
and	O
decreased	O
levels	O
of	O
hyperphosphorylated	O
retinoblastoma	B
protein	I
(	O
pRb	B
)	O
.	O

RESULTS	O
:	O
Circulating	O
leptin	B
concentrations	O
in	O
AN	O
were	O
3.5+	O
/	O
-0.5	O
versus	O
7.6+	O
/	O
-1.2	O
ng	O
/	O
ml	O
in	O
control	O
subjects	O
.	O

Copyright	O
1999	O
Academic	O
Press	O
.	O

Oligonucleotide	O
probes	O
corresponding	O
to	O
wild	O
-	O
type	O
and	O
mutant	O
EpRE	O
sequences	O
were	O
used	O
in	O
gel	O
-	O
shift	O
and	O
super	O
-	O
shift	O
analyses	O
to	O
identify	O
proteins	O
binding	O
.	O

PKNbeta	B
had	O
high	O
sequence	O
homology	O
with	O
PKNalpha	B
,	O
originally	O
isolated	O
PKN	B
,	O
especially	O
in	O
the	O
repeats	O
of	O
charged	O
amino	O
acid	O
-	O
rich	O
region	O
with	O
leucine	O
-	O
zipper	O
like	O
sequences	O
(	O
CZ	O
region	O
/	O
HR1	O
)	O
,	O
in	O
the	O
carboxyl	O
-	O
terminal	O
catalytic	O
domain	O
,	O
and	O
in	O
approximately	O
130	O
amino	O
acid	O
stretch	O
(	O
D	O
region	O
/	O
HR2	O
)	O
,	O
located	O
between	O
CZ	O
region	O
/	O
HR1	O
and	O
the	O
catalytic	O
domain	O
.	O

At	O
baseline	O
,	O
serum	O
levels	O
of	O
lycopene	O
and	O
FLOP	O
were	O
abnormally	O
high	O
and	O
serum	O
FLOP	O
was	O
correlated	O
significantly	O
with	O
plasma	O
cyclosporine	O
levels	O
(	O
r	O
=	O
0.646	O
,	O
p	O
=	O
0.016	O
)	O
.	O

BACKGROUND	O
:	O
Chronic	O
alcohol	O
consumption	O
has	O
been	O
demonstrated	O
to	O
be	O
deleterious	O
to	O
bone	O
health	O
.	O

Interestingly	O
,	O
following	O
induction	O
of	O
stress	O
by	O
heat	O
shock	O
,	O
high	O
salt	O
,	O
or	O
ethanol	O
,	O
conditions	O
under	O
which	O
most	O
mRNA	O
export	O
is	O
blocked	O
,	O
Npl3p	B
is	O
still	O
exported	O
from	O
the	O
nucleus	O
.	O

For	O
symptomatic	O
relief	O
and	O
inhibition	O
of	O
the	O
growth	O
of	O
the	O
metastases	O
interferon	B
-	I
a	I
and	O
somatostatin	B
analogues	O
can	O
be	O
employed	O
.	O

In	O
summary	O
,	O
the	O
no	O
-	O
adverse	O
-	O
effect	O
-	O
level	O
for	O
this	O
study	O
was	O
determined	O
to	O
be	O
1000	O
ppm	O
,	O
based	O
on	O
decreased	O
weight	O
gain	O
in	O
female	O
rats	O
,	O
and	O
on	O
slight	O
organ	O
weight	O
changes	O
in	O
both	O
sexes	O
at	O
3000	O
ppm	O
.	O

Some	O
of	O
them	O
produce	O
gigantic	O
sperm	O
several	O
times	O
the	O
total	O
male	O
body	O
length	O
.	O

John	O
leonard	O
dawson	O

PDGF	B
A	I
-	I
chain	I
levels	O
increase	O
in	O
cultured	O
vascular	O
smooth	O
muscle	O
cells	O
(	O
SMCs	O
)	O
exposed	O
to	O
ATII	B
.	O

M	B
-	I
Ras	I
interacted	O
poorly	O
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
assay	O
with	O
multiple	O
Ras	B
effectors	O
,	O
including	O
c	B
-	I
Raf-1	I
,	O
A	B
-	I
Raf	I
,	O
B	B
-	I
Raf	I
,	O
phosphoinositol-3	B
kinase	I
delta	I
,	O
RalGDS	B
,	O
and	O
Rin1	B
.	O

Deletion	O
mapping	O
of	O
the	O
human	B
presenilin-1	I
(	O
PS1	B
)	O
promoter	O
delineated	O
the	O
most	O
active	O
fragment	O
from	O
-118	O
to	O
+	O
178	O
in	O
relation	O
to	O
the	O
transcription	O
start	O
site	O
mapped	O
in	O
this	O
study	O
,	O
in	O
both	O
human	O
neuroblastoma	O
SK	O
-	O
N	O
-	O
SH	O
and	O
hepatoma	O
HepG2	O
cells	O
.	O

Microcirculatory	O
oxygenation	O
and	O
shunting	O
in	O
sepsis	O
and	O
shock	O
.	O

Analysis	O
of	O
the	O
E2F1	B
gene	I
promoter	I
showed	O
that	O
the	O
-146	O
to	O
-54	O
region	O
was	O
required	O
for	O
E2-responsiveness	B
in	O
transient	O
transfection	O
assays	O
,	O
and	O
subsequent	O
deletion	O
/	O
mutation	O
analysis	O
showed	O
that	O
a	O
single	O
upstream	O
GC	O
-	O
rich	O
and	O
two	O
downstream	O
CCAAT	O
-	O
binding	O
sites	O
were	O
required	O
for	O
transactivation	O
by	O
E2	B
.	O

In	O
the	O
course	O
of	O
investigating	O
the	O
mechanisms	O
by	O
which	O
OF5	B
and	O
OF3	B
regulated	O
CYP11A1	B
transcription	O
,	O
we	O
found	O
that	O
OF5	B
and	O
OF3	B
bound	O
Sp1	B
and	O
Sp3	B
in	O
JEG-3	O
cells	O
.	O

In	O
contrast	O
,	O
the	O
differentiation	O
of	O
neoplastically	O
transformed	O
cells	O
does	O
not	O
repress	O
mitogenic	O
responsiveness	O
or	O
junB	B
or	O
c	B
-	I
fos	I
inducibility	O
.	O

Adipocyte	O
differentiation	O
of	O
nontransformed	O
cells	O
also	O
markedly	O
represses	O
the	O
ability	O
of	O
SRF	B
to	O
bind	O
to	O
the	O
junB	B
SRE	O
,	O
the	O
c	B
-	I
fos	I
SRE	O
,	O
and	O
other	O
SREs	O
,	O
as	O
determined	O
by	O
mobility	O
shift	O
and	O
gel	O
supershift	O
assays	O
,	O
without	O
affecting	O
the	O
DNA	O
binding	O
characteristics	O
of	O
the	O
nuclear	O
protein	O
SP-1	O
.	O

Transformation	O
blocks	O
differentiation	O
-	O
induced	O
inhibition	O
of	O
serum	B
response	I
factor	I
interactions	O
with	O
serum	O
response	O
elements	O
.	O

The	O
core	B
enzyme	I
is	O
homologous	O
to	O
those	O
of	O
bacteriophages	O
T3	O
,	O
T7	O
and	O
SP6	O
whereas	O
the	O
specificity	O
factor	O
shows	O
similarities	O
with	O
bacterial	B
sigma	I
factors	I
.	O

The	O
Cr.psbA-4	B
ORF	I
contains	O
an	O
H	O
-	O
N	O
-	O
H	O
motif	O
,	O
and	O
possibly	O
a	O
GIY	O
-	O
YIG	O
motif	O
.	O

The	O
interaction	O
of	O
zf4	B
-	I
6	I
with	O
full	B
-	I
length	I
5	I
S	I
RNA	I
was	O
far	O
more	O
sensitive	O
to	O
non	O
-	O
specific	O
competitor	O
concentration	O
than	O
was	O
the	O
zf4	B
-	I
7:5	I
S	B
RNA	I
interaction	O
,	O
suggesting	O
that	O
finger	O
seven	O
contributes	O
to	O
both	O
affinity	O
and	O
specificity	O
in	O
this	O
protein	O
:	O
RNA	O
interaction	O
.	O

The	O
STAT	B
protein	I
accumulation	O
resulting	O
from	O
C	B
/	I
EBP	I
expression	O
was	O
tightly	O
coupled	O
to	O
the	O
morphological	O
conversion	O
of	O
fibroblasts	O
to	O
adipocytes	O
and	O
represents	O
an	O
expression	O
profile	O
identical	O
to	O
that	O
reported	O
for	O
mature	O
adipocytes	O
in	O
vivo	O
.	O

The	O
median	O
durations	O
for	O
response	O
and	O
survival	O
time	O
in	O
the	O
late	O
phase	O
II	O
trial	O
were	O
2.3	O
months	O
and	O
5.8	O
months	O
,	O
respectively	O
.	O

The	O
role	O
of	O
'	O
scientific	O
psychiatry	O
'	O
in	O
understanding	O
patients	O
with	O
chronic	O
schizophrenia	O
or	O
severe	O
personality	O
disorder	O
.	O

Myocardial	O
antioxidant	O
enzymes	O
,	O
catalase	B
,	O
glutathione	B
peroxidase	I
and	O
superoxide	B
dismutase	I
,	O
in	O
the	O
MCT	O
-	O
treated	O
rats	O
were	O
not	O
different	O
compared	O
to	O
control	O
rats	O
.	O

The	O
second	O
goal	O
was	O
to	O
ascertain	O
the	O
somatotopic	O
arrangement	O
of	O
the	O
GPi	O
in	O
PD	O
.	O

These	O
overall	O
results	O
indicate	O
that	O
there	O
is	O
generally	O
one	O
PERV	O
copy	O
per	O
integration	O
site	O
.	O

The	O
present	O
investigation	O
conducted	O
in	O
a	O
population	O
of	O
258	O
dentally	O
aware	O
individuals	O
in	O
the	O
age	O
range	O
20	O
-	O
69	O
years	O
,	O
was	O
initiated	O
to	O
elucidate	O
the	O
relationship	O
between	O
tobacco	O
smoking	O
and	O
supragingival	O
calculus	O
,	O
taking	O
into	O
account	O
possible	O
confounding	O
factors	O
such	O
as	O
age	O
,	O
gender	O
,	O
oral	O
hygiene	O
and	O
gingival	O
inflammation	O
.	O

Patients	O
were	O
assessed	O
for	O
cardiac	O
MIBG	O
uptake	O
,	O
circulating	O
norepinephrine	O
concentration	O
,	O
LVEF	O
,	O
peak	O
Vo2	O
,	O
x	O
-	O
ray	O
cardiothoracic	O
ratio	O
,	O
M	O
-	O
mode	O
echographic	O
end	O
-	O
diastolic	O
diameter	O
and	O
right	O
-	O
sided	O
heart	O
catheterization	O
parameters	O
.	O

Nuclear	O
hormone	O
receptors	O
(	O
NRs	O
)	O
are	O
ligand	O
-	O
inducible	O
transcription	O
factors	O
that	O
mediate	O
critical	O
functions	O
in	O
many	O
species	O
.	O

These	O
cells	O
were	O
able	O
to	O
present	O
influenza	O
virus	O
particles	O
to	O
HLA	B
-	I
DR1-restricted	I
T	O
cell	O
clones	O
.	O

Sequencing	O
of	O
zebrafish	O
(	O
Danio	O
rerio	O
)	O
bacterial	O
artificial	O
chromosome	O
and	O
P1	O
artificial	O
chromosome	O
genomic	O
clone	O
fragments	O
and	O
of	O
cDNA	O
clones	O
has	O
led	O
to	O
the	O
identification	O
of	O
five	O
new	O
loci	O
coding	O
for	O
beta	O
subunits	O
of	O
proteasomes	O
(	O
PSMB	B
)	O
.	O

In	O
addition	O
to	O
homologues	O
of	O
the	O
human	B
genes	I
PSMB5	I
through	O
PSMB9	B
,	O
two	O
new	O
genes	O
,	O
PSMB11	B
and	O
PSMB12	B
,	O
have	O
been	O
found	O
for	O
which	O
there	O
are	O
no	O
known	O
corresponding	O
genes	O
in	O
humans	O
.	O

It	O
applies	O
Udry	O
's	O
biosocial	O
perspective	O
,	O
which	O
attempts	O
to	O
reconcile	O
the	O
biological	O
and	O
sociological	O
models	O
of	O
premarital	O
sexual	O
and	O
reproductive	O
behaviour	O
.	O

Weight	O
and	O
height	O
z	O
-	O
scores	O
were	O
significantly	O
associated	O
with	O
BMD	O
z	O
-	O
scores	O
.	O

A	O
limited	O
sampling	O
strategy	O
was	O
used	O
based	O
on	O
a	O
bayesian	O
parameter	O
estimation	O
algorithm	O
that	O
is	O
part	O
of	O
the	O
ADAPT	O
II	O
software	O
package	O
.	O

Interaction	O
of	O
HRI	B
with	O
Hsc70	B
was	O
required	O
for	O
the	O
transformation	O
of	O
HRI	B
,	O
as	O
the	O
Hsc70	B
antagonist	O
clofibric	O
acid	O
inhibited	O
the	O
folding	O
of	O
HRI	B
into	O
a	O
mature	O
-	O
competent	O
conformation	O
.	O

The	O
amino	O
acid	O
changes	O
D206A	O
and	O
D208A	O
abolish	O
singly	O
or	O
in	O
combination	O
the	O
exonuclease	O
activity	O
in	O
vivo	O
.	O

Previous	O
experimental	O
evidence	O
had	O
indicated	O
that	O
Reg1	B
might	O
target	O
Glc7	B
to	O
nuclear	O
substrates	O
such	O
as	O
the	O
Snf1	B
kinase	I
complex	I
.	O

In	O
the	O
budding	O
yeast	O
,	O
Saccharomyces	O
cerevisiae	O
,	O
replicators	O
can	O
function	O
outside	O
the	O
chromosome	O
as	O
autonomously	O
replicating	O
sequence	O
(	O
ARS	O
)	O
elements	O
;	O
however	O
,	O
within	O
chromosome	O
III	O
,	O
certain	O
ARSs	O
near	O
the	O
transcriptionally	O
silent	O
HML	B
locus	I
show	O
no	O
replication	O
origin	O
activity	O
.	O

These	O
results	O
suggest	O
that	O
,	O
for	O
the	O
HML	B
ARS	O
cluster	O
(	O
ARS303	B
,	O
ARS320	B
,	O
and	O
ARS302	B
)	O
,	O
inactivity	O
of	O
origins	O
is	O
independent	O
of	O
local	O
transcriptional	O
silencing	O
,	O
even	O
though	O
origins	O
and	O
silencers	O
share	O
key	O
cis-	O
and	O
trans	O
-	O
acting	O
components	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
expression	O
of	O
TD	B
-	I
IkappaBalpha	I
blocked	O
phorbol	O
myristate	O
acetate	B
-	I
phytohemagglutinin	I
or	O
tumor	B
necrosis	I
factor	I
alpha	I
-	O
induced	O
IkappaBalpha	B
gene	I
transcription	O
and	O
abolished	O
NF	B
-	I
kappaB	I
DNA	O
binding	O
activity	O
,	O
due	O
to	O
the	O
continued	O
cytoplasmic	O
sequestration	O
of	O
RelA	B
(	O
p65	B
)	O
by	O
TD	B
-	I
IkappaBalpha	I
.	O

The	O
analysis	O
of	O
two	O
distinct	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
pathways	O
shows	O
that	O
stress	B
-	I
activated	I
protein	I
kinase	I
-	O
Jun	B
N	I
-	I
terminal	I
kinase	I
activation	O
,	O
resulting	O
in	O
the	O
phosphorylation	O
of	O
ATF-2	B
,	O
c	B
-	I
Jun	I
,	O
and	O
JunD	B
,	O
is	O
required	O
not	O
only	O
for	O
the	O
IL-1-	B
but	O
also	O
for	O
the	O
TPA	O
-	O
dependent	O
induction	O
,	O
while	O
the	O
extracellular	B
signal	I
-	I
related	I
kinase	I
1	I
(	O
ERK-1	B
)	O
and	O
ERK-2	B
activation	O
is	O
involved	O
in	O
the	O
TPA-	O
but	O
not	O
in	O
the	O
IL-1-dependent	B
stimulation	O
of	O
the	O
uPA	B
enhancer	I
.	O

Interdomain	O
signaling	O
in	O
a	O
two	O
-	O
domain	O
fragment	O
of	O
the	O
human	B
glucocorticoid	I
receptor	I
.	O

In	O
contrast	O
,	O
the	O
xtRNA	B
(	O
Sec	B
)	O
gene	O
needs	O
the	O
binding	O
of	O
the	O
seven	O
Staf	B
zinc	I
fingers	I
,	O
but	O
not	O
Oct-1	B
,	O
for	O
optimal	O
transcriptional	O
capacity	O
.	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
the	O
differential	O
utilization	O
of	O
Staf	B
zinc	I
finger	I
1	I
represents	O
a	O
new	O
,	O
critical	O
determinant	O
of	O
the	O
transcriptional	O
activation	O
mechanism	O
for	O
the	O
Xenopus	B
tRNA	I
(	O
Sec	B
)	O
and	O
human	B
U6	I
snRNA	I
genes	I
.	O

In	O
B	O
cells	O
,	O
HEF1	B
is	O
phosphorylated	O
by	O
a	O
cytoskeleton	O
-	O
dependent	O
mechanism	O
that	O
is	O
triggered	O
by	O
integrin	B
ligation	O
.	O

The	O
calcitonin	B
-	O
induced	O
tyrosine	O
phosphorylation	O
of	O
HEF1	B
increased	O
in	O
a	O
time-	O
and	O
dose	O
-	O
dependent	O
manner	O
.	O

Independent	O
protrudor	O
muscle	O
stimulation	O
increased	O
VI	O
,	O
max	O
(	O
peak	O
increase	O
61	O
%	O
,	O
P	O
<	O
0.05	O
)	O
,	O
did	O
not	O
change	O
Pcrit	O
,	O
and	O
decreased	O
Rn	O
(	O
peak	O
decrease	O
of	O
41	O
%	O
,	O
P	O
<	O
0.05	O
)	O
.	O

We	O
report	O
the	O
construction	O
of	O
an	O
approximately	O
1.7-Mb	O
sequence	O
-	O
ready	O
YAC	O
/	O
BAC	O
clone	O
contig	O
of	O
8p22-p23	O
.	O

The	O
human	B
RAD30B	I
and	O
mouse	B
Rad30b	I
mRNA	I
transcripts	I
,	O
like	O
many	O
repair	O
proteins	O
,	O
are	O
highly	O
expressed	O
in	O
the	O
testis	O
.	O

Analysis	O
of	O
the	O
mouse	B
STAP	I
gene	I
isolated	O
from	O
the	O
genomic	O
library	O
revealed	O
that	O
the	O
STAP	B
gene	I
spans	O
a	O
region	O
of	O
over	O
11	O
kb	O
and	O
comprises	O
eight	O
exons	O
.	O

A	O
reduced	O
matrix	O
distribution	O
and	O
enhanced	O
cell	O
density	O
were	O
observed	O
as	O
the	O
biofilm	O
aged	O
.	O

After	O
10	O
months	O
of	O
treatment	O
with	O
the	O
conjugated	O
estrogen	O
,	O
both	O
his	O
height	O
and	O
weight	O
showed	O
improvement	O
,	O
while	O
his	O
bone	O
mineral	O
density	O
and	O
bone	O
age	O
were	O
increased	O
.	O

Viscosity	O
experiments	O
on	O
the	O
catalytic	O
fragment	O
kinase	O
reaction	O
demonstrated	O
that	O
the	O
chemical	O
(	O
phosphoryl	O
transfer	O
)	O
step	O
had	O
a	O
reduced	O
rate	O
.	O

Velocity	O
sedimentation	O
,	O
cross	O
-	O
linking	O
,	O
and	O
immunoprecipitation	O
analyses	O
of	O
detergent	O
-	O
solubilized	O
rat	O
brain	O
revealed	O
that	O
the	O
32	O
and	O
34	O
kDa	O
polypeptides	O
reside	O
within	O
heterotetramers	O
.	O

In	O
vitro	O
expression	O
levels	O
of	O
the	O
different	O
plasmids	O
differed	O
by	O
as	O
much	O
as	O
tenfold	O
.	O

In	O
EEG	O
only	O
single	O
slow	O
waves	O
above	O
left	O
temporal	O
region	O
were	O
revealed	O
.	O

Molecular	O
characterization	O
of	O
type	O
-	O
specific	O
capsular	O
polysaccharide	O
biosynthesis	O
genes	O
of	O
Streptococcus	O
agalactiae	O
type	O
Ia.	O

(	O
1998	O
)	O
FASEB	O
J.	O

IL-1beta	B
(	O
10	O
ng	O
/	O
ml	O
)	O
drastically	O
increased	O
both	O
PDGFalphaR	B
and	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
delta	I
(	O
C	B
/	I
EBPdelta	I
)	O
mRNA	O
levels	O
in	O
a	O
time	O
dependent	O
manner	O
.	O

The	O
recruitment	O
of	O
constitutively	O
phosphorylated	O
p185	B
(	O
neu	B
)	O
and	O
the	O
activated	O
mitogenic	O
pathway	O
proteins	O
to	O
this	O
membrane	O
-	O
microfilament	O
interaction	O
site	O
provides	O
a	O
physical	O
model	O
for	O
integrating	O
the	O
assembly	O
of	O
the	O
mitogenic	O
pathway	O
with	O
the	O
transmission	O
of	O
growth	O
factor	O
signal	O
to	O
the	O
cytoskeleton	O
.	O

Transient	O
tyrosine	O
phosphorylation	O
of	O
Crk	B
in	O
fibroblast	B
growth	I
factor-2-stimulated	I
endothelial	O
cells	O
was	O
dependent	O
on	O
the	O
juxtamembrane	O
tyrosine	O
residue	O
463	O
in	O
FGFR-1	B
,	O
and	O
a	O
Crk	B
SH2	B
domain	I
precipitated	O
FGFR-1	B
via	O
phosphorylated	O
Tyr-463	O
,	O
indicating	O
direct	O
complex	O
formation	O
between	O
Crk	B
and	O
FGFR-1	B
.	O

ECG	O
-	O
gated	O
myocardial	O
Technetium-99	O
m	O
sestamibi	O
SPECT	O
is	O
a	O
useful	O
technique	O
to	O
measure	O
myocardial	O
perfusion	O
and	O
function	O
simultaneously	O
.	O

Role	O
of	O
the	O
3	O
'	O
untranslated	O
region	O
of	O
baculovirus	B
p10	I
mRNA	I
in	O
high	O
-	O
level	O
expression	O
of	O
foreign	O
genes	O
.	O

The	O
intron	O
is	O
capable	O
of	O
splicing	O
despite	O
the	O
fact	O
that	O
both	O
the	O
EBS1	B
/	O
IBS1	B
and	O
the	O
EBS2	B
/	O
IBS2	B
sequence	O
motifs	O
,	O
thought	O
to	O
be	O
necessary	O
for	O
correct	O
splicing	O
,	O
extend	O
over	O
5	O
instead	O
of	O
6	O
bp	O
.	O

The	O
Trk	B
/	I
Nerve	I
Growth	I
Factor	I
receptor	I
mediates	O
the	O
rapid	O
activation	O
of	O
a	O
number	O
of	O
intracellular	O
signaling	O
proteins	O
,	O
including	O
phosphatidylinositol	B
3-kinase	I
(	O
PI	B
3-kinase	I
)	O
.	O

The	O
controversy	O
of	O
significance	O
testing	O
:	O
misconceptions	O
and	O
alternatives	O
.	O

Chemical	O
uptake	O
into	O
human	O
stratum	O
corneum	O
in	O
vivo	O
from	O
volatile	O
and	O
non	O
-	O
volatile	O
solvents	O
.	O

Like	O
DNA	O
binding	O
,	O
transcriptional	O
enhancement	O
required	O
amino	O
-	O
terminally	O
located	O
basic	O
amino	O
acid	O
residues	O
but	O
not	O
the	O
carboxyl	O
-	O
terminal	O
portion	O
of	O
Hap46	B
known	O
to	O
participate	O
in	O
hsp70	B
interaction	O
.	O

We	O
have	O
tested	O
the	O
function	O
of	O
two	O
potential	O
NF	B
-	I
kappaB	I
-	I
like	I
sites	I
present	O
in	O
the	O
PAI-2	B
proximal	I
promoter	I
for	O
responsiveness	O
to	O
TNFalpha	B
using	O
chloramphenicol	B
acetyl	I
transferase	I
reporter	I
gene	I
deletion	O
and	O
mutation	O
analyses	O
.	O

N	O
-	O
terminal	O
sequence	O
analysis	O
and	O
NMR	O
measurements	O
revealed	O
that	O
this	O
fragment	O
originates	O
from	O
the	O
C	O
-	O
terminal	O
80	O
residues	O
of	O
MBF1	B
and	O
form	O
a	O
well	O
structured	O
C	O
-	O
terminal	O
domain	O
of	O
MBF1	B
,	O
MBF1CTD	B
.	O

The	O
nucleosomal	O
response	O
associated	O
with	O
immediate	B
-	I
early	I
gene	I
induction	O
is	O
mediated	O
via	O
alternative	O
MAP	B
kinase	I
cascades	I
:	O
MSK1	B
as	O
a	O
potential	O
histone	B
H3	I
/	O
HMG-14	B
kinase	O
.	O

The	O
arrangement	O
of	O
these	O
cutoff	O
-	O
levels	O
leads	O
to	O
a	O
sensitivity	O
of	O
85	O
%	O
at	O
a	O
specificity	O
of	O
55	O
%	O
for	O
Protein	B
S100	I
when	O
measured	O
by	O
RIA	O
,	O
and	O
to	O
a	O
sensitivity	O
of	O
77	O
%	O
at	O
a	O
specificity	O
of	O
61	O
%	O
when	O
measured	O
by	O
LIA	O
.	O

Using	O
16	O
strains	O
of	O
C.	O
trachomatis	O
in	O
triplicate	O
assays	O
,	O
we	O
found	O
the	O
RT	O
-	O
PCR	O
method	O
consistently	O
more	O
sensitive	O
than	O
the	O
conventional	O
technique	O
for	O
all	O
eight	O
antimicrobials	O
tested	O
,	O
with	O
resultant	O
MICs	O
determined	O
by	O
RT	O
-	O
PCR	O
ranging	O
from	O
1.6-fold	O
higher	O
(	O
erythromycin	O
)	O
to	O
>	O
/=195-fold	O
higher	O
(	O
amoxicillin	O
)	O
.	O

Null	O
alleles	O
of	O
SAS4	B
and	O
SAS5	B
bypassed	O
the	O
role	O
of	O
the	O
Abf1p	B
binding	I
site	I
of	O
the	O
HMR	B
-	I
E	I
silencer	I
but	O
not	O
the	O
role	O
of	O
the	O
ACS	B
or	O
Rap1p	B
binding	I
site	I
.	O

Recent	O
molecular	O
analysis	O
has	O
revealed	O
that	O
the	O
S	B
locus	I
is	O
highly	O
polymorphic	O
and	O
contains	O
several	O
genes	O
,	O
i.e.	O
,	O
SLG	B
,	O
SRK	B
,	O
the	O
as	O
-	O
yet	O
-	O
unidentified	O
pollen	B
S	I
gene	I
(	I
s	I
)	I
,	O
and	O
other	O
linked	O
genes	O
.	O

A	O
cDNA	O
encoding	O
a	O
putative	O
RNA	B
and/or	I
DNA	I
helicase	I
has	O
been	O
isolated	O
from	O
Arabidopsis	O
thaliana	O
cDNA	O
libraries	O
.	O

In	O
vivo	O
,	O
MyoD	B
requires	O
this	O
tryptophan	O
motif	O
to	O
evoke	O
chromatin	O
remodeling	O
in	O
the	O
Myogenin	B
promoter	I
and	O
to	O
activate	O
Myogenin	B
transcription	O
.	O

RESULTS	O
:	O
256	O
Periods	O
of	O
TTP	O
or	O
PUNP	O
were	O
reported	O
by	O
men	O
and	O
174	O
by	O
women	O
.	O

Feed	O
intake	O
and	O
BW	O
gains	O
were	O
decreased	O
(	O
P	O
<	O
0.05	O
)	O
by	O
dietary	O
treatments	O
containing	O
M.	O

The	O
N	O
terminus	O
of	O
beta	O
(	O
95	O
kDa	O
)	O
corresponds	O
to	O
alpha	O
with	O
the	O
integrase	B
domain	I
attached	O
to	O
the	O
C	O
terminus	O
(	O
32	O
kDa	O
)	O
.	O

Skn-1a	B
lacking	O
the	O
C	O
-	O
terminal	O
region	O
completely	O
lost	O
transactivation	O
ability	O
,	O
irrespective	O
of	O
the	O
promoter	O
tested	O
,	O
and	O
was	O
able	O
to	O
block	O
transactivation	O
by	O
normal	O
Skn-1a	B
in	O
competition	O
assays	O
.	O

In	O
early	O
Xenopus	O
embryos	O
,	O
the	O
transforming	B
growth	I
factor	I
-	I
beta	I
member	O
activin	B
induces	O
the	O
gene	B
Mix.2	I
by	O
stimulating	O
the	O
formation	O
of	O
a	O
multiprotein	O
complex	O
,	O
activin	B
-	I
responsive	I
factor	I
(	O
ARF	B
)	O
.	O

To	O
further	O
characterize	O
the	O
structure	O
and	O
evolutionary	O
synthesis	O
of	O
the	O
CMT1A	O
-	O
REP	O
repeat	O
,	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
analysis	O
and	O
heterologous	O
PCR	O
-	O
based	O
assays	O
were	O
carried	O
out	O
for	O
a	O
series	O
of	O
primates	O
.	O

Natl	O
.	O

In	O
the	O
face	O
of	O
the	O
outbreak	O
,	O
there	O
was	O
a	O
delay	O
before	O
vaccination	O
was	O
able	O
to	O
stop	O
deaths	O
.	O

Here	O
we	O
show	O
that	O
a	O
novel	O
isoform	O
of	O
Rapl	B
GTPase	I
-	I
activating	I
protein	I
,	O
called	O
rap1GAPII	B
,	O
binds	O
specifically	O
to	O
the	O
alpha	O
-	O
subunits	O
of	O
the	O
G	B
(	I
i	I
)	I
family	I
of	O
heterotrimeric	B
G	I
-	I
proteins	I
.	O

The	O
B	O
-	O
oligomer	O
of	O
pertussis	B
toxin	I
deactivates	O
CC	B
chemokine	I
receptor	I
5	I
and	O
blocks	O
entry	O
of	O
M	O
-	O
tropic	O
HIV-1	O
strains	O
.	O

Cross	O
-	O
linking	O
the	O
B	B
cell	I
Ag	I
receptor	I
(	O
BCR	B
)	O
to	O
surface	B
Fc	I
receptors	I
for	O
IgG	B
(	O
Fc	B
gamma	I
R	I
)	O
inhibits	O
G1-to	O
-	O
S	O
progression	O
;	O
the	O
mechanism	O
by	O
which	O
this	O
occurs	O
is	O
not	O
completely	O
known	O
.	O

Cross	O
-	O
linking	O
the	O
B	B
cell	I
Ag	I
receptor	I
(	O
BCR	B
)	O
to	O
surface	B
Fc	I
receptors	I
for	O
IgG	B
(	O
Fc	B
gamma	I
R	I
)	O
inhibits	O
G1-to	O
-	O
S	O
progression	O
;	O
the	O
mechanism	O
by	O
which	O
this	O
occurs	O
is	O
not	O
completely	O
known	O
.	O

TRAF2	B
is	O
a	O
potent	O
activator	O
of	O
a	O
95-kDa	B
serine	I
/	I
threonine	I
kinase	I
termed	O
germinal	B
center	I
kinase	I
related	I
(	O
GCKR	B
,	O
also	O
referred	O
to	O
as	O
KHS1	B
)	O
,	O
which	O
signals	O
activation	O
of	O
the	O
SAPK	B
pathway	O
.	O

An	O
activation	O
-	O
responsive	O
element	O
in	O
single	B
C	I
motif-1	I
/	O
lymphotactin	B
promoter	O
is	O
a	O
site	O
of	O
constitutive	O
and	O
inducible	O
DNA	O
-	O
protein	O
interactions	O
involving	O
nuclear	O
factor	O
of	O
activated	O
T	O
cell	O
.	O

Cytokine	O
-	O
induced	O
NF	B
-	I
kappa	I
B	I
DNA	O
binding	O
activity	O
,	O
RelA	B
nuclear	O
translocation	O
,	O
I	B
kappa	I
B	I
alpha	I
degradation	O
,	O
I	B
kappa	I
B	I
serine	O
32	O
phosphorylation	O
,	O
and	O
I	B
kappa	I
B	I
kinase	I
(	O
IKK	B
)	O
activity	O
were	O
blocked	O
by	O
curcumin	O
treatment	O
.	O

A	O
portion	O
of	O
p193	B
is	O
nuclear	O
and	O
localizes	O
to	O
the	O
mitotic	O
spindle	O
.	O

The	O
main	O
issues	O
are	O
the	O
need	O
to	O
explain	O
a	O
number	O
of	O
still	O
unknown	O
mechanisms	O
,	O
to	O
determine	O
which	O
""""	O
natural	O
diet	O
""""	O
carries	O
the	O
minimum	O
coronary	O
risk	O
and	O
whether	O
""""	O
new	O
""""	O
foods	O
produced	O
by	O
modern	O
technology	O
are	O
really	O
needed	O
to	O
contrast	O
this	O
epidemic	O
.	O

Cotransfection	O
of	O
the	O
coactivator	O
CREB	B
-	I
binding	I
protein	I
relieved	O
the	O
transcriptional	O
repression	O
of	O
PPARalphawt	B
by	O
PPARalphatr	B
,	O
suggesting	O
that	O
the	O
dominant	O
negative	O
effect	O
of	O
PPARalphatr	B
might	O
occur	O
through	O
competition	O
for	O
essential	O
coactivators	O
.	O

SF-1	B
does	O
not	O
have	O
an	O
N	O
-	O
terminal	O
AF1	O
domain	O
.	O

To	O
estimate	O
the	O
locations	O
of	O
sources	O
with	O
the	O
TF	O
-	O
MUSIC	O
algorithm	O
,	O
we	O
first	O
set	O
the	O
target	O
region	O
on	O
the	O
spectrogram	O
of	O
the	O
somatosensory	O
responses	O
.	O

We	O
discuss	O
these	O
results	O
in	O
terms	O
of	O
the	O
influence	O
that	O
time	O
and	O
nutritional	O
constraints	O
have	O
on	O
odonate	O
development	O
patterns	O
and	O
fitness	O
.	O

In	O
vitro	O
transcription	O
results	O
indicate	O
that	O
this	O
5	O
'	O
structure	O
functions	O
in	O
the	O
attenuation	O
mechanism	O
,	O
since	O
deletion	O
of	O
the	O
stem	O
-	O
loop	O
caused	O
an	O
increase	O
in	O
transcription	O
readthrough	O
.	O

A	O
5	O
'	O
RNA	O
stem	O
-	O
loop	O
participates	O
in	O
the	O
transcription	O
attenuation	O
mechanism	O
that	O
controls	O
expression	O
of	O
the	O
Bacillus	B
subtilis	I
trpEDCFBA	I
operon	I
.	O

Single	O
-	O
alanine	O
-	O
substitution	O
mutations	O
had	O
minimal	O
,	O
if	O
any	O
,	O
effects	O
on	O
S	O
-	O
induced	O
cell	O
-	O
to	O
-	O
cell	O
fusion	O
.	O

Furthermore	O
,	O
we	O
demonstrate	O
that	O
transcription	O
from	O
the	O
MMTV	B
5	I
'	I
LTR	I
is	O
highly	O
active	O
in	O
the	O
absence	O
of	O
Stat5a	B
,	O
a	O
transcription	O
factor	O
that	O
had	O
been	O
shown	O
previously	O
to	O
be	O
required	O
for	O
transcription	O
from	O
the	O
MMTV	B
LTR	I
.	O

Regional	O
insertional	O
mutagenesis	O
of	O
specific	O
genes	O
on	O
the	O
CIC5F11	B
/	O
CIC2B9	B
locus	O
of	O
Arabidopsis	O
thaliana	O
chromosome	O
5	O
using	O
the	O
Ac	B
/	O
Ds	B
transposon	O
in	O
combination	O
with	O
the	O
cDNA	O
scanning	O
method	O
.	O

Thus	O
,	O
NART	O
-	O
R	O
performance	O
may	O
not	O
be	O
a	O
valid	O
estimate	O
of	O
baseline	O
IQ	O
for	O
patients	O
with	O
neurologic	O
disorders	O
with	O
suspected	O
language	O
impairment	O
.	O

Activated	O
areas	O
have	O
been	O
identified	O
by	O
means	O
of	O
cross	O
-	O
correlation	O
analysis	O
.	O

Natural	O
Haemophilus	O
influenzae	O
type	O
b	O
capsular	O
polysaccharide	O
antibodies	O
in	O
412	O
infants	O
and	O
children	O
from	O
West	O
Africa	O
(	O
Burkina	O
-	O
Faso	O
)	O
and	O
France	O
:	O
a	O
cross	O
-	O
sectional	O
serosurvey	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
Sp1	B
and	O
Sp3	B
as	O
major	O
factors	O
binding	O
to	O
the	O
Sp1	B
sites	I
of	O
the	O
p21	B
/	O
WAF1	B
/	O
Cip1	B
promoter	O
in	O
MG63	O
cells	O
through	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
showed	O
that	O
TSA	O
treatment	O
did	O
not	O
change	O
their	O
binding	O
activities	O
.	O

Galoyan	O
has	O
summarized	O
the	O
results	O
of	O
his	O
discovery	O
of	O
cardioactive	O
neurohormones	O
.	O

To	O
study	O
the	O
regulation	O
of	O
its	O
expression	O
,	O
the	O
human	B
aldehyde	I
reductase	I
gene	I
and	O
promoter	O
were	O
cloned	O
and	O
characterized	O
.	O

Immunohistochemical	O
staining	O
with	O
MIB-1	B
and	O
p53	B
antibodies	I
showed	O
low	O
(	O
<	O
1	O
%	O
)	O
and	O
negative	O
reaction	O
.	O

The	O
C2C	B
-	O
Prx	B
is	O
encoded	O
as	O
a	O
preprotein	O
of	O
273	O
amino	O
acids	O
containing	O
a	O
putative	O
chloroplast	O
-	O
targeting	O
signal	O
of	O
65	O
amino	O
acids	O
at	O
its	O
N	O
-	O
terminus	O
.	O

Immediately	O
before	O
surgery	O
patients	O
received	O
either	O
intravenous	O
hydrocortisone	O
100	O
mg	O
or	O
placebo	O
in	O
random	O
,	O
double	O
-	O
blind	O
order	O
.	O

A	O
tyrosine	O
-	O
based	O
sorting	O
signal	O
in	O
the	O
beta2	B
integrin	I
cytoplasmic	I
domain	I
mediates	O
its	O
recycling	O
to	O
the	O
plasma	O
membrane	O
and	O
is	O
required	O
for	O
ligand	O
-	O
supported	O
migration	O
.	O

The	O
injection	O
of	O
XDRP1	B
protein	I
into	O
fertilized	O
Xenopus	O
eggs	O
blocked	O
embryonic	O
cell	O
division	O
.	O

Using	O
transgenic	O
Xenopus	O
embryos	O
,	O
we	O
demonstrate	O
that	O
the	O
integrity	O
of	O
these	O
two	O
sequences	O
is	O
necessary	O
for	O
correct	O
spatial	O
expression	O
of	O
a	O
Xbra2	B
promoter	I
-	I
driven	I
reporter	I
gene	I
.	O

In	O
order	O
to	O
screen	O
for	O
such	O
cofactors	O
,	O
we	O
have	O
used	O
a	O
transcriptionally	O
inactive	O
mutant	O
of	O
Xenopus	B
MEF2D	I
in	O
a	O
yeast	O
two	O
-	O
hybrid	O
screen	O
.	O

NuA4	B
has	O
an	O
apparent	O
molecular	O
mass	O
of	O
1.3	O
MDa	O
.	O

ATF1	B
transcription	O
is	O
negatively	O
regulated	O
by	O
unsaturated	O
fatty	O
acids	O
and	O
oxygen	O
.	O

Two	O
patients	O
with	O
recurrent	O
tumors	O
had	O
high	O
S	O
-	O
phase	O
fractions	O
both	O
on	O
the	O
first	O
resected	O
specimens	O
and	O
at	O
the	O
time	O
of	O
the	O
second	O
operation	O
.	O

Mutation	O
of	O
TTF-1-binding	B
sites	I
(	I
TBE	I
)	I
1	I
,	I
3	I
,	I
and	I
4	I
in	O
combination	O
markedly	O
decreased	O
transcriptional	O
activity	O
of	O
SP	B
-	I
A	I
promoter	O
-	O
chloramphenicol	B
acetyltransferase	I
constructs	O
containing	O
SP	B
-	I
A	I
gene	I
sequences	O
from	O
-256	O
to	O
+	O
45	O
.	O

Insulin	B
-	I
like	I
growth	I
factor	I
-	I
I	I
induces	O
bcl-2	B
promoter	I
through	O
the	O
transcription	O
factor	O
cAMP	B
-	I
response	I
element	I
-	I
binding	I
protein	I
.	O

Synthesis	O
of	O
antisense	O
RNA	O
and	O
S	O
phase	O
-	O
dependent	O
binding	O
of	O
E2F	B
complexes	I
in	O
intron	O
1	O
.	O

Identification	O
of	O
eotaxin-3	B
will	O
further	O
promote	O
our	O
understanding	O
of	O
the	O
control	O
of	O
eosinophil	O
trafficking	O
and	O
other	O
CCR3-mediated	B
biological	O
phenomena	O
.	O

NF	B
-	I
kappaB	I
plays	O
a	O
critical	O
role	O
in	O
activation	O
of	O
HIV-1	O
gene	O
expression	O
by	O
cytokines	O
and	O
other	O
stimuli	O
,	O
but	O
the	O
signal	O
transduction	O
pathways	O
that	O
regulate	O
the	O
switch	O
from	O
latent	O
to	O
productive	O
infection	O
have	O
not	O
been	O
defined	O
.	O

These	O
studies	O
suggest	O
that	O
MAPK	B
acts	O
by	O
stimulating	O
AP-1	B
and	O
a	O
subsequent	O
physical	O
and	O
functional	O
interaction	O
of	O
AP-1	B
with	O
NF	B
-	I
kappaB	I
,	O
resulting	O
in	O
a	O
complex	O
that	O
synergistically	O
transactivates	O
the	O
HIV-1	B
LTR	I
.	O

ERK	B
MAP	B
kinase	I
links	O
cytokine	O
signals	O
to	O
activation	O
of	O
latent	O
HIV-1	O
infection	O
by	O
stimulating	O
a	O
cooperative	O
interaction	O
of	O
AP-1	B
and	O
NF	B
-	I
kappaB.	I

A	O
human	O
nuclear	O
-	O
localized	O
chaperone	O
that	O
regulates	O
dimerization	O
,	O
DNA	O
binding	O
,	O
and	O
transcriptional	O
activity	O
of	O
bZIP	B
proteins	I
.	O

Clinical	O
differentiation	O
of	O
patients	O
with	O
mild	O
diplegic	O
cerebral	O
palsy	O
(	O
CP	O
)	O
and	O
idiopathic	O
toe	O
walking	O
(	O
ITW	O
)	O
can	O
be	O
difficult	O
.	O

Sputum	B
IL-8	I
and	O
MPO	B
were	O
significantly	O
increased	O
after	O
BPT	O
in	O
both	O
TDI-	O
and	O
grain	O
dust	O
-	O
asthma	O
(	O
P	O
<	O
0.05	O
)	O
.	O

Montelukast	O
reduces	O
airway	O
eosinophilic	O
inflammation	O
in	O
asthma	O
:	O
a	O
randomized	O
,	O
controlled	O
trial	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
kinase	O
-	O
dead	O
but	O
not	O
wild	O
-	O
type	O
forms	O
of	O
Fyn	B
,	O
Lck	B
,	O
and	O
ZAP-70	B
block	O
70Z	O
Cbl	B
-	O
mediated	O
NFAT	B
activation	O
.	O

Substitutions	O
of	O
region	O
I	O
with	O
synthetic	O
sequences	O
showed	O
that	O
no	O
specific	O
sequence	O
but	O
rather	O
repeats	O
of	O
three	O
or	O
more	O
consecutive	O
adenines	O
or	O
thymines	O
,	O
without	O
interruption	O
by	O
guanine	O
or	O
cytosine	O
,	O
are	O
required	O
for	O
the	O
ARS	O
activity	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
,	O
PHO85	B
encodes	O
a	O
cyclin	B
-	I
dependent	I
protein	I
kinase	I
(	O
Cdk	B
)	O
catalytic	O
subunit	O
with	O
multiple	O
regulatory	O
roles	O
thought	O
to	O
be	O
specified	O
by	O
association	O
with	O
different	O
cyclin	B
partners	O
(	O
Pcls	B
)	O
.	O

Mutants	O
with	O
mild	O
lace	B
alleles	I
grow	O
to	O
become	O
adults	O
with	O
multiple	O
aberrant	O
morphologies	O
in	O
the	O
appendages	O
,	O
compound	O
eye	O
,	O
and	O
bristles	O
.	O

In	O
fact	O
,	O
SPT	B
activity	O
in	O
the	O
fly	O
expressing	O
epitope	O
-	O
tagged	O
Lace	B
was	O
absorbed	O
by	O
epitope	O
-	O
specific	O
antibody	O
.	O

Mutations	O
of	O
the	O
RET	B
gene	I
,	O
encoding	O
a	O
receptor	B
tyrosine	I
kinase	I
,	O
have	O
been	O
associated	O
with	O
the	O
inherited	O
cancer	O
syndromes	O
MEN	O
2A	O
and	O
MEN	O
2B	O
.	O

These	O
results	O
show	O
that	O
targeting	O
of	O
Ras	B
-	O
GAP	B
could	O
represent	O
a	O
novel	O
anticancer	O
approach	O
.	O

EB-1	B
,	O
a	O
tyrosine	B
kinase	I
signal	I
transduction	I
gene	I
,	O
is	O
transcriptionally	O
activated	O
in	O
the	O
t	O
(	O
1;19	O
)	O
subset	O
of	O
pre	O
-	O
B	O
ALL	O
,	O
which	O
express	O
oncoprotein	O
E2a	B
-	O
Pbx1	B
.	O

Protein	B
kinase	I
A	I
-	I
Ialpha	I
subunit	O
-	O
directed	O
antisense	O
inhibition	O
of	O
ovarian	O
cancer	O
cell	O
growth	O
:	O
crosstalk	O
with	O
tyrosine	B
kinase	I
signaling	O
pathway	O
.	O

BCL6	B
encodes	O
a	O
POZ	B
/	I
Zn	I
finger	I
protein	I
,	O
a	O
structure	O
similar	O
to	O
that	O
of	O
many	O
Drosophila	O
developmental	O
regulators	O
and	O
to	O
another	O
protein	O
involved	O
in	O
a	O
human	O
hematopoietic	O
malignancy	O
,	O
PLZF	B
.	O

Beta	B
1	I
integrin-	I
and	O
proteoglycan	O
-	O
mediated	O
stimulation	O
of	O
T	O
lymphoma	O
cell	O
adhesion	O
and	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
signaling	O
by	O
thrombospondin-1	B
and	O
thrombospondin-1	B
peptides	I
.	O

Optical	O
CD	O
,	O
and	O
spectral	O
and	O
activity	O
analyses	O
were	O
used	O
to	O
examine	O
reactivity	O
of	O
HO	B
isozymes	I
with	O
NO	O
species	O
produced	O
by	O
NO	O
donors	O
.	O

The	O
phosphotransferase	O
system	O
(	O
PTS	O
)	O
of	O
Streptomyces	O
coelicolor	O
identification	O
and	O
biochemical	O
analysis	O
of	O
a	O
histidine	B
phosphocarrier	I
protein	I
HPr	B
encoded	O
by	O
the	O
gene	O
ptsH.	B

Serum	O
concentrations	O
of	O
bone	B
specific	I
alkaline	I
phosphatase	I
(	O
BALP	B
)	O
and	O
osteocalcin	B
(	O
bone	B
Gla	I
protein	I
,	O
BGP	B
)	O
,	O
urinary	O
levels	O
of	O
pyridinoline	O
(	O
Pyr	O
)	O
and	O
deoxypyridinoline	O
(	O
Dpyr	O
)	O
and	O
computed	O
tomography	O
(	O
CT	O
)	O
measurements	O
of	O
the	O
cross	O
-	O
sectional	O
areas	O
of	O
the	O
vertebrae	O
and	O
the	O
femurs	O
,	O
the	O
apparent	O
density	O
of	O
cancellous	O
bone	O
in	O
the	O
vertebrae	O
,	O
and	O
the	O
volume	O
and	O
the	O
material	O
density	O
of	O
cortical	O
bone	O
in	O
the	O
femurs	O
were	O
determined	O
in	O
126	O
boys	O
and	O
143	O
girls	O
,	O
ages	O
7	O
-	O
18	O
years	O
.	O

In	O
another	O
study	O
,	O
intravenous	O
administration	O
of	O
devazepide	O
,	O
a	O
specific	O
cholecystokinin	B
-	I
A	I
receptor	I
antagonist	O
,	O
at	O
a	O
dose	O
of	O
0.1	O
mg	O
/	O
kg	O
/	O
hr	O
was	O
begun	O
15	O
min	O
before	O
postprandial	O
saline	O
intake	O
and	O
continued	O
for	O
1	O
hr	O
.	O

This	O
cluster	O
consisted	O
of	O
four	O
apparently	O
unrelated	O
ESTs	O
and	O
two	O
genes	O
,	O
pregnancy	B
-	I
associated	I
plasma	I
protein	I
-	I
A	I
(	O
PAPP	B
-	I
A	I
)	O
and	O
a	O
novel	O
gene	O
(	O
tentatively	O
named	O
EST	B
-	I
YD1	I
)	O
.	O

Prognostic	O
value	O
of	O
a	O
treadmill	O
exercise	O
score	O
in	O
symptomatic	O
patients	O
with	O
nonspecific	O
ST	O
-	O
T	O
abnormalities	O
on	O
resting	O
ECG	O
.	O

Structural	O
changes	O
in	O
the	O
C	O
-	O
terminus	O
of	O
Ca2	O
+	O
-bound	O
rat	B
S100B	I
(	O
beta	B
beta	I
)	O
upon	O
binding	O
to	O
a	O
peptide	O
derived	O
from	O
the	O
C	O
-	O
terminal	O
regulatory	O
domain	O
of	O
p53	B
.	O

We	O
propose	O
that	O
Gly84	O
is	O
part	O
of	O
a	O
putative	O
""""	O
oxyanion	O
hole	O
""""	O
involved	O
in	O
the	O
stabilization	O
of	O
the	O
transition	O
state	O
similar	O
to	O
the	O
C	B
group	I
of	O
the	O
esterase	B
/	O
lipase	B
family	O
.	O

The	O
solution	O
structure	O
of	O
the	O
adduct	O
derived	O
from	O
the	O
covalent	O
bonding	O
of	O
the	O
fjord	O
region	O
(	O
+	O
)	O
-	O
(	O
11S	O
,	O
12R	O
,	O
13R	O
,	O
14S	O
)	O
stereoisomer	O
of	O
anti	O
-11,12-dihydroxy-13,14-epoxy-11,12,13	O
,	O
14-tetrahydrobenzo	O
[	O
g	O
]	O
chrysene	O
,	O
(	O
+	O
)	O
-	O
anti	O
-B	O
[	O
g	O
]	O
CDE	O
,	O
to	O
the	O
exocyclic	O
N	O
(	O
6	O
)	O
amino	O
group	O
of	O
the	O
adenine	O
residue	O
dA6	O
,	O
(	O
designated	O
(	O
+	O
)	O
-	O
trans	O
-	O
anti	O
-	O
(	O
B	O
[	O
g	O
]	O
C	O
)	O
dA6	O
)	O
,	O
positioned	O
opposite	O
a	O
thymine	O
residue	O
dT17	O
in	O
the	O
DNA	O
sequence	O
context	O
d	O
(	O
C1-T2-C3-T4-C5-	O
(	O
B	O
[	O
g	O
]	O
C	O
)	O
A6-C7-T8-T9-C10-C11	O
)	O
.	O

d	O
(	O
G12-G13-A14-A15-G16-T17-G18-A19-G20++	O
+	O
-A21-G22	O
)	O
(	O
designated	O
(	O
B	O
[	O
g	O
]	O
C	O
)	O
dA.	O
dT	O
11-mer	O
duplex	O
)	O
,	O
has	O
been	O
studied	O
using	O
structural	O
information	O
derived	O
from	O
NMR	O
data	O
in	O
combination	O
with	O
molecular	O
dynamics	O
(	O
MD	O
)	O
calculations	O
.	O

Since	O
sildenafil	O
came	O
on	O
the	O
market	O
,	O
it	O
seems	O
that	O
the	O
place	O
of	O
MUSE	O
is	O
reduced	O
because	O
comparative	O
studies	O
give	O
better	O
results	O
for	O
sildenafil	O
than	O
MUSE	O
(	O
70	O
%	O
vs	O
40	O
%	O
)	O
and	O
of	O
course	O
with	O
a	O
better	O
acceptance	O
.	O

Serum	O
antibodies	O
were	O
detected	O
in	O
at	O
least	O
95	O
%	O
of	O
the	O
infected	O
guinea	O
pigs	O
between	O
4	O
-	O
30	O
WPI	O
and	O
rats	O
between	O
3	O
-	O
16	O
WPI	O
.	O

During	O
both	O
encephalopathy	O
episodes	O
,	O
CSF	O
protein	O
and	O
immunoglobulin	B
G	I
(	O
IgG	B
)	O
levels	O
were	O
elevated	O
without	O
an	O
increased	O
IgG	B
index	O
or	O
IgG	B
synthesis	O
rate	O
.	O

CONCLUSIONS	O
:	O
These	O
results	O
show	O
that	O
once	O
daily	O
oral	O
valganciclovir	O
can	O
produce	O
exposures	O
of	O
ganciclovir	O
(	O
AUC24	O
)	O
exceeding	O
those	O
attained	O
using	O
intravenous	O
ganciclovir	O
10	O
mg	O
/	O
kg	O
.	O

Except	O
for	O
nonperfusion	O
of	O
neurosensory	O
retinal	O
vessels	O
at	O
a	O
light	O
dose	O
of	O
150	O
J	O
/	O
cm2	O
,	O
no	O
other	O
adverse	O
events	O
were	O
of	O
concern	O
.	O

Except	O
for	O
nonperfusion	O
of	O
neurosensory	O
retinal	O
vessels	O
at	O
a	O
light	O
dose	O
of	O
150	O
J	O
/	O
cm2	O
,	O
no	O
other	O
adverse	O
events	O
were	O
of	O
concern	O
.	O

The	O
healing	O
rate	O
in	O
HIV	O
-	O
positive	O
patients	O
was	O
66	O
percent	O
after	O
14	O
weeks	O
and	O
100	O
percent	O
after	O
32	O
weeks	O
;	O
the	O
corresponding	O
figures	O
for	O
patients	O
with	O
acquired	O
immunodeficiency	O
syndrome	O
were	O
0	O
and	O
50	O
percent	O
.	O

The	O
P	B
mRNA	I
also	O
contains	O
a	O
third	O
ORF	O
for	O
the	O
V	B
protein	I
,	O
although	O
it	O
is	O
unclear	O
how	O
or	O
whether	O
this	O
ORF	O
is	O
accessed	O
.	O

A	O
genetic	O
screen	O
in	O
yeast	O
has	O
allowed	O
us	O
to	O
identify	O
a	O
novel	O
transcriptional	O
factor	O
binding	O
to	O
the	O
GlRE	O
,	O
i.e.	O
the	O
chicken	B
ovalbumin	I
upstream	I
promoter	I
-	I
transcription	I
factor	I
II	I
(	O
COUP	B
-	I
TFII	I
)	O
.	O

We	O
have	O
cloned	O
the	O
single	O
-	O
copy	O
gene	O
for	O
the	O
trans	B
-spliceosomal	I
U5	I
snRNA	I
from	O
the	O
trypanosomatid	O
species	O
Leptomonas	O
seymouri	O
,	O
using	O
U5	B
RNA	I
affinity	O
selection	O
and	O
cDNA	O
cloning	O
.	O

The	O
MMPI	O
-	O
A	O
(	O
Butcher	O
et	O
al.	O
,	O
1992	O
)	O
,	O
like	O
the	O
older	O
MMPI	O
(	O
Hathaway	O
&	O
McKinley	O
,	O
1983	O
)	O
,	O
distinguishes	O
between	O
anorexia	O
and	O
bulimia	O
.	O

On	O
the	O
other	O
hand	O
,	O
phosphatidyl	O
inositol	O
4,5	O
bisphosphate	O
(	O
PIP2	O
)	O
hydrolysis	O
requires	O
direct	O
phosphorylation	O
at	O
tyrosine	O
residue	O
of	O
the	O
PLC	B
-	I
gamma1	I
isozyme	I
.	O

A	O
G22V	B
mutant	I
of	O
M	B
-	I
Ras	I
was	O
constitutively	O
active	O
and	O
its	O
expression	O
in	O
an	O
interleukin-3	B
(	O
IL-3	B
)	O
-dependent	O
mast	O
cell	O
/	O
megakaryocyte	O
cell	O
line	O
resulted	O
in	O
increased	O
survival	O
in	O
the	O
absence	O
of	O
IL-3	B
,	O
increased	O
growth	O
in	O
IL-4	B
,	O
and	O
,	O
at	O
high	O
expression	O
levels	O
,	O
in	O
factor	O
-	O
independent	O
growth	O
.	O

Mammalian	B
M	I
-	I
Ras	I
and	O
a	O
Caenorhabditis	O
elegans	O
orthologue	O
exhibit	O
conserved	O
structural	O
features	O
,	O
and	O
these	O
are	O
likely	O
to	O
mediate	O
activation	O
of	O
distinctive	O
signaling	O
paths	O
that	O
function	O
in	O
parallel	O
to	O
those	O
downstream	O
of	O
p21	B
Ras	I
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
PecS	B
attenuates	O
pelD	B
and	O
pelE	B
expression	O
rather	O
than	O
acting	O
as	O
a	O
true	O
repressor	O
like	O
KdgR.	B

These	O
observations	O
establish	O
that	O
RsmC	B
negatively	O
regulates	O
rsmB	B
transcription	O
but	O
positively	O
affects	O
RsmA	B
production	O
.	O

All	O
were	O
experienced	O
hearing	O
aid	O
users	O
who	O
wore	O
linear	O
Class	O
D	O
instruments	O
with	O
input	O
compression	O
limiting	O
at	O
the	O
time	O
of	O
their	O
enrollment	O
in	O
this	O
study	O
.	O

SCOB	O
testing	O
of	O
food	O
-	O
restricted	O
animals	O
,	O
using	O
a	O
multiple	O
fixed	O
ratio	O
(	O
FR	O
)	O
/	O
fixed	O
interval	O
(	O
FI	O
)	O
schedule	O
(	O
FR20	O
:	O
FI120	O
)	O
,	O
was	O
conducted	O
prior	O
to	O
each	O
exposure	O
to	O
maintain	O
the	O
operant	O
behavior	O
;	O
the	O
data	O
from	O
Weeks	O
-1	O
,	O
4	O
,	O
8	O
,	O
and	O
13	O
were	O
evaluated	O
for	O
evidence	O
of	O
neurotoxicity	O
.	O

Ribonuclease	O
protection	O
assays	O
revealed	O
that	O
hmg1	B
and	O
hmg2	B
are	O
differentially	O
expressed	O
in	O
a	O
developmentally-	O
and	O
spatially	O
-	O
modulated	O
manner	O
during	O
morphogenesis	O
of	O
specialized	O
terpenoid	O
-	O
containing	O
pigment	O
glands	O
in	O
embryos	O
.	O

Differential	O
expression	O
was	O
confirmed	O
by	O
Northern	O
blot	O
analysis	O
employing	O
multiple	O
normal	O
and	O
tumor	O
cell	O
lines	O
.	O

Inactivation	O
of	O
the	O
Neurospora	B
crassa	I
mitochondrial	I
outer	I
membrane	I
protein	I
TOM70	I
by	O
repeat	O
-	O
induced	O
point	O
mutation	O
(	O
RIP	O
)	O
causes	O
defects	O
in	O
mitochondrial	O
protein	O
import	O
and	O
morphology	O
.	O

Several	O
genes	O
or	O
transcriptional	O
units	O
were	O
identified	O
,	O
including	O
the	O
3	O
'	O
end	O
of	O
ribosomal	B
s6	I
kinase	I
(	O
Rsk3	B
)	O
;	O
two	O
apparently	O
intronless	O
and	O
ORF	O
-	O
less	O
genes	O
;	O
and	O
Gpr31	B
,	O
an	O
intronless	O
,	O
putative	O
G	B
-	I
protein	I
coupled	I
receptor	I
.	O

The	O
results	O
suggest	O
that	O
GATA-5	B
may	O
have	O
specific	O
downstream	O
targets	O
and	O
that	O
GATA-4	B
,	I
-5	I
,	I
and	I
-6	I
can	O
only	O
partially	O
substitute	O
for	O
each	O
other	O
in	O
cardiogenesis	O
.	O

This	O
study	O
was	O
designed	O
to	O
compare	O
the	O
efficacy	O
of	O
efegatran	O
plus	O
streptokinase	B
versus	O
heparin	O
plus	O
accelerated	O
tissue	B
plasminogen	I
activator	I
(	O
TPA	B
)	O
in	O
coronary	O
reperfusion	O
in	O
acute	O
MI	O
.	O

Recently	O
,	O
cell	O
-	O
surface	O
TRAIL	B
has	O
been	O
shown	O
to	O
be	O
expressed	O
by	O
activated	O
human	O
and	O
mouse	O
T	O
lymphocytes	O
,	O
raising	O
the	O
possibility	O
that	O
TRAIL	B
might	O
be	O
involved	O
in	O
T	O
cell	O
-	O
mediated	O
cytotoxicity	O
and/or	O
immune	O
regulation	O
.	O

A	O
panel	O
of	O
pharmacologic	O
inhibitors	O
was	O
used	O
to	O
investigate	O
the	O
signal	O
transduction	O
pathways	O
involved	O
in	O
TRAIL	B
gene	I
induction	O
following	O
T	O
lymphocyte	O
activation	O
.	O

From	O
February	O
1991	O
to	O
August	O
1997	O
,	O
124	O
patients	O
with	O
endometrial	O
carcinoma	O
were	O
treated	O
postoperatively	O
with	O
high	O
-	O
dose	O
-	O
rate	O
vaginal	O
vault	O
brachytherapy	O
as	O
the	O
only	O
adjuvant	O
treatment	O
.	O

Twelve	O
patients	O
had	O
stage	O
IBG3	O
,	O
14	O
had	O
ICG1	O
,	O
9	O
had	O
ICG2	O
,	O
and	O
3	O
had	O
ICG3	O
disease	O
.	O

Defective	O
provirus	O
genomes	O
of	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
are	O
frequently	O
detected	O
in	O
lymphocytes	O
from	O
infected	O
individuals	O
and	O
in	O
infected	O
cell	O
lines	O
.	O

A	O
total	O
of	O
174	O
primer	O
pairs	O
gave	O
interpretable	O
banding	O
patterns	O
,	O
137	O
(	O
79	O
%	O
)	O
of	O
which	O
revealed	O
at	O
least	O
two	O
alleles	O
on	O
native	O
polyacrylamide	O
gels	O
.	O

A	O
population	O
pharmacokinetic	O
study	O
of	O
cyclosporin	O
in	O
organ	O
transplant	O
patients	O
,	O
including	O
elderly	O
allograft	O
recipients	O
up	O
to	O
75	O
years	O
of	O
age	O
,	O
did	O
not	O
identify	O
age	O
as	O
a	O
covariable	O
influencing	O
cyclosporin	O
pharmacokinetics	O
.	O

Immunofluoresence	O
data	O
indicated	O
that	O
once	O
bound	O
to	O
the	O
mutant	O
receptor	O
,	O
fluorescent	O
-	O
labeled	O
RAP	B
co	O
-	O
localized	O
with	O
markers	O
of	O
the	O
endosomal	O
pathway	O
,	O
whereas	O
,	O
in	O
cells	O
expressing	O
the	O
wild	O
-	O
type	O
receptor	O
,	O
RAP	B
fluorescence	O
co	O
-	O
localized	O
with	O
lysosomal	O
markers	O
.	O

Interleukin-12	B
(	O
IL-12	B
)	O
is	O
a	O
cytokine	O
produced	O
by	O
peripheral	O
blood	O
mononuclear	O
cells	O
(	O
PBMC	O
)	O
that	O
causes	O
interferon	B
-	I
gamma	I
(	O
IFN	B
-	I
gamma	I
)	O
production	O
and	O
enhancement	O
of	O
cell	O
-	O
mediated	O
cytotoxicity	O
.	O

IL-12	B
production	O
was	O
correlated	O
with	O
C3a	O
concentration	O
measured	O
at	O
the	O
outlet	O
of	O
hemodialyzer	O
after	O
15	O
min	O
of	O
dialysis	O
(	O
r	O
=	O
0.69	O
,	O
P	O
<	O
0.01	O
)	O
.	O

In	O
HeLa	O
cells	O
,	O
the	O
JNKK2-JNK1	B
fusion	O
protein	O
showed	O
significant	O
JNK	B
activity	O
,	O
which	O
was	O
comparable	O
with	O
that	O
of	O
JNK1	B
activated	O
by	O
many	O
stimuli	O
and	O
activators	O
,	O
including	O
EGF	B
,	O
TNF	B
-	I
alpha	I
,	O
anisomycin	O
,	O
UV	O
irradiation	O
,	O
MEKK1	B
,	O
and	O
small	B
GTP	I
binding	I
proteins	I
Rac1	I
and	O
Cdc42Hs	B
.	O

Our	O
results	O
implicate	O
TGF	B
-	I
beta	I
RII	I
as	O
a	O
direct	O
target	O
of	O
EWS	B
-	O
FLI1	B
.	O

The	O
reduction	O
in	O
saturated	O
fatty	O
acids	O
intake	O
led	O
to	O
modest	O
(	O
but	O
in	O
group	O
1	O
significant	O
)	O
0.15	O
mmol	O
/	O
l	O
(	O
2.5	O
%	O
)	O
reduction	O
in	O
total	O
serum	O
cholesterol	O
level	O
.	O

Secondly	O
,	O
an	O
ethanol	O
repression	O
autoregulation	O
(	O
ERA	O
)	O
/	O
twelve	O
-	O
fold	O
TA	O
repeat	O
(	O
TAB	O
)	O
repressor	O
element	O
was	O
identified	O
within	O
the	O
promoter	O
region	O
of	O
the	O
GLK1	B
gene	I
.	O

A	O
crucial	O
transcription	O
factor	O
in	O
this	O
process	O
is	O
STAT6	B
,	O
which	O
binds	O
to	O
a	O
specific	O
DNA	O
element	O
upon	O
cytokine	O
activation	O
.	O

CONCLUSIONS	O
:	O
Congenital	O
horizontal	O
tarsal	O
kink	O
is	O
rare	O
and	O
its	O
cause	O
is	O
unknown	O
.	O

A	O
local	O
,	O
high	O
-	O
density	O
,	O
single	O
-	O
nucleotide	O
polymorphism	O
map	O
used	O
to	O
clone	O
Caenorhabditis	B
elegans	I
cdf-1	I
.	O

This	O
machinery	O
involves	O
a	O
secondary	O
structure	O
,	O
SECIS	O
element	O
,	O
in	O
the	O
selenoprotein	B
-	O
encoding	O
mRNA	O
,	O
directing	O
selenocysteine	O
insertion	O
at	O
the	O
position	O
of	O
an	O
opal	O
(	O
UGA	O
)	O
codon	O
,	O
normally	O
conferring	O
termination	O
of	O
translation	O
.	O

High	O
-	O
level	O
expression	O
in	O
Escherichia	O
coli	O
of	O
selenocysteine	O
-	O
containing	O
rat	B
thioredoxin	I
reductase	I
utilizing	O
gene	O
fusions	O
with	O
engineered	O
bacterial	O
-	O
type	O
SECIS	O
elements	O
and	O
co	O
-	O
expression	O
with	O
the	O
selA	B
,	O
selB	B
and	O
selC	B
genes	I
.	O

In	O
Wnt	B
signaling	O
,	O
beta	B
-	I
catenin	I
and	O
plakoglobin	B
transduce	O
signals	O
to	O
the	O
nucleus	O
through	O
interactions	O
with	O
TCF	B
-	I
type	I
transcription	I
factors	I
.	O

Assembly	O
of	O
a	O
complex	O
between	O
FAK	B
and	O
Src	B
kinases	I
may	O
serve	O
to	O
regulate	O
the	O
subcellular	O
localization	O
and	O
the	O
enzymatic	O
activity	O
of	O
members	O
of	O
the	O
Src	B
family	I
of	O
kinases	O
.	O

For	O
EPV	O
3	O
,	O
10	O
,	O
or	O
40	O
,	O
the	O
bias	O
exceeded	O
25	O
%	O
for	O
7	O
,	O
3	O
,	O
and	O
1	O
in	O
the	O
8-predictor	O
model	O
respectively	O
,	O
when	O
a	O
conventional	O
selection	O
criterion	O
was	O
used	O
(	O
alpha	O
=	O
0.05	O
)	O
.	O

Our	O
study	O
also	O
demonstrated	O
significant	O
increases	O
in	O
the	O
number	O
of	O
larger	O
myelinated	O
fibers	O
crossing	O
the	O
repair	O
site	O
in	O
comparison	O
with	O
the	O
neonatal	O
and	O
adult	O
groups	O
(	O
p	O
<	O
0.04	O
)	O
.	O

Me	O
(	O
2	O
)	O
SO	O
-	O
induced	O
neuronal	O
differentiation	O
of	O
N1E-115	O
neuroblastoma	O
cells	O
increased	O
both	O
the	O
expression	O
of	O
the	O
endogenous	B
Ntr-1	I
gene	I
and	O
reporter	O
genes	O
driven	O
by	O
NTR-1	B
promoter	I
sequences	I
by	O
3	O
-	O
4-fold	O
.	O

Cortical	O
dysplasias	O
,	O
genetics	O
,	O
and	O
epileptogenesis	O
.	O

In	O
the	O
work	O
reported	O
here	O
,	O
we	O
used	O
peptide	O
mapping	O
,	O
mass	O
spectrometry	O
,	O
and	O
site	O
-	O
directed	O
mutagenesis	O
to	O
identify	O
two	O
sets	O
of	O
pAP	B
phosphorylation	O
sites	O
.	O

Both	O
HERV	O
-	O
K	O
type	O
1	O
and	O
2	O
clones	O
were	O
isolated	O
.	O

At	O
all	O
time	O
-	O
points	O
,	O
most	O
patients	O
(	O
>	O
/=87	O
%	O
)	O
were	O
receiving	O
irbesartan	O
/	O
HCTZ	O
alone	O
.	O

Modification	O
of	O
dopamine	B
D2	I
receptor	I
activity	O
by	O
pergolide	O
in	O
Parkinson	O
's	O
disease	O
:	O
an	O
in	O
vivo	O
study	O
by	O
PET	O
.	O

High	O
-	O
affinity	O
binding	O
sites	O
for	O
both	O
GR	B
and	O
AP-1	B
nucleoproteins	I
were	O
identified	O
at	O
adjacent	O
elements	O
within	O
the	O
nGRE	O
.	O

When	O
the	O
73-bp	O
fragment	O
was	O
fused	O
to	O
an	O
alpha1-globin	B
promoter	O
-	O
CAT	B
construct	O
and	O
cotransfected	O
with	O
CCAAT	B
transcription	I
factor	I
1	I
(	O
CTF1	B
)	O
/	O
NF1	B
into	O
Drosophila	O
Schneider	O
SL2	O
insect	O
cells	O
(	O
which	O
lack	O
NF1-like	B
proteins	I
)	O
trans	O
-	O
activation	O
of	O
CAT	B
activity	O
was	O
observed	O
.	O

Western	O
blot	O
analysis	O
showed	O
a	O
rapid	O
corresponding	O
increase	O
in	O
p21WAF1	B
/	O
CIP1	B
protein	O
,	O
whereas	O
protein	O
levels	O
of	O
another	O
member	O
of	O
the	O
cyclin	B
-	I
dependent	I
kinase	I
inhibitor	I
family	I
,	O
p27kip1	B
,	O
were	O
unchanged	O
.	O

Aggregation	O
of	O
vHnf1-deficient	B
embryonic	O
stem	O
cells	O
with	O
wild	O
-	O
type	O
tetraploid	O
embryos	O
,	O
which	O
contribute	O
exclusively	O
to	O
extraembryonic	O
tissues	O
,	O
rescues	O
periimplantation	O
lethality	O
and	O
allows	O
development	O
to	O
progress	O
to	O
early	O
organogenesis	O
.	O

nos-1	B
and	O
nos-2	B
,	O
two	O
genes	O
related	O
to	O
Drosophila	B
nanos	I
,	O
regulate	O
primordial	O
germ	O
cell	O
development	O
and	O
survival	O
in	O
Caenorhabditis	O
elegans	O
.	O

Although	O
upstream	O
regulators	O
of	O
Tec	B
family	I
kinases	I
are	O
relatively	O
well	O
characterized	O
,	O
little	O
is	O
known	O
of	O
the	O
downstream	O
effectors	O
of	O
these	O
enzymes	O
.	O

Efficient	O
phosphorylation	O
of	O
BRDG1	B
by	O
Tec	B
required	O
the	O
PH	B
and	O
SH2	B
domains	I
as	O
well	O
as	O
the	O
kinase	O
domain	O
of	O
the	O
latter	O
.	O

CONCLUSION	O
:	O
These	O
findings	O
imply	O
that	O
eotaxin	O
either	O
is	O
mechanistically	O
involved	O
in	O
acute	O
asthma	O
or	O
serves	O
as	O
a	O
biomarker	O
for	O
activity	O
of	O
the	O
CCR3	B
receptor	I
ligand	I
system	O
,	O
which	O
is	O
functionally	O
linked	O
to	O
asthma	O
.	O

The	O
expression	O
analysis	O
of	O
the	O
KlHIS4	B
gene	I
under	O
phosphate	O
starvation	O
or	O
high	O
adenine	O
supply	O
shows	O
that	O
factors	O
,	O
such	O
as	O
Bas1	B
or	O
Bas2	B
,	O
involved	O
in	O
the	O
basal	O
control	O
may	O
also	O
operate	O
in	O
a	O
different	O
way	O
in	O
K.	O
lactis	O
.	O

These	O
thyroid	O
hormone	O
changes	O
may	O
be	O
mediated	O
in	O
part	O
by	O
cytokines	O
or	O
other	O
inflammatory	O
mediators	O
,	O
acting	O
at	O
the	O
level	O
of	O
the	O
hypothalamus	O
and	O
pituitary	O
gland	O
,	O
the	O
thyroid	O
gland	O
,	O
and	O
the	O
hepatic	B
deiodinase	I
system	O
.	O

ESS	O
type	O
1	O
,	O
with	O
FT3	O
low	O
and	O
FT4	O
and	O
TSH	B
normal	O
,	O
is	O
the	O
most	O
frequent	O
form	O
.	O

METHODS	O
:	O
We	O
studied	O
20	O
symptomatic	O
patients	O
with	O
HOCM	O
(	O
12	O
men	O
)	O
,	O
mean	O
age	O
52	O
+	O
/-	O

17	O
years	O
,	O
before	O
and	O
after	O
septal	O
reduction	O
using	O
echocardiography	O
and	O
electrocardiogram	O
(	O
ECG	O
)	O
.	O

Paleoceanographic	O
data	O
from	O
the	O
Laurentian	O
Fan	O
,	O
used	O
as	O
a	O
proxy	O
for	O
sea	O
surface	O
temperature	O
,	O
reveal	O
that	O
surface	O
slope	O
waters	O
north	O
of	O
the	O
Gulf	O
Stream	O
experienced	O
warming	O
during	O
the	O
Little	O
Ice	O
Age	O
of	O
the	O
16th	O
to	O
19th	O
centuries	O
and	O
support	O
the	O
notion	O
of	O
an	O
NAO	O
-	O
driven	O
coupled	O
system	O
.	O

This	O
effect	O
required	O
(	O
i	O
)	O
IR	B
activation	O
since	O
it	O
was	O
abrogated	O
by	O
IR	B
mutation	O
at	O
tyrosines	O
1162	O
and	O
1163	O
and	O
(	O
ii	O
)	O
NF	B
-	I
kappaB	I
activation	O
since	O
it	O
was	O
abolished	O
by	O
overexpression	O
of	O
dominant	B
-	I
negative	I
IkappaB	I
-	I
alpha	I
(	I
A32	I
/	I
36	I
)	I
and	O
mimicked	O
by	O
overexpression	O
of	O
the	O
NF	B
-	I
kappaB	I
c	B
-	I
Rel	I
subunit	I
.	O

The	O
factor	O
designated	O
B	O
formed	O
a	O
complex	O
centered	O
on	O
the	O
sequence	O
TGTGGT	O
,	O
a	O
core	O
motif	O
recognized	O
by	O
members	O
of	O
the	O
AML	B
/	I
CBFalpha	I
transcription	I
factor	I
family	I
.	O

Furthermore	O
,	O
overexpression	O
of	O
AML3	B
/	O
CBFalpha1	B
could	O
rescue	O
the	O
AML1-ETO	B
repression	O
.	O

We	O
examined	O
Akt	B
activation	O
in	O
Lyn-	B
,	O
Syk-	B
and	O
Btk	B
-	O
deficient	O
DT40	O
cells	O
and	O
B	O
cells	O
from	O
Lyn	B
(	I
-	I
/	I
-	I
)	I
mice	O
.	O

Regulators	O
of	O
G	B
protein	I
signaling	I
(	I
RGS	I
)	I
proteins	I
that	O
contain	O
DEP	B
(	O
disheveled	B
,	O
EGL-10	B
,	O
pleckstrin	B
)	O
and	O
GGL	B
(	O
G	B
protein	I
gamma	I
subunit	I
-	I
like	I
)	O
domains	O
form	O
a	O
subfamily	O
that	O
includes	O
the	O
mammalian	B
RGS	I
proteins	I
RGS6	B
,	O
RGS7	B
,	O
RGS9	B
,	O
and	O
RGS11	B
.	O

Cloning	O
and	O
expression	O
of	O
a	O
specific	O
human	B
alpha	I
1,2-mannosidase	I
that	O
trims	O
Man9GlcNAc2	O
to	O
Man8GlcNAc2	O
isomer	O
B	O
during	O
N	O
-	O
glycan	O
biosynthesis	O
.	O

The	O
ORs	O
of	O
GC	O
,	O
adjusted	O
for	O
age	O
and	O
sex	O
,	O
varied	O
from	O
17.1	O
,	O
for	O
those	O
with	O
baseline	O
diagnoses	O
of	O
superficial	O
intestinal	O
metaplasia	O
(	O
IM	O
)	O
,	O
to	O
29.3	O
,	O
for	O
those	O
with	O
deep	O
IM	O
or	O
mild	O
dysplasia	O
(	O
DYS	O
)	O
or	O
IM	O
with	O
glandular	O
atrophy	O
and	O
neck	O
hyperplasia	O
,	O
to	O
104.2	O
,	O
for	O
those	O
with	O
moderate	O
or	O
severe	O
DYS	O
,	O
as	O
compared	O
with	O
subjects	O
with	O
superficial	O
gastritis	O
(	O
SG	O
)	O
or	O
chronic	O
atrophic	O
gastritis	O
(	O
CAG	O
)	O
at	O
baseline	O
.	O

Here	O
we	O
report	O
that	O
Dbp5p	B
and	O
Rat7p	B
interact	O
through	O
their	O
Nterminal	O
domains	O
.	O

Thus	O
,	O
the	O
nematode	O
genes	O
could	O
be	O
the	O
homologs	B
of	I
Hh	I
molecules	I
in	O
other	O
phyla	O
.	O

A	O
subset	O
of	O
mutations	O
in	O
the	O
Psi	B
synthase	I
domain	I
impairs	O
association	O
of	O
the	O
altered	O
Cbf5p	B
proteins	I
with	O
selected	O
box	O
H	B
/	I
ACA	I
snoRNAs	I
,	O
suggesting	O
that	O
the	O
functional	O
catalytic	O
domain	O
is	O
essential	O
for	O
that	O
interaction	O
.	O

Although	O
the	O
Src	B
tyrosine	I
kinase	I
induces	O
constitutive	O
Stat3	B
phosphorylation	O
on	O
tyrosine	O
,	O
activation	O
of	O
Stat3-mediated	B
gene	O
regulation	O
requires	O
both	O
tyrosine	O
and	O
serine	O
phosphorylation	O
of	O
Stat3	B
.	O

The	O
transcription	B
factor	I
CHOP	I
(	O
C	B
/	I
EBP	I
homologous	I
protein	I
10	I
)	O
is	O
a	O
bZIP	B
protein	I
induced	O
by	O
a	O
variety	O
of	O
stimuli	O
that	O
evoke	O
cellular	O
stress	O
responses	O
and	O
has	O
been	O
shown	O
to	O
arrest	O
cell	O
growth	O
and	O
to	O
promote	O
programmed	O
cell	O
death	O
.	O

Thus	O
,	O
CHOP	B
not	O
only	O
is	O
a	O
negative	O
or	O
a	O
positive	O
regulator	O
of	O
C	B
/	I
EBP	I
target	O
genes	O
but	O
also	O
,	O
when	O
tethered	O
to	O
AP-1	B
factors	I
,	O
can	O
activate	O
AP-1	B
target	O
genes	O
.	O

This	O
motif	O
,	O
first	O
described	O
for	O
the	O
Drosophila	B
homeobox	I
activator	I
DEAF-1	I
,	O
identifies	O
an	O
emerging	O
group	O
of	O
metazoan	O
transcriptional	O
modulators	O
.	O

RNase	B
MRP	I
is	O
a	O
ribonucleoprotein	O
endoribonuclease	O
that	O
has	O
been	O
shown	O
to	O
have	O
roles	O
in	O
both	O
mitochondrial	O
DNA	O
replication	O
and	O
nuclear	B
5.8S	I
rRNA	I
processing	O
.	O

We	O
have	O
examined	O
the	O
regulation	O
of	O
the	O
FGFR-1	B
gene	I
(	O
cek-1	B
)	O
in	O
avian	O
myogenic	O
cultures	O
by	O
immunocytochemistry	O
and	O
Northern	O
blot	O
analysis	O
.	O

Regulation	O
of	O
avian	B
fibroblast	I
growth	I
factor	I
receptor	I
1	I
(	O
FGFR-1	B
)	O
gene	O
expression	O
during	O
skeletal	O
muscle	O
differentiation	O
.	O

The	O
backbone	O
dynamics	O
of	O
residues	O
located	O
in	O
the	O
folded	O
part	O
of	O
CRP2	B
(	O
LIM2	B
)	O
R122A	B
have	O
been	O
characterized	O
by	O
proton	O
-	O
detected	O
(	O
15	O
)	O
N	O
NMR	O
spectroscopy	O
.	O

Rac	B
causes	O
uncapping	O
of	O
actin	B
filaments	I
(	O
F	B
-	I
actin	I
)	O
at	O
the	O
plus	O
-	O
ends	O
,	O
through	O
phosphatidylinositol	O
4,5	O
bisphosphate	O
(	O
PIP2	O
)	O
,	O
and	O
eventually	O
induces	O
membrane	O
ruffling	O
.	O

However	O
,	O
a	O
specific	O
ICE	B
/	O
caspase-1	B
inhibitor	O
called	O
N1445	O
completely	O
abolished	O
the	O
CK	B
-	O
induced	O
apoptosis	O
by	O
reactivating	O
PKB	B
,	O
but	O
without	O
affecting	O
the	O
CK	B
-	O
induced	O
suppression	O
of	O
Ras	B
transformation	O
.	O

The	O
AL	O
-	O
R8	O
SI	O
:	O
the	O
next	O
generation	O
staging	O
container	O
for	O
plutonium	O
pits	O
at	O
the	O
USDOE	O
Pantex	O
Plant	O
.	O

One	O
form	O
of	O
the	O
SBEI	B
gene	I
transcript	I
in	O
12-day	O
old	O
kernels	O
contained	O
the	O
exon	O
I+II+III	O
combination	O
at	O
the	O
5	O
'	O
end	O
,	O
whereas	O
other	O
forms	O
differed	O
by	O
inclusion	O
of	O
intron	O
1	O
or	O
exclusion	O
of	O
exon	O
II	O
sequences	O
.	O

In	O
PC	O
,	O
rare	O
MNGCs	O
had	O
intranuclear	O
inclusions	O
and	O
grooves	O
.	O

16	O
percent	O
,	O
P<0.001	O
)	O
,	O
and	O
sustained	O
normalization	O
of	O
serum	B
alanine	I
aminotransferase	I
levels	O
(	O
41	O
percent	O
vs.	O

Its	O
C	O
-	O
terminal	O
catalytic	O
domain	O
was	O
found	O
to	O
be	O
highly	O
conserved	O
in	O
the	O
homologues	O
p140	B
(	O
ras	B
-	O
GRF	B
)	O
and	O
Sos	B
.	O

356	O
,	O
93	O
-	O
98	O
]	O
.	O

The	O
proteasome	O
is	O
a	O
large	O
complex	O
consisting	O
of	O
two	O
multisubunit	O
structures	O
,	O
the	O
20S	B
and	O
19S	B
(	O
PA700	B
)	O
or	O
P28	B
complexes	I
,	O
that	O
combine	O
to	O
form	O
the	O
26S	B
particles	I
.	O

In	O
assays	O
with	O
purified	O
enzymes	O
,	O
wild	O
-	O
type	O
but	O
not	O
PTPS	B
-	O
S19A	B
was	O
a	O
specific	O
substrate	O
for	O
the	O
cGMP	B
-	I
dependent	I
protein	I
kinase	I
(	I
cGK	I
)	I
type	I
I	I
and	I
II	I
.	O

R.	O
,	O
Fleischmann	O
,	O
R.	O
,	O
Venter	O
,	O
J.	O

The	O
N	O
-	O
terminal	O
domain	O
of	O
approximately	O
70	O
kDa	O
exhibits	O
11	O
imperfect	O
amino	O
acid	O
repeats	O
that	O
show	O
some	O
homology	O
to	O
promastigote	O
surface	O
glycoproteins	O
of	O
the	O
psa2	B
/	O
gp46	B
complex	O
.	O

In	O
contrast	O
to	O
previously	O
characterized	O
proteophosphoglycans	O
,	O
the	O
ppg1	B
gene	O
product	O
is	O
predominantly	O
membrane	O
-	O
associated	O
and	O
it	O
is	O
expressed	O
on	O
the	O
promastigote	O
cell	O
surface	O
.	O

Most	O
important	O
,	O
infection	O
of	O
the	O
cells	O
with	O
an	O
adenoviral	O
construct	O
expressing	O
this	O
mutant	O
inhibited	O
the	O
induction	O
of	O
VEGF	B
mRNA	I
under	O
conditions	O
that	O
mimic	O
hypoxia	O
.	O

Neuregulin	B
stimulates	O
ErbB2	B
,	O
ErbB3	B
,	O
and	O
ErbB4	B
,	O
members	O
of	O
the	O
ErbB	B
family	I
of	O
receptor	B
tyrosine	I
kinases	I
.	O

Our	O
results	O
suggest	O
that	O
Anu2p	B
is	O
the	O
yeast	B
homologue	I
of	I
mammalian	I
epsilon	I
-	I
COP	I
and	O
the	O
abrupt	O
accumulation	O
of	O
the	O
ER	O
membrane	O
caused	O
by	O
a	O
blockage	O
of	O
the	O
early	O
protein	O
transport	O
pathway	O
leads	O
to	O
alteration	O
of	O
nuclear	O
morphology	O
of	O
the	O
budding	O
yeast	O
cells	O
.	O

In	O
PC12	O
cells	O
,	O
nerve	B
growth	I
factor	I
induces	O
neuronal	O
differentiation	O
and	O
repressed	O
expression	O
of	O
nrg-1	B
.	O

In	O
a	O
PC12	O
cell	O
mutant	O
that	O
is	O
deficient	O
in	O
protein	B
kinase	I
A	I
activity	O
(	O
AB.11	O
)	O
,	O
all	O
three	O
differentiating	O
agents	O
were	O
unable	O
to	O
down	O
-	O
regulate	O
nrg-1	B
mRNA	I
.	O

TSC1	B
mutations	I
include	O
two	O
nonsense	O
mutations	O
,	O
four	O
insertions	O
,	O
and	O
three	O
splice	O
mutations	O
.	O

Twelve	O
patients	O
without	O
abnormalities	O
in	O
the	O
PTT	O
are	O
assumed	O
to	O
harbor	O
missense	O
mutations	O
,	O
probably	O
in	O
TSC2	B
.	O

The	O
first	O
algorithm	O
,	O
FOREPROJ	O
,	O
is	O
a	O
fast	O
-	O
forward	O
projection	O
algorithm	O
that	O
allows	O
calculation	O
of	O
the	O
3-D	O
attenuation	O
correction	O
factors	O
(	O
ACF	O
's	O
)	O
directly	O
from	O
a	O
two	O
-	O
dimensional	O
(	O
2-D	O
)	O
transmission	O
scan	O
,	O
without	O
first	O
reconstructing	O
the	O
attenuation	O
map	O
and	O
then	O
performing	O
a	O
3-D	O
forward	O
projection	O
.	O

We	O
have	O
cloned	O
cDNA	O
and	O
genomic	O
DNA	O
for	O
a	O
mouse	O
gene	O
encoding	O
a	O
protein	O
with	O
significant	O
sequence	O
similarity	O
to	O
conserved	O
domains	O
found	O
in	O
proteins	O
of	O
the	O
Spo11p	B
family	I
.	O

RT	O
-	O
PCR	O
and	O
in	O
situ	O
hybridization	O
analyses	O
of	O
a	O
time	O
course	O
of	O
juvenile	O
testis	O
development	O
indicate	O
that	O
Spo11	B
expression	O
begins	O
in	O
early	O
meiotic	O
Prophase	O
I	O
,	O
prior	O
to	O
the	O
pachytene	O
stage	O
,	O
with	O
increasing	O
accumulation	O
of	O
mRNA	O
through	O
the	O
pachytene	O
stage	O
.	O

Animals	O
were	O
put	O
to	O
death	O
8	O
weeks	O
later	O
and	O
the	O
grafts	O
were	O
sterilely	O
explanted	O
and	O
analyzed	O
via	O
microbiologic	O
culture	O
and	O
standard	O
histologic	O
procedures	O
for	O
evidence	O
of	O
infection	O
.	O

The	O
RMR	O
was	O
measured	O
twice	O
in	O
each	O
phase	O
and	O
found	O
to	O
be	O
similar	O
(	O
F	O
(	O
1,18	O
)	O
=	O
0.863	O
)	O
across	O
the	O
follicular	O
(	O
5018	O
kJ	O
/	O
24	O
h	O
)	O
and	O
the	O
luteal	O
(	O
5098	O
kJ	O
/	O
24	O
h	O
)	O
phases	O
.	O

Oseltamivir	O
(	O
GS4104	O
)	O
,	O
which	O
can	O
be	O
administered	O
orally	O
,	O
is	O
the	O
prodrug	O
of	O
GS4071	O
,	O
a	O
potent	O
and	O
selective	O
inhibitor	O
of	O
influenzavirus	B
neuraminidases	I
.	O

In	O
gel	O
mobility	O
shift	O
assays	O
,	O
we	O
found	O
no	O
evidence	O
for	O
VDR	B
-	O
TR	B
heterodimer	O
interaction	O
with	O
any	O
tested	O
element	O
.	O

The	O
relative	O
importance	O
of	O
these	O
two	O
mechanisms	O
differed	O
in	O
a	O
response	O
element	O
-	O
specific	O
manner	O
.	O

After	O
14	O
d	O
of	O
overfeeding	O
,	O
hepatic	O
PL	O
profiles	O
were	O
identical	O
in	O
the	O
two	O
breeds	O
and	O
similar	O
to	O
that	O
in	O
control	O
livers	O
;	O
choline	O
-	O
containing	O
PL	O
accounted	O
for	O
95	O
%	O
of	O
total	O
PL	O
.	O

C	O
-	O
SP	O
duration	O
was	O
significantly	O
reduced	O
in	O
ALS	O
patients	O
compared	O
to	O
controls	O
at	O
low	O
stimulation	O
intensity	O
corresponding	O
to	O
an	O
MEP	O
threshold	O
increased	O
by	O
15	O
%	O
.	O

These	O
data	O
show	O
that	O
the	O
spv	B
virulence	I
genes	I
belong	O
simultaneously	O
to	O
several	O
regulons	O
in	O
the	O
cell	O
,	O
raising	O
the	O
possibility	O
that	O
spv	B
expression	O
can	O
be	O
fine	O
-	O
tuned	O
in	O
response	O
to	O
multiple	O
environmental	O
inputs	O
.	O

Intensive	O
synthesis	O
of	O
PNA	B
in	O
the	O
cells	O
of	O
microvascular	O
wall	O
evidenced	O
of	O
their	O
high	O
functional	O
activity	O
,	O
and	O
the	O
synthesis	O
of	O
DNA	O
in	O
them	O
showed	O
their	O
ability	O
for	O
proliferation	O
,	O
i.g	O
.--	O
for	O
growth	O
.	O

Tracheal	O
transsection	O
combined	O
with	O
hilar	O
ligation	O
(	O
TL&PL	O
)	O
effected	O
a	O
reduction	O
of	O
19.9	O
%	O
(	O
n.s	O
.	O
)	O
.	O

Kinase	O
-	O
deficient	O
erbB	B
proteins	I
reduced	O
epidermal	B
growth	I
factor	I
(	O
EGF	B
)	O
-induced	O
tyrosine	O
phosphorylation	O
of	O
endogenous	O
Shc	B
proteins	I
and	O
also	O
reduced	O
immediate	O
and	O
sustained	O
EGF	B
-	I
induced	I
ERK	I
MAPK	I
activities	O
in	O
human	O
glioblastoma	O
cells	O
,	O
although	O
basal	O
ERK	B
MAPK	I
activities	O
were	O
unaffected	O
.	O

Using	O
immunolocalization	O
,	O
we	O
observe	O
that	O
ACE3	B
,	O
a	O
440-bp	O
chorion	O
element	O
that	O
contains	O
information	O
sufficient	O
to	O
drive	O
amplification	O
,	O
directs	O
DmORC	B
localization	O
in	O
follicle	O
cells	O
.	O

Therefore	O
,	O
homozygous	O
co	O
-	O
deletions	O
of	O
CDKN2A	B
and	O
CDKN2B	B
rather	O
than	O
mutations	O
targeting	O
individual	O
transcripts	O
are	O
frequently	O
selected	O
for	O
in	O
these	O
tumors	O
.	O

Here	O
,	O
we	O
show	O
that	O
aortic	O
explants	O
isolated	O
from	O
PPARalpha	B
-	O
null	O
mice	O
display	O
an	O
exacerbated	O
response	O
to	O
inflammatory	O
stimuli	O
,	O
such	O
as	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
as	O
demonstrated	O
by	O
increased	O
IL-6	B
secretion	O
.	O

Albumin	O
expression	O
is	O
maintained	O
in	O
the	O
liver	O
by	O
a	O
combination	O
of	O
liver	O
-	O
enriched	O
transcription	O
factors	O
such	O
as	O
CAAT	B
enhancer	I
-	I
binding	I
protein	I
(	I
C	I
/	I
EBP	I
)	I
alpha	I
and	O
C	B
/	I
EBPbeta	I
.	O

The	O
requirement	O
for	O
proteolytic	O
activity	O
of	O
both	O
FVIIa	B
and	O
FXa	B
suggests	O
that	O
protease	O
-	O
activated	O
receptors	O
may	O
be	O
involved	O
.	O

Amyloid	B
beta	I
-	I
protein	I
(	O
Abeta	B
)	O
is	O
the	O
main	O
constituent	O
of	O
amyloid	O
fibrils	O
found	O
in	O
senile	O
plaques	O
and	O
cerebral	O
vessels	O
in	O
Alzheimer	O
's	O
disease	O
(	O
AD	O
)	O
and	O
is	O
derived	O
by	O
proteolysis	O
from	O
the	O
beta	B
-	I
amyloid	I
precursor	I
protein	I
(	O
APP	B
)	O
.	O

We	O
also	O
show	O
that	O
activation	O
of	O
protein	B
kinase	I
A	I
(	O
PKA	B
)	O
signaling	O
is	O
sufficient	O
to	O
down	O
-	O
regulate	O
caveolin-1	B
protein	I
expression	O
and	O
promoter	O
activity	O
.	O

The	O
importin	B
alpha.beta	I
heterodimer	I
mediates	O
nuclear	O
import	O
of	O
proteins	O
containing	O
classical	O
nuclear	O
localization	O
signals	O
.	O

The	O
expressed	O
G1-G2	B
bound	O
to	O
both	O
hyaluronan	O
and	O
link	B
protein	I
indicating	O
that	O
the	O
immunoglobulin	B
-	I
fold	I
motif	I
and	O
proteoglycan	O
tandem	O
repeat	O
loops	O
of	O
the	O
G1	B
domain	I
were	O
correctly	O
folded	O
.	O

The	O
results	O
suggest	O
that	O
the	O
presence	O
or	O
absence	O
per	O
se	O
of	O
keratan	O
sulfate	O
on	O
native	O
G1-G2	O
does	O
not	O
affect	O
the	O
activity	O
of	O
atrolysin	O
C	O
toward	O
the	O
two	O
sites	O
.	O

Despite	O
i.v	O
.	O

steroid	O
therapy	O
,	O
[	O
NOexh	O
]	O
remained	O
elevated	O
throughout	O
recovery	O
(	O
37.9+	O
/	O
-4.8	O
ppb	O
,	O
p<0.001	O
)	O
until	O
discharge	O
(	O
40.9+	O
/	O
-4.3	O
ppb	O
,	O
p<0.001	O
)	O
.	O

It	O
contains	O
binding	O
sites	O
for	O
several	O
transcription	O
factors	O
,	O
for	O
example	O
:	O
(	O
i	O
)	O
a	O
well	O
-	O
characterized	O
binding	O
site	O
for	O
rel	B
/	O
NF	B
-	I
kappaB	I
transcription	O
factors	O
in	O
its	O
3'-end	O
(	O
the	O
H2TF1	B
or	O
kappaB1	B
element	I
)	O
,	O
(	O
ii	O
)	O
a	O
second	O
kappaB	B
site	I
(	O
the	O
kappaB2	B
element	I
)	O
,	O
which	O
is	O
located	O
immediately	O
adjacent	O
5	O
'	O
to	O
the	O
H2TF1	B
element	I
and	O
which	O
is	O
recognized	O
by	O
p65	B
/	O
relA	B
in	O
the	O
human	B
HLA	I
system	O
,	O
and	O
(	O
iii	O
)	O
an	O
AP-1	B
/	O
ATF	B
recognition	O
sequence	O
in	O
the	O
5	O
'	O
end	O
(	O
EnA	B
-	I
TRE	I
)	O
.	O

The	O
tumorigenic	O
E1A	B
+	O
cHa	B
-	I
ras	I
cells	O
are	O
characterized	O
by	O
high	O
and	O
constitutive	O
DNA	O
binding	O
activities	O
of	O
AP-1	B
,	O
in	O
contrast	O
to	O
nontransformed	O
cells	O
and	O
the	O
E1A	B
cells	O
.	O

The	O
yeast	O
C	B
-	I
type	I
cyclin	I
Ume3p	B
/	O
Srb11p	B
and	O
its	O
cyclin	B
-	I
dependent	I
kinase	I
(	O
Cdk	B
)	O
Ume5p	B
are	O
required	O
for	O
the	O
full	O
repression	O
of	O
genes	O
involved	O
in	O
the	O
stress	O
response	O
or	O
meiosis	O
.	O

In	O
particular	O
,	O
the	O
S1	B
'	I
specificity	I
site	I
is	O
a	O
deep	O
and	O
highly	O
hydrophobic	O
cavity	O
.	O

FZD4	B
is	O
homologous	O
to	O
FZD9	B
and	O
FZD10	B
,	O
and	O
overall	O
amino	O
acid	O
identity	O
is	O
as	O
follows	O
:	O
FZD4	B
vs	O
FZD9	B
,	O
51.6	O
%	O
;	O
FZD4	B
vs	O
FZD10	B
,	O
51.2	O
%	O
;	O
FZD9	B
vs	O
FZD10	B
,	O
65.7	O
%	O
.	O

The	O
NF	B
-	I
kappaB	I
responsive	O
reporter	O
construct	O
,	O
(	B
PRDII	I
)	I
(	I
4	I
)	I
-CAT	O
,	O
was	O
used	O
to	O
explore	O
transcription	O
resulting	O
from	O
NF	B
-	I
kappaB	I
activated	O
by	O
Tat	B
.	O

The	O
RNA	O
transcripts	O
structurally	O
equivalent	O
to	O
I	B
(	I
2	I
)	I
sgRNAs	I
of	O
TMV	B
U1	I
and	O
crTMV	O
,	O
but	O
containing	O
a	O
hairpin	O
structure	O
(	O
H	O
)	O
immediately	O
upstream	O
of	O
IRES	B
(	I
MP,75	I
)	I
(	I
HIRES	I
(	I
MP	I
)	I
,	I
(	I
75	I
)	I
(	I
CR	I
)	I
-MP	I
-	I
CP-3'UTR	I
;	O
HIRES	B
(	I
MP,75	I
)	I
(	I
U1	I
)	I
-MP	I
-	I
CP-3'UTR	I
)	O
,	O
were	O
able	O
to	O
express	O
the	O
MP	B
gene	I
in	O
vitro	O
.	O

EIAV	B
LTR	I
sequence	I
variability	O
is	O
confined	O
mostly	O
to	O
a	O
small	O
portion	O
of	O
the	O
enhancer	O
within	O
the	O
U3	O
segment	O
of	O
the	O
LTR	O
.	O

Phosphatidylinositol	B
3-kinase	I
requirement	O
in	O
activation	O
of	O
the	O
ras	B
/	O
C	B
-	I
raf-1	I
/	O
MEK	B
/	O
ERK	B
and	O
p70	B
(	O
s6k	B
)	O
signaling	O
cascade	O
by	O
the	O
insulinomimetic	O
agent	O
vanadyl	O
sulfate	O
.	O

The	O
core	O
of	O
this	O
enhancer	O
contains	O
two	O
evolutionarily	O
conserved	O
binding	O
sites	O
for	O
the	O
homeodomain	B
protein	I
Tinman	B
(	O
Tin	B
)	O
,	O
expressed	O
in	O
developing	O
cardiac	O
,	O
somatic	O
,	O
and	O
visceral	O
muscle	O
lineages	O
.	O

For	O
example	O
,	O
introduction	O
of	O
immunogenic	O
and	O
purification	O
tag	O
sequences	O
into	O
the	O
C	O
-	O
terminal	O
coding	O
region	O
significantly	O
decreased	O
bop	B
gene	I
mRNA	I
and	O
protein	O
accumulation	O
.	O

Furthermore	O
,	O
the	O
striking	O
ability	O
of	O
polyoma	B
middle	I
T	I
antigens	I
to	O
promote	O
retinoic	O
acid	O
-	O
induced	O
differentiation	O
appears	O
to	O
utilize	O
ERK	B
,	O
but	O
not	O
JNK	B
/	O
SPK	B
or	O
p38	B
signaling	O
.	O

We	O
recommend	O
that	O
paracervical	O
block	O
with	O
lignocaine	O
should	O
be	O
used	O
in	O
conjunction	O
with	O
i.v	O
.	O

sedation	O
/	O
analgesia	O
during	O
egg	O
collection	O
performed	O
through	O
the	O
transvaginal	O
route	O
under	O
ultrasound	O
guidance	O
(	O
TUGOR	O
)	O
to	O
reduce	O
the	O
pain	O
of	O
the	O
procedure	O
.	O

All	O
loci	O
have	O
a	O
similar	O
organization	O
,	O
except	O
for	O
H1.8	B
that	O
harbors	O
two	O
TcP2beta	B
genes	I
arranged	O
in	O
tandem	O
and	O
separated	O
by	O
a	O
short	O
repetitive	O
sequence	O
,	O
named	O
SIRE	O
(	O
short	O
interspersed	O
repetitive	O
element	O
)	O
,	O
which	O
is	O
also	O
found	O
upstream	O
of	O
the	O
first	O
gene	O
of	O
the	O
tandem	O
and	O
downstream	O
of	O
the	O
second	O
.	O

A	O
proportion	O
of	O
APC	B
wild	O
-	O
type	O
colon	O
carcinomas	O
and	O
melanomas	O
also	O
contains	O
constitutive	O
nuclear	O
Tcf-4	B
/	O
beta	B
-	I
catenin	I
complexes	O
as	O
a	O
result	O
of	O
dominant	O
mutations	O
in	O
the	O
N	O
terminus	O
of	O
beta	B
-	I
catenin	I
that	O
render	O
it	O
insensitive	O
to	O
downregulation	O
by	O
APC	B
,	O
GSK3	B
beta	I
,	O
and	O
Axin	B
/	O
Conductin	B
.	O

Similar	O
mechanisms	O
leading	O
to	O
deregulation	O
of	O
Tcf	B
target	I
gene	I
activity	O
are	O
likely	O
to	O
be	O
involved	O
in	O
melanoma	O
and	O
other	O
forms	O
of	O
cancer	O
.	O

This	O
report	O
describes	O
a	O
patient	O
with	O
a	O
previous	O
inferior	O
acute	O
myocardial	O
infarction	O
who	O
developed	O
right	O
ventricular	O
infarction	O
with	O
significant	O
anterior	O
lead	O
ST	O
segment	O
elevation	O
(	O
V1-V4	O
)	O
caused	O
by	O
the	O
loss	O
of	O
two	O
large	O
right	O
ventricular	O
branches	O
during	O
a	O
coronary	O
angioplasty	O
of	O
the	O
right	O
coronary	O
artery	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
Immediately	O
before	O
radical	O
prostatectomy	O
,	O
bone	O
marrow	O
aspirates	O
from	O
both	O
sides	O
of	O
the	O
iliac	O
crest	O
were	O
taken	O
from	O
287	O
patients	O
.	O

With	O
regard	O
to	O
nonhematologic	O
toxicities	O
,	O
diarrhea	O
,	O
infection	O
and	O
elevated	O
serum	B
alkaline	I
phosphatase	I
of	O
grade	O
3	O
or	O
over	O
were	O
observed	O
in	O
2	O
%	O
of	O
cycles	O
,	O
but	O
were	O
tolerable	O
and	O
reversible	O
.	O

LHbeta	B
is	O
expressed	O
in	O
pituitary	O
gonadotrope	O
cells	O
and	O
CGbeta	B
is	O
expressed	O
in	O
placental	O
trophoblast	O
cells	O
.	O

Regulation	O
of	O
HIV-1	O
transcription	O
.	O

Human	B
LTBP-1	I
is	O
known	O
to	O
exist	O
in	O
different	O
forms	O
.	O

It	O
consists	O
of	O
2185	O
amino	O
acid	O
residues	O
encoded	O
by	O
a	O
9-kilobase	O
pair	O
mRNA	O
;	O
several	O
splice	O
variants	O
have	O
been	O
detected	O
in	O
human	O
and	O
rat	O
cDNA	O
libraries	O
.	O

Cyclic	B
AMP	I
-	I
dependent	I
protein	I
kinase	I
binding	O
to	O
A	B
-	I
kinase	I
anchoring	O
proteins	O
in	O
living	O
cells	O
by	O
fluorescence	O
resonance	O
energy	O
transfer	O
of	O
green	B
fluorescent	I
protein	I
fusion	O
proteins	O
.	O

CONCLUSIONS	O
:	O
In	O
addition	O
to	O
the	O
superiority	O
of	O
octafluoropropane	O
-	O
filled	O
microspheres	O
to	O
air	O
-	O
filled	O
microspheres	O
for	O
LV	O
opacification	O
,	O
the	O
efficacy	O
of	O
OCTA	O
is	O
relatively	O
unaffected	O
by	O
impaired	O
LV	O
function	O
and	O
is	O
less	O
susceptible	O
to	O
the	O
effects	O
of	O
poor	O
echogenicity	O
than	O
AIR	O
.	O

Factor	B
XI	I
deficiency	O
is	O
a	O
rare	O
hereditary	O
bleeding	O
disorder	O
affecting	O
the	O
intrinsic	O
pathway	O
.	O

The	O
Ishasha	O
samples	O
show	O
a	O
range	O
encompassing	O
three	O
trophic	O
levels	O
.	O

The	O
more	O
traditional	O
SERMS	O
,	O
clomiphene	O
citrate	O
and	O
tamoxifen	O
,	O
will	O
be	O
reviewed	O
along	O
with	O
such	O
modern	O
drugs	O
as	O
raloxifene	O
and	O
faslodex	O
,	O
with	O
emphasis	O
upon	O
their	O
actions	O
on	O
breast	O
,	O
uterus	O
,	O
bone	O
and	O
lipids	O
.	O

Ti	O
exhibited	O
a	O
feather	O
-	O
like	O
morphology	O
.	O

This	O
organization	O
suggests	O
that	O
duplication	O
events	O
that	O
have	O
generated	O
the	O
primate	O
FUT3-FUT5-FUT6	B
cluster	O
might	O
have	O
occurred	O
through	O
a	O
long	O
-	O
interspersed	O
-	O
nuclear	O
-	O
element	O
-	O
based	O
mechanism	O
of	O
unequal	O
crossing	O
over	O
,	O
as	O
described	O
for	O
the	O
globin	B
cluster	I
.	O

S.	O
,	O
Kim	O
,	O
S.	O

The	O
cop	B
region	I
also	O
harbors	O
a	O
region	O
of	O
plasmid	O
incompatibility	O
,	O
inc	B
,	O
encompassing	O
a	O
stem	O
-	O
loop	O
structure	O
,	O
the	O
repA	B
promoter	I
,	O
Prep	B
,	O
as	O
well	O
as	O
two	O
distinct	O
RepA	B
binding	I
sites	I
,	O
BD-1	O
and	O
BD-2	O
.	O

WA	O
constructs	O
afforded	O
relaxed	O
and	O
positive	O
topoisomers	O
,	O
and	O
cyclization	O
kinetics	O
indicated	O
slow	O
interconversion	O
of	O
precursors	O
to	O
the	O
two	O
topoisomers	O
.	O

The	O
RFX	B
protein	I
family	I
includes	O
members	O
from	O
yeast	O
to	O
humans	O
,	O
which	O
function	O
in	O
various	O
biological	O
systems	O
,	O
and	O
share	O
a	O
DNA	O
-	O
binding	O
domain	O
and	O
a	O
conserved	O
C	O
-	O
terminal	O
region	O
.	O

Binding	O
to	O
sulphatides	O
and	O
the	O
alpha	B
-	I
dystroglycan	I
receptor	I
was	O
much	O
stronger	O
and	O
required	O
at	O
least	O
two	O
LG	B
modules	I
.	O

Here	O
,	O
we	O
propose	O
that	O
an	O
antagonistic	O
,	O
BMP	B
/	O
ALK2	B
/	O
Smad	B
-	O
mediated	O
signaling	O
pathway	O
is	O
active	O
on	O
the	O
right	O
side	O
of	O
the	O
Xenopus	O
embryo	O
.	O

These	O
kinases	O
belong	O
to	O
a	O
new	O
subfamily	O
related	O
to	O
the	O
Trk	B
subfamily	I
.	O

The	O
data	O
indicate	O
that	O
etr-1	B
is	O
essential	O
for	O
muscle	O
development	O
in	O
C.	O
elegans	O
,	O
perhaps	O
by	O
playing	O
a	O
role	O
in	O
post	O
-	O
transcriptional	O
processing	O
of	O
some	O
muscle	O
component	O
,	O
and	O
thus	O
suggesting	O
a	O
possible	O
conservation	O
of	O
gene	O
function	O
with	O
human	B
CUG	I
-	I
bp	I
.	O

Gentamicin	O
given	O
by	O
DPI	O
and	O
SVN	O
significantly	O
decreased	O
the	O
sputum	O
Psa	O
density	O
(	O
p	O
<	O
0.05	O
)	O
,	O
by	O
almost	O
one	O
order	O
of	O
magnitude	O
.	O

An	O
analysis	O
of	O
sequence	O
of	O
the	O
mutant	B
recN	I
gene	I
revealed	O
a	O
G	O
:	O
C	O
to	O
T	O
:	O
A	O
transversion	O
near	O
the	O
3	O
'	O
end	O
of	O
the	O
coding	O
region	O
.	O

Nevertheless	O
,	O
in	O
view	O
of	O
the	O
potential	O
transmission	O
rates	O
of	O
HGV	O
and	O
the	O
lack	O
of	O
effective	O
immunization	O
,	O
HGV	O
should	O
be	O
regarded	O
as	O
a	O
potential	O
occupational	O
hazard	O
for	O
medical	O
and	O
dental	O
staff	O
.	O

Detection	O
of	O
poisoning	O
by	O
Impila	O
(	O
Callilepis	O
laureola	O
)	O
in	O
a	O
mother	O
and	O
child	O
.	O

We	O
have	O
previously	O
identified	O
mouse	B
and	I
human	I
cDNAs	I
encoding	I
UNC-51-like	I
kinase	I
(	O
ULK1	B
)	O
.	O

ULKs	B
and	O
UNC-51	B
share	O
a	O
typical	O
domain	O
structure	O
of	O
an	O
amino	O
-	O
terminal	O
kinase	O
domain	O
,	O
a	O
central	O
proline	O
/	O
serine	O
rich	O
(	O
PS	O
)	O
domain	O
,	O
and	O
a	O
carboxy	O
-	O
terminal	O
(	O
C	O
)	O
domain	O
.	O

These	O
results	O
suggest	O
that	O
ULK2	B
is	O
involved	O
in	O
a	O
previously	O
uncharacterized	O
signaling	O
pathway	O
in	O
mammalian	O
cells	O
.	O

Connector	B
enhancer	I
of	I
KSR	I
(	O
CNK	B
)	O
is	O
a	O
multidomain	O
protein	O
required	O
for	O
RAS	B
signaling	O
.	O

In	O
simpler	O
organisms	O
,	O
the	O
ATP	B
sulfurylase	I
and	O
APS	B
kinase	I
reactions	O
are	O
catalyzed	O
by	O
separate	O
enzymes	O
encoded	O
by	O
two	O
or	O
three	O
genes	O
,	O
suggesting	O
that	O
a	O
fusion	O
of	O
separate	O
genes	O
during	O
the	O
course	O
of	O
evolution	O
generated	O
the	O
bifunctional	O
enzyme	O
.	O

Epstein	B
-	I
Barr	I
virus	I
(	I
EBV	I
)	I
latent	I
membrane	I
protein	I
1	I
(	O
LMP1	B
)	O
is	O
essential	O
for	O
EBV	O
-	O
mediated	O
transformation	O
of	O
primary	O
B	O
lymphocytes	O
.	O

The	O
amino	O
-	O
terminal	O
half	O
of	O
1a	B
is	O
a	O
distant	O
homolog	B
of	I
alphavirus	I
nonstructural	I
protein	I
nsP1	I
,	O
which	O
has	O
been	O
implicated	O
in	O
capping	O
viral	O
RNAs	O
.	O

Moreover	O
,	O
a	O
recombinant	O
Ad	O
expressing	O
Ad5	B
E4orf6	I
/	I
7	I
induced	O
apoptosis	O
in	O
rat	O
cells	O
when	O
coinfected	O
with	O
wild	O
-	O
type	O
p53-expressing	B
Ad	O
.	O

In	O
HCMV	O
(	O
Towne	O
)	O
-infected	O
HF	O
cells	O
at	O
24	O
to	O
48	O
h	O
,	O
IE2	B
also	O
accumulated	O
in	O
newly	O
formed	O
viral	O
DNA	O
replication	O
compartments	O
containing	O
the	O
polymerase	B
processivity	I
factor	I
(	O
UL44	B
)	O
,	O
the	O
single	B
-	I
stranded	I
DNA	I
binding	I
protein	I
(	O
SSB	B
;	O
UL57	B
)	O
,	O
the	O
UL112	B
-	I
113	I
accessory	I
protein	I
,	O
and	O
newly	O
incorporated	O
bromodeoxyuridine	O
(	O
BrdU	O
)	O
.	O

Macroscopic	O
researches	O
on	O
heart	O
vascularization	O
have	O
indicated	O
that	O
the	O
angioarchitecture	O
of	O
the	O
conducting	O
system	O
differs	O
from	O
that	O
of	O
the	O
normal	O
myocardium	O
.	O

CONCLUSION	O
(	O
S	O
)	O
:	O
Measuring	O
urinary	O
LH	B
levels	O
is	O
an	O
excellent	O
method	O
for	O
determining	O
ovulation	O
.	O

However	O
,	O
reoperation	O
for	O
bulky	O
cervical	O
disease	O
(	O
group	O
3	O
)	O
rarely	O
results	O
in	O
normal	O
calcitonin	B
levels	O
and	O
is	O
associated	O
with	O
a	O
high	O
incidence	O
of	O
permanent	O
hypoparathyroidism	O
.	O

We	O
present	O
a	O
case	O
of	O
carcinoma	O
of	O
the	O
breast	O
presenting	O
concurrently	O
with	O
SSc	O
that	O
subsequently	O
progressed	O
to	O
dialysis	O
-	O
dependent	O
renal	O
failure	O
in	O
just	O
1	O
month	O
.	O

The	O
GPI	O
anchor	O
moiety	O
is	O
either	O
absent	O
or	O
present	O
at	O
a	O
very	O
low	O
level	O
in	O
the	O
polypeptide	O
expressed	O
from	O
the	O
cDNA	O
that	O
contained	O
both	O
the	O
signal	O
peptide	O
and	O
GPI	O
signal	O
sequences	O
.	O

We	O
have	O
cloned	O
a	O
novel	O
100-kDa	O
mammalian	O
protein	O
,	O
which	O
was	O
recognized	O
by	O
an	O
anti	O
-	O
peptide	O
antibody	O
against	O
an	O
epitope	O
-	O
containing	O
nuclear	O
localization	O
signal	O
of	O
NF	B
-	I
kappaB	I
p65	B
subunit	I
.	O

Insulin	B
-	O
regulated	O
events	O
,	O
however	O
,	O
occur	O
in	O
all	O
cells	O
.	O

Regulatory	O
regions	O
in	O
the	O
promoter	O
and	O
third	O
intron	O
of	O
the	O
growth	B
hormone	I
gene	I
in	I
rainbow	I
trout	I
,	O
Oncorhynchus	O
mykiss	O
walbaum	O
.	O

They	O
self	O
-	O
completed	O
the	O
SF-36	O
questionnaire	O
and	O
their	O
QoL	O
was	O
described	O
and	O
retrospectively	O
compared	O
to	O
that	O
of	O
historical	O
controls	O
.	O

In	O
addition	O
,	O
media	O
containing	O
F	B
beta	I
alpha	I
/	O
CG	B
beta	I
displayed	O
high	O
-	O
affinity	O
binding	O
to	O
both	O
CG	B
and	I
FSH	I
receptors	I
.	O

Here	O
,	O
we	O
describe	O
a	O
tyrosine	O
-	O
phosphorylated	O
nuclear	O
protein	O
,	O
YT521-B	B
,	O
and	O
show	O
that	O
it	O
interacts	O
with	O
the	O
nuclear	B
transcriptosomal	I
component	I
scaffold	I
attachment	I
factor	I
B	I
,	O
and	O
the	O
68-kDa	B
Src	I
substrate	O
associated	O
during	O
mitosis	O
,	O
Sam68	B
.	O

These	O
mutants	O
all	O
failed	O
to	O
interact	O
with	O
the	O
TraR	B
fusion	I
in	O
the	O
two	O
-	O
hybrid	O
system	O
.	O

With	O
constructs	O
containing	O
the	O
binding	O
site	O
of	O
one	O
gene	O
fused	O
to	O
the	O
promoter	O
of	O
the	O
other	O
,	O
we	O
demonstrated	O
that	O
the	O
positional	O
requirements	O
are	O
a	O
function	O
of	O
the	O
specific	O
binding	O
site	O
,	O
not	O
the	O
promoter	O
.	O

The	O
MXR	B
gene	I
encodes	O
a	O
half	O
-	O
transporter	O
and	O
the	O
absence	O
of	O
cytogenetic	O
evidence	O
of	O
coamplification	O
of	O
other	O
regions	O
suggests	O
that	O
a	O
partner	O
may	O
not	O
be	O
overexpressed	O
,	O
and	O
instead	O
the	O
MXR	B
half	I
-	I
transporter	I
homodimerizes	O
to	O
mediate	O
drug	O
transport	O
.	O

The	O
effect	O
of	O
smoking	O
was	O
not	O
examined	O
in	O
this	O
study	O
,	O
as	O
such	O
data	O
were	O
not	O
available	O
.	O

Additional	O
studies	O
revealed	O
that	O
bovine	B
brain	I
Galpha	I
(	I
q	I
/	I
11	I
)	I
could	O
also	O
bind	O
to	O
an	O
N	O
-	O
terminal	O
construct	O
of	O
GRK2	B
,	O
while	O
no	O
binding	O
of	O
Galpha	B
(	I
q	I
/	I
11	I
)	I
,	O
Galpha	B
(	I
s	I
)	I
,	O
Galpha	B
(	I
i	I
)	I
,	O
or	O
Galpha	B
(	I
12	I
/	I
13	I
)	I
to	O
comparable	O
constructs	O
of	O
GRK5	B
or	O
GRK6	B
was	O
observed	O
.	O

The	O
elm1	B
kinase	I
functions	O
in	O
a	O
mitotic	O
signaling	O
network	O
in	O
budding	O
yeast	O
.	O

We	O
determined	O
whether	O
a	O
single	O
injection	O
of	O
slow	O
-	O
release	O
estradiol-17beta	O
(	O
SRE2	O
)	O
would	O
induce	O
pseudopregnancy	O
in	O
gilts	O
and	O
whether	O
PGF2alpha	O
would	O
regress	O
the	O
corpora	O
lutea	O
(	O
CL	O
)	O
of	O
pseudopregnancy	O
.	O

Activation	O
of	O
T	O
cells	O
via	O
the	O
TCR	B
and	O
other	O
costimulatory	O
receptors	O
triggers	O
a	O
number	O
of	O
signaling	O
cascades	O
.	O

A	O
phylogenetic	O
analysis	O
with	O
the	O
TK	B
domains	I
from	O
these	O
sequences	O
and	O
a	O
fourth	O
,	O
from	O
a	O
novel	O
scavenger	B
RTK	I
(	O
all	O
domains	O
comprise	O
the	O
signature	O
for	O
the	O
TK	B
class	I
II	I
receptors	I
)	O
,	O
showed	O
that	O
they	O
are	O
distantly	O
related	O
to	O
the	O
insulin	B
and	O
insulin	B
-	I
like	I
receptors	I
.	O

Several	O
7SL	B
RNA	I
-	I
encoding	I
sequences	I
and	O
various	O
intergenic	O
spacers	O
were	O
amplified	O
from	O
the	O
individual	O
HindIII	B
fragments	I
of	O
about	O
1.3	O
and	O
2.8	O
kb	O
.	O

We	O
have	O
isolated	O
a	O
binding	O
partner	O
for	O
the	O
Fanconi	B
anemia	I
group	I
C	I
protein	I
(	O
FANCC	B
)	O
by	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

These	O
results	O
suggest	O
that	O
both	O
transcription	O
activators	O
depend	O
on	O
or	O
interact	O
with	O
different	O
subunits	O
of	O
RNA	B
polymerase	I
,	O
although	O
their	O
role	O
in	O
formation	O
of	O
proper	O
DNA	O
geometry	O
may	O
also	O
be	O
crucial	O
.	O

Klebsiella	O
oxytoca	O
can	O
assimilate	O
nitrate	O
and	O
nitrite	O
by	O
using	O
enzymes	O
encoded	O
by	O
the	O
nasFEDCBA	B
operon	I
.	O

By	O
negatively	O
regulating	O
GRK	B
-	O
mediated	O
receptor	O
phosphorylation	O
,	O
beta	B
-	I
arrestin	I
-	O
mediated	O
processes	O
such	O
as	O
Src	B
recruitment	O
and	O
clathrin	B
-	O
mediated	O
internalization	O
,	O
which	O
are	O
required	O
for	O
GPCR	B
-	O
mediated	O
ERK	B
activation	O
,	O
are	O
inhibited	O
,	O
thus	O
dampening	O
further	O
ERK	B
activation	O
.	O

Based	O
on	O
subcellular	O
fractionation	O
,	O
the	O
47-kDa	B
P	I
-	I
CIP2	I
protein	I
is	O
mostly	O
cytosolic	O
.	O

Supershift	O
EMSAs	O
identified	O
that	O
upstream	B
stimulatory	I
factor-1	I
and	I
-2	I
(	O
USF-1	B
and	I
-2	I
)	O
were	O
part	O
of	O
these	O
complexes	O
.	O

These	O
include	O
the	O
CACCC	O
and	O
CAAT	O
motifs	O
.	O

Skin	O
pH	O
changes	O
associated	O
with	O
iontophoresis	O
.	O

Phosphorylation	O
of	O
myosin	B
-	I
binding	I
subunit	I
(	O
MBS	B
)	O
of	O
myosin	B
phosphatase	I
by	O
Rho	B
-	I
kinase	I
in	O
vivo	O
.	O

Immunohistochemical	O
staining	O
was	O
positive	O
for	O
S-100	B
in	O
all	O
9	O
cases	O
stained	O
,	O
positive	O
for	O
HMB-45	B
in	O
9	O
(	O
90	O
%	O
)	O
of	O
10	O
,	O
and	O
negative	O
for	O
cytokeratin	B
in	O
all	O
9	O
cases	O
in	O
which	O
myxoid	O
melanoma	O
remained	O
in	O
the	O
block	O
after	O
previous	O
sections	O
.	O

Residual	O
urinary	O
abnormalities	O
were	O
significantly	O
more	O
frequent	O
in	O
patients	O
with	O
type	O
III	O
than	O
type	O
I	O
MPGN	O
.	O

We	O
describe	O
here	O
a	O
Drosophila	B
melanogaster	I
FAK	I
homologue	I
,	O
DFak56	B
,	O
which	O
maps	O
to	O
band	O
56D	O
on	O
the	O
right	O
arm	O
of	O
the	O
second	O
chromosome	O
.	O

Because	O
the	O
Pit-1	B
sites	I
in	O
the	O
hGH	B
-	I
N	I
gene	I
promoter	I
are	O
insufficient	O
for	O
such	O
gene	O
activation	O
in	O
vivo	O
,	O
these	O
data	O
suggested	O
a	O
unique	O
chromatin	O
-	O
mediated	O
developmental	O
role	O
for	O
Pit-1	B
in	O
the	O
hGH	B
LCR	I
.	O

Recombinant	B
prenylcysteine	I
lyase	I
was	O
produced	O
in	O
a	O
baculovirus	O
-	O
Sf9	O
expression	O
system	O
.	O

In	O
gel	O
mobility	O
shift	O
assays	O
,	O
low	O
binding	O
activity	O
of	O
CBF	B
to	O
the	O
wild	B
-	I
type	I
AtpC	I
promoter	I
sequence	I
was	O
observed	O
with	O
nuclear	O
extracts	O
from	O
tissue	O
with	O
low	O
AtpC	B
expression	O
levels	O
,	O
i.e.	O
extracts	O
from	O
etiolated	O
and	O
photobleached	O
seedlings	O
,	O
whereas	O
high	O
binding	O
activity	O
was	O
detectable	O
with	O
extracts	O
from	O
tissues	O
with	O
high	O
AtpC	B
expression	O
levels	O
,	O
i.e.	O
extracts	O
from	O
light	O
-	O
grown	O
seedlings	O
and	O
etiolated	O
seedlings	O
treated	O
with	O
cytokinin	B
.	O

For	O
this	O
purpose	O
,	O
we	O
used	O
a	O
series	O
of	O
plasmid	O
constructs	O
encoding	O
different	O
forms	O
of	O
the	O
envelope	B
glycoprotein	I
E	I
of	I
the	I
flavivirus	I
tick	I
-	I
borne	I
encephalitis	I
virus	I
.	O

We	O
report	O
here	O
that	O
out	O
of	O
the	O
major	O
pro	O
-	O
inflammatory	O
cytokines	O
examined	O
,	O
IL-1alpha	B
,	O
IL-1beta	B
,	O
TNF	B
-	I
alpha	I
and	O
IL-6	B
,	O
only	O
IL-6	B
was	O
generated	O
and	O
secreted	O
in	O
PKCeta	B
-expressing	O
cells	O
without	O
any	O
additional	O
inducer	O
in	O
serum	O
-	O
supplemented	O
cultures	O
(	O
10	O
%	O
FCS	O
)	O
.	O

By	O
an	O
induced	O
-	O
fit	O
mechanism	O
,	O
contacts	O
with	O
the	O
anticodon	O
can	O
activate	O
formation	O
of	O
a	O
robust	O
transition	O
state	O
at	O
a	O
site	O
over	O
70	O
A	O
away	O
.	O

These	O
REPs	O
,	O
or	O
clusters	O
of	O
paralogous	O
loci	O
,	O
are	O
15	O
-	O
100	O
kb	O
and	O
harbor	O
at	O
least	O
four	O
ESTs	O
and	O
an	O
expressed	O
SH3GL	B
pseudogene	I
.	O

This	O
revealed	O
a	O
minimum	O
of	O
six	O
novel	O
OSBP	B
-	I
related	I
proteins	I
,	O
designated	O
ORP-1	B
to	O
ORP-6	B
.	O

However	O
,	O
mechanisms	O
underlying	O
HIV-1	O
gene	O
expression	O
in	O
the	O
CNS	O
are	O
poorly	O
understood	O
.	O

A	O
key	O
event	O
in	O
this	O
process	O
is	O
the	O
selective	O
recognition	O
of	O
the	O
target	O
membrane	O
by	O
the	O
vesicle	O
and	O
the	O
current	O
view	O
is	O
that	O
SNARE	B
protein	I
interactions	O
likely	O
play	O
a	O
central	O
role	O
in	O
vesicle	O
-	O
target	O
recognition	O
and	O
or	O
membrane	O
fusion	O
.	O

Scapulae	O
with	O
a	O
Type	O
I	O
configuration	O
were	O
found	O
to	O
have	O
low	O
values	O
for	O
the	O
coraco	O
-	O
glenoid	O
angle	O
and	O
coracoid	O
overlap	O
,	O
which	O
are	O
known	O
to	O
be	O
associated	O
with	O
a	O
short	O
coraco	O
-	O
humeral	O
distance	O
.	O

In	O
conclusion	O
:	O
(	O
i	O
)	O
TECRA	O
kit	O
is	O
suggested	O
to	O
be	O
used	O
for	O
screening	O
SE	O
producing	O
strains	O
;	O
(	O
ii	O
)	O
SET	O
-	O
RPLA	O
and	O
RIDASCREEN	O
kits	O
are	O
suitable	O
for	O
epidemiological	O
investigation	O
of	O
SE	O
types	O
,	O
but	O
the	O
lack	O
of	O
ability	O
for	O
detecting	O
SEE	O
,	O
long	O
time	O
required	O
for	O
testing	O
with	O
SET	O
-	O
RPLA	O
kit	O
and	O
high	O
background	O
when	O
using	O
RIDASCREEN	O
kit	O
must	O
be	O
overcome	O
;	O
and	O
(	O
iii	O
)	O
because	O
of	O
the	O
complicated	O
test	O
procedures	O
and	O
the	O
lack	O
of	O
ability	O
for	O
detecting	O
SEE	O
,	O
the	O
practicality	O
of	O
SET	O
-	O
EIA	O
kit	O
in	O
screening	O
and	O
epidemiological	O
research	O
purposes	O
is	O
low	O
.	O

Comparison	O
of	O
immunoassay	O
kits	O
for	O
detection	O
of	O
staphylococcal	B
enterotoxins	I
produced	O
by	O
Staphylococcus	O
aureus	O

Despite	O
the	O
high	O
frequency	O
of	O
natural	O
infection	O
,	O
the	O
seropositive	O
rates	O
of	O
JEV	O
antibody	O
still	O
correlated	O
well	O
with	O
the	O
dose	O
of	O
vaccine	O
received	O
,	O
i.e.	O
,	O
67	O
%	O
(	O
1122	O
/	O
1664	O
)	O
,	O
66	O
%	O
(	O
65	O
/	O
97	O
)	O
,	O
33	O
%	O
(	O
4	O
/	O
12	O
)	O
and	O
40	O
%	O
(	O
19	O
/	O
47	O
)	O
for	O
children	O
receiving	O
3	O
,	O
2	O
,	O
1	O
,	O
and	O
0	O
dose	O
of	O
JE	O
vaccines	O
,	O
respectively	O
(	O
P	O
<	O
0.0001	O
Chi	O
-	O
square	O
for	O
trend	O
test	O
)	O
.	O

Furthermore	O
,	O
in	O
vivo	O
and	O
in	O
vitro	O
protein	O
-	O
protein	O
interaction	O
experiments	O
have	O
shown	O
that	O
SR33	B
protein	I
interacts	O
with	O
itself	O
and	O
with	O
SR45	B
protein	I
but	O
not	O
with	O
two	O
other	O
members	O
(	O
SRZ21	B
and	O
SRZ22	B
)	O
of	O
the	O
SR	B
family	I
that	O
are	O
known	O
to	O
interact	O
with	O
the	O
Arabidopsis	O
full	O
-	O
length	O
U-70	B
K	I
only	O
.	O

Tih1	B
maps	O
to	O
distal	O
mouse	O
Chr	O
1	O
and	O
human	O
Chr	O
1q31	O
,	O
chromosomal	O
regions	O
that	O
have	O
not	O
shown	O
evidence	O
for	O
imprinting	O
and	O
,	O
in	O
contrast	O
to	O
Ipl	B
,	O
Tih1	B
is	O
expressed	O
equally	O
from	O
both	O
parental	O
alleles	O
.	O

A	O
novel	O
pleckstrin	B
homology	I
-	I
related	I
gene	I
family	I
defined	O
by	O
Ipl	B
/	O
Tssc3	B
,	O
TDAG51	B
,	O
and	O
Tih1	B
:	O
tissue	O
-	O
specific	O
expression	O
,	O
chromosomal	O
location	O
,	O
and	O
parental	O
imprinting	O
.	O

The	O
potential	O
for	O
highly	O
reactive	O
nanoparticles	O
(	O
RNP	O
)	O
to	O
absorb	O
destructively	O
,	O
i.e.	O
to	O
neutralize	O
highly	O
toxic	O
substances	O
such	O
as	O
the	O
warfare	O
agents	O
GA	O
,	O
GB	O
,	O
HD	O
and	O
VX	O
,	O
has	O
been	O
demonstrated	O
in	O
the	O
laboratory	O
.	O

There	O
were	O
minimal	O
negative	O
effects	O
on	O
hematological	O
parameters	O
,	O
acid	O
-	O
base	O
status	O
,	O
and	O
blood	O
gases	O
.	O

Twelve	O
out	O
of	O
43	O
renal	O
failure	O
patients	O
had	O
troponin	B
I	I
0.13	O
-	O
0.9	O
microg	O
/	O
l	O
using	O
Axsym	O
method	O
and	O
4	O
had	O
levels	O
of	O
0.07	O
-	O
0.13	O
microg	O
/	O
l	O
using	O
Immuno	O
1	O
.	O

Transient	O
,	O
high	O
-	O
level	O
Ras	B
-	O
expression	O
induces	O
transcriptional	O
activation	O
of	O
p21	B
mediated	O
by	O
a	O
GC	O
-	O
rich	O
region	O
in	O
p21	B
promoter	I
-83	O
-	O
54	O
bp	O
relative	O
to	O
the	O
transcription	O
initiation	O
site	O
containing	O
binding	O
sites	O
for	O
Sp1-family	B
transcription	I
factors	I
.	O

The	O
RET	B
/	O
PTC3	B
rearrangement	O
is	O
formed	O
by	O
fusion	O
of	O
the	O
ELE1	B
and	O
RET	B
genes	I
,	O
and	O
is	O
highly	O
prevalent	O
in	O
radiation	O
-	O
induced	O
post	O
-	O
Chernobyl	O
papillary	O
thyroid	O
carcinomas	O
.	O

Apoptosis	O
of	O
small	O
cells	O
is	O
still	O
observed	O
after	O
co	O
-	O
transfection	O
of	O
JBD	B
and	O
LMP1	B
but	O
in	O
addition	O
a	O
few	O
apoptotic	O
HD	O
-	O
MyZ	O
cells	O
with	O
large	O
fused	O
nuclear	O
masses	O
are	O
identified	O
suggesting	O
that	O
specific	O
inhibition	O
of	O
JNK	B
leads	O
also	O
to	O
apoptosis	O
of	O
LMP1	B
induced	O
RS	O
cells	O
.	O

The	O
mEmBP-1	B
protein	I
can	O
activate	O
transcription	O
from	O
a	O
truncated	O
promoter	O
containing	O
a	O
pentamer	O
of	O
the	O
O2	B
site	I
in	O
yeast	O
cells	O
;	O
however	O
,	O
it	O
inhibited	O
regulated	O
transcription	O
of	O
a	O
22	B
kDa	I
zein	I
promoter	I
in	O
a	O
transient	O
expression	O
assay	O
using	O
cultured	O
maize	O
endosperm	O
cells	O
.	O

There	O
were	O
15	O
deaths	O
,	O
seven	O
of	O
which	O
were	O
felt	O
to	O
be	O
avoidable	O
.	O

With	O
this	O
GH	B
and	O
estrogen	O
treatment	O
regimen	O
,	O
most	O
girls	O
with	O
TS	O
can	O
grow	O
and	O
develop	O
much	O
more	O
in	O
conformity	O
with	O
their	O
healthy	O
peers	O
.	O

Higher	O
CYP3A23	B
basal	O
activity	O
appears	O
to	O
be	O
due	O
to	O
an	O
E	O
-	O
box	O
in	O
3A23SiteA	B
that	O
interacts	O
with	O
USF1	B
,	O
a	O
ubiquitous	O
bHLH	B
/	I
leucine	I
zipper	I
transcription	I
factor	I
.	O

To	O
understand	O
the	O
basis	O
for	O
the	O
increased	O
cell	O
surface	O
stability	O
compared	O
with	O
wild	O
-	O
type	O
peptide	O
and	O
to	O
understand	O
the	O
differences	O
in	O
T	O
cell	O
recognition	O
between	O
I1Y	B
and	O
I1F	B
,	O
we	O
determined	O
the	O
x	O
-	O
ray	O
crystal	O
structures	O
of	O
the	O
two	O
class	B
I	I
MHC	I
-	I
peptide	I
complexes	I
.	O

Redistribution	O
of	O
mannosidase	B
I	I
was	O
also	O
observed	O
in	O
cells	O
incubated	O
at	O
15	O
degrees	O
C.	O

In	O
conclusion	O
,	O
our	O
data	O
do	O
not	O
support	O
a	O
role	O
for	O
IVIg	B
in	O
the	O
remyelination	O
of	O
stable	O
multiple	O
sclerosis	O
lesions	O
as	O
measured	O
by	O
central	O
conduction	O
time	O
.	O

Relative	O
to	O
coherent	O
control	O
words	O
(	O
e.g.	O
,	O
quick	O
)	O
,	O
these	O
discourse	O
-	O
dependent	O
semantic	O
anomalies	O
elicited	O
a	O
large	O
N400	O
effect	O
that	O
began	O
at	O
about	O
200	O
to	O
250	O
msec	O
after	O
word	O
onset	O
.	O

Like	O
the	O
Tob	B
protein	I
,	O
Tob2	B
inhibited	O
cell	O
cycle	O
progression	O
from	O
the	O
G0	O
/	O
G1	O
to	O
S	O
phases	O
.	O

The	O
coordinate	O
increase	O
in	O
cyclin	B
D1	I
and	O
p21	B
had	O
the	O
effect	O
of	O
decreasing	O
the	O
specific	O
but	O
not	O
absolute	O
activity	O
of	O
cyclin	B
D1	I
/	O
cdk4	B
.	O

p53	B
was	O
not	O
involved	O
since	O
CSF-1	B
induction	O
of	O
p21	B
was	O
unaffected	O
by	O
dominant	B
-	I
negative	I
p53	I
expression	O
.	O

In	O
addition	O
,	O
SLK	B
displays	O
high	O
homology	O
to	O
microtubule	B
and	I
nuclear	I
associated	I
protein	I
(	O
M	B
-	I
NAP	I
)	O
and	O
AT1	B
-	I
46	I
,	O
both	O
of	O
unknown	O
function	O
.	O

In	O
this	O
study	O
26	O
patients	O
(	O
20	O
females	O
and	O
6	O
males	O
)	O
were	O
evaluated	O
.	O

Albumin	B
dialysis	O
:	O
effective	O
removal	O
of	O
copper	O
in	O
a	O
patient	O
with	O
fulminant	O
Wilson	O
disease	O
and	O
successful	O
bridging	O
to	O
liver	O
transplantation	O
:	O
a	O
new	O
possibility	O
for	O
the	O
elimination	O
of	O
protein	O
-	O
bound	O
toxins	O
.	O

Both	O
domains	O
were	O
required	O
for	O
specific	O
DNA	O
binding	O
to	O
the	O
beta	B
-	I
retinoic	I
acid	I
receptor	I
element	I
,	O
producing	O
a	O
DNase	B
I	I
footprint	O
covering	O
predominantly	O
one	O
strand	O
.	O

Snail	B
family	I
proteins	I
are	O
zinc	O
finger	O
transcriptional	O
regulators	O
first	O
identified	O
in	O
Drosophila	O
which	O
play	O
critical	O
roles	O
in	O
cell	O
fate	O
determination	O
.	O

Thrombolysis	O
was	O
followed	O
by	O
a	O
similar	O
increase	O
of	O
platelet	O
activity	O
with	O
maximal	O
values	O
reached	O
at	O
the	O
3rd	O
hour	O
in	O
both	O
groups	O
(	O
196	O
+	O
/-	O

43	O
IU	O
/	O
ml	O
in	O
Group	O
1	O
and	O
192	O
+	O
/-	O

39	O
in	O
Group	O
2	O
:	O
p	O
<	O
001versus	O
baseline	O
and	O
p	O
NS	O
between	O
the	O
groups	O
)	O
.	O

Similar	O
to	O
Hp140	B
,	O
isolated	O
Hp55	B
binds	O
DNA	O
with	O
moderate	O
strength	O
and	O
was	O
a	O
specificity	O
for	O
double	O
-	O
stranded	O
primer	O
-	O
template	O
DNA	O
.	O

12:2684	O
-	O
2697	O
,	O
1998	O
)	O

:	O
a	O
key	O
step	O
of	O
this	O
model	O
is	O
the	O
activation	O
of	O
the	O
MAPK	B
Fus3p	I
through	O
the	O
G	B
(	I
betagamma	I
)	I
-dependent	O
relocalization	O
of	O
the	O
Ste5p	B
-	O
MAPK	B
cascade	O
to	O
the	O
plasma	O
membrane	O
.	O

Consistent	O
with	O
this	O
finding	O
,	O
wild	B
-	I
type	I
SAGA	I
inhibits	O
TBP	B
binding	O
to	O
the	O
HIS3	B
promoter	I
in	O
vitro	O
,	O
while	O
SAGA	B
lacking	O
Spt3	B
or	O
Spt8	B
is	O
not	O
inhibitory	O
.	O

Particularly	O
striking	O
was	O
the	O
conservation	O
of	O
an	O
AP-4	B
binding	I
site	I
within	O
100	O
nucleotides	O
upstream	O
of	O
the	O
transcription	O
initiation	O
site	O
in	O
both	O
Aal	B
-	O
rpL34	B
and	O
Aal	B
-	O
rpL8	B
genes	O
.	O

However	O
,	O
no	O
genetic	O
alteration	O
was	O
detected	O
in	O
any	O
of	O
the	O
cancers	O
examined	O
.	O

All	O
problems	O
were	O
associated	O
with	O
fractured	O
or	O
lost	O
screws	O
.	O

Statins	B
:	O
lower	O
lipids	O
and	O
better	O
bones	O
?	O

Although	O
statins	O
are	O
widely	O
used	O
as	O
cholesterol	O
-	O
lowering	O
drugs	O
,	O
a	O
recent	O
study	O
suggests	O
that	O
these	O
compounds	O
have	O
anabolic	O
effects	O
on	O
bone	O
and	O
could	O
be	O
developed	O
into	O
new	O
treatments	O
for	O
common	O
metabolic	O
bone	O
diseases	O
such	O
as	O
osteoporosis	O

The	O
accumulated	O
products	O
of	O
ancient	O
duplication	O
events	O
can	O
be	O
readily	O
observed	O
among	O
the	O
genes	O
encoding	O
voltage	O
-	O
dependent	O
Ca	O
(	O
2	O
+	O
)	O
ion	O
channels	O
.	O

The	O
VirR	B
response	I
regulator	I
from	O
Clostridium	O
perfringens	O
binds	O
independently	O
to	O
two	O
imperfect	O
direct	O
repeats	O
located	O
upstream	O
of	O
the	O
pfoA	B
promoter	I
.	O

Cloning	O
and	O
sequencing	O
of	O
the	O
upstream	O
region	O
of	O
pepX	B
revealed	O
the	O
presence	O
of	O
two	O
ORFs	O
of	O
360	O
and	O
1,338	O
bp	O
that	O
were	O
shown	O
to	O
be	O
able	O
to	O
encode	O
proteins	O
with	O
high	O
homology	O
to	O
GlnR	B
and	O
GlnA	B
proteins	I
,	O
respectively	O
.	O

Objective	O
:	O
To	O
evaluate	O
endometrial	O
thickness	O
and	O
the	O
incidence	O
of	O
uterine	O
bleeding	O
in	O
postmenopausal	O
women	O
using	O
either	O
tibolone	O
2.5	O
mg	O
or	O
continuous	O
combined	O
2	O
mg	O
estradiol	O
and	O
1	O
mg	O
norethisterone	O
acetate	O
(	O
E+NETA	O
)	O
daily	O
as	O
hormone	O
replacement	O
therapy	O
.	O

Histological	O
analysis	O
showed	O
that	O
the	O
neuronal	O
loss	O
in	O
the	O
DHED	O
-	O
treated	O
group	O
was	O
notably	O
reduced	O
in	O
the	O
hippocampal	O
area	O
(	O
CA1	O
)	O
of	O
ischemic	O
rats	O
and	O
in	O
the	O
dentate	O
gyrus	O
and	O
hippocampal	O
area	O
(	O
CA1	O
and	O
CA3	O
)	O
of	O
EC	O
-	O
lesioned	O
rats	O
compared	O
with	O
the	O
nontreated	O
group	O
.	O

The	O
extents	O
of	O
phosphorylation	O
of	O
Ser44	O
and	O
Ser64	O
were	O
1:1	O
,	O
whereas	O
those	O
of	O
the	O
four	O
minor	O
sites	O
all	O
together	O
were	O
<	O
30	O
%	O
of	O
the	O
major	O
one	O
.	O

Serum	O
HBV	O
-	O
DNA	O
,	O
viral	O
serology	O
,	O
and	O
liver	O
enzymes	O
were	O
measured	O
sequentially	O
;	O
liver	O
histology	O
was	O
taken	O
before	O
and	O
during	O
treatment	O
in	O
12	O
patients	O
.	O

Chem	O
.	O

Animal	O
studies	O
showed	O
that	O
beam	O
equalization	O
significantly	O
improved	O
fluoroscopic	O
and	O
angiographic	O
image	O
quality	O
.	O

AB004534	B
.	O

The	O
prevalence	O
of	O
hepatitis	O
C	O
virus	O
(	O
HCV	O
)	O
infection	O
is	O
relatively	O
low	O
in	O
childhood	O
,	O
with	O
anti	B
-	I
HCV	I
prevalence	O
rates	O
of	O
0.1	O
-	O
0.4	O
%	O
in	O
the	O
Western	O
world	O
.	O

During	O
latency	O
,	O
more	O
than	O
1	O
%	O
of	O
neurons	O
in	O
ganglia	O
that	O
innervate	O
the	O
footpad	O
expressed	O
beta	B
-	I
galactosidase	I
,	O
with	O
the	O
number	O
of	O
positive	O
cells	O
remaining	O
constant	O
for	O
at	O
least	O
5	O
months	O
.	O

Compared	O
to	O
those	O
with	O
normal	O
renal	O
functions	O
,	O
these	O
patients	O
were	O
older	O
(	O
P	O
<	O
or	O
=	O
0.01	O
)	O
,	O
had	O
significantly	O
elevated	O
blood	O
pressures	O
(	O
P	O
<	O
0.01	O
or	O
P	O
=	O
0.0001	O
)	O
,	O
and	O
in	O
the	O
case	O
of	O
Type	O
1	O
DM	O
,	O
with	O
a	O
higher	O
body	O
mass	O
index	O
(	O
P	O
=	O
0.0001	O
)	O
and	O
waist	O
-	O
hip	O
ratio	O
(	O
P	O
<	O
0.01	O
)	O
.	O

These	O
results	O
show	O
that	O
the	O
CAAT	O
-	O
region	O
is	O
involved	O
in	O
upregulating	O
the	O
MDR1	B
promoter	I
in	O
HL60	O
/	O
VCR	O
cells	O
.	O

Both	O
receptors	O
utilize	O
protein	B
tyrosine	I
kinases	I
(	O
PTKs	B
)	O
for	O
the	O
phosphorylation	O
of	O
various	O
signaling	O
molecules	O
,	O
a	O
process	O
that	O
is	O
critical	O
for	O
the	O
function	O
of	O
both	O
receptors	O
.	O

Hypothermia	O
After	O
Cardiac	O
Arrest	O
(	O
HACA	O
)	O
Study	O
Group	O
.	O

We	O
demonstrate	O
that	O
both	O
R	B
and	O
Z	B
activate	O
the	O
cellular	O
stress	O
mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinases	I
,	O
p38	B
and	O
JNK	B
,	O
resulting	O
in	O
phosphorylation	O
(	O
and	O
activation	O
)	O
of	O
the	O
cellular	B
transcription	I
factor	I
ATF2	I
.	O

Two	O
US	O
commercial	O
cultivars	O
(	O
Tehama	O
and	O
Vina	O
)	O
,	O
three	O
European	O
commercial	O
cultivars	O
(	O
Esterhazy	O
,	O
139	O
,	O
G120	O
)	O
and	O
five	O
New	O
Zealand	O
selections	O
(	O
Rex	O
,	O
Dublin	O
's	O
Glory	O
,	O
Meyric	O
,	O
McKinster	O
,	O
Stanley	O
)	O
were	O
evaluated	O
.	O

Anatomy	O
of	O
the	O
uterine	O
artery	O
.	O

However	O
,	O
activation	O
of	O
the	O
cAMP	O
pathway	O
,	O
which	O
is	O
known	O
to	O
regulate	O
inhibin	B
alpha	I
expression	O
,	O
greatly	O
enhanced	O
the	O
actions	O
of	O
SF-1	B
.	O

Previously	O
,	O
we	O
showed	O
that	O
the	O
APRE	O
is	O
a	O
cytokine	O
[	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNFalpha	B
)	O
]	O
-	O
inducible	O
enhancer	O
by	O
binding	O
the	O
heterodimeric	B
nuclear	I
factor	I
-	I
kappaB	I
(	O
NF	B
-	I
kappaB	I
)	O
complex	O
Rel	B
A	I
x	O
NF	B
-	I
kappaB1	I
.	O

Angiotensin	B
II	I
induces	O
nuclear	B
factor	I
(	I
NF	I
)	I
-kappaB1	I
isoforms	I
to	O
bind	O
the	O
angiotensinogen	B
gene	I
acute	O
-	O
phase	O
response	O
element	O
:	O
a	O
stimulus	O
-	O
specific	O
pathway	O
for	O
NF	B
-	I
kappaB	I
activation	O
.	O

In	O
addition	O
,	O
CaMig1	B
formed	O
specific	O
complexes	O
with	O
the	O
URS1	O
region	O
of	O
the	O
S.	B
cerevisiae	I
FBP1	I
gene	I
.	O

We	O
describe	O
a	O
case	O
of	O
acetaminophen	O
overdose	O
that	O
was	O
treated	O
with	O
both	O
hemodialysis	O
(	O
HD	O
)	O
and	O
NAC	O
due	O
to	O
severe	O
intoxication	O
and	O
slow	O
drug	O
clearance	O
.	O

Following	O
conditioning	O
,	O
a	O
single	O
coat	O
of	O
adhesive	O
was	O
applied	O
and	O
light	O
-	O
cured	O
.	O

Eastern	O
Cooperative	O
Oncology	O
Group	O
trial	O
E3186	O
was	O
initiated	O
to	O
explore	O
this	O
question	O
.	O

We	O
determined	O
how	O
DNA	O
repair	O
is	O
affected	O
by	O
TFA1	B
conditional	O
mutations	O
.	O

These	O
articles	O
both	O
report	O
the	O
results	O
of	O
multi	O
-	O
institutional	O
,	O
randomized	O
,	O
phase	O
3	O
trials	O
for	O
the	O
treatment	O
of	O
patients	O
with	O
localized	O
(	O
T1	O
-	O
3	O
N0	O
-	O
1	O
M0	O
)	O
esophageal	O
squamous	O
cell	O
carcinoma	O
(	O
SCC	O
)	O
or	O
esophageal	O
adenocarcinoma	O
.	O

Studies	O
of	O
MPO	B
gene	I
regulation	O
can	O
help	O
to	O
elucidate	O
the	O
mechanism	O
of	O
normal	O
and	O
abnormal	O
myeloid	O
differentiation	O
.	O

NDRF	B
/	O
NeuroD2	B
was	O
co	O
-	O
precipitated	O
with	O
PKN	B
from	O
the	O
lysate	O
of	O
COS-7	O
cells	O
transfected	O
with	O
both	O
expression	O
constructs	O
for	O
NDRF	B
/	O
NeuroD2	B
and	O
PKN	B
.	O

Transient	O
transfection	O
assays	O
using	O
P19	O
cells	O
revealed	O
that	O
expression	O
of	O
NDRF	B
/	O
NeuroD2	B
increased	O
the	O
transactivation	O
of	O
the	O
rat	B
insulin	I
promoter	I
element	I
3	I
(	O
RIPE3	B
)	O
enhancer	O
up	O
to	O
approximately	O
12-fold	O
and	O
that	O
co	O
-	O
expression	O
of	O
catalytically	O
active	O
form	O
of	O
PKN	B
,	O
but	O
not	O
kinase	O
-	O
deficient	O
derivative	O
,	O
resulted	O
in	O
a	O
further	O
threefold	O
increase	O
of	O
NDRF	B
/	O
NeuroD2-mediated	B
transcription	O
.	O

Upon	O
tyrosine	O
phosphorylation	O
at	O
the	O
ITIMs	O
,	O
these	O
molecules	O
recruit	O
SH2	B
domain	O
-	O
containing	O
phosphatases	O
such	O
as	O
SH2-containing	B
tyrosine	B
phosphatase-1	I
and	O
negatively	O
regulate	O
cell	O
activity	O
.	O

AF154055	B
.	O

Competition	O
experiments	O
demonstrate	O
a	O
negative	O
allosteric	O
relationship	O
between	O
these	O
RGD	O
recognition	O
sites	O
.	O

Sequence	O
analysis	O
showed	O
that	O
the	O
5'-flanking	O
region	O
upstream	O
to	O
the	O
ATG	O
codon	O
did	O
not	O
contain	O
a	O
conventional	O
TATA	O
box	O
.	O

After	O
i.v	O
.	O

administration	O
of	O
500	O
mg	O
acetazolamide	O
and	O
disinfection	O
of	O
the	O
conjunctiva	O
,	O
50	O
micrograms	O
rt	B
-	I
PA	I
in	O
0.1	O
ml	O
(	O
BSS	O
)	O
and	O
0.5	O
ml	O
SF6	O
were	O
injected	O
intravitreally	O
.	O

Differential	O
expression	O
and	O
regulation	O
by	O
20-hydroxyecdysone	O
of	O
mosquito	O
ultraspiracle	O
isoforms	O
.	O

The	O
differentiation	O
and	O
maintenance	O
of	O
a	O
neurotransmitter	O
phenotype	O
is	O
guided	O
by	O
the	O
interaction	O
of	O
exogenous	O
cues	O
with	O
intrinsic	O
genetic	O
machinery	O
.	O

Analysis	O
of	O
functional	O
domains	O
of	O
Arix	B
reveals	O
an	O
N	O
-	O
terminal	O
activation	O
domain	O
and	O
a	O
C	O
-	O
terminal	O
repression	O
domain	O
.	O

BACKGROUND	O
:	O
Left	O
ventricular	O
hypertrophy	O
is	O
a	O
heterogeneous	O
disorder	O
with	O
distinct	O
morphologies	O
.	O

Overexpression	O
of	O
ICBP90	B
in	O
COS-1-transfected	O
cells	O
induced	O
an	O
enhanced	O
expression	O
of	O
endogenous	B
topoisomerase	I
IIalpha	I
.	O

To	O
quantify	O
any	O
mechanical	O
inhibitory	O
effect	O
of	O
nasal	O
intermittent	O
positive	O
pressure	O
ventilation	O
(	O
IPPV	O
)	O
on	O
inspiratory	O
activity	O
of	O
the	O
diaphragm	O
we	O
ventilated	O
five	O
conscious	O
relaxed	O
subjects	O
on	O
two	O
occasions	O
at	O
respiratory	O
rates	O
similar	O
to	O
quiet	O
breathing	O
(	O
QB	O
)	O
and	O
at	O
three	O
levels	O
of	O
applied	O
pressure	O
(	O
Pappl	O
)	O
--6	O
,	O
9	O
and	O
12	O
cmH2O	O
,	O
each	O
during	O
hypocapnia	O
(	O
P	O
(	O
CO2	O
)	O
allowed	O
to	O
decrease	O
)	O
and	O
eucapnia	O
(	O
CO2	O
added	O
to	O
inspired	O
gas	O
)	O
.	O

We	O
have	O
investigated	O
the	O
contribution	O
of	O
specific	O
TATA	B
-	I
binding	I
protein	I
(	O
TBP	B
)	O
-TATA	O
interactions	O
to	O
the	O
promoter	O
activity	O
of	O
a	O
constitutively	O
expressed	O
silkworm	B
tRNA	I
(	I
C	I
)	I
(	I
Ala	I
)	I
gene	I
and	O
have	O
also	O
asked	O
whether	O
the	O
lack	O
of	O
similar	O
interactions	O
accounts	O
for	O
the	O
low	O
promoter	O
activity	O
of	O
a	O
silk	B
gland	I
-	I
specific	I
tRNA	I
(	I
SG	I
)	I
(	I
Ala	I
)	I
gene	I
.	O

The	O
sequences	O
showed	O
extensive	O
homologies	O
with	O
squalene	B
synthase	I
genes	I
and	O
enzymes	O
from	O
a	O
number	O
of	O
other	O
organisms	O
and	O
extreme	O
amino	O
acid	O
conservation	O
within	O
the	O
binding	O
and	O
catalytic	O
domains	O
.	O

All	O
clones	O
and	O
strains	O
produced	O
have	O
been	O
deposited	O
in	O
the	O
EUROFAN	O
genetic	O
stock	O
centre	O
(	O
EUROSCARF	O
,	O
Frankfurt	O
)	O
.	O

Two	O
episodes	O
of	O
peritonitis	O
occurred	O
while	O
the	O
patient	O
received	O
CAPD	O
(	O
1	O
episode	O
/	O
3.5	O
patient	O
-	O
months	O
)	O
.	O

Two	O
estrogen	B
receptor	I
(	O
ER	B
)	O
isoforms	O
with	O
different	O
estrogen	O
dependencies	O
are	O
generated	O
from	O
the	O
trout	B
ER	I
gene	I
.	O

In	O
myometrial	O
SMC	O
,	O
both	O
isoforms	O
of	O
the	O
progesterone	B
receptor	I
,	O
PR	B
-	I
B	I
and	O
PR	B
-	I
A	I
,	O
caused	O
a	O
ligand	O
-	O
dependent	O
activation	O
of	O
PGDH-2368	B
/	O
luc3	B
.	O

Element	O
B	O
(	O
-249	O
/	O
-229	O
)	O
shows	O
more	O
than	O
80	O
%	O
homology	O
to	O
a	O
consensus	B
c	I
-	I
myb	I
element	I
,	O
but	O
formed	O
two	O
specific	O
complexes	O
that	O
differed	O
from	O
that	O
of	O
c	B
-	I
myb	I
in	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

High	O
resolution	O
computed	O
tomography	O
of	O
the	O
lungs	O
in	O
patients	O
with	O
rheumatoid	O
arthritis	O
.	O

Moreover	O
,	O
increasing	O
the	O
dosage	O
of	O
wild	B
-	I
type	I
Fus3	I
intensifies	O
the	O
inhibition	O
of	O
both	O
Ty1	B
transposition	O
and	O
invasive	O
growth	O
.	O

Consistently	O
,	O
activation	O
of	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
downstream	O
of	O
Rho	B
family	I
GTP	I
-	I
binding	I
proteins	I
was	O
also	O
enhanced	O
when	O
Dbl	B
was	O
tyrosine	O
-	O
phosphorylated	O
.	O

However	O
,	O
its	O
participation	O
in	O
collagen	B
binding	O
has	O
not	O
been	O
shown	O
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
the	O
carboxyl	O
terminus	O
of	O
CFTR	B
contains	O
a	O
tyrosine	O
-	O
based	O
internalization	O
signal	O
that	O
interacts	O
with	O
the	O
endocytic	O
adaptor	O
complex	O
AP-2	B
to	O
facilitate	O
efficient	O
entry	O
of	O
CFTR	B
into	O
clathrin	B
-	O
coated	O
vesicles	O
.	O

The	O
insulin	B
therapy	O
regimen	O
did	O
not	O
affect	O
the	O
evolution	O
of	O
the	O
patients	O
and	O
no	O
significant	O
relationship	O
existed	O
between	O
the	O
age	O
at	O
diagnosis	O
,	O
duration	O
of	O
diabetes	O
,	O
daily	O
insulin	B
dosage	O
or	O
metabolic	O
control	O
and	O
height	O
or	O
BMI	O
.	O

The	O
applicability	O
of	O
laparoscopic	O
donor	O
nephrectomy	O
(	O
LDN	O
)	O
has	O
not	O
been	O
assessed	O
in	O
the	O
obese	O
donor	O
.	O

The	O
RING	O
finger	O
,	O
B2	O
box	O
,	O
and	O
coiled	O
-	O
coil	O
region	O
are	O
required	O
for	O
oligomerization	O
of	O
KAP-1-RBCC	B
and	O
KRAB	B
binding	O
,	O
as	O
mutations	O
in	O
these	O
domains	O
concomitantly	O
abolished	O
these	O
functions	O
.	O

Actins	B
show	O
two	O
different	O
forms	O
of	O
N	O
-	O
terminal	O
processing	O
dependent	O
on	O
their	O
N	O
-	O
terminal	O
sequence	O
.	O

JPEG	O
53	O
,	O
resulting	O
in	O
a	O
compression	O
ratio	O
of	O
1:21	O
,	O
does	O
not	O
compromise	O
the	O
diagnostic	O
performance	O
in	O
general	O
.	O

Like	O
their	O
yeast	O
counterpart	O
,	O
the	O
mouse	O
GCN2	B
isoforms	O
contain	O
HisRS	B
-	I
related	I
sequences	I
juxtaposed	O
to	O
the	O
kinase	O
catalytic	O
domain	O
.	O

Five	O
women	O
(	O
15.6	O
%	O
)	O
met	O
criteria	O
for	O
PMS	O
.	O

MBI	O
and	O
MMBI	O
showed	O
similar	O
Cmax	O
values	O
,	O
but	O
the	O
former	O
disappeared	O
slower	O
in	O
the	O
serum	O
than	O
the	O
latter	O
and	O
resulted	O
in	O
its	O
larger	O
AUC	O
values	O
.	O

Another	O
long	O
insertion	O
in	O
the	O
cathepsin	B
X	I
amino	I
acid	I
sequence	I
forms	O
a	O
beta	O
-	O
hairpin	O
pointing	O
away	O
from	O
the	O
active	O
site	O
.	O

Transfection	O
experiments	O
demonstrated	O
that	O
the	O
5'-flanking	O
region	O
(	O
-1894	O
to	O
+	O
37	O
)	O
of	O
the	O
mStaf	B
gene	I
drives	O
transcription	O
in	O
mouse	O
NMuMG	O
cells	O
and	O
that	O
a	O
construct	O
containing	O
a	O
fragment	O
from	O
-387	O
to	O
+	O
37	O
showed	O
the	O
highest	O
transcriptional	O
activity	O
.	O

Pretreatment	O
of	O
cells	O
or	O
mouse	O
skin	O
with	O
antisense	O
oligonucleotides	O
of	O
PKCzeta	B
impaired	O
UV	O
-	O
induced	O
activation	O
of	O
AP-1	B
in	O
JB6	O
cells	O
as	O
well	O
as	O
in	O
AP-1-luciferase	B
transgenic	O
mice	O
.	O

The	O
level	O
of	O
subclinical	O
infection	O
was	O
75	O
%	O
among	O
seropositive	O
dogs	O
.	O

METHODS	O
:	O
The	O
former	O
group	O
included	O
patients	O
who	O
had	O
been	O
treated	O
with	O
at	O
least	O
four	O
PGE1	O
alpha	O
-	O
ciclodestrina	O
,	O
short	O
-	O
term	O
treatment	O
cycles	O
per	O
year	O
while	O
the	O
latter	O
was	O
a	O
historical	O
reference	O
group	O
managed	O
without	O
prostaglandins	O
.	O

The	O
rrd1,2delta	B
mutant	I
was	O
partially	O
rescued	O
by	O
inactivation	O
of	O
HOG1	B
or	O
PBS2	B
,	O
suggesting	O
an	O
interaction	O
between	O
the	O
RRD	B
genes	I
and	O
the	O
Hog1p	B
signal	I
transduction	I
pathway	I
.	O

Members	O
of	O
the	O
JAK	B
/	O
Tyk	B
family	O
of	O
tyrosine	B
kinases	I
mediate	O
phosphorylation	O
of	O
STAT3	B
at	O
Tyr705	O
during	O
CNTF	B
signaling	O
;	O
however	O
,	O
the	O
kinase	O
responsible	O
for	O
phosphorylation	O
at	O
STAT3	B
Tyr727	O
appears	O
to	O
depend	O
on	O
both	O
the	O
extracellular	O
stimulus	O
and	O
the	O
cellular	O
context	O
.	O

In	O
vivo	O
,	O
CARbeta	B
/	O
RXRalpha	B
activated	O
transcription	O
from	O
an	O
HD	B
-	O
PPRE	O
luciferase	B
reporter	I
construct	I
.	O

Thus	O
,	O
SOX8	B
is	O
a	O
good	O
candidate	O
gene	O
contributing	O
to	O
the	O
mental	O
retardation	O
phenotype	O
seen	O
in	O
ATR-16	O
patients	O
.	O

The	O
genome	O
organization	O
of	O
the	O
mite	O
-	O
transmitted	O
wheat	O
streak	O
mosaic	O
virus	O
(	O
WSMV	O
)	O
appears	O
to	O
parallel	O
that	O
of	O
members	O
of	O
the	O
Potyviridae	O
with	O
monopartite	O
genomes	O
,	O
but	O
there	O
are	O
substantial	O
amino	O
acid	O
dissimilarities	O
with	O
other	O
potyviral	O
polyproteins	O
.	O

The	O
two	O
-	O
hybrid	O
assay	O
was	O
then	O
performed	O
using	O
full	O
-	O
length	O
genes	O
of	O
CI	B
,	O
HC	B
-	I
Pro	I
,	O
P1	B
,	O
P3	B
,	O
and	O
CP	B
,	O
but	O
no	O
heterologous	O
interactions	O
were	O
detected	O
.	O

Diverse	O
endogenous	O
light	O
chains	O
contribute	O
to	O
basement	O
membrane	O
reactivity	O
in	O
nonautoimmune	O
mice	O
transgenic	O
for	O
an	O
anti	B
-	I
laminin	I
Ig	B
heavy	I
chain	I
.	O

Patch	O
test	O
results	O
obtained	O
with	O
corticosteroid	O
allergic	O
patients	O
tested	O
with	O
a	O
large	O
corticosteroid	O
series	O
validated	O
the	O
earlier	O
classification	O
of	O
corticosteroid	O
molecules	O
in	O
four	O
groups	O
of	O
cross	O
-	O
reacting	O
molecules	O
:	O
i.e.	O
,	O
group	O
A	O
(	O
hydrocortisone	O
type	O
)	O
,	O
group	O
B	O
(	O
acetonides	O
)	O
,	O
group	O
C	O
(	O
betamethasone	O
type	O
-	O
non	O
esterified	O
)	O
and	O
group	O
D	O
(	O
esters	O
)	O
.	O

Mechanisms	O
of	O
tachyphylaxis	O
in	O
regional	O
anesthesia	O
of	O
long	O
duration	O

An	O
increase	O
in	O
the	O
level	O
of	O
serum	O
enzymes	O
,	O
such	O
as	O
aspartate	B
transaminase	I
,	O
alkaline	B
phosphatase	I
,	O
creatine	B
phosphokinase	I
,	O
lactate	B
dehydrogenase	I
after	O
D.	O
russelli	O
venom	O
injection	O
in	O
albino	O
rats	O
is	O
indicative	O
of	O
cell	O
or	O
tissue	O
damage	O
.	O

The	O
partial	O
farm	O
budget	O
highlighted	O
the	O
importance	O
of	O
reducing	O
sub	O
-	O
clinical	O
lesions	O
in	O
a	O
feedlot	O
.	O

Surprisingly	O
,	O
3	O
full	B
-	I
length	I
murine	I
survivin	I
cDNA	I
clones	O
were	O
isolated	O
,	O
predicting	O
the	O
existence	O
of	O
3	O
distinct	O
survivin	B
proteins	I
.	O

We	O
show	O
that	O
stabilization	O
of	O
the	O
hairpin	O
reduced	O
the	O
amount	O
of	O
tRNA	O
primer	O
that	O
is	O
annealed	O
to	O
the	O
PBS	O
.	O

Ischemia	O
-	O
induced	O
biphasic	O
arrhythmias	O
were	O
suppressed	O
in	O
both	O
zatebradine	O
and	O
propranolol	O
groups	O
.	O

No	O
definite	O
conclusions	O
are	O
possible	O
because	O
of	O
the	O
small	O
number	O
of	O
patients	O
involved	O
in	O
this	O
phase	O
II	O
trial	O
.	O

Two	O
distinct	O
Salmonella	B
fimbrins	I
,	O
AgfA	B
and	O
SefA	B
,	O
comprising	O
thin	O
aggregative	O
fimbriae	O
SEF17	B
and	O
SEF14	B
,	O
respectively	O
,	O
were	O
each	O
genetically	O
engineered	O
to	O
carry	O
PT3	B
,	O
an	O
alpha	O
-	O
helical	O
16-amino	O
acid	O
Leishmania	O
T	O
-	O
cell	O
epitope	O
derived	O
from	O
the	O
metalloprotease	B
gp63	B
.	O

In	O
marked	O
contrast	O
to	O
AgfA	B
,	O
none	O
of	O
the	O
chimeric	B
SefA	I
proteins	I
were	O
expressed	O
or	O
assembled	O
into	O
fimbriae	O
.	O

Productive	O
growth	O
of	O
phage	O
P22	O
in	O
wild	O
-	O
type	O
Salmonella	O
typhimurium	O
correlates	O
with	O
the	O
presence	O
of	O
Abc2	B
,	O
but	O
is	O
independent	O
of	O
the	O
absolute	O
level	O
of	O
ATP	B
-	I
dependent	I
nuclease	I
activity	O
,	O
suggesting	O
a	O
qualitative	O
change	O
in	O
the	O
nature	O
of	O
Abc2-modified	B
RecBCD	B
nuclease	I
activity	O
relative	O
to	O
the	O
native	O
enzyme	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
molecular	O
mechanisms	O
underlying	O
the	O
inducible	O
expression	O
of	O
the	O
flt-1	B
gene	I
during	O
the	O
activation	O
of	O
THP-1	O
cells	O
.	O

Dermatology	O
is	O
no	O
exception	O
.	O

4	O
.	O

Molecular	O
cloning	O
of	O
a	O
novel	O
human	B
I	I
-	I
mfa	I
domain	I
-	I
containing	I
protein	I
that	O
differently	O
regulates	O
human	O
T	O
-	O
cell	O
leukemia	O
virus	O
type	O
I	O
and	O
HIV-1	O
expression	O
.	O

With	O
chemical	O
shift	O
imaging	O
,	O
the	O
signal	O
intensity	O
decreased	O
on	O
the	O
out	O
-	O
of	O
-	O
phase	O
images	O
in	O
six	O
of	O
seven	O
(	O
86	O
%	O
)	O
patients	O
with	O
APA	O
and	O
in	O
eight	O
of	O
nine	O
(	O
89	O
%	O
)	O
patients	O
with	O
BAH	O
.	O

For	O
each	O
night	O
,	O
the	O
diary	O
allowed	O
the	O
subjective	O
measurement	O
of	O
bedtime	O
,	O
wake	O
time	O
,	O
time	O
in	O
bed	O
(	O
TIB	O
)	O
,	O
sleep	O
efficiency	O
,	O
number	O
of	O
minutes	O
of	O
wake	O
after	O
sleep	O
onset	O
(	O
WASO	O
)	O
,	O
alertness	O
on	O
awakening	O
,	O
and	O
percentage	O
of	O
morning	O
needing	O
an	O
alarm	O
(	O
or	O
a	O
person	O
functioning	O
as	O
one	O
)	O
.	O

Acad	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
expression	O
of	O
the	O
gene	O
for	O
the	O
reproductive	O
neuropeptide	O
,	O
GnRH	B
,	O
is	O
repressed	O
by	O
the	O
glutamate	O
/	O
NO	O
/	O
cyclic	O
GMP	O
(	O
cGMP	O
)	O
signal	O
transduction	O
pathway	O
through	O
cGMP	B
-	I
dependent	I
protein	I
kinase	I
in	O
the	O
hypothalamic	O
GnRH	B
-	O
secreting	O
neuronal	O
cell	O
line	O
GT1	O
-	O
7	O
.	O

Extreme	O
potency	O
of	O
botulinum	B
toxin	I
.	O

In	O
contrast	O
,	O
c	B
-	I
Src	I
activated	O
by	O
isoproterenol	O
led	O
to	O
tyrosine	O
phosphorylation	O
of	O
Shc	B
and	O
subsequent	O
Erk	B
activation	O
,	O
but	O
not	O
tyrosine	O
phosphorylation	O
of	O
cortactin	B
or	O
Stat3	B
.	O

For	O
wild	O
type	O
MutT	B
and	O
its	O
E53D	B
and	O
E44D	B
mutants	I
,	O
plots	O
of	O
log	O
(	O
k	O
(	O
cat	O
)	O
)	O
versus	O
pH	O
exhibited	O
a	O
limiting	O
slope	O
of	O
1	O
on	O
the	O
ascending	O
limb	O
and	O
then	O
a	O
hump	O
,	O
i.e.	O
,	O
a	O
sharply	O
defined	O
maximum	O
near	O
pH	O
8	O
followed	O
by	O
a	O
plateau	O
,	O
yielding	O
apparent	O
pK	O
(	O
a	O
)	O
values	O
of	O
7.6	O
+	O
/-	O

0.3	O
and	O
8.4	O
+	O
/-	O

0.4	O
for	O
an	O
essential	O
base	O
and	O
a	O
nonessential	O
acid	O
catalyst	O
,	O
respectively	O
,	O
in	O
the	O
active	O
quaternary	O
MutT	B
-	O
Mg	O
(	O
2+	O
)	O
-dGTP	O
-	O
Mg	O
(	O
2	O
+	O
)	O
complex	O
.	O

Structural	O
changes	O
in	O
the	O
kinetically	O
more	O
damaged	O
E44D	O
mutant	O
detected	O
in	O
(	O
1	O
)	O
H-	O
(	O
15	O
)	O
N	O
HSQC	O
spectra	O
were	O
largely	O
limited	O
to	O
the	O
loop	O
I	O
-	O
helix	O
I	O
motif	O
,	O
suggesting	O
that	O
Glu-44	O
stabilizes	O
the	O
active	O
site	O
region	O
.	O

After	O
i.v	O
.	O

The	O
emerging	O
view	O
based	O
on	O
studies	O
in	O
yeast	O
is	O
that	O
each	O
class	O
of	O
snoRNPs	O
is	O
composed	O
of	O
a	O
unique	O
set	O
of	O
proteins	O
.	O

Activation	O
of	O
a	O
CRE	O
-	O
dependent	O
junB	B
promoter	I
/	O
chloramphenicol	B
acetyltransferase	I
(	O
CAT	B
)	O
reporter	O
gene	O
by	O
the	O
BCR	B
was	O
also	O
blocked	O
by	O
SB203580	O
.	O

We	O
present	O
evidence	O
that	O
the	O
upstream	O
open	O
reading	O
frame	O
(	O
uORF	O
)	O
represses	O
the	O
translation	O
of	O
the	O
downstream	O
major	O
open	O
reading	O
frame	O
(	O
mORF	O
)	O
.	O

Ras	B
-	O
GRF1	B
transiently	O
expressed	O
with	O
v	B
-	I
Src	I
was	O
tyrosine	O
-	O
phosphorylated	O
and	O
showed	O
significant	O
GEF	B
activity	O
toward	O
Rac	B
,	O
but	O
not	O
Rho	B
and	O
Cdc42	B
,	O
which	O
was	O
comparable	O
with	O
that	O
induced	O
by	O
Gbetagamma	B
.	O

EMSA	O
showed	O
that	O
nuclear	O
proteins	O
from	O
PC12	O
but	O
not	O
C6	O
or	O
Rat2	O
cells	O
bind	O
the	O
CRE	O
as	O
a	O
complex	O
containing	O
activating	B
transcription	I
factor	I
(	I
ATF	I
)	I
-4	I
and	O
CCAAT	B
enhancer	I
-	I
binding	I
protein	I
beta	I
,	O
while	O
both	O
PC12	O
and	O
C6	O
cell	O
nuclear	O
extracts	O
were	O
recruited	O
by	O
the	O
CCAAT	O
-	O
box	O
as	O
a	O
complex	O
containing	O
nuclear	B
factor	I
Y.	I

Despite	O
resolution	O
of	O
the	O
solid	O
portion	O
of	O
the	O
tumor	O
,	O
serial	O
MRI	O
showed	O
enlargement	O
of	O
a	O
bilobar	O
tumor	O
cyst	O
3	O
years	O
after	O
the	O
original	O
diagnosis	O
.	O

LPO	O
and	O
SOD	B
levels	O
were	O
measured	O
at	O
five	O
points	O
before	O
and	O
during	O
the	O
operation	O
.	O

Second	O
,	O
when	O
the	O
NBF1+R	B
protein	I
,	O
the	O
NBF2	B
protein	I
,	O
and	O
a	O
mixture	O
of	O
the	O
two	O
proteins	O
were	O
folded	O
separately	O
and	O
analyzed	O
by	O
molecular	O
sieve	O
chomatography	O
,	O
the	O
mixture	O
was	O
found	O
to	O
elute	O
prior	O
to	O
either	O
NBF1+R	B
or	O
NBF2	B
.	O

Sulfhydryl	O
titration	O
with	O
iodoacetamide	O
,	O
monitored	O
by	O
quantitating	O
the	O
residual	O
thiols	O
after	O
reaction	O
with	O
a	O
maleimide	O
derivative	O
of	O
biotin	O
,	O
revealed	O
a	O
striking	O
difference	O
in	O
the	O
apparent	O
pK	O
(	O
a	O
)	O
values	O
of	O
the	O
cysteines	O
at	O
the	O
two	O
splice	O
junctions	O
.	O

After	O
nitric	O
oxide	O
inhalation	O
,	O
the	O
results	O
showed	O
moderate	O
increases	O
in	O
PaO2	O
and	O
SaO2	O
(	O
P	O
>	O
0.05	O
)	O
and	O
a	O
significant	O
decrease	O
in	O
Qs	O
/	O
Q	O
tau	O
ratio	O
(	O
P	O
<	O
0.01	O
)	O
.	O

The	O
results	O
showed	O
that	O
MIP	O
,	O
MMIF	O
,	O
FIC	O
,	O
Wimax	O
,	O
P0.1	O
and	O
minute	O
ventilation	O
(	O
Vr	O
)	O
were	O
significantly	O
increased	O
after	O
administration	O
of	O
methylphenidatum	O
and	O
aminophylline	O
.	O

It	O
has	O
also	O
been	O
shown	O
that	O
a	O
variety	O
of	O
extracellular	O
factors	O
stimulate	O
a	O
pair	O
of	O
MAPK	O
p44	B
and	O
MAPK	O
p42	B
of	O
MAPK	B
family	I
members	I
.	O

Covalent	O
modification	O
of	O
the	O
transactivator	O
protein	O
IE2-p86	B
of	O
human	O
cytomegalovirus	O
by	O
conjugation	O
to	O
the	O
ubiquitin	B
-	I
homologous	I
proteins	I
SUMO-1	B
and	O
hSMT3b	B
.	O

73:658	O
-	O
666	O
,	O
1999	O
)	O
.	O

The	O
interaction	O
between	O
U	O
(	O
L	O
)	O
3	O
.	O

Protamine	B
and	O
heparin	O
doses	O
,	O
their	O
sum	O
(	O
Sigma	O
-	O
dose	O
)	O
and	O
differential	O
(	O
Delta	O
-	O
dose	O
)	O
doses	O
,	O
and	O
activated	O
clotting	O
times	O
were	O
tabulated	O
.	O

In	O
this	O
study	O
,	O
a	O
common	O
mechanism	O
has	O
been	O
identified	O
to	O
coordinate	O
the	O
growth-	O
and	O
FC	O
-	O
dependent	O
expression	O
of	O
caveolin	B
.	O

Expression	O
in	O
early	O
postnatal	O
pituitary	O
and	O
in	O
pre	O
-	O
somatotrophic	O
cells	O
suggests	O
that	O
Zn-16	B
could	O
play	O
a	O
role	O
in	O
pituitary	O
development	O
prior	O
to	O
somatotroph	O
differentiation	O
.	O

The	O
CCAAT	O
core	O
sequence	O
mutants	O
in	O
which	O
both	O
CIII	O
and	O
CI	O
/	O
CII	O
were	O
abolished	O
,	O
also	O
increased	O
the	O
promoter	O
activity	O
.	O

Deglutition	O
is	O
considered	O
to	O
be	O
immature	O
in	O
infants	O
and	O
to	O
mature	O
postnatally	O
.	O

This	O
repression	O
does	O
not	O
require	O
the	O
PU.1	B
transactivation	O
or	O
PEST	O
domains	O
and	O
can	O
not	O
be	O
reversed	O
by	O
p300	B
expression	O
.	O

First	O
,	O
human	O
erythroid	O
K562	O
cells	O
stably	O
integrated	O
with	O
various	O
HS-40	B
mutants	I
cis	O
linked	O
to	O
a	O
human	B
alpha	I
-	I
globin	I
promoter	I
-	O
growth	B
hormone	I
hybrid	O
gene	O
were	O
analyzed	O
by	O
genomic	O
footprinting	O
and	O
expression	O
analysis	O
.	O

Interestingly	O
,	O
addition	O
of	O
purified	O
CBP	B
to	O
the	O
nuclear	O
extracts	O
of	O
T47D	O
cells	O
markedly	O
stimulated	O
progesterone-	O
and	O
PR	B
-	O
dependent	O
transcription	O
from	O
a	O
nucleosome	O
-	O
free	O
,	O
progesterone	O
response	O
element	O
(	O
PRE	O
)	O
-linked	O
reporter	O
DNA	O
template	O
.	O

Its	O
cognate	O
binding	O
protein	O
,	O
REST	B
/	O
NRSF	B
,	O
is	O
an	O
essential	O
transcription	O
factor	O
;	O
its	O
null	O
mutations	O
result	O
in	O
embryonic	O
lethality	O
,	O
and	O
its	O
dominant	O
negative	O
mutants	O
produce	O
aberrant	O
expression	O
of	O
neuron	O
-	O
specific	O
genes	O
.	O

Finally	O
,	O
the	O
mechanism	O
of	O
ASK1	B
activation	O
involves	O
,	O
in	O
part	O
,	O
homo	O
-	O
oligomerization	O
.	O

OUTCOME	O
:	O
Acetylcholine	B
receptor	I
antibodies	I
and	O
single	O
-	O
fibre	O
electromyogram	O
were	O
useful	O
in	O
the	O
diagnosis	O
of	O
myasthenia	O
gravis	O
.	O

Two	O
other	O
patients	O
underwent	O
PRFR	O
.	O

Characterization	O
of	O
the	O
5'-flanking	O
region	O
of	O
the	O
human	B
multidrug	I
resistance	I
protein	I
2	I
(	O
MRP2	B
)	O
gene	O
and	O
its	O
regulation	O
in	O
comparison	O
withthe	O
multidrug	B
resistance	I
protein	I
3	I
(	O
MRP3	B
)	O
gene	O
.	O

Of	O
the	O
153	O
patients	O
studied	O
,	O
CK	B
-	I
MB	I
results	O
were	O
positive	O
in	O
91	O
(	O
59	O
%	O
)	O
patients	O
;	O
ECG	O
revealed	O
AMI	O
in	O
72	O
(	O
47	O
%	O
)	O
patients	O
.	O

The	O
effect	O
of	O
MIB	O
on	O
the	O
dose	O
-	O
response	O
curve	O
of	O
externally	O
applied	O
noradrenaline	O
was	O
also	O
studied	O
.	O

Linearized	O
overall	O
infection	O
rates	O
(	O
events	O
/	O
100	O
patient	O
-	O
days	O
)	O
were	O
2.05	O
+	O
/-	O

0.33	O
(	O
heart	O
-	O
lung	O
)	O
and	O
2.34	O
+	O
/-	O

0.34	O
(	O
double	O
-	O
lung	O
;	O
P	O
=	O
NS	O
)	O
at	O
3	O
months	O
.	O

Static	O
and	O
dynamic	O
compliance	O
was	O
measured	O
after	O
induction	O
of	O
anesthesia	O
,	O
before	O
and	O
immediately	O
after	O
filtration	O
in	O
the	O
operating	O
theater	O
,	O
1	O
hour	O
after	O
return	O
to	O
the	O
pediatric	O
intensive	O
care	O
unit	O
,	O
and	O
24	O
hours	O
after	O
the	O
operation	O
.	O

KFC	B
,	O
a	O
Ste20-like	B
kinase	I
with	O
mitogenic	O
potential	O
and	O
capability	O
to	O
activate	O
the	O
SAPK	B
/	O
JNK	B
pathway	O
.	O

TIP30	B
has	O
an	O
intrinsic	O
kinase	O
activity	O
required	O
for	O
up	O
-	O
regulation	O
of	O
a	O
subset	O
of	O
apoptotic	O
genes	O
.	O

We	O
have	O
mapped	O
the	O
human	B
STAG3	I
gene	I
to	O
the	O
7q22	O
region	O
of	O
chromosome	O
7	O
;	O
six	O
human	B
STAG3-related	I
genes	I
have	O
also	O
been	O
mapped	O
:	O
two	O
at	O
7q22	O
near	O
the	O
functional	O
gene	O
,	O
one	O
at	O
7q11.22	O
,	O
and	O
three	O
at	O
7q11.23	O
,	O
two	O
of	O
them	O
flanking	O
the	O
breakpoints	O
commonly	O
associated	O
with	O
the	O
Williams	B
-	I
Beuren	I
syndrome	I
(	I
WBS	I
)	I
deletion	I
.	O

In	O
experiment	O
2	O
the	O
rats	O
had	O
free	O
access	O
to	O
two	O
bottles	O
,	O
one	O
of	O
which	O
contained	O
tap	O
water	O
,	O
and	O
the	O
other	O
contained	O
either	O
an	O
ethanol	O
(	O
6	O
%	O
)	O
or	O
a	O
sucrose	O
(	O
5	O
%	O
)	O
solution	O
.	O

RESULTS	O
:	O
In	O
this	O
group	O
of	O
patients	O
,	O
male	O
gender	O
(	O
P	O
=	O
0	O
.	O

Selective	O
visual	O
attention	O
involves	O
dynamic	O
interplay	O
between	O
attentional	O
control	O
systems	O
and	O
sensory	O
brain	O
structures	O
.	O

However	O
,	O
the	O
a1	O
isoform	O
is	O
expressed	O
most	O
heavily	O
in	O
brain	O
and	O
heart	O
,	O
a2	O
in	O
liver	O
and	O
kidney	O
,	O
and	O
a3	O
in	O
liver	O
,	O
lung	O
,	O
heart	O
,	O
brain	O
,	O
spleen	O
,	O
and	O
kidney	O
.	O

During	O
the	O
cloning	O
by	O
reverse	B
transcriptase	I
-	O
polymerase	O
chain	O
reaction	O
of	O
the	O
human	B
HIF-1alpha	I
subunit	I
,	O
we	O
isolated	O
two	O
cDNA	O
clones	O
which	O
corresponded	O
to	O
alternative	O
splicing	O
of	O
the	O
HIF-1alpha	B
gene	I
.	O

To	O
assess	O
the	O
relationship	O
between	O
G	B
(	I
q	I
)	I
/	O
G	B
(	I
11	I
)	I
function	O
with	O
the	O
phosphatidylinositol	B
3-kinase	I
dependent	O
pathway	O
,	O
expression	O
of	O
a	O
dominant	O
-	O
interfering	O
p85	B
regulatory	I
subunit	I
,	O
as	O
well	O
as	O
wortmannin	O
treatment	O
inhibited	O
insulin	B
-	O
stimulated	O
but	O
not	O
G	B
(	I
q	I
)	I
/	I
Q209L	I
-	O
stimulated	O
GLUT4-EGFP	B
translocation	O
.	O

In	O
endemic	O
BL	O
,	O
the	O
RB2	B
/	O
p130	B
gene	O
is	O
mutated	O
in	O
most	O
of	O
the	O
cases	O
,	O
and	O
the	O
protein	O
is	O
restricted	O
to	O
the	O
cytoplasm	O
.	O

Together	O
,	O
these	O
data	O
identify	O
ERK2	B
as	O
a	O
specific	O
and	O
direct	O
target	O
of	O
HePTP	B
and	O
are	O
consistent	O
with	O
a	O
model	O
in	O
which	O
HePTP	B
negatively	O
regulates	O
ERK2	B
activity	O
as	O
part	O
of	O
a	O
feedback	O
mechanism	O
.	O

Strontium	O
nitrate	O
mixed	O
with	O
glycolic	O
acid	O
,	O
in	O
comparison	O
with	O
glycolic	O
acid	O
alone	O
,	O
markedly	O
(	O
p<0.01	O
)	O
shortened	O
the	O
duration	O
of	O
the	O
irritation	O
sensation	O
from	O
24.4+	O
/	O
-4.1	O
(	O
mean+	O
/	O
-SEM	O
)	O
min	O
to	O
8.9+	O
/	O
-3.7	O
(	O
mean+	O
/	O
-SEM	O
)	O
min	O
,	O
and	O
significantly	O
(	O
p<0.05	O
)	O
reduced	O
the	O
mean	O
magnitude	O
of	O
the	O
irritation	O
sensation	O
at	O
all	O
time	O
points	O
(	O
overall	O
)	O
.	O

Analysis	O
of	O
1	O
Mb	O
of	O
published	O
sequence	O
from	O
the	O
region	O
of	O
conserved	O
synteny	O
on	O
human	O
chromosome	O
5q31-q33	O
identified	O
45	O
gene	O
candidates	O
,	O
including	O
35	O
expressed	O
genes	O
in	O
the	O
human	B
IL-4	I
cytokine	I
gene	I
cluster	I
.	O

Human	B
AP-2rep	I
repressed	O
both	O
reporter	O
expression	O
from	O
a	O
transiently	O
transfected	O
AP-2alpha	B
promoter	I
and	O
the	O
endogenous	O
AP-2alpha	B
gene	I
and	O
inversely	O
was	O
negatively	O
regulated	O
by	O
AP-2alpha	B
.	O

Clb	B
/	O
Cdc28	B
kinases	O
promote	O
nuclear	O
export	O
of	O
the	O
replication	B
initiator	I
proteins	I
Mcm2	I
-	I
7	I
.	O

Alternatively	O
,	O
PC12-E2	O
cells	O
were	O
submitted	O
to	O
treatment	O
with	O
antibodies	O
to	O
the	O
fibroblast	B
growth	I
factor	I
(	I
FGF	I
)	I
receptor	I
,	O
inhibitors	O
of	O
the	O
nonreceptor	B
tyrosine	I
kinase	I
p59	B
(	O
fyn	B
)	O
,	O
PLC	B
,	O
PKC	B
and	O
MEK	B
and	O
an	O
activator	O
of	O
PKC	B
,	O
phorbol-12-myristate-13-acetate	O
(	O
PMA	O
)	O
.	O

Cooperative	O
roles	O
of	O
Bozozok	B
/	O
Dharma	B
and	O
Nodal	B
-	I
related	I
proteins	I
in	O
the	O
formation	O
of	O
the	O
dorsal	O
organizer	O
in	O
zebrafish	O
.	O

Thiopentone	O
sodium	O
administered	O
at	O
30	O
and	O
10	O
min	O
before	O
or	O
5	O
,	O
10	O
and	O
15	O
min	O
after	O
exposure	O
to	O
NOC-5	O
,	O
but	O
not	O
thereafter	O
,	O
significantly	O
attenuated	O
NO	O
-	O
induced	O
neurotoxicity	O
compared	O
with	O
controls	O
.	O

We	O
also	O
show	O
that	O
zygotically	O
activated	O
Xretpos	O
transcripts	O
are	O
restricted	O
to	O
ventro	O
-	O
posterior	O
specific	O
regions	O
and	O
induced	O
by	O
UV	O
-	O
irradiation	O
and	O
BMP-4	B
overexpression	O
in	O
cycloheximide	O
-	O
dependent	O
way	O
.	O

genesis	O
26:198	O
-	O
207	O
,	O
2000	O
.	O

In	O
all	O
other	O
cases	O
,	O
vestibular	O
neurectomy	O
or	O
chemical	O
vestibular	O
labyrinthectomy	O
,	O
by	O
means	O
of	O
intratympanic	O
low	O
concentration	O
gentamicin	O
(	O
20	O
mg	O
/	O
mL	O
)	O
,	O
are	O
indicated	O
.	O

However	O
,	O
when	O
,	O
where	O
and	O
how	O
the	O
DSPP	B
is	O
cleaved	O
into	O
DSP	B
and	O
DPP	B
is	O
not	O
clear	O
.	O

We	O
found	O
that	O
TCR	B
signaling	O
induces	O
AP-1	B
binding	O
to	O
this	O
site	O
and	O
regulates	O
the	O
fasl	B
promoter	I
function	O
in	O
a	O
fashion	O
dependent	O
on	O
NF	B
-	I
kappaB	I
binding	O
.	O

Approximately	O
20	O
%	O
of	O
ALCLs	O
that	O
express	O
ALK	B
do	O
not	O
contain	O
the	O
t	O
(	O
2;5	O
)	O
,	O
suggesting	O
that	O
other	O
genetic	O
abnormalities	O
can	O
result	O
in	O
aberrant	O
ALK	B
expression	O
.	O

In	O
addition	O
,	O
expected	O
decreases	O
in	O
ATIC	B
enzymatic	O
function	O
in	O
ATIC	B
-	O
ALK	B
-	O
containing	O
lymphomas	O
may	O
render	O
these	O
tumors	O
more	O
sensitive	O
to	O
antifolate	O
drugs	O
such	O
as	O
methotrexate	O
.	O

Manganese	O
ions	O
were	O
found	O
to	O
be	O
essential	O
for	O
autophosphorylation	O
of	O
BGLF4	B
,	O
and	O
magnesium	O
can	O
stimulate	O
the	O
activity	O
.	O

The	O
Mif1	B
5	I
'	I
flanking	I
region	I
contains	O
a	O
functional	O
ER	O
stress	O
-	O
responsive	O
element	O
which	O
is	O
sufficient	O
for	O
induction	O
by	O
tunicamycin	O
.	O

Rigid	O
point	O
feature	O
registration	O
using	O
mutual	O
information	O
.	O

PURPOSE	O
:	O
A	O
two	O
-	O
generation	O
consanguineous	O
Pakistani	O
family	O
with	O
autosomal	O
recessive	O
Leber	O
congenital	O
amaurosis	O
(	O
LCA	O
,	O
MIM	O
204,000	O
)	O
and	O
keratoconus	O
was	O
identified	O
.	O

Ste18p	B
was	O
targeted	O
to	O
the	O
plasma	O
membrane	O
even	O
in	O
the	O
absence	O
of	O
prenylation	O
or	O
thioacylation	O
.	O

An	O
amino	O
-	O
acid	O
sequence	O
comparison	O
revealed	O
that	O
Bacillus	B
YM55	I
-	I
1	I
aspartase	I
shared	O
71	O
%	O
homology	O
with	O
Bacillus	B
subtilis	I
aspartase	I
and	O
49	O
%	O
with	O
Escherichia	O
coli	O
and	O
Pseudomonas	B
fluorescens	I
aspartases	I
.	O

Collectively	O
,	O
the	O
results	O
suggest	O
that	O
ARF	B
binding	O
to	O
Mdm2	B
induces	O
a	O
conformational	O
change	O
that	O
facilitates	O
nucleolar	O
import	O
of	O
the	O
ARF	B
-	O
Mdm2	B
complex	O
and	O
p53-dependent	B
cell	O
cycle	O
arrest	O
.	O

Cyclin	B
A	I
expression	O
is	O
repressed	O
in	O
quiescent	O
cells	O
by	O
E2F	B
acting	O
in	O
conjunction	O
with	O
its	O
pocket	O
protein	O
partners	O
Rb	B
,	O
p107	B
,	O
and	O
p130	B
;	O
however	O
,	O
v	B
-	I
Jun	I
overrides	O
this	O
control	O
,	O
causing	O
phosphorylated	O
Rb	B
and	O
proliferation	O
-	O
specific	O
E2F	B
-	O
p107	B
complexes	O
to	O
persist	O
after	O
mitogen	O
withdrawal	O
.	O

D	B
-	I
cyclin	I
-	O
cdk	B
activity	O
is	O
required	O
for	O
Rb	B
phosphorylation	O
in	O
v	B
-	I
Jun	I
-	O
transformed	O
cells	O
,	O
since	O
ectopic	O
expression	O
of	O
the	O
cdk4-	B
and	O
cdk6-specific	B
inhibitor	O
p16	B
(	O
INK4A	B
)	O
inhibits	O
both	O
DNA	O
synthesis	O
and	O
cell	O
proliferation	O
.	O

CONCLUSION	O
:	O
A	O
valve	O
-	O
like	O
mechanism	O
formed	O
by	O
the	O
capsulorhexis	O
rim	O
partially	O
adhered	O
to	O
the	O
IOL	O
optic	O
can	O
occur	O
postoperatively	O
.	O

The	O
protein	O
first	O
identified	O
by	O
the	O
monoclonal	B
antibody	I
Q18	I
is	O
encoded	O
by	O
a	O
gene	O
located	O
in	O
57A	O
on	O
polytene	O
chromosomes	O
and	O
has	O
been	O
consequently	O
named	O
Hrb57A	B
.	O

3	O
'	O
RNA	O
boundary	O
experiments	O
indicate	O
that	O
the	O
5	O
'	O
structure	O
reduces	O
the	O
number	O
of	O
(	O
G	O
/	O
U	O
)	O
AG	O
repeats	O
required	O
for	O
stable	O
TRAP	B
-	O
trp	B
leader	O
RNA	O
association	O
.	O

The	O
AtERF	B
genes	I
were	O
differentially	O
regulated	O
by	O
ethylene	O
and	O
by	O
abiotic	O
stress	O
conditions	O
,	O
such	O
as	O
wounding	O
,	O
cold	O
,	O
high	O
salinity	O
,	O
or	O
drought	O
,	O
via	O
ETHYLENE	B
-	I
INSENSITIVE2	I
(	O
EIN2	B
)	O
-dependent	O
or	O
-independent	O
pathways	O
.	O

BACKGROUND	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
response	O
rates	O
and	O
toxicity	O
of	O
two	O
regimens	O
containing	O
granulocyte	B
-	I
macrophage	I
-	I
colony	I
stimulating	I
factor	I
(	O
GM	B
-	I
CSF	I
)	O
in	O
combination	O
with	O
interleukin-2	B
(	O
IL-2	B
)	O
in	O
the	O
treatment	O
of	O
patients	O
with	O
metastatic	O
renal	O
cell	O
carcinoma	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
revealed	O
that	O
Sp1	B
binds	O
to	O
two	O
different	O
regions	O
in	O
the	O
proximal	O
promoter	O
,	O
a	O
typical	O
Sp1	B
site	I
located	O
at	O
(	O
-38	O
;	O
-33	O
)	O
and	O
a	O
G	O
/	O
C	O
-	O
rich	O
region	O
between	O
(	O
-67	O
;	O
-62	O
)	O
.	O

Fgd3	B
and	O
FGD1	B
share	O
a	O
high	O
degree	O
of	O
sequence	O
identity	O
that	O
spans	O
>	O
560	O
contiguous	O
amino	O
acid	O
residues	O
.	O

Molecular	O
cloning	O
of	O
mouse	B
thioredoxin	I
reductases	I
.	O

The	O
HPLC	O
method	O
involves	O
an	O
octadecylsilane	O
column	O
at	O
55	O
degrees	O
C	O
,	O
a	O
mixture	O
of	O
water	O
-	O
acetonitrile	O
-	O
orthophosphoric	O
acid	O
(	O
779:220:1	O
,	O
v	O
/	O
v	O
)	O
as	O
mobile	O
phase	O
and	O
detection	O
at	O
226	O
nm	O
.	O

Eight	O
patients	O
received	O
1.5	O
mg	O
of	O
adefovir	O
dipivoxil	O
per	O
kg	O
of	O
body	O
weight	O
,	O
and	O
six	O
patients	O
received	O
3.0	O
mg	O
of	O
adefovir	O
dipivoxil	O
per	O
kg	O
.	O

To	O
determine	O
if	O
CYC2	B
is	O
found	O
in	O
a	O
complex	O
with	O
previously	O
identified	O
trypanosome	B
cdc2-related	I
kinases	I
(	O
CRKs	B
)	O
,	O
the	O
CYC2	B
gene	I
was	O
fused	O
to	O
the	O
TY	B
epitope	I
tag	O
,	O
integrated	O
into	O
the	O
trypanosome	O
genome	O
,	O
and	O
expressed	O
under	O
inducible	O
control	O
.	O

These	O
findings	O
indicate	O
the	O
involvement	O
of	O
Sp1	B
and	O
an	O
Inr	O
in	O
non	O
-	O
cell	O
-	O
specific	O
regulation	O
and	O
a	O
Kruppel	B
-	I
like	I
transcription	I
factor	I
and	O
Sp1	B
in	O
the	O
cell	O
-	O
specific	O
regulation	O
of	O
the	O
LTC	B
(	I
4	I
)	I
S	I
gene	I
.	O

The	O
newly	O
defined	O
region	O
contains	O
an	O
intron	O
that	O
may	O
be	O
alternatively	O
spliced	O
and	O
seven	O
polyadenylation	O
signal	O
sequences	O
.	O

Most	O
likely	O
they	O
might	O
represent	O
regulatory	O
RNAs	O
or	O
transcribed	O
transposable	O
elements	O
.	O

Although	O
MAP	B
(	I
mitogen	I
-	I
activated	I
protein	I
)	I
kinases	I
are	O
implicated	O
in	O
cell	O
proliferation	O
and	O
differentiation	O
in	O
many	O
cell	O
types	O
,	O
the	O
role	O
of	O
MAP	B
kinases	I
in	O
cardiac	O
hypertrophy	O
remains	O
unclear	O
.	O

Transfection	O
with	O
a	O
CSF-1R	B
expression	O
plasmid	O
permitted	O
CSF-1-dependent	B
activation	O
of	O
the	O
signalling	O
pathway	O
targeting	O
an	O
Ets	B
/	O
AP1	B
(	O
activator	B
protein	I
1	I
)	O
element	O
in	O
the	O
uPA	B
promoter	I
that	O
has	O
been	O
shown	O
previously	O
to	O
be	O
a	O
target	O
of	O
oncogenic	B
ras	I
and	O
protein	O
kinase	O
C	O
pathways	O
.	O

Regulation	O
of	O
urokinase	B
plasminogen	I
activator	I
gene	I
transcription	O
in	O
the	O
RAW264	O
murine	O
macrophage	O
cell	O
line	O
by	O
macrophage	B
colony	I
-	I
stimulating	I
factor	I
(	O
CSF-1	B
)	O
is	O
dependent	O
upon	O
the	O
level	O
of	O
cell	O
-	O
surface	O
receptor	O
.	O

Coactivation	O
of	O
endogenous	O
or	O
exogenous	O
G	B
(	I
q	I
)	I
-coupled	I
receptors	I
with	O
the	O
delta	B
-	I
opioid	I
receptor	I
produced	O
strong	O
stimulations	O
of	O
PLCbeta	B
and	O
such	O
responses	O
could	O
be	O
partially	O
blocked	O
by	O
pertussis	B
toxin	I
.	O

Patients	O
enrolled	O
in	O
the	O
Integrilin	O
to	O
Minimize	O
Platelet	O
Aggregation	O
and	O
Coronary	O
Thrombosis	O
-	O
II	O
(	O
IMPACT	O
-	O
II	O
)	O
trial	O
were	O
analyzed	O
.	O

The	O
Wnt	B
signaling	O
pathway	O
functions	O
reiteratively	O
during	O
animal	O
development	O
to	O
control	O
cell	O
fate	O
decisions	O
.	O

The	O
two	O
contiguous	O
IGF2	B
(	O
human	B
insulin	I
-	I
like	I
growth	I
factor	I
II	I
)	O
and	O
H19	B
genes	I
are	O
reciprocally	O
imprinted	O
in	O
both	O
human	O
and	O
mouse	O
.	O

The	O
asymmetric	O
methylation	O
was	O
associated	O
with	O
tissue	O
-	O
specific	O
disruption	O
of	O
H19	B
genomic	O
imprinting	O
in	O
fetal	O
brain	O
.	O

Early	O
treatment	O
mechanics	O
of	O
the	O
Class	O
II	O
division	O
2	O
malocclusion	O
.	O

Among	O
mammalian	B
HSFs	I
,	O
HSF1	B
has	O
been	O
shown	O
to	O
be	O
important	O
for	O
regulation	O
of	O
the	O
heat	O
-	O
induced	O
stress	O
gene	O
expression	O
,	O
whereas	O
the	O
function	O
of	O
HSF2	B
in	O
stress	O
response	O
is	O
unclear	O
.	O

They	O
share	O
many	O
downstream	O
targets	O
,	O
including	O
remodeling	O
of	O
the	O
actin	B
cytoskeleton	O
,	O
activation	O
of	O
p70	B
(	I
S6	I
)	I
kinase	I
and	O
c	B
-	I
jun	I
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
)	O
,	O
and	O
regulation	O
of	O
transcription	O
and	O
cell	O
proliferation	O
.	O

Expression	O
of	O
activated	O
Cdc42	B
results	O
in	O
the	O
translocation	O
of	O
PKClambda	B
from	O
the	O
nucleus	O
into	O
the	O
cytosol	O
,	O
and	O
Cdc42	B
and	O
PKClambda	B
colocalize	O
at	O
the	O
plasma	O
membrane	O
and	O
in	O
the	O
cytoplasm	O
.	O

To	O
understand	O
whether	O
Shc	B
localization	O
in	O
membrane	O
rafts	O
is	O
sufficient	O
to	O
regulate	O
Shc	B
function	O
,	O
we	O
constructed	O
a	O
Shc	B
chimera	I
containing	O
the	O
Ras	B
membrane	I
localization	I
motif	I
at	O
the	O
C	O
-	O
terminus	O
.	O

Southern	O
blotting	O
and	O
single	O
strand	O
conformation	O
polymorphism	O
analyses	O
did	O
not	O
show	O
tumor	O
-	O
specific	O
alterations	O
of	O
this	O
gene	O
in	O
gliomas	O
and	O
RT	O
-	O
PCR	O
studies	O
showed	O
expression	O
in	O
glioma	O
cell	O
lines	O
,	O
suggesting	O
that	O
ANOVA	B
is	O
not	O
the	O
chromosome	O
19q	O
glioma	O
tumor	O
suppressor	O
gene	O
.	O

RegA	B
is	O
a	O
positive	O
yet	O
nonessential	O
regulator	O
of	O
tol	B
-	O
oprL	B
expression	O
.	O

Enzyme	B
I	I
of	O
the	O
phosphoenolpyruvate	B
:	I
sugar	I
phosphotransferase	I
system	O
.	O

Based	O
on	O
these	O
data	O
,	O
we	O
conclude	O
that	O
transcription	O
of	O
prgX	B
is	O
initiated	O
from	O
the	O
Qa	B
promoter	I
in	O
prgQ	B
,	O
and	O
PrgX	B
autoregulates	O
its	O
transcription	O
either	O
by	O
mediating	O
transcriptional	O
readthrough	O
or	O
increasing	O
mRNA	O
stability	O
.	O

Molecular	O
mimicry	O
of	O
human	O
cytokine	O
and	O
cytokine	O
response	O
pathway	O
genes	O
by	O
KSHV	O
.	O

By	O
electrophoresis	O
mobility	O
shift	O
assays	O
using	O
probes	O
corresponding	O
to	O
different	O
segments	O
of	O
the	O
putative	O
human	B
c	I
-	I
myb	I
intron	I
1	I
transcription	I
pause	I
region	I
and	O
nuclear	O
extracts	O
from	O
myeloid	O
leukemia	O
HL	O
60	O
and	O
fibroblast	O
WI	O
38	O
cells	O
,	O
we	O
detected	O
a	O
HL-60-specific	O
DNA	O
-	O
protein	O
complex	O
with	O
a	O
123-bp	O
fragment	O
containing	O
binding	O
sites	O
for	O
the	O
interferon	B
regulatory	I
factors	I
(	O
IRFs	B
)	O
nuclear	O
proteins	O
.	O

STUDY	O
DESIGN	O
:	O
Fine	O
needle	O
aspiration	O
cytologic	O
smears	O
from	O
21	O
cases	O
of	O
invasive	O
lobular	O
carcinoma	O
(	O
ILC	O
)	O
of	O
breast	O
were	O
subjected	O
to	O
detailed	O
cytomorphologic	O
analysis	O
.	O

A	O
new	O
technique	O
to	O
create	O
an	O
artificial	O
stenosis	O
in	O
the	O
native	O
LAD	O
using	O
a	O
hemoclip	O
.	O

Dll3	B
is	O
mutated	O
in	O
the	O
X	O
-	O
ray	O
-	O
induced	O
mouse	B
mutant	I
pudgy	I
(	O
pu	B
)	O
,	O
causing	O
a	O
variety	O
of	O
vertebrocostal	O
defects	O
similar	O
to	O
SD	O
phenotypes	O
.	O

Invertases	B
are	O
responsible	O
for	O
the	O
breakdown	O
of	O
sucrose	O
to	O
fructose	O
and	O
glucose	O
.	O

To	O
investigate	O
the	O
molecular	O
mechanisms	O
of	O
this	O
Tax	B
-	O
mediated	O
inhibition	O
,	O
we	O
analyzed	O
its	O
effect	O
on	O
the	O
transcriptional	O
activity	O
of	O
the	O
myogenic	O
MyoD	B
protein	I
,	O
which	O
was	O
used	O
as	O
a	O
paradigm	O
of	O
bHLH	B
factors	I
.	O

The	O
cell	O
cycle	O
and	O
transcriptional	O
defects	O
caused	O
by	O
taf17	B
(	O
slm7	B
-	I
1	I
)	O
are	O
consistent	O
with	O
the	O
role	O
of	O
TAF	B
(	I
II	I
)	I
s	I
as	O
modulators	O
of	O
transcriptional	O
activation	O
and	O
may	O
reflect	O
a	O
role	O
for	O
TAF17	B
in	O
regulating	O
activation	O
by	O
SBF	B
and	O
MBF	B
.	O

Extracellular	B
-	I
regulated	I
kinase	I
(	O
ERK	B
)	O
activation	O
and	O
molecular	O
coupling	O
of	O
the	O
adaptor	O
proteins	O
p130	B
Crk	B
-	I
associated	I
substrate	I
(	O
CAS	B
)	O
and	O
c	B
-	I
CrkII	I
(	O
Crk	B
)	O
represent	O
two	O
distinct	O
pathways	O
that	O
induce	O
cell	O
invasion	O
and	O
protect	O
cells	O
from	O
apoptosis	O
in	O
a	O
three	O
-	O
dimensional	O
collagen	B
matrix	O
.	O

These	O
results	O
indicate	O
that	O
residue	O
266	O
serves	O
as	O
a	O
""""	O
protein	O
sensor	O
""""	O
of	O
altered	O
minor	O
groove	O
interactions	O
and	O
identifies	O
which	O
base	O
pair	O
interactions	O
are	O
altered	O
by	O
these	O
lesions	O
.	O

The	O
recombinant	O
enzymes	O
exist	O
as	O
monomers	O
.	O

A	O
pathway	O
for	O
regulation	O
of	O
B	B
lymphocyte	I
antigen	I
receptor	I
-	O
induced	O
calcium	O
flux	O
.	O

We	O
now	O
describe	O
a	O
second	O
RIM	B
protein	I
,	O
called	O
RIM2	B
,	O
that	O
is	O
highly	O
homologous	O
to	O
RIM1	B
and	O
also	O
expressed	O
primarily	O
in	O
brain	O
.	O

Scanning	O
mutations	O
throughout	O
the	O
AC	O
element	O
interfered	O
with	O
induction	O
but	O
allowed	O
us	O
to	O
define	O
five	O
overlapping	O
sites	O
for	O
regulatory	O
factors	O
in	O
AC	O
and	O
to	O
design	O
probes	O
binding	O
just	O
one	O
or	O
two	O
factors	O
.	O

The	O
substrates	O
for	O
glycan	O
synthesis	O
in	O
the	O
lumen	O
of	O
the	O
Golgi	O
are	O
nucleotide	O
sugars	O
that	O
must	O
be	O
transported	O
from	O
the	O
cytosol	O
by	O
specific	O
membrane	O
-	O
bound	O
transporters	O
.	O

Synaptic	O
targeting	O
of	O
the	O
postsynaptic	B
density	I
protein	I
PSD-95	I
mediated	O
by	O
a	O
tyrosine	O
-	O
based	O
trafficking	O
signal	O
.	O

Bites	O
by	O
two	O
species	O
of	O
adders	O
(	O
Vipera	O
aspis	O
and	O
Vipera	O
berus	O
)	O
can	O
lead	O
to	O
extensive	O
swelling	O
with	O
multiorgan	O
failure	O
.	O

Both	O
normal	O
and	O
transforming	O
PCPH	B
proteins	I
have	O
guanosine	B
diphosphatase	I
activity	O
but	O
only	O
the	O
oncoprotein	O
cooperates	O
with	O
Ras	B
in	O
activating	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
ERK1	B
.	O

Paxillin	B
acts	O
as	O
an	O
adaptor	O
molecule	O
in	O
integrin	B
signaling	O
.	O

Furthermore	O
,	O
analysis	O
of	O
deletion	O
promoter	O
-	O
reporter	O
constructs	O
found	O
that	O
the	O
basal	O
activity	O
of	O
P2	O
resided	O
in	O
the	O
proximal	O
region	O
of	O
P2	O
.	O

In	O
addition	O
,	O
the	O
transcription	O
of	O
c	B
-	I
IAP2	I
promoter	I
was	O
strongly	O
up	O
-	O
regulated	O
when	O
CD40	B
or	O
Epstein	B
-	I
Barr	I
virus	I
latent	I
membrane	I
protein	I
1	I
was	O
overexpressed	O
.	O

These	O
studies	O
identify	O
several	O
of	O
the	O
signal	O
-	O
transduction	O
events	O
involved	O
in	O
the	O
apoptosis	O
of	O
malignant	O
B	O
cells	O
that	O
transpire	O
following	O
ligation	O
of	O
CD20	B
by	O
anti	B
-	I
CD20	I
antibodies	I
in	O
the	O
presence	O
of	O
Fc	B
-	I
receptor	I
-	O
expressing	O
cells	O
or	O
secondary	O
goat	O
anti-	B
(	I
mouse	I
Ig	I
)	I
antibodies	I
and	O
which	O
may	O
contribute	O
to	O
the	O
tumor	O
regressions	O
observed	O
in	O
mouse	O
models	O
and	O
clinical	O
trials	O
.	O

CONCLUSION	O
:	O
Treatment	O
of	O
sepsis	O
with	O
the	O
platelet	B
-	I
activating	I
factor	I
antagonist	O
BB-882	O
offers	O
no	O
advantage	O
over	O
placebo	O
on	O
survival	O
,	O
hemodynamic	O
status	O
,	O
respiratory	O
function	O
,	O
or	O
organ	O
failure	O
scores	O
.	O

Recently	O
,	O
identical	O
RBE	B
sequences	I
have	O
been	O
identified	O
at	O
other	O
locations	O
in	O
the	O
human	O
genome	O
.	O

EM	O
analysis	O
demonstrated	O
that	O
only	O
one	O
Rep	B
-	I
DNA	I
complex	I
was	O
formed	O
on	O
ch-19	O
target	O
DNA	O
.	O

In	O
vivo	O
dimethyl	O
sulfate	O
footprinting	O
of	O
the	O
cyclin	B
E	I
promoter	I
revealed	O
several	O
regions	O
of	O
protection	O
and	O
hypersensitivity	O
that	O
were	O
unique	O
to	O
infected	O
cells	O
.	O

A	O
total	O
of	O
194	O
STSs	O
map	O
to	O
this	O
interval	O
of	O
3	O
Mb	O
,	O
giving	O
an	O
average	O
marker	O
resolution	O
of	O
approximately	O
one	O
per	O
15	O
kb	O
.	O

Biol	O
.	O

METHODS	O
:	O
We	O
determined	O
an	O
odds	O
ratio	O
(	O
OR	O
)	O
,	O
as	O
a	O
measure	O
of	O
the	O
relative	O
risk	O
of	O
being	O
exposed	O
to	O
a	O
potential	O
interaction	O
,	O
comparing	O
the	O
use	O
of	O
the	O
H2-receptor	B
antagonist	O
,	O
cimetidine	O
,	O
with	O
that	O
of	O
the	O
noninteracting	O
agents	O
ranitidine	O
,	O
famotidine	O
and	O
nizatidine	O
in	O
users	O
and	O
nonusers	O
of	O
warfarin	O
,	O
phenytoin	O
and	O
theophylline	O
.	O

Our	O
data	O
suggest	O
that	O
,	O
at	O
least	O
at	O
high	O
temperature	O
,	O
a	O
critical	O
minimal	O
level	O
of	O
Ypt	B
protein	I
prenylation	O
is	O
required	O
for	O
maintaining	O
vesicle	O
polarization	O
.	O

The	O
second	O
functional	O
pair	O
of	O
CreA	B
sites	I
is	O
located	O
between	O
the	O
two	O
transcription	O
initiation	O
sites	O
.	O

The	O
'	O
Newcastle	O
'	O
model	O
,	O
which	O
is	O
based	O
on	O
Hotelling	O
's	O
T2	O
statistic	O
,	O
proved	O
to	O
be	O
more	O
sensitive	O
and	O
diagnosed	O
a	O
systematic	O
displacement	O
for	O
three	O
prostate	O
patients	O
.	O

After	O
phosphorylation	O
,	O
STAT	B
proteins	I
are	O
transported	O
into	O
the	O
nucleus	O
and	O
exhibit	O
transcriptional	O
activity	O
.	O

Overexpression	O
of	O
mcl-1	B
is	O
sufficient	O
to	O
protect	O
against	O
apoptosis	O
,	O
while	O
transfection	O
of	O
a	O
mcl-1	B
antisense	O
plasmid	O
causes	O
cell	O
death	O
.	O

Thus	O
,	O
although	O
multiple	O
senescence	O
pathways	O
are	O
activated	O
in	O
response	O
to	O
a	O
ras	B
oncogene	I
,	O
inactivation	O
of	O
TGFbeta1	B
secretion	O
or	O
response	O
is	O
sufficient	O
to	O
block	O
the	O
senescence	O
program	O
.	O

In	O
this	O
study	O
,	O
the	O
abilities	O
of	O
constitutive	O
and	O
conditional	O
forms	O
of	O
the	O
three	O
Raf	B
kinases	I
to	O
abrogate	O
the	O
cytokine	O
dependency	O
of	O
FDC	O
-	O
P1	O
cells	O
were	O
examined	O
.	O

The	O
complete	O
cDNA	O
sequence	O
of	O
human	B
betaV	I
spectrin	I
is	O
available	O
from	O
GenBank	O
(	O
TM	O
)	O
as	O
accession	O
number	O
.	O

Transactivation	O
of	O
naturally	O
occurring	O
HIV-1	B
long	I
terminal	I
repeats	I
by	O
the	O
JNK	B
signaling	O
pathway	O
.	O

These	O
data	O
show	O
that	O
the	O
alpha	O
-	O
helix	O
domain	O
of	O
p57	B
(	O
Kip2	B
)	O
,	O
which	O
is	O
conserved	O
in	O
the	O
Cip	B
/	O
Kip	B
proteins	O
,	O
is	O
implicated	O
in	O
protein	O
-	O
protein	O
interaction	O
and	O
confers	O
a	O
specific	O
regulatory	O
mechanism	O
,	O
outside	O
of	O
their	O
Cdk	B
-	O
inhibitory	O
activity	O
,	O
by	O
which	O
the	O
p57	B
(	O
Kip2	B
)	O
family	O
members	O
positively	O
act	O
on	O
myogenic	O
differentiation	O
.	O

This	O
study	O
was	O
carried	O
out	O
to	O
analyze	O
PRL	B
secretion	O
in	O
metastatic	O
prostate	O
cancer	O
patients	O
both	O
at	O
basal	O
conditions	O
and	O
in	O
response	O
to	O
L	O
-	O
Dopa	O
and	O
metoclopramide	O
,	O
which	O
represents	O
the	O
most	O
classical	O
inhibitory	O
and	O
stimulatory	O
tests	O
for	O
PRL	B
secretion	O
,	O
respectively	O
.	O

Intra	O
-	O
operative	O
ultrasound	O
(	O
IOUS	O
)	O
has	O
been	O
widely	O
used	O
in	O
an	O
attempt	O
to	O
overcome	O
these	O
difficulties	O
,	O
but	O
is	O
limited	O
by	O
its	O
two	O
-	O
dimensional	O
nature	O
,	O
inter	O
-	O
user	O
variability	O
,	O
and	O
image	O
obliteration	O
with	O
ablative	O
or	O
resectional	O
techniques	O
.	O

Hailey	O
-	O
Hailey	O
disease	O
is	O
caused	O
by	O
mutations	O
in	O
ATP2C1	B
encoding	O
a	O
novel	O
Ca	O
(	O
2	O
+	O
)	O
pump	O
.	O

Hex	B
is	O
expressed	O
in	O
the	O
developing	O
liver	O
coincident	O
with	O
the	O
forkhead	B
/	O
winged	B
helix	I
transcription	O
factor	O
,	O
Hepatocyte	B
Nuclear	I
Factor	I
3beta	I
(	O
HNF3beta	B
)	O
.	O

The	O
clinical	O
stage	O
was	O
I	O
(	O
T1N0M0	O
)	O
,	O
and	O
S2	O
sleeve	O
segmentectomy	O
with	O
lymph	O
node	O
dissection	O
(	O
R	O
2	O
b	O
)	O
was	O
performed	O
.	O

Benztropine	O
for	O
venlafaxine	O
-	O
induced	O
night	O
sweats	O
.	O

A	O
cause	O
of	O
increase	O
of	O
alkaline	B
phosphatase	I
in	O
children	O

Viral	O
cell	O
-	O
to	O
-	O
cell	O
movement	O
of	O
PVX	B
CP	I
mutant	I
was	O
complemented	O
in	O
Nicotiana	O
tabacum	O
cv	O
.	O

Induction	O
of	O
CD86	B
expression	O
by	O
stimulation	O
of	O
U937	O
cells	O
with	O
IFN	B
-	I
gamma	I
revealed	O
the	O
presence	O
of	O
two	O
functional	O
GAS	B
(	O
gamma	B
-	I
interferon	I
activation	I
site	I
)	O
elements	O
.	O

Significantly	O
,	O
two	O
proximal	O
GATA-1-binding	B
sites	I
(	O
-118	O
/	O
-113	O
and	O
-98	O
/	O
-93	O
)	O
and	O
a	O
region	O
located	O
within	O
-518	O
to	O
-315bp	O
of	O
the	O
mouse	B
ALAS2	I
promoter	I
were	O
essential	O
for	O
transcriptional	O
activation	O
during	O
chemically	O
induced	O
differentiation	O
of	O
MEL	O
cells	O
,	O
implying	O
their	O
importance	O
in	O
conferring	O
erythroid	O
specificity	O
to	O
the	O
ALAS2	B
transcriptional	O
activation	O
.	O

SNAP-23	B
plays	O
an	O
important	O
role	O
in	O
the	O
regulation	O
of	O
vesicle	O
trafficking	O
in	O
mammalian	O
cells	O
.	O

IgM	B
and	O
IgG	B
anti	I
A	I
and	O
anti	B
B	I
antibody	I
status	O
of	O
100	O
antenatal	O
O	O
group	O
mothers	O
(	O
who	O
had	O
non	O
O	O
group	O
husbands	O
)	O
were	O
studied	O
.	O

Retroviral	O
transduction	O
of	O
T	B
/	I
T	I
(	I
L	I
)	I
causes	O
a	O
rapidly	O
fatal	O
myeloproliferative	O
disease	O
in	O
a	O
murine	O
bone	O
marrow	O
transplant	O
(	O
BMT	O
)	O
model	O
,	O
whereas	O
T	B
/	I
T	I
(	I
F	I
)	I
causes	O
a	O
long	O
-	O
latency	O
,	O
pre	O
-	O
B	O
-	O
cell	O
lymphoblastic	O
lymphoma	O
.	O

Ab	O
-	O
MLV	O
strains	O
expressing	O
P70	B
/	O
S2	B
failed	O
to	O
transform	O
NIH	O
3T3	O
cells	O
and	O
demonstrated	O
a	O
greatly	O
reduced	O
capacity	O
to	O
mediate	O
signaling	O
events	O
associated	O
with	O
the	O
Ras	B
-	O
dependent	O
mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinase	I
pathway	O
.	O

The	O
p53-homolog	B
p73beta	B
also	O
activated	O
the	O
PIG3	B
promoter	I
,	O
but	O
in	O
contrast	O
to	O
p53	B
,	O
the	O
proline	O
-	O
rich	O
domain	O
of	O
p73beta	B
(	I
residues	I
81	I
-	I
113	I
)	I
was	O
dispensable	O
to	O
induce	O
the	O
PIG3	B
promoter	I
.	O

Results	O
from	O
transient	O
assays	O
using	O
these	O
mutants	O
showed	O
that	O
the	O
DE1	O
received	O
signals	O
from	O
phytochromes	B
A	I
and	I
B	I
,	O
demonstrating	O
that	O
this	O
element	O
is	O
indeed	O
a	O
light	O
-	O
responsive	O
element	O
.	O

Co	O
-	O
immunoprecipitation	O
and	O
DNA	O
affinity	O
chromatography	O
prove	O
that	O
Sp1	B
heterodimerizes	O
with	O
ZBP-89	B
when	O
bound	O
to	O
the	O
silencer	O
element	O
to	O
yield	O
a	O
DNA	O
-	O
protein	O
complex	O
whose	O
mobility	O
is	O
indistinguishable	O
from	O
that	O
displayed	O
by	O
HeLa	O
nuclear	O
extract	O
in	O
band	O
shift	O
assays	O
.	O

The	O
ZNF274	B
gene	I
is	O
mapped	O
distal	O
to	O
marker	O
RP	O
S28	O
1	O
in	O
the	O
human	O
chromosome	O
19qter	O
region	O
,	O
by	O
RH	O
mapping	O
.	O

We	O
report	O
here	O
on	O
the	O
molecular	O
nature	O
of	O
an	O
EMS	O
-	O
induced	O
mutant	O
,	O
mn1	B
-	I
89	I
,	O
a	O
leaky	O
semidominant	O
allele	O
of	O
the	O
Miniature1	B
(	O
Mn1	B
)	O
seed	O
locus	O
that	O
encodes	O
a	O
seed	B
-	I
specific	I
cell	I
wall	I
invertase	I
,	O
INCW2	B
.	O

Identification	O
of	O
a	O
novel	O
E2F3	B
product	I
suggests	O
a	O
mechanism	O
for	O
determining	O
specificity	O
of	O
repression	O
by	O
Rb	B
proteins	I
.	O

In	O
DNase	B
I	I
footprinting	O
protection	O
analysis	O
,	O
both	O
SFRE	B
and	O
ERE	O
regions	O
were	O
protected	O
by	O
glutathione	B
S	I
-	I
transferase	I
-	O
ERRalpha1	B
fusion	O
protein	O
.	O

We	O
examine	O
current	O
models	O
of	O
the	O
effects	O
of	O
aging	O
on	O
mean	O
response	O
time	O
and	O
show	O
how	O
they	O
might	O
be	O
reinterpreted	O
.	O

The	O
median	O
levels	O
of	O
particles	O
with	O
50	O
%	O
cut	O
-	O
off	O
aerodynamic	O
diameters	O
of	O
10	O
(	O
PM10	O
)	O
and	O
2.5	O
microm	O
(	O
PM2.5	O
)	O
were	O
170	O
(	O
range	O
103	O
-	O
613	O
)	O
and	O
95	O
(	O
range	O
61	O
-	O
218	O
)	O
micro	O
x	O
m-3	O
,	O
respectively	O
.	O

Specific	O
and	O
heritable	O
genetic	O
interference	O
by	O
double	O
-	O
stranded	O
RNA	O
in	O
Arabidopsis	O
thaliana	O
.	O

Two	O
additional	O
cis	O
-	O
acting	O
sequences	O
,	O
conserved	O
in	O
both	O
the	O
region	O
1	O
and	O
3	O
promoters	O
,	O
were	O
identified	O
,	O
suggesting	O
a	O
role	O
for	O
these	O
sequences	O
in	O
the	O
coordinate	O
regulation	O
of	O
transcription	O
from	O
these	O
promoters	O
.	O

Purple	O
photosynthetic	O
bacteria	O
are	O
capable	O
of	O
generating	O
cellular	O
energy	O
from	O
several	O
sources	O
,	O
including	O
photosynthesis	O
,	O
respiration	O
,	O
and	O
H	O
(	O
2	O
)	O
oxidation	O
.	O

An	O
analysis	O
of	O
synthetic	O
peptides	O
revealed	O
a	O
minimal	O
CTD	O
sequence	O
that	O
is	O
sufficient	O
to	O
bind	O
to	O
the	O
second	O
Rsp5	B
WW	I
domain	I
(	O
Rsp5	B
WW2	I
)	O
in	O
vitro	O
and	O
in	O
yeast	O
two	O
-	O
hybrid	O
assays	O
.	O

METHOD	O
:	O
The	O
sample	O
of	O
subjects	O
was	O
drawn	O
from	O
the	O
Suffolk	O
County	O
Mental	O
Health	O
Project	O
,	O
a	O
longitudinal	O
epidemiologic	O
study	O
of	O
first	O
-	O
hospitalized	O
subjects	O
with	O
psychotic	O
disorders	O
;	O
the	O
present	O
study	O
focused	O
on	O
patients	O
with	O
schizophrenic	O
disorders	O
.	O

Marrow	O
dysplasia	O
is	O
a	O
major	O
characteristic	O
of	O
patients	O
with	O
myelodysplastic	O
syndrome	O
(	O
MDS	O
)	O
,	O
along	O
with	O
marrow	O
blastosis	O
,	O
cytopenia	O
and	O
cytogenetic	O
anomalies	O
.	O

How	O
plants	O
respond	O
to	O
attack	O
by	O
the	O
range	O
of	O
herbivores	O
and	O
pathogens	O
that	O
confront	O
them	O
in	O
the	O
field	O
is	O
the	O
subject	O
of	O
considerable	O
research	O
by	O
both	O
molecular	O
biologists	O
and	O
ecologists	O
.	O

CONCLUSION	O
:	O
The	O
probability	O
of	O
cardiopulmonary	O
complications	O
increases	O
significantly	O
when	O
patients	O
develop	O
class	O
1	O
HELLP	O
syndrome	O
.	O

The	O
rate	O
-	O
limiting	O
step	O
for	O
telomerase	B
activity	O
seems	O
to	O
be	O
the	O
expression	O
of	O
the	O
catalytic	O
subunit	O
of	O
the	O
enzyme	O
,	O
encoded	O
by	O
the	O
human	B
telomerase	I
reverse	I
transcriptase	I
(	O
hTERT	B
)	O
gene	O
.	O

In	O
the	O
control	O
group	O
,	O
platelet	O
markers	O
increased	O
1	O
h	O
after	O
surgery	O
.	O

However	O
,	O
the	O
element	O
proximal	O
to	O
the	O
transcription	O
start	O
site	O
is	O
dependent	O
on	O
the	O
SRE-1	O
.	O

Regulation	O
of	O
mitochondrial	O
single	O
-	O
stranded	O
DNA	O
-	O
binding	O
protein	O
gene	O
expression	O
links	O
nuclear	O
and	O
mitochondrial	O
DNA	O
replication	O
in	O
drosophila	O
.	O

They	O
are	O
present	O
in	O
many	O
kinds	O
of	O
living	O
things	O
,	O
but	O
their	O
functions	O
,	O
especially	O
those	O
in	O
humans	O
,	O
are	O
unclear	O
.	O

Transduction	O
of	O
the	O
human	O
leukemic	O
cell	O
line	O
K562	O
showed	O
that	O
viral	O
MRP1-PG13	B
supernatants	O
routinely	O
transfer	O
the	O
MRP1	B
gene	I
to	O
approximately	O
35	O
%	O
of	O
target	O
K562	O
cells	O
,	O
of	O
which	O
at	O
least	O
one	O
third	O
are	O
capable	O
of	O
proliferating	O
in	O
the	O
presence	O
of	O
otherwise	O
toxic	O
concentrations	O
of	O
etoposide	O
.	O

Identification	O
of	O
an	O
AfsA	B
homologue	I
(	O
BarX	B
)	O
from	O
Streptomyces	O
virginiae	O
as	O
a	O
pleiotropic	O
regulator	O
controlling	O
autoregulator	O
biosynthesis	O
,	O
virginiamycin	O
biosynthesis	O
and	O
virginiamycin	O
M1	O
resistance	O
.	O

Given	O
its	O
relative	O
longevity	O
on	O
the	O
Web	O
,	O
TIE	O
researchers	O
have	O
been	O
in	O
a	O
unique	O
position	O
to	O
observe	O
trends	O
in	O
telemedicine	O
.	O

The	O
structural	O
study	O
of	O
peptides	O
belonging	O
to	O
the	O
terminal	O
domains	O
of	O
histone	B
H1	I
can	O
be	O
considered	O
as	O
a	O
step	O
toward	O
the	O
understanding	O
of	O
the	O
function	O
of	O
H1	B
in	O
chromatin	O
.	O

Cerebral	O
vasculitis	O
secondary	O
to	O
Crohn	O
's	O
disease	O
seems	O
to	O
be	O
a	O
very	O
rare	O
phenomenon	O
.	O

SELECTION	O
CRITERIA	O
:	O
Randomised	O
and	O
possibly	O
randomised	O
trials	O
using	O
acupuncture	O
to	O
treat	O
asthma	O
and	O
asthma	O
-	O
like	O
symptoms	O
.	O

To	O
test	O
the	O
hypothesis	O
that	O
progestin	O
-	O
mediated	O
increases	O
in	O
resting	O
core	O
temperature	O
and	O
the	O
core	O
temperature	O
threshold	O
for	O
sweating	O
onset	O
are	O
counteracted	O
by	O
estrogen	O
,	O
we	O
studied	O
eight	O
women	O
(	O
24	O
+	O
/-	O

2	O
yr	O
)	O
at	O
27	O
degrees	O
C	O
rest	O
,	O
during	O
20	O
min	O
of	O
passive	O
heating	O
(	O
35	O
degrees	O
C	O
)	O
,	O
and	O
during	O
40	O
min	O
of	O
exercise	O
at	O
35	O
degrees	O
C.	O

These	O
studies	O
suggest	O
an	O
additional	O
component	O
or	O
cellular	O
environment	O
is	O
required	O
for	O
SPRK	B
activation	O
by	O
Cdc42	B
.	O

Jkappa	B
DNA	I
-	I
binding	I
sites	I
were	O
not	O
required	O
for	O
this	O
activation	O
,	O
and	O
a	O
mutant	B
EBNA-3C	I
protein	I
unable	O
to	O
bind	O
Jkappa	B
activated	O
transcription	O
as	O
efficiently	O
as	O
wild	B
-	I
type	I
EBNA-3C	I
,	O
indicating	O
that	O
EBNA-3C	B
can	O
regulate	O
transcription	O
through	O
a	O
mechanism	O
that	O
is	O
independent	O
of	O
Jkappa	B
.	O

Thus	O
,	O
both	O
YY1	B
and	O
CDP	B
appear	O
to	O
be	O
negative	O
regulators	O
of	O
the	O
differentiation	O
-	O
induced	O
HPV-6	B
E1	I
promoter	I
and	O
thereby	O
the	O
HPV	O
life	O
cycle	O
.	O

Sequential	O
cleavage	O
by	O
metallopeptidases	B
and	O
proteasomes	O
is	O
involved	O
in	O
processing	O
HIV-1	B
ENV	I
epitope	I
for	O
endogenous	O
MHC	B
class	I
I	I
antigen	I
presentation	O
.	O

We	O
also	O
show	O
that	O
p65	B
binds	O
to	O
these	O
targets	O
with	O
almost	O
equal	O
affinity	O
and	O
that	O
different	O
residues	O
have	O
variable	O
roles	O
in	O
binding	O
different	O
kappaB	B
targets	I
.	O

Transcriptional	O
regulation	O
of	O
the	O
yeast	B
PHO8	I
promoter	I
in	O
comparison	O
to	O
the	O
coregulated	O
PHO5	B
promoter	I
.	O

In	O
the	O
present	O
study	O
,	O
we	O
characterized	O
cis	O
-	O
elements	O
of	O
the	O
human	B
PCI	I
gene	I
required	O
for	O
expression	O
in	O
the	O
hepatoma	O
-	O
derived	O
cell	O
line	O
,	O
HepG2	O
cells	O
,	O
and	O
also	O
evaluated	O
rat	B
PCI	I
mRNA	I
expression	O
,	O
particularly	O
on	O
the	O
effect	O
of	O
androgen	O
in	O
rat	O
reproductive	O
tissues	O
.	O

Mutational	O
analysis	O
of	O
mammalian	B
translation	I
initiation	I
factor	I
5	I
(	O
eIF5	B
)	O
:	O
role	O
of	O
interaction	O
between	O
the	O
beta	O
subunit	O
of	O
eIF2	B
and	O
eIF5	B
in	O
eIF5	B
function	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

This	O
activity	O
is	O
stimulated	O
by	O
complex	O
formation	O
with	O
the	O
other	O
eIF2B	B
subunits	I
.	O

Our	O
analysis	O
of	O
nonsense	O
mutations	O
indicates	O
that	O
the	O
C	O
terminus	O
of	O
eIF2Bepsilon	B
(	I
residues	I
518	I
to	I
712	I
)	I
is	O
required	O
for	O
both	O
catalytic	O
activity	O
and	O
interaction	O
with	O
eIF2	B
.	O

CONCLUSIONS	O
:	O
Physiologic	O
pacing	O
provides	O
little	O
benefit	O
over	O
ventricular	O
pacing	O
for	O
the	O
prevention	O
of	O
stroke	O
or	O
death	O
due	O
to	O
cardiovascular	O
causes	O
.	O

Among	O
non	O
-	O
cirrhotics	O
,	O
lack	O
of	O
portal	O
vein	O
visualisation	O
had	O
a	O
90	O
%	O
sensitivity	O
,	O
88	O
%	O
specificity	O
,	O
94	O
%	O
negative	O
predictive	O
value	O
,	O
and	O
83	O
%	O
positive	O
predictive	O
value	O
in	O
the	O
diagnosis	O
of	O
pre	O
-	O
sinusoidal	O
portal	O
hypertension	O
.	O

D5	B
/	I
D1	I
(	I
CT	I
)	I
or	O
D5	B
/	I
D1D	I
(	I
CT	I
)	I
tail	O
substitution	O
mutants	O
displayed	O
a	O
rank	O
order	O
of	O
potency	O
and	O
agonist	O
affinities	O
virtually	O
mimicking	O
wild	B
-	I
type	I
(	I
wt	I
)	I
D1	I
receptors	I
,	O
as	O
indexed	O
by	O
both	O
ligand	O
binding	O
and	O
dopamine	O
-	O
stimulated	O
cAMP	O
accumulation	O
assays	O
,	O
and	O
,	O
similar	O
to	O
wt	O
D1	B
receptors	I
,	O
did	O
not	O
exhibit	O
receptor	O
constitutive	O
activity	O
or	O
responsiveness	O
to	O
inverse	O
agonists	O
.	O

Stat	B
activation	O
in	O
response	O
to	O
GH	B
and	O
IL-6	B
was	O
determined	O
by	O
reporter	O
gene	O
induction	O
.	O

HFA	O
134a	O
had	O
a	O
greater	O
tendency	O
to	O
take	O
up	O
moisture	O
from	O
the	O
environment	O
than	O
did	O
HFA	O
227	O
.	O

RESULTS	O
:	O
Abnormal	O
color	O
perception	O
was	O
found	O
in	O
32	O
%	O
of	O
the	O
epilepsy	O
patients	O
treated	O
with	O
vigabatrin	O
monotherapy	O
and	O
28	O
%	O
of	O
the	O
epilepsy	O
patients	O
treated	O
with	O
carbamazepine	O
monotherapy	O
.	O

Mitogen	B
-	I
activated	I
protein	I
(	I
MAP	I
)	I
kinase	I
phosphatase-3	I
(	O
MKP-3	B
)	O
is	O
a	O
dual	O
specificity	O
phosphatase	O
that	O
inactivates	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
(	O
ERK	B
)	O
MAP	B
kinases	I
.	O

Consistent	O
with	O
this	O
,	O
we	O
show	O
that	O
peptides	O
representing	O
docking	O
sites	O
within	O
the	O
target	O
substrates	O
Elk-1	B
and	O
p90	B
(	O
rsk	B
)	O
inhibit	O
ERK	B
-	O
dependent	O
activation	O
of	O
MKP-3	B
.	O

When	O
the	O
entire	O
diet	O
consisted	O
of	O
SBF	O
,	O
voluntary	O
feed	O
intake	O
was	O
reduced	O
,	O
indicating	O
that	O
SBF	O
should	O
not	O
be	O
fed	O
to	O
ponies	O
as	O
the	O
sole	O
dietary	O
ingredient	O
.	O

Hepatitis	O
C	O
virus	O
infection	O
and	O
lymphoproliferative	O
diseases	O
in	O
France	O
:	O
a	O
national	O
study	O
.	O

C.	O
elegans	O
KLP-11	B
/	O
OSM-3	B
/	O
KAP-1	B
:	O
orthologs	O
of	O
the	O
sea	B
urchin	I
kinesin	I
-	I
II	I
,	O
and	O
mouse	O
KIF3A	B
/	O
KIFB	B
/	O
KAP3	B
kinesin	B
complexes	O
.	O

Flavonoids	O
from	O
Brosimum	O
acutifolium	O
.	O

The	O
C	O
terminus	O
of	O
TRBP	B
binds	O
to	O
CBP	B
/	O
p300	B
and	O
DRIP130	B
,	O
a	O
component	O
of	O
the	O
DRIP	B
/	O
TRAP	B
/	O
ARC	B
complex	O
,	O
which	O
suggests	O
that	O
TRBP	B
may	O
activate	O
transcription	O
by	O
means	O
of	O
such	O
interactions	O
.	O

The	O
patients	O
who	O
presented	O
with	O
mucocutaneous	O
disease	O
also	O
had	O
low	O
CD4	B
+	I
T	O
lymphocyte	O
counts	O
,	O
and	O
most	O
of	O
them	O
had	O
AIDS	O
defining	O
illnesses	O
.	O

Double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
.	O

Here	O
,	O
it	O
is	O
shown	O
that	O
TAFII250	B
,	O
the	O
largest	O
subunit	O
of	O
TFIID	B
,	O
contains	O
two	O
tandem	O
bromodomain	O
modules	O
that	O
bind	O
selectively	O
to	O
multiply	O
acetylated	O
histone	B
H4	I
peptides	I
.	O

Endostatin	O
treatment	O
for	O
10	O
minutes	O
or	O
24	O
hours	O
induced	O
tyrosine	O
phosphorylation	O
of	O
Shb	B
and	O
formation	O
of	O
multiprotein	O
complexes	O
.	O

Therefore	O
,	O
analogs	O
of	O
vitamin	O
D3	O
have	O
been	O
investigated	O
in	O
a	O
number	O
of	O
trials	O
showing	O
improvement	O
of	O
psoriasis	O
.	O

The	O
transcript	O
was	O
initially	O
identified	O
as	O
a	O
partial	O
cDNA	O
sequence	O
in	O
the	O
course	O
of	O
constructing	O
a	O
transcript	O
map	O
of	O
the	O
region	O
between	O
markers	O
D11S1765	B
and	O
uteroglobin	B
known	O
to	O
encompass	O
the	O
gene	O
causing	O
Best	O
disease	O
.	O

Iodine	O
deficiency	O
disorders	O
in	O
Bangladesh	O
.	O

RESULTS	O
:	O
Soluble	O
CD23	B
levels	O
were	O
significantly	O
higher	O
in	O
women	O
with	O
endometriosis	O
before	O
treatment	O
than	O
in	O
ten	O
normal	O
controls	O
.	O

To	O
isolate	O
this	O
gene	O
,	O
a	O
P-1	O
artificial	O
chromosome	O
(	O
PAC	O
)	O
library	O
was	O
screened	O
with	O
a	O
full	B
length	I
UGT2B7	I
probe	O
and	O
a	O
clone	O
of	O
approximately	O
100	O
kb	O
in	O
length	O
was	O
isolated	O
.	O

Age	O
>	O
/=	O
50	O
years	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
,	O
14.1	O
)	O
,	O
BMI	O
>	O
/=	O
28	O
kg	O
/	O
m	O
(	O
2	O
)	O
(	O
OR	O
,	O
5.7	O
)	O
,	O
triglycerides	O
>	O
/=	O
1.7	O
mmol	O
/	O
L	O
(	O
OR	O
,	O
5	O
)	O
,	O
and	O
alanine	B
aminotransferase	I
(	O
ALT	B
)	O
>	O
/=	O
2N	O
(	O
OR	O
,	O
4.6	O
)	O
were	O
independently	O
associated	O
with	O
septal	O
fibrosis	O
.	O

Here	O
,	O
we	O
show	O
that	O
the	O
zinc	B
finger	I
protein	I
Gis1	I
acts	O
as	O
a	O
dosage	O
-	O
dependent	O
suppressor	O
of	O
the	O
rim15Delta	B
defect	O
in	O
nutrient	O
limitation	O
-	O
induced	O
transcriptional	O
derepression	O
of	O
SSA3	B
.	O

To	O
begin	O
to	O
characterize	O
the	O
role	O
of	O
the	O
RNA	O
subunits	O
in	O
enzyme	O
function	O
and	O
substrate	O
specificity	O
,	O
we	O
swapped	O
two	O
hairpin	O
structures	O
(	O
MRP3	O
and	O
P3	O
)	O
between	O
RNase	B
MRP	I
RNA	I
and	O
RNase	B
P	I
RNA	I
of	I
S.	I
cerevisiae	I
.	O

Similarly	O
,	O
comparison	O
of	O
percentage	O
reductions	O
of	O
heart	O
rate	O
at	O
supine	O
,	O
sitting	O
and	O
exercise	O
by	O
repeated	O
measure	O
analysis	O
showed	O
the	O
Malays	O
to	O
have	O
significantly	O
higher	O
change	O
compared	O
to	O
the	O
Chinese	O
(	O
p	O
=	O
0.040	O
)	O
.	O

Mucin	B
gene	I
expression	O
has	O
been	O
shown	O
to	O
be	O
altered	O
in	O
many	O
intestinal	O
diseases	O
and	O
especially	O
cancers	O
of	O
the	O
gastrointestinal	O
tract	O
.	O

The	O
experimentally	O
mapped	O
regions	O
of	O
RPB5	B
involved	O
in	O
these	O
interactions	O
correspond	O
to	O
distinct	O
and	O
surface	O
-	O
exposed	O
alpha	O
-	O
helical	O
structures	O
.	O

The	O
model	O
indicates	O
that	O
a	O
0.076	O
%	O
reduction	O
in	O
cigarette	O
consumption	O
is	O
associated	O
with	O
the	O
availability	O
of	O
nicotine	O
patches	O
after	O
1992	O
.	O

The	O
tryptase	B
locus	I
also	O
contains	O
at	O
least	O
four	O
tryptase	B
-	I
like	I
pseudogenes	I
,	O
including	O
mastin	B
,	O
a	O
gene	O
expressed	O
in	O
dogs	O
but	O
not	O
in	O
humans	O
.	O

OBJECTIVE	O
:	O
This	O
study	O
was	O
conducted	O
to	O
assess	O
the	O
relative	O
roles	O
of	O
99mTc	O
-	O
sestamibi	O
scintimammography	O
and	O
sonography	O
in	O
the	O
evaluation	O
of	O
breast	O
lesions	O
that	O
are	O
indeterminate	O
or	O
suspicious	O
on	O
mammography	O
or	O
clinical	O
examination	O
.	O

Mutational	O
analyses	O
showed	O
that	O
in	O
-	O
frame	O
stop	O
codons	O
introduced	O
into	O
five	O
of	O
seven	O
RNA	B
2	I
ORFs	I
did	O
not	O
affect	O
accumulation	O
of	O
progeny	O
LIYV	B
RNA	I
1	I
or	O
RNA	B
2	I
,	O
confirming	O
that	O
RNA	B
2	I
does	O
not	O
encode	O
proteins	O
necessary	O
for	O
LIYV	O
RNA	O
replication	O
.	O

RESULTS	O
:	O
Fournier	O
's	O
gangrene	O
occurs	O
worldwide	O
.	O

IL-2	B
is	O
accepted	O
as	O
a	O
standard	O
treatment	O
used	O
alone	O
,	O
or	O
in	O
combination	O
with	O
chemotherapy	O
or	O
biotherapy	O
in	O
the	O
management	O
of	O
metastatic	O
melanoma	O
and	O
metastatic	O
renal	O
cell	O
carcinoma	O
.	O

Moreover	O
,	O
expression	O
of	O
antisense	B
Ha	I
-	I
Ras	I
or	O
dominant	B
negative	I
Raf-1	I
abrogated	O
the	O
mitogenic	O
effect	O
of	O
TGF	B
-	I
beta1	I
in	O
TSU	O
-	O
Pr1	O
,	O
and	O
the	O
TGF	B
-	I
beta1	I
inhibition	O
of	O
DU145	O
was	O
switched	O
to	O
stimulation	O
by	O
V12Ha	B
-	I
Ras	I
transfection	O
.	O

Taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
prostate	O
carcinomas	O
with	O
the	O
Ras	B
/	O
MAPK	B
pathway	O
activation	O
might	O
have	O
a	O
selective	O
growth	O
advantage	O
by	O
autocrine	O
TGF	B
-	I
beta1	I
production	O
.	O

In	O
experiment	O
2	O
,	O
no	O
difference	O
in	O
gastric	O
emptying	O
of	O
40	O
%	O
peptone	O
or	O
25	O
%	O
glucose	O
was	O
found	O
between	O
rats	O
receiving	O
TPN	O
and	O
those	O
receiving	O
intragastric	O
nutrition	O
for	O
10	O
to	O
12	O
days	O
.	O

In	O
contrast	O
,	O
H	B
-	I
NS	I
negative	O
regulation	O
operated	O
only	O
in	O
the	O
absence	O
of	O
Fur	B
.	O

Thus	O
,	O
SAG	B
appears	O
to	O
control	O
cell	O
cycle	O
progression	O
in	O
yeast	O
by	O
promoting	O
ubiquitination	O
and	O
degradation	O
of	O
cell	O
cycle	O
regulatory	O
proteins	O
.	O

It	O
brings	O
about	O
fatigue	O
,	O
negative	O
moods	O
,	O
and	O
impaired	O
health	O
,	O
sleep	O
,	O
safety	O
,	O
and	O
working	O
capacity	O
.	O

This	O
demonstrates	O
that	O
treatment	O
of	O
the	O
graft	O
recipient	O
for	O
a	O
relatively	O
short	O
period	O
during	O
and	O
after	O
surgery	O
has	O
a	O
favorable	O
effect	O
on	O
the	O
survival	O
of	O
grafted	O
dopaminergic	O
neurons	O
.	O

The	O
relationships	O
among	O
blood	O
concentrations	O
of	O
thyroid	O
hormones	O
and	O
selenium	O
,	O
zinc	O
,	O
retinol	O
,	O
and	O
alpha	O
-	O
tocopherol	O
were	O
studied	O
in	O
44	O
healthy	O
Northern	O
Italian	O
oldest	O
-	O
old	O
subjects	O
(	O
age	O
range	O
,	O
90	O
-	O
107	O
yr	O
)	O
,	O
selected	O
by	O
the	O
criteria	O
of	O
the	O
SENIEUR	O
protocol	O
.	O

Investigations	O
using	O
hippocampal	O
slices	O
maintained	O
in	O
vitro	O
have	O
demonstrated	O
that	O
bursts	O
of	O
oscillatory	O
field	O
potentials	O
in	O
the	O
gamma	O
frequency	O
range	O
(	O
30	O
-	O
80	O
Hz	O
)	O
are	O
followed	O
by	O
a	O
slower	O
oscillation	O
in	O
the	O
beta	O
1	O
range	O
(	O
12	O
-	O
20	O
Hz	O
)	O
.	O

Karger	O
AG	O
,	O
Basel	O

Urinary	O
LTE4	O
increased	O
after	O
both	O
challenges	O
the	O
rise	O
being	O
higher	O
following	O
oral	O
as	O
compared	O
to	O
inhalation	O
provocation	O
(	O
p=0.0001	O
)	O
.	O

Basal	O
FVR	O
was	O
reduced	O
by	O
approximately	O
18	O
%	O
by	O
ERT	O
and	O
HRT	O
,	O
but	O
FVR	O
responses	O
to	O
noradrenaline	O
,	O
angiotensin	B
II	I
,	O
acetylcholine	O
and	O
nitroprusside	O
were	O
unaffected	O
.	O

Transfection	O
of	O
cDNAs	O
for	O
three	O
mutant	O
enzymes	O
into	O
FPGS	B
-	O
null	O
Chinese	O
hamster	O
ovary	O
cells	O
restored	O
a	O
reduced	O
level	O
of	O
clonal	O
growth	O
,	O
whereas	O
a	O
T339I	O
mutant	O
supported	O
growth	O
at	O
a	O
level	O
comparable	O
to	O
that	O
of	O
the	O
wild	O
-	O
type	O
enzyme	O
.	O

SETTING	O
:	O
University	O
of	O
Paris	O
VII	O
hospital	O
.	O

Patient	O
(	O
s	O
)	O
:	O
Nine	O
women	O
had	O
embolization	O
for	O
symptomatic	O
myoma	O
,	O
with	O
12	O
pregnancies	O
observed	O
.	O

Improving	O
fissure	O
sealant	O
quality	O
:	O
mechanical	O
preparation	O
and	O
filling	O
level	O
.	O

The	O
protein	O
encoded	O
by	O
the	O
fruA	B
transcript	I
is	O
well	O
conserved	O
with	O
the	O
D.	B
melanogaster	I
type	I
A	I
protein	I
,	O
particularly	O
the	O
BTB	B
protein	I
-	O
protein	O
-	O
binding	O
domain	O
,	O
which	O
is	O
encoded	O
by	O
exons	O
I	O
and	O
II	O
and	O
is	O
100	O
%	O
conserved	O
.	O

In	O
addition	O
,	O
the	O
mouse	O
ortholog	O
(	O
Mharp	B
/	O
Smarcal1	B
)	O
was	O
cloned	O
,	O
and	O
the	O
Caenorhabditis	O
elegans	O
ortholog	O
(	O
CEHARP	B
)	O
was	O
identified	O
in	O
the	O
GenBank	O
database	O
.	O

ECP	B
and	O
tryptase	B
levels	O
in	O
serum	O
were	O
measured	O
before	O
and	O
after	O
the	O
last	O
oral	O
challenge	O
.	O

For	O
an	O
unsupervised	O
program	O
,	O
the	O
costs	O
were	O
estimated	O
at	O
$	O
311	O
for	O
the	O
first	O
year	O
and	O
$	O
73	O
for	O
all	O
additional	O
years	O
.	O

The	O
presence	O
of	O
such	O
a	O
putative	O
RNA-	O
binding	O
domain	O
suggests	O
a	O
mechanism	O
for	O
the	O
observed	O
autoregulation	O
of	O
bacteriophage	O
T4	B
DNA	I
polymerase	I
synthesis	O
by	O
binding	O
to	O
its	O
own	O
mRNA	O
.	O

Deletion	O
and	O
mutational	O
analyses	O
revealed	O
two	O
positive	O
cis	O
-	O
regulatory	O
elements	O
in	O
this	O
region	O
that	O
are	O
essential	O
for	O
CSX1	B
expression	O
in	O
cardiomyocytes	O
.	O

Functional	O
studies	O
which	O
introduced	O
a	O
mutation	O
in	O
the	O
AP2	B
core	I
binding	I
region	I
as	O
well	O
as	O
cotransfection	O
experiments	O
using	O
an	O
AP2	B
expression	O
vector	O
revealed	O
that	O
AP2	B
exerts	O
a	O
repressive	O
role	O
on	O
the	O
HGF	B
gene	I
promoter	I
activity	O
.	O

Using	O
adenoviral	O
transfer	O
of	O
IkappaBalpha	B
(	O
IkappaBalpha	B
overexpression	O
)	O
,	O
the	O
production	O
of	O
TNF	B
-	I
alpha	I
induced	O
by	O
whole	O
GBS	O
was	O
inhibited	O
by	O
only	O
20	O
%	O
.	O

The	O
pJR	O
vectors	O
differ	O
among	O
them	O
in	O
:	O
(	O
a	O
)	O
the	O
selectable	O
marker	O
(	O
Saccharomyces	O
cerevisiae	O
LEU	B
2	I
gene	I
,	O
which	O
complements	O
S.	B
pombe	I
leu1-	I
gene	I
and	O
S.	O
pombe	O
ura4	B
+	I
and	O
his3	B
+	I
genes	I
)	O
;	O
(	O
b	O
)	O
the	O
thiamine	O
-	O
repressible	O
nmt1	B
promoter	I
(	O
3X	O
,	O
41X	O
and	O
81X	O
with	O
extremely	O
high	O
,	O
moderate	O
or	O
low	O
transcription	O
efficiency	O
,	O
respectively	O
)	O
;	O
and	O
(	O
c	O
)	O
the	O
multiple	O
cloning	O
site	O
(	O
two	O
multiple	O
cloning	O
sites	O
,	O
with	O
12	O
restriction	O
sites	O
each	O
)	O
.	O

Franz	O
Schubert	O
--	O
his	O
life	O
,	O
music	O
and	O
diseases	O

The	O
results	O
suggest	O
that	O
the	O
role	O
of	O
S.	O
argyrostoma	O
in	O
the	O
dissemination	O
of	O
Trichinella	O
larvae	O
in	O
nature	O
is	O
limited	O
in	O
comparison	O
to	O
the	O
role	O
played	O
by	O
mammals	O
with	O
scavenger	O
and	O
cannibalistic	O
behavior	O
.	O

The	O
equilibrium	O
dissociation	O
binding	O
constant	O
for	O
the	O
interaction	O
of	O
TnrA	B
with	O
the	O
nrgAB	B
promoter	I
fragment	I
was	O
7.7	O
nM	O
under	O
the	O
conditions	O
used	O
here	O
.	O

These	O
results	O
demonstrate	O
that	O
N	O
-	O
glycans	O
flanking	O
the	O
receptor	O
-	O
binding	O
site	O
of	O
the	O
HA	B
molecule	I
are	O
potent	O
regulators	O
of	O
influenza	O
virus	O
growth	O
,	O
with	O
the	O
glycan	O
at	O
Asn149	O
being	O
dominant	O
and	O
that	O
at	O
Asn123	O
being	O
less	O
effective	O
.	O

All	O
were	O
tested	O
for	O
serum	O
ferritin	B
(	O
SF	B
)	O
,	O
hemoglobin	B
(	O
Hb	B
)	O
level	O
and	O
asked	O
for	O
detailed	O
histories	O
of	O
donations	O
and	O
iron	O
supplementation	O
.	O

We	O
further	O
studied	O
the	O
effects	O
of	O
SIE-1	B
hypermethylation	O
on	O
p21WAF1	B
induction	O
by	O
STAT	B
activation	O
.	O

In	O
the	O
pRb	B
(	I
-	I
)	I
SAOS-2	O
cell	O
line	O
transiently	O
transfected	O
with	O
a	O
reporter	O
plasmid	O
containing	O
six	O
tal-1	B
binding	I
site	I
,	O
pRb	B
enhances	O
the	O
transcriptional	O
activity	O
of	O
tal-1-E12-Lmo2	B
and	O
tal-1-E12-Lmo2-Ldb1	B
complexes	O
but	O
not	O
that	O
of	O
a	O
tal-1-E12	B
heterodimer	O
.	O

This	O
effect	O
was	O
not	O
seen	O
in	O
conjunction	O
with	O
oxycodone	O
,	O
a	O
morphine	B
-	I
like	I
mu	I
-	I
receptor	I
agonist	O
.	O

Neurofibromatosis	O
of	O
the	O
breast	O
in	O
a	O
patient	O
with	O
Morbus	O
von	O
Recklinghausen	O

In	O
the	O
premating	O
period	O
male	O
rate	O
of	O
aggression	O
was	O
not	O
significantly	O
correlated	O
with	O
testosterone	O
level	O
.	O

Prevention	O
,	O
differential	O
diagnosis	O
and	O
therapy	O
of	O
travel	O
diarrhea	O

This	O
study	O
shows	O
that	O
C	B
/	I
EBPbeta	I
is	O
the	O
predominant	O
C	B
/	I
EBP	I
isoform	I
found	O
in	O
activated	O
stellate	O
cells	O
and	O
that	O
increased	O
C	B
/	I
EBPbeta	I
protein	I
and	O
C	B
/	I
EBPbeta	I
binding	O
to	O
a	O
proximal	O
C	B
/	I
EBP	I
binding	I
site	I
in	O
the	O
promoter	O
mediates	O
the	O
activating	O
effect	O
of	O
acetaldehyde	O
.	O

Mutation	O
analysis	O
demonstrates	O
that	O
the	O
motif	O
TCCCCT	O
is	O
critical	O
for	O
PyRo1	B
interaction	O
.	O

After	O
two	O
successive	O
rounds	O
of	O
selection	O
by	O
focus	O
formation	O
assay	O
,	O
a	O
transforming	O
ribozyme	O
(	O
Rz007	B
)	O
was	O
identified	O
.	O

G.	O
,	O
and	O
Hyde	O
,	O
C.	O

Our	O
results	O
suggest	O
that	O
proteasome	O
inhibition	O
leads	O
to	O
upregulation	O
of	O
specific	O
members	O
of	O
transcription	O
factor	O
families	O
controlling	O
cellular	O
stress	O
response	O
and	O
proliferation	O
.	O

The	O
ATR	O
-	O
X	O
syndrome	O
results	O
from	O
mutations	O
of	O
the	O
XH2	B
gene	I
,	O
located	O
on	O
the	O
X	O
chromosome	O
(	O
Xq13.3	O
)	O
and	O
coding	O
for	O
a	O
transacting	O
factor	O
which	O
regulates	O
gene	O
expression	O
.	O

AIMS	O
:	O
To	O
evaluate	O
the	O
role	O
of	O
environmental	O
intra	O
-	O
uterine	O
factors	O
in	O
determining	O
the	O
birthweights	O
of	O
twins	O
with	O
increased	O
susceptibility	O
to	O
diabetes	O
and	O
discordant	O
for	O
abnormal	O
responses	O
to	O
the	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
and	O
verify	O
the	O
possible	O
association	O
of	O
within	O
-	O
pair	O
birthweight	O
differences	O
and	O
metabolic	O
abnormalities	O
in	O
adult	O
life	O
.	O

In	O
NASCIS	O
III	O
,	O
a	O
randomization	O
imbalance	O
occurred	O
that	O
allocated	O
a	O
disproportionate	O
number	O
of	O
patients	O
with	O
no	O
motor	O
deficit	O
(	O
and	O
therefore	O
no	O
chance	O
for	O
recovery	O
)	O
to	O
the	O
lower	O
dose	O
control	O
group	O
.	O

Penicillin	B
acylase	I
(	O
PA	B
)	O
from	O
Escherichia	O
coli	O
ATCC11105	O
is	O
a	O
periplasmic	O
heterodimer	O
consisting	O
of	O
a	O
24	O
kDa	O
small	O
subunit	O
and	O
a	O
65	O
kDa	O
large	O
subunit	O
.	O

We	O
have	O
isolated	O
and	O
functionally	O
characterized	O
the	O
mouse	O
gene	O
for	O
the	O
C2	O
subunit	O
of	O
the	O
20S	B
proteasome	I
.	O

Furthermore	O
,	O
as	O
in	O
the	O
human	O
gene	O
,	O
the	O
3	O
'	O
end	O
of	O
the	O
Cacna1f	B
gene	I
maps	O
within	O
5	O
kb	O
of	O
the	O
5	O
'	O
end	O
of	O
the	O
mouse	B
synaptophysin	I
gene	I
in	O
a	O
region	O
orthologous	O
to	O
Xp11.23	O
.	O

With	O
the	O
human	B
Rhotekin	I
cDNA	I
as	O
a	O
probe	O
,	O
Northern	O
hybridization	O
revealed	O
that	O
a	O
4.0-kb	O
transcript	O
was	O
expressed	O
at	O
a	O
high	O
level	O
in	O
prostate	O
and	O
at	O
a	O
middle	O
level	O
in	O
13	O
of	O
16	O
tissues	O
examined	O
,	O
but	O
it	O
can	O
not	O
be	O
detected	O
in	O
liver	O
and	O
lung	O
tissues	O
.	O

It	O
is	O
mainly	O
transcribed	O
in	O
neural	O
structures	O
and	O
in	O
developing	O
organs	O
characterized	O
by	O
epithelial	O
-	O
mesenchymal	O
interactions	O
.	O

CONCLUSION	O
:	O
The	O
alpha2-adrenergic	O
antagonist	O
idazoxan	O
increases	O
glucose	O
-	O
induced	O
sympathetic	O
activity	O
but	O
not	O
energy	O
expenditure	O
in	O
obese	O
subjects	O
.	O

ID	O
-	O
PaGIA	O
diphtheria	B
toxin	I
polymer	O
particle	O
diagnostic	O
agent	O
manufactured	O
by	O
DiaMed	O
AG	O
,	O
Switzerland	O
,	O
was	O
tried	O
at	O
bacteriological	O
laboratory	O
of	O
Institute	O
of	O
Childhood	O
Infections	O
in	O
St.	O

Next	O
,	O
we	O
show	O
that	O
two	O
EMS	O
-	O
induced	O
mutations	O
,	O
previously	O
shown	O
to	O
interact	O
genetically	O
with	O
zipper	O
(	O
Ebr	B
)	O
,	O
disrupt	O
the	O
RhoA	B
locus	I
.	O

Therefore	O
,	O
the	O
results	O
indicate	O
that	O
repeated	O
exposure	O
to	O
amphetamine	O
or	O
apomorphine	O
overcomes	O
the	O
context	O
-	O
dependent	O
component	O
of	O
sensitization	O
of	O
amphetamine-	O
or	O
apomorphine	O
-	O
induced	O
stereotyped	O
behavior	O
.	O

Topics	O
reviewed	O
here	O
include	O
:	O
data	O
supporting	O
the	O
association	O
of	O
myositis	O
with	O
cancer	O
and	O
the	O
appropriate	O
evaluations	O
for	O
malignancy	O
in	O
a	O
myositis	O
patient	O
;	O
an	O
approach	O
to	O
the	O
assessment	O
of	O
patients	O
with	O
dermatomyositis	O
sine	O
myositis	O
;	O
the	O
usefulness	O
of	O
the	O
clinicopathological	O
and	O
serological	O
classifications	O
;	O
a	O
discussion	O
of	O
whether	O
childhood	O
and	O
adult	O
myositis	O
are	O
the	O
same	O
or	O
different	O
entities	O
;	O
a	O
review	O
of	O
those	O
prognostic	O
factors	O
to	O
consider	O
in	O
the	O
clinical	O
management	O
of	O
myositis	O
patients	O
;	O
current	O
approaches	O
and	O
their	O
limitations	O
for	O
assessing	O
disease	O
activity	O
and	O
damage	O
.	O

The	O
science	O
of	O
tissue	O
engineering	O
.	O

Acquired	O
bile	O
duct	O
blockage	O
:	O
entry	O
of	O
hepatobiliary	O
agent	O
into	O
an	O
intrahepatic	O
abscess	O
.	O

The	O
outer	O
diameter	O
and	O
the	O
thickness	O
of	O
the	O
rotor	O
are	O
60	O
mm	O
and	O
8	O
mm	O
,	O
respectively	O
.	O

Both	O
the	O
MVBF	O
and	O
the	O
maximum	O
EMG	O
activity	O
in	O
the	O
right	O
masseter	O
and	O
the	O
left	O
anterior	O
temporalis	O
muscles	O
were	O
significantly	O
decreased	O
during	O
muscle	O
pain	O
when	O
the	O
subjects	O
bit	O
on	O
the	O
painful	O
side	O
.	O

CONCLUSIONS	O
:	O
There	O
is	O
a	O
relation	O
in	O
the	O
topography	O
of	O
some	O
visual	O
field	O
areas	O
assessed	O
by	O
SWAP	O
and	O
the	O
inferotemporal	O
neuroretinal	O
rim	O
area	O
,	O
which	O
may	O
play	O
a	O
role	O
in	O
the	O
diagnosis	O
and	O
follow	O
-	O
up	O
of	O
suspected	O
glaucoma	O
.	O

The	O
total	O
alkaloids	O
contained	O
in	O
the	O
peel	O
of	O
Atzimba	O
,	O
Lopez	O
,	O
Marciana	O
,	O
Montsama	O
,	O
Murca	O
,	O
and	O
Puebla	O
was	O
lower	O
than	O
the	O
limits	O
recommended	O
for	O
food	O
safety	O
.	O

The	O
detection	O
success	O
rate	O
was	O
determined	O
for	O
different	O
markers	O
using	O
this	O
MEK	B
.	O

ACE-2	B
has	O
a	O
hydrophobic	O
C	O
terminus	O
of	O
H	O
type	O
.	O

Furthermore	O
,	O
a	O
pTyr317	B
Shc	I
phosphopeptide	I
selectively	O
recognized	O
Grb2	B
,	O
Sos1	B
,	O
SHIP	B
,	O
and	O
the	O
p85	B
subunit	I
of	O
phosphatidylinositol	B
3	I
'	I
kinase	I
from	O
mast	O
cells	O
,	O
as	O
characterized	O
by	O
mass	O
spectrometry	O
.	O

Although	O
increased	O
expression	O
of	O
the	O
HMG	B
-	I
I	I
/	I
Y	I
proteins	I
is	O
associated	O
with	O
cellular	O
proliferation	O
,	O
neoplastic	O
transformation	O
,	O
and	O
several	O
human	O
cancers	O
,	O
the	O
role	O
of	O
these	O
proteins	O
in	O
the	O
pathogenesis	O
of	O
malignancy	O
remains	O
unclear	O
.	O

The	O
naltrexone	O
/	O
lofexidine	O
combination	O
was	O
associated	O
with	O
a	O
more	O
rapid	O
resolution	O
of	O
the	O
opiate	O
withdrawal	O
syndrome	O
than	O
a	O
7-day	O
lofexidine	O
-	O
only	O
treatment	O
schedule	O
,	O
without	O
substantial	O
increases	O
in	O
withdrawal	O
symptoms	O
or	O
hypotensive	O
side	O
-	O
effects	O
.	O

The	O
first	O
symptoms	O
of	O
enzootic	O
calcinosis	O
were	O
noted	O
in	O
March	O
1998	O
,	O
when	O
some	O
of	O
the	O
cows	O
developed	O
locomotor	O
abnormalities	O
.	O

Transcriptional	O
regulation	O
of	O
the	O
mouse	B
cytosolic	I
chaperonin	I
subunit	I
gene	I
Ccta	B
/	I
t	I
-	I
complex	I
polypeptide	I
1	I
by	O
selenocysteine	B
tRNA	I
gene	I
transcription	I
activating	I
factor	I
family	I
zinc	I
finger	I
proteins	I
.	O

The	O
unfolded	O
protein	O
response	O
regulates	O
multiple	O
aspects	O
of	O
secretory	O
and	O
membrane	O
protein	O
biogenesis	O
and	O
endoplasmic	O
reticulum	O
quality	O
control	O
.	O

PNRC	B
:	O
a	O
proline	O
-	O
rich	O
nuclear	O
receptor	O
coregulatory	O
protein	O
that	O
modulates	O
transcriptional	O
activation	O
of	O
multiple	O
nuclear	O
receptors	O
including	O
orphan	O
receptors	O
SF1	B
(	O
steroidogenic	B
factor	I
1	I
)	O
and	O
ERRalpha1	B
(	O
estrogen	B
related	I
receptor	I
alpha-1	I
)	O
.	O

However	O
,	O
there	O
is	O
still	O
a	O
subset	O
of	O
tumors	O
that	O
displayed	O
no	O
changes	O
in	O
these	O
genes	O
.	O

We	O
have	O
shown	O
that	O
the	O
epidural	O
(	O
EPI	O
)	O
delivery	O
of	O
morphine	O
encapsulated	O
in	O
multivesicular	O
liposomes	O
(	O
DepoFoam	O
drug	O
delivery	O
system	O
)	O
produces	O
a	O
sustained	O
clearance	O
of	O
morphine	O
and	O
a	O
prolonged	O
analgesia	O
.	O

Following	O
EPI	O
-	O
C0401	O
,	O
but	O
not	O
saline	O
or	O
DepoFoam	O
vehicle	O
,	O
there	O
were	O
transient	O
(	O
<	O
72	O
hr	O
)	O
decreases	O
in	O
food	O
consumption	O
,	O
arousal	O
,	O
hindlimb	O
muscle	O
tone	O
,	O
and	O
body	O
temperature	O
.	O

Bailey	O
Instruments	O
and	O
Owen	O
Mumford	O
filaments	O
were	O
the	O
most	O
accurate	O
with	O
100	O
%	O
buckling	O
within	O
+	O
/-1.0	O
g	O
of	O
10	O
g.	O

The	O
effect	O
of	O
water	O
deprivation	O
for	O
19	O
h	O
on	O
renal	O
Na	O
excretion	O
of	O
conscious	O
adrenalectomized	O
(	O
ADX	O
)	O
sheep	O
maintained	O
on	O
a	O
constant	O
intravenous	O
infusion	O
of	O
aldosterone	O
and	O
cortisol	O
(	O
ADX	O
-	O
constant	O
steroid	O
sheep	O
)	O
was	O
investigated	O
.	O

Neither	O
is	O
it	O
a	O
major	O
cause	O
of	O
rehydration	O
-	O
induced	O
renal	O
Na	O
retention	O
.	O

CONCLUSION	O
:	O
Rheumatic	O
fever	O
in	O
the	O
Nazareth	O
area	O
is	O
still	O
manifest	O
.	O

Antithrombin	B
III	I
deficiency	O
:	O
when	O
substitute	O
,	O
when	O
heparin	O
?	O

Thrombosis	O
ABC	O
,	O
3	O
:	O
The	O
role	O
of	O
antithrombin	B
III	I

Specific	O
class	B
I	I
and	I
II	I
histone	I
deacetylases	I
(	O
HDACs	B
)	O
interact	O
in	O
vivo	O
with	O
BCoR	B
,	O
suggesting	O
that	O
BCoR	B
may	O
functionally	O
link	O
these	O
two	O
classes	O
of	O
HDACs	B
.	O

After	O
screening	O
the	O
Berkeley	O
Drosophila	O
Genome	O
Project	O
database	O
with	O
sequences	O
from	O
a	O
recently	O
characterized	O
Leu	B
-	I
rich	I
repeats	I
-	I
containing	I
G	I
protein	I
-	I
coupled	I
receptor	I
(	O
LGR	B
)	O
from	O
Drosophila	O
(	O
DLGR-1	B
)	O
,	O
we	O
identified	O
a	O
second	O
gene	O
for	O
a	O
different	O
LGR	B
(	O
DLGR-2	B
)	O
and	O
cloned	O
its	O
cDNA	O
.	O

Degenerate	O
primers	O
homologous	O
to	O
highly	O
conserved	O
regions	O
of	O
known	O
CYP3A	B
sequences	I
were	O
used	O
for	O
initial	O
RT	O
-	O
PCRs	O
.	O

Methyllevamisole	O
was	O
used	O
as	O
the	O
internal	O
standard	O
.	O

Resistance	O
ratios	O
for	O
the	O
other	O
field	O
strains	O
obtained	O
by	O
comparison	O
with	O
the	O
R5	O
strain	O
ranged	O
from	O
24.5	O
to	O
239	O
for	O
topical	O
application	O
and	O
from	O
1.2	O
to	O
9.8	O
for	O
the	O
glass	O
jar	O
method	O
.	O

Only	O
transcripts	O
specific	O
for	O
TSGF-2	B
are	O
detected	O
in	O
ovary	O
and	O
testes	O
tissues	O
of	O
adults	O
as	O
well	O
as	O
in	O
puparia	O
,	O
while	O
neither	O
gene	O
is	O
expressed	O
during	O
the	O
larval	O
developmental	O
stages	O
.	O

Reliability	O
of	O
cervical	O
range	O
of	O
motion	O
using	O
the	O
OSI	O
CA	O
6000	O
spine	O
motion	O
analyser	O
on	O
asymptomatic	O
and	O
symptomatic	O
subjects	O
.	O

Since	O
the	O
RINX	B
gene	I
is	O
likely	O
an	O
ortholog	O
of	O
the	O
goldfish	B
Vsx1	I
gene	I
,	O
it	O
has	O
been	O
named	O
VSX1	B
by	O
the	O
Human	O
Gene	O
Nomenclature	O
Committee	O
.	O

The	O
chromosomal	O
localization	O
on	O
distal	O
chromosome	O
7	O
places	O
it	O
in	O
a	O
cluster	O
of	O
imprinted	O
genes	O
,	O
flanked	O
by	O
the	O
previously	O
described	O
Tapa1	B
and	O
Kcnq1	B
genes	I
.	O

Activation	O
of	O
PKA	B
by	O
8-bromo	O
-	O
cyclic	O
AMP	O
or	O
forskolin	O
,	O
and	O
inhibition	O
of	O
PKC	B
by	O
calphostin	O
C	O
,	O
resulted	O
in	O
a	O
significant	O
decrease	O
in	O
3TP	B
activity	O
as	O
well	O
as	O
in	O
vitro	O
ERK	B
kinase	I
activity	O
in	O
CRAC	O
.	O

Double	O
mutant	O
analysis	O
suggests	O
that	O
Rad54p	B
and	O
Mus81p	B
act	O
in	O
one	O
pathway	O
for	O
the	O
repair	O
of	O
,	O
or	O
tolerance	O
to	O
,	O
UV	O
-	O
induced	O
DNA	O
damage	O
.	O

The	O
measurement	O
of	O
NO	O
in	O
biological	O
systems	O
using	O
chemiluminescence	O
.	O

Atorvastatin	O
was	O
the	O
most	O
cost	O
-	O
effective	O
HMG	B
-	I
CoA	I
reductase	I
inhibitor	O
.	O

Interestingly	O
,	O
although	O
E	O
domains	O
of	O
these	O
two	O
receptors	O
are	O
much	O
less	O
conserved	O
,	O
replacement	O
of	O
this	O
domain	O
in	O
rtER	B
by	O
its	O
human	O
counterpart	O
resulted	O
in	O
higher	O
estradiol	O
sensitivity	O
but	O
no	O
increase	O
in	O
the	O
magnitude	O
of	O
transactivation	O
.	O

G	O
-	O
DNA	O
is	O
a	O
four	O
-	O
stranded	O
DNA	O
structure	O
with	O
diverse	O
putative	O
biological	O
roles	O
.	O

The	O
effectiveness	O
of	O
NRT	O
appears	O
to	O
be	O
largely	O
independent	O
of	O
the	O
intensity	O
of	O
additional	O
support	O
provided	O
to	O
the	O
smoker	O
.	O

8	O
%	O
(	O
95	O
%	O
CI	O
,	O
21.3	O
-	O
44.3	O
%	O
)	O
.	O

In	O
contrast	O
,	O
the	O
action	O
of	O
GLP-1	B
at	O
the	O
CRE	O
was	O
not	O
blocked	O
by	O
cotransfection	O
with	O
M1-CREB	B
,	O
an	O
isoform	O
that	O
lacks	O
a	O
consensus	O
serine	O
residue	O
serving	O
as	O
substrate	O
for	O
PKA	B
-	O
mediated	O
phosphorylation	O
.	O

Because	O
all	O
PDGFbetaR	B
fusions	I
described	O
thus	O
far	O
result	O
in	O
splicing	O
to	O
a	O
common	O
exon	O
of	O
this	O
gene	O
,	O
we	O
performed	O
5'-rapid	O
amplification	O
of	O
cDNA	O
ends	O
PCR	O
on	O
patient	O
RNA	O
.	O

CONCLUSIONS	O
:	O
In	O
essential	O
hypertension	O
an	O
acute	O
protein	O
load	O
induces	O
a	O
decrease	O
in	O
GFR	O
that	O
may	O
normalize	O
under	O
antihypertensive	O
treatment	O
.	O

The	O
carboxyl	O
-	O
terminal	O
proline	O
-	O
rich	O
domain	O
of	O
SOS1	B
is	O
involved	O
in	O
the	O
interaction	O
with	O
the	O
PLC	B
-	I
gamma1	I
SH3	B
domain	I
.	O

Six	O
distinct	O
Ets	B
mRNAs	I
were	O
identified	O
:	O
Ets2	B
,	O
Fli1	B
,	O
GABPalpha	B
,	O
SAP1	B
,	O
Elk1	B
,	O
and	O
PE1	B
.	O

A	O
2	O
kb	O
transcript	O
was	O
isolated	O
from	O
brain	O
that	O
encodes	O
a	O
approximately	O
57	O
kDa	O
protein	O
;	O
the	O
predicted	O
protein	O
contains	O
the	O
known	O
N	B
-	I
terminal	I
Ets	I
domain	I
of	O
PE1	B
and	O
a	O
novel	O
C	O
-	O
terminal	O
domain	O
with	O
signficant	O
homology	O
to	O
murine	B
ERF	I
.	O

Intravenous	O
versus	O
oral	O
administration	O
of	O
amitriptyline	O
in	O
patients	O
with	O
major	O
depression	O
.	O

Deletion	O
of	O
the	O
RVH	B
domain	I
resulted	O
in	O
loss	O
of	O
Ca	O
(	O
2+	O
)	O
-dependent	O
activation	O
.	O

Erythema	O
exsudativum	O
multiforme	O
induced	O
by	O
granulocyte	B
colony	I
-	I
stimulating	I
factor	I
in	O
an	O
allogeneic	O
peripheral	O
blood	O
stem	O
cell	O
donor	O
.	O

It	O
is	O
now	O
well	O
accepted	O
that	O
the	O
p53	B
C	I
-	I
terminus	I
plays	O
a	O
central	O
role	O
in	O
controlling	O
the	O
activity	O
of	O
the	O
wild	O
-	O
type	O
molecule	O
.	O

The	O
transcription	O
factor	O
Jun	B
(	O
c	B
-	I
Jun	I
)	O
functions	O
as	O
a	O
recipient	O
of	O
extracellular	O
growth	O
signals	O
and	O
converts	O
them	O
into	O
patterns	O
of	O
gene	O
expression	O
.	O

Developmental	O
toxicity	O
of	O
the	O
class	O
III	O
antiarrhythmic	O
agent	O
almokalant	O
in	O
mice	O
.	O

This	O
compound	O
is	O
the	O
main	O
bioactive	O
metabolite	O
of	O
trimebutine	O
II	O
(	O
Debridat	O
,	O
CAS	O
39133	O
-	O
31	O
-	O
8	O
)	O
,	O
an	O
antispasmodic	O
widely	O
used	O
for	O
intestinal	O
diseases	O
since	O
1969	O
.	O

In	O
addition	O
to	O
its	O
effect	O
in	O
augmenting	O
the	O
neutrophil	O
response	O
to	O
eccentric	O
exercise	O
,	O
vitamin	O
E	O
causes	O
a	O
greater	O
increase	O
in	O
circulating	O
creatine	B
kinase	I
activity	O
,	O
perhaps	O
indicating	O
increased	O
skeletal	O
muscle	O
repair	O
.	O

This	O
enabled	O
the	O
formation	O
of	O
stem	O
-	O
loop	O
templates	O
with	O
the	O
fusion	O
point	O
of	O
the	O
chimeric	O
transcript	O
in	O
the	O
loop	O
and	O
the	O
use	O
of	O
MLL	B
primers	O
in	O
two	O
-	O
sided	O
PCR	O
.	O

Measurements	O
were	O
compared	O
with	O
two	O
computerised	O
treatment	O
planning	O
systems	O
--	O
Theraplan	O
VO5B	O
and	O
ADAC	O
Pinnacle3	O
V4.0b	O
.	O

Activation	O
was	O
biphasic	O
;	O
peaking	O
at	O
5	O
-	O
10	O
min	O
and	O
24	O
h	O
after	O
treatment	O
.	O

Partial	O
correction	O
of	O
anemia	O
with	O
recombinant	B
human	I
erythropoietin	I
likely	O
reduces	O
left	O
ventricular	O
mass	O
and	O
volume	O
.	O

This	O
study	O
demonstrated	O
that	O
the	O
PFA-100	O
analyzer	O
can	O
accurately	O
assess	O
vWF	B
-	O
dependent	O
platelet	O
function	O
and	O
detect	O
other	O
platelet	O
defects	O
under	O
high	O
shear	O
stress	O
in	O
complex	O
patient	O
populations	O
.	O

We	O
recently	O
reported	O
the	O
molecular	O
cloning	O
of	O
a	O
PL	B
scramblase	I
of	O
human	O
(	O
HuPLSCR1	B
)	O
and	O
mouse	O
origin	O
,	O
respectively	O
.	O

Using	O
an	O
oligomer	O
duplex	O
5'-A	O
(	O
GGGTTA	O
)	O
(	O
5	O
)	O
-3'	O
/	O
5'-	O
(	O
TAACCC	O
)	O
(	O
5	O
)	O
T-3	O
'	O
as	O
a	O
template	O
-	O
primer	O
,	O
we	O
show	O
that	O
both	O
the	O
Klenow	B
fragment	I
of	I
Escherichia	I
coli	I
DNA	I
polymerase	I
I	I
and	O
HIV	B
reverse	I
transcriptase	I
could	O
expand	O
telomere	O
DNA	O
sequences	O
as	O
well	O
,	O
giving	O
products	O
greater	O
than	O
the	O
size	O
of	O
the	O
template	O
DNA	O
.	O

Mutations	O
in	O
the	O
RP2	B
locus	I
at	I
Xp11.3	I
were	O
found	O
in	O
a	O
further	O
10	O
-	O
20	O
%	O
of	O
XLRP	O
patients	O
,	O
as	O
predicted	O
from	O
linkage	O
studies	O
.	O

Subsequently	O
,	O
HD	O
inhibited	O
healing	O
because	O
it	O
significantly	O
delayed	O
epithelialization	O
and	O
caused	O
protracted	O
inflammation	O
.	O

The	O
effectiveness	O
of	O
the	O
haemodialysate	O
Solcoseryl	O
for	O
second	O
-	O
intention	O
wound	O
healing	O
in	O
horses	O
and	O
ponies	O
.	O

These	O
findings	O
were	O
reinforced	O
by	O
an	O
analysis	O
that	O
was	O
restricted	O
to	O
living	O
donor	O
transplants	O
without	O
acute	O
rejection	O
.	O

These	O
results	O
further	O
support	O
an	O
important	O
role	O
for	O
CBF2	B
in	O
mediating	O
EBNA2	B
transactivation	O
;	O
they	O
identify	O
the	O
hnRNP	B
protein	I
AUF1	I
as	O
a	O
major	O
component	O
of	O
CBF2	B
and	O
are	O
also	O
the	O
first	O
evidence	O
of	O
a	O
cis	O
-	O
acting	O
sequence	O
other	O
than	O
a	O
CBF1	B
binding	I
element	I
that	O
is	O
able	O
to	O
confer	O
responsiveness	O
to	O
EBNA2	B
.	O

The	O
genome	O
of	O
the	O
human	O
herpesvirus	O
8	O
(	O
HHV-8	O
)	O
contains	O
a	O
cluster	O
of	O
open	O
reading	O
frames	O
(	O
ORFs	O
)	O
encoding	O
proteins	O
with	O
homology	O
to	O
the	O
cellular	O
transcription	O
factors	O
of	O
the	O
interferon	B
regulatory	I
factor	I
(	O
IRF	B
)	O
family	O
.	O

Despite	O
these	O
limitations	O
the	O
CHIME	O
monitor	O
provides	O
an	O
opportunity	O
to	O
record	O
physiological	O
data	O
previously	O
unavailable	O
in	O
the	O
home	O
.	O

CREST	O
syndrome	O
;	O
a	O
changing	O
clinical	O
significance	O

Troglitazone	O
also	O
induced	O
an	O
endogenous	B
PPARgamma	I
target	I
gene	I
in	O
T24	O
cells	O
,	O
adipocyte	B
-	I
type	I
fatty	I
acid	I
binding	I
protein	I
(	O
A	B
-	I
FABP	I
)	O
,	O
the	O
expression	O
of	O
which	O
correlates	O
with	O
bladder	O
cancer	O
differentiation	O
.	O

The	O
RS447	B
human	B
megasatellite	I
tandem	I
repetitive	I
sequence	I
encodes	O
a	O
novel	O
deubiquitinating	O
enzyme	O
with	O
a	O
functional	O
promoter	O
.	O

Previous	O
experience	O
and	O
contextual	O
cues	O
are	O
essential	O
elements	O
in	O
the	O
generation	O
of	O
a	O
subjective	O
prediction	O
.	O

To	O
characterize	O
this	O
effect	O
,	O
we	O
looked	O
for	O
targets	O
of	O
NS1	B
influenza	I
virus	I
protein	I
among	O
cellular	O
translation	O
factors	O
.	O

(	O
iii	O
)	O
In	O
these	O
cells	O
,	O
PKCbeta	B
plays	O
a	O
unique	O
Ras	B
-	O
independent	O
role	O
in	O
mediating	O
insulin	B
but	O
not	O
EGF	B
or	O
other	O
growth	O
factor	O
mitogenic	O
signals	O
.	O

However	O
,	O
it	O
is	O
not	O
known	O
whether	O
the	O
recently	O
identified	O
isoforms	O
Vav2	B
and	O
Vav3	B
,	O
which	O
are	O
broadly	O
expressed	O
,	O
can	O
couple	O
with	O
similar	O
classes	O
of	O
receptors	O
,	O
nor	O
is	O
it	O
known	O
whether	O
all	O
Vav	B
isoforms	I
possess	O
identical	O
functional	O
activities	O
.	O

Transcriptional	O
regulation	O
of	O
fbp1	B
promoter	I
constructs	I
containing	O
only	O
UAS1	O
or	O
UAS2	O
confirms	O
that	O
the	O
PKA	B
and	O
MAPK	B
regulation	O
is	O
targeted	O
to	O
both	O
sites	O
.	O

X	O
-	O
ray	O
crystallographic	O
data	O
show	O
that	O
the	O
PLZF	B
BTB	B
/	O
POZ	O
domain	O
forms	O
an	O
obligate	O
homodimer	O
via	O
an	O
extensive	O
interface	O
.	O

The	O
ability	O
of	O
SMRT	B
to	O
associate	O
with	O
these	O
transcription	O
factors	O
and	O
thereby	O
to	O
mediate	O
repression	O
is	O
strongly	O
inhibited	O
by	O
activation	O
of	O
tyrosine	B
kinase	I
signaling	O
pathways	O
,	O
such	O
as	O
that	O
represented	O
by	O
the	O
epidermal	B
growth	I
factor	I
receptor	I
.	O

Patients	O
were	O
randomly	O
assigned	O
to	O
treatment	O
with	O
the	O
ACE	B
inhibitor	O
perindopril	O
(	O
and	O
the	O
diuretic	O
indapamide	O
for	O
those	O
with	O
no	O
definite	O
indication	O
for	O
or	O
contraindication	O
to	O
treatment	O
with	O
a	O
diuretic	O
)	O
or	O
matching	O
placebo	O
(	O
s	O
)	O
.	O

Sequence	O
analysis	O
reveals	O
that	O
the	O
newly	O
discovered	O
oasA2	B
gene	I
represents	O
a	O
pseudogene	O
that	O
is	O
still	O
transcribed	O
,	O
but	O
is	O
not	O
functionally	O
translated	O
.	O

Two	O
distinct	O
recessive	O
susceptibility	O
loci	O
for	O
vasculitis	O
were	O
mapped	O
on	O
chromosome	O
(	O
Chr	O
)	O
4	O
at	O
D4Mit89	B
and	O
D4Mit147	B
in	O
both	O
progenies	O
.	O

TNF	B
-	I
alpha	I
induced	O
a	O
dose-	O
and	O
time	O
-	O
dependent	O
increase	O
in	O
cyclooxygenase-2	B
(	O
COX-2	B
)	O
expression	O
and	O
PGE2	O
formation	O
in	O
human	O
NCI	O
-	O
H292	O
epithelial	O
cells	O
.	O

Mis3	B
is	O
needed	O
for	O
the	O
formation	O
of	O
18S	B
ribosome	I
RNA	I
,	O
and	O
may	O
hence	O
direct	O
the	O
level	O
of	O
proteins	O
required	O
for	O
the	O
coupling	O
.	O

CONCLUSION	O
:	O
Vitrectomy	O
for	O
vitreous	O
hemorrhage	O
in	O
Terson	O
syndrome	O
is	O
a	O
safe	O
and	O
effective	O
procedure	O
,	O
offering	O
a	O
rapid	O
and	O
prolonged	O
improvement	O
in	O
vision	O
.	O

RNA	O
in	O
situ	O
hybridization	O
on	O
brain	O
sections	O
of	O
normal	O
human	O
embryos	O
revealed	O
a	O
strong	O
labeling	O
in	O
restricted	O
areas	O
of	O
the	O
cerebral	O
cortex	O
.	O

To	O
facilitate	O
manipulation	O
of	O
large	O
genomic	O
sequences	O
,	O
we	O
developed	O
a	O
method	O
of	O
converting	O
Escherichia	O
coli	O
P1	O
artificial	O
chromosomes	O
(	O
PACs	O
)	O
into	O
yeast	O
artificial	O
chromosomes	O
(	O
YACs	O
)	O
.	O

A	O
degenerate	O
DNA	O
transposon	O
,	O
Pat	B
,	O
was	O
identified	O
in	O
the	O
genomes	O
of	O
various	O
wild	O
-	O
type	O
strains	O
of	O
the	O
filamentous	O
fungus	O
Podospora	O
anserina	O
.	O

However	O
,	O
the	O
presence	O
of	O
Tax	B
I	I
increased	O
the	O
extent	O
and	O
altered	O
the	O
profile	O
of	O
proteins	O
binding	O
TRE-2	B
in	O
vivo	O
.	O

A	O
2.3-kb	O
full	O
-	O
length	O
cDNA	O
clone	O
of	O
an	O
Atlantic	B
halibut	I
Mx	I
gene	I
was	O
isolated	O
from	O
a	O
liver	O
cDNA	O
library	O
.	O

Once	O
HIT	O
II	O
is	O
suspected	O
,	O
heparin	O
(	O
and	O
low	O
-	O
molecular	O
-	O
weight	O
heparins	O
)	O
should	O
be	O
stopped	O
immediately	O
.	O

The	O
reduced	O
efficiency	O
in	O
the	O
glycosylase	B
activity	O
is	O
also	O
reflected	O
in	O
a	O
reduced	O
ability	O
of	O
S120	B
K	I
MutY	I
to	O
prevent	O
DNA	O
mutations	O
in	O
vivo	O
.	O

METHODS	O
AND	O
RESULTS	O
:	O
We	O
prospectively	O
compared	O
the	O
automated	O
measurements	O
of	O
left	O
ventricular	O
ejection	O
fraction	O
(	O
LVEF	O
)	O
and	O
volumes	O
from	O
rest	O
-	O
injected	O
gated	O
Technetium	O
99	O
m	O
(	O
Tc99	O
m	O
)	O
perfusion	O
SPECT	O
with	O
equilibrium	O
radionuclide	O
angiocardiography	O
(	O
ERNA	O
)	O
in	O
62	O
patients	O
and	O
the	O
assessment	O
of	O
regional	O
function	O
with	O
echocardiography	O
in	O
22	O
patients	O
.	O

The	O
2	O
cDNAs	O
differed	O
in	O
the	O
length	O
of	O
their	O
respective	O
3	O
'	O
untranslated	O
regions	O
,	O
of	O
577	O
bp	O
in	O
Cp	B
.	I

F6	B
and	O
72	O
bp	O
in	O
Cp	B
.	I

F10	B
,	O
in	O
both	O
of	O
which	O
a	O
putative	O
polyadenylation	O
signal	O
was	O
identified	O
.	O

The	O
spacing	O
of	O
the	O
essential	O
N	O
-	O
terminal	O
domain	O
(	O
END	O
)	O
relative	O
to	O
the	O
HFD	B
can	O
be	O
changed	O
significantly	O
without	O
an	O
apparent	O
effect	O
on	O
Cse4p	B
function	O
.	O

In	O
invertebrates	O
,	O
Fhit	B
is	O
encoded	O
as	O
a	O
fusion	O
protein	O
with	O
Nit	B
,	O
a	O
member	O
of	O
the	O
nitrilase	B
superfamily	I
.	O

The	O
manifestations	O
often	O
include	O
a	O
moderate	O
thrombocytopenia	O
and	O
,	O
less	O
commonly	O
,	O
hemolysis	O
.	O

A	O
beta2	B
RARE	I
reporter	I
construct	I
in	O
which	O
the	O
methylation	O
-	O
susceptible	O
cytosines	O
in	O
the	O
sense	O
strand	O
were	O
replaced	O
by	O
thymine	O
displayed	O
marked	O
loss	O
of	O
activity	O
in	O
a	O
replicated	O
chromatin	O
-	O
dependent	O
manner	O
.	O

Multiparity	O
had	O
a	O
protective	O
effect	O
with	O
0.66	O
less	O
risk	O
(	O
95	O
%	O
CI	O
0.44	O
-	O
0.99	O
)	O
.	O

Picture	O
the	O
smell	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
evaluate	O
the	O
level	O
of	O
oxidative	O
stress	O
in	O
healthy	O
controls	O
(	O
CTL	O
)	O
compared	O
with	O
CRF	O
and	O
HD	O
patients	O
before	O
(	O
pre	O
-	O
HD	O
)	O
and	O
after	O
(	O
post	O
-	O
HD	O
)	O
the	O
dialysis	O
session	O
,	O
carried	O
out	O
on	O
a	O
high	O
biocompatible	O
polyacrylonitrile	O
membrane	O
AN69	O
.	O

Taken	O
together	O
,	O
they	O
uphold	O
the	O
emerging	O
concern	O
that	O
women	O
with	O
ER	B
(	I
+	I
)	I
cancers	O
may	O
not	O
benefit	O
significantly	O
from	O
endocrine	O
treatment	O
if	O
the	O
tumors	O
also	O
overexpress	O
HER-2	B
.	O

Promoter	O
activity	O
was	O
dose	O
-	O
dependently	O
inhibited	O
by	O
cotransfection	O
with	O
either	O
ras	B
or	O
mos	B
oncogenes	I
,	O
but	O
oncogene	O
inhibition	O
was	O
reversed	O
and	O
the	O
overall	O
activity	O
increased	O
when	O
cells	O
were	O
treated	O
with	O
the	O
MAP	B
kinase	I
kinase	I
(	O
MKK	B
)	O
inhibitor	O
PD98059	O
.	O

Our	O
results	O
indicate	O
that	O
the	O
expression	O
of	O
Cktsf1b1	B
,	O
a	O
gene	O
associated	O
with	O
early	O
development	O
and	O
cell	O
transformation	O
,	O
is	O
sensitive	O
to	O
MKK	B
levels	O
and	O
may	O
be	O
regulated	O
via	O
multiple	O
transcription	O
factor	O
complexes	O
.	O

Functional	O
magnetic	O
resonance	O
imaging	O
(	O
fMRI	O
)	O
has	O
been	O
increasingly	O
used	O
in	O
studying	O
human	O
brain	O
function	O
given	O
its	O
non	O
-	O
invasive	O
feature	O
and	O
good	O
spatial	O
resolution	O
.	O

After	O
declamping	O
of	O
the	O
aorta	O
,	O
there	O
were	O
also	O
severe	O
edema	O
,	O
local	O
fibre	O
necrosis	O
,	O
and	O
adhesion	O
of	O
leucocytes	O
,	O
whereas	O
muscle	O
fibre	O
areas	O
became	O
3,935.18	O
micro	O
531	O
microm	O
(	O
2	O
)	O
for	O
type	O
I	O
and	O
5,804	O
+	O
/-	O

1,075	O
microm	O
(	O
2	O
)	O
for	O
type	O
II	O
.	O

The	O
results	O
indicate	O
that	O
the	O
relationship	O
between	O
comprehension	O
and	O
production	O
is	O
different	O
at	O
different	O
stages	O
in	O
development	O
.	O

It	O
was	O
found	O
that	O
increase	O
in	O
the	O
RH	O
level	O
boosts	O
the	O
current	O
values	O
by	O
2	O
-	O
3	O
orders	O
of	O
magnitude	O
;	O
contrariwise	O
,	O
the	O
voltage	O
values	O
rise	O
by	O
about	O
three	O
times	O
with	O
drop	O
in	O
the	O
RH	O
.	O

The	O
tumor	B
-	I
suppressor	I
protein	I
p53	I
is	O
involved	O
in	O
maintaining	O
genomic	O
stability	O
.	O

Abrogation	O
of	O
p53	B
function	O
by	O
E6	B
resulted	O
in	O
an	O
increase	O
in	O
the	O
spontaneous	O
mutation	O
frequencies	O
at	O
the	O
heterozygous	O
thymidine	B
kinase	I
(	O
TK	B
)	O
locus	O
but	O
not	O
at	O
the	O
hemizygous	O
hypoxanthine	B
phosphoribosyl	I
transferase	I
(	O
HPRT	B
)	O
locus	O
.	O

The	O
importance	O
of	O
this	O
new	O
epidemiological	O
profile	O
of	O
schistosomiasis	O
in	O
the	O
State	O
of	O
Pernambuco	O
relies	O
on	O
the	O
fact	O
that	O
it	O
can	O
be	O
related	O
with	O
the	O
drastic	O
human	O
interference	O
on	O
the	O
environment	O
.	O

RESULTS	O
:	O
No	O
significant	O
deformation	O
in	O
vertebral	O
artery	O
flow	O
was	O
noted	O
in	O
the	O
flexion	O
-	O
distraction	O
Stage	O
I	O
injuries	O
within	O
the	O
physiologic	O
range	O
of	O
cervical	O
flexion	O
.	O

The	O
human	O
cDNA	O
clone	O
NFBD1	O
(	O
previously	O
designated	O
KIAA0170	O
)	O
encodes	O
a	O
novel	O
protein	O
(	O
2089	O
amino	O
acids	O
in	O
length	O
;	O
calculated	O
molecular	O
mass	O
226,440	O
D	O
)	O
with	O
possible	O
BRCT	B
domains	I
at	O
its	O
carboxy	O
terminus	O
(	O
amino	O
acid	O
residues	O
1894	O
-	O
2089	O
)	O
.	O

RESULTS	O
:	O
Neither	O
basal	O
FSH	B
level	O
nor	O
stimulated	O
FSH	B
level	O
alone	O
were	O
statistically	O
significant	O
predictors	O
of	O
IVF	O
success	O
;	O
however	O
,	O
no	O
patient	O
with	O
a	O
day	O
3	O
FSH	B
level	O
>	O
11.1	O
mIU	O
/	O
ml	O
or	O
a	O
stimulated	O
day	O
10	O
FSH	B
level	O
>	O
13.5	O
mIU	O
/	O
ml	O
conceived	O
and	O
carried	O
a	O
pregnancy	O
.	O

Parathyroid	B
hormone	I
regulation	O
of	O
bone	B
sialoprotein	I
(	O
BSP	B
)	O
gene	O
transcription	O
is	O
mediated	O
through	O
a	O
pituitary	B
-	I
specific	I
transcription	I
factor-1	I
(	O
Pit-1	B
)	O
motif	O
in	O
the	O
rat	B
BSP	I
gene	I
promoter	I
.	O

Linking	O
continuous	O
community	O
-	O
based	O
morbidity	O
recording	O
of	O
influenza	O
-	O
like	O
illness	O
(	O
ILI	O
)	O
with	O
virological	O
sampling	O
has	O
consistently	O
proved	O
its	O
value	O
as	O
one	O
of	O
the	O
earliest	O
indicators	O
of	O
circulating	O
influenza	O
activity	O
.	O

The	O
muskox	O
is	O
a	O
new	O
host	O
record	O
for	O
T.	O
gondii	O
.	O

We	O
show	O
here	O
that	O
this	O
difference	O
is	O
due	O
to	O
the	O
presence	O
of	O
a	O
Mot3	B
binding	I
site	I
in	O
OpA.	B

The	O
article	O
deals	O
with	O
the	O
diagnosing	O
and	O
correction	O
of	O
reversible	O
ischemia	O
of	O
the	O
intestine	O
.	O

Functional	O
recognition	O
of	O
5	O
'	O
splice	O
site	O
by	O
U4	B
/	O
U6.U5	B
tri	O
-	O
snRNP	O
defines	O
a	O
novel	O
ATP	O
-	O
dependent	O
step	O
in	O
early	O
spliceosome	O
assembly	O
.	O

As	O
control	O
,	O
the	O
cells	O
were	O
transfected	O
with	O
DNA	O
mixtures	O
containing	O
vector	O
mU6-C1	O
or	O
mU6-C2	O
.	O

In	O
the	O
lattice	O
,	O
23	O
%	O
of	O
the	O
sites	O
are	O
occupied	O
,	O
95	O
%	O
of	O
the	O
atoms	O
are	O
in	O
the	O
lowest	O
energy	O
magnetic	O
sublevel	O
,	O
and	O
37	O
%	O
are	O
in	O
the	O
lowest	O
3D	O
vibrational	O
state	O
.	O

Regarding	O
""""	O
the	O
relation	O
between	O
sexual	O
orientation	O
and	O
penile	O
size	O
,	O
""""	O
by	O
A.	O

This	O
slope	O
was	O
further	O
significantly	O
decreased	O
at	O
5	O
min	O
ischemia	O
(	O
-26.5	O
+	O
/-	O

8.8	O
microm	O
/	O
mmHg	O
)	O
but	O
returned	O
toward	O
control	O
values	O
in	O
short	O
-	O
term	O
hibernating	O
myocardium	O
at	O
90	O
min	O
ischemia	O
(	O
-17.2	O
+	O
/-	O

6.6	O
microm	O
/	O
mmHg	O
)	O
.	O

Whereas	O
both	O
MAP	O
and	O
MSNA	O
increase	O
during	O
SHG	O
,	O
the	O
transition	O
from	O
SHG	O
to	O
PHI	O
is	O
characterized	O
by	O
a	O
transient	O
reduction	O
in	O
MAP	O
but	O
sustained	O
elevation	O
in	O
MSNA	O
,	O
facilitating	O
separation	O
of	O
these	O
factors	O
in	O
vivo	O
.	O

Analysis	O
of	O
Standard	O
Reference	O
Material	O
1846	O
,	O
Infant	O
Formula	O
,	O
gave	O
a	O
mean	O
value	O
of	O
0.95	O
+	O
/-	O

0.088	O
mg	O
vitamin	O
K	O
/	O
kg	O
(	O
K	O
or	O
K1	O
?	O
)	O
(	O
n	O
=	O
31	O
)	O
with	O
a	O
coefficient	O
of	O
variation	O
of	O
9.26	O
.	O

We	O
have	O
recently	O
discovered	O
that	O
CCAAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
-	I
beta	I
(	O
C	B
/	I
EBP	I
-	I
beta	I
)	O
induces	O
gene	O
transcription	O
through	O
a	O
novel	O
IFN	B
response	I
element	I
called	O
the	O
gamma	B
-	I
IFN	I
-	I
activated	I
transcriptional	I
element	I

Northern	O
blot	O
analysis	O
demonstrated	O
that	O
the	O
STORP	B
gene	I
has	O
a	O
ubiquitous	O
pattern	O
of	O
expression	O
similar	O
to	O
that	O
of	O
the	O
PML	B
gene	I
.	O

In	O
the	O
TLE	O
patients	O
the	O
NAA	O
:	O
Cr	O
ratios	O
were	O
reduced	O
in	O
the	O
seizure	O
focus	O
,	O
while	O
in	O
the	O
FLE	O
patients	O
they	O
were	O
not	O
always	O
reduced	O
in	O
the	O
seizure	O
focus	O
.	O

The	O
psychologic	O
factors	O
associated	O
wth	O
serious	O
illness	O
,	O
terminal	O
prognoses	O
,	O
and	O
dying	O
complicate	O
the	O
scenario	O
even	O
more	O
as	O
compared	O
with	O
that	O
of	O
nonmalignant	O
pain	O
.	O

However	O
,	O
if	O
the	O
spatial	O
resolution	O
is	O
not	O
critical	O
and	O
interest	O
is	O
to	O
compare	O
a	O
pathologic	O
area	O
with	O
a	O
contralateral	O
VOI	O
,	O
then	O
the	O
acquisition	O
of	O
two	O
single	O
-	O
voxel	O
spectra	O
may	O
be	O
preferred	O
.	O

We	O
found	O
that	O
the	O
amplitude	O
of	O
the	O
cortical	O
evoked	O
potentials	O
(	O
amplitude	O
of	O
the	O
N2	O
/	O
P2	O
peak	O
)	O
increased	O
from	O
5.1	O
+	O
/-	O

0.7	O
microV	O
at	O
5	O
mA	O
to	O
16.3	O
+	O
/-	O

1.1	O
microV	O
at	O
20	O
mA.	O

While	O
mutations	O
in	O
K	B
-	I
Rev	I
that	O
inactivate	O
any	O
one	O
of	O
these	O
properties	O
also	O
blocked	O
K	B
-	I
Rev	I
-	O
dependent	O
nuclear	O
RNA	O
export	O
,	O
several	O
K	B
-	I
Rev	I
mutants	I
were	O
comparable	O
to	O
wild	O
type	O
when	O
assayed	O
for	O
any	O
of	O
these	O
individual	O
activities	O
yet	O
nevertheless	O
defective	O
for	O
RNA	O
export	O
.	O

METHODS	O
:	O
In	O
the	O
current	O
study	O
the	O
authors	O
reported	O
on	O
PPB	O
cases	O
from	O
a	O
national	O
retrospective	O
search	O
performed	O
in	O
18	O
Italian	O
Associations	O
for	O
Pediatric	O
Hematology	O
and	O
Oncology	O
centers	O
.	O

These	O
results	O
suggest	O
that	O
Cdc42p	B
is	O
in	O
fact	O
required	O
for	O
pheromone	O
response	O
and	O
that	O
interaction	O
with	O
the	O
PAK	B
Ste20p	B
is	O
critical	O
for	O
that	O
role	O
.	O

Deletion	O
of	O
an	O
intergenic	O
DNA	O
-	O
binding	O
site	O
for	O
this	O
complex	O
from	O
a	O
human	B
beta	I
-	I
globin	I
locus	I
construct	I
results	O
in	O
delayed	O
human	B
gamma-	I
to	I
beta	I
-	I
globin	I
switching	O
in	O
transgenic	O
mice	O
,	O
suggesting	O
that	O
the	O
PYR	B
complex	I
acts	O
to	O
facilitate	O
the	O
switch	O
.	O

Studies	O
suggest	O
that	O
the	O
DGOR	O
without	O
acid	O
reflux	O
may	O
result	O
in	O
symptoms	O
but	O
unless	O
acid	O
reflux	O
is	O
present	O
simultaneously	O
,	O
it	O
does	O
not	O
cause	O
oesophagitis	O
.	O

Symptoms	O
,	O
however	O
,	O
appear	O
to	O
correlate	O
poorly	O
with	O
oesophagitis	O
;	O
hence	O
,	O
severe	O
symptoms	O
do	O
not	O
indicate	O
there	O
is	O
greater	O
oesophageal	O
damage	O
.	O

These	O
results	O
demonstrate	O
Ras-	B
and	O
Raf	B
-	O
independent	O
ERK	B
MAPK	O
activation	O
maintains	O
cell	O
viability	O
following	O
heat	O
shock	O
.	O

Three	O
cDNAs	O
encoding	O
basic	B
leucine	I
zipper	I
(	I
bZIP	I
)	I
-type	I
ABRE	I
-	I
binding	I
proteins	I
were	O
isolated	O
by	O
using	O
the	O
yeast	O
one	O
-	O
hybrid	O
system	O
and	O
were	O
designated	O
AREB1	B
,	O
AREB2	B
,	O
and	O
AREB3	B
(	O
ABA	B
-	I
responsive	I
element	I
binding	I
protein	I
)	O
.	O

In	O
the	O
PMR	O
target	O
area	O
but	O
not	O
in	O
the	O
nontreated	O
area	O
an	O
improvement	O
in	O
regional	O
myocardial	O
flow	O
reserve	O
occurs	O
in	O
wall	O
segments	O
with	O
initially	O
severely	O
or	O
moderately	O
reduced	O
stress	O
perfusion	O
.	O

For	O
this	O
purpose	O
,	O
a	O
segment	O
of	O
dxr	B
was	O
amplified	O
from	O
Synechococcus	O
leopoliensis	O
SAUG	O
1402	O
-	O
1	O
DNA	O
via	O
PCR	O
using	O
oligonucleotides	O
for	O
conserved	O
regions	O
.	O

Perceptual	O
learning	O
for	O
a	O
pattern	O
discrimination	O
task	O
.	O

The	O
detector	O
has	O
the	O
advantage	O
of	O
finding	O
both	O
ST	O
segment	O
deviations	O
and	O
entire	O
ST	O
-	O
T	O
complex	O
changes	O
thereby	O
providing	O
a	O
wider	O
characterization	O
of	O
the	O
potential	O
ischemic	O
events	O
.	O

Primary	O
adrenal	O
hypersensitivity	O
to	O
ACTH	B
drive	O
in	O
obesity	O
has	O
also	O
been	O
suggested	O
.	O

Multiple	O
transcription	O
start	O
sites	O
were	O
revealed	O
by	O
primer	O
extension	O
analysis	O
of	O
the	O
mouse	O
gene	O
,	O
and	O
transfection	O
constructs	O
containing	O
the	O
prospective	O
promoter	O
generated	O
transcriptional	O
activity	O
comparable	O
to	O
that	O
of	O
the	O
SV40	B
promoter	I
.	O

From	O
two	O
inhibitor	O
scaffolds	O
,	O
we	O
have	O
identified	O
potent	O
and	O
selective	O
inhibitors	O
for	O
sensitized	O
kinases	O
from	O
five	O
distinct	O
subfamilies	O
.	O

To	O
determine	O
whether	O
interaction	O
of	O
arsenite	O
with	O
the	O
hormone	O
-	O
binding	O
domain	O
results	O
in	O
receptor	O
activation	O
,	O
COS-1	O
cells	O
were	O
transiently	O
cotransfected	O
with	O
the	O
chimeric	B
receptors	I
GAL	I
-	I
ER	I
,	O
which	O
contains	O
the	O
hormone	O
-	O
binding	O
domain	O
of	O
ERalpha	B
and	O
the	O
DNA	O
-	O
binding	O
domain	O
of	O
the	O
transcription	O
factor	O
GAL4	B
,	O
and	O
a	O
GAL4-responsive	B
CAT	B
reporter	I
gene	I
.	O

By	O
progressive	O
5'-deletion	O
studies	O
,	O
we	O
have	O
identified	O
a	O
248-bp	O
DNA	O
fragment	O
(	O
-1018	O
to	O
-771	O
,	O
relative	O
to	O
the	O
translation	O
start	O
site	O
)	O
at	O
the	O
5'-flanking	O
region	O
of	O
the	O
human	B
GnRHR	I
gene	I
that	O
is	O
responsible	O
for	O
the	O
GnRHa	O
-	O
mediated	O
down	O
-	O
regulation	O
of	O
human	B
GnRHR	I
promoter	I
activity	O
.	O

The	O
mean	O
day	O
of	O
diagnosis	O
of	O
periventricular	O
echodensities	O
was	O
3	O
+	O
/-	O

2	O
days	O
(	O
range	O
1	O
-	O
11	O
days	O
)	O
,	O
and	O
of	O
cystic	O
PVL	O
21	O
+	O
/-	O

8	O
days	O
(	O
range	O
2	O
-	O
47	O
days	O
)	O
.	O

In	O
group	O
B	O
37	O
MBq	O
in	O
150	O
microL	O
of	O
99mTc	O
-	O
HSA	O
nanocolloid	O
was	O
additionally	O
injected	O
intradermally	O
18	O
h	O
before	O
surgery	O
(	O
3	O
-	O
6	O
aliquots	O
injected	O
perilesionally	O
)	O
.	O

AGO1	B
is	O
similar	O
to	O
QDE-2	B
required	O
for	O
quelling	O
and	O
RDE-1	B
required	O
for	O
RNAi	O
.	O

We	O
could	O
demonstrate	O
the	O
involvement	O
of	O
cAMP	B
-	I
dependent	I
protein	I
kinase	I
(	O
PKA	B
)	O
in	O
the	O
phosphorylation	O
of	O
CDC25Mm	B
in	O
fibroblasts	O
overexpressing	O
this	O
RasGEF	B
as	O
well	O
as	O
in	O
mouse	O
brain	O
synaptosomal	O
membranes	O
.	O

We	O
find	O
that	O
3T1	O
-	O
3T2	O
mixing	O
has	O
a	O
pronounced	O
effect	O
on	O
the	O
line	O
shape	O
and	O
radiative	O
decay	O
rate	O
of	O
emission	O
from	O
the	O
3T2	O
state	O
and	O
that	O
the	O
extent	O
of	O
mixing	O
depends	O
critically	O
on	O
the	O
magnitude	O
of	O
nontetrahedral	O
distortions	O
.	O

Concurrently	O
,	O
we	O
monitored	O
weather	O
conditions	O
and	O
used	O
time	O
-	O
activity	O
budget	O
data	O
of	O
free	O
-	O
living	O
birds	O
and	O
laboratory	O
data	O
on	O
resting	O
metabolic	O
rate	O
to	O
construct	O
time	O
-	O
activity	O
laboratory	O
(	O
TAL	O
)	O
estimates	O
of	O
daily	O
energy	O
expenditure	O
(	O
DEE	O
)	O
and	O
to	O
partition	O
the	O
verdins	O
'	O
energy	O
budget	O
into	O
thermoregulatory	O
,	O
activity	O
and	O
basal	O
components	O
.	O

L	O
/	O
H	O
>	O
0.61	O
(	O
chi	O
(	O
2	O
)	O
=10.8	O
;	O
P:<0.001	O
)	O
and	O
a	O
restrictive	O
filling	O
pattern	O
(	O
chi	O
(	O
2	O
)	O
=3.6	O
;	O
P:<0.05	O
)	O
were	O
independent	O
predictors	O
of	O
events	O
.	O

The	O
high	O
selectivity	O
of	O
arrestins	B
for	O
this	O
particular	O
functional	O
form	O
of	O
receptor	O
ensures	O
their	O
timely	O
binding	O
and	O
dissociation	O
.	O

When	O
cotransfected	O
in	O
fibroblasts	O
with	O
a	O
C	B
/	I
EBP	I
alpha	I
expression	O
vector	O
,	O
reporter	O
gene	O
expression	O
increased	O
3-fold	O
only	O
in	O
the	O
wild	O
-	O
type	O
constructs	O
.	O

Nature	O
398	O
,	O
828	O
-	O
830	O
)	O
that	O
the	O
amino	O
acid	O
sequences	O
of	O
peptide	O
fragments	O
obtained	O
from	O
a	O
polypeptide	O
found	O
in	O
a	O
complex	O
of	O
proteins	O
that	O
alters	O
chromatin	O
structure	O
(	O
ARC	B
)	O
are	O
identical	O
to	O
portions	O
of	O
the	O
deduced	O
open	O
reading	O
frame	O
of	O
TIG-1	B
mRNA	I
.	O

Abnormalities	O
of	O
plasma	B
cholecystokinin	I
were	O
observed	O
only	O
in	O
patients	O
with	O
delayed	O
gastric	O
emptying	O
.	O

5	O
(	O
Sunset	O
Yellow	O
FCF	O
)	O
were	O
determined	O
using	O
liquid	O
chromatography	O
/	O
mass	O
spectrometry	O
(	O
LC	O
/	O
MS	O
)	O
with	O
electrospray	O
ionization	O
.	O

Polysome	O
and	O
40S	B
ribosome	I
fractions	O
were	O
severely	O
decreased	O
in	O
the	O
krr1	B
mutant	I
and	O
Kri1p	B
-	O
depleted	O
cells	O
.	O

They	O
also	O
negatively	O
modulate	O
the	O
PI	B
3-kinase	I
catalytic	O
activity	O
but	O
to	O
different	O
extents	O
,	O
dependent	O
on	O
the	O
unique	O
N	O
-	O
terminal	O
structure	O
of	O
each	O
isoform	O
.	O

Cam	B
kinase	I
II	I
induces	O
in	O
vivo	O
phosphorylation	O
of	O
Smad2	B
and	O
Smad4	B
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
Smad3	B
.	O

Recombinant	B
BRI1-KD	I
autophosphorylated	O
on	O
serine	O
(	O
Ser	O
)	O
and	O
threonine	O
(	O
Thr	O
)	O
residues	O
with	O
p	O
-	O
Ser	O
predominating	O
.	O

Flow	O
cytomery	O
was	O
used	O
for	O
cell	O
cycle	O
analysis	O
.	O

Cost	O
-	O
effectiveness	O
of	O
interferon	B
beta-1b	I
in	O
slowing	O
multiple	O
sclerosis	O
disability	O
progression	O
.	O

Hyperactivation	O
of	O
Cdc2	B
in	O
fission	O
yeast	O
causes	O
cells	O
to	O
undergo	O
a	O
lethal	O
premature	O
mitosis	O
called	O
mitotic	O
catastrophe	O
.	O

Cells	O
differentiate	O
in	O
response	O
to	O
various	O
extracellular	O
stimuli	O
.	O

Transforming	B
growth	I
factor	I
-	I
beta1	I
(	O
TGF	B
-	I
beta1	I
)	O
can	O
act	O
as	O
a	O
tumor	O
suppressor	O
or	O
a	O
tumor	O
promoter	O
depending	O
on	O
the	O
characteristics	O
of	O
the	O
malignant	O
cell	O
.	O

Mn2	O
+	O
increased	O
both	O
the	O
junction	O
binding	O
and	O
cleaving	O
activities	O
of	O
the	O
mutant	O
proteins	O
.	O

Moreover	O
,	O
an	O
in	O
vitro	O
pull	O
-	O
down	O
assay	O
showed	O
that	O
Os;CycH;1	B
specifically	O
bound	O
to	O
R2	B
but	O
not	O
to	O
other	O
rice	B
CDKs	I
.	O

Overexpression	O
of	O
Trdpm1	B
in	O
a	O
dpm1	B
(	I
+	I
)	I
::his7	O
/	B
dpm1	I
(	I
+	I
)	I
S.pombe	O
diploid	O
resulted	O
in	O
a	O
4-fold	O
increase	O
in	O
specific	O
DPM	B
synthase	I
activity	O
.	O

The	O
LMW	B
FGF-2	I
up	O
-	O
regulated	O
the	O
PKC	B
epsilon	I
levels	O
by	O
1.6-fold	O
;	O
by	O
contrast	O
the	O
HMW	B
isoform	I
down	O
-	O
regulated	O
the	O
level	O
of	O
this	O
PKC	B
isotype	I
by	O
about	O
3-fold	O
and	O
increased	O
the	O
amount	O
of	O
PKC	B
delta	I
by	O
1.7-fold	O
.	O

Helicobacter	O
pylori	O
and	O
stomach	O
diseases	O
:	O
from	O
clinical	O
point	O
of	O
view	O

2000	O
update	O
of	O
recommendations	O
for	O
the	O
use	O
of	O
hematopoietic	B
colony	I
-	I
stimulating	I
factors	I
:	O
evidence	O
-	O
based	O
,	O
clinical	O
practice	O
guidelines	O
.	O

In	O
vitro	O
,	O
Arix	B
and	O
NBPhox	B
form	O
DNA	O
-	O
independent	O
multimers	O
and	O
exhibit	O
cooperative	O
binding	O
to	O
the	O
DB1	B
regulatory	I
element	I
,	O
which	O
contains	O
two	O
homeodomain	B
recognition	I
sites	I
.	O

We	O
conclude	O
from	O
this	O
study	O
that	O
Arix	B
and	O
NBPhox	B
exhibit	O
indistinguishable	O
and	O
independent	O
transcriptional	O
regulatory	O
properties	O
on	O
the	O
DBH	B
promoter	I
.	O

An	O
increase	O
in	O
hypothalamic	O
expression	O
of	O
at	O
least	O
two	O
of	O
the	O
erbB	B
receptors	I
is	O
initiated	O
before	O
the	O
pubertal	O
augmentation	O
of	O
gonadal	O
steroid	O
secretion	O
and	O
is	O
completed	O
on	O
the	O
day	O
of	O
the	O
first	O
preovulatory	O
surge	O
of	O
gonadotropins	B
.	O

Dsh	B
is	O
required	O
for	O
two	O
different	O
pathways	O
,	O
the	O
Wnt	B
pathway	O
and	O
planar	O
polarity	O
pathway	O
in	O
Drosophila	O
.	O

Methyl	O
formate	O
was	O
used	O
as	O
the	O
solvent	O
of	O
biodegradable	O
oligoesters	O
for	O
the	O
fabrication	O
of	O
microspheres	O
with	O
encapsulated	O
bovine	B
serum	I
albumin	I
(	O
BSA	B
)	O
.	O

The	O
small	B
monomeric	I
GTP	I
-	I
binding	I
proteins	I
of	O
the	O
RAB	B
subfamily	I
are	O
key	O
regulatory	O
elements	O
of	O
the	O
machinery	O
that	O
controls	O
membrane	O
traffic	O
in	O
eukaryotic	O
cells	O
.	O

Furthermore	O
,	O
loss	O
of	O
methylation	O
also	O
greatly	O
reduced	O
the	O
association	O
of	O
another	O
yeast	O
B	O
-	O
type	O
subunit	O
,	O
Rts1p	B
.	O

The	O
subjects	O
were	O
diagnosed	O
on	O
the	O
basis	O
of	O
DSM	O
-	O
IV	O
pathological	O
gambling	O
criteria	O
and	O
completed	O
the	O
Turkish	O
Version	O
of	O
South	O
Oaks	O
Gambling	O
Screen	O
(	O
SOGS	O
)	O
.	O

Lys	O
(	O
193	O
)	O
and	O
Arg	O
(	O
194	O
)	O
,	O
located	O
at	O
the	O
COOH	O
-	O
terminal	O
end	O
of	O
HD	B
,	O
are	O
essential	O
for	O
dimerization	O
.	O

When	O
BFDS	O
was	O
taken	O
as	O
the	O
reference	O
,	O
W	O
/	O
A	O
Z	O
scores	O
showed	O
consistent	O
positive	O
increments	O
,	O
from	O
birth	O
in	O
girls	O
and	O
1	O
mo	O
in	O
boys	O
.	O

These	O
probable	O
border	O
sequences	O
are	O
closely	O
related	O
to	O
those	O
of	O
other	O
known	O
T	O
-	O
regions	O
and	O
define	O
a	O
second	O
T	O
-	O
region	O
of	O
pTiChry5	O
,	O
called	O
T	O
-	O
right	O
(	O
TR	O
)	O
,	O
that	O
confers	O
production	O
of	O
the	O
Amadoriopines	O
.	O

High	B
-	I
mobility	I
-	I
group	I
protein	I
I	I
can	O
modulate	O
binding	O
of	O
transcription	O
factors	O
to	O
the	O
U5	B
region	I
of	O
the	O
human	B
immunodeficiency	I
virus	I
type	I
1	I
proviral	I
promoter	I
.	O

Another	O
cis	O
-	O
acting	O
element	O
,	O
exonic	O
splicing	O
suppressor	O
1	O
(	O
ESS1	O
)	O
,	O
represses	O
use	O
of	O
the	O
nt	O
3225	O
3	O
'	O
splice	O
site	O
.	O

LMP2A	B
enhances	O
Lyn	B
and	O
Syk	B
ubiquitination	O
in	O
vivo	O
in	O
a	O
fashion	O
that	O
depends	O
on	O
the	O
activity	O
of	O
Nedd4	B
family	O
members	O
and	O
correlates	O
with	O
destabilization	O
of	O
the	O
Lyn	B
tyrosine	I
kinase	I
.	O

Our	O
results	O
,	O
however	O
,	O
were	O
obtained	O
for	O
Z	O
itself	O
and	O
not	O
for	O
[	O
Z	O
]	O
.	O

RESULTS	O
:	O
In	O
the	O
pregnant	O
group	O
,	O
serum	O
PP14	B
concentrations	O
were	O
markedly	O
increased	O
after	O
ET	O
,	O
and	O
a	O
significant	O
difference	O
between	O
the	O
pregnant	O
group	O
and	O
the	O
nonpregnant	O
group	O
was	O
observed	O
8	O
days	O
following	O
ET	O
(	O
p	O
<	O
0.01	O
)	O
.	O

Thromboelastography	O
is	O
a	O
test	O
that	O
could	O
potentially	O
correlate	O
with	O
the	O
degree	O
of	O
anticoagulation	O
produced	O
by	O
low	O
molecular	O
weight	O
heparin	O
.	O

These	O
results	O
provide	O
direct	O
evidence	O
for	O
differential	O
susceptibility	O
to	O
endonuclease	O
-	O
mediated	O
mRNA	O
decay	O
resulting	O
from	O
the	O
differential	O
affinity	O
of	O
a	O
RNA	O
-	O
binding	O
protein	O
for	O
cis	O
-	O
acting	O
stability	O
determinants	O
.	O

Aspirin	O
causes	O
peptic	O
ulcers	O
predominately	O
by	O
reducing	O
gastric	B
mucosal	I
cyclooxygenase	I
(	O
COX	B
)	O
activity	O
and	O
prostaglandin	O
synthesis	O
.	O

A	O
total	O
of	O
1060	O
clones	O
were	O
randomly	O
selected	O
for	O
sequencing	O
of	O
one	O
end	O
.	O

Expression	O
of	O
a	O
hybrid	O
protein	O
containing	O
the	O
cytoplasmic	O
C	O
-	O
terminal	O
half	O
of	O
UhpB	B
fused	O
to	O
glutathione	B
S	I
-	I
transferase	I
(	O
GST	B
)	O
also	O
interfered	O
with	O
Uhp	B
signaling	O
.	O

The	O
gene	O
is	O
separated	O
into	O
four	O
exons	O
by	O
three	O
short	O
introns	O
,	O
and	O
the	O
open	O
reading	O
frame	O
consists	O
of	O
6660	O
base	O
pairs	O
(	O
bp	O
)	O
capable	O
of	O
encoding	O
a	O
polypeptide	O
of	O
2220	O
amino	O
acid	O
residues	O
.	O

Like	O
the	O
p190-B	B
exon	O
,	O
the	O
first	O
exon	O
of	O
p190-A	B
is	O
extremely	O
large	O
(	O
3.7	O
kb	O
in	O
length	O
)	O
,	O
encoding	O
both	O
the	O
GTPase	B
and	O
middle	O
domains	O
(	O
residues	O
1	O
-	O
1228	O
)	O
,	O
but	O
not	O
the	O
remaining	O
GAP	B
domain	I
,	O
suggesting	O
a	O
high	O
conservation	O
of	O
genomic	O
structure	O
between	O
two	O
p190	B
genes	I
.	O

The	O
entire	O
human	B
teneurin-1	I
(	O
TEN1	B
)	O
gene	O
is	O
contained	O
in	O
eight	O
PAC	O
clones	O
representing	O
part	O
of	O
the	O
chromosomal	O
locus	O
Xq25	O
.	O

The	O
plexiform	O
neurofibroma	O
and	O
multiple	O
localized	O
neurofibromas	O
are	O
characteristic	O
of	O
NF1	B
.	O

In	O
general	O
lookback	O
,	O
all	O
patients	O
who	O
received	O
blood	O
before	O
being	O
tested	O
for	O
hepatitis	O
C	O
are	O
advised	O
to	O
undergo	O
testing	O
.	O

It	O
contained	O
seven	O
extra	O
amino	O
acids	O
of	O
FVVLNLQ	O
;	O
this	O
short	O
stretch	O
of	O
extra	O
sequence	O
was	O
found	O
between	O
Gln	O
(	O
421	O
)	O
and	O
Phe	O
(	O
422	O
)	O
within	O
the	O
SET	B
(	O
Suvar3	B
-	I
9	I
,	O
Enhancer	B
-	I
of	I
-	I
zeste	I
,	O
Trithorax	B
)	O
interacting	O
domain	O
(	O
SID	O
)	O
of	O
rMTM	B
.	O

MED1	B
has	O
a	O
weak	O
glycosylase	B
activity	O
on	O
the	O
mutagenic	O
adduct	O
3,N	O
(	O
4	O
)	O
-ethenocytosine	O
,	O
a	O
metabolite	O
of	O
vinyl	O
chloride	O
and	O
ethyl	O
carbamate	O
.	O

Among	O
the	O
total	O
CDSs	O
,	O
8.8	O
%	O
match	O
sequences	O
of	O
proteins	O
found	O
only	O
in	O
Bacillus	O
subtilis	O
and	O
66.7	O
%	O
are	O
widely	O
conserved	O
in	O
comparison	O
with	O
the	O
proteins	O
of	O
various	O
organisms	O
,	O
including	O
B.subtilis	O
.	O

Tobramycin	O
-	O
loaded	O
SLN	O
administered	O
i.v	O
.	O
showed	O
a	O
prolonged	O
circulation	O
time	O
compared	O
to	O
the	O
i.v	O
.	O

administered	O
tobramycin	O
solution	O
.	O

Bacteriol	O
.	O

Terminal	B
deoxynucleotidyl	I
transferase	I
-	O
mediated	O
nick	O
end	O
labeling	O
assays	O
revealed	O
that	O
hormonal	O
activation	O
of	O
the	O
PAX3	B
repressors	I
induced	O
extensive	O
apoptosis	O
that	O
correlated	O
with	O
down	O
-	O
regulation	O
of	O
BCL	B
-	I
X	I
(	I
L	I
)	I
expression	O
.	O

VEGF	B
promoter	I
activity	O
in	O
transient	O
transfections	O
was	O
decreased	O
by	O
either	O
pharmacological	O
or	O
genetic	O
inhibition	O
of	O
EGFR	B
,	O
Ras	B
,	O
or	O
phosphatidylinositol	B
3'-kinase	I
[	B
PI	I
(	I
3	I
)	I
kinase	I
]	I
.	O

Epidermal	B
growth	I
factor	I
receptor	I
transcriptionally	O
up	O
-	O
regulates	O
vascular	B
endothelial	I
growth	I
factor	I
expression	O
in	O
human	O
glioblastoma	O
cells	O
via	O
a	O
pathway	O
involving	O
phosphatidylinositol	B
3'-kinase	I
and	O
distinct	O
from	O
that	O
induced	O
by	O
hypoxia	O
.	O

Stress	B
-	I
activated	I
protein	I
kinase	I
1	I
(	O
SAPK1	B
)	O
,	O
also	O
called	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
(	O
JNK	B
)	O
,	O
becomes	O
activated	O
in	O
vivo	O
in	O
response	O
to	O
pro	O
-	O
inflammatory	O
cytokines	O
or	O
cellular	O
stresses	O
.	O

Combined	O
intravenous	O
and	O
intra	O
-	O
arterial	O
recombinant	O
tissue	B
plasminogen	I
activator	I
in	O
acute	O
ischemic	O
stroke	O
.	O

To	O
begin	O
to	O
understand	O
this	O
role	O
,	O
we	O
overexpressed	O
ATF-2	B
in	O
a	O
human	O
cancer	O
cell	O
line	O
.	O

Signal	O
transduction	O
via	O
modulation	O
of	O
phosphorylation	O
after	O
selective	O
inhibition	O
of	O
protein	B
phosphatase	I
(	I
PP	I
)	I
1	I
and/or	O
PP2A	B
appears	O
to	O
play	O
a	O
role	O
in	O
okadaic	O
acid	O
(	O
OA	O
)	O
-mediated	O
effects	O
.	O

NF	B
-	I
kappaB	I
is	O
a	O
redox	O
-	O
sensitive	O
transcription	O
factor	O
known	O
to	O
be	O
activated	O
by	O
oxidative	O
stress	O
as	O
well	O
as	O
chemical	O
and	O
biological	O
reductants	O
.	O

What	O
to	O
look	O
for	O
during	O
a	O
compliance	O
review	O
:	O
10	O
common	O
mistakes	O
made	O
by	O
SNFs	O
.	O

CONCLUSIONS	O
:	O
EBCT	O
technology	O
allows	O
minimally	O
invasive	O
evaluation	O
of	O
intramyocardial	O
microcirculatory	O
function	O
and	O
permits	O
assessment	O
of	O
microvascular	O
BV	O
distribution	O
in	O
different	O
functional	O
components	O
.	O

SSF	O
experiments	O
were	O
carried	O
out	O
in	O
bench	O
-	O
scale	O
bioreactors	O
(	O
equipped	O
with	O
CO2	O
and	O
volatile	O
organic	O
traps	O
)	O
containing	O
a	O
mixture	O
of	O
lignocellulosic	O
materials	O
and	O
a	O
radiolabeled	O
pesticide	O
.	O

Characterization	O
of	O
a	O
Xenopus	B
laevis	I
CXC	I
chemokine	I
receptor	I
4	I
:	O
implications	O
for	O
hematopoietic	O
cell	O
development	O
in	O
the	O
vertebrate	O
embryo	O
.	O

Abbreviations	O
:	O
CAS	B
,	O
CRK	B
-	I
associated	I
substrate	I
;	O
CH	B
,	O
calponin	B
-	I
homology	I
domain	I
;	O
CSK	B
,	O
C	B
-	I
terminal	I
SRC	I
kinase	I
;	O
E6	B
,	O
Papillomavirus	B
E6	I
protein	I
;	O
FAK	B
,	O
focal	B
adhesion	I
kinase	I
;	O
GIT	B
,	O
GRK	B
interacter	I
;	O
GPCR	B
,	O
heterotrimeric	B
-	I
G	I
-	I
protein	I
-	I
coupled	I
receptor	I
;	O
GRK	B
,	O
G	B
-	I
protein	I
-	I
coupled	I
-	I
receptor	I
kinase	I
;	O
MAPK	B
,	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
ERK	B
,	O
p38	B
,	O
JNK	B
)	O
;	O
PAK	B
,	O
p21-activated	B
kinase	I
;	O
PBS	B
,	O
paxillin	B
-	I
binding	I
subdomain	I
;	O
PIX	B
,	O
PAK	B
-	I
interacting	I
exchange	I
factor	I
;	O
PKL	B
,	O
paxillin	B
kinase	I
linker	I
;	O
POR1	B
,	O
partner	B
of	I
Rac	I
;	O
PS	O
,	O
phosphoserine	O
;	O
PT	O
,	O
phosphothreonine	O
;	O
PY	O
,	O
phosphotyrosine	O
;	O
RTK	B
,	O
growth	B
factor	I
receptor	I
tyrosine	I
kinase	I
;	O
SH	B
,	O
SRC	B
-	I
homology	I
domain	I
.	O

There	O
were	O
122	O
cases	O
of	O
tuberculosis	O
over	O
an	O
average	O
10.3	O
yr	O
of	O
follow	O
-	O
up	O
(	O
crude	O
annual	O
incidence	O
,	O
76.2	O
/	O
100,000	O
)	O
.	O

These	O
results	O
suggested	O
that	O
BACH1	B
t	I
recruits	O
BACH1	B
to	O
the	O
nucleus	O
through	O
BTB	B
domain	O
-	O
mediated	O
interaction	O
.	O

The	O
U17	B
/	O
U16	B
and	O
the	O
U16	B
+	I
gene	I
products	I
transactivated	O
the	O
HIV	B
LTR	I
.	O

Transcription	O
of	O
the	O
six	O
EBNA	B
genes	I
,	O
which	O
are	O
expressed	O
in	O
EBV	O
-	O
immortalized	O
primary	O
B	O
cells	O
,	O
arises	O
from	O
one	O
of	O
two	O
promoters	O
,	O
Cp	B
and	O
Wp	B
,	O
located	O
near	O
the	O
left	O
end	O
of	O
the	O
viral	O
genome	O
.	O

The	O
Cili-2	B
sequences	I
possess	O
similarity	O
to	O
the	O
RNaseH	B
domain	I
of	O
Lian	B
-	O
Aa1	B
,	O
a	O
mosquito	B
non	I
-	I
LTR	I
retrotransposon	I
.	O

There	O
was	O
a	O
weak	O
significant	O
correlation	O
between	O
TGF	B
beta	I
1	I
levels	O
and	O
normal	O
cell	O
radiosensitivity	O
(	O
lymphocyte	O
SF2	O
)	O
.	O

Acute	O
feasibility	O
and	O
safety	O
of	O
a	O
smoking	O
reduction	O
strategy	O
for	O
smokers	O
with	O
schizophrenia	O
.	O

Tightly	O
ordered	O
proteasomal	O
degradation	O
of	O
proteins	O
critical	O
for	O
cell	O
cycle	O
control	O
implies	O
a	O
role	O
of	O
the	O
proteasome	O
in	O
maintaining	O
cell	O
proliferation	O
and	O
cell	O
survival	O
.	O

The	O
sixth	O
nucleotide	O
was	O
bulged	O
out	O
to	O
allow	O
stacking	O
of	O
this	O
U.G	O
pair	O
on	O
the	O
adjacent	O
helical	O
region	O
.	O

Functional	O
analysis	O
of	O
the	O
mutant	B
desmin	I
in	O
SW13	O
(	O
vim-	B
)	O
cells	O
showed	O
aggregation	O
of	O
abnormal	O
coarse	O
clumps	O
of	O
desmin	B
positive	O
material	O
dispersed	O
throughout	O
the	O
cytoplasm	O
.	O

Patients	O
with	O
lesions	O
affecting	O
the	O
PRC	O
but	O
sparing	O
the	O
PHC	O
,	O
and	O
patients	O
with	O
lesions	O
affecting	O
both	O
PRC	O
and	O
PHC	O
,	O
performed	O
an	O
oculomotor	O
delayed	O
response	O
task	O
with	O
unpredictably	O
varied	O
memory	O
delays	O
of	O
up	O
to	O
30	O
s.	O

In	O
addition	O
,	O
26	O
amino	O
acid	O
residues	O
,	O
K69	O
,	O
D88	O
,	O
E94	O
,	O
D134	O
,	O
R154	O
,	O
K169	O
,	O
H197	O
,	O
D233	O
,	O
G235	O
,	O
G236	O
,	O
G237	O
,	O
F238	O
,	O
E274	O
,	O
G276	O
,	O
R277	O
,	O
Y278	O
,	O
K294	O
,	O
Y323	O
,	O
Y331	O
,	O
D332	O
,	O
C360	O
,	O
D361	O
,	O
D364	O
,	O
G387	O
,	O
Y389	O
,	O
and	O
F397	O
(	O
mouse	O
ODC	B
numbering	O
)	O
,	O
all	O
of	O
which	O
are	O
implicated	O
in	O
the	O
formation	O
of	O
the	O
pyridoxal	O
phosphate	O
-	O
binding	O
domain	O
and	O
the	O
substrate	O
-	O
binding	O
domain	O
and	O
in	O
dimer	O
stabilization	O
with	O
the	O
eukaryotic	O
ODCs	B
,	O
were	O
also	O
conserved	O
in	O
S.	O
ruminantium	O
LDC	B
.	O

The	O
Psc2	B
cDNA	I
contained	O
an	O
open	O
reading	O
frame	O
homologous	O
to	O
CP2	B
family	I
proteins	I
.	O

Our	O
results	O
indicate	O
that	O
Shh	B
can	O
drive	O
continued	O
cycling	O
in	O
immature	O
,	O
proliferating	O
CGNPs	O
.	O

In	O
addition	O
,	O
npm3	B
,	O
which	O
is	O
usually	O
coactivated	O
with	O
fgf8	B
by	O
MMTV	O
insertion	O
,	O
was	O
not	O
up	O
-	O
regulated	O
by	O
androgens	O
in	O
SC-3	O
cells	O
.	O

Experiments	O
with	O
epitope	O
-	O
tagged	O
proteins	O
show	O
that	O
UEV1A	B
is	O
a	O
nuclear	O
protein	O
,	O
whereas	O
both	O
Kua	B
and	O
Kua	B
-	O
UEV	B
localize	O
to	O
cytoplasmic	O
structures	O
,	O
indicating	O
that	O
the	O
Kua	B
domain	I
determines	O
the	O
cytoplasmic	O
localization	O
of	O
Kua	B
-	O
UEV	B
.	O

Stoichiometric	O
phosphorylation	O
of	O
human	B
p53	I
at	O
Ser315	O
stimulates	O
p53-dependent	B
transcription	O
.	O

p53	B
protein	I
activity	O
as	O
a	O
transcription	O
factor	O
can	O
be	O
activated	O
in	O
vivo	O
by	O
antibodies	O
that	O
target	O
its	O
C	O
-	O
terminal	O
negative	O
regulatory	O
domain	O
suggesting	O
that	O
cellular	O
enzymes	O
that	O
target	O
this	O
domain	O
may	O
play	O
a	O
role	O
in	O
stimulating	O
p53-dependent	B
gene	O
expression	O
.	O

The	O
Tax	B
/	O
IKKgamma	B
interaction	O
serves	O
to	O
recruit	O
Tax	B
to	O
the	O
IKK	B
catalytic	I
subunits	I
,	O
IKKalpha	B
and	O
IKKbeta	B
,	O
and	O
this	O
recruitment	O
appears	O
to	O
be	O
an	O
essential	O
mechanism	O
by	O
which	O
Tax	B
stimulates	O
the	O
activity	O
of	O
IKK	B
.	O

An	O
anchored	O
AFLP-	O
and	O
retrotransposon	O
-	O
based	O
map	O
of	O
diploid	O
Avena	O
.	O

In	O
addition	O
,	O
we	O
identified	O
a	O
novel	O
type	O
of	O
inhibitory	O
domain	O
in	O
the	O
N	O
-	O
terminal	O
60	O
amino	O
acids	O
of	O
IRF-1	B
which	O
strongly	O
inhibits	O
its	O
transcriptional	O
activity	O
.	O

Effects	O
of	O
spatial	O
and	O
temporal	O
smoothing	O
on	O
stimulated	O
brillouin	O
scattering	O
in	O
the	O
independent	O
-	O
hot	O
-	O
spot	O
model	O
limit	O
The	O
influence	O
of	O
laser	O
beam	O
smoothing	O
on	O
stimulated	O
Brillouin	O
backscattering	O
(	O
SBBS	O
)	O
is	O
studied	O
analytically	O
in	O
the	O
limit	O
of	O
the	O
independent	O
hot	O
spot	O
model	O
.	O

Simultaneous	O
determination	O
of	O
theophylline	O
and	O
its	O
metabolites	O
by	O
HPLC	O
]	O
A	O
high	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
method	O
has	O
been	O
developed	O
for	O
the	O
simultaneous	O
determination	O
of	O
theophylline	O
and	O
its	O
metabolites	O
,	O
with	O
caffeine	O
and	O
its	O
metabolites	O
.	O

Ten	O
males	O
performed	O
both	O
test	O
conditions	O
and	O
oxygen	O
uptake	O
VO2	O
,	O
heart	O
rate	O
,	O
minute	O
ventilation	O
VE	O
,	O
perceived	O
exertion	O
and	O
spinal	O
shrinkage	O
were	O
recorded	O
.	O

CONCLUSION	O
:	O
SPT	O
is	O
more	O
useful	O
than	O
WST	O
in	O
differentiating	O
patients	O
predisposed	O
to	O
aspiration	O
.	O

Studied	O
groups	O
were	O
(	O
1	O
)	O
untreated	O
control	O
,	O
n	O
=	O
12	O
;	O
(	O
2	O
)	O
FK-1	O
,	O
n	O
=	O
8	O
;	O
(	O
3	O
)	O
FK-3	O
,	O
n	O
=	O
8	O
.	O

DNA	O
binding	O
and	O
glutathione	B
S	I
-	I
transferase	I
pull	O
-	O
down	O
assays	O
demonstrate	O
that	O
binding	O
requires	O
Elk-1	B
(	I
1	I
-	I
212	I
)	I
but	O
not	O
the	O
C	O
-	O
terminal	O
transactivation	O
domain	O
.	O

Unexpectedly	O
,	O
ALK7	B
signaling	O
produced	O
a	O
remarkable	O
change	O
in	O
cell	O
morphology	O
characterized	O
by	O
cell	O
flattening	O
and	O
elaboration	O
of	O
blunt	O
,	O
short	O
cell	O
processes	O
.	O

The	O
swa2	B
-	I
1	I
allele	I
recovered	O
from	O
the	O
original	O
screen	O
carries	O
a	O
point	O
mutation	O
in	O
its	O
tetratricopeptide	O
repeat	O
(	O
TPR	O
)	O
domain	O
,	O
a	O
motif	O
not	O
found	O
in	O
auxilin	B
but	O
known	O
in	O
other	O
proteins	O
to	O
mediate	O
interaction	O
with	O
heat	B
-	I
shock	I
proteins	I
.	O

Transformation	O
of	O
the	O
sconC3	B
mutant	I
with	O
sconB+	B
restores	O
the	O
wild	O
-	O
type	O
phenotype	O
.	O

The	O
non	O
-	O
homologous	O
sequences	O
in	O
the	O
5	O
'	O
untranslated	O
regions	O
might	O
be	O
acquired	O
at	O
or	O
after	O
transcription	O
during	O
retrotransposition	O
of	O
the	O
ATLN	O
elements	O
.	O

The	O
time	O
course	O
of	O
RNA1	B
replication	O
and	O
RNA3	B
synthesis	O
in	O
induced	O
yeast	O
paralleled	O
that	O
in	O
yeast	O
transfected	O
with	O
natural	O
FHV	O
virion	O
RNA	O
.	O

The	O
transcription	O
and	O
alternative	O
splicing	O
of	O
human	B
ORL1	I
and	O
GAIP	B
are	O
cell	O
-	O
type	O
specific	O
.	O

The	O
extraction	O
was	O
subsequently	O
rated	O
as	O
'	O
easy	O
'	O
or	O
'	O
difficult'.Taking	O
Pell	O
-	O
Gregory	O
class	O
C	O
as	O
a	O
predictor	O
of	O
a	O
'	O
difficult	O
'	O
extraction	O
,	O
specificity	O
was	O
88	O
%	O
but	O
sensitivity	O
was	O
low	O
at	O
15	O
%	O
.	O

Based	O
on	O
16S	B
rRNA	I
gene	I
sequence	I
analysis	O
,	O
the	O
11	O
species	O
having	O
two	O
tuf	B
genes	I
all	O
have	O
a	O
common	O
ancestor	O
,	O
while	O
the	O
six	O
species	O
having	O
only	O
one	O
copy	O
diverged	O
from	O
the	O
enterococcal	O
lineage	O
before	O
that	O
common	O
ancestor	O
.	O

Nevertheless	O
,	O
protein	B
kinase	I
A	I
stimulation	O
induces	O
CREMalpha	B
to	O
activate	O
the	O
complex	O
native	O
promoter	O
in	O
the	O
phosphoenolpyruvate	B
carboxykinase	I
(	O
PEPCK	B
)	O
gene	O
.	O

Another	O
putative	O
HNF3	B
site	I
in	O
close	O
apposition	O
to	O
a	O
NF1	B
/	O
CTF	B
site	O
was	O
localized	O
upstream	O
of	O
the	O
silencer	O
-	O
like	O
element	O
.	O

DNase	B
I	I
genomic	O
footprinting	O
revealed	O
that	O
the	O
c	B
-	I
Myb	I
site	I
is	O
occupied	O
in	O
a	O
tissue	O
-	O
specific	O
fashion	O
in	O
vivo	O
.	O

We	O
conclude	O
that	O
c	B
-	I
Myb	I
regulates	O
the	O
RAG-2	B
promoter	I
in	O
T	O
cells	O
by	O
binding	O
to	O
this	O
consensus	B
c	I
-	I
Myb	I
binding	I
site	I
.	O

A	O
recently	O
reported	O
new	O
member	O
of	O
the	O
Vav	B
family	I
proteins	I
,	O
Vav3	B
has	O
been	O
identified	O
as	O
a	O
Ros	B
receptor	B
protein	I
tyrosine	I
kinase	I
(	O
RPTK	B
)	O
interacting	O
protein	O
by	O
yeast	O
two	O
-	O
hybrid	O
screening	O
.	O

Induced	O
expression	O
of	O
Rnd3	B
is	O
associated	O
with	O
transformation	O
of	O
polarized	O
epithelial	O
cells	O
by	O
the	O
Raf	B
-	O
MEK	B
-	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
pathway	O
.	O

The	O
activity	O
of	O
the	O
transcription	B
factor	I
CREB	I
is	O
regulated	O
by	O
extracellular	O
stimuli	O
that	O
result	O
in	O
its	O
phosphorylation	O
at	O
a	O
critical	O
serine	O
residue	O
,	O
Ser133	O
.	O

RESULTS	O
:	O
Average	O
age	O
at	O
symptom	O
onset	O
was	O
41.2	O
years	O
.	O

When	O
10	O
fields	O
were	O
analysed	O
,	O
a	O
strong	O
relationship	O
was	O
found	O
between	O
the	O
presence	O
of	O
bacteria	O
on	O
Gram	O
staining	O
and	O
the	O
final	O
diagnosis	O
of	O
VAP	O
(	O
for	O
PSB	O
and	O
PTC	O
respectively	O
:	O
sensitivity	O
74	O
and	O
81	O
%	O
,	O
specificity	O
94	O
and	O
100	O
%	O
,	O
positive	O
predictive	O
value	O
91	O
and	O
100	O
%	O
,	O
negative	O
predictive	O
value	O
82	O
and	O
88	O
%	O
)	O
.	O

The	O
objectives	O
of	O
the	O
present	O
study	O
were	O
to	O
evaluate	O
the	O
effects	O
of	O
adding	O
Equex	O
to	O
a	O
TRIS	O
-	O
extender	O
,	O
diluting	O
the	O
semen	O
in	O
1	O
or	O
2	O
steps	O
,	O
freezing	O
according	O
to	O
2	O
methods	O
,	O
thawing	O
at	O
2	O
rates	O
,	O
and	O
the	O
interactions	O
between	O
these	O
treatments	O
,	O
on	O
the	O
post	O
-	O
thaw	O
survival	O
of	O
dog	O
spermatozoa	O
at	O
38	O
degrees	O
C.	O

This	O
study	O
is	O
a	O
further	O
and	O
more	O
extensive	O
validation	O
of	O
the	O
clinician	O
rated	O
NIMH	O
-	O
LCM	O
-	O
p	O
.	O

The	O
Aie1	B
locus	I
was	O
mapped	O
to	O
mouse	O
chromosome	O
7A2-A3	O
by	O
fluorescent	O
in	O
situ	O
hybridization	O
.	O

Psychiatric	O
disorders	O
in	O
children	O
and	O
adolescents	O
carry	O
considerable	O
morbidity	O
,	O
impede	O
development	O
,	O
and	O
carry	O
a	O
significant	O
mortality	O
by	O
suicide	O
.	O

Molecular	O
cloning	O
and	O
expression	O
of	O
human	B
UDP	I
-	I
d	I
-	I
Xylose	I
:	I
proteoglycan	I
core	I
protein	I
beta	B
-	I
d	I
-	I
xylosyltransferase	I
and	O
its	O
first	O
isoform	B
XT	I
-	I
II	I
.	O

Thyrotoxicosis	O
due	O
to	O
amiodarone	O
is	O
difficult	O
to	O
treat	O
and	O
is	O
further	O
complicated	O
by	O
the	O
pro	O
-	O
arrhythmic	O
potential	O
of	O
thyrotoxicosis	O
and	O
the	O
fading	O
antiarrhythmic	O
effect	O
after	O
amiodarone	O
withdrawal	O
.	O

We	O
describe	O
the	O
identification	O
and	O
initial	O
characterization	O
of	O
neurobeachin	B
,	O
a	O
neuron	O
-	O
specific	O
multidomain	O
protein	O
of	O
327	O
kDa	O
with	O
a	O
high	O
-	O
affinity	O
binding	O
site	O
(	O
K	O
(	O
d	O
)	O
,	O
10	O
nm	O
)	O
for	O
the	O
type	B
II	I
regulatory	I
subunit	I
of	I
protein	I
kinase	I
A	I
(	O
PKA	B
RII	I
)	O
.	O

Children	O
with	O
ADD	O
showed	O
an	O
attenuated	O
frontal	O
CNV-1	O
amplitude	O
and	O
a	O
trend	O
towards	O
increased	O
CNV-1	O
and	O
CNV-2	O
occipital	O
amplitudes	O
.	O

Overexpression	O
of	O
c	B
-	I
Myc	I
in	O
serum	O
-	O
starved	O
human	O
or	O
mouse	O
embryonic	O
cells	O
leads	O
to	O
apoptosis	O
which	O
is	O
significantly	O
reduced	O
in	O
the	O
presence	O
of	O
growth	O
factor	O
-	O
containing	O
serum	O
.	O

c	B
-	I
Myc	I
-	O
induced	O
apoptosis	O
appears	O
to	O
be	O
deficient	O
in	O
bax	B
-	O
null	O
as	O
compared	O
with	O
bax	B
-	O
wild	O
-	O
type	O
mouse	O
embryonic	O
fibroblasts	O
.	O

Antimicrobial	O
Susceptibility	O
of	O
Klebsiella	O
pneumoniae	O
Producing	O
Extended	B
-	I
Spectrum	I
beta	I
-	I
lactamase	I
(	O
ESBL	B
)	O
Isolated	O
in	O
Hospitals	O
in	O
Brazil	O
.	O

CONCLUSION	O
:	O
Our	O
results	O
suggest	O
that	O
AIF	O
peak	O
saturation	O
leads	O
to	O
a	O
significant	O
systematic	O
error	O
in	O
the	O
determination	O
of	O
CBV	O
and	O
CBF	O
values	O
and	O
has	O
necessarily	O
to	O
be	O
taken	O
into	O
account	O
for	O
dynamic	O
contrast	O
-	O
enhanced	O
MR	O
perfusion	O
studies	O
.	O

Furthermore	O
,	O
transfection	O
of	O
cells	O
with	O
the	O
spacer	O
-	O
RING	O
domain	O
alone	O
suppressed	O
the	O
antiapoptotic	O
function	O
of	O
the	O
N	O
-	O
terminal	O
BIR	B
domain	O
of	O
c	B
-	I
IAP1	I
and	O
induced	O
apoptosis	O
.	O

The	O
determination	O
of	O
the	O
double	O
bounds	O
in	O
blood	O
serum	O
lipids	O
by	O
titration	O
with	O
ozone	O
:	O
the	O
pathophysiology	O
and	O
diagnostic	O
significance	O
]	O

In	O
this	O
article	O
the	O
method	O
of	O
definition	O
of	O
double	O
binders	O
in	O
lipids	O
of	O
blood	O
serum	O
in	O
patients	O
with	O
different	O
diseases	O
basically	O
atherosclerosis	O
and	O
ischemic	O
heart	O
disease	O
,	O
with	O
use	O
titration	O
by	O
ozone	O
is	O
given	O
.	O

Acoust	O
.	O

MS	O
characteristics	O
of	O
coumarins	O
,	O
psoralens	O
and	O
polymethoxylated	O
flavones	O
with	O
different	O
substitution	O
patterns	O
were	O
determined	O
on	O
the	O
basis	O
of	O
the	O
response	O
obtained	O
with	O
the	O
APcI	O
interface	O
.	O

T	O
cells	O
express	O
two	O
isoforms	O
of	O
S6k1	B
:	O
a	O
70	O
kDa	O
cytoplasmic	O
kinase	O
and	O
an	O
85	O
kDa	O
isoform	O
that	O
has	O
a	O
classic	O
nuclear	O
localisation	O
.	O

A	O
prospectively	O
gated	O
2D	O
axial	O
sequence	O
with	O
velocity	O
encoding	O
in	O
the	O
craniocaudal	O
direction	O
in	O
the	O
cervical	O
region	O
was	O
set	O
at	O
a	O
velocity	O
of	O
+	O
/-	O

10	O
cm	O
/	O
s	O
.	O

It	O
was	O
subsequently	O
shown	O
that	O
Tip60	B
had	O
histone	B
acetyltransferase	I
(	O
HAT	B
)	O
activity	O
.	O

Our	O
data	O
show	O
that	O
multiple	O
MLSN1	B
transcripts	I
,	O
both	O
constitutively	O
expressed	O
and	O
inducible	O
,	O
are	O
present	O
in	O
cultured	O
pigmented	O
melanoma	O
cells	O
,	O
and	O
suggest	O
that	O
MLSN1	B
expression	O
can	O
be	O
regulated	O
at	O
the	O
level	O
of	O
both	O
transcription	O
and	O
mRNA	O
processing	O
.	O

Copyright	O
2000	O
Academic	O
Press	O
.	O

Plectin	B
and	O
desmoplakin	B
have	O
GSR	O
-	O
containing	O
domains	O
at	O
their	O
C	O
-	O
termini	O
and	O
we	O
further	O
demonstrate	O
that	O
the	O
GSR	O
-	O
containing	O
domain	O
of	O
plectin	B
,	O
but	O
not	O
desmoplakin	B
,	O
can	O
bind	O
to	O
MTs	O
in	O
vivo	O
.	O

We	O
show	O
that	O
in	O
contrast	O
to	O
SRC1	B
,	O
direct	O
binding	O
of	O
CBP	B
to	O
the	O
estrogen	B
receptor	I
is	O
weak	O
,	O
suggesting	O
that	O
SRC1	B
functions	O
primarily	O
as	O
an	O
adaptor	O
to	O
recruit	O
CBP	B
and	O
p300	B
.	O

Since	O
MEK	B
acts	O
as	O
a	O
cytoplasmic	O
anchor	O
for	O
the	O
ERKs	B
,	O
the	O
lack	O
of	O
a	O
MEK	B
interaction	O
resulted	O
in	O
the	O
aberrant	O
nuclear	O
localization	O
of	O
ERK2-Delta19	B
-	B
25	I
mutants	O
in	O
serum	O
-	O
starved	O
cells	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
risk	O
factors	O
for	O
background	O
diabetic	O
retinopathy	O
(	O
BDR	O
)	O
and	O
PDR	O
by	O
following	O
394	O
Japanese	O
patients	O
with	O
early	O
-	O
onset	O
type	O
2	O
diabetes	O
diagnosed	O
before	O
30	O
years	O
of	O
age	O
(	O
mean	O
age	O
27	O
,	O
mean	O
blood	O
pressure	O
at	O
entry	O
116	O
/	O
73	O
mm	O
Hg	O
)	O
.	O

Of	O
the	O
21	O
quadrants	O
positive	O
in	O
the	O
controls	O
,	O
17	O
were	O
correlated	O
with	O
previously	O
detected	O
jaw	O
pathoses	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
the	O
pro	O
-	O
inflammatory	O
cytokines	O
tumor	B
necrosis	I
factor	I
alpha	I
and	O
interferon	B
gamma	I
reduce	O
the	O
expression	O
of	O
the	O
cystic	B
fibrosis	I
transmembrane	I
conductance	I
regulator	I
(	O
CFTR	B
)	O
gene	O
(	O
CFTR	B
)	O
in	O
HT-29	O
and	O
T84	O
cells	O
by	O
acting	O
post	O
-	O
transcriptionally	O
.	O

Regulation	O
of	O
RhoA	B
is	O
required	O
to	O
maintain	O
adhesion	O
in	O
stationary	O
cells	O
,	O
but	O
is	O
also	O
critical	O
for	O
cell	O
spreading	O
and	O
migration	O
[	O
3	O
]	O
.	O

Here	O
we	O
show	O
in	O
mouse	O
fibroblasts	O
stably	O
transformed	O
by	O
v	B
-	I
Src	I
that	O
mRNA	O
and	O
protein	O
levels	O
of	O
p21	B
(	O
WAF1	B
/	O
CIP1	B
)	O
,	O
cyclin	B
D1	I
,	O
and	O
cyclin	B
E	I
are	O
elevated	O
.	O

ORFA	O
and	O
ccdA	B
were	O
constitutively	O
cotranscribed	O
as	O
determined	O
by	O
primer	O
extension	O
analysis	O
.	O

Mouse	B
Impact	I
is	O
a	O
paternally	O
expressed	O
gene	O
encoding	O
an	O
evolutionarily	O
conserved	O
protein	O
of	O
unknown	O
function	O
.	O

In	O
contrast	O
,	O
high	O
COUP	B
-	I
TFI	I
expression	O
impeded	O
the	O
neuronal	O
differentiation	O
of	O
P19	O
cells	O
induced	O
with	O
RA	O
,	O
resulting	O
in	O
cell	O
cultures	O
lacking	O
neurons	O
.	O

Because	O
PET	O
is	O
also	O
useful	O
for	O
the	O
pretreatment	O
and	O
follow	O
-	O
up	O
evaluation	O
,	O
the	O
use	O
of	O
stereotactic	O
PET	O
in	O
these	O
patients	O
can	O
enable	O
an	O
accurate	O
comparison	O
of	O
PET	O
-	O
based	O
metabolic	O
data	O
with	O
MR	O
-	O
based	O
anatomical	O
data	O
.	O

Here	O
,	O
we	O
describe	O
the	O
isolation	O
of	O
MdPin1	B
,	O
a	O
Pin1	B
homologue	O
from	O
the	O
plant	O
species	O
apple	O
(	O
Malus	O
domestica	O
)	O
and	O
show	O
that	O
it	O
has	O
the	O
same	O
phosphorylation	O
-	O
specific	O
substrate	O
specificity	O
and	O
can	O
be	O
inhibited	O
by	O
juglone	O
in	O
vitro	O
,	O
as	O
is	O
the	O
case	O
for	O
Pin1	B
.	O

Differential	O
association	O
of	O
products	O
of	O
alternative	O
transcripts	O
of	O
the	O
candidate	O
tumor	B
suppressor	I
ING1	I
with	O
the	O
mSin3	B
/	O
HDAC1	B
transcriptional	O
corepressor	O
complex	O
.	O

These	O
and	O
other	O
data	O
presented	O
suggest	O
that	O
TAg	B
'	O
re	O
-	O
models	O
'	O
host	O
cell	O
transcription	O
factors	O
that	O
are	O
used	O
early	O
in	O
viral	O
infection	O
,	O
and	O
thereby	O
mimics	O
an	O
event	O
that	O
naturally	O
occurs	O
during	O
transformation	O
.	O

ORFK10.5	B
encodes	O
a	O
protein	O
,	O
latency	B
-	I
associated	I
nuclear	I
antigen	I
2	I
(	O
LANA2	B
)	O
,	O
which	O
is	O
expressed	O
in	O
KSHV	O
-	O
infected	O
hematopoietic	O
tissues	O
,	O
including	O
PEL	O
and	O
CD	O
but	O
not	O
KS	O
lesions	O
.	O

As	O
hypothesized	O
,	O
believers	O
showed	O
relatively	O
higher	O
right	O
hemispheric	O
activation	O
and	O
reduced	O
hemispheric	O
asymmetry	O
of	O
functional	O
complexity	O
.	O

Presently	O
four	O
unique	O
variants	O
carrying	O
distinct	O
GAF	B
sequences	I
in	O
the	O
N	O
-	O
terminal	O
region	O
have	O
been	O
identified	O
.	O

The	O
present	O
findings	O
revealed	O
that	O
the	O
rib-2	B
protein	I
was	O
a	O
unique	O
alpha1,4-N	B
-	I
acetylglucosaminyltransferase	I
involved	O
in	O
the	O
biosynthetic	O
initiation	O
and	O
elongation	O
of	O
heparan	O
sulfate	O
.	O

Inhibition	O
of	O
the	O
Mek	B
/	O
Erk	B
pathway	O
in	O
Rat1	O
/	O
ras	B
cells	O
,	O
using	O
the	O
Mek	B
inhibitor	O
,	O
PD98059	O
,	O
resulted	O
in	O
complete	O
cytoskeletal	O
recovery	O
,	O
indistinguishable	O
from	O
that	O
induced	O
by	O
HR12	O
.	O

Addition	O
of	O
synthetic	O
tyrosine	O
-	O
phosphorylated	O
peptides	O
derived	O
from	O
betac	O
cytoplasmic	O
tyrosines	O
prior	O
to	O
GM	B
-	I
CSF	I
stimulation	O
inhibited	O
the	O
in	O
vitro	O
activation	O
of	O
STAT5	B
.	O

MAIN	O
OUTCOME	O
MEASURES	O
:	O
Percentage	O
change	O
in	O
the	O
apnea	O
-	O
hypopnea	O
index	O
(	O
AHI	O
;	O
apnea	O
events	O
+	O
hypopnea	O
events	O
per	O
hour	O
of	O
sleep	O
)	O
and	O
odds	O
of	O
developing	O
moderate	O
-	O
to	O
-	O
severe	O
SDB	O
(	O
defined	O
by	O
an	O
AHI	O
>	O
or	O
=	O
15	O
events	O
per	O
hour	O
of	O
sleep	O
)	O
,	O
with	O
respect	O
to	O
change	O
in	O
weight	O
.	O

This	O
article	O
reviews	O
recent	O
information	O
on	O
the	O
frequency	O
,	O
characteristics	O
,	O
and	O
possible	O
pathogenic	O
mechanisms	O
of	O
the	O
vasculitides	O
occurring	O
in	O
patients	O
with	O
the	O
main	O
connective	O
tissue	O
diseases	O
.	O

Tec	B
kinase	I
signaling	O
in	O
T	O
cells	O
is	O
regulated	O
by	O
phosphatidylinositol	B
3-kinase	I
and	O
the	O
Tec	B
pleckstrin	B
homology	I
domain	I
.	O

The	O
structure	O
of	O
the	O
free	O
SH2	B
domain	I
has	O
been	O
compared	O
to	O
that	O
of	O
the	O
SH2	B
complexed	O
with	O
a	O
doubly	O
phosphorylated	O
peptide	O
derived	O
from	O
polyomavirus	B
middle	I
T	I
antigen	I
(	O
MT	B
)	O
.	O

We	O
have	O
identified	O
three	O
binding	O
sites	O
for	O
protein	O
complexes	O
:	O
a	O
palindrome	O
,	O
a	O
direct	O
repeat	O
,	O
and	O
a	O
C+T	O
sequence	O
that	O
corresponds	O
to	O
seven	O
GAGA	O
motifs	O
on	O
the	O
transcribed	O
strand	O
.	O

Nucleotide	O
sequence	O
,	O
genome	O
organization	O
and	O
phylogenetic	O
analysis	O
of	O
pineapple	O
mealybug	O
wilt	O
-	O
associated	O
virus-2	O
.	O

Increased	O
levels	O
of	O
anticardiolipin	B
immunoglobulin	I
G	I
may	O
also	O
cause	O
bleeding	O
.	O

RESULTS	O
:	O
Prevalence	O
of	O
obesity	O
(	O
BMI	O
SDS>2.0	O
)	O
was	O
<	O
2	O
%	O
at	O
diagnosis	O
,	O
but	O
increased	O
to	O
16	O
%	O
at	O
3y	O
.	O

Bupropion	O
to	O
aid	O
smoking	O
cessation	O
.	O

BACKGROUND	O
:	O
The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
and	O
compare	O
interleukin-6	B
(	O
IL-6	B
)	O
levels	O
in	O
gingival	O
crevicular	O
fluid	O
(	O
GCF	O
)	O
and	O
clinical	O
periodontal	O
findings	O
in	O
patients	O
with	O
rheumatoid	O
arthritis	O
(	O
RA	O
)	O
and	O
adult	O
periodontitis	O
(	O
AP	O
)	O
.	O

Studies	O
are	O
necessary	O
to	O
assess	O
the	O
source	O
of	O
contamination	O
and	O
potential	O
role	O
of	O
MRSA	O
-	O
contaminated	O
milk	O
in	O
the	O
transmission	O
of	O
MRSA	O
to	O
neonates	O
.	O

Effects	O
of	O
Trypanosoma	O
vivax	O
on	O
pregnancy	O
of	O
Yankasa	O
sheep	O
and	O
the	O
results	O
of	O
homidum	O
chloride	O
chemotherapy	O
.	O

Depending	O
on	O
treatment	O
exposures	O
,	O
this	O
at	O
-	O
risk	O
population	O
may	O
experience	O
life	O
-	O
threatening	O
late	O
effects	O
,	O
such	O
as	O
cirrhosis	O
secondary	O
to	O
hepatitis	O
C	O
or	O
late	O
-	O
onset	O
anthracycline	O
-	O
induced	O
cardiomyopathy	O
,	O
or	O
life	O
-	O
changing	O
late	O
effects	O
,	O
such	O
as	O
cognitive	O
dysfunction	O
.	O

The	O
presence	O
of	O
locus	O
-	O
specific	O
residues	O
throughout	O
the	O
entire	O
promoter	O
region	O
strongly	O
suggests	O
that	O
the	O
various	O
HLA	B
class	I
I	I
loci	I
are	O
differentially	O
regulated	O
.	O

Because	O
the	O
number	O
of	O
parameters	O
required	O
by	O
a	O
Volterra	O
series	O
grows	O
rapidly	O
with	O
both	O
the	O
length	O
of	O
its	O
memory	O
and	O
the	O
order	O
of	O
its	O
nonlinearity	O
,	O
methods	O
for	O
identifying	O
these	O
models	O
from	O
measurements	O
of	O
input	O
/	O
output	O
data	O
are	O
limited	O
to	O
low	O
-	O
order	O
systems	O
with	O
relatively	O
short	O
memories	O
.	O

The	O
standard	O
method	O
for	O
calculating	O
the	O
composite	O
score	O
on	O
the	O
S	O
-	O
B	O
IV	O
excludes	O
subtests	O
with	O
a	O
raw	O
score	O
of	O
0	O
,	O
which	O
overestimates	O
cognitive	O
functioning	O
in	O
young	O
biologically	O
high	O
risk	O
children	O
.	O

Validity	O
of	O
NIR	O
spectroscopy	O
for	O
quantitatively	O
measuring	O
muscle	O
oxidative	O
metabolic	O
rate	O
in	O
exercise	O
.	O

Previous	O
studies	O
have	O
demonstrated	O
that	O
tissue	O
-	O
restricted	O
transcription	O
factors	O
including	O
PU.1	B
and	O
PU.1	B
interaction	I
partner	I
(	O
PIP	B
)	O
function	O
synergistically	O
with	O
c	B
-	I
Fos	I
plus	O
c	B
-	I
Jun	I
to	O
stimulate	O
the	O
kappaE3'-enhancer	B
in	O
3T3	O
cells	O
.	O

An	O
int6	B
deletion	I
(	O
int6Delta	B
)	O
mutant	O
was	O
viable	O
but	O
grew	O
slowly	O
in	O
minimal	O
medium	O
.	O

We	O
produced	O
transgenic	O
plants	O
expressing	O
the	O
antisense	B
Arabidopsis	I
HD	I
(	O
AtHD1	B
)	O
gene	O
.	O

We	O
used	O
the	O
Toshiba	O
IIDR	O
system	O
,	O
which	O
is	O
composed	O
of	O
an	O
X	O
-	O
ray	O
TV	O
system	O
and	O
a	O
digital	O
image	O
managing	O
circuit	O
.	O

[	O
18F	O
]	O
(	O
+	O
)	O
-4-fluorobenzyltrozamicol	O
(	O
FBT	O
)	O
,	O
which	O
selectively	O
binds	O
to	O
the	O
vesicular	O
acetylcholine	B
transporter	I
in	O
the	O
presynaptic	O
cholinergic	O
neuron	O
,	O
has	O
previously	O
been	O
shown	O
to	O
be	O
a	O
useful	O
ligand	O
for	O
the	O
study	O
of	O
cholinergic	O
terminal	O
density	O
in	O
the	O
basal	O
ganglia	O
with	O
PET	O
.	O

LH	B
/	I
CG	I
receptor	I
activation	O
of	O
ARNO	B
is	O
not	O
mediated	O
by	O
activation	O
of	O
phosphatidylinositol	B
3-kinase	I
(	O
PI	B
3-kinase	I
)	O
or	O
by	O
G	B
protein	I
beta	I
gamma	I
subunits	I
.	O

Changes	O
in	O
stimulation	O
levels	O
over	O
time	O
in	O
nucleus	O
22	O
cochlear	O
implant	O
users	O
.	O

A	O
marked	O
decrease	O
in	O
the	O
type	B
1	I
insulin	I
-	I
like	I
growth	I
factor	I
(	I
IGF	I
)	I
receptor	I
(	O
IGF	B
-	I
IR	I
)	O
occurs	O
in	O
prostate	O
epithelial	O
cells	O
during	O
transformation	O
from	O
the	O
benign	O
to	O
the	O
metastatic	O
state	O
.	O

The	O
P69	O
cell	O
line	O
was	O
derived	O
by	O
immortalization	O
of	O
human	O
primary	O
prostate	O
epithelial	O
cells	O
with	O
simian	B
virus-40	I
T	I
antigen	I
and	O
is	O
rarely	O
tumorigenic	O
.	O

Because	O
the	O
high	B
-	I
density	I
lipoprotein	I
receptor	I
(	O
HDL	B
-	I
R	I
)	O
is	O
a	O
key	O
element	O
in	O
cholesterol	O
homeostasis	O
and	O
a	O
potential	O
therapeutic	O
target	O
for	O
hypercholesterolemic	O
drugs	O
,	O
an	O
understanding	O
of	O
HDL	B
-	I
R	I
regulation	O
is	O
essential	O
.	O

To	O
understand	O
the	O
molecular	O
regulation	O
of	O
these	O
genes	O
in	O
thyroid	O
cells	O
,	O
the	O
effect	O
of	O
thyroid	B
transcription	I
factor	I
1	I
(	O
TTF-1	B
)	O
and	O
the	O
paired	B
domain	I
-	I
containing	I
protein	I
8	I
(	O
Pax-8	B
)	O
on	O
the	O
transcriptional	O
activity	O
of	O
the	O
deiodinase	B
promoters	I
were	O
studied	O
.	O

Regional	O
blood	O
blow	O
was	O
measured	O
by	O
means	O
of	O
microspheres	O
in	O
predefined	O
regions	O
of	O
the	O
C6	O
,	O
T11	O
,	O
and	O
L6	O
vertebrae	O
.	O

The	O
mechanism	O
of	O
ligand	O
-	O
activated	O
estrogen	B
receptor	I
alpha	I
(	O
ERalpha	B
)	O
-dependent	O
activation	O
of	O
gene	O
expression	O
through	O
the	O
SRE	O
was	O
determined	O
by	O
mutational	O
analysis	O
of	O
the	O
promoter	O
,	O
analysis	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	O
MAPK	B
)	O
pathway	O
activation	O
by	O
E2	O
,	O
and	O
transforming	B
growth	I
factor	I
alpha	I
(	O
TGF	B
-	I
alpha	I
)	O
as	O
a	O
positive	O
control	O
.	O

CONCLUSIONS	O
:	O
Under	O
current	O
immunization	O
practices	O
,	O
the	O
authors	O
estimate	O
that	O
nearly	O
13,000	O
Asian	O
and	O
Pacific	O
Islander	O
children	O
living	O
in	O
the	O
United	O
States	O
today	O
will	O
become	O
infected	O
with	O
HBV	O
in	O
the	O
future	O
,	O
resulting	O
in	O
more	O
than	O
600	O
liver	O
carcinoma	O
deaths	O
.	O

A	O
novel	O
approach	O
was	O
developed	O
for	O
identifying	O
transcription	O
factor	O
activities	O
associated	O
with	O
NGF	B
-	O
activated	O
,	O
but	O
not	O
EGF	B
-	O
activated	O
,	O
signaling	O
,	O
using	O
random	O
oligonucleotide	O
clones	O
from	O
a	O
DNA	O
recognition	O
library	O
to	O
isolate	O
specific	O
DNA	O
binding	O
proteins	O
from	O
PC12	O
nuclear	O
extracts	O
.	O

NGF	B
elicits	O
a	O
more	O
delayed	O
and	O
sustained	O
ERK	B
phosphorylation	O
than	O
EGF	B
,	O
consistent	O
with	O
previous	O
reports	O
.	O

NGF	B
,	O
but	O
not	O
EGF	B
,	O
enhances	O
the	O
upper	O
bands	O
,	O
corresponding	O
to	O
phosphorylated	B
Fra-2	I
.	O

Workload	O
,	O
UAPs	O
,	O
and	O
you	O
.	O

Adding	O
10	O
mmol	O
SDS	O
/	O
l	O
led	O
to	O
transient	O
inhibition	O
of	O
acidification	O
,	O
metal	O
solubilization	O
and	O
sulfur	O
oxidation	O
.	O

We	O
have	O
investigated	O
the	O
role	O
of	O
NGF	B
in	O
regulating	O
gene	O
transcription	O
in	O
PC12	O
and	O
INS-1	O
cells	O
,	O
in	O
order	O
to	O
define	O
if	O
there	O
are	O
NGF	B
-	O
regulated	O
genes	O
per	O
se	O
.	O

These	O
data	O
indicate	O
that	O
the	O
SmSmad2	B
responds	O
to	O
the	O
TGF	B
-	I
beta	I
signals	O
by	O
interaction	O
with	O
receptor	B
I	I
,	O
which	O
phosphorylates	O
it	O
,	O
whereupon	O
it	O
translocates	O
into	O
the	O
nucleus	O
presumably	O
to	O
regulate	O
target	O
gene	O
transcription	O
and	O
consequently	O
elicit	O
a	O
specific	O
TGF	B
-	I
beta	I
effect	O
.	O

Naltrexone	O
hydrochloride	O
is	O
a	O
synthetic	O
opioid	B
receptor	I
antagonist	O
recently	O
used	O
in	O
efforts	O
to	O
provide	O
rapid	O
opioid	O
detoxification	O
.	O

METHODS	O
:	O
Thyroid	O
status	O
was	O
measured	O
at	O
baseline	O
(	O
1990	O
-	O
93	O
)	O
,	O
through	O
assessment	O
of	O
serum	O
antibodies	O
to	O
thyroid	B
peroxidase	I
(	O
TPO	B
-	I
Abs	I
,	O
positive	O
:	O
>	O
10	O
IU	O
/	O
ml	O
)	O
,	O
serum	B
TSH	I
levels	O
,	O
and	O
when	O
TSH	B
was	O
abnormal	O
(	O
<	O
0.4	O
or	O
>	O
4.0	O
mU	O
/	O
l	O
)	O
,	O
serum	B
thyroxin	I
levels	O
(	O
T4	O
)	O
.	O

We	O
suggest	O
that	O
ventriculopleural	O
shunting	O
should	O
be	O
considered	O
as	O
the	O
preferred	O
alternative	O
to	O
peritoneal	O
drainage	O
in	O
children	O
with	O
intra	O
-	O
abdominal	O
adhesions	O
or	O
with	O
a	O
history	O
of	O
recent	O
peritoneal	O
infection	O
.	O

Derivation	O
and	O
initial	O
characterization	O
of	O
a	O
mouse	O
mammary	O
tumor	O
cell	O
line	O
carrying	O
the	O
polyomavirus	B
middle	I
T	I
antigen	I
:	O
utility	O
in	O
the	O
development	O
of	O
novel	O
cancer	O
therapeutics	O
.	O

Long	O
-	O
range	O
comparison	O
of	O
human	B
and	I
mouse	I
SCL	I
loci	I
:	O
localized	O
regions	O
of	O
sensitivity	O
to	O
restriction	O
endonucleases	O
correspond	O
precisely	O
with	O
peaks	O
of	O
conserved	O
noncoding	O
sequences	O
.	O

The	O
utilities	O
measured	O
in	O
our	O
study	O
can	O
be	O
applied	O
directly	O
to	O
quality	O
-	O
of	O
-	O
life	O
determinations	O
in	O
clinical	O
trials	O
of	O
adjuvant	O
IFN	B
alpha-2b	I
to	O
measure	O
the	O
net	O
benefit	O
of	O
therapy	O
.	O

Structure	O
of	O
the	O
EMAPII	B
domain	I
of	O
human	B
aminoacyl	I
-	I
tRNA	I
synthetase	I
complex	I
reveals	O
evolutionary	O
dimer	O
mimicry	O
.	O

Hypomorphic	O
dSLBP	B
alleles	I
support	O
zygotic	O
development	O
but	O
cause	O
female	O
sterility	O
.	O

We	O
mapped	O
the	O
DGCR6	B
gene	I
to	O
chromosome	O
22q11	O
within	O
a	O
low	O
copy	O
repeat	O
,	O
termed	O
sc11.1a	O
,	O
and	O
identified	O
a	O
second	O
copy	O
of	O
the	O
gene	O
,	O
DGCR6L	B
,	O
within	O
the	O
duplicate	O
locus	O
,	O
termed	O
sc11.1b	O
.	O

Nerve	B
growth	I
factor	I
(	O
NGF	B
)	O
and	O
retinoic	O
acid	O
(	O
RA	O
)	O
exert	O
important	O
actions	O
on	O
PC12	O
cells	O
.	O

Recruitment	O
of	O
an	O
RNA	B
polymerase	I
II	I
complex	I
is	O
mediated	O
by	O
the	O
constitutive	O
activation	O
domain	O
in	O
CREB	B
,	O
independently	O
of	O
CREB	B
phosphorylation	O
.	O

The	O
region	O
containing	O
both	O
serines	O
is	O
homologous	O
to	O
the	O
N	O
-	O
terminal	O
destruction	O
box	O
of	O
IkappaBalpha	B
,	I
-beta	I
,	I
and	I
-epsilon	I
.	O

This	O
function	O
requires	O
not	O
only	O
the	O
kinase	O
domain	O
of	O
Csk	B
,	O
but	O
also	O
its	O
Src	B
homology	I
3	I
(	O
SH3	B
)	O
and	O
SH2	B
regions	O
.	O

Furthermore	O
,	O
we	O
showed	O
that	O
ERSF	B
including	O
NF	B
-	I
Y	I
and	O
ATF6alpha	B
and/or	I
beta	I
and	O
capable	O
of	O
binding	O
to	O
ERSE	O
is	O
indeed	O
formed	O
when	O
the	O
cellular	O
UPR	O
is	O
activated	O
.	O

The	O
observed	O
phenotypes	O
may	O
be	O
explained	O
by	O
(	O
i	O
)	O
a	O
selective	O
disruption	O
of	O
very	B
-	I
low	I
-	I
density	I
lipoprotein	I
secretion	O
due	O
to	O
decreased	O
expression	O
of	O
genes	O
encoding	O
apolipoprotein	B
B	I
and	O
microsomal	B
triglyceride	I
transfer	I
protein	I
,	O
(	O
ii	O
)	O
an	O
increase	O
in	O
hepatic	O
cholesterol	O
uptake	O
due	O
to	O
increased	O
expression	O
of	O
the	O
major	O
high	B
-	I
density	I
lipoprotein	I
receptor	I
,	O
scavenger	B
receptor	I
BI	I
,	O
and	O
(	O
iii	O
)	O
a	O
decrease	O
in	O
bile	O
acid	O
uptake	O
to	O
the	O
liver	O
due	O
to	O
down	O
-	O
regulation	O
of	O
the	O
major	O
basolateral	B
bile	I
acid	I
transporters	I
sodium	I
taurocholate	I
cotransporter	I
protein	I
and	O
organic	B
anion	I
transporter	I
protein	I
1	I
.	O

These	O
effects	O
were	O
not	O
seen	O
with	O
SHIP2	B
possessing	O
a	O
mutation	O
in	O
the	O
SH2	B
domain	I
(	O
R47	B
G	I
)	O
.	O

The	O
gonadotrope	O
-	O
specific	O
and	O
regulated	O
expression	O
of	O
the	O
GnRH	B
receptor	I
(	O
GnRH	B
-	I
R	I
)	O
gene	O
is	O
dependent	O
on	O
multiple	O
transcription	O
factors	O
that	O
interact	O
with	O
the	O
noncanonical	B
GnRH	I
-	I
R	I
activating	I
sequence	I
(	O
GRAS	B
)	O
,	O
the	O
activator	B
protein-1	I
(	O
AP-1	B
)	O
element	O
,	O
and	O
the	O
steroidogenic	B
factor-1	I
(	O
SF-1	B
)	O
binding	O
site	O
.	O

Methylation	O
at	O
both	O
cytosine	O
residues	O
in	O
the	O
E2F	B
element	O
(	O
(	O
m	O
)	O
CG	O
(	O
m	O
)	O
CG	O
)	O
generated	O
a	O
new	O
methylcytosine	O
-	O
specific	O
DNA	O
-	O
protein	O
complex	O
.	O

As	O
well	O
,	O
IFN	B
-	I
gamma	I
-	O
induced	O
expression	O
of	O
IRF-1	B
and	O
its	O
binding	O
to	O
the	O
IRF	B
element	I
is	O
inhibited	O
.	O

This	O
molecule	O
,	O
wH22xeGFP	B
,	O
consists	O
of	O
the	O
entire	B
humanized	I
anti	I
-	I
FcgammaRI	I
mAb	I
H22	B
with	O
eGFP	B
genetically	O
fused	O
to	O
the	O
C	O
-	O
terminal	O
end	O
of	O
each	O
CH3	B
domain	I
.	O

wH22xeGFP	B
binds	O
within	O
the	O
ligand	O
-	O
binding	O
region	O
by	O
its	O
Fc	B
end	O
,	O
as	O
well	O
as	O
outside	O
the	O
ligand	O
-	O
binding	O
region	O
by	O
its	O
Fab	B
ends	O
,	O
thereby	O
cross	O
-	O
linking	O
FcgammaRI	B
.	O

Transient	O
transfections	O
showed	O
that	O
a	O
single	O
mutation	O
(	O
556	O
M	O
)	O
decreased	O
TBLV	B
enhancer	I
activity	O
at	O
least	O
20-fold	O
in	O
two	O
different	O
T	O
-	O
cell	O
lines	O
.	O

Vector	O
stocks	O
containing	O
envelope	B
proteins	I
from	O
three	O
different	O
SIVmac	O
clones	O
,	O
namely	O
,	O
SIVmac239	O
(	O
T	O
-	O
lymphocyte	O
tropic	O
[	O
T	O
-	O
tropic	O
]	O
)	O
,	O
SIVmac316	O
(	O
macrophage	O
tropic	O
[	O
M	O
-	O
tropic	O
]	O
)	O
,	O
and	O
SIVmac1A11	O
(	O
dualtropic	O
)	O
,	O
were	O
tested	O
.	O

Both	O
Z	B
and	O
R	B
expression	O
resulted	O
in	O
PML	O
dispersion	O
in	O
EBV	O
-	O
positive	O
cells	O
.	O

Interestingly	O
,	O
the	O
activity	O
of	O
IkappaB	B
kinase	I
(	O
IKK	B
-	I
beta	I
)	O
,	O
which	O
plays	O
an	O
essential	O
role	O
in	O
NF	B
-	I
kappaB	I
activation	O
through	O
IkappaB	B
phosphorylation	O
,	O
was	O
largely	O
enhanced	O
in	O
paclitaxel	O
-	O
treated	O
cells	O
,	O
detected	O
as	O
IkappaBalpha	B
phosphorylation	O
.	O

Immunofluorescence	O
studies	O
in	O
C2C12	O
myotubes	O
show	O
that	O
Smad2	B
and	O
MEF2A	B
co	O
-	O
localise	O
in	O
the	O
nucleus	O
of	O
multinuclear	O
myotubes	O
during	O
differentiation	O
.	O

Rapid	O
evolution	O
of	O
the	O
DNA	O
-	O
binding	O
site	O
in	O
LAGLIDADG	B
homing	I
endonucleases	I
.	O

Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
from	O
somatic	O
cell	O
hybrids	O
showed	O
that	O
endothelial	B
-	I
TACC	I
-	I
related	I
cDNA	I
maps	O
to	O
chromosome	O
10	O
.	O

Copyright	O
2001	O
Academic	O
Press	O
.	O

Mental	O
rotation	O
of	O
paired	O
figures	O
engendered	O
activation	O
in	O
the	O
left	O
superior	O
parietal	O
lobule	O
and	O
the	O
right	O
frontal	O
medial	O
gyrus	O
.	O

We	O
also	O
reported	O
the	O
identification	O
of	O
three	O
corresponding	O
alternative	O
first	O
exons	O
and	O
an	O
intronic	O
promoter	O
in	O
the	O
human	B
PDE5A	I
gene	I
.	O

In	O
the	O
present	O
work	O
,	O
the	O
complete	O
genome	O
sequences	O
of	O
Pyrococcus	O
horikoshii	O
and	O
Pyrococcus	O
abyssi	O
,	O
two	O
species	O
in	O
a	O
genus	O
of	O
hyperthermophilic	O
archaeon	O
(	O
archaebacterium	O
)	O
,	O
were	O
compared	O
to	O
detect	O
large	O
genome	O
polymorphisms	O
linked	O
with	O
restriction	O
-	O
modification	O
gene	O
homologs	O
.	O

This	O
animal	O
model	O
of	O
dystonia	O
appears	O
to	O
be	O
a	O
model	O
of	O
NAD	O
in	O
man	O
from	O
the	O
viewpoint	O
of	O
treatment	O
-	O
response	O
.	O

Peripheral	O
and	O
preemptive	O
opioid	O
antinociception	O
in	O
a	O
mouse	O
visceral	O
pain	O
model	O
.	O

Twenty	O
-	O
six	O
(	O
55	O
%	O
)	O
(	O
95	O
%	O
CI	O
,	O
41	O
-	O
69	O
%	O
)	O
patients	O
experienced	O
>	O
or	O
=	O
grade	O
3	O
acute	O
toxicity	O
(	O
RTOG	O
)	O
.	O

No	O
'	O
TATA	O
'	O
motif	O
was	O
identified	O
near	O
either	O
the	O
GABPalpha	B
or	O
ATPsynCF6	B
transcription	O
start	O
sites	O
.	O

Significantly	O
higher	O
lung	O
function	O
parameters	O
were	O
obtained	O
in	O
extubated	O
recipients	O
of	O
LPD	O
preserved	O
grafts	O
2	O
weeks	O
after	O
TX	O
.	O

Acquired	O
antithrombin	B
deficiency	O
in	O
sepsis	O
.	O

In	O
addition	O
,	O
we	O
have	O
isolated	O
a	O
genomic	O
fragment	O
containing	O
the	O
most	O
distal	O
5	O
'	O
sequences	O
of	O
the	O
major	O
GGT	B
mRNA	I
in	O
HepG2	O
cells	O
.	O

Increased	O
erythropoietin	B
synthesis	O
in	O
patients	O
with	O
COLD	O
or	O
left	O
heart	O
failure	O
is	O
related	O
to	O
alterations	O
in	O
renal	O
haemodynamics	O
.	O

Expression	O
of	O
herpes	B
simplex	I
virus	I
type	I
2	I
US3	I
affects	O
the	O
Cdc42	B
/	O
Rac	B
pathway	O
and	O
attenuates	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
activation	O
.	O

If	O
you	O
think	O
education	O
is	O
expensive	O
--	O
try	O
ignorance	O
--	O
Bok	O
's	O
Law	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
SNTCS	O
is	O
highly	O
malignant	O
.	O

High	O
-	O
affinity	O
binding	O
of	O
NF-1	B
to	O
PSE	B
-	I
B	I
,	O
but	O
not	O
to	O
PSE	B
-	I
A	I
,	O
was	O
confirmed	O
by	O
competition	O
of	O
DNA	O
-	O
protein	O
interactions	O
by	O
using	O
NF-1	B
DNA	O
elements	O
and	O
antibodies	O
.	O

Coexpression	O
of	O
the	O
p120	B
(	O
ctn	B
)	O
protein	O
with	O
an	O
N	O
-	O
terminal	O
deletion	O
,	O
which	O
eliminates	O
some	O
potential	O
tyrosine	O
phosphorylation	O
sites	O
,	O
or	O
the	O
protein	O
with	O
a	O
single	O
amino	O
acid	O
substitution	O
(	O
tyrosine	O
at	O
217	O
to	O
phenylalanine	O
)	O
resulted	O
in	O
an	O
increase	O
in	O
the	O
aggregation	O
of	O
v	B
-	I
Src	I
-	O
transformed	O
EL	O
and	O
EalphaCL	O
cells	O
.	O

We	O
show	O
that	O
p73	B
can	O
transcriptionally	O
inhibit	O
a	O
number	O
of	O
cellular	O
and	O
viral	O
promoters	O
.	O

Identification	O
of	O
pulmonary	O
vein	O
stenosis	O
after	O
radiofrequency	O
ablation	O
for	O
atrial	O
fibrillation	O
using	O
MRI	O
.	O

Tumor	O
cell	O
lines	O
transduced	O
at	O
an	O
MOI	O
of	O
8	O
for	O
3	O
days	O
led	O
to	O
>	O
90	O
%	O
gene	O
transfer	O
efficiency	O
.	O

Finally	O
,	O
we	O
compared	O
the	O
differential	O
screening	O
techniques	O
in	O
terms	O
of	O
sensitivity	O
,	O
efficiency	O
and	O
occurrence	O
of	O
false	O
positives	O
.	O

To	O
investigate	O
the	O
effects	O
of	O
exogenous	O
hyaluronic	O
acid	O
,	O
the	O
development	O
of	O
port	O
-	O
site	O
metastasis	O
was	O
examined	O
using	O
mouse	O
adenocarcinoma	O
cell	O
-	O
line	O
colon	O
26	O
cells	O
.	O

Cytomegalovirus	O
,	O
Chlamydia	O
pneumoniae	O
,	O
and	O
Helicobacter	O
pylori	O
IgG	B
antibodies	I
and	O
restenosis	O
after	O
stent	O
implantation	O
:	O
an	O
angiographic	O
and	O
intravascular	O
ultrasound	O
study	O
.	O

Architecture	O
and	O
anatomy	O
of	O
the	O
genomic	O
locus	O
encoding	O
the	O
human	O
leukemia	O
-	O
associated	O
transcription	O
factor	O
RUNX1	B
/	O
AML1	B
.	O

In	O
this	O
paper	O
the	O
tyrosine	O
dephosphorylating	O
enzymes	O
,	O
the	O
protein	B
-	I
tyrosine	I
phosphatases	I
(	O
PTPs	B
)	O
,	O
are	O
studied	O
which	O
can	O
be	O
grouped	O
into	O
two	O
subfamilies	O
,	O
the	O
soluble	B
PTPs	I
and	O
the	O
receptor	B
PTPs	I
(	O
RPTPs	B
)	O
.	O

The	O
Ig	B
-	O
related	O
,	O
typical	O
metazoan	O
,	O
module	O
is	O
classified	O
to	O
the	O
disulphide	O
lacking	O
Ig	B
members	I
and	O
represents	O
the	O
phylogenetic	O
earliest	O
member	O
of	O
this	O
group	O
.	O

While	O
these	O
results	O
are	O
consistent	O
with	O
previously	O
reported	O
effects	O
of	O
the	O
C	O
-	O
terminal	O
domain	O
on	O
nucleotide	O
binding	O
,	O
they	O
also	O
demonstrate	O
that	O
interactions	O
with	O
the	O
N	O
-	O
terminal	O
domains	O
are	O
necessary	O
to	O
inhibit	O
proton	O
transport	O
.	O

By	O
analyzing	O
5'-deletion	O
insulin	B
promoter	I
-	I
reporter	I
constructs	I
in	O
transient	O
transfections	O
of	O
clonal	O
INS-1	B
beta	I
-	O
cells	O
,	O
we	O
located	O
activating	O
Hh	B
-	O
responsive	O
regions	O
within	O
the	O
rat	B
insulin	I
I	I
promoter	I
that	O
include	O
the	O
glucose	O
-	O
response	O
elements	O
Far	O
(	O
E2	O
)	O
and	O
Flat	O
(	O
A2	O
/	O
A3	O
)	O
.	O

The	O
androgen	B
receptor	I
(	O
AR	B
)	O
amino	O
-	O
terminus	O
imposes	O
androgen	O
-	O
specific	O
regulation	O
of	O
AR	B
gene	I
expression	O
via	O
an	O
exonic	O
enhancer	O
.	O

An	O
additional	O
9	O
patients	O
achieved	O
normal	O
levels	O
with	O
adjunctive	O
drug	O
therapy	O
.	O

By	O
Caveman	O
.	O

Corneal	O
scrapping	O
and	O
deep	O
stromal	O
biopsy	O
were	O
obtained	O
and	O
stained	O
for	O
microscopic	O
evaluation	O
with	O
periodic	O
acid	O
-	O
Schiff	O
,	O
Giemsa	O
,	O
and	O
Gomori	O
's	O
methenamine	O
silver	O
stains	O
.	O

These	O
results	O
indicate	O
that	O
BACM	O
has	O
antiplaque	O
and	O
stronger	O
antidegradation	O
effects	O
than	O
GLCM	O
.	O

Susceptibility	O
to	O
ischemia	O
-	O
induced	O
arrhythmias	O
was	O
lower	O
in	O
1-week	O
diabetics	O
:	O
only	O
42	O
%	O
of	O
diabetic	O
hearts	O
exhibited	O
ventricular	O
tachycardia	O
(	O
VT	O
)	O
and	O
16	O
%	O
had	O
short	O
episodes	O
of	O
ventricular	O
fibrillation	O
(	O
VF	O
)	O
as	O
compared	O
to	O
VT	O
100	O
%	O
and	O
VF	O
70	O
%	O
(	O
including	O
sustained	O
VF	O
36	O
%	O
)	O
in	O
the	O
non	O
-	O
diabetics	O
(	O
P<0.05	O
)	O
.	O

A	O
picture	O
is	O
emerging	O
showing	O
a	O
gradient	O
of	O
function	O
among	O
p53	B
,	O
p73	B
,	O
p63	B
ranging	O
from	O
tumor	O
suppression	O
to	O
development	O
.	O

This	O
could	O
lead	O
to	O
subsequent	O
outbreaks	O
if	O
Babesia	O
carrier	O
animals	O
were	O
to	O
be	O
introduced	O
into	O
the	O
herd	O
.	O

Contagious	O
bovine	O
pleuropneumonia	O
is	O
a	O
major	O
threat	O
for	O
cattle	O
in	O
Africa	O
.	O

The	O
increase	O
in	O
number	O
of	O
terminal	O
hairs	O
,	O
which	O
are	O
defined	O
as	O
hairs	O
more	O
than	O
60	O
microm	O
in	O
diameter	O
,	O
in	O
the	O
designated	O
area	O
(	O
0.5	O
cm	O
square	O
=	O
0.25	O
cm2	O
area	O
)	O
of	O
the	O
procyanidin	O
B-2	O
group	O
subjects	O
after	O
the	O
6-month	O
trial	O
was	O
significantly	O
greater	O
than	O
that	O
of	O
the	O
placebo	O
control	O
group	O
subjects	O
(	O
procyanidin	O
B-2	O
,	O
1.99	O
+	O
/-	O

2.58	O
(	O
mean	O
+	O
/-	O

SD	O
)	O
/	O
0.25	O
cm2	O
;	O
placebo	O
,	O
-0.82	O
+	O
/-	O

3.40	O
(	O
mean	O
+	O
/-	O

SD	O
)	O
/	O
0.25	O
cm2	O
;	O
P	O
<	O
0.02	O
,	O
two	O
-	O
sample	O
t	O
test	O
)	O
.	O

Ectopic	O
expression	O
of	O
the	O
dominant	B
mutant	I
Lg3	I
allele	I
is	O
believed	O
to	O
cause	O
the	O
phenotype	O
.	O

High	O
plasma	B
AVP	I
levels	O
observed	O
in	O
the	O
two	O
cases	O
suggest	O
that	O
SSRIs	O
stimulate	O
AVP	B
secretion	O
,	O
thereby	O
causing	O
SIADH	O
.	O

Thus	O
,	O
in	O
T47D	O
breast	O
carcinoma	O
cells	O
,	O
IL-6	B
acts	O
in	O
synergy	O
with	O
EGF	B
receptor	I
autocrine	O
activity	O
to	O
signal	O
through	O
the	O
MAPK	B
/	O
PI3	B
K	I
pathways	O
.	O

For	O
immunological	O
methods	O
,	O
identification	O
of	O
such	O
antigens	O
with	O
intermolecular	O
variability	O
,	O
e.g.	O
,	O
the	O
structural	O
aescin	O
analogs	O
,	O
is	O
of	O
unknown	O
validity	O
.	O

Most	O
patients	O
harboring	O
metronidazole-	O
and	O
clarithromycin	O
-	O
resistant	O
strains	O
were	O
eradicated	O
at	O
an	O
equal	O
rate	O
by	O
each	O
of	O
the	O
three	O
regimens	O
.	O

RESULTS	O
:	O
During	O
the	O
stabilization	O
period	O
,	O
PaCO2	O
(	O
mean	O
+	O
/-	O

SD	O
)	O
was	O
33	O
+	O
/-	O

5	O
mm	O
Hg	O
,	O
and	O
arrhythmias	O
were	O
not	O
detected	O
.	O

BACKGROUND	O
:	O
Previous	O
studies	O
have	O
indicated	O
that	O
the	O
60-	O
,	O
30-	O
,	O
28-	O
and	O
12-item	O
versions	O
of	O
the	O
General	O
Health	O
Questionnaire	O
(	O
GHQ	O
)	O
are	O
liable	O
to	O
retest	O
effects	O
,	O
especially	O
when	O
administered	O
multiple	O
times	O
with	O
short	O
intervals	O
.	O

Decreased	O
serum	B
ceruloplasmin	I
and	O
copper	O
levels	O
in	O
cervical	O
dystonia	O
.	O

A	O
microsporidian	O
,	O
Nosema	O
algerae	O
Vavra	O
and	O
undeen	O
,	O
was	O
found	O
parasitizing	O
larvae	O
and	O
adults	O
of	O
a	O
laboratory	O
colony	O
of	O
Culex	O
pipiens	O
L.	O
originated	O
from	O
Gharbia	O
Governorate	O
.	O

Molecular	O
cloning	O
and	O
characterization	O
of	O
OsPSK	B
,	O
a	O
gene	O
encoding	O
a	O
precursor	O
for	O
phytosulfokine	B
-	I
alpha	I
,	O
required	O
for	O
rice	O
cell	O
proliferation	O
.	O

Plasma	O
DHE	O
concentration	O
rose	O
promptly	O
above	O
5	O
ng	O
/	O
ml	O
after	O
the	O
application	O
of	O
the	O
PSA	O
tape	O
onto	O
the	O
damaged	O
skin	O
in	O
hairless	O
rat	O
.	O

Implications	O
in	O
biomonitoring	O
of	O
the	O
observed	O
accumulation	O
patterns	O
,	O
especially	O
in	O
the	O
different	O
tissues	O
of	O
Posidonia	O
oceanica	O
,	O
are	O
discussed	O
.	O

Thus	O
,	O
Xlim-1	B
not	O
only	O
contains	O
a	O
unique	O
tyrosine	O
-	O
rich	O
activation	O
domain	O
but	O
also	O
contains	O
a	O
negative	O
regulatory	O
domain	O
in	O
CT239	O
-	O
403	O
,	O
suggesting	O
a	O
complex	O
regulatory	O
mechanism	O
underlying	O
the	O
transcriptional	O
activity	O
of	O
Xlim-1	B
in	O
the	O
organizer	O
.	O

After	O
allowing	O
time	O
for	O
absorption	O
,	O
participants	O
completed	O
a	O
bridge	O
simulator	O
task	O
.	O

Anti	B
-	I
nucleolin	I
mAb	I
was	O
used	O
to	O
confirm	O
the	O
antigenic	O
properties	O
of	O
this	O
p95	B
component	I
.	O

Substitutions	O
in	O
the	O
YFV	B
Ag	B
-	I
binding	I
region	I
(	O
ABR	B
)	O
occur	O
at	O
four	O
of	O
the	O
eight	O
highly	O
conserved	O
residues	O
that	O
are	O
essential	O
for	O
binding	O
of	O
peptide	O
-	O
Ag	O
in	O
the	O
class	O
Ia	O
molecules	O
.	O

Similarly	O
,	O
curcumin	O
(	O
diferuloylmethane	O
)	O
,	O
an	O
anti	O
-	O
inflammatory	O
agent	O
,	O
suppressed	O
OSM	B
-	O
stimulated	O
STAT1	B
phosphorylation	O
,	O
DNA	O
-	O
binding	O
activity	O
of	O
STAT1	B
,	O
and	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinase	I
activation	O
without	O
affecting	O
JAK1	B
,	O
JAK2	B
,	O
JAK3	B
,	O
ERK1	B
/	I
2	I
,	O
and	O
p38	B
phosphorylation	O
.	O

A	O
cDNA	O
clone	O
encoding	O
C2H2-type	B
zinc	I
finger	I
protein	I
,	O
SCOF-1	B
,	O
was	O
isolated	O
from	O
soybean	O
.	O

Apart	O
from	O
antimicrobial	O
properties	O
,	O
recent	O
data	O
indicate	O
that	O
PMN	O
also	O
exert	O
anti	O
-	O
inflammatory	O
effects	O
by	O
stimulation	O
and	O
release	O
of	O
cytokine	O
antagonists	O
such	O
as	O
interleukin-1	B
receptor	I
antagonist	I
(	O
IL-1ra	B
)	O
.	O

The	O
purpose	O
of	O
this	O
investigation	O
was	O
to	O
study	O
the	O
morphological	O
characteristics	O
of	O
the	O
fibrous	O
tissue	O
capsule	O
resulting	O
from	O
the	O
implantation	O
of	O
aluminum	O
calcium	O
phosphate	O
(	O
ALCAP	O
)	O
and	O
hydroxyapetite	O
(	O
HA	O
)	O
bioceramics	O
.	O

Before	O
PO3	O
administration	O
,	O
more	O
than	O
half	O
(	O
57.4	O
%	O
)	O
of	O
the	O
patients	O
received	O
only	O
1	O
or	O
2	O
antituberculous	O
drugs	O
(	O
ethambutole	O
and	O
ethionamide	O
or	O
ethambutole	O
and	O
oprofloxacin	O
)	O
.	O

Can	O
survival	O
be	O
prolonged	O
for	O
patients	O
with	O
hormone	O
-	O
resistant	O
prostate	O
cancer	O
?	O

The	O
effects	O
of	O
the	O
transfected	O
receptors	O
were	O
associated	O
with	O
antagonism	O
of	O
activator	B
protein	I
1	I
(	O
AP-1	B
)	O
activity	O
.	O

Recent	O
studies	O
using	O
isolated	O
rat	O
adipocytes	O
and	O
chemically	O
synthesized	O
PIG	O
compounds	O
point	O
to	O
IRS1	B
/	I
3	I
tyrosine	O
phosphorylation	O
by	O
p59Lyn	B
kinase	I
as	O
the	O
site	O
of	O
cross	O
-	O
talk	O
,	O
the	O
negative	O
regulation	O
of	O
which	O
by	O
interaction	O
with	O
caveolin	B
is	O
apparently	O
abrogated	O
by	O
PIG	O
.	O

RESULTS	O
:	O
The	O
parameters	O
SF2	O
and	O
plating	O
efficiency	O
were	O
stable	O
throughout	O
the	O
4-year	O
test	O
period	O
.	O

VE	O
-	O
DEF	O
animals	O
had	O
significantly	O
higher	O
(	O
p	O
<	O
0.05	O
)	O
levels	O
of	O
myocardial	O
lipid	O
peroxidation	O
and	O
lower	O
(	O
p	O
<	O
0.05	O
)	O
protein	O
thiols	O
following	O
I	O
-	O
R	O
compared	O
to	O
the	O
CON	O
animals	O
.	O

The	O
child	O
left	O
behind	O
.	O

The	O
contrasting	O
effects	O
of	O
dopaminergic	O
stimulation	O
on	O
the	O
motor	O
performance	O
and	O
on	O
some	O
aspects	O
of	O
cognitive	O
processing	O
suggest	O
the	O
existence	O
of	O
complex	O
interactions	O
within	O
pre-	O
and	O
postsynaptic	O
brain	B
dopamine	I
receptors	I
,	O
and	O
an	O
intervention	O
of	O
segregated	O
basal	O
ganglia	O
-	O
prefrontal	O
cortex	O
loops	O
in	O
motor	O
and	O
cognitive	O
behaviour	O
.	O

HexA71	B
negatively	O
affects	O
RpoS	B
,	O
as	O
the	O
levels	O
of	O
this	O
alternative	O
sigma	B
factor	I
are	O
higher	O
in	O
the	O
HexA-	B
mutant	I
than	O
in	O
the	O
HexA+	B
strain	O
.	O

Multiple	O
copies	O
of	O
rsmB+	B
DNA	I
,	O
on	O
the	O
other	O
hand	O
,	O
stimulate	O
exoenzyme	O
production	O
by	O
relieving	O
the	O
negative	O
effects	O
of	O
a	O
chromosomal	O
copy	O
of	O
hexA+	B
.	O

0	O
%	O
)	O
and	O
IL-12	B
(	O
42.6	O
%	O
vs.	O

Systematic	O
review	O
of	O
diagnostic	O
tests	O
for	O
vaginal	O
trichomoniasis	O
.	O

More	O
importantly	O
,	O
this	O
fusion	O
converted	O
a	O
less	O
effective	O
vaccine	O
into	O
one	O
with	O
significant	O
potency	O
against	O
established	O
E7-expressing	B
metastatic	O
tumors	O
.	O

We	O
compared	O
previously	O
the	O
methylation	O
status	O
between	O
normal	O
liver	O
and	O
liver	O
tumors	O
in	O
SV40	B
T	I
/	I
t	I
antigen	I
transgenic	O
mice	O
(	O
MT	O
-	O
D2	O
mice	O
)	O
using	O
Restriction	O
Landmark	O
Genomic	O
Scanning	O
for	O
Methylation	O
(	O
RLGS	O
-	O
M	O
)	O
and	O
identified	O
several	O
loci	O
/	O
spots	O
that	O
appeared	O
to	O
be	O
methylated	O
frequently	O
in	O
liver	O
tumors	O
.	O

Northern	O
blot	O
analysis	O
revealed	O
that	O
mlt	B
1	I
is	O
normally	O
expressed	O
in	O
brain	O
,	O
spleen	O
,	O
stom	O
ach	O
,	O
and	O
liver	O
.	O

Treatment	O
of	O
N18TG-2	O
cells	O
with	O
a	O
demethylating	O
agent	O
,	O
5-aza	O
-	O
deoxycytidine	O
,	O
resulted	O
in	O
an	O
expression	O
of	O
mlt	B
1	I
,	O
indicating	O
that	O
the	O
repression	O
of	O
mlt	B
1	I
is	O
attributable	O
to	O
methylation	O
Thus	O
,	O
mlt	B
1	I
is	O
a	O
novel	O
target	O
gene	O
that	O
is	O
silenced	O
by	O
methylation	O
during	O
liver	O
tumorigenesis	O
initiated	O
by	O
SV40	B
T	I
antigen	I
.	O

These	O
results	O
suggested	O
a	O
critical	O
role	O
for	O
tyrosine	O
residue	O
1229	O
in	O
the	O
regulation	O
of	O
L1	B
endocytosis	O
.	O

We	O
conclude	O
that	O
RPMS	B
acts	O
as	O
a	O
negative	O
regulator	O
of	O
EBNA2	B
and	O
Notch	B
activity	O
through	O
its	O
interactions	O
with	O
the	O
CBF1-associated	B
corepressor	I
complex	I
.	O

Folate	O
metabolism	O
in	O
the	O
human	O
malaria	O
parasite	O
Plasmodium	O
falciparum	O
is	O
an	O
essential	O
activity	O
for	O
cell	O
growth	O
and	O
replication	O
,	O
and	O
the	O
target	O
of	O
an	O
important	O
class	O
of	O
therapeutic	O
agents	O
in	O
widespread	O
use	O
.	O

Retinoids	O
participate	O
in	O
the	O
onset	O
of	O
differentiation	O
,	O
apoptosis	O
and	O
the	O
inhibition	O
of	O
growth	O
in	O
a	O
wide	O
variety	O
of	O
normal	O
and	O
cancerous	O
cells	O
.	O

Transactivation	O
of	O
oIFNtau	B
enhancer	O
-	O
reporter	O
constructs	O
was	O
primarily	O
regulated	O
by	O
three	O
regions	O
containing	O
AP-1	B
site	I
,	O
GATA	B
like	I
sequence	I
and	O
site	O
(	O
s	O
)	O
unidentified	O
.	O

Drosophila	B
Menin1	I
gene	I
transcripts	I
use	O
alternative	O
polyadenylation	O
sites	O
resulting	O
in	O
4.3	O
and	O
5-kb	O
messages	O
.	O

Sequence	O
analysis	O
indicates	O
that	O
RBP21	B
shares	O
homology	O
with	O
other	O
retinoblastoma	B
-	I
binding	I
proteins	I
in	O
the	O
pRb	B
-	I
binding	I
motif	I
LxCxE	O
at	O
the	O
C	O
-	O
terminal	O
region	O
.	O

In	O
addition	O
,	O
the	O
consensus	O
amino	O
acid	O
motif	O
for	O
serine	B
threonine	I
receptor	I
kinases	I
was	O
also	O
present	O
.	O

OsBBPI	B
was	O
found	O
to	O
be	O
rapidly	O
induced	O
in	O
rice	O
seedling	O
leaf	O
in	O
response	O
to	O
cut	B
,	O
exogenous	O
jasmonic	O
acid	O
(	O
JA	O
)	O
,	O
and	O
two	O
potent	O
protein	B
phosphatase	I
2A	I
(	O
PP2A	B
)	O
inhibitors	O
,	O
cantharidin	O
(	O
CN	O
)	O
and	O
endothall	O
(	O
EN	O
)	O
,	O
in	O
a	O
light	O
/	O
dark-	O
,	O
time-	O
and	O
dose	O
-	O
dependent	O
manner	O
;	O
this	O
induction	O
was	O
completely	O
inhibited	O
by	O
cycloheximide	O
(	O
CHX	O
)	O
,	O
indicating	O
a	O
requirement	O
for	O
de	O
novo	O
protein	O
synthesis	O
in	O
its	O
induction	O
.	O

Copyright	O
2000	O
John	O
Wiley	O
&	O
Sons	O
,	O
Ltd.	O

The	O
effects	O
of	O
chlordiazepoxide	O
(	O
2.5	O
-	O
15.0mg	O
/	O
kg	O
)	O
,	O
a	O
full	O
benzodiazepine	B
receptor	I
agonist	O
,	O
and	O
bretazenil	O
(	O
5.0	O
-	O
30.0mg	O
/	O
kg	O
)	O
,	O
a	O
partial	O
benzodiazepine	B
receptor	I
agonist	O
,	O
were	O
examined	O
in	O
the	O
murine	O
elevated	O
plus	O
-	O
maze	O
paradigm	O
.	O

However	O
,	O
plasmids	O
carrying	O
the	O
yeast	B
TyrRS	I
gene	I
could	O
not	O
be	O
stably	O
maintained	O
in	O
E.	O
coli	O
.	O

In	O
mammalian	O
tissue	O
culture	O
cells	O
,	O
overexpression	O
of	O
any	O
of	O
the	O
four	O
mouse	O
deltex	O
homologs	O
suppressed	O
the	O
transcriptional	O
activity	O
of	O
E47	B
,	O
a	O
basic	B
helix	I
-	I
loop	I
-	I
helix	I
(	I
bHLH	I
)	I
protein	I
,	O
in	O
a	O
manner	O
similar	O
to	O
suppression	O
by	O
an	O
activated	O
form	O
of	O
human	B
Notch1	I
or	O
human	B
DTX1	I
.	O

Multiparous	O
women	O
presented	O
higher	O
BMI	O
(	O
P	O
=	O
0.01	O
)	O
and	O
PBF	O
(	O
P	O
=	O
0.03	O
)	O
compared	O
with	O
primi-	O
and	O
nulliparous	O
groups	O
.	O

Fluorimetric	O
determination	O
of	O
methylmercury	O
as	O
an	O
ion	O
-	O
association	O
complex	O
with	O
rhodamine	O
B	O
in	O
the	O
presence	O
of	O
iodide	O
.	O

Our	O
results	O
suggest	O
that	O
the	O
central	O
role	O
of	O
the	O
Notch	B
-	O
CBF1	B
/	O
RBP	B
-	I
Jkappa	I
signaling	O
pathway	O
in	O
cell	O
fate	O
decisions	O
renders	O
it	O
susceptible	O
to	O
pathways	O
of	O
viral	O
replication	O
and	O
oncogenic	O
conversion	O
.	O

Using	O
a	O
novel	O
method	O
combining	O
chromatin	O
immunoprecipitation	O
and	O
genomic	O
array	O
hybridization	O
,	O
we	O
have	O
identified	O
a	O
460-kb	B
CENP	I
-	I
A	I
-	I
binding	I
DNA	I
domain	I
of	O
a	O
neocentromere	O
derived	O
from	O
the	O
20p12	O
region	O
of	O
an	O
invdup	O
(	O
20p	O
)	O
human	O
marker	O
chromosome	O
.	O

Prophylactic	O
lymph	O
node	O
dissection	O
or	O
radiation	O
therapy	O
to	O
the	O
nodal	O
chain	O
may	O
decrease	O
local	O
recurrence	O
but	O
does	O
not	O
consistently	O
affect	O
overall	O
survival	O
.	O

We	O
can	O
classify	O
antibiotics	O
into	O
two	O
groups	O
based	O
on	O
initial	O
bactericidal	O
activity	O
against	O
P.	O
aeruginosa	O
;	O
one	O
class	O
is	O
antibiotics	O
having	O
rapid	O
initial	O
killing	O
such	O
as	O
AMK	O
,	O
IPM	O
and	O
PAPM	O
,	O
the	O
other	O
is	O
CAZ	O
,	O
MEPM	O
showing	O
slow	O
initial	O
killing	O
.	O

In	O
Klinefelter	O
's	O
syndrome	O
(	O
47XXY	O
)	O
,	O
serum	O
testosterone	O
levels	O
are	O
at	O
the	O
lower	O
end	O
of	O
the	O
normal	O
range	O
and	O
dihydrotestosterone	O
levels	O
are	O
low	O
.	O

The	O
histamine	B
H1	I
receptor	I
antagonists	O
(	O
antihistamines	O
)	O
are	O
an	O
important	O
class	O
of	O
medications	O
used	O
for	O
the	O
relief	O
of	O
common	O
symptoms	O
associated	O
with	O
hyperhistaminic	O
conditions	O
occurring	O
in	O
children	O
and	O
adults	O
.	O

Conclusion	O
:	O
The	O
Lp	B
(	I
a	I
)	I
levels	O
in	O
these	O
children	O
were	O
the	O
lower	O
ever	O
reported	O
.	O

AIMS	O
:	O
To	O
establish	O
a	O
baseline	O
and	O
intraindividual	O
fluctuations	O
of	O
the	O
tumour	O
markers	O
CEA	B
,	O
CA	B
50	I
and	O
CA	B
242	I
in	O
patients	O
cured	O
from	O
colorectal	O
cancer	O
,	O
and	O
to	O
test	O
the	O
hypothesis	O
that	O
serum	O
concentrations	O
and	O
intraindividual	O
fluctuations	O
do	O
not	O
differ	O
from	O
the	O
concentrations	O
in	O
cancer	O
-	O
free	O
individuals	O
.	O

The	O
homologous	O
active	O
-	O
site	O
framework	O
of	O
these	O
enzymes	O
with	O
distinct	O
structures	O
suggests	O
convergent	O
evolution	O
of	O
a	O
common	O
catalytic	O
mechanism	O
.	O

We	O
found	O
that	O
RhoA	B
can	O
initiate	O
a	O
linear	O
kinase	O
cascade	O
leading	O
to	O
the	O
activation	O
of	O
ERK6	B
(	O
p38	B
gamma	I
)	O
,	O
a	O
recently	O
identified	O
member	O
of	O
the	O
p38	B
family	I
of	O
MAPKs	O
.	O

We	O
show	O
that	O
several	O
heme	O
-	O
responsive	O
mechanisms	O
combine	O
to	O
regulate	O
DAN	B
/	O
TIR	B
gene	O
expression	O
.	O

In	O
strains	O
lacking	O
tup11	B
and	O
tup12	B
,	O
the	O
atf1-pcr1	B
transcriptional	O
activator	O
continues	O
to	O
play	O
a	O
central	O
role	O
in	O
fbp1-lacZ	B
expression	O
;	O
however	O
,	O
spc1	B
MAPK	I
phosphorylation	O
of	O
atf1	B
is	O
no	O
longer	O
essential	O
for	O
its	O
activation	O
.	O

In	O
vitro	O
binding	O
studies	O
demonstrate	O
that	O
eIF-5A	B
is	O
required	O
for	O
efficient	O
interaction	O
of	O
Rev	B
-	O
NES	B
with	O
CRM1	B
/	O
exportin1	B
and	O
that	O
eIF-5A	B
interacts	O
with	O
the	O
nucleoporins	O
CAN	B
/	O
nup214	B
,	O
nup153	B
,	O
nup98	B
,	O
and	O
nup62	B
.	O

Structural	O
studies	O
have	O
shown	O
that	O
class	B
I	I
major	I
histocompatibility	I
complex	I
(	O
MHC	B
)	O
-restricted	O
peptide	O
-	O
specific	O
T	B
cell	I
receptor	I
(	I
TCR	I
)	I
-alpha	I
/	I
betas	I
make	O
multiple	O
contacts	O
with	O
the	O
alpha1	O
and	O
alpha2	O
helices	O
of	O
the	O
MHC	B
,	O
but	O
it	O
is	O
unclear	O
which	O
or	O
how	O
many	O
of	O
these	O
interactions	O
contribute	O
to	O
functional	O
binding	O
.	O

Mice	O
homozygous	O
for	O
the	O
dlg	B
mutation	O
exhibit	O
growth	O
retardation	O
in	O
utero	O
,	O
have	O
hypoplasia	O
of	O
the	O
premaxilla	O
and	O
mandible	O
,	O
have	O
a	O
cleft	O
secondary	O
palate	O
,	O
and	O
die	O
perinatally	O
.	O

A	O
single	O
base	O
change	O
(	O
A8	O
G	O
)	O
in	O
either	O
sequence	O
reduces	O
hnRNP	B
A2	I
binding	O
and	O
,	O
in	O
the	O
case	O
of	O
A2RE-2	B
,	O
inhibits	O
RNA	O
transport	O
.	O

TaqMan	O
analysis	O
of	O
gene	O
expression	O
following	O
chronic	O
FA	O
treatment	O
showed	O
neither	O
a	O
decrease	O
in	O
the	O
amount	O
of	O
leptin	B
receptor	I
(	O
Ob	B
-	I
R	I
)	O
mRNA	O
,	O
nor	O
an	O
increase	O
in	O
the	O
negative	O
regulators	O
of	O
STAT	B
signalling	O
,	O
SOCS3	B
(	O
suppressors	B
of	I
cytokine	I
signalling	I
)	O
or	O
cytokine	B
inducible	I
sequence	I
(	O
CIS	B
)	O
.	O

The	O
mutant	O
receptors	O
,	O
as	O
well	O
as	O
sBMPR	B
-	I
IA	I
,	O
were	O
expressed	O
as	O
fusion	O
proteins	O
with	O
thioredoxin	B
in	O
Escherichia	O
coli	O
,	O
and	O
purified	O
using	O
reverse	O
phase	O
high	O
performance	O
liquid	O
chromatography	O
(	O
RP	O
-	O
HPLC	O
)	O
after	O
digestion	O
with	O
enterokinase	B
.	O

The	O
authors	O
undertook	O
a	O
retrospective	O
analysis	O
of	O
pathology	O
with	O
quantification	O
of	O
the	O
percentage	O
of	O
papillary	O
serous	O
component	O
(	O
%	O
PSC	O
)	O
and	O
p53	B
expression	O
.	O

Cloning	O
and	O
characterization	O
of	O
the	O
murine	B
beta	I
(	I
3	I
)	I
integrin	I
gene	I
promoter	O
:	O
identification	O
of	O
an	O
interleukin-4	B
responsive	I
element	I
and	O
regulation	O
by	O
STAT-6	B
.	O

CONCLUSIONS	O
:	O
Although	O
the	O
levels	O
of	O
oxLDL	B
antibodies	I
might	O
be	O
modified	O
in	O
early	O
hypertension	O
,	O
once	O
advanced	O
coronary	O
artery	O
disease	O
has	O
developed	O
the	O
presence	O
of	O
hypertension	O
does	O
not	O
affect	O
anti	B
-	I
oxLDL	I
levels	O
.	O

GafChromic	O
(	O
MD-55	O
-	O
2	O
)	O
radiochromic	O
film	O
has	O
become	O
increasingly	O
popular	O
for	O
medical	O
applications	O
and	O
has	O
proven	O
to	O
be	O
useful	O
for	O
brachytherapy	O
dosimetry	O
.	O

Cis	O
-	O
acting	O
CCAAT	O
elements	O
are	O
frequently	O
found	O
in	O
eukaryotic	O
promoter	O
regions	O
.	O

Twenty	O
-	O
five	O
patients	O
also	O
received	O
PET	O
examinations	O
during	O
the	O
staging	O
procedures	O
.	O

The	O
Gap69C	B
is	O
a	O
single	O
-	O
copy	O
gene	O
producing	O
a	O
major	O
2.1-kb	O
mRNA	O
throughout	O
development	O
,	O
but	O
its	O
amount	O
is	O
decreased	O
in	O
larvae	O
.	O

OBJECTIVE	O
:	O
To	O
investigate	O
the	O
association	O
between	O
complete	O
congenital	O
heart	O
block	O
(	O
CCHB	O
)	O
in	O
the	O
fetus	O
and	O
adult	O
disease	O
.	O

Two	O
families	O
with	O
concordant	O
inheritance	O
of	O
DNAH9	B
alleles	I
in	O
affected	O
individuals	O
were	O
observed	O
.	O

Efficacy	O
of	O
first	O
-	O
generation	O
Cavermap	O
to	O
verify	O
location	O
and	O
function	O
of	O
cavernous	O
nerves	O
during	O
radical	O
prostatectomy	O
:	O
a	O
multi	O
-	O
institutional	O
evaluation	O
by	O
experienced	O
surgeons	O
.	O

The	O
(	O
two	O
-	O
motif	O
)	O
domain	O
fold	O
contains	O
a	O
pair	O
of	O
calcium	O
binding	O
sites	O
very	O
similar	O
to	O
those	O
found	O
in	O
a	O
two	B
-	I
domain	I
prokaryotic	I
betagamma	I
-	I
crystallin	I
fold	I
family	I
member	I
,	O
Protein	B
S.	I

Deletional	O
analyses	O
of	O
VDR	B
indicated	O
that	O
GRIP1	B
and	O
RAC3	B
required	O
an	O
intact	O
VDR	B
activation	O
function	O
(	O
AF-2	O
)	O
domain	O
for	O
efficient	O
interaction	O
as	O
well	O
as	O
additional	O
but	O
distinct	O
regions	O
of	O
the	O
VDR	B
.	O

Only	O
nine	O
patients	O
were	O
offered	O
surgery	O
(	O
six	O
were	O
resected	O
and	O
three	O
were	O
found	O
inoperable	O
)	O
.	O

However	O
,	O
the	O
promoter	O
region	O
contains	O
several	O
potential	O
cis	O
-	O
regulatory	O
elements	O
such	O
as	O
Sp1	B
,	O
early	B
growth	I
response-1	I
,	O
activator	B
protein-2	I
,	O
MyoD	B
,	O
p300	B
,	O
nuclear	B
factor	I
-	I
kappaB	I
,	O
myeloid	B
zinc	I
finger	I
protein-1	I
,	O
caudal	B
-	I
related	I
homeobox	I
(	I
Cdx	I
)	I
gene	I
A	I
,	O
and	O
Cdx	B
protein-2	I
binding	I
sites	I
.	O

Thus	O
,	O
the	O
interaction	O
of	O
Tat	B
with	O
the	O
components	O
of	O
this	O
rel	B
/	O
AP1	B
cooperative	O
complex	O
seems	O
to	O
induce	O
quantitative	O
and	O
qualitative	O
alterations	O
of	O
this	O
complex	O
as	O
activation	O
progresses	O
,	O
resulting	O
in	O
a	O
decrease	O
of	O
IL-2	B
gene	I
transcription	O
.	O

2001	O
.	O

Adjuvant	O
and	O
neoadjuvant	O
treatment	O
of	O
breast	O
cancer	O
.	O

Unlike	O
other	O
progenitor	O
cells	O
of	O
the	O
brain	O
,	O
SVZa	O
progenitor	O
cells	O
have	O
the	O
capacity	O
to	O
divide	O
even	O
though	O
they	O
express	O
a	O
neuronal	O
phenotype	O
.	O

Furthermore	O
,	O
the	O
soluble	O
forms	O
of	O
ATF6	B
and	O
the	O
G13	B
gene	I
product	I
are	O
unable	O
to	O
bind	O
to	O
several	O
point	O
mutants	O
of	O
the	O
cis	O
-	O
acting	O
ER	O
stress	O
response	O
element	O
in	O
vitro	O
that	O
hardly	O
respond	O
to	O
ER	O
stress	O
in	O
vivo	O
.	O

The	O
present	O
study	O
was	O
initiated	O
to	O
explore	O
the	O
potential	O
of	O
a	O
hybrid	O
biological	O
reactor	O
,	O
combining	O
trickling	O
filter	O
(	O
TF	O
)	O
and	O
activated	O
sludge	O
process	O
(	O
ASP	O
)	O
,	O
to	O
treat	O
wastewater	O
containing	O
trichloroethylene	O
(	O
TCE	O
)	O
at	O
ambient	O
temperature	O
at	O
different	O
hydraulic	O
retention	O
time	O
(	O
HRT	O
)	O
.	O

In	O
DNA	O
strand	O
exchange	O
reactions	O
using	O
oligonucleotides	O
,	O
we	O
found	O
that	O
Rec2	B
exhibited	O
a	O
pairing	O
bias	O
that	O
is	O
opposite	O
that	O
of	O
RecA.	B

Anecdotal	O
observations	O
scattered	O
throughout	O
the	O
literature	O
have	O
often	O
provided	O
clues	O
to	O
underlying	O
variations	O
in	O
humans	O
'	O
ability	O
to	O
handle	O
dietary	O
chemicals	O
.	O

Analysis	O
of	O
ace2Delta	O
cells	O
reveals	O
that	O
Ace2p	B
is	O
required	O
for	O
cell	O
separation	O
but	O
not	O
for	O
polarized	O
growth	O
.	O

The	O
results	O
presented	O
here	O
show	O
that	O
AR1	B
of	O
the	O
promoter	O
-	O
proximal	O
CAP	B
subunit	I
was	O
required	O
for	O
papBA	B
transcription	O
even	O
in	O
the	O
absence	O
of	O
the	O
histone	B
-	I
like	I
protein	I
H	B
-	I
NS	I
.	O

A.	O
,	O
Slatkin	O
,	O
D.	O

RESULTS	O
:	O
A	O
significant	O
correlation	O
(	O
p	O
<	O
0.001	O
)	O
was	O
observed	O
for	O
mean	O
wall	O
thickness	O
and	O
vessel	O
wall	O
area	O
between	O
MRI	O
and	O
histopathology	O
(	O
r	O
=	O
0.87	O
and	O
r	O
=	O
0.85	O
,	O
respectively	O
)	O
.	O

SIP1	B
(	O
Smad	B
interacting	I
protein	I
1	I
)	O
and	O
deltaEF1	B
(	O
delta	B
-	I
crystallin	I
enhancer	I
binding	I
factor	I
)	O
are	O
structurally	O
similar	O
transcriptional	O
repressors	O
.	O

Nucleotide	O
sequence	O
,	O
transcription	O
map	O
,	O
and	O
mutation	O
analysis	O
of	O
the	O
13q14	O
chromosomal	O
region	O
deleted	O
in	O
B	O
-	O
cell	O
chronic	O
lymphocytic	O
leukemia	O
.	O

Requirements	O
for	O
the	O
nuclear	O
-	O
cytoplasmic	O
translocation	O
of	O
infected	B
-	I
cell	I
protein	I
0	I
of	O
herpes	O
simplex	O
virus	O
1	O
.	O

The	O
human	B
cytomegalovirus	I
(	I
HCMV	I
)	I
major	I
immediate	I
-	I
early	I
protein	I
IE2	I
is	O
a	O
nuclear	O
phosphoprotein	O
that	O
is	O
believed	O
to	O
be	O
a	O
key	O
regulator	O
in	O
both	O
lytic	O
and	O
latent	O
infections	O
.	O

OBJECTIVE	O
:	O
To	O
determine	O
whether	O
RSTD	O
predicts	O
coronary	O
anatomy	O
during	O
acute	O
coronary	O
occlusion	O
.	O

Atheroma	O
appears	O
as	O
a	O
very	O
low	O
signal	O
intensity	O
area	O
on	O
2-dimensional	O
time	O
-	O
of	O
-	O
flight	O
(	O
TOF	O
)	O
magnetic	O
resonance	O
(	O
MR	O
)	O
images	O
,	O
and	O
its	O
components	O
have	O
various	O
signal	O
intensities	O
on	O
spin	O
-	O
echo	O
(	O
SE	O
)	O
images	O
.	O

We	O
have	O
now	O
tested	O
all	O
known	O
mammalian	B
Groucho	I
family	I
members	I
for	O
their	O
ability	O
to	O
interact	O
specifically	O
with	O
individual	O
Tcf	B
/	O
Lef	B
family	O
members	O
.	O

Nephrotoxicity	O
after	O
orthotopic	O
liver	O
transplantation	O
in	O
cyclosporin	O
A	O
and	O
FK	O
506-treated	O
patients	O
.	O

Compared	O
with	O
normal	O
control	O
subjects	O
,	O
all	O
74	O
TOF	O
patients	O
had	O
decreased	O
systolic	O
and	O
diastolic	O
myocardial	O
velocities	O
and	O
a	O
longer	O
isovolumic	O
relaxation	O
time	O
.	O

Mutational	O
analysis	O
showed	O
that	O
the	O
U	O
-	O
box	O
,	O
like	O
the	O
RING	O
finger	O
in	O
other	O
proteins	O
,	O
forms	O
the	O
physical	O
basis	O
for	O
the	O
interaction	O
with	O
E2	B
enzymes	I
.	O

Fetal	O
lung	O
volume	O
:	O
estimation	O
at	O
MR	O
imaging	O
-	O
initial	O
results	O
.	O

Of	O
its	O
gene	O
products	O
,	O
E6	B
binds	O
to	O
and	O
inactivates	O
p53	B
tumor	I
suppressor	I
protein	I
by	O
ubiquitin	B
/	O
proteasome	O
-	O
dependent	O
degradation	O
.	O

In	O
mouse	O
,	O
Mmip1	B
(	O
Mad	B
member	I
interacting	I
protein	I
1	I
)	O
and	O
Smc3	B
share	O
99	O
%	O
sequence	O
identity	O
and	O
are	O
products	O
of	O
the	O
same	O
gene	O
.	O

In	O
SN-48	O
neuronal	O
cells	O
that	O
express	O
MR	B
,	O
GR	B
,	O
and	O
5-HT1A	B
receptors	I
,	O
deletion	O
or	O
inactivation	O
of	O
the	O
nGRE	O
(	O
negative	O
GRE	O
)	O
eliminated	O
negative	O
regulation	O
of	O
the	O
rat	B
5-HT1A	I
or	O
heterologous	O
promoters	O
by	O
corticosteroids	O
,	O
whereas	O
its	O
inclusion	O
conferred	O
corticosteroid	O
-	O
induced	O
inhibition	O
to	O
a	O
heterologous	O
promoter	O
.	O

Both	O
pancreatic	O
and	O
intestinal	O
cell	O
lines	O
were	O
found	O
to	O
express	O
a	O
number	O
of	O
POU	B
(	O
OCT	B
binding	O
)	O
homeodomain	O
proteins	O
examined	O
by	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

The	O
v	B
-	I
Src	I
SH3	B
domain	I
facilitates	O
a	O
cell	O
adhesion	O
-	O
independent	O
association	O
with	O
focal	B
adhesion	I
kinase	I
.	O

A	O
20-base	O
pair	O
oligonucleotide	O
containing	O
this	O
nonamer	O
confers	O
up	O
-	O
regulation	O
by	O
hypoxia	O
and	O
inhibition	O
by	O
unsaturated	O
fatty	O
acids	O
when	O
placed	O
upstream	O
of	O
a	O
heterologous	O
promoter	O
in	O
a	O
lacZ	B
reporter	I
construct	I
.	O

Exchanging	O
the	O
human	O
propeptide	O
in	O
this	O
chimera	O
with	O
either	O
the	O
murine	B
MIC-1	I
or	O
TGF	B
-	I
beta1	I
propeptide	I
resulted	O
in	O
secretion	O
of	O
the	O
unprocessed	O
,	O
monomeric	O
chimera	O
,	O
suggesting	O
a	O
specific	O
interaction	O
between	O
the	O
human	B
MIC-1	I
propeptide	I
and	O
mature	O
peptide	O
.	O

Radiolabeled	O
biantennary	O
N	O
-	O
glycans	O
synthesized	O
by	O
Pro	O
(	O
-	O
)	O
5Lec20	O
were	O
proportionately	O
less	O
ricin	O
-	O
bound	O
than	O
similar	O
species	O
from	O
parental	O
CHO	O
cells	O
,	O
and	O
Lec20	O
cell	O
extracts	O
had	O
a	O
markedly	O
reduced	O
ability	O
to	O
transfer	O
Gal	O
to	O
GlcNAc	O
-	O
terminating	O
acceptors	O
.	O

We	O
found	O
that	O
the	O
SOCS	B
box	I
interacted	O
with	O
Cullin-2	B
and	O
promoted	O
ubiquitination	O
of	O
TEL	B
-	O
JAK2	B
.	O

Neuron	B
-	I
specific	I
Bcl-2	I
homology	I
3	I
domain	I
-	I
only	I
splice	I
variant	I
of	O
Bak	B
is	O
anti	O
-	O
apoptotic	O
in	O
neurons	O
,	O
but	O
pro	O
-	O
apoptotic	O
in	O
non	O
-	O
neuronal	O
cells	O
.	O

Furthermore	O
,	O
SB203580	O
inhibited	O
LPS	O
-	O
induced	O
activation	O
of	O
Sp1	B
,	O
as	O
well	O
as	O
the	O
promoter	O
activity	O
in	O
cells	O
transfected	O
with	O
a	O
plasmid	O
containing	O
the	O
Sp1	B
consensus	O
sequence	O
.	O

Based	O
on	O
mutational	O
data	O
and	O
possible	O
mRNA	O
structure	O
,	O
we	O
hypothesized	O
about	O
the	O
effect	O
of	O
mRNA	O
structure	O
on	O
translation	O
of	O
the	O
two	O
major	O
C	B
/	I
EBPepsilon	I
isoforms	I
:	O
p32	B
and	O
p30	B
.	O

Biol	O
.	O

The	O
size	O
of	O
the	O
infarct	O
was	O
determined	O
using	O
the	O
creatine	B
kinase	I
integral	O
method	O
.	O

SELECTION	O
CRITERIA	O
:	O
Randomised	O
controlled	O
trials	O
of	O
cabergoline	O
versus	O
placebo	O
in	O
patients	O
with	O
a	O
clinical	O
diagnosis	O
of	O
idiopathic	O
Parkinson	O
's	O
disease	O
and	O
long	O
-	O
term	O
complications	O
of	O
levodopa	O
therapy	O
.	O

CONCLUSIONS	O
:	O
Using	O
icodextrin	O
-	O
based	O
instead	O
of	O
glucose	O
-	O
based	O
PD	O
fluids	O
can	O
largely	O
reduce	O
the	O
formation	O
of	O
Amadori	O
albumin	B
and	O
AGEs	O
.	O

In	O
contrast	O
,	O
exogenous	B
PTHrP1	I
-	I
34	I
and	I
1	I
-	I
86	I
peptides	I
did	O
not	O
significantly	O
affect	O
IL-8	B
production	O
;	O
moreover	O
,	O
PTHrP	B
-	I
neutralizing	I
antibodies	I
did	O
not	O
inhibit	O
the	O
production	O
of	O
IL-8	B
by	O
transfected	O
PTHrP.	B

Unusual	O
two	B
-	I
domain	I
arginine	I
kinases	I
(	O
AKs	B
)	O
arose	O
independently	O
at	O
least	O
two	O
times	O
during	O
molecular	O
evolution	O
of	O
phosphagen	B
kinases	I
:	O
AKs	B
from	O
the	O
primitive	O
sea	O
anemone	O
Anthopleurura	O
japonicus	O
and	O
from	O
the	O
clam	O
Pseudocardium	O
sachalinensis	O
.	O

Baseline	O
MBF	O
in	O
females	O
was	O
significantly	O
(	O
P<0.001	O
)	O
higher	O
than	O
in	O
males	O
.	O

Phase	O
II	O
study	O
of	O
paclitaxel	O
and	O
oral	O
etoposide	O
in	O
patients	O
with	O
locally	O
advanced	O
or	O
metastatic	O
non	O
-	O
small	O
cell	O
lung	O
cancer	O
.	O

Oral	O
supplementation	O
of	O
L	O
-	O
arginine	O
significantly	O
increased	O
plasma	O
L	O
-	O
citrulline	O
,	O
which	O
indicated	O
enhancement	O
of	O
NO	O
production	O
.	O

Our	O
results	O
suggest	O
that	O
WASP	B
activates	O
transcription	O
following	O
TCR	B
stimulation	O
in	O
a	O
manner	O
that	O
is	O
independent	O
of	O
its	O
role	O
in	O
Arp2	B
/	I
3-directed	I
actin	B
polymerization	O
.	O

Two	O
independent	O
transgenic	O
lines	O
were	O
produced	O
,	O
and	O
both	O
showed	O
expression	O
of	O
the	O
Gus	B
gene	I
specifically	O
in	O
the	O
endosperm	O
during	O
mid	O
-	O
development	O
(	O
first	O
detected	O
10	O
-	O
12	O
d	O
after	O
anthesis	O
)	O
.	O

Here	O
we	O
demonstrate	O
that	O
native	B
MRCK	I
exists	O
in	O
high	O
-	O
molecular	O
-	O
weight	O
complexes	O
.	O

These	O
data	O
define	O
a	O
conserved	O
pathway	O
wherein	O
sequential	O
histone	B
modifications	O
establish	O
a	O
""""	O
histone	B
code	O
""""	O
essential	O
for	O
the	O
epigenetic	O
inheritance	O
of	O
heterochromatin	O
assembly	O
.	O

Regression	O
analyses	O
showed	O
that	O
SOREMP	O
dream	O
occurrences	O
were	O
significantly	O
related	O
to	O
the	O
amount	O
of	O
REM	O
sleep	O
,	O
while	O
NREMP	O
dream	O
occurrences	O
were	O
related	O
to	O
arousals	O
from	O
NREM	O
sleep	O
.	O

9.7	O
(	O
95	O
%	O
CI	O
:	O
9.6	O
-	O
9.7	O
)	O
micromol	O
/	O
L	O
among	O
women	O
(	O
P	O
=	O
0.003	O
)	O
.	O

Three	O
patients	O
received	O
additional	O
cycles	O
of	O
5-fluorouracil	O
+	O
/-	O

leucovorin	O
as	O
maintenance	O
chemotherapy	O
.	O

RESULTS	O
:	O
Thirty	O
males	O
and	O
21	O
females	O
with	O
a	O
median	O
age	O
of	O
55	O
years	O
(	O
range	O
31	O
-	O
-73	O
years	O
)	O
were	O
treated	O
.	O

Secretion	O
of	O
interleukin-8	B
,	O
RANTES	B
,	O
macrophage	B
inflammatory	I
protein	I
1alpha	I
,	O
and	O
10-kappaDa	B
IFN	I
-	I
gamma	I
-	I
inducible	I
protein	I
were	O
increased	O
in	O
differentiating	O
keratinocytes	O
by	O
E6	B
.	O

Herein	O
PPARgamma	B
,	O
liganded	O
by	O
either	O
natural	O
(	O
15d	O
-	O
PGJ	O
(	O
2	O
)	O
and	O
PGD	O
(	O
2	O
)	O
)	O
or	O
synthetic	O
ligands	O
(	O
BRL49653	O
and	O
troglitazone	O
)	O
,	O
selectively	O
inhibited	O
expression	O
of	O
the	O
cyclin	B
D1	I
gene	I
.	O

Here	O
we	O
demonstrate	O
that	O
the	O
Ras	B
-	O
activated	O
Raf	B
-	O
MEK	B
-	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
(	O
ERK	B
)	O
signaling	O
pathway	O
can	O
specifically	O
control	O
the	O
expression	O
of	O
individual	O
integrin	B
subunits	I
in	O
a	O
variety	O
of	O
human	O
and	O
mouse	O
cell	O
lines	O
.	O

Children	O
who	O
developed	O
lower	O
respiratory	O
tract	O
infections	O
or	O
PCP	O
had	O
increased	O
rates	O
of	O
decline	O
of	O
CD4	B
cell	O
counts	O
during	O
the	O
first	O
6	O
months	O
of	O
life	O
.	O

The	O
reproductive	O
effects	O
of	O
the	O
administration	O
of	O
4-chloro-2-methylphenoxyacetic	O
acid	O
(	O
MCPA	O
)	O
to	O
rats	O
were	O
evaluated	O
through	O
two	O
generations	O
,	O
from	O
prior	O
to	O
mating	O
,	O
throughout	O
mating	O
,	O
to	O
gestation	O
and	O
lactation	O
.	O

Coexposure	O
to	O
FP	O
also	O
resulted	O
in	O
a	O
more	O
pronounced	O
and	O
sustained	O
activation	O
of	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
kinase	I
/	O
extracellular	B
signal	I
-	I
regulated	I
protein	I
kinase	I
cascade	O
after	O
PMA	O
treatment	O
,	O
although	O
disruption	O
of	O
this	O
pathway	O
by	O
the	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
kinase	I
1	I
inhibitor	O
U0126	O
did	O
not	O
prevent	O
potentiation	O
of	O
apoptosis	O
.	O

Also	O
,	O
the	O
EWS	B
protein	I
stimulates	O
transcription	O
mediated	O
by	O
the	O
COOH	O
-	O
terminal	O
transactivation	O
domain	O
of	O
the	O
cofactor	O
CREB	B
-	I
binding	I
protein	I
(	O
CBP	B
)	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
determined	O
the	O
ICBP90	B
gene	I
structure	O
by	O
screening	O
of	O
a	O
human	O
placenta	O
genomic	O
library	O
and	O
PCR	O
analysis	O
.	O

Tumor	O
-	O
like	O
accumulation	O
on	O
Tl-201	O
SPECT	O
in	O
subacute	O
hemorrhagic	O
cerebral	O
infarction	O
.	O

Its	O
transcription	O
in	O
vitro	O
by	O
pol	B
III	I
requires	O
the	O
same	O
factors	O
as	O
the	O
U6	B
gene	I
with	O
the	O
major	O
exception	O
that	O
the	O
modified	O
TATA	O
-	O
box	O
of	O
this	O
construct	O
only	O
interacts	O
with	O
a	O
TATA	B
-	I
binding	I
protein	I
(	O
TBP	B
)	O
mutant	O
(	O
TBP	B
-	I
DR2	I
)	O
but	O
not	O
with	O
TBP	B
wild	I
-	I
type	I
(	O
TBPwt	B
)	O
.	O

HSF	B
binds	O
DNA	O
as	O
a	O
trimer	O
,	O
and	O
additional	O
trimers	O
can	O
bind	O
DNA	O
co	O
-	O
operatively	O
.	O

We	O
also	O
demonstrate	O
that	O
the	O
spo20	B
(	I
+	I
)	I
gene	I
product	I
is	O
structurally	O
homologous	O
to	O
Saccharomyces	B
cerevisiae	I
Sec14	I
,	O
the	O
major	O
phosphatidylinositol	O
transfer	O
protein	O
of	O
budding	O
yeast	O
.	O

There	O
was	O
no	O
evidence	O
of	O
linkage	O
disequilibrium	O
between	O
the	O
polymorphic	O
site	O
in	O
the	O
B	O
cell	O
specific	O
promoter	O
and	O
those	O
in	O
the	O
3	O
'	O
UTR	O
.	O

In	O
conclusion	O
,	O
tube	O
size	O
estimated	O
by	O
Cole	O
's	O
formula	O
tends	O
to	O
be	O
smaller	O
than	O
practically	O
appropriate	O
tube	O
size	O
for	O
pediatric	O
cardiac	O
anesthesia	O
,	O
and	O
therefore	O
we	O
suggest	O
new	O
formula	O
to	O
estimate	O
the	O
tube	O
size	O
.	O

An	O
F222W	B
:	I
W21F	I
rGST	I
A1	I
-	I
1	I
double	I
mutant	I
provides	O
a	O
direct	O
fluorescence	O
probe	O
of	O
changes	O
in	O
the	O
environment	O
of	O
the	O
C	O
-	O
terminal	O
residue	O
.	O

The	O
recessive	O
hos1	B
mutation	O
causes	O
enhanced	O
induction	O
of	O
the	O
CBF	B
transcription	I
factors	I
by	O
low	O
temperature	O
as	O
well	O
as	O
of	O
their	O
downstream	O
cold	O
-	O
responsive	O
genes	O
.	O

Stable	O
transfection	O
of	O
human	B
CHOP	I
cDNA	I
into	O
mammary	O
carcinoma	O
cells	O
demonstrated	O
that	O
CHOP	B
functioned	O
not	O
as	O
a	O
mediator	O
of	O
hGH	B
-	O
stimulated	O
mitogenesis	O
but	O
rather	O
enhanced	O
the	O
protection	O
from	O
apoptosis	O
afforded	O
by	O
hGH	B
in	O
a	O
p38	B
MAPK	O
-	O
dependent	O
manner	O
.	O

Instead	O
,	O
affective	O
flattening	O
was	O
associated	O
with	O
both	O
dopamine	B
receptor	I
sensitivity	O
and	O
psychomotor	O
slowing	O
.	O

These	O
data	O
reveal	O
a	O
complex	O
network	O
of	O
interactions	O
between	O
GTPases	B
in	O
the	O
ARF	B
family	I
and	O
their	O
effectors	O
and	O
reveal	O
a	O
potential	O
for	O
cross	O
-	O
talk	O
not	O
demonstrated	O
previously	O
.	O

With	O
NEU	B
overexpression	O
,	O
nodal	O
control	O
decreased	O
from	O
72	O
%	O
to	O
34	O
%	O
(	O
p	O
=	O
.008	O
)	O
.	O

Using	O
RACE	O
techniques	O
we	O
have	O
cloned	O
and	O
sequenced	O
one	O
of	O
the	O
hamster	O
liver	O
3-hydroxy	B
-	I
hexobarbital	I
dehydrogenases	I
which	O
catalyze	O
not	O
only	O
cyclic	O
alcohols	O
but	O
also	O
17beta	O
-	O
hydroxy	O
-	O
steroids	O
and	O
3alpha	O
-	O
hydroxysteroids	O
.	O

An	O
association	O
was	O
demonstrated	O
between	O
the	O
expression	O
of	O
aberrantly	O
and/or	O
alternatively	O
spliced	O
mdm2	B
mRNAs	I
and	O
a	O
lack	O
of	O
progesterone	B
receptor	I
.	O

We	O
find	O
that	O
our	O
response	O
function	O
is	O
well	O
approximated	O
by	O
the	O
GSER	O
only	O
within	O
a	O
particular	O
frequency	O
range	O
determined	O
by	O
the	O
material	O
parameters	O
of	O
both	O
the	O
bead	O
and	O
the	O
network	O
.	O

Analysis	O
of	O
mCTR	B
mRNAs	I
has	O
revealed	O
that	O
the	O
three	O
alternative	O
promoters	O
give	O
rise	O
to	O
at	O
least	O
seven	O
mCTR	B
isoforms	I
in	O
the	O
5	O
'	O
region	O
of	O
the	O
gene	O
and	O
generate	O
5'-untranslated	O
regions	O
of	O
very	O
different	O
lengths	O
.	O

Effects	O
of	O
3	O
'	O
terminus	O
modifications	O
on	O
mRNA	O
functional	O
decay	O
during	O
in	O
vitro	O
protein	O
synthesis	O
.	O

A	O
comprehensive	O
neuropsychological	O
battery	O
was	O
administered	O
to	O
48	O
veterans	O
with	O
Gulf	O
War	O
Illness	O
(	O
GWI	O
)	O
characterized	O
by	O
severe	O
fatigue	O
(	O
GV	O
-	O
F	O
)	O
and	O
39	O
healthy	O
veterans	O
(	O
GV	O
-	O
H	O
)	O
.	O

Reverse	O
transcription	O
-	O
PCR	O
analysis	O
of	O
mRNA	O
from	O
patients	O
shows	O
that	O
each	O
of	O
these	O
five	O
mutations	O
results	O
in	O
aberrant	O
splicing	O
.	O

RESULTS	O
:	O
Coronary	O
mortality	O
during	O
the	O
median	O
follow	O
-	O
up	O
time	O
of	O
17	O
months	O
was	O
6-fold	O
higher	O
in	O
the	O
highest	O
tertile	O
for	O
CRP	B
and	O
IL-6	B
and	O
3.5-fold	O
higher	O
in	O
the	O
highest	O
tertile	O
for	O
fibrinogen	B
and	O
TNF	B
-	I
alpha	I
than	O
in	O
the	O
respective	O
combined	O
lower	O
tertiles	O
.	O

The	O
relationship	O
of	O
the	O
factor	B
V	I
Leiden	I
mutation	I
or	O
the	O
deletion	O
-	O
deletion	O
polymorphism	O
of	O
the	O
angiotensin	B
converting	I
enzyme	I
to	O
postoperative	O
thromboembolic	O
events	O
following	O
total	O
joint	O
arthroplasty	O
.	O

Sural	O
nerve	O
biopsy	O
showed	O
mild	O
thickening	O
of	O
the	O
perineurium	O
,	O
vascular	O
alterations	O
with	O
inflammatory	O
cell	O
infiltration	O
in	O
the	O
perineurium	O
,	O
and	O
remarkable	O
loss	O
of	O
large	O
and	O
small	O
myelinated	O
fibers	O
.	O

To	O
examine	O
transcriptional	O
regulation	O
of	O
the	O
rat	B
eIF4E	I
gene	I
,	O
2.1	O
kB	O
of	O
the	O
rat	B
eIF4E	I
promoter	I
region	I
was	O
cloned	O
and	O
the	O
contribution	O
of	O
specific	O
elements	O
in	O
regulating	O
transcription	O
was	O
determined	O
in	O
primary	O
cultures	O
of	O
rat	O
cardiocytes	O
and	O
in	O
a	O
murine	O
C	O
(	O
2	O
)	O
C	O
(	O
12	O
)	O
myoblast	O
cell	O
line	O
.	O

When	O
this	O
CCAAT	O
box	O
was	O
inserted	O
into	O
a	O
heterologous	O
promoter	O
construct	O
,	O
OA	O
induction	O
was	O
dependent	O
on	O
an	O
intact	O
CCAAT	O
box	O
.	O

In	O
the	O
remaining	O
case	O
,	O
the	O
aneurysm	O
originated	O
from	O
the	O
proximal	O
end	O
of	O
the	O
associated	O
A1	O
fenestration	O
.	O

Raes	O
,	O
P.	O

We	O
used	O
a	O
rev-	B
and	O
RRE	B
-	O
defective	O
HIV	O
type	O
1	O
(	O
HIV-1	O
)	O
molecular	O
clone	O
in	O
complementation	O
experiments	O
to	O
establish	O
a	O
method	O
for	O
the	O
rapid	O
isolation	O
of	O
posttranscriptional	O
regulatory	O
elements	O
from	O
the	O
mammalian	O
genome	O
by	O
selecting	O
for	O
rescue	O
of	O
virus	O
replication	O
.	O

A	O
novel	O
myeloid	O
-	O
restricted	O
zebrafish	O
CCAAT	B
/	I
enhancer	I
-	I
binding	I
protein	I
with	O
a	O
potent	O
transcriptional	O
activation	O
domain	O
.	O

Recently	O
,	O
we	O
discovered	O
that	O
alanine	O
substitutions	O
of	O
the	O
active	O
center	O
cleft	O
residues	O
significantly	O
impair	O
the	O
depurinating	O
and	O
ribosome	O
inhibitory	O
activity	O
of	O
PAP	B
.	O

SH2D1A	B
protein	I
levels	O
are	O
up	O
-	O
regulated	O
by	O
CD40	B
cross	O
-	O
linking	O
and	O
down	O
-	O
regulated	O
by	O
B	B
cell	I
receptor	I
ligation	O
.	O

A	O
novel	O
potential	O
effector	O
of	O
M	B
-	I
Ras	I
and	O
p21	B
Ras	I
negatively	O
regulates	O
p21	B
Ras	I
-	O
mediated	O
gene	O
induction	O
and	O
cell	O
growth	O
.	O

The	O
mice	O
are	O
phenotypically	O
normal	O
and	O
do	O
not	O
develop	O
spontaneous	O
tumors	O
at	O
an	O
early	O
age	O
,	O
in	O
contrast	O
to	O
knock	O
-	O
out	O
(	O
p53	B
(	I
-	I
/	I
-	I
)	I
)	O
strains	O
with	O
a	O
defective	O
p53	B
gene	I
.	O

Our	O
results	O
suggest	O
that	O
the	O
C	O
-	O
terminal	O
region	O
of	O
Crk	B
contains	O
negative	O
regulatory	O
elements	O
important	O
for	O
both	O
Abl	B
and	O
FAK	B
dependent	O
signal	O
pathways	O
,	O
and	O
offers	O
a	O
paradigm	O
for	O
an	O
autoinhibitory	O
region	O
in	O
the	O
SH3	B
linker	O
/	O
C	O
-	O
terminal	O
SH3	B
domain	O
.	O

Further	O
,	O
the	O
osteo	O
-	O
retentive	O
ability	O
of	O
the	O
hydroxyapatite	O
in	O
the	O
sockets	O
was	O
seen	O
to	O
be	O
close	O
to	O
significance	O
(	O
after	O
six	O
months	O
width	O
differences	O
,	O
in	O
the	O
canine	O
region	O
:	O
P	O
=	O
0.059	O
,	O
LHS	O
,	O
and	O
P	O
=	O
0.065	O
,	O
RHS	O
)	O
.	O

Nearly	O
all	O
isolates	O
of	O
S.	O
intermedius	O
and	O
most	O
isolates	O
of	O
S.	O
constellatus	O
,	O
but	O
only	O
19	O
%	O
of	O
those	O
of	O
S.	O
anginosus	O
,	O
were	O
associated	O
with	O
abscess	O
.	O

DESIGN	O
:	O
Retrospective	O
study	O
.	O

Human	O
brain	O
cDNA	O
library	O
screening	O
and	O
5	O
'	O
rapid	O
amplification	O
of	O
cDNA	O
ends	O
yielded	O
full	B
-	I
length	I
DENTT	I
cDNA	I
containing	O
an	O
1899-bp	O
open	O
reading	O
frame	O
encoding	O
a	O
predicted	O
633-amino	O
-	O
acid	O
protein	O
with	O
four	O
potential	O
nuclear	O
localization	O
signals	O
(	O
NLSs	O
)	O
and	O
two	O
coiled	O
-	O
coil	O
regions	O
.	O

Rapamycin	O
(	O
FRAP	B
/	O
mTOR	B
inhibitor	O
)	O
blocked	O
4E	B
-	I
BP1	I
phosphorylation	O
causing	O
a	O
predominance	O
of	O
the	O
alpha	O
(	O
hypophosphorylated	O
)	O
band	O
.	O

Far	O
Western	O
blot	O
analysis	O
suggested	O
that	O
the	O
tandem	O
SH2	B
domains	I
of	O
SHP2	B
bind	O
to	O
Gab1	B
in	O
a	O
specific	O
orientation	O
,	O
in	O
which	O
the	O
N	B
-	I
SH2	I
domain	I
binds	O
to	O
phosphotyrosine	O
(	O
Tyr	O
(	O
P	O
)	O
)	O
-627	O
and	O
the	O
C	B
-	I
SH2	I
domain	I
binds	O
to	O
Tyr	O
(	O
P	O
)	O
-659	O
.	O

Molecular	O
cloning	O
,	O
genomic	O
mapping	O
,	O
and	O
expression	O
of	O
two	O
secretor	B
blood	I
group	I
alpha	I
(	I
1,2	I
)	I
fucosyltransferase	I
genes	I
differentially	O
regulated	O
in	O
mouse	O
uterine	O
epithelium	O
and	O
gastrointestinal	O
tract	O
.	O

It	O
was	O
found	O
that	O
intrathecal	O
administration	O
(	O
i.t	O
.	O
)	O
of	O
D2	B
receptor	I
agonist	O
LY171555	O
or	O
D1	B
/	I
D2	I
receptor	I
agonist	O
apomorphine	O
increased	O
pain	O
threshold	O
and	O
had	O
a	O
potentiating	O
effect	O
on	O
AA	O
.	O

After	O
all	O
doses	O
of	O
d	O
-	O
amphetamine	O
,	O
responding	O
occurred	O
largely	O
on	O
the	O
saline	O
key	O
under	O
both	O
schedules	O
.	O

Intravenous	O
L	O
-	O
carnitine	O
treatment	O
increased	O
plasma	O
carnitine	O
concentrations	O
,	O
improved	O
patient	O
-	O
assessed	O
fatigue	O
,	O
and	O
may	O
prevent	O
the	O
decline	O
in	O
peak	O
exercise	O
capacity	O
in	O
hemodialysis	O
patients	O
.	O

Elevated	O
expression	O
of	O
full	B
-	I
length	I
UhpB	I
or	O
of	O
a	O
soluble	O
hybrid	O
protein	O
,	O
GST	B
-	O
Bc	B
,	O
which	O
is	O
glutathione	B
S	I
-	I
transferase	I
(	O
GST	B
)	O
fused	O
to	O
the	O
cytoplasmic	O
C	O
-	O
terminal	O
portion	O
of	O
UhpB	B
,	O
results	O
in	O
complete	O
blockage	O
of	O
uhpT	B
expression	O
in	O
a	O
uhp	B
(	I
+	I
)	I
strain	O
.	O

Examination	O
of	O
various	O
promoter	O
deletion	O
mutants	O
indicated	O
that	O
SF-1	B
acts	O
through	O
the	O
proximal	O
promoter	O
region	O
and	O
upstream	O
promoter	O
sequences	O
.	O

Consistent	O
effects	O
on	O
pVHL	B
function	O
were	O
observed	O
for	O
all	O
mutations	O
within	O
each	O
subclass	O
.	O

Based	O
on	O
this	O
analysis	O
,	O
we	O
propose	O
that	O
the	O
interactions	O
of	O
Sos	B
with	O
the	O
switch	O
1	O
and	O
switch	O
2	O
regions	O
of	O
Ras	B
have	O
distinct	O
functional	O
consequences	O
:	O
the	O
interaction	O
with	O
switch	O
2	O
mediates	O
the	O
anchoring	O
of	O
Ras	B
to	O
Sos	B
,	O
whereas	O
the	O
interaction	O
with	O
switch	O
1	O
leads	O
to	O
disruption	O
of	O
the	O
nucleotide	O
-	O
binding	O
site	O
and	O
GDP	O
dissociation	O
.	O

Bandshift	O
experiments	O
demonstrate	O
that	O
BmHR3A	B
binds	O
specifically	O
to	O
RORE	B
(	O
Retinoic	B
acid	I
-	I
related	I
Orphan	I
receptor	I
Response	I
Element	I
)	O
-like	O
sequences	O
in	O
the	O
promoters	O
of	O
both	O
genes	O
,	O
thus	O
suggesting	O
a	O
direct	O
role	O
for	O
BmHR3A	B
in	O
regulating	O
the	O
expression	O
of	O
BmGATAbeta	B
and	O
ESP	B
genes	I
during	O
vitellogenesis	O
.	O

Here	O
,	O
we	O
identify	O
Rsc3	B
and	O
Rsc30	B
as	O
novel	O
components	O
of	O
the	O
essential	O
yeast	B
remodeler	I
RSC	I
complex	I
.	O

Three	O
of	O
the	O
proteins	O
involved	O
in	O
checkpoint	O
signaling	O
,	O
Rad1	B
,	O
Hus1	B
,	O
and	O
Rad9	B
,	O
have	O
been	O
shown	O
to	O
interact	O
by	O
immunoprecipitation	O
and	O
yeast	O
two	O
-	O
hybrid	O
studies	O
.	O

Based	O
on	O
the	O
hypothesis	O
that	O
evolutionarily	O
conserved	O
regions	O
are	O
functionally	O
important	O
and	O
likely	O
to	O
interact	O
with	O
coactivators	O
,	O
we	O
compared	O
the	O
amino	O
acid	O
sequence	O
of	O
C	B
/	I
EBPalpha	I
from	O
different	O
species	O
(	O
frog	O
to	O
human	O
)	O
and	O
identified	O
four	O
highly	O
conserved	O
regions	O
(	O
CR1-CR4	O
)	O
within	O
the	O
transactivation	O
domain	O
.	O

Of	O
the	O
patients	O
in	O
each	O
regimen	O
who	O
reached	O
study	O
end	O
points	O
,	O
17	O
of	O
29	O
(	O
59	O
%	O
)	O
were	O
in	O
regimen	O
A	O
,	O
11	O
of	O
20	O
(	O
55	O
%	O
)	O
were	O
in	O
regimen	O
B	O
,	O
and	O
28	O
of	O
43	O
(	O
65	O
%	O
)	O
were	O
in	O
regimen	O
C	O
met	O
the	O
treatment	O
success	O
criterion	O
.	O

Early	O
indicators	O
of	O
the	O
effect	O
of	O
a	O
breast	O
cancer	O
screening	O
program	O
for	O
low	O
-	O
income	O
women	O
.	O

Percentages	O
of	O
recovery	O
for	O
overload	O
and	O
dilution	O
tests	O
were	O
between	O
87	O
and	O
120	O
%	O
.	O

One	O
of	O
the	O
conserved	O
RNA	O
subdomains	O
,	O
designated	O
P3	B
,	O
has	O
previously	O
been	O
shown	O
to	O
be	O
required	O
for	O
nucleolar	O
localization	O
.	O

Measurements	O
were	O
obtained	O
:	O
(	O
i	O
)	O
just	O
after	O
the	O
traumatic	O
exposure	O
(	O
D0	O
)	O
;	O
(	O
ii	O
)	O
3	O
days	O
after	O
this	O
first	O
measurement	O
(	O
D3	O
)	O
;	O
and	O
(	O
iii	O
)	O
30	O
days	O
after	O
(	O
D30	O
)	O
.	O

Here	O
we	O
present	O
evidence	O
that	O
the	O
distal	O
half	O
(	O
Stem	O
2	O
)	O
of	O
the	O
conserved	O
base	O
-	O
paired	O
stem	O
structure	O
found	O
in	O
all	O
hY	B
RNAs	I
also	O
plays	O
a	O
critical	O
role	O
in	O
the	O
export	O
process	O
.	O

PACAP	B
mRNA	I
was	O
widely	O
expressed	O
in	O
most	O
human	O
tissues	O
;	O
in	O
transfected	O
cells	O
,	O
PACAP	B
was	O
diffusely	O
expressed	O
in	O
the	O
cytoplasm	O
.	O

Here	O
we	O
provide	O
the	O
first	O
evidence	O
for	O
the	O
involvement	O
of	O
GCN1-GCN2	B
interaction	O
in	O
activation	O
of	O
GCN2	B
per	O
se	O
.	O

The	O
radial	O
forearm	O
flap	O
is	O
used	O
most	O
commonly	O
,	O
however	O
the	O
lateral	O
arm	O
flap	O
may	O
be	O
the	O
flap	O
of	O
choice	O
in	O
certain	O
situations	O
.	O

By	O
comparison	O
,	O
in	O
nontumorigenic	O
Ad5	O
cells	O
,	O
class	O
I	O
expression	O
is	O
high	O
due	O
to	O
negligible	O
binding	O
of	O
COUP	B
-	I
TF	I
and	O
strong	O
binding	O
of	O
NF	B
-	I
kappaB.	I

As	O
an	O
application	O
of	O
reverse	O
genetics	O
,	O
we	O
introduced	O
one	O
nucleotide	O
change	O
(	O
UCU	O
to	O
ACU	O
)	O
to	O
immediate	O
downstream	O
of	O
the	O
RNA	O
-	O
editing	O
site	O
of	O
the	O
V	B
gene	I
in	O
the	O
full	O
-	O
length	O
hPIV2	O
cDNA	O
and	O
were	O
able	O
to	O
obtain	O
infectious	O
viruses	O
[	O
rPIV2V	O
(	O
-	O
)	O
]	O
from	O
the	O
cDNA	O
.	O

In	O
regards	O
to	O
the	O
latter	O
activity	O
,	O
it	O
has	O
been	O
shown	O
that	O
S3	B
contains	O
vigorous	O
N	B
-	I
glycosylase	I
activity	O
for	O
the	O
removal	O
of	O
8-oxoguanine	O
residues	O
in	O
DNA	O
that	O
leaves	O
baseless	O
sites	O
in	O
their	O
places	O
.	O

The	O
improved	O
CSF	O
outflow	O
conductance	O
may	O
increase	O
the	O
intracranial	O
compliance	O
and	O
thereby	O
dampen	O
a	O
pathological	O
ICP	O
waveform	O
.	O

The	O
cyclins	B
bind	O
to	O
and	O
activate	O
the	O
CDK	B
,	O
which	O
leads	O
to	O
phosphorylation	O
(	O
and	O
then	O
inhibition	O
)	O
of	O
the	O
tumor	O
suppressor	O
protein	O
,	O
pRb	B
.	O

pRb	B
controls	O
commitment	O
to	O
progress	O
from	O
the	O
G1	O
to	O
S	O
phase	O
,	O
at	O
least	O
in	O
part	O
by	O
repressing	O
the	O
activity	O
of	O
the	O
E2F	B
transcription	I
factors	I
known	O
to	O
promote	O
cell	O
proliferation	O
.	O

Additional	O
education	O
and	O
research	O
is	O
needed	O
to	O
provide	O
further	O
direction	O
for	O
intervention	O
and	O
incorporation	O
into	O
practice	O
.	O

The	O
difference	O
of	O
hardness	O
over	O
time	O
of	O
composite	O
specimens	O
was	O
measured	O
using	O
Knoop	O
hardness	O
measurements	O
taken	O
at	O
the	O
top	O
and	O
bottom	O
surfaces	O
of	O
resin	O
specimens	O
made	O
in	O
a	O
Teflon	O
mold	O
the	O
same	O
dimensions	O
as	O
the	O
cavity	O
prepared	O
in	O
dentin	O
.	O

An	O
18-kb	O
genomic	O
clone	O
including	O
sequences	O
encoding	O
for	O
the	O
two	O
GHS	B
-	I
R	I
variants	I
was	O
isolated	O
.	O

In	O
Ka13	O
cells	O
,	O
CoCl	O
(	O
2	O
)	O
stimulated	O
expression	O
of	O
a	O
luciferase	B
reporter	I
gene	I
under	O
the	O
control	O
of	O
a	O
15-kilobase	B
pair	I
mouse	I
ho-1	I
promoter	I
(	O
pHO15luc	B
)	O
.	O

Members	O
of	O
the	O
AP-1	B
superfamily	I
of	I
basic	I
-	I
leucine	I
zipper	I
factors	I
bind	O
to	O
the	O
StRE	O
.	O

Like	O
the	O
consensus	B
mammalian	I
LHbeta	I
gene	I
,	O
the	O
5'-flanking	O
region	O
of	O
the	O
gpLH	B
/	O
CGbeta	B
gene	O
contains	O
a	O
single	O
TATA	O
sequence	O
37	O
bp	O
upstream	O
of	O
the	O
translation	O
start	O
codon	O
.	O

This	O
shows	O
that	O
in	O
situations	O
of	O
separated	O
breaks	O
,	O
NHEJ	O
deficiency	O
leads	O
to	O
genomic	O
rearrangements	O
,	O
in	O
agreement	O
with	O
chromosomal	O
studies	O
.	O

Foxp1	B
and	O
Foxp2	B
are	O
expressed	O
at	O
high	O
levels	O
in	O
the	O
lung	O
as	O
early	O
as	O
E12.5	O
of	O
mouse	O
development	O
with	O
Foxp2	B
expression	O
restricted	O
to	O
the	O
airway	O
epithelium	O
.	O

Molecular	O
analysis	O
of	O
the	O
pRA2	O
partitioning	O
region	O
:	O
ParB	B
autoregulates	O
parAB	B
transcription	O
and	O
forms	O
a	O
nucleoprotein	O
complex	O
with	O
the	O
plasmid	O
partition	O
site	O
,	O
parS.	B

Several	O
dozen	O
HIF-1	B
targets	I
are	O
known	O
,	O
including	O
the	O
gene	O
encoding	O
vascular	B
endothelial	I
growth	I
factor	I
(	O
VEGF	B
)	O
.	O

We	O
previously	O
reported	O
that	O
Tax	B
induced	O
cell	O
cycle	O
progression	O
from	O
G0	O
/	O
G1	O
phase	O
to	O
S	O
and	O
G2	O
/	O
M	O
phases	O
in	O
human	O
T	O
-	O
cell	O
line	O
Kit	O
225	O
cells	O
.	O

Here	O
,	O
the	O
PEX5-TPR	B
domains	O
from	O
human	O
,	O
tobacco	O
,	O
and	O
nematode	O
were	O
inserted	O
into	O
a	O
TPR	O
-	O
less	O
yeast	O
Pex5p	B
construct	O
to	O
generate	O
Pex5p	B
chimaeras	O
.	O

HIV-1	O
and	O
hepatitis	O
B	O
virus	O
infections	O
in	O
adolescents	O
lodged	O
in	O
security	O
institutes	O
of	O
Buenos	O
Aires	O
.	O

Immunofixation	O
experiments	O
of	O
C4A	B
and	O
C4B	B
demonstrate	O
>	O
41	O
allotypes	O
in	O
the	O
two	O
classes	O
of	O
proteins	O
.	O

In	O
the	O
course	O
of	O
screening	O
for	O
transcription	O
factors	O
which	O
interact	O
with	O
the	O
human	B
myeloperoxidase	I
(	O
MPO	B
)	O
promoter	O
we	O
,	O
for	O
the	O
first	O
time	O
,	O
identified	O
and	O
cloned	O
the	O
cDNA	O
and	O
genomic	O
DNA	O
for	O
human	B
HBP1	I
(	O
HMG	B
-	I
Box	I
containing	I
protein	I
1	I
)	O
,	O
a	O
member	O
of	O
the	O
high	B
mobility	I
group	I
of	I
non	I
-	I
histone	I
chromosomal	I
proteins	I
.	O

In	O
contrast	O
the	O
human	O
and	O
mouse	B
BCNT	I
proteins	I
contain	O
one	O
repeat	O
unit	O
and	O
lack	O
the	O
RTE-1-derived	B
portion	O
.	O

Molecular	O
identification	O
of	O
smg-4	B
,	O
required	O
for	O
mRNA	O
surveillance	O
in	O
C.	O
elegans	O
.	O

The	O
first	O
hypothesis	O
was	O
supported	O
in	O
the	O
sense	O
that	O
stimulus	O
differences	O
might	O
affect	O
behaviour	O
even	O
without	O
their	O
successful	O
attentive	O
processing	O
in	O
normal	O
participants	O
.	O

CSR	O
is	O
directed	O
to	O
specific	O
heavy	O
chain	O
isotypes	O
by	O
cytokines	O
and	O
B	O
cell	O
activators	O
that	O
induce	O
transcription	O
from	O
the	O
unrearranged	O
,	O
or	O
germline	O
(	O
GL	O
)	O
,	O
C	B
(	I
H	I
)	I
region	I
genes	I
.	O

In	O
this	O
manuscript	O
we	O
demonstrate	O
that	O
two	O
tandem	B
Ets	I
sites	I
in	O
the	O
mouse	B
GL	I
alpha	I
promoter	I
bind	O
the	O
transcription	B
factors	I
Elf-1	I
and	O
PU.1	B
,	O
and	O
that	O
the	O
3	O
'	O
site	O
is	O
essential	O
for	O
expression	O
of	O
a	O
luciferase	B
reporter	I
gene	I
driven	O
by	O
the	O
GL	B
alpha	I
promoter	I
.	O

Cell	O
.	O

The	O
proportion	O
of	O
the	O
biopsies	O
found	O
to	O
be	O
seropositive	O
for	O
HBs	B
antigen	I
was	O
27.9	O
%	O
,	O
and	O
these	O
showed	O
either	O
MGN	O
or	O
MPGN	O
pattern	O
.	O

This	O
domain	O
without	O
the	O
canonical	O
anticodon	O
loop	O
or	O
the	O
tyrosine	O
anticodon	O
acts	O
as	O
an	O
anchor	O
for	O
TyrRS	B
interaction	O
leading	O
to	O
a	O
better	O
efficiency	O
of	O
tyrosylation	O
.	O

In	O
summary	O
,	O
we	O
conclude	O
that	O
the	O
adenoviral	O
oncoprotein	O
E1A	B
activates	O
transcription	O
from	O
the	O
endogenous	O
AP-2alpha	B
gene	I
,	O
an	O
effect	O
that	O
involves	O
transcriptional	O
derepression	O
of	O
the	O
AP-2alpha	B
promoter	I
by	O
interaction	O
of	O
E1A	B
with	O
the	O
AP-2rep	B
corepressor	O
CtBP1	B
.	O

SERS	O
spectra	O
were	O
obtained	O
by	O
vacuum	O
evaporation	O
and	O
casting	O
of	O
p	O
-	O
NTP	O
onto	O
silver	O
island	O
films	O
,	O
and	O
also	O
from	O
colloidal	O
silver	O
solutions	O
.	O

Copyright	O
2001	O
Academic	O
Press	O
.	O

The	O
core	O
promoter	O
of	O
human	B
thioredoxin	I
reductase	I
1	I
:	O
cloning	O
,	O
transcriptional	O
activity	O
,	O
and	O
Oct-1	B
,	O
Sp1	B
,	O
and	O
Sp3	B
binding	O
reveal	O
a	O
housekeeping	O
-	O
type	O
promoter	O
for	O
the	O
AU	O
-	O
rich	O
element	O
-	O
regulated	O
gene	O
.	O

Here	O
we	O
show	O
that	O
phosphorylation	O
-	O
induced	O
loss	O
of	O
the	O
protein	O
kinase	O
activity	O
of	O
DNA	B
-	I
PK	I
is	O
restored	O
by	O
the	O
addition	O
of	O
the	O
purified	O
catalytic	O
subunit	O
of	O
either	O
protein	B
phosphatase	I
1	I
or	O
protein	B
phosphatase	I
2A	I
(	O
PP2A	B
)	O
and	O
that	O
this	O
reactivation	O
is	O
blocked	O
by	O
the	O
potent	O
protein	O
phosphatase	O
inhibitor	O
,	O
microcystin	O
.	O

The	O
first	O
exon	O
(	O
exon	O
1A	O
)	O
that	O
corresponded	O
to	O
the	O
5'-untranslated	O
region	O
of	O
the	O
GHR	B
1A	I
mRNA	I
was	O
15,250	O
bp	O
upstream	O
from	O
exon	O
2	O
in	O
the	O
GHR	B
gene	I
.	O

These	O
corrections	O
do	O
not	O
involve	O
sequences	O
predicted	O
to	O
function	O
as	O
transcription	O
factor	O
binding	O
sites	O
.	O

FLP	B
and	O
Cre	B
recombinase	I
function	O
in	O
Xenopus	O
embryos	O
.	O

A	O
method	O
of	O
three	O
-	O
station	O
three	O
-	O
dimensional	O
magnetic	O
resonance	O
(	O
MR	O
)	O
angiography	O
of	O
the	O
lower	O
extremities	O
with	O
segmented	O
volume	O
acquisition	O
is	O
presented	O
.	O

Our	O
previous	O
studies	O
have	O
shown	O
that	O
SHP-1	B
,	O
a	O
SH2	B
domain	I
-	I
containing	I
protein	I
-	I
tyrosine	I
phosphatase	I
,	O
is	O
expressed	O
not	O
only	O
in	O
cells	O
of	O
hematopoietic	O
lineages	O
,	O
but	O
also	O
in	O
many	O
non	O
-	O
hematopoietic	O
cells	O
under	O
the	O
control	O
of	O
an	O
alternative	O
tissue	O
-	O
specific	O
promoter	O
,	O
P1	O
.	O

Unexpectedly	O
,	O
Arg1-expressing	B
COS1	O
cells	O
showed	O
no	O
significant	O
proteinase	O
activity	O
to	O
various	O
synthesized	O
substrates	O
under	O
neutral	O
or	O
acidic	O
conditions	O
in	O
this	O
study	O
.	O

ORF1	O
(	O
1029	O
bp	O
;	O
EMBL	O
databank	O
,	O
Accession	O
No.	O

In	O
the	O
meantime	O
,	O
one	O
has	O
succeeded	O
to	O
establish	O
the	O
deammonification	O
processes	O
in	O
a	O
continuous	O
flow	O
moving	O
-	O
bed	O
pilot	O
plant	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
simplified	O
methods	O
for	O
estimation	O
of	O
Technetium	O
Tc	O
99	O
m	O
(	O
99mTc	O
)	O
-pentetate	O
and	O
orthoiodohippurate	O
I	O
131	O
(	O
131I	O
-	O
OIH	O
)	O
plasma	O
clearance	O
in	O
dogs	O
and	O
cats	O
with	O
1	O
and	O
2	O
blood	O
samples	O
.	O

Interventions	O
aimed	O
at	O
these	O
specific	O
mediators	O
and	O
processes	O
may	O
be	O
successful	O
in	O
reducing	O
the	O
very	O
significant	O
human	O
and	O
economic	O
costs	O
of	O
vascular	O
access	O
dysfunction	O
.	O

In	O
addition	O
,	O
stonin	B
2	I
binds	O
to	O
the	O
C2B	O
domains	O
of	O
synaptotagmins	B
I	I
and	I
II	I
.	O

However	O
,	O
the	O
N63S	O
mutation	O
in	O
the	O
wild	B
-	I
type	I
VP5	I
background	O
increased	O
the	O
interaction	O
,	O
as	O
judged	O
by	O
the	O
beta	B
-	I
galactosidase	I
activity	O
,	O
by	O
a	O
factor	O
of	O
9	O
relative	O
to	O
when	O
the	O
PR7	O
mutation	O
was	O
present	O
.	O

In	O
addition	O
,	O
severe	O
vision	O
loss	O
can	O
be	O
seen	O
with	O
interferon	B
alfa-2b	I
-	O
associated	O
retinopathy	O
.	O

SKP1-SnRK	B
protein	O
kinase	O
interactions	O
mediate	O
proteasomal	O
binding	O
of	O
a	O
plant	O
SCF	B
ubiquitin	I
ligase	I
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
Between	O
June	O
1991	O
and	O
December	O
1996	O
,	O
we	O
administered	O
the	O
nucleoside	O
analog	O
2-chlorodeoxyadenosine	O
(	O
2-CDA	O
)	O
to	O
73	O
children	O
with	O
primary	O
AML	O
and	O
20	O
children	O
with	O
secondary	O
AML	O
or	O
myelodysplastic	O
syndrome	O
(	O
MDS	O
)	O
.	O

Experimental	O
study	O
of	O
ta	O
chengchi	O
tang	O
decoction	O
for	O
relieving	O
lung	O
injury	O
during	O
acute	O
necrotizing	O
pancreatitis	O
]	O

The	O
objectives	O
of	O
the	O
study	O
were	O
to	O
investigate	O
the	O
changes	O
of	O
leukocyte	O
adhesiveness	O
and	O
tumor	B
necrosis	I
factor	I
(	O
TNF	B
)	O
in	O
the	O
early	O
stage	O
of	O
acute	O
necrotizing	O
pancreatitis	O
(	O
ANP	O
)	O
,	O
to	O
go	O
further	O
into	O
the	O
relation	O
of	O
those	O
changes	O
to	O
lung	O
injury	O
of	O
ANP	O
,	O
and	O
to	O
evaluate	O
the	O
prohibitive	O
effect	O
of	O
ta	O
chengchi	O
tang	O
Decoction	O
on	O
leukocyte	O
adhesion	O
and	O
TNF	B
secretion	O
.	O

A	O
variety	O
of	O
receptor	O
-	O
mediated	O
signaling	O
pathways	O
are	O
controlled	O
by	O
both	O
positive	O
and	O
negative	O
extracellular	O
regulators	O
.	O

Reciprocally	O
,	O
HMGI	B
-	I
C	I
expression	O
also	O
coordinately	O
enhances	O
PIAS3-mediated	B
repression	O
of	O
STAT3-dependent	B
transactivation	O
.	O

Additional	O
deletion	O
mutations	O
revealed	O
a	O
new	O
,	O
67-amino	O
-	O
acid	O
functional	O
domain	O
within	O
the	O
proline	O
-	O
rich	O
region	O
of	O
SLP-76	B
,	O
which	O
we	O
have	O
termed	O
the	O
P-1	O
domain	O
.	O

Finally	O
,	O
profiling	O
of	O
a	O
gcn4Delta	B
mutant	I
uncovered	O
an	O
alternative	O
induction	O
pathway	O
operating	O
at	O
many	O
Gcn4p	B
target	I
genes	I
in	O
histidine	O
-	O
starved	O
cells	O
.	O

Evidence	O
from	O
a	O
Northern	O
hybridization	O
indicated	O
that	O
jadM	B
expression	O
is	O
correlated	O
with	O
jadomycin	B
B	I
synthesis	O
.	O

Right	O
LHR	O
(	O
R	O
-	O
LHR	O
)	O
provided	O
the	O
best	O
interobserver	O
and	O
intraobserver	O
reproducibility	O
.	O

Online	O
teaching	O
:	O
design	O
and	O
techniques	O
.	O

The	O
application	O
of	O
the	O
biotechnology	O
at	O
the	O
plants	O
for	O
treatment	O
of	O
the	O
surface	O
storm	O
waters	O
from	O
the	O
industrial	O
zone	O
Telychka	O
of	O
the	O
city	O
of	O
Kyiv	O
has	O
allowed	O
the	O
content	O
of	O
petroleum	O
in	O
water	O
dropped	O
to	O
the	O
Dnieper	O
to	O
be	O
constantly	O
reduced	O
50	O
-	O
100	O
times	O
.	O

Northern	O
blot	O
analysis	O
of	O
RNAs	O
from	O
a	O
number	O
of	O
mouse	O
tissues	O
reveals	O
that	O
Atp6i	B
is	O
expressed	O
predominantly	O
in	O
osteoclasts	O
,	O
and	O
this	O
predominant	O
expression	O
was	O
confirmed	O
by	O
reverse	O
-	O
transcription	O
polymerase	O
chain	O
reaction	O
(	O
RT	O
-	O
PCR	O
)	O
assay	O
and	O
immunohistochemical	O
analysis	O
.	O

Indeed	O
,	O
mutation	O
of	O
two	O
of	O
these	O
motifs	O
,	O
known	O
to	O
be	O
important	O
to	O
regulation	O
of	O
sid1	B
,	O
altered	O
the	O
differential	O
regulation	O
of	O
sid2	B
by	O
iron	O
.	O

Guidelines	O
for	O
performing	O
a	O
routine	O
spiral	O
assay	O
are	O
presented	O
,	O
and	O
alternative	O
test	O
methods	O
intended	O
to	O
overcome	O
a	O
variety	O
of	O
technical	O
difficulties	O
(	O
such	O
as	O
restricted	O
sample	O
availability	O
,	O
sample	O
viscosity	O
or	O
volatility	O
,	O
etc	O
.	O
)	O
are	O
recommended	O
.	O

In	O
conclusion	O
,	O
obesity	O
,	O
alcohol	O
intake	O
,	O
and	O
multimetabolic	O
disorders	O
were	O
determined	O
to	O
be	O
independent	O
predictors	O
for	O
the	O
development	O
of	O
hyperuricemia	O
.	O

Fans	O
in	O
tunnels	O
and	O
open	O
windows	O
at	O
aboveground	O
locations	O
appeared	O
to	O
greatly	O
reduce	O
the	O
likelihood	O
of	O
high	O
PH3	O
concentrations	O
in	O
enclosed	O
areas	O
.	O

The	O
first	O
case	O
of	O
HCV	O
seroconversion	O
in	O
Portugal	O
after	O
the	O
introduction	O
of	O
HCV	O
NAT	O
screening	O
.	O

The	O
co	O
-	O
existence	O
of	O
TE	B
domains	I
within	O
modular	O
PKSs	B
along	O
with	O
physically	O
separated	O
,	O
monofunctional	O
TEs	B
(	O
TE	B
IIs	I
)	O
has	O
been	O
reported	O
for	O
a	O
number	O
of	O
modular	O
polyketide	O
and	O
non	B
-	I
ribosomal	I
peptide	I
synthases	I
(	O
NRPS	B
)	O
.	O

To	O
gain	O
an	O
understanding	O
of	O
the	O
mGSTM2	B
regulation	O
,	O
we	O
have	O
also	O
cloned	O
and	O
analyzed	O
its	O
promoter	O
region	O
.	O

SELECTION	O
CRITERIA	O
:	O
All	O
randomised	O
controlled	O
trials	O
comparing	O
IUSs	O
with	O
other	O
forms	O
of	O
reversible	O
contraceptives	O
and	O
reporting	O
on	O
pre	O
-	O
determined	O
outcomes	O
in	O
women	O
of	O
reproductive	O
years	O
.	O

OBJECTIVES	O
:	O
The	O
objective	O
of	O
this	O
review	O
was	O
to	O
compare	O
the	O
effectiveness	O
,	O
safety	O
and	O
acceptability	O
of	O
the	O
diaphragm	O
with	O
and	O
without	O
spermicide	O
.	O

Our	O
results	O
are	O
reassuring	O
and	O
we	O
therefore	O
advise	O
that	O
in	O
patients	O
undergoing	O
free	O
jejunum	O
flap	O
reconstruction	O
of	O
the	O
hypopharyngo	O
-	O
esophageal	O
tract	O
voice	O
restoration	O
should	O
be	O
attempted	O
by	O
placing	O
a	O
voice	O
prosthesis	O
through	O
a	O
secondary	O
tracheo	O
-	O
esophageal	O
puncture	O
and	O
providing	O
intensive	O
speech	O
training	O
.	O

Hypercalcemia	O
associated	O
with	O
elevated	O
serum	B
PTH	I
concentration	O
indicating	O
primary	O
hyperparathyroidism	O
was	O
found	O
in	O
7	O
BC	O
patients	O
(	O
7	O
%	O
)	O
and	O
in	O
none	O
of	O
healthy	O
women	O
or	O
patients	O
with	O
thyroid	O
cancer	O
.	O

In	O
Saccharomyces	O
cerevisiae	O
,	O
entry	O
into	O
mitosis	O
requires	O
activation	O
of	O
the	O
cyclin	B
-	I
dependent	I
kinase	I
Cdc28	B
in	O
its	O
cyclin	B
B	I
(	O
Clb	B
)	O
-associated	O
form	O
.	O

We	O
investigated	O
the	O
production	O
of	O
hyaluronan	O
(	O
HA	O
)	O
and	O
its	O
effect	O
on	O
cell	O
motility	O
in	O
cells	O
expressing	O
the	O
v	B
-	I
src	I
mutants	I
.	O

We	O
used	O
stored	O
plasma	O
samples	O
from	O
409	O
patients	O
in	O
the	O
National	O
Institute	O
of	O
Neurological	O
Diseases	O
and	O
Stroke	O
(	O
NINDS	O
)	O
tissue	B
plasminogen	I
activator	I
(	O
t	B
-	I
PA	I
)	O
Stroke	O
Trial	O
to	O
examine	O
the	O
relationship	O
between	O
an	O
apolipoprotein	B
(	I
Apo	I
)	I
E2	I
or	O
an	O
Apo	B
E4	I
phenotype	O
and	O
a	O
favorable	O
outcome	O
3	O
months	O
after	O
stroke	O
,	O
the	O
risk	O
of	O
intracerebral	O
hemorrhage	O
,	O
and	O
the	O
response	O
to	O
intravenous	O
t	B
-	I
PA	I
therapy	O
.	O

NIRS	O
was	O
used	O
for	O
the	O
quantitative	O
measurement	O
of	O
muscle	O
O	O
(	O
2	O
)	O
consumption	O
(	O
mV.O	O
(	O
2	O
)	O
)	O
and	O
forearm	O
blood	O
flow	O
(	O
FBF	O
)	O
in	O
78	O
healthy	O
subjects	O
.	O

No	O
dominant	O
clinical	O
factor	O
of	O
risk	O
was	O
found	O
,	O
but	O
multiple	O
regression	O
analysis	O
identified	O
age	O
,	O
body	O
surface	O
area	O
,	O
valve	O
size	O
,	O
shop	O
order	O
fracture	O
rate	O
,	O
and	O
manufacturing	O
period	O
as	O
risk	O
factors	O
for	O
OSF	O
.	O

In	O
this	O
report	O
this	O
technique	O
was	O
applied	O
to	O
human	O
breast	O
carcinoma	O
MDA	O
-	O
MB231	O
cells	O
overexpressing	O
human	B
MPG	I
in	O
order	O
to	O
assess	O
whether	O
up	O
-	O
regulation	O
of	O
the	O
initial	O
step	O
in	O
BER	O
alters	O
the	O
activity	O
of	O
selected	O
other	O
BER	O
(	O
hOGG1	B
and	O
APE	B
/	O
ref-1	B
)	O
or	O
direct	O
reversal	O
(	O
MGMT	B
)	O
repair	O
activities	O
.	O

Colorectal	O
cancer	O
was	O
shown	O
to	O
disproportionately	O
overburden	O
Ashkenazi	O
Jews	O
,	O
who	O
may	O
also	O
be	O
at	O
increased	O
risk	O
for	O
ovarian	O
,	O
pancreatic	O
and	O
stomach	O
cancer	O
,	O
and	O
non	O
-	O
Hodgkin	O
's	O
lymphoma	O
.	O

Influence	O
of	O
compression	O
therapy	O
on	O
symptoms	O
following	O
soft	O
tissue	O
injury	O
from	O
maximal	O
eccentric	O
exercise	O
.	O

Keratoconjunctivitis	O
sicca	O
appears	O
to	O
be	O
a	O
common	O
ocular	O
complication	O
and	O
all	O
children	O
with	O
JRA	O
should	O
be	O
screened	O
for	O
it	O
with	O
a	O
comprehensive	O
battery	O
of	O
tests	O
.	O

In	O
conclusion	O
,	O
primary	O
chemotherapy	O
based	O
on	O
high	O
dose	O
MTX	O
and	O
ara	O
-	O
C	O
is	O
highly	O
efficient	O
in	O
PCNSL	O
.	O

Reovirus	O
mRNAs	O
are	O
efficiently	O
translated	O
within	O
host	O
cells	O
despite	O
the	O
absence	O
of	O
3	O
'	O
polyadenylated	O
tails	O
.	O

Myasthenia	O
gravis	O
is	O
an	O
autoimmune	O
disease	O
resulting	O
from	O
the	O
production	O
of	O
antibodies	O
against	O
the	O
ACh	B
receptors	I
of	O
the	O
neuromuscular	O
synapse	O
.	O

Using	O
the	O
postural	O
and	O
force	O
data	O
as	O
input	O
to	O
a	O
3-D	O
biomechanical	O
model	O
,	O
the	O
lumbosacral	O
spinal	O
compression	O
was	O
calculated	O
.	O

Angina	O
(	O
Q	O
)	O
persistence	O
showed	O
marked	O
associations	O
with	O
previous	O
myocardial	O
infarction	O
,	O
diagnosed	O
angina	O
,	O
electrocardiogram	O
ischemia	O
,	O
and	O
subsequent	O
major	O
ischemic	O
heart	O
disease	O
events	O
from	O
Q5	O
onward	O
.	O

To	O
assess	O
more	O
specific	O
PKA	B
-	O
dependent	O
mediation	O
of	O
LH	B
's	I
contribution	O
to	O
combined	O
hormonal	O
drive	O
,	O
the	O
LDL	B
receptor	I
(	I
-1076	I
to	I
+	I
11	I
bp	I
)	I
reporter	I
plasmid	O
was	O
cotransfected	O
with	O
a	O
full	B
-	I
sequence	I
rabbit	I
muscle	I
protein	I
kinase	I
inhibitor	I
(	O
PKI	B
)	O
minigene	O
driven	O
constitutively	O
by	O
a	O
Rous	B
sarcoma	I
virus	I
promoter	I
.	O

To	O
investigate	O
the	O
convergent	O
role	O
of	O
the	O
insulin	B
/	O
IGF	B
-	I
I	I
effector	O
pathway	O
mediating	O
bihormonal	O
stimulation	O
of	O
LDL	B
receptor	I
promoter	I
expression	O
,	O
transfected	O
granulosa	O
-	O
luteal	O
cells	O
were	O
pretreated	O
for	O
30	O
min	O
with	O
two	O
specific	O
inhibitors	O
of	O
phophatidylinositol	B
3-kinase	I
,	O
wortmannin	O
(	O
100	O
nM	O
)	O
and	O
LY	O
294002	O
(	O
10	O
microM	O
)	O
,	O
or	O
of	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
kinase	I
,	O
PD	O
98059	O
(	O
50	O
microM	O
)	O
,	O
U0126	O
(	O
10	O
microM	O
)	O
,	O
or	O
the	O
latter	O
's	O
inactive	O
derivative	O
,	O
U0124	O
(	O
10	O
microM	O
)	O
.	O

These	O
studies	O
demonstrate	O
that	O
site	O
-	O
specific	O
recognition	O
of	O
the	O
bxd	B
PRE	I
by	O
d	O
(	O
GA	O
)	O
(	O
n	O
)	O
repeat	O
binding	O
activities	O
mediates	O
PcG	B
-	O
dependent	O
silencing	O
.	O

Our	O
findings	O
further	O
our	O
understanding	O
of	O
how	O
ZBP-89	B
modulates	O
cell	O
proliferation	O
and	O
reveals	O
a	O
novel	O
mechanism	O
by	O
which	O
the	O
p53	B
protein	I
is	O
stabilized	O
.	O

A	O
computerized	O
method	O
of	O
determining	O
the	O
focal	O
point	O
of	O
electrical	O
activity	O
in	O
the	O
pallidum	O
of	O
parkinsonian	O
patients	O
was	O
developed	O
using	O
on	O
-	O
line	O
quantitative	O
physiological	O
data	O
analysis	O
.	O

Isolated	O
Systolic	O
Hypertension	O
:	O

An	O
Update	O
.	O

Arterial	O
blood	O
gas	O
tensions	O
were	O
similar	O
across	O
all	O
ventilation	O
modes	O
.	O

As	O
expected	O
,	O
homologous	B
loxP	I
sequences	I
efficiently	O
underwent	O
Cre	B
-	O
mediated	O
recombination	O
.	O

The	O
N	O
-	O
terminal	O
portion	O
of	O
Notch	B
(	I
IC	I
)	I
inhibited	O
p50	B
DNA	O
binding	O
and	O
interacted	O
specifically	O
with	O
p50	B
subunit	I
,	O
not	O
p65	B
of	O
NF	B
-	I
kappaB.	I

Conformational	O
changes	O
of	O
the	O
ferric	B
uptake	I
regulation	I
protein	I
upon	O
metal	O
activation	O
and	O
DNA	O
binding	O
;	O
first	O
evidence	O
of	O
structural	O
homologies	O
with	O
the	O
diphtheria	B
toxin	I
repressor	I
.	O

As	O
a	O
complement	O
to	O
genome	O
-	O
wide	O
mapping	O
and	O
sequencing	O
efforts	O
,	O
it	O
is	O
often	O
important	O
to	O
generate	O
detailed	O
maps	O
and	O
sequence	O
data	O
for	O
specific	O
regions	O
of	O
interest	O
.	O

Thus	O
,	O
the	O
screen	O
for	O
toxic	O
p53	B
mutants	I
in	O
yeast	O
can	O
identify	O
novel	O
p53	B
variants	O
that	O
may	O
be	O
useful	O
in	O
dissecting	O
p53	B
regulated	O
cellular	O
responses	O
and	O
in	O
developing	O
p53-based	B
cancer	O
therapies	O
.	O

Since	O
the	O
latter	O
is	O
very	O
small	O
for	O
physiological	O
flows	O
,	O
the	O
result	O
is	O
that	O
alpha	O
<	O
1	O
even	O
at	O
relatively	O
high	O
values	O
of	O
the	O
Reynolds	O
number	O
(	O
i.e.	O
,	O
for	O
non	O
-	O
negligible	O
inertia	O
)	O
and	O
we	O
validate	O
our	O
perturbation	O
theory	O
results	O
by	O
comparison	O
with	O
a	O
numerical	O
integration	O
of	O
the	O
full	O
model	O
.	O

Cells	O
lacking	O
p116	B
exhibit	O
a	O
striking	O
defect	O
in	O
the	O
formation	O
of	O
these	O
macropinocytic	O
structures	O
,	O
a	O
concomitant	O
reduction	O
in	O
the	O
rate	O
of	O
fluid	O
phase	O
pinocytosis	O
,	O
a	O
significant	O
decrease	O
in	O
the	O
efficiency	O
of	O
chemotactic	O
aggregation	O
,	O
and	O
a	O
decrease	O
in	O
cellular	O
F	B
-	I
actin	I
content	O
.	O

The	O
validity	O
of	O
the	O
FPS	O
-	O
R	O
was	O
further	O
supported	O
by	O
strong	O
positive	O
correlations	O
with	O
the	O
VAS	O
(	O
r=0.92	O
,	O
N=45	O
)	O
and	O
the	O
CAS	O
(	O
r=0.84	O
,	O
N=45	O
)	O
in	O
this	O
clinical	O
sample	O
.	O

The	O
Van	O
der	O
Hoeve	O
's	O
syndrome	O
lesions	O
as	O
poorly	O
mineralized	O
,	O
with	O
low	O
calcium	O
salt	O
and	O
apparent	O
increase	O
of	O
phosphates	O
.	O

A	O
5-month	O
-	O
old	O
infant	O
with	O
persistent	O
congenital	O
stridor	O
and	O
acute	O
respiratory	O
distress	O
is	O
presented	O
.	O

DESIGN	O
:	O
A	O
retrospective	O
chart	O
review	O
of	O
9,322	O
patients	O
undergoing	O
surgical	O
procedures	O
in	O
the	O
period	O
January	O
1993	O
to	O
December	O
1998	O
.	O

Biochemical	O
experiments	O
have	O
shown	O
that	O
CopG	B
co	O
-	O
operatively	O
associates	O
to	O
its	O
target	O
DNA	O
at	O
low	O
protein	O
:	O
DNA	O
ratios	O
,	O
completely	O
protecting	O
four	O
helical	O
turns	O
on	O
the	O
same	O
face	O
of	O
the	O
double	O
helix	O
in	O
both	O
directions	O
from	O
the	O
inverted	O
repeat	O
that	O
constitutes	O
the	O
CopG	B
primary	O
target	O
.	O

We	O
demonstrated	O
that	O
,	O
under	O
serum	O
-	O
starved	O
conditions	O
,	O
KMS-11	O
and	O
OPM-2	O
cells	O
express	O
appreciable	O
levels	O
of	O
phosphorylated	O
FGFR3	B
mutants	I
indicating	O
a	O
constitutive	O
activation	O
of	O
the	O
Y373C	B
and	I
K650E	I
receptors	I
;	O
the	O
addition	O
of	O
the	O
aFGF	B
ligand	I
further	O
increased	O
the	O
level	O
of	O
receptor	O
phosphorylation	O
.	O

[	O
figure	O
:	O
see	O
text	O
]	O

The	O
Stille	O
coupling	O
reaction	O
has	O
been	O
performed	O
in	O
1-butyl-3-methylimidazolium	O
tetrafluoroborate	O
(	O
BMIM	O
BF4	O
)	O
,	O
a	O
room	O
-	O
temperature	O
ionic	O
liquid	O
(	O
RTIL	O
)	O
.	O

The	O
students	O
who	O
had	O
abnormal	O
urine	O
screening	O
results	O
at	O
the	O
first	O
time	O
received	O
a	O
second	O
urine	O
analysis	O
10	O
to	O
15	O
days	O
later	O
to	O
confirm	O
the	O
abnormal	O
urine	O
analysis	O
.	O

Regulation	O
of	O
laminin	B
beta2	I
chain	I
gene	I
expression	O
in	O
human	O
cancer	O
cell	O
lines	O
.	O

However	O
,	O
when	O
directed	O
to	O
the	O
nucleosome	O
by	O
fusion	O
to	O
core	B
histone	I
H2A	I
or	O
H2B	B
,	O
the	O
non	O
-	O
histone	B
tail	O
forms	O
an	O
MCB	O
that	O
appears	O
identical	O
to	O
that	O
of	O
the	O
endogenous	O
protein	O
.	O

These	O
data	O
suggest	O
that	O
proper	O
direct	O
binding	O
of	O
Nhp2p	B
to	O
H	B
/	I
ACA	I
snoRNAs	I
is	O
required	O
for	O
the	O
assembly	O
of	O
H	B
/	I
ACA	I
snoRNPs	I
and	O
hence	O
for	O
the	O
stability	O
of	O
some	O
of	O
their	O
components	O
.	O

SIT	B
(	O
SHP2-interacting	B
transmembrane	I
adaptor	I
protein	I
)	O
is	O
a	O
recently	O
identified	O
transmembrane	O
adaptor	O
protein	O
,	O
which	O
is	O
expressed	O
in	O
lymphocytes	O
.	O

In	O
35	O
of	O
those	O
patients	O
DD	O
was	O
measured	O
also	O
with	O
microlatex	O
tests	O
--	O
Tinaquant	O
and	O
BC	O
d	O
-	O
dimer	O
.	O

Ileal	O
digestibilities	O
of	O
DM	O
,	O
OM	O
,	O
CP	O
,	O
total	O
dietary	O
fiber	O
(	O
TDF	O
)	O
,	O
fat	O
and	O
gross	O
energy	O
(	O
GE	O
)	O
were	O
lower	O
(	O
P	O
<	O
0.05	O
)	O
for	O
dogs	O
fed	O
diets	O
containing	O
supplemental	O
fiber	O
compared	O
with	O
dogs	O
fed	O
the	O
control	O
diet	O
.	O

Together	O
these	O
data	O
imply	O
that	O
the	O
HFV	B
R	I
region	I
acts	O
in	O
the	O
nucleus	O
to	O
modify	O
the	O
cytoplasmic	O
fate	O
of	O
target	O
HFV	O
mRNA	O
.	O

These	O
TxRE	B
contain	O
cyclic	O
AMP	O
-	O
responsive	O
elements	O
(	O
CRE	O
)	O
,	O
but	O
,	O
remarkably	O
,	O
the	O
""""	O
TGACGTCA	O
""""	O
consensus	O
is	O
never	O
strictly	O
conserved	O
in	O
any	O
viral	O
strain	O
(	O
e.g.,AGACGTCA	O
,	O
TGACGGCA	O
,	O
TGACCTCA	O
)	O
.	O

And	O
,	O
most	O
importantly	O
,	O
reconstitution	O
of	O
a	O
consensus	O
CRE	O
,	O
within	O
the	O
21-bp	O
enhancers	O
increases	O
binding	O
of	O
CREB	B
/	O
ATF	B
proteins	O
but	O
abrogates	O
basal	O
repression	O
of	O
LTR	O
-	O
directed	O
transcription	O
in	O
vitro	O
.	O

Site	O
-	O
directed	O
mutagenesis	O
of	O
CAR	B
revealed	O
that	O
CAR	B
residues	O
Leu73	O
and	O
Lys121	O
and/or	O
Lys123	O
are	O
critical	O
contact	O
residues	O
,	O
with	O
Tyr80	O
and	O
Tyr83	O
being	O
peripherally	O
involved	O
in	O
the	O
binding	O
interaction	O
with	O
the	O
Ad5	B
,	I
Ad9	I
,	I
Ad12	I
,	I
and	I
Ad41L	I
fiber	I
knobs	I
.	O

This	O
subfamily	O
of	O
genes	O
all	O
have	O
a	O
single	O
ATP	O
-	O
binding	O
domain	O
at	O
the	O
N	O
-	O
terminus	O
and	O
a	O
single	O
C	O
-	O
terminal	O
set	O
of	O
transmembrane	O
segments	O
.	O

Tolerance	O
in	O
renal	O
transplantation	O
after	O
allogeneic	O
bone	O
marrow	O
transplantation-6-year	O
follow	O
-	O
up	O
.	O

The	O
promoter	O
activity	O
of	O
the	O
proximal	O
region	O
was	O
found	O
to	O
be	O
restricted	O
to	O
a	O
subset	O
of	O
prestalk	O
cells	O
.	O

Thus	O
,	O
replication	O
fork	O
movement	O
near	O
HML	B
pauses	O
at	O
a	O
silent	O
origin	O
which	O
is	O
competent	O
for	O
replication	O
initiation	O
but	O
kept	O
silent	O
through	O
Orc2p	B
,	O
a	O
component	O
of	O
the	O
replication	O
initiator	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
adapter	O
Gab1	B
may	O
redirect	O
c	B
-	I
Met	I
signaling	O
through	O
PI3	B
K	I
away	O
from	O
a	O
c	B
-	I
Akt	I
/	O
Pak1	B
cell	O
survival	O
pathway	O
.	O

Foreigners	O
return	O
.	O

Long	O
-	O
term	O
results	O
with	O
MACOP	O
-	O
B	O
and	O
radiation	O
therapy	O
for	O
aggressive	O
lymphomas	O
]	O

BACKGROUND	O
:	O
Long	O
-	O
term	O
results	O
are	O
needed	O
to	O
evaluate	O
chemotherapy	O
regimens	O
and	O
prognostic	O
factors	O
in	O
non	O
-	O
Hodgkin	O
's	O
lymphomas	O
(	O
NHL	O
)	O
.	O

At	O
the	O
end	O
of	O
each	O
day	O
of	O
migration	O
the	O
pulmonary	O
hemolymph	O
PO2	O
decreased	O
by	O
1	O
-	O
2.5	O
kPa	O
,	O
but	O
the	O
hemocyanin	O
remained	O
saturated	O
with	O
O2	O
and	O
the	O
venous	O
reserve	O
was	O
largely	O
unchanged	O
(	O
O2	O
>	O
0.4	O
mmol	O
x	O
l	O
(	O
-1	O
)	O
)	O
.	O

DESIGN	O
:	O
Prospective	O
cohort	O
study	O
with	O
a	O
20	O
y	O
follow	O
-	O
up	O
period	O
,	O
the	O
First	O
National	O
Health	O
and	O
Examination	O
Survey	O
(	O
NHANES	O
1	O
)	O
Epidemiologic	O
Follow	O
-	O
up	O
Study	O
(	O
NHEFS	O
)	O
.	O

There	O
are	O
many	O
different	O
proposals	O
for	O
the	O
statistical	O
analysis	O
of	O
data	O
to	O
determine	O
early	O
onset	O
of	O
action	O
.	O

The	O
assay	O
herein	O
described	O
allows	O
the	O
comparison	O
of	O
relative	O
FGFR	B
expression	O
levels	O
,	O
both	O
within	O
a	O
single	O
RNA	O
pool	O
and	O
among	O
multiple	O
RNA	O
pool	O
samples	O
.	O

The	O
median	O
preoperative	O
best	O
-	O
corrected	O
visual	O
acuity	O
of	O
0.08	O
(	O
range	O
hand	O
motions	O
/	O
0.003	O
to	O
0.4	O
)	O
,	O
improved	O
by	O
5	O
lines	O
to	O
a	O
median	O
final	O
postoperative	O
best	O
-	O
corrected	O
visual	O
acuity	O
of	O
0.25	O
(	O
range	O
0.025	O
-	O
0.5	O
)	O
(	O
P	O
=	O
0.001	O
)	O
.	O

Gimpl	O
,	O
F.	O

The	O
present	O
chemotherapy	O
of	O
AE	O
is	O
based	O
on	O
the	O
administration	O
of	O
benzimidazole	O
carbamate	O
derivatives	O
,	O
such	O
as	O
mebendazole	O
and	O
albendazole	O
.	O

Topological	O
and	O
mutational	O
analysis	O
of	O
Saccharomyces	B
cerevisiae	I
Ste14p	I
,	O
founding	O
member	O
of	O
the	O
isoprenylcysteine	B
carboxyl	I
methyltransferase	I
family	I
.	O

Hormonal	O
regulation	O
of	O
multiple	O
promoters	O
of	O
the	O
rat	B
mitochondrial	I
glycerol-3-phosphate	I
dehydrogenase	I
gene	I
:	O
identification	O
of	O
a	O
complex	O
hormone	O
-	O
response	O
element	O
in	O
the	O
ubiquitous	O
promoter	O
B.	O

BACKGROUND	O
/	O
AIMS	O
:	O
Hepatitis	O
C	O
and	O
nonalcoholic	O
fatty	O
liver	O
disease	O
(	O
NAFL	O
)	O
are	O
the	O
two	O
most	O
common	O
forms	O
of	O
liver	O
disease	O
in	O
the	O
United	O
States	O
.	O

Our	O
results	O
show	O
that	O
CVN	B
specifically	O
recognizes	O
with	O
nanomolar	O
affinity	O
Man	O
(	O
9	O
)	O
GlcNAc	O
(	O
2	O
)	O
and	O
the	O
D1D3	O
isomer	O
of	O
Man	O
(	O
8	O
)	O
GlcNAc	O
(	O
2	O
)	O
.	O

Here	O
we	O
show	O
that	O
independent	O
of	O
uncertainties	O
in	O
the	O
models	O
,	O
terrestrial	O
planets	O
with	O
dense	O
atmosphere	O
like	O
Venus	O
can	O
evolve	O
into	O
one	O
of	O
only	O
four	O
possible	O
rotation	O
states	O
.	O

Enantiomer	O
separation	O
of	O
venlafaxine	O
and	O
O	O
-	O
desmethylvenlafaxine	O
in	O
human	O
plasma	O
.	O

They	O
consist	O
of	O
at	O
least	O
two	O
separable	O
components	O
,	O
one	O
heat	O
stable	O
and	O
the	O
other	O
heat	O
labile	O
.	O

In	O
the	O
last	O
case	O
,	O
both	O
hydroxychloroquine	O
,	O
carbamazepine	O
and	O
fluvoxamine	O
had	O
a	O
common	O
imputability	O
which	O
was	O
plausible	O
.	O

We	O
investigate	O
the	O
reaction	O
kinetics	O
of	O
small	O
spherical	O
particles	O
with	O
inertia	O
,	O
obeying	O
coalescence	O
type	O
of	O
reaction	O
,	O
B+B-->B	O
,	O
and	O
being	O
advected	O
by	O
hydrodynamical	O
flows	O
with	O
time	O
-	O
periodic	O
forcing	O
.	O

The	O
role	O
of	O
the	O
Vp1	B
DBD	I
during	O
infection	O
was	O
investigated	O
by	O
taking	O
advantage	O
of	O
NLS	O
phenotypic	O
complementation	O
(	O
N.	O

2	O
were	O
nonviable	O
,	O
and	O
the	O
mutant	B
Vp1s	I
unexpectedly	O
failed	O
to	O
localize	O
to	O
the	O
nucleus	O
though	O
Vp2	B
and	O
Vp3	B
did	O
,	O
suggesting	O
that	O
the	O
mutated	B
NLS1	I
acted	O
as	O
a	O
dominant	O
signal	O
for	O
the	O
cytoplasmic	O
localization	O
of	O
Vp1	B
.	O

Fasting	O
gastrin	B
levels	O
(	O
normal	O
range	O
:	O
25	O
-	O
110	O
mU	O
/	O
L	O
)	O
varied	O
from	O
48.78	O
mU	O
/	O
L-168.20	O
(	O
mean	O
:	O
85.23	O
mU	O
/	O
L	O
)	O
.	O

Such	O
knowledge	O
could	O
advance	O
diagnosis	O
and	O
treatment	O
of	O
the	O
patient	O
and	O
counseling	O
of	O
the	O
affected	O
family	O
.	O

BACKGROUND	O
:	O
There	O
is	O
increasing	O
interest	O
on	O
the	O
part	O
of	O
investigators	O
and	O
the	O
public	O
at	O
large	O
in	O
finding	O
ways	O
to	O
study	O
and	O
improve	O
treatments	O
for	O
the	O
seriously	O
mentally	O
ill	O
without	O
exposing	O
such	O
individuals	O
to	O
unnecessary	O
risks	O
.	O

In	O
the	O
next	O
week	O
,	O
the	O
beta	O
-	O
adrenergic	O
antagonist	O
atenolol	O
was	O
added	O
at	O
an	O
initial	O
dose	O
of	O
25	O
mg	O
/	O
day	O
and	O
titrated	O
to	O
50	O
mg	O
/	O
day	O
within	O
1	O
week	O
.	O

Lack	O
of	O
association	O
between	O
Kawasaki	O
syndrome	O
and	O
infection	O
with	O
Rickettsia	O
conorii	O
,	O
Rickettsia	O
typhi	O
,	O
Coxiella	O
burnetii	O
or	O
Ehrlichia	O
phagocytophila	O
group	O
.	O

The	O
presence	O
of	O
AS	O
-	O
oligo	O
had	O
no	O
further	O
effect	O
on	O
the	O
FSH	B
-	O
mediated	O
activation	O
of	O
the	O
EB*-mTf	O
-	O
CAT	B
construct	O
but	O
reduced	O
cAMP	O
-	O
mediated	O
activation	O
.	O

This	O
is	O
a	O
challenging	O
task	O
insofar	O
as	O
direct	O
measures	O
of	O
ISF	O
glucose	O
are	O
not	O
readily	O
available	O
.	O

We	O
developed	O
a	O
system	O
for	O
domain	O
shuffling	O
to	O
establish	O
the	O
function	O
of	O
C1	B
domains	O
from	O
human	B
Raf	I
kinase	I
and	O
rat	B
PKC	I
eta	I
in	O
yeast	O
.	O

We	O
interpret	O
these	O
data	O
as	O
further	O
evidence	O
that	O
interaction	O
with	O
a	O
small	B
GTPase	I
is	O
the	O
main	O
regulatory	O
function	O
of	O
the	O
C1	B
domain	O
in	O
yeast	O
.	O

RESULTS	O
:	O
There	O
is	O
a	O
considerable	O
amount	O
of	O
variation	O
between	O
the	O
results	O
of	O
TRA1	O
and	O
TRA2	O
and	O
between	O
the	O
results	O
of	O
both	O
TRA	O
's	O
and	O
the	O
door	O
-	O
to	O
-	O
door	O
survey	O
.	O

CONCLUSION	O
:	O
Extrusion	O
cooking	O
is	O
effective	O
for	O
the	O
inactivation	O
of	O
DON	O
but	O
is	O
of	O
limited	O
value	O
for	O
AFB1	B
,	O
even	O
if	O
metabisulphite	O
is	O
added	O
.	O

The	O
differences	O
in	O
the	O
CPIgG	B
,	O
CRP	B
,	O
and	O
fibrinogen	B
levels	O
in	O
patients	O
who	O
were	O
diagnosed	O
with	O
ACS	O
versus	O
those	O
who	O
were	O
not	O
(	O
non	O
-	O
ACS	O
)	O
were	O
evaluated	O
.	O

NaeI	B
,	O
a	O
novel	O
DNA	B
endonuclease	I
,	O
shows	O
topoisomerase	B
and	O
recombinase	B
activities	O
when	O
a	O
Lys	O
residue	O
is	O
substituted	O
for	O
Leu	O
43	O
.	O

Mss4	B
also	O
acts	O
as	O
a	O
relatively	O
inefficient	O
guanine	B
nucleotide	I
exchange	I
factor	I
(	O
GEF	B
)	O
.	O

She	O
has	O
since	O
developed	O
a	O
positive	O
anti	B
-	I
cardiolipin	I
antibody	I
but	O
does	O
not	O
meet	O
diagnostic	O
criteria	O
for	O
systemic	O
lupus	O
erythematosis	O
.	O

CONCLUSION	O
:	O
The	O
presence	O
of	O
known	O
autoimmune	O
disease	O
in	O
a	O
woman	O
with	O
POF	O
should	O
not	O
dissuade	O
the	O
clinician	O
from	O
evaluating	O
for	O
a	O
potential	O
genetic	O
cause	O
.	O

Effects	O
of	O
aerosol	O
-	O
vapor	O
JP-8	O
jet	O
fuel	O
on	O
the	O
functional	O
observational	O
battery	O
,	O
and	O
learning	O
and	O
memory	O
in	O
the	O
rat	O
.	O

We	O
randomly	O
assigned	O
1,219	O
subjects	O
to	O
receive	O
either	O
the	O
standard	O
three	O
-	O
times	O
-	O
weekly	O
(	O
TIW	O
)	O
interferon	B
alfa-2b	I
dose	O
(	O
3	O
MIU	O
)	O
or	O
the	O
once	O
-	O
weekly	O
(	O
QW	O
)	O
peginterferon	B
alfa-2b	I
(	O
0.5	O
,	O
1.0	O
,	O
or	O
1.5	O
microg	O
/	O
kg	O
)	O
.	O

At	O
cross	O
purposes	O
.	O

Many	O
factors	O
do	O
influence	O
the	O
educational	O
outcome	O
in	O
students	O
and	O
large	O
statistical	O
power	O
(	O
such	O
as	O
meta	O
analysis	O
)	O
should	O
be	O
helpful	O
to	O
eliminate	O
many	O
sources	O
of	O
error	O
.	O

The	O
combination	O
of	O
ifosfamide	O
,	O
epirubicin	O
and	O
etoposide	O
(	O
IEV	O
)	O
is	O
an	O
effective	O
salvage	O
regimen	O
for	O
lymphoproliferative	O
disease	O
.	O

Cardiac	O
markers	O
troponin	B
T	I
,	O
CK	B
-	O
MB	B
mass	O
and	O
myoglobin	B
were	O
helpful	O
in	O
the	O
differential	O
diagnosis	O
of	O
chest	O
pain	O
,	O
even	O
when	O
the	O
ECG	O
was	O
unremarkable	O
or	O
nonspecific	O
.	O

One	O
maternal	O
death	O
,	O
reduced	O
body	O
weight	O
,	O
and	O
reduced	O
weight	O
gain	O
were	O
noted	O
at	O
the	O
high	O
dose	O
;	O
confirmed	O
pregnancy	O
rates	O
were	O
84	O
to	O
100	O
%	O
for	O
each	O
group	O
.	O

Our	O
results	O
demonstrated	O
that	O
50	O
%	O
of	O
the	O
hepatic	O
artery	O
-	O
alone	O
ALT	O
graft	O
showed	O
almost	O
normal	O
structure	O
histologically	O
at	O
1	O
month	O
after	O
grafting	O
,	O
with	O
bile	O
secretion	O
preserved	O
.	O

The	O
authors	O
made	O
an	O
analysis	O
of	O
social	O
-	O
economical	O
conditions	O
limiting	O
the	O
possibilities	O
of	O
rendering	O
cardiosurgical	O
care	O
to	O
children	O
.	O

In	O
mammals	O
,	O
the	O
transcriptional	O
repressors	O
in	O
the	O
Wnt	B
pathway	O
are	O
not	O
well	O
defined	O
.	O

The	O
human	B
ABCG1	I
gene	I
encodes	O
a	O
member	O
of	O
the	O
ATP	B
-	I
binding	I
cassette	I
(	O
ABC	B
)	O
superfamily	O
of	O
transporter	B
proteins	I
and	O
is	O
highly	O
induced	O
when	O
macrophages	O
are	O
incubated	O
with	O
oxysterols	O
.	O

Despite	O
abundant	O
expression	O
of	O
NtmybAS	B
transcripts	I
in	O
mature	O
pollen	O
,	O
gPAL1	B
transcripts	I
were	O
not	O
detectable	O
in	O
pollen	O
.	O

C	B
/	I
EBPbeta	I
LIP	I
overexpressing	O
HC11	O
cells	O
did	O
not	O
express	O
beta	B
-	I
casein	I
mRNA	I
(	O
mammary	O
epithelial	O
cell	O
differentiation	O
marker	O
)	O
in	O
response	O
to	O
lactogenic	O
hormones	O
.	O

These	O
findings	O
suggest	O
a	O
novel	O
ankyrin	B
-	O
independent	O
role	O
for	O
LAD-1	B
related	O
to	O
FGFR	B
signaling	O
.	O

Competition	O
electrophoretic	O
mobility	O
shift	O
and	O
immunoshift	O
assays	O
confirmed	O
that	O
NF1	B
factors	I
present	O
in	O
nuclear	O
extracts	O
of	O
HeLa	O
and	O
CV-1	O
cells	O
bind	O
to	O
the	O
BKV	B
-	I
MLP	I
.	O

This	O
study	O
demonstrates	O
that	O
inducible	O
expression	O
in	O
response	O
to	O
either	O
PMA	O
or	O
TPO	B
is	O
mediated	O
through	O
the	O
Ets	B
site	I
in	O
the	O
proximal	O
promoter	O
of	O
GPIX	B
and	O
is	O
dependent	O
upon	O
the	O
upstream	O
activation	O
of	O
MAPK	B
/	O
extracellular	B
signal	I
-	I
regulated	I
kinase	I
.	O

On	O
Cox	O
proportional	O
hazards	O
regression	O
adenocarcinoma	O
(	O
P=0.006	O
)	O
,	O
the	O
development	O
of	O
BPF	O
(	O
P=0.003	O
)	O
,	O
older	O
age	O
(	O
P=0.03	O
)	O
and	O
higher	O
pathological	O
stage	O
(	O
P=0.02	O
)	O
were	O
independent	O
adverse	O
predictors	O
of	O
survival	O
.	O

Phosphatidylinositol	B
3-kinase	I
potentiates	O
,	O
but	O
does	O
not	O
trigger	O
,	O
T	O
cell	O
proliferation	O
mediated	O
by	O
the	O
IL-2	B
receptor	I
.	O

The	O
loop	O
domain	O
of	O
heat	B
shock	I
transcription	I
factor	I
1	I
dictates	O
DNA	O
-	O
binding	O
specificity	O
and	O
responses	O
to	O
heat	O
stress	O
.	O

EXAFS	O
measurements	O
around	O
the	O
Ge	O
-	O
K	O
edge	O
have	O
been	O
carried	O
out	O
for	O
liquid	O
Ge	O
-	O
Si	O
alloys	O
for	O
the	O
first	O
time	O
to	O
investigate	O
the	O
local	O
structure	O
around	O
a	O
Ge	O
atom	O
.	O

Progressive	O
study	O
and	O
robustness	O
test	O
of	O
QSAR	O
model	O
based	O
on	O
quantum	O
chemical	O
parameters	O
for	O
predicting	O
BCF	O
of	O
selected	O
polychlorinated	O
organic	O
compounds	O
(	O
PCOCs	O
)	O
.	O

Of	O
the	O
six	O
cases	O
of	O
malignant	O
polyposis	O
,	O
none	O
were	O
identified	O
using	O
CT	O
,	O
and	O
only	O
two	O
were	O
diagnosed	O
by	O
small	O
bowel	O
follow	O
-	O
through	O
.	O

Using	O
the	O
two	O
-	O
hybrid	O
system	O
,	O
we	O
show	O
that	O
nonprenylated	O
Rac1	B
interacts	O
very	O
weakly	O
with	O
Rho	B
-	I
GDI	I
,	O
pointing	O
to	O
the	O
predominant	O
role	O
of	O
protein	O
-	O
isoprene	O
interaction	O
in	O
complex	O
formation	O
.	O

Although	O
metabolized	O
by	O
the	O
cytochrome	B
P-450	I
(	O
CYP	B
)	O
system	O
,	O
venlafaxine	O
inhibits	O
CYP	B
2D6	I
and	I
3A4	I
to	O
a	O
far	O
lesser	O
extent	O
than	O
do	O
the	O
SSRIs	O
.	O

Analysis	O
of	O
the	O
promoter	O
sequence	O
revealed	O
the	O
presence	O
of	O
a	O
major	O
transcriptional	O
start	O
site	O
,	O
a	O
canonical	O
TATA	O
box	O
and	O
putative	O
cis	O
regulatory	O
elements	O
for	O
pituitary	O
specific	O
expression	O
as	O
well	O
as	O
an	O
E	O
-	O
responsive	O
element	O
.	O

Pitx2	B
rescues	O
the	O
GABAergic	O
differentiation	O
defect	O
and	O
partially	O
rescues	O
the	O
axon	O
guidance	O
and	O
behavioral	O
phenotypes	O
of	O
unc-30	B
mutants	I
,	O
indicating	O
a	O
high	O
degree	O
of	O
functional	O
conservation	O
between	O
these	O
evolutionarily	O
related	O
genes	O
.	O

The	O
patterns	O
of	O
early	O
mRNA	O
and	O
protein	O
expression	O
in	O
these	O
seven	O
mutants	O
were	O
examined	O
,	O
and	O
it	O
was	O
found	O
that	O
mutation	O
of	O
the	O
T'	B
(	I
135	I
)	I
acceptor	O
site	O
resulted	O
in	O
the	O
utilization	O
of	O
cryptic	O
splice	O
sites	O
and	O
the	O
generation	O
of	O
new	O
T	B
'	I
species	O
.	O

Sixty	O
-	O
one	O
cases	O
of	O
cholera	O
,	O
all	O
caused	O
by	O
V.	O
cholerae	O
O1	O
,	O
were	O
reported	O
.	O

Thus	O
,	O
BALB	O
/	O
c	O
mice	O
appear	O
to	O
be	O
the	O
most	O
appropriate	O
strain	O
of	O
mice	O
to	O
perform	O
studies	O
on	O
the	O
possible	O
connection	O
between	O
infection	O
with	O
T.	O
canis	O
and	O
allergic	O
asthma	O
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
adenoviral	B
12S	I
E1A	I
protein	I
modulates	O
the	O
phosphorylation	O
status	O
of	O
p130	B
and	O
p107	B
without	O
apparent	O
changes	O
in	O
the	O
cell	O
cycle	O
dependent	O
phosphorylation	O
of	O
the	O
retinoblastoma	B
protein	I
.	O

Furthermore	O
,	O
hormonal	O
regulation	O
of	O
G	O
(	O
1	O
)	O
gene	O
transcription	O
can	O
occur	O
even	O
without	O
additional	O
activation	O
of	O
the	O
Mek	B
-	O
Erk1	B
/	I
2	I
pathway	O
by	O
estrogen	B
receptors	I
.	O

Therefore	O
,	O
to	O
understand	O
how	O
ErbB1	B
/	O
ErbB2	B
signaling	O
contributes	O
to	O
this	O
process	O
,	O
we	O
used	O
the	O
ErbB	B
kinase	I
inhibitor	O
AG1478	O
in	O
ErbB2-dependent	B
BT-474	O
and	O
SKBR-3	O
human	O
breast	O
cancer	O
cells	O
.	O

This	O
plus	O
the	O
reduced	O
phosphorylation	O
of	O
p27	B
by	O
MAPK	B
enhanced	O
the	O
stability	O
of	O
p27	B
that	O
associated	O
with	O
nuclear	B
Cdk2	I
at	O
high	O
stoichiometry	O
and	O
inhibited	O
its	O
kinase	O
activity	O
.	O

ICA	O
in	O
the	O
reference	O
solution	O
was	O
characterised	O
by	O
LC	O
and	O
time	O
-	O
of	O
-	O
flight	O
(	O
TOF	O
)	O
MS	O
and	O
quantified	O
by	O
LC	O
chemiluminescent	O
nitrogen	O
detection	O
(	O
LC	O
-	O
CLND	O
)	O
.	O

Inhibition	O
of	O
JNK1	B
and	O
ERK	B
kinase	O
activities	O
either	O
by	O
expression	O
of	O
the	O
dominant	O
negative	O
mutant	O
JNK1	B
or	O
by	O
treatment	O
with	O
a	O
selective	O
chemical	O
inhibitor	O
of	O
ERK	B
(	O
PD098059	O
)	O
substantially	O
abrogates	O
the	O
UV	O
induction	O
of	O
the	O
GADD45	B
promoter	I
.	O

NF	B
-	I
kappaB	I
is	O
involved	O
in	O
the	O
regulation	O
of	O
CD154	B
(	O
CD40	B
ligand	I
)	O
expression	O
in	O
primary	O
human	O
T	O
cells	O
.	O

Subacute	O
diencephalic	O
angioencephalopathy	O
(	O
SDAE	O
)	O
is	O
a	O
rare	O
and	O
fatal	O
disease	O
of	O
unknown	O
etiology	O
that	O
involves	O
the	O
thalami	O
bilaterally	O
.	O

Mutation	O
of	O
the	O
octamer	O
element	O
also	O
significantly	O
reduced	O
the	O
ability	O
of	O
HDAC1	B
to	O
confer	O
repression	O
of	O
inducible	O
HLA	B
-	I
DRA	I
promoter	I
activation	O
.	O

In	O
the	O
single	O
case	O
the	O
restoration	O
of	O
a	O
structured	O
daily	O
routine	O
represents	O
the	O
presupposition	O
for	O
a	O
cognitive	O
therapy	O
.	O

However	O
these	O
search	O
engines	O
respond	O
with	O
such	O
cumbersome	O
results	O
that	O
domain	O
specific	O
experts	O
can	O
not	O
tolerate	O
.	O

From	O
the	O
above	O
results	O
,	O
we	O
might	O
infer	O
that	O
the	O
seizure	O
type	O
of	O
TLE	O
and	O
a	O
high	O
frequency	O
of	O
seizure	O
are	O
two	O
major	O
independent	O
precipitate	O
factors	O
for	O
abnormal	O
latencies	O
of	O
P300	O
in	O
the	O
epileptic	O
patients	O
.	O

Audiological	O
findings	O
in	O
pregnancy	O
.	O

The	O
isoform	O
,	O
designated	O
HDAC9a	B
,	O
is	O
132	O
aa	O
shorter	O
at	O
the	O
C	O
terminus	O
than	O
HDAC9	B
.	O

Pulmonary	O
embolectomy	O
and	O
lung	O
transplantation	O
are	O
the	O
main	O
indications	O
for	O
the	O
use	O
of	O
heart	O
-	O
lung	O
-	O
machine	O
.	O

In	O
such	O
conditions	O
,	O
the	O
following	O
kinetic	O
reactions	O
have	O
been	O
studied	O
:	O
N2	O
(	O
A	O
)	O
+	O
N2	O
(	O
A	O
)	O
--	O
>	O
N2	O
(	O
C	O
,	O
B	O
,	O
V	O
'	O
)	O
+	O
N2	O
(	O
X	O
)	O
,	O
N2	O
(	O
A	O
)	O
+	O
N2	O
(	O
X	O
,	O
V>5	O
)	O
--	O
>	O
N2	O
(	O
X	O
)	O
+	O
N2	O
(	O
B	O
,	O
V	O
'	O
)	O
in	O
pure	O
N2	O
post	O
-	O
discharges	O
and	O
N2	O
(	O
A	O
)	O
+	O
CH4	O
--	O
>	O
products	O
,	O
C	O
+	O
N	O
+	O
M2	O
--	O
>	O
CN	O
(	O
B	O
,	O
V	O
'	O
)	O
+	O
M2	O
,	O
N2	O
(	O
X	O
,	O
V>4	O
)	O
+	O
CN	O
--	O
>	O
N2	O
(	O
X	O
)	O
+	O
CN	O
(	O
B	O
,	O
A	O
,	O
V	O
'	O
)	O
,	O
in	O
N2	O
-	O
1	O
%	O
CH4	O
post	O
-	O
discharges	O
.	O

The	O
NAUSICAA	O
system	O
gives	O
a	O
good	O
knowledge	O
of	O
LET	O
spectra	O
for	O
the	O
first	O
time	O
in	O
space	O
dosimetry	O
.	O

In	O
order	O
to	O
quantify	O
these	O
effects	O
,	O
tests	O
were	O
conducted	O
in	O
the	O
NASA	O
MSFC	O
Neutral	O
Buoyancy	O
Simulator	O
,	O
in	O
the	O
NASA	O
KC-135	O
in	O
parabolic	O
flight	O
,	O
and	O
in	O
space	O
with	O
the	O
EASE	O
program	O
during	O
the	O
Shuttle	O
Atlantis	O
mission	O
61-B	O
.	O

Different	O
thermoluminescent	O
detectors	O
(	O
TLD	O
)	O
have	O
been	O
used	O
to	O
measure	O
the	O
contribution	O
of	O
the	O
low	O
linear	O
energy	O
transfer	O
component	O
(	O
LET	O
<	O
10	O
keV	O
/	O
micrometer	O
)	O
and	O
plastic	O
nuclear	O
track	O
detectors	O
(	O
PNTD	O
)	O
for	O
the	O
high	O
linear	O
energy	O
tranfer	O
(	O
LET	O
)	O
component	O
.	O

Responses	O
of	O
TLD	O
Mg2SiO4	O
:	O
Tb	O
and	O
radiophotoluminescent	O
glass	O
to	O
heavy	O
charged	O
particles	O
and	O
space	O
radiation	O
.	O

The	O
absorbed	O
dose	O
was	O
measured	O
by	O
combination	O
of	O
two	O
integrating	O
detectors	O
:	O
thermo-	O
luminescent	O
dosemeter	O
of	O
Mg2SiO4	O
:	O
Tb	O
(	O
TDMS	O
)	O
and	O
plastic	O
nuclear	O
track	O
detector	O
(	O
PNTD	O
)	O
.	O

Six	O
of	O
the	O
gstC	B
'	I
mutants	I
,	O
primarily	O
in	O
the	O
C	O
-	O
terminal	O
half	O
of	O
C	B
'	I
,	O
exhibited	O
a	O
defect	O
in	O
the	O
ability	O
to	O
bind	O
L	B
protein	I
.	O

METHODS	O
:	O
Experiments	O
testing	O
the	O
new	O
catheter	O
and	O
comparing	O
it	O
to	O
the	O
existing	O
catheter	O
included	O
:	O
(	O
1	O
)	O
measurement	O
of	O
the	O
laser	O
output	O
beam	O
sizes	O
and	O
divergences	O
;	O
(	O
2	O
)	O
evaluation	O
of	O
particulate	O
matter	O
generation	O
during	O
ablation	O
of	O
atherosclerotic	O
tissue	O
;	O
(	O
3	O
)	O
measurement	O
of	O
ablation	O
hole	O
sizes	O
and	O
tissue	O
penetration	O
rates	O
;	O
(	O
4	O
)	O
histopathologic	O
examination	O
of	O
laser	O
-	O
induced	O
in	O
vivo	O
vessel	O
wall	O
injury	O
.	O

A	O
proposal	O
of	O
50	O
performance	O
indicators	O
divided	O
into	O
five	O
different	O
groups	O
is	O
presented	O
here	O
,	O
namely	O
structural	O
indicators	O
,	O
operational	O
indicators	O
,	O
water	O
and	O
service	O
quality	O
indicators	O
,	O
personnel	O
indicators	O
and	O
economic	O
indicators	O
.	O

Overexpression	O
of	O
RORgamma	B
has	O
been	O
shown	O
to	O
inhibit	O
T	B
cell	I
receptor	I
-	O
mediated	O
apoptosis	O
in	O
T	O
cell	O
hybridomas	O
and	O
to	O
repress	O
the	O
induction	O
of	O
Fas	B
-	I
ligand	I
and	O
interleukin	B
2	I
.	O

Once	O
ICP	O
reaches	O
critical	O
values	O
(	O
>	O
30	O
mm	O
Hg	O
)	O
herniation	O
occurs	O
,	O
usually	O
within	O
2	O
to	O
5	O
days	O
.	O

Other	O
therapies	O
are	O
also	O
available	O
,	O
including	O
hypertonic	O
saline	O
solution	O
,	O
THAM	O
(	O
Tris	O
-	O
hydroxy	O
-	O
methyl	O
-	O
aminomethane	O
)	O
buffer	O
,	O
and	O
high	O
-	O
dose	O
barbiturates	O
.	O

CYP2C19	B
genotype	I
was	O
determined	O
by	O
the	O
polymerase	O
chain	O
reaction	O
-	O
restriction	O
fragment	O
length	O
polymorphism	O
method	O
.	O

The	O
results	O
indicate	O
that	O
a	O
more	O
differentiated	O
diagnosis	O
of	O
the	O
molar	O
relationship	O
will	O
allow	O
for	O
a	O
more	O
causally	O
directed	O
correction	O
of	O
Class	O
II	O
molar	O
relationship	O
.	O

These	O
analyses	O
re	O
-	O
open	O
the	O
question	O
whether	O
all	O
the	O
CesA	B
genes	I
encode	O
cellulose	B
synthases	I
or	O
whether	O
some	O
of	O
the	O
sub	O
-	O
class	O
members	O
may	O
encode	O
other	O
non	B
-	I
cellulosic	I
(	I
1	I
-	I
->4	I
)	I
beta	I
-	I
glycan	I
synthases	I
in	O
plants	O
.	O

Experience	O
with	O
xylene	O
-	O
free	O
sections	O
since	O
1995	O
at	O
the	O
Vrinnevi	O
Hospital	O
is	O
favorable	O
.	O

Interestingly	O
,	O
the	O
CYP71D20-encoded	B
enzyme	I
activity	O
was	O
capable	O
of	O
converting	O
both	O
5-epi	O
-	O
aristolochene	O
and	O
1-deoxycapsidiol	O
to	O
capsidiol	O
in	O
vitro	O
,	O
consistent	O
with	O
the	O
notion	O
that	O
this	O
P450	B
enzyme	I
catalyzes	O
both	O
hydroxylations	O
of	O
its	O
hydrocarbon	O
substrate	O
.	O

E2F1-mediated	B
transcriptional	O
inhibition	O
of	O
the	O
plasminogen	B
activator	I
inhibitor	I
type	I
1	I
gene	I
.	O

Transcriptional	O
regulation	O
of	O
the	O
estrogen	O
-	O
inducible	O
pS2	B
breast	B
cancer	I
marker	I
gene	I
by	O
the	O
ERR	B
family	I
of	O
orphan	B
nuclear	I
receptors	I
.	O

However	O
,	O
during	O
our	O
work	O
with	O
a	O
replication	O
-	O
deficient	O
virus	O
expressing	O
the	O
ASF	B
/	O
SF2	B
splicing	O
factor	O
from	O
a	O
progesterone	O
antagonist	O
-	O
inducible	O
gene	O
cassette	O
,	O
we	O
discovered	O
that	O
ASF	B
/	O
SF2	B
was	O
expressed	O
at	O
a	O
significant	O
level	O
in	O
the	O
293	O
producer	O
cell	O
line	O
,	O
even	O
in	O
the	O
absence	O
of	O
inducer	O
.	O

DNA	O
binding	O
assays	O
confirmed	O
the	O
interference	O
of	O
p30	B
(	I
II	I
)	I
with	O
the	O
assembly	O
of	O
CREB	B
-	O
Tax	B
-	O
p300	B
/	O
CBP	B
multiprotein	O
complexes	O
on	O
21-bp	O
repeat	O
oligonucleotides	O
in	O
vitro	O
.	O

Using	O
the	O
presented	O
categorical	O
structure	O
as	O
domain	O
model	O
a	O
prototype	O
DSS	O
for	O
dipslide	O
urine	O
cultures	O
has	O
been	O
developed	O
.	O

E47	B
protein	I
levels	O
remain	O
high	O
until	O
the	O
double	O
positive	O
developmental	O
stage	O
,	O
at	O
which	O
point	O
they	O
drop	O
to	O
relatively	O
moderate	O
levels	O
,	O
and	O
are	O
further	O
downregulated	O
upon	O
transition	O
to	O
the	O
single	O
positive	O
stage	O
.	O

The	O
dual	O
specificity	O
kinases	O
mitogen	B
-	I
activated	I
protein	I
kinase	I
(	I
MAPK	I
)	I
kinase	I
(	I
MKK	I
)	I
7	I
and	O
MKK4	B
are	O
the	O
only	O
molecules	O
known	O
to	O
directly	O
activate	O
the	O
stress	O
kinases	O
stress	B
-	I
activated	I
protein	I
kinases	I
(	O
SAPKs	B
)	O
/	O
c	B
-	I
Jun	I
N	I
-	I
terminal	I
kinases	I
(	O
JNKs	B
)	O
in	O
response	O
to	O
environmental	O
or	O
mitogenic	O
stimuli	O
.	O

SAPK	B
/	O
JNK	B
activation	O
was	O
completely	O
abolished	O
in	O
the	O
absence	O
of	O
MKK7	B
,	O
even	O
though	O
expression	O
of	O
MKK4	B
was	O
strongly	O
upregulated	O
in	O
mkk7	B
(	I
-	I
/	I
-	I
)	I
mast	O
cell	O
lines	O
,	O
and	O
phosphorylation	O
of	O
MKK4	B
occurred	O
normally	O
in	O
response	O
to	O
multiple	O
stress	O
stimuli	O
.	O

The	O
small	O
copepod	O
Pseudonychocamptus	O
proximus	O
progressively	O
replaced	O
the	O
large	O
Tisbe	O
furcata	O
in	O
sand	O
filters	O
during	O
the	O
fall	O
of	O
1995	O
and	O
was	O
responsible	O
for	O
the	O
large	O
increase	O
in	O
meiofaunal	O
biomass	O
observed	O
after	O
spring	O
1996	O
.	O

When	O
mixed	O
with	O
aqueous	O
solutions	O
of	O
TMT-55	O
,	O
aqueous	O
solutions	O
of	O
either	O
reagent	O
-	O
grade	O
zinc	O
,	O
cadmium	O
,	O
or	O
lead	O
salts	O
precipitate	O
crystalline	O
""""	O
Zn	O
-	O
TMT	O
""""	O
,	O
amorphous	O
or	O
crystalline	O
""""	O
Cd	O
-	O
TMT	O
""""	O
or	O
amorphous	O
""""	O
Pb	O
-	O
TMT	O
""""	O
(	O
M3	O
[	O
S3C3N3	O
]	O
2.nH2O	O
,	O
where	O
M	O
=	O
Cd2	O
+	O
,	O
Pb2	O
+	O
,	O
and	O
Zn2	O
+	O
and	O
n	O
>	O
or	O
=	O
0	O
)	O
that	O
may	O
eventually	O
crystallize	O
if	O
stored	O
in	O
air	O
.	O

Many	O
of	O
the	O
important	O
genes	O
associated	O
with	O
G1	O
regulation	O
have	O
been	O
shown	O
to	O
play	O
a	O
key	O
role	O
in	O
proliferation	O
,	O
differentiation	O
and	O
oncogenic	O
transformation	O
and	O
programmed	O
cell	O
death	O
(	O
apoptosis	O
)	O
.	O

Thus	O
,	O
through	O
a	O
change	O
in	O
conformation	O
upon	O
repair	O
of	O
the	O
6RG	O
lesion	O
,	O
MGMT	B
switches	O
from	O
a	O
DNA	O
repair	O
factor	O
to	O
a	O
transcription	O
regulator	O
(	O
R	B
-	I
MGMT	I
)	O
,	O
enabling	O
the	O
cell	O
to	O
sense	O
as	O
well	O
as	O
respond	O
to	O
mutagens	O
.	O

Data	O
from	O
in	O
vitro	O
splicing	O
assays	O
,	O
UV	O
crosslinking	O
and	O
RNA	O
-	O
binding	O
competition	O
experiments	O
indicates	O
a	O
strong	O
correlation	O
between	O
the	O
binding	O
affinities	O
of	O
PSI	B
for	O
the	O
SELEX	O
sequences	O
and	O
their	O
ability	O
to	O
modulate	O
splicing	O
of	O
P	B
element	I
IVS3	B
in	O
vitro	O
.	O

Temperature	O
measurement	O
in	O
microfluidic	O
systems	O
using	O
a	O
temperature	O
-	O
dependent	O
fluorescent	O
dye	O
.	O

Zarix	O
expected	O
patient	O
enrollment	O
in	O
Canadian	O
clinical	O
sites	O
to	O
begin	O
in	O
Spring	O
2001	O
[	O
397955	O
]	O
,	O
[	O
405928	O
]	O
.	O

RESULTS	O
:	O
The	O
subjects	O
in	O
the	O
augmented	O
feedback	O
group	O
significantly	O
reduced	O
their	O
peak	O
vertical	O
ground	O
reaction	O
force	O
in	O
both	O
post	O
-	O
test	O
conditions	O
(	O
2-minute	O
post	O
-	O
test	O
reduction	O
,	O
0.85+	O
/	O
-0.62	O
;	O
1-week	O
post	O
-	O
test	O
reduction	O
,	O
0.74+	O
/	O
-0.58	O
)	O
as	O
compared	O
to	O
the	O
sensory	O
,	O
control	O
I	O
,	O
and	O
control	O
II	O
feedback	O
groups	O
.	O

Use	O
of	O
a	O
dual	O
-	O
pulse	O
lithotripter	O
to	O
generate	O
a	O
localized	O
and	O
intensified	O
cavitation	O
field	O
.	O

When	O
the	O
blood	O
clot	O
is	O
formed	O
in	O
the	O
vitreous	O
cavity	O
,	O
intravitreal	O
injection	O
of	O
t	B
-	I
PA	I
can	O
convert	O
plasminogen	B
to	O
plasmin	B
and	O
remove	O
the	O
clot	O
.	O

Management	O
of	O
postvitrectomy	O
diabetic	O
vitreous	O
hemorrhage	O
with	O
tissue	B
plasminogen	I
activator	I
(	O
t	B
-	I
PA	I
)	O
and	O
volume	O
homeostatic	O
fluid	O
-	O
fluid	O
exchanger	O
.	O

Effect	O
of	O
heat	O
treatments	O
on	O
the	O
meltability	O
of	O
cheeses	O
.	O

RESULTS	O
:	O
Sixty	O
per	O
cent	O
of	O
African	O
Americans	O
exposed	O
in	O
26	O
community	O
outbreaks	O
were	O
TST	O
positive	O
compared	O
to	O
only	O
40	O
%	O
of	O
whites	O
following	O
comparable	O
exposures	O
.	O

The	O
mean	O
waiting	O
time	O
to	O
receive	O
the	O
pancreas	O
transplant	O
was	O
244	O
days	O
for	O
SPK	O
and	O
167	O
days	O
for	O
PAK	O
recipients	O
(	O
P	O
=	O
0.001	O
)	O
.	O

Patients	O
with	O
antibody	O
peaks	O
,	O
defined	O
as	O
fivefold	O
or	O
higher	O
increase	O
in	O
antibody	O
titer	O
compared	O
to	O
the	O
lowest	O
antibody	O
titer	O
over	O
the	O
course	O
of	O
GBS	O
,	O
had	O
higher	O
disability	O
scores	O
during	O
the	O
first	O
two	O
weeks	O
of	O
GBS	O
and	O
a	O
worse	O
clinical	O
outcome	O
(	O
anti	B
-	I
GM1	I
IgG	I
and	O
anti	B
-	I
GD1a	I
IgM	I
antibody	I
peaks	O
)	O
and	O
axonal	O
damage	O
(	O
anti	B
-	I
GD1a	I
IgM	I
antibody	I
peaks	O
)	O
,	O
compared	O
to	O
patients	O
without	O
peak	O
antibody	O
titers	O
.	O

Following	O
baseline	O
clinical	O
examination	O
and	O
initial	O
periodontal	O
therapy	O
,	O
32	O
patients	O
received	O
mucogingival	O
surgery	O
with	O
free	O
gingival	O
grafts	O
for	O
treatment	O
of	O
insufficient	O
attached	O
gingiva	O
.	O

However	O
,	O
patients	O
with	O
isolated	O
office	O
hypertension	O
had	O
fewer	O
previous	O
cardiovascular	O
complications	O
.	O

These	O
findings	O
suggest	O
that	O
an	O
intracellular	O
WT-1	B
/	O
HSAL2	B
pathway	O
may	O
play	O
a	O
role	O
in	O
development	O
and	O
hematopoiesis	O
.	O

ICAM-1	B
has	O
been	O
suggested	O
a	O
predictor	O
of	O
the	O
onset	O
of	O
GO	O
.	O

Phosphotyrosyl	O
peptides	O
block	O
Stat3-mediated	B
DNA	O
binding	O
activity	O
,	O
gene	O
regulation	O
,	O
and	O
cell	O
transformation	O
.	O

Plane	O
wave	O
geometry	O
is	O
impractical	O
for	O
clinical	O
use	O
but	O
the	O
results	O
of	O
this	O
work	O
encouraged	O
us	O
to	O
further	O
develop	O
the	O
P3	O
approximation	O
for	O
a	O
spherical	O
geometry	O
,	O
described	O
in	O
this	O
paper	O
.	O

The	O
diagnosis	O
of	O
HCV	O
arthritis	O
in	O
patients	O
with	O
positive	O
rheumatoid	B
factor	I
and	O
chronic	O
inflammatory	O
polyarthritis	O
may	O
be	O
difficult	O
.	O

METHODS	O
:	O
We	O
retrospectively	O
selected	O
13	O
TFCD	O
patients	O
who	O
underwent	O
surgery	O
for	O
intractable	O
epilepsy	O
with	O
the	O
aim	O
of	O
removing	O
the	O
magnetic	O
resonance	O
(	O
MR	O
)	O
-detectable	O
lesion	O
and/or	O
the	O
epileptogenic	O
zone	O
defined	O
by	O
stereoelectroencephalographic	O
recordings	O
.	O

RESULTS	O
:	O
At	O
latest	O
examination	O
,	O
mean	O
UPDRS	O
II	O
and	O
III	O
scores	O
had	O
improved	O
by	O
30	O
%	O
(	O
on	O
stimulation	O
,	O
off	O
therapy	O
)	O
with	O
mean	O
50	O
%	O
reduction	O
in	O
daily	O
off	O
time	O
.	O

Endovascular	O
aneurysm	O
repair	O
with	O
the	O
AneuRx	O
stent	O
-	O
graft	O
is	O
safe	O
,	O
but	O
is	O
it	O
effective	O
?	O

Chronic	O
nutritional	O
diseases	O
of	O
infectious	O
origin	O
:	O
an	O
assessment	O
of	O
a	O
nascent	O
field	O
.	O

Drug	O
interactions	O
have	O
been	O
found	O
with	O
drugs	O
that	O
compete	O
for	O
the	O
same	O
CYP450	B
isoenzymes	I
as	O
statins	O
.	O

Because	O
of	O
differences	O
in	O
patient	O
characteristics	O
,	O
control	O
measurements	O
were	O
obtained	O
from	O
normal	O
muscle	O
in	O
all	O
patients	O
.	O

However	O
,	O
the	O
abi1	B
-	I
1	I
gene	I
product	I
has	O
no	O
effect	O
on	O
the	O
ABA	O
suppression	O
of	O
a	O
GA	O
-	O
responsive	O
alpha	B
-	I
amylase	I
gene	I
.	O

In	O
children	O
unable	O
to	O
perform	O
forced	O
expiratory	O
maneuvers	O
(	O
n	O
=	O
25	O
)	O
,	O
FOT	O
,	O
contrary	O
to	O
the	O
interrupter	O
technique	O
,	O
clearly	O
identified	O
a	O
subgroup	O
of	O
young	O
children	O
with	O
high	O
resistance	O
values	O
at	O
baseline	O
,	O
which	O
returned	O
to	O
normal	O
after	O
bronchodilation	O
.	O

In	O
budding	O
yeast	O
,	O
this	O
latter	O
checkpoint	O
response	O
involves	O
the	O
proteins	O
Mad1	B
,	I
2	I
,	I
3	I
,	O
Bub1	B
and	O
Bub3	B
,	O
whose	O
vertebrate	O
counterparts	O
localize	O
to	O
unattached	O
kinetochores	O
.	O

HTLV-1	O
decreases	O
Th2	O
type	O
of	O
immune	O
response	O
in	O
patients	O
with	O
strongyloidiasis	O
.	O

However	O
,	O
the	O
beta5L	O
splice	O
variant	O
was	O
found	O
only	O
in	O
the	O
retina	O
.	O

PROCEDURE	O
:	O
Cannulas	O
were	O
surgically	O
positioned	O
in	O
the	O
abomasal	O
body	O
and	O
pyloric	O
antrum	O
of	O
each	O
calf	O
.	O

Transforming	B
growth	I
factor	I
-	I
beta	I
(	O
TGF	B
-	I
beta	I
)	O
induced	O
growth	O
arrest	O
of	O
cells	O
involves	O
regulation	O
of	O
the	O
activities	O
of	O
both	O
D-	B
and	I
E	I
-	I
type	I
cyclin	I
kinase	I
complexes	I
thought	O
to	O
be	O
mediated	O
primarily	O
by	O
the	O
regulation	O
of	O
p15	B
(	O
Ink4b	B
)	O
and	O
p27	B
(	O
Kip1	B
)	O
cyclin	O
kinase	O
inhibitors	O
.	O

Alignment	O
of	O
different	O
cDNAs	O
of	O
the	O
NR5A2	B
(	O
hB1F	B
)	O
gene	O
with	O
the	O
genomic	O
sequence	O
facilitated	O
the	O
delineation	O
of	O
its	O
structural	O
organization	O
,	O
which	O
spans	O
over	O
150	O
kb	O
and	O
consists	O
of	O
eight	O
exons	O
interrupted	O
by	O
seven	O
introns	O
.	O

The	O
genomic	O
structure	O
of	O
the	O
human	B
SPEC1	I
gene	I
reveals	O
complex	O
splicing	O
and	O
close	O
promoter	O
proximity	O
to	O
the	O
AF1q	B
translocation	I
gene	I
.	O

Hp	O
positive	O
relatives	O
of	O
gastric	O
cancer	O
had	O
a	O
markedly	O
higher	O
prevalence	O
of	O
atrophy	O
than	O
those	O
with	O
Hp	O
negativity	O
without	O
cancer	O
relatives	O
(	O
29	O
vs.	O

Peripheral	O
metabolism	O
of	O
androgens	O
takes	O
place	O
in	O
various	O
areas	O
within	O
the	O
pilosebaceous	O
unit	O
,	O
as	O
indicated	O
by	O
local	O
differences	O
in	O
the	O
activities	O
of	O
aromatase	B
,	O
5alpha	B
-	I
reductase	I
as	O
well	O
as	O
of	O
the	O
presence	O
of	O
the	O
androgen	B
receptors	I
.	O

The	O
uptake	O
of	O
fluorine-18	O
fluorodeoxyglucose	O
(	O
F-18	O
FDG	O
)	O
by	O
a	O
malignant	O
tumor	O
depends	O
on	O
the	O
blood	O
glucose	O
level	O
.	O

Northern	O
blot	O
analysis	O
with	O
one	O
of	O
the	O
PARNAs	B
revealed	O
a	O
highly	O
abundant	O
signal	O
of	O
approximately	O
2.0	O
kilobases	O
(	O
kb	O
)	O
present	O
in	O
all	O
cell	O
lines	O
tested	O
.	O

This	O
analysis	O
supports	O
the	O
use	O
of	O
fluticasone	O
propionate	O
88	O
microg	O
twice	O
daily	O
as	O
first	O
-	O
line	O
treatment	O
in	O
patients	O
with	O
persistent	O
asthma	O
previously	O
treated	O
with	O
short	O
-	O
acting	O
beta2-agonist	B
alone	O
.	O

By	O
using	O
space	O
-	O
discrete	O
/	O
continuous	O
metapopulation	O
dynamic	O
models	O
and	O
computer	O
simulations	O
,	O
we	O
show	O
that	O
there	O
can	O
be	O
two	O
principally	O
different	O
regimes	O
of	O
metapopulation	O
dynamics	O
.	O

Eight	O
CAD	O
patients	O
who	O
were	O
matched	O
to	O
the	O
treated	O
patients	O
for	O
age	O
(	O
+	O
/-3	O
years	O
)	O
,	O
baseline	O
low	B
density	I
lipoprotein	I
(	O
+	O
/-5	O
mg	O
/	O
dL	O
)	O
,	O
and	O
triglycerides	O
(	O
+	O
/-50	O
mg	O
/	O
dL	O
)	O
but	O
who	O
had	O
never	O
been	O
treated	O
with	O
lipid	O
-	O
lowering	O
drugs	O
were	O
selected	O
as	O
controls	O
.	O

The	O
corresponding	O
orifice	O
voltages	O
for	O
the	O
three	O
instruments	O
were	O
20	O
/	O
50	O
/	O
80	O
V	O
(	O
API	O
365	O
)	O
,	O
30	O
/	O
90	O
/	O
130	O
V	O
(	O
API	O
2000	O
)	O
and	O
40	O
/	O
80	O
/	O
120	O
V	O
(	O
API	O
3000	O
)	O
.	O

RESULTS	O
:	O
A	O
novel	O
gene	O
was	O
cloned	O
.	O

The	O
moduli	O
of	O
elasticity	O
of	O
the	O
gray	O
and	O
white	O
matter	O
were	O
3.4+	O
/	O
-1.4	O
kPa	O
(	O
mean	O
+	O
/-	O

standard	O
deviation	O
)	O
and	O
3.4+	O
/	O
-0.9	O
kPa	O
in	O
the	O
axial	O
section	O
,	O
3+	O
/	O
-0.3	O
kPa	O
and	O
3.5+	O
/	O
-0.5	O
kPa	O
in	O
the	O
frontal	O
section	O
,	O
and	O
3.5+	O
/	O
-0.9	O
kPa	O
and	O
2.8+	O
/	O
-0.4	O
kPa	O
in	O
the	O
sagittal	O
section	O
,	O
respectively	O
.	O

The	O
LA	O
50s	O
derived	O
from	O
this	O
combined	O
data	O
when	O
compared	O
with	O
our	O
earlier	O
series	O
from	O
1965	O
to	O
1970	O
also	O
did	O
not	O
show	O
a	O
significant	O
change	O
in	O
mortality	O
.	O

Direct	O
current	O
polarography	O
and	O
differential	O
pulse	O
polarographic	O
methods	O
have	O
been	O
developed	O
for	O
the	O
qualitative	O
as	O
well	O
as	O
quantitative	O
analysis	O
of	O
vitamin	O
B1	O
,	O
B2	O
and	O
B6	O
.	O

Against	O
gram	O
-	O
positive	O
organisms	O
,	O
E-4767	O
and	O
E-5065	O
were	O
,	O
in	O
general	O
,	O
eight-	O
and	O
fourfold	O
more	O
active	O
than	O
tosufloxacin	O
,	O
which	O
is	O
the	O
most	O
potent	O
of	O
the	O
reference	O
compounds	O
.	O

However	O
,	O
most	O
produced	O
significant	O
alteration	O
of	O
small	O
intestinal	O
permeability	O
.	O

These	O
included	O
HNF-3	B
beta	I
,	O
HFH-1	B
,	O
HFH-2	B
,	O
HFH-3	B
,	O
C	B
/	I
EBP	I
,	O
and	O
C	B
/	I
EBP	I
beta	I
,	O
all	O
of	O
which	O
are	O
consistent	O
with	O
the	O
tissue	O
-	O
specific	O
expression	O
profiles	O
of	O
the	O
gene	O
.	O

Managing	O
vertigo	O
and	O
vertigo	O
syndromes	O
in	O
the	O
elderly	O

The	O
MABP	O
and	O
MCBFV	O
signals	O
were	O
bandpass	O
filtered	O
in	O
the	O
very	O
low	O
-	O
frequency	O
range	O
(	O
VLF	O
,	O
0.015	O
-	O
0.07	O
Hz	O
)	O
,	O
low	O
-	O
frequency	O
range	O
(	O
LF	O
,	O
0.07	O
-	O
0.15	O
Hz	O
)	O
and	O
high	O
-	O
frequency	O
range	O
(	O
HF	O
,	O
0.15	O
-	O
0.40	O
Hz	O
)	O
before	O
applying	O
CCF	O
for	O
the	O
purpose	O
of	O
studying	O
the	O
effect	O
of	O
different	O
bandwidths	O
on	O
the	O
resulting	O
mean	O
CCFs	O
.	O

Treatment	O
of	O
ischemic	O
heart	O
disease	O
in	O
the	O
elderly	O

Hepatitis	O
B	O
and	O
C	O
seroprevalence	O
rates	O
among	O
high	O
-	O
risk	O
adolescents	O
are	O
lower	O
in	O
El	O
Paso	O
than	O
in	O
other	O
similar	O
US	O
populations	O
,	O
presenting	O
an	O
ideal	O
climate	O
for	O
prevention	O
programs	O
.	O

A	O
twelfth	O
insertion	O
disrupts	O
two	O
genes	O
,	O
Nrk	B
,	O
a	O
""""	B
neurospecific	I
""""	I
receptor	I
tyrosine	I
kinase	I
,	O
and	O
Tpp	B
,	O
which	O
encodes	O
a	O
neuropeptidase	B
.	O

A	O
peculiar	O
people	O
:	O
""""	O
the	O
physiological	O
aspects	O
of	O
Mormonism	O
1850	O
-	O
1975	O
.	O
""""	O

Not	O
Available	O

This	O
unique	O
work	O
needs	O
to	O
be	O
edited	O
critically	O
and	O
afterwards	O
translated	O
into	O
Urdu	O
and	O
other	O
languages	O
for	O
the	O
benefit	O
of	O
the	O
present	O
day	O
students	O
and	O
scholars	O
.	O

Comparison	O
of	O
German	O
language	O
versions	O
of	O
the	O
QWB	O
-	O
SA	O
and	O
SF-36	O
evaluating	O
outcomes	O
for	O
patients	O
with	O
prostate	O
disease	O
.	O

Disciplinary	O
action	O
for	O
DNA	O
violation	O
.	O

Epithelial	O
cytotoxicity	O
of	O
combined	O
antibiotics	O
was	O
additive	O
,	O
with	O
no	O
evidence	O
of	O
competition	O
or	O
synergism	O
.	O

Pro	O
-	O
inflammatory	O
cytokine	O
,	O
tumor	B
necrosis	I
factor	I
-	I
alpha	I
(	O
TNF	B
-	I
alpha	I
)	O
,	O
produced	O
from	O
adipose	O
tissues	O
in	O
obese	O
subjects	O
,	O
is	O
known	O
to	O
play	O
a	O
predominant	O
role	O
in	O
inducing	O
insulin	B
resistance	O
.	O

She	O
drank	O
alcohol	O
once	O
or	O
twice	O
a	O
week	O
and	O
regularly	O
took	O
an	O
analgesic	O
preparation	O
,	O
containing	O
aspirin	O
and	O
acetaminophen	O
,	O
for	O
alleviation	O
of	O
headaches	O
.	O

The	O
most	O
important	O
risk	O
factors	O
are	O
:	O
1	O
)	O
genetic	O
;	O
2	O
)	O
Epstein	O
-	O
Barr	O
virus	O
(	O
infectious	O
mononucleosis	O
)	O
;	O
3	O
)	O
congenital	O
and	O
acquired	O
immunodeficiency	O
;	O
4	O
)	O
occupational	O
exposure	O
(	O
the	O
wood	O
industry	O
)	O
.	O

The	O
most	O
important	O
finding	O
,	O
however	O
,	O
was	O
that	O
IMT	O
values	O
were	O
related	O
with	O
24	O
h	O
SBP	O
or	O
PP	O
standard	O
deviation	O
(	O
P	O
<	O
0.001	O
)	O
,	O
a	O
measure	O
of	O
overall	O
SBP	O
or	O
PP	O
variability	O
.	O

The	O
difference	O
between	O
the	O
patients	O
and	O
the	O
controls	O
was	O
statistically	O
significant	O
(	O
p	O
=	O
0.03	O
)	O
.	O

The	O
effect	O
of	O
crude	O
oil	O
spillage	O
on	O
growth	O
,	O
productivity	O
and	O
nutrient	O
uptake	O
of	O
maize	O
(	O
Zea	O
mays	O
L.	O
)	O
was	O
assessed	O
in	O
a	O
pot	O
experiment	O
using	O
an	O
Evwreni	O
manifold	O
sample	O
of	O
a	O
petroleum	O
development	O
company	O
,	O
which	O
had	O
a	O
specific	O
gravity	O
of	O
0.8778	O
.	O

NO	O
metabolites	O
were	O
determined	O
by	O
the	O
measurement	O
of	O
nitrate	O
/	O
nitrite	O
(	O
NOx	O
,	O
micromol	O
/	O
mmol	O
creatinine	O
)	O
and	O
cyclic	O
guanosine	O
monophosphate	O
(	O
cGMP	O
,	O
nmol	O
/	O
mmol	O
creatinine	O
)	O
in	O
plasma	O
and	O
urine	O
.	O

In	O
the	O
base	O
-	O
case	O
analysis	O
,	O
total	O
direct	O
costs	O
per	O
patient	O
were	O
$	O
728	O
for	O
zoledronic	O
acid	O
and	O
$	O
776	O
for	O
pamidronate	O
.	O

The	O
diet	O
of	O
migrants	O
showed	O
both	O
positive	O
(	O
macronutrients	O
)	O
and	O
negative	O
(	O
micronutrients	O
)	O
differences	O
with	O
the	O
general	O
Dutch	O
diet	O
.	O

C.	O
elegans	O
embryogenesis	O
begins	O
with	O
a	O
stereotyped	O
sequence	O
of	O
asymmetric	O
cell	O
divisions	O
that	O
are	O
largely	O
responsible	O
for	O
establishing	O
the	O
nematode	O
body	O
plan	O
.	O

Finally	O
,	O
a	O
chromogenic	O
method	O
was	O
used	O
,	O
based	O
on	O
thrombin	B
inhibition	O
and	O
the	O
substrate	O
S-2238	O
.	O

The	O
5	O
'	O
flanking	O
sequence	O
of	O
the	O
3B	B
gene	I
is	O
extremely	O
A	O
+	O
T	O
rich	O
but	O
contains	O
five	O
G	O
/	O
C	O
rich	O
stretches	O
,	O
each	O
approximately	O
7bp	O
long	O
,	O
which	O
have	O
strong	O
sequence	O
similarity	O
to	O
the	O
G	O
boxes	O
found	O
upstream	O
of	O
other	O
developmentally	O
regulated	O
Dictyostelium	O
genes	O
.	O

Considering	O
that	O
the	O
reactor	O
is	O
thoroughly	O
mixed	O
during	O
each	O
discharge	O
and	O
that	O
LD50	O
=	O
0.9	O
values	O
are	O
nearly	O
independent	O
of	O
E.	O
coli	O
concentrations	O
in	O
the	O
range	O
of	O
2	O
x	O
10	O
(	O
3	O
)	O
<	O
or	O
=	O
E	O
coli	O
/	O
cfu	O
mL	O
(	O
-1	O
)	O
<	O
or	O
=	O
3	O
x	O
10	O
(	O
6	O
)	O
,	O
we	O
ascribe	O
the	O
nonexponential	O
Pn	O
decay	O
of	O
single	O
-	O
strain	O
E.	O
coli	O
colonies	O
to	O
a	O
shielding	O
phenomenon	O
where	O
inactive	O
cells	O
protect	O
the	O
successively	O
smaller	O
numbers	O
of	O
viable	O
cells	O
in	O
the	O
EHD	O
.	O

In	O
the	O
long	O
term	O
,	O
questions	O
still	O
remain	O
about	O
whether	O
pre	O
-	O
dialysis	O
rHu	B
EPO	I
either	O
speeds	O
up	O
or	O
delays	O
the	O
onset	O
of	O
dialysis	O
.	O

No	O
ISREs	B
could	O
be	O
identified	O
in	O
the	O
mouse	O
promoter	O
.	O

BACKGROUND	O
:	O
Ischemic	O
heart	O
disease	O
is	O
the	O
primary	O
cause	O
of	O
morbidity	O
and	O
mortality	O
among	O
diabetics	O
,	O
especially	O
those	O
who	O
became	O
ill	O
at	O
a	O
young	O
age	O
.	O

A	O
38-year	O
-	O
old	O
woman	O
with	O
ulcerative	O
colitis	O
subsequently	O
developed	O
sarcoidosis	O
.	O

Cholesteryl	B
ester	I
transfer	I
protein	I
and	O
atherosclerosis	O
in	O
Japanese	O
subjects	O
:	O
a	O
study	O
based	O
on	O
coronary	O
angiography	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
and	O
coimmunoprecipitation	O
studies	O
suggest	O
that	O
homo-	O
and	O
heterodimerization	O
occurs	O
between	O
cKrox	B
family	I
members	I
.	O

The	O
hcKrox	B
gene	O
family	O
regulates	O
multiple	O
extracellular	O
matrix	O
genes	O
.	O

A	O
review	O
of	O
the	O
literature	O
identified	O
8	O
comprehensive	O
clinical	O
studies	O
,	O
all	O
of	O
which	O
failed	O
to	O
document	O
any	O
relationship	O
between	O
NF1	B
and	O
intracranial	O
aneurysms	O
.	O

These	O
utilisation	O
data	O
imply	O
annual	O
drug	O
costs	O
in	O
the	O
range	O
of	O
$	O
US	O
480,000	O
to	O
$	O
US	O
3,600,000	O
for	O
TNF	B
antagonists	O
for	O
RA	O
per	O
1	O
million	O
population	O
.	O

Under	O
our	O
conditions	O
,	O
the	O
combination	O
O3	O
/	O
UV	O
did	O
not	O
improve	O
the	O
degradation	O
rate	O
obtained	O
by	O
ozonation	O
.	O

This	O
study	O
investigated	O
whether	O
boron	O
would	O
enhance	O
the	O
ability	O
of	O
17beta	O
-	O
estradiol	O
(	O
E2	O
)	O
or	O
parathyroid	B
hormone	I
(	O
PTH	B
)	O
to	O
improve	O
bone	O
quality	O
in	O
ovariectomized	O
OVX	O
rats	O
.	O

We	O
found	O
in	O
the	O
control	O
subjects	O
rCBF	O
increases	O
in	O
regions	O
associated	O
with	O
the	O
meso	O
-	O
striatal	O
and	O
meso	O
-	O
corticolimbic	O
circuits	O
in	O
response	O
to	O
both	O
monetary	O
reward	O
and	O
nonmonetary	O
reinforcement	O
.	O

Doxorubicin	O
(	O
DOX	O
)	O
is	O
commonly	O
used	O
for	O
the	O
treatment	O
of	O
hematological	O
and	O
solid	O
tumors	O
.	O

The	O
event	O
rate	O
in	O
patients	O
with	O
chronic	O
Irr	O
-	O
rMFP	O
or	O
Un	O
-	O
nrMFP	O
was	O
markedly	O
higher	O
than	O
it	O
was	O
in	O
those	O
with	O
Rev	O
-	O
rMFP	O
or	O
Sta	O
-	O
nrMFP	O
.	O

Subtraction	O
hybridization	O
identified	O
melanoma	B
differentiation	I
associated	I
gene-7	I
(	O
mda-7	B
)	O
,	O
as	O
a	O
gene	O
induced	O
during	O
these	O
physiological	O
changes	O
in	O
human	O
melanoma	O
cells	O
.	O

Therefore	O
,	O
vitamin	O
D3	O
analogues	O
have	O
a	O
substantial	O
antipsoriatic	O
effect	O
.	O

Hydrocoele	O
is	O
common	O
in	O
men	O
in	O
Wuchereria	O
bancrofti	O
-	O
endemic	O
areas	O
,	O
the	O
treatment	O
for	O
which	O
is	O
currently	O
surgical	O
intervention	O
.	O

Growth	B
hormone	I
and	O
insulin	B
-	I
like	I
growth	I
factor	I
I	I
receptors	I
in	O
the	O
temporomandibular	O
joint	O
of	O
the	O
rat	O
.	O

On	O
the	O
other	O
hand	O
,	O
hepatic	O
arterial	O
infusion	O
therapy	O
prolongs	O
the	O
survival	O
of	O
H3	O
patients	O
only	O
.	O

In	O
addition	O
to	O
that	O
,	O
she	O
received	O
hepatic	O
intra	O
-	O
arterial	O
infusion	O
of	O
levoforinate	O
(	O
l	O
-	O
LV	O
)	O
250	O
mg	O
and	O
5-fluorouracil	O
(	O
5-FU	O
)	O
500	O
mg	O
for	O
combined	O
multiple	O
hepatic	O
metastases	O
starting	O
on	O
postoperative	O
day	O
14	O
,	O
and	O
these	O
medications	O
were	O
administered	O
over	O
48	O
hours	O
once	O
weekly	O
by	O
infuser	O
pump	O
.	O

The	O
astronaut	O
crew	O
operates	O
the	O
payload	O
and	O
documents	O
its	O
operation	O
.	O

For	O
these	O
patients	O
the	O
introduction	O
of	O
a	O
separate	O
category	O
""""	O
extended	O
oligoarthritis	O
at	O
onset	O
""""	O
should	O
be	O
considered	O
to	O
establish	O
comparable	O
patient	O
groups	O
.	O

Finally	O
,	O
there	O
are	O
a	O
growing	O
number	O
of	O
arguments	O
favouring	O
the	O
use	O
of	O
ACE	B
inhibitors	O
very	O
early	O
in	O
patients	O
with	O
diabetes	O
mellitus	O
.	O

Phase	O
II	O
trial	O
of	O
the	O
anti	B
-	I
G	I
(	I
D2	I
)	I
monoclonal	I
antibody	I
3F8	I
and	O
granulocyte	B
-	I
macrophage	I
colony	I
-	I
stimulating	I
factor	I
for	O
neuroblastoma	O
.	O

Eliminating	O
any	O
subset	O
of	O
ASCUS	O
reduces	O
the	O
ASCUS	O
/	O
SIL	O
ratio	O
but	O
also	O
significantly	O
diminishes	O
the	O
sensitivity	O
of	O
the	O
Papanicolaou	O
test	O
.	O

Eliminating	O
any	O
subset	O
of	O
ASCUS	O
reduces	O
the	O
ASCUS	O
/	O
SIL	O
ratio	O
but	O
also	O
significantly	O
diminishes	O
the	O
sensitivity	O
of	O
the	O
Papanicolaou	O
test	O
.	O

Two	O
nuclear	O
medicine	O
physicians	O
blinded	O
to	O
the	O
surgical	O
findings	O
interpreted	O
all	O
available	O
images	O
and	O
various	O
Tc-99	O
m	O
MIBI	O
image	O
combinations	O
at	O
15	O
minutes	O
alone	O
;	O
15	O
minutes	O
and	O
2	O
hours	O
,	O
15	O
minutes	O
and	O
4	O
hours	O
;	O
and	O
15	O
minutes	O
and	O
2	O
and	O
4	O
hours	O
each	O
with	O
and	O
without	O
correlative	O
pertechnetate	O
thyroid	O
imaging	O
.	O

Is	O
clopidogrel	O
superior	O
to	O
aspirin	O
in	O
secondary	O
prevention	O
of	O
vascular	O
disease	O
?	O

The	O
cornerstone	O
in	O
clinical	O
evidence	O
of	O
the	O
relative	O
efficacy	O
of	O
thienopyridines	O
(	O
clopidogrel	O
,	O
ticlopidine	O
)	O
versus	O
aspirin	O
in	O
the	O
secondary	O
prevention	O
of	O
vascular	O
disease	O
is	O
the	O
Clopidogrel	O
versus	O
Aspirin	O
in	O
Patients	O
at	O
Risk	O
of	O
Ischaemic	O
Events	O
trial	O
.	O

We	O
hypothesize	O
that	O
proprioception	O
may	O
be	O
used	O
to	O
calibrate	O
the	O
efference	O
copy	O
during	O
development	O
and	O
in	O
response	O
to	O
perturbations	O
by	O
signaling	O
potential	O
mismatches	O
between	O
eye	O
movement	O
information	O
derived	O
from	O
the	O
efferent	O
command	O
and	O
the	O
actual	O
motion	O
of	O
the	O
eye	O
transduced	O
by	O
the	O
proprioceptive	O
organs	O
.	O

Between	O
1967	O
and	O
1994	O
,	O
495	O
patients	O
underwent	O
surgery	O
for	O
primary	O
PTC	O
at	O
the	O
Department	O
of	O
Surgery	O
,	O
Helsinki	O
University	O
Central	O
Hospital	O
.	O

ISS	O
and	O
the	O
acute	O
physiology	O
and	O
chronic	O
health	O
evaluation	O
(	O
APACHE	O
II	O
)	O
calculated	O
on	O
admission	O
.	O

The	O
procedure	O
is	O
less	O
aggressive	O
and	O
painful	O
than	O
sternotomy	O
.	O

Regarding	O
gestational	O
risk	O
,	O
3,243	O
drugs	O
used	O
(	O
34	O
%	O
)	O
belonged	O
to	O
category	O
A	O
risk	O
,	O
1,923	O
(	O
22.6	O
%	O
)	O
to	O
category	O
B	O
,	O
3,798	O
(	O
39.7	O
%	O
)	O
to	O
category	O
C	O
,	O
289	O
(	O
3.0	O
%	O
)	O
to	O
category	O
D	O
,	O
and	O
55	O
(	O
0.6	O
%	O
)	O
to	O
category	O
X.	O

The	O
severity	O
of	O
clinical	O
course	O
was	O
expressed	O
by	O
means	O
of	O
SOFA	O
score	O
(	O
group	O
A	O
0.3	O
-	O
1	O
-	O
1.3	O
point	O
,	O
group	O
B	O
2.2	O
-	O
2.9	O
-	O
2.6	O
point	O
,	O
group	O
C	O
7.4	O
-	O
8.3	O
-	O
7.7	O
point	O
)	O
and	O
APACHE	O
II	O
score	O
(	O
group	O
A	O
3.7	O
-	O
7.6	O
-	O
8.1	O
point	O
,	O
group	O
B	O
8.6	O
-	O
11.1	O
-	O
10.5	O
point	O
,	O
group	O
C	O
16.3	O
-	O
15.2	O
-	O
14.3	O
point	O
)	O
.	O

The	O
process	O
has	O
been	O
applied	O
to	O
the	O
river	O
reclamation	O
in	O
Yangpu	O
District	O
of	O
Shanghai	O
City	O
,	O
China	O
.	O

Physical	O
principles	O
in	O
therapeutic	O
apheresis	O
.	O

These	O
results	O
were	O
compared	O
with	O
the	O
estimates	O
of	O
penetration	O
from	O
steady	O
-	O
state	O
calculations	O
,	O
square	O
root	O
of	O
time	O
calculations	O
,	O
and	O
a	O
biologically	O
based	O
mathematical	O
model	O
.	O

Rind	O
et	O
al.	O
's	O
study	O
's	O
main	O
conclusions	O
were	O
not	O
supported	O
by	O
the	O
original	O
data	O
.	O

Of	O
major	O
concern	O
to	O
food	O
processors	O
is	O
the	O
inadvertent	O
cross	O
-	O
contact	O
of	O
food	O
products	O
with	O
allergenic	O
residues	O
,	O
which	O
could	O
result	O
in	O
potentially	O
life	O
-	O
threatening	O
reactions	O
in	O
those	O
with	O
a	O
food	O
allergy	O
.	O

Lactate	O
accumulation	O
peak	O
was	O
unaffected	O
by	O
supplementation	O
(	O
HMB	O
,	O
8.1	O
+	O
/-	O

1.1	O
mM	O
;	O
LEU	O
,	O
6.2	O
+	O
/-	O

0.8	O
mM	O
;	O
CON	O
,	O
7.5	O
+	O
/-	O

1.3	O
mM	O
)	O
.	O

The	O
increased	O
clearance	O
observed	O
in	O
young	O
infants	O
is	O
in	O
contrast	O
to	O
other	O
opioids	O
.	O

These	O
results	O
were	O
robust	O
to	O
changes	O
in	O
the	O
baseline	O
assumptions	O
of	O
the	O
model	O
.	O

CONCLUSION	O
:	O
The	O
training	O
of	O
novices	O
using	O
MIST	O
-	O
VR	O
yields	O
quantifiable	O
changes	O
in	O
skill	O
that	O
are	O
transferable	O
to	O
a	O
simple	O
real	O
task	O
and	O
are	O
similar	O
to	O
the	O
results	O
achieved	O
with	O
conventional	O
training	O
.	O

The	O
patients	O
and	O
their	O
families	O
were	O
closely	O
questioned	O
,	O
and	O
full	O
clinical	O
examination	O
included	O
a	O
test	O
for	O
orthostasia	O
.	O

They	O
have	O
not	O
been	O
previously	O
reported	O
as	O
a	O
reaction	O
to	O
i.v	O
.	O

contrast	O
material	O
.	O

There	O
was	O
a	O
statistically	O
significant	O
correlation	O
between	O
simultaneous	O
weekly	O
average	O
pollen	O
levels	O
in	O
Philadelphia	O
and	O
in	O
Cherry	O
Hill	O
(	O
Acer	O
,	O
r	O
(	O
p	O
)	O
=	O
0.987	O
,	O
Quercus	O
,	O
r	O
(	O
p	O
)	O
=	O
0.645	O
,	O
Betula	O
,	O
r	O
(	O
p	O
)	O
=	O
0.896	O
,	O
Pinus	O
,	O
r	O
(	O
p	O
)	O
=	O
0.732	O
,	O
Cupressaceae	O
,	O
r	O
(	O
p	O
)	O
=	O
0.695	O
,	O
Poaceae	O
,	O
r	O
(	O
p	O
)	O
=	O
0.950	O
,	O
Ambrosia	O
,	O
r	O
(	O
p	O
)	O
=	O
0.903	O
,	O
and	O
Rumex	O
,	O
r	O
(	O
p	O
)	O
=	O
0.572	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Encouraged	O
by	O
a	O
Dutch	O
study	O
using	O
etidronate	O
/	O
fluoride	O
in	O
corticoid	O
-	O
induced	O
osteoporosis	O
,	O
we	O
performed	O
a	O
pilot	O
study	O
in	O
33	O
men	O
with	O
severe	O
established	O
primary	O
osteoporosis	O
giving	O
cyclically	O
etidronate	O
for	O
14	O
days	O
followed	O
by	O
fluoride	O
plus	O
calcium	O
/	O
vitamin	O
D	O
for	O
76	O
days	O
.	O

Treadmill	O
training	O
at	O
least	O
for	O
2	O
weeks	O
can	O
reduce	O
the	O
infarction	O
size	O
and	O
edema	O
caused	O
by	O
MCA	O
occlusion	O
(	O
P<0.01	O
)	O
.	O

In	O
order	O
to	O
overcome	O
the	O
false	O
positive	O
readings	O
that	O
are	O
possible	O
in	O
sphincter	O
manometry	O
,	O
we	O
proposed	O
to	O
use	O
secretin	B
stimulated	O
endoscopic	O
ultrasound	O
(	O
SSEUS	O
)	O
to	O
measure	O
pancreatic	O
ductal	O
response	O
as	O
an	O
adjunctive	O
method	O
to	O
aid	O
and	O
supplement	O
the	O
diagnosis	O
.	O

The	O
cut	O
-	O
off	O
percentage	O
positivity	O
value	O
was	O
established	O
using	O
500	O
brucellosis	O
-	O
positive	O
and	O
500	O
brucellosis	O
-	O
negative	O
serum	O
samples	O
,	O
confirmed	O
with	O
reference	O
to	O
the	O
sample	O
data	O
using	O
the	O
indirect	O
ELISA	O
kit	O
.	O

An	O
analysis	O
of	O
the	O
dynamics	O
is	O
performed	O
of	O
exactly	O
solvable	O
models	O
for	O
fragile	O
and	O
strong	O
glasses	O
,	O
exploiting	O
the	O
partitioning	O
of	O
the	O
free	O
-	O
energy	O
landscape	O
in	O
inherent	O
structures	O
.	O

Fifty	O
-	O
six	O
semen	O
samples	O
were	O
included	O
in	O
this	O
study	O
;	O
18	O
were	O
subnormal	O
(	O
G1	O
)	O
and	O
38	O
were	O
normal	O
(	O
G2	O
)	O
based	O
on	O
World	O
Health	O
Organization	O
criteria	O
,	O
except	O
for	O
morphology	O
,	O
which	O
was	O
evaluated	O
according	O
to	O
strict	O
criteria	O
.	O

At	O
this	O
timepoint	O
,	O
many	O
leucocytes	O
in	O
the	O
ME	O
and	O
ET	O
mucosa	O
had	O
incorporated	O
BrdU	O
(	O
between	O
15	O
and	O
25	O
%	O
within	O
the	O
subsets	O
)	O
.	O

Modality	O
-	O
specific	O
areas	O
(	O
e.g.	O
,	O
right	O
Wernicke	O
,	O
left	O
fusiform	O
gyrus	O
,	O
Broca	O
BA44	O
,	O
supramarginal	O
gyrus	O
)	O
,	O
appear	O
to	O
cope	O
with	O
the	O
computations	O
relevant	O
to	O
making	O
contact	O
with	O
these	O
more	O
abstract	O
dimensions	O
.	O

We	O
found	O
no	O
correlation	O
between	O
plasma	O
COP	O
and	O
body	O
weight	O
at	O
the	O
same	O
age	O
(	O
r2	O
=	O
0.05	O
,	O
P	O
=	O
0.155	O
)	O
.	O

Their	O
chemical	O
structures	O
were	O
elucidated	O
as	O
1	O
alpha,2	O
alpha	O
-	O
diacetoxy-8	O
beta	O
-	O
isobutanoyloxy-	O
9	O
alpha	O
-	O
benzoyloxy-13-	O
(	O
alpha	O
-	O
methyl	O
)	O
butanoyloxy-4	O
beta	O
,	O
6	O
beta	O
-	O
dihydroxy	O
-	O
beta	O
-	O
dihydroagarofuran	O
(	O
1	O
)	O
,	O
1	O
alpha,2	O
alpha	O
-	O
diacetoxy-8	O
beta-	O
(	O
beta-	O
furancarbonyloxy	O
)	O
-9	O
alpha	O
-	O
benzoyloxy-13-isobutanoyloxy-4	O
beta	O
,	O
6	O
beta	O
-	O
dihydroxy	O
-	O
beta	O
-	O
dihydroagarofuran	O
(	O
2	O
)	O
and	O
1	O
alpha	O
,	O
6	O
beta	O
,	O
8	O
alpha,13-tetraacetoxy-9	O
alpha	O
-	O
benzoyloxy-2	O
alpha	O
-	O
hydroxy	O
-	O
beta	O
-	O
dihydroagarofuran	O
(	O
3	O
)	O
mainly	O
by	O
analyses	O
NMR	O
and	O
MS	O
spectral	O
data	O
.	O

Both	O
toxins	O
in	O
a	O
dose	O
10-fold	O
surpassing	O
the	O
maximum	O
permissible	O
concentration	O
increased	O
activity	O
of	O
glutathione	B
peroxidase	I
in	O
brain	O
tissue	O
;	O
moreover	O
,	O
toluene	O
increased	O
chemiluminescence	O
intensity	O
,	O
which	O
attested	O
to	O
activation	O
of	O
free	O
radical	O
processes	O
.	O

The	O
performance	O
of	O
pH	O
-	O
sensitive	O
particles	O
is	O
attributed	O
to	O
their	O
ability	O
to	O
release	O
the	O
drug	O
selectively	O
in	O
the	O
upper	O
part	O
of	O
the	O
intestine	O
in	O
a	O
molecular	O
or	O
amorphous	O
form	O
.	O

Comparison	O
of	O
remnant	O
-	O
like	O
lipoprotein	O
particles	O
in	O
postmenopausal	O
women	O
with	O
and	O
without	O
coronary	O
artery	O
disease	O
and	O
in	O
men	O
with	O
coronary	O
artery	O
disease	O
.	O

Because	O
results	O
of	O
recent	O
randomized	O
trials	O
indicate	O
minimal	O
efficacy	O
of	O
continuing	O
MAC	O
prophylaxis	O
in	O
patients	O
who	O
respond	O
to	O
potent	O
combination	O
antiretroviral	O
therapy	O
,	O
the	O
observed	O
high	O
incidence	O
of	O
macrolide	O
-	O
resistant	O
bacterial	O
colonization	O
of	O
the	O
respiratory	O
tract	O
in	O
this	O
trial	O
supports	O
the	O
discontinuation	O
of	O
macrolide	O
prophylaxis	O
in	O
all	O
AIDS	O
patients	O
whose	O
CD4	B
counts	O
have	O
risen	O
above	O
100	O
cells	O
/	O
microL.	O

Acute	O
stress	O
in	O
7	O
rats	O
also	O
increased	O
the	O
mean	O
amount	O
of	O
IL-6	B
released	O
in	O
the	O
urine	O
by	O
31.5	O
%	O
from	O
775.9	O
+	O
/-	O

69.2	O
to	O
1,021.1	O
+	O
/-	O

93.3	O
pg.	O
/	O
ml	O
.	O

Patients	O
with	O
CF	O
and	O
meconium	O
ileus	O
presented	O
a	O
poor	O
nutritional	O
status	O
at	O
diagnosis	O
and	O
a	O
lower	O
survival	O
rate	O
compared	O
to	O
the	O
general	O
CF	O
population	O
.	O

(	O
Cactaceae	O
)	O
waste	O
matter	O
.	O

Skin	O
cancers	O
,	O
followed	O
by	O
gastrointestinal	O
tract	O
and	O
male	O
genital	O
system	O
affected	O
mostly	O
older	O
age	O
patients	O
.	O

CONCLUSION	O
:	O
MMF	O
(	O
2	O
-	O
3	O
g	O
/	O
day	O
)	O
is	O
unable	O
to	O
control	O
the	O
signs	O
of	O
mucocutaneous	O
Adamantiades	O
-	O
Behcet	O
's	O
disease	O
.	O

In	O
the	O
treatment	O
of	O
opioid	O
naive	O
patients	O
who	O
underwent	O
surgery	O
and	O
received	O
opioids	O
for	O
acute	O
pain	O
,	O
oral	O
ADL	O
8	O
-	O
2698	O
(	O
6.0	O
mg	O
)	O
improved	O
the	O
management	O
of	O
postoperative	O
ileus	O
(	O
POI	O
)	O
by	O
shortening	O
the	O
time	O
to	O
achieve	O
normal	O
bowel	O
function	O
and	O
,	O
ultimately	O
,	O
hospital	O
stay	O
.	O

METHODS	O
:	O
302	O
consecutive	O
patients	O
with	O
BS	O
and	O
438	O
patients	O
with	O
other	O
rheumatological	O
conditions	O
were	O
surveyed	O
for	O
the	O
presence	O
or	O
absence	O
of	O
the	O
features	O
of	O
BS	O
by	O
means	O
of	O
a	O
standard	O
form	O
which	O
had	O
been	O
prepared	O
according	O
to	O
ISG	O
criteria	O
.	O

Evidence	O
suggests	O
that	O
PHACES	O
syndrome	O
is	O
not	O
a	O
random	O
association	O
but	O
a	O
true	O
phakomatosis	O
;	O
further	O
studies	O
are	O
awaited	O
to	O
shed	O
light	O
on	O
a	O
possible	O
genetic	O
background	O
.	O

A	O
computer	O
program	O
,	O
ACCESS	O
-	O
IAQ	O
,	O
is	O
developed	O
to	O
simulate	O
the	O
airflow	O
pattern	O
,	O
the	O
time	O
history	O
of	O
the	O
contaminant	O
concentrations	O
in	O
the	O
occupied	O
zone	O
,	O
and	O
the	O
inhalation	O
exposures	O
.	O

Moreover	O
,	O
a	O
severe	O
decrease	O
of	O
antithrombin	B
activity	O
became	O
evident	O
during	O
both	O
experiments	O
(	O
eg	O
,	O
in	O
experiment	O
2	O
from	O
95.6	O
+	O
/-	O

4.8	O
to	O
59.2	O
+	O
/-	O

6.6	O
%	O
)	O
.	O

Classification	O
according	O
to	O
the	O
ILAR	O
criteria	O
was	O
possible	O
in	O
321	O
patients	O
;	O
290	O
patients	O
had	O
a	O
disease	O
duration	O
>	O
or	O
=	O
3	O
months	O
and	O
were	O
classified	O
according	O
to	O
the	O
EULAR	O
criteria	O
.	O

Described	O
X	O
-	O
ray	O
projection	O
were	O
performed	O
in	O
70	O
patients	O
.	O

We	O
conducted	O
a	O
clinical	O
and	O
pathologic	O
review	O
of	O
nine	O
patients	O
with	O
immature	O
ovarian	O
teratoma	O
.	O

Pyrethroid	O
insecticides	O
are	O
widely	O
used	O
in	O
agriculture	O
and	O
private	O
households	O
.	O

The	O
sorption	O
mechanisms	O
changed	O
from	O
adsorption	O
to	O
partition	O
in	O
the	O
process	O
of	O
repetitious	O
sorption	O
.	O

Although	O
the	O
spatial	O
and	O
temporal	O
variability	O
of	O
LDF	O
signals	O
evoked	O
by	O
cerebrocortical	O
microflow	O
is	O
in	O
the	O
same	O
range	O
as	O
with	O
other	O
methods	O
and	O
in	O
other	O
organs	O
,	O
LDF	O
cerebrocortical	O
mapping	O
is	O
restricted	O
by	O
the	O
large	O
temporal	O
and	O
spatial	O
heterogeneity	O
of	O
the	O
cerebrocortical	O
vasculature	O
.	O

The	O
5-year	O
overall	O
survival	O
(	O
OS	O
)	O
and	O
progression	O
-	O
free	O
survival	O
(	O
PFS	O
)	O
rates	O
were	O
58.9	O
%	O
and	O
55.4	O
%	O
for	O
arm	O
A	O
and	O
44.5	O
%	O
and	O
41.3	O
%	O
for	O
arm	O
B	O
(	O
P	O
=	O
.007	O
and	O
P	O
=	O
.02	O
)	O
,	O
respectively	O
.	O

Traditional	O
surgical	O
exploration	O
was	O
followed	O
by	O
survey	O
with	O
a	O
gamma	O
-	O
detecting	O
probe	O
.	O

No	O
effect	O
of	O
the	O
intervention	O
on	O
depression	O
scores	O
was	O
found	O
.	O

IV	O
.	O
combined	O
sclerosis	O
and	O
resorption	O
of	O
the	O
skull	O
base	O
(	O
6	O
cases	O
,	O
2	O
group	O
I	O
lesions	O
and	O
4	O
group	O
II	O
lesions	O
)	O
.	O

The	O
quantity	O
of	O
each	O
population	O
(	O
L.	O
bulgaricus	O
,	O
S.	O
thermophilus	O
)	O
was	O
then	O
estimated	O
in	O
the	O
pellet	O
by	O
PyMS	O
,	O
and	O
the	O
data	O
were	O
analysed	O
by	O
artificial	O
neural	O
networks	O
(	O
ANNs	O
)	O
.	O

AF	B
showed	O
a	O
mixed	O
nuclear	O
/	O
cytoplasmic	O
pattern	O
of	O
expression	O
in	O
the	O
epithelial	O
,	O
endothelial	O
,	O
and	O
stromal	O
component	O
of	O
the	O
normal	O
breast	O
and	O
benign	O
lesions	O
,	O
whereas	O
an	O
impressive	O
loss	O
of	O
AF	B
expression	O
was	O
noted	O
in	O
in	O
situ	O
and	O
invasive	O
breast	O
cancer	O
and	O
tumoral	O
stroma	O
.	O

We	O
derive	O
joint	O
probability	O
density	O
distributions	O
for	O
three	O
key	O
uncertain	O
properties	O
of	O
the	O
climate	O
system	O
,	O
using	O
an	O
optimal	O
fingerprinting	O
approach	O
to	O
compare	O
simulations	O
of	O
an	O
intermediate	O
complexity	O
climate	O
model	O
with	O
three	O
distinct	O
diagnostics	O
of	O
recent	O
climate	O
observations	O
.	O

Frequency	O
of	O
seeing	O
curves	O
were	O
examined	O
for	O
the	O
method	O
most	O
similar	O
to	O
FDT	O
.	O

Chronic	O
graft	O
-	O
versus	O
-	O
host	O
disease	O
(	O
cGVHD	O
)	O
is	O
a	O
major	O
complication	O
of	O
allogeneic	O
hematopoietic	O
cell	O
transplantation	O
.	O

Compared	O
to	O
white	O
-	O
on	O
-	O
white	O
(	O
W	O
-	O
W	O
)	O
perimetry	O
,	O
SWAP	O
is	O
limited	O
clinically	O
by	O
:	O
greater	O
variability	O
associated	O
with	O
the	O
estimation	O
of	O
threshold	O
,	O
ocular	O
media	O
absorption	O
,	O
increased	O
examination	O
duration	O
and	O
an	O
additional	O
learning	O
effect	O
.	O

Preservatives	O
are	O
an	O
important	O
component	O
of	O
ophthalmic	O
preparations	O
,	O
providing	O
antimicrobial	O
activity	O
in	O
the	O
bottle	O
and	O
preventing	O
decomposition	O
of	O
active	O
drug	O
.	O

Comparative	O
analysis	O
of	O
various	O
techniques	O
of	O
prostatic	O
drainage	O
in	O
patients	O
with	O
chronic	O
obstructive	O
prostatitis	O
]	O

The	O
efficacy	O
of	O
prostatic	O
drainage	O
using	O
transurethral	O
vacuum	O
aspiration	O
(	O
Introl-4	O
unit	O
)	O
and	O
transrectal	O
pneumovibromassage	O
(	O
PVM	O
-	O
R-01	O
)	O
was	O
compared	O
in	O
1511	O
patients	O
with	O
chronic	O
obstructive	O
prostatitis	O
.	O

The	O
results	O
are	O
discussed	O
in	O
relation	O
to	O
acoustical	O
models	O
of	O
sound	O
propagation	O
and	O
physiology	O
,	O
and	O
it	O
is	O
suggested	O
that	O
height	O
-	O
dependent	O
degradation	O
within	O
a	O
forest	O
is	O
an	O
important	O
selection	O
pressure	O
for	O
transmissibility	O
in	O
avian	O
communication	O
.	O

Consumption	O
of	O
4	O
%	O
sucrose	O
was	O
not	O
affected	O
by	O
excitotoxic	O
lesions	O
of	O
the	O
PPTg	O
,	O
but	O
PPTg	O
lesioned	O
rats	O
consumed	O
significantly	O
more	O
12	O
%	O
and	O
20	O
%	O
sucrose	O
than	O
sham	O
controls	O
.	O

Mental	O
development	O
is	O
generally	O
normal	O
.	O

In	O
sterilized	O
milk	O
there	O
was	O
a	O
slight	O
decrease	O
of	O
linoleic	O
acid	O
(	O
C18:2n6	O
;	O
-0.7	O
%	O
vs.	O
fresh	O
;	O
P	O
=	O
0.006	O
)	O
and	O
arachidonic	O
acid	O
(	O
C20:4n6	O
;	O
-2.5	O
%	O
;	O
P	O
=	O
0.045	O
)	O
.	O

Vitrectomy	O
and	O
removal	O
of	O
retained	O
lens	O
fragments	O
restores	O
good	O
visual	O
acuity	O
and	O
reduces	O
secondary	O
glaucoma	O
in	O
the	O
majority	O
of	O
patients	O
.	O

Proteomic	O
patterns	O
of	O
nipple	O
aspirate	O
fluids	O
obtained	O
by	O
SELDI	O
-	O
TOF	O
:	O
potential	O
for	O
new	O
biomarkers	O
to	O
aid	O
in	O
the	O
diagnosis	O
of	O
breast	O
cancer	O
.	O

According	O
to	O
the	O
laboratory	O
results	O
,	O
the	O
application	O
of	O
neural	O
network	O
can	O
solve	O
the	O
problem	O
successfully	O
.	O

A	O
high	O
-	O
efficiency	O
cross	O
-	O
flow	O
micronebulizer	O
interface	O
for	O
capillary	O
electrophoresis	O
and	O
inductively	O
coupled	O
plasma	O
mass	O
spectrometry	O
.	O

The	O
electrodes	O
themselves	O
do	O
not	O
need	O
to	O
be	O
polished	O
prior	O
to	O
their	O
use	O
but	O
are	O
observed	O
to	O
be	O
slightly	O
recessed	O
from	O
the	O
surrounding	O
insulating	O
surface	O
.	O

The	O
experimental	O
results	O
showed	O
that	O
the	O
coagulation	O
-	O
electrooxidation	O
process	O
could	O
efficiently	O
remove	O
the	O
color	O
and	O
the	O
COD	O
from	O
the	O
simulated	O
dye	O
wastewater	O
.	O

Cyclic	O
loading	O
of	O
bone	O
during	O
normal	O
daily	O
activity	O
leads	O
to	O
the	O
formation	O
of	O
microcracks	O
within	O
the	O
tissue	O
matrix	O
of	O
compact	O
bone	O
.	O

The	O
weight	O
-	O
bearing	O
surface	O
of	O
the	O
PE	O
head	O
became	O
smoother	O
with	O
time	O
after	O
THA	O
,	O
and	O
the	O
friction	O
coefficient	O
did	O
not	O
differ	O
significantly	O
from	O
that	O
of	O
an	O
unused	O
PE	O
head	O
.	O

OBJECTIVE	O
:	O
To	O
demonstrate	O
a	O
lack	O
of	O
effect	O
of	O
steady	O
-	O
state	O
concentrations	O
of	O
cilomilast	O
,	O
a	O
new	O
oral	O
phosphodiesterase	B
4	I
inhibitor	O
for	O
the	O
treatment	O
of	O
chronic	O
obstructive	O
pulmonary	O
disease	O
,	O
on	O
warfarin	O
-	O
induced	O
anticoagulation	O
.	O

The	O
design	O
principle	O
based	O
on	O
a	O
uniform	O
vibration	O
mode	O
is	O
presented	O
.	O

Because	O
the	O
DPPD	B
gene	I
is	O
not	O
present	O
in	O
non	O
-	O
tuberculous	O
bacilli	O
,	O
these	O
results	O
suggest	O
that	O
this	O
molecule	O
can	O
be	O
an	O
additional	O
tool	O
for	O
a	O
more	O
specific	O
diagnosis	O
of	O
tuberculosis	O
.	O

Dynamic	O
imaging	O
of	O
nuclear	O
wave	O
functions	O
with	O
ultrashort	O
UV	O
laser	O
pulses	O
.	O

The	O
General	O
Practice	O
Research	O
Database	O
(	O
GPRD	O
)	O
is	O
the	O
world	O
's	O
largest	O
computerized	O
database	O
of	O
anonymized	O
longitudinal	O
patient	O
records	O
from	O
general	O
practice	O
and	O
is	O
a	O
unique	O
public	O
health	O
research	O
tool	O
.	O

This	O
paper	O
reports	O
the	O
results	O
of	O
a	O
laboratory	O
study	O
on	O
aldicarb	O
and	O
its	O
main	O
metabolites	O
,	O
aldicarb	O
sulfone	O
and	O
aldicarb	O
sulfoxide	O
.	O

Only	O
one	O
DC	O
cardioversion	O
was	O
required	O
in	O
the	O
HBS	O
group	O
,	O
whereas	O
2	O
DC	O
in	O
the	O
CBC	O
group	O
and	O
total	O
7	O
DC	O
in	O
the	O
GIK	O
group	O
.	O

Since	O
August	O
1994	O
,	O
the	O
ENRP	O
has	O
retained	O
70.3	O
metric	O
tons	O
of	O
TP	O
that	O
otherwise	O
would	O
have	O
entered	O
the	O
Everglades	O
.	O

It	O
was	O
found	O
that	O
the	O
disappearance	O
of	O
BOD5	O
and	O
NH3-N	O
could	O
be	O
approximated	O
using	O
first	O
-	O
order	O
kinetics	O
,	O
but	O
the	O
kinetics	O
of	O
TP	O
removal	O
were	O
unclear	O
.	O

It	O
was	O
found	O
that	O
the	O
disappearance	O
of	O
BOD5	O
and	O
NH3-N	O
could	O
be	O
approximated	O
using	O
first	O
-	O
order	O
kinetics	O
,	O
but	O
the	O
kinetics	O
of	O
TP	O
removal	O
were	O
unclear	O
.	O

Losses	O
of	O
dichlofluanid	O
(	O
54	O
%	O
)	O
,	O
chlozolinate	O
(	O
22	O
%	O
)	O
,	O
and	O
etridiazole	O
(	O
40	O
%	O
)	O
,	O
previously	O
reported	O
to	O
occur	O
during	O
ambient	O
processing	O
of	O
apples	O
,	O
were	O
reduced	O
to	O
barely	O
significant	O
levels	O
(	O
10	O
,	O
17	O
,	O
and	O
14	O
%	O
,	O
respectively	O
)	O
by	O
cryogenic	O
processing	O
.	O

The	O
TB	O
incidence	O
in	O
the	O
""""	O
AIRIN	O
""""	O
area	O
,	O
where	O
about	O
20	O
%	O
TB	O
patients	O
are	O
homeless	O
,	O
shows	O
highest	O
rate	O
of	O
above	O
1,000	O
/	O
100,000	O
.	O

It	O
is	O
shown	O
that	O
the	O
displacement	O
distribution	O
measured	O
by	O
q	O
-	O
space	O
MRI	O
in	O
both	O
the	O
large	O
displacement	O
(	O
i.e.	O
,	O
large	O
r	O
)	O
and	O
the	O
long	O
-	O
wavelength	O
(	O
i.e.	O
,	O
small	O
q	O
)	O
limits	O
is	O
the	O
same	O
3D	O
Gaussian	O
displacement	O
distribution	O
assumed	O
in	O
DT	O
-	O
MRI	O
.	O

The	O
procedure	O
facilitated	O
the	O
retention	O
of	O
a	O
mandibular	O
molar	O
with	O
a	O
Class	O
III	O
FI	O
in	O
a	O
manner	O
acceptable	O
to	O
both	O
the	O
patient	O
and	O
the	O
clinician	O
.	O

The	O
results	O
of	O
our	O
ten	O
-	O
fold	O
cross	O
-	O
validation	O
experiments	O
show	O
that	O
,	O
on	O
the	O
average	O
,	O
the	O
system	O
increases	O
the	O
specificity	O
from	O
0.19	O
(	O
0.35	O
)	O
to	O
0.69	O
(	O
0.74	O
)	O
at	O
a	O
sensitivity	O
level	O
of	O
1.0	O
(	O
0.95	O
)	O
.	O

The	O
physical	O
characteristics	O
of	O
these	O
calls	O
vary	O
among	O
species	O
of	O
bat	O
,	O
and	O
variations	O
also	O
exist	O
in	O
the	O
timing	O
and	O
patterns	O
of	O
respiratory	O
muscle	O
recruitment	O
during	O
echolocation	O
.	O

Clicking	O
on	O
""""	O
Examples	O
and	O
Explanations	O
of	O
APA	O
Form	O
""""	O
provides	O
a	O
help	O
system	O
with	O
examples	O
of	O
the	O
various	O
sections	O
of	O
a	O
review	O
article	O
,	O
journal	O
article	O
that	O
has	O
one	O
experiment	O
,	O
or	O
journal	O
article	O
that	O
has	O
two	O
or	O
more	O
experiments	O
.	O

The	O
drug	O
packets	O
contained	O
acetyl	O
aspirin	O
,	O
acetaminophen	O
and	O
chloramphenicol	O
.	O

Karger	O
AG	O
,	O
Basel	O

AIM	O
:	O
To	O
understand	O
the	O
role	O
of	O
nutritional	O
status	O
in	O
cirrhotic	O
patients	O
without	O
clinical	O
porto	O
-	O
systemic	O
encephalopathy	O
(	O
PSE	O
)	O
.METHODS	O
:	O
Fifty	O
-	O
one	O
non	O
-	O
alcoholic	O
patients	O
with	O
cirrhosis	O
without	O
PSE	O
were	O
studied	O
prospectively	O
and	O
compared	O
with	O
20	O
healthy	O
volunteers	O
.	O

For	O
instance	O
,	O
a	O
total	O
SIP	O
score	O
of	O
an	O
individual	O
patient	O
of	O
28.3	O
%	O
(	O
which	O
is	O
taken	O
as	O
an	O
example	O
,	O
being	O
the	O
mean	O
score	O
in	O
the	O
study	O
population	O
)	O
should	O
decrease	O
by	O
at	O
least	O
9.26	O
%	O
or	O
approximately	O
13	O
items	O
,	O
before	O
any	O
improvement	O
beyond	O
reproducibility	O
noise	O
can	O
be	O
detected	O
.	O

Group	O
I	O
comprised	O
5	O
adult	O
Collies	O
that	O
received	O
at	O
least	O
400	O
microg	O
/	O
kg	O
ivermectin	O
p.o	O
.	O
and	O
were	O
presented	O
to	O
the	O
VMTH	O
3	O
hours	O
after	O
intoxication	O
.	O

Patients	O
with	O
a	O
secondary	O
cardiac	O
event	O
had	O
more	O
common	O
Type	O
A	O
behavior	O
patterns	O
and	O
higher	O
Bortner	O
scores	O
than	O
patients	O
without	O
a	O
secondary	O
cardiac	O
event	O
.	O

Interestingly	O
,	O
continuation	O
of	O
the	O
interferon	B
therapy	O
in	O
the	O
presence	O
of	O
a	O
mild	O
-	O
to	O
-	O
moderate	O
exacerbation	O
of	O
sarcoidosis	O
may	O
be	O
safe	O
in	O
a	O
minority	O
of	O
patients	O
with	O
noncritical	O
organ	O
involvement	O
.	O

No	O
increased	O
tumor	O
-	O
related	O
mortality	O
was	O
observed	O
after	O
a	O
mean	O
follow	O
-	O
up	O
of	O
44	O
months	O
.	O

Dissociable	O
effects	O
of	O
lidocaine	O
inactivation	O
of	O
the	O
rostral	O
and	O
caudal	O
basolateral	O
amygdala	O
on	O
the	O
maintenance	O
and	O
reinstatement	O
of	O
cocaine	O
-	O
seeking	O
behavior	O
in	O
rats	O
.	O

The	O
population	O
studied	O
comprised	O
4472	O
men	O
and	O
5212	O
women	O
aged	O
30	O
-	O
74	O
years	O
,	O
without	O
coronary	O
heart	O
disease	O
,	O
who	O
had	O
CRP	B
measurements	O
in	O
the	O
Third	O
National	O
Health	O
and	O
Nutrition	O
Examination	O
Survey	O
(	O
NHANES	O
III	O
)	O
.	O

Herceptin	O
,	O
which	O
recognizes	O
the	O
HER-2	B
/	O
neu	B
antigen	O
and	O
has	O
similar	O
size	O
(	O
10	O
nm	O
)	O
to	O
G6-	O
(	O
1B4M	O
-	O
Gd	O
)	O
(	O
256	O
)	O
,	O
accumulated	O
and	O
internalized	O
in	O
the	O
WIBC-9	O
tumors	O
more	O
quickly	O
than	O
in	O
the	O
control	O
MC-5	O
tumors	O
that	O
progress	O
with	O
normal	O
angiogenesis	O
.	O

Forty	O
-	O
eight	O
pigs	O
were	O
removed	O
from	O
sows	O
at	O
1	O
d	O
of	O
age	O
and	O
randomly	O
assigned	O
to	O
one	O
of	O
three	O
treatments	O
:	O
1	O
)	O
control	O
with	O
lactose	O
as	O
the	O
carbohydrate	O
source	O
,	O
2	O
)	O
lactose	O
replaced	O
(	O
gram	O
for	O
gram	O
)	O
with	O
CSS	O
(	O
dextrose	O
equivalent	O
[	O
DE	O
]	O
-20	O
)	O
,	O
and	O
3	O
)	O
lactose	O
replaced	O
with	O
DE-42	O
.	O

CONCLUSIONS	O
:	O
AMVT	O
is	O
rare	O
but	O
a	O
potentially	O
lethal	O
emergency	O
disease	O
.	O

There	O
was	O
no	O
difference	O
in	O
apnea	O
duration	O
between	O
the	O
supine	O
and	O
prone	O
positions	O
.	O

Therefore	O
,	O
in	O
a	O
large	O
animal	O
model	O
of	O
permanent	O
focal	O
ischemia	O
in	O
which	O
transfusion	O
starts	O
30	O
min	O
after	O
ischemia	O
,	O
tetrameric	O
cross	O
-	O
linked	O
hemoglobin	B
transfusion	O
can	O
augment	O
oxygen	O
transport	O
to	O
the	O
ischemic	O
cortex	O
,	O
but	O
the	O
increase	O
can	O
be	O
delayed	O
and	O
not	O
necessarily	O
provide	O
protection	O
.	O

Since	O
the	O
early	O
1980s	O
there	O
has	O
been	O
increasing	O
awareness	O
of	O
the	O
importance	O
of	O
quantifying	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
HRQL	O
)	O
in	O
patients	O
with	O
chronic	O
respiratory	O
disorders	O
included	O
in	O
clinical	O
trials	O
.	O

They	O
were	O
randomly	O
allocated	O
to	O
receive	O
either	O
625	O
mg	O
of	O
calcium	O
carbonate	O
(	O
250	O
mg	O
of	O
elemental	O
calcium	O
)	O
at	O
the	O
end	O
of	O
a	O
meal	O
three	O
times	O
a	O
day	O
(	O
group	O
A	O
,	O
n=26	O
)	O
or	O
calcium	O
carbonate	O
in	O
the	O
same	O
manner	O
plus	O
0.625	O
mg	O
/	O
day	O
of	O
conjugated	O
equine	O
estrogen	O
and	O
5	O
mg	O
medrogestone	O
acetate	O
from	O
day	O
1	O
-	O
12	O
each	O
month	O
(	O
group	O
B	O
,	O
n=30	O
)	O
.	O

TNFalpha	B
and	O
IL-6	B
levels	O
were	O
determined	O
in	O
the	O
culture	O
supernatants	O
.	O

Therefore	O
,	O
this	O
study	O
has	O
demonstrated	O
that	O
prenatal	O
disturbance	O
can	O
induce	O
a	O
lasting	O
change	O
in	O
cytokine	O
biology	O
,	O
which	O
persists	O
well	O
beyond	O
the	O
fetal	O
and	O
infant	O
stage	O
.	O

The	O
two	O
-	O
wave	O
,	O
1995	O
-	O
1996	O
National	O
Longitudinal	O
Study	O
of	O
Adolescent	O
Health	O
uses	O
a	O
measure	O
of	O
depressive	O
symptomatology	O
across	O
a	O
12-month	O
interval	O
.	O

METHODS	O
:	O
9	O
cases	O
of	O
conventional	O
intermittent	O
tissue	O
expansion	O
(	O
CITE	O
)	O
and	O
9	O
cases	O
of	O
continuous	O
pressure	O
-	O
controlled	O
tissue	O
expansion	O
(	O
CPTE	O
)	O
were	O
chosen	O
for	O
the	O
study	O
.	O

There	O
was	O
a	O
significant	O
effect	O
of	O
hematocrit	O
on	O
the	O
General	O
Health	O
scale	O
on	O
the	O
SF-36	O
(	O
P	O
=	O
0.03	O
)	O
.	O

Based	O
on	O
analytic	O
precisions	O
,	O
a	O
+	O
/-	O

2	O
%	O
urine	O
-	O
plasma	O
difference	O
was	O
set	O
as	O
the	O
cut	O
-	O
off	O
value	O
.	O

A	O
global	O
response	O
rate	O
was	O
17	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
95	O
%	O
CI	O
)	O
:	O
2%-32	O
%	O
)	O
and	O
the	O
median	O
overall	O
survival	O
was	O
12	O
months	O
.	O

We	O
also	O
studied	O
a	O
new	O
parameter	O
:	O
the	O
angle	O
to	O
maximal	O
peak	O
torque	O
(	O
APT	O
)	O
.	O

For	O
the	O
2.5	O
to	O
4	O
ng	O
/	O
mL	O
model	O
,	O
the	O
AUC	O
of	O
the	O
ANN	O
ROC	O
curve	O
was	O
significantly	O
higher	O
than	O
the	O
AUCs	O
for	O
percentage	O
of	O
free	O
PSA	B
(	O
P	O
=	O
.0239	O
)	O
,	O
PSA	O
-	O
TZ	O
(	O
P	O
=	O
.0204	O
)	O
,	O
and	O
PSA	B
density	O
and	O
total	O
prostate	O
volume	O
(	O
P	O
<	O
.01	O
for	O
both	O
)	O
.	O

Potential	O
treatments	O
include	O
dobutamine	O
,	O
KATP	O
channel	O
activators	O
,	O
and	O
21-aminosteroids	O
.	O

Selenium	O
is	O
an	O
essential	O
element	O
for	O
humans	O
,	O
animals	O
and	O
some	O
species	O
of	O
microorganisms	O
.	O

The	O
GT	O
-	O
foreign	O
-	O
pictures	O
showed	O
that	O
the	O
judgment	O
of	O
other	O
subjects	O
changed	O
toward	O
hedonic	O
and	O
permeability	O
directions	O
.	O

Emphysematous	O
cholecystitis	O
:	O
sonographic	O
findings	O
.	O

We	O
therefore	O
applied	O
a	O
radiolabelled	O
serumalbumin	B
method	O
to	O
determine	O
blood	O
volume	O
after	O
haemodilution	O
with	O
crosslinked	O
or	O
conjugated	O
haemoglobin	B
,	O
in	O
comparison	O
with	O
a	O
reference	O
solution	O
of	O
hydroxyethyl	O
starch	O
(	O
HES	O
)	O
.	O

The	O
equilibrium	O
phosphorus	O
content	O
(	O
EPC0	O
)	O
of	O
surface	O
soil	O
was	O
generally	O
higher	O
than	O
the	O
SRP	O
content	O
of	O
drainage	O
water	O
,	O
at	O
one	O
farm	O
by	O
1	O
order	O
of	O
magnitude	O
.	O

The	O
long	O
-	O
term	O
prediction	O
is	O
based	O
on	O
an	O
algorithm	O
for	O
R	O
-	O
R	O
interval	O
estimation	O
.	O

Despite	O
considerable	O
research	O
,	O
an	O
explanation	O
of	O
this	O
effect	O
has	O
been	O
elusive	O
.	O

The	O
structure	O
has	O
been	O
established	O
by	O
a	O
study	O
of	O
its	O
mono-	O
and	O
bidimensional	O
NMR	O
spectra	O
and	O
mass	O
spectrometry	O
.	O

We	O
argue	O
that	O
this	O
is	O
the	O
general	O
property	O
of	O
QSAR	O
models	O
developed	O
using	O
LOO	O
cross	O
-	O
validation	O
.	O

We	O
compared	O
the	O
efficacy	O
and	O
costs	O
of	O
valacyclovir	O
in	O
preventing	O
HSV	O
reactivation	O
among	O
HSV	O
seropositive	O
autologous	O
progenitor	O
cell	O
transplantation	O
(	O
APCT	O
)	O
patients	O
with	O
historical	O
controls	O
in	O
whom	O
intravenous	O
acyclovir	O
or	O
no	O
HSV	O
prophylaxis	O
were	O
used	O
.	O

All	O
adults	O
attending	O
the	O
outpatient	O
clinics	O
of	O
a	O
dermatological	O
hospital	O
on	O
predetermined	O
days	O
were	O
given	O
the	O
12-item	O
General	O
Health	O
Questionnaire	O
.	O

Data	O
on	O
prosthesis	O
use	O
are	O
encouraging	O
,	O
although	O
a	O
follow	O
-	O
up	O
study	O
is	O
required	O
to	O
determine	O
the	O
functional	O
outcome	O
for	O
prosthesis	O
users	O
and	O
non	O
-	O
users	O
.	O

A	O
mail	O
survey	O
of	O
Georgia	O
members	O
of	O
the	O
American	O
College	O
of	O
Obstetricians	O
and	O
Gynecologists	O
was	O
conducted	O
.	O

HIV-1	O
C	O
subtype	O
in	O
IDUs	O
accounted	O
for	O
61.3	O
%	O
.	O

When	O
a	O
plateau	O
of	O
enhancement	O
was	O
reached	O
,	O
a	O
single	O
lesion	O
in	O
each	O
patient	O
was	O
imaged	O
using	O
five	O
different	O
continuous	O
scanning	O
modes	O
,	O
fundamental	O
grey	O
scale	O
(	O
FGS	O
)	O
;	O
fundamental	O
colour	O
Doppler	O
(	O
FCD	O
)	O
;	O
fundamental	O
power	O
Doppler	O
(	O
FPD	O
)	O
;	O
second	O
harmonic	O
grey	O
scale	O
(	O
HGS	O
)	O
;	O
and	O
pulse	O
inversion	O
mode	O
(	O
Pim	O
)	O
using	O
an	O
HDI5000	O
scanner	O
and	O
C5	O
-	O
2	O
probe	O
(	O
ATL	O
,	O
Bothell	O
,	O
WA	O
)	O
.	O

A	O
comparative	O
study	O
of	O
the	O
effects	O
of	O
carbamazepine	O
and	O
the	O
NMDA	B
receptor	I
antagonist	O
remacemide	O
on	O
road	O
tracking	O
and	O
car	O
-	O
following	O
performance	O
in	O
actual	O
traffic	O
.	O

We	O
find	O
that	O
the	O
measured	O
Nusselt	O
number	O
decreased	O
about	O
20	O
%	O
over	O
the	O
range	O
of	O
Pr	O
spanned	O
in	O
the	O
experiment	O
.	O

Viral	O
and	O
atypical	O
pathogens	O
as	O
causes	O
of	O
type	O
1	O
acute	O
exacerbations	O
of	O
chronic	O
bronchitis	O
.	O

Treatment	O
for	O
this	O
condition	O
often	O
involves	O
use	O
of	O
a	O
wax	O
softening	O
or	O
dispersing	O
agent	O
(	O
cerumenolytic	O
)	O
before	O
syringing	O
.	O

In	O
addition	O
,	O
benzocaine	O
and	O
2-phenoxyethanol	O
depressed	O
complement	O
activity	O
and	O
phagocytosis	O
,	O
while	O
MS222	O
and	O
quinaldine	O
sulphate	O
did	O
not	O
.	O

The	O
EC	O
(	O
50	O
)	O
for	O
suppression	O
of	O
long	O
-	O
term	O
memory	O
(	O
the	O
concentration	O
decreasing	O
memory	O
by	O
50	O
%	O
)	O
of	O
fear	O
conditioning	O
to	O
context	O
was	O
2.00	O
%	O
plus	O
/	O
minus	O
0.01	O
%	O
(	O
mean	O
plus	O
/	O
minus	O
SEM	O
)	O
,	O
and	O
for	O
fear	O
conditioning	O
to	O
tone	O
was	O
3.45	O
%	O
plus	O
/	O
minus	O
0.26	O
%	O
,	O
(	O
P	O
<	O
0.05	O
)	O
.	O

The	O
utility	O
of	O
such	O
analyses	O
in	O
the	O
design	O
of	O
ceramic	O
/	O
substrate	O
bilayer	O
systems	O
for	O
optimal	O
resistance	O
to	O
lifetime	O
-	O
threatening	O
damage	O
is	O
discussed	O
.	O

Dementia	O
is	O
being	O
avoided	O
in	O
NHS	O
and	O
social	O
care	O
.	O

The	O
use	O
of	O
highly	O
active	O
antiretroviral	O
therapy	O
(	O
HAART	O
)	O
has	O
resulted	O
in	O
significant	O
improvements	O
in	O
the	O
treatment	O
of	O
HIV	O
infection	O
,	O
including	O
a	O
decrease	O
in	O
the	O
incidence	O
and	O
severity	O
of	O
several	O
acquired	O
immune	O
deficiency	O
syndrome	O
(	O
AIDS	O
)	O
-related	O
malignancies	O
.	O

Time	O
to	O
progression	O
was	O
6	O
months	O
(	O
5	O
-	O
7	O
months	O
)	O
with	O
a	O
median	O
survival	O
from	O
registration	O
of	O
9.6	O
months	O
(	O
95	O
%	O
CI	O
8	O
-	O
12	O
months	O
)	O
.	O

Heparin	O
(	O
100	O
U	O
.	O
kg	O
(	O
-1	O
)	O
.	O

day	O
(	O
-1	O
)	O
)	O
was	O
injected	O
subcutaneously	O
to	O
the	O
rats	O
in	O
H	O
group	O
while	O
normal	O
saline	O
to	O
those	O
in	O
N	O
group	O
once	O
a	O
day	O
.	O

MAIN	O
OUTCOME	O
MEASURE	O
:	O
A	O
positive	O
test	O
result	O
for	O
gonococcal	O
or	O
chlamydial	O
infection	O
by	O
the	O
ligase	B
chain	O
reaction	O
assay	O
;	O
secondary	O
outcome	O
measure	O
was	O
a	O
positive	O
test	O
result	O
for	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
develop	O
a	O
reliable	O
and	O
culturally	O
meaningful	O
exercise	O
self	O
-	O
efficacy	O
questionnaire	O
for	O
older	O
Mexican	O
American	O
women	O
.	O

Neutrophil	O
:	O
lymphocyte	O
ratio	O
,	O
plasma	O
haptoglobin	B
,	O
and	O
CBG	B
levels	O
were	O
greater	O
(	O
P	O
<	O
0.01	O
)	O
during	O
the	O
INITIAL	O
period	O
than	O
during	O
the	O
PRE	O
or	O
POST	O
periods	O
but	O
did	O
not	O
differ	O
between	O
treatments	O
.	O

Adjacent	O
to	O
those	O
lesions	O
,	O
and	O
in	O
homologous	O
contralateral	O
structures	O
,	O
FMZ	O
binding	O
was	O
analysed	O
in	O
four	O
pairs	O
of	O
cortical	O
9	O
x	O
9-mm	O
regions	O
of	O
interest	O
(	O
ROIs	O
)	O
placed	O
on	O
transaxial	O
and	O
coronal	O
slices	O
,	O
respectively	O
,	O
as	O
well	O
as	O
in	O
the	O
lesion	O
volume	O
and	O
its	O
mirror	O
region	O
.	O

Because	O
a	O
close	O
correlation	O
between	O
regional	O
decreases	O
in	O
FMZ	O
binding	O
and	O
spiking	O
activity	O
was	O
recently	O
demonstrated	O
in	O
neocortical	O
epilepsies	O
,	O
abnormal	O
peri	O
-	O
lesional	O
FMZ	O
binding	O
may	O
bear	O
some	O
relation	O
to	O
the	O
mechanisms	O
of	O
epileptogenesis	O
in	O
symptomatic	O
epilepsies	O
.	O

CD	O
was	O
determined	O
using	O
the	O
Farnsworth	O
D-15	O
method	O
.	O

Here	O
is	O
presented	O
the	O
monitoring	O
of	O
the	O
accidental	O
spill	O
on	O
vertical	O
distribution	O
of	O
heavy	O
metals	O
in	O
the	O
estuarine	O
sediments	O
.	O

The	O
large	O
fluxes	O
of	O
239	O
+	O
240Pu	O
might	O
be	O
attributed	O
to	O
episodic	O
lateral	O
transport	O
of	O
particles	O
that	O
flow	O
down	O
the	O
continental	O
slope	O
with	O
the	O
nepheloid	O
layer	O
which	O
was	O
considered	O
to	O
be	O
significant	O
for	O
239	O
+	O
240Pu	O
transport	O
on	O
the	O
continental	O
slope	O
in	O
the	O
East	O
China	O
Sea	O
.	O

Rigorous	O
treatment	O
protocols	O
for	O
diet	O
delivery	O
and	O
EEN	O
-	O
related	O
GI	O
adverse	O
effects	O
were	O
applied	O
.	O

We	O
found	O
three	O
out	O
of	O
four	O
original	O
(	O
Volkan	O
's	O
)	O
groups	O
of	O
linking	O
objects	O
,	O
but	O
also	O
an	O
additional	O
one	O
,	O
hitherto	O
undescribed	O
,	O
comprising	O
objects	O
used	O
for	O
designing	O
a	O
memorial	O
shrine	O
to	O
the	O
deceased	O
.	O

The	O
range	O
of	O
200	O
000	O
-	O
300	O
000	O
spermatozoa	O
/	O
microl	O
appeared	O
to	O
be	O
a	O
reasonable	O
compromise	O
for	O
both	O
criteria	O
.	O

Gastritis	O
score	O
was	O
significantly	O
lower	O
in	O
nod-	O
/	O
CagA-	B
children	O
than	O
in	O
nod+	O
/	O
CagA-	B
(	O
p	O
=	O
.004	O
)	O
,	O
nod-	O
/	O
CagA+	B
(	O
p	O
=	O
.002	O
)	O
and	O
nod+	O
/	O
CagA+	B
(	O
p	O
<	O
.001	O
)	O
,	O
both	O
in	O
the	O
antrum	O
and	O
corpus	O
.	O

The	O
mean	O
thickness	O
of	O
the	O
visceral	O
peritoneum	O
was	O
comparable	O
in	O
both	O
groups	O
of	O
animals	O
,	O
but	O
,	O
macroscopically	O
,	O
more	O
severe	O
fibrosis	O
was	O
found	O
in	O
the	O
peritoneum	O
of	O
rats	O
exposed	O
to	O
CAPD	O
3	O
as	O
compared	O
with	O
animals	O
treated	O
with	O
CAPD	O
3	O
Balance	O
(	O
p	O
<	O
0.05	O
)	O
.	O

A	O
further	O
analysis	O
has	O
been	O
performed	O
using	O
the	O
series	O
of	O
maximum	O
intensity	O
for	O
fixed	O
duration	O
(	O
1	O
,	O
3	O
,	O
6	O
,	O
12	O
,	O
24	O
hrs	O
)	O
and	O
annual	O
daily	O
maxima	O
.	O

BACKGROUND	O
:	O
We	O
hypothesized	O
that	O
the	O
postoperative	O
serum	O
level	O
of	O
TA90-IC	B
,	O
an	O
immune	O
complex	O
of	O
a	O
90-kDa	O
tumor	O
-	O
associated	O
antigen	O
and	O
its	O
antibody	O
,	O
might	O
have	O
a	O
significant	O
correlation	O
with	O
recurrence	O
and	O
survival	O
in	O
patients	O
with	O
thick	O
primary	O
melanomas	O
.	O

Genetics	O
Institute	O
has	O
developed	O
and	O
launched	O
oprelvekin	B
(	O
rhIL-11	B
;	O
Neumega	O
)	O
,	O
a	O
recombinant	O
form	O
of	O
human	B
IL-11	I
.	O

Patients	O
subsequently	O
returned	O
to	O
the	O
clinic	O
every	O
3	O
days	O
to	O
have	O
the	O
wounds	O
checked	O
and	O
dressings	O
changed	O
.	O

Elements	O
that	O
are	O
fundamental	O
to	O
the	O
safety	O
evaluation	O
of	O
flavor	O
ingredients	O
include	O
exposure	O
,	O
structural	O
analogy	O
,	O
metabolism	O
,	O
pharmacokinetics	O
and	O
toxicology	O
.	O

The	O
mass	O
-	O
specific	O
resting	O
minute	O
ventilation	O
(	O
E	O
)	O
and	O
the	O
ventilatory	O
equivalent	O
(	O
VE	O
/	O
(	O
O	O
(	O
2	O
)	O
)	O
)	O
were	O
approximately	O
the	O
same	O
at	O
the	O
two	O
ages	O
,	O
with	O
a	O
breathing	O
pattern	O
significantly	O
deeper	O
and	O
slower	O
at	O
day	O
1	O
.	O

INTERPRETATION	O
:	O

It	O
is	O
probable	O
that	O
the	O
cognitive	O
dissonance	O
created	O
by	O
more	O
health	O
information	O
on	O
smoking	O
after	O
1964	O
,	O
i.e.	O
the	O
necessary	O
motivation	O
to	O
quit	O
,	O
was	O
reduced	O
as	O
a	O
result	O
of	O
strategic	O
changes	O
in	O
the	O
amount	O
and	O
content	O
of	O
advertising	O
.	O

Nine	O
cases	O
of	O
GBS	O
and	O
five	O
of	O
TM	O
reported	O
to	O
the	O
active	O
AFP	O
surveillance	O
were	O
not	O
found	O
in	O
the	O
hospital	O
searches	O
.	O

The	O
ability	O
of	O
rats	O
with	O
control	O
or	O
hippocampal	O
lesions	O
to	O
learn	O
an	O
object	O
-	O
place	O
,	O
odor	O
-	O
place	O
,	O
or	O
object	O
-	O
odor	O
paired	O
-	O
associate	O
task	O
was	O
assessed	O
in	O
a	O
cheeseboard	O
maze	O
apparatus	O
.	O

The	O
shift	O
in	O
the	O
earliest	O
activation	O
site	O
after	O
administration	O
of	O
esmolol	O
was	O
compared	O
with	O
the	O
shift	O
after	O
RFA	O
.	O

RESULTS	O
:	O
The	O
heart	O
rate	O
at	O
rest	O
and	O
in	O
drug	O
-	O
free	O
state	O
ranged	O
between	O
95	O
and	O
125	O
beats	O
/	O
min	O
(	O
mean	O
99	O
+	O
/-	O

14	O
beats	O
/	O
min	O
)	O
.	O

Urine	O
samples	O
collected	O
after	O
the	O
administration	O
of	O
these	O
supplements	O
can	O
test	O
positive	O
.	O

Data	O
management	O
in	O
practice	O
-	O
based	O
research	O
.	O

We	O
have	O
previously	O
reported	O
reduced	O
levels	O
of	O
choline	B
acetyltransferase	I
activity	O
in	O
the	O
cerebral	O
cortex	O
of	O
patients	O
who	O
died	O
after	O
a	O
head	O
injury	O
,	O
demonstrating	O
that	O
there	O
is	O
a	O
loss	O
of	O
cortical	O
cholinergic	O
innervation	O
.	O

After	O
taking	O
smears	O
from	O
lesions	O
of	O
the	O
oral	O
mucosa	O
(	O
tongue	O
,	O
cheeks	O
,	O
palate	O
)	O
and	O
the	O
contiguous	O
denture	O
surface	O
by	O
cotton	O
wool	O
swabs	O
and	O
inoculating	O
them	O
onto	O
Sabouraud	O
glucose	O
agar	O
and	O
CHROMagar	O
Candida	O
,	O
individual	O
yeast	O
species	O
were	O
identified	O
by	O
a	O
germ	O
tube	O
,	O
filamentous	O
,	O
and	O
assimilation	O
tests	O
employing	O
the	O
commercial	O
kit	O
AuxaColor	O
.	O

The	O
effects	O
of	O
pharmacological	O
treatment	O
and	O
professional	O
care	O
and	O
support	O
may	O
improve	O
when	O
dementia	O
is	O
detected	O
in	O
an	O
early	O
stage	O
.	O

Sexually	O
conditioned	O
incentives	O
:	O
attenuation	O
of	O
motivational	O
impact	O
during	O
dopamine	B
receptor	I
antagonism	O
.	O

PATIENTS	O
AND	O
METHODS	O
:	O
This	O
study	O
is	O
a	O
retrospective	O
cohort	O
study	O
of	O
all	O
children	O
with	O
cancer	O
admitted	O
to	O
a	O
single	O
institution	O
with	O
fever	O
and	O
neutropenia	O
(	O
defined	O
as	O
an	O
absolute	O
neutrophil	O
count	O
<	O
500	O
cells	O
/	O
mm3	O
)	O
in	O
a	O
1-year	O
period	O
.	O

Concentrations	O
of	O
N	O
(	O
O3-	O
)	O
-N	O
and	O
N	O
(	O
H3-	O
)	O
-N	O
at	O
Deoprayag	O
varied	O
from	O
0.30	O
to	O
0.50	O
and	O
0.02	O
to	O
0.12	O
mg	O
/	O
L	O
,	O
respectively	O
,	O
depending	O
on	O
season	O
.	O

Steal	O
is	O
a	O
pathophysiological	O
process	O
in	O
which	O
increased	O
blood	O
flow	O
through	O
a	O
low	O
-	O
resistance	O
vascular	O
bed	O
is	O
sufficient	O
to	O
divert	O
flow	O
away	O
from	O
a	O
region	O
of	O
the	O
central	O
nervous	O
system	O
.	O

The	O
orientations	O
of	O
the	O
contact	O
surfaces	O
and	O
their	O
locations	O
relative	O
to	O
the	O
object	O
's	O
center	O
of	O
mass	O
were	O
varied	O
.	O

The	O
results	O
are	O
given	O
as	O
:	O
flux	O
,	O
number	O
of	O
stars	O
per	O
cm3	O
,	O
charge	O
of	O
the	O
ions	O
,	O
comparison	O
with	O
other	O
detectors	O
(	O
plastics	O
,	O
AgCl	O
crystals	O
,	O
LiF	O
)	O
,	O
energy	O
loss	O
,	O
hit	O
region	O
in	O
the	O
biological	O
objects	O
.	O

Nodal	O
domains	O
are	O
regions	O
where	O
a	O
function	O
has	O
definite	O
sign	O
.	O

DESIGN	O
:	O
Prospective	O
,	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
controlled	O
trial	O
.	O

In	O
patients	O
who	O
respond	O
to	O
quetiapine	O
,	O
therapy	O
should	O
be	O
continued	O
at	O
the	O
optimal	O
dose	O
that	O
maintains	O
remission	O
,	O
within	O
the	O
range	O
of	O
150	O
to	O
750	O
mg	O
/	O
d	O
.	O

Calcimimetic	O
agents	O
directly	O
inhibit	O
PTH	B
secretion	O
by	O
activating	O
the	O
calcium	O
-	O
sensing	O
receptor	O
in	O
the	O
parathyroid	O
glands	O
,	O
but	O
clinical	O
experience	O
with	O
them	O
is	O
limited	O
.	O

With	O
such	O
analysis	O
,	O
one	O
can	O
test	O
hypotheses	O
about	O
the	O
structure	O
of	O
latent	O
variability	O
within	O
a	O
given	O
data	O
set	O
.	O

The	O
subjects	O
were	O
shown	O
to	O
be	O
capable	O
of	O
assessing	O
integrally	O
the	O
value	O
of	O
accelerations	O
and	O
estimating	O
it	O
with	O
an	O
error	O
of	O
0.1	O
-	O
0.12	O
g.	O

The	O
observed	O
incidence	O
rates	O
were	O
compared	O
to	O
expected	O
rates	O
in	O
the	O
general	O
population	O
.	O

The	O
only	O
predictor	O
of	O
response	O
to	O
tacrolimus	O
was	O
a	O
previous	O
response	O
to	O
cyclosporin	O
and	O
prednisone	O
,	O
either	O
as	O
a	O
complete	O
or	O
partial	O
remission	O
(	O
remission	O
rate	O
75	O
%	O
vs	O
15.3	O
;	O
P=0.036	O
)	O
.	O

Based	O
on	O
a	O
morphological	O
study	O
of	O
the	O
resin	O
-	O
dentine	O
interface	O
,	O
a	O
broad	O
selection	O
of	O
dentine	O
adhesive	O
systems	O
was	O
classified	O
following	O
their	O
adhesion	O
-	O
strategy	O
.	O

Copyright	O
2002	O
American	O
Cancer	O
Society	O
.	O

DOI	O
10.1002	O
/	O
cncr.10318	O

In	O
this	O
study	O
we	O
wanted	O
to	O
assess	O
the	O
DR	O
using	O
the	O
'	O
combined	O
test	O
'	O
in	O
an	O
unselected	O
population	O
of	O
self	O
-	O
referred	O
pregnant	O
women	O
at	O
a	O
false	O
-	O
positive	O
rate	O
(	O
FPR	O
)	O
of	O
about	O
5	O
%	O
.	O

As	O
measured	O
by	O
the	O
PDQ-39	O
,	O
STN	O
-	O
DBS	O
significantly	O
improves	O
important	O
aspects	O
of	O
QoL	O
in	O
patients	O
with	O
advanced	O
PD	O
.	O

